PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	James, RG; Bosch, KA; Kulikauskas, RM; Yang, PTT; Robin, NC; Toroni, RA; Biechele, TL; Berndt, JD; von Haller, PD; Eng, JK; Wolf-Yadlin, A; Chien, AJ; Moon, RT				James, Richard G.; Bosch, Katherine A.; Kulikauskas, Rima M.; Yang, Peitzu T.; Robin, Nick C.; Toroni, Rachel A.; Biechele, Travis L.; Berndt, Jason D.; von Haller, Priska D.; Eng, Jimmy K.; Wolf-Yadlin, Alejandro; Chien, Andy J.; Moon, Randall T.			Protein Kinase PKN1 Represses Wnt/beta-Catenin Signaling in Human Melanoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; -Catenin; Melanoma; Phosphorylation; Wnt Signaling; GSK3-; PKN1	C-RELATED KINASE; BETA-CATENIN; GENE-EXPRESSION; SMALL GTPASE; PHOSPHORYLATION; INHIBITION; LRP6; RECEPTOR; ACTIVATION; DOMAIN	Background: Wnt/-catenin signaling inhibits melanoma cell viability. Results: Integration of phosphoproteomics and RNA interference screens querying the Wnt/-catenin pathway reveals protein kinase N1 as an inhibitor of signaling. Conclusion: Protein kinase N1 inhibits Wnt/-catenin signaling and apoptosis in melanoma cells. Significance: This study identifies a kinase that inhibits Wnt/-catenin signaling, a pathway critical to melanoma cell viability. Advances in phosphoproteomics have made it possible to monitor changes in protein phosphorylation that occur at different steps in signal transduction and have aided the identification of new pathway components. In the present study, we applied this technology to advance our understanding of the responses of melanoma cells to signaling initiated by the secreted ligand WNT3A. We started by comparing the phosphopeptide patterns of cells treated with WNT3A for different periods of time. Next, we integrated these data sets with the results from a siRNA screen that targeted protein kinases. This integration of siRNA screening and proteomics enabled us to identify four kinases that exhibit altered phosphorylation in response to WNT3A and that regulate a luciferase reporter of -catenin-responsive transcription (-catenin-activated reporter). We focused on one of these kinases, an atypical PKC kinase, protein kinase N1 (PKN1). Reducing the levels of PKN1 with siRNAs significantly enhances activation of -catenin-activated reporter and increases apoptosis in melanoma cell lines. Using affinity purification followed by mass spectrometry, we then found that PKN1 is present in a protein complex with a WNT3A receptor, Frizzled 7, as well as with proteins that co-purify with Frizzled 7. These data establish that the protein kinase PKN1 inhibits Wnt/-catenin signaling and sensitizes melanoma cells to cell death stimulated by WNT3A.	[James, Richard G.; Bosch, Katherine A.; Kulikauskas, Rima M.; Yang, Peitzu T.; Robin, Nick C.; Toroni, Rachel A.; Biechele, Travis L.; Berndt, Jason D.; Moon, Randall T.] Univ Washington, Dept Pharmacol, Seattle, WA 98109 USA; [von Haller, Priska D.; Eng, Jimmy K.; Wolf-Yadlin, Alejandro] Univ Washington, Dept Genome Sci, Seattle, WA 98109 USA; [James, Richard G.; Bosch, Katherine A.; Yang, Peitzu T.; Robin, Nick C.; Biechele, Travis L.; Berndt, Jason D.; Chien, Andy J.; Moon, Randall T.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA; [Yang, Peitzu T.; Robin, Nick C.; Biechele, Travis L.; Moon, Randall T.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98109 USA; [Kulikauskas, Rima M.; Toroni, Rachel A.; Chien, Andy J.] Univ Washington, Dept Med, Div Dermatol, Seattle, WA 98109 USA; [von Haller, Priska D.; Eng, Jimmy K.; Wolf-Yadlin, Alejandro] Univ Washington, Seattle, WA 98109 USA; [James, Richard G.; Bosch, Katherine A.; Kulikauskas, Rima M.; Yang, Peitzu T.; Robin, Nick C.; Toroni, Rachel A.; Biechele, Travis L.; Berndt, Jason D.; von Haller, Priska D.; Eng, Jimmy K.; Wolf-Yadlin, Alejandro; Chien, Andy J.; Moon, Randall T.] Univ Washington, Sch Med, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	James, RG (corresponding author), Seattle Childrens Res Inst, Ctr Immun & Immunotherapies, Seattle, WA 98115 USA.	rickerj@uw.edu; rtmoon@uw.edu	Moon, Randall T/B-1743-2014; Moon, Randall/M-5605-2019; Eng, Jimmy K/I-4202-2012; Wolf-Yadlin, Alejandro/E-6574-2011	Moon, Randall T/0000-0002-9352-1408; Moon, Randall/0000-0002-9352-1408; Eng, Jimmy K/0000-0001-6352-6737; Wolf-Yadlin, Alejandro/0000-0003-2909-3880; james, richard/0000-0002-2302-7367	National Institutes of Health from the NHLBI [K99/R00 1K99HL103768-01]; NCI [K08CA128565]; NIAMS [T32AR056969]; University of Washington's Proteomics Resource [UWPR 95794]; NATIONAL CANCER INSTITUTE [K08CA128565] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL103768, R00HL103768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR056969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007507] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); University of Washington's Proteomics Resource; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant K99/R00 1K99HL103768-01 from the NHLBI (to R. G. J.), Grant K08CA128565 from the NCI (to A. J. C.), a grant from the NCI (to R. M. K.), and Training Grant T32AR056969 from the NIAMS (to T. L B.). This work was also supported by University of Washington's Proteomics Resource Grant UWPR 95794.	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bachmann IM, 2005, CLIN CANCER RES, V11, P8606, DOI 10.1158/1078-0432.CCR-05-0011; Balendran A, 1999, CURR BIOL, V9, P393, DOI 10.1016/S0960-9822(99)80186-9; Biechele TL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002274; Bilechele Travis L., 2008, V468, P99, DOI 10.1007/978-1-59745-249-6_8; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Carmon KS, 2012, MOL CELL BIOL, V32, P2054, DOI 10.1128/MCB.00272-12; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Collazos A, 2011, BIOCHEM J, V438, P535, DOI 10.1042/BJ20110521; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; Damsky WE, 2011, CANCER CELL, V20, P741, DOI 10.1016/j.ccr.2011.10.030; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Delmas V, 2007, GENE DEV, V21, P2923, DOI 10.1101/gad.450107; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; Gampel A, 1999, CURR BIOL, V9, P955, DOI 10.1016/S0960-9822(99)80422-9; Han DK, 2001, NAT BIOTECHNOL, V19, P946, DOI 10.1038/nbt1001-946; Hilger M, 2012, J PROTEOME RES, V11, P982, DOI 10.1021/pr200740a; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Hoek KS, 2007, PIGM CELL RES, V20, P466, DOI 10.1111/j.1600-0749.2007.00412.x; Huang XD, 2013, SCIENCE, V339, P1441, DOI 10.1126/science.1232253; James R. G., 2012, PLOS ONE, V7; James RG, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000230; Jiang Y, 2012, EMBO J, V31, P2336, DOI 10.1038/emboj.2012.83; Kageshita T, 2001, BRIT J DERMATOL, V145, P210, DOI 10.1046/j.1365-2133.2001.04336.x; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Koh H, 2000, J BIOL CHEM, V275, P34451, DOI 10.1074/jbc.M001753200; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; Lu Y, 1999, GENE DEV, V13, P1168, DOI 10.1101/gad.13.9.1168; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maelandsmo GM, 2003, CLIN CANCER RES, V9, P3383; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Major MB, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.2000037; Mammen AL, 1997, J NEUROSCI, V17, P7351; Manser C, 2008, FEBS LETT, V582, P2303, DOI 10.1016/j.febslet.2008.05.034; Marinissen MT, 2001, GENE DEV, V15, P535, DOI 10.1101/gad.855801; Mellor H, 1998, J BIOL CHEM, V273, P4811, DOI 10.1074/jbc.273.9.4811; Metcalfe C, 2011, J CELL SCI, V124, P3537, DOI 10.1242/jcs.091991; Metzger E, 2003, EMBO J, V22, P270, DOI 10.1093/emboj/cdg023; Meyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038222; Mi KH, 2006, J BIOL CHEM, V281, P4787, DOI 10.1074/jbc.M508657200; Miller BW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.72; Mukai A, 2010, EMBO J, V29, P2114, DOI 10.1038/emboj.2010.100; Mukai H, 2003, J BIOCHEM, V133, P17, DOI 10.1093/jb/mvg019; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Rothberg BEG, 2009, J CLIN ONCOL, V27, P5772, DOI 10.1200/JCO.2009.22.8239; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Sun WY, 2000, J BIOL CHEM, V275, P24421, DOI 10.1074/jbc.M003148200; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Terabayashi T, 2009, J BIOL CHEM, V284, P26716, DOI 10.1074/jbc.M109.039313; Tiedemann RE, 2010, BLOOD, V115, P1594, DOI 10.1182/blood-2009-09-243980; Torbett NE, 2003, J BIOL CHEM, V278, P32344, DOI 10.1074/jbc.M303532200; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Wick MJ, 2000, J BIOL CHEM, V275, P40400, DOI 10.1074/jbc.M003937200; Wu G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004926; Yasui T, 2012, P NATL ACAD SCI USA, V109, P21022, DOI 10.1073/pnas.1218925110; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020	65	28	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34658	34670		10.1074/jbc.M113.500314	http://dx.doi.org/10.1074/jbc.M113.500314			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24114839	Green Published, hybrid			2022-12-25	WOS:000329812800033
J	Giang, AH; Raymond, T; Brookes, P; Bentley, KD; Schwarz, E; O'Keefe, R; Eliseev, R				Giang, An-Hoa; Raymond, Tamara; Brookes, Paul; Bentley, Karen de Mesy; Schwarz, Edward; O'Keefe, Regis; Eliseev, Roman			Mitochondrial Dysfunction and Permeability Transition in Osteosarcoma Cells Showing the Warburg Effect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Glycolysis; Mitochondria; Mitochondrial Permeability Transition; Osteosarcoma; Warburg Effect; Cyclophilin D	CYCLOPHILIN-D; CANCER-CELLS; REPERFUSION INJURY; CYCLING HYPOXIA; APOPTOSIS; PORE; P53; INHIBITION; GLYCOLYSIS; METABOLISM	Background: The Warburg effect in cancer is manifested by increased glycolysis and decreased respiration. Our goal was to determine how mitochondria are suppressed in osteosarcoma (OS). Results: OS cells showing the Warburg effect have markers of the mitochondrial permeability transition (MPT). Conclusion: MPT plays a possible role in suppression of mitochondrial function in OS. Significance: Our data implicate the MPT in metabolic reprogramming in cancer. Metabolic reprogramming in cancer is manifested by persistent aerobic glycolysis and suppression of mitochondrial function and is known as the Warburg effect. The Warburg effect contributes to cancer progression and is considered to be a promising therapeutic target. Understanding the mechanisms used by cancer cells to suppress their mitochondria may lead to development of new approaches to reverse metabolic reprogramming. We have evaluated mitochondrial function and morphology in poorly respiring LM7 and 143B osteosarcoma (OS) cell lines showing the Warburg effect in comparison with actively respiring Saos2 and HOS OS cells and noncancerous osteoblastic hFOB cells. In LM7 and 143B cells, we detected markers of the mitochondrial permeability transition (MPT), such as mitochondrial swelling, depolarization, and membrane permeabilization. In addition, we detected mitochondrial swelling in human OS xenografts in mice and archival human OS specimens using electron microscopy. The MPT inhibitor sanglifehrin A reversed MPT markers and increased respiration in LM7 and 143B cells. Our data suggest that the MPT may play a role in suppression of mitochondrial function, contributing to the Warburg effect in cancer.	[Giang, An-Hoa; Raymond, Tamara; Schwarz, Edward; O'Keefe, Regis; Eliseev, Roman] Univ Rochester, Ctr Musculoskeletal Res, Sch Med & Dent, Rochester, NY 14642 USA; [Brookes, Paul] Univ Rochester, Dept Anesthesiol, Sch Med & Dent, Rochester, NY 14642 USA; [Bentley, Karen de Mesy] Univ Rochester, Dept Pathol, Sch Med & Dent, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Eliseev, R (corresponding author), Univ Rochester, Sch Med & Dent, 575 Elmwood Ave,Rm 1-8541, Rochester, NY 14642 USA.	roman_eliseev@urmc.rochester.edu		Brookes, Paul/0000-0002-8639-8413	National Institutes of Health from the National Center for Research Resources [KL2 RR024136]; NIAMS [R03 AR061515, P30 AR061307]; Center for Musculoskeletal Research, BeatSarcoma; Karen D'Amico Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000095] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR061307, R03AR061515] Funding Source: NIH RePORTER	National Institutes of Health from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Center for Musculoskeletal Research, BeatSarcoma; Karen D'Amico Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant KL2 RR024136 from the National Center for Research Resources and Grants R03 AR061515 and P30 AR061307 from NIAMS. This work was also supported by the Center for Musculoskeletal Research, BeatSarcoma, and the Karen D'Amico Foundation.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Czarnecka AM, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-31; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Eliseev RA, 2005, J CELL BIOCHEM, V96, P1262, DOI 10.1002/jcb.20607; Eliseev RA, 2009, J BIOL CHEM, V284, P9692, DOI 10.1074/jbc.M808750200; Gabriel AM, 2009, INT J BIOCHEM CELL B, V41, P2062, DOI 10.1016/j.biocel.2009.02.002; Gasparre G, 2011, BBA-BIOENERGETICS, V1807, P633, DOI 10.1016/j.bbabio.2010.08.006; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gregory MA, 2011, ANTIMICROB AGENTS CH, V55, P1975, DOI 10.1128/AAC.01627-10; Halestrap AP, 2006, BIOCHEM SOC T, V34, P232, DOI 10.1042/BST0340232; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0; Jia SF, 1999, CLIN EXP METASTAS, V17, P501, DOI 10.1023/A:1006623001465; Kimura H, 1996, CANCER RES, V56, P5522; Lafleur EA, 2004, CLIN CANCER RES, V10, P8114, DOI 10.1158/1078-0432.CCR-04-0353; Lesnefsky EJ, 2003, ARCH BIOCHEM BIOPHYS, V420, P287, DOI 10.1016/j.abb.2003.09.046; Luu HH, 2005, CLIN EXP METASTAS, V22, P319, DOI 10.1007/s10585-005-0365-9; Machida K, 2006, J BIOL CHEM, V281, P14314, DOI 10.1074/jbc.M513297200; Macho A, 1996, CYTOMETRY, V25, P333, DOI 10.1002/(SICI)1097-0320(19961201)25:4<333::AID-CYTO4>3.0.CO;2-E; Maldonado EN, 2013, J BIOL CHEM, V288, P11920, DOI 10.1074/jbc.M112.433847; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Matsumoto S, 2010, CANCER RES, V70, P10019, DOI 10.1158/0008-5472.CAN-10-2821; Metivier D, 1998, IMMUNOL LETT, V61, P157, DOI 10.1016/S0165-2478(98)00013-3; Nieminen AL, 1997, AM J PHYSIOL-CELL PH, V272, pC1286; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P211, DOI 10.1007/s10863-007-9094-x; Petit PX, 1998, FEBS LETT, V426, P111, DOI 10.1016/S0014-5793(98)00318-4; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Rasola A, 2011, CELL CALCIUM, V50, P222, DOI 10.1016/j.ceca.2011.04.007; Rasola A, 2010, FEBS LETT, V584, P1989, DOI 10.1016/j.febslet.2010.02.022; Rostovtseva TK, 2012, BBA-BIOMEMBRANES, V1818, P1526, DOI 10.1016/j.bbamem.2011.11.004; Schubert A, 2004, CANCER RES, V64, P85, DOI 10.1158/0008-5472.CAN-03-0476; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shapovalov Y, 2011, J BIOL CHEM, V286, P22331, DOI 10.1074/jbc.M111.250092; Shapovalov Y, 2010, INT J CANCER, V127, P67, DOI 10.1002/ijc.25024; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O. H., 1930, METABOLISM TUMOURS I; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wenner CE, 2012, J CELL PHYSIOL, V227, P450, DOI 10.1002/jcp.22788; Yasui H, 2010, CANCER RES, V70, P6427, DOI 10.1158/0008-5472.CAN-10-1350; Zamzami N, 2005, CELL DEATH DIFFER, V12, P1478, DOI 10.1038/sj.cdd.4401682	48	42	46	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33303	33311		10.1074/jbc.M113.507129	http://dx.doi.org/10.1074/jbc.M113.507129			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24100035	hybrid, Green Published			2022-12-25	WOS:000328841700044
J	Shi, M; Kumar, SR; Motajo, O; Kretschmer, F; Mu, XQ; Badea, TC				Shi, Melody; Kumar, Sumit R.; Motajo, Oluwaseyi; Kretschmer, Friedrich; Mu, Xiuqian; Badea, Tudor C.			Genetic Interactions between Brn3 Transcription Factors in Retinal Ganglion Cell Type Specification	PLOS ONE			English	Article							DOMAIN FACTOR BRN-3B; AMACRINE CELLS; MOUSE RETINA; SOMATOSENSORY NEURONS; MAMMALIAN RETINA; NERVOUS-SYSTEM; PRIMATE RETINA; VISUAL-SYSTEM; EXPRESSION; DIFFERENTIATION	Background: Visual information is conveyed from the retina to the brain via 15-20 Retinal Ganglion Cell (RGC) types. The developmental mechanisms by which RGC types acquire their distinct molecular, morphological, physiological and circuit properties are essentially unknown, but may involve combinatorial transcriptional regulation. Brn3 transcription factors are expressed in RGCs from early developmental stages, and are restricted in adults to distinct, partially overlapping populations of RGC types. Previously, we described cell autonomous effects of Brn3b (Pou4f2) and Brn3a (Pou4f1) on RGC axon and dendrites development. Methods and Findings: We now have investigated genetic interactions between Brn3 transcription factors with respect to RGC development, by crossing conventional knock-out alleles of each Brn3 gene with conditional knock-in reporter alleles of a second Brn3 gene, and analyzing the effects of single or double Brn3 knockouts on RGC survival and morphology. We find that Brn3b loss results in axon defects and dendritic arbor area and lamination defects in Brn3a positive RGCs, and selectively affects survival and morphology of specific Brn3c (Pou4f3) positive RGC types. Brn3a and Brn3b interact synergistically to control RGC numbers. Melanopsin positive ipRGCs are resistant to combined Brn3 loss but are under the transcriptional control of Isl1, expanding the combinatorial code of RGC specification. Conclusions: Taken together these results complete our knowledge on the mechanisms of transcriptional control of RGC type specification. They demonstrate that Brn3b is required for the correct development of more RGC cell types than suggested by its expression pattern in the adult, but that several cell types, including some Brn3a, Brn3c or Melanopsin positive RGCs are Brn3b independent.	[Shi, Melody; Kumar, Sumit R.; Motajo, Oluwaseyi; Kretschmer, Friedrich; Badea, Tudor C.] NEI, NIH, Bethesda, MD 20892 USA; [Mu, Xiuqian] SUNY Buffalo, Dept Ophthalmol, Ross Eye Inst, Dev Genom Grp, Buffalo, NY 14260 USA; [Mu, Xiuqian] SUNY Buffalo, Ctr Excellence Bioinformat & Life Sci, Buffalo, NY 14260 USA; [Mu, Xiuqian] SUNY Eye Inst, Buffalo, NY USA; [Mu, Xiuqian] Roswell Pk Canc Inst, CCSG Genet Program, Buffalo, NY 14263 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute	Badea, TC (corresponding author), NEI, NIH, Bethesda, MD 20892 USA.	badeatc@mail.nih.gov	Badea, Tudor Constantin/B-1654-2018; Mu, Xiuqian/I-9146-2014	Badea, Tudor Constantin/0000-0003-3086-6713; Mu, Xiuqian/0000-0002-8003-7529	National Eye Institute; NEI [EY020545]; Whitehall Foundation; Research to Prevent Blindness to the Department of Ophthalmology of University at Buffalo; NATIONAL EYE INSTITUTE [R01EY020545, ZIAEY000504] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Whitehall Foundation; Research to Prevent Blindness to the Department of Ophthalmology of University at Buffalo; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding for this work was provided by the Intramural Research Program of the National Eye Institute for M. S., S. R. K., O.M., F. K. and T. C. B. and NEI grant EY020545, the Whitehall Foundation and an unrestricted grant from the Research to Prevent Blindness to the Department of Ophthalmology of University at Buffalo to X. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badea TC, 2003, J NEUROSCI, V23, P2314; Badea TC, 2004, J COMP NEUROL, V480, P331, DOI 10.1002/cne.20304; Badea TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007859; Badea TC, 2009, NEURON, V61, P852, DOI 10.1016/j.neuron.2009.01.020; Badea TC, 2012, J NEUROSCI, V32, P995, DOI 10.1523/JNEUROSCI.4755-11.2012; Badea TC, 2011, VISION RES, V51, P269, DOI 10.1016/j.visres.2010.08.039; Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Brown NL, 2001, DEVELOPMENT, V128, P2497; Chen SK, 2011, NATURE, V476, P92, DOI 10.1038/nature10206; Dumitrescu ON, 2009, J COMP NEUROL, V517, P226, DOI 10.1002/cne.22158; Dykes IM, 2011, J NEUROSCI, V31, P9789, DOI 10.1523/JNEUROSCI.0901-11.2011; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Elshatory Y, 2007, J NEUROSCI, V27, P12707, DOI 10.1523/JNEUROSCI.3951-07.2007; Elshatory Y, 2007, J COMP NEUROL, V503, P182, DOI 10.1002/cne.21390; Erkman L, 1996, NATURE, V381, P603, DOI 10.1038/381603a0; Erkman L, 2000, NEURON, V28, P779, DOI 10.1016/S0896-6273(00)00153-7; Field GD, 2007, ANNU REV NEUROSCI, V30, P1, DOI 10.1146/annurev.neuro.30.051606.094252; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Gan L, 1999, DEV BIOL, V210, P469, DOI 10.1006/dbio.1999.9280; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; GERRERO MR, 1993, P NATL ACAD SCI USA, V90, P10841, DOI 10.1073/pnas.90.22.10841; Guillemot F, 2007, DEVELOPMENT, V134, P3771, DOI 10.1242/dev.006379; Gustincich S, 1997, NEURON, V18, P723, DOI 10.1016/S0896-6273(00)80313-X; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hobert O, 2011, ANNU REV CELL DEV BI, V27, P681, DOI 10.1146/annurev-cellbio-092910-154226; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Jain V, 2012, J COMP NEUROL, V520, P742, DOI 10.1002/cne.22765; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jin KX, 2010, J NEUROSCI, V30, P11902, DOI 10.1523/JNEUROSCI.2187-10.2010; Karnas D, 2013, J COMP NEUROL, V521, P912, DOI 10.1002/cne.23210; Kay JN, 2004, DEVELOPMENT, V131, P1331, DOI 10.1242/dev.01040; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Kim IJ, 2010, J NEUROSCI, V30, P1452, DOI 10.1523/JNEUROSCI.4779-09.2010; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; Komiyama T, 2007, CURR BIOL, V17, P278, DOI 10.1016/j.cub.2006.11.067; LEVICK WR, 1975, NATURE, V254, P659, DOI 10.1038/254659a0; Lin B, 2004, NEURON, V43, P475, DOI 10.1016/j.neuron.2004.08.002; Mao CA, 2008, DEVELOPMENT, V135, P271, DOI 10.1242/dev.009688; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Masland RH, 2001, CURR OPIN NEUROBIOL, V11, P431, DOI 10.1016/S0959-4388(00)00230-0; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; McEvilly RJ, 1996, NATURE, V384, P574, DOI 10.1038/384574a0; Moshiri A, 2008, DEV BIOL, V316, P214, DOI 10.1016/j.ydbio.2008.01.015; Mu XQ, 2008, P NATL ACAD SCI USA, V105, P6942, DOI 10.1073/pnas.0802627105; Pan L, 2005, DEVELOPMENT, V132, P703, DOI 10.1242/dev.01646; Pan L, 2008, DEVELOPMENT, V135, P1981, DOI 10.1242/dev.010751; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Quina LA, 2005, J NEUROSCI, V25, P11595, DOI 10.1523/JNEUROSCI.2837-05.2005; Raymond ID, 2008, MOL VIS, V14, P1559; Schmidt TM, 2009, J NEUROSCI, V29, P476, DOI 10.1523/JNEUROSCI.4117-08.2009; Sun YF, 2008, NAT NEUROSCI, V11, P1283, DOI 10.1038/nn.2209; Trieu M, 2003, DEVELOPMENT, V130, P111, DOI 10.1242/dev.00194; Troy JB, 2002, PROG RETIN EYE RES, V21, P263, DOI 10.1016/S1350-9462(02)00002-2; TURNER EE, 1994, NEURON, V12, P205, DOI 10.1016/0896-6273(94)90164-3; Wang SW, 2002, DEVELOPMENT, V129, P467; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; WATANABE M, 1989, J COMP NEUROL, V289, P434, DOI 10.1002/cne.902890308; Xiang M, 1997, COLD SPRING HARB SYM, V62, P325; Xiang MQ, 1996, P NATL ACAD SCI USA, V93, P11950, DOI 10.1073/pnas.93.21.11950; Xiang MQ, 1998, DEV BIOL, V197, P155, DOI 10.1006/dbio.1998.8868; Xiang MQ, 1997, P NATL ACAD SCI USA, V94, P9445, DOI 10.1073/pnas.94.17.9445; XIANG MQ, 1993, NEURON, V11, P689, DOI 10.1016/0896-6273(93)90079-7; XIANG MQ, 1995, J NEUROSCI, V15, P4762; XUE D, 1993, SCIENCE, V261, P1324, DOI 10.1126/science.8103239; Yonehara K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001533; Yonehara K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004320	71	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76347	10.1371/journal.pone.0076347	http://dx.doi.org/10.1371/journal.pone.0076347			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116103	Green Published, Green Submitted, gold			2022-12-25	WOS:000325552200051
J	Almeda, R; Wambaugh, Z; Chai, C; Wang, ZC; Liu, ZF; Buskey, EJ				Almeda, Rodrigo; Wambaugh, Zoe; Chai, Chao; Wang, Zucheng; Liu, Zhanfei; Buskey, Edward J.			Effects of Crude Oil Exposure on Bioaccumulation of Polycyclic Aromatic Hydrocarbons and Survival of Adult and Larval Stages of Gelatinous Zooplankton	PLOS ONE			English	Article							CTENOPHORE MNEMIOPSIS-LEIDYI; WATER-SOLUBLE FRACTIONS; AURELIA SP SCYPHOZOA; NO-2 FUEL-OIL; PETROLEUM-HYDROCARBONS; ACCOMMODATED FRACTION; PELAGIC COELENTERATES; INVASIVE CTENOPHORE; MARINE-ENVIRONMENT; JELLYFISH BLOOMS	Gelatinous zooplankton play an important role in marine food webs both as major consumers of metazooplankton and as prey of apex predators (e. g., tuna, sunfish, sea turtles). However, little is known about the effects of crude oil spills on these important components of planktonic communities. We determined the effects of Louisiana light sweet crude oil exposure on survival and bioaccumulation of polycyclic aromatic hydrocarbons (PAHs) in adult stages of the scyphozoans Pelagia noctiluca and Aurelia aurita and the ctenophore Mnemiopsis leidyi, and on survival of ephyra larvae of A. aurita and cydippid larvae of M. leidyi, in the laboratory. Adult P. noctiluca showed 100% mortality at oil concentration >= 20 mu L L-1 after 16 h. In contrast, low or non-lethal effects were observed on adult stages of A. aurita and M. leidyi exposed at oil concentration <= 25 mu L L-1 after 6 days. Survival of ephyra and cydippid larva decreased with increasing crude oil concentration and exposition time. The median lethal concentration (LC50) for ephyra larvae ranged from 14.41 to 0.15 mu L L-1 after 1 and 3 days, respectively. LC50 for cydippid larvae ranged from 14.52 to 8.94 mu L L-1 after 3 and 6 days, respectively. We observed selective bioaccumulation of chrysene, phenanthrene and pyrene in A. aurita and chrysene, pyrene, benzo[a] pyrene, benzo[b] fluoranthene, benzo[k] fluoranthene, and benzo[a] anthracene in M. leidyi. Overall, our results indicate that (1) A. aurita and M. leidyi adults had a high tolerance to crude oil exposure compared to other zooplankton, whereas P. noctiluca was highly sensitive to crude oil, (2) larval stages of gelatinous zooplankton were more sensitive to crude oil than adult stages, and (3) some of the most toxic PAHs of crude oil can be bioaccumulated in gelatinous zooplankton and potentially be transferred up the food web and contaminate apex predators.	[Almeda, Rodrigo; Wambaugh, Zoe; Chai, Chao; Wang, Zucheng; Liu, Zhanfei; Buskey, Edward J.] Univ Texas Austin, Inst Marine Sci, Port Aransas, TX USA; [Wambaugh, Zoe] Humboldt State Univ, Dept Oceanog, Arcata, CA 95521 USA; [Chai, Chao] Qingdao Agr Univ, Coll Resource & Environm, Qingdao, Peoples R China; [Wang, Zucheng] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China	University of Texas System; University of Texas Austin; California State University System; California State Polytechnic University, Humboldt; Qingdao Agricultural University; East China Normal University	Almeda, R (corresponding author), Univ Texas Austin, Inst Marine Sci, Port Aransas, TX USA.	ralmeda@utexas.edu	ALMEDA, RODRIGO/R-1189-2016; Kang, Sonia/L-4802-2016; Liu, Zhanfei/B-5613-2014; Buskey, Edward/L-8443-2017	ALMEDA, RODRIGO/0000-0002-0090-112X; Kang, Sonia/0000-0002-0293-5323; Buskey, Edward/0000-0002-1729-6640	National Science Foundation (NSF) Research Experiences for Undergraduates (REU) program [OCE-1062745]; BP/The Gulf of Mexico Research Initiative through the University of Texas Marine Science Institute (DROPPS consortium: 'Dispersion Research on Oil: Physics and Plankton Studies')	National Science Foundation (NSF) Research Experiences for Undergraduates (REU) program(National Science Foundation (NSF)NSF - Office of the Director (OD)); BP/The Gulf of Mexico Research Initiative through the University of Texas Marine Science Institute (DROPPS consortium: 'Dispersion Research on Oil: Physics and Plankton Studies')	Zoe Wambaugh was supported by the National Science Foundation (NSF) Research Experiences for Undergraduates (REU) program (grant OCE-1062745). This research was made possible by a grant from BP/The Gulf of Mexico Research Initiative through the University of Texas Marine Science Institute (DROPPS consortium: 'Dispersion Research on Oil: Physics and Plankton Studies'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz M, 2010, POLAR BIOL, V33, P1719, DOI 10.1007/s00300-010-0789-9; Allan SE, 2012, ENVIRON SCI TECHNOL, V46, P2033, DOI 10.1021/es202942q; Almeda R, 2013, PLOS ONE IN PRESS; ANDERSON JW, 1974, MAR BIOL, V27, P75, DOI 10.1007/BF00394763; ANDREWS AR, 1974, MAR BIOL, V25, P7, DOI 10.1007/BF00395102; [Anonymous], [No title captured]; Appeltans W., 2013, **NON-TRADITIONAL**; Arai M.N., 1997, FUNCTIONAL BIOL SCYP; Arai MN, 2001, HYDROBIOLOGIA, V451, P69, DOI 10.1023/A:1011840123140; Arai MN, 2005, J MAR BIOL ASSOC UK, V85, P523, DOI 10.1017/S0025315405011458; Avila T.R., 2010, Journal of the Brazilian Society of Ecotoxicology, V5, P19; BAILEY TG, 1995, MAR ECOL PROG SER, V122, P121, DOI 10.3354/meps122121; BANSE K, 1995, ICES J MAR SCI, V52, P265, DOI 10.1016/1054-3139(95)80043-3; Barata C, 2005, ENVIRON TOXICOL CHEM, V24, P2992, DOI 10.1897/05-189R.1; Barazandeh M, 2004, P 4 INT IR RUSS C, P1407; Barron MG, 2003, ENVIRON TOXICOL CHEM, V22, P650, DOI 10.1002/etc.5620220326; Bejarano AC, 2006, J EXP MAR BIOL ECOL, V332, P49, DOI 10.1016/j.jembe.2005.11.006; BERDUGO V, 1977, Marine Pollution Bulletin, V8, P138, DOI 10.1016/0025-326X(77)90154-0; Berrojalbiz N, 2009, ENVIRON SCI TECHNOL, V43, P2295, DOI 10.1021/es8018226; Boese BL, 1997, ARCH ENVIRON CON TOX, V32, P389, DOI 10.1007/s002449900201; Brodersen CC., 1977, INT OIL SPILL C, P575, DOI [10.7901/2169-3358-1977-1-575, DOI 10.7901/2169-3358-1977-1-575]; Calbet A, 2007, MAR BIOL, V151, P195, DOI 10.1007/s00227-006-0468-0; Cardona L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031329; Cass CJ, 2011, MAR ECOL PROG SER, V439, P127, DOI 10.3354/meps09324; Castonguay M, 2008, CAN J FISH AQUAT SCI, V65, P1528, DOI 10.1139/F08-126; CLARKE A, 1992, J EXP MAR BIOL ECOL, V155, P55, DOI 10.1016/0022-0981(92)90027-8; Condon RH, 2012, BIOSCIENCE, V62, P160, DOI 10.1525/bio.2012.62.2.9; CONOVER RJ, 1971, J FISH RES BOARD CAN, V28, P1327, DOI 10.1139/f71-202; Corner E.D.S., 1978, Advances in Marine Biology, V15, P289; CORNER EDS, 1976, J MAR BIOL ASSOC UK, V56, P121, DOI 10.1017/S0025315400020488; Couillard CM, 2005, ENVIRON TOXICOL CHEM, V24, P1496, DOI 10.1897/04-267R.1; CURL H JR, 1962, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V153, P183; Dalsoren SB, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2005JD006927; De Flora S, 1991, TRENDS BIOL DOSIMETR, P69; DEASON EE, 1982, ESTUAR COAST SHELF S, V15, P121, DOI 10.1016/0272-7714(82)90023-3; DEFLORA S, 1991, MUTAT RES, V258, P285, DOI 10.1016/0165-1110(91)90013-L; Delvigne G.A.L., 1988, OIL CHEM POLLUTION, V4, P281, DOI [10.1016/S0269-8579(88)80003-0, DOI 10.1016/S0269-8579(88)80003-0]; Duesterloh S, 2002, ENVIRON SCI TECHNOL, V36, P3953, DOI 10.1021/es020685y; Duesterloh S, 2002, THESIS U ALASKA FAIR; Ericson G, 1998, CAN J FISH AQUAT SCI, V55, P815, DOI 10.1139/cjfas-55-4-815; Faasse Marco A., 2006, Aquatic Invasions, V1, P270, DOI 10.3391/ai.2006.1.4.9; Fernandez GA, 1977, P S WARM WAT ZOOPL N, P432; French-McCay DP, 2002, ENVIRON TOXICOL CHEM, V21, P2080, DOI 10.1897/1551-5028(2002)021<2080:DAAOAO>2.0.CO;2; Fuentes VL, 2010, HYDROBIOLOGIA, V645, P23, DOI 10.1007/s10750-010-0205-z; GESAMP, 1997, GESAMP REP STUD; Goodbody-Gringley G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0045574; Graham WM, 2010, ENVIRON RES LETT; Gray JS, 2002, MAR POLLUT BULL, V45, P46, DOI 10.1016/S0025-326X(01)00323-X; GYLLENBERG G, 1981, ANN ZOOL FENN, V18, P225; Harris R.P., 1977, FATE EFFECTS PETROLE, P286; HEBERT R, 1980, MAR ENVIRON RES, V4, P121, DOI 10.1016/0141-1136(80)90050-1; Hylland K, 2006, J TOXICOL ENV HEAL A, V69, P109, DOI 10.1080/15287390500259327; Jensen LK, 2012, ECOTOX ENVIRON SAFE, V78, P225, DOI 10.1016/j.ecoenv.2011.11.029; Jiang ZB, 2012, MAR ENVIRON RES, V81, P12, DOI 10.1016/j.marenvres.2012.08.003; Jiang Zhibing, 2010, Acta Ecologica Sinica, V30, P8; Jung SW, 2012, J HAZARD MATER, V217, P338, DOI 10.1016/j.jhazmat.2012.03.034; Kerr RA, 2010, SCIENCE, V329, P734, DOI 10.1126/science.329.5993.734; Kvenvolden KA, 2003, GEO-MAR LETT, V23, P140, DOI 10.1007/s00367-003-0135-0; LARSON RJ, 1986, J EXP MAR BIOL ECOL, V99, P107, DOI 10.1016/0022-0981(86)90231-5; LAUGHLIN RB, 1978, MAR BIOL, V47, P87, DOI 10.1007/BF00397022; Lee, 1975, P 1975 INT OIL SPILL, P549; Lee RF, 2012, J PLANKTON RES, V34, P1058, DOI 10.1093/plankt/fbs065; LEE WY, 1978, ENVIRON POLLUT, V15, P167, DOI 10.1016/0013-9327(78)90063-0; LEE WY, 1977, ENVIRON POLLUT, V12, P279, DOI 10.1016/0013-9327(77)90022-2; Lichtenthaler R.G., 1985, INT OIL SPILL C AM P, V1985, P471; LINDEN O, 1979, AMBIO, V8, P244; LINDEN O, 1975, Ambio, V4, P130; LINDEN O, 1976, ENVIRON POLLUT, V10, P239, DOI 10.1016/0013-9327(76)90007-0; Liu ZF, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/035302; Lotufo GR, 1998, AQUAT TOXICOL, V44, P1, DOI 10.1016/S0166-445X(98)00072-1; Lucas CH, 2001, HYDROBIOLOGIA, V451, P229, DOI 10.1023/A:1011836326717; MACKIE PR, 1978, MAR POLLUT BULL, V9, P296, DOI 10.1016/0025-326X(78)90252-7; Malej A, 2007, MAR BIOL, V151, P827, DOI 10.1007/s00227-006-0503-1; McAuliffe CD, 1981, IOSC P, V1981, P269; Meador JP, 1995, REV ENVIRON CONTA<D>, V143, P79; Mianzan HW, 1996, FISH RES, V27, P69, DOI 10.1016/0165-7836(95)00459-9; Mills CE, 2001, HYDROBIOLOGIA, V451, P55, DOI 10.1023/A:1011888006302; MIRONOV OG, 1980, HELGOLANDER MEERESUN, V33, P292, DOI 10.1007/BF02414754; Mukherjee B, 2009, ENVIRON ENG SCI, V26, P1725, DOI 10.1089/ees.2009.0159; Muschenheim DK, 2002, SPILL SCI TECHNOL B, V8, P9, DOI 10.1016/S1353-2561(02)00129-9; MYERS MS, 1991, ENVIRON HEALTH PERSP, V90, P7, DOI 10.2307/3430840; Neff J.M., 1981, RESPONSE MARINE ANIM; Neff J.M., 1985, FUNDAMENTALS AQUATIC, P416; Newman M.C., 2003, FUNDAMENTALS ECOTOXI, P458; NRC (National Research Council), 2003, OIL SEA; Ohman MD, 1997, J PLANKTON RES, V19, P1235, DOI 10.1093/plankt/19.9.1235; Pauly D, 2009, HYDROBIOLOGIA, V616, P67, DOI 10.1007/s10750-008-9583-x; Pelletier E, 2006, PHOTOCHEM PHOTOBIOL, V82, P981, DOI 10.1562/2005-09-18-RA-688.1; Pelletier MC, 1997, ENVIRON TOXICOL CHEM, V16, P2190, DOI 10.1002/etc.5620161029; Peters LD, 1997, AQUAT TOXICOL, V38, P67, DOI 10.1016/S0166-445X(96)00838-7; Pitt KA, 2005, J EXP MAR BIOL ECOL, V315, P71, DOI 10.1016/j.jembe.2004.09.007; Pugh P.R., 1989, Progress in Underwater Science, V14, P67; Purcell JE, 1997, ANN I OCEANOGR PARIS, V73, P125; Purcell JE, 2001, DEV HYDROBIOLOGY, V155; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Purcell JE, 2012, ANNU REV MAR SCI, V4, P209, DOI 10.1146/annurev-marine-120709-142751; Ramachandran SD, 2004, ECOTOX ENVIRON SAFE, V59, P300, DOI 10.1016/j.ecoenv.2003.08.018; Ramachandran SD, 2006, MAR POLLUT BULL, V52, P1182, DOI 10.1016/j.marpolbul.2006.02.009; Raskoff KA, 2003, BIOL BULL-US, V204, P68, DOI 10.2307/1543497; Riisgard HU, 2012, AQUAT INVASIONS, V7, P147, DOI 10.3391/ai.2012.7.2.001; Roohi A, 2008, MAR ECOL-EVOL PERSP, V29, P421, DOI 10.1111/j.1439-0485.2008.00254.x; Ruppert EE, 2004, INVERTEBRATE ZOOLOGY; Ruppert EE, 1994, INVERTEBRATE ZOOLOGY; Ruzicka JJ, 2007, CAL COOP OCEAN FISH, V48, P106; Saiz E, 2009, ENVIRON POLLUT, V157, P1219, DOI 10.1016/j.envpol.2008.12.011; Sanchez-Bayo F, 2006, ENVIRON POLLUT, V139, P385, DOI 10.1016/j.envpol.2005.06.016; Seuront L, 2011, PLOS ONE, V6, DOI [10.1371/journal.-pone.0026283, DOI 10.1371/J0URNAL.-P0NE.0026283]; Shiganova TA, 2001, MAR BIOL, V139, P431; SPANGENBERG DB, 1965, J EXP ZOOL, V159, P303, DOI 10.1002/jez.1401590303; SPANGENBERG DB, 1984, MAR ENVIRON RES, V14, P281, DOI 10.1016/0141-1136(84)90083-7; Stark JS, 2003, J EXP MAR BIOL ECOL, V283, P21, DOI 10.1016/S0022-0981(02)00449-5; STRAUGHAN D, 1972, J PETROL TECHNOL, V24, P250, DOI 10.2118/3204-PA; STRAUGHAN D, 1972, MARINE POLLUTION SEA, P00355; Suderman BL, 2002, ENVIRON POLLUT, V120, P787, DOI 10.1016/S0269-7491(02)00169-0; Sullivan LJ, 2004, J PLANKTON RES, V26, P417, DOI 10.1093/plankt/fbh033; Templeman MA, 2010, MAR ENVIRON RES, V69, P63, DOI 10.1016/j.marenvres.2009.08.001; Titelman J, 2006, MAR ECOL PROG SER, V325, P43, DOI 10.3354/meps325043; Turk V, 2008, MAR ECOL-EVOL PERSP, V29, P495, DOI 10.1111/j.1439-0485.2008.00250.x; TUVIKENE A, 1995, ANN ZOOL FENN, V32, P295; Valiela I, 1991, FUNDAMENTALS AQUATIC, P29; Van Brummelen T., 1998, HDB ENV CHEM, V3, P203; Ventura M, 2006, MAR ECOL PROG SER, V327, P233, DOI 10.3354/meps327233; Walsh G.E., 1978, PRINCIPLES ECOTOXICO, P257; White HK, 2012, P NATL ACAD SCI USA, V109, P20303, DOI 10.1073/pnas.1118029109; Whitehead A, 2011, P NATL ACAD SCI USA; Yu HT, 2002, J ENVIRON SCI HEAL C, V20, P149, DOI 10.1081/GNC-120016203	126	69	71	2	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e74476	10.1371/journal.pone.0074476	http://dx.doi.org/10.1371/journal.pone.0074476			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116004	Green Published, gold, Green Submitted			2022-12-25	WOS:000325501300007
J	Grisewood, MJ; Gifford, NP; Pantazes, RJ; Li, Y; Cirino, PC; Janik, MJ; Maranas, CD				Grisewood, Matthew J.; Gifford, Nathanael P.; Pantazes, Robert J.; Li, Ye; Cirino, Patrick C.; Janik, Michael J.; Maranas, Costas D.			OptZyme: Computational Enzyme Redesign Using Transition State Analogues	PLOS ONE			English	Article							BETA-GLUCURONIDASE; BIOMOLECULAR SIMULATION; DIRECTED EVOLUTION; LIBRARY DESIGN; PROTEIN; RECOMBINATION; SPECIFICITY; PREDICTION; CATALYSIS; MUTAGENESIS	OptZyme is a new computational procedure for designing improved enzymatic activity (i.e., k(cat) or k(cat)/K-M) with a novel substrate. The key concept is to use transition state analogue compounds, which are known for many reactions, as proxies for the typically unknown transition state structures. Mutations that minimize the interaction energy of the enzyme with its transition state analogue, rather than with its substrate, are identified that lower the transition state formation energy barrier. Using Escherichia coli beta-glucuronidase as a benchmark system, we confirm that K-M correlates (R-2 = 0.960) with the computed interaction energy between the enzyme and the para-nitrophenyl- beta, D-glucuronide substrate, k(cat)/K-M correlates (R-2 = 0.864) with the interaction energy of the transition state analogue, 1,5-glucarolactone, and k(cat) correlates (R-2 = 0.854) with a weighted combination of interaction energies with the substrate and transition state analogue. OptZyme is subsequently used to identify mutants with improved K-M, k(cat), and k(cat)/K-M for a new substrate, para-nitrophenyl-beta, D-galactoside. Differences between the three libraries reveal structural differences that underpin improving K-M, k(cat), or k(cat)/K-M. Mutants predicted to enhance the activity for para-nitrophenyl- beta, D-galactoside directly or indirectly create hydrogen bonds with the altered sugar ring conformation or its substituents, namely H162S, L361G, W549R, and N550S.	[Grisewood, Matthew J.; Gifford, Nathanael P.; Pantazes, Robert J.; Janik, Michael J.; Maranas, Costas D.] Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA; [Li, Ye; Cirino, Patrick C.] Univ Houston, Dept Chem & Biomol Engn, Houston, TX USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Houston System; University of Houston	Maranas, CD (corresponding author), Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA.	costas@psu.edu	Cirino, Patrick/AAM-1203-2021; Janik, Michael/AAE-7213-2019; Maranas, Costas D/A-4774-2011	Maranas, Costas D/0000-0002-1508-1398; Pantazes, Robert/0000-0002-0994-007X	National Science Foundation (nsf.gov) grant [CBET-0967062]	National Science Foundation (nsf.gov) grant(National Science Foundation (NSF))	This research was supported by funding from the National Science Foundation (nsf.gov) grant: CBET-0967062. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, SUIT 2012 JAG; Arul L, 2008, BIOINFORMATION, V2, P339, DOI 10.6026/97320630002339; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Bjelic S, 2013, ACS CHEM BIOL, V8, P749, DOI 10.1021/cb3006227; Bolon DN, 2001, P NATL ACAD SCI USA, V98, P14274, DOI 10.1073/pnas.251555398; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Christen M, 2005, J COMPUT CHEM, V26, P1719, DOI 10.1002/jcc.20303; Cliff MJ, 2010, J AM CHEM SOC, V132, P6507, DOI 10.1021/ja100974t; CONCHIE J, 1967, BIOCHEM J, V102, P929, DOI 10.1042/bj1020929; Dalby PA, 2011, CURR OPIN STRUC BIOL, V21, P473, DOI 10.1016/j.sbi.2011.05.003; DUNBRACK RL, 1993, J MOL BIOL, V230, P543, DOI 10.1006/jmbi.1993.1170; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Evans GB, 2003, J MED CHEM, V46, P5271, DOI 10.1021/jm030305z; Faiella M, 2009, NAT CHEM BIOL, V5, P882, DOI 10.1038/nchembio.257; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Friesner RA, 2005, ANNU REV PHYS CHEM, V56, P389, DOI 10.1146/annurev.physchem.55.091602.094410; Frushicheva MP, 2010, P NATL ACAD SCI USA, V107, P16869, DOI 10.1073/pnas.1010381107; Geddie ML, 2004, J BIOL CHEM, V279, P26462, DOI 10.1074/jbc.M401447200; de Andrade DVG, 2012, INT J QUANTUM CHEM, V112, P3164, DOI 10.1002/qua.24102; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; Hilvert D, 2013, ANNU REV BIOCHEM, V82, P447, DOI 10.1146/annurev-biochem-072611-101825; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Khare SD, 2012, NAT CHEM BIOL, V8, P294, DOI [10.1038/NCHEMBIO.777, 10.1038/nchembio.777]; Kiss G, 2013, ANGEW CHEM INT EDIT, V52, P5700, DOI 10.1002/anie.201204077; Kitaura K, 2009, FRAGMENT MOLECULAR ORBITAL METHOD: PRACTICAL APPLICATIONS TO LARGE MOLECULAR SYSTEMS, P1; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Lassila JK, 2007, BIOCHEMISTRY-US, V46, P6883, DOI 10.1021/bi700215x; Lee MS, 2003, J COMPUT CHEM, V24, P1348, DOI 10.1002/jcc.10272; Lee-Huang S, 1999, P NATL ACAD SCI USA, V96, P2678, DOI 10.1073/pnas.96.6.2678; MARSH CA, 1986, CARBOHYD RES, V153, P119, DOI 10.1016/S0008-6215(00)90201-5; Matsumura I, 2001, J MOL BIOL, V305, P331, DOI 10.1006/jmbi.2000.4259; Matsumura I, 1999, NAT BIOTECHNOL, V17, P696, DOI 10.1038/10910; Menon V, 2012, PROG ENERG COMBUST, V38, P522, DOI 10.1016/j.pecs.2012.02.002; Meyer MM, 2006, PROTEIN ENG DES SEL, V19, P563, DOI 10.1093/protein/gzl045; Moore GL, 2004, AICHE J, V50, P262, DOI 10.1002/aic.10025; Moore GL, 2003, P NATL ACAD SCI USA, V100, P5091, DOI 10.1073/pnas.0831190100; Murphy PM, 2009, P NATL ACAD SCI USA, V106, P9215, DOI 10.1073/pnas.0811070106; Ni Y, 2011, APPL MICROBIOL BIOT, V90, P193, DOI 10.1007/s00253-010-3051-z; Otey CR, 2006, PLOS BIOL, V4, P789, DOI 10.1371/journal.pbio.0040112; Pantazes RJ, 2007, PROTEIN ENG DES SEL, V20, P361, DOI 10.1093/protein/gzm030; Powers DC, 2013, ORGANOMETALLICS, V32, P2042, DOI 10.1021/om4000456; Privett HK, 2012, P NATL ACAD SCI USA, V109, P3790, DOI 10.1073/pnas.1118082108; Ray J, 1998, GENOMICS, V48, P248, DOI 10.1006/geno.1997.5189; Richter F, 2012, J AM CHEM SOC, V134, P16197, DOI 10.1021/ja3037367; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Rowe LA, 2003, J MOL BIOL, V332, P851, DOI 10.1016/S0022-2836(03)00972-0; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Saraf MC, 2006, BIOPHYS J, V90, P4167, DOI 10.1529/biophysj.105.079277; Saraf MC, 2003, PROTEIN ENG, V16, P1025, DOI 10.1093/protein/gzg129; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SECEMSKI II, 1972, J BIOL CHEM, V247, P4740; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; Vellard M, 2003, CURR OPIN BIOTECH, V14, P444, DOI 10.1016/S0958-1669(03)00092-2; Voigt CA, 2002, NAT STRUCT BIOL, V9, P553, DOI 10.1038/nsb805; Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175; WOLFENDEN R, 1972, ACCOUNTS CHEM RES, V5, P10, DOI 10.1021/ar50049a002; Xu CG, 2010, BIORESOURCE TECHNOL, V101, P9560, DOI 10.1016/j.biortech.2010.07.065; Xu G, 2001, CLIN CANCER RES, V7, P3314; Yang WC, 2009, BIOPHYS J, V96, P1931, DOI 10.1016/j.bpj.2008.11.051; Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106; Zhou RH, 2003, PROTEINS, V53, P148, DOI 10.1002/prot.10483	68	17	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75358	10.1371/journal.pone.0075358	http://dx.doi.org/10.1371/journal.pone.0075358			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116038	gold, Green Published, Green Submitted			2022-12-25	WOS:000325501300026
J	Smits, SM; von Oerthel, L; Hoekstra, EJ; Burbach, JPH; Smidt, MP				Smits, Simone M.; von Oerthel, Lars; Hoekstra, Elisa J.; Burbach, J. Peter H.; Smidt, Marten P.			Molecular Marker Differences Relate to Developmental Position and Subsets of Mesodiencephalic Dopaminergic Neurons	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; ANTERIOR NEURAL PLATE; SUBSTANTIA-NIGRA; TYROSINE-HYDROXYLASE; PARKINSONS-DISEASE; PROSOMERIC MODEL; HUMAN EMBRYOS; MIDBRAIN; EXPRESSION; RAT	The development of mesodiencephalic dopaminergic (mdDA) neurons located in the substantia nigra compacta (SNc) and ventral tegmental area (VTA) follow a number of stages marked by distinct events. After preparation of the region by signals that provide induction and patterning, several transcription factors have been identified, which are involved in specifying the neuronal fate of these cells. The specific vulnerability of SNc neurons is thought to root in these specific developmental programs. The present study examines the positions of young postmitotic mdDA neurons to relate developmental position to mdDA subset specific markers. MdDA neurons were mapped relative to the neuromeric domains (prosomeres 1-3 (P1-3), midbrain, and hindbrain) as well as the longitudinal subdivisions (floor plate, basal plate, alar plate), as proposed by the prosomeric model. We found that postmitotic mdDA neurons are located mainly in the floorplate domain and very few in slightly more lateral domains. Moreover, mdDA neurons are present along a large proportion of the anterior/posterior axis extending from the midbrain to P3 in the diencephalon. The specific positions relate to some extent to the presence of specific subset markers as Ahd2. In the adult stage more of such subsets specific expressed genes are present and may represent a molecular map defining molecularly distinct groups of mdDA neurons.	[von Oerthel, Lars; Hoekstra, Elisa J.; Smidt, Marten P.] Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Smits, Simone M.; von Oerthel, Lars; Burbach, J. Peter H.; Smidt, Marten P.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosci & Pharmacol, Utrecht, Netherlands	University of Amsterdam; Utrecht University; Utrecht University Medical Center	Smidt, MP (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands.	m.p.smidt@uva.nl		Smidt, Marten/0000-0002-8815-747X	Korczak Foundation for Autism and Related Disorders, the Netherlands; Netherlands Organization of Scientific Research NWO [903-42-075]; Netherlands Organization of Scientific Research NWO (VICI-ALW) [865.09.002]	Korczak Foundation for Autism and Related Disorders, the Netherlands; Netherlands Organization of Scientific Research NWO(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization of Scientific Research NWO (VICI-ALW)	This work was supported by the Korczak Foundation for Autism and Related Disorders, the Netherlands, and by the Netherlands Organization of Scientific Research NWO (fellowship 903-42-075 and VICI-ALW (865.09.002) to MPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acampora D, 1999, MOL CELL NEUROSCI, V13, P1, DOI 10.1006/mcne.1998.0730; Blaess S, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-29; Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X; Brodski C, 2003, J NEUROSCI, V23, P4199; BULFONE A, 1993, J NEUROSCI, V13, P3155; Di Salvio M, 2010, INT J DEV BIOL, V54, P939, DOI 10.1387/ijdb.092974ms; Greene JG, 2005, NEUROBIOL DIS, V18, P19, DOI 10.1016/j.nbd.2004.10.003; Grimm J, 2004, P NATL ACAD SCI USA, V101, P13891, DOI 10.1073/pnas.0405340101; HANAWAY J, 1970, AM J ANAT, V129, P417, DOI 10.1002/aja.1001290404; HANAWAY J, 1971, J COMP NEUROL, V142, P59, DOI 10.1002/cne.901420105; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Hynes M, 1999, CURR OPIN NEUROBIOL, V9, P26, DOI 10.1016/S0959-4388(99)80004-X; Jacobs FMJ, 2007, DEVELOPMENT, V134, P2673, DOI 10.1242/dev.02865; Jacobs FMJ, 2011, DEVELOPMENT, V138, P5213, DOI 10.1242/dev.071704; Jacobs FMJ, 2009, DEVELOPMENT, V136, P2363, DOI 10.1242/dev.037556; JAEGER CB, 1983, SCIENCE, V219, P1233, DOI 10.1126/science.6131537; Joksimovic M, 2009, P NATL ACAD SCI USA, V106, P19185, DOI 10.1073/pnas.0904285106; KAWANO H, 1995, DEV BRAIN RES, V86, P101, DOI 10.1016/0165-3806(95)00018-9; Lahti L, 2012, DEVELOPMENT, V139, P894, DOI 10.1242/dev.071936; Marin F, 2005, DEV DYNAM, V234, P709, DOI 10.1002/dvdy.20467; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; Puelles L, 2003, TRENDS NEUROSCI, V26, P469, DOI 10.1016/S0166-2236(03)00234-0; Puelles L, 1998, J COMP NEUROL, V394, P283, DOI 10.1002/(SICI)1096-9861(19980511)394:3<283::AID-CNE2>3.0.CO;2-Y; RUBENSTEIN JLR, 1994, SCIENCE, V266, P578, DOI 10.1126/science.7939711; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Shimamura K, 1995, DEVELOPMENT, V121, P3923; SHULTS CW, 1990, NEUROSCIENCE, V38, P427, DOI 10.1016/0306-4522(90)90039-7; Simeone A, 2000, TRENDS GENET, V16, P237, DOI 10.1016/S0168-9525(00)02000-X; Simeone A, 1998, EMBO J, V17, P6790, DOI 10.1093/emboj/17.23.6790; Smidt MP, 2007, NAT REV NEUROSCI, V8, P21, DOI 10.1038/nrn2039; Smidt MP, 2004, DEVELOPMENT, V131, P1145, DOI 10.1242/dev.01022; Smits SM, 2006, PROG NEUROBIOL, V78, P1, DOI 10.1016/j.pneurobio.2005.12.003; Vernay B, 2005, J NEUROSCI, V25, P4856, DOI 10.1523/JNEUROSCI.5158-04.2005; Verney C, 2001, J COMP NEUROL, V429, P22, DOI 10.1002/1096-9861(20000101)429:1<22::AID-CNE3>3.0.CO;2-X; Wallen A, 1999, EXP CELL RES, V253, P737, DOI 10.1006/excr.1999.4691; Wolfart J, 2001, J NEUROSCI, V21, P3443, DOI 10.1523/JNEUROSCI.21-10-03443.2001; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3	37	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76037	10.1371/journal.pone.0076037	http://dx.doi.org/10.1371/journal.pone.0076037			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116087	Green Published, Green Submitted, gold			2022-12-25	WOS:000325501300046
J	Volker, C; Boedicker, C; Daubenthaler, J; Oetken, M; Oehlmann, J				Voelker, Carolin; Boedicker, Cathinka; Daubenthaler, Jan; Oetken, Matthias; Oehlmann, Joerg			Comparative Toxicity Assessment of Nanosilver on Three Daphnia Species in Acute, Chronic and Multi-Generation Experiments	PLOS ONE			English	Article							SILVER NANOPARTICLES; MAGNA-STRAUS; RISK-ASSESSMENT; KNOWLEDGE GAPS; EXPOSURE; NANOMATERIALS; TOLERANCE; ECOTOXICITY; ACCLIMATION; ORGANISMS	The antibacterial properties of nanosilver have led to a versatile application spectrum including medical purposes and personal care products. However, the increasing use of nanosilver has raised concerns about its environmental impacts. Long-term exposure studies with aquatic invertebrates are essential to assess possible adverse effects on aquatic ecosystems. In the present study, acute (48 h), chronic (21 d) and long-term effects of nanosilver (primary size 15 nm) on five successive generations of three Daphnia species (D. magna, D. pulex, and D. galeata) were investigated. Acute EC50 values of nanosilver were 121 mu g Ag L-1 for D. magna being the least sensitive species and 8.95 and 13.9 mu g Ag L-1 for D. pulex and D. galeata, respectively. Chronic exposure provided EC10 values of 0.92 mu g Ag L-1 for D. magna showing the most sensitive chronic reaction and 2.25 and 3.45 mu g Ag L-1 for D. pulex and D. galeata, respectively. Comparative exposure to AgNO3 revealed a generally higher toxicity of the soluble form of silver. The multi-generation experiments resulted in effects on the population level for all tested species. Exposure of D. magna indicated an increased toxicity of nanosilver in the fifth generation of animals exposed to 10 mu g Ag L-1. Neonates from pre-exposed parental daphnids did not completely recover when transferred into clean water. Exposure of D. pulex and D. galeata revealed not only increasing toxicity in some generations, but also greater tolerance to nanosilver. This study contributes to the assessment of the risk potential of nanosilver on aquatic ecosystems. It shows that effects of nanosilver vary within one genus and change with exposure duration. Therefore, long-term studies considering different aquatic species are needed to better understand the possible effects of nanosilver on aquatic ecosystems.	[Voelker, Carolin; Boedicker, Cathinka; Daubenthaler, Jan; Oetken, Matthias; Oehlmann, Joerg] Goethe Univ Frankfurt, Dept Aquat Ecotoxicol, D-60054 Frankfurt, Germany	Goethe University Frankfurt	Volker, C (corresponding author), Goethe Univ Frankfurt, Dept Aquat Ecotoxicol, D-60054 Frankfurt, Germany.	c.voelker@bio.uni-frankfurt.de	Völker, Carolin/ABG-6320-2020; Oetken, Matthias/C-9906-2010; Oehlmann, Jörg/B-4565-2010	Völker, Carolin/0000-0002-3009-8729; Oehlmann, Jörg/0000-0002-6075-2701	German National Academic Foundation	German National Academic Foundation	This work was funded by by the German National Academic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HJ, 2010, ENVIRON TOXICOL CHEM, V29, P2742, DOI 10.1002/etc.329; Asharani PV, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/25/255102; Baun A, 2008, ECOTOXICOLOGY, V17, P387, DOI 10.1007/s10646-008-0208-y; Benn TM, 2008, ENVIRON SCI TECHNOL, V42, P4133, DOI 10.1021/es7032718; Bossuyt BTA, 2004, ENVIRON TOXICOL CHEM, V23, P2029, DOI 10.1897/03-377; Bradford A, 2009, ENVIRON SCI TECHNOL, V43, P4530, DOI 10.1021/es9001949; BRENDELBERGER H, 1985, J PLANKTON RES, V7, P473, DOI 10.1093/plankt/7.4.473; BURNS CW, 1969, LIMNOL OCEANOGR, V14, P693, DOI 10.4319/lo.1969.14.5.0693; COWGILL UM, 1984, J CRUSTACEAN BIOL, V4, P173, DOI 10.2307/1548014; Eisler R., 1996, SILVER HAZARDS FISH; ELENDT BP, 1990, WATER RES, V24, P1157, DOI 10.1016/0043-1354(90)90180-E; ELENDT BP, 1989, ARCH HYDROBIOL, V116, P415; Farkas J, 2011, ENVIRON INT, V37, P1057, DOI 10.1016/j.envint.2011.03.006; Gaiser BK, 2011, J ENVIRON MONITOR, V13, P1227, DOI 10.1039/c1em10060b; Gaiser BK, 2009, ENV HLTH, V8; Gottschalk F, 2011, ENVIRON POLLUT, V159, P3439, DOI 10.1016/j.envpol.2011.08.023; Griffitt RJ, 2008, ENVIRON TOXICOL CHEM, V27, P1972, DOI 10.1897/08-002.1; Guan R, 2004, ENVIRON SCI TECHNOL, V38, P6051, DOI 10.1021/es049562z; Hammers-Wirtz M, 2000, ENVIRON TOXICOL CHEM, V19, P1856, DOI 10.1002/etc.5620190720; Handy RD, 2008, ECOTOXICOLOGY, V17, P287, DOI 10.1007/s10646-008-0199-8; High KA, 1997, ENVIRON TOXICOL CHEM, V16, P1111, DOI 10.1002/etc.5620160604; Hoheisel SM, 2012, ENVIRON TOXICOL CHEM, V31, P2557, DOI 10.1002/etc.1978; Kahru A, 2010, TOXICOLOGY, V269, P105, DOI 10.1016/j.tox.2009.08.016; Kennedy AJ, 2010, ENVIRON SCI TECHNOL, V44, P9571, DOI 10.1021/es1025382; Klaine SJ, 2012, ENVIRON TOXICOL CHEM, V31, P3, DOI 10.1002/etc.733; Klein C., 2011, 24693EN2011 EUR, DOI 10.2788/23079; KLINE ER, 1989, ENVIRON POLLUT, V56, P11, DOI 10.1016/0269-7491(89)90117-6; KOIVISTO S, 1992, HYDROBIOLOGIA, V248, P125, DOI 10.1007/BF00006080; Li T, 2010, ANAL BIOANAL CHEM, V398, P689, DOI 10.1007/s00216-010-3915-1; Lotka A.J., 1913, NATURAL POPULATION N; Martinez-Castanon GA, 2008, J NANOPART RES, V10, P1343, DOI 10.1007/s11051-008-9428-6; Massarin S, 2010, AQUAT TOXICOL, V99, P309, DOI 10.1016/j.aquatox.2010.05.006; MUNZINGER A, 1990, WATER RES, V24, P845, DOI 10.1016/0043-1354(90)90134-R; Muyssen BTA, 2004, ENVIRON POLLUT, V130, P309, DOI 10.1016/j.envpol.2004.01.003; Muyssen BTA, 2001, ENVIRON TOXICOL CHEM, V20, P2053, DOI 10.1002/etc.5620200926; Navarro E, 2008, ENVIRON SCI TECHNOL, V42, P8959, DOI 10.1021/es801785m; OECD, 2004, OECD GUID TEST CHEM; OECD, 2012, OECD GUID TEST CHEM, V211; Ratte HT, 1999, ENVIRON TOXICOL CHEM, V18, P89, DOI [10.1002/etc.5620180112, 10.1897/1551-5028(1999)018&lt;0089:BATOSC&gt;2.3.CO;2]; Roh JY, 2009, ENVIRON SCI TECHNOL, V43, P3933, DOI 10.1021/es803477u; Seeland A, 2012, ENVIRON POLLUT, V168, P161, DOI 10.1016/j.envpol.2012.04.020; STUHLBACHER A, 1992, COMP BIOCHEM PHYS C, V101, P571, DOI 10.1016/0742-8413(92)90088-O; Villarroel MJ, 1999, ECOTOX ENVIRON SAFE, V44, P40, DOI 10.1006/eesa.1999.1817; Volker C, 2013, REV ENVIRON CONTAM T, V223, P81, DOI 10.1007/978-1-4614-5577-6_4; Wang Z, 2012, ENVIRON TOXICOL CHEM, V31, P2408, DOI 10.1002/etc.1964; Wijnhoven SWP, 2009, NANOTOXICOLOGY, V3, P109, DOI 10.1080/17435390902725914; WINNER RW, 1976, J FISH RES BOARD CAN, V33, P1685, DOI 10.1139/f76-215; WoodrowWilson International Center for Scholars, 2011, PROJ EM NAN; Zhao CM, 2012, NANOTOXICOLOGY, V6, P361, DOI 10.3109/17435390.2011.579632; Zhao CM, 2011, ENVIRON TOXICOL CHEM, V30, P885, DOI 10.1002/etc.451; Zhao CM, 2010, ENVIRON SCI TECHNOL, V44, P7699, DOI 10.1021/es101484s	51	85	89	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75026	10.1371/journal.pone.0075026	http://dx.doi.org/10.1371/journal.pone.0075026			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116021	Green Submitted, gold, Green Published			2022-12-25	WOS:000325501300021
J	Punjabi, GA; Chellam, R; Vanak, AT				Punjabi, Girish Arjun; Chellam, Ravi; Vanak, Abi Tamim			Importance of Native Grassland Habitat for Den-Site Selection of Indian Foxes in a Fragmented Landscape	PLOS ONE			English	Article							CLASSIFICATION-BASED ANALYSES; VULPES-BENGALENSIS; RESOURCE SELECTION; RED FOXES; COMPETITION; SURVIVAL; COYOTES; DOGS; HOME	Fragmentation of native habitats is now a ubiquitous phenomenon affecting wildlife at various scales. We examined selection of den-sites (n = 26) by Indian foxes (Vulpes bengalensis) in a highly modified short-grassland landscape in central India (Jan-May, 2010). At the scale of the home-range, defined by an 800 m circular buffer around den sites, we examined the effect of land-cover edges and roads on selection of sites for denning using a distance-based approach. At the smaller den-area scale, defined by a 25 m x 25 m plot around den and paired available sites, the effect of microhabitat characteristics was examined using discrete-choice models. Indian foxes selected den-sites closer to native grasslands (t = -9.57, P < 0.001) and roads (t = -2.04, P = 0.05) than random at the home-range scale. At the smaller scale, abundance of rodents and higher visibility increased the odds of selection of a site by eight and four times respectively, indicating resource availability and predator avoidance to be important considerations for foxes. Indian foxes largely chose to den in human-made structures, indicated by the proportion of dens found in earthen bunds (0.69) and boulder piles (0.27) in the study area. With agricultural expansion and human modification threatening native short-grassland habitats, their conservation and effective management in human-dominated landscapes will benefit the Indian fox. The presence of some human-made structures within native grasslands would also be beneficial for this den-dependent species. We suggest future studies examine the impact of fragmentation and connectivity of grasslands on survival and reproductive success of the Indian fox.	[Punjabi, Girish Arjun] Tata Inst Fundamental Res, Post Grad Programme Wildlife Biol & Conservat, Wildlife Conservat Soc, India Program,Natl Ctr Biol Sci, Bengaluru, India; [Chellam, Ravi] Ctr Herpetol, Madras Crocodile Bank Trust, Mamallapuram, Tamil Nadu, India; [Vanak, Abi Tamim] Ashoka Trust Res Ecol & Environm, Ctr Biodivers & Conservat, Bengaluru, India; [Vanak, Abi Tamim] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of Kwazulu Natal	Punjabi, GA (corresponding author), Tata Inst Fundamental Res, Post Grad Programme Wildlife Biol & Conservat, Wildlife Conservat Soc, India Program,Natl Ctr Biol Sci, Bengaluru, India.	girisharjunpunjabi@gmail.com	Vanak, Abi/F-8519-2010	Vanak, Abi/0000-0003-2435-4260	Department of Science & Technology, Government of India	Department of Science & Technology, Government of India(Department of Science & Technology (India))	The study was funded by the Department of Science & Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, R VERS 2 15 2; Bhaskaran A, 2006, MODELLING HABITAT SE; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.2307/3802723, DOI 10.2307/3802723]; Conner LM, 2005, ECOLOGY, V86, P3125, DOI 10.1890/05-0760; Conner LM, 2003, ECOLOGY, V84, P526, DOI 10.1890/0012-9658(2003)084[0526:ACODBA]2.0.CO;2; Cooper AB, 1999, ECOLOGY, V80, P566, DOI 10.1890/0012-9658(1999)080[0566:TAODCM]2.0.CO;2; Di Bitetti MS, 2009, J MAMMAL, V90, P479, DOI 10.1644/08-MAMM-A-113.1; Ditchkoff Stephen S., 2006, Urban Ecosystems, V9, P5, DOI 10.1007/s11252-006-3262-3; EBERHARDT LE, 1983, J MAMMAL, V64, P97, DOI 10.2307/1380754; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Fitz-Gibbon Carol T., 1987, HOW TO ANAL DATA; Gompper Matthew E., 2006, Mammalian Species, P1, DOI 10.1644/795.1; Google Inc, 2011, GOOGL EARTH VERS 5 1; Gosselink TE, 2003, J WILDLIFE MANAGE, V67, P90, DOI 10.2307/3803065; GRASS Development Team, 2012, GEOGRAPHIC RESOURCES; Habib B, 2007, J ZOOL, V272, P259, DOI 10.1111/j.1469-7998.2006.00265.x; Home Chandrima, 2010, Canid News, V13, P1; Home C, 2009, MAMM BIOL, V74, P403, DOI 10.1016/j.mambio.2009.05.011; Johnsingh AJT, 2008, IUCN 2010 IUCN RED L; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kamler JF, 2012, J WILDLIFE MANAGE, V76, P1241, DOI 10.1002/jwmg.354; Kamler JF, 2003, J MAMMAL, V84, P989, DOI 10.1644/BJK-033; Koopman ME, 1998, J WILDLIFE MANAGE, V62, P373, DOI 10.2307/3802301; Lesmeister DB, 2008, J MAMMAL, V89, P1512, DOI 10.1644/07-MAMM-A-361.1; Manakadan Ranjit, 2000, Journal of the Bombay Natural History Society, V97, P3; Mazerolle M. J., 2012, MODEL SELECTION MULT; Nelson JL, 2007, J WILDLIFE MANAGE, V71, P1467, DOI 10.2193/2006-234; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; QGIS, 2020, QGIS GEOGR INF SYST; Ramesh D, 2013, POPUL ECOL, V55, P241, DOI 10.1007/s10144-012-0340-7; Rice KJ, 2003, FRONT ECOL ENVIRON, V1, P469, DOI 10.1890/1540-9295(2003)001[0469:MMRITF]2.0.CO;2; ROBEL RI, 1970, J RANGE MANAGE, V23, P295, DOI 10.2307/3896225; SARGEANT AB, 1987, J WILDLIFE MANAGE, V51, P285, DOI 10.2307/3801004; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Singh P., 2006, REPORT TASK FORCE GR; Snow NP, 2012, J WILDLIFE MANAGE, V76, P243, DOI 10.1002/jwmg.247; Szor G, 2008, POLAR BIOL, V31, P351, DOI 10.1007/s00300-007-0364-1; Tannerfeldt M., 2003, ECOLOGY CONSERVATION, P167; Vanak AT, 2010, J ZOOL, V281, P140, DOI 10.1111/j.1469-7998.2010.00690.x; Vanak A.T., 2008, INTRAGUILD INTERACTI; Vanak AT, 2007, WILDLIFE BIOL, V13, P219, DOI 10.2981/0909-6396(2007)13[219:EONTFS]2.0.CO;2; Vanak AT, 2010, J APPL ECOL, V47, P1225, DOI 10.1111/j.1365-2664.2010.01870.x; Vanak Abi Tamim, 2005, Canid News, V8, P1; Vanak AT, 2009, J MAMMAL, V90, P1058, DOI 10.1644/09-MAMM-A-107.1; Vieira EM, 2007, J ZOOL, V272, P57, DOI 10.1111/j.1469-7998.2006.00237.x; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054	47	11	13	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76410	10.1371/journal.pone.0076410	http://dx.doi.org/10.1371/journal.pone.0076410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098494	Green Published, Green Submitted, gold			2022-12-25	WOS:000325483600046
J	Siegl, C; Hamminger, P; Jank, H; Ahting, U; Bader, B; Danek, A; Gregory, A; Hartig, M; Hayflick, S; Hermann, A; Prokisch, H; Sammler, EM; Yapici, Z; Prohaska, R; Salzer, U				Siegl, Claudia; Hamminger, Patricia; Jank, Herbert; Ahting, Uwe; Bader, Benedikt; Danek, Adrian; Gregory, Allison; Hartig, Monika; Hayflick, Susan; Hermann, Andreas; Prokisch, Holger; Sammler, Esther M.; Yapici, Zuhal; Prohaska, Rainer; Salzer, Ulrich			Alterations of Red Cell Membrane Properties in Nneuroacanthocytosis	PLOS ONE			English	Article							PHOSPHATIDYLSERINE EXPOSURE; LYSOPHOSPHATIDIC ACID; ERYTHROCYTE-MEMBRANE; CHOREA-ACANTHOCYTOSIS; MOLECULAR-MECHANISM; MCLEOD-SYNDROME; PROTEIN; BLOOD; CYTOSKELETON; BRAIN	Neuroacanthocytosis (NA) refers to a group of heterogenous, rare genetic disorders, namely chorea acanthocytosis (ChAc), McLeod syndrome (MLS), Huntington's disease-like 2 (HDL2) and pantothenate kinase associated neurodegeneration (PKAN), that mainly affect the basal ganglia and are associated with similar neurological symptoms. PKAN is also assigned to a group of rare neurodegenerative diseases, known as NBIA (neurodegeneration with brain iron accumulation), associated with iron accumulation in the basal ganglia and progressive movement disorder. Acanthocytosis, the occurrence of misshaped erythrocytes with thorny protrusions, is frequently observed in ChAc and MLS patients but less prevalent in PKAN (about 10%) and HDL2 patients. The pathological factors that lead to the formation of the acanthocytic red blood cell shape are currently unknown. The aim of this study was to determine whether NA/NBIA acanthocytes differ in their functionality from normal erythrocytes. Several flow-cytometry-based assays were applied to test the physiological responses of the plasma membrane, namely drug-induced endocytosis, phosphatidylserine exposure and calcium uptake upon treatment with lysophosphatidic acid. ChAc red cell samples clearly showed a reduced response in drug-induced endovesiculation, lysophosphatidic acid-induced phosphatidylserine exposure, and calcium uptake. Impaired responses were also observed in acanthocyte-positive NBIA (PKAN) red cells but not in patient cells without shape abnormalities. These data suggest an "acanthocytic state" of the red cell where alterations in functional and interdependent membrane properties arise together with an acanthocytic cell shape. Further elucidation of the aberrant molecular mechanisms that cause this acanthocytic state may possibly help to evaluate the pathological pathways leading to neurodegeneration.	[Siegl, Claudia; Hamminger, Patricia; Jank, Herbert; Prohaska, Rainer; Salzer, Ulrich] Med Univ Vienna, Max F Perutz Labs, Vienna, Austria; [Ahting, Uwe; Hartig, Monika; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany; [Bader, Benedikt; Danek, Adrian] Univ Munich, Neurol Klin & Poliklin, Munich, Germany; [Gregory, Allison; Hayflick, Susan] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Hermann, Andreas] Tech Univ Dresden, Div Neurodegenerat Dis, Dept Neurol, Dresden, Germany; [Hermann, Andreas] German Ctr Neurodegenerat Dis DZNE, Dresden, Germany; [Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Sammler, Esther M.] Univ Dundee, Ninewells Hosp & Med Sch, Dept Neurol, Dundee DD1 9SY, Scotland; [Yapici, Zuhal] Istanbul Univ, Div Child Neurol, Dept Neurol, Istanbul Fac Med, Istanbul, Turkey; [Hayflick, Susan] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA; [Hayflick, Susan] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; Oregon Health & Science University; Technische Universitat Dresden; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technische Universitat Dresden; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Dundee; Istanbul University; Oregon Health & Science University; Oregon Health & Science University	Salzer, U (corresponding author), Med Univ Vienna, Max F Perutz Labs, Vienna, Austria.	ulrich.salzer@meduniwien.ac.at	Prokisch, Holger/N-8964-2013; Hermann, Andreas/D-4213-2017; Danek, Adrian/G-7339-2011	Hermann, Andreas/0000-0002-7364-7791; Danek, Adrian/0000-0001-8857-5383; Prokisch, Holger/0000-0003-2379-6286; Salzer, Ulrich/0000-0002-3721-7225; Sammler, Esther/0000-0003-3218-7116	Advocacy for Neuroacanthocytosis Patients; NBIA Disorders Association; Herzfelder'sche Familienstiftung; Austrian Science Fund (FWF) [I 438-B13]; ERA-Net/E-Rare project "EMINA" (European Multidisciplinary Initiative on Neuroacanthocytosis); European Commission [277984]; Austrian Science Fund (FWF) [I 438] Funding Source: researchfish	Advocacy for Neuroacanthocytosis Patients; NBIA Disorders Association; Herzfelder'sche Familienstiftung; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); ERA-Net/E-Rare project "EMINA" (European Multidisciplinary Initiative on Neuroacanthocytosis); European Commission(European CommissionEuropean Commission Joint Research Centre); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was funded in part by the Advocacy for Neuroacanthocytosis Patients (www.naadvocacy.org), the NBIA Disorders Association, the Herzfelder'sche Familienstiftung, the Austrian Science Fund (FWF), grant I 438-B13, the ERA-Net/E-Rare project "EMINA" (European Multidisciplinary Initiative on Neuroacanthocytosis (www.e-rare.eu/financed-projects/emina), the European Commission Seventh Framework Programme (FP7/2007-2013, HEALTH-F2-2011, No. 277984, TIRCON) and Tenovus Scotland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An XL, 2001, J BIOL CHEM, V276, P35778, DOI 10.1074/jbc.M101364200; An XL, 2004, BIOCHEMISTRY-US, V43, P310, DOI 10.1021/bi035653h; Anong WA, 2009, BLOOD, V114, P1904, DOI 10.1182/blood-2009-02-203216; Bader B, 2010, MOVEMENT DISORD, V25, P127, DOI 10.1002/mds.22863; Chung SM, 2007, ARTERIOSCL THROM VAS, V27, P414, DOI 10.1161/01.ATV.0000252898.48084.6a; De Franceschi L, 2011, BLOOD, V118, P5652, DOI 10.1182/blood-2011-05-355339; de Jong K, 2002, BIOCHEMISTRY-US, V41, P12562, DOI 10.1021/bi025882o; Dobson-Stone C, 2004, ANN NEUROL, V56, P299, DOI 10.1002/ana.20200; Nguyen DB, 2011, CELL PHYSIOL BIOCHEM, V28, P847, DOI 10.1159/000335798; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; FEINBERG TE, 1991, NEUROLOGY, V41, P1000, DOI 10.1212/WNL.41.7.1000; Foller M, 2012, FASEB J, V26, P1526, DOI 10.1096/fj.11-198317; Gimsa J, 1998, BIOPHYS J, V75, P568, DOI 10.1016/S0006-3495(98)77546-0; GIMSA J, 1995, MOL MEMBR BIOL, V12, P247, DOI 10.3109/09687689509072424; Hartig MB, 2011, AM J HUM GENET, V89, P543, DOI 10.1016/j.ajhg.2011.09.007; Hayflick SJ, 2003, NEW ENGL J MED, V348, P33, DOI 10.1056/NEJMoa020817; HO MF, 1994, CELL, V77, P869, DOI 10.1016/0092-8674(94)90136-8; Hogarth P, 2013, NEUROLOGY, V80, P268, DOI 10.1212/WNL.0b013e31827e07be; Hosokawa T, 1992, No To Shinkei, V44, P739; Jeremy KP, 2009, HAEMATOL-HEMATOL J, V94, P1354, DOI 10.3324/haematol.2009.006585; KHODADAD JK, 1989, J MEMBRANE BIOL, V107, P213, DOI 10.1007/BF01871936; Khodadad JK, 1996, BIOPHYS J, V70, P1036, DOI 10.1016/S0006-3495(96)79649-2; Kotzbauer PT, 2005, J NEUROSCI, V25, P689, DOI 10.1523/JNEUROSCI.4265-04.2005; LANGE Y, 1984, J MEMBRANE BIOL, V77, P153; MARIANI M, 1993, J BIOL CHEM, V268, P12996; Nans A, 2011, BIOPHYS J, V101, P2341, DOI 10.1016/j.bpj.2011.09.050; Olivieri O, 1997, HAEMATOLOGICA, V82, P648; Ory S, 2013, J NEUROSCI, V33, P3545, DOI 10.1523/JNEUROSCI.3654-12.2013; Prohaska R, 2012, NEUROBIOL DIS, V46, P607, DOI 10.1016/j.nbd.2012.03.006; Rampoldi L, 2001, NAT GENET, V28, P119, DOI 10.1038/88821; Salomao M, 2008, P NATL ACAD SCI USA, V105, P8026, DOI 10.1073/pnas.0803225105; Salzer U, 2002, BLOOD, V99, P2569, DOI 10.1182/blood.V99.7.2569; Salzer U, 2008, ADV PLANAR LIP BILAY, V6, P49, DOI 10.1016/S1554-4516(07)06003-6; Sayas CL, 2002, BBA-MOL CELL BIOL L, V1582, P144, DOI 10.1016/S1388-1981(02)00149-X; Scheid R, 2009, NEUROLOGY, V73, P1419, DOI 10.1212/WNL.0b013e3181bd80d4; SCHRIER SL, 1983, J CLIN INVEST, V72, P1698, DOI 10.1172/JCI111129; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; Terada N, 1999, ACTA HAEMATOL-BASEL, V101, P25, DOI 10.1159/000040917; Ueno S, 2001, NAT GENET, V28, P121, DOI 10.1038/88825; Walker RH, 2007, NEUROLOGY, V68, P92, DOI 10.1212/01.wnl.0000250356.78092.cc; Walker RH, 2003, NEUROLOGY, V61, P1002, DOI 10.1212/01.WNL.0000085866.68470.6D; Wieschhaus A, 2012, BIOCHEM J, V448, P141, DOI 10.1042/BJ20121008; Wong P, 1999, J THEOR BIOL, V196, P343, DOI 10.1006/jtbi.1998.0845; Yang L, 2000, BLOOD, V95, P2420, DOI 10.1182/blood.V95.7.2420.007k12_2420_2425	45	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76715	10.1371/journal.pone.0076715	http://dx.doi.org/10.1371/journal.pone.0076715			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098554	Green Published, gold, Green Submitted			2022-12-25	WOS:000325483600073
J	Yamanaka-Tatematsu, M; Nakashima, A; Fujita, N; Shima, T; Yoshimori, T; Saito, S				Yamanaka-Tatematsu, Mikiko; Nakashima, Akitoshi; Fujita, Naonobu; Shima, Tomoko; Yoshimori, Tamotsu; Saito, Shigeru			Autophagy Induced by HIF1 alpha Overexpression Supports Trophoblast Invasion by Supplying Cellular Energy	PLOS ONE			English	Article							HUMAN PLACENTAL DEVELOPMENT; INDUCIBLE FACTOR-I; 1ST TRIMESTER; HYPOXIA; CELLS; OXYGEN; PREECLAMPSIA; ESTABLISHMENT; RECEPTORS; PREGNANCY	Extravillous trophoblasts (EVTs) characterize the invasion of the maternal decidua under low oxygen and poor nutrition at the early feto-maternal interface to establish a successful pregnancy. We previously reported that autophagy in EVTs was activated under 2% O-2 in vitro, and autophagy activation was also observed in EVTs at the early feto-maternal interface in vivo. Here, we show that autophagy is an energy source for the invasion of EVTs. Cobalt chloride (CoCl2), which induces hypoxia inducible factor 1 alpha (HIF1 alpha) overexpression, activated autophagy in HTR8/SVneo cells, an EVT cell line. The number of invading HTR8-ATG4B(C74A) cells, an autophagy-deficient EVT cell line, was markedly reduced by 81 percent with the CoCl2 treatment through the suppression of MMP9 level, although CoCl2 did not affect the cellular invasion of HTR8-mStrawberry cells, a control cell line. HTR8-ATG4B(C74A) cells treated with CoCl2 showed a decrease in cellular adenosine triphosphate (ATP) levels and a compensatory increase in the expression of purinergic receptor P2X ligand-gated ion channel 7 (P2RX7), which is stimulated with ATP, whereas HTR8- mStrawberry cells maintained cellular ATP levels and did not affect P2RX7 expression. Furthermore, the decreased invasiveness of HTR8-ATG4B(C74A) cells treated with CoCl2 was neutralized by ATP supplementation to the level of HTR8-ATG4B(C74A) cells treated without CoCl2. These results suggest that autophagy plays a role in maintaining homeostasis by countervailing HIF1 alpha-mediated cellular energy consumption in EVTs.	[Yamanaka-Tatematsu, Mikiko; Nakashima, Akitoshi; Shima, Tomoko; Saito, Shigeru] Toyama Univ, Fac Med, Dept Obstet & Gynecol, Toyama 930, Japan; [Fujita, Naonobu; Yoshimori, Tamotsu] Osaka Univ, Dept Genet, Grad Sch Med, Suita, Osaka, Japan	University of Toyama; Osaka University	Saito, S (corresponding author), Toyama Univ, Fac Med, Dept Obstet & Gynecol, Toyama 930, Japan.	s30saito@med.u-toyama.ac.jp	Fujita, Naonobu/A-1218-2010	Fujita, Naonobu/0000-0003-1914-8438	Ministry of Education, Culture, Sports, Science, and Technology of Japan [23390386, 22659297, 23791817]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [a Grant-in-Aid for Scientific Research, (B)-23390386, a Grant-in-Aid for Challenging Exploratory Research, (C)-22659297, and a Grant-in-Aid for young scientists, (B)-23791817]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Caniggia I, 2000, J CLIN INVEST, V105, P577, DOI 10.1172/JCI8316; Chen G, 2013, CARDIOVASC RES, V98, P437, DOI 10.1093/cvr/cvt035; Choi Jong-Ho, 2012, Clin Exp Reprod Med, V39, P73, DOI 10.5653/cerm.2012.39.2.73; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Genbacev O, 1997, SCIENCE, V277, P1669, DOI 10.1126/science.277.5332.1669; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Ietta F, 2006, BIOL REPROD, V75, P112, DOI 10.1095/biolreprod.106.051557; Jauniaux E, 2005, J CLIN ENDOCR METAB, V90, P1171, DOI 10.1210/jc.2004-1513; Jauniaux E, 2001, AM J OBSTET GYNECOL, V184, P998, DOI 10.1067/mob.2001.111935; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Lai ZB, 2011, HYPERTENSION, V57, P505, DOI 10.1161/HYPERTENSIONAHA.110.163329; Lu HF, 2007, BIOCHEM BIOPH RES CO, V362, P946, DOI 10.1016/j.bbrc.2007.08.095; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897; Nakashima A, 2013, AUTOPHAGY, V9, P303, DOI 10.4161/auto.22927; Nakashima A, 2010, AM J REPROD IMMUNOL, V63, P104, DOI 10.1111/j.1600-0897.2009.00771.x; Omi H, 2009, INT J MOL MED, V23, P229, DOI 10.3892/ijmm_00000121; Poellinger L, 2004, CURR OPIN GENET DEV, V14, P81, DOI 10.1016/j.gde.2003.12.006; Rajakumar A, 2004, PLACENTA, V25, P763, DOI 10.1016/j.placenta.2004.02.011; Redman CWG, 1997, NAT MED, V3, P610, DOI 10.1038/nm0697-610; Rolfo A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013288; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Starzyk KA, 1997, HUM PATHOL, V28, P353, DOI 10.1016/S0046-8177(97)90135-0; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Trabanelli S, 2012, J IMMUNOL, V189, P1303, DOI 10.4049/jimmunol.1103800; Tuuli MG, 2011, PLACENTA, V32, pS109, DOI 10.1016/j.placenta.2010.12.013; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200	32	57	59	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76605	10.1371/journal.pone.0076605	http://dx.doi.org/10.1371/journal.pone.0076605			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098539	Green Submitted, Green Published, gold			2022-12-25	WOS:000325483600067
J	Larsen, BB; Chen, LN; Maust, BS; Kim, M; Zhao, H; Deng, WJ; Westfall, D; Beck, I; Frenkel, LM; Mullins, JI				Larsen, Brendan B.; Chen, Lennie; Maust, Brandon S.; Kim, Moon; Zhao, Hong; Deng, Wenjie; Westfall, Dylan; Beck, Ingrid; Frenkel, Lisa M.; Mullins, James I.			Improved Detection of Rare HIV-1 Variants using 454 Pyrosequencing	PLOS ONE			English	Article							GENERATION SEQUENCING DATA; LIMITING DILUTION ASSAYS; VIRUS TYPE-1 RNA; ANTIRETROVIRAL THERAPY; TREATMENT-NAIVE; REVERSE-TRANSCRIPTASE; RESISTANT VARIANTS; DRUG-RESISTANCE; VIRAL VARIANTS; PCR ASSAY	454 pyrosequencing, a massively parallel sequencing (MPS) technology, is often used to study HIV genetic variation. However, the substantial mismatch error rate of the PCR required to prepare HIV-containing samples for pyrosequencing has limited the detection of rare variants within viral populations to those present above similar to 1%. To improve detection of rare variants, we varied PCR enzymes and conditions to identify those that combined high sensitivity with a low error rate. Substitution errors were found to vary up to 3-fold between the different enzymes tested. The sensitivity of each enzyme, which impacts the number of templates amplified for pyrosequencing, was shown to vary, although not consistently across genes and different samples. We also describe an amplicon-based method to improve the consistency of read coverage over stretches of the HIV-1 genome. Twenty-two primers were designed to amplify 11 overlapping amplicons in the HIV-1 clade B gag-pol and env gp120 coding regions to encompass 4.7 kb of the viral genome per sample at sensitivities as low as 0.01-0.2%.	[Larsen, Brendan B.; Chen, Lennie; Maust, Brandon S.; Kim, Moon; Zhao, Hong; Deng, Wenjie; Westfall, Dylan; Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Beck, Ingrid; Frenkel, Lisa M.] Childrens Hosp Res Inst, Seattle, WA USA; [Beck, Ingrid; Frenkel, Lisa M.; Mullins, James I.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Frenkel, Lisa M.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Mullins, James I.] Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Mullins, JI (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	jmullins@uw.edu		Frenkel, Lisa M/0000-0001-9566-8959	National Institute of Allergy and Infectious Diseases [PO1AI057005, UM1AI068618, R37AI47734]; University of Washington Centers for AIDS Research Computational Biology Core [P30AI027757]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, R37AI047734, P01AI057005, UM1AI068618] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Washington Centers for AIDS Research Computational Biology Core; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by grants from National Institute of Allergy and Infectious Diseases to J.I.M. (PO1AI057005, UM1AI068618 and R37AI47734) and the University of Washington Centers for AIDS Research Computational Biology Core (P30AI027757). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Astrovskaya I, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S6-S1; Balduin M, 2009, J CLIN VIROL, V45, P34, DOI 10.1016/j.jcv.2009.03.002; Becker EA, 2012, GENOME BIOL EVOL, V4, P457, DOI 10.1093/gbe/evs029; Bimber BN, 2010, J VIROL, V84, P12087, DOI 10.1128/JVI.01378-10; Bimber BN, 2009, J VIROL, V83, P8247, DOI 10.1128/JVI.00897-09; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Buzon MJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002314; Campbell MS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016986, 10.1371/journal.pone.0018283]; Fischer W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012303; Geretti AM, 2009, JAIDS-J ACQ IMM DEF, V52, P569, DOI 10.1097/QAI.0b013e3181ba11e8; Gianella S, 2011, J VIROL, V85, P8359, DOI 10.1128/JVI.02582-10; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Hedskog C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011345; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Iyer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073015; Jabara CB, 2011, P NATL ACAD SCI USA, V108, P20166, DOI 10.1073/pnas.1110064108; Jakobsen MR, 2010, CLIN INFECT DIS, V50, P566, DOI 10.1086/650001; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Knierim E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028240; Lataillade M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030118; Liu SL, 1996, SCIENCE, V273, P415, DOI 10.1126/science.273.5274.415; Love TMT, 2010, J VIROL, V84, P5802, DOI 10.1128/JVI.00117-10; Luo LX, 2013, BIOINFORMATICS: CONCEPTS, METHODOLOGIES, TOOLS, AND APPLICATIONS, P798, DOI 10.4018/978-1-4666-3604-0.ch042; Macalalad AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002417; Mallona I, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-404; Metzner KJ, 2010, J INFECT DIS, V201, P1063, DOI 10.1086/651136; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; MULDER J, 1994, J CLIN MICROBIOL, V32, P292, DOI 10.1128/JCM.32.2.292-300.1994; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Paredes R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543; Peuchant O, 2008, AIDS, V22, P1417, DOI 10.1097/QAD.0b013e3283034953; Prosperi MCF, 2012, BIOINFORMATICS, V28, P132, DOI 10.1093/bioinformatics/btr627; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Redd AD, 2011, J CLIN MICROBIOL, V49, P2859, DOI 10.1128/JCM.00804-11; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; Rodrigo AG, 1997, AIDS RES HUM RETROV, V13, P737, DOI 10.1089/aid.1997.13.737; Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; Schmitt MW, 2012, P NATL ACAD SCI US; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Stekler JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028952; TASWELL C, 1981, J IMMUNOL, V126, P1614; Vandenbroucke I, 2011, BIOTECHNIQUES, V51, P167, DOI 10.2144/000113733; Varghese V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010992; Zagordi O, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-119	47	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76502	10.1371/journal.pone.0076502	http://dx.doi.org/10.1371/journal.pone.0076502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098517	Green Published, Green Submitted, gold			2022-12-25	WOS:000325434500069
J	Moquin, DM; McQuade, T; Chan, FKM				Moquin, David M.; McQuade, Thomas; Chan, Francis Ka-Ming			CYLD Deubiquitinates RIP1 in the TNF alpha-Induced Necrosome to Facilitate Kinase Activation and Programmed Necrosis	PLOS ONE			English	Article							NF-KAPPA-B; RECEPTOR-INTERACTING PROTEIN; MIXED LINEAGE KINASE; CELL-DEATH; INDUCED APOPTOSIS; DEPENDENT APOPTOSIS; SIGNALING COMPLEX; ENZYME CYLD; DOMAIN-LIKE; UBIQUITINATION	Background: Necroptosis/programmed necrosis is initiated by a macro-molecular protein complex termed the necrosome. Receptor interacting protein kinase 1 (RIPK1/RIP1) and RIP3 are key components of the necrosome. TNF alpha is a prototypic inducer of necrosome activation, and it is widely believed that deubiquitination of RIP1 at the TNFR-1 signaling complex precedes transition of RIP1 into the cytosol where it forms the RIP1-RIP3 necrosome. Cylindromatosis (CYLD) is believed to promote programmed necrosis by facilitating RIP1 deubiquitination at this membrane receptor complex. Methodology/Principal Findings: We demonstrate that RIP1 is indeed the primary target of CYLD in TNF alpha-induced programmed necrosis. We observed that CYLD does not regulate RIP1 ubiquitination at the TNF receptor. TNF and zVAD-induced programmed necrosis was highly attenuated in CYLD-/- cells. However, in the presence of cycloheximide or SMAC mimetics, programmed necrosis was only moderately reduced in CYLD-/- cells. Under the latter conditions, RIP1-RIP3 necrosome formation is only delayed, but not abolished in CYLD-/- cells. We further demonstrate that RIP1 within the NP-40 insoluble necrosome is ubiquitinated and that CYLD regulates RIP1 ubiquitination in this compartment. Hence, RIP1 ubiquitination in this late-forming complex is greatly increased in CYLD-/- cells. Increased RIP1 ubiquitination impairs RIP1 and RIP3 phosphorylation, a signature of kinase activation. Conclusions/Significance: Our results show that CYLD regulates RIP1 ubiquitination in the TNFa-induced necrosome, but not in the TNFR-1 signaling complex. In cells sensitized to programmed necrosis with SMAC mimetics, CYLD is not essential for necrosome assembly. Since SMAC mimetics induces the loss of the E3 ligases cIAP1 and cIAP2, reduced RIP1 ubiquitination could lead to reduced requirement for CYLD to remove ubiquitin chains from RIP1 in the TNFR-1 complex. As increased RIP1 ubiquitination in the necrosome correlates with impaired RIP1 and RIP3 phosphorylation and function, these results suggest that CYLD controls RIP1 kinase activity during necrosome assembly.	[Moquin, David M.; McQuade, Thomas; Chan, Francis Ka-Ming] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Chan, FKM (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA.	francis.chan@umassmed.edu	Chan, Francis Ka-Ming/E-9647-2014; Chan, Francis/ABB-1895-2021	Chan, Francis Ka-Ming/0000-0002-4803-8353; 	NIH [AI083497, AI088502]; NIH T32 training grant [T32 AI07349]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007349, R21AI088502, R01AI083497] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH T32 training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants AI083497 and AI088502 (to FKMC). DMM is supported by NIH T32 training grant (T32 AI07349). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bonnet MC, 2011, IMMUNITY, V35, P572, DOI 10.1016/j.immuni.2011.08.014; Ch'en IL, 2011, J EXP MED; Challa S, 2010, J VIROL, V84, P10467, DOI 10.1128/JVI.00983-10; Challa S, 2010, CELL MOL LIFE SCI, V67, P3241, DOI 10.1007/s00018-010-0413-8; Chan FK, 2012, COLD SPRING HARB PER, V4; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Cho Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023209; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Feng SS, 2007, CELL SIGNAL, V19, P2056, DOI 10.1016/j.cellsig.2007.05.016; Fujikura D, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.3; Green DR, 2011, MOL CELL, V44, P9, DOI 10.1016/j.molcel.2011.09.003; Han JH, 2011, NAT IMMUNOL, V12, P1143, DOI 10.1038/ni.2159; Harhaj EW, 2012, IMMUNOL REV, V246, P107, DOI 10.1111/j.1600-065X.2012.01100.x; Harper N, 2003, J BIOL CHEM, V278, P25534, DOI 10.1074/jbc.M303399200; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Lu JV, 2012, IMMUNOL REV, V249, P205, DOI 10.1111/j.1600-065X.2012.01147.x; Massoumi R, 2010, TRENDS BIOCHEM SCI, V35, P392, DOI 10.1016/j.tibs.2010.02.007; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Moriwaki K, 2013, GENE DEV, V27, P1640, DOI 10.1101/gad.223321.113; Moujalled DM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.201; O'Donnell MA, 2007, CURR BIOL, V17, P418, DOI 10.1016/j.cub.2007.01.027; O'Donnell MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041238; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; O'Donnell MA, 2011, FEBS J, V278, P877, DOI 10.1111/j.1742-4658.2011.08016.x; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Reiley WW, 2006, NAT IMMUNOL, V7, P411, DOI 10.1038/ni1315; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vanlangenakker N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.111; Vanlangenakker N, 2011, CELL DEATH DIFFER, V18, P656, DOI 10.1038/cdd.2010.138; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wright A, 2007, DEV CELL, V13, P705, DOI 10.1016/j.devcel.2007.09.007; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109	48	208	219	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76841	10.1371/journal.pone.0076841	http://dx.doi.org/10.1371/journal.pone.0076841			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098568	Green Published, gold			2022-12-25	WOS:000325434500089
J	Beckham, TH; Cheng, JC; Lu, P; Marrison, ST; Norris, JS; Liu, X				Beckham, Thomas H.; Cheng, Joseph C.; Lu, Ping; Marrison, S. Tucker; Norris, James S.; Liu, Xiang			Acid Ceramidase Promotes Nuclear Export of PTEN through Sphingosine 1-Phosphate Mediated Akt Signaling	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PROTEIN; PROSTATE-CANCER; THYROID-TUMORS; UP-REGULATION; CELL-CYCLE; EXPRESSION; PHOSPHATASE; APOPTOSIS; CHROMOSOME-10; PROGRESSION	The tumor suppressor PTEN is now understood to regulate cellular processes at the cytoplasmic membrane, where it classically regulates PI3K signaling, as well as in the nucleus where multiple roles in controlling cell cycle and genome stability have been elucidated. Mechanisms that dictate nuclear import and, less extensively, nuclear export of PTEN have been described, however the relevance of these processes in disease states, particularly cancer, remain largely unknown. We investigated the impact of acid ceramidase on the nuclear-cytoplasmic trafficking of PTEN. Immunohistochemical analysis of a human prostate tissue microarray revealed that nuclear PTEN was lost in patients whose tumors had elevated acid ceramidase. We found that acid ceramidase promotes a reduction in nuclear PTEN that is dependent upon sphingosine 1-phosphate-mediated activation of Akt. We were further able to show that sphingosine 1-phosphate promotes formation of a complex between Crm1 and PTEN, and that leptomycin B prevents acid ceramidase and sphingosine 1-phosphate mediated loss of nuclear PTEN, suggesting an active exportin-mediated event. To investigate whether the tumor promoting aspects of acid ceramidase in prostate cancer depend upon its ability to export PTEN from the nucleus, we used enforced nuclear expression of PTEN to study docetaxel-induced apoptosis and cell killing, proliferation, and xenoengraftment. Interestingly, while acid ceramidase was able to protect cells expressing wild type PTEN from docetaxel, promote proliferation and xenoengraftment, acid ceramidase had no impact in cells expressing PTEN-NLS. These findings suggest that acid ceramidase, through sphingosine 1-phosphate, promotes nuclear export of PTEN as a means of promoting tumor formation, cell proliferation, and resistance to therapy.	[Beckham, Thomas H.; Cheng, Joseph C.; Lu, Ping; Marrison, S. Tucker; Norris, James S.; Liu, Xiang] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA	Medical University of South Carolina	Beckham, TH (corresponding author), Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA.	beckham@musc.edu		Beckham, Thomas/0000-0001-6189-6996	Department of Defense PCTA [W81XWH-11-1-0334, NCI 5P01CA097132]; National Center For Research Resources [UL1RR029882]; Cancer Center [P30 CA138313]; Lipidomics Core in the SC Lipidomics and Pathobiology COBRE [P20 RR017677]; NATIONAL CANCER INSTITUTE [P01CA097132, P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008716] Funding Source: NIH RePORTER	Department of Defense PCTA; National Center For Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Cancer Center; Lipidomics Core in the SC Lipidomics and Pathobiology COBRE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Department of Defense PCTA W81XWH-11-1-0334, NCI 5P01CA097132, and National Center For Research Resources UL1RR029882. All core facilities were supported, in part, by Cancer Center Support Grant P30 CA138313 to the Hollings Cancer Center, Medical University of South Carolina. This work was also supported by Lipidomics Core in the SC Lipidomics and Pathobiology COBRE (P20 RR017677). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckham TH, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.14; Beckham TH, 2012, INT J CANCER, V131, P2034, DOI 10.1002/ijc.27480; BROTHMAN AR, 1991, J UROLOGY, V145, P1088, DOI 10.1016/S0022-5347(17)38540-3; Chung JH, 2005, CANCER RES, V65, P8096, DOI 10.1158/0008-5472.CAN-05-1888; Dahia PLM, 1997, CANCER RES, V57, P4710; Gil A, 2007, CELL DEATH DIFFER, V14, P395, DOI 10.1038/sj.cdd.4402073; Gil A, 2006, MOL BIOL CELL, V17, P4002, DOI 10.1091/mbc.E06-05-0380; Gimm O, 2000, AM J PATHOL, V156, P1693, DOI 10.1016/S0002-9440(10)65040-7; Ginn-Pease ME, 2003, CANCER RES, V63, P282; Jang KS, 2010, HISTOPATHOLOGY, V56, P229, DOI 10.1111/j.1365-2559.2009.03468.x; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Li AG, 2006, MOL CELL, V23, P575, DOI 10.1016/j.molcel.2006.06.028; Liu JL, 2007, CANCER RES, V67, P11054, DOI 10.1158/0008-5472.CAN-07-1263; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mahdy AEM, 2009, MOL THER, V17, P430, DOI 10.1038/mt.2008.281; Mosessian S, 2009, J BIOL CHEM, V284, P30159, DOI 10.1074/jbc.M109.027995; Norris JS, 2006, CANCER GENE THER, V13, P1045, DOI 10.1038/sj.cgt.7700965; Perren A, 2000, AM J PATHOL, V157, P1097, DOI 10.1016/S0002-9440(10)64624-X; Perren A, 1999, AM J PATHOL, V155, P1253, DOI 10.1016/S0002-9440(10)65227-3; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Saad AF, 2007, CANCER BIOL THER, V6, P1455; Seelan RS, 2000, GENE CHROMOSOME CANC, V29, P137, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1018>3.0.CO;2-E; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Shen Y, 2001, ADV CANCER RES, V82, P55, DOI 10.1016/S0065-230X(01)82002-9; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Vazquez F, 2000, BBA-REV CANCER, V1470, pM21, DOI 10.1016/S0304-419X(99)00032-3; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; Whiteman DC, 2002, INT J CANCER, V99, P63, DOI 10.1002/ijc.10294; Yu ZB, 2002, J BIOL CHEM, V277, P40247, DOI 10.1074/jbc.M207608200	32	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76593	10.1371/journal.pone.0076593	http://dx.doi.org/10.1371/journal.pone.0076593			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098536	Green Published, Green Submitted, gold			2022-12-25	WOS:000325427100078
J	Salinas, JL; Alave, JL; Westfall, AO; Paz, J; Moran, F; Carbajal-Gonzalez, D; Callacondo, D; Avalos, O; Rodriguez, M; Gotuzzo, E; Echevarria, J; Willig, JH				Salinas, Jorge L.; Alave, Jorge L.; Westfall, Andrew O.; Paz, Jorge; Moran, Fiorella; Carbajal-Gonzalez, Danny; Callacondo, David; Avalos, Odalie; Rodriguez, Martin; Gotuzzo, Eduardo; Echevarria, Juan; Willig, James H.			Medication Possession Ratio Predicts Antiretroviral Regimens Persistence in Peru	PLOS ONE			English	Article							HIV-INFECTED ADULTS; EARLY VIROLOGICAL FAILURE; OF-THE-LITERATURE; MEASURING RETENTION; THERAPY; CARE; ADHERENCE; ENGAGEMENT; SURVIVAL	Objectives: In developing nations, the use of operational parameters (OPs) in the prediction of clinical care represents a missed opportunity to enhance the care process. We modeled the impact of multiple measurements of antiretroviral treatment (ART) adherence on antiretroviral treatment outcomes in Peru. Design And Methods: Retrospective cohort study including ART naive, non-pregnant, adults initiating therapy at Hospital Nacional Cayetano Heredia, Lima-Peru (2006-2010). Three OPs were defined: 1) Medication possession ratio (MPR): days with antiretrovirals dispensed/days on first-line therapy; 2) Laboratory monitory constancy (LMC): proportion of 6 months intervals with >= 1 viral load or CD4 reported; 3) Clinic visit constancy (CVC): proportion of 6 months intervals with >= 1 clinic visit. Three multi-variable Cox proportional hazard (PH) models (one per OP) were fit for (1) time of first-line ART persistence and (2) time to second-line virologic failure. All models were adjusted for socio-demographic, clinical and laboratory variables. Results: 856 patients were included in first-line persistence analyses, median age was 35.6 years [29.4-42.9] and most were male (624; 73%). In multivariable PH models, MPR (per 10% increase HR=0.66; 95% CI=0.61-0.71) and LMC (per 10% increase 0.83; 0.71-0.96) were associated with prolonged time on first-line therapies. Among 79 individuals included in time to second-line virologic failure analyses, MPR was the only OP independently associated with prolonged time to second-line virologic failure (per 10% increase 0.88; 0.77-0.99). Conclusions: The capture and utilization of program level parameters such as MPR can provide valuable insight into patient-level treatment outcomes.	[Salinas, Jorge L.; Rodriguez, Martin; Willig, James H.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Alave, Jorge L.; Avalos, Odalie; Gotuzzo, Eduardo; Echevarria, Juan] Hosp Nacl Cayetano Heredia, Minist Salud, Lima, Peru; [Westfall, Andrew O.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Alave, Jorge L.; Paz, Jorge; Gotuzzo, Eduardo; Echevarria, Juan] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Moran, Fiorella; Carbajal-Gonzalez, Danny] Minist Salud, Serv Rural & Urbano Marginal Salud, Lima, Peru; [Callacondo, David] Univ Peruana Cayetano Heredia, Dept Microbiol, Labs Invest & Desarrollo, Lima, Peru	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia	Salinas, JL (corresponding author), Emory Univ, Atlanta, GA 30322 USA.	jlsalinas@emory.edu; jwillig@uab.edu	Alave, Jorge/GSN-3726-2022; Salinas, Jorge/ABC-7735-2021	Alave, Jorge/0000-0002-1178-2445; Salinas, Jorge/0000-0002-9193-820X; Westfall, Andrew/0000-0002-0468-4695	Mary Fisher CARE fund; Fogarty International Center at the U.S. National Institutes of Health (NIH) through Peru International Clinical, Operational, and Health Services Research and Training Award (Peru ICOHRTA network for AIDS/TB research) [1U2RTW007368-01A1]	Mary Fisher CARE fund; Fogarty International Center at the U.S. National Institutes of Health (NIH) through Peru International Clinical, Operational, and Health Services Research and Training Award (Peru ICOHRTA network for AIDS/TB research)	This study was partially financed by the Mary Fisher CARE fund and the Fogarty International Center at the U.S. National Institutes of Health (NIH) through Peru International Clinical, Operational, and Health Services Research and Training Award (Peru ICOHRTA network for AIDS/TB research) [grant number 1U2RTW007368-01A1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JW, 2011, AIDS, V25, P279, DOI 10.1097/QAD.0b013e328340feb0; Bisson GP, 2008, PLOS MED, V5, P777, DOI 10.1371/journal.pmed.0050109; Chen RY, 2003, CLIN INFECT DIS, V37, P714, DOI 10.1086/377271; Danel C, 2009, AIDS RES HUM RETROV, V25, P783, DOI 10.1089/aid.2009.0018; Davila JA, 2013, AIDS CARE, V25, P202, DOI 10.1080/09540121.2012.689811; Giordano TP, 2007, CLIN INFECT DIS, V44, P1493, DOI 10.1086/516778; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; Hong SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056307; Kavasery R, 2009, JAIDS-J ACQ IMM DEF, V50, P360, DOI 10.1097/QAI.0b013e318198a800; Leon A, 2005, AIDS, V19, P213, DOI 10.1097/00002030-200501280-00017; Li XH, 2005, JAIDS-J ACQ IMM DEF, V38, P320; Lodwick RK, 2008, AIDS, V22, P1039, DOI 10.1097/QAD.0b013e3282fec415; Maitland D, 2005, AIDS, V19, P1183, DOI 10.1097/01.aids.0000176218.40861.14; McMahon JH, 2011, CLIN INFECT DIS, V52, P493, DOI 10.1093/cid/ciq167; *MIN SAL PER, 2006, NAC AT GUIA INT PERS, P99152; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V61, P574, DOI 10.1097/QAI.0b013e318273762f; Mugavero MJ, 2010, AIDS PATIENT CARE ST, V24, P607, DOI 10.1089/apc.2010.0086; Mugavero MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P100, DOI 10.1097/QAI.0b013e31818d5c37; *NAC EST I INF, 2008, PER COMP EST, P99152; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; Olatosi BA, 2009, AIDS, V23, P725, DOI 10.1097/QAD.0b013e328326f546; Torian LV, 2011, AIDS PATIENT CARE ST, V25, P79, DOI 10.1089/apc.2010.0151; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; UNAIDS, 2010, GLOB REP UNAIDS REP; WHO, 2010, ANT THER HIV INF AD; Willig JH, 2010, JAIDS-J ACQ IMM DEF, V53, P215, DOI 10.1097/QAI.0b013e3181bc0f10; Yehia BR, 2012, AIDS, V26, P1131, DOI 10.1097/QAD.0b013e3283528afa	27	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76323	10.1371/journal.pone.0076323	http://dx.doi.org/10.1371/journal.pone.0076323			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098475	gold, Green Submitted, Green Published			2022-12-25	WOS:000325427100058
J	Webb, IC; Coolen, LM; Lehman, MN				Webb, Ian C.; Coolen, Lique M.; Lehman, Michael N.			NMDA and PACAP Receptor Signaling Interact to Mediate Retinal-Induced SCN Cellular Rhythmicity in the Absence of Light	PLOS ONE			English	Article							GASTRIN-RELEASING-PEPTIDE; CYCLASE-ACTIVATING POLYPEPTIDE; RAT SUPRACHIASMATIC NUCLEUS; CLOCK GENE-EXPRESSION; INDUCED PHASE-SHIFT; PROTEIN-KINASE-C; CIRCADIAN-RHYTHMS; GANGLION-CELLS; NEURONAL-ACTIVITY; SYRIAN-HAMSTER	The "core" region of the suprachiasmatic nucleus (SCN), a central clock responsible for coordinating circadian rhythms, shows a daily rhythm in phosphorylation of extracellular regulated kinase (pERK). This cellular rhythm persists under constant darkness and, despite the absence of light, is dependent upon inputs from the eye. The neural signals driving this rhythmicity remain unknown and here the roles of glutamate and PACAP are examined. First, rhythmic phosphorylation of the NR1 NMDA receptor subunit (pNR1, a marker for receptor activation) was shown to coincide with SCN core pERK, with a peak at circadian time (CT) 16. Enucleation and intraocular TTX administration attenuated the peak in the pERK and pNR1 rhythms, demonstrating that activation of the NMDA receptor and ERK in the SCN core at CT16 are dependent on retinal inputs. In contrast, ERK and NR1 phosphorylation in the SCN shell region were unaffected by these treatments. Intraventricular administration of the NMDA receptor antagonist MK-801 also attenuated the peak in SCN core pERK, indicating that ERK phosphorylation in this region requires NMDA receptor activation. As PACAP is implicated in photic entrainment and is known to modulate glutamate signaling, the effects of a PAC(1) receptor antagonist (PACAP (6-38)) on SCN core pERK and pNR1 also were examined. PACAP (6-38) administration attenuated SCN core pERK and pNR1, suggesting that PACAP induces pERK directly, and indirectly via a modulation of NMDA receptor signaling. Together, these data indicate that, in the absence of light, retinal-mediated NMDA and PAC(1) receptor activation interact to induce cellular rhythms in the SCN core. These results highlight a novel function for glutamate and PACAP release in the hamster SCN apart from their well-known roles in the induction of photic circadian clock resetting.	[Webb, Ian C.; Coolen, Lique M.; Lehman, Michael N.] Univ Mississippi, Med Ctr, Dept Neurobiol & Anat Sci, Jackson, MS 39216 USA; [Coolen, Lique M.; Lehman, Michael N.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Coolen, Lique M.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; Western University (University of Western Ontario)	Lehman, MN (corresponding author), Univ Mississippi, Med Ctr, Dept Neurobiol & Anat Sci, Jackson, MS 39216 USA.	mlehman@umc.edu	Lehman, Michael/ABC-9076-2020	Lehman, Michael/0000-0002-9076-5108; Coolen, Lique/0000-0003-2920-1116	NSERC Discovery grant; CIHR Fellowship	NSERC Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR Fellowship(Canadian Institutes of Health Research (CIHR))	This work was supported by a NSERC Discovery grant to MNL and a CIHR Fellowship to ICW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Aida R, 2002, MOL PHARMACOL, V61, P26, DOI 10.1124/mol.61.1.26; Aioun J, 1998, CELL TISSUE RES, V291, P239, DOI 10.1007/s004410050994; Akashi M, 2008, J NEUROSCI, V28, P4619, DOI 10.1523/JNEUROSCI.3410-07.2008; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Albrecht U, 2012, NEURON, V74, P246, DOI 10.1016/j.neuron.2012.04.006; Antle MC, 2005, TRENDS NEUROSCI, V28, P145, DOI 10.1016/j.tins.2005.01.003; Arima H, 2002, ENDOCRINOLOGY, V143, P4165, DOI 10.1210/en.2002-220393; Bergstrom AL, 2003, EUR J NEUROSCI, V18, P2552, DOI 10.1046/j.1460-9568.2003.03000.x; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Bryant DN, 2000, J BIOL RHYTHM, V15, P103, DOI 10.1177/074873040001500204; Butcher GQ, 2005, J NEUROSCI, V25, P5305, DOI 10.1523/JNEUROSCI.4361-04.2005; Butcher GQ, 2002, J BIOL CHEM, V277, P29519, DOI 10.1074/jbc.M203301200; CARD JP, 1984, NEUROSCIENCE, V13, P415, DOI 10.1016/0306-4522(84)90240-9; Chen D, 1999, P NATL ACAD SCI USA, V96, P13468, DOI 10.1073/pnas.96.23.13468; COLWELL CS, 1992, J BIOL RHYTHM, V7, P125, DOI 10.1177/074873049200700204; Coogan AN, 2003, J NEUROSCI, V23, P3085; DAAN S, 1976, J COMP PHYSIOL, V106, P253, DOI 10.1007/BF01417857; DEVRIES MJ, 1994, BRAIN RES, V642, P206, DOI 10.1016/0006-8993(94)90923-7; Dominguez JM, 2007, BEHAV NEUROSCI, V121, P1023, DOI 10.1037/0735-7044.121.5.1023; Doyle SE, 2002, VISUAL NEUROSCI, V19, P593, DOI 10.1017/S0952523802195058; Dziema H, 2002, J NEUROPHYSIOL, V88, P1374, DOI 10.1152/jn.2002.88.3.1374; EARNEST DJ, 1993, BRAIN RES, V627, P205, DOI 10.1016/0006-8993(93)90322-E; Engelund A, 2010, CELL TISSUE RES, V340, P243, DOI 10.1007/s00441-010-0950-3; Gamble KL, 2007, J NEUROSCI, V27, P12078, DOI 10.1523/JNEUROSCI.1109-07.2007; Gamble KL, 2011, J BIOL RHYTHM, V26, P99, DOI 10.1177/0748730410396678; GILLETTE MU, 1987, BRAIN RES BULL, V19, P135, DOI 10.1016/0361-9230(87)90176-6; GLASS JD, 1993, J BIOL RHYTHM, V8, pS47; Glickman G, 2012, J BIOL RHYTHM, V27, P308, DOI 10.1177/0748730412450826; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Guillaumond F, 2007, J NEUROCHEM, V101, P1224, DOI 10.1111/j.1471-4159.2006.04416.x; Hannibal J, 2000, J COMP NEUROL, V418, P147; Hannibal J, 1997, J NEUROSCI, V17, P2637, DOI 10.1523/jneurosci.17-07-02637.1997; Hannibal J, 2002, CELL TISSUE RES, V309, P73, DOI 10.1007/s00441-002-0574-3; Hannibal J, 2001, J NEUROSCI, V21, P4883, DOI 10.1523/JNEUROSCI.21-13-04883.2001; Hannibal J, 2006, INT REV CYTOL, V251, P1, DOI 10.1016/S0074-7696(06)51001-0; Harlow E., 1988, ANTIBODIES LAB MANUA; Harrington ME, 1999, J NEUROSCI, V19, P6637; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Herzog ED, 2004, J BIOL RHYTHM, V19, P35, DOI 10.1177/0748730403260776; Honma S, 1996, AM J PHYSIOL-REG I, V271, pR579, DOI 10.1152/ajpregu.1996.271.3.R579; Kopp MDA, 2001, J NEUROCHEM, V79, P161, DOI 10.1046/j.1471-4159.2001.00553.x; Lee HS, 2003, NAT NEUROSCI, V6, P111, DOI 10.1038/nn1006; Lee HS, 2003, J BIOL RHYTHM, V18, P435, DOI 10.1177/0748730403259106; LeSauter J, 2011, J NEUROPHYSIOL, V106, P576, DOI 10.1152/jn.00060.2011; Liu XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050602; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Lupi D, 1999, NEUROSCIENCE, V89, P363, DOI 10.1016/S0306-4522(98)00353-4; Macdonald DS, 2005, J NEUROSCI, V25, P11374, DOI 10.1523/JNEUROSCI.3871-05.2005; Maywood ES, 2011, P NATL ACAD SCI US; Maywood ES, 2011, EXP NEUROL; McArthur AJ, 2000, J NEUROSCI, V20, P5496, DOI 10.1523/JNEUROSCI.20-14-05496.2000; Michel S, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-15; Minami Y, 2002, NEUROSCIENCE, V113, P37, DOI 10.1016/S0306-4522(02)00148-3; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Morin LP, 2006, NEUROSCIENCE, V137, P1285, DOI 10.1016/j.neuroscience.2005.10.030; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; NEWMAN GC, 1986, BRAIN RES, V381, P345, DOI 10.1016/0006-8993(86)90086-7; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; PIGGINS HD, 1995, J NEUROSCI, V15, P5612; Piggins HD, 2001, NEUROSCI LETT, V305, P25, DOI 10.1016/S0304-3940(01)01796-7; REA MA, 1993, AM J PHYSIOL, V265, pR1191, DOI 10.1152/ajpregu.1993.265.5.R1191; Romijn HJ, 1996, J COMP NEUROL, V372, P1; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Ruan GX, 2006, P NATL ACAD SCI USA, V103, P9703, DOI 10.1073/pnas.0601940103; Ruan GX, 2008, PLOS BIOL, V6, P2248, DOI 10.1371/journal.pbio.0060249; Sakamoto K, 2005, EUR J NEUROSCI, V22, P3129, DOI 10.1111/j.1460-9568.2005.04512.x; Sakamoto K, 2004, J NEUROSCI, V24, P9693, DOI 10.1523/JNEUROSCI.2556-04.2004; Schmidt TM, 2011, TRENDS NEUROSCI, V34, P572, DOI 10.1016/j.tins.2011.07.001; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; SHIBATA S, 1982, BRAIN RES, V247, P154, DOI 10.1016/0006-8993(82)91041-1; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Shinohara K, 1998, NEUROREPORT, V9, P137, DOI 10.1097/00001756-199801050-00027; Staudt MD, 2011, J SEX MED, V8, P1015, DOI 10.1111/j.1743-6109.2010.02168.x; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Tanaka M, 1997, NEUROREPORT, V8, P2187, DOI 10.1097/00001756-199707070-00020; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; Tosini G, 1998, BRAIN RES, V789, P221, DOI 10.1016/S0006-8993(97)01446-7; Tosini G, 2007, BRAIN RES, V1148, P76, DOI 10.1016/j.brainres.2007.02.055; Tosini G, 2007, BRAIN RES, V1159, P134, DOI 10.1016/j.brainres.2007.05.023; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; Weng SJ, 2009, J BIOL RHYTHM, V24, P391, DOI 10.1177/0748730409343767; Yamazaki S, 2002, J BIOL RHYTHM, V17, P315, DOI 10.1177/074873040201700405; Zhou CJ, 2001, PEPTIDES, V22, P1111, DOI 10.1016/S0196-9781(01)00437-5	87	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76365	10.1371/journal.pone.0076365	http://dx.doi.org/10.1371/journal.pone.0076365			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098484	Green Published, Green Submitted, gold			2022-12-25	WOS:000325427100064
J	Chaalali, A; Beaugrand, G; Raybaud, V; Goberville, E; David, V; Boet, P; Sautour, B				Chaalali, Aurelie; Beaugrand, Gregory; Raybaud, Virginie; Goberville, Eric; David, Valerie; Boet, Philippe; Sautour, Benoit			Climatic Facilitation of the Colonization of an Estuary by Acartia tonsa	PLOS ONE			English	Article							LONG-TERM CHANGES; GIRONDE ESTUARY; EGG-PRODUCTION; SPATIAL-DISTRIBUTION; CALANOID COPEPODS; HATCHING SUCCESS; ZOOPLANKTON; SALINITY; FISH; TEMPERATURE	Global change has become a major driving force of both terrestrial and marine systems. Located at the interface between these two realms, estuarine ecosystems are probably the place where both direct and indirect effects of human activities conspire together to affect biodiversity from phytoplankton to top predators. Among European estuarine systems, the Gironde is the largest estuary of Western Europe and many studies have provided evidence that it has been affected by a variety of anthropogenic stressors such as thermal and chemical pollution, physical alterations and exploitation, especially for maritime traffic. In such a context, species introduction is also a current major issue with the establishment of strong competitive species that could lead to ecosystem reorganization with potential decrease or even disappearance of native species. In the Gironde estuary, this hypothesis was proposed for the invasive shrimp species Palaemon macrodactylus as a decrease in the native species abundance was observed at the same time. Although species introduction often takes place via ballast water, the influence of climate-driven changes on the establishment of new species remains a key issue. The calanoid copepod Acartia tonsa, observed in the Gironde estuary for the first time in 1983, have since colonized most part of the estuary, reaching a level of abundance comparable to the dominant native species Eurytemora affinis. In this study, using both the concept of the ecological niche sensu Hutchinson (fundamental and realized niches) and statistical models, we reveal that the dynamics of the colonization of A. tonsa was facilitated by environmental conditions that have become closer to its environmental optimum with respect to temperature and salinity.	[Chaalali, Aurelie; David, Valerie; Sautour, Benoit] Univ Bordeaux 1, UMR EPOC 5805, Stn Marine Arcachon, Arcachon, France; [Chaalali, Aurelie; David, Valerie; Sautour, Benoit] CNRS, UMR EPOC 5805, Arcachon, France; [Beaugrand, Gregory; Raybaud, Virginie; Goberville, Eric] Univ Lille 1, UMR LOG 8187, Lab Oceanol & Geosci, Wimereux, France; [Beaugrand, Gregory; Raybaud, Virginie; Goberville, Eric] CNRS, UMR LOG 8187, Lab Oceanol & Geosci, Wimereux, France; [Beaugrand, Gregory] Sir Alister Hardy Fdn Ocean Sci, Plymouth, Devon, England; [Goberville, Eric] Univ Lille 1, UMR GEPV 8198, Lab Genet & Evolut Populat Vegetales, F-59655 Villeneuve Dascq, France; [Boet, Philippe] Irstea, Unite Ecosyst Estuariens & Poissons Migrateurs Am, Cestas, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lille - ISITE; Universite de Lille; INRAE	Chaalali, A (corresponding author), Univ Bordeaux 1, UMR EPOC 5805, Stn Marine Arcachon, Arcachon, France.	a.chaalali@epoc.u-bordeaux1.fr	David, Valerie/A-8770-2017; Goberville, Eric/A-2621-2017	David, Valerie/0000-0001-6950-9604; Goberville, Eric/0000-0002-1843-7855; BEAUGRAND, GREGORY/0000-0002-0712-5223; Boet, Philippe/0000-0002-9387-9071; Raybaud, Virginie/0000-0001-6426-3326	Electricite de France (EDF); Institut Francais de Recherche pour l'Exploitation de la Mer (IFREMER); Centre National de la Recherche Scientifique (CNRS); Conseil Regional d'Aquitaine; IFREMER	Electricite de France (EDF)(Electricite de France (EDF)); Institut Francais de Recherche pour l'Exploitation de la Mer (IFREMER); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); IFREMER	The data the authors used for their research article come from monitoring programs supported by Electricite de France (EDF), the Institut Francais de Recherche pour l'Exploitation de la Mer (IFREMER), and the Centre National de la Recherche Scientifique (CNRS). This study was funded by the Conseil Regional d'Aquitaine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril G, 1999, LIMNOL OCEANOGR, V44, P1304, DOI 10.4319/lo.1999.44.5.1304; ALLEN GP, 1972, CR ACAD SCI D NAT, V275, P181; Allen JI, 2007, J MARINE SYST, V64, P3, DOI 10.1016/j.jmarsys.2006.02.010; Aravena G, 2009, ESTUAR COAST SHELF S, V83, P621, DOI 10.1016/j.ecss.2009.05.013; Arrehenius A S, 1889, PHYS CHEM, V4, P226; BAKKER C, 1975, Netherlands Journal of Sea Research, V9, P145, DOI 10.1016/0077-7579(75)90013-7; BARETTA JW, 1988, NETH J SEA RES, V22, P69, DOI 10.1016/0077-7579(88)90053-1; Beaugrand G, 2007, PROG OCEANOGR, V72, P259, DOI 10.1016/j.pocean.2007.01.002; Beaugrand G, 2011, MAR ECOL PROG SER, V424, P175, DOI 10.3354/meps08939; Beaugrand G, 2003, GLOBAL CHANGE BIOL, V9, P801, DOI 10.1046/j.1365-2486.2003.00632.x; Beaugrand G, 2010, CLIM RES, V41, P15, DOI 10.3354/cr00838; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Beguer M, 2011, AQUAT INVASIONS, V6, P301, DOI 10.3391/ai.2011.6.3.07; BLABER SJM, 1980, J FISH BIOL, V17, P143, DOI 10.1111/j.1095-8649.1980.tb02749.x; BRYLINSKI J M, 1981, Journal of Plankton Research, V3, P255, DOI 10.1093/plankt/3.2.255; CARLTON JT, 1993, SCIENCE, V261, P78, DOI 10.1126/science.261.5117.78; Cervetto G, 1999, J EXP MAR BIOL ECOL, V239, P33, DOI 10.1016/S0022-0981(99)00023-4; Chaalali A, ESTUARINE C IN PRESS; Chaalali A, ESTUARIES C IN PRESS; Coupry B, 2008, EVALUATION IMPACTS C; David V, 2005, ESTUAR COAST SHELF S, V64, P171, DOI 10.1016/j.ecss.2005.01.014; David V, 2007, ESTUAR COAST SHELF S, V71, P429, DOI 10.1016/j.ecss.2006.08.018; Diekmann ABS, 2012, MAR BIOL, V159, P2399, DOI 10.1007/s00227-012-1955-0; Dzialowski AR, 2010, HYDROBIOLOGIA, V652, P139, DOI 10.1007/s10750-010-0326-4; Edwards M, 2001, J MAR BIOL ASSOC UK, V81, P207, DOI 10.1017/S0025315401003654; Fort J., 2012, PLOS ONE, V7; Gasparini S, 1997, J PLANKTON RES, V19, P877, DOI 10.1093/plankt/19.7.877; Gaudy R, 2000, J EXP MAR BIOL ECOL, V247, P51, DOI 10.1016/S0022-0981(00)00139-8; Goberville E, 2010, MAR ECOL PROG SER, V408, P129, DOI 10.3354/meps08564; GONZALEZ JG, 1974, MAR BIOL, V27, P219, DOI 10.1007/BF00391947; Gucu AC, 2002, ESTUAR COAST SHELF S, V54, P439, DOI 10.1006/ecss.2000.0657; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Haedrich R.L., 1983, P183; Helaouet P, 2007, MAR ECOL PROG SER, V345, P147, DOI 10.3354/meps06775; Helaouet P, 2009, ECOSYSTEMS, V12, P1235, DOI 10.1007/s10021-009-9261-5; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Hojgaard JK, 2008, AQUAC RES, V39, P828, DOI 10.1111/j.1365-2109.2008.01936.x; Holste L, 2006, MAR BIOL, V148, P1061, DOI 10.1007/s00227-005-0132-0; Hutchinson G.E., 1978, INTRO POPULATION ECO; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; Jousson O, 2000, NATURE, V408, P157, DOI 10.1038/35041623; Lenoir S, 2011, GLOBAL CHANGE BIOL, V17, P115, DOI 10.1111/j.1365-2486.2010.02229.x; Lobry J, 2008, MAR ECOL PROG SER, V358, P13, DOI 10.3354/meps07294; Loots C, 2010, ICES J MAR SCI, V67, P244, DOI 10.1093/icesjms/fsp238; MacDonald Ian A. W., 1994, P199; MAGNUSON JJ, 1979, AM ZOOL, V19, P331; Mauchline J, 1998, BIOL CALANOID COPEPO; Nicolas D, 2011, REG ENVIRON CHANGE, V11, P639, DOI 10.1007/s10113-010-0196-3; Norse E.A., 1993, GLOBAL MARINE BIOL D; OMORI M, 1994, PROG OCEANOGR, V34, P211, DOI 10.1016/0079-6611(94)90009-4; Omori M, 1998, ANTHROPOGENIC SHORT, P279; Parkes SM, 2012, DIVERS DISTRIB, V18, P1199, DOI 10.1111/j.1472-4642.2012.00913.x; Pasquaud S, 2008, ESTUAR COAST SHELF S, V78, P267, DOI 10.1016/j.ecss.2007.12.014; Pasquaud S, 2008, ESTUARINE COASTAL SH, V86, P237; Pasquaud S, 2012, ESTUAR COAST SHELF S, V104, P46, DOI 10.1016/j.ecss.2012.03.021; Pastorinho R, 2003, ACTA OECOL, V24, pS259, DOI 10.1016/S1146-609X(03)00018-3; Pauly D, 2003, GLOBAL CHANGE NEWSLE, V55, P21; Peck MA, 2006, AQUACULTURE, V255, P341, DOI 10.1016/j.aquaculture.2005.11.055; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; Raick C, 2006, PROG OCEANOGR, V70, P27, DOI 10.1016/j.pocean.2006.03.001; Raitsos DE, 2010, LIMNOL OCEANOGR, V55, P1478, DOI 10.4319/lo.2010.55.4.1478; Raybaud V, 2011, J MARINE SYST, V84, P1, DOI 10.1016/j.jmarsys.2010.08.001; Ricciardi A, 2000, TRENDS ECOL EVOL, V15, P62, DOI 10.1016/S0169-5347(99)01745-0; Rombouts I, 2012, ESTUAR COAST SHELF S, V99, P153, DOI 10.1016/j.ecss.2011.12.026; SAUTOUR B, 1995, HYDROBIOLOGIA, V311, P139, DOI 10.1007/BF00008577; Savoye N, 2012, ESTUAR COAST SHELF S, V108, P16, DOI 10.1016/j.ecss.2011.12.005; Selleslagh J, 2012, ESTUAR COAST SHELF S, V112, P243, DOI 10.1016/j.ecss.2012.07.030; SORBE JC, 1981, OCEANIS, V6, P579; Sottolichio A, 1999, CR ACAD SCI II-MEC P, V329, P895; Staneck RS, 1998, TRENDS ECOL EVOL, V13, P429, DOI 10.1016/S0169-5347(98)01494-3; Svetlichny L, 2010, MAR ECOL PROG SER, V419, P109, DOI 10.3354/meps08837; Taylor CM, 2012, BIOL INVASIONS, V14, P307, DOI 10.1007/s10530-011-0063-2; Taylor KE, 2001, J GEOPHYS RES-ATMOS, V106, P7183, DOI 10.1029/2000JD900719; Tester P.A., 1991, P 4 INT C COPEPODA K, P603; Vilas C, 2009, J EXP MAR BIOL ECOL, V369, P165, DOI 10.1016/j.jembe.2008.11.010; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; WHITE JR, 1992, MAR ECOL PROG SER, V86, P239, DOI 10.3354/meps086239; Williams RJ, 2002, P NATL ACAD SCI USA, V99, P12913, DOI 10.1073/pnas.192448799; Zillioux EJ, 1972, EGG DORMANCY NERITIC, P217	79	29	30	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74531	10.1371/journal.pone.0074531	http://dx.doi.org/10.1371/journal.pone.0074531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098656	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500027
J	Chen, YY; Wu, JF; Tu, LL; Xiong, XK; Hu, XD; Huang, J; Xu, ZG; Zhang, XS; Hu, CM; Hu, XY; Guo, AZ; Wang, YL; Chen, HC				Chen, Yingyu; Wu, Junfang; Tu, Lingling; Xiong, Xuekai; Hu, Xidan; Huang, Jiong; Xu, Zhiguang; Zhang, Xiansong; Hu, Changmin; Hu, Xueying; Guo, Aizhen; Wang, Yulan; Chen, Huanchun			H-1-NMR Spectroscopy Revealed Mycobacterium tuberculosis Caused Abnormal Serum Metabolic Profile of Cattle	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; INFECTION; BOVIS; HOST; H-1; TRANSMISSION; MARKER	To re-evaluate virulence of Mycobacterium tuberculosis (M. tb) in cattle, we experimentally infected calves with M. tb and Mycobacterium bovisvia intratracheal injection at a dose of 2.0x10(7) CFU and observed the animals for 33 weeks. The intradermal tuberculin test and IFN-gamma in vitro release assay showed that both M. tb and M. bovis induced similar responses. Immunohistochemical staining of pulmonary lymph nodes indicated that the antigen MPB83 of both M. tb and M. bovis were similarly distributed in the tissue samples. Histological examinations showed all of the infected groups exhibited neutrophil infiltration to similar extents. Although the infected cattle did not develop granulomatous inflammation, the metabolic profiles changed significantly, which were characterized by a change in energy production pathways and increased concentrations of N-acetyl glycoproteins. Glycolysis was induced in the infected cattle by decreased glucose and increased lactate content, and enhanced fatty acid beta-oxidation was induced by decreased TG content, and decreased gluconeogenesis indicated by the decreased concentration of glucogenic and ketogenic amino acids promoted utilization of substances other than glucose as energy sources. In addition, an increase in acute phase reactive serum glycoproteins, together with neutrophil infiltration and increased of IL-1 beta production indicated an early inflammatory response before granuloma formation. In conclusion, this study indicated that both M. tb and M. bovis were virulent to cattle. Therefore, it is likely that cattle with M. tb infections would be critical to tuberculosis transmission from cattle to humans. Nuclear magnetic resonance was demonstrated to be an efficient method to systematically evaluate M. tb and M. bovi sinfection in cattle.	[Chen, Yingyu; Tu, Lingling; Xiong, Xuekai; Zhang, Xiansong; Guo, Aizhen; Chen, Huanchun] Huazhong Agr Univ, Natl Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China; [Chen, Yingyu] Huazhong Agr Univ, Coll Anim Sci, Wuhan, Hubei, Peoples R China; [Xiong, Xuekai; Zhang, Xiansong; Hu, Changmin; Hu, Xueying; Guo, Aizhen; Chen, Huanchun] Huazhong Agr Univ, Coll Vet Med, Wuhan, Hubei, Peoples R China; [Wu, Junfang; Wang, Yulan] Chinese Acad Sci, Key Lab Magnet Resonance Biol Syst, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan Ctr Magnet Resonance,Wuhan Inst Phys & Math, Wuhan, Hubei, Peoples R China; [Tu, Lingling] Wuhan Keqian Anim Biol Prod Co Ltd, Wuhan, Hubei, Peoples R China; [Hu, Xidan; Huang, Jiong; Xu, Zhiguang] Xinjiang Acad Anim Husb & Vet Inst, Urumqi, Xinjiang, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS	Guo, AZ (corresponding author), Huazhong Agr Univ, Natl Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China.	aizhen@mail.hzau.edu.cn; yulan.wang@wipm.ac.cn	chen, ying/HHS-8254-2022; Wang, Yulan/A-8864-2012; Wu, Junfang/AAN-9409-2020	Wang, Yulan/0000-0002-2831-8737; 	China National Basic Research (973) Program [2012CB518801, 2009CB118804, 2012CB934004]; Key Special Science and Technology Program for Important Infectious Diseases such as AIDS and viral hepatitis [2012ZX10003002-016, 2012ZX10004214-004]; National Natural Science Foundation of China (NSFC) [31101843, 20825520, 20921004, 21105115, 20221064]; NSFC Science Fund for Creative Research Groups [31121004]; Fok Ying Tung Education Foundation [132026]	China National Basic Research (973) Program(National Basic Research Program of China); Key Special Science and Technology Program for Important Infectious Diseases such as AIDS and viral hepatitis; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC Science Fund for Creative Research Groups; Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation)	This work was supported by the China National Basic Research (973) Program (2012CB518801, 2009CB118804, 2012CB934004), the Key Special Science and Technology Program for Important Infectious Diseases such as AIDS and viral hepatitis (2012ZX10003002-016; 2012ZX10004214-004), and National Natural Science Foundation of China (NSFC) (31101843, 20825520, 20921004, 21105115, 20221064), the NSFC Science Fund for Creative Research Groups (31121004) and Supported by Fok Ying Tung Education Foundation (132026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta A, 2011, MALAYS J MED SCI, V18, P5; Ameni G, 2011, VET J, V188, P359, DOI 10.1016/j.tvjl.2010.05.005; Arriaga AK, 2002, CLIN EXP IMMUNOL, V128, P229, DOI 10.1046/j.1365-2249.2002.01832.x; BELL JD, 1987, FEBS LETT, V215, P311, DOI 10.1016/0014-5793(87)80168-0; BIRD TA, 1990, J BIOL CHEM, V265, P13578; Chen YingYu, 2012, African Journal of Biotechnology, V11, P15733; Chen YY, 2009, TUBERCULOSIS, V89, P95, DOI 10.1016/j.tube.2008.07.003; de Kantor IN, 2010, INT J TUBERC LUNG D, V14, P1369; Santangelo MD, 2011, J BIOL CHEM, V286, P40219, DOI 10.1074/jbc.M111.259440; de la Rua-Domenech R, 2006, TUBERCULOSIS, V86, P77, DOI 10.1016/j.tube.2005.05.002; Dong FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051060; du Preez I, 2013, TUBERCULOSIS, V93, P330, DOI 10.1016/j.tube.2013.02.008; Du YF, 2011, RES VET SCI, V90, P385, DOI 10.1016/j.rvsc.2010.07.020; Fan WMT, 1996, PROG NUCL MAG RES SP, V28, P161, DOI 10.1016/0079-6565(95)01017-3; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Hewinson RG, 1996, SCAND J IMMUNOL, V43, P490, DOI 10.1046/j.1365-3083.1996.d01-78.x; Kang DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016161; Koch R, 1901, BOSTON MED SURG J, V145, P2; Kunnath-Velayudhan S, 2011, CLIN MICROBIOL REV, V24, P792, DOI 10.1128/CMR.00014-11; Kurtis JD, 2011, INFECT IMMUN, V79, P1254, DOI 10.1128/IAI.01072-10; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; NODA C, 1976, J BIOCHEM, V80, P1159, DOI 10.1093/oxfordjournals.jbchem.a131371; Ocepek M, 2005, J CLIN MICROBIOL, V43, P3555, DOI 10.1128/JCM.43.7.3555-3557.2005; OIE website, OIE TERR MAN MAN DIA; OREILLY LM, 1995, TUBERCLE LUNG DIS, V76, P1, DOI 10.1016/0962-8479(95)90591-X; Phong WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056037; Qi J, 2012, PLOS ONE, V7, DOI [10.1371/journal. pone.0038239, DOI 10.1371/J0URNAL.P0NE.0038239, 10.1371/journal.pone.0038239]; Saric J, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000254; Saule P, 2005, J PARASITOL, V91, P737, DOI 10.1645/GE-3402.1; Schluger NW, 1998, AM J RESP CRIT CARE, V157, P679, DOI 10.1164/ajrccm.157.3.9708002; Shin JH, 2011, J PROTEOME RES, V10, P2238, DOI 10.1021/pr101054m; Slupsky CM, 2007, ANAL CHEM, V79, P6995, DOI 10.1021/ac0708588; Somashekar BS, 2011, J PROTEOME RES, V10, P4186, DOI 10.1021/pr2003352; Somashekar BS, 2012, J PROTEOME RES, V11, P4873, DOI 10.1021/pr300345x; Sun LY, 2012, J PROTEOME RES, V11, P2937, DOI 10.1021/pr3000317; Sunder S, 2009, J CLIN MICROBIOL, V47, P1249, DOI 10.1128/JCM.02042-08; Tao L, 2010, THESIS HUAZHONG AGR, P38; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; Venkatesh SK, 2001, J MAGN RESON IMAGING, V14, P8, DOI 10.1002/jmri.1144; Vordermeier M, 2012, COMP IMMUNOL MICROB, V35, P227, DOI 10.1016/j.cimid.2012.01.003; Wallimann T, 2011, AMINO ACIDS, V40, P1271, DOI 10.1007/s00726-011-0877-3; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Whelan AO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008527; Winters A., 2005, Morbidity and Mortality Weekly Report, V54, P605; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; World Health Organization, 2011, GLOB TUB CONTR WHO R; WU DH, 1995, J MAGN RESON SER A, V115, P260, DOI 10.1006/jmra.1995.1176; Wu J, 2010, PLOS NEGLECT TROP D, P4; Zhang X, 2012, MICROBIOLOGY; Zinsstag JSE, 2006, EC BOVINE TUBERCULOS, P68	54	10	14	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74507	10.1371/journal.pone.0074507	http://dx.doi.org/10.1371/journal.pone.0074507			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098654	Green Submitted, gold, Green Published			2022-12-25	WOS:000325423500025
J	Gauthy, E; Cuende, J; Stockis, J; Huygens, C; Lethe, B; Collet, JF; Bommer, G; Coulie, PG; Lucas, S				Gauthy, Emilie; Cuende, Julia; Stockis, Julie; Huygens, Caroline; Lethe, Bernard; Collet, Jean-Francois; Bommer, Guido; Coulie, Pierre G.; Lucas, Sophie			GARP Is Regulated by miRNAs and Controls Latent TGF-beta 1 Production by Human Regulatory T Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CYCLIC ADENOSINE-MONOPHOSPHATE; TGF-BETA; SELECTIVE DEPLETION; TUMOR-IMMUNITY; REG-CELLS; EXPRESSION; SURFACE; FOXP3; TREG	GARP is a transmembrane protein present on stimulated human regulatory T lymphocytes (Tregs), but not on other T lymphocytes (Th cells). It presents the latent form of TGF-beta 1 on the Treg surface. We report here that GARP favors the cleavage of the pro-TGF-beta 1 precursor and increases the amount of secreted latent TGF-beta 1. Stimulated Tregs, which naturally express GARP, and Th cells transfected with GARP secrete a previously unknown form of latent TGF-beta 1 that is disulfide-linked to GARP. These GARP/TGF-beta 1 complexes are possibly shed from the T cell surface. Secretion of GARP/TGF-beta 1 complexes was not observed with transfected 293 cells and may thus be restricted to the T cell lineage. We conclude that in stimulated human Tregs, GARP not only displays latent TGF-beta 1 at the cell surface, but also increases its secretion by forming soluble disulfide-linked complexes. Moreover, we identified six microRNAs (miRNAs) that are expressed at lower levels in Treg than in Th clones and that target a short region of the GARP 3' UTR. In transfected Th cells, the presence of this region decreased GARP levels, cleavage of pro-TGF-beta 1, and secretion of latent TGF-beta 1.	[Gauthy, Emilie; Cuende, Julia; Stockis, Julie; Huygens, Caroline; Collet, Jean-Francois; Coulie, Pierre G.; Lucas, Sophie] Catholic Univ Louvain, WELBIO, B-1200 Brussels, Belgium; [Gauthy, Emilie; Cuende, Julia; Stockis, Julie; Huygens, Caroline; Collet, Jean-Francois; Bommer, Guido; Coulie, Pierre G.; Lucas, Sophie] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Lethe, Bernard] Ludwig Inst Canc Res Ltd, Brussels Branch, Brussels, Belgium	Universite Catholique Louvain; WELBIO; Universite Catholique Louvain; Ludwig Institute for Cancer Research	Lucas, S (corresponding author), Catholic Univ Louvain, WELBIO, B-1200 Brussels, Belgium.	sophie.lucas@uclouvain.be	; Bommer, Guido/A-8425-2011	Collet, Jean-Francois/0000-0001-8069-7036; Bommer, Guido/0000-0001-6898-4884; Lucas, Sophie/0000-0003-1287-7996; Stockis, Julie/0000-0003-4911-6891	Fonds National pour la Recherche Scientifique (Belgium); Fonds Speciaux de la Recherche (Belgium); Televie grant (Belgium); Belgian Programme on Interuniversity Poles of Attraction; Belgian State, Prime Minister's Office, Science Policy Programming; Belgian Cancer Plan [29_049]; Fondation contre le Cancer (Belgium); Fondation Salus Sanguinis (Belgium); Actions de Recherche Concertees (Belgium); Fonds J. Maisin (Belgium)	Fonds National pour la Recherche Scientifique (Belgium)(Fonds de la Recherche Scientifique - FNRS); Fonds Speciaux de la Recherche (Belgium); Televie grant (Belgium); Belgian Programme on Interuniversity Poles of Attraction; Belgian State, Prime Minister's Office, Science Policy Programming; Belgian Cancer Plan; Fondation contre le Cancer (Belgium); Fondation Salus Sanguinis (Belgium); Actions de Recherche Concertees (Belgium); Fonds J. Maisin (Belgium)	E.G., J.S., G.B., J.-F.C. and S.L. are supported by the Fonds National pour la Recherche Scientifique (Belgium). J.C. is supported by a post-doctoral fellowship from the Fonds Speciaux de la Recherche (Belgium) and C. H. is supported by a Televie grant (Belgium). This work was supported by grants from the Belgian Programme on Interuniversity Poles of Attraction initiated by the Belgian State, Prime Minister's Office, Science Policy Programming, by grants from the Belgian Cancer Plan (Action 29_049), the Fonds National pour la Recherche Scientifique (Belgium), the Fondation contre le Cancer (Belgium), the Fondation Salus Sanguinis (Belgium), the Actions de Recherche Concertees (Belgium) and the Fonds J. Maisin (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Bopp T, 2007, J EXP MED, V204, P1303, DOI 10.1084/jem.20062129; BRUNNER AM, 1989, J BIOL CHEM, V264, P13660; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; de Vries IJM, 2011, CLIN CANCER RES, V17, P841, DOI 10.1158/1078-0432.CCR-10-2227; Dubois CM, 2001, AM J PATHOL, V158, P305, DOI 10.1016/S0002-9440(10)63970-3; DUBOIS CM, 1995, J BIOL CHEM, V270, P10618, DOI 10.1074/jbc.270.18.10618; Fayyad-Kazan H, 2012, J BIOL CHEM, V287, P9910, DOI 10.1074/jbc.M111.337154; Huang B, 2009, EMBO REP, V10, P180, DOI 10.1038/embor.2008.224; Jeker LT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036684; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; KEHRL JH, 1986, J IMMUNOL, V137, P3855; Klages K, 2010, CANCER RES, V70, P7788, DOI 10.1158/0008-5472.CAN-10-1736; Klein M, 2012, J IMMUNOL, V188, P1091, DOI 10.4049/jimmunol.1102045; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Li XR, 2010, EUR J IMMUNOL, V40, P3325, DOI 10.1002/eji.201041093; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; MIYAZONO K, 1991, EMBO J, V10, P1091, DOI 10.1002/j.1460-2075.1991.tb08049.x; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Nakamura K, 2004, J IMMUNOL, V172, P834, DOI 10.4049/jimmunol.172.2.834; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; Onizuka S, 1999, CANCER RES, V59, P3128; Pesu M, 2008, NATURE, V455, P246, DOI 10.1038/nature07210; Probst-Kepper M, 2009, J CELL MOL MED, V13, P3343, DOI 10.1111/j.1582-4934.2009.00782.x; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Rossi RL, 2011, NAT IMMUNOL, V12, P796, DOI 10.1038/ni.2057; Rouas R, 2009, EUR J IMMUNOL, V39, P1608, DOI 10.1002/eji.200838509; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Shimizu J, 1999, J IMMUNOL, V163, P5211; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Stockis J, 2009, EUR J IMMUNOL, V39, P3315, DOI 10.1002/eji.200939684; Stockis J, 2009, EUR J IMMUNOL, V39, P869, DOI 10.1002/eji.200838807; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Todorovic V, 2012, J CELL BIOCHEM, V113, P410, DOI 10.1002/jcb.23385; Tran DQ, 2009, P NATL ACAD SCI USA, V106, P13445, DOI 10.1073/pnas.0901944106; Turk MJ, 2004, J EXP MED, V200, P771, DOI 10.1084/jem.20041130; Wang HY, 2007, CURR OPIN IMMUNOL, V19, P217, DOI 10.1016/j.coi.2007.02.004; Wang R, 2012, MOL BIOL CELL, V23, P1129, DOI 10.1091/mbc.E11-12-1018; Wang R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002705; Wieczorek G, 2009, CANCER RES, V69, P599, DOI 10.1158/0008-5472.CAN-08-2361; Zhao J, 2010, CANCER RES, V70, P4850, DOI 10.1158/0008-5472.CAN-10-0283; Zhou QH, 2013, J IMMUNOL, V190, P6579, DOI 10.4049/jimmunol.1202993; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	50	34	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76186	10.1371/journal.pone.0076186	http://dx.doi.org/10.1371/journal.pone.0076186			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098777	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500147
J	Hou, CC; Yang, WX				Hou, Cong-Cong; Yang, Wan-Xi			Acroframosome-Dependent KIFC1 Facilitates Acrosome Formation during Spermatogenesis in the Caridean Shrimp Exopalaemon modestus	PLOS ONE			English	Article							VESICLE TRANSPORT; NUCLEAR-ENVELOPE; MOTOR PROTEINS; MACROBRACHIUM-NIPPONENSE; MANCHETTE MICROTUBULES; EXPRESSION PATTERN; CYTOPLASMIC DYNEIN; CANDIDATE MOTORS; KINESIN GENE; SPERMIOGENESIS	Background: Acrosome formation and nuclear shaping are the main events in spermatogenesis. During spermiogenesis in Exopalaemon modestus, a unique microtubular structure called the acroframosome (AFS) forms in spermatids. The AFS links to a temporary organelle called the lamellar complex (LCx) leading to the formation of an everted umbrella-shaped acrosome and a dish-shaped nucleus in the mature sperm. These morphological changes require complex cell motility in which the C-terminal kinesin motor protein called KIFC1 is involved. In this study, we demonstrate that KIFC1 moves along the AFS and plays an important role in acrosome formation and nuclear shaping during spermatogenesis in E. modestus. Methodology/Principal Findings: We cloned a 3125 bp complete cDNA of kifc1 from the testis of E. modestus by PCR. The predicted secondary and tertiary structures of E. modestus KIFC1 contain three domains: a) the C-terminus, b) the stalk region, and the c) N-terminusl. Semi-quantitative RT-PCR detected the expression of kifc1 mRNA in different tissues of E. modestus. In situ hybridization demonstrated the temporal and spatial expression profile of kifc1 during spermiogenesis. Western blot identified the expression of KIFC1 in different tissues of E. modestus, including the testis. Immunofluorescence localized KIFC1, tubulin, GM130, and mitochondria in order to elucidate their role during spermiogenesis in E. modestus. Conclusion/Significance: Our results indicate that KIFC1 transports the Golgi complex, mitochondria, and other cellular components that results in acrosome formation and nuclear shaping in E. modestus. The KIFC1 transport function depends upon the microtubular structure called the acroframosome (AFS). This study describes some of the molecular mechanisms involved in the acrosome formation and nuclear shaping in E. modestus. In addition, this study may provide a model for studying the molecular mechanisms involved in spermatogenesis in other crustacean species and lead to a better understanding of the fertilization process in crustaceans.	[Hou, Cong-Cong; Yang, Wan-Xi] Zhejiang Univ, Coll Life Sci, Sperm Lab, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Yang, WX (corresponding author), Zhejiang Univ, Coll Life Sci, Sperm Lab, Hangzhou 310003, Zhejiang, Peoples R China.	wxyang@spermlab.org	Yang, Wan-Xi/D-4401-2011	Yang, Wan-Xi/0000-0001-5695-0150; Yang, Wan-Xi/0000-0001-9304-195X	National Natural Science Foundation of China [41276151, 31072198]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 41276151 and 31072198). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge AC, 2007, FLY, V1, P38, DOI 10.4161/fly.3913; ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Baker SA, 2003, J BIOL CHEM, V278, P34211, DOI 10.1074/jbc.M300156200; Barkus RV, 2008, MOL BIOL CELL, V19, P274, DOI 10.1091/mbc.E07-03-0261; BRADKE DL, 1963, ANAT REC, V145, P210; COLE A, 1988, BIOL REPROD, V38, P385, DOI 10.1095/biolreprod38.2.385; COURTENS JL, 1981, REPROD NUTR DEV, V21, P467, DOI 10.1051/rnd:19810312; Dorner C, 1998, J BIOL CHEM, V273, P20267, DOI 10.1074/jbc.273.32.20267; Du Nanshan, 1988, Oceanologia et Limnologia Sinica, V19, P71; Du Nanshan, 1987, Oceanologia et Limnologia Sinica, V18, P119; Erickson RP, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002032; HALL ES, 1992, BIOL REPROD, V46, P817, DOI 10.1095/biolreprod46.5.817; Hayasaka S, 2008, ASIAN J ANDROL, V10, P561, DOI 10.1111/j.1745-7262.2008.00392.x; Henthorn KS, 2011, MOL BIOL CELL, V22, P4038, DOI 10.1091/mbc.E10-07-0572; Hou CC, 2013, MOL BIOL REP, V40, P1043, DOI 10.1007/s11033-012-2145-3; Hu JR, 2012, MOL BIOL REP, V39, P4207, DOI 10.1007/s11033-011-1206-3; Jiang YQ, 2002, DONGHAI MARINE SCI, V20, P45; KALLIO M, 1995, ENVIRON MOL MUTAGEN, V25, P106, DOI 10.1002/em.2850250204; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; Li Z, 2010, INVERTEBR REPROD DEV, V54, P121, DOI 10.1080/07924259.2010.9652324; MACKINNON EA, 1972, Z ZELLFORSCH MIK ANA, V124, P1; MEISTRICH ML, 1990, AM J ANAT, V188, P74, DOI 10.1002/aja.1001880109; Miller MG, 1999, BIOL REPROD, V60, P1047, DOI 10.1095/biolreprod60.4.1047; Mochizuki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019632; Nakata T, 2011, J CELL BIOL, V194, P245, DOI 10.1083/jcb.201104034; Navolanic PM, 2000, BIOL REPROD, V62, P1360, DOI 10.1095/biolreprod62.5.1360; Pack-Chung E, 2007, NAT NEUROSCI, V10, P980, DOI 10.1038/nn1936; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; RUSSELL LD, 1991, AM J ANAT, V192, P97, DOI 10.1002/aja.1001920202; Schmidt MR, 2009, P NATL ACAD SCI USA, V106, P15344, DOI 10.1073/pnas.0904268106; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Sperry AO, 1996, MOL BIOL CELL, V7, P289, DOI 10.1091/mbc.7.2.289; Stauber T, 2006, CURR BIOL, V16, P2245, DOI 10.1016/j.cub.2006.09.060; Terada S, 2000, CELL, V103, P141, DOI 10.1016/S0092-8674(00)00094-5; Wang DH, 2010, COMP BIOCHEM PHYS A, V157, P123, DOI 10.1016/j.cbpa.2010.05.015; Wang W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015616; Wang W, 2010, COMP BIOCHEM PHYS A, V157, P237, DOI 10.1016/j.cbpa.2010.07.004; Wang YT, 2012, MOL BIOL REP, V39, P7591, DOI 10.1007/s11033-012-1593-0; Watanabe TM, 2007, BIOPHYS J, V92, P4109, DOI 10.1529/biophysj.106.094649; Yang W. Y., 1998, CHIN J APPL ENV BIOL, V4, P49; Yang Wan-Xi, 1998, Acta Zoologica Sinica, V44, P377; Yang WX, 2006, BIOL REPROD, V74, P684, DOI 10.1095/biolreprod.105.049312; Yang WX, 2003, BIOL REPROD, V69, P1719, DOI 10.1095/biolreprod.102.014878; YOSHIDA T, 1994, J CELL SCI, V107, P625; Yu KM, 2009, CELL TISSUE RES, V337, P113, DOI 10.1007/s00441-009-0800-3; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702; Zhang YG, 2004, CELL MOTIL CYTOSKEL, V58, P213, DOI 10.1002/cm.20008; Zhang Y, 2012, DEV BIOL, V366, P101, DOI 10.1016/j.ydbio.2012.04.026; Zhou J, 2009, DEVELOPMENT, V136, P373, DOI 10.1242/dev.030858; Zou Y, 2002, BIOL REPROD, V66, P843, DOI 10.1095/biolreprod66.3.843	51	15	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76065	10.1371/journal.pone.0076065	http://dx.doi.org/10.1371/journal.pone.0076065			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098763	Green Submitted, Green Published, gold			2022-12-25	WOS:000325423500133
J	Lernout, T; Cardinale, E; Jego, M; Despres, P; Collet, L; Zumbo, B; Tillard, E; Girard, S; Filleul, L				Lernout, Tinne; Cardinale, Eric; Jego, Mael; Despres, Philippe; Collet, Louis; Zumbo, Betty; Tillard, Emmanuel; Girard, Sebastien; Filleul, Laurent			Rift Valley Fever in Humans and Animals in Mayotte, an Endemic Situation?	PLOS ONE			English	Article							NORTHEASTERN KENYA; VIRUS; OUTBREAK; SEROPREVALENCE; RUMINANTS; SENEGAL; SHEEP	Retrospective studies and surveillance on humans and animals revealed that Rift Valley Fever virus (RVFV) has been circulating on Mayotte for at least several years. A study was conducted in 2011 to estimate the seroprevalence of RVF in humans and in animals and to identify associated risk factors. Using a multistage cluster sampling method, 1420 individuals were enrolled in the human study, including 337 children aged 5 to 14 years. For the animal study, 198 seronegative ruminants from 33 randomly selected sentinel ruminant herds were followed up for more than one year. In both studies, information on environment and risk factors was collected through a standardized questionnaire. The overall weighted seroprevalence of RVFV antibodies in the general population aged >= 5 years was 3.5% (95% CI 2.6-4.8). The overall seroprevalence of RVFV antibodies in the ruminant population was 25.3% (95% CI 19.8-32.2). Age (>= 15), gender (men), place of birth on the Comoros, living in Mayotte since less than 5 years, low educational level, farming and living close to a water source were significantly associated with RVFV seropositivity in humans. Major risk factors for RFV infection in animals were the proximity of the farm to a water point, previous two-month rainfall and absence of abortions disposal. Although resulting in few clinical cases in humans and in animals, RVFV has been circulating actively on the island of Mayotte, in a context of regular import of the virus from nearby countries through illegal animal movements, the presence of susceptible animals and a favorable environment for mosquito vectors to maintain virus transmission locally. Humans and animals share the same ways of RVFV transmission, with mosquitoes playing an important role. The studies emphasize the need for a one health approach in which humans and animals within their ecosystems are included.	[Lernout, Tinne; Filleul, Laurent] French Inst Publ Hlth Surveillance, Inst Veille Sanitaire, Reg Off Cire, Mamoudzou, Mayotte, France; [Cardinale, Eric; Jego, Mael; Girard, Sebastien] French Agr Res Ctr Int Dev CIRAD, Emerging & Exot Anim Dis Control Joint Res Unit U, Montpellier, France; [Cardinale, Eric] Cyclotron Reunion Indian Ocean Platform Cyroi, Ctr Res & Surveillance Emerging Dis Indian Ocean, St Denis, Reunion, France; [Despres, Philippe] Inst Pasteur, Interact Mol Flavivirus Hotes Unit, Paris, France; [Despres, Philippe] Inst Pasteur, WHO Collaborating Ctr Reference & Res Arboviruses, Paris, France; [Collet, Louis] Lab Hosp Ctr Mayotte CHM, Mamoudzou, Mayotte, France; [Zumbo, Betty] Agence Sante Ocean Indien, Publ Hlth Author, Vector Control Unit, Mamoudzou, Mayotte, France; [Tillard, Emmanuel] French Agr Res Ctr Int Dev CIRAD, Trop & Mediterranean Anim Prod Syst Joint Res Uni, Montpellier, France	Institute of Public Health Surveillance; AgroParisTech; CIRAD; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; AgroParisTech; CIRAD	Lernout, T (corresponding author), French Inst Publ Hlth Surveillance, Inst Veille Sanitaire, Reg Off Cire, Mamoudzou, Mayotte, France.	tinne.lernout@gmail.com; eric.cardinale@cirad.fr			Agence de sante ocean Indien (ARS); Prefecture of Mayotte with CIRAD	Agence de sante ocean Indien (ARS); Prefecture of Mayotte with CIRAD	The study in humans was financed by the Agence de sante ocean Indien (ARS), representing the Public Health Authority in Mayotte and for the animal part by the Prefecture of Mayotte with CIRAD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P157; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P169; Beaty B.J., 1996, BIOL DIS VECTORS; Bird BH, 2009, JAVMA-J AM VET MED A, V234, P883, DOI 10.2460/javma.234.7.883; Cetre-Sossah C, 2012, EMERG INFECT DIS, V18, P969, DOI 10.3201/eid1806.110994; Cetre-Sossah C, 2012, EMERG INFECT DIS, V18, P972, DOI 10.3201/eid1806.111165; Chevalier W, 2005, EMERG INFECT DIS, V11, P1693, DOI 10.3201/eid1111.050193; CRAIG DE, 1967, APPL MICROBIOL, V15, P446, DOI 10.1128/AEM.15.2.446-447.1967; Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418; Elfadil AA, 2006, REV SCI TECH OIE, V25, P1137, DOI 10.20506/rst.25.3.1722; Heinrich N, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001557; Hosmer D. W., APPL LOGISTIC REGRES; Institut national de la statistique et des etudes economiques (Insee), 2007, REP POP AG REC; Jeanmaire EM, 2011, VECTOR-BORNE ZOONOT, V11, P395, DOI 10.1089/vbz.2009.0249; LaBeaud AD, 2008, EMERG INFECT DIS, V14, P1240, DOI 10.3201/eid1408.080082; Le Goff G, 2011, C MULT APPR IMPR PES; LeBreton M, 2006, EMERG INFECT DIS, V12, P702, DOI 10.3201/eid1204.051428; Lernout T, 2009, B VEILLE SANITAIRE, V02; Lernout T, 2011, B VEILLE SANITAIRE, V12; Munyua P, 2010, AM J TROP MED HYG, V83, P58, DOI 10.4269/ajtmh.2010.09-0292; Nabeth P, 2001, EMERG INFECT DIS, V7, P1052, DOI 10.3201/eid0706.010627; Pepin M, 2011, MED MALADIES INFECT, V41, P322, DOI 10.1016/j.medmal.2010.12.010; Pourrut X, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000763; Roger M, 2011, EMERG INFECT DIS, V17, P1319, DOI 10.3201/eid1707.102031; Sissoko D, 2009, EMERGENCE CHEZ HOMME; SWANEPOEL R, 1986, J HYG-CAMBRIDGE, V97, P331, DOI 10.1017/S0022172400065426; THEILER M, 1957, P SOC EXP BIOL MED, V96, P380, DOI 10.3181/00379727-96-23483; Turell MJ, 2008, J MED ENTOMOL, V45, P102, DOI 10.1603/0022-2585(2008)45[102:VCOSAM]2.0.CO;2; WILSON ML, 1994, AM J TROP MED HYG, V50, P663, DOI 10.4269/ajtmh.1994.50.663; Woods CW, 2002, EMERG INFECT DIS, V8, P138, DOI 10.3201/eid0802.010023	31	32	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74192	10.1371/journal.pone.0074192	http://dx.doi.org/10.1371/journal.pone.0074192			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098637	Green Submitted, Green Published, gold			2022-12-25	WOS:000325423500008
J	Sadjadi, A; Yazdanbod, A; Lee, YY; Boreiri, M; Samadi, F; Alizadeh, BZ; Islami, F; Fyfe, V; Babaei, M; Namazi, MJ; Going, JJ; Sotoudeh, M; de Bock, GH; Malekzadeh, R; Derakhshan, MH				Sadjadi, Alireza; Yazdanbod, Abbas; Lee, Yeong Yeh; Boreiri, Majid; Samadi, Fatemeh; Alizadeh, Behrooz Z.; Islami, Farhad; Fyfe, Valerie; Babaei, Masoud; Namazi, Mohammad J.; Going, James J.; Sotoudeh, Masoud; de Bock, Geertruida H.; Malekzadeh, Reza; Derakhshan, Mohammad H.			Serum Ghrelin; A New Surrogate Marker of Gastric Mucosal Alterations in Upper Gastrointestinal Carcinogenesis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HELICOBACTER-PYLORI INFECTION; 2 DISTINCT ETIOLOGIES; INCREASED RISK-FACTOR; SEROLOGICAL MARKERS; ESOPHAGEAL CANCER; CARDIA CANCER; ATROPHY; ADENOCARCINOMA; JAPAN	Background: A few studies have indicated inverse relationships between serum ghrelin and gastric and esophageal cancers but those associations have been restricted to specific populations, including smokers and overweight individuals. We examined the association between ghrelin and gastroesophageal cancers and atrophic gastritis in a population-based setting. Methods: In total 220 gastroesophageal cancers, comprising non-cardia and cardia gastric cancer, esophageal adenocarcinoma, esophageal squamous cell carcinoma (SCC) and age and gender-matched controls were recruited. Serum ghrelin, pepsinogen I/II ratio (PGI/II) and anti-H. pylori IgG antibodies were measured. Relationships between ghrelin and gastroesophageal cancers, after adjustment for PGI/II ratio, H. pylori status and smoking, were tested using logistic regression. Furthermore, in 125 endoscopically normal volunteers, with and without histological atrophic gastritis, the relationship with ghrelin was compared. Results: Serum ghrelin (lowest vs. highest quintile) was inversely associated with gastric cancer: OR (95% CI) 8.71 (1.70-44.59) for cardia and 6.58 (1.26-34.46) for non-cardia cancer. Lower serum ghrelin was also associated with esophageal SCC: OR (95% CI) 5.69 (1.36-23.78), but not with esophageal adenocarcinoma. A similar association was observed between gastric cancer (cardia and non-cardia) and esophageal SCC when serum ghrelin was analysed as a continuous scaled variable. In endoscopically-normal volunteers, extensive atrophic gastritis was associated with low serum ghrelin [OR (95% CI) 0.25 (0.10-0.64)]. Conclusion: Inverse associations between ghrelin and some gastroesophageal cancers suggest a potential role for serum ghrelin as a biomarker of upper gastrointestinal cancers and atrophic gastritis. In areas with a high incidence of gastric and/or esophageal cancer, screening might be more effectively targeted to individuals with low serum ghrelin in addition to the PGI/II ratio.	[Sadjadi, Alireza; Boreiri, Majid; Alizadeh, Behrooz Z.; Sotoudeh, Masoud; Malekzadeh, Reza; Derakhshan, Mohammad H.] Univ Tehran Med Sci, Digest Dis Res Ctr, Tehran, Iran; [Sadjadi, Alireza; Alizadeh, Behrooz Z.; de Bock, Geertruida H.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Yazdanbod, Abbas; Samadi, Fatemeh; Babaei, Masoud] Ardabil Univ Med Sci, Gastrointestinal Canc Res Ctr, Ardebil, Iran; [Lee, Yeong Yeh; Fyfe, Valerie; Namazi, Mohammad J.; Derakhshan, Mohammad H.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Lee, Yeong Yeh] Univ Sains Malaysia, Sch Med Sci, Kubang Kerian, Kelantan, Malaysia; [Islami, Farhad] Mt Sinai Sch Med, Inst Translat Epidemiol, New York, NY USA; [Namazi, Mohammad J.] Sabzevar Univ Med Sci, Sabzevar, Iran; [Going, James J.] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland	Tehran University of Medical Sciences; University of Groningen; Ardabil University of Medical Sciences; University of Glasgow; Universiti Sains Malaysia; Icahn School of Medicine at Mount Sinai; University of Glasgow	Derakhshan, MH (corresponding author), Univ Tehran Med Sci, Digest Dis Res Ctr, Tehran, Iran.	mohammad.derakhshan@glasgow.ac.uk	Malekzadeh, Reza/U-1382-2017; Alizadeh, Behrooz Z Ziad/J-2921-2017; Yazdanbod, Abbas/S-2266-2017; de Bock, Geertruida Hendrika/F-6529-2014; Lee, Yeong Yeh/H-2777-2019; , Alireza/AAE-4134-2022; Derakhshan, Mohammad H/K-8694-2016; Lee, Yeong Yeh/G-2470-2010	Malekzadeh, Reza/0000-0002-9820-6335; Alizadeh, Behrooz Z Ziad/0000-0002-1415-8007; de Bock, Geertruida Hendrika/0000-0003-3104-4471; Lee, Yeong Yeh/0000-0002-6486-7717; , Alireza/0000-0003-0788-2491; Derakhshan, Mohammad H/0000-0002-2549-7100; Lee, Yeong Yeh/0000-0002-6486-7717; Namazi, Mohammad Javad/0000-0001-5680-3919; Malekzadeh, Reza/0000-0003-1043-3814; Islami, Farhad/0000-0002-7357-5994; Going, James/0000-0001-9120-919X; Yazdanbod, Abbas/0000-0002-1381-6717	Digestive Disease Research Centre (DDRC) of Tehran University of Medical Sciences [301/438]; Iran's National Elites Foundation (INEF); Nano Engineering Company, Tehran, Iran	Digestive Disease Research Centre (DDRC) of Tehran University of Medical Sciences; Iran's National Elites Foundation (INEF); Nano Engineering Company, Tehran, Iran	This work was supported by a research grant (301/438) from the Digestive Disease Research Centre (DDRC) of Tehran University of Medical Sciences, a postdoctoral fund from Iran's National Elites Foundation (INEF) and a research grant from Nano Engineering Company, Tehran, Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-34; Atalayer D, 2013, PROG NEURO-PSYCHOPH, V40, P70, DOI 10.1016/j.pnpbp.2012.08.011; Carrasco F, 2012, NUTRITION, V28, P757, DOI 10.1016/j.nut.2011.11.004; Chopin L, 2011, MOL CELL ENDOCRINOL, V340, P65, DOI 10.1016/j.mce.2011.04.013; Cook MB, 2010, CANCER EPIDEM BIOMAR, V19, P1966, DOI 10.1158/1055-9965.EPI-10-0270; CORREA P, 1992, CANCER RES, V52, P6735; de Martel C, 2007, AM J GASTROENTEROL, V102, P1166, DOI 10.1111/j.1572-0241.2007.01116.x; de Vries AC, 2009, INT J CANCER, V124, P2135, DOI 10.1002/ijc.23955; Derakhshan MH, 2008, GUT, V57, DOI 10.1136/gut.2007.137364; Derakhshan MH, 2007, GUT, V56, pA68; Derakhshan MH, 2006, J CLIN PATHOL, V59, P1293, DOI 10.1136/jcp.2005.036111; Derakhshan MH, 2004, GUT, V53, P1262, DOI 10.1136/gut.2003.035857; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Hansen S, 2007, GUT, V56, P918, DOI 10.1136/gut.2006.114504; Hosoda H, 2004, CLIN CHEM, V50, P1077, DOI 10.1373/clinchem.2003.025841; Iijima K, 2007, AM J GASTROENTEROL, V102, P1603, DOI 10.1111/j.1572-0241.2007.01257.x; Islami F, 2011, ANN ONCOL, V22, P754, DOI 10.1093/annonc/mdq411; Isomoto H, 2005, AM J GASTROENTEROL, V100, P1711, DOI 10.1111/j.1572-0241.2005.41492.x; Kamangar F, 2009, INT J CANCER, V124, P456, DOI 10.1002/ijc.23918; Kawashima J, 2009, J GASTROENTEROL, V44, P1046, DOI 10.1007/s00535-009-0120-0; Kerem M, 2008, WORLD J GASTROENTERO, V14, P3633, DOI 10.3748/wjg.14.3633; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Komarowska H, 2012, NEUROENDOCRINOL LETT, V33, P749; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; McColl KEL, 2008, GUT, V57, P721, DOI 10.1136/gut.2007.144774; McColl Kenneth E L, 2002, Keio J Med, V51 Suppl 2, P53; Murphy G, 2012, GUT, V61, P1533, DOI 10.1136/gutjnl-2011-300653; Murphy G, 2011, J NATL CANCER I, V103, P1123, DOI 10.1093/jnci/djr194; Ohata H, 2005, CANCER SCI, V96, P713, DOI 10.1111/j.1349-7006.2005.00098.x; Percy C, 2000, INT CLASSIFICATION D; Rindi G, 2002, HISTOCHEM CELL BIOL, V117, P511, DOI 10.1007/s00418-002-0415-1; Sadeghi-Bazargani H, 2011, VASC HEALTH RISK MAN, V7, P417, DOI 10.2147/VHRM.S22727; Sadjadi A, 2003, INT J CANCER, V107, P113, DOI 10.1002/ijc.11359; Sadjadi A, 2014, INT J CANCER, V134, P181, DOI 10.1002/ijc.28344; Strickertsson JAB, 2011, WORLD J GASTROENTERO, V17, P3117, DOI 10.3748/wjg.v17.i26.3117; Taniaka-Shintani M, 2005, J GASTROENTEROL, V40, P345, DOI 10.1007/s00535-004-155-03; WU Y, 1993, INT J CANCER, V54, P713, DOI 10.1002/ijc.2910540502; Ye WM, 2004, JNCI-J NATL CANCER I, V96, P388, DOI 10.1093/jnci/djh057; Zub-Pokrowiecka A, 2010, MED SCI MONITOR, V16, pCR493; Zub-Pokrowiecka A, 2011, WORLD J GASTROENTERO, V17, P449, DOI 10.3748/wjg.v17.i4.449	41	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74440	10.1371/journal.pone.0074440	http://dx.doi.org/10.1371/journal.pone.0074440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098650	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000325423500021
J	Schwarzkopf, A; Rosenberger, D; Niebergall, M; Gershenzon, J; Kunert, G				Schwarzkopf, Alexander; Rosenberger, Daniel; Niebergall, Martin; Gershenzon, Jonathan; Kunert, Grit			To Feed or Not to Feed: Plant Factors Located in the Epidermis, Mesophyll, and Sieve Elements Influence Pea Aphid's Ability to Feed on Legume Species	PLOS ONE			English	Article							SYMPATRIC HOST RACES; AMINO-ACID-COMPOSITION; ACYRTHOSIPHON-PISUM; MEDICAGO-TRUNCATULA; TISSUE LOCALIZATION; GENETIC-DIVERGENCE; PHLOEM SAP; RESISTANCE; BEHAVIOR; POTATO	The pea aphid (Acyrthosiphon pisum HARRIS), a legume specialist, encompasses at least 11 genetically distinct sympatric host races. Each host race shows a preference for a certain legume species. Six pea aphid clones from three host races were used to localize plant factors influencing aphid probing and feeding behavior on four legume species. Aphid performance was tested by measuring survival and growth. The location of plant factors influencing aphid probing and feeding was determined using the electrical penetration graph (EPG) technique. Every aphid clone performed best on the plant species from which it was originally collected, as well as on Vicia faba. On other plant species, clones showed intermediate or poor performance. The most important plant factors influencing aphid probing and feeding behavior were localized in the epidermis and sieve elements. Repetitive puncturing of sieve elements might be relevant for establishing phloem feeding, since feeding periods appear nearly exclusively after these repetitive sieve element punctures. A combination of plant factors influences the behavior of pea aphid host races on different legume species and likely contributes to the maintenance of these races.	[Schwarzkopf, Alexander; Rosenberger, Daniel; Niebergall, Martin; Gershenzon, Jonathan; Kunert, Grit] Max Planck Inst Chem Ecol, Dept Biochem, Jena, Germany	Max Planck Society	Kunert, G (corresponding author), Max Planck Inst Chem Ecol, Dept Biochem, Jena, Germany.	gkunert@ice.mpg.de	Kunert, Grit/H-4271-2014; Gershenzon, Jonathan/K-1331-2013	Kunert, Grit/0000-0002-9969-8044; Gershenzon, Jonathan/0000-0002-1812-1551	Max Planck Society	Max Planck Society(Max Planck Society)	The work was funded by the Max Planck Society (http://www.mpg.de/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AE, 2006, ENTOMOL EXP APPL, V121, P145, DOI 10.1111/j.1570-8703.2006.00464.x; BACKUS EA, 1985, ENTOMOL EXP APPL, V37, P219, DOI 10.1111/j.1570-7458.1985.tb03478.x; Bos JIB, 2010, PLOS GENET, V6; Caillaud MC, 1999, ENTOMOL EXP APPL, V91, P227, DOI 10.1023/A:1003623915679; Caillaud MC, 2000, AM NAT, V156, P606, DOI 10.1086/316991; Carolan JC, 2011, J PROTEOME RES, V10, P1505, DOI 10.1021/pr100881q; Carolan JC, 2009, PROTEOMICS, V9, P2457, DOI 10.1002/pmic.200800692; Del Campo ML, 2003, ECOL ENTOMOL, V28, P405, DOI 10.1046/j.1365-2311.2003.00524.x; DREYER DL, 1987, J CHEM ECOL, V13, P925, DOI 10.1007/BF01020171; Ferrari J, 2008, EVOLUTION, V62, P2508, DOI 10.1111/j.1558-5646.2008.00468.x; Gabrys B, 1997, J CHEM ECOL, V23, P1661, DOI 10.1023/B:JOEC.0000006442.56544.1a; Gao LL, 2008, PLANT PHYSIOL, V146, P996, DOI 10.1104/pp.107.111971; GIBSON RW, 1983, NATURE, V302, P608, DOI 10.1038/302608a0; Goggin FL, 2007, CURR OPIN PLANT BIOL, V10, P399, DOI 10.1016/j.pbi.2007.06.004; Golawska S, 2006, J INSECT PHYSIOL, V52, P737, DOI 10.1016/j.jinsphys.2006.04.001; Golawska S, 2009, BIOLOGIA, V64, P377, DOI 10.2478/s11756-009-0051-5; Gururani MA, 2012, PHYSIOL MOL PLANT P, V78, P51, DOI 10.1016/j.pmpp.2012.01.002; Hewer A, 2011, J EXP BIOL, V214, P3868, DOI 10.1242/jeb.060913; Hogenhout SA, 2011, CURR OPIN PLANT BIOL, V14, P422, DOI 10.1016/j.pbi.2011.05.003; Kaloshian I, 2000, ENVIRON ENTOMOL, V29, P690, DOI 10.1603/0046-225X-29.4.690; Karley AJ, 2002, J EXP BIOL, V205, P3009; Klingler J, 1998, ENTOMOL EXP APPL, V86, P79, DOI 10.1023/A:1003153410049; Klingler J, 2005, PLANT PHYSIOL, V137, P1445, DOI 10.1104/pp.104.051243; Martin B, 1997, J GEN VIROL, V78, P2701, DOI 10.1099/0022-1317-78-10-2701; MCLEAN DL, 1968, ANN ENTOMOL SOC AM, V61, P927, DOI 10.1093/aesa/61.4.927; Mutti NS, 2008, P NATL ACAD SCI USA, V105, P9965, DOI 10.1073/pnas.0708958105; Mutti NS, 2006, J INS SCI, V6; Pallipparambil GR, 2010, ENTOMOL EXP APPL, V135, P295, DOI 10.1111/j.1570-7458.2010.00995.x; Peccoud J, 2010, ECOL ENTOMOL, V35, P119, DOI 10.1111/j.1365-2311.2009.01147.x; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P16315, DOI 10.1073/pnas.0905129106; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P7495, DOI 10.1073/pnas.0811117106; Pitino M, 2013, MOL PLANT MICROBE IN, V26, P130, DOI 10.1094/MPMI-07-12-0172-FI; Powell G, 2006, ANNU REV ENTOMOL, V51, P309, DOI 10.1146/annurev.ento.51.110104.151107; Powell G, 1999, ENTOMOL EXP APPL, V91, P115, DOI 10.1023/A:1003639225674; Powell G, 2000, PHYSIOL ENTOMOL, V25, P54, DOI 10.1046/j.1365-3032.2000.00164.x; R Core Team, 2011, R LANG ENV STAT COMP; SANDSTROM J, 1994, J INSECT PHYSIOL, V40, P947, DOI 10.1016/0022-1910(94)90133-3; Sarria E, 2009, COMPUT ELECTRON AGR, V67, P35, DOI 10.1016/j.compag.2009.02.006; Tjallingii WF, 1999, ENTOMOL EXP APPL, V91, P97, DOI 10.1023/A:1003655902224; TJALLINGII WF, 1993, PHYSIOL ENTOMOL, V18, P317, DOI 10.1111/j.1365-3032.1993.tb00604.x; TJALLINGII WF, 1986, ENTOMOL EXP APPL, V40, P89, DOI 10.1007/BF00187027; Tjallingii WF, 2006, J EXP BOT, V57, P739, DOI 10.1093/jxb/erj088; Van Hoof HA, 1958, INVESTIGATION BIOL T, P81; VANHELDEN M, 1993, ENTOMOL EXP APPL, V68, P269, DOI 10.1007/BF02380780; Via S, 1999, EVOLUTION, V53, P1446, DOI 10.1111/j.1558-5646.1999.tb05409.x; Walling LL, 2008, PLANT PHYSIOL, V146, P859, DOI 10.1104/pp.107.113142; Webster B, 2008, J CHEM ECOL, V34, P1153, DOI 10.1007/s10886-008-9510-7; WENSLER RJ, 1969, J MORPHOL, V129, P473, DOI 10.1002/jmor.1051290406; Wilkinson TL, 1998, ENTOMOL EXP APPL, V87, P43, DOI 10.1023/A:1003255713767; Will T, 2006, J EXP BOT, V57, P729, DOI 10.1093/jxb/erj089; Will T, 2007, P NATL ACAD SCI USA, V104, P10536, DOI 10.1073/pnas.0703535104; Will T, 2009, J EXP BIOL, V212, P3305, DOI 10.1242/jeb.028514; YAMAMOTO RT, 1974, J INSECT PHYSIOL, V20, P641, DOI 10.1016/0022-1910(74)90185-1	53	47	48	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75298	10.1371/journal.pone.0075298	http://dx.doi.org/10.1371/journal.pone.0075298			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098691	Green Submitted, Green Published, gold			2022-12-25	WOS:000325423500062
J	Yamamoto, K; Tsuzuki, S; Minami, Y; Yamamoto, Y; Abe, A; Ohshima, K; Seto, M; Naoe, T				Yamamoto, Kiyoko; Tsuzuki, Shinobu; Minami, Yosuke; Yamamoto, Yukiya; Abe, Akihiro; Ohshima, Koichi; Seto, Masao; Naoe, Tomoki			Functionally Deregulated AML1/RUNX1 Cooperates with BCR-ABL to Induce a Blastic Phase-Like Phenotype of Chronic Myelogenous Leukemia in Mice	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; MYELODYSPLASTIC SYNDROME; GENE-EXPRESSION; RUNX GENES; AML1 GENE; PHILADELPHIA-CHROMOSOME; SOMATIC MUTATIONS; RAPID INDUCTION; POINT MUTATIONS	Patients in the chronic phase (CP) of chronic myelogenous leukemia (CML) have been treated successfully following the advent of ABL kinase inhibitors, but once they progress to the blast crisis (BC) phase the prognosis becomes dismal. Although mechanisms underlying the progression are largely unknown, recent studies revealed the presence of alterations of key molecules for hematopoiesis, such as AML1/RUNX1. Our analysis of 13 BC cases revealed that three cases had AML1 mutations and the transcript levels of wild-type (wt.) AML1 were elevated in BC compared with CP. Functional analysis of representative AML1 mutants using mouse hematopoietic cells revealed the possible contribution of some, but not all, mutants for the BC-phenotype. Specifically, K83Q and R139G, but neither R80C nor D171N mutants, conferred upon BCR-ABL-expressing cells a growth advantage over BCR-ABL-alone control cells in cytokine-free culture, and the cells thus grown killed mice upon intravenous transfer. Unexpectedly, wt. AML1 behaved similarly to K83Q and R139G mutants. In a bone marrow transplantation assay, K83Q and wt. AML1s induced the emergence of blast-like cells. The overall findings suggest the roles of altered functions of AML1 imposed by some, but not all, mutants, and the elevated expression of wt. AML1 for the disease progression of CML.	[Yamamoto, Kiyoko; Tsuzuki, Shinobu; Seto, Masao] Aichi Canc Ctr, Res Inst, Div Mol Med, Nagoya, Aichi 464, Japan; [Yamamoto, Kiyoko; Minami, Yosuke; Naoe, Tomoki] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi 4648601, Japan; [Yamamoto, Yukiya; Abe, Akihiro] Fujita Hlth Univ, Sch Med, Dept Hematol, Toyoake, Aichi 47011, Japan; [Ohshima, Koichi] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 830, Japan	Aichi Cancer Center; Nagoya University; Fujita Health University; Kurume University	Tsuzuki, S (corresponding author), Aichi Canc Ctr, Res Inst, Div Mol Med, Nagoya, Aichi 464, Japan.	stsuzuki@aichi-cc.jp	Yamamoto, Yukiya/E-9529-2010; Naoe, Tomoki/I-1888-2012; Yamamoto, Yukiya/M-5713-2019	Yamamoto, Yukiya/0000-0002-7439-4925; Yamamoto, Yukiya/0000-0002-7439-4925; Tsuzuki, Shinobu/0000-0002-3209-3550	Health and Labor Scientific Research Grant for Clinical Cancer Research [H23-Gan Rinsho-Ippan-004]; Ministry of Health, Labor and Welfare [23-A-23]; Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science; Princess Takamatsu Cancer Research Fund [11-24307]	Health and Labor Scientific Research Grant for Clinical Cancer Research; Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Princess Takamatsu Cancer Research Fund	This work was supported by the Health and Labor Scientific Research Grant for Clinical Cancer Research (H23-Gan Rinsho-Ippan-004), Grant-in-Aid for Reseach from the Ministry of Health, Labor and Welfare (23-A-23), grant-in-aid for scientific research from The Ministry of Education, Culture, Sports, Science and Technology (M. S.), a grant-in-aid for scientific research from the Japan Society for the Promotion of Science (S. T.), and a research grant from the Princess Takamatsu Cancer Research Fund (11-24307) (S. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE A, 1995, LEUKEMIA, V9, P341; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Boyapati A, 2011, BIOCHEM BIOPH RES CO, V411, P115, DOI 10.1016/j.bbrc.2011.06.107; Cameron ER, 2004, ONCOGENE, V23, P4308, DOI 10.1038/sj.onc.1207130; Cuenco GM, 2000, P NATL ACAD SCI USA, V97, P1760, DOI 10.1073/pnas.030421197; Cuenco GM, 2001, ONCOGENE, V20, P8236, DOI 10.1038/sj.onc.1205095; Dash AB, 2002, P NATL ACAD SCI USA, V99, P7622, DOI 10.1073/pnas.102583199; De Keersmaecker K, 2012, NAT MED, V16, P1321; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Grossmann V, 2011, LEUKEMIA, V25, P557, DOI 10.1038/leu.2010.298; Hamelin V, 2006, BLOOD, V107, P3106, DOI 10.1182/blood-2005-07-2953; Harada H, 2004, BLOOD, V103, P2316, DOI 10.1182/blood-2003-09-3074; Harada H, 2003, BLOOD, V101, P673, DOI 10.1182/blood-2002-04-1010; Hosokawa H, 2006, J IMMUNOL, V177, P7656, DOI 10.4049/jimmunol.177.11.7656; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Imai Y, 2000, BLOOD, V96, P3154, DOI 10.1182/blood.V96.9.3154.h8003154_3154_3160; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Ito Y, 1999, GENES CELLS, V4, P685, DOI 10.1046/j.1365-2443.1999.00298.x; Makishima H, 2011, BLOOD, V117, pE198, DOI 10.1182/blood-2010-06-292433; Matsuura S, 2012, BLOOD, V120, P4028, DOI 10.1182/blood-2012-01-404533; Mayotte N, 2002, BLOOD, V100, P4177, DOI 10.1182/blood-2002-04-1244; Miething C, 2007, P NATL ACAD SCI USA, V104, P4594, DOI 10.1073/pnas.0604716104; MITANI K, 1994, EMBO J, V13, P504, DOI 10.1002/j.1460-2075.1994.tb06288.x; MIYOSHI H, 1995, NUCLEIC ACIDS RES, V23, P2762, DOI 10.1093/nar/23.14.2762; Nakagawa M, 2011, HAEMATOL-HEMATOL J, V96, P1318, DOI 10.3324/haematol.2011.041053; Nakahara F, 2010, BLOOD, V115, P2872, DOI 10.1182/blood-2009-05-222836; Nowicki MO, 2004, BLOOD, V104, P3746, DOI 10.1182/blood-2004-05-1941; NUCIFORA G, 1994, P NATL ACAD SCI USA, V91, P4004, DOI 10.1073/pnas.91.9.4004; OGURA M, 1985, BLOOD, V66, P1384; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Osato M, 2004, ONCOGENE, V23, P4284, DOI 10.1038/sj.onc.1207779; Osato M, 1999, BLOOD, V93, P1817, DOI 10.1182/blood.V93.6.1817.406k36_1817_1824; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Perrotti D, 2010, J CLIN INVEST, V120, P2254, DOI 10.1172/JCI41246; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Rizo A, 2010, BLOOD, V116, P4621, DOI 10.1182/blood-2010-02-270660; Roche-Lestienne C, 2008, BLOOD, V111, P3735, DOI 10.1182/blood-2007-07-102533; RUBIN CM, 1990, BLOOD, V76, P2594; Shen Q, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-42; Signer RAJ, 2008, GENE DEV, V22, P3115, DOI 10.1101/gad.1715808; Sood R, 1999, LEUKEMIA, V13, P348, DOI 10.1038/sj.leu.2401360; Speck NA, 2002, NAT REV CANCER, V2, P502, DOI 10.1038/nrc840; Takeda A, 2006, CANCER RES, V66, P6628, DOI 10.1158/0008-5472.CAN-06-0458; TANAKA T, 1995, EMBO J, V14, P341, DOI 10.1002/j.1460-2075.1995.tb07008.x; TANAKA T, 1995, MOL CELL BIOL, V15, P2383; Tsuzuki S, 2007, PLOS MED, V4, P880, DOI 10.1371/journal.pmed.0040172; Tsuzuki S, 2012, BLOOD, V119, P727, DOI 10.1182/blood-2011-06-362277; Tsuzuki S, 2011, BLOOD, V117, P3858, DOI 10.1182/blood-2010-11-320515; Watanabe-Okochi N, 2008, BLOOD, V111, P4297, DOI 10.1182/blood-2007-01-068346; Wolyniec K, 2009, ONCOGENE, V28, P2502, DOI 10.1038/onc.2009.101; Wotton S, 2002, CANCER RES, V62, P7181; Wotton SF, 2004, ONCOGENE, V23, P5476, DOI 10.1038/sj.onc.1207729; Yanagida M, 2005, ONCOGENE, V24, P4477, DOI 10.1038/sj.onc.1208675; Zhao LJ, 2012, BLOOD, V119, P2873, DOI 10.1182/blood-2011-08-370981	57	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74864	10.1371/journal.pone.0074864	http://dx.doi.org/10.1371/journal.pone.0074864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098673	Green Submitted, gold, Green Published			2022-12-25	WOS:000325423500044
J	Stack, J; Hurst, TP; Flannery, SM; Brennan, K; Rupp, S; Oda, S; Khan, AR; Bowie, AG				Stack, Julianne; Hurst, Tara P.; Flannery, Sinead M.; Brennan, Kiva; Rupp, Sebastian; Oda, Shun-ichiro; Khan, Amir R.; Bowie, Andrew G.			Poxviral Protein A52 Stimulates p38 Mitogen-activated Protein Kinase (MAPK) Activation by Causing Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) Self-association Leading to Transforming Growth Factor beta-activated Kinase 1 (TAK1) Recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						NF-kappa B (NF-KB); p38 MAPK; Pox Viruses; Signal Transduction; Viral Protein; TRAF6	NF-KAPPA-B; VACCINIA-VIRUS; MEDIATED ACTIVATION; GENE-PRODUCT; RECOGNITION; COMPLEX; TARGETS; BINDING; JNK; UBIQUITINATION	Vaccinia virus encodes a number of proteins that inhibit and manipulate innate immune signaling pathways that also have a role in virulence. These include A52, a protein shown to inhibit IL-1- and Toll-like receptor-stimulated NFB activation, via interaction with interleukin-1 receptor-associated kinase 2 (IRAK2). Interestingly, A52 was also found to activate p38 MAPK and thus enhance Toll-like receptor-dependent IL-10 induction, which was TRAF6-dependent, but the manner in which A52 manipulates TRAF6 to stimulate p38 activation was unclear. Here, we show that A52 has a non-canonical TRAF6-binding motif that is essential for TRAF6 binding and p38 activation but dispensable for NFB inhibition and IRAK2 interaction. Wild-type A52, but not a mutant defective in p38 activation and TRAF6 binding (F154A), caused TRAF6 oligomerization and subsequent TRAF6-TAK1 association. The crystal structure of A52 shows that it adopts a Bcl2-like fold and exists as a dimer in solution. Residue Met-65 was identified as being located in the A52 dimer interface, and consistent with that, A52-M65E was impaired in its ability to dimerize. A52-M65E although capable of interacting with TRAF6, was unable to cause either TRAF6 self-association, induce the TRAF6-TAK1 association, or activate p38 MAPK. The results suggest that an A52 dimer causes TRAF6 self-association, leading to TAK1 recruitment and p38 activation. This reveals a molecular mechanism whereby poxviruses manipulate TRAF6 to activate MAPKs (which can be proviral) without stimulating antiviral NFB activation.	[Stack, Julianne; Hurst, Tara P.; Flannery, Sinead M.; Brennan, Kiva; Rupp, Sebastian; Oda, Shun-ichiro; Khan, Amir R.; Bowie, Andrew G.] Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Immunol Res Ctr, Dublin 2, Ireland	Trinity College Dublin	Bowie, AG (corresponding author), Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland.	agbowie@tcd.ie	Oda, Shun-ichiro/P-1365-2015; Hurst, Tara/AAL-1296-2020	Oda, Shun-ichiro/0000-0001-9068-460X; Hurst, Tara/0000-0001-5474-7132; Brennan, Kiva/0000-0003-4960-7076; Khan, Amir/0000-0003-1176-6952; Bowie, Andrew/0000-0001-5316-4373	Science Foundation Ireland [07/IN1/B934, 08/RFP/BIC980]; Science Foundation Ireland-funded Immunology Research Centre [07/SRC/B1144]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Science Foundation Ireland-funded Immunology Research Centre(Science Foundation Ireland)	This work was supported by Science Foundation Ireland Grants 07/IN1/B934 and 08/RFP/BIC980 and as part of the Science Foundation Ireland-funded Immunology Research Centre (Grant 07/SRC/B1144).	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Assarsson E, 2008, P NATL ACAD SCI USA, V105, P2140, DOI 10.1073/pnas.0711573105; Benfield CTO, 2011, J BIOL CHEM, V286, P20727, DOI 10.1074/jbc.M111.231381; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Chen RAJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040022; Cooray S, 2007, J GEN VIROL, V88, P1656, DOI 10.1099/vir.0.82772-0; de Motes CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002430; DiPerna G, 2004, J BIOL CHEM, V279, P36570, DOI 10.1074/jbc.M400567200; Ember SWJ, 2012, J GEN VIROL, V93, P2098, DOI 10.1099/vir.0.045070-0; Gentry JJ, 2004, J BIOL CHEM, V279, P16646, DOI 10.1074/jbc.M309209200; Graham S. C., 2008, PLOS PATHOG, V4; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Hu NJ, 2009, VACCINE, V27, P2994, DOI 10.1016/j.vaccine.2009.02.103; Kalverda AP, 2009, J MOL BIOL, V385, P843, DOI 10.1016/j.jmb.2008.09.048; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Katsoulidis E, 2005, J INTERF CYTOK RES, V25, P749, DOI 10.1089/jir.2005.25.749; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272; LaMonica R, 2001, J BIOL CHEM, V276, P19889, DOI 10.1074/jbc.M100499200; Landstrom M, 2010, INT J BIOCHEM CELL B, V42, P585, DOI 10.1016/j.biocel.2009.12.023; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Liu SQ, 2011, CELL RES, V21, P6, DOI 10.1038/cr.2010.170; Maloney G, 2005, J BIOL CHEM, V280, P30838, DOI 10.1074/jbc.M501917200; Mansur DS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003183; Meads MB, 2010, J IMMUNOL, V185, P1606, DOI 10.4049/jimmunol.0902026; Noels H, 2007, J BIOL CHEM, V282, P10180, DOI 10.1074/jbc.M611038200; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oda S, 2009, STRUCTURE, V17, P1528, DOI 10.1016/j.str.2009.09.005; Park KJ, 2003, J BIOL CHEM, V278, P30711, DOI 10.1074/jbc.M209623200; Poole E, 2006, EMBO J, V25, P4390, DOI 10.1038/sj.emboj.7601287; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Shisler JL, 2004, J VIROL, V78, P3553, DOI 10.1128/JVI.78.7.3553-3560.2004; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Stack J, 2012, J BIOL CHEM, V287, P22672, DOI 10.1074/jbc.M112.349225; Takeuchi O, 2002, CURR TOP MICROBIOL, V270, P155; Uemura N, 2006, J BIOL CHEM, V281, P7863, DOI 10.1074/jbc.M509834200; Unterholzner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002247; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605; Yu XF, 2011, J BIOL CHEM, V286, P18795, DOI 10.1074/jbc.M111.224345	48	14	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33642	33653		10.1074/jbc.M113.485490	http://dx.doi.org/10.1074/jbc.M113.485490			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24114841	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000327250200013
J	Abdali, N; Barth, E; Norouzy, A; Schulz, R; Nau, WM; Kleinekathofer, U; Tauch, A; Benz, R				Abdali, Narges; Barth, Enrico; Norouzy, Amir; Schulz, Robert; Nau, Werner M.; Kleinekathoefer, Ulrich; Tauch, Andreas; Benz, Roland			Corynebacterium jeikeium jk0268 Constitutes for the 40 Amino Acid Long PorACj, Which Forms a Homooligomeric and Anion- Selective Cell Wall Channel	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; MATRIX PROTEIN PORIN; CORYNEBACTERIUM-GLUTAMICUM; BIOPHYSICAL CHARACTERIZATION; BIOCHEMICAL-IDENTIFICATION; MYCOBACTERIUM-SMEGMATIS; PHYLOGENETIC ANALYSIS; MYCOLIC ACID; L-LYSINE; GENE	Corynebacterium jeikeium, a resident of human skin, is often associated with multidrug resistant nosocomial infections in immunodepressed patients. C. jeikeium K411 belongs to mycolic acid-containing actinomycetes, the mycolata and contains a channel-forming protein as judged from reconstitution experiments with artificial lipid bilayer experiments. The channel-forming protein was present in detergent treated cell walls and in extracts of whole cells using organic solvents. A gene coding for a 40 amino acid long polypeptide possibly responsible for the pore-forming activity was identified in the known genome of C. jeikeium by its similar chromosomal localization to known porH and porA genes of other Corynebacterium strains. The gene jk0268 was expressed in a porin deficient Corynebacterium glutamicum strain. For purification temporarily histidine-tailed or with a GST-tag at the N-terminus, the homogeneous protein caused channel-forming activity with an average conductance of 1.25 nS in 1M KCl identical to the channels formed by the detergent extracts. Zero-current membrane potential measurements of the voltage dependent channel implied selectivity for anions. This preference is according to single-channel analysis caused by some excess of cationic charges located in the channel lumen formed by oligomeric alpha-helical wheels. The channel has a suggested diameter of 1.4 nm as judged from the permeability of different sized hydrated anions using the Renkin correction factor. Surprisingly, the genome of C. jeikeium contained only one gene coding for a cell wall channel of the PorA/PorH type found in other Corynebacterium species. The possible evolutionary relationship between the heterooligomeric channels formed by certain Corynebacterium strains and the homooligomeric pore of C. jeikeium is discussed.	[Abdali, Narges; Norouzy, Amir; Schulz, Robert; Nau, Werner M.; Kleinekathoefer, Ulrich; Benz, Roland] Univ Bremen, Sch Sci & Engn, D-28359 Bremen, Germany; [Barth, Enrico; Benz, Roland] Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, D-97070 Wurzburg, Germany; [Tauch, Andreas] Univ Bielefeld, Inst Genome Res & Syst Biol, Ctr Biotechnol CeBiTec, D-33615 Bielefeld, Germany	University of Bremen; German Research Foundation (DFG); University of Wurzburg; University of Bielefeld	Benz, R (corresponding author), Univ Bremen, Sch Sci & Engn, D-28359 Bremen, Germany.	roland.benz@uni-wuerzburg.de	Kleinekathöfer, Ulrich/I-2329-2013; Nau, Werner/E-6686-2011	Kleinekathöfer, Ulrich/0000-0002-6114-7431; Nau, Werner/0000-0002-7654-6232; Norouzy, Amir/0000-0002-9712-6755; Benz, Roland/0000-0002-9510-9265	Jacobs University	Jacobs University	Funds by Jacobs University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barksdale L, 1981, PROKARYOTES, P1827; Barreiro C, 2004, J BACTERIOL, V186, P4813, DOI 10.1128/JB.186.14.4813-4817.2004; Barth E, 2010, J BACTERIOL, V192, P786, DOI 10.1128/JB.01142-09; BENZ R, 1979, BIOCHIM BIOPHYS ACTA, V551, P238, DOI 10.1016/0005-2736(89)90002-3; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; BENZ R, 1988, ANNU REV MICROBIOL, V42, P359, DOI 10.1146/annurev.mi.42.100188.002043; Benz R., 1994, BACTERIAL CELL WALL, P397; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Brune I, 2006, J BIOTECHNOL, V127, P21, DOI 10.1016/j.jbiotec.2006.06.011; CASTELLAN GW, 1983, PHYSICAL CHEM, P769; Chugh JK, 2001, BIOCHEM SOC T, V29, P565, DOI 10.1042/BST0290565; Costa-Riu N, 2003, MOL MICROBIOL, V50, P1295, DOI 10.1046/j.1365-2958.2003.03754.x; Costa-Riu N, 2003, J BACTERIOL, V185, P4779, DOI 10.1128/JB.185.16.4779-4786.2003; DAFFE M, 1990, J BIOL CHEM, V265, P6734; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; De E, 2001, MOL MICROBIOL, V41, P189, DOI 10.1046/j.1365-2958.2001.02501.x; Dorner U, 2004, BBA-BIOMEMBRANES, V1667, P47, DOI 10.1016/j.bbamem.2004.09.001; Eggeling L, 1999, APPL MICROBIOL BIOT, V52, P146, DOI 10.1007/s002530051501; Faller M, 2004, SCIENCE, V303, P1189, DOI 10.1126/science.1094114; FREUDL R, 1992, J BIOTECHNOL, V23, P231, DOI 10.1016/0168-1656(92)90072-H; Funke G, 1997, CLIN MICROBIOL REV, V10, P125, DOI 10.1128/CMR.10.1.125; GOODFELLOW M, 1976, J GEN MICROBIOL, V96, P351, DOI 10.1099/00221287-96-2-351; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Hallin PF, 2004, BIOINFORMATICS, V20, P3682, DOI 10.1093/bioinformatics/bth423; Hansmeier N, 2007, PROTEOMICS, V7, P1076, DOI 10.1002/pmic.200600833; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Holt JG, 1994, BERGEYS MANUAL DETER, P625; Hunten P, 2005, BBA-BIOMEMBRANES, V1715, P25, DOI 10.1016/j.bbamem.2005.07.011; Hunten P, 2005, MICROBIOL-SGM, V151, P2429, DOI 10.1099/mic.0.27903-0; JACKMAN PJH, 1986, J GEN MICROBIOL, V132, P1911; JOHNSON WD, 1970, ANN NY ACAD SCI, V174, P568, DOI 10.1111/j.1749-6632.1970.tb45582.x; KEILHAUER C, 1993, J BACTERIOL, V175, P5595, DOI 10.1128/JB.175.17.5595-5603.1993; Khamis A, 2004, J CLIN MICROBIOL, V42, P3925, DOI 10.1128/JCM.42.9.3925-3931.2004; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Kinoshita S, 2004, J GEN APPL MICROBIOL, V50, P331; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lechevalier H A, 1971, Adv Appl Microbiol, V14, P47, DOI 10.1016/S0065-2164(08)70539-2; Leuchtenberger W., 1996, BIOTECHNOLOGY, V6, P465; Lichtinger T, 2000, J BACTERIOL, V182, P764, DOI 10.1128/JB.182.3.764-770.2000; Lichtinger T, 1999, FEBS LETT, V454, P349, DOI 10.1016/S0014-5793(99)00844-3; Lichtinger T, 2001, EUR J BIOCHEM, V268, P462; Lichtinger T, 1998, BIOCHEMISTRY-US, V37, P15024, DOI 10.1021/bi980961e; LUDWIG O, 1986, BIOCHIM BIOPHYS ACTA, V860, P268, DOI 10.1016/0005-2736(86)90523-7; MacGregor RR, 1995, PRINCIPLES PRACTICE, P1865; MINNIKIN DE, 1974, FEBS LETT, V39, P322, DOI 10.1016/0014-5793(74)80140-7; Minnikin DE, 1987, CHEMOTHERAPY TROPICA, P19; Mookadam F, 2006, EUR J CLIN MICROBIOL, V25, P349, DOI 10.1007/s10096-006-0145-8; Niederweis M, 1999, MOL MICROBIOL, V33, P933, DOI 10.1046/j.1365-2958.1999.01472.x; NIKAIDO H, 1992, MOL MICROBIOL, V6, P435, DOI 10.1111/j.1365-2958.1992.tb01487.x; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; OCHI K, 1995, INT J SYST BACTERIOL, V45, P653, DOI 10.1099/00207713-45-4-653; Oteo J, 2001, ENFERM INFEC MICR CL, V19, P103, DOI 10.1016/S0213-005X(01)72578-5; PASCUAL C, 1995, INT J SYST BACTERIOL, V45, P724, DOI 10.1099/00207713-45-4-724; Riess FG, 1998, MOL MICROBIOL, V29, P139, DOI 10.1046/j.1365-2958.1998.00914.x; Riess FG, 2000, BBA-BIOMEMBRANES, V1509, P485, DOI 10.1016/S0005-2736(00)00332-1; Riess FG, 2001, J MEMBRANE BIOL, V182, P147, DOI 10.1007/s00232-001-0037-x; RUIMY R, 1995, INT J SYST BACTERIOL, V45, P740, DOI 10.1099/00207713-45-4-740; Sahm H, 1996, ANN NY ACAD SCI, V782, P25, DOI 10.1111/j.1749-6632.1996.tb40544.x; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schiffler B, 2007, J BACTERIOL, V189, P7709, DOI 10.1128/JB.00864-07; Schulz G. E., 2004, BACTERIAL EUKARYOTIC, P25; Stephan J, 2005, MOL MICROBIOL, V58, P714, DOI 10.1111/j.1365-2958.2005.04878.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tauch A, 2005, J BACTERIOL, V187, P4671, DOI 10.1128/JB.187.13.4671-4682.2005; Tauch A, 2004, PLASMID, V52, P102, DOI 10.1016/j.plasmid.2004.05.003; Tauch A, 2008, J BIOTECHNOL, V136, P11, DOI 10.1016/j.jbiotec.2008.02.009; Ton-That H, 2004, BBA-MOL CELL RES, V1694, P269, DOI 10.1016/j.bbamcr.2004.04.014; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRIAS J, 1994, MOL MICROBIOL, V14, P283, DOI 10.1111/j.1365-2958.1994.tb01289.x; TRIAS J, 1992, SCIENCE, V258, P1479, DOI 10.1126/science.1279810; TRIAS JQ, 1993, J BIOL CHEM, V268, P6234; UDAKA S, 1960, J BACTERIOL, V79, P754, DOI 10.1128/JB.79.5.754-755.1960; van der Rest ME, 1999, APPL MICROBIOL BIOT, V52, P541, DOI 10.1007/s002530051557; van Wely KHM, 2001, FEMS MICROBIOL REV, V25, P437, DOI 10.1016/S0168-6445(01)00062-6; YANO I, 1972, FEBS LETT, V23, P352, DOI 10.1016/0014-5793(72)80314-4; Zhang JH, 1997, GENOME RES, V7, P649, DOI 10.1101/gr.7.6.649; Ziegler K, 2008, J MOL BIOL, V379, P482, DOI 10.1016/j.jmb.2008.04.017	81	10	10	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75651	10.1371/journal.pone.0075651	http://dx.doi.org/10.1371/journal.pone.0075651			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116064	Green Submitted, Green Published, gold			2022-12-25	WOS:000325552200033
J	Sugimoto, K; Ichikawa-Tomikawa, N; Satohisa, S; Akashi, Y; Kanai, R; Saito, T; Sawada, N; Chiba, H				Sugimoto, Kotaro; Ichikawa-Tomikawa, Naoki; Satohisa, Seiro; Akashi, Yushi; Kanai, Risa; Saito, Tsuyoshi; Sawada, Norimasa; Chiba, Hideki			The Tight-Junction Protein Claudin-6 Induces Epithelial Differentiation from Mouse F9 and Embryonic Stem Cells	PLOS ONE			English	Article							CLOSTRIDIUM-PERFRINGENS ENTEROTOXIN; BLASTOCYST FORMATION; GROWTH-FACTORS; EXPRESSION; GENE; OCCLUDIN; POLARITY; DOMAIN; FATE	During epithelialization, cell adhesions and polarity must be established to maintain tissue assemblies and separate the biological compartments in the body. However, the molecular basis of epithelial morphogenesis, in particular, a role of cell adhesion molecules in epithelial differentiation from stem cells, remains unclear. Here, we show that the stable and conditional expression of a tight-junction protein, claudin-6 (Cldn6), triggers epithelial morphogenesis in mouse F9 stem cells. We also demonstrate that Cldn6 induces the expression of other tight-junction and microvillus molecules including Cldn7, occludin, ZO-1 alpha+, and ezrin/radixin/moesin-binding phosphoprotein50. These events were inhibited by attenuation of Cldn6 using RNA interference or the C-terminal half of Clostridium Perfringens enterotoxin. Furthermore, similar results were obtained in mouse embryonic stem cells. Thus, we have uncovered that the Cldn6 functions as a novel cue to induce epithelial differentiation.	[Sugimoto, Kotaro; Sawada, Norimasa] Sapporo Med Univ, Sch Med, Dept Pathol, Sapporo, Hokkaido, Japan; [Satohisa, Seiro; Akashi, Yushi; Saito, Tsuyoshi] Sapporo Med Univ, Sch Med, Dept Obstet & Gynecol, Sapporo, Hokkaido, Japan; [Ichikawa-Tomikawa, Naoki; Kanai, Risa; Chiba, Hideki] Fukushima Med Univ, Sch Med, Dept Basic Pathol, Fukushima, Japan	Sapporo Medical University; Sapporo Medical University; Fukushima Medical University	Chiba, H (corresponding author), Fukushima Med Univ, Sch Med, Dept Basic Pathol, Fukushima, Japan.	hidchiba@fmu.ac.jp	Sugimoto, Kotaro/AAE-9873-2020	Sugimoto, Kotaro/0000-0002-5299-7610	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in Aid for the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Naito Foundation, and the Uehara Memorial Foundation. K. S. received the research fellowship for young scientists from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WJ, 2008, DEV DYNAM, V237, P504, DOI 10.1002/dvdy.21437; Brizzi MF, 2012, CURR OPIN CELL BIOL, V24, P645, DOI 10.1016/j.ceb.2012.07.001; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Chiba H, 2003, EXP CELL RES, V286, P288, DOI 10.1016/S0014-4827(03)00116-2; Chiba H, 1997, J CELL BIOL, V139, P735, DOI 10.1083/jcb.139.3.735; Chiba H, 2000, EXP CELL RES, V260, P334, DOI 10.1006/excr.2000.5022; Chiba H, 2008, BBA-BIOMEMBRANES, V1778, P588, DOI 10.1016/j.bbamem.2007.08.017; Chiba H, 2006, J CELL BIOL, V175, P971, DOI 10.1083/jcb.200608012; Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Fujita K, 2000, FEBS LETT, V476, P258, DOI 10.1016/S0014-5793(00)01744-0; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Haakensen VD, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-77; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; HOGAN BLM, 1981, NATURE, V291, P235, DOI 10.1038/291235a0; Holmberg J, 2012, NAT REV GENET, V13, P429, DOI 10.1038/nrg3209; Ishizaki T, 2003, EXP CELL RES, V290, P275, DOI 10.1016/S0014-4827(03)00354-9; Kubota H, 2001, EXP CELL RES, V263, P163, DOI 10.1006/excr.2000.5113; Losick VP, 2011, DEV CELL, V21, P159, DOI 10.1016/j.devcel.2011.06.018; Lyashenko N, 2011, NAT CELL BIOL, V13, P753, DOI 10.1038/ncb2260; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; Mitchell LA, 2010, TOXINS, V2, P1595, DOI 10.3390/toxins2071595; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Moriwaki K, 2007, DEV BIOL, V312, P509, DOI 10.1016/j.ydbio.2007.09.049; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Redmer T, 2011, EMBO REP, V12, P720, DOI 10.1038/embor.2011.88; Saitou M, 1998, J CELL BIOL, V141, P397, DOI 10.1083/jcb.141.2.397; Satohisa S, 2005, EXP CELL RES, V310, P66, DOI 10.1016/j.yexcr.2005.06.025; Sheth B, 1997, DEVELOPMENT, V124, P2027; Simon DB, 1999, SCIENCE, V285, P103, DOI 10.1126/science.285.5424.103; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Turksen K, 2001, DEV DYNAM, V222, P292, DOI 10.1002/dvdy.1174; Uchida H, 2010, BIOCHEM PHARMACOL, V79, P1437, DOI 10.1016/j.bcp.2010.01.010; Van Itallie CM, 2008, J BIOL CHEM, V283, P268, DOI 10.1074/jbc.M708066200; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Winkler L, 2009, J BIOL CHEM, V284, P18863, DOI 10.1074/jbc.M109.008623; Zhao LN, 2008, AM J PHYSIOL-REG I, V294, pR1856, DOI 10.1152/ajpregu.00862.2007	44	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75106	10.1371/journal.pone.0075106	http://dx.doi.org/10.1371/journal.pone.0075106			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116027	Green Published, gold, Green Submitted			2022-12-25	WOS:000325552200011
J	Castro, RA; Kubitschek-Barreira, PH; Teixeira, PAC; Sanches, GF; Teixeira, MM; Quintella, LP; Almeida, SR; Costa, RO; Camargo, ZP; Felipe, MSS; de Souza, W; Lopes-Bezerra, LM				Castro, Rafaela A.; Kubitschek-Barreira, Paula H.; Teixeira, Pedro A. C.; Sanches, Glenda F.; Teixeira, Marcus M.; Quintella, Leonardo P.; Almeida, Sandro R.; Costa, Rosane O.; Camargo, Zoilo P.; Felipe, Maria S. S.; de Souza, Wanderley; Lopes-Bezerra, Leila M.			Differences in Cell Morphometry, Cell Wall Topography and Gp70 Expression Correlate with the Virulence of Sporothrix brasiliensis Clinical Isolates	PLOS ONE			English	Article							BETA-KETOADIPATE PATHWAY; SCHENCKII; SPOROTRICHOSIS; PATHOGENICITY; INVOLVEMENT; CLEAVAGE; ANTIBODY; REVEALS; COMPLEX; GLOBOSA	Sporotrichosis is a chronic infectious disease affecting both humans and animals. For many years, this subcutaneous mycosis had been attributed to a single etiological agent; however, it is now known that this taxon consists of a complex of at least four pathogenic species, including Sporothrix schenckii and Sporothrix brasiliensis. Gp70 was previously shown to be an important antigen and adhesin expressed on the fungal cell surface and may have a key role in immunomodulation and host response. The aim of this work was to study the virulence, morphometry, cell surface topology and gp70 expression of clinical isolates of S. brasiliensis compared with two reference strains of S. schenckii. Several clinical isolates related to severe human cases or associated with the Brazilian zoonotic outbreak of sporotrichosis were genotyped and clustered as S. brasiliensis. Interestingly, in a murine subcutaneous model of sporotrichosis, these isolates showed a higher virulence profile compared with S. schenckii. A single S. brasiliensis isolate from an HIV-positive patient not only showed lower virulence but also presented differences in cell morphometry, cell wall topography and abundant gp70 expression compared with the virulent isolates. In contrast, the highly virulent S. brasiliensis isolates showed reduced levels of cell wall gp70. These observations were confirmed by the topographical location of the gp70 antigen using immunoelectromicroscopy in both species. In addition, the gp70 molecule was sequenced and identified using mass spectrometry, and the sequenced peptides were aligned into predicted proteins using Blastp with the S. schenckii and S. brasiliensis genomes.	[Castro, Rafaela A.; Kubitschek-Barreira, Paula H.; Teixeira, Pedro A. C.; Sanches, Glenda F.; Lopes-Bezerra, Leila M.] Univ Estado Rio De Janeiro, Inst Biol Roberto Alcantara Gomes, Lab Micol Celular & Prote, Rio De Janeiro, Brazil; [Teixeira, Marcus M.; Felipe, Maria S. S.] Univ Brasilia, Inst Ciencias Biol, Lab Biol Mol, Brasilia, DF, Brazil; [Quintella, Leonardo P.] Univ Estado Rio De Janeiro, Fac Ciencias Med, Dept Patol & Labs, Rio De Janeiro, Brazil; [Almeida, Sandro R.] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, Sao Paulo, Brazil; [Costa, Rosane O.] Univ Estado Rio De Janeiro, Hosp Univ Pedro Ernesto, Lab Micol, Rio De Janeiro, Brazil; [Camargo, Zoilo P.] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil; [de Souza, Wanderley] Univ Fed Rio de Janeiro, Lab Ultraestrutura Celular Hertha Meyer, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Universidade de Brasilia; Universidade do Estado do Rio de Janeiro; Universidade de Sao Paulo; Universidade do Estado do Rio de Janeiro; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Rio de Janeiro	Lopes-Bezerra, LM (corresponding author), Univ Estado Rio De Janeiro, Inst Biol Roberto Alcantara Gomes, Lab Micol Celular & Prote, Rio De Janeiro, Brazil.	leila@uerj.br	Felipe, Maria Sueli/L-6260-2016; Kubitschek-Barreira, Paula/C-1200-2015; almeida, sandro r/F-5816-2012; Camargo, Zoilo P/C-5305-2013; Orofino-Costa, Rosane/AAF-6844-2020	Felipe, Maria Sueli/0000-0003-4347-6853; Kubitschek-Barreira, Paula/0000-0001-9083-2908; almeida, sandro r/0000-0002-0562-1610; Camargo, Zoilo P/0000-0002-2971-7983; Orofino-Costa, Rosane/0000-0002-1603-418X; Sanches, Glenda/0000-0002-9144-1826	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Faperj); CNPq; PRONEX	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Faperj)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PRONEX	LMLB is a research fellow of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Faperj), CNPq and PRONEX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida SR, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00409; Almeida-Paes R, 2012, APPL ENVIRON MICROB, V78, P8623, DOI 10.1128/AEM.02414-12; Arrillaga-Moncrieff I, 2009, CLIN MICROBIOL INFEC, V15, P651, DOI 10.1111/j.1469-0691.2009.02824.x; Bonifaz A, 2010, GIORN ITAL DERMAT V, V145, P659; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; Teixeira PAC, 2010, MED MYCOL, V48, P687, DOI 10.3109/13693780903453287; Teixeira PAC, 2009, MICROBIOL-SGM, V155, P3730, DOI 10.1099/mic.0.029439-0; Da Rosa D, 2009, REV INST MED TROP SP, V51, P1, DOI 10.1590/S0036-46652009000100001; DELIMAFRANCO D, 2011, SCAND J IMMUNOL, V75, P42; de Oliveira MME, 2010, MYCOPATHOLOGIA, V169, P359, DOI 10.1007/s11046-010-9276-7; Oliveira MME, 2011, MYCOPATHOLOGIA, V172, P257, DOI 10.1007/s11046-011-9437-3; Fernandes GF, 2013, VIRULENCE, V4, P241, DOI 10.4161/viru.23112; Fernandes KSS, 2000, IMMUNOLOGY, V101, P563, DOI 10.1046/j.1365-2567.2000.00125.x; Ghosh A, 2002, MYCOSES, V45, P449, DOI 10.1046/j.1439-0507.2002.d01-121.x; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553; Kubitschek-Barreira PH, 2013, J PROTEOMICS, V78, P522, DOI 10.1016/j.jprot.2012.10.022; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lima OC, 2001, INFECT IMMUN, V69, P6874, DOI 10.1128/IAI.69.11.6874-6880.2001; Lopes-Bezerra LM, 2012, DIMORPHIC FUNGI: THEIR IMPORTANCE AS MODELS FOR DIFFERENTIATION AND FUNGAL PATHOGENESIS, P67; Lopes-Bezerra LM, 2006, AN ACAD BRAS CIENC, V78, P293, DOI 10.1590/S0001-37652006000200009; Madrid IM, 2010, MICROBES INFECT, V12, P162, DOI 10.1016/j.micinf.2009.10.004; Marimon R, 2008, MED MYCOL, V46, P621, DOI 10.1080/13693780801992837; Marimon R, 2007, J CLIN MICROBIOL, V45, P3198, DOI 10.1128/JCM.00808-07; Marimon R, 2006, J CLIN MICROBIOL, V44, P3251, DOI 10.1128/JCM.00081-06; Mesa-Arango AC, 2002, J CLIN MICROBIOL, V40, P3004, DOI 10.1128/JCM.40.8.3004-3011.2002; Michielse CB, 2012, MOL PLANT PATHOL, V13, P1089, DOI 10.1111/j.1364-3703.2012.00818.x; Nascimento RC, 2005, FEMS IMMUNOL MED MIC, V43, P241, DOI 10.1016/j.femsim.2004.08.004; Nascimento RC, 2008, EUR J IMMUNOL, V38, P3080, DOI 10.1002/eji.200838513; Oliveira DC, 2011, J CLIN MICROBIOL, V49, P3047, DOI 10.1128/JCM.00255-11; Orofino-Costa R, 2013, MED MYCOL CASE REP, V2, P65, DOI 10.1016/j.mmcr.2013.02.004; Queiroz-Telles F, 2011, MED MYCOL, V49, P225, DOI 10.3109/13693786.2010.539631; Rappleye CA, 2006, ANNU REV MICROBIOL, V60, P281, DOI 10.1146/annurev.micro.59.030804.121055; Rodrigues AM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002281; Rodrigues AM, 2013, MED MYCOL, V51, P405, DOI 10.3109/13693786.2012.719648; Ruiz-Baca E, 2009, MED MYCOL, V47, P185, DOI 10.1080/13693780802165789; Schubach A, 2008, CURR OPIN INFECT DIS, V21, P129, DOI 10.1097/QCO.0b013e3282f44c52; Silva-Vergara MLO, 2012, AM J TROP MED HYG, V86, P477, DOI 10.4269/ajtmh.2012.11-0441; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wuthrich M, 2006, MED MYCOL, V44, P41, DOI 10.1080/13693780500220217; YOSHIIKE T, 1993, MYCOPATHOLOGIA, V123, P69, DOI 10.1007/BF01365082; Yuan SY, 2002, VASC PHARMACOL, V39, P213, DOI 10.1016/S1537-1891(03)00010-7; Zhang ZY, 2006, MYCOSES, V49, P305, DOI 10.1111/j.1439-0507.2006.01256.x; Zhou X, 2014, FUNGAL DIVERS, V66, P153, DOI 10.1007/s13225-013-0220-2	45	68	70	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75656	10.1371/journal.pone.0075656	http://dx.doi.org/10.1371/journal.pone.0075656			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116065	Green Published, Green Submitted, gold			2022-12-25	WOS:000325501300037
J	Miyahara, K; Nouso, K; Saito, S; Hiraoka, S; Harada, K; Takahashi, S; Morimoto, Y; Kobayashi, S; Ikeda, F; Miyake, Y; Shiraha, H; Takaki, A; Okada, H; Amano, M; Hirose, K; Nishimura, SI; Yamamoto, K				Miyahara, Koji; Nouso, Kazuhiro; Saito, Shunsuke; Hiraoka, Sakiko; Harada, Keita; Takahashi, Sakuma; Morimoto, Yuki; Kobayashi, Sayo; Ikeda, Fusao; Miyake, Yasuhiro; Shiraha, Hidenori; Takaki, Akinobu; Okada, Hiroyuki; Amano, Maho; Hirose, Kazuko; Nishimura, Shin-Ichiro; Yamamoto, Kazuhide			Serum Glycan Markers for Evaluation of Disease Activity and Prediction of Clinical Course in Patients with Ulcerative Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; ALPHA-1-ACID GLYCOPROTEIN; 5-AMINOSALICYLIC ACID; GLYCOSYLATION; HAPTOGLOBIN; DIAGNOSIS; CANCER	Background: The aims of this study were to determine the change of whole-serum N-glycan profile in ulcerative colitis (UC) patients and to investigate its clinical utility. Methods: We collected serum from 75 UC patients at the time of admission and the same number of age/sex-matched healthy volunteers. Serum glycan profile was measured by comprehensive quantitative high-throughput glycome analysis and was compared with disease activity and prognosis. Results: Out of 61 glycans detected, 24 were differentially expressed in UC patients. Pathway analysis demonstrated that highly sialylated multi-branched glycans and agalactosyl bi-antennary glycans were elevated in UC patients; in addition, the glycan ratio m/z 2378/1914, which also increased in UC, showed the highest Area under Receiver Operating Characteristic curve (0.923) for the diagnosis of UC. Highly sialylated multi-branched glycans and the glycan ratio m/z 2378/1914 were higher in the patients with total colitis, Clinical Activity Index > 10, Mayo endoscopic score 3, or a steroid-refractory status. In particular, the glycan ratio m/z 2378/1914 (above median) was an independent prognostic factor for the need for an operation (hazard ratio, 2.67; 95% confidence interval, 1.04-7.84). Conclusions: Whole-serum glycan profiles revealed that the glycan ratio m/z 2378/1914 and highly sialylated multibranched glycans increase in UC patients, and are correlated with disease activity. The glycan ratio m/z 2378/1914 was an independent predictive factor of the prognosis of UC.	[Miyahara, Koji; Nouso, Kazuhiro; Saito, Shunsuke; Hiraoka, Sakiko; Harada, Keita; Takahashi, Sakuma; Morimoto, Yuki; Kobayashi, Sayo; Ikeda, Fusao; Miyake, Yasuhiro; Shiraha, Hidenori; Takaki, Akinobu; Okada, Hiroyuki; Yamamoto, Kazuhide] Okayama Univ, Dept Gastroenterol & Hepatol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Nouso, Kazuhiro; Ikeda, Fusao] Okayama Univ, Dept Mol Hepatol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Okada, Hiroyuki] Okayama Univ Hosp, Dept Endoscopy, Okayama, Japan; [Amano, Maho; Nishimura, Shin-Ichiro] Hokkaido Univ, Field Drug Discovery Res, Fac Adv Life Sci, Sapporo, Hokkaido, Japan; [Amano, Maho; Hirose, Kazuko; Nishimura, Shin-Ichiro] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido, Japan; [Amano, Maho; Nishimura, Shin-Ichiro] Med Chem Pharmaceut Co Ltd, Sapporo, Hokkaido, Japan	Okayama University; Okayama University; Okayama University; Hokkaido University; Hokkaido University	Nouso, K (corresponding author), Okayama Univ, Dept Gastroenterol & Hepatol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.	nouso@cc.okayama-u.ac.jp			Japan Society for the Promotion of Science [KAKENHI 23590976]; Japan Science and Technology Agency (JST); Ministry of Education, Culture, Science, and Technology, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (KAKENHI 23590976), partly by a grant for "Development of Systems and Technology for Advanced Measurement and Analysis (SENTAN)'' and "The Matching Program for Innovations in Future Drug Discovery and Medical Care'' from the Japan Science and Technology Agency (JST) and the Ministry of Education, Culture, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold JN, 2008, PROTEOMICS, V8, P3284, DOI 10.1002/pmic.200800163; AXFORD JS, 1992, J CLIN INVEST, V89, P1021, DOI 10.1172/JCI115643; Azuma Y, 2000, CLIN CHIM ACTA, V294, P93, DOI 10.1016/S0009-8981(99)00248-X; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Bekesova S, 2012, J PROTEOMICS, V75, P2216, DOI 10.1016/j.jprot.2012.01.024; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; Breda L, 2010, SEMIN ARTHRITIS RHEU, V40, P53, DOI 10.1016/j.semarthrit.2008.12.001; FASSBENDER K, 1991, CLIN CHIM ACTA, V203, P315, DOI 10.1016/0009-8981(91)90304-U; Goodarzi MT, 1998, GLYCOCONJUGATE J, V15, P469, DOI 10.1023/A:1006930902625; Henriksen M, 2008, GUT, V57, P1518, DOI 10.1136/gut.2007.146357; Hiraoka S, 2012, ANN PHARMACOTHER, V46, P1315, DOI 10.1345/aph.1R210; Ishida H, 2000, TRANSPLANTATION, V69, P59, DOI 10.1097/00007890-200001150-00012; LANGHOLZ E, 1994, GASTROENTEROLOGY, V107, P3, DOI 10.1016/0016-5085(94)90054-X; MACKIEWICZ A, 1995, GLYCOCONJUGATE J, V12, P241, DOI 10.1007/BF00731326; Mowat C, 2011, GUT, V60, P571, DOI 10.1136/gut.2010.224154; Nakajima S, 2011, INFLAMM BOWEL DIS, V17, P927, DOI 10.1002/ibd.21459; Nishimura SI, 2011, ADV CARBOHYD CHEM BI, V65, P219, DOI 10.1016/B978-0-12-385520-6.00005-4; Nouso K, 2013, J GASTROENT IN PRESS; Pepys M B, 1977, Ciba Found Symp, P283; Peter S, 2008, INFLAMM BOWEL DIS, V14, P1287, DOI 10.1002/ibd.20398; PHILLIPS ML, 1990, SCIENCE, V250, P1130, DOI 10.1126/science.1701274; RACHMILEWITZ D, 1989, BMJ-BRIT MED J, V298, P82, DOI 10.1136/bmj.298.6666.82; Saldova R, 2007, GLYCOBIOLOGY, V17, P1344, DOI 10.1093/glycob/cwm100; SAVERYMUTTU SH, 1986, GUT, V27, P809, DOI 10.1136/gut.27.7.809; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Shinzaki S, 2008, AM J GASTROENTEROL, V103, P1173, DOI 10.1111/j.1572-0241.2007.01699.x; Shinzaki S, 2012, GASTROENTEROLOGY, V142, P1172, DOI 10.1053/j.gastro.2012.02.008; THOMPSON S, 1993, CLIN CHIM ACTA, V220, P107, DOI 10.1016/0009-8981(93)90011-R; VANDIJK W, 1995, GLYCOCONJUGATE J, V12, P227, DOI 10.1007/BF00731324; Vermeire S, 2006, GUT, V55, P426, DOI 10.1136/gut.2005.069476; Vilela EG, 2012, WORLD J GASTROENTERO, V18, P872, DOI 10.3748/wjg.v18.i9.872	31	38	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e74861	10.1371/journal.pone.0074861	http://dx.doi.org/10.1371/journal.pone.0074861			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116015	Green Published, Green Submitted, gold			2022-12-25	WOS:000325501300016
J	Dutton, JL; Li, B; Woo, WP; Marshak, JO; Xu, Y; Huang, ML; Dong, LC; Frazer, IH; Koelle, DM				Dutton, Julie L.; Li, Bo; Woo, Wai-Ping; Marshak, Joshua O.; Xu, Yan; Huang, Meei-li; Dong, Lichun; Frazer, Ian H.; Koelle, David M.			A Novel DNA Vaccine Technology Conveying Protection against a Lethal Herpes Simplex Viral Challenge in Mice	PLOS ONE			English	Article							T-CELL EPITOPES; VIRUS TYPE-2; DENDRITIC CELLS; GLYCOPROTEIN-B; GENITAL HERPES; WILD-TYPE; IMMUNITY; UBIQUITIN; EFFICACY; INFECTION	While there are a number of licensed veterinary DNA vaccines, to date, none have been licensed for use in humans. Here, we demonstrate that a novel technology designed to enhance the immunogenicity of DNA vaccines protects against lethal herpes simplex virus 2 (HSV-2) challenge in a murine model. Polynucleotides were modified by use of a codon optimization algorithm designed to enhance immune responses, and the addition of an ubiquitin-encoding sequence to target the antigen to the proteasome for processing and to enhance cytotoxic T cell responses. We show that a mixture of these codon-optimized ubiquitinated and non-ubiquitinated constructs encoding the same viral envelope protein, glycoprotein D, induced both B and T cell responses, and could protect against lethal viral challenge and reduce ganglionic latency. The optimized vaccines, subcloned into a vector suitable for use in humans, also provided a high level of protection against the establishment of ganglionic latency, an important correlate of HSV reactivation and candidate endpoint for vaccines to proceed to clinical trials.	[Dutton, Julie L.; Li, Bo; Woo, Wai-Ping; Xu, Yan; Frazer, Ian H.] Coridon Pty Ltd, Brisbane, Qld, Australia; [Marshak, Joshua O.; Dong, Lichun; Koelle, David M.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Huang, Meei-li; Koelle, David M.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Huang, Meei-li; Koelle, David M.] Fred Hutchinson Canc Res Inst, Vaccine & Infect Dis Div, Seattle, WA USA; [Frazer, Ian H.] Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia; [Koelle, David M.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Koelle, David M.] Benaroya Res Inst, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Queensland; University of Washington; University of Washington Seattle; Benaroya Research Institute	Koelle, DM (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	viralimm@u.washington.edu	Koelle, David/Q-6529-2016; Frazer, Ian/A-1137-2007	Koelle, David/0000-0003-1255-9023; Woo, Yvonne/0000-0002-1293-5124; Dutton, Julie/0000-0002-9798-1284; Frazer, Ian/0000-0002-8002-4680	Australian Government; Jagen Pty Ltd.; Coridon Pty Ltd.; National Institutes of Health [AI030731]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI030731] Funding Source: NIH RePORTER	Australian Government(Australian GovernmentCGIAR); Jagen Pty Ltd.; Coridon Pty Ltd.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was in-part funded by an R & D Start Grant from the Australian Government, by Jagen Pty Ltd. and by Coridon Pty Ltd. National Institutes of Health grant AI030731, Lab Core, supported development of the HSV-2 PCR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awasthi S, 2012, J VIROL, V86, P4586, DOI 10.1128/JVI.07203-11; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; Bergman PJ, 2006, VACCINE, V24, P4582, DOI 10.1016/j.vaccine.2005.08.027; Chou B, 2010, BIOCHEM BIOPH RES CO, V392, P277, DOI 10.1016/j.bbrc.2009.12.166; Davidson AH, 2005, JAVMA-J AM VET MED A, V226, P240, DOI 10.2460/javma.2005.226.240; Delogu G, 2000, INFECT IMMUN, V68, P3097, DOI 10.1128/IAI.68.6.3097-3102.2000; Di Giovine P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002277; Domingo C, 2003, VACCINE, V21, P3565, DOI 10.1016/S0264-410X(03)00423-7; Duda RL, 1998, CELL, V94, P55, DOI 10.1016/S0092-8674(00)81221-0; Frazer IH, 2011, St Lucia US, Patent No. [2011/0287039 A1, 20110287039]; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Garver KA, 2005, DIS AQUAT ORGAN, V64, P13, DOI 10.3354/dao064013; Halford WP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017748; Hou YH, 2008, VACCINE, V26, P1438, DOI 10.1016/j.vaccine.2007.12.057; Hu K, 2011, IMMUNOL INVEST, V40, P265, DOI 10.3109/08820139.2010.534219; Iijima N, 2008, J EXP MED, V205, P3041, DOI 10.1084/jem.20082039; Ilyinskii PO, 2008, VACCINE, V26, P2177, DOI 10.1016/j.vaccine.2008.02.050; Johnson JE, 1998, CURR BIOL, V8, pR914, DOI 10.1016/S0960-9822(98)00008-6; Johnston C, 2011, J CLIN INVEST, V121, P4600, DOI 10.1172/JCI57148; Kask AS, 2010, VACCINE, V28, P7483, DOI 10.1016/j.vaccine.2010.09.014; Koelle DM, 2008, ANNU REV MED, V59, P381, DOI 10.1146/annurev.med.59.061606.095540; Lee AJ, 2012, CURR OPIN INFECT DIS, V25, P92, DOI 10.1097/QCO.0b013e32834e9a56; Liu K, 2012, VACCINE, V30, P3034, DOI 10.1016/j.vaccine.2011.10.010; Liu WJ, 2001, VACCINE, V20, P862, DOI 10.1016/S0264-410X(01)00406-6; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; McCormack PL, 2010, DRUGS, V70, P2449, DOI 10.2165/11204920-000000000-00000; Milligan GN, 1998, J IMMUNOL, V160, P6093; Mo A, 2011, VACCINE, V29, P8530, DOI 10.1016/j.vaccine.2011.07.011; Mueller SN, 2006, J IMMUNOL, V176, P7379, DOI 10.4049/jimmunol.176.12.7379; Muller WJ, 2009, J GEN VIROL, V90, P1153, DOI 10.1099/vir.0.008771-0; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; PARR MB, 1994, LAB INVEST, V70, P369; Shao Wen-ai, 2006, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V22, P286; Shen HG, 2009, VIROLOGY, V393, P104, DOI 10.1016/j.virol.2009.07.035; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Shlapobersky M, 2012, J GEN VIROLOGY; Sin JI, 2001, HUM GENE THER, V12, P1091, DOI 10.1089/104303401750214302; SLOBEDMAN B, 1994, J GEN VIROL, V75, P2469, DOI 10.1099/0022-1317-75-9-2469; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; Steven AC, 2005, CURR OPIN STRUC BIOL, V15, P227, DOI 10.1016/j.sbi.2005.03.008; Veselenak RL, 2012, VACCINE, V30, P7046, DOI 10.1016/j.vaccine.2012.09.057; Wald A, 2003, J INFECT DIS, V188, P1345, DOI 10.1086/379043; Wang KN, 2012, J VIROL, V86, P12891, DOI 10.1128/JVI.01055-12; Zhang M, 2005, GENE THER, V12, P1049, DOI 10.1038/sj.gt.3302490	46	33	37	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76407	10.1371/journal.pone.0076407	http://dx.doi.org/10.1371/journal.pone.0076407			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098493	gold, Green Submitted, Green Published			2022-12-25	WOS:000325483600045
J	Wang, Q; Wright, CJ; Huang, DM; Uriarte, SM; Lamont, RJ				Wang, Qian; Wright, Christopher J.; Huang Dingming; Uriarte, Silvia M.; Lamont, Richard J.			Oral Community Interactions of Filifactor alocis In Vitro	PLOS ONE			English	Article							PORPHYROMONAS-GINGIVALIS; STREPTOCOCCUS-GORDONII; AGGRESSIVE PERIODONTITIS; MICROBIAL COMMUNITIES; BIOFILM FORMATION; AGGREGATIBACTER-ACTINOMYCETEMCOMITANS; SUBGINGIVAL PLAQUE; EPITHELIAL-CELLS; RED COMPLEX; HEALTH	Filifactor alocis is a gram positive anaerobe that is emerging as an important periodontal pathogen. In the oral cavity F. alocis colonizes polymicrobial biofilm communities; however, little is known regarding the nature of the interactions between F. alocis and other oral biofilm bacteria. Here we investigate the community interactions of two strains of F. alocis with Streptococcus gordonii, Fusobacterium nucleatum, Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans, organisms with differing pathogenic potential in the oral cavity. In an in vitro community development model, S. gordonii was antagonistic to the accumulation of F. alocis into a dual species community. In contrast, F. nucleatum and the type strain of F. alocis formed a synergistic partnership. Accumulation of a low passage isolate of F. alocis was also enhanced by F. nucleatum. In three species communities of S. gordonii, F. nucleatum and F. alocis, the antagonistic effects of S. gordonii superseded the synergistic effects of F. nucleatum toward F. alocis. The interaction between A. actinomycetemcomitans and F. alocis was strain specific and A. actinomycetemcomitans could either stimulate F. alocis accumulation or have no effect depending on the strain. P. gingivalis and F. alocis formed heterotypic communities with the amount of P. gingivalis greater than in the absence of F. alocis. However, while P. gingivalis benefited from the relationship, levels of F. alocis in the dual species community were lower compared to F. alocis alone. The inhibitory effect of P. gingivalis toward F. alocis was dependent, at least partially, on the presence of the Mfa1 fimbrial subunit. In addition, Al-2 production by P. gingivalis helped maintain levels of F. alocis. Collectively, these results show that the pattern of F. alocis colonization will be dictated by the spatial composition of microbial microenvironments, and that the organism may preferentially accumulate at sites rich in F. nucleatum.	[Wang, Qian; Wright, Christopher J.; Lamont, Richard J.] Univ Louisville, Sch Dent, Ctr Oral Hlth & Syst Dis, Louisville, KY 40292 USA; [Uriarte, Silvia M.] Univ Louisville, Dept Med, Louisville, KY 40292 USA; [Wang, Qian; Huang Dingming] Sichuan Univ, State Key Lab Oral Dis, Chengdu 610064, Peoples R China	University of Louisville; University of Louisville; Sichuan University	Lamont, RJ (corresponding author), Univ Louisville, Sch Dent, Ctr Oral Hlth & Syst Dis, Louisville, KY 40292 USA.	rich.lamont@louisville.edu	Wang, Qian/C-5155-2016; Wang, Qian/H-1111-2015	Wang, Qian/0000-0001-8516-4482; Wang, Qian/0000-0002-1355-1616	National Institutes of Health [DE22867, DE12505]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE022867, R01DE012505] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding provided by National Institutes of Health DE22867, DE12505. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abusleme L, 2013, ISME J, V7, P1016, DOI 10.1038/ismej.2012.174; Aruni AW, 2012, PROTEOMICS, V12, P3343, DOI 10.1002/pmic.201200211; Aruni AW, 2011, INFECT IMMUN, V79, P3872, DOI 10.1128/IAI.05631-11; Barlow AL, 2010, MICROSC MICROANAL, V16, P710, DOI 10.1017/S143192761009389X; Bradshaw DJ, 1998, INFECT IMMUN, V66, P4729, DOI 10.1128/IAI.66.10.4729-4732.1998; Capestany CA, 2008, J BACTERIOL, V190, P1436, DOI 10.1128/JB.01632-07; Chung WO, 2000, INFECT IMMUN, V68, P6758, DOI 10.1128/IAI.68.12.6758-6762.2000; Colombo APV, 2009, J PERIODONTOL, V80, P1421, DOI 10.1902/jop.2009.090185; Cuadra-Saenz G, 2012, MICROBIOL-SGM, V158, P1783, DOI 10.1099/mic.0.057182-0; Daep CA, 2011, INFECT IMMUN, V79, P67, DOI 10.1128/IAI.00361-10; Dahlen G, 2006, ORAL MICROBIOL IMMUN, V21, P6, DOI 10.1111/j.1399-302X.2005.00243.x; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Fine DH, 2013, J CLIN MICROBIOL, V51, P2850, DOI 10.1128/JCM.00729-13; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Hajishengallis G, 2012, MOL ORAL MICROBIOL, V27, P409, DOI 10.1111/j.2041-1014.2012.00663.x; Haubek D, 2010, APMIS, V118, P1, DOI 10.1111/j.1600-0463.2010.02665.x; Herce HD, 2013, J MICROSC-OXFORD, V249, P184, DOI 10.1111/jmi.12008; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Jenkinson HF, 2005, TRENDS MICROBIOL, V13, P589, DOI 10.1016/j.tim.2005.09.006; Kolenbrander PE, 2011, INT J ORAL SCI, V3, P49, DOI 10.4248/IJOS11025; Kuboniwa M, 2006, MOL MICROBIOL, V60, P121, DOI 10.1111/j.1365-2958.2006.05099.x; Kuboniwa M, 2010, PERIODONTOL 2000, V52, P38, DOI 10.1111/j.1600-0757.2009.00311.x; Kumar PS, 2005, J CLIN MICROBIOL, V43, P3944, DOI 10.1128/JCM.43.8.3944-3955.2005; Kumar PS, 2006, J CLIN MICROBIOL, V44, P3665, DOI 10.1128/JCM.00317-06; Mans JJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-380; Mansfield JM, 2012, J ORAL MAXIL SURG, V70, P1507, DOI 10.1016/j.joms.2011.09.049; McNab R, 2003, J BACTERIOL, V185, P274, DOI 10.1128/JB.185.1.274-284.2003; Moffatt CE, 2011, MOL ORAL MICROBIOL, V26, P365, DOI 10.1111/j.2041-1014.2011.00624.x; Montagner F, 2012, J ENDODONT, V38, P158, DOI 10.1016/j.joen.2011.09.029; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Park Y, 2005, INFECT IMMUN, V73, P3983, DOI 10.1128/IAI.73.7.3983-3989.2005; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Rickard AH, 2006, MOL MICROBIOL, V60, P1446, DOI 10.1111/j.1365-2958.2006.05202.x; Rosan B, 2000, MICROBES INFECT, V2, P1599, DOI 10.1016/S1286-4579(00)01316-2; Rylev M, 2011, MOL ORAL MICROBIOL, V26, P35, DOI 10.1111/j.2041-1014.2010.00593.x; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Schlafer S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-66; Shaddox LM, 2012, J DENT RES, V91, P927, DOI 10.1177/0022034512456039; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Wang BY, 2009, J CLIN MICROBIOL, V47, P3902, DOI 10.1128/JCM.00072-09; WESTERGAARD J, 1978, SCAND J DENT RES, V86, P421; Whitmore SE, 2011, MOL MICROBIOL, V81, P305, DOI 10.1111/j.1365-2958.2011.07707.x; Wright CJ, 2013, MOL ORAL MICROBIOL, V28, P83, DOI 10.1111/omi.12012; Xie H, 2007, MICROBIOL-SGM, V153, P3228, DOI 10.1099/mic.0.2007/009050-0; Zeituni AE, 2010, J BACTERIOL, V192, P4103, DOI 10.1128/JB.00275-10	45	37	41	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76271	10.1371/journal.pone.0076271	http://dx.doi.org/10.1371/journal.pone.0076271			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098460	Green Published, gold, Green Submitted			2022-12-25	WOS:000325483600034
J	Machnes, ZM; Huang, TCT; Chang, PKY; Gill, R; Reist, N; Dezsi, G; Ozturk, E; Charron, F; O'Brien, TJ; Jones, NC; McKinney, RA; Szyf, M				Machnes, Ziv M.; Huang, Tony C. T.; Chang, Philip K. Y.; Gill, Raminder; Reist, Nicholas; Dezsi, Gabriella; Ozturk, Ezgi; Charron, Francois; O'Brien, Terence J.; Jones, Nigel C.; McKinney, R. Anne; Szyf, Moshe			DNA Methylation Mediates Persistent Epileptiform Activity In Vitro and In Vivo	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; GENE-EXPRESSION; CPG METHYLATION; MESSENGER-RNA; RAT MODEL; GLUR2; TWINS; ACID; NEUROTRANSMISSION; DEMETHYLATION	Epilepsy is a chronic brain disorder involving recurring seizures often precipitated by an earlier neuronal insult. The mechanisms that link the transient neuronal insult to the lasting state of epilepsy are unknown. Here we tested the possible role of DNA methylation in mediating long-term induction of epileptiform activity by transient kainic acid exposure using in vitro and in vivo rodent models. We analyzed changes in the gria2 gene, which encodes for the GluA2 subunit of the ionotropic glutamate, alpha-amino-3-hydroxy-5-methyl-4-isoxazole proprionic acid receptor and is well documented to play a role in epilepsy. We show that kainic acid exposure for two hours to mouse hippocampal slices triggers methylation of a 5' regulatory region of the gria2 gene. Increase in methylation persists one week after removal of the drug, with concurrent suppression of gria2 mRNA expression levels. The degree of kainic acid-induced hypermethylation of gria2 5' region varies between individual slices and correlates with the changes in excitability induced by kainic acid. In a rat in vivo model of post kainic acid-induced epilepsy, we show similar hypermethylation of the 5' region of gria2. Inter-individual variations in gria2 methylation, correlate with the frequency and intensity of seizures among epileptic rats. Luciferase reporter assays support a regulatory role for methylation of gria2 5' region. Inhibition of DNA methylation by RG108 blocked kainic acid-induced hypermethylation of gria2 5' region in hippocampal slice cultures and bursting activity. Our results suggest that DNA methylation of such genes as gria2 mediates persistent epileptiform activity and inter-individual differences in the epileptic response to neuronal insult and that pharmacological agents that block DNA methylation inhibit epileptiform activity raising the prospect of DNA methylation inhibitors in epilepsy therapeutics.	[Machnes, Ziv M.; Huang, Tony C. T.; Chang, Philip K. Y.; Gill, Raminder; Reist, Nicholas; Charron, Francois; McKinney, R. Anne; Szyf, Moshe] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Dezsi, Gabriella; Ozturk, Ezgi; O'Brien, Terence J.; Jones, Nigel C.] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Melbourne Brain Ctr, Parkville, Vic 3052, Australia	McGill University; Royal Melbourne Hospital; University of Melbourne	McKinney, RA (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.	anne.mckinney@mcgill.ca; moshe.szyf@mcgill.ca	O'Brien, Terence/L-8102-2013; O'Brien, Terence/AAU-5525-2021	O'Brien, Terence/0000-0002-7198-8621; Jones, Nigel/0000-0002-1080-8439; Chang, Philip Keng-Yu/0000-0002-4732-1536	Canadian Institute Health Research [MOP-42411, MOP 86724]; NHMRC [566544, 1006077]; Sackler program in epigenetics and psychobiology at McGill University; GSK/CIHR professorship in pharmacology	Canadian Institute Health Research(Canadian Institutes of Health Research (CIHR)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Sackler program in epigenetics and psychobiology at McGill University; GSK/CIHR professorship in pharmacology	This work was supported by Canadian Institute Health Research grants MS (MOP-42411), RAM (MOP 86724) and by NHMRC project grants to NJ and TO (566544 & 1006077). This work was also supported by the Sackler program in epigenetics and psychobiology at McGill University (MS). MS is a fellow of the Canadian Institute for Advanced research and is supported by a GSK/CIHR professorship in pharmacology. NR held an NSERC USRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arion D, 2006, NEUROBIOL DIS, V22, P374, DOI 10.1016/j.nbd.2005.12.012; Bao GS, 2011, CHINESE MED J-PEKING, V124, P2622, DOI 10.3760/cma.j.issn.0366-6999.2011.17.011; Bell JT, 2012, INT J EPIDEMIOL, V41, P140, DOI 10.1093/ije/dyr179; Bell JT, 2011, TRENDS GENET, V27, P116, DOI 10.1016/j.tig.2010.12.005; Brueckner B, 2005, CANCER RES, V65, P6305, DOI 10.1158/0008-5472.CAN-04-2957; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Dempster EL, 2011, HUM MOL GENET, V20, P4786, DOI 10.1093/hmg/ddr416; Detich N, 2003, J BIOL CHEM, V278, P27586, DOI 10.1074/jbc.M303740200; Dong E, 2007, P NATL ACAD SCI USA, V104, P4676, DOI 10.1073/pnas.0700529104; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; FRENCH JA, 1993, ANN NEUROL, V34, P774, DOI 10.1002/ana.410340604; FRIEDMAN LK, 1994, J NEUROSCI, V14, P2697; Friedman LK, 1999, J NEUROSCI, V19, P9412; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Grooms SY, 2000, P NATL ACAD SCI USA, V97, P3631, DOI 10.1073/pnas.050586497; Holopainen IE, 2004, NEUROCHEM INT, V45, P1, DOI 10.1016/j.neuint.2004.01.005; Huang YF, 2002, J NEUROSCI, V22, P8422; Jamali S, 2006, BRAIN, V129, P625, DOI 10.1093/brain/awl001; Jones NC, 2008, EXP NEUROL, V209, P254, DOI 10.1016/j.expneurol.2007.09.026; Jupp B, 2012, EPILEPSIA, V53, P1233, DOI 10.1111/j.1528-1167.2012.03525.x; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Kobow K, 2012, EPILEPSIA, V53, P1868, DOI 10.1111/j.1528-1167.2012.03716.x; Kobow K, 2012, EPILEPSIA, V53, P11, DOI 10.1111/epi.12031; Kobow K, 2011, EPILEPSIA, V52, P15, DOI 10.1111/j.1528-1167.2011.03145.x; Kobow K, 2009, J NEUROPATH EXP NEUR, V68, P356, DOI 10.1097/NEN.0b013e31819ba737; Levenson JM, 2006, J BIOL CHEM, V281, P15763, DOI 10.1074/jbc.M511767200; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Ludbrook J, 1998, CLIN EXP PHARMACOL P, V25, P1032, DOI 10.1111/j.1440-1681.1998.tb02179.x; MATEVOSSIAN A, 2008, JOVE-J VIS EXP, P78943; Miller-Delaney SFC, 2012, J NEUROSCI, V32, P1577, DOI 10.1523/JNEUROSCI.5180-11.2012; Milutinovic S, 2007, CARCINOGENESIS, V28, P560, DOI 10.1093/carcin/bgl167; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Myers SJ, 1998, J NEUROSCI, V18, P6723; Nelson ED, 2008, J NEUROSCI, V28, P395, DOI 10.1523/JNEUROSCI.3796-07.2008; Nguyen A, 2010, FASEB J, V24, P3036, DOI 10.1096/fj.10-154484; Patel A, 2003, HIPPOCAMPUS, V13, P59, DOI 10.1002/hipo.10045; PellegriniGiampietro DE, 1997, TRENDS NEUROSCI, V20, P464, DOI 10.1016/S0166-2236(97)01100-4; Pernot F, 2010, J NEUROSCI RES, V88, P1000, DOI 10.1002/jnr.22282; Petronis A, 2006, TRENDS GENET, V22, P347, DOI 10.1016/j.tig.2006.04.010; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; PORTELA A, 2013, ONCOGENE, P86312; Qureshi IA, 2010, NEUROBIOL DIS, V39, P53, DOI 10.1016/j.nbd.2010.02.005; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; Routbort MJ, 1999, NEUROSCIENCE, V94, P755, DOI 10.1016/S0306-4522(99)00358-9; Scharfman HE, 2007, EPILEPSIA, V48, P33, DOI 10.1111/j.1528-1167.2007.01065.x; Singh S, 2002, CLIN GENET, V62, P97, DOI 10.1034/j.1399-0004.2002.620201.x; Suzuki F, 2000, NEUROSCIENCE, V101, P41, DOI 10.1016/S0306-4522(00)00359-6; Szyf M, 2011, EPIGENETICS-US, V6, P971, DOI 10.4161/epi.6.8.16793; Szyf M, 2009, ANNU REV PHARMACOL, V49, P243, DOI 10.1146/annurev-pharmtox-061008-103102; Tanaka H, 2000, BRAIN RES, V886, P190, DOI 10.1016/S0006-8993(00)02951-6; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wierschke S, 2010, BIOCHEM BIOPH RES CO, V403, P385, DOI 10.1016/j.bbrc.2010.10.138; Xi ZQ, 2009, SYNAPSE, V63, P1017, DOI 10.1002/syn.20681; Zachariah RM, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/415825	57	39	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76299	10.1371/journal.pone.0076299	http://dx.doi.org/10.1371/journal.pone.0076299			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098468	Green Submitted, Green Published, gold			2022-12-25	WOS:000325434500060
J	Sharvit, E; Abramovitch, S; Reif, S; Bruck, R				Sharvit, Efrat; Abramovitch, Shirley; Reif, Shimon; Bruck, Rafael			Amplified Inhibition of Stellate Cell Activation Pathways by PPAR-gamma, RAR and RXR Agonists	PLOS ONE			English	Article							PANCREATIC-CANCER CELLS; RECEPTOR-GAMMA; MOLECULAR-MECHANISMS; GROWTH-INHIBITION; HEPATIC-FIBROSIS; GENE-EXPRESSION; ALL-TRANS; LIGANDS; PTEN; APOPTOSIS	Peroxisome proliferator activator receptors (PPAR) ligands such as 15-Delta 12,13-prostaglandin L(2) [PJ] and all trans retinoic acid (ATRA) have been shown to inhibit the development of liver fibrosis. The role of ligands of retinoic X receptor (RXR) and its ligand, 9-cis, is less clear. The purpose of this study was to investigate the effects of combined treatment of the three ligends, PJ, ATRA and 9-cis, on key events during liver fibrosis in rat primary hepatic stellate cells (HSCs). We found that the anti-proliferative effect of the combined treatment of PJ, ATRA and 9-cis on HSCs was additive. Further experiments revealed that this inhibition was due to cell cycle arrest at the G(0)/G(1) phase as demonstrated by FACS analysis. In addition, the combined treatment reduced cyclin D1 expression and increased p21 and p27 protein levels. Furthermore, we found that the three ligands down regulated the phosphorylation of mTOR and p70(S6K). The activation of HSCs was also inhibited by the three ligands as shown by inhibition of vitamin A lipid droplets depletion from HSCs. Studies using real time PCR and western blot analysis showed marked inhibition of collagen I alpha 1 and alpha SMA by the combination of the three ligands. These findings suggest that the combined use of PJ, ATRA and 9-cis causes inhibition of cell proliferation by cell cycle arrest and down-regulation of fibrotic markers to a greater extent compared to each of the ligands alone.	[Sharvit, Efrat; Reif, Shimon; Bruck, Rafael] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Inst Gastroenterol & Liver Dis, IL-69978 Tel Aviv, Israel; [Sharvit, Efrat; Reif, Shimon; Bruck, Rafael] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Sharvit, Efrat; Abramovitch, Shirley; Reif, Shimon] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dana Childrens Hosp, Pediat Gastroenterol Unit, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Bruck, R (corresponding author), Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Inst Gastroenterol & Liver Dis, IL-69978 Tel Aviv, Israel.	rafib@tlvmc.gov.il						Blaner WS, 2009, BBA-MOL CELL BIOL L, V1791, P467, DOI 10.1016/j.bbalip.2008.11.001; Bruck R, 2009, DIGEST DIS SCI, V54, P292, DOI 10.1007/s10620-008-0336-5; Chang Q, 2007, J NEURO-ONCOL, V84, P263, DOI 10.1007/s11060-007-9380-9; FRIEDMAN SL, 1993, AM J PHYSIOL, V264, pG947, DOI 10.1152/ajpgi.1993.264.5.G947; Fujiyoshi M, 2011, J HEPATO-BIL-PAN SCI, V18, P13, DOI 10.1007/s00534-010-0304-2; Gabele E, 2005, J BIOL CHEM, V280, P13374, DOI 10.1074/jbc.M409444200; Galli A, 2002, GASTROENTEROLOGY, V122, P1924, DOI 10.1053/gast.2002.33666; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Glass CK, 2000, GENE DEV, V14, P121; Hao LS, 2009, APMIS, V117, P681, DOI 10.1111/j.1600-0463.2009.02515.x; Hazra S, 2004, J BIOL CHEM, V279, P11392, DOI 10.1074/jbc.M310284200; Hellemans K, 1999, GUT, V45, P134, DOI 10.1136/gut.45.1.134; Hisamori S, 2008, LIVER INT, V28, P1217, DOI 10.1111/j.1478-3231.2008.01745.x; Imai K, 2000, ANAT RECORD, V258, P338, DOI 10.1002/(SICI)1097-0185(20000401)258:4<338::AID-AR2>3.0.CO;2-G; Karpen SJ, 2002, J HEPATOL, V36, P832, DOI 10.1016/S0168-8278(02)00129-0; Lee SJ, 2006, MOL PHARMACOL, V70, P415, DOI 10.1124/mol.106.022954; Lee YR, 2007, INT J HEMATOL, V85, P231, DOI 10.1532/IJH97.A30615; Liu H, 2003, BREAST CANCER RES TR, V79, P63, DOI 10.1023/A:1023366117157; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Marra F, 2000, GASTROENTEROLOGY, V119, P466, DOI 10.1053/gast.2000.9365; Miyahara T, 2000, J BIOL CHEM, V275, P35715, DOI 10.1074/jbc.M006577200; Morais AD, 2007, INT J MOL MED, V19, P105; Pratt MAC, 2003, J CELL BIOCHEM, V90, P692, DOI 10.1002/jcb.10682; RAVID A, 1990, J CLIN ENDOCR METAB, V70, P1687, DOI 10.1210/jcem-70-6-1687; Sun K, 2006, ACTA PHARMACOL SIN, V27, P715, DOI 10.1111/j.1745-7254.2006.00299.x; Toyota M, 2002, LIFE SCI, V70, P1565, DOI 10.1016/S0024-3205(01)01524-7; Tsujie M, 2003, INT J ONCOL, V23, P325; White ES, 2003, AM J RESP CRIT CARE, V168, P436, DOI 10.1164/rccm.200301-041OC; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Zang CB, 2003, J NEURO-ONCOL, V65, P107, DOI 10.1023/B:NEON.0000003728.80052.a8; Zhou YJ, 2007, LAB INVEST, V87, P488, DOI 10.1038/labinvest.3700532	31	33	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76541	10.1371/journal.pone.0076541	http://dx.doi.org/10.1371/journal.pone.0076541			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098526	Green Published, gold, Green Submitted			2022-12-25	WOS:000325427100075
J	Bergan, J; Skotland, T; Sylvanne, T; Simolin, H; Ekroos, K; Sandvig, K				Bergan, Jonas; Skotland, Tore; Sylvanne, Tuulia; Simolin, Helena; Ekroos, Kim; Sandvig, Kirsten			The Ether Lipid Precursor Hexadecylglycerol Causes Major Changes in the Lipidome of HEp-2 Cells	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT; ELECTROSPRAY-IONIZATION; MOLECULAR LIPIDOMICS; BIOSYNTHESIS; PLASMALOGENS; CANCER; ACID; QUANTIFICATION; FRAGMENTATION	The ether-lipid precursor sn-1-O-hexadecylglycerol (HG) can be used to compensate for early metabolic defects in ether-lipid biosynthesis. To investigate a possible metabolic link between ether-linked phospholipids and the rest of the cellular lipidome, we incubated HEp-2 cells with HG. Mass spectrometry analysis revealed major changes in the lipidome of HG-treated cells compared to that of untreated cells or cells treated with palmitin, a control substance for HG containing an acyl group instead of the ether group. We present quantitative data for a total of 154 species from 17 lipid classes. These species are those constituting more than 2% of their lipid class for most lipid classes, but more than 1% for the ether lipids and glycosphingolipids. In addition to the expected ability of HG to increase the levels of ether-linked glycerophospholipids with 16 carbon atoms in the sn-1 position, this precursor also decreased the amounts of glycosphingolipids and increased the amounts of ceramide, phosphatidylinositol and lysophosphatidylinositol. However, incubation with palmitin, the fatty acyl analogue of HG, also increased the amounts of ceramide and phosphatidylinositols. Thus, changes in these lipid classes were not ether lipid-dependent. No major effects were observed for the other lipid classes, and cellular functions such as growth and endocytosis were unaffected. The data presented clearly demonstrate the importance of performing detailed quantitative lipidomic studies to reveal how the metabolism of ether-linked glycerophospholipids is coupled to that of glycosphingolipids and ester-linked glycerophospholipids, especially phosphatidylinositols.	[Bergan, Jonas; Skotland, Tore; Sandvig, Kirsten] Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway; [Bergan, Jonas; Skotland, Tore; Sandvig, Kirsten] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Biochem, Oslo, Norway; [Bergan, Jonas; Sandvig, Kirsten] Univ Oslo, Dept Biosci, Oslo, Norway; [Sylvanne, Tuulia; Simolin, Helena; Ekroos, Kim] Zora Biosci, Espoo, Finland	University of Oslo; University of Oslo; University of Oslo	Sandvig, K (corresponding author), Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway.	kirsten.sandvig@ibv.uio.no		Bergan, Jonas/0000-0003-4267-8904	The Norwegian Council for Science and Humanities, The Norwegian Cancer Society; Southern and Eastern Norway Regional Authority	The Norwegian Council for Science and Humanities, The Norwegian Cancer Society; Southern and Eastern Norway Regional Authority	The work performed by the Oslo group has been supported by The Norwegian Council for Science and Humanities, The Norwegian Cancer Society, and Southern and Eastern Norway Regional Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baines AT, 2011, FUTURE MED CHEM, V3, P1787, DOI [10.4155/FMC.11.121, 10.4155/fmc.11.121]; Bakovic M, 2007, BIOCHEM CELL BIOL, V85, P283, DOI 10.1139/O07-006; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Brites P, 2004, BBA-MOL CELL BIOL L, V1636, P219, DOI 10.1016/j.bbalip.2003.12.010; Brites P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028539; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; da Silva TF, 2012, BBA-MOL BASIS DIS, V1822, P1501, DOI 10.1016/j.bbadis.2012.05.014; DAS AK, 1992, LIPIDS, V27, P401, DOI 10.1007/BF02536379; Deniau AL, 2011, BIOCHIMIE, V93, P1, DOI 10.1016/j.biochi.2009.12.010; Ejsing CS, 2006, ANAL CHEM, V78, P6202, DOI 10.1021/ac060545x; Ekroos K, 2003, J LIPID RES, V44, P2181, DOI 10.1194/jlr.D300020-JLR200; Ekroos K, 2002, ANAL CHEM, V74, P941, DOI 10.1021/ac015655c; FELLMANN P, 1993, CHEM PHYS LIPIDS, V66, P225, DOI 10.1016/0009-3084(93)90010-Z; FORD DA, 1994, BIOCHEMISTRY-US, V33, P1216, DOI 10.1021/bi00171a022; Gorgas K, 2006, BBA-MOL CELL RES, V1763, P1511, DOI 10.1016/j.bbamcr.2006.08.038; Grzelczyk A, 2013, BIOCHIMIE, V95, P667, DOI 10.1016/j.biochi.2012.10.009; Hsu FF, 2009, J CHROMATOGR B, V877, P2673, DOI 10.1016/j.jchromb.2009.02.033; Iannitti T, 2010, MAR DRUGS, V8, P2267, DOI 10.3390/md8082267; Ivanova PT, 2010, J LIPID RES, V51, P1581, DOI 10.1194/jlr.D003715; Jung HR, 2011, BBA-MOL CELL BIOL L, V1811, P925, DOI 10.1016/j.bbalip.2011.06.025; Kanzawa N, 2009, P NATL ACAD SCI USA, V106, P17711, DOI 10.1073/pnas.0904762106; Lessig J, 2009, CURR MED CHEM, V16, P2021; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Llorente A, 2013, BBA-MOL CELL BIOL L, V1831, P1302, DOI 10.1016/j.bbalip.2013.04.011; Mayinger P, 2012, BBA-MOL CELL BIOL L, V1821, P1104, DOI 10.1016/j.bbalip.2012.01.002; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Munn NJ, 2003, J LIPID RES, V44, P182, DOI 10.1194/jlr.M200363-JLR200; Murphy RA, 2012, CURR OPIN CLIN NUTR, V15, P246, DOI 10.1097/MCO.0b013e328351c32f; Ong WY, 2010, CURR MED CHEM, V17, P2746, DOI 10.2174/092986710791859289; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P2075, DOI 10.1021/bi0156557; Pineiro R, 2012, BBA-MOL CELL BIOL L, V1821, P694, DOI 10.1016/j.bbalip.2012.01.009; Raa H, 2009, TRAFFIC, V10, P868, DOI 10.1111/j.1600-0854.2009.00919.x; Rodemer C, 2003, HUM MOL GENET, V12, P1881, DOI 10.1093/hmg/ddg191; Sandvig K, 2010, FEBS LETT, V584, P2626, DOI 10.1016/j.febslet.2010.04.008; SCHRAKAMP G, 1988, J LIPID RES, V29, P325; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Smith RE, 2008, LIPIDS, V43, P79, DOI 10.1007/s11745-007-3133-6; Stahlman M, 2009, J CHROMATOGR B, V877, P2664, DOI 10.1016/j.jchromb.2009.02.037; Styger R, 2002, BBA-MOL CELL BIOL L, V1585, P39, DOI 10.1016/S1388-1981(02)00320-7; Wallner S, 2011, CHEM PHYS LIPIDS, V164, P573, DOI 10.1016/j.chemphyslip.2011.06.008; Wood PL, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-182	42	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75904	10.1371/journal.pone.0075904	http://dx.doi.org/10.1371/journal.pone.0075904			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098742	Green Submitted, Green Published, gold			2022-12-25	WOS:000325423500113
J	Cai, SX; Zhong, Y; Li, YH; Huang, JN; Zhang, J; Luo, GA; Liu, ZH				Cai, Shuxian; Zhong, Yuan; Li, Yinhua; Huang, Jianan; Zhang, Jing; Luo, Guoan; Liu, Zhonghua			Blockade of the Formation of Insoluble Ubiquitinated Protein Aggregates by EGCG3 '' Me in the Alloxan-Induced Diabetic Kidney	PLOS ONE			English	Article							END-PRODUCTS; EGCG; P62; ACTIVATION; MECHANISMS; FIBRILS; SYSTEM; MICE	Background: Renal accumulation of reactive carbonyl compounds (RCCs) has been linked to the progression of diabetic nephropathy. We previously demonstrated that carbonyl stress induces the formation of amino-carbonyl cross-links and sharply increases the content of beta-sheet-rich structures, which is the seed of insoluble aggregates formation, and tea catechin (-)-epigallocatechin 3-gallate (EGCG) can reverse this process in vitro and in vivo. In this study, methylated derivative (-)-epigallocatechin-3-O-(3-O-methyl)-gallate (EGCG3 '' Me) was hypothesized to neutralize carbonyl stress mediating the formation of insoluble ubiquitinated protein (IUP) aggregates, and reduce the early development of diabetic nephropathy. Methods and results: Diabetes was induced in mice by intraperitoneally injecting alloxan monohydrate (200 mg/kg/d) twice and administering EGCG3 '' Me by gavage for 15 d. Reagent case and western blot results showed that, in diabetic kidneys, the carbonyl proteins in the serum increased; and in insoluble protein fraction, 4-hydroxynonenal-modified proteins, IUP aggregates and p62 accumulated; FT-IR study demonstrated that the lipid content, anti-parallel beta-sheet structure and aggregates increased. EGCG3 '' Me treatment could effectively reverse this process, even better than the negative control treatment. Conclusions: EGCG3 '' Me exhibiting anti-beta-sheet-rich IUP aggregate properties, maybe represents a new strategy to impede the progression of diabetic nephropathy and other diabetic complications.	[Cai, Shuxian; Zhong, Yuan; Huang, Jianan; Liu, Zhonghua] Hunan Agr Univ, Key Lab, Minist Educ Tea Sci, Changsha, Hunan, Peoples R China; [Cai, Shuxian] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China; [Zhong, Yuan; Li, Yinhua; Zhang, Jing; Liu, Zhonghua] Natl Res Ctr Engn Technol Utilizat Bot Funct Ingr, Changsha, Hunan, Peoples R China; [Luo, Guoan; Liu, Zhonghua] Tsinghua Univ, Dept Chem Tsinghua, Beijing 100084, Peoples R China; [Luo, Guoan; Liu, Zhonghua] Tsinghua Univ, Key Lab Biol Organ Phosphorus & Chem Biol, Minist Educ, Beijing 100084, Peoples R China	Hunan Agricultural University; Peking University; Tsinghua University; Tsinghua University	Liu, ZH (corresponding author), Hunan Agr Univ, Key Lab, Minist Educ Tea Sci, Changsha, Hunan, Peoples R China.	larkin-liu@163.com			National Natural Science Foundation of China [31100501]; China Postdoctoral Science Foundation [2012M520128]; National Science and Technology Support Program [2011BAD01B01]; Ministry of Education Innovation Team Program [201042]; National Tea Industry Technology System Projects [CARS-23-C]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Science and Technology Support Program; Ministry of Education Innovation Team Program; National Tea Industry Technology System Projects	This study was supported by the National Natural Science Foundation of China (No. 31100501), the China Postdoctoral Science Foundation (No. 2012M520128), National Science and Technology Support Program (NO. 2011BAD01B01), Ministry of Education Innovation Team Program (NO. 201042), and National Tea Industry Technology System Projects (CARS-23-C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony T, 2003, J BIOL CHEM, V278, P3235, DOI 10.1074/jbc.M208249200; Bansode SB, 2013, MOL CELL PROTEOMICS, V12, P228, DOI 10.1074/mcp.M112.020651; Bartlett BJ, 2011, AUTOPHAGY, V7, P572, DOI 10.4161/auto.7.6.14943; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Cai SX, 2011, J MED PLANTS RES, V5, P5470; Cai ShuXian, 2010, Journal of Tea Science, V30, P1; Caine S, 2012, NEUROIMAGE, V59, P3624, DOI 10.1016/j.neuroimage.2011.11.033; Chandrashekaran IR, 2011, ARCH BIOCHEM BIOPHYS, V513, P153, DOI 10.1016/j.abb.2011.07.008; Demidenko ZN, 2008, CELL CYCLE, V7, P3355, DOI 10.4161/cc.7.21.6919; Di Scala C, 2014, J NEUROCHEM, V128, P186, DOI 10.1111/jnc.12390; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Finley KD, 2003, J NEUROSCI, V23, P1254, DOI 10.1523/JNEUROSCI.23-04-01254.2003; Forbes JM, 2003, FASEB J, V17, P1762, DOI 10.1096/fj.02-1102fje; Goh BC, 2012, EUR PHYS J E, V35, DOI 10.1140/epje/i2012-12027-8; Inagaki H, 2009, J JPN SOC FOOD SCI, V56, P403, DOI 10.3136/nskkk.56.403; Inami Y, 2011, J CELL BIOL, V193, P275, DOI 10.1083/jcb.201102031; JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Koch M, 2010, STRUCTURE, V18, P1342, DOI 10.1016/j.str.2010.05.017; Lenzen S, 2008, DIABETOLOGIA, V51, P216, DOI 10.1007/s00125-007-0886-7; Maeda-Yamamoto M, 2004, J IMMUNOL, V172, P4486, DOI 10.4049/jimmunol.172.7.4486; Negre-Salvayre A, 2008, BRIT J PHARMACOL, V153, P6, DOI 10.1038/sj.bjp.0707395; Osawa M, 2007, BBA-GEN SUBJECTS, V1770, P1468, DOI 10.1016/j.bbagen.2007.07.003; Rak M, 2007, BIOPOLYMERS, V87, P207, DOI 10.1002/bip.20820; Ramasamy R, 2011, ANN NY ACAD SCI, V1243, P88, DOI 10.1111/j.1749-6632.2011.06320.x; Ren WK, 2012, AMINO ACIDS, V42, P2089, DOI 10.1007/s00726-011-0942-y; Seidel K, 2012, NEUROPATH APPL NEURO, V38, P548, DOI 10.1111/j.1365-2990.2011.01220.x; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Waschuk S, 2002, NEUROBIOL AGING, V23, pS393; Yano S, 2007, J AGR FOOD CHEM, V55, P7144, DOI 10.1021/jf071176o; Yao K, 2012, AMINO ACIDS, V42, P2491, DOI 10.1007/s00726-011-1060-6; Yin DZ, 1995, GERONTOLOGY, V41, P159; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zhao J, 2012, BBA-BIOMEMBRANES, V1818, P3121, DOI 10.1016/j.bbamem.2012.08.012	36	15	15	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75687	10.1371/journal.pone.0075687	http://dx.doi.org/10.1371/journal.pone.0075687			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098713	gold, Green Submitted, Green Published			2022-12-25	WOS:000325423500084
J	Chen, SH; Lin, QS; Xiao, Y; Deng, YY; Chang, CQ; Zhong, GH; Hu, MY; Zhang, LH				Chen, Shaohua; Lin, Qingsheng; Xiao, Ying; Deng, Yinyue; Chang, Changqing; Zhong, Guohua; Hu, Meiying; Zhang, Lian-Hui			Monooxygenase, a Novel Beta-Cypermethrin Degrading Enzyme from Streptomyces sp	PLOS ONE			English	Article							HYDROLYZING CARBOXYLESTERASE GENE; PYRETHROID INSECTICIDES; MOLECULAR-CLONING; BIOCHEMICAL-CHARACTERIZATION; STRAIN; BIODEGRADATION; EXPOSURE; PURIFICATION; URBAN; DEGRADATION	The widely used insecticide beta-cypermethrin has become a public concern because of its environmental contamination and toxic effects on mammals. In this study, a novel beta-cypermethrin degrading enzyme designated as CMO was purified to apparent homogeneity from a Streptomyces sp. isolate capable of utilizing beta-cypermethrin as a growth substrate. The native enzyme showed a monomeric structure with a molecular mass of 41 kDa and pI of 5.4. The enzyme exhibited the maximal activity at pH 7.5 and 30 degrees C. It was fairly stable in the pH range from 6.5-8.5 and at temperatures below 10 degrees C. The enzyme activity was significantly stimulated by Fe2+, but strongly inhibited by Ag+, Al3+, and Cu2+. The enzyme catalyzed the degradation of beta-cypermethrin to form five products via hydroxylation and diaryl cleavage. A novel beta-cypermethrin detoxification pathway was proposed based on analysis of these products. The purified enzyme was identified as a monooxygenase by matrix-assisted laser desorption/ionization time-of-flight/time-of-flight mass spectrometry analysis (MALDI-TOF-MS) and N-terminal protein sequencing. Given that all the characterized pyrethroid-degrading enzymes are the members of hydrolase family, CMO represents the first pyrethroid-degrading monooxygenase identified from environmental microorganisms. Taken together, our findings depict a novel pyrethroid degradation mechanism and indicate that the purified enzyme may be a promising candidate for detoxification of beta-cypermethrin and environmental protection.	[Chen, Shaohua; Lin, Qingsheng; Xiao, Ying; Zhong, Guohua; Hu, Meiying; Zhang, Lian-Hui] South China Agr Univ, Coll Nat Resources & Environm, Guangzhou, Guangdong, Peoples R China; [Deng, Yinyue; Chang, Changqing; Zhang, Lian-Hui] Inst Mol & Cell Biol, Singapore, Singapore	South China Agricultural University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Hu, MY (corresponding author), South China Agr Univ, Coll Nat Resources & Environm, Guangzhou, Guangdong, Peoples R China.	humy@scau.edu.cn; lianhui@imcb.a-star.edu.sg	Chen, Shaohua/AAQ-9860-2021	Chen, Shaohua/0000-0001-8306-2626	National Natural Science Foundation of China [30871660]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors are grateful to the National Natural Science Foundation (No.30871660) of China for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari RA, 2011, ECOTOX ENVIRON SAFE, V74, P150, DOI 10.1016/j.ecoenv.2010.08.036; Arora PK, 2012, APPL MICROBIOL BIOT, V93, P2265, DOI 10.1007/s00253-012-3927-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao ZY, 2011, ENVIRON HEALTH PERSP, V119, P1239, DOI 10.1289/ehp.1003394; Chen S, 2012, PLOS ONE, V6; Chen SH, 2013, BIORESOURCE TECHNOL, V132, P16, DOI 10.1016/j.biortech.2013.01.002; Chen SH, 2012, BIORESOURCE TECHNOL, V110, P97, DOI 10.1016/j.biortech.2012.01.106; Chen SH, 2011, BIORESOURCE TECHNOL, V102, P8110, DOI 10.1016/j.biortech.2011.06.055; Chen SH, 2011, J HAZARD MATER, V187, P433, DOI 10.1016/j.jhazmat.2011.01.049; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; Corcellas C, 2012, ENVIRON INT, V47, P17, DOI 10.1016/j.envint.2012.05.007; Cycon M, 2013, J ENVIRON MANAGE, V117, P7, DOI 10.1016/j.jenvman.2012.12.031; Cycon M, 2011, BIODEGRADATION, V22, P573, DOI 10.1007/s10532-010-9430-4; Delgado-Moreno L, 2011, J AGR FOOD CHEM, V59, P9448, DOI 10.1021/jf202049s; Fan XJ, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-33; Farag AT, 2007, REPROD TOXICOL, V23, P560, DOI 10.1016/j.reprotox.2007.01.002; Gao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038137; George J, 2011, PROTEOMICS, V11, P4411, DOI 10.1002/pmic.201100233; Guo P, 2009, INT BIODETER BIODEGR, V63, P1107, DOI 10.1016/j.ibiod.2009.09.008; Heidari R, 2005, INSECT BIOCHEM MOLEC, V35, P597, DOI 10.1016/j.ibmb.2005.02.018; Jin YX, 2011, CHEMOSPHERE, V84, P124, DOI 10.1016/j.chemosphere.2011.02.034; Jin YX, 2011, FISH SHELLFISH IMMUN, V30, P1049, DOI 10.1016/j.fsi.2011.02.001; Jin YX, 2011, CHEMOSPHERE, V82, P398, DOI 10.1016/j.chemosphere.2010.09.072; Kuivila KM, 2012, ENVIRON SCI TECHNOL, V46, P4297, DOI 10.1021/es2044882; Kumar A, 2012, CELL MOL BIOL, V58, P153, DOI 10.1170/T935; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li G, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-38; Liang WQ, 2005, J AGR FOOD CHEM, V53, P7415, DOI 10.1021/jf051460k; Lin QS, 2011, INT J ENVIRON SCI TE, V8, P45, DOI 10.1007/BF03326194; Lu CS, 2013, ENVIRON SCI TECHNOL, V47, P2018, DOI 10.1021/es303912n; Lubick N, 2008, ENVIRON SCI TECHNOL, V42, P8622, DOI 10.1021/es802697m; MALONEY SE, 1993, APPL ENVIRON MICROB, V59, P2007, DOI 10.1128/AEM.59.7.2007-2013.1993; Meeker JD, 2009, REPROD TOXICOL, V27, P155, DOI 10.1016/j.reprotox.2008.12.012; Morgan MK, 2012, INT J ENV RES PUB HE, V9, P2964, DOI 10.3390/ijerph9082964; Peng Y, 2009, APPL MICROBIOL BIOT, V85, P85, DOI 10.1007/s00253-009-2061-1; Shafer TJ, 2005, ENVIRON HEALTH PERSP, V113, P123, DOI 10.1289/ehp.7254; Tallur PN, 2008, BIODEGRADATION, V19, P77, DOI 10.1007/s10532-007-9116-8; Wang BZ, 2009, APPL ENVIRON MICROB, V75, P5496, DOI 10.1128/AEM.01298-09; Wang H, 2011, ENVIRON TOXICOL, V26, P382, DOI 10.1002/tox.20566; Wang XZ, 2009, THERIOGENOLOGY, V72, P599, DOI 10.1016/j.theriogenology.2009.04.016; Weston DP, 2009, ENVIRON POLLUT, V157, P287, DOI 10.1016/j.envpol.2008.06.037; Weston DP, 2010, ENVIRON SCI TECHNOL, V44, P1833, DOI 10.1021/es9035573; Wolansky MJ, 2008, NEUROTOXICOL TERATOL, V30, P55, DOI 10.1016/j.ntt.2007.10.005; Wu PC, 2006, J AGR FOOD CHEM, V54, P836, DOI 10.1021/jf052691u; Yang L, 2011, BIOL FERT SOILS, V47, P917, DOI 10.1007/s00374-011-0602-0; Zhai Y, 2012, J HAZARD MATER, V221, P206, DOI 10.1016/j.jhazmat.2012.04.031; Zhang C, 2011, BIORESOURCE TECHNOL, V102, P7139, DOI 10.1016/j.biortech.2011.03.086; Zhang C, 2010, BIORESOURCE TECHNOL, V101, P3423, DOI 10.1016/j.biortech.2009.12.083; Zhuang RS, 2011, J HAZARD MATER, V189, P323, DOI 10.1016/j.jhazmat.2011.02.034	49	23	28	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75450	10.1371/journal.pone.0075450	http://dx.doi.org/10.1371/journal.pone.0075450			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098697	Green Submitted, gold, Green Published			2022-12-25	WOS:000325423500068
J	Dong, ZY; Yang, YS; Li, YW; Zhang, KP; Lou, HJ; An, XL; Dong, LL; Gu, YQ; Anderson, OD; Liu, X; Qin, HJ; Wang, DW				Dong, Zhenying; Yang, Yushuang; Li, Yiwen; Zhang, Kunpu; Lou, Haijuan; An, Xueli; Dong, Lingli; Gu, Yong Qiang; Anderson, Olin D.; Liu, Xin; Qin, Huanju; Wang, Daowen			Haplotype Variation of Glu-D1 Locus and the Origin of Glu-D1d Allele Conferring Superior End-Use Qualities in Common Wheat	PLOS ONE			English	Article							SEED STORAGE PROTEINS; GLUTENIN SUBUNIT COMPOSITION; MARKER-ASSISTED SELECTION; BREAD-MAKING QUALITY; TRITICUM-SPELTA L.; AEGILOPS-TAUSCHII; HEAT-STRESS; MOLECULAR ANALYSIS; HEXAPLOID WHEAT; D-GENOME	In higher plants, seed storage proteins (SSPs) are frequently expressed from complex gene families, and allelic variation of SSP genes often affects the quality traits of crops. In common wheat, the Glu-D1 locus, encoding 1Dx and 1Dy SSPs, has multiple alleles. The Glu-D1d allele frequently confers superior end-use qualities to commercial wheat varieties. Here, we studied the haplotype structure of Glu-D1 genomic region and the origin of Glu-D1d. Using seven diagnostic DNA markers, 12 Glu-D1 haplotypes were detected among common wheat, European spelt wheat (T. spelta, a primitive hexaploid relative of common wheat), and Aegilops tauschii (the D genome donor of hexaploid wheat). By comparatively analyzing Glu-D1 haplotypes and their associated 1Dx and 1Dy genes, we deduce that the haplotype carrying Glu-D1d was likely differentiated in the ancestral hexaploid wheat around 10,000 years ago, and was subsequently transmitted to domesticated common wheat and T. spelta. A group of relatively ancient Glu-D1 haplotypes was discovered in Ae. tauschii, which may serve for the evolution of other haplotypes. Moreover, a number of new Glu-D1d variants were found in T. spelta. The main steps in Glu-D1d differentiation are proposed. The implications of our work for enhancing the utility of Glu-D1d in wheat quality improvement and studying the SSP alleles in other crop species are discussed.	[Dong, Zhenying; Yang, Yushuang; Li, Yiwen; Zhang, Kunpu; Lou, Haijuan; An, Xueli; Dong, Lingli; Liu, Xin; Qin, Huanju; Wang, Daowen] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosomal Engn, Beijing, Peoples R China; [Yang, Yushuang; Lou, Haijuan] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Gu, Yong Qiang; Anderson, Olin D.] USDA ARS, Western Reg Res Ctr, Albany, CA 94710 USA	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; United States Department of Agriculture (USDA)	Wang, DW (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosomal Engn, Beijing, Peoples R China.	dwwang@genetics.ac.cn		wang, dao wen/0000-0002-6230-8735	Ministry of Science and Technology of China [2009CB118300, 2011BAD07B02-2]; Ministry of Agriculture of China [2011ZX08002-004, 2011ZX08009-003-004]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs)	This project was supported by grants from Ministry of Science and Technology of China (2009CB118300, 2011BAD07B02-2) and Ministry of Agriculture of China (2011ZX08002-004, 2011ZX08009-003-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeret O, 2005, VEG HIST ARCHAEOBOT, V14, P279, DOI 10.1007/s00334-005-0071-1; Akhunov ED, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-702; Anderson O. D., 2003, Functional & Integrative Genomics, V3, P56; ANDERSON OD, 1989, NUCLEIC ACIDS RES, V17, P461, DOI 10.1093/nar/17.1.461; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Blatter RHE, 2004, THEOR APPL GENET, V108, P360, DOI 10.1007/s00122-003-1441-7; BLUMENTHAL C, 1995, CEREAL CHEM, V72, P539; Caldwell KS, 2004, GENETICS, V167, P941, DOI 10.1534/genetics.103.016303; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Don C, 2005, J CEREAL SCI, V42, P69, DOI 10.1016/j.jcs.2005.01.005; Dvorak J, 1998, THEOR APPL GENET, V97, P657, DOI 10.1007/s001220050942; Dvorak J, 2012, J HERED, V103, P426, DOI 10.1093/jhered/esr152; Feldman M., 2001, WORLD WHEAT BOOK HIS, P3; Garg M, 2009, BREEDING SCI, V59, P519, DOI 10.1270/jsbbs.59.519; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; Gibbon BC, 2005, TRENDS GENET, V21, P227, DOI 10.1016/j.tig.2005.02.009; Giles RJ, 2006, THEOR APPL GENET, V112, P1563, DOI 10.1007/s00122-006-0259-5; Groos C, 2007, THEOR APPL GENET, V115, P313, DOI 10.1007/s00122-007-0563-8; Gu YQ, 2006, GENETICS, V174, P1493, DOI 10.1534/genetics.106.060756; Gu YQ, 2010, FUNCT INTEGR GENOMIC, V10, P111, DOI 10.1007/s10142-009-0135-x; Gustafson P., 2009, WHEAT SCI TRADE, P3, DOI DOI 10.1002/9780813818832.CH1; Holding DR, 2008, ADV PL BIOCH MOL BIO, V1, P107, DOI 10.1016/S1755-0408(07)01005-3; Irmak S, 2008, J CEREAL SCI, V48, P513, DOI 10.1016/j.jcs.2007.12.002; Jegadeesan S, 2012, THEOR APPL GENET, V124, P365, DOI 10.1007/s00122-011-1711-8; Kawakatsu T, 2008, J EXP BOT, V59, P4233, DOI 10.1093/jxb/ern265; Kim WS, 2008, J AGR FOOD CHEM, V56, P11320, DOI 10.1021/jf801831w; Krattinger SG, 2013, THEOR APPL GENET, V126, P663, DOI 10.1007/s00122-012-2009-1; Krattinger SG, 2011, PLANT J, V65, P392, DOI 10.1111/j.1365-313X.2010.04430.x; LAFIANDRA D, 1993, J CEREAL SCI, V18, P197, DOI 10.1006/jcrs.1993.1046; Li W. H, 1997, MOL EVOLUTION; Liu SX, 2008, THEOR APPL GENET, V118, P177, DOI 10.1007/s00122-008-0886-0; Liu YN, 2012, THEOR APPL GENET, V125, P1, DOI 10.1007/s00122-012-1829-3; Liu Z, 2003, THEOR APPL GENET, V106, P1368, DOI 10.1007/s00122-002-1175-y; Ma JX, 2004, P NATL ACAD SCI USA, V101, P12404, DOI 10.1073/pnas.0403715101; Matsuoka Y, 2011, PLANT CELL PHYSIOL, V52, P750, DOI 10.1093/pcp/pcr018; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Miclaus M, 2011, GENETICS, V189, P1271, DOI 10.1534/genetics.111.133918; Miclaus M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002131; Paux E, 2010, PLANT BIOTECHNOL J, V8, P196, DOI 10.1111/j.1467-7652.2009.00477.x; Payne P. I., 1983, Cereal Research Communications, V11, P29; PAYNE PI, 1987, ANNU REV PLANT PHYS, V38, P141, DOI 10.1146/annurev.pp.38.060187.001041; PAYNE PI, 1987, J SCI FOOD AGR, V40, P51, DOI 10.1002/jsfa.2740400108; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Salamini F, 2002, NAT REV GENET, V3, P429, DOI 10.1038/nrg817; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; Shewry PR, 2009, J EXP BOT, V60, P1537, DOI 10.1093/jxb/erp058; SHEWRY PR, 1995, PLANT CELL, V7, P945, DOI 10.1105/tpc.7.7.945; Shewry PR, 2002, J EXP BOT, V53, P947, DOI 10.1093/jexbot/53.370.947; Stadler T, 2002, P NATL ACAD SCI USA, V99, P11730, DOI 10.1073/pnas.182267799; Surjani Uthayakumaran, 2012, Journal of Agricultural Science (Toronto), V4, P41; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Terasawa Y, 2011, GENET RESOUR CROP EV, V58, P283, DOI 10.1007/s10722-010-9573-5; Wang G, 2011, GENETICS, V189, P1281, DOI 10.1534/genetics.111.133967; Wang YH, 2005, CELL RES, V15, P622, DOI 10.1038/sj.cr.7290332; Wani, 2009, J PLANT BREED CROP S, V1, P244, DOI DOI 10.5897/JPBCS.9000113; Wanjugi H, 2009, GENOME, V52, P576, DOI [10.1139/G09-033, 10.1139/g09-033]; Wicker T, 2003, PLANT CELL, V15, P1186, DOI 10.1105/tpc.011023; Wicker T, 2009, PLANT PHYSIOL, V149, P258, DOI 10.1104/pp.108.129734; Wrigley C., 2009, WHEAT SCI TRADE, P495, DOI DOI 10.1002/9780813818832.CH21; Wu YR, 2010, P NATL ACAD SCI USA, V107, P12810, DOI 10.1073/pnas.1004721107; Yahiaoui N, 2006, PLANT J, V47, P85, DOI 10.1111/j.1365-313X.2006.02772.x; Yan Y, 2003, THEOR APPL GENET, V107, P1321, DOI 10.1007/s00122-003-1315-z; Yan ZH, 2008, CEREAL RES COMMUN, V36, P477, DOI 10.1556/CRC.36.2008.3.12; [张平平 ZHANG Ping-Ping], 2009, [作物学报, Acta Agronomica Sinica], V35, P1606; Zhang Y, 2008, GENETICS, V178, P23, DOI 10.1534/genetics.107.077412	65	6	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74859	10.1371/journal.pone.0074859	http://dx.doi.org/10.1371/journal.pone.0074859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098671	Green Submitted, Green Published, gold			2022-12-25	WOS:000325423500042
J	Higo, K; Ikura, T; Oda, M; Morii, H; Takahashi, J; Abe, R; Ito, N				Higo, Kunitake; Ikura, Teikichi; Oda, Masayuki; Morii, Hisayuki; Takahashi, Jun; Abe, Ryo; Ito, Nobutoshi			High Resolution Crystal Structure of the Grb2 SH2 Domain with a Phosphopeptide Derived from CD28	PLOS ONE			English	Article							HIGH-AFFINITY; BINDING; PATHWAY	Src homology 2 (SH2) domains play a critical role in cellular signal transduction. They bind to peptides containing phosphotyrosine (pY) with various specificities that depend on the flanking amino-acid residues. The SH2 domain of growth-factor receptor-bound protein 2 (Grb2) specifically recognizes pY-X-N-X, whereas the SH2 domains in phosphatidylinositol 3-kinase (PI3K) recognize pY-X-X-M. Binding of the pY site in CD28 (pY-M-N-M) by PI3K and Grb2 through their SH2 domains is a key step that triggers the CD28 signal transduction for T cell activation and differentiation. In this study, we determined the crystal structure of the Grb2 SH2 domain in complex with a pY-containing peptide derived from CD28 at 1.35 angstrom resolution. The peptide was found to adopt a twisted U-type conformation, similar to, but distinct from type-I beta-turn. In all previously reported crystal structures, the peptide bound to the Grb2 SH2 domains adopts a type-I beta-turn conformation, except those with a proline residue at the pY+3 position. Molecular modeling also suggests that the same peptide bound to PI3K might adopt a very different conformation.	[Higo, Kunitake; Takahashi, Jun; Abe, Ryo] Tokyo Univ Sci, Res Inst Biomed Sci, Noda, Chiba 278, Japan; [Ikura, Teikichi; Ito, Nobutoshi] Tokyo Med & Dent Univ, Med Res Inst, Bunkyo Ku, Tokyo, Japan; [Oda, Masayuki] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Sakyo Ku, Kyoto 606, Japan; [Morii, Hisayuki] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki, Japan	Tokyo University of Science; Tokyo Medical & Dental University (TMDU); Kyoto Prefectural University; National Institute of Advanced Industrial Science & Technology (AIST)	Ito, N (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Bunkyo Ku, Tokyo, Japan.	ito.str@tmd.ac.jp	Ikura, Teikichi/N-1490-2015; Ikura, Teikichi/T-5912-2019	Ikura, Teikichi/0000-0003-2377-5434; Oda, Masayuki/0000-0002-8568-4223	JSPS KAKENHI [20159453]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was in part supported by JSPS KAKENHI Grant Number 20159453 (http://www.jsps.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENFIELD AP, 2006, ANGEW CHEM INT ED EN, V0118; Das S, 2011, J MOL BIOL, V414, P217, DOI 10.1016/j.jmb.2011.09.046; DeLorbe JE, 2010, ACS MED CHEM LETT, V1, P448, DOI 10.1021/ml100142y; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ettmayer P, 1999, J MED CHEM, V42, P971, DOI 10.1021/jm9811007; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNemar C, 1997, BIOCHEMISTRY-US, V36, P10006, DOI 10.1021/bi9704360; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nioche P, 2002, J MOL BIOL, V315, P1167, DOI 10.1006/jmbi.2001.5299; Nolte RT, 1996, NAT STRUCT BIOL, V3, P364, DOI 10.1038/nsb0496-364; Ogura K, 1999, J MOL BIOL, V289, P439, DOI 10.1006/jmbi.1999.2792; Rahuel J, 1998, J MOL BIOL, V279, P1013, DOI 10.1006/jmbi.1998.1790; Rahuel J, 1996, NAT STRUCT BIOL, V3, P586, DOI 10.1038/nsb0796-586; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Rudd CE, 2003, NAT REV IMMUNOL, V3, P544, DOI 10.1038/nri1131; Rudolph R, 1996, FASEB J, V10, P49, DOI 10.1096/fasebj.10.1.8566547; SCHNEIDER H, 1995, EUR J IMMUNOL, V25, P1044, DOI 10.1002/eji.1830250428; Suga T, 1998, ACTA CRYSTALLOGR C, V54, P83, DOI 10.1107/S0108270197009827; Thornton KH, 1996, BIOCHEMISTRY-US, V35, P11852, DOI 10.1021/bi952615s; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	23	14	14	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74482	10.1371/journal.pone.0074482	http://dx.doi.org/10.1371/journal.pone.0074482			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098653	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500024
J	Huebner, L; Engeli, S; Wrann, CD; Goudeva, L; Laue, T; Kielstein, H				Huebner, Lena; Engeli, Stefan; Wrann, Christiane D.; Goudeva, Lilia; Laue, Tobias; Kielstein, Heike			Human NK Cell Subset Functions Are Differentially Affected by Adipokines	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; ADIPOSE-TISSUE; IFN-GAMMA; OBESITY; LEPTIN; INFLAMMATION; ADIPONECTIN; DYSFUNCTION; CYTOKINES; IDENTIFICATION	Background: Obesity is a risk factor for various types of infectious diseases and cancer. The increase in adipose tissue causes alterations in both adipogenesis and the production of adipocyte-secreted proteins (adipokines). Since natural killer (NK) cells are the host's primary defense against virus-infected and tumor cells, we investigated how adipocyte-conditioned medium (ACM) affects functions of two distinct human NK cell subsets. Methods: Isolated human peripheral blood mononuclear cells (PBMCs) were cultured with various concentrations of human and murine ACM harvested on two different days during adipogenesis and analyzed by fluorescent-activated cell sorting (FACS). Results: FACS analyses showed that the expression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), granzyme A (GzmA) and interferon (IFN)-gamma in NK cells was regulated in a subset-specific manner. ACM treatment altered IFN-gamma expression in CD56(dim) NK cells. The production of GzmA in CD56(bright) NK cells was differentially affected by the distinct adipokine compositions harvested at different states of adipogenesis. Comparison of the treatment with either human or murine ACM revealed that adipokine-induced effects on NK cell expression of the leptin receptor (Ob-R), TRAIL and IFN-gamma were species-specific. Conclusion: Considering the growing prevalence of obesity and the various disorders related to it, the present study provides further insights into the roles human NK cell subsets play in the obesity-associated state of chronic low-grade inflammation.	[Huebner, Lena; Laue, Tobias] Hannover Med Sch, Inst Funct & Appl Anat, Hannover, Germany; [Huebner, Lena] Univ Med Berlin, Charite, Dept Gen Visceral Vasc & Thorac Surg, Berlin, Germany; [Engeli, Stefan] Hannover Med Sch, Inst Clin Pharmacol, Hannover, Germany; [Wrann, Christiane D.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Endocrinol, Boston, MA 02215 USA; [Goudeva, Lilia] Hannover Med Sch, Inst Transfus Med, Hannover, Germany; [Kielstein, Heike] Univ Halle Wittenberg, Dept Anat & Cell Biol, Fac Med, D-06108 Halle, Saale, Germany	Hannover Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hannover Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Hannover Medical School; Martin Luther University Halle Wittenberg	Kielstein, H (corresponding author), Univ Halle Wittenberg, Dept Anat & Cell Biol, Fac Med, D-06108 Halle, Saale, Germany.	heike.kielstein@medizin.uni-halle.de	Kielstein, Heike/GNW-4839-2022; Kielstein, Jan T./I-2956-2019	Kielstein, Jan T./0000-0001-8110-9064; Seidemann, Lena/0000-0002-1531-7735	Institute for Functional and Applied Anatomy, Hannover Medical School, Hannover, Germany	Institute for Functional and Applied Anatomy, Hannover Medical School, Hannover, Germany	The study was an investigator initiated study that was mainly supported by an institutional grant from the Institute for Functional and Applied Anatomy, Hannover Medical School, Hannover, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner P, 2010, BIOCHEM BIOPH RES CO, V396, P101, DOI 10.1016/j.bbrc.2010.02.165; Bluhre M, 2009, EXP CLIN ENDOCR DIAB, V117, P241, DOI 10.1055/s-0029-1192044; Caballero B, 2007, EPIDEMIOL REV, V29, P1, DOI 10.1093/epirev/mxm012; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Corazza N, 2009, ANN NY ACAD SCI, V1171, P50, DOI 10.1111/j.1749-6632.2009.04905.x; De Maria A, 2011, P NATL ACAD SCI USA, V108, P728, DOI 10.1073/pnas.1012356108; Dixit VD, 2008, J LEUKOCYTE BIOL, V84, P882, DOI 10.1189/jlb.0108028; Dunn C, 2007, J EXP MED, V204, P667, DOI 10.1084/jem.20061287; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; Falschlehner C, 2009, IMMUNOLOGY, V127, P145, DOI 10.1111/j.1365-2567.2009.03058.x; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Fernandez-Riejos P, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/568343; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Housa D, 2006, PHYSIOL RES, V55, P233, DOI 10.33549/physiolres.930848; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kim KY, 2006, J IMMUNOL, V176, P5958, DOI 10.4049/jimmunol.176.10.5958; La Cava A, 2004, NAT REV IMMUNOL, V4, P371, DOI 10.1038/nri1350; Lago F, 2007, CYTOKINE GROWTH F R, V18, P313, DOI 10.1016/j.cytogfr.2007.04.007; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lautenbach A, 2009, OBESITY, V17, P1848, DOI 10.1038/oby.2009.140; Lynch LA, 2009, OBESITY, V17, P601, DOI 10.1038/oby.2008.565; McLaughlin T, 2010, DIABETOLOGIA, V53, P369, DOI 10.1007/s00125-009-1496-3; Moschen AR, 2007, J IMMUNOL, V178, P1748, DOI 10.4049/jimmunol.178.3.1748; Nave H, 2008, ENDOCRINOLOGY, V149, P3370, DOI 10.1210/en.2007-1516; O'Shea D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008660; Ogden Cynthia L, 2007, NCHS Data Brief, P1; Poulos SP, 2010, EXP BIOL MED, V235, P1185, DOI 10.1258/ebm.2010.010063; Rosenow A, 2010, J PROTEOME RES, V9, P5389, DOI 10.1021/pr100621g; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Takeda K, 2001, CELL IMMUNOL, V214, P194, DOI 10.1006/cimm.2001.1896; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Trayhurn P, 2005, ENDOCRINOLOGY, V146, P1003, DOI 10.1210/en.2004-1597; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867; Wolf AM, 2004, BIOCHEM BIOPH RES CO, V323, P630, DOI 10.1016/j.bbrc.2004.08.145; Wrann CD, 2012, AM J PHYSIOL-ENDOC M, V302, pE108, DOI 10.1152/ajpendo.00057.2011; Wulster-Radcliffe MC, 2004, BIOCHEM BIOPH RES CO, V316, P924, DOI 10.1016/j.bbrc.2004.02.130; Zhao YR, 2003, BIOCHEM BIOPH RES CO, V300, P247, DOI 10.1016/S0006-291X(02)02838-3; Zhong J, 2010, J PROTEOME RES, V9, P5228, DOI 10.1021/pr100521c	44	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75703	10.1371/journal.pone.0075703	http://dx.doi.org/10.1371/journal.pone.0075703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098717	Green Submitted, Green Published, gold			2022-12-25	WOS:000325423500088
J	Liu, CH; Ren, JQ; Liu, CM; Liu, PK				Liu, Christina H.; Ren, Jiaqian; Liu, Charng-Ming; Liu, Philip K.			Intracellular gene transcription factor protein-guided MRI by DNA aptamers in vivo	FASEB JOURNAL			English	Article						AP1 knockout; attention; monoamine oxidase A; stress; transgenic mice	LIVING BRAINS; CELL TRACKING; LIVE ANIMALS; ACUTE STRESS; EXPRESSION; PROBES; AMPHETAMINE; CONTRAST; EXPOSURE; DELIVERY	The mechanisms by which transcription factor (TF) protein AP-1 modulates amphetamine's effects on gene transcription in living brains are unclear. We describe here the first part of our studies to investigate these mechanisms, specifically, our efforts to develop and validate aptamers containing the binding sequence of TF AP-1 (5ECdsAP1), in order to elucidate its mechanism of action in living brains. This AP-1-targeting aptamer, as well as a random sequence aptamer with no target (5ECdsRan) as a control, was partially phosphorothioate modified and tagged with superparamagnetic iron oxide nanoparticles (SPIONs), gold, or fluorescein isothiothianate contrast agent for imaging. Optical and transmission electron microscopy studies revealed that 5ECdsAP1 is taken up by endocytosis and is localized in the neuronal endoplasmic reticulum. The results of magnetic resonance imaging (MRI) with SPION-5ECdsAP1 revealed that neuronal AP-1 TF protein levels were elevated in neurons of live male C57black6 mice after amphetamine exposure; however, pretreatment with SCH23390, a dopaminergic receptor antagonist, suppressed this elevation. As studies in transgenic mice with neuronal dominant-negative A-FOS mutant protein, which has no binding affinity for the AP-1 sequence, showed a completely null MRI signal in the striatum, we can conclude that the MR signal reflects specific binding between the 5ECdsAP1 aptamer and endogenous AP-1 protein. Together, these data lend support to the application of 5ECdsAP1 aptamer for intracellular protein-guided imaging and modulation of gene transcription, which will thus allow investigation of the mechanisms of signal transduction in living brains.Liu, C. H., Ren, J., Liu, C.-M., Liu, P. K. Intracellular gene transcription factor protein-guided MRI by DNA aptamers in vivo.	[Liu, Christina H.; Ren, Jiaqian; Liu, Charng-Ming; Liu, Philip K.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Liu, PK (corresponding author), Massachusetts Gen Hosp, CNY149 2301 Thirteenth St, Charlestown, MA 02129 USA.	philipl@nmr.mgh.harvard.edu		Liu, Christina/0000-0002-5723-177X	U.S. National Institutes of Health (NIH) [R01DK43351, R01DK57521]; National Institute on Drug Abuse [R01DA029889]; National Institute of Biomedical Imaging and Bioengineering [R01EB013768]; National Center for Alternative Medicine of the NIH [AT004974]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT004974] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB013768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521, P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029889] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Center for Alternative Medicine of the NIH; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank Dr. M. Schwartzchild for allowing them to use the locomotion detection device. The authors also thank Dr. C. Vinson (National Cancer Institute, Frederick, MD, USA) for use of the double-transgenic A-FOS mutant mouse strain, Dr. H. Prentice for reading and critical evaluation, and Ms. N. Eusemann for assistance with editing the manuscript. The authors appreciate the help of M. McKee with TEM and the availability of the Massachusetts General Hospital Microscopy Core [supported by U.S. National Institutes of Health (NIH) grants R01DK43351 and R01DK57521]. This project was supported by research grants from the National Institute on Drug Abuse (R01DA029889), the National Institute of Biomedical Imaging and Bioengineering (R01EB013768), and the National Center for Alternative Medicine (AT004974) of the NIH.	BELTINGER C, 1995, J CLIN INVEST, V95, P1814, DOI 10.1172/JCI117860; Berman SC, 2011, MAGN RESON MED, V65, P564, DOI 10.1002/mrm.22613; Bonovich M, 2002, CANCER GENE THER, V9, P62, DOI 10.1038/sj/cgt/7700409; BOXERMAN JL, 1995, MAGNET RESON MED, V34, P555, DOI 10.1002/mrm.1910340412; Brody SA, 2003, PSYCHOPHARMACOLOGY, V169, P240, DOI 10.1007/s00213-003-1421-2; Bulte JWM, 2004, METHOD ENZYMOL, V386, P275; Fitzgerald ML, 2007, J LIPID RES, V48, P621, DOI 10.1194/jlr.M600449-JLR200; Hogemann D, 2000, BIOCONJUGATE CHEM, V11, P941, DOI 10.1021/bc000079x; Ichikawa T, 2002, NEOPLASIA, V4, P523, DOI 10.1038/sj.neo.7900266; Komatsu T, 2011, MECH AGEING DEV, V132, P103, DOI 10.1016/j.mad.2011.01.002; Lind K, 2002, J DRUG TARGET, V10, P221, DOI 10.1080/10611860290022651; Liu CH, 2004, MAGN RESON MED, V51, P978, DOI 10.1002/mrm.20047; Liu CH, 2008, FASEB J, V22, P1193, DOI 10.1096/fj.07-9557com; Liu CH, 2007, FASEB J, V21, P3004, DOI 10.1096/fj.07-8203com; Liu CH, 2007, J NEUROSCI, V27, P713, DOI 10.1523/JNEUROSCI.4660-06.2007; Liu CH, 2013, FASEB J, V27, P712, DOI 10.1096/fj.12-220061; Liu CH, 2012, FASEB J, V26, P1652, DOI 10.1096/fj.11-199547; Liu CH, 2009, J NEUROSCI, V29, P10663, DOI 10.1523/JNEUROSCI.2167-09.2009; Liu PK, 2008, NEUROSCIENTIST, V14, P503, DOI 10.1177/1073858407309746; LIU PK, 1994, ANN NEUROL, V36, P566, DOI 10.1002/ana.410360405; MULDOON LL, 1995, AM J PATHOL, V147, P1840; Paletzki RF, 2008, NEUROSCIENCE, V152, P1040, DOI 10.1016/j.neuroscience.2008.01.045; Soliman A, 2012, J NEUROSCI, V32, P17120, DOI 10.1523/JNEUROSCI.2091-12.2012; SORENSEN AG, 1995, AM J NEURORADIOL, V16, P1753; Sterrenburg L, 2012, J NEUROSCI RES, V90, P179, DOI 10.1002/jnr.22737; Strome EM, 2002, P NATL ACAD SCI USA, V99, P15749, DOI 10.1073/pnas.232480899; WAHLESTEDT C, 1993, NATURE, V363, P260, DOI 10.1038/363260a0; Zhang ZM, 2001, NEUROIMAGE, V14, P1159, DOI 10.1006/nimg.2001.0902; Zhu XM, 2012, INT J NANOMED, V7, P953, DOI 10.2147/IJN.S28316; ZIMMER C, 1995, RADIOLOGY, V196, P521, DOI 10.1148/radiology.196.2.7617871	30	16	16	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					464	473		10.1096/fj.13-234229	http://dx.doi.org/10.1096/fj.13-234229			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24115049	Green Published			2022-12-25	WOS:000333526100043
J	Buhrman, JD; Jordan, KR; Munson, DJ; Moore, BL; Kappler, JW; Slansky, JE				Buhrman, Jonathan D.; Jordan, Kimberly R.; Munson, Daniel J.; Moore, Brandon L.; Kappler, John W.; Slansky, Jill E.			Improving Antigenic Peptide Vaccines for Cancer Immunotherapy Using a Dominant Tumor-specific T Cell Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antigen; Peptide Arrays; T Cell; T Cell Receptor; Tumor Immunology; Vaccines	MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I BINDING; SELF-ANTIGEN; ANTITUMOR IMMUNITY; MOLECULAR MIMICRY; CENTRAL TOLERANCE; MHC COMPLEXES; HIGH-AFFINITY; TCR-BINDING; RECOGNITION	Background: Vaccination with mimotopes, peptide mimics of epitopes, stimulates a range of T cell protection. Results: Mimotopes identified from peptide libraries by T cells with common receptors increased immunity more than those with rare high affinity receptors. Conclusion: T cell prevalence must be considered when designing peptide vaccines. Significance: Optimizing mimotopes will improve antigen-specific vaccines for applications including cancer immunotherapies. Vaccines that incorporate peptide mimics of tumor antigens, or mimotope vaccines, are commonly used in cancer immunotherapy and function by eliciting increased numbers of T cells that cross-react with the native tumor antigen. Unfortunately, they often elicit T cells that do not cross-react with or that have low affinity for the tumor antigen. Using a high affinity tumor-specific T cell clone, we identified a panel of mimotope vaccines for the dominant peptide antigen from a mouse colon tumor that elicits a range of tumor protection following vaccination. The TCR from this high affinity T cell clone was rarely identified in ex vivo evaluation of tumor-specific T cells elicited by mimotope vaccination. Conversely, a low affinity clone found in the tumor and following immunization was frequently identified. Using peptide libraries, we determined if this frequently identified TCR improved the discovery of efficacious mimotopes. We demonstrated that the representative TCR identified more protective mimotopes than the high affinity TCR. These results suggest that targeting a dominant fraction of tumor-specific T cells generates potent immunity and that consideration of the available T cell repertoire is necessary for targeted T cell therapy. These results have important implications when optimizing mimotope vaccines for cancer immunotherapy.	[Buhrman, Jonathan D.; Jordan, Kimberly R.; Munson, Daniel J.; Moore, Brandon L.; Kappler, John W.; Slansky, Jill E.] Univ Colorado, Sch Med, Integrated Dept Immunol, Aurora, CO 80045 USA; [Jordan, Kimberly R.] Univ Colorado, Sch Med, Dept Surg, Aurora, CO 80045 USA; [Kappler, John W.] Natl Jewish Hlth, Howard Hughes Med Inst, Denver, CO 80206 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Howard Hughes Medical Institute; National Jewish Health	Slansky, JE (corresponding author), Univ Colorado, Sch Med, Integrated Dept Immunol, Natl Jewish Hlth, 1400 Jackson St,Rm K511, Denver, CO 80206 USA.	Jill.Slansky@ucdenver.edu			National Institutes of Health [CA109560, P30CA046934]; American Cancer Society [RSG-08-184-01-L1B]; Cancer Research Institute Pre-doctoral Emphasis Pathway in Tumor Immunology Fellowship; NATIONAL CANCER INSTITUTE [R01CA109560, P30CA046934] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Cancer Research Institute Pre-doctoral Emphasis Pathway in Tumor Immunology Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA109560 and P30CA046934. This work was also supported by American Cancer Society Grant RSG-08-184-01-L1B.; Both authors contributed equally to this work. Supported by the Cancer Research Institute Pre-doctoral Emphasis Pathway in Tumor Immunology Fellowship.	Adams JJ, 2011, IMMUNITY, V35, P681, DOI 10.1016/j.immuni.2011.09.013; Almeida JR, 2009, BLOOD, V113, P6351, DOI 10.1182/blood-2009-02-206557; Appay V, 2008, NAT MED, V14, P623, DOI 10.1038/nm.f.1774; Appay V, 2006, EUR J IMMUNOL, V36, P1805, DOI 10.1002/eji.200535805; Balendiran GK, 1997, P NATL ACAD SCI USA, V94, P6880, DOI 10.1073/pnas.94.13.6880; Birnbaum ME, 2012, IMMUNOL REV, V250, P82, DOI 10.1111/imr.12006; Bridgeman JS, 2012, IMMUNOLOGY, V135, P9, DOI 10.1111/j.1365-2567.2011.03515.x; Buhrman JD, 2013, CANCER RES, V73, P74, DOI 10.1158/0008-5472.CAN-12-1005; Chastain EML, 2012, IMMUNOL REV, V245, P227, DOI 10.1111/j.1600-065X.2011.01076.x; Clay TM, 1999, J IMMUNOL, V162, P1749; Cole DK, 2007, J IMMUNOL, V178, P5727, DOI 10.4049/jimmunol.178.9.5727; Cole DK, 2010, J IMMUNOL, V185, P2600, DOI 10.4049/jimmunol.1000629; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; Crawford F, 2006, IMMUNOL REV, V210, P156, DOI 10.1111/j.0105-2896.2006.00365.x; Crawford F, 2004, PLOS BIOL, V2, P523, DOI 10.1371/journal.pbio.0020090; de Visser KE, 2003, J IMMUNOTHER, V26, P1, DOI 10.1097/00002371-200301000-00001; de Visser KE, 2001, J IMMUNOL, V167, P3818, DOI 10.4049/jimmunol.167.7.3818; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Ekeruche-Makinde J, 2012, J BIOL CHEM, V287, P37269, DOI 10.1074/jbc.M112.386409; Enouz S, 2012, J EXP MED, V209, P1769, DOI 10.1084/jem.20120905; HASKINS K, 1983, J EXP MED, V157, P1149, DOI 10.1084/jem.157.4.1149; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Holler PD, 2003, NAT IMMUNOL, V4, P55, DOI 10.1038/ni863; Hou YF, 2008, J IMMUNOL, V180, P1526, DOI 10.4049/jimmunol.180.3.1526; Iero M, 2007, CANCER IMMUNOL IMMUN, V56, P1979, DOI 10.1007/s00262-007-0342-z; Jordan KR, 2008, J IMMUNOL, V180, P188, DOI 10.4049/jimmunol.180.1.188; Jordan KR, 2012, CANCER IMMUNOL IMMUN, V61, P1627, DOI 10.1007/s00262-012-1217-5; Jordan KR, 2010, P NATL ACAD SCI USA, V107, P4652, DOI 10.1073/pnas.0914879107; Kedl RM, 2000, J EXP MED, V192, P1105, DOI 10.1084/jem.192.8.1105; Kedl RM, 2002, NAT IMMUNOL, V3, P27, DOI 10.1038/ni742; Kersh GJ, 1996, J EXP MED, V184, P1259, DOI 10.1084/jem.184.4.1259; KHILKO SN, 1993, J BIOL CHEM, V268, P15425; Liu CP, 1998, P NATL ACAD SCI USA, V95, P4522, DOI 10.1073/pnas.95.8.4522; LIU GY, 1995, IMMUNITY, V3, P407, DOI 10.1016/1074-7613(95)90170-1; Macdonald WA, 2009, IMMUNITY, V31, P897, DOI 10.1016/j.immuni.2009.09.025; McMahan RH, 2006, J CLIN INVEST, V116, P2543, DOI 10.1172/JCI26936; McWilliams JA, 2008, VACCINE, V26, P1863, DOI 10.1016/j.vaccine.2008.01.052; Miles JJ, 2011, IMMUNOL CELL BIOL, V89, P375, DOI 10.1038/icb.2010.139; Miller JFAP, 1996, CURR OPIN IMMUNOL, V8, P815, DOI 10.1016/S0952-7915(96)80010-0; Ohlen C, 2002, J EXP MED, V195, P1407, DOI 10.1084/jem.20011063; Overwijk WW, 1998, J EXP MED, V188, P277, DOI 10.1084/jem.188.2.277; OZATO K, 1980, J IMMUNOL, V125, P2473; Rubio V, 2003, NAT MED, V9, P1377, DOI 10.1038/nm942; Sanchez PJ, 2007, J IMMUNOL, V178, P1564, DOI 10.4049/jimmunol.178.3.1564; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sewell AK, 2012, NAT REV IMMUNOL, V12, P668, DOI 10.1038/nri3279; Slansky JE, 2000, IMMUNITY, V13, P529, DOI 10.1016/S1074-7613(00)00052-2; Speiser DE, 2008, P NATL ACAD SCI USA, V105, P3849, DOI 10.1073/pnas.0800080105; Stuge TB, 2004, PLOS MED, V1, P149, DOI 10.1371/journal.pmed.0010028; Tam RC, 1996, J IMMUNOL, V156, P3765; Tang Y, 2007, CANCER IMMUNOL IMMUN, V56, P319, DOI 10.1007/s00262-006-0195-x; Truscott SM, 2007, J IMMUNOL, V178, P6280, DOI 10.4049/jimmunol.178.10.6280; Tumenjargal S, 2003, EUR J IMMUNOL, V33, P3175, DOI 10.1002/eji.200324244; Wang YB, 2005, P NATL ACAD SCI USA, V102, P2476, DOI 10.1073/pnas.0409798102; Wieckowski S, 2009, J IMMUNOL, V183, P5397, DOI 10.4049/jimmunol.0901460; WILSON RK, 1988, IMMUNOL REV, V101, P149, DOI 10.1111/j.1600-065X.1988.tb00736.x; Wooldridge L, 2012, J BIOL CHEM, V287, P1168, DOI 10.1074/jbc.M111.289488; Zaremba S, 1997, CANCER RES, V57, P4570; Zugel U, 1998, J IMMUNOL, V161, P1705	59	16	16	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33213	33225		10.1074/jbc.M113.509554	http://dx.doi.org/10.1074/jbc.M113.509554			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24106273	Green Published, hybrid			2022-12-25	WOS:000328841700036
J	Shen, H; Xu, SJ; Hong, L; Wang, ZM; Ye, WH				Shen, Hao; Xu, Shu-Jun; Hong, Lan; Wang, Zhang-Ming; Ye, Wan-Hui			Growth but Not Photosynthesis Response of a Host Plant to Infection by a Holoparasitic Plant Depends on Nitrogen Supply	PLOS ONE			English	Article							SINK-STIMULATED PHOTOSYNTHESIS; PARASITE CUSCUTA-CAMPESTRIS; NITRATE UPTAKE NITROGEN; MIKANIA-MICRANTHA; STRIGA-HERMONTHICA; BIOMASS ALLOCATION; RICINUS-COMMUNIS; CARBON RELATIONS; GAS-EXCHANGE; ELEVATED CO2	Parasitic plants can adversely influence the growth of their hosts by removing resources and by affecting photosynthesis. Such negative effects depend on resource availability. However, at varied resource levels, to what extent the negative effects on growth are attributed to the effects on photosynthesis has not been well elucidated. Here, we examined the influence of nitrogen supply on the growth and photosynthesis responses of the host plant Mikania micrantha to infection by the holoparasite Cuscuta campestris by focusing on the interaction of nitrogen and infection. Mikania micrantha plants fertilized at 0.2, 1 and 5 mM nitrate were grown with and without C. campestris infection. We observed that the infection significantly reduced M. micrantha growth at each nitrate fertilization and more severely at low than at high nitrate. Such alleviation at high nitrate was largely attributed to a stronger influence of infection on root biomass at low than at high nitrate fertilization. However, although C. campestris altered allometry and inhibited host photosynthesis, the magnitude of the effects was independent of nitrate fertilizations. The infection reduced light saturation point, net photosynthesis at saturating irradiances, apparent quantum yield, CO2 saturated rate of photosynthesis, carboxylation efficiency, the maximum carboxylation rate of Rubisco, and maximum light-saturated rate of electron transport, and increased light compensation point in host leaves similarly across nitrate levels, corresponding to a similar magnitude of negative effects of the parasite on host leaf soluble protein and Rubisco concentrations, photosynthetic nitrogen use efficiency and stomatal conductance across nitrate concentrations. Thus, the more severe inhibition in host growth at low than at high nitrate supplies cannot be attributed to a greater parasite-induced reduction in host photosynthesis, but the result of a higher proportion of host resources transferred to the parasite at low than at high nitrate levels.	[Shen, Hao; Xu, Shu-Jun; Wang, Zhang-Ming; Ye, Wan-Hui] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Xu, Shu-Jun] Univ Chinese Acad Sci, Coll Life Sci, Beijing, Peoples R China; [Hong, Lan] Zhongkai Univ Agr & Engn, Coll Hort & Landscape Architecture, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Zhongkai University of Agriculture & Engineering	Shen, H (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China.	shenhao@scbg.ac.cn			National Key Technologies R&D Program of China [2012BAC07B04]	National Key Technologies R&D Program of China(National Key Technology R&D Program)	This work was funded by the National Key Technologies R&D Program of China (2012BAC07B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Barker ER, 1996, NEW PHYTOL, V133, P637, DOI 10.1111/j.1469-8137.1996.tb01932.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CECHIN I, 1994, J EXP BOT, V45, P925, DOI 10.1093/jxb/45.7.925; CECHIN I, 1993, PLANT CELL ENVIRON, V16, P237, DOI 10.1111/j.1365-3040.1993.tb00866.x; Chen H, 2011, BIOL PLANTARUM, V55, P545, DOI 10.1007/s10535-011-0122-7; Dawson Jean H., 1994, Reviews of Weed Science, V6, P265; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; HARLEY PC, 1991, PHOTOSYNTH RES, V27, P169, DOI 10.1007/BF00035838; HARLEY PC, 1992, PLANT CELL ENVIRON, V15, P271, DOI 10.1111/j.1365-3040.1992.tb00974.x; Hieke S, 2002, TREE PHYSIOL, V22, P1249, DOI 10.1093/treephys/22.17.1249; Holm L. G., 1977, WORLDS WORST WEEDS D; HUNT R, 1974, J APPL ECOL, V11, P297, DOI 10.2307/2402022; Irving LJ, 2006, NEW PHYTOL, V169, P493, DOI 10.1111/j.1469-8137.2005.01584.x; Jeschke WD, 1997, J EXP BOT, V48, P915, DOI 10.1093/jxb/48.4.915; Jeschke WD, 1997, PLANT CELL ENVIRON, V20, P47, DOI 10.1046/j.1365-3040.1997.d01-2.x; JESCHKE WD, 1994, J EXP BOT, V45, P801, DOI 10.1093/jxb/45.6.801; JIANG CZ, 1993, PLANT PHYSIOL, V101, P105, DOI 10.1104/pp.101.1.105; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAKINO A, 1986, AGR BIOL CHEM TOKYO, V50, P1911, DOI 10.1080/00021369.1986.10867672; Murchie EH, 1999, PLANT PHYSIOL, V119, P553, DOI 10.1104/pp.119.2.553; Navabpour S, 2003, J EXP BOT, V54, P2285, DOI 10.1093/jxb/erg267; Parker C., 1993, PARASITIC WEEDS WORL; PEUKE AD, 1994, J EXP BOT, V45, P741, DOI 10.1093/jxb/45.6.741; PRESS MC, 1990, PLANT CELL ENVIRON, V13, P91, DOI 10.1111/j.1365-3040.1990.tb01281.x; Press MC, 1999, PHYSIOLOGICAL PLANT ECOLOGY, P175; Shen H, 2006, PLANT BIOLOGY, V8, P175, DOI 10.1055/s-2006-923796; Shen H, 2005, J EXP BOT, V56, P1277, DOI 10.1093/jxb/eri128; Shen H, 2007, J EXP BOT, V58, P2929, DOI 10.1093/jxb/erm168; Shen H, 2011, BOT STUD, V52, P89; Vanacker H, 2006, J EXP BOT, V57, P1735, DOI 10.1093/jxb/erl012; VONCAEMMERER S, 1981, PLANTA, V153, P376, DOI 10.1007/BF00384257; Watling JR, 2001, PLANT BIOLOGY, V3, P244, DOI 10.1055/s-2001-15195; Watling JR, 2000, GLOB CHANGE BIOL, V6, P919, DOI 10.1046/j.1365-2486.2000.00366.x; WOLSWINKEL P, 1974, ACTA BOT NEERL, V23, P48, DOI 10.1111/j.1438-8677.1974.tb00916.x; Zhang LY, 2004, WEED RES, V44, P42, DOI 10.1111/j.1365-3180.2003.00371.x	36	14	15	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75555	10.1371/journal.pone.0075555	http://dx.doi.org/10.1371/journal.pone.0075555			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116055	Green Published, gold, Green Submitted			2022-12-25	WOS:000325501300033
J	Tolba, MEM; Kobayashi, S; Imada, M; Suzuki, Y; Sugano, S				Tolba, Mohammed E. M.; Kobayashi, Seiki; Imada, Mihoko; Suzuki, Yutaka; Sugano, Sumio			Giardia lamblia Transcriptome Analysis Using TSS-Seq and RNA-Seq	PLOS ONE			English	Article							PRIMITIVE EUKARYOTE; MESSENGER-RNA; GENE; INTESTINALIS; PROMOTER; GENOME; ABUNDANCE	Giardia lamblia is a protozoan parasite that is found worldwide and has both medical and veterinary importance. We applied the transcription start sequence (TSS-seq) and RNA sequence (RNA-seq) techniques to study the transcriptome of the assemblage A WB strain trophozoite. We identified 8000 transcription regions (TR) with significant transcription. Of these regions, 1881 TRs were more than 500 nucleotides upstream of an annotated ORF. Combining both techniques helped us to identify 24 ORFs that should be re-annotated and 60 new ORFs. From the 8000 TRs, we were able to identify an AT-rich consensus that includes the transcription initiation site. It is possible that transcription that was previously thought to be bidirectional is actually unidirectional.	[Tolba, Mohammed E. M.; Suzuki, Yutaka; Sugano, Sumio] Univ Tokyo, Dept Med Genom, Grad Sch Frontier Sci, Tokyo, Japan; [Tolba, Mohammed E. M.] Assiut Univ, Dept Parasitol, Fac Med, Assiut, Egypt; [Kobayashi, Seiki; Imada, Mihoko] Keio Univ, Sch Med, Dept Infect Dis, Tokyo, Japan	University of Tokyo; Egyptian Knowledge Bank (EKB); Assiut University; Keio University	Tolba, MEM (corresponding author), Univ Tokyo, Dept Med Genom, Grad Sch Frontier Sci, Tokyo, Japan.	essa3eg@yahoo.com	Kobayashi, seiki/L-4026-2013		Tokyo Biochemical Research Foundation (TBRF); Ministry of Education, Culture, Sports, Science and Technology of Japan	Tokyo Biochemical Research Foundation (TBRF); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Mohammed E. M. Tolba was supported by The Tokyo Biochemical Research Foundation (TBRF) for postdoctoral fellowship. This work was in part supported by KAKENHI (Grant-in-Aid for Scientific Research) in the Priority Area of "Genome Science" from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam RD, 2000, INT J PARASITOL, V30, P475, DOI 10.1016/S0020-7519(99)00191-5; Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Ali SA, 2003, CURR OPIN INFECT DIS, V16, P453, DOI 10.1097/00001432-200310000-00012; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD526, DOI 10.1093/nar/gkn631; Blumenthal T, 2011, CURR BIOL, V21, pR162, DOI 10.1016/j.cub.2011.01.032; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Elmendorf HG, 2001, NUCLEIC ACIDS RES, V29, P4674, DOI 10.1093/nar/29.22.4674; Erlandsen SL, 2013, J EUKARYOT MICROBIOL, V43, P416; Hoff KJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-217; Hoff KJ, 2009, NUCLEIC ACIDS RES, V37, pW101, DOI 10.1093/nar/gkp327; HOLBERTON DV, 1995, NUCLEIC ACIDS RES, V23, P2945, DOI 10.1093/nar/23.15.2945; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kamikawa R, 2011, CURR BIOL, V21, P311, DOI 10.1016/j.cub.2011.01.025; Keister DI, 1983, AXENIC CULTURE GIARD; Knodler LA, 1999, MOL MICROBIOL, V34, P327, DOI 10.1046/j.1365-2958.1999.01602.x; Li L, 2004, J BIOL CHEM, V279, P14656, DOI 10.1074/jbc.M309879200; MARUYAMA K, 1994, GENE, V138, P171; Monis PT, 1999, MOL BIOL EVOL, V16, P1135, DOI 10.1093/oxfordjournals.molbev.a026204; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Nagalakshmi Ugrappa, 2010, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0411s89; Plutzer J, 2010, INT J HYG ENVIR HEAL, V213, P321, DOI 10.1016/j.ijheh.2010.06.005; Prucca CG, 2008, NATURE, V456, P750, DOI 10.1038/nature07585; Rivero MR, 2010, J PARASITOL, V96, P815, DOI 10.1645/GE-2406.1; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Svard SG, 2003, FEMS MICROBIOL LETT, V218, P3, DOI 10.1016/S0378-1097(02)01107-2; Teodorovic S, 2007, NUCLEIC ACIDS RES, V35, P2544, DOI 10.1093/nar/gkm105; Thompson RCA, 2012, ADV PARASIT, V78, P57, DOI 10.1016/B978-0-12-394303-3.00003-7; Thorvaldsdottir H, 2012, INTEGRATIVE GENOMICS; Tsuchihara K, 2009, NUCLEIC ACIDS RES, V37, P2249, DOI 10.1093/nar/gkp066; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yee J, 2000, J BIOL CHEM, V275, P11432, DOI 10.1074/jbc.275.15.11432; Yee J, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-26; Yoder Jonathan S., 2012, Morbidity and Mortality Weekly Report, V61, P13	34	7	7	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76184	10.1371/journal.pone.0076184	http://dx.doi.org/10.1371/journal.pone.0076184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116096	gold, Green Published			2022-12-25	WOS:000325501300051
J	Emadi, N; Esteky, H				Emadi, Nazli; Esteky, Hossein			Neural Representation of Ambiguous Visual Objects in the Inferior Temporal Cortex	PLOS ONE			English	Article							ANTERIOR INFEROTEMPORAL CORTEX; PERCEPTUAL DECISION-MAKING; MACAQUE CEREBRAL-CORTEX; RESPONSE PROPERTIES; SINGLE NEURONS; RHESUS-MONKEYS; RECOGNITION; CATEGORIZATION; ATTENTION; COMPLEX	Inferior temporal (IT) cortex as the final stage of the ventral visual pathway is involved in visual object recognition. In our everyday life we need to recognize visual objects that are degraded by noise. Psychophysical studies have shown that the accuracy and speed of the object recognition decreases as the amount of visual noise increases. However, the neural representation of ambiguous visual objects and the underlying neural mechanisms of such changes in the behavior are not known. Here, by recording the neuronal spiking activity of macaque monkeys' IT we explored the relationship between stimulus ambiguity and the IT neural activity. We found smaller amplitude, later onset, earlier offset and shorter duration of the response as visual ambiguity increased. All of these modulations were gradual and correlated with the level of stimulus ambiguity. We found that while category selectivity of IT neurons decreased with noise, it was preserved for a large extent of visual ambiguity. This noise tolerance for category selectivity in IT was lost at 60% noise level. Interestingly, while the response of the IT neurons to visual stimuli at 60% noise level was significantly larger than their baseline activity and full (100%) noise, it was not category selective anymore. The latter finding shows a neural representation that signals the presence of visual stimulus without signaling what it is. In general these findings, in the context of a drift diffusion model, explain the neural mechanisms of perceptual accuracy and speed changes in the process of recognizing ambiguous objects.	[Emadi, Nazli; Esteky, Hossein] Inst Res Fundamental Sci IPM, Sch Cognit Sci, Tehran, Iran; [Emadi, Nazli; Esteky, Hossein] Shahid Beheshti Univ, Sch Med, Res Ctr Brain & Cognit, Tehran, Iran; [Emadi, Nazli] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Emadi, Nazli] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Shahid Beheshti University; Howard Hughes Medical Institute; Stanford University; Stanford University	Emadi, N (corresponding author), Inst Res Fundamental Sci IPM, Sch Cognit Sci, Tehran, Iran.	nazlie@stanford.edu; esteky@ipm.ir						Afraz SR, 2006, NATURE, V442, P692, DOI 10.1038/nature04982; Bell AH, 2009, J NEUROPHYSIOL, V101, P688, DOI 10.1152/jn.90657.2008; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; BUCHWALD JS, 1970, J NEUROPHYSIOL, V33, P148, DOI 10.1152/jn.1970.33.1.148; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; DESIMONE R, 1984, J NEUROSCI, V4, P2051; DiCarlo JJ, 2003, J NEUROPHYSIOL, V89, P3264, DOI 10.1152/jn.00358.2002; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; Gazzaniga M. S., 2009, COGNITIVE NEUROSCIEN; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Grill-Spector K, 2005, PSYCHOL SCI, V16, P152, DOI 10.1111/j.0956-7976.2005.00796.x; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; ITO M, 1995, J NEUROPHYSIOL, V73, P218, DOI 10.1152/jn.1995.73.1.218; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kiani R, 2005, J NEUROPHYSIOL, V94, P1587, DOI 10.1152/jn.00540.2004; Kiani R, 2007, J NEUROPHYSIOL, V97, P4296, DOI 10.1152/jn.00024.2007; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; KOVACS G, 1995, J NEUROSCI, V15, P1984, DOI 10.1523/JNEUROSCI.15-03-01984.1995; Kriegeskorte N, 2008, NEURON, V60, P1126, DOI 10.1016/j.neuron.2008.10.043; Larsson J, 1999, EUR J NEUROSCI, V11, P4024, DOI 10.1046/j.1460-9568.1999.00805.x; Lee TS, 2001, P NATL ACAD SCI USA, V98, P1907, DOI 10.1073/pnas.031579998; Lerner Y, 2002, CEREB CORTEX, V12, P163, DOI 10.1093/cercor/12.2.163; Li N, 2009, J NEUROPHYSIOL, V102, P360, DOI 10.1152/jn.90745.2008; Liu Y, 2008, J NEUROPHYSIOL, V100, P966, DOI 10.1152/jn.01354.2007; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Mack ML, 2008, PSYCHON B REV, V15, P28, DOI 10.3758/PBR.15.1.28; Mack ML, 2010, J EXP PSYCHOL HUMAN, V36, P1067, DOI 10.1037/a0020254; Martinez-Trujillo JC, 2002, NEURON, V35, P365, DOI 10.1016/S0896-6273(02)00778-X; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MCCARTHY RA, 1986, J NEUROL NEUROSUR PS, V49, P1233, DOI 10.1136/jnnp.49.11.1233; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Mruczek REB, 2007, J NEUROSCI, V27, P2825, DOI 10.1523/JNEUROSCI.4102-06.2007; Oram MW, 2010, J PHYSIOL-PARIS, V104, P167, DOI 10.1016/j.jphysparis.2009.11.021; Oram MW, 2002, PHILOS T ROY SOC B, V357, P987, DOI 10.1098/rstb.2002.1113; PENFIELD W, 1963, BRAIN, V86, P595, DOI 10.1093/brain/86.4.595; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; Pinsk MA, 2005, P NATL ACAD SCI USA, V102, P6996, DOI 10.1073/pnas.0502605102; Rainer G, 2002, NEUROIMAGE, V16, P607, DOI 10.1006/nimg.2002.1086; Ratcliff R, 2004, PSYCHOL REV, V111, P333, DOI 10.1037/0033-295X.111.2.333; Reynolds JH, 2003, NEURON, V37, P853, DOI 10.1016/S0896-6273(03)00097-7; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; ROLLS ET, 1984, HUM NEUROBIOL, V3, P209; Rorie AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009308; Sachdev RNS, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00043; Saleem KS, 1996, J NEUROSCI, V16, P4757; Saleem KS, 2000, J NEUROSCI, V20, P5083; Salimpour Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021256; Sary G, 2008, EUR J NEUROSCI, V28, P2137, DOI 10.1111/j.1460-9568.2008.06499.x; Sary G, 2007, EUR J NEUROSCI, V25, P2558, DOI 10.1111/j.1460-9568.2007.05494.x; Sato T, 2009, CEREB CORTEX, V19, P1870, DOI 10.1093/cercor/bhn218; SCHWARTZ EL, 1983, P NATL ACAD SCI-BIOL, V80, P5776, DOI 10.1073/pnas.80.18.5776; Shidara M, 2005, EXP BRAIN RES, V163, P239, DOI 10.1007/s00221-005-2230-0; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Stark E, 2007, J NEUROSCI, V27, P8387, DOI 10.1523/JNEUROSCI.1321-07.2007; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; Super H, 2005, PROG BRAIN RES, V147, P263, DOI 10.1016/S0079-6123(04)47020-4; Tamura H, 2001, CEREB CORTEX, V11, P384, DOI 10.1093/cercor/11.5.384; Tanaka K, 1992, Curr Opin Neurobiol, V2, P502, DOI 10.1016/0959-4388(92)90187-P; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tanaka K, 2003, CEREB CORTEX, V13, P90, DOI 10.1093/cercor/13.1.90; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; Tompa T, 2010, BRAIN RES REV, V62, P165, DOI 10.1016/j.brainresrev.2009.10.001; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; Uka T, 2005, J NEUROSCI, V25, P10796, DOI 10.1523/JNEUROSCI.1637-05.2005; Vogels R, 1999, EUR J NEUROSCI, V11, P1239, DOI 10.1046/j.1460-9568.1999.00531.x; Vogels R, 1999, EUR J NEUROSCI, V11, P1223, DOI 10.1046/j.1460-9568.1999.00530.x; Zipser K, 1996, J NEUROSCI, V16, P7376	73	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76856	10.1371/journal.pone.0076856	http://dx.doi.org/10.1371/journal.pone.0076856			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098569	Green Published, Green Submitted, gold			2022-12-25	WOS:000325483600079
J	Walmer, DK; Eder, PS; Bell, L; Salim, H; Kobayashi, L; Ndirangu, J; Tinfo, N; Castle, PE				Walmer, David K.; Eder, Paul S.; Bell, Laura; Salim, Hiam; Kobayashi, Lori; Ndirangu, Jackie; Tinfo, Nicole; Castle, Philip E.			Human Papillomavirus Prevalence in a Population of Women Living in Port-au-Prince and Leogane, Haiti	PLOS ONE			English	Article							CERVICAL INTRAEPITHELIAL NEOPLASIA; CANCER; INFECTION; HPV; DISEASE; BIOPSY; TRENDS; RISK; AGE; DNA	Background: There have been no published studies of carcinogenic human papillomavirus (HPV)-the necessary cause of cervical cancer-in Haiti, a nation that has one of the greatest burdens of cervical cancer globally. Objective: Characterize prevalence of carcinogenic HPV and the prevalence of individual carcinogenic HPV genotypes in women with cervical precancer or cancer, cervical intraepithelial neoplasia grade 2 (CIN2) or more severe (CIN2+). Methods: Women (n=9,769; aged 25-60 years) were screened for carcinogenic HPV by Hybrid Capture 2 (HC2; Qiagen, Gaithersburg, MD). Carcinogenic HPV positives underwent colposcopy and visible lesions were biopsied. A subset of carcinogenic HPV positives was tested for individual HPV genotypes using a GP5+/6+ assay. Results: The prevalence of carcinogenic HPV was 19.0% (95% confidence interval: 18.4%-19.9%) and decreased with increasing age (p(trend) < 0.001). Women with 3 or more sexual partners and who started sex before the age of 18 years had twice the age-adjusted prevalence of carcinogenic HPV of women with one partner and who started sex after the age of 21 (24.3% vs. 12.9%, respectively). HPV16 and HPV35 were the most common HPV genotypes detected in CIN2+ and more common in women with CIN2+ than those without CIN2+. HPV16 and/or HPV18 were detected in 21.0% of CIN2 (n = 42), 46.2% of CIN3 (n = 52), and 80% of cancers (n = 5). Conclusions: The prevalence of carcinogenic HPV in Haiti was much greater than the prevalence in other Latin American countries. High carcinogenic HPV prevalence and a lack of cervical cancer screening may explain the high burden of cervical cancer in Haiti.	[Walmer, David K.; Ndirangu, Jackie; Tinfo, Nicole] Family Hlth Minist, Durham, NC USA; [Walmer, David K.] Duke Global Hlth Inst, Durham, NC USA; [Eder, Paul S.; Bell, Laura; Salim, Hiam; Kobayashi, Lori] Qiagen Sci Inc, Gaithersburg, MD USA; [Castle, Philip E.] Global Canc Initiat, Chestertown, MD USA	Duke University	Walmer, DK (corresponding author), Family Hlth Minist, Durham, NC USA.	dkwalmer@atlanticreproductive.com	Castle, Philip/AAP-6395-2020	Castle, Philip/0000-0003-1082-6554; Ndirangu, Jackie/0000-0001-8346-7359	Family Health Ministries; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518] Funding Source: NIH RePORTER	Family Health Ministries; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was supplied by Family Health Ministries, no grants were used to perform these studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegoke O, 2012, J WOMENS HEALTH, V21, P1031, DOI 10.1089/jwh.2011.3385; Almonte M, 2011, INT J GYNECOL CANCER, V21, P1654, DOI 10.1097/IGC.0b013e3182288104; Arbyn M, 2012, VACCINE, V30, pF88, DOI 10.1016/j.vaccine.2012.06.095; Arrossi S, 2003, SALUD PUBLICA MEXICO, V45, pS306; Bray F, 2005, CANCER EPIDEM BIOMAR, V14, P2191, DOI 10.1158/1055-9965.EPI-05-0231; Carozzi FM, 2010, CANCER EPIDEM BIOMAR, V19, P2389, DOI 10.1158/1055-9965.EPI-10-0131; Castle PE, 2010, CANCER EPIDEM BIOMAR, V19, P1675, DOI 10.1158/1055-9965.EPI-10-0251; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; DURST M, 1983, P NATL ACAD SCI-BIOL, V80, P3812, DOI 10.1073/pnas.80.12.3812; Eklund C, 2010, J CLIN MICROBIOL, V48, P4147, DOI 10.1128/JCM.00918-10; FARLEY J, 2010, GLOBOCAN 2008 CANC I, P45237; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Franceschi S, 2006, INT J CANCER, V119, P2677, DOI 10.1002/ijc.22241; Gage JC, 2006, OBSTET GYNECOL, V108, P264, DOI 10.1097/01.AOG.0000220505.18525.85; GISSMANN L, 1977, VIROLOGY, V76, P569, DOI 10.1016/0042-6822(77)90239-2; Herrero R, 2005, J INFECT DIS, V191, P1796, DOI 10.1086/428850; Khan MJ, 2005, JNCI-J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187; Kobetz E, 2012, J ONCOL, V2012, DOI 10.1155/2012/728397; Lazcano-Ponce E, 2010, CANCER CAUSE CONTROL, V21, P1693, DOI 10.1007/s10552-010-9598-2; MITACEK EJ, 1986, INT J CANCER, V38, P9, DOI 10.1002/ijc.2910380103; Nazarenko I, 2008, J VIROL METHODS, V154, P76, DOI 10.1016/j.jviromet.2008.09.002; Porras C, 2009, CANCER EPIDEM BIOMAR, V18, P863, DOI 10.1158/1055-9965.EPI-08-0951; Pretorius RG, 2004, AM J OBSTET GYNECOL, V191, P430, DOI 10.1016/j.ajog.2004.02.065; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; Simonella LM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-114; Valles X, 2009, INT J CANCER, V125, P1161, DOI 10.1002/ijc.24444; Wheeler CM, 2009, JNCI-J NATL CANCER I, V101, P475, DOI 10.1093/jnci/djn510; Zandberg DP, 2013, CA-CANCER J CLIN, V63, P57, DOI 10.3322/caac.21167	29	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76110	10.1371/journal.pone.0076110	http://dx.doi.org/10.1371/journal.pone.0076110			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098429	gold, Green Submitted, Green Published			2022-12-25	WOS:000325483600027
J	Cunha, MR; Matos, FL; Genio, L; Hilario, A; Moura, CJ; Ravara, A; Rodrigues, CF				Cunha, Marina R.; Matos, Fabio L.; Genio, Luciana; Hilario, Ana; Moura, Carlos J.; Ravara, Ascensao; Rodrigues, Clara F.			Are Organic Falls Bridging Reduced Environments in the Deep Sea? - Results from Colonization Experiments in the Gulf of Cadiz	PLOS ONE			English	Article							WOOD-BORING BIVALVES; WHALE-FALL; SPECIES-DIVERSITY; BACTERIAL ENDOSYMBIONTS; MARINE-ENVIRONMENT; NORTHEAST ATLANTIC; SEEP COMMUNITIES; PLANT REMAINS; MUD VOLCANOS; DWARF MALES	Organic falls create localised patches of organic enrichment and disturbance where enhanced degradation is mediated by diversified microbial assemblages and specialized fauna. The view of organic falls as "stepping stones" for the colonization of deep-sea reducing environments has been often loosely used, but much remains to be proven concerning their capability to bridge dispersal among such environments. Aiming the clarification of this issue, we used an experimental approach to answer the following questions: Are relatively small organic falls in the deep sea capable of sustaining taxonomically and trophically diverse assemblages over demographically relevant temporal scales? Are there important depth- or site-related sources of variability for the composition and structure of these assemblages? Is the proximity of other reducing environments influential for their colonization? We analysed the taxonomical and trophic diversity patterns and partitioning (alpha- and beta-diversity) of the macrofaunal assemblages recruited in small colonization devices with organic and inorganic substrata after 1-2 years of deployment on mud volcanoes of the Gulf of Cadiz. Our results show that small organic falls can sustain highly diverse and trophically coherent assemblages for time periods allowing growth to reproductive maturity, and successive generations of dominant species. The composition and structure of the assemblages showed variability consistent with their biogeographic and bathymetric contexts. However, the proximity of cold seeps had limited influence on the similarity between the assemblages of these two habitats and organic falls sustained a distinctive fauna with dominant substrate-specific taxa. We conclude that it is unlikely that small organic falls may regularly ensure population connectivity among cold seeps and vents. They may be a recurrent source of evolutionary candidates for the colonization of such ecosystems. However, there may be a critical size of organic fall to create the necessary intense and persistent reducing conditions for sustaining typical chemosymbiotic vent and seep organisms.	[Cunha, Marina R.; Matos, Fabio L.; Genio, Luciana; Hilario, Ana; Moura, Carlos J.; Ravara, Ascensao; Rodrigues, Clara F.] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Cunha, Marina R.; Matos, Fabio L.; Genio, Luciana; Hilario, Ana; Moura, Carlos J.; Ravara, Ascensao; Rodrigues, Clara F.] Univ Aveiro, Ctr Estudos Ambiente & Mar, P-3800 Aveiro, Portugal; [Moura, Carlos J.] Univ Acores, Dept Oceanog & Pescas, Horta, Acores, Portugal	Universidade de Aveiro; Universidade de Aveiro; Universidade dos Acores	Cunha, MR (corresponding author), Univ Aveiro, Dept Biol, Campus Santiago, P-3800 Aveiro, Portugal.	marina.cunha@ua.pt	Ravara, Ascensão/C-6613-2018; Hilário, Ana/C-1260-2008; Matos, Fábio L./K-3556-2012; Cunha, Marina R/B-7644-2008; Rodrigues, Clara F./A-4536-2009; Gènio, Luciana/M-4325-2013; Moura, Carlos J./F-1822-2011	Ravara, Ascensão/0000-0002-1689-2985; Hilário, Ana/0000-0001-8287-1528; Matos, Fábio L./0000-0002-5447-4055; Cunha, Marina R/0000-0001-8833-6980; Rodrigues, Clara F./0000-0002-3426-8342; Gènio, Luciana/0000-0003-3120-7875; Moura, Carlos J./0000-0002-6243-5988	CHEMECO ESF EURODEEP project (FCT) [EURODEEP/0001/2007]; HERMES project (EC) under European Commission [GOCE-CT-511234]; HERMIONE project European Commission [ENV/2008/1/226354]; Fundacao para a Ciencia e Tecnologia [SFRH/BPD/22383/2005, SFRH/BD/31155/2006, SFRH/BD/16563/2004, SFRH/BPD/64154/2009]; Fundação para a Ciência e a Tecnologia [2021.04780.BD, EURODEEP/0001/2007] Funding Source: FCT	CHEMECO ESF EURODEEP project (FCT); HERMES project (EC) under European Commission; HERMIONE project European Commission; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	This work was funded by the CHEMECO ESF EURODEEP project (FCT; EURODEEP/0001/2007) as well as by the HERMES project (EC contract number GOCE-CT-511234) under the European Commission's Framework Sixth Programme and by the HERMIONE project (contract ENV/2008/1/226354) under the European Commission's Framework Seventh Programme. A Hilario, CJ Moura, A Ravara and CF Rodrigues were supported by Fundacao para a Ciencia e Tecnologia, grants SFRH/BPD/22383/2005, SFRH/BD/31155/2006, SFRH/BD/16563/2004, and SFRH/BPD/64154/2009, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardino AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033515; Bernardino AF, 2010, DEEP-SEA RES PT I, V57, P708, DOI 10.1016/j.dsr.2010.03.004; Bienhold C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053590; Blair NE, 2012, ANNU REV MAR SCI, V4, P401, DOI 10.1146/annurev-marine-120709-142717; Braby CE, 2007, DEEP-SEA RES PT I, V54, P1773, DOI 10.1016/j.dsr.2007.05.014; CAYRE P, 2002, RECHERCHE, V355, P59; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Cordes EE, 2010, DEEP-SEA RES PT II, V57, P1870, DOI 10.1016/j.dsr2.2010.05.010; Crist TO, 2003, AM NAT, V162, P734, DOI 10.1086/378901; Cunha MR, 2013, BIOGEOSCIENCES, V10, P2553, DOI 10.5194/bg-10-2553-2013; DANDO PR, 1992, NATURE, V356, P667, DOI 10.1038/356667a0; De Robertis A, 2001, MAR ECOL PROG SER, V219, P221, DOI 10.3354/meps219221; Dial R, 1998, ECOLOGY, V79, P1412, DOI 10.2307/176752; Distel DL, 2003, ACS SYM SER, V845, P253; Distel DL, 1997, BIOL BULL, V192, P253, DOI 10.2307/1542719; Distel DL, 2000, NATURE, V403, P725, DOI 10.1038/35001667; DUGGINS DO, 1989, SCIENCE, V245, P170, DOI 10.1126/science.245.4914.170; Duperron S, 2008, FEMS MICROBIOL ECOL, V63, P338, DOI 10.1111/j.1574-6941.2008.00438.x; Fagervold SK, 2012, FEMS MICROBIOL ECOL, V82, P616, DOI 10.1111/j.1574-6941.2012.01432.x; Feldman RA, 1998, BIOL BULL, V194, P116, DOI 10.2307/1543041; Foggo A, 2007, J ANIM ECOL, V76, P695, DOI 10.1111/j.1365-2656.2007.01245.x; Gaudron SM, 2010, MAR ENVIRON RES, V70, P1, DOI 10.1016/j.marenvres.2010.02.002; Gaudron SM, 2012, BIOL BULL-US, V222, P6, DOI 10.1086/BBLv222n1p6; Genio L, 2013, BIOGEOSCIENCES, V10, P5159, DOI 10.5194/bg-10-5159-2013; Genio L, 2012, DEEP-SEA RES PT I, V64, P86, DOI 10.1016/j.dsr.2012.02.002; Goffredi SK, 2004, DEEP-SEA RES PT I, V51, P1295, DOI 10.1016/j.dsr.2004.05.009; Grieshaber MK, 1998, ANNU REV PHYSIOL, V60, P33, DOI 10.1146/annurev.physiol.60.1.33; Haga T, 2013, J MOLLUS STUD, V79, P90, DOI 10.1093/mollus/eys037; HECKER B, 1985, BIOL SOC WASH B, V6, P465; Hilario A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016309; Hoyoux C, 2009, MAR BIOL, V156, P2421, DOI 10.1007/s00227-009-1266-2; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Jorgensen BB, 2007, NAT REV MICROBIOL, V5, P770, DOI 10.1038/nrmicro1745; JUMARS PA, 1989, LIFE SCI R, V44, P235; Khelaifia S, 2011, INT J SYST EVOL MICR, V61, P2706, DOI 10.1099/ijs.0.028670-0; Kiel S, 2006, P ROY SOC B-BIOL SCI, V273, P2625, DOI 10.1098/rspb.2006.3620; LAMBSHEAD PJD, 1983, J NAT HIST, V17, P859, DOI 10.1080/00222938300770671; Levin LA, 2003, OCEANOGR MAR BIOL, V41, P1; Levin LA, 2013, DEEP-SEA RES PT II, V92, P214, DOI 10.1016/j.dsr2.2013.02.006; Levin LA, 2012, P ROY SOC B-BIOL SCI, V279, P2580, DOI 10.1098/rspb.2012.0205; Levin LA, 2012, ANNU REV MAR SCI, V4, P79, DOI 10.1146/annurev-marine-120709-142714; Lorion J, 2010, MOL PHYLOGENET EVOL, V57, P71, DOI 10.1016/j.ympev.2010.05.027; Macdonald T, 2010, CAN TECH REP FISH AQ, V2874, P63; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; MARTILL DM, 1995, PALAIOS, V10, P96, DOI 10.2307/3515011; Nishimoto A, 2009, DEEP-SEA RES PT II, V56, P1683, DOI 10.1016/j.dsr2.2009.05.032; Palacios C, 2009, MICROB ECOL, V58, P737, DOI 10.1007/s00248-009-9538-4; PIELOU E C, 1969, P286; Pradillon F, 2001, NATURE, V413, P698, DOI 10.1038/35099674; Prevedelli D, 2005, MAR ECOL-EVOL PERSP, V26, P286, DOI 10.1111/j.1439-0485.2005.00067.x; Ritt B, 2012, MAR ECOL PROG SER, V466, P93, DOI 10.3354/meps09896; Rodrigues CF, 2013, NATURWISSENSCHAFTEN, V100, P21, DOI 10.1007/s00114-012-0985-2; SAINTE-MARIE B, 1990, CAN J ZOOL, V68, P1639, DOI 10.1139/z90-243; Samadi S, 2010, CAH BIOL MAR, V51, P459; SHILLING FM, 1994, BIOL BULL, V187, P398, DOI 10.2307/1542296; Smith CR, 2003, OCEANOGR MAR BIOL, V41, P311; SMITH CR, 1985, DEEP-SEA RES, V32, P417, DOI 10.1016/0198-0149(85)90089-5; SMITH CR, 1989, NATURE, V341, P27, DOI 10.1038/341027a0; Smith CR, 2008, TRENDS ECOL EVOL, V23, P518, DOI 10.1016/j.tree.2008.05.002; STOCKTON WL, 1982, DEEP-SEA RES, V29, P157, DOI 10.1016/0198-0149(82)90106-6; Swearer SE, 2002, B MAR SCI, V70, P251; Tarasov VG, 2005, CHEM GEOL, V224, P5, DOI 10.1016/j.chemgeo.2005.07.021; Thornhill DJ, 2012, ECOL EVOL, V2, P1958, DOI 10.1002/ece3.314; Treude T, 2009, MAR ECOL PROG SER, V382, P1, DOI 10.3354/meps07972; TURNER RD, 1973, SCIENCE, V180, P1377, DOI 10.1126/science.180.4093.1377; Turner RD, 1977, B AM MALACOLOGICAL U, V213, P13; Turner Ruth D., 2002, Bulletin of the Museum of Comparative Zoology, V157, P223; Tyler PA, 2007, MAR ECOL PROG SER, V343, P151, DOI 10.3354/meps06832; Vetter EW, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002617; VETTER EW, 1994, NATURE, V372, P47, DOI 10.1038/372047a0; Vetter EW, 1999, MAR ECOL PROG SER, V186, P137, DOI 10.3354/meps186137; Vetter EW, 1998, DEEP-SEA RES PT II, V45, P25, DOI 10.1016/S0967-0645(97)00048-9; Voight JR, 2007, J MOLLUS STUD, V73, P377, DOI 10.1093/mollus/eym034; Voight JR, 2009, J MOLLUS STUD, V75, P167, DOI 10.1093/mollus/eyp012; Vrijenhoek RC, 2008, MOL ECOL, V17, P4535, DOI 10.1111/j.1365-294X.2008.03937.x; Vrijenhoek RC, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-74; Wagner HH, 2000, LANDSCAPE ECOL, V15, P219, DOI 10.1023/A:1008114117913; West AJ, 2011, LIMNOL OCEANOGR, V56, P77, DOI 10.4319/lo.2011.56.1.0077; Wiklund H, 2009, ZOOTAXA, P43, DOI 10.11646/zootaxa.2228.1.3; WOLFF T, 1979, SARSIA, V64, P117, DOI 10.1080/00364827.1979.10411373; Young CM, 2003, ECOSY WORLD, V28, P381; YOUNG CM, 1999, AQUATIC LIFE CYCLE S, P1; Young CM, 2013, DEEP-SEA RES PT II, V92, P36, DOI 10.1016/j.dsr2.2013.01.027; Yucel M, 2013, CHEMOSPHERE, V90, P403, DOI 10.1016/j.chemosphere.2012.07.036; Zbinden M, 2010, FEMS MICROBIOL ECOL, V74, P450, DOI 10.1111/j.1574-6941.2010.00959.x	85	34	35	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76688	10.1371/journal.pone.0076688	http://dx.doi.org/10.1371/journal.pone.0076688			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098550	gold, Green Published, Green Submitted			2022-12-25	WOS:000325434500082
J	Elgamal, OA; Park, JK; Gusev, Y; Azevedo-Pouly, ACP; Jiang, JM; Roopra, A; Schmittgen, TD				Elgamal, Ola A.; Park, Jong-Kook; Gusev, Yuriy; Azevedo-Pouly, Ana Clara P.; Jiang, Jinmai; Roopra, Avtar; Schmittgen, Thomas D.			Tumor Suppressive Function of mir-205 in Breast Cancer Is Linked to HMGB3 Regulation	PLOS ONE			English	Article							EXPRESSION ANALYSIS; LUNG-CANCER; MICRORNA-205; MELANOMA; CARCINOMAS; PROGNOSIS; PROFILES; PROSTATE; PROTEIN; FAMILY	Identifying targets of dysregulated microRNAs (miRNAs) will enhance our understanding of how altered miRNA expression contributes to the malignant phenotype of breast cancer. The expression of miR-205 was reduced in four breast cancer cell lines compared to the normal-like epithelial cell line MCF10A and in tumor and metastatic tissues compared to adjacent benign breast tissue. Two predicted binding sites for miR-205 were identified in the 3' untranslated region of the high mobility group box 3 gene, HMGB3. Both dual-luciferase reporter assay and Western blotting confirmed that miR-205 binds to and regulates HMGB3. To further explore miR-205 targeting of HMGB3, WST-1 proliferation and in vitro invasion assays were performed in MDA-MB-231 and BT549 cells transiently transfected with precursor miR-205 oligonucleotide or HMGB3 small interfering RNA (siRNA). Both treatments reduced the proliferation and invasion of the cancer cells. The mRNA and protein levels of HMGB3 were higher in the tumor compared to adjacent benign specimens and there was an indirect correlation between the expression of HMGB3 mRNA and patient survival. Treatment of breast cancer cells with 5-Aza/TSA derepressed miR-205 and reduced HMGB3 mRNA while knockdown of the transcriptional repressor NRSF/REST, reduced miR-205 and increased HMGB3. In conclusion, regulation of HMGB3 by miR-205 reduced both proliferation and invasion of breast cancer cells. Our findings suggest that modulating miR-205 and/or targeting HMGB3 are potential therapies for advanced breast cancer.	[Elgamal, Ola A.; Park, Jong-Kook; Azevedo-Pouly, Ana Clara P.; Jiang, Jinmai; Schmittgen, Thomas D.] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA; [Gusev, Yuriy] Georgetown Univ, Ctr Canc, Washington, DC USA; [Roopra, Avtar] Univ Wisconsin, Dept Neurosci, Madison, WI USA	University System of Ohio; Ohio State University; Georgetown University; University of Wisconsin System; University of Wisconsin Madison	Schmittgen, TD (corresponding author), Ohio State Univ, Coll Pharm, 500 W 12Th Ave, Columbus, OH 43210 USA.	Schmittgen.2@osu.edu		Azevedo-Pouly, Ana Clara/0000-0001-8308-9271; Elgamal, Ola/0000-0001-5011-3909; Park, Jong Kook/0000-0002-3946-5687; Gusev, Yuriy/0000-0001-7371-4715	Ohio State University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065067] Funding Source: NIH RePORTER	Ohio State University(Ohio State University); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by a Provost's Targeted Investment in Excellence (TIE) Award from The Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chen CS, 2001, GENOMICS, V77, P135, DOI 10.1006/geno.2001.6631; Chung TKH, 2009, INT J CANCER, V124, P1358, DOI 10.1002/ijc.24071; Dar AA, 2011, J BIOL CHEM, V286, P16606, DOI 10.1074/jbc.M111.227611; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Ellerman JE, 2007, CLIN CANCER RES, V13, P2836, DOI 10.1158/1078-0432.CCR-06-1953; Greene SB, 2010, RNA BIOL, V7, P300, DOI 10.4161/rna.7.3.11837; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; GROSSCHEDL R, 1994, TRENDS GENET, V10, P94, DOI 10.1016/0168-9525(94)90232-1; Hulf T, 2013, ONCOGENE, V32, P2891, DOI 10.1038/onc.2012.300; Hulf T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-54; Iorio MV, 2009, CANCER RES, V69, P2195, DOI 10.1158/0008-5472.CAN-08-2920; Lange SS, 2009, MOL CARCINOGEN, V48, P571, DOI 10.1002/mc.20544; Lebanony D, 2009, J CLIN ONCOL, V27, P2030, DOI 10.1200/JCO.2008.19.4134; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maciotta S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043464; Markou A, 2008, CLIN CHEM, V54, P1696, DOI 10.1373/clinchem.2007.101741; Nemeth MJ, 2003, BLOOD, V102, P1298, DOI 10.1182/blood-2002-11-3541; Philippidou D, 2010, CANCER RES, V70, P4163, DOI 10.1158/0008-5472.CAN-09-4512; Radojicic J, 2011, CELL CYCLE, V10, P507, DOI 10.4161/cc.10.3.14754; Rodriguez-Pinilla SM, 2006, CLIN CANCER RES, V12, P1533, DOI 10.1158/1078-0432.CCR-05-2281; Savad S, 2012, ASIAN PAC J CANCER P, V13, P873, DOI 10.7314/APJCP.2012.13.3.873; Wagoner MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000979; Wu HL, 2009, EXPERT OPIN THER TAR, V13, P1439, DOI 10.1517/14728220903338777; Wu HL, 2009, CELL RES, V19, P439, DOI 10.1038/cr.2009.18; Xu Y, 2012, BRIT J CANCER, V106, P553, DOI 10.1038/bjc.2011.568; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025	30	87	90	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76402	10.1371/journal.pone.0076402	http://dx.doi.org/10.1371/journal.pone.0076402			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098490	Green Published, Green Submitted, gold			2022-12-25	WOS:000325434500066
J	Xu, LR; Liu, XL; Chen, J; Liang, Y				Xu, Li-Rong; Liu, Xiao-Ling; Chen, Jie; Liang, Yi			Protein Disulfide Isomerase Interacts with Tau Protein and Inhibits Its Fibrillization	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; THIOREDOXIN-LIKE DOMAINS; BINDING SITE; AGGREGATION; DISEASE; NEURODEGENERATION; DIMERIZATION; INCLUSIONS; PLASTICITY; SUBSTRATE	Background: Tau protein is implicated in the pathogenesis of neurodegenerative disorders such as tauopathies including Alzheimer disease, and Tau fibrillization is thought to be related to neuronal toxicity. Physiological inhibitors of Tau fibrillization hold promise for developing new strategies for treatment of Alzheimer disease. Because protein disulfide isomerase (PDI) is both an enzyme and a chaperone, and implicated in neuroprotection against Alzheimer disease, we want to know whether PDI can prevent Tau fibrillization. In this study, we have investigated the interaction between PDI and Tau protein and the effect of PDI on Tau fibrillization. Methodology/Principal Findings: As evidenced by co-immunoprecipitation and confocal laser scanning microscopy, human PDI interacts and co-locates with some endogenous human Tau on the endoplasmic reticulum of undifferentiated SH-SY5Y neuroblastoma cells. The results from isothermal titration calorimetry show that one full-length human PDI binds to one full-length human Tau (or human Tau fragment Tau(244-372)) monomer with moderate, micromolar affinity at physiological pH and near physiological ionic strength. As revealed by thioflavin T binding assays, Sarkosyl-insoluble SDS-PAGE, and transmission electron microscopy, full-length human PDI remarkably inhibits both steps of nucleation and elongation of Tau(244-372) fibrillization in a concentration-dependent manner. Furthermore, we find that two molecules of the a-domain of human PDI interact with one Tau(244-372) molecule with sub-micromolar affinity, and inhibit both steps of nucleation and elongation of Tau(244-372) fibrillization more strongly than full-length human PDI. Conclusions/Significance: We demonstrate for the first time that human PDI binds to Tau protein mainly through its thioredoxin-like catalytic domain a, forming a 1:1 complex and preventing Tau misfolding. Our findings suggest that PDI could act as a physiological inhibitor of Tau fibrillization, and have applications for developing novel strategies for treatment and early diagnosis of Alzheimer disease.	[Xu, Li-Rong; Liu, Xiao-Ling; Chen, Jie; Liang, Yi] Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University	Liang, Y (corresponding author), Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China.	liangyi@whu.edu.cn	Liang, Yi/V-1396-2017; Liu, Xiaoling/HGD-3566-2022	Liang, Yi/0000-0002-7349-8300; 	National Key Basic Research Foundation of China [2013CB910702, 2012CB911003]; National Natural Science Foundation of China [31170744, 31370774]; Fundamental Research Funds for the Central Universities of China [1104006]	National Key Basic Research Foundation of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This study was supported by National Key Basic Research Foundation of China (http://www.most.gov.cn/, Grant nos. 2013CB910702 and 2012CB911003, YL), National Natural Science Foundation of China (http://www.nsfc.gov.cn/, Grant nos. 31170744 and 31370774, YL), and Fundamental Research Funds for the Central Universities of China (http://www.moe.edu.cn/, Grant no. 1104006, YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanen HI, 2003, ANTIOXID REDOX SIGN, V5, P367, DOI 10.1089/152308603768295096; Alanen HI, 2003, J BIOL CHEM, V278, P28912, DOI 10.1074/jbc.M304598200; Andreu CI, 2012, FEBS LETT, V586, P2826, DOI 10.1016/j.febslet.2012.07.023; Arrasate M, 2000, NEUROCHEM RES, V25, P43, DOI 10.1023/A:1007583214722; Atkin JD, 2008, NEUROBIOL DIS, V30, P400, DOI 10.1016/j.nbd.2008.02.009; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Barghorn Stefan, 2004, V299, P35; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Cheng H, 2010, CELL STRESS CHAPERON, V15, P415, DOI 10.1007/s12192-009-0157-2; Chirita CN, 2004, BIOCHEMISTRY-US, V43, P1704, DOI 10.1021/bi036034b; Congdon EE, 2008, J BIOL CHEM, V283, P13806, DOI 10.1074/jbc.M800247200; Conn KJ, 2004, BRAIN RES, V1022, P164, DOI 10.1016/j.brainres.2004.07.026; DARBY NJ, 1995, BIOCHEMISTRY-US, V34, P11725, DOI 10.1021/bi00037a009; Darby NJ, 1995, BIOCHEMISTRY-US, V34, P16770, DOI 10.1021/bi00051a027; DeSantis ME, 2012, CELL, V151, P778, DOI 10.1016/j.cell.2012.09.038; Erickson RR, 2005, BIOCHEM BIOPH RES CO, V332, P50, DOI 10.1016/j.bbrc.2005.04.090; Farg MA, 2012, NEUROBIOL AGING, V33, P2855, DOI 10.1016/j.neurobiolaging.2012.02.009; Freedman RB, 2002, EMBO REP, V3, P136, DOI 10.1093/embo-reports/kvf035; Freedman RB, 1998, BIOL CHEM, V379, P321, DOI 10.1515/bchm.1998.379.3.321; Friedhoff P, 2000, BBA-MOL BASIS DIS, V1502, P122, DOI 10.1016/S0925-4439(00)00038-7; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; GOEDERT M, 1993, TRENDS NEUROSCI, V16, P460, DOI 10.1016/0166-2236(93)90078-Z; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Hetz C, 2005, J NEUROSCI, V25, P2793, DOI 10.1523/JNEUROSCI.4090-04.2005; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hoffstrom BG, 2010, NAT CHEM BIOL, V6, P900, DOI [10.1038/nchembio.467, 10.1038/NCHEMBIO.467]; Honjo Y, 2012, NEUROREPORT, V23, P611, DOI 10.1097/WNR.0b013e3283552a75; Honjo Y, 2010, BRAIN RES, V1349, P90, DOI 10.1016/j.brainres.2010.06.016; Hu BR, 2000, J NEUROSCI, V20, P3191, DOI 10.1523/JNEUROSCI.20-09-03191.2000; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Ko HS, 2002, J BIOL CHEM, V277, P35386, DOI 10.1074/jbc.M203412200; Koivunen P, 1999, EMBO J, V18, P65, DOI 10.1093/emboj/18.1.65; Kosuri P, 2012, CELL, V151, P794, DOI 10.1016/j.cell.2012.09.036; Kuret J, 2005, BBA-MOL BASIS DIS, V1739, P167, DOI 10.1016/j.bbadis.2004.06.016; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; Liang Y, 2003, J BIOL CHEM, V278, P30098, DOI 10.1074/jbc.M304050200; Ma Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036288; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; Matus S, 2011, CURR OPIN CELL BIOL, V23, P239, DOI 10.1016/j.ceb.2011.01.003; Meng SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038903; Mo ZY, 2009, J BIOL CHEM, V284, P34648, DOI 10.1074/jbc.M109.058883; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; NOIVA R, 1992, J BIOL CHEM, V267, P3553; Patterson KR, 2011, BIOCHEMISTRY-US, V50, P10300, DOI 10.1021/bi2009147; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Tanaka S, 2000, J BIOL CHEM, V275, P10388, DOI 10.1074/jbc.275.14.10388; Tian G, 2008, J BIOL CHEM, V283, P33630, DOI 10.1074/jbc.M806026200; Uberti D, 1997, NEUROSCI LETT, V235, P149, DOI 10.1016/S0304-3940(97)00715-5; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Voss K, 2012, BIOCHEMISTRY-US, V51, P888, DOI 10.1021/bi2018078; Walker AK, 2010, BRAIN, V133, P105, DOI 10.1093/brain/awp267; WANG CC, 1993, FASEB J, V7, P1515, DOI 10.1096/fasebj.7.15.7903263; Wang C, 2013, ANTIOXID REDOX SIGN, V19, P44, DOI 10.1089/ars.2012.4630; Wang C, 2010, J BIOL CHEM, V285, P26788, DOI 10.1074/jbc.M110.107839; Watts JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000608; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; Zhou Z, 2011, BIOPHYS J, V101, P1483, DOI 10.1016/j.bpj.2011.08.018; Zhou Z, 2009, J BIOL CHEM, V284, P30148, DOI 10.1074/jbc.M109.002832; Zhu HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025020; Zhu HL, 2010, J BIOL CHEM, V285, P3592, DOI 10.1074/jbc.M109.035691	68	75	77	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76657	10.1371/journal.pone.0076657	http://dx.doi.org/10.1371/journal.pone.0076657			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098548	Green Published, gold, Green Submitted			2022-12-25	WOS:000325434500081
J	Yang, TW; Rao, ZM; Zhang, X; Xu, MJ; Xu, ZH; Yang, ST				Yang, Taowei; Rao, Zhiming; Zhang, Xian; Xu, Meijuan; Xu, Zhenghong; Yang, Shang-Tian			Improved Production of 2,3-Butanediol in Bacillus amyloliquefaciens by Over-Expression of Glyceraldehyde-3-Phosphate Dehydrogenase and 2,3-butanediol Dehydrogenase	PLOS ONE			English	Article							METABOLIC FLUX REDISTRIBUTION; KLEBSIELLA-PNEUMONIAE; ACETOIN; REDUCTION; SUBTILIS; ETHANOL	Background: Previously, a safe strain, Bacillus amyloliquefaciens B10-127 was identified as an excellent candidate for industrial-scale microbial fermentation of 2,3-butanediol (2,3-BD). However, B. amyloliquefaciens fermentation yields large quantities of acetoin, lactate and succinate as by-products, and the 2,3-BD yield remains prohibitively low for commercial production. Methodology/Principal Findings: In the 2,3-butanediol metabolic pathway, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) catalyzes the conversion of 3-phosphate glyceraldehyde to 1,3-bisphosphoglycerate, with concomitant reduction of NAD(+) to NADH. In the same pathway, 2,3-BD dehydrogenase (BDH) catalyzes the conversion of acetoin to 2,3-BD with concomitant oxidation of NADH to NAD(+). In this study, to improve 2,3-BD production, we first over-produced NAD(+)-dependent GAPDH and NADH-dependent BDH in B. amyloliquefaciens. Excess GAPDH reduced the fermentation time, increased the 2,3-BD yield by 12.7%, and decreased the acetoin titer by 44.3%. However, the process also enhanced lactate and succinate production. Excess BDH increased the 2,3-BD yield by 16.6% while decreasing acetoin, lactate and succinate production, but prolonged the fermentation time. When BDH and GAPDH were co-overproduced in B. amyloliquefaciens, the fermentation time was reduced. Furthermore, in the NADH-dependent pathways, the molar yield of 2,3-BD was increased by 22.7%, while those of acetoin, lactate and succinate were reduced by 80.8%, 33.3% and 39.5%, relative to the parent strain. In fed-batch fermentations, the 2,3-BD concentration was maximized at 132.9 g/l after 45 h, with a productivity of 2.95 g/l.h. Conclusions/Significance: Co-overexpression of bdh and gapA genes proved an effective method for enhancing 2,3-BD production and inhibiting the accumulation of unwanted by-products (acetoin, lactate and succinate). To our knowledge, we have attained the highest 2,3-BD fermentation yield thus far reported for safe microorganisms.	[Yang, Taowei; Rao, Zhiming; Zhang, Xian; Xu, Meijuan; Xu, Zhenghong] Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Jiangsu Provinc, Peoples R China; [Xu, Zhenghong] Jiangnan Univ, Sch Med & Pharmaceut, Lab Pharmaceut Engn, Wuxi, Jiangsu Provinc, Peoples R China; [Yang, Shang-Tian] Ohio State Univ, Dept Chem & Biomol Engn, Columbus, OH 43210 USA	Jiangnan University; Jiangnan University; University System of Ohio; Ohio State University	Rao, ZM (corresponding author), Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Jiangsu Provinc, Peoples R China.	raozhm@jiangnan.edu.cn; zhenghxu@163.com	Xu, Meijuan/C-1790-2012; Yang, Shang-Tian/A-7892-2009		Program for New Century Excellent Talents in University [NCET-10-0459]; National Basic Research Program of China (973 Program) [2012CB725202]; High-tech Research and Development Programs of China [2011AA02A211]; National Natural Science Foundation of China [21276110]; Fundamental Research Funds for the Central Universities [JUSRP51306A, JUSRP1009]; Research Fund for the Doctoral Program of Higher Education of China [20110093120001]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); High-tech Research and Development Programs of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the Program for New Century Excellent Talents in University (NCET-10-0459), the National Basic Research Program of China (973 Program) (2012CB725202), the High-tech Research and Development Programs of China (2011AA02A211), the National Natural Science Foundation of China (21276110), the Fundamental Research Funds for the Central Universities (JUSRP51306A, JUSRP1009), the Research Fund for the Doctoral Program of Higher Education of China (20110093120001) and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas R, 2012, APPL MICROBIOL BIOT, V94, P651, DOI 10.1007/s00253-011-3774-5; Celinska E, 2009, BIOTECHNOL ADV, V27, P715, DOI 10.1016/j.biotechadv.2009.05.002; DEBOER AS, 1991, APPL MICROBIOL BIOT, V36, P1; Ehsani M, 2009, APPL ENVIRON MICROB, V75, P3196, DOI 10.1128/AEM.02157-08; Ezeji TC, 2004, APPL MICROBIOL BIOT, V63, P653, DOI 10.1007/s00253-003-1400-x; FERDINAND W, 1964, BIOCHEM J, V92, P578, DOI 10.1042/bj0920578; FLICKINGER MC, 1980, BIOTECHNOL BIOENG, V22, P27; GARG SK, 1995, BIORESOURCE TECHNOL, V51, P103, DOI 10.1016/0960-8524(94)00136-O; Han SH, 2013, NEW BIOTECHNOL, V30, P166, DOI 10.1016/j.nbt.2012.09.004; Hespell RB, 1996, CURR MICROBIOL, V32, P291, DOI 10.1007/s002849900052; Ji XJ, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-7; Ji XJ, 2011, BIOTECHNOL ADV, V29, P351, DOI 10.1016/j.biotechadv.2011.01.007; Jung MY, 2012, APPL MICROBIOL BIOT, V95, P461, DOI 10.1007/s00253-012-3883-9; JUNI E, 1952, J BIOL CHEM, V195, P715; LARSEN SH, 1973, EUR J BIOCHEM, V34, P100, DOI 10.1111/j.1432-1033.1973.tb02734.x; Li ZJ, 2010, APPL MICROBIOL BIOT, V87, P2001, DOI 10.1007/s00253-010-2676-2; Ma CQ, 2009, APPL MICROBIOL BIOT, V82, P49, DOI 10.1007/s00253-008-1732-7; Ma Z, 2013, J BASIC MICROB, V53, P348, DOI 10.1002/jobm.201100580; Menzel K, 1998, BIOTECHNOL BIOENG, V60, P617, DOI 10.1002/(SICI)1097-0290(19981205)60:5<617::AID-BIT12>3.3.CO;2-C; Metsoviti M, 2012, PROCESS BIOCHEM, V47, P1872, DOI 10.1016/j.procbio.2012.06.011; NELSON K, 1991, P NATL ACAD SCI USA, V88, P6667, DOI 10.1073/pnas.88.15.6667; Nicholson WL, 2008, APPL ENVIRON MICROB, V74, P6832, DOI 10.1128/AEM.00881-08; Sambrook J, 2001, MOL CLONING LAB MANU; San KY, 2002, METAB ENG, V4, P182, DOI 10.1006/mben.2001.0220; Shen X, 2012, J IND MICROBIOL BIOT; Siemerink MAJ, 2011, APPL ENVIRON MICROB, V77, P2582, DOI 10.1128/AEM.01616-10; van Haveren J, 2008, BIOFUEL BIOPROD BIOR, V2, P41, DOI 10.1002/bbb.43; Vojcic L, 2012, APPL MICROBIOL BIOT, V94, P487, DOI 10.1007/s00253-012-3987-2; Xiao ZJ, 2007, CRIT REV MICROBIOL, V33, P127, DOI 10.1080/10408410701364604; Yang TW, 2012, WORLD J MICROB BIOT, V28, P1563, DOI 10.1007/s11274-011-0960-7; Yang TW, 2011, J BASIC MICROB, V51, P650, DOI 10.1002/jobm.201100033; Zhang LY, 2010, J IND MICROBIOL BIOT, V37, P857, DOI 10.1007/s10295-010-0733-6; Zhang WG, 2012, GREEN CHEM, V14, P3441, DOI 10.1039/c2gc36324k; Zhang YP, 2009, METAB ENG, V11, P101, DOI 10.1016/j.ymben.2008.11.001	34	47	51	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76149	10.1371/journal.pone.0076149	http://dx.doi.org/10.1371/journal.pone.0076149			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098433	gold, Green Published, Green Submitted			2022-12-25	WOS:000325434500045
J	Lan, KC; Chen, YT; Chang, CS; Chang, YC; Lin, HJ; Huang, KE; Kang, HY				Lan, Kuo-Chung; Chen, Yen-Ta; Chang, Chawnshang; Chang, Yung-Chiao; Lin, Hsin-Jung; Huang, Ko-En; Kang, Hong-Yo			Up-Regulation of SOX9 in Sertoli Cells from Testiculopathic Patients Accounts for Increasing Anti-Mullerian Hormone Expression via Impaired Androgen Receptor Signaling	PLOS ONE			English	Article							FUNCTIONAL MATURATION; CAMPOMELIC DYSPLASIA; MICE LACKING; HUMAN TESTIS; GERM-CELLS; GENE; SEX; PROTEIN; SPERMATOGENESIS; AZOOSPERMIA	Background: Testosterone provokes Sertoli cell maturation and represses AMH production. In adult patients with Sertoli-cells-only syndrome (SCOS) and androgen insensitivity syndrome (AIS), high level of AMH expression is detected in Sertoli cells due to defect of androgen/AR signaling. Objective: We postulated that up-regulation of SOX9 due to impairment of androgen/AR signaling in Sertoli cells might explain why high level of anti-Mullerian hormone (AMH) expression occur in these testiculopathic patients. Methods: Biological research of testicular specimens from men with azoospermia or mouse. The serum hormone levels were studied in 23 men with obstructive azoospermia, 33 men with SCOS azoospermia and 21 volunteers with normal seminograms during a period of 4 years. Immunohistochemical staining and reverse-transcription PCR were used to examine the relationships among AR, SOX9 and AMH expression in adult human and mouse testes. The ability of AR to repress the expression of SOX9 and AMH was evaluated in vitro in TM4 Sertoli cells and C3H10T1/2 cells. Results: SCOS specimens showed up-regulation of SOX9 and AMH proteins but down-regulation of AR proteins in Sertoli cells. The mRNA levels of AR were significantly lower and the SOX9, AMH mRNA levels higher in all SCOS patients compared to controls (P<0.05). The testosterone levels in the SCOS patients were within the normal range, but most were below the median of the controls. Furthermore, our in vitro cell line experiments demonstrated that androgen/AR signaling suppressed the gene and protein levels of AMH via repression of SOX9. Conclusions: Our data show that the functional androgen/AR signaling to repress SOX9 and AMH expression is essential for Sertoli cell maturation. Impairment of androgen/AR signaling promotes SOX9-mediated AMH production, accounts for impairments of Sertoli cells in SCOS azoospermic patients.	[Lan, Kuo-Chung; Huang, Ko-En] Kaohsiung Chang Gung Mem Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan; [Lan, Kuo-Chung; Chen, Yen-Ta; Chang, Yung-Chiao; Lin, Hsin-Jung; Huang, Ko-En; Kang, Hong-Yo] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Lan, Kuo-Chung; Kang, Hong-Yo] Chang Gung Univ, Grad Inst Clin Med Sci, Kaohsiung, Taiwan; [Lan, Kuo-Chung; Chang, Yung-Chiao; Lin, Hsin-Jung; Huang, Ko-En; Kang, Hong-Yo] Kaohsiung Chang Gung Mem Hosp, Hormone Res Ctr, Kaohsiung, Taiwan; [Chen, Yen-Ta] Kaohsiung Chang Gung Mem Hosp, Dept Urol, Kaohsiung, Taiwan; [Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Pathol, George H Whipple Lab Canc Res, Rochester, NY 14642 USA; [Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Urol, Rochester, NY 14642 USA; [Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Radiat Oncol, Rochester, NY 14642 USA; [Chang, Chawnshang] Univ Rochester, Med Ctr, Wilmot Canc Ctr, Rochester, NY 14642 USA	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; University of Rochester; University of Rochester; University of Rochester; University of Rochester	Kang, HY (corresponding author), Chang Gung Univ, Grad Inst Clin Med Sci, Kaohsiung, Taiwan.	hkang3@mail.cgu.edu.tw	Kang, Hong-Yo/W-9031-2019	Kang, Hong-Yo/0000-0003-0626-5037; Chang, Chawnshang/0000-0001-8510-3516	Chang Gung Memorial Hospital [CMRPG890541-2]; National Science Council of Taiwan [NMRPG896041-3]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants CMRPG890541-2 from the Chang Gung Memorial Hospital and NMRPG896041-3 from the National Science Council of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlAttar L, 1997, J CLIN INVEST, V100, P1335, DOI 10.1172/JCI119653; Anniballo R, 2000, HUM REPROD, V15, P2269, DOI 10.1093/humrep/15.11.2269; Bhasin S, 2007, J CLIN ENDOCR METAB, V92, P1995, DOI 10.1210/jc.2007-0634; Boukari K, 2009, J CLIN ENDOCR METAB, V94, P1818, DOI 10.1210/jc.2008-1909; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; Chang CS, 2004, P NATL ACAD SCI USA, V101, P6876, DOI 10.1073/pnas.0307306101; Chemes HE, 2008, J CLIN ENDOCR METAB, V93, P4408, DOI 10.1210/jc.2008-0915; Clarkson MJ, 2002, TRENDS ENDOCRIN MET, V13, P106, DOI 10.1016/S1043-2760(01)00541-0; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; De Sanctis Vincenzo, 2010, Pediatr Endocrinol Rev, V8 Suppl 1, P178; De Santa Barbara P, 1998, MOL CELL BIOL, V18, P6653, DOI 10.1128/MCB.18.11.6653; Elliott MR, 2010, NATURE, V467, P333, DOI 10.1038/nature09356; Frojdman K, 2000, HISTOCHEM CELL BIOL, V113, P31, DOI 10.1007/s004180050004; Gao F, 2006, P NATL ACAD SCI USA, V103, P11987, DOI 10.1073/pnas.0600994103; Harley VR, 2003, ENDOCR REV, V24, P466, DOI 10.1210/er.2002-0025; Hiort O, 2003, INT J ANDROL, V26, P16, DOI 10.1046/j.1365-2605.2003.00369.x; Jorgensen JS, 2001, MOL ENDOCRINOL, V15, P1505, DOI 10.1210/me.15.9.1505; Josso N, 2001, MOL CELL ENDOCRINOL, V179, P25, DOI 10.1016/S0303-7207(01)00467-1; Kang HY, 2008, MOL CELL BIOL, V28, P7354, DOI 10.1128/MCB.00582-08; Kato T, 2012, REPRODUCTION, V143, P663, DOI 10.1530/REP-11-0365; Klein Claudia, 2011, BMC Res Notes, V4, P120, DOI 10.1186/1756-0500-4-120; Kobayashi A, 2005, ANN NY ACAD SCI, V1061, P9, DOI 10.1196/annals.1336.003; KWOK C, 1995, AM J HUM GENET, V57, P1028; Lan KC, 2008, FERTIL STERIL, V89, P1397, DOI 10.1016/j.fertnstert.2007.03.092; Lasala C, 2011, AM J PHYSIOL-ENDOC M, V301, pE539, DOI 10.1152/ajpendo.00187.2011; Laurich VM, 2002, ENDOCRINOLOGY, V143, P3351, DOI 10.1210/en.2001-211352; Mackay S, 2000, INT REV CYTOL, V200, P47, DOI 10.1016/S0074-7696(00)00002-4; Majumdar SS, 2012, HUM REPROD, V27, P2515, DOI 10.1093/humrep/des184; Maymon BBS, 2002, FERTIL STERIL, V77, P904, DOI 10.1016/S0015-0282(02)03060-1; McLachlan RI, 2007, HUM REPROD, V22, P2, DOI 10.1093/humrep/del279; Meyer J, 1997, HUM MOL GENET, V6, P91, DOI 10.1093/hmg/6.1.91; Papanastasopoulos P, 2009, FERTIL STERIL, V92, DOI 10.1016/j.fertnstert.2009.05.030; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Racine C, 1998, P NATL ACAD SCI USA, V95, P594, DOI 10.1073/pnas.95.2.594; Regadera J, 2001, J CLIN ENDOCR METAB, V86, P413, DOI 10.1210/jc.86.1.413; REY R, 1993, J CLIN ENDOCR METAB, V77, P1220, DOI 10.1210/jc.77.5.1220; Rey R, 2003, MOL CELL ENDOCRINOL, V211, P21, DOI 10.1016/j.mce.2003.09.007; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; Steger K, 1999, HUM REPROD, V14, P136, DOI 10.1093/humrep/14.1.136; Suarez-Quian CA, 1999, J CLIN ENDOCR METAB, V84, P350, DOI 10.1210/jc.84.1.350; Toulis KA, 2010, HUM REPROD UPDATE, V16, P713, DOI 10.1093/humupd/dmq024; TRAN D, 1987, J HISTOCHEM CYTOCHEM, V35, P733, DOI 10.1177/35.7.3295030; Wang HY, 2007, CANCER RES, V67, P528, DOI 10.1158/0008-5472.CAN-06-1672; Wang RS, 2009, ENDOCR REV, V30, P119, DOI 10.1210/er.2008-0025; Wikstrom AM, 2007, J CLIN ENDOCR METAB, V92, P714, DOI 10.1210/jc.2006-1892; Willems A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014168	46	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76303	10.1371/journal.pone.0076303	http://dx.doi.org/10.1371/journal.pone.0076303			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098470	Green Submitted, gold, Green Published			2022-12-25	WOS:000325427100056
J	Chang, YJ; Ho, TY; Wu, ML; Hwang, SM; Chiou, TW; Tsai, MS				Chang, Yu-Jen; Ho, Tsung-Yen; Wu, Mei-Ling; Hwang, Shiaw-Min; Chiou, Tzyy-Wen; Tsai, Ming-Song			Amniotic Fluid Stem Cells with Low gamma-Interferon Response Showed Behavioral Improvement in Parkinsonism Rat Model	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CLASS-II EXPRESSION; HUMAN BONE-MARROW; DOPAMINERGIC-NEURONS; STROMAL CELLS; IFN-GAMMA; IN-VIVO; HLA-G; DISEASE; TRANSPLANTATION	Amniotic fluid stem cells (AFSCs) are multipotent stem cells that may be used in transplantation medicine. In this study, AFSCs established from amniocentesis were characterized on the basis of surface marker expression and differentiation potential. To further investigate the properties of AFSCs for translational applications, we examined the cell surface expression of human leukocyte antigens (HLA) of these cells and estimated the therapeutic effect of AFSCs in parkinsonian rats. The expression profiles of HLA-II and transcription factors were compared between AFSCs and bone marrow-derived mesenchymal stem cells (BMMSCs) following treatment with gamma-IFN. We found that stimulation of AFSCs with gamma-IFN prompted only a slight increase in the expression of HLA-Ia and HLA-E, and the rare HLA-II expression could also be observed in most AFSCs samples. Consequently, the expression of CIITA and RFX5 was weakly induced by gamma-IFN stimulation of AFSCs compared to that of BMMSCs. In the transplantation test, Sprague Dawley rats with 6-hydroxydopamine lesioning of the substantia nigra were used as a parkinsonian-animal model. Following the negative gamma-IFN response AFSCs injection, apomorphine-induced rotation was reduced by 75% in AFSCs engrafted parkinsonian rats but was increased by 53% in the control group after 12-weeks post-transplantation. The implanted AFSCs were viable, and were able to migrate into the brain's circuitry and express specific proteins of dopamine neurons, such as tyrosine hydroxylase and dopamine transporter. In conclusion, the relative insensitivity AFSCs to gamma-IFN implies that AFSCs might have immune-tolerance in gamma-IFN inflammatory conditions. Furthermore, the effective improvement of AFSCs transplantation for apomorphine-induced rotation paves the way for the clinical application in parkinsonian therapy.	[Chang, Yu-Jen; Wu, Mei-Ling; Hwang, Shiaw-Min] Food Ind Res & Dev Inst, Bioresource Collect & Res Ctr, Hsinchu, Taiwan; [Ho, Tsung-Yen; Chiou, Tzyy-Wen] Natl Dong Hwa Univ, Dept Life Sci, Hualien, Taiwan; [Ho, Tsung-Yen; Chiou, Tzyy-Wen] Natl Dong Hwa Univ, Inst Biotechnol, Hualien, Taiwan; [Tsai, Ming-Song] Cathay Gen Hosp, Prenatal Diag Ctr, Taipei, Taiwan; [Tsai, Ming-Song] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Tsai, Ming-Song] Taipei Med Univ, Dept Obstet & Gynecol, Coll Med, Taipei, Taiwan	National Dong Hwa University; National Dong Hwa University; Cathay General Hospital; Fu Jen Catholic University; Taipei Medical University	Chiou, TW (corresponding author), Natl Dong Hwa Univ, Dept Life Sci, Hualien, Taiwan.	twchiou@mail.ndhu.edu.tw; mstsai@cgh.org.tw			Ministry of Economic Affairs, Taiwan [101-EC-17-A-01-04-0525]; National Science Council, Taiwan [NSC 99-2311-B-080-001-MY2, NSC97-2314-B-281-002-MY3]	Ministry of Economic Affairs, Taiwan(Ministry of Economic Affairs, Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Grant 101-EC-17-A-01-04-0525 from the Ministry of Economic Affairs, Taiwan (http://www.moea.gov.tw), and Grant NSC 99-2311-B-080-001-MY2 and NSC97-2314-B-281-002-MY3 from the National Science Council, Taiwan (http://www.sinica.edu.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlskog JE, 2001, MOVEMENT DISORD, V16, P448, DOI 10.1002/mds.1090; Antonucci I, 2011, CELL TRANSPLANT, V20, P789, DOI 10.3727/096368910X539074; Chan JL, 2006, BLOOD, V107, P4817, DOI 10.1182/blood-2006-01-0057; Chang YJ, 2006, STEM CELLS, V24, P679, DOI 10.1634/stemcells.2004-0308; Chiavegato A, 2007, J MOL CELL CARDIOL, V42, P746, DOI 10.1016/j.yjmcc.2006.12.008; Cho PS, 2008, BLOOD, V111, P430, DOI 10.1182/blood-2007-03-078774; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Donaldson AE, 2009, STEM CELLS DEV, V18, P1003, DOI 10.1089/scd.2008.0300; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; Fondaneche MC, 1998, HUM MOL GENET, V7, P879, DOI 10.1093/hmg/7.5.879; Fu YS, 2006, STEM CELLS, V24, P115, DOI 10.1634/stemcells.2005-0053; Ghannam S, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt2; Gobin SJP, 2000, HUM IMMUNOL, V61, P1102, DOI 10.1016/S0198-8859(00)00198-1; Hellmann MA, 2006, NEUROSCI LETT, V395, P124, DOI 10.1016/j.neulet.2005.10.097; Isacson O, 2003, ANN NEUROL, V53, pS135, DOI 10.1002/ana.10482; Jezierski A, 2010, STEM CELL REV REP, V6, P199, DOI 10.1007/s12015-010-9116-7; Kaviani A, 2001, J PEDIATR SURG, V36, P1662, DOI 10.1053/jpsu.2001.27945; Klemmt PAB, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt20; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; MCGEER PL, 1987, NEUROSCI LETT, V79, P195, DOI 10.1016/0304-3940(87)90696-3; McLaughlin D, 2006, J NEUROSCI RES, V83, P1190, DOI 10.1002/jnr.20828; Mendez I, 2002, J NEUROSURG, V96, P589, DOI 10.3171/jns.2002.96.3.0589; Moretta L, 2001, TRANSPLANT P, V33, P60, DOI 10.1016/S0041-1345(00)02790-1; Mount MP, 2007, J NEUROSCI, V27, P3328, DOI 10.1523/JNEUROSCI.5321-06.2007; Neumann H, 1997, J EXP MED, V185, P305, DOI 10.1084/jem.185.2.305; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Pan HC, 2007, J CLIN NEUROSCI, V14, P1089, DOI 10.1016/j.jocn.2006.08.008; Peng H, 2007, J NEUROIMMUNE PHARM, V2, P251, DOI 10.1007/s11481-007-9081-3; Piccini P, 1999, NAT NEUROSCI, V2, P1137, DOI 10.1038/16060; Prasanna SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0009016, 10.1371/journal.pone.0014189]; ROGERS J, 1988, NEUROBIOL AGING, V9, P339, DOI 10.1016/S0197-4580(88)80079-4; Romieu-Mourez R, 2007, J IMMUNOL, V179, P1549, DOI 10.4049/jimmunol.179.3.1549; Rousseau P, 2004, IMMUNOLOGY, V111, P53, DOI 10.1111/j.1365-2567.2004.01783.x; Selmani Z, 2009, TRANSPLANTATION, V87, pS62, DOI 10.1097/TP.0b013e3181a2a4b3; Shaw SWS, 2011, CELL TRANSPLANT, V20, P1015, DOI 10.3727/096368910X543402; Stagg J, 2006, BLOOD, V107, P2570, DOI 10.1182/blood-2005-07-2793; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Toulouse A, 2008, PROG NEUROBIOL, V85, P376, DOI 10.1016/j.pneurobio.2008.05.003; Trounson A, 2007, NAT BIOTECHNOL, V25, P62, DOI 10.1038/nbt0107-62; Tsai MS, 2006, BIOL REPROD, V74, P545, DOI 10.1095/biolreprod.105.046029; Tsai MS, 2004, HUM REPROD, V19, P1450, DOI 10.1093/humrep/deh279; Wang Y, 2007, J NEUROIMMUNE PHARM, V2, P243, DOI 10.1007/s11481-007-9074-2; Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Yasuhara T, 2006, J NEUROSCI, V26, P12497, DOI 10.1523/JNEUROSCI.3719-06.2006	45	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76118	10.1371/journal.pone.0076118	http://dx.doi.org/10.1371/journal.pone.0076118			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098771	Green Submitted, gold, Green Published			2022-12-25	WOS:000325423500141
J	Dobler, CC; Luu, Q; Marks, GB				Dobler, Claudia C.; Luu, Queenie; Marks, Guy B.			What Patient Factors Predict Physicians' Decision Not to Treat Latent Tuberculosis Infection in Tuberculosis Contacts?	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; UNITED-STATES; RISK; HEPATOTOXICITY; TRANSMISSION; POPULATION; REACTIVITY; AUSTRALIA; ATTITUDES; HEPATITIS	Objective: The study aimed to determine factors that are associated with physicians' decision to offer treatment for latent tuberculosis infection (LTBI) in contacts of patients with tuberculosis. Methods: We performed a nested case-control study in a cohort of contacts of patients with pulmonary tuberculosis who had a tuberculin skin test (TST) >= 10 mm. Cases were those who were offered treatment for LTBI. Controls were randomly selected from those who were not offered treatment for LTBI by the reviewing physician. Odds ratios were estimated by multivariate logistic regression. Results: There were 195 cases and 279 controls. The following factors were significantly (positively or negatively) associated with being offered LTBI treatment in the multivariate analysis: female gender (OR 2.9; 95% CI 1.6-5.5), TST conversion (OR 3.9; 2.0-7.9), TST > 20 mm (OR 4.1; 1.8-9.1, for TST of 21-30 mm and OR 7.9; 2.6-23.8, for TST > 30 mm), sputum smear positive index case (OR 12.7; 4.5-36.1), being overseas-born and immigration more than 2 years ago (OR 0.1; 0.06-0.3), being a health care worker (OR 0.2; 0.1-0.6), being a non-household contact of the TB index case (OR 0.3; 0.2-0.6) and age >35 years (OR 0.2; 0.1-0.5 for age 35 to 54.9 years and OR 0.04; 0.01-0.2 for age >= 55 years). Previous BCG vaccine and chest x-ray findings were not significantly associated with physicians' decision to offer treatment for LTBI. Conclusions: Most factors that influenced physicians' decisions on treatment for LTBI were based on evidence of an association with risk of developing TB or risk of having an adverse reaction to treatment for LTBI. However, the decreased likelihood of offering treatment for LTBI to people born overseas, men and health care workers, was apparently not based on any evidence of risk. Efforts should be made to ensure that these groups are given access to treatment for LTBI.	[Dobler, Claudia C.; Marks, Guy B.] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia; [Dobler, Claudia C.; Marks, Guy B.] Univ Sydney, Cent Clin Sch, Sydney, NSW 2006, Australia; [Dobler, Claudia C.; Luu, Queenie; Marks, Guy B.] Univ New S Wales, Liverpool Hosp, Dept Resp Med, Sydney, NSW, Australia	University of Sydney; Woolcock Institute of Medical Research; University of Sydney; Liverpool Hospital; University of New South Wales Sydney	Dobler, CC (corresponding author), Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia.	cdobler@med.usyd.edu.au	Marks, Guy B./F-5058-2013	Marks, Guy B./0000-0002-8976-8053; Dobler, Claudia/0000-0002-5460-0189	University of Sydney	University of Sydney(University of Sydney)	CCD is supported by a University of Sydney Postgraduate Award Scholarship. There was no other study funding. The funders of the research scholarship had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida LMD, 2001, PEDIATR INFECT DIS J, V20, P1061, DOI 10.1097/00006454-200111000-00011; Barry C, 2012, COMMUN DIS INTELL, V36, P82; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Bhanot N, 2012, INT J TUBERC LUNG D, V16, P169, DOI 10.5588/ijtld.11.0232; Cohn DL, 2000, AM J RESP CRIT CARE, V161, pS221; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Colson PW, 2013, INT J TUBERC LUNG D, V17, P473, DOI 10.5588/ijtld.12.0697; Connolly Maire, 1996, World Health Statistics Quarterly, V49, P115; Dobler Claudia C, 2013, N S W Public Health Bull, V24, P34, DOI 10.1071/NB12099; Dobler CC, 2013, EUR RESPIR J, V41, P1459, DOI 10.1183/09031936.00183812; Dobler CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048900; Dobler CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029563; Dobler CC, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000666; FEREBEE SH, 1970, BIBL TUBERC MED THOR, V17, P28; FRANKS AL, 1989, PUBLIC HEALTH REP, V104, P151; Gershon AS, 2004, CLIN INFECT DIS, V39, P667, DOI 10.1086/422995; Hirsch-Moverman Y, 2008, INT J TUBERC LUNG D, V12, P1235; Hirsch-Moverman Y, 2006, INT J TUBERC LUNG D, V10, P1178; Jimenez-Corona ME, 2006, THORAX, V61, P348, DOI 10.1136/thx.2005.049452; JOHNSON H, 1995, TUBERCLE LUNG DIS, V76, P122, DOI 10.1016/0962-8479(95)90553-7; KOPANOFF DE, 1978, AM REV RESPIR DIS, V117, P991; Kunst H, 2010, INT J TUBERC LUNG D, V14, P1374; Linas BP, 2011, AM J RESP CRIT CARE, V184, P590, DOI 10.1164/rccm.201101-0181OC; Lohmann EM, 2012, INT J TUBERC LUNG D, V16, P1477, DOI 10.5588/ijtld.12.0129; Marks GB, 2000, AM J RESP CRIT CARE, V162, P1851, DOI 10.1164/ajrccm.162.5.2004154; Menzies D, 2000, CLIN INFECT DIS, V31, pS71, DOI 10.1086/314075; Menzies D, 2008, INT J TUBERC LUNG D, V12, P498; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; Moran-Mendoza O, 2007, INT J TUBERC LUNG D, V11, P1014; Moran-Mendoza O, 2010, INT J TUBERC LUNG D, V14, P1112; Nolan CM, 1999, JAMA-J AM MED ASSOC, V281, P1014, DOI 10.1001/jama.281.11.1014; NSW Department of Health, 2005, POL DIR PREV THER; Santiago EM, 2003, PEDIATRICS, V112, pE298, DOI 10.1542/peds.112.4.e298; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Sterne JAC, 1998, INT J TUBERC LUNG D, V2, P200; THOMPSON NJ, 1982, B WORLD HEALTH ORGAN, V60, P555; Uplekar MW, 2001, INT J TUBERC LUNG D, V5, P220	37	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76552	10.1371/journal.pone.0076552	http://dx.doi.org/10.1371/journal.pone.0076552			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098794	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500165
J	Wang, G; Edwards, H; Caldwell, JT; Buck, SA; Qing, WY; Taub, JW; Ge, YB; Wang, ZH				Wang, Guan; Edwards, Holly; Caldwell, J. Timothy; Buck, Steven A.; Qing, William Y.; Taub, Jeffrey W.; Ge, Yubin; Wang, Zhihong			Panobinostat Synergistically Enhances the Cytotoxic Effects of Cisplatin, Doxorubicin or Etoposide on High-Risk Neuroblastoma Cells	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; ACUTE MYELOID-LEUKEMIA; MYELODYSPLASTIC SYNDROMES; PLASMA-CONCENTRATIONS; VALPROIC ACID; PHASE-I; CHILDREN; PHARMACOKINETICS; THERAPY; CANCER	High-risk neuroblastoma remains a therapeutic challenge with a long-term survival rate of less than 40%. Therefore, new agents are urgently needed to overcome chemotherapy resistance so as to improve the treatment outcome of this deadly disease. Histone deacetylase (HDAC) inhibitors (HDACIs) represent a novel class of anticancer drugs. Recent studies demonstrated that HDACIs can down-regulate the CHK1 pathway by which cancer cells can develop resistance to conventional chemotherapy drugs. This prompted our hypothesis that combining HDACIs with DNA damaging chemotherapeutic drugs for treating neuroblastoma would result in enhanced anti-tumor activities of these drugs. Treatment of high-risk neuroblastoma cell lines with a novel pan-HDACI, panobinostat (LBH589), resulted in dose-dependent growth arrest and apoptosis in 4 high-risk neuroblastoma cell lines. Further, the combination of panobinostat with cisplatin, doxorubicin, or etoposide resulted in highly synergistic antitumor interactions in the high-risk neuroblastoma cell lines, independent of the sequence of drug administration. This was accompanied by cooperative induction of apoptosis. Furthermore, panobinostat treatment resulted in substantial down-regulation of CHK1 and its downstream pathway and abrogation of the G2 cell cycle checkpoint. Synergistic antitumor interactions were also observed when the DNA damaging agents were combined with a CHK1-specific inhibitor, LY2603618. Contrary to panobinostat treatment, LY2603618 treatments neither resulted in abrogation of the G2 cell cycle checkpoint nor enhanced cisplatin, doxorubicin, or etoposide-induced apoptosis in the high-risk neuroblastoma cells. Surprisingly, LY2603618 treatments caused substantial down-regulation of total CDK1. Despite this discrepancy between panobinostat and LY2603618, our results indicate that suppression of the CHK1 pathway by panobinostat is at least partially responsible for the synergistic antitumor interactions between panobinostat and the DNA damaging agents in high-risk neuroblastoma cells. The results of this study provide a rationale for clinical evaluation of the combination of panobinostat and cisplatin, doxorubicin, or etoposide for treating children with high-risk neuroblastoma.	[Wang, Guan; Taub, Jeffrey W.; Wang, Zhihong] Wayne State Univ, Sch Med, Dept Pediat, Detroit, MI 48201 USA; [Wang, Guan; Ge, Yubin] Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China; [Edwards, Holly; Qing, William Y.; Ge, Yubin] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA; [Edwards, Holly; Qing, William Y.; Ge, Yubin] Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI USA; [Caldwell, J. Timothy] Wayne State Univ, Sch Med, MD PhD Program, Detroit, MI USA; [Caldwell, J. Timothy] Wayne State Univ, Sch Med, Canc Biol Program, Detroit, MI USA; [Buck, Steven A.; Taub, Jeffrey W.; Wang, Zhihong] Childrens Hosp Michigan, Div Pediat Hematol Oncol, Detroit, MI 48201 USA	Wayne State University; Jilin University; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University; Children's Hospital of Michigan	Ge, YB (corresponding author), Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China.	gey@karmanos.org; Jwang2@med.wayne.edu		Ge, Yubin/0000-0002-8748-716X	Barbara Ann Karmanos Cancer Institute; Hyundai Hope on Wheels; Herrick Foundation; Leukemia Research Life; Ring Screw Textron Endowed Chair for Pediatric Cancer Research; National Cancer Institute [T32 CA009531]; NATIONAL CANCER INSTITUTE [T32CA009531] Funding Source: NIH RePORTER	Barbara Ann Karmanos Cancer Institute; Hyundai Hope on Wheels; Herrick Foundation; Leukemia Research Life; Ring Screw Textron Endowed Chair for Pediatric Cancer Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by a Start-up Fund from the Barbara Ann Karmanos Cancer Institute, grants from Hyundai Hope on Wheels, the Herrick Foundation, Leukemia Research Life, and the Ring Screw Textron Endowed Chair for Pediatric Cancer Research. Mr. JTC is a predoctoral trainee supported by T32 CA009531 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bolderson E, 2009, CLIN CANCER RES, V15, P6314, DOI 10.1158/1078-0432.CCR-09-0096; Brazelle W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014335; BRODEUR GM, 1981, CANCER RES, V41, P4678; Byrd JC, 2005, BLOOD, V105, P959, DOI 10.1182/blood-2004-05-1693; Dai Y, 2010, CLIN CANCER RES, V16, P376, DOI 10.1158/1078-0432.CCR-09-1029; Garcia-Manero G, 2008, BLOOD, V112, P981, DOI 10.1182/blood-2007-10-115873; Garcia-Manero G, 2008, BLOOD, V111, P1060, DOI 10.1182/blood-2007-06-098061; Garrett MD, 2011, TRENDS PHARMACOL SCI, V32, P308, DOI 10.1016/j.tips.2011.02.014; GILBERT F, 1984, CANCER RES, V44, P5444; Giles F, 2006, CLIN CANCER RES, V12, P4628, DOI 10.1158/1078-0432.CCR-06-0511; Gimsing P, 2008, EUR J HAEMATOL, V81, P170, DOI 10.1111/j.1600-0609.2008.01102.x; Gojo I, 2007, BLOOD, V109, P2781, DOI 10.1182/blood-2006-05-021873; Goodisman J, 2006, J CLIN PHARMACOL, V46, P443, DOI 10.1177/0091270006286793; HALPERIN EC, 1986, INT J RADIAT ONCOL, V12, P1829, DOI 10.1016/0360-3016(86)90326-3; Hara J, 2012, INT J CLIN ONCOL, V17, P196, DOI 10.1007/s10147-012-0417-5; Hempel G, 2002, CANCER CHEMOTH PHARM, V49, P133, DOI 10.1007/s00280-001-0392-4; Kato Y, 2003, PEDIATR INT, V45, P74, DOI 10.1046/j.1442-200X.2003.01675.x; Klimek VM, 2008, CLIN CANCER RES, V14, P826, DOI 10.1158/1078-0432.CCR-07-0318; Kuendgen A, 2006, CANCER-AM CANCER SOC, V106, P112, DOI 10.1002/cncr.21552; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Marks PA, 2010, EXPERT OPIN INV DRUG, V19, P1049, DOI 10.1517/13543784.2010.510514; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Modak S, 2010, CANCER TREAT REV, V36, P307, DOI 10.1016/j.ctrv.2010.02.006; Prince HM, 2009, CLIN CANCER RES, V15, P3958, DOI 10.1158/1078-0432.CCR-08-2785; Russo C, 1997, MED PEDIATR ONCOL, V28, P284, DOI 10.1002/(SICI)1096-911X(199704)28:4<284::AID-MPO7>3.0.CO;2-E; Wang G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052095; Weiss GJ, 2013, INVEST NEW DRUG, V31, P136, DOI 10.1007/s10637-012-9815-9; WHITE PS, 1995, P NATL ACAD SCI USA, V92, P5520, DOI 10.1073/pnas.92.12.5520; Xie CZ, 2010, CLIN CANCER RES, V16, P5499, DOI 10.1158/1078-0432.CCR-10-1707; Xu XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017138; ZAIZEN Y, 1993, J PEDIATR SURG, V28, P766, DOI 10.1016/0022-3468(93)90321-B	33	32	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76662	10.1371/journal.pone.0076662	http://dx.doi.org/10.1371/journal.pone.0076662			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098799	Green Published, gold, Green Submitted			2022-12-25	WOS:000325423500170
J	Zhou, ZS; Rasmann, S; Li, M; Guo, JY; Chen, HS; Wan, FH				Zhou, Zhong-Shi; Rasmann, Sergio; Li, Min; Guo, Jian-Ying; Chen, Hong-Song; Wan, Fang-Hao			Cold Temperatures Increase Cold Hardiness in the Next Generation Ophraella communa Beetles	PLOS ONE			English	Article							RICE STEM BORER; ARMIGERA HUBNER LEPIDOPTERA; CHILO-SUPPRESSALIS WALKER; DROSOPHILA-MELANOGASTER; LIFE-TABLE; SEASONAL-CHANGES; COLEOPTERA-CHRYSOMELIDAE; LESAGE COLEOPTERA; GLYCEROL CONTENT; SHONAI ECOTYPE	The leaf beetle, Ophraella communa, has been introduced to control the spread of the common ragweed, Ambrosia artemisiifolia, in China. We hypothesized that the beetle, to be able to track host-range expansion into colder climates, can phenotypically adapt to cold temperatures across generations. Therefore, we questioned whether parental experience of colder temperatures increases cold tolerance of the progeny. Specifically, we studied the demography, including development, fecundity, and survival, as well as physiological traits, including supercooling point (SCP), water content, and glycerol content of O. communa progeny whose parents were maintained at different temperature regimes. Overall, the entire immature stage decreased survival of about 0.2%-4.2% when parents experienced cold temperatures compared to control individuals obtained from parents raised at room temperature. However, intrinsic capacity for increase (r), net reproductive rate (R-0) and finite rate of increase (lambda) of progeny O. communa were maximum when parents experienced cold temperatures. Glycerol contents of both female and male in progeny was significantly higher when maternal and paternal adults were cold acclimated as compared to other treatments. This resulted in the supercooling point of the progeny adults being significantly lower compared to beetles emerging from parents that experienced room temperatures. These results suggest that cold hardiness of O. communa can be promoted by cold acclimation in previous generation, and it might counter-balance reduced survival in the next generation, especially when insects are tracking their host-plants into colder climates.	[Zhou, Zhong-Shi; Guo, Jian-Ying; Chen, Hong-Song; Wan, Fang-Hao] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Rasmann, Sergio] Univ Calif Irvine, Irvine, CA USA; [Li, Min] Fujian Entry Exit Inspect & Quarantine Bur, Fuzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; University of California System; University of California Irvine	Wan, FH (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	wanfanghao@caas.cn	Rasmann, Sergio/T-5376-2017	Rasmann, Sergio/0000-0002-3120-6226	National Natural Science Foundation of China [31171908, 31170392]; National Basic Research and Development Program of China [2009CB119200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research and Development Program of China(National Basic Research Program of China)	This work was funded by the National Natural Science Foundation of China (No. 31171908; 31170392), and the National Basic Research and Development Program of China (No. 2009CB119200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, AM NAT, V157, P555, DOI 10.1086/319932; Agrawal AA, 1999, NATURE, V401, P60, DOI 10.1038/43425; ASAHINA E, 1969, Advances in Insect Physiology, V(6), P1; Bale JS, 2002, PHILOS T R SOC B, V357, P849, DOI 10.1098/rstb.2002.1074; Berger D, 2008, FUNCT ECOL, V22, P523, DOI 10.1111/j.1365-2435.2008.01392.x; Bernardo J, 1996, AM ZOOL, V36, P83; BLOCK W, 1990, PHILOS T ROY SOC B, V326, P613, DOI 10.1098/rstb.1990.0035; Block W, 2001, POLAR BIOL, V24, P764; BRADSHAW AD, 1991, ANN BOT-LONDON, V67, P5, DOI 10.1093/oxfordjournals.aob.a088209; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Carey JR, 2001, ANNU REV ENTOMOL, V46, P79, DOI 10.1146/annurev.ento.46.1.79; Chantarasa-ard S., 1984, Esakia, V22, P145; Chen WL, 2008, BIOL CONTROL, V46, P122, DOI 10.1016/j.biocontrol.2008.04.007; CHI H, 1988, ENVIRON ENTOMOL, V17, P26, DOI 10.1093/ee/17.1.26; CHI H, 1985, Bulletin of the Institute of Zoology Academia Sinica (Taipei), V24, P225; Chi H., 2005, TWOSEX MSCHART COMPU; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Chitwood DH, 2010, NATURE, V467, P415, DOI 10.1038/nature09351; Costanzo JP, 1998, J INSECT PHYSIOL, V44, P1173, DOI 10.1016/S0022-1910(98)00082-1; COULSON SC, 1992, J INSECT PHYSIOL, V38, P421, DOI 10.1016/0022-1910(92)90118-W; Daane KM, 2004, BIOL CONTROL, V31, P123, DOI 10.1016/j.biocontrol.2004.04.010; Danks HV, 1996, EUR J ENTOMOL, V93, P383; Diss AL, 1996, OECOLOGIA, V106, P470, DOI 10.1007/BF00329704; Farhadi R, 2011, BIOL CONTROL, V59, P83, DOI 10.1016/j.biocontrol.2011.07.013; Gibbs M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-345; Gilchrist GW, 2001, EVOLUTION, V55, P209, DOI 10.1111/j.0014-3820.2001.tb01287.x; GOEDEN RD, 1985, PAN-PAC ENTOMOL, V61, P32; GOODMAN D, 1982, AM NAT, V119, P803, DOI 10.1086/283956; Goto M, 2001, APPL ENTOMOL ZOOL, V36, P323, DOI 10.1303/aez.2001.323; Guo JY, 2012, BIOL INVASIONS, V14, P1597, DOI 10.1007/s10530-010-9932-3; Holmstrup M, 1999, J COMP PHYSIOL B, V169, P207, DOI 10.1007/s003600050213; Huang Yu-Bing, 2012, Insect Science, V19, P263, DOI 10.1111/j.1744-7917.2011.01424.x; Huang Z, 2008, BIOL CONTROL, V46, P209, DOI 10.1016/j.biocontrol.2008.04.004; Huffaker Carl, 1999, P269; Ines SM, 2009, CHEMOSPHERE, V76, P1451; Irwin JT, 2000, J INSECT PHYSIOL, V46, P655, DOI 10.1016/S0022-1910(99)00153-5; Ishiguro S, 2007, J INSECT PHYSIOL, V53, P392, DOI 10.1016/j.jinsphys.2006.12.014; Jervis MA, 2005, ECOL ENTOMOL, V30, P359, DOI 10.1111/j.0307-6946.2005.00712.x; Jervis MA, 2007, EVOL ECOL, V21, P307, DOI 10.1007/s10682-006-9102-3; Jha RK, 2012, ENVIRON ENTOMOL, V41, P30, DOI 10.1603/EN11206; Kavousi A, 2009, J ECON ENTOMOL, V102, P595, DOI 10.1603/029.102.0217; Lee R.E. Jr, 1991, P17; LeSage L, 1986, MEMOIRS ENTOMOLOGICA, V133, P1, DOI [10.4039/entm118133fv, DOI 10.4039/ENTM118133FV]; Li YP, 2002, ARCH INSECT BIOCHEM, V50, P53, DOI 10.1002/arch.10024; Liu ZD, 2007, J INSECT PHYSIOL, V53, P1016, DOI 10.1016/j.jinsphys.2007.05.005; Luna E, 2012, PLANT PHYSIOL, V158, P844, DOI 10.1104/pp.111.187468; Luo Min, 2011, Acta Entomologica Sinica, V54, P76; MacAlpine JLP, 2011, J INSECT PHYSIOL, V57, P35, DOI 10.1016/j.jinsphys.2010.09.003; Marshall DJ, 2003, ECOLOGY, V84, P3131, DOI 10.1890/02-0311; Marshall DJ, 2003, MAR ECOL PROG SER, V259, P139, DOI 10.3354/meps259139; Marshall DJ, 2006, INTEGR COMP BIOL, V46, P643, DOI 10.1093/icb/icl013; Marshall KE, 2010, P ROY SOC B-BIOL SCI, V277, P963, DOI 10.1098/rspb.2009.1807; Montiel PO, 1998, POLAR BIOL, V19, P250, DOI 10.1007/s003000050242; MOUSSEAU TA, 1991, ANNU REV ENTOMOL, V36, P511, DOI 10.1146/annurev.en.36.010191.002455; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Muise AM, 1999, CRYO-LETT, V20, P223; Nedved O, 1998, FUNCT ECOL, V12, P816, DOI 10.1046/j.1365-2435.1998.00250.x; Neven LG, 1999, CRYOBIOLOGY, V38, P43, DOI 10.1006/cryo.1998.2140; PALMER WA, 1991, COLEOPTS BULL, V45, P115; Papaj DR, 2000, ANNU REV ENTOMOL, V45, P423, DOI 10.1146/annurev.ento.45.1.423; Rako L, 2006, J INSECT PHYSIOL, V52, P94, DOI 10.1016/j.jinsphys.2005.09.007; Rasmann S, 2012, PLANT PHYSIOL, V158, P854, DOI 10.1104/pp.111.187831; Rivers DB, 2000, J INSECT PHYSIOL, V46, P99, DOI 10.1016/S0022-1910(99)00106-7; Roff DA, 2004, J EVOLUTION BIOL, V17, P663, DOI 10.1046/j.1420-9101.2003.00673.x; Roff Derek, 2002, pi; SALT RW, 1961, ANNU REV ENTOMOL, V6, P55, DOI 10.1146/annurev.en.06.010161.000415; SAS Institute, 2004, SAS US GUID STAT; Sharaf N., 1996, Dirasat Agricultural Sciences, V23, P214; Sinclair BJ, 1999, EUR J ENTOMOL, V96, P157; Stelgenga MJ, 2007, J THERM BIOL, V32, P396, DOI 10.1016/j.jtherbio.2007.06.001; Sung DY, 2003, TRENDS PLANT SCI, V8, P179, DOI 10.1016/S1360-1385(03)00047-5; TANIGOSHI LK, 1977, HILGARDIA, V45, P237, DOI 10.3733/hilg.v45n08p237; Terblanche JS, 2005, J INSECT PHYSIOL, V51, P1013, DOI 10.1016/j.jinsphys.2005.04.016; Teshler M. P., 2002, BIOL CONTROL PROGRAM, P290, DOI DOI 10.1079/9780851995274.0290; Teshler M.P., 2000, WEED SCI SOC AM ABST, V40, P29; Tsumuki H., 1990, Advances in Invertebrate Reproduction, V5, P273; Tsumuki H, 1978, BER OHARA I LANDWIRT, V17, P98; Uckan Fevzi, 2001, Turkish Journal of Zoology, V25, P187; van Lenteren JC, 2006, ANNU REV ENTOMOL, V51, P609, DOI 10.1146/annurev.ento.51.110104.151129; Wan F.H., 2005, BIOL MANAGEMENT INVA, P662; Wang HS, 2006, CRYOBIOLOGY, V53, P206, DOI 10.1016/j.cryobiol.2006.06.003; Wang HS, 2005, CRYOBIOLOGY, V51, P220, DOI 10.1016/j.cryobiol.2005.07.003; Worland MR, 2008, J INSECT PHYSIOL, V54, P1281, DOI 10.1016/j.jinsphys.2008.06.009; Yoder JA, 2006, J INSECT PHYSIOL, V52, P202, DOI 10.1016/j.jinsphys.2005.10.005; Zhou ZS, 2011, ENTOMOL EXP APPL, V140, P85, DOI 10.1111/j.1570-7458.2011.01128.x; Zhou Zhong-shi, 2008, Chinese Journal of Biological Control, V24, P376; Zhou ZS, 2010, ENVIRON ENTOMOL, V39, P1021, DOI 10.1603/EN09176	87	21	27	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74760	10.1371/journal.pone.0074760	http://dx.doi.org/10.1371/journal.pone.0074760			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098666	Green Published, gold			2022-12-25	WOS:000325423500037
J	Honsho, M; Asaoku, S; Fukumoto, K; Fujiki, Y				Honsho, Masanori; Asaoku, Shunsuke; Fukumoto, Keiko; Fujiki, Yukio			Topogenesis and Homeostasis of Fatty Acyl-CoA Reductase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Lipid Ether; Peroxisomes; Plasmalogen; Protein Stability; Protein Targeting; Ether Lipid	OVARY CELL MUTANTS; MEMBRANE-PROTEIN; COMPLEMENTATION GROUP; DIHYDROXYACETONEPHOSPHATE ACYLTRANSFERASE; PLASMALOGEN DEFICIENCY; ZELLWEGER-SYNDROME; BIOSYNTHESIS; BIOGENESIS; LOCALIZATION; PEROXISOMES	Background: Stability of Far1, an essential enzyme for plasmalogen synthesis, is regulated by the cellular plasmalogen level. Results: Expression of a mutant Far1 harboring the mutation in its C-terminal membrane-flanking region increased plasmalogen synthesis because of the inhibition of its degradation. Conclusion: Elevation of plasmalogen synthesis is achieved by expression of Far1. Significance: Far1 is a rate-limiting enzyme for plasmalogen synthesis. Peroxisomal fatty acyl-CoA reductase 1 (Far1) is essential for supplying fatty alcohols required for ether bond formation in ether glycerophospholipid synthesis. The stability of Far1 is regulated by a mechanism that is dependent on cellular plasmalogen levels. However, the membrane topology of Far1 and how Far1 is targeted to membranes remain largely unknown. Here, Far1 is shown to be a peroxisomal tail-anchored protein. The hydrophobic C terminus of Far1 binds to Pex19p, a cytosolic receptor harboring a C-terminal CAAX motif, which is responsible for the targeting of Far1 to peroxisomes. Far1, but not Far2, was preferentially degraded in response to the cellular level of plasmalogens. Experiments in which regions of Far1 or Far2 were replaced with the corresponding region of the other protein showed that the region flanking the transmembrane domain of Far1 is required for plasmalogen-dependent modulation of Far1 stability. Expression of Far1 increased plasmalogen synthesis in wild-type Chinese hamster ovary cells, strongly suggesting that Far1 is a rate-limiting enzyme for plasmalogen synthesis.	[Honsho, Masanori; Fujiki, Yukio] Kyushu Univ, Dept Biol, Fac Sci, Higashi Ku, Fukuoka 8128581, Japan; [Honsho, Masanori; Asaoku, Shunsuke; Fukumoto, Keiko; Fujiki, Yukio] Kyushu Univ, Grad Sch Syst Life Sci, Higashi Ku, Fukuoka 8128581, Japan; [Fujiki, Yukio] Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo 1020075, Japan	Kyushu University; Kyushu University; Japan Science & Technology Agency (JST)	Fujiki, Y (corresponding author), Kyushu Univ, Grad Sch, Fac Sci, Dept Biol,Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	yfujiki@kyudai.jp		Honsho, Masanori/0000-0001-6165-4516	Science and Technology Agency of Japan CREST; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Foundation for Applied Enzymology; Takeda Science Foundation; Grants-in-Aid for Scientific Research [23570236] Funding Source: KAKEN	Science and Technology Agency of Japan CREST; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Foundation for Applied Enzymology; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Science and Technology Agency of Japan CREST grant (to Y. F.); by grants-in-aid for scientific research (to M. H. and Y. F.); by the global COE program and grants for excellent graduate schools from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; and by grants from the Japan Foundation for Applied Enzymology (to Y. F.) and the Takeda Science Foundation (to M. H. and Y. F.).	BISHOP JE, 1981, J BIOL CHEM, V256, P9542; Brites P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028539; BURDETT K, 1991, J BIOL CHEM, V266, P12201; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; Delille HK, 2008, J BIOL CHEM, V283, P31107, DOI 10.1074/jbc.M803332200; FUJIKI Y, 1984, P NATL ACAD SCI-BIOL, V81, P7127, DOI 10.1073/pnas.81.22.7127; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Ghaedi K, 2000, MOL BIOL CELL, V11, P2085, DOI 10.1091/mbc.11.6.2085; GINSBERG L, 1995, BRAIN RES, V698, P223, DOI 10.1016/0006-8993(95)00931-F; Halbach A, 2005, J BIOL CHEM, V280, P21176, DOI 10.1074/jbc.M501750200; Halbach A, 2006, J CELL SCI, V119, P2508, DOI 10.1242/jcs.02979; Han XL, 2001, J NEUROCHEM, V77, P1168, DOI 10.1046/j.1471-4159.2001.00332.x; Honsho M, 1998, AM J HUM GENET, V63, P1622, DOI 10.1086/302161; Honsho M, 2002, J BIOL CHEM, V277, P44513, DOI 10.1074/jbc.M206139200; Honsho M, 2001, J BIOL CHEM, V276, P9375, DOI 10.1074/jbc.M003304200; Honsho M, 2008, BBA-MOL CELL RES, V1783, P1857, DOI 10.1016/j.bbamcr.2008.05.018; Honsho M, 2010, J BIOL CHEM, V285, P8537, DOI 10.1074/jbc.M109.083311; KAWAJIRI K, 1977, J BIOCHEM, V82, P1403, DOI 10.1093/oxfordjournals.jbchem.a131828; Kinoshita N, 1998, J BIOL CHEM, V273, P24122, DOI 10.1074/jbc.273.37.24122; Kobayashi S, 2007, EXP CELL RES, V313, P1675, DOI 10.1016/j.yexcr.2007.02.028; Liu DL, 2005, J LIPID RES, V46, P727, DOI 10.1194/jlr.M400364-JLR200; Matsuzaki T, 2008, J CELL BIOL, V183, P1275, DOI 10.1083/jcb.200806062; Matsuzono Y, 1999, P NATL ACAD SCI USA, V96, P2116, DOI 10.1073/pnas.96.5.2116; MIURA S, 1992, J BIOL CHEM, V267, P14405; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; MOTLEY A, 1994, J CELL BIOL, V125, P755, DOI 10.1083/jcb.125.4.755; Mukai S, 2002, J BIOL CHEM, V277, P9548, DOI 10.1074/jbc.M108635200; Nagan N, 1997, P NATL ACAD SCI USA, V94, P4475, DOI 10.1073/pnas.94.9.4475; Nagan N, 1998, BIOCHEM J, V332, P273, DOI 10.1042/bj3320273; Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0; Nishimukai M, 2003, LIPIDS, V38, P1227, DOI 10.1007/s11745-003-1183-9; Okumoto K, 1997, EXP CELL RES, V233, P11, DOI 10.1006/excr.1997.3552; Okumoto K, 1997, NAT GENET, V17, P265, DOI 10.1038/ng1197-265; Otera H, 1998, MOL CELL BIOL, V18, P388, DOI 10.1128/MCB.18.1.388; Rosenberger TA, 2002, J LIPID RES, V43, P59; Steinberg SJ, 2006, BBA-MOL CELL RES, V1763, P1733, DOI 10.1016/j.bbamcr.2006.09.010; TSUKAMOTO T, 1990, J CELL BIOL, V110, P651, DOI 10.1083/jcb.110.3.651; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; Wanders RJA, 2006, BBA-MOL CELL RES, V1763, P1707, DOI 10.1016/j.bbamcr.2006.08.010; Weller S, 2003, ANNU REV GENOM HUM G, V4, P165, DOI 10.1146/annurev.genom.4.070802.110424; WELSH CJ, 1994, ARCH BIOCHEM BIOPHYS, V315, P41, DOI 10.1006/abbi.1994.1468; Wood PL, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-102; Yagita Y, 2013, J CELL BIOL, V200, P651, DOI 10.1083/jcb.201211077	43	43	44	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34588	34598		10.1074/jbc.M113.498345	http://dx.doi.org/10.1074/jbc.M113.498345			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24108123	Green Published, hybrid			2022-12-25	WOS:000329812800027
J	Satou, R; Miyanaga, A; Ozawa, H; Funa, N; Katsuyama, Y; Miyazono, KI; Tanokura, M; Ohnishi, Y; Horinouchi, S				Satou, Ryutaro; Miyanaga, Akimasa; Ozawa, Hiroki; Funa, Nobutaka; Katsuyama, Yohei; Miyazono, Ken-ichi; Tanokura, Masaru; Ohnishi, Yasuo; Horinouchi, Sueharu			Structural Basis for Cyclization Specificity of Two Azotobacter Type III Polyketide Synthases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Metabolism; Crystallography; Kinetics; Polyketides; Site-directed Mutagenesis	I FATTY-ACID; ALKYLRESORCYLIC ACID; CHALCONE SYNTHASE; BIOSYNTHESIS; LIPIDS	Background: Type III polyketide synthases (PKSs) show diverse cyclization specificity. Results: A single amino acid substitution in two Azotobacter type III PKSs reversed their cyclization specificity. Crystal structures were determined. Conclusion: The volume of the active site cavity is a crucial determinant of the cyclization specificity. Significance: An important insight into the cyclization specificity of type III PKSs was provided. Type III polyketide synthases (PKSs) show diverse cyclization specificity. We previously characterized two Azotobacter type III PKSs (ArsB and ArsC) with different cyclization specificity. ArsB and ArsC, which share a high sequence identity (71%), produce alkylresorcinols and alkylpyrones through aldol condensation and lactonization of the same polyketomethylene intermediate, respectively. Here we identified a key amino acid residue for the cyclization specificity of each enzyme by site-directed mutagenesis. Trp-281 of ArsB corresponded to Gly-284 of ArsC in the amino acid sequence alignment. The ArsB W281G mutant synthesized alkylpyrone but not alkylresorcinol. In contrast, the ArsC G284W mutant synthesized alkylresorcinol with a small amount of alkylpyrone. These results indicate that this amino acid residue (Trp-281 of ArsB or Gly-284 of ArsC) should occupy a critical position for the cyclization specificity of each enzyme. We then determined crystal structures of the wild-type and G284W ArsC proteins at resolutions of 1.76 and 1.99 , respectively. Comparison of these two ArsC structures indicates that the G284W substitution brings a steric wall to the active site cavity, resulting in a significant reduction of the cavity volume. We postulate that the polyketomethylene intermediate can be folded to a suitable form for aldol condensation only in such a relatively narrow cavity of ArsC G284W (and presumably ArsB). This is the first report on the alteration of cyclization specificity from lactonization to aldol condensation for a type III PKS. The ArsC G284W structure is significant as it is the first reported structure of a microbial resorcinol synthase.	[Ohnishi, Yasuo; Horinouchi, Sueharu] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Miyazono, Ken-ichi; Tanokura, Masaru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo; University of Tokyo	Ohnishi, Y (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	ayasuo@mail.ecc.u-tokyo.ac.jp	Miyanaga, Akimasa/C-1472-2015; Miyazono, Kenichi/P-9654-2019	Miyanaga, Akimasa/0000-0003-2219-6051; Miyazono, Kenichi/0000-0002-9354-2604; Katsuyama, Yohei/0000-0003-4905-5320; Ohnishi, Yasuo/0000-0001-7633-9236; Tanokura, Masaru/0000-0001-5072-2480	Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Funding Program for Next Generation World-leading Researchers from the Bureau of Science, Technology, and Innovation Policy, Cabinet Office, Government of Japan	Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Funding Program for Next Generation World-leading Researchers from the Bureau of Science, Technology, and Innovation Policy, Cabinet Office, Government of Japan	This work was supported in part by the Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science, and Technology, Japan and a Funding Program for Next Generation World-leading Researchers from the Bureau of Science, Technology, and Innovation Policy, Cabinet Office, Government of Japan. This work was performed under the approval of the Photon Factory Program Advisory Committee (proposal 2008S2-001).	Austin MB, 2004, J BIOL CHEM, V279, P45162, DOI 10.1074/jbc.M406567200; Austin MB, 2004, CHEM BIOL, V11, P1179, DOI 10.1016/j.chembiol.2004.05.024; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Austin MB, 2006, NAT CHEM BIOL, V2, P494, DOI 10.1038/nchembio811; Awakawa T, 2011, CHEMBIOCHEM, V12, P439, DOI 10.1002/cbic.201000628; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; Funa N, 2006, P NATL ACAD SCI USA, V103, P6356, DOI 10.1073/pnas.0511227103; Funa N, 2002, BIOCHEM J, V367, P781, DOI 10.1042/BJ20020953; Funa N, 2007, J BIOL CHEM, V282, P14476, DOI 10.1074/jbc.M701239200; Funabashi M, 2008, J BIOL CHEM, V283, P13983, DOI 10.1074/jbc.M710461200; Goyal A, 2008, J STRUCT BIOL, V162, P411, DOI 10.1016/j.jsb.2008.02.009; Hayashi T, 2011, CHEMBIOCHEM, V12, P2166, DOI 10.1002/cbic.201100344; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Jez JM, 2000, CHEM BIOL, V7, P919, DOI 10.1016/S1074-5521(00)00041-7; Katsuyama Y, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 1: NATURAL PRODUCTS STRUCTURAL DIVERSITY-I: SECONDARY METABOLITES: ORGANIZATION AND BIOSYNTHESIS, P147; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Matsuzawa M, 2010, PHYTOCHEMISTRY, V71, P1059, DOI 10.1016/j.phytochem.2010.02.012; Miyanaga A, 2008, P NATL ACAD SCI USA, V105, P871, DOI 10.1073/pnas.0709819105; Morita H, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 1: NATURAL PRODUCTS STRUCTURAL DIVERSITY-I: SECONDARY METABOLITES: ORGANIZATION AND BIOSYNTHESIS, P171; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakano C, 2009, J BACTERIOL, V191, P4916, DOI 10.1128/JB.00407-09; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Posehn SE, 2012, CHEMBIOCHEM, V13, P2212, DOI 10.1002/cbic.201200346; Rubin-Pitel SB, 2008, CHEM BIOL, V15, P1079, DOI 10.1016/j.chembiol.2008.08.011; Sankaranarayanan R, 2004, NAT STRUCT MOL BIOL, V11, P894, DOI 10.1038/nsmb809; Shimokawa Y, 2010, BIOORG MED CHEM LETT, V20, P5099, DOI 10.1016/j.bmcl.2010.07.022; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215	32	19	19	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34146	34157		10.1074/jbc.M113.487272	http://dx.doi.org/10.1074/jbc.M113.487272			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24100027	Green Published, hybrid			2022-12-25	WOS:000327250200058
J	Cheng, JC; Chang, HM; Leung, PCK				Cheng, Jung-Chien; Chang, Hsun-Ming; Leung, Peter C. K.			Transforming Growth Factor-beta 1 Inhibits Trophoblast Cell Invasion by Inducing Snail-mediated Down-regulation of Vascular Endothelial-cadherin Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cadherins; Invasion; SMAD Transcription Factor; Transforming Growth Factor- (TGF); Trophoblast; Snail; VE-cadherin	GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITIONS; PLASMINOGEN-ACTIVATOR SYSTEM; VE-CADHERIN; HUMAN CYTOTROPHOBLASTS; ENDOVASCULAR INVASION; EXPRESSION; ADHESION; PREECLAMPSIA; MIGRATION	Background: Transforming growth factor (TGF)-1 treatment decreases human trophoblast invasion. Results: Smad-dependent up-regulation of Snail mediates TGF-1-induced down-regulation of VE-cadherin. Conclusion: TGF-1 decreases human trophoblast invasion by down-regulating VE-cadherin. Significance: Our results provide important insights into the molecular mechanisms mediating TGF-1-induced down-regulation of VE-cadherin and decreased cell invasion in human trophoblast cells. Human trophoblast cells express transforming growth factor- (TGF-) and TGF- receptors. It has been shown that TGF-1 treatment decreases the invasiveness of trophoblast cells. However, the molecular mechanisms underlying TGF-1-decreased trophoblast invasion are still not fully understood. In the current study, we demonstrated that treatment of HTR-8/SVneo human trophoblast cells with TGF-1 decreased cell invasion and down-regulated the expression of vascular endothelial cadherin (VE-cadherin). In addition, the inhibitory effect of TGF-1 on VE-cadherin was confirmed in primary cultures of human trophoblast cells. Moreover, knockdown of VE-cadherin using siRNA decreased the invasiveness of HTR-8/SVneo cells and primary cultures of trophoblast cells. Treatment with TGF-1 induced the activation of Smad-dependent signaling pathways and the expression of Snail and Slug. Knockdown of Smads attenuated TGF-1-induced up-regulation of Snail and Slug and down-regulation of VE-cadherin. Interestingly, depletion of Snail, but not Slug, attenuated TGF-1-induced down-regulation of VE-cadherin. Furthermore, overexpression of Snail suppressed VE-cadherin expression. Chromatin immunoprecipitation analyses showed the direct binding of Snail to the VE-cadherin promoter. These results provide evidence that Snail mediates TGF-1-induced down-regulation of VE-cadherin, which subsequently contributed to TGF-1-decreased trophoblast cell invasion.	[Cheng, Jung-Chien; Chang, Hsun-Ming; Leung, Peter C. K.] Univ British Columbia, Child & Family Res Inst, Dept Obstet & Gynaecol, Vancouver, BC V6H 3V5, Canada	Child & Family Research Institute; University of British Columbia	Leung, PCK (corresponding author), Rm 317,950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada.	peter.leung@ubc.ca	Chang, Hsun-Ming/M-8584-2018; Cheng, Jung-Chien/T-4258-2019	Cheng, Jung-Chien/0000-0002-5399-9327; Leung, Peter/0000-0003-3152-3800	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by an operating grant from the Canadian Institutes of Health Research (to P. C. K. L.).	Becker KF, 2007, CELLS TISSUES ORGANS, V185, P204, DOI 10.1159/000101321; Benian A, 2002, OBSTET GYNECOL, V100, P327, DOI 10.1016/S0029-7844(02)02077-X; Birdsey GM, 2008, BLOOD, V111, P3498, DOI 10.1182/blood-2007-08-105346; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Bottner M, 2000, J NEUROCHEM, V75, P2227, DOI 10.1046/j.1471-4159.2000.0752227.x; Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Chaddha Vandana, 2004, Semin Fetal Neonatal Med, V9, P357, DOI 10.1016/j.siny.2004.03.006; Chen Y, 2013, BIOCHEM BIOPH RES CO, V432, P116, DOI 10.1016/j.bbrc.2013.01.075; Deleuze V, 2007, MOL CELL BIOL, V27, P2687, DOI 10.1128/MCB.00493-06; Fritzmann J, 2009, GASTROENTEROLOGY, V137, P165, DOI 10.1053/j.gastro.2009.03.041; Gleeson LM, 2001, J CLIN ENDOCR METAB, V86, P2484, DOI 10.1210/jc.86.6.2484; Gory S, 1998, J BIOL CHEM, V273, P6750, DOI 10.1074/jbc.273.12.6750; GRAHAM CH, 1992, BIOL REPROD, V46, P561, DOI 10.1095/biolreprod46.4.561; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Graham CH, 1997, PLACENTA, V18, P137, DOI 10.1016/S0143-4004(97)90085-0; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; HOLTING T, 1994, J CLIN ENDOCR METAB, V79, P806, DOI 10.1210/jc.79.3.806; Humbert L, 2013, CELL SIGNAL, V25, P490, DOI 10.1016/j.cellsig.2012.10.011; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jones RL, 2006, REPRODUCTION, V132, P217, DOI 10.1530/rep.1.01076; Karmakar S, 2002, AM J REPROD IMMUNOL, V48, P210, DOI 10.1034/j.1600-0897.2002.01151.x; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433; Kokkinos MI, 2010, PLACENTA, V31, P747, DOI 10.1016/j.placenta.2010.06.017; KRIEGLSTEIN K, 1995, INT J DEV NEUROSCI, V13, P301, DOI 10.1016/0736-5748(94)00062-8; Lala N, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.097881; Lala PK, 2001, PLACENTA, V22, P889, DOI 10.1053/plac.2001.0736; Lash GE, 2005, BIOL REPROD, V73, P374, DOI 10.1095/biolreprod.105.040337; Le Guelte A, 2011, BIOL CELL, V103, P593, DOI 10.1042/BC20110069; Li HW, 2003, INT J GYNECOL PATHOL, V22, P63, DOI 10.1097/00004347-200301000-00013; Li ZD, 2011, ARTHRITIS RHEUM-US, V63, P2473, DOI 10.1002/art.30317; Lim J, 2012, DEVELOPMENT, V139, P3471, DOI 10.1242/dev.071209; Lim KH, 1997, AM J PATHOL, V151, P1809; Lopez D, 2009, ARCH BIOCHEM BIOPHYS, V482, P77, DOI 10.1016/j.abb.2008.11.016; Maroni D, 2011, J CELL SCI, V124, P2501, DOI 10.1242/jcs.084558; Meissner A, 1999, MOL HUM REPROD, V5, P252, DOI 10.1093/molehr/5.3.252; Muy-Rivera M, 2004, AM J HYPERTENS, V17, P334, DOI 10.1016/j.amjhyper.2003.12.010; Ng YH, 2012, ENDOCRINOLOGY, V153, P925, DOI 10.1210/en.2011-1488; Saitoh M, 2012, J BIOCHEM, V151, P563, DOI 10.1093/jb/mvs040; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Wang XM, 2011, GENE, V485, P160, DOI 10.1016/j.gene.2011.06.023; Ward ST, 2011, J CELL BIOCHEM, V112, P2966, DOI 10.1002/jcb.23215; Woo MMM, 2007, IN VITRO CELL DEV-AN, V43, P7, DOI 10.1007/s11626-006-9002-4; Xu GX, 2001, BIOCHEM BIOPH RES CO, V287, P47, DOI 10.1006/bbrc.2001.5533; Xuan YH, 2007, HISTOL HISTOPATHOL, V22, P227, DOI 10.14670/HH-22.227; Yang H, 2011, MED SCI MONITOR, V17, pBR55, DOI 10.12659/MSM.881439; Zhao MR, 2006, REPRODUCTION, V132, P333, DOI 10.1530/rep.1.01112; Zhou Y, 1997, J CLIN INVEST, V99, P2139, DOI 10.1172/JCI119387; Zhou Y, 1997, J CLIN INVEST, V99, P2152, DOI 10.1172/JCI119388	53	76	77	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33181	33192		10.1074/jbc.M113.488866	http://dx.doi.org/10.1074/jbc.M113.488866			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24106276	hybrid, Green Published			2022-12-25	WOS:000328841700033
J	Glineburg, MR; Chavez, A; Agrawal, V; Brill, SJ; Johnson, FB				Glineburg, M. Rebecca; Chavez, Alejandro; Agrawal, Vishesh; Brill, Steven J.; Johnson, F. Brad			Resolution by Unassisted Top3 Points to Template Switch Recombination Intermediates during DNA Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Damage; DNA Replication; DNA Topoisomerase; DNA Topology; Homologous Recombination; Holliday Junction; Rec-X; Sgs1; Template Switch Recombination; Top3	DOUBLE HOLLIDAY JUNCTIONS; TOPOISOMERASE III-ALPHA; STRAND BREAK REPAIR; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; IN-VIVO; SUBSTRATE-SPECIFICITY; HYPER-RECOMBINATION; GENOME INSTABILITY; ESCHERICHIA-COLI	Background: The Sgs1/Top3/Rmi1 (STR) complex resolves DNA linkages formed during replication of methyl methanesulfonate (MMS)-damaged templates. Results: Even without Sgs1 and Rmi1, Top3 can provide some resistance to MMS and resolve linkages that have recombination-dependent X-molecule (Rec-X) topology. Conclusion: Rec-Xs form during replication of MMS-damaged DNA. Significance: The findings provide novel insight into replication, STR function, and genome maintenance. The evolutionarily conserved Sgs1/Top3/Rmi1 (STR) complex plays vital roles in DNA replication and repair. One crucial activity of the complex is dissolution of toxic X-shaped recombination intermediates that accumulate during replication of damaged DNA. However, despite several years of study the nature of these X-shaped molecules remains debated. Here we use genetic approaches and two-dimensional gel electrophoresis of genomic DNA to show that Top3, unassisted by Sgs1 and Rmi1, has modest capacities to provide resistance to MMS and to resolve recombination-dependent X-shaped molecules. The X-shaped molecules have structural properties consistent with hemicatenane-related template switch recombination intermediates (Rec-Xs) but not Holliday junction (HJ) intermediates. Consistent with these findings, we demonstrate that purified Top3 can resolve a synthetic Rec-X but not a synthetic double HJ in vitro. We also find that unassisted Top3 does not affect crossing over during double strand break repair, which is known to involve double HJ intermediates, confirming that unassisted Top3 activities are restricted to substrates that are distinct from HJs. These data help illuminate the nature of the X-shaped molecules that accumulate during replication of damaged DNA templates, and also clarify the roles played by Top3 and the STR complex as a whole during the resolution of replication-associated recombination intermediates.	[Glineburg, M. Rebecca; Chavez, Alejandro; Agrawal, Vishesh; Johnson, F. Brad] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Glineburg, M. Rebecca; Chavez, Alejandro; Johnson, F. Brad] Univ Penn, Sch Med, Cell & Mol Biol Grp, Philadelphia, PA 19104 USA; [Chavez, Alejandro; Johnson, F. Brad] Univ Penn, Sch Med, Inst Aging, Philadelphia, PA 19104 USA; [Chavez, Alejandro; Brill, Steven J.] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Rutgers State University New Brunswick	Johnson, FB (corresponding author), Univ Penn, Stellar Chance Labs 405A, 422 Curie Blvd, Philadelphia, PA 19104 USA.	johnsonb@mail.med.upenn.edu			National Institutes of Health from the NCI [R25 CA101871];  [sT32-AG000255];  [R01-GM071268];  [R01-AG021521];  [P01-AG031862]; NATIONAL CANCER INSTITUTE [R25CA101871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000255, R01AG021521, P01AG031862] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R25 CA101871 from the NCI (to M. R. G.) and Grants sT32-AG000255 (to A. C.), R01-GM071268 (to S. J. B.), and R01-AG021521 and P01-AG031862 (to F. B. J.).	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Ashton TM, 2011, MOL CELL BIOL, V31, P1921, DOI 10.1128/MCB.01130-10; Ashton TM, 2010, DNA REPAIR, V9, P303, DOI 10.1016/j.dnarep.2009.12.007; Bachrati CZ, 2009, METHODS MOL BIOL, V582, P91, DOI 10.1007/978-1-60761-340-4_8; Bennett RJ, 2000, J BIOL CHEM, V275, P26898; Bennett RJ, 2001, P NATL ACAD SCI USA, V98, P11108, DOI 10.1073/pnas.201387098; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Bohr VA, 2008, TRENDS BIOCHEM SCI, V33, P609, DOI 10.1016/j.tibs.2008.09.003; Bolt EL, 2002, MOL CELL, V10, P187, DOI 10.1016/S1097-2765(02)00560-9; Branzei D, 2011, FEBS LETT, V585, P2810, DOI 10.1016/j.febslet.2011.04.053; Branzei D, 2008, NATURE, V456, P915, DOI 10.1038/nature07587; Bzymek M, 2010, NATURE, V464, P937, DOI 10.1038/nature08868; Cejka P, 2012, MOL CELL, V47, P886, DOI 10.1016/j.molcel.2012.06.032; Cejka P, 2010, NAT STRUCT MOL BIOL, V17, P1377, DOI 10.1038/nsmb.1919; Chakraverty RK, 2001, MOL CELL BIOL, V21, P7150, DOI 10.1128/MCB.21.21.7150-7162.2001; Chan SN, 1997, J BIOL CHEM, V272, P14873, DOI 10.1074/jbc.272.23.14873; Chang M, 2005, EMBO J, V24, P2024, DOI 10.1038/sj.emboj.7600684; Chavez A, 2011, J BIOL CHEM, V286, P5119, DOI 10.1074/jbc.M110.201608; Chavez A, 2010, J BIOL CHEM, V285, P11922, DOI 10.1074/jbc.M109.041277; Chen CF, 2007, J BIOL CHEM, V282, P28971, DOI 10.1074/jbc.M705427200; Chen YH, 2009, P NATL ACAD SCI USA, V106, P21252, DOI 10.1073/pnas.0908258106; Choi KY, 2010, MOL BIOL CELL, V21, P2306, DOI 10.1091/mbc.E10-01-0050; Fricke WM, 2005, DNA REPAIR, V4, P243, DOI 10.1016/j.dnarep.2004.10.001; Fricke WM, 2001, J BIOL CHEM, V276, P8848, DOI 10.1074/jbc.M009719200; Fritsch O, 2010, DNA REPAIR, V9, P879, DOI 10.1016/j.dnarep.2010.05.003; FU TJ, 1994, BIOCHEMISTRY-US, V33, P3896, DOI 10.1021/bi00179a015; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Gangloff S, 1999, EMBO J, V18, P1701, DOI 10.1093/emboj/18.6.1701; Hanai R, 1996, P NATL ACAD SCI USA, V93, P3653, DOI 10.1073/pnas.93.8.3653; Ip SCY, 2008, NATURE, V456, P357, DOI 10.1038/nature07470; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Kaliraman V, 2001, GENE DEV, V15, P2730, DOI 10.1101/gad.932201; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; KIM RA, 1992, J BIOL CHEM, V267, P17178; Koster DA, 2010, CELL, V142, P519, DOI 10.1016/j.cell.2010.08.001; Larsen NB, 2013, ADV EXP MED BIOL, V973, P161, DOI 10.1007/978-1-4614-5037-5_8; Lee JY, 2007, PLOS BIOL, V5, P1334, DOI 10.1371/journal.pbio.0050160; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Liberi G, 2006, METHOD ENZYMOL, V409, P442, DOI 10.1016/S0076-6879(05)09026-9; Liberi G, 2010, CELL RES, V20, P611, DOI 10.1038/cr.2010.73; Lopes M, 2003, MOL CELL, V12, P1499, DOI 10.1016/S1097-2765(03)00473-8; Lundin C, 2005, NUCLEIC ACIDS RES, V33, P3799, DOI 10.1093/nar/gki681; Mankouri HW, 2007, MOL BIOL CELL, V18, P4062, DOI 10.1091/mbc.E07-05-0490; Mankouri HW, 2006, MOL BIOL CELL, V17, P4473, DOI 10.1091/mbc.E06-06-0516; Mankouri HW, 2011, P NATL ACAD SCI USA, V108, P4944, DOI 10.1073/pnas.1014240108; Monnat RJ, 2010, SEMIN CANCER BIOL, V20, P329, DOI 10.1016/j.semcancer.2010.10.002; Mullen JR, 2005, MOL CELL BIOL, V25, P4476, DOI 10.1128/MCB.25.11.4476-4487.2005; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Onodera R, 2002, GENES GENET SYST, V77, P11, DOI 10.1266/ggs.77.11; Rass U, 2010, GENE DEV, V24, P1559, DOI 10.1101/gad.585310; Robert T, 2006, EMBO J, V25, P2837, DOI 10.1038/sj.emboj.7601158; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; Szakal B, 2013, EMBO J, V32, P1155, DOI 10.1038/emboj.2013.67; Tay YD, 2010, NUCLEIC ACIDS RES, V38, P1889, DOI 10.1093/nar/gkp1199; Ui A, 2001, MOL GENET GENOMICS, V265, P837, DOI 10.1007/s004380100479; Vanoli F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001205; Wagner M, 2006, GENETICS, V174, P555, DOI 10.1534/genetics.104.036905; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WATT PM, 1995, CELL, V81, P253, DOI 10.1016/0092-8674(95)90335-6; Whitby MC, 1996, J MOL BIOL, V264, P878, DOI 10.1006/jmbi.1996.0684; Wilson TM, 2000, J BIOL CHEM, V275, P1533, DOI 10.1074/jbc.275.3.1533; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Yang J, 2010, J BIOL CHEM, V285, P21426, DOI 10.1074/jbc.M110.123216	65	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33193	33204		10.1074/jbc.M113.496133	http://dx.doi.org/10.1074/jbc.M113.496133			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24100144	Green Published, hybrid			2022-12-25	WOS:000328841700034
J	Zippin, JH; Chen, YQ; Straub, SG; Hess, KC; Diaz, A; Lee, D; Tso, P; Holz, GG; Sharp, GWG; Levin, LR; Buck, J				Zippin, Jonathan H.; Chen, Yanqiu; Straub, Susanne G.; Hess, Kenneth C.; Diaz, Ana; Lee, Dana; Tso, Patrick; Holz, George G.; Sharp, Geoffrey W. G.; Levin, Lonny R.; Buck, Jochen			CO2/HCO3-- and Calcium-regulated Soluble Adenylyl Cyclase as a Physiological ATP Sensor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adenylate Cyclase (Adenylyl Cyclase); Cyclic AMP (cAMP); Glucose Metabolism; Metabolic Regulation; Pancreatic Islets	PANCREATIC BETA-CELLS; CYCLIC-AMP; INSULIN-SECRETION; CA2+ SENSOR; CAMP; GLUCOSE; BICARBONATE; PROTEIN; OSCILLATIONS; MITOCHONDRIA	Background: The affinity of soluble adenylyl cyclase (sAC) for its substrate ATP suggested that it might be sensitive to fluctuations in ATP. Results: In sAC-overexpressing and glucose-responsive cells, sAC-generated cAMP reflects intracellular ATP levels. Conclusion: sAC can be an ATP sensor inside cells. Significance: sAC serves as a metabolic sensor via regulation by three cellular metabolites: ATP, bicarbonate, and calcium. The second messenger molecule cAMP is integral for many physiological processes. In mammalian cells, cAMP can be generated from hormone- and G protein-regulated transmembrane adenylyl cyclases or via the widely expressed and structurally and biochemically distinct enzyme soluble adenylyl cyclase (sAC). sAC activity is uniquely stimulated by bicarbonate ions, and in cells, sAC functions as a physiological carbon dioxide, bicarbonate, and pH sensor. sAC activity is also stimulated by calcium, and its affinity for its substrate ATP suggests that it may be sensitive to physiologically relevant fluctuations in intracellular ATP. We demonstrate here that sAC can function as a cellular ATP sensor. In cells, sAC-generated cAMP reflects alterations in intracellular ATP that do not affect transmembrane AC-generated cAMP. In cells of the pancreas, glucose metabolism generates ATP, which corresponds to an increase in cAMP, and we show here that sAC is responsible for an ATP-dependent cAMP increase. Glucose metabolism also elicits insulin secretion, and we further show that sAC is necessary for normal glucose-stimulated insulin secretion in vitro and in vivo.	[Zippin, Jonathan H.; Chen, Yanqiu; Hess, Kenneth C.; Diaz, Ana; Levin, Lonny R.; Buck, Jochen] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Zippin, Jonathan H.] Cornell Univ, Weill Med Coll, Dept Dermatol, New York, NY 10065 USA; [Zippin, Jonathan H.] Cornell Univ, Weill Med Coll, Triinst MD PhD Program, New York, NY 10065 USA; [Straub, Susanne G.; Sharp, Geoffrey W. G.] Cornell Univ, Dept Mol Med, Coll Vet Med, Ithaca, NY 14853 USA; [Lee, Dana; Tso, Patrick] Univ Cincinnati, Metab Dis Inst, Dept Pathol & Lab Med, Cincinnati, OH 45237 USA; [Holz, George G.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA	Cornell University; Cornell University; Cornell University; Cornell University; University System of Ohio; University of Cincinnati; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Levin, LR (corresponding author), Cornell Univ, Weill Med Coll, Dept Pharmacol, 1300 York Ave, New York, NY 10065 USA.	llevin@med.cornell.edu	Hess, Kenneth/K-6546-2019; Levin, Lonny R/A-7215-2011; Holz, George G/A-3386-2012	Hess, Kenneth/0000-0003-1377-6070; Levin, Lonny/0000-0002-5204-6356; Holz, George/0000-0002-1781-3580	National Institutes of Health [GM62328, HD059913]; American Diabetes Association; Tri-Institutional Medical Scientist Training Program; Dermatology Foundation; La Roche-Posay; Woman's Dermatological Society; American Skin Association; Barbara and Stephen Friedman fellowship; University of Cincinnati Mouse Metabolic Phenotyping Center [U24 DK059630]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059913] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K08CA160657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059630, R01DK069575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Tri-Institutional Medical Scientist Training Program; Dermatology Foundation; La Roche-Posay; Woman's Dermatological Society; American Skin Association; Barbara and Stephen Friedman fellowship; University of Cincinnati Mouse Metabolic Phenotyping Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM62328 and HD059913 (to L. R. L. and J. B.). This work was also supported by the American Diabetes Association (to L. R. L.); by the Tri-Institutional Medical Scientist Training Program, the Dermatology Foundation, La Roche-Posay, the Woman's Dermatological Society, the American Skin Association, and a Barbara and Stephen Friedman fellowship (to J. H. Z.); and by University of Cincinnati Mouse Metabolic Phenotyping Center Grant U24 DK059630 (to D. L. and P. T.). Drs. Zippin, Buck, and Levin own equity interest in CEP Biotech, which has licensed commercialization of a panel of monoclonal antibodies directed against sAC.	Acin-Perez R, 2011, CELL METAB, V13, P712, DOI 10.1016/j.cmet.2011.03.024; Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; AMMALA C, 1993, NATURE, V363, P356, DOI 10.1038/363356a0; Antinozzi PA, 2002, J BIOL CHEM, V277, P11746, DOI 10.1074/jbc.M108462200; Bitterman J. L., 2013, J PHARM EXP THER, DOI 10.1124/jpet.113.208496; BRAUN T, 1975, J CYCLIC NUCL PROT, V1, P271; BRAUN T, 1991, METHOD ENZYMOL, V195, P130; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; CHARLES MA, 1975, J BIOL CHEM, V250, P6134; CHARLES MA, 1973, SCIENCE, V179, P569, DOI 10.1126/science.179.4073.569; Chen J, 2013, BRAIN RES, V1518, P1, DOI 10.1016/j.brainres.2013.04.027; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Choi HB, 2012, NEURON, V75, P1094, DOI 10.1016/j.neuron.2012.08.032; Di Benedetto G, 2013, CELL METAB, V17, P965, DOI 10.1016/j.cmet.2013.05.003; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Dyachok O, 2008, CELL METAB, V8, P26, DOI 10.1016/j.cmet.2008.06.003; Esposito G, 2004, P NATL ACAD SCI USA, V101, P2993, DOI 10.1073/pnas.0400050101; Fujimoto K, 2002, J BIOL CHEM, V277, P50497, DOI 10.1074/jbc.M210146200; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; HERBERT V, 1965, J CLIN ENDOCR METAB, V25, P1375, DOI 10.1210/jcem-25-10-1375; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Holz GG, 2004, DIABETES, V53, P5, DOI 10.2337/diabetes.53.1.5; Jaiswal BS, 2003, P NATL ACAD SCI USA, V100, P10676, DOI 10.1073/pnas.1831008100; Jaiswal BS, 2001, J BIOL CHEM, V276, P31698, DOI 10.1074/jbc.M011698200; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Kamenetsky M, 2006, J MOL BIOL, V362, P623, DOI 10.1016/j.jmb.2006.07.045; Kang GX, 2003, J BIOL CHEM, V278, P8279, DOI 10.1074/jbc.M211682200; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Lee YS, 2011, J BIOL CHEM, V286, P41353, DOI 10.1074/jbc.M111.284679; Lefkimmiatis K, 2013, J CELL BIOL, V202, P453, DOI 10.1083/jcb.201303159; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Neer E J, 1978, Adv Cyclic Nucleotide Res, V9, P69; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Parkkila AK, 1998, J BIOL CHEM, V273, P24620, DOI 10.1074/jbc.273.38.24620; Pastor-Soler N, 2003, J BIOL CHEM, V278, P49523, DOI 10.1074/jbc.M309543200; Paunescu TG, 2008, AM J PHYSIOL-RENAL, V294, pF130, DOI 10.1152/ajprenal.00406.2007; Paunescu TG, 2010, AM J PHYSIOL-RENAL, V298, pF643, DOI 10.1152/ajprenal.00584.2009; Ramos LS, 2008, J GEN PHYSIOL, V132, P329, DOI 10.1085/jgp.200810044; Renstrom E, 1997, J PHYSIOL-LONDON, V502, P105, DOI 10.1111/j.1469-7793.1997.105bl.x; Ruiz-Stewart I, 2004, P NATL ACAD SCI USA, V101, P37, DOI 10.1073/pnas.0305080101; Rutter Guy A., 2001, Molecular Aspects of Medicine, V22, P247, DOI 10.1016/S0098-2997(01)00013-9; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; Shibasaki T, 2004, J BIOL CHEM, V279, P7956, DOI 10.1074/jbc.M309068200; Steegborn C, 2005, J BIOL CHEM, V280, P31754, DOI 10.1074/jbc.M507144200; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Tengholm A, 2012, UPSALA J MED SCI, V117, P355, DOI 10.3109/03009734.2012.724732; Tian G, 2011, DIABETES, V60, P1535, DOI 10.2337/db10-1087; Tinsley FC, 2004, OBES RES, V12, P150, DOI 10.1038/oby.2004.20; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Tresguerres M, 2010, PFLUG ARCH EUR J PHY, V460, P953, DOI 10.1007/s00424-010-0865-6; Wu KY, 2006, NAT NEUROSCI, V9, P1257, DOI 10.1038/nn1767; Zippin JH, 2004, J CELL BIOL, V164, P527, DOI 10.1083/jcb.200311119; Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje; Zippin JH, 2001, TRENDS ENDOCRIN MET, V12, P366, DOI 10.1016/S1043-2760(01)00454-4	55	81	82	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33283	33291		10.1074/jbc.M113.510073	http://dx.doi.org/10.1074/jbc.M113.510073			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24100033	hybrid, Green Published			2022-12-25	WOS:000328841700042
J	Alvarez-Perez, S; de Vega, C; Herrera, CM				Alvarez-Perez, Sergio; de Vega, Clara; Herrera, Carlos M.			Multilocus Sequence Analysis of Nectar Pseudomonads Reveals High Genetic Diversity and Contrasting Recombination Patterns	PLOS ONE			English	Article							FLORAL NECTAR; MAXIMUM-LIKELIHOOD; SP NOV.; MOSAIC STRUCTURE; FIRE BLIGHT; ECOLOGY; YEASTS; COMMUNITIES; CLONALITY; FLOWERS	The genetic and evolutionary relationships among floral nectar-dwelling Pseudomonas 'sensu stricto' isolates associated to South African and Mediterranean plants were investigated by multilocus sequence analysis (MLSA) of four core housekeeping genes (rrs, gyrB, rpoB and rpoD). A total of 35 different sequence types were found for the 38 nectar bacterial isolates characterised. Phylogenetic analyses resulted in the identification of three main clades [nectar groups (NGs) 1, 2 and 3] of nectar pseudomonads, which were closely related to five intrageneric groups: Pseudomonas oryzihabitans (NG 1); P. fluorescens, P. lutea and P. syringae (NG 2); and P. rhizosphaerae (NG 3). Linkage disequilibrium analysis pointed to a mostly clonal population structure, even when the analysis was restricted to isolates from the same floristic region or belonging to the same NG. Nevertheless, signatures of recombination were observed for NG 3, which exclusively included isolates retrieved from the floral nectar of insect-pollinated Mediterranean plants. In contrast, the other two NGs comprised both South African and Mediterranean isolates. Analyses relating diversification to floristic region and pollinator type revealed that there has been more unique evolution of the nectar pseudomonads within the Mediterranean region than would be expected by chance. This is the first work analysing the sequence of multiple loci to reveal geno- and ecotypes of nectar bacteria.	[Alvarez-Perez, Sergio; de Vega, Clara; Herrera, Carlos M.] CSIC, Estn Biol Donana, E-41080 Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Alvarez-Perez, S (corresponding author), Hosp Gen Univ Gregorio Maranon, Dept Clin Microbiol & Infect Dis, Madrid, Spain.	sealperez@gmail.com	Herrera, Carlos/AAS-3831-2020; Álvarez-Pérez, Sergio/H-6342-2019; Herrera, Carlos M/A-4088-2008; de Vega, Clara/AAQ-8839-2021; de Vega, Clara/A-5822-2012; Álvarez-Pérez, Sergio/J-5737-2016	Herrera, Carlos/0000-0003-2452-3888; Álvarez-Pérez, Sergio/0000-0002-6587-8995; Herrera, Carlos M/0000-0003-2452-3888; de Vega, Clara/0000-0003-4553-798X; de Vega, Clara/0000-0003-4553-798X; Álvarez-Pérez, Sergio/0000-0002-6587-8995	Ministerio de Ciencia e Innovacion; Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia (Proyecto de Excelencia) [P09-RNM- 4517]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia (Proyecto de Excelencia)(Junta de Andalucia)	This work was supported by funds from Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia (Proyecto de Excelencia P09-RNM- 4517 to C. M. H.), and Ministerio de Ciencia e Innovacion (Juan de la Cierva Program to C.dV.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Adler LS, 2000, OIKOS, V91, P409, DOI 10.1034/j.1600-0706.2000.910301.x; Alvarez-Perez S, 2013, INT J SYST EVOL MICR, V63, P1532, DOI 10.1099/ijs.0.043489-0; Alvarez-Perez S, 2013, FEMS MICROBIOL ECOL, V83, P685, DOI 10.1111/1574-6941.12027; Alvarez-Perez S, 2012, FEMS MICROBIOL ECOL, V80, P591, DOI 10.1111/j.1574-6941.2012.01329.x; Andrews JH, 2000, ANNU REV PHYTOPATHOL, V38, P145, DOI 10.1146/annurev.phyto.38.1.145; BEATTIE GA, 1995, ANNU REV PHYTOPATHOL, V33, P145, DOI 10.1146/annurev.py.33.090195.001045; Belisle M, 2012, MICROB ECOL, V63, P711, DOI 10.1007/s00248-011-9975-8; Bodilis J, 2011, MOL BIOL EVOL, V28, P2723, DOI 10.1093/molbev/msr099; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Brysch-Herzberg M, 2004, FEMS MICROBIOL ECOL, V50, P87, DOI 10.1016/j.femsec.2004.06.003; Campbell LT, 2005, EUKARYOT CELL, V4, P1403, DOI 10.1128/EC.4.8.1403-1409.2005; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cladera AM, 2004, J BACTERIOL, V186, P5239, DOI 10.1128/JB.186.16.5239-5248.2004; Coenye T, 2003, MICROBIOL-SGM, V149, P77, DOI 10.1099/mic.0.25850-0; Cohan FM, 2006, PHILOS T R SOC B, V361, P1985, DOI 10.1098/rstb.2006.1918; de Vega C, 2013, AM J BOT, V100, P792, DOI 10.3732/ajb.1200626; de Vega C, 2012, OIKOS, V121, P1878, DOI 10.1111/j.1600-0706.2012.20295.x; de Vega C, 2012, INT J SYST EVOL MICR, V62, P2538, DOI 10.1099/ijs.0.040790-0; de Vega C, 2009, S AFR J BOT, V75, P798, DOI 10.1016/j.sajb.2009.07.016; den Bakker HC, 2010, MOL BIOL EVOL, V27, P2474, DOI 10.1093/molbev/msq155; DEVOS P, 1989, INT J SYST BACTERIOL, V39, P35, DOI 10.1099/00207713-39-1-35; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Escalante-Perez M, 2012, PROGR BOT, V74, P239; Farkas A, 2012, TREES-STRUCT FUNCT, V26, P47, DOI 10.1007/s00468-011-0627-x; Frapolli M, 2007, ENVIRON MICROBIOL, V9, P1939, DOI 10.1111/j.1462-2920.2007.01310.x; Frapolli M, 2012, MOL PHYLOGENET EVOL, V63, P877, DOI 10.1016/j.ympev.2012.02.030; Fridman S, 2012, ENV MICROBIOL REP, V4, P97, DOI 10.1111/j.1758-2229.2011.00309.x; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Gimenez-Jurado G, 2003, INT J SYST EVOL MICR, V53, P1665, DOI 10.1099/ijs.0.02470-0; Gonzalez-Teuber M, 2009, PLANT SIGNAL BEHAV, V4, P809, DOI 10.4161/psb.4.9.9393; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hao Weilong, 2013, Mob Genet Elements, V3, pe23463; Hasiow-Jaroszewska B, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-318; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Heil M, 2011, TRENDS PLANT SCI, V16, P191, DOI 10.1016/j.tplants.2011.01.003; Herrera CM, 2011, MOL ECOL, V20, P4395, DOI 10.1111/j.1365-294X.2011.05217.x; Herrera CM, 2008, ECOLOGY, V89, P2369, DOI 10.1890/08-0241.1; Herrera CM, 2013, ECOLOGY, V94, P273, DOI 10.1890/12-0595.1; Herrera CM, 2010, P ROY SOC B-BIOL SCI, V277, P1827, DOI 10.1098/rspb.2009.2252; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Jacquemyn H, 2013, MICROBIOLOGYOPEN, V2, P644, DOI 10.1002/mbo3.103; Jacquemyn H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056917; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Jukes T. H, 1969, MAMMALIAN PROTEIN ME, P21, DOI DOI 10.1093/BIOINFORMATICS/BTM404; Kassen R, 2004, ANNU REV MICROBIOL, V58, P207, DOI 10.1146/annurev.micro.58.030603.123654; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; KINKEL LL, 1987, OECOLOGIA, V71, P405, DOI 10.1007/BF00378714; Lau JA, 2011, NEW PHYTOL, V192, P215, DOI 10.1111/j.1469-8137.2011.03790.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Manson JS, 2007, ANTON LEEUW INT J G, V92, P37, DOI 10.1007/s10482-006-9132-4; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; McVean G, 2002, GENETICS, V160, P1231; Mercado-Blanco J, 2007, ANTON LEEUW INT J G, V92, P367, DOI 10.1007/s10482-007-9167-1; Mithani A, 2011, MOL BIOL EVOL, V28, P483, DOI 10.1093/molbev/msq213; Moore ERB, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P646, DOI 10.1007/0-387-30746-x_21; Mulet M, 2010, ENVIRON MICROBIOL, V12, P1513, DOI 10.1111/j.1462-2920.2010.02181.x; Nei M, 1987, MOL EVOLUTIONARY GEN; Nicolson Susan W., 2007, P215, DOI 10.1007/978-1-4020-5937-7_5; Octavia S, 2006, MICROBIOL-SGM, V152, P1099, DOI 10.1099/mic.0.28486-0; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Peay KG, 2012, P ROY SOC B-BIOL SCI, V279, P749, DOI 10.1098/rspb.2011.1230; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pozo MI, 2012, FEMS MICROBIOL ECOL, V80, P281, DOI 10.1111/j.1574-6941.2011.01286.x; Pozo MI, 2011, MICROB ECOL, V61, P82, DOI 10.1007/s00248-010-9682-x; Pusey PL, 1999, PHYTOPATHOLOGY, V89, P39, DOI 10.1094/PHYTO.1999.89.1.39; Rainey PB, 1999, ENVIRON MICROBIOL, V1, P243, DOI 10.1046/j.1462-2920.1999.00040.x; Reynolds HL, 2003, ECOLOGY, V84, P2281, DOI 10.1890/02-0298; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ryss AY, 2011, ENTOMOLOGICAL REV, V91, P908; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sarkar SF, 2004, APPL ENVIRON MICROB, V70, P1999, DOI 10.1128/AEM.70.4.1999-2012.2004; Sasu MA, 2010, AM J BOT, V97, P1025, DOI 10.3732/ajb.0900381; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Silby MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/j.1574-6976.2011.00269.x; SMITH JM, 1992, J MOL EVOL, V34, P126; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Sorokin A, 2006, APPL ENVIRON MICROB, V72, P1569, DOI 10.1128/AEM.72.2.1569-1578.2006; Spiers AJ, 2000, MICROBIOL-SGM, V146, P2345, DOI 10.1099/00221287-146-10-2345; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Stackebrandt E., 2006, MICROBIOL TODAY, V33, P152; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vannette RL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2601; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Whipps JM, 2008, J APPL MICROBIOL, V105, P1744, DOI 10.1111/j.1365-2672.2008.03906.x; Wicker E, 2012, ISME J, V6, P961, DOI 10.1038/ismej.2011.160; Zhao BG, 2005, FOREST PATHOL, V35, P339, DOI 10.1111/j.1439-0329.2005.00417.x	98	19	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75797	10.1371/journal.pone.0075797	http://dx.doi.org/10.1371/journal.pone.0075797			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116076	Green Submitted, gold, Green Published			2022-12-25	WOS:000325552200039
J	Maaswinkel, H; Zhu, LQ; Weng, W				Maaswinkel, Hans; Zhu, Liqun; Weng, Wei			Assessing Social Engagement in Heterogeneous Groups of Zebrafish: A New Paradigm for Autism-Like Behavioral Responses	PLOS ONE			English	Article							DANIO-RERIO; CIRCLING BEHAVIOR; NEGATIVE SYMPTOMS; MK-801; ANTAGONIST; BUSPIRONE; MODEL; RATS; SCHIZOPHRENIA; DISRUPTION	Because of its highly developed social character, zebrafish is a promising model system for the study of the genetic and neurochemical basis of altered social engagement such as is common in autism and schizophrenia. The traditional shoaling paradigm investigates social cohesion in homogeneous groups of zebrafish. However, the social dynamics of mixed groups is gaining interest from a therapeutic point of view and thus warrants animal modeling. Furthermore, mutant zebrafish are not always available in large numbers. Therefore, we developed a new paradigm that allows exploring shoaling in heterogeneous groups. The effects of MK-801, a non-competitive antagonist of the glutamate N-methyl-D-aspartate (NMDA) receptor, on social cohesion were studied to evaluate the paradigm. The drug has previously been shown to mimic aspects of autism and schizophrenia. Our results show that a single MK-801-treated zebrafish reduced social cohesion of the entire shoal drastically. Preliminary observations suggest that the social dynamics of the shoal as a whole was altered.	[Maaswinkel, Hans; Zhu, Liqun; Weng, Wei] XyZfish, Res & Dev, Ronkonkoma, NY USA		Maaswinkel, H (corresponding author), XyZfish, Res & Dev, Ronkonkoma, NY USA.	hmaaswinkel@xyzfish.com	Zhu, Li/GXH-9801-2022					Akillioglu K, 2012, BEHAV BRAIN RES, V233, P157, DOI 10.1016/j.bbr.2012.04.041; Blaser RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036931; Brosda J, 2011, PHARMACOL BIOCHEM BE, V99, P22, DOI 10.1016/j.pbb.2011.03.017; Burket JA, 2010, BRAIN RES BULL, V83, P337, DOI 10.1016/j.brainresbull.2010.08.014; Champagne DL, 2010, BEHAV BRAIN RES, V214, P332, DOI 10.1016/j.bbr.2010.06.001; Chen John, 2010, Int J Comp Psychol, V23, P82; CHIVERS DP, 1995, CAN J ZOOL, V73, P955, DOI 10.1139/z95-111; Cognato GD, 2012, NEUROBIOL LEARN MEM, V98, P321, DOI 10.1016/j.nlm.2012.09.008; CoussiKorbel S, 1995, ANIM BEHAV, V50, P1441, DOI 10.1016/0003-3472(95)80001-8; Darrow KO, 2004, ZEBRAFISH, V1, P40, DOI 10.1089/154585404774101662; Dvorkin A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000638; Echevarria DJ., 2008, INT J COMP PSYCHOL, V21, P19; Engeszer RE, 2004, CURR BIOL, V14, P881, DOI 10.1016/j.cub.2004.04.042; Gebauer DL, 2011, PHARMACOL BIOCHEM BE, V99, P480, DOI 10.1016/j.pbb.2011.04.021; Gogolla N, 2009, J NEURODEV DISORD, V1, P172, DOI 10.1007/s11689-009-9023-x; Green J, 2012, J NEUROSCI METH, V210, P266, DOI 10.1016/j.jneumeth.2012.07.017; Gururajan A, 2012, J PSYCHOPHARMACOL, V26, P1317, DOI 10.1177/0269881112441865; Horder J, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.53; Krause J, 1999, ANIM BEHAV, V57, P771, DOI 10.1006/anbe.1998.1010; Lindeyer CM, 2010, ANIM BEHAV, V79, P827, DOI 10.1016/j.anbehav.2009.12.024; Maaswinkel H, JOVE IN PRESS; Maaswinkel H, 2013, PHARMACOL BIOCHEM BE, V108, P16, DOI 10.1016/j.pbb.2013.04.009; Maaswinkel H, 2012, BEHAV BRAIN RES, V234, P365, DOI 10.1016/j.bbr.2012.07.014; Maskey M, 2013, J AUTISM DEV DISORD, V43, P851, DOI 10.1007/s10803-012-1622-9; Mathur P, 2010, NEUROBIOL DIS, V40, P66, DOI 10.1016/j.nbd.2010.05.016; Matson JL, 2009, DEV NEUROREHABIL, V12, P122, DOI 10.1080/17518420902936730; Miller NY, 2011, REV NEUROSCIENCE, V22, P17, DOI 10.1515/RNS.2011.004; Moy SS, 2013, NEUROTOXICOL TERATOL, V36, P36, DOI 10.1016/j.ntt.2012.07.007; Neill JC, 2010, PHARMACOL THERAPEUT, V128, P419, DOI 10.1016/j.pharmthera.2010.07.004; Ng MC, 2012, FISH PHYSIOL BIOCHEM, V38, P1099, DOI 10.1007/s10695-011-9595-8; O'Haire ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057010; Paull GC, 2010, ZEBRAFISH, V7, P109, DOI 10.1089/zeb.2009.0618; Philpott C, 2012, ZEBRAFISH, V9, P191, DOI 10.1089/zeb.2012.0764; Rosemberg DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019397; Rung JP, 2005, PROG NEURO-PSYCHOPH, V29, P827, DOI 10.1016/j.pnpbp.2005.03.004; Saunders JA, 2012, BEHAV BRAIN RES, V234, P233, DOI 10.1016/j.bbr.2012.06.032; Seibt KJ, 2011, BEHAV BRAIN RES, V224, P135, DOI 10.1016/j.bbr.2011.05.034; Sison M, 2011, NEUROBIOL LEARN MEM, V96, P230, DOI 10.1016/j.nlm.2011.04.016; Sison M, 2011, BEHAV BRAIN RES, V220, P331, DOI 10.1016/j.bbr.2011.02.019; Snekser JL., 2010, INT J COMP PSYCHOL, V23, P70; Solomon R, 2007, AUTISM, V11, P205, DOI 10.1177/1362361307076842; Speedie N, 2008, BEHAV BRAIN RES, V188, P168, DOI 10.1016/j.bbr.2007.10.031; Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x; Stewart A, 2010, BEHAV PROCESS, V85, P198, DOI 10.1016/j.beproc.2010.07.009; Swain HA, 2004, NEUROTOXICOL TERATOL, V26, P725, DOI 10.1016/j.ntt.2004.06.009; Tropepe V, 2003, GENES BRAIN BEHAV, V2, P268, DOI 10.1034/j.1601-183X.2003.00038.x; Vital C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055503; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; White SW, 2009, CLIN PSYCHOL REV, V29, P216, DOI 10.1016/j.cpr.2009.01.003; Zhu L., 2012, US Patent, Patent No. [8,306,260, 8306260]; Zhu LQ, 2007, PHYSIOL BEHAV, V91, P106, DOI 10.1016/j.physbeh.2007.01.023	51	38	39	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75955	10.1371/journal.pone.0075955	http://dx.doi.org/10.1371/journal.pone.0075955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116082	Green Submitted, Green Published, gold			2022-12-25	WOS:000325552200044
J	Raghavan, M; Amrutur, B; Narayanan, R; Sikdar, SK				Raghavan, Mohan; Amrutur, Bharadwaj; Narayanan, Rishikesh; Sikdar, Sujit Kumar			Synconset Waves and Chains: Spiking Onsets in Synchronous Populations Predict and Are Predicted by Network Structure	PLOS ONE			English	Article							GAMMA-OSCILLATIONS; NEURONAL ENSEMBLES; SENSORY RESPONSES; CORTICAL-NEURONS; IN-VIVO; CORTEX; MECHANISMS; DYNAMICS; RHYTHM; SYNCHRONIZATION	Synfire waves are propagating spike packets in synfire chains, which are feedforward chains embedded in random networks. Although synfire waves have proved to be effective quantification for network activity with clear relations to network structure, their utilities are largely limited to feedforward networks with low background activity. To overcome these shortcomings, we describe a novel generalisation of synfire waves, and define 'synconset wave' as a cascade of first spikes within a synchronisation event. Synconset waves would occur in 'synconset chains', which are feedforward chains embedded in possibly heavily recurrent networks with heavy background activity. We probed the utility of synconset waves using simulation of single compartment neuron network models with biophysically realistic conductances, and demonstrated that the spread of synconset waves directly follows from the network connectivity matrix and is modulated by top-down inputs and the resultant oscillations. Such synconset profiles lend intuitive insights into network organisation in terms of connection probabilities between various network regions rather than an adjacency matrix. To test this intuition, we develop a Bayesian likelihood function that quantifies the probability that an observed synfire wave was caused by a given network. Further, we demonstrate it's utility in the inverse problem of identifying the network that caused a given synfire wave. This method was effective even in highly subsampled networks where only a small subset of neurons were accessible, thus showing it's utility in experimental estimation of connectomes in real neuronal-networks. Together, we propose synconset chains/waves as an effective framework for understanding the impact of network structure on function, and as a step towards developing physiology-driven network identification methods. Finally, as synconset chains extend the utilities of synfire chains to arbitrary networks, we suggest utilities of our framework to several aspects of network physiology including cell assemblies, population codes, and oscillatory synchrony.	[Raghavan, Mohan; Amrutur, Bharadwaj] Indian Inst Sci, Dept Elect Commun Engn, Bangalore 560012, Karnataka, India; [Narayanan, Rishikesh; Sikdar, Sujit Kumar] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Raghavan, M (corresponding author), Indian Inst Sci, Dept Elect Commun Engn, Bangalore 560012, Karnataka, India.	mohanr@ece.iisc.ernet.in	Narayanan, Rishikesh/C-3191-2009; Raghavan, Mohan/Y-8624-2019	Raghavan, Mohan/0000-0002-9196-8193; Narayanan, Rishikesh/0000-0002-1362-4635	MCIT (Ministry of Communication & Information Technology, Government of India) under project Centre for Excellence in Nanoelectronics - Phase II", Aeronautics and Research Development Board [DARO/08/2021551/M/I DTD 31/05/2010]; Department of Science and Technology, Mathematical Biology program at Indian Institute of Science (IISc) [SR/S4/MS419/07]	MCIT (Ministry of Communication & Information Technology, Government of India) under project Centre for Excellence in Nanoelectronics - Phase II", Aeronautics and Research Development Board; Department of Science and Technology, Mathematical Biology program at Indian Institute of Science (IISc)	The research was supported by grants from the MCIT (Ministry of Communication & Information Technology, Government of India) under the project Centre for Excellence in Nanoelectronics - Phase II", Aeronautics and Research Development Board (DARO/08/2021551/M/I DTD 31/05/2010) and Department of Science and Technology, Mathematical Biology program at Indian Institute of Science (IISc) (SR/S4/MS419/07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assisi C, 2011, NEURON, V69, P373, DOI 10.1016/j.neuron.2010.12.019; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Aviel Y, 2002, NEUROCOMPUTING, V44, P285, DOI 10.1016/S0925-2312(02)00352-1; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Bosking WH, 1997, J NEUROSCI, V17, P2112; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Buzsaki G., 2009, RHYTHMS BRAIN, DOI [10.1093/acprof:oso/9780195301069.001.0001, DOI 10.1093/ACPROF:OSO/9780195301069.001.0001]; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Denk W, 2012, NAT REV NEUROSCI, V13, P351, DOI 10.1038/nrn3169; Eytan D, 2006, J NEUROSCI, V26, P8465, DOI 10.1523/JNEUROSCI.1627-06.2006; Gerhard Felipe, 2011, FRONTIERS COMPUTATIO, V5; Gilbert CD, 1996, P NATL ACAD SCI USA, V93, P615, DOI 10.1073/pnas.93.2.615; Gloveli T, 2005, P NATL ACAD SCI USA, V102, P13295, DOI 10.1073/pnas.0506259102; Havenith MN, 2011, J NEUROSCI, V31, P8570, DOI 10.1523/JNEUROSCI.2817-10.2011; Heil P, 1997, J NEUROPHYSIOL, V78, P2438, DOI 10.1152/jn.1997.78.5.2438; HERRMANN M, 1995, NETWORK-COMP NEURAL, V6, P403, DOI 10.1088/0954-898X/6/3/006; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Lee AK, 2004, J NEUROPHYSIOL, V92, P2555, DOI 10.1152/jn.01030.2003; Lee SH, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016102; Lisman J, 2008, SCHIZOPHRENIA BULL, V34, P974, DOI 10.1093/schbul/sbn060; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; MIGLIORE M, 1995, J NEUROPHYSIOL, V73, P1157, DOI 10.1152/jn.1995.73.3.1157; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; PALM G, 1988, BIOL CYBERN, V59, P1, DOI 10.1007/BF00336885; Panzeri S, 2001, NEURON, V29, P769, DOI 10.1016/S0896-6273(01)00251-3; Patnaik D, 2008, SCI PROGRAMMING-NETH, V16, P49, DOI [10.1155/2008/324626, 10.3233/SPR-2008-0242]; Raghavan M, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/5/056002; Raichman N, 2008, J NEUROSCI METH, V170, P96, DOI 10.1016/j.jneumeth.2007.12.020; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Shteingart H, 2010, FRONTIERS COMPUTATIO; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Srinivas KV, 2007, EUR J NEUROSCI, V25, P3276, DOI 10.1111/j.1460-9568.2007.05559.x; Stumpf MPH, 2005, P NATL ACAD SCI USA, V102, P4221, DOI 10.1073/pnas.0501179102; Takano H, 2012, J NEUROSCI, V32, P4743, DOI 10.1523/JNEUROSCI.4277-11.2012; Tiesinga P, 2008, NAT REV NEUROSCI, V9, P97, DOI 10.1038/nrn2315; Trengove C, 2012, J COMPUTATIONAL NEUR, P1; Uhlhaas PJ, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.017.2009; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	53	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e74910	10.1371/journal.pone.0074910	http://dx.doi.org/10.1371/journal.pone.0074910			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116018	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000325552200005
J	Mendivelso, HA; Camarero, JJ; Obregon, OR; Gutierrez, E; Toledo, M				Mendivelso, Hooz A.; Julio Camarero, J.; Royo Obregon, Oriol; Gutierrez, Emilia; Toledo, Marisol			Differential Growth Responses to Water Balance of Coexisting Deciduous Tree Species Are Linked to Wood Density in a Bolivian Tropical Dry Forest	PLOS ONE			English	Article							SEASONAL-VARIATION; LIFE-HISTORY; CANOPY TREES; PHENOLOGY; TRAITS; RATES; SOIL; CLIMATE; PERIODICITY; DIVERSITY	A seasonal period of water deficit characterizes tropical dry forests (TDFs). There, sympatric tree species exhibit a diversity of growth rates, functional traits, and responses to drought, suggesting that each species may possess different strategies to grow under different conditions of water availability. The evaluation of the long-term growth responses to changes in the soil water balance should provide an understanding of how and when coexisting tree species respond to water deficit in TDFs. Furthermore, such differential growth responses may be linked to functional traits related to water storage and conductance. We used dendrochronology and climate data to retrospectively assess how the radial growth of seven coexisting deciduous tree species responded to the seasonal soil water balance in a Bolivian TDF. Linear mixed-effects models were used to quantify the relationships between basal area increment and seasonal water balance. We related these relationships with wood density and sapwood production to assess if they affect the growth responses to climate. The growth of all species responded positively to water balance during the wet season, but such responses differed among species as a function of their wood density. For instance, species with a strong growth response to water availability averaged a low wood density which may facilitate the storage of water in the stem. By contrast, species with very dense wood were those whose growth was less sensitive to water availability. Coexisting tree species thus show differential growth responses to changes in soil water balance during the wet season. Our findings also provide a link between wood density, a trait related to the ability of trees to store water in the stem, and wood formation in response to water availability.	[Mendivelso, Hooz A.; Toledo, Marisol] Univ Autonoma Gabriel Rene Moreno, IBIF, Santa Cruz, Bolivia; [Mendivelso, Hooz A.; Julio Camarero, J.; Royo Obregon, Oriol] Inst Pirenaico Ecol CSIC, Zaragoza, Spain; [Julio Camarero, J.] Inst Pirenaico Ecol CSIC, ARAID, Zaragoza, Spain; [Julio Camarero, J.; Gutierrez, Emilia] Univ Barcelona, Dept Ecol, E-08028 Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); University of Barcelona	Camarero, JJ (corresponding author), Inst Pirenaico Ecol CSIC, Zaragoza, Spain.	jjcamarero@ipe.csic.es	Gutierrez, Emilia/O-7568-2014; Camarero, J. Julio/A-8602-2013	Gutierrez, Emilia/0000-0002-6085-5700; Camarero, J. Julio/0000-0003-2436-2922	BBVA Foundation; AECID [11-CAP2-1730]	BBVA Foundation(BBVA Foundation); AECID	This project was funded by BBVA Foundation project "Analisis retrospectivos mediante dendrocronologia para profundizar en la ecologia y mejorar la gestion de los bosques tropicales secos (Dentropicas)'' and AECID project "Regeneracion, crecimiento y modelos dinamicos de bosques tropicales secos: herramientas para su conservacion y para el uso sostenible de especies maderables" (11-CAP2-1730). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Baker TR, 2003, PERSPECT PLANT ECOL, V6, P21, DOI 10.1078/1433-8319-00040; Biondi F, 2008, TREE-RING RES, V64, P81, DOI 10.3959/2008-6.1; Borchert R, 1999, IAWA J, V20, P239, DOI 10.1163/22941932-90000687; BORCHERT R, 1994, ECOLOGY, V75, P1437, DOI 10.2307/1937467; Bowman DMJS, 2013, TRENDS PLANT SCI, V18, P11, DOI 10.1016/j.tplants.2012.08.005; Brienen RJW, 2010, OECOLOGIA, V163, P485, DOI 10.1007/s00442-009-1540-5; Bullock Stephen H., 1995, P277, DOI 10.1017/CBO9780511753398.011; Choat B, 2005, TREES-STRUCT FUNCT, V19, P305, DOI 10.1007/s00468-004-0392-1; Clark DB, 2010, GLOBAL CHANGE BIOL, V16, P747, DOI 10.1111/j.1365-2486.2009.02004.x; Clark JS, 2010, SCIENCE, V327, P1129, DOI 10.1126/science.1183506; Dirzo R, 2011, SEASONALLY DRY TROPI; Duchesne L, 2003, CAN J FOREST RES, V33, P2074, DOI 10.1139/X03-141; Eamus D, 1999, TRENDS ECOL EVOL, V14, P11, DOI 10.1016/S0169-5347(98)01532-8; Eamus D, 2001, ADV ECOL RES, V32, P113, DOI 10.1016/S0065-2504(01)32012-3; Enquist BJ, 2001, J TROP ECOL, V17, P41, DOI 10.1017/S0266467401001031; Fan ZX, 2012, J ECOL, V100, P732, DOI 10.1111/j.1365-2745.2011.01939.x; HARGREAVES GH, 1982, J IRR DRAIN DIV-ASCE, V108, P225; Herault B, 2011, J ECOL, V99, P1431, DOI 10.1111/j.1365-2745.2011.01883.x; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Iida Y, 2012, FUNCT ECOL, V26, P274, DOI 10.1111/j.1365-2435.2011.01921.x; Janzen D.H., 1988, P130; Killeen TJ, 1998, J TROP ECOL, V14, P803, DOI 10.1017/S0266467498000583; Krepkowski J, 2011, TREES-STRUCT FUNCT, V25, P59, DOI 10.1007/s00468-010-0460-7; Kutscha NP, 1962, COLOR TESTS DIFFEREN; LIEBERMAN D, 1987, J TROP ECOL, V3, P347, DOI 10.1017/S0266467400002327; Lisi CS, 2008, IAWA J, V29, P189, DOI 10.1163/22941932-90000179; Lopez L, 2011, BIOTROPICA, V43, P41, DOI 10.1111/j.1744-7429.2010.00653.x; MAGEE L, 1990, AM STAT, V44, P250, DOI 10.2307/2685352; Markesteijn L, 2009, J ECOL, V97, P311, DOI 10.1111/j.1365-2745.2008.01466.x; Markesteijn L, 2011, NEW PHYTOL, V191, P480, DOI 10.1111/j.1469-8137.2011.03708.x; Markesteijn L, 2010, J TROP ECOL, V26, P497, DOI 10.1017/S0266467410000271; Meinzer FC, 1999, OECOLOGIA, V121, P293, DOI 10.1007/s004420050931; Meinzer FC, 2001, TREE PHYSIOL, V21, P19, DOI 10.1093/treephys/21.1.19; Missouri Botanical Garden, 2013, MISS BOT GARD; Mostacedo B., 2007, THESIS U FLORIDA GAI; Muller-Landau HC, 2004, BIOTROPICA, V36, P20, DOI 10.1111/j.1744-7429.2004.tb00292.x; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; OLIVARES E, 1992, J VEG SCI, V3, P383, DOI 10.2307/3235764; Pinheiro JC, 2012, NLME LINEAR NONLINEA, P1; Poorter L, 2010, NEW PHYTOL, V185, P481, DOI 10.1111/j.1469-8137.2009.03092.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Rasband WS., 2013, IMAGE J; REICH PB, 1984, J ECOL, V72, P61, DOI 10.2307/2260006; Reyes-Garcia C, 2012, TREES-STRUCT FUNCT, V26, P1317, DOI 10.1007/s00468-012-0708-5; Roig Fidel A., 2005, Dendrochronologia, V22, P187, DOI 10.1016/j.dendro.2005.05.007; Rozendaal DMA, 2011, TREES-STRUCT FUNCT, V25, P3, DOI 10.1007/s00468-010-0480-3; Schongart J, 2006, GLOBAL CHANGE BIOL, V12, P1139, DOI 10.1111/j.1365-2486.2006.01154.x; Schulman E., 1956, Dendroclimatic changes in semiarid America.; SOBRADO MA, 1993, OECOLOGIA, V96, P19, DOI 10.1007/BF00318025; Stahl C, 2010, J TROP ECOL, V26, P393, DOI 10.1017/S0266467410000155; Toledo M, 2011, J ECOL, V99, P254, DOI 10.1111/j.1365-2745.2010.01741.x; Villegas Z, 2009, FOREST ECOL MANAG, V258, P971, DOI 10.1016/j.foreco.2008.10.031; Volland-Voigt F, 2011, TREES-STRUCT FUNCT, V25, P39, DOI 10.1007/s00468-010-0461-6; Worbes M, 1999, J ECOL, V87, P391, DOI 10.1046/j.1365-2745.1999.00361.x; Worbes M, 1995, IAWA J, V16, P337, DOI 10.1163/22941932-90001424; Worbes Martin, 2002, Dendrochronologia, V20, P217, DOI 10.1078/1125-7865-00018; Zuidema PA, 2009, AM NAT, V174, P709, DOI 10.1086/605981; Zuur Alain F., 2009, P1	59	35	35	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e73855	10.1371/journal.pone.0073855	http://dx.doi.org/10.1371/journal.pone.0073855			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116001	Green Published, Green Submitted, gold			2022-12-25	WOS:000325501300004
J	Sharma, P; Stagge, S; Bekker, M; Bettenbrock, K; Hellingwerf, KJ				Sharma, Poonam; Stagge, Stefan; Bekker, Martijn; Bettenbrock, Katja; Hellingwerf, Klaas J.			Kinase Activity of ArcB from Escherichia coli Is Subject to Regulation by Both Ubiquinone and Demethylmenaquinone	PLOS ONE			English	Article							2-COMPONENT SYSTEM; IN-VITRO; TRANSCRIPTIONAL REGULATION; REDOX REGULATION; SENSOR KINASE; QUINONE POOL; SIGNAL; PHOSPHORYLATION; REQUIREMENT; PROTEIN	Expression of the catabolic network in Escherichia coli is predominantly regulated, via oxygen availability, by the two-component system ArcBA. It has been shown that the kinase activity of ArcB is controlled by the redox state of two critical pairs of cysteines in dimers of the ArcB sensory kinase. Among the cellular components that control the redox state of these cysteines of ArcB are the quinones from the cytoplasmic membrane of the cell, which function in 'respiratory' electron transfer. This study is an effort to understand how the redox state of the quinone pool(s) is sensed by the cell via the ArcB kinase. We report the relationship between growth, quinone content, ubiquinone redox state, the level of ArcA phosphorylation, and the level of ArcA-dependent gene expression, in a number of mutants of E. coli with specific alterations in their set of quinones, under a range of physiological conditions. Our results provide experimental evidence for a previously formulated hypothesis that not only ubiquinone, but also demethylmenaquinone, can inactivate kinase activity of ArcB. Also, in a mutant strain that only contains demethylmenaquinone, the extent of ArcA phosphorylation can be modulated by the oxygen supply rate, which shows that demethylmenaquinone can also inactivate ArcB in its oxidized form. Furthermore, in batch cultures of a strain that contains ubiquinone as its only quinone species, we observed that the ArcA phosphorylation level closely followed the redox state of the ubiquinone/ubiquinol pool, much more strictly than it does in the wild type strain. Therefore, at low rates of oxygen supply in the wild type strain, the activity of ArcB may be inhibited by demethylmenaquinone, in spite of the fact that the ubiquinones are present in the ubiquinol form.	[Sharma, Poonam; Bekker, Martijn; Hellingwerf, Klaas J.] Univ Amsterdam, Swammerdam Inst Life Sci, Mol Microbial Physiol Grp, Amsterdam, Netherlands; [Sharma, Poonam; Bekker, Martijn; Hellingwerf, Klaas J.] Netherlands Inst Syst Biol, Amsterdam, Netherlands; [Stagge, Stefan; Bettenbrock, Katja] MPI Dynam Komplexer Tech Syst, Magdeburg, Germany	University of Amsterdam	Hellingwerf, KJ (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Mol Microbial Physiol Grp, Amsterdam, Netherlands.	K.J.Hellingwerf@uva.nl	Bettenbrock, Katja/AAN-5812-2020	Stagge, Stefan/0000-0003-4908-0913	SysMo-SUMO2 project; Erasmus Mundus External Cooperation Window (EMECW) [327]	SysMo-SUMO2 project; Erasmus Mundus External Cooperation Window (EMECW)	This work was supported by the SysMo-SUMO2 project and the Erasmus Mundus External 327 Cooperation Window (EMECW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeeva S, 2003, J BACTERIOL, V185, P204, DOI 10.1128/JB.185.1.204-209.2003; Alexeeva S, 2000, J BACTERIOL, V182, P4934, DOI 10.1128/JB.182.17.4934-4940.2000; Alvarez AF, 2013, J BACTERIOL, V195, P3054, DOI 10.1128/JB.00406-13; Barbieri CM, 2008, ANAL BIOCHEM, V376, P73, DOI 10.1016/j.ab.2008.02.004; Bekker M, 2007, MICROBIOL-SGM, V153, P1974, DOI 10.1099/mic.0.2007/006098-0; Bekker Martijn, 2006, Science Progress, V89, P213, DOI 10.3184/003685006783238308; Bekker M, 2010, J BACTERIOL, V192, P746, DOI 10.1128/JB.01156-09; Evans CGT, 1970, CONTINUOUS CULTURE M, V2; GARCIAHORSMAN JA, 1994, J BACTERIOL, V176, P5587, DOI 10.1128/JB.176.18.5587-5600.1994; Gennis RB, 2004, FRONT BIOSCI, V9, P581, DOI 10.2741/1237; Georgellis D, 1999, J BIOL CHEM, V274, P35950, DOI 10.1074/jbc.274.50.35950; Georgellis D, 1998, J BIOL CHEM, V273, P32864, DOI 10.1074/jbc.273.49.32864; Georgellis D, 1997, J BACTERIOL, V179, P5429, DOI 10.1128/jb.179.17.5429-5435.1997; Georgellis D, 2001, SCIENCE, V292, P2314, DOI 10.1126/science.1059361; IUCHI S, 1993, J BIOL CHEM, V268, P23972; Jeremy MB, 2002, BIOCHEMISTRY, V5th; Kwon O, 2000, J BACTERIOL, V182, P3858, DOI 10.1128/JB.182.13.3858-3862.2000; Liu XQ, 2004, J BIOL CHEM, V279, P12588, DOI 10.1074/jbc.M313454200; Lynch AS, 1996, J BACTERIOL, V178, P6238, DOI 10.1128/JB.178.21.6238-6249.1996; Malpica R, 2004, P NATL ACAD SCI USA, V101, P13318, DOI 10.1073/pnas.0403064101; Nakamura A, 2011, PLANT CELL PHYSIOL, V52, P815, DOI 10.1093/pcp/pcr034; Oreza LAN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038187; Pena-Sandoval GR, 2010, J BACTERIOL, V192, P1735, DOI 10.1128/JB.01401-09; Pena-Sandoval GR, 2005, J BACTERIOL, V187, P3267, DOI 10.1128/JB.187.9.3267-3272.2005; Perrenoud A, 2005, J BACTERIOL, V187, P3171, DOI 10.1128/JB.187.9.3171-3179.2005; Rodriguez C, 2004, J BACTERIOL, V186, P2085, DOI 10.1128/JB.186.7.2085-2090.2004; Rolfe MD, 2011, J BIOL CHEM, V286, P10147, DOI 10.1074/jbc.M110.211144; Sharma P, 2012, APPL ENV MICROBIOL; Sharma P, 2012, FEBS J; Shestopalov AI, 1997, FEBS LETT, V404, P272, DOI 10.1016/S0014-5793(97)00143-9; Soballe B, 1998, MICROBIOL-UK, V144, P361, DOI 10.1099/00221287-144-2-361; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0	32	18	19	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75412	10.1371/journal.pone.0075412	http://dx.doi.org/10.1371/journal.pone.0075412			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116043	Green Submitted, Green Published, gold			2022-12-25	WOS:000325501300027
J	Tomczak, MT; Heymans, JJ; Yletyinen, J; Niiranen, S; Otto, SA; Blenckner, T				Tomczak, Maciej T.; Heymans, Johanna J.; Yletyinen, Johanna; Niiranen, Susa; Otto, Saskia A.; Blenckner, Thorsten			Ecological Network Indicators of Ecosystem Status and Change in the Baltic Sea	PLOS ONE			English	Article							FOOD-WEB MODELS; REGIME SHIFTS; SOUTHERN BENGUELA; TROPHIC STRUCTURE; MARINE ECOSYSTEM; UPWELLING ECOSYSTEMS; FISHERIES MANAGEMENT; POSSIBLE MECHANISMS; STABILITY; DYNAMICS	Several marine ecosystems under anthropogenic pressure have experienced shifts from one ecological state to another. In the central Baltic Sea, the regime shift of the 1980s has been associated with food-web reorganization and redirection of energy flow pathways. These long-term dynamics from 1974 to 2006 have been simulated here using a food-web model forced by climate and fishing. Ecological network analysis was performed to calculate indices of ecosystem change. The model replicated the regime shift. The analyses of indicators suggested that the system's resilience was higher prior to 1988 and lower thereafter. The ecosystem topology also changed from a web-like structure to a linearized food-web.	[Tomczak, Maciej T.] Stockholm Univ, Balt Sea Ctr, S-10691 Stockholm, Sweden; [Heymans, Johanna J.] Scottish Marine Inst, Scottish Assoc Marine Sci, Oban, Argyll, Scotland; [Yletyinen, Johanna] Stockholm Univ, Stockholm Resilience Ctr, Nord Ctr Res Marine Ecosyst & Resources Climate C, S-10691 Stockholm, Sweden; [Yletyinen, Johanna; Niiranen, Susa; Otto, Saskia A.; Blenckner, Thorsten] Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden	Stockholm University; UHI Millennium Institute; Stockholm University; Stockholm University	Tomczak, MT (corresponding author), Stockholm Univ, Balt Sea Ctr, S-10691 Stockholm, Sweden.	maciej.tomczak@su.se	Yletyinen, Johanna/ABC-5785-2020; Heymans, Johanna J/H-4848-2012	Heymans, Johanna J/0000-0002-7290-8988; Yletyinen, Johanna/0000-0002-7410-6794; Blenckner, Thorsten/0000-0002-6991-7680; Niiranen, Susa/0000-0001-8405-8717	EU [226675]; Swedish FORMAS project "Regime Shifts in the Baltic Sea Ecosystem-Modelling Complex Adaptive Ecosystems and Governance Implications''; Baltic Ecosystem Adaptive Management (BEAM) program; Swedish FORMAS; Norden Top-level Research Initiative sub-programme 'Effect Studies and Adaptation to Climate Change' through the Nordic Centre for Research on Marine Ecosystems and Resources under Climate Change (NorMER)	EU(European Commission); Swedish FORMAS project "Regime Shifts in the Baltic Sea Ecosystem-Modelling Complex Adaptive Ecosystems and Governance Implications''; Baltic Ecosystem Adaptive Management (BEAM) program; Swedish FORMAS(Swedish Research Council Formas); Norden Top-level Research Initiative sub-programme 'Effect Studies and Adaptation to Climate Change' through the Nordic Centre for Research on Marine Ecosystems and Resources under Climate Change (NorMER)	The study has been carried out with financial support from the EU 7th Framework Project KnowSeas (FP7/2007-2013) under grant agreement number 226675 and the Swedish FORMAS project "Regime Shifts in the Baltic Sea Ecosystem-Modelling Complex Adaptive Ecosystems and Governance Implications''. Further, the research leading to these results has received funding from the Baltic Ecosystem Adaptive Management (BEAM) program funded by Swedish FORMAS, and from the Norden Top-level Research Initiative sub-programme 'Effect Studies and Adaptation to Climate Change' through the Nordic Centre for Research on Marine Ecosystems and Resources under Climate Change (NorMER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca-Arenas LG, 2002, ECOL MODEL, V149, P285, DOI 10.1016/S0304-3800(01)00474-4; Ainsworth CH, 2006, ECOL INDIC, V6, P623, DOI 10.1016/j.ecolind.2005.08.024; Alheit J, 2005, ICES J MAR SCI, V62, P1205, DOI 10.1016/j.icesjms.2005.04.024; [Anonymous], 1993, 1993J22 ICES CM; [Anonymous], 2008, 2008BCC04145 ICES CM; Armitage DR, 2009, FRONT ECOL ENVIRON, V7, P95, DOI 10.1890/070089; Aydin KY, 2004, AFR J MAR SCI, V26, P289, DOI 10.2989/18142320409504062; BAIRD D, 1993, MAR ECOL PROG SER, V99, P221, DOI 10.3354/meps099221; Bascompte J, 2009, SCIENCE, V325, P416, DOI 10.1126/science.1170749; Bianchi TS, 2000, LIMNOL OCEANOGR, V45, P716, DOI 10.4319/lo.2000.45.3.0716; Bondavalli C, 2000, J BIOGEOGR, V27, P697, DOI 10.1046/j.1365-2699.2000.00423.x; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Christensen V., 1995, ECOL MODEL, V7, P3; Christensen V, 2005, ECOPATH ECOSIM USERS; Coll M, 2006, ECOL MODEL, V198, P53, DOI 10.1016/j.ecolmodel.2006.04.009; Coll M, 2012, FISH FISH, V13, P60, DOI 10.1111/j.1467-2979.2011.00420.x; Coll Marta, 2009, P225, DOI 10.1007/978-1-4020-8636-6_8; Conley DJ, 2009, HYDROBIOLOGIA, V629, P21, DOI 10.1007/s10750-009-9764-2; Conley DJ, 2002, ENVIRON SCI TECHNOL, V36, P5315, DOI 10.1021/es025763w; Costanza R, 1992, ECOSYSTEM HLTH NEW G; Cury P, 2004, PROG OCEANOGR, V60, P223, DOI 10.1016/j.pocean.2004.02.007; Cury PM, 2005, ICES J MAR SCI, V62, P430, DOI 10.1016/j.icesjms.2004.12.006; Daskalov GM, 2007, P NATL ACAD SCI USA, V104, P10518, DOI 10.1073/pnas.0701100104; Daskalov GM, 2002, MAR ECOL PROG SER, V225, P53, DOI 10.3354/meps225053; Diekmann R., 2010, ICES COOPERATIVE RES, V302, P94; Dunne JA, 2005, AQUATIC FOOD WEBS: AN ECOSYSTEM APPROACH, P117; Eero M, 2012, MAR POLICY, V36, P235, DOI 10.1016/j.marpol.2011.05.010; FINN JT, 1980, ECOLOGY, V61, P562, DOI 10.2307/1937422; FINN JT, 1976, J THEOR BIOL, V56, P363, DOI 10.1016/S0022-5193(76)80080-X; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Heymans JJ, 2000, ECOL MODEL, V131, P97, DOI 10.1016/S0304-3800(00)00275-1; Heymans JJ, 2007, ECOSYSTEMS, V10, P488, DOI 10.1007/s10021-007-9034-y; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Horbowy J, 2005, J APPL ICHTHYOL, V21, P198, DOI 10.1111/j.1439-0426.2005.00596.x; ICES, 2008, 2008ACOM06692 ICES C, V817; ICES, 2012, 2012SSGRSP02178 ICES, P178; IEEP, 2005, REV IND EC STRUCT FU; Jordan F., 2004, Physics of Life Reviews, V1, DOI 10.1016/j.plrev.2004.08.001; Kay J. J., 1989, NETWORK ANAL MARINE, P15, DOI DOI 10.1007/978-3-642-75017-5_2; Kenny AJ, 2009, PROG OCEANOGR, V81, P132, DOI 10.1016/j.pocean.2009.04.007; Larsson P., 2001, SYSTEMS ANAL BALTIC; Lees K, 2006, FISH FISH, V7, P104, DOI 10.1111/j.1467-2979.2006.00215.x; LEGENDRE P, 1985, AM NAT, V125, P257, DOI 10.1086/284340; Lindegren M, 2010, MAR ECOL PROG SER, V402, P239, DOI 10.3354/meps08454; Link JS, 2002, CAN J FISH AQUAT SCI, V59, P1429, DOI 10.1139/F02-115; Mageau MT, 1998, ECOL MODEL, V112, P1, DOI 10.1016/S0304-3800(98)00092-1; Martinez ND, 2006, SFI S SCI C, P163; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McKinnell SM, 2001, PROG OCEANOGR, V49, P1; Mollmann C, 2008, ICES J MAR SCI, V65, P302, DOI 10.1093/icesjms/fsm197; Mollmann C, 2009, GLOBAL CHANGE BIOL, V15, P1377, DOI 10.1111/j.1365-2486.2008.01814.x; Moloney CL, 2005, ICES J MAR SCI, V62, P493, DOI 10.1016/j.icesjms.2004.11.009; Monaco ME, 1997, MAR ECOL PROG SER, V161, P239, DOI 10.3354/meps161239; Niiranen S, 2012, AMBIO, V41, P613, DOI 10.1007/s13280-012-0324-z; Novak M, 2011, ECOLOGY, V92, P836, DOI 10.1890/10-1354.1; O'Gorman EJ, 2009, P NATL ACAD SCI USA, V106, P13393, DOI 10.1073/pnas.0903682106; Odum E, 1969, STRATEGY ECOSYSTEM D, V104, P262; Odum E. P., 1953, FUNDAMENTALS ECOLOGY; ODUM EP, 1985, BIOSCIENCE, V35, P419, DOI 10.2307/1310021; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Pinnegar JK, 2005, ECOL MODEL, V184, P229, DOI 10.1016/j.ecolmodel.2004.09.003; Plaganyi EE, 2004, AFR J MAR SCI, V26, P261, DOI 10.2989/18142320409504061; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; Rodionov SN, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019448; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Shannon LJ, 2009, ECOL INDIC, V9, P1078, DOI 10.1016/j.ecolind.2008.12.007; Shannon LJ, 2004, ECOL MODEL, V172, P269, DOI 10.1016/j.ecolmodel.2003.09.011; Sole RV, 2001, P ROY SOC B-BIOL SCI, V268, P2039, DOI 10.1098/rspb.2001.1767; Tallis H, 2010, MAR POLICY, V34, P340, DOI 10.1016/j.marpol.2009.08.003; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Thurow F, 1997, ICES J MAR SCI, V54, P444, DOI 10.1006/jmsc.1996.0195; Tomczak MT, 2012, ECOL MODEL, V230, P123, DOI 10.1016/j.ecolmodel.2011.12.014; Tomczak MT, 2009, PROG OCEANOGR, V81, P111, DOI 10.1016/j.pocean.2009.04.017; Ulanowicz R. E., 1986, GROWTH DEV ECOSYSTEM; Ulanowicz RE, 2004, COMPUT BIOL CHEM, V28, P321, DOI 10.1016/j.compbiolchem.2004.09.001; Ulanowicz RE, 1997, ECOL MODEL, V95, P1, DOI 10.1016/S0304-3800(96)00032-4; Ulanowicz Robert E., 2000, P99; Vasconcellos M, 1997, ECOL MODEL, V100, P125, DOI 10.1016/S0304-3800(97)00150-6; Walters C, 1997, REV FISH BIOL FISHER, V7, P139, DOI 10.1023/A:1018479526149; Watermeyer KE, 2008, AFR J MAR SCI, V30, P351, DOI 10.2989/AJMS.2008.30.2.11.561; Wulff F., 1989, NETWORK ANAL MARINE	83	54	55	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75439	10.1371/journal.pone.0075439	http://dx.doi.org/10.1371/journal.pone.0075439			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116045	Green Published, gold			2022-12-25	WOS:000325501300028
J	Zhao, H; Wang, B; He, JR; Yang, JP; Pan, L; Sun, DF; Peng, JH				Zhao, Hua; Wang, Bo; He, Junrong; Yang, Junpin; Pan, Lei; Sun, Dongfa; Peng, Junhua			Genetic Diversity and Population Structure of Miscanthus sinensis Germplasm in China	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; ENERGY CROP; X-GIGANTEUS; MICROSATELLITE MARKERS; AGRONOMIC TRAITS; ASSOCIATION; BIOMASS; VARIABILITY; SOFTWARE; EUROPE	Miscanthus is a perennial rhizomatous C4 grass native to East Asia. Endowed with great biomass yield, high ligno-cellulose composition, efficient use of radiation, nutrient and water, as well as tolerance to stress, Miscanthus has great potential as an excellent bioenergy crop. Despite of the high potential for biomass production of the allotriploid hybrid M. xgiganteus, derived from M. sacchariflorus and M. sinensis, other options need to be explored to improve the narrow genetic base of M. xgiganteus, and also to exploit other Miscanthus species, including M. sinensis (2n=2x=38), as bioenergy crops. In the present study, a large number of 459 M. sinensis accessions, collected from the wide geographical distribution regions in China, were genotyped using 23 SSR markers transferable from Brachypodium distachyon. Genetic diversity and population structure were assessed. High genetic diversity and differentiation of the germplasm were observed, with 115 alleles in total, a polymorphic rate of 0.77, Nei's genetic diversity index (He) of 0.32 and polymorphism information content (PIC) of 0.26. Clustering of germplasm accessions was primarily in agreement with the natural geographic distribution. AMOVA and genetic distance analyses confirmed the genetic differentiation in the M. sinensis germplasm and it was grouped into five clusters or subpopulations. Significant genetic variation among subpopulations indicated obvious genetic differentiation in the collections, but within-subpopulation variation (83%) was substantially greater than the between-subpopulation variation (17%). Considerable phenotypic variation was observed for multiple traits among 300 M. sinensis accessions. Nine SSR markers were found to be associated with heading date and biomass yield. The diverse Chinese M. sinensis germplasm and newly identified SSR markers were proved to be valuable for breeding Miscanthus varieties with desired bioenergy traits.	[Zhao, Hua; Sun, Dongfa; Peng, Junhua] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China; [Wang, Bo; Pan, Lei] Chinese Acad Sci, Wuhan Bot Garden, Wuhan, Hubei, Peoples R China; [Wang, Bo] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [He, Junrong] Sichuan Acad Agr Sci, Inst Hort, Chengdu, Peoples R China; [Yang, Junpin] Sichuan Acad Agr Sci, Crop Res Inst, Chengdu, Peoples R China	Huazhong Agricultural University; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Sichuan Academy of Agricultural Sciences (SAAS); Sichuan Academy of Agricultural Sciences (SAAS)	Sun, DF (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China.	sundongfa@mail.hzau.edu.cn; junhuapeng@yahoo.com	Peng, Junhua/HHZ-2344-2022	Peng, Junhua/0000-0002-8428-3137	Natural National Science Foundation [31100243, 30870233]	Natural National Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural National Science Foundation grants 31100243 and 30870233. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrama H. A., 2010, Natural Science, V2, P247, DOI 10.4236/ns.2010.24036; Atienza SG, 2003, EUPHYTICA, V132, P353, DOI 10.1023/A:1025041926259; Atienza SG, 2003, THEOR APPL GENET, V107, P123, DOI 10.1007/s00122-003-1220-5; Bellamy PE, 2009, BIOMASS BIOENERG, V33, P191, DOI 10.1016/j.biombioe.2008.07.001; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chou CH, 2000, CAN J BOT, V78, P1262, DOI 10.1139/cjb-78-10-1262; Christian D. G., 2001, MISCANTHUS ENERGY FI; Clark L.V., 2013, GENETIC STRUCTURE MI; Clifton-Brown J., 2000, MISCANTHUS ENERGY FI, P46; Clifton-Brown J. C., 2001, EUROPEAN J AGRONOMY, V6, P97; Clifton-Brown JC, 2000, NEW PHYTOL, V148, P287, DOI 10.1046/j.1469-8137.2000.00764.x; Clifton-Brown JC, 2001, AGRON J, V93, P1013, DOI 10.2134/agronj2001.9351013x; Clifton-Brown John, 2008, P273, DOI 10.1007/978-0-387-70805-8_10; Cox CB, 2001, J BIOGEOGR, V28, P511; Deuter M., 2000, EUROPEAN MISCANTHUS, P28; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fang LQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002268; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Greef JM, 1997, GENET RESOUR CROP EV, V44, P185, DOI 10.1023/A:1008693214629; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Hastings A, 2009, GCB BIOENERGY, V1, P154, DOI 10.1111/j.1757-1707.2009.01007.x; Hastings A, 2009, GCB BIOENERGY, V1, P180, DOI 10.1111/j.1757-1707.2009.01012.x; Heaton EA, 2008, GLOBAL CHANGE BIOL, V14, P2000, DOI 10.1111/j.1365-2486.2008.01662.x; Heaton EA, 2008, CURR OPIN BIOTECH, V19, P202, DOI 10.1016/j.copbio.2008.05.001; Heaton EA, 2009, GCB BIOENERGY, V1, P297, DOI 10.1111/j.1757-1707.2009.01022.x; Hernandez P, 2001, THEOR APPL GENET, V102, P616, DOI 10.1007/s001220051688; Huang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050002; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Humphries C., 1999, CLADISTIC BIOGEOGRAP, P21; Hung KH, 2009, CONSERV GENET, V10, P1377, DOI 10.1007/s10592-008-9699-6; Jorgensen U, 2000, NEW PHYTOL, V148, P190, DOI 10.1046/j.1469-8137.2000.00768.x; JORGENSEN U, 2001, MISCANTHUS ENERGY FI, P68; LAFFERTY J, 1994, PLANT BREEDING, V113, P246, DOI 10.1111/j.1439-0523.1994.tb00730.x; Lewandowski I, 2000, BIOMASS BIOENERG, V19, P209, DOI 10.1016/S0961-9534(00)00032-5; Lewandowski I, 2003, BIOMASS BIOENERG, V25, P335, DOI 10.1016/S0961-9534(03)00030-8; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; LINDELAURSEN I, 1993, HEREDITAS, V119, P297, DOI 10.1111/j.1601-5223.1993.00297.x; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Ma XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033821; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Nelson G., 1981, SYSTEMATICS BIOGEOGR, V368, P524; Pressoir G, 2009, PLANT J, V58, P618, DOI 10.1111/j.1365-313X.2009.03802.x; Price L, 2004, BIOMASS BIOENERG, V26, P3, DOI 10.1016/S0961-9534(03)00062-X; Pritchard JK, 2000, GENETICS, V155, P945; Rafalski JA, 2010, CURR OPIN PLANT BIOL, V13, P174, DOI 10.1016/j.pbi.2009.12.004; Rayburn AL, 2009, PLANT MOL BIOL REP, V27, P184, DOI 10.1007/s11105-008-0070-3; Semere T, 2007, BIOMASS BIOENERG, V31, P20, DOI 10.1016/j.biombioe.2006.07.001; Swaminathan K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-142; Wang ML, 2009, THEOR APPL GENET, V120, P13, DOI 10.1007/s00122-009-1155-6; Yan J, 2012, GCB BIOENERGY, V4, P49, DOI 10.1111/j.1757-1707.2011.01108.x; Yan WG, 2009, MOL BREEDING, V24, P277, DOI 10.1007/s11032-009-9290-y; Yang XH, 2010, THEOR APPL GENET, V121, P417, DOI 10.1007/s00122-010-1320-y; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhao H, 2011, J INTEGR PLANT BIOL, V53, P232, DOI 10.1111/j.1744-7909.2010.01026.x; Zhou HF, 2011, AM J BOT, V98, pE195, DOI 10.3732/ajb.1100040	60	31	33	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75672	10.1371/journal.pone.0075672	http://dx.doi.org/10.1371/journal.pone.0075672			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116066	Green Published, Green Submitted, gold			2022-12-25	WOS:000325501300038
J	Kowalkowski, MA; Mims, MP; Amiran, ES; Lulla, P; Chiao, EY				Kowalkowski, Marc A.; Mims, Martha P.; Amiran, E. Susan; Lulla, Premal; Chiao, Elizabeth Y.			Effect of Immune Reconstitution on the Incidence of HIV-Related Hodgkin Lymphoma	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; EPSTEIN-BARR-VIRUS; AIDS-DEFINING MALIGNANCIES; UNITED-STATES; CANCER-RISK; IMMUNODEFICIENCY; ERA; EPIDEMIOLOGY; POPULATION; PEOPLE	Background: The incidence of Hodgkin lymphoma (HL) has increased since introduction of combined antiretroviral therapy (cART). While HIV-related HL is highly associated with EBV, the causes underlying the rising incidence remain unclear. The aim of this study was to evaluate the effect of immune reconstitution on HL incidence among a cohort of HIV-infected male veterans ever receiving cART. Methods: We performed a retrospective cohort study utilizing data from the Veterans Affairs HIV Clinical Case Registry from 1985-2010. HL cases were identified using ICD-9 codes (201.4-9). Poisson regression was conducted to evaluate relationships between cART-related immunologic measures (e.g., nadir CD4 before cART, time-updated CD4, % time undetectable HIV RNA) and HL incidence. Additionally, we examined CD4 change after cART initiation. Results: 31,056 cART users contributed 287,256 person-years and 196 HL cases (IR=6.8/10,000 person-years). Rate of CD4 increase after cART was worse among HL cases than non-cases (p<0.05). In multivariate regression, HL risk was elevated among veterans with recent CD4 200-350 cells/mu L (IRR=1.67, 95% CI=1.16-2.40) and <200 cells/mu L (IRR=1.61, 95% CI=1.09-2.39), compared to >350 cells/mu L. HL risk was lower among veterans with >80% time undetectable HIV RNA (IRR=0.57, 95% CI=0.35-0.92) and 40-80% undetectable (IRR=0.68, 95% CI=0.47-0.99), compared to <40% undetectable. HL risk was higher in the first 12 months (IRR=2.02, 95% CI=1.32-3.10) and 12-24 months (IRR=1.75, 95% CI=1.16-2.64) after cART initiation, compared to >36 months. Conclusion: These data highlight immunosuppression and poor viral control may increase HL risk, specifically during immune reconstitution in the interval post cART initiation. Findings suggest an immune reconstitution type mechanism in HIV-related HL development.	[Kowalkowski, Marc A.; Mims, Martha P.; Lulla, Premal; Chiao, Elizabeth Y.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Kowalkowski, Marc A.; Chiao, Elizabeth Y.] Michael E DeBakey VA Med Ctr, Houston Hlth Serv Res & Dev Ctr Excellence, Houston, TX USA; [Amiran, E. Susan] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Amiran, E. Susan] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Kowalkowski, MA (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.	kowalkow@bcm.edu		Chiao, Elizabeth/0000-0001-5752-2916; Kowalkowski, Marc/0000-0003-2624-4209	Houston Health Services Research and Development Center of Excellence [HFP90-020]; Michael E. DeBakey Veterans Affairs Medical Center; Baylor College of Medicine Dan L. Duncan Cancer Center [P30CA125123-04S1]; Baylor-UTHouston Center for AIDS Research (CFAR), NIH [AI036211]; National Cancer Institute [P50CA126752, R01CA163103]; NATIONAL CANCER INSTITUTE [P50CA126752, R01CA163103, P30CA125123] Funding Source: NIH RePORTER	Houston Health Services Research and Development Center of Excellence; Michael E. DeBakey Veterans Affairs Medical Center; Baylor College of Medicine Dan L. Duncan Cancer Center; Baylor-UTHouston Center for AIDS Research (CFAR), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by resources and the use of facilities at the Houston Health Services Research and Development Center of Excellence (HFP90-020), Michael E. DeBakey Veterans Affairs Medical Center and the Baylor College of Medicine Dan L. Duncan Cancer Center (P30CA125123-04S1). This research was also supported by the Baylor-UTHouston Center for AIDS Research (CFAR), an NIH-funded program (AI036211). Martha Mims (P50CA126752) and Elizabeth Chiao (R01CA163103) also received support from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backus L, 2001, J CLIN EPIDEMIOL, V54, pS12, DOI 10.1016/S0895-4356(01)00442-5; Backus LI, 2009, J AM MED INFORM ASSN, V16, P775, DOI 10.1197/jamia.M3203; Bedimo RJ, 2009, JAIDS-J ACQ IMM DEF, V52, P203, DOI 10.1097/QAI.0b013e3181b033ab; Biggar RJ, 2006, BLOOD, V108, P3786, DOI 10.1182/blood-2006-05-024109; Bohlius J, 2011, BLOOD, V117, P6100, DOI 10.1182/blood-2010-08-301531; Boulware DR, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000384; Carbone A, 2009, CURR OPIN HIV AIDS, V4, P3, DOI 10.1097/COH.0b013e32831a722b; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chiao EY, 2008, J CLIN ONCOL, V26, P474, DOI 10.1200/JCO.2007.14.2810; Clifford GM, 2009, BLOOD, V113, P5737, DOI 10.1182/blood-2009-02-204172; Clifford GM, 2005, JNCI-J NATL CANCER I, V97, P425, DOI 10.1093/jnci/dji072; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dolcetti R, 2001, EUR J CANCER, V37, P1276, DOI 10.1016/S0959-8049(01)00105-8; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Engels EA, 2006, AIDS, V20, P1645, DOI 10.1097/01.aids.0000238411.75324.59; Engels EA, 2009, AIDS, V23, P875, DOI 10.1097/QAD.0b013e328329216a; Friis AMC, 2010, VIRUSES-BASEL, V2, P867, DOI 10.3390/v2040867; Frisch M, 2001, JAMA-J AM MED ASSOC, V285, P1736, DOI 10.1001/jama.285.13.1736; Gloghini A, 2007, INT J CANCER, V120, P2753, DOI 10.1002/ijc.22650; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Guiguet M, 2009, LANCET ONCOL, V10, P1152, DOI 10.1016/S1470-2045(09)70282-7; Herida M, 2003, J CLIN ONCOL, V21, P3447, DOI 10.1200/JCO.2003.01.096; Hessol NA, 2007, AM J EPIDEMIOL, V165, P1143, DOI 10.1093/aje/kwm017; Kaplan JE, 2000, CLIN INFECT DIS, V30, pS5, DOI 10.1086/313843; Kramer JR, 2005, AM J GASTROENTEROL, V100, P56, DOI 10.1111/j.1572-0241.2005.40670.x; Kutok JL, 2006, ANNU REV PATHOL-MECH, V1, P375, DOI 10.1146/annurev.pathol.1.110304.100209; Lanoy E, 2011, BLOOD, V118, P44, DOI 10.1182/blood-2011-02-339275; Levine AM, 2006, BLOOD, V108, P3630, DOI 10.1182/blood-2006-09-047498; Mahnke YD, 2012, BLOOD, V119, P3105, DOI 10.1182/blood-2011-09-380840; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Powles T, 2009, J CLIN ONCOL, V27, P884, DOI 10.1200/JCO.2008.19.6626; Regidor DL, 2011, AIDS, V25, P303, DOI 10.1097/QAD.0b013e32834273ad; Righetti E, 2002, AIDS, V16, P63, DOI 10.1097/00002030-200201040-00009; Sereti I, 2010, CURR OPIN HIV AIDS, V5, P504, DOI 10.1097/COH.0b013e32833ed774; Shiels MS, 2011, J NATL CANCER I, V103, P753, DOI 10.1093/jnci/djr076; Shiels MS, 2009, JAIDS-J ACQ IMM DEF, V52, P611, DOI 10.1097/QAI.0b013e3181b327ca	36	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e77409	10.1371/journal.pone.0077409	http://dx.doi.org/10.1371/journal.pone.0077409			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098586	Green Published, Green Submitted, gold			2022-12-25	WOS:000325434500100
J	Adesso, S; Popolo, A; Bianco, G; Sorrentino, R; Pinto, A; Autore, G; Marzocco, S				Adesso, Simona; Popolo, Ada; Bianco, Giuseppe; Sorrentino, Rosalinda; Pinto, Aldo; Autore, Giuseppina; Marzocco, Stefania			The Uremic Toxin Indoxyl Sulphate Enhances Macrophage Response to LPS	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; NF-KAPPA-B; STAGE RENAL-DISEASE; OXIDATIVE STRESS; NITRIC-OXIDE; IMMUNE DYSFUNCTION; NADPH OXIDASE; METHYLGUANIDINE; INFLAMMATION; ACTIVATION	Indoxyl sulphate (IS) is a protein-bound uremic toxin that results from the metabolism of dietary tryptophan normally excreted by kidney through the proximal tubules. Thus the toxin accumulates in the blood of patients with impaired renal function such as in chronic kidney disease (CKD). High IS serum levels in patients with CKD suggest its involvement in CKD progression and in the onset of complications. Its presence in plasma is also a powerful predictor of overall and cardiovascular morbidity/mortality. IS is a well known nephrovascular toxin but very little is known regarding its effects on the immune system and in particular during inflammation. In this study we examined the effect of IS on macrophage activation in response to lipopolysaccharide from E. coli (LPS), a gram negative bacterial endotoxin associated with inflammation and septic shock. To simulate the uremic condition, J774A.1 macrophages were incubated with IS at concentrations observed in uremic patients (1000-62.5 mu M) both alone and during LPS challenge. IS alone induced release of reactive oxygen species (ROS), through a mechanism involving pro- and anti-oxidant systems, and alteration in intracellular calcium homeostasis. When added to J774A.1 macrophages in presence of LPS, IS significantly increased the nitric oxide (NO) release, inducible nitric oxide synthase (iNOS) and cycloxygenase-2 (COX-2) expression. IS pre-treatment was also associated with an increase in tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) production by macrophages stimulated with LPS. Mechanistic studies revealed that IS increased LPS-induced NF-kB nuclear translocation, ROS release and altered calcium concentrations, mainly because of mitochondrial calcium overloading. Moreover also in primary mouse peritoneal macrophages IS enhances the inflammatory response to LPS increasing ROS, NO, iNOS, COX-2, TNF-alpha, IL-6 and NF-kB levels. This study provides evidences that IS stimulates macrophage function and enhances inflammatory reasponse associated with LPS, thus contributing to altered immune response dysfunctions observed in CKD.	[Adesso, Simona; Popolo, Ada; Bianco, Giuseppe; Sorrentino, Rosalinda; Pinto, Aldo; Autore, Giuseppina; Marzocco, Stefania] Univ Salerno, Sch Pharm, Dept Pharm, Fisciano, SA, Italy	University of Salerno	Marzocco, S (corresponding author), Univ Salerno, Sch Pharm, Dept Pharm, Fisciano, SA, Italy.	smarzocco@unisa.it	Sorrentino, Rosalinda/AAK-9540-2020; Marzocco, Stefania/AAI-1493-2020	Popolo, Ada/0000-0002-9843-8443; Sorrentino, Rosalinda/0000-0001-9201-9857	University of Salerno (FARB)	University of Salerno (FARB)	This work was supported by grant from the University of Salerno (FARB 2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2002, J LEUKOCYTE BIOL, V71, P1005; Autore G, 1999, LIFE SCI, V65, pPL121, DOI 10.1016/S0024-3205(99)00355-0; Autore G, 2010, MOLECULES, V15, P2028, DOI 10.3390/molecules15032028; Ben Jemia M, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-47; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bianco G, 2012, TOXICON, V59, P644, DOI 10.1016/j.toxicon.2012.02.010; Bianco G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052051; Brown DM, 2004, AM J PHYSIOL-LUNG C, V286, pL344, DOI 10.1152/ajplung.00139.2003; Carrero JJ, 2009, CLIN J AM SOC NEPHRO, V4, pS49, DOI 10.2215/CJN.02720409; Castilla P, 2008, AM J CLIN NUTR, V87, P1053, DOI 10.1093/ajcn/87.4.1053; Cioffi G, 2006, J NAT PROD, V69, P1323, DOI 10.1021/np060257w; Cohen G, 2007, NEPHROL DIAL TRANSPL, V22, P3381, DOI 10.1093/ndt/gfm210; Cohen G, 2012, TOXINS, V4, P962, DOI 10.3390/toxins4110962; Di Micco L, 2012, CURR HYPERTENS REV, V8, P291, DOI 10.2174/1573402111208040291; Dou L, 2007, J THROMB HAEMOST, V5, P1302, DOI 10.1111/j.1538-7836.2007.02540.x; Drey N, 2003, AM J KIDNEY DIS, V42, P677, DOI 10.1016/S0272-6386(03)00916-8; Dugo L, 2004, BRIT J PHARMACOL, V141, P979, DOI 10.1038/sj.bjp.0705683; Fortuno A, 2005, KIDNEY INT, V68, P71; Hauser AB, 2006, PERITON DIALYSIS INT, V28, P183; Hischi S, 1989, DERMATOLOGICA, V179, P68; Holmes CL, 2003, CLIN CHEST MED, V24, P775, DOI 10.1016/S0272-5231(03)00107-2; Ito S, 2013, J LEUKOCYTE BIOL, V93, P837, DOI 10.1189/jlb.0112023; Ito S, 2010, J BIOL CHEM, V285, P38869, DOI 10.1074/jbc.M110.166686; Karpati I, 2001, NEPHROL DIAL TRANSPL, V16, P1409, DOI 10.1093/ndt/16.7.1409; Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208; Kaysen GA, 2004, J AM SOC NEPHROL, V15, P538, DOI 10.1097/01.ASN.0000111744.00916.E6; Kimmel PL, 1998, KIDNEY INT, V54, P236, DOI 10.1046/j.1523-1755.1998.00981.x; Libetta C, 2011, CLIN BIOCHEM, V44, P1189, DOI 10.1016/j.clinbiochem.2011.06.988; Marzocco S, 2004, FREE RADICAL RES, V38, P1143, DOI 10.1080/10715760410001725517; Marzocco S, 2004, LIFE SCI, V75, P1417, DOI 10.1016/j.lfs.2004.02.031; Marzocco S, 2004, EUR J PHARMACOL, V484, P341, DOI 10.1016/j.ejphar.2003.11.011; Marzocco S, 2013, BLOOD PURIFICAT, V35, P196, DOI 10.1159/000346628; Marzocco S, 2010, NEUROCHEM INT, V57, P518, DOI 10.1016/j.neuint.2010.06.016; Masai N, 2010, CIRC J, V74, P2216, DOI 10.1253/circj.CJ-10-0117; Morena M, 2002, KIDNEY INT, V61, pS109, DOI 10.1046/j.1523-1755.61.s80.20.x; Mozar A, 2011, THER APHER DIAL, V15, P135, DOI 10.1111/j.1744-9987.2010.00885.x; NIWA T, 1988, CLIN CHEM, V34, P2264; Niwa T, 1996, SEMIN NEPHROL, V16, P167; Niwa T, 2001, TXB NEPHROLOGY, P1269; Niwa T, 2011, THER APHER DIAL, V15, P120, DOI 10.1111/j.1744-9987.2010.00882.x; Oberg BP, 2004, KIDNEY INT, V65, P1009, DOI 10.1111/j.1523-1755.2004.00465.x; PARRILLO JE, 1993, NEW ENGL J MED, V328, P1471, DOI 10.1056/nejm199305203282008; Patel KP, 2012, CLIN J AM SOC NEPHRO, V7, P982, DOI 10.2215/CJN.12491211; Popolo A, 2013, FREE RADICAL RES, V47, P346, DOI 10.3109/10715762.2013.779373; RADDASSI K, 1994, CELL IMMUNOL, V153, P443, DOI 10.1006/cimm.1994.1041; Raff AC, 2008, CURR OPIN NEPHROL HY, V17, P560, DOI 10.1097/MNH.0b013e32830f45b6; Rodriguez-Ayala E, 2005, ATHEROSCLEROSIS, V180, P333, DOI 10.1016/j.atherosclerosis.2004.12.007; Sarnak MJ, 2000, KIDNEY INT, V58, P1758, DOI 10.1111/j.1523-1755.2000.00337.x; Shimizu H, 2013, LIFE SCI, V92, P143, DOI 10.1016/j.lfs.2012.11.012; Stenvinkel P, 2003, J AM SOC NEPHROL, V14, P1927, DOI 10.1097/01.ASN.0000069165.79509.42; Stenvinkel P, 2005, KIDNEY INT, V67, P1216, DOI 10.1111/j.1523-1755.2005.00200.x; Szabo C, 1995, New Horiz, V3, P2; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Thiemermann C, 1994, Adv Pharmacol, V28, P45, DOI 10.1016/S1054-3589(08)60493-7; Thiemermann C, 1997, GEN PHARMACOL-VASC S, V29, P159, DOI 10.1016/S0306-3623(96)00410-7; THIEMERMANN C, 1993, BRIT J PHARMACOL, V110, P177, DOI 10.1111/j.1476-5381.1993.tb13789.x; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Vanholder R, 2001, INT J ARTIF ORGANS, V24, P695, DOI 10.1177/039139880102401004; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Yu M, 2011, CLIN J AM SOC NEPHRO, V6, P30, DOI 10.2215/CJN.05340610; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001	62	85	88	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76778	10.1371/journal.pone.0076778	http://dx.doi.org/10.1371/journal.pone.0076778			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098806	gold, Green Published			2022-12-25	WOS:000325423500177
J	Dai, H; Zhao, Y; Qian, C; Cai, M; Zhang, RY; Chu, MJ; Dai, JC; Hu, ZB; Shen, HB; Chen, F				Dai, Hui; Zhao, Yang; Qian, Cheng; Cai, Min; Zhang, Ruyang; Chu, Minjie; Dai, Juncheng; Hu, Zhibin; Shen, Hongbing; Chen, Feng			Weighted SNP Set Analysis in Genome-Wide Association Study	PLOS ONE			English	Article							MULTIPLE SNPS; SUSCEPTIBILITY; DISEASE; GENE; TESTS; LOCI	Genome-wide association studies (GWAS) are popular for identifying genetic variants which are associated with disease risk. Many approaches have been proposed to test multiple single nucleotide polymorphisms (SNPs) in a region simultaneously which considering disadvantages of methods in single locus association analysis. Kernel machine based SNP set analysis is more powerful than single locus analysis, which borrows information from SNPs correlated with causal or tag SNPs. Four types of kernel machine functions and principal component based approach (PCA) were also compared. However, given the loss of power caused by low minor allele frequencies (MAF), we conducted an extension work on PCA and used a new method called weighted PCA (wPCA). Comparative analysis was performed for weighted principal component analysis (wPCA), logistic kernel machine based test (LKM) and principal component analysis (PCA) based on SNP set in the case of different minor allele frequencies (MAF) and linkage disequilibrium (LD) structures. We also applied the three methods to analyze two SNP sets extracted from a real GWAS dataset of non-small cell lung cancer in Han Chinese population. Simulation results show that when the MAF of the causal SNP is low, weighted principal component and weighted IBS are more powerful than PCA and other kernel machine functions at different LD structures and different numbers of causal SNPs. Application of the three methods to a real GWAS dataset indicates that wPCA and wIBS have better performance than the linear kernel, IBS kernel and PCA.	[Dai, Hui; Zhao, Yang; Qian, Cheng; Cai, Min; Zhang, Ruyang; Chu, Minjie; Dai, Juncheng; Hu, Zhibin; Shen, Hongbing; Chen, Feng] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Ctr Canc, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Clin Epidemiol Sect, Nanjing, Jiangsu, Peoples R China; [Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Chen, F (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	fengchen@njmu.edu.cn		Chen, Feng/0000-0002-2699-7190	National Natural Science Foundation of China [NSFC81072389, NSFC30901232]; Natural Science Foundation of the Jiangsu Higher Education Institutions of China [11KJA330001, 10KJA33034]; Research Fund for the Doctoral Program of Higher Education of China [2011323411002]; Research and the Innovation Project for College Graduates of Jiangsu Province [CXZZ11_0733]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Research and the Innovation Project for College Graduates of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (NSFC81072389 to FC, NSFC30901232 to YZ), Key Grant of Natural Science Foundation of the Jiangsu Higher Education Institutions of China (11KJA330001 and 10KJA33034), the Research Fund for the Doctoral Program of Higher Education of China (2011323411002), the Research and the Innovation Project for College Graduates of Jiangsu Province (CXZZ11_0733) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or prepararion of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Gao QS, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-75; Gauderman WJ, 2007, GENET EPIDEMIOL, V31, P383, DOI 10.1002/gepi.20219; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Khoury MJ, 2007, INT J EPIDEMIOL, V36, P439, DOI 10.1093/ije/dyl253; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Li Ang, 2005, Zhonghua Yi Xue Za Zhi, V85, P2623; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Liu DW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-292; Liu PY, 2010, CANCER EPIDEM BIOMAR, V19, P517, DOI 10.1158/1055-9965.EPI-09-0791; McKeen HD, 2011, BIOCHEM SOC T, V39, P663, DOI 10.1042/BST0390663; Montana G, 2005, BIOINFORMATICS, V21, P4309, DOI 10.1093/bioinformatics/bti689; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Pan W, 2009, GENET EPIDEMIOL, V33, P497, DOI 10.1002/gepi.20402; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Witte JS, 2010, ANNU REV PUBL HEALTH, V31, P9, DOI 10.1146/annurev.publhealth.012809.103723; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Zhao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044978; Zienolddiny S, 2009, CARCINOGENESIS, V30, P1368, DOI 10.1093/carcin/bgp131	25	3	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75897	10.1371/journal.pone.0075897	http://dx.doi.org/10.1371/journal.pone.0075897			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098741	Green Published, gold, Green Submitted			2022-12-25	WOS:000325423500112
J	Lucidarme, J; Findlow, J; Chan, H; Feavers, IM; Gray, SJ; Kaczmarski, EB; Parkhill, J; Bai, XL; Borrow, R; Bayliss, CD				Lucidarme, Jay; Findlow, Jamie; Chan, Hannah; Feavers, Ian M.; Gray, Stephen J.; Kaczmarski, Edward B.; Parkhill, Julian; Bai, Xilian; Borrow, Ray; Bayliss, Christopher D.			The Distribution and 'In Vivo' Phase Variation Status of Haemoglobin Receptors in Invasive Meningococcal Serogroup B Disease: Genotypic and Phenotypic Analysis	PLOS ONE			English	Article							TRANSFERRIN-BINDING PROTEINS; NEISSERIA-MENINGITIDIS; MULTICOMPONENT VACCINE; CONTINGENCY LOCI; FACTOR-H; ANTIBODIES; HPUAB; HMBR; HAPTOGLOBIN; VIRULENCE	Two haemoglobin-binding proteins, HmbR and HpuAB, contribute to iron acquisition by Neisseria meningitidis. These receptors are subject to high frequency, reversible switches in gene expression - phase variation (PV) - due to mutations in homopolymeric (poly-G) repeats present in the open reading frame. The distribution and PV state of these receptors was assessed for a representative collection of isolates from invasive meningococcal disease patients of England, Wales and Northern Ireland. Most of the major clonal complexes had only the HmbR receptor whilst the recently expanding ST-275-centred cluster of the ST-269 clonal complex had both receptors. At least one of the receptors was in an 'ON' configuration in 76.3% of the isolates, a finding that was largely consistent with phenotypic analyses. As PV status may change during isolation and culture of meningococci, a PCR-based protocol was utilised to confirm the expression status of the receptors within contemporaneously acquired clinical specimens (blood/cerebrospinal fluid) from the respective patients. The expression state was confirmed for all isolate/specimen pairs with <15 tract repeats indicating that the PV status of these receptors is stable during isolation. This study therefore establishes a protocol for determining in vivo PV status to aid in determining the contributions of phase variable genes to invasive meningococcal disease. Furthermore, the results of the study support a putative but non-essential role of the meningococcal haemoglobin receptors as virulence factors whilst further highlighting their vaccine candidacy.	[Lucidarme, Jay; Findlow, Jamie; Gray, Stephen J.; Kaczmarski, Edward B.; Bai, Xilian; Borrow, Ray] Publ Hlth England, Manchester, Lancs, England; [Chan, Hannah; Feavers, Ian M.] Natl Inst Biol Stand & Controls, Potters Bar, Herts, England; [Parkhill, Julian] Wellcome Trust Sanger Inst, Cambridge, England; [Bayliss, Christopher D.] Univ Leicester, Leicester, Leics, England	Public Health England; National Institute for Biological Standards & Control; Wellcome Trust Sanger Institute; University of Leicester	Lucidarme, J (corresponding author), Publ Hlth England, Manchester, Lancs, England.	jay.lucidarme@phe.gov.uk	Parkhill, Julian/G-4703-2011	Parkhill, Julian/0000-0002-7069-5958; Bayliss, Christopher/0000-0002-5564-2145	Meningitis Research Foundation [1002.0]	Meningitis Research Foundation(Meningitis Research Foundation (MRF))	This study was supported by the Meningitis Research Foundation, grant number 1002.0 entitled "Examination of meningococcal haemoglobin receptors as potential vaccine targets". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAALDEEN DAA, 1994, INFECT IMMUN, V62, P2984, DOI 10.1128/IAI.62.7.2984-2990.1994; Arnold R, 2011, VACCINE, V29, P7100, DOI 10.1016/j.vaccine.2011.06.120; Bai XL, 2011, EXPERT OPIN BIOL TH, V11, P969, DOI 10.1517/14712598.2011.585965; Bayliss CD, 2001, J CLIN INVEST, V107, P657, DOI 10.1172/JCI12557; Bidmos FA, 2011, J CLIN MICROBIOL, V49, P506, DOI 10.1128/JCM.01322-10; CARTWRIGHT KAV, 1987, EPIDEMIOL INFECT, V99, P591, DOI 10.1017/S0950268800066449; Chang Qiuzhi, 2012, Clin Epidemiol, V4, P237, DOI 10.2147/CLEP.S28410; Chen CJ, 2002, J BACTERIOL, V184, P420, DOI 10.1128/JB.184.2.420-426.2002; DANVE B, 1993, VACCINE, V11, P1214, DOI 10.1016/0264-410X(93)90045-Y; Evans NJ, 2010, MICROBIOL-SGM, V156, P1384, DOI 10.1099/mic.0.036475-0; Gray SJ, 2006, J MED MICROBIOL, V55, P887, DOI 10.1099/jmm.0.46288-0; Harrison OB, 2009, J INFECT DIS, V200, P94, DOI 10.1086/599377; HOLBEIN BE, 1981, INFECT IMMUN, V34, P120, DOI 10.1128/IAI.34.1.120-125.1981; Jiang HQ, 2010, VACCINE, V28, P6086, DOI 10.1016/j.vaccine.2010.06.083; Lewis LA, 1997, MOL MICROBIOL, V23, P737, DOI 10.1046/j.1365-2958.1997.2501619.x; Lewis LA, 1999, MOL MICROBIOL, V32, P977, DOI 10.1046/j.1365-2958.1999.01409.x; Lewis LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001027; Lucidarme J, 2012, THESIS U MANCHESTER; Lucidarme J, 2009, J CLIN MICROBIOL, V47, P3577, DOI 10.1128/JCM.00936-09; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Martin P, 2003, MOL MICROBIOL, V50, P245, DOI 10.1046/j.1365-2958.2003.03678.x; Omer H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017145; Pace D, 2009, VACCINE, V27, pB30, DOI 10.1016/j.vaccine.2009.05.003; Perkins-Balding D, 2004, MICROBIOL MOL BIOL R, V68, P154, DOI 10.1128/MMBR.68.1.154-171.2004; Pintor M, 1996, MICROB PATHOGENESIS, V20, P127, DOI 10.1006/mpat.1996.0012; Riepsamen AH, 2011, J MOL EVOL, V72, P182, DOI 10.1007/s00239-010-9414-3; Rohde KH, 2004, INFECT IMMUN, V72, P2494, DOI 10.1128/IAI.72.5.2494-2506.2004; Rokbi B, 2000, INFECT IMMUN, V68, P4938, DOI 10.1128/IAI.68.9.4938-4947.2000; Serruto D, 2012, VACCINE, V30, pB87, DOI 10.1016/j.vaccine.2012.01.033; SIERRA G V G, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P195; STOJILJKOVIC I, 1995, MOL MICROBIOL, V15, P531, DOI 10.1111/j.1365-2958.1995.tb02266.x; Tauseef I, 2011, MICROBIOL-SGM, V157, P1446, DOI 10.1099/mic.0.046946-0; Vogel U, 2013, LANCET INFECT DIS, V13, P416, DOI 10.1016/S1473-3099(13)70006-9; Weynants VE, 2007, INFECT IMMUN, V75, P5434, DOI 10.1128/IAI.00411-07; WYLE FA, 1972, J INFECT DIS, V126, P514, DOI 10.1093/infdis/126.5.514	36	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76932	10.1371/journal.pone.0076932	http://dx.doi.org/10.1371/journal.pone.0076932			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098814	Green Published, gold, Green Submitted			2022-12-25	WOS:000325423500185
J	Ruff, SE; Arnds, J; Knittel, K; Amann, R; Wegener, G; Ramette, A; Boetius, A				Ruff, S. Emil; Arnds, Julia; Knittel, Katrin; Amann, Rudolf; Wegener, Gunter; Ramette, Alban; Boetius, Antje			Microbial Communities of Deep-Sea Methane Seeps at Hikurangi Continental Margin (New Zealand)	PLOS ONE			English	Article							MOSBY MUD VOLCANO; IN-SITU HYBRIDIZATION; COLD SEEP; ANAEROBIC METHANOTROPHS; BACTERIAL DIVERSITY; SULFATE REDUCTION; IDENTIFICATION; OXIDATION; HABITATS; BIOGEOCHEMISTRY	The methane-emitting cold seeps of Hikurangi margin (New Zealand) are among the few deep-sea chemosynthetic ecosystems of the Southern Hemisphere known to date. Here we compared the biogeochemistry and microbial communities of a variety of Hikurangi cold seep ecosystems. These included highly reduced seep habitats dominated by bacterial mats, partially oxidized habitats populated by heterotrophic ampharetid polychaetes and deeply oxidized habitats dominated by chemosynthetic frenulate tubeworms. The ampharetid habitats were characterized by a thick oxic sediment layer that hosted a diverse and biomass-rich community of aerobic methanotrophic Gammaproteobacteria. These bacteria consumed up to 25% of the emanating methane and clustered within three deep-branching groups named Marine Methylotrophic Group (MMG) 1-3. MMG1 and MMG2 methylotrophs belong to the order Methylococcales, whereas MMG3 methylotrophs are related to the Methylophaga. Organisms of the groups MMG1 and MMG3 are close relatives of chemosynthetic endosymbionts of marine invertebrates. The anoxic sediment layers of all investigated seeps were dominated by anaerobic methanotrophic archaea (ANME) of the ANME-2 clade and sulfate-reducing Deltaproteobacteria. Microbial community analysis using Automated Ribosomal Intergenic Spacer Analysis (ARISA) showed that the different seep habitats hosted distinct microbial communities, which were strongly influenced by the seep-associated fauna and the geographic location. Despite outstanding features of Hikurangi seep communities, the organisms responsible for key ecosystem functions were similar to those found at seeps worldwide. This suggests that similar types of biogeochemical settings select for similar community composition regardless of geographic distance. Because ampharetid polychaetes are widespread at cold seeps the role of aerobic methanotrophy may have been underestimated in seafloor methane budgets.	[Ruff, S. Emil; Wegener, Gunter; Ramette, Alban; Boetius, Antje] Max Planck Inst Marine Mikrobiol, HGF MPG Grp Deep Sea Ecol & Technol, D-28359 Bremen, Germany; [Ruff, S. Emil; Arnds, Julia; Knittel, Katrin; Amann, Rudolf] Max Planck Inst Marine Mikrobiol, Dept Mol Ecol, D-28359 Bremen, Germany; [Wegener, Gunter; Boetius, Antje] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany; [Boetius, Antje] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany	Max Planck Society; Max Planck Society; University of Bremen; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Ruff, SE (corresponding author), Max Planck Inst Marine Mikrobiol, HGF MPG Grp Deep Sea Ecol & Technol, D-28359 Bremen, Germany.	eruff@mpi-bremen.de	Amann, Rudolf I/C-6534-2014; Boetius, Antje/D-5459-2013; Ruff, Emil/H-4249-2019; Ramette, Alban/E-9197-2016	Amann, Rudolf I/0000-0002-0846-7372; Boetius, Antje/0000-0003-2117-4176; Ruff, Emil/0000-0002-6872-6188; Ramette, Alban/0000-0002-3437-4639; Wegener, Gunter/0000-0002-6819-373X	German Ministry of Education and Research [03G0608A]; Max Planck Society; DFG Leibniz program	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); DFG Leibniz program(German Research Foundation (DFG))	Cruise SO191 was part of the COMET/MUMM II project within the program GEOTECHNOLOGIEN funded by the German Ministry of Education and Research (Grant No: 03G0608A). Further support was provided by the Max Planck Society, and by the DFG Leibniz program to AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNDS J, 2009, MOL CHARACTERIZATION, P158; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Baco AR, 2010, MAR GEOL, V272, P251, DOI 10.1016/j.margeo.2009.06.015; Bent SJ, 2008, ISME J, V2, P689, DOI 10.1038/ismej.2008.44; Bernardino AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033515; BIALAS J, 2007, SO LEIBN I MAR SCI F, P190; Bienhold C, 2012, ISME J, V6, P724, DOI 10.1038/ismej.2011.140; Boer SI, 2009, ISME J, V3, P780, DOI 10.1038/ismej.2009.29; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Carlier A, 2010, MAR BIOL, V157, P2545, DOI 10.1007/s00227-010-1518-1; CHAO A, 1984, SCAND J STAT, V11, P265; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Degelmann DM, 2010, APPL ENVIRON MICROB, V76, P3228, DOI 10.1128/AEM.02730-09; Felden J, 2010, LIMNOL OCEANOGR, V55, P2366, DOI 10.4319/lo.2010.55.6.2366; FELDEN J, 2013, BIOGEOSCIENCES DISCU, V10, P335, DOI DOI 10.5194/BGD-10-335-2013; Fischer D., 2011, BIOGEOSCIENCES DISCU, V8, P9763, DOI DOI 10.5194/BGD-8-9763-2011; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; Greinert J, 2010, MAR GEOL, V272, P6, DOI 10.1016/j.margeo.2010.01.017; Grunke S, 2012, BIOGEOSCIENCES, V9, P2947, DOI 10.5194/bg-9-2947-2012; Hamdan LJ, 2011, FEMS MICROBIOL ECOL, V77, P518, DOI 10.1111/j.1574-6941.2011.01133.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hankeln W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024797; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HAYASHI T, 2007, RES J ENV SCI, V1, P275, DOI DOI 10.3923/RJES.2007.275.284; Hewson I, 2006, MICROB ECOL, V51, P147, DOI 10.1007/s00248-005-0144-9; Hewson I, 2007, ENVIRON MICROBIOL, V9, P923, DOI 10.1111/j.1462-2920.2006.01214.x; Inagaki F, 2004, APPL ENVIRON MICROB, V70, P7445, DOI 10.1128/AEM.70.12.7445-7455.2004; Ishii K, 2004, FEMS MICROBIOL ECOL, V50, P203, DOI 10.1016/j.femsec.2004.06.015; Jones AT, 2010, MAR GEOL, V272, P154, DOI 10.1016/j.margeo.2009.03.008; JORGENSEN BB, 1977, LIMNOL OCEANOGR, V22, P657, DOI 10.4319/lo.1977.22.4.0657; Jorgensen BB, 2001, DEEP-SEA RES PT I, V48, P2097, DOI 10.1016/S0967-0637(01)00007-3; JUKES TH, 1969, EVOLUTION PROTEIN MO, P566; Kallmeyer J, 2004, LIMNOL OCEANOGR-METH, V2, P171, DOI 10.4319/lom.2004.2.171; KIMURA M, 1983, NEUTRAL THEORY MOL E, P369; Klaucke I, 2010, MAR GEOL, V272, P49, DOI 10.1016/j.margeo.2009.02.009; Knittel K, 2005, APPL ENVIRON MICROB, V71, P467, DOI 10.1128/AEM.71.1.467-479.2005; Knittel K, 2003, GEOMICROBIOL J, V20, P269, DOI 10.1080/01490450303896; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Krabbenhoeft A, 2010, MAR GEOL, V272, P71, DOI 10.1016/j.margeo.2009.08.001; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Levin LA, 2007, MAR ECOL-EVOL PERSP, V28, P131, DOI 10.1111/j.1439-0485.2006.00131.x; Lewis KB, 1996, NEW ZEAL J GEOL GEOP, V39, P181, DOI 10.1080/00288306.1996.9514704; Lichtschlag A, 2010, LIMNOL OCEANOGR, V55, P931, DOI 10.4319/lo.2009.55.2.0931; Losekann T, 2007, APPL ENVIRON MICROB, V73, P3348, DOI 10.1128/AEM.00016-07; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Naudts L, 2010, MAR GEOL, V272, P233, DOI 10.1016/j.margeo.2009.08.002; Thang NM, 2013, ESTUAR COAST, V36, P98, DOI 10.1007/s12237-012-9557-0; Niemann H, 2009, BIOGEOSCIENCES, V6, P2383, DOI 10.5194/bg-6-2383-2009; Niemann H, 2006, NATURE, V443, P854, DOI 10.1038/nature05227; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Pruesse E, 2012, BIOINFORMATICS; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ramette A, 2009, APPL ENVIRON MICROB, V75, P2495, DOI 10.1128/AEM.02409-08; RIDGWAY N M, 1969, New Zealand Journal of Marine and Freshwater Research, V3, P57; Ristova PP, 2012, BIOGEOSCIENCES, V9, P5031, DOI 10.5194/bg-9-5031-2012; Roalkvam I, 2011, FEMS MICROBIOL ECOL, V78, P233, DOI 10.1111/j.1574-6941.2011.01153.x; Rogers AD, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001234; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schreiber L, 2010, ENVIRON MICROBIOL, V12, P2327, DOI 10.1111/j.1462-2920.2010.02275.x; Sellanes J, 2008, ICES J MAR SCI, V65, P1102, DOI 10.1093/icesjms/fsn099; Sommer S, 2010, MAR GEOL, V272, P223, DOI 10.1016/j.margeo.2009.06.003; Tavormina PL, 2008, APPL ENVIRON MICROB, V74, P3985, DOI 10.1128/AEM.00069-08; Thurber AR, 2010, MAR GEOL, V272, P260, DOI 10.1016/j.margeo.2009.06.001; Urakawa H, 2000, ENVIRON MICROBIOL, V2, P542, DOI 10.1046/j.1462-2920.2000.00137.x; Villeneuve C, 2012, J BACTERIOL, V194, P4126, DOI 10.1128/JB.00726-12; Walsh DA, 2009, SCIENCE, V326, P578, DOI 10.1126/science.1175309; Wegener G, 2008, BIOGEOSCIENCES, V5, P1127, DOI 10.5194/bg-5-1127-2008; Yilmaz P, 2011, NAT BIOTECHNOL, V29, P415, DOI 10.1038/nbt.1823; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	73	57	60	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e72627	10.1371/journal.pone.0072627	http://dx.doi.org/10.1371/journal.pone.0072627			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098632	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500004
J	Schaumberg, DA; Uchino, M; Christen, WG; Semba, RD; Buring, JE; Li, JZ				Schaumberg, Debra A.; Uchino, Miki; Christen, William G.; Semba, Richard D.; Buring, Julie E.; Li, Jim Z.			Patient Reported Differences in Dry Eye Disease between Men and Women: Impact, Management, and Patient Satisfaction	PLOS ONE			English	Article							WORKSHOP 2007; CARDIOVASCULAR-DISEASE; PHYSICIANS HEALTH; BETA-CAROTENE; HIGH-ALTITUDE; PREVALENCE; SUBCOMMITTEE; POPULATION; VALIDATION; THERAPY	Purpose: Dry eye disease affects women twice as often as men, but there is little information on whether dry eye treatments, treatment satisfaction, or the impact of dry eye disease on patients' lives and vision might differ by sex. Design: Questionnaire survey of 4000 participants in the Women's Health Study and the Physicians' Health Studies I and II with a prior report of a diagnosis of DED. Methods: Among participants who re-confirmed a diagnosis of dry eye disease, we assessed symptoms, treatments, patient satisfaction and impact of dry eye disease, and analyzed differences between men and women using regression models. Results: The final study population consisted of 1,518 women (mean age 70.7 years) and 581 men (mean age 76.7 years), with a mean reported duration of dry eye disease of 10.5 years and 10.1 years, respectively. The frequency and severity of dry eye disease symptoms were higher among women (each P<0.0001), and women reported a greater impact on everyday activities (P<0.0001). Women were more likely to use artificial tears (P<0.0001) use them more often (P<0.0001), and to use Restasis (R) (P<0.0001), omega-3 fatty acids (P=0.0006), and have punctal occlusion (P=0.005). Women spent more money per month on dry eye treatments (P<0.0001), but reported greater dissatisfaction with treatment side effects (P=0.001), and the amount of time before treatments started working (P=0.03). Conclusions: These data show that dry eye disease is generally experienced as being more severe among women, having a greater impact on their self-assessed well-being.	[Schaumberg, Debra A.; Christen, William G.; Semba, Richard D.; Buring, Julie E.] Harvard Univ, Brigham & Womens Hosp, Div Prevent Med, Sch Med, Boston, MA 02115 USA; [Schaumberg, Debra A.] Univ Utah, Dept Ophthalmol & Visual Sci, Ctr Translat Med, John A Moran Eye Ctr,Sch Med, Salt Lake City, UT USA; [Schaumberg, Debra A.] Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA USA; [Schaumberg, Debra A.; Buring, Julie E.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Uchino, Miki] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Semba, Richard D.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA; [Li, Jim Z.] Pfizer Inc, Global Outcomes Res, San Diego, CA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Utah System of Higher Education; University of Utah; Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Harvard T.H. Chan School of Public Health; Keio University; Johns Hopkins University; Johns Hopkins Medicine; Pfizer	Schaumberg, DA (corresponding author), Harvard Univ, Brigham & Womens Hosp, Div Prevent Med, Sch Med, Boston, MA 02115 USA.	debra.schaumberg@utah.edu	Uchino, Miki/T-9102-2019		Pfizer, Inc.; National Institutes of Health (NIH) [CA40360, CA47988, HL43851]; NATIONAL CANCER INSTITUTE [R01CA047988, R01CA040360] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851] Funding Source: NIH RePORTER	Pfizer, Inc.(Pfizer); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was sponsored by Pfizer, Inc. Follow-up of the Physicians' Health Study cohort is supported by National Institutes of Health (NIH) grant CA40360, and the Women's Health Study by NIH grants CA47988 and HL43851. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Christen WG, 2000, ANN EPIDEMIOL, V10, P125, DOI 10.1016/S1047-2797(99)00042-3; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; Gulati A, 2006, AM J OPHTHALMOL, V142, P125, DOI 10.1016/j.ajo.2006.02.038; Guo B, 2010, OPHTHAL EPIDEMIOL, V17, P234, DOI 10.3109/09286586.2010.498659; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; Lee AJ, 2002, BRIT J OPHTHALMOL, V86, P1347, DOI 10.1136/bjo.86.12.1347; Lemp MA, 2007, OCUL SURF, V5, P75; Lin PY, 2003, OPHTHALMOLOGY, V110, P1096, DOI 10.1016/S0161-6420(03)00262-8; Lu P, 2008, CORNEA, V27, P545, DOI 10.1097/ICO.0b013e318165b1b7; Miljanovic B, 2005, AM J CLIN NUTR, V82, P887, DOI 10.1093/ajcn/82.4.887; Miljanovic B, 2007, AM J OPHTHALMOL, V143, P409, DOI 10.1016/j.ajo.2006.11.060; Pflugfelder SC, 2007, OCUL SURF, V5, P163; Popescu A, 2010, PAIN, V150, P309, DOI 10.1016/j.pain.2010.05.013; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Riley JL, 1998, PAIN, V74, P181, DOI 10.1016/S0304-3959(97)00199-1; Schaumberg DA, 2003, AM J OPHTHALMOL, V136, P318, DOI 10.1016/S0002-9394(03)00218-6; Schaumberg DA, 2001, JAMA-J AM MED ASSOC, V286, P2114, DOI 10.1001/jama.286.17.2114; Schaumberg DA, 2007, OCUL SURF, V5, P50, DOI 10.1016/S1542-0124(12)70053-8; Schaumberg DA, 2009, ARCH OPHTHALMOL-CHIC, V127, P763, DOI 10.1001/archophthalmol.2009.103; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615; Smith JA, 2007, OCUL SURF, V5, P93; Uchino M, 2008, AM J OPHTHALMOL, V146, P925, DOI 10.1016/j.ajo.2008.06.030; Uchino M, 2008, OPHTHALMOLOGY, V115, P1982, DOI 10.1016/j.ophtha.2008.06.022	23	80	80	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76121	10.1371/journal.pone.0076121	http://dx.doi.org/10.1371/journal.pone.0076121			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098772	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500142
J	Schuetz, JM; Daley, D; Leach, S; Conde, L; Berry, BR; Gallagher, RP; Connors, JM; Gascoyne, RD; Bracci, PM; Skibola, CF; Spinelli, JJ; Brooks-Wilson, AR				Schuetz, Johanna M.; Daley, Denise; Leach, Stephen; Conde, Lucia; Berry, Brian R.; Gallagher, Richard P.; Connors, Joseph M.; Gascoyne, Randy D.; Bracci, Paige M.; Skibola, Christine F.; Spinelli, John J.; Brooks-Wilson, Angela R.			Non-Hodgkin Lymphoma Risk and Variants in Genes Controlling Lymphocyte Development	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; GERMLINE VARIATION; MISMATCH REPAIR; EARLY-ONSET; NEUROFIBROMATOSIS; SUSCEPTIBILITY; POLYMORPHISMS; INSTABILITY; EXPRESSION; APOPTOSIS	Non-Hodgkin lymphomas (NHL) are a heterogeneous group of solid tumours of lymphoid cell origin. Three important aspects of lymphocyte development include immunity and inflammation, DNA repair, and programmed cell death. We have used a previously established case-control study of NHL to ask whether genetic variation in genes involved in these three important processes influences risk of this cancer. 118 genes in these three categories were tagged with single nucleotide polymorphisms (SNPs), which were tested for association with NHL and its subtypes. The main analysis used logistic regression (additive model) to estimate odds ratios in European-ancestry cases and controls. 599 SNPs and 1116 samples (569 cases and 547 controls) passed quality control measures and were included in analyses. Following multiple-testing correction, one SNP in MSH3, a mismatch repair gene, showed an association with diffuse large B-cell lymphoma (OR: 1.91; 95% CI: 1.41-2.59; uncorrected p = 0.00003; corrected p = 0.010). This association was not replicated in an independent European-ancestry sample set of 251 diffuse large B-cell lymphoma cases and 737 controls, indicating this result was likely a false positive. It is likely that moderate sample size, inter-subtype and other genetic heterogeneity, and small true effect sizes account for the lack of replicable findings.	[Schuetz, Johanna M.; Leach, Stephen; Brooks-Wilson, Angela R.] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Daley, Denise] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Conde, Lucia; Skibola, Christine F.] Univ Alabama Birmingham, Ctr Comprehens Canc, Dept Epidemiol, Birmingham, AL 35294 USA; [Berry, Brian R.] Royal Jubilee Hosp, Dept Pathol, Victoria, BC, Canada; [Gallagher, Richard P.; Spinelli, John J.] BC Canc Agcy, Vancouver, BC, Canada; [Connors, Joseph M.] BC Canc Agcy, Div Med Oncol, Vancouver, BC, Canada; [Connors, Joseph M.; Gascoyne, Randy D.] BC Canc Agcy, Ctr Lymphoid Canc, Vancouver, BC, Canada; [Gascoyne, Randy D.] BC Canc Agcy, Dept Pathol, Vancouver, BC, Canada; [Bracci, Paige M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Spinelli, John J.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Brooks-Wilson, Angela R.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada	British Columbia Cancer Agency; University of British Columbia; University of Alabama System; University of Alabama Birmingham; British Columbia Cancer Agency; British Columbia Cancer Agency; British Columbia Cancer Agency; British Columbia Cancer Agency; University of California System; University of California San Francisco; University of British Columbia; Simon Fraser University	Brooks-Wilson, AR (corresponding author), BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada.	abrooks-wilson@bcgsc.ca	Brooks-Wilson, Angela/E-9399-2012; Gascoyne, Randy D/A-6009-2013; Conde, Lucia/D-9295-2011; Spinelli, John J./B-6210-2013; Connors, Joseph/AAF-5284-2019	Brooks-Wilson, Angela/0000-0003-1009-6408; Gascoyne, Randy D/0000-0002-2610-5690; Spinelli, John J./0000-0002-9119-3287; Connors, Joseph/0000-0002-1361-7531; Conde, Lucia/0000-0001-5180-543X	Canadian Institutes for Health Research (CIHR); Canadian Cancer Society; National Institutes of Health, National Cancer Institute [R01CA87014, R03CA143947, R03CA150037, R01CA104682, RO1CA122663, RO1CA154643]; NATIONAL CANCER INSTITUTE [R03CA150037, R01CA104682, R03CA143947, R01CA087014, R01CA154643, R01CA122663] Funding Source: NIH RePORTER	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Canadian Institutes for Health Research (CIHR) and the Canadian Cancer Society. DD holds a Tier II Canada Research Chair (Genetic Epidemiology of Common Complex Diseases). AB-W is a Senior Scholar, and DD and JG are Scholars of the Michael Smith Foundation for Health Research. For the UCSF study, CFS and PMB have support from the National Institutes of Health, National Cancer Institute (R01CA87014, R03CA143947, R03CA150037, R01CA104682, RO1CA122663, RO1CA154643). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bajdik CD, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-17; Bandipalliam P, 2005, FAM CANCER, V4, P323, DOI 10.1007/s10689-005-8351-6; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Browning BL, 2009, AM J HUM GENET, V85, P847, DOI 10.1016/j.ajhg.2009.11.004; CALVERT R, 1995, LANCET, V345, P26, DOI 10.1016/S0140-6736(95)91154-5; Campbell MR, 2005, CANCER RES, V65, P2626, DOI 10.1158/0008-5472.CAN-04-3158; Cerhan JR, 2008, CANCER EPIDEM BIOMAR, V17, P3161, DOI 10.1158/1055-9965.EPI-08-0536; Cerhan JR, 2007, BLOOD, V110, P4455, DOI 10.1182/blood-2007-05-088682; Halder I, 2008, HUM MUTAT, V29, P648, DOI 10.1002/humu.20695; HAMILTON SR, 1995, NEW ENGL J MED, V332, P839, DOI 10.1056/NEJM199503303321302; INOKUCHI K, 1995, BIOCHEM BIOPH RES CO, V214, P171, DOI 10.1006/bbrc.1995.2271; Jiricny J, 1998, EMBO J, V17, P6427, DOI 10.1093/emboj/17.22.6427; Kelly JL, 2010, CANCER EPIDEM BIOMAR, V19, P2847, DOI 10.1158/1055-9965.EPI-10-0581; Morton LM, 2009, CANCER EPIDEM BIOMAR, V18, P1259, DOI 10.1158/1055-9965.EPI-08-1037; Nagy M, 2000, LEUKEMIA, V14, P2142, DOI 10.1038/sj.leu.2401978; Ostergaard JR, 2005, AM J MED GENET A, V139A, P96, DOI 10.1002/ajmg.a.30998; Purdue MP, 2007, CARCINOGENESIS, V28, P704, DOI 10.1093/carcin/bgl200; Rothman N, 2006, LANCET ONCOL, V7, P27, DOI 10.1016/S1470-2045(05)70434-4; Schuetz JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031560; Schuetz JM, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-117; Skibola CF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002816; Spinelli JJ, 2007, INT J CANCER, V121, P2767, DOI 10.1002/ijc.23005; Tan A, 2011, BIOINFORMATICS, V27, P2422, DOI 10.1093/bioinformatics/btr389; Trimbath J D, 2001, Fam Cancer, V1, P101; Volpe G, 1996, ANN HEMATOL, V72, P67, DOI 10.1007/BF00641310; Wang SS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005360	28	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75170	10.1371/journal.pone.0075170	http://dx.doi.org/10.1371/journal.pone.0075170			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098683	gold, Green Submitted, Green Published			2022-12-25	WOS:000325423500054
J	Tan, K; Hu, ZW; Chen, WW; Wang, ZW; Wang, YC; Nieh, JC				Tan, Ken; Hu, Zongwen; Chen, Weiwen; Wang, Zhengwei; Wang, Yuchong; Nieh, James C.			Fearful Foragers: Honey Bees Tune Colony and Individual Foraging to Multi-Predator Presence and Food Quality	PLOS ONE			English	Article							CRAB SPIDERS; TOP-DOWN; TROPHIC CASCADES; ECOLOGY; CHOICE; RISK; ANTIPREDATOR; POLLINATORS; HYMENOPTERA; BEHAVIOR	Fear can have strong ecosystem effects by giving predators a role disproportionate to their actual kill rates. In bees, fear is shown through foragers avoiding dangerous food sites, thereby reducing the fitness of pollinated plants. However, it remains unclear how fear affects pollinators in a complex natural scenario involving multiple predator species and different patch qualities. We studied hornets, Vespa velutina (smaller) and V. tropica (bigger) preying upon the Asian honey bee, Apis cerana in China. Hornets hunted bees on flowers and were attacked by bee colonies. Bees treated the bigger hornet species (which is 4 fold more massive) as more dangerous. It received 4.5 fold more attackers than the smaller hornet species. We tested bee responses to a three-feeder array with different hornet species and varying resource qualities. When all feeders offered 30% sucrose solution (w/w), colony foraging allocation, individual visits, and individual patch residence times were reduced according to the degree of danger. Predator presence reduced foraging visits by 55-79% and residence times by 17-33%. When feeders offered different reward levels (15%, 30%, or 45% sucrose), colony and individual foraging favored higher sugar concentrations. However, when balancing food quality against multiple threats (sweeter food corresponding to higher danger), colonies exhibited greater fear than individuals. Colonies decreased foraging at low and high danger patches. Individuals exhibited less fear and only decreased visits to the high danger patch. Contrasting individual with emergent colony-level effects of fear can thus illuminate how predators shape pollination by social bees.	[Tan, Ken] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Peoples R China; [Tan, Ken; Hu, Zongwen; Chen, Weiwen; Wang, Zhengwei; Wang, Yuchong] Yunnan Agr Univ, Eastern Bee Res Inst, Kunming, Peoples R China; [Nieh, James C.] Univ Calif San Diego, Sect Ecol Behav & Evolut, Div Biol Sci, La Jolla, CA 92093 USA	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Yunnan Agricultural University; University of California System; University of California San Diego	Tan, K (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Peoples R China.	kentan@xtbg.ac.cn	Nieh, James C/H-8705-2014	Nieh, James C/0000-0001-6237-0726	Key Laboratory of Tropical Forest Ecology, Xishuangbanna Tropical Botanical Garden; Chinese Academy of Science [XTBG-T01]; China National Research Fund [31260585]	Key Laboratory of Tropical Forest Ecology, Xishuangbanna Tropical Botanical Garden; Chinese Academy of Science(Chinese Academy of Sciences); China National Research Fund	This work was supported by the Key Laboratory of Tropical Forest Ecology, Xishuangbanna Tropical Botanical Garden, and the CAS 135 program (XTBG-T01) of Chinese Academy of Science, China National Research Fund (31260585) to Ken Tan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KR, 2009, ANIM BEHAV, V78, P633, DOI 10.1016/j.anbehav.2009.05.029; Abrol Dharam Pal, 2006, Journal of Apicultural Science, V50, P39; Anderson C, 1999, BEHAV ECOL SOCIOBIOL, V46, P73, DOI 10.1007/s002650050595; Blumstein DT, 2006, ANIM BEHAV, V71, P389, DOI 10.1016/j.anbehav.2005.05.010; Borrell BJ, 2006, J EXP BIOL, V209, P4901, DOI 10.1242/jeb.02593; Brown JS, 1999, J MAMMAL, V80, P385, DOI 10.2307/1383287; Buchmann S.L., 1997, FORGOTTEN POLLINATOR; Burgett M., 1982, Psyche (Cambridge), V89, P347, DOI 10.1155/1982/37970; COLINVAUX P, 1978, WHY BIG FIERCE ANIMA; Corlett RT, 2001, J TROP ECOL, V17, P155, DOI 10.1017/S0266467401001109; Dukas R, 2005, ECOLOGY, V86, P1401, DOI 10.1890/04-1663; Dukas R, 2005, ECOSCIENCE, V12, P244, DOI 10.2980/i1195-6860-12-2-244.1; Dukas R, 2003, OIKOS, V101, P157, DOI 10.1034/j.1600-0706.2003.12143.x; Dukas R, 2001, ECOL LETT, V4, P327, DOI 10.1046/j.1461-0248.2001.00228.x; Dyer FC, 2002, ANNU REV ENTOMOL, V47, P917, DOI 10.1146/annurev.ento.47.091201.145306; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Giurfa M, 2004, NATURWISSENSCHAFTEN, V91, P228, DOI 10.1007/s00114-004-0530-z; Goncalves-Souza T, 2008, ECOLOGY, V89, P2407, DOI 10.1890/07-1881.1; Guan Huang Y, 2005, ACTA ENTOMOLOGICA SI, V3; Hanna C, 2013, J APPL ECOL, V50, P147, DOI 10.1111/1365-2664.12027; Higginson AD, 2010, OECOLOGIA, V164, P411, DOI 10.1007/s00442-010-1681-6; Hilton GM, 1999, OIKOS, V87, P295, DOI 10.2307/3546744; IVES AR, 1987, AM NAT, V130, P431, DOI 10.1086/284719; Jha S, 2013, P NATL ACAD SCI USA, V110, P555, DOI 10.1073/pnas.1208682110; Jones EI, 2011, BEHAV ECOL SOCIOBIOL, V65, P1505, DOI 10.1007/s00265-011-1160-z; Kim W, 2011, P NATL ACAD SCI USA, V108, P16618, DOI 10.1073/pnas.1108642108; Kingsolver J.G., 1995, P32; Knight TM, 2006, ECOL LETT, V9, P1173, DOI 10.1111/j.1461-0248.2006.00967.x; Knight TM, 2005, NATURE, V437, P880, DOI 10.1038/nature03962; KOTLER BP, 1991, ECOLOGY, V72, P2249, DOI 10.2307/1941575; Laundre J.W., 2010, OPEN ECOL J, V3, P1, DOI [10.2174/1874213001003030001, DOI 10.2174/1874213001003030001]; Lehman A., 2005, JMP BASIC UNIVARIATE; LIMA SL, 1992, ANN ZOOL FENN, V29, P217; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; Lima SL, 1998, ADV STUD BEHAV, V27, P215; Matsuura M, 1990, BIOL VESPINE WASPS; MORSE DH, 1986, AM MIDL NAT, V116, P341, DOI 10.2307/2425742; MORSE DH, 1979, OECOLOGIA, V39, P309, DOI 10.1007/BF00345442; MORSE DH, 1986, OIKOS, V46, P223, DOI 10.2307/3565470; MORSE DH, 1982, ECOLOGY, V63, P172, DOI 10.2307/1937042; Nieh JC, 2004, APIDOLOGIE, V35, P159, DOI 10.1051/apido:2004007; NONACS P, 1990, ECOLOGY, V71, P1886, DOI 10.2307/1937596; Partap U, 2011, HONEYBEES OF ASIA, P227, DOI 10.1007/978-3-642-16422-4_11; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Ranabhat N. B., 2009, J NATURAL HIST MUSEU, V23, P125, DOI DOI 10.3126/JNHM.V23I0.1849; Reader T, 2006, BEHAV ECOL, V17, P933, DOI 10.1093/beheco/arl027; Riginos C, 2008, ECOLOGY, V89, P2228, DOI 10.1890/07-1250.1; Robertson IC, 2005, OIKOS, V109, P577, DOI 10.1111/j.0030-1299.2005.13903.x; Romero GQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020689; ROUBIK DW, 1984, OECOLOGIA, V61, P1, DOI 10.1007/BF00379082; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; SEELEY TD, 1982, ECOL MONOGR, V52, P43, DOI 10.2307/2937344; Shurin JB, 2012, PHILOS T R SOC B, V367, P3008, DOI 10.1098/rstb.2012.0243; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; SIH A, 1992, AM NAT, V139, P1052, DOI 10.1086/285372; Suttle KB, 2003, ECOL LETT, V6, P688, DOI 10.1046/j.1461-0248.2003.00490.x; Tan K, 2008, NATURWISSENSCHAFTEN, V95, P1165, DOI 10.1007/s00114-008-0437-1; Tan K, 2007, NATURWISSENSCHAFTEN, V94, P469, DOI 10.1007/s00114-006-0210-2; Tan K, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14102; Tan K, 2012, ANIM BEHAV, V83, P879, DOI 10.1016/j.anbehav.2011.12.031; Tan K, 2012, APIDOLOGIE, V43, P195, DOI 10.1007/s13592-011-0098-5; Tepedino VJ, 1980, GREAT BASIN NAT, V3, P139; THOMSON JD, 1989, CAN J ZOOL, V67, P2588, DOI 10.1139/z89-364; WADDINGTON KD, 1990, J INSECT BEHAV, V3, P429, DOI 10.1007/BF01052010; WELLS P H, 1968, Journal of Apicultural Research, V7, P77; Wendorf CA, 2012, STAT APA STYLE STA 4, P1; Wilby A, 2010, APPL MICROBIOL BIOT, V87, P87, DOI [10.1007/s00253-010-2573-8, DOI 10.1007/S00253-010-2573-8]; Wilson EE, 2010, ECOLOGY, V91, P3294, DOI 10.1890/09-1187.1; Zar J. H., 2009, BIOSTATISTICAL ANAL	70	28	30	3	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75841	10.1371/journal.pone.0075841	http://dx.doi.org/10.1371/journal.pone.0075841			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098734	Green Published, gold			2022-12-25	WOS:000325423500105
J	Chen, PC; Kryukova, YN; Shyng, SL				Chen, Pei-Chun; Kryukova, Yelena N.; Shyng, Show-Ling			Leptin Regulates K-ATP Channel Trafficking in Pancreatic beta-Cells by a Signaling Mechanism Involving AMP-activated Protein Kinase (AMPK) and cAMP-dependent Protein Kinase (PKA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Actin; AMP-activated kinase (AMPK); Endocytosis; Potassium Channels; cAMP-dependent Protein Kinase (PKA); Signal Transduction	SENSITIVE POTASSIUM CHANNELS; STIMULATED INSULIN-SECRETION; CONGENITAL HYPERINSULINISM; GLUCOSE-HOMEOSTASIS; ACTIN CYTOSKELETON; POMC NEURONS; FOOD-INTAKE; RAT; PHOSPHORYLATION; EXOCYTOSIS	Background: Leptin inhibits insulin secretion by increasing -cell K-ATP currents. Results: Leptin causes a transient increase in surface K-ATP channel density. This increase is dependent on AMPK and PKA and actin depolymerization. Conclusion: Leptin increases K-ATP currents by recruiting K-ATP channels to the -cell membrane. Significance: K-ATP channel trafficking is an important physiological mechanism to regulate channel activity. Pancreatic -cells secrete insulin in response to metabolic and hormonal signals to maintain glucose homeostasis. Insulin secretion is under the control of ATP-sensitive potassium (K-ATP) channels that play key roles in setting -cell membrane potential. Leptin, a hormone secreted by adipocytes, inhibits insulin secretion by increasing K-ATP channel conductance in -cells. We investigated the mechanism by which leptin increases K-ATP channel conductance. We show that leptin causes a transient increase in surface expression of K-ATP channels without affecting channel gating properties. This increase results primarily from increased channel trafficking to the plasma membrane rather than reduced endocytosis of surface channels. The effect of leptin on K-ATP channels is dependent on the protein kinases AMP-activated protein kinase (AMPK) and PKA. Activation of AMPK or PKA mimics and inhibition of AMPK or PKA abrogates the effect of leptin. Leptin activates AMPK directly by increasing AMPK phosphorylation at threonine 172. Activation of PKA leads to increased channel surface expression even in the presence of AMPK inhibitors, suggesting AMPK lies upstream of PKA in the leptin signaling pathway. Leptin signaling also leads to F-actin depolymerization. Stabilization of F-actin pharmacologically occludes, whereas destabilization of F-actin simulates, the effect of leptin on K-ATP channel trafficking, indicating that leptin-induced actin reorganization underlies enhanced channel trafficking to the plasma membrane. Our study uncovers the signaling and cellular mechanism by which leptin regulates K-ATP channel trafficking to modulate -cell function and insulin secretion.	[Chen, Pei-Chun; Kryukova, Yelena N.; Shyng, Show-Ling] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University	Shyng, SL (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Dept Biochem & Mol Biol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	shyngs@ohsu.edu		Chen, Pei-Chun/0000-0002-2550-6556	National Institutes of Health [DK57699, T32 DK007680]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007680, R01DK057699] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK57699 (to S.-L.S.). This work was presented in abstract form at the 2013 American Society for Biochemistry and Molecular Biology (ASBMB) Annual Meeting.; Supported by National Institutes of Health Grant T32 DK007680.	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; Beguin P, 1999, EMBO J, V18, P4722, DOI 10.1093/emboj/18.17.4722; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Bruederle CE, 2011, TRAFFIC, V12, P1242, DOI 10.1111/j.1600-0854.2011.01227.x; Chang TJ, 2009, DIABETOLOGIA, V52, P1112, DOI 10.1007/s00125-009-1337-4; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; CONGET JI, 1994, PANCREAS, V9, P157, DOI 10.1097/00006676-199403000-00003; Covey SD, 2006, CELL METAB, V4, P291, DOI 10.1016/j.cmet.2006.09.005; Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339; Fehmann HC, 1997, PEPTIDES, V18, P1267, DOI 10.1016/S0196-9781(97)00135-6; Gao S, 2007, P NATL ACAD SCI USA, V104, P17358, DOI 10.1073/pnas.0708385104; Geng XH, 2003, DIABETES, V52, P767, DOI 10.2337/diabetes.52.3.767; Gimenez-Cassina A, 2012, NEURON, V74, P719, DOI 10.1016/j.neuron.2012.03.032; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Harvey J, 2000, J BIOL CHEM, V275, P4660, DOI 10.1074/jbc.275.7.4660; Harvey J, 1998, J PHYSIOL-LONDON, V510, P47, DOI 10.1111/j.1469-7793.1998.047bz.x; Harvey J, 1997, J PHYSIOL-LONDON, V504, P527, DOI 10.1111/j.1469-7793.1997.527bd.x; Harvey J, 2000, J PHYSIOL-LONDON, V527, P95, DOI 10.1111/j.1469-7793.2000.00095.x; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hohmeier HE, 1997, DIABETES, V46, P968, DOI 10.2337/diabetes.46.6.968; Holzinger A, 2009, METHODS MOL BIOL, V586, P71, DOI 10.1007/978-1-60761-376-3_4; Inagaki N, 1997, FEBS LETT, V409, P232, DOI 10.1016/S0014-5793(97)00488-2; Insall RH, 2001, DEV CELL, V1, P743, DOI 10.1016/S1534-5807(01)00086-7; Jewell JL, 2008, J BIOL CHEM, V283, P10716, DOI 10.1074/jbc.M709876200; Johnson JL, 2012, MOL BIOL CELL, V23, P1902, DOI 10.1091/mbc.E11-12-1001; Kieffer TJ, 2000, AM J PHYSIOL-ENDOC M, V278, pE1, DOI 10.1152/ajpendo.2000.278.1.E1; Kieffer TJ, 1997, DIABETES, V46, P1087, DOI 10.2337/diabetes.46.6.1087; Kulkarni RN, 1997, J CLIN INVEST, V100, P2729, DOI 10.1172/JCI119818; Lam NT, 2004, J MOL ENDOCRINOL, V32, P415, DOI 10.1677/jme.0.0320415; Lee YM, 2008, J BIOL CHEM, V283, P33969, DOI 10.1074/jbc.M804469200; Licinio J, 1997, NAT MED, V3, P575, DOI 10.1038/nm0597-575; Lin CW, 2006, DIABETES, V55, P1738, DOI 10.2337/db05-1571; Lin YW, 2008, J BIOL CHEM, V283, P9146, DOI 10.1074/jbc.M708798200; Liss B, 2001, TRENDS PHARMACOL SCI, V22, P599, DOI 10.1016/S0165-6147(00)01861-7; McCann CM, 2005, BIOTECHNIQUES, V38, P945, DOI 10.2144/05386IT02; Meares GP, 2010, J BIOL CHEM, V285, P3191, DOI 10.1074/jbc.M109.047365; Miki T, 2001, NAT NEUROSCI, V4, P507, DOI 10.1038/87455; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Morioka T, 2007, J CLIN INVEST, V117, P2860, DOI 10.1172/JCI30910; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Ning K, 2006, EMBO J, V25, P2377, DOI 10.1038/sj.emboj.7601118; Ning K, 2009, J BIOL CHEM, V284, P9331, DOI 10.1074/jbc.M806774200; Niswender KD, 2007, J CLIN INVEST, V117, P2753, DOI 10.1172/JCI33528; Park SH, 2013, P NATL ACAD SCI USA, V110, P12673, DOI 10.1073/pnas.1216351110; Plum L, 2006, J CLIN INVEST, V116, P1886, DOI 10.1172/JCI27123; Schiemann J, 2012, NAT NEUROSCI, V15, P1272, DOI 10.1038/nn.3185; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Tobin VA, 2007, BIOCHEM SOC T, V35, P1243, DOI 10.1042/BST0351243; Tomas A, 2006, J CELL SCI, V119, P2156, DOI 10.1242/jcs.02942; Tomas A, 2010, TRAFFIC, V11, P123, DOI 10.1111/j.1600-0854.2009.00996.x; Uenishi E, 2013, J BIOL CHEM, V288, P25851, DOI 10.1074/jbc.M113.464420; Uotani S, 2006, BIOCHEM BIOPH RES CO, V351, P171, DOI 10.1016/j.bbrc.2006.10.015; Varadi A, 2006, DIABETOLOGIA, V49, P1567, DOI 10.1007/s00125-006-0257-9; Wakatsuki T, 2001, J CELL SCI, V114, P1025; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Yan FF, 2007, DIABETES, V56, P2339, DOI 10.2337/db07-0150; Yang SN, 2007, CELL METAB, V6, P217, DOI 10.1016/j.cmet.2007.08.002; Yang SB, 2012, NEURON, V75, P425, DOI 10.1016/j.neuron.2012.03.043; Yoshida H, 2012, J MOL CELL CARDIOL, V52, P410, DOI 10.1016/j.yjmcc.2011.08.013	66	58	59	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34098	34109		10.1074/jbc.M113.516880	http://dx.doi.org/10.1074/jbc.M113.516880			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24100028	Green Published, hybrid			2022-12-25	WOS:000327250200053
J	Crist, SA; Elzey, BD; Ahmann, MT; Ratliff, TL				Crist, Scott A.; Elzey, Bennett D.; Ahmann, Michelle T.; Ratliff, Timothy L.			Early Growth Response-1 (EGR-1) and Nuclear Factor of Activated T Cells (NFAT) Cooperate to Mediate CD40L Expression in Megakaryocytes and Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endothelial Cell; Inflammation; Platelets; Signaling; Transcription; Megakaryocytes	GENE-EXPRESSION; TRANSCRIPTION FACTORS; LIGAND EXPRESSION; CD34(+) CELLS; DIFFERENTIATION; INDUCE; CD154; MECHANISMS	Increasing evidence implicates circulating platelets as mediators of chronic inflammatory and autoimmune diseases via the expression and release of CD40L, an important modulator of inflammation and adaptive immune responses traditionally associated with activated T cells. Emerging evidence suggests that platelet CD40L is dynamically regulated in several chronic inflammatory and autoimmune diseases and may mediate progression and secondary pathology associated with those disease states. The present study identifies NFATc2 as a key transcriptional modulator of CD40L expression in megakaryocytes and inflammatory activity of platelets. Furthermore, the current data show that EGR-1, a member of the early growth response family of zinc finger transcription factors, modulates NFATc2-dependent regulation of CD40L expression in megakaryocytes. Our novel demonstration that in vivo biochemical or genetic inhibition of NFATc2 activity in megakaryocyte diminishes platelet CD40L implicates the NFATc2/EGR-1 axis as a key regulatory pathway of inflammatory and immunomodulatory activity in platelets and represents a target for the development of therapeutics for the potential treatment of chronic inflammatory and autoimmune diseases.	[Crist, Scott A.; Elzey, Bennett D.; Ahmann, Michelle T.; Ratliff, Timothy L.] Purdue Univ, Dept Comparat Pathobiol, Sch Vet Med, W Lafayette, IN 47907 USA; [Crist, Scott A.; Elzey, Bennett D.; Ratliff, Timothy L.] Purdue Univ, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Ratliff, TL (corresponding author), 239A Hansen Life Sci Bldg,201 S Univ St, W Lafayette, IN 47907 USA.	scrist@purdue.edu			National Institutes of Health [R01-AI06924]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AI06924.	Alfonso-Jaume MA, 2004, BIOCHEM J, V380, P735, DOI 10.1042/BJ20031281; Aliprantis AO, 2008, J CLIN INVEST, V118, P3775, DOI 10.1172/JCI35711; Arabanian LS, 2012, BRIT J HAEMATOL, V156, P523, DOI 10.1111/j.1365-2141.2011.08970.x; Athanasiou M, 1996, CELL GROWTH DIFFER, V7, P1525; Balow JE, 2000, CURR OPIN NEPHROL HY, V9, P107, DOI 10.1097/00041552-200003000-00003; Bastian LS, 1999, BLOOD, V93, P2637, DOI 10.1182/blood.V93.8.2637.408k20_2637_2644; Cha JK, 2000, J KOREAN MED SCI, V15, P273, DOI 10.3346/jkms.2000.15.3.273; Crist SA, 2008, BLOOD, V111, P3553, DOI 10.1182/blood-2007-05-088161; Cron RQ, 2006, J IMMUNOL, V176, P811, DOI 10.4049/jimmunol.176.2.811; Crow MK, 2001, CURR OPIN RHEUMATOL, V13, P361, DOI 10.1097/00002281-200109000-00004; Danese S, 2005, CRIT REV IMMUNOL, V25, P103; Daub K, 2006, FASEB J, V20, P2559, DOI 10.1096/fj.06-6265fje; Day CJ, 2005, J CELL BIOCHEM, V95, P17, DOI 10.1002/jcb.20410; Decker EL, 2003, NUCLEIC ACIDS RES, V31, P911, DOI 10.1093/nar/gkg186; Decker EL, 1998, J BIOL CHEM, V273, P26923, DOI 10.1074/jbc.273.41.26923; Delmas Y, 2005, KIDNEY INT, V68, P2068, DOI 10.1111/j.1523-1755.2005.00663.x; Delmas Y, 2005, M S-MED SCI, V21, P825, DOI 10.1051/medsci/20052110825; Ertenli I, 2003, RHEUMATOL INT, V23, P49, DOI 10.1007/s00296-003-0289-0; Graff J, 2005, CLIN PHARMACOL THER, V78, P468, DOI 10.1016/j.clpt.2005.08.002; Harding SA, 2004, ATHEROSCLEROSIS, V176, P321, DOI 10.1016/j.atherosclerosis.2004.05.008; Hart A, 2000, IMMUNITY, V13, P167, DOI 10.1016/S1074-7613(00)00017-0; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Horsley V, 2002, J CELL BIOL, V156, P771, DOI 10.1083/jcb.200111073; Horsley V, 2001, J CELL BIOL, V153, P329, DOI 10.1083/jcb.153.2.329; Im SH, 2004, MOL CELLS, V18, P1; Jackers P, 2004, J BIOL CHEM, V279, P52183, DOI 10.1074/jbc.M407489200; Jalagadugula G, 2006, J THROMB HAEMOST, V4, P2678, DOI 10.1111/j.1538-7836.2006.02229.x; Kairaitis L, 2003, KIDNEY INT, V64, P1265, DOI 10.1046/j.1523-1755.2003.00223.x; Kato K, 1999, J CLIN INVEST, V104, P947, DOI 10.1172/JCI7014; Kiani A, 2004, J LEUKOCYTE BIOL, V76, P1057, DOI 10.1189/jlb.0404259; Kiani A, 2007, EXP HEMATOL, V35, P757, DOI 10.1016/j.exphem.2007.02.001; Kyttala S, 2009, BRIT J HAEMATOL, V144, P395, DOI 10.1111/j.1365-2141.2008.07490.x; LEMARCHANDEL V, 1993, MOL CELL BIOL, V13, P668, DOI 10.1128/MCB.13.1.668; Luo C, 1996, J EXP MED, V184, P141, DOI 10.1084/jem.184.1.141; Macian F, 2000, EMBO J, V19, P4783, DOI 10.1093/emboj/19.17.4783; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Milovanovic A, 2004, CLIN CHIM ACTA, V343, P237, DOI 10.1016/j.cccn.2003.12.030; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rengarajan J, 2000, IMMUNITY, V12, P293, DOI 10.1016/S1074-7613(00)80182-X; Schabbauer G, 2007, THROMB HAEMOSTASIS, V97, P988, DOI 10.1160/TH07-01-0037; Schonbeck U, 2001, CELL MOL LIFE SCI, V58, P4, DOI 10.1007/PL00000776; Shelly C, 2000, CELL GROWTH DIFFER, V11, P501; Whalen AM, 1997, MOL CELL BIOL, V17, P1947, DOI 10.1128/MCB.17.4.1947; Yazdany J, 2004, LUPUS, V13, P377, DOI 10.1191/0961203304lu1030oa; Yu JX, 2004, MOL CELL, V15, P83, DOI 10.1016/j.molcel.2004.06.030	47	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33985	33996		10.1074/jbc.M113.511881	http://dx.doi.org/10.1074/jbc.M113.511881			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24106272	Green Published, hybrid			2022-12-25	WOS:000327250200040
J	Lander, N; Ulrich, PN; Docampo, R				Lander, Noelia; Ulrich, Paul N.; Docampo, Roberto			Trypanosoma brucei Vacuolar Transporter Chaperone 4 (TbVtc4) Is an Acidocalcisome Polyphosphate Kinase Required for in Vivo Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Catalysis; Parasite; Parasite Metabolism; Trypanosoma brucei; Vacuolar Acidification; Acidocalcisome; Osmoregulation; Polyphosphate; Vacuolar Transporter Chaperone	LEISHMANIA-MAJOR; GENE-EXPRESSION; PHOSPHOLIPASE-C; VTC PROTEINS; V-ATPASE; GROWTH; CRUZI; STRESS; EXOPOLYPHOSPHATASE; COMPLEX	Background: Polyphosphate (polyP) accumulates in an acidic calcium store named the acidocalcisome. Results: TbVtc4 is an acidocalcisome polyP kinase required for osmoregulation and virulence. Conclusion: TbVtc4 is a potential drug target in T. bruceiSignificance: This is the first demonstration of an essential polyP kinase in trypanosomes. Polyphosphate (polyP) is an anionic polymer of orthophosphate groups linked by high energy bonds that typically accumulates in acidic, calcium-rich organelles known as acidocalcisomes. PolyP synthesis in eukaryotes was unclear until it was demonstrated that the protein named Vtc4p (vacuolar transporter chaperone 4) is a long chain polyP kinase that localizes to the yeast vacuole. Here, we report that TbVtc4 (Vtc4 ortholog of Trypanosoma brucei) encodes, in contrast, a short chain polyP kinase that localizes to acidocalcisomes. The subcellular localization of TbVtc4 was demonstrated by fluorescence and electron microscopy of cell lines expressing TbVtc4 in its endogenous locus fused to an epitope tag and by purified polyclonal antibodies against TbVtc4. Recombinant TbVtc4 was expressed in bacteria, and polyP kinase activity was assayed in vitro. The in vitro growth of conditional knock-out bloodstream form trypanosomes (TbVtc4-KO) was significantly affected relative to the parental cell line. This mutant had reduced polyP kinase activity and short chain polyP content and was considerably less virulent in mice. The wild-type phenotype was recovered when an ectopic copy of the TbVtc4 gene was expressed in the presence of doxycycline. The mutant also exhibited a defect in volume recovery under osmotic stress conditions in vitro, underscoring the relevance of polyP in osmoregulation.	[Docampo, Roberto] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Docampo, Roberto] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Docampo, R (corresponding author), Univ Georgia, Dept Cellular Biol, 350B Paul D Coverdell Ctr, Athens, GA 30602 USA.	rdocampo@uga.edu		Lander, Noelia/0000-0003-2178-381X	National Institutes of Health [AI077538]; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI077538 (to R.D.). This work was also supported by an American Heart Association predoctoral fellowship (to N.L.) and postdoctoral fellowship (to P.N.U.).	Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Cagnac O, 2007, J BIOL CHEM, V282, P24284, DOI 10.1074/jbc.M703116200; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Cohen A, 1999, J BIOL CHEM, V274, P26885, DOI 10.1074/jbc.274.38.26885; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; Docampo R, 2011, CELL CALCIUM, V50, P113, DOI 10.1016/j.ceca.2011.05.012; Docampo R, 2011, ADV PARASIT, V75, P307, DOI 10.1016/B978-0-12-385863-4.00014-9; Emmer BT, 2011, EUKARYOT CELL, V10, P455, DOI 10.1128/EC.00248-10; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; Fang JM, 2007, J BIOL CHEM, V282, P32501, DOI 10.1074/jbc.M704841200; Fang JM, 2007, BIOCHEM J, V407, P161, DOI 10.1042/BJ20070612; Furuya T, 2000, J BIOL CHEM, V275, P6428, DOI 10.1074/jbc.275.9.6428; HERBERT WJ, 1976, EXP PARASITOL, V40, P427, DOI 10.1016/0014-4894(76)90110-7; Hothorn M, 2009, SCIENCE, V324, P513, DOI 10.1126/science.1168120; Huang GZ, 2013, P NATL ACAD SCI USA, V110, P1887, DOI 10.1073/pnas.1216955110; Huang GZ, 2011, J BIOL CHEM, V286, P36619, DOI 10.1074/jbc.M111.284661; Kocic I, 2001, CARDIOVASC RES, V51, P59, DOI 10.1016/S0008-6363(01)00279-6; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; de Jesus TCL, 2010, J BIOL CHEM, V285, P24131, DOI 10.1074/jbc.M110.120212; Lemercier G, 2002, J BIOL CHEM, V277, P37369, DOI 10.1074/jbc.M204744200; Li ZH, 2011, J BIOL CHEM, V286, P43959, DOI 10.1074/jbc.M111.311530; Martins VD, 2010, J BIOL CHEM, V285, P30906, DOI 10.1074/jbc.M110.142190; MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V59, P327, DOI 10.1016/0166-6851(93)90231-L; Moreno B, 2000, J BIOL CHEM, V275, P28356, DOI 10.1074/jbc.M003893200; Moreno SNJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003230; Moreno-Sanchez D, 2012, J BIOL CHEM, V287, P28435, DOI 10.1074/jbc.M112.385823; Morrissey JH, 2012, BLOOD, V119, P5972, DOI 10.1182/blood-2012-03-306605; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; Muller O, 2003, J CELL SCI, V116, P1107, DOI 10.1242/jcs.00328; Muller O, 2002, EMBO J, V21, P259, DOI 10.1093/emboj/21.3.259; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; Patel S, 2010, TRENDS CELL BIOL, V20, P277, DOI 10.1016/j.tcb.2010.02.003; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Rao NN, 1996, J BACTERIOL, V178, P1394, DOI 10.1128/jb.178.5.1394-1400.1996; Rodrigues CO, 1999, MOL CELL BIOL, V19, P7712; Rodrigues CO, 2002, J BIOL CHEM, V277, P50899, DOI 10.1074/jbc.M208940200; Rohloff P, 2003, MOL BIOCHEM PARASIT, V126, P219, DOI 10.1016/S0166-6851(02)00277-3; Rohloff P, 2008, EXP PARASITOL, V118, P17, DOI 10.1016/j.exppara.2007.04.013; Ruiz FA, 2004, J BIOL CHEM, V279, P44250, DOI 10.1074/jbc.M406261200; Ruiz FA, 2001, J BIOL CHEM, V276, P26114, DOI 10.1074/jbc.M102402200; Scott DA, 1997, J BIOL CHEM, V272, P28020, DOI 10.1074/jbc.272.44.28020; Sethuraman A, 2001, P NATL ACAD SCI USA, V98, P8542, DOI 10.1073/pnas.151269398; Smith SA, 2006, P NATL ACAD SCI USA, V103, P903, DOI 10.1073/pnas.0507195103; Tammenkoski M, 2008, BIOCHEMISTRY-US, V47, P9707, DOI 10.1021/bi8010847; Ulrich PN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018013; VERCESI AE, 1994, BIOCHEM J, V304, P227, DOI 10.1042/bj3040227; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WIRTZ E, 1995, SCIENCE, V268, P1179, DOI 10.1126/science.7761835; WURST H, 1995, J BACTERIOL, V177, P898, DOI 10.1128/jb.177.4.898-906.1995	49	51	53	0	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34205	34216		10.1074/jbc.M113.518993	http://dx.doi.org/10.1074/jbc.M113.518993			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24114837	Green Published, hybrid			2022-12-25	WOS:000327250200063
J	Naito, Y; Sawada, H; Oboshi, M; Fujii, A; Hirotani, S; Iwasaku, T; Okuhara, Y; Eguchi, A; Morisawa, D; Ohyanagi, M; Tsujino, T; Masuyama, T				Naito, Yoshiro; Sawada, Hisashi; Oboshi, Makiko; Fujii, Aya; Hirotani, Shinichi; Iwasaku, Toshihiro; Okuhara, Yoshitaka; Eguchi, Akiyo; Morisawa, Daisuke; Ohyanagi, Mitsumasa; Tsujino, Takeshi; Masuyama, Tohru			Increased Renal Iron Accumulation in Hypertensive Nephropathy of Salt-Loaded Hypertensive Rats	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; BLOOD-PRESSURE; DAMAGE	Although iron is reported to be associated with the pathogenesis of chronic kidney disease, it is unknown whether iron participates in the pathophysiology of nephrosclerosis. Here, we investigate whether iron is involved in the development of hypertensive nephropathy and the effects of iron restriction on nephrosclerosis in salt-loaded stroke-prone spontaneously hypertensive rats (SHRSP). SHRSP were given either a normal or high-salt diet for 8 weeks. Another subset of SHRSP were fed a high-salt with iron-restricted diet. SHRSP given a high-salt diet developed severe hypertension and nephrosclerosis. As a result, survival rate was decreased after 8 weeks diet. Importantly, massive iron accumulation and increased iron content were observed in the kidneys of salt-loaded SHRSP, along with increased superoxide production, urinary 8-Hydroxy-2 '-deoxyguanosine excretion, and urinary iron excretion; however, these changes were markedly attenuated by iron restriction. Of interest, expression of cellular iron transport proteins, transferrin receptor 1 and divalent metal transporter 1, was increased in the tubules of salt-loaded SHRSP. Notably, iron restriction attenuated the development of severe hypertension and nephrosclerosis, thereby improving survival rate in salt-loaded SHRSP. Taken together, these results suggest a novel mechanism by which iron plays a role in the development of hypertensive nephropathy and establish the effects of iron restriction on salt-induced nephrosclerosis.	[Naito, Yoshiro; Sawada, Hisashi; Oboshi, Makiko; Fujii, Aya; Hirotani, Shinichi; Iwasaku, Toshihiro; Okuhara, Yoshitaka; Eguchi, Akiyo; Morisawa, Daisuke; Masuyama, Tohru] Hyogo Coll Med, Dept Internal Med, Div Cardiovasc, Nishinomiya, Hyogo 6638501, Japan; [Ohyanagi, Mitsumasa] Hyogo Coll Med, Dept Internal Med, Div Coronary Heart Dis, Nishinomiya, Hyogo 6638501, Japan; [Tsujino, Takeshi] Hyogo Univ Hlth Sci, Dept Pharm, Kobe, Hyogo, Japan	Hyogo College of Medicine; Hyogo College of Medicine	Naito, Y (corresponding author), Hyogo Coll Med, Dept Internal Med, Div Cardiovasc, Nishinomiya, Hyogo 6638501, Japan.	ynaito@hyo-med.ac.jp			JSPS KAKENHI [25460919]; Salt Science Research Foundation [1232]; Takeda Science Foundation; Hyogo Science and Technology Association	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Salt Science Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Hyogo Science and Technology Association	This study was supported by a Grant-in-Aid for Scientific Research (C) (JSPS KAKENHI Grant No. 25460919) and grants from The Salt Science Research Foundation (No. 1232), Takeda Science Foundation, and Hyogo Science and Technology Association (to Y. Naito). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonios TFT, 1996, LANCET, V348, P250, DOI 10.1016/S0140-6736(96)01463-8; CAMARGO MJF, 1993, J HYPERTENS, V11, P31, DOI 10.1097/00004872-199301000-00006; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; Fishbane S, 2003, AM J KIDNEY DIS, V41, pS18, DOI 10.1016/S0272-638(03)00373-1; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; HARRIS DCH, 1994, CLIN EXP PHARMACOL P, V21, P73, DOI 10.1111/j.1440-1681.1994.tb02472.x; Izuhara Y, 2005, J AM SOC NEPHROL, V16, P3631, DOI 10.1681/ASN.2005050522; Luke RG, 1999, NEPHROL DIAL TRANSPL, V14, P2271, DOI 10.1093/ndt/14.10.2271; Naito Y, 2012, J HYPERTENS, V30, P2192, DOI 10.1097/HJH.0b013e3283581a64; Naito Y, 2011, HYPERTENSION, V57, P497, DOI 10.1161/HYPERTENSIONAHA.110.159681; Naito Y, 2009, AM J PHYSIOL-HEART C, V296, pH585, DOI 10.1152/ajpheart.00463.2008; NANKIVELL BJ, 1994, J AM SOC NEPHROL, V4, P1598; NANKIVELL BJ, 1992, AM J KIDNEY DIS, V20, P580, DOI 10.1016/S0272-6386(12)70222-6; Pillebout E, 2003, J CLIN INVEST, V112, P843, DOI 10.1172/JCI200317647	14	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75906	10.1371/journal.pone.0075906	http://dx.doi.org/10.1371/journal.pone.0075906			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116080	gold, Green Published, Green Submitted			2022-12-25	WOS:000325552200042
J	Su, Y; Cui, LL; Piao, CS; Li, B; Zhao, LR				Su, Ye; Cui, Lili; Piao, Chunshu; Li, Bin; Zhao, Li-Ru			The Effects of Hematopoietic Growth Factors on Neurite Outgrowth	PLOS ONE			English	Article							NF-KAPPA-B; STEM-CELL FACTOR; COLONY-STIMULATING FACTOR; FACTOR G-CSF; RAT PC12 CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; CORTICAL-NEURONS; NERVOUS-SYSTEM; BRAIN; SURVIVAL	Stem cell factor (SCF) and granulocyte colony-stimulating factor (G-CSF) are initially discovered as the essential hematopoietic growth factors regulating bone marrow stem cell proliferation and differentiation, and SCF in combination with G-CSF (SCF+G-CSF) has synergistic effects on bone marrow stem cell mobilization. In this study we have determined the effect of SCF and G-CSF on neurite outgrowth in rat cortical neurons. Using molecular and cellular biology and live cell imaging approaches, we have revealed that receptors for SCF and G-CSF are expressed on the growth core of cortical neurons, and that SCF+G-CSF synergistically enhances neurite extension through PI3K/AKT and NF kappa B signaling pathways. Moreover, SCF+G-CSF induces much greater NF kappa B activation, NF kappa B transcriptional binding and brain-derived neurotrophic factor (BDNF) production than SCF or G-CSF alone. In addition, we have also observed that BDNF, the target gene of NF kappa B, is required for SCF+G-CSF-induced neurite outgrowth. These data suggest that SCF+G-CSF has synergistic effects to promote neurite growth. This study provides new insights into the contribution of hematopoietic growth factors in neuronal plasticity.	[Su, Ye; Cui, Lili; Piao, Chunshu; Li, Bin; Zhao, Li-Ru] Louisiana State Univ, Hlth Sci Ctr, Dept Neurol, Shreveport, LA 71105 USA; [Cui, Lili; Zhao, Li-Ru] SUNY Upstate Med Univ, Dept Neurosurg, Syracuse, NY 13210 USA; [Zhao, Li-Ru] Louisiana State Univ, Hlth Sci Ctr, Dept Cellular Biol & Anat, Shreveport, LA 71105 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Zhao, LR (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Neurol, Shreveport, LA 71105 USA.	ZHAOL@upstate.edu			National Institutes of Health, National Institute of Neurological Disorders and Stroke (NINDS) [R01 NS060911]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060911] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by The National Institutes of Health, National Institute of Neurological Disorders and Stroke (NINDS), R01 NS060911 to L.R.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleyasin H, 2004, J NEUROSCI, V24, P2963, DOI 10.1523/JNEUROSCI.0155-04.2004; Benowitz LI, 2010, NEUROBIOL DIS, V37, P259, DOI 10.1016/j.nbd.2009.11.009; BERNSTEIN SE, 1970, AM J SURG, V119, P448, DOI 10.1016/0002-9610(70)90148-0; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Cui LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064684; DEMETRI GD, 1991, BLOOD, V78, P2791; Dhandapani KM, 2005, J NEUROCHEM, V95, P9, DOI 10.1111/j.1471-4159.2005.03319.x; Diederich K, 2009, J NEUROSCI, V29, P11572, DOI 10.1523/JNEUROSCI.0453-09.2009; Duarte RF, 2002, LEUKEMIA LYMPHOMA, V43, P1179, DOI 10.1080/10428190290026231; Encinas M, 1999, J NEUROCHEM, V73, P1409, DOI 10.1046/j.1471-4159.1999.0731409.x; Esch T, 1999, J NEUROSCI, V19, P6417; Foehr ED, 2000, J NEUROSCI, V20, P7556; Friedman WJ, 1996, J BIOL CHEM, V271, P31115, DOI 10.1074/jbc.271.49.31115; Gallagher D, 2007, J NEUROSCI, V27, P9664, DOI 10.1523/JNEUROSCI.0608-07.2007; Greenbaum AM, 2011, LEUKEMIA, V25, P211, DOI 10.1038/leu.2010.248; Gutierrez H, 2005, DEVELOPMENT, V132, P1713, DOI 10.1242/dev.01702; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Horch HW, 2002, NAT NEUROSCI, V5, P1177, DOI 10.1038/nn927; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Jin K, 2002, J CLIN INVEST, V110, P311, DOI 10.1172/JCI200215251; Johansson BB, 2000, STROKE, V31, P223, DOI 10.1161/01.STR.31.1.223; Kaltschmidt B, 2002, NEUROMOL MED, V2, P299, DOI 10.1385/NMM:2:3:299; Katafuchi T, 2000, LEARN MEMORY, V7, P383, DOI 10.1101/lm.33900; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; KIMURA K, 1994, J BIOL CHEM, V269, P18961; Kita Y, 1998, J CELL SCI, V111, P907; Kobayashi M, 1997, J BIOL CHEM, V272, P16089, DOI 10.1074/jbc.272.26.16089; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; Laurino L, 2005, J CELL SCI, V118, P3653, DOI 10.1242/jcs.02490; Lipsky RH, 2001, J NEUROCHEM, V78, P254, DOI 10.1046/j.1471-4159.2001.00386.x; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; MCNIECE IK, 1995, J LEUKOCYTE BIOL, V58, P14, DOI 10.1002/jlb.58.1.14; Memet S, 2006, BIOCHEM PHARMACOL, V72, P1180, DOI 10.1016/j.bcp.2006.09.003; Motro B, 1996, P NATL ACAD SCI USA, V93, P1808, DOI 10.1073/pnas.93.5.1808; Mullen LM, 2012, BRAIN RES, V1430, P25, DOI 10.1016/j.brainres.2011.10.054; O'Shea JM, 2010, BIOCHEM J, V426, P345, DOI 10.1042/BJ20091630; Piao CS, 2012, DIFFERENTIATION, V83, P17, DOI 10.1016/j.diff.2011.08.006; Pizzi M, 2002, J BIOL CHEM, V277, P20717, DOI 10.1074/jbc.M201014200; Rabacchi SA, 1999, J NEUROBIOL, V40, P254, DOI 10.1002/(SICI)1097-4695(199908)40:2<254::AID-NEU11>3.0.CO;2-4; Salie R, 2005, INT J DEV NEUROSCI, V23, P587, DOI 10.1016/j.ijdevneu.2005.07.003; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Valerio A, 2006, J BIOL CHEM, V281, P12950, DOI 10.1074/jbc.M508691200; WELTE K, 1985, P NATL ACAD SCI USA, V82, P1526, DOI 10.1073/pnas.82.5.1526; Wirth MJ, 2003, DEVELOPMENT, V130, P5827, DOI 10.1242/dev.00826; Yan Q, 1997, J COMP NEUROL, V378, P135; Zhao LR, 2007, STROKE, V38, P2804, DOI 10.1161/STROKEAHA.107.486217; Zhao LR, 2007, STROKE, V38, P2584, DOI 10.1161/STROKEAHA.106.476457; Zhao LR, 2007, EXP NEUROL, V204, P569, DOI 10.1016/j.expneurol.2006.12.001; ZSEBO KM, 1990, CELL, V63, P195, DOI 10.1016/0092-8674(90)90300-4	52	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75562	10.1371/journal.pone.0075562	http://dx.doi.org/10.1371/journal.pone.0075562			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116056	gold, Green Published, Green Submitted			2022-12-25	WOS:000325552200028
J	Wang, JX; Shi, X; Johnson, RH; Kelbauskas, L; Zhang, WW; Meldrum, DR				Wang, Jiangxin; Shi, Xu; Johnson, Roger H.; Kelbauskas, Laimonas; Zhang, Weiwen; Meldrum, Deirdre R.			Single-Cell Analysis Reveals Early Manifestation of Cancerous Phenotype in Pre-Malignant Esophageal Cells	PLOS ONE			English	Article							DNA COPY NUMBER; STOCHASTIC GENE-EXPRESSION; HYPOXIA-INDUCIBLE FACTOR; MITOCHONDRIAL-DNA; BARRETTS-ESOPHAGUS; NEOPLASTIC PROGRESSION; QUANTITATIVE-ANALYSIS; MESSENGER-RNA; BREAST-CANCER; TUMOR HYPOXIA	Cellular heterogeneity plays a pivotal role in a variety of functional processes in vivo including carcinogenesis. However, our knowledge about cell-to-cell diversity and how differences in individual cells manifest in alterations at the population level remains very limited mainly due to the lack of appropriate tools enabling studies at the single-cell level. We present a study on changes in cellular heterogeneity in the context of pre-malignant progression in response to hypoxic stress. Utilizing premalignant progression of Barrett's esophagus (BE) as a disease model system we studied molecular mechanisms underlying the progression from metaplastic to dysplastic (pre-cancerous) stage. We used newly developed methods enabling measurements of cell-to-cell differences in copy numbers of mitochondrial DNA, expression levels of a set of mitochondrial and nuclear genes involved in hypoxia response pathways, and mitochondrial membrane potential. In contrast to bulk cell studies reported earlier, our study shows significant differences between metaplastic and dysplastic BE cells in both average values and single-cell parameter distributions of mtDNA copy numbers, mitochondrial function, and mRNA expression levels of studied genes. Based on single-cell data analysis, we propose that mitochondria may be one of the key factors in pre-malignant progression in BE.	[Wang, Jiangxin; Shi, Xu; Johnson, Roger H.; Kelbauskas, Laimonas; Zhang, Weiwen; Meldrum, Deirdre R.] Arizona State Univ, Ctr Biosignatures Discovery Automat, Biodesign Inst, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe	Kelbauskas, L (corresponding author), Arizona State Univ, Ctr Biosignatures Discovery Automat, Biodesign Inst, Tempe, AZ USA.	lkelbaus@asu.edu; wwzhang8@tju.edu.cn; deirdre.meldrum@asu.edu	Shi, Xu/F-9805-2011; WANG, Jiangxin/AFE-8446-2022	WANG, Jiangxin/0000-0002-9917-067X; Zhang, Weiwen/0000-0001-8305-5653	National Institutes of Health (NIH), National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) Center of Excellence in Genomic Sciences (CEGS); National Institutes of Health (NIH) Microscale Life Sciences Center [5 P50 HG002360]; National Institutes of Health (NIH); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002360] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health (NIH) Center of Excellence in Genomic Sciences (CEGS); National Institutes of Health (NIH) Microscale Life Sciences Center; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Funding came from the National Institutes of Health (NIH), National Human Genome Research Institute (NHGRI), Center of Excellence in Genomic Sciences (CEGS) and Microscale Life Sciences Center Grant No. 5 P50 HG002360 (PI D.R.M.) http://www.genome.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2004, FORENSIC SCI INT, V139, P141, DOI 10.1016/j.forsciint.2003.10.008; Anis YH, 2010, IEEE T AUTOM SCI ENG, V7, P598, DOI 10.1109/TASE.2009.2035709; Ashili SP, 2011, P MICROFLUIDICS BIOM, V7929; Axelson H, 2005, SEMIN CELL DEV BIOL, V16, P554, DOI 10.1016/j.semcdb.2005.03.007; Barrett MT, 2003, CANCER RES, V63, P4211; Bengtsson M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-63; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Boettiger AN, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001136; Brahimi-Horn MC, 2011, CURR OPIN GENET DEV, V21, P67, DOI 10.1016/j.gde.2010.10.006; Brouwer M, 2008, MAR ENVIRON RES, V66, P143, DOI 10.1016/j.marenvres.2008.02.046; Chen G, 2009, ANTIOXID REDOX SIGN, V11, P1083, DOI [10.1089/ars.2008.2321, 10.1089/ARS.2008.2321]; Chen XX, 2001, CARCINOGENESIS, V22, P1119, DOI 10.1093/carcin/22.8.1119; Coco D, 2011, LAB INVEST, V91, p145A; Cormio Antonella, 2012, BMC Res Notes, V5, P279, DOI 10.1186/1756-0500-5-279; Cosse JP, 2008, ANTI-CANCER AGENT ME, V8, P790, DOI 10.2174/187152008785914798; Cree LM, 2008, DIABETOLOGIA, V51, P1440, DOI 10.1007/s00125-008-1054-4; DAVIS S, 1985, J BIOL CHEM, V260, P3844; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Feng S, 2011, ONCOL LETT, V2, P899, DOI 10.3892/ol.2011.322; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gao WM, 2011, J MICROBIOL METH, V85, P221, DOI 10.1016/j.mimet.2011.03.008; GARCIAHORSMAN JA, 1994, J BACTERIOL, V176, P5587, DOI 10.1128/JB.176.18.5587-5600.1994; Heddleston JM, 2010, BRIT J CANCER, V102, P789, DOI 10.1038/sj.bjc.6605551; Heerdt BG, 2006, CANCER RES, V66, P1591, DOI 10.1158/0008-5472.CAN-05-2717; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; Houston MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025207; Huang HM, 2004, NEUROCHEM RES, V29, P651, DOI 10.1023/B:NERE.0000014835.34495.9c; Jones JB, 2001, CANCER RES, V61, P1299; KADOWAKI T, 1991, EXP CELL RES, V192, P243, DOI 10.1016/0014-4827(91)90182-T; Kelbauskas L, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.3.037008; Kim MM, 2004, CLIN CANCER RES, V10, P8512, DOI 10.1158/1078-0432.CCR-04-0734; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P10014, DOI 10.1073/pnas.1633614100; Koi M, 2011, J OBSTET GYNAECOL RE, V37, P85, DOI 10.1111/j.1447-0756.2010.01377.x; Kuznetsov AV, 2009, INT J MOL SCI, V10, P1911, DOI 10.3390/ijms10041911; Lee JJ, 2010, CARCINOGENESIS, V31, P427, DOI 10.1093/carcin/bgp326; Li YZ, 2010, ANAL BIOANAL CHEM, V397, P1853, DOI 10.1007/s00216-010-3754-0; Lidstrom ME, 2003, NAT REV MICROBIOL, V1, P158, DOI 10.1038/nrmicro755; Lin CS, 2010, J THORAC CARDIOV SUR, V139, P189, DOI 10.1016/j.jtcvs.2009.04.007; Liu TZ, 2007, MOL CANCER THER, V6, P1814, DOI 10.1158/1535-7163.MCT-06-0279; Longo D, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100110; Matarrese P, 2001, BIOCHEM J, V355, P587, DOI 10.1042/bj3550587; McIntire M, 2011, LAB INVEST, V91, p159A; Mizumachi T, 2008, PROSTATE, V68, P408, DOI 10.1002/pros.20697; Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5; Moro L, 2008, CELL ONCOL, V30, P307, DOI 10.3233/CLO-2008-0427; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Murata M, 2009, J ORTHOP RES, V27, P50, DOI 10.1002/jor.20703; Nordgren IK, 2011, CHEM SOC REV, V40, P4307, DOI 10.1039/c1cs15032d; Olliver JR, 2005, GUT, V54, pA51; Palanca-Wessels MC, 1998, GASTROENTEROLOGY, V114, P295, DOI 10.1016/S0016-5085(98)70480-9; Penta JS, 2001, MUTAT RES-REV MUTAT, V488, P119, DOI 10.1016/S1383-5742(01)00053-9; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2009, ANNU REV BIOPHYS, V38, P255, DOI 10.1146/annurev.biophys.37.032807.125928; Reid BJ, 2011, CLIN CANCER RES, V17, P3512, DOI 10.1158/1078-0432.CCR-09-2358; Semenza GL, 2011, BBA-MOL CELL RES, V1813, P1263, DOI 10.1016/j.bbamcr.2010.08.006; Shapovalov Y, 2011, J BIOL CHEM, V286, P22331, DOI 10.1074/jbc.M111.250092; Solaini G, 2011, BBA-BIOENERGETICS, V1807, P534, DOI 10.1016/j.bbabio.2010.09.003; St John JC, 2006, METH MOL B, V331, P347; Tang CM, 2013, J GASTROEN HEPATOL, V28, P401, DOI 10.1111/jgh.12038; Taniguchi K, 2009, NAT METHODS, V6, P503, DOI 10.1038/nmeth.1338; Thyagarajan B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065968; Torres-Garcia W, 2012, MOL BIOSYST, V8, P804, DOI 10.1039/c2mb05429a; Wang B, 2008, BIOCHEM BIOPH RES CO, V368, P88, DOI 10.1016/j.bbrc.2008.01.036; Wang GC, 2000, NUCLEIC ACIDS RES, V28, P2135, DOI 10.1093/nar/28.10.2135; Wang S, 2006, ONCOGENE, V25, P3346, DOI 10.1038/sj.onc.1209357; Wang Y, 2006, BRIT J CANCER, V95, P1087, DOI 10.1038/sj.bjc.6603377; Yang YZ, 2013, J CELL BIOCHEM, V114, P967, DOI 10.1002/jcb.24438; Yoshiji H, 1996, CANCER RES, V56, P2013; Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955; Yu M, 2011, LIFE SCI, V89, P65, DOI 10.1016/j.lfs.2011.05.010; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; Zeng J, 2011, ANAL BIOANAL CHEM, V401, P3, DOI 10.1007/s00216-011-5084-2; Zhu HX, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/6/065013	73	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75365	10.1371/journal.pone.0075365	http://dx.doi.org/10.1371/journal.pone.0075365			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116039	Green Published, Green Submitted, gold			2022-12-25	WOS:000325552200018
J	Weiskirchen, R; Weimer, J; Meurer, SK; Kron, A; Seipel, B; Vater, I; Arnold, N; Siebert, R; Xu, LM; Friedman, SL; Bergmann, C				Weiskirchen, Ralf; Weimer, Joerg; Meurer, Steffen K.; Kron, Anja; Seipel, Barbara; Vater, Inga; Arnold, Norbert; Siebert, Reiner; Xu, Lieming; Friedman, Scott L.; Bergmann, Carsten			Genetic Characteristics of the Human Hepatic Stellate Cell Line LX-2	PLOS ONE			English	Article							LIVER FIBROSIS; EXPRESSION; PROTEINS; MISIDENTIFICATION; IDENTIFICATION; PATHWAYS; CULTURES; BIOLOGY; VIRUS; TOOLS	The human hepatic cell line LX-2 has been described as tool to study mechanisms of hepatic fibrogenesis and the testing of antifibrotic compounds. It was originally generated by immortalisation with the Simian Vacuolating Virus 40 (SV40) transforming (T) antigen and subsequent propagation in low serum conditions. Although this immortalized line is used in an increasing number of studies, detailed genetic characterisation has been lacking. We here have performed genetic characterisation of the LX-2 cell line and established a single-locus short tandem repeat (STR) profile for the cell line and characterized the LX-2 karyotype by several cytogenetic and molecular cytogenetic techniques. Spectral karyotyping (SKY) revealed a complex karyotype with a set of aberrations consistently present in the metaphases analyses which might serve as cytogenetic markers. In addition, various subclonal and single cell aberrations were detected. Our study provides criteria for genetic authentication of LX-2 and offers insights into the genotype changes which might underlie part of its phenotypic features.	[Weiskirchen, Ralf; Meurer, Steffen K.] Rhein Westfal TH Aachen, Inst Clin Chem & Pathobiochem, Aachen, Germany; [Weimer, Joerg; Arnold, Norbert] UKSH Campus Kiel, Dept Obstet & Gynaecol, Kiel, Germany; [Kron, Anja; Seipel, Barbara; Bergmann, Carsten] Bioscientia, Ctr Human Genet, Ingelheim, Germany; [Vater, Inga; Siebert, Reiner] Univ Hosp Schleswig Holstein, Inst Human Genet, Kiel, Germany; [Vater, Inga; Siebert, Reiner] Univ Kiel, Kiel, Germany; [Xu, Lieming] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Inst Liver Dis, Shanghai, Peoples R China; [Friedman, Scott L.] Mt Sinai Sch Med, Div Liver Dis, New York, NY USA; [Bergmann, Carsten] Rhein Westfal TH Aachen, Dept Human Genet, Aachen, Germany; [Bergmann, Carsten] Univ Hosp Freiburg, Clin Res Ctr, Freiburg, Germany	RWTH Aachen University; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Shanghai University of Traditional Chinese Medicine; Icahn School of Medicine at Mount Sinai; RWTH Aachen University; University of Freiburg	Weiskirchen, R (corresponding author), Rhein Westfal TH Aachen, Inst Clin Chem & Pathobiochem, Aachen, Germany.	rweiskirchen@ukaachen.de	Arnold, Norbert/E-3012-2010; Weiskirchen, Ralf/O-1734-2018; Siebert, Reiner/A-8049-2010; Weimer, Jörg Paul/E-3472-2010	Arnold, Norbert/0000-0003-4523-8808; Weiskirchen, Ralf/0000-0003-3888-0931; Weimer, Jörg Paul/0000-0002-4528-8509	German Research Foundation (DFG) [SFB/TRR57]; National Institutes of Health [DK56621]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056621, R56DK056621] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the German Research Foundation (DFG, SFB/TRR57) and National Institutes of Health (DK56621 to SLF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barallon R, 2010, IN VITRO CELL DEV-AN, V46, P727, DOI 10.1007/s11626-010-9333-z; BRAND KG, 1962, J NATL CANCER I, V28, P147; Cao Q, 2006, J CELL BIOCHEM, V97, P188, DOI 10.1002/jcb.20622; Chatterjee R, 2007, SCIENCE, V315, P928, DOI 10.1126/science.315.5814.928; Che J, 2007, MOL PHARMACOL, V72, P1626, DOI 10.1124/mol.107.038760; DEFENDI V, 1960, J NATL CANCER I, V25, P359; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Gao Q, 2011, HEPATOLOGY, V54, P1894, DOI 10.1002/hep.24475; Gartler S M, 1967, Natl Cancer Inst Monogr, V26, P167; Geerts A, 2001, SEMIN LIVER DIS, V21, P311, DOI 10.1055/s-2001-17550; GIRARDI AJ, 1965, J CELL COMPAR PHYSL, V65, P69, DOI 10.1002/jcp.1030650110; Hasegawa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013590; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; He H, 2011, HEPATOLOGY, V53, P548, DOI 10.1002/hep.24047; Herrmann J, 2007, J CELL MOL MED, V11, P704, DOI 10.1111/j.1582-4934.2007.00060.x; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Landry JJM, 2013, G3-GENES GENOM GENET, V3, P1213, DOI 10.1534/g3.113.005777; Mangasser-Stephan K, 2001, LIVER, V21, P105, DOI 10.1034/j.1600-0676.2001.021002105.x; Masters JRW, 2010, NAT REV CANCER, V10, P441, DOI 10.1038/nrc2852; Masters JR, 2001, P NATL ACAD SCI USA, V98, P8012, DOI 10.1073/pnas.121616198; Melgar-Lesmes P, 2010, ENDOCRINOLOGY, V151, P5306, DOI 10.1210/en.2010-0754; Meurer SK, 2005, J BIOL CHEM, V280, P3078, DOI 10.1074/jbc.M405411200; Meurer SK, 2012, EUR J CELL BIOL, V91, P450, DOI 10.1016/j.ejcb.2011.09.004; Meurer SK, 2011, CELL SIGNAL, V23, P683, DOI 10.1016/j.cellsig.2010.12.002; Nardone RM, 2007, CELL BIOL TOXICOL, V23, P367, DOI 10.1007/s10565-007-9019-9; Okabe H, 2011, ANN SURG ONCOL, V18, P1175, DOI 10.1245/s10434-010-1391-7; Shaffer LG, 2013, ISCN 2013 INT SYST H; Tacke F, 2012, EXPERT REV GASTROENT, V6, P67, DOI [10.1586/EGH.11.92, 10.1586/egh.11.92]; Taimr P, 2003, HEPATOLOGY, V37, P87, DOI 10.1053/jhep.2003.50002; Tuyama AC, 2010, HEPATOLOGY, V52, P612, DOI 10.1002/hep.23679; Wang SM, 1996, J VIROL, V70, P8422, DOI 10.1128/JVI.70.12.8422-8430.1996; Wasmuth HE, 2009, GASTROENTEROLOGY, V137, P309, DOI 10.1053/j.gastro.2009.03.053; Weiskirchen R, 2011, FRONT BIOSCI-LANDMRK, V16, P1939, DOI 10.2741/3832; Woodrow KA, 2009, TISSUE ENG PT A, V15, P1169, DOI 10.1089/ten.tea.2008.0265; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127	35	34	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75692	10.1371/journal.pone.0075692	http://dx.doi.org/10.1371/journal.pone.0075692			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116068	Green Submitted, Green Published, gold			2022-12-25	WOS:000325552200034
J	Bhattacharya, S; Kumar, NM; Ganguli, A; Tantak, MP; Kumar, D; Chakrabarti, G				Bhattacharya, Surela; Kumar, N. Maruthi; Ganguli, Arnab; Tantak, Mukund P.; Kumar, Dalip; Chakrabarti, Gopal			NMK-TD-100, a Novel Microtubule Modulating Agent, Blocks Mitosis and Induces Apoptosis in HeLa Cells by Binding to Tubulin	PLOS ONE			English	Article							ANTIPROLIFERATIVE ACTIVITY; HEPATOCELLULAR-CARCINOMA; COLCHICINE BINDING; BETA-TUBULIN; EXPRESSION; RESISTANCE; DYNAMICS; CANCER; TUMORS; ALPHA	Thiadiazoles are one of the most widely utilized agents in medicinal chemistry, having a wide range of pharmacologic activity. Microtubules (MTs) have always remained a sought-after target in rapidly proliferating cancer cells. We screened for the growth inhibitory effect of synthetic 5-(3-indolyl)-2-substituted-1,3,4-thiadiazoles on cancer cells and identified NMK-TD-100, as the most potent agent. Cell viability experiments using human cervical carcinoma cell line (HeLa cells) indicated that the IC50 value was 1.42 +/- 0.11 mu M for NMK-TD-100 for 48 h treatment. In further study, we examined the mode of interaction of NMK-TD-100 with tubulin and unraveled the cellular mechanism responsible for its anti-tumor activity. NMK-TD-100 induced arrest in mitotic phase of cell cycle, caused decline in mitochondrial membrane potential and induced apoptosis in HeLa cells. Immunofluorescence studies using an anti-a-tubulin antibody showed a significant depolymerization of the interphase microtubule network and spindle microtubule in HeLa cells in a concentration-dependent manner. However, the cytotoxicity of NMK-TD-100 towards human peripheral blood mononuclear cells (PBMC) was lower compared to that in cancer cells. Polymerization of tissue purified tubulin into microtubules was inhibited by NMK-TD-100 with an IC50 value of 17.5 +/- 0.35 mu M. The binding of NMK-TD-100 with tubulin was studied using NMK-TD-100 fluorescence enhancement and intrinsic tryptophan fluorescence of tubulin. The stoichiometry of NMK-TD-100 binding to tubulin is 1: 1 (molar ratio) with a dissociation constant of similar to 1 mu M. Fluorescence spectroscopic and molecular modeling data showed that NMK-TD-100 binds to tubulin at a site which is very near to the colchicine binding site. The binding of NMK-TD-100 to tubulin was estimated to be similar to 10 times faster than that of colchicine. The results indicated that NMK-TD-100 exerted anti-proliferative activity by disrupting microtubule functions through tubulin binding and provided insights into its potential of being a chemotherapeutic agent.	[Bhattacharya, Surela; Ganguli, Arnab; Chakrabarti, Gopal] Univ Calcutta, Dept Biotechnol, Kolkata, India; [Bhattacharya, Surela; Ganguli, Arnab; Chakrabarti, Gopal] Univ Calcutta, Dr BC Guha Ctr Genet Engn & Biotechnol, Kolkata, India; [Kumar, N. Maruthi; Tantak, Mukund P.; Kumar, Dalip] Birla Inst Technol & Sci, Dept Chem, Pilani, Rajasthan, India	University of Calcutta; University of Calcutta; Birla Institute of Technology & Science Pilani (BITS Pilani)	Kumar, D (corresponding author), Birla Inst Technol & Sci, Dept Chem, Pilani, Rajasthan, India.	dalipk@pilani.bits-pilani.ac.in; gcbcg@caluniv.ac.in	Tantak, Mukund/ABD-8443-2021; Ganguli, Arnab/AAO-8635-2020; Narayanam, Maruthi Kumar/F-8726-2011	Tantak, Mukund/0000-0001-9230-7533; Ganguli, Arnab/0000-0001-9939-027X; Narayanam, Maruthi Kumar/0000-0001-8612-5602	DBT, Govt. of India [BT/PR12889/AGR/36/624/2009]	DBT, Govt. of India(Department of Biotechnology (DBT) India)	The work was supported by grant from DBT, Govt. of India (No. BT/PR12889/AGR/36/624/2009) to GC. SB is a Senior Research fellow of University Grants Commission (UGC), Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya BR, 2009, BIOCHEMISTRY-US, V48, P6963, DOI 10.1021/bi900152k; Asbury R, 1996, AM J CLIN ONCOL-CANC, V19, P400, DOI 10.1097/00000421-199608000-00017; BANERJEE A, 1992, J BIOL CHEM, V267, P13335; Bhattacharyya B, 2010, METHOD CELL BIOL, V95, P301, DOI 10.1016/S0091-679X(10)95017-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buolamwini JK, 2005, CURR CANCER DRUG TAR, V5, P57, DOI 10.2174/1568009053332672; Calligaris D, 2010, CELL MOL LIFE SCI, V67, P1089, DOI 10.1007/s00018-009-0245-6; Canavan TP, 2000, AM FAM PHYSICIAN, V61, P1369; Chattopadhyay A, 2003, PROTEIN SCI, V12, P2389, DOI 10.1110/ps.03302003; Chhabra S, 2010, J OBSTET GYNAECOL, V30, P725, DOI 10.3109/01443615.2010.501412; Dogan HN, 2002, BIOORGAN MED CHEM, V10, P2893, DOI 10.1016/S0968-0896(02)00143-8; FOJO AT, 1987, P NATL ACAD SCI USA, V84, P265, DOI 10.1073/pnas.84.1.265; Foroumadi A, 2003, EUR J MED CHEM, V38, P851, DOI 10.1016/S0223-5234(03)00148-X; Garuti L, 2001, BIOORG MED CHEM LETT, V11, P3147, DOI 10.1016/S0960-894X(01)00639-4; GASKIN F, 1974, J MOL BIOL, V89, P737, DOI 10.1016/0022-2836(74)90048-5; Gupta KK, 2006, FEBS J, V273, P5320, DOI 10.1111/j.1742-4658.2006.05525.x; HAMEL E, 1981, ARCH BIOCHEM BIOPHYS, V209, P29, DOI 10.1016/0003-9861(81)90253-8; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kadi AA, 2007, EUR J MED CHEM, V42, P235, DOI 10.1016/j.ejmech.2006.10.003; Kamath K, 2003, CANCER RES, V63, P6026; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; Kumar D, 2010, EUR J MED CHEM, V45, P4664, DOI 10.1016/j.ejmech.2010.07.023; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; LAMBEIR A, 1981, J BIOL CHEM, V256, P3279; Li J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-215; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Paino IMM, 2012, TOXICOL LETT, V215, P119, DOI 10.1016/j.toxlet.2012.09.025; MAS MT, 1985, BIOCHEMISTRY-US, V24, P1634, DOI 10.1021/bi00328a011; Matysiak J, 2007, EUR J MED CHEM, V42, P940, DOI 10.1016/j.ejmech.2006.12.033; MINOTTI AM, 1991, J BIOL CHEM, V266, P3987; Morris M, 2004, J CLIN ONCOL, V22, P3340, DOI 10.1200/JCO.2004.12.006; Nogales E, 2006, CURR OPIN CELL BIOL, V18, P179, DOI 10.1016/j.ceb.2006.02.009; Padmavathi V, 2009, EUR J MED CHEM, V44, P2106, DOI 10.1016/j.ejmech.2008.10.012; Peifer C, 2008, J MED CHEM, V51, P3814, DOI 10.1021/jm8001185; Poorrajab F, 2009, EUR J MED CHEM, V44, P1758, DOI 10.1016/j.ejmech.2008.03.039; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Shen L, 2007, J MED CHEM, V50, P3954, DOI 10.1021/jm070511x; SLADOWSKI D, 1993, J IMMUNOL METHODS, V157, P203, DOI 10.1016/0022-1759(93)90088-O; Tian W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010499; Torfs S, 2012, EUR J CANCER, V48, P1332, DOI 10.1016/j.ejca.2012.01.006; TURNER S, 1988, J MED CHEM, V31, P902, DOI 10.1021/jm00400a003; *US FDA, 2006, FDA APPR 1 DRUG TREA; WARD LD, 1985, METHOD ENZYMOL, V117, P400; Xie ZG, 2008, CANCER CHEMOTH PHARM, V62, P949, DOI 10.1007/s00280-008-0684-z; Yusuf M, 2008, BIOORGAN MED CHEM, V16, P8029, DOI 10.1016/j.bmc.2008.07.056	45	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76286	10.1371/journal.pone.0076286	http://dx.doi.org/10.1371/journal.pone.0076286			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116100	Green Published, Green Submitted, gold			2022-12-25	WOS:000325501300055
J	Cui, J; Petritis, K; Tegeler, T; Petritis, B; Ma, XP; Jin, YF; Gao, SJ; Zhang, J				Cui, Jian; Petritis, Konstantinos; Tegeler, Tony; Petritis, Brianne; Ma, Xuepo; Jin, Yufang; Gao, Shou-Jiang (SJ); Zhang, Jianqiu (Michelle)			Accurate LC Peak Boundary Detection for O-16/O-18 Labeled LC-MS Data	PLOS ONE			English	Article							PEPTIDE DETECTION ALGORITHM; MASS-SPECTROMETRY; PROTEIN QUANTIFICATION; PROTEOMICS; RATIOS; IDENTIFICATION; SOFTWARE; SUITE; TOOL	In liquid chromatography-mass spectrometry (LC-MS), parts of LC peaks are often corrupted by their co-eluting peptides, which results in increased quantification variance. In this paper, we propose to apply accurate LC peak boundary detection to remove the corrupted part of LC peaks. Accurate LC peak boundary detection is achieved by checking the consistency of intensity patterns within peptide elution time ranges. In addition, we remove peptides with erroneous mass assignment through model fitness check, which compares observed intensity patterns to theoretically constructed ones. The proposed algorithm can significantly improve the accuracy and precision of peptide ratio measurements.	[Cui, Jian; Ma, Xuepo; Jin, Yufang; Zhang, Jianqiu (Michelle)] Univ Texas San Antonio, Dept Elect Engn, San Antonio, TX 78249 USA; [Petritis, Konstantinos; Tegeler, Tony; Petritis, Brianne] Translat Genom Res Inst, Ctr Prote, Phoenix, AZ USA; [Gao, Shou-Jiang (SJ)] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA	University of Texas System; University of Texas at San Antonio (UTSA); Translational Genomics Research Institute; University of Southern California	Zhang, J (corresponding author), Univ Texas San Antonio, Dept Elect Engn, San Antonio, TX 78249 USA.	michelle.zhang@utsa.edu	Gao, Shou-Jiang/B-8641-2012; Petritis, Konstantinos/AAP-4353-2021	Petritis, Konstantinos/0000-0001-8660-8532; Gao, Shou-Jiang/0000-0001-6194-1742	National Institute on Minority Health and Health Disparities [G12MD007591]; National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA124332] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by a grant from the National Institute on Minority Health and Health Disparities (G12MD007591) from the National Institutes of Health (website: http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; BAYNE CK, 1984, INT J MASS SPECTROM, V59, P315, DOI 10.1016/0168-1176(84)85105-8; Bellew M, 2006, BIOINFORMATICS, V22, P1902, DOI 10.1093/bioinformatics/btl276; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Eckel-Passow JE, 2006, BIOINFORMATICS, V22, P2739, DOI 10.1093/bioinformatics/btl464; Eckel-Passow Jeanette E, 2010, J Proteomics Bioinform, V3, P314; Geiger T., 2010, NATURE METHODS; Haskins WE, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-74; Hero AO, 1996, IEEE T SIGNAL PROCES, V44, P2026, DOI 10.1109/78.533723; Kullback S., 1997, INFORM THEORY STAT; Lei XF, 2010, NAT CELL BIOL, V12, P193, DOI 10.1038/ncb2019; Leptos KC, 2006, PROTEOMICS, V6, P1770, DOI 10.1002/pmic.200500201; Li XJ, 2003, ANAL CHEM, V75, P6648, DOI 10.1021/ac034633i; Mann B, 2008, RAPID COMMUN MASS SP, V22, P3823, DOI 10.1002/rcm.3781; Mueller LN, 2007, PROTEOMICS, V7, P3470, DOI 10.1002/pmic.200700057; Renard BY, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-355; Sun YT, 2012, BIOINFORMATICS, V28, P564, DOI 10.1093/bioinformatics/btr675; Sun YT, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-490; Valkenborg D, 2012, MASS SPECTROM REV, V31, P96, DOI 10.1002/mas.20339; Wang GH, 2006, ANAL CHEM, V78, P5752, DOI 10.1021/ac060611v; Yao XD, 2001, ANAL CHEM, V73, P2836, DOI 10.1021/ac001404c; Ye XY, 2010, ANAL CHEM, V82, P5878, DOI 10.1021/ac101284c; Ye Xiaoying, 2009, Briefings in Functional Genomics & Proteomics, V8, P136, DOI 10.1093/bfgp/eln055; Zhu Q, 2011, INT J PROTEOMICS; Zhu Q, 2010, J PROTEOME RES, V9, P2669, DOI 10.1021/pr100169a; Zhu Q, 2011, J FLUID MECH, V675, P495, DOI 10.1017/S0022112011000334	26	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e72951	10.1371/journal.pone.0072951	http://dx.doi.org/10.1371/journal.pone.0072951			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24115998	Green Published, Green Submitted, gold			2022-12-25	WOS:000325501300001
J	Qin, WT; Zhang, JL; Lv, WH; Wang, X; Sun, BW				Qin, Weiting; Zhang, Jinli; Lv, Wanghui; Wang, Xu; Sun, Bingwei			Effect of Carbon Monoxide-Releasing Molecules II-liberated CO on Suppressing Inflammatory Response in Sepsis by Interfering with Nuclear Factor Kappa B Activation	PLOS ONE			English	Article							THERMALLY-INJURED MICE; PROTEIN-KINASE PATHWAY; MYELOPEROXIDASE ACTIVITY; ENDOTHELIAL-CELLS; LEUKOCYTES SEQUESTRATION; MURINE MACROPHAGES; ICAM-1 EXPRESSION; OXIDATIVE STRESS; SMALL-INTESTINE; LUNG INJURY	Sepsis continues to be a challenge in clinic. The rates of mortality in sepsis patients remain high. The present study aimed to investigate the effects and the underlying mechanisms of carbon monoxide-releasing molecules II (CORM-2)-liberated CO on suppressing inflammatory response in sepsis. It was shown that treatment of septic mice with CORM-2 attenuated PMN accumulation, downregulated cytokines production, inhibited expressions of iNOS and NF-kappa B activity in the lung and liver. In parallel, CORM-2 prevented activation of NF-kappa B in LPS-stimulated HUVEC. This was accompanied by a decrease in ROS and NO production, expression of ICAM-1 and subsequent PMN adhesion to HUVEC. These findings demonstrated that CORM-released CO attenuates inflammatory responses by interfering with NF-kappa B activation and therefore decreasing the expression of ICAM-1 and NO production, attenuating the oxidative stress and inflammation in sepsis.	[Qin, Weiting; Zhang, Jinli; Lv, Wanghui; Wang, Xu; Sun, Bingwei] Jiangsu Univ, Affiliated Hosp, Dept Burn & Plast Surg, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University	Sun, BW (corresponding author), Jiangsu Univ, Affiliated Hosp, Dept Burn & Plast Surg, Zhenjiang, Jiangsu, Peoples R China.	sunbinwe@hotmail.com			National Natural Science Foundation of China [30772256, 81071546, 81272148]; Jiangsu Provincial Natural Science Foundation [BK2012703]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Natural Science Foundation(Natural Science Foundation of Jiangsu Province)	This work was supported by National Natural Science Foundation of China, No. 30772256, 81071546 and No. 81272148, and Jiangsu Provincial Natural Science Foundation, No. BK2012703. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basuroy S, 2011, AM J PHYSIOL-CELL PH, V300, pC256, DOI 10.1152/ajpcell.00272.2010; Cakir B, 2005, REGUL PEPTIDES, V125, P135, DOI 10.1016/j.regpep.2004.08.032; Cepinskas G, 1999, CIRC RES, V84, P103; Chapman JT, 2001, AM J PHYSIOL-LUNG C, V281, pL209, DOI 10.1152/ajplung.2001.281.1.L209; Chen LW, 2006, CRIT CARE MED, V34, P142, DOI 10.1097/01.CCM.0000190621.48720.8C; Clark JE, 2003, CIRC RES, V93, pE2, DOI 10.1161/01.RES.0000084381.86567.08; Coburn RF, 2012, J APPL PHYSIOL, V112, P1949, DOI 10.1152/japplphysiol.00174.2012; Condotta SA, 2013, CRIT REV IMMUNOL, V33, P23, DOI 10.1615/CritRevImmunol.2013006721; Cuschieri J, 2003, J TRAUMA, V54, P104, DOI 10.1097/00005373-200301000-00013; Deveci M, 2000, BURNS, V26, P41, DOI 10.1016/S0305-4179(99)00107-2; Foresti R, 2004, BRIT J PHARMACOL, V142, P453, DOI 10.1038/sj.bjp.0705825; Guo YR, 2004, AM J PHYSIOL-HEART C, V286, pH1649, DOI 10.1152/ajpheart.00971.2003; Han EH, 2012, FOOD CHEM TOXICOL, V50, P1616, DOI 10.1016/j.fct.2012.02.006; Hansbrough JF, 1996, J SURG RES, V61, P17, DOI 10.1006/jsre.1996.0074; Harjai M, 2013, ANAESTH INTENS CARE, V41, P175, DOI 10.1177/0310057X1304100207; Hernandez G, 2013, CURR VASC PHARMACOL, V11, P161; Johnson TR, 2003, ANGEW CHEM INT EDIT, V42, P3722, DOI 10.1002/anie.200301634; Karahocagil MK, 2012, CLIN BIOCHEM, V45, P733, DOI 10.1016/j.clinbiochem.2012.03.017; Khalatbary Ali Reza, 2011, Iranian Biomedical Journal, V15, P164, DOI 10.6091/IBJ.1026.2012; Liu DM, 2008, ACTA PHARMACOL SIN, V29, P838, DOI 10.1111/j.1745-7254.2008.00816.x; Lomas JL, 2003, SHOCK, V19, P358, DOI 10.1097/00024382-200304000-00011; Madonna R, 2012, VASC PHARMACOL, V57, P41, DOI 10.1016/j.vph.2012.02.005; Motterlini R, 2004, FASEB J, V18, P284, DOI 10.1096/fj.04-2169fje; Motterlini R, 2003, CURR PHARM DESIGN, V9, P2525, DOI 10.2174/1381612033453785; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Nakao A, 2003, GUT, V52, P1278, DOI 10.1136/gut.52.9.1278; Odobasic D, 2013, BLOOD, V121, P4195, DOI 10.1182/blood-2012-09-456483; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Otterbein LE, 1999, AM J PHYSIOL-LUNG C, V276, pL688; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Otterbein LE, 2003, AM J PATHOL, V163, P2555, DOI 10.1016/S0002-9440(10)63610-3; Ozaki KS, 2012, TRANSPL INT, V25, P107, DOI 10.1111/j.1432-2277.2011.01363.x; Panes J, 1995, AM J PHYSIOL-HEART C, V269, pH1955, DOI 10.1152/ajpheart.1995.269.6.H1955; Park KH, 2013, J IMMUNOL, V190, P6550, DOI 10.4049/jimmunol.1202284; Parsa CJ, 2003, J CLIN INVEST, V112, P999, DOI 10.1172/JCI200318200; Piantadosi CA, 2002, ANTIOXID REDOX SIGN, V4, P259, DOI 10.1089/152308602753666316; Remick DG, 2007, AM J PATHOL, V170, P1435, DOI 10.2353/ajpath.2007.060872; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Rupesh KR, 2010, EUR J MED CHEM, V45, P2141, DOI 10.1016/j.ejmech.2010.01.041; Ryter SW, 2013, KOREAN J INTERN MED, V28, P123, DOI 10.3904/kjim.2013.28.2.123; Sagara Daisuke, 2010, Ann Vasc Dis, V3, P131, DOI 10.3400/avd.AVDoa00930; Sanadgol N, 2010, CLIN BIOCHEM, V43, P968, DOI 10.1016/j.clinbiochem.2010.04.066; Sawle P, 2005, BRIT J PHARMACOL, V145, P800, DOI 10.1038/sj.bjp.0706241; Schmidt A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002179; Schwer CI, 2013, INT J BIOCHEM CELL B, V45, P201, DOI 10.1016/j.biocel.2012.09.020; Sriskandan S, 2011, J ROY COLL PHYS EDIN, V41, P339, DOI 10.4997/JRCPE.2011.411; Sun BW, 2007, J BURN CARE RES, V28, P173, DOI 10.1097/BCR.0b013E31802CA491; Sun BW, 2008, INT J BIOL SCI, V4, P270; Sun BW, 2008, INT J BIOL SCI, V4, P176; Sun BW, 2007, J SURG RES, V139, P128, DOI 10.1016/j.jss.2006.08.032; Tse MT, 2013, NAT REV DRUG DISCOV, V12, P334, DOI 10.1038/nrd4016; Wang X, 2012, WORLD J GASTROENTERO, V18, P5719, DOI 10.3748/wjg.v18.i40.5719; Wantha S, 2013, CIRC RES, V112, P792, DOI 10.1161/CIRCRESAHA.112.300666; Zhang N, 2013, NAT MED, V19, P500, DOI 10.1038/nm.3110	54	19	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75840	10.1371/journal.pone.0075840	http://dx.doi.org/10.1371/journal.pone.0075840			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116078	Green Published, gold, Green Submitted			2022-12-25	WOS:000325501300043
J	Chaimani, A; Higgins, JPT; Mavridis, D; Spyridonos, P; Salanti, G				Chaimani, Anna; Higgins, Julian P. T.; Mavridis, Dimitris; Spyridonos, Panagiota; Salanti, Georgia			Graphical Tools for Network Meta-Analysis in STATA	PLOS ONE			English	Article							PUBLICATION BIAS; INCONSISTENCY; CONSISTENCY; INTERVENTIONS; INFERENCE; MODEL	Network meta-analysis synthesizes direct and indirect evidence in a network of trials that compare multiple interventions and has the potential to rank the competing treatments according to the studied outcome. Despite its usefulness network meta-analysis is often criticized for its complexity and for being accessible only to researchers with strong statistical and computational skills. The evaluation of the underlying model assumptions, the statistical technicalities and presentation of the results in a concise and understandable way are all challenging aspects in the network meta-analysis methodology. In this paper we aim to make the methodology accessible to non-statisticians by presenting and explaining a series of graphical tools via worked examples. To this end, we provide a set of STATA routines that can be easily employed to present the evidence base, evaluate the assumptions, fit the network meta-analysis model and interpret its results.	[Chaimani, Anna; Mavridis, Dimitris; Salanti, Georgia] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Higgins, Julian P. T.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Higgins, Julian P. T.] Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England; [Mavridis, Dimitris] Univ Ioannina, Dept Primary Educ, GR-45110 Ioannina, Greece; [Spyridonos, Panagiota] Univ Ioannina, Sch Med, Dept Med Phys, GR-45110 Ioannina, Greece	University of Ioannina; University of Bristol; University of York - UK; University of Ioannina; University of Ioannina	Salanti, G (corresponding author), Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece.	gsalanti@cc.uoi.gr	Chaimani, Anna/AAA-3048-2020; Mavrids, Dimitris/H-5452-2019; Spyridonos, Panagiota/AAN-8293-2021; Higgins, Julian PT/H-4008-2011	Chaimani, Anna/0000-0003-2828-6832; Mavrids, Dimitris/0000-0003-1041-4592; Higgins, Julian PT/0000-0002-8323-2514; Salanti, Georgia/0000-0002-3830-8508	European Research Council [IMMA 260559]; MRC [MC_U105285807] Funding Source: UKRI; Medical Research Council [MC_U105285807] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	AC, DM and GS received funding from the European Research Council (IMMA 260559 project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, STAT STAT SOFTW REL; ANSCOMBE FJ, 1973, AM STAT, V27, P17, DOI 10.2307/2682899; Anzures-Cabrera J, 2010, RES SYNTH METHODS, V1, P66, DOI 10.1002/jrsm.6; Bax L, 2009, AM J EPIDEMIOL, V169, P249, DOI 10.1093/aje/kwn340; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Chaimani A, 2012, RES SYNTH METHODS, V3, P161, DOI 10.1002/jrsm.57; Chung HJ, 2008, CLIN TRIALS, V5, P301, DOI 10.1177/1740774508093614; Cipriani A, 2013, ANN INTERN MED, V159, P130, DOI 10.7326/0003-4819-159-2-201307160-00008; Cipriani A, 2011, LANCET, V378, P1306, DOI 10.1016/S0140-6736(11)60873-8; Cooper H, 2009, HDB RES SYNTHESIS ME; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Dias S., 2011, NICE DSU TECHNICAL S; Donegan S, 2013, RES SYN MET IN PRESS; Donegan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011054; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Everitt B., 1997, ANAL PROXIMITY DATA; Higgins JPT, 2012, RES SYNTH METHODS, V3, P98, DOI 10.1002/jrsm.1044; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Jackson D, 2012, STAT MED, V31, P3805, DOI 10.1002/sim.5453; Jackson D, 2011, STAT MED, V30, P2481, DOI 10.1002/sim.4172; Jansen JP, 2011, VALUE HEALTH, V14, P417, DOI 10.1016/j.jval.2011.04.002; Krahn U, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-35; Li TJ, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-79; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lu G, 2006, J AM STAT ASS, V101; Lu GB, 2011, RES SYNTH METHODS, V2, P43, DOI 10.1002/jrsm.34; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Mavridis D, 2013, STAT METHODS MED RES, V22, P133, DOI 10.1177/0962280211432219; Mavridis D, 2013, STAT MED, V32, P51, DOI 10.1002/sim.5494; MORRIS CN, 1983, J AM STAT ASSOC, V78, P47, DOI 10.2307/2287098; Peters JL, 2010, J R STAT SOC A STAT, V173, P575, DOI 10.1111/j.1467-985X.2009.00629.x; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Romesburg, 1985, CLUSTER ANAL RES; Rucker G, 2013, NETMETA R PACKAGE NE; Rucker G, 2012, RES SYNTH METHODS, V3, P312, DOI 10.1002/jrsm.1058; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Salanti G, 2012, RES SYNTH METHODS, V3, P80, DOI 10.1002/jrsm.1037; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Salanti G, 2009, J CLIN EPIDEMIOL, V62, P857, DOI 10.1016/j.jclinepi.2008.10.001; Singh JA, 2009, CAN MED ASSOC J, V181, P787, DOI 10.1503/cmaj.091391; Song F, 2008, J CLIN EPIDEMIOL, V61, P455, DOI 10.1016/j.jclinepi.2007.06.006; Song FJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1147; Trikalinos TA, 2009, LANCET, V373, P911, DOI 10.1016/S0140-6736(09)60319-6; Veroniki AA, 2013, INT J EPIDEMIOL, V42, P332, DOI 10.1093/ije/dys222; Viechtbauer W, 2005, J EDUC BEHAV STAT, V30, P261, DOI 10.3102/10769986030003261; White IR, 2012, RES SYNTH METHODS, V3, P111, DOI 10.1002/jrsm.1045; White IR, 2011, STATA J, V11, P255, DOI 10.1177/1536867X1101100206	48	1232	1249	3	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76654	10.1371/journal.pone.0076654	http://dx.doi.org/10.1371/journal.pone.0076654			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098547	Green Submitted, Green Published, gold			2022-12-25	WOS:000325483600069
J	Guan, AL; Gong, H; Ye, Y; Jia, JG; Zhang, GP; Li, BY; Yang, CJ; Qian, SL; Sun, AJ; Chen, RZ; Ge, JB; Zou, YZ				Guan, Aili; Gong, Hui; Ye, Yong; Jia, Jianguo; Zhang, Guoping; Li, Bingyu; Yang, Chunjie; Qian, Sanli; Sun, Aijun; Chen, Ruizhen; Ge, Junbo; Zou, Yunzeng			Regulation of p53 by Jagged1 Contributes to Angiotensin II-Induced Impairment of Myocardial Angiogenesis	PLOS ONE			English	Article							PRESSURE-OVERLOAD; ENDOTHELIAL-CELLS; CARDIAC-HYPERTROPHY; NOTCH; ACTIVATION; HEART; EXPRESSION; PROTECTS; TUMOR; INHIBITOR	Angiotensin II (AngII) is a major contributor to the development of heart failure, however, the molecular and cellular mechanisms still remain elucidative. Inadequate angiogenesis in myocardium leads to transition from cardiac hypertrophy to dysfunction, this study was therefore conducted to examine the effects of AngII on myocardial angiogenesis and the underlying mechanisms. AngII treatment significantly impaired angiogenetic responses, which were determined by counting the capillaries either in matrigel formed by cultured cardiac microvascular endothelial cells (CMVECs) or in myocardium of mice and by measuring the in vitro and in vivo production of VEGF proteins, and stimulated accumulation and phosphorylation of cytosolic p53 which led to increases in phosphorylated p53 and decreases of hypoxia inducible factor (Hif-1) in nucleus. All of these cellular and molecular events induced by AngII in CEMCs and hearts of mice were largely reduced by a p53 inhibitor, pifithrin-alpha (PFT-alpha). Interestingly, AngII stimulated the upregulation of Jagged1, a ligand of Notch, but it didn't affect the expression of Delta-like 4 (Dll-4), another ligand of Notch. Inhibition of p53 by PFT-alpha partly abolished this effect of AngII. Further experiments showed that knockdown of Jagged1 by addition of siRNA to cultured CMVECs dramatically declined AngII-stimulated accumulation and phosphorylation of p53 in cytosol, upregulation of phosphorylated p53 and downregulation of Hif-1 expression in nucleus, decrease of VEGF production and impairment of capillary-like tube formation by the cells. Our data collectively suggest that AngII impairs myocardial angiogenetic responses through p53-dependent downregulation of Hif-1 which is regulated by Jagged1/Notch1 signaling.	[Guan, Aili; Gong, Hui; Ye, Yong; Jia, Jianguo; Zhang, Guoping; Li, Bingyu; Yang, Chunjie; Qian, Sanli; Sun, Aijun; Chen, Ruizhen; Ge, Junbo; Zou, Yunzeng] Fudan Univ, Shanghai Inst Cardiovasc Dis, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Guan, Aili; Gong, Hui; Ye, Yong; Jia, Jianguo; Zhang, Guoping; Li, Bingyu; Yang, Chunjie; Qian, Sanli; Sun, Aijun; Chen, Ruizhen; Ge, Junbo; Zou, Yunzeng] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Guan, Aili] Qingdao Municipal Hosp, Dept Cardiol, Qingdao, Peoples R China	Fudan University; Fudan University; Qingdao Municipal Hospital	Zou, YZ (corresponding author), Fudan Univ, Shanghai Inst Cardiovasc Dis, Zhongshan Hosp, Shanghai 200433, Peoples R China.	zou.yunzeng@zs-hospital.sh.cn			National Natural Science Foundation of China [30930043, 81000041]; Doctoral Fund of Ministry of Education of China [20110071110051]; Science and Technology Commission of Shanghai Municipality [11JC1402400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by National Natural Science Foundation of China (30930043, 81000041), Doctoral Fund of Ministry of Education of China (20110071110051), and Science and Technology Commission of Shanghai Municipality (11JC1402400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainscough JFX, 2009, CARDIOVASC RES, V81, P592, DOI 10.1093/cvr/cvn230; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Belabbas H, 2008, AM J PHYSIOL-REG I, V295, pR1512, DOI 10.1152/ajpregu.00014.2008; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Gottifredi V, 2001, SCIENCE, V292, P1851, DOI 10.1126/science.1062238; Guan AL, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/737134; He ZH, 2005, J BIOL CHEM, V280, P15719, DOI 10.1074/jbc.M413493200; Ilagan Maria Xenia G, 2007, Cell, V128, P1246; Keller DM, 2001, MOL CELL, V7, P283, DOI 10.1016/S1097-2765(01)00176-9; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Le TT, 2012, DEV DYNAM, V241, P493, DOI 10.1002/dvdy.23739; Li L, 2010, HYPERTENS RES, V33, P1289, DOI 10.1038/hr.2010.182; Liang SH, 2001, EUR J BIOCHEM, V268, P2779, DOI 10.1046/j.1432-1327.2001.02227.x; Lin L, 2011, BIOCHEM BIOPH RES CO, V404, P28, DOI 10.1016/j.bbrc.2010.11.037; Liu PT, 2006, SHOCK, V26, P608, DOI 10.1097/01.shk.0000232273.11225.af; Luo Y, 2009, ANN NEUROL, V65, P520, DOI 10.1002/ana.21592; Marelli-Berg FM, 2000, J IMMUNOL METHODS, V244, P205, DOI 10.1016/S0022-1759(00)00258-1; Masuda T, 2012, AM J PHYSIOL-HEART C, V302, pH1871, DOI 10.1152/ajpheart.00663.2011; Prives C, 1999, J PATHOL, V187, P112; Pugh CW, 2003, SEMIN CANCER BIOL, V13, P83, DOI 10.1016/S1044-579X(02)00103-7; Rehman AO, 2006, TRENDS CELL BIOL, V16, P293, DOI 10.1016/j.tcb.2006.04.003; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; SCHUNKERT H, 1990, J CLIN INVEST, V86, P1913, DOI 10.1172/JCI114924; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Sohn D, 2009, CELL DEATH DIFFER, V16, P869, DOI 10.1038/cdd.2009.17; Tao LW, 2011, STEM CELLS, V29, P119, DOI 10.1002/stem.552; Wang XH, 2009, LIFE SCI, V84, P240, DOI 10.1016/j.lfs.2008.12.010; Yu XB, 2008, CELL STEM CELL, V2, P461, DOI 10.1016/j.stem.2008.03.001; Zeng QH, 2005, CANCER CELL, V8, P13, DOI 10.1016/j.ccr.2005.06.004; Zou YZ, 2011, J MOL CELL CARDIOL, V51, P821, DOI 10.1016/j.yjmcc.2011.07.030	33	17	20	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76529	10.1371/journal.pone.0076529	http://dx.doi.org/10.1371/journal.pone.0076529			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098521	Green Published, Green Submitted, gold			2022-12-25	WOS:000325483600061
J	Kaushik, M; Wang, CY; Barnett, MH; Garrick, R; Parratt, J; Graham, SL; Sriram, P; Yiannikas, C; Klistorner, A				Kaushik, Megha; Wang, Chen Yu; Barnett, Michael H.; Garrick, Raymond; Parratt, John; Graham, Stuart L.; Sriram, Prema; Yiannikas, Con; Klistorner, Alexandr			Inner Nuclear Layer Thickening Is Inversley Proportional to Retinal Ganglion Cell Loss in Optic Neuritis	PLOS ONE			English	Article							MICROCYSTIC MACULAR EDEMA; MULTIPLE-SCLEROSIS; COHERENCE TOMOGRAPHY; DEGENERATION; PATHOLOGY; ABNORMALITIES; THICKNESS	Aim: To examine the relationship between retinal ganglion cell loss and changes in the inner nuclear layer (INL) in optic neuritis (ON). Methods: 36 multiple sclerosis (MS) patients with a history of ON and 36 age and sex-matched controls underwent Optical Coherence Tomography. The paramacular retinal nerve fiber layer (RNFL), combined ganglion cell and inner plexiform layers (GCL/IPL) and inner nuclear layer (INL) thickness were measured at 36 points around the fovea. To remove inter-subject variability, the difference in thickness of each layer between the ON and fellow eye of each patient was calculated. A topographic analysis was conducted. Results: The INL of the ON patients was thicker than the controls (42.9 mu m versus 39.6 mu m, p=0.002). ON patients also had a thinner RNFL (27.8 mu m versus 32.2 mu m, p<0.001) and GCL/IPL (69.3 mu m versus 98.1 mu m, p<0.001). Among the controls, there was no correlation between RNFL and GCL/IPL as well as RNFL and INL, but a positive correlation was seen between GCL/IPL and INL (r=0.65, p<0.001). In the ON group, there was a positive correlation between RNFL and GCL/IPL (r=0.80, p<0.001) but a negative correlation between RNFL and INL (r=-0.61, p<0.001) as well as GCL/IPL and INL (r=-0.44, p=0.007). The negative correlation between GCL/IPL and INL strengthened in the ON group when inter-subject variability was removed (r=-0.75, p<0.001). Microcysts within the INL were present in 5 ON patients, mainly in the superior and infero-nasal paramacular regions. While patients with microcysts lay at the far end of the correlation curve between GCL/IPL and INL (i.e. larger INL and smaller GCL/IPL compared to other patients), their exclusion did not affect the correlation (r=-0.76, p<0.001). Conclusions: INL enlargement in MS-related ON is associated with the severity of GCL loss. This is a continuous relationship and patients with INL microcysts may represent the extreme end of the scale.	[Kaushik, Megha; Sriram, Prema; Klistorner, Alexandr] Univ Sydney, Save Sight Inst, Sydney, NSW 2006, Australia; [Wang, Chen Yu; Barnett, Michael H.] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia; [Garrick, Raymond] St Vincents Hosp, Dept Neurol, Sydney, NSW 2010, Australia; [Parratt, John] Royal N Shore Hosp, Dept Neurol, Sydney, NSW, Australia; [Graham, Stuart L.; Sriram, Prema; Klistorner, Alexandr] Macquarie Univ, Sydney, NSW 2109, Australia; [Yiannikas, Con] Concord Hosp, Dept Neurol, Sydney, NSW, Australia	University of Sydney; University of Sydney; St Vincents Hospital Sydney; Royal North Shore Hospital; University of Sydney; Macquarie University; Concord Repatriation General Hospital	Klistorner, A (corresponding author), Univ Sydney, Save Sight Inst, Sydney, NSW 2006, Australia.	sasha.klistorner@sydney.edu.au		Sriram, P.S/0000-0002-6103-3573; Klistorner, Alexander/0000-0003-0361-6399; Graham, Stuart/0000-0001-7519-969X	National Health and Medical Research Council [1056517]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Funding provided by National Health and Medical Research Council (number: 1056517). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegg M, 2012, BRAIN, V135, DOI 10.1093/brain/aws215; Albrecht P, 2012, MULT SCLER J, V18, P1422, DOI 10.1177/1352458512439237; Arnold AC, 2005, AM J OPHTHALMOL, V139, P1101, DOI 10.1016/j.ajo.2005.01.031; Balk LJ, 2012, BRAIN, V135, DOI 10.1093/brain/aws216; Barboni P, 2013, BRAIN; Chen Ling, 2005, Curr Opin Ophthalmol, V16, P315, DOI 10.1097/01.icu.0000179804.49842.e2; Davies EC, 2011, J NEURO-OPHTHALMOL, V31, P260, DOI 10.1097/WNO.0b013e318221b434; Forooghian F, 2006, DOC OPHTHALMOL, V113, P123, DOI 10.1007/s10633-006-9022-0; Garas A, 2011, EUR J OPHTHALMOL, V21, P473, DOI 10.5301/EJO.2010.5844; Gelfand JM, 2013, JAMA NEUROL, V70, P629, DOI 10.1001/jamaneurol.2013.1832; Gelfand JM, 2012, BRAIN, V135, P1786, DOI 10.1093/brain/aws098; Green AJ, 2013, BRAIN, V136, DOI 10.1093/brain/awt155; Green AJ, 2010, BRAIN, V133, P1591, DOI 10.1093/brain/awq080; Gundogan FC, 2007, INVEST OPHTH VIS SCI, V48, P5773, DOI 10.1167/iovs.07-0834; KERRISON JB, 1994, RETINA-J RET VIT DIS, V14, P445, DOI 10.1097/00006982-199414050-00010; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Petzold A, 2012, LANCET NEUROL, V11, P933, DOI 10.1016/S1474-4422(12)70231-4; Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X; Saidha S, 2012, LANCET NEUROL, V11, P963, DOI 10.1016/S1474-4422(12)70213-2; Saidha S, 2011, MULT SCLER J, V17, P1449, DOI 10.1177/1352458511418630; Saidha S, 2011, BRAIN, V134, P518, DOI 10.1093/brain/awq346; Seigo MA, 2012, J NEUROL, V259, P2119, DOI 10.1007/s00415-012-6466-x; Sigler EJ, 2013, GRAEF ARCH CLIN EXP, V251, P1679, DOI 10.1007/s00417-012-2253-8; Sotirchos ES, 2013, NEUROLOGY, V80, P1406, DOI 10.1212/WNL.0b013e31828c2f7a; Sriram P, 2012, INVEST OPHTH VIS SCI, V53, P1271, DOI 10.1167/iovs.11-8732; Syc SB, 2012, BRAIN, V135, P521, DOI 10.1093/brain/awr264; Walter SD, 2012, OPHTHALMOLOGY, V119, P1250, DOI 10.1016/j.ophtha.2011.11.032; Wolff B, 2013, RETINAL INNER NUCL L	28	31	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e78341	10.1371/journal.pone.0078341	http://dx.doi.org/10.1371/journal.pone.0078341			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098599	Green Submitted, gold, Green Published			2022-12-25	WOS:000325483600092
J	Park, EJ; Jang, HJ; Tsoyi, K; Kim, YM; Park, SW; Kim, HJ; Lee, JH; Chang, KC				Park, Eun Jung; Jang, Hwa Jin; Tsoyi, Konstantin; Kim, Young Min; Park, Sang Won; Kim, Hye Jung; Lee, Jae Heun; Chang, Ki Churl			The Heme Oxygenase-1 Inducer THI-56 Negatively Regulates iNOS Expression and HMGB1 Release in LPS-Activated RAW 264.7 Cells and CLP-Induced Septic Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; VASCULAR SMOOTH-MUSCLE; MOBILITY GROUP BOX-1; EXPERIMENTAL ENDOTOXEMIA; SIGNALING PATHWAY; CECAL LIGATION; YS 49; MONOXIDE; LIPOPOLYSACCHARIDE; MACROPHAGES	The nuclear DNA binding protein high mobility group box 1 (HMGB1) has recently been suggested to act as a late mediator of septic shock. The effect of ((S)-6,7-dihydroxy-1-(4-hydroxynaphthylmethyl)-1,2,3,4-tetrahydroisoquinoline alkaloid, also known as THI-56, in an experimental model of sepsis was investigated. THI-56 exhibited potent anti-inflammatory properties in response to LPS in RAW 264.7 cells. In particular, THI-56 significantly inhibited the expression of inducible nitric oxide synthase (iNOS) and the release of HMGB1 in activated macrophages. THI-56 activated NE-F2-regulated factor 2 (Nrf-2)/heme oxygenase 1 (HO-1). The specific knockdown of the HO-1 gene by HO-1 siRNA significantly reversed the inhibitory effects of THI-56 on iNOS expression and HMGB1 release in LPS-stimulated macrophages. Importantly, THI-56 administration protected animals from death induced by either a lethal dose of LPS or cecal ligation and puncture (CLP). Furthermore, the ALT, AST, BUN, creatinine, and HMGB1 levels in the blood were significantly increased in CLP-induced septic mice, and the administration of THI-56 reduced these levels in a concentration-dependent and zinc protoporphyrin IX (ZnPPIX)-sensitive manner. In addition, the administration of THI-56 significantly ameliorated not only lung damage but also macrophage infiltration in the livers of CLP-induced septic mice, and these effects were also abrogated in the presence of ZnPPIX. Thus, we conclude that THI-56 significantly attenuates the proinflammatory response induced by LPS and reduces organ damage in a CLP-induced sepsis model through the upregulation of Nrf-2/HO-1.	[Chang, Ki Churl] Gyeongsang Natl Univ, Dept Pharmacol, Sch Med, Jinju, South Korea; Inst Hlth Sci, Jinju, South Korea	Gyeongsang National University	Chang, KC (corresponding author), Gyeongsang Natl Univ, Dept Pharmacol, Sch Med, Jinju, South Korea.	kcchang@gnu.kr			Ministry of Health and Welfare [A111425]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007633] Funding Source: NIH RePORTER	Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Ministry of Health and Welfare (A111425). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Bani-Hani Mohamed G, 2006, Pharmacol Rep, V58 Suppl, P132; Beutler B, 2008, J IMMUNOL, V181, P7; DiNapoli MR, 1996, J EXP MED, V183, P1323, DOI 10.1084/jem.183.4.1323; DINARELLO CA, 1991, IMMUNOL TODAY, V12, P404, DOI 10.1016/0167-5699(91)90142-G; ESKANDARI MK, 1992, J IMMUNOL, V148, P2724; HEINZEL FP, 1990, J IMMUNOL, V145, P2920; Heo JM, 2007, BIOCHEM PHARMACOL, V74, P1361, DOI 10.1016/j.bcp.2007.07.023; Horvath I., 2001, European Respiratory Journal, V18, P420, DOI 10.1183/09031936.01.00231201; Jiang WW, 2006, J IMMUNOL, V177, P3337, DOI 10.4049/jimmunol.177.5.3337; Kang YJ, 2002, J PHARMACOL EXP THER, V301, P561, DOI 10.1124/jpet.301.2.561; Kang YJ, 1999, BRIT J PHARMACOL, V128, P357, DOI 10.1038/sj.bjp.0702787; Kim HJ, 2007, J PHARMACOL EXP THER, V320, P782, DOI 10.1124/jpet.106.112052; Kim JH, 2009, J IMMUNOL, V182, P2458, DOI 10.4049/jimmunol.0801364; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Nakahira K, 2006, J EXP MED, V203, P2377, DOI 10.1084/jem.20060845; Oberholzer A, 2001, SHOCK, V16, P83, DOI 10.1097/00024382-200116020-00001; Oh YJ, 2009, J IMMUNOL, V182, P5800, DOI 10.4049/jimmunol.0801873; Park EJ, 2013, FOOD CHEM TOXICOL, V55, P386, DOI 10.1016/j.fct.2012.12.027; Park JE, 2006, INT IMMUNOPHARMACOL, V6, P226, DOI 10.1016/j.intimp.2005.08.007; Qin SX, 2006, J EXP MED, V203, P1637, DOI 10.1084/jem.20052203; Remy S, 2009, J IMMUNOL, V182, P1877, DOI 10.4049/jimmunol.0802436; Ryter SW, 2009, AM J RESP CELL MOL, V41, P251, DOI 10.1165/rcmb.2009-0170TR; Sato K, 2001, J IMMUNOL, V166, P4185, DOI 10.4049/jimmunol.166.6.4185; Sawle P, 2005, BRIT J PHARMACOL, V145, P800, DOI 10.1038/sj.bjp.0706241; Su X, 2004, INTENS CARE MED, V30, P133, DOI 10.1007/s00134-003-2001-y; Sun JJ, 2008, LIFE SCI, V82, P600, DOI 10.1016/j.lfs.2007.12.015; Takamiya R, 2009, AM J RESP CELL MOL, V41, P129, DOI 10.1165/rcmb.2008-0331OC; Tsoyi K, 2008, CELL SIGNAL, V20, P1839, DOI 10.1016/j.cellsig.2008.06.012; Tsoyi K, 2009, ATHEROSCLEROSIS, V207, P412, DOI 10.1016/j.atherosclerosis.2009.05.012; Tsoyi K, 2009, INFLAMMATION, V32, P364, DOI 10.1007/s10753-009-9144-0; Tsoyi K, 2009, MOL PHARMACOL, V76, P173, DOI 10.1124/mol.109.055137; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Zhang XH, 2008, J IMMUNOL, V181, P5015, DOI 10.4049/jimmunol.181.7.5015	35	20	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76293	10.1371/journal.pone.0076293	http://dx.doi.org/10.1371/journal.pone.0076293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098466	Green Published, Green Submitted, gold			2022-12-25	WOS:000325483600036
J	Tarantal, AF; Lee, CCI; Kukis, DL; Cherry, SR				Tarantal, Alice F.; Lee, C. Chang I.; Kukis, David L.; Cherry, Simon R.			Radiolabeling Human Peripheral Blood Stem Cells for Positron Emission Tomography (PET) Imaging in Young Rhesus Monkeys	PLOS ONE			English	Article							MACACA-MULATTA; FETAL; MICROPET; EXPRESSION	These studies focused on a new radiolabeling technique with copper (Cu-64) and zirconium (Zr-89) for positron emission tomography (PET) imaging using a CD45 antibody. Synthesis of Cu-64-CD45 and Zr-89-CD45 immunoconjugates was performed and the evaluation of the potential toxicity of radiolabeling human peripheral blood stem cells (hPBSC) was assessed in vitro (viability, population doubling times, colony forming units). hPBSC viability was maintained as the dose of Cu-64-TETA-CD45 increased from 0 (92%) to 160 mu Ci/mL (76%, p>0.05). Radiolabeling efficiency was not significantly increased with concentrations of Cu-64-TETA-CD45 >20 mu Ci/mL (p>0.50). Toxicity affecting both growth and colony formation was observed with hPBSC radiolabeled with >= 40 mu Ci/mL (p<0.05). For Zr-89, there were no significant differences in viability (p>0.05), and a trend towards increased radiolabeling efficiency was noted as the dose of Zr-89-Df-CD45 increased, with a greater level of radiolabeling with 160 mCi/mL compared to 0-40 mu Ci/mL (p<0.05). A greater than 2,000 fold-increase in the level of Zr-89-Df-CD45 labeling efficiency was observed when compared to Cu-64-TETA-CD45. Similar to Cu-64-TETA-CD45, toxicity was noted when hPBSC were radiolabeled with >= 40 mu Ci/mL (p<0.05) (growth, colony formation). Taken together, 20 mu Ci/mL resulted in the highest level of radiolabeling efficiency without altering cell function. Young rhesus monkeys that had been transplanted prenatally with 25x10(6) hPBSC expressing firefly luciferase were assessed with bioluminescence imaging (BLI), then 0.3 mCi of Zr-89-Df-CD45, which showed the best radiolabeling efficiency, was injected intravenously for PET imaging. Results suggest that Zr-89-Df-CD45 was able to identify engrafted hPBSC in the same locations identified by BLI, although the background was high.	[Tarantal, Alice F.] Univ Calif Davis, Dept Pediat, Davis, CA 95616 USA; [Tarantal, Alice F.] Univ Calif Davis, Dept Cell Biol & Human Anat, Davis, CA 95616 USA; [Tarantal, Alice F.; Lee, C. Chang I.; Cherry, Simon R.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Cherry, Simon R.] Univ Calif Davis, Dept Radiol, Davis, CA 95616 USA; [Kukis, David L.; Cherry, Simon R.] Univ Calif Davis, Ctr Mol & Genom Imaging, Davis, CA 95616 USA; [Cherry, Simon R.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Tarantal, AF (corresponding author), Univ Calif Davis, Dept Pediat, Davis, CA 95616 USA.	afterantal@primate.ucdavis.edu	Cherry, Simon/AAH-1000-2019	Cherry, Simon/0000-0002-0155-5644	California Institute for Regenerative Medicine (CIRM) Tools and Technologies grant [RT1-01019]; Primate Center base operating grant [OD011107]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM) Tools and Technologies grant; Primate Center base operating grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	These studies were supported by the California Institute for Regenerative Medicine (CIRM) Tools and Technologies grant #RT1-01019 and the Primate Center base operating grant #OD011107. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Freedenberg M, 2013, PHYS MED; Huang J, 2008, MOL IMAGING, V7, P1, DOI 10.2310/7290.2008.00001; MEIJS WE, 1992, APPL RADIAT ISOTOPES, V43, P1443, DOI 10.1016/0883-2889(92)90170-J; Pecking AP, 2012, CLIN EXP METASTAS, V29, P847, DOI 10.1007/s10585-012-9501-5; Rizvi SNF, 2012, EUR J NUCL MED MOL I, V39, P512, DOI 10.1007/s00259-011-2008-5; Tai YC, 2001, PHYS MED BIOL, V46, P1845, DOI 10.1088/0031-9155/46/7/308; Tarantal AF, 2000, TRANSPLANTATION, V69, P1818, DOI 10.1097/00007890-200005150-00015; Tarantal Alice F., 2005, P317, DOI 10.1016/B978-012080261-6/50020-9; Tarantal AF, 2006, HUM GENE THER, V17, P1254, DOI 10.1089/hum.2006.17.1254; Tarantal AF, 2012, MOL IMAGING BIOL, V14, P197, DOI 10.1007/s11307-011-0487-1; Tarantal AF, 2010, HUM GENE THER, V21, P143, DOI 10.1089/hum.2009.126; Wallhaus TR, 2001, J NUCL CARDIOL, V8, P67, DOI 10.1067/mnc.2001.109929; Zhang Y, 2011, CURR RADIOPHARM, V4, P131, DOI 10.2174/1874471011104020131	13	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e77148	10.1371/journal.pone.0077148	http://dx.doi.org/10.1371/journal.pone.0077148			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098579	Green Submitted, Green Published, gold			2022-12-25	WOS:000325483600084
J	Umegaki-Arao, N; Tamai, K; Nimura, K; Serada, S; Naka, T; Nakano, H; Katayama, I				Umegaki-Arao, Noriko; Tamai, Katsuto; Nimura, Keisuke; Serada, Satoshi; Naka, Tetsuji; Nakano, Hajime; Katayama, Ichiro			Karyopherin Alpha2 Is Essential for rRNA Transcription and Protein Synthesis in Proliferative Keratinocytes	PLOS ONE			English	Article							IMPORTIN-ALPHA; GENE-EXPRESSION; NUCLEAR-IMPORT; CANCER; SURVIVAL; BINDING; GROWTH; CELLS; KPNA2; CYCLE	Karyopherin proteins mediate nucleocytoplasmic trafficking and are critical for protein and RNA subcellular localization. Recent studies suggest KPNA2 expression is induced in tumor cells and is strongly associated with prognosis, although the precise roles and mechanisms of KPNA2 overexpression in proliferative disorders have not been defined. We found that KPNA2 expression is induced in various proliferative disorders of the skin such as psoriasis, Bowen's disease, actinic keratosis, squamous cell carcinoma, Paget's disease, Merkel cell carcinoma, and mycosis fungoides. siRNA-mediated KPNA suppression revealed that KPNA2 is essential for significant suppression of HaCaT proliferation under starvation conditions. Ribosomal RNA transcription and protein synthesis were suppressed by starvation combined with knockdown of KPNA (including KPNA2) expression. KPNA2 localized to the nucleolus and interacted with proteins associated with mRNA processing, ribonucleoprotein complex biogenesis, chromatin modification, and transcription, as demonstrated by tandem affinity purification and mass spectrometry. KPNA2 may be an important promoter of ribosomal RNA and protein synthesis in tumor cells.	[Umegaki-Arao, Noriko; Katayama, Ichiro] Osaka Univ, Grad Sch Med, Dept Dermatol, Osaka, Japan; [Tamai, Katsuto] Osaka Univ, Dept Stem Cell Therapy Sci, Grad Sch Med, Osaka, Japan; [Nimura, Keisuke] Osaka Univ, Grad Sch Med, Div Gene Therapy Sci, Osaka, Japan; [Serada, Satoshi; Naka, Tetsuji] Natl Inst Biomed Innovat Lab Immune Signal, Osaka, Japan; [Nakano, Hajime] Hirosaki Univ, Sch Med, Dept Dermatol, Hirosaki, Aomori 036, Japan	Osaka University; Osaka University; Osaka University; Hirosaki University	Tamai, K (corresponding author), Osaka Univ, Dept Stem Cell Therapy Sci, Grad Sch Med, Osaka, Japan.	tamai@gts.med.osaka-u.ac.jp	Nimura, Keisuke/AAE-9925-2020	yi lang, pian shan/0000-0002-3270-1085; Serada, Satoshi/0000-0001-6948-9009; Naka, Tetsuji/0000-0002-1269-3997	Ministry of Education, Culture, Science and Technology of Japan; Health and Labour Science Research Grant from the Ministry of Health, Labour and Welfare of Japan	Ministry of Education, Culture, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labour Science Research Grant from the Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid of Scientific Research from the Ministry of Education, Culture, Science and Technology of Japan, and a Health and Labour Science Research Grant from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askjaer P, 2002, MOL BIOL CELL, V13, P4355, DOI 10.1091/mbc.E02-06-0346; Ems-McClung SC, 2004, MOL BIOL CELL, V15, P46, DOI 10.1091/mbc.E03-07-0454; Freire J, 2001, BIOCHEM CELL BIOL, V79, P123, DOI 10.1139/bcb-79-2-123; Ghoshal K, 2004, J BIOL CHEM, V279, P6783, DOI 10.1074/jbc.M309393200; Gluz O, 2008, INT J CANCER, V123, P1433, DOI 10.1002/ijc.23628; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Hall MN, 2011, DEV BIOL, V357, P248, DOI 10.1016/j.ydbio.2011.06.032; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Mortezavi A, 2011, CLIN CANCER RES, V17, P1111, DOI 10.1158/1078-0432.CCR-10-0081; Moss T, 2004, CURR OPIN GENET DEV, V14, P210, DOI 10.1016/j.gde.2004.02.005; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; Nimura K, 2009, NATURE, V460, P287, DOI 10.1038/nature08086; Noetzel E, 2012, ONCOGENE, V31, P2101, DOI 10.1038/onc.2011.403; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rotem A, 2009, MOL BIOL CELL, V20, P4031, DOI 10.1091/mbc.E09-02-0150; Schatz CA, 2003, EMBO J, V22, P2060, DOI 10.1093/emboj/cdg195; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Tanaka Y, 2010, EMBO J, V29, P1510, DOI 10.1038/emboj.2010.56; Teng SC, 2006, J MOL HISTOL, V37, P293, DOI 10.1007/s10735-006-9032-y; Umegaki N, 2007, J INVEST DERMATOL, V127, P1456, DOI 10.1038/sj.jid.5700716; van der Watt PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027723; Van der Watt PJ, 2009, INT J CANCER, V124, P1829, DOI 10.1002/ijc.24146; Wang CI, 2011, INT J CANCER, V128, P2364, DOI 10.1002/ijc.25568; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Yasuda Y, 2012, EMBO J, V31, P83, DOI 10.1038/emboj.2011.360; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521; Yasuharaa N, 2009, SEMIN CELL DEV BIOL, V20, P590, DOI 10.1016/j.semcdb.2009.05.003	29	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76416	10.1371/journal.pone.0076416	http://dx.doi.org/10.1371/journal.pone.0076416			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098495	Green Submitted, Green Published, gold			2022-12-25	WOS:000325483600047
J	Barton, KL; Misuraca, K; Cordero, F; Dobrikova, E; Min, HD; Gromeier, M; Kirsch, DG; Becher, OJ				Barton, Kelly L.; Misuraca, Katherine; Cordero, Francisco; Dobrikova, Elena; Min, Hooney D.; Gromeier, Matthias; Kirsch, David G.; Becher, Oren J.			PD-0332991, a CDK4/6 Inhibitor, Significantly Prolongs Survival in a Genetically Engineered Mouse Model of Brainstem Glioma	PLOS ONE			English	Article							INTRINSIC PONTINE GLIOMAS; DEPENDENT KINASE 4/6; PD 0332991; GLIOBLASTOMA; MUTATION; GROWTH; CELLS; PHOSPHORYLATION; INACTIVATION; SENSITIVITY	Diffuse intrinsic pontine glioma (DIPG) is an incurable tumor that arises in the brainstem of children. To date there is not a single approved drug to effectively treat these tumors and thus novel therapies are desperately needed. Recent studies suggest that a significant fraction of these tumors contain alterations in cell cycle regulatory genes including amplification of the D-type cyclins and CDK4/6, and less commonly, loss of Ink4a-ARF leading to aberrant cell proliferation. In this study, we evaluated the therapeutic approach of targeting the cyclin-CDK-Retinoblastoma (Rb) pathway in a genetically engineered PDGF-B-driven brainstem glioma (BSG) mouse model. We found that PD-0332991 (PD), a CDK4/6 inhibitor, induces cell-cycle arrest in our PDGF-B; Ink4a-ARF deficient model both in vitro and in vivo. By contrast, the PDGF-B; p53 deficient model was mostly resistant to treatment with PD. We noted that a 7-day treatment course with PD significantly prolonged survival by 12% in the PDGF-B; Ink4a-ARF deficient BSG model. Furthermore, a single dose of 10 Gy radiation therapy (RT) followed by 7 days of treatment with PD increased the survival by 19% in comparison to RT alone. These findings provide the rationale for evaluating PD in children with Ink4a-ARF deficient gliomas.	[Barton, Kelly L.; Cordero, Francisco; Becher, Oren J.] Duke Univ, Dept Pediat, Durham, NC 27706 USA; [Cordero, Francisco; Becher, Oren J.] Duke Univ, Dept Pathol, Durham, NC 27706 USA; [Barton, Kelly L.; Cordero, Francisco; Becher, Oren J.] Duke Univ, Preston Robert Tisch Brain Tumor Ctr, Durham, NC 27706 USA; [Misuraca, Katherine] Duke Univ, Grad Program Mol Canc Biol, Durham, NC 27706 USA; [Dobrikova, Elena; Gromeier, Matthias] Duke Univ, Dept Surg, Durham, NC 27706 USA; [Min, Hooney D.; Kirsch, David G.] Duke Univ, Dept Radiat Oncol, Durham, NC 27706 USA; [Kirsch, David G.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27706 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Duke University	Becher, OJ (corresponding author), Duke Univ, Dept Pediat, Durham, NC 27706 USA.	oren.becher@duke.edu	Becher, Oren/AAI-7495-2020	Becher, Oren/0000-0003-4016-8492	Duke Cancer Institute; Rory David Deutsch Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040372] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA124756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI093866] Funding Source: NIH RePORTER	Duke Cancer Institute; Rory David Deutsch Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Duke Cancer Institute seed grant to OJB and DGK. OJB is also supported by the Rory David Deutsch Foundation. http://www.roryd.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders L, 2011, CANCER CELL, V20, P620, DOI 10.1016/j.ccr.2011.10.001; Aoki Y, 2012, J NEURO-ONCOL, V108, P29, DOI 10.1007/s11060-011-0796-x; Becher OJ, 2010, CANCER RES, V70, P2548, DOI 10.1158/0008-5472.CAN-09-2503; Cen L, 2012, NEURO-ONCOLOGY, V14, P870, DOI 10.1093/neuonc/nos114; Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; Khuong-Quang DA, 2012, ACTA NEUROPATHOL, V124, P439, DOI 10.1007/s00401-012-0998-0; Flaherty KT, 2012, CLIN CANCER RES, V18, P568, DOI 10.1158/1078-0432.CCR-11-0509; Fry DW, 2004, MOL CANCER THER, V3, P1427; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Hargrove D, 2006, LANCET ONCOL, V7, P241, DOI 10.1016/S1470-2045(06)70615-5; Huillard E, 2012, P NATL ACAD SCI USA, V109, P8710, DOI 10.1073/pnas.1117255109; Katsumi Y, 2011, BIOCHEM BIOPH RES CO, V413, P62, DOI 10.1016/j.bbrc.2011.08.047; Leonard JP, 2012, BLOOD, V119, P4597, DOI 10.1182/blood-2011-10-388298; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Michaud K, 2010, CANCER RES, V70, P3228, DOI 10.1158/0008-5472.CAN-09-4559; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Newton J, 2011, MED PHYS, V38, P6754, DOI 10.1118/1.3663675; Paugh BS, 2011, J CLIN ONCOL, V29, P3999, DOI 10.1200/JCO.2011.35.5677; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Puget S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030313; Warren KE, 2012, NEURO-ONCOLOGY, V14, P326, DOI 10.1093/neuonc/nor190; Wiedemeyer WR, 2010, P NATL ACAD SCI USA, V107, P11501, DOI 10.1073/pnas.1001613107; Zarghooni M, 2010, J CLIN ONCOL, V28, P1337, DOI 10.1200/JCO.2009.25.5463	24	107	109	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e77639	10.1371/journal.pone.0077639	http://dx.doi.org/10.1371/journal.pone.0077639			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098593	Green Submitted, Green Published, gold			2022-12-25	WOS:000325434500103
J	Lu, GR; Wu, YN; Jiang, YY; Wang, S; Hou, YN; Guan, XQ; Brunzelle, J; Sirinupong, N; Sheng, SJ; Li, CY; Yang, Z				Lu, Guorong; Wu, Yanning; Jiang, Yuanyuan; Wang, Shuo; Hou, Yuning; Guan, Xiaoqing; Brunzelle, Joseph; Sirinupong, Nualpun; Sheng, Shijie; Li, Chunying; Yang, Zhe			Structural Insights into Neutrophilic Migration Revealed by the Crystal Structure of the Chemokine Receptor CXCR2 in Complex with the First PDZ Domain of NHERF1	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; BINDING; SPECIFICITY; PROTEINS; CFTR; INFLAMMATION; INHIBITION; REFINEMENT; MECHANISM; PARTNERS	Neutrophil plays an essential role in host defense against infection, but uncontrolled neutrophilic infiltration can cause inflammation and severe epithelial damage. We recently showed that CXCR2 formed a signaling complex with NHERF1 and PLC-2, and that the formation of this complex was required for intracellular calcium mobilization and neutrophilic transepithelial migration. To uncover the structural basis of the complex formation, we report here the crystal structure of the NHERF1 PDZ1 domain in complex with the C-terminal sequence of CXCR2 at 1.16 angstrom resolution. The structure reveals that the CXCR2 peptide binds to PDZ1 in an extended conformation with the last four residues making specific side chain interactions. Remarkably, comparison of the structure to previously studied PDZ1 domains has allowed the identification of PDZ1 ligand-specific interactions and the mechanisms that govern PDZ1 target selection diversities. In addition, we show that CXCR2 can bind both NHERF1 PDZ1 and PDZ2 in pulldown experiments, consistent with the observation that the peptide binding pockets of these two PDZ domains are highly structurally conserved. The results of this study therefore provide structural basis for the CXCR2-mediated neutrophilic migration and could have important clinical applications in the prevention and treatment of numerous neutrophil-dependent inflammatory disorders.	[Lu, Guorong; Wu, Yanning; Jiang, Yuanyuan; Wang, Shuo; Hou, Yuning; Guan, Xiaoqing; Li, Chunying; Yang, Zhe] Wayne State Univ, Dept Biochem & Mol Biol, Sch Med, Detroit, MI 48202 USA; [Brunzelle, Joseph] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; [Sirinupong, Nualpun] Prince Songkla Univ, Nutraceut & Funct Food Res & Dev Ctr, Hat Yai, Songkhla, Thailand; [Sheng, Shijie] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA	Wayne State University; United States Department of Energy (DOE); Argonne National Laboratory; Prince of Songkla University; Wayne State University	Li, CY (corresponding author), Wayne State Univ, Dept Biochem & Mol Biol, Sch Med, Detroit, MI 48202 USA.	cl@med.wayne.edu; zyang@med.wayne.edu	jiang, anyi/GPT-0379-2022; Sirinupong, Nualpun/AAX-4886-2020	Sirinupong, Nualpun/0000-0002-9986-3011; Hou, Yuning/0000-0001-9894-3821	Leukemia Research Foundation; Aplastic Anemia & MDS International Foundation; Elsa U. Pardee Foundation; American Heart Association	Leukemia Research Foundation; Aplastic Anemia & MDS International Foundation; Elsa U. Pardee Foundation; American Heart Association(American Heart Association)	This study was supported by the Leukemia Research Foundation (to ZY) and the Aplastic Anemia & MDS International Foundation (to ZY), as well as the Elsa U. Pardee Foundation (to CL) and American Heart Association (to CL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison CL, 2000, J IMMUNOL, V165, P5269, DOI 10.4049/jimmunol.165.9.5269; Ardura JA, 2011, PHARMACOL REV, V63, P882, DOI 10.1124/pr.110.004176; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; Bhattacharya S, 2013, J MOL BIOL, V425, P2509, DOI 10.1016/j.jmb.2013.04.001; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Cardone RA, 2012, MOL BIOL CELL, V23, P2028, DOI 10.1091/mbc.E11-11-0911; Chapman RW, 2009, PHARMACOL THERAPEUT, V121, P55, DOI 10.1016/j.pharmthera.2008.10.005; Cushing PR, 2008, BIOCHEMISTRY-US, V47, P10084, DOI 10.1021/bi8003928; Elkins JM, 2007, PROTEIN SCI, V16, P683, DOI 10.1110/ps.062657507; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Geng JG, 2001, CELL RES, V11, P85, DOI 10.1038/sj.cr.7290071; Glynn PC, 2002, PULM PHARMACOL THER, V15, P103, DOI 10.1006/pupt.2001.0323; Harris BZ, 2001, J CELL SCI, V114, P3219; Jamieson T, 2012, J CLIN INVEST, V122, P3127, DOI 10.1172/JCI61067; Karthikeyan S, 2002, J BIOL CHEM, V277, P18973, DOI 10.1074/jbc.M201507200; Karthikeyan S, 2001, J BIOL CHEM, V276, P19683, DOI 10.1074/jbc.C100154200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Mamonova T, 2012, BIOCHEMISTRY-US, V51, P3110, DOI 10.1021/bi201213w; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Molina JR, 2012, ONCOGENE, V31, P1264, DOI 10.1038/onc.2011.324; Morales FC, 2007, MOL CELL BIOL, V27, P2527, DOI 10.1128/MCB.01372-06; Munz M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002749; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Raghuram V, 2001, P NATL ACAD SCI USA, V98, P1300, DOI 10.1073/pnas.031538898; Raghuram V, 2003, P NATL ACAD SCI USA, V100, P9620, DOI 10.1073/pnas.1633250100; Runyon ST, 2007, PROTEIN SCI, V16, P2454, DOI 10.1110/ps.073049407; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Sheng R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2221; Stein A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002524; Takahashi Y, 2006, EMBO J, V25, P910, DOI 10.1038/sj.emboj.7600979; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P515, DOI 10.1107/S0907444908004319; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Tsai HH, 2002, CELL, V110, P373, DOI 10.1016/S0092-8674(02)00838-3; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Velthuis AJWT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016047; Voltz JW, 2007, J BIOL CHEM, V282, P33879, DOI 10.1074/jbc.M703481200; Voltz JW, 2001, ONCOGENE, V20, P6309, DOI 10.1038/sj.onc.1204774; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wang B, 2009, MOL PHARMACOL, V75, P1189, DOI 10.1124/mol.108.054486; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; Weinman EJ, 2000, AM J PHYSIOL-RENAL, V279, pF393, DOI 10.1152/ajprenal.2000.279.3.F393; Wu YN, 2012, J BIOL CHEM, V287, P5744, DOI 10.1074/jbc.M111.315762; Zhang YN, 2006, J BIOL CHEM, V281, P22299, DOI 10.1074/jbc.M602902200	45	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76219	10.1371/journal.pone.0076219	http://dx.doi.org/10.1371/journal.pone.0076219			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098448	Green Published, Green Submitted, gold			2022-12-25	WOS:000325434500053
J	Peacey, M; Hall, RJ; Wang, J; Todd, AK; Yen, S; Chan-Hyams, J; Rand, CJ; Stanton, JA; Huang, QS				Peacey, Matthew; Hall, Richard J.; Wang, Jing; Todd, Angela K.; Yen, Seiha; Chan-Hyams, Jasmine; Rand, Christy J.; Stanton, Jo-Ann; Huang, Q. Sue			Enterovirus 74 Infection in Children	PLOS ONE			English	Article							MOLECULAR-IDENTIFICATION; FREQUENT RECOMBINATION; EVOLUTION; VP1; SEROTYPES; REGIONS; GENOME; CHINA	Enterovirus 74 (EV74) is a rarely detected viral infection of children. In 2010, EV74 was identified in New Zealand in a 2 year old child with acute flaccid paralysis (AFP) through routine polio AFP surveillance. A further three cases of EV74 were identified in children within six months. These cases are the first report of EV74 in New Zealand. In this study we describe the near complete genome sequence of four EV74 isolates from New Zealand, which shows only limited sequence identity in the non-structural proteins when compared to the other two known EV74 sequences. As is typical of enteroviruses multiple recombination events were evident, particularly in the P2 region and P3 regions. This is the first complete EV74 genome sequenced from a patient with acute flaccid paralysis.	[Peacey, Matthew; Hall, Richard J.; Wang, Jing; Todd, Angela K.; Yen, Seiha; Chan-Hyams, Jasmine; Huang, Q. Sue] Natl Ctr Biosecur & Infect Dis, Inst Environm Sci & Res, Wellington, New Zealand; [Rand, Christy J.; Stanton, Jo-Ann] Univ Otago, Dept Anat, Dunedin, New Zealand	Institute of Environmental Science & Research (ESR) - New Zealand; University of Otago	Peacey, M (corresponding author), Natl Ctr Biosecur & Infect Dis, Inst Environm Sci & Res, Wellington, New Zealand.	matthew.peacey@esr.cri.nz	Stanton, Jo-Ann L/C-6621-2009; Yen, Seiha/L-7678-2015	Stanton, Jo-Ann L/0000-0001-8139-4694; Yen, Seiha/0000-0001-6208-3313; Huang, Q. Sue/0000-0002-3923-5195; Hall, Richard/0000-0002-9879-9476; Peacey, Matthew/0000-0002-4312-8085; Rand, Christy/0000-0003-1617-6089	Ministry for Business, Innovation and Employment; Ministry of Health	Ministry for Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE)); Ministry of Health	This study was funded by the Ministry for Business, Innovation and Employment and the Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bessaud M, 2012, J CLIN MICROBIOL, V50, P1650, DOI 10.1128/JCM.06657-11; Blomqvist S, 2008, J CLIN MICROBIOL, V46, P2410, DOI 10.1128/JCM.00313-08; Han JF, 2012, EMERG INFECT DIS, V18, P351, DOI 10.3201/eid1802.111524; Jee YM, 2003, ARCH VIROL, V148, P1735, DOI 10.1007/s00705-003-0133-6; Lindberg AM, 2003, J GEN VIROL, V84, P1223, DOI 10.1099/vir.0.18971-0; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lukashev AN, 2005, J GEN VIROL, V86, P3281, DOI 10.1099/vir.0.81264-0; Lukashev AN, 2005, REV MED VIROL, V15, P157, DOI 10.1002/rmv.457; Lukashev AN, 2003, J VIROL, V77, P10423, DOI 10.1128/JVI.77.19.10423-10431.2003; Norder H, 2003, J GEN VIROL, V84, P827, DOI 10.1099/vir.0.18647-0; Oberste MS, 2013, J VIROL, V87, P558, DOI 10.1128/JVI.00837-12; Oberste MS, 2004, J GEN VIROL, V85, P3205, DOI 10.1099/vir.0.80148-0; Oberste MS, 2004, J VIROL, V78, P855, DOI 10.1128/JVI.78.2.855-867.2004; Phan TG, 2005, J MED VIROL, V77, P257, DOI 10.1002/jmv.20445; Santti J, 1999, J VIROL, V73, P8741, DOI 10.1128/JVI.73.10.8741-8749.1999; Simmonds P, 2006, J VIROL, V80, P483, DOI 10.1128/JVI.80.1.483-493.2006; Simon-Loriere E, 2011, NAT REV MICROBIOL, V9, P617, DOI 10.1038/nrmicro2614; Smura T, 2011, FUTURE VIROL, V6, P109, DOI 10.2217/FVL.10.62; Tan CYQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018022; Tapparel C, 2009, EMERG INFECT DIS, V15, P719, DOI 10.3201/eid1505.081286; Wang JT, 2012, ARCH VIROL, V157, P1593, DOI 10.1007/s00705-012-1332-9; Yozwiak NL, 2010, J VIROL, V84, P9047, DOI 10.1128/JVI.00698-10	23	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76492	10.1371/journal.pone.0076492	http://dx.doi.org/10.1371/journal.pone.0076492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098514	Green Published, Green Submitted, gold			2022-12-25	WOS:000325434500068
J	Schmidt, SA; Akrofi, K; Carpenter-Thompson, JR; Husain, FT				Schmidt, Sara A.; Akrofi, Kwaku; Carpenter-Thompson, Jake R.; Husain, Fatima T.			Default Mode, Dorsal Attention and Auditory Resting State Networks Exhibit Differential Functional Connectivity in Tinnitus and Hearing Loss	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; BRAIN; FMRI; PLASTICITY	We investigated auditory, dorsal attention, and default mode networks in adults with tinnitus and hearing loss in a resting state functional connectivity study. Data were obtained using continuous functional magnetic resonance imaging (fMRI) while the participants were at "rest" and were not performing any task. Participants belonged to one of three groups: middle-aged adults with tinnitus and mild-to-moderate high frequency hearing loss (TIN), age-matched controls with normal hearing and no tinnitus (NH), and a second control group with mild-to-moderate high frequency hearing loss without tinnitus (HL). After standard preprocessing, (a) a group independent component analysis (ICA) using 30 components and (b) a seeding-based connectivity analysis were conducted. In the group ICA, the default mode network was the only network to display visual differences between subject groups. In the seeding analysis, we found increased connectivity between the left parahippocampus and the auditory resting state network in the TIN group when compared to NH controls. Similarly, there was also an increased correlation between the right parahippocampus and the dorsal attention network when compared to HL controls. Other group differences in this attention network included decreased correlations between the seed regions and the right supramarginal gyrus in TIN patients when compared to HL controls. In the default mode network, there was a strong decrease in correlation between the seed regions and the precuneus when compared to both control groups. The findings of this study identify specific alterations in the connectivity of the default mode, dorsal attention, and auditory resting state networks due to tinnitus. The results suggest that therapies for tinnitus that mitigate the increased connectivity of limbic regions with auditory and attention resting state networks and the decreased coherence of the default mode network could be effective at reducing tinnitus-related distress.	[Schmidt, Sara A.; Akrofi, Kwaku; Carpenter-Thompson, Jake R.; Husain, Fatima T.] Univ Illinois, Neurosci Program, Champaign, IL USA; [Akrofi, Kwaku; Husain, Fatima T.] Univ Illinois, Dept Speech & Hearing Sci, Champaign, IL USA; [Husain, Fatima T.] Univ Illinois, Beckman Inst Adv Sci & Technol, Champaign, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Schmidt, SA (corresponding author), Univ Illinois, Neurosci Program, Champaign, IL USA.	schmsr@gmail.com		Schmidt, Sara/0000-0002-0161-8350	Tinnitus Research Consortium; NeuroEngineering NSF IGERT; NSF [0903622]	Tinnitus Research Consortium; NeuroEngineering NSF IGERT; NSF(National Science Foundation (NSF))	Funding was provided by the Tinnitus Research Consortium (through http://www.aro.org/index.html). Funding for graduate students (Sara Schmidt, Jake Carpenter-Thompson) was provided via the NeuroEngineering NSF IGERT (Integrative Graduate Education and Research Traineeship), NSF Grant No. 0903622. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Tinnitus Association website ATA's top 10 most frequently asked questions, ATAS TOP 10 MOST FRE; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; Bluhm R, 2009, PSYCHIAT CLIN NEUROS, V63, P754, DOI 10.1111/j.1440-1819.2009.02030.x; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Bluhm RL, 2009, J PSYCHIATR NEUROSCI, V34, P187; Brett M., 2002, 8 INT C FUNCT MAPP H, DOI DOI 10.1016/S1053-8119(02)90010-8; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Burton H, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-3; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Cavanna AE, 2007, CNS SPECTRUMS, V12, P545, DOI 10.1017/S1092852900021295; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; De Ridder D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024273; Filippi M, 2011, J ALZHEIMERS DIS, V24, P455, DOI 10.3233/JAD-2011-101854; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Golm D, 2013, HEARING RES, V295, P87, DOI 10.1016/j.heares.2012.03.003; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Gu JW, 2010, J NEUROPHYSIOL, V104, P3361, DOI 10.1152/jn.00226.2010; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hafkemeijer A, 2012, BBA-MOL BASIS DIS, V1822, P431, DOI 10.1016/j.bbadis.2011.07.008; Himberg J, 2003, 2003 IEEE XIII WORKSHOP ON NEURAL NETWORKS FOR SIGNAL PROCESSING - NNSP'03, P259, DOI 10.1109/NNSP.2003.1318025; Husain FT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026639; Kim JY, 2012, INT J AUDIOL, V51, P413, DOI 10.3109/14992027.2011.652677; Lockwood AH, 2002, NEW ENGL J MED, V347, P904, DOI 10.1056/NEJMra013395; Lorenz I, 2009, NEUROSCI LETT, V453, P225, DOI 10.1016/j.neulet.2009.02.028; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Maudoux A, 2012, BRAIN RES, V1485, P10, DOI 10.1016/j.brainres.2012.05.006; Maudoux A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036222; Mulders WHAM, 2009, NEUROSCIENCE, V164, P733, DOI 10.1016/j.neuroscience.2009.08.036; Northoff G, 2011, SCHIZOPHR RES, V127, P202, DOI 10.1016/j.schres.2010.11.009; Ongur D, 2010, PSYCHIAT RES-NEUROIM, V183, P59, DOI 10.1016/j.pscychresns.2010.04.008; Ooms E, 2012, EUR ARCH OTO-RHINO-L; Perrachione TK, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00055; Pihlajamaki M, 2009, BEHAV NEUROL, V21, P77, DOI 10.3233/BEN-2009-0231; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Repovs G, 2011, BIOL PSYCHIAT, V69, P967, DOI 10.1016/j.biopsych.2010.11.009; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Salvi RJ, 2000, HEARING RES, V147, P261, DOI 10.1016/S0378-5955(00)00136-2; Schlee W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-11; Shore SE, 2011, HEARING RES, V281, P38, DOI 10.1016/j.heares.2011.05.001; Swanson N, 2011, HUM BRAIN MAPP, V32, P654, DOI 10.1002/hbm.21055; the Gabrieli Lab McGovern Institute for Brain Research Massachusetts Institute of Technology, 2013, REX REG INT EXTR TOO; Vanneste S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013618; Vanneste S, 2010, NEUROIMAGE, V52, P470, DOI 10.1016/j.neuroimage.2010.04.029; Vernon JA, 1997, TINNITUS TREATMENT R; Weisz N, 2007, J NEUROSCI, V27, P1479, DOI 10.1523/JNEUROSCI.3711-06.2007; Weisz N, 2007, PROG BRAIN RES, V166, P61, DOI 10.1016/S0079-6123(07)66006-3; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Wineland AM, 2012, OTOLARYNG HEAD NECK, V147, P900, DOI 10.1177/0194599812451414; Woodward ND, 2011, SCHIZOPHR RES, V130, P86, DOI 10.1016/j.schres.2011.03.010; Zhang HY, 2010, RADIOLOGY, V256, P598, DOI 10.1148/radiol.10091701	54	139	139	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76488	10.1371/journal.pone.0076488	http://dx.doi.org/10.1371/journal.pone.0076488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098513	Green Published, gold, Green Submitted			2022-12-25	WOS:000325434500067
J	Tsou, YL; Lin, YW; Chang, HW; Lin, HY; Shao, HY; Yu, SL; Liu, CC; Chitra, E; Sia, C; Chow, YH				Tsou, Yueh-Liang; Lin, Yi-Wen; Chang, Hsuen-Wen; Lin, Hsiang-Yin; Shao, Hsiao-Yun; Yu, Shu-Ling; Liu, Chia-Chyi; Chitra, Ebenezer; Sia, Charles; Chow, Yen-Hung			Heat Shock protein 90: Role in Enterovirus 71 Entry and Assembly and Potential Target for Therapy	PLOS ONE			English	Article							SELECTIN GLYCOPROTEIN LIGAND-1; CENTRAL-NERVOUS-SYSTEM; MOLECULAR CHAPERONE; CYNOMOLGUS MONKEYS; CELLULAR RECEPTOR; CAPSID PROTEIN; MOUTH-DISEASE; INFECTION; HSP90; GELDANAMYCIN	Although several factors participating in enterovirus 71 (EV71) entry and replication had been reported, the precise mechanisms associated with these events are far from clear. In the present study, we showed that heat shock protein 90 (HSP90) is a key element associated with EV71 entry and replication in a human rhabdomyosarcoma of RD cells. Inhibition of HSP90 by pretreating host cells with HSP90 beta siRNA or blocking HSP90 with a HSP90-specific antibody or geldanamycin (GA), a specific inhibitor of HSP90, as well as recombinant HSP90 beta resulted in inhibiting viral entry and subsequent viral replication. Co-immunprecipitation of EV71 with recombinant HSP90 beta and colocalization of EV71-HSP90 in the cells demonstrated that HSP90 was physically associated with EV71 particles. HSP90 seems to mediate EV71 replication by preventing proteosomal degradation of the newly synthesized capsid proteins, but does not facilitate viral gene expression at transcriptional level. This was evident by post-treatment of host cells with GA, which did not affect the expression of viral transcripts but accelerated the degradation of viral capsid proteins and interfered with the formation of assembled virions. In vivo studies were carried out using human SCARB2-transgenic mice to evaluate the protection conferred by HSP90 inhibitor, 17-allyamino-17-demethoxygeldanamycin (17-AAG), an analog of geldanamycin, that elicited similar activity but with less toxicity. The results showed that the administration of 17-AAG twice conferred the resistance to hSCARB2 mice challenged with C2, C4, and B4 genotypes of EV71. Our data supports HSP90 plays an important role in EV71 infection. Targeting of HSP90 with clinically available drugs might provide a feasible therapeutic approach to treat EV71 infection.	[Tsou, Yueh-Liang; Lin, Yi-Wen; Chang, Hsuen-Wen; Lin, Hsiang-Yin; Shao, Hsiao-Yun; Yu, Shu-Ling; Liu, Chia-Chyi; Chitra, Ebenezer; Sia, Charles; Chow, Yen-Hung] Natl Hlth Res Inst, Inst Infect Dis & Vaccinol, Zhunan Town, Miaoli County, Taiwan; [Tsou, Yueh-Liang; Lin, Yi-Wen] Natl Tsing Hua Univ, Grad Program Biotechnol Med, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Sia, Charles] China Med Univ, Grad Inst Immunol, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Tsing Hua University; China Medical University Taiwan	Sia, C (corresponding author), Natl Hlth Res Inst, Inst Infect Dis & Vaccinol, Zhunan Town, Miaoli County, Taiwan.	siady@nhri.org.tw; choeyenh@nhri.org.tw	Sia, Dwo-Yuan/E-3860-2010; Liu, Chia-Chyi/A-8215-2012; Chow, Yen-Hung/E-3863-2010; Chitra, Ebenezer/F-5984-2019	Liu, Chia-Chyi/0000-0002-6257-0389; Chitra, Ebenezer/0000-0002-5818-6587	National Science Council [100-2311-B-400-003-, 101-2311-B-400-002-]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council's funding (http://web1.nsc.gov.tw/), 100-2311-B-400-003- and 101-2311-B-400-002-. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 1999, VIRUS RES, V61, P1, DOI 10.1016/S0168-1702(99)00019-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Chen YC, 2004, J GEN VIROL, V85, P69, DOI 10.1099/vir.0.19423-0; Chung YC, 2008, VACCINE, V26, P1855, DOI 10.1016/j.vaccine.2008.01.058; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Geller R, 2007, GENE DEV, V21, P195, DOI 10.1101/gad.1505307; Glaze ER, 2005, CANCER CHEMOTH PHARM, V56, P637, DOI 10.1007/s00280-005-1000-9; Guang D, 2007, VIRUS RES, V125, P61, DOI 10.1016/j.virusres.2006.12.005; HASHIMOTO I, 1978, ARCH VIROL, V56, P257, DOI 10.1007/BF01317855; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Huang PN, 2011, NUCLEIC ACIDS RES, V39, P9633, DOI 10.1093/nar/gkr682; Hung CY, 2011, J GEN VIROL, V92, P2803, DOI 10.1099/vir.0.033993-0; Isaacs JS, 2003, CANCER CELL, V3, P213, DOI 10.1016/S1535-6108(03)00029-1; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kawashima D, 2013, J VIROL, V87, P6482, DOI 10.1128/JVI.03428-12; Khong WX, 2012, J VIROL, V86, P2121, DOI 10.1128/JVI.06103-11; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lin JY, 2008, J GEN VIROL, V89, P2540, DOI 10.1099/vir.0.2008/003673-0; Lin KH, 2006, J MED VIROL, V78, P254, DOI 10.1002/jmv.20534; Lin TW, 2007, J VIROL, V81, P8730, DOI 10.1128/JVI.00332-07; Lin YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057591; Lin YW, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030507, 10.1371/journal.pone.0052490]; Liu CC, 2000, J CLIN VIROL, V17, P23, DOI 10.1016/S1386-6532(00)00068-8; Liu CC, 2007, VACCINE, V25, P19, DOI 10.1016/j.vaccine.2006.06.083; Liu CC, 2011, VACCINE, V29, P4362, DOI 10.1016/j.vaccine.2011.04.010; Liu JN, 2012, ARCH VIROL, V157, P539, DOI 10.1007/s00705-011-1198-2; Lu CH, 2008, PROTEINS, V72, P625, DOI 10.1002/prot.21954; MELNICK JL, 1979, INTERVIROLOGY, V12, P297, DOI 10.1159/000149088; Nagata N, 2004, J GEN VIROL, V85, P2981, DOI 10.1099/vir.0.79883-0; NAGY G, 1982, ARCH VIROL, V71, P217, DOI 10.1007/BF01314873; Neckers L, 1999, INVEST NEW DRUG, V17, P361, DOI 10.1023/A:1006382320697; Neckers Len, 2003, Current Opinion in Oncology, V15, P419, DOI 10.1097/00001622-200311000-00003; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; Ochel HJ, 2001, CELL STRESS CHAPERON, V6, P105, DOI 10.1379/1466-1268(2001)006<0105:GTPOAC>2.0.CO;2; Ong KC, 2008, J NEUROPATH EXP NEUR, V67, P532, DOI 10.1097/NEN.0b013e31817713e7; Perez-Velez CM, 2007, CLIN INFECT DIS, V45, P950, DOI 10.1086/521895; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; REED L. J., 1938, AMER JOUR HYG, V27, P493; Schneider-Schaulies J, 2000, J GEN VIROL, V81, P1413, DOI 10.1099/0022-1317-81-6-1413; Schulte TW, 1998, CANCER CHEMOTH PHARM, V42, P273, DOI 10.1007/s002800050817; Sharp S, 2006, ADV CANCER RES, V95, P323, DOI 10.1016/S0065-230X(06)95009-X; Sidera K, 2004, J BIOL CHEM, V279, P45379, DOI 10.1074/jbc.M405486200; Smith AE, 2004, SCIENCE, V304, P237, DOI 10.1126/science.1094823; Stuart Kirsty, 2006, Aust Fam Physician, V35, P219; SUPKO JG, 1995, CANCER CHEMOTH PHARM, V36, P305, DOI 10.1007/BF00689048; Tan CW, 2013, J VIROL, V87, P611, DOI 10.1128/JVI.02226-12; Tung Wong Siew, 2007, Genet Vaccines Ther, V5, P6, DOI 10.1186/1479-0556-5-6; Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005; Wang RYL, 2013, VIROLOGY, V443, P236, DOI 10.1016/j.virol.2013.05.001; Wang SM, 1999, CLIN INFECT DIS, V29, P184, DOI 10.1086/520149; Wang YF, 2004, J VIROL, V78, P7916, DOI 10.1128/JVI.78.15.7916-7924.2004; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Weng KF, 2010, MICROBES INFECT, V12, P505, DOI 10.1016/j.micinf.2010.03.006; Wu CN, 2001, VACCINE, V20, P895, DOI 10.1016/S0264-410X(01)00385-1; Wu SC, 2004, VACCINE, V22, P3858, DOI 10.1016/j.vaccine.2004.05.037; Wu TN, 1999, EMERG INFECT DIS, V5, P458, DOI 10.3201/eid0503.990321; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992; Yang B, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-141; Yang SL, 2011, J VIROL, V85, P11809, DOI 10.1128/JVI.00297-11	64	40	46	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e77133	10.1371/journal.pone.0077133	http://dx.doi.org/10.1371/journal.pone.0077133			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098578	Green Published, gold, Green Submitted			2022-12-25	WOS:000325434500095
J	Wang, WJ; Yao, Y; Jiang, LL; Hu, TH; Ma, JQ; Liao, ZJ; Yao, JT; Li, DF; Wang, SH; Nan, KJ				Wang, Wen-Juan; Yao, Yu; Jiang, Li-Li; Hu, Ting-Hua; Ma, Jie-Qun; Liao, Zi-Jun; Yao, Jun-Tao; Li, Dong-Fan; Wang, Shu-Hong; Nan, Ke-Jun			Knockdown of Lymphoid Enhancer factor 1 Inhibits Colon Cancer Progression In Vitro and In Vivo	PLOS ONE			English	Article							COLORECTAL-CANCER; BREAST-CANCER; NOTCH; LEF-1; GROWTH; EXPRESSION; PROTEIN; TARGET; GENE; PROLIFERATION	Expression of lymphoid enhancer factor 1 (LEF1) is frequently altered in different human cancers. This study aimed to assess LEF1 expression in colon cancer tissues and to explore changed phenotypes, gene expressions, and the possible mechanism after knocked down LEF1 expression in colon cancer cell lines. A total of 106 colon cancer and matched paratumorous normal tissues were used to assess LEF1 expression using immunohistochemistry and qRT-PCR. LEF1 lentivirus was used to knockdown LEF1 expression for the assessment of cell viability, cell cycle distribution, apoptosis, and gene expressions. The nude mouse xenograft assay was performed to detect the effects of LEF1 knockdown in vivo. The data showed that the levels of LEF1 mRNA and protein were significantly increased in human colon cancer tissues compared to the matched paratumorous normal tissues and were associated with infiltration depth, lymph node and distant metastases, advanced TNM (tumor-node-metastasis) stages, and shorter overall survival. Furthermore, LEF1 knockdown reduced tumor cell viability, invasion capacity, MMP2 and MMP-9 expression, but induced apoptosis. Nude mouse xenograft assay showed that LEF1 knockdown suppressed tumor formation and growth in vivo. In addition, the expression of Notch pathway-related proteins RBP-jk and Hes1 was reduced in LEF1 knockdown cells. Taken together, LEF1 protein was overexpressed in colon cancer tissues and knockdown of LEF1 expression inhibited colon cancer growth in vitro and in vivo. These data suggest that targeting of LEF1 expression should be further evaluated for colon cancer prevention and therapy.	[Wang, Wen-Juan; Yao, Yu; Jiang, Li-Li; Hu, Ting-Hua; Ma, Jie-Qun; Wang, Shu-Hong; Nan, Ke-Jun] Xi An Jiao Tong Univ, Dept Oncol, Affiliated Hosp 1, Coll Med, Xian 710049, Peoples R China; [Liao, Zi-Jun; Yao, Jun-Tao] Xi An Jiao Tong Univ, Affiliated Shaanxi Prov Canc Hosp, Coll Med, Xian 710049, Peoples R China; [Li, Dong-Fan] Xian Cent Hosp, Xian, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Wang, SH (corresponding author), Xi An Jiao Tong Univ, Dept Oncol, Affiliated Hosp 1, Coll Med, Xian 710049, Peoples R China.	wsh2003@126.com; nankejun@126.com			National Natural Science Foundation of China [81001090]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (No. 81001090) (http://www.nsfc.gov.cn/nsfc/cen/xxgk/slzz.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Amen M, 2007, MOL CELL BIOL, V27, P7560, DOI 10.1128/MCB.00315-07; Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002; Bucan V, 2012, GENES CELLS, V17, P559, DOI 10.1111/j.1365-2443.2012.01613.x; Chen DL, 2013, CARCINOGENESIS, V34, P803, DOI 10.1093/carcin/bgs400; Espinosa L, 2003, J BIOL CHEM, V278, P32227, DOI 10.1074/jbc.M304001200; Estrach S, 2006, DEVELOPMENT, V133, P4427, DOI 10.1242/dev.02644; Fre S, 2009, P NATL ACAD SCI USA, V106, P6309, DOI 10.1073/pnas.0900427106; Gansler T, 2010, CA-CANCER J CLIN, V60, P345, DOI 10.3322/caac.20088; Gao X, 2008, J BIOL CHEM, V283, P35679, DOI 10.1074/jbc.M804088200; Guo H, 2011, CARCINOGENESIS, V32, P1897, DOI 10.1093/carcin/bgr220; Hoeppner LH, 2011, J BIOL CHEM, V286, P10950, DOI 10.1074/jbc.M110.165100; Holnthoner W, 2002, J BIOL CHEM, V277, P45847, DOI 10.1074/jbc.M209354200; Huang FI, 2012, CARCINOGENESIS, V33, P1142, DOI 10.1093/carcin/bgs131; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kriegl L, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-123; Lei Tao, 2009, Zhonghua Zhongliu Zazhi, V31, P428, DOI 10.3760/cma.j.issn.0253-3766.2009.06.007; Li YR, 2009, CANCER RES, V69, P3332, DOI 10.1158/0008-5472.CAN-08-3380; Lin AY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016636; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Miele L, 2006, CURR CANCER DRUG TAR, V6, P313, DOI 10.2174/156800906777441771; Miele L, 2006, CLIN CANCER RES, V12, P1074, DOI 10.1158/1078-0432.CCR-05-2570; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Pannequin J, 2009, CANCER RES, V69, P6065, DOI 10.1158/0008-5472.CAN-08-2409; Ross DA, 2001, MOL CELL BIOL, V21, P7537, DOI 10.1128/MCB.21.22.7537-7544.2001; Shelton DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040312; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Somiari SB, 2006, INT J CANCER, V119, P1403, DOI 10.1002/ijc.21989; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; Ungerback J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017957; Wang SH, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-53; Waterman ML, 2004, CANCER METAST REV, V23, P41, DOI 10.1023/A:1025858928620; WATERMAN ML, 1991, GENE DEV, V5, P656, DOI 10.1101/gad.5.4.656; Yokoyama NN, 2010, NUCLEIC ACIDS RES, V38, P6375, DOI 10.1093/nar/gkq492	33	15	16	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76596	10.1371/journal.pone.0076596	http://dx.doi.org/10.1371/journal.pone.0076596			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098538	Green Published, Green Submitted, gold			2022-12-25	WOS:000325434500076
J	Biddle, AS; Black, SJ; Blanchard, JL				Biddle, Amy S.; Black, Samuel J.; Blanchard, Jeffrey L.			An In Vitro Model of the Horse Gut Microbiome Enables Identification of Lactate-Utilizing Bacteria That Differentially Respond to Starch Induction	PLOS ONE			English	Article							EQUINE LARGE-INTESTINE; OLIGOFRUCTOSE-INDUCED LAMINITIS; GASTROINTESTINAL-TRACT; MEGASPHAERA-ELSDENII; ACID PRODUCTION; RNA; RUMEN; COMMUNITY; HINDGUT; DIET	Laminitis is a chronic, crippling disease triggered by the sudden influx of dietary starch. Starch reaches the hindgut resulting in enrichment of lactic acid bacteria, lactate accumulation, and acidification of the gut contents. Bacterial products enter the bloodstream and precipitate systemic inflammation. Hindgut lactate levels are normally low because specific bacterial groups convert lactate to short chain fatty acids. Why this mechanism fails when lactate levels rapidly rise, and why some hindgut communities can recover is unknown. Fecal samples from three adult horses eating identical diets provided bacterial communities for this in vitro study. Triplicate microcosms of fecal slurries were enriched with lactate and/or starch. Metabolic products (short chain fatty acids, headspace gases, and hydrogen sulfide) were measured and microbial community compositions determined using Illumina 16S rRNA sequencing over 12-hour intervals. We report that patterns of change in short chain fatty acid levels and pH in our in vitro system are similar to those seen in in vivo laminitis induction models. Community differences between microcosms with disparate abilities to clear excess lactate suggest profiles conferring resistance of starch-induction conditions. Where lactate levels recover following starch induction conditions, propionate and acetate levels rise correspondingly and taxa related to Megasphaera elsdenii reach levels exceeding 70% relative abundance. In lactate and control cultures, taxa related to Veillonella montpellierensis are enriched as lactate levels fall. Understanding these community differences and factors promoting the growth of specific lactate utilizing taxa may be useful to prevent acidosis under starch-induction conditions.	[Biddle, Amy S.] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; [Black, Samuel J.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Black, Samuel J.; Blanchard, Jeffrey L.] Univ Massachusetts, Grad Program Mol & Cellular Biol, Amherst, MA 01003 USA; [Blanchard, Jeffrey L.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Blanchard, Jeffrey L.] Univ Massachusetts, Grad Program Organismal & Evolutionary Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Biddle, AS (corresponding author), Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA.	abiddle@microbio.umass.edu	Black, Samuel/L-8429-2016; Blanchard, Jeffrey/AAA-5173-2020	Blanchard, Jeffrey/0000-0002-7310-9678; Biddle, Amy/0000-0001-8261-1128	National Science Foundation Graduate Research Fellowship; Div Of Industrial Innovation & Partnersh [1342640] Funding Source: National Science Foundation	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Div Of Industrial Innovation & Partnersh(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	Support of research supplies and services provided by: Pilot Study: Morris Animal Foundation: D-12EQ-814: Identifying bacteria associated with starch induced laminitis and colic with the potential to attenuate lactate in the equine gut http://www.morrisanimalfoundation.org. For salary support: National Science Foundation Graduate Research Fellowship: http://www.nsfgrfp.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikman PC, 2011, J DAIRY SCI, V94, P2840, DOI 10.3168/jds.2010-3783; Al Jassim R. A. M., 2005, RECENT ADV ANIMAL NU, V15, P155; Al Jassim RAM, 2009, VET CLIN N AM-EQUINE, V25, P199, DOI 10.1016/j.cveq.2009.04.005; Al Jassim RAM, 2005, FEMS MICROBIOL LETT, V248, P75, DOI 10.1016/j.femsle.2005.05.023; Andrews S., 2012, FASTQC; ARGENZIO RA, 1974, AM J PHYSIOL, V226, P1043, DOI 10.1152/ajplegacy.1974.226.5.1043; ARGENZIO RA, 1972, J NUTR, V102, P879, DOI 10.1093/jn/102.7.879; ARGENZIO RA, 1975, CORNELL VET, V65, P303; Bailey SR, 2009, VET IMMUNOL IMMUNOP, V129, P167, DOI 10.1016/j.vetimm.2008.11.009; Bailey SR, 2003, APPL ENVIRON MICROB, V69, P2087, DOI 10.1128/AEM.69.4.2087-2093.2003; BRYANT MP, 1953, J DAIRY SCI, V36, P205, DOI 10.3168/jds.S0022-0302(53)91482-9; Caporaso J.G., 2012, ISME J; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; de Carvalho IPC, 2011, REV BRAS ZOOTECN, V40, P1260, DOI 10.1590/S1516-35982011000600014; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Crawford C, 2007, J ANIM SCI, V85, P2949, DOI 10.2527/jas.2006-600; Daly K, 2001, FEMS MICROBIOL ECOL, V38, P141, DOI 10.1111/j.1574-6941.2001.tb00892.x; Daly K, 2012, BRIT J NUTR, V107, P989, DOI 10.1017/S0007114511003825; de Fombelle A, 2003, ANIM SCI, V77, P293; de Fombelle A, 2001, J EQUINE VET SCI, V21, P439, DOI 10.1016/S0737-0806(01)70018-4; DeAngelis KM, 2010, ENVIRON MICROBIOL, V12, P3137, DOI 10.1111/j.1462-2920.2010.02286.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; GARNER HE, 1975, AM J VET RES, V36, P441; GARNER HE, 1978, EQUINE VET J, V10, P249, DOI 10.1111/j.2042-3306.1978.tb02273.x; Goncalves S, 2002, VET RES, V33, P641, DOI 10.1051/vetres:2002044; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Haikara A, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P965, DOI 10.1007/0-387-30744-3_32; JANIS C, 1976, EVOLUTION, V30, P757, DOI 10.1111/j.1558-5646.1976.tb00957.x; KERN DL, 1974, J ANIM SCI, V38, P559, DOI 10.2527/jas1974.383559x; Kolenbrander P, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P1022, DOI 10.1007/0-387-30744-3_36; Kumar PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020956; KUNG LM, 1995, J ANIM SCI, V73, P250; Lameness and Laminitis in U. S. Horses, 2005, USDAAPHISVS CEAH, V4, P250; MACKIE RI, 1988, APPL ENVIRON MICROB, V54, P2155, DOI 10.1128/AEM.54.9.2155-2160.1988; MACKIE RI, 1979, APPL ENVIRON MICROB, V38, P416, DOI 10.1128/AEM.38.3.416-421.1979; MACKIE RI, 1984, J AGR SCI, V103, P37, DOI 10.1017/S0021859600043306; MAROUNEK M, 1987, J APPL BACTERIOL, V63, P233, DOI 10.1111/j.1365-2672.1987.tb04941.x; Milinovich GJ, 2008, ISME J, V2, P1089, DOI 10.1038/ismej.2008.67; Milinovich GJ, 2007, ENVIRON MICROBIOL, V9, P2090, DOI 10.1111/j.1462-2920.2007.01327.x; Milinovich GJ, 2006, ENVIRON MICROBIOL, V8, P885, DOI 10.1111/j.1462-2920.2005.00975.x; Poyart C, 2002, INT J SYST EVOL MICR, V52, P1247, DOI 10.1099/00207713-52-4-1247; Respondek F, 2008, J ANIM SCI, V86, P316, DOI 10.2527/jas.2006-782; ROBINSON J A, 1992, Journal of Animal Science, V70, P310; Schlegel L, 2003, INT J SYST EVOL MICR, V53, P631, DOI 10.1099/ijs.0.02361-0; Shepherd ML, 2012, FEMS MICROBIOL LETT, V326, P62, DOI 10.1111/j.1574-6968.2011.02434.x; van Eps AW, 2006, EQUINE VET J, V38, P203, DOI 10.2746/042516406776866327; Willing B, 2009, EQUINE VET J, V41, P908, DOI 10.2746/042516409X447806	51	59	60	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e77599	10.1371/journal.pone.0077599	http://dx.doi.org/10.1371/journal.pone.0077599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098591	Green Submitted, gold, Green Published			2022-12-25	WOS:000325427100087
J	DeKrey, GK; Teagarden, RE; Lenberg, JL; Titus, RG				DeKrey, Gregory K.; Teagarden, Riane E.; Lenberg, Jerica L.; Titus, Richard G.			2,3,7,8-Tetrachlorodibenzo-p-dioxin Slows the Progression of Experimental Cutaneous Leishmaniasis in Susceptible BALB/c and SCID Mice	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; STREPTOCOCCUS-PNEUMONIAE; COSTIMULATORY MOLECULES; INFLAMMATORY RESPONSE; NITRIC-OXIDE; IFN-GAMMA; IN-VITRO; TCDD; CELLS; ACTIVATION	In a model of experimental cutaneous leishmaniasis, pre-exposure of Leishmania major-resistant mice to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), an aryl hydrocarbon receptor agonist, causes suppression of the protective anti-parasite T helper 1 response while paradoxically also reducing parasite burdens in those animals. In this study, we examined if TCDD exposure could also reduce parasite burdens in L. major-susceptible BALB/c mice. In the highest dose group (160 mu g/Kg), TCDD treatment caused a significant reduction of parasite burdens by 10-fold after three weeks while also causing a significant lymphoid atrophy indicating suppression of the non-protective T helper 2 response. A dose-dependent delay of foot lesion progression was also observed such that lesion size in the highest dose group was less than half that of controls after 35 days of infection. Importantly, although TCDD exposure initially reduced disease severity and prolonged the course of disease by as much as three fold in some animals, this effect was transitory and TCDD did not induce resistance to L. major infection. Because TCDD exposure reduced L. major burdens in both resistant and susceptible mice, we hypothesized that TCDD reduces L. major burdens in mice by a mechanism that does not involve adaptive immunity. To test this, severe combined immunodeficient (SCID) mice were used. In mice infected with a moderate number of L. major (10,000), TCDD treatment caused a time-and dose-dependent decrease of parasite burdens by nearly 100-fold after six weeks in the highest dose group (200 mu g/Kg). A significant and dose-dependent delay of foot lesion progression was also observed in these animals. These results indicate that TCDD exposure can reduce the severity of leishmanial disease in mice independent of adaptive immunity.	[DeKrey, Gregory K.; Teagarden, Riane E.; Lenberg, Jerica L.] Univ No Colorado, Sch Biol Sci, Coll Nat & Hlth Sci, Greeley, CO 80639 USA; [Titus, Richard G.] Colorado State Univ, Coll Vet & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	University of Northern Colorado; Colorado State University	DeKrey, GK (corresponding author), Univ No Colorado, Sch Biol Sci, Coll Nat & Hlth Sci, Greeley, CO 80639 USA.	gregory.dekrey@unco.edu			Colorado State University; University of Northern Colorado; Public Health Service grant from the National Institute of Allergy and Infectious Disease [29955]	Colorado State University; University of Northern Colorado; Public Health Service grant from the National Institute of Allergy and Infectious Disease	Supported by Colorado State University: http://www.colostate.edu; University of Northern Colorado: http://www.unco.edu; and Public Health Service grant 29955 from the National Institute of Allergy and Infectious Disease: http://www.niaid.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 2005, IMMUNOL LETT, V99, P17, DOI 10.1016/j.imlet.2005.01.009; Antoine JC, 1998, TRENDS MICROBIOL, V6, P392, DOI 10.1016/S0966-842X(98)01324-9; Benson JM, 2011, TOXICOL SCI, V120, P68, DOI 10.1093/toxsci/kfq360; Birnbaum LS, 2000, FOOD ADDIT CONTAM A, V17, P275, DOI 10.1080/026520300283351; Bogdan C, 1996, CURR OPIN IMMUNOL, V8, P517, DOI 10.1016/S0952-7915(96)80040-9; Bowers OJ, 2006, AM J TROP MED HYG, V75, P749, DOI 10.4269/ajtmh.2006.75.749; Brodskyn CI, 2001, INFECT IMMUN, V69, P665, DOI 10.1128/IAI.69.2.665-672.2001; CLARK GC, 1994, EXP CLIN IMMUNOGENET, V11, P136; CORRADIN SB, 1991, J IMMUNOL, V146, P279; Corsini E, 2011, J IMMUNOTOXICOL, V8, P251, DOI 10.3109/1547691X.2011.598885; DEKREY GK, 1995, TOXICOLOGY, V97, P105, DOI 10.1016/0300-483X(94)02929-O; DeKrey GK, 1999, J IMMUNOL METHODS, V228, P1, DOI 10.1016/S0022-1759(99)00085-X; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Dong B, 2008, MOL PHARMACOL, V74, P255, DOI 10.1124/mol.107.044669; Elizondo G, 2011, INT J BIOL SCI, V7, P1220, DOI 10.7150/ijbs.7.1220; EVANS TG, 1993, J IMMUNOL, V151, P907; Frericks M, 2007, TOXICOL APPL PHARM, V220, P320, DOI 10.1016/j.taap.2007.01.014; Funatake CJ, 2005, J IMMUNOL, V175, P4184, DOI 10.4049/jimmunol.175.7.4184; Goto Y, 2007, PARASITOL INT, V56, P231, DOI 10.1016/j.parint.2007.02.007; Gramiccia M, 2005, INT J PARASITOL, V35, P1169, DOI 10.1016/j.ijpara.2005.07.001; GREEN SJ, 1990, J IMMUNOL, V145, P4290; GREIG JB, 1984, TOXICOL APPL PHARM, V74, P17, DOI 10.1016/0041-008X(84)90265-5; GUY RA, 1995, CLIN EXP IMMUNOL, V100, P440; Haarmann-Stemmann T, 2009, BIOCHEM PHARMACOL, V77, P508, DOI 10.1016/j.bcp.2008.09.013; Hezarjaribi HZ, 2013, EXP PARASITOL, V134, P341, DOI 10.1016/j.exppara.2013.03.012; HINSDILL RD, 1980, J ENVIRON PATHOL TOX, V4, P401; HOLSAPPLE MP, 1991, ANNU REV PHARMACOL, V31, P73; Kerkvliet NI, 2002, INT IMMUNOPHARMACOL, V2, P277, DOI 10.1016/S1567-5769(01)00179-5; Laberton J, 1979, Am Ind Hyg Assoc J, V40, P816; LATCHNEY SE, 2012, J NEUROCHEM; Launois P, 1998, Int Rev Immunol, V17, P157, DOI 10.3109/08830189809084491; LIEW FY, 1990, IMMUNOLOGY, V71, P556; LIEW FY, 1989, CLIN EXP IMMUNOL, V75, P438; Lima HC, 1997, PARASITOL TODAY, V13, P80, DOI 10.1016/S0169-4758(96)40010-2; Lohoff M, 1998, INT ARCH ALLERGY IMM, V115, P191, DOI 10.1159/000023900; LOUIS J, 1979, EUR J IMMUNOL, V9, P841, DOI 10.1002/eji.1830091103; LUSTER MI, 1980, INT J IMMUNOPHARMACO, V2, P301, DOI 10.1016/0192-0561(80)90030-2; Mbow ML, 2001, EUR J IMMUNOL, V31, P1400, DOI 10.1002/1521-4141(200105)31:5&lt;1400::AID-IMMU1400&gt;3.0.CO;2-J; Moos AB, 1997, TOXICOL LETT, V90, P145, DOI 10.1016/S0378-4274(96)03838-6; MOOS AB, 1994, TOXICOL APPL PHARM, V127, P331, DOI 10.1006/taap.1994.1169; MULLER RL, 1990, MED PARASITOLOGY; Myler PJ, 2008, LEISHMANIA GENOME; National Toxicology Program, 1982, Natl Toxicol Program Tech Rep Ser, V209, P1; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Okwor I, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00128; POLAND A, 1994, MOL PHARMACOL, V46, P915; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Roth J, 2003, TRENDS IMMUNOL, V24, P155, DOI 10.1016/S1471-4906(03)00062-0; Shi LZ, 2007, J IMMUNOL, V179, P6952, DOI 10.4049/jimmunol.179.10.6952; Solbach W, 2000, Adv Immunol, V74, P275, DOI 10.1016/S0065-2776(08)60912-8; Steinbrink K, 2000, IMMUNOBIOLOGY, V202, P442, DOI 10.1016/S0171-2985(00)80103-5; Stejskalova L, 2011, CURR DRUG METAB, V12, P198, DOI 10.2174/138920011795016818; Sugita-Konishi Y, 2003, BIOSCI BIOTECH BIOCH, V67, P89, DOI 10.1271/bbb.67.89; Sun YV, 2004, NUCLEIC ACIDS RES, V32, P4512, DOI 10.1093/nar/gkh782; SUNDERKOTTER C, 1993, J IMMUNOL, V151, P4891; TAYLOR MJ, 1992, TOXICOL APPL PHARM, V117, P126, DOI 10.1016/0041-008X(92)90227-J; Temchura VV, 2005, EUR J IMMUNOL, V35, P2738, DOI 10.1002/eji.200425641; TITUS RG, 1989, J EXP MED, V170, P2097, DOI 10.1084/jem.170.6.2097; Titus RG, 2001, INFECT IMMUN, V69, P5189, DOI 10.1128/IAI.69.8.5189-5192.2001; VANDENBERG M, 1994, CRIT REV TOXICOL, V24, P1; VARKILA K, 1993, EUR J IMMUNOL, V23, P262, DOI 10.1002/eji.1830230141; Veiga-Parga T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002427; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vogel Christoph F A, 2004, Cardiovasc Toxicol, V4, P363, DOI 10.1385/CT:4:4:363; Vogel CFA, 2007, ARCH BIOCHEM BIOPHYS, V461, P169, DOI 10.1016/j.abb.2007.01.015; Vorderstrasse BA, 2006, INFECT IMMUN, V74, P5679, DOI 10.1128/IAI.00837-06; VOS JG, 1974, TOXICOL APPL PHARM, V29, P229, DOI 10.1016/0041-008X(74)90060-X; Wang T, 2012, INT IMMUNOPHARMACOL, V13, P490, DOI 10.1016/j.intimp.2012.05.008	69	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76259	10.1371/journal.pone.0076259	http://dx.doi.org/10.1371/journal.pone.0076259			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098456	gold, Green Published			2022-12-25	WOS:000325427100051
J	Raida, Z; Hundahl, CA; Nyengaard, JR; Hay-Schmidt, A				Raida, Zindy; Hundahl, Christian Ansgar; Nyengaard, Jens R.; Hay-Schmidt, Anders			Neuroglobin Over Expressing Mice: Expression Pattern and Effect on Brain Ischemic Infarct Size	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; CYTOGLOBIN EXPRESSION; PROTECTS NEURONS; MESSENGER-RNA; IN-VIVO; MOUSE; STROKE; OXYGEN; OVEREXPRESSION; OCCLUSION	Background: Stroke is a major cause of death and severe disability, but effective treatments are limited. Neuroglobin, a neuronal heme-globin, has been advocated as a novel pharmacological target in combating stroke and neurodegenerative disorders based on cytoprotective properties. Using thoroughly validated antibodies and oligos, we give a detailed brain anatomical characterization of transgenic mice over expressing Neuroglobin. Moreover, using permanent middle artery occlusion the effect of elevated levels of Neuroglobin on ischemic damage was studied. Lastly, the impact of mouse strain genetic background on ischemic damage was investigated. Principal Findings: A four to five fold increase in Neuroglobin mRNA and protein expression was seen in the brain of transgenic mice. A beta-actin promoter was used to drive Neuroglobin over expression, but immunohistochemistry and in situ hybridization showed over expression to be confined to primarily the cortex, hippocampus, cerebellum, and only in neurons. The level and expression pattern of endogenous Neuroglobin was unaffected by insertion of the over expressing Ngb transgene. Neuroglobin over expression resulted in a significant reduction in infarct volume 24 hours after ischemia. Immunohistochemistry showed no selective sparing of Neuroglobin expressing cells in the ischemic core or penumbra. A significant difference in infarct volume was found between mice of the same strain, but from different colonies. Significance: In contrast to some previous reports, Neuroglobin over expression is not global but confined to a few welldefined brain regions, and only in neurons. This study confirms previous reports showing a correlation between reduced infarct volume and elevated Neuroglobin levels, but underlines the need to study the likely contribution from compensatory mechanisms to the phenotype following a genetic perturbation. We also stress, that care should be taken when comparing results where different mouse strains and colonies have been used due to large genetic background contribution to the observed phenotype.	[Raida, Zindy; Hay-Schmidt, Anders] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Hundahl, Christian Ansgar] Univ Tartu, Ctr Excellence Translat Med, EE-50090 Tartu, Estonia; [Nyengaard, Jens R.] Aarhus Univ, Ctr Stochast Geometry & Adv Bioimaging, Stereol & Elect Microscopy Lab, Aarhus, Denmark	University of Copenhagen; University of Tartu; Aarhus University	Raida, Z (corresponding author), Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark.	zindy@sund.ku.dk; c.hundahl@gmail.com; ahay@sund.ku.dk	Hundahl, Christian Ansgar/H-3938-2015		Lundbeck Foundation; NOVO-Nordisk Foundation; Foundation for Providing Medical Research; Hartmann Foundation, the Estonian Ministry of Science and Education [GARFS0120P]; European Regional Development Fund; Villum Foundation; Lundbeck Foundation [R77-2010-7108] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); NOVO-Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Foundation for Providing Medical Research; Hartmann Foundation, the Estonian Ministry of Science and Education; European Regional Development Fund(European Commission); Villum Foundation(Villum Fonden); Lundbeck Foundation(Lundbeckfonden)	Financial support was given by Lundbeck Foundation, the NOVO-Nordisk Foundation, the Foundation for Providing Medical Research, the Hartmann Foundation, the Estonian Ministry of Science and Education (GARFS0120P) and the European Regional Development Fund. Centre for Stochastic Geometry and Advanced Bioimaging is supported by Villum Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brittain Thomas, 2012, Cells, V1, P1133, DOI 10.3390/cells1041133; Brunori M, 2005, P NATL ACAD SCI USA, V102, P8483, DOI 10.1073/pnas.0408766102; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Carmichael S Thomas, 2005, NeuroRx, V2, P396; Davis J, 2012, CIRC RES, V111, P761, DOI 10.1161/CIRCRESAHA.111.262717; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Dietz GPH, 2011, EXP NEUROL, V231, P1, DOI 10.1016/j.expneurol.2011.05.010; Eberspacher E, 2009, ACTA ANAESTH SCAND, V53, P774, DOI 10.1111/j.1399-6576.2009.01954.x; Fordel E, 2007, GENE, V398, P114, DOI 10.1016/j.gene.2007.03.022; Fordel E, 2007, FEBS J, V274, P1312, DOI 10.1111/j.1742-4658.2007.05679.x; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Goldstein LB, 2006, STROKE, V37, P1583, DOI 10.1161/01.STR.0000223048.70103.F1; GUNDERSEN HJG, 1988, J MICROSC-OXFORD, V151, P3, DOI 10.1111/j.1365-2818.1988.tb04609.x; Herold S, 2004, J BIOL CHEM, V279, P22841, DOI 10.1074/jbc.M313732200; Heuschmann PU, 2009, STROKE, V40, P1557, DOI 10.1161/STROKEAHA.108.535088; Hundahl CA, 2012, BIOCHEM BIOPH RES CO, V425, P100, DOI 10.1016/j.bbrc.2012.07.061; Hundahl C, 2006, BRAIN RES, V1085, P19, DOI 10.1016/j.brainres.2006.02.040; Hundahl CA, 2013, BRAIN STRUCT FUNCT, V218, P603, DOI 10.1007/s00429-012-0480-8; Hundahl CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028160; Hundahl CA, 2010, BRAIN RES, V1331, P58, DOI 10.1016/j.brainres.2010.03.056; Institute for Laboratory Animal Research, 2011, GUIDE CARE USE LAB A; Khan AA, 2007, GENE, V398, P172, DOI 10.1016/j.gene.2007.02.044; Khan AA, 2006, P NATL ACAD SCI USA, V103, P17944, DOI 10.1073/pnas.0607497103; Lee HM, 2011, FREE RADICAL BIO MED, V51, P2281, DOI 10.1016/j.freeradbiomed.2011.09.026; Li RC, 2010, J CEREBR BLOOD F MET, V30, P1874, DOI 10.1038/jcbfm.2010.90; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majid A, 2000, STROKE, V31, P2707, DOI 10.1161/01.STR.31.11.2707; Mammen PPA, 2002, J HISTOCHEM CYTOCHEM, V50, P1591, DOI 10.1177/002215540205001203; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Pesce A, 2003, STRUCTURE, V11, P1087, DOI 10.1016/S0969-2126(03)00166-7; Raida Zindy, 2012, Exp Transl Stroke Med, V4, P15, DOI 10.1186/2040-7378-4-15; Raida Z, 2012, BIOCHEM BIOPH RES CO, V424, P274, DOI 10.1016/j.bbrc.2012.06.105; Schellinger PD, 2001, CRIT CARE MED, V29, P1812, DOI 10.1097/00003246-200109000-00027; Schmidt M, 2003, J BIOL CHEM, V278, P1932, DOI 10.1074/jbc.M209909200; Schmidt-Kastner R, 2006, BRAIN RES, V1103, P173, DOI 10.1016/j.brainres.2006.05.047; Steward O, 1999, EXP NEUROL, V157, P19, DOI 10.1006/exnr.1999.7040; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Sun YJ, 2003, P NATL ACAD SCI USA, V100, P3497, DOI 10.1073/pnas.0637726100; Truelsen T, 2005, EUR J NEUROL, V12, P78, DOI 10.1111/j.1468-1331.2005.01199.x; Wang SL, 2010, CIRC RES, V107, P558, DOI 10.1161/CIRCRESAHA.110.224634; Wang XY, 2008, STROKE, V39, P1869, DOI 10.1161/STROKEAHA.107.506022; WARD R, 1985, BEHAV GENET, V15, P537, DOI 10.1007/BF01065449; WARD R, 1990, J ANAT, V173, P87; Williams RS, 2000, J APPL PHYSIOL, V88, P1119, DOI 10.1152/jappl.2000.88.3.1119; Yang GM, 1997, BRAIN RES, V752, P209, DOI 10.1016/S0006-8993(96)01453-9; Zhang H, 2010, J CEREBR BLOOD F MET, V30, P923, DOI 10.1038/jcbfm.2010.10	48	32	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76565	10.1371/journal.pone.0076565	http://dx.doi.org/10.1371/journal.pone.0076565			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098534	Green Submitted, Green Published, gold			2022-12-25	WOS:000325427100077
J	Docampo, E; Collado, A; Escaramis, G; Carbonell, J; Rivera, J; Vidal, J; Alegre, J; Rabionet, R; Estivill, X				Docampo, Elisa; Collado, Antonio; Escaramis, Georgia; Carbonell, Jordi; Rivera, Javier; Vidal, Javier; Alegre, Jose; Rabionet, Raquel; Estivill, Xavier			Cluster Analysis of Clinical Data Identifies Fibromyalgia Subgroups	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; SYMPTOM CLUSTERS; HEALTH SURVEY; FATIGUE; SEVERITY; IMPACT; SCALE; PAIN; DEFINITION; VALIDATION	Introduction: Fibromyalgia (FM) is mainly characterized by widespread pain and multiple accompanying symptoms, which hinder FM assessment and management. In order to reduce FM heterogeneity we classified clinical data into simplified dimensions that were used to define FM subgroups. Material and Methods: 48 variables were evaluated in 1,446 Spanish FM cases fulfilling 1990 ACR FM criteria. A partitioning analysis was performed to find groups of variables similar to each other. Similarities between variables were identified and the variables were grouped into dimensions. This was performed in a subset of 559 patients, and cross-validated in the remaining 887 patients. For each sample and dimension, a composite index was obtained based on the weights of the variables included in the dimension. Finally, a clustering procedure was applied to the indexes, resulting in FM subgroups. Results: Variables clustered into three independent dimensions: "symptomatology", "comorbidities" and "clinical scales". Only the two first dimensions were considered for the construction of FM subgroups. Resulting scores classified FM samples into three subgroups: low symptomatology and comorbidities (Cluster 1), high symptomatology and comorbidities (Cluster 2), and high symptomatology but low comorbidities (Cluster 3), showing differences in measures of disease severity. Conclusions: We have identified three subgroups of FM samples in a large cohort of FM by clustering clinical data. Our analysis stresses the importance of family and personal history of FM comorbidities. Also, the resulting patient clusters could indicate different forms of the disease, relevant to future research, and might have an impact on clinical assessment.	[Docampo, Elisa; Escaramis, Georgia; Rabionet, Raquel; Estivill, Xavier] CRG, Genom & Dis Grp, Barcelona, Spain; [Docampo, Elisa; Escaramis, Georgia; Rabionet, Raquel; Estivill, Xavier] Univ Pompeu Fabra, Barcelona, Spain; [Docampo, Elisa; Escaramis, Georgia; Rabionet, Raquel; Estivill, Xavier] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Barcelona, Spain; [Collado, Antonio] Hosp Clin Barcelona, Rheumatol Serv, Fibromyalgia Unit, Barcelona, Spain; [Carbonell, Jordi] Parc Salut Mar, Rheumatol Serv, Fibromyalgia Unit, Barcelona, Spain; [Carbonell, Jordi] Hosp del Mar, Res Inst, Barcelona, Spain; [Rivera, Javier] Hosp Univ Gregorio Maranon, Inst Prov Rehabil, Rheumatol Unit, Madrid, Spain; [Vidal, Javier] Hosp Gen Guadalajara, Rheumatol Unit, Guadalajara, Spain; [Alegre, Jose] Hosp Valle De Hebron, Chron Fatigue Syndrome Unit, Barcelona, Spain; [Collado, Antonio; Carbonell, Jordi; Rivera, Javier; Vidal, Javier; Alegre, Jose] Fdn Fibromyalgia & Fatigue, Fibromyalgia & Chron Fatigue Syndrome Spanish Gen, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Barcelona; Hospital Clinic de Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; General University Gregorio Maranon Hospital; Hospital Universitari Vall d'Hebron	Collado, A (corresponding author), Hosp Clin Barcelona, Rheumatol Serv, Fibromyalgia Unit, Barcelona, Spain.	ACOLLADO@clinic.ub.es	Escaramis, Georgia/B-2997-2015; Estivill, Xavier/A-3125-2013; Alegre, Jose/M-7218-2014; Rabionet, Raquel/C-8379-2009; Escaramis, Georgia/AAR-5586-2020; rabionet, raquel/A-7407-2009	Escaramis, Georgia/0000-0002-5416-3177; Estivill, Xavier/0000-0002-0723-2256; Alegre, Jose/0000-0002-7582-7585; Rabionet, Raquel/0000-0001-5006-8140; rabionet, raquel/0000-0001-5006-8140	Foundation FF of affected people with Fibromyalgia and/or Chronic Fatigue Syndrome; Lilly Foundation; Spanish Ministry of Health (FIS-PFIS)	Foundation FF of affected people with Fibromyalgia and/or Chronic Fatigue Syndrome; Lilly Foundation; Spanish Ministry of Health (FIS-PFIS)	This study was supported by an unrestricted grant provided by the Foundation FF of affected people with Fibromyalgia and/or Chronic Fatigue Syndrome, and by the Lilly Foundation to Xavier Estivill. Elisa Docampo is supported by the Spanish Ministry of Health (FIS-PFIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas A, 2010, PALLIATIVE MED, V24, P373, DOI 10.1177/0269216310367842; ALONSO J, 1995, MED CLIN-BARCELONA, V104, P771; Benito-Leon J, 2007, MULT SCLER J, V13, P645, DOI 10.1177/1352458506073528; Bennett RM, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-134; BURCKHARDT CS, 1991, J RHEUMATOL, V18, P728; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Collado AG-MA, 2011, PAIN EUR 7 7 C EUR F; Cuesta-Vargas A, 2012, QUAL LIFE RES; de Souza JB, 2009, RHEUMATOL INT, V29, P509, DOI 10.1007/s00296-008-0722-5; Fraley C, 1998, COMPUT J, V41, P578, DOI 10.1093/comjnl/41.8.578; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Gaston-Johansson F, 1999, CANCER PRACT, V7, P240, DOI 10.1046/j.1523-5394.1999.75008.x; Giesecke T, 2003, ARTHRITIS RHEUM, V48, P2916, DOI 10.1002/art.11272; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Herrero MJ, 2003, GEN HOSP PSYCHIAT, V25, P277, DOI 10.1016/S0163-8343(03)00043-4; Hurtig IM, 2001, CLIN J PAIN, V17, P316, DOI 10.1097/00002508-200112000-00005; Kashikar-Zuck S, 2008, ARTHRIT RHEUM-ARTHR, V59, P1392, DOI 10.1002/art.24099; Kindler LL, 2010, J PAIN, V11, P1320, DOI 10.1016/j.jpain.2010.03.007; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Kuner R, 2010, NAT MED, V16, P1258, DOI 10.1038/nm.2231; Loevinger BL, 2012, CLIN RHEUMATOL; Okifuji A, 1997, J RHEUMATOL, V24, P377; Rehm SE, 2010, RHEUMATOLOGY, V49, P1146, DOI 10.1093/rheumatology/keq066; Rutledge DN, 2009, NURS RES, V58, P359, DOI 10.1097/NNR.0b013e3181b499d2; Silverman S, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-66; Turk DC, 1998, ARTHRIT CARE RES, V11, P397, DOI 10.1002/art.1790110511; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wilson HD, 2009, ARTHRIT RHEUM-ARTHR, V61, P527, DOI 10.1002/art.24163; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2011, J RHEUMATOL, V38, P1113, DOI 10.3899/jrheum.100594; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Zigmond AS, 1983, PSYCHIAT SCAND, V76, P361, DOI [DOI 10.1111/J.1600-0447.1983.TB09716.X, DOI 10.1111/J.1600-0447.1983.TB09716.X.PUBMED:6880820]	32	44	45	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74873	10.1371/journal.pone.0074873	http://dx.doi.org/10.1371/journal.pone.0074873			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098674	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500045
J	Flores, F; Collier, CJ; Mercurio, P; Negri, AP				Flores, Florita; Collier, Catherine J.; Mercurio, Philip; Negri, Andrew P.			Phytotoxicity of Four Photosystem II Herbicides to Tropical Seagrasses	PLOS ONE			English	Article							GREAT-BARRIER-REEF; ECOSYSTEM SERVICES; PSII HERBICIDES; HERVEY BAY; ATRAZINE; TOXICITY; DIURON; EXPOSURE; IMPACT; PESTICIDE	Coastal waters of the Great Barrier Reef (GBR) are contaminated with agricultural pesticides, including the photosystem II (PSII) herbicides which are the most frequently detected at the highest concentrations. Designed to control weeds, these herbicides are equally potent towards non-target marine species, and the close proximity of seagrass meadows to flood plumes has raised concerns that seagrasses may be the species most threatened by herbicides from runoff. While previous work has identified effects of PSII herbicides on the photophysiology, growth and mortality in seagrass, there is little comparative quantitative toxicity data for seagrass. Here we applied standard ecotoxicology protocols to quantify the concentrations of four priority PSII herbicides that inhibit photochemistry by 10, 20 and 50% (IC10, IC20 and IC50) over 72 h in two common seagrass species from the GBR lagoon. The photosystems of seagrasses Zostera muelleri and Halodule uninervis were shown to be generally more sensitive to the PSII herbicides Diuron, Atrazine, Hexazinone and Tebuthiuron than corals and tropical microalgae. The herbicides caused rapid inhibition of effective quantum yield (Delta F/F-m'), indicating reduced photosynthesis and maximum effective yields (F-v/F-m) corresponding to chronic damage to PSII. The PSII herbicide concentrations which affected photosynthesis have been exceeded in the GBR lagoon and all of the herbicides inhibited photosynthesis at concentrations lower than current marine park guidelines. There is a strong likelihood that the impacts of light limitation from flood plumes and reduced photosynthesis from PSII herbicides exported in the same waters would combine to affect seagrass productivity. Given that PSII herbicides have been demonstrated to affect seagrass at environmental concentrations, we suggest that revision of environmental guidelines and further efforts to reduce PSII herbicide concentrations in floodwaters may both help protect seagrass meadows of the GBR from further decline.	[Flores, Florita; Mercurio, Philip; Negri, Andrew P.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Collier, Catherine J.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Mercurio, Philip] Univ Queensland, Sch Med, Coopers Plains, Qld, Australia; [Mercurio, Philip] Natl Res Ctr Environm Toxicol, Coopers Plains, Qld, Australia	Australian Institute of Marine Science; James Cook University; University of Queensland	Negri, AP (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	a.negri@aims.gov.au	Collier, Catherine/M-6308-2014; Negri, Andrew P/G-9909-2017; Flores, Florita/I-3033-2017	Collier, Catherine/0000-0001-9494-6582; Negri, Andrew P/0000-0003-1388-7395; Flores, Florita/0000-0003-4637-1379	Australian Government [4.2]	Australian Government(Australian GovernmentCGIAR)	This research was conducted with the support of funding from the Australian Government's National Environmental Research Program (http://www.environment.gov.au/index.html) NERP Tropical Ecosystems Hub Project 4.2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan S, 2012, GEOCHEM J, V46, P169, DOI 10.2343/geochemj.1.0163; Barrett K, 2012, INT J ENVIRON HEAL R, V22, P481, DOI 10.1080/09603123.2012.667794; BAYLEY S, 1978, ESTUARIES, V1, P73; Chesworth JC, 2004, AQUAT TOXICOL, V66, P293, DOI 10.1016/j.aquatox.2003.10.002; Collier CJ, 2012, ECOL INDIC, V23, P211, DOI 10.1016/j.ecolind.2012.04.005; Collier CJ, 2012, MAR POLLUT BULL, V65, P342, DOI 10.1016/j.marpolbul.2011.06.017; Collier CJ, 2011, LIMNOL OCEANOGR, V56, P2200, DOI 10.4319/lo.2011.56.6.2200; CORRELL DL, 1982, AQUAT BOT, V14, P151, DOI 10.1016/0304-3770(82)90094-8; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Cullen-Unsworth L, 2013, ENVIRONMENT, V55, P14, DOI 10.1080/00139157.2013.785864; Davis AM, 2012, MAR POLLUT BULL, V65, P182, DOI 10.1016/j.marpolbul.2011.08.025; DELISTRATY DA, 1984, AQUAT BOT, V18, P353, DOI 10.1016/0304-3770(84)90056-1; den Hartog C., 1975, AQUAT BOT, V1, P141, DOI DOI 10.1016/0304-3770(75)90019-4; Devault AD, 2013, SCIENCE, V340, P353; Escher BI, 2008, J ENVIRON MONITOR, V10, P612, DOI 10.1039/b800949j; Fabricius KE, 2013, ESTUAR COAST SHELF S, V116, P57, DOI 10.1016/j.ecss.2012.03.010; Gao YP, 2011, MAR POLLUT BULL, V62, P1628, DOI 10.1016/j.marpolbul.2011.06.014; GBRMPA, 2010, WAT QUAL GUID GREAT; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Haynes D, 2000, MAR POLLUT BULL, V41, P288, DOI 10.1016/S0025-326X(00)00127-2; Haynes D, 2000, MAR POLLUT BULL, V41, P279, DOI 10.1016/S0025-326X(00)00097-7; Heck KL, 2008, ECOSYSTEMS, V11, P1198, DOI 10.1007/s10021-008-9155-y; JOHNSON JR, 1995, BOT MAR, V38, P307, DOI 10.1515/botm.1995.38.1-6.307; Jones R, 2005, MAR POLLUT BULL, V51, P495, DOI 10.1016/j.marpolbul.2005.06.027; Jones RJ, 2004, MAR ECOL PROG SER, V284, P133, DOI 10.3354/meps284133; Jones RJ, 2003, MAR ECOL PROG SER, V261, P149, DOI 10.3354/meps261149; Jones RJ, 2003, MAR ECOL PROG SER, V251, P153, DOI 10.3354/meps251153; JONES TW, 1984, J ENVIRON QUAL, V13, P243, DOI 10.2134/jeq1984.00472425001300020014x; Kennedy K, 2012, MAR POLLUT BULL, V65, P292, DOI 10.1016/j.marpolbul.2011.10.029; Kroon FJ, 2012, MAR POLLUT BULL, V65, P167, DOI 10.1016/j.marpolbul.2011.10.018; Lewis SE, 2011, 19TH INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION (MODSIM2011), P2051; Lewis SE, 2012, MAR POLLUT BULL, V65, P280, DOI 10.1016/j.marpolbul.2011.11.009; Lewis SE, 2009, ENVIRON POLLUT, V157, P2470, DOI 10.1016/j.envpol.2009.03.006; Limpus CJ, 2012, MARINE WILDLIFE STRA, V3, P1; Longstaff BJ, 1999, AQUAT BOT, V65, P105, DOI 10.1016/S0304-3770(99)00035-2; Lough J., 2007, CLIMATE CHANGE GREAT, P15; Macinnis-Ng CMO, 2004, AQUAT TOXICOL, V67, P227, DOI 10.1016/j.aquatox.2004.01.012; Magnusson M, 2013, WATER RES, V47, P5211, DOI 10.1016/j.watres.2013.06.003; Magnusson M, 2010, MAR POLLUT BULL, V60, P1978, DOI 10.1016/j.marpolbul.2010.07.031; Marsh H., 2012, ECOLOGY CONSERVATION; McMahon K, 2005, MAR POLLUT BULL, V51, P325, DOI 10.1016/j.marpolbul.2004.10.045; Muller R, 2008, SCI TOTAL ENVIRON, V401, P51, DOI 10.1016/j.scitotenv.2008.02.062; Nash SMB, 2005, MAR POLLUT BULL, V51, P351, DOI 10.1016/j.marpolbul.2004.10.017; Nasha SMB, 2005, BIOSENS BIOELECTRON, V20, P1443, DOI 10.1016/j.bios.2004.09.019; Negri AP, 2011, LIMNOL OCEANOGR, V56, P471, DOI 10.4319/lo.2011.56.2.0471; Oettmeier W., 1992, PHOTOSYSTEMS STRUCTU, V11, P349; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Osmond CB, 1999, PHYSIOLOGICAL PLANT ECOLOGY, P1; Packett R, 2009, MAR POLLUT BULL, V58, P976, DOI 10.1016/j.marpolbul.2009.02.017; Ralph P. J., 2007, Toxicological and Environmental Chemistry, V89, P589, DOI 10.1080/02772240701561593; Ralph PJ, 2000, AQUAT BOT, V66, P141, DOI 10.1016/S0304-3770(99)00024-8; Scarlett A, 1999, AQUAT TOXICOL, V45, P159, DOI 10.1016/S0166-445X(98)00098-8; Schreiber U., 1995, ECOL STUD, P49, DOI DOI 10.1007/978-3-642-79354-7_3; Schreiber U, 2007, BIOSENS BIOELECTRON, V22, P2554, DOI 10.1016/j.bios.2006.10.018; SCHWARZSCHILD AC, 1994, J EXP MAR BIOL ECOL, V183, P77, DOI 10.1016/0022-0981(94)90158-9; Shaw CM, 2008, MAR POLLUT BULL, V57, P473, DOI 10.1016/j.marpolbul.2008.04.002; Shaw M, 2005, MAR POLLUT BULL, V51, P876, DOI 10.1016/j.marpolbul.2005.04.015; Shaw M, 2010, MAR POLLUT BULL, V60, P113, DOI 10.1016/j.marpolbul.2009.08.026; Short FT, 2001, GLOBAL SEAGRASS RESEARCH METHODS, P155; Smith R, 2012, MAR POLLUT BULL, V65, P117, DOI 10.1016/j.marpolbul.2011.08.010; Tomlin C., 2000, PESTICIDE MANUAL WOR; van Dam JW, 2012, MAR POLLUT BULL, V65, P373, DOI 10.1016/j.marpolbul.2011.08.008; Wahedally S.F., 2012, TANZ J NAT APPL SCI, V3, P458; WALSH GE, 1982, MAR ENVIRON RES, V7, P1, DOI 10.1016/0141-1136(82)90047-2; Warne Michael St J., 2008, Australasian Journal of Ecotoxicology, V14, P1; Waters DK, 2013, TECHNICAL REPORT; Waycott M., 2004, GUIDE TROPICAL SEAGR, P72; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481	69	48	50	5	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75798	10.1371/journal.pone.0075798	http://dx.doi.org/10.1371/journal.pone.0075798			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098726	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000325423500097
J	Huang, N; Singh, N; Yoon, K; Loiacono, CM; Kohut, ML; Birt, DF				Huang, Nan; Singh, Navrozedeep; Yoon, Kyoungjin; Loiacono, Christina M.; Kohut, Marian L.; Birt, Diane F.			The Immuno-Regulatory Impact of Orally-Administered Hypericum perforatum Extract on Balb/C Mice Inoculated with H1n1 Influenza A Virus	PLOS ONE			English	Article							ST JOHNS WORT; ALVEOLAR MACROPHAGES; INFECTION; SOCS3; IDENTIFICATION; INFLAMMATION; INVOLVEMENT; INHIBITION; ACTIVATION; SUPPRESSOR	Hypericum perforatum (H. perforatum) ethanol extract has been found to inhibit lipopolysaccharide-induced production of inflammatory mediators and cytokines in cultured macrophages. Therefore, it may be able to protect the host from excessive inflammation during viral infection. In the current study, the immune-regulatory effect of H. perforatum extract was evaluated in A549 lung epithelial cells and BALB/c mice exposed to Influenza A/PR/8/34 H1N1 virus. In A549 cells, the extract (30 mu g/mL) significantly inhibited influenza virus induced monocyte chemotactic protein (MCP)-1 and interferon-gamma induced protein 10 kD (IP-10), but dramatically increased interleukin-6 (IL-6). In mice inoculated intranasally with 10(7.9) EID50 of Influenza A/PR/8/34 H1N1 (high dose), daily oral treatment of H. perforatum extract at a rate of 110 mg/kg of body weight increased lung viral titer, bronchoalveolar lavage (BAL) pro-inflammatory cytokine and chemokine levels, and the infiltration of pro-inflammatory cells in the lung 5 days post-inoculation, as compared to ethanol vehicle treated mice. Transcription of suppressor of cytokine signaling 3 (SOCS3) was increased by H. perforatum extract both in A549 cells and BALB/c mice, which could have interrupted anti-viral immune response and thus led to the inefficient viral clearance and increased lung inflammation. H. perforatum treatment resulted in minor reduction in viral titer without affecting body weight when mice were inoculated with a lower dose (similar to 10(5.0) EID50) and H. perforatum was applied in the later phase of infection. Mice challenged intranasally with high dose of influenza virus (10(7.9) EID50) suffered from a higher mortality rate when dosed with H. perforatum extract. In conclusion, the current study showed that SOCS3 elevation by H. perforatum may cause impaired immune defense against influenza virus infection and lead to higher mortality.	[Huang, Nan; Singh, Navrozedeep; Kohut, Marian L.; Birt, Diane F.] Iowa State Univ, Ctr Res Bot Dietary Supplements, Ames, IA 50011 USA; [Huang, Nan] Iowa State Univ, Interdept Grad Program Nutr Sci, Ames, IA 50011 USA; [Huang, Nan; Birt, Diane F.] Iowa State Univ, Dept Food Sci & Human Nutr, Ames, IA 50011 USA; [Singh, Navrozedeep; Kohut, Marian L.] Iowa State Univ, Dept Kinesiol, Ames, IA 50011 USA; [Yoon, Kyoungjin] Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA 50011 USA; [Loiacono, Christina M.] Anim & Plant Hlth Inspect Serv, USDA, Natl Vet Serv Labs, Pathobiol Lab,Pathol Sect, Ames, IA USA	Iowa State University; Iowa State University; Iowa State University; Iowa State University; Iowa State University; United States Department of Agriculture (USDA)	Birt, DF (corresponding author), Iowa State Univ, Ctr Res Bot Dietary Supplements, Ames, IA 50011 USA.	dbirt@iastate.edu	Huang, Nan/B-3435-2009; Huang, Nan/J-1916-2019	Huang, Nan/0000-0002-7873-7294; Huang, Nan/0000-0002-7873-7294; Birt, Diane/0000-0002-1784-5582	National Center for Complementary and Alternative [P50 AT004155-06]; Medicine/Office of Dietary Supplements, National Institute of Health; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [P50AT004155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES012020] Funding Source: NIH RePORTER	National Center for Complementary and Alternative; Medicine/Office of Dietary Supplements, National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work is sponsored by P50 AT004155-06 from National Center for Complementary and Alternative and Medicine/Office of Dietary Supplements, National Institute of Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the ODS, NCCAM, or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baetz A, 2004, J BIOL CHEM, V279, P54708, DOI 10.1074/jbc.M410992200; Berlato C, 2002, J IMMUNOL, V168, P6404, DOI 10.4049/jimmunol.168.12.6404; Birt DF, 2009, PHARM BIOL, V47, P774, DOI 10.1080/13880200902988645; Calapai G, 2001, PHARMACOPSYCHIATRY, V34, pS8, DOI 10.1055/s-2001-15507; Davidson BA, 2005, EXP LUNG RES, V31, P323, DOI 10.1080/01902140590918524; Davis JM, 2008, AM J PHYSIOL-REG I, V295, pR505, DOI 10.1152/ajpregu.90319.2008; Di Carlo G, 2001, TRENDS PHARMACOL SCI, V22, P292, DOI 10.1016/S0165-6147(00)01716-8; Dushoff J, 2006, AM J EPIDEMIOL, V163, P181, DOI 10.1093/aje/kwj024; Gao HW, 2006, J IMMUNOL, V177, P612, DOI 10.4049/jimmunol.177.1.612; Grundmann O, 2010, NEUROPHARMACOLOGY, V58, P767, DOI 10.1016/j.neuropharm.2009.12.014; Hammer KDP, 2010, PHYTOCHEMISTRY, V71, P716, DOI 10.1016/j.phytochem.2010.02.006; HARTSHORN KL, 1990, J LEUKOCYTE BIOL, V47, P176, DOI 10.1002/jlb.47.2.176; Herold S, 2008, J EXP MED, V205, P3065, DOI 10.1084/jem.20080201; Huang N, 2012, PHYTOCHEMISTRY, V76, P106, DOI 10.1016/j.phytochem.2011.12.001; Huang N, 2011, PHYTOCHEMISTRY, V72, P2015, DOI 10.1016/j.phytochem.2011.07.016; Huang N, 2009, J AGR FOOD CHEM, V57, P10579, DOI 10.1021/jf9023728; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Kohut ML, 2009, J INFECT DIS, V200, P1434, DOI 10.1086/606014; Liu Zhao, 2010, Virologica Sinica, V25, P445, DOI 10.1007/s12250-010-3142-0; MAUS UA, 2006, J IMMUNOL, V177, P1817; McGill J, 2009, J LEUKOCYTE BIOL, V86, P803, DOI 10.1189/jlb.0509368; Mordstein M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000151; Pamer EG, 2009, P NATL ACAD SCI USA, V106, P4961, DOI 10.1073/pnas.0901574106; Paterniti I, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-73; Pauli EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000196; Peiris JSM, 2009, TRENDS IMMUNOL, V30, P574, DOI 10.1016/j.it.2009.09.004; Pothlichet J, 2008, J IMMUNOL, V180, P2034, DOI 10.4049/jimmunol.180.4.2034; Qasimi P, 2006, J BIOL CHEM, V281, P6316, DOI 10.1074/jbc.M508608200; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Sanders CJ, 2011, CELL TISSUE RES, V343, P13, DOI 10.1007/s00441-010-1043-z; Tate MD, 2009, J IMMUNOL, V183, P7441, DOI 10.4049/jimmunol.0902497; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Tscherne DM, 2011, J CLIN INVEST, V121, P6, DOI 10.1172/JCI44947; Viksman MY, 1997, AM J RESP CRIT CARE, V155, P858, DOI 10.1164/ajrccm.155.3.9117017; Wareing MD, 2004, J LEUKOCYTE BIOL, V76, P886, DOI 10.1189/jlb.1203644; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938	36	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76491	10.1371/journal.pone.0076491	http://dx.doi.org/10.1371/journal.pone.0076491			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098792	Green Submitted, gold, Green Published			2022-12-25	WOS:000325423500163
J	Ji, GZ; Ruan, WM; Liu, K; Wang, F; Sakellariou, D; Chen, JJ; Yang, Y; Okuka, M; Han, JY; Liu, ZH; Lai, LX; Gagos, S; Xiao, L; Deng, HK; Li, N; Liu, L				Ji, Guangzhen; Ruan, Weimin; Liu, Kai; Wang, Fang; Sakellariou, Despoina; Chen, Jijun; Yang, Yang; Okuka, Maja; Han, Jianyong; Liu, Zhonghua; Lai, Liangxue; Gagos, Sarantis; Xiao, Lei; Deng, Hongkui; Li, Ning; Liu, Lin			Telomere Reprogramming and Maintenance in Porcine iPS Cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; GENOMIC STABILITY; LENGTH; GENERATION; DNA; CIRCLES; PIG; INDUCTION; RECOMBINATION; ASSOCIATION	Telomere reprogramming and silencing of exogenous genes have been demonstrated in mouse and human induced pluripotent stem cells (iPS cells). Pigs have the potential to provide xenotransplant for humans, and to model and test human diseases. We investigated the telomere length and maintenance in porcine iPS cells generated and cultured under various conditions. Telomere lengths vary among different porcine iPS cell lines, some with telomere elongation and maintenance, and others telomere shortening. Porcine iPS cells with sufficient telomere length maintenance show the ability to differentiate in vivo by teratoma formation test. IPS cells with short or dysfunctional telomeres exhibit reduced ability to form teratomas. Moreover, insufficient telomerase and incomplete telomere reprogramming and/or maintenance link to sustained activation of exogenous genes in porcine iPS cells. In contrast, porcine iPS cells with reduced expression of exogenous genes or partial exogene silencing exhibit insufficient activation of endogenous pluripotent genes and telomerase genes, accompanied by telomere shortening with increasing passages. Moreover, telomere doublets, telomere sister chromatid exchanges and t-circles that presumably are involved in telomere lengthening by recombination also are found in porcine iPS cells. These data suggest that both telomerase-dependent and telomerase-independent mechanisms are involved in telomere reprogramming during induction and passages of porcine iPS cells, but these are insufficient, resulting in increased telomere damage and shortening, and chromosomal instability. Active exogenes might compensate for insufficient activation of endogenous genes and incomplete telomere reprogramming and maintenance of porcine iPS cells. Further understanding of telomere reprogramming and maintenance may help improve the quality of porcine iPS cells.	[Ji, Guangzhen; Liu, Kai; Wang, Fang; Liu, Lin] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Ruan, Weimin; Han, Jianyong; Li, Ning] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Sakellariou, Despoina; Gagos, Sarantis] Acad Athens Greece BRFAA, Biomed Res Fdn, Ctr Basic Res 2, Genet Lab, Athens, Greece; [Chen, Jijun; Xiao, Lei] Zhejiang Univ, Coll Anim Sci, Stem Cell & Dev Biol Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Yang; Deng, Hongkui] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Okuka, Maja] Univ S Florida, Coll Med, Dept Obstet & Gynecol, Tampa, FL USA; [Liu, Zhonghua] North East Agr Univ, Life Sci Coll, Harbin, Heilongjiang, Peoples R China; [Lai, Liangxue] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China	Nankai University; China Agricultural University; Academy of Athens; Zhejiang University; Peking University; State University System of Florida; University of South Florida; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Liu, L (corresponding author), Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	liulin@nankai.edu.cn	chen, JJ/HGB-6029-2022; Liu, Zhunghua/F-2485-2010	Liu, Zhunghua/0000-0002-9199-6493; Sakellariou, Despoina/0000-0001-5894-7879; GAGOS, SARANTIS/0000-0003-4907-7706	MOST National Major Basic Research Program [2009CB941000, 2011CBA01002]; National Natural Science Foundation of China [31271587]	MOST National Major Basic Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by MOST National Major Basic Research Program (2009CB941000 and 2011CBA01002) and National Natural Science Foundation of China (31271587). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam SJ, 2008, METHOD ENZYMOL, V439, P39, DOI 10.1016/S0076-6879(07)00404-1; Agarwal S, 2010, NATURE, V464, P292, DOI 10.1038/nature08792; Alberio R, 2010, STEM CELLS DEV, V19, P1627, DOI 10.1089/scd.2010.0012; Bailey SM, 2004, NUCLEIC ACIDS RES, V32, P3743, DOI 10.1093/nar/gkh691; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Callicott RJ, 2006, COMPARATIVE MED, V56, P17; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cesare AJ, 2004, MOL CELL BIOL, V24, P9948, DOI 10.1128/MCB.24.22.9948-9957.2004; Chan SRWL, 2004, PHILOS T R SOC B, V359, P109, DOI 10.1098/rstb.2003.1370; Chen JL, 2000, CELL, V100, P503, DOI 10.1016/S0092-8674(00)80687-X; Cohen S, 1996, MOL CELL BIOL, V16, P2002; Cozzi E, 2009, ORGANOGENESIS, V5, P288; Daley GQ, 2012, CELL STEM CELL, V10, P740, DOI 10.1016/j.stem.2012.05.010; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Fan NN, 2013, CELL RES, V23, P162, DOI 10.1038/cr.2012.176; Giraud S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/532127; GREIDER CW, 1990, BIOESSAYS, V12, P363, DOI 10.1002/bies.950120803; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Henson JD, 2009, NAT BIOTECHNOL, V27, P1181, DOI 10.1038/nbt.1587; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Huang JJ, 2011, CELL RES, V21, P779, DOI 10.1038/cr.2011.16; Ji GZ, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-36; Ji GZ, 2012, SCI CHINA LIFE SCI, V55, P1029, DOI 10.1007/s11427-012-4420-x; Jiang J, 2013, CELL RES, V23, P92, DOI 10.1038/cr.2012.157; Kawamura M, 2012, CIRCULATION, V126, pS29, DOI 10.1161/CIRCULATIONAHA.111.084343; Li BM, 2008, MOL CELL BIOL, V28, P1892, DOI 10.1128/MCB.01364-07; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Londono-Vallejo JA, 2004, CANCER RES, V64, P2324, DOI 10.1158/0008-5472.CAN-03-4035; Lu WS, 2013, EXP CELL RES, V319, P133, DOI 10.1016/j.yexcr.2012.09.005; Lyssiotis CA, 2009, P NATL ACAD SCI USA, V106, P8912, DOI 10.1073/pnas.0903860106; Marion RM, 2010, CURR OPIN GENET DEV, V20, P190, DOI 10.1016/j.gde.2010.01.005; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Martinez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509; Mathew R, 2010, FASEB J, V24, P2702, DOI 10.1096/fj.09-148973; Mitchell TRH, 2009, MOL CELL BIOL, V29, P4918, DOI 10.1128/MCB.00009-09; Montanaro L, 2008, CELL ONCOL, V30, P483, DOI 10.3233/CLO-2008-0436; Montserrat N, 2011, J CARDIOVASC TRANSL, V4, P121, DOI 10.1007/s12265-010-9233-3; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Oganesian L, 2011, MOL CELL, V42, P224, DOI 10.1016/j.molcel.2011.03.015; Okada M, 2011, BBA-GEN SUBJECTS, V1810, P226, DOI 10.1016/j.bbagen.2010.10.004; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pickett HA, 2011, HUM MOL GENET, V20, P4684, DOI 10.1093/hmg/ddr402; Pickett HA, 2009, EMBO J, V28, P799, DOI 10.1038/emboj.2009.42; Podlevsky JD, 2008, NUCLEIC ACIDS RES, V36, pD339, DOI 10.1093/nar/gkm700; Poon SSS, 1999, CYTOMETRY, V36, P267, DOI 10.1002/(SICI)1097-0320(19990801)36:4<267::AID-CYTO1>3.0.CO;2-O; Rodriguez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049079; Ruan WM, 2011, SCI CHINA LIFE SCI, V54, P553, DOI 10.1007/s11427-011-4179-5; Samstein B, 2001, J AM SOC NEPHROL, V12, P182, DOI 10.1681/ASN.V121182; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Smith KP, 2009, J CELL PHYSIOL, V220, P21, DOI 10.1002/jcp.21681; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Suhr ST, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008124, 10.1371/journal.pone.0014095]; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Telugu BPVL, 2010, INT J DEV BIOL, V54, P1703, DOI 10.1387/ijdb.103200bt; Vaziri H, 2010, REGEN MED, V5, P345, DOI 10.2217/RME.10.21; Vodicka P, 2005, ANN NY ACAD SCI, V1049, P161, DOI 10.1196/annals.1334.015; Wang F, 2012, CELL RES, V22, P757, DOI 10.1038/cr.2011.201; West F, 2011, ANN NY ACAD SCI, V1245, P21, DOI 10.1111/j.1749-6632.2011.06337.x; West FD, 2011, STEM CELLS, V29, P1640, DOI 10.1002/stem.713; West FD, 2010, STEM CELLS DEV, V19, P1211, DOI 10.1089/scd.2009.0458; Whyte JJ, 2011, MOL REPROD DEV, V78, P879, DOI 10.1002/mrd.21333; Wu Z, 2009, J MOL CELL BIOL, V1, P46, DOI 10.1093/jmcb/mjp003; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002	72	23	23	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74202	10.1371/journal.pone.0074202	http://dx.doi.org/10.1371/journal.pone.0074202			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098638	gold, Green Submitted, Green Published			2022-12-25	WOS:000325423500009
J	Kregting, LT; Bass, AL; Guadayol, O; Yund, PO; Thomas, FIM				Kregting, Louise T.; Bass, Anna L.; Guadayol, Oscar; Yund, Philip O.; Thomas, Florence I. M.			Effects of Oscillatory Flow on Fertilization in the Green Sea Urchin Strongylocentrotus droebachiensis	PLOS ONE			English	Article							SUCCESSFUL EXTERNAL FERTILIZATION; FREE-SPAWNING INVERTEBRATE; DOPPLER-VELOCIMETER DATA; ACANTHASTER-PLANCI; REPRODUCTIVE SUCCESS; LARGE POPULATIONS; FLUID SHEAR; SPERM; DENSITY; CONSEQUENCES	Broadcast spawning invertebrates that live in shallow, high-energy coastal habitats are subjected to oscillatory water motion that creates unsteady flow fields above the surface of animals. The frequency of the oscillatory fluctuations is driven by the wave period, which will influence the stability of local flow structures and may affect fertilization processes. Using an oscillatory water tunnel, we quantified the percentage of eggs fertilized on or near spawning green sea urchins, Strongylocentrotus droebachiensis. Eggs were sampled in the water column, wake eddy, substratum and aboral surface under a range of different periods (T = 4.5 - 12.7 s) and velocities of oscillatory flow. The root-mean-square wave velocity (rms(u(w))) was a good predictor of fertilization in oscillatory flow, although the root-mean-square of total velocity (rms(u)), which incorporates all the components of flow (current, wave and turbulence), also provided significant predictions. The percentage of eggs fertilized varied between 50 - 85% at low flows (rms(u(w)) < 0.02 m s(-1)), depending on the location sampled, but declined to below 10% for most locations at higher rms(u(w)). The water column was an important location for fertilization with a relative contribution greater than that of the aboral surface, especially at medium and high rms(u(w)) categories. We conclude that gametes can be successfully fertilized on or near the parent under a range of oscillatory flow conditions.	[Kregting, Louise T.; Bass, Anna L.; Yund, Philip O.] Univ New England, Ctr Marine Sci, Biddeford, ME USA; [Kregting, Louise T.; Guadayol, Oscar; Thomas, Florence I. M.] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI USA	University of New England - Maine; University of Hawaii System	Kregting, LT (corresponding author), Queens Univ Belfast, Sch Planning Architecture & Civil Engn, Belfast BT7 1NN, Antrim, North Ireland.	l.kregting@qub.ac.uk	Guadayol, Òscar/N-2940-2013	Guadayol, Òscar/0000-0001-9552-1041; Yund, Philip/0000-0003-0474-5205; Thomas, Florence/0000-0003-4347-6474	National Science Foundation, Ocean Science Division [OCE-04-25088, OCE-12-33868, OCE-04-24978]	National Science Foundation, Ocean Science Division	Funding was provided by the National Science Foundation, Ocean Science Division, OCE-04-25088 and OCE-12-33868 to POY and OCE-04-24978 to FIMT. This is contribution number 1563 from the Hawaii Institute of Marine Biology and 8858 from University of Hawaii, School of Ocean and Earth Science and Technology. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABCOCK RC, 1992, AUST J MAR FRESH RES, V43, P525; BABCOCK RC, 1994, BIOL BULL-US, V186, P17, DOI 10.2307/1542033; BENZIE JAH, 1994, BIOL BULL, V186, P153, DOI 10.2307/1542049; Chen CC, 2009, INT J NUMER METH FL, V60, P79, DOI 10.1002/fld.1881; Crimaldi JP, 2004, J MARINE SYST, V49, P3, DOI 10.1016/j.jmarsys.2003.06.005; DENNY M, 1992, BIOL BULL, V183, P220, DOI 10.2307/1542209; Gaudette J, 2006, LIMNOL OCEANOGR, V51, P1485, DOI 10.4319/lo.2006.51.3.1485; Goring DG, 2002, J HYDRAUL ENG-ASCE, V128, P117, DOI 10.1061/(ASCE)0733-9429(2002)128:1(117); Guichard F, 1998, MAR ECOL PROG SER, V171, P59, DOI 10.3354/meps171059; Himmelman JH, 2008, MAR ECOL PROG SER, V361, P161, DOI 10.3354/meps07415; IPCC, 2007, CONTRIBUTION WORKING; Keesing JK, 2011, MAR BIOL, V158, P1163, DOI 10.1007/s00227-011-1638-2; KEULEGAN GH, 1958, J RES NAT BUR STAND, V60, P423, DOI 10.6028/jres.060.043; Lam KM, 2010, J FLUID STRUCT, V26, P703, DOI 10.1016/j.jfluidstructs.2010.03.007; Lamare MD, 1998, MAR BIOL, V132, P135, DOI 10.1007/s002270050379; Levitan D.R., 1988, P181; Levitan DR, 2006, SCIENCE, V312, P267, DOI 10.1126/science.1122183; LEVITAN DR, 1992, ECOLOGY, V73, P248, DOI 10.2307/1938736; Levitan DR, 2002, ECOLOGY, V83, P464, DOI 10.2307/2680028; LEVITAN DR, 1991, BIOL BULL-US, V181, P261, DOI 10.2307/1542097; LEVITAN DR, 1995, J EXP MAR BIOL ECOL, V190, P221, DOI 10.1016/0022-0981(95)00039-T; Marshall DJ, 2002, MAR ECOL PROG SER, V236, P113, DOI 10.3354/meps236113; McLelland SJ, 2000, HYDROL PROCESS, V14, P351, DOI 10.1002/(SICI)1099-1085(20000215)14:2<351::AID-HYP963>3.0.CO;2-K; MEAD KS, 1995, BIOL BULL-US, V188, P46, DOI 10.2307/1542066; Meidel SK, 2001, BIOL BULL, V201, P84, DOI 10.2307/1543529; Palumbi SR, 1999, P NATL ACAD SCI USA, V96, P12632, DOI 10.1073/pnas.96.22.12632; Pearson GA, 1996, MAR ECOL PROG SER, V143, P211, DOI 10.3354/meps143211; PENNINGTON JT, 1985, BIOL BULL-US, V169, P417, DOI 10.2307/1541492; Reuter KE, 2010, BIOL BULL-US, V219, P198, DOI 10.1086/BBLv219n3p198; Riffell JA, 2007, J EXP BIOL, V210, P3644, DOI 10.1242/jeb.008516; Serrao EA, 1996, P NATL ACAD SCI USA, V93, P5286, DOI 10.1073/pnas.93.11.5286; Shields MA, 2011, OCEAN COAST MANAGE, V54, P2, DOI 10.1016/j.ocecoaman.2010.10.036; Simon TN, 2011, BIOL BULL-US, V220, P32, DOI 10.1086/BBLv220n1p32; Stiansen JE, 2001, SCI MAR, V65, P151, DOI 10.3989/scimar.2001.65n2151; THOMAS FIM, 1994, J EXP BIOL, V194, P263; Voulgaris G, 1998, J ATMOS OCEAN TECH, V15, P272, DOI 10.1175/1520-0426(1998)015<0272:EOTADV>2.0.CO;2; Wahl TL, 2003, J HYDRAUL ENG-ASCE, V129, P484, DOI 10.1061/(ASCE)0733-9429(2003)129:6(484); Wahle RA, 1999, MAR BIOL, V134, P127, DOI 10.1007/s002270050531; Weitzman JS, 2013, MAR ECOL PROG SER, V475, P65, DOI 10.3354/meps09965; Witman JD, 2001, MARINE COMMUNITY ECOLOGY, P339; YUND PO, 1994, ECOLOGY, V75, P2151, DOI 10.2307/1940874; Yund PO, 2003, LIMNOL OCEANOGR, V48, P795, DOI 10.4319/lo.2003.48.2.0795; Zimmer RK, 2011, P NATL ACAD SCI USA, V108, P13200, DOI 10.1073/pnas.1018666108	43	6	6	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76082	10.1371/journal.pone.0076082	http://dx.doi.org/10.1371/journal.pone.0076082			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098766	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000325423500136
J	Li, X; Liu, YY; Hou, XL; Peng, HJ; Zhang, L; Jiang, QB; Shi, M; Ji, Y; Wang, YY; Shi, WF				Li, Xiang; Liu, Yuanyuan; Hou, Xueling; Peng, Hongjun; Zhang, Li; Jiang, Qingbo; Shi, Mei; Ji, Yun; Wang, Yuyue; Shi, Weifeng			Chlorogenic Acid Inhibits the Replication and Viability of Enterovirus 71 In Vitro	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; APOPTOTIC CELL-DEATH; PROINFLAMMATORY CYTOKINES; ANTIVIRAL ACTIVITY; DRUG DISCOVERY; CAFFEIC ACID; MACROPHAGES; INFECTION; PROTEASE; POLYMERASE	Enterovirus 71 (EV71) is an etiology for a number of diseases in humans. Traditional Chinese herbs have been reported to be effective for treating EV71 infection. However, there is no report about the antiviral effects of CHA against EV71. In this study, plaque reduction assay demonstrated that the inhibitory concentration 50% (IC50) of CHA on EV71 replication is 6.3 mu g/ml. When both CHA (20 mu g/ml) and EV71 were added, or added post-infection at different time points, CHA was able to effectively inhibit EV71 replication between 0 and 10 h. In addition, CHA inhibited EV71 2A transcription and translation in EV71-infected RD cells, but did not affect VP1, 3C, and 3D expression. Furthermore, CHA inhibited secretions of IL-6, TNF-alpha, IFN-gamma and MCP-1 in EV71-infected RD cells. Altogether, these results revealed that CHA may have antiviral properties for treating EV71 infection.	[Li, Xiang; Hou, Xueling; Peng, Hongjun; Zhang, Li; Jiang, Qingbo; Shi, Mei; Ji, Yun; Wang, Yuyue; Shi, Weifeng] Suzhou Univ, Affiliated Hosp 3, Dept Clin Lab, Changzhou, Jiangsu, Peoples R China; [Liu, Yuanyuan] Nanjing Med Univ, Huai An Affliated Hosp 1, Dept Endocrinol, Huaian, Jiangsu, Peoples R China	Nanjing Medical University	Shi, WF (corresponding author), Suzhou Univ, Affiliated Hosp 3, Dept Clin Lab, Changzhou, Jiangsu, Peoples R China.	shiweifeng67@163.com	liu, yuanyuan/GWZ-5838-2022		Health Department of Jiangsu province, China [ky 0904]	Health Department of Jiangsu province, China	This work was supported by Health Department of Jiangsu province, China(grant ky 0904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105; Bougie I, 2004, J BIOL CHEM, V279, P22124, DOI 10.1074/jbc.M400908200; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Chen XM, 2010, VIROLOGY, V398, P251, DOI 10.1016/j.virol.2009.12.007; Chiang LC, 2002, ANTIVIR RES, V55, P53, DOI 10.1016/S0166-3542(02)00007-4; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; De Francesco R, 2007, ADV DRUG DELIVER REV, V59, P1242, DOI 10.1016/j.addr.2007.04.016; Goldstaub D, 2000, MOL CELL BIOL, V20, P1271, DOI 10.1128/MCB.20.4.1271-1277.2000; Gong X, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-224; Hsu BM, 2007, VIRUS RES, V126, P69, DOI 10.1016/j.virusres.2007.01.018; Hsu CH, 2011, J MICROBIOL IMMUNOL, V44, P265, DOI 10.1016/j.jmii.2011.01.029; Hung HC, 2010, J ANTIMICROB CHEMOTH, V65, P676, DOI 10.1093/jac/dkp502; Ikeda K, 2011, INT J MOL MED, V28, P595, DOI 10.3892/ijmm.2011.739; Irani DN, 2008, NEUROL CLIN, V26, P635, DOI 10.1016/j.ncl.2008.03.003; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Khan MTH, 2005, ANTIVIR RES, V67, P107, DOI 10.1016/j.antiviral.2005.05.002; Kleymann G, 2003, EXPERT OPIN INV DRUG, V12, P165, DOI 10.1517/13543784.12.2.165; Kuo RL, 2002, J GEN VIROL, V83, P1367, DOI 10.1099/0022-1317-83-6-1367; Lei XB, 2010, J VIROL, V84, P8051, DOI 10.1128/JVI.02491-09; Lin CW, 2008, INT J ANTIMICROB AG, V32, P355, DOI 10.1016/j.ijantimicag.2008.04.018; Lin TY, 2009, AM J CHINESE MED, V37, P143, DOI 10.1142/S0192415X09006734; Luckemeyer DD, 2012, PHYTOTHER RES, V26, P535, DOI 10.1002/ptr.3590; McDougall B, 1998, ANTIMICROB AGENTS CH, V42, P140, DOI 10.1128/AAC.42.1.140; Morrison JM, 2009, J VIROL, V83, P4412, DOI 10.1128/JVI.02177-08; Olivier AK, 2011, EXP LUNG RES, V37, P131, DOI 10.3109/01902148.2010.484518; Peppa D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001227; Qi W, 2011, J PHARM ANAL, V1, P270, DOI 10.1016/j.jpha.2011.09.006; Rivas-Aravena A, 2011, J VIROL, V85, P8037, DOI 10.1128/JVI.00533-11; Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004; Shang LQ, 2013, ANTIVIR RES, V97, P183, DOI 10.1016/j.antiviral.2012.12.005; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Superti F, 2008, CURR MED CHEM, V15, P900, DOI 10.2174/092986708783955419; Tamura H, 2006, MOL NUTR FOOD RES, V50, P396, DOI 10.1002/mnfr.200500216; Wang GF, 2009, ANTIVIR RES, V83, P186, DOI 10.1016/j.antiviral.2009.05.002; Wong SSY, 2010, EPIDEMIOL INFECT, V138, P1071, DOI 10.1017/S0950268809991555; Wu BW, 2007, AM J CHINESE MED, V35, P153, DOI 10.1142/S0192415X07004709; Wu KX, 2010, DRUG DISCOV TODAY, V15, P1041, DOI 10.1016/j.drudis.2010.10.008	37	42	49	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76007	10.1371/journal.pone.0076007	http://dx.doi.org/10.1371/journal.pone.0076007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098754	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500124
J	Lomate, PR; Jadhav, BR; Giri, AP; Hivrale, VK				Lomate, Purushottam R.; Jadhav, Bhakti R.; Giri, Ashok P.; Hivrale, Vandana K.			Alterations in the Helicoverpa armigera Midgut Digestive Physiology after Ingestion of Pigeon Pea Inducible Leucine Aminopeptidase	PLOS ONE			English	Article							POLYPHENOL OXIDASE; PLANT DEFENSE; JASMONATE; MECHANISM; ELECTROPHORESIS; OVEREXPRESSION; PURIFICATION; HERBIVORES; RESISTANCE; INHIBITORS	Jasmonate inducible plant leucine aminopeptidase (LAP) is proposed to serve as direct defense in the insect midgut. However, exact functions of inducible plant LAPs in the insect midgut remain to be estimated. In the present investigation, we report the direct defensive role of pigeon pea inducible LAP in the midgut of Helicoverpa armigera (Lepidoptera: Noctuidae) and responses of midgut soluble aminopeptidases and serine proteinases upon LAP ingestion. Larval growth and survival was significantly reduced on the diets supplemented with pigeon pea LAP. Aminopeptidase activities in larvae remain unaltered in presence or absence of inducible LAP in the diet. On the contrary, serine proteinase activities were significantly decreased in the larvae reared on pigeon pea LAP containing diet as compared to larvae fed on diet without LAP. Our data suggest that pigeon pea inducible LAP is responsible for the degradation of midgut serine proteinases upon ingestion. Reduction in the aminopeptidase activity with LpNA in the H. armigera larvae was compensated with an induction of aminopeptidase activity with ApNA. Our findings could be helpful to further dissect the roles of plant inducible LAPs in the direct plant defense against herbivory.	[Lomate, Purushottam R.; Jadhav, Bhakti R.; Hivrale, Vandana K.] Dr Babasaheb Ambedkar Marathwada Univ, Dept Biochem, Aurangabad, Maharashtra, India; [Lomate, Purushottam R.; Giri, Ashok P.] CSIR, Natl Chem Lab, Div Biochem Sci, Plant Mol Biol Unit, Pune, Maharashtra, India	Dr. Babasaheb Ambedkar Marathwada University (BAMU); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL)	Hivrale, VK (corresponding author), Dr Babasaheb Ambedkar Marathwada Univ, Dept Biochem, Aurangabad, Maharashtra, India.	vkhbiochem@gmail.com		Lomate, Purushottam/0000-0003-4765-3597	Department of Biotechnology (DBT), Government of India, New Delhi	Department of Biotechnology (DBT), Government of India, New Delhi(Department of Biotechnology (DBT) India)	PRL acknowledges support from Department of Biotechnology (DBT), Government of India, New Delhi for Research Associateship.	Bozic N, 2003, COMP BIOCHEM PHYS B, V134, P231, DOI 10.1016/S1096-4959(02)00257-9; Bozic NA, 2005, ELECTROPHORESIS, V26, P2476, DOI 10.1002/elps.200500047; BROADWAY RM, 1988, J INSECT PHYSIOL, V34, P1111, DOI 10.1016/0022-1910(88)90213-2; BROADWAY RM, 1995, J INSECT PHYSIOL, V41, P107, DOI 10.1016/0022-1910(94)00101-L; BROADWAY RM, 1986, J INSECT PHYSIOL, V32, P827, DOI 10.1016/0022-1910(86)90097-1; Chao WS, 1999, PLANT PHYSIOL, V120, P979, DOI 10.1104/pp.120.4.979; Chao WS, 2000, PLANTA, V210, P563, DOI 10.1007/s004250050045; Chen H, 2005, P NATL ACAD SCI USA, V102, P19237, DOI 10.1073/pnas.0509026102; CONSTABEL CP, 1995, P NATL ACAD SCI USA, V92, P407, DOI 10.1073/pnas.92.2.407; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; Duffey SS, 1996, ARCH INSECT BIOCHEM, V32, P3, DOI 10.1002/(SICI)1520-6327(1996)32:1&lt;3::AID-ARCH2&gt;3.0.CO;2-1; Felicioli R, 1997, ANAL BIOCHEM, V244, P176, DOI 10.1006/abio.1996.9917; Fowler JH, 2009, PLANT CELL, V21, P1239, DOI 10.1105/tpc.108.065029; Gatehouse JA, 2002, NEW PHYTOL, V156, P145, DOI 10.1046/j.1469-8137.2002.00519.x; GREEN TR, 1972, SCIENCE, V175, P776, DOI 10.1126/science.175.4023.776; Gu YQ, 1999, EUR J BIOCHEM, V263, P726, DOI 10.1046/j.1432-1327.1999.00548.x; Hartl M, 2008, NEW PHYTOL, V179, P356, DOI 10.1111/j.1469-8137.2008.02479.x; Jongsma MA, 1997, J INSECT PHYSIOL, V43, P885, DOI 10.1016/S0022-1910(97)00040-1; Kessler A, 2004, SCIENCE, V305, P665, DOI 10.1126/science.1096931; Li XC, 2002, NATURE, V419, P712, DOI 10.1038/nature01003; Lomate PR, 2011, PLANT PHYSIOL BIOCH, V49, P609, DOI 10.1016/j.plaphy.2011.02.023; Lomate PR, 2010, COMP BIOCHEM PHYS B, V155, P164, DOI 10.1016/j.cbpb.2009.10.018; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mahanil S, 2008, PLANT SCI, V174, P456, DOI 10.1016/j.plantsci.2008.01.006; Matsui M, 2006, BIOL CHEM, V387, P1535, DOI 10.1515/BC.2006.191; MCDONALD JK, 1986, MAMMALIAN PROTEASES, V2; Nagarkatti S., 1974, TECHNICAL B COMMONWE, V17; PAUTOT V, 1993, P NATL ACAD SCI USA, V90, P9906, DOI 10.1073/pnas.90.21.9906; Pechan T, 2002, P NATL ACAD SCI USA, V99, P13319, DOI 10.1073/pnas.202224899; RENDUELES PS, 1988, FEMS MICROBIOL LETT, V54, P17; Walling LL, 2006, CURR OPIN PLANT BIOL, V9, P227, DOI 10.1016/j.pbi.2006.03.009; WALLING LL, 1996, AMINOPEPTIDASES, P174	32	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74889	10.1371/journal.pone.0074889	http://dx.doi.org/10.1371/journal.pone.0074889			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098675	gold, Green Published, Green Submitted			2022-12-25	WOS:000325423500046
J	Mezzaroba, N; Zorzet, S; Secco, E; Biffi, S; Tripodo, C; Calvaruso, M; Mendoza-Maldonado, R; Capolla, S; Granzotto, M; Spretz, R; Larsen, G; Noriega, S; Lucafo, M; Mansilla, E; Garrovo, C; Marin, GH; Baj, G; Gattei, V; Pozzato, G; Nunez, L; Macor, P				Mezzaroba, Nelly; Zorzet, Sonia; Secco, Erika; Biffi, Stefania; Tripodo, Claudio; Calvaruso, Marco; Mendoza-Maldonado, Ramiro; Capolla, Sara; Granzotto, Marilena; Spretz, Ruben; Larsen, Gustavo; Noriega, Sandra; Lucafo, Marianna; Mansilla, Eduardo; Garrovo, Chiara; Marin, Gustavo H.; Baj, Gabriele; Gattei, Valter; Pozzato, Gabriele; Nunez, Luis; Macor, Paolo			New Potential Therapeutic Approach for the Treatment of B-Cell Malignancies Using Chlorambucil/Hydroxychloroquine- Loaded Anti-CD20 Nanoparticles	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; MONOCLONAL-ANTIBODY; IN-VIVO; BIODEGRADABLE NANOPARTICLES; LYMPHOMA-CELLS; CANCER; RITUXIMAB; COMPLEMENT; HYDROXYCHLOROQUINE; CD55	Current B-cell disorder treatments take advantage of dose-intensive chemotherapy regimens and immunotherapy via use of monoclonal antibodies. Unfortunately, they may lead to insufficient tumor distribution of therapeutic agents, and often cause adverse effects on patients. In this contribution, we propose a novel therapeutic approach in which relatively high doses of Hydroxychloroquine and Chlorambucil were loaded into biodegradable nanoparticles coated with an anti-CD20 antibody. We demonstrate their ability to effectively target and internalize in tumor B-cells. Moreover, these nanoparticles were able to kill not only p53 mutated/deleted lymphoma cell lines expressing a low amount of CD20, but also circulating primary cells purified from chronic lymphocitic leukemia patients. Their safety was demonstrated in healthy mice, and their therapeutic effects in a new model of Burkitt's lymphoma. The latter serves as a prototype of an aggressive lymphoproliferative disease. In vitro and in vivo data showed the ability of anti-CD20 nanoparticles loaded with Hydroxychloroquine and Chlorambucil to increase tumor cell killing in comparison to free cytotoxic agents or Rituximab. These results shed light on the potential of anti-CD20 nanoparticles carrying Hydroxychloroquine and Chlorambucil for controlling a disseminated model of aggressive lymphoma, and lend credence to the idea of adopting this therapeutic approach for the treatment of B-cell disorders.	[Mezzaroba, Nelly; Zorzet, Sonia; Secco, Erika; Capolla, Sara; Lucafo, Marianna; Baj, Gabriele; Macor, Paolo] Univ Trieste, Dept Life Sci, Trieste, Italy; [Biffi, Stefania; Granzotto, Marilena] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy; [Tripodo, Claudio; Calvaruso, Marco] Univ Palermo, Dept Human Pathol, Palermo, Italy; [Mendoza-Maldonado, Ramiro] Int Ctr Genet Engn & Biotechnol, Mol Med Lab, I-34012 Trieste, Italy; [Spretz, Ruben; Larsen, Gustavo; Noriega, Sandra] LNK Chemsolut LLC, Lincoln, NE USA; [Larsen, Gustavo; Nunez, Luis] Biotarget, Chicago, IL USA; [Mansilla, Eduardo; Marin, Gustavo H.] Minist Hlth, Ctr Unico Coordinador Ablac & Implante Prov Bueno, La Plata, Buenos Aires, Argentina; [Garrovo, Chiara] Opt Imaging Lab, Cluster BioMed, Trieste, Italy; [Gattei, Valter] Ctr Riferimento Oncol, Clin & Expt Oncohematol Unit, I-33081 Aviano, Italy; [Pozzato, Gabriele] Univ Trieste, Dipartimento Univ Clin Sci Med Chirurg & Salute, Trieste, Italy; [Nunez, Luis] Univ Chicago, Chicago, IL 60637 USA	University of Trieste; IRCCS Burlo Garofolo; University of Palermo; International Center for Genetic Engineering & Biotechnology (ICGEB); IRCCS Aviano (CRO); University of Trieste; University of Chicago	Macor, P (corresponding author), Univ Trieste, Dept Life Sci, Trieste, Italy.	pmacor@units.it	Tripodo, Claudio/O-4536-2016; Biffi, Stefania/C-6652-2015; Lucafo, Marianna/K-2312-2018; Tripodo, Claudio/AAB-6004-2022; Gattei, Valter/AAB-5048-2020; Baj, Gabriele/H-4228-2012	Tripodo, Claudio/0000-0002-0821-6231; Biffi, Stefania/0000-0003-2257-2053; Lucafo, Marianna/0000-0003-1355-3782; Tripodo, Claudio/0000-0002-0821-6231; Gattei, Valter/0000-0001-5933-9680; Macor, Paolo/0000-0003-3079-4019; Marin, Gustavo/0000-0002-6380-6453; Baj, Gabriele/0000-0002-2625-9454; Sonia, Zorzet/0000-0001-5161-3542; Garrovo, Chiara/0000-0003-1432-0147; CALVARUSO, MARCO/0000-0003-2387-8273	Italian Association for Cancer Research (AIRC) [12965/2012]; Fondazione Casali - Trieste; National Institutes of Health, USA [2R44CA135906-02]; NATIONAL CANCER INSTITUTE [R44CA135906] Funding Source: NIH RePORTER	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Casali - Trieste; National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study has been made possible by research grants from Italian Association for Cancer Research (AIRC. Project nu 12965/2012) and Fondazione Casali - Trieste. Nanoparticles fabrication at LNK Chemsolutions, USA, was possible in part by Grant 2R44CA135906-02 (SBIR Phase II) from the National Institutes of Health, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 2009, BIOMATERIALS, V30, P5737, DOI 10.1016/j.biomaterials.2009.07.008; Agemy L, 2010, BLOOD, V116, P2847, DOI 10.1182/blood-2010-03-274258; Aldoss IT, 2008, ONCOLOGY-NY, V22, P1508; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Bae KH, 2011, MOL CELLS, V31, P295, DOI 10.1007/s10059-011-0051-5; Bellosillo B, 2001, BLOOD, V98, P2771, DOI 10.1182/blood.V98.9.2771; Bicho A, 2010, INT J PHARMACEUT, V399, P80, DOI 10.1016/j.ijpharm.2010.08.005; Biffi S, 2008, MOL IMAGING, V7, P272, DOI 10.2310/7290.2008.00028; Bloehdorn J, 2010, J NUCL ACIDS INVESTI, V2, pe8; Cheson BD, 2006, CANCER IMMUNOL IMMUN, V55, P188, DOI 10.1007/s00262-005-0010-0; Chiellini F, 2008, NANOMEDICINE-UK, V3, P367, DOI 10.2217/17435889.3.3.367; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; de Jong D, 2011, J PATHOL, V223, P274, DOI 10.1002/path.2807; Di Gaetano N, 2003, J IMMUNOL, V171, P1581, DOI 10.4049/jimmunol.171.3.1581; Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088; Fayad L, 2007, CLIN LYMPHOMA MYELOM, V8, pS57, DOI 10.3816/CLM.2007.s.034; Feng SS, 2008, BIOMATERIALS, V29, P4146; Feng SS, 2006, NANOMEDICINE-UK, V1, P297, DOI 10.2217/17435889.1.3.297; Golay J, 2000, BLOOD, V95, P3900; Golay J, 2006, HAEMATOL-HEMATOL J, V91, P176; Golay J, 2003, HAEMATOLOGICA, V88, P1002; Jaffe E. S., 2008, WHO CLASSIFICATION T; Johnson NA, 2009, BLOOD, V113, P3773, DOI 10.1182/blood-2008-09-177469; Kalil N, 2000, DRUG AGING, V16, P9, DOI 10.2165/00002512-200016010-00002; Krystof V, 2010, CURR DRUG TARGETS, V11, P291, DOI 10.2174/138945010790711950; Lagneaux L, 2002, LEUKEMIA LYMPHOMA, V43, P1087, DOI 10.1080/10428190290021506; Li Y, 2011, CANCER RES, V71, P7481, DOI 10.1158/0008-5472.CAN-11-0940; Macor P, 2007, CANCER RES, V67, P10556, DOI 10.1158/0008-5472.CAN-07-1811; Macor P, 2007, IMMUNOL LETT, V111, P6, DOI 10.1016/j.imlet.2007.04.014; Mahoney E, 2012, BLOOD, V120, P1262, DOI 10.1182/blood-2011-12-400184; Malavasi F, 2011, BLOOD, V118, P3470, DOI 10.1182/blood-2011-06-275610; Mansilla E, 2010, CANCER BIOTHER RADIO, V25, P97, DOI 10.1089/cbr.2009.0655; Marin GH, 2010, CURR CLIN PHARMACOL, V5, P246, DOI 10.2174/157488410793352058; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McLaughlin P, 1998, ONCOLOGY-NY, V12, P1763; Mead GM, 2008, BLOOD, V112, P2248, DOI 10.1182/blood-2008-03-145128; Mendoza-Maldonado R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013720; Molyneux EM, 2012, LANCET, V379, P1234, DOI 10.1016/S0140-6736(11)61177-X; Parveen S, 2008, J DRUG TARGET, V16, P108, DOI [10.1080/10611860701794353, 10.1080/10611860701794353 ]; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Pridgen EM, 2007, NANOMEDICINE-UK, V2, P669, DOI 10.2217/17435889.2.5.669; Rahim R, 2009, ANTI-CANCER DRUG, V20, P736, DOI 10.1097/CAD.0b013e32832f4e50; Rao DA, 2010, J PHARM SCI-US, V99, P2018, DOI 10.1002/jps.21970; REFF ME, 1994, BLOOD, V83, P435; Rima W, 2013, BIOMATERIALS, V34, P181, DOI 10.1016/j.biomaterials.2012.09.029; Ruoslahti E, 2010, J CELL BIOL, V188, P759, DOI 10.1083/jcb.200910104; Stein M, 2000, J RHEUMATOL, V27, P2927; Tehrani Rodney, 2008, Semin Ophthalmol, V23, P201, DOI 10.1080/08820530802049962; Vasir JK, 2007, ADV DRUG DELIVER REV, V59, P718, DOI 10.1016/j.addr.2007.06.003; Verma A, 2008, NAT MATER, V7, P588, DOI 10.1038/nmat2202; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; ZABUCCHI G, 1986, AM J PATHOL, V124, P510; Zauli G, 2011, CLIN CANCER RES, V17, P762, DOI 10.1158/1078-0432.CCR-10-2572; Zhou Y, 2003, BLOOD, V101, P4098, DOI 10.1182/blood-2002-08-2512; Ziller F, 2005, EUR J IMMUNOL, V35, P2175, DOI 10.1002/eji.200425920	55	26	46	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74216	10.1371/journal.pone.0074216	http://dx.doi.org/10.1371/journal.pone.0074216			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098639	Green Published, gold			2022-12-25	WOS:000325423500010
J	Mirkin, EV; Chang, FS; Kleckner, N				Mirkin, Ekaterina V.; Chang, Frederick S.; Kleckner, Nancy			Dynamic Trans Interactions in Yeast Chromosomes	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; ODORANT RECEPTOR GENES; BUDDING YEAST; EXPRESSION; MEIOSIS; LOCALIZATION; LOCI; TRANSCRIPTION; ORGANIZATION; PROTEINS	Three-dimensional organization of the genome is important for regulation of gene expression and maintenance of genomic stability. It also defines, and is defined by, contacts between different chromosomal loci. Interactions between loci positioned on different chromosomes, i.e. "trans'' interactions are one type of such contacts. Here, we describe a case of inducible trans interaction in chromosomes of the budding yeast S. cerevisiae. Special DNA sequences, inserted in two ectopic chromosomal loci positioned in trans, pair with one another in an inducible manner. The spatial proximity diagnostic of pairing is observable by both chromosome capture analysis (3C) and epifluorescence microscopy in whole cells. Protein synthesis de novo appears to be required for this process. The three-dimensional organization of the yeast nucleus imposes a constraint on such pairing, presumably by dictating the probability with which the two sequences collide with one another.	[Mirkin, Ekaterina V.; Chang, Frederick S.; Kleckner, Nancy] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Kleckner, N (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	kleckner@fas.harvard.edu			National Institutes of Health [RO1GM044794, F32GM083427]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044794, F32GM083427] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a grant to N.K. from the National Institutes of Health RO1GM044794 and a postdoctoral fellowship to E.M. from the National Institutes of Health F32GM083427. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; Bateman JR, 2008, GENETICS, V180, P1329, DOI 10.1534/genetics.108.094862; Bateman JR, 2012, G3-GENES GENOM GENET, V2, P731, DOI 10.1534/g3.112.002840; Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Boateng KA, 2013, DEV CELL, V24, P196, DOI 10.1016/j.devcel.2012.12.002; Brar GA, 2009, MOL BIOL CELL, V20, P1030, DOI 10.1091/mbc.E08-06-0637; Brickner DG, 2007, PLOS BIOL, V5, P704, DOI 10.1371/journal.pbio.0050081; Burgess SM, 1999, GENE DEV, V13, P1871, DOI 10.1101/gad.13.14.1871; Burgess SM, 1999, GENE DEV, V13, P1627, DOI 10.1101/gad.13.12.1627; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Duncan IW, 2002, ANNU REV GENET, V36, P521, DOI 10.1146/annurev.genet.36.060402.100441; Fisher JK, 2013, CELL, V153, P882, DOI 10.1016/j.cell.2013.04.006; Fuss SH, 2007, CELL, V130, P373, DOI 10.1016/j.cell.2007.06.023; Gartenberg MR, 2009, GENE DEV, V23, P1027, DOI 10.1101/gad.1805309; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hediger F, 2004, METHOD ENZYMOL, V375, P345; HIRAOKA Y, 1993, J CELL BIOL, V120, P591, DOI 10.1083/jcb.120.3.591; Hubner MR, 2010, ANNU REV BIOPHYS, V39, P471, DOI 10.1146/annurev.biophys.093008.131348; Hunter N, 2007, MOL GENETICS RECOMBI, P381; Ishii K, 2002, CELL, V109, P551, DOI 10.1016/S0092-8674(02)00756-0; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Joyce EF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002667; Keeney S, 1996, GENES CELLS, V1, P475, DOI 10.1046/j.1365-2443.1996.d01-257.x; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kim KP, 2010, CELL, V143, P924, DOI 10.1016/j.cell.2010.11.015; Kitamura E, 2006, CELL, V125, P1297, DOI 10.1016/j.cell.2006.04.041; Koeman JM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000176; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Kundu S, 2007, GENE DEV, V21, P997, DOI 10.1101/gad.1506607; LaSalle JM, 1996, SCIENCE, V272, P725, DOI 10.1126/science.272.5262.725; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Lisby M, 2009, DNA REPAIR, V8, P1068, DOI 10.1016/j.dnarep.2009.04.007; LOIDL J, 1990, GENOME, V33, P759, DOI 10.1139/g90-115; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Macqueen AJ, 2005, CELL, V123, P1037, DOI 10.1016/j.cell.2005.09.034; McIsaac RS, 2011, MOL BIOL CELL, V22, P4447, DOI 10.1091/mbc.E11-05-0466; McKee BD, 2004, BBA-GENE STRUCT EXPR, V1677, P165, DOI 10.1016/j.bbaexp.2003.11.017; Meaburn KJ, 2007, SEMIN CANCER BIOL, V17, P80, DOI 10.1016/j.semcancer.2006.10.008; Meldi L, 2011, TRENDS CELL BIOL, V21, P701, DOI 10.1016/j.tcb.2011.08.001; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Molnar M, 2008, GENETICS, V178, P99, DOI 10.1534/genetics.107.082826; Nishizumi H, 2007, P NATL ACAD SCI USA, V104, P20067, DOI 10.1073/pnas.0706544105; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Oza P, 2009, GENE DEV, V23, P912, DOI 10.1101/gad.1782209; Phillips CM, 2005, CELL, V123, P1051, DOI 10.1016/j.cell.2005.09.035; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Picard D, 1999, NUCL RECEPTORS PRACT, P261; Rog O, 2013, CURR OPIN CELL BIOL; Sadoni N, 2008, CHROMOSOMA, V117, P381, DOI 10.1007/s00412-008-0157-5; Sandhu KS, 2009, GENE DEV, V23, P2598, DOI 10.1101/gad.552109; Schober H, 2009, GENE DEV, V23, P928, DOI 10.1101/gad.1787509; Schoenfelder S, 2010, CURR OPIN GENET DEV, V20, P127, DOI 10.1016/j.gde.2010.02.002; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; Taddei A, 2012, GENETICS, V192, P107, DOI 10.1534/genetics.112.140608; Teller K, 2007, P NATL ACAD SCI USA, V104, P14970, DOI 10.1073/pnas.0704285104; Therizols P, 2010, P NATL ACAD SCI USA, V107, P2025, DOI 10.1073/pnas.0914187107; Thomas SE, 2005, CELL, V123, P555, DOI 10.1016/j.cell.2005.08.043; Tsai JH, 2011, J CELL SCI, V124, P1955, DOI 10.1242/jcs.006387; Wahba L, 2011, MOL CELL, V44, P978, DOI 10.1016/j.molcel.2011.10.017; WEINER BM, 1994, CELL, V77, P977, DOI 10.1016/0092-8674(94)90438-3; Williams A, 2010, TRENDS GENET, V26, P188, DOI 10.1016/j.tig.2010.01.007; Williams RRE, 2006, J CELL SCI, V119, P132, DOI 10.1242/jcs.02727; Xu M, 2008, BBA-MOL CELL RES, V1783, P2155, DOI 10.1016/j.bbamcr.2008.07.013; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984; Xu N, 2007, NAT GENET, V39, P1390, DOI 10.1038/ng.2007.5; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	75	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75895	10.1371/journal.pone.0075895	http://dx.doi.org/10.1371/journal.pone.0075895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098740	Green Submitted, Green Published, gold			2022-12-25	WOS:000325423500111
J	Moller, M; Nielsen, SS; Ramachandran, S; Li, YX; Tria, G; Streicher, W; Petoukhov, MV; Cerione, RA; Gillilan, RE; Vestergaard, B				Moller, Magda; Nielsen, Soren S.; Ramachandran, Sekar; Li, Yuxing; Tria, Giancarlo; Streicher, Werner; Petoukhov, Maxim V.; Cerione, Richard A.; Gillilan, Richard E.; Vestergaard, Bente			Small Angle X-Ray Scattering Studies of Mitochondrial Glutaminase C Reveal Extended Flexible Regions, and Link Oligomeric State with Enzyme Activity	PLOS ONE			English	Article							KIDNEY-TYPE GLUTAMINASE; BIOLOGICAL MACROMOLECULES; PROTEINS; CANCER; MECHANISM; PROGRAM; INHIBITION; ACTIVATION; EXPRESSION; SYSTEM	Glutaminase C is a key metabolic enzyme, which is unregulated in many cancer systems and believed to play a central role in the Warburg effect, whereby cancer cells undergo changes to an altered metabolic profile. A long-standing hypothesis links enzymatic activity to the protein oligomeric state, hence the study of the solution behavior in general and the oligomer state in particular of glutaminase C is important for the understanding of the mechanism of protein activation and inhibition. In this report, this is extensively investigated in correlation to enzyme concentration or phosphate level, using a high-throughput microfluidic-mixing chip for the SAXS data collection, and we confirm that the oligomeric state correlates with activity. The in-depth solution behavior analysis further reveals the structural behavior of flexible regions of the protein in the dimeric, tetrameric and octameric state and investigates the C-terminal influence on the enzyme solution behavior. Our data enable SAXS-based rigid body modeling of the full-length tetramer states, thereby presenting the first ever experimentally derived structural model of mitochondrial glutaminase C including the N- and C-termini of the enzyme.	[Moller, Magda; Vestergaard, Bente] Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Nielsen, Soren S.] Univ Copenhagen, Dept Struct Biophys, Copenhagen, Denmark; [Nielsen, Soren S.; Gillilan, Richard E.] Cornell Univ, CHESS, Ithaca, NY USA; [Nielsen, Soren S.; Gillilan, Richard E.] Cornell Univ, CHESS MacCHESS, Macromol Diffract Facil, Ithaca, NY USA; [Ramachandran, Sekar; Li, Yuxing; Cerione, Richard A.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY USA; [Tria, Giancarlo; Petoukhov, Maxim V.] DESY, European Mol Biol Lab, Hamburg Outstn, Hamburg, Germany; [Tria, Giancarlo] Univ Hamburg, Ctr Bioinformat, Hamburg, Germany; [Streicher, Werner] Novo Nordisk Fdn Ctr Prot Res, Copenhagen, Denmark; [Cerione, Richard A.] Cornell Univ, Dept Mol Med, Ithaca, NY USA	University of Copenhagen; University of Copenhagen; Cornell University; Cornell University; Cornell University; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Hamburg; Cornell University	Vestergaard, B (corresponding author), Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark.	bente.vestergaard@sund.ku.dk	Petoukhov, Maxim V/R-7371-2016; Ramachandran, Sekar/AAP-2287-2020	Petoukhov, Maxim V/0000-0001-6760-4595; Ramachandran, Sekar/0000-0002-2243-1368; Streicher, Werner/0000-0002-2425-5839; TRIA, Giancarlo/0000-0003-4736-471X; Vestergaard, Bente/0000-0001-8011-6414	Faculty of Health and Medical Sciences, University of Copenhagen; Bioxtas project group; NABITT program of the Danish Ministry of Science, Technology and Development [2106-050047]; National Science Foundation (NSF); National Institutes of Health/National Institute of General Medical Sciences under NSF [DMR-0936384]; National Institutes of Health through its National Center for Research Resources [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047458] Funding Source: NIH RePORTER	Faculty of Health and Medical Sciences, University of Copenhagen; Bioxtas project group; NABITT program of the Danish Ministry of Science, Technology and Development; National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health/National Institute of General Medical Sciences under NSF(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health through its National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was funded in part by The Faculty of Health and Medical Sciences, University of Copenhagen and the Bioxtas project group with funding from the NABITT program of the Danish Ministry of Science, Technology and Development (grant number 2106-050047). This work is based in part upon research conducted at the Cornell High Energy Synchrotron Source (CHESS), which is supported by the National Science Foundation (NSF) and the National Institutes of Health/National Institute of General Medical Sciences under NSF award DMR-0936384, using the Macromolecular Diffraction at CHESS (MacCHESS) facility, which is supported by award RR-01646 from the National Institutes of Health through its National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamenko II, 2006, J MOL LIQ, V127, P90, DOI 10.1016/j.molliq.2006.03.023; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Boulay A-C, 2012, BIOCHIMIE; Cassago A, 2012, P NATL ACAD SCI USA, V109, P1092, DOI 10.1073/pnas.1112495109; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Elgadi KM, 1999, PHYSIOL GENOMICS, V1, P51, DOI 10.1152/physiolgenomics.1999.1.2.51; Erickson JW, 2010, GLUTAMINASE HOT SPOT; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; GODFREY S, 1977, J BIOL CHEM, V252, P1927; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Katt WP, 2012, MOL CANCER THER, V11, P1269, DOI 10.1158/1535-7163.MCT-11-0942; Kenny J, 2003, PROTEIN EXPRES PURIF, V31, P140, DOI 10.1016/S1046-5928(03)00161-X; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Konarev PV, 2001, J APPL CRYSTALLOGR, V34, P527, DOI 10.1107/S0021889801006100; Lafleur JP, 2011, J APPL CRYSTALLOGR, V44, P1090, DOI 10.1107/S0021889811030068; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; MOREHOUSE RF, 1981, BIOCHEM J, V193, P709, DOI 10.1042/bj1930709; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; Nielsen SS, 2009, J APPL CRYSTALLOGR, V42, P959, DOI 10.1107/S0021889809023863; OLSEN BR, 1973, J MOL BIOL, V74, P239, DOI 10.1016/0022-2836(73)90109-5; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Robinson MM, 2007, BIOCHEM J, V406, P407, DOI 10.1042/BJ20070039; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Seltzer MJ, 2010, CANCER RES, V70, P8981, DOI 10.1158/0008-5472.CAN-10-1666; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 2003, REP PROG PHYS, V66, P1735, DOI 10.1088/0034-4885/66/10/R05; Thangavelu K, 2012, P NATL ACAD SCI USA, V109, P7705, DOI 10.1073/pnas.1116573109; Toft KN, 2008, ANAL CHEM, V80, P3648, DOI 10.1021/ac800011y; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yoshimune K, 2010, FEBS J, V277, P738, DOI 10.1111/j.1742-4658.2009.07523.x	35	19	18	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74783	10.1371/journal.pone.0074783	http://dx.doi.org/10.1371/journal.pone.0074783			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098668	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500039
J	Uchiyama, T; Miyazaki, K				Uchiyama, Taku; Miyazaki, Kentaro			Metagenomic Screening for Aromatic Compound-Responsive Transcriptional Regulators	PLOS ONE			English	Article							DIOXYGENASE GENES; DEGRADATION; PSEUDOMONAS; EXPRESSION; DIVERSITY; EVOLUTION; ENZYMES; METABOLISM; RESISTANCE; PATHWAYS	We applied a metagenomics approach to screen for transcriptional regulators that sense aromatic compounds. The library was constructed by cloning environmental DNA fragments into a promoter-less vector containing green fluorescence protein. Fluorescence-based screening was then performed in the presence of various aromatic compounds. A total of 12 clones were isolated that fluoresced in response to salicylate, 3-methyl catechol, 4-chlorocatechol and chlorohydroquinone. Sequence analysis revealed at least 1 putative transcriptional regulator, excluding 1 clone (CHLO8F). Deletion analysis identified compound-specific transcriptional regulators; namely, 8 LysR-types, 2 two-component-types and 1 AraC-type. Of these, 9 representative clones were selected and their reaction specificities to 18 aromatic compounds were investigated. Overall, our transcriptional regulators were functionally diverse in terms of both specificity and induction rates. LysR- and AraC- type regulators had relatively narrow specificities with high induction rates (5-50 fold), whereas two-component-types had wide specificities with low induction rates (3 fold). Numerous transcriptional regulators have been deposited in sequence databases, but their functions remain largely unknown. Thus, our results add valuable information regarding the sequence-function relationship of transcriptional regulators.	[Uchiyama, Taku] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan; [Miyazaki, Kentaro] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Sapporo, Hokkaido, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST)	Miyazaki, K (corresponding author), Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Sapporo, Hokkaido, Japan.	miyazaki-kentaro@aist.go.jp	Miyazaki, Kentaro/F-7022-2010	Miyazaki, Kentaro/0000-0002-4349-566X	Japan Society for Promotion of Science [19880040]	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for Promotion of Science (No. 19880040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai H, 2000, MICROBIOL-UK, V146, P1707, DOI 10.1099/00221287-146-7-1707; Bosch R, 1999, J BACTERIOL, V181, P2315, DOI 10.1128/JB.181.8.2315-2322.1999; Brennerova MV, 2009, ENVIRON MICROBIOL, V11, P2216, DOI 10.1111/j.1462-2920.2009.01943.x; Chen SH, 1999, ENVIRON SCI TECHNOL, V33, P435, DOI 10.1021/es9805730; Duffner FM, 2000, GENE, V256, P215, DOI 10.1016/S0378-1119(00)00352-8; Esteve-Nunez A, 2001, MICROBIOL MOL BIOL R, V65, P335, DOI 10.1128/MMBR.65.3.335-352.2001; EVANS WC, 1971, BIOCHEM J, V122, P509, DOI 10.1042/bj1220509; Furukawa K, 2004, J BACTERIOL, V186, P5189, DOI 10.1128/JB.186.16.5189-5196.2004; Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05; Galvao TC, 2005, TRENDS BIOTECHNOL, V23, P497, DOI 10.1016/j.tibtech.2005.08.002; Gibson DT, 2000, CURR OPIN BIOTECH, V11, P236, DOI 10.1016/S0958-1669(00)00090-2; Gibson J, 2002, ANNU REV MICROBIOL, V56, P345, DOI 10.1146/annurev.micro.56.012302.160749; Lessner DJ, 2003, J BACTERIOL, V185, P3895, DOI 10.1128/JB.185.13.3895-3904.2003; McPhee JB, 2003, MOL MICROBIOL, V50, P205, DOI 10.1046/j.1365-2958.2003.03673.x; Meyer S, 1999, MICROBIOL-SGM, V145, P1731, DOI 10.1099/13500872-145-7-1731; MILLS SD, 1993, J BACTERIOL, V175, P1656, DOI 10.1128/JB.175.6.1656-1664.1993; Silva CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061811; Suenaga H, 2007, ENVIRON MICROBIOL, V9, P2289, DOI 10.1111/j.1462-2920.2007.01342.x; Suenaga H, 2009, ISME J, V3, P1335, DOI 10.1038/ismej.2009.76; Suenaga H, 2009, FEMS MICROBIOL ECOL, V69, P472, DOI 10.1111/j.1574-6941.2009.00719.x; Sul WJ, 2009, APPL ENVIRON MICROB, V75, P5501, DOI 10.1128/AEM.00121-09; Uchiyama T, 2005, NAT BIOTECHNOL, V23, P88, DOI 10.1038/nbt1048; van Hellemond EW, 2007, APPL ENVIRON MICROB, V73, P5832, DOI 10.1128/AEM.02708-06; WILLIAMS PA, 1976, J BACTERIOL, V125, P818, DOI 10.1128/JB.125.3.818-828.1976; Williams Peter A., 1994, Biodegradation, V5, P195, DOI 10.1007/BF00696460; Wittich RM, 1998, APPL MICROBIOL BIOT, V49, P489, DOI 10.1007/s002530051203; YOU IS, 1988, J BACTERIOL, V170, P5409, DOI 10.1128/jb.170.12.5409-5415.1988; Zhou NY, 2001, J BACTERIOL, V183, P700, DOI 10.1128/JB.183.2.700-708.2001; ZYLSTRA GJ, 1988, APPL ENVIRON MICROB, V54, P1498, DOI 10.1128/AEM.54.6.1498-1503.1988	29	16	17	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75795	10.1371/journal.pone.0075795	http://dx.doi.org/10.1371/journal.pone.0075795			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098725	Green Published, gold, Green Submitted			2022-12-25	WOS:000325423500096
J	Wu, MJ; Zhang, H; Hu, JH; Weng, ZY; Li, CY; Li, H; Zhao, Y; Mei, XF; Ren, F; Li, LH				Wu, Minjun; Zhang, Hua; Hu, Jiehua; Weng, Zhiyong; Li, Chenyuan; Li, Hong; Zhao, Yan; Mei, Xifan; Ren, Fu; Li, Lihua			Isoalantolactone Inhibits UM-SCC-10A Cell Growth via Cell Cycle Arrest and Apoptosis Induction	PLOS ONE			English	Article							S-PHASE ARREST; LEUKEMIA HL-60 CELLS; SESQUITERPENE LACTONES; INULA-HELENIUM; SMALL-MOLECULE; CANCER CELLS; DNA-DAMAGE; DEATH; MITOCHONDRIA; PROGRESSION	Isoalantolactone is a sesquiterpene lactone compound isolated from the roots of Inula helenium L. Previous studies have demonstrated that isoalantolactone possesses antifungal, anti-bacterial, anti-helminthic and anti-proliferative properties in a variety of cells, but there are no studies concerning its effects on head and neck squamous cell carcinoma (HNSCC). In the present study, an MTT assay demonstrated that isoalantolactone has anti-proliferative activity against the HNSCC cell line (UM-SCC-10A). Immunostaining identified that this compound induced UM-SCC-10A cell apoptosis but not necrosis. To explain the molecular mechanisms underlying its effects, flow cytometry and western blot analysis showed that the apoptosis was associated with cell cycle arrest during the G1 phase, up-regulation of p53 and p21, and down-regulation of cyclin D. Furthermore, our results revealed that induction of apoptosis through a mitochondrial pathway led to upregulation of pro-apoptotic protein expression (Bax), down-regulation of anti-apoptotic protein expression (Bcl-2), mitochondrial release of cytochrome c (Cyto c), reduction of mitochondrial membrane potential (MMP) and activation of caspase-3 (Casp-3). Involvement of the caspase apoptosis pathway was confirmed using caspase inhibitor Z-VAD-FMK pretreatment. Together, our findings suggest that isoalantolactone induced caspase-dependent apoptosis via a mitochondrial pathway and was associated with cell cycle arrest in the G1 phase in UM-SCC-10A cells. Therefore, isoalantolactone may become a potential drug for treating HNSCC.	[Wu, Minjun; Zhang, Hua; Weng, Zhiyong; Li, Chenyuan; Li, Hong; Zhao, Yan; Mei, Xifan; Ren, Fu; Li, Lihua] Liaoning Med Univ, Dept Cell Biol & Anat, Jinzhou, Peoples R China; [Hu, Jiehua] Naval Univ, Educ Technol & Simulat Training Ctr, Tianjin, Peoples R China	Jinzhou Medical University; Wuhan Naval University of Engineering	Ren, F (corresponding author), Liaoning Med Univ, Dept Cell Biol & Anat, Jinzhou, Peoples R China.	renpu1970@hotmail.com; lilihua1018@sina.com		REN, Fu/0000-0003-4432-6320	National Natural Science Foundation of China [81200262]; Projects of Science and Technology of Liaoning [20121092]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Projects of Science and Technology of Liaoning	This work was supported by National Natural Science Foundation of China (No. 81200262), Projects of Science and Technology of Liaoning (No. 20121092). The funder of this study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bursch W, 2001, CELL DEATH DIFFER, V8, P569, DOI 10.1038/sj.cdd.4400852; Curado MP, 2009, CURR OPIN ONCOL, V21, P194, DOI 10.1097/CCO.0b013e32832a68ca; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Fujimoto K, 1999, INT J CANCER, V81, P637, DOI 10.1002/(SICI)1097-0215(19990517)81:4<637::AID-IJC21>3.0.CO;2-4; Gamet-Payrastre L, 2000, CANCER RES, V60, P1426; Gartel AL, 2002, MOL CANCER THER, V1, P639; Ghantous A, 2010, DRUG DISCOV TODAY, V15, P668, DOI 10.1016/j.drudis.2010.06.002; Hail N, 2005, APOPTOSIS, V10, P687, DOI 10.1007/s10495-005-0792-8; Hall B, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-45; Ji YB, 2011, EXP TOXICOL PATHOL, V63, P69, DOI 10.1016/j.etp.2009.09.010; Khan M, 2012, INT J BIOL SCI, V8, P533, DOI 10.7150/ijbs.3753; Konishi T, 2002, BIOL PHARM BULL, V25, P1370, DOI 10.1248/bpb.25.1370; Lawrence NJ, 2001, BIOORG MED CHEM LETT, V11, P429, DOI 10.1016/S0960-894X(00)00686-7; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Li Y, 2012, Z NATURFORSCH C, V67, P375; Lu YJ, 2007, TOXICOL IN VITRO, V21, P90, DOI 10.1016/j.tiv.2006.09.008; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Ogryzko VV, 1997, MOL CELL BIOL, V17, P4877, DOI 10.1128/MCB.17.8.4877; Orren DK, 1997, MOL BIOL CELL, V8, P1129, DOI 10.1091/mbc.8.6.1129; Pabla N, 2011, J CLIN INVEST, V121, P2709, DOI 10.1172/JCI45586; Pal HC, 2010, TOXICOL IN VITRO, V24, P1599, DOI 10.1016/j.tiv.2010.06.007; Roy A, 2008, MOL PHARMACOL, V74, P1292, DOI 10.1124/mol.108.050161; Schultz DR, 2003, SEMIN ARTHRITIS RHEU, V32, P345, DOI 10.1053/sarh.2003.50005; Shapiro GI, 1999, J CLIN INVEST, V104, P1645, DOI 10.1172/JCI9054; Tang HJ, 2006, GYNECOL ONCOL, V100, P308, DOI 10.1016/j.ygyno.2005.08.044; Toogood PL, 2002, CURR OPIN CHEM BIOL, V6, P472, DOI 10.1016/S1367-5931(02)00342-3; Torres K, 1998, CANCER RES, V58, P3620; Xie SQ, 2009, TOXICOLOGY, V263, P127, DOI 10.1016/j.tox.2009.07.001; Zhang Siyuan, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P239, DOI 10.2174/1568011053765976; Zhang YX, 2000, CANCER RES, V60, P2025; Zhang Z, 2002, CHEM RES TOXICOL, V15, P950, DOI 10.1021/tx0255018; Zhu HB, 2004, ONCOGENE, V23, P4984, DOI 10.1038/sj.onc.1207645; Zinkel S, 2006, CELL DEATH DIFFER, V13, P1351, DOI 10.1038/sj.cdd.4401987	33	73	77	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76000	10.1371/journal.pone.0076000	http://dx.doi.org/10.1371/journal.pone.0076000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098753	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500123
J	Yan, XP; Fan, C; Ma, J; Li, JH; Dong, DH; Wang, HH; Ma, F; Zheng, XL; Lv, Y				Yan, Xiaopeng; Fan, Chao; Ma, Jia; Li, Jianhui; Dong, Dinghui; Wang, Haohua; Ma, Feng; Zheng, Xinglong; Lv, Yi			Portacaval Shunt Established in Six Dogs Using Magnetic Compression Technique	PLOS ONE			English	Article							PORTAL-HYPERTENSION; VASCULAR ANASTOMOSIS; MANAGEMENT; SURGERY; MODEL; RINGS; TIPS	Background and Aims: Installing the transjugular intrahepatic portosystemic shunt for portal hypertension is relatively safe, but complications are still high. To explore a new method of portacaval shunt, the magnetic compression technique was introduced into the shunting procedure. Methods: A portal-inferior vena cava shunt was performed on 6 male mongrel dogs by two hemocompatible Nd-Fe-B permanent magnets, parent and daughter. The parent magnet was applied to the inferior vena cava guided by a catheter through the femoral vein. The daughter magnet was moved to the anastomosis position on the portal vein with a balloon catheter through the splenic vein. After the daughter magnet reached the target position, the two magnets acted to compress the vessel wall and hold it in place. Five to 7 days later, under X-ray guidance, the magnets were detached from the vessel wall with a rosch-uchida transjugular liver access set. One month later, histological analysis and portal venography were performed. Results: 5-7 days after the first surgery, a mild intimal hyperplasia in the portal vein and the inferior vena cava, and continuity of the vascular adventitia from the portal vein to the inferior vena cava as observed. During the second surgery, the contrast media could be observed flowing from the portal vein into the inferior vena cava. Portal venography revealed that the portosystemic shunt was still present one month after the second surgery. Conclusions: Magnamosis via a device of novel design was successfully used to establish a portacaval shunt in dogs.	[Yan, Xiaopeng; Fan, Chao; Ma, Jia; Dong, Dinghui; Zheng, Xinglong; Lv, Yi] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian 710049, Shaanxi Provinc, Peoples R China; [Fan, Chao] Fourth Mil Med Univ, Tangdu Hosp, Dept Gen Surg, Xian 710032, Shaanxi Provinc, Peoples R China; [Li, Jianhui] Xi An Jiao Tong Univ, Shaanxi Prov Peoples Hosp, Coll Med, Dept Surg Oncol,Affiliated Hosp 3, Xian 710049, Shaanxi Provinc, Peoples R China; [Yan, Xiaopeng; Ma, Jia; Li, Jianhui; Dong, Dinghui; Wang, Haohua; Ma, Feng; Zheng, Xinglong; Lv, Yi] Xi An Jiao Tong Univ, XJTU Res Inst Adv Surg Technol & Engn, Xian 710049, Shaanxi Provinc, Peoples R China	Xi'an Jiaotong University; Air Force Military Medical University; Xi'an Jiaotong University; Xi'an Medical University; Xi'an Jiaotong University	Lv, Y (corresponding author), Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian 710049, Shaanxi Provinc, Peoples R China.	luyi169@126.com	Yan, Xiaopeng/GWV-6620-2022		Ministry of Health Subordinates of China [2010105]; National Natural Science Foundation of China [30830099]	Ministry of Health Subordinates of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the Key Project of Clinical Discipline of Ministry of Health Subordinates of China (2010105) and the National Natural Science Foundation of China (30830099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2005, J AM COLL SURGEONS, V201, P965, DOI 10.1016/j.jamcollsurg.2005.06.255; Bari K, 2012, WORLD J GASTROENTERO, V18, P1166, DOI 10.3748/wjg.v18.i11.1166; Boyer TD, 2010, HEPATOLOGY, V51, P306, DOI 10.1002/hep.23383; Chattopadhyay S, 2012, HPB, V14, P441, DOI 10.1111/j.1477-2574.2012.00473.x; Colombato L, 2007, J CLIN GASTROENTEROL, V41, pS344, DOI 10.1097/MCG.0b013e318157e500; Cope C, 1999, J VASC INTERV RADIOL, V10, P1379, DOI 10.1016/S1051-0443(99)70248-4; Corbett C, 2012, LIVER INT; Dib N, 2006, CAN MED ASSOC J, V174, P1433, DOI 10.1503/cmaj.051700; Erdmann D, 2004, J VASC SURG, V40, P505, DOI 10.1016/j.jvs.2004.05.026; Fan C, 2012, HEPATOB PANCREAT DIS, V11, P81, DOI 10.1016/S1499-3872(11)60129-X; Gugig R, 2012, WORLD J GASTROENTERO, V18, P1176, DOI 10.3748/wjg.v18.i11.1176; Jing K, 2012, SURG INNOV; Kopelman D, 2007, EXPERT REV MED DEVIC, V4, P821, DOI 10.1586/17434440.4.6.821; OBORA Y, 1978, SURG NEUROL, V9, P117; Pomier-Layrargues G, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/167868; Procaccini NJ, 2009, GASTROINTEST ENDOSC, V70, P881, DOI 10.1016/j.gie.2009.03.1169; RAVITCH MM, 1978, AUST NZ J SURG, V48, P444, DOI 10.1111/j.1445-2197.1978.tb04899.x; Saxon RR, 2004, J VASC INTERV RADIOL, V15, P217, DOI 10.1097/01.RVI.0000116862.34422.A5; Shi Y, 2006, TRANSPL P, V38, P3070, DOI 10.1016/j.transproceed.2006.08.174; Zeebregts CJ, 2003, BRIT J SURG, V90, P261, DOI 10.1002/bjs.4063	20	25	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76873	10.1371/journal.pone.0076873	http://dx.doi.org/10.1371/journal.pone.0076873			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098809	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500180
J	Yan, ZQ; Wang, J				Yan, Zhiqiang; Wang, Jin			Optimizing Scoring Function of Protein-Nucleic Acid Interactions with Both Affinity and Specificity	PLOS ONE			English	Article							KNOWLEDGE-BASED POTENTIALS; COMPUTATIONAL REDESIGN; MEAN FORCE; BINDING-AFFINITY; ENERGY FUNCTION; DATA-BANK; DOCKING; DESIGN; LIGAND; RECOGNITION	Protein-nucleic acid (protein-DNA and protein-RNA) recognition is fundamental to the regulation of gene expression. Determination of the structures of the protein-nucleic acid recognition and insight into their interactions at molecular level are vital to understanding the regulation function. Recently, quantitative computational approach has been becoming an alternative of experimental technique for predicting the structures and interactions of biomolecular recognition. However, the progress of protein-nucleic acid structure prediction, especially protein-RNA, is far behind that of the protein-ligand and protein-protein structure predictions due to the lack of reliable and accurate scoring function for quantifying the protein-nucleic acid interactions. In this work, we developed an accurate scoring function (named as SPA-PN, SPecificity and Affinity of the Protein-Nucleic acid interactions) for protein-nucleic acid interactions by incorporating both the specificity and affinity into the optimization strategy. Specificity and affinity are two requirements of highly efficient and specific biomolecular recognition. Previous quantitative descriptions of the biomolecular interactions considered the affinity, but often ignored the specificity owing to the challenge of specificity quantification. We applied our concept of intrinsic specificity to connect the conventional specificity, which circumvents the challenge of specificity quantification. In addition to the affinity optimization, we incorporated the quantified intrinsic specificity into the optimization strategy of SPA-PN. The testing results and comparisons with other scoring functions validated that SPA-PN performs well on both the prediction of binding affinity and identification of native conformation. In terms of its performance, SPA-PN can be widely used to predict the protein-nucleic acid structures and quantify their interactions.	[Yan, Zhiqiang; Wang, Jin] SUNY Stony Brook, Dept Chem & Phys, Stony Brook, NY 11794 USA; [Yan, Zhiqiang; Wang, Jin] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS	Wang, J (corresponding author), SUNY Stony Brook, Dept Chem & Phys, Stony Brook, NY 11794 USA.	jin.wang.1@stonybrook.edu	Yan, Zhiqiang/AAI-2187-2019	Yan, Zhiqiang/0000-0003-3865-3229	National Science Foundation [0947767, 0926287]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation (grant numbers 0947767,0926287). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Bahadur RP, 2008, NUCLEIC ACIDS RES, V36, P2705, DOI 10.1093/nar/gkn102; Barik A, 2012, PROTEINS, V80, P1866, DOI 10.1002/prot.24083; Bolon DN, 2005, P NATL ACAD SCI USA, V102, P12724, DOI 10.1073/pnas.0506124102; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Bujalowski W, 2006, CHEM REV, V106, P556, DOI 10.1021/cr040462l; Bustamante C, 2011, CELL, V144, P480, DOI 10.1016/j.cell.2011.01.033; Chaudhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022477; Chiu W, 2006, TRENDS CELL BIOL, V16, P144, DOI 10.1016/j.tcb.2006.01.002; CLARK M, 1989, J COMPUT CHEM, V10, P982, DOI 10.1002/jcc.540100804; Dominy BN, 2004, J MED CHEM, V47, P4538, DOI 10.1021/jm0498046; Donald JE, 2007, NUCLEIC ACIDS RES, V35, P1039, DOI 10.1093/nar/gkl1103; Dutta S, 2005, STRUCTURE, V13, P381, DOI 10.1016/j.str.2005.01.008; Fleishman SJ, 2012, CELL, V149, P262, DOI 10.1016/j.cell.2012.03.016; GOLDSTEIN RA, 1992, P NATL ACAD SCI USA, V89, P4918, DOI 10.1073/pnas.89.11.4918; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Guha R, 2006, J CHEM INF MODEL, V46, P991, DOI 10.1021/ci050400b; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; Huang SY, 2008, PROTEINS, V72, P557, DOI 10.1002/prot.21949; Huang SY, 2010, PHYS CHEM CHEM PHYS, V12, P12899, DOI 10.1039/c0cp00151a; Janin J, 1996, PROTEINS, V25, P438, DOI 10.1002/(SICI)1097-0134(199608)25:4<438::AID-PROT4>3.3.CO;2-1; Janin J, 2002, PROTEINS, V47, P257, DOI 10.1002/prot.10111; JANIN J, 1995, BIOCHIMIE, V77, P497, DOI 10.1016/0300-9084(96)88166-1; Janin J, 2010, PROTEINS, V78, P3067, DOI 10.1002/prot.22774; Jiang L, 2002, PROTEINS, V46, P190, DOI 10.1002/prot.10031; Kirsanov DD, 2013, NUCLEIC ACIDS RES, V41, pD517, DOI 10.1093/nar/gks1199; Koppensteiner WA, 1998, BIOCHEMISTRY-MOSCOW+, V63, P247; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; Levy Y, 2004, P NATL ACAD SCI USA, V101, P511, DOI 10.1073/pnas.2534828100; Liu ZJ, 2005, NUCLEIC ACIDS RES, V33, P546, DOI 10.1093/nar/gki204; Liu ZJ, 2004, J AM CHEM SOC, V126, P8515, DOI 10.1021/ja032018q; Lu Q, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.128105; Luscombe NM, 2000, GENOME BIOL, V1; Miller DW, 1997, PROTEIN SCI, V6, P2166; Muegge I, 1999, J MED CHEM, V42, P791, DOI 10.1021/jm980536j; Norambuena T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-262; Perez-Cano L, 2012, PROTEINS, V80, P1872, DOI 10.1002/prot.24075; Pommier Yves, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P421; Rejto PA, 1996, P NATL ACAD SCI USA, V93, P8945, DOI 10.1073/pnas.93.17.8945; Ritchie DW, 2008, CURR PROTEIN PEPT SC, V9, P1, DOI 10.2174/138920308783565741; Rose PW, 2011, NUCLEIC ACIDS RES, V39, pD392, DOI 10.1093/nar/gkq1021; Saven JG, 2011, CURR OPIN CHEM BIOL, V15, P452, DOI 10.1016/j.cbpa.2011.03.014; Shifman JM, 2003, P NATL ACAD SCI USA, V100, P13274, DOI 10.1073/pnas.2234277100; SIPPL MJ, 1990, J MOL BIOL, V213, P859, DOI 10.1016/S0022-2836(05)80269-4; Spirin S, 2007, BIOINFORMATICS, V23, P3247, DOI 10.1093/bioinformatics/btm519; Steven AC, 2008, J STRUCT BIOL, V163, P186, DOI 10.1016/j.jsb.2008.06.002; Su Y, 2009, PROTEIN SCI, V18, P2550, DOI 10.1002/pro.257; Thomas PD, 1996, J MOL BIOL, V257, P457, DOI 10.1006/jmbi.1996.0175; Thomas PD, 1996, P NATL ACAD SCI USA, V93, P11628, DOI 10.1073/pnas.93.21.11628; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; Uil TG, 2003, NUCLEIC ACIDS RES, V31, P6064, DOI 10.1093/nar/gkg815; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; van Dijk M, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn386; Wall M. E., 2012, QUANTITATIVE BIOL MO; Wang J, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.188101; Wang J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.198101; Wang W, 2001, ANNU REV BIOPH BIOM, V30, P211, DOI 10.1146/annurev.biophys.30.1.211; Xu BS, 2009, PROTEINS, V76, P718, DOI 10.1002/prot.22384; Yan ZQ, 2013, CHEM SCI, V4, P2387, DOI 10.1039/c3sc50478f; Yan ZQ, 2013, BIOINFORMATICS, V29, P1127, DOI 10.1093/bioinformatics/btt121; Yan ZQ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00309; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178; Zhang C, 2005, J MED CHEM, V48, P2325, DOI 10.1021/jm049314d	64	16	16	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74443	10.1371/journal.pone.0074443	http://dx.doi.org/10.1371/journal.pone.0074443			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098651	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500022
J	Zhu, XY; Yang, ZY				Zhu, Xiaoyuan; Yang, Zhiyong			Multi-Scale Spatial Concatenations of Local Features in Natural Scenes and Scene Classification	PLOS ONE			English	Article							REPRESENTATIONS; STATISTICS; SHAPE; PERCEPTION; IMAGES; CORTEX; MODEL; V2	How does the visual system encode natural scenes? What are the basic structures of natural scenes? In current models of scene perception, there are two broad feature representations, global and local representations. Both representations are useful and have some successes; however, many observations on human scene perception seem to point to an intermediate-level representation. In this paper, we proposed natural scene structures, i.e., multi-scale spatial concatenations of local features, as an intermediate-level representation of natural scenes. To compile the natural scene structures, we first sampled a large number of multi-scale circular scene patches in a hexagonal configuration. We then performed independent component analysis on the patches and classified the independent components into a set of clusters using the K-means method. Finally, we obtained a set of natural scene structures, each of which is characterized by a set of dominant clusters of independent components. We examined a range of statistics of the natural scene structures, compiled from two widely used datasets of natural scenes, and modeled their spatial arrangements at larger spatial scales using adjacency matrices. We found that the natural scene structures include a full range of concatenations of visual features in natural scenes, and can be used to encode spatial information at various scales. We then selected a set of natural scene structures with high information, and used the occurring frequencies and the eigenvalues of the adjacency matrices to classify scenes in the datasets. We found that the performance of this model is comparable to or better than the state-of-the-art models on the two datasets. These results suggest that the natural scene structures are a useful intermediate-level representation of visual scenes for our understanding of natural scene perception.	[Zhu, Xiaoyuan; Yang, Zhiyong] Georgia Regents Univ, Brain & Behav Discovery Inst, Augusta, GA USA; [Yang, Zhiyong] Georgia Regents Univ, James & Jean Culver Vis Discovery Inst, Augusta, GA USA; [Yang, Zhiyong] Georgia Regents Univ, Dept Ophthalmol, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Yang, ZY (corresponding author), Georgia Regents Univ, Brain & Behav Discovery Inst, Augusta, GA USA.	zhyang@gru.edu			Culver Vision Discovery Institute/GRU; Knights Templar Education Foundation	Culver Vision Discovery Institute/GRU; Knights Templar Education Foundation	This material is based upon work supported by, or in part by, a pilot award from the Culver Vision Discovery Institute/GRU and a pilot award from the Knights Templar Education Foundation (all to ZY). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzai A, 2007, NAT NEUROSCI, V10, P1313, DOI 10.1038/nn1975; Bay H, 2008, COMPUT VIS IMAGE UND, V110, P346, DOI 10.1016/j.cviu.2007.09.014; Berkes P, 2005, J VISION, V5, P579, DOI 10.1167/5.6.9; Bosch A., 2007, P 6 ACM INT C IM VID, V5, P401, DOI [10.1145/1282280.1282340, DOI 10.1145/1282280, DOI 10.1145/1282280.1282340]; BOUREAU YL, 2010, PROC CVPR IEEE, P2559, DOI DOI 10.1109/CVPR.2010.5539963; Brady TF, 2008, P NATL ACAD SCI USA, V105, P14325, DOI 10.1073/pnas.0803390105; Cadieu CF, 2012, NEURAL COMPUT, V24, P827, DOI 10.1162/NECO_a_00247; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen XD, 2007, P NATL ACAD SCI USA, V104, P19120, DOI 10.1073/pnas.0706938104; Cvetkovic DM, 1995, SPECTRA GRAPHS; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; DiMattina C, 2012, J VISION, V12, DOI 10.1167/12.13.15; Dixit M, 2011, PROC CVPR IEEE, P937, DOI 10.1109/CVPR.2011.5995674; Elder JH, 2002, J VISION, V2, DOI 10.1167/2.4.5; Fei-Fei L, 2005, PROC CVPR IEEE, P524; FIELD DJ, 1994, NEURAL COMPUT, V6, P559, DOI 10.1162/neco.1994.6.4.559; Geisler WS, 2008, ANNU REV PSYCHOL, V59, P167, DOI 10.1146/annurev.psych.58.110405.085632; Geisler WS, 2009, VISUAL NEUROSCI, V26, P1, DOI 10.1017/S0952523808081005; Geisler WS, 2001, VISION RES, V41, P711, DOI 10.1016/S0042-6989(00)00277-7; He XF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020002; Hegde J, 2008, CURR BIOL, V18, P597, DOI 10.1016/j.cub.2008.03.058; Hegde J, 2007, CEREB CORTEX, V17, P1100, DOI 10.1093/cercor/bhl020; Huang TK, 2006, J MACH LEARN RES, V7, P85; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Karklin Y, 2009, NATURE, V457, P83, DOI 10.1038/nature07481; Kourtzi Zoe, 2011, Annu Rev Neurosci, V34, P45, DOI 10.1146/annurev-neuro-060909-153218; Kravitz DJ, 2013, TRENDS COGN SCI, V17, P26, DOI 10.1016/j.tics.2012.10.011; Kriegeskorte N, 2008, NEURON, V60, P1126, DOI 10.1016/j.neuron.2008.10.043; Lazebnik S., 2006, P IEEE INT C COMP VI, V2, P2169, DOI DOI 10.1109/CVPR.2006.68; Lee H., 2008, ADV NEURAL INFORM PR, V20, P873; Li L.-J., 2010, NEURAL INFORM PROCES, P1378; Li LW, 2007, 2007 ASIA-PACIFIC CONFERENCE ON APPLIED ELECTROMAGNETICS, PROCEEDINGS, P1; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Naselaris T, 2009, NEURON, V63, P902, DOI 10.1016/j.neuron.2009.09.006; Niu ZX, 2012, PROC CVPR IEEE, P2743, DOI 10.1109/CVPR.2012.6247997; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Pasupathy A, 2002, NAT NEUROSCI, V5, P1332, DOI 10.1038/nn972; Peelen MV, 2009, NATURE, V460, P94, DOI 10.1038/nature08103; Pinto N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000579; Roe AW, 2012, NEURON, V74, P12, DOI 10.1016/j.neuron.2012.03.011; Serre T, 2007, P NATL ACAD SCI USA, V104, P6424, DOI 10.1073/pnas.0700622104; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; STANDING L, 1973, Q J EXP PSYCHOL, V25, P207, DOI 10.1080/14640747308400340; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Tu ZW, 2005, INT J COMPUT VISION, V63, P113, DOI 10.1007/s11263-005-6642-x; Ullman S, 2002, NAT NEUROSCI, V5, P682, DOI 10.1038/nn870; van Dam ER, 2003, LINEAR ALGEBRA APPL, V373, P241, DOI 10.1016/S0024-3795(03)00483-X; Wu JX, 2011, IEEE T PATTERN ANAL, V33, P1489, DOI 10.1109/TPAMI.2010.224; Wu JR, 2009, CHINESE SCI BULL, V54, P1, DOI 10.1007/s11434-009-0027-4; Xu JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015796; Yang Jun, 2009, Proceedings of the 2009 2nd International Congress on Image and Signal Processing (CISP), DOI 10.1109/CISP.2009.5304123; Yang Z, 2012, VISUAL CORTEX CURREN, P201; Yang ZY, 2004, P NATL ACAD SCI USA, V101, P8745, DOI 10.1073/pnas.0402192101; Yang ZY, 2003, NETWORK-COMP NEURAL, V14, P371, DOI 10.1088/0954-898X/14/3/301; Yang ZY, 2003, NAT NEUROSCI, V6, P632, DOI 10.1038/nn1059; Zhang J, 2007, INT J COMPUT VISION, V73, P213, DOI 10.1007/s11263-006-9794-4; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046686	59	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76393	10.1371/journal.pone.0076393	http://dx.doi.org/10.1371/journal.pone.0076393			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098789	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500160
J	Gao, XG; Zhi, Y; Sun, L; Peng, XX; Zhang, T; Xue, HT; Tai, GH; Zhou, YF				Gao, Xiaoge; Zhi, Yuan; Sun, Lin; Peng, Xiaoxia; Zhang, Tao; Xue, Huiting; Tai, Guihua; Zhou, Yifa			The Inhibitory Effects of a Rhamnogalacturonan I (RG-I) Domain from Ginseng Pectin on Galectin-3 and Its Structure-Activity Relationship	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate-binding Protein; Carbohydrate Structure; Galectin; Oligosaccharide; Polysaccharide; Galectin-3 Inhibitors; Ginseng Pectin; Rhamnogalacturonan I; Structure-Activity Relationship	CARBOHYDRATE-RECOGNITION DOMAIN; PROSTATE-CANCER CELLS; HUMAN BREAST; METASTASIS; POLYSACCHARIDES; AGGREGATION; ACTIVATION; APOPTOSIS; GCS-100; LECTIN	Pectin has been shown to inhibit the actions of galectin-3, a -galactoside-binding protein associated with cancer progression. The structural features of pectin involved in this activity remain unclear. We investigated the effects of different ginseng pectins on galectin-3 action. The rhamnogalacturonan I-rich pectin fragment, RG-I-4, potently inhibited galectin-3-mediated hemagglutination, cancer cell adhesion and homotypic aggregation, and binding of galectin-3 to T-cells. RG-I-4 specifically bound to the carbohydrate recognition domain of galectin-3 with a dissociation constant of 22.2 nm, which was determined by surface plasmon resonance analysis. The structure-activity relationship of RG-I-4 was investigated by modifying the structure through various enzymatic and chemical methods followed by activity tests. The results showed that (a) galactan side chains were essential to the activity of RG-I-4, whereas arabinan side chains positively or negatively regulated the activity depending on their location within the RG-I-4 molecule. (b) The activity of galactan chain was proportional to its length up to 4 Gal residues and largely unchanged thereafter. (c) The majority of galactan side chains in RG-I-4 were short with low activities. (d) The high activity of RG-I-4 resulted from the cooperative action of these side chains. (e) The backbone of the molecule was very important to RG-I-4 activity, possibly by maintaining a structural conformation of the whole molecule. (f) The isolated backbone could bind galectin-3, which was insensitive to lactose treatment. The novel discovery that the side chains and backbone play distinct roles in regulating RG-I-4 activity is valuable for producing highly active pectin-based galectin-3 inhibitors.	[Gao, Xiaoge; Zhi, Yuan; Sun, Lin; Peng, Xiaoxia; Zhang, Tao; Xue, Huiting; Tai, Guihua; Zhou, Yifa] NE Normal Univ, Sch Life Sci, Changchun 130024, Peoples R China	Northeast Normal University - China	Tai, GH (corresponding author), NE Normal Univ, Sch Life Sci, Changchun 130024, Peoples R China.	taigh477@nenu.edu.cn; zhouyf383@nenu.edu.cn			National Natural Science Foundation of China [31370805, 31170770]; Chinese New Drug Creation and Manufacturing Program [2012ZX09502001-001]; Fundamental Research Funds for the Central Universities [12SSXM005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese New Drug Creation and Manufacturing Program; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China Grants 31370805 and 31170770, Chinese New Drug Creation and Manufacturing Program Grant 2012ZX09502001-001, and Fundamental Research Funds for the Central Universities Grant 12SSXM005.	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Argueso P, 2009, J BIOL CHEM, V284, P23037, DOI 10.1074/jbc.M109.033332; Bi HT, 2009, CARBOHYD RES, V344, P1254, DOI 10.1016/j.carres.2009.04.009; Chauhan D, 2005, CANCER RES, V65, P8350, DOI 10.1158/0008-5472.CAN-05-0163; Cheng HR, 2011, MED ONCOL, V28, P175, DOI 10.1007/s12032-010-9449-8; Clark MC, 2012, BLOOD, V120, P4635, DOI 10.1182/blood-2012-06-438234; Cumpstey I, 2005, ANGEW CHEM INT EDIT, V44, P5110, DOI 10.1002/anie.200500627; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Demotte N, 2010, CANCER RES, V70, P7476, DOI 10.1158/0008-5472.CAN-10-0761; Deng CH, 2009, CARBOHYD RES, V344, P1852, DOI 10.1016/j.carres.2008.11.011; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Fan YY, 2010, CARBOHYD POLYM, V81, P340, DOI 10.1016/j.carbpol.2010.02.028; Fukumori T, 2003, CANCER RES, V63, P8302; Fukumori T, 2007, DRUG RESIST UPDATE, V10, P101, DOI 10.1016/j.drup.2007.04.001; Gao X, 2012, PLOS ONE, V7; Gao XG, 2012, GLYCOCONJUGATE J, V29, P159, DOI 10.1007/s10719-012-9382-5; Glinsky VV, 2009, CARBOHYD RES, V344, P1788, DOI 10.1016/j.carres.2008.08.038; Glinsky VV, 2001, CANCER RES, V61, P4851; Glinsky VV, 2003, CANCER RES, V63, P3805; Gunning AP, 2009, FASEB J, V23, P415, DOI 10.1096/fj.08-106617; INOHARA H, 1994, GLYCOCONJUGATE J, V11, P527, DOI 10.1007/BF00731303; Iurisci I, 2000, CLIN CANCER RES, V6, P1389; John CM, 2003, CLIN CANCER RES, V9, P2374; LEVI G, 1981, J BIOL CHEM, V256, P5735; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Maxwell EG, 2012, TRENDS FOOD SCI TECH, V24, P64, DOI 10.1016/j.tifs.2011.11.002; Nangia-Makker P, 2002, JNCI-J NATL CANCER I, V94, P1854, DOI 10.1093/jnci/94.24.1854; Nangia-Makker P, 2000, AM J PATHOL, V156, P899, DOI 10.1016/S0002-9440(10)64959-0; Obro J, 2004, PHYTOCHEMISTRY, V65, P1429, DOI 10.1016/j.phytochem.2004.05.002; PIENTA KJ, 1995, J NATL CANCER I, V87, P348, DOI 10.1093/jnci/87.5.348; PLATT D, 1992, J NATL CANCER I, V84, P438, DOI 10.1093/jnci/84.6.438; Rabinovich GA, 2006, GLYCOBIOLOGY, V16, P210, DOI 10.1093/glycob/cwj056; Sathisha UV, 2007, GLYCOCONJUGATE J, V24, P497, DOI 10.1007/s10719-007-9042-3; Seetharaman J, 1998, J BIOL CHEM, V273, P13047, DOI 10.1074/jbc.273.21.13047; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Streetly MJ, 2010, BLOOD, V115, P3939, DOI 10.1182/blood-2009-10-251660; Tejler J, 2007, CARBOHYD RES, V342, P1869, DOI 10.1016/j.carres.2007.03.012; Thijssen VLJL, 2007, BLOOD, V110, P2819, DOI 10.1182/blood-2007-03-077792; Vayssade M, 2010, PHYTOTHER RES, V24, P982, DOI 10.1002/ptr.3040; Wang Y, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.79; Yu L, 2011, PLANTA, V234, P487, DOI 10.1007/s00425-011-1417-9; Yu L, 2010, CARBOHYD POLYM, V79, P811, DOI 10.1016/j.carbpol.2009.08.028; Zhang X, 2009, CARBOHYD POLYM, V77, P544, DOI 10.1016/j.carbpol.2009.01.034; Zou J, 2005, CARCINOGENESIS, V26, P309, DOI 10.1093/carcin/bgh329	44	87	94	7	79	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33953	33965		10.1074/jbc.M113.482315	http://dx.doi.org/10.1074/jbc.M113.482315			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24100038	Green Published, hybrid			2022-12-25	WOS:000327250200037
J	Merrins, MJ; Van Dyke, AR; Mapp, AK; Rizzo, MA; Satin, LS				Merrins, Matthew J.; Van Dyke, Aaron R.; Mapp, Anna K.; Rizzo, Mark A.; Satin, Leslie S.			Direct Measurements of Oscillatory Glycolysis in Pancreatic Islet beta-Cells Using Novel Fluorescence Resonance Energy Transfer (FRET) Biosensors for Pyruvate Kinase M2 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Beta Cell; Flavin; Fluorescence Resonance Energy Transfer (FRET); Glycolysis; Mitochondrial Metabolism; NADH; Pancreatic Islets	METABOLIC OSCILLATIONS; FREE CA2+; OXYGEN-CONSUMPTION; INSULIN-SECRETION; PULSATILE INSULIN; YEAST-CELLS; GLUCOSE; MECHANISMS; CALCIUM; NAD(P)H	Background: Pyruvate kinase M2 controls glycolytic efflux. Results: Novel FRET sensors report PKM2 structural changes in response to activation by metabolites and phosphorylation events in pancreatic -cells. Conclusion: PKM2 activity is oscillatory and synchronized between islet -cells. Significance: This approach is broadly applicable for measuring pyruvate kinase M2 activity in living cells. Pulses of insulin released from pancreatic -cells maintain blood glucose in a narrow range, although the source of these pulses is unclear. We and others have proposed that positive feedback mediated by the glycolytic enzyme phosphofructokinase-1 (PFK1) enables -cells to generate metabolic oscillations via autocatalytic activation by its product fructose 1,6-bisphosphate (FBP). Although much indirect evidence has accumulated in favor of this hypothesis, a direct measurement of oscillating glycolytic intermediates has been lacking. To probe glycolysis directly, we engineered a family of inter- and intramolecular FRET biosensors based on the glycolytic enzyme pyruvate kinase M2 (PKAR; pyruvate kinase activity reporter), which multimerizes and is activated upon binding FBP. When introduced into Min6 -cells, PKAR FRET efficiency increased rapidly in response to glucose. Importantly, however, metabolites entering downstream of PFK1 (glyceraldehyde, pyruvate, and ketoisocaproate) failed to activate PKAR, consistent with sensor activation by FBP; the dependence of PKAR on FBP was further confirmed using purified sensor in vitro. Using a novel imaging modality for monitoring mitochondrial flavin fluorescence in mouse islets, we show that slow oscillations in mitochondrial redox potential stimulated by 10 mm glucose are in phase with glycolytic efflux through PKM2, measured simultaneously from neighboring islet -cells expressing PKAR. These results indicate that PKM2 activity in -cells is oscillatory and are consistent with pulsatile PFK1 being the mediator of slow glycolytic oscillations.	[Merrins, Matthew J.; Satin, Leslie S.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48105 USA; [Merrins, Matthew J.; Satin, Leslie S.] Univ Michigan, Sch Med, Brehm Ctr Diabet Res, Ann Arbor, MI 48105 USA; [Van Dyke, Aaron R.] Univ Michigan, Dept Chem, Ann Arbor, MI 48105 USA; [Mapp, Anna K.; Rizzo, Mark A.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University System of Maryland; University of Maryland Baltimore	Satin, LS (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48105 USA.	lsatin@umich.edu	, Dr Anna Mapp/GPX-8261-2022	Merrins, Matthew J./0000-0003-1599-9227	National Institutes of Health [R01DK46409, F32DK085960]; University of Michigan Diabetes Research and Training Center [5P60 DK-20572]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK046409, P60DK020572, F32DK085960] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Diabetes Research and Training Center(University of Michigan System); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK46409 (to L. S. S.) and F32DK085960 (to M. J. M.). Additional support was provided by Dr. Steve Lentz and the Morphology and the Image Analysis Core of the University of Michigan Diabetes Research and Training Center (5P60 DK-20572).	Allali-Hassani A, 2009, BIOCHEM J, V424, P15, DOI 10.1042/BJ20090723; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; ASHIZAWA K, 1991, J BIOL CHEM, V266, P16842; Benninger RKP, 2008, BIOPHYS J, V95, P5048, DOI 10.1529/biophysj.108.140863; Bertram R, 2004, BIOPHYS J, V87, P3074, DOI 10.1529/biophysj.104.049262; Bertram R, 2007, AM J PHYSIOL-ENDOC M, V293, pE890, DOI 10.1152/ajpendo.00359.2007; Bertram R, 2009, ISLETS, V1, P87, DOI 10.4161/isl.1.2.9109; BETZ A, 1965, ARCH BIOCHEM BIOPHYS, V109, P585, DOI 10.1016/0003-9861(65)90404-2; BRATUSCHMARRAIN PR, 1986, DIABETES, V35, P922, DOI 10.2337/diabetes.35.8.922; CHANCE B, 1979, J BIOL CHEM, V254, P4764; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; CHATTERTON TA, 1982, BIOCHEM J, V204, P605, DOI 10.1042/bj2040605; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Civelek VN, 1996, BIOCHEM J, V318, P615, DOI 10.1042/bj3180615; Dahgren GM, 2005, BBA-GEN SUBJECTS, V1724, P23, DOI 10.1016/j.bbagen.2005.04.007; Depry C., 2010, CURR PROTOC MOL BIOL, V18; Ewald JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028245; Fridlyand LE, 2009, BIOPHYS J, V96, P3126, DOI 10.1016/j.bpj.2009.01.029; Fridlyand LE, 2005, AM J PHYSIOL-ENDOC M, V289, pE839, DOI 10.1152/ajpendo.00595.2004; Fridlyand LE, 2003, AM J PHYSIOL-ENDOC M, V285, pE138, DOI 10.1152/ajpendo.00194.2002; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; GILON P, 1993, J BIOL CHEM, V268, P22265; Heart E, 2007, AM J PHYSIOL-ENDOC M, V292, pE1295, DOI 10.1152/ajpendo.00648.2006; Heart E, 2007, BIOCHEM J, V403, P197, DOI 10.1042/BJ20061209; HESS B, 1971, ANNU REV BIOCHEM, V40, P237, DOI 10.1146/annurev.bi.40.070171.001321; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Hou BH, 2011, NAT PROTOC, V6, P1818, DOI 10.1038/nprot.2011.392; Ikeda Y, 1998, J BIOL CHEM, V273, P12227, DOI 10.1074/jbc.273.20.12227; Jung SK, 2000, J BIOL CHEM, V275, P6642, DOI 10.1074/jbc.275.9.6642; Jung SK, 1999, BIOCHEM BIOPH RES CO, V259, P331, DOI 10.1006/bbrc.1999.0784; KEIZER J, 1989, BIOPHYS J, V56, P229, DOI 10.1016/S0006-3495(89)82669-4; Kennedy RT, 2002, DIABETES, V51, pS152, DOI 10.2337/diabetes.51.2007.S152; Koushik SV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008031; Li J, 2013, DIABETOLOGIA, V56, P1577, DOI 10.1007/s00125-013-2894-0; LONGO EA, 1991, J BIOL CHEM, V266, P9314; Luciani DS, 2006, J PHYSIOL-LONDON, V572, P379, DOI 10.1113/jphysiol.2005.101766; MacDonald MJ, 2003, J BIOL CHEM, V278, P51894, DOI 10.1074/jbc.M309038200; MACDONALD MJ, 1985, MOL CELL BIOCHEM, V68, P115; MacDonald MJ, 1997, DIABETES, V46, P1996, DOI 10.2337/diabetes.46.12.1996; Markwardt ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017896; Martens GA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014214; Matveyenko AV, 2012, DIABETES, V61, P2269, DOI 10.2337/db11-1462; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; Meier JJ, 2005, DIABETES, V54, P1649, DOI 10.2337/diabetes.54.6.1649; Menge BA, 2011, DIABETES, V60, P2160, DOI 10.2337/db11-0251; Merrins MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034036; Merrins MJ, 2010, BIOPHYS J, V99, P76, DOI 10.1016/j.bpj.2010.04.012; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Morgan HP, 2013, P NATL ACAD SCI USA, V110, P5881, DOI 10.1073/pnas.1217157110; Nilsson T, 1996, BIOCHEM J, V314, P91, DOI 10.1042/bj3140091; Nunemaker CS, 2005, DIABETES, V54, P3517, DOI 10.2337/diabetes.54.12.3517; Nunemaker CS, 2004, ENDOCRINE, V25, P61, DOI 10.1385/ENDO:25:1:61; ORAHILLY S, 1988, NEW ENGL J MED, V318, P1225, DOI 10.1056/NEJM198805123181902; Patterson GH, 2000, P NATL ACAD SCI USA, V97, P5203, DOI 10.1073/pnas.090098797; Quesada I, 2006, BIOPHYS J, V90, P2641, DOI 10.1529/biophysj.105.069906; Ravier MA, 2011, DIABETES, V60, P2533, DOI 10.2337/db10-1543; Richard P, 2003, FEMS MICROBIOL REV, V27, P547, DOI 10.1016/S0168-6445(03)00065-2; RICHARD P, 1994, FEBS LETT, V341, P223, DOI 10.1016/0014-5793(94)80461-3; Rizzo MA, 2005, BIOPHYS J, V88, pL14, DOI 10.1529/biophysj.104.055442; Rocheleau JV, 2004, J BIOL CHEM, V279, P31780, DOI 10.1074/jbc.M314005200; San Martin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057712; SCHNECKENBURGER H, 1992, J HISTOCHEM CYTOCHEM, V40, P1573, DOI 10.1177/40.10.1527376; TORNHEIM K, 1979, J THEOR BIOL, V79, P491, DOI 10.1016/0022-5193(79)90240-6; TORNHEIM K, 1991, J BIOL CHEM, V266, P15675; TORNHEIM K, 1988, J BIOL CHEM, V263, P2619; Tornheim K, 1997, DIABETES, V46, P1375, DOI 10.2337/diabetes.46.9.1375; Yamada K, 1999, BIOCHEM J, V337, P1, DOI 10.1042/0264-6021:3370001	69	56	56	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33312	33322		10.1074/jbc.M113.508127	http://dx.doi.org/10.1074/jbc.M113.508127			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24100037	Green Published, hybrid			2022-12-25	WOS:000328841700045
J	Kosugi, S; Natsume, S; Yoshida, K; MacLean, D; Cano, L; Kamoun, S; Terauchi, R				Kosugi, Shunichi; Natsume, Satoshi; Yoshida, Kentaro; MacLean, Daniel; Cano, Liliana; Kamoun, Sophien; Terauchi, Ryohei			Coval: Improving Alignment Quality and Variant Calling Accuracy for Next-Generation Sequencing Data	PLOS ONE			English	Article							END SHORT READS; SNP DISCOVERY; MOLECULAR-SPECTRUM; HUMAN GENOME; DNA; GENOTYPE; BREAKPOINTS; MUTATIONS; DELETIONS; COVERAGE	Accurate identification of DNA polymorphisms using next-generation sequencing technology is challenging because of a high rate of sequencing error and incorrect mapping of reads to reference genomes. Currently available short read aligners and DNA variant callers suffer from these problems. We developed the Coval software to improve the quality of short read alignments. Coval is designed to minimize the incidence of spurious alignment of short reads, by filtering mismatched reads that remained in alignments after local realignment and error correction of mismatched reads. The error correction is executed based on the base quality and allele frequency at the non-reference positions for an individual or pooled sample. We demonstrated the utility of Coval by applying it to simulated genomes and experimentally obtained short-read data of rice, nematode, and mouse. Moreover, we found an unexpectedly large number of incorrectly mapped reads in 'targeted' alignments, where the whole genome sequencing reads had been aligned to a local genomic segment, and showed that Coval effectively eliminated such spurious alignments. We conclude that Coval significantly improves the quality of short-read sequence alignments, thereby increasing the calling accuracy of currently available tools for SNP and indel identification.	[Kosugi, Shunichi; Natsume, Satoshi; Yoshida, Kentaro; Terauchi, Ryohei] Iwate Biotechnol Res Ctr, Kitakami, Iwate, Japan; [Kosugi, Shunichi] Kazusa DNA Res Inst, Chiba, Japan; [MacLean, Daniel; Cano, Liliana; Kamoun, Sophien] Sainsbury Lab, Norwich, Norfolk, England	Iwate Biotechnology Research Center; Kazusa DNA Research Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Kosugi, S (corresponding author), Iwate Biotechnol Res Ctr, Kitakami, Iwate, Japan.	skosugi@kazusa.or.jp; terauchi@ibrc.or.jp	Kamoun, Sophien/B-3529-2009; Cano, Liliana M/O-7041-2016; Terauchi, Ryohei/Y-2992-2019; MacLean, Dan/C-7046-2013	Kamoun, Sophien/0000-0002-0290-0315; Cano, Liliana M/0000-0002-7996-4181; Terauchi, Ryohei/0000-0002-0095-4651; Kosugi, Shunichi/0000-0002-5882-9255; MacLean, Dan/0000-0003-1032-0887; Yoshida, Kentaro/0000-0002-3614-1759	Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Ministry of Agriculture, Forestry, and Fisheries of Japan; Ministry of Education, Cultures, Sports and Technology, Japan [23113009]; JSPS KAKENHI [22510217]; Gatsby Charitable Foundation; Grants-in-Aid for Scientific Research [22510217] Funding Source: KAKEN	Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Ministry of Education, Cultures, Sports and Technology, Japan; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Gatsby Charitable Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN), the Ministry of Agriculture, Forestry, and Fisheries of Japan and Grant-in-aid for Scientific Research from the Ministry of Education, Cultures, Sports and Technology, Japan to RT (Grant-in-Aid for Scientific Research on Innovative Areas 23113009) and by JSPS KAKENHI Grant Number 22510217. LC, DM, and S. Kamoun were supported by the Gatsby Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Abyzov A, 2011, BIOINFORMATICS, V27, P595, DOI 10.1093/bioinformatics/btq713; Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Chan EY, 2009, METHODS MOL BIOL, V578, P95, DOI 10.1007/978-1-60327-411-1_5; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Druley TE, 2009, NAT METHODS, V6, P263, DOI [10.1038/NMETH.1307, 10.1038/nmeth.1307]; Fujimoto A, 2010, NAT GENET, V42, P931, DOI 10.1038/ng.691; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Goya R, 2010, BIOINFORMATICS, V26, P730, DOI 10.1093/bioinformatics/btq040; Grimm D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-132; Homer N, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r99; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Hu X, 2012, BIOINFORMATICS; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r134; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Liu Q, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S8; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Malhis N, 2010, BIOINFORMATICS, V26, P1029, DOI 10.1093/bioinformatics/btq092; Martin ER, 2010, BIOINFORMATICS, V26, P2803, DOI 10.1093/bioinformatics/btq526; Miyao A, 2012, PLANT CELL PHYSIOL, V53, P256, DOI 10.1093/pcp/pcr172; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Reumers J, 2012, NAT BIOTECHNOL, V30, P61, DOI 10.1038/nbt.2053; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Shen YF, 2010, GENOME RES, V20, P273, DOI 10.1101/gr.096388.109; Simola DF, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r55; Smeds L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026314; Smith AD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-128; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; You N, 2012, BIOINFORMATICS, V28, P643, DOI 10.1093/bioinformatics/bts001; Zhang J, 2011, BIOINFORMATICS, V27, P3228, DOI 10.1093/bioinformatics/btr563; Zhang Y, 2013, BIOINFORMATICS, V29, P878, DOI 10.1093/bioinformatics/btt065; Zhao Z, 2002, GENOME RES, V12, P1679, DOI 10.1101/gr.287302	45	45	46	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75402	10.1371/journal.pone.0075402	http://dx.doi.org/10.1371/journal.pone.0075402			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116042	Green Published, gold, Green Submitted			2022-12-25	WOS:000325552200021
J	Lei, KF; Chen, KH; Tsui, PH; Tsang, NM				Lei, Kin Fong; Chen, Kuan-Hao; Tsui, Po-Hsiang; Tsang, Ngan-Ming			Real-Time Electrical Impedimetric Monitoring of Blood Coagulation Process under Temperature and Hematocrit Variations Conducted in a Microfluidic Chip	PLOS ONE			English	Article							IMPEDANCE; SYSTEM; DEVICE; CASCADE; DESIGN; POINT	Blood coagulation is an extremely complicated and dynamic physiological process. Monitoring of blood coagulation is essential to predict the risk of hemorrhage and thrombosis during cardiac surgical procedures. In this study, a high throughput microfluidic chip has been developed for the investigation of the blood coagulation process under temperature and hematocrit variations. Electrical impedance of the whole blood was continuously recorded by on-chip electrodes in contact with the blood sample during coagulation. Analysis of the impedance change of the blood was conducted to investigate the characteristics of blood coagulation process and the starting time of blood coagulation was defined. The study of blood coagulation time under temperature and hematocrit variations was shown a good agreement with results in the previous clinical reports. The electrical impedance measurement for the definition of blood coagulation process provides a fast and easy measurement technique. The microfluidic chip was shown to be a sensitive and promising device for monitoring blood coagulation process even in a variety of conditions. It is found valuable for the development of point-of-care coagulation testing devices that utilizes whole blood sample in microliter quantity.	[Lei, Kin Fong; Chen, Kuan-Hao] Chang Gung Univ, Grad Inst Med Mechatron, Tao Yuan, Taiwan; [Lei, Kin Fong] Chang Gung Univ, Dept Mech Engn, Tao Yuan, Taiwan; [Tsui, Po-Hsiang] Chang Gung Univ, Dept Med Imaging & Radiol Sci, Tao Yuan, Taiwan; [Tsang, Ngan-Ming] Chang Gung Univ, Sch Tradit Chinese Med, Tao Yuan, Taiwan; [Tsang, Ngan-Ming] Chang Gung Mem Hosp, Dept Radiat Oncol, Tao Yuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Lei, KF (corresponding author), Chang Gung Univ, Grad Inst Med Mechatron, Tao Yuan, Taiwan.	kflei@mail.cgu.edu.tw	Tsui, Po-Hsiang/AHE-7426-2022; Lei, Kin Fong/Q-8340-2018	Lei, Kin Fong/0000-0002-5356-2221; Tsui, Po-Hsiang/0000-0002-5604-1800	Chang Gung Memorial Hospital [CMRPD2B0011]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	Financial support came from Chang Gung Memorial Hospital (Project number: CMRPD2B0011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrus J. L., 1999, Journal of Medicine (Westbury), V30, P299; Andersson M, 2005, BIOSENS BIOELECTRON, V21, P79, DOI 10.1016/j.bios.2004.09.026; Berney H, 2008, ANALOG DIALOGUE, P42; Bhattacharyya A, 2007, BIOMED MICRODEVICES, V9, P245, DOI 10.1007/s10544-006-9026-2; BLAIR SD, 1987, CLIN LAB HAEMATOL, V9, P91; Burns MA, 1998, SCIENCE, V282, P484, DOI 10.1126/science.282.5388.484; CARPENTER GP, 1994, P SOC PHOTO-OPT INS, V2136, P205, DOI 10.1117/12.180788; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; DEVRIES PMJM, 1993, MED BIOL ENG COMPUT, V31, P445, DOI 10.1007/BF02441978; Diercks AH, 2009, ANAL BIOCHEM, V386, P30, DOI 10.1016/j.ab.2008.12.012; Erickson D, 2004, ANAL CHEM, V76, P7269, DOI 10.1021/ac049396d; Fricke H, 1925, J GEN PHYSIOL, V9, P153, DOI 10.1085/jgp.9.2.153; Glawdel T, 2009, MECH RES COMMUN, V36, P75, DOI 10.1016/j.mechrescom.2008.06.015; HARRISON DJ, 1993, SCIENCE, V261, P895, DOI 10.1126/science.261.5123.895; Huang CC, 2006, JPN J APPL PHYS 1, V45, P7191, DOI 10.1143/JJAP.45.7191; LANGDELL RD, 1953, J LAB CLIN MED, V41, P637; Lei KF, 2012, JALA-J LAB AUTOM, V17, P330, DOI 10.1177/2211068212454853; Lei KF, 2012, MICROELECTRON ENG, V91, P174, DOI 10.1016/j.mee.2011.10.002; Lei KF, 2012, MICROFLUID NANOFLUID, V12, P117, DOI 10.1007/s10404-011-0854-x; Lei KF, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/10/105802; Lemaire P, 2009, PROCEDIA CHEM, V1, P521, DOI 10.1016/j.proche.2009.07.130; Maasrani M, 1997, MED BIOL ENG COMPUT, V35, P167, DOI 10.1007/BF02530032; Melin J, 2007, ANNU REV BIOPH BIOM, V36, P213, DOI 10.1146/annurev.biophys.36.040306.132646; Metref L., 2009, Micro and Nanosystems, V1, P41, DOI 10.2174/1876402910901010041; Murano G, 2000, BASIC CONCEPTS HEMOS; Puckett LG, 2003, BIOSENS BIOELECTRON, V18, P675, DOI 10.1016/S0956-5663(03)00033-2; Ramaswamy B, 2013, SENSOR ACTUAT B-CHEM, V180, P21, DOI 10.1016/j.snb.2011.11.031; ROSENTHAL RL, 1948, J LAB CLIN MED, V33, P1110; Schenone M, 2004, CURR OPIN HEMATOL, V11, P272, DOI 10.1097/01.moh.0000130308.37353.d4; SHUNG KP, 1975, IEEE T BIO-MED ENG, VBM22, P334, DOI 10.1109/TBME.1975.324454; Spence N, 2002, Br J Biomed Sci, V59, P223; Tefferi A, 2000, AM J MED, V109, P141, DOI 10.1016/S0002-9343(00)00449-6; UR A, 1970, NATURE, V226, P269, DOI 10.1038/226269a0; Ur A, 1970, Biomed Eng, V5, P342; Vander AJ, 2001, HUMAN PHYSL MECH BOD; Wang L, 2011, ANAL CHIM ACTA, V687, P12, DOI 10.1016/j.aca.2010.11.056; White GC, 2003, J THROMB HAEMOST, V1, P2267, DOI 10.1046/j.1538-7836.2003.00459.x; Wolberg AS, 2004, J TRAUMA, V56, P1221, DOI 10.1097/01.TA.0000064328.97941.FC; Zhao TX, 1996, J MED ENG TECHNOL, V20, P115, DOI 10.3109/03091909609008389; ZHAO TX, 1993, PHYSIOL MEAS, V14, P145, DOI 10.1088/0967-3334/14/2/006; Zhao TX, 1997, MED BIOL ENG COMPUT, V35, P181, DOI 10.1007/BF02530035	41	39	46	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76243	10.1371/journal.pone.0076243	http://dx.doi.org/10.1371/journal.pone.0076243			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116099	Green Submitted, gold, Green Published			2022-12-25	WOS:000325501300054
J	Wouters, J; Stas, M; Gremeaux, L; Govaere, O; Van den Broeck, A; Maes, H; Agostinis, P; Roskams, T; van den Oord, JJ; Vankelecom, H				Wouters, Jasper; Stas, Marguerite; Gremeaux, Lies; Govaere, Olivier; Van den Broeck, Anke; Maes, Hannelore; Agostinis, Patrizia; Roskams, Tania; van den Oord, Joost J.; Vankelecom, Hugo			The Human Melanoma Side Population Displays Molecular and Functional Characteristics of Enriched Chemoresistance and Tumorigenesis	PLOS ONE			English	Article							P-GLYCOPROTEIN; STEM-CELLS; CANCER-CELLS; DNA METHYLTRANSFERASE; INITIATING CELLS; EXPRESSION; GROWTH; ESTABLISHMENT; CHEMOTHERAPY; METHYLATION	Melanoma remains the most lethal skin cancer, mainly because of high resistance to therapy. Side population (SP) cells are found in many types of cancer and are usually enriched in therapy-resistant as well as tumorigenic cells. Here, we identified a Hoechst dye-effluxing SP in a large series of human melanoma samples representing different progression phases. The SP size did not change with disease stage but was correlated with the prognostic "Breslow's depth" in the primary (cutaneous) tumors. When injected into immunodeficient mice, the SP generated larger tumors than the bulk "main population" (MP) melanoma cells in two consecutive generations, and showed tumorigenic capacity at lower cell numbers than the MP. In addition, the SP reconstituted the heterogeneous composition of the human A375 melanoma cell line, and its clonogenic activity was 2.5-fold higher than that of the MP. Gene-expression analysis revealed upregulated expression in the melanoma SP (versus the MP) of genes associated with chemoresistance and anti-apoptosis. Consistent with these molecular characteristics, the SP increased in proportion when A375 cells were exposed to the melanoma standard chemotherapeutic agent dacarbazine, and to the aggravating condition of hypoxia. In addition, the SP showed enhanced expression of genes related to cell invasion and migration, as well as to putative (melanoma) cancer stem cells (CSC) including ABCB1 and JARID1B. ABCB1 immunoreactivity was detected in a number of tumor cells in human melanomas, and in particular in clusters at the invasive front of the primary tumors. Together, our findings support that the human melanoma SP is enriched in tumorigenic and chemoresistant capacity, considered key characteristics of CSC. The melanoma SP may therefore represent an interesting therapeutic target.	[Wouters, Jasper; Govaere, Olivier; Roskams, Tania; van den Oord, Joost J.] Univ Leuven KU Leuven, Dept Imaging & Pathol, Leuven, Belgium; [Wouters, Jasper; Gremeaux, Lies; Van den Broeck, Anke; Vankelecom, Hugo] Univ Leuven KU Leuven, Dept Dev & Regenerat, Cluster Stem Cell Biol & Embryol, Res Unit Stem Cell Res,Lab Tissue Plast, Leuven, Belgium; [Stas, Marguerite; Van den Broeck, Anke] Univ Leuven KU Leuven, Dept Oncol, Leuven, Belgium; [Maes, Hannelore; Agostinis, Patrizia] Univ Leuven KU Leuven, Dept Cellular & Mol Med, Lab Cell Death Res & Therapy, Leuven, Belgium	KU Leuven; KU Leuven; KU Leuven; KU Leuven	Vankelecom, H (corresponding author), Univ Leuven KU Leuven, Dept Dev & Regenerat, Cluster Stem Cell Biol & Embryol, Res Unit Stem Cell Res,Lab Tissue Plast, Leuven, Belgium.	hugo.vankelecom@med.kuleuven.be	Govaere, Olivier/R-9372-2019; Wouters, Jasper/AAK-8597-2020; Agostinis, Patrizia/AAO-2468-2020; Agostinis, Patrizia/ABI-1177-2020	Govaere, Olivier/0000-0002-4426-6930; Wouters, Jasper/0000-0002-7129-2990; Agostinis, Patrizia/0000-0003-1314-2115; Roskams, Tania/0000-0002-2816-1530; Vankelecom, Hugo/0000-0002-2251-7284	Fund for Scientific Research-Flanders (Belgium) (FWO-Vlaanderen); Research Fund (Onderzoeksfonds) of the KU Leuven; Cycle For Life Award from the Leuven Cancer Institute (Leuven, Belgium); Flemish Association against Cancer (Belgium)	Fund for Scientific Research-Flanders (Belgium) (FWO-Vlaanderen)(FWO); Research Fund (Onderzoeksfonds) of the KU Leuven; Cycle For Life Award from the Leuven Cancer Institute (Leuven, Belgium); Flemish Association against Cancer (Belgium)	Research was made possible by financial support from the Fund for Scientific Research-Flanders (Belgium) (FWO-Vlaanderen), the Research Fund (Onderzoeksfonds) of the KU Leuven, and the Cycle For Life Award from the Leuven Cancer Institute (Leuven, Belgium). JW is currently funded as Emmanuel Vanderschueren Fellow of the Flemish Association against Cancer (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACS, 2012, CANC FACTS FIG 2012; Arancia G, 2001, MARC MALPIG SYMP SER, V7, P59; Bangoura G, 2007, WORLD J GASTROENTERO, V13, P3176, DOI 10.3748/wjg.v13.i23.3176; Baugh LR, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.5.e29; Beck S, 2011, MOL CELLS, V31, P9, DOI 10.1007/s10059-011-0008-8; Biroccio A, 2002, ONCOGENE, V21, P3011, DOI 10.1038/sj.onc.1205415; Blokzijl H, 2007, INFLAMM BOWEL DIS, V13, P710, DOI 10.1002/ibd.20088; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Borght SV, 2008, LIVER INT, V28, P1370, DOI 10.1111/j.1478-3231.2008.01889.x; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; BRESLOW A, 1970, ANN SURG, V172, P902, DOI 10.1097/00000658-197011000-00017; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chen JH, 2009, STEM CELLS, V27, P1182, DOI 10.1002/stem.51; Chen MF, 2012, CANCER-AM CANCER SOC, V118, P4074, DOI 10.1002/cncr.26736; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Civenni G, 2011, CANCER RES, V71, P3098, DOI 10.1158/0008-5472.CAN-10-3997; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Colone M, 2008, J INVEST DERMATOL, V128, P957, DOI 10.1038/sj.jid.5701082; Depeille P, 2005, BRIT J CANCER, V93, P216, DOI 10.1038/sj.bjc.6602681; Dou J, 2009, CELL BIOL INT, V33, P807, DOI 10.1016/j.cellbi.2009.05.003; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Engelmann K, 2008, CANCER RES, V68, P2419, DOI 10.1158/0008-5472.CAN-07-2249; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Fukunaga-Kalabis M, 2010, ONCOGENE, V29, P6115, DOI 10.1038/onc.2010.350; Fukunaga-Kalabis M, 2012, J INVEST DERMATOL, V132, P2317, DOI 10.1038/jid.2012.220; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Giatromanolaki A, 2003, MELANOMA RES, V13, P493, DOI 10.1097/00008390-200310000-00008; Girouard SD, 2011, LAB INVEST, V91, P647, DOI 10.1038/labinvest.2011.50; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Grade M, 2007, CANCER RES, V67, P41, DOI 10.1158/0008-5472.CAN-06-1514; Graham SM, 2007, STEM CELLS, V25, P3111, DOI 10.1634/stemcells.2007-0250; Grichnik JM, 2006, J INVEST DERMATOL, V126, P142, DOI 10.1038/sj.jid.5700017; Hayami S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-59; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Jilaveanu LB, 2009, CLIN DERMATOL, V27, P614, DOI 10.1016/j.clindermatol.2008.09.020; Keshet GI, 2008, BIOCHEM BIOPH RES CO, V368, P930, DOI 10.1016/j.bbrc.2008.02.022; Kim M, 2010, CANCER RES, V70, P10411, DOI 10.1158/0008-5472.CAN-10-2591; Klinger P, 2011, TRANSCR-AUSTIN, V2, P269, DOI 10.4161/trns.2.6.18619; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Lindgren D, 2006, ONCOGENE, V25, P2685, DOI 10.1038/sj.onc.1209249; Linhart HG, 2007, GENE DEV, V21, P3110, DOI 10.1101/gad.1594007; Luo YC, 2012, J INVEST DERMATOL, V132, P2440, DOI 10.1038/jid.2012.161; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; Martins-Taylor K, 2012, EPIGENETICS-US, V7, P71, DOI 10.4161/epi.7.1.18750; METELMANN H-R, 1983, International Journal of Cell Cloning, V1, P24; Milde-Langosch K, 2005, BRIT J CANCER, V92, P2206, DOI 10.1038/sj.bjc.6602655; Molinari A., 2005, Italian Journal of Anatomy and Embryology, V110, P135; Molinari A, 2002, MELANOMA RES, V12, P109, DOI 10.1097/00008390-200204000-00002; Molinari A, 1998, INT J CANCER, V75, P885, DOI 10.1002/(SICI)1097-0215(19980316)75:6<885::AID-IJC11>3.0.CO;2-2; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; Murakami T, 2001, BIOCHEM BIOPH RES CO, V288, P8, DOI 10.1006/bbrc.2001.5719; Paranjape AN, 2012, ONCOGENE, V31, P1896, DOI 10.1038/onc.2011.378; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Rausch V, 2012, J PATHOL, V227, P325, DOI 10.1002/path.3994; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Roberts AM, 2009, CANCER RES, V69, P9056, DOI 10.1158/0008-5472.CAN-09-1770; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; SCHEPER RJ, 1988, INT J CANCER, V42, P389, DOI 10.1002/ijc.2910420314; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seong I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031477; Shen GM, 2010, FEBS LETT, V584, P4366, DOI 10.1016/j.febslet.2010.09.040; Shibuya H, 2003, MELANOMA RES, V13, P457, DOI 10.1097/00008390-200310000-00004; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tadokoro Y, 2007, J EXP MED, V204, P715, DOI 10.1084/jem.20060750; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Vander Borght S, 2005, J PATHOL, V207, P471, DOI 10.1002/path.1852; Vasquez-Moctezuma I, 2010, ACTAS DERMO-SIFILOGR, V101, P341, DOI 10.1016/S1578-2190(10)70645-4; VIRAG L, 1995, J IMMUNOL METHODS, V185, P199, DOI 10.1016/0022-1759(95)00115-Q; Walsh N, 2010, BRIT J CANCER, V102, P1157, DOI 10.1038/sj.bjc.6605590; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Wouters J, 2009, EXPERT REV DERMATOL, V4, P225, DOI DOI 10.1586/EDM.09.17; Wouters J, 2012, PIGM CELL MELANOMA R, V25, P454, DOI 10.1111/j.1755-148X.2012.01004.x; Wu C, 2008, CANCER LETT, V268, P1, DOI 10.1016/j.canlet.2008.03.048; Wu CL, 2007, CANCER RES, V67, P8216, DOI 10.1158/0008-5472.CAN-07-0999; Zabierowski SE, 2008, CANCER CELL, V13, P185, DOI 10.1016/j.ccr.2008.02.015	79	42	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76550	10.1371/journal.pone.0076550	http://dx.doi.org/10.1371/journal.pone.0076550			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098529	gold, Green Submitted, Green Published			2022-12-25	WOS:000325483600064
J	El-Sayed, MA; Shabaka, AA; El-Shabrawy, OA; Yassin, NA; Mahmoud, SS; El-Shenawy, SM; Al-Ashqar, E; Eisa, WH; Farag, NM; El-Shaer, MA; Salah, N; Al-Abd, AM				El-Sayed, Mostafa A.; Shabaka, Ali A.; El-Shabrawy, Osama A.; Yassin, Nemat A.; Mahmoud, Sawsan S.; El-Shenawy, Siham M.; Al-Ashqar, Emad; Eisa, Wael H.; Farag, Niveen M.; El-Shaer, Marwa A.; Salah, Nabila; Al-Abd, Ahmed M.			Tissue Distribution and Efficacy of Gold Nanorods Coupled with Laser Induced Photoplasmonic Therapy in Ehrlich Carcinoma Solid Tumor Model	PLOS ONE			English	Article							PLASMONIC PHOTOTHERMAL THERAPY; PENETRATION; RESISTANCE; NANOPARTICLES; MECHANISM; PROSPECTS; PPTT	Gold nanorods (GNR) within tumor microregions are characterized by their ability to absorb near IR light and emit heat in what is called photoplasmonic effect. Yet, the efficacy of nanoparticles is limited due to intratumoral tissue distribution reasons. In addition, distribution of GNRs to normal tissue might result in non specific toxicity. In the current study, we are assessing the intratumoral and tissue distribution of PEGylated GNRs on the top of its antitumor characteristics when given intravenously or intratumoral to solid tumor bearing mice and coupled with laser photoplasmonic sessions. PEGylated GNRs with a longitudinal size of less than 100 nm were prepared with aspect ratio of 4.6 showing strong surface plasmon absorption at wavelength 800 nm. Pharmacokinetics of GNR after single I. V. administration (0.1 mg/kg) showed very short systemic circulating time (less than 3 h). On the other hand, tissue distribution of I. V. GNR (0.1 mg/kg) to normal animals showed preferential deposition in spleen tissue. Repeated administration of I. V. GNR resulted in preferential accumulation in both liver and spleen tissues. In addition, I. V. administration of GNR to Ehrlich carcinoma tumor bearing mice resulted in similar tissue distribution; tumor accumulation and anti-tumor effect compared to intratumoral administration. In conclusion, the concentration of GNR achieved within tumors microregions after I. V. administration was comparable to I. T. administration and sufficient to elicit tumoral growth arrest when coupled with laser-aided photoplasmonic treatment.	[El-Sayed, Mostafa A.] Georgia Inst Technol, Sch Chem & Biochem, Laser Dynam Lab, Atlanta, GA 30332 USA; [Shabaka, Ali A.; Al-Ashqar, Emad; Eisa, Wael H.; Farag, Niveen M.] Natl Res Ctr, Dept Laser Phys, Giza, Egypt; [El-Shabrawy, Osama A.; Yassin, Nemat A.; Mahmoud, Sawsan S.; El-Shenawy, Siham M.; Al-Abd, Ahmed M.] Natl Res Ctr, Dept Pharmacol, Giza, Egypt; [El-Shaer, Marwa A.; Salah, Nabila] Natl Res Ctr, Dept Pathol, Giza, Egypt; [Al-Abd, Ahmed M.] King Abdulaziz Univ, Fac Pharm, Dept Pharmacol, Jeddah 21413, Saudi Arabia	University System of Georgia; Georgia Institute of Technology; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); National Research Centre (NRC); King Abdulaziz University	Al-Abd, AM (corresponding author), Natl Res Ctr, Dept Pharmacol, Giza, Egypt.	amalabd@kau.edu.sa	Al-Abd, Ahmed/J-2826-2012	Al-Abd, Ahmed/0000-0001-7872-4867; Mahmoud, Sawasn/0000-0003-2172-0763; , Siham/0000-0002-8057-0331; Al Ashkar, Emad/0000-0003-3160-6833; El-Shaer, Marwa/0000-0003-0562-3680; El-Shabrawy, Osama/0000-0003-4320-9499; Eisa, Wael/0000-0001-5570-4994; Yassin, Nemat/0000-0001-8895-7533	Misr El-Kheir Foundation, Cairo, Egypt; National Research Center, Dokki, Giza, Egypt	Misr El-Kheir Foundation, Cairo, Egypt(Misr El Kheir Foundation (MEK)); National Research Center, Dokki, Giza, Egypt(National Research Centre (NRC))	This work was supported by a grant from the Misr El-Kheir Foundation, Cairo, Egypt. The project was partly supported by the internal project fund of the National Research Center, Dokki, Giza, Egypt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2011, ACS NANO, V5, P4919, DOI 10.1021/nn201010q; Akiyama Y, 2009, J CONTROL RELEASE, V139, P81, DOI 10.1016/j.jconrel.2009.06.006; Al-Abd AM, 2009, J CONTROL RELEASE, V137, P130, DOI 10.1016/j.jconrel.2009.03.009; Arnida, 2011, EUR J PHARM BIOPHARM, V77, P417, DOI 10.1016/j.ejpb.2010.11.010; Arnida, 2010, J APPL TOXICOL, V30, P212, DOI 10.1002/jat.1486; Boca SC, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/23/235601; Bogliotti N, 2011, J COLLOID INTERF SCI, V357, P75, DOI 10.1016/j.jcis.2011.01.053; Chen T, 2011, NANOSCALE, V3, P546, DOI 10.1039/c0nr00646g; Choi WI, 2012, ANN BIOMED ENG, V40, P534, DOI 10.1007/s10439-011-0388-0; Dickerson EB, 2008, CANCER LETT, V269, P57, DOI 10.1016/j.canlet.2008.04.026; Dua P, 2011, METHODS, V54, P215, DOI 10.1016/j.ymeth.2011.02.002; Goodrich GP, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3290817; Gormley AJ, 2011, J DRUG TARGET, V19, P915, DOI 10.3109/1061186X.2011.623701; Gormley AJ, 2011, INT J PHARMACEUT, V415, P315, DOI 10.1016/j.ijpharm.2011.05.068; Gu M, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3502566; Hainfeld JF, 2004, PHYS MED BIOL, V49, pN309, DOI 10.1088/0031-9155/49/18/N03; Hicks KO, 2003, CANCER RES, V63, P5970; Huang HC, 2011, J CONTROL RELEASE, V155, P344, DOI 10.1016/j.jconrel.2011.06.004; Huang P, 2011, BIOMATERIALS, V32, P9796, DOI 10.1016/j.biomaterials.2011.08.086; Huang XH, 2008, LASER MED SCI, V23, P217, DOI 10.1007/s10103-007-0470-x; Huang YF, 2008, LANGMUIR, V24, P11860, DOI 10.1021/la801969c; Huff TB, 2007, NANOMEDICINE-UK, V2, P125, DOI 10.2217/17435889.2.1.125; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kopwitthaya A, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/31/315101; Kyle AH, 2007, CLIN CANCER RES, V13, P2804, DOI 10.1158/1078-0432.CCR-06-1941; Lassen U, 2012, BRIT J CANCER, V106, P678, DOI 10.1038/bjc.2011.609; Li PC, 2008, OPT EXPRESS, V16, P18605, DOI 10.1364/OE.16.018605; Li ZM, 2010, MOL PHARMACEUT, V7, P94, DOI 10.1021/mp9001415; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Niidome T, 2010, BIOORGAN MED CHEM, V18, P4453, DOI 10.1016/j.bmc.2010.04.070; Niidome T, 2009, J BIOMAT SCI-POLYM E, V20, P1203, DOI 10.1163/156856209X452953; Nikoobakht B, 2003, CHEM MATER, V15, P1957, DOI [10.1021/cm020732l, 10.1021/cm0207321]; Pissuwan D, 2008, BIOTECHNOL GENET ENG, V25, P93, DOI 10.5661/bger-25-93; Schroeder A, 2012, NAT REV CANCER, V12, P39, DOI 10.1038/nrc3180; Shan L, 2004, POLYETHYLENE GLYCOL; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Tunggal JK, 1999, CLIN CANCER RES, V5, P1583; Wang X, 2011, MINI-REV MED CHEM, V11, P114, DOI 10.2174/138955711794519528; Yamashita S, 2011, BIOORGAN MED CHEM, V19, P2130, DOI 10.1016/j.bmc.2011.02.042; Yang DP, 2008, CHEM-ASIAN J, V3, P2010, DOI 10.1002/asia.200800195	40	38	39	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76207	10.1371/journal.pone.0076207	http://dx.doi.org/10.1371/journal.pone.0076207			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098446	Green Published, gold, Green Submitted			2022-12-25	WOS:000325434500052
J	Tsai, SW; Liaw, JW; Kao, YC; Huang, MY; Lee, CY; Rau, LR; Huang, CY; Wei, KC; Ye, TC				Tsai, Shiao-Wen; Liaw, Jiunn-Woei; Kao, Ya-Chen; Huang, Meng-Yu; Lee, Chia-Ying; Rau, Lih-Rou; Huang, Chiung-Yin; Wei, Kuo-Chen; Ye, Tzu-Chen			Internalized Gold Nanoparticles Do Not Affect the Osteogenesis and Apoptosis of MG63 Osteoblast-Like Cells: A Quantitative, In Vitro Study	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; CELLULAR UPTAKE; QUANTUM DOTS; CYTOTOXICITY; TOXICITY; SURFACE; DIFFERENTIATION; NANORODS; THERAPY; CANCER	The long-term toxicity effects of gold nanoparticles (GNPs) on the proliferation and differentiation of a progenitor cell line, MG63 osteoblast-like cells, was investigated. These cells were treated for 20 hours with two media that contained 10 nm GNPs at concentrations of 1 ppm and 10 ppm. The mitosis of the GNP-treated MG63 was observed after at least 21 hours using dark-field and fluorescence microscopy. The TEM, LSCM and dark-field hyperspectral images indicated that the late endosomes in cells that contained aggregated GNPs were caused by vesicle fusion. Subsequently, after 21 days of being cultured in fresh medium, the specific nodule-like phenotypes and bone-associated gene expression of the treated MG63 cells exhibited the same behaviors as those of the control group. Statistically, after 21 days, the viability of the treated cells was identical to that of the untreated ones. During the cell death program analysis, the apoptosis and necrosis percentages of cells treated for 8 or fewer days were also observed to exhibit no significant difference with those of the untreated cells. In summary, our experiments show that the long-term toxicity of GNPs on the osteogenetic differentiation of MG63 is low. In addition, because of their low toxicity and non-biodegradability, GNPs can potentially be used as biomarkers for the long-term optical observation of the differentiation of progenitor or stem cells based on their plasmonic light-scattering properties.	[Tsai, Shiao-Wen; Kao, Ya-Chen; Lee, Chia-Ying; Rau, Lih-Rou] Chang Gung Univ, Grad Inst Biochem & Biomed Engn, Tao Yuan, Taiwan; [Tsai, Shiao-Wen; Liaw, Jiunn-Woei] Chang Gung Univ, Ctr Biomed Engn, Tao Yuan, Taiwan; [Liaw, Jiunn-Woei; Huang, Meng-Yu] Chang Gung Univ, Dept Mech Engn, Tao Yuan, Taiwan; [Huang, Chiung-Yin; Wei, Kuo-Chen] Chang Gung Mem Hosp, Dept Neurosurg, Linkou, Taiwan; [Wei, Kuo-Chen] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Ye, Tzu-Chen] Chang Gung Univ, Dept Med Imaging & Radiol Sci, Tao Yuan, Taiwan; [Ye, Tzu-Chen] Chang Gung Mem Hosp, Dept Nucl Med, Linkou, Taiwan; [Ye, Tzu-Chen] Chang Gung Mem Hosp, Mol Imaging Ctr, Linkou, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Tsai, SW (corresponding author), Chang Gung Univ, Grad Inst Biochem & Biomed Engn, Tao Yuan, Taiwan.	swtsai@mail.cgu.edu.tw		Tsai, Shiao-Wen/0000-0002-6225-6613; Wei, Kuochen/0000-0003-3505-2196	National Science Council, Taiwan, R.O.C. [NSC 99-2221-E-182-010-MY3]; Chang Gung Memorial Hospital [CMRPD290041, CMRPD2A0051]	National Science Council, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	The authors are grateful to the Molecular Imaging Center, Chang Gung Memorial Hospital for providing the hyperspectral microscopy. This research was supported by the National Science Council, Taiwan, R.O.C. (NSC 99-2221-E-182-010-MY3) and by Chang Gung Memorial Hospital (CMRPD290041 and CMRPD2A0051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron J, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2737351; Alkilany AM, 2009, SMALL, V5, P701, DOI 10.1002/smll.200801546; Arnida, 2010, J APPL TOXICOL, V30, P212, DOI 10.1002/jat.1486; Balasubramanian SK, 2010, BIOMATERIALS, V31, P2034, DOI 10.1016/j.biomaterials.2009.11.079; Busson MP, 2011, NANO LETT, V11, P5060, DOI 10.1021/nl2032052; Chen YS, 2009, NANOSCALE RES LETT, V4, P858, DOI 10.1007/s11671-009-9334-6; Chen YS, 2010, OPT EXPRESS, V18, P8867, DOI 10.1364/OE.18.008867; Cho EC, 2009, NANO LETT, V9, P1080, DOI 10.1021/nl803487r; Cho WS, 2009, TOXICOL APPL PHARM, V236, P16, DOI 10.1016/j.taap.2008.12.023; Cloyd KL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone 0047562, DOI 10.1371/J0URNAL.P0NE.0047562.PUBMED:23082177]; Comenge J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047562; Connor EE, 2005, SMALL, V1, P325, DOI 10.1002/smll.200400093; DEBRUIJN JD, 1992, J BIOMED MATER RES, V26, P1365, DOI 10.1002/jbm.820261008; El-Sayed IH, 2006, CANCER LETT, V239, P129, DOI 10.1016/j.canlet.2005.07.035; Goodman CM, 2004, BIOCONJUGATE CHEM, V15, P897, DOI 10.1021/bc049951i; Helary G, 2009, ACTA BIOMATER, V5, P124, DOI 10.1016/j.actbio.2008.07.037; HEREMANS H, 1978, ONCOLOGY, V35, P246, DOI 10.1159/000225298; Hsieh SC, 2006, J BIOMED MATER RES B, V79B, P95, DOI 10.1002/jbm.b.30517; Im GI, 2004, BIOMATERIALS, V25, P4105, DOI 10.1016/j.biomaterials.2003.11.024; Ji XH, 2007, J AM CHEM SOC, V129, P13939, DOI 10.1021/ja074447k; Klein S, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3461170; Kumar S, 2007, NANO LETT, V7, P1338, DOI 10.1021/nl070365i; Lee H, 2008, BIOMATERIALS, V29, P4709, DOI 10.1016/j.biomaterials.2008.08.038; Li HX, 2004, P NATL ACAD SCI USA, V101, P14036, DOI 10.1073/pnas.0406115101; Liaw JW, 2012, J QUANT SPECTROSC RA, V113, P2234, DOI 10.1016/j.jqsrt.2012.08.002; Liaw JW, 2010, J NANOSCI NANOTECHNO, V10, P467, DOI 10.1166/jnn.2010.2021; Liu KK, 2009, BIOMATERIALS, V30, P4249, DOI 10.1016/j.biomaterials.2009.04.056; Male KB, 2008, ANAL CHEM, V80, P5487, DOI 10.1021/ac8004555; Paino IMM, 2012, TOXICOL LETT, V215, P119, DOI 10.1016/j.toxlet.2012.09.025; Mironava T, 2010, NANOTOXICOLOGY, V4, P120, DOI 10.3109/17435390903471463; Murphy CJ, 2008, ACCOUNTS CHEM RES, V41, P1721, DOI 10.1021/ar800035u; Nam J, 2009, J AM CHEM SOC, V131, P13639, DOI 10.1021/ja902062j; Pan Y, 2007, SMALL, V3, P1941, DOI 10.1002/smll.200700378; Pepper C, 1998, LEUKEMIA RES, V22, P439, DOI 10.1016/S0145-2126(98)00013-7; Pernodet N, 2006, SMALL, V2, P766, DOI 10.1002/smll.200500492; Raji V, 2011, EXP CELL RES, V317, P2052, DOI 10.1016/j.yexcr.2011.04.010; Shukla R, 2005, LANGMUIR, V21, P10644, DOI 10.1021/la0513712; Soenen SJ, 2012, ACS NANO, V6, P5767, DOI 10.1021/nn301714n; Tarantola M, 2011, NANOTOXICOLOGY, V5, P254, DOI 10.3109/17435390.2010.528847; Tarantola M, 2009, ACS NANO, V3, P213, DOI 10.1021/nn800721j; Taylor U, 2010, CYTOM PART A, V77A, P439, DOI 10.1002/cyto.a.20846; Thakor AS, 2011, SMALL, V7, P126, DOI 10.1002/smll.201001466; Tsai SW, 2008, SENSORS-BASEL, V8, P2306, DOI 10.3390/s8042306; Tsai SW, 2008, SENSORS-BASEL, V8, P6660, DOI 10.3390/s8106660; Yen HJ, 2009, SMALL, V5, P1553, DOI 10.1002/smll.200900126; Yi CQ, 2010, ACS NANO, V4, P6439, DOI 10.1021/nn101373r; Yu CX, 2007, LANGMUIR, V23, P9114, DOI 10.1021/la701111e; Zhang XX, 2009, J BIOL CHEM, V284, P18174, DOI 10.1074/jbc.M109.001354	48	44	46	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76545	10.1371/journal.pone.0076545	http://dx.doi.org/10.1371/journal.pone.0076545			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098527	Green Submitted, Green Published, gold			2022-12-25	WOS:000325434500073
J	Mori, T; Maeda, N; Inoue, K; Sekimoto, R; Tsushima, Y; Matsuda, K; Yamaoka, M; Suganami, T; Nishizawa, H; Ogawa, Y; Funahashi, T; Shimomura, I				Mori, Takuya; Maeda, Norikazu; Inoue, Kana; Sekimoto, Ryohei; Tsushima, Yu; Matsuda, Keisuke; Yamaoka, Masaya; Suganami, Takayoshi; Nishizawa, Hitoshi; Ogawa, Yoshihiro; Funahashi, Tohru; Shimomura, Iichiro			A Novel Role for Adipose Ephrin-B1 in Inflammatory Response	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; ENDOPLASMIC-RETICULUM STRESS; INSULIN-RESISTANCE; METABOLIC SYNDROME; TYROSINE KINASE; EXPRESSION; OBESITY; EPH; IMPACT; TISSUE	Aims: Ephrin-B1 (EfnB1) was selected among genes of unknown function in adipocytes or adipose tissue and subjected to thorough analysis to understand its role in the development of obesity. Methods and Results: EfnB1 mRNA and protein levels were significantly decreased in adipose tissues of obese mice and such reduction was mainly observed in mature adipocytes. Exposure of 3T3-L1 adipocytes to tumor necrosis factor-alpha (TNF-alpha) and their culture with RAW264.7 cells reduced EFNB1 levels. Knockdown of adipose EFNB1 increased monocyte chemoattractant protein-1 (Mcp-1) mRNA level and augmented the TNF-alpha-mediated THP-1 monocyte adhesion to adipocytes. Adenovirus-mediated adipose EFNB1-overexpression significantly reduced the increase in Mcp-1 mRNA level induced by coculture of 3T3-L1 adipocytes with RAW264.7 cells. Monocyte adherent assay showed that adipose EfnB1-overexpression significantly decreased the increase of monocyte adhesion by coculture with RAW264.7 cells. TNF-alpha-induced activation of extracellular signal-regulated kinase 1/2 (ERK1/2) was reduced by EFNB1-overexpression. Conclusions: EFNB1 contributes to the suppression of adipose inflammatory response. In obesity, reduction of adipose EFNB1 may accelerate the vicious cycle involved in adipose tissue inflammation.	[Mori, Takuya; Maeda, Norikazu; Inoue, Kana; Sekimoto, Ryohei; Tsushima, Yu; Matsuda, Keisuke; Yamaoka, Masaya; Nishizawa, Hitoshi; Funahashi, Tohru; Shimomura, Iichiro] Osaka Univ, Dept Metab Med, Grad Sch Med, Suita, Osaka, Japan; [Suganami, Takayoshi] Tokyo Med & Dent Univ, Dept Organ Network, Grad Sch Med & Dent Sci, Tokyo, Japan; [Suganami, Takayoshi; Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Dept Metab, Grad Sch Med & Dent Sci, Tokyo, Japan; [Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Dept Mol Endocrinol, Grad Sch Med & Dent Sci, Tokyo, Japan; [Funahashi, Tohru] Osaka Univ, Dept Metab, Grad Sch Med, Suita, Osaka, Japan; [Funahashi, Tohru] Osaka Univ, Dept Atherosclerosis, Grad Sch Med, Suita, Osaka, Japan	Osaka University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Osaka University; Osaka University	Maeda, N (corresponding author), Osaka Univ, Dept Metab Med, Grad Sch Med, Suita, Osaka, Japan.	norikazu_maeda@endmet.med.osaka-u.ac.jp	SUGANAMI, Takayoshi/A-9475-2016	Ogawa, Yoshihiro/0000-0002-0834-2836	Takeda Science Foundation;  [22590979];  [24390238];  [22126008]	Takeda Science Foundation(Takeda Science Foundation (TSF)); ; ; 	This work was supported in part by a Grants-in-Aid for Scientific Research (C) no. 22590979 (to NM), a Grants-in-Aid for Scientific Research (B) no. 24390238 (to IS), a Grants-in-Aid for Scientific Research on Innovative Areas no. 22126008 (to TF), and Takeda Science Foundation (to NM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asamizu S, 2009, J ENDOCRINOL, V202, P199, DOI 10.1677/JOE-08-0363; BARTLEY TD, 1994, NATURE, V368, P558, DOI 10.1038/368558a0; Elowe S, 2001, MOL CELL BIOL, V21, P7429, DOI 10.1128/MCB.21.21.7429-7441.2001; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Funahashi T, 2007, ANN MED, V39, P482, DOI 10.1080/07853890701491026; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; HIRAI H, 1987, SCIENCE, V238, P1717, DOI 10.1126/science.2825356; Hiuge-Shimizu A, 2011, ARTERIOSCL THROM VAS, V31, P792, DOI 10.1161/ATVBAHA.110.221747; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Hosono T, 2005, GENE, V348, P157, DOI 10.1016/j.gene.2005.01.005; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Ito A, 2007, J BIOL CHEM, V282, P25445, DOI 10.1074/jbc.M701549200; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Maeda K, 1997, GENE, V190, P227, DOI 10.1016/S0378-1119(96)00730-5; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maeda N, 2004, P NATL ACAD SCI USA, V101, P17801, DOI 10.1073/pnas.0406230101; Maeda N, 2013, ENDOCR J, V60, P251, DOI 10.1507/endocrj.EJ13-0016; Matsuzawa Y, 2006, NAT CLIN PRACT CARD, V3, P35, DOI 10.1038/ncpcardio0380; Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF; Neels JG, 2006, J CLIN INVEST, V116, P33, DOI 10.1172/JCI27280; OKUBO K, 1992, NAT GENET, V2, P173, DOI 10.1038/ng1192-173; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Sakamoto A, 2008, CLIN SCI, V114, P643, DOI 10.1042/CS20070339; Sakamoto A, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/127149; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Suganami T, 2010, J LEUKOCYTE BIOL, V88, P33, DOI 10.1189/jlb.0210072; Thompson WL, 2009, BRAIN RES, V1287, P47, DOI 10.1016/j.brainres.2009.06.081; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Yamaoka M, 2013, BIOCHEM BIOPH RES CO, V433, P450, DOI 10.1016/j.bbrc.2013.02.096; Yamaoka M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047377; Yoshimura H, 2006, INFLAMM RES, V55, P543, DOI 10.1007/s00011-006-5144-9	37	13	13	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76199	10.1371/journal.pone.0076199	http://dx.doi.org/10.1371/journal.pone.0076199			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098442	Green Submitted, Green Published, gold			2022-12-25	WOS:000325427100047
J	Roy, A; Lahiry, L; Banerjee, D; Ghosh, M; Banerjee, S				Roy, Anita; Lahiry, Lakshmishri; Banerjee, Debasis; Ghosh, Malay; Banerjee, Subrata			Increased Cytoplasmic Localization of p27(kip1) and Its Modulation of RhoA Activity during Progression of Chronic Myeloid Leukemia	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; BCR-ABL; CELL-CYCLE; C-JUN; HEMATOPOIETIC-CELLS; SIGNALING PATHWAYS; KINASE; APOPTOSIS; EXPRESSION; INHIBITION	The role of p27(kip1) in Chronic Myeloid Leukemia (CML) has been well studied in relation to its function as a cell cycle inhibitor. However, its cytoplasmic function especially in CML remains to be seen. We studied the localization of p27(kip1) and its function during the progression of CML from chronic to blast phase. Our investigations revealed an increased localization of p27(kip1) in the cytoplasm of CD34(+) cells in the blast phase compared to chronic phase. Cytoplasmic p27(kip1) was found to modulate RhoA activity in CD34(+) stem and progenitor cells. Further, RhoA activity was shown to be dependent on cytoplasmic p27(kip1) which in turn was dependent on p210(Bcr-Abl) kinase activity. Interestingly, RhoA activity was observed to affect cell survival in the presence of imatinib through the SAPK/JNK pathway. Accordingly, inhibition of SAPK/JNK pathway using SP600125 increased apoptosis of K562 cells in presence of imatinib. Our results, for the first time, thus reveal a crucial link between cytoplasmic p27(kip1), RhoA activity and SAPK/JNK signalling. To this effect we observed a correlation between increased cytoplasmic p27(kip1), increased RhoA protein levels, decreased RhoA-GTP levels and increased SAPK/JNK phosphorylation in blast phase CD34(+) cells compared to chronic phase CD34(+) cells.	[Roy, Anita; Lahiry, Lakshmishri; Banerjee, Subrata] Saha Inst Nucl Phys, Struct Genom Div, Kolkata, W Bengal, India; [Banerjee, Debasis] Ramkrishna Mission Seva Pratisthan, Dept Haematol, Kolkata, W Bengal, India; [Ghosh, Malay] NRS Med Coll & Hosp, Dept Haematol, Kolkata, W Bengal, India	Saha Institute of Nuclear Physics	Banerjee, S (corresponding author), Saha Inst Nucl Phys, Struct Genom Div, Kolkata, W Bengal, India.	subrata.banerjee@saha.ac.in		Roy, Anita/0000-0002-7297-2920	IBOP project of DAE, Govt. of India	IBOP project of DAE, Govt. of India	The study was funded by the IBOP project of DAE, Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2008, BLOOD, V112, P1960, DOI 10.1182/blood-2007-09-113860; Alberts AS, 1998, EMBO J, V17, P4075, DOI 10.1093/emboj/17.14.4075; Andreu EJ, 2005, CANCER RES, V65, P3264, DOI 10.1158/0008-5472.CAN-04-1357; Barnes DJ, 2005, CANCER RES, V65, P8912, DOI 10.1158/0008-5472.CAN-05-0076; BEDI A, 1994, BLOOD, V83, P2038; Bellucci R, 2004, BLOOD, V103, P656, DOI 10.1182/blood-2003-07-2559; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; BOKOCH GM, 1994, J BIOL CHEM, V269, P31674; Borriello A, 2011, CARCINOGENESIS, V32, P10, DOI 10.1093/carcin/bgq211; Burgess GS, 1998, BLOOD, V92, P2450, DOI 10.1182/blood.V92.7.2450.2450_2450_2460; Chu S, 2010, LEUKEMIA, V24, P779, DOI 10.1038/leu.2010.24; Corbin AS, 2011, J CLIN INVEST, V121, P396, DOI 10.1172/JCI35721; Cortez D, 1997, ONCOGENE, V15, P2333, DOI 10.1038/sj.onc.1201400; CORTEZ D, 1995, MOL CELL BIOL, V15, P5531; Daubon T, 2008, ONCOGENE, V27, P2673, DOI 10.1038/sj.onc.1210933; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; Del Re DP, 2007, J BIOL CHEM, V282, P8069, DOI 10.1074/jbc.M604298200; Denicourt C, 2007, CANCER RES, V67, P9238, DOI 10.1158/0008-5472.CAN-07-1375; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fromigue O, 2008, J BIOL CHEM, V283, P30549, DOI 10.1074/jbc.M801436200; Gomez-Casares MT, 2013, ONCOGENE, V32, P2239, DOI 10.1038/onc.2012.246; HENGST L, 1994, P NATL ACAD SCI USA, V91, P5291, DOI 10.1073/pnas.91.12.5291; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Hess P, 2002, NAT GENET, V32, P201, DOI 10.1038/ng946; HIRATA K, 1992, J BIOL CHEM, V267, P8719; Jena N, 2002, CANCER RES, V62, P535; Jonuleit T, 2000, BLOOD, V96, P1933, DOI 10.1182/blood.V96.5.1933.h8001933_1933_1939; KISHI K, 1993, J CELL BIOL, V120, P1187, DOI 10.1083/jcb.120.5.1187; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Larreaa MD, 2009, P NATL ACAD SCI USA, V106, P9268, DOI 10.1073/pnas.0805057106; Li XW, 2002, J BIOL CHEM, V277, P15309, DOI 10.1074/jbc.M201253200; Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4; McAllister SS, 2003, MOL CELL BIOL, V23, P216, DOI 10.1128/MCB.23.1.216-228.2003; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Minambres R, 2006, J CELL SCI, V119, P271, DOI 10.1242/jcs.02723; O'Hare T, 2007, BLOOD, V110, P2242, DOI 10.1182/blood-2007-03-066936; Ohmine K, 2003, STEM CELLS, V21, P315, DOI 10.1634/stemcells.21-3-315; Parada Y, 2001, J BIOL CHEM, V276, P23572, DOI 10.1074/jbc.M101885200; RAITANO AB, 1995, P NATL ACAD SCI USA, V92, P11746, DOI 10.1073/pnas.92.25.11746; Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672; Roy A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.119; Sahay S, 2008, ONCOGENE, V27, P2064, DOI 10.1038/sj.onc.1210841; Sengupta A, 2007, LEUKEMIA, V21, P2559, DOI 10.1038/sj.leu.2404842; Sengupta A, 2007, LEUKEMIA, V21, P949, DOI 10.1038/sj.leu.2404657; Sengupta A, 2006, J GENE MED, V8, P1251, DOI 10.1002/jgm.959; Street CA, 2011, ANTICANCER RES, V31, P3645; TAKAISHI K, 1993, MOL CELL BIOL, V13, P72, DOI 10.1128/MCB.13.1.72; Tomoda K, 2005, BLOOD, V105, P775, DOI 10.1182/blood-2004-04-1242; Unwin RD, 2005, J BIOL CHEM, V280, P6316, DOI 10.1074/jbc.M410598200; Wander SA, 2011, CLIN CANCER RES, V17, P12, DOI 10.1158/1078-0432.CCR-10-0752; Yoshioka K, 1999, CANCER RES, V59, P2004; Zhang SY, 2009, MOL CANCER RES, V7, P570, DOI 10.1158/1541-7786.MCR-08-0248; Zhao RC, 2001, BLOOD, V97, P2406, DOI 10.1182/blood.V97.8.2406; Zhu S, 2008, ONCOGENE, V27, P1580, DOI 10.1038/sj.onc.1210790	54	11	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76527	10.1371/journal.pone.0076527	http://dx.doi.org/10.1371/journal.pone.0076527			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098519	gold, Green Published, Green Submitted			2022-12-25	WOS:000325427100074
J	Bosutti, A; Qi, J; Pennucci, R; Bolton, D; Matou, S; Ali, K; Tsai, LH; Krupinski, J; Petcu, EB; Montaner, J; Al Baradie, R; Caccuri, F; Caruso, A; Alessandri, G; Kumar, S; Rodriguez, C; Martinez-Gonzalez, J; Slevin, M				Bosutti, Alessandra; Qi, Jie; Pennucci, Roberta; Bolton, David; Matou, Sabine; Ali, Kamela; Tsai, Li-Huei; Krupinski, Jerzy; Petcu, Eugene B.; Montaner, Joan; Al Baradie, Raid; Caccuri, Francesca; Caruso, Arnaldo; Alessandri, Giulio; Kumar, Shant; Rodriguez, Cristina; Martinez-Gonzalez, Jose; Slevin, Mark			Targeting p35/Cdk5 Signalling via CIP-Peptide Promotes Angiogenesis in Hypoxia	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; MYOCYTE ENHANCER FACTOR-2; ACUTE ISCHEMIC-STROKE; TRANSCRIPTION FACTOR; ENDOTHELIAL-CELLS; ACTIVATOR P35; IN-VITRO; BRAIN; CDK5; EXPRESSION	Cyclin-dependent kinase-5 (Cdk5) is over-expressed in both neurons and microvessels in hypoxic regions of stroke tissue and has a significant pathological role following hyper-phosphorylation leading to calpain-induced cell death. Here, we have identified a critical role of Cdk5 in cytoskeleton/focal dynamics, wherein its activator, p35, redistributes along actin microfilaments of spreading cells co-localising with p((Tyr15))Cdk5, talin/integrin beta-1 at the lamellipodia in polarising cells. Cdk5 inhibition (roscovitine) resulted in actin-cytoskeleton disorganisation, prevention of protein co-localization and inhibition of movement. Cells expressing Cdk5 (D144N) kinase mutant, were unable to spread, migrate and form tube-like structures or sprouts, while Cdk5 wild-type over-expression showed enhanced motility and angiogenesis in vitro, which was maintained during hypoxia. Gene microarray studies demonstrated myocyte enhancer factor (MEF2C) as a substrate for Cdk5-mediated angiogenesis in vitro. MEF2C showed nuclear co-immunoprecipitation with Cdk5 and almost complete inhibition of differentiation and sprout formation following siRNA knock-down. In hypoxia, insertion of Cdk5/p25-inhibitory peptide (CIP) vector preserved and enhanced in vitro angiogenesis. These results demonstrate the existence of critical and complementary signalling pathways through Cdk5 and p35, and through which coordination is a required factor for successful angiogenesis in sustained hypoxic condition.	[Bosutti, Alessandra; Qi, Jie; Matou, Sabine; Ali, Kamela; Krupinski, Jerzy; Kumar, Shant; Slevin, Mark] Manchester Metropolitan Univ, Sch Healthcare Sci, Manchester M15 6BH, Lancs, England; [Pennucci, Roberta] Dibit Ist Sci San Raffaele, Dept Neurosci Dibit, Cell Adhes Unit, Milan, Italy; [Bolton, David] Chip Man Technol Ltd, Tampere, Finland; [Tsai, Li-Huei] MIT, Howard Hughes Med Inst, Picower Inst Learning & Memory, Cambridge, MA USA; [Tsai, Li-Huei] MIT, Stanley Ctr Psychiat Res, Broad Inst, Cambridge, MA 02139 USA; [Krupinski, Jerzy] Hosp Univ Mutua Terrassa, Dept Neurol, Barcelona, Spain; [Petcu, Eugene B.; Slevin, Mark] Griffith Univ, Sch Med, Southport, Qld 4215, Australia; [Montaner, Joan] Vall DeHebron Univ Hosp, Neurovasc Res Lab, Barcelona, Spain; [Al Baradie, Raid] Almajmaah Univ, Coll Appl Med Sci, Almajmaah, Saudi Arabia; [Caccuri, Francesca; Caruso, Arnaldo] Univ Brescia, Microbiol Sect, Dept Expt & Appl Med, Sch Med, Brescia, Italy; [Alessandri, Giulio] Fdn Ist Ricovero & Cura Carattere Sci Neurol Inst, Cellular Neurobiol Lab, Dept Cerebrovasc Dis, Milan, Italy; [Kumar, Shant] Univ Manchester, Dept Pathol Sci, Manchester, Lancs, England; [Kumar, Shant] Christie Hosp, Manchester, Lancs, England; [Rodriguez, Cristina; Martinez-Gonzalez, Jose] Hosp Santa Creu & St, Ctr Invest Cardiovasc, Barcelona, Spain	Manchester Metropolitan University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Northwell Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Hospital Universitario Mutua Terrassa; Griffith University; Majmaah University; University of Brescia; University of Manchester; Christie NHS Foundation Trust; Christie Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC)	Slevin, M (corresponding author), Manchester Metropolitan Univ, Sch Healthcare Sci, Manchester M15 6BH, Lancs, England.	m.a.slevin@mmu.ac.uk	Rodriguez, Cristina/D-3099-2011; Slevin, Mark/AFT-1420-2022; slevin, mark a/A-1593-2008; Montaner, Joan/D-3063-2015; Caccuri, Francesca/AAC-1281-2022; Petcu, Eugen B/C-3824-2011; Caruso, Arnaldo/H-7818-2014	Rodriguez, Cristina/0000-0002-6472-5647; Montaner, Joan/0000-0003-4845-2279; Caccuri, Francesca/0000-0002-1923-9033; Petcu, Eugen B/0000-0001-5726-729X; Martinez-Gonzalez, Jose/0000-0002-3894-7166; CARUSO, Arnaldo/0000-0001-5178-566X; alessandri, giulio/0000-0002-1861-8461; slevin, mark/0000-0003-3767-4861	Wellcome Trust [082496/Z/07/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (Project number: 082496/Z/07/Z)URL: http://www.wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres V, 2004, CARDIOVASC RES, V63, P11, DOI 10.1016/j.cardiores.2004.02.009; Antoniou X, 2011, BRAIN RES, V1381, P1, DOI 10.1016/j.brainres.2010.10.071; Avraham HK, 2003, J BIOL CHEM, V278, P36661, DOI 10.1074/jbc.M301253200; Barros-Minones L, 2013, BBA-MOL BASIS DIS, V1832, P705, DOI 10.1016/j.bbadis.2013.02.002; Contreras-Vallejos E, 2012, CELL SIGNAL, V24, P44, DOI 10.1016/j.cellsig.2011.08.022; Duong TQ, 2001, MAGN RESON MED, V45, P61, DOI 10.1002/1522-2594(200101)45:1<61::AID-MRM1010>3.0.CO;2-8; Futatsugi A, 2012, CELL CYCLE, V11, P1603, DOI 10.4161/cc.20009; Haarmann A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013568; Hayashi T, 1999, NEUROSCI LETT, V265, P37, DOI 10.1016/S0304-3940(99)00201-3; He LS, 2011, CELL MOL LIFE SCI, V68, P1633, DOI 10.1007/s00018-010-0562-9; Hsieh WS, 2009, CLIN CANCER RES, V15, P1435, DOI 10.1158/1078-0432.CCR-08-1748; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; Jin G, 2011, SURGERY, V150, P429, DOI 10.1016/j.surg.2011.07.001; Kanungo J, 2009, CELL MOL NEUROBIOL, V29, P1073, DOI 10.1007/s10571-009-9410-6; Kesavapany Sashi, 2007, Biotechnology Journal, V2, P978, DOI 10.1002/biot.200700057; Koumura A, 2008, NEUROSCIENCE, V157, P309, DOI 10.1016/j.neuroscience.2008.09.007; Le Goff MM, 2012, J BIOL CHEM, V287, P28027, DOI 10.1074/jbc.M111.331157; Liebl J, 2010, J BIOL CHEM, V285, P35932, DOI 10.1074/jbc.M110.126177; Lin Q, 1998, DEVELOPMENT, V125, P4565; Love CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012812; Love S, 2003, NEUROSCI LETT, V353, P29, DOI 10.1016/j.neulet.2003.09.004; MAAS AIR, 1993, ACTA NEUROCHIR, P50; Maiti D, 2008, INVEST OPHTH VIS SCI, V49, P3640, DOI 10.1167/iovs.08-1760; Metzger W, 2011, CYTOTHERAPY, V13, P1000, DOI 10.3109/14653249.2011.583233; Mitsios N, 2007, BRAIN PATHOL, V17, P11, DOI 10.1111/j.1750-3639.2006.00031.x; Munoz-Chapuli R, 2004, CELL MOL LIFE SCI, V61, P2224, DOI 10.1007/s00018-004-4070-7; Novitch BG, 1999, CURR BIOL, V9, P449, DOI 10.1016/S0960-9822(99)80210-3; Potthoff MJ, 2007, MOL CELL BIOL, V27, P8143, DOI 10.1128/MCB.01187-07; Qiao F, 2008, EXP CELL RES, V314, P3542, DOI 10.1016/j.yexcr.2008.08.023; Rashidian J, 2009, J NEUROSCI, V29, P12497, DOI 10.1523/JNEUROSCI.3892-09.2009; Shi LL, 2012, NEUROCHEM INT, V61, P227, DOI 10.1016/j.neuint.2012.04.019; Slevin M, 2006, CLIN SCI, V111, P171, DOI 10.1042/CS20060049; Slevin M, 2009, CURR OPIN PHARMACOL, V9, P119, DOI 10.1016/j.coph.2008.10.003; Smith PD, 2006, J NEUROSCI, V26, P440, DOI 10.1523/JNEUROSCI.2875-05.2006; Stec J, 2005, J MOL DIAGN, V7, P357, DOI 10.1016/S1525-1578(10)60565-X; Tang XL, 2005, J NEUROSCI, V25, P4823, DOI 10.1523/JNEUROSCI.1331-05.2005; Timsit S, 2012, CLIN PHARMACOL THER, V91, P327, DOI 10.1038/clpt.2011.312; Vath A, 2002, ACT NEUR S, V81, P307; Wesierska-Gadek J, 2008, J CELL BIOCHEM, V105, P1161, DOI 10.1002/jcb.21903; Zahler S, 2010, ANGIOGENESIS, V13, P239, DOI 10.1007/s10456-010-9181-1	40	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75538	10.1371/journal.pone.0075538	http://dx.doi.org/10.1371/journal.pone.0075538			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098701	gold, Green Published, Green Accepted			2022-12-25	WOS:000325423500072
J	Latronico, N; Filosto, M; Fagoni, N; Gheza, L; Guarneri, B; Todeschini, A; Lombardi, R; Padovani, A; Lauria, G				Latronico, Nicola; Filosto, Massimiliano; Fagoni, Nazzareno; Gheza, Laura; Guarneri, Bruno; Todeschini, Alice; Lombardi, Raffaella; Padovani, Alessandro; Lauria, Giuseppe			Small Nerve Fiber Pathology in Critical Illness	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; SKIN BIOPSY; CUTANEOUS INNERVATION; PERIPHERAL-NERVE; CHRONIC PAIN; ILL PATIENTS; CARE; NEUROPATHY; WEAKNESS; POLYNEUROPATHY	Background: Degeneration of intraepidermal nerve fibers (IENF) is a hallmark of small fiber neuropathy of different etiology, whose clinical picture is dominated by neuropathic pain. It is unknown if critical illness can affect IENF. Methods: We enrolled 14 adult neurocritical care patients with prolonged intensive care unit (ICU) stay and artificial ventilation (>= 3 days), and no previous history or risk factors for neuromuscular disease. All patients underwent neurological examination including evaluation of consciousness, sensory functions, muscle strength, nerve conduction study and needle electromyography, autonomic dysfunction using the finger wrinkling test, and skin biopsy for quantification of IENF and sweat gland innervation density during ICU stay and at follow-up visit. Development of infection, sepsis and multiple organ failure was recorded throughout the ICU stay. Results: Of the 14 patients recruited, 13 (93%) had infections, sepsis or multiple organ failure. All had severe and non-length dependent loss of IENF. Sweat gland innervation was reduced in all except one patient. Of the 7 patients available for follow-up visit, three complained of diffuse sensory loss and burning pain, and another three showed clinical dysautonomia. Conclusions: Small fiber pathology can develop in the acute phase of critical illness and may explain chronic sensory impairment and pain in neurocritical care survivors. Its impact on long term disability warrants further studies involving also non-neurologic critical care patients.	[Latronico, Nicola; Fagoni, Nazzareno; Gheza, Laura] Univ Brescia, Spedali Civili, Sect Neuroanesthesia & Neurocrit Care, Dept Anesthesia & Crit Care Med, Brescia, Italy; [Filosto, Massimiliano; Todeschini, Alice; Padovani, Alessandro] Univ Brescia, Spedali Civili, Dept Clin Neurol, Sect Neuromuscular Dis & Neuropathies, Brescia, Italy; [Guarneri, Bruno] Univ Brescia, Spedali Civili, Dept Clin Neurophysiol, Brescia, Italy; [Lombardi, Raffaella; Lauria, Giuseppe] IRCCS Fdn, Carlo Besta Neurol Inst, Neuromuscular Dis Unit, Milan, Italy	Hospital Spedali Civili Brescia; University of Brescia; Hospital Spedali Civili Brescia; University of Brescia; Hospital Spedali Civili Brescia; University of Brescia; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Istituto Neurologico Besta	Latronico, N (corresponding author), Univ Brescia, Spedali Civili, Sect Neuroanesthesia & Neurocrit Care, Dept Anesthesia & Crit Care Med, Brescia, Italy.	nicola.latronico@med.unibs.it	Fagoni, Nazzareno/I-1156-2016; lauria, giuseppe/AAN-5371-2020; Padovani, Alessandro/ABI-7312-2020; Lombardi, Raffaella/K-7951-2016; Filosto, Massimiliano/S-9446-2019; Lauria, Giuseppe/T-1378-2017; LATRONICO, Nicola/F-1557-2010	Fagoni, Nazzareno/0000-0002-7312-8174; lauria, giuseppe/0000-0001-9773-020X; Padovani, Alessandro/0000-0002-0119-3639; Lombardi, Raffaella/0000-0003-0080-6699; Filosto, Massimiliano/0000-0002-2852-7512; Lauria, Giuseppe/0000-0001-9773-020X; LATRONICO, Nicola/0000-0002-2521-5871	University of Brescia; "Carlo Besta" Neurological Institute	University of Brescia; "Carlo Besta" Neurological Institute	The study was funded with internal funds of the University of Brescia and of the "Carlo Besta" Neurological Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel MJ, 2007, CAN J NEUROL SCI, V34, P427, DOI 10.1017/S0317167100007307; Batt J, 2013, AM J RESP CRIT CARE, V187, P238, DOI 10.1164/rccm.201205-0954SO; Battle CE, 2013, CRIT CARE, V17, DOI 10.1186/cc12746; Bolton C, 2007, CAN J NEUROL SCI, V34, P313, DOI 10.1017/S0317167100006739; Chiang MC, 2002, NEUROLOGY, V59, P1094, DOI 10.1212/WNL.59.7.1094; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Devigili G, 2008, BRAIN, V131, P1912, DOI 10.1093/brain/awn093; England JD, 2009, NEUROLOGY, V72, P177, DOI 10.1212/01.wnl.0000336345.70511.0f; Faber CG, 2012, ANN NEUROL, V71, P26, DOI 10.1002/ana.22485; Fenzi F, 2003, ACTA NEUROPATHOL, V106, P75, DOI 10.1007/s00401-003-0704-3; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Guarneri B, 2008, J NEUROL NEUROSUR PS, V79, P838, DOI 10.1136/jnnp.2007.142430; Iwashyna TJ, 2010, ANN INTERN MED, V153, P204, DOI 10.7326/0003-4819-153-3-201008030-00013; Kramer HH, 2004, DIABETES CARE, V27, P2386, DOI 10.2337/diacare.27.10.2386; Kyranou M, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-36; Latronico N, 2005, CURR OPIN CRIT CARE, V11, P381, DOI 10.1097/01.ccx.0000168530.30702.3e; Latronico N, 2007, CRIT CARE, V11, DOI 10.1186/cc5671; Latronico N, 2011, LANCET NEUROL, V10, P931, DOI 10.1016/S1474-4422(11)70178-8; Lauria G, 2004, MUSCLE NERVE, V30, P310, DOI 10.1002/mus.20098; Lauria G, 2010, EUR J NEUROL, V17, P903, DOI 10.1111/j.1468-1331.2010.03023.x; Lauria G, 2007, BRIT MED J, V334, P1159, DOI 10.1136/bmj.39192.488125.BE; Lauria G, 2010, J PERIPHER NERV SYST, V15, P202, DOI 10.1111/j.1529-8027.2010.00271.x; Martinez V, 2010, PAIN, V151, P53, DOI 10.1016/j.pain.2010.05.017; Misak CJ, 2011, AM J RESP CRIT CARE, V183, P845, DOI 10.1164/rccm.201007-1110OE; Needham DM, 2012, CRIT CARE MED, V40, P502, DOI 10.1097/CCM.0b013e318232da75; Pan CL, 2003, BRAIN, V126, P386, DOI 10.1093/brain/awg039; Ruts L, 2012, PAIN, V153, P399, DOI 10.1016/j.pain.2011.10.037; Seneviratne U, 2002, J NEUROL NEUROSUR PS, V72, P540; Sghirlanzoni A, 2005, LANCET NEUROL, V4, P349, DOI 10.1016/S1474-4422(05)70096-X; Singer M, 2004, LANCET, V364, P545, DOI 10.1016/S0140-6736(04)16815-3; Sommer C, 2007, LANCET NEUROL, V6, P632, DOI 10.1016/S1474-4422(07)70172-2; Sorensen L, 2006, DIABETES CARE, V29, P883, DOI 10.2337/diacare.29.04.06.dc05-2180; Teoh HL, 2008, J NEUROL NEUROSUR PS, V79, P835, DOI 10.1136/jnnp.2007.140947; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Uceyler N, 2013, BRAIN, V136, P1857, DOI 10.1093/brain/awt053; Wilder-Smith EP, 2009, CLIN NEUROPHYSIOL, V120, P953, DOI 10.1016/j.clinph.2009.03.011; Zamperetti N, 2008, INTENS CARE MED, V34, P1330, DOI 10.1007/s00134-008-1096-6	37	33	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75696	10.1371/journal.pone.0075696	http://dx.doi.org/10.1371/journal.pone.0075696			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098716	Green Published, gold, Green Submitted			2022-12-25	WOS:000325423500087
J	Liao, WC; Wang, YJ; Huang, MC; Tseng, GF				Liao, Wen-Chieh; Wang, Yueh-Jan; Huang, Min-Chuan; Tseng, Guo-Fang			Methylcobalamin Facilitates Collateral Sprouting of Donor Axons and Innervation of Recipient Muscle in End-to-Side Neurorrhaphy in Rats	PLOS ONE			English	Article							NERVE REGENERATION; SCHWANN-CELLS; PLEIOTROPHIN; REPAIR; VITAMIN-B-12; DEFICIENCY; COAPTATION; NEUROPATHY; PATHWAYS; RECOVERY	Using ulnar nerve as donor and musculocutaneous nerve as recipient we found earlier that end-to-side neurorrhaphy resulted in weak functional reinnervation after lengthy survival. End-to-side neurorrhaphy however is the sole choice of nerve repair at times and has the advantage of conserving donor nerve function. Here, we investigated whether myelination-enhancing agent methylcobalamin and motoneuron trophic factor pleiotrophin enhances the recovery after end-to-side neurorrhaphy. Methylcobalamin significantly increased the expression of growth associated protein 43 and S100 protein and beta III tubulin in musculocutaneous nerve 1 month after neurorrhaphy suggesting the ingrowth of ulnar axonal sprouts in reactive Schwann cell environment. Upper limb functional test, compound muscle action potential measurements, motor end plate counts, and axon and myelin analyses showed that methylcobalamin treatment alone or with pleiotrophin improved the recovery significantly, 3 and 6 months post-surgery. There were fewer axons, closer in number to that of the intact recipient nerve, found in the distal repaired nerve of the methylcobalamin-treated than that of the vehicle control, suggesting that methylcobalamin facilitates axonal maturation and eliminates supernumerary sprouts. In conclusion, our results showed that methylcobalamin does indeed enhance the recovery of peripheral nerve repaired in end-to-side configuration.	[Liao, Wen-Chieh] Chung Shan Med Univ, Fac Med, Dept Anat, Taichung, Taiwan; [Liao, Wen-Chieh] Chung Shan Med Univ Hosp, Dept Pediat, Taichung, Taiwan; [Wang, Yueh-Jan; Tseng, Guo-Fang] Tzu Chi Univ, Dept Anat, Coll Med, Hualien, Taiwan; [Huang, Min-Chuan] Natl Taiwan Univ, Coll Med, Inst Anat & Cell Biol, Taipei, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Tzu Chi University; National Taiwan University	Tseng, GF (corresponding author), Tzu Chi Univ, Dept Anat, Coll Med, Hualien, Taiwan.	guofang@mail.tcu.edu.tw		HUANG, MIN-CHUAN/0000-0002-0704-3447; Liao, Wen Chieh/0000-0001-7848-2124	Tzu-Chi University [TCIRP 95003, 98006]; National Science council of Taiwan [NSC101-2320- B-320-001, NSC101-2320-B-040-003]	Tzu-Chi University; National Science council of Taiwan(Ministry of Science and Technology, Taiwan)	The study is supported by grants from the Tzu-Chi University (TCIRP 95003 and 98006 to YJW and GFT) and National Science council of Taiwan (NSC101-2320- B-320-001 to GFT; NSC101-2320-B-040-003 to WCL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeda K, 2006, PLAST RECONSTR SURG, V117, P1194, DOI 10.1097/01.prs.0000201460.54187.d7; Alfonsi E, 1984, Minerva Med, V75, P1727; Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; Beris A, 2007, J NEUROTRAUM, V24, P909, DOI 10.1089/neu.2006.0165; BEUCHE W, 1984, J NEUROCYTOL, V13, P767, DOI 10.1007/BF01148493; Blondet B, 2005, J HISTOCHEM CYTOCHEM, V53, P971, DOI 10.1369/jhc.4A6574.2005; Chang HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053444; Chen JR, 2010, NEUROSCIENCE, V167, P414, DOI 10.1016/j.neuroscience.2010.02.028; Chen YG, 1998, J HAND SURG-AM, V23A, P1025, DOI 10.1016/S0363-5023(98)80010-5; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Geuna S, 2006, BRAIN RES REV, V52, P381, DOI 10.1016/j.brainresrev.2006.05.002; Guntinas-Lichius O, 2007, NEUROSURGERY, V61, P1276, DOI 10.1227/01.neu.0000306107.70421.a4; HAN YF, 2011, CHIN J HEMORHEOL, V21, P761; Izumi Yuishin, 2007, Brain and Nerve (Tokyo), V59, P1141; KONG X, 2004, EYE SCI, V20, P171; Ladak A, 2011, NEUROSURGERY, V68, P1654, DOI 10.1227/NEU.0b013e31821246a8; Li JB, 2010, NUTR NEUROSCI, V13, P79, DOI 10.1179/147683010X12611460763607; Liao WC, 2010, NEUROSCIENCE, V171, P934, DOI 10.1016/j.neuroscience.2010.09.036; Liao WC, 2009, J ANAT, V215, P506, DOI 10.1111/j.1469-7580.2009.01135.x; Lovblad KO, 1997, PEDIATR RADIOL, V27, P155, DOI 10.1007/s002470050090; Matsuda K, 2005, J RECONSTR MICROSURG, V21, P581, DOI 10.1055/s-2005-922439; Matsumoto M, 1999, J RECONSTR MICROSURG, V15, P281, DOI 10.1055/s-2007-1000102; Mi RF, 2007, P NATL ACAD SCI USA, V104, P4664, DOI 10.1073/pnas.0603243104; Miller A, 2005, J NEUROL SCI, V233, P93, DOI 10.1016/j.jns.2005.03.009; Millesi H, 2007, ACTA NEUROCHIR SUPPL, V100, P103; Mizukami H, 2011, EUR J CLIN INVEST, V41, P442, DOI 10.1111/j.1365-2362.2010.02430.x; Okada K, 2010, EXP NEUROL, V222, P191, DOI 10.1016/j.expneurol.2009.12.017; Perez-Pinera P, 2008, CURR OPIN HEMATOL, V15, P210, DOI 10.1097/MOH.0b013e3282fdc69e; RHODE BM, 1995, OBES SURG, V5, P154, DOI 10.1381/096089295765557953; Sato Y, 2005, J NEUROL SCI, V231, P13, DOI 10.1016/j.jns.2004.12.005; Scalabrino G, 2006, TRENDS MOL MED, V12, P247, DOI 10.1016/j.molmed.2006.04.008; Schmidhammer R, 2009, EXP NEUROL, V217, P388, DOI 10.1016/j.expneurol.2009.03.027; SCHRIMSHER GW, 1992, EXP NEUROL, V117, P287, DOI 10.1016/0014-4886(92)90138-G; Streppel M, 2002, EUR J NEUROSCI, V15, P1327, DOI 10.1046/j.1460-9568.2002.01971.x; VITERBO F, 1994, PLAST RECONSTR SURG, V94, P1038, DOI 10.1097/00006534-199412000-00019; Viterbo F, 1992, Rev Paul Med, V110, P267; Viterbo Fausto, 2009, Plast Reconstr Surg, V124, pe351, DOI 10.1097/PRS.0b013e3181bf8471; Vrbova G, 2009, EUR J NEUROSCI, V30, P366, DOI 10.1111/j.1460-9568.2009.06847.x; Yamatsu K, 1976, Nihon Yakurigaku Zasshi, V72, P269	39	23	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76302	10.1371/journal.pone.0076302	http://dx.doi.org/10.1371/journal.pone.0076302			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098787	gold, Green Published, Green Submitted			2022-12-25	WOS:000325423500158
J	Molderings, GJ; Haenisch, B; Bogdanow, M; Fimmers, R; Nothen, MM				Molderings, Gerhard J.; Haenisch, Britta; Bogdanow, Manuela; Fimmers, Rolf; Noethen, Markus M.			Familial Occurrence of Systemic Mast Cell Activation Disease	PLOS ONE			English	Article							TYROSINE KINASE; KIT MUTATION; MASTOCYTOSIS; CLASSIFICATION; FIBROMYALGIA; PATHOGENESIS; DIAGNOSTICS; DISORDER; CRITERIA; THERAPY	Systemic mast cell activation disease (MCAD) comprises disorders characterized by an enhanced release of mast cell mediators accompanied by accumulation of dysfunctional mast cells. Demonstration of familial clustering would be an important step towards defining the genetic contribution to the risk of systemic MCAD. The present study aimed to quantify familial aggregation for MCAD and to investigate the variability of clinical and molecular findings (e. g. somatic mutations in KIT) among affected family members in three selected pedigrees. Our data suggest that systemic MCAD pedigrees include more systemic MCAD cases than would be expected by chance, i.e., compared with the prevalence of MCAD in the general population. The prevalence of MCAD suspected by symptom self-report in first-degree relatives of patients with MCAD amounted to approximately 46%, compared to prevalence in the general German population of about 17% (p < 0.0001). In three families with a high familial loading of MCAD, the subtype of MCAD and the severity of mediator-related symptoms varied between family members. In addition, genetic alterations detected in KIT were variable, and included mutations at position 816 of the amino acid sequence. In conclusion, our data provide evidence for common familial occurrence of MCAD. Our findings observed in the three pedigrees together with recent reports in the literature suggest that, in familial cases (i.e., in the majority of MCAD), mutated disease-related operator and/or regulator genes could be responsible for the development of somatic mutations in KIT and other proteins important for the regulation of mast cell activity. Accordingly, the immunohistochemically different subtypes of MCAD (i.e. mast cell activation syndrome and systemic mastocytosis) should be more accurately regarded as varying presentations of a common generic root process of mast cell dysfunction, than as distinct diseases.	[Molderings, Gerhard J.; Haenisch, Britta; Noethen, Markus M.] Univ Hosp Bonn, Inst Human Genet, Bonn, Germany; [Haenisch, Britta] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Haenisch, Britta] Fed Inst Drugs & Med Devices BfArM, Bonn, Germany; [Haenisch, Britta] Univ Bonn, Dept Psychiat, Bonn, Germany; [Bogdanow, Manuela; Fimmers, Rolf] Univ Hosp Bonn, Inst Med Biometry Informat & Epidemiol, Bonn, Germany	University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; University of Bonn	Molderings, GJ (corresponding author), Univ Hosp Bonn, Inst Human Genet, Bonn, Germany.	molderings@uni-bonn.de		Nothen, Markus/0000-0002-8770-2464	B. Braun-Stiftung; Forderclub Mastzellforschung e.V.	B. Braun-Stiftung; Forderclub Mastzellforschung e.V.	This study was supported by grants from the B. Braun-Stiftung and the Forderclub Mastzellforschung e.V.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Kar S, 2013, HAEMATOLOGICA, V98, P107, DOI 10.3324/haematol.2012.064048; Akin C, 2010, J ALLERGY CLIN IMMUN, V126, P1099, DOI 10.1016/j.jaci.2010.08.035; Alfter K, 2009, LIVER INT, V29, P181, DOI 10.1111/j.1478-3231.2008.01839.x; Alvarez-Twose I, 2010, J ALLERGY CLIN IMMUN, V125, P1269, DOI 10.1016/j.jaci.2010.02.019; Blanco I, 2010, CLIN RHEUMATOL, V29, P1403, DOI 10.1007/s10067-010-1474-7; Bodemer C, 2010, J INVEST DERMATOL, V130, P804, DOI 10.1038/jid.2009.281; Broesby-Olsen S, 2012, J ALLERGY CLIN IMMUN, V130, P806, DOI 10.1016/j.jaci.2012.04.013; Burks KD, 2005, J INVEST MED, V53, pS300; Bursztejn AC, 2009, J INVEST DERMATOL, V129, P2528; Frieling T, 2011, Z GASTROENTEROL, V49, P191, DOI 10.1055/s-0029-1245707; Haenisch B, 2012, IMMUNOLOGY, V137, P197, DOI 10.1111/j.1365-2567.2012.03627.x; Hamilton MJ, 2011, J ALLERGY CLIN IMMUN, V128, P147, DOI 10.1016/j.jaci.2011.04.037; Lim KH, 2009, BLOOD, V113, P5727, DOI 10.1182/blood-2009-02-205237; Longley BJ, 1999, P NATL ACAD SCI USA, V96, P1609, DOI 10.1073/pnas.96.4.1609; Lucas HJ, 2006, INT J IMMUNOPATH PH, V19, P5; Molderings GJ, 2006, DEUT MED WOCHENSCHR, V131, P2095, DOI 10.1055/s-2006-951337; Molderings GJ, 2007, SCAND J GASTROENTERO, V42, P1045, DOI 10.1080/00365520701245744; Molderings GJ, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-10; Molderings GJ, 2010, IMMUNOGENETICS, V62, P721, DOI 10.1007/s00251-010-0474-8; Seidel H, 2011, THROMB HAEMOSTASIS, V106, P987, DOI 10.1160/TH11-05-0351; Soucie E, 2012, BLOOD, V120, P4846, DOI 10.1182/blood-2011-12-397588; Spector MS, 2012, LEUKEMIA, V26, P1422, DOI 10.1038/leu.2011.354; Tefferi A, 2009, LEUKEMIA, V23, P900, DOI 10.1038/leu.2009.37; Teodosio C, 2010, J ALLERGY CLIN IMMUN, V125, P719, DOI 10.1016/j.jaci.2009.10.020; Traina F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043090; Valent P, 2007, EUR J CLIN INVEST, V37, P435, DOI 10.1111/j.1365-2362.2007.01807.x; Valent P, 2013, ALLERGY, V68, P417, DOI 10.1111/all.12126; Valent P, 2012, INT ARCH ALLERGY IMM, V157, P215, DOI 10.1159/000328760; Wohrl S, 2013, J INVEST DERMATOL, V133, P839, DOI 10.1038/jid.2012.394; Zanotti R, 2013, J ALLERGY CLIN IMMUN, V131, P605, DOI 10.1016/j.jaci.2012.11.040; Zhang LY, 2006, LEUKEMIA RES, V30, P373, DOI 10.1016/j.leukres.2005.08.015	31	66	66	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76241	10.1371/journal.pone.0076241	http://dx.doi.org/10.1371/journal.pone.0076241			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098785	Green Published, gold, Green Submitted			2022-12-25	WOS:000325423500156
J	Wu, CC; Lin, YM; Gao, J; Winston, JH; Cheng, LK; Shi, XZ				Wu, Chester C.; Lin, You-Min; Gao, Jerry; Winston, John H.; Cheng, Leo K.; Shi, Xuan-Zheng			Are Interstitial Cells of Cajal Involved in Mechanical Stress-Induced Gene Expression and Impairment of Smooth Muscle Contractility in Bowel Obstruction?	PLOS ONE			English	Article							MOTILITY DYSFUNCTION; ICC	Background and Aims: The network of interstitial cells of Cajal (ICC) is altered in obstructive bowel disorders (OBD). However, whether alteration in ICC network is a cause or consequence of OBD remains unknown. This study tested the hypothesis that mechanical dilation in obstruction disrupts the ICC network and that ICC do not mediate mechanotranscription of COX-2 and impairment of smooth muscle contractility in obstruction. Methods: Medical-grade silicon bands were wrapped around the distal colon to induce partial obstruction in wild-type and ICC deficient (W/W-v) mice. Results: In wild-type mice, colon obstruction led to time-dependent alterations of the ICC network in the proximal colon segment. Although unaffected on days 1 and 3, the ICC density decreased markedly and the network was disrupted on day 7 of obstruction. COX-2 expression increased, and circular muscle contractility decreased significantly in the segment proximal to obstruction. In W/Wv control mice, COX-2 mRNA level was 4.0 (+/- 1.1)-fold higher (n=4) and circular muscle contractility was lower than in wild-type control mice. Obstruction further increased COX-2 mRNA level in W/Wv mice to 7.2 (+/- 1.0)-fold vs. W/Wv controls [28.8 (+/- 4.1)-fold vs. wild-type controls] on day 3. Obstruction further suppressed smooth muscle contractility in W/Wv mice. However, daily administration of COX-2 inhibitor NS-398 significantly improved muscle contractility in both W/Wv sham and obstruction mice. Conclusions: Lumen dilation disrupts the ICC network. ICC deficiency has limited effect on stretch-induced expression of COX-2 and suppression of smooth muscle contractility in obstruction. Rather, stretch-induced COX-2 plays a critical role in motility dysfunction in partial colon obstruction.	[Wu, Chester C.; Lin, You-Min; Winston, John H.; Shi, Xuan-Zheng] Univ Texas Med Branch, Dept Internal Med, Div Gastroenterol & Hepatol, Galveston, TX 77555 USA; [Gao, Jerry; Cheng, Leo K.] Univ Auckland, Auckland Bioengn Inst, Auckland 1, New Zealand; [Cheng, Leo K.] Vanderbilt Univ, Depertment Surg, Nashville, TN 37235 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Auckland; Vanderbilt University	Shi, XZ (corresponding author), Univ Texas Med Branch, Dept Internal Med, Div Gastroenterol & Hepatol, Galveston, TX 77555 USA.	xushi@utmb.edu			National Institute of Health (NIH) [DK082563]; NIH [DK064775]; University of Auckland Health Research Doctoral Scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064775, R01DK082563] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Auckland Health Research Doctoral Scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Health (NIH) (DK082563 to XZS). LKC was supported in part by NIH DK064775. JG was supported by a University of Auckland Health Research Doctoral Scholarship, a Freemason Postgraduate Scholarship and a R. H. T. Bates Postgraduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang IY, 2001, J PHYSIOL-LONDON, V536, P555, DOI 10.1111/j.1469-7793.2001.0555c.xd; FAUSSONEPELLEGRINI MS, 1985, J SUBMICR CYTOL PATH, V17, P673; Gao J, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0421; Goyal RK, 2010, AM J PHYSIOL-GASTR L, V298, pG10, DOI 10.1152/ajpgi.00426.2009; He CL, 2000, GASTROENTEROLOGY, V118, P14, DOI 10.1016/S0016-5085(00)70409-4; Isozaki K, 1997, AM J GASTROENTEROL, V92, P332; Jordan G L Jr, 1980, Adv Surg, V14, P259; Li F, 2012, AM J PHYSIOL-GASTR L, V303, pG646, DOI 10.1152/ajpgi.00440.2011; Lin YM, 2012, NEUROGASTROENT MOTIL, V24, DOI 10.1111/j.1365-2982.2012.01918.x; Lin YM, 2012, AM J PHYSIOL-GASTR L, V302, pG267, DOI 10.1152/ajpgi.00326.2011; Okada T, 2010, J PEDIATR SURG, V45, pE11, DOI 10.1016/j.jpedsurg.2010.03.024; Okishio Yutaka, 2005, Journal of Smooth Muscle Research, V41, P163, DOI 10.1540/jsmr.41.163; Russell J., 1990, BOWEL OBSTRUCTION, P28; Sanders KM, 1999, NEUROGASTROENT MOTIL, V11, P311; Sarna SK, 2008, AM J PHYSIOL-GASTR L, V294, pG372, DOI 10.1152/ajpgi.00344.2007; Shi XZ, 2007, GASTROENTEROLOGY, V132, P1388, DOI 10.1053/j.gastro.2007.02.016; Shi XZ, 2011, AM J PHYSIOL-GASTR L, V300, pG99, DOI 10.1152/ajpgi.00379.2010; Summers RW, 1999, TXB GASTROENTEROLOGY, V1, P715; Thomsen L, 1998, NAT MED, V4, P848, DOI 10.1038/nm0798-848; Vanderwinden JM, 1996, GASTROENTEROLOGY, V111, P279, DOI 10.1053/gast.1996.v111.pm8690192; Wedel T, 2002, GASTROENTEROLOGY, V123, P1459, DOI 10.1053/gast.2002.36600; Welch J.P., 1990, BOWEL OBSTRUCTION, P59; Won KJ, 2006, NEUROGASTROENT MOTIL, V18, P53, DOI 10.1111/j.1365-2982.2005.00718.x; Won KJ, 2005, P NATL ACAD SCI USA, V102, P14913, DOI 10.1073/pnas.0503628102; Zarate N, 2003, GUT, V52, P966, DOI 10.1136/gut.52.7.966	25	10	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76222	10.1371/journal.pone.0076222	http://dx.doi.org/10.1371/journal.pone.0076222			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098782	Green Submitted, Green Published, gold			2022-12-25	WOS:000325423500152
J	Zhong, XW; Zou, Y; Liu, SP; Yi, QY; Hu, CM; Wang, C; Xia, QY; Zhao, P				Zhong, Xiao-wu; Zou, Yong; Liu, Shi-ping; Yi, Qi-ying; Hu, Cui-mei; Wang, Chen; Xia, Qing-you; Zhao, Ping			Proteomic-Based Insight into Malpighian Tubules of Silkworm Bombyx mori	PLOS ONE			English	Article							DOMESTICATED SILKWORM; RENAL TUBULE; H+-ATPASE; DROSOPHILA; ELECTROPHORESIS; SUBUNIT; GENOME; TOOL; L.	Malpighian tubules (MTs) are highly specific organs of arthropods (Insecta, Myriapoda and Arachnida) for excretion and osmoregulation. In order to highlight the important genes and pathways involved in multi-functions of MTs, we performed a systematic proteomic analysis of silkworm MTs in the present work. Totally, 1,367 proteins were identified by one-dimensional gel electrophoresis coupled with liquid chromatography-tandem mass spectrometry, and as well as by Trans Proteomic Pipeline (TPP) and Absolute protein expression (APEX) analyses. Forty-one proteins were further identified by two-dimensional gel electrophoresis. Some proteins were revealed to be significantly associated with various metabolic processes, organic solute transport, detoxification and innate immunity. Our results might lay a good foundation for future functional studies of MTs in silkworm and other lepidoptera.	[Zhong, Xiao-wu; Zou, Yong; Liu, Shi-ping; Yi, Qi-ying; Hu, Cui-mei; Wang, Chen; Xia, Qing-you; Zhao, Ping] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China	Southwest University - China	Zhao, P (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	zhaop@swu.edu.cn	Liu, Shiping/W-2577-2019	Liu, Shiping/0000-0002-2917-0172	National Basic Research Program of China [2012CB114604]; National Hi-Tech Research and Development Program of China [2011AA100306]; National Natural Science Foundation [31172157]	National Basic Research Program of China(National Basic Research Program of China); National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Basic Research Program of China (Grant No. 2012CB114604), http://www.973.gov.cn/Default_3.aspx, the National Hi-Tech Research and Development Program of China (Grant No. 2011AA100306), http://www.863.gov.cn/, the National Natural Science Foundation (Grant No. 31172157), http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyenbach KW, 2010, ANNU REV ENTOMOL, V55, P351, DOI 10.1146/annurev-ento-112408-085512; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Couble P, 2008, INSECT BIOCHEM MOLEC, V38, P1035, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Crabb DW, 2004, P NUTR SOC, V63, P49, DOI 10.1079/PNS2003327; Craig CL, 1997, ANNU REV ENTOMOL, V42, P231, DOI 10.1146/annurev.ento.42.1.231; Davies SA, 1996, J BIOL CHEM, V271, P30677, DOI 10.1074/jbc.271.48.30677; Dow JAT, 2003, PHYSIOL REV, V83, P687, DOI 10.1152/physrev.00035.2002; Dow JAT, 2001, ADV INSECT PHYSIOL, V28, P1, DOI 10.1016/S0065-2806(01)28008-4; Dow JAT, 2006, J INSECT PHYSIOL, V52, P365, DOI 10.1016/j.jinsphys.2005.10.007; Dow JAT, 2009, J EXP BIOL, V212, P435, DOI 10.1242/jeb.024224; Duan J, 2010, NUCLEIC ACIDS RES, V38, pD453, DOI 10.1093/nar/gkp801; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Fu Q, 2011, PROTEOMICS, V11, P3761, DOI 10.1002/pmic.201000506; Fuster DG, 2008, KIDNEY INT, V73, P1151, DOI 10.1038/ki.2008.96; Hou Y, 2007, INSECT BIOCHEM MOLEC, V37, P486, DOI 10.1016/j.ibmb.2007.02.011; Hou Y, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-45; Igarashi P, 2005, J AM SOC NEPHROL, V16, P296, DOI 10.1681/ASN.2004110951; Jung AC, 2005, J AM SOC NEPHROL, V16, P322, DOI 10.1681/ASN.2004090729; Kajiwara H, 2009, J ELECTROPHORESIS, V53, P33; KENCHINGTON W, 1983, J INSECT PHYSIOL, V29, P355, DOI 10.1016/0022-1910(83)90037-9; Kuntumalla S, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-22; LEE SHC, 1986, BIOCHEM J, V233, P621, DOI 10.1042/bj2330621; Li JY, 2010, INSECT BIOCHEM MOLEC, V40, P293, DOI 10.1016/j.ibmb.2010.01.008; Li JY, 2009, J PROTEOME RES, V8, P2620, DOI 10.1021/pr8006123; Li JY, 2010, AMINO ACIDS, V39, P751, DOI 10.1007/s00726-010-0517-3; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; McGettigan J, 2005, INSECT BIOCHEM MOLEC, V35, P741, DOI 10.1016/j.ibmb.2005.02.017; Millares P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033590; Moe OW, 2006, LANCET, V367, P333, DOI 10.1016/S0140-6736(06)68071-9; Nappi AJ, 2000, NITRIC OXIDE-BIOL CH, V4, P423, DOI 10.1006/niox.2000.0294; Neilson KA, 2011, PROTEOMICS, V11, P535, DOI 10.1002/pmic.201000553; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; Reidegeld KA, 2008, PROTEOMICS, V8, P1129, DOI 10.1002/pmic.200701073; TEIGLER DJ, 1972, TISSUE CELL, V4, P173, DOI 10.1016/S0040-8166(72)80014-4; Wang J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r69; Weng XH, 2003, J EXP BIOL, V206, P2211, DOI 10.1242/jeb.00385; WESSING A, 1993, J COMP PHYSIOL B, V163, P452; Xia QY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r162; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6; Yang HJ, 2010, AMINO ACIDS, V38, P1333, DOI 10.1007/s00726-009-0342-8; Yang J, 2007, PHYSIOL GENOMICS, V30, P223, DOI 10.1152/physiolgenomics.00018.2007; Yao HP, 2009, BIOSCIENCE REP, V29, P363, DOI 10.1042/BSR20080144; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhong XW, 2012, INSECT SCI, V19, P559, DOI 10.1111/j.1744-7917.2011.01479.x; Zhong XW, 2012, BMB REP, V45, P665, DOI 10.5483/BMBRep.2012.45.11.261	46	13	15	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75731	10.1371/journal.pone.0075731	http://dx.doi.org/10.1371/journal.pone.0075731			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098719	Green Submitted, Green Published, gold			2022-12-25	WOS:000325423500090
J	Goggs, R; Harper, MT; Pope, RJ; Savage, JS; Williams, CM; Mundell, SJ; Heesom, KJ; Bass, M; Mellor, H; Poole, AW				Goggs, Robert; Harper, Matthew T.; Pope, Robert J.; Savage, Joshua S.; Williams, Christopher M.; Mundell, Stuart J.; Heesom, Kate J.; Bass, Mark; Mellor, Harry; Poole, Alastair W.			RhoG Protein Regulates Platelet Granule Secretion and Thrombus Formation in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Platelets; Proteomics; Rho GTPases; Secretion; Thrombosis; Transgenic Mice	NUCLEOTIDE EXCHANGE FACTOR; PHOSPHATIDYLSERINE EXPOSURE DOWNSTREAM; GLYCOPROTEIN-VI DEFICIENCY; ACTIN CYTOSKELETON; ACTIVATES RAC1; STABILITY; KINASE; GROWTH; PHOSPHORYLATION; MECHANISMS	Background: Rho family GTPases are essential for normal platelet function, but the role of RhoG in platelets has not been studied previously. Results: Platelets lacking RhoG have reduced granule secretion, and RhoG null mice have impaired thrombus formation. Conclusion: RhoG is required for normal platelet granule secretion. Significance: RhoG is a novel regulator of platelet function and thrombosis. Rho GTPases such as Rac, RhoA, and Cdc42 are vital for normal platelet function, but the role of RhoG in platelets has not been studied. In other cells, RhoG orchestrates processes integral to platelet function, including actin cytoskeletal rearrangement and membrane trafficking. We therefore hypothesized that RhoG would play a critical role in platelets. Here, we show that RhoG is expressed in human and mouse platelets and is activated by both collagen-related peptide (CRP) and thrombin stimulation. We used RhoG(-/-) mice to study the function of RhoG in platelets. Integrin activation and aggregation were reduced in RhoG(-/-) platelets stimulated by CRP, but responses to thrombin were normal. The central defect in RhoG(-/-) platelets was reduced secretion from -granules, dense granules, and lysosomes following CRP stimulation. The integrin activation and aggregation defects could be rescued by ADP co-stimulation, indicating that they are a consequence of diminished dense granule secretion. Defective dense granule secretion in RhoG(-/-) platelets limited recruitment of additional platelets to growing thrombi in flowing blood in vitro and translated into reduced thrombus formation in vivo. Interestingly, tail bleeding times were normal in RhoG(-/-) mice, suggesting that the functions of RhoG in platelets are particularly relevant to thrombotic disorders.	[Goggs, Robert; Harper, Matthew T.; Pope, Robert J.; Savage, Joshua S.; Williams, Christopher M.; Mundell, Stuart J.; Poole, Alastair W.] Univ Bristol, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England; [Heesom, Kate J.] Univ Bristol, Prote Facil, Bristol BS8 1TD, Avon, England; [Bass, Mark; Mellor, Harry] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England	University of Bristol; University of Bristol; University of Bristol	Poole, AW (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Med Sci Bldg, Bristol BS8 1TD, Avon, England.	a.poole@bris.ac.uk	Harper, Matthew T/G-5630-2013; Savage, Joshua/A-8738-2008	Harper, Matthew T/0000-0002-4740-637X; Savage, Joshua/0000-0003-0599-0245; Goggs, Robert/0000-0001-7446-6987; Mellor, Harry/0000-0003-3894-0623; Poole, Alastair/0000-0002-0868-297X; Mundell, Stuart/0000-0001-7754-3271	Wellcome Trust Clinical Research Training Fellowship Award [WT090093MA]; British Heart Foundation grants [RG/10/006/28299, RG/05/083]; Medical Research Council [G1000432]; MRC [G1000432] Funding Source: UKRI; British Heart Foundation [RG/10/006/28299, PG/11/68/29074] Funding Source: researchfish	Wellcome Trust Clinical Research Training Fellowship Award(Wellcome Trust); British Heart Foundation grants; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation)	This work was supported by Wellcome Trust Clinical Research Training Fellowship Award WT090093MA (to R.G., H.M., and A.W.P.). British Heart Foundation grants (to A.W.P.) supported M.T.H. and C.M.W. (Grant RG/10/006/28299) and J.S.S. (Grant RG/05/083), and Medical Research Council Grant G1000432 (to Stuart Mundell) supported R.J.P.	Andre P, 2003, J CLIN INVEST, V112, P398, DOI 10.1172/JCI200317864; Aslan JE, 2013, J THROMB HAEMOST, V11, P35, DOI 10.1111/jth.12051; Bender M, 2011, J THROMB HAEMOST, V9, P1423, DOI 10.1111/j.1538-7836.2011.04328.x; Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001; Brass LF, 2011, J THROMB HAEMOST, V9, P66, DOI 10.1111/j.1538-7836.2011.04364.x; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; Chen D, 2000, BLOOD, V96, P1782, DOI 10.1182/blood.V96.5.1782.h8001782_1782_1788; Coppinger JA, 2004, BLOOD, V103, P2096, DOI 10.1182/blood-2003-08-2804; Daniel JL, 1998, J BIOL CHEM, V273, P2024, DOI 10.1074/jbc.273.4.2024; Daniel S, 2002, BIOCHEMISTRY-US, V41, P9663, DOI 10.1021/bi025604p; de Boer JD, 2012, BLOOD, V119, P3236, DOI 10.1182/blood-2011-11-391532; DeGeer J, 2013, MOL CELL BIOL, V33, P739, DOI 10.1128/MCB.01264-12; Dubois C, 2006, BLOOD, V107, P3902, DOI 10.1182/blood-2005-09-3687; Eckly A, 2011, J THROMB HAEMOST, V9, P779, DOI 10.1111/j.1538-7836.2011.04218.x; Ellerbroek SM, 2004, MOL BIOL CELL, V15, P3309, DOI 10.1091/mbc.E04-02-0146; Gauthier-Rouviere C, 1998, MOL BIOL CELL, V9, P1379, DOI 10.1091/mbc.9.6.1379; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Gilio K, 2010, J BIOL CHEM, V285, P23408, DOI 10.1074/jbc.M110.136176; Goggs R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054663; Harper MT, 2011, J THROMB HAEMOST, V9, P1599, DOI 10.1111/j.1538-7836.2011.04393.x; Harper MT, 2010, J BIOL CHEM, V285, P19865, DOI 10.1074/jbc.M109.085654; Ho E, 2012, MOL BIOL CELL, V23, P492, DOI 10.1091/mbc.E11-07-0596; Kaplan ZS, 2011, HEMATOL-AM SOC HEMAT, P51, DOI 10.1182/asheducation-2011.1.51; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Katoh H, 2000, MOL CELL BIOL, V20, P7378, DOI 10.1128/MCB.20.19.7378-7387.2000; Kim JY, 2011, J BIOL CHEM, V286, P37615, DOI 10.1074/jbc.M111.268029; Konopatskaya O, 2009, J CLIN INVEST, V119, P399, DOI 10.1172/JCI34665; Konstantinides S, 2006, J THROMB HAEMOST, V4, P2014, DOI 10.1111/j.1538-7836.2006.02086.x; Lenain N, 2003, J THROMB HAEMOST, V1, P1144, DOI 10.1046/j.1538-7836.2003.00144.x; Mangin P, 2006, BLOOD, V107, P4346, DOI 10.1182/blood-2005-10-4244; Massberg S, 2003, J EXP MED, V197, P41, DOI 10.1084/jem.20020945; McCarty OJT, 2005, J BIOL CHEM, V280, P39474, DOI 10.1074/jbc.M504672200; Monroe DM, 2006, ARTERIOSCL THROM VAS, V26, P41, DOI 10.1161/01.ATV.0000193624.28251.83; Ory S, 2011, SEMIN CELL DEV BIOL, V22, P27, DOI 10.1016/j.semcdb.2010.12.002; Pearce AC, 2002, BLOOD, V100, P3561, DOI 10.1182/blood.V100.10.3561; Pleines I, 2012, BLOOD, V119, P1054, DOI 10.1182/blood-2011-08-372193; Pleines I, 2010, BLOOD, V115, P3364, DOI 10.1182/blood-2009-09-242271; Pleines I, 2009, PFLUG ARCH EUR J PHY, V457, P1173, DOI 10.1007/s00424-008-0573-7; Ren QS, 2008, CURR OPIN HEMATOL, V15, P537, DOI 10.1097/MOH.0b013e328309ec74; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Savage JS, 2013, J THROMB HAEMOST, V11, P771, DOI 10.1111/jth.12138; Schuebel KE, 1998, EMBO J, V17, P6608, DOI 10.1093/emboj/17.22.6608; Schwer HD, 2001, CURR BIOL, V11, P579, DOI 10.1016/S0960-9822(01)00153-1; Stalker Timothy J, 2012, Handb Exp Pharmacol, P59, DOI 10.1007/978-3-642-29423-5_3; Steinberg F, 2012, J CELL BIOL, V197, P219, DOI 10.1083/jcb.201111121; van Rijssel J, 2012, CELL ADHES MIGR, V6, P482, DOI 10.4161/cam.21418; Vignal E, 2001, MOL CELL BIOL, V21, P8022, DOI 10.1128/MCB.21.23.8022-8034.2001; Vigorito E, 2003, ONCOGENE, V22, P330, DOI 10.1038/sj.onc.1206116; Vigorito E, 2004, MOL CELL BIOL, V24, P719, DOI 10.1128/MCB.24.2.719-729.2004; Watson SP, 2005, J THROMB HAEMOST, V3, P1752, DOI 10.1111/j.1538-7836.2005.01429.x; Woronowicz K, 2010, BIOCHEMISTRY-US, V49, P4533, DOI 10.1021/bi100541t; Yokoyama S, 2005, J AM COLL CARDIOL, V45, P1280, DOI 10.1016/j.jacc.2004.12.071	53	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34217	34229		10.1074/jbc.M113.504100	http://dx.doi.org/10.1074/jbc.M113.504100			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24106270	Green Published, hybrid			2022-12-25	WOS:000327250200064
J	Liu, YF; Sun, LY; Singer, DV; Ginnan, R; Singer, HA				Liu, Yongfeng; Sun, Li-Yan; Singer, Diane V.; Ginnan, Roman; Singer, Harold A.			CaMKII delta-dependent Inhibition of cAMP-response Element-binding Protein Activity in Vascular Smooth Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; CaMKII; CREB; Thrombin; Vascular Smooth Muscle Cells; RGS2; SIK1	KINASE-II; ISOFORM REGULATION; CREB ACTIVATION; GENE-EXPRESSION; ANGIOTENSIN-II; TRANSCRIPTION; PHOSPHORYLATION; IDENTIFICATION; CA2+; IV	One transcription factor mediator of Ca2+-signals is cAMP response element-binding protein (CREB). CREB expression and/or activity negatively correlates with vascular smooth muscle (VSM) cell proliferation and migration. Multifunctional Ca2+/calmodulin-dependent protein kinases, including CaMKII, have been demonstrated to regulate CREB activity through both positive and negative phosphorylation events in vitro, but the function of CaMKII as a proximal regulator of CREB in intact cell systems, including VSM, is not clear. In this study, we used gain- and loss-of-function approaches to determine the function of CaMKII in regulating CREB phosphorylation, localization, and activity in VSM. Overexpression of constitutively active CaMKII specifically increased CREB phosphorylation on Ser(142) and silencing CaMKII expression by siRNA or blocking endogenous CaMKII activity with KN93 abolished thrombin- or ionomycin-induced CREB phosphorylation on Ser(142) without affecting Ser(133) phosphorylation. CREB-Ser(142) phosphorylation correlated with transient nucleocytoplasmic translocation of CREB. Thrombin-induced CREB promoter activity, CREB binding to Sik1 and Rgs2 promoters, and Sik1/Rgs2 transcription were enhanced by a kinase-negative CaMKII2 (K43A) mutant and inhibited by a constitutively active (T287D) mutant. Taken together, these studies establish negative regulation of CREB activity by endogenous CaMKII-dependent CREB-Ser(142) phosphorylation and suggest a potential mechanism for CaMKII/CREB signaling in modulating proliferation and migration in VSM cells.	[Liu, Yongfeng; Sun, Li-Yan; Singer, Diane V.; Ginnan, Roman; Singer, Harold A.] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA	Albany Medical College	Singer, HA (corresponding author), 47 New Scotland Ave, Albany, NY 12208 USA.	SingerH@mail.amc.edu			National Institutes of Health from the National Heart, Lung and Blood Institute [RO1-HL4942, RO1-HL092510]; Albany Medical College Candice Weir Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049426, R01HL092510] Funding Source: NIH RePORTER	National Institutes of Health from the National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Albany Medical College Candice Weir Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-HL4942 and RO1-HL092510 from the National Heart, Lung and Blood Institute (to H.A.S.) and the Albany Medical College Candice Weir Fund.	Anderson ME, 1998, J PHARMACOL EXP THER, V287, P996; Barlow CA, 2006, J PHYSIOL-LONDON, V570, P59, DOI 10.1113/jphysiol.2005.098426; Bell KFS, 2013, J NEUROCHEM, V126, P274, DOI 10.1111/jnc.12176; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Cartin L, 2000, CIRC RES, V86, P760, DOI 10.1161/01.RES.86.7.760; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; EDMAN CF, 1994, BBA-MOL CELL RES, V1221, P89, DOI 10.1016/0167-4889(94)90221-6; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Erickson JR, 2011, PHYSIOL REV, V91, P889, DOI 10.1152/physrev.00018.2010; Garat CV, 2006, MOL CELL BIOL, V26, P4934, DOI 10.1128/MCB.02477-05; GEISTERFER AAT, 1988, CIRC RES, V62, P749, DOI 10.1161/01.RES.62.4.749; Ginnan R, 2004, AM J PHYSIOL-CELL PH, V286, pC1281, DOI 10.1152/ajpcell.00202.2003; Ginnan R, 2012, BIOCHEM J, V444, P105, DOI 10.1042/BJ20120152; Gomez D, 2012, CARDIOVASC RES, V95, P156, DOI 10.1093/cvr/cvs115; Halees AS, 2003, NUCLEIC ACIDS RES, V31, P3554, DOI 10.1093/nar/gkg549; House SJ, 2008, ARTERIOSCL THROM VAS, V28, P441, DOI 10.1161/ATVBAHA.107.156810; House SJ, 2007, AM J PHYSIOL-CELL PH, V292, pC2276, DOI 10.1152/ajpcell.00606.2006; Klemm DJ, 2001, J BIOL CHEM, V276, P46132, DOI 10.1074/jbc.M104769200; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Li J, 2012, ACTA PHARMACOL SIN, V33, P1030, DOI 10.1038/aps.2012.61; Li L., 2012, PLOS ONE, V7; Li WW, 2011, J BIOL CHEM, V286, P7990, DOI 10.1074/jbc.M110.163006; Matchkov VV, 2012, BASIC CLIN PHARMACOL, V110, P42, DOI 10.1111/j.1742-7843.2011.00818.x; MAYER P, 1995, BASIC RES CARDIOL, V90, P372, DOI 10.1007/BF00788498; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Miyamoto E, 2006, J PHARMACOL SCI, V100, P433, DOI 10.1254/jphs.CPJ06007X; Ono H, 2004, ARTERIOSCL THROM VAS, V24, P1634, DOI 10.1161/01.ATV.0000138052.86051.0d; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pfleiderer PJ, 2004, AM J PHYSIOL-CELL PH, V286, pC1238, DOI 10.1152/ajpcell.00536.2003; Popov S, 2011, J HYPERTENS, V29, P2395, DOI 10.1097/HJH.0b013e32834d3d55; Sanchez-Munoz I, 2010, J NEUROSCI RES, V88, P825, DOI 10.1002/jnr.22264; Schauer IE, 2010, ARTERIOSCL THROM VAS, V30, P733, DOI 10.1161/ATVBAHA.109.199133; SCHWORER CM, 1993, J BIOL CHEM, V268, P14443; SCHWORER CM, 1988, J BIOL CHEM, V263, P13486; Scott JA, 2012, AM J PHYSIOL-HEART C, V302, pH1953, DOI 10.1152/ajpheart.00978.2011; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shetty PK, 2008, J BIOL CHEM, V283, P5389, DOI 10.1074/jbc.M708479200; SRINIVASAN M, 1994, J CELL BIOL, V126, P839, DOI 10.1083/jcb.126.4.839; Stevenson AS, 2001, EXP CELL RES, V263, P118, DOI 10.1006/excr.2000.5107; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Takeda H, 2007, BRAIN RES, V1184, P306, DOI 10.1016/j.brainres.2007.09.055; Taub M, 2010, BIOCHEM BIOPH RES CO, V393, P339, DOI 10.1016/j.bbrc.2010.02.037; Tokunou T, 2001, ARTERIOSCL THROM VAS, V21, P1764, DOI 10.1161/hq2112.098770; Van Riper DA, 2000, MOL CELL BIOCHEM, V213, P83, DOI 10.1023/A:1007116231678; Wamhoff BR, 2006, CIRC RES, V98, P868, DOI 10.1161/01.RES.0000216596.73005.3c; Wang Z, 2010, J BIOL CHEM, V285, P21303, DOI 10.1074/jbc.M110.120790; Wheeler DG, 2008, J CELL BIOL, V183, P849, DOI 10.1083/jcb.200805048; Wu XL, 2001, J BIOL CHEM, V276, P1735, DOI 10.1074/jbc.M006727200; Xie ZW, 2011, J BIOL CHEM, V286, P44646, DOI 10.1074/jbc.M111.265462; Zhang T, 2004, CARDIOVASC RES, V63, P476, DOI 10.1016/j.cardiores.2004.04.026	51	19	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33519	33529		10.1074/jbc.M113.490870	http://dx.doi.org/10.1074/jbc.M113.490870			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24106266	Green Published, hybrid			2022-12-25	WOS:000327250200003
J	Simandlova, J; Zagelbaum, J; Payne, MJ; Chu, WK; Shevelev, I; Hanada, K; Chatterjee, S; Reid, DA; Liu, Y; Janscak, P; Rothenberg, E; Hickson, ID				Simandlova, Jitka; Zagelbaum, Jennifer; Payne, Miranda J.; Chu, Wai Kit; Shevelev, Igor; Hanada, Katsuhiro; Chatterjee, Sujoy; Reid, Dylan A.; Liu, Ying; Janscak, Pavel; Rothenberg, Eli; Hickson, Ian D.			FBH1 Helicase Disrupts RAD51 Filaments in Vitro and Modulates Homologous Recombination in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Damage; DNA Helicase; DNA Recombination; DNA Repair; DNA Replication	BOX DNA HELICASE; PROTEIN; INHIBITION; COMPLEX; REPAIR; TUMORS; ROLES	Background: Homologous recombination is regulated both positively and negatively in eukaryotic cells to suppress genomic instability. Results: FBH1 can disrupt RAD51 filaments in vitro and suppresses formation of spontaneous RAD51 foci in mammalian cells. In cells defective for FBH1, hyper-recombination is observed. Conclusion: FBH1 is a negative regulator of homologous recombination. Significance: RAD51 activity must be carefully controlled to preserve genomic integrity. Efficient repair of DNA double strand breaks and interstrand cross-links requires the homologous recombination (HR) pathway, a potentially error-free process that utilizes a homologous sequence as a repair template. A key player in HR is RAD51, the eukaryotic ortholog of bacterial RecA protein. RAD51 can polymerize on DNA to form a nucleoprotein filament that facilitates both the search for the homologous DNA sequences and the subsequent DNA strand invasion required to initiate HR. Because of its pivotal role in HR, RAD51 is subject to numerous positive and negative regulatory influences. Using a combination of molecular genetic, biochemical, and single-molecule biophysical techniques, we provide mechanistic insight into the mode of action of the FBH1 helicase as a regulator of RAD51-dependent HR in mammalian cells. We show that FBH1 binds directly to RAD51 and is able to disrupt RAD51 filaments on DNA through its ssDNA translocase function. Consistent with this, a mutant mouse embryonic stem cell line with a deletion in the FBH1 helicase domain fails to limit RAD51 chromatin association and shows hyper-recombination. Our data are consistent with FBH1 restraining RAD51 DNA binding under unperturbed growth conditions to prevent unwanted or unscheduled DNA recombination.	[Simandlova, Jitka; Shevelev, Igor; Janscak, Pavel] Acad Sci Czech Republ, Inst Mol Genet, Prague 14300, Czech Republic; [Zagelbaum, Jennifer; Chatterjee, Sujoy; Reid, Dylan A.; Rothenberg, Eli] NYU, Sch Med, Dept Mol Pharmacol & Biochem, New York, NY USA; [Payne, Miranda J.; Chu, Wai Kit; Hanada, Katsuhiro; Hickson, Ian D.] Univ Oxford, Weatherall Inst Mol Med, Dept Oncol, Oxford OX3 9DS, England; [Chu, Wai Kit; Liu, Ying; Hickson, Ian D.] Univ Copenhagen, Nordea Ctr Healthy Aging, Dept Cellular & Mol Med, DK-2200 Copenhagen N, Denmark; [Janscak, Pavel] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; New York University; University of Oxford; University of Copenhagen; University of Zurich	Janscak, P (corresponding author), Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland.	pjanscak@imcr.uzh.ch; eli.rothenberg@nyumc.org; iandh@sund.ku.dk	Chu, Wai Kit/F-9405-2016; Janscak, Pavel/Q-3795-2018; Chatterjee, Sujoy/L-7325-2015; Hickson, Ian/AAJ-7548-2020; Janscak, Pavel/G-6189-2014	Chu, Wai Kit/0000-0003-2903-3247; Janscak, Pavel/0000-0002-1748-7789; Payne, Miranda/0000-0002-4908-5717; Hickson, Ian/0000-0002-0583-566X; Rothenberg, Eli/0000-0002-1382-1380; Hanada, Katsuhiro/0000-0003-0429-1899	Cancer Research UK; Nordea Foundation (Denmark); Czech Science Foundation [GAP305/10/0281]; Swiss National Science Foundation [31003A_129747]	Cancer Research UK(Cancer Research UK); Nordea Foundation (Denmark); Czech Science Foundation(Grant Agency of the Czech Republic); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Cancer Research UK, the Nordea Foundation (Denmark), Czech Science Foundation Grant GAP305/10/0281, and Swiss National Science Foundation Grant 31003A_129747.	Antony E, 2009, MOL CELL, V35, P105, DOI 10.1016/j.molcel.2009.05.026; BENSON FE, 1994, EMBO J, V13, P5764, DOI 10.1002/j.1460-2075.1994.tb06914.x; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Bugreev DV, 2007, GENE DEV, V21, P3085, DOI 10.1101/gad.1609007; Bugreev DV, 2009, J BIOL CHEM, V284, P26349, DOI 10.1074/jbc.M109.029371; Chi P, 2006, DNA REPAIR, V5, P381, DOI 10.1016/j.dnarep.2005.11.005; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Fugger K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2395; Fugger K, 2009, J CELL BIOL, V186, P655, DOI 10.1083/jcb.200812138; Garcia PL, 2004, EMBO J, V23, P2882, DOI 10.1038/sj.emboj.7600301; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Hu Y, 2007, GENE DEV, V21, P3073, DOI 10.1101/gad.1609107; Kim J, 2002, J BIOL CHEM, V277, P24530, DOI 10.1074/jbc.M201612200; Kim JH, 2004, NUCLEIC ACIDS RES, V32, P2287, DOI 10.1093/nar/gkh534; Kohzaki M, 2007, MOL CELL BIOL, V27, P2812, DOI 10.1128/MCB.02043-06; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Laulier C, 2010, DNA REPAIR, V9, P708, DOI 10.1016/j.dnarep.2010.03.011; Liu J, 2010, NAT STRUCT MOL BIOL, V17, P1260, DOI 10.1038/nsmb.1904; Lorenz A, 2009, MOL CELL BIOL, V29, P4742, DOI 10.1128/MCB.00471-09; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; Moldovan GL, 2012, MOL CELL, V45, P75, DOI 10.1016/j.molcel.2011.11.010; Morishita T, 2005, MOL CELL BIOL, V25, P8074, DOI 10.1128/MCB.25.18.8074-8083.2005; Myong S, 2005, NATURE, V437, P1321, DOI 10.1038/nature04049; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; Osman F, 2005, MOL CELL BIOL, V25, P8084, DOI 10.1128/MCB.25.18.8084-8096.2005; Pierce AJ, 2005, METH MOL B, V291, P373; Qiu YP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3281; Rothenberg E, 2010, METHODS MOL BIOL, V587, P29, DOI 10.1007/978-1-60327-355-8_3; Sigurdsson S, 2002, J BIOL CHEM, V277, P42790, DOI 10.1074/jbc.M208004200; Sigurdsson S, 2001, GENE DEV, V15, P3308, DOI 10.1101/gad.935501; Tan TLR, 2003, DNA REPAIR, V2, P787, DOI 10.1016/S1568-7864(03)00070-3; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Ward JD, 2010, MOL CELL, V37, P259, DOI 10.1016/j.molcel.2009.12.026; Wu L, 2006, ANNU REV GENET, V40, P279, DOI 10.1146/annurev.genet.40.110405.090636; Yodh JG, 2009, EMBO J, V28, P405, DOI 10.1038/emboj.2008.298; Yusa K, 2004, NATURE, V429, P896, DOI 10.1038/nature02646	39	55	57	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34168	34180		10.1074/jbc.M113.484493	http://dx.doi.org/10.1074/jbc.M113.484493			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24108124	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000327250200060
J	Zhang, AL; Chi, XJ; Luo, GJ; Hei, ZQ; Xia, H; Luo, CF; Wang, YL; Mao, XW; Xia, ZY				Zhang, Ailan; Chi, Xinjin; Luo, Gangjian; Hei, Ziqing; Xia, Hua; Luo, Chenfang; Wang, Yanling; Mao, Xiaowen; Xia, Zhengyuan			Mast Cell Stabilization Alleviates Acute Lung Injury after Orthotopic Autologous Liver Transplantation in Rats by Downregulating Inflammation	PLOS ONE			English	Article							INTESTINAL ISCHEMIA-REPERFUSION; PLATELET-ACTIVATING-FACTOR; FC-GAMMA-RI; CROMOLYN SODIUM; PULMONARY-EDEMA; TNF-ALPHA; VASCULAR-PERMEABILITY; AIRWAY INFLAMMATION; UP-REGULATION; KAPPA-B	Background: Acute lung injury (ALI) is one of the most severe complications after orthotopic liver transplantation. Amplified inflammatory response after transplantation contributes to the process of ALI, but the mechanism underlying inflammation activation is not completely understood. We have demonstrated that mast cell stabilization attenuated inflammation and ALI in a rodent intestine ischemia/reperfusion model. We hypothesized that upregulation of inflammation triggered by mast cell activation may be involve in ALI after liver transplantation. Methods: Adult male Sprague-Dawley rats received orthotopic autologous liver transplantation (OALT) and were executed 4, 8, 16, and 24 h after OALT. The rats were pretreated with the mast cell stabilizers cromolyn sodium or ketotifen 15 min before OALT and executed 8 h after OALT. Lung tissues and arterial blood were collected to evaluate lung injury. beta-hexosaminidase and mast cell tryptase levels were assessed to determine the activation of mast cells. Tumor necrosis factor alpha (TNF-alpha), interleukin (IL)-1 beta and IL-6 in serum and lung tissue were analyzed by enzyme-linked immunosorbent assay. Nuclear factor-kappa B (NF-kappa B) p65 translocation was assessed by Western blot. Results: The rats that underwent OALT exhibited severe pulmonary damage with a high wet-to-dry ratio, low partial pressure of oxygen, and low precursor surfactant protein C levels, which corresponded to the significant elevation of pro-inflammatory cytokines, beta-hexosaminidase, and tryptase levels in serum and lung tissues. The severity of ALI progressed and maximized 8 h after OALT. Mast cell stabilization significantly inhibited the activation of mast cells, downregulated pro-inflammatory cytokine levels and translocation of NF-kappa B, and attenuated OALT-induced ALI. Conclusions: Mast cell activation amplified inflammation and played an important role in the process of post-OALT related ALI.	[Zhang, Ailan; Chi, Xinjin; Luo, Gangjian; Hei, Ziqing; Luo, Chenfang; Wang, Yanling] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Anesthesiol, Guangzhou 510275, Guangdong, Peoples R China; [Xia, Hua] Luzhou Med Coll, Affiliated Hosp, Dept Anesthesiol, Luzhou City, Peoples R China; [Mao, Xiaowen; Xia, Zhengyuan] Univ Hong Kong, Dept Anesthesiol, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China	Sun Yat Sen University; Southwest Medical University; University of Hong Kong	Hei, ZQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Anesthesiol, Guangzhou 510275, Guangdong, Peoples R China.	heiziqing@sina.com	Irwin, Michael Garnet/C-4286-2009; Irwin, Michael Garnet/GLR-9714-2022; chen, chaojin/M-6701-2014	Irwin, Michael Garnet/0000-0001-5801-274X; Irwin, Michael Garnet/0000-0001-5801-274X; Hei, Zi-qing/0000-0001-7466-2769	National Natural Science Foundation of China [30972858]; Natural Science Foundation of Guangdong Province, China [S2012010008930]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	The study was supported by the National Natural Science Foundation of China (NO. 30972858) and the Natural Science Foundation of Guangdong Province, China (NO. S2012010008930). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arieff AI, 1999, CHEST, V115, P1371, DOI 10.1378/chest.115.5.1371; BERNSTEIN IL, 1972, J ALLERGY CLIN IMMUN, V50, P235, DOI 10.1016/0091-6749(72)90017-6; Caughey GH, 2007, IMMUNOL REV, V217, P141, DOI 10.1111/j.1600-065X.2007.00509.x; Chevrel G, 2005, ANN RHEUM DIS, V64, P1257, DOI 10.1136/ard.2004.032359; CRAPS L, 1983, PHARMATHERAPEUTICA, V3, P314; Gan XL, 2012, INFLAMMATION, V35, P1144, DOI 10.1007/s10753-011-9422-5; Glasgow SC, 2005, SURGERY, V138, P64, DOI 10.1016/j.surg.2005.03.005; Glasgow SC, 2007, AM J PHYSIOL-LUNG C, V293, pL491, DOI 10.1152/ajplung.00009.2007; GRANT SM, 1990, DRUGS, V40, P412, DOI 10.2165/00003495-199040030-00006; Guo Na, 2009, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V21, P74; Gurkan OU, 2011, EXP LUNG RES, V37, P575, DOI 10.3109/01902148.2011.620680; He X, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001527; Hei ZQ, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-42; Henderson WR, 1996, J EXP MED, V184, P1483, DOI 10.1084/jem.184.4.1483; Hofbauer B, 1998, GASTROENTEROLOGY, V115, P1238, DOI 10.1016/S0016-5085(98)70096-4; Huang PJ, 2012, INJURY, V43, P1250, DOI 10.1016/j.injury.2011.12.027; Jiang A, 2012, WORLD J GASTROENTERO, V18, P323, DOI 10.3748/wjg.v18.i4.323; Jin EJ, 2003, CANCER-AM CANCER SOC, V97, P703, DOI 10.1002/cncr.11087; Kajiwara N, 2010, J ALLERGY CLIN IMMUN, V125, P1137, DOI 10.1016/j.jaci.2010.01.056; Kalia N, 2005, J GASTROEN HEPATOL, V20, P1032, DOI 10.1111/j.1440-1746.2005.03767.x; Kiupel M, 2004, VET PATHOL, V41, P371, DOI 10.1354/vp.41-4-371; Kox M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034431; Kuehn Hye Sun, 2010, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0738s91; Li Gang-Shan, 2002, Hepatobiliary Pancreat Dis Int, V1, P330; Li Shang-Rong, 2008, Zhonghua Yi Xue Za Zhi, V88, P3049; MAZUREK N, 1983, NATURE, V303, P528, DOI 10.1038/303528a0; MAZUREK N, 1980, NATURE, V286, P722, DOI 10.1038/286722a0; MEDICI TC, 1989, CHEST, V96, P1252, DOI 10.1378/chest.96.6.1252; Menoret A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040184; MONIE RD, 1982, BRIT J DIS CHEST, V76, P383, DOI 10.1016/0007-0971(82)90074-2; Mueller AR, 2004, BEST PRACT RES CL GA, V18, P881, DOI 10.1016/j.bpg.2004.07.004; MYLONAKARAYANNI C, 1990, J ASTHMA, V27, P87, DOI 10.3109/02770909009073302; O'Mahony DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051104; Okayama Y, 2003, EUR J IMMUNOL, V33, P1450, DOI 10.1002/eji.200323563; Ortis F, 2008, DIABETOLOGIA, V51, P1213, DOI 10.1007/s00125-008-0999-7; Parkash J, 2011, EXP THER MED, V2, P21, DOI 10.3892/etm.2010.161; Reuter S, 2010, YONSEI MED J, V51, P797, DOI 10.3349/ymj.2010.51.6.797; Rodewald HR, 1996, SCIENCE, V271, P818, DOI 10.1126/science.271.5250.818; ROMANSKI B, 1983, ALLERGOL IMMUNOPATH, V11, P34; Ruh J, 2000, ACTA PHYSIOL SCAND, V170, P137, DOI 10.1046/j.1365-201x.2000.00760.x; Santone DJ, 2008, AM J PHYSIOL-HEART C, V294, pH2456, DOI 10.1152/ajpheart.00925.2007; SHAPIRO GG, 1985, PHARMACOTHERAPY, V5, P156; Shiraishi Y, 2005, J PHARMACOL EXP THER, V312, P954, DOI 10.1124/jpet.104.078212; SIROIS MG, 1994, BRIT J PHARMACOL, V111, P1111, DOI 10.1111/j.1476-5381.1994.tb14859.x; Sokolova E, 2007, PHARMACOL THERAPEUT, V115, P70, DOI 10.1016/j.pharmthera.2007.04.002; Stafforini DM, 2003, CRIT REV CL LAB SCI, V40, P643, DOI 10.1080/714037693; Su X, 2005, J IMMUNOL, V175, P2598, DOI 10.4049/jimmunol.175.4.2598; Sur R, 2007, INT IMMUNOPHARMACOL, V7, P555, DOI 10.1016/j.intimp.2007.01.009; Takizawa T, 2005, J PHARMACOL SCI, V98, P99, DOI 10.1254/jphs.SCZ050138; Tran TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023660; Venkatesha RT, 2005, MOL IMMUNOL, V42, P581, DOI 10.1016/j.molimm.2004.09.009; Vieira SM, 2009, BRIT J PHARMACOL, V158, P779, DOI 10.1111/j.1476-5381.2009.00367.x; Walcher F, 1996, J SURG RES, V61, P244, DOI 10.1006/jsre.1996.0111; Webster JD, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-85; Woolhiser MR, 2001, EUR J IMMUNOL, V31, P3298, DOI 10.1002/1521-4141(200111)31:11<3298::AID-IMMU3298>3.0.CO;2-U; Yang HW, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-37; Yost CS, 2001, CHEST, V119, P219, DOI 10.1378/chest.119.1.219; Zhao HF, 2009, HEPATOB PANCREAT DIS, V8, P247; Zimmerman GA, 2004, TRENDS MOL MED, V10, P245, DOI 10.1016/j.molmed.2004.03.009	59	29	32	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75262	10.1371/journal.pone.0075262	http://dx.doi.org/10.1371/journal.pone.0075262			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116032	Green Published, Green Submitted, gold			2022-12-25	WOS:000325552200014
J	Kizach, J; Nyvad, AM; Christensen, KR				Kizach, Johannes; Nyvad, Anne Mette; Christensen, Ken Ramshoj			Structure before Meaning: Sentence Processing, Plausibility, and Subcategorization	PLOS ONE			English	Article							UNBOUNDED DEPENDENCIES; LEXICAL GUIDANCE; COMPREHENSION; CONSTRAINTS; ONLINE; SERIAL	Natural language processing is a fast and automatized process. A crucial part of this process is parsing, the online incremental construction of a syntactic structure. The aim of this study was to test whether a wh-filler extracted from an embedded clause is initially attached as the object of the matrix verb with subsequent reanalysis, and if so, whether the plausibility of such an attachment has an effect on reaction time. Finally, we wanted to examine whether subcategorization plays a role. We used a method called G-Maze to measure response time in a self-paced reading design. The experiments confirmed that there is early attachment of fillers to the matrix verb. When this attachment is implausible, the off-line acceptability of the whole sentence is significantly reduced. The on-line results showed that G-Maze was highly suited for this type of experiment. In accordance with our predictions, the results suggest that the parser ignores (or has no access to information about) implausibility and attaches fillers as soon as possible to the matrix verb. However, the results also show that the parser uses the subcategorization frame of the matrix verb. In short, the parser ignores semantic information and allows implausible attachments but adheres to information about which type of object a verb can take, ensuring that the parser does not make impossible attachments. We argue that the evidence supports a syntactic parser informed by syntactic cues, rather than one guided by semantic cues or one that is blind, or completely autonomous.	[Kizach, Johannes; Nyvad, Anne Mette; Christensen, Ken Ramshoj] Aarhus Univ, Dept Aesthet & Commun, Aarhus, Denmark	Aarhus University	Kizach, J (corresponding author), Aarhus Univ, Dept Aesthet & Commun, Aarhus, Denmark.	engjk@hum.au.dk		Nyvad, Anne Mette/0000-0001-9554-6716; Christensen, Ken Ramshoj/0000-0001-8758-240X	Danish Ministry of Science, Technology and Innovation (the MindLab project, Aarhus University); Danish Council for Independent Research; Faculty of Arts, Aarhus University	Danish Ministry of Science, Technology and Innovation (the MindLab project, Aarhus University); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Faculty of Arts, Aarhus University	This research project was supported by grants from The Danish Ministry of Science, Technology and Innovation (the MindLab project, Aarhus University), from The Danish Council for Independent Research, and from The Faculty of Arts, Aarhus University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D., 2011, PACKAGE LME4 LINEAR; Boland JE, 1995, J MEM LANG, V34, P774, DOI 10.1006/jmla.1995.1034; Christensen KR, 2013, J PSYCHOLINGUIST RES, V42, P51, DOI 10.1007/s10936-012-9210-x; Fanselow Gisbert, 2006, GRADIENCE GRAMMAR GE, P291, DOI [10.1093/acprof:oso/9780199274796.003.0015, DOI 10.1093/ACPROF:OSO/9780199274796.003.0015]; FERREIRA F, 1986, J MEM LANG, V25, P348, DOI 10.1016/0749-596X(86)90006-9; Fodor Janet Dean, 1998, REANALYSIS SENTENCE, P101; Forster KI, 2009, BEHAV RES METHODS, V41, P163, DOI 10.3758/BRM.41.1.163; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; FRAZIER L, 1987, ATTENTION PERFORM, P559; Frazier L., 1996, CONSTRUAL; GARNSEY SM, 1989, J PSYCHOLINGUIST RES, V18, P51, DOI 10.1007/BF01069046; Gibson E, 2000, J PSYCHOLINGUIST RES, V29, P231, DOI 10.1023/A:1005153330168; Gibson E, 2003, ENCY COGNITIVE SCI, P1137; Gibson E.A.F., 1991, THESIS CARNEGIE MELL; Gorrell Paul, 1995, SYNTAX PARSING; Hawkins JA, 1994, PERFORMANCE THEORY O; Hawkins John A., 2004, EFFICIENCY COMPLEXIT; HOLM S, 1979, SCAND J STAT, V6, P65; Kizach J, 2012, RUSS LINGUIST, V36, P251, DOI 10.1007/s11185-012-9096-0; Lau Ellen F., HYPERACTIVE IN PRESS; Lewis RL, 2000, J PSYCHOLINGUIST RES, V29, P241, DOI 10.1023/A:1005105414238; McRae K, 1998, J MEM LANG, V38, P283, DOI 10.1006/jmla.1997.2543; MILLER GA, 1963, HDB MATH PSYCHOL, P421; MITCHELL DC, 1987, ATTENTION PERFORM, P601; Pickering MJ, 2003, LANG COGNITIVE PROC, V18, P469, DOI 10.1080/01690960344000017; Pritchett B.L., 1992, GRAMMATICAL COMPETEN; R Development Core Team, 2009, R LANG ENV STAT COMP, P409; SHAPIRO LP, 1987, COGNITION, V27, P219, DOI 10.1016/S0010-0277(87)80010-0; Shetreet E, 2009, NEUROIMAGE, V48, P707, DOI 10.1016/j.neuroimage.2009.07.001; Smith N. J., 2013, COGNITION IN PRESS; Staub A, 2007, J EXP PSYCHOL LEARN, V33, P550, DOI 10.1037/0278-7393.33.3.550; STOWE LA, 1991, LANG SPEECH, V34, P319, DOI 10.1177/002383099103400402; Stowe Laurie A., 1986, LANG COGNITIVE PROC, V1, P227, DOI DOI 10.1080/01690968608407062; Traxler MJ, 1996, J MEM LANG, V35, P454, DOI 10.1006/jmla.1996.0025; TRUESWELL JC, 1993, J EXP PSYCHOL LEARN, V19, P528, DOI 10.1037/0278-7393.19.3.528; van Gompel RPG, 2001, PSYCHON B REV, V8, P851, DOI 10.3758/BF03196228; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Witzel N, 2012, J PSYCHOLINGUIST RES, V41, P105, DOI 10.1007/s10936-011-9179-x	38	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76326	10.1371/journal.pone.0076326	http://dx.doi.org/10.1371/journal.pone.0076326			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232NS	24116101	Green Published, gold, Green Submitted			2022-12-25	WOS:000325501300056
J	Li, SJ; Li, XF; Guo, HP; Liu, ST; Huang, HB; Liu, NN; Yang, CS; Tang, P; Liu, JB				Li, Shujue; Li, Xiaofen; Guo, Haiping; Liu, Shouting; Huang, Hongbiao; Liu, Ningning; Yang, Changshan; Tang, Ping; Liu, Jinbao			Intracellular ATP Concentration Contributes to the Cytotoxic and Cytoprotective Effects of Adenosine	PLOS ONE			English	Article							HUMAN ENDOTHELIAL-CELLS; EXTRACELLULAR ADENOSINE; COMPARTMENTALIZED ATP; RECEPTOR ACTIVATION; A(3) RECEPTORS; MUSCLE-CELLS; IN-VITRO; APOPTOSIS; RAT; ISCHEMIA	Extracellular adenosine (Ade) interacts with cells by two pathways: by activating cell surface receptors at nanomolar/micromolar concentrations; and by interfering with the homeostasis of the intracellular nucleotide pool at millimolar concentrations. Ade shows both cytotoxic and cytoprotective effects; however, the underlying mechanisms remain unclear. In the present study, the effects of adenosine-mediated ATP on cell viability were investigated. Adenosine treatment was found to be cytoprotective in the low intracellular ATP state, but cytotoxic under the normal ATP state. Adenosine-mediated cytotoxicity and cytoprotection rely on adenosine-derived ATP formation, but not via the adenosine receptor pathway. Ade enhanced proteasome inhibition-induced cell death mediated by ATP generation. These data provide a new pathway by which adenosine exerts dual biological effects on cell viability, suggesting an important role for adenosine as an ATP precursor besides the adenosine receptor pathway.	[Li, Shujue; Li, Xiaofen; Guo, Haiping; Liu, Shouting; Huang, Hongbiao; Liu, Ningning; Yang, Changshan; Tang, Ping; Liu, Jinbao] Guangzhou Med Univ, Dept Pathophysiol, Prot Modificat & Degradat Lab, Guangzhou, Guangdong, Peoples R China; [Li, Shujue] Guangzhou Med Univ, Dept Urol, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Liu, Ningning] Guangzhou Med Univ, Guangzhou Res Inst Cardiovasc Dis, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University	Liu, JB (corresponding author), Guangzhou Med Univ, Dept Pathophysiol, Prot Modificat & Degradat Lab, Guangzhou, Guangdong, Peoples R China.	jliu@gzhmc.edu.cn			National High Technology Research and Development Program of China [2006AA02Z4B5]; National Natural Science Foundation of China [81070033/H0108, 30770835, 81072091]; Guangdong Province Natural Science Foundation [9251018201002, 94510018201003604]; Guangzhou Municipal Education Commission [10A057S, 08A108]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangzhou Municipal Education Commission	Supported by the National High Technology Research and Development Program of China (Project 2006AA02Z4B5), National Natural Science Foundation of China (Project 81070033/H0108, 30770835, 81072091), Key Projects (9251018201002, 94510018201003604) from Guangdong Province Natural Science Foundation, and Key Projects from Guangzhou Municipal Education Commission (10A057S, 08A108) (to JL and PT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 1995, MOL PHARMACOL, V48, P1038; Apasov S, 2000, BLOOD, V95, P3859; Baharav E, 2005, J RHEUMATOL, V32, P469; Barankiewicz J, 1997, J PHARMACOL EXP THER, V283, P1230; Bes S, 2002, EUR J PHARMACOL, V452, P145, DOI 10.1016/S0014-2999(02)02295-1; Duranski MR, 2005, J CLIN INVEST, V115, P1232, DOI 10.1172/JCI200522493; Eguchi Y, 1997, CANCER RES, V57, P1835; ETHIER MF, 1993, AM J PHYSIOL, V265, pH131, DOI 10.1152/ajpheart.1993.265.1.H131; Ethier MF, 1997, AM J PHYSIOL-HEART C, V272, pH1470, DOI 10.1152/ajpheart.1997.272.3.H1470; Fishman P, 1998, CANCER RES, V58, P3181; Fishman P, 2001, EXP CELL RES, V269, P230, DOI 10.1006/excr.2001.5327; FOZARD JR, 1993, BRIT J PHARMACOL, V109, P3, DOI 10.1111/j.1476-5381.1993.tb13522.x; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Gao ZH, 2001, MOL PHARMACOL, V59, P76, DOI 10.1124/mol.59.1.76; Gu JG, 1996, J NEUROCHEM, V67, P972; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Huang HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049062; Huang HB, 2010, CELL RES, V20, P1372, DOI 10.1038/cr.2010.123; Imura T, 2000, J NEUROSCI RES, V62, P539; Jacobson KA, 1998, TRENDS PHARMACOL SCI, V19, P184, DOI 10.1016/S0165-6147(98)01203-6; Kohno Y, 1996, BIOCHEM BIOPH RES CO, V219, P904, DOI 10.1006/bbrc.1996.0331; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Li XF, 2013, CELL REP, V3, P211, DOI 10.1016/j.celrep.2012.11.023; Livingston M, 2004, INFLAMM RES, V53, P171, DOI 10.1007/s00011-004-1248-2; Merighi S, 2002, J INVEST DERMATOL, V119, P923, DOI 10.1046/j.1523-1747.2002.00111.x; Montesinos MC, 1997, J EXP MED, V186, P1615, DOI 10.1084/jem.186.9.1615; Okusa MD, 2000, AM J PHYSIOL-RENAL, V279, pF809, DOI 10.1152/ajprenal.2000.279.5.F809; Ongini E, 1998, DRUG DEVELOP RES, V45, P387, DOI 10.1002/(SICI)1098-2299(199811/12)45:3/4<387::AID-DDR39>3.0.CO;2-U; PEARSON JD, 1978, BIOCHEM J, V170, P265, DOI 10.1042/bj1700265; Ramkumar V, 2001, JPN J PHARMACOL, V86, P265, DOI 10.1254/jjp.86.265; RAPAPORT E, 1980, J CELL PHYSIOL, V105, P267, DOI 10.1002/jcp.1041050210; RAPAPORT E, 1976, P NATL ACAD SCI USA, V73, P3122, DOI 10.1073/pnas.73.9.3122; Schrier SM, 2001, BIOCHEM PHARMACOL, V61, P417, DOI 10.1016/S0006-2952(00)00573-6; Shneyvays V, 2000, EXP CELL RES, V257, P111, DOI 10.1006/excr.2000.4882; Xu RH, 2005, CANCER RES, V65, P613	35	16	17	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76731	10.1371/journal.pone.0076731	http://dx.doi.org/10.1371/journal.pone.0076731			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098558	Green Submitted, Green Published, gold			2022-12-25	WOS:000325483600075
J	Mathioni, SM; Patel, N; Riddick, B; Sweigard, JA; Czymmek, KJ; Caplan, JL; Kunjeti, SG; Kunjeti, S; Raman, V; Hillman, BI; Kobayashi, DY; Donofrio, NM				Mathioni, Sandra M.; Patel, Nrupali; Riddick, Bianca; Sweigard, James A.; Czymmek, Kirk J.; Caplan, Jeffrey L.; Kunjeti, Sridhara G.; Kunjeti, Saritha; Raman, Vidhyavathi; Hillman, Bradley I.; Kobayashi, Donald Y.; Donofrio, Nicole M.			Transcriptomics of the Rice Blast Fungus Magnaporthe oryzae in Response to the Bacterial Antagonist Lysobacter enzymogenes Reveals Candidate Fungal Defense Response Genes	PLOS ONE			English	Article							BIOLOGICAL-CONTROL ACTIVITY; SACCHAROMYCES-CEREVISIAE; STRAIN C3; PROTEIN; PREDICTION; LOCALIZATION; GRISEA; COEXPRESSION; BIOCONTROL; EXPRESSION	Plants and animals have evolved a first line of defense response to pathogens called innate or basal immunity. While basal defenses in these organisms are well studied, there is almost a complete lack of understanding of such systems in fungal species, and more specifically, how they are able to detect and mount a defense response upon pathogen attack. Hence, the goal of the present study was to understand how fungi respond to biotic stress by assessing the transcriptional profile of the rice blast pathogen, Magnaporthe oryzae, when challenged with the bacterial antagonist Lysobacter enzymogenes. Based on microscopic observations of interactions between M. oryzae and wild-type L. enzymogenes strain C3, we selected early and intermediate stages represented by time-points of 3 and 9 hours post-inoculation, respectively, to evaluate the fungal transcriptome using RNA-seq. For comparative purposes, we also challenged the fungus with L. enzymogenes mutant strain DCA, previously demonstrated to be devoid of antifungal activity. A comparison of transcriptional data from fungal interactions with the wild-type bacterial strain C3 and the mutant strain DCA revealed 463 fungal genes that were down-regulated during attack by C3; of these genes, 100 were also found to be up-regulated during the interaction with DCA. Functional categorization of genes in this suite included those with roles in carbohydrate metabolism, cellular transport and stress response. One gene in this suite belongs to the CFEM-domain class of fungal proteins. Another CFEM class protein called PTH11 has been previously characterized, and we found that a deletion in this gene caused advanced lesion development by C3 compared to its growth on the wild-type fungus. We discuss the characterization of this suite of 100 genes with respect to their role in the fungal defense response.	[Mathioni, Sandra M.; Riddick, Bianca; Kunjeti, Sridhara G.; Kunjeti, Saritha; Raman, Vidhyavathi; Donofrio, Nicole M.] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19717 USA; [Patel, Nrupali; Hillman, Bradley I.; Kobayashi, Donald Y.] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA; [Sweigard, James A.] DuPont Stine Haskell Res Ctr, Newark, DE USA; [Czymmek, Kirk J.; Caplan, Jeffrey L.] Univ Delaware, Delaware Biotechnol Inst BioImaging Ctr, Newark, DE USA; [Czymmek, Kirk J.] Univ Delaware, Dept Biol Sci, Newark, DE USA	University of Delaware; Rutgers State University New Brunswick; DuPont; University of Delaware; University of Delaware	Kobayashi, DY (corresponding author), Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA.	kobayashi@aesop.rutgers.edu; ndonof@udel.edu	Kunjeti, Sridhara/AFU-0653-2022	Caplan, Jeffrey/0000-0002-3991-0912; Kunjeti, Sridhara/0000-0002-6326-2644; Czymmek, Kirk/0000-0002-5471-7395; Hillman, Bradley/0000-0002-2552-5087	USDA/NRI [2008-35319-04474]; EPSCoR [0814251] Funding Source: National Science Foundation	USDA/NRI(United States Department of Agriculture (USDA)); EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	This research was supported by a joint grant between Kobayashi and Donofrio from USDA/NRI grant number 2008-35319-04474. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktories K, 2011, NAT REV MICROBIOL, V9, P487, DOI 10.1038/nrmicro2592; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Bohnert HU, 2004, PLANT CELL, V16, P2499, DOI 10.1105/tpc.104.022715; Bourett TM, 2002, FUNGAL GENET BIOL, V37, P211, DOI 10.1016/S1087-1845(02)00524-8; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Chen X, 2009, ADVANCES IN GENETICS, GENOMICS AND CONTROL OF RICE BLAST DISEASE, P51, DOI 10.1007/978-1-4020-9500-9_6; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Crowe JD, 2001, APPL ENVIRON MICROB, V67, P2088, DOI 10.1128/AEM.67.5.2088-2094.2001; Dawson K, 2008, EUKARYOT CELL, V7, P926, DOI 10.1128/EC.00037-08; de Boer M, 2000, NUCLEIC ACIDS RES, V28, P974; Dean R., 2012, MOL PLANT PATHOL, V13, P1; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; DeZwaan TM, 1999, PLANT CELL, V11, P2013, DOI 10.1105/tpc.11.10.2013; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fowler JH, 2009, PLANT CELL, V21, P1239, DOI 10.1105/tpc.108.065029; GARCIAESTRADA C, 2010, CURRENT RES TECHNOLO, V1, P577; Giallourakis C, 2006, GENOME RES, V16, P1056, DOI 10.1101/gr.5285206; Giesler LJ, 1998, CROP PROT, V17, P509, DOI 10.1016/S0261-2194(98)00049-0; Hiller K, 2004, NUCLEIC ACIDS RES, V32, pW375, DOI 10.1093/nar/gkh378; Holcombe LJ, 2011, FUTURE MICROBIOL, V6, P799, DOI [10.2217/FMB.11.60, 10.2217/fmb.11.60]; Horton P, 2006, SER ADV BIOINFORM, V3, P39, DOI 10.1142/9781860947292_0007; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Kim S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000909; Kobayashi D.Y., 2007, CAB REV PERSPECT AGR, V2, DOI DOI 10.1079/PAVSNNR20072007; Kobayashi D. Y, 2005, FUNGAL COMMUNITY ITS, P399; Kobayashi DY, 2005, CAN J MICROBIOL, V51, P719, DOI 10.1139/W05-056; Kobayashi DY, 2005, APPL ENVIRON MICROB, V71, P261, DOI 10.1128/AEM.71.1.261-269.2005; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kulkarni RD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r24; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li QL, 2011, BIOL CONTROL, V58, P139, DOI 10.1016/j.biocontrol.2011.04.013; Li SJ, 2009, J EUKARYOT MICROBIOL, V56, P182, DOI 10.1111/j.1550-7408.2008.00384.x; Lindow SE, 2002, CURR OPIN BIOTECH, V13, P238, DOI 10.1016/S0958-1669(02)00313-0; Lou LL, 2011, J AM CHEM SOC, V133, P643, DOI 10.1021/ja105732c; Marco A, 2009, BIOINFORMATICS, V25, P2473, DOI 10.1093/bioinformatics/btp462; Mathioni SM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-49; Meier S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-24; Mela F, 2011, ISME J, V5, P1494, DOI 10.1038/ismej.2011.29; Missall TA, 2004, EUKARYOT CELL, V3, P835, DOI 10.1128/EC.3.4.835-846.2004; Mulligan CN, 2005, ENVIRON POLLUT, V133, P183, DOI 10.1016/j.envpol.2004.06.009; Neuberger G, 2003, J MOL BIOL, V328, P581, DOI 10.1016/S0022-2836(03)00319-X; Newcomb LL, 2002, MOL CELL BIOL, V22, P1607, DOI 10.1128/MCB.22.5.1607-1614.2002; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; Palumbo JD, 2005, PHYTOPATHOLOGY, V95, P701, DOI 10.1094/PHYTO-95-0701; PATEL N, 2013, ANTON LEEUW INT J G, V103, P1; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Saikia R, 2011, MICROBIOL RES, V166, P216, DOI 10.1016/j.micres.2010.03.002; Schouten A, 2008, ENVIRON MICROBIOL, V10, P1145, DOI 10.1111/j.1462-2920.2007.01531.x; Schroeckh V, 2009, P NATL ACAD SCI USA, V106, P14558, DOI 10.1073/pnas.0901870106; Sesma A, 2004, NATURE, V431, P582, DOI 10.1038/nature02880; Shah J, 2003, CURR OPIN PLANT BIOL, V6, P365, DOI 10.1016/S1369-5266(03)00058-X; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; SINGH RS, 1971, MYCOPATH MYCOL APPL, V44, P373, DOI 10.1007/BF02052711; Soanes DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012725; Sweeney MJ, 1999, FEMS MICROBIOL LETT, V175, P149, DOI [10.1016/S0378-1097(99)00103-2, 10.1111/j.1574-6968.1999.tb13614.x]; THURSTON CF, 1994, MICROBIOL-SGM, V140, P19, DOI 10.1099/13500872-140-1-19; van den Brink J, 2011, APPL MICROBIOL BIOT, V91, P1477, DOI 10.1007/s00253-011-3473-2; Wolpert TJ, 2002, ANNU REV PHYTOPATHOL, V40, P251, DOI 10.1146/annurev.phyto.40.011402.114210; Yoshida S, 2000, MOL GEN GENET, V263, P877, DOI 10.1007/s004380000255; Yuan Z, 2002, BIOINFORMATICS, V18, P1109, DOI 10.1093/bioinformatics/18.8.1109; Zhang Z, 2001, PHYTOPATHOLOGY, V91, P204, DOI 10.1094/PHYTO.2001.91.2.204; Zhang Z, 2010, BIOINFORMATICS, V26, P1918, DOI 10.1093/bioinformatics/btq303	68	25	25	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76487	10.1371/journal.pone.0076487	http://dx.doi.org/10.1371/journal.pone.0076487			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098512	Green Published, Green Submitted, gold			2022-12-25	WOS:000325483600058
J	Lafontaine, ER; Zimmerman, SM; Shaffer, TL; Michel, F; Gao, XD; Hogan, RJ				Lafontaine, Eric R.; Zimmerman, Shawn M.; Shaffer, Teresa L.; Michel, Frank; Gao, Xiudan; Hogan, Robert J.			Use of a Safe, Reproducible, and Rapid Aerosol Delivery Method to Study Infection by Burkholderia pseudomallei and Burkholderia mallei in Mice	PLOS ONE			English	Article							POLYSACCHARIDE MICROARRAY TECHNOLOGY; CAPSULAR POLYSACCHARIDE; MOLECULAR CHARACTERIZATION; SUBTRACTIVE HYBRIDIZATION; IN-VITRO; MELIOIDOSIS; GLANDERS; VIRULENCE; IDENTIFICATION; BALB/C	Burkholderia pseudomallei, the etiologic agent of melioidosis, is a saprophytic bacterium readily isolated from wet soils of countries bordering the equator. Burkholderia mallei is a host-adapted clone of B. pseudomallei that does not persist outside of its equine reservoir and causes the zoonosis glanders, which is endemic in Asia, Africa, the Middle East and South America. Infection by these organisms typically occurs via percutaneous inoculation or inhalation of aerosols, and the most common manifestation is severe pneumonia leading to fatal bacteremia. Glanders and melioidosis are difficult to diagnose and require prolonged antibiotic therapy with low success rates. There are no vaccines available to protect against either Burkholderia species, and there is concern regarding their use as biological warfare agents given that B. mallei has previously been utilized in this manner. Hence, experiments were performed to establish a mouse model of aerosol infection to study the organisms and develop countermeasures. Using a hand-held aerosolizer, BALB/c mice were inoculated intratracheally with strains B. pseudomallei 1026b and B. mallei ATCC23344 and growth of the agents in the lungs, as well as dissemination to the spleen, were examined. Mice infected with 10(2), 10(3) and 10(4) organisms were unable to control growth of B. mallei in the lungs and bacteria rapidly disseminated to the spleen. Though similar results were observed in mice inoculated with 10(3) and 10(4) B. pseudomallei cells, animals infected with 10(2) organisms controlled bacterial replication in the lungs, dissemination to the spleen, and the extent of bacteremia. Analysis of sera from mice surviving acute infection revealed that animals produced antibodies against antigens known to be targets of the immune response in humans. Taken together, these data show that small volume aerosol inoculation of mice results in acute disease, dose-dependent chronic infection, and immune responses that correlate with those seen in human infections.	[Lafontaine, Eric R.; Zimmerman, Shawn M.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA; [Shaffer, Teresa L.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Michel, Frank; Gao, Xiudan; Hogan, Robert J.] Univ Georgia, Dept Vet Biosci & Diagnost Imaging, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Hogan, RJ (corresponding author), Univ Georgia, Dept Vet Biosci & Diagnost Imaging, Athens, GA 30602 USA.	jhogan@uga.edu			DTRA [HDTRA1-09-1-0003]	DTRA(United States Department of DefenseDefense Threat Reduction Agency)	This study was supported by DTRA contract HDTRA1-09-1-0003. The funders had input in the study design and decision to publish (DTRA PA-13-325). The funders had no role in data collection and analysis or preparation of the manuscript.	Adler NRL, 2009, FEMS MICROBIOL REV, V33, P1079, DOI 10.1111/j.1574-6976.2009.00189.x; Alibek K, 1999, BIOHAZARD CHILLING T; Andreu N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010777; Anuntagool N, 2002, MICROBIOL IMMUNOL, V46, P143, DOI 10.1111/j.1348-0421.2002.tb02679.x; Arun S, 1999, VET REC, V144, P255, DOI 10.1136/vr.144.10.255; ATOYNATAN T, 1969, AM J EPIDEMIOL, V89, P472, DOI 10.1093/oxfordjournals.aje.a120959; Balder R, 2007, INFECT IMMUN, V75, P2765, DOI 10.1128/IAI.00079-07; Balder R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-250; Barnes KB, 2013, INT J ANTIMICROB AG, V41, P552, DOI 10.1016/j.ijantimicag.2013.02.007; Bivas-Benita M, 2005, EUR J PHARM BIOPHARM, V61, P214, DOI 10.1016/j.ejpb.2005.04.009; Bondi SK, 2008, EXPERT REV VACCINES, V7, P1357, DOI 10.1586/14760584.7.9.1357; Bryan L E, 1994, Can J Infect Dis, V5, P170; Burtnick MN, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00108; Burtnick MN, 1999, ANTIMICROB AGENTS CH, V43, P2648, DOI 10.1128/AAC.43.11.2648; Carr-Gregory B, 2007, MED ASPECTS BIOL WAR, P121; Chandenier J, 2009, MYCOSES, V52, P239, DOI 10.1111/j.1439-0507.2009.01695.x; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Cowell R, 2008, DIAGNOSTIC CYTOLOGY, P238; Cowell R, 2002, DIAGNOSTIC CYTOLOGY, P70; Currie BJ, 2000, T ROY SOC TROP MED H, V94, P301, DOI 10.1016/S0035-9203(00)90333-X; Currie BJ, 2000, CLIN INFECT DIS, V31, P981, DOI 10.1086/318116; Dance DAB, 2000, ACTA TROP, V74, P115, DOI 10.1016/S0001-706X(99)00059-5; DeShazer D, 2001, MICROB PATHOGENESIS, V30, P253, DOI 10.1006/mpat.2000.0430; DeShazer D, 1998, MOL MICROBIOL, V30, P1081, DOI 10.1046/j.1365-2958.1998.01139.x; DeShazer D, 1997, J BACTERIOL, V179, P2116, DOI 10.1128/jb.179.7.2116-2125.1997; Felgner PL, 2009, P NATL ACAD SCI USA, V106, P13499, DOI 10.1073/pnas.0812080106; Funk CJ, 2009, J GEN VIROL, V90, P2956, DOI 10.1099/vir.0.014282-0; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Goff AJ, 2011, J VIROL, V85, P4898, DOI 10.1128/JVI.02525-10; Goodyear A, 2012, INFECT IMMUN, V80, P110, DOI 10.1128/IAI.05819-11; Goodyear A, 2010, J IMMUNOL, V184, P1445, DOI 10.4049/jimmunol.0900411; Goodyear A, 2009, INFECT IMMUN, V77, P1579, DOI 10.1128/IAI.01384-08; Harkema JR, 2006, TOXICOL PATHOL, V34, P252, DOI 10.1080/01926230600713475; Ho M, 1997, INFECT IMMUN, V65, P3648, DOI 10.1128/IAI.65.9.3648-3653.1997; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Howe C., 1950, OXFORD MED, P185; Jeddeloh JA, 2003, INFECT IMMUN, V71, P584, DOI 10.1128/IAI.71.1.584-587.2003; Judy BM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-88; KNIREL YA, 1992, CARBOHYD RES, V233, P185, DOI 10.1016/S0008-6215(00)90930-3; Kortepeter M, 2001, USAMRIIDS MED MANAGE, P44; Lehavi O, 2002, HAREFUAH, V141, P88; Lever MS, 2009, INT J EXP PATHOL, V90, P16, DOI 10.1111/j.1365-2613.2008.00619.x; Lever MS, 2003, J MED MICROBIOL, V52, P1109, DOI 10.1099/jmm.0.05180-0; Lipsitz R., 2012, EMERG INFECT DIS, V18, pe2; Lipski SL, 2007, INFECT IMMUN, V75, P314, DOI 10.1128/IAI.01330-06; Majerczyk C, 2013, INFECT IMMUN, V81, P1471, DOI 10.1128/IAI.00048-13; Massey S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00174; Munder A, 2002, EXP TOXICOL PATHOL, V54, P127, DOI 10.1078/0940-2993-00240; Neubauer H., 1997, Revue Internationale des Services de Sante des Forces Armees, V70, P258; Nierman WC, 2004, P NATL ACAD SCI USA, V101, P14246, DOI 10.1073/pnas.0403306101; Owen SJ, 2009, J INFECT DIS, V199, P1761, DOI 10.1086/599210; Parthasarathy N, 2008, CARBOHYD RES, V343, P2783, DOI 10.1016/j.carres.2008.05.021; Parthasarathy N, 2008, J CARBOHYD CHEM, V27, P32, DOI 10.1080/07328300802030761; Parthasarathy N, 2006, DIAGN MICR INFEC DIS, V56, P329, DOI 10.1016/j.diagmicrobio.2006.04.018; PERRY MB, 1995, INFECT IMMUN, V63, P3348, DOI 10.1128/IAI.63.9.3348-3352.1995; Peyron P, 2001, J BIOL CHEM, V276, P35512, DOI 10.1074/jbc.M104399200; Prakash H, 2010, J BIOL CHEM, V285, P20291, DOI 10.1074/jbc.M109.096297; Reckseidler SL, 2001, INFECT IMMUN, V69, P34, DOI 10.1128/IAI.69.1.34-44.2001; Reed L.J., 1938, AM J HYG, V27, P793; Regis E, 1999, BIOL DOOM; Revelli DA, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00164; Rolim DB, 2005, EMERG INFECT DIS, V11, P1458, DOI 10.3201/eid1109.050493; Sambrook J, 2001, MOL CLONING LAB MANU; SHOHAM D, 1998, NONPROLIFERATION REV, V5, P48, DOI DOI 10.1080/10736709808436720; Sim BMQ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r89; Smart JK, 1997, TXB MILITARY MED, P16; Song H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000922; Srinivasan A, 2001, NEW ENGL J MED, V345, P256, DOI 10.1056/NEJM200107263450404; Su X, 2004, EXP LUNG RES, V30, P479, DOI 10.1080/01902140490476382; Tan GYG, 2008, J MED MICROBIOL, V57, P508, DOI 10.1099/jmm.0.47596-0; Thibault FM, 2004, J ANTIMICROB CHEMOTH, V54, P1134, DOI 10.1093/jac/dkh471; Titball Richard W, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS111, DOI 10.1016/S0035-9203(08)70026-9; Tiyawisutsri R, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-19; Ulrich RL, 2005, VACCINE, V23, P1986, DOI 10.1016/j.vaccine.2004.10.017; Vietri N. J., 2007, MED ASPECTS BIOL WAR, P147; Viktorov Dimitry V, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS103, DOI 10.1016/S0035-9203(08)70025-7; Waag DM, 2004, BIOL WEAPONS DEFENSE; Warawa JM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00133; Warawa JM, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00141; Weiss D, 2010, SCHALMS VET HEMATOLO, P270; Wheelis M, 1998, NATURE, V395, P213, DOI 10.1038/26089; Wheelis M., 1999, BIOLOGICAL TOXIN WEA, P35; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Whitlock GC, 2007, FEMS MICROBIOL LETT, V277, P115, DOI 10.1111/j.1574-6968.2007.00949.x; Whitlock GC, 2009, J MED MICROBIOL, V58, P554, DOI 10.1099/jmm.0.007724-0; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699; Wiersinga WJ, 2009, CURR OPIN INFECT DIS, V22, P102, DOI 10.1097/QCO.0b013e328322e727; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Zou NX, 2008, HYBRIDOMA, V27, P231, DOI 10.1089/hyb.2008.0012	89	23	23	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76804	10.1371/journal.pone.0076804	http://dx.doi.org/10.1371/journal.pone.0076804			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098563	gold, Green Published, Green Submitted			2022-12-25	WOS:000325434500085
J	Gijsbers, EF; van Sighem, A; Harskamp, AM; Welkers, MRA; de Wolf, F; Brinkman, K; Prins, JM; Schuitemaker, H; van 't Wout, AB; Kootstra, NA				Gijsbers, Esther F.; van Sighem, Ard; Harskamp, Agnes M.; Welkers, Matthijs R. A.; de Wolf, Frank; Brinkman, Kees; Prins, Jan M.; Schuitemaker, Hanneke; van 't Wout, Angelique B.; Kootstra, Neeltje A.			The Presence of CXCR4-Using HIV-1 Prior to Start of Antiretroviral Therapy Is an Independent Predictor of Delayed Viral Suppression	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SYNCYTIUM-INDUCING PHENOTYPE; CD4 CELL COUNT; DISEASE PROGRESSION; BIOLOGICAL PHENOTYPE; TYPE-1 INFECTION; CORECEPTOR TROPISM; PROGNOSTIC VALUE; CLINICAL-COURSE; IMPACT	The emergence of CXCR4-using HIV variants (X4-HIV) is associated with accelerated disease progression in the absence of antiretroviral therapy. However, the effect of X4-HIV variants on the treatment response remains unclear. Here we determined whether the presence of X4-HIV variants influenced the time to undetectable viral load and CD4+ T cell reconstitution after initiation of cART in 732 patients. The presence of X4-HIV variants was determined by MT-2 assay prior to cART initiation and viral load and CD4+ T cell counts were analyzed every 3 to 6 months during a three year follow-up period. Kaplan-Meier and Cox proportional hazard analyses were performed to compare time to viral suppression and the absolute CD4+ T cell counts and increases in CD4+ T cell counts during follow-up were compared for patients with and without X4-HIV at start of cART. Patients harboring X4-HIV variants at baseline showed a delay in time to achieve viral suppression below the viral load detection limit. This delay in viral suppression was independently associated with high viral load and the presence of X4-HIV variants. Furthermore, the absolute CD4+ T cell counts were significantly lower in patients harboring X4-HIV variants at all time points during follow-up. However, no differences were observed in the increase in absolute CD4+ T cell numbers after treatment initiation, indicating that the reconstitution of CD4+ T cells is independent of the presence of X4-HIV variants. The emergence of X4-HIV has been associated with an accelerated CD4+ T cell decline during the natural course of infection and therefore, patients who develop X4-HIV variants may benefit from earlier treatment initiation in order to obtain faster reconstitution of the CD4+ T cell population to normal levels.	[Gijsbers, Esther F.; Harskamp, Agnes M.; Welkers, Matthijs R. A.; Schuitemaker, Hanneke; van 't Wout, Angelique B.; Kootstra, Neeltje A.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Sanquin Res,Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Gijsbers, Esther F.; Harskamp, Agnes M.; Welkers, Matthijs R. A.; Schuitemaker, Hanneke; van 't Wout, Angelique B.; Kootstra, Neeltje A.] Univ Amsterdam, Acad Med Ctr, Ctr Infect Dis & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [van Sighem, Ard; de Wolf, Frank] Stichting HIV Monitoring, Amsterdam, Netherlands; [de Wolf, Frank] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Sch Publ Hlth, London, England; [Brinkman, Kees] Onze Lieve Vrouw Hosp, Dept Internal Med, Amsterdam, Netherlands; [Prins, Jan M.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Ctr Infect Dis & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Imperial College London; Onze Lieve Vrouwe Gasthuis Hospital; University of Amsterdam; Academic Medical Center Amsterdam	Kootstra, NA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Sanquin Res,Landsteiner Lab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	N.A.Kootstra@amc.uva.nl	Prins, Jan M./AAF-4945-2020	Prins, Jan/0000-0002-5415-8933; Kootstra, Neeltje A./0000-0001-9429-7754; van 't Wout, Angelique/0000-0003-3705-2392; Welkers, Matthijs/0000-0002-2982-0278	Aids Fonds Netherlands [2008023]	Aids Fonds Netherlands	This work was supported by the Aids Fonds Netherlands [grant 2008023]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaak H, 2000, P NATL ACAD SCI USA, V97, P1269, DOI 10.1073/pnas.97.3.1269; Brumme ZL, 2004, AIDS, V18, pF1, DOI 10.1097/00002030-200403050-00001; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Daar ES, 2007, CLIN INFECT DIS, V45, P643, DOI 10.1086/520650; Goetz MB, 2009, JAIDS-J ACQ IMM DEF, V50, P259, DOI 10.1097/QAI.0b013e3181989a8b; Gras L, 2007, JAIDS-J ACQ IMM DEF, V45, P183, DOI 10.1097/QAI.0b013e31804d685b; Husman AMD, 1997, ANN INTERN MED, V127, P882, DOI 10.7326/0003-4819-127-10-199711150-00004; Isaacman-Beck J, 2009, J VIROL, V83, P8208, DOI 10.1128/JVI.00296-09; KARLSSON A, 1994, J CLIN MICROBIOL, V32, P364, DOI 10.1128/JCM.32.2.364-370.1994; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; KOOT M, 1992, AIDS, V6, P49, DOI 10.1097/00002030-199201000-00006; Koot M, 1996, J INFECT DIS, V173, P349, DOI 10.1093/infdis/173.2.349; Koot M, 1999, J INFECT DIS, V179, P254, DOI 10.1086/314539; KOOT M, 1993, J INFECT DIS, V168, P733, DOI 10.1093/infdis/168.3.733; Lanca AM, 2012, MEM I OSWALDO CRUZ, V107, P96, DOI 10.1590/S0074-02762012000100014; Lusso P, 2006, EMBO J, V25, P447, DOI 10.1038/sj.emboj.7600947; RICHMAN DD, 1994, J INFECT DIS, V169, P968, DOI 10.1093/infdis/169.5.968; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; Schuitemaker H, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S5; Seclen E, 2011, J INFECT DIS, V204, P139, DOI 10.1093/infdis/jir218; van Rij RP, 1998, J INFECT DIS, V178, P1806, DOI 10.1086/314522; van't Wout AB, 2008, NAT PROTOC, V3, P363, DOI 10.1038/nprot.2008.3; VANTWOUT AB, 1994, J CLIN INVEST, V94, P2060, DOI 10.1172/JCI117560; Waters L, 2008, CLIN INFECT DIS, V46, P1617, DOI 10.1086/587660; Weiser B, 2008, AIDS, V22, P469, DOI 10.1097/QAD.0b013e3282f4196c; Wilen CB, 2011, J VIROL, V85, P8514, DOI 10.1128/JVI.00736-11	28	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76255	10.1371/journal.pone.0076255	http://dx.doi.org/10.1371/journal.pone.0076255			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098454	Green Published, Green Submitted, gold			2022-12-25	WOS:000325427100050
J	Hou, LJ; Han, X; Sheng, P; Tong, WS; Li, ZQ; Xu, DY; Yu, MK; Huang, LQ; Zhao, ZX; Lu, YC; Dong, Y				Hou, Lijun; Han, Xi; Sheng, Ping; Tong, Wusong; Li, Zhiqiang; Xu, Dayuan; Yu, Mingkun; Huang, Liuqing; Zhao, Zhongxin; Lu, Yicheng; Dong, Yan			Risk Factors Associated with Sleep Disturbance following Traumatic Brain Injury: Clinical Findings and Questionnaire Based Study	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; EXCESSIVE DAYTIME SLEEPINESS; INSOMNIA; COMPLAINTS; PREVALENCE	Background: Sleep disturbance is very common following traumatic brain injury (TBI), which may initiate or exacerbate a variety of co-morbidities and negatively impact rehabilitative treatments. To date, there are paradoxical reports regarding the associations between inherent characteristics of TBI and sleep disturbance in TBI population. The current study was designed to explore the relationship between the presence of sleep disturbance and characteristics of TBI and identify the factors which are closely related to the presence of sleep disturbance in TBI population. Methods: 98 TBI patients (72 males, mean age +/- SD, 47 +/- 13 years, range 18-70) were recruited. Severity of TBI was evaluated based on Glasgow Coma Scale (GCS). All participants performed cranial computed tomography and were examined on self-reported sleep quality, anxiety, and depression. Results: TBI was mild in 69 (70%), moderate in 15 (15%) and severe in 14 (15%) patients. 37 of 98 patients (38%) reported sleep disturbance following TBI. Insomnia was diagnosed in 28 patients (29%) and post-traumatic hypersomnia in 9 patients (9%). In TBI with insomnia group, 5 patients (18%) complained of difficulty falling asleep only, 8 patients (29%) had difficulty maintaining sleep without difficulty in initial sleep and 15 patients (53%) presented both difficulty falling asleep and difficulty maintaining sleep. Risk factors associated with insomnia were headache and/or dizziness and more symptoms of anxiety and depression rather than GCS. In contrast, GCS was independently associated with the presence of hypersomnia following TBI. Furthermore, there was no evidence of an association between locations of brain injury and the presence of sleep disturbance after TBI. Conclusion: Our data support and contribute to a growing body of evidence which indicates that TBI patients with insomnia are prone to suffer from concomitant headache and/or dizziness, report more symptoms of anxiety and depression and severe TBI patients are likely to experience hypersomnia.	[Hou, Lijun; Sheng, Ping; Yu, Mingkun; Lu, Yicheng; Dong, Yan] Second Mil Med Univ, Dept Neurosurg, Shanghai Inst Neurosurg, PLA Inst Neurosurg,Changzhang Hosp, Shanghai, Peoples R China; [Han, Xi] Fudan Univ, Dept Neurosurg, Huashan Hosp, Shanghai 200433, Peoples R China; [Tong, Wusong] Pudong New Area Peoples Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Li, Zhiqiang; Xu, Dayuan] Fengxian Cent Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Huang, Liuqing; Zhao, Zhongxin] Second Mil Med Univ, Dept Neurol, Changzhang Hosp, Shanghai, Peoples R China	Naval Medical University; Fudan University; Naval Medical University	Hou, LJ (corresponding author), Second Mil Med Univ, Dept Neurosurg, Shanghai Inst Neurosurg, PLA Inst Neurosurg,Changzhang Hosp, Shanghai, Peoples R China.	lj_hou@hotmail.com; dongyan2006@yahoo.com			Natural Science Foundation from Science and Technology Commission of Shanghai Municipality [11ZR1448700]; Research Foundation for Returned Scholars from Ministry of Education of China	Natural Science Foundation from Science and Technology Commission of Shanghai Municipality; Research Foundation for Returned Scholars from Ministry of Education of China	Dr. Yan Dong is supported by Natural Science Foundation from Science and Technology Commission of Shanghai Municipality (11ZR1448700) and Research Foundation for Returned Scholars from Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, P298; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Boivin DB, 2003, NEUROLOGY, V60, P1841, DOI 10.1212/01.WNL.0000061482.24750.7C; Bryan CJ, 2013, J HEAD TRAUMA REHAB, V28, P13, DOI 10.1097/HTR.0b013e31826c73cc; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313; Fichtenberg NL, 2000, BRAIN INJURY, V14, P659; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Flesher MR, 2001, BRAIN INJURY, V15, P879, DOI 10.1080/02699050110065682; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Hossain Jamil L, 2002, Sleep Breath, V6, P85, DOI 10.1055/s-2002-32322; Johnson VE, 2012, EXP NEUROL; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Liang Siyu, 2013, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V38, P370, DOI 10.3969/j.issn.1672-7347.2013.04.006; Liu Y, 2013, CHINA MED HERALD, V10, P60; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Masel BE, 2001, ARCH PHYS MED REHAB, V82, P1526, DOI 10.1053/apmr.2001.26093; Mayers AG, 2006, INT J PSYCHIAT CLIN, V10, P2, DOI 10.1080/13651500500328087; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Perlis ML, 1997, PERCEPT MOTOR SKILL, V84, P595, DOI 10.2466/pms.1997.84.2.595; Plante DT, 2009, SLEEP MED CLIN, V4, P407, DOI 10.1016/j.jsmc.2009.04.008; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; SNAITH RP, 1986, BRIT MED J, V292, P344, DOI 10.1136/bmj.292.6516.344; Tobe EH, 1999, J NEUROPSYCH CLIN N, V11, P504, DOI 10.1176/jnp.11.4.504; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Watson NF, 2007, J CLIN SLEEP MED, V3, P363; Wu SQ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-849	40	29	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76087	10.1371/journal.pone.0076087	http://dx.doi.org/10.1371/journal.pone.0076087			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231OR	24098425	gold, Green Published, Green Submitted			2022-12-25	WOS:000325427100040
J	Lin, KJ; Weng, YH; Hsieh, CJ; Lin, WY; Wey, SP; Kung, MP; Yen, TC; Lu, CS; Hsiao, IT				Lin, Kun-Ju; Weng, Yi-Hsin; Hsieh, Chia-Ju; Lin, Wey-Yil; Wey, Shiaw-Pyng; Kung, Mei-Ping; Yen, Tzu-Chen; Lu, Chin-Song; Hsiao, Ing-Tsung			Brain Imaging of Vesicular Monoamine Transporter Type 2 in Healthy Aging Subjects by F-18-FP-(+)-DTBZ PET	PLOS ONE			English	Article							IDIOPATHIC PARKINSONS-DISEASE; POSITRON-EMISSION-TOMOGRAPHY; DOPAMINE; DENSITY; BINDING; MARKERS; AGE	F-18-FP-(+)-DTBZ is a novel PET radiotracer targeting vesicular monoamine transporter type 2 (VMAT2). The goal was to explore the image features in normal human brains with F-18-FP-(+)-DTBZ as a reference of molecular landmark for clinical diagnosis in Parkinson's disease (PD) and related disorders. Materials and Methods: A total of 22 healthy subjects (59.3 +/- 6.0 years old) including 7 men and 15 women were recruited for MRI and F-18-FP-(+)-DTBZ PET scans. A total number of 55 brain VOIs were selected for quantitation analysis. The regional specific uptake ratio (SUR) was calculated with occipital as reference from MRI-based spatially normalized F-18-FP-(+)-DTBZ images. Regional percentage SUR to that of anterior putamen was calculated. Average SUR images were displayed in 2D and 3D space to illustrate the image patterns. The correlation between age and regional VMAT2 uptake was also examined. Results: Visual assessment showed symmetric uptake of F-18-FP-(+)-DTBZ and obviously highest in striatum, followed by nucleus accumbens, hypothalamus, substantia nigra, and raphe nuclei. Quantification analysis revealed striatal VMAT2 density of anterior putamen > posterior putamen > caudate nucleus. Other subcortical regions were with moderate VMAT2 distribution (6 similar to 51% SUR of anterior putamen), while slightly lower VMAT2 was observed in cerebellum (10.60% SUR) and much lower in neocortex (<5% SUR). No significant correlation of SUR to age was found in subcortical regions. Conclusion: Using F-18-FP-(+)-DTBZ PET, we showed the 2D and 3D imaging features of the VMAT2 distribution in vivo in healthy aging brains. The in vivo imaging characteristics of VMAT2 is consistent with the expression of VMAT2 in a recent autopsy study. Therefore, 3D visualization and higher image quality of F-18-FP-(+)-DTBZ PET imaging might potentially be a powerful biomarker in detecting VMAT2 distribution of subcortical regions, and for Parkinson's disease and related neuropsychiatric disorders involving related monoaminergic systems.	[Lin, Kun-Ju; Hsieh, Chia-Ju; Wey, Shiaw-Pyng; Kung, Mei-Ping; Hsiao, Ing-Tsung] Chang Gung Univ, Coll Med, Dept Med Imaging & Radiol Sci, Tao Yuan, Taiwan; [Lin, Kun-Ju; Weng, Yi-Hsin; Hsieh, Chia-Ju; Wey, Shiaw-Pyng; Kung, Mei-Ping; Lu, Chin-Song; Hsiao, Ing-Tsung] Chang Gung Univ, Hlth Aging Res Ctr, Tao Yuan, Taiwan; [Lin, Kun-Ju; Yen, Tzu-Chen; Hsiao, Ing-Tsung] Chang Gung Mem Hosp, Dept Nucl Med, Tao Yuan, Taiwan; [Lin, Kun-Ju; Yen, Tzu-Chen; Hsiao, Ing-Tsung] Chang Gung Mem Hosp, Mol Imaging Ctr, Tao Yuan, Taiwan; [Weng, Yi-Hsin; Lin, Wey-Yil; Lu, Chin-Song] Chang Gung Mem Hosp, Dept Neurol, Div Movement Disorders, Tao Yuan, Taiwan; [Weng, Yi-Hsin; Lin, Wey-Yil; Lu, Chin-Song] Chang Gung Mem Hosp, Neurosci Res Ctr, Tao Yuan, Taiwan; [Weng, Yi-Hsin; Lu, Chin-Song] Chang Gung Univ, Sch Med, Tao Yuan, Taiwan; [Kung, Mei-Ping] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; University of Pennsylvania	Lu, CS (corresponding author), Chang Gung Univ, Hlth Aging Res Ctr, Tao Yuan, Taiwan.	bob.cslu@gmail.com; ihsiao@mail.cgu.edu.tw	Lin, Wey-Yil/AAE-5068-2020; Lin, Kun-Ju/H-3120-2015	Lin, Kun-Ju/0000-0003-1933-4564; Hsiao, Ing-Tsung/0000-0002-5255-7498; Hsieh, Chia-Ju/0000-0002-2833-7727	National Science Council, Taiwan [NSC-98-2314-B-182-034-MY2, 99-2314-B-182A-067-MY2, 100-2314-B-182-038, 100-2314-B-182A-092-MY3, 101-2314-B-182-061-MY2]; Research Fund of Chang Gung Memorial Hospital [CMRPD1A0312, CMRPD1C0381, CMRPG390912, CMRPG390913]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Research Fund of Chang Gung Memorial Hospital	This study was carried out with financial support from the National Science Council, Taiwan (Grant NSC-98-2314-B-182-034-MY2 and 99-2314-B-182A-067-MY2, 100-2314-B-182-038, 100-2314-B-182A-092-MY3, 101-2314-B-182-061-MY2), and grants from the Research Fund of Chang Gung Memorial Hospital (CMRPD1A0312, CMRPD1C0381, CMRPG390912, CMRPG390913). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohnen NI, 2006, J CEREBR BLOOD F MET, V26, P1198, DOI 10.1038/sj.jcbfm.9600276; Braak H, 2003, J NEURAL TRANSM, V110, P517, DOI 10.1007/s00702-002-0808-2; Brooks DJ, 2006, BIOL PSYCHIAT, V59, P908, DOI 10.1016/j.biopsych.2005.12.017; Chan GLY, 1999, J NUCL MED, V40, P283; FAHN S, 1971, J NEUROL SCI, V14, P427, DOI 10.1016/0022-510X(71)90178-X; Frey KA, 1996, ANN NEUROL, V40, P873, DOI 10.1002/ana.410400609; Gilman S, 1998, ANN NEUROL, V44, P326, DOI 10.1002/ana.410440307; Goswami R, 2006, NUCL MED BIOL, V33, P685, DOI 10.1016/j.nucmedbio.2006.05.006; Haycock JW, 2003, J NEUROCHEM, V87, P574, DOI 10.1046/j.1471-4159.2003.02017.x; HENRY JP, 1989, BIOCHEM PHARMACOL, V38, P2395, DOI 10.1016/0006-2952(89)90082-8; Hirano S, 2012, J NEUROL NEUROSUR PS, V83, P963, DOI 10.1136/jnnp-2011-301818; KILBOURN MR, 1993, J NEUROCHEM, V60, P2315, DOI 10.1111/j.1471-4159.1993.tb03521.x; Kim J, 2007, IEEE T INF TECHNOL B, V11, P161, DOI 10.1109/TITB.2006.875669; Kim JK, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.3.1790763; Koeppe RA, 1999, J CEREBR BLOOD F MET, V19, P1376, DOI 10.1097/00004647-199912000-00011; Koeppe RA, 1996, J CEREBR BLOOD F MET, V16, P1288, DOI 10.1097/00004647-199611000-00025; Lin KJ, 2011, NUCL MED BIOL; Lin KJ, 2010, J NUCL MED, V51, P1480, DOI 10.2967/jnumed.110.078196; Litvan I, 1998, ARCH NEUROL-CHICAGO, V55, P1313, DOI 10.1001/archneur.55.10.1313; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; McNamee RL, 2009, J NUCL MED, V50, P348, DOI 10.2967/jnumed.108.057612; Oh M, 2012, J NUCL MED, V53, P399, DOI 10.2967/jnumed.111.095224; Okamura N, 2010, J NUCL MED, V51, P223, DOI 10.2967/jnumed.109.070094; Rahman S, 2008, MOVEMENT DISORD, V23, P1428, DOI 10.1002/mds.21667; SCHERMAN D, 1988, J NEUROCHEM, V50, P1131, DOI 10.1111/j.1471-4159.1988.tb10583.x; Siderowf A, 2012, MOVEMENT DISORD, V27, P608, DOI 10.1002/mds.24954; Sun JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049483; Tong J, 2007, J NEUROCHEM, V102, P1691, DOI 10.1111/j.1471-4159.2007.04636.x; Tong JC, 2011, J CEREBR BLOOD F MET, V31, P2065, DOI 10.1038/jcbfm.2011.63; Troiano AR, 2010, SYNAPSE, V64, P146, DOI 10.1002/syn.20708; Tsao HH, 2010, NUCL MED BIOL, V37, P413, DOI 10.1016/j.nucmedbio.2010.01.002; Tzen KY, 2001, J NUCL MED, V42, P408; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Dyck CH, 2002, AM J GERIAT PSYCHIAT, V10, P36, DOI 10.1176/appi.ajgp.10.1.36; Villablanca JP, 2002, AM J NEURORADIOL, V23, P1187; VOLKOW ND, 1994, ANN NEUROL, V36, P237, DOI 10.1002/ana.410360218; Weng YH, 2004, J NUCL MED, V45, P393	38	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75952	10.1371/journal.pone.0075952	http://dx.doi.org/10.1371/journal.pone.0075952			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098749	Green Submitted, Green Published, gold			2022-12-25	WOS:000325423500119
J	Ratnik, K; Viru, L; Merits, A				Ratnik, Kaspar; Viru, Liane; Merits, Andres			Control of the Rescue and Replication of Semliki Forest Virus Recombinants by the Insertion of miRNA Target Sequences	PLOS ONE			English	Article							EQUINE ENCEPHALITIS-VIRUS; SINDBIS VIRAL VECTORS; IN-VIVO; PLASMA-MEMBRANE; MOSQUITO CELLS; MESSENGER-RNA; HUMAN CANCERS; DNA VACCINES; MICRORNA; PROTEIN	Due to their broad cell- and tissue-tropism, alphavirus-based replication-competent vectors are of particular interest for anti-cancer therapy. These properties may, however, be potentially hazardous unless the virus infection is controlled. While the RNA genome of alphaviruses precludes the standard control techniques, host miRNAs can be used to down-regulate viral replication. In this study, target sites from ubiquitous miRNAs and those of miRNAs under-represented in cervical cancer cells were inserted into replication-competent DNA/RNA layered vectors of Semliki Forest virus. It was found that in order to achieve the most efficient suppression of recombinant virus rescue, the introduced target sequences must be fully complementary to those of the corresponding miRNAs. Target sites of ubiquitous miRNAs, introduced into the 39 untranslated region of the viral vector, profoundly reduced the rescue of recombinant viruses. Insertion of the same miRNA targets into coding region of the viral vector was approximately 300-fold less effective. Viruses carrying these miRNAs were genetically unstable and rapidly lost the target sequences. This process was delayed, but not completely prevented, by miRNA inhibitors. Target sites of miRNA under-represented in cervical cancer cells had much smaller but still significant effects on recombinant virus rescue in cervical cancer-derived HeLa cells. Over-expression of miR-214, one of these miRNAs, reduced replication of the targeted virus. Though the majority of rescued viruses maintained the introduced miRNA target sequences, genomes with deletions of these sequences were also detected. Thus, the low-level repression of rescue and replication of targeted virus in HeLa cells was still sufficient to cause genetic instability.	[Ratnik, Kaspar; Viru, Liane; Merits, Andres] Univ Tartu, Inst Technol, EE-50090 Tartu, Estonia	University of Tartu	Merits, A (corresponding author), Univ Tartu, Inst Technol, Ulikooli 18, EE-50090 Tartu, Estonia.	andres.merits@ut.ee	Merits, Andres/H-3125-2015	Merits, Andres/0000-0001-8193-0071	Estonian Science Foundation [7501, 9400, SF0180087s08]; European Union through the European Regional Development Fund via the Center of Excellence in Chemical Biology	Estonian Science Foundation; European Union through the European Regional Development Fund via the Center of Excellence in Chemical Biology	The work was supported by Estonian Science Foundation grants 7501 and 9400, target financing project SF0180087s08, and by the European Union through the European Regional Development Fund via the Center of Excellence in Chemical Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhrymuk I, 2012, J VIROL, V86, P7180, DOI 10.1128/JVI.00541-12; Atasheva S, 2008, J VIROL, V82, P4028, DOI 10.1128/JVI.02330-07; Barnes D, 2008, CELL HOST MICROBE, V4, P239, DOI 10.1016/j.chom.2008.08.003; Barry G, 2010, J VIROL, V84, P7369, DOI 10.1128/JVI.02310-09; Berezikov E, 2006, GENOME RES, V16, P1289, DOI 10.1101/gr.5159906; Berglund P, 1998, NAT BIOTECHNOL, V16, P562, DOI 10.1038/nbt0698-562; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; FROLOV I, 1994, J VIROL, V68, P1721, DOI 10.1128/JVI.68.3.1721-1727.1994; Frolova EI, 2010, J VIROL, V84, P11679, DOI 10.1128/JVI.01441-10; Fros JJ, 2010, J VIROL, V84, P10877, DOI 10.1128/JVI.00949-10; Garmashova N, 2006, J VIROL, V80, P5686, DOI 10.1128/JVI.02739-05; Heiss BL, 2011, J VIROL, V85, P1464, DOI 10.1128/JVI.02091-10; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kamrud KI, 2010, J VIROL, V84, P7713, DOI 10.1128/JVI.00310-10; Karlsson Gunilla B, 2004, Methods Mol Biol, V246, P543; Kelly EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000820; Kelly EJ, 2010, J VIROL, V84, P1550, DOI 10.1128/JVI.01788-09; Kelvin AA, 2011, J INFECT DEV COUNTR, V5, P441, DOI 10.3855/jidc.2171; Kim DY, 2013, J VIROL, V87, P4202, DOI 10.1128/JVI.03142-12; Lee CYF, 2009, CLIN CANCER RES, V15, P5126, DOI 10.1158/1078-0432.CCR-09-0051; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Leitner WW, 2004, VACCINE, V22, P1537, DOI 10.1016/j.vaccine.2003.10.013; Li N, 2013, NUCLEIC ACIDS RES, V41, P3619, DOI 10.1093/nar/gkt072; Li N, 2008, NUCLEIC ACIDS RES, V36, P4277, DOI 10.1093/nar/gkn388; LILJESTROM P, 1991, BIO-TECHNOL, V9, P1356, DOI 10.1038/nbt1291-1356; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Lulla A, 2012, J VIROL, V86, P553, DOI 10.1128/JVI.05195-11; Lundstrom Kenneth, 2003, Expert Rev Vaccines, V2, P447; Mavrakis KJ, 2010, NAT CELL BIOL, V12, P372, DOI 10.1038/ncb2037; Merits A, 2001, J GEN VIROL, V82, P765, DOI 10.1099/0022-1317-82-4-765; Plante K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002142; Quetglas JI, 2010, VIRUS RES, V153, P179, DOI 10.1016/j.virusres.2010.07.027; RAJU R, 1991, J VIROL, V65, P2501, DOI 10.1128/JVI.65.5.2501-2510.1991; Rausalu K, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-33; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Simion A, 2010, BIOCHEM BIOPH RES CO, V391, P293, DOI 10.1016/j.bbrc.2009.11.052; Spuul P, 2010, J VIROL, V84, P7543, DOI 10.1128/JVI.00477-10; Stelter L, 2013, MOL IMAGING BIOL, V15, P166, DOI 10.1007/s11307-012-0585-8; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Tamberg N, 2007, J GEN VIROL, V88, P1225, DOI 10.1099/vir.0.82436-0; Thomas JM, 2003, J VIROL, V77, P5598, DOI 10.1128/JVI.77.10.5598-5606.2003; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tseng JC, 2009, GENE THER, V16, P291, DOI 10.1038/gt.2008.153; Tseng JC, 2010, CANCER GENE THER, V17, P244, DOI 10.1038/cgt.2009.70; Tseng JC, 2004, NAT BIOTECHNOL, V22, P70, DOI 10.1038/nbt917; Ulper L, 2008, J VIROL METHODS, V148, P265, DOI 10.1016/j.jviromet.2007.10.007; Varjak M, 2013, J VIROL; Ventoso I, 2006, GENE DEV, V20, P87, DOI 10.1101/gad.357006; Viru L, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-243; Volkova E, 2008, VIROLOGY, V377, P160, DOI 10.1016/j.virol.2008.04.020; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Ylosmaki E, 2013, J VIROL, V87, P335, DOI 10.1128/JVI.01940-12; Zheng Z, 2013, J VIROL; Zhigou W, 2009, MICRORNA INTERFERENC; Zusinaite E, 2007, J GEN VIROL, V88, P1977, DOI 10.1099/vir.0.82865-0	60	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75802	10.1371/journal.pone.0075802	http://dx.doi.org/10.1371/journal.pone.0075802			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098728	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500099
J	Soumya, RS; Vineetha, VP; Reshma, PL; Raghu, KG				Soumya, Rema Sreenivasan; Vineetha, Vadavanath Prabhakaran; Reshma, Premachandran Latha; Raghu, Kozhiparambil Gopalan			Preparation and Characterization of Selenium Incorporated Guar Gum Nanoparticle and Its Interaction with H9c2 Cells	PLOS ONE			English	Article							DRUG-DELIVERY; SURFACE DECORATION; CELLULAR UPTAKE; POLYSACCHARIDES; CANCER; TOXICITY	This study deals with the preparation and characterization of selenium incorporated guar gum nanoparticle (SGG), and its effect on H9c2 cardiomyoblast. Herein, nanoprecipitation techniques had been employed for the preparation of SGG nanoparticle. The prepared nanoparticle had been subjected to various types of analytical techniques like transmission electron microscopy (TEM), X-ray diffraction (XRD) and particle size analysis to confirm the characteristics of nanoparticle as well as for selenium incorporation. Physical characterization of nanoparticle showed that the size of nanoparticles increase upto similar to 69-173 nm upon selenium incorporation from similar to 41-132 nm. Then the prepared nanoparticles were evaluated for its effect on H9c2 cells. In this regard, the effect of nanoparticle on various vital parameters of H9c2 cells was studied. Parameters like cell viability, uptake of selenium incorporated guar gum nanoparticle by the cells, effect of SGG on DNA integrity, apoptosis, reactive oxygen species generation, alteration in transmembrane potential of mitochondria and cytoskeletal integrity had been investigated. Viability results showed that up to 25 nM of SGG was safe (10.31%) but beyond that it induces cytotoxicity. Cellular uptake of selenium showed that cell permeability for SGG is significantly high compared to normal selenium (7.2 nM of selenium for 25 nM SGG compared with 5.2 nM selenium for 25 nM sodium selenite). There was no apoptosis with SGG and also it protects DNA from hydroxyl radical induced breakage. Likewise no adverse effect on mitochondria and cytoskeleton was observed for 25 nM of SGG. Overall results reveal that SGG is highly suitable for biomedical research application.	[Soumya, Rema Sreenivasan; Vineetha, Vadavanath Prabhakaran; Reshma, Premachandran Latha; Raghu, Kozhiparambil Gopalan] NIIST, CSIR, Agroproc & Nat Prod Div, Thiruvananthapuram, Kerala, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute Interdisciplinary Science & Technology (NIIST)	Raghu, KG (corresponding author), NIIST, CSIR, Agroproc & Nat Prod Div, Thiruvananthapuram, Kerala, India.	raghukgopal2009@gmail.com	Raghu, K G/AAT-8042-2021		Indian Council of Medical Research, Govt. of India [45/32/2010-PHA/BMS]	Indian Council of Medical Research, Govt. of India(Indian Council of Medical Research (ICMR))	Funder - Indian Council of Medical Research, Govt. of India, for Senior Research Fellowship (45/32/2010-PHA/BMS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Halim ES, 2011, CARBOHYD POLYM, V85, P692, DOI 10.1016/j.carbpol.2011.03.039; Bayliss C. E., 1986, APPL ENVIRON MICROB, V48, P626; Bilati U, 2005, EUR J PHARM SCI, V24, P67, DOI 10.1016/j.ejps.2004.09.011; Bjorkhem-Bergman L, 2002, BIOCHEM PHARMACOL, V63, P1875, DOI 10.1016/S0006-2952(02)00981-4; Chakravarthi SS, 2007, NANOPARTICULATE DRUG, P51; Cheng WH, 2009, ENVIRON MOL MUTAGEN, V50, P349, DOI 10.1002/em.20489; Couvreur P, 2006, PROG SOLID STATE CH, V34, P231, DOI 10.1016/j.progsolidstchem.2005.11.009; El-Ansary A, 2009, J TOXICOL-US, V2009, DOI 10.1155/2009/754810; Goldstein AM, 1993, IND GUMS POLYSACCHAR; Guhagarkar SA, 2009, AAPS PHARMSCITECH, V10, P935, DOI 10.1208/s12249-009-9284-4; Hans ML, 2002, CURR OPIN SOLID ST M, V6, P319, DOI 10.1016/S1359-0286(02)00117-1; Lee JW, 2000, J PHARM SCI-US, V89, P850, DOI 10.1002/1520-6017(200007)89:7<850::AID-JPS2>3.0.CO;2-G; Lemarchand C, 2004, EUR J PHARM BIOPHARM, V58, P327, DOI 10.1016/j.ejpb.2004.02.016; Li YH, 2011, BIOMATERIALS, V32, P9068, DOI 10.1016/j.biomaterials.2011.08.001; Liu ZH, 2008, ADV DRUG DELIVER REV, V60, P1650, DOI 10.1016/j.addr.2008.09.001; Mahapatro A, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-55; Moak MA, 2001, BIOL TRACE ELEM RES, V79, P257, DOI 10.1385/BTER:79:3:257; Navas-Acien A, 2008, CURR OPIN LIPIDOL, V19, P43, DOI 10.1097/MOL.0b013e3282f2b261; Pandey S, 2012, INT J BIOL MACROMOL, V51, P583, DOI 10.1016/j.ijbiomac.2012.06.033; Pandya VM, 2011, PHARM LETT, V3, P129; Prabaharan M, 2011, INT J BIOL MACROMOL, V49, P117, DOI 10.1016/j.ijbiomac.2011.04.022; Ramoutar RR, 2007, J INORG BIOCHEM, V101, P1028, DOI 10.1016/j.jinorgbio.2007.03.016; Ray AL, 2006, J NUTR, V136, P172, DOI 10.1093/jn/136.1.172; Rayman MP, 2005, P NUTR SOC, V64, P527, DOI 10.1079/PNS2005467; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Rubinstein A, 2000, DRUG DEVELOP RES, V50, P435, DOI 10.1002/1098-2299(200007/08)50:3/4<435::AID-DDR26>3.0.CO;2-5; Ruiz-Meana M, 2010, CARDIOVASC RES, V88, P30, DOI 10.1093/cvr/cvq225; Sanmartin C, 2012, INT J MOL SCI, V13, P9649, DOI 10.3390/ijms13089649; Shimizu R, 2009, J HEALTH SCI, V55, P271, DOI 10.1248/jhs.55.271; Soenen SJ, 2011, NANO TODAY, V6, P446, DOI 10.1016/j.nantod.2011.08.001; Sohaebuddin S, 2010, FIBRE TOXICOL, V7, P1; Soumya RS, 2010, INT J BIOL MACROMOL, V46, P267, DOI 10.1016/j.ijbiomac.2009.11.003; Thomson CD, 2004, EUR J CLIN NUTR, V58, P391, DOI 10.1038/sj.ejcn.1601800; Vandamme TF, 2002, CARBOHYD POLYM, V48, P219, DOI 10.1016/S0144-8617(01)00263-6; Vineetha VP, 2013, CARDIOVASC TOXICOL, V13, P123, DOI 10.1007/s12012-012-9191-x; Wu HL, 2012, J MATER CHEM, V22, P9602, DOI 10.1039/c2jm16828f; Xiang N, 2009, CANCER CHEMOTH PHARM, V63, P351, DOI 10.1007/s00280-008-0745-3; Yang F, 2012, INT J NANOMED, V7, P835, DOI 10.2147/IJN.S28278; Zhang S, 2011, J NUTR BIOCHEM, V22, P1137, DOI 10.1016/j.jnutbio.2010.09.014; Zhang YB, 2013, NANOMED-NANOTECHNOL, V9, P74, DOI 10.1016/j.nano.2012.04.002; Zhang YF, 2010, LANGMUIR, V26, P17617, DOI 10.1021/la1033959	41	35	36	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74411	10.1371/journal.pone.0074411	http://dx.doi.org/10.1371/journal.pone.0074411			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098647	Green Submitted, gold, Green Published			2022-12-25	WOS:000325423500018
J	Starr, KF; Porsch, EA; Heiss, C; Black, I; Azadi, P; St Geme, JW				Starr, Kimberly F.; Porsch, Eric A.; Heiss, Christian; Black, Ian; Azadi, Parastoo; St Geme, Joseph W., III			Characterization of the Kingella kingae Polysaccharide Capsule and Exopolysaccharide	PLOS ONE			English	Article							K-ANTIGENS; CHILDREN; INFECTIONS; GENETICS; LIPOPOLYSACCHARIDES; ASSOCIATION; C-13	Recent evidence indicates that Kingella kingae produces a polysaccharide capsule. In an effort to determine the composition and structure of this polysaccharide capsule, in the current study we purified capsular material from the surface of K. kingae strain 269-492 variant KK01 using acidic conditions to release the capsule and a series of steps to remove DNA, RNA, and protein. Analysis of the resulting material by gas chromatography and mass spectrometry revealed N-acetyl galactosamine (GalNAc), 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo), and galactose (Gal). Further analysis by NMR demonstrated two distinct polysaccharides, one consisting of GalNAc and Kdo with the structure -> 3)-beta-GalpNAc-(1 -> 5)-beta-Kdop-(2 -> and the other containing galactose alone with the structure -> 5)-beta-Galf-(1 ->. Disruption of the ctrA gene required for surface localization of the K. kingae polysaccharide capsule resulted in elimination of GalNAc and Kdo but had no effect on the presence of Gal in bacterial surface extracts. In contrast, deletion of the pamABCDE locus involved in production of a reported galactan exopolysaccharide eliminated Gal but had no effect on the presence of GalNAc and Kdo in surface extracts. Disruption of ctrA and deletion of pamABCDE resulted in a loss of all carbohydrates in surface extracts. These results establish that K. kingae strain KK01 produces a polysaccharide capsule with the structure -> 3)-beta-GalpNAc-(1 -> 5)-beta-Kdop-(2 -> and a separate exopolysaccharide with the structure -> 5)-beta-Galf-(1 ->. The polysaccharide capsule and the exopolysaccharide require distinct genetic loci for surface localization.	[Starr, Kimberly F.; Porsch, Eric A.; St Geme, Joseph W., III] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Starr, Kimberly F.; Porsch, Eric A.; St Geme, Joseph W., III] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA; [Heiss, Christian; Black, Ian; Azadi, Parastoo] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Duke University; Duke University; University System of Georgia; University of Georgia	St Geme, JW (corresponding author), Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA.	j.stgeme@duke.edu	Heiss, Christian/GPX-7678-2022	Heiss, Christian/0000-0003-1118-8953	Ubited States Department of Energy [DE-FG02-93ER-20097]	Ubited States Department of Energy(United States Department of Energy (DOE))	This study was supported by the Ubited States Department of Energy, DE-FG02-93ER-20097. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit U, 2012, CLIN INFECT DIS, V55, P1074, DOI 10.1093/cid/cis622; Bendaoud M, 2011, J BACTERIOL, V193, P3879, DOI 10.1128/JB.00311-11; BHATTACHARJEE AK, 1978, BIOCHEMISTRY-US, V17, P645, DOI 10.1021/bi00597a013; Bidet P, 2013, PEDIATR INFECT DIS J, V32, P558, DOI 10.1097/INF.0b013e3182867f5e; Corbett D, 2010, PROKARYOTIC CELL WALL COMPOUNDS: STRUCTURE AND BIOCHEMISTRY, P111, DOI 10.1007/978-3-642-05062-6_3; Dolan-Livengood JM, 2003, J INFECT DIS, V187, P1616, DOI 10.1086/374740; Donot F, 2012, CARBOHYD POLYM, V87, P951, DOI 10.1016/j.carbpol.2011.08.083; Dubnov-Raz G, 2008, PEDIATRICS, V122, P1305, DOI 10.1542/peds.2007-3070; Fraysse N, 2005, GLYCOBIOLOGY, V15, P101, DOI 10.1093/glycob/cwh142; Heiss C, 2009, CARBOHYD RES, V344, P915, DOI 10.1016/j.carres.2009.03.003; JANN B, 1983, CARBOHYD RES, V120, P131, DOI 10.1016/0008-6215(83)88012-4; JANN K, 1983, PROG ALLERGY, V33, P53; Kalin M, 1998, THORAX, V53, P159, DOI 10.1136/thx.53.3.159; Kehl-Fie TE, 2008, J BACTERIOL, V190, P7157, DOI 10.1128/JB.00884-08; Kehl-Fie TE, 2010, INFECT IMMUN, V78, P1692, DOI 10.1128/IAI.00908-09; Kim JS, 1996, GLYCOBIOLOGY, V6, P433, DOI 10.1093/glycob/6.4.433; Kumar AS, 2007, J BASIC MICROB, V47, P103, DOI 10.1002/jobm.200610203; ORSKOV I, 1977, BACTERIOL REV, V41, P667, DOI 10.1128/MMBR.41.3.667-710.1977; PERRY MB, 1990, SERODIAG IMMUN INF D, V4, P299, DOI 10.1016/0888-0786(90)90018-J; Porsch EA, 2012, MBIO, V3, DOI 10.1128/mBio.00372-12; REISTAD R, 1993, CARBOHYD RES, V245, P129, DOI 10.1016/0008-6215(93)80065-M; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; Sambrook J., 1989, MOL CLONING LAB MANU, V2; TURK DC, 1984, J MED MICROBIOL, V18, P1, DOI 10.1099/00222615-18-1-1; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Weinberger DM, 2010, CLIN INFECT DIS, V51, P692, DOI 10.1086/655828; Weiss-Salz I, 2011, ADV EXP MED BIOL, V719, P67, DOI 10.1007/978-1-4614-0204-6_7; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; YAGUPSKY P, 1995, PEDIATR INFECT DIS J, V14, P673, DOI 10.1097/00006454-199508000-00005; YAGUPSKY P, 1992, J CLIN MICROBIOL, V30, P1278, DOI 10.1128/JCM.30.5.1278-1281.1992; Yagupsky P, 2011, PEDIATRICS, V127, P557, DOI 10.1542/peds.2010-1867; Yagupsky P, 2009, PEDIATR INFECT DIS J, V28, P155, DOI 10.1097/INF.0b013e318184dbb8	32	28	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75409	10.1371/journal.pone.0075409	http://dx.doi.org/10.1371/journal.pone.0075409			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098695	Green Published, gold, Green Submitted			2022-12-25	WOS:000325423500066
J	Dai, XM; She, PL; Chi, FT; Feng, Y; Liu, H; Jin, DQ; Zhao, YQ; Guo, XC; Jiang, DD; Guan, KL; Zhong, TP; Zhao, B				Dai, Xiaoming; She, Peilu; Chi, Fangtao; Feng, Ying; Liu, Huan; Jin, Daqing; Zhao, Yiqiang; Guo, Xiaocan; Jiang, Dandan; Guan, Kun-Liang; Zhong, Tao P.; Zhao, Bin			Phosphorylation of Angiomotin by Lats1/2 Kinases Inhibits F-actin Binding, Cell Migration, and Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Angiogenesis; Cell Migration; Protein Kinases; Protein Phosphorylation; Lats; AMOT; Protein Kinase; the Hippo Pathway	HIPPO-YAP PATHWAY; TUMOR-SUPPRESSOR; PROMOTES APOPTOSIS; EMBRYONIC-DEVELOPMENT; PROLIFERATION ARREST; PROTEIN-KINASE; GROWTH-CONTROL; TISSUE-GROWTH; SIZE-CONTROL; CYCLE EXIT	The Hippo tumor suppressor pathway plays important roles in organ size control through Lats1/2 mediated phosphorylation of the YAP/TAZ transcription co-activators. However, YAP/TAZ independent functions of the Hippo pathway are largely unknown. Here we report a novel role of the Hippo pathway in angiogenesis. Angiomotin p130 isoform (AMOTp130) is phosphorylated on a conserved HXRXXS motif by Lats1/2 downstream of GPCR signaling. Phosphorylation disrupts AMOT interaction with F-actin and correlates with reduced F-actin stress fibers and focal adhesions. Furthermore, phosphorylation of AMOT by Lats1/2 inhibits endothelial cell migration in vitro and angiogenesis in zebrafish embryos in vivo. Thus AMOT is a direct substrate of Lats1/2 mediating functions of the Hippo pathway in endothelial cell migration and angiogenesis.	[Dai, Xiaoming; Chi, Fangtao; Feng, Ying; Liu, Huan; Zhao, Yiqiang; Guo, Xiaocan; Jiang, Dandan; Zhao, Bin] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Dai, Xiaoming; Chi, Fangtao; Feng, Ying; Liu, Huan; Zhao, Yiqiang; Guo, Xiaocan; Jiang, Dandan; Zhao, Bin] Zhejiang Univ, Innovat Ctr Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China; [She, Peilu; Jin, Daqing; Zhong, Tao P.] Fudan Univ, Sch Life Sci, Dept Genet, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Zhejiang University; Zhejiang University; Fudan University; University of California System; University of California San Diego; University of California System; University of California San Diego	Zhao, B (corresponding author), Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	binzhao@zju.edu.cn	Guan, Kun-Liang/ADK-7088-2022; Liu, Huan/CAA-2351-2022	Dai, Xiaoming/0000-0001-9671-8137; /0000-0002-5730-2830	National Natural Science Foundation of China [31271508]; State Key Development Program for Basic Research of China [2013CB945303]; Natural Science Foundation of Zhejiang [LR12C07001]; Thousand Young Talents Plan of China; NATIONAL CANCER INSTITUTE [R01CA132809] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); Natural Science Foundation of Zhejiang(Natural Science Foundation of Zhejiang Province); Thousand Young Talents Plan of China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants (to B. Z.) from the National Natural Science Foundation of China (31271508), State Key Development Program for Basic Research of China (2013CB945303), Natural Science Foundation of Zhejiang (LR12C07001), and the Thousand Young Talents Plan of China.	Aase K, 2007, GENE DEV, V21, P2055, DOI 10.1101/gad.432007; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chiyoda T, 2012, J CELL BIOL, V197, P625, DOI 10.1083/jcb.201110110; Cross LM, 2003, ARTERIOSCL THROM VAS, V23, P911, DOI 10.1161/01.ATV.0000068685.72914.7E; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Dutta S, 2008, CURR BIOL, V18, P1466, DOI 10.1016/j.cub.2008.08.052; Emoto K, 2006, NATURE, V443, P210, DOI 10.1038/nature05090; Ernkvist M, 2006, FEBS J, V273, P2000, DOI 10.1111/j.1742-4658.2006.05216.x; Ernkvist M, 2008, BBA-MOL CELL RES, V1783, P429, DOI 10.1016/j.bbamcr.2007.11.018; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hirate Y, 2013, CURR BIOL, V23, P1181, DOI 10.1016/j.cub.2013.05.014; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; McPherson JP, 2004, EMBO J, V23, P3677, DOI 10.1038/sj.emboj.7600371; Mikeladze-Dvali T, 2005, CELL, V122, P775, DOI 10.1016/j.cell.2005.07.026; Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005; Mo JS, 2012, GENE DEV, V26, P2138, DOI 10.1101/gad.197582.112; Oka T, 2012, ONCOGENE, V31, P128, DOI 10.1038/onc.2011.216; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Paramasivam M, 2011, MOL BIOL CELL, V22, P3725, DOI 10.1091/mbc.E11-04-0300; Ranahan WP, 2011, CANCER RES, V71, P2203, DOI 10.1158/0008-5472.CAN-10-1995; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Shah Kavita, 2003, Methods Mol Biol, V233, P253; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Tschop K, 2011, GENE DEV, V25, P814, DOI 10.1101/gad.2000211; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; XU TA, 1995, DEVELOPMENT, V121, P1053; Yang XL, 2004, NAT CELL BIOL, V6, P609, DOI 10.1038/ncb1140; Yi CL, 2011, CANCER CELL, V19, P527, DOI 10.1016/j.ccr.2011.02.017; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhang K, 2012, EMBO J, V31, P29, DOI 10.1038/emboj.2011.357; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhong TP, 2001, NATURE, V414, P216, DOI 10.1038/35102599; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	53	115	124	3	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34041	34051		10.1074/jbc.M113.518019	http://dx.doi.org/10.1074/jbc.M113.518019			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24106267	hybrid, Green Published			2022-12-25	WOS:000327250200045
J	Loya, TJ; O'Rourke, TW; Degtyareva, N; Reines, D				Loya, Travis J.; O'Rourke, Thomas W.; Degtyareva, Natalya; Reines, Daniel			A Network of Interdependent Molecular Interactions Describes a Higher Order Nrd1-Nab3 Complex Involved in Yeast Transcription Termination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Regulation; Polyglutamine; RNA; RNA-binding Protein; RNA Polymerase II; Transcription Elongation Factors; Transcription Termination; Nab3; Nrd1	RNA-BINDING PROTEINS; CELL-FREE FORMATION; HNRNP-C; SEQUENCE; NRD1; IDENTIFICATION; SNORNA; DOMAIN; AGGREGATION; RECOGNITION	Background: How the yeast proteins Nrd1 and Nab3 provoke transcription termination is poorly understood. Results: An essential part of Nab3 contains a self-assembly domain that appears unstructured. Nrd1/Nab3 double mutants disrupt the function of this higher order complex, causing lethality. Conclusion: A large network of molecular interactions is needed for termination. Significance: A new essential function of Nab3 has been identified. Nab3 and Nrd1 are yeast heterogeneous nuclear ribonucleoprotein (hnRNP)-like proteins that heterodimerize and bind RNA. Genetic and biochemical evidence reveals that they are integral to the termination of transcription of short non-coding RNAs by RNA polymerase II. Here we define a Nab3 mutation (nab3134) that removes an essential part of the protein's C terminus but nevertheless can rescue, in trans, the phenotype resulting from a mutation in the RNA recognition motif of Nab3. This low complexity region of Nab3 appears intrinsically unstructured and can form a hydrogel in vitro. These data support a model in which multiple Nrd1-Nab3 heterodimers polymerize onto substrate RNA to effect termination, allowing complementation of one mutant Nab3 molecule by another lacking a different function. The self-association property of Nab3 adds to the previously documented interactions between these hnRNP-like proteins, RNA polymerase II, and the nascent transcript, leading to a network of nucleoprotein interactions that define a higher order Nrd1-Nab3 complex. This was underscored from the synthetic phenotypes of yeast strains with pairwise combinations of Nrd1 and Nab3 mutations known to affect their distinct biochemical activities. The mutations included a Nab3 self-association defect, a Nab3-Nrd1 heterodimerization defect, a Nrd1-polymerase II binding defect, and an Nab3-RNA recognition motif mutation. Although no single mutation was lethal, cells with any two mutations were not viable for four such pairings, and a fifth displayed a synthetic growth defect. These data strengthen the idea that a multiplicity of interactions is needed to assemble a higher order Nrd1-Nab3 complex that coats specific nascent RNAs in preparation for termination.	[Loya, Travis J.; O'Rourke, Thomas W.; Degtyareva, Natalya; Reines, Daniel] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Reines, D (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Rollins Res Ctr, Atlanta, GA 30322 USA.	dreines@emory.edu	excellency, Your/R-2357-2019; Degtyareva, Natalya/AAI-5500-2021	excellency, Your/0000-0003-0832-6243; Degtyareva, Natalya/0000-0002-7141-6308	National Institutes of Health, NIGMS [R01GM46331]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367, R01GM046331] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grant R01GM46331.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Arigo JT, 2006, MOL CELL, V23, P841, DOI 10.1016/j.molcel.2006.07.024; BARNETT SF, 1989, MOL CELL BIOL, V9, P492, DOI 10.1128/MCB.9.2.492; BEYER AL, 1977, CELL, V11, P127, DOI 10.1016/0092-8674(77)90323-3; Carroll KL, 2004, MOL CELL BIOL, V24, P6241, DOI 10.1128/MCB.24.14.6241-6252.2004; Carroll KL, 2007, RNA, V13, P361, DOI 10.1261/rna.338407; Conrad NK, 2000, GENETICS, V154, P557; Creamer TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002329; Fiumara F, 2010, CELL, V143, P1121, DOI 10.1016/j.cell.2010.11.042; Galea CA, 2006, J PROTEOME RES, V5, P2839, DOI 10.1021/pr060328c; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Hobor F, 2011, J BIOL CHEM, V286, P3645, DOI 10.1074/jbc.M110.158774; HUANG M, 1994, MOL CELL BIOL, V14, P518, DOI 10.1128/MCB.14.1.518; Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1; Johnson DE, 2012, J STRUCT BIOL, V180, P201, DOI 10.1016/j.jsb.2012.05.013; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Kim M, 2006, MOL CELL, V24, P723, DOI 10.1016/j.molcel.2006.11.011; Kloimwieder A, 2011, G3-GENES GENOM GENET, V1, P143, DOI 10.1534/g3.111.000323; Loya TJ, 2013, J BIOL CHEM, V288, P2111, DOI 10.1074/jbc.M112.430678; Loya TJ, 2012, NUCLEIC ACIDS RES, V40, P7476, DOI 10.1093/nar/gks377; Lunde BM, 2011, NUCLEIC ACIDS RES, V39, P337, DOI 10.1093/nar/gkq751; Nedea E, 2008, MOL CELL, V29, P577, DOI 10.1016/j.molcel.2007.12.031; Orr HT, 2012, CURR OPIN GENET DEV, V22, P251, DOI 10.1016/j.gde.2012.01.001; Petrakis S, 2013, BIOESSAYS, V35, P503, DOI 10.1002/bies.201300001; Porrua O, 2012, EMBO J, V31, P3935, DOI 10.1038/emboj.2012.237; REINES D, 1985, J BIOL CHEM, V260, P4248; Riordan DP, 2011, NUCLEIC ACIDS RES, V39, P1501, DOI 10.1093/nar/gkq920; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Schaefer MH, 2012, NUCLEIC ACIDS RES, V40, P4273, DOI 10.1093/nar/gks011; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Steinmetz EJ, 1996, MOL CELL BIOL, V16, P6993, DOI 10.1128/mcb.16.12.6993; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Thual C, 1999, J BIOL CHEM, V274, P13666, DOI 10.1074/jbc.274.19.13666; Vasiljeva L, 2006, MOL CELL, V21, P239, DOI 10.1016/j.molcel.2005.11.028; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; Whitson SR, 2005, J MOL BIOL, V350, P319, DOI 10.1016/j.jmb.2005.05.002; WILSON SM, 1994, J CELL BIOL, V127, P1173, DOI 10.1083/jcb.127.5.1173; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003	41	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34158	34167		10.1074/jbc.M113.516765	http://dx.doi.org/10.1074/jbc.M113.516765			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24100036	Green Published, hybrid			2022-12-25	WOS:000327250200059
J	Yang, D; Okamura, H; Nakashima, Y; Haneji, T				Yang, Di; Okamura, Hirohiko; Nakashima, Yoshiki; Haneji, Tatsuji			Histone Demethylase Jmjd3 Regulates Osteoblast Differentiation via Transcription Factors Runx2 and Osterix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone; Bone morphogenetic protein (BMP); Differentiation; Histone methylation; Osteoblasts	BONE MORPHOGENETIC PROTEIN-2; 2A C-ALPHA; GENE-EXPRESSION; PHOSPHATASE; OSTEOCALCIN; INDUCTION; CULTURES; FAMILY; MATRIX; CELLS	Post-translational modifications of histones including methylation play important roles in cell differentiation. Jumonji domain-containing 3 (Jmjd3) is a histone demethylase, which specifically catalyzes the removal of trimethylation of histone H3 at lysine 27 (H3K27me3). In this study, we examined the expression of Jmjd3 in osteoblasts and its roles in osteoblast differentiation. Jmjd3 expression in the nucleus was induced in response to the stimulation of osteoblast differentiation as well as treatment of bone morphogenetic protein-2 (BMP-2). Either treatment with Noggin, an inhibitor of BMP-2, or silencing of Smad1/5 suppressed Jmjd3 expression during osteoblast differentiation. Silencing of Jmjd3 expression suppressed osteoblast differentiation through the expression of bone-related genes including Runx2, osterix, osteopontin, bone sialoprotein (BSP), and osteocalcin (OCN). Silencing of Jmjd3 decreased the promoter activities of Runx2 and osterix and increased the level of H3K27me3 on the promoter regions of Runx2 and osterix. Introduction of the exogenous Runx2 and osterix partly rescued osteoblast differentiation in the shJmjd3 cells. The present results indicate that Jmjd3 plays important roles in osteoblast differentiation and regulates the expressions of BSP and OCN via transcription factors Runx2 and osterix.	[Yang, Di; Okamura, Hirohiko; Nakashima, Yoshiki; Haneji, Tatsuji] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Histol & Oral Histol, Kuramoto, Tokushima 7708504, Japan; [Yang, Di] China Med Univ, Sch Stomatol, Dept Endodont, Shenyang 110002, Peoples R China	Tokushima University; China Medical University	Haneji, T (corresponding author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Histol & Oral Histol, 3-18-15 Kuramoto, Tokushima 7708504, Japan.	tat-hane@tokushima-u.ac.jp	Nakashima, Yoshiki/AAE-3808-2020; Okamura, Hirohiko/I-5917-2019	Okamura, Hirohiko/0000-0002-3254-5238; Nakashima, Yoshiki/0000-0003-1827-7609	Ministry of Education, Science, Sports, and Culture of Japan [21592330, 23592703, 25462859]	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grants-in-aid for Scientific Research 21592330, 23592703, and 25462859 from the Ministry of Education, Science, Sports, and Culture of Japan.	Amorim BR, 2007, BIOCHEM BIOPH RES CO, V355, P347, DOI 10.1016/j.bbrc.2007.01.150; Canovas S, 2012, P NATL ACAD SCI USA, V109, P2400, DOI 10.1073/pnas.1119112109; Chen D, 1997, CALCIFIED TISSUE INT, V60, P283, DOI 10.1007/s002239900230; Chen SZ, 2013, CELL RES, V23, P326, DOI 10.1038/cr.2012.136; Chen SZ, 2012, GENE DEV, V26, P1364, DOI 10.1101/gad.186056.111; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Estaras C, 2012, DEVELOPMENT, V139, P2681, DOI 10.1242/dev.078345; Fei T, 2010, GENOME RES, V20, P36, DOI 10.1101/gr.092114.109; Fonseca M. B., 2012, PLOS ONE, V7; Ge WS, 2011, STEM CELLS, V29, P1112, DOI 10.1002/stem.663; Ghosh-Choudhury Nandini, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P345; Hanai J, 1999, J BIOL CHEM, V274, P31577, DOI 10.1074/jbc.274.44.31577; HARRIS SE, 1994, J BONE MINER RES, V9, P855; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Komori T, 2008, FRONT BIOSCI-LANDMRK, V13, P898, DOI 10.2741/2730; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee SU, 2008, INT IMMUNOPHARMACOL, V8, P741, DOI 10.1016/j.intimp.2008.01.027; Lee SU, 2010, AMINO ACIDS, V38, P85, DOI 10.1007/s00726-008-0208-5; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Okamura H, 2013, J CELL PHYSIOL, V228, P1031, DOI 10.1002/jcp.24250; Okamura H, 2013, FEBS LETT, V587, P48, DOI 10.1016/j.febslet.2012.10.041; Okamura H, 2011, BONE, V49, P368, DOI 10.1016/j.bone.2011.06.004; Pedersen MT, 2010, TRENDS CELL BIOL, V20, P662, DOI 10.1016/j.tcb.2010.08.011; Rivenbark AG, 2007, SCIENCE, V318, P403, DOI 10.1126/science.1150321; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Sinha KM, 2010, EMBO J, V29, P68, DOI 10.1038/emboj.2009.332; Sola S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018421; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Wozney JM, 1998, CLIN ORTHOP RELAT R, P26; Xiang Y, 2007, CELL RES, V17, P850, DOI 10.1038/cr.2007.83; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Yasui T, 2011, J BONE MINER RES, V26, P2665, DOI 10.1002/jbmr.464; Yu H, 2008, GENOME RES, V18, P1314, DOI 10.1101/gr.073080.107	37	79	82	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33530	33541		10.1074/jbc.M113.497040	http://dx.doi.org/10.1074/jbc.M113.497040			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24106268	Green Published, hybrid			2022-12-25	WOS:000327250200004
J	Hoffmann, H; Rath, T				Hoffmann, Holger; Rath, Thomas			Future Bloom and Blossom Frost Risk for Malus domestica Considering Climate Model and Impact Model Uncertainties	PLOS ONE			English	Article							PHENOLOGICAL MODELS; WINTER CHILL; SPRING FROST; FRUIT-TREES; APPLE; TIME; TRENDS; DAMAGE; CROPS; DATES	The future bloom and risk of blossom frosts for Malus domestica were projected using regional climate realizations and phenological (= impact) models. As climate impact projections are susceptible to uncertainties of climate and impact models and model concatenation, the significant horizon of the climate impact signal was analyzed by applying 7 impact models, including two new developments, on 13 climate realizations of the IPCC emission scenario A1B. Advancement of phenophases and a decrease in blossom frost risk for Lower Saxony (Germany) for early and late ripeners was determined by six out of seven phenological models. Single model/single grid point time series of bloom showed significant trends by 2021-2050 compared to 1971-2000, whereas the joint signal of all climate and impact models did not stabilize until 2043. Regarding blossom frost risk, joint projection variability exceeded the projected signal. Thus, blossom frost risk cannot be stated to be lower by the end of the 21st century despite a negative trend. As a consequence it is however unlikely to increase. Uncertainty of temperature, blooming date and blossom frost risk projection reached a minimum at 2078-2087. The projected phenophases advanced by 5.5 d K-1, showing partial compensation of delayed fulfillment of the winter chill requirement and faster completion of the following forcing phase in spring. Finally, phenological model performance was improved by considering the length of day.	[Hoffmann, Holger; Rath, Thomas] Leibniz Univ Hannover, Inst Biol Prod Syst, D-30167 Hannover, Germany	Leibniz University Hannover	Hoffmann, H (corresponding author), Univ Bonn, Inst Crop Sci & Resource Conservat INRES, Bonn, Germany.	hhoffmann@uni-bonn.de	Hoffmann, Holger/H-3165-2019; Hoffmann, Holger/A-8169-2013	Hoffmann, Holger/0000-0001-9811-5065; Hoffmann, Holger/0000-0001-9811-5065	Ministry for Science and Culture of Lower Saxony within the network KLIFF - climate impact and adaptation research in Lower Saxony	Ministry for Science and Culture of Lower Saxony within the network KLIFF - climate impact and adaptation research in Lower Saxony	The study was supported by the Ministry for Science and Culture of Lower Saxony within the network KLIFF - climate impact and adaptation research in Lower Saxony. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura T, 2011, ACTA HORTIC, V919, P65; Bai J, 2011, ADV ATMOS SCI, V28, P564, DOI 10.1007/s00376-010-9219-8; Blanke MM, 2011, ACTA HORTIC, V922, P381; Blanke M, 2009, ERWERBS-OBSTBAU, V51, P101, DOI 10.1007/s10341-009-0086-3; Blumel K, 2012, AGR FOREST METEOROL, V164, P10, DOI 10.1016/j.agrformet.2012.05.001; Bowman AW, 1997, APPL SMOOTHING TECHN; CANNELL MGR, 1986, J APPL ECOL, V23, P177, DOI 10.2307/2403090; Chitu E, 2011, ACTA HORTIC, V919, P57; Chmielewski F, 2005, ANN METEOROL, V41, P488; Chmielewski F, 2009, KLIO KLIMAWANDEL OBS; Chmielewski FM, 2005, INT J BIOMETEOROL, V50, P96, DOI 10.1007/s00484-005-0275-1; Chmielewski FM, 2004, AGR FOREST METEOROL, V121, P69, DOI 10.1016/S0168-1923(03)00161-8; Chmielewski FM, 2001, AGR FOREST METEOROL, V108, P101, DOI 10.1016/S0168-1923(01)00233-7; Chmielewski FM, 2011, METEOROL Z, V20, P487, DOI 10.1127/0941-2948/2011/0258; Chuine I, 1998, PLANT CELL ENVIRON, V21, P455, DOI 10.1046/j.1365-3040.1998.00299.x; Chuine I, 2010, SCIENCE, V329, P277, DOI 10.1126/science.329.5989.277-e; Deque M, 2007, CLIMATIC CHANGE, V81, P53, DOI 10.1007/s10584-006-9228-x; Dosio A, 2012, J GEOPHYS RES-ATMOS, P117; Eccel E, 2009, INT J BIOMETEOROL, V53, P273, DOI 10.1007/s00484-009-0213-8; Fan Xiao-chun, 2010, Shengtaixue Zazhi, V29, P50; Farajzadeh M, 2009, METEOROL APPL, V17, P45; Hakkinen R, 1998, TREE PHYSIOL, V18, P707; Harrington CA, 2010, FOREST ECOL MANAG, V259, P798, DOI 10.1016/j.foreco.2009.06.018; Hawkins E, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050087; Hawkins E, 2009, B AM METEOROL SOC, V90, P1095, DOI 10.1175/2009BAMS2607.1; Hoffmann H, 2012, ACTA HORTIC, V957, P289; Hoffmann H, 2012, EUR J HORTIC SCI, V77, P241; Hoffmann H, 2012, THEOR APPL CLIMATOL, V110, P129, DOI 10.1007/s00704-012-0618-x; Ibanez I, 2010, PHILOS T R SOC B, V365, P3247, DOI 10.1098/rstb.2010.0120; Jacob D, 2009, REMO AIB SCENARIO; Juroszek P, 2012, EUR J PLANT PATHOL, P1; Kaukoranta T, 2010, AGR FOOD SCI, V19, P144, DOI 10.2137/145960610791542352; Keuler K, 2009, CLIMATE SIMULATION C, DOI [10.1594/WDCC/CLM_A1B_1_D2, DOI 10.1594/WDCC/CLM_]; Kunz A, 2011, ACTA HORTIC, V903, P1121, DOI 10.17660/ActaHortic.2011.903.156; LANDSBERG JJ, 1974, ANN BOT-LONDON, V38, P1013, DOI 10.1093/oxfordjournals.aob.a084891; Legave JM, 2008, J HORTIC SCI BIOTECH, V83, P76, DOI 10.1080/14620316.2008.11512350; Lewis PAW, 1966, STAT ANAL SERIES EVE; Luedeling E, 2012, SCI HORTIC-AMSTERDAM, V144, P218, DOI 10.1016/j.scienta.2012.07.011; Luedeling E, 2009, ERWERBS-OBSTBAU, V51, P81, DOI 10.1007/s10341-009-0085-4; Luedeling E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006166; Luedeling E, 2009, AGR ECOSYST ENVIRON, V133, P23, DOI 10.1016/j.agee.2009.04.016; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; Masson-Delmotte V, 2018, SPEC REP GLOB WARM 1; Meier U., 1994, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes, V46, P141; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; MURRAY MB, 1989, J APPL ECOL, V26, P693, DOI 10.2307/2404093; Oliver M. A., 1990, International Journal of Geographical Information Systems, V4, P313, DOI 10.1080/02693799008941549; Piani C, 2010, THEOR APPL CLIMATOL, V99, P187, DOI 10.1007/s00704-009-0134-9; Rea R, 2006, INT J BIOMETEOROL, V51, P1, DOI 10.1007/s00484-006-0043-x; Rodrigo J, 2000, SCI HORTIC-AMSTERDAM, V85, P155, DOI 10.1016/S0304-4238(99)00150-8; Rojas R, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017461; Rugienius R, 2009, ACTA HORTIC, V825, P117, DOI 10.17660/ActaHortic.2009.825.14; Scheifinger H, 2003, THEOR APPL CLIMATOL, V74, P41, DOI 10.1007/s00704-002-0704-6; Schwartz MD, 2006, GLOBAL CHANGE BIOL, V12, P343, DOI 10.1111/j.1365-2486.2005.01097.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sugiura T., 2010, Acta Horticulturae, P85; Sunley RJ, 2006, J HORTIC SCI BIOTECH, V81, P949, DOI 10.1080/14620316.2006.11512181; Tooke F, 2010, J EXP BOT, V61, P2853, DOI 10.1093/jxb/erq165; van der Linden P., 2009, ENSEMBLES CLIMATE CH; Yip S, 2011, J CLIMATE, V24, P4634, DOI 10.1175/2011JCLI4085.1	60	35	35	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75033	10.1371/journal.pone.0075033	http://dx.doi.org/10.1371/journal.pone.0075033			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116022	Green Published, Green Submitted, gold			2022-12-25	WOS:000325552200006
J	Oguma, T; Hirai, T; Niimi, A; Matsumoto, H; Muro, S; Shigematsu, M; Nishimura, T; Kubo, Y; Mishima, M				Oguma, Tsuyoshi; Hirai, Toyohiro; Niimi, Akio; Matsumoto, Hisako; Muro, Shigeo; Shigematsu, Michio; Nishimura, Takashi; Kubo, Yoshiro; Mishima, Michiaki			Limitations of Airway Dimension Measurement on Images Obtained Using Multi-Detector Row Computed Tomography	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CT; VALIDATION; ACCURACY; ASTHMA; LUMEN; COPD	Objectives: (a) To assess the effects of computed tomography (CT) scanners, scanning conditions, airway size, and phantom composition on airway dimension measurement and (b) to investigate the limitations of accurate quantitative assessment of small airways using CT images. Methods: An airway phantom, which was constructed using various types of material and with various tube sizes, was scanned using four CT scanner types under different conditions to calculate airway dimensions, luminal area (Ai), and the wall area percentage (WA%). To investigate the limitations of accurate airway dimension measurement, we then developed a second airway phantom with a thinner tube wall, and compared the clinical CT images of healthy subjects with the phantom images scanned using the same CT scanner. The study using clinical CT images was approved by the local ethics committee, and written informed consent was obtained from all subjects. Data were statistically analyzed using one-way ANOVA. Results: Errors noted in airway dimension measurement were greater in the tube of small inner radius made of material with a high CT density and on images reconstructed by body algorithm (p<0.001), and there was some variation in error among CT scanners under different fields of view. Airway wall thickness had the maximum effect on the accuracy of measurements with all CT scanners under all scanning conditions, and the magnitude of errors for WA% and Ai varied depending on wall thickness when airways of <1.0-mm wall thickness were measured. Conclusions: The parameters of airway dimensions measured were affected by airway size, reconstruction algorithm, composition of the airway phantom, and CT scanner types. In dimension measurement of small airways with wall thickness of <1.0 mm, the accuracy of measurement according to quantitative CT parameters can decrease as the walls become thinner.	[Oguma, Tsuyoshi; Hirai, Toyohiro; Matsumoto, Hisako; Muro, Shigeo; Mishima, Michiaki] Kyoto Univ, Dept Resp Med, Grad Sch Med, Kyoto, Japan; [Niimi, Akio] Nagoya City Univ, Dept Med Oncol & Immunol, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Shigematsu, Michio] Sumitomo Hosp, Dept Resp Med, Osaka, Japan; [Nishimura, Takashi] Kyoto Katsura Hosp, Dept Resp Med, Kyoto, Japan; [Kubo, Yoshiro] Kansai Elect Power Hosp, Dept Respirol, Osaka, Japan	Kyoto University; Nagoya City University; Sumitomo Hospital	Hirai, T (corresponding author), Kyoto Univ, Dept Resp Med, Grad Sch Med, Kyoto, Japan.	t_hirai@kuhp.kyoto-u.ac.jp			JSPS KAKENHI [22590861]; Ministry from Health, Labour and Welfare, Japan	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry from Health, Labour and Welfare, Japan	This study was partly supported by JSPS KAKENHI Grant No. 22590861 and a grant to the Respiratory Failure Research Group from the Ministry from Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Coxson HO, 2009, AM J RESP CRIT CARE, V180, P588, DOI 10.1164/rccm.200901-0159PP; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2011, GLOB STRAT DIAGN MAN; Hasegawa M, 2006, AM J RESP CRIT CARE, V173, P1309, DOI 10.1164/rccm.200601-037OC; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Kim N, 2008, KOREAN J RADIOL, V9, P226, DOI 10.3348/kjr.2008.9.3.226; King GG, 2000, AM J RESP CRIT CARE, V161, P574, DOI 10.1164/ajrccm.161.2.9812073; Montaudon M, 2007, RADIOLOGY, V242, P563, DOI 10.1148/radiol.2422060029; Montaudon M, 2009, RADIOLOGY, V253, P844, DOI 10.1148/radiol.2533090303; Nakano Y, 2000, AM J RESP CRIT CARE, V162, P1102, DOI 10.1164/ajrccm.162.3.9907120; Niimi A, 2003, AM J RESP CRIT CARE, V168, P983, DOI 10.1164/rccm.200211-1268OC; Ohara T, 2006, RESPIROLOGY, V11, P579, DOI 10.1111/j.1440-1843.2006.00899.x; Reinhardt JM, 1997, IEEE T MED IMAGING, V16, P820, DOI 10.1109/42.650878; Robinson TE, 2009, ACAD RADIOL, V16, P1134, DOI 10.1016/j.acra.2009.02.018; Saba OI, 2003, J APPL PHYSIOL, V95, P1063, DOI 10.1152/japplphysiol.00962.2002; Shimizu K, 2011, RESP MED, V105, P1275, DOI 10.1016/j.rmed.2011.04.007; Takahashi M, 2011, EUR J RADIOL, V80, pE524, DOI 10.1016/j.ejrad.2010.12.035; Weinheimer O, 2008, IEEE T MED IMAGING, V27, P64, DOI 10.1109/TMI.2007.902798	17	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76381	10.1371/journal.pone.0076381	http://dx.doi.org/10.1371/journal.pone.0076381			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116105	Green Published, gold, Green Submitted			2022-12-25	WOS:000325552200053
J	Crisan, M; Taulescu, M; Crisan, D; Cosgarea, R; Parvu, A; Catoi, C; Drugan, T				Crisan, Maria; Taulescu, Marian; Crisan, Diana; Cosgarea, Rodica; Parvu, Alina; Catoi, Cornel; Drugan, Tudor			Expression of Advanced Glycation End-Products on Sun-Exposed and Non-Exposed Cutaneous Sites during the Ageing Process in Humans	PLOS ONE			English	Article							INCREASED ACCUMULATION; IN-VITRO; SKIN; PROTEIN; AGES; N-EPSILON-(CARBOXYMETHYL)LYSINE; GENERATION; RECEPTOR; TISSUES; MODEL	The glycation process is involved in both the intrinsic (individual, genetic) and extrinsic (ultraviolet light, polution and lifestyle) aging processes, and can be quantified at the epidermal or dermal level by histological, immunohistochemical (IHC), or imagistic methods. Our study is focused on a histological and immunohistological comparison of sun-protected regions versus sun-exposed regions from different age groups of skin phototype III subjects, related to the aging process. Skin samples collected from non-protected and UV protected regions of four experimental groups with different ages, were studied using histology and IHC methods for AGE-CML [N(epsilon)-(carboxymethyl) lysine]. A semi-quantitative assessment of the CML expression in the microvascular endothelium and dermal fibroblasts was performed. The Pearson one-way ANOVA was used to compare data between the groups. In the dermis of sun-exposed skin, the number and the intensity of CML positive cells in both fibroblasts and endothelial cells (p<0.05) was higher compared to sun-protected skin, and was significantly increased in older patients. The sun-exposed areas had a more than 10% higher AGE-CML score than the protected areas. No statistically significant correlation was observed between the histological score and the IHC expression of CML. We concluded that in healthy integument, the accumulation of final glycation products increases with age and is amplified by ultraviolet exposure. The study provides new knowledge on differences of AGE-CML between age groups and protected and unprotected areas and emphasizes that endothelium and perivascular area are most affected, justifying combined topical and systemic therapies.	[Crisan, Maria] Iuliu Hatieganu Univ Med & Pharm, Dept Histol, Cluj Napoca, Romania; [Taulescu, Marian; Catoi, Cornel] Univ Agr Sci & Vet Med, Fac Vet Med, Dept Pathol, Cluj Napoca, Romania; [Crisan, Diana; Cosgarea, Rodica] Iuliu Hatieganu Univ Med & Pharm, Dermatol Clin, Cluj Napoca, Romania; [Parvu, Alina] Iuliu Hatieganu Univ Med & Pharm, Dept Pathophysiol, Cluj Napoca, Romania; [Drugan, Tudor] Iuliu Hatieganu Univ Med & Pharm, Dept Med Informat, Cluj Napoca, Romania	Iuliu Hatieganu University of Medicine & Pharmacy; University of Agricultural Sciences & Veterinary Medicine Cluj Napoca; Iuliu Hatieganu University of Medicine & Pharmacy; Iuliu Hatieganu University of Medicine & Pharmacy; Iuliu Hatieganu University of Medicine & Pharmacy	Taulescu, M (corresponding author), Univ Agr Sci & Vet Med, Fac Vet Med, Dept Pathol, Cluj Napoca, Romania.	taulescumarian@yahoo.com	Drugan, Tudor/N-1405-2014; crisan, maria/AAA-8119-2021; Crisan, Maria/AAA-4298-2019; Taulescu, Marian/C-6594-2012	Drugan, Tudor/0000-0003-0097-262X; Taulescu, Marian/0000-0002-8987-6038	University of Medicine; University of Medicine and Pharmacy "Iuliu Hatieganu", Cluj-Napoca (Romania) [2624/2008]	University of Medicine; University of Medicine and Pharmacy "Iuliu Hatieganu", Cluj-Napoca (Romania)	This study was performed as part of a financed grant from the University of Medicine and Pharmacy "Iuliu Hatieganu", Cluj-Napoca (Romania), no. 2624/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405; BRAUN RD, 1995, INVEST OPHTH VIS SCI, V36, P542; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; Cotton SA, 1999, J PATHOL, V189, P273; Crisan D, 2012, INDIAN J DERMATOL VE, V78, DOI 10.4103/0378-6323.98096; DUNN JA, 1989, BIOCHEMISTRY-US, V28, P9464, DOI 10.1021/bi00450a033; DYER DG, 1991, Z ERNAHRUNGSWISS, V30, P29, DOI 10.1007/BF01910730; Giacomoni PU, 2001, BIOGERONTOLOGY, V2, P219, DOI 10.1023/A:1013222629919; Hofmann B, 2013, EXP GERONTOL, V48, P38, DOI 10.1016/j.exger.2012.04.011; Jeanmaire C, 2001, BRIT J DERMATOL, V145, P10, DOI 10.1046/j.1365-2133.2001.04275.x; Kasper M, 2001, ARCH GERONTOL GERIAT, V32, P233, DOI 10.1016/S0167-4943(01)00103-0; Lohwasser C, 2006, J INVEST DERMATOL, V126, P291, DOI 10.1038/sj.jid.5700070; Masaki H, 1999, BBA-GEN SUBJECTS, V1428, P45, DOI 10.1016/S0304-4165(99)00056-2; Okano Y, 2002, J DERMATOL SCI, V29, P171, DOI 10.1016/S0923-1811(02)00021-X; Pageon H, 2008, EXP GERONTOL, V43, P584, DOI 10.1016/j.exger.2008.04.004; Pageon H, 2007, EUR J DERMATOL, V17, P12; PARVER L M, 1991, Eye (London), V5, P181; Schalkwijk CG, 2004, BBA-MOL CELL BIOL L, V1636, P82, DOI 10.1016/j.bbalip.2003.07.002; Schleicher ED, 1997, J CLIN INVEST, V99, P457, DOI 10.1172/JCI119180; Toyoda M, 2001, J DERMATOL SCI, V27, pS32; Valencia JV, 2004, DIABETOLOGIA, V47, P844, DOI 10.1007/s00125-004-1392-9; Vlassara H, 1996, KIDNEY INT, V49, P1795, DOI 10.1038/ki.1996.270; Waller JM, 2006, SKIN RES TECHNOL, V12, P145, DOI 10.1111/j.0909-752X.2006.00146.x	23	26	26	4	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75003	10.1371/journal.pone.0075003	http://dx.doi.org/10.1371/journal.pone.0075003			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116020	Green Published, gold, Green Submitted			2022-12-25	WOS:000325501300020
J	Groth, AC; Liu, MD; Wang, H; Lovelett, E; Emery, DW				Groth, Amy C.; Liu, Mingdong; Wang, Hao; Lovelett, Emilie; Emery, David W.			Identification and Characterization of Enhancer-Blocking Insulators to Reduce Retroviral Vector Genotoxicity	PLOS ONE			English	Article							BETA-GLOBIN INSULATOR; CHROMATIN INSULATOR; GENE-THERAPY; CTCF; CELLS; THALASSEMIA; ACTIVATION; MECHANISMS; EXPRESSION; PROTECTS	The chromatin insulator cHS4 can reduce silencing chromosomal position effects and genotoxicity associated with integrating viral vectors. However, the fully active version of this element can also reduce vector titers and is only partially effective. In order to identify alternatives to cHS4, we developed a functional lentiviral vector-based reporter screen for enhancer-blocking insulators. Using this system, we screened candidate sequences that were initially identified by chromatin profiling for binding by CTCF and for DNase hypersensitivity. All 12 analyzed candidates blocked enhancer-promoter activity. The enhancer-blocking activity of the top two candidates was confirmed in two complementary plasmid-based assays. Studies in a gammaretroviral reporter vector indicated these two candidates have little to no effect on vector titers, and do not diminish vector expression in primary mouse bone marrow cultures. Subsequent assessment in a mouse in vivo tumor formation model demonstrated that both candidates reduced the rate of gammaretroviral vector-mediated genotoxicity as effectively as the cHS4 insulator. In summary, we have developed a novel lentiviral vector-based method of screening candidate elements for insulator activity, and have used this method to identify two new insulator elements capable of improving the safety of retroviral vectors without diminishing vector titers or expression. These findings expand the limited arsenal of insulators functionally validated to reduce the rate of retroviral vector-mediated genotoxicity.	[Groth, Amy C.; Liu, Mingdong; Lovelett, Emilie; Emery, David W.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Wang, Hao] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Emery, David W.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Emery, DW (corresponding author), Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA.	demery@uw.edu			National Institutes of Health [PO1 HL53750, RO1 HL75713]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL053750, R01HL075713] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants PO1 HL53750 and RO1 HL75713. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aker M, 2007, HUM GENE THER, V18, P333, DOI 10.1089/hum.2007.021; Aker M, 2010, J BIOL CHEM, V285, P37589, DOI 10.1074/jbc.M110.174532; Arumugam PI, 2009, MOL THER, V17, P1929, DOI 10.1038/mt.2009.183; Arumugam PI, 2009, PLOS ONE, V4, pe6995, DOI [10.1371/journal.pone.0006995, DOI 10.1371/J0URNAL.P0NE.0006995.PUBMED:19746166]; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bos TJ, 2010, J BIOTECHNOL, V150, P37, DOI 10.1016/j.jbiotec.2010.07.010; Bowers SR, 2009, MOL CELL BIOL, V29, P1682, DOI 10.1128/MCB.01411-08; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Emery DW, 2011, HUM GENE THER, V22, P761, DOI 10.1089/hum.2010.233; Emery DW, 2000, P NATL ACAD SCI USA, V97, P9150, DOI 10.1073/pnas.160159597; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Gaussin A, 2012, GENE THER, V19, P15, DOI 10.1038/gt.2011.70; GREENBERGER JS, 1983, P NATL ACAD SCI-BIOL, V80, P2931, DOI 10.1073/pnas.80.10.2931; HANTZOPOULOS PA, 1989, P NATL ACAD SCI USA, V86, P3519, DOI 10.1073/pnas.86.10.3519; HAWLEY RG, 1994, GENE THER, V1, P136; Horn PA, 2004, BLOOD, V103, P3710, DOI 10.1182/blood-2003-07-2414; Li CL, 2009, MOL THER, V17, P716, DOI 10.1038/mt.2009.7; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; PATHAK VK, 1990, P NATL ACAD SCI USA, V87, P6024, DOI 10.1073/pnas.87.16.6024; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Ramezani A, 2008, STEM CELLS, V26, P3257, DOI 10.1634/stemcells.2008-0258; Riviere I, 2012, BLOOD, V119, P1107, DOI 10.1182/blood-2011-09-349993; Ryu BY, 2008, BLOOD, V111, P1866, DOI 10.1182/blood-2007-04-085506; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tubb J, 2005, BIOTECHNIQUES, V39, P553, DOI 10.2144/000112030; Urbinati F, 2009, MOL THER, V17, P1527, DOI 10.1038/mt.2009.89; Wang H, 2012, GENOME RES, V22, P1680, DOI 10.1101/gr.136101.111; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136; Yannaki E, 2002, MOL THER, V5, P589, DOI 10.1006/mthe.2002.0582; Yannaki E, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001626; Yusufzai TM, 2004, P NATL ACAD SCI USA, V101, P8620, DOI 10.1073/pnas.0402938101; ZHANG JW, 1990, DEV GENET, V11, P168, DOI 10.1002/dvg.1020110207; Zychlinski D, 2008, MOL THER, V16, P718, DOI 10.1038/mt.2008.5	36	13	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76528	10.1371/journal.pone.0076528	http://dx.doi.org/10.1371/journal.pone.0076528			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098520	gold, Green Published, Green Submitted			2022-12-25	WOS:000325483600060
J	Olaiya, MT; Chiou, HY; Jeng, JS; Lien, LM; Hsieh, FI				Olaiya, Muideen Tunbosun; Chiou, Hung-Yi; Jeng, Jiann-Shing; Lien, Li-Ming; Hsieh, Fang-I			Significantly Increased Risk of Cardiovascular Disease among Patients with Gallstone Disease: A Population-Based Cohort Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; GROWTH-FACTOR-I; GALLBLADDER-DISEASE; TOTAL HOMOCYSTEINE; OXIDATIVE STRESS; ARTERY-DISEASE; GLOBAL BURDEN; CHOLELITHIASIS; EPIDEMIOLOGY; ASSOCIATION	Objective: To investigate whether gallstone disease (GD) increases the risk of developing cardiovascular disease (CVD) in a large population-based cohort. Methods: A study population including 6,981 patients with GD was identified from The Taiwan National Health Insurance Research Database between 2004 and 2005. GD patients were defined as patients with principal discharge diagnoses of cholelithiasis using the ICD-9-CM code 574. 27,924 patients without GD were randomly selected and matched for age and gender. All patients were followed for 6 years or until diagnosis for CVD. Cox proportional hazards regression model was used to assess the risk of developing CVD with adjustment for age, gender and co-morbid conditions. Results: During the six years follow-up period, 935 patients with GD and 2,758 patients without GD developed CVD. Patients with GD had an elevated risk of CVD (HR, 1.32; 95% CI, 1.22-1.43) when compared with those without GD. Similar relationship was observed when CVD was categorized i.e. stroke (HR, 1.15; 95% CI, 1.01-1.32), coronary heart disease (HR, 1.42; 95% CI, 1.28-1.58) and heart failure (HR, 1.31; 95% CI, 1.00-1.73). When GD was classified according to the level of severity, using patients without GD as reference, the risks of CVD were elevated in patients with non-severe GD (HR, 1.34; 95% CI, 1.24-1.46) as well as those with severe GD (HR, 1.20, 95% CI, 1.02-1.40), after adjusting for age, gender and comorbidities. In age-stratified analysis, patients aged 18-40 years with GD were at higher risk of developing CVD (HR, 1.42; 95% CI, 1.09-1.84) than older GD patients. Conclusion: This study found an increased risk of CVD in patients diagnosed with GD. The excess risk was particularly high in younger GD patients. Prevention of GD could help reduce the risk of developing CVD, and the better effect could be achieved for the younger age groups.	[Olaiya, Muideen Tunbosun; Chiou, Hung-Yi; Hsieh, Fang-I] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan; [Jeng, Jiann-Shing] Natl Taiwan Univ Hosp, Stroke Ctr, Taipei, Taiwan; [Jeng, Jiann-Shing] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Lien, Li-Ming] Shin Kong WHS Mem Hosp, Dept Neurol, Taipei, Taiwan	Taipei Medical University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Shin Kong Wu Ho Su Memorial Hospital	Hsieh, FI (corresponding author), Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan.	hsiehfangi@tmu.edu.tw		Chiou, Hung Yi/0000-0002-4545-9697; JENG, JIANN-SHING/0000-0002-1456-3686	National Science Council of Taiwan [NSC99-2314-B-038-022-MY3, NSC00-2314-B-038-030-My3, NSC100-2314-B-038-031-My3]; Taipei Medical University [TMU99-AE1-B07]; Department of Health Center of Excellence for Clinical Trial and Research in Neuroscience [DOH101-TD-B-111-003, DOH102-TD-B-111-003]; Dr. Chi-Chin Huang Stroke Research Center	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taipei Medical University; Department of Health Center of Excellence for Clinical Trial and Research in Neuroscience; Dr. Chi-Chin Huang Stroke Research Center	This study was supported by grants from the National Science Council of Taiwan (NSC99-2314-B-038-022-MY3, NSC00-2314-B-038-030-My3, NSC100-2314-B-038-031-My3), Taipei Medical University (TMU99-AE1-B07), the Department of Health Center of Excellence for Clinical Trial and Research in Neuroscience (DOH101-TD-B-111-003, DOH102-TD-B-111-003), and Dr. Chi-Chin Huang Stroke Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ata N, 2011, CAN J GASTROENTEROL, V25, P274, DOI 10.1155/2011/356761; BORTNICHAK EA, 1985, AM J EPIDEMIOL, V121, P19, DOI 10.1093/oxfordjournals.aje.a113978; Browning Jeffrey D, 2003, Semin Gastrointest Dis, V14, P165; Cavalca V, 2001, CLIN CHEM, V47, P887; Chavez-Tapia NC, 2012, ANN HEPATOL, V11, P85, DOI 10.1016/S1665-2681(19)31490-5; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chilton Robert J, 2004, J Am Osteopath Assoc, V104, pS5; Cho JY, 2010, ARCH SURG-CHICAGO, V145, P329, DOI 10.1001/archsurg.2010.35; Conti E, 2011, CLIN SCI, V120, P377, DOI 10.1042/CS20100400; Deaton C, 2011, J CARDIOVASC NURS, V26, pS5, DOI 10.1097/JCN.0b013e318213efcf; Eaton CB, 2005, PRIMARY CARE, V32, P963, DOI 10.1016/j.pop.2005.09.009; Geetha A, 2002, J Biochem Mol Biol Biophys, V6, P427, DOI 10.1080/1025814021000036179; Huang J, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-63; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; Kozak LJ, 2002, VITAL HLTH STAT, V13, P1; LamonFava S, 1996, ARTERIOSCL THROM VAS, V16, P1509, DOI 10.1161/01.ATV.16.12.1509; Lloyd-Jones DM, 2006, CIRCULATION, V113, P791, DOI 10.1161/CIRCULATIONAHA.105.548206; Marschall HU, 2007, J INTERN MED, V261, P529, DOI 10.1111/j.1365-2796.2007.01783.x; Mendez-Sanchez N, 2005, AM J GASTROENTEROL, V100, P827, DOI 10.1111/j.1572-0241.2005.41214.x; Mendez-Sanchez N, 2008, LIVER INT, V28, P402, DOI 10.1111/j.1478-3231.2007.01632.x; Moschetta A, 2004, DIGEST DIS SCI, V49, P529, DOI 10.1023/B:DDAS.0000020515.75879.2f; Nieto FJ, 1999, AM J PUBLIC HEALTH, V89, P292, DOI 10.2105/AJPH.89.3.292; Otani H, 2011, ANTIOXID REDOX SIGN, V15, P1911, DOI 10.1089/ars.2010.3739; Portincasa P, 2006, LANCET, V368, P230, DOI 10.1016/S0140-6736(06)69044-2; Ren J, 1999, J MOL CELL CARDIOL, V31, P2049, DOI 10.1006/jmcc.1999.1036; Ruhl CE, 2011, GASTROENTEROLOGY, V140, P508, DOI 10.1053/j.gastro.2010.10.060; Sakuta H, 2005, J GASTROENTEROL, V40, P1061, DOI 10.1007/s00535-005-1691-z; Schroecksnadel K, 2010, THROMB HAEMOSTASIS, V103, P926, DOI 10.1160/TH09-07-0422; Scott J, 2004, CURR OPIN GENET DEV, V14, P271, DOI 10.1016/j.gde.2004.04.012; Shaffer EA, 2006, BEST PRACT RES CL GA, V20, P981, DOI 10.1016/j.bpg.2006.05.004; Sin DD, 2005, CAN J PHYSIOL PHARM, V83, P8, DOI 10.1139/Y04-116; Stinton LM, 2012, GUT LIVER, V6, P172, DOI 10.5009/gnl.2012.6.2.172; STOLK MFJ, 1995, GASTROENTEROLOGY, V108, P1882, DOI 10.1016/0016-5085(95)90153-1; Sukhanov S, 2007, ARTERIOSCL THROM VAS, V27, P2684, DOI 10.1161/ATVBAHA.107.156257; Twickler MTB, 2005, AM J GASTROENTEROL, V100, P2363, DOI 10.1111/j.1572-0241.2005.50650_3.x; Vogt DP, 2002, CLEV CLIN J MED, V69, P977, DOI 10.3949/ccjm.69.12.977; WHO, 2013, CARD DIS ATL HEART D; World Health Organization, 2012, CARD DIS; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488; Zaliekas J, 2008, SURG CLIN N AM, V88, P1345, DOI 10.1016/j.suc.2008.07.011	40	27	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76448	10.1371/journal.pone.0076448	http://dx.doi.org/10.1371/journal.pone.0076448			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098504	Green Submitted, Green Published, gold			2022-12-25	WOS:000325483600054
J	Pang, LH; Wei, ZL; Li, O; Huang, RD; Qin, JZ; Chen, HY; Fan, XJ; Chen, ZJ				Pang, Lihong; Wei, Zhouling; Li, Ouyang; Huang, Rudian; Qin, Junzhen; Chen, Hongyan; Fan, Xiaojing; Chen, Zi-Jiang			An Increase in Vascular Endothelial Growth Factor (VEGF) and VEGF Soluble Receptor-1 (sFlt-1) Are Associated with Early Recurrent Spontaneous Abortion	PLOS ONE			English	Article							PREECLAMPSIA; HYPERTENSION; PREGNANCY	Recurrent spontaneous abortion (RSA) is a health problem that affects approximately 1% to 5% reproductive age woman. Yet, in around half of these patients, the mechanism for RSA is unexplained. Recent studies have indicated that placental ischemia/hypoxia and endothelial dysfunction are important factors in miscarriage. Other studies have indicated that the level and expression of soluble FMS-like tyrosine kinase-1 (sFlt1) is increased under a hypoxic environment. However, decreased sFlt-1 in the maternal circulation during the first trimester has recently been proposed as a potential marker for identifying risk of pregnancy loss. In this prospective study clinical samples were obtained within a short time after the fetal death, protein expression and maternal serum levels of sFlt1 were assessed and compared to samples taken from those with normal pregnancies. Our results indicate that levels of VEGF and sFlt-1 are both increased in women during early pregnancy compared women that are not pregnant (p<0.05) indicating that VEGF and sFlt-1 are both associated with pregnancy. More importantly, we detected a significant (p<0.05) increase in sFlt1 and VEGF levels and expression in the RSA patients who suffered subsequent miscarriages compare to controls. These results demonstrate that there is likely a relationship between VEGF, sFlt-1 and RSA suggesting that the high levels and over expression of sFlt-1 and VEGF might be associated with the pathogenesis of RSA.	[Pang, Lihong] Shandong Univ, Jinan 250100, Peoples R China; [Wei, Zhouling; Li, Ouyang; Huang, Rudian; Qin, Junzhen; Chen, Hongyan; Fan, Xiaojing] GuangXi Med Univ, Affiliated Hosp 1, Nanning, Peoples R China; [Chen, Zi-Jiang] Shandong Univ, Prov Hosp, Ctr Reprod Med, Jinan 250100, Peoples R China; [Chen, Zi-Jiang] Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan, Peoples R China; [Chen, Zi-Jiang] Minist Educ, Key Lab Reprod Endocrinol, Jinan, Peoples R China; [Chen, Zi-Jiang] Shandong Prov Key Lab Reprod Med, Jinan, Peoples R China	Shandong University; Guangxi Medical University; Shandong University	Chen, ZJ (corresponding author), Shandong Univ, Prov Hosp, Ctr Reprod Med, Jinan 250100, Peoples R China.	chenzijiang@hotmail.com	Yan, Junhao/AAH-8310-2019; Li, Yuan/GXV-1310-2022; Chen, Zi-Jiang/GOE-6119-2022	Chen, Zi-Jiang/0000-0001-6637-6631	National Natural Science Foundation of China [81060053]; National Basic Research Program of China (973 Program) [2012CB944700]; National Key Technology Research and Development Program [2011BAI17B00]; Scientific Research and Technological Development Fund of Guangxi, China [11217004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Key Technology Research and Development Program(National Key Technology R&D Program); Scientific Research and Technological Development Fund of Guangxi, China	This study was supported by a grant from the National Natural Science Foundation of China (81060053), National Basic Research Program of China (973 Program) (2012CB944700) and the National Key Technology Research and Development Program square 2011BAI17B00), and The Scientific Research and Technological Development Fund of Guangxi, China (11217004). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Clark DE, 1998, BIOL REPROD, V59, P1540, DOI 10.1095/biolreprod59.6.1540; Daponte A, 2011, J CLIN ENDOCR METAB, V96, pE1444, DOI 10.1210/jc.2011-0037; Dib C, 2012, TEX HEART I J, V39, P249; Genbacev O, 1997, SCIENCE, V277, P1669, DOI 10.1126/science.277.5332.1669; Goldman CK, 1998, P NATL ACAD SCI USA, V95, P8795, DOI 10.1073/pnas.95.15.8795; Jauniaux E, 2006, HUM REPROD UPDATE, V12, P747, DOI 10.1093/humupd/dml016; Kaitu'u-Lino TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032509; Lin QD, 1993, CHIN J OBSTET GYNECO, V28, P674; Lin Qi-de, 2003, Zhonghua Fu Chan Ke Za Zhi, V38, P481; Makris A, 2007, KIDNEY INT, V71, P977, DOI 10.1038/sj.ki.5002175; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; McKeeman GC, 2004, AM J OBSTET GYNECOL, V191, P1240, DOI 10.1016/j.ajog.2004.03.004; Muttukrishna S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018041; Muttukrishna S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002302; Pang LH, 2011, J INT MED RES, V39, P830, DOI 10.1177/147323001103900316; SCOTT JR, 1987, OBSTET GYNECOL, V70, P645; Stephenson MD, 1996, FERTIL STERIL, V66, P24; Tintu A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005155; Vuorela P, 2000, OBSTET GYNECOL, V95, P353, DOI 10.1016/S0029-7844(99)00565-7; Weimar CHE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041424; Yu CC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056667, 10.1371/journal.pone.0054627]; Zhou Y, 2002, AM J PATHOL, V160, P1405, DOI 10.1016/S0002-9440(10)62567-9	22	41	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75759	10.1371/journal.pone.0075759	http://dx.doi.org/10.1371/journal.pone.0075759			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098721	gold, Green Submitted, Green Published			2022-12-25	WOS:000325423500092
J	Young, A; Wang, Y; Ahmedli, NB; Jiang, MS; Farber, DB				Young, Alejandra; Wang, Ying; Ahmedli, Novruz B.; Jiang, Meisheng; Farber, Debora B.			A Constitutively Active G alpha i3 Protein Corrects the Abnormal Retinal Pigment Epithelium Phenotype of Oa1-/- mice	PLOS ONE			English	Article							OCULAR ALBINISM TYPE-1; HETEROTRIMERIC G-PROTEIN; GOLGI MEMBRANES; ALPHA-SUBUNITS; GENE; CELLS; EXPRESSION; MUTATIONS; TRANSPORT; RECEPTOR	Purpose: Ocular Albinism type 1 (OA1) is a disease caused by mutations in the OA1 gene and characterized by the presence of macromelanosomes in the retinal pigment epithelium (RPE) as well as abnormal crossing of the optic axons at the optic chiasm. We showed in our previous studies in mice that Oa1 activates specifically G alpha i3 in its signaling pathway and thus, hypothesized that a constitutively active G alpha i3 in the RPE of Oa1-/- mice might keep on the Oa1 signaling cascade and prevent the formation of macromelanosomes. To test this hypothesis, we have generated transgenic mice that carry the constitutively active G alpha i3 (Q204L) protein in the RPE of Oa1-/- mice and are now reporting the effects that the transgene produced on the Oa1-/- RPE phenotype. Methods: Transgenic mice carrying RPE-specific expression of the constitutively active G alpha i3 (Q204L) were generated by injecting fertilized eggs of Oa1-/- females with a lentivirus containing the G alpha i3 (Q204L) cDNA. PCR, Southern blots, Western blots and confocal microscopy were used to confirm the presence of the transgene in the RPE of positive transgenic mice. Morphometrical analyses were performed using electron microscopy to compare the size and number of melanosomes per RPE area in putative Oa1-/-, G alpha i3 (Q204L) transgenic mice with those of wild-type NCrl and Oa1-/- mice. Results: We found a correlation between the presence of the constitutively active G alpha i3 (Q204L) transgene and the rescue of the normal phenotype of RPE melanosomes in Oa1-/-, G alpha i3 (Q204L) mice. These mice have higher density of melanosomes per RPE area and a larger number of small melanosomes than Oa1-/- mice, and their RPE phenotype is similar to that of wild-type mice. Conclusions: Our results show that a constitutively active G alpha i3 protein can by-pass the lack of Oa1 protein in Oa1-/- mice and consequently rescue the RPE melanosomal phenotype.	[Young, Alejandra; Ahmedli, Novruz B.; Farber, Debora B.] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90024 USA; [Young, Alejandra; Farber, Debora B.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Farber, Debora B.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Wang, Ying; Jiang, Meisheng] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Jiang, MS (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	jm@ucla.edu; farber@jsei.ucla.edu		Young, Alejandra/0000-0002-1855-0559; Farber, Debora/0000-0002-3207-697X	Vision of Children Foundation; NATIONAL EYE INSTITUTE [P30EY000331] Funding Source: NIH RePORTER	Vision of Children Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Financial support from the Vision of Children Foundation is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassi MT, 1996, GENOME RES, V6, P880, DOI 10.1101/gr.6.9.880; BIRNBAUMER L, 1992, CELL, V71, P1069, DOI 10.1016/S0092-8674(05)80056-X; Brand SH, 1996, AM J PHYSIOL-CELL PH, V270, pC1362, DOI 10.1152/ajpcell.1996.270.5.C1362; CREEL DJ, 1990, OPHTHALMIC PAED GEN, V11, P193, DOI 10.3109/13816819009020979; d'Addio M, 2000, HUM MOL GENET, V9, P3011, DOI 10.1093/hmg/9.20.3011; Denker SP, 1996, J CELL BIOL, V133, P1027, DOI 10.1083/jcb.133.5.1027; ERCOLANI L, 1990, P NATL ACAD SCI USA, V87, P4635, DOI 10.1073/pnas.87.12.4635; Gohla A, 2007, AUTOPHAGY, V3, P393, DOI 10.4161/auto.4256; GUILLERY RW, 1975, BRAIN RES, V96, P373, DOI 10.1016/0006-8993(75)90750-7; Hamaguchi I, 2000, J VIROL, V74, P10778, DOI 10.1128/JVI.74.22.10778-10784.2000; Incerti B, 2000, HUM MOL GENET, V9, P2781, DOI 10.1093/hmg/9.19.2781; KING RA, 1988, DERMATOL CLIN, V6, P217, DOI 10.1016/S0733-8635(18)30668-5; LANG GE, 1990, OPHTHALMIC PAED GEN, V11, P265, DOI 10.3109/13816819009015712; LEYTE A, 1992, EMBO J, V11, P4795, DOI 10.1002/j.1460-2075.1992.tb05585.x; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Newton JM, 1996, GENOMICS, V37, P219, DOI 10.1006/geno.1996.0545; OgierDenis E, 1997, J BIOL CHEM, V272, P24599, DOI 10.1074/jbc.272.39.24599; OGIERDENIS E, 1995, J BIOL CHEM, V270, P13, DOI 10.1074/jbc.270.1.13; Rachel RA, 2002, PIGM CELL RES, V15, P273, DOI 10.1034/j.1600-0749.2002.02019.x; SCHIAFFINO MV, 1995, HUM MOL GENET, V4, P2319, DOI 10.1093/hmg/4.12.2319; Schiaffino MV, 1996, P NATL ACAD SCI USA, V93, P9055, DOI 10.1073/pnas.93.17.9055; Schnur RE, 1998, AM J HUM GENET, V62, P800, DOI 10.1086/301776; Shen B, 2001, PIGM CELL RES, V14, P243, DOI 10.1034/j.1600-0749.2001.140403.x; Somia N, 2000, NAT REV GENET, V1, P91, DOI 10.1038/35038533; STOW JL, 1991, J CELL BIOL, V114, P1113, DOI 10.1083/jcb.114.6.1113; WILSON BS, 1993, P NATL ACAD SCI USA, V90, P1681, DOI 10.1073/pnas.90.5.1681; Young A, 2008, INVEST OPHTH VIS SCI, V49, P3245, DOI 10.1167/iovs.08-1806; Young A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024376	29	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76240	10.1371/journal.pone.0076240	http://dx.doi.org/10.1371/journal.pone.0076240			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098784	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500155
J	Zhu, Y; Hollis, JH				Zhu, Yong; Hollis, James H.			Soup Consumption Is Associated with a Reduced Risk of Overweight and Obesity but Not Metabolic Syndrome in US Adults: NHANES 2003-2006	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; NATIONAL-HEALTH; UNITED-STATES; WEIGHT-LOSS; PREVALENCE; PREVENTION; MORTALITY; SATIETY	A limited number of studies have found that soup consumption is related to a lower risk of overweight and obesity in Asian and European populations, however, these studies do not provide a consistent picture regarding the association between soup consumption and markers of metabolic syndrome. To date, no study examining the relationship between soup and body weight or metabolic syndrome have been conducted in the US population. The present study used a sample of 4158 adults aged 19-64 who participated in the National Health and Nutrition Examination Survey between 2003 and 2006. The frequency of soup consumption was determined using a food frequency questionnaire. The weighted prevalence of soup consumption was 94%, with a seasonal variation in the frequency of soup consumption being found. Non-consumers of soup were at a higher risk of being overweight or obese (adjusted odds ratio = 1.381, P = 0.013), with a higher adjusted prevalence of reduced HDL cholesterol (adjusted odds ratio = 1.280, P = 0.045), but there was no association between soup consumption and metabolic syndrome (P = 0.520). The frequency of soup consumption was inversely associated with covariate-adjusted body mass index and waist circumference (P<0.05), but not with biomarkers of metabolic syndrome, except for a lower fasting insulin level in frequent soup consumers (P = 0.022). Results from the present study suggest soup consumption is not associated with metabolic syndrome. However, there is an inverse relationship between soup consumption and body weight status in US adults, which support laboratory studies showing a potential benefit of soup consumption for body weight management.	[Zhu, Yong] Univ Iowa, Dept Epidemiol, Iowa City, IA 52240 USA; [Hollis, James H.] Iowa State Univ, Dept Food Sci & Human Nutr, Ames, IA 50011 USA	University of Iowa; Iowa State University	Hollis, JH (corresponding author), Iowa State Univ, Dept Food Sci & Human Nutr, Ames, IA 50011 USA.	jhollis@iastate.edu						Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Bertrais S, 2001, J HUM NUTR DIET, V14, P121, DOI 10.1046/j.1365-277X.2001.00275.x; Bessa M, 2008, ACTA MEDICA PORT, V21, P161; Brauchla M, 2012, J NUTR METAB, V2012; Centers for Disease Control and Prevenion, NHANES 2003 2004; Centers for Disease Control and Prevention, NHANES 2005 2006; Centers for Disease Control and Prevention, BMI AD; Clegg ME, 2013, EUR J CLIN NUTR, V67, P8, DOI 10.1038/ejcn.2012.152; Cugnet-Anceau C, 2010, BRIT J NUTR, V103, P422, DOI 10.1017/S0007114509991875; Ervin R.B., 2009, NATL HLTH STAT REPOR, V5, P1; Feldeisen SE, 2007, APPL PHYSIOL NUTR ME, V32, P46, DOI [10.1139/H06-101, 10.1139/h06-101]; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Flood JE, 2007, APPETITE, V49, P626, DOI 10.1016/j.appet.2007.04.002; Ford ES, 2004, ATHEROSCLEROSIS, V173, P309, DOI 10.1016/j.atherosclerosis.2003.12.022; Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444; FOREYT JP, 1986, J AM DIET ASSOC, V86, P524; Freiberg MS, 2004, DIABETES CARE, V27, P2954, DOI 10.2337/diacare.27.12.2954; Galan P, 2003, INT J VITAM NUTR RES, V73, P315, DOI 10.1024/0300-9831.73.5.315; Giacosa A, 1997, MED DOCTOR, V8, P40; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Himaya A, 1998, APPETITE, V30, P199, DOI 10.1006/appe.1997.0138; James PT, 2004, EUR J CARDIOV PREV R, V11, P3, DOI 10.1097/01.hjr.0000114707.27531.48; JORDAN HA, 1981, J AM DIET ASSOC, V79, P24; Kuroda M, 2011, J AM DIET ASSOC, V111, P137, DOI 10.1016/j.jada.2010.10.004; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; Martinez-Tomas R, 2012, EUR J NUTR, V51, P231, DOI 10.1007/s00394-011-0211-6; Mattes R, 2005, PHYSIOL BEHAV, V83, P739, DOI 10.1016/j.physbeh.2004.09.021; Moreira Pedro, 2006, Eat Behav, V7, P220, DOI 10.1016/j.eatbeh.2005.08.008; O'Neil CE, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-107; O'Neil CE, 2011, J AM COLL NUTR, V30, P502, DOI 10.1080/07315724.2011.10719996; Poppitt SD, 1996, APPETITE, V26, P153, DOI 10.1006/appe.1996.0013; Subar AF, 2001, AM J EPIDEMIOL, V154, P1089, DOI 10.1093/aje/154.12.1089; Swinburn BA, 2004, PUBLIC HEALTH NUTR, V7, P123, DOI 10.1079/PHN2003585; Vernarelli JA, 2013, EUR J NUTR, V52, P1039, DOI 10.1007/s00394-012-0410-9; Wang Y, 2009, INT J OBESITY, V33, P621, DOI 10.1038/ijo.2009.45; Zhu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067482; Zhu Y, 2013, BRIT J NUTR, V110, P384, DOI 10.1017/S0007114512005053; Zhu Y, 2013, INT J FOOD SCI NUTR, V64, P385, DOI 10.3109/09637486.2012.759183	39	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75630	10.1371/journal.pone.0075630	http://dx.doi.org/10.1371/journal.pone.0075630			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098709	gold, Green Published			2022-12-25	WOS:000325423500080
J	Ngadjeua, F; Chiaravalli, J; Traincard, F; Raynal, B; Fontan, E; Agou, F				Ngadjeua, Flora; Chiaravalli, Jeanne; Traincard, Francois; Raynal, Bertrand; Fontan, Elisabeth; Agou, Fabrice			Two-sided Ubiquitin Binding of NF-kappa B Essential Modulator (NEMO) Zinc Finger Unveiled by a Mutation Associated with Anhidrotic Ectodermal Dysplasia with Immunodeficiency Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fluorescence; Immunodeficiency; NF-B; Ubiquitin; Zinc Finger; EDA-ID; IKK Complex; NEMO	IKK-GAMMA; LYS63-LINKED POLYUBIQUITIN; SEDIMENTATION-VELOCITY; LINEAR POLYUBIQUITIN; STRUCTURAL BASIS; MAP KINASE; ACTIVATION; DOMAIN; CHAINS; RECOGNITION	Hypomorphic mutations in the X-linked human NEMO gene result in various forms of anhidrotic ectodermal dysplasia with immunodeficiency. NEMO function is mediated by two distal ubiquitin binding domains located in the regulatory C-terminal domain of the protein: the coiled-coil 2-leucine zipper (CC2-LZ) domain and the zinc finger (ZF) domain. Here, we investigated the effect of the D406V mutation found in the NEMO ZF of an ectodermal dysplasia with immunodeficiency patients. This point mutation does not impair the folding of NEMO ZF or mono-ubiquitin binding but is sufficient to alter NEMO function, as NEMO-deficient fibroblasts and Jurkat T lymphocytes reconstituted with full-length D406V NEMO lead to partial and strong defects in NF-B activation, respectively. To further characterize the ubiquitin binding properties of NEMO ZF, we employed di-ubiquitin (di-Ub) chains composed of several different linkages (Lys-48, Lys-63, and linear (Met-1-linked)). We showed that the pathogenic mutation preferentially impairs the interaction with Lys-63 and Met-1-linked di-Ub, which correlates with its ubiquitin binding defect in vivo. Furthermore, sedimentation velocity and gel filtration showed that NEMO ZF, like other NEMO related-ZFs, binds mono-Ub and di-Ub with distinct stoichiometries, indicating the presence of a new Ub site within the NEMO ZF. Extensive mutagenesis was then performed on NEMO ZF and characterization of mutants allowed the proposal of a structural model of NEMO ZF in interaction with a Lys-63 di-Ub chain.	[Ngadjeua, Flora; Chiaravalli, Jeanne; Traincard, Francois; Fontan, Elisabeth; Agou, Fabrice] Inst Pasteur, Dept Struct Biol & Chem, CNRS, Unite Biochim Struct & Cellulaire,UMR 3528, F-75724 Paris 15, France; [Raynal, Bertrand] Inst Pasteur, Dept Struct Biol & Chem, CNRS, UMR 3528, F-75724 Paris 15, France; [Ngadjeua, Flora] Univ Paris 06, Cellule Pasteur UPMC, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite	Agou, F (corresponding author), Inst Pasteur, Dept Struct Biol & Chem, CNRS, Unite Biochim Struct & Cellulaire,UMR 3528, 25-28 Rue Dr Roux, F-75724 Paris 15, France.	fabrice.agou@pasteur.fr	, AGOU/GXA-2760-2022	raynal, Bertrand/0000-0001-5634-0408	Foundation BNP Paribas; Institut de Recherches SERVIER (Croissy sur Seine, France)	Foundation BNP Paribas; Institut de Recherches SERVIER (Croissy sur Seine, France)	This work was supported, in whole or in part, by Foundation BNP Paribas and the Institut de Recherches SERVIER (Croissy sur Seine, France).	Ajibade AA, 2012, IMMUNITY, V36, P43, DOI 10.1016/j.immuni.2011.12.010; Bomar MG, 2007, EMBO REP, V8, P247, DOI 10.1038/sj.embor.7400901; Bosanac I, 2010, MOL CELL, V40, P548, DOI 10.1016/j.molcel.2010.10.009; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Chiaravalli J, 2011, BIOCHEM PHARMACOL, V82, P1163, DOI 10.1016/j.bcp.2011.07.083; Cordier F, 2008, J MOL BIOL, V377, P1419, DOI 10.1016/j.jmb.2008.01.048; Cordier F, 2009, J BIOL CHEM, V284, P2902, DOI 10.1074/jbc.M806655200; Courtois G, 2011, CURR TOP MICROBIOL, V349, P73, DOI 10.1007/82_2010_98; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Derewenda ZS, 2006, ACTA CRYSTALLOGR D, V62, P116, DOI 10.1107/S0907444905035237; Emmerich CH, 2013, P NATL ACAD SCI USA, V110, P15247, DOI 10.1073/pnas.1314715110; Fushman D, 2010, J MOL BIOL, V395, P803, DOI 10.1016/j.jmb.2009.10.039; Gautheron J, 2010, HUM MOL GENET, V19, P3138, DOI 10.1093/hmg/ddq222; Grubisha O, 2010, J MOL BIOL, V395, P89, DOI 10.1016/j.jmb.2009.10.018; Hadian K, 2011, J BIOL CHEM, V286, P26107, DOI 10.1074/jbc.M111.233163; Harhaj EW, 2000, ONCOGENE, V19, P1448, DOI 10.1038/sj.onc.1203445; Hartwig A, 2010, METHODS MOL BIOL, V649, P399, DOI 10.1007/978-1-60761-753-2_25; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hoffmann A, 2010, BBA-MOL CELL RES, V1803, P650, DOI 10.1016/j.bbamcr.2010.01.017; Huang TT, 2002, MOL CELL BIOL, V22, P5813, DOI 10.1128/MCB.22.16.5813-5825.2002; Hubeau M, 2011, BLOOD, V118, P926, DOI 10.1182/blood-2010-10-315234; Ivins FJ, 2009, BIOCHEM J, V421, P243, DOI 10.1042/BJ20090427; Jain A, 2001, NAT IMMUNOL, V2, P223, DOI 10.1038/85277; Kensche T, 2012, J BIOL CHEM, V287, P23626, DOI 10.1074/jbc.M112.347195; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; Kulathu Y, 2009, NAT STRUCT MOL BIOL, V16, P1328, DOI 10.1038/nsmb.1731; Laplantine E, 2009, EMBO J, V28, P2885, DOI 10.1038/emboj.2009.241; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; Makris C, 2002, MOL CELL BIOL, V22, P6573, DOI 10.1128/MCB.22.18.6573-6581.2002; Mankouri J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000778; Papoutsopoulou S, 2006, NAT IMMUNOL, V7, P606, DOI 10.1038/ni1334; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; RICHARME G, 1982, BIOCHEM BIOPH RES CO, V105, P476, DOI 10.1016/0006-291X(82)91459-0; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Salvay AG, 2007, J BIOL PHYS, V33, P399, DOI 10.1007/s10867-008-9058-3; Sato Y, 2009, EMBO J, V28, P3903, DOI 10.1038/emboj.2009.345; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Schrofelbauer B, 2012, MOL CELL, V47, P111, DOI 10.1016/j.molcel.2012.04.020; Shifera AS, 2008, MOL IMMUNOL, V45, P1633, DOI 10.1016/j.molimm.2007.09.036; Sims JJ, 2012, NAT METHODS, V9, P303, DOI [10.1038/NMETH.1888, 10.1038/nmeth.1888]; Sims JJ, 2009, NAT STRUCT MOL BIOL, V16, P883, DOI 10.1038/nsmb.1637; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Tokunaga F, 2012, EMBO J, V31, P3856, DOI 10.1038/emboj.2012.241; Verhelst K, 2012, EMBO J, V31, P3845, DOI 10.1038/emboj.2012.240; Vinolo E, 2006, J BIOL CHEM, V281, P6334, DOI 10.1074/jbc.M510118200; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Wu H, 2013, CELL, V153, P287, DOI 10.1016/j.cell.2013.03.013; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xu GZ, 2011, NATURE, V472, P325, DOI 10.1038/nature09853; Yamazaki K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000387; Yang F, 2004, J IMMUNOL, V172, P2446, DOI 10.4049/jimmunol.172.4.2446; Yang WW, 2012, MOL CELL, V48, P771, DOI 10.1016/j.molcel.2012.09.028	52	8	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33722	33737		10.1074/jbc.M113.483305	http://dx.doi.org/10.1074/jbc.M113.483305			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24100029	Green Published, hybrid			2022-12-25	WOS:000327250200019
J	Frick, U; Frick, H; Langguth, B; Landgrebe, M; Hubner-Liebermann, B; Hajak, G				Frick, Ulrich; Frick, Hannah; Langguth, Berthold; Landgrebe, Michael; Huebner-Liebermann, Bettina; Hajak, Goeran			The Revolving Door Phenomenon Revisited: Time to Readmission in 17'415 Patients with 37'697 Hospitalisations at a German Psychiatric Hospital	PLOS ONE			English	Article							SURVIVAL-ANALYSIS; RECURRENT EVENTS; FRAILTY MODELS; UNITED-STATES; EARLY-ONSET; FOLLOW-UP; SCHIZOPHRENIA; DISORDER; STAY; RISK	Objective: Despite the recurring nature of the disease process in many psychiatric patients, individual careers and time to readmission rarely have been analysed by statistical models that incorporate sequence and velocity of recurrent hospitalisations. This study aims at comparing four statistical models specifically designed for recurrent event history analysis and evaluating the potential impact of predictor variables from different sources (patient, treatment process, social environment). Method: The so called Andersen-Gil counting process model, two variants of the conditional models of Prentice, Williams, and Peterson (gap time model, conditional probability model), and the so called frailty model were applied to a dataset of 17'415 patients observed during a 12 years period starting from 1996 and leading to 37'697 psychiatric hospitalisations. Potential prognostic factors stem from a standardized patient documentation form. Results: Estimated regression coefficients over different models were highly similar, but the frailty model best represented the sequentiality of individual treatment careers and differing velocities of disease progression. It also avoided otherwise likely misinterpretations of the impact of gender, partnership, historical time and length of stay. A widespread notion of psychiatric diseases as inevitably chronic and worsening could be rejected. Time in community was found to increase over historical time for all patients. Most important protective factors beyond diagnosis were employment, partnership, and sheltered living situation. Risky conditions were urban living and a concurrent substance use disorder. Conclusion: Prognostic factors for course of diseases should be determined only by statistical models capable of adequately incorporating the recurrent nature of psychiatric illnesses.	[Frick, Ulrich; Langguth, Berthold; Landgrebe, Michael; Huebner-Liebermann, Bettina; Hajak, Goeran] Univ Regensburg, Dept Psychiat & Psychotherapy, D-93053 Regensburg, Germany; [Frick, Ulrich] Dopfer Univ Appl Sci, Dept Psychol, Cologne, Germany; [Frick, Ulrich] Univ Zurich, Res Inst Publ Hlth & Addict, Zurich, Switzerland; [Frick, Hannah] Univ Innsbruck, Dept Stat, A-6020 Innsbruck, Austria; [Landgrebe, Michael; Hajak, Goeran] Sozialstiftung Bamberg, Dept Psychiat Psychosomat & Psychotherapy, Bamberg, Germany	University of Regensburg; University of Zurich; University of Innsbruck	Langguth, B (corresponding author), Univ Regensburg, Dept Psychiat & Psychotherapy, D-93053 Regensburg, Germany.	Berthold.Langguth@medbo.de	Langguth, Berthold/AAP-2638-2021		UIniversity of Regensburg	UIniversity of Regensburg	The study was funded by the UIniversity of Regensburg, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; [Anonymous], 2010, R LANG ENV STAT COMP; Appleby L, 1996, PSYCHIATR SERV, V47, P985; APPLEBY L, 1993, AM J PSYCHIAT, V150, P72; Baethge C, 2004, BIPOLAR DISORD, V6, P115, DOI 10.1111/j.1399-5618.2004.00104.x; Clemmensen L, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-150; Cording C, 1995, SPEKTRUM PSYCHIAT PS, V24, P3; Coryell W, 2012, J AFFECTIVE DISORDER; Doering S, 1998, SCHIZOPHRENIA BULL, V24, P87, DOI 10.1093/oxfordjournals.schbul.a033316; Frank D, 2005, PSYCHIAT SERV, V56, P867, DOI 10.1176/appi.ps.56.7.867; Frick U, 2010, DREHTURE STATIONAREN; Frick U, 2008, BASISDATEN STATIONAR; Frick U, 1999, QUALITAT PSYCHIAT RE, P11; Frick U, 2010, ERGEBNISSE MED STAT; Glidden DV, 2004, STAT MED, V23, P369, DOI 10.1002/sim.1599; Hardeveld F, 2013, PSYCHOL MED, V43, P39, DOI 10.1017/S0033291712002395; Heggestad T, 2011, SOC PSYCH PSYCH EPID, V46, P1275, DOI 10.1007/s00127-010-0295-y; HERZ MI, 1979, ARCH GEN PSYCHIAT, V36, P701; Johnstone P, 1999, BRIT MED J, V318, P1387, DOI 10.1136/bmj.318.7195.1387; Kessing Lars Vedel, 2005, Curr Psychiatry Rep, V7, P413, DOI 10.1007/s11920-005-0061-0; Kessing LV, 1999, AM J EPIDEMIOL, V149, P404; Kessler RC, 2001, BIOL PSYCHIAT, V49, P1002, DOI 10.1016/S0006-3223(01)01129-5; Kim HM, 2011, PSYCHIAT SERV, V62, P1346, DOI 10.1176/ps.62.11.pss6211_1346; Krabbendam L, 2005, SCHIZOPHRENIA BULL, V31, P795, DOI 10.1093/schbul/sbi060; Kuehner C, 2012, EUR ARCH PSYCHIAT CL; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; Lees J, 1999, THERAPEUTIC COMMUNIT; LEWIS T, 1990, ACTA PSYCHIAT SCAND, V82, P130, DOI 10.1111/j.1600-0447.1990.tb01369.x; Lim HJ, 2007, ACCIDENT ANAL PREV, V39, P290, DOI 10.1016/j.aap.2006.07.009; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; MARTIN BA, 1976, CAN MED ASSOC J, V115, P322; Menezes NM, 2006, PSYCHOL MED, V36, P1349, DOI 10.1017/S0033291706007951; Meyer-Lindenberg A, 2012, NAT NEUROSCI, V15, P663, DOI 10.1038/nn.3083; MODESTIN J, 1988, NERVENARZT, V59, P344; Mojtabai R, 2005, AM J PSYCHIAT, V162, P1291, DOI 10.1176/appi.ajp.162.7.1291; Mojtabai R, 1997, PSYCHIAT QUART, V68, P117, DOI 10.1023/A:1025401621060; MORTENSEN PB, 1994, PSYCHOL MED, V24, P223, DOI 10.1017/S0033291700026982; Newgard CD, 2007, ACAD EMERG MED, V14, P669, DOI 10.1197/j.aem.2006.11.038; Olesen AV, 2006, STAT MED, V25, P1672, DOI 10.1002/sim.2298; Olesen AV, 2002, PSYCHOL MED, V32, P1301, DOI 10.1017/S0033291702005548; Perlis RH, 2004, BIOL PSYCHIAT, V55, P875, DOI 10.1016/j.biopsych.2004.01.022; PRENTICE RL, 1981, BIOMETRIKA, V68, P373, DOI 10.1093/biomet/68.2.373; Prince JD, 2008, PSYCHIAT SERV, V59, P1038, DOI 10.1176/appi.ps.59.9.1038; Saarento O, 1997, ACTA PSYCHIAT SCAND, V95, P132, DOI 10.1111/j.1600-0447.1997.tb00386.x; Schennach R, 2012, CURR PSYCHIAT REP, V14, P229, DOI 10.1007/s11920-012-0261-3; Schmutte T, 2010, J NERV MENT DIS, V198, P860, DOI 10.1097/NMD.0b013e3181fe726b; Silva NC, 2009, PSYCHIAT SERV, V60, P786, DOI 10.1176/ps.2009.60.6.786; Stahler GJ, 2009, AM J PSYCHIAT, V166, P1258, DOI 10.1176/appi.ajp.2009.08111667; Terry Therneau and original Splus-&GT;R port by Thomas Lumley, 2010, SURVIVAL SURVIVAL AN; Therneau TM, 2003, J COMPUT GRAPH STAT, V12, P156, DOI 10.1198/1061860031365; Tulloch AD, 2011, ADM POLICY MENT HLTH, V38, P155, DOI 10.1007/s10488-010-0310-3; Viinamaki H, 1996, ACTA PSYCHIAT SCAND, V94, P365, DOI 10.1111/j.1600-0447.1996.tb09874.x; Viinamaki H, 1998, ACTA PSYCHIAT SCAND, V97, P47, DOI 10.1111/j.1600-0447.1998.tb09962.x; Wienke A, 2003, BIOMETRICS, V59, P1178, DOI 10.1111/j.0006-341X.2003.00135.x; Wieselgren IM, 1996, ACTA PSYCHIAT SCAND, V93, P9, DOI 10.1111/j.1600-0447.1996.tb10613.x; WOOGH CM, 1986, CAN J PSYCHIAT, V31, P214, DOI 10.1177/070674378603100306; WOOGH CM, 1977, CAN MED ASSOC J, V116, P876	57	32	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75612	10.1371/journal.pone.0075612	http://dx.doi.org/10.1371/journal.pone.0075612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	233FK	24116059	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000325552200029
J	Martin, ME; Bhatnagar, S; George, MD; Paster, BJ; Canfield, DR; Eisen, JA; Solnick, JV				Martin, Miriam E.; Bhatnagar, Srijak; George, Michael D.; Paster, Bruce J.; Canfield, Don R.; Eisen, Jonathan A.; Solnick, Jay V.			The Impact of Helicobacter pylori Infection on the Gastric Microbiota of the Rhesus Macaque	PLOS ONE			English	Article							RIBOSOMAL-RNA; BACTERIAL MICROBIOTA; MAXIMUM-LIKELIHOOD; SPIRAL BACTERIA; GUT MICROBIOTA; IDENTIFICATION; CONSERVATION; ACQUISITION; HEILMANNII; ORGANISMS	Helicobacter pylori colonization is highly prevalent among humans and causes significant gastric disease in a subset of those infected. When present, this bacterium dominates the gastric microbiota of humans and induces antimicrobial responses in the host. Since the microbial context of H. pylori colonization influences the disease outcome in a mouse model, we sought to assess the impact of H. pylori challenge upon the pre-existing gastric microbial community members in the rhesus macaque model. Deep sequencing of the bacterial 16S rRNA gene identified a community profile of 221 phylotypes that was distinct from that of the rhesus macaque distal gut and mouth, although there were taxa in common. High proportions of both H. pylori and H. suis were observed in the post-challenge libraries, but at a given time, only one Helicobacter species was dominant. However, the relative abundance of non-Helicobacter taxa was not significantly different before and after challenge with H. pylori. These results suggest that while different gastric species may show competitive exclusion in the gastric niche, the rhesus gastric microbial community is largely stable despite immune and physiological changes due to H. pylori infection.	[Martin, Miriam E.; Solnick, Jay V.] Univ Calif Davis, Dept Med, Davis, CA 95616 USA; [Martin, Miriam E.; Bhatnagar, Srijak; George, Michael D.; Eisen, Jonathan A.; Solnick, Jay V.] Univ Calif Davis, Dept Microbiol & Immunol, Davis, CA 95616 USA; [Bhatnagar, Srijak; Eisen, Jonathan A.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Bhatnagar, Srijak] Univ Calif Davis, Microbiol Grad Grp, Davis, CA 95616 USA; [Canfield, Don R.; Solnick, Jay V.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Paster, Bruce J.] Forsyth Inst, Cambridge, MA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Harvard University; Forsyth Institute	Solnick, JV (corresponding author), Univ Calif Davis, Dept Med, Davis, CA 95616 USA.	jvsolnick@ucdavis.edu	Eisen, Jonathan A./H-2706-2019; Paster, Bruce J/AAP-8559-2021	Eisen, Jonathan A./0000-0002-0159-2197; Solnick, Jay/0000-0002-7435-8393; Bhatnagar, Srijak/0000-0003-0240-2655; Markum, Miriam/0000-0001-5356-8036	National Institutes of Health [R21 AI080788, R21 DE020025]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI080788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE020025] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by grants from the National Institutes of Health to JVS (R21 AI080788) and to MDG (R21 DE020025). http://www.nih.gov/. The sponsors of this research had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; DEBONGNIE JC, 1995, AM J GASTROENTEROL, V90, P411; Debongnie JC, 1998, EUR J GASTROEN HEPAT, V10, P251, DOI 10.1097/00042737-199803000-00011; Dewhirst FE, 1999, APPL ENVIRON MICROB, V65, P3287; DEWHIRST FE, 1994, INT J SYST BACTERIOL, V44, P553, DOI 10.1099/00207713-44-3-553; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; DRAZEK ES, 1994, J CLIN MICROBIOL, V32, P1799, DOI 10.1128/JCM.32.7.1799-1804.1994; DUBOIS A, 1991, GASTROENTEROLOGY, V100, P884, DOI 10.1016/0016-5085(91)90260-R; DUBOIS A, 1994, GASTROENTEROLOGY, V106, P1405, DOI 10.1016/0016-5085(94)90392-1; FAITH DP, 1992, CLADISTICS, V8, P361, DOI 10.1111/j.1096-0031.1992.tb00078.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Haesebrouck F, 2009, CLIN MICROBIOL REV, V22, P202, DOI 10.1128/CMR.00041-08; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hornsby MJ, 2008, GASTROENTEROLOGY, V134, P1049, DOI 10.1053/j.gastro.2008.01.018; Huff JL, 2004, INFECT IMMUN, V72, P5216, DOI 10.1128/IAI.72.9.5216-5226.2004; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Johansson MEV, 2012, METHODS MOL BIOL, V842, P229, DOI 10.1007/978-1-61779-513-8_13; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Lane D.J., 1991, NUCL ACID TECHNIQUES, P115, DOI DOI 10.4135/9781446279281.N7; Li XX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007985; Lofgren JL, 2011, GASTROENTEROLOGY, V140, P210, DOI 10.1053/j.gastro.2010.09.048; Maldonado-Contreras A, 2011, ISME J, V5, P574, DOI 10.1038/ismej.2010.149; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Mattapallil JJ, 2000, GASTROENTEROLOGY, V118, P307, DOI 10.1016/S0016-5085(00)70213-7; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; MORGNER A, 1995, LANCET, V346, P511, DOI 10.1016/S0140-6736(95)91364-5; Muller A, 2011, HELICOBACTER, V16, P26, DOI 10.1111/j.1523-5378.2011.00877.x; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nawrocki E.P., 2009, STRUCTURAL RNA HOMOL, DOI 10.7936/K78050MP; O'Rourke JL, 2004, INT J SYST EVOL MICR, V54, P2203, DOI 10.1099/ijs.0.63117-0; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Putsep K, 1999, FEBS LETT, V451, P249, DOI 10.1016/S0014-5793(99)00582-7; REED KD, 1988, LAB ANIM SCI, V38, P329; REYSENBACH AL, 1994, APPL ENVIRON MICROB, V60, P2113, DOI 10.1128/AEM.60.6.2113-2119.1994; Sachs G, 2005, PHYSIOLOGY, V20, P429, DOI 10.1152/physiol.00032.2005; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; SHAMES B, 1989, J CLIN MICROBIOL, V27, P2849, DOI 10.1128/JCM.27.12.2849-2850.1989; Shumway M, 2010, NUCLEIC ACIDS RES, V38, pD870, DOI 10.1093/nar/gkp1078; Smolka AJ, 2012, J GASTROENTEROL, V47, P609, DOI 10.1007/s00535-012-0592-1; Solnick JV, 2006, J CLIN MICROBIOL, V44, P3799, DOI 10.1128/JCM.01482-06; Solnick JV, 2003, J CLIN MICROBIOL, V41, P5511, DOI 10.1128/JCM.41.12.5511-5516.2003; Solnick JV, 1999, LAB ANIM SCI, V49, P197; Stecher B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000711; Van den Bulck K, 2005, J CLIN MICROBIOL, V43, P2256, DOI 10.1128/JCM.43.5.2256-2260.2005; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wroblewski LE, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-29	54	39	41	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76375	10.1371/journal.pone.0076375	http://dx.doi.org/10.1371/journal.pone.0076375			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116104	Green Published, gold			2022-12-25	WOS:000325552200052
J	Pfeilsticker, JA; Umeda, A; Farrow, B; Hsueh, CL; Deyle, KM; Kim, JT; Lai, BT; Heath, JR				Pfeilsticker, Jessica A.; Umeda, Aiko; Farrow, Blake; Hsueh, Connie L.; Deyle, Kaycie M.; Kim, Jocelyn T.; Lai, Bert T.; Heath, James R.			A Cocktail of Thermally Stable, Chemically Synthesized Capture Agents for the Efficient Detection of Anti-Gp41 Antibodies from Human Sera	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; INFECTION; DIAGNOSTICS; PROTEIN; WORLD; GP41	We report on a method to improve in vitro diagnostic assays that detect immune response, with specific application to HIV-1. The inherent polyclonal diversity of the humoral immune response was addressed by using sequential in situ click chemistry to develop a cocktail of peptide-based capture agents, the components of which were raised against different, representative anti-HIV antibodies that bind to a conserved epitope of the HIV-1 envelope protein gp41. The cocktail was used to detect anti-HIV-1 antibodies from a panel of sera collected from HIV-positive patients, with improved signal-to-noise ratio relative to the gold standard commercial recombinant protein antigen. The capture agents were stable when stored as a powder for two months at temperatures close to 60 degrees C.	[Pfeilsticker, Jessica A.; Umeda, Aiko; Hsueh, Connie L.; Deyle, Kaycie M.; Heath, James R.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Farrow, Blake] CALTECH, Div Engn & Appl Sci, Div Biol, Pasadena, CA 91125 USA; [Kim, Jocelyn T.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Lai, Bert T.] Indi Mol, Culver City, CA USA	California Institute of Technology; California Institute of Technology; California Institute of Technology	Heath, JR (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	heath@caltech.edu		Farrow, Blake/0000-0002-1007-7111; Kim, Jocelyn/0000-0001-7040-5773; Butler, Kaycie/0000-0002-8365-5867	Bill and Melinda Gates Foundation; Institute for Collaborative Biotechnologies through U.S. Army Research Office [W911NF-09-0001]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Institute for Collaborative Biotechnologies through U.S. Army Research Office	This work was funded primarily by a grant from the Bill and Melinda Gates Foundation. Additional funding for the development of screening approaches, and for certain capture agent characterization methods, was provided by the Institute for Collaborative Biotechnologies through grant W911NF-09-0001 from the U.S. Army Research Office. The content of the information does not necessarily reflect the position or the policy of the Government, and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew HD, 2009, ANGEW CHEM INT EDIT, V48, P4944, DOI 10.1002/anie.200900488; Alvarez Marta, 2012, Open Virol J, V6, P135, DOI 10.2174/1874357901206010135; Brachman PS, 1996, MED MICROBIOLOGY; Butto S, 2010, ANN I SUPER SANITA, V46, P24, DOI 10.4415/ANN_10_01_04; Chin CD, 2011, NAT MED, V17, P1015, DOI 10.1038/nm.2408; Daskalakis Demetre, 2011, Top Antivir Med, V19, P18; Du APC, 2002, J MOL BIOL, V323, P503, DOI 10.1016/S0022-2836(02)00701-5; Fanales-Belasio E, 2010, ANN I SUPER SANITA, V46, P5, DOI 10.4415/ANN_10_01_02; Finn MG, 2010, CHEM SOC REV, V39, P1231, DOI 10.1039/c003740k; Ginocchio CC, 2011, J CLIN VIROL, V52, pS1, DOI 10.1016/j.jcv.2011.09.025; Huisgen R., 1984, 1 3 DIPOLAR CYCLOADD, V1-2, P1; Iweala OI, 2004, CONTRACEPTION, V70, P141, DOI 10.1016/j.contraception.2004.03.012; Korenromp EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005950; Lam KS, 1997, CHEM REV, V97, P411, DOI 10.1021/cr9600114; Millward SW, 2011, J AM CHEM SOC, V133, P18280, DOI 10.1021/ja2064389; Tebourski F, 2004, DIAGN MICR INFEC DIS, V48, P59, DOI 10.1016/j.diagmicrobio.2003.08.004; Thirumurugan P., 2013, CHEM REV, DOI org/10.1021/cr200409f; Tiwari RP, 2013, J IMMUNOL METHODS, V387, P157, DOI 10.1016/j.jim.2012.10.009; XU JY, 1991, J VIROL, V65, P4832, DOI 10.1128/JVI.65.9.4832-4838.1991	19	12	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76224	10.1371/journal.pone.0076224	http://dx.doi.org/10.1371/journal.pone.0076224			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116098	Green Accepted, Green Published, gold			2022-12-25	WOS:000325501300053
J	Xiong, J; Zhou, T				Xiong, Jie; Zhou, Tong			A Kalman-Filter Based Approach to Identification of Time-Varying Gene Regulatory Networks	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; RADIATION TOLERANCE; SPINAL-CORD; INFERENCE; SYSTEMS; EXPRESSION; DYNAMICS; MODELS	Motivation: Conventional identification methods for gene regulatory networks (GRNs) have overwhelmingly adopted static topology models, which remains unchanged over time to represent the underlying molecular interactions of a biological system. However, GRNs are dynamic in response to physiological and environmental changes. Although there is a rich literature in modeling static or temporally invariant networks, how to systematically recover these temporally changing networks remains a major and significant pressing challenge. The purpose of this study is to suggest a two-step strategy that recovers time-varying GRNs. Results: It is suggested in this paper to utilize a switching auto-regressive model to describe the dynamics of time-varying GRNs, and a two-step strategy is proposed to recover the structure of time-varying GRNs. In the first step, the change points are detected by a Kalman-filter based method. The observed time series are divided into several segments using these detection results; and each time series segment belonging to two successive demarcating change points is associated with an individual static regulatory network. In the second step, conditional network structure identification methods are used to reconstruct the topology for each time interval. This two-step strategy efficiently decouples the change point detection problem and the topology inference problem. Simulation results show that the proposed strategy can detect the change points precisely and recover each individual topology structure effectively. Moreover, computation results with the developmental data of Drosophila Melanogaster show that the proposed change point detection procedure is also able to work effectively in real world applications and the change point estimation accuracy exceeds other existing approaches, which means the suggested strategy may also be helpful in solving actual GRN reconstruction problem.	[Xiong, Jie] Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China; [Zhou, Tong] Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China; [Zhou, Tong] Tsinghua Univ, Tsinghua Natl Lab Informat Sci & Technol TNList, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University	Xiong, J (corresponding author), Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China.	xiongj08@mails.tsinghua.edu.cn	Zhou, Tong/AAD-1593-2019		973 Program [2012CB316504, 2009CB320602]; National Natural Science Foundation of China [61174122, 61021063, 60721003, 60625305]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported in part by the 973 Program under Grant 2012CB316504 and 2009CB320602, and by the National Natural Science Foundation of China under Grants 61174122, 61021063, 60721003 and 60625305. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2009, P NATL ACAD SCI USA, V106, P11878, DOI 10.1073/pnas.0901910106; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Dondelinger F, 2013, MACH LEARN, V90, P191, DOI 10.1007/s10994-012-5311-x; Ferrazzi F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S5-S2; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Grzegorczyk M, 2011, MACH LEARN, V83, P355, DOI 10.1007/s10994-010-5230-7; Hempel S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.054101; HOMYK T, 1988, GENETICS, V119, P105; Ljung L., 1999, SYSTEM IDENTIFICATIO; Ljung L., 1983, THEORY PRACTICE RECU; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Marbach D, 2012, GENOME RES, V22, P1334, DOI 10.1101/gr.127191.111; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Martin S, 2007, BIOINFORMATICS, V23, P866, DOI 10.1093/bioinformatics/btm021; Nongthomba U, 2003, GENETICS, V164, P209; PARKHURST SM, 1991, GENE DEV, V5, P341, DOI 10.1101/gad.5.3.341; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Robinson JW, 2010, J MACH LEARN RES, V11, P3647; Sanchez C, 1999, NUCLEIC ACIDS RES, V27, P89, DOI 10.1093/nar/27.1.89; Stafford SL, 2003, INT J RADIAT ONCOL, V55, P1177, DOI 10.1016/S0360-3016(02)04380-8; VANDERKOGEL AJ, 1977, RADIOLOGY, V122, P505, DOI 10.1148/122.2.505; VONESSEN CF, 1969, ACTA RADIOL THER PHY, V8, P311, DOI 10.3109/02841866909134462; WARA WM, 1975, CANCER, V35, P1558, DOI 10.1002/1097-0142(197506)35:6<1558::AID-CNCR2820350613>3.0.CO;2-7; Wu FX, 2010, IEEE ENG MED BIO, P795, DOI 10.1109/IEMBS.2010.5626506; Xiong J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043819; Yoshida R, 2005, 2005 IEEE Computational Systems Bioinformatics Conference, Proceedings, P289, DOI 10.1109/CSB.2005.32; Zhang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042306; Zhou T, 2010, BIOINFORMATICS, V26, P2020, DOI 10.1093/bioinformatics/btq325	31	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e74571	10.1371/journal.pone.0074571	http://dx.doi.org/10.1371/journal.pone.0074571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116005	gold, Green Published, Green Submitted			2022-12-25	WOS:000325501300008
J	Segard, BD; Delort, F; Bailleux, V; Simon, S; Leccia, E; Gausseres, B; Briki, F; Vicart, P; Batonnet-Pichon, S				Segard, Bertrand-David; Delort, Florence; Bailleux, Virginie; Simon, Stephanie; Leccia, Emilie; Gausseres, Blandine; Briki, Fatma; Vicart, Patrick; Batonnet-Pichon, Sabrina			N-Acetyl-L-Cysteine Prevents Stress-Induced Desmin Aggregation in Cellular Models of Desminopathy	PLOS ONE			English	Article							ALPHA-B-CRYSTALLIN; HEAT-SHOCK-PROTEIN; OXIDATIVE STRESS; SKELETAL MYOPATHY; MOUSE MODEL; MUTATIONS; MUSCLE; EXPRESSION; MICE; CADMIUM	Mutations within the human desmin gene are responsible for a subcategory of myofibrillar myopathies called desminopathies. However, a single inherited mutation can produce different phenotypes within a family, suggesting that environmental factors influence disease states. Although several mouse models have been used to investigate organ-specific desminopathies, a more general mechanistic perspective is required to advance our knowledge toward patient treatment. To improve our understanding of disease pathology, we have developed cellular models to observe desmin behaviour in early stages of disease pathology, e. g., upon formation of cytoplasmic desmin aggregates, within an isogenic background. We cloned the wildtype and three mutant desmin cDNAs using a Tet-On Advanced (R) expression system in C2C12 cells. Mutations were selected based on positioning within desmin and capacity to form aggregates in transient experiments, as follows: DesS46Y (head domain; low aggregation), DesD399Y (central rod domain; high aggregation), and DesS460I (tail domain; moderate aggregation). Introduction of these proteins into a C2C12 background permitted us to compare between desmin variants as well as to determine the role of external stress on aggregation. Three different types of stress, likely encountered during muscle activity, were introduced to the cell models-thermal (heat shock), redox-associated (H2O2 and cadmium chloride), and mechanical (stretching) stresses-after which aggregation was measured. Cells containing variant DesD399Y were more sensitive to stress, leading to marked cytoplasmic perinuclear aggregations. We then evaluated the capacity of biochemical compounds to prevent this aggregation, applying dexamethasone (an inducer of heat shock proteins), fisetin or N-acetyl-L-cysteine (antioxidants) before stress induction. Interestingly, N-acetyl-L-cysteine pretreatment prevented DesD399Y aggregation during most stress. N-acetyl-L-cysteine has recently been described as a promising antioxidant in myopathies linked to selenoprotein N or ryanodin receptor defects. Our findings indicate that this drug warrants further study in animal models to speed its potential development as a therapy for DesD399Y-linked desminopathies.	[Segard, Bertrand-David; Delort, Florence; Simon, Stephanie; Gausseres, Blandine; Vicart, Patrick; Batonnet-Pichon, Sabrina] Univ Paris Diderot, Unite Biol Fonct & Adaptat, CNRS, Sorbonne Paris Cite,EAC4413, Paris, France; [Bailleux, Virginie; Leccia, Emilie; Briki, Fatma] Univ Paris 11, Phys Solides Lab, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay	Vicart, P (corresponding author), Univ Paris Diderot, Unite Biol Fonct & Adaptat, CNRS, Sorbonne Paris Cite,EAC4413, Paris, France.	patrick.vicart@univ-paris-diderot.fr	Stephanie, Simon/A-3845-2013; Ségard, Bertrand-David/B-8251-2015	Ségard, Bertrand-David/0000-0001-8972-9786	Universite Paris Diderot; "Centre National de la Recherche Scientifique" (CNRS); Association Francaise contre les Myopathies (AFM) [15454]; National Research Agency (ANR); ministere de la recherche et de l'enseignement superieur; AFM	Universite Paris Diderot; "Centre National de la Recherche Scientifique" (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); National Research Agency (ANR)(French National Research Agency (ANR)); ministere de la recherche et de l'enseignement superieur; AFM(Association Francaise contre les Myopathies)	This work was supported by "Universite Paris Diderot" (http://www.univ-paris-diderot.fr), the "Centre National de la Recherche Scientifique" (CNRS, http://www.cnrs.fr), and grants from the "Association Francaise contre les Myopathies" (AFM No15454; http://www.afm-telethon.fr). The authors are also grateful for financial support from the "rare diseases program" of the National Research Agency (ANR, http://www.agence-nationale-recherche.fr). BDS was supported by a fellowship from the "ministere de la recherche et de l'enseignement superieur" and AFM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbulut O, 1996, BIOL CELL, V88, P131, DOI 10.1016/S0248-4900(97)83528-9; Arbogast S, 2009, ANN NEUROL, V65, P677, DOI 10.1002/ana.21644; Bar H, 2006, J MOL BIOL, V360, P1031, DOI 10.1016/j.jmb.2006.05.068; Bar H, 2004, J STRUCT BIOL, V148, P137, DOI 10.1016/j.jsb.2004.04.003; Bar H, 2005, P NATL ACAD SCI USA, V102, P15099, DOI 10.1073/pnas.0504568102; Bar H, 2007, HUM MUTAT, V28, P374, DOI 10.1002/humu.20459; Bertin G, 2006, BIOCHIMIE, V88, P1549, DOI 10.1016/j.biochi.2006.10.001; Biol AJ, 2007, J NEUROPATH EXP NEUR, V66, P711, DOI 10.1097/nen.0b013e3181256b4c; Blunt BC, 2007, AM J PHYSIOL-HEART C, V293, pH1518, DOI 10.1152/ajpheart.00269.2006; Bonakdar N, 2012, BIOCHEM BIOPH RES CO, V419, P703, DOI 10.1016/j.bbrc.2012.02.083; Capetanaki Y, 1997, CELL STRUCT FUNCT, V22, P103, DOI 10.1247/csf.22.103; Chourbagi O, 2011, EXP CELL RES, V317, P886, DOI 10.1016/j.yexcr.2011.01.013; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Clemen CS, 2013, ACTA NEUROPATHOL, V125, P47, DOI 10.1007/s00401-012-1057-6; Clemen CS, 2005, FEBS LETT, V579, P3777, DOI 10.1016/j.febslet.2005.05.051; Croute F, 2005, J TOXICOL ENV HEAL A, V68, P703, DOI 10.1080/15287390590925447; Dalakas MC, 2000, NEW ENGL J MED, V342, P770, DOI 10.1056/NEJM200003163421104; Dowling JJ, 2012, BRAIN, V135, P1115, DOI 10.1093/brain/aws036; Duband-Goulet I, 2011, EXP CELL RES, V317, P2800, DOI 10.1016/j.yexcr.2011.09.012; Goldfarb LG, 1998, NAT GENET, V19, P402, DOI 10.1038/1300; Goldfarb LG, 2004, BRAIN, V127, P723, DOI 10.1093/brain/awh033; Goudeau B, 2006, HUM MUTAT, V27, P906, DOI 10.1002/humu.20351; Hoffman EP, 2003, MUSCLE NERVE, V27, P643, DOI 10.1002/mus.10400; Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328; Janue A, 2007, BRAIN PATHOL, V17, P377, DOI 10.1111/j.1750-3639.2007.00087.x; Joanne P, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-4; KHAN N, 2012, ANTIOXID REDOX SIGNA, P99152; Kostareva A, 2008, J MUSCLE RES CELL M, V29, P25, DOI 10.1007/s10974-008-9139-8; Kreplak L, 2009, J MOL BIOL, V385, P1043, DOI 10.1016/j.jmb.2008.10.095; Kreplak L, 2008, BIOPHYS J, V94, P2790, DOI 10.1529/biophysj.107.119826; Lapouge K, 2006, J CELL SCI, V119, P4974, DOI 10.1242/jcs.03255; Launay N, 2006, EXP CELL RES, V312, P3570, DOI 10.1016/j.yexcr.2006.07.025; Leccia E, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/1/016001; Li DX, 1999, CIRCULATION, V100, P461, DOI 10.1161/01.CIR.100.5.461; Li ZL, 1996, DEV BIOL, V175, P362, DOI 10.1006/dbio.1996.0122; Li ZL, 1997, J CELL BIOL, V139, P129, DOI 10.1083/jcb.139.1.129; Mavroidis M, 2008, FASEB J, V22, P3318, DOI 10.1096/fj.07-088724; Milner DJ, 1996, J CELL BIOL, V134, P1255, DOI 10.1083/jcb.134.5.1255; Muntoni F, 2006, BRAIN, V129, P1260, DOI 10.1093/brain/awl062; Nedellec P, 2002, NEUROMUSCULAR DISORD, V12, P457, DOI 10.1016/S0960-8966(01)00306-6; Sanbe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005351; Selcen D, 2011, NEUROMUSCULAR DISORD, V21, P161, DOI 10.1016/j.nmd.2010.12.007; Sharma S, 2009, J MOL MED, V87, P1207, DOI 10.1007/s00109-009-0521-9; Singh BN, 2007, J MOL BIOL, V366, P756, DOI 10.1016/j.jmb.2006.12.012; Thornell LE, 1997, J MOL CELL CARDIOL, V29, P2107, DOI 10.1006/jmcc.1997.0446; Vigouroux C, 2001, J CELL SCI, V114, P4459; Wang XJ, 2001, CIRCULATION, V103, P2402, DOI 10.1161/01.cir.103.19.2402; Wu W, 1996, TOXICOL APPL PHARM, V141, P330; Zheng HQ, 2010, J AM COLL CARDIOL, V56, P1418, DOI 10.1016/j.jacc.2010.01.075; Zobel ATC, 2003, HUM MOL GENET, V12, P1609, DOI 10.1093/hmg/ddg173	50	20	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76361	10.1371/journal.pone.0076361	http://dx.doi.org/10.1371/journal.pone.0076361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098483	Green Submitted, gold, Green Published			2022-12-25	WOS:000325427100063
J	Wood, TJ; Thistlethwaite, A; Harris, MR; Lovell, SC; Millar, CB				Wood, Thomas J.; Thistlethwaite, Angela; Harris, Michael R.; Lovell, Simon C.; Millar, Catherine B.			Mutations in Non-Acid Patch Residues Disrupt H2A.Z's Association with Chromatin through Multiple Mechanisms	PLOS ONE			English	Article							HISTONE VARIANT H2A.Z; N-TERMINUS; CHAPERONE; TRANSCRIPTION; ACETYLATION; RECRUITMENT; HTZ1; ACTIVATION; DEPOSITION; VERSATILE	The incorporation of histone variants into nucleosomes is a critical mechanism for regulating essential DNA-templated processes and for establishing distinct chromatin architectures with specialised functions. H2A.Z is an evolutionarily conserved H2A variant that has diverse roles in transcriptional regulation, heterochromatin boundary definition, chromosome stability and DNA repair. The H2A.Z C-terminus diverges in sequence from canonical H2A and imparts unique functions to H2A.Z in the yeast S. cerevisiae. Although mediated in part through the acid patch-containing M6 region, many molecular determinants of this divergent structure-function relationship remain unclear. Here, by using an unbiased random mutagenesis screen of H2A.Z alleles, we identify point mutations in the C-terminus outside of the M6 region that disrupt the normal function of H2A.Z in response to cytotoxic stress. These functional defects correlate with reduced chromatin association, which we attribute to reduced physical stability within chromatin, but also to altered interactions with the SWR and INO80 chromatin remodeling complexes. Together with experimental data, computational modelling of these residue changes in the context of protein structure suggests the importance of C-terminal domain integrity and configuration for maintaining the level of H2A.Z in nucleosomes.	[Wood, Thomas J.; Thistlethwaite, Angela; Harris, Michael R.; Lovell, Simon C.; Millar, Catherine B.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Millar, CB (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	catherine.millar@manchester.ac.uk	Wood, Thomas/GWZ-2481-2022	Wood, Thomas/0000-0001-8962-8571; Millar, Catherine/0000-0002-8649-5408; Lovell, Simon/0000-0002-4092-8458	Wellcome Trust through a Career Development Fellowship [WT082335MA]; Wellcome Trust PhD studentship; Biotechnology and Biological Sciences Research Council [BB/I020489/1] Funding Source: researchfish; BBSRC [BB/I020489/1] Funding Source: UKRI	Wellcome Trust through a Career Development Fellowship(Wellcome Trust); Wellcome Trust PhD studentship(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust through a Career Development Fellowship to CBM (WT082335MA) and a Wellcome Trust PhD studentship to TJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam M, 2001, MOL CELL BIOL, V21, P6270, DOI 10.1128/MCB.21.18.6270-6279.2001; Babiarz JE, 2006, GENE DEV, V20, P700, DOI 10.1101/gad.1386306; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Chen VB, 2009, PROTEIN SCI, V18, P2403, DOI 10.1002/pro.250; Clarkson MJ, 1999, NATURE, V399, P694, DOI 10.1038/21436; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Gardner JM, 2011, J CELL BIOL, V193, P489, DOI 10.1083/jcb.201011017; Halley JE, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000401; Jackson JD, 1996, TRENDS BIOCHEM SCI, V21, P466, DOI 10.1016/S0968-0004(96)20028-3; Jensen K, 2011, MOL GENET GENOMICS, V285, P287, DOI 10.1007/s00438-011-0604-5; Kalocsay M, 2009, MOL CELL, V33, P335, DOI 10.1016/j.molcel.2009.01.016; Kawano A, 2011, GENES CELLS, V16, P590, DOI 10.1111/j.1365-2443.2011.01512.x; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Larochelle M, 2003, EMBO J, V22, P4512, DOI 10.1093/emboj/cdg427; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Luk E, 2007, MOL CELL, V25, P357, DOI 10.1016/j.molcel.2006.12.015; Mehta M, 2010, J BIOL CHEM, V285, P39855, DOI 10.1074/jbc.M110.185967; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; MIZUGUCHI G, 2004, ATP DRIVEN EXCHANGE, P45854; Morillo-Huesca M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012143; Papamichos-Chronakis M, 2011, CELL, V144, P200, DOI 10.1016/j.cell.2010.12.021; Ramey CJ, 2004, MOL CELL BIOL, V24, P10313, DOI 10.1128/MCB.24.23.10313-10327.2004; Santisteban MS, 2000, CELL, V103, P411, DOI 10.1016/S0092-8674(00)00133-1; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; SHARP JA, 2001, YEAST HISTONE DEPOSI, P1; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Suto RK, 2000, NAT STRUCT BIOL, V7, P1121; Wan YK, 2009, MOL CELL BIOL, V29, P2346, DOI 10.1128/MCB.01233-08; Wang AY, 2011, MOL CELL BIOL, V31, P3871, DOI 10.1128/MCB.05182-11; Watanabe S, 2013, SCIENCE, V340, P195, DOI 10.1126/science.1229758; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Word JM, 1999, J MOL BIOL, V285, P1711, DOI 10.1006/jmbi.1998.2400; Wratting D, 2012, J BIOL CHEM, V287, P19148, DOI 10.1074/jbc.M111.317990; Wu WH, 2009, J BIOL CHEM, V284, P6200, DOI 10.1074/jbc.M808830200; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Zabaronick SR, 2005, MOL CELL BIOL, V25, P652, DOI 10.1128/MCB.25.2.652-660.2005; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zhou Z, 2008, NAT STRUCT MOL BIOL, V15, P868, DOI 10.1038/nsmb.1465	42	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76394	10.1371/journal.pone.0076394	http://dx.doi.org/10.1371/journal.pone.0076394			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098487	Green Published, gold, Green Submitted			2022-12-25	WOS:000325427100065
J	Boettcher, J; Leek, L; Matson, L; Holmes, EA; Browning, M; MacLeod, C; Andersson, G; Carlbring, P				Boettcher, Johanna; Leek, Linda; Matson, Lisa; Holmes, Emily A.; Browning, Michael; MacLeod, Colin; Andersson, Gerhard; Carlbring, Per			Internet-Based Attention Bias Modification for Social Anxiety: A Randomised Controlled Comparison of Training towards Negative and Training Towards Positive Cues	PLOS ONE			English	Article							SELECTIVE ATTENTION; SELF-REPORT; PSYCHOMETRIC PROPERTIES; MODIFICATION PROGRAM; FACIAL EXPRESSIONS; AVOIDANCE PATTERN; PHOBIA; THREAT; VULNERABILITY; VALIDATION	Biases in attention processes are thought to play a crucial role in the aetiology and maintenance of Social Anxiety Disorder (SAD). The goal of the present study was to examine the efficacy of a programme intended to train attention towards positive cues and a programme intended to train attention towards negative cues. In a randomised, controlled, double-blind design, the impact of these two training conditions on both selective attention and social anxiety were compared to that of a control training condition. A modified dot probe task was used, and delivered via the internet. A total of 129 individuals, diagnosed with SAD, were randomly assigned to one of these three conditions and took part in a 14-day programme with daily training/control sessions. Participants in all three groups did not on average display an attentional bias prior to the training. Critically, results on change in attention bias implied that significantly differential change in selective attention to threat was not detected in the three conditions. However, symptoms of social anxiety reduced significantly from pre- to follow-up-assessment in all three conditions (d(within) = 0.63-1.24), with the procedure intended to train attention towards threat cues producing, relative to the control condition, a significantly greater reduction of social fears. There were no significant differences in social anxiety outcome between the training condition intended to induce attentional bias towards positive cues and the control condition. To our knowledge, this is the first RCT where a condition intended to induce attention bias to negative cues yielded greater emotional benefits than a control condition. Intriguingly, changes in symptoms are unlikely to be by the mechanism of change in attention processes since there was no change detected in bias per se. Implications of this finding for future research on attention bias modification in social anxiety are discussed. Trial Registration: ClinicalTrials.gov NCT01463137	[Boettcher, Johanna; Carlbring, Per] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden; [Boettcher, Johanna] Free Univ Berlin, Berlin, Germany; [Leek, Linda; Matson, Lisa] Umea Univ, Dept Psychol, S-90187 Umea, Sweden; [Holmes, Emily A.] MRC Cognit & Brain Sci Unit, Cambridge, England; [Browning, Michael] Univ Oxford, Funct MRI Brain Ctr, Oxford, England; [MacLeod, Colin] Univ Western Australia, Sch Psychol, Perth, WA 6009, Australia; [Andersson, Gerhard] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden; [Andersson, Gerhard] Karolinska Inst, Dept Clin Neurosci, Psychiat Sect, Stockholm, Sweden	Stockholm University; Free University of Berlin; Umea University; University of Oxford; University of Western Australia; Linkoping University; Karolinska Institutet	Boettcher, J (corresponding author), Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden.	johanna.boettcher@fu-berlin.de	Andersson, Gerhard/J-8529-2012; Carlbring, Per/R-1220-2019; browning, michael/M-7338-2017; Carlbring, Per/D-3628-2009; Holmes, Emily/ABD-4367-2020	Andersson, Gerhard/0000-0003-4753-6745; Carlbring, Per/0000-0002-2172-8813; browning, michael/0000-0001-9108-3144; Carlbring, Per/0000-0002-2172-8813; Holmes, Emily/0000-0001-7319-3112; MacLeod, Colin/0000-0003-2407-7339; Boettcher, Johanna/0000-0002-8220-9291	Swedish Council for Working Life and Social Research [FAS 2009-0222]; MRC [MC_UP_0901/1] Funding Source: UKRI; Medical Research Council [MC_UP_0901/1] Funding Source: researchfish	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was made possible by a grant from the Swedish Council for Working Life and Social Research (www.fas.se; Grant number: FAS 2009-0222). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir N, 2003, BEHAV RES THER, V41, P1325, DOI 10.1016/S0005-7967(03)00039-1; Amir N, 2008, J ABNORM PSYCHOL, V117, P860, DOI 10.1037/a0013445; Amir N, 2011, J CONSULT CLIN PSYCH, V79, P533, DOI 10.1037/a0023808; Amir N, 2009, J CONSULT CLIN PSYCH, V77, P961, DOI 10.1037/a0016685; Andersson Gerhard, 2006, Cognitive Behaviour Therapy, V35, P55, DOI 10.1080/16506070500372469; [Anonymous], 2010, R LANG ENV STAT COMP; ASMUNDSON GJG, 1994, J ANXIETY DISORD, V8, P107, DOI 10.1016/0887-6185(94)90009-4; Baker SL, 2002, BEHAV RES THER, V40, P701, DOI 10.1016/S0005-7967(01)00060-2; Beard C, 2012, BEHAV THER, V43, P724, DOI 10.1016/j.beth.2012.01.002; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Berry AC, 2009, DEPRESS ANXIETY, V26, P22, DOI 10.1002/da.20511; Biehl M, 1997, J NONVERBAL BEHAV, V21, P3, DOI 10.1023/A:1024902500935; Boettcher J, 2012, COGNITIVE THER RES, V36, P522, DOI 10.1007/s10608-011-9374-y; Bradley BP, 1997, BEHAV RES THER, V35, P911, DOI 10.1016/S0005-7967(97)00053-3; Browning M, 2010, COGN AFFECT BEHAV NE, V10, P8, DOI 10.3758/CABN.10.1.8; Calamaras MR, 2012, J CLIN PSYCHOL, V68, P745, DOI 10.1002/jclp.21875; Carlbring P, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-66; Chen YP, 2002, BEHAV RES THER, V40, P677, DOI 10.1016/S0005-7967(01)00086-9; Cisler JM, 2010, CLIN PSYCHOL REV, V30, P203, DOI 10.1016/j.cpr.2009.11.003; Clark D. M., 1995, SOCIAL PHOBIA DIAGNO, P69, DOI DOI 10.1017/S1352465808004487; Clark DM, 2006, J CONSULT CLIN PSYCH, V74, P568, DOI 10.1037/0022-006X.74.3.568; Dear BF, 2011, J PAIN, V12, P1247, DOI 10.1016/j.jpain.2011.07.003; Eldar S, 2012, AM J PSYCHIAT, V169, P213, DOI 10.1176/appi.ajp.2011.11060886; Field A., 2012, DISCOVERING STAT USI; First M.B., 2004, STRUCTURED CLIN INTE, DOI DOI 10.1002/9780471726753; Fresco DM, 2001, PSYCHOL MED, V31, P1025, DOI 10.1017/S0033291701004056; Frisch M.B., 1992, PSYCHOL ASSESS, V4, P92, DOI [10.1037/1040-3590.4.1.92, DOI 10.1037/1040-3590.4.1.92]; Furmark T, 1999, SOC PSYCH PSYCH EPID, V34, P416, DOI 10.1007/s001270050163; Goeleven E, 2008, COGNITION EMOTION, V22, P1094, DOI 10.1080/02699930701626582; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P127, DOI 10.1037/0021-843X.113.1.121; Hakamata Y, 2010, BIOL PSYCHIAT, V68, P982, DOI 10.1016/j.biopsych.2010.07.021; Hedman E, 2010, COMPUT HUM BEHAV, V26, P736, DOI 10.1016/j.chb.2010.01.010; Heeren A, 2012, BEHAV RES THER, V50, P30, DOI 10.1016/j.brat.2011.10.005; Helfinstein SM, 2008, BEHAV RES THER, V46, P799, DOI 10.1016/j.brat.2008.03.011; HOPE DA, 1990, COGNITIVE THER RES, V14, P177, DOI 10.1007/BF01176208; Houck PR, 2004, PSYCHIAT RES, V129, P209, DOI 10.1016/j.psychres.2004.08.001; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Jose P., 2012, NLME LINEAR NONLINEA; Julian K, 2012, BEHAV RES THER, V50, P350, DOI 10.1016/j.brat.2012.02.015; Klumpp H, 2010, COGNITIVE THER RES, V34, P263, DOI 10.1007/s10608-009-9251-0; Klumpp H, 2009, ANXIETY STRESS COPIN, V22, P283, DOI 10.1080/10615800802449602; Kraemer HC, 2002, ARCH GEN PSYCHIAT, V59, P877, DOI 10.1001/archpsyc.59.10.877; LeMoult J, 2012, COGNITIVE THER RES, V36, P47, DOI 10.1007/s10608-010-9322-2; Li SW, 2008, BEHAV RES THER, V46, P905, DOI 10.1016/j.brat.2008.04.005; Lindner P, COGNITIVE B IN PRESS; Lundh LG, 1996, PERS INDIV DIFFER, V20, P725, DOI 10.1016/0191-8869(96)00008-6; MacLeod C, 2002, J ABNORM PSYCHOL, V111, P107, DOI 10.1037//0021-843X.111.1.107; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; Macleod C, 2012, AM J PSYCHIAT, V169, P118, DOI 10.1176/appi.ajp.2011.11111682; Maidenberg E, 1996, J ANXIETY DISORD, V10, P529, DOI 10.1016/S0887-6185(96)00028-X; MATTIA JI, 1993, BEHAV RES THER, V31, P305, DOI 10.1016/0005-7967(93)90029-T; Mattick RP, 1998, BEHAV RES THER, V36, P455, DOI 10.1016/S0005-7967(97)10031-6; Mogg K, 2004, J ABNORM PSYCHOL, V113, P160, DOI 10.1037/0021-843X.113.1.160; Mogg K, 2002, BEHAV RES THER, V40, P1403, DOI 10.1016/S0005-7967(02)00017-7; Muhlberger A, 2008, CYBERPSYCHOL BEHAV, V11, P425, DOI 10.1089/cpb.2007.0084; Mueller EM, 2009, PSYCHOL MED, V39, P1141, DOI 10.1017/S0033291708004820; Musa C, 2003, BEHAV RES THER, V41, P1043, DOI 10.1016/S0005-7967(02)00212-7; Neubauer K, 2013, BEHAV RES THER, V51, P87, DOI 10.1016/j.brat.2012.10.006; Nielsen T, 2007, NORD PSYCHOL, V59, P231, DOI 10.1027/1901-2276.59.3.231; Ononaiye MSP, 2007, COGNITIVE THER RES, V31, P727, DOI 10.1007/s10608-006-9096-8; PATTERSON WM, 1983, PSYCHOSOMATICS, V24, P343, DOI 10.1016/S0033-3182(83)73213-5; Pflugshaupt T, 2005, J ANXIETY DISORD, V19, P105, DOI 10.1016/j.janxdis.2003.12.002; Pineles SL, 2005, J ABNORM PSYCHOL, V114, P314, DOI 10.1037/0021-843X.114.2.314; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Rapee RM, 1997, BEHAV RES THER, V35, P741, DOI 10.1016/S0005-7967(97)00022-3; Roberts KE, 2010, COGNITIVE THER RES, V34, P388, DOI 10.1007/s10608-009-9245-y; ROSNOW RL, 1991, PSYCHOL BULL, V110, P574, DOI 10.1037/0033-2909.110.3.574; Samuelsson H, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2196; Schmidt NB, 2009, J ABNORM PSYCHOL, V118, P5, DOI 10.1037/a0013643; Schmukle SC, 2005, EUR J PERSONALITY, V19, P595, DOI 10.1002/per.554; Schofield CA, 2012, COGNITION EMOTION, V26, P300, DOI 10.1080/02699931.2011.602050; See J, 2009, J ABNORM PSYCHOL, V118, P65, DOI 10.1037/a0014377; Staugaard SR., 2009, PSYCHOL SCI Q, V51, P339, DOI [DOI 10.1080/02699930903205698, 10.4081/mi.2011.e5, DOI 10.4081/MI.2011.E5]; SVANBORG P, 1994, ACTA PSYCHIAT SCAND, V89, P21, DOI 10.1111/j.1600-0447.1994.tb01480.x; Thorndike FP, 2009, COMPUT HUM BEHAV, V25, P393, DOI 10.1016/j.chb.2008.05.006; Vassilopoulos SP, 2005, BEHAV COGN PSYCHOTH, V33, P13, DOI 10.1017/S1352465804001730; Wieser MJ, 2009, J NEURAL TRANSM, V116, P717, DOI 10.1007/s00702-008-0101-0; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3	78	70	71	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e71760	10.1371/journal.pone.0071760	http://dx.doi.org/10.1371/journal.pone.0071760			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231NL	24098630	Green Published, gold, Green Submitted			2022-12-25	WOS:000325423500002
J	Chung, RY; Leung, JCS; Chan, DCC; Woo, J; Wong, CKM; Wong, SYS				Chung, Roger Y.; Leung, Jason C. S.; Chan, Dicken C. C.; Woo, Jean; Wong, Carmen K. M.; Wong, Samuel Y. S.			Lower Urinary Tract Symptoms (LUTS) as a Risk Factor for Depressive Symptoms in Elderly Men: Results from a Large Prospective Study in Southern Chinese Men	PLOS ONE			English	Article							QUALITY-OF-LIFE; BENIGN PROSTATIC HYPERPLASIA; HONG-KONG CHINESE; ERECTILE DYSFUNCTION; OVERACTIVE BLADDER; PREVALENCE; DISEASE; IMPACT; ASSOCIATION; HOSPITALIZATION	A cross-sectional relationship between lower urinary tract symptoms (LUTS) and depressive symptoms was previously reported among Southern Chinese men; however, the temporal relationship was unclear. Our objective is to evaluate the temporal relationship between moderate to severe lower urinary tract symptoms and clinically significant depressive symptoms in elderly Chinese men aged 65 in a prospective manner. In a prospective cohort of 2,000 Chinese men aged 65 to 92 years in Hong Kong, we studied the association of having moderate to severe LUTS at baseline and having clinically relevant depressive symptoms at year 2 follow-up. After excluding men with prostate or bladder cancer or surgery (n = 20) and lost to follow-up (n = 254), data on 1,726 subjects were analyzed. LUTS were measured by the International Prostate Symptom score; and clinically relevant depressive symptoms were measured by the Geriatric Depression Scale. The multiple logistic regressions showed that the presence of moderate-to-severe LUTS at baseline were significantly associated with increased risk for being depressed at two-year follow-up, with adjustments for demographic, lifestyle, medical factors, weight status and stressful life events (OR = 2.97; CI: 1.70-5.20). Association remained significant with additional adjustments for baseline GDS score (OR = 1.88; CI: 1.03-3.41). LUTS are important risk factors in predicting the presence of clinically relevant depressive symptoms. In elderly men, increased awareness and possible screening are needed to detect the increased risk of clinically relevant depressive symptoms.	[Chung, Roger Y.; Chan, Dicken C. C.; Wong, Carmen K. M.; Wong, Samuel Y. S.] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Leung, Jason C. S.] Chinese Univ Hong Kong, Jockey Club Ctr Osteoporosis Care & Control, Hong Kong, Hong Kong, Peoples R China; [Woo, Jean] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Wong, SYS (corresponding author), Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China.	yeungshanwong@cuhk.edu.hk	Woo, Jean/K-2625-2014; Chung, Roger Y. N./B-7288-2016; WONG, Samuel Yeung Shan/D-7311-2013	Woo, Jean/0000-0001-7593-3081; WONG, Samuel Yeung Shan/0000-0003-0934-6385	Food and Health Bureau, the Hong Kong Special Administrative Region [02030661]	Food and Health Bureau, the Hong Kong Special Administrative Region	This work was supported by the Health and Health Services Research Fund (Grant no. 02030661), Food and Health Bureau, the Hong Kong Special Administrative Region. URL of funder's website: http://www.fhb.gov.hk/grants/english/funds/funds_hmrf/funds_hmrf_abt/funds_hmrf_abt.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo AB, 2000, AM J EPIDEMIOL, V152, P533, DOI 10.1093/aje/152.6.533; Bertaccini A, 2001, EUR UROL, V40, P13, DOI 10.1159/000049872; Bula CJ, 2001, ARCH INTERN MED, V161, P2609, DOI 10.1001/archinte.161.21.2609; Chan HC, 2004, THESIS HONG KONG U H; Chi I, 2005, AM J GERIAT PSYCHIAT, V13, P409, DOI 10.1176/appi.ajgp.13.5.409; Chou KL, 2005, INT J GERIATR PSYCH, V20, P41, DOI 10.1002/gps.1246; Coyne KS, 2008, BJU INT, V101, P1388, DOI 10.1111/j.1464-410X.2008.07601.x; Eckhardt MD, 2001, J UROLOGY, V166, P563, DOI 10.1016/S0022-5347(05)65985-X; Engstrom G, 2005, BJU INT, V95, P810, DOI 10.1111/j.1464-410X.2005.05406.x; Fitzgerald MP, 2007, EUR UROL, V52, P407, DOI 10.1016/j.eururo.2007.03.014; Gannon K, 2005, BJU INT, V96, P823, DOI 10.1111/j.1464-410X.2005.05720.x; Glover L, 2004, BJU INT, V94, P563, DOI 10.1111/j.1464-410X.2004.05001.x; Irwin DE, 2006, BJU INT, V97, P96, DOI 10.1111/j.1464-410X.2005.05889.x; Kirby RS, 2000, UROLOGY, V56, P3, DOI 10.1016/S0090-4295(00)00747-0; Lau EMC, 1996, J BONE MINER RES, V11, P1364; Laumann EO, 2008, J UROLOGY, V180, P233, DOI 10.1016/j.juro.2008.03.055; Lee H.-c.B., 1993, CLIN GERONTOLOGIST, V14, P37; Marc LG, 2008, AM J GERIAT PSYCHIAT, V16, P914, DOI 10.1097/JGP.0b013e318186bd67; Mariappan P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004742.pub2; Marschall-Kehrel D, 2004, UROLOGY, V64, P21, DOI 10.1016/j.urology.2004.10.072; Ng TP, 2007, ARCH INTERN MED, V167, P60, DOI 10.1001/archinte.167.1.60; Platz EA, 2002, UROLOGY, V59, P877, DOI 10.1016/S0090-4295(01)01673-9; Quek KF, 2004, INT J UROL, V11, P848, DOI 10.1111/j.1442-2042.2004.00903.x; Roehrborn Claus G, 2004, Rev Urol, V6, P121; Rosen RC, 2004, BJU INT, V93, P689, DOI 10.1111/j.1464-410X.2003.04767.x; Sherwood A, 2007, ARCH INTERN MED, V167, P367, DOI 10.1001/archinte.167.4.367; Sundquist J, 2005, AM J PREV MED, V29, P428, DOI 10.1016/j.amepre.2005.08.002; Takao T, 2011, AGING MALE, V14, P110, DOI 10.3109/13685538.2010.512374; Trueman P, 1999, BJU INT, V83, P410; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; Welch G, 2002, UROLOGY, V59, P245, DOI 10.1016/S0090-4295(01)01506-0; Whooley MA, 2006, JAMA-J AM MED ASSOC, V295, P2874, DOI 10.1001/jama.295.24.2874; Wong SY, 2010, AGING MALE, V13, P113, DOI 10.3109/13685530903440432; Wong SYS, 2007, BRIT J NUTR, V98, P1237, DOI 10.1017/S0007114507787433; Wong SYS, 2006, J AFFECT DISORDERS, V96, P83, DOI 10.1016/j.jad.2006.05.013; Wong SYS, 2006, INT J UROL, V13, P1304, DOI 10.1111/j.1442-2042.2006.01560.x; Wong SYS, 2005, OSTEOPOROSIS INT, V16, P1933, DOI 10.1007/s00198-005-1968-3	37	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76017	10.1371/journal.pone.0076017	http://dx.doi.org/10.1371/journal.pone.0076017			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098757	Green Submitted, gold, Green Published			2022-12-25	WOS:000325423500127
J	Maynard, ME; Leasure, JL				Maynard, Mark E.; Leasure, J. Leigh			Exercise Enhances Hippocampal Recovery following Binge Ethanol Exposure	PLOS ONE			English	Article							CELL-PROLIFERATION; ALCOHOL DEPENDENCE; PHYSICAL-EXERCISE; MESSENGER-RNA; GROWTH-FACTOR; BRAIN-DAMAGE; ADULT-RATS; NEUROGENESIS; ABSTINENCE; INDUCTION	Binge drinking damages the brain, and although a significant amount of recovery occurs with abstinence, there is a need for effective strategies to maximize neurorestoration. In contrast to binge drinking, exercise promotes brain health, so the present study assessed whether it could counteract ethanol-induced damage by augmenting natural self-repair processes following one or more binge exposures. Adult female rats were exposed to 0 (control), 1 or 2 binges, using an established 4-day model of binge-induced neurodegeneration. Half of the animals in each group remained sedentary, or had running wheel access beginning 7 days after the final binge, and were sacrificed 28 days later. To assess binge-induced hippocampal damage and exercise restoration, we quantified volume of the dentate gyrus and number of granule neurons. We found that a single binge exposure significantly decreased the volume of the dentate gyrus and number of granule neurons. A second binge did not exacerbate the damage. Exercise completely restored baseline volume and granule neuron numbers. To investigate a potential mechanism of this restoration, we administered IdU (a thymidine analog) in order to label cells generated after the first binge. Previous studies have shown that neurogenesis in the dentate gyrus is decreased by binge alcohol exposure, and that the hippocampus responds to this insult by increasing cell genesis during abstinence. We found increased IdU labeling in binge-exposed animals, and a further increase in binged animals that exercised. Our results indicate that exercise reverses long-lasting hippocampal damage by augmenting natural self-repair processes.	[Maynard, Mark E.; Leasure, J. Leigh] Univ Houston, Dept Psychol, Houston, TX USA; [Leasure, J. Leigh] Univ Houston, Dept Biol & Biochem, Houston, TX USA	University of Houston System; University of Houston; University of Houston System; University of Houston	Leasure, JL (corresponding author), Univ Houston, Dept Psychol, Houston, TX USA.	jlleasure@uh.edu		Leasure, J. Leigh/0000-0002-9014-2525	University of Houston's College of Liberal Arts and Social Sciences; University of Houston's Biology of Behavior Institute	University of Houston's College of Liberal Arts and Social Sciences; University of Houston's Biology of Behavior Institute	This study was supported by a Grant in Aid to J.L.L. from the University of Houston's College of Liberal Arts and Social Sciences, and a summer fellowship awarded to M. M. by the University of Houston's Biology of Behavior Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agartz I, 2003, ALCOHOL ALCOHOLISM, V38, P71, DOI 10.1093/alcalc/agg020; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Berchtold NC, 2001, EUR J NEUROSCI, V14, P1992, DOI 10.1046/j.0953-816x.2001.01825.x; Berchtold NC, 2005, NEUROSCIENCE, V133, P853, DOI 10.1016/j.neuroscience.2005.03.026; Cardenas VA, 2007, NEUROIMAGE, V34, P879, DOI 10.1016/j.neuroimage.2006.10.015; Collins MA, 1996, ALCOHOL CLIN EXP RES, V20, P284, DOI 10.1111/j.1530-0277.1996.tb01641.x; Crews FT, 2009, ALCOHOL ALCOHOLISM, V44, P115, DOI 10.1093/alcalc/agn079; Crews FT, 2009, PHARMACOL BIOCHEM BE, V93, P237, DOI 10.1016/j.pbb.2009.04.018; Duka T, 2004, ALCOHOL CLIN EXP RES, V28, P233, DOI 10.1097/01.ALC.0000113780.41701.81; Duka T, 2003, ALCOHOL CLIN EXP RES, V27, P1563, DOI 10.1097/01.ALC.0000090142.11260.D7; Duka T, 2011, BIOL PSYCHIAT, V70, P545, DOI 10.1016/j.biopsych.2011.04.006; Goldman JM, 2007, BIRTH DEFECTS RES B, V80, P84, DOI 10.1002/bdrb.20106; Gomez-Pinilla F, 1998, NEUROSCIENCE, V85, P53, DOI 10.1016/S0306-4522(97)00576-9; Gomez-Pinilla F, 2001, EUR J NEUROSCI, V13, P1078, DOI 10.1046/j.0953-816x.2001.01484.x; Gomez-Pinilla F, 2008, EUR J NEUROSCI, V28, P2278, DOI 10.1111/j.1460-9568.2008.06524.x; GomezPinilla F, 1997, BRAIN RES, V764, P1, DOI 10.1016/S0006-8993(97)00375-2; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Gupta S, 2008, BRIT J PSYCHIAT, V193, P351, DOI 10.1192/bjp.bp.108.051425; Helfer JL, 2009, BRAIN RES, V1294, P1, DOI 10.1016/j.brainres.2009.07.090; Humm JL, 1998, BRAIN RES, V783, P286, DOI 10.1016/S0006-8993(97)01356-5; HUNT WA, 1993, ALCOHOL, V10, P559, DOI 10.1016/0741-8329(93)90083-Z; Jarvenpaa T, 2005, EPIDEMIOLOGY, V16, P766, DOI 10.1097/01.ede.0000181307.30826.6c; Kanny Dafna, 2012, Morbidity and Mortality Weekly Report, V61, P14; Kelso ML, 2011, NEUROSCIENCE, V197, P381, DOI 10.1016/j.neuroscience.2011.09.019; Kozlowski DA, 2013, COMPR PHYSIOL, V3, P121, DOI 10.1002/cphy.c110005; Leasure JL, 2010, ALCOHOL CLIN EXP RES, V34, P404, DOI 10.1111/j.1530-0277.2009.01105.x; MAJCHROWICZ E, 1975, PSYCHOPHARMACOLOGIA, V43, P245, DOI 10.1007/BF00429258; Nixon K, 2008, NEUROBIOL DIS, V31, P218, DOI 10.1016/j.nbd.2008.04.009; Nixon K, 2004, J NEUROSCI, V24, P9714, DOI 10.1523/JNEUROSCI.3063-04.2004; Nixon K, 2002, J NEUROCHEM, V83, P1087, DOI 10.1046/j.1471-4159.2002.01214.x; Obernier JA, 2002, PHARMACOL BIOCHEM BE, V72, P521, DOI 10.1016/S0091-3057(02)00715-3; Obernier JA, 2002, ALCOHOL CLIN EXP RES, V26, P547, DOI 10.1097/00000374-200204000-00016; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Penland S, 2001, ALCOHOL, V24, P45, DOI 10.1016/S0741-8329(01)00142-2; PFEFFERBAUM A, 1995, ALCOHOL CLIN EXP RES, V19, P1177, DOI 10.1111/j.1530-0277.1995.tb01598.x; Redila VA, 2006, HIPPOCAMPUS, V16, P305, DOI 10.1002/hipo.20164; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; SCHALLERT T, 1993, J NEURAL TRANSP PLAS, V4, P193, DOI 10.1155/NP.1993.193; Schallert T, 1997, ADV NEUROL, V73, P229; Stephens DN, 2008, PHILOS T R SOC B, V363, P3169, DOI 10.1098/rstb.2008.0097; Sundell L, 2008, STROKE, V39, P3179, DOI 10.1161/STROKEAHA.108.520817; Tanapat P, 1999, J NEUROSCI, V19, P5792, DOI 10.1523/JNEUROSCI.19-14-05792.1999; Thomas JD, 2008, BEHAV NEUROSCI, V122, P1264, DOI 10.1037/a0013271; TIVIS R, 1995, ALCOHOL CLIN EXP RES, V19, P496, DOI 10.1111/j.1530-0277.1995.tb01537.x; Trejo JL, 2002, REV NEUROSCIENCE, V13, P365; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001; Wobrock T, 2009, EUR ARCH PSY CLIN N, V259, P143, DOI 10.1007/s00406-008-0846-3	49	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76644	10.1371/journal.pone.0076644	http://dx.doi.org/10.1371/journal.pone.0076644			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098797	Green Submitted, Green Published, gold			2022-12-25	WOS:000325423500168
J	Minicucci, MF; dos Santos, PP; Rafacho, BPM; Goncalves, AF; Silva, RAC; Chiuso-Minicucci, F; Azevedo, PS; Polegato, BF; Okoshi, K; Pereira, EJ; Paiva, SAR; Zornoff, LAM				Minicucci, Marcos F.; dos Santos, Priscila P.; Rafacho, Bruna P. M.; Goncalves, Andrea F.; Silva, Renata A. C.; Chiuso-Minicucci, Fernanda; Azevedo, Paula S.; Polegato, Bertha F.; Okoshi, Katashi; Pereira, Elenize J.; Paiva, Sergio A. R.; Zornoff, Leonardo A. M.			Mechanisms Involved in the Beneficial Effects of Spironolactone after Myocardial Infarction	PLOS ONE			English	Article							MINERALOCORTICOID RECEPTOR ANTAGONISTS; VENTRICULAR SYSTOLIC DYSFUNCTION; SUDDEN CARDIAC DEATH; HEART-FAILURE; CLINICAL-IMPLICATIONS; EPLERENONE; MORTALITY; PERIOSTIN; PROLIFERATION; METAANALYSIS	Introduction: Our objective was to analyze the effect of spironolactone on cardiac remodeling after experimental myocardial infarction (MI), assessed by matricellular proteins levels, cardiac collagen amount and distribution, myocardial tissue metalloproteinase inhibitor-1(TIMP-1) concentration, myocyte hypertrophy, left ventricular architecture, and in vitro and in vivo cardiac function. Methods: Wistar rats were assigned to 4 groups: control group, in which animals were submitted to simulated surgery (SHAM group; n=9); group that received spironolactone and in which animals were submitted to simulated surgery (SHAM-S group, n=9); myocardial infarction group, in which animals were submitted to coronary artery ligation (MI group, n=15); and myocardial infarction group with spironolactone supplementation (MI-S group, n=15). The rats were observed for 3 months. Results: The MI group had higher values of left cardiac chambers and mass index and lower relative wall thicknesses compared with the SHAM group. In addition, diastolic and systolic functions were worse in the MI groups. However, spironolactone did not influence any of these variables. The MI-S group had a lower myocardial hydroxyproline concentration and myocyte cross-sectional area compared with the MI group. Myocardial periostin and collagen type III were lower in the MI-S group compared with the MI-group. In addition, TIMP-1 concentration in myocardium was higher in the MI-S group compared with the MI group. Conclusions: The predominant consequence of spironolactone supplementation after MI is related to reductions in collagens, with discrete attenuation of other remodeling variables. Importantly, this effect may be modulated by periostin and TIMP-1 levels.	[Minicucci, Marcos F.; dos Santos, Priscila P.; Rafacho, Bruna P. M.; Goncalves, Andrea F.; Silva, Renata A. C.; Azevedo, Paula S.; Polegato, Bertha F.; Okoshi, Katashi; Pereira, Elenize J.; Paiva, Sergio A. R.; Zornoff, Leonardo A. M.] Univ Estadual Paulista, Botucatu Med Sch, Dept Internal Med, Sao Paulo, Brazil; [Chiuso-Minicucci, Fernanda] Univ Estadual, Inst Biosci, Dept Microbiol & Immunol, Sao Paulo, Brazil	Universidade Estadual Paulista	Minicucci, MF (corresponding author), Univ Estadual Paulista, Botucatu Med Sch, Dept Internal Med, Sao Paulo, Brazil.	minicucci@fmb.unesp.br	Rafacho, Bruna Paola Murino/AGW-5794-2022; Azevedo, Paula Schmidt/S-1597-2019; Azevedo, Paula S/F-2701-2012; Minicucci, Fernanda C/A-9220-2015; Zornoff, Leonardo/A-5612-2008; Okoshi, Katashi/A-3955-2011; Minicucci, Marcos F/A-9094-2008; Rafacho, Bruna Paola Murino/B-5460-2013; Polegato, Bertha Furlan/E-8842-2012; Paiva, Sergio AR/A-5101-2008; dos Santos, Priscila Portugal/U-5345-2018	Rafacho, Bruna Paola Murino/0000-0001-8825-6980; Azevedo, Paula Schmidt/0000-0002-5843-6232; Azevedo, Paula S/0000-0002-5843-6232; Minicucci, Fernanda C/0000-0002-4155-6414; Zornoff, Leonardo/0000-0002-9831-8820; Okoshi, Katashi/0000-0001-8980-8839; Minicucci, Marcos F/0000-0002-5980-4367; Rafacho, Bruna Paola Murino/0000-0001-8825-6980; Polegato, Bertha Furlan/0000-0002-2875-9532; Paiva, Sergio AR/0000-0003-4412-1990; dos Santos, Priscila Portugal/0000-0003-1159-5030	Botucatu Medical School	Botucatu Medical School	This work was supported by Botucatu Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardisson LP, 2012, INT J CARDIOL, V156, P265, DOI 10.1016/j.ijcard.2010.10.128; Azevedo PS, 2010, CELL PHYSIOL BIOCHEM, V26, P395, DOI 10.1159/000320563; Bapoje SR, 2013, CIRC-HEART FAIL, V6, P166, DOI 10.1161/CIRCHEARTFAILURE.112.000003; Brandimarte F, 2008, CARDIOL CLIN, V26, P91, DOI 10.1016/j.ccl.2007.08.011; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; de Paiva SAR, 2003, AM J PHYSIOL-HEART C, V284, pH2242, DOI 10.1152/ajpheart.00646.2002; dos Santos PP, 2012, CELL PHYSIOL BIOCHEM, V30, P1191, DOI 10.1159/000343309; Fraccarollo D, 2008, HYPERTENSION, V51, P905, DOI 10.1161/HYPERTENSIONAHA.107.100941; Frangogiannis NG, 2012, PHYSIOL REV, V92, P635, DOI 10.1152/physrev.00008.2011; Gulati A, 2013, JAMA-J AM MED ASSOC, V309, P896, DOI 10.1001/jama.2013.1363; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Li XB, 2013, CIRC-HEART FAIL, V6, P156, DOI 10.1161/CIRCHEARTFAILURE.112.000074; Matsubara LS, 2000, AM J PHYSIOL-HEART C, V279, pH1534, DOI 10.1152/ajpheart.2000.279.4.H1534; Matsui Yutaka, 2010, World J Biol Chem, V1, P69, DOI 10.4331/wjbc.v1.i5.69; Mill JG, 2003, CLIN EXP PHARMACOL P, V30, P739, DOI 10.1046/j.1440-1681.2003.03906.x; Minicucci MF, 2011, INT J CARDIOL, V151, P242, DOI 10.1016/j.ijcard.2011.06.068; Minicucci MF, 2011, CLIN CARDIOL, V34, P410, DOI 10.1002/clc.20922; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Paiva SAR, 2005, J NUTR, V135, P2109, DOI 10.1093/jn/135.9.2109; Pfeffer JM, 2000, CARDIOVASC DRUG THER, V14, P579, DOI 10.1023/A:1007890126061; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; Spinale FG, 2002, CIRC RES, V90, P520, DOI 10.1161/01.RES.0000013290.12884.A3; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Udelson JE, 2010, CIRC-HEART FAIL, V3, P347, DOI 10.1161/CIRCHEARTFAILURE.109.906909; Weir RAP, 2009, AM HEART J, V157, P1088, DOI 10.1016/j.ahj.2009.04.001; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492; Zornoff LAM, 2000, BASIC RES CARDIOL, V95, P208, DOI 10.1007/s003950050183; Zornoff LAM, 2009, ARQ BRAS CARDIOL, V93, P434, DOI 10.1590/S0066-782X2009001000018; Zornoff LAM, 2009, ARQ BRAS CARDIOL, V92, P157, DOI 10.1590/S0066-782X2009000200013	33	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76866	10.1371/journal.pone.0076866	http://dx.doi.org/10.1371/journal.pone.0076866			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098808	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500179
J	Singh, N; Bhattacharya, A; Bhattacharya, S				Singh, Nishant; Bhattacharya, Alok; Bhattacharya, Sudha			Homologous Recombination Occurs in Entamoeba and Is Enhanced during Growth Stress and Stage Conversion	PLOS ONE			English	Article							DOUBLE-STRAND BREAK; CONTINUOUS EXPRESSION; AXENIC CULTIVATION; HETEROLOGOUS GENES; PROVIDES EVIDENCE; MEIOTIC GENES; CELL-CYCLE; HISTOLYTICA; GIARDIA; MEIOSIS	Homologous recombination (HR) has not been demonstrated in the parasitic protists Entamoeba histolytica or Entamoeba invadens, as no convenient method is available to measure it. However, HR must exist to ensure genome integrity, and possible genetic exchange, especially during stage conversion from trophozoite to cyst. Here we show the up regulation of mitotic and meiotic HR genes in Entamoeba during serum starvation, and encystation. To directly demonstrate HR we use a simple PCR-based method involving inverted repeats, which gives a reliable read out, as the recombination junctions can be determined by sequencing the amplicons. Using this read out, we demonstrate enhanced HR under growth stress in E. histolytica, and during encystation in E. invadens. We also demonstrate recombination between chromosomal inverted repeats. This is the first experimental demonstration of HR in Entamoeba and will help future investigations into this process, and to explore the possibility of meiosis in Entamoeba.	[Singh, Nishant; Bhattacharya, Sudha] Jawaharlal Nehru Univ, Sch Environm Sci, New Delhi 110067, India; [Bhattacharya, Alok] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi	Bhattacharya, S (corresponding author), Jawaharlal Nehru Univ, Sch Environm Sci, New Delhi 110067, India.	sbjnu110@gmail.com	Singh, Nishant/T-9054-2019	Singh, Nishant/0000-0002-8466-8862	Department of Biotechnology; Council of Scientific and Industrial Research India	Department of Biotechnology; Council of Scientific and Industrial Research India(Council of Scientific & Industrial Research (CSIR) - India)	This work is supported by Department of Biotechnology and Council of Scientific and Industrial Research India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkhipova I, 2000, P NATL ACAD SCI USA, V97, P14473, DOI 10.1073/pnas.97.26.14473; AVRON B, 1986, J PROTOZOOL, V33, P522, DOI 10.1111/j.1550-7408.1986.tb05655.x; BaezCamargo M, 1997, INVAS METAST, V16, P269; Bagchi A, 1999, INT J PARASITOL, V29, P1775, DOI 10.1016/S0020-7519(99)00125-3; Bakre AA, 2005, EXP PARASITOL, V110, P207, DOI 10.1016/j.exppara.2005.02.009; Bhattacharya A, 2000, INT J PARASITOL, V30, P401, DOI 10.1016/S0020-7519(99)00189-7; Birky CW, 2010, TRENDS PARASITOL, V26, P70, DOI 10.1016/j.pt.2009.11.007; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Borts RH, 2000, MUTAT RES-FUND MOL M, V451, P129, DOI 10.1016/S0027-5107(00)00044-0; Brandsma Inger, 2012, Genome Integr, V3, P9, DOI 10.1186/2041-9414-3-9; Carpenter ML, 2012, J CELL SCI, V125, P2523, DOI 10.1242/jcs.103879; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Cline SD, 2003, NAT REV MOL CELL BIO, V4, P361, DOI 10.1038/nrm1101; Conway C, 2002, MOL MICROBIOL, V45, P1687, DOI 10.1046/j.1365-2958.2002.03122.x; Cooper MA, 2007, CURR BIOL, V17, P1984, DOI 10.1016/j.cub.2007.10.020; Das S, 2002, CELL MICROBIOL, V4, P55, DOI 10.1046/j.1462-5822.2002.00165.x; Deitsch KW, 1999, MOL BIOCHEM PARASIT, V101, P107, DOI 10.1016/S0166-6851(99)00062-6; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; DIAMOND LS, 1995, J EUKARYOT MICROBIOL, V42, P277, DOI 10.1111/j.1550-7408.1995.tb01579.x; DiRuggiero J, 1999, J MOL EVOL, V49, P474, DOI 10.1007/PL00006570; DVORAK JA, 1995, J EUKARYOT MICROBIOL, V42, P610, DOI 10.1111/j.1550-7408.1995.tb05915.x; Ehrenkaufer GM, 2007, CELL MICROBIOL, V9, P1426, DOI 10.1111/j.1462-5822.2006.00882.x; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Ganguly A, 2001, MOL BIOCHEM PARASIT, V112, P277, DOI 10.1016/S0166-6851(00)00376-5; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gerton JL, 2002, P NATL ACAD SCI USA, V99, P6895, DOI 10.1073/pnas.102167899; GLAZER PM, 1989, P NATL ACAD SCI USA, V86, P1163, DOI 10.1073/pnas.86.4.1163; Groth P, 2012, NUCLEIC ACIDS RES, V40, P6585, DOI 10.1093/nar/gks315; Gupta AK, 2012, SCI REP-UK, V2, DOI 10.1038/srep00303; HAMANN L, 1995, P NATL ACAD SCI USA, V92, P8975, DOI 10.1073/pnas.92.19.8975; Hopfner KP, 2000, J BACTERIOL, V182, P6036, DOI 10.1128/JB.182.21.6036-6041.2000; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Huntley DM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-321; Jeggo PA, 2011, RADIOTHER ONCOL, V101, P7, DOI 10.1016/j.radonc.2011.06.019; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Krogstad D, 1988, AMEBIASIS HUMAN INFE; Lopez-Camarillo C, 2009, INFECT GENET EVOL, V9, P1051, DOI 10.1016/j.meegid.2009.06.024; Lopez-Casamichana M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-35; Lorenzi Hernan, 2008, BMC Genomics, V9, P595, DOI 10.1186/1471-2164-9-595; Malik SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002879; Masson JY, 2001, TRENDS BIOCHEM SCI, V26, P131, DOI 10.1016/S0968-0004(00)01742-4; Moreau S, 1999, MOL CELL BIOL, V19, P556; Mukherjee C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000281; Papadopoulou B, 1997, NUCLEIC ACIDS RES, V25, P4278, DOI 10.1093/nar/25.21.4278; Poxleitner MK, 2008, SCIENCE, V319, P1530, DOI 10.1126/science.1153752; Ramesh MA, 2005, CURR BIOL, V15, P185, DOI 10.1016/j.cub.2005.01.003; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SANCHEZ L, 1994, MOL BIOCHEM PARASIT, V67, P125, DOI 10.1016/0166-6851(94)90102-3; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shrimal S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000929; Singh N, 2010, EXP PARASITOL, V127, P329; Singh N, 2012, MOL BIOCHEM PARASIT, V184, P9, DOI 10.1016/j.molbiopara.2012.02.012; Singh N, 2012, MOL BIOCHEM PARASIT, V183, P90, DOI 10.1016/j.molbiopara.2012.01.003; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; Teodorovic S, 2007, EUKARYOT CELL, V6, P1421, DOI 10.1128/EC.00138-07; Tsubouchi H, 2002, MOL CELL BIOL, V22, P3078, DOI 10.1128/MCB.22.9.3078-3088.2002; Weber C, 2009, MOL BIOCHEM PARASIT, V164, P165, DOI 10.1016/j.molbiopara.2008.12.005; Weedall GD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001209; Weitzer S, 2003, CURR BIOL, V13, P1930, DOI 10.1016/j.cub.2003.10.030; Willers H, 2001, CARCINOGENESIS, V22, P1757, DOI 10.1093/carcin/22.11.1757; Willhoeft U, 1999, MOL BIOCHEM PARASIT, V99, P41, DOI 10.1016/S0166-6851(98)00178-9; Yadav VP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1855; Yamamoto K, 1996, GENETICS, V143, P27	63	23	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74465	10.1371/journal.pone.0074465	http://dx.doi.org/10.1371/journal.pone.0074465			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098652	gold, Green Published, Green Submitted			2022-12-25	WOS:000325423500023
J	Tzika, AA; Constantinou, C; Bandyopadhaya, A; Psychogios, N; Lee, S; Mindrinos, M; Martyn, JAJ; Tompkins, RG; Rahme, LG				Tzika, A. Aria; Constantinou, Caterina; Bandyopadhaya, Arunava; Psychogios, Nikolaos; Lee, Sangseok; Mindrinos, Michael; Martyn, J. A. Jeevendra; Tompkins, Ronald G.; Rahme, Laurence G.			A Small Volatile Bacterial Molecule Triggers Mitochondrial Dysfunction in Murine Skeletal Muscle	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; MUCOID PSEUDOMONAS-AERUGINOSA; LIPOPROTEIN-LIPASE ACTIVITY; ACTIVATED-RECEPTOR-GAMMA; FREE FATTY-ACIDS; INSULIN-RESISTANCE; CYSTIC-FIBROSIS; PPAR-GAMMA; IN-VIVO; LIPID-CONTENT	Mitochondria integrate distinct signals that reflect specific threats to the host, including infection, tissue damage, and metabolic dysfunction; and play a key role in insulin resistance. We have found that the Pseudomonas aeruginosa quorum sensing infochemical, 2-amino acetophenone (2-AA), produced during acute and chronic infection in human tissues, including in the lungs of cystic fibrosis (CF) patients, acts as an interkingdom immunomodulatory signal that facilitates pathogen persistence, and host tolerance to infection. Transcriptome results have led to the hypothesis that 2-AA causes further harm to the host by triggering mitochondrial dysfunction in skeletal muscle. As normal skeletal muscle function is essential to survival, and is compromised in many chronic illnesses, including infections and CF-associated muscle wasting, we here determine the global effects of 2-AA on skeletal muscle using high-resolution magic-angle-spinning (HRMAS), proton (1 H) nuclear magnetic resonance (NMR) metabolomics, in vivo P-31 NMR, whole-genome expression analysis and functional studies. Our results show that 2-AA when injected into mice, induced a biological signature of insulin resistance as determined by 1 H NMR analysis-, and dramatically altered insulin signaling, glucose transport, and mitochondrial function. Genes including Glut4, IRS1, PPAR-c, PGC1 and Sirt1 were downregulated, whereas uncoupling protein UCP3 was up-regulated, in accordance with mitochondrial dysfunction. Although 2-AA did not alter high-energy phosphates or pH by in vivo P-31 NMR analysis, it significantly reduced the rate of ATP synthesis. This affect was corroborated by results demonstrating down-regulation of the expression of genes involved in energy production and muscle function, and was further validated by muscle function studies. Together, these results further demonstrate that 2-AA, acts as a mediator of interkingdom modulation, and likely effects insulin resistance associated with a molecular signature of mitochondrial dysfunction in skeletal muscle. Reduced energy production and mitochondrial dysfunctional may further favor infection, and be an important step in the establishment of chronic and persistent infections.	[Tzika, A. Aria; Constantinou, Caterina; Bandyopadhaya, Arunava; Psychogios, Nikolaos; Tompkins, Ronald G.; Rahme, Laurence G.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Tzika, A. Aria; Constantinou, Caterina; Bandyopadhaya, Arunava; Psychogios, Nikolaos; Lee, Sangseok; Martyn, J. A. Jeevendra; Tompkins, Ronald G.; Rahme, Laurence G.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Tzika, A. Aria; Psychogios, Nikolaos] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA 02114 USA; [Mindrinos, Michael] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Lee, Sangseok; Martyn, J. A. Jeevendra] Harvard Univ, Sch Med, Dept Anesthesiol & Crit Care, Boston, MA USA; [Tzika, A. Aria; Constantinou, Caterina; Bandyopadhaya, Arunava; Psychogios, Nikolaos; Lee, Sangseok; Martyn, J. A. Jeevendra; Rahme, Laurence G.] Shriners Hosp Children Boston, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Stanford University; Harvard University; Harvard Medical School	Tzika, AA (corresponding author), Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA.	atzika@hms.harvard.edu; rahme@molbio.mgh.harvard.edu	Lee, Sangseok/AAF-5091-2021; Constantinou, Caterina/D-3844-2018	Lee, Sangseok/0000-0001-7023-3668; Constantinou, Caterina/0000-0003-3589-0739; Psychogios, Nikolaos/0000-0002-2747-6012	Shriner's Hospital for Children [87100]; Center grant of the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI105902, R21AI105902] Funding Source: NIH RePORTER	Shriner's Hospital for Children; Center grant of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by a Shriner's Hospital for Children research grant no. 87100 to Laurence G. Rahme, and by a Center grant of the National Institutes of Health to the Stanford Genome Technology Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2004, INT MICROBIOL, V7, P181; Amar J, 2008, AM J CLIN NUTR, V87, P1219, DOI 10.1093/ajcn/87.5.1219; Anderwald C, 2002, DIABETES, V51, P3025, DOI 10.2337/diabetes.51.10.3025; Arnoult D, 2011, EMBO REP, V12, P901, DOI 10.1038/embor.2011.157; Astrakas LG, 2005, FASEB J, V19, P1431, DOI 10.1096/fj.04-2005com; Auwerx J, 1999, DIABETOLOGIA, V42, P1033, DOI 10.1007/s001250051268; Bandyopadhaya A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003024; Befroy DE, 2009, METHOD ENZYMOL, V457, P373, DOI 10.1016/S0076-6879(09)05021-6; BEISEL WR, 1967, ANN INTERN MED, V67, P744, DOI 10.7326/0003-4819-67-4-744; BEISEL WR, 1975, ANNU REV MED, V26, P9, DOI 10.1146/annurev.me.26.020175.000301; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Boesch C, 1997, MAGN RESON MED, V37, P484, DOI 10.1002/mrm.1910370403; BRINDLE KM, 1989, BIOCHEMISTRY-US, V28, P4887, DOI 10.1021/bi00437a054; Cobas JC, 2006, J MAGN RESON, V183, P145, DOI 10.1016/j.jmr.2006.07.013; CHANDRA RK, 1983, LANCET, V1, P688; Chang HR, 1998, JPEN-PARENTER ENTER, V22, P156, DOI 10.1177/0148607198022003156; Chiang MC, 2012, NEUROBIOL DIS, V45, P322, DOI 10.1016/j.nbd.2011.08.016; COX CD, 1979, J CLIN MICROBIOL, V9, P479; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Debril MB, 2001, J MOL MED, V79, P30, DOI 10.1007/s001090000145; Dekkers JF, 2012, TRENDS MOL MED, V18, P283, DOI 10.1016/j.molmed.2012.03.004; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; FORSEN S, 1963, J CHEM PHYS, V39, P2892, DOI 10.1063/1.1734121; Frick CG, 2008, INTENS CARE MED, V34, P561, DOI 10.1007/s00134-007-0852-3; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Hammarstedt A, 2003, BIOCHEM BIOPH RES CO, V301, P578, DOI 10.1016/S0006-291X(03)00014-7; Hardin DS, 2001, AM J PHYSIOL-ENDOC M, V281, pE1022, DOI 10.1152/ajpendo.2001.281.5.E1022; HAVEL RJ, 1964, J APPL PHYSIOL, V19, P613, DOI 10.1152/jappl.1964.19.4.613; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Hussey J, 2002, J Cyst Fibros, V1, P116, DOI 10.1016/S1569-1993(02)00074-7; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Ilyinskii PO, 2007, CELL CYCLE, V6, P2043, DOI 10.4161/cc.6.16.4564; Jacob S, 1999, DIABETES, V48, P1113, DOI 10.2337/diabetes.48.5.1113; Jahoor A, 2008, J BACTERIOL, V190, P4408, DOI 10.1128/JB.01444-07; Jiang JH, 2012, IUBMB LIFE, V64, P397, DOI 10.1002/iub.1021; Jucker BM, 2000, P NATL ACAD SCI USA, V97, P6880, DOI 10.1073/pnas.120131997; KAYAR SR, 1986, EUR J APPL PHYSIOL O, V54, P578, DOI 10.1007/BF00943344; Keller L, 2006, NAT REV MICROBIOL, V4, P249, DOI 10.1038/nrmicro1383; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kerr KG, 2009, J HOSP INFECT, V73, P338, DOI 10.1016/j.jhin.2009.04.020; Kesarwani M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002192; KIENS B, 1989, J CLIN INVEST, V84, P1124, DOI 10.1172/JCI114275; KINGSLEYHICKMAN PB, 1990, J BIOL CHEM, V265, P1545; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; Kulhmann J, 2005, MAGN RESON MED, V53, P1275, DOI 10.1002/mrm.20501; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Macallan DC, 1998, CLIN SCI, V94, P321, DOI 10.1042/cs0940321; MACALLAN DC, 1995, AM J CLIN NUTR, V61, P818, DOI 10.1093/ajcn/61.4.818; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Majai G, 2007, EUR J IMMUNOL, V37, P1343, DOI 10.1002/eji.200636398; Manes S, 2003, NAT REV IMMUNOL, V3, P557, DOI 10.1038/nri1129; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; MORTON RE, 1988, AM J CLIN NUTR, V47, P214, DOI 10.1093/ajcn/47.2.214; Morvan D, 2003, MAGN RESON MED, V49, P241, DOI 10.1002/mrm.10368; Navon-Venezia S, 2005, CURR OPIN INFECT DIS, V18, P306, DOI 10.1097/01.qco.0000171920.44809.f0; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; O'Riordan SMP, 2008, PEDIATR DIABETES, V9, P338, DOI 10.1111/j.1399-5448.2008.00437.x; Padfield KE, 2005, P NATL ACAD SCI USA, V102, P5368, DOI 10.1073/pnas.0501211102; Paton NI, 2001, CLIN SCI, V100, P101, DOI 10.1042/CS20000037; Perez A, 2008, AM J PHYSIOL-LUNG C, V295, pL303, DOI 10.1152/ajplung.90276.2008; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; PETERSEN KF, 2004, NEW ENGL J MED, V350, P664, DOI [10.1056/NEJMoa031314, DOI 10.1056/NEJMOA031314]; Picard F, 2002, ANNU REV NUTR, V22, P167, DOI 10.1146/annurev.nutr.22.010402.102808; POLLARE T, 1991, ARTERIOSCLER THROMB, V11, P1192, DOI 10.1161/01.ATV.11.5.1192; REES D, 1989, MAGNET RESON MED, V9, P39, DOI 10.1002/mrm.1910090107; REYNOLDS HY, 1976, JAMA-J AM MED ASSOC, V236, P2190, DOI 10.1001/jama.236.19.2190; Rietschel E, 2008, INT J REHABIL RES, V31, P253, DOI 10.1097/MRR.0b013e3282fb783d; Righi V, 2010, INT J MOL MED, V26, P175, DOI 10.3892/ijmm_00000450; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Rumbaugh KP, 2011, CURR OPIN MICROBIOL; Rutanen J, 2010, DIABETES, V59, P829, DOI 10.2337/db09-1191; SAKO EY, 1988, J BIOL CHEM, V263, P10600; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Savage David B., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405008793; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Scott-Thomas A, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/4/046002; Scott-Thomas AJ, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-56; Sinha R, 2002, DIABETES, V51, P1022, DOI 10.2337/diabetes.51.4.1022; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Szczepaniak LS, 1999, AM J PHYSIOL-ENDOC M, V276, pE977, DOI 10.1152/ajpendo.1999.276.5.E977; TRUMPOWER BL, 1990, MICROBIOL REV, V54, P101, DOI 10.1128/MMBR.54.2.101-129.1990; Tschopp J, 2011, EUR J IMMUNOL, V41, P1196, DOI 10.1002/eji.201141436; Tzika AA, 2008, INT J MOL MED, V21, P825; van Heeckeren AM, 2000, AM J RESP CRIT CARE, V161, P271, DOI 10.1164/ajrccm.161.1.9903019; VANARK G, 1977, BIOCHIM BIOPHYS ACTA, V459, P119, DOI 10.1016/0005-2728(77)90014-7; Vermathen P, 2004, MAGNET RESON MED, V51, P253, DOI 10.1002/mrm.10721; Yasuhara S, 2000, AM J PHYSIOL-ENDOC M, V279, pE1114, DOI 10.1152/ajpendo.2000.279.5.E1114; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	93	21	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74528	10.1371/journal.pone.0074528	http://dx.doi.org/10.1371/journal.pone.0074528			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098655	Green Published, gold, Green Submitted			2022-12-25	WOS:000325423500026
J	Peden, EA; Boehm, M; Mulder, DW; Davis, R; Old, WM; King, PW; Ghirardi, ML; Dubini, A				Peden, Erin A.; Boehm, Marko; Mulder, David W.; Davis, ReAnna; Old, William M.; King, Paul W.; Ghirardi, Maria L.; Dubini, Alexandra			Identification of Global Ferredoxin Interaction Networks in Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergetics; Electron Transfer Complex; Chlamydomonas; Energy Metabolism; Protein-Protein Interactions; Redox; Ferredoxin; Network	AMINO-ACID SEQUENCE; GREEN-ALGA; STATE TRANSITIONS; ELECTRON-TRANSFER; ESCHERICHIA-COLI; PHOTOSYSTEM-I; PROTEINS; OXIDOREDUCTASE; DESATURATION; HYDROGENASE	Background:Chlamydomonas contains six chloroplast ferredoxins (FDXs) whose function is still unclear. Results: A global FDX interactome was obtained where FDX1 has a predominant role and is the most relevant electron donor to FNR1 and HYDA1. Conclusion: FDXs have distinct but also overlapping function. Significance: We discovered new FDX interaction partners and specific roles for each FDX isoform. Ferredoxins (FDXs) can distribute electrons originating from photosynthetic water oxidation, fermentation, and other reductant-generating pathways to specific redox enzymes in different organisms. The six FDXs identified in Chlamydomonas reinhardtii are not fully characterized in terms of their biological function. In this report, we present data from the following: (a) yeast two-hybrid screens, identifying interaction partners for each Chlamydomonas FDX; (b) pairwise yeast two-hybrid assays measuring FDX interactions with proteins from selected biochemical pathways; (c) affinity pulldown assays that, in some cases, confirm and even expand the interaction network for FDX1 and FDX2; and (d) in vitro NADP(+) reduction and H-2 photo-production assays mediated by each FDX that verify their role in these two pathways. Our results demonstrate new potential roles for FDX1 in redox metabolism and carbohydrate and fatty acid biosynthesis, for FDX2 in anaerobic metabolism, and possibly in state transition. Our data also suggest that FDX3 is involved in nitrogen assimilation, FDX4 in glycolysis and response to reactive oxygen species, and FDX5 in hydrogenase maturation. Finally, we provide experimental evidence that FDX1 serves as the primary electron donor to two important biological pathways, NADPH and H-2 photo-production, whereas FDX2 is capable of driving these reactions at less than half the rate observed for FDX1.	[Peden, Erin A.; Boehm, Marko; Mulder, David W.; Davis, ReAnna; King, Paul W.; Ghirardi, Maria L.; Dubini, Alexandra] Natl Renewable Energy Lab, Golden, CO 80401 USA; [Old, William M.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; University of Colorado System; University of Colorado Boulder	Dubini, A (corresponding author), Natl Renewable Energy Lab, Mail Stop 3313,15013 Denver West Pkwy, Golden, CO 80401 USA.	alexandra.dubini@nrel.gov	Mulder, David/AHC-0138-2022; dubini, alexandra/A-7252-2016; dubini, alexandra/Q-6277-2019; King, Paul W./D-9979-2011	Mulder, David/0000-0003-0559-0145; dubini, alexandra/0000-0001-8825-3915; dubini, alexandra/0000-0001-8825-3915; King, Paul W./0000-0001-5039-654X; OLD, WILLIAM/0000-0002-9499-8478	United States Department of Energy [DE-AC36-08GO28308]; National Renewable Energy Laboratory; Biological and Environmental Research program, Division of Energy Biosciences, Office of Science; United States Department of Energy; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy	United States Department of Energy(United States Department of Energy (DOE)); National Renewable Energy Laboratory(United States Department of Energy (DOE)); Biological and Environmental Research program, Division of Energy Biosciences, Office of Science; United States Department of Energy(United States Department of Energy (DOE)); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE))	This work was supported by the United States Department of Energy under Contract DE-AC36-08GO28308 from the National Renewable Energy Laboratory, a grant from the Biological and Environmental Research program, Division of Energy Biosciences, Office of Science, the United States Department of Energy (to M. L G.), and the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy (to P. W. K.).	Aguilar PS, 2006, MOL MICROBIOL, V62, P1507, DOI 10.1111/j.1365-2958.2006.05484.x; Allahverdiyeva Y, 2011, J BIOL CHEM, V286, P24007, DOI 10.1074/jbc.M111.223289; Baier M, 1999, PLANT PHYSIOL, V119, P1407, DOI 10.1104/pp.119.4.1407; BARTEL P, 1993, BIOTECHNIQUES, V14, P920; Bertini I, 2002, PROTEINS, V46, P110, DOI 10.1002/prot.10009; Bruckner A, 2009, INT J MOL SCI, V10, P2763, DOI 10.3390/ijms10062763; BUCHANAN BB, 1964, P NATL ACAD SCI USA, V52, P839, DOI 10.1073/pnas.52.3.839; Bukhov N, 2004, PHOTOSYNTH RES, V82, P17, DOI 10.1023/B:PRES.0000040442.59311.72; BULTE L, 1990, BIOCHIM BIOPHYS ACTA, V1020, P72, DOI 10.1016/0005-2728(90)90095-L; Chazarreta-Cifre L, 2011, J BACTERIOL, V193, P4043, DOI 10.1128/JB.05103-11; Elrad D, 2002, PLANT CELL, V14, P1801, DOI 10.1105/tpc.002154; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; GarciaSanchez MI, 1997, EUR J BIOCHEM, V250, P364, DOI 10.1111/j.1432-1033.1997.0364a.x; Ghirardi ML, 2009, CHEM SOC REV, V38, P52, DOI 10.1039/b718939g; Ghirardi ML, 1997, APPL BIOCHEM BIOTECH, V63-5, P141, DOI 10.1007/BF02920420; Gou P, 2006, BIOCHEMISTRY-US, V45, P14389, DOI 10.1021/bi061779d; GUERRERO MG, 1981, ANNU REV PLANT PHYS, V32, P169, DOI 10.1146/annurev.pp.32.060181.001125; Hanke GT, 2011, BBA-PROTEINS PROTEOM, V1814, P366, DOI 10.1016/j.bbapap.2010.09.011; Hanke G, 2013, PLANT CELL ENVIRON, V36, P1071, DOI 10.1111/pce.12046; Harris EH., 2009, CHLAMYDOMONAS SOURCE, VSecond Edition; HASE T, 1991, PLANT PHYSIOL, V97, P1395, DOI 10.1104/pp.97.4.1395; HASE T, 1976, J BIOCHEM-TOKYO, V79, P329, DOI 10.1093/oxfordjournals.jbchem.a131076; Helman Y, 2003, CURR BIOL, V13, P230, DOI 10.1016/S0960-9822(03)00046-0; HEWITT EJ, 1975, ANNU REV PLANT PHYS, V26, P73, DOI 10.1146/annurev.pp.26.060175.000445; HUISMAN JG, 1978, BIOCHEM BIOPH RES CO, V82, P1121, DOI 10.1016/0006-291X(78)90303-0; HUTSON KG, 1978, BIOCHEM J, V172, P465, DOI 10.1042/bj1720465; Iwasaki T, 2011, J BIOL INORG CHEM, V16, P923, DOI 10.1007/s00775-011-0793-8; Jacobs J, 2009, FEBS LETT, V583, P325, DOI 10.1016/j.febslet.2008.12.018; Jacquot JP, 1997, FEBS LETT, V401, P143, DOI 10.1016/S0014-5793(96)01459-7; Kameda H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021947; King PW, 2006, J BACTERIOL, V188, P2163, DOI 10.1128/JB.188.6.2163-2172.2006; Kromer S, 1996, BIOCHEM SOC T, V24, P761; Lambertz C, 2010, EUKARYOT CELL, V9, P1747, DOI 10.1128/EC.00127-10; Lemaire SD, 2005, PLANT PHYSIOL, V137, P514, DOI 10.1104/pp.104.052670; Lemeille S, 2010, MOL CELL PROTEOMICS, V9, P1281, DOI 10.1074/mcp.M000020-MCP201; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Long H, 2008, BIOPHYS J, V95, P3753, DOI 10.1529/biophysj.107.127548; MATSUBARA H, 1968, J BIOL CHEM, V243, P1732; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Meuser JE, 2012, BIOCHEM BIOPH RES CO, V417, P704, DOI 10.1016/j.bbrc.2011.12.002; Meyer-Arendt K, 2011, J PROTEOME RES, V10, P3060, DOI 10.1021/pr200039p; Michoux F, 2010, BIOCHEMISTRY-US, V49, P7411, DOI 10.1021/bi1011145; Mus F, 2007, J BIOL CHEM, V282, P25475, DOI 10.1074/jbc.M701415200; Noth J, 2013, J BIOL CHEM, V288, P4368, DOI 10.1074/jbc.M112.429985; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Onda Y, 2000, PLANT PHYSIOL, V123, P1037, DOI 10.1104/pp.123.3.1037; ORMEJOHN.WH, 1973, ANNU REV BIOCHEM, V42, P159, DOI 10.1146/annurev.bi.42.070173.001111; Peng LW, 2009, PLANT CELL, V21, P3623, DOI 10.1105/tpc.109.068791; Peters JW, 2012, ANNU REV BIOCHEM, V81, P429, DOI 10.1146/annurev-biochem-052610-094911; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Scheibe R, 2012, PLANT CELL ENVIRON, V35, P202, DOI 10.1111/j.1365-3040.2011.02319.x; SCHMITTER JM, 1988, EUR J BIOCHEM, V172, P405, DOI 10.1111/j.1432-1033.1988.tb13901.x; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; SMEEKENS S, 1990, TRENDS BIOCHEM SCI, V15, P73, DOI 10.1016/0968-0004(90)90180-J; TAKAHASHI Y, 1986, P NATL ACAD SCI USA, V83, P2434, DOI 10.1073/pnas.83.8.2434; Terashima M, 2012, P NATL ACAD SCI USA, V109, P17717, DOI 10.1073/pnas.1207118109; Terashima M, 2010, MOL CELL PROTEOMICS, V9, P1514, DOI 10.1074/mcp.M900421-MCP200; Terauchi AM, 2009, J BIOL CHEM, V284, P25867, DOI 10.1074/jbc.M109.023622; Vallese F, 2012, J BIOL CHEM, V287, P36544, DOI 10.1074/jbc.M112.388900; van Lis R, 2013, PLANT PHYSIOL, V161, P57, DOI 10.1104/pp.112.208181; VandenKoornhuyse N, 1996, J BIOL CHEM, V271, P16281, DOI 10.1074/jbc.271.27.16281; WADA H, 1993, J BACTERIOL, V175, P544, DOI 10.1128/JB.175.2.544-547.1993; WADA K, 1974, J BIOCHEM-TOKYO, V76, P1217, DOI 10.1093/oxfordjournals.jbchem.a130674; Winkler M, 2010, EUR J CELL BIOL, V89, P998, DOI 10.1016/j.ejcb.2010.06.018; Wojcik J, 2002, J MOL BIOL, V323, P763, DOI 10.1016/S0022-2836(02)01009-4; Yacoby I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035886; Yacoby I, 2011, P NATL ACAD SCI USA, V108, P9396, DOI 10.1073/pnas.1103659108; Yonekura-Sakakibara K, 2000, PLANT PHYSIOL, V122, P887, DOI 10.1104/pp.122.3.887	69	72	74	3	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35192	35209		10.1074/jbc.M113.483727	http://dx.doi.org/10.1074/jbc.M113.483727			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24100040	hybrid, Green Published			2022-12-25	WOS:000329867600020
J	Pradhan, A; Singh, TR; Ali, AM; Wahengbam, K; Meetei, AR				Pradhan, Arun; Singh, Thiyam Ramsing; Ali, Abdullah Mahmood; Wahengbam, Kebola; Meetei, Amom Ruhikanta			Monopolar Spindle 1 (MPS1) Protein-dependent Phosphorylation of RecQ-mediated Genome Instability Protein 2 (RMI2) at Serine 112 Is Essential for BLM-Topo III alpha-RMI1-RMI2 (BTR) Protein Complex Function upon Spindle Assembly Checkpoint (SAC) Activation during Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Helicase; Posttranslational Modification; Protein Phosphorylation; shRNA; Subcellular Fractionation; BTR Complex; Bloom Syndrome; RMI2; Genome Instability; Spindle Assembly Checkpoint (SAC)	ESSENTIAL COMPONENT; CORE-COMPLEX; REPAIR	Genomic instability and a predisposition to cancer are hallmarks of Bloom syndrome, an autosomal recessive disease arising from mutations in the BLM gene. BLM is a RecQ helicase component of the BLM-Topo III -RMI1-RMI2 (BTR) complex, which maintains chromosome stability at the spindle assembly checkpoint (SAC). Other members of the BTR complex include Topo IIIa, RMI1, and RMI2. All members of the BTR complex are essential for maintaining the stable genome. Interestingly, the BTR complex is posttranslationally modified upon SAC activation during mitosis, but its significance remains unknown. In this study, we show that two proteins that interact with BLM, RMI1 and RMI2, are phosphorylated upon SAC activation, and, like BLM, RMI1, and RMI2, are phosphorylated in an MPS1-dependent manner. An S112A mutant of RMI2 localized normally in cells and was found in SAC-induced coimmunoprecipitations of the BTR complex. However, in RMI2-depleted cells, an S112A mutant disrupted the mitotic arrest upon SAC activation. The failure of cells to maintain mitotic arrest, due to lack of phosphorylation at Ser-112, results in high genomic instability characterized by micronuclei, multiple nuclei, and a wide distribution of aberrantly segregating chromosomes. We found that the S112A mutant of RMI2 showed defects in redistribution between the nucleoplasm and nuclear matrix. The phosphorylation at Ser-112 of RMI2 is independent of BLM and is not required for the stability of the BTR complex, BLM focus formation, and chromatin targeting in response to replication stress. Overall, this study suggests that the phosphorylation of the BTR complex is essential to maintain a stable genome.	[Pradhan, Arun; Singh, Thiyam Ramsing; Ali, Abdullah Mahmood; Wahengbam, Kebola; Meetei, Amom Ruhikanta] Cincinnati Childrens Hosp Med Ctr, Expt Hematol & Canc Biol & Canc & Blood Dis Inst, Cincinnati, OH 45229 USA; [Meetei, Amom Ruhikanta] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45229 USA; [Singh, Thiyam Ramsing] Manipur Univ, Dept Biotechnol, Imphal 795003, India	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Manipur University	Meetei, AR (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, 240 Albert Sabin Way, Cincinnati, OH 45229 USA.	Ruhikanta.Meetei@cchmc.org	Ali, Abdullah Mahmood/AAI-4094-2020	Ali, Abdullah Mahmood/0000-0002-4007-6769; singh, thiyam/0000-0002-0441-6818	National Institutes of Health Research [HL084082]; Ohio Cancer Research Associates Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084082] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio Cancer Research Associates Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Research Grant HL084082. This work was also supported by a grant from the Ohio Cancer Research Associates Fund (to A.R.M.).	Ali AM, 2012, BLOOD, V119, P3285, DOI 10.1182/blood-2011-10-385963; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Dutertre S, 2000, ONCOGENE, V19, P2731, DOI 10.1038/sj.onc.1203595; GERMAN J, 2002, GENETIC BASIS HUMAN, P267; Hoadley KA, 2010, STRUCTURE, V18, P1149, DOI 10.1016/j.str.2010.06.009; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Leng M, 2006, P NATL ACAD SCI USA, V103, P11485, DOI 10.1073/pnas.0601828103; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Musacchio A, 2011, PHILOS T R SOC B, V366, P3595, DOI 10.1098/rstb.2011.0072; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Singh TR, 2008, GENE DEV, V22, P2856, DOI 10.1101/gad.1725108; Wang F, 2010, STRUCTURE, V18, P1159, DOI 10.1016/j.str.2010.06.008; Wang Y, 2000, GENE DEV, V14, P927; Xu DY, 2008, GENE DEV, V22, P2843, DOI 10.1101/gad.1708608; Yin JH, 2005, EMBO J, V24, P1465, DOI 10.1038/sj.emboj.7600622	16	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33500	33508		10.1074/jbc.M113.470823	http://dx.doi.org/10.1074/jbc.M113.470823			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24108125	hybrid, Green Published			2022-12-25	WOS:000327250200001
J	Chang, Q; Miao, XF; Ju, XW; Zhu, LG; Huang, CL; Huang, T; Zuo, XC; Gao, CF				Chang, Qi; Miao, Xinfang; Ju, Xiaowei; Zhu, Lvgang; Huang, Changlin; Huang, Tao; Zuo, Xincheng; Gao, Chunfang			Effects of Pulse Current on Endurance Exercise and Its Anti-Fatigue Properties in the Hepatic Tissue of Trained Rats	PLOS ONE			English	Article							PHYSICAL-EXERCISE; CELL-DEATH; MUSCLE; METABOLISM; EXTRACT; MICE	Fatigue is synonymous with a wide spectrum of familiar physiological conditions, from pathology and general health, to sport and physical exercise. Strenuous, prolonged exercise training causes fatigue. Although several studies have investigated the effects of electrical stimulation frequency on muscle fatigue, the effects of percutaneous pulse current stimulation on fatigue in the hepatic tissue of trained rats is still unclear. In order to find an effective strategy to prevent fatigue or enhance recovery, the effects of pulse current on endurance exercise and its anti-fatigue properties in exercised rats were studied. Rats were subjected to one, three or five weeks of swimming exercise training. After exercise training, rats in the treated group received daily applications of pulse current. All rats were sacrificed after one, three or five weeks of swimming exercise, and the major biochemical indexes were measured in serum and liver. The results demonstrate that pulse current could prolong the exhaustion swimming time, as well as decrease serum ALT, AST and LD levels and liver MDA content. It also elevated serum LDH activity, liver SOD activity and glycogen content. Furthermore, pulse current increased the expression of Bcl-2 and decreased the expression of Bax. Taken together, these results show that pulse current can elevate endurance capacity and facilitate recovery from fatigue.	[Chang, Qi; Ju, Xiaowei; Zhu, Lvgang; Huang, Changlin; Huang, Tao; Zuo, Xincheng] PLA, Hosp 150, Inst Mil Training Related Med Sci, Luoyang, Henan, Peoples R China; [Miao, Xinfang] PLA, Gen Logist Dept, Dept Internal Med, Beijing, Peoples R China; [Gao, Chunfang] PLA, Hosp 150, Inst Anus & Intestine, Luoyang, Henan, Peoples R China		Gao, CF (corresponding author), PLA, Hosp 150, Inst Anus & Intestine, Luoyang, Henan, Peoples R China.	chunfanggaohn@163.com			General program of the General Logistics Department of PLA [13BJZ10]; Scientific Research Plan of the Logistics Department of Jinan Military Region [JN11L035]	General program of the General Logistics Department of PLA; Scientific Research Plan of the Logistics Department of Jinan Military Region	This research was funded by the General program of the General Logistics Department of PLA (grant number: 13BJZ10) and the Scientific Research Plan of the Logistics Department of Jinan Military Region (grant number: JN11L035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ament W, 2009, SPORTS MED, V39, P389, DOI 10.2165/00007256-200939050-00005; Anderson FH, 2000, HEPATOL RES, V18, P63, DOI 10.1016/S1386-6346(99)00085-6; BROOKS GA, 1986, MED SCI SPORT EXER, V18, P360, DOI 10.1249/00005768-198606000-00019; Carvalho JF, 2005, COMP BIOCHEM PHYS A, V140, P409, DOI 10.1016/j.cbpb.2004.12.002; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Drachenberg CB, 1997, ARCH PATHOL LAB MED, V121, P54; Ellemberg D, 2010, PSYCHOL SPORT EXERC, V11, P122, DOI 10.1016/j.psychsport.2009.09.006; Feng ZH, 2011, FREE RADICAL BIO MED, V50, P1437, DOI 10.1016/j.freeradbiomed.2011.03.001; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Gondin J, 2011, J APPL PHYSIOL, V110, P433, DOI 10.1152/japplphysiol.00914.2010; Gore RK, 2010, AVIAT SPACE ENVIR MD, V81, P719, DOI 10.3357/ASEM.2755.2010; Hsu CC, 2005, WORLD J GASTROENTERO, V11, P5327, DOI 10.3748/wjg.v11.i34.5327; Iaia FM, 2010, SCAND J MED SCI SPOR, V20, P619, DOI 10.1111/j.1600-0838.2009.00942.x; Kesar T, 2008, J ELECTROMYOGR KINES, V18, P662, DOI 10.1016/j.jelekin.2007.01.001; Kim Hyunjung, 2003, Journal of Medicinal Food, V6, P345; Knochel C, 2012, PROG NEUROBIOL, V96, P46, DOI 10.1016/j.pneurobio.2011.11.007; Liu JK, 2000, J APPL PHYSIOL, V89, P21; Liu LP, 2002, CHINESE J SPOR MED, V2; Matsumoto K, 1996, J APPL PHYSIOL, V81, P1843, DOI 10.1152/jappl.1996.81.4.1843; Mestre-Alfaro A, 2011, EUR J APPL PHYSIOL, V111, P2281, DOI 10.1007/s00421-011-1862-y; Navas FJ, 1997, MED SCI SPORT EXER, V29, P882, DOI 10.1097/00005768-199707000-00007; Sun LJ, 2010, LIFE SCI, V86, P39, DOI 10.1016/j.lfs.2009.11.003; Tan W, 2012, INT J BIOL MACROMOL, V50, P59, DOI 10.1016/j.ijbiomac.2011.09.019; Thyfault JP, 2011, CURR OPIN CLIN NUTR, V14, P374, DOI 10.1097/MCO.0b013e3283468e69; Tomic S, 2012, ARCH MED SCI, V8, P886, DOI 10.5114/aoms.2012.31620; Yan B, 2010, AFR J TRADIT COMPLEM, V7, P291; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	27	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75093	10.1371/journal.pone.0075093	http://dx.doi.org/10.1371/journal.pone.0075093			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116026	gold, Green Published, Green Submitted			2022-12-25	WOS:000325552200010
J	Ueda, K; Ogasawara, S; Akiba, J; Nakayama, M; Todoroki, K; Ueda, K; Sanada, S; Suekane, S; Noguchi, M; Matsuoka, K; Yano, H				Ueda, Kosuke; Ogasawara, Sachiko; Akiba, Jun; Nakayama, Masamichi; Todoroki, Keita; Ueda, Keiko; Sanada, Sakiko; Suekane, Shigetaka; Noguchi, Masanori; Matsuoka, Kei; Yano, Hirohisa			Aldehyde Dehydrogenase 1 Identifies Cells with Cancer Stem Cell-Like Properties in a Human Renal Cell Carcinoma Cell Line	PLOS ONE			English	Article							SIDE POPULATION CELLS; MARKER; TUMORS; CD133; METASTASIS; EXPRESSION; THERAPY; EFFLUX	Cancer stem cells (CSC) or cancer stem cell-like cells (CSC-LCs) have been identified in many malignant tumors. CSCs are proposed to be related with drug resistance, tumor recurrence, and metastasis and are considered as a new target for cancer treatment; however, there are only a few reports on CSCs or CSC-LCs in renal cell carcinoma (RCC). Different approaches have been reported for CSC identification, but there are no universal markers for CSC. We used two different approaches, the traditional side population (SP) approach, and the enzymatic (aldehyde dehydrogenase 1 (ALDH1)) approach to identify CSC-LC population in two RCC cell lines, ACHN and KRC/Y. We found that ACHN and KRC/Y contain 1.4% and 1.7% SP cells, respectively. ACHN SP cells showed a higher sphere forming ability, drug resistance, and a slightly higher tumorigenic ability in NOD/SCID mice than Non-SP (NSP) cells, suggesting that cells with CSC-LC properties are included in ACHN SP cells. KRC/Y SP and NSP cells showed no difference in such properties. ALDH1 activity analysis revealed that ACHN SP cells expressed a higher level of activity than NSP cells (SP vs. NSP: 32.7% vs 14.6%). Analysis of ALDH1-positive ACHN cells revealed that they have a higher sphere forming ability, self-renewal ability, tumorigenicity and express higher mRNA levels of CSC-LC property-related genes (e. g., ABC transporter genes, self-replication genes, anti-apoptosis genes, and so forth) than ALDH1-negative cells. Drug treatment or exposure to hypoxic condition induced a 2- to 3-fold increase in number of ALDH1-positive cells. In conclusion, the results suggest that the ALDH1-positive cell population rather than SP cells show CSC-LC properties in a RCC cell line, ACHN.	[Ueda, Kosuke; Ogasawara, Sachiko; Akiba, Jun; Nakayama, Masamichi; Todoroki, Keita; Ueda, Keiko; Yano, Hirohisa] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 830, Japan; [Ueda, Kosuke; Sanada, Sakiko; Suekane, Shigetaka; Noguchi, Masanori; Matsuoka, Kei] Kurume Univ, Sch Med, Dept Urol, Kurume, Fukuoka 830, Japan; [Noguchi, Masanori] Kurume Univ, Sch Med, Res Ctr Innovat Canc Therapy, Kurume, Fukuoka 830, Japan	Kurume University; Kurume University; Kurume University	Akiba, J (corresponding author), Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 830, Japan.	akiba@med.kurume-u.ac.jp						Addla SK, 2008, AM J PHYSIOL-RENAL, V295, pF680, DOI 10.1152/ajprenal.90286.2008; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Borovski T, 2011, CANCER RES, V71, P634, DOI 10.1158/0008-5472.CAN-10-3220; Broadley KWR, 2011, STEM CELLS, V29, P452, DOI 10.1002/stem.582; Burkert J, 2008, J PATHOL, V214, P564, DOI 10.1002/path.2307; Bussolati B, 2008, FASEB J, V22, P3696, DOI 10.1096/fj.08-102590; Bussolati B, 2011, INT J NEPHROL, V2011, DOI 10.4061/2011/286985; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Conley SJ, 2012, P NATL ACAD SCI USA, V109, P2784, DOI 10.1073/pnas.1018866109; Costa LJ, 2007, ONCOLOGIST, V12, P1404, DOI 10.1634/theoncologist.12-12-1404; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Flanigan Robert C, 2003, Curr Treat Options Oncol, V4, P385, DOI 10.1007/s11864-003-0039-2; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Hisaka T, 2004, J HEPATOL, V41, P782, DOI 10.1016/j.jhep.2004.07.012; Huang CP, 2013, CANCER LETT, V328, P144, DOI 10.1016/j.canlet.2012.08.021; Hulspas R, 2000, CYTOMETRY, V40, P245, DOI 10.1002/1097-0320(20000701)40:3<245::AID-CYTO10>3.3.CO;2-X; Ibrahim SF, 2007, EXP CELL RES, V313, P1921, DOI 10.1016/j.yexcr.2007.02.025; Ikeda K, 1999, HEPATOLOGY, V29, P1124, DOI 10.1002/hep.510290439; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Kim K, 2012, HUM PATHOL, V43, P2109, DOI 10.1016/j.humpath.2012.05.006; Kim K, 2011, ONCOL LETT, V2, P1095, DOI 10.3892/ol.2011.368; Kim MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020636; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Kroeger N, 2012, EUR UROL, V61, P888, DOI 10.1016/j.eururo.2012.01.012; Lim YC, 2011, ORAL ONCOL, V47, P83, DOI 10.1016/j.oraloncology.2010.11.011; Loebinger MR, 2008, BRIT J CANCER, V98, P380, DOI 10.1038/sj.bjc.6604185; Luo YC, 2012, J INVEST DERMATOL, V132, P2440, DOI 10.1038/jid.2012.161; Ma I, 2011, STEM CELL REV REP, V7, P292, DOI 10.1007/s12015-010-9208-4; Ma S, 2008, MOL CANCER RES, V6, P1146, DOI 10.1158/1541-7786.MCR-08-0035; Marcato P, 2011, CELL CYCLE, V10, P1378, DOI 10.4161/cc.10.9.15486; Marcato P, 2011, STEM CELLS, V29, P32, DOI 10.1002/stem.563; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Nishizawa S, 2012, CANCER RES, V72, P2844, DOI 10.1158/0008-5472.CAN-11-3062; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Ooka H, 2012, ACTA OTO-LARYNGOL, V132, P693, DOI 10.3109/00016489.2012.657358; Ozbek Emin, 2012, Arch Ital Urol Androl, V84, P7; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Resetkova E, 2010, BREAST CANCER RES TR, V123, P97, DOI 10.1007/s10549-009-0619-3; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Smith PJ, 2012, CYTOM PART A, V83, P161; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; van den Hoogen C, 2010, CANCER RES, V70, P5163, DOI 10.1158/0008-5472.CAN-09-3806; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Yajima T, 2009, INT J ONCOL, V35, P273, DOI 10.3892/ijo_00000337; YANO H, 1988, IN VITRO CELL DEV B, V24, P9	52	51	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75463	10.1371/journal.pone.0075463	http://dx.doi.org/10.1371/journal.pone.0075463			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116047	Green Submitted, Green Published, gold			2022-12-25	WOS:000325552200023
J	Huang, CC; Tu, SH; Lien, HH; Jeng, JY; Huang, CS; Huang, CJ; Lai, LC; Chuang, EY				Huang, Chi-Cheng; Tu, Shih-Hsin; Lien, Heng-Hui; Jeng, Jaan-Yeh; Huang, Ching-Shui; Huang, Chi-Jung; Lai, Liang-Chuan; Chuang, Eric Y.			Concurrent Gene Signatures for Han Chinese Breast Cancers	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER ALTERATIONS; CIRCULAR BINARY SEGMENTATION; ARRAY-CGH; EXPRESSION PATTERNS; MOLECULAR PORTRAITS; WIDE ANALYSIS; SUBTYPES; GROWTH; TRANSCRIPTION	The interplay between copy number variation (CNV) and differential gene expression may be able to shed light on molecular process underlying breast cancer and lead to the discovery of cancer-related genes. In the current study, genes concurrently identified in array comparative genomic hybridization (CGH) and gene expression microarrays were used to derive gene signatures for Han Chinese breast cancers. We performed 23 array CGHs and 81 gene expression microarrays in breast cancer samples from Taiwanese women. Genes with coherent patterns of both CNV and differential gene expression were identified from the 21 samples assayed using both platforms. We used these genes to derive signatures associated with clinical ER and HER2 status and disease-free survival. Distributions of signature genes were strongly associated with chromosomal location: chromosome 16 for ER and 17 for HER2. A breast cancer risk predictive model was built based on the first supervised principal component from 16 genes (RCAN3, MCOLN2, DENND2D, RWDD3, ZMYM6, CAPZA1, GPR18, WARS2, TRIM45, SCRN1, CSNK1E, HBXIP, CSDE1, MRPL20, IKZF1, and COL20A1), and distinct survival patterns were observed between the high- and low-risk groups from the combined dataset of 408 microarrays. The risk score was significantly higher in breast cancer patients with recurrence, metastasis, or mortality than in relapse-free individuals (0.241 versus 0, P<0.001). The concurrent gene risk predictive model remained discriminative across distinct clinical ER and HER2 statuses in subgroup analysis. Prognostic comparisons with published gene expression signatures showed a better discerning ability of concurrent genes, many of which were rarely identifiable if expression data were pre-selected by phenotype correlations or variability of individual genes. We conclude that parallel analysis of CGH and microarray data, in conjunction with known gene expression patterns, can be used to identify biomarkers with prognostic values in breast cancer.	[Huang, Chi-Cheng; Chuang, Eric Y.] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Huang, Chi-Cheng; Jeng, Jaan-Yeh] Cathay Gen Hosp SiJhih, Taipei, Taiwan; [Huang, Chi-Cheng; Lien, Heng-Hui; Jeng, Jaan-Yeh; Huang, Chi-Jung] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Huang, Chi-Cheng; Tu, Shih-Hsin; Huang, Ching-Shui] Taipei Med Univ, Sch Med, Taipei, Taiwan; [Tu, Shih-Hsin; Lien, Heng-Hui; Huang, Ching-Shui] Cathay Gen Hosp, Dept Surg, Taipei, Taiwan; [Huang, Chi-Jung] Cathay Med Res Inst, New Taipei City, Taiwan; [Lai, Liang-Chuan] Natl Taiwan Univ, Grad Inst Physiol, Taipei 10764, Taiwan	National Taiwan University; Cathay General Hospital; Fu Jen Catholic University; Taipei Medical University; Cathay General Hospital; Cathay General Hospital; National Taiwan University	Chuang, EY (corresponding author), Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan.	chuangey@ntu.edu.tw	Lai, Liang-Chuan/B-4768-2009	Lai, Liang-Chuan/0000-0002-3913-5338; Tu, Shih-Hsin/0000-0002-4106-8146	Cathay Medical Research Institute [CGH-P-101057]; National Science Council [100-2314-B-281-005-MY2]	Cathay Medical Research Institute; National Science Council(Ministry of Science and Technology, Taiwan)	The work was supported in part by Cathay Medical Research Institute grant CGH-P-101057 and National Science Council grant 100-2314-B-281-005-MY2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2009, CLIN CANCER RES, V15, P441, DOI 10.1158/1078-0432.CCR-08-1791; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Ciucci A, 2006, MOL PHARMACOL, V70, P1812, DOI 10.1124/mol.106.025759; Cui WJ, 2012, FEBS LETT, V586, P766, DOI 10.1016/j.febslet.2012.01.039; Elston C W, 2002, Histopathology, V41, P154; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Fazeny-Dorner B, 2003, CANCER GENET CYTOGEN, V146, P161, DOI 10.1016/S0165-4608(03)00144-4; Han W, 2008, GENE CHROMOSOME CANC, V47, P490, DOI 10.1002/gcc.20550; Haverty PM, 2008, GENE CHROMOSOME CANC, V47, P530, DOI 10.1002/gcc.20558; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huang CC, IJDMB IN PRESS; Huang CC, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-S1-S10; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; Hyman E, 2002, CANCER RES, V62, P6240; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kamalakaran S, 2005, J BIOL CHEM, V280, P21491, DOI 10.1074/jbc.M409176200; Kao KJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-143; Karn T, 2010, BREAST CANCER RES TR, V120, P567, DOI 10.1007/s10549-009-0416-z; Kim SY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008979; Ling B, 2013, LUNG CANCER, V79, P104, DOI 10.1016/j.lungcan.2012.10.012; Liu SP, 2012, J BIOL CHEM, V287, P30228, DOI 10.1074/jbc.M112.343947; Lu XS, 2008, BREAST CANCER RES TR, V108, P191, DOI 10.1007/s10549-007-9596-6; Miyoshi N, 2010, J SURG ONCOL, V101, P156, DOI 10.1002/jso.21459; Nessling M, 2005, CANCER RES, V65, P439; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Oostlander AE, 2004, CLIN GENET, V66, P488, DOI 10.1111/j.1399-0004.2004.00322.x; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reis JS, 2005, PATHOL RES PRACT, V201, P713, DOI 10.1016/j.prp.2005.05.013; Shibata M, 2012, BIOCHEM BIOPH RES CO, V423, P104, DOI 10.1016/j.bbrc.2012.05.090; Simon R, 2007, CANCER INFORM, V3, P11; Singh S, 2007, MOL CANCER THER, V6, P1973, DOI 10.1158/1535-7163.MCT-07-0063; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Staaf J, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2568; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van Beers EH, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1510; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wang XS, 2008, CANCER EPIDEM BIOMAR, V17, P2101, DOI 10.1158/1055-9965.EPI-08-0134; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Willenbrock H, 2005, BIOINFORMATICS, V21, P4084, DOI 10.1093/bioinformatics/bti677; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; Zudaire I, 2002, HISTOPATHOLOGY, V40, P547, DOI 10.1046/j.1365-2559.2002.01413.x	55	47	49	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76421	10.1371/journal.pone.0076421	http://dx.doi.org/10.1371/journal.pone.0076421			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098497	Green Published, gold, Green Submitted			2022-12-25	WOS:000325483600049
J	Krais, JJ; De Crescenzo, O; Harrison, RG				Krais, John J.; De Crescenzo, Olivier; Harrison, Roger G.			Purine Nucleoside Phosphorylase Targeted by Annexin V to Breast Cancer Vasculature for Enzyme Prodrug Therapy	PLOS ONE			English	Article							FLUDARABINE PHOSPHATE; ANIONIC PHOSPHOLIPIDS; TUMOR-CELLS; IN-VIVO; GENE-THERAPY; GROWTH; PHOSPHATIDYLSERINE; MALIGNANCIES; SUPPRESSES; METABOLISM	Background and Purpose: The targeting of therapeutics is a promising approach for the development of new cancer treatments that seek to reduce the devastating side effects caused by the systemic administration of current drugs. This study evaluates a fusion protein developed as an enzyme prodrug therapy targeted to the tumor vasculature. Cytotoxicity would be localized to the site of the tumor using a protein fusion of purine nucleoside phosphorylase (PNP) and annexin V. Annexin V acts as the tumor-targeting component of the fusion protein as it has been shown to bind to phosphatidylserine expressed externally on cancer cells and the endothelial cells of the tumor vasculature, but not normal vascular endothelial cells. The enzymatic component of the fusion, PNP, converts the FDA-approved cancer therapeutic, fludarabine, into a more cytotoxic form. The purpose of this study is to determine if this system has a good potential as a targeted therapy for breast cancer. Methods: A fusion of E. coli purine nucleoside phosphorylase and human annexin V was produced in E. coli and purified. Using human breast cancer cell lines MCF-7 and MDA-MB-231 and non-confluent human endothelial cells grown in vitro, the binding strength of the fusion protein and the cytotoxicity of the enzyme prodrug system were determined. Endothelial cells that are not confluent expose phosphatidylserine and therefore mimic the tumor vasculature. Results: The purified recombinant fusion protein had good enzymatic activity and strong binding to the three cell lines. There was significant cell killing (p < 0.001) by the enzyme prodrug treatment for all three cell lines, with greater than 80% cytotoxicity obtained after 6 days of treatment. Conclusion: These results suggest that this treatment could be useful as a targeted therapy for breast cancer.	[Krais, John J.; De Crescenzo, Olivier; Harrison, Roger G.] Univ Oklahoma, Ctr Bioengn, Norman, OK 73019 USA; [Krais, John J.; De Crescenzo, Olivier; Harrison, Roger G.] Univ Oklahoma, Sch Chem Biol & Mat Engn, Norman, OK 73019 USA; [Harrison, Roger G.] Univ Oklahoma, Hlth Sci Ctr, Stephenson Canc Ctr, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma Health Sciences Center	Harrison, RG (corresponding author), Univ Oklahoma, Ctr Bioengn, Norman, OK 73019 USA.	rharrison@ou.edu		Krais, John/0000-0002-3916-3435	Oklahoma Center for the Advancement of Science and Technology Health Research Program [HR11-210]; School of Chemical, Biological and Materials Engineering at the University of Oklahoma	Oklahoma Center for the Advancement of Science and Technology Health Research Program; School of Chemical, Biological and Materials Engineering at the University of Oklahoma	This study was supported by a grant from the Oklahoma Center for the Advancement of Science and Technology Health Research Program (grant number HR11-210; www.ok.gov/ocast) and by funding from the School of Chemical, Biological and Materials Engineering at the University of Oklahoma (www.cbme.ou.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar S, 2009, MOL CANCER THER, V8, P185, DOI 10.1158/1535-7163.MCT-08-0652; Boogaerts MA, 2004, HEMATOL J, V5, pS31, DOI 10.1038/sj.thj.6200389; CASPER ES, 1985, CANCER CHEMOTH PHARM, V15, P233; Chan N, 2011, BLOOD BRAIN BARRIER, V686; DANHAUSER L, 1986, CANCER CHEMOTH PHARM, V18, P145; Ding XY, 2008, EXPERT REV OPHTHALMO, V3, P97, DOI 10.1586/17469899.3.1.97; HERSHFIELD MS, 1991, P NATL ACAD SCI USA, V88, P7185, DOI 10.1073/pnas.88.16.7185; Hong JS, 2004, CANCER RES, V64, P6610, DOI 10.1158/0008-5472.CAN-04-0012; Kikuchi E, 2007, CANCER GENE THER, V14, P279, DOI 10.1038/sj.cgt.7701013; Koellner G, 2002, J MOL BIOL, V315, P351, DOI 10.1006/jmbi.2001.5211; Kremmidiotis G, 2010, MOL CANCER THER, V9, P1562, DOI 10.1158/1535-7163.MCT-09-0815; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee J, 2001, PROTEIN EXPRES PURIF, V22, P180, DOI 10.1006/prep.2001.1437; LEVELT CN, 1994, CYTOMETRY, V15, P84, DOI 10.1002/cyto.990150114; Mao C, 1997, STRUCTURE, V5, P1373, DOI 10.1016/S0969-2126(97)00287-6; Martiniello-Wilks R, 2004, J GENE MED, V6, P1343, DOI 10.1002/jgm.629; Mikleusevic G, 2011, BIOCHIMIE, V93, P1610, DOI 10.1016/j.biochi.2011.05.030; MITTELMAN A, 1988, CANCER CHEMOTH PHARM, V22, P63; Modrak-Wojcik A, 2006, PROTEIN SCI, V15, P1794, DOI 10.1110/ps.062183206; Mohr L, 2000, HEPATOLOGY, V31, P606, DOI 10.1002/hep.510310310; MONTGOMERY JA, 1969, J MED CHEM, V12, P498, DOI 10.1021/jm00303a605; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Parker WB, 1998, BIOCHEM PHARMACOL, V55, P1673, DOI 10.1016/S0006-2952(98)00034-3; Parker WB, 1997, HUM GENE THER, V8, P1637, DOI 10.1089/hum.1997.8.14-1637; Pierige F, 2010, INT J ONCOL, V37, P133, DOI 10.3892/ijo_00000661; Ran S, 2005, CLIN CANCER RES, V11, P1551, DOI 10.1158/1078-0432.CCR-04-1645; Ran S, 2002, CANCER RES, V62, P6132; Riedl S, 2011, BBA-BIOMEMBRANES, V1808, P2638, DOI 10.1016/j.bbamem.2011.07.026; Sigma, 1994, ENZ ASS NUCL PHOSPH; SUGIMURA M, 1994, BLOOD COAGUL FIBRIN, V5, P365; UTSUGI T, 1991, CANCER RES, V51, P3062; Van Den Neste E, 2005, INT J ONCOL, V27, P1113; Van Rite BD, 2011, CANCER LETT, V307, P53, DOI 10.1016/j.canlet.2011.03.016; Van Rite BD, 2011, CANCER LETT, V301, P177, DOI 10.1016/j.canlet.2010.11.013; VONHOFF DD, 1990, SEMIN ONCOL, V17, P33; Xie X, 2011, J GENE MED; Zang XP, 2006, ANTICANCER RES, V26, P1745	37	14	16	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76403	10.1371/journal.pone.0076403	http://dx.doi.org/10.1371/journal.pone.0076403			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098491	gold, Green Published, Green Submitted			2022-12-25	WOS:000325483600043
J	Alves, CRR; Merege, CAA; Benatti, FB; Brucki, S; Pereira, RMR; Pinto, ALD; Lima, FR; Roschel, H; Gualano, B				Rodrigues Alves, Christiano Robles; Abujabra Merege Filho, Carlos Alberto; Benatti, Fabiana Braga; Brucki, Sonia; Pereira, Rosa Maria R.; de Sa Pinto, Ana Lucia; Lima, Fernanda Rodrigues; Roschel, Hamilton; Gualano, Bruno			Creatine Supplementation Associated or Not with Strength Training upon Emotional and Cognitive Measures in Older Women: A Randomized Double-Blind Study	PLOS ONE			English	Article							MINI-MENTAL-STATE; PHYSICAL-ACTIVITY; ORAL SUPPLEMENTATION; HUMAN BRAIN; EXERCISE; PERFORMANCE; MONOHYDRATE; DEPRESSION; STRESS; MOOD	Purpose: To assess the effects of creatine supplementation, associated or not with strength training, upon emotional and cognitive measures in older woman. Methods: This is a 24-week, parallel-group, double-blind, randomized, placebo-controlled trial. The individuals were randomly allocated into one of the following groups (n=14 each): 1) placebo, 2) creatine supplementation, 3) placebo associated with strength training or 4) creatine supplementation associated with strength training. According to their allocation, the participants were given creatine (4 x 5 g/d for 5 days followed by 5 g/d) or placebo (dextrose at the same dosage) and were strength trained or not. Cognitive function, assessed by a comprehensive battery of tests involving memory, selective attention, and inhibitory control, and emotional measures, assessed by the Geriatric Depression Scale, were evaluated at baseline, after 12 and 24 weeks of the intervention. Muscle strength and food intake were evaluated at baseline and after 24 weeks. Results: After the 24-week intervention, both training groups (ingesting creatine supplementation and placebo) had significant reductions on the Geriatric Depression Scale scores when compared with the non-trained placebo group (p = 0.001 and p = 0.01, respectively) and the non-trained creatine group (p < 0.001 for both comparison). However, no significant differences were observed between the non-trained placebo and creatine (p = 0.60) groups, or between the trained placebo and creatine groups (p = 0.83). Both trained groups, irrespective of creatine supplementation, had better muscle strength performance than the non-trained groups. Neither strength training nor creatine supplementation altered any parameter of cognitive performance. Food intake remained unchanged. Conclusion: Creatine supplementation did not promote any significant change in cognitive function and emotional parameters in apparently healthy older individuals. In addition, strength training per se improved emotional state and muscle strength, but not cognition, with no additive effects of creatine supplementation.	[Rodrigues Alves, Christiano Robles; Roschel, Hamilton; Gualano, Bruno] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil; [Abujabra Merege Filho, Carlos Alberto; Benatti, Fabiana Braga; Brucki, Sonia; Pereira, Rosa Maria R.; de Sa Pinto, Ana Lucia; Lima, Fernanda Rodrigues; Roschel, Hamilton; Gualano, Bruno] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Gualano, B (corresponding author), Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil.	gualano@usp.br	Gualano, Bruno/C-7190-2012; Brucki, Sonia MD/B-5736-2014; Pereira, Rosa M R/C-5192-2012; Benatti, Fabiana/H-7167-2016; Brucki, Sonia/L-4201-2019; Roschel, Hamilton/D-4353-2012; Alves, Christiano RR/C-5912-2013; Gualano, Bruno/ABA-9571-2020	Gualano, Bruno/0000-0001-7100-8681; Brucki, Sonia MD/0000-0002-8303-6732; Pereira, Rosa M R/0000-0002-3723-5028; Benatti, Fabiana/0000-0002-8320-7044; Brucki, Sonia/0000-0002-8303-6732; Roschel, Hamilton/0000-0002-9513-6132; Alves, Christiano RR/0000-0002-2646-9689; Gualano, Bruno/0000-0001-7100-8681	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors received support from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGREN H, 1988, J NEURAL TRANSM, V74, P55, DOI 10.1007/BF01243575; ALMEIDA OP, 2003, ARQ NEURO-PSIQUIAT, V57, P421; Amital D, 2006, J CLIN PSYCHIAT, V67, P836, DOI 10.4088/JCP.v67n0521c; Andres RH, 2008, BRAIN RES BULL, V76, P329, DOI 10.1016/j.brainresbull.2008.02.035; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; BENTON D, 2010, BJ NUTR, V105, P1; Brucki SMD, 2003, ARQ NEURO-PSIQUIAT, V61, P777, DOI 10.1590/S0004-282X2003000500014; Burroughs S., 2007, CURRENT ANAESTHESIA, V18, P4, DOI [10.1016/j.cacc.2007.01.007, DOI 10.1016/J.CACC.2007.01.007]; Cassilhas RC, 2007, MED SCI SPORT EXER, V39, P1401, DOI 10.1249/mss.0b013e318060111f; Cassilhas RC, 2010, PERCEPT MOTOR SKILL, V110, P265, DOI 10.2466/PMS.110.1.265-276; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; CRONHOLM B, 1956, Nord Med, V56, P1612; Czeh B, 2001, P NATL ACAD SCI USA, V98, P12796, DOI 10.1073/pnas.211427898; Dechent P, 1999, AM J PHYSIOL-REG I, V277, pR698, DOI 10.1152/ajpregu.1999.277.3.R698; Dechent P, 1999, BIOL PSYCHIAT, V46, P406, DOI 10.1016/S0006-3223(98)00346-1; Duman RS, 1999, BIOL PSYCHIAT, V46, P1181, DOI 10.1016/S0006-3223(99)00177-8; Etnier JL, 2006, BRAIN RES REV, V52, P119, DOI 10.1016/j.brainresrev.2006.01.002; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gabbay V, 2007, AM J PSYCHIAT, V164, P1881, DOI 10.1176/appi.ajp.2007.06122032; Heyn P, 2004, ARCH PHYS MED REHAB, V85, P1694, DOI 10.1016/j.apmr.2004.03.019; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Iosifescu DV, 2008, BIOL PSYCHIAT, V63, P1127, DOI 10.1016/j.biopsych.2007.11.020; Kaldis P, 1996, DEV NEUROSCI-BASEL, V18, P542, DOI 10.1159/000111452; Kalia M, 2005, METABOLISM, V54, P24, DOI 10.1016/j.metabol.2005.01.009; KATO T, 1994, J AFFECT DISORDERS, V31, P125, DOI 10.1016/0165-0327(94)90116-3; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Liu-Ambrose T, 2010, ARCH INTERN MED, V170, P170, DOI 10.1001/archinternmed.2009.494; Lyoo IK, 2003, PSYCHIAT RES-NEUROIM, V123, P87, DOI 10.1016/S0925-4927(03)00046-5; Manji HK, 2000, MOL PSYCHIATR, V5, P578, DOI 10.1038/sj.mp.4000811; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; McEwen BS, 2005, METABOLISM, V54, P20, DOI 10.1016/j.metabol.2005.01.008; McMorris T, 2007, PHYSIOL BEHAV, V90, P21, DOI 10.1016/j.physbeh.2006.08.024; McMorris T, 2007, AGING NEUROPSYCHOL C, V14, P517, DOI 10.1080/13825580600788100; Moore CM, 1997, AM J PSYCHIAT, V154, P116; Moretti A, 2003, MOL PSYCHIATR, V8, P773, DOI 10.1038/sj.mp.4001353; Nitrini R, 2004, J INT NEUROPSYCH SOC, V10, P634, DOI 10.1017/S1355617704104062; Parkin AJ, 1999, NEUROPSYCHOLOGY, V13, P539, DOI 10.1037/0894-4105.13.4.539; Perrig-Chiello P, 1998, AGE AGEING, V27, P469, DOI 10.1093/ageing/27.4.469; Rae C, 2003, P ROY SOC B-BIOL SCI, V270, P2147, DOI 10.1098/rspb.2003.2492; Rawson ES, 2011, AMINO ACIDS, V40, P1349, DOI 10.1007/s00726-011-0855-9; Roitman S, 2007, BIPOLAR DISORD, V9, P754, DOI 10.1111/j.1399-5618.2007.00532.x; Salomons GS, 2003, J INHERIT METAB DIS, V26, P309, DOI 10.1023/A:1024405821638; Sofi F, 2011, J INTERN MED, V269, P107, DOI 10.1111/j.1365-2796.2010.02281.x; SPIRDUSO WW, 1975, J GERONTOL, V30, P435, DOI 10.1093/geronj/30.4.435; Spreen O, 1998, COMPENDIUM NEUROPSYC; Stockler S, 1996, LANCET, V348, P789, DOI 10.1016/S0140-6736(96)04116-5; van Gool CH, 2007, AM J PUBLIC HEALTH, V97, P2121, DOI [10.2105/AJPH.2004.053199, 10.2105/AJPH.2004.053199e]; van Gool CH, 2003, AGE AGEING, V32, P81, DOI 10.1093/ageing/32.1.81; Watanabe A, 2002, NEUROSCI RES, V42, P279, DOI 10.1016/S0168-0102(02)00007-X; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107	51	36	38	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76301	10.1371/journal.pone.0076301	http://dx.doi.org/10.1371/journal.pone.0076301			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098469	Green Submitted, gold, Green Published			2022-12-25	WOS:000325483600037
J	Gong, XH; Wu, X; Ma, XJ; Wu, DD; Zhang, T; He, L; Qin, SY; Li, XT				Gong, Xiaohui; Wu, Xi; Ma, Xiaojing; Wu, Dandan; Zhang, Ting; He, Li; Qin, Shengying; Li, Xiaotian			Microdeletion and Microduplication Analysis of Chinese Conotruncal Defects Patients with Targeted Array Comparative Genomic Hybridization	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; CHROMOSOME 22Q11.2 DELETION; CLINICAL-FEATURES; GENE DELETIONS; CGH; SINGLE; ACGH; EXPERIENCE; DIAGNOSIS; SPECTRUM	Objective: The current study aimed to develop a reliable targeted array comparative genomic hybridization (aCGH) to detect microdeletions and microduplications in congenital conotruncal defects (CTDs), especially on 22q11.2 region, and for some other chromosomal aberrations, such as 5p15-5p, 7q11.23 and 4p16.3. Methods: Twenty-seven patients with CTDs, including 12 pulmonary atresia (PA), 10 double-outlet right ventricle (DORV), 3 transposition of great arteries (TGA), 1 tetralogy of Fallot (TOF) and one ventricular septal defect (VSD), were enrolled in this study and screened for pathogenic copy number variations (CNVs), using Agilent 8 x 15K targeted aCGH. Real-time quantitative polymerase chain reaction (qPCR) was performed to test the molecular results of targeted aCGH. Results: Four of 27 patients (14.8%) had 22q11.2 CNVs, 1 microdeletion and 3 microduplications. qPCR test confirmed the microdeletion and microduplication detected by the targeted aCGH. Conclusion: Chromosomal abnormalities were a well-known cause of multiple congenital anomalies (MCA). This aCGH using arrays with high-density coverage in the targeted regions can detect genomic imbalances including 22q11.2 and other 10 kinds CNVs effectively and quickly. This approach has the potential to be applied to detect aneuploidy and common microdeletion/microduplication syndromes on a single microarray.	[Gong, Xiaohui; Li, Xiaotian] Shanghai Fudan Univ, Obstet & Gynecol Hosp, Shanghai Key Lab Female Reprod Endocrine Related, Shanghai, Peoples R China; [Wu, Xi; He, Li; Qin, Shengying] Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China; [Ma, Xiaojing] Shanghai Fudan Univ, Pediat Hosp, Shanghai, Peoples R China; [Wu, Dandan] Shanghai Jiao Tong Univ, Peoples Hosp 9, Shanghai 200030, Peoples R China; [Zhang, Ting] Capital Inst Pediat, Beijing, Peoples R China	Fudan University; Shanghai Jiao Tong University; Fudan University; Shanghai Jiao Tong University; Capital Institute of Pediatrics (CIP)	Qin, SY (corresponding author), Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China.	chinsir@sjtu.edu.cn; xiaotianli555@163.com	Li, Xiaotian/ABI-3309-2020	Li, Xiaotian/0000-0002-2051-4581	Health industry special funds for Public Benefit Research Foundation from the Ministry of Health, People's Republic of China [201002013]; National Science Fund of China [81270712]; Program of Shanghai Subject Chief Scientist [12XD1401300]; Program of Shanghai Leading Talent; Shanghai Municipal Health Bureau [12GWZX0301]; National Key Basic Research Plan of China (973 Plan) [2010CB529500]; Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases; Key Specialty Project of the Ministry of Health, People's Republic of China; 863 Program [2012AA02A515]; 973 Program [2010CB529600]; National Key Technology RD Program [2012BAI01B09]; National Nature Science Foundation of China [81121001, 81273596, J1210047, 30900799, 30972823]; Shanghai Municipal Commission of Science and Technology Program [11DZ1950300, 09DJ1400601]; Public Health Key Disciplines in Shanghai-Health Microbiology [square12GWZX0801square]; Public Science and Technology Research Funds [201210056]; Shanghai Jiaotong University Interdisciplinary Research fund; Shanghai Leading Academic Discipline Project [B205]	Health industry special funds for Public Benefit Research Foundation from the Ministry of Health, People's Republic of China; National Science Fund of China(National Natural Science Foundation of China (NSFC)); Program of Shanghai Subject Chief Scientist; Program of Shanghai Leading Talent; Shanghai Municipal Health Bureau; National Key Basic Research Plan of China (973 Plan)(National Basic Research Program of China); Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases; Key Specialty Project of the Ministry of Health, People's Republic of China; 863 Program(National High Technology Research and Development Program of China); 973 Program(National Basic Research Program of China); National Key Technology RD Program(National Key Technology R&D Program); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission of Science and Technology Program; Public Health Key Disciplines in Shanghai-Health Microbiology; Public Science and Technology Research Funds; Shanghai Jiaotong University Interdisciplinary Research fund; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was partly supported by the grants from Health industry special funds for Public Benefit Research Foundation from the Ministry of Health, People's Republic of China (201002013), the National Science Fund of China (81270712), Program of Shanghai Subject Chief Scientist (12XD1401300), Program of Shanghai Leading Talent (2012), Shanghai Municipal Health Bureau (12GWZX0301), National Key Basic Research Plan of China (973 Plan) (2010CB529500), the Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, and the Key Specialty Project of the Ministry of Health, People's Republic of China, and 863 Program (2012AA02A515), the 973 Program (2010CB529600), the National Key Technology R&D Program (2012BAI01B09), the National Nature Science Foundation of China (81121001, 81273596, J1210047, 30900799, 30972823), the Shanghai Municipal Commission of Science and Technology Program (11DZ1950300, 09DJ1400601), the Public Health Key Disciplines in Shanghai-Health Microbiology square 12GWZX0801 square, Public Science and Technology Research Funds (201210056), the Shanghai Jiaotong University Interdisciplinary Research fund, and the Shanghai Leading Academic Discipline Project (B205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bales AM, 2010, GENET MED, V12, P135, DOI 10.1097/GIM.0b013e3181cdeb9a; Bittel DC, 2009, CYTOGENET GENOME RES, V124, P113, DOI 10.1159/000207515; Borozdin W, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9396; Brunet A, 2006, AM J MED GENET A, V140A, P2426, DOI 10.1002/ajmg.a.31499; Butler MG, 2008, AM J MED GENET A, V146A, P854, DOI 10.1002/ajmg.a.32249; Chew C, 2007, ULTRASOUND OBST GYN, V29, P619, DOI 10.1002/uog.4023; Derbent M, 2003, AM J MED GENET A, V116A, P129, DOI 10.1002/ajmg.a.10832; Dhami P, 2005, AM J HUM GENET, V76, P750, DOI 10.1086/429588; Ensenauer RE, 2003, AM J HUM GENET, V73, P1027, DOI 10.1086/378818; Gagnon A, 2009, J OBSTET GYNAECOL CA, V31, P875, DOI 10.1016/S1701-2163(16)34307-9; Halder A, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-101; Harris Susan E, 2011, J Registry Manag, V38, P24; Harvard C, 2005, CLIN GENET, V67, P341, DOI 10.1111/j.1399-0004.2005.00406.x; Helen Dolk ML, 2010, AM J MED GENET A, V158A, P509; Hu YL, 2009, CARDIOL YOUNG, V19, P179, DOI 10.1017/S1047951109003667; Lu XY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000327; Marino B, 1999, AM J CARDIOL, V84, P360, DOI 10.1016/S0002-9149(99)00297-0; Matsumoto A, 2012, PEDIATR INT, V54, P634, DOI 10.1111/j.1442-200X.2012.03639.x; Momma K, 2010, AM J CARDIOL, V105, P1617, DOI 10.1016/j.amjcard.2010.01.333; Oster ME, 2013, PEDIATRICS, V131, pE1502, DOI 10.1542/peds.2012-3435; Ryan AK, 1997, J MED GENET, V34, P798, DOI 10.1136/jmg.34.10.798; Scott TE, 2013, J ULTRAS MED, V32, P973, DOI 10.7863/ultra.32.6.973; Shen YP, 2007, CLIN CHEM, V53, P2051, DOI 10.1373/clinchem.2007.090290; Staaf J, 2008, HUM MUTAT, V29, P555, DOI 10.1002/humu.20678; Syrmou A, 2013, PEDIATR RES, V73, P772, DOI 10.1038/pr.2013.41; Tanner K, 2005, PEDIATRICS, V116, pE833, DOI 10.1542/peds.2005-0397; Tayeh MK, 2009, GENET MED, V11, P232, DOI 10.1097/GIM.0b013e318195e191; Vasson A, 2013, EUR J HUM GENET; Vissers LELM, 2005, HUM MOL GENET, V14, pR215, DOI 10.1093/hmg/ddi268; Wang J, 2012, MOL GENET METAB, V106, P221, DOI 10.1016/j.ymgme.2012.03.005; Wong LJC, 2008, CLIN CHEM, V54, P1141, DOI 10.1373/clinchem.2008.103721; Wu DD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054404; Xu YJ, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-169	33	6	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76314	10.1371/journal.pone.0076314	http://dx.doi.org/10.1371/journal.pone.0076314			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098474	Green Submitted, gold, Green Published			2022-12-25	WOS:000325434500061
J	Kang, K; Zhong, JS; Jiang, L; Liu, G; Gou, CY; Wu, Q; Wang, Y; Luo, J; Gou, DM				Kang, Kang; Zhong, Jiasheng; Jiang, Liang; Liu, Gang; Gou, Christine Yuan; Wu, Qiong; Wang, You; Luo, Jun; Gou, Deming			Identification of microRNA-Like RNAs in the Filamentous Fungus Trichoderma reesei by Solexa Sequencing	PLOS ONE			English	Article							GENE; EXPRESSION; CRE1	microRNAs (miRNAs) are non-coding small RNAs (sRNAs) capable of negatively regulating gene expression. Recently, microRNA-like small RNAs (milRNAs) were discovered in several filamentous fungi but not yet in Trichoderma reesei, an industrial filamentous fungus that can secrete abundant hydrolases. To explore the presence of milRNA in T. reesei and evaluate their expression under induction of cellulose, two T. reesei sRNA libraries of cellulose induction (IN) and non-induction (CON) were generated and sequenced using Solexa sequencing technology. A total of 726 and 631 sRNAs were obtained from the IN and CON samples, respectively. Global expression analysis showed an extensively differential expression of sRNAs in T. reesei under the two conditions. Thirteen predicted milRNAs were identified in T. reesei based on the short hairpin structure analysis. The milRNA profiles obtained in deep sequencing were further validated by RT-qPCR assay. Computational analysis predicted a number of potential targets relating to many processes including regulation of enzyme expression. The presence and differential expression of T. reesei milRNAs imply that milRNA might play a role in T. reesei growth and cellulase induction. This work lays foundation for further functional study of fungal milRNAs and their industrial application.	[Kang, Kang; Jiang, Liang; Liu, Gang; Wang, You; Gou, Deming] Shenzhen Univ, Coll Life Sci, Shenzhen Key Lab Microbial Genet Engn, Shenzhen, Peoples R China; [Zhong, Jiasheng; Wu, Qiong] Shenzhen Univ, Dept Marine Biol, Shenzhen Key Lab Marine Biotechnol & Ecol, Shenzhen, Peoples R China; [Kang, Kang; Luo, Jun] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Gou, Christine Yuan] Northwestern Univ, Evanston, IL USA	Shenzhen University; Shenzhen University; Northwest A&F University - China; Northwestern University	Luo, J (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.	luojun1@yahoo.com; dmgou@hotmail.com		zhong, jiasheng/0000-0001-6864-2294	National Basic Research Program of China (973 Program) [2012CB124701]; National Natural Science Foundation of China [81170047, 81370151]; Shenzhen overseas high-level talents innovation program [YFZZ20111009]; Shenzhen Municipal Basic Research Program [JC201006010725A, JCYJ20130329120507746]; Postdoctoral Science Foundation of China [2013M542203]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen overseas high-level talents innovation program; Shenzhen Municipal Basic Research Program; Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation)	This study was supported in part by National Basic Research Program of China (973 Program, 2012CB124701); National Natural Science Foundation of China No. 81170047, 81370151 (to D. G.); Shenzhen overseas high-level talents innovation program No. YFZZ20111009 (to D. G.); Shenzhen Municipal Basic Research Program No. JC201006010725A (to D. G.); Shenzhen Municipal Basic Research Program No. JCYJ20130329120507746 (to K. K.); and Postdoctoral Science Foundation of China No. 2013M542203 (to K. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader AG, 2010, CANCER RES, V70, P7027, DOI 10.1158/0008-5472.CAN-10-2010; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brody HM, 2009, IND BIOTECHNOL, V5, P53, DOI [10.1089/ind.2009.5.53, DOI 10.1089/IND.2009.5.53]; Cziferszky A, 2002, J BIOL CHEM, V277, P14688, DOI 10.1074/jbc.M200744200; Dang YK, 2011, EUKARYOT CELL, V10, P1148, DOI 10.1128/EC.05109-11; Fu YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022957; Fulci V, 2007, CURR OPIN MICROBIOL, V10, P199, DOI 10.1016/j.mib.2007.03.016; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; Hancock MH, 2012, VIROLOGY, V425, P133, DOI 10.1016/j.virol.2012.01.009; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Ilmen M, 1996, MOL GEN GENET, V251, P451, DOI 10.1007/s004380050189; Kang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048536; Kubicek CP, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-19; Lee HC, 2010, MOL CELL, V38, P803, DOI 10.1016/j.molcel.2010.04.005; Lee HJ, 2012, FEMS MICROBIOL LETT, V326, P131, DOI 10.1111/j.1574-6968.2011.02441.x; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li L, 2007, ANNU REV MICROBIOL, V61, P423, DOI 10.1146/annurev.micro.61.080706.093432; Lin WC, 2009, GENOMICS, V93, P487, DOI 10.1016/j.ygeno.2009.01.004; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Molnar A, 2007, NATURE, V447, P1126, DOI 10.1038/nature05903; Portnoy T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-269; Qin LN, 2012, BIORESOURCE TECHNOL, V109, P116, DOI 10.1016/j.biortech.2012.01.013; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang YQ, 2009, COMPUT BIOL CHEM, V33, P391, DOI 10.1016/j.compbiolchem.2009.07.013; Zhao T, 2007, GENE DEV, V21, P1190, DOI 10.1101/gad.1543507; Zhou JH, 2012, MOL GENET GENOMICS, V287, P275, DOI 10.1007/s00438-012-0678-8; Zhou Q, 2012, FUNGAL BIOL-UK, V116, P1156, DOI 10.1016/j.funbio.2012.09.001; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	29	46	49	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76288	10.1371/journal.pone.0076288	http://dx.doi.org/10.1371/journal.pone.0076288			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098464	Green Submitted, Green Published, gold			2022-12-25	WOS:000325434500059
J	Li, Y; Li, J; Li, Y; Wang, XX; Cao, AC				Li, Yan; Li, Jun; Li, Yuan; Wang, Xia-xia; Cao, Ao-cheng			Antimicrobial Constituents of the Leaves of Mikania micrantha H. B. K.	PLOS ONE			English	Article							OCCURRING TERPENE DERIVATIVES; SESQUITERPENE LACTONES; PHENOLIC CONSTITUENTS; SCANDENOLIDE	Background: To isolate plant-derived compounds with antimicrobial activity from the leaves of Mikania micrantha, to determine the compounds configuration, and to evaluate their antimicrobial activity against eight plant pathogenic fungi (Exserohilum turcicum, Colletotrichum lagenarium, Pseudoperonispora cubensis, Botrytis cirerea, Rhizoctonia solani, Phytophthora parasitica, Fusarium solani, and Pythium aphanidermatum,) and four plant pathogenic bacteria (gram negative bacteria: Ralstonia dolaanacearum, Xanthomonas oryzae pv. Oryzae, Xanthomonas Campestris pv. Vesicatoria, and Xanthomonas campestris pv. Citri), and four bacteria (gram positive bacteria: Staphyloccocus aureus, Bacillus subtilis, Micrococcus luteus, and Bacillus cereus). Methods and Results: Antimicrobial constituents of the leaves of M. micrantha were isolated using bioactivity-guided fractionation. The antifungal activity of the isolated compounds was evaluated by the inhibit hypha growth method and inhibit spore germination method. Characterization of antibacterial activity was carried out using the minimum inhibitory concentrations (MICs) and the minimum bactericidal concentrations (MBCs). MIC and MBC were determined by the broth microdilution method. Six compounds - deoxymikanolide, scandenolide, dihydroscandenolide, mikanolide, dihydromikanolide, and m - methoxy benzoic acid - have been isolated from leaves of Mikania micrantha H. B. K. Deoxymikanolide, scandenolide, and dihydroscandenolide were new compounds. The result of bioassay showed that all of isolated compounds were effective against tested strains and deoxymikanolide showed the strongest activity. Conclusions and Significance: The leaves of M. micrantha may be a promising source in the search for new antimicrobial drugs due to its efficacy and the broadest range. Meanwhile, adverse impact of M. micrantha will be eliminated.	[Li, Yan; Li, Jun; Li, Yuan; Cao, Ao-cheng] Chinese Acad Agr Sci, Inst Plant Protect, Beijing 100193, Peoples R China; [Li, Jun] South China Agr Univ, Coll Resources & Environm, Guangzhou, Guangdong, Peoples R China; [Wang, Xia-xia] Anhui Acad Agr Sci, Inst Anim Sci, Hefei, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; South China Agricultural University; Anhui Academy of Agricultural Sciences	Cao, AC (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, Beijing 100193, Peoples R China.	caoac@vip.sina.com			Study of Invasive Plants Comprehensive Prevention [201103027]; Research of Chemistry Prevention and Control Technology [1610142012012]	Study of Invasive Plants Comprehensive Prevention; Research of Chemistry Prevention and Control Technology	Thanks are due to the Study of Invasive Plants Comprehensive Prevention (201103027) and the Research of Chemistry Prevention and Control Technology about Mikania micrantha (1610142012012) for its financial support to the present research. The funders had no role in study design, data collection and analysis, decision to publishi, or preparation of the manuscript.	Ahmed M, 2001, FITOTERAPIA, V72, P919, DOI 10.1016/S0367-326X(01)00318-5; [Anonymous], 1997, M7A4 NCCLS; Ayensu E. S., 1981, MED PLANTS W INDIES; Bakir M, 2004, ACTA CRYSTALLOGR C, V60, pO798, DOI 10.1107/S0108270104017809; BOEKER R, 1987, PLANTA MED, P105, DOI 10.1055/s-2006-962638; BOHLMANN F, 1984, PHYTOCHEMISTRY, V23, P1099, DOI 10.1016/S0031-9422(00)82617-5; BOHLMANN F, 1982, PHYTOCHEMISTRY, V21, P1349, DOI 10.1016/0031-9422(82)80140-4; BOHLMANN F, 1982, PHYTOCHEMISTRY, V21, P173, DOI 10.1016/0031-9422(82)80037-X; CUENCA MD, 1988, J NAT PROD, V51, P625, DOI 10.1021/np50057a040; Dolomanov OV, 2009, J APPL CRYSTALLOGR, V42, P339, DOI 10.1107/S0021889808042726; Facey PC, 1999, J PHARM PHARMACOL, V51, P1455, DOI 10.1211/0022357991777119; Feng Hui-ling, 2002, Journal of Tropical and Subtropical Botany, V10, P263; Francis JS, 2005, CLIN INFECT DIS, V40, P100, DOI 10.1086/427148; GUTIERREZ AB, 1985, PHYTOCHEMISTRY, V24, P2967, DOI 10.1016/0031-9422(85)80037-6; HERZ W, 1970, J ORG CHEM, V35, P1453, DOI 10.1021/jo00830a043; HERZ W, 1975, PHYTOCHEMISTRY, V14, P233, DOI 10.1016/0031-9422(75)85045-X; HERZ W, 1981, PHYTOCHEMISTRY, V20, P1740, DOI 10.1016/S0031-9422(00)98568-6; Huang HJ, 2008, BIOCHEM SYST ECOL, V36, P867, DOI 10.1016/j.bse.2008.09.004; Jiang RW, 2001, CHEM PHARM BULL, V49, P1166, DOI 10.1248/cpb.49.1166; Kruszewska D, 2004, J ANTIMICROB CHEMOTH, V54, P648, DOI 10.1093/jac/dkh387; Li Yan, 2013, African Journal of Microbiology Research, V7, P2409; Lowe S, 2001, 100 WORLDS WORST INV; MATHUR SB, 1973, PHYTOCHEMISTRY, V12, P226, DOI 10.1016/S0031-9422(00)84663-4; National committee for clinical laboratory standards, 1999, M26A NCCLS; NICOLLIER G, 1981, PHYTOCHEMISTRY, V20, P2587, DOI 10.1016/0031-9422(81)83102-0; Palatinus L, 2007, J APPL CRYSTALLOGR, V40, P786, DOI 10.1107/S0021889807029238; PICMAN AK, 1986, BIOCHEM SYST ECOL, V14, P255, DOI 10.1016/0305-1978(86)90101-8; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Valdes DA, 1998, BIOCHEM SYST ECOL, V26, P685, DOI 10.1016/S0305-1978(98)00026-X; Wang RL, 2009, ALLELOPATHY J, V24, P35; Wei XY, 2004, BIOCHEM SYST ECOL, V32, P1091, DOI 10.1016/j.bse.2004.04.013; YSRAEL MC, 1990, PLANTA MED, V56, P268, DOI 10.1055/s-2006-960953; Zhuang ShiHong, 2010, Journal of Zhejiang University (Agriculture and Life Sciences), V36, P293	33	13	14	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76725	10.1371/journal.pone.0076725	http://dx.doi.org/10.1371/journal.pone.0076725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098556	gold, Green Published, Green Submitted			2022-12-25	WOS:000325434500084
J	Walton, E; Geisler, D; Hass, J; Liu, JY; Turner, J; Yendiki, A; Smolka, MN; Ho, BC; Manoach, DS; Gollub, RL; Roessner, V; Calhoun, VD; Ehrlich, S				Walton, Esther; Geisler, Daniel; Hass, Johanna; Liu, Jingyu; Turner, Jessica; Yendiki, Anastasia; Smolka, Michael N.; Ho, Beng-Choon; Manoach, Dara S.; Gollub, Randy L.; Roessner, Veit; Calhoun, Vince D.; Ehrlich, Stefan			The Impact of Genome-Wide Supported Schizophrenia Risk Variants in the Neurogranin Gene on Brain Structure and Function	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; LONG-TERM POTENTIATION; WORKING-MEMORY; ENCODING NEUROGRANIN; FLIP-FLOP; DYSFUNCTION; METAANALYSIS; RELIABILITY; ASSOCIATION; PERFORMANCE	The neural mechanisms underlying genetic risk for schizophrenia, a highly heritable psychiatric condition, are still under investigation. New schizophrenia risk genes discovered through genome-wide association studies (GWAS), such as neurogranin (NRGN), can be used to identify these mechanisms. In this study we examined the association of two common NRGN risk single nucleotide polymorphisms (SNPs) with functional and structural brain-based intermediate phenotypes for schizophrenia. We obtained structural, functional MRI and genotype data of 92 schizophrenia patients and 114 healthy volunteers from the multisite Mind Clinical Imaging Consortium study. Two schizophrenia-associated NRGN SNPs (rs12807809 and rs12541) were tested for association with working memory-elicited dorsolateral prefrontal cortex (DLPFC) activity and surface-wide cortical thickness. NRGN rs12541 risk allele homozygotes (TT) displayed increased working memory-related activity in several brain regions, including the left DLPFC, left insula, left somatosensory cortex and the cingulate cortex, when compared to non-risk allele carriers. NRGN rs12807809 non-risk allele (C) carriers showed reduced cortical gray matter thickness compared to risk allele homozygotes (TT) in an area comprising the right pericalcarine gyrus, the right cuneus, and the right lingual gyrus. Our study highlights the effects of schizophrenia risk variants in the NRGN gene on functional and structural brain-based intermediate phenotypes for schizophrenia. These results support recent GWAS findings and further implicate NRGN in the pathophysiology of schizophrenia by suggesting that genetic NRGN risk variants contribute to subtle changes in neural functioning and anatomy that can be quantified with neuroimaging methods.	[Walton, Esther; Geisler, Daniel; Hass, Johanna; Roessner, Veit; Ehrlich, Stefan] Tech Univ Dresden, Dept Child & Adolescent Psychiat, Univ Hosp Carl Gustav Carus, Dresden, Germany; [Liu, Jingyu; Turner, Jessica; Calhoun, Vince D.] MIND Res Network, Albuquerque, NM USA; [Liu, Jingyu; Calhoun, Vince D.] Univ New Mexico, Dept Elect & Comp Engn, Albuquerque, NM 87131 USA; [Yendiki, Anastasia; Manoach, Dara S.; Gollub, Randy L.; Ehrlich, Stefan] Massachusetts Gen Hosp, MGH MIT HMS Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Smolka, Michael N.] Tech Univ Dresden, Dept Psychiat & Psychotherapy, Dresden, Germany; [Smolka, Michael N.] Tech Univ Dresden, Neuroimaging Ctr, Dept Psychol, Dresden, Germany; [Ho, Beng-Choon] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; [Manoach, Dara S.; Gollub, Randy L.; Ehrlich, Stefan] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Lovelace Respiratory Research Institute; University of New Mexico; Harvard University; Massachusetts General Hospital; Technische Universitat Dresden; Technische Universitat Dresden; University of Iowa; Harvard University; Massachusetts General Hospital	Ehrlich, S (corresponding author), Tech Univ Dresden, Dept Child & Adolescent Psychiat, Univ Hosp Carl Gustav Carus, Dresden, Germany.	transden.lab@uniklinikum-dresden.de	Turner, Jessica A/N-2228-2017; Walton, Esther/GSN-8429-2022; Calhoun, Vince D./ACN-9399-2022; Turner, Jessica A/H-7282-2015; Roessner, Veit/AAQ-8760-2020; Walton, Esther/P-9832-2019; Smolka, Michael/B-4865-2011; Ehrlich, Stefan/ABB-4650-2020; Ho, Beng-Choon/D-6959-2011	Turner, Jessica A/0000-0003-0076-8434; Calhoun, Vince D./0000-0001-9058-0747; Turner, Jessica A/0000-0003-0076-8434; Walton, Esther/0000-0002-0935-2200; Smolka, Michael/0000-0001-5398-5569; Ehrlich, Stefan/0000-0003-2132-4445; Ho, Beng-Choon/0000-0003-3976-1555; Roessner, Veit/0000-0002-1873-7081; Geisler, Daniel/0000-0003-2076-5329; Liu, Jingyu/0000-0002-1724-7523; Yendiki, Anastasia/0000-0003-1386-3828; Gollub, Randy L./0000-0002-9434-4044	National Institutes of Health (NIH/NCRR) [P41RR14075]; Department of Energy [DE-FG02-99ER62764]; Mind Research Network, Morphometry BIRN [1U24, RR021382A]; Function BIRN [U24RR021992]; NIH.NCRR [MO1 RR025758-01]; NIMH [1RC1MH089257, 2 R01MH067720]; NIH/NIBIB [K99/R00]; Deutsche Forschungsgemeinschaft; NARSAD Young Investigator Grant; Friedrich-Ebert Stiftung;  [EB008129]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075, UL1RR025758, U24RR021992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K99EB008129, R00EB008129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH089257, R01MH067720] Funding Source: NIH RePORTER	National Institutes of Health (NIH/NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Department of Energy(United States Department of Energy (DOE)); Mind Research Network, Morphometry BIRN; Function BIRN; NIH.NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH/NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NARSAD Young Investigator Grant(NARSAD); Friedrich-Ebert Stiftung; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health (NIH/NCRR P41RR14075), Department of Energy (DE-FG02-99ER62764), Mind Research Network, Morphometry BIRN (1U24, RR021382A), Function BIRN (U24RR021992-01, NIH.NCRR MO1 RR025758-01, NIMH 1RC1MH089257 to VDC), 2 R01MH067720 (DSM), NIH/NIBIB K99/R00 Pathway to Independence award EB008129 (AY), the Deutsche Forschungsgemeinschaft (research fellowship to SE), the NARSAD Young Investigator Grant (to SE) and the Friedrich-Ebert Stiftung (stipend to EW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 2010, NAT PROTOC, V5, P1564, DOI 10.1038/nprot.2010.116; Bergen SE, 2012, MOL PSYCHIATR, V17, P880, DOI 10.1038/mp.2012.73; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blokland GAM, 2012, TWIN RES HUM GENET, V15, P351, DOI 10.1017/thg.2012.11; Broadbelt K, 2006, SCHIZOPHR RES, V87, P6, DOI 10.1016/j.schres.2006.04.028; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Callicott JH, 2003, AM J PSYCHIAT, V160, P2209, DOI 10.1176/appi.ajp.160.12.2209; Carter CS, 1997, AM J PSYCHIAT, V154, P1670, DOI 10.1176/ajp.154.12.1670; Clarke GM, 2010, GENET EPIDEMIOL, V34, P266, DOI 10.1002/gepi.20458; Ehrlich S, 2012, SCHIZOPHRENIA BULL, V38, P1050, DOI 10.1093/schbul/sbr018; Ehrlich S, 2010, NEUROIMAGE, V53, P992, DOI 10.1016/j.neuroimage.2009.12.046; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; First MB, 2002, STRUCTURED CLIN INTE; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fusar-Poli P, 2010, ARCH GEN PSYCHIAT, V67, P683, DOI 10.1001/archgenpsychiatry.2010.77; Glahn DC, 2005, HUM BRAIN MAPP, V25, P60, DOI 10.1002/hbm.20138; Goldman AL, 2009, ARCH GEN PSYCHIAT, V66, P467, DOI 10.1001/archgenpsychiatry.2009.24; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Gur RE, 2007, AM J PSYCHIAT, V164, P442, DOI 10.1176/appi.ajp.164.3.442; Hall MH, 2010, HARVARD REV PSYCHIAT, V18, P67, DOI 10.3109/10673220903523532; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Haznedar MM, 2004, SCHIZOPHR RES, V71, P249, DOI 10.1016/j.schres.2004.02.025; Higo N, 2006, BRAIN RES, V1078, P35, DOI 10.1016/j.brainres.2006.01.062; Higo N, 2004, CEREB CORTEX, V14, P1134, DOI 10.1093/cercor/bhh073; Huang KP, 2004, J NEUROSCI, V24, P10660, DOI 10.1523/JNEUROSCI.2213-04.2004; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Jovicich J, 2009, NEUROIMAGE, V46, P177, DOI 10.1016/j.neuroimage.2009.02.010; Karlsgodt KH, 2007, SCHIZOPHR RES, V89, P191, DOI 10.1016/j.schres.2006.08.016; Koch K, 2008, NEUROSCIENCE, V153, P54, DOI 10.1016/j.neuroscience.2008.01.063; Kremen WS, 2010, NEUROIMAGE, V49, P1213, DOI 10.1016/j.neuroimage.2009.09.043; Krug A, 2013, SCHIZOPHRENIA BULL, V39, P141, DOI 10.1093/schbul/sbr076; Li T, 2010, BIOL PSYCHIAT, V68, P671, DOI 10.1016/j.biopsych.2010.06.014; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Lisman JE, 1998, NAT NEUROSCI, V1, P273, DOI 10.1038/1086; MacDonald AW, 2009, SCHIZOPHRENIA BULL, V35, P493, DOI 10.1093/schbul/sbp017; Manoach DS, 1999, BIOL PSYCHIAT, V45, P1128, DOI 10.1016/S0006-3223(98)00318-7; Manoach DS, 2000, BIOL PSYCHIAT, V48, P99, DOI 10.1016/S0006-3223(00)00227-4; Manoach DS, 2003, SCHIZOPHR RES, V60, P285, DOI 10.1016/S0920-9964(02)00294-3; Manoach DS, 2001, AM J PSYCHIAT, V158, P955, DOI 10.1176/appi.ajp.158.6.955; Minzenberg MJ, 2009, ARCH GEN PSYCHIAT, V66, P811, DOI 10.1001/archgenpsychiatry.2009.91; Miyakawa T, 2001, HIPPOCAMPUS, V11, P763, DOI 10.1002/hipo.1092; Ohi K, 2012, AM J MED GENET B, V159B, P405, DOI 10.1002/ajmg.b.32043; Ohi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029780; Pantelis C, 2007, INT REV PSYCHIATR, V19, P373, DOI 10.1080/09540260701512079; Parent A, 1995, HUMAN NEUROANATOMY; Posner MI, 1998, ATTENTIVE BRAIN, P401; Potkin SG, 2009, SCHIZOPHRENIA BULL, V35, P19, DOI 10.1093/schbul/sbn162; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rapoport JL, 2005, MOL PSYCHIATR, V10, P434, DOI 10.1038/sj.mp.4001642; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Roffman JL, 2008, P NATL ACAD SCI USA, V105, P17573, DOI 10.1073/pnas.0803727105; Roiz-Santianez R, 2012, SCHIZOPHR RES, V141, P22, DOI 10.1016/j.schres.2012.07.014; Rose EJ, 2012, TWIN RES HUM GENET, V15, P296, DOI 10.1017/thg.2012.7; Ruano D, 2008, J PSYCHIATR RES, V42, P125, DOI 10.1016/j.jpsychires.2006.10.008; Schmitt JE, 2008, CEREB CORTEX, V18, P1737, DOI 10.1093/cercor/bhm211; Schultz CC, 2010, SCHIZOPHR RES, V123, P137, DOI 10.1016/j.schres.2010.08.033; Schultz CC, 2010, PSYCHIAT RES-NEUROIM, V182, P134, DOI 10.1016/j.pscychresns.2010.01.008; Shen YC, 2012, SCHIZOPHR RES, V137, P7, DOI 10.1016/j.schres.2012.01.011; Slemmon JR, 2000, MOL NEUROBIOL, V22, P99, DOI 10.1385/MN:22:1-3:099; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Ullsperger M, 2010, BRAIN STRUCT FUNCT, V214, P629, DOI 10.1007/s00429-010-0261-1; van Veelen NMJ, 2010, SCHIZOPHR RES, V123, P22, DOI 10.1016/j.schres.2010.07.004; Walton E, 2013, SCHIZOPHRENIA BULL, V39, P703, DOI 10.1093/schbul/sbr190; Wang XJ, 1999, J NEUROSCI, V19, P9587; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Zaykin DV, 2008, AM J HUM GENET, V82, P794, DOI 10.1016/j.ajhg.2008.02.001; Zecevic N, 1991, CEREB CORTEX, V1, P510, DOI 10.1093/cercor/1.6.510	70	20	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76815	10.1371/journal.pone.0076815	http://dx.doi.org/10.1371/journal.pone.0076815			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098564	Green Published, gold, Green Submitted			2022-12-25	WOS:000325434500086
J	Hoshino, T; Suzuki, K; Matsushima, T; Yamakawa, N; Suzuki, T; Mizushima, T				Hoshino, Tatsuya; Suzuki, Koichiro; Matsushima, Takahide; Yamakawa, Naoki; Suzuki, Toshiharu; Mizushima, Tohru			Suppression of Alzheimer's Disease-Related Phenotypes by Geranylgeranylacetone in Mice	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; AMYLOID-BETA CLEARANCE; KAPPA-B ACTIVATION; PHARMACOLOGICAL INDUCTION; PROSTAGLANDIN E-2; MOUSE MODELS; HEAT-SHOCK-PROTEIN-70; NEURODEGENERATION; IMPAIRMENT; EXPRESSION	Amyloid-beta peptide (A beta) plays an important role in the pathogenesis of Alzheimer's disease (AD). A beta is generated by the secretase-mediated proteolysis of beta-amyloid precursor protein (APP), and cleared by enzyme-mediated degradation and phagocytosis. Transforming growth factor (TGF)-beta 1 stimulates this phagocytosis. We recently reported that the APP23 mouse model for AD showed fewer AD-related phenotypes when these animals were crossed with transgenic mice expressing heat shock protein (HSP) 70. We here examined the effect of geranylgeranylacetone, an inducer of HSP70 expression, on the AD-related phenotypes. Repeated oral administration of geranylgeranylacetone to APP23 mice for 9 months not only improved cognitive function but also decreased levels of A beta, A beta plaque deposition and synaptic loss. The treatment also up-regulated the expression of an A beta-degrading enzyme and TGF-beta 1 but did not affect the maturation of APP and secretase activities. These outcomes were similar to those observed in APP23 mice genetically modified to overexpress HSP70. Although the repeated oral administration of geranylgeranylacetone did not increase the level of HSP70 in the brain, a single oral administration of geranylgeranylacetone significantly increased the level of HSP70 when A beta was concomitantly injected directly into the hippocampus. Since geranylgeranylacetone has already been approved for use as an anti-ulcer drug and its safety in humans has been confirmed, we propose that this drug be considered as a candidate drug for the prevention of AD.	[Hoshino, Tatsuya; Suzuki, Koichiro; Yamakawa, Naoki; Mizushima, Tohru] Keio Univ, Fac Pharm, Minato Ku, Tokyo, Japan; [Matsushima, Takahide; Suzuki, Toshiharu] Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido, Japan	Keio University; Hokkaido University	Mizushima, T (corresponding author), Keio Univ, Fac Pharm, Minato Ku, Tokyo, Japan.	mizushima-th@pha.keio.ac.jp	Suzuki, Toshiharu/B-5342-2013		Ministry of Health, Labour, and Welfare of Japan; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [23390017] Funding Source: KAKEN	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Health, Labour, and Welfare of Japan, as well as the Japan Science and Technology Agency, Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe E, 2010, BRAIN RES, V1330, P151, DOI 10.1016/j.brainres.2010.02.074; Adachi H, 2003, J NEUROSCI, V23, P2203; Asano T, 2009, J PHARMACOL EXP THER, V330, P458, DOI 10.1124/jpet.109.152181; Calderwood SK, 2007, FEBS LETT, V581, P3689, DOI 10.1016/j.febslet.2007.04.044; Chan JYH, 2004, CIRCULATION, V110, P3560, DOI 10.1161/01.CIR.0000143082.63063.33; Evans CG, 2006, J BIOL CHEM, V281, P33182, DOI 10.1074/jbc.M606192200; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hirakawa T, 1996, GASTROENTEROLOGY, V111, P345, DOI 10.1053/gast.1996.v111.pm8690199; Hoshino T, 2007, J BIOL CHEM, V282, P32676, DOI 10.1074/jbc.M703087200; Hoshino T, 2012, J NEUROCHEM, V120, P795, DOI 10.1111/j.1471-4159.2011.07567.x; Hoshino T, 2011, J NEUROSCI, V31, P5225, DOI 10.1523/JNEUROSCI.5478-10.2011; Hoshino T, 2010, J BIOL CHEM, V285, P13254, DOI 10.1074/jbc.M110.103051; Hoshino T, 2009, J BIOL CHEM, V284, P18493, DOI 10.1074/jbc.M109.003269; Ikeda M, 2011, LIVER INT, V31, P873, DOI 10.1111/j.1478-3231.2011.02499.x; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; Kakimura J, 2002, FASEB J, V16, P601, DOI 10.1096/fj.01-0530fje; Katsuno M, 2005, P NATL ACAD SCI USA, V102, P16801, DOI 10.1073/pnas.0506249102; Kim DH, 2010, PHARMACOL BIOCHEM BE, V97, P239, DOI 10.1016/j.pbb.2010.08.005; Kumar P, 2007, HUM MOL GENET, V16, P848, DOI 10.1093/hmg/ddm030; KUNISAKI C, 1992, DIGESTION, V53, P45, DOI 10.1159/000200970; Labbadia J, 2011, J CLIN INVEST, V121, P3306, DOI 10.1172/JCI57413; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Liberek K, 2008, EMBO J, V27, P328, DOI 10.1038/sj.emboj.7601970; Magrane J, 2004, J NEUROSCI, V24, P1700, DOI 10.1523/JNEUROSCI.4330-03.2004; Matsuda M, 2010, J BIOL CHEM, V285, P5848, DOI 10.1074/jbc.M109.063453; Miners JS, 2008, BRAIN PATHOL, V18, P240, DOI 10.1111/j.1750-3639.2008.00132.x; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; NISHIZAWA Y, 1983, PROG MED, V3, P1029; OKETANI K, 1983, JPN J PHARMACOL, V33, P593, DOI 10.1254/jjp.33.593; Piermartiri TCB, 2010, EXP NEUROL, V226, P274, DOI 10.1016/j.expneurol.2010.08.030; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; SENO K, 1995, J LAB CLIN MED, V126, P287; Sinn DI, 2007, BRAIN RES, V1135, P167, DOI 10.1016/j.brainres.2006.11.098; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Suemasu S, 2009, J BIOL CHEM, V284, P19705, DOI 10.1074/jbc.M109.006817; SUMIGAMA K, 1983, PROG MED, V3, P1053; Sun DX, 2005, J SURG RES, V129, P114, DOI 10.1016/j.jss.2005.05.028; Takeshita S, 2012, J GASTROENTEROL, V47, P195, DOI 10.1007/s00535-011-0481-z; Tanaka KI, 2007, MOL PHARMACOL, V71, P985, DOI 10.1124/mol.106.033282; Tanaka KI, 2010, BIOCHEM PHARMACOL, V80, P920, DOI 10.1016/j.bcp.2010.05.025; Tanaka KI, 2010, AM J PHYSIOL-LUNG C, V298, pL348, DOI 10.1152/ajplung.00289.2009; Tanito M, 2005, J NEUROSCI, V25, P2396, DOI 10.1523/JNEUROSCI.4866-04.2005; Tesseur I, 2006, J CLIN INVEST, V116, P3060, DOI 10.1172/JCI27341; Upadhaya AR, 2012, NEUROBIOL AGING, V33, P2641, DOI 10.1016/j.neurobiolaging.2011.12.032; Ushijima H, 2005, MOL PHARMACOL, V68, P1156, DOI 10.1124/mol.105.015784; Wyss-Coray T, 2001, NAT MED, V7, P612, DOI 10.1038/87945; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Yasuda H, 2005, BRAIN RES, V1032, P176, DOI 10.1016/j.brainres.2004.11.009	50	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76306	10.1371/journal.pone.0076306	http://dx.doi.org/10.1371/journal.pone.0076306			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098472	Green Published, gold			2022-12-25	WOS:000325427100057
J	Prasad, MK; Bhalla, K; Pan, ZH; O'Connell, JR; Weder, AB; Chakravarti, A; Tian, B; Chang, YPC				Prasad, Megana K.; Bhalla, Kavita; Pan, Zhen Hua; O'Connell, Jeffrey R.; Weder, Alan B.; Chakravarti, Aravinda; Tian, Bin; Chang, Yen-Pei C.			A Polymorphic 3 ' UTR Element in ATP1B1 Regulates Alternative Polyadenylation and Is Associated with Blood Pressure	PLOS ONE			English	Article							PRE-MESSENGER-RNA; INDUCED HYPERTENSION; DOWNSTREAM ELEMENTS; NA,K-ATPASE; GENES; GENETICS; LOCI; RAT; NA; DISEQUILIBRIUM	Although variants in many genes have previously been shown to be associated with blood pressure (BP) levels, the molecular mechanism underlying these associations are mostly unknown. We identified a multi-allelic T-rich sequence (TRS) in the 3'UTR of ATP1B1 that varies in length and sequence composition (T22-27 and T(12)GT (3)GT(6)). The 3'UTR of ATP1B1 contains 2 functional polyadenylation signals and the TRS is downstream of the proximal polyadenylation site (A2). Therefore, we hypothesized that alleles of this TRS might influence ATP1B1 expression by regulating alternative polyadenylation. In vitro, the T(12)GT (3)GT(6) allele increases polyadenylation at the A2 polyadenylation site as compared to the T-23 allele. Consistent with our hypothesis, the relative abundance of the A2-polyadenylated ATP1B1 mRNA was higher in human kidneys with at least one copy of the T(12)GT (3)GT(6) allele than in those lacking this allele. The T(12)GT (3)GT(6) allele is also associated with higher systolic BP (beta = 3.3 mmHg, p = 0.014) and diastolic BP (beta = 2.4 mmHg, p = 0.003) in a European-American population. Therefore, we have identified a novel multi-allelic TRS in the 3'UTR of ATP1B1 that is associated with higher BP and may mediate its effect by regulating the polyadenylation of the ATP1B1 mRNA.	[Prasad, Megana K.; O'Connell, Jeffrey R.; Chang, Yen-Pei C.] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Bhalla, Kavita] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Pan, Zhen Hua; Tian, Bin] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA; [Weder, Alan B.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Michigan System; University of Michigan; Johns Hopkins University	Chang, YPC (corresponding author), Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA.	cchang@medicine.umaryland.edu		Tian, Bin/0000-0001-8903-8256	National Heart, Lung and Blood Institute [R01HL088120]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084089] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by grant number R01HL088120 from the National Heart, Lung and Blood Institute awarded to YCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barwe SP, 2009, J MOL CELL CARDIOL, V47, P552, DOI 10.1016/j.yjmcc.2009.07.018; Beyer K, 1997, J BIOL CHEM, V272, P26769, DOI 10.1074/jbc.272.42.26769; Binder A, 2007, CURR OPIN CARDIOL, V22, P176, DOI 10.1097/HCO.0b013e3280d357f9; Chang YPC, 2007, AM J HUM GENET, V80, P253, DOI 10.1086/510918; Chen JM, 2006, HUM GENET, V120, P1, DOI 10.1007/s00439-006-0180-7; Clausen T, 1998, CLIN SCI, V95, P3, DOI 10.1042/CS19970254; Cui JSS, 2003, HYPERTENSION, V41, P207, DOI 10.1161/01.HYP.0000044938.94050.E3; Danckwardt S, 2004, BLOOD, V104, P428, DOI 10.1182/blood-2003-08-2894; Willige SU, 2007, J THROMB HAEMOST, V5, P1243, DOI 10.1111/j.1538-7836.2007.02566.x; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Dostanic I, 2005, AM J PHYSIOL-HEART C, V288, pH477, DOI 10.1152/ajpheart.00083.2004; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Faruque MU, 2011, J HYPERTENS, V29, P1906, DOI 10.1097/HJH.0b013e32834b000d; Ferrandi M, 1996, HYPERTENSION, V28, P1018, DOI 10.1161/01.HYP.28.6.1018; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; GUYTON AC, 1991, SCIENCE, V252, P1813, DOI 10.1126/science.2063193; Hunt SC, 2002, HYPERTENSION, V40, P1, DOI 10.1161/01.HYP.0000022660.28915.B1; JORGENSEN PL, 1986, KIDNEY INT, V29, P10, DOI 10.1038/ki.1986.3; Kava L, 2012, AM J HYPERTENS, V25, P487, DOI 10.1038/ajh.2011.247; KAWAKAMI K, 1986, NUCLEIC ACIDS RES, V14, P2833, DOI 10.1093/nar/14.7.2833; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kochunov P, 2010, STROKE, V41, P2137, DOI 10.1161/STROKEAHA.110.590943; LANE LK, 1989, GENOMICS, V5, P445, DOI 10.1016/0888-7543(89)90008-6; Lanzani C, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001814; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; MCDONOUGH AA, 1990, FASEB J, V4, P1598, DOI 10.1096/fasebj.4.6.2156741; MCDONOUGH AA, 1988, AM J PHYSIOL, V254, pC323, DOI 10.1152/ajpcell.1988.254.2.C323; MELZI ML, 1991, PEDIATR NEPHROL, V5, P700, DOI 10.1007/BF00857877; Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176; Pan ZH, 2006, GENE, V366, P325, DOI 10.1016/j.gene.2005.09.024; Pancevac C, 2010, NUCLEIC ACIDS RES, V38, P3119, DOI 10.1093/nar/gkq002; Perola M, 2000, J HYPERTENS, V18, P1579, DOI 10.1097/00004872-200018110-00008; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Shao Y, 1999, EUR J BIOCHEM, V260, P1, DOI 10.1046/j.1432-1327.1999.00111.x; Shao Y, 2001, ARCH BIOCHEM BIOPHYS, V390, P78, DOI 10.1006/abbi.2001.2354; Shen HQ, 2010, ARCH INTERN MED, V170, P1850, DOI 10.1001/archinternmed.2010.384; Simino J, 2012, CURR OPIN NEPHROL HY, V21, P500, DOI 10.1097/MNH.0b013e328354e78f; Sorkin J, 2005, MECH AGEING DEV, V126, P347, DOI 10.1016/j.mad.2004.08.027; Stoll M, 2000, GENOME RES, V10, P473, DOI 10.1101/gr.10.4.473; Sugiyama F, 2001, GENOMICS, V71, P70, DOI 10.1006/geno.2000.6401; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Thomas LF, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002621; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Tobin MD, 2005, CIRCULATION, V112, P3423, DOI 10.1161/CIRCULATIONAHA.105.555474; van Rijn MJE, 2007, J HYPERTENS, V25, P565, DOI 10.1097/HJH.0b013e32801449fb; Vereninov AA, 2001, CELL PHYSIOL BIOCHEM, V11, P19, DOI 10.1159/000047788; Virlon B, 1999, P NATL ACAD SCI USA, V96, P15286, DOI 10.1073/pnas.96.26.15286; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wei ZY, 2011, CIRC-CARDIOVASC GENE, V4, P381, DOI 10.1161/CIRCGENETICS.111.959767; WILLIGE SUD, 2005, BLOOD, V106, P4176, DOI DOI 10.1182/BL00D-2005-05-2180.PUBMED:16144795; Xiao B, 2009, CLIN CHIM ACTA, V407, P47, DOI 10.1016/j.cca.2009.06.026; Yoshio TD, 1997, MOL CELL BIOL, V17, P3907, DOI 10.1128/MCB.17.7.3907; YOUNG RM, 1987, J BIOL CHEM, V262, P4905; Zapata C, 2001, ANN HUM GENET, V65, P395, DOI 10.1017/S0003480001008697; Zarudnaya MI, 2003, NUCLEIC ACIDS RES, V31, P1375, DOI 10.1093/nar/gkg241; Zhao JH, 2004, BIOINFORMATICS, V20, P1325, DOI 10.1093/bioinformatics/bth071; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	59	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76290	10.1371/journal.pone.0076290	http://dx.doi.org/10.1371/journal.pone.0076290			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098465	Green Submitted, Green Published, gold			2022-12-25	WOS:000325427100054
J	Vo, AH; Swaroop, A; Liu, Y; Norris, ZG; Shavit, JA				Vo, Andy H.; Swaroop, Alok; Liu, Yang; Norris, Zachary G.; Shavit, Jordan A.			Loss of Fibrinogen in Zebrafish Results in Symptoms Consistent with Human Hypofibrinogenemia	PLOS ONE			English	Article							VERTEBRATE BLOOD-COAGULATION; VON-WILLEBRAND-FACTOR; CARDIOVASCULAR-SYSTEM; GENES; THROMBOSIS; EVOLUTION; MODIFIER; SEQUENCE; LIVER; FIBRINOLYSIS	Cessation of bleeding after trauma is a necessary evolutionary vertebrate adaption for survival. One of the major pathways regulating response to hemorrhage is the coagulation cascade, which ends with the cleavage of fibrinogen to form a stable clot. Patients with low or absent fibrinogen are at risk for bleeding. While much detailed information is known about fibrinogen regulation and function through studies of humans and mammalian models, bleeding risk in patients cannot always be accurately predicted purely based on fibrinogen levels, suggesting an influence of modifying factors and a need for additional genetic models. The zebrafish has orthologs to the three components of fibrinogen (fga, fgb, and fgg), but it hasn't yet been shown that zebrafish fibrinogen functions to prevent bleeding in vivo. Here we show that zebrafish fibrinogen is incorporated into an induced thrombus, and deficiency results in hemorrhage. An Fgb-eGFP fusion protein is incorporated into a developing thrombus induced by laser injury, but causes bleeding in adult transgenic fish. Antisense morpholino knockdown results in intracranial and intramuscular hemorrhage at 3 days post fertilization. The observed phenotypes are consistent with symptoms exhibited by patients with hypo-and afibrinogenemia. These data demonstrate that zebrafish possess highly conserved orthologs of the fibrinogen chains, which function similarly to mammals through the formation of a fibrin clot.	[Vo, Andy H.; Swaroop, Alok; Liu, Yang; Norris, Zachary G.; Shavit, Jordan A.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Shavit, JA (corresponding author), Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA.	jshavit@umich.edu		Liu, Yang/0000-0002-0413-5637; Swaroop, Alok/0000-0003-0317-6688	American Society of Hematology Trainee Research Award; Bayer Hemophilia Awards Program; Hemophilia of Georgia Clinical Scientist Development Grant; National Hemophilia Foundation/Novo Nordisk Career Development Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007381] Funding Source: NIH RePORTER	American Society of Hematology Trainee Research Award; Bayer Hemophilia Awards Program; Hemophilia of Georgia Clinical Scientist Development Grant; National Hemophilia Foundation/Novo Nordisk Career Development Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	J.A.S. is the Diane and Larry Johnson Family Scholar of Pediatrics and Communicable Diseases, American Society of Hematology Trainee Research Award (A. S., www.hematology.org), Bayer Hemophilia Awards Program (J.A.S., www.bayer-hemophilia-awards.com), Hemophilia of Georgia Clinical Scientist Development Grant (J.A.S., www.hog.org), National Hemophilia Foundation/Novo Nordisk Career Development Award (J.A.S., www.hemophilia.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajjan R, 2008, BLOOD, V111, P643, DOI 10.1182/blood-2007-05-091231; ALMONDHIRY H, 1994, AM J HEMATOL, V46, P343, DOI 10.1002/ajh.2830460416; Bill BR, 2009, ZEBRAFISH, V6, P69, DOI 10.1089/zeb.2008.0555; Bowman TV, 2010, ACS CHEM BIOL, V5, P159, DOI 10.1021/cb100029t; Buchner DA, 2007, P NATL ACAD SCI USA, V104, P13996, DOI 10.1073/pnas.0700947104; Carradice D, 2008, BLOOD, V111, P3331, DOI 10.1182/blood-2007-10-052761; Carrillo M, 2010, BLOOD CELL MOL DIS, V45, P326, DOI 10.1016/j.bcmd.2010.10.002; Cheli Y, 2008, BLOOD, V111, P1266, DOI 10.1182/blood-2007-09-111369; Chen JN, 1996, DEVELOPMENT, V123, P293; Chu J, 2009, HEPATOLOGY, V50, P1656, DOI 10.1002/hep.23157; Curado S, 2007, DEV DYNAM, V236, P1025, DOI 10.1002/dvdy.21100; Davidson CJ, 2003, THROMB HAEMOSTASIS, V89, P420, DOI 10.1055/s-0037-1613369; Davie EW, 2003, J BIOL CHEM, V278, P50819, DOI 10.1074/jbc.X300009200; Day K, 2004, BLOOD CELL MOL DIS, V32, P191, DOI 10.1016/j.bcmd.2003.09.004; de Moerloose P, 2009, SEMIN THROMB HEMOST, V35, P356, DOI 10.1055/s-0029-1225758; Degen JL, 2001, ANN NY ACAD SCI, V936, P276; Falati S, 2002, NAT MED, V8, P1175, DOI 10.1038/nm782; Fish RJ, 2012, THROMB HAEMOSTASIS, V108, P427, DOI 10.1160/TH12-04-0274; Fish RJ, 2012, THROMB HAEMOSTASIS, V107, P158, DOI 10.1160/TH11-04-0221; Fort A, 2011, BLOOD, V117, P276, DOI 10.1182/blood-2010-07-295410; Ghosh A., 2012, ADV HEMATOL, V2012; Ginsburg D, 2002, EMERY RIMOINS PRINCI, VII, P1926; Gregory M, 2002, BLOOD CELL MOL DIS, V29, P286, DOI 10.1006/bcmd.2002.0568; Gulledge AA, 2001, THROMB HAEMOSTASIS, V86, P511, DOI 10.1055/s-0037-1616079; Hanss M, 2001, ANN NY ACAD SCI, V936, P89; Hanumanthaiah R, 2002, BLOOD CELL MOL DIS, V29, P57, DOI 10.1006/bcmd.2002.0534; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; IUCHI I, 1983, J EXP ZOOL, V226, P409, DOI 10.1002/jez.1402260311; Jagadeeswaran P, 2007, J THROMB HAEMOST, V5, P300, DOI 10.1111/j.1538-7836.2007.02518.x; Jagadeeswaran P, 2011, METHOD CELL BIOL, V101, P197, DOI 10.1016/B978-0-12-387036-0.00009-8; Jiang Y, 2003, P NATL ACAD SCI USA, V100, P7527, DOI 10.1073/pnas.0932632100; Jin SW, 2007, DEV BIOL, V307, P29, DOI 10.1016/j.ydbio.2007.03.526; Jones CF, 2012, ACS NANO, V6, P9900, DOI 10.1021/nn303472r; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; La Corte ALC, 2011, ADV PROTEIN CHEM STR, V83, P75, DOI 10.1016/B978-0-12-381262-9.00003-3; Lemmerhirt HL, 2007, J THROMB HAEMOST, V5, P329, DOI 10.1111/j.1538-7836.2007.02325.x; Lemmerhirt HL, 2006, BLOOD, V108, P3061, DOI 10.1182/blood-2006-04-014688; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; Mohlke KL, 1999, CELL, V96, P111, DOI 10.1016/S0092-8674(00)80964-2; Paffett-Lugassy NN, 2004, METH MOLEC MED, V105, P171; Patton EE, 2001, NAT REV GENET, V2, P956, DOI 10.1038/35103567; Ploplis VA, 2000, AM J PATHOL, V157, P703, DOI 10.1016/S0002-9440(10)64582-8; Rosen ED, 2006, BLOOD CELL MOL DIS, V36, P131, DOI 10.1016/j.bcmd.2005.12.037; SELTEN GCM, 1982, BIOCHIM BIOPHYS ACTA, V699, P131, DOI 10.1016/0167-4781(82)90146-4; Shavit JA, 2009, BLOOD, V114, P5368, DOI 10.1182/blood-2009-07-233213; Stainier DYR, 1996, DEVELOPMENT, V123, P285; SUH TT, 1995, GENE DEV, V9, P2020, DOI 10.1101/gad.9.16.2020; Sullivan-Brown J, 2011, NAT PROTOC, V6, P46, DOI 10.1038/nprot.2010.165; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Wolberg AS, 2012, CURR OPIN HEMATOL, V19, P349, DOI 10.1097/MOH.0b013e32835673c2	53	35	35	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74682	10.1371/journal.pone.0074682	http://dx.doi.org/10.1371/journal.pone.0074682			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098662	Green Submitted, gold, Green Published			2022-12-25	WOS:000325423500033
J	Wang, S; Dong, XR; Zhu, YQ; Wang, C; Sun, G; Luo, T; Tian, WD; Zheng, HJ; Gao, Q				Wang, Sen; Dong, Xinran; Zhu, Yongqiang; Wang, Chuan; Sun, Gang; Luo, Tao; Tian, Weidong; Zheng, Huajun; Gao, Qian			Revealing of Mycobacterium marinum Transcriptome by RNA-seq	PLOS ONE			English	Article							TUBERCULOSIS GENE-EXPRESSION; VII SECRETION; PATHOGENESIS; ALIGNMENT; INSIGHTS; BIOLOGY; BLAST	Transcriptome analysis has played an essential role for revealing gene expression and the complexity of regulations at transcriptional level. RNA-seq is a powerful tool for transcriptome profiling, which uses deep-sequencing technologies to directly determine the cDNA sequence. Here, we utilized RNA-seq to explore the transcriptome of Mycobacterium marinum (M. marinum), which is a useful model to study the pathogenesis of Mycobacterium tuberculosis (Mtb). Two profiles of exponential and early stationary phase cultures were generated after a physical ribosome RNA removal step. We systematically described the transcriptome and analyzed the functions for the differentiated expressed genes between the two phases. Furthermore, we predicted 360 operons throughout the whole genome, and 13 out of 17 randomly selected operons were validated by qRT-PCR. In general, our study has primarily uncovered M. marinum transcriptome, which could help to gain a better understanding of the regulation system in Mtb that underlines disease pathogenesis.	[Wang, Sen; Wang, Chuan; Sun, Gang; Luo, Tao; Gao, Qian] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Wang, Sen; Wang, Chuan; Sun, Gang; Luo, Tao; Gao, Qian] Fudan Univ, Shanghai Med Coll, Inst Med Microbiol, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Dong, Xinran; Tian, Weidong] Fudan Univ, Sch Life Sci, Inst Biostat, Shanghai 200433, Peoples R China; [Zhu, Yongqiang; Zheng, Huajun] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University	Gao, Q (corresponding author), Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China.	qgao99@yahoo.com	Dong, Xinran/AAF-7799-2019; , 罗涛/AHA-1191-2022		Ministry of Science and Technology, China [2010DFA34440]; National Natural Science Foundation of China [91231115, 81271790]	Ministry of Science and Technology, China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants International Cooperation Project of Ministry of Science and Technology, China (2010DFA34440), and National Natural Science Foundation of China Grants (#91231115 and #81271790). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnvig KB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002342; Arnvig KB, 2009, MOL MICROBIOL, V73, P397, DOI 10.1111/j.1365-2958.2009.06777.x; Carlsson F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000285; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Deng WY, 2011, CRIT REV EUKAR GENE, V21, P337, DOI 10.1615/CritRevEukarGeneExpr.v21.i4.40; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Guida A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-628; Haas BJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-734; Huang R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027288; Kapopoulou A, 2011, TUBERCULOSIS, V91, P8, DOI 10.1016/j.tube.2010.09.006; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Komorowski M, 2009, BIOPHYS J, V96, P372, DOI 10.1016/j.bpj.2008.09.052; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Liu F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-153; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Miotto P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051950; Passalacqua KD, 2009, J BACTERIOL, V191, P3203, DOI 10.1128/JB.00122-09; Pellin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032723; Price MN, 2005, NUCLEIC ACIDS RES, V33, P880, DOI 10.1093/nar/gki232; Rachman H, 2006, MICROBES INFECT, V8, P747, DOI 10.1016/j.micinf.2005.09.011; Roback P, 2007, NUCLEIC ACIDS RES, V35, P5085, DOI 10.1093/nar/gkm518; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Tobin DM, 2008, CELL MICROBIOL, V10, P1027, DOI 10.1111/j.1462-5822.2008.01133.x; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Triccas JA, 2000, IMMUNOL CELL BIOL, V78, P311, DOI 10.1046/j.1440-1711.2000.00934.x; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Voskuil MI, 2004, TUBERCULOSIS, V84, P256, DOI 10.1016/j.tube.2003.12.014; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wurtzel O, 2010, GENOME RES, V20, P133, DOI 10.1101/gr.100396.109; Xu J, 2007, MOL MICROBIOL, V66, P787, DOI 10.1111/j.1365-2958.2007.05959.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang Zhao, 2012, Silence, V3, P9, DOI 10.1186/1758-907X-3-9; 2010, WKLY EPIDEMIOL REC, V85, P69	40	13	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75828	10.1371/journal.pone.0075828	http://dx.doi.org/10.1371/journal.pone.0075828			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098731	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500102
J	Tsou, WL; Burr, AA; Ouyang, M; Blount, JR; Scaglione, KM; Todi, SV				Tsou, Wei-Ling; Burr, Aaron A.; Ouyang, Michelle; Blount, Jessica R.; Scaglione, K. Matthew; Todi, Sokol V.			Ubiquitination Regulates the Neuroprotective Function of the Deubiquitinase Ataxin-3 in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Deubiquitination; Drosophila; Neurodegeneration; Polyglutamine Disease; Protease; Ubiquitin; Machado-Joseph Disease; Neuroprotection; Ataxin-3	POLYGLUTAMINE DISEASE PROTEIN; SMALL-MOLECULE INHIBITOR; CELLULAR FUNCTIONS; MYOSIN-VIIA; NEURODEGENERATION; ENZYME; LOCALIZATION; SUPPRESSION; PROTEOLYSIS; DROSOPHILA	Background: Ubiquitination of ataxin-3 enhances its DUB activity in vitro, but it is unknown whether it controls its function in intact organisms. Results: Ubiquitination at lysine 117 regulates the neuroprotective function of ataxin-3 in Drosophila.Conclusion: Ataxin-3 ubiquitination is a critical regulator of its in vivo functions. Significance: Ubiquitination may constitute a general regulatory mechanism of DUB activities in vivo. Deubiquitinases (DUBs) are proteases that regulate various cellular processes by controlling protein ubiquitination. Cell-based studies indicate that the regulation of the activity of DUBs is important for homeostasis and is achieved by multiple mechanisms, including through their own ubiquitination. However, the physiological significance of the ubiquitination of DUBs to their functions in vivo is unclear. Here, we report that ubiquitination of the DUB ataxin-3 at lysine residue 117, which markedly enhances its protease activity in vitro, is critical for its ability to suppress toxic protein-dependent degeneration in Drosophila melanogaster. Compared with ataxin-3 with only Lys-117 present, ataxin-3 that does not become ubiquitinated performs significantly less efficiently in suppressing or delaying the onset of toxic protein-dependent degeneration in flies. According to further studies, the C terminus of Hsc70-interacting protein (CHIP), an E3 ubiquitin ligase that ubiquitinates ataxin-3 in vitro, is dispensable for its ubiquitination in vivo and is not required for the neuroprotective function of this DUB in Drosophila. Our work also suggests that ataxin-3 suppresses degeneration by regulating toxic protein aggregation rather than stability.	[Tsou, Wei-Ling; Burr, Aaron A.; Ouyang, Michelle; Blount, Jessica R.; Todi, Sokol V.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Tsou, Wei-Ling; Burr, Aaron A.; Ouyang, Michelle; Blount, Jessica R.; Todi, Sokol V.] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA; [Burr, Aaron A.; Todi, Sokol V.] Wayne State Univ, Sch Med, Grad Program Canc Biol, Detroit, MI 48201 USA; [Scaglione, K. Matthew] Med Coll Wisconsin, Neurosci Res Ctr, Milwaukee, WI 53226 USA; [Scaglione, K. Matthew] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Wayne State University; Wayne State University; Wayne State University; Medical College of Wisconsin; Medical College of Wisconsin	Todi, SV (corresponding author), 540 E Canfield,Scott Hall Rm 3108, Detroit, MI 48201 USA.	stodi@med.wayne.edu	Tsou, Wei-Ling/AAI-2655-2021	Tsou, Wei-Ling/0000-0001-9136-2581; TODI, SOKOL/0000-0003-4399-5549; Scaglione, Kenneth/0000-0002-3858-9418	National Institutes of Health from the NINDS [R00NS064097, NS073936]; NCI [T32-CA009531]; National Ataxia Foundation; NATIONAL CANCER INSTITUTE [T32CA009531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS073936, R00NS064097, R00NS073936] Funding Source: NIH RePORTER	National Institutes of Health from the NINDS; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Ataxia Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R00NS064097 (to S. V. T.) and NS073936 (to K. M. S.) from the NINDS and an NCI T32-CA009531 slot (to A. A. B.). This work was also supported by awards from the National Ataxia Foundation (to W.-L.T. and S.V.T.).	Berke SJS, 2004, J NEUROCHEM, V89, P908, DOI 10.1111/j.1471-4159.2004.02369.x; Blount JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036542; BRAND AH, 1993, DEVELOPMENT, V118, P401; Burnett BG, 2005, P NATL ACAD SCI USA, V102, P4330, DOI 10.1073/pnas.0407252102; Cemal CK, 2002, HUM MOL GENET, V11, P1075, DOI 10.1093/hmg/11.9.1075; Clague MJ, 2013, PHYSIOL REV, V93, P1289, DOI 10.1152/physrev.00002.2013; Clague MJ, 2012, J CELL SCI, V125, P277, DOI 10.1242/jcs.090985; Colland F, 2009, MOL CANCER THER, V8, P2286, DOI 10.1158/1535-7163.MCT-09-0097; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Costa MD, 2012, PROG NEUROBIOL, V97, P239, DOI 10.1016/j.pneurobio.2011.11.006; Denuc A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005571; Dickey CA, 2007, TRENDS MOL MED, V13, P32, DOI 10.1016/j.molmed.2006.11.003; Franca Marcondes C Jr, 2012, Front Neurol, V3, P164, DOI 10.3389/fneur.2012.00164; Franke JD, 2005, CURR BIOL, V15, P2208, DOI 10.1016/j.cub.2005.11.064; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Hubener J, 2010, NEUROBIOL DIS, V38, P116, DOI 10.1016/j.nbd.2010.01.005; Kessler BM, 2011, CELL BIOCHEM BIOPHYS, V60, P21, DOI 10.1007/s12013-011-9176-6; LANG AE, 1994, ANN NEUROL, V36, P443, DOI 10.1002/ana.410360318; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Li LB, 2007, J BIOL CHEM, V282, P37694, DOI 10.1074/jbc.M705211200; McGurk L, 2012, HUM MOL GENET, V21, P76, DOI 10.1093/hmg/ddr439; Meray RK, 2007, J BIOL CHEM, V282, P10567, DOI 10.1074/jbc.M611153200; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Pozzi C, 2008, NEUROBIOL DIS, V30, P190, DOI 10.1016/j.nbd.2008.01.011; Reina CP, 2010, HUM MOL GENET, V19, P235, DOI 10.1093/hmg/ddp482; Romero E, 2008, NEURON, V57, P27, DOI 10.1016/j.neuron.2007.11.025; Sacco JJ, 2010, IUBMB LIFE, V62, P140, DOI 10.1002/iub.300; Scaglione KM, 2011, MOL CELL, V43, P599, DOI 10.1016/j.molcel.2011.05.036; Seki T, 2013, J BIOL CHEM, V288, P17145, DOI 10.1074/jbc.M113.463406; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Todi S., 2012, CLIN PHARM BIOPHARMA, V1; Todi S.V., 2007, MOL NEUROLOGY, P257; Todi SV, 2007, J BIOL CHEM, V282, P29348, DOI 10.1074/jbc.M704126200; Todi SV, 2011, TRENDS NEUROSCI, V34, P370, DOI 10.1016/j.tins.2011.05.004; Todi SV, 2010, J BIOL CHEM, V285, P39303, DOI 10.1074/jbc.M110.181610; Todi SV, 2009, EMBO J, V28, P372, DOI 10.1038/emboj.2008.289; Todi SV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002115; Todi SV, 2005, CURR BIOL, V15, P862, DOI 10.1016/j.cub.2005.03.050; Tsou WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043112; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200	43	33	34	4	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34460	34469		10.1074/jbc.M113.513903	http://dx.doi.org/10.1074/jbc.M113.513903			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24106274	hybrid, Green Published			2022-12-25	WOS:000329812800016
J	Artamonov, MV; Momotani, K; Stevenson, A; Trentham, DR; Derewenda, U; Derewenda, ZS; Read, PW; Gutkind, JS; Somlyo, AV				Artamonov, Mykhaylo V.; Momotani, Ko; Stevenson, Andra; Trentham, David R.; Derewenda, Urszula; Derewenda, Zygmunt S.; Read, Paul W.; Gutkind, J. Silvio; Somlyo, Avril V.			Agonist-induced Ca2+ Sensitization in Smooth Muscle REDUNDANCY OF RHO GUANINE NUCLEOTIDE EXCHANGE FACTORS (RhoGEFs) AND RESPONSE KINETICS, A CAGED COMPOUND STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; Guanine Nucleotide Exchange Factor (GEF); Rho; Signal Transduction; Smooth Muscle	HETEROTRIMERIC G-PROTEINS; LEUKEMIA-ASSOCIATED RHO; PDZ-RHOGEF; MYOSIN PHOSPHATASE; ANGIOTENSIN-II; ADENOSINE-TRIPHOSPHATE; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; FLASH-PHOTOLYSIS; LIVING CELLS	Many agonists, acting through G-protein-coupled receptors and G subunits of the heterotrimeric G-proteins, induce contraction of smooth muscle through an increase of [Ca2+](i) as well as activation of the RhoA/RhoA-activated kinase pathway that amplifies the contractile force, a phenomenon known as Ca2+ sensitization. G(12/13) subunits are known to activate the regulator of G-protein signaling-like family of guanine nucleotide exchange factors (RhoGEFs), which includes PDZ-RhoGEF (PRG) and leukemia-associated RhoGEF (LARG). However, their contributions to Ca2+-sensitized force are not well understood. Using permeabilized blood vessels from PRG(-/-) mice and a new method to silence LARG in organ-cultured blood vessels, we show that both RhoGEFs are activated by the physiologically and pathophysiologically important thromboxane A(2) and endothelin-1 receptors. The co-activation is the result of direct and independent activation of both RhoGEFs as well as their co-recruitment due to heterodimerization. The isolated recombinant C-terminal domain of PRG, which is responsible for heterodimerization with LARG, strongly inhibited Ca2+-sensitized force. We used photolysis of caged phenylephrine, caged guanosine 5-O-(thiotriphosphate) (GTPS) in solution, and caged GTPS or caged GTP loaded on the RhoARhoGDI complex to show that the recruitment and activation of RhoGEFs is the cause of a significant time lag between the initial Ca2+ transient and phasic force components and the onset of Ca2+-sensitized force.	[Artamonov, Mykhaylo V.; Momotani, Ko; Derewenda, Urszula; Derewenda, Zygmunt S.; Somlyo, Avril V.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Artamonov, Mykhaylo V.; Momotani, Ko; Derewenda, Urszula; Derewenda, Zygmunt S.; Somlyo, Avril V.] Univ Virginia, Dept Radiat Oncol, Charlottesville, VA 22908 USA; [Stevenson, Andra] Merck Res Labs, Dept Cardiovasc Dis, Kenilworth, NJ 07033 USA; [Trentham, David R.] Kings Coll London, Sch Biomed Sci, Randall Div Cell & Mol Biophys, London SE1 1UK, England; [Gutkind, J. Silvio] NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA	University of Virginia; University of Virginia; Merck & Company; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Somlyo, AV (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, POB 736, Charlottesville, VA 22903 USA.	avs5u@virginia.edu	Artamonov, Mykhaylo/AAD-3488-2021; Gutkind, J. Silvio/J-1201-2016	Artamonov, Mykhaylo/0000-0002-0848-2054; Gutkind, J. Silvio/0000-0002-5150-4482	National Institutes of Health [GM086457, R01DK088905]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants GM086457 and R01DK088905.	Adjobo-Hermans MJW, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-32; Aittaleb M, 2011, J BIOL CHEM, V286, P34448, DOI 10.1074/jbc.M111.273342; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Cario-Toumaniantz C, 2012, AM J PHYSIOL-CELL PH, V302, pC1394, DOI 10.1152/ajpcell.00423.2011; Chen Z, 2005, NAT STRUCT MOL BIOL, V12, P191, DOI 10.1038/nsmb888; Chikumi H, 2004, ONCOGENE, V23, P233, DOI 10.1038/sj.onc.1207012; CORRIE JET, 1992, J CHEM SOC PERK T 1, P1015, DOI 10.1039/p19920001015; Derewenda U, 2004, STRUCTURE, V12, P1955, DOI 10.1016/j.str.2004.09.003; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Gohla A, 2000, CIRC RES, V87, P221, DOI 10.1161/01.RES.87.3.221; GOLDMAN YE, 1984, J PHYSIOL-LONDON, V354, P605, DOI 10.1113/jphysiol.1984.sp015395; Grabocka E, 2007, MOL PHARMACOL, V72, P993, DOI 10.1124/mol.107.035162; Groves JT, 2010, NAT STRUCT MOL BIOL, V17, P659, DOI 10.1038/nsmb.1844; Guilluy C, 2010, NAT MED, V16, P183, DOI 10.1038/nm.2079; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; Hong F, 2011, ARCH BIOCHEM BIOPHYS, V510, P135, DOI 10.1016/j.abb.2011.04.018; HORIUTI K, 1989, J GEN PHYSIOL, V94, P769, DOI 10.1085/jgp.94.4.769; Ichikawa K, 1996, J BIOL CHEM, V271, P4733; Jaiswal M, 2013, J BIOL CHEM, V288, P4486, DOI 10.1074/jbc.M112.429746; Jaiswal M, 2011, J BIOL CHEM, V286, P18202, DOI 10.1074/jbc.M111.226431; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Longenecker KL, 2001, STRUCTURE, V9, P559, DOI 10.1016/S0969-2126(01)00620-7; MCCRAY JA, 1989, ANNU REV BIOPHYS BIO, V18, P239, DOI 10.1146/annurev.biophys.18.1.239; Medina F, 2013, J BIOL CHEM, V288, P11325, DOI 10.1074/jbc.M113.450056; Mikelis CM, 2013, J BIOL CHEM, V288, P12232, DOI 10.1074/jbc.M112.428599; Momotani K, 2012, TRENDS CARDIOVAS MED, V22, P122, DOI 10.1016/j.tcm.2012.07.007; Momotani K, 2011, CIRC RES, V109, P993, DOI 10.1161/CIRCRESAHA.111.248898; Neppl RL, 2009, J BIOL CHEM, V284, P6348, DOI 10.1074/jbc.M807040200; Oleksy A, 2006, J BIOL CHEM, V281, P32891, DOI 10.1074/jbc.M606220200; Pfreimer M, 2012, CELL SIGNAL, V24, P652, DOI 10.1016/j.cellsig.2011.10.014; Read PW, 2000, PROTEIN SCI, V9, P376; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; SCHEIDIG AJ, 1995, J MOL BIOL, V253, P132, DOI 10.1006/jmbi.1995.0541; Shankaranarayanan A, 2010, CELL SIGNAL, V22, P1114, DOI 10.1016/j.cellsig.2010.03.006; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; SOMLYO AV, 1992, J BIOL CHEM, V267, P22316; SOMLYO AV, 1988, J GEN PHYSIOL, V91, P165, DOI 10.1085/jgp.91.2.165; WALKER JW, 1988, BIOPHYS J, V53, pA596; WALKER JW, 1993, BIOCHEMISTRY-US, V32, P1338, DOI 10.1021/bi00056a020; WALKER JW, 1989, METHOD ENZYMOL, V172, P288; Wettschureck N, 2002, J MOL MED, V80, P629, DOI 10.1007/s00109-002-0370-2; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Wuertz CM, 2010, FASEB J, V24, P4865, DOI 10.1096/fj.10-155499; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09	49	17	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34030	34040		10.1074/jbc.M113.514596	http://dx.doi.org/10.1074/jbc.M113.514596			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24106280	hybrid, Green Published			2022-12-25	WOS:000327250200044
J	Kim, S; Dangelmaier, C; Bhavanasi, D; Meng, S; Wang, H; Goldfinger, LE; Kunapuli, SP				Kim, Soochong; Dangelmaier, Carol; Bhavanasi, Dheeraj; Meng, Shu; Wang, Hong; Goldfinger, Lawrence E.; Kunapuli, Satya P.			RhoG Protein Regulates Glycoprotein VI-Fc Receptor gamma-Chain Complex-mediated Platelet Activation and Thrombus Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Collagen; Fc Receptors; Platelets; Rho GTPases; Thrombosis; Glycoprotein VI	EXCHANGE FACTOR TRIO; COLLAGEN RECEPTOR; TYROSINE PHOSPHORYLATION; PHOSPHOLIPASE C-GAMMA-2; ACTIN CYTOSKELETON; APOPTOTIC CELLS; SMALL GTPASES; KINASE SYK; T-CELLS; RAC	Background: RhoG is a ubiquitously expressed member of the Rho family of GTPases. Results: RhoG-deficient platelets display severely impaired GPVI-dependent platelet activation. Conclusion: RhoG plays an important role in GPVI-FcR complex-mediated platelet activation and thrombus formation. Significance: Our study enhances the understanding of the molecular mechanisms of GPVI-FcR complex activation. We investigated the mechanism of activation and functional role of a hitherto uncharacterized signaling molecule, RhoG, in platelets. We demonstrate for the first time the expression and activation of RhoG in platelets. Platelet aggregation, integrin IIb3 activation, and -granule and dense granule secretion in response to the glycoprotein VI (GPVI) agonists collagen-related peptide (CRP) and convulxin were significantly inhibited in RhoG-deficient platelets. In contrast, 2-MeSADP- and AYPGKF-induced platelet aggregation and secretion were minimally affected in RhoG-deficient platelets, indicating that the function of RhoG in platelets is GPVI-specific. CRP-induced phosphorylation of Syk, Akt, and ERK, but not SFK (Src family kinase), was significantly reduced in RhoG-deficient platelets. CRP-induced RhoG activation was consistently abolished by a pan-SFK inhibitor but not by Syk or PI3K inhibitors. Interestingly, unlike CRP, platelet aggregation and Syk phosphorylation induced by fucoidan, a CLEC-2 agonist, were unaffected in RhoG-deficient platelets. Finally, RhoG(-/-) mice had a significant delay in time to thrombotic occlusion in cremaster arterioles compared with wild-type littermates, indicating the important in vivo functional role of RhoG in platelets. Our data demonstrate that RhoG is expressed and activated in platelets, plays an important role in GPVI-Fc receptor -chain complex-mediated platelet activation, and is critical for thrombus formation in vivo.	[Kim, Soochong; Bhavanasi, Dheeraj; Kunapuli, Satya P.] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19140 USA; [Meng, Shu; Wang, Hong; Kunapuli, Satya P.] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA; [Goldfinger, Lawrence E.] Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA; [Kim, Soochong; Dangelmaier, Carol; Bhavanasi, Dheeraj; Meng, Shu; Wang, Hong; Goldfinger, Lawrence E.; Kunapuli, Satya P.] Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Goldfinger, LE (corresponding author), Temple Univ, Sch Med, Dept Anat & Cell Biol, 3420 N Broad St, Philadelphia, PA 19140 USA.	goldfinger@temple.edu; spk@temple.edu			National Institutes of Health [HL93231, HL118593]; American Heart Association [12SDG8980013]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093231, R01HL093416, R01HL118593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL93231 and HL118593 (to S.P.K.). This work was also supported by American Heart Association Grant 12SDG8980013 (to S.K.).	Akbar H, 2007, J THROMB HAEMOST, V5, P1747, DOI 10.1111/j.1538-7836.2007.02646.x; Asazuma N, 2000, J BIOL CHEM, V275, P33427, DOI 10.1074/jbc.M001439200; Azim AC, 2000, BLOOD, V95, P959, DOI 10.1182/blood.V95.3.959.003k22_959_964; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Daniel JL, 2010, J BIOL CHEM, V285, P17282, DOI 10.1074/jbc.M109.080200; DANIEL JL, 1994, BIOCHEM J, V302, P617, DOI 10.1042/bj3020617; DeBakker CD, 2004, CURR BIOL, V14, P2208, DOI 10.1016/j.cub.2004.12.029; DeGeer J, 2013, MOL CELL BIOL, V33, P739, DOI 10.1128/MCB.01264-12; Ezumi Y, 1998, J EXP MED, V188, P267, DOI 10.1084/jem.188.2.267; Francischetti IMB, 1997, TOXICON, V35, P1217, DOI 10.1016/S0041-0101(97)00021-4; Gauthier-Rouviere C, 1998, MOL BIOL CELL, V9, P1379, DOI 10.1091/mbc.9.6.1379; Gibbins JM, 1998, J BIOL CHEM, V273, P34437, DOI 10.1074/jbc.273.51.34437; Gibbins JM, 1997, FEBS LETT, V413, P255, DOI 10.1016/S0014-5793(97)00926-5; Goggs R, 2013, J BIOL CHEM, V288, P34217, DOI 10.1074/jbc.M113.504100; Gratacap MP, 2001, J BIOL CHEM, V276, P47906, DOI 10.1074/jbc.M104442200; Ichinohe T, 1997, J BIOL CHEM, V272, P63; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Katoh H, 2006, J CELL SCI, V119, P56, DOI 10.1242/jcs.02720; Kim S, 2006, BLOOD, V107, P947, DOI 10.1182/blood-2005-07-3040; Lagrue AH, 1999, FEBS LETT, V448, P95, DOI 10.1016/S0014-5793(99)00340-3; Manne BK, 2013, J BIOL CHEM, V288, P7717, DOI 10.1074/jbc.M112.424473; Miranti CK, 1998, CURR BIOL, V8, P1289, DOI 10.1016/S0960-9822(07)00559-3; Movilla N, 1999, MOL CELL BIOL, V19, P7870; Nieswandt B, 2000, J BIOL CHEM, V275, P23998, DOI 10.1074/jbc.M003803200; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; O'Kane EM, 2003, MOL BRAIN RES, V114, P1, DOI 10.1016/S0169-328X(03)00121-9; Obergfell A, 2001, J BIOL CHEM, V276, P5916, DOI 10.1074/jbc.M010639200; Patel KN, 2008, ARTERIOSCL THROM VAS, V28, P2225, DOI 10.1161/ATVBAHA.108.175679; Pearce AC, 2004, J BIOL CHEM, V279, P53955, DOI 10.1074/jbc.M410355200; Pearce AC, 2002, BLOOD, V100, P3561, DOI 10.1182/blood.V100.10.3561; Pleines I, 2009, PFLUG ARCH EUR J PHY, V457, P1173, DOI 10.1007/s00424-008-0573-7; Pollitt AY, 2010, BLOOD, V115, P2938, DOI 10.1182/blood-2009-12-257212; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; Quek LS, 1998, CURR BIOL, V8, P1137, DOI 10.1016/S0960-9822(98)70471-3; Quek LS, 2000, BLOOD, V96, P4246; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Schuebel KE, 1998, EMBO J, V17, P6608, DOI 10.1093/emboj/17.22.6608; Severin S, 2011, J BIOL CHEM, V286, P4107, DOI 10.1074/jbc.M110.167502; Soulet C, 2001, FEBS LETT, V507, P253, DOI 10.1016/S0014-5793(01)02984-2; Spiering D, 2011, CELL ADHES MIGR, V5, P170, DOI 10.4161/cam.5.2.14403; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Takaya N, 2005, J MOL CELL CARDIOL, V39, P856, DOI 10.1016/j.yjmcc.2005.07.006; van Rijssel J, 2012, CELL ADHES MIGR, V6, P482, DOI 10.4161/cam.21418; Vignal E, 2001, MOL CELL BIOL, V21, P8022, DOI 10.1128/MCB.21.23.8022-8034.2001; Vigorito E, 2003, ONCOGENE, V22, P330, DOI 10.1038/sj.onc.1206116; Vigorito E, 2004, MOL CELL BIOL, V24, P719, DOI 10.1128/MCB.24.2.719-729.2004; VINCENT S, 1992, MOL CELL BIOL, V12, P3138, DOI 10.1128/MCB.12.7.3138; Watson SP, 2010, J THROMB HAEMOST, V8, P1457, DOI 10.1111/j.1538-7836.2010.03875.x; Watson SP, 2005, J THROMB HAEMOST, V3, P1752, DOI 10.1111/j.1538-7836.2005.01429.x; Watson SP, 1998, IMMUNOL TODAY, V19, P260, DOI 10.1016/S0167-5699(98)01267-5; Yamaki N, 2007, EXP CELL RES, V313, P2821, DOI 10.1016/j.yexcr.2007.05.010	51	17	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34230	34238		10.1074/jbc.M113.504928	http://dx.doi.org/10.1074/jbc.M113.504928			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24106269	Green Published, hybrid			2022-12-25	WOS:000327250200065
J	Zhang, W; Zhao, F; Hoffmann, AA; Ma, CS				Zhang, Wei; Zhao, Fei; Hoffmann, Ary A.; Ma, Chun-Sen			Single Hot Event That Does Not Affect Survival but Decreases Reproduction in the Diamondback Moth, Plutella xylostella	PLOS ONE			English	Article							HEAT-STRESS; JUVENILE-HORMONE; TEMPERATURE EXTREMES; GENE-EXPRESSION; THERMAL-STRESS; DROSOPHILA; LEPIDOPTERA; EXPOSURE; FECUNDITY; TOLERANCE	Extremely hot events (usually involving a few hours at extreme high temperatures in summer) are expected to increase in frequency in temperate regions under global warming. The impact of these events is generally overlooked in insect population prediction, since they are unlikely to cause widespread mortality, however reproduction may be affected by them. In this study, we examined such stress effects in the diamondback moth, Plutella xylostella. We simulated a single extreme hot day (maximum of 40 degrees C lasting for 3, 4 or 5 h) increasingly experienced under field conditions. This event had no detrimental effects on immediate mortality, copulation duration, mating success, longevity or lifetime fecundity, but stressed females produced 21% (after 3 or 4 h) fewer hatched eggs because of a decline in the number and hatching success of eggs laid on the first two days. These negative effects on reproduction were no longer evident in the following days. Male heat exposure led to a similar but smaller effect on fertile egg production, and exposure extended pre-mating period in both sexes. Our results indicate that a single hot day can have detrimental effects on reproduction, particularly through maternal effects on egg hatching, and thereby influence the population dynamics of diamondback moth.	[Zhang, Wei; Zhao, Fei; Ma, Chun-Sen] Chinese Acad Agr Sci, Climate Change Biol Res Grp, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China; [Hoffmann, Ary A.] Univ Melbourne, Dept Zool, Inst Bio21, Melbourne, Vic 3010, Australia; [Hoffmann, Ary A.] Univ Melbourne, Dept Genet, Inst Bio21, Melbourne, Vic 3010, Australia	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; University of Melbourne; University of Melbourne	Ma, CS (corresponding author), Chinese Acad Agr Sci, Climate Change Biol Res Grp, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China.	csma@ippcaas.cn	Ma, Chun-Sen/K-5414-2019; Hoffmann, Ary/C-2961-2011; Hoffmann, Ary/R-2972-2019; 赵, 飞/AAC-8601-2019	Ma, Chun-Sen/0000-0002-3253-6921; Hoffmann, Ary/0000-0001-9497-7645; Zhang, Wei/0000-0002-9262-0631; Zhao, Fei/0000-0003-4158-3604	Ministry of Agriculture (MOA), PR China [201103021]	Ministry of Agriculture (MOA), PR China	This research was financially supported by a research grant (201103021) from the Ministry of Agriculture (MOA), PR China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezemer TM, 1998, OECOLOGIA, V116, P128, DOI 10.1007/s004420050571; Cannon RJC, 1998, GLOBAL CHANGE BIOL, V4, P785, DOI 10.1046/j.1365-2486.1998.00190.x; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; David JR, 2005, J EVOLUTION BIOL, V18, P838, DOI 10.1111/j.1420-9101.2005.00914.x; DEBARRO PJ, 1993, AUST J ZOOL, V41, P123, DOI 10.1071/ZO9930123; Denlinger DL, 1998, TEMPERATURES SENSITIVITY IN INSECTS AND APPLICATION IN INTEGRATED PEST MANAGEMENT, P7; Dillon ME, 2007, J EXP BIOL, V210, P2897, DOI 10.1242/jeb.007591; Dong Shuanglin, 2002, Yingyong Shengtai Xuebao, V13, P1633; Ducatez S, 2012, EVOLUTION, V66, P3558, DOI 10.1111/j.1558-5646.2012.01704.x; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Fasolo AG, 2004, BIOL J LINN SOC, V83, P197, DOI 10.1111/j.1095-8312.2004.00380.x; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Friedenberg NA, 2008, ENVIRON ENTOMOL, V37, P650, DOI 10.1603/0046-225X(2008)37[650:TEDDAS]2.0.CO;2; Geister TL, 2009, J COMP PHYSIOL B, V179, P87, DOI 10.1007/s00360-008-0293-5; GIEBULTOWICZ JM, 1992, ENVIRON ENTOMOL, V21, P822, DOI 10.1093/ee/21.4.822; Golizadeh A, 2007, INSECT SCI, V14, P309, DOI 10.1111/j.1744-7917.2007.00157.x; GROETERS FR, 1994, EVOLUTION, V48, P197, DOI 10.2307/2410015; Gruntenko NE, 2003, INSECT MOL BIOL, V12, P393, DOI 10.1046/j.1365-2583.2003.00424.x; Gu HN, 2009, ENVIRON ENTOMOL, V38, P524, DOI 10.1603/022.038.0303; Guo JY, 2012, ENVIRON ENTOMOL, V41, P1672, DOI 10.1603/EN12108; Han Guibiao, 1999, Scientia Silvae Sinicae, V35, P75; Harrington R, 2001, AGR FOREST ENTOMOL, V3, P233, DOI 10.1046/j.1461-9555.2001.00120.x; Hercus MJ, 2003, BIOGERONTOLOGY, V4, P149, DOI 10.1023/A:1024197806855; Hoffmann AA, 2010, J EXP BIOL, V213, P870, DOI 10.1242/jeb.037630; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Huang LH, 2007, J INSECT PHYSIOL, V53, P1199, DOI 10.1016/j.jinsphys.2007.06.011; IPCC, 2007, CONTRIBUTION WORKING; Janowitz SA, 2011, J THERM BIOL, V36, P283, DOI 10.1016/j.jtherbio.2011.04.001; Jia FX, 2009, ENVIRON ENTOMOL, V38, P1365, DOI 10.1603/022.038.0503; Krebs RA, 2005, J THERM BIOL, V30, P335, DOI 10.1016/j.jtherbio.2005.02.002; KREBS RA, 1994, J EVOLUTION BIOL, V7, P39, DOI 10.1046/j.1420-9101.1994.7010039.x; KREBS RA, 1994, FUNCT ECOL, V8, P730, DOI 10.2307/2390232; Le Bourg E, 2001, BIOGERONTOLOGY, V2, P155, DOI 10.1023/A:1011561107055; Lee Song-Tay, 1995, Chinese Journal of Entomology, V15, P81; Liu SS, 2002, ENVIRON ENTOMOL, V31, P221, DOI 10.1603/0046-225X-31.2.221; [马春森 Ma Chunsen], 2010, [生态学报, Acta Ecologica Sinica], V21, P3628; Ma CS, 2004, ENTOMOL EXP APPL, V110, P65, DOI 10.1111/j.0013-8703.2004.00123.x; Ma CS., 1993, J JILIN AGR SCI, V3, P44; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Menendez Rosa, 2007, Tijdschrift voor Entomologie, V150, P355; Mironidis GK, 2010, J THERM BIOL, V35, P59, DOI 10.1016/j.jtherbio.2009.11.001; MOUSSEAU TA, 1991, ANNU REV ENTOMOL, V36, P511, DOI 10.1146/annurev.en.36.010191.002455; Patton ZJ, 2001, PHYSIOL BIOCHEM ZOOL, V74, P783, DOI 10.1086/323327; PIVNICK KA, 1990, ENVIRON ENTOMOL, V19, P587, DOI 10.1093/ee/19.3.587; Piyaphongkul J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047413; Rahmstorf S, 2011, P NATL ACAD SCI USA, V108, P17905, DOI 10.1073/pnas.1101766108; RAUSCHENBACH IY, 1995, J INSECT PHYSIOL, V41, P179, DOI 10.1016/0022-1910(94)00084-T; Rauschenbach IY, 1996, J INSECT PHYSIOL, V42, P735, DOI 10.1016/0022-1910(96)00027-3; Rinehart JP, 2000, PHYSIOL ENTOMOL, V25, P330, DOI 10.1046/j.1365-3032.2000.00201.x; Roux O, 2010, B ENTOMOL RES, V100, P543, DOI 10.1017/S0007485309990575; Shirai Y, 2000, B ENTOMOL RES, V90, P357, DOI 10.1017/S0007485300000481; Silbermann R, 2000, EVOLUTION, V54, P2038; Sorensen JG, 2005, CELL STRESS CHAPERON, V10, P312, DOI 10.1379/CSC-128R1.1; TALEKAR NS, 1993, ANNU REV ENTOMOL, V38, P275, DOI 10.1146/annurev.en.38.010193.001423; Wakisaka Shigekazu, 1992, P15; Wan FH, 2008, J INSECT SCI, V8, P49; Wang XP, 2005, J APPL ENTOMOL, V129, P39, DOI 10.1111/j.1439-0418.2005.00931.x; YAMADA H, 1983, JPN J APPL ENTOMOL Z, V27, P17, DOI 10.1303/jjaez.27.17; YAMADA H, 1972, Japanese Journal of Applied Entomology and Zoology, V16, P180, DOI 10.1303/jjaez.16.180	59	61	76	5	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75923	10.1371/journal.pone.0075923	http://dx.doi.org/10.1371/journal.pone.0075923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116081	Green Published, gold			2022-12-25	WOS:000325552200043
J	Duhachek-Muggy, S; Li, H; Qi, Y; Zolkiewska, A				Duhachek-Muggy, Sara; Li, Hui; Qi, Yue; Zolkiewska, Anna			Alternative mRNA Splicing Generates Two Distinct ADAM12 Prodomain Variants	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; MELTRIN-ALPHA; BREAST-CANCER; TUMOR PROGRESSION; SECRETED FORM; REGULATED EXPRESSION; CARDIAC-HYPERTROPHY; CELL-PROLIFERATION; DISINTEGRIN ADAM12; MOLECULAR SWITCH	Human ADAM12, transcript variant 1 (later on referred to as Var-1b), present in publicly available databases contains the sequence 59-GTAATTCTG-3' at the nucleotide positions 340-348 of the coding region, at the 3' end of exon 4. The translation product of this variant, ADAM12-Lb, includes the three amino acid motif (VIL116)-V-114 in the prodomain. This motif is not conserved in ADAM12 from different species and is not present in other human ADAMs. Currently, it is not clear whether a shorter variant, Var-1a, encoding the protein version without the (VIL116)-V-114 motif, ADAM12-La, is expressed in human. In this work, we have established that human mammary epithelial cells and breast cancer cells express both Var-1a and Var-1b transcripts. Importantly, the proteolytic processing and intracellular trafficking of the corresponding ADAM12-La and ADAM12-Lb proteins are different. While ADAM12-La is cleaved and trafficked to the cell surface in a manner similar to ADAM12 in other species, ADAM12-Lb is retained in the ER and is not proteolytically processed. Furthermore, the relative abundance of ADAM12-La and ADAM12-Lb proteins detected in several breast cancer cell lines varies significantly. We conclude that the canonical form of transmembrane ADAM12 is represented by Var-1a/ ADAM12-La, rather than Var-1b/ADAM12-Lb currently featured in major sequence databases.	[Duhachek-Muggy, Sara; Li, Hui; Qi, Yue; Zolkiewska, Anna] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA	Kansas State University	Zolkiewska, A (corresponding author), Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA.	zolkiea@ksu.edu	LI, HUI/G-1227-2011	LI, HUI/0000-0002-4114-8349	National Institutes of Health [R15CA151065, R01CA172222]; Innovative Research Award from Terry C. Johnson Center for Basic Cancer Research at KSU; NATIONAL CANCER INSTITUTE [R15CA151065, R01CA172222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Innovative Research Award from Terry C. Johnson Center for Basic Cancer Research at KSU; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants R15CA151065 and R01CA172222, and Innovative Research Award from Terry C. Johnson Center for Basic Cancer Research at KSU. This is contribution 13-393-J from Kansas Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Atfi A, 2007, J CELL BIOL, V178, P201, DOI 10.1083/jcb.200612046; Barnabas N, 2013, INT J BREAST CANCER, V2013, DOI 10.1155/2013/872743; Bertucci F, 2006, CANCER RES, V66, P4636, DOI 10.1158/0008-5472.CAN-06-0031; Bornemann A, 2000, J MUSCLE RES CELL M, V21, P475, DOI 10.1023/A:1005657607591; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Capasso R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031388; Carmel I, 2004, RNA, V10, P828, DOI 10.1261/rna.5196404; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; Diaz B, 2013, J CELL BIOL, V201, P279, DOI 10.1083/jcb.201209151; Dulauroy S, 2012, NAT MED, V18, P1262, DOI 10.1038/nm.2848; Dyczynska E, 2007, J BIOL CHEM, V282, P436, DOI 10.1074/jbc.M605451200; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Frohlich C, 2006, CLIN CANCER RES, V12, P7359, DOI 10.1158/1078-0432.CCR-06-1066; Frohlich C, 2013, BIOCHEM J, V452, P97, DOI 10.1042/BJ20121558; Georges S, 2013, EUR J CANCER, V49, P2253, DOI 10.1016/j.ejca.2013.02.020; Gilpin BJ, 1998, J BIOL CHEM, V273, P157, DOI 10.1074/jbc.273.1.157; Godde NJ, 2007, GENE, V403, P80, DOI 10.1016/j.gene.2007.07.033; Gonzales PE, 2004, J BIOL CHEM, V279, P31638, DOI 10.1074/jbc.M401311200; Harsha A, 2008, J MOL MED, V86, P961, DOI 10.1007/s00109-008-0353-z; Hiller M, 2006, AM J HUM GENET, V78, P291, DOI 10.1086/500151; Hiller M, 2008, TRENDS GENET, V24, P246, DOI 10.1016/j.tig.2008.03.003; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Hotoda N, 2002, BIOCHEM BIOPH RES CO, V293, P800, DOI 10.1016/S0006-291X(02)00302-9; Howard L, 2000, BIOCHEM J, V348, P21, DOI 10.1042/0264-6021:3480021; Iba K, 1999, AM J PATHOL, V154, P1489, DOI 10.1016/S0002-9440(10)65403-X; Ieguchi K, 2013, ONCOGENE, DOI [10.1038/onc.2013.180, DOI 10.1038/0NC.2013.180]; Kleino I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-90; Kleino I, 2009, J CELL BIOCHEM, V108, P877, DOI 10.1002/jcb.22317; Kodama T, 2004, AM J PATHOL, V165, P1743, DOI 10.1016/S0002-9440(10)63429-3; Kurisaki T, 1998, MECH DEVELOP, V73, P211, DOI 10.1016/S0925-4773(98)00043-4; Kurisaki T, 2003, MOL CELL BIOL, V23, P55, DOI 10.1128/MCB.23.1.55-61.2003; Kurisaki T, 2002, FEBS LETT, V532, P419, DOI 10.1016/S0014-5793(02)03732-8; Kveiborg M, 2005, CANCER RES, V65, P4754, DOI 10.1158/0008-5472.CAN-05-0262; Kveiborg M, 2008, INT J BIOCHEM CELL B, V40, P1685, DOI 10.1016/j.biocel.2008.01.025; Le Pabic H, 2003, HEPATOLOGY, V37, P1056, DOI 10.1053/jhep.2003.50205; Lendeckel U, 2005, J CANCER RES CLIN, V131, P41, DOI 10.1007/s00432-004-0619-y; Li H, 2013, BREAST CANCER RES TR, V139, P691, DOI 10.1007/s10549-013-2602-2; Li H, 2012, BREAST CANCER RES TR, V135, P759, DOI 10.1007/s10549-012-2220-4; Mazzocca A, 2005, CANCER RES, V65, P4728, DOI 10.1158/0008-5472.CAN-04-4449; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Mino N, 2009, J SURG ONCOL, V100, P267, DOI 10.1002/jso.21313; Mitsui Y, 2006, CANCER RES, V66, P9913, DOI 10.1158/0008-5472.CAN-06-0377; Ohlig S, 2011, DEV CELL, V20, P764, DOI 10.1016/j.devcel.2011.05.010; Ortiz RM, 2004, GENE CHROMOSOME CANC, V41, P366, DOI 10.1002/gcc.20102; Peduto L, 2006, ONCOGENE, V25, P5462, DOI 10.1038/sj.onc.1209536; Powell RM, 2004, AM J RESP CELL MOL, V31, P13, DOI 10.1165/rcmb.2003-0330OC; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Rao VH, 2012, ONCOGENE, V31, P2888, DOI 10.1038/onc.2011.460; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Roberts CM, 1999, J BIOL CHEM, V274, P29251, DOI 10.1074/jbc.274.41.29251; Sagane K, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-33; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Skubitz KM, 2004, J LAB CLIN MED, V143, P89, DOI 10.1016/j.lab.2003.10.002; Sorensen HP, 2008, J BIOL CHEM, V283, P31920, DOI 10.1074/jbc.M804113200; Stautz D, 2012, TRAFFIC, V13, P1532, DOI 10.1111/j.1600-0854.2012.01405.x; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Uehara E, 2012, INT J ONCOL, V40, P1414, DOI 10.3892/ijo.2012.1339; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Wang X, 2009, CIRCULATION, V119, P2480, DOI 10.1161/CIRCULATIONAHA.108.835488; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Weber S, 2012, DEVELOPMENT, V139, P3693, DOI 10.1242/dev.076398; Gomis-Ruth FX, 2009, J BIOL CHEM, V284, P15353, DOI 10.1074/jbc.R800069200; Xu SW, 2007, MATRIX BIOL, V26, P625, DOI 10.1016/j.matbio.2007.06.003	64	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75730	10.1371/journal.pone.0075730	http://dx.doi.org/10.1371/journal.pone.0075730			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116070	gold, Green Submitted, Green Published			2022-12-25	WOS:000325501300040
J	Watkins, S; Pichler, WJ				Watkins, Stephan; Pichler, Werner J.			Sulfamethoxazole Induces a Switch Mechanism in T Cell Receptors Containing TCRV beta 20-1, Altering pHLA Recognition	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; TOXIC EPIDERMAL NECROLYSIS; LABIAL SALIVARY-GLANDS; MOLECULAR-DYNAMICS; SJOGRENS-SYNDROME; CROSS-REACTIVITY; CONFORMATIONAL-CHANGES; PEPTIDE-MHC; TCR; SPECIFICITY	T cell receptors (TCR) containing V beta 20-1 have been implicated in a wide range of T cell mediated disease and allergic reactions, making it a target for understanding these. Mechanics of T cell receptors are largely unexplained by static structures available from x-ray crystallographic studies. A small number of molecular dynamic simulations have been conducted on TCR, however are currently lacking either portions of the receptor or explanations for differences between binding and non-binding TCR recognition of respective peptide-HLA. We performed molecular dynamic simulations of a TCR containing variable domain V beta 20-1, sequenced from drug responsive T cells. These were initially from a patient showing maculopapular eruptions in response to the sulfanilamide-antibiotic sulfamethoxazole (SMX). The CDR2 beta domain of this TCR was found to dock SMX with high affinity. Using this compound as a perturbation, overall mechanisms involved in responses mediated by this receptor were explored, showing a chemical action on the TCR free from HLA or peptide interaction. Our simulations show two completely separate modes of binding cognate peptide-HLA complexes, with an increased affinity induced by SMX bound to the V beta 20-1. Overall binding of the TCR is mediated through a primary recognition by either the variable beta or a domain, and a switch in recognition within these across TCR loops contacting the peptide and HLA occurs when SMX is present in the CDR2 beta loop. Large binding affinity differences are induced by summed small amino acid changes primarily by SMX modifying only three critical CDR2 beta loop amino acid positions. These residues, TYR beta 57, ASP beta 64, and LYS beta 65 initially hold hydrogen bonds from the CDR2 beta to adjacent CDR loops. Effects from SMX binding are amplified and traverse longer distances through internal TCR hydrogen bonding networks, controlling the overall TCR conformation. Thus, the CDR2 beta of V beta 20-1 acts as a ligand controlled switch affecting overall TCR binding affinity.	[Watkins, Stephan; Pichler, Werner J.] Univ Hosp Bern, Inselspital, Dept Rheumatol Clin Immunol & Allergol, CH-3010 Bern, Switzerland; [Watkins, Stephan] Univ Bern, Dept Grad Cell Biol, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern	Watkins, S (corresponding author), Univ Hosp Bern, Inselspital, Dept Rheumatol Clin Immunol & Allergol, CH-3010 Bern, Switzerland.	Stephan.lloyd@students.unibe.ch		Pichler, Werner J./0000-0002-8117-359X	Swiss National Science Foundation [SNF 310030_129828/1]; Swiss Center of Human Toxicology (SCAHT)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Center of Human Toxicology (SCAHT)	This study was supported by the Swiss National Science Foundation, supporting grant number SNF 310030_129828/1, and Swiss Center of Human Toxicology (SCAHT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allerbring EB, 2012, EUR J IMMUNOL, V42, P2990, DOI 10.1002/eji.201242588; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; APOSTOLOV R, 2010, GROMACS USER MANUAL, P352; Arechaga I, 2010, INT IMMUNOL, V22, P897, DOI 10.1093/intimm/dxq443; Armstrong KM, 2008, BIOCHEM J, V415, P183, DOI 10.1042/BJ20080850; Baker BM, 2012, IMMUNOL REV, V250, P10, DOI 10.1111/j.1600-065X.2012.01165.x; Beddoe T, 2009, IMMUNITY, V30, P777, DOI 10.1016/j.immuni.2009.03.018; Berrie JL, 2012, TRANSPLANTATION, V93, P949, DOI 10.1097/TP.0b013e3182497561; Beyer K, 1999, J IMMUNOL, V162, P1186; Budinger L, 2001, J IMMUNOL, V167, P6038, DOI 10.4049/jimmunol.167.10.6038; Burrows SR, 2010, P NATL ACAD SCI USA, V107, P10608, DOI 10.1073/pnas.1004926107; Castrejon JL, 2010, J ALLERGY CLIN IMMUN, V125, P411, DOI 10.1016/j.jaci.2009.10.031; Choudhury N, 2006, J PHYS CHEM B, V110, P8459, DOI 10.1021/jp056909r; Cuendet MA, 2008, BIOPHYS J, V95, P3575, DOI 10.1529/biophysj.108.131383; Cuendet MA, 2011, PROTEINS, V79, P3007, DOI 10.1002/prot.23104; de Groot BL, 1998, PROTEINS, V31, P116, DOI 10.1002/(SICI)1097-0134(19980501)31:2<116::AID-PROT2>3.0.CO;2-K; Durrant JD, 2009, CHEM BIOL DRUG DES, V73, P168, DOI 10.1111/j.1747-0285.2008.00761.x; Ellis NMJ, 2005, J IMMUNOL, V175, P5448, DOI 10.4049/jimmunol.175.8.5448; Esposito M, 2011, J PHYS CHEM B, V115, P5144, DOI 10.1021/jp104780z; Fukuda I, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.016203; Gagnon SJ, 2006, J MOL BIOL, V363, P228, DOI 10.1016/j.jmb.2006.08.045; GARCIA AE, 1992, PHYS REV LETT, V68, P2696, DOI 10.1103/PhysRevLett.68.2696; Garcia KC, 2001, P NATL ACAD SCI USA, V98, P6818, DOI 10.1073/pnas.111161198; Garcia KC, 1997, P NATL ACAD SCI USA, V94, P13838, DOI 10.1073/pnas.94.25.13838; Garcia-Carrasco M, 2006, ARCH MED RES, V37, P921, DOI 10.1016/j.arcmed.2006.08.002; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Harr T, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-39; Hausmann Oliver, 2010, Handb Exp Pharmacol, P29, DOI 10.1007/978-3-642-00663-0_2; Hayward Steven, 2008, V443, P89, DOI 10.1007/978-1-59745-177-2_5; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; Holland CJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00629; Holland SJ, 2012, P NATL ACAD SCI USA, V109, pE3111, DOI 10.1073/pnas.1210882109; Hub JS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000480; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HUNENBERGER PH, 1995, J MOL BIOL, V252, P492, DOI 10.1006/jmbi.1995.0514; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Ko TM, 2012, EXPERT REV CLIN IMMU, V8, P467, DOI [10.1586/eci.12.31, 10.1586/ECI.12.31]; Kuhns MS, 2012, IMMUNOL REV, V250, P120, DOI 10.1111/imr.12000; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lee JK, 2004, J EXP MED, V200, P1455, DOI 10.1084/jem.20041251; Lee MS, 2006, BIOPHYS J, V90, P864, DOI 10.1529/biophysj.105.071589; Lefranc MP, 1998, EXP CLIN IMMUNOGENET, V15, P1, DOI 10.1159/000019049; McArthur CP, 1997, J AUTOIMMUN, V10, P59, DOI 10.1006/jaut.1996.0109; Miah M A, 2008, Mymensingh Med J, V17, pS1; MICHAUDAGRAWAL N, 2011, J COMPUT CHEM, P218; Molina C, 2006, ANN RHEUM DIS, V65, P178, DOI 10.1136/ard.2004.033837; Moza B, 2007, EMBO J, V26, P1187, DOI 10.1038/sj.emboj.7601531; Oostenbrink C, 2005, EUR BIOPHYS J BIOPHY, V34, P273, DOI 10.1007/s00249-004-0448-6; Osterberg T, 2001, EUR J PHARM SCI, V12, P327, DOI 10.1016/S0928-0987(00)00189-5; Park H, 2006, PROTEINS, V65, P549, DOI 10.1002/prot.21183; Pichler Werner J, 2006, Allergol Int, V55, P17, DOI 10.2332/allergolint.55.17; Pichler WJ, 2011, J ALLERGY CLIN IMMUN, V127, pS74, DOI 10.1016/j.jaci.2010.11.048; Pichler WJ, 2003, ANN INTERN MED, V139, P683, DOI 10.7326/0003-4819-139-8-200310210-00012; Reantragoon R, 2012, J EXP MED, V209, P761, DOI 10.1084/jem.20112095; Roccatano D, 1999, PROTEIN SCI, V8, P2130, DOI 10.1110/ps.8.10.2130; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Schnyder B, 2000, J IMMUNOL, V164, P6647, DOI 10.4049/jimmunol.164.12.6647; Shen Z, 2005, J DERMATOL SCI, V38, P25, DOI 10.1016/j.jdermsci.2005.01.001; Shirts MR, 2007, J PHYS CHEM B, V111, P13052, DOI 10.1021/jp0735987; SUMIDA T, 1994, J RHEUMATOL, V21, P1655; SUMIDA T, 1992, J CLIN INVEST, V89, P681, DOI 10.1172/JCI115635; Sundberg EJ, 2002, J MOL BIOL, V319, P449, DOI 10.1016/S0022-2836(02)00370-4; Thomson CT, 2001, J IMMUNOL, V166, P3994, DOI 10.4049/jimmunol.166.6.3994; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Westen GJP, 2010, PROTEIN SCI, V19, P742, DOI 10.1002/pro.350; vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047; von Greyerz S, 1999, J IMMUNOL, V162, P595; Wolfson MY, 2011, J PHYS CHEM B, V115, P8317, DOI 10.1021/jp202471d; Yang CWO, 2007, J ALLERGY CLIN IMMUN, V120, P870, DOI 10.1016/j.jaci.2007.06.017; Yin L, 2012, IMMUNOL REV, V250, P49, DOI 10.1111/imr.12004; Yin YY, 2012, P NATL ACAD SCI USA, V109, P5405, DOI 10.1073/pnas.1118801109; Yoshioka T, 1999, IMMUNOLOGY, V96, P465, DOI 10.1046/j.1365-2567.1999.00695.x; Zanni MP, 1998, J CLIN INVEST, V102, P1591, DOI 10.1172/JCI3544	77	39	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76211	10.1371/journal.pone.0076211	http://dx.doi.org/10.1371/journal.pone.0076211			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116097	gold, Green Published			2022-12-25	WOS:000325501300052
J	Hanson, D; Cooke, S; Hirano, Y; Malaquias, MAE; Crocetta, F; Valdes, A				Hanson, Dieta; Cooke, Samantha; Hirano, Yayoi; Malaquias, Manuel A. E.; Crocetta, Fabio; Valdes, Angel			Slipping through the Cracks: The Taxonomic Impediment Conceals the Origin and Dispersal of Haminoea japonica, an Invasive Species with Impacts to Human Health	PLOS ONE			English	Article							POPULATION-GENETICS; GASTROPODA; OPISTHOBRANCHIA; CEPHALASPIDEA; STRATEGIES; PILSBRY; MODEL	Haminoea japonica is a species of opisthobranch sea slug native to Japan and Korea. Non-native populations have spread unnoticed for decades due to difficulties in the taxonomy of Haminoea species. Haminoea japonica is associated with a schistosome parasite in San Francisco Bay, thus further spread could have consequence to human health and economies. Anecdotal evidence suggests that H. japonica has displaced native species of Haminoea in North America and Europe, becoming locally dominant in estuaries and coastal lagoons. In this paper we study the population genetics of native and non-native populations of H. japonica based on mt-DNA data including newly discovered populations in Italy and France. The conclusions of this study further corroborate a Northeastern Japan origin for the non-native populations and suggest possible independent introductions into North America and Europe. Additionally, the data obtained revealed possible secondary introductions within Japan. Although non-native populations have experienced severe genetic bottlenecks they have colonized different regions with a broad range of water temperatures and other environmental conditions. The environmental tolerance of this species, along with its ability to become dominant in invaded areas and its association with a schistosome parasite, suggest H. japonica could be a dangerous invasive species.	[Hanson, Dieta; Cooke, Samantha; Valdes, Angel] Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA; [Hanson, Dieta] McGill Univ, Redpath Museum, Montreal, PQ H3A 2K6, Canada; [Hanson, Dieta] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Hirano, Yayoi] Chiba Univ, Grad Sch Sci, Chiba, Japan; [Malaquias, Manuel A. E.] Univ Museum Bergen, Phylogenet Systemat & Evolut Res Grp, Bergen, Norway; [Crocetta, Fabio] Staz Zool Anton Dohrn, Naples, Italy	California State University System; California State Polytechnic University Pomona; McGill University; McGill University; Chiba University; University of Bergen; Stazione Zoologica Anton Dohrn di Napoli	Valdes, A (corresponding author), Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA.	aavaldes@csupomona.edu	Valdes, Angel/K-3051-2012; Valdes, Angel/Q-1729-2018; Malaquias, Manuel/N-2450-2019; Crocetta, Fabio/AAA-6927-2022	Valdes, Angel/0000-0002-2347-4896; Valdes, Angel/0000-0002-2347-4896; Malaquias, Manuel/0000-0002-9668-945X; Crocetta, Fabio/0000-0002-2800-3735	California State University Agricultural Research Institute (ARI); Ernest Prete, Jr. Student Environmental Research Fellowship; Southern California Academy of Sciences; Conchologists of America; Houston Conchology Society; Research, Scholarship and Creative Activity (RSCA) Program at California State University; California State University Council on Ocean Affairs, Science, and Technology (COAST)	California State University Agricultural Research Institute (ARI); Ernest Prete, Jr. Student Environmental Research Fellowship; Southern California Academy of Sciences; Conchologists of America; Houston Conchology Society; Research, Scholarship and Creative Activity (RSCA) Program at California State University; California State University Council on Ocean Affairs, Science, and Technology (COAST)	This work was supported by the California State University Agricultural Research Institute (ARI) (http://www.csupomona.edu/similar to ari/), the Ernest Prete, Jr. Student Environmental Research Fellowship, the Southern California Academy of Sciences (http://scas.nhm.org/), Conchologists of America (http://www.conchologistsofamerica.org/home/), the Houston Conchology Society (http://www.houstonshellclub.com/), the Research, Scholarship and Creative Activity (RSCA) Program at California State University (http://www.csupomona.edu/similar to research/rsp/rsca_info.shtml), and the California State University Council on Ocean Affairs, Science, and Technology (COAST) (http://www.calstate.edu/coast/index.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aranishi Futoshi, 2004, Journal of Applied Genetics, V45, P435; Brant SV, 2010, EMERG INFECT DIS, V16, P1357, DOI 10.3201/eid1609.091664; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Colwell R. K., 2006, ESTIMATES VERSION 8; Crocetta F, 2013, ZOOKEYS, P91, DOI 10.3897/zookeys.277.4362; Crocetta F, 2012, J MAR BIOL ASSOC UK, V92, P1357, DOI 10.1017/S002531541100186X; Drummond AJ, 2009, GENEIOUS VERSION 4 8; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; GARCIA FJ, 1991, J MOLLUS STUD, V57, P395, DOI 10.1093/mollus/57.4.395; Gosliner Terrence M., 2006, Proceedings of the California Academy of Sciences, V57, P1003; Hanson D, 2013, BIOL INVASIONS, V15, P395, DOI 10.1007/s10530-012-0294-x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Lipscomb D, 2003, TRENDS ECOL EVOL, V18, P65, DOI 10.1016/S0169-5347(02)00060-5; Macali A, 2013, SCI MAR, V77, P649, DOI 10.3989/scimar.03858.05M; Maddison D.R., 2000, MACCLADE4 ANAL PHYLO; Malaquias MAE, 2006, J MOLLUS STUD, V72, P89, DOI 10.1093/mollus/eyi052; Malaquias MAE, 2005, ESTUAR COAST SHELF S, V63, P177, DOI 10.1016/j.ecss.2004.11.005; Malaquias MAE, 2009, ZOOL SCR, V38, P23, DOI 10.1111/j.1463-6409.2008.00354.x; Mehta SV, 2007, ECOL ECON, V61, P237, DOI 10.1016/j.ecolecon.2006.10.024; Pejchar L, 2009, TRENDS ECOL EVOL, V24, P497, DOI 10.1016/j.tree.2009.03.016; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548; Rambaut A, 2007, TRACER 1 4; Soldanova M, 2013, TRENDS PARASITOL, V29, P65, DOI 10.1016/j.pt.2012.12.002; TALAVERA P, 1987, Bollettino Malacologico, V23, P53; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON TE, 1981, J MOLLUS STUD, V47, P73, DOI 10.1093/oxfordjournals.mollus.a065559; Wheeler QD, 2004, SCIENCE, V303, P285, DOI 10.1126/science.303.5656.285	30	23	23	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e77457	10.1371/journal.pone.0077457	http://dx.doi.org/10.1371/journal.pone.0077457			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098588	gold, Green Submitted, Green Published			2022-12-25	WOS:000325483600087
J	Vuoristo, S; Toivonen, S; Weltner, J; Mikkola, M; Ustinov, J; Trokovic, R; Palgi, J; Lund, R; Tuuri, T; Otonkoski, T				Vuoristo, Sanna; Toivonen, Sanna; Weltner, Jere; Mikkola, Milla; Ustinov, Jarkko; Trokovic, Ras; Palgi, Jaan; Lund, Riikka; Tuuri, Timo; Otonkoski, Timo			A Novel Feeder-Free Culture System for Human Pluripotent Stem Cell Culture and Induced Pluripotent Stem Cell Derivation	PLOS ONE			English	Article							SUPPORTS UNDIFFERENTIATED GROWTH; BASEMENT-MEMBRANES; RESTRICTED DISTRIBUTION; DIFFERENTIATION; INHIBITOR; STABILITY; EXPANSION; LINES	Correct interactions with extracellular matrix are essential to human pluripotent stem cells (hPSC) to maintain their pluripotent self-renewal capacity during in vitro culture. hPSCs secrete laminin 511/521, one of the most important functional basement membrane components, and they can be maintained on human laminin 511 and 521 in defined culture conditions. However, large-scale production of purified or recombinant laminin 511 and 521 is difficult and expensive. Here we have tested whether a commonly available human choriocarcinoma cell line, JAR, which produces high quantities of laminins, supports the growth of undifferentiated hPSCs. We were able to maintain several human pluripotent stem cell lines on decellularized matrix produced by JAR cells using a defined culture medium. The JAR matrix also supported targeted differentiation of the cells into neuronal and hepatic directions. Importantly, we were able to derive new human induced pluripotent stem cell (hiPSC) lines on JAR matrix and show that adhesion of the early hiPSC colonies to JAR matrix is more efficient than to matrigel. In summary, JAR matrix provides a cost-effective and easy-to-prepare alternative for human pluripotent stem cell culture and differentiation. In addition, this matrix is ideal for the efficient generation of new hiPSC lines.	[Vuoristo, Sanna; Toivonen, Sanna; Weltner, Jere; Mikkola, Milla; Ustinov, Jarkko; Trokovic, Ras; Palgi, Jaan; Tuuri, Timo; Otonkoski, Timo] Univ Helsinki, Res Programs Unit, Mol Neurol & Biomedicum Stem Cell Ctr, Helsinki, Finland; [Lund, Riikka] Univ Turku, Turku Ctr Biotechnol, Finnish Microarray & Sequencing Ctr, Turku, Finland; [Lund, Riikka] Abo Akad Univ, Turku, Finland; [Otonkoski, Timo] Univ Helsinki, Cent Hosp, Childrens Hosp, Helsinki, Finland	University of Helsinki; University of Turku; Abo Akademi University; University of Helsinki; Helsinki University Central Hospital	Vuoristo, S (corresponding author), Univ Helsinki, Res Programs Unit, Mol Neurol & Biomedicum Stem Cell Ctr, Helsinki, Finland.	sanna.vuoristo@helsinki.fi	Lund, Riikka J/F-7320-2014; Lund, Riikka/AAW-7853-2020; Lund, Riikka/K-2441-2019; Trokovic, Ras/AAC-7309-2022	Lund, Riikka/0000-0002-1068-5918; Trokovic, Ras/0000-0002-3065-6663	Academy of Finland; Sigrid Juselius Foundation; Helsinki University Hospital EVO-research funds; Helsinki Biomedical Graduate Program; Instrumentarium Science Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Helsinki University Hospital EVO-research funds; Helsinki Biomedical Graduate Program; Instrumentarium Science Foundation	The work was funded by Academy of Finland, Sigrid Juselius Foundation, Helsinki University Hospital EVO-research funds, Helsinki Biomedical Graduate Program (SV, ST, JW) and Instrumentarium Science Foundation (SV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Aumailley M, 1998, J ANAT, V193, P1, DOI 10.1046/j.1469-7580.1998.19310001.x; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; BRAAM SR, 2008, STEM CELLS; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Dravid G, 2006, METH MOL B, V331, P91; ENGVALL E, 1990, CELL REGUL, V1, P731, DOI 10.1091/mbc.1.10.731; Fukusumi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055226; Hay DC, 2008, STEM CELLS, V26, P894, DOI 10.1634/stemcells.2007-0718; Hongisto H, 2012, STEM CELL RES, V8, P97, DOI 10.1016/j.scr.2011.08.005; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Lebkowski JS, 2001, CANCER J, V7, pS83; Li Y, 2005, BIOTECHNOL BIOENG, V91, P688, DOI 10.1002/bit.20536; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Lund RJ, 2012, STEM CELL RES, V9, P192, DOI 10.1016/j.scr.2012.06.008; Lund RJ, 2012, NAT REV GENET, V13, P732, DOI 10.1038/nrg3271; Mikkola M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-40; Mikkola M, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0365; Miyazaki T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2231; Murray P, 2000, J CELL BIOL, V150, P1215, DOI 10.1083/jcb.150.5.1215; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; Stojkovic P, 2005, STEM CELLS, V23, P895, DOI 10.1634/stemcells.2004-0326; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Tang C, 2011, NAT BIOTECHNOL, V29, P829, DOI 10.1038/nbt.1947; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208; Virtanen I, 2000, EXP CELL RES, V257, P298, DOI 10.1006/excr.2000.4883; Vuoristo S, 2009, J CELL MOL MED, V13, P2622, DOI 10.1111/j.1582-4934.2008.00643.x; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xu CH, 2005, STEM CELLS, V23, P315, DOI 10.1634/stemcells.2004-0211; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006; Zhou JX, 2010, STEM CELLS, V28, P1741, DOI 10.1002/stem.504	33	22	24	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76205	10.1371/journal.pone.0076205	http://dx.doi.org/10.1371/journal.pone.0076205			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098444	Green Published, gold, Green Submitted			2022-12-25	WOS:000325434500051
J	Hu, LB; Wang, DD; Liu, L; Chen, J; Xue, YF; Shi, ZQ				Hu, Liangbin; Wang, Dede; Liu, Li; Chen, Jian; Xue, Yanfeng; Shi, Zhiqi			Ca2+ Efflux Is Involved in Cinnamaldehyde-Induced Growth Inhibition of Phytophthora capsici	PLOS ONE			English	Article							CALCIUM HOMEOSTASIS; ANTIFUNGAL ACTIVITY; NEUROSPORA-CRASSA; CANDIDA-ALBICANS; CELL-WALL; IDENTIFICATION; AMIODARONE; INCREASE; EUGENOL; FUNGI	As a destructive fungus-like plant pathogen, the oomycete Phytophthora capsici is unable to synthesize its own ergosterol as the potential target of fungicide cinnamaldehyde (CA). In this study, CA exerted efficient inhibitory effects on both mycelial growth (EC50=0.75 mM) and zoospore germination (MIC=0.4 mM) of P. capsici. CA-induced immediate Ca2+ efflux from zoospores could be confirmed by the rapid decrease in intracellular Ca2+ content determined by using Fluo-3 AM and the increase in extracellular Ca2+ concentration determined by using ICP-AES (inductively coupled plasma atomic emission spectrometry). Blocking Ca2+ influx with ruthenium red and verapamil led to a higher level of CA-induced Ca2+ efflux, suggesting the simultaneous occurrence of Ca2+ influx along with the Ca2+ efflux under CA exposure. Further results showed that EGTA-induced decrease in intracellular Ca2+ gave rise to the impaired vitality of P. capsici while the addition of exogenous Ca2+ could suppress the growth inhibitory effect of CA. These results suggested that Ca2+ efflux played an important role in CA-induced growth inhibition of P. capsici. The application of 3-phenyl-1-propanal, a CA analog without alpha,beta-unsaturated bond, resulted in a marked Ca2+ influx in zoospores but did not show any growth inhibitory effects. In addition, exogenous cysteine, an antagonist against the Michael addition (the nucleophilic addition of a carbanion or another nucleophile) between CA and its targets, could attenuate CA-induced growth inhibition of P. capsici by suppressing Ca2+ efflux. Our results suggest that CA inhibits the growth of P. capsici by stimulating a transient Ca2+ efflux via Michael addition, which provides important new insights into the antimicrobial action of CA.	[Hu, Liangbin; Wang, Dede; Liu, Li; Chen, Jian; Xue, Yanfeng; Shi, Zhiqi] Jiangsu Acad Agr Sci, Inst Food Safety & Monitoring Technol, Nanjing, Jiangsu, Peoples R China; [Wang, Dede] Nanjing Agr Univ, Plant Protect Coll, Nanjing, Jiangsu, Peoples R China; [Liu, Li] Nanjing Normal Univ, Sch Life Sci, Nanjing, Jiangsu, Peoples R China; [Hu, Liangbin] Henan Inst Sci & Technol, Sch Food Sci, Xinxiang, Peoples R China	Jiangsu Academy of Agricultural Sciences; Nanjing Agricultural University; Nanjing Normal University; Henan Institute of Science & Technology	Shi, ZQ (corresponding author), Jiangsu Acad Agr Sci, Inst Food Safety & Monitoring Technol, Nanjing, Jiangsu, Peoples R China.	jaasinput@gmail.com		Hu, `Liangbin/0000-0003-0747-093X	Jiangsu Agricultural Science Independent Innovation Funds [CX(12)1004]	Jiangsu Agricultural Science Independent Innovation Funds	This research work was financially supported by Jiangsu Agricultural Science Independent Innovation Funds [CX(12)1004]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinolfi E, 2009, J BIOL CHEM, V284, P10120, DOI 10.1074/jbc.M805805200; Bang KH, 2000, BIOSCI BIOTECH BIOCH, V64, P1061, DOI 10.1271/bbb.64.1061; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Binder U, 2010, EUKARYOT CELL, V9, P1374, DOI 10.1128/EC.00050-10; Brand A, 2007, CURR BIOL, V17, P347, DOI 10.1016/j.cub.2006.12.043; Brini  M., 2011, COLD SPRING HARB PER, V3; Bublitz M, 2010, CURR OPIN STRUC BIOL, V20, P431, DOI 10.1016/j.sbi.2010.06.007; Cai XJ, 2012, MOL BIOL EVOL, V29, P91, DOI 10.1093/molbev/msr149; Cerella Claudia, 2010, Int J Cell Biol, V2010, P546163, DOI 10.1155/2010/546163; Cheng SS, 2008, BIORESOURCE TECHNOL, V99, P5145, DOI 10.1016/j.biortech.2007.09.013; Courchesne WE, 2002, J PHARMACOL EXP THER, V300, P195, DOI 10.1124/jpet.300.1.195; Courchesne WE, 2009, CAN J MICROBIOL, V55, P288, DOI [10.1139/W08-132, 10.1139/w08-132]; Curry MC, 2012, J BIOL CHEM, V287, P28598, DOI 10.1074/jbc.M112.364737; Di A, 2010, CURR OPIN PHARMACOL, V10, P127, DOI 10.1016/j.coph.2009.11.010; Enomoto M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039499; Erwin D. C., 1996, Phytophthora diseases worldwide.; Gaulin E, 2010, PLANT SIGNAL BEHAV, V5, P258, DOI 10.4161/psb.5.3.10551; Gevens AJ, 2007, PHYTOPATHOLOGY, V97, P421, DOI 10.1094/PHYTO-97-4-0421; Gill AO, 2004, APPL ENVIRON MICROB, V70, P5750, DOI 10.1128/AEM.70.10.5750-5755.2004; Greene V, 2002, CELL SIGNAL, V14, P437, DOI 10.1016/S0898-6568(01)00266-2; Hausbeck MK, 2004, PLANT DIS, V88, P1292, DOI 10.1094/PDIS.2004.88.12.1292; Kallies A, 1998, ARCH MICROBIOL, V170, P191, DOI 10.1007/s002030050633; Kwon JA, 2003, LETT APPL MICROBIOL, V37, P61, DOI 10.1046/j.1472-765X.2003.01350.x; Li HX, 2008, POSTHARVEST BIOL TEC, V47, P239, DOI 10.1016/j.postharvbio.2007.06.022; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Magnone M, 2012, J BIOL CHEM, V287, P21067, DOI 10.1074/jbc.M111.324269; Pang ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056513; Shigaki T, 2006, J MOL EVOL, V63, P815, DOI 10.1007/s00239-006-0048-4; Shreaz S, 2010, MICROB PATHOGENESIS, V49, P75, DOI 10.1016/j.micpath.2010.03.013; Silvar C, 2005, EUR J PLANT PATHOL, V112, P43, DOI 10.1007/s10658-004-8232-0; Silverman-Gavrila LB, 2002, J CELL SCI, V115, P5013, DOI 10.1242/jcs.00180; Spelbrink RG, 2004, PLANT PHYSIOL, V135, P2055, DOI 10.1104/pp.104.040873; Steinbach WJ, 2006, EUKARYOT CELL, V5, P1091, DOI 10.1128/EC.00139-06; Vernier PT, 2003, BIOCHEM BIOPH RES CO, V310, P286, DOI 10.1016/j.bbrc.2003.08.140; Wang SY, 2005, BIORESOURCE TECHNOL, V96, P813, DOI 10.1016/j.biortech.2004.07.010; Yu QL, 2012, MICROBIOL-SGM, V158, P2272, DOI 10.1099/mic.0.057232-0	36	26	30	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76264	10.1371/journal.pone.0076264	http://dx.doi.org/10.1371/journal.pone.0076264			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098458	Green Submitted, Green Published, gold			2022-12-25	WOS:000325427100052
J	Smigielska-Czepiel, K; van den Berg, A; Jellema, P; Slezak-Prochazka, I; Maat, H; van den Bos, H; van der Lei, RJ; Kluiver, J; Brouwer, E; Boots, AMH; Kroesen, BJ				Smigielska-Czepiel, Katarzyna; van den Berg, Anke; Jellema, Pytrick; Slezak-Prochazka, Izabella; Maat, Henny; van den Bos, Hilda; van der Lei, Roelof Jan; Kluiver, Joost; Brouwer, Elisabeth; Boots, Anne Mieke H.; Kroesen, Bart-Jan			Dual Role of miR-21 in CD4+T-Cells: Activation-Induced miR-21 Supports Survival of Memory T-Cells and Regulates CCR7 Expression in Naive T-Cells	PLOS ONE			English	Article							NEGATIVE FEEDBACK; MICRORNA-21; IDENTIFICATION; MODULATOR; EFFECTOR; IMMUNITY; AP-1; RNA	Immune cell-type specific miRNA expression patterns have been described but the detailed role of single miRNAs in the function of T-cells remains largely unknown. We investigated the role of miR-21 in the function of primary human CD4+ T-cells. MiR-21 is substantially expressed in T-cells with a memory phenotype, and is robustly upregulated upon alpha CD3/CD28 activation of both naive and memory T-cells. By inhibiting the endogenous miR-21 function in activated naive and memory T-cells, we showed that miR-21 regulates fundamentally different aspects of T-cell biology, depending on the differentiation status of the T-cell. Stable inhibition of miR-21 function in activated memory T-cells led to growth disadvantage and apoptosis, indicating that the survival of memory T-cells depends on miR-21 function. In contrast, stable inhibition of miR-21 function in activated naive T-cells did not result in growth disadvantage, but led to a significant induction of CCR7 protein expression. Direct interaction between CCR7 and miR-21 was confirmed in a dual luciferase reporter assay. Our data provide evidence for a dual role of miR-21 in CD4+ T cells; Regulation of T-cell survival is confined to activated memory T-cells, while modulation of potential homing properties, through downregulation of CCR7 protein expression, is observed in activated naive T-cells.	[Smigielska-Czepiel, Katarzyna; van den Berg, Anke; Jellema, Pytrick; Slezak-Prochazka, Izabella; Maat, Henny; van den Bos, Hilda; van der Lei, Roelof Jan; Kluiver, Joost; Kroesen, Bart-Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Brouwer, Elisabeth; Boots, Anne Mieke H.] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands; [Kroesen, Bart-Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands; [Smigielska-Czepiel, Katarzyna; Brouwer, Elisabeth; Boots, Anne Mieke H.; Kroesen, Bart-Jan] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Initiat Healthy Ageing & Immune Lon, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Kroesen, BJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.	b.j.kroesen@umcg.nl	Slezak-Prochazka, Izabella/F-7674-2019; Brouwer, Elisabeth/AAL-9029-2020; Kluiver, Joost/G-6406-2014; van den Berg, Anke/H-1718-2011; Brouwer, Elisabeth/A-3198-2015	Slezak-Prochazka, Izabella/0000-0002-0707-2213; Brouwer, Elisabeth/0000-0002-5652-4423; Kluiver, Joost/0000-0001-7650-2937; van den Berg, Anke/0000-0002-8894-2638; Brouwer, Elisabeth/0000-0002-5652-4423	Jan Kornelis de Cock Foundation; Ubbo Emmius Fellowship	Jan Kornelis de Cock Foundation; Ubbo Emmius Fellowship	This study was supported by a grant from the Jan Kornelis de Cock Foundation and by an Ubbo Emmius Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bronevetsky Y, 2013, J EXP MED, V210, P417, DOI 10.1084/jem.20111717; Campbell JJ, 2001, J IMMUNOL, V166, P877, DOI 10.4049/jimmunol.166.2.877; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Curtale G, 2010, BLOOD, V115, P265, DOI 10.1182/blood-2009-06-225987; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Garchow BG, 2011, EMBO MOL MED, V3, P605, DOI 10.1002/emmm.201100171; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gibcus JH, 2009, NEOPLASIA, V11, P167, DOI 10.1593/neo.08980; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grigoryev YA, 2011, J IMMUNOL, V187, P2233, DOI 10.4049/jimmunol.1101233; Haining WN, 2008, J IMMUNOL, V181, P1859, DOI 10.4049/jimmunol.181.3.1859; Haining WN, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-44; Hardtke S, 2005, BLOOD, V106, P1924, DOI 10.1182/blood-2004-11-4494; Iliopoulos D, 2011, EUR J IMMUNOL, V41, P1754, DOI 10.1002/eji.201040646; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Ma CS, 2004, IMMUNOL CELL BIOL, V82, P67, DOI 10.1046/j.0818-9641.2003.01206.x; Meisgen F, 2012, EXP DERMATOL, V21, P312, DOI 10.1111/j.1600-0625.2012.01462.x; Niu JX, 2012, J BIOL CHEM, V287, P21783, DOI 10.1074/jbc.M112.355495; Rossi RL, 2011, NAT IMMUNOL; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Siegel AM, 2011, IMMUNITY, V35, P806, DOI 10.1016/j.immuni.2011.09.016; Stagakis E, 2011, ANN RHEUM DIS, V70, P1496, DOI 10.1136/ard.2010.139857; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; van der Fits L, 2011, J INVEST DERMATOL, V131, P762, DOI 10.1038/jid.2010.349; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Yang CH, 2010, CANCER RES, V70, P8108, DOI 10.1158/0008-5472.CAN-10-2579; Zhang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038510; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707	35	53	58	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76217	10.1371/journal.pone.0076217	http://dx.doi.org/10.1371/journal.pone.0076217			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098447	gold, Green Published, Green Submitted			2022-12-25	WOS:000325427100049
J	Blasius, TL; Reed, N; Slepchenko, BM; Verhey, KJ				Blasius, T. Lynne; Reed, Nathan; Slepchenko, Boris M.; Verhey, Kristen J.			Recycling of Kinesin-1 Motors by Diffusion after Transport	PLOS ONE			English	Article							FAST AXONAL-TRANSPORT; TUG-OF-WAR; LIVING CAENORHABDITIS-ELEGANS; RETROGRADE ENDOSOME MOTILITY; MICROTUBULE PLUS-ENDS; CYTOPLASMIC DYNEIN; MOLECULAR MOTORS; VESICLE TRANSPORT; SCAFFOLD PROTEIN; ORGANELLE TRANSPORT	Kinesin motors drive the long-distance anterograde transport of cellular components along microtubule tracks. Kinesin-dependent transport plays a critical role in neurogenesis and neuronal function due to the large distance separating the soma and nerve terminal. The fate of kinesin motors after delivery of their cargoes is unknown but has been postulated to involve degradation at the nerve terminal, recycling via retrograde motors, and/or recycling via diffusion. We set out to test these models concerning the fate of kinesin-1 motors after completion of transport in neuronal cells. We find that kinesin-1 motors are neither degraded nor returned by retrograde motors. By combining mathematical modeling and experimental analysis, we propose a model in which the distribution and recycling of kinesin-1 motors fits a "loose bucket brigade" where individual motors alter between periods of active transport and free diffusion within neuronal processes. These results suggest that individual kinesin-1 motors are utilized for multiple rounds of transport.	[Blasius, T. Lynne; Reed, Nathan; Verhey, Kristen J.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Slepchenko, Boris M.] Univ Connecticut, Dept Cell Biol, RD Berlin Ctr Cell Anal & Modeling, Ctr Hlth, Farmington, CT 06030 USA	University of Michigan System; University of Michigan; University of Connecticut	Verhey, KJ (corresponding author), Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.	kjverhey@umich.edu			NIH [1U54-RR022232, P41-RR13186, GM070862]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013186, U54RR022232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103313, R01GM070862] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants to BMS (1U54-RR022232 and P41-RR13186) and KJV (GM070862). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Akhmanova A, 2010, CURR OPIN CELL BIOL, V22, P479, DOI 10.1016/j.ceb.2010.04.008; Allan VJ, 2011, BIOCHEM SOC T, V39, P1169, DOI 10.1042/BST0391169; Anderson C, 2002, INSECT SOC, V49, P171, DOI 10.1007/s00040-002-8298-7; Arimoto M, 2011, J NEUROSCI, V31, P2216, DOI 10.1523/JNEUROSCI.2653-10.2011; Astanina K, 2010, CELL MOL LIFE SCI, V67, P1331, DOI 10.1007/s00018-009-0253-6; Bananis E, 2004, MOL BIOL CELL, V15, P3688, DOI 10.1091/mbc.E04-04-0278; Barkus RV, 2008, MOL BIOL CELL, V19, P274, DOI 10.1091/mbc.E07-03-0261; Barlan K, 2013, CURR OPIN CELL BIOL; Baumann S, 2012, J CELL SCI, V125, P2740, DOI 10.1242/jcs.101212; Blasius TL, 2007, J CELL BIOL, V176, P11, DOI 10.1083/jcb.200605099; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; BRADY ST, 1985, NATURE, V317, P73, DOI 10.1038/317073a0; Bratcu AI, 2005, J INTELL MANUF, V16, P139, DOI 10.1007/s10845-004-5885-7; Brendza RP, 2002, CURR BIOL, V12, P1541, DOI 10.1016/S0960-9822(02)01108-9; Brown CL, 2005, TRAFFIC, V6, P1114, DOI 10.1111/j.1600-0854.2005.00347.x; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Byrd DT, 2001, NEURON, V32, P787, DOI 10.1016/S0896-6273(01)00532-3; Cai DW, 2007, BIOPHYS J, V92, P4137, DOI 10.1529/biophysj.106.100206; Cai DW, 2007, J CELL BIOL, V176, P51, DOI 10.1083/jcb.200605097; Cai DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000216; Cavalli V, 2005, J CELL BIOL, V168, P775, DOI 10.1083/jcb.200410136; CORTHESYTHEULAZ I, 1992, J CELL BIOL, V118, P1333, DOI 10.1083/jcb.118.6.1333; DAHLSTROM AB, 1991, ACTA PHYSIOL SCAND, V141, P469, DOI 10.1111/j.1748-1716.1991.tb09107.x; Dajas-Ballador F, 2008, CURR BIOL, V18, P221, DOI 10.1016/j.cub.2008.01.025; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; DeBoer SR, 2008, BIOCHEMISTRY-US, V47, P4535, DOI 10.1021/bi702445j; Encalada SE, 2011, CELL, V144, P551, DOI 10.1016/j.cell.2011.01.021; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; GIOIO AE, 1994, J NEUROCHEM, V63, P13; Gross SP, 2003, CURR BIOL, V13, P1660, DOI 10.1016/j.cub.2003.08.032; Gross SP, 2002, J CELL BIOL, V156, P855, DOI 10.1083/jcb.200105055; Haghnia M, 2007, MOL BIOL CELL, V18, P2081, DOI 10.1091/mbc.E06-08-0695; Hammond JW, 2010, MOL BIOL CELL, V21, P572, DOI 10.1091/mbc.E09-01-0044; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; HIROKAWA N, 1991, J CELL BIOL, V114, P295, DOI 10.1083/jcb.114.2.295; HIROKAWA N, 1990, J CELL BIOL, V111, P1027, DOI 10.1083/jcb.111.3.1027; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; HOLLENBECK PJ, 1989, J CELL BIOL, V108, P2335, DOI 10.1083/jcb.108.6.2335; Horiuchi D, 2005, CURR BIOL, V15, P2137, DOI 10.1016/j.cub.2005.10.047; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kelkar N, 2005, MOL CELL BIOL, V25, P2733, DOI 10.1128/MCB.25.7.2733-2743.2005; Kholodenko BN, 2003, J EXP BIOL, V206, P2073, DOI 10.1242/jeb.00298; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; Koushika SP, 2004, J NEUROSCI, V24, P3907, DOI 10.1523/JNEUROSCI.5039-03.2004; Kumar J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001200; Lagache T, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.030901; Laib JA, 2009, P NATL ACAD SCI USA, V106, P3190, DOI 10.1073/pnas.0809849106; Leduc C, 2012, P NATL ACAD SCI USA, V109, P6100, DOI 10.1073/pnas.1107281109; LEE KD, 1995, J BIOL CHEM, V270, P5600, DOI 10.1074/jbc.270.10.5600; Lenz JH, 2006, EMBO J, V25, P2275, DOI 10.1038/sj.emboj.7601119; Li JY, 1999, J NEUROSCI RES, V58, P226, DOI 10.1002/(SICI)1097-4547(19991015)58:2<226::AID-JNR3>3.3.CO;2-O; Li JY, 2000, J NEUROSCI RES, V61, P151, DOI 10.1002/1097-4547(20000715)61:2<151::AID-JNR6>3.3.CO;2-E; Ligon LA, 2004, J BIOL CHEM, V279, P19201, DOI 10.1074/jbc.M313472200; LIN SXH, 1994, J CELL BIOL, V127, P1009, DOI 10.1083/jcb.127.4.1009; Lo KY, 2011, NEUROSCI LETT, V491, P168, DOI 10.1016/j.neulet.2011.01.018; Martin M, 1999, MOL BIOL CELL, V10, P3717, DOI 10.1091/mbc.10.11.3717; Miller KE, 2008, EXP CELL RES, V314, P1981, DOI 10.1016/j.yexcr.2008.03.004; Muller MJI, 2008, P NATL ACAD SCI USA, V105, P4609, DOI 10.1073/pnas.0706825105; Muresan V, 1996, J CELL BIOL, V135, P383, DOI 10.1083/jcb.135.2.383; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Nedelec F, 2001, PHYS REV LETT, V86, P3192, DOI 10.1103/PhysRevLett.86.3192; NODA Y, 1995, J CELL BIOL, V129, P157, DOI 10.1083/jcb.129.1.157; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pedersen LB, 2006, CURR BIOL, V16, P450, DOI 10.1016/j.cub.2006.02.020; POPOV S, 1992, J NEUROSCI, V12, P77; Qi YP, 1997, J NEUROSCI, V17, P1217; Rahman A, 1999, J CELL BIOL, V146, P1277, DOI 10.1083/jcb.146.6.1277; Rai AK, 2013, CELL, V152, P172, DOI 10.1016/j.cell.2012.11.044; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; SABRY J, 1995, NEURON, V14, P1247, DOI 10.1016/0896-6273(95)90271-6; SCHNAPP BJ, 1992, J CELL BIOL, V119, P389, DOI 10.1083/jcb.119.2.389; Schuster M, 2011, MOL BIOL CELL, V22, P3645, DOI [10.1091/E11-03-0217, 10.1091/mbc.E11-03-0217]; Schuster M, 2011, P NATL ACAD SCI USA, V108, P3618, DOI 10.1073/pnas.1015839108; Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021; Signor D, 1999, J CELL BIOL, V147, P519, DOI 10.1083/jcb.147.3.519; Silverman MA, 2010, CYTOSKELETON, V67, P784, DOI 10.1002/cm.20487; Slepchenko BM, 2010, INT REV CEL MOL BIO, V283, P1, DOI 10.1016/S1937-6448(10)83001-1; Soppina V, 2009, P NATL ACAD SCI USA, V106, P19381, DOI 10.1073/pnas.0906524106; Susalka SJ, 2000, BBA-MOL CELL RES, V1496, P76, DOI 10.1016/S0167-4889(00)00010-0; Szpankowski L, 2012, P NATL ACAD SCI USA, V109, P8582, DOI 10.1073/pnas.1120510109; Taya S, 2007, J NEUROSCI, V27, P15, DOI 10.1523/JNEUROSCI.3826-06.2006; Tosha T, 2010, J AM CHEM SOC, V132, P14562, DOI 10.1021/ja105583d; Towns WL, 2009, CELL MOTIL CYTOSKEL, V66, P80, DOI 10.1002/cm.20327; Tsai MY, 2000, MOL BIOL CELL, V11, P2161, DOI 10.1091/mbc.11.6.2161; Uchida A, 2009, MOL BIOL CELL, V20, P4997, DOI 10.1091/mbc.E09-04-0304; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; VALE RD, 1985, CELL, V43, P623, DOI 10.1016/0092-8674(85)90234-X; Veniamin S, 2011, FREE RADICAL BIO MED, V51, P1589, DOI 10.1016/j.freeradbiomed.2011.06.024; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; Verhey KJ, 2009, NAT REV MOL CELL BIO, V10, P765, DOI 10.1038/nrm2782; Wagner OI, 2009, P NATL ACAD SCI USA, V106, P19605, DOI 10.1073/pnas.0902949106; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; Wozniak MJ, 2006, EMBO J, V25, P5457, DOI 10.1038/sj.emboj.7601427; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; Yang ZH, 2001, MOL CELL BIOL, V21, P2463, DOI 10.1128/MCB.21.7.2463-2466.2001; Yang ZH, 1998, MOL BIOL CELL, V9, P249, DOI 10.1091/mbc.9.2.249; Zhang J, 2003, MOL BIOL CELL, V14, P1479, DOI 10.1091/mbc.E02-08-0516; Zhou HM, 2001, J NEUROSCI, V21, P3749, DOI 10.1523/JNEUROSCI.21-11-03749.2001	104	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76081	10.1371/journal.pone.0076081	http://dx.doi.org/10.1371/journal.pone.0076081			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098765	gold, Green Submitted, Green Published			2022-12-25	WOS:000325423500135
J	Qu, XY; Randhawa, G; Friedman, C; Kurland, BF; Glaskova, L; Coleman, I; Mostaghel, E; Higano, CS; Porter, C; Vessella, R; Nelson, PS; Fang, M				Qu, Xiaoyu; Randhawa, Grace; Friedman, Cynthia; Kurland, Brenda F.; Glaskova, Lena; Coleman, Ilsa; Mostaghel, Elahe; Higano, Celestia S.; Porter, Christopher; Vessella, Robert; Nelson, Peter S.; Fang, Min			A Three-Marker FISH Panel Detects More Genetic Aberrations of AR, PTEN and TMPRSS2/ERG in Castration-Resistant or Metastatic Prostate Cancers than in Primary Prostate Tumors	PLOS ONE			English	Article							ANDROGEN RECEPTOR GENE; IN-SITU HYBRIDIZATION; GENOMIC DELETION; ERG EXPRESSION; FUSION; TMPRSS2-ERG; PROGRESSION; AMPLIFICATION; BONE; HETEROGENEITY	TMPRSS2/ERG rearrangement, PTEN gene deletion, and androgen receptor (AR) gene amplification have been observed in various stages of human prostate cancer. We hypothesized that using these markers as a combined panel would allow better differentiation between low-risk and high-risk prostate cancer. We analyzed 110 primary prostate cancer samples, 70 metastatic tumor samples from 11 patients, and 27 xenograft tissues derived from 22 advanced prostate cancer patients using fluorescence in situ hybridization (FISH) analysis with probes targeting the TMPRSS2/ERG, PTEN, and AR gene loci. Heterogeneity of the aberrations detected was evaluated. Genetic patterns were also correlated with transcript levels. Among samples with complete data available, the three-marker FISH panel detected chromosomal abnormalities in 53% of primary prostate cancers and 87% of metastatic (Met) or castration-resistant (CRPC) tumors. The number of markers with abnormal FISH result had a different distribution between the two groups (P<0.001). At the patient level, Met/CRPC tumors are 4.5 times more likely to show abnormalities than primary cancer patients (P<0.05). Heterogeneity among Met/CRPC tumors is mostly inter-patient. Intra-patient heterogeneity is primarily due to differences between the primary prostate tumor and the metastases while multiple metastatic sites show consistent abnormalities. Intra-tumor variability is most prominent with the AR copy number in primary tumors. AR copy number correlated well with the AR mRNA expression (rho = 0.52, P<0.001). Especially among TMPRSS2: ERG fusion-positive CRPC tumors, AR mRNA and ERG mRNA levels are strongly correlated (rho = 0.64, P<0.001). Overall, the three-marker FISH panel may represent a useful tool for risk stratification of prostate cancer patients.	[Qu, Xiaoyu; Kurland, Brenda F.; Coleman, Ilsa; Mostaghel, Elahe; Higano, Celestia S.; Nelson, Peter S.; Fang, Min] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Randhawa, Grace; Friedman, Cynthia; Glaskova, Lena; Higano, Celestia S.; Fang, Min] Seattle Canc Care Alliance, Seattle, WA USA; [Mostaghel, Elahe; Higano, Celestia S.; Vessella, Robert; Nelson, Peter S.; Fang, Min] Univ Washington, Seattle, WA 98195 USA; [Porter, Christopher] Virginia Mason Med Ctr, Seattle, WA 98101 USA; [Vessella, Robert] Puget Sound VA Hlth Care Syst, Seattle, WA USA	Fred Hutchinson Cancer Center; Seattle Cancer Care Alliance; University of Washington; University of Washington Seattle; Virginia Mason Medical Center	Fang, M (corresponding author), Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.	mfang@fhcrc.org	Kurland, Brenda F/AAM-9239-2020	Kurland, Brenda F/0000-0002-5669-0595	PNW SPORE [P50 CA097186, P50CA138293, P01CA085859, PC093372, PC093509]; National Cancer Institute; NATIONAL CANCER INSTITUTE [P50CA138293, P01CA085859, P50CA097186] Funding Source: NIH RePORTER	PNW SPORE; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by PNW SPORE P50 CA097186, P50CA138293, P01CA085859, PC093372, and PC093509 awarded by the National Cancer Institute. The xenograft generation and clinical specimen collection was supported by Richard M. Lucas Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attard G, 2008, ONCOGENE, V27, P253, DOI 10.1038/sj.onc.1210640; Brown RSD, 2002, J PATHOL, V198, P237, DOI 10.1002/path.1206; Bubendorf L, 1999, CANCER RES, V59, P803; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Chaux A, 2011, AM J SURG PATHOL, V35, P1014, DOI 10.1097/PAS.0b013e31821e8761; Clark JP, 2009, NAT REV UROL, V6, P429, DOI 10.1038/nrurol.2009.127; Corey Eva, 2007, P3, DOI 10.1007/978-1-59745-224-3_1; Esgueva R, 2010, MODERN PATHOL, V23, P539, DOI 10.1038/modpathol.2009.193; FitzGerald LM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-230; Ford OH, 2003, J UROLOGY, V170, P1817, DOI 10.1097/01.ju.0000091873.09677.f4; Gallucci M, 2006, CANCER LETT, V237, P76, DOI 10.1016/j.canlet.2005.05.033; Gallucci M, 2009, UROL ONCOL-SEMIN ORI, V27, P502, DOI 10.1016/j.urolonc.2008.04.008; Gopalan A, 2009, CANCER RES, V69, P1400, DOI 10.1158/0008-5472.CAN-08-2467; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; HANKINSON SE, 1995, CANCER EPIDEM BIOMAR, V4, P649; Holcomb IN, 2008, CANCER RES, V68, P5599, DOI 10.1158/0008-5472.CAN-08-0812; Holcomb IN, 2009, CANCER RES, V69, P7793, DOI 10.1158/0008-5472.CAN-08-3810; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Lindberg J, 2012, EUR UROL; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Mehra R, 2008, CANCER RES, V68, P3584, DOI 10.1158/0008-5472.CAN-07-6154; Morrissey C, 2008, CLIN EXP METASTAS, V25, P377, DOI 10.1007/s10585-007-9116-4; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Perner S, 2006, CANCER RES, V66, P8337, DOI 10.1158/0008-5472.CAN-06-1482; Qu XY, 2013, CANCER GENET-NY, V206, P1, DOI 10.1016/j.cancergen.2012.12.004; Reid AHM, 2010, BRIT J CANCER, V102, P678, DOI 10.1038/sj.bjc.6605554; Roudier MP, 2003, HUM PATHOL, V34, P646, DOI 10.1016/S0046-8177(03)00190-4; Sharma A, 2010, J CLIN INVEST, V120, P4478, DOI 10.1172/JCI44239; Sircar K, 2009, J PATHOL, V218, P505, DOI 10.1002/path.2559; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Verhagen PCMS, 2006, J PATHOL, V208, P699, DOI 10.1002/path.1929; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Wang Y, 2011, ONCOGENE, V30, P4327, DOI 10.1038/onc.2011.144; Yoshimoto M, 2007, BRIT J CANCER, V97, P678, DOI 10.1038/sj.bjc.6603924; Yoshimoto M, 2006, CANCER GENET CYTOGEN, V169, P128, DOI 10.1016/j.cancergencyto.2006.04.003; Yoshimoto M, 2008, MODERN PATHOL, V21, P1451, DOI 10.1038/modpathol.2008.96; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	38	16	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74671	10.1371/journal.pone.0074671	http://dx.doi.org/10.1371/journal.pone.0074671			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098661	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500032
J	Rebours, V; Albuquerque, M; Sauvanet, A; Ruszniewski, P; Levy, P; Paradis, V; Bedossa, P; Couvelard, A				Rebours, Vinciane; Albuquerque, Miguel; Sauvanet, Alain; Ruszniewski, Philippe; Levy, Philippe; Paradis, Valerie; Bedossa, Pierre; Couvelard, Anne			Hypoxia Pathways and Cellular Stress Activate Pancreatic Stellate Cells: Development of an Organotypic Culture Model of Thick Slices of Normal Human Pancreas	PLOS ONE			English	Article							IN-VITRO MODEL; LIVER SLICES; DUCTAL ADENOCARCINOMA; INDUCE FIBROSIS; CANCER CELLS; ACINAR; RAT; TRANSDIFFERENTIATION; PROLIFERATION; PLASTICITY	Pancreatic stellate cells (PSC) are involved in fibrogenesis and oncogenesis by modulating the extracellular matrix. Aim: To evaluate the effect of cellular stress on PSC activation using a model of normal human pancreatic tissue slices culture preserving the microenvironment. Methods: Thin sections (300 mu m) of normal human pancreas were cultured under hyperoxia (90% O2) during 72 hours. Viability and morphological analysis were performed at baseline, H24, H48 and H72. Cell differentiation (insulin, trypsin, CA9 and CK7), hypoxia (HIF1-alpha), apoptosis (caspase-3), proliferation (Ki67), TGF-beta expression and PSC activation (smooth muscle actin (SMA), nestin) were assessed using immunostaining, longitudinally. Control experiments were performed under normoxic conditions (21% O2). Results: Thirty sections per specimen (n=10) were cultured. Hypoxia pathways were activated by the higher expression of HIF1-a at H48 and H72. Apoptosis was limited with only rare acinar cells expressing of the caspase-3 at 48 and H72 (NS). Morphological analysis showed gradual appearance of acinoductal metaplasia, proven by CK7 expression and ductal phenotype of dedifferentiated acini. Transdifferentiation of PSC was shown by de novo SMA immunochemistry at H24 and H48. Expression of Ki67 index identified significant proliferation of activated PSC (double immunostaining Ki67-SMA) at H48 and H72 (p=0.02). In vitro culture of normal human pancreas thin sections is feasible with optimized cell viability at 72 hours. This model of culture in hyperoxic conditions provides evidences that cellular stress may rapidly induce transactivation of PSC with ducto-acinar metaplasia.	[Rebours, Vinciane; Ruszniewski, Philippe; Levy, Philippe] Paris Diderot Univ, Beaujon Hosp, AP HP, Pancreatol Dept, Clichy, France; [Rebours, Vinciane; Albuquerque, Miguel; Ruszniewski, Philippe; Paradis, Valerie; Bedossa, Pierre; Couvelard, Anne] Paris Diderot Univ, INSERM, U773, CRB3, Paris, France; [Albuquerque, Miguel; Paradis, Valerie; Bedossa, Pierre] Paris Diderot Univ, Beaujon Hosp, AP HP, Dept Pathol, Clichy, France; [Sauvanet, Alain] Paris Diderot Univ, Beaujon Hosp, AP HP, Pancreat Surg Dept, Clichy, France; [Couvelard, Anne] Paris Diderot Univ, Bichat Hosp, AP HP, Dept Pathol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Rebours, V (corresponding author), Paris Diderot Univ, Beaujon Hosp, AP HP, Pancreatol Dept, Clichy, France.	vinciane.rebours@bjn.aphp.fr	Albuquerque, Miguel/X-9008-2019; Paradis, Valerie/X-9097-2019	Albuquerque, Miguel/0000-0001-7311-1623; Anne, Couvelard/0000-0002-6316-1210; Bedossa, Pierre/0000-0002-8487-7322; Paradis, Valerie/0000-0003-3142-3762; SAUVANET, alain/0000-0002-7436-5999				Apte MV, 1998, GUT, V43, P128, DOI 10.1136/gut.43.1.128; Bachem MG, 2005, GASTROENTEROLOGY, V128, P907, DOI 10.1053/j.gastro.2004.12.036; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Clouzeau-Girard H, 2006, LAB INVEST, V86, P275, DOI 10.1038/labinvest.3700386; Erkan M, 2007, GASTROENTEROLOGY, V132, P1447, DOI 10.1053/j.gastro.2007.01.031; Erkan M, 2012, GUT, V61, P172, DOI 10.1136/gutjnl-2011-301220; Erkan MM, 2009, NEOPLASIA, V11, P497, DOI 10.1593/neo.81618; Guyot C, 2010, LIVER INT, V30, P1529, DOI 10.1111/j.1478-3231.2010.02342.x; HALL PA, 1992, J PATHOL, V166, P97, DOI 10.1002/path.1711660203; Houbracken I, 2011, GASTROENTEROLOGY, V141, P731, DOI 10.1053/j.gastro.2011.04.050; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Jaster R, 2005, J CELL MOL MED, V9, P670, DOI 10.1111/j.1582-4934.2005.tb00497.x; Laake JH, 1999, BRAIN RES PROTOC, V4, P173, DOI 10.1016/S1385-299X(99)00021-5; Lerche-Langrand C, 2000, TOXICOLOGY, V153, P221, DOI 10.1016/S0300-483X(00)00316-4; Lipsett MA, 2007, PANCREAS, V34, P452, DOI 10.1097/MPA.0b013e3180335c80; LOWENFELS AB, 1993, NEW ENGL J MED, V328, P1433, DOI 10.1056/NEJM199305203282001; Masamune A, 2008, AM J PHYSIOL-GASTR L, V295, pG709, DOI 10.1152/ajpgi.90356.2008; Means AL, 2005, DEVELOPMENT, V132, P3767, DOI 10.1242/dev.01925; Olinga P, 2001, J PHARMACOL TOXICOL, V45, P55, DOI 10.1016/S1056-8719(01)00127-7; Rooman I, 2012, GUT, V61, P449, DOI 10.1136/gut.2010.235804; Tuchweber B, 1996, LAB INVEST, V74, P265; van Geer MA, 2009, WORLD J GASTROENTERO, V15, P1359, DOI 10.3748/wjg.15.1359; VILA MR, 1994, LAB INVEST, V71, P423; Vonlaufen A, 2008, CANCER RES, V68, P7707, DOI 10.1158/0008-5472.CAN-08-1132; Vonlaufen A, 2008, CANCER RES, V68, P2085, DOI 10.1158/0008-5472.CAN-07-2477; WATARI N, 1982, Okajimas Folia Anatomica Japonica, V58, P837	26	18	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76229	10.1371/journal.pone.0076229	http://dx.doi.org/10.1371/journal.pone.0076229			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098783	Green Published, gold, Green Submitted			2022-12-25	WOS:000325423500153
J	Shahinas, D; Folefoc, A; Taldone, T; Chiosis, G; Crandall, I; Pillai, DR				Shahinas, Dea; Folefoc, Asongna; Taldone, Tony; Chiosis, Gabriela; Crandall, Ian; Pillai, Dylan R.			A Purine Analog Synergizes with Chloroquine (CQ) by Targeting Plasmodium falciparum Hsp90 (PfHsp90)	PLOS ONE			English	Article							ARTEMISININ-RESISTANT MALARIA; HEAT-SHOCK PROTEINS; IN-VITRO; MOLECULAR CHAPERONE; INHIBITORS; HEAT-SHOCK-PROTEIN-90; GELDANAMYCIN; COMBINATIONS; TOXICITY; REVERSAL	Background: Drug resistance, absence of an effective vaccine, and inadequate public health measures are major impediments to controlling Plasmodium falciparum malaria worldwide. The development of antimalarials to which resistance is less likely is paramount. To this end, we have exploited the chaperone function of P. falciparum Hsp90 (PfHsp90) that serves to facilitate the expression of resistance determinants. Methods: The affinity and activity of a purine analogue Hsp90 inhibitor (PU-H71) on PfHsp90 was determined using surface plasmon resonance (SPR) studies and an ATPase activity assay, respectively. In vitro, antimalarial activity was quantified using flow cytometry. Interactors of PfHsp90 were determined by LC-MS/MS. In vivo studies were conducted using the Plasmodium berghei infection mouse model. Results: PU-H71 exhibited antimalarial activity in the nanomolar range, displayed synergistic activity with chloroquine in vitro. Affinity studies reveal that the PfHsp90 interacts either directly or indirectly with the P. falciparum chloroquine resistance transporter (PfCRT) responsible for chloroquine resistance. PU-H71 synergized with chloroquine in the P. berghei mouse model of malaria to reduce parasitemia and improve survival. Conclusions: We propose that the interaction of PfHsp90 with PfCRT may account for the observed antimalarial synergy and that PU-H71 is an effective adjunct for combination therapy.	[Shahinas, Dea; Crandall, Ian] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Taldone, Tony; Chiosis, Gabriela] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Folefoc, Asongna; Pillai, Dylan R.] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada; [Folefoc, Asongna; Pillai, Dylan R.] Univ Calgary, Calgary, AB, Canada; [Pillai, Dylan R.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada	University of Toronto; Memorial Sloan Kettering Cancer Center; University of Calgary; University of Calgary; University of Calgary	Pillai, DR (corresponding author), Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada.	drpillai@ucalgary.ca			Ontario Agency for Health Protection and Promotion; NATIONAL CANCER INSTITUTE [R01CA172546, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS050838] Funding Source: NIH RePORTER	Ontario Agency for Health Protection and Promotion; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for this project was provided by the Ontario Agency for Health Protection and Promotion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya P, 2007, MOL BIOCHEM PARASIT, V153, P85, DOI 10.1016/j.molbiopara.2007.01.009; Bahl A, 2003, NUCLEIC ACIDS RES, V31, P212, DOI 10.1093/nar/gkg081; Bahl A, 2002, NUCLEIC ACIDS RES, V30, P87, DOI 10.1093/nar/30.1.87; Banumathy G, 2003, J BIOL CHEM, V278, P18336, DOI 10.1074/jbc.M211309200; Banumathy G, 2004, THESIS DEP BIOCH; Bell A, 2005, FEMS MICROBIOL LETT, V253, P171, DOI 10.1016/j.femsle.2005.09.035; Birnby DA, 2000, GENETICS, V155, P85; Caldas-Lopes E, 2009, P NATL ACAD SCI USA, V106, P8368, DOI 10.1073/pnas.0903392106; Chiosis G, 2006, EXPERT OPIN THER TAR, V10, P37, DOI 10.1517/14728222.10.1.37; Chiosis G, 2002, BIOORGAN MED CHEM, V10, P3555, DOI 10.1016/S0968-0896(02)00253-5; Chiosis G, 2006, CURR OPIN INVEST DR, V7, P534; Corbett KD, 2010, PROTEINS, V78, P2738, DOI 10.1002/prot.22799; Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370; Cowen LE, 2006, EUKARYOT CELL, V5, P2184, DOI 10.1128/EC.00274-06; Cowen LE, 2009, P NATL ACAD SCI USA, V106, P2818, DOI 10.1073/pnas.0813394106; Dey A, 2007, ARCH BIOCHEM BIOPHYS, V461, P275, DOI 10.1016/j.abb.2007.02.014; Dey A, 2006, J PHARMACOL EXP THER, V317, P1391, DOI 10.1124/jpet.106.101808; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Freeman BC, 1996, EMBO J, V15, P2969, DOI 10.1002/j.1460-2075.1996.tb00660.x; Health UNIo, 2011, 1 IN HUM PHAS 1 TRIA; Immormino RM, 2004, J BIOL CHEM, V279, P46162, DOI 10.1074/jbc.M405253200; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Luo WJ, 2007, P NATL ACAD SCI USA, V104, P9511, DOI 10.1073/pnas.0701055104; Luo WJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-24; McDonald E, 2006, CURR TOP MED CHEM, V6, P1091, DOI 10.2174/156802606777812004; Min-Oo G, 2010, ANTIMICROB AGENTS CH, V54, P3262, DOI 10.1128/AAC.01719-09; Mishra LC, 2007, AM J TROP MED HYG, V76, P497, DOI 10.4269/ajtmh.2007.76.497; Neckers L, 2002, TRENDS MOL MED, V8, pS55, DOI 10.1016/S1471-4914(02)02316-X; Noedl H, 2002, ANTIMICROB AGENTS CH, V46, P1658, DOI 10.1128/AAC.46.6.1658-1664.2002; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Noedl H, 2009, NEW ENGL J MED, V361, P540, DOI 10.1056/NEJMc0900231; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Oduola AMJ, 1998, AM J TROP MED HYG, V58, P625, DOI 10.4269/ajtmh.1998.58.625; Pallavi R, 2010, J BIOL CHEM, V285, P37964, DOI 10.1074/jbc.M110.155317; Pavithra SR, 2007, PLOS COMPUT BIOL, V3, P1701, DOI 10.1371/journal.pcbi.0030168; Pavithra SR, 2004, J BIOL CHEM, V279, P46692, DOI 10.1074/jbc.M409165200; Pereira MR, 2011, ANTIMICROB AGENTS CH, V55, P3115, DOI 10.1128/AAC.01566-10; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Shahinas D, 2010, J MED CHEM, V53, P3552, DOI 10.1021/jm901796s; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shapiro RS, 2009, CURR BIOL, V19, P621, DOI 10.1016/j.cub.2009.03.017; Shonhai A, 2010, FEMS IMMUNOL MED MIC, V58, P61, DOI 10.1111/j.1574-695X.2009.00639.x; Sidhu ABS, 2007, J BIOL CHEM, V282, P2494, DOI 10.1074/jbc.M608615200; Singh SD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000532; SU XZ, 1994, GENE, V151, P225, DOI 10.1016/0378-1119(94)90661-0; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Taldone T, 2008, CURR OPIN PHARMACOL, V8, P370, DOI 10.1016/j.coph.2008.06.015; Taldone T, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000714; Taldone T, 2009, CURR TOP MED CHEM, V9, P1436, DOI 10.2174/156802609789895737; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WIECH H, 1992, NATURE, V358, P169, DOI 10.1038/358169a0; Wiesgigl M, 2001, MOL BIOL CELL, V12, P3307, DOI 10.1091/mbc.12.11.3307; Workman P, 2004, CANCER LETT, V206, P149, DOI 10.1016/j.canlet.2003.08.032; Zhao RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009934	56	25	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75446	10.1371/journal.pone.0075446	http://dx.doi.org/10.1371/journal.pone.0075446			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098696	Green Published, gold			2022-12-25	WOS:000325423500067
J	Tokunaga, M; Shiheido, H; Tabata, N; Sakuma-Yonemura, Y; Takashima, H; Horisawa, K; Doi, N; Yanagawa, H				Tokunaga, Mayuko; Shiheido, Hirokazu; Tabata, Noriko; Sakuma-Yonemura, Yuko; Takashima, Hideaki; Horisawa, Kenichi; Doi, Nobuhide; Yanagawa, Hiroshi			MIP-2A Is a Novel Target of an Anilinoquinazoline Derivative for Inhibition of Tumour Cell Proliferation	PLOS ONE			English	Article							C-MYC; GROWTH-FACTOR; IN-VITRO; PROTEIN; CANCER; VIRUS; EXPRESSION; ADDICTION; ONCOGENES; SELECTION	We recently identified a novel anilinoquinazoline derivative, Q15, as a potent apoptosis inducer in a panel of human cancer cell lines and determined that Q15 targets hCAP-G2, a subunit of condensin II complex, leading to abnormal cell division. However, whether the defect in normal cell division directly results in cell death remains unclear. Here, we used an mRNA display method on a microfluidic chip to search for other Q15-binding proteins. We identified an additional Q15-binding protein, MIP-2A (MBP-1 interacting protein-2A), which has been reported to interact with MBP-1, a repressor of the c-Myc promoter. Our results indicate that Q15 inhibits the interaction between MIP-2A and MBP-1 as well as the expression of c-Myc protein, thereby inducing cell death. This study suggests that the simultaneous targeting of hCAP-G2 and MIP-2A is a promising strategy for the development of antitumor drugs as a treatment for intractable tumours.	[Tokunaga, Mayuko; Shiheido, Hirokazu; Tabata, Noriko; Sakuma-Yonemura, Yuko; Takashima, Hideaki; Horisawa, Kenichi; Doi, Nobuhide; Yanagawa, Hiroshi] Keio Univ, Dept Biosci & Informat, Yokohama, Kanagawa 223, Japan	Keio University	Yanagawa, H (corresponding author), Keio Univ, Dept Biosci & Informat, Yokohama, Kanagawa 223, Japan.	hyana@bio.keio.ac.jp	Doi, Nobuhide/C-4481-2014	Shiheido, Hirokazu/0000-0002-1415-2019; Doi, Nobuhide/0000-0002-2402-6390	National Institute of Biomedical Innovation (NIBIO), Japan; Ministry of Education, Culture, Sport, Science, and Technology (MEXT), Japan [22310121, S0801008, S0901009]; grants for a basic research program (CREST) of the Japan Science and Technology Agency	National Institute of Biomedical Innovation (NIBIO), Japan(National Institute of Biomedical Innovation); Ministry of Education, Culture, Sport, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); grants for a basic research program (CREST) of the Japan Science and Technology Agency	This work was supported by grants for a basic research program (CREST) of the Japan Science and Technology Agency and a program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO), Japan, as well as a Grant-in-Aid for Scientific Research (22310121) and a grant for Strategic Research Foundation Grant-aided Projects for Private Universities (S0801008 and S0901009) from Ministry of Education, Culture, Sport, Science, and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gao XR, 2004, J VIROL, V78, P11798, DOI 10.1128/JVI.78.21.11798-11806.2004; Ghosh AK, 2003, J BIOL CHEM, V278, P24033, DOI 10.1074/jbc.M211982200; Ghosh AK, 2001, MOL CELL BIOL, V21, P655, DOI 10.1128/MCB.21.2.655-662.2001; Jang SB, 2002, J BIOL CHEM, V277, P49863, DOI 10.1074/jbc.M207436200; Jeyabalan J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010646; Mahtouk K, 2005, ONCOGENE, V24, P3512, DOI 10.1038/sj.onc.1208536; Miyamoto-Sato E, 2005, GENOME RES, V15, P710, DOI 10.1101/gr.3510505; Miyamoto-Sato E, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng078; Nemoto N, 1997, FEBS LETT, V414, P405, DOI 10.1016/S0014-5793(97)01026-0; Otsuki T, 1999, INT J ONCOL, V15, P1205; RAY R, 1991, MOL CELL BIOL, V11, P2154, DOI 10.1128/MCB.11.4.2154; Ray RB, 1995, INDUCTION CELL DEATH; Sedoris KC, 2007, BIOCHEMISTRY-US, V46, P8659, DOI 10.1021/bi7003558; Shiheido H, 2012, PLOS ONE, V7; Shiheido H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044889; Tabata N, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp184; Weinstein B, 2008, ADV EXP MED BIOL, V617, P3, DOI 10.1007/978-0-387-69080-3_1; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Willis RE, 2012, INT J MOL SCI, V13, P316, DOI 10.3390/ijms13010316	21	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76774	10.1371/journal.pone.0076774	http://dx.doi.org/10.1371/journal.pone.0076774			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098805	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500176
J	Kemp, KL; Lin, ZH; Zhao, F; Gao, BX; Song, JX; Zhang, KZ; Fang, DY				Kemp, Kyeorda L.; Lin, Zhenghong; Zhao, Fang; Gao, Beixue; Song, Jianxun; Zhang, Kezhong; Fang, Deyu			The Serine-threonine Kinase Inositol-requiring Enzyme 1 alpha (IRE1 alpha) Promotes IL-4 Production in T Helper Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokine; ER Stress; Lymphocyte; Signal Transduction; T Cell Biology; IL-4; IRE1; T Cell Differentiation	UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM; MESSENGER-RNA; GENE-EXPRESSION; STRESS-RESPONSE; ER STRESS; TH2 CELLS; C-THETA; ACTIVATION; DIFFERENTIATION	Background: IRE1 is a kinase important for the misfolded protein response. Results: IRE1 promotes IL-4 production by stabilizing IL-4 mRNA, and IRE1-specific inhibitor 48C suppresses IL-4 production. Conclusion: IRE1 is a positive regulator of IL-4 production by T helper cells. Significance: Cytokine IL-4 has been implicated in allergic response. Our discovery that IRE1 promotes IL-4 production implies that IRE1 inhibition has a therapeutic potential in allergic disease treatment. The inositol-requiring enzyme 1 (IRE1) is a serine-threonine kinase that plays crucial roles in activating the unfolded protein response. Studies suggest that IRE1 is activated during thymic T cell development and in effector CD8(+) T cells. However, its role in regulating T helper cell differentiation remains unknown. We find that IRE1 is up-regulated and activated upon CD4(+) T cell activation and plays an important role in promoting cytokine IL-4 production. CD4(+) T cells from IRE1 KO mice have reduced IL-4 protein expression, and this impaired IL-4 production is not due to the altered expression of Th2 lineage-specific transcription factors, such as GATA3. Instead, IL-4 mRNA stability is reduced in IRE1 KO T cells. Furthermore, treatment of T cells with an IRE1-specific inhibitor, 48C, leads to a block in IL-4, IL-5, and IL-13 production, confirming the role of IRE1 in the regulation of IL-4. This study identifies a regulatory function for IRE1 in the promotion of IL-4 in T cells.	[Kemp, Kyeorda L.; Lin, Zhenghong; Zhao, Fang; Gao, Beixue; Fang, Deyu] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Song, Jianxun] Penn State Univ, Dept Microbiol & Immunol, Coll Med, Hershey, PA 17033 USA; [Zhang, Kezhong] Wayne State Univ, Sch Med, Dept Immunol & Microbiol, Ctr Mol Med & Genet, Detroit, MI 48201 USA	Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Wayne State University	Kemp, KL (corresponding author), Northwestern Univ, Dept Pathol, Feinberg Sch Med, 3-754 Tarry Bldg,300 E Super St, Chicago, IL 60611 USA.	k-kemp@northwestern.edu; fangd@northwestern.edu	Fang, Deyu/I-7245-2013	Fang, Deyu/0000-0002-4211-2751; Zhang, Kezhong/0000-0002-6062-235X; Lin, Zhenghong/0000-0002-6354-0042	National Institutes of Health [1 K12 GM088020, AI079056, DK083050, DK090313, ES017829]; American Heart Association [09GRNT2280479]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079056, R56AI079056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090313, DP2DK083050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES017829] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM088020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants 1 K12 GM088020 (to K. K.), AI079056 (to D. F.), DK083050 (to D. F.), and National Institutes of Health Grants DK090313 and ES017829 and American Heart Association Grant 09GRNT2280479 (to K. Z.).	ALLEN JM, 1992, MOL CELL BIOL, V12, P2758, DOI 10.1128/MCB.12.6.2758; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Brunsing R, 2008, J BIOL CHEM, V283, P17954, DOI 10.1074/jbc.M801395200; Cannons JL, 2004, IMMUNITY, V21, P693, DOI 10.1016/j.immuni.2004.09.012; Chen CH, 2000, J IMMUNOL, V165, P5597, DOI 10.4049/jimmunol.165.10.5597; Chen Z, 2008, IMMUNOL RES, V41, P87, DOI 10.1007/s12026-007-8014-9; Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109; Dodeller F, 2005, EUR J IMMUNOL, V35, P3631, DOI 10.1002/eji.200535029; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Gao BX, 2012, P NATL ACAD SCI USA, V109, P899, DOI 10.1073/pnas.1118462109; Guo LY, 2008, J IMMUNOL, V181, P3984, DOI 10.4049/jimmunol.181.6.3984; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Isakov N, 2002, ANNU REV IMMUNOL, V20, P761, DOI 10.1146/annurev.immunol.20.100301.064807; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Kamimura D, 2008, J IMMUNOL, V181, P5433, DOI 10.4049/jimmunol.181.8.5433; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Khabar KSA, 2007, J LEUKOCYTE BIOL, V81, P1335, DOI 10.1189/jlb.0207109; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Lafarga V, 2009, MOL CELL BIOL, V29, P4341, DOI 10.1128/MCB.00210-09; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee JHW, 2011, J HYDRO-ENVIRON RES, V5, P143, DOI 10.1016/j.jher.2011.07.001; Lee SM, 2008, BLOOD, V111, P3599, DOI 10.1182/blood-2007-09-115014; Lee SM, 2009, OTOLARYNG HEAD NECK, V140, P197, DOI 10.1016/j.otohns.2008.08.016; Lin ZH, 2012, MOL CELL, V46, P484, DOI 10.1016/j.molcel.2012.03.024; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; Pino SC, 2008, CELL STRESS CHAPERON, V13, P421, DOI 10.1007/s12192-008-0038-0; Qiu Q, 2013, EMBO J, V32, P2477, DOI 10.1038/emboj.2013.183; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sabapathy K, 1999, CURR BIOL, V9, P116, DOI 10.1016/S0960-9822(99)80065-7; Scheu S, 2006, NAT IMMUNOL, V7, P644, DOI 10.1038/ni1338; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Shirakawa T, 2011, J BIOL CHEM, V286, P4003, DOI 10.1074/jbc.M110.168435; Staron M, 2010, BLOOD, V115, P2380, DOI 10.1182/blood-2009-07-233031; Stevens L, 2006, EUR J IMMUNOL, V36, P3305, DOI 10.1002/eji.200636400; Tirosh B, 2006, J BIOL CHEM, V281, P5852, DOI 10.1074/jbc.M509061200; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; WILDIN RS, 1991, J EXP MED, V173, P383, DOI 10.1084/jem.173.2.383; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; Yarovinsky TO, 2006, J IMMUNOL, V177, P4426, DOI 10.4049/jimmunol.177.7.4426; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zhang KZ, 2011, EMBO J, V30, P1357, DOI 10.1038/emboj.2011.52	50	28	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33272	33282		10.1074/jbc.M113.493171	http://dx.doi.org/10.1074/jbc.M113.493171			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24100031	Green Published, hybrid			2022-12-25	WOS:000328841700041
J	Xu, J; Xu, ZF; Zhou, JY; Zhuang, ZP; Wang, EH; Boerner, J; Wu, GS				Xu, Jing; Xu, Zhengfan; Zhou, Jun-Ying; Zhuang, Zhengping; Wang, Enhua; Boerner, Julie; Wu, Gen Sheng			Regulation of the Src-PP2A Interaction in Tumor Necrosis Factor (TNF)-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Death; Phosphorylation; PP2A; Src; Trail	PROTEIN PHOSPHATASE 2A; TRAIL-INDUCED APOPTOSIS; DEATH-RECEPTOR; LIPID RAFTS; SRC; FAMILY; MECHANISM; MEMBER; CELLS; IDENTIFICATION	Background: The mechanisms of TRAIL resistance in cancer cells are not fully understood. Results: TRAIL activates Src, which in turn phosphorylates caspase-8. Src inhibition increases TRAIL-induced apoptosis. TRAIL also relieves PP2A-mediated Src inhibition, leading to Src activation. Conclusion: The interaction between Src and PP2A plays an important role in TRAIL resistance. Significance: Inhibition of Src survival signaling may enhance TRAIL-induced apoptosis in cancer cells. TNF-related apoptosis-inducing ligand (TRAIL) selectively induces apoptosis in transformed and tumor cells but not in normal cells, making it a promising agent for cancer therapy. However, many cancer cells are resistant to TRAIL, and the underlying mechanisms are not fully understood. Here, we show that the regulation of the PP2A and Src interaction plays a critical role in TRAIL resistance. Specifically, we show that TRAIL treatment activates the tyrosine kinase Src, which subsequently phosphorylates caspase-8 at tyrosine 380, leading to the inhibition of caspase-8 activation. We also show that upon TRAIL treatment, Src, caspase-8, and PP2A/C (a catalytic subunit of the PP2A phosphatase) are redistributed into lipid rafts, a microdomain of the plasma membrane enriched with cholesterol, where PP2A dephosphorylates Src at tyrosine 418 and in turn inhibits caspase-8 phosphorylation. Furthermore, we find that TRAIL treatment causes PP2A/C degradation. These data suggest that the balance between Src-mediated caspase-8 phosphorylation and the inactivation of Src-mediated caspase-8 phosphorylation by PP2A determines the outcome of TRAIL treatment in breast cancer cells. Therefore, this work identifies a novel mechanism by which the interaction between PP2A and Src in the context of caspase-8 activation modulates TRAIL sensitivity in cancer cells.	[Xu, Jing; Xu, Zhengfan; Zhou, Jun-Ying; Boerner, Julie; Wu, Gen Sheng] Wayne State Univ, Sch Med, Depts Oncol, Karmanos Canc Inst, Detroit, MI 48201 USA; [Xu, Jing; Xu, Zhengfan; Zhou, Jun-Ying; Boerner, Julie; Wu, Gen Sheng] Wayne State Univ, Sch Med, Dept Pathol, Karmanos Canc Inst, Detroit, MI 48201 USA; [Xu, Zhengfan; Wang, Enhua] China Med Univ, Dept Pathol, Affiliated Hosp 1, Shenyang 110001, Peoples R China; [Xu, Zhengfan; Wang, Enhua] China Med Univ, Coll Basic Med Sci, Shenyang 110001, Peoples R China; [Zhuang, Zhengping] NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; China Medical University; China Medical University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Wu, GS (corresponding author), Wayne State Univ, Sch Med, Depts Oncol, Karmanos Canc Inst, Detroit, MI 48201 USA.	wug@karmanos.org			Karmanos Cancer Institute Strategic Research Initiative grant; National Institutes of Health [P30 CA22453]; NATIONAL CANCER INSTITUTE [P30CA022453] Funding Source: NIH RePORTER	Karmanos Cancer Institute Strategic Research Initiative grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Karmanos Cancer Institute Strategic Research Initiative grant supported in part by National Institutes of Health Grant P30 CA22453.	Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Azijli K, 2012, J CELL SCI, V125, P4651, DOI 10.1242/jcs.109587; Burns TF, 2001, J BIOL CHEM, V276, P37879; Cursi S, 2006, EMBO J, V25, P1895, DOI 10.1038/sj.emboj.7601085; Eichhorn PJA, 2007, PLOS GENET, V3, P2381, DOI 10.1371/journal.pgen.0030218; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Finn RS, 2008, ANN ONCOL, V19, P1379, DOI 10.1093/annonc/mdn291; Hietakangas V, 2003, MOL CELL BIOL, V23, P1278, DOI 10.1128/MCB.23.4.1278-1291.2003; Hopkins-Donaldson S, 2003, CELL DEATH DIFFER, V10, P356, DOI 10.1038/sj.cdd.4401157; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Kim Y, 2002, J BIOL CHEM, V277, P22320, DOI 10.1074/jbc.M202458200; Leong S, 2009, J CLIN ONCOL, V27, P4413, DOI 10.1200/JCO.2008.21.7422; Lu J, 2010, J NEUROSURG, V113, P225, DOI 10.3171/2009.11.JNS091272; Merino D, 2006, MOL CELL BIOL, V26, P7046, DOI 10.1128/MCB.00520-06; Mom CH, 2009, CLIN CANCER RES, V15, P5584, DOI 10.1158/1078-0432.CCR-09-0996; Muppidi JR, 2004, NAT IMMUNOL, V5, P182, DOI 10.1038/ni1024; Pai SI, 1998, CANCER RES, V58, P3513; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1998, FEBS LETT, V424, P41, DOI 10.1016/S0014-5793(98)00135-5; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Pradhan S, 2010, J BIOL CHEM, V285, P29059, DOI 10.1074/jbc.M109.085167; Rowinsky EK, 2005, J CLIN ONCOL, V23, P9394, DOI 10.1200/JCO.2005.02.2889; Screaton GR, 1997, CURR BIOL, V7, P693, DOI 10.1016/S0960-9822(06)00297-1; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Song JJ, 2010, CELL SIGNAL, V22, P377, DOI 10.1016/j.cellsig.2009.10.007; Song JH, 2007, CANCER RES, V67, P6946, DOI 10.1158/0008-5472.CAN-06-3896; Van Schaeybroeck S, 2008, CANCER RES, V68, P8312, DOI 10.1158/0008-5472.CAN-07-6736; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wu GS, 2009, CANCER LETT, V285, P1, DOI 10.1016/j.canlet.2009.02.029; Wu GS, 1996, CLIN CANCER RES, V2, P623; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Xu JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010306; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017	39	20	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33263	33271		10.1074/jbc.M113.508093	http://dx.doi.org/10.1074/jbc.M113.508093			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24100030	Green Published, hybrid			2022-12-25	WOS:000328841700040
J	Zhang, XM; Tan, FL; Skidgel, RA				Zhang, Xianming; Tan, Fulong; Skidgel, Randal A.			CarboxypeptidaseMIs a Positive Allosteric Modulator of the Kinin B1 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Carboxypeptidase; G Protein-coupled Receptors (GPCR); Glycosyl Phosphatidylinositol Anchors; Peptidases; Peptide Hormones; Bradykinin; Kallidin	CONVERTING-ENZYME-INHIBITORS; MEMBRANE-BOUND CARBOXYPEPTIDASE; NITRIC-OXIDE PRODUCTION; 2ND EXTRACELLULAR LOOP; G-PROTEIN; BRADYKININ B1; B-1 RECEPTOR; CRYSTAL-STRUCTURE; ACTIVATION; GPCRS	Background: Carboxypeptidase M (CPM) generates agonist for the kinin B1 receptor (B1R). Results: CPM binds to B1R on the cell membrane and allosterically increases B1R agonist affinity. Conclusion: CPM is a positive allosteric modulator of the B1R, thereby increasing receptor signaling. Significance: Interfering with CPM binding to B1R could be a novel approach to inhibit deleterious effects of B1R signaling in inflammation. Ligand binding to extracellular domains of G protein-coupled receptors can result in novel and nuanced allosteric effects on receptor signaling. We previously showed that the protein-protein interaction of carboxypeptidase M (CPM) and kinin B1 receptor (B1R) enhances B1R signaling in two ways; 1) kinin binding to CPM causes a conformational activation of the B1R, and 2) CPM-generated des-Arg-kinin agonist is efficiently delivered to the B1R. Here, we show CPM is also a positive allosteric modulator of B1R signaling to its agonist, des-Arg(10)-kallidin (DAKD). In HEK cells stably transfected with B1R, co-expression of CPM enhanced DAKD-stimulated increases in intracellular Ca2+ or phosphoinositide turnover by a leftward shift of the dose-response curve without changing the maximum. CPM increased B1R affinity for DAKD by approximate to 5-fold but had no effect on basal B1R-dependent phosphoinositide turnover. Soluble, recombinant CPM bound to HEK cells expressing B1Rs without stimulating receptor signaling. CPM positive allosteric action was independent of enzyme activity but depended on interaction of its C-terminal domain with the B1R extracellular loop 2. Disruption of the CPM/B1R interaction or knockdown of CPM in cytokine-treated primary human endothelial cells inhibited the allosteric enhancement of CPM on B1R DAKD binding or ERK1/2 activation. CPM also enhanced the DAKD-induced B1R conformational change as detected by increased intramolecular fluorescence or bioluminescence resonance energy transfer. Thus, CPM binding to extracellular loop 2 of the B1R results in positive allosteric modulation of B1R signaling, and disruption of this interaction could provide a novel therapeutic approach to reduce pathological B1R signaling.	[Zhang, Xianming; Tan, Fulong; Skidgel, Randal A.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; [Skidgel, Randal A.] Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Skidgel, RA (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol MC 868, 835 S Wolcott, Chicago, IL 60612 USA.	rskidgel@uic.edu	zhang, xian/GYA-0290-2022		National Institutes of Health [RO1 DK41431, PO1 HL60678]; American Heart Association Postdoctoral Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Postdoctoral Fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health B1R activation is also involved in the therapeutic effects of Grants RO1 DK41431 and PO1 HL60678.; Recipient of an American Heart Association Postdoctoral Fellowship.	Alhenc-Gelas F, 2011, CURR PHARM DESIGN, V17, P2654, DOI 10.2174/138161211797416002; Aloy P, 2001, J BIOL CHEM, V276, P16177, DOI 10.1074/jbc.M011457200; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Burford NT, 2011, BIOCHEM PHARMACOL, V81, P691, DOI 10.1016/j.bcp.2010.12.012; Canals M, 2011, TRENDS BIOCHEM SCI, V36, P663, DOI 10.1016/j.tibs.2011.08.005; Cayla C, 2007, FASEB J, V21, P1689, DOI 10.1096/fj.06-7175com; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; DEDDISH PA, 1990, J BIOL CHEM, V265, P15083; DEDDISH PA, 1989, BIOCHEM J, V261, P289, DOI 10.1042/bj2610289; Deiteren K, 2009, CLIN CHIM ACTA, V399, P24, DOI 10.1016/j.cca.2008.10.003; Duka A, 2008, HYPERTENSION, V51, P1352, DOI 10.1161/HYPERTENSIONAHA.107.108506; Duka I, 2003, HYPERTENSION, V42, P1021, DOI 10.1161/01.HYP.0000097550.98865.35; Emanueli C, 2002, CIRCULATION, V105, P360, DOI 10.1161/hc0302.102142; Eng FJ, 1998, J BIOL CHEM, V273, P8382, DOI 10.1074/jbc.273.14.8382; Erdos EG, 2010, HYPERTENSION, V55, P214, DOI 10.1161/HYPERTENSIONAHA.109.144600; Hadkar V, 2004, AM J PHYSIOL-LUNG C, V287, pL35, DOI 10.1152/ajplung.00346.2003; Hagiwara M, 2004, HYPERTENS RES, V27, P399, DOI 10.1291/hypres.27.399; Hillmeister P, 2011, CIRC RES, V109, P524, DOI 10.1161/CIRCRESAHA.111.240986; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Ignjatovic T, 2002, J BIOL CHEM, V277, P16847, DOI 10.1074/jbc.M200355200; Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134; Kakoki M, 2007, P NATL ACAD SCI USA, V104, P7576, DOI 10.1073/pnas.0701617104; Kalatskaya I, 2004, J BIOL CHEM, V279, P31268, DOI 10.1074/jbc.M401796200; Keil C, 2007, J MOL BIOL, V366, P504, DOI 10.1016/j.jmb.2006.11.025; Kenakin TP, 2009, TRENDS PHARMACOL SCI, V30, P460, DOI 10.1016/j.tips.2009.06.007; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Kuhr F, 2010, NEUROPEPTIDES, V44, P145, DOI 10.1016/j.npep.2009.12.004; Leeb-Lundberg LMF, 2001, J BIOL CHEM, V276, P8785, DOI 10.1074/jbc.M007396200; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Li JQ, 2002, GENE, V284, P189, DOI 10.1016/S0378-1119(01)00898-8; Li XY, 1999, BIOCHEM BIOPH RES CO, V258, P204, DOI 10.1006/bbrc.1999.0619; Marcic B, 2000, J BIOL CHEM, V275, P16110, DOI 10.1074/jbc.M909490199; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; MCGWIRE GB, 1995, J BIOL CHEM, V270, P17154, DOI 10.1074/jbc.270.29.17154; Merino VF, 2008, J MOL MED, V86, P791, DOI 10.1007/s00109-008-0345-z; Moniwa N, 2006, BIOL CHEM, V387, P203, DOI 10.1515/BC.2006.027; Nakanishi J, 2006, BIOCHEM BIOPH RES CO, V343, P1191, DOI 10.1016/j.bbrc.2006.03.064; Pesquero JB, 2006, BIOL CHEM, V387, P119, DOI 10.1515/BC.2006.017; Pesquero JB, 2000, P NATL ACAD SCI USA, V97, P8140, DOI 10.1073/pnas.120035997; Pfleger KDG, 2006, NAT PROTOC, V1, P337, DOI 10.1038/nprot.2006.52; Potier L, 2013, J PHARMACOL EXP THER, V346, P23, DOI 10.1124/jpet.113.203927; Reverter D, 2004, J MOL BIOL, V338, P257, DOI 10.1016/j.jmb.2004.02.058; Reznik SE, 2001, CELL MOL LIFE SCI, V58, P1790, DOI 10.1007/PL00000819; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Sangsree S, 2003, AM J PHYSIOL-HEART C, V284, pH1959, DOI 10.1152/ajpheart.00036.2003; Schremmer-Danninger E, 1998, BIOCHEM BIOPH RES CO, V243, P246, DOI 10.1006/bbrc.1997.7999; Skidgel R. A., 1996, ZINC METALLOPROTEASE, P241; Skidgel RA, 1998, IMMUNOL REV, V161, P129, DOI 10.1111/j.1600-065X.1998.tb01577.x; SKIDGEL RA, 1989, J BIOL CHEM, V264, P2236; SKIDGEL RA, 1988, TRENDS PHARMACOL SCI, V9, P299, DOI 10.1016/0165-6147(88)90015-6; SKIDGEL RA, 1984, BIOCHEM PHARMACOL, V33, P3471, DOI 10.1016/0006-2952(84)90122-9; SKIDGEL RA, 1998, LUNG BIOL HEALTH DIS, V112, P459; Smith NJ, 2010, PHARMACOL REV, V62, P701, DOI 10.1124/pr.110.002667; Su JB, 2006, CURR PHARM DESIGN, V12, P3423; Talbot S, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-36; TAN FL, 1995, METHOD ENZYMOL, V248, P663; TAN FL, 1989, J BIOL CHEM, V264, P13165; Tan FL, 2003, BIOCHEM J, V370, P567, DOI 10.1042/BJ20021495; Tan FL, 1997, BIOCHEM J, V327, P81, DOI 10.1042/bj3270081; Tschope C, 2004, CARDIOVASC RES, V61, P559, DOI 10.1016/j.cardiores.2003.10.018; Unal H, 2012, ADV EXP MED BIOL, V749, P187, DOI 10.1007/978-1-4614-3381-1_13; Unal H, 2012, TRENDS PHARMACOL SCI, V33, P79, DOI 10.1016/j.tips.2011.09.007; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Vijayaraghavan K, 2011, CARDIOL CLIN, V29, P137, DOI 10.1016/j.ccl.2010.11.003; Wang CIA, 2013, BIOCHEM PHARMACOL, V85, P153, DOI 10.1016/j.bcp.2012.09.001; Westermann D, 2009, DIABETES, V58, P1373, DOI 10.2337/db08-0329; Wheatley M, 2012, BRIT J PHARMACOL, V165, P1688, DOI 10.1111/j.1476-5381.2011.01629.x; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 ; Xu J, 2009, EXP PHYSIOL, V94, P322, DOI 10.1113/expphysiol.2008.045583; Zhang XM, 2008, J BIOL CHEM, V283, P7994, DOI 10.1074/jbc.M709837200; Zhang XM, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P1357, DOI 10.1016/B978-0-12-382219-2.00305-7; Zhang XM, 2013, BIOL CHEM, V394, P335, DOI 10.1515/hsz-2012-0290; Zhang XM, 2011, J BIOL CHEM, V286, P18547, DOI 10.1074/jbc.M110.214940	74	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33226	33240		10.1074/jbc.M113.520791	http://dx.doi.org/10.1074/jbc.M113.520791			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24108126	Green Published, hybrid			2022-12-25	WOS:000328841700037
J	Guillot, M; Gavrilova, N; Torgasheva, L; Denisenko, M				Guillot, Michel; Gavrilova, Natalia; Torgasheva, Liudmila; Denisenko, Mikhail			Divergent Paths for Adult Mortality in Russia and Central Asia: Evidence from Kyrgyzstan	PLOS ONE			English	Article							HEALTH LIFE-STYLES; ALCOHOL; EXPECTANCY	Adult mortality has been lower in Kyrgyzstan vs. Russia among males since at least 1981 and among females since 1999. Also, Kyrgyzstan's mortality fluctuations have had smaller amplitude. This has occurred in spite of worse macro-economic outcomes in Kyrgyzstan. To understand these surprising patterns, we analyzed cause-specific mortality in Kyrgyzstan vs. Russia for the period 1981-2010, using unpublished official data. We find that, as in Russia, fluctuations in Kyrgyzstan have been primarily due to changes in external causes and circulatory causes, and alcohol appears to play an important role. However, in contrast with Russia, mortality from these causes in Kyrgyzstan has been lower and has increased by a smaller amount. As a result, the mortality gap between the two countries is overwhelmingly attributable to external and cardio-vascular causes, and more generally, to causes that have been shown to be strongly related to alcohol consumption. These cause-specific results, together with the existence of large ethnic differentials in mortality in Kyrgyzstan, highlight the importance of cultural and religious differences, and their impact on patterns of alcohol consumption, in explaining the mortality gap between the two countries. These findings show that explanatory frameworks relying solely on macro-economic factors are not sufficient for understanding differences in mortality levels and trends among former Soviet republics.	[Guillot, Michel] Univ Penn, Philadelphia, PA 19104 USA; [Gavrilova, Natalia] Univ Chicago, Chicago, IL 60637 USA; [Torgasheva, Liudmila] Natl Stat Comm Kyrgyz Republ, Bishkek, Kyrgyzstan; [Denisenko, Mikhail] Natl Res Univ Higher Sch Econ, Moscow, Russia	University of Pennsylvania; University of Chicago; HSE University (National Research University Higher School of Economics)	Guillot, M (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.	miguillo@sas.upenn.edu	Gavrilova, Natalia/AAH-2917-2020; Denisenko, Mikhail B./K-3462-2015	Denisenko, Mikhail B./0000-0001-7983-5323	National Institutes of Health [R03HD38752, R01HD045531]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007242] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045531, R03HD038752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the National Institutes of Health (www.nih.gov) grant number R03HD38752 and R01HD045531. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson B., 1997, PREMATURE DEATH NEW, P120; [Anonymous], EUR HLTH ALL DAT; Bank World, 2012, WORLD DEV IND; Becker CM, 1998, WORLD DEV, V26, P2057, DOI 10.1016/S0305-750X(98)00093-X; Brainerd E, 1998, WORLD DEV, V26, P2013, DOI 10.1016/S0305-750X(98)00096-5; Cockerham WC, 2000, SOC SCI MED, V51, P1313, DOI 10.1016/S0277-9536(00)00094-0; Cockerham WC, 2004, SOC SCI MED, V59, P1409, DOI 10.1016/j.socscimed.2004.01.023; Cornia GA, 1995, UNICEF INNOCENTI OCC; Guillot M., 2004, NASELENIE KYRGYZSTAN, P53; Guillot M, 2013, POPUL STUD IN PRESS; Guillot M., 2007, ESPACE POPULATIONS S, V1, P113, DOI DOI 10.4000/EPS.2025; Guillot M, 2011, DEMOGRAPHY, V48, P1081, DOI 10.1007/s13524-011-0036-1; Heath Douglas, 1995, INT HDB ALCOHOL CULT; Leon DA, 1998, JAMA-J AM MED ASSOC, V279, P790, DOI 10.1001/jama.279.10.790; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6; Leon DA, 2009, ADDICTION, V104, P1630, DOI 10.1111/j.1360-0443.2009.02655.x; McKee M, 2001, ANN EPIDEMIOL, V11, P1, DOI 10.1016/S1047-2797(00)00080-6; MESLE F, 1996, TENDANCES RECENTES M; Notzon FC, 1998, JAMA-J AM MED ASSOC, V279, P793, DOI 10.1001/jama.279.10.793; Shapiro J., 1995, RUSSIAN EC REFORM RI, P149; Shkolnikov V, 2001, LANCET, V357, P917, DOI 10.1016/S0140-6736(00)04212-4; Shkolnikov VM, 1998, WORLD DEV, V26, P1995, DOI 10.1016/S0305-750X(98)00102-8; Stuckler D, 2009, LANCET, V373, P399, DOI 10.1016/S0140-6736(09)60005-2; University of California Berkeley (USA) and Max Planck Institute for Demographic Research (Germany), HUM MORT DAT; World Health Organization, WHO MORT DAT; Zaridze D, 2009, INT J EPIDEMIOL, V38, P143, DOI 10.1093/ije/dyn160; Zaridze D, 2009, LANCET, V373, P2201, DOI 10.1016/S0140-6736(09)61034-5	28	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75314	10.1371/journal.pone.0075314	http://dx.doi.org/10.1371/journal.pone.0075314			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	233FK	24116034	Green Submitted, gold, Green Published			2022-12-25	WOS:000325552200015
J	Merler, S; Ajelli, M; Camilloni, B; Puzelli, S; Bella, A; Rota, MC; Tozzi, AE; Muraca, M; Meledandri, M; Iorio, AM; Donatelli, I; Rizzo, C				Merler, Stefano; Ajelli, Marco; Camilloni, Barbara; Puzelli, Simona; Bella, Antonino; Rota, Maria Cristina; Tozzi, Alberto Eugenio; Muraca, Maurizio; Meledandri, Marcello; Iorio, Anna Maria; Donatelli, Isabella; Rizzo, Caterina			Pandemic Influenza A/H1N1pdm in Italy: Age, Risk and Population Susceptibility	PLOS ONE			English	Article							H1N1 VIRUS; A VIRUS; SEROPREVALENCE; TRANSMISSION; PREVALENCE; ANTIBODIES	Background: A common pattern emerging from several studies evaluating the impact of the 2009 A/H1N1 pandemic influenza (A/H1N1pdm) conducted in countries worldwide is the low attack rate observed in elderly compared to that observed in children and young adults. The biological or social mechanisms responsible for the observed age-specific risk of infection are still to be deeply investigated. Methods: The level of immunity against the A/H1N1pdm in pre and post pandemic sera was determined using left over sera taken for diagnostic purposes or routine ascertainment obtained from clinical laboratories. The antibody titres were measured by the haemagglutination inhibition (HI) assay. To investigate whether certain age groups had higher risk of infection the presence of protective antibody (>= 1: 40), was calculated using exact binomial 95% CI on both pre- and post-pandemic serological data in the age groups considered. To estimate age-specific susceptibility to infection we used an age-structured SEIR model. Results: By comparing pre- and post-pandemic serological data in Italy we found age-specific attack rates similar to those observed in other countries. Cumulative attack rate at the end of the first A/H1N1pdm season in Italy was estimated to be 16.3% (95% CI 9.4%-23.1%). Modeling results allow ruling out the hypothesis that only age-specific characteristics of the contact network and levels of pre-pandemic immunity are responsible for the observed age-specific risk of infection. This means that age-specific susceptibility to infection, suspected to play an important role in the pandemic, was not only determined by pre-pandemic levels of H1N1pdm antibody measured by HI. Conclusions: Our results claim for new studies to better identify the biological mechanisms, which might have determined the observed pattern of susceptibility with age. Moreover, our results highlight the need to obtain early estimates of differential susceptibility with age in any future pandemics to obtain more reliable real time estimates of critical epidemiological parameters.	[Merler, Stefano; Ajelli, Marco] Bruno Kessler Fdn, Trento, Italy; [Puzelli, Simona; Donatelli, Isabella] Natl Inst Hlth, Dept Infect Parasit & Immune Mediated Dis, Rome, Italy; [Camilloni, Barbara; Iorio, Anna Maria] Univ Perugia, Dept Med & Surg Specialties & Publ Hlth, I-06100 Perugia, Italy; [Bella, Antonino; Rota, Maria Cristina; Rizzo, Caterina] Natl Ctr Epidemiol Surveillance & Hlth Promot, Natl Inst Hlth, Rome, Italy; [Tozzi, Alberto Eugenio; Muraca, Maurizio] Bambino Gesu Children Hosp & Res Inst, Rome, Italy; [Meledandri, Marcello] San Filippo Neri Hosp, Rome, Italy	Fondazione Bruno Kessler; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS); University of Perugia; Istituto Superiore di Sanita (ISS); IRCCS Bambino Gesu; San Filippo Neri Hospital	Rizzo, C (corresponding author), Natl Ctr Epidemiol Surveillance & Hlth Promot, Natl Inst Hlth, Rome, Italy.	caterina.rizzo@iss.it	Bella, Antonino/AAB-9943-2019; Camilloni, Barbara/AAU-4394-2020; Muraca, Maurizio/G-3063-2012; Tozzi, Alberto Eugenio/F-9494-2012; Ajelli, Marco/AAX-1113-2020; Rizzo, Caterina/H-4092-2012; merler, stefano/I-3557-2017; Puzelli, Simona/C-2542-2016	Tozzi, Alberto Eugenio/0000-0002-6884-984X; Ajelli, Marco/0000-0003-1753-4749; Rizzo, Caterina/0000-0002-5583-7508; merler, stefano/0000-0002-5117-0611; MURACA, MAURIZIO/0000-0003-1218-097X; Puzelli, Simona/0000-0003-4497-9719; rota, maria cristina/0000-0002-9861-446X	EU FP7 EPIWORK project [231807]; Italian Ministry of Health [1M22]	EU FP7 EPIWORK project; Italian Ministry of Health(Ministry of Health, Italy)	SM and MA thank the EU FP7 EPIWORK project (contract no. 231807) for research funding. CR, MCR, and AB thank the Italian Ministry of Health project "Tuning epidemiological tools for influenza monitoring in Italy'' (Grant n. 1M22) for research funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achonu C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026427; Adamson WE, 2011, J CLIN VIROL, V52, P300, DOI 10.1016/j.jcv.2011.08.019; Adamson WE, 2010, EUROSURVEILLANCE, V15; Ajelli M, 2010, EPIDEMIOL INFECT, P1; Allwinn R, 2010, MED MICROBIOL IMMUN, V199, P117, DOI 10.1007/s00430-010-0143-4; Baguelin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017074; Bandaranayake D, 2011, EUROSURVEILLANCE, V16, P14; Bone A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033056; Broberg E, 2011, CLIN VACCINE IMMUNOL, V18, P1205, DOI 10.1128/CVI.05072-11; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; Delangue J, 2012, CLIN MICROBIOL INFEC, V18, P177, DOI 10.1111/j.1469-0691.2011.03545.x; Dorigatti I, 2012, EPIDEMICS-NETH, V4, P9, DOI 10.1016/j.epidem.2011.11.001; Dudareva S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021340; EMEA, 1996, 21496 EMEA CPMPBWP; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Fumanelli L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002673; Ghani AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004383; Gilbert GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012562; Harmon M, 1992, INFLUENZA VIRUSES, P515; Iozzi F, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001021; Istituto Superiore di Sanita, 2010, INFL SURV SYST; Jacobs JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042328; Lim M, 2010, C P OPT CONTR INFL 7; Maltezou HC, 2011, VACCINE, V29, P6664, DOI 10.1016/j.vaccine.2011.06.098; Merler S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002205; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Morner A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053511; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Reinheimer C, 2012, EUR J CLIN MICROBIOL, V31, P1467, DOI 10.1007/s10096-011-1465-x; Reinheimer C, 2011, INFECTION, V39, P101, DOI 10.1007/s15010-011-0105-9; Riley S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000442; Rizzo C., 2010, EURO SURVEILL, V15; Rizzo C, 2010, VACCINE, V28, P3558, DOI 10.1016/j.vaccine.2010.03.006; Skowronski DM, 2010, CAN MED ASSOC J, V182, P1851, DOI 10.1503/cmaj.100910; Subelj V, 2012, WIEN KLIN WOCHENSCHR, V124, P177, DOI 10.1007/s00508-012-0126-0; Van K, 2013, INFLUENZA OTHER RESP; von Kries R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023955; Waalen K, 2010, EUROSURVEILLANCE, V15, P2; Wagar LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028063; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x; WHO, 2010, H1N1 POSTP PER; World Health Organization, 2009, INFL LIK ILL US MEX; Wu JT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001103; Xu C, 2012, ACTA VIROL, V56, P329, DOI 10.4149/av_2012_04_329; Zimmer SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011601	46	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e74785	10.1371/journal.pone.0074785	http://dx.doi.org/10.1371/journal.pone.0074785			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116010	gold, Green Submitted, Green Published			2022-12-25	WOS:000325501300013
J	Niemann, H; Linke, P; Knittel, K; MacPherson, E; Boetius, A; Bruckmann, W; Larvik, G; Wallmann, K; Schacht, U; Omoregie, E; Hilton, D; Brown, K; Rehder, G				Niemann, Helge; Linke, Peter; Knittel, Katrin; MacPherson, Enrique; Boetius, Antje; Brueckmann, Warner; Larvik, Gaute; Wallmann, Klaus; Schacht, Ulrike; Omoregie, Enoma; Hilton, David; Brown, Kevin; Rehder, Gregor			Methane-Carbon Flow into the Benthic Food Web at Cold Seeps - A Case Study from the Costa Rica Subduction Zone	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIA; STABLE-ISOTOPE SIGNATURES; IN-SITU HYBRIDIZATION; MOSBY MUD VOLCANO; DEEP-SEA FAN; HYDROTHERMAL VENT; ANAEROBIC OXIDATION; MICROBIAL COMMUNITIES; EPSILON-PROTEOBACTERIA; SURFACE SEDIMENTS	Cold seep ecosystems can support enormous biomasses of free-living and symbiotic chemoautotrophic organisms that get their energy from the oxidation of methane or sulfide. Most of this biomass derives from animals that are associated with bacterial symbionts, which are able to metabolize the chemical resources provided by the seeping fluids. Often these systems also harbor dense accumulations of non-symbiotic megafauna, which can be relevant in exporting chemosynthetically fixed carbon from seeps to the surrounding deep sea. Here we investigated the carbon sources of lithodid crabs (Paralomis sp.) feeding on thiotrophic bacterial mats at an active mud volcano at the Costa Rica subduction zone. To evaluate the dietary carbon source of the crabs, we compared the microbial community in stomach contents with surface sediments covered by microbial mats. The stomach content analyses revealed a dominance of epsilonproteobacterial 16S rRNA gene sequences related to the free-living and epibiotic sulfur oxidiser Sulfurovum sp. We also found Sulfurovum sp. as well as members of the genera Arcobacter and Sulfurimonas in mat-covered surface sediments where Epsilonproteobacteria were highly abundant constituting 10% of total cells. Furthermore, we detected substantial amounts of bacterial fatty acids such as i-C15:0 and C17:1 omega 6c with stable carbon isotope compositions as low as -53 parts per thousand in the stomach and muscle tissue. These results indicate that the white microbial mats at Mound 12 are comprised of Epsilonproteobacteria and that microbial mat-derived carbon provides an important contribution to the crab's nutrition. In addition, our lipid analyses also suggest that the crabs feed on other C-13-depleted organic matter sources, possibly symbiotic megafauna as well as on photosynthetic carbon sources such as sedimentary detritus.	[Niemann, Helge] Univ Basel, Dept Environm Sci, Basel, Switzerland; [Niemann, Helge; Knittel, Katrin; Boetius, Antje; Larvik, Gaute; Omoregie, Enoma] Max Planck Inst Marine Microbiol, Bremen, Germany; [Linke, Peter; Brueckmann, Warner; Wallmann, Klaus; Schacht, Ulrike; Rehder, Gregor] Univ Kiel, Sonderforsch Bereich 574, Kiel, Germany; [Linke, Peter; Brueckmann, Warner; Wallmann, Klaus] GEOMAR, Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [MacPherson, Enrique] Ctr Estudios Avanzados Blanes CEAB CSIC, Blanes, Spain; [Boetius, Antje] Alfred Wegener Inst Marine & Polar Res, Bremerhaven, Germany; [Omoregie, Enoma] Inst Nacl Tecn Aeroespacial Torrejon de Ardoz, Ctr Astrobiol CSIC INTA, Madrid, Spain; [Hilton, David; Brown, Kevin] Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92103 USA; [Rehder, Gregor] Leibniz Inst Balt Sea Res Warnemunde IOW, Rostock, Germany	University of Basel; Max Planck Society; University of Kiel; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); University of California System; University of California San Diego; Scripps Institution of Oceanography; Leibniz Institut fur Ostseeforschung Warnemunde	Niemann, H (corresponding author), Univ Basel, Dept Environm Sci, Basel, Switzerland.	helge.niemann@unibas.ch	Niemann, Helge/C-6630-2014; Wallmann, Klaus/D-4380-2017; Boetius, Antje/D-5459-2013; Linke, Peter/A-4401-2014; Macpherson, Enrique/J-8982-2012	Niemann, Helge/0000-0002-3468-8304; Wallmann, Klaus/0000-0002-1795-376X; Boetius, Antje/0000-0003-2117-4176; Linke, Peter/0000-0001-7373-7335; Macpherson, Enrique/0000-0003-4849-4532; Brueckmann, Warner/0000-0001-6636-8148; Omoregie, Enoma/0000-0002-7701-4182	DFG; NSF [OCE-0242034, OCE-0242091]; Max Planck Society; Helmholtz Association; University of Basel	DFG(German Research Foundation (DFG)); NSF(National Science Foundation (NSF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Helmholtz Association(Helmholtz Association); University of Basel	Financial support for the M66-Subflux cruise came through the Collaborative Research Center (SFB) 574 ("Volatiles and Fluids in Subduction Zones'') at Kiel University funded by the DFG. This work was further supported by NSF (OCE-0242034 and OCE-0242091), the Max Planck Society, the Helmholtz Association and the University of Basel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beal EJ, 2009, SCIENCE, V325, P184, DOI 10.1126/science.1169984; Berge JP, 2005, ADV BIOCHEM ENG BIOT, V96, P49, DOI 10.1007/b135782; Bernardino AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033515; Blankenship LE, 2005, MOL ECOL, V14, P891, DOI 10.1111/j.1365-294X.2005.02448.x; Blumenberg M, 2004, P NATL ACAD SCI USA, V101, P11111, DOI 10.1073/pnas.0401188101; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Borin S, 2009, P NATL ACAD SCI USA, V106, P9151, DOI 10.1073/pnas.0811984106; Bowles MW, 2011, GEOCHIM COSMOCHIM AC, V75, P500, DOI 10.1016/j.gca.2010.09.043; Bruckmann W, 2009, METEOR BERICHTE; Campbell BJ, 2006, NAT REV MICROBIOL, V4, P458, DOI 10.1038/nrmicro1414; Canfield DE, 2005, ADV MAR BIOL, V48, P313; Cary SC, 1997, APPL ENVIRON MICROB, V63, P1124, DOI 10.1128/AEM.63.3.1124-1130.1997; Chevaldonne P, 1996, P BIOL SOC WASH, V109, P286; CHILDRESS JJ, 1986, SCIENCE, V233, P1306, DOI 10.1126/science.233.4770.1306; Cordes EE, 2010, LIMNOL OCEANOGR, V55, P2537, DOI 10.4319/lo.2010.55.6.2537; de Beer D, 2006, LIMNOL OCEANOGR, V51, P1315, DOI 10.4319/lo.2006.51.3.1315; Decker C, 2012, MAR ECOL-EVOL PERSP, V33, P231, DOI 10.1111/j.1439-0485.2011.00486.x; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Duperron S, 2007, ENVIRON MICROBIOL, V9, P1423, DOI 10.1111/j.1462-2920.2007.01259.x; Durand L, 2010, FEMS MICROBIOL ECOL, V71, P291, DOI 10.1111/j.1574-6941.2009.00806.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Elvert M, 2003, GEOMICROBIOL J, V20, P403, DOI 10.1080/01490450303894; Fetzner S, 2010, HDB HYDROCARBON LIPI, P865, DOI [10.1007/978-3-540-77587-4_62, DOI 10.1007/978-3-540-77587-4_62]; Fiedler PC, 2002, DEEP-SEA RES PT I, V49, P321, DOI 10.1016/S0967-0637(01)00057-7; FISHER CR, 1990, REV AQUAT SCI, V2, P399; Girnth AC, 2011, ENVIRON MICROBIOL, V13, P495, DOI 10.1111/j.1462-2920.2010.02353.x; Goffredi SK, 2004, APPL ENVIRON MICROB, V70, P3082, DOI 10.1128/AEM.70.5.3082-3090.2004; Grunke S, 2012, BIOGEOSCIENCES, V9, P2947, DOI 10.5194/bg-9-2947-2012; Grunke S, 2011, GEOBIOLOGY, V9, P330, DOI 10.1111/j.1472-4669.2011.00281.x; Hensen C, 2004, GEOLOGY, V32, P201, DOI 10.1130/G20119.1; Holler T, 2011, P NATL ACAD SCI USA, V108, pE1484, DOI 10.1073/pnas.1106032108; Hovland M, 2007, GEO-MAR LETT, V27, P197, DOI 10.1007/s00367-007-0070-6; Inagaki F, 2004, INT J SYST EVOL MICR, V54, P1477, DOI 10.1099/ijs.0.03042-0; Ishii K, 2004, FEMS MICROBIOL ECOL, V50, P203, DOI 10.1016/j.femsec.2004.06.015; Jahnke RA, 1996, GLOBAL BIOGEOCHEM CY, V10, P71, DOI 10.1029/95GB03525; JORGENSEN BB, 1978, GEOMICROBIOL J, V1, P11; Jorgensen BB, 2007, NAT REV MICROBIOL, V5, P770, DOI 10.1038/nrmicro1745; Joye SB, 2009, NAT GEOSCI, V2, P349, DOI 10.1038/NGEO475; KENNICUTT MC, 1985, NATURE, V317, P351, DOI 10.1038/317351a0; Kleindienst S, 2012, ENVIRON MICROBIOL, V14, P2689, DOI 10.1111/j.1462-2920.2012.02832.x; Knittel K, 2003, GEOMICROBIOL J, V20, P269, DOI 10.1080/01490450303896; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Kopf A, 2000, MAR GEOL, V167, P1, DOI 10.1016/S0025-3227(00)00026-8; Kostanjsek R, 2007, APPL ENVIRON MICROB, V73, P5566, DOI 10.1128/AEM.02468-06; Lanoil BD, 2001, APPL ENVIRON MICROB, V67, P5143, DOI 10.1128/AEM.67.11.5143-5153.2001; Levin LA, 2005, OCEANOGR MAR BIOL, V43, P1, DOI 10.1201/9781420037449.ch1; Levin LA, 2002, LIMNOL OCEANOGR, V47, P1336, DOI 10.4319/lo.2002.47.5.1336; Linke P, 2005, EARTH PLANET SC LETT, V235, P79, DOI 10.1016/j.epsl.2005.03.009; Losekann T, 2008, ENVIRON MICROBIOL, V10, P3237, DOI 10.1111/j.1462-2920.2008.01712.x; MacAvoy SE, 2005, MAR ECOL PROG SER, V292, P51, DOI 10.3354/meps292051; MacAvoy SE, 2003, CHEM GEOL, V201, P229, DOI 10.1016/S0009-2541(03)00204-3; MacAvoy SE, 2002, MAR ECOL PROG SER, V225, P65, DOI 10.3354/meps225065; MacAvoy SE, 2002, CHEM GEOL, V185, P1, DOI 10.1016/S0009-2541(01)00394-1; MACDONALD IR, 1989, MAR BIOL, V101, P235, DOI 10.1007/BF00391463; Macpherson E, 2010, CRUSTACEANA, V83, P143, DOI 10.1163/001121609X12487811051660; Madigan M. T., 2012, BROCK BIOL MICROORGA; Martin JW, 2005, ZOOL J LINN SOC-LOND, V145, P445, DOI 10.1111/j.1096-3642.2005.00178.x; Mau S, 2006, MAR GEOL, V225, P129, DOI 10.1016/j.margeo.2005.09.007; Meziti A, 2007, RUSS J MAR BIOL+, V33, P84, DOI 10.1134/S1063074007020022; Meziti A, 2010, FEMS MICROBIOL ECOL, V74, P472, DOI 10.1111/j.1574-6941.2010.00964.x; Milucka J, 2012, NATURE, V491, P541, DOI 10.1038/nature11656; Moerz T, 2005, NATO SCI S SS IV EAR, V51, P49; Moussard H, 2006, FEMS MICROBIOL ECOL, V58, P449, DOI 10.1111/j.1574-6941.2006.00192.x; Nakagawa S, 2007, P NATL ACAD SCI USA, V104, P12146, DOI 10.1073/pnas.0700687104; Nechitaylo TY, 2009, ENVIRON MICROBIOL, V11, P1016, DOI 10.1111/j.1462-2920.2008.01837.x; Niemann H, 2006, GEOCHIM COSMOCHIM AC, V70, P5336, DOI 10.1016/j.gca.2006.08.010; Niemann H, 2005, BIOGEOSCIENCES, V2, P335, DOI 10.5194/bg-2-335-2005; Niemann H, 2009, BIOGEOSCIENCES, V6, P2383, DOI 10.5194/bg-6-2383-2009; Niemann H, 2010, HDB HYDROCARBON LIPI, P205, DOI 10.1007/978-3-540-77587-4_13; Niemann H, 2008, ORG GEOCHEM, V39, P1668, DOI 10.1016/j.orggeochem.2007.11.003; Niemann H, 2006, NATURE, V443, P854, DOI 10.1038/nature05227; Niggemann J, 2007, GEOCHIM COSMOCHIM AC, V71, P1513, DOI 10.1016/j.gca.2006.12.012; Omoregie EO, 2008, APPL ENVIRON MICROB, V74, P3198, DOI 10.1128/AEM.01751-07; Omoregie EO, 2009, MAR GEOL, V261, P114, DOI 10.1016/j.margeo.2009.02.001; PAULL CK, 1985, NATURE, V317, P709, DOI 10.1038/317709a0; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Petersen J. E., 2009, P1; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Ranero CR, 2000, NATURE, V404, P748, DOI 10.1038/35008046; Rojo F., 2010, HDB HYDROCARBON LIPI, P781, DOI DOI 10.1007/978-3-540-77587-4_59; Sahling H, 2003, DEEP-SEA RES PT I, V50, P1391, DOI 10.1016/j.dsr.2003.08.004; Sahling H, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI [10.1029/2008GC001978mor, DOI 10.1029/2008GC001978M0]; Schauer R, 2011, ENVIRON MICROBIOL, V13, P2633, DOI 10.1111/j.1462-2920.2011.02530.x; Sibuet M, 1998, DEEP-SEA RES PT II, V45, P517, DOI 10.1016/S0967-0645(97)00074-X; Sommer S, 2010, MAR GEOL, V272, P223, DOI 10.1016/j.margeo.2009.06.003; SUESS E, 1980, NATURE, V288, P260, DOI 10.1038/288260a0; Takai K, 2005, APPL ENVIRON MICROB, V71, P7310, DOI 10.1128/AEM.71.11.7310-7320.2005; Thamdrup B, 1996, LIMNOL OCEANOGR, V41, P1629, DOI 10.4319/lo.1996.41.8.1629; Thurber AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026243; Thurber AR, 2010, MAR GEOL, V272, P260, DOI 10.1016/j.margeo.2009.06.001; Timmis, 2010, HDB HYDROCARBON LIPI, P187, DOI DOI 10.1007/978-3-540-77587-4_12; Tokuda G, 2008, MAR ECOL-EVOL PERSP, V29, P106, DOI 10.1111/j.1439-0485.2007.00211.x; Treude T, 2003, MAR ECOL PROG SER, V264, P1, DOI 10.3354/meps264001; Tsuchida S, 2011, J MAR BIOL ASSOC UK, V91, P23, DOI 10.1017/S0025315410001827; Van Dover CL, 2007, ECOL METHOD CONCEPT, P202, DOI 10.1002/9780470691854.ch8; VANDENOORD A, 1964, COMP BIOCHEM PHYSIOL, V13, P461, DOI 10.1016/0010-406X(64)90038-6; Vanreusel A, 2009, OCEANOGRAPHY, V22, P110, DOI 10.5670/oceanog.2009.12; Wang W, 2011, INT J SYST EVOL MICR, V61, P703, DOI 10.1099/ijs.0.020529-0; WHITCOMB RF, 1981, ANNU REV ENTOMOL, V26, P397, DOI 10.1146/annurev.en.26.010181.002145; Yamamoto M, 2010, ENVIRON MICROBIOL, V12, P1144, DOI 10.1111/j.1462-2920.2010.02155.x	100	46	47	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e74894	10.1371/journal.pone.0074894	http://dx.doi.org/10.1371/journal.pone.0074894			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116017	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000325501300018
J	Su, LH; Wan, CX; Zhou, JR; Wang, YG; Wang, L; Ai, YL; Zhao, X				Su, Lihong; Wan, Caixia; Zhou, Jianren; Wang, Yiguang; Wang, Liang; Ai, Yanling; Zhao, Xu			Piezochromic Phenomena of Nanometer Voids Formed by Mono-Dispersed Nanometer Powders Compacting Process	PLOS ONE			English	Article							ZINC-OXIDE; HIGH-PRESSURES; COMPLEXES; EMISSION; BEHAVIOR; PHOTOLUMINESCENT; NANOPARTICLES; TRANSITIONS	Piezochromism describes a tendency of certain materials changing colors when they are subjected to various pressure levels. It occurs particularly in some polymers or inorganic materials, such as in palladium complexes. However, piezochromism is generally believed to work at high pressure range of 0.1-10 GPa. This research work focused on unique piezochromism responses of the nanometer voids formed by the 5-20 nm inorganic ISOH nanometer powders. It was discovered that microstructures of the nanometer voids could change color at very low pressures of only 0.002-0.01 GPa; its sensitivity to pressure was increased by tens of times. It is believed that the uniform microstructures of nanometer powders contributed to the material's high sensitivity of piezochromic phenomena. One factor which quantum optical change caused by nanometer voids affected the quantum confinement effect; another is surface Plasmon Resonance of great difference dielectric property between conductive ITO powder and insulation hydroxide.	[Su, Lihong; Wan, Caixia; Wang, Yiguang; Wang, Liang; Ai, Yanling; Zhao, Xu] Northwestern Polytech Univ, Dept Applying Chem, Xian, Shaanxi Provinc, Peoples R China; [Zhou, Jianren] Prairie View A&M Univ, Coll Engn, Prairie View, TX USA	Northwestern Polytechnical University; Texas A&M University System; Prairie View A&M University	Su, LH (corresponding author), Northwestern Polytech Univ, Dept Applying Chem, Xian, Shaanxi Provinc, Peoples R China.	hlshong@nwpu.edu.cn	Wang, Liang/N-8904-2014	Wang, Liang/0000-0001-6223-5962; su, lihong/0000-0001-8889-4624				Bagnall DM, 1998, APPL PHYS LETT, V73, P1038, DOI 10.1063/1.122077; BARNETT JD, 1973, REV SCI INSTRUM, V44, P1, DOI 10.1063/1.1685943; BYLANDER EG, 1978, J APPL PHYS, V49, P1188, DOI 10.1063/1.325059; Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+; DINGLE R, 1969, PHYS REV LETT, V23, P579, DOI 10.1103/PhysRevLett.23.579; Galloway KW, 2010, CRYSTENGCOMM, V12, P2516, DOI 10.1039/c001376e; Henry PF, 2010, ACTA CRYSTALLOGR B, V66, P412, DOI 10.1107/S0108768110020720; Hideo DT, 2004, PLATIN MET REV, V48, P117; Kim MI, 2011, CHEM-EUR J, V17, P10700, DOI 10.1002/chem.201101191; KOTOWSKI M, 1987, INORG CHIM ACTA, V131, P225, DOI 10.1016/S0020-1693(00)96029-8; Lihong S, 2009, MICRO NANO LETT, V4, P48, DOI 10.1049/mnl:20080055; Linhong S, 2011, PHYS DIFFERENCE BOUN; Muramatsu Y, 2001, POLYMER, V42, P6673, DOI 10.1016/S0032-3861(01)00136-7; Nalwa H. S., 1988, HDB ORGANIC CONDUCTI, V2; Righetti L, 2011, ACS APPL MATER INTER, V3, P1319, DOI 10.1021/am2001218; Sagara Y, 2008, ANGEW CHEM INT EDIT, V47, P5175, DOI 10.1002/anie.200800164; Sagara Y, 2009, NAT CHEM, V1, P605, DOI [10.1038/nchem.411, 10.1038/NCHEM.411]; Sagara Y, 2009, ADV FUNCT MATER, V19, P1869, DOI 10.1002/adfm.200801726; Salaneck MR, 1998, J CHEM PHYS, V89, P4613; Samuelsen EJ, 1999, SYNTHETIC MET, V101, P98, DOI 10.1016/S0379-6779(98)01241-7; Sase M, 2011, J MATER CHEM, V21, P8347, DOI 10.1039/c0jm03950k; SHIROTANI I, 1991, B CHEM SOC JPN, V64, P1607, DOI 10.1246/bcsj.64.1607; SHIROTANI I, 1992, B CHEM SOC JPN, V65, P1078, DOI 10.1246/bcsj.65.1078; Skotheim T.A., 1997, HDB CONDUCTING POLYM; Van de Walle CG, 2000, PHYS REV LETT, V85, P1012, DOI 10.1103/PhysRevLett.85.1012; Zhang ZL, 2011, CHEM COMMUN, V47, P7782, DOI 10.1039/c1cc11882j	26	0	0	5	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e72964	10.1371/journal.pone.0072964	http://dx.doi.org/10.1371/journal.pone.0072964			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24115999	Green Submitted, gold, Green Published			2022-12-25	WOS:000325501300002
J	Wang, ZG; Si, XL; Xu, A; Meng, XN; Gao, SL; Qi, YJ; Zhu, L; Li, TJ; Li, WP; Dong, LY				Wang, Zhengguang; Si, Xiulian; Xu, Aman; Meng, Xiangning; Gao, Shile; Qi, Yijun; Zhu, Liang; Li, Tuanjie; Li, Weiping; Dong, Liuyi			Activation of STAT3 in Human Gastric Cancer Cells via Interleukin (IL)-6-Type Cytokine Signaling Correlates with Clinical Implications	PLOS ONE			English	Article							PROGNOSTIC MARKER; MOLECULAR TARGETS; IMMUNE-RESPONSES; EXPRESSION; TRANSDUCER; CARCINOMA; PATHWAY; PROTEIN; GROWTH; IDENTIFICATION	Background: The signal transducers and activators of transcription 3 (STAT3) signaling pathway plays important roles in oncogenesis, angiogenesis, immunity, and tumor cell invasion. In the present study, we investigated the association of interleukin (IL)-6/STAT3 signaling pathway with T lymphocytes and clinical implication in patients with gastric cancer. Methods: Seventy one patients who underwent gastrectomy due to gastric adenocarcinoma were studied. Blood samples were collected before and after surgical gastrectomy to quantify the levels of IL-6, IL-10 and VEGF using an enzyme-linked immunosorbent assay, as well as T lymphocyte subsets (CD3(+), CD4(+), CD8(+), CD4(+)/CD8(+)) and natural killer (NK) cells by a flow cytometry. Furthermore, the expression of IL-6, survivin, STAT3, STAT3 phosphorylation (p-STAT3), and VEGF were determined in human gastric cancer and adjacent normal mucosa through Western blot and immunohistochemistry. Results: Postoperative levels of IL-6, IL-10 and VEGF in serum were significantly lower than preoperative levels. Percentages of T-cell subsets and NK cells in blood were significantly increased after postoperative-week 1 as compared to preoperative group, which was further augmented at 1 month after gastrectomy. In addition, the expression of IL-6, survivin, STAT3, p-STAT3, and VEGF were increased in human gastric cancer tissues as compared to adjacent normal mucosa. Their expression was associated with TNM stage of gastric cancer. The level of STAT3 activation in clinical samples was correlated with IL-6 expression. All gastric tumor samples, which expressed p-STAT3, also expressed IL-6 with weak expression detected in adjacent normal mucosa. Conclusion: Increased IL-6-induced activation of STAT3 was observed in neoplastic gastric tissue, which positively correlated with tumor progression. Moreover, IL-6 and STAT3 downstream signals such as IL-10 and VEGF were reduced in patients after removal of gastric cancer as compared to pre-operation. Therefore, inhibition of the IL-6/STAT3 signaling pathway may provide a new therapeutic strategy against gastric cancer.	[Wang, Zhengguang; Si, Xiulian; Gao, Shile; Li, Weiping; Dong, Liuyi] Anhui Med Univ, Key Lab Antiinflammatory & Immunopharmacol, Key Lab Chinese Med Res & Dev, Dept Pharmacol,Minist Educ,State Adm Tradit Chine, Hefei, Anhui, Peoples R China; [Wang, Zhengguang; Xu, Aman; Meng, Xiangning; Qi, Yijun; Zhu, Liang; Li, Tuanjie] Anhui Med Univ, Affiliated Hosp 1, Dept Surg, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Li, WP (corresponding author), Anhui Med Univ, Key Lab Antiinflammatory & Immunopharmacol, Key Lab Chinese Med Res & Dev, Dept Pharmacol,Minist Educ,State Adm Tradit Chine, Hefei, Anhui, Peoples R China.	weipingli19@hotmail.com; dongly@ahmu.edu.cn	LI, TUANJIE/S-3903-2018; 黎, 伟/GXM-4040-2022; li, wj/HGD-7322-2022	LI, TUANJIE/0000-0002-5540-6345; 	Educational Commission of Anhui Province, China [kj2011Z210]	Educational Commission of Anhui Province, China	This study, performed in the authors' laboratory, was supported by grants from Educational Commission of Anhui Province, China (Grant No. kj2011Z210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Amedei A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/690571; Benekli M, 2002, BLOOD, V99, P252, DOI 10.1182/blood.V99.1.252; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Buettner R, 2002, CLIN CANCER RES, V8, P945; Burdelya L, 2005, J IMMUNOL, V174, P3925, DOI 10.4049/jimmunol.174.7.3925; Cai GF, 1999, EUR J IMMUNOL, V29, P2658, DOI 10.1002/(SICI)1521-4141(199909)29:09<2658::AID-IMMU2658>3.3.CO;2-7; Chen J, 2012, MOL CANCER THER, V11, P277, DOI 10.1158/1535-7163.MCT-11-0648; Choi JH, 2006, APMIS, V114, P619, DOI 10.1111/j.1600-0463.2006.apm_401.x; De Vita F, 1999, CANCER, V86, P1936, DOI 10.1002/(SICI)1097-0142(19991115)86:10<1936::AID-CNCR9>3.0.CO;2-9; Dolled-Filhart M, 2003, CLIN CANCER RES, V9, P594; Ezzati M, 2005, INT J CANCER, V116, P963, DOI 10.1002/ijc.21100; Fortis C, 1996, CANCER LETT, V104, P1, DOI 10.1016/0304-3835(96)04213-9; Gamero AM, 2004, CANCER CELL, V5, P111, DOI 10.1016/S1535-6108(04)00028-5; Giraud AS, 2012, EXPERT OPIN THER TAR, V16, P889, DOI 10.1517/14728222.2012.709238; Gritsko T, 2006, CLIN CANCER RES, V12, P11, DOI 10.1158/1078-0432.CCR-04-1752; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; Hirano T, 1998, Int Rev Immunol, V16, P249; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Hong Weon-Seon, 1995, Journal of Korean Medical Science, V10, P164; Hsu KW, 2012, CARCINOGENESIS, V33, P1459, DOI 10.1093/carcin/bgs165; Huang SL, 2012, CANCER LETT, V315, P198, DOI 10.1016/j.canlet.2011.10.011; Huang SY, 2007, CLIN CANCER RES, V13, P1362, DOI 10.1158/1078-0432.CCR-06-2313; Jackson CB, 2007, J PATHOL, V213, P140, DOI 10.1002/path.2218; Jackson CB, 2009, J GASTROEN HEPATOL, V24, P505, DOI 10.1111/j.1440-1746.2009.05822.x; Kanda N, 2004, ONCOGENE, V23, P4921, DOI 10.1038/sj.onc.1207606; Kim DY, 2009, J GASTROEN HEPATOL, V24, P646, DOI 10.1111/j.1440-1746.2008.05671.x; Kinoshita H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060914; Leu CM, 2003, ONCOGENE, V22, P7809, DOI 10.1038/sj.onc.1207084; Lin MT, 2007, INT J CANCER, V120, P2600, DOI 10.1002/ijc.22599; Masuda M, 2002, CANCER RES, V62, P3351; Mocellin S, 2004, GENES IMMUN, V5, P621, DOI 10.1038/sj.gene.6364135; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Sekikawa A, 2008, CARCINOGENESIS, V29, P76, DOI 10.1093/carcin/bgm250; Shahini VM, 2011, ACS MED CHEM LETT, V2, P79, DOI 10.1021/ml100224d; Shin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021492; Szczepanik AM, 2011, WORLD J GASTROENTERO, V17, P343, DOI 10.3748/wjg.v17.i3.343; Szkaradkiewicz A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/901564; TERANISHI T, 1982, J IMMUNOL, V128, P1903; Toyonaga T, 2003, CANCER LETT, V201, P107, DOI 10.1016/S0304-3835(03)00482-8; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Wei DY, 2003, ONCOGENE, V22, P319, DOI 10.1038/sj.onc.1206122; Xiong H, 2012, J MOL MED, V90, P1037, DOI 10.1007/s00109-012-0869-0; Yakata Y, 2007, INT J ONCOL, V30, P437; Yang L, 2003, BIOCHEM BIOPH RES CO, V305, P462, DOI 10.1016/S0006-291X(03)00792-7; Yao XX, 2002, WORLD J GASTROENTERO, V8, P586, DOI 10.3748/wjg.v8.i4.586; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	49	39	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75788	10.1371/journal.pone.0075788	http://dx.doi.org/10.1371/journal.pone.0075788			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116074	Green Published, gold, Green Submitted			2022-12-25	WOS:000325501300042
J	Barbu, EM; Shirazi, F; McGrath, DM; Albert, N; Sidman, RL; Pasqualini, R; Arap, W; Kontoyiannis, DP				Barbu, E. Magda; Shirazi, Fazal; McGrath, Danielle M.; Albert, Nathaniel; Sidman, Richard L.; Pasqualini, Renata; Arap, Wadih; Kontoyiannis, Dimitrios P.			An Antimicrobial Peptidomimetic Induces Mucorales Cell Death through Mitochondria-Mediated Apoptosis	PLOS ONE			English	Article							COMBINATORIAL PEPTIDE SELECTION; FACTOR RECEPTOR PATHWAY; AMPHOTERICIN-B; ANTIFUNGAL; RESISTANCE; YEAST; METACASPASES; PATHOGENESIS; MECHANISMS; PROSTATE	The incidence of mucormycosis has dramatically increased in immunocompromised patients. Moreover, the array of cellular targets whose inhibition results in fungal cell death is rather limited. Mitochondria have been mechanistically identified as central regulators of detoxification and virulence in fungi. Our group has previously designed and developed a proteolytically-resistant peptidomimetic motif (D)(KLAKLAK)(2) with pleiotropic action ranging from targeted (i.e., ligand-directed) activity against cancer and obesity to non-targeted activity against antibiotic resistant gram-negative rods. Here we evaluated whether this non-targeted peptidomimetic motif is active against Mucorales. We show that (D)(KLAKLAK)(2) has marked fungicidal action, inhibits germination, and reduces hyphal viability. We have also observed cellular changes characteristic of apoptosis in (D)(KLAKLAK)(2)-treated Mucorales cells. Moreover, the fungicidal activity was directly correlated with vacuolar injury, mitochondrial swelling and mitochondrial membrane depolarization, intracellular reactive oxygen species accumulation (ROS), and increased caspase-like enzymatic activity. Finally, these apoptotic features were prevented by the addition of the ROS scavenger N-acetyl-cysteine indicating mechanistic pathway specificity. Together, these findings indicate that (D)(KLAKLAK)(2) makes Mucorales exquisitely susceptible via mitochondrial injury-induced apoptosis. This prototype may serve as a candidate drug for the development of translational applications against mucormycosis and perhaps other fungal infections.	[Barbu, E. Magda; McGrath, Danielle M.; Pasqualini, Renata; Arap, Wadih] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, David H Koch Ctr, Houston, TX 77030 USA; [Barbu, E. Magda; Shirazi, Fazal; Albert, Nathaniel; Kontoyiannis, Dimitrios P.] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis, Houston, TX 77030 USA; [Sidman, Richard L.] Harvard Univ, Sch Med, Boston, MA USA; [Sidman, Richard L.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Pasqualini, R (corresponding author), Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA.	rpasqual@salud.unm.edu; warap@salud.unm.edu; dkontoyi@mdanderson.org	Shirazi, Fazal/C-7398-2014	Shirazi, Fazal/0000-0002-6097-1779	National Institutes of Health [AI089812]; AngelWorks; Gillson-Longenbaugh Foundation; Marcus Foundation; NATIONAL CANCER INSTITUTE [U54CA151668, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI089812] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AngelWorks; Gillson-Longenbaugh Foundation; Marcus Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI089812 (http://www.niaid.nih.gov/Pages/default.aspx) and awards from AngelWorks (http://myangelworks.org/wp/), the Gillson-Longenbaugh Foundation, and the Marcus Foundation (http://www.marcusfound.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antachopoulos C, 2006, J CLIN MICROBIOL, V44, P553, DOI 10.1128/JCM.44.2.553-560.2006; Arap W, 2002, P NATL ACAD SCI USA, V99, P1527, DOI 10.1073/pnas.241655998; Barnhart KF, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002621; Ben-Ami R, 2010, ANTIMICROB AGENTS CH, V54, P484, DOI 10.1128/AAC.00956-09; BESSALLE R, 1990, FEBS LETT, V274, P151, DOI 10.1016/0014-5793(90)81351-N; Cardo-Vila M, 2010, P NATL ACAD SCI USA, V107, P5118, DOI 10.1073/pnas.0915146107; Cho J, 2011, BIOCHEM BIOPH RES CO, V405, P422, DOI 10.1016/j.bbrc.2011.01.046; Clinical and Laboratory Standards Institute, 2012, M100S19 CLSI; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Farina C, 2012, MED MYCOL, V50, P427, DOI 10.3109/13693786.2011.614964; Giordano RJ, 2010, P NATL ACAD SCI USA, V107, P5112, DOI 10.1073/pnas.0915141107; Gray KC, 2012, P NATL ACAD SCI USA, V109, P2234, DOI 10.1073/pnas.1117280109; GROVE SN, 1970, J BACTERIOL, V104, P989, DOI 10.1128/JB.104.2.989-1009.1970; Higgins DL, 2005, ANTIMICROB AGENTS CH, V49, P1127, DOI 10.1128/AAC.49.3.1127-1134.2005; Hof H, 2006, MYCOSES, V49, P2, DOI 10.1111/j.1439-0507.2006.01295.x; Hwang B, 2011, BIOCHEM BIOPH RES CO, V405, P267, DOI 10.1016/j.bbrc.2011.01.026; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kirimura K, 2006, J BIOSCI BIOENG, V102, P210, DOI 10.1263/jbb.102.210; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Kontoyiannis DP, 2006, INFECT DIS CLIN N AM, V20, P581, DOI 10.1016/j.idc.2006.06.003; Lahdenranta J, 2007, FASEB J, V21, P3272, DOI 10.1096/fj.07-8273com; Lionakis MS, 2005, INFECT IMMUN, V73, P7747, DOI 10.1128/IAI.73.11.7747-7758.2005; Ma LJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000549; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; MALOY WL, 1995, BIOPOLYMERS, V37, P105, DOI 10.1002/bip.360370206; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; Matejuk A, 2010, DRUG FUTURE, V35, P197, DOI 10.1358/dof.2010.035.03.1452077; McGrath DM, 2013, P NATL ACAD SCI USA, V110, P3477, DOI 10.1073/pnas.1221924110; Meletiadis J, 2001, J CLIN MICROBIOL, V39, P3402, DOI 10.1128/JCM.39.9.3402-3408.2001; Niimi K, 2004, ANTIMICROB AGENTS CH, V48, P1256, DOI 10.1128/AAC.48.4.1256-1271.2004; Onuchic JN, 2013, P NATL ACAD SCI USA, V110, P3212, DOI 10.1073/pnas.1222882110; Ostrosky-Zeichner L, 2012, AM J MED, V125, pS14, DOI 10.1016/j.amjmed.2011.10.008; Perrone GG, 2008, BBA-MOL CELL RES, V1783, P1354, DOI 10.1016/j.bbamcr.2008.01.023; Peters BM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001067; Pfaller MA, 2012, AM J MED, V125, pS3, DOI 10.1016/j.amjmed.2011.11.001; Phillips AJ, 2003, P NATL ACAD SCI USA, V100, P14327, DOI 10.1073/pnas.2332326100; Porter EA, 2000, NATURE, V404, P565, DOI 10.1038/35007145; Shirazi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063393; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Tian J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030147, 10.1371/journal.pone.0035164]; Tsiatsiani L, 2011, CELL DEATH DIFFER, V18, P1279, DOI 10.1038/cdd.2011.66; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Vitale RG, 2003, J ANTIMICROB CHEMOTH, V52, P65, DOI 10.1093/jac/dkg285; Weber SU, 2009, APOPTOSIS, V14, P97, DOI 10.1007/s10495-008-0280-z; Wu XZ, 2009, BIOCHIM BIOPHYS ACTA, V1790, P439; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A; Zurita AJ, 2004, CANCER RES, V64, P435, DOI 10.1158/0008-5472.CAN-03-2675	48	22	23	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76981	10.1371/journal.pone.0076981	http://dx.doi.org/10.1371/journal.pone.0076981			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098573	Green Published, gold, Green Submitted			2022-12-25	WOS:000325483600082
J	Chaudhary, R; Chugh, M; Darokhan, Z; Katreddi, RR; Ramachandra, R; Rema, V				Chaudhary, Rahul; Chugh, Manisha; Darokhan, Ziauddin; Katreddi, Raghu Ram; Ramachandra, Renuka; Rema, V.			Physiological Slowing and Upregulation of Inhibition in Cortex Are Correlated with Behavioral Deficits in Protein Malnourished Rats	PLOS ONE			English	Article							KINDLING-INDUCED ALTERATIONS; GRANULE CELL EXCITABILITY; BARREL FIELD CORTEX; DENTATE GYRUS; INFANT MALNUTRITION; PYRAMIDAL CELLS; HIPPOCAMPAL-FORMATION; CHILD UNDERNUTRITION; INCREASED FREQUENCY; NEURONAL-ACTIVITY	Protein malnutrition during early development has been correlated with cognitive and learning disabilities in children, but the neuronal deficits caused by long-term protein deficiency are not well understood. We exposed rats from gestation up to adulthood to a protein-deficient (PD) diet, to emulate chronic protein malnutrition in humans. The offspring exhibited significantly impaired performance on the 'Gap-crossing' (GC) task after reaching maturity, a behavior that has been shown to depend on normal functioning of the somatosensory cortex. The physiological state of the somatosensory cortex was examined to determine neuronal correlates of the deficits in behavior. Extracellular multi-unit recording from layer 4 (L4) neurons that receive direct thalamocortical inputs and layers 2/3 (L2/3) neurons that are dominated by intracortical connections in the whisker-barrel cortex of PD rats exhibited significantly low spontaneous activity and depressed responses to whisker stimulation. L4 neurons were more severely affected than L2/3 neurons. The response onset was significantly delayed in L4 cells. The peak response latency of L4 and L2/3 neurons was delayed significantly. In L2/3 and L4 of the barrel cortex there was a substantial increase in GAD65 (112% over controls) and much smaller increase in NMDAR1 (12-20%), suggesting enhanced inhibition in the PD cortex. These results show that chronic protein deficiency negatively affects both thalamo-cortical and cortico-cortical transmission during somatosensory information processing. The findings support the interpretation that sustained protein deficiency interferes with features of cortical sensory processing that are likely to underlie the cognitive impairments reported in humans who have suffered from prolonged protein deficiency.	[Chaudhary, Rahul; Chugh, Manisha; Darokhan, Ziauddin; Katreddi, Raghu Ram; Ramachandra, Renuka; Rema, V.] Natl Brain Res Ctr, Manesar, Haryana, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Rema, V (corresponding author), Natl Brain Res Ctr, Manesar, Haryana, India.	rema.velayudhan@gmail.com		Katreddi, Raghu Ram/0000-0002-6475-9927	Wellcome Trust [GR066676MA]; Wellcome Trust, UK; NBRC; Department of Biotechnology, India [BT/PR6615/MED/14/857/2005]	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust, UK(Wellcome Trust); NBRC(Department of Biotechnology (DBT) India); Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work was supported by Wellcome Trust International Senior Research Fellowship Grant GR066676MA (V. R.). V. R. acknowledges full salary support from the Wellcome Trust, UK for 5 years. Part of this work was funded by NBRC core funds and a grant from Department of Biotechnology, India BT/PR6615/MED/14/857/2005. Z.U.D. was research fellow of the Council of Scientific and Industrial Research, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL KN, 1989, ACTA PAEDIATR SCAND, V78, P873, DOI 10.1111/j.1651-2227.1989.tb11166.x; Agarwal KN, 1995, ACTA PAEDIATR, V84, P1357, DOI 10.1111/j.1651-2227.1995.tb13568.x; Alamy M, 2012, NEUROSCI BIOBEHAV R, V36, P1463, DOI 10.1016/j.neubiorev.2012.03.009; ANDRADE JP, 1991, EXP NEUROL, V112, P119, DOI 10.1016/0014-4886(91)90121-R; ANGELMEZA ARD, 2002, INT J DEV NEUROSCI, V20, P47, DOI DOI 10.1016/S0736-5748(01)00066-1; ARMSTRONGJAMES M, 1991, J COMP NEUROL, V303, P193, DOI 10.1002/cne.903030203; ARMSTRONGJAMES M, 1993, J NEUROSCI, V13, P2149; ARMSTRONGJAMES M, 1987, J COMP NEUROL, V263, P265, DOI 10.1002/cne.902630209; ARMSTRONGJAMES M, 1994, J NEUROSCI, V14, P6978; Atalabi OM, 2010, INT J NEUROSCI, V120, P23, DOI 10.3109/00207450903315727; AUSTIN KB, 1992, BRAIN RES BULL, V28, P245, DOI 10.1016/0361-9230(92)90186-2; AUSTIN KB, 1986, DEV BRAIN RES, V29, P267, DOI 10.1016/0165-3806(86)90102-1; AUSTIN KB, 1989, EXP BRAIN RES, V77, P594; BARNEOUD P, 1991, BEHAV BRAIN RES, V44, P87, DOI 10.1016/S0166-4328(05)80242-6; BARTEL PR, 1979, AM J CLIN NUTR, V32, P753, DOI 10.1093/ajcn/32.4.753; Benitez-Bribiesca L, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.2.e21; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; BRONZINO JD, 1991, EXP NEUROL, V112, P206, DOI 10.1016/0014-4886(91)90071-J; Bronzino JD, 1996, HIPPOCAMPUS, V6, P109, DOI 10.1002/(SICI)1098-1063(1996)6:2<109::AID-HIPO2>3.0.CO;2-K; BRONZINO JD, 1991, EXP NEUROL, V112, P216, DOI 10.1016/0014-4886(91)90072-K; Bronzino JD, 1999, BRAIN RES, V849, P45, DOI 10.1016/S0006-8993(99)02071-5; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Chang YM, 2003, NUTR NEUROSCI, V6, P263, DOI 10.1080/1028415031000151549; CORDERO ME, 1986, EARLY HUM DEV, V14, P245, DOI 10.1016/0378-3782(86)90186-6; CORDERO ME, 1976, AM J CLIN NUTR, V29, P358, DOI 10.1093/ajcn/29.4.358; CORDERO ME, 1993, PEDIATR NEUROL, V9, P457, DOI 10.1016/0887-8994(93)90025-8; Cordero ME, 2003, DEV BRAIN RES, V142, P37, DOI 10.1016/S0165-3806(03)00013-0; CRNIC LS, 1978, J NUTR, V108, P1755, DOI 10.1093/jn/108.11.1755; De Frias V, 2010, NEUROSCI LETT, V482, P203, DOI 10.1016/j.neulet.2010.07.033; de Onis M, 2012, PUBLIC HEALTH NUTR, V15, P142, DOI 10.1017/S1368980011001315; de Rooij SR, 2010, P NATL ACAD SCI USA, V107, P16881, DOI 10.1073/pnas.1009459107; Diaz-Cintra S, 2007, EXP NEUROL, V208, P47, DOI 10.1016/j.expneurol.2007.07.003; DIAZCINTRA S, 1990, J COMP NEUROL, V292, P117, DOI 10.1002/cne.902920108; Durmaz S, 1999, PEDIATR INT, V41, P615, DOI 10.1046/j.1442-200X.1999.t01-1-01150.x; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Feoli AM, 2006, J NUTR, V136, P2357, DOI 10.1093/jn/136.9.2357; FLINN JM, 1993, PERCEPT MOTOR SKILL, V76, P1359, DOI 10.2466/pms.1993.76.3c.1359; Galler JR, 2010, J CHILD PSYCHOL PSYC, V51, P789, DOI 10.1111/j.1469-7610.2010.02208.x; Galler JR, 2012, NUTR NEUROSCI, V15, P186, DOI 10.1179/1476830512Y.0000000012; Galler JR, 2012, J NUTR, V142, P788, DOI 10.3945/jn.111.145441; GARCIARUIZ M, 1993, BRAIN RES, V625, P203, DOI 10.1016/0006-8993(93)91060-6; Granados-Rojas L, 2004, NUTR NEUROSCI, V7, P301, DOI 10.1080/10284150400017306; Granados-Rojas L, 2002, BRAIN RES, V933, P164, DOI 10.1016/S0006-8993(02)02314-4; GUICROBLES E, 1992, BEHAV BRAIN RES, V48, P145, DOI 10.1016/S0166-4328(05)80150-0; Hazin AN, 2007, INT J NEUROSCI, V117, P1209, DOI 10.1080/00207450600934945; Hernandez Alejandro, 2008, Neural Plasticity, V2008, P1, DOI 10.1155/2008/646919; HUTSON KA, 1986, J NEUROPHYSIOL, V56, P1196, DOI 10.1152/jn.1986.56.4.1196; Jenkinson EW, 2000, J NEUROPHYSIOL, V84, P1781, DOI 10.1152/jn.2000.84.4.1781; Kash SF, 1997, P NATL ACAD SCI USA, V94, P14060, DOI 10.1073/pnas.94.25.14060; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; Laus MF, 2011, INT J ENV RES PUB HE, V8, P590, DOI 10.3390/ijerph8020590; Li L, 2005, J NEUROPHYSIOL, V94, P3342, DOI 10.1152/jn.00357.2005; Luebke J, 2000, SYNAPSE, V37, P23, DOI 10.1002/(SICI)1098-2396(200007)37:1&lt;23::AID-SYN3&gt;3.0.CO;2-Y; MORGANE PJ, 1978, NEUROSCI BIOBEHAV R, V2, P137, DOI 10.1016/0149-7634(78)90059-3; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Mueller Arthur J., 1946, JOUR NUTRITION, V31, P249, DOI 10.1093/jn/31.2.249; Nassar MF, 2012, J TROP PEDIATRICS, V58, P226, DOI 10.1093/tropej/fmr081; Odabas D, 2005, INT J PEDIATR OTORHI, V69, P923, DOI 10.1016/j.ijporl.2005.01.034; Odabas D, 2005, INT J NEUROSCI, V115, P829, DOI 10.1080/00207450590882082; Palmer AA, 2004, BRAIN RES, V996, P193, DOI 10.1016/j.brainres.2003.09.077; Patel AB, 2006, J NEUROCHEM, V97, P385, DOI 10.1111/j.1471-4159.2006.03741.x; PAULABARBOSA MM, 1989, EXP NEUROL, V103, P186, DOI 10.1016/0014-4886(89)90081-2; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; PINE AP, 1994, BRIT J NUTR, V72, P815, DOI 10.1079/BJN19940087; Plagemann A, 2000, J NUTR, V130, P2582, DOI 10.1093/jn/130.10.2582; Ranade SC, 2008, NEUROSCIENCE, V152, P859, DOI 10.1016/j.neuroscience.2008.01.002; Ranade SC, 2012, BRIT J NUTR, V107, P1167, DOI 10.1017/S0007114511004119; Rema V, 1996, J COMP NEUROL, V368, P165; Rema V, 2003, J NEUROSCI, V23, P10378; Rema V, 1998, J NEUROSCI, V18, P10196; Rema V, 1999, J NEUROSCI, V19, P10993, DOI 10.1523/JNEUROSCI.19-24-10993.1999; RESNICK O, 1982, NEUROSCI BIOBEHAV R, V6, P55, DOI 10.1016/0149-7634(82)90007-0; Schweigert ID, 2005, DEV BRAIN RES, V154, P177, DOI 10.1016/j.devbrainres.2004.10.013; Soto-Moyano R, 2005, J NEUROCHEM, V93, P1099, DOI 10.1111/j.1471-4159.2005.03094.x; Steiger JL, 2003, NEUROREPORT, V14, P1731, DOI 10.1097/00001756-200309150-00015; Steiger JL, 2002, EUR J PHARMACOL, V446, P201, DOI 10.1016/S0014-2999(02)01815-0; STERN WC, 1984, BRAIN RES, V306, P227, DOI 10.1016/0006-8993(84)90372-X; STERN WC, 1983, DEV BRAIN RES, V9, P95, DOI 10.1016/0165-3806(83)90113-X; STRUPP BJ, 1995, J NUTR, V125, pS2221, DOI 10.1093/jn/125.suppl_8.2221S; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; VONGDOKMAI R, 1980, J COMP NEUROL, V191, P283, DOI 10.1002/cne.901910209; Walker SP, 2005, LANCET, V366, P1804, DOI 10.1016/S0140-6736(05)67574-5; WEST CD, 1976, BRAIN RES, V107, P221, DOI 10.1016/0006-8993(76)90223-7; WONGRILEY MTT, 1980, P NATL ACAD SCI-BIOL, V77, P2333, DOI 10.1073/pnas.77.4.2333	84	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76556	10.1371/journal.pone.0076556	http://dx.doi.org/10.1371/journal.pone.0076556			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098531	Green Published, Green Submitted, gold			2022-12-25	WOS:000325483600066
J	Khaladkar, M; Buckley, PT; Lee, MT; Francis, C; Eghbal, MM; Chuong, T; Suresh, S; Kuhn, B; Eberwine, J; Kim, J				Khaladkar, Mugdha; Buckley, Peter T.; Lee, Miler T.; Francis, Chantal; Eghbal, Mitra M.; Chuong, Tina; Suresh, Sangita; Kuhn, Bernhard; Eberwine, James; Kim, Junhyong			Subcellular RNA Sequencing Reveals Broad Presence of Cytoplasmic Intron-Sequence Retaining Transcripts in Mouse and Rat Neurons	PLOS ONE			English	Article							PRE-MESSENGER-RNA; LARGE GENE LISTS; RETENTION; DATABASE; DNA; ELEMENT; CELLS	Recent findings have revealed the complexity of the transcriptional landscape in mammalian cells. One recently described class of novel transcripts are the Cytoplasmic Intron-sequence Retaining Transcripts (CIRTs), hypothesized to confer post-transcriptional regulatory function. For instance, the neuronal CIRT KCNMA1i16 contributes to the firing properties of hippocampal neurons. Intronic sub-sequence retention within IL1-beta mRNA in anucleate platelets has been implicated in activity-dependent splicing and translation. In a recent study, we showed CIRTs harbor functional SINE ID elements which are hypothesized to mediate dendritic localization in neurons. Based on these studies and others, we hypothesized that CIRTs may be present in a broad set of transcripts and comprise novel signals for post-transcriptional regulation. We carried out a transcriptome-wide survey of CIRTs by sequencing micro-dissected subcellular RNA fractions. We sequenced two batches of 150-300 individually dissected dendrites from primary cultures of hippocampal neurons in rat and three batches from mouse hippocampal neurons. After statistical processing to minimize artifacts, we found a broad prevalence of CIRTs in the neurons in both species (44-60% of the expressed transcripts). The sequence patterns, including stereotypical length, biased inclusion of specific introns, and intron-intron junctions, suggested CIRT-specific nuclear processing. Our analysis also suggested that these cytoplasmic intron-sequence retaining transcripts may serve as a primary transcript for ncRNAs. Our results show that retaining intronic sequences is not isolated to a few loci but may be a genome-wide phenomenon for embedding functional signals within certain mRNA. The results hypothesize a novel source of cis-sequences for post-transcriptional regulation. Our results hypothesize two potentially novel splicing pathways: one, within the nucleus for CIRT biogenesis; and another, within the cytoplasm for removing CIRT sequences before translation. We also speculate that release of CIRT sequences prior to translation may form RNA-based signals within the cell potentially comprising a novel class of signaling pathways.	[Khaladkar, Mugdha; Francis, Chantal; Eghbal, Mitra M.; Chuong, Tina; Kim, Junhyong] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Buckley, Peter T.; Eberwine, James; Kim, Junhyong] Univ Penn, Penn Genome Frontiers Inst, Philadelphia, PA 19104 USA; [Buckley, Peter T.; Eberwine, James] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Eberwine, James; Kim, Junhyong] Univ Penn, Genom & Computat Biol Program, Philadelphia, PA 19104 USA; [Lee, Miler T.] Yale Univ, Dept Genet, New Haven, CT USA; [Suresh, Sangita; Kuhn, Bernhard] Boston Childrens Hosp, Dept Pediat, Boston, MA USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Yale University; Harvard University; Boston Children's Hospital	Eberwine, J (corresponding author), Univ Penn, Penn Genome Frontiers Inst, Philadelphia, PA 19104 USA.	eberwine@mail.med.upenn.edu; junhyong@sas.upenn.edu			Pennsylvania Department of Health; Department of Cardiology (Boston Children's Hospital); Translational Research Program (Boston Children's Hospital); NIH [R01HL106302, K08 HL085143]; Children's Cardiomyopathy Foundation;  [NIMH 5R01MH088849]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106302, K08HL085143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH088849] Funding Source: NIH RePORTER	Pennsylvania Department of Health; Department of Cardiology (Boston Children's Hospital); Translational Research Program (Boston Children's Hospital); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Cardiomyopathy Foundation; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by grant NIMH 5R01MH088849 to JK. This paper was also supported in part by a Health Research Formula Funds to Penn Genome Frontiers Institute from the Pennsylvania Department of Health, which disclaims responsibility for any analyses, interpretations or conclusions. BK was supported by the Department of Cardiology and the Translational Research Program (Boston Children's Hospital), the NIH (R01HL106302, K08 HL085143), and the Children's Cardiomyopathy Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTIERI DC, 1994, BIOCHEMISTRY-US, V33, P13848, DOI 10.1021/bi00250a039; Bell TJ, 2008, P NATL ACAD SCI USA, V105, P1901, DOI 10.1073/pnas.0711796105; Bell TJ, 2010, P NATL ACAD SCI USA, V107, P21152, DOI 10.1073/pnas.1015264107; Blencowe BJ, 2002, CURR BIOL, V12, pR147, DOI 10.1016/S0960-9822(02)00711-X; Buckley PT, 2011, NEURON, V69, P877, DOI 10.1016/j.neuron.2011.02.028; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Costa E, 2002, Mol Interv, V2, P47, DOI 10.1124/mi.2.1.47; Denis MM, 2005, CELL, V122, P379, DOI 10.1016/j.cell.2005.06.015; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Djebali S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028213; Durr A, 2004, ARCH NEUROL-CHICAGO, V61, P1867, DOI 10.1001/archneur.61.12.1867; Eberwine J, 2002, NEUROCHEM RES, V27, P1065, DOI 10.1023/A:1020956805307; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Galante PAF, 2004, RNA, V10, P757, DOI 10.1261/rna.5123504; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Grant GR, 2011, BIOINFORMATICS, V27, P2518, DOI 10.1093/bioinformatics/btr427; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kim J, 2010, TRENDS CELL BIOL, V20, P311, DOI 10.1016/j.tcb.2010.03.003; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Konig H, 2007, CELL, V131, P718, DOI 10.1016/j.cell.2007.09.043; Korf I, 2001, BIOINFORMATICS, V17, pS140, DOI DOI 10.1093/BI0INF0RMATICS/17.SUPPL_; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Lee JY, 2007, NUCLEIC ACIDS RES, V35, pD165, DOI 10.1093/nar/gkl870; Li Y, 2006, NATURE, V443, P234, DOI 10.1038/nature05107; Lipkin SM, 2000, NAT GENET, V24, P27, DOI 10.1038/71643; Mansilla A, 2005, EMBO REP, V6, P1182, DOI 10.1038/sj.embor.7400539; Marinescu V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000828; Marz P, 2004, J BIOL CHEM, V279, P35542, DOI 10.1074/jbc.M405865200; Melhuish TA, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-2; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; MIYASHIRO K, 1994, P NATL ACAD SCI USA, V91, P10800, DOI 10.1073/pnas.91.23.10800; MOWRY KL, 1987, SCIENCE, V238, P1682, DOI 10.1126/science.2825355; Sakabe NJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-59; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Spaethling JM, 2013, J BIOL CHEM; SPYCHER C, 1994, NUCLEIC ACIDS RES, V22, P4023, DOI 10.1093/nar/22.20.4023; Sugnet C W, 2004, Pac Symp Biocomput, P66; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433	43	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76194	10.1371/journal.pone.0076194	http://dx.doi.org/10.1371/journal.pone.0076194			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098440	gold, Green Published, Green Submitted			2022-12-25	WOS:000325483600029
J	Pinheiro, DS; Rocha, CR; Mundim, CA; de Marco, P; Ulhoa, CJ; Reis, AAS; Ghedini, PC				Pinheiro, Denise S.; Rocha Filho, Cesar R.; Mundim, Claudia A.; de Marco Junior, Paulo; Ulhoa, Cirano J.; Reis, Angela A. S.; Ghedini, Paulo C.			Evaluation of Glutathione S-Transferase GSTM1 and GSTT1 Deletion Polymorphisms on Type-2 Diabetes Mellitus Risk	PLOS ONE			English	Article							OXIDATIVE STRESS; GENETIC POLYMORPHISMS; ASSOCIATION; POPULATION; T1; SUSCEPTIBILITY; GENOTYPES; CANCER; CYP1A1; CELLS	Background: Due to the activity of GSTs in the detoxification of oxidative stress products, deletion polymorphisms of GSTM1 and GSTT1 may contribute to susceptibility to T2DM, since B-cells express very low levels of antioxidant enzymes. Recently, some studies have shown an association between GSTM1-null/GSTT1-null genotypes and an increased susceptibility to T2DM. A relationship between these polymorphisms and changes in the clinical parameters of diabetic patients has also been investigated. However, the results diverge considerably among the studies. Thus, this case-control study was designed to contribute to existing knowledge, as there are no studies on this issue performed in the Brazilian population. Methods and Findings: A total of 120 patients and 147 healthy individuals were included in this study. GSTT1 and GSTM1 deletion polymorphisms were genotyped by multiplex SYBR Green Real-Time PCR. The GSTT1-null genotype conferred a 3.2-fold increased risk to T2DM relative to the present genotype. There was no association between GSTM1-null and T2DM risk. In diabetic patients, GSTT1-null conferred higher levels of triglycerides and VLDL-cholesterol, while GSTM1-null was associated with increased levels of fasting blood glucose, glycated hemoglobin and blood pressure. We emphasized a necessity for applying log-linear analysis in order to explore an interaction between these polymorphisms properly. Conclusion: These results suggest that the GSTT1 polymorphism may play an important role in the pathogenesis of T2DM in the Brazilian population. This gene could then be added to a set of genetic markers to identify individuals with an increased risk for developing T2DM and complications associated with dyslipidemia in diabetic patients. Although there was no association of GSTM1 deletion polymorphism with susceptibility to T2DM, the influence of this polymorphism on important clinical parameters related to glycemia and blood pressure levels was verified. This finding suggests that both GSTM1-null and GSTT1-null may contribute to the clinical course of T2DM patients.	[Pinheiro, Denise S.] Fed Univ Goias UFG, Inst Biol Sci ICB, Goiania, Go, Brazil; [Rocha Filho, Cesar R.] Fed Univ Goias UFG, Inst Trop Pathol IPTSP, Goiania, Go, Brazil; [Mundim, Claudia A.] Fed Univ Goias UFG, Serv Endocrinol, Clin Hosp HC, Goiania, Go, Brazil; [Ulhoa, Cirano J.; Reis, Angela A. S.] Fed Univ Goias UFG, Dept Biochem & Mol Biol DBBM, Inst Biol Sci ICB, Goiania, Go, Brazil; [de Marco Junior, Paulo] Fed Univ Goias UFG, DE, Inst Biol Sci ICB, Goiania, Go, Brazil; [Ghedini, Paulo C.] Fed Univ Goias UFG, Dept Physiol Sci DCIF, Inst Biol Sci ICB, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal de Goias	Reis, AAS (corresponding author), Fed Univ Goias UFG, Dept Biochem & Mol Biol DBBM, Inst Biol Sci ICB, Goiania, Go, Brazil.	angeladamski@gmail.com	da Silva Pinheiro, Denise/Y-9276-2019; Ulhoa, CIRANO/AAV-9374-2020; DA SILVA, ANGELA ADAMSKI/AAJ-1403-2021; De Marco, Paulo/B-2209-2009	da Silva Pinheiro, Denise/0000-0001-7405-6822; DA SILVA, ANGELA ADAMSKI/0000-0002-8281-7334; De Marco, Paulo/0000-0002-3628-6405; Ulhoa, Cirano/0000-0002-4171-6465; Ramos Rocha-Filho, Cesar/0000-0002-7190-0263; Ghedini, Paulo/0000-0003-2104-4064	Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG)	Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG)	D.S. Pinheiro received fellowship from Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG). Funder's website: www.fapeg.go.gov.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman SZ, 1998, CANCER DETECT PREV, V22, P129; Amer MA, 2011, GENET MOL RES, V10, P3722, DOI 10.4238/2011.October.31.14; Andreassi MG, 2009, MUTAT RES-FUND MOL M, V667, P35, DOI 10.1016/j.mrfmmm.2008.10.018; Arruda VR, 1998, CLIN GENET, V54, P210; Bid HK, 2010, J POSTGRAD MED, V56, P176, DOI 10.4103/0022-3859.68633; Burim RV, 2004, MUTAGENESIS, V19, P291, DOI 10.1093/mutage/geh034; Colombo J, 2004, WORLD J GASTROENTERO, V10, P1240; D'Alo F, 2004, HAEMATOLOGICA, V89, P664; Datta SK, 2010, RENAL FAILURE, V32, P1189, DOI 10.3109/0886022X.2010.517348; Doney ASF, 2005, CIRCULATION, V111, P2927, DOI 10.1161/CIRCULATIONAHA.104.509224; Eizirik DL, 1996, DIABETOLOGIA, V39, P875; Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396; Hori M, 2007, PHARMACOGENOMICS, V8, P1307, DOI 10.2217/14622416.8.10.1307; Kajimoto Y, 2004, ANN NY ACAD SCI, V1011, P168, DOI 10.1196/annals.1293.017; Marin F, 2010, J MOL DIAGN, V12, P300, DOI 10.2353/jmoldx.2010.090076; Ramprasath T, 2011, BIOCHEM BIOPH RES CO, V407, P49, DOI 10.1016/j.bbrc.2011.02.097; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Streiner DL, 1998, CAN J PSYCHIAT, V43, P837, DOI 10.1177/070674379804300809; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Tiwari AK, 2009, J DIABETES COMPLICAT, V23, P102, DOI 10.1016/j.jdiacomp.2007.10.003; Wang GY, 2006, BIOCHEM BIOPH RES CO, V341, P310, DOI 10.1016/j.bbrc.2005.12.195; West IC, 2000, DIABETIC MED, V17, P171, DOI 10.1046/j.1464-5491.2000.00259.x; Yalin S, 2007, CELL BIOCHEM FUNCT, V25, P509, DOI 10.1002/cbf.1339; Zar JH., 2010, BIOSTAT ANAL; Zhang JW, 2013, GENE, V518, P405, DOI 10.1016/j.gene.2012.12.086	26	37	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76262	10.1371/journal.pone.0076262	http://dx.doi.org/10.1371/journal.pone.0076262			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098457	Green Published, Green Submitted, gold			2022-12-25	WOS:000325483600033
J	Tran, S; Wang, Y; Lamba, P; Zhou, X; Boehm, U; Bernard, DJ				Tran, Stella; Wang, Ying; Lamba, Pankaj; Zhou, Xiang; Boehm, Ulrich; Bernard, Daniel J.			The CpG Island in the Murine Foxl2 Proximal Promoter Is Differentially Methylated in Primary and Immortalized Cells	PLOS ONE			English	Article							HORMONE BETA-SUBUNIT; EPICANTHUS INVERSUS SYNDROME; TRANSCRIPTION FACTOR FOXL2; GENOTYPE-PHENOTYPE CORRELATION; ORGANOGENESIS IN-VIVO; HUMAN CANCER-CELLS; DNA METHYLATION; HISTONE DEACETYLASE; FORKHEAD TRANSCRIPTION; CHROMATIN-STRUCTURE	Forkhead box L2 (Foxl2), a member of the forkhead transcription factor family, plays important roles in pituitary follicle-stimulating hormone synthesis and in ovarian maintenance and function. Mutations in the human FOXL2 gene cause eyelid malformations and premature ovarian failure. FOXL2/Foxl2 is expressed in pituitary gonadotrope and thyrotrope cells, the perioptic mesenchyme of the developing eyelid, and ovarian granulosa cells. The mechanisms governing this cell-restricted expression have not been described. We mapped the Foxl2 transcriptional start site in immortalized murine gonadotrope-like cells, L beta T2, by 5' rapid amplification of cDNA ends and then PCR amplified approximately 1 kb of 5' flanking sequence from murine genomic DNA. When ligated into a reporter plasmid, the proximal promoter conferred luciferase activity in both homologous (L beta T2) and, unexpectedly, heterologous (NIH3T3) cells. In silico analyses identified a CpG island in the proximal promoter and 5' untranslated region, suggesting that Foxl2 transcription might be regulated epigenetically. Indeed, pyrosequencing and quantitative analysis of DNA methylation using real-time PCR revealed Foxl2 proximal promoter hypomethylation in homologous compared to some, though not all, heterologous cell lines. The promoter was also hypomethylated in purified murine gonadotropes. In vitro promoter methylation completely silenced reporter activity in heterologous and homologous cells. Collectively, the data suggest that differential proximal promoter DNA methylation may contribute to cell-specific Foxl2 expression in some cellular contexts. However, gonadotrope-specific expression of the gene cannot be explained by promoter hypomethylation alone.	[Tran, Stella; Wang, Ying; Lamba, Pankaj; Zhou, Xiang; Bernard, Daniel J.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Tran, Stella] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Lamba, Pankaj] St Mary Mercy Hosp, Livonia, MI USA; [Boehm, Ulrich] Univ Saarland, Sch Med, Homburg, Germany; [Bernard, Daniel J.] McGill Univ, Dept Obstet & Gynecol, Montreal, PQ H3A 2T5, Canada; [Bernard, Daniel J.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada	McGill University; University of California System; University of California Los Angeles; Saarland University; McGill University; McGill University	Bernard, DJ (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.	daniel.bernard@mcgill.ca		Bernard, Daniel/0000-0001-5365-5586	CIHR [MOP-89991]; FRSQ; McGill University Faculty of Medicine	CIHR(Canadian Institutes of Health Research (CIHR)); FRSQ(Fonds de la Recherche en Sante du Quebec); McGill University Faculty of Medicine	This work was funded by CIHR operating grant MOP-89991 to DJB. DJB and ST were supported by salary and fellowship awards from the FRSQ. ST also held a one-year studentship from the McGill University Faculty of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alao MJ, 2012, EUR J MED GENET, V55, P630, DOI 10.1016/j.ejmg.2012.07.005; Alarid ET, 1996, DEVELOPMENT, V122, P3319; ANTEQUERA F, 1990, CELL, V62, P503, DOI 10.1016/0092-8674(90)90015-7; Asdell S. A., 1944, SCIENCE, V99, P124, DOI 10.1126/science.99.2563.124; Benayoun BA, 2008, HUM MOL GENET, V17, P3118, DOI 10.1093/hmg/ddn209; Benayoun BA, 2009, HUM MOL GENET, V18, P632, DOI 10.1093/hmg/ddn389; Bernard DJ, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.107797; Bernard DJ, 2004, MOL ENDOCRINOL, V18, P606, DOI 10.1210/me.2003-0264; Beysen D, 2005, AM J HUM GENET, V77, P205, DOI 10.1086/432083; Beysen D, 2009, HUM MUTAT, V30, P158, DOI 10.1002/humu.20807; Beysen D, 2008, HUM MUTAT, V29, pE205, DOI 10.1002/humu.20819; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; BUONASSISI V, 1962, P NATL ACAD SCI USA, V48, P1184, DOI 10.1073/pnas.48.7.1184; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Corpuz PS, 2010, MOL ENDOCRINOL, V24, P1037, DOI 10.1210/me.2009-0425; Coss D, 2010, TRENDS ENDOCRIN MET, V21, P562, DOI 10.1016/j.tem.2010.05.006; Crisponi L, 2004, GENOMICS, V83, P757, DOI 10.1016/j.ygeno.2003.11.010; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; D'haene B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000522; De Baere E, 2000, GENOMICS, V68, P296, DOI 10.1006/geno.2000.6304; De Baere E, 2003, AM J HUM GENET, V72, P478, DOI 10.1086/346118; De Baere E, 2001, HUM MOL GENET, V10, P1591, DOI 10.1093/hmg/10.15.1591; DENAMUR E, 1995, DNA CELL BIOL, V14, P811, DOI 10.1089/dna.1995.14.811; Dodge JE, 2005, J BIOL CHEM, V280, P17986, DOI 10.1074/jbc.M413246200; El-Osta A, 2000, GENE EXPRESSION, V9, P63; Ellsworth BS, 2006, MOL ENDOCRINOL, V20, P2796, DOI 10.1210/me.2005-0303; FLATAU E, 1983, CANCER RES, V43, P4901; Fortin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059058; FRASER IS, 1988, FERTIL STERIL, V50, P747; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Ghochani Y, 2012, ENDOCRINOLOGY, V153, P2023, DOI 10.1210/en.2011-1763; Gonzalez-Gonzalez C, 2012, OPHTHALMIC GENET, V33, P107, DOI 10.3109/13816810.2011.634879; Han TD, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-183; Hoivik EA, 2008, ENDOCRINOLOGY, V149, P5599, DOI 10.1210/en.2008-0104; Hoivik EA, 2011, ENDOCRINOLOGY, V152, P2100, DOI 10.1210/en.2010-1305; INOUE K, 1992, ENDOCRINOLOGY, V131, P3110, DOI 10.1210/en.131.6.3110; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Justice NJ, 2011, MOL ENDOCRINOL, V25, P1404, DOI 10.1210/me.2011-0093; KAWAI J, 1994, MOL CELL BIOL, V14, P7421, DOI 10.1128/MCB.14.11.7421; Kim GD, 2002, EMBO J, V21, P4183, DOI 10.1093/emboj/cdf401; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; KOTHARY R, 1989, DEVELOPMENT, V105, P707; Kuck D, 2010, MOL CANCER THER, V9, P3015, DOI 10.1158/1535-7163.MCT-10-0609; Lamba P, 2010, ENDOCRINOLOGY, V151, P5456, DOI 10.1210/en.2010-0605; Lamba P, 2009, MOL ENDOCRINOL, V23, P1001, DOI 10.1210/me.2008-0324; Lee KB, 2007, J MOL ENDOCRINOL, V38, P315, DOI 10.1677/jme.1.02196; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Moumne L, 2008, HUM MOL GENET, V17, P1010, DOI 10.1093/hmg/ddm373; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Oakes Christopher C., 2009, V507, P271, DOI 10.1007/978-1-59745-522-0_20; Oka M, 2006, J BIOL CHEM, V281, P9901, DOI 10.1074/jbc.M511100200; Ou JN, 2007, BIOCHEM PHARMACOL, V73, P1297, DOI 10.1016/j.bcp.2006.12.032; Pailhoux E, 2001, NAT GENET, V29, P453, DOI 10.1038/ng769; Pannetier M, 2005, GENOMICS, V85, P715, DOI 10.1016/j.ygeno.2005.02.011; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Praphanphoj V, 2000, GENOMICS, V65, P67, DOI 10.1006/geno.2000.6157; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Rosenfeld MG, 2000, RECENT PROG HORM RES, V55, P1; Samlowski WE, 2005, J CLIN ONCOL, V23, P3897, DOI 10.1200/JCO.2005.06.118; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Schlade-Bartusiak K, 2012, AM J MED GENET A, V158A, P2322, DOI 10.1002/ajmg.a.35516; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Smiraglia DJ, 2001, HUM MOL GENET, V10, P1413, DOI 10.1093/hmg/10.13.1413; Stromme PS, 1996, ACTA OPHTHALMOL SCAN, V74, P45; Suzuki-Ishigaki S, 2000, NUCLEIC ACIDS RES, V28, P2627, DOI 10.1093/nar/28.14.2627; Tran S, 2013, MOL ENDOCRINOL, V27, P407, DOI 10.1210/me.2012-1286; Tran S, 2011, MOL ENDOCRINOL, V25, P1170, DOI 10.1210/me.2010-0480; Treier M, 1998, GENE DEV, V12, P1691, DOI 10.1101/gad.12.11.1691; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; Udar N, 2003, HUM MUTAT, V22, P222, DOI 10.1002/humu.10251; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Vaiman D, 1996, MAMM GENOME, V7, P133, DOI 10.1007/s003359900033; Wade PA, 2001, BIOESSAYS, V23, P1131, DOI 10.1002/bies.10008; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; WATT F, 1988, GENE DEV, V2, P1136, DOI 10.1101/gad.2.9.1136; Wen S, 2008, ENDOCRINOLOGY, V149, P2701, DOI 10.1210/en.2007-1502; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yusta B, 1998, ENDOCRINOLOGY, V139, P4476, DOI 10.1210/en.139.11.4476; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	83	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76642	10.1371/journal.pone.0076642	http://dx.doi.org/10.1371/journal.pone.0076642			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098544	Green Published, Green Submitted, gold			2022-12-25	WOS:000325434500078
J	Bellucci, L; Corni, S; Di Felice, R; Paci, E				Bellucci, Luca; Corni, Stefano; Di Felice, Rosa; Paci, Emanuele			The Structure of Neuronal Calcium Sensor-1 in Solution Revealed by Molecular Dynamics Simulations	PLOS ONE			English	Article							SURFACE SALT BRIDGES; PROTEINS; STABILITY; NCS-1	Neuronal calcium sensor-1 (NCS-1) is a protein able to trigger signal transduction processes by binding a large number of substrates and re-shaping its structure depending on the environmental conditions. The X-ray crystal structure of the unmyristoilated NCS-1 shows a large solvent-exposed hydrophobic crevice (HC); this HC is partially occupied by the C-terminal tail and thus elusive to the surrounding solvent. We studied the native state of NCS-1 by performing room temperature molecular dynamics (MD) simulations starting from the crystal and the solution structures. We observe relaxation to a state independent of the initial structure, in which the C-terminal tail occupies the HC. We suggest that the C-terminal tail shields the HC binding pocket and modulates the affinity of NCS-1 for its natural targets. By analyzing the topology and nature of the inter-residue potential energy, we provide a compelling description of the interaction network that determines the three-dimensional organization of NCS-1.	[Bellucci, Luca; Corni, Stefano; Di Felice, Rosa] CNR Inst Nanosci, Ctr S3, Modena, Italy; [Paci, Emanuele] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England	Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); University of Leeds	Bellucci, L (corresponding author), CNR Inst Nanosci, Ctr S3, Modena, Italy.	luca.bellucci_s3@unimore.it	Bellucci, Luca/J-9096-2016; Paci, Emanuele/B-1893-2010; Corni, Stefano/A-6198-2012; Bellucci, Luca/AAB-2834-2021	Bellucci, Luca/0000-0003-2031-064X; Paci, Emanuele/0000-0002-4891-2768; Bellucci, Luca/0000-0003-2031-064X; DIFELICE, ROSA/0000-0002-7772-6550; Corni, Stefano/0000-0001-6707-108X	Italian Institute of Technology; EC through project DNA-NANODEVICES; Research Infrastructure Action HPC-EUROPA2; Fondazione CRMO	Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT); EC through project DNA-NANODEVICES; Research Infrastructure Action HPC-EUROPA2; Fondazione CRMO(Fondazione CarifeFondazione Caritro)	This work was funded by the Italian Institute of Technology (project MOPROSURF and Computational Platform), by the EC through project DNA-NANODEVICES and the Research Infrastructure Action HPC-EUROPA2, and by Fondazione CRMO. The authors are grateful to CINECA (Bologna, Italy) for supercomputing time and staff support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison Jane R, 2012, Biophys Rev, V4, P189, DOI 10.1007/s12551-012-0087-6; Allison JR, 2012, J CHEM THEORY COMPUT, V8, P3430, DOI 10.1021/ct300393b; Ames JB, 2012, BBA-GEN SUBJECTS, V1820, P1205, DOI 10.1016/j.bbagen.2011.10.003; Ames JB, 2000, BIOCHEMISTRY-US, V39, P12149, DOI 10.1021/bi0012890; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; Amici M, 2009, BIOCHEM SOC T, V37, P1359, DOI 10.1042/BST0371359; Bendova-Biedermannova L, 2008, PROTEINS, V72, P402, DOI 10.1002/prot.21938; Bosshard HR, 2004, J MOL RECOGNIT, V17, P1, DOI 10.1002/jmr.657; Bourne Y, 2001, J BIOL CHEM, V276, P11949, DOI 10.1074/jbc.M009373200; Braunewell KH, 2005, TRENDS PHARMACOL SCI, V26, P345, DOI 10.1016/j.tips.2005.04.008; Burgoyne RD, 2004, TRENDS NEUROSCI, V27, P203, DOI 10.1016/j.tins.2004.01.010; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Burgoyne RD, 2010, BIOL REP; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Burgoyne RD, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-2; Chelli R, 2004, PROTEINS, V55, P139, DOI 10.1002/prot.20030; Donald JE, 2011, PROTEINS, V79, P898, DOI 10.1002/prot.22927; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fan H, 2003, PROTEINS, V53, P111, DOI 10.1002/prot.10496; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; GREST GS, 1986, PHYS REV A, V33, P3628, DOI 10.1103/PhysRevA.33.3628; Handley MTW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010534; Heidarsson PO, 2012, J MOL BIOL, V417, P51, DOI 10.1016/j.jmb.2011.12.049; HENDSCH ZS, 1994, PROTEIN SCI, V3, P211; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Koh PO, 2003, P NATL ACAD SCI USA, V100, P313, DOI 10.1073/pnas.232693499; Lian LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027779; Lim S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208868; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Makhatadze GI, 2003, J MOL BIOL, V327, P1135, DOI 10.1016/S0022-2836(03)00233-X; McFerran BW, 1999, J BIOL CHEM, V274, P30258, DOI 10.1074/jbc.274.42.30258; O'Callaghan DW, 2002, J BIOL CHEM, V277, P14227, DOI 10.1074/jbc.M111750200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schneider M, 2009, PROTEINS, V77, P97, DOI 10.1002/prot.22421; Seeber M, 2011, J COMPUT CHEM, V32, P1183, DOI 10.1002/jcc.21688; Seibert MM, 2005, J MOL BIOL, V354, P173, DOI 10.1016/j.jmb.2005.09.030; Strop P, 2000, BIOCHEMISTRY-US, V39, P1251, DOI 10.1021/bi992257j; Torres KCL, 2009, PROG NEURO-PSYCHOPH, V33, P229, DOI 10.1016/j.pnpbp.2008.11.011; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Weiergraber OH, 2006, J BIOL CHEM, V281, P37594, DOI 10.1074/jbc.M603700200; Weiss JL, 2010, CELL MOL NEUROBIOL, V30, P1283, DOI 10.1007/s10571-010-9588-7	43	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74383	10.1371/journal.pone.0074383	http://dx.doi.org/10.1371/journal.pone.0074383			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098643	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500014
J	Friend, LR; Landsberg, MJ; Nouwens, AS; Wei, Y; Rothnagel, JA; Smith, R				Friend, Lexie R.; Landsberg, Michael J.; Nouwens, Amanda S.; Wei, Ying; Rothnagel, Joseph A.; Smith, Ross			Arginine Methylation of hnRNP A2 Does Not Directly Govern Its Subcellular Localization	PLOS ONE			English	Article							HETEROGENEOUS-NUCLEAR-RIBONUCLEOPROTEIN; RNA-BINDING PROTEINS; MESSENGER-RNA; RESPONSE ELEMENT; RICH DOMAIN; IN-VIVO; TRAFFICKING; PARTICLES; IDENTIFICATION; RECOGNITION	The hnRNP A/B paralogs A1, A2/B1 and A3 are key components of the nuclear 40S hnRNP core particles. Despite a high degree of sequence similarity, increasing evidence suggests they perform additional, functionally distinct roles in RNA metabolism. Here we identify and study the functional consequences of differential post-translational modification of hnRNPs A1, A2 and A3. We show that while arginine residues in the RGG box domain of hnRNP A1 and A3 are almost exhaustively, asymmetrically dimethylated, hnRNP A2 is dimethylated at only a single residue (Arg-254) and this modification is conserved across cell types. It has been suggested that arginine methylation regulates the nucleocytoplasmic distribution of hnRNP A/B proteins. However, we show that transfected cells expressing an A2(R254A) point mutant exhibit no difference in subcellular localization. Similarly, immunostaining and mass spectrometry of endogenous hnRNP A2 in transformed cells reveals a naturally-occurring pool of unmethylated protein but an exclusively nuclear pattern of localization. Our results suggest an alternative role for post-translational arginine methylation of hnRNPs and offer further evidence that the hnRNP A/B paralogs are not functionally redundant.	[Friend, Lexie R.; Nouwens, Amanda S.; Wei, Ying; Rothnagel, Joseph A.; Smith, Ross] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [Landsberg, Michael J.; Rothnagel, Joseph A.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia	University of Queensland; University of Queensland	Smith, R (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia.	ross.s@uq.edu.au	Landsberg, Michael/A-3363-2011; Rothnagel, Joe/A-4874-2010	Landsberg, Michael/0000-0002-2464-990X; Rothnagel, Joe/0000-0002-6710-3165; Nouwens, Amanda/0000-0003-4069-8266	Australian National Health and Medical Research Council [ID631551]; Cancer Council of Queensland [ID455870]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Queensland(Cancer Council Queensland)	This work has been funded in part by grants to RS and JAR from the Australian National Health and Medical Research Council (ID631551) and the Cancer Council of Queensland (ID455870). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMERO SA, 1992, P NATL ACAD SCI USA, V89, P8409, DOI 10.1073/pnas.89.18.8409; BARNETT SF, 1991, MOL CELL BIOL, V11, P864, DOI 10.1128/MCB.11.2.864; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; BENNETT M, 1992, MOL CELL BIOL, V12, P3165, DOI 10.1128/MCB.12.7.3165; BEYER AL, 1980, CELL, V20, P75, DOI 10.1016/0092-8674(80)90236-6; BEYER AL, 1977, CELL, V11, P127, DOI 10.1016/0092-8674(77)90323-3; Blifernez O, 2011, PLANT J, V65, P119, DOI 10.1111/j.1365-313X.2010.04406.x; BOFFA LC, 1977, BIOCHEM BIOPH RES CO, V74, P969, DOI 10.1016/0006-291X(77)91613-8; Brumwell C, 2002, EXP CELL RES, V279, P310, DOI 10.1006/excr.2002.5604; CALNAN BJ, 1991, SCIENCE, V252, P1167, DOI 10.1126/science.252.5009.1167; Cartegni L, 1996, J MOL BIOL, V259, P337, DOI 10.1006/jmbi.1996.0324; CHRISTENSEN ME, 1977, BIOCHEM BIOPH RES CO, V74, P621, DOI 10.1016/0006-291X(77)90348-5; CONWAY G, 1988, MOL CELL BIOL, V8, P2884, DOI 10.1128/MCB.8.7.2884; Friend LR, 2008, BBA-MOL CELL RES, V1783, P1972, DOI 10.1016/j.bbamcr.2008.05.021; Gehrig PM, 2004, J AM SOC MASS SPECTR, V15, P142, DOI 10.1016/j.jasms.2003.10.002; GHISOLFI L, 1992, J BIOL CHEM, V267, P2955; Godin KS, 2007, RNA BIOL, V4, P69, DOI 10.4161/rna.4.2.4869; Han SP, 2010, TRAFFIC, V11, P886, DOI 10.1111/j.1600-0854.2010.01072.x; Hatfield JT, 2002, GENE, V295, P33, DOI 10.1016/S0378-1119(02)00800-4; Herrmann F, 2009, J CELL SCI, V122, P667, DOI 10.1242/jcs.039933; Hoek KS, 1998, BIOCHEMISTRY-US, V37, P7021, DOI 10.1021/bi9800247; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; Kim S, 1997, BIOCHEMISTRY-US, V36, P5185, DOI 10.1021/bi9625509; KUMAR A, 1986, J BIOL CHEM, V261, P1266; Landsberg MJ, 2006, BIOCHEMISTRY-US, V45, P3943, DOI 10.1021/bi052440e; Lee MS, 1996, GENE DEV, V10, P1233, DOI 10.1101/gad.10.10.1233; LIU Q, 1995, MOL CELL BIOL, V15, P2800; Ma ASW, 2002, J BIOL CHEM, V277, P18010, DOI 10.1074/jbc.M200050200; Maggipinto M, 2004, J NEUROSCI RES, V75, P614, DOI 10.1002/jnr.20014; Michael WM, 1997, EMBO J, V16, P3587, DOI 10.1093/emboj/16.12.3587; Munro TP, 1999, J BIOL CHEM, V274, P34389, DOI 10.1074/jbc.274.48.34389; Nichols RC, 2000, EXP CELL RES, V256, P522, DOI 10.1006/excr.2000.4827; Ostareck-Lederer A, 2006, J BIOL CHEM, V281, P11115, DOI 10.1074/jbc.M513053200; RAJPUROHIT R, 1994, BIOCHEM J, V304, P903, DOI 10.1042/bj3040903; Samarina OP, 1968, J MOL BIOL, V14, P251; Shen EC, 1998, GENE DEV, V12, P679, DOI 10.1101/gad.12.5.679; Speicher K D, 2000, J Biomol Tech, V11, P74; STEINERT PM, 1991, INT J BIOL MACROMOL, V13, P130, DOI 10.1016/0141-8130(91)90037-U; STEITZ JA, 1981, MOL CELL BIOL, V1, P21, DOI 10.1128/MCB.1.1.21; WILLIAMS KR, 1985, P NATL ACAD SCI USA, V82, P5666, DOI 10.1073/pnas.82.17.5666	40	10	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75669	10.1371/journal.pone.0075669	http://dx.doi.org/10.1371/journal.pone.0075669			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098712	gold, Green Published, Green Submitted			2022-12-25	WOS:000325423500083
J	Shin, D; Richards, SL; Alto, BW; Bettinardi, DJ; Smartt, CT				Shin, Dongyoung; Richards, Stephanie L.; Alto, Barry W.; Bettinardi, David J.; Smartt, Chelsea T.			Genome Sequence Analysis of Dengue Virus 1 Isolated in Key West, Florida	PLOS ONE			English	Article							AEDES-ALBOPICTUS; UNITED-STATES; PUERTO-RICO; RECOMBINATION; COMPETITION; CULICIDAE; INFECTION; MOSQUITOS; OUTBREAK; AEGYPTI	Dengue virus (DENV) is transmitted to humans through the bite of mosquitoes. In November 2010, a dengue outbreak was reported in Monroe County in southern Florida (FL), including greater than 20 confirmed human cases. The virus collected from the human cases was verified as DENV serotype 1 (DENV-1) and one isolate was provided for sequence analysis. RNA was extracted from the DENV-1 isolate and was used in reverse transcription polymerase chain reaction (RT-PCR) to amplify PCR fragments to sequence. Nucleic acid primers were designed to generate overlapping PCR fragments that covered the entire genome. The DENV-1 isolate found in Key West (KW), FL was sequenced for whole genome characterization. Sequence assembly, Genbank searches, and recombination analyses were performed to verify the identity of the genome sequences and to determine percent similarity to known DENV-1 sequences. We show that the KW DENV-1 strain is 99% identical to Nicaraguan and Mexican DENV-1 strains. Phylogenetic and recombination analyses suggest that the DENV-1 isolated in KW originated from Nicaragua (NI) and the KW strain may circulate in KW. Also, recombination analysis results detected recombination events in the KW strain compared to DENV-1 strains from Puerto Rico. We evaluate the relative growth of KW strain of DENV-1 compared to other dengue viruses to determine whether the underlying genetics of the strain is associated with a replicative advantage, an important consideration since local transmission of DENV may result because domestic tourism can spread DENVs.	[Shin, Dongyoung; Alto, Barry W.; Smartt, Chelsea T.] Univ Florida, Dept Entomol & Nematol, Vero Beach, FL USA; [Richards, Stephanie L.] E Carolina Univ, Coll Hlth & Human Performance, Dept Hlth Educ & Promot, Greenville, NC USA; [Bettinardi, David J.] Univ Illinois, Dept Mol & Cellular Biol, Urbana, IL 61801 USA	State University System of Florida; University of Florida; University of North Carolina; East Carolina University; University of Illinois System; University of Illinois Urbana-Champaign	Shin, D (corresponding author), Univ Florida, Dept Entomol & Nematol, Vero Beach, FL USA.	dshin@ufl.edu			Department of Agriculture and Consumer Services (DACS) [00090369]; Southeast Regional Center of Excellence for Emerging Infections & Biodefense (SERCEB) [00102092]	Department of Agriculture and Consumer Services (DACS); Southeast Regional Center of Excellence for Emerging Infections & Biodefense (SERCEB)	This study is supported by Department of Agriculture and Consumer Services (DACS: http://www.freshfromflorida.com) 2010 grant 00090369 and Southeast Regional Center of Excellence for Emerging Infections & Biodefense (SERCEB: http://www.serceb.org) 2011 grant 00102092. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto BW, 2008, P ROY SOC B-BIOL SCI, V275, P463, DOI 10.1098/rspb.2007.1497; Anez G, 2012, AM J TROP MED HYG, V87, P548, DOI 10.4269/ajtmh.2012.12-0091; Anoop M, 2010, INDIAN J EXP BIOL, V48, P849; Ayala A., 2006, Morbidity and Mortality Weekly Report, V55, P700; Barrera R., 2006, SCI WORK GROUP M DEN, P92; Braks MAH, 2004, ANN ENTOMOL SOC AM, V97, P130, DOI 10.1603/0013-8746(2004)097[0130:ICBTIS]2.0.CO;2; Britch SC, 2008, J AM MOSQUITO CONTR, V24, P115, DOI 10.2987/5594.1; Centers for Disease Control, 2006, DENG PUERT RIC; Centers for Disease Control, 2013, DENG TROP SUBTR REG; de Figueiredo RMP, 2011, REV INST MED TROP SP, V53, P321, DOI 10.1590/S0036-46652011000600004; EBENHARD T, 1991, BIOL J LINN SOC, V42, P105, DOI 10.1111/j.1095-8312.1991.tb00554.x; Effler PV, 2005, EMERG INFECT DIS, V11, P742; Florida Department of Health, 2010, FLOR ARB SURV; Graham AS, 2011, EMERG INFECT DIS, V17, P2074, DOI 10.3201/eid1711.110419; Griffitts THD, 1935, J FLA MED ASSOC, V21, P395; Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326; Hanley Kathryn A., 2008, BMC Ecology, V8, P1, DOI 10.1186/1472-6785-8-1; Hanski I., 1999, METAPOPULATION ECOLO; Hanson H, 1936, AM J PUBLIC HEALTH N, V26, P256, DOI 10.2105/AJPH.26.3.256; Holmes EC, 1999, MOL BIOL EVOL, V16, P405, DOI 10.1093/oxfordjournals.molbev.a026121; Kuno Goro, 1997, P61; San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346; Mac Donell GN, 1935, J FLA MED ASSOC, V21, P392; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Mohammed HP, 2010, J TRAVEL MED, V17, P8, DOI 10.1111/j.1708-8305.2009.00374.x; Munoz-Jordan JL, 2013, EMERG INFECT DIS, V19, P652, DOI 10.3201/eid1904.121295; Nowicki S., 2010, Morbidity and Mortality Weekly Report, V59, P557; OhAinle M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003084; OMEARA GF, 1995, J MED ENTOMOL, V32, P554, DOI 10.1093/jmedent/32.4.554; Pan American Health Organization, 1994, PAN AM HLTH ORG PUBL, V548; Pan American Health Organization, 2007, NUMB REP CAS DENG DE; Pickett BE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-165; Pinheiro Fransisco P., 1997, World Health Statistics Quarterly, V50, P161; Ramos MM, 2008, AM J TROP MED HYG, V78, P364; Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Tolou HJG, 2001, J GEN VIROL, V82, P1283, DOI 10.1099/0022-1317-82-6-1283; Tomashek KM, 2009, AM J TROP MED HYG, V81, P467, DOI 10.4269/ajtmh.2009.81.467; United State Geological Survey, 2012, CUM HUM DIS CAS LOC; Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006; Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003; Worobey M, 1999, J GEN VIROL, V80, P2535, DOI 10.1099/0022-1317-80-10-2535	42	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74582	10.1371/journal.pone.0074582	http://dx.doi.org/10.1371/journal.pone.0074582			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098658	gold, Green Published, Green Submitted			2022-12-25	WOS:000325423500029
J	Xia, J; Luo, M; Ni, N; Chen, JZ; Hu, YM; Deng, Y; Ji, J; Zhou, JB; Fan, XQ; Gu, P				Xia, Jing; Luo, Min; Ni, Ni; Chen, Junzhao; Hu, Yamin; Deng, Yuan; Ji, Jing; Zhou, Jibo; Fan, Xianqun; Gu, Ping			Bone Marrow Mesenchymal Stem Cells Stimulate Proliferation and Neuronal Differentiation of Retinal Progenitor Cells	PLOS ONE			English	Article							SELF-RENEWAL; TRANSPLANTATION; MULTIPOTENTIALITY; NEUROGENESIS; EXPRESSION; NICHE; ACID; FATE	During retina development, retinal progenitor cell (RPC) proliferation and differentiation are regulated by complex inter-and intracellular interactions. Bone marrow mesenchymal stem cells (BMSCs) are reported to express a variety of cytokines and neurotrophic factors, which have powerful trophic and protective functions for neural tissue-derived cells. Here, we show that the expanded RPC cultures treated with BMSC-derived conditioned medium (CM) which was substantially enriched for bFGF and CNTF, expressed clearly increased levels of nuclear receptor TLX, an essential regulator of neural stem cell (NSC) self-renewal, as well as betacellulin (BTC), an EGF-like protein described as supporting NSC expansion. The BMSC CM- or bFGF-treated RPCs also displayed an obviously enhanced proliferation capability, while BMSC CM-derived bFGF knocked down by anti-bFGF, the effect of BMSC CM on enhancing RPC proliferation was partly reversed. Under differentiation conditions, treatment with BMSC CM or CNTF markedly favoured RPC differentiation towards retinal neurons, including Brn3a-positive retinal ganglion cells (RGCs) and rhodopsin-positive photoreceptors, and clearly diminished retinal glial cell differentiation. These findings demonstrate that BMSCs supported RPC proliferation and neuronal differentiation which may be partly mediated by BMSC CM-derived bFGF and CNTF, reveal potential limitations of RPC culture systems, and suggest a means for optimizing RPC cell fate determination in vitro.	[Xia, Jing; Luo, Min; Ni, Ni; Chen, Junzhao; Hu, Yamin; Deng, Yuan; Ji, Jing; Zhou, Jibo; Fan, Xianqun; Gu, Ping] Shanghai Jiao Tong Univ, Dept Ophthalmol, Shanghai Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Fan, XQ (corresponding author), Shanghai Jiao Tong Univ, Dept Ophthalmol, Shanghai Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China.	fanxq@sh163.net; guping2009@hotmail.com			National Natural Science Foundations of China [81070737]; Education Commission of Shanghai [11YZ47]; Scientific Research Foundation for the Returned Overseas Chinese Scholars [[2011]1568]; Shanghai Public Health Bureau [2011Y081]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Education Commission of Shanghai; Scientific Research Foundation for the Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Shanghai Public Health Bureau	This research was supported by the National Natural Science Foundations of China (81070737), the Education Commission of Shanghai (11YZ47), the Scientific Research Foundation for the Returned Overseas Chinese Scholars ([2011]1568), and the Shanghai Public Health Bureau (2011Y081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028147; Coles BLK, 2004, P NATL ACAD SCI USA, V101, P15772, DOI 10.1073/pnas.0401596101; Croft AP, 2009, EXP NEUROL, V216, P329, DOI 10.1016/j.expneurol.2008.12.010; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gamm DM, 2008, STEM CELLS, V26, P3182, DOI 10.1634/stemcells.2008-0300; Gomez-Gaviro MV, 2012, P NATL ACAD SCI USA, V109, P1317, DOI 10.1073/pnas.1016199109; Gu P, 2007, MOL VIS, V13, P1045; Gu P, 2009, MOL VIS, V15, P2111; Hu YM, 2013, NEUROSCI LETT, V534, P90, DOI 10.1016/j.neulet.2012.11.006; Johnson TV, 2010, INVEST OPHTH VIS SCI, V51, P2051, DOI 10.1167/iovs.09-4509; Li QM, 2009, BIOCHEM BIOPH RES CO, V384, P372, DOI 10.1016/j.bbrc.2009.04.147; Liu XY, 2010, BIOMATERIALS, V31, P3063, DOI 10.1016/j.biomaterials.2009.12.054; LOLLEY RN, 1994, INVEST OPHTH VIS SCI, V35, P358; Longhi L, 2005, TRANSPL IMMUNOL, V15, P143, DOI 10.1016/j.trim.2005.09.003; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Nakanishi C, 2008, BIOCHEM BIOPH RES CO, V374, P11, DOI 10.1016/j.bbrc.2008.06.074; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rivolta C, 2002, HUM MOL GENET, V11, P1219, DOI 10.1093/hmg/11.10.1219; Sadan O, 2012, EXP NEUROL, V234, P417, DOI 10.1016/j.expneurol.2011.12.045; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Strassburg S, 2010, REGEN MED, V5, P701, DOI 10.2217/RME.10.59; Wang JM, 2010, MOL VIS, V16, P2850; Xia J, 2012, BRAIN RES, V1433, P38, DOI 10.1016/j.brainres.2011.11.054; Yang J, 2006, STEM CELLS, V24, P2766, DOI 10.1634/stemcells.2006-0103; Zhang Y, 2010, INVEST OPHTH VIS SCI, V51, P3742, DOI 10.1167/iovs.08-3314; Zhou HF, 2011, INVEST OPHTH VIS SCI, V52, P1735, DOI 10.1167/iovs.10-5988	28	25	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76157	10.1371/journal.pone.0076157	http://dx.doi.org/10.1371/journal.pone.0076157			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098776	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500146
J	Chen, YC; Pristera, A; Ayub, M; Swanwick, RS; Karu, K; Hamada, Y; Rice, ASC; Okuse, K				Chen, Ya-Chun; Pristera, Alessandro; Ayub, Mahmood; Swanwick, Richard S.; Karu, Kersti; Hamada, Yosuke; Rice, Andrew S. C.; Okuse, Kenji			Identification of a Receptor for Neuropeptide VGF and Its Role in Neuropathic Pain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Intracellular Release; Macrophages; Neurons; Neuropeptide; Pain; VGF; gC1qR; Neuropathic Pain; Sensory Neurons	DORSAL-ROOT GANGLION; GENE-EXPRESSION; PEPTIDE TLQP-21; IN-VITRO; PROTEIN; MACROPHAGES; ACTIVATION; CALCIUM; BINDING; C1Q	Background: VGF is a neuropeptide involved in chronic pain. Results: VGF-derived peptide TLQP-21 activates macrophages. We identified gC1qR as a receptor for TLQP-21. Conclusion: TLQP-21 and gC1qR are involved in chronic pain pathways. Significance: TLQP-21 and gC1qR may be drug targets for chronic pain treatment. VGF (nonacronymic) is a neuropeptide precursor that plays multiple roles in regulation of energy balance, reproduction, hippocampal synaptic plasticity, and pain. Data from a number of pain models showed significant up-regulation of VGF in sensory neurons. TLQP-21, one of the VGF-derived neuropeptides, has been shown to induce a hyperalgesic response when injected subcutaneously into the hind paw of mice. However, the precise role of VGF-derived neuropeptides in neuropathic pain and the molecular identity of the receptor for VGF-derived peptides are yet to be investigated. Here we identified gC1qR, the globular heads of the C1q receptor, as the receptor for TLQP-21 using chemical cross-linking combined with mass spectrometry analysis. TLQP-21 caused an increase in intracellular Ca2+ levels in rat macrophages and microglia. Inoculation of TLQP-21-stimulated macrophages into rat hind paw caused mechanical hypersensitivity. The increase in intracellular Ca2+ levels in macrophages was attenuated by either siRNA or neutralizing antibodies against gC1qR. Furthermore, application of the gC1qR-neutralizing antibody to rats with partial sciatic nerve ligation resulted in a delayed onset of nerve injury-associated mechanical hypersensitivity. These results indicate that gC1qR is the receptor for TLQP-21 and plays an important role in chronic pain through activation of macrophages. Because direct association between TLQP-21 and gC1qR is required for activation of macrophages and causes hypersensitivity, disrupting this interaction may be a useful new approach to develop novel analgesics.	[Chen, Ya-Chun; Pristera, Alessandro; Ayub, Mahmood; Swanwick, Richard S.; Karu, Kersti; Hamada, Yosuke; Okuse, Kenji] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Dept Life Sci, London SW7 2AZ, England; [Rice, Andrew S. C.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Surg & Canc, London SW10 9NH, England	Imperial College London; Imperial College London	Okuse, K (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Dept Life Sci, London SW7 2AZ, England.	k.okuse@imperial.ac.uk	Rice, Andrew/I-7501-2012; Ayub, Mahmood/V-8792-2019	Ayub, Mahmood/0000-0002-2096-2704	Wellcome Trust United Kingdom; BBSRC; EU-IMI	Wellcome Trust United Kingdom(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU-IMI	This work was supported by the Wellcome Trust United Kingdom (to Y.-C. C., A. P., R. S. S., A. S. C. R., and K. O.), BBSRC (to M. A.), and EU-IMI (to K. K, A. S. C. R., and K. O.).	Abbadie C, 2003, P NATL ACAD SCI USA, V100, P7947, DOI 10.1073/pnas.1331358100; Baker MD, 2011, MOL CELL NEUROSCI, V48, P258, DOI 10.1016/j.mcn.2011.08.007; Barbasz A, 2008, INT IMMUNOPHARMACOL, V8, P211, DOI 10.1016/j.intimp.2007.08.002; Bordin S, 1998, J PERIODONTOL, V69, P642, DOI 10.1902/jop.1998.69.6.642; Brown DM, 2004, AM J PHYSIOL-LUNG C, V286, pL344, DOI 10.1152/ajplung.00139.2003; Calvo M, 2012, LANCET NEUROL, V11, P629, DOI 10.1016/S1474-4422(12)70134-5; Cassina V, 2013, BBA-BIOMEMBRANES, V1828, P455, DOI 10.1016/j.bbamem.2012.10.023; Costigan M, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-16; Duus K, 2010, FEBS J, V277, P3526, DOI 10.1111/j.1742-4658.2010.07762.x; Fleetwood AJ, 2009, J LEUKOCYTE BIOL, V86, P411, DOI 10.1189/jlb.1108702; Garlatti V, 2010, J IMMUNOL, V185, P808, DOI 10.4049/jimmunol.1000184; Ghebrehiwet B, 2004, MOL IMMUNOL, V41, P173, DOI 10.1016/j.molimm.2004.03.014; Hannedouche S, 2013, J BIOL CHEM, V288, P27434, DOI 10.1074/jbc.M113.497214; Kim KB, 2009, PROTEOMICS, V9, P2373, DOI 10.1002/pmic.200800811; Korhonen R, 2001, BIOCHEM J, V354, P351, DOI 10.1042/0264-6021:3540351; Liu T, 2000, PAIN, V86, P25, DOI 10.1016/S0304-3959(99)00306-1; Maratou K, 2009, EUR J PAIN, V13, P387, DOI 10.1016/j.ejpain.2008.05.011; Mert T, 2009, N-S ARCH PHARMACOL, V379, P445, DOI 10.1007/s00210-008-0387-3; Moss A, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-62; Mueller M, 2001, AM J PATHOL, V159, P2187, DOI 10.1016/S0002-9440(10)63070-2; NAKAJIMA K, 1992, J NEUROCHEM, V58, P1401, DOI 10.1111/j.1471-4159.1992.tb11356.x; Possenti R, 2012, BIOCHEM J, V441, P511, DOI 10.1042/BJ20111165; Prakash M, 2011, CELL SIGNAL, V23, P1563, DOI 10.1016/j.cellsig.2011.04.009; Pristera A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040079; Riedl MS, 2009, J NEUROSCI, V29, P13377, DOI 10.1523/JNEUROSCI.1127-09.2009; Rizzi R, 2008, NEUROSCI LETT, V441, P129, DOI 10.1016/j.neulet.2008.06.018; Roumenina LT, 2006, BIOCHEMISTRY-US, V45, P4093, DOI 10.1021/bi052646f; Severini C, 2008, J NEUROCHEM, V104, P534, DOI 10.1111/j.1471-4159.2007.05068.x; Shao D, 2009, MOL CELL NEUROSCI, V42, P219, DOI 10.1016/j.mcn.2009.07.003; Simonetti M, 2013, NEURON, V77, P43, DOI 10.1016/j.neuron.2012.10.037; Storz P, 2000, J BIOL CHEM, V275, P24601, DOI 10.1074/jbc.M002964200; Tan LA, 2010, PROTEIN CELL, V1, P1033, DOI 10.1007/s13238-010-0125-8; Tange TO, 1996, J BIOL CHEM, V271, P10066, DOI 10.1074/jbc.271.17.10066; Valder CR, 2003, J NEUROCHEM, V87, P560, DOI 10.1046/j.1471-4159.2003.02016.x; Vulchanova L., 2012, SOC NEUR ABSTR, V267; Wallace VCJ, 2007, BRAIN, V130, P2688, DOI 10.1093/brain/awm195; Wang H, 2002, NEUROSCIENCE, V114, P529, DOI 10.1016/S0306-4522(02)00341-X; Xiao S, 2001, CLIN EXP IMMUNOL, V125, P360, DOI 10.1046/j.1365-2249.2001.01597.x; Zutter MM, 2007, IMMUNOBIOLOGY, V212, P343, DOI 10.1016/j.imbio.2006.11.013	39	50	50	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34638	34646		10.1074/jbc.M113.510917	http://dx.doi.org/10.1074/jbc.M113.510917			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24106277	Green Published, hybrid			2022-12-25	WOS:000329812800031
J	Nagae, M; Yamanaka, K; Hanashima, S; Ikeda, A; Morita-Matsumoto, K; Satoh, T; Matsumoto, N; Yamamoto, K; Yamaguchi, Y				Nagae, Masamichi; Yamanaka, Kousuke; Hanashima, Shinya; Ikeda, Akemi; Morita-Matsumoto, Kana; Satoh, Tadashi; Matsumoto, Naoki; Yamamoto, Kazuo; Yamaguchi, Yoshiki			Recognition of Bisecting N-Acetylglucosamine STRUCTURAL BASIS FOR ASYMMETRIC INTERACTION WITH THE MOUSE LECTIN DENDRITIC CELL INHIBITORY RECEPTOR 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate; Crystal Structure; Dendritic Cells; Lectin; Receptors; C-type Lectin; DCIR2; Bisecting N-Acetylglucosamine; Glycan	IMMUNOGLOBULIN-G; SUGAR CHAINS; DC-SIGN; LINKED OLIGOSACCHARIDES; IMMUNE-RESPONSES; INHIBITORY MOTIF; SURFACE-RECEPTOR; LIGAND-BINDING; COMPLEX; AFFINITY	Dendritic cell inhibitory receptor 2 (DCIR2) is a C-type lectin expressed on classical dendritic cells. We recently identified the unique ligand specificity of mouse DCIR2 (mDCIR2) toward biantennary complex-type glycans containing bisecting N-acetylglucosamine (GlcNAc). Here, we report the crystal structures of the mDCIR2 carbohydrate recognition domain in unliganded form as well as in complex with an agalactosylated complex-type N-glycan unit carrying a bisecting GlcNAc residue. Bisecting GlcNAc and the 1-3 branch of the biantennary oligosaccharide asymmetrically interact with canonical and non-canonical mDCIR2 residues. Ligand-protein interactions occur directly through mDCIR2-characteristic amino acid residues as well as via a calcium ion and water molecule. Our structural and biochemical data elucidate for the first time the unique binding mode of mDCIR2 for bisecting GlcNAc-containing glycans, a mode that contrasts sharply with that of other immune C-type lectin receptors such as DC-SIGN.	[Nagae, Masamichi; Hanashima, Shinya; Ikeda, Akemi; Morita-Matsumoto, Kana; Satoh, Tadashi; Yamaguchi, Yoshiki] RIKEN, Global Res Cluster, RIKEN Max Planck Joint Res Ctr, Struct Glycobiol Team,Syst Glycobiol Res Grp, Wako, Saitama 3510198, Japan; [Yamanaka, Kousuke; Matsumoto, Naoki; Yamamoto, Kazuo] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan	RIKEN; University of Tokyo	Yamaguchi, Y (corresponding author), RIKEN, Global Res Cluster, RIKEN Max Planck Joint Res Ctr, Struct Glycobiol Team,Syst Glycobiol Res Grp, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	yyoshiki@riken.jp	Yamaguchi, Yoshiki/N-5246-2015; Satoh, Tadashi/M-5157-2017; Hanashima, Shinya/AGN-0921-2022	Yamaguchi, Yoshiki/0000-0003-0100-5439; Hanashima, Shinya/0000-0003-3102-7890; Nagae, Masamichi/0000-0002-5470-3807; Satoh, Tadashi/0000-0002-4493-4978	Ministry of Education, Culture, Sports, Science, and Technology of Japan [25460054, 24770111]; Grants-in-Aid for Scientific Research [25460054, 24770102] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-aid for Scientific Research (C) 25460054 (to Y. Y.) and for Young Scientists (B) 24770111 (to M. N.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Bates EEM, 1999, J IMMUNOL, V163, P1973; Benevides RG, 2012, J BIOL CHEM, V287, P26352, DOI 10.1074/jbc.M112.375816; Bhattacharyya R, 2002, J BIOL CHEM, V277, P26300, DOI 10.1074/jbc.M202276200; BHAUMIK M, 1995, GENE, V164, P295, DOI 10.1016/0378-1119(95)00260-D; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Feinberg H, 2007, J BIOL CHEM, V282, P17250, DOI 10.1074/jbc.M701624200; Feinberg H, 2007, J BIOL CHEM, V282, P4202, DOI 10.1074/jbc.M609689200; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Fiala M, 2007, P NATL ACAD SCI USA, V104, P12849, DOI 10.1073/pnas.0701267104; Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723; Flornes LM, 2004, IMMUNOGENETICS, V56, P506, DOI 10.1007/s00251-004-0714-x; FUJII S, 1990, J BIOL CHEM, V265, P6009; Futakawa S, 2012, NEUROBIOL AGING, V33, P1807, DOI 10.1016/j.neurobiolaging.2011.02.023; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; HOFFMANN A, 1995, FEBS LETT, V359, P164, DOI 10.1016/0014-5793(95)00034-7; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Igarashi T, 2007, FEBS LETT, V581, P2416, DOI 10.1016/j.febslet.2007.04.057; IRIMURA T, 1981, BIOCHEMISTRY-US, V20, P560, DOI 10.1021/bi00506a018; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Kaden SA, 2009, J IMMUNOL, V183, P5069, DOI 10.4049/jimmunol.0900908; Kanazawa N, 2002, J INVEST DERMATOL, V118, P261, DOI 10.1046/j.0022-202x.2001.01633.x; Kasahara S, 2012, J LEUKOCYTE BIOL, V91, P437, DOI 10.1189/jlb.0711384; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lambert AA, 2008, BLOOD, V112, P1299, DOI 10.1182/blood-2008-01-136473; Lee RT, 2011, GLYCOBIOLOGY, V21, P512, DOI 10.1093/glycob/cwq193; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lutteke T, 2006, GLYCOBIOLOGY, V16, p71R, DOI 10.1093/glycob/cwj049; Meyer-Wentrup F, 2008, BLOOD, V111, P4245, DOI 10.1182/blood-2007-03-081398; Meyer-Wentrup F, 2009, J LEUKOCYTE BIOL, V85, P518, DOI 10.1189/jlb.0608352; Miwa HE, 2012, GLYCOCONJUGATE J, V29, P609, DOI 10.1007/s10719-012-9373-6; MIZUOCHI T, 1990, J IMMUNOL, V145, P1794; MIZUOCHI T, 1987, ARCH BIOCHEM BIOPHYS, V257, P387, DOI 10.1016/0003-9861(87)90581-9; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nairn AV, 2008, J BIOL CHEM, V283, P17298, DOI 10.1074/jbc.M801964200; NAKAGAWA H, 1995, ANAL BIOCHEM, V226, P130, DOI 10.1006/abio.1995.1200; NARASIMHAN S, 1982, J BIOL CHEM, V257, P235; Nishima W, 2012, J PHYS CHEM B, V116, P8504, DOI 10.1021/jp212550z; NUSSENZWEIG MC, 1982, P NATL ACAD SCI-BIOL, V79, P161, DOI 10.1073/pnas.79.1.161; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; Qin SY, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.394288; Re S, 2011, BIOPHYS J, V101, pL44, DOI 10.1016/j.bpj.2011.10.019; Riboldi E, 2011, J BIOL CHEM, V286, P35329, DOI 10.1074/jbc.C111.290494; Sancho D, 2012, ANNU REV IMMUNOL, V30, P491, DOI 10.1146/annurev-immunol-031210-101352; Shibukawa Y, 2003, J BIOL CHEM, V278, P3197, DOI 10.1074/jbc.M207870200; Shigeta M, 2006, GLYCOBIOLOGY, V16, P564, DOI 10.1093/glycob/cwj100; SHIMIZU H, 1993, J BIOCHEM-TOKYO, V114, P334, DOI 10.1093/oxfordjournals.jbchem.a124177; Stanley P, 2002, BBA-GEN SUBJECTS, V1573, P363, DOI 10.1016/S0304-4165(02)00404-X; Takahashi M, 2009, CARBOHYD RES, V344, P1387, DOI 10.1016/j.carres.2009.04.031; TAKAHASHI N, 1987, BIOCHEMISTRY-US, V26, P1137, DOI 10.1021/bi00378a023; TAKAHASHI N, 1995, ANAL BIOCHEM, V226, P139, DOI 10.1006/abio.1995.1201; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wurzburg BA, 2006, STRUCTURE, V14, P1049, DOI 10.1016/j.str.2006.03.017; YAMASHITA K, 1983, J BIOL CHEM, V258, P4753; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	60	39	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33598	33610		10.1074/jbc.M113.513572	http://dx.doi.org/10.1074/jbc.M113.513572			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24108122	Green Published, hybrid			2022-12-25	WOS:000327250200009
J	Chen, CR; Yang, SR; Liu, YY; Qu, WM; Urade, Y; Huang, ZL				Chen, Chang-Rui; Yang, Su-Rong; Liu, Yuan-Yuan; Qu, Wei-Min; Urade, Yoshihiro; Huang, Zhi-Li			Roles of Adrenergic alpha(1) and Dopamine D-1 and D-2 Receptors in the Mediation of the Desynchronization Effects of Modafinil in a Mouse EEG Synchronization Model	PLOS ONE			English	Article							MAJOR BIOACTIVE CONSTITUENT; DEEP BRAIN-STIMULATION; EYE-MOVEMENT SLEEP; HISTAMINERGIC SYSTEM; MAGNOLIA-OFFICINALIS; PREFRONTAL CORTEX; IN-VITRO; MICE; RAT; ACTIVATION	Background: Synchronized electroencephalogram (EEG) activity is observed in pathological stages of cognitive impairment and epilepsy. Modafinil, known to increase the release of catecholamines, is a potent wake-promoting agent, and has shown some abilities to desynchronize EEG, but its receptor mechanisms by which modafinil induces desynchoronization remain to be elucidated. Here we used a pharmacological EEG synchronization model to investigate the involvement of adrenergic alpha(1) receptors (R, alpha R-1) and dopamine (DA) D-1 and D-2 receptors (D(1)Rs and D(2)Rs) on modafinil-induced desynchronization in mice. Methodology/Principal Findings: Mice were treated with cholinergic receptor antagonist scopolamine and monoamine depletor reserpine to produce experimental EEG synchronization characterized by continuous large-amplitude synchronized activity, with prominent increased delta and decreased theta, alpha, and beta power density. The results showed that modafinil produced an EEG desynchronization in the model. This was characterized by a general decrease in amplitude of all the frequency bands between 0 and 20 Hz, a prominent reduction in delta power density, and an increase in theta power density. Adrenergic alpha R-1 antagonist terazosin (1 mg/kg, i.p.) completely antagonized the EEG desynchronization effects of modafinil at 90 mg/kg. However, DA D1R and D2R blockers partially attenuated the effects of modafinil. The modafinil-induced decrease in the amplitudes of the delta, theta, alpha, and beta waves and in delta power density were completely abolished by pretreatment with a combination of the D1R antagonist SCH 23390 (30 mu g/kg) and the D2R antagonist raclopride (2 mg/kg, i.p.). Conclusions/Significance: These results suggest that modafinil-mediated desynchronization may be attributed to the activation of adrenergic alpha R-1, and dopaminergic D1R and D2R in a model of EEG synchronization.	[Chen, Chang-Rui; Yang, Su-Rong; Liu, Yuan-Yuan; Qu, Wei-Min; Huang, Zhi-Li] Fudan Univ, Dept Pharmacol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Qu, Wei-Min; Huang, Zhi-Li] Fudan Univ, Inst Brain Sci, Shanghai 200433, Peoples R China; [Urade, Yoshihiro] Osaka Biosci Inst, Dept Mol Behav Biol, Suita, Osaka 565, Japan; [Huang, Zhi-Li] Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Huang, ZL (corresponding author), Fudan Univ, Dept Pharmacol, Shanghai Med Coll, Shanghai 200433, Peoples R China.	huangzl@fudan.edu.cn	liu, yuanyuan/GWZ-5838-2022	Huang, Zhi-Li/0000-0001-9359-1150	National Natural Science Foundation of China [30901797, 31171010, 31121061, 31271164]; Shanghai Committee of Science and Technology [10441901600, 11ZR1402000, 13140903100]; National Basic Research Program of China [2009CB5220004, 2011CB711000]; Shanghai Leading Academic Discipline Project [B119]; Ph.D. Programs Foundation of Ministry of Education of China [20110071110033]; China National Science and Technology Major Project for Drug Discovery [2009ZX09303-006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); National Basic Research Program of China(National Basic Research Program of China); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); China National Science and Technology Major Project for Drug Discovery	This study was supported in part by grants-in-aid for scientific research from National Natural Science Foundation of China (30901797, 31171010, 31121061, 31271164), Shanghai Committee of Science and Technology (10441901600, 11ZR1402000, 13140903100), National Basic Research Program of China (2009CB5220004, 2011CB711000), Shanghai Leading Academic Discipline Project (B119), Ph.D. Programs Foundation of Ministry of Education of China (20110071110033) and China National Science and Technology Major Project for Drug Discovery (2009ZX09303-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banjo OC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014322; Beck C, 1999, CAN J PSYCHIAT, V44, P680, DOI 10.1177/070674379904400705; Chen CR, 2007, NEUROPHARMACOLOGY, V53, P534, DOI 10.1016/j.neuropharm.2007.06.017; Chen CR, 2011, BRIT J PHARMACOL, V164, P1534, DOI 10.1111/j.1476-5381.2011.01456.x; Chen CR, 2012, NEUROPHARMACOLOGY, V63, P1191, DOI 10.1016/j.neuropharm.2012.06.031; Dringenberg HC, 2002, EUR J PHARMACOL, V447, P43, DOI 10.1016/S0014-2999(02)01829-0; Dringenberg HC, 2000, NEUROBIOL AGING, V21, P135, DOI 10.1016/S0197-4580(00)00108-1; DUTEIL J, 1990, EUR J PHARMACOL, V180, P49, DOI 10.1016/0014-2999(90)90591-S; Echeverria V, 2012, CNS NEUROSCI THER, V18, P517, DOI 10.1111/j.1755-5949.2012.00317.x; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Gallopin T, 2004, SLEEP, V27, P19; GESSA GL, 1985, EUR J PHARMACOL, V109, P269, DOI 10.1016/0014-2999(85)90429-7; Ghahremani DG, 2011, NEUROPSYCHOPHARMACOL, V36, P950, DOI 10.1038/npp.2010.233; GINGRICH JA, 1993, ANNU REV NEUROSCI, V16, P299, DOI 10.1146/annurev.ne.16.030193.001503; Gozzi A, 2012, NEUROPSYCHOPHARMACOL, V37, P822, DOI 10.1038/npp.2011.260; Greely H, 2008, NATURE, V456, P702, DOI 10.1038/456702a; Hilaire ZD, 2001, NEUROREPORT, V12, P3533, DOI 10.1097/00001756-200111160-00032; Jasinski DR, 2000, CLIN NEUROPHARMACOL, V23, P149, DOI 10.1097/00002826-200005000-00004; Kelley AM, 2012, AVIAT SPACE ENVIR MD, V83, P685, DOI 10.3357/ASEM.3212.2012; Kobayashi M, 2004, P NATL ACAD SCI USA, V101, P11465, DOI 10.1073/pnas.0402028101; KROPF W, 1991, NEUROPHARMACOLOGY, V30, P953, DOI 10.1016/0028-3908(91)90108-N; KROPF W, 1993, NEUROPHARMACOLOGY, V32, P493, DOI 10.1016/0028-3908(93)90175-3; Lazarus M., 2013, CURR OPIN NEUROBIOL; Lazarus M, 2012, TRENDS NEUROSCI, V35, P723, DOI 10.1016/j.tins.2012.07.001; Liu Z, 2012, CNS NEUROSCI THER, V18, P623, DOI 10.1111/j.1755-5949.2012.00334.x; Madras BK, 2006, J PHARMACOL EXP THER, V319, P561, DOI 10.1124/jpet.106.106583; Manni R, 2005, NEUROL SCI, V26, pS181, DOI 10.1007/s10072-005-0484-8; MIGNOT E, 1994, SLEEP, V17, P436, DOI 10.1093/sleep/17.5.436; Minzenberg MJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1477, DOI 10.1038/sj.npp.1301534; Minzenberg MJ, 2008, SCIENCE, V322, P1700, DOI 10.1126/science.1164908; MONTI JM, 1988, PSYCHOPHARMACOLOGY, V95, P395; Nishida N, 2007, EXP NEUROL, V205, P132, DOI 10.1016/j.expneurol.2007.01.021; Oishi Y, 2008, P NATL ACAD SCI USA, V105, P19992, DOI 10.1073/pnas.0810926105; ONGINI E, 1993, J PHARMACOL EXP THER, V266, P726; ONGINI E, 1985, LIFE SCI, V37, P2327, DOI 10.1016/0024-3205(85)90025-6; Qu WM, 2008, J NEUROSCI, V28, P8462, DOI 10.1523/JNEUROSCI.1819-08.2008; Qu WM, 2010, J NEUROSCI, V30, P4382, DOI 10.1523/JNEUROSCI.4936-09.2010; Sahakian B, 2007, NATURE, V450, P1157, DOI 10.1038/4501157a; Sebban C, 1999, BRIT J PHARMACOL, V128, P1045, DOI 10.1038/sj.bjp.0702894; Shi LH, 2006, BRAIN RES, V1090, P202, DOI 10.1016/j.brainres.2006.03.050; Sofuoglu M, 2013, NEUROPHARMACOLOGY, V64, P452, DOI 10.1016/j.neuropharm.2012.06.021; STERIADE M, 1990, J NEUROSCI, V10, P2541; STERIADE M, 1993, J NEUROPHYSIOL, V70, P1385, DOI 10.1152/jn.1993.70.4.1385; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; STEWART DJ, 1984, BRAIN RES, V322, P219, DOI 10.1016/0006-8993(84)90112-4; Stone EA, 2002, SYNAPSE, V46, P269, DOI 10.1002/syn.10127; Tiligada E, 2011, CNS NEUROSCI THER, V17, P620, DOI 10.1111/j.1755-5949.2010.00212.x; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; Velasco M, 2000, ARCH MED RES, V31, P304, DOI 10.1016/S0188-4409(00)00085-0; Wisor JP, 2005, NEUROSCIENCE, V132, P1027, DOI 10.1016/j.neuroscience.2005.02.003	50	11	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76102	10.1371/journal.pone.0076102	http://dx.doi.org/10.1371/journal.pone.0076102			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116090	Green Published, Green Submitted, gold			2022-12-25	WOS:000325501300047
J	Wang, WB; Jiang, T; Gardner, S				Wang, Wei-Bung; Jiang, Tao; Gardner, Shea			Detection of Homologous Recombination Events in Bacterial Genomes	PLOS ONE			English	Article							MULTIPLE ALIGNMENT; SMALLPOX; DIVERSITY; SEQUENCE	We study the detection of mutations, sequencing errors, and homologous recombination events (HREs) in a set of closely related microbial genomes. We base the model on single nucleotide polymorphisms (SNPs) and break the genomes into blocks to handle the rearrangement problem. Then we apply a dynamic programming algorithm to model whether changes within each block are likely a result of mutations, sequencing errors, or HREs. Results from simulation experiments show that we can detect 31%-61% of HREs and the precision of our detection is about 48%-90% depending on the rates of mutation and missing data. The HREfinder software for predicting HREs in a set of whole genomes is available as open source (http://sourceforge.net/projects/hrefinder/).	[Wang, Wei-Bung; Jiang, Tao] Univ Calif Riverside, Dept Comp Sci, Riverside, CA 92521 USA; [Gardner, Shea] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA	University of California System; University of California Riverside; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Gardner, S (corresponding author), Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.	Gardner26@llnl.gov	Jiang, Tao/AGX-8391-2022; jiang, tao/GWC-7108-2022	Jiang, Tao/0000-0003-3833-4498; 	United States Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; National Institutes of Health [2R01LM008991]; NATIONAL LIBRARY OF MEDICINE [R01LM008991] Funding Source: NIH RePORTER	United States Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was performed under the auspices of the United States Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344 and was also partially funded by grant National Institutes of Health 2R01LM008991. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angiuoli SV, 2011, BIOINFORMATICS, V27, P334, DOI 10.1093/bioinformatics/btq665; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darling AE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000128; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dias U, 2010, LECT N BIOINFORMAT, V6398, P240, DOI 10.1007/978-3-642-16181-0_20; Eisen JA, 2000, GENOME BIOL, V1; Esposito JJ, 2006, SCIENCE, V313, P807, DOI 10.1126/science.1125134; Gardner SN, 2010, J FORENSIC RES, V01, P2, DOI [10.4172/2157-7145.1000107, DOI 10.4172/2157-7145.1000107]; Hanage WP, 2006, J THEOR BIOL, V239, P210, DOI 10.1016/j.jtbi.2005.08.035; Hill T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-42; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; JONES NC, 2000, INTRO BIOINFORMATICS; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; KUHNER MK, 1994, MOL BIOL EVOL, V11, P459; Leiserson CE, 2001, INTRO ALGORITHMS; Lerat E, 2005, PLOS BIOL, V3, P807, DOI 10.1371/journal.pbio.0030130; Li Y, 2007, P NATL ACAD SCI USA, V104, P15787, DOI 10.1073/pnas.0609268104; Mau B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r44; Osborne JD, 2007, VACCINE, V25, P8807, DOI 10.1016/j.vaccine.2007.10.040; Park H, 2010, P 9 ANN INT C COMP S, P114; Pearson T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-78; Pearson T, 2009, INFECT GENET EVOL, V9, P1010, DOI 10.1016/j.meegid.2009.05.014; Pond SLK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000581; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Westesson O, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000318	28	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75230	10.1371/journal.pone.0075230	http://dx.doi.org/10.1371/journal.pone.0075230			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116030	Green Published, Green Submitted, gold			2022-12-25	WOS:000325501300023
J	Zhang, ZH; Meng, HW; Hou, ZY; Ma, J; Feng, L; Lin, XT; Tang, YC; Zhang, XL; Liu, QW; Liu, SW				Zhang, Zhonghe; Meng, Haiwei; Hou, Zhongyu; Ma, Jun; Feng, Lei; Lin, Xiangtao; Tang, Yuchun; Zhang, Xiaoli; Liu, Qingwei; Liu, Shuwei			Fetal Adrenal Gland in the Second Half of Gestation: Morphometrical Assessment with 3.0T Post-Mortem MRI	PLOS ONE			English	Article							2ND TRIMESTER ASSESSMENT; BRAIN	Background: The morphometry of fetal adrenal gland is rarely described with MRI of high magnetic field. The purpose of this study is to assess the normal fetal adrenal gland length (AL), width (AW), height (AH), surface area (AS) and volume (AV) in the second half of gestation with 3.0T post-mortem MRI. Methods and Findings: Fifty-two fetal specimens of 23-40 weeks gestational age (GA) were scanned by 3.0T MRI. Morphological changes and quantitative measurements of the fetal adrenal gland were analyzed. Asymmetry and sexual dimorphism were also obtained. The shape of the fetal adrenal gland did not change substantially from 23 to 40 weeks GA. The bilateral adrenal glands appeared as a 'Y', pyramidal or half-moon shape after reconstruction. There was a highly linear correlation between AL, AW, AH, AS, AV and GA. AW, AH, AS and AV were larger for the left adrenal gland than the right. No sexual dimorphism was found. Conclusions: Our data delineated the normal fetal adrenal gland during the second half of gestation, and can serve as a useful precise reference for anatomy or in vivo fetus.	[Zhang, Zhonghe; Hou, Zhongyu; Liu, Qingwei] Shandong Univ, Dept Med Imaging, Shandong Prov Hosp, Jinan 250100, Shandong, Peoples R China; [Zhang, Zhonghe; Meng, Haiwei; Hou, Zhongyu; Feng, Lei; Lin, Xiangtao; Tang, Yuchun; Liu, Shuwei] Shandong Univ, Res Ctr Sect & Imaging Anat, Sch Med, Jinan 250100, Shandong, Peoples R China; [Ma, Jun] Guilin Med Coll, Dept Anat, Guilin, Guangxi, Peoples R China; [Zhang, Xiaoli] Shandong Univ, Sch Med, Dept Histol & Embryol, Jinan 250100, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University; Guilin Medical University; Shandong University	Liu, SW (corresponding author), Shandong Univ, Res Ctr Sect & Imaging Anat, Sch Med, Jinan 250100, Shandong, Peoples R China.	liusw@sdu.edu.cn			National Natural Science Foundation of China [31071050, 81001223, 81300497]; Shandong Province Young and Middle-Aged Scientists Research Awards Fund [BS2010YY042, BS2010YY048, BS2012YY009]; scientific and technological research project of Shandong provincial population and family planning commission	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province Young and Middle-Aged Scientists Research Awards Fund; scientific and technological research project of Shandong provincial population and family planning commission	This work was supported by National Natural Science Foundation of China (NO. 31071050; 81001223; 81300497), Shandong Province Young and Middle-Aged Scientists Research Awards Fund (No. BS2010YY042; BS2010YY048; BS2012YY009), and the scientific and technological research project of Shandong provincial population and family planning commission (The 12th fund in 2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brugger PC, 2006, EUR J RADIOL, V57, P278, DOI 10.1016/j.ejrad.2005.11.030; Chang CH, 2002, ULTRASOUND MED BIOL, V28, P1383, DOI 10.1016/S0301-5629(02)00650-6; Huisman TAGM, 2002, EUR RADIOL, V12, P1941, DOI 10.1007/s00330-001-1209-x; Kinoshita Y, 2001, AM J NEURORADIOL, V22, P382; Kostovic I, 2009, SEMIN PERINATOL, V33, P220, DOI 10.1053/j.semperi.2009.04.003; Lan LM, 2000, RADIOLOGY, V215, P205, DOI 10.1148/radiology.215.1.r00ap05205; McEwing Rachael, 2003, Australas Radiol, V47, P101, DOI 10.1046/j.0004-8461.2003.01136.x; Meng HW, 2012, NEURORADIOLOGY, V54, P1153, DOI 10.1007/s00234-012-1069-x; Nowak D, 2007, ANN ANAT, V189, P575, DOI 10.1016/j.aanat.2007.03.004; Parazzini C, 2008, NEURORADIOLOGY, V50, P877, DOI 10.1007/s00234-008-0421-7; Saada J, 2004, PRENATAL DIAG, V24, P627, DOI 10.1002/pd.948; Sherer DM, 2008, J ULTRAS MED, V27, P1091, DOI 10.7863/jum.2008.27.7.1091; Shinmoto H, 2003, ABDOM IMAGING, V28, P877, DOI 10.1004/s00261-003-0047-5; Zhang Z, 2013, AM J NEURORADIOL, V34, P1462, DOI 10.3174/ajnr.A3406; Zhang ZH, 2011, EUR J RADIOL, V80, pE432, DOI 10.1016/j.ejrad.2010.11.024; Zhang ZH, 2011, NEURORADIOLOGY, V53, P177, DOI 10.1007/s00234-010-0781-7; Zhang ZH, 2010, INT J DEV NEUROSCI, V28, P537, DOI 10.1016/j.ijdevneu.2010.05.001	17	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75511	10.1371/journal.pone.0075511	http://dx.doi.org/10.1371/journal.pone.0075511			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116052	gold, Green Published, Green Submitted			2022-12-25	WOS:000325501300032
J	Meng, Y; Qian, Y; Gao, L; Cai, LB; Cui, YG; Liu, JY				Meng, Yan; Qian, Yi; Gao, Li; Cai, Ling-Bo; Cui, Yu-Gui; Liu, Jia-Yin			Downregulated Expression of Peroxiredoxin 4 in Granulosa Cells from Polycystic Ovary Syndrome	PLOS ONE			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; FOLLICULAR-FLUID; GENE-EXPRESSION; FOLLICLES; WOMEN; IV; PEROXIDASE; PROTEINS; PROTECTS	Peroxiredoxin 4 (PRDX4), a member of Peroxiredoxin (PRDX) family, is a typical 2-Cys PRDX. PRDX4 monitors the oxidative burden within cellular compartment and reduces hydrogen peroxide and alkyl hydroperoxide related to oxidative stress and apoptosis. Antioxidant, like PRDX4, may promote follicle development and participate in the pathophysiology of PCOS. In our previous study, we found that PRDX4 was expressed in mice oocyte cumulus oophorus complex, and that PRDX4 could be associated with follicle development. In this study, we explored the expression of PRDX4 in human follicles and possible role of PRDX4 in PCOS pathophysiology. Our data showed that PRDX4 was mainly expressed in granulosa cells in human ovaries. When compared to control group, both PRDX4 mRNA level and protein level decreased in PCOS group. The lowered levels of PRDX4 may relate to oxidative stress in the pathophysiologic progress of PCOS. Furthermore, expression of PRDX4 in the granulosa cells of in vivo or in vitro matured follicles was higher than that in immatured follicles, which suggested that PRDX4 may have a close relationship with follicular development. Altogether, our findings may provide new clues of the pathophysiologic mechanism of PCOS and potential therapeutic strategy using antioxidant, like PRDX4.	[Meng, Yan; Qian, Yi; Gao, Li; Cai, Ling-Bo; Cui, Yu-Gui; Liu, Jia-Yin] Nanjing Med Univ, Affiliated Hosp 1, Clin Ctr Reprod Med, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Liu, JY (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Clin Ctr Reprod Med, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	jyliu_nj@126.com		cai, lingbo/0000-0001-5094-0082	China National Nature Foundation [81200439]	China National Nature Foundation	This study was supported by projects from China National Nature Foundation (NO. 81200439). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28; Al-Gubory KH, 2010, INT J BIOCHEM CELL B, V42, P1634, DOI 10.1016/j.biocel.2010.06.001; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; BALEN AH, 1995, HUM REPROD, V10, P2107, DOI 10.1093/oxfordjournals.humrep.a136243; Burton GJ, 2011, BEST PRACT RES CL OB, V25, P287, DOI 10.1016/j.bpobgyn.2010.10.016; Catteau-Jonard S, 2008, J CLIN ENDOCR METAB, V93, P4456, DOI 10.1210/jc.2008-1231; Chian RC, 1999, NEW ENGL J MED, V341, P1624, DOI 10.1056/NEJM199911183412118; Cindrova-Davies T, 2007, AM J PATHOL, V171, P1168, DOI 10.2353/ajpath.2007.070528; Devine PJ, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095224; Ding Y, 2010, ANTIOXID REDOX SIGN, V13, P1477, DOI 10.1089/ars.2010.3137; ERICKSON GF, 1992, HUM REPROD, V7, P293, DOI 10.1093/oxfordjournals.humrep.a137638; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; FRANKS S, 1989, CLIN ENDOCRINOL, V31, P87, DOI 10.1111/j.1365-2265.1989.tb00457.x; Franks S, 2008, HUM REPROD UPDATE, V14, P367, DOI 10.1093/humupd/dmn015; Haridas V, 1998, J IMMUNOL, V161, P1; Hennet ML, 2013, J ASSIST REPROD GEN, V30, P333, DOI 10.1007/s10815-012-9925-5; Hughesdon P E, 1982, Obstet Gynecol Surv, V37, P59, DOI 10.1097/00006254-198202000-00001; Iuchi Y, 2009, BIOCHEM J, V419, P149, DOI 10.1042/BJ20081526; Jin DY, 1997, J BIOL CHEM, V272, P30952, DOI 10.1074/jbc.272.49.30952; Kang SW, 2005, TRENDS MOL MED, V11, P571, DOI 10.1016/j.molmed.2005.10.006; Karuputhula NB, 2013, SYST BIOL REPROD MED, V59, P91, DOI 10.3109/19396368.2012.743197; Lee HC, 2005, J KOREAN MED SCI, V20, P456, DOI 10.3346/jkms.2005.20.3.456; Leyens G, 2004, BIOL REPROD, V71, P1646, DOI 10.1095/biolreprod.104.030155; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meng Y, 2007, BBA-PROTEINS PROTEOM, V1774, P1477, DOI 10.1016/j.bbapap.2007.08.026; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; Murri M, 2013, HUM REPROD UPDATE; Nakahara K, 1997, FERTIL STERIL, V68, P312, DOI 10.1016/S0015-0282(97)81521-X; Palacio JR, 2006, CLIN EXP IMMUNOL, V144, P217, DOI 10.1111/j.1365-2249.2006.03061.x; Palande KK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016340; Peter AT, 2003, REPROD DOMEST ANIM, V38, P209, DOI 10.1046/j.1439-0531.2003.00438.x; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; Suzuki T, 1999, FERTIL STERIL, V72, P720, DOI 10.1016/S0015-0282(99)00332-5; Tavender TJ, 2008, BIOCHEM J, V411, P191, DOI 10.1042/BJ20071428; Tavender TJ, 2010, J CELL SCI, V123, P2672, DOI 10.1242/jcs.067843; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Victor VM, 2011, J CLIN ENDOCR METAB, V96, P3115, DOI 10.1210/jc.2011-0651; Webber LJ, 2003, LANCET, V362, P1017, DOI 10.1016/S0140-6736(03)14410-8; Wei QO, 2011, P NATL ACAD SCI USA, V108, P7004, DOI 10.1073/pnas.1013012108	40	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76460	10.1371/journal.pone.0076460	http://dx.doi.org/10.1371/journal.pone.0076460			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098506	Green Published, Green Submitted, gold			2022-12-25	WOS:000325483600056
J	Muller, A; Rychli, K; Muhterem-Uyar, M; Zaiser, A; Stessl, B; Guinane, CM; Cotter, PD; Wagner, M; Schmitz-Esser, S				Mueller, Anneliese; Rychli, Kathrin; Muhterem-Uyar, Meryem; Zaiser, Andreas; Stessl, Beatrix; Guinane, Caitriona M.; Cotter, Paul D.; Wagner, Martin; Schmitz-Esser, Stephan			Tn6188 - A Novel Transposon in Listeria monocytogenes Responsible for Tolerance to Benzalkonium Chloride	PLOS ONE			English	Article							PLASMID-BORNE CADMIUM; STAPHYLOCOCCUS-AUREUS; MULTIDRUG-RESISTANCE; COMPARATIVE GENOMICS; GENES; DISINFECTANTS; SENSITIVITY; OUTBREAK; ADAPTATION; EXPRESSION	Controlling the food-borne pathogen Listeria (L.) monocytogenes is of great importance from a food safety perspective, and thus for human health. The consequences of failures in this regard have been exemplified by recent large listeriosis outbreaks in the USA and Europe. It is thus particularly notable that tolerance to quaternary ammonium compounds such as benzalkonium chloride (BC) has been observed in many L. monocytogenes strains. However, the molecular determinants and mechanisms of BC tolerance of L. monocytogenes are still largely unknown. Here we describe Tn6188, a novel transposon in L. monocytogenes conferring tolerance to BC. Tn6188 is related to Tn554 from Staphylococcus (S.) aureus and other Tn554-like transposons such as Tn558, Tn559 and Tn5406 found in various Firmicutes. Tn6188 comprises 5117 bp, is integrated chromosomally within the radC gene and consists of three transposase genes (tnpABC) as well as genes encoding a putative transcriptional regulator and QacH, a small multidrug resistance protein family (SMR) transporter putatively associated with export of BC that shows high amino acid identity to Smr/QacC from S. aureus and to EmrE from Escherichia coli. We screened 91 L. monocytogenes strains for the presence of Tn6188 by PCR and found Tn6188 in 10 of the analyzed strains. These isolates were from food and food processing environments and predominantly from serovar 1/2a. L. monocytogenes strains harboring Tn6188 had significantly higher BC minimum inhibitory concentrations (MICs) (28.5 +/- 4.7 mg/l) than strains without Tn6188 (14 +/- 3.2 mg/l). Using quantitative reverse transcriptase PCR we could show a significant increase in qacH expression in the presence of BC. QacH deletion mutants were generated in two L. monocytogenes strains and growth analysis revealed that Delta qacH strains had lower BC MICs than wildtype strains. In conclusion, our results provide evidence that Tn6188 is responsible for BC tolerance in various L. monocytogenes strains.	[Mueller, Anneliese; Rychli, Kathrin; Muhterem-Uyar, Meryem; Zaiser, Andreas; Stessl, Beatrix; Wagner, Martin; Schmitz-Esser, Stephan] Univ Vet Med Vienna, Inst Milk Hyg, Vienna, Austria; [Wagner, Martin] Univ Vet Med, Christian Doppler Lab Molecularbiol Food Analyt, Vienna, Austria; [Guinane, Caitriona M.; Cotter, Paul D.] Teagasc Food Res Ctr, Cork, Ireland; [Cotter, Paul D.] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; Teagasc; University College Cork	Schmitz-Esser, S (corresponding author), Univ Vet Med Vienna, Inst Milk Hyg, Vienna, Austria.	stephan.schmitz-esser@vetmeduni.ac.at	Schmitz-Esser, Stephan/AAA-7287-2019; STANTON, CATHERINE/A-9549-2015	Schmitz-Esser, Stephan/0000-0002-1907-0709; STANTON, CATHERINE/0000-0002-6724-7011; Kober-Rychli, Kathrin/0000-0001-6147-577X; Guinane, Caitriona/0000-0001-8215-1387; Stessl, Beatrix/0000-0001-6172-0587	Austrian Science Fund (FWF) [P22703-B17]; European Union [036272]; EU [FP7-KBBE-2010-4]; Austrian Science Fund (FWF) [P 22703] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Union(European Commission); EU(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by a grant from the Austrian Science Fund (FWF, http://www.fwf.ac.at/) to SSE (grant no. P22703-B17), by the European Union funded integrated project BIOTRACER (contract no. 036272) under the 6th RTD framework and by the EU grant FP7-KBBE-2010-4 (FOODSEG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aase B, 2000, INT J FOOD MICROBIOL, V62, P57, DOI 10.1016/S0168-1605(00)00357-3; Allerberger F, 2010, CLIN MICROBIOL INFEC, V16, P16, DOI 10.1111/j.1469-0691.2009.03109.x; Attaiech L, 2008, J BACTERIOL, V190, P5729, DOI 10.1128/JB.00425-08; Aureli P, 2000, NEW ENGL J MED, V342, P1236, DOI 10.1056/NEJM200004273421702; Bay DC, 2008, BBA-BIOMEMBRANES, V1778, P1814, DOI 10.1016/j.bbamem.2007.08.015; Bertsch D, 2013, J ANTIMICROB CHEMOTH, V68, P986, DOI 10.1093/jac/dks531; BEST M, 1990, APPL ENVIRON MICROB, V56, P377, DOI 10.1128/AEM.56.2.377-380.1990; Bjorland J, 2003, ANTIMICROB AGENTS CH, V47, P3046, DOI 10.1128/AAC.47.10.3046-3052.2003; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cosgrove Shaun, 2011, Morbidity and Mortality Weekly Report, V60, P1357; den Bakker HC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-688; Earnshaw AM, 1998, J APPL MICROBIOL, V84, P642, DOI 10.1046/j.1365-2672.1998.00395.x; Elhanafi D, 2010, APPL ENVIRON MICROB, V76, P8231, DOI 10.1128/AEM.02056-10; FLEMING DW, 1985, NEW ENGL J MED, V312, P404, DOI 10.1056/NEJM198502143120704; Fox EM, 2011, APPL ENVIRON MICROB, V77, P6559, DOI 10.1128/AEM.05529-11; FRETZ R, 2010, EUROSURVEILLANCE, V15, P2; FRETZ R, 2010, EUROSURVEILLANCE, V15, P2; Glaser P, 2001, SCIENCE, V294, P849; Goulet V, 2008, EMERG INFECT DIS, V14, P734, DOI 10.3201/eid1405.071395; GRINIUS LL, 1994, J BIOL CHEM, V269, P29998; Haroche J, 2002, ANTIMICROB AGENTS CH, V46, P2337, DOI 10.1128/AAC.46.8.2337-2343.2002; Heir E, 1998, FEMS MICROBIOL LETT, V163, P49, DOI 10.1111/j.1574-6968.1998.tb13025.x; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Ivanek R, 2006, FOODBORNE PATHOG DIS, V3, P319, DOI 10.1089/fpd.2006.3.319; Kadlec K, 2010, ANTIMICROB AGENTS CH, V54, P3475, DOI 10.1128/AAC.00464-10; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kehrenberg C, 2005, ANTIMICROB AGENTS CH, V49, P813, DOI 10.1128/AAC.49.2.813-815.2005; KROLEWSKI JJ, 1981, J MOL BIOL, V152, P19, DOI 10.1016/0022-2836(81)90093-0; Kuenne C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-47; Kuenne C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012511; LEBRUN M, 1994, J BACTERIOL, V176, P3040, DOI 10.1128/JB.176.10.3040-3048.1994; LEBRUN M, 1994, J BACTERIOL, V176, P3049, DOI 10.1128/JB.176.10.3049-3061.1994; Lopez M, 2012, MICROB DRUG RESIST, V18, P13, DOI 10.1089/mdr.2011.0073; McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147, DOI 10.1128/CMR.12.1.147; Mereghetti L, 2000, APPL ENVIRON MICROB, V66, P5083, DOI 10.1128/AEM.66.11.5083-5086.2000; Mullapudi S, 2008, APPL ENVIRON MICROB, V74, P1464, DOI 10.1128/AEM.02426-07; MURPHY E, 1984, NATURE, V307, P292, DOI 10.1038/307292a0; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; Pan Y, 2006, APPL ENVIRON MICROB, V72, P7711, DOI 10.1128/AEM.01065-06; PAULSEN IT, 1995, J BACTERIOL, V177, P2827, DOI 10.1128/jb.177.10.2827-2833.1995; Rajkovic A, 2009, FOOD MICROBIOL, V26, P889, DOI 10.1016/j.fm.2009.06.006; Rakic-Martinez M, 2011, APPL ENVIRON MICROB, V77, P8714, DOI 10.1128/AEM.05941-11; Romanova N, 2002, APPL ENVIRON MICROB, V68, P6405, DOI 10.1128/AEM.68.12.6405-6409.2002; Romanova NA, 2006, APPL ENVIRON MICROB, V72, P3498, DOI 10.1128/AEM.72.5.3498-3503.2006; Ibusquiza PS, 2011, FOOD MICROBIOL, V28, P418, DOI 10.1016/j.fm.2010.09.014; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Sauders B.D., 2007, LISTERIA LISTERIOSIS, V161, P21, DOI DOI 10.1201/9781420015188.CH2; SCHLECH WF, 1983, NEW ENGL J MED, V308, P203, DOI 10.1056/NEJM198301273080407; Schuldiner S, 2009, BBA-PROTEINS PROTEOM, V1794, P748, DOI 10.1016/j.bbapap.2008.12.018; SMITH K, 1992, BIOCHIMIE, V74, P705, DOI 10.1016/0300-9084(92)90143-3; Soumet C, 2005, LETT APPL MICROBIOL, V41, P291, DOI 10.1111/j.1472-765X.2005.01763.x; Tasara T, 2007, FEMS MICROBIOL LETT, V269, P265, DOI 10.1111/j.1574-6968.2007.00633.x; To MS, 2002, APPL ENVIRON MICROB, V68, P5258, DOI 10.1128/AEM.68.11.5258-5264.2002; Vallenet D, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap021; YERUSHALMI H, 1995, J BIOL CHEM, V270, P6856, DOI 10.1074/jbc.270.12.6856	55	108	109	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76835	10.1371/journal.pone.0076835	http://dx.doi.org/10.1371/journal.pone.0076835			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098567	Green Published, gold, Green Submitted			2022-12-25	WOS:000325434500088
J	Takai, E; Tsukimoto, M; Kojima, S				Takai, Erina; Tsukimoto, Mitsutoshi; Kojima, Shuji			TGF-beta 1 Downregulates COX-2 Expression Leading to Decrease of PGE2 Production in Human Lung Cancer A549 Cells, Which Is Involved in Fibrotic Response to TGF-beta 1	PLOS ONE			English	Article							PROSTAGLANDIN E-2; TGF-BETA; CYCLOOXYGENASE-2 EXPRESSION; STIMULATES CYCLOOXYGENASE-2; MESENCHYMAL TRANSITION; SIGNALING PATHWAY; GENE-EXPRESSION; GROWTH; PULMONARY; MIGRATION	Transforming growth factor-beta 1 (TGF-beta 1) is a multifunctional cytokine that is involved in various pathophysiological processes, including cancer progression and fibrotic disorders. Here, we show that treatment with TGF-beta 1 (5 ng/mL) induced downregulation of cyclooxygenase-2 (COX-2), leading to reduced synthesis of prostaglandin E2 (PGE2), in human lung cancer A549 cells. Treatment of cells with specific inhibitors of COX-2 or PGE2 receptor resulted in growth inhibition, indicating that the COX-2/PGE2 pathway contributes to proliferation in an autocrine manner. TGF-beta 1 treatment induced growth inhibition, which was attenuated by exogenous PGE2. TGF-beta 1 is also a potent inducer of epithelial mesenchymal transition (EMT), a phenotype change in which epithelial cells differentiate into fibroblastoid cells. Supplementation with PGE2 or PGE2 receptor EP4 agonist PGE1-alcohol, as compared with EP1/3 agonist sulprostone, inhibited TGF-beta 1-induced expression of fibronectin and collagen I (extracellular matrix components). Exogenous PGE2 or PGE2 receptor agonists also suppressed actin remodeling induced by TGF-beta 1. These results suggest that PGE2 has an anti-fibrotic effect. We conclude that TGF-beta 1-induced downregulation of COX-2/PGE2 signaling is involved in facilitation of fibrotic EMT response in A549 cells.	[Takai, Erina; Tsukimoto, Mitsutoshi; Kojima, Shuji] Tokyo Univ Sci, Dept Radiat Biosci, Fac Pharmaceut Sci, Noda, Chiba 278, Japan	Tokyo University of Science	Tsukimoto, M (corresponding author), Tokyo Univ Sci, Dept Radiat Biosci, Fac Pharmaceut Sci, Noda, Chiba 278, Japan.	tsukim@rs.noda.tus.ac.jp						Baratelli F, 2005, J IMMUNOL, V175, P1483, DOI 10.4049/jimmunol.175.3.1483; Bozyk PD, 2011, AM J RESP CELL MOL, V45, P445, DOI 10.1165/rcmb.2011-0025RT; Cao SQ, 2011, INT J ONCOL, V39, P383, DOI 10.3892/ijo.2011.1053; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chen YC, 2005, BBA-MOL CELL RES, V1743, P291, DOI 10.1016/j.bbamcr.2004.10.016; Chun KS, 2004, BIOCHEM PHARMACOL, V68, P1089, DOI 10.1016/j.bcp.2004.05.031; Cocolakis E, 2008, J BIOL CHEM, V283, P1293, DOI 10.1074/jbc.M707492200; Desmouliere A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90; Diers AR, 2010, BIOCHEM J, V430, P69, DOI 10.1042/BJ20091193; Doherty GA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-207; Eichele K, 2008, ONCOGENE, V27, P3032, DOI 10.1038/sj.onc.1210962; Go C, 1999, CANCER RES, V59, P2861; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Huang S, 2007, AM J PHYSIOL-LUNG C, V292, pL405, DOI 10.1152/ajplung.00232.2006; Huang SK, 2008, CHEST, V133, P1442, DOI 10.1378/chest.08-0306; Inagaki Y, 2007, GUT, V56, P284, DOI 10.1136/gut.2005.088690; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kohyama T, 2001, AM J PHYSIOL-LUNG C, V281, pL1257, DOI 10.1152/ajplung.2001.281.5.L1257; Koon HW, 2006, J IMMUNOL, V176, P5050, DOI 10.4049/jimmunol.176.8.5050; Krysan K, 2004, CANCER RES, V64, P6359, DOI 10.1158/0008-5472.CAN-04-1681; KUHN C, 1989, AM REV RESPIR DIS, V140, P1693, DOI 10.1164/ajrccm/140.6.1693; Larkins TL, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-181; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Li F, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-27; Li YJ, 2011, AM J RESP CELL MOL, V44, P99, DOI 10.1165/rcmb.2009-0163OC; Liu F, 2010, J CELL BIOL, V190, P693, DOI 10.1083/jcb.201004082; Liu JF, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-43; Mayoral R, 2005, CARCINOGENESIS, V26, P753, DOI 10.1093/carcin/bgi022; Mumm JB, 2008, ONCOGENE, V27, P5913, DOI 10.1038/onc.2008.275; Neil JR, 2008, CARCINOGENESIS, V29, P2227, DOI 10.1093/carcin/bgn202; NOGUCHI M, 1995, CANCER-AM CANCER SOC, V75, P2844, DOI 10.1002/1097-0142(19950615)75:12<2844::AID-CNCR2820751209>3.0.CO;2-#; OZAKI T, 1987, J APPL PHYSIOL, V62, P219, DOI 10.1152/jappl.1987.62.1.219; Radisky DC, 2007, J CELL BIOCHEM, V101, P830, DOI 10.1002/jcb.21186; Rask K, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-62; Rieder F, 2010, INFLAMM BOWEL DIS, V16, P1505, DOI 10.1002/ibd.21255; Riedl K, 2004, DRUG RESIST UPDATE, V7, P169, DOI 10.1016/j.drup.2004.04.003; Sabe H, 2011, J BIOCHEM, V149, P633, DOI 10.1093/jb/mvr044; Sawaoka H, 1998, AM J PHYSIOL-GASTR L, V274, pG1061, DOI 10.1152/ajpgi.1998.274.6.G1061; Sharma S, 2005, CANCER RES, V65, P5211, DOI 10.1158/0008-5472.CAN-05-0141; Sharma SD, 2010, MOL CANCER THER, V9, P569, DOI 10.1158/1535-7163.MCT-09-0638; SHIMOSATO Y, 1980, AM J SURG PATHOL, V4, P365, DOI 10.1097/00000478-198008000-00005; Siegel PM, 2003, P NATL ACAD SCI USA, V100, P8430, DOI 10.1073/pnas.0932636100; Soslow RA, 2000, CANCER, V89, P2637, DOI 10.1002/1097-0142(20001215)89:12<2637::AID-CNCR17>3.0.CO;2-B; Stolina M, 2000, J IMMUNOL, V164, P361, DOI 10.4049/jimmunol.164.1.361; Takai E, 2012, J CELL SCI, V125, P5051, DOI 10.1242/jcs.104976; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; TODARO GJ, 1981, J SUPRAMOL STR CELL, V15, P287, DOI 10.1002/jsscb.1981.380150306; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Wang ZL, 2013, CARCINOGENESIS, V34, P638, DOI 10.1093/carcin/bgs367; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Yano T, 2002, FEBS LETT, V518, P154, DOI 10.1016/S0014-5793(02)02689-3; Zhang AH, 2006, AM J PHYSIOL-RENAL, V291, pF1332, DOI 10.1152/ajprenal.00131.2006; ZHANG K, 1994, AM J PATHOL, V145, P114	54	43	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76346	10.1371/journal.pone.0076346	http://dx.doi.org/10.1371/journal.pone.0076346			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098479	Green Submitted, Green Published, gold			2022-12-25	WOS:000325434500062
J	Luque, MCA; Gutierrez, PS; Debbas, V; Martins, WK; Puech-Leao, P; Porto, G; Coelho, V; Boumsell, L; Kalil, J; Stolf, B				Aquino Luque, Maria Carolina; Gutierrez, Paulo Sampaio; Debbas, Victor; Martins, Waleska Kerllen; Puech-Leao, Pedro; Porto, Georgia; Coelho, Veronica; Boumsell, Laurence; Kalil, Jorge; Stolf, Beatriz			Phage Display Identification of CD100 in Human Atherosclerotic Plaque Macrophages and Foam Cells	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; SURFACE EXPRESSION; SCAVENGER RECEPTORS; VASCULAR-LESIONS; SOLUBLE CD100; ARTERIOSCLEROSIS; DEFINITION; ACTIVATION; COMMITTEE; COUNCIL	Atherosclerosis is a complex disease in which vessels develop plaques comprising dysfunctional endothelium, monocyte derived lipid laden foam cells and activated lymphocytes. Considering that humans and animal models of the disease develop quite distinct plaques, we used human plaques to search for proteins that could be used as markers of human atheromas. Phage display peptide libraries were probed to fresh human carotid plaques, and a bound phage homologous to plexin B1, a high affinity receptor for CD100, was identified. CD100 is a member of the semaphorin family expressed by most hematopoietic cells and particularly by activated T cells. CD100 expression was analyzed in human plaques and normal samples. CD100 mRNA and protein were analyzed in cultured monocytes, macrophages and foam cells. The effects of CD100 in oxLDL-induced foam cell formation and in CD36 mRNA abundance were evaluated. Human atherosclerotic plaques showed strong labeling of CD100/SEMA4D. CD100 expression was further demonstrated in peripheral blood monocytes and in in vitro differentiated macrophages and foam cells, with diminished CD100 transcript along the differentiation of these cells. Incubation of macrophages with CD100 led to a reduction in oxLDL-induced foam cell formation probably through a decrease of CD36 expression, suggesting for the first time an atheroprotective role for CD100 in the human disease. Given its differential expression in the numerous foam cells and macrophages of the plaques and its capacity to decrease oxLDL engulfment by macrophages we propose that CD100 may have a role in atherosclerotic plaque development, and may possibly be employed in targeted treatments of these atheromas.	[Aquino Luque, Maria Carolina; Gutierrez, Paulo Sampaio; Debbas, Victor; Puech-Leao, Pedro; Porto, Georgia; Coelho, Veronica; Kalil, Jorge; Stolf, Beatriz] HC FMUSP, Heart Inst Sao Paulo InCor, Sao Paulo, Brazil; [Aquino Luque, Maria Carolina; Coelho, Veronica; Kalil, Jorge; Stolf, Beatriz] Univ Sao Paulo, Sch Med, Dept Clin Med, HC FMUSP, Sao Paulo, Brazil; [Coelho, Veronica; Kalil, Jorge] Natl Inst Sci & Technol, INCT, Inst Invest Immunol, Sao Paulo, Brazil; [Boumsell, Laurence] Univ Paris 05, Inst Cochin, INSERM, U567, Paris, France; [Martins, Waleska Kerllen] Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil; [Stolf, Beatriz] Univ Sao Paulo, Dept Parasitol, Inst Biomed Sci, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universidade de Sao Paulo; Universidade de Sao Paulo	Luque, MCA (corresponding author), HC FMUSP, Heart Inst Sao Paulo InCor, Sao Paulo, Brazil.	bstolf@usp.br	Martins, Waleska Kerllen/L-5187-2018; Stolf, Beatriz S/H-7943-2012; Leao, Pedro P/B-5495-2016; PUECH-LEAO, PEDRO/AAW-8801-2020; Gutierrez, Paulo S/E-6783-2012; KALIL, JORGE/C-8029-2012	Martins, Waleska Kerllen/0000-0003-1502-4606; Stolf, Beatriz S/0000-0001-7661-3311; PUECH-LEAO, PEDRO/0000-0002-6974-9509; Gutierrez, Paulo S/0000-0002-9544-2359; KALIL, JORGE/0000-0001-8415-4274; Coelho, Veronica/0000-0002-0989-2581	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; BANKA CL, 1991, J LIPID RES, V32, P35; BOUGERET C, 1992, J IMMUNOL, V148, P318; Bover LC, 2007, J IMMUNOL, V178, P8183, DOI 10.4049/jimmunol.178.12.8183; Chabbert-de Ponnat I, 2005, INT IMMUNOL, V17, P439, DOI 10.1093/intimm/dxh224; Cominacini L, 2000, J BIOL CHEM, V275, P12633, DOI 10.1074/jbc.275.17.12633; Elhabazi A, 2003, CRIT REV IMMUNOL, V23, P65, DOI 10.1615/CritRevImmunol.v23.i12.40; Elhabazi A, 2001, J IMMUNOL, V166, P4341, DOI 10.4049/jimmunol.166.7.4341; Greaves DR, 2005, J LIPID RES, V46, P11, DOI 10.1194/jlr.R400011-JLR200; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hong HY, 2008, J CELL MOL MED, V12, P2003, DOI 10.1111/j.1582-4934.2008.00189.x; Houston P, 2001, FEBS LETT, V492, P73, DOI 10.1016/S0014-5793(01)02191-3; Hu Y, 2008, J IMMUNOL, V180, P8057, DOI 10.4049/jimmunol.180.12.8057; Ji JD, 2009, HUM IMMUNOL, V70, P211, DOI 10.1016/j.humimm.2009.01.026; Kamperidis P, 2011, ARTHRITIS RHEUM-US, V63, P3758, DOI 10.1002/art.30650; Karjalainen K, 2011, BLOOD, V117, P920, DOI 10.1182/blood-2010-05-282921; Kikutani H, 2007, ADV IMMUNOL, V93, P121, DOI 10.1016/S0065-2776(06)93003-X; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Krieger M, 1997, CURR OPIN LIPIDOL, V8, P275, DOI 10.1097/00041433-199710000-00006; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; Porto G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021702; Rajotte D, 1998, J CLIN INVEST, V102, P430, DOI 10.1172/JCI3008; Rekhter MD, 2001, CELL BIOCHEM BIOPHYS, V35, P103, DOI 10.1385/CBB:35:1:103; Robert R, 2006, J BIOL CHEM, V281, P40135, DOI 10.1074/jbc.M609344200; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sierra JR, 2008, J EXP MED, V205, P1673, DOI 10.1084/jem.20072602; STARY HC, 1994, CIRCULATION, V89, P2462, DOI 10.1161/01.CIR.89.5.2462; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Steinberg D, 1997, J BIOL CHEM, V272, P20963, DOI 10.1074/jbc.272.34.20963; Yacoby I, 2008, EXPERT OPIN DRUG DEL, V5, P321, DOI 10.1517/17425247.5.3.321 ; Yukawa K, 2010, INT J MOL MED, V26, P39, DOI 10.3892/ijmm_00000432; Zhu L, 2007, P NATL ACAD SCI USA, V104, P1621, DOI 10.1073/pnas.0606344104; Zhu L, 2009, ARTERIOSCL THROM VAS, V29, P1039, DOI 10.1161/ATVBAHA.109.185405	34	15	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75772	10.1371/journal.pone.0075772	http://dx.doi.org/10.1371/journal.pone.0075772			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098722	gold, Green Published, Green Submitted			2022-12-25	WOS:000325423500093
J	Bertrand, C; Blanchet, E; Pessemesse, L; Annicotte, JS; Feillet-Coudray, C; Chabi, B; Levin, J; Fajas, L; Cabello, G; Wrutniak-Cabello, C; Casas, F				Bertrand, Christelle; Blanchet, Emilie; Pessemesse, Laurence; Annicotte, Jean Sebastien; Feillet-Coudray, Christine; Chabi, Beatrice; Levin, Jonathan; Fajas, Lluis; Cabello, Gerard; Wrutniak-Cabello, Chantal; Casas, Francois			Mice Lacking the p43 Mitochondrial T3 Receptor Become Glucose Intolerant and Insulin Resistant during Aging	PLOS ONE			English	Article							REGULATES MYOBLAST DIFFERENTIATION; SECRETION; EXPRESSION; OVEREXPRESSION; FAT	Thyroid hormones (TH) play an important regulatory role in energy expenditure regulation and are key regulators of mitochondrial activity. We have previously identified a mitochondrial triiodothyronine (T3) receptor (p43) which acts as a mitochondrial transcription factor of the organelle genome, which leads in vitro and in vivo, to a stimulation of mitochondrial biogenesis. Recently, we generated mice carrying a specific p43 invalidation. At 2 months of age, we reported that p43 depletion in mice induced a major defect in insulin secretion both in vivo and in isolated pancreatic islets, and a loss of glucose-stimulated insulin secretion. The present study was designed to determine whether p43 invalidation influences life expectancy and modulates blood glucose and insulin levels as well as glucose tolerance or insulin sensitivity during aging. We report that from 4 months old onwards, mice lacking p43 are leaner than wild-type mice. p43-/- mice also have a moderate reduction of life expectancy compared to wild type. We found no difference in blood glucose levels, excepted at 24 months old where p43-/- mice showed a strong hyperglycemia in fasting conditions compared to controls animals. However, the loss of glucose-stimulated insulin secretion was maintained whatever the age of mice lacking p43. If up to 12 months old, glucose tolerance remained unchanged, beyond this age p43-/- mice became increasingly glucose intolerant. In addition, if up to 12 months old p43 deficient animals were more sensitive to insulin, after this age we observed a loss of this capacity, culminating in 24 months old mice with a decreased sensitivity to the hormone. In conclusion, we demonstrated that during aging the depletion of the mitochondrial T3 receptor p43 in mice progressively induced an increased glycemia in the fasted state, glucose intolerance and an insulin-resistance several features of type-2 diabetes.	[Bertrand, Christelle; Pessemesse, Laurence; Feillet-Coudray, Christine; Chabi, Beatrice; Levin, Jonathan; Cabello, Gerard; Wrutniak-Cabello, Chantal; Casas, Francois] INRA, Dynam Musculaire & Metab UMR866, F-34060 Montpellier, France; [Bertrand, Christelle; Blanchet, Emilie; Pessemesse, Laurence; Annicotte, Jean Sebastien; Feillet-Coudray, Christine; Chabi, Beatrice; Levin, Jonathan; Fajas, Lluis; Cabello, Gerard; Wrutniak-Cabello, Chantal; Casas, Francois] Univ Montpellier I, Montpellier, France; [Bertrand, Christelle; Blanchet, Emilie; Pessemesse, Laurence; Annicotte, Jean Sebastien; Feillet-Coudray, Christine; Chabi, Beatrice; Levin, Jonathan; Fajas, Lluis; Cabello, Gerard; Wrutniak-Cabello, Chantal; Casas, Francois] Univ Montpellier 2, Montpellier, France; [Blanchet, Emilie; Annicotte, Jean Sebastien; Fajas, Lluis] CNRS, UMR5535, IGMM, Montpellier, France	INRAE; Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Casas, F (corresponding author), INRA, Dynam Musculaire & Metab UMR866, F-34060 Montpellier, France.	casasf@supagro.inra.fr	Coll, Lluis Fajas/C-8567-2014; Levin, Jonathan/N-3189-2018; Annicotte, Jean-Sébastien/H-4641-2018; Chabi, Beatrice/AAI-6545-2020; BERTRAND-GADAY, Christelle/ABA-8619-2021	Annicotte, Jean-Sébastien/0000-0002-2109-4849; Chabi, Beatrice/0000-0002-5604-5668; BERTRAND-GADAY, Christelle/0000-0003-0461-2402; Francois, Casas/0000-0002-5535-8195; Fajas, Lluis/0000-0002-1283-9503	Institut National de la Recherche Agronomique (INRA); Societe Francophone du Diabete (SFD)	Institut National de la Recherche Agronomique (INRA); Societe Francophone du Diabete (SFD)	This work was supported by grants from the Institut National de la Recherche Agronomique (INRA) and the Societe Francophone du Diabete (SFD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo-Mazzucato C, 2011, DIABETOLOGIA, V54, P583, DOI 10.1007/s00125-010-2026-z; Aguayo-Mazzucato C, 2013, DIABETES, V62, P1569, DOI 10.2337/db12-0849; Annicotte JS, 2003, MOL CELL BIOL, V23, P6713, DOI 10.1128/MCB.23.19.6713-6724.2003; Blanchet E, 2012, FASEB J, V26, P40, DOI 10.1096/fj.11-186841; BRENT GA, 1991, ANNU REV PHYSIOL, V53, P17, DOI 10.1146/annurev.ph.53.030191.000313; Casas F, 1999, MOL CELL BIOL, V19, P7913; Casas F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005631; Casas F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002501; DIAZ GB, 1993, ARCH INT PHYSIOL BIO, V101, P263, DOI 10.3109/13813459309003922; Fajas L, 2004, J CLIN INVEST, V113, P1288, DOI 10.1172/JCI200418555; Furuya F, 2010, J BIOL CHEM, V285, P24477, DOI 10.1074/jbc.M109.100222; Grandemange S, 2005, CANCER RES, V65, P4282, DOI 10.1158/0008-5472.CAN-04-3652; Jornayvaz FR, 2012, ENDOCRINOLOGY, V153, P583, DOI 10.1210/en.2011-1793; Kondo T, 2009, MOL ENDOCRINOL, V23, P1281, DOI 10.1210/me.2008-0482; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; LIGGETT SB, 1989, J CLIN INVEST, V83, P803, DOI 10.1172/JCI113961; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Misiti S, 2005, J CELL PHYSIOL, V204, P286, DOI 10.1002/jcp.20293; OMEARA NM, 1993, J CLIN ENDOCR METAB, V76, P79, DOI 10.1210/jc.76.1.79; Pelletier P, 2008, ENDOCRINOLOGY, V149, P6471, DOI 10.1210/en.2008-0718; Pessemesse L, 2012, FASEB J, V26, P748, DOI 10.1096/fj.11-195933; Rochard P, 2000, J BIOL CHEM, V275, P2733, DOI 10.1074/jbc.275.4.2733; Seyer P, 2006, J CELL PHYSIOL, V207, P75, DOI 10.1002/jcp.20539; Seyer P, 2011, EXP CELL RES, V317, P2059, DOI 10.1016/j.yexcr.2011.05.020; Sjogren M, 2007, EMBO J, V26, P4535, DOI 10.1038/sj.emboj.7601882; Taylor SI, 1999, CELL, V97, P9, DOI 10.1016/S0092-8674(00)80709-6; Verga Falzacappa C, 2006, J CELL PHYSIOL, V206, P309, DOI 10.1002/jcp.20460; WRUTNIAK C, 1995, J BIOL CHEM, V270, P16347, DOI 10.1074/jbc.270.27.16347; Wrutniak-Cabello C, 2001, J MOL ENDOCRINOL, V26, P67, DOI 10.1677/jme.0.0260067	29	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75111	10.1371/journal.pone.0075111	http://dx.doi.org/10.1371/journal.pone.0075111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098680	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500051
J	Nangia, V; Jonas, JB; Matin, A; Bhojwani, K; Sinha, A; Kulkarni, M; Gupta, R; Khare, A; Agarwal, S; Bhate, K; Nangia, P; Nangia, P; Panda-Jonas, S				Nangia, Vinay; Jonas, Jost B.; Matin, Arshia; Bhojwani, Krishna; Sinha, Ajit; Kulkarni, Maithili; Gupta, Rajesh; Khare, Anshu; Agarwal, Shubhra; Bhate, Karishma; Nangia, Prabhat; Nangia, Purna; Panda-Jonas, Songhomitra			Prevalence and Associated Factors of Glaucoma in Rural Central India. The Central India Eye and Medical Study	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; POPULATION-BASED SURVEY; CEREBROSPINAL-FLUID PRESSURE; BODY-MASS INDEX; SOUTHERN INDIA; CLOSURE GLAUCOMA; RISK-FACTORS; ISNT RULE; OCULAR HYPERTENSION; CHENNAI GLAUCOMA	Purpose: To assess the prevalence of glaucoma in rural Central India. Methods: The population-based Central India Eye and Medical Study is a population-based study performed in a rural region of Central India. The study included 4711 subjects (aged 30+ years). A detailed ophthalmic and medical examination was performed. Glaucoma was defined by glaucomatous optic disc morphology, and in a second step, by the criteria of the International Society of Geographical and Epidemiological Ophthalmology (ISGEO). Results: Optic disc photographs were available for 4570 (97.0%) subjects. Glaucoma was detected in 122 subjects (51 unilateral) (2.67% (95% CI: 2.20, 3.14). Glaucoma prevalence for the age groups of 30-39yrs, 40-49yrs, 50-59yrs, 60-69yrs, 70-79yrs, and 80+ years was 0.54% (95% CI: 0.11, 0.98), 1.03% (95% CI: 0.49, 1.57), 1.40% (95% CI: 0.58, 2.23), 6.62% (95% CI: 4.92, 8.31), 8.71% (95% CI: 5.55, 11.75), and 14.3% (95% CI: 4.13, 24.4), respectively. In multivariable analysis, glaucoma was associated with higher age (P<0.001), lower body mass index (P = 0.025), lower blood hemoglobin concentration (P = 0.03), higher intraocular pressure (P<0.001), disc hemorrhages (P<0.001), higher prevalence of myopic retinopathy (P<0.001), lower level of education (P = 0.03), longer axial length (P<0.001), thinner retinal nerve fiber layer (P<0.001), higher vertical cup/disc diameter ratio (P<0.001), and narrow anterior chamber angle (P = 0.02). Ratio of open-angle glaucoma to angle-closure glaucoma was 7.7: 1 (1.93% (95% CI: 1.64, 2.22) to 0.24% (95% CI: 0.14, 0.34)). Using the ISGEO criteria, glaucoma prevalence was 2.8% (95% CI: 2.3, 3.3) with a less clear association with older age. Conclusions: Glaucoma prevalence in remote rural Central India is comparable to other regions. Associated factors were older age, lower body mass index, lower blood concentration of hemoglobin, lower level of education, higher intraocular pressure, disc hemorrhage, myopic retinopathy, and longer axial length. The ratio of open-angle glaucoma to angle-closure glaucoma was about 8:1.	[Nangia, Vinay; Jonas, Jost B.; Matin, Arshia; Bhojwani, Krishna; Sinha, Ajit; Kulkarni, Maithili; Gupta, Rajesh; Khare, Anshu; Agarwal, Shubhra; Bhate, Karishma; Nangia, Prabhat; Nangia, Purna; Panda-Jonas, Songhomitra] Suraj Eye Inst, Nagpur, Maharashtra, India; [Jonas, Jost B.; Panda-Jonas, Songhomitra] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany	Suraj Eye Institute; Ruprecht Karls University Heidelberg	Nangia, V (corresponding author), Suraj Eye Inst, Nagpur, Maharashtra, India.	nagpursuraj@gmail.com; Jost.Jonas@medma.uni-heidelberg.de	Bhate, Karishma/AAD-8609-2019		Om Drishti Trust, Nagpur, India; Heidelberg Engineering Co., Heidelberg, Germany; Rotary Sight Saver Netherlands; ORBIS International; Carl Zeiss Meditec Co., Jena, Germany	Om Drishti Trust, Nagpur, India; Heidelberg Engineering Co., Heidelberg, Germany; Rotary Sight Saver Netherlands; ORBIS International; Carl Zeiss Meditec Co., Jena, Germany	This work was supported by an unrestricted grant from Om Drishti Trust, Nagpur, India; Heidelberg Engineering Co., Heidelberg, Germany; Rotary Sight Saver Netherlands; ORBIS International; and Carl Zeiss Meditec Co., Jena, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENGTSSON B, 1980, ACTA OPHTHALMOL, V58, P726; Bourne RRA, 2003, BRIT J OPHTHALMOL, V87, P1069, DOI 10.1136/bjo.87.9.1069; Brandt JD, 2001, OPHTHALMOLOGY, V108, P1779, DOI 10.1016/S0161-6420(01)00760-6; Buhrmann RR, 2000, INVEST OPHTH VIS SCI, V41, P40; Chauhan BC, 2008, ARCH OPHTHALMOL-CHIC, V126, P1030, DOI 10.1001/archopht.126.8.1030; Curtin B J, 1977, Trans Am Ophthalmol Soc, V75, P67; Dandona L, 2000, OPHTHALMOLOGY, V107, P1710, DOI 10.1016/S0161-6420(00)00274-8; Dandona L, 2000, OPHTHALMOLOGY, V107, P1702, DOI 10.1016/S0161-6420(00)00275-X; DIELEMANS I, 1994, OPHTHALMOLOGY, V101, P1851; Ekstrom C, 1996, ACTA OPHTHALMOL SCAN, V74, P107; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Foster PJ, 1996, ARCH OPHTHALMOL-CHIC, V114, P1235, DOI 10.1001/archopht.1996.01100140435011; Foster PJ, 2000, BRIT J OPHTHALMOL, V84, P186, DOI 10.1136/bjo.84.2.186; Foster PJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P1105, DOI 10.1001/archopht.118.8.1105; Garudadri C, 2010, OPHTHALMOLOGY, V117, P1352, DOI 10.1016/j.ophtha.2009.11.006; Grodum K, 2001, ACTA OPHTHALMOL SCAN, V79, P560, DOI 10.1034/j.1600-0420.2001.790603.x; Harizman N, 2006, ARCH OPHTHALMOL-CHIC, V124, P1579, DOI 10.1001/archopht.124.11.1579; He MG, 2006, INVEST OPHTH VIS SCI, V47, P2782, DOI 10.1167/iovs.06-0051; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Jacob Aby, 1998, Indian Journal of Ophthalmology, V46, P81; Jonas JB, 1998, BRIT J OPHTHALMOL, V82, P1366, DOI 10.1136/bjo.82.12.1366; JONAS JB, 1988, INVEST OPHTH VIS SCI, V29, P1151; Jonas JB, 1999, SURV OPHTHALMOL, V43, P293, DOI 10.1016/S0039-6257(98)00049-6; JONAS JB, 1989, AM J OPHTHALMOL, V107, P137, DOI 10.1016/0002-9394(89)90212-2; Jonas JB, 2000, INVEST OPHTH VIS SCI, V41, P1764; Jonas JB, 2012, CLIN EXP OPHTHALMOL, V40, pE116, DOI 10.1111/j.1442-9071.2011.02731.x; Jonas JB, 2010, AM J HYPERTENS, V23, P347, DOI 10.1038/ajh.2009.276; Kassoff A, 2001, AM J OPHTHALMOL, V131, P167; KLEIN BEK, 1992, OPHTHALMOLOGY, V99, P1499; Krishnadas R, 2003, AM J OPHTHALMOL, V135, P830, DOI 10.1016/S0002-9394(02)02271-7; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; LESKE MC, 1995, ARCH OPHTHALMOL-CHIC, V113, P918, DOI 10.1001/archopht.1995.01100070092031; LESKE MC, 1994, ARCH OPHTHALMOL-CHIC, V112, P821, DOI 10.1001/archopht.1994.01090180121046; Mitchell P, 1999, OPHTHALMOLOGY, V106, P2010, DOI 10.1016/S0161-6420(99)90416-5; Morgan JE, 2012, OPHTHALMOLOGY, V119, P723, DOI 10.1016/j.ophtha.2011.10.004; Musch DC, 2009, OPHTHALMOLOGY, V116, P200, DOI 10.1016/j.ophtha.2008.08.051; Nangia V, 2010, OPHTHALMOLOGY, V117, P1360, DOI 10.1016/j.ophtha.2009.11.040; Narayanaswamy A, 2013, INVEST OPHTH VIS SCI, V54, P4621, DOI 10.1167/iovs.13-11950; Nouri-Mahdavi K, 2004, OPHTHALMOLOGY, V111, P1627, DOI 10.1016/j.ophtha.2004.02.017; Pasquale LR, 2010, OPHTHALMOLOGY, V117, P1521, DOI 10.1016/j.ophtha.2009.12.017; Pogrebniak AE, 2010, INVEST OPHTH VIS SCI, V51, P890, DOI 10.1167/iovs.09-3837; Ramakrishnan R, 2003, OPHTHALMOLOGY, V110, P1484, DOI 10.1016/S0161-6420(03)00564-5; Raychaudhuri A, 2005, BRIT J OPHTHALMOL, V89, P1559, DOI 10.1136/bjo.2005.074948; Ren RJ, 2012, GRAEF ARCH CLIN EXP, V250, P445, DOI 10.1007/s00417-011-1746-1; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; Rotchford AP, 2002, ARCH OPHTHALMOL-CHIC, V120, P471, DOI 10.1001/archopht.120.4.471; Shen SY, 2008, INVEST OPHTH VIS SCI, V49, P3846, DOI 10.1167/iovs.08-1759; Sihota R, 2008, EYE, V22, P819, DOI 10.1038/sj.eye.6702798; Steidl SM, 1997, AM J OPHTHALMOL, V123, P181, DOI 10.1016/S0002-9394(14)71034-7; Thomas R, 2007, CLIN EXP OPHTHALMOL, V35, P374, DOI 10.1111/j.1442-9071.2007.01489.x; Thomas R, 2012, INDIAN J OPHTHALMOL, V60, P446, DOI 10.4103/0301-4738.100546; Thomas R, 2011, INDIAN J OPHTHALMOL, V59, pS3, DOI 10.4103/0301-4738.73678; VANHERICK W, 1969, AM J OPHTHALMOL, V68, P626, DOI 10.1016/0002-9394(69)91241-0; Varma R, 2004, OPHTHALMOLOGY, V111, P1439, DOI 10.1016/j.ophtha.2004.01.025; Vijaya L, 2008, OPHTHALMOLOGY, V115, P648, DOI 10.1016/j.ophtha.2007.04.062; Vijaya L, 2008, OPHTHALMOLOGY, V115, P655, DOI 10.1016/j.ophtha.2007.05.034; Vongphanit J, 2002, OPHTHALMOLOGY, V109, P704, DOI 10.1016/S0161-6420(01)01024-7; Wang YX, 2010, AM J OPHTHALMOL, V150, P917, DOI 10.1016/j.ajo.2010.06.037; Wensor MD, 1998, OPHTHALMOLOGY, V105, P733, DOI 10.1016/S0161-6420(98)94031-3; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050; Xu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030104; Yamamoto T, 2005, OPHTHALMOLOGY, V112, P1661, DOI 10.1016/j.ophtha.2005.05.012; Zheng YF, 2010, INVEST OPHTH VIS SCI, V51, P2998, DOI 10.1167/iovs.09-4470	63	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76434	10.1371/journal.pone.0076434	http://dx.doi.org/10.1371/journal.pone.0076434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098790	gold, Green Published, Green Submitted			2022-12-25	WOS:000325423500161
J	Souza, C; Davis, WC; Eckstein, TM; Sreevatsan, S; Weiss, DJ				Souza, Cleverson; Davis, William C.; Eckstein, Torsten M.; Sreevatsan, Srinand; Weiss, Douglas J.			Mannosylated Lipoarabinomannans from Mycobacterium Avium Subsp Paratuberculosis Alters the Inflammatory Response by Bovine Macrophages and Suppresses Killing of Mycobacterium Avium Subsp Avium Organisms	PLOS ONE			English	Article							MONONUCLEAR PHAGOCYTES; DIFFERENTIAL RESPONSES; TUBERCULOSIS; INTERLEUKIN-10; RECRUITMENT; PHAGOSOMES; INDUCTION; PATHWAY	Analysis of the mechanisms through which pathogenic mycobacteria interfere with macrophage activation and phagosome maturation have shown that engagement of specific membrane receptors with bacterial ligands is the initiating event. Mannosylated lipoarabinomannan (Man-LAM) has been identified as one of the ligands that modulates macrophage function. We evaluated the effects of Man-LAM derived from Mycobacterium avium subsp. paratuberculosis (MAP) on bovine macrophages. Man-LAM induced a rapid and prolonged expression of IL-10 message as well as transient expression of TNF-alpha. Preincubation with Man-LAM for up to 16 h did not suppress expression of IL-12 in response to interferon-gamma. Evaluation of the effect of Man-LAM on phagosome acidification, phagosome maturation, and killing of Mycobacterium avium subsp. avium (MAA) showed that preincubation of macrophages with Man-LAM before addition of MAA inhibited phagosome acidification, phagolysosome fusion, and reduced killing. Analysis of signaling pathways provided indirect evidence that inhibition of killing was associated with activation of the MAPK-p38 signaling pathway but not the pathway involved in regulation of expression of IL-10. These results support the hypothesis that MAP Man-LAM is one of the virulence factors facilitating survival of MAP in macrophages.	[Souza, Cleverson] Washington State Univ, Dept Vet Clin Sci, Pullman, WA 99164 USA; [Davis, William C.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Eckstein, Torsten M.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Sreevatsan, Srinand] Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA; [Weiss, Douglas J.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA	Washington State University; Washington State University; Colorado State University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Souza, C (corresponding author), Washington State Univ, Dept Vet Clin Sci, Pullman, WA 99164 USA.	souza@vetmed.wsu.edu	Sreevatsan, Srinand/V-6808-2019	Sreevatsan, Srinand/0000-0002-5162-2403	United States Department of Agriculture [CSREES-NRI 2004-35605-14243, CSREES-NRI 2005-35204-16198]	United States Department of Agriculture(United States Department of Agriculture (USDA))	This research was supported through United States Department of Agriculture grants CSREES-NRI 2004-35605-14243 and CSREES-NRI 2005-35204-16198. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2001, CLIN DIAGN LAB IMMUN, V8, P460, DOI 10.1128/CDLI.8.2.460-464.2001; Appelmelk BJ, 2008, CELL MICROBIOL, V10, P930, DOI 10.1111/j.1462-5822.2007.01097.x; Bernardo J, 1998, INFECT IMMUN, V66, P28, DOI 10.1128/IAI.66.1.28-35.1998; Deretic V, 1999, MOL MICROBIOL, V31, P1603, DOI 10.1046/j.1365-2958.1999.01279.x; Doz E, 2007, J BIOL CHEM, V282, P26014, DOI 10.1074/jbc.M702690200; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Fratti RA, 2003, J BIOL CHEM, V278, P46961, DOI 10.1074/jbc.M305225200; Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100; Gomes MS, 1999, INFECT IMMUN, V67, P3199, DOI 10.1128/IAI.67.7.3199-3206.1999; KHOO KH, 1995, J BIOL CHEM, V270, P12380, DOI 10.1074/jbc.270.21.12380; Kwong LS, 2002, VET IMMUNOL IMMUNOP, V85, P213, DOI 10.1016/S0165-2427(02)00007-7; Maiti D, 2001, J BIOL CHEM, V276, P329, DOI 10.1074/jbc.M002650200; Majumder N, 2008, SCAND J IMMUNOL, V67, P329, DOI 10.1111/j.1365-3083.2008.02070.x; Miller BH, 2004, INFECT IMMUN, V72, P2872, DOI 10.1128/IAI.72.5.2872-2878.2004; Nigou J, 2002, MICROBES INFECT, V4, P945, DOI 10.1016/S1286-4579(02)01621-0; Nigou J, 2001, J IMMUNOL, V166, P7477, DOI 10.4049/jimmunol.166.12.7477; Pathak SK, 2005, J BIOL CHEM, V280, P42794, DOI 10.1074/jbc.M506471200; ROACH TIA, 1995, IMMUNOLOGY, V85, P106; Souza CD, 2007, MICROBES INFECT, V9, P1545, DOI 10.1016/j.micinf.2007.08.008; Souza CD, 2006, MICROB PATHOGENESIS, V41, P59, DOI 10.1016/j.micpath.2006.04.002; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Vergne I, 2004, MOL BIOL CELL, V15, P751, DOI 10.1091/mbc.E03-05-0307; Weiss DJ, 2005, AM J VET RES, V66, P721, DOI 10.2460/ajvr.2005.66.721; Weiss DJ, 2002, INFECT IMMUN, V70, P5556, DOI 10.1128/IAI.70.10.5556-5561.2002; Weiss DJ, 2008, J LEUKOCYTE BIOL, V83, P48, DOI 10.1189/jlb.0707490; Wells SJ, 2006, CLIN VACCINE IMMUNOL, V13, P1125, DOI 10.1128/CVI.00236-06	26	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75924	10.1371/journal.pone.0075924	http://dx.doi.org/10.1371/journal.pone.0075924			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098744	Green Published, gold, Green Submitted			2022-12-25	WOS:000325423500114
J	Proctor, CJ; Boche, D; Gray, DA; Nicoll, JAR				Proctor, Carole J.; Boche, Delphine; Gray, Douglas A.; Nicoll, James A. R.			Investigating Interventions in Alzheimer's Disease with Computer Simulation Models	PLOS ONE			English	Article							AMYLOID-BETA-PEPTIDE; GLYCOGEN-SYNTHASE KINASE-3-BETA; IN-VITRO GROWTH; A-BETA; HYPERPHOSPHORYLATED-TAU; MATHEMATICAL-MODEL; TRANSGENIC MODEL; SENILE PLAQUES; FIBRIL GROWTH; IMMUNIZATION	Progress in the development of therapeutic interventions to treat or slow the progression of Alzheimer's disease has been hampered by lack of efficacy and unforeseen side effects in human clinical trials. This setback highlights the need for new approaches for pre-clinical testing of possible interventions. Systems modelling is becoming increasingly recognised as a valuable tool for investigating molecular and cellular mechanisms involved in ageing and age-related diseases. However, there is still a lack of awareness of modelling approaches in many areas of biomedical research. We previously developed a stochastic computer model to examine some of the key pathways involved in the aggregation of amyloid-beta (A beta) and the micro-tubular binding protein tau. Here we show how we extended this model to include the main processes involved in passive and active immunisation against A beta and then demonstrate the effects of this intervention on soluble A beta, plaques, phosphorylated tau and tangles. The model predicts that immunisation leads to clearance of plaques but only results in small reductions in levels of soluble A beta, phosphorylated tau and tangles. The behaviour of this model is supported by neuropathological observations in Alzheimer patients immunised against A beta. Since, soluble A beta, phosphorylated tau and tangles more closely correlate with cognitive decline than plaques, our model suggests that immunotherapy against A beta may not be effective unless it is performed very early in the disease process or combined with other therapies.	[Proctor, Carole J.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Boche, Delphine; Nicoll, James A. R.] Univ Southampton, Southampton, Hants, England; [Gray, Douglas A.] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Gray, Douglas A.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	Newcastle University - UK; University of Southampton; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Proctor, CJ (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	carole.proctor@ncl.ac.uk	Boche, Delphine/K-9954-2019; Boche, Delphine/A-7589-2011; Nicoll, James/I-9253-2017; /U-3554-2018	Boche, Delphine/0000-0002-5884-130X; Boche, Delphine/0000-0002-5884-130X; Nicoll, James/0000-0002-9444-7246; /0000-0002-8634-4984; Proctor, Carole/0000-0002-1366-1399	Alzheimer Scotland; Alzheimer's Research UK [ART-RF2008-3]; BBSRC; Canadian Institutes of Health Research; Canadian Cancer Society Research Institute; Cancer Research Society, Inc.; MRC [G0501033] Funding Source: UKRI; Alzheimers Research UK [ART-ESG2005-3, ART-PG2006-4, ART-RF2008-3] Funding Source: researchfish; Medical Research Council [G0501033] Funding Source: researchfish	Alzheimer Scotland; Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Cancer Research Society, Inc.; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Dr. Carole Proctor built the model whilst funded by Alzheimer Scotland and Alzheimer's Research UK (http://www.alzscot.org/; http://www.alzheimersresearchuk.org/), (Grant Ref: ART-RF2008-3). The work was taken forward within the research context of the Centre for Integrated Systems Biology of Ageing and Nutrition (initially funded by BBSRC) and the UK NIHR Biomedical Research Centre for Ageing and Age-related Disease award to the Newcastle upon Tyne Foundation Hospitals NHS Trust. Dr. Douglas Gray is funded by the Canadian Institutes of Health Research, the Canadian Cancer Society Research Institute, and the Cancer Research Society, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez G, 1999, FEBS LETT, V453, P260, DOI 10.1016/S0014-5793(99)00685-7; Ardiles AO, 2012, P NATL ACAD SCI USA, V109, P13835, DOI 10.1073/pnas.1201209109; Baker AM, 2011, NEUROPATH APPL NEURO, V37, P33; Bales KR, 2012, EXPERT OPIN DRUG DIS, V7, P281, DOI 10.1517/17460441.2012.666234; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bayer AJ, 2005, NEUROLOGY, V64, P94, DOI 10.1212/01.WNL.0000148604.77591.67; Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011; Boche D, 2010, ACTA NEUROPATHOL, V120, P369, DOI 10.1007/s00401-010-0719-5; Boche D, 2010, ACTA NEUROPATHOL, V120, P13, DOI 10.1007/s00401-010-0705-y; Chaves RS, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-144; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Craft DL, 2002, B MATH BIOL, V64, P1011, DOI 10.1006/bulm.2002.0304; Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160; Cruz L, 1997, P NATL ACAD SCI USA, V94, P7612, DOI 10.1073/pnas.94.14.7612; Dodel RC, 2003, LANCET NEUROL, V2, P215, DOI 10.1016/S1474-4422(03)00349-1; Dolan PJ, 2010, CURR OPIN DRUG DISC, V13, P595; Esler WP, 1996, BIOCHEMISTRY-US, V35, P749, DOI 10.1021/bi951685w; Gendron TF, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-13; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Giovanna C, 2010, AMINO ACIDS, V38, P1101, DOI 10.1007/s00726-009-0319-7; Gomez-Sintes R, 2010, J CLIN INVEST, V120, P2432, DOI 10.1172/JCI37873; GONG CX, 1994, NEUROSCIENCE, V61, P765, DOI 10.1016/0306-4522(94)90400-6; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x; Hooper C, 2007, NEUROSCI LETT, V418, P34, DOI 10.1016/j.neulet.2007.03.026; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017668; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; HYMAN BT, 1993, J NEUROPATH EXP NEUR, V52, P594, DOI 10.1097/00005072-199311000-00006; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Jucker M, 2010, NAT MED, V16, P1210, DOI 10.1038/nm.2224; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kim JR, 2004, PROTEIN SCI, V13, P2888, DOI 10.1110/ps.04847404; Lannfelt L, 2008, LANCET NEUROL, V7, P779, DOI 10.1016/S1474-4422(08)70167-4; Le Novere N, 2006, NUCLEIC ACIDS RES, V34, pD689, DOI 10.1093/nar/gkj092; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Maarouf CL, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-39; MAGGIO JE, 1992, P NATL ACAD SCI USA, V89, P5462, DOI 10.1073/pnas.89.12.5462; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; McDonald DR, 1997, J NEUROSCI, V17, P2284; Miners JS, 2011, J NEUROPATH EXP NEUR, V70, P944, DOI 10.1097/NEN.0b013e3182345e46; MORRIS JC, 1991, NEUROLOGY, V41, P469, DOI 10.1212/WNL.41.4.469; NAGY Z, 1995, DEMENTIA, V6, P21, DOI 10.1159/000106918; Nelson PT, 2009, J NEUROPATH EXP NEUR, V68, P774, DOI 10.1097/NEN.0b013e3181aacbe9; Nicoll JAR, 2006, J NEUROPATH EXP NEUR, V65, P1040, DOI 10.1097/01.jnen.0000240466.10758.ce; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Ohyagi Y, 2004, FASEB J; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Pallitto MM, 2001, BIOPHYS J, V81, P1805, DOI 10.1016/S0006-3495(01)75831-6; Parihar MS, 2010, J ALZHEIMERS DIS, V22, P741, DOI 10.3233/JAD-2010-101020; Patton RL, 2006, AM J PATHOL, V169, P1048, DOI 10.2353/ajpath.2006.060269; PERLMUTTER LS, 1990, NEUROSCI LETT, V119, P32, DOI 10.1016/0304-3940(90)90748-X; Proctor CJ, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-32; Proctor CJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-7; Proctor CJ, 2012, INT J ALZHEIMERS DIS, V2012; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Rockenstein E, 2007, J NEUROSCI, V27, P1981, DOI 10.1523/JNEUROSCI.4321-06.2007; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; Sato K, 2012, J NEUROSCI RES, V90, P870, DOI 10.1002/jnr.22796; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Serrano-Pozo A, 2010, BRAIN, V133, P1312, DOI 10.1093/brain/awq056; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Small SA, 2008, NEURON, V60, P534, DOI 10.1016/j.neuron.2008.11.007; Solomon B, 1997, P NATL ACAD SCI USA, V94, P4109, DOI 10.1073/pnas.94.8.4109; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P367, DOI 10.1016/j.jalz.2011.05.2351; Tang X, 2007, ONCOGENE, V26, P7302, DOI 10.1038/sj.onc.1210542; Tseng BP, 2008, NEUROBIOL AGING, V29, P1607, DOI 10.1016/j.neurobiolaging.2007.04.014; Tseng BP, 1999, BIOCHEMISTRY-US, V38, P10424, DOI 10.1021/bi990718v; Watcharasit P, 2003, J BIOL CHEM, V278, P48872, DOI 10.1074/jbc.M305870200; Watcharasit P, 2002, P NATL ACAD SCI USA, V99, P7951, DOI 10.1073/pnas.122062299; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilcock DM, 2003, J NEUROSCI, V23, P3745, DOI 10.1523/jneurosci.23-09-03745.2003; WILCOCK GK, 1982, J NEUROL SCI, V56, P343, DOI 10.1016/0022-510X(82)90155-1; Wilkinso D.J., 2006, STOCHASTIC MODELLING; Zotova E, 2011, NEUROPATHOL APPL NEU	86	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e73631	10.1371/journal.pone.0073631	http://dx.doi.org/10.1371/journal.pone.0073631			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24098635	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000324494000042
J	Oyewole, AO; Wilmot, MC; Fowler, M; Birch-Machin, MA				Oyewole, Anne O.; Wilmot, Marie-Claire; Fowler, Mark; Birch-Machin, Mark A.			Comparing the effects of mitochondrial targeted and localized antioxidants with cellular antioxidants in human skin cells exposed to UVA and hydrogen peroxide	FASEB JOURNAL			English	Article						DNA damage; mitochondria; ultraviolet radiation; reactive oxygen species; ROS; Nrf2	IRON REGULATORY PROTEIN-1; INDUCED OXIDATIVE STRESS; ENDOPLASMIC-RETICULUM STRESS; FREE-RADICAL GENERATION; GREEN TEA POLYPHENOL; DNA-DAMAGE; DERMAL FIBROBLASTS; VISIBLE RADIATION; BETA-CAROTENE; HACAT CELLS	Skin cancer and aging are linked to increased cellular reactive oxygen species (ROS), particularly following exposure to ultraviolet A (UVA) in sunlight. As mitochondria are the main source of cellular ROS, this study compared the protective effects of mitochondria-targeted and -localized antioxidants (MitoQ and tiron, respectively) with cellular antioxidants against oxidative stress-induced [UVA and hydrogen peroxide (H2O2)] mitochondrial DNA (mtDNA) damage in human dermal fibroblasts. With the use of a long quantitative PCR assay, tiron (EC50 10 mM) was found to confer complete (100%) protection (P<0.001) against both UVA- and H2O2-induced mtDNA damage, whereas MitoQ (EC50 750 nM) provided less protection (17 and 32%, respectively; P<0.05). This particular protective effect of tiron was greater than a range of cellular antioxidants investigated. The nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway provides cellular protection against oxidative stress. An ELISA assay for the Nrf2 target gene heme oxygenase-1 (HO-1) and studies using Nrf2 small interfering RNA both indicated that tiron's mode of action was Nrf2 independent. The comet assay showed that tiron's protective effect against H2O2-induced nuclear DNA damage was greater than the cellular antioxidants and MitoQ (P<0.001). This study provides a platform to investigate molecules with similar structure to tiron as potent and clinically relevant antioxidants.Oyewole, A. O., Wilmot, M.-C., Fowler, M., Birch-Machin, M. A. Comparing the effects of mitochondrial targeted and localized antioxidants with cellular antioxidants in human skin cells exposed to UVA and hydrogen peroxide.	[Oyewole, Anne O.; Wilmot, Marie-Claire; Birch-Machin, Mark A.] Newcastle Univ, Sch Med, Inst Cellular Med, Dept Dermatol Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Fowler, Mark] Unilever Res & Dev Colworth, Sharnbrook, Beds, England	Newcastle University - UK; Unilever	Birch-Machin, MA (corresponding author), Newcastle Univ, Sch Med, Inst Cellular Med, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	m.a.birch-machin@ncl.ac.uk			Biotechnology and Biological Sciences Research Council (BBSRC);  [Unilever]	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); 	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC; BBSRC CASE award with Unilever). The authors thank Dr. Jane Armstrong and Dr. Elaine Mutch (both Newcastle University) for their scientific expertise. The authors declare no conflicts of interest.	Agar NS, 2004, P NATL ACAD SCI USA, V101, P4954, DOI 10.1073/pnas.0401141101; Aitken GR, 2007, CLIN EXP DERMATOL, V32, P722, DOI 10.1111/j.1365-2230.2007.02474.x; Armstrong JL, 2010, J BIOL CHEM, V285, P6091, DOI 10.1074/jbc.M109.014092; Aroun A, 2012, PHOTOCH PHOTOBIO SCI, V11, P118, DOI 10.1039/c1pp05204g; Atherton KM, 2009, BIOMARKERS, V14, P443, DOI 10.3109/13547500903137265; Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619; Basu-Modak S, 2006, FREE RADICAL BIO MED, V41, P1197, DOI 10.1016/j.freeradbiomed.2006.06.008; Bergstrom P, 2011, NEUROPHARMACOLOGY, V60, P343, DOI 10.1016/j.neuropharm.2010.09.023; Berneburg M, 1999, J BIOL CHEM, V274, P15345, DOI 10.1074/jbc.274.22.15345; Berneburg M, 1997, PHOTOCHEM PHOTOBIOL, V66, P271, DOI 10.1111/j.1751-1097.1997.tb08654.x; Birch-Machin MA, 1998, J INVEST DERMATOL, V110, P149, DOI 10.1046/j.1523-1747.1998.00099.x; Birch-Machin M, 2009, MUTAGENESIS, V24, P101; Brazzolotto X, 1999, J BIOL CHEM, V274, P21625, DOI 10.1074/jbc.274.31.21625; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Cantu D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007095; Chan WH, 2003, J CELL BIOCHEM, V90, P327, DOI 10.1002/jcb.10638; Corazzari M, 2007, BRIT J CANCER, V96, P1062, DOI 10.1038/sj.bjc.6603672; Delaval E, 2004, EUR J BIOCHEM, V271, P4559, DOI 10.1111/j.1432-1033.2004.04422.x; Diffey BL, 2002, METHODS, V28, P4, DOI 10.1016/S1046-2023(02)00204-9; Durham SE, 2003, BRIT J CANCER, V88, P90, DOI 10.1038/sj.bjc.6600773; Eicker J, 2003, PHOTOCH PHOTOBIO SCI, V2, P655, DOI 10.1039/b300808h; Fang Y, 2012, AUSTRALAS J DERMATOL, V53, P172, DOI 10.1111/j.1440-0960.2012.00912.x; Giordani A, 1998, PHOTOCHEM PHOTOBIOL, V68, P309, DOI 10.1111/j.1751-1097.1998.tb09686.x; Giordani A, 2000, PHOTOCHEM PHOTOBIOL, V72, P746, DOI 10.1562/0031-8655(2000)072<0746:IOIREB>2.0.CO;2; Heinrich U, 2003, J NUTR, V133, P98, DOI 10.1093/jn/133.1.98; Henderson JR, 2009, FREE RADICAL RES, V43, P796, DOI 10.1080/10715760903062895; Hirota A, 2011, EXP DERMATOL, V20, P664, DOI 10.1111/j.1600-0625.2011.01292.x; Hseu YC, 2012, FOOD CHEM TOXICOL, V50, P1245, DOI 10.1016/j.fct.2012.02.020; Huang XX, 2009, AM J PATHOL, V174, P1534, DOI 10.2353/ajpath.2009.080318; James AM, 2005, J BIOL CHEM, V280, P21295, DOI 10.1074/jbc.M501527200; James AM, 2007, J BIOL CHEM, V282, P14708, DOI 10.1074/jbc.M611463200; Jian Z, 2011, J INVEST DERMATOL, V131, P1420, DOI 10.1038/jid.2011.56; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Kensler TW, 2013, TOP CURR CHEM, V329, P163, DOI 10.1007/128_2012_339; KRISHNA CM, 1992, ARCH BIOCHEM BIOPHYS, V294, P98, DOI 10.1016/0003-9861(92)90142-J; Krishnan KJ, 2006, J INVEST DERMATOL, V126, P408, DOI 10.1038/sj.jid.5700099; Krishnan KJ, 2004, J INVEST DERMATOL, V123, P1020, DOI 10.1111/j.0022-202X.2004.23457.x; Kruszewski M, 2003, MUTAT RES-FUND MOL M, V531, P81, DOI 10.1016/j.mrfmmm.2003.08.004; Li Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030186, 10.1371/journal.pone.0029003, 10.1371/journal.pone.0042558, 10.1371/journal.pone.0030835, 10.1371/journal.pone.0044441, 10.1371/journal.pone.0035543, 10.1371/journal.pone.0035122]; Liu Y, 2011, EUR J PHARMACOL, V650, P130, DOI 10.1016/j.ejphar.2010.10.009; Lloyd J. J., 2006, ULTRAVIOLET RAD MED, V6; Ma YS, 2009, BBA-GEN SUBJECTS, V1790, P1021, DOI 10.1016/j.bbagen.2009.04.012; Marrot L, 2008, PIGM CELL MELANOMA R, V21, P79, DOI 10.1111/j.1755-148X.2007.00424.x; McArdle F, 2005, FREE RADICAL BIO MED, V39, P651, DOI 10.1016/j.freeradbiomed.2005.04.010; McKinlay AF., 1987, CIE J, P83; Meewes C, 2001, FREE RADICAL BIO MED, V30, P238, DOI 10.1016/S0891-5849(00)00463-9; Morley N, 2005, PHOTODERMATOL PHOTO, V21, P15, DOI 10.1111/j.1600-0781.2005.00119.x; Morley N, 2003, J PHOTOCH PHOTOBIO B, V72, P55, DOI 10.1016/j.jphotobiol.2003.06.004; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Offord EA, 2002, FREE RADICAL BIO MED, V32, P1293, DOI 10.1016/S0891-5849(02)00831-6; Otterbein LE, 2000, AM J PHYSIOL-LUNG C, V279, pL1029, DOI 10.1152/ajplung.2000.279.6.L1029; Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110; Pourzand C, 1999, P NATL ACAD SCI USA, V96, P6751, DOI 10.1073/pnas.96.12.6751; Pygmalion MJ, 2010, FREE RADICAL BIO MED, V49, P1629, DOI 10.1016/j.freeradbiomed.2010.08.009; Rizwan M, 2011, BRIT J DERMATOL, V164, P154, DOI 10.1111/j.1365-2133.2010.10057.x; Sakurai H, 2005, PHOTOCH PHOTOBIO SCI, V4, P715, DOI 10.1039/b417319h; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Silveira LR, 2003, FREE RADICAL BIO MED, V35, P455, DOI 10.1016/S0891-5849(03)00271-5; Sood A, 2011, NAT NANOTECHNOL, V6, P824, DOI [10.1038/nnano.2011.188, 10.1038/NNANO.2011.188]; Stewart MS, 1996, J INVEST DERMATOL, V106, P1086, DOI 10.1111/1523-1747.ep12339344; Supinski G, 1999, J APPL PHYSIOL, V87, P2177, DOI 10.1152/jappl.1999.87.6.2177; Swalwell H, 2012, FREE RADICAL BIO MED, V52, P626, DOI 10.1016/j.freeradbiomed.2011.11.019; Talalay P, 2007, P NATL ACAD SCI USA, V104, P17500, DOI 10.1073/pnas.0708710104; Tobi SE, 2002, INT J CANCER, V102, P439, DOI 10.1002/ijc.10730; Tulah AS, 2013, MITOCHONDRION, V13, P444, DOI 10.1016/j.mito.2012.11.007; Ungvari Z, 2010, AM J PHYSIOL-HEART C, V299, pH18, DOI 10.1152/ajpheart.00260.2010; Wang N, 2012, DIGEST DIS SCI, V57, P1792, DOI 10.1007/s10620-012-2094-7; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168; Yarian CS, 2006, MECH AGEING DEV, V127, P79, DOI 10.1016/j.mad.2005.09.028; Yiakouvaki A, 2006, J INVEST DERMATOL, V126, P2287, DOI 10.1038/sj.jid.5700373; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; Zhong JL, 2004, J INVEST DERMATOL, V123, P771, DOI 10.1111/j.0022-202X.2004.23419.x; Zhong JL, 2010, PHOTOCH PHOTOBIO SCI, V9, P18, DOI 10.1039/b9pp00068b	73	58	60	0	33	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					485	494		10.1096/fj.13-237008	http://dx.doi.org/10.1096/fj.13-237008			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24115050				2022-12-25	WOS:000333526100045
J	Dumarieh, R; D'Antonio, J; Deliz-Liang, A; Smirnova, T; Svistunenko, DA; Ghiladi, RA				Dumarieh, Rania; D'Antonio, Jennifer; Deliz-Liang, Alexandria; Smirnova, Tatyana; Svistunenko, Dimitri A.; Ghiladi, Reza A.			Tyrosyl Radicals in Dehaloperoxidase HOW NATURE DEALS WITH EVOLVING AN OXYGEN-BINDING GLOBIN TO A BIOLOGICALLY RELEVANT PEROXIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hemoglobin; Iron; Peroxidase; Radicals; Tyrosine; Compound ES; Compound I; Compound II; Dehaloperoxidase; Ferryl	AMPHITRITE-ORNATA DEHALOPEROXIDASE; CATALASE-PEROXIDASE KATG; NOTOMASTUS-LOBATUS CHLOROPEROXIDASE; TRP CROSS-LINK; COMPOUND-I; HORSERADISH-PEROXIDASE; DISTAL HISTIDINE; SPECTROSCOPIC CHARACTERIZATION; OXIDATIVE DEHALOGENATION; ELECTRONIC-STRUCTURE	Dehaloperoxidase (DHP) from Amphitrite ornata, having been shown to catalyze the hydrogen peroxide-dependent oxidation of trihalophenols to dihaloquinones, is the first oxygen binding globin that possesses a biologically relevant peroxidase activity. The catalytically competent species in DHP appears to be Compound ES, a reactive intermediate that contains both a ferryl heme and a tyrosyl radical. By simulating the EPR spectra of DHP activated by H2O2, Thompson et al. (Thompson, M. K., Franzen, S., Ghiladi, R. A., Reeder, B. J., and Svistunenko, D. A. (2010) J. Am. Chem. Soc. 132, 17501-17510) proposed that two different radicals, depending on the pH, are formed, one located on either Tyr-34 or Tyr-28 and the other on Tyr-38. To provide additional support for these simulation-based assignments and to deduce the role(s) that tyrosyl radicals play in DHP, stopped-flow UV-visible and rapid-freeze-quench EPR spectroscopic methods were employed to study radical formation in DHP when three tyrosine residues, Tyr-28, Tyr-34, and Tyr-38, were replaced either individually or in combination with phenylalanines. The results indicate that radicals form on all three tyrosines in DHP. Evidence for the formation of DHP Compound I in several tyrosine mutants was obtained. Variants that formed Compound I showed an increase in the catalytic rate for substrate oxidation but also an increase in heme bleaching, suggesting that the tyrosines are necessary for protecting the enzyme from oxidizing itself. This protective role of tyrosines is likely an evolutionary adaptation allowing DHP to avoid self-inflicted damage in the oxidative environment.	[Dumarieh, Rania; D'Antonio, Jennifer; Deliz-Liang, Alexandria; Smirnova, Tatyana; Ghiladi, Reza A.] N Carolina State Univ, Dept Chem, Raleigh, NC 27695 USA; [Svistunenko, Dimitri A.] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England	University of North Carolina; North Carolina State University; University of Essex	Svistunenko, DA (corresponding author), Univ Essex, Sch Biol Sci, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England.	svist@essex.ac.uk; Reza_Ghiladi@ncsu.edu	Ghiladi, Reza/J-8492-2017	Ghiladi, Reza/0000-0002-6450-9311; Liang, Alexandria Deliz/0000-0002-9897-2822; Svistunenko, Dimitri/0000-0001-8060-2738; Smirnova, Tatyana/0000-0001-7867-7116	National Institutes of Health [S10RR023614]; National Science Foundation [CHE-0840501]; North Carolina Biotechnology Center [2009-IDG-1015]; Division Of Chemistry [1150709] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); North Carolina Biotechnology Center; Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	EPR instrumentation employed in this work was supported by National Institutes of Health Grant S10RR023614, National Science Foundation Grant CHE-0840501, and North Carolina Biotechnology Center Grant 2009-IDG-1015. Mass spectra were obtained at the Mass Spectrometry Facility for Biotechnology at North Carolina State University. Partial funding for the facility was obtained from the North Carolina Biotechnology Center and the National Science Foundation.	ADEDIRAN SA, 1984, J PROTEIN CHEM, V3, P437, DOI 10.1007/BF01025062; Ayala M, 2007, BIOCHEM BIOPH RES CO, V357, P804, DOI 10.1016/j.bbrc.2007.04.020; Battistuzzi G, 2007, J BIOL INORG CHEM, V12, P951, DOI 10.1007/s00775-007-0267-1; Battistuzzi G, 2006, BIOCHEMISTRY-US, V45, P12750, DOI 10.1021/bi061647k; BEERS RF, 1952, J BIOL CHEM, V195, P133; Belyea J, 2006, BIOCHEMISTRY-US, V45, P14275, DOI 10.1021/bi0609218; CHEN YP, 1991, J BIOL CHEM, V266, P23909; Chen YP, 1996, J BIOL CHEM, V271, P4609; Chen Z, 2009, ACTA CRYSTALLOGR D, V65, P34, DOI 10.1107/S0907444908036548; CHIANCONE E, 1981, BIOCHIM BIOPHYS ACTA, V670, P84, DOI 10.1016/0005-2795(81)90052-0; CHIANCONE E, 1980, BIOCHIM BIOPHYS ACTA, V623, P146, DOI 10.1016/0005-2795(80)90017-3; Chouchane S, 2003, J BIOL CHEM, V278, P8154, DOI 10.1074/jbc.M208256200; Conant JB, 1932, J BIOL CHEM, V98, P0057; D'Antonio EL, 2012, J ELECTROANAL CHEM, V668, P37, DOI 10.1016/j.jelechem.2011.12.015; D'Antonio J, 2011, BIOCHEMISTRY-US, V50, P5999, DOI 10.1021/bi200311u; D'Antonio J, 2010, BIOCHEMISTRY-US, V49, P6600, DOI 10.1021/bi100407v; Davis MF, 2009, BIOCHEMISTRY-US, V48, P2164, DOI 10.1021/bi801568s; Davydov R, 2010, J AM CHEM SOC, V132, P14995, DOI 10.1021/ja1059747; de Serrano V, 2007, ACTA CRYSTALLOGR D, V63, P1094, DOI 10.1107/S0907444907043417; de Serrano V, 2010, ACTA CRYSTALLOGR D, V66, P529, DOI 10.1107/S0907444910004580; DEFELIPPIS MR, 1989, BIOCHEMISTRY-US, V28, P4847, DOI 10.1021/bi00437a049; Du J, 2010, BIOCHEMISTRY-US, V49, P6064, DOI 10.1021/bi100741z; Egawa T, 2000, J BIOL CHEM, V275, P34858, DOI 10.1074/jbc.M004026200; FARHANGRAZI ZS, 1994, BIOCHEMISTRY-US, V33, P5647, DOI 10.1021/bi00184a038; Feducia J, 2009, BIOCHEMISTRY-US, V48, P995, DOI 10.1021/bi801916j; FIELMAN KT, 1995, MAR ECOL PROG SER, V116, P125, DOI 10.3354/meps116125; Franzen S, 2007, BBA-PROTEINS PROTEOM, V1774, P121, DOI 10.1016/j.bbapap.2006.09.019; Franzen S, 2006, BIOCHEMISTRY-US, V45, P9085, DOI 10.1021/bi060020z; Franzen S, 2006, J PHYS CHEM B, V110, P14483, DOI 10.1021/jp056790m; Franzen S, 2012, BBA-PROTEINS PROTEOM, V1824, P578, DOI 10.1016/j.bbapap.2011.12.008; Ghiladi RA, 2005, BIOCHEMISTRY-US, V44, P15093, DOI 10.1021/bi051463q; Ghiladi RA, 2005, J AM CHEM SOC, V127, P13428, DOI 10.1021/ja054366t; Ghiladi RA, 2005, J BIOL CHEM, V280, P22651, DOI 10.1074/jbc.M502486200; GOODIN DB, 1993, BIOCHEMISTRY-US, V32, P3313, DOI 10.1021/bi00064a014; Han KP, 2001, MAR BIOTECHNOL, V3, P287, DOI 10.1007/s10126-001-0003-8; Heineman W. R., 1979, J ELECTROANAL CHEM, V104, P577; HEWSON WD, 1979, J BIOL CHEM, V254, P3182; KING GM, 1986, NATURE, V323, P257, DOI 10.1038/323257a0; LaCount MW, 2000, J BIOL CHEM, V275, P18712, DOI 10.1074/jbc.M001194200; Lebioda L, 1999, NATURE, V401, P445, DOI 10.1038/46728; Lincoln DE, 2005, BIOCHEM SYST ECOL, V33, P559, DOI 10.1016/j.bse.2004.12.006; Ma HA, 2010, J PHYS CHEM B, V114, P13823, DOI 10.1021/jp1014516; MARANON MJR, 1994, BIOCHEM J, V301, P335, DOI 10.1042/bj3010335; Matsui T, 1997, J BIOL CHEM, V272, P32735, DOI 10.1074/jbc.272.52.32735; McKinley AB, 2004, SPECTROSC LETT, V37, P275, DOI 10.1081/SL-120038763; Miksovska J, 2008, BIOCHEMISTRY-US, V47, P11510, DOI 10.1021/bi8012033; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nicoletti FP, 2010, BIOCHEMISTRY-US, V49, P1903, DOI 10.1021/bi9020567; Nienhaus K, 2008, BIOCHEMISTRY-US, V47, P12985, DOI 10.1021/bi801564r; Nilges M. J., 2007, ESR SPECTROSCOPY MEM, P379; Nissum M, 2001, BBA-PROTEIN STRUCT M, V1545, P339, DOI 10.1016/S0167-4838(00)00295-8; Osborne RL, 2004, BIOCHEM BIOPH RES CO, V324, P1194, DOI 10.1016/j.bbrc.2004.09.174; Osborne RL, 2006, J AM CHEM SOC, V128, P1036, DOI 10.1021/ja056213b; Osborne RL, 2007, BIOCHEMISTRY-US, V46, P9823, DOI 10.1021/bi700684u; Osborne RL, 2006, J INORG BIOCHEM, V100, P1100, DOI 10.1016/j.jinorgbio.2006.02.008; Osborne RL, 2009, BIOCHEMISTRY-US, V48, P4231, DOI 10.1021/bi900367e; POULOS TL, 1980, J BIOL CHEM, V255, P8199; Reeder BJ, 2012, J AM CHEM SOC, V134, P7741, DOI 10.1021/ja211745g; Roach MP, 1997, BIOCHEMISTRY-US, V36, P2197, DOI 10.1021/bi9621371; Singh R, 2010, BIOCHEMISTRY-US, V49, P8857, DOI 10.1021/bi100499a; SIVARAJA M, 1989, SCIENCE, V245, P738, DOI 10.1126/science.2549632; Smirnova TI, 2008, J AM CHEM SOC, V130, P2128, DOI 10.1021/ja0772952; Svistunenko D, 2004, TYROSINE RESIDUES DI; Svistunenko DA, 2004, BIOPHYS J, V87, P582, DOI 10.1529/biophysj.104.041046; Tanaka M, 1997, BIOCHEMISTRY-US, V36, P9791, DOI 10.1021/bi9706172; Thompson MK, 2010, J AM CHEM SOC, V132, P17501, DOI 10.1021/ja106620q; Wang CX, 2013, BIOCHEMISTRY-US, V52, P6203, DOI 10.1021/bi400627w; WEBER RE, 1977, COMP BIOCHEM PHYS A, V56, P179, DOI 10.1016/0300-9629(77)90182-7; WOODIN SA, 1987, J EXP MAR BIOL ECOL, V107, P209, DOI 10.1016/0022-0981(87)90038-4; WOODIN SA, 1991, AM ZOOL, V31, P797; Zhang E, 1996, ACTA CRYSTALLOGR D, V52, P1191, DOI 10.1107/S0907444996007974; Zhao J, 2013, BIOCHEMISTRY-US, V52, P2427, DOI 10.1021/bi301307f	73	18	19	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33470	33482		10.1074/jbc.M113.496497	http://dx.doi.org/10.1074/jbc.M113.496497			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24100039	Green Published, hybrid			2022-12-25	WOS:000328841700059
J	Blagitko-Dorfs, N; Jiang, Y; Duque-Afonso, J; Hiller, J; Yalcin, A; Greve, G; Abdelkarim, M; Hackanson, B; Lubbert, M				Blagitko-Dorfs, Nadja; Jiang, Yi; Duque-Afonso, Jesus; Hiller, Jan; Yalcin, Arzu; Greve, Gabriele; Abdelkarim, Mahmoud; Hackanson, Bjoern; Luebbert, Michael			Epigenetic Priming of AML Blasts for All-trans Retinoic Acid-Induced Differentiation by the HDAC Class-I Selective Inhibitor Entinostat	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; ACUTE MYELOID-LEUKEMIA; RECEPTOR-BETA; OLDER PATIENTS; VALPROIC ACID; METHYLATION; MS-275; TRIAL; GENE; HYPERMETHYLATION	All-trans retinoic acid (ATRA) has only limited single agent activity in AML without the PML-RAR alpha fusion (non-M3 AML). In search of a sensitizing strategy to overcome this relative ATRA resistance, we investigated the potency of the HDAC class-I selective inhibitor entinostat in AML cell lines Kasumi-1 and HL-60 and primary AML blasts. Entinostat alone induced robust differentiation of both cell lines, which was enhanced by the combination with ATRA. This "priming'' effect on ATRA-induced differentiation was at least equivalent to that achieved with the DNA hypomethylating agent decitabine, and could overall be recapitulated in primary AML blasts treated ex vivo. Moreover, entinostat treatment established the activating chromatin marks acH3, acH3K9, acH4 and H3K4me3 at the promoter of the RAR beta 2 gene, an essential mediator of retinoic acid (RA) signaling in different solid tumor models. Similarly, RAR beta 2 promoter hypermethylation (which in primary blasts from 90 AML/MDS patients was surprisingly infrequent) could be partially reversed by decitabine in the two cell lines. Re-induction of the epigenetically silenced RAR beta 2 gene was achieved only when entinostat or decitabine were given prior to ATRA treatment. Thus in this model, reactivation of RAR beta 2 was not necessarily required for the differentiation effect, and pharmacological RAR beta 2 promoter demethylation may be a bystander phenomenon rather than an essential prerequisite for the cellular effects of decitabine when combined with ATRA. In conclusion, as a "priming'' agent for non-M3 AML blasts to the differentiation-inducing effects of ATRA, entinostat is at least as active as decitabine, and both act in part independently from RAR beta 2. Further investigation of this treatment combination in non-M3 AML patients is therefore warranted, independently of RAR beta 2 gene silencing by DNA methylation.	[Blagitko-Dorfs, Nadja; Jiang, Yi; Duque-Afonso, Jesus; Hiller, Jan; Yalcin, Arzu; Greve, Gabriele; Abdelkarim, Mahmoud; Hackanson, Bjoern; Luebbert, Michael] Univ Med Ctr Freiburg, Dept Hematol & Oncol, Freiburg, Germany; [Jiang, Yi] Shanghai Jiao Tong Univ, Sch Med, Dept Pathophysiol, Shanghai 200030, Peoples R China; [Duque-Afonso, Jesus] Stanford Univ, Med Ctr, Dept Pathol, Stanford, CA 94305 USA; [Yalcin, Arzu; Greve, Gabriele] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany	University of Freiburg; Shanghai Jiao Tong University; Stanford University; University of Freiburg	Lubbert, M (corresponding author), Univ Med Ctr Freiburg, Dept Hematol & Oncol, Freiburg, Germany.	michael.luebbert@uniklinik-freiburg.de			German Research Council [Lu 429/7-1]; CRC [992]; German Cancer Aid [108397]; German Carreras Leukemia Foundation [DJCLS R10/30f]	German Research Council(German Research Foundation (DFG)); CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); German Cancer Aid(Deutsche Krebshilfe); German Carreras Leukemia Foundation	This work was supported by the German Research Council Priority Programme 1463 (Lu 429/7-1), CRC 992 (ML), German Cancer Aid (grant 108397 to BH), German Carreras Leukemia Foundation (DJCLS R10/30f). JDA was participant in the Research Fellowship Program at the Department of Hematology and Oncology of the University of Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altucci L, 2001, NAT MED, V7, P680, DOI 10.1038/89050; Burnett AK, 2010, BLOOD, V115, P948, DOI 10.1182/blood-2009-08-236588; Cimino G, 2006, CANCER RES, V66, P8903, DOI 10.1158/0008-5472.CAN-05-2726; Claus R, 2012, EPIGENETICS-US, V7, P772, DOI 10.4161/epi.20299; Claus R, 2012, INT J CANCER, V131, pE138, DOI 10.1002/ijc.26429; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; Duque-Afonso J, 2011, ONCOGENE, V30, P3062, DOI 10.1038/onc.2011.32; Ekmekci CG, 2004, AM J HEMATOL, V77, P233, DOI 10.1002/ajh.20186; Fandy TE, 2009, BLOOD, V114, P2764, DOI 10.1182/blood-2009-02-203547; Fazi F, 2005, ONCOGENE, V24, P1820, DOI 10.1038/sj.onc.1208286; Fazi F, 2007, BLOOD, V109, P4432, DOI 10.1182/blood-2006-09-045781; Gojo I, 2007, BLOOD, V109, P2781, DOI 10.1182/blood-2006-05-021873; HOFFMANN B, 1990, MOL ENDOCRINOL, V4, P1727, DOI 10.1210/mend-4-11-1727; Idres N, 2002, J BIOL CHEM, V277, P31491, DOI 10.1074/jbc.M205016200; Juergens RA, 2011, CANCER DISCOV, V1, P598, DOI 10.1158/2159-8290.CD-11-0214; Kantarjian HM, 2012, J CLIN ONCOL, V30, P2670, DOI 10.1200/JCO.2011.38.9429; Klimek V, 2012, BLOOD, V120, P3815; Kuendgen A, 2005, ANN HEMATOL, V84, P61, DOI 10.1007/s00277-005-0026-8; Lavelle D, 2012, BLOOD, V119, P1240, DOI 10.1182/blood-2011-08-371690; Li C, 1998, CANCER LETT, V124, P205, DOI 10.1016/S0304-3835(97)00475-8; Lo-Coco F, 2013, NEW ENGL J MED, V369, P111, DOI 10.1056/NEJMoa1300874; Lubbert M, 2012, HAEMATOL-HEMATOL J, V97, P393, DOI 10.3324/haematol.2011.048231; Maggio SC, 2004, CANCER RES, V64, P2590, DOI 10.1158/0008-5472.CAN-03-2631; MATOZAKI S, 1995, BRIT J HAEMATOL, V89, P805; Moison C, 2013, FASEB J, V27, P1468, DOI 10.1096/fj.12-210971; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; Pili R, 2012, BRIT J CANCER, V106, P77, DOI 10.1038/bjc.2011.527; Prebet T, 2010, ASH ANN M, V116, P601; Raffoux E, 2010, ONCOTARGET, V1, P34, DOI 10.18632/oncotarget.106; Rethmeier A, 2006, BRIT J HAEMATOL, V133, P276, DOI 10.1111/j.1365-2141.2006.06014.x; Rosato RR, 2003, CANCER RES, V63, P3637; Schlenk RF, 2009, HAEMATOL-HEMATOL J, V94, P54, DOI 10.3324/haematol.13378; Sirchia SM, 2000, ONCOGENE, V19, P1556, DOI 10.1038/sj.onc.1203456; Sirchia SM, 2002, CANCER RES, V62, P2455; Smiraglia DJ, 2001, HUM MOL GENET, V10, P1413, DOI 10.1093/hmg/10.13.1413; Tabe Y, 2006, ANN HEMATOL, V85, P689, DOI 10.1007/s00277-006-0148-7; Tang XH, 2011, ANNU REV PATHOL-MECH, V6, P345, DOI 10.1146/annurev-pathol-011110-130303; Tost J, 2003, BIOTECHNIQUES, V35, P152, DOI 10.2144/03351md02; Wang XF, 2005, CLIN CANCER RES, V11, P3535, DOI 10.1158/1078-0432.CCR-04-1092; Wardley AM, 2010, J CLIN ONCOL S, V28, p15 s; Witta SE, 2012, J CLIN ONCOL, V30, P2248, DOI 10.1200/JCO.2011.38.9411; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Xu XC, 2007, CANCER LETT, V253, P14, DOI 10.1016/j.canlet.2006.11.019	43	21	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75258	10.1371/journal.pone.0075258	http://dx.doi.org/10.1371/journal.pone.0075258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116031	gold, Green Published, Green Submitted			2022-12-25	WOS:000325552200013
J	Goris, MGA; Kikken, V; Straetemans, M; Alba, S; Goeijenbier, M; van Gorp, ECM; Boer, KR; Wagenaar, JFP; Hartskeerl, RA				Goris, Marga G. A.; Kikken, Vanessa; Straetemans, Masja; Alba, Sandra; Goeijenbier, Marco; van Gorp, Eric C. M.; Boer, Kimberly R.; Wagenaar, Jiri F. P.; Hartskeerl, Rudy A.			Towards the Burden of Human Leptospirosis: Duration of Acute Illness and Occurrence of Post-Leptospirosis Symptoms of Patients in The Netherlands	PLOS ONE			English	Article							HEMODIALYSIS-PATIENTS; STRESS-DISORDER	Background: Leptospirosis is a global zoonotic disease. Although important for the assessment of the burden of leptospirosis, data on the duration of the illness and the occurrence of post-leptospirosis complaints are not well documented. Hence the main objective of this study was to estimate the occurrence of persistent complaints and duration of hospital stay in laboratory confirmed leptospirosis patients in the Netherlands during 1985 to 2010. Additionally, several risk factors potentially impacting on the occurrence of post-leptospirosis complaints were investigated. Methods/Principal Findings: The duration of the acute phase of leptospirosis was 16 days (IQR 12-23); 10 days (IQR 7-16) were spent hospitalized. Eighteen fatal cases were excluded from this analysis. Complaints of leptospirosis patients by passive case investigations (CPC) derived from files on ambulant consultations occurring one month after hospital discharge, revealed persistent complaints in 108 of 236 (45.8%) laboratory confirmed cases. Data on persistent complaints after acute leptospirosis (PCAC), assessed in 225 laboratory confirmed leptospirosis cases collected through questionnaires during 1985-1993, indicated 68 (30.2%) PCAC cases. Frequently reported complaints included (extreme) fatigue, myalgia, malaise, headache, and a weak physical condition. These complaints prolonged in 21.1% of the cases beyond 24 months after onset of disease. There was no association between post-leptospirosis complaints and hospitalization. However, individuals admitted at the intensive care unit (ICU) were twice as likely to have continuing complaints after discharge adjusting for age and dialysis (OR 2.0 95% CI 0.8-4.8). No significant association could be found between prolongation of complaints and infecting serogroup, although subgroup analysis suggest that infection with serogroups Sejroe (OR 4.8, 95% CI 0.9-27.0) and icterohaemorrhagiae (OR 2.0, 95% CI 0.9-4.3 CI) are more likely to result in CPC than infections with serogroup Grippotyphosa. Conclusion/Significance: In addition to the acute disease, persistent complaints have an impact on the burden of leptospirosis.	[Goris, Marga G. A.; Straetemans, Masja; Alba, Sandra; Boer, Kimberly R.; Wagenaar, Jiri F. P.; Hartskeerl, Rudy A.] KIT Biomed Res, WHO FAO OIE, Amsterdam, Netherlands; [Goris, Marga G. A.; Straetemans, Masja; Alba, Sandra; Boer, Kimberly R.; Wagenaar, Jiri F. P.; Hartskeerl, Rudy A.] KIT Biomed Res, Natl Leptospirosis Reference Ctr, Amsterdam, Netherlands; [Goris, Marga G. A.; Straetemans, Masja; Alba, Sandra; Boer, Kimberly R.; Wagenaar, Jiri F. P.; Hartskeerl, Rudy A.] KIT Biomed Res, Epidemiol Sect, Royal Trop Inst, Amsterdam, Netherlands; [Kikken, Vanessa] Free Univ Amsterdam, Athena Inst, Amsterdam, Netherlands; [Goeijenbier, Marco; van Gorp, Eric C. M.; Wagenaar, Jiri F. P.] Erasmus MC, Dept Virol, Rotterdam, Netherlands	Food & Agriculture Organization of the United Nations (FAO); Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC	Goris, MGA (corresponding author), KIT Biomed Res, WHO FAO OIE, Amsterdam, Netherlands.	m.goris@kit.nl	Alba, Sandra/AAQ-7009-2021	Goeijenbier, Marco/0000-0002-3165-8193	Dutch Government via the Ministry of Foreign Affairs [8027]	Dutch Government via the Ministry of Foreign Affairs	Institutional core funding from the Dutch Government via the Ministry of Foreign Affairs was used, Grant # 8027. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, GEZONDHEID ZORG CIJF; [Anonymous], 2011, 2 M LEPT BURD EP REF; [Anonymous], 2003, HUM LEPT GUID DIAGN; Boer KR, 2007, THESIS; Botterweck A., 2003, PLAUSIBILITEIT NIEUW; Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103; Dowdy DW, 2009, CRIT CARE MED, V37, P1702, DOI 10.1097/CCM.0b013e31819fea55; FARR RW, 1995, CLIN INFECT DIS, V21, P1, DOI 10.1093/clinids/21.1.1; Goris MGA, 2013, EMERG INFECT DIS, V19, P371, DOI 10.3201/eid1903.111260; Goris MGA, 2008, ANALYSE, V62, P295; Griffiths JA, 2004, CONTIN ED ANAESTH CR, V4, P202, DOI DOI 10.1093/BJACEACCP/MKH054; Hartskeerl RA, 2011, CLIN MICROBIOL INFEC, V17, P494, DOI 10.1111/j.1469-0691.2011.03474.x; Hartskeerl RA, 2008, LCI GUIDELINES INFEC; Hartskeerl RA, 2003, J MED MICROBIOL, V11, P94; Hatch R, 2011, CRIT CARE, V15, DOI 10.1186/cc10054; Huitema S W, 1989, Ned Tijdschr Geneeskd, V133, P1939; Hyre AD, 2007, AM J KIDNEY DIS, V50, P585, DOI 10.1053/j.ajkd.2007.07.013; Jansen A, 2007, CLIN INFECT DIS, V44, pE69, DOI 10.1086/513431; Katz AR, 2001, CLIN INFECT DIS, V33, P1834, DOI 10.1086/324084; Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9; Olszyna D P, 1998, Ned Tijdschr Geneeskd, V142, P1270; POND K, 2005, WATER RECREATION DIS; Rathinam S R, 2002, Curr Opin Ophthalmol, V13, P381, DOI 10.1097/00055735-200212000-00007; Scragg P, 2001, ANAESTHESIA, V56, P9, DOI 10.1046/j.1365-2044.2001.01714.x; Spichler A, 2011, INT J INFECT DIS, V15, pE486, DOI 10.1016/j.ijid.2011.03.020; Tagay S, 2007, AM J KIDNEY DIS, V50, P594, DOI 10.1053/j.ajkd.2007.06.018; Terpstra W J, 1984, Ned Tijdschr Geneeskd, V128, P1040; Van der Stegen RHM, 1981, METHODEBESCHRIJVING; Wunsch H, 2006, J CRIT CARE, V21, P1, DOI 10.1016/j.jcrc.2006.01.004	29	32	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76549	10.1371/journal.pone.0076549	http://dx.doi.org/10.1371/journal.pone.0076549			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098528	Green Published, Green Submitted, gold			2022-12-25	WOS:000325483600063
J	Wagner, CS; Grotzke, J; Cresswell, P				Wagner, Claudia S.; Grotzke, Jeff; Cresswell, Peter			Intracellular Regulation of Cross-Presentation during Dendritic Cell Maturation	PLOS ONE			English	Article							LYSOSOMAL THIOL REDUCTASE; MHC CLASS-I; PHAGOSOME MATURATION; ANTIGEN PRESENTATION; RECEPTOR LIGANDS; NADPH OXIDASE; ACTIVATION; RECOGNITION; CAPTURE; GILT	We have investigated the effect of different maturation stimuli on the ability of mature dendritic cells (DCs) to cross-present newly acquired particulate antigens. Cross-presentation was impaired in DCs matured by treatment with TNF-alpha, CpG and LPS, but was less affected upon CD40L-induced maturation. The difference could not be explained by decreased antigen uptake or translocation into the cytosol, but decreased cross-presentation ability did correlate with increased phagosomal/lysosomal acidification. Nevertheless, intra-phagosomal degradation of OVA was not increased in matured samples, suggesting that decreasing phagosomal pH may also regulate cross-presentation by a mechanism other than enhancing degradation.	[Wagner, Claudia S.; Grotzke, Jeff; Cresswell, Peter] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University	Cresswell, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06510 USA.	peter.cresswell@yale.edu		Wagner, Claudia/0000-0002-7311-2236	Howard Hughes Medical Institute; Deutsche Forschungsgemeinschaft	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by the Howard Hughes Medical Institute (P. C.) and funding from the Deutsche Forschungsgemeinschaft (C. S. W). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amigorena S, 2010, CURR OPIN IMMUNOL, V22, P109, DOI 10.1016/j.coi.2010.01.022; Arunachalam B, 2000, P NATL ACAD SCI USA, V97, P745, DOI 10.1073/pnas.97.2.745; Belizaire R, 2009, P NATL ACAD SCI USA, V106, P17463, DOI 10.1073/pnas.0908583106; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; Datta SK, 2003, J IMMUNOL, V170, P4102, DOI 10.4049/jimmunol.170.8.4102; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Delamarre L, 2003, J EXP MED, V198, P111, DOI 10.1084/jem.20021542; Delamarre L, 2011, SEMIN IMMUNOL, V23, P2, DOI 10.1016/j.smim.2011.02.001; den Haan JMM, 2002, J EXP MED, V196, P817, DOI 10.1084/jem.20020295; Di Pucchio T, 2008, NAT IMMUNOL, V9, P551, DOI 10.1038/ni.1602; Drutman SB, 2010, J IMMUNOL, V185, P2140, DOI 10.4049/jimmunol.1000642; Gil-Torregrosa BC, 2004, EUR J IMMUNOL, V34, P398, DOI 10.1002/eji.200324508; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Haque MA, 2002, J EXP MED, V195, P1267, DOI 10.1084/jem.20011853; Henri S, 2007, EUR J IMMUNOL, V37, P1184, DOI 10.1002/eji.200636793; Jancic C, 2007, NAT CELL BIOL, V9, P367, DOI 10.1038/ncb1552; Lackman RL, 2007, TRAFFIC, V8, P1179, DOI 10.1111/j.1600-0854.2007.00600.x; Laroux FS, 2005, J IMMUNOL, V175, P5596, DOI 10.4049/jimmunol.175.9.5596; Lennon-Dumenil AM, 2002, J EXP MED, V196, P529, DOI 10.1084/jem.20020327; Lin ML, 2008, P NATL ACAD SCI USA, V105, P3029, DOI 10.1073/pnas.0712394105; Machy P, 2000, EUR J IMMUNOL, V30, P848, DOI 10.1002/1521-4141(200003)30:3<848::AID-IMMU848>3.3.CO;2-H; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Mueller SN, 2002, J EXP MED, V195, P651, DOI 10.1084/jem.20012023; Phan UT, 2000, J BIOL CHEM, V275, P25907, DOI 10.1074/jbc.M003459200; Platt CD, 2010, P NATL ACAD SCI USA, V107, P4287, DOI 10.1073/pnas.0910609107; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; Russell DG, 2007, NAT IMMUNOL, V8, P217, DOI 10.1038/ni0307-217a; SALVUCCI LA, 1995, J VIROL, V69, P1122, DOI 10.1128/JVI.69.2.1122-1131.1995; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Savina A, 2010, METHODS MOL BIOL, V595, P383, DOI 10.1007/978-1-60761-421-0_25; Savina A, 2009, IMMUNITY, V30, P544, DOI 10.1016/j.immuni.2009.01.013; Segura E, 2011, TRAFFIC, V12, P1677, DOI 10.1111/j.1600-0854.2011.01254.x; Singh R, 2010, SCIENCE, V328, P1394, DOI 10.1126/science.1189176; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Vulcano M, 2004, J IMMUNOL, V173, P5749, DOI 10.4049/jimmunol.173.9.5749; Wagner CS, 2012, J IMMUNOL, V188, P686, DOI 10.4049/jimmunol.1102214; Weck MM, 2007, BLOOD, V109, P3890, DOI 10.1182/blood-2006-04-015719; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Wilson NS, 2006, NAT IMMUNOL, V7, P165, DOI 10.1038/ni1300; Wilson NS, 2005, ADV IMMUNOL, V86, P241, DOI 10.1016/S0065-2776(04)86007-3; Yates RM, 2005, TRAFFIC, V6, P413, DOI 10.1111/j.1600-0854.2005.00284.x; Yates RM, 2005, IMMUNITY, V23, P409, DOI 10.1016/j.immuni.2005.09.007; Yates Robin A., 2008, V445, P311, DOI 10.1007/978-1-59745-157-4_20	48	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76801	10.1371/journal.pone.0076801	http://dx.doi.org/10.1371/journal.pone.0076801			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098562	Green Published, Green Submitted, gold			2022-12-25	WOS:000325483600078
J	Fassler, M; Weissberg, I; Levy, N; Diaz-Griffero, F; Monsonego, A; Friedman, A; Taube, R				Fassler, Michael; Weissberg, Itai; Levy, Nitzan; Diaz-Griffero, Felipe; Monsonego, Alon; Friedman, Alon; Taube, Ran			Preferential Lentiviral Targeting of Astrocytes in the Central Nervous System	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; IN-VIVO; GENE-TRANSFER; GLUTAMATE TRANSPORTERS; NEUROVASCULAR UNIT; ENDOTHELIAL-CELLS; MAMMALIAN-CELLS; SINDBIS VIRUS; MOUSE MODEL; VECTORS	The ability to visualize and genetically manipulate specific cell populations of the central nervous system (CNS) is fundamental to a better understanding of brain functions at the cellular and molecular levels. Tools to selectively target cells of the CNS include molecular genetics, imaging, and use of transgenic animals. However, these approaches are technically challenging, time consuming, and difficult to control. Viral-mediated targeting of cells in the CNS can be highly beneficial for studying and treating neurodegenerative diseases. Yet, despite specific marking of numerous cell types in the CNS, in vivo selective targeting of astrocytes has not been optimized. In this study, preferential targeting of astrocytes in the CNS was demonstrated using engineered lentiviruses that were pseudotyped with a modified Sindbis envelope and displayed anti-GLAST IgG on their surfaces as an attachment moiety. Viral tropism for astrocytes was initially verified in vitro in primary mixed glia cultures. When injected into the brains of mice, lentiviruses that displayed GLAST IgG on their surface, exhibited preferential astrocyte targeting, compared to pseudotyped lentiviruses that did not incorporate any IgG or that expressed a control isotype IgG. Overall, this approach is highly flexible and can be exploited to selectively target astrocytes or other cell types of the CNS. As such, it can open a window to visualize and genetically manipulate astrocytes or other cells of the CNS as means of research and treatment.	[Fassler, Michael; Levy, Nitzan; Monsonego, Alon; Taube, Ran] Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol Immunol & Genet, Beer Sheva, Israel; [Weissberg, Itai; Friedman, Alon] Ben Gurion Univ Negev, Dept Physiol & Cell Biol, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; [Weissberg, Itai; Friedman, Alon] Ben Gurion Univ Negev, Dept Cognit & Brain Sci, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; [Diaz-Griffero, Felipe] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA	Ben Gurion University; Ben Gurion University; Ben Gurion University; Yeshiva University; Albert Einstein College of Medicine	Taube, R (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol Immunol & Genet, Beer Sheva, Israel.	rantaube@bgu.ac.il	TAUBE, RAN/F-2029-2012; Weissberg, Itai/AGU-9930-2022	TAUBE, RAN/0000-0002-2062-4537; 	Kreitman School for advanced studies at BGU; Faculty of Health Sciences at the Ben Gurion University of the Negev; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087390] Funding Source: NIH RePORTER	Kreitman School for advanced studies at BGU; Faculty of Health Sciences at the Ben Gurion University of the Negev; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	MF is supported by the Kreitman School for advanced studies at BGU. Funding for RT is from the Faculty of Health Sciences at the Ben Gurion University of the Negev. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2012, EPILEPSIA, V53, P1, DOI 10.1111/j.1528-1167.2012.03696.x; Akkina RK, 1996, J VIROL, V70, P2581, DOI 10.1128/JVI.70.4.2581-2585.1996; Anliker B, 2010, NAT METHODS, V7, P929, DOI 10.1038/nmeth.1514; Baron R, 2008, FASEB J, V22, P2843, DOI 10.1096/fj.08-105866; Cannon JR, 2011, EXP NEUROL, V228, P41, DOI 10.1016/j.expneurol.2010.10.016; Cetin A, 2006, NAT PROTOC, V1, P3166, DOI 10.1038/nprot.2006.450; Choi J, 2010, P NATL ACAD SCI USA, V107, P16703, DOI 10.1073/pnas.1006233107; Chuquet J, 2007, J NEUROSCI, V27, P4036, DOI 10.1523/JNEUROSCI.0721-07.2007; Colin A, 2009, GLIA, V57, P667, DOI 10.1002/glia.20795; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; De Palma M, 2003, HUM GENE THER, V14, P1193, DOI 10.1089/104303403322168028; DeFelipe J, 2010, SCIENCE, V330, P1198, DOI 10.1126/science.1193378; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Edry E, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00057; Enkirch T, 2012, GENE THER; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Frecha C, 2012, BLOOD, V119, P1139, DOI 10.1182/blood-2011-04-346619; Funke S, 2009, GENE THER, V16, P700, DOI 10.1038/gt.2009.11; Furman JL, 2012, J NEUROSCI, V32, P16129, DOI 10.1523/JNEUROSCI.2323-12.2012; Gaveriaux-Ruff C, 2007, PHARMACOL THERAPEUT, V113, P619, DOI 10.1016/j.pharmthera.2006.12.003; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Goyvaerts C, 2012, GENE THER, V19, P1133, DOI 10.1038/gt.2011.206; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Jakobsson J, 2006, MOL THER, V13, P484, DOI 10.1016/j.ymthe.2005.11.012; Jakobsson J, 2006, GENE THER, V13, P966, DOI 10.1038/sj.gt.3302701; Jakobsson J, 2003, J NEUROSCI RES, V73, P876, DOI 10.1002/jnr.10719; Kaufer D, 2004, NAT NEUROSCI, V7, P947, DOI 10.1038/nn1296; Lai Z, 2002, J NEUROSCI RES, V67, P363, DOI 10.1002/jnr.10137; Lecrux C, 2011, ACTA PHYSIOL, V203, P47, DOI 10.1111/j.1748-1716.2011.02256.x; Lee Y, 2008, GLIA, V56, P481, DOI 10.1002/glia.20622; Lentz TB, 2012, NEUROBIOL DIS, V48, P179, DOI 10.1016/j.nbd.2011.09.014; Levy C, 2012, MOL THER, V20, P1699, DOI 10.1038/mt.2012.96; Liang M, 2009, J GENE MED, V11, P185, DOI 10.1002/jgm.1290; Lichtman JW, 2008, NAT REV NEUROSCI, V9, P417, DOI 10.1038/nrn2391; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Losi G, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00132; LOWENADLER B, 1987, GENE, V58, P87, DOI 10.1016/0378-1119(87)90032-1; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Marumoto T, 2009, NAT MED, V15, P110, DOI 10.1038/nm.1863; Mazarakis ND, 2001, HUM MOL GENET, V10, P2109, DOI 10.1093/hmg/10.19.2109; McCarty JH, 2009, CURR OPIN HEMATOL, V16, P209, DOI 10.1097/MOH.0b013e32832a07eb; Morizono K, 2005, CELL CYCLE, V4, P854, DOI 10.4161/cc.4.7.1789; Morizono K, 2005, NAT MED, V11, P346, DOI 10.1038/nm1192; Morizono K, 2001, J VIROL, V75, P8016, DOI 10.1128/JVI.75.17.8016-8020.2001; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Ohno K, 1997, NAT BIOTECHNOL, V15, P763, DOI 10.1038/nbt0897-763; Pariente N, 2008, J GENE MED, V10, P242, DOI 10.1002/jgm.1151; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; SCHLEGEL R, 1983, CELL, V32, P639, DOI 10.1016/0092-8674(83)90483-X; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Sung BK, 2003, J NEUROSCI, V23, P2899; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Voutsinos-Porche B, 2003, NEURON, V37, P275, DOI 10.1016/S0896-6273(02)01170-4; Watson DJ, 2002, MOL THER, V5, P528, DOI 10.1006/mthe.2002.0584; Wong LF, 2006, HUM GENE THER, V17, P1, DOI 10.1089/hum.2006.17.1; Xin WJ, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-15; Xing CH, 2012, NEUROL RES, V34, P325, DOI 10.1179/1743132812Y.0000000019; Xu R, 2001, GENE THER, V8, P1323, DOI 10.1038/sj.gt.3301529; Yang L, 2008, NAT BIOTECHNOL, V26, P326, DOI 10.1038/nbt1390; Zhang L, 2012, TRENDS PHARMACOL SCI, V33, P415, DOI 10.1016/j.tips.2012.04.006; Zhang XY, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-3; Zhou Q, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22566; Ziegler L, 2008, HUM GENE THER, V19, P861, DOI [10.1089/hum.2007.149, 10.1089/hgt.2007.149]	66	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76092	10.1371/journal.pone.0076092	http://dx.doi.org/10.1371/journal.pone.0076092			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098426	Green Published, gold, Green Submitted			2022-12-25	WOS:000325434500043
J	Gebauer, K; Dickinson, KJM; Whigham, PA; Seddon, PJ				Gebauer, Konstanze; Dickinson, Katharine J. M.; Whigham, Peter A.; Seddon, Philip J.			Matrix Matters: Differences of Grand Skink Metapopulation Parameters in Native Tussock Grasslands and Exotic Pasture Grasslands	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; HABITAT SUITABILITY MODELS; OLIGOSOMA-GRANDE; PATCH OCCUPANCY; SOUTH ISLAND; NEW-ZEALAND; QUALITY; DYNAMICS; CONSERVATION; CONNECTIVITY	Modelling metapopulation dynamics is a potentially very powerful tool for conservation biologists. In recent years, scientists have broadened the range of variables incorporated into metapopulation modelling from using almost exclusively habitat patch size and isolation, to the inclusion of attributes of the matrix and habitat patch quality. We investigated the influence of habitat patch and matrix characteristics on the metapopulation parameters of a highly endangered lizard species, the New Zealand endemic grand skink (Oligosoma grande) taking into account incomplete detectability. The predictive ability of the developed zxmetapopulation model was assessed through cross-validation of the data and with an independent data-set. Grand skinks occur on scattered rock-outcrops surrounded by indigenous tussock (bunch) and pasture grasslands therefore implying a metapopulation structure. We found that the type of matrix surrounding the habitat patch was equally as important as the size of habitat patch for estimating occupancy, colonisation and extinction probabilities. Additionally, the type of matrix was more important than the physical distance between habitat patches for colonisation probabilities. Detection probability differed between habitat patches in the two matrix types and between habitat patches with different attributes such as habitat patch composition and abundance of vegetation on the outcrop. The developed metapopulation models can now be used for management decisions on area protection, monitoring, and the selection of translocation sites for the grand skink. Our study showed that it is important to incorporate not only habitat patch size and distance between habitat patches, but also those matrix type and habitat patch attributes which are vital in the ecology of the target species.	[Gebauer, Konstanze; Whigham, Peter A.] Univ Otago, Dept Bot, Dunedin, New Zealand; [Dickinson, Katharine J. M.] Univ Otago, Dept Informat Sci, Dunedin, New Zealand; [Seddon, Philip J.] Univ Otago, Dept Zool, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago	Gebauer, K (corresponding author), Univ Otago, Dept Bot, POB 56, Dunedin, New Zealand.	konstanze.gebauer@web.de	Dickinson, Katharine J.M./M-1728-2017; Seddon, Philip/G-8659-2011	Dickinson, Katharine J.M./0000-0001-6769-552X; Seddon, Philip/0000-0001-9076-9566	University of Otago; Hellaby Indigenous Grasslands Research Trust	University of Otago; Hellaby Indigenous Grasslands Research Trust	This work was funded by: University of Otago Research Grant (PJS), University of Otago Doctoral Scholarship (KG), Hellaby Indigenous Grasslands Research Trust (KG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya H. Resit, 2000, Ecological Bulletins, V48, P23; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Anderson D.R., 2008, MODEL BASED INFERENC; [Anonymous], 2010, R LANG ENV STAT COMP; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Armstrong DP, 2005, CONSERV BIOL, V19, P1402, DOI 10.1111/j.1523-1739.2005.00117.x; Baguette M, 2007, LANDSCAPE ECOL, V22, P1117, DOI 10.1007/s10980-007-9108-4; Bailey LL, 2007, ECOL APPL, V17, P281, DOI 10.1890/1051-0761(2007)017[0281:SDTIOS]2.0.CO;2; Barbosa AM, 2003, BIOL CONSERV, V114, P377, DOI 10.1016/S0006-3207(03)00066-1; Berry O, 2005, CONSERV BIOL, V19, P855, DOI 10.1111/j.1523-1739.2005.00161.x; Berry O, 2004, MOL ECOL, V13, P551, DOI 10.1046/j.1365-294X.2004.2081.x; Berry OF, 2006, CONSERV GENET, V7, P427, DOI 10.1007/s10592-005-9054-0; Blevins E, 2011, LANDSCAPE ECOL, V26, P837, DOI 10.1007/s10980-011-9612-4; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Bulman CR, 2007, ECOL APPL, V17, P1460, DOI 10.1890/06-1032.1; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cianfrani C, 2010, J APPL ECOL, V47, P421, DOI 10.1111/j.1365-2664.2010.01781.x; CLOBERT J, 1994, LIZARD ECOLOGY, P183; Coddington E. J., 1997, PAC CONSERV BIOL, V3, P379, DOI [10.1071/PC980379, DOI 10.1071/PC980379]; CREE A, 1994, NEW ZEAL J ZOOL, V21, P351, DOI 10.1080/03014223.1994.9518005; Dennis RLH, 1997, J INSECT CONSERV, V1, P167, DOI 10.1023/A:1018455714879; Doerr VAJ, 2011, J APPL ECOL, V48, P143, DOI 10.1111/j.1365-2664.2010.01899.x; Driscoll DA, 2007, CAN J ZOOL, V85, P1031, DOI 10.1139/Z07-096; DUNNING JB, 1992, OIKOS, V65, P169, DOI 10.2307/3544901; DUNNING JB, 1995, ECOL APPL, V5, P3, DOI 10.2307/1942045; Fahrig L, 2007, FUNCT ECOL, V21, P1003, DOI 10.1111/j.1365-2435.2007.01326.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; HANSKI I, 1994, J ANIM ECOL, V63, P151, DOI 10.2307/5591; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; HANSKI I, 1991, BIOL J LINN SOC, V42, P17, DOI 10.1111/j.1095-8312.1991.tb00549.x; HANSKI I, 1997, METAPOPULATION BIOL; Hastie T., 2009, UNSUPERVISED LEARNIN; Hill JK, 1996, J ANIM ECOL, V65, P725, DOI 10.2307/5671; Hines, 2017, OCCUPANCY ESTIMATION; Hines JE, 2006, RESENCE2 SOFTWARE ES; Hirzel AH, 2006, ECOL MODEL, V199, P142, DOI 10.1016/j.ecolmodel.2006.05.017; HOSMER DW, 1989, APPL LOGISTIC REGRES; Houghton C, 2000, DISPERSAL METAPOPULA; Jaquiery J, 2008, ECOLOGY, V89, P2777, DOI 10.1890/07-1833.1; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Lima SL, 1996, TRENDS ECOL EVOL, V11, P131, DOI 10.1016/0169-5347(96)81094-9; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; MacKenzie DI, 2006, J WILDLIFE MANAGE, V70, P367, DOI 10.2193/0022-541X(2006)70[367:MTPORU]2.0.CO;2; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; McGlone MS, 2001, NEW ZEAL J ECOL, V25, P1; McWethy DB, 2010, P NATL ACAD SCI USA, V107, P21343, DOI 10.1073/pnas.1011801107; Moilanen A, 2002, OIKOS, V96, P516, DOI 10.1034/j.1600-0706.2002.960313.x; Moilanen A, 1998, ECOLOGY, V79, P2503, DOI 10.1890/0012-9658(1998)079[2503:MDEOHQ]2.0.CO;2; Moilanen A, 1999, ECOLOGY, V80, P1031, DOI 10.1890/0012-9658(1999)080[1031:POMOMD]2.0.CO;2; Murphy TJ, 1994, ACTIVITY RHYTHMS MIC; NCAR-Research Application Program, 2010, VER FOR VER UT R SOF; Norbury G, 2001, J APPL ECOL, V38, P1350, DOI 10.1046/j.0021-8901.2001.00685.x; Patterson GB, 1992, DEV OTAGO SKINK GRAN, P133; Prugh LR, 2009, ECOL APPL, V19, P1300, DOI 10.1890/08-1524.1; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Roughton CM, 2006, WILDLIFE RES, V33, P193, DOI 10.1071/WR05045; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Seddon PJ, 2011, N Z J ECOL, V35; Sjogren-Gulve Per, 2000, Ecological Bulletins, V48, P53; Stanley MC, 1998, J HERPETOL, V32, P461, DOI 10.2307/1565468; THOMAS CD, 1992, J ANIM ECOL, V61, P437, DOI 10.2307/5334; Thomas JA, 2001, P ROY SOC B-BIOL SCI, V268, P1791, DOI 10.1098/rspb.2001.1693; Tischendorf L, 2000, OIKOS, V90, P7, DOI 10.1034/j.1600-0706.2000.900102.x; Tocher MD, 2003, NEW ZEAL J ZOOL, V30, P243, DOI 10.1080/03014223.2003.9518342; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Vogeli M, 2010, BIOL CONSERV, V143, P1057, DOI 10.1016/j.biocon.2009.12.040; Wardle P, 2002, VEGETATION NZ; Whitaker AH, 1996, IMPACT AGR DEV GRAND; Whitaker AH, 1995, OTAGO SKINKS GRAND S; [No title captured]	75	13	13	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76076	10.1371/journal.pone.0076076	http://dx.doi.org/10.1371/journal.pone.0076076			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098423	gold, Green Published, Green Submitted			2022-12-25	WOS:000325434500042
J	Imanishi, H; Takibuchi, G; Kobayashi, T; Ishikawa, K; Nakada, K; Mori, M; Kikkawa, Y; Takenaga, K; Toyama-Sorimachi, N; Hayashi, JI				Imanishi, Hirotake; Takibuchi, Gaku; Kobayashi, Toshihiko; Ishikawa, Kaori; Nakada, Kazuto; Mori, Masayuki; Kikkawa, Yoshiaki; Takenaga, Keizo; Toyama-Sorimachi, Noriko; Hayashi, Jun-Ichi			Specific mtDNA Mutations in Mouse Carcinoma Cells Suppress Their Tumor Formation via Activation of the Host Innate Immune System	PLOS ONE			English	Article							MITOCHONDRIAL-DNA MUTATIONS; MICE	mammalian species, mitochondrial DNA (mtDNA) with pathogenic mutations that induce mitochondrial respiration defects has been proposed to be involved in tumor phenotypes via induction of enhanced glycolysis under normoxic conditions (the Warburg effects). However, because both nuclear DNA and mtDNA control mitochondrial respiratory function, it is difficult to exclude the possible contribution of nuclear DNA mutations to mitochondrial respiration defects and the resultant expression of tumor phenotypes. Therefore, it is important to generate transmitochondrial cybrids sharing the same nuclear DNA background but carrying mtDNA with and without the mutations by using intercellular mtDNA transfer technology. Our previous studies isolated transmitochondrial cybrids and showed that specific mtDNA mutations enhanced tumor progression as a consequence of overproduction of reactive oxygen species (ROS). This study assessed whether mtDNA mutations inducing ROS overproduction always enhance tumor progression. We introduced mtDNA from senescence-accelerated mice P1 (SAMP1) into C57BL/6J (B6) mice-derived Lewis lung carcinoma P29 cells, and isolated new transmitochondrial cybrids (P29mtSAMP1 cybrids) that overproduced ROS. The inoculation of the cybrids into B6 mice unexpectedly showed that mtDNA from SAMP1 mice conversely induced tumor suppression. Moreover, the tumor suppression of P29mtSAMP1 cybrids in B6 mice occurred as a consequence of innate immune responses of the host B6 mice. Enzyme pretreatment experiments of P29mtSAMP1 cybrids revealed that some peptides encoded by mtDNA and expressed on the cell surface of P29mtSAMP1 cybrids induce increased IL-6 production from innate immune cells (dendritic cells) of B6 mice, and mediate augmented inflammatory responses around the tumor-inoculated environment. These observations indicate presence of a novel role of mtDNA in tumor phenotype, and provide new insights into the fields of mitochondrial tumor biology and tumor immunology.	[Imanishi, Hirotake; Takibuchi, Gaku; Ishikawa, Kaori; Nakada, Kazuto; Hayashi, Jun-Ichi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Imanishi, Hirotake] Japan Soc Promot Sci, Tokyo, Japan; [Imanishi, Hirotake; Kobayashi, Toshihiko; Toyama-Sorimachi, Noriko] Natl Ctr Global Hlth & Med, Dept Mol Immunol & Inflammat, Tokyo, Japan; [Nakada, Kazuto; Hayashi, Jun-Ichi] Univ Tsukuba, Int Inst Integrat Sleep Med, Tsukuba, Ibaraki, Japan; [Mori, Masayuki] Shinshu Univ, Sch Med, Res Ctr Aging & Adaptat, Dept Aging Angiol, Matsumoto, Nagano 390, Japan; [Kikkawa, Yoshiaki] Tokyo Metropolitan Inst Med Sci, Mammalian Genet Project, Tokyo 113, Japan; [Takenaga, Keizo] Shimane Univ, Fac Med, Dept Life Sci, Izumo, Shimane, Japan	University of Tsukuba; Japan Society for the Promotion of Science; National Center for Global Health & Medicine - Japan; University of Tsukuba; Shinshu University; Tokyo Metropolitan Institute of Medical Science; Shimane University	Hayashi, JI (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan.	jih45@biol.tsukuba.ac.jp	Kikkawa, Yoshiaki/AAI-7229-2020	ISHIKAWA, Kaori/0000-0001-9895-5996; Kikkawa, Yoshiaki/0000-0001-8859-4998	Japan Society for the Promotion of Science (JSPS) [25250011, 23240058, 24117503]; World Premier International Research Center Initiative, Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research [25871165] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); World Premier International Research Center Initiative, Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research A 25250011 (to JIH), Scientific Research A 23240058 (to KN), and Scientific Research on Innovative Areas 24117503 (to JIH) from Japan Society for the Promotion of Science (JSPS). This work was also supported by Grant-in-Aid for JSPS Fellows (to HI) and by World Premier International Research Center Initiative, Ministry of Education, Culture, Sports, Science, and Technology, Japan (to KN and JIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscripts.	Hashizume O, 2012, P NATL ACAD SCI USA, V109, P10528, DOI 10.1073/pnas.1202367109; Ishikawa K, 2008, FEBS LETT, V582, P3525, DOI 10.1016/j.febslet.2008.09.024; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Ishikawa K, 2010, J EXP MED, V207, P2297, DOI 10.1084/jem.20092296; Jacobs HT, 2003, AGING CELL, V2, P11, DOI 10.1046/j.1474-9728.2003.00032.x; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Khrapko K, 2009, TRENDS GENET, V25, P91, DOI 10.1016/j.tig.2008.11.007; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Mizutani J, 2001, J HERED, V92, P352, DOI 10.1093/jhered/92.4.352; Nakahara H, 1998, FREE RADICAL BIO MED, V24, P85, DOI 10.1016/S0891-5849(97)00164-0; Okatani Y, 2002, J PINEAL RES, V32, P143, DOI 10.1034/j.1600-079x.2002.1o106.x; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takenaga K, 1997, ONCOGENE, V14, P331, DOI 10.1038/sj.onc.1200820; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Yokota M, 2010, FEBS LETT, V584, P3943, DOI 10.1016/j.febslet.2010.07.048; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	20	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75981	10.1371/journal.pone.0075981	http://dx.doi.org/10.1371/journal.pone.0075981			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098752	Green Published, gold, Green Submitted			2022-12-25	WOS:000325423500122
J	Mottaghitalab, F; Farokhi, M; Zaminy, A; Kokabi, M; Soleimani, M; Mirahmadi, F; Shokrgozar, MA; Sadeghizadeh, M				Mottaghitalab, Fatemeh; Farokhi, Mehdi; Zaminy, Arash; Kokabi, Mehrdad; Soleimani, Masoud; Mirahmadi, Fereshteh; Shokrgozar, Mohammad Ali; Sadeghizadeh, Majid			A Biosynthetic Nerve Guide Conduit Based on Silk/SWNT/Fibronectin Nanocomposite for Peripheral Nerve Regeneration	PLOS ONE			English	Article							WALLED CARBON NANOTUBES; SILK FIBROIN; FIBRONECTIN; SCAFFOLDS; FABRICATION; ADSORPTION; DISPERSION; ADHESION; CELLS	As a contribution to the functionality of nerve guide conduits (NGCs) in nerve tissue engineering, here we report a conduit processing technique through introduction and evaluation of topographical, physical and chemical cues. Porous structure of NGCs based on freeze-dried silk/single walled carbon nanotubes (SF/SWNTs) has shown a uniform chemical and physical structure with suitable electrical conductivity. Moreover, fibronectin (FN) containing nanofibers within the structure of SF/SWNT conduits produced through electrospinning process have shown aligned fashion with appropriate porosity and diameter. Moreover, fibronectin remained its bioactivity and influenced the adhesion and growth of U373 cell lines. The conduits were then implanted to 10 mm left sciatic nerve defects in rats. The histological assessment has shown that nerve regeneration has taken places in proximal region of implanted nerve after 5 weeks following surgery. Furthermore, nerve conduction velocities (NCV) and more myelinated axons were observed in SF/SWNT and SF/SWNT/FN groups after 5 weeks post implantation, indicating a functional recovery for the injured nerves. With immunohistochemistry, the higher S-100 expression of Schwann cells in SF/SWNT/FN conduits in comparison to other groups was confirmed. In conclusion, an oriented conduit of biocompatible SF/SWNT/FN has been fabricated with acceptable structure that is particularly applicable in nerve grafts.	[Mottaghitalab, Fatemeh] Tarbiat Modares Univ, Fac Biol Sci, Dept Nanobiotechnol, Tehran, Iran; [Farokhi, Mehdi] Univ Tehran Med Sci, Sch Adv Technol Med, Dept Tissue Engn, Tehran, Iran; [Zaminy, Arash; Mirahmadi, Fereshteh; Shokrgozar, Mohammad Ali] Pasteur Inst Iran, Natl Cell Bank Iran, Tehran, Iran; [Kokabi, Mehrdad] Tarbiat Modares Univ, Fac Chem Engn, Dept Polymer Engn, Tehran, Iran; [Soleimani, Masoud] Tarbiat Modares Univ, Sch Med Sci, Dept Hematol, Tehran, Iran; [Sadeghizadeh, Majid] Tarbiat Modares Univ, Fac Biol Sci, Dept Genet, Tehran, Iran	Tarbiat Modares University; Tehran University of Medical Sciences; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Tarbiat Modares University; Tarbiat Modares University; Tarbiat Modares University	Shokrgozar, MA (corresponding author), Pasteur Inst Iran, Natl Cell Bank Iran, Tehran, Iran.	mashokrgozar@pasteur.ac.ir; sadeghma@modares.ac.ir	Zaminy, Arash/A-1346-2015; Kokabi, Mehrdad/D-1672-2010; Farokhi, Mehdi/P-9672-2017; Mottaghitalab, Fatemeh/AAL-8988-2020; Shokrgozar, Mohammad Ali/HDM-1639-2022; shokrgozar, mohammad ali/L-4149-2017; Farokhi, Mehdi/V-3661-2019; Zaminy, Arash/M-5119-2019	Zaminy, Arash/0000-0002-2388-481X; Kokabi, Mehrdad/0000-0003-1826-1949; Farokhi, Mehdi/0000-0001-7023-2905; shokrgozar, mohammad ali/0000-0001-5123-4155; Farokhi, Mehdi/0000-0001-7023-2905; Zaminy, Arash/0000-0002-2388-481X; , Fatemeh/0000-0003-3850-8902	Pasteur Institute of Iran [2456-65]	Pasteur Institute of Iran	This study has been funded by Pasteur Institute of Iran with grant number 2456-65. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abatangelo G, 2002, INTEGRATED BIOMATERIALS SCIENCE, P885, DOI 10.1007/0-306-47583-9_31; AE A, 2008, INFRARED PHYS TECHN, V16, P130; Ahmed Z, 1999, CELL MOTIL CYTOSKEL, V42, P331; Beachley V, 2010, PROG POLYM SCI, V35, P868, DOI 10.1016/j.progpolymsci.2010.03.003; Bellamkonda RV, 2006, BIOMATERIALS, V27, P3515, DOI 10.1016/j.biomaterials.2006.02.030; Belyanskaya LWS, 2011, NEUROTOXICOLOGY, V30, P702; Bian YZ, 2009, BIOMATERIALS, V30, P217, DOI 10.1016/j.biomaterials.2008.09.036; Chang CJ, 2006, BIOMATERIALS, V27, P1035, DOI 10.1016/j.biomaterials.2005.07.003; Chen SM, 2005, CHEM PHYS LETT, V402, P312, DOI 10.1016/j.cplett.2004.12.035; Chennazhy KP, 2005, BIOMATERIALS, V26, P5658, DOI 10.1016/j.biomaterials.2005.02.024; Cooper A, 2011, CARBOHYD POLYM, V85, P149, DOI 10.1016/j.carbpol.2011.02.008; Cunha C, 2011, NANOMED-NANOTECHNOL, V7, P50, DOI 10.1016/j.nano.2010.07.004; de Ruiter GCW, 2009, NEUROSURG CLIN N AM, V20, P91, DOI 10.1016/j.nec.2008.08.001; Dubey G, 2011, ACTA BIOMATER, V7, P1114, DOI 10.1016/j.actbio.2010.11.010; Dyakonov TYC, 2012, J DRUG DELIV, P490; Edwards SL, 2009, BIOMATERIALS, V30, P1725, DOI 10.1016/j.biomaterials.2008.12.031; Fansa H, 2001, PLAST RECONSTR SURG, V107, P485, DOI 10.1097/00006534-200102000-00026; Firme CP, 2010, NANOMED-NANOTECHNOL, V6, P245, DOI 10.1016/j.nano.2009.07.003; Gandhi M, 2009, POLYMER, V50, P1918, DOI 10.1016/j.polymer.2009.02.022; Gonzalez-Garcia C, 2010, COLLOID SURFACE B, V77, P181, DOI 10.1016/j.colsurfb.2010.01.021; Hsu SH, 2011, BIOMATERIALS, V32, P3764, DOI 10.1016/j.biomaterials.2011.01.065; Jiang X, 2010, EXP NEUROL, V223, P86, DOI 10.1016/j.expneurol.2009.09.009; Kang M, 2007, COLLOID POLYM SCI, V285, P1163, DOI 10.1007/s00396-007-1668-y; Kehoe S, 2012, INJURY, V43, P553, DOI 10.1016/j.injury.2010.12.030; Kengne-Momo RP, 2012, INT J SPECTROSC, DOI 10.1155/2012/462901; Kim BS, 2011, PROG POLYM SCI, V36, P238, DOI 10.1016/j.progpolymsci.2010.10.001; Kim HS, 2009, BIOMACROMOLECULES, V10, P82, DOI 10.1021/bm800896e; Kim H, 2008, J NANOSCI NANOTECHNO, V8, P5543, DOI 10.1166/jnn.2008.1310; Kokai LE, 2009, ACTA BIOMATER, V5, P2540, DOI 10.1016/j.actbio.2009.03.009; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022; Lietz M, 2006, BIOMATERIALS, V27, P1425, DOI 10.1016/j.biomaterials.2005.08.007; Lopez-Manchado MA, 2004, J APPL POLYM SCI, V92, P3394, DOI 10.1002/app.20358; Matsumoto K, 2000, BRAIN RES, V868, P315, DOI 10.1016/S0006-8993(00)02207-1; Mhuka V, 2012, INT J BIOL MACROMOLE; Mosahebi A, 2003, TISSUE ENG, V9, P209, DOI 10.1089/107632703764664684; Motta A, 2002, MACROMOL CHEM PHYS, V203, P1658, DOI 10.1002/1521-3935(200207)203:10/11<1658::AID-MACP1658>3.0.CO;2-3; Mottaghitalab F, 2011, CARBOHYD POLYM, V86, P526, DOI 10.1016/j.carbpol.2011.04.066; Mukhatyar VJ, 2011, BIOMATERIALS, V32, P3958, DOI 10.1016/j.biomaterials.2011.02.015; Oh SH, 2008, BIOMATERIALS, V29, P1601, DOI 10.1016/j.biomaterials.2007.11.036; Roach P, 2010, SURF SCI REP, V65, P145, DOI 10.1016/j.surfrep.2010.07.001; Roganovic Z, 2007, ACTA NEUROCHIR, V149, P1033, DOI 10.1007/s00701-007-1269-z; Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471; Sakiyama SE, 1999, FASEB J, V13, P2214, DOI 10.1096/fasebj.13.15.2214; Shokrgozar MA, 2011, J BIOMED NANOTECHNOL, V7, P276, DOI 10.1166/jbn.2011.1284; Stang F, 2009, MATERIALS, V2, P1480, DOI 10.3390/ma2041480; Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013; Wang XD, 2005, BRAIN, V128, P1897, DOI 10.1093/brain/awh517; Wang Y, 2010, BIOMATERIALS, V31, P4672, DOI 10.1016/j.biomaterials.2010.02.006; Wenk E, 2011, J CONTROL RELEASE, V150, P128, DOI 10.1016/j.jconrel.2010.11.007; Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014; Xu HX, 2011, BIOMATERIALS, V32, P4506, DOI 10.1016/j.biomaterials.2011.02.023; Ziabari M, 2008, KOREAN J CHEM ENG, V25, P923, DOI 10.1007/s11814-008-0151-x; Ziabari M, 2007, NANOSCALE RES LETT, V2, P597, DOI 10.1007/s11671-007-9093-1	54	67	67	5	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74417	10.1371/journal.pone.0074417	http://dx.doi.org/10.1371/journal.pone.0074417			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098649	Green Submitted, Green Published, gold			2022-12-25	WOS:000325423500020
J	Schumacher, MA; Chinnam, N; Ohashi, T; Shah, RS; Erickson, HP				Schumacher, Maria A.; Chinnam, Nagababu; Ohashi, Tomoo; Shah, Riddhi Sanjay; Erickson, Harold P.			The Structure of Irisin Reveals a Novel Intersubunit beta-Sheet Fibronectin Type III (FNIII) Dimer IMPLICATIONS FOR RECEPTOR ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Exercise; Hormones; Muscle; Receptors; X-ray Crystallography	SKELETAL-MUSCLE; ADIPOSE-TISSUE; EXERCISE; FNDC5; DIFFERENTIATION; EXPRESSION; MARKERS; PROTEIN; OBESITY; DOMAIN	Irisin was recently identified as a putative myokine that is induced by exercise. Studies suggest that it is produced by cleavage of the FNDC5 (fibronectin domain-containing protein 5) receptor; irisin corresponds to the extracellular receptor ectodomain. Data suggesting that irisin stimulates white-to-brown fat conversion have led to the hypothesis that it does so by binding an unknown receptor, thus functioning as a myokine. As brown fat promotes energy dissipation, myokines that elicit the transformation of white to brown fat have potentially profound benefits in the treatment of obesity and metabolic disorders. Understanding the molecular basis for such exercise-induced phenomena is thus of considerable interest. Moreover, FNDC5-like receptors are highly conserved and have been shown to be critical for neuronal development. However, the structural and molecular mechanisms utilized by these proteins are currently unknown. Here, we describe the crystal structure and biochemical characterization of the FNDC5 ectodomain, corresponding to the irisin myokine. The 2.28 structure shows that irisin consists of an N-terminal fibronectin III (FNIII)-like domain attached to a flexible C-terminal tail. Strikingly, the FNIII-like domain forms a continuous intersubunit -sheet dimer, previously unobserved for any FNIII protein. Biochemical data confirm that irisin is a dimer and that dimerization is unaffected by glycosylation. This finding suggests a possible mechanism for receptor activation by the irisin domain as a preformed myokine dimer ligand or as a paracrine or autocrine dimerization module on FNDC5-like receptors.	[Schumacher, Maria A.; Chinnam, Nagababu; Erickson, Harold P.] Duke Univ, Sch Med, Dept Biochem, Durham, NC 27710 USA; [Ohashi, Tomoo; Shah, Riddhi Sanjay; Erickson, Harold P.] Duke Univ, Sch Med, Dept Cell Biol & Biochem, Durham, NC 27710 USA	Duke University; Duke University	Schumacher, MA (corresponding author), Duke Univ, Sch Med, Dept Biochem, DUMC, 255 Nanaline H Duke,POB 3711, Durham, NC 27710 USA.	maria.schumacher@duke.edu	Chinnam, Nagababu/ABF-5512-2021; chinnam, Nagababu/AFS-2420-2022	Chinnam, Nagababu/0000-0001-8925-5365; chinnam, Nagababu/0000-0001-8925-5365	Office of Science, Office of Basic Energy Sciences, and Material Science Division of the United States Department of Energy at the Lawrence Berkeley National Laboratory; NATIONAL CANCER INSTITUTE [R37CA047056, R01CA047056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074815] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences, and Material Science Division of the United States Department of Energy at the Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Advanced Light Source (ALS) and the support staff. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, and Material Science Division of the United States Department of Energy at the Lawrence Berkeley National Laboratory.	Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Dun SL, 2013, NEUROSCIENCE, V240, P155, DOI 10.1016/j.neuroscience.2013.02.050; Elbelt U, 2013, CURR OPIN CLIN NUTR, V16, P541, DOI 10.1097/MCO.0b013e328363bc65; Erickson HP, 2013, ADIPOCYTE, V2, P289, DOI 10.4161/adip.26082; Ferrer-Martinez A, 2002, DEV DYNAM, V224, P154, DOI 10.1002/dvdy.10099; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Hashemi MS, 2013, NEUROSCIENCE, V231, P296, DOI 10.1016/j.neuroscience.2012.11.041; HOLLENBERG MD, 1991, FASEB J, V5, P178, DOI 10.1096/fasebj.5.2.1848518; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Keller P, 2011, J APPL PHYSIOL, V110, P46, DOI 10.1152/japplphysiol.00634.2010; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; LEAHY DJ, 1992, SCIENCE, V258, P987, DOI 10.1126/science.1279805; Liu JJ, 2013, J DIABETES COMPLICAT, V27, P365, DOI 10.1016/j.jdiacomp.2013.03.002; Melov S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000465; Moon HS, 2013, METABOLISM, V62, P1131, DOI 10.1016/j.metabol.2013.04.007; Ohashi T, 2011, J BIOL CHEM, V286, P39188, DOI 10.1074/jbc.M111.262337; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pedersen BK, 2003, J MUSCLE RES CELL M, V24, P113, DOI 10.1023/A:1026070911202; Pekkala S., 2013, J PHYSL IN PRESS; Pinto A, 2012, CURR PHARM DESIGN, V18, P4326, DOI 10.2174/138161212802481192; Raschke S., 2013, PLOS ONE, V8; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Roca-Rivada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060563; Santiveri CM, 2010, BIOPOLYMERS, V94, P779, DOI 10.1002/bip.21436; Schiefner A, 2012, J BIOL CHEM, V287, P17578, DOI 10.1074/jbc.M111.303131; Schwarzbauer JE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005041; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; Stengel A, 2013, PEPTIDES, V39, P125, DOI 10.1016/j.peptides.2012.11.014; Teufel A, 2002, GENE, V297, P79, DOI 10.1016/S0378-1119(02)00828-4; Thompson D, 2012, PHYSIOL REV, V92, P157, DOI 10.1152/physrev.00012.2011; Timmons JA, 2012, NATURE, V488, pE9, DOI 10.1038/nature11364; Wang SS, 2002, ACTA CRYSTALLOGR D, V58, P571, DOI 10.1107/S0907444902001191; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106	35	147	158	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33738	33744		10.1074/jbc.M113.516641	http://dx.doi.org/10.1074/jbc.M113.516641			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24114836	Green Published, hybrid			2022-12-25	WOS:000327250200020
J	Atek, M; Traissac, P; El Ati, J; Laid, Y; Aounallah-Skhiri, H; Eymard-Duvernay, S; Mezimeche, N; Bougatef, S; Beji, C; Boutekdjiret, L; Martin-Prevel, Y; Lebcir, H; Gartner, A; Kolsteren, P; Delpeuch, F; Ben Romdhane, H; Maire, B				Atek, Madjid; Traissac, Pierre; El Ati, Jalila; Laid, Youcef; Aounallah-Skhiri, Hajer; Eymard-Duvernay, Sabrina; Mezimeche, Nadia; Bougatef, Souha; Beji, Chiraz; Boutekdjiret, Leila; Martin-Prevel, Yves; Lebcir, Hassiba; Gartner, Agnes; Kolsteren, Patrick; Delpeuch, Francis; Ben Romdhane, Habiba; Maire, Bernard			Obesity and Association with Area of Residence, Gender and Socio-Economic Factors in Algerian and Tunisian Adults	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; NUTRITION TRANSITION; RISK-FACTORS; WOMEN; UNDERWEIGHT; PREVALENCE; OVERWEIGHT; POSITION; BMI	Introduction: The epidemiological transition has resulted in a major increase in the prevalence of obesity in North Africa. This study investigated differences in obesity and its association with area of residence, gender and socio-economic position among adults in Algeria and Tunisia, two countries with socio-economic and socio-cultural similarities. Methods: Cross-sectional studies used stratified, three-level, clustered samples of 35-70 year old adults in Algeria, (women n = 2741, men n = 2004) and Tunisia (women n = 2964, men n = 2379). Thinness was defined as Body Mass Index (BMI) = weight/height,< 18.5 kg/m(2), obesity as BMI >= 30, and abdominal obesity as waist circumference/height >= 0.6. Associations with area of residence, gender, age, education, profession and household welfare were assessed. Results: Prevalence of thinness was very low except among men in Algeria (7.3% C.I.[5.9-8.7]). Prevalence of obesity among women was high in Algeria (30.1% C.I.[27.8-32.4]) and Tunisia (37.0% C.I.[34.4-39.6]). It was less so among men (9.1% C.I.[7.1-11.0] and 13.3% C.I.[11.2-15.4]). The results were similar for abdominal obesity. In both countries women were much more obesity-prone than men: the women versus men obesity Odds-Ratio was 4.3 C.I.[3.4-5.5] in Algeria and 3.8 C.I.[3.1-4.7] in Tunisia. Obesity was more prevalent in urban versus rural areas in Tunisia, but not in Algeria (e. g. for women, urban versus rural Odds-Ratio was 2.4 C.I.[1.9-3.1] in Tunisia and only 1.2 C.I.[1.0-5.5] in Algeria). Obesity increased with household welfare, but more markedly in Tunisia, especially among women. Nevertheless, in both countries, even in the lowest quintile of welfare, a fifth of the women were obese. Conclusion: The prevention of obesity, especially in women, is a public health issue in both countries, but there were differences in the patterning of obesity according to area of residence and socio-economic position. These specificities must be taken into account in the management of obesity inequalities.	[Atek, Madjid; Laid, Youcef; Mezimeche, Nadia; Boutekdjiret, Leila; Lebcir, Hassiba] INSP, Algiers, Algeria; [Traissac, Pierre; Eymard-Duvernay, Sabrina; Martin-Prevel, Yves; Gartner, Agnes; Delpeuch, Francis; Maire, Bernard] IRD, NUTRIPASS Res Unit, Montpellier, France; [El Ati, Jalila; Beji, Chiraz] INNTA Natl Inst Nutr & Food Technol, Tunis, Tunisia; [El Ati, Jalila; Beji, Chiraz] SURVEN Nutr Surveillance & Epidemiol Tunisia, Res Unit, Tunis, Tunisia; [Aounallah-Skhiri, Hajer; Bougatef, Souha] INSP, Tunis, Tunisia; [Aounallah-Skhiri, Hajer] El Manar Univ, Fac Med, Tunis, Tunisia; [Kolsteren, Patrick] ITM, Antwerp, Belgium; [Ben Romdhane, Habiba] Fac Med, Epidemiol & Prevent Cardiovasc Dis Unit, Tunis, Tunisia	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Tunis-El-Manar; Institut National de Nutrition Technologie Alimentaire; Universite de Tunis-El-Manar; Faculte de Medecine de Tunis (FMT); Institute of Tropical Medicine (ITM); Universite de Tunis-El-Manar; Faculte de Medecine de Tunis (FMT)	Traissac, P (corresponding author), IRD, NUTRIPASS Res Unit, Montpellier, France.	pierre.traissac@ird.fr	Martin-Prevel, Yves/E-7637-2011; ATI, Jalila EL/Y-5467-2018	Martin-Prevel, Yves/0000-0002-4689-7867; Traissac, Pierre/0000-0002-3184-5597; EL ATI, Jalila/0000-0002-8715-455X	European Union [ICA3-CT-2002-10011]; INNTA (National Nutrition and Food Technology Institute of Tunisia); INSP (National Public Health Institute of Tunisia); INSP (Algerian National Public Health Institute); IRD (Institut de Recherche pour le Developpement, France)	European Union(European Commission); INNTA (National Nutrition and Food Technology Institute of Tunisia); INSP (National Public Health Institute of Tunisia); INSP (Algerian National Public Health Institute); IRD (Institut de Recherche pour le Developpement, France)	This research was funded by the European Union (INCO: Med Projects 1998-2002, TAHINA: Epidemiological Transition And Health Impact in North Africa - Contract Number: ICA3-CT-2002-10011), INNTA (National Nutrition and Food Technology Institute of Tunisia), INSP (National Public Health Institute of Tunisia), INSP (Algerian National Public Health Institute), and IRD (Institut de Recherche pour le Developpement, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, WORLD URB PROSP 2011; Aounallah-Skhiri H, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-38; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Ashwell M., 2011, OPEN OBESITY J, V3, P78, DOI [10.2174/1876823701103010078, DOI 10.2174/1876823701103010078]; Batnitzky A, 2008, SOCIOL HEALTH ILL, V30, P445, DOI 10.1111/j.1467-9566.2007.01067.x; Batnitzky AK, 2011, HEALTH PLACE, V17, P345, DOI 10.1016/j.healthplace.2010.11.012; Beltaifa L, 2009, OBES REV, V10, P145, DOI 10.1111/j.1467-789X.2008.00543.x; Benjelloun S, 2002, PUBLIC HEALTH NUTR, V5, P135, DOI 10.1079/PHN2001285; Central Intelligence Agency, 2012, WORLD FACTBOOK; Charrad M, 2007, WASHINGTON LEE LAW R, V64, P1513; Chebel M, 1995, ENCY AMOUR ISLAM ERO; Corsi DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025120; Dahly DL, 2007, SOC SCI MED, V64, P1407, DOI 10.1016/j.socscimed.2006.11.019; Doak CM, 2000, J NUTR, V130, P2965, DOI 10.1093/jn/130.12.2965; El Ati J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048153; El Rhazi K, 2011, PUBLIC HEALTH NUTR, V14, P160, DOI 10.1017/S1368980010001825; Elmadfa I, 2009, FORUM NUTR, V62, P1, DOI [10.1159/000244607, 10.1159/000242367]; Florencio TMDT, 2001, BRIT J NUTR, V86, P277, DOI 10.1079/BJN2001396; Hassan R, 1995, Plan Parent Chall, P5; Hausmann R., 2010, GLOBAL GENDER GAP RE; Holdsworth M, 2012, HLTH POLICY PLAN, P1; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Howe LD, 2012, INT J EPIDEMIOL, V41, P871, DOI 10.1093/ije/dys037; Janghorbani M, 2008, ARCH IRAN MED, V11, P274, DOI 08113/AIM.008; Jones-Smith JC, 2012, INT J OBESITY, V36, P1114, DOI 10.1038/ijo.2011.179; Kanter R, 2012, ADV NUTR, V3, P491, DOI 10.3945/an.112.002063; Korn EL, 1999, ANAL HLTH SURVEYS; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Lauritsen JM, 2000, EPIDATA DATA ENTRY D; Levy P, 1999, SAMPLING POPULATIONS; Lohman T.J., 1988, ANTHROPOMETRIC STAND; Lowi M. R., 2004, J N AFR STUD, V9, P83, DOI DOI 10.1080/1362938042000325822; MARSHALL SE, 1981, J MOD AFR STUD, V19, P625, DOI 10.1017/S0022278X0002019X; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Measure DHS, 2012, DEMOGRAPHIC HLTH SUR; Mendez MA, 2005, AM J CLIN NUTR, V81, P714; Mokhtar N, 2001, J NUTR, V131, p887S, DOI 10.1093/jn/131.3.887S; Musaiger AO, 2011, J OBES, V2011, DOI 10.1155/2011/407237; Neuman M, 2011, AM J CLIN NUTR, V94, P1348, DOI 10.3945/ajcn.111.018127; Office National de la Famille et de la Population - Ministere de la Sante Publique Macro Systems Inc, 1988, ENQ DEM SANT TUN; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Ravelli ACJ, 1999, AM J CLIN NUTR, V70, P811; Schooling CM, 2011, INT J EPIDEMIOL, V40, P1556, DOI 10.1093/ije/dyr128; Searle S.R., 1987, LINEAR MODELS UNBALA; StataCorp, 2011, STAT STAT SOFTW REL, P173; Subramanian SV, 2011, AM J CLIN NUTR, V93, P413, DOI 10.3945/ajcn.110.004820; Tessier S, 2010, PUBLIC HEALTH NUTR, V13, P1410, DOI 10.1017/S1368980010000601; Tlili F, 2008, ECOL FOOD NUTR, V47, P399, DOI 10.1080/03670240802003942; Traissac P, 2012, INT J EPIDEMIOL, V41, P1207, DOI 10.1093/ije/dys122; UNDP, 2007, HUMAN DEV REPORT 200; Wells JCK, 2011, AM J HUM BIOL, V23, P65, DOI 10.1002/ajhb.21100; World Health Organization, 1995, PHYS STAT US INT ANT	53	27	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75640	10.1371/journal.pone.0075640	http://dx.doi.org/10.1371/journal.pone.0075640			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	233FK	24116063	Green Published, gold, Green Submitted			2022-12-25	WOS:000325552200032
J	He, WJ; Chan, LY; Clark, RJ; Tang, J; Zeng, GZ; Franco, OL; Cantacessi, C; Craik, DJ; Daly, NL; Tan, NH				He, Wen-Jun; Chan, Lai Yue; Clark, Richard J.; Tang, Jun; Zeng, Guang-Zhi; Franco, Octavio L.; Cantacessi, Cinzia; Craik, David J.; Daly, Norelle L.; Tan, Ning-Hua			Novel Inhibitor Cystine Knot Peptides from Momordica charantia	PLOS ONE			English	Article							AMINO-ACID-SEQUENCES; TRYPSIN-INHIBITOR; PROTEINASE-INHIBITORS; CYTOTOXIC CYCLOTIDES; FOLDING PATHWAYS; X-RAY; FAMILY; SEEDS; PROGRAM	Two new peptides, MCh-1 and MCh-2, along with three known trypsin inhibitors (MCTI-I, MCTI-II and MCTI-III), were isolated from the seeds of the tropical vine Momordica charantia. The sequences of the peptides were determined using mass spectrometry and NMR spectroscopy. Using a strategy involving partial reduction and stepwise alkylation of the peptides, followed by enzymatic digestion and tandem mass spectrometry sequencing, the disulfide connectivity of MCh-1 was elucidated to be CysI-CysIV, CysII-CysV and CysIII-CysVI. The three-dimensional structures of MCh-1 and MCh-2 were determined using NMR spectroscopy and found to contain the inhibitor cystine knot (ICK) motif. The sequences of the novel peptides differ significantly from peptides previously isolated from this plant. Therefore, this study expands the known peptide diversity in M. charantia and the range of sequences that can be accommodated by the ICK motif. Furthermore, we show that a stable two-disulfide intermediate is involved in the oxidative folding of MCh-1. This disulfide intermediate is structurally homologous to the proposed ancestral fold of ICK peptides, and provides a possible pathway for the evolution of this structural motif, which is highly prevalent in nature.	[He, Wen-Jun; Tang, Jun; Zeng, Guang-Zhi; Tan, Ning-Hua] Chinese Acad Sci, State Key Lab Phytochem & Plant Resources West Ch, Kunming Inst Bot, Kunming, Yunnan, Peoples R China; [Chan, Lai Yue; Clark, Richard J.; Craik, David J.; Daly, Norelle L.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Clark, Richard J.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Franco, Octavio L.] Univ Catolica Brasilia, Ctr Anal Prote & Bioquim, Programa Posgrad Ciencias Genom & Biotecnol, Brasilia, DF, Brazil; [Cantacessi, Cinzia; Daly, Norelle L.] James Cook Univ, Ctr Biodiscovery & Mol Dev Therapeut, Cairns, Qld, Australia	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; University of Queensland; University of Queensland; Universidade Catolica de Brasilia; James Cook University	Daly, NL (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	norelle.daly@jcu.edu.au; nhtan@mail.kib.ac.cn	CHAN, LAI YUE/C-6489-2014; Clark, Richard J/G-8848-2012; Franco, Octavio L/T-3020-2017; Craik, David/B-1695-2010; Daly, Norelle L/D-4302-2013; Cantacessi, Cinzia/B-7356-2014	CHAN, LAI YUE/0000-0002-9346-2487; Clark, Richard J/0000-0002-6807-5426; Craik, David/0000-0003-0007-6796; Daly, Norelle L/0000-0002-4697-6602; Cantacessi, Cinzia/0000-0001-6863-2950; Franco, Octavio/0000-0001-9546-0525	National Basic Research Program of China [2013CB127505, 2009CB522300]; National New Drug Innovation Great Project of China [2011ZX09307-002-02]; National Natural Science Foundation of China [21202174, U1032602, 91013002, 30725048]; foundation of Chinese Academy of Sciences (Hundred Talents Program); Natural Science Foundation of Yunnan Province [2012GA003]; China Scholarship Council; Queensland Smart State Fellowship; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Apoio a Pesquisa do Distrito Federal	National Basic Research Program of China(National Basic Research Program of China); National New Drug Innovation Great Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); foundation of Chinese Academy of Sciences (Hundred Talents Program); Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province); China Scholarship Council(China Scholarship Council); Queensland Smart State Fellowship; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Apoio a Pesquisa do Distrito Federal(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the National Basic Research Program of China (2013CB127505, 2009CB522300), the National New Drug Innovation Great Project of China (2011ZX09307-002-02), the National Natural Science Foundation of China (21202174, U1032602, 91013002, 30725048), the foundation of Chinese Academy of Sciences (Hundred Talents Program), and the Natural Science Foundation of Yunnan Province (2012GA003). WJH is a recipient of a fellowship from the China Scholarship Council. NLD was supported by a Queensland Smart State Fellowship and is currently an ARC Future Fellow. DJC is a National Health and Medical Research Council Professorial Research Fellow. OLF is supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior and Fundacao de Apoio a Pesquisa do Distrito Federal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arolas JL, 2004, J BIOL CHEM, V279, P37261, DOI 10.1074/jbc.M405565200; ASAHI H, 1994, PARASITOLOGY, V109, P397, DOI 10.1017/S0031182000080641; Begum K, 2003, PARASITOL RES, V90, P221, DOI 10.1007/s00436-003-0830-9; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Brunger AT, 1997, STRUCTURE, V5, P325, DOI 10.1016/S0969-2126(97)00190-1; Cemazar M, 2006, J BIOL CHEM, V281, P8224, DOI 10.1074/jbc.M513399200; Chan LY, 2009, J NAT PROD, V72, P1453, DOI 10.1021/np900174n; Chan LY, 2013, PEPTIDES, V39, P29, DOI 10.1016/j.peptides.2012.09.018; Chen J, 1995, SPERMATOPHYTA; Craik DJ, 2001, TOXICON, V39, P1809, DOI 10.1016/S0041-0101(01)00129-5; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Daly NL, 1999, BIOCHEMISTRY-US, V38, P10606, DOI 10.1021/bi990605b; Daly NL, 2003, J BIOL CHEM, V278, P6314, DOI 10.1074/jbc.M210492200; Daly NL, 2011, CURR OPIN CHEM BIOL, V15, P362, DOI 10.1016/j.cbpa.2011.02.008; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Foley SF, 2008, ANAL BIOCHEM, V377, P95, DOI 10.1016/j.ab.2008.02.025; Goddard TD, KNELLER DG SPARKY 3; Goransson U, 2003, J BIOL CHEM, V278, P48188, DOI 10.1074/jbc.M308771200; Gracy J, 2008, NUCLEIC ACIDS RES, V36, pD314, DOI 10.1093/nar/gkm939; GRAY WR, 1993, PROTEIN SCI, V2, P1732, DOI 10.1002/pro.5560021017; HAMATO N, 1995, J BIOCHEM-TOKYO, V117, P432, DOI 10.1093/jb/117.2.432; HARA S, 1989, J BIOCHEM-TOKYO, V105, P88, DOI 10.1093/oxfordjournals.jbchem.a122625; He WJ, 2011, PEPTIDES, V32, P1719, DOI 10.1016/j.peptides.2011.06.016; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Ikeya T, 2006, MAGN RESON CHEM, V44, pS152, DOI 10.1002/mrc.1815; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Kim Hye-Sook, 1998, Parasitology International, V47, P59, DOI 10.1016/S1383-5769(98)00003-8; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LENGUYEN D, 1993, PROTEIN SCI, V2, P165; LING MH, 1993, J BIOL CHEM, V268, P810; Ling MH, 1996, ACTA BIOCH BIOPH SIN, V28, P233; MIURA S, 1995, BIOSCI BIOTECH BIOCH, V59, P469, DOI 10.1271/bbb.59.469; Mylne JS, 2012, PLANT CELL, V24, P2765, DOI 10.1105/tpc.112.099085; Otlewski J, 1996, ACTA BIOCHIM POL, V43, P431; Qiu LJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-278; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; RYLE AP, 1955, BIOCHEM J, V60, P535, DOI 10.1042/bj0600535; Smith JJ, 2011, P NATL ACAD SCI USA, V108, P10478, DOI 10.1073/pnas.1103501108; Tan NH, 2006, CHEM REV, V106, P840, DOI 10.1021/cr040699h; Tang J, 2010, HELV CHIM ACTA, V93, P2287, DOI 10.1002/hlca.201000115; Tang J, 2010, PEPTIDES, V31, P1434, DOI 10.1016/j.peptides.2010.05.004; Telang M, 2003, PHYTOCHEMISTRY, V63, P643, DOI 10.1016/S0031-9422(03)00239-5; van den Hooven HW, 2001, BIOCHEMISTRY-US, V40, P3458, DOI 10.1021/bi0023089; Wang CK, 2009, J BIOL CHEM, V284, P10672, DOI 10.1074/jbc.M900021200; Wang XH, 2000, NAT STRUCT BIOL, V7, P505, DOI 10.1038/75921; Wu J, 1998, ANAL BIOCHEM, V258, P268, DOI 10.1006/abio.1998.2596; Wu J, 1997, PROTEIN SCI, V6, P391; Wu J, 1996, ANAL BIOCHEM, V235, P161, DOI 10.1006/abio.1996.0108; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Xu WY, 2008, CHINESE SCI BULL, V53, P1671, DOI 10.1007/s11434-008-0178-8; Zhou T, 2000, CHINESE SCI BULL, V45, P1825	55	14	14	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75334	10.1371/journal.pone.0075334	http://dx.doi.org/10.1371/journal.pone.0075334			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116036	Green Accepted, Green Published, gold			2022-12-25	WOS:000325552200016
J	Jiao, YY; Chen, X; Wang, X; Liao, XW; Xiao, L; Miao, AJ; Wu, J; Yang, LY				Jiao, Yiying; Chen, Xu; Wang, Xin; Liao, Xuewei; Xiao, Lin; Miao, Aijun; Wu, Jun; Yang, Liuyan			Identification and Characterization of a Cold-Active Phthalate Esters Hydrolase by Screening a Metagenomic Library Derived from Biofilms of a Wastewater Treatment Plant	PLOS ONE			English	Article							MICROCOCCUS SP YGJ1; N-BUTYL PHTHALATE; CHINA; PURIFICATION; DEGRADATION; CHEMICALS; TOXICITY; ENZYMES; LIPASES; PAES	A cold-active phthalate esters hydrolase gene (designated dphB) was identified through functional screening of a metagenomic library derived from biofilms of a wastewater treatment plant. The enzyme specifically catalyzed the hydrolysis of dipropyl phthalate, dibutyl phthalate, and dipentyl phthalate to the corresponding monoalkyl phthalate esters at low temperatures. The catalytic triad residues of DphB were proposed to be Ser159, Asp251, and His281.	[Jiao, Yiying; Chen, Xu; Wang, Xin; Xiao, Lin; Miao, Aijun; Wu, Jun; Yang, Liuyan] Nanjing Univ, State Key Lab Pollut Control & Resource Reuse, Dept Environm Biol, Sch Environm, Nanjing 210008, Jiangsu, Peoples R China; [Liao, Xuewei] Nanjing Normal Univ, Ctr Anal & Testing, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing Normal University	Wu, J (corresponding author), Nanjing Univ, State Key Lab Pollut Control & Resource Reuse, Dept Environm Biol, Sch Environm, Nanjing 210008, Jiangsu, Peoples R China.	wujun2008@nju.edu.cn; yangly@nju.edu.cn	yang, liu/GVU-8760-2022; liu, yang/HHY-8583-2022		Major Science and Technology Program for Water Pollution Control and Treatment [2012ZX07101006]; National Natural Science Foundation [21107047]	Major Science and Technology Program for Water Pollution Control and Treatment; National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the Major Science and Technology Program for Water Pollution Control and Treatment (Project no. 2012ZX07101006), and the National Natural Science Foundation (Project no. 21107047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita K, 2001, BIOSCI BIOTECH BIOCH, V65, P1680, DOI 10.1271/bbb.65.1680; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Bell PJL, 2002, MICROBIOL-SGM, V148, P2283, DOI 10.1099/00221287-148-8-2283; BRADY L, 1990, NATURE, V343, P767, DOI 10.1038/343767a0; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; David RM, 1999, TOXICOL SCI, V50, P195, DOI 10.1093/toxsci/50.2.195; DEREWENDA ZS, 1993, TRENDS BIOCHEM SCI, V18, P20, DOI 10.1016/0968-0004(93)90082-X; Hara H, 2010, APPL ENVIRON MICROB, V76, P1516, DOI 10.1128/AEM.02621-09; Huff J E, 1984, Prog Clin Biol Res, V141, P137; JAEGER KE, 1994, FEMS MICROBIOL REV, V15, P29, DOI 10.1016/0168-6445(94)90025-6; JOBLING S, 1995, ENVIRON HEALTH PERSP, V103, P582, DOI 10.2307/3432434; Jonsson S, 2003, ENVIRON TOXICOL CHEM, V22, P3037, DOI 10.1897/02-548; Ma M, 2007, ENVIRON POLLUT, V147, P331, DOI 10.1016/j.envpol.2006.05.032; Maruyama K, 2005, J BIOCHEM, V137, P27, DOI 10.1093/jb/mvi004; Nishioka T, 2006, APPL ENVIRON MICROB, V72, P2394, DOI 10.1128/AEM.72.4.2394-2399.2006; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Piersma AH, 2000, REPROD TOXICOL, V14, P417, DOI 10.1016/S0890-6238(00)00100-3; Staples CA, 1997, CHEMOSPHERE, V35, P667, DOI 10.1016/S0045-6535(97)00195-1; Vamsee-Krishna C, 2008, INDIAN J MICROBIOL, V48, P19, DOI 10.1007/s12088-008-0003-8; Wang F, 2008, J HAZARD MATER, V154, P317, DOI 10.1016/j.jhazmat.2007.10.028; Wang P, 2008, CHEMOSPHERE, V72, P1567, DOI 10.1016/j.chemosphere.2008.04.032; Wu J, 2013, APPL MICROBIOL BIOT, V97, P2483, DOI 10.1007/s00253-012-4232-8; Xu Y, 2003, J BACTERIOL, V185, P2161, DOI 10.1128/JB.185.7.2161-2168.2003; Xu Y, 2003, J BACTERIOL, V185, P5519, DOI 10.1128/JB.185.18.5519-5526.2003; Zeng F, 2008, ENVIRON POLLUT, V156, P425, DOI 10.1016/j.envpol.2008.01.045	27	33	35	6	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75977	10.1371/journal.pone.0075977	http://dx.doi.org/10.1371/journal.pone.0075977			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116085	gold, Green Published, Green Submitted			2022-12-25	WOS:000325552200045
J	King, JR; Warren, RJ; Bradford, MA				King, Joshua R.; Warren, Robert J.; Bradford, Mark A.			Social Insects Dominate Eastern US Temperate Hardwood Forest Macroinvertebrate Communities in Warmer Regions	PLOS ONE			English	Article							NET PRIMARY PRODUCTION; SUBTERRANEAN TERMITES; NEST ARCHITECTURE; ANT COMMUNITIES; SOIL FUNCTION; ABUNDANCE; RETICULITERMES; PATTERNS; BIOMASS; EARTHWORMS	Earthworms, termites, and ants are common macroinvertebrates in terrestrial environments, although for most ecosystems data on their abundance and biomass is sparse. Quantifying their areal abundance is a critical first step in understanding their functional importance. We intensively sampled dead wood, litter, and soil in eastern US temperate hardwood forests at four sites, which span much of the latitudinal range of this ecosystem, to estimate the abundance and biomass m(-2) of individuals in macroinvertebrate communities. Macroinvertebrates, other than ants and termites, differed only slightly among sites in total abundance and biomass and they were similar in ordinal composition. Termites and ants were the most abundant macroinvertebrates in dead wood, and ants were the most abundant in litter and soil. Ant abundance and biomass m(-2) in the southernmost site (Florida) were among the highest values recorded for ants in any ecosystem. Ant and termite biomass and abundance varied greatly across the range, from < 1% of the total macroinvertebrate abundance (in the northern sites) to > 95% in the southern sites. Our data reveal a pronounced shift to eusocial insect dominance with decreasing latitude in a temperate ecosystem. The extraordinarily high social insect relative abundance outside of the tropics lends support to existing data suggesting that ants, along with termites, are globally the most abundant soil macroinvertebrates, and surpass the majority of other terrestrial animal (vertebrate and invertebrate) groups in biomass m(-2). Our results provide a foundation for improving our understanding of the functional role of social insects in regulating ecosystem processes in temperate forest.	[King, Joshua R.] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA; [Warren, Robert J.] SUNY Buffalo State, Dept Biol, Buffalo, NY USA; [Bradford, Mark A.] Yale Univ, Yale Sch Forestry & Environm Studies, New Haven, CT USA	State University System of Florida; University of Central Florida; State University of New York (SUNY) System; Buffalo State College; Yale University	King, JR (corresponding author), Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA.	joshua.king@ucf.edu	Bradford, Mark A/G-3850-2012	Bradford, Mark A/0000-0002-2022-8331; Warren II, Robert/0000-0001-6765-2351	National Science Foundation (NSF) [DEB 1020415]; University of Central Florida; NSF [DEB-0823293, DEB-0218001]; Division Of Environmental Biology [0823293] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); University of Central Florida; NSF(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	JRK was supported by National Science Foundation (NSF) grant DEB 1020415 and an In-House grant from the University of Central Florida. MAB and RJW were supported by NSF grants DEB-0823293 and DEB-0218001 to the Coweeta LTER Program (http://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T., 1990, P29; Abe T., 2000, TERMITES EVOLUTION S; Andersen AN, 1997, J BIOGEOGR, V24, P433, DOI 10.1111/j.1365-2699.1997.00137.x; Baroni-Urbani C, 1978, PRODUCTION ECOLOGY A, P336; Bignell DE, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P363; Bolstad PV, 2001, FOREST PRODUCTIVITY; Bolton B., 2006, BOLTONS CATALOGUE AN; Brian M. V., 1978, PRODUCTION ECOLOGY A; Brown Jr W.L., 1973, TROPICAL FOREST ECOS, P161, DOI DOI 10.5281/ZENODO.17403; Brussaard L, 2013, SOIL ECOLOGY AND ECOSYSTEM SERVICES, P201; BURTON TM, 1975, COPEIA, P541; Callaham MA, 1997, SOIL BIOL BIOCHEM, V29, P317, DOI 10.1016/S0038-0717(96)00095-8; Cammeraat ELH, 2008, J APPL ENTOMOL, V132, P285, DOI 10.1111/j.1439-0418.2008.01281.x; Chojnacky DC, 2004, ENVIRON MANAGE, V33, pS44, DOI 10.1007/s00267-003-9116-3; Clark RE, 2012, ENVIRON ENTOMOL, V41, P1405, DOI 10.1603/EN12131; Cornwell WK, 2009, GLOBAL CHANGE BIOL, V15, P2431, DOI 10.1111/j.1365-2486.2009.01916.x; Davidson DW, 1997, BIOL J LINN SOC, V61, P153, DOI 10.1006/bijl.1996.0128; de Bruyn LAL, 1999, AGR ECOSYST ENVIRON, V74, P425, DOI 10.1016/S0167-8809(99)00047-X; DEBRUYN LAL, 1990, AUST J SOIL RES, V28, P55, DOI 10.1071/SR9900055; Deyrup M, 2003, FLA ENTOMOL, V86, P43, DOI 10.1653/0015-4040(2003)086[0043:AULOFA]2.0.CO;2; Edwards C.A, 1998, EARTHWORM ECOLOGY; Elliott KJ, 2011, FOREST ECOL MANAG, V261, P900, DOI 10.1016/j.foreco.2010.03.010; Ellison AM, 2007, ENVIRON ENTOMOL, V36, P766, DOI 10.1603/0046-225X(2007)36[766:RIOTAA]2.0.CO;2; EMERSON ALFRED E., 1936, SCIENCE, V83, P410, DOI 10.1126/science.83.2157.410; Fierer N, 2009, ECOL LETT, V12, P1238, DOI 10.1111/j.1461-0248.2009.01360.x; Folgarait PJ, 1998, BIODIVERS CONSERV, V7, P1221, DOI 10.1023/A:1008891901953; Goodale E, 2009, FOREST ECOL MANAG, V258, P314, DOI 10.1016/j.foreco.2009.04.020; Hendrix Paul F., 1994, Megadrilogica, V5, P73; Holldobler B., 1990, pi; Irland L.C, 1999, NE CHANGING FOREST; Jimenez JJ, 2008, APPL SOIL ECOL, V40, P120, DOI 10.1016/j.apsoil.2008.03.009; Kaspari M, 2000, P ROY SOC B-BIOL SCI, V267, P485, DOI 10.1098/rspb.2000.1026; Kaspari M, 2012, ECOGRAPHY, V35, P65, DOI 10.1111/j.1600-0587.2011.06971.x; Khattree R, 1999, APPL MULTIVARIATE ST; King JR, 2007, EVOL ECOL RES, V9, P757; King JR, 2010, ECOL ENTOMOL, V35, P287, DOI 10.1111/j.1365-2311.2010.01177.x; King JR, 2005, ENVIRON ENTOMOL, V34, P1566, DOI 10.1603/0046-225X-34.6.1566; Korb J, 2007, CURR BIOL, V17, pR995, DOI 10.1016/j.cub.2007.10.033; Lach L, 2010, ANT ECOLOGY, P1; Lavelle P., 1984, Biology International, P2; Lavelle P, 2006, EUR J SOIL BIOL, V42, pS3, DOI 10.1016/j.ejsobi.2006.10.002; LAVELLE P, 1992, SSSA SPEC PUBL, V29, P157; Lavelle P, 1997, EUR J SOIL BIOL, V33, P159; Lavelle P, 1997, ADV ECOL RES, V27, P93, DOI 10.1016/S0065-2504(08)60007-0; Lavelle P., 2001, SOIL ECOLOGY; Lugo AE, 1999, J BIOGEOGR, V26, P1025, DOI 10.1046/j.1365-2699.1999.00329.x; Lugo AE, 1978, DOE S SERIES, P790; Mickler RA, 2002, J AIR WASTE MANAGE, V52, P407, DOI 10.1080/10473289.2002.10470793; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Ollinger SV, 1998, LANDSCAPE ECOL, V13, P323, DOI 10.1023/A:1008004423783; Packard C. E., 1936, Science New York, V83, P575, DOI 10.1126/science.83.2163.575; PETERSEN H, 1982, OIKOS, V39, P287, DOI 10.2307/3544689; Platt W.J., 1990, ECOSYSTEMS FLORIDA, P194; PRINS HHT, 1989, J ANIM ECOL, V58, P851, DOI 10.2307/5128; Rodda GH, 2001, J TROP ECOL, V17, P331, DOI 10.1017/S0266467401001225; SCHALLER G B, 1983, Arquivos de Zoologia (Sao Paulo), V31, P1; Shakir SH, 1997, SOIL BIOL BIOCHEM, V29, P275, DOI 10.1016/S0038-0717(96)00051-X; SRIKOSAMATARA S, 1993, J TROP ECOL, V9, P33, DOI 10.1017/S026646740000691X; STORK NE, 1988, BIOL J LINN SOC, V35, P321, DOI 10.1111/j.1095-8312.1988.tb00474.x; Suarez ER, 2006, ECOL APPL, V16, P154, DOI 10.1890/04-0788; Thorne BL, 1999, ETHOL ECOL EVOL, V11, P149, DOI 10.1080/08927014.1999.9522833; Tobin John E., 1995, P129; TSCHINKEL WR, 1991, INSECT SOC, V38, P77, DOI 10.1007/BF01242715; Tschinkel WR, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.21; Tschinkel WR, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.9; TURNER MG, 1987, ENVIRON MANAGE, V11, P237, DOI 10.1007/BF01867202; Vargo EL, 2013, MOL ECOL, V22, P1447, DOI 10.1111/mec.12166; Vargo EL, 2009, ANNU REV ENTOMOL, V54, P379, DOI 10.1146/annurev.ento.54.110807.090443; Warren RJ, 2010, CASTANEA, V75, P67, DOI 10.2179/08-048.1; Watt AD, 2002, J APPL ECOL, V39, P18, DOI 10.1046/j.1365-2664.2002.00699.x; Wheller WM, 1911, J MORPHOL, V22, P307; Wood T.G., 1978, International Biological Programme, P245	72	47	49	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75843	10.1371/journal.pone.0075843	http://dx.doi.org/10.1371/journal.pone.0075843			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116079	Green Published, gold			2022-12-25	WOS:000325552200041
J	Chen, GQ; Qiu, Y; Sun, LH; Yu, M; Wang, WS; Xiao, WD; Yang, Y; Liu, Y; Yang, SW; Teitelbaum, DH; Ma, YH; Lu, DS; Yang, H				Chen, Guoqing; Qiu, Yuan; Sun, Lihua; Yu, Min; Wang, Wensheng; Xiao, Weidong; Yang, Yang; Liu, Yong; Yang, Songwei; Teitelbaum, Daniel H.; Ma, Yuanhang; Lu, Dingsong; Yang, Hua			The Jagged-2/Notch-1/Hes-1 Pathway Is Involved in Intestinal Epithelium Regeneration after Intestinal Ischemia-Reperfusion Injury	PLOS ONE			English	Article							RAT SMALL-INTESTINE; CELL-PROLIFERATION; PROGENITOR CELLS; NOTCH; EXPRESSION; FATE; DIFFERENTIATION; DECARBOXYLASE; P27(KIP1); PROMOTES	Background: Notch signaling plays a critical role in the maintenance of intestinal crypt epithelial cell proliferation. The aim of this study was to investigate the role of Notch signaling in the proliferation and regeneration of intestinal epithelium after intestinal ischemia reperfusion (I/R) injury. Methods: Male Sprague-Dawley rats were subjected to sham operation or I/R by occlusion of the superior mesenteric artery (SMA) for 20 min. Intestinal tissue samples were collected at 0, 1, 2, 4, and 6 h after reperfusion. Proliferation of the intestinal epithelium was evaluated by immunohistochemical staining of proliferating nuclear antigen (PCNA). The mRNA and protein expression levels of Notch signaling components were examined using Real-time PCR and Western blot analyses. Immunofluorescence was also performed to detect the expression and location of Jagged-2, cleaved Notch-1, and Hes-1 in the intestine. Finally, the gamma-secretase inhibitor DAPT and the siRNA for Jagged-2 and Hes-1 were applied to investigate the functional role of Notch signaling in the proliferation of intestinal epithelial cells in an in vitro IEC-6 culture system. Results: I/R injury caused increased intestinal crypt epithelial cell proliferation and increased mRNA and protein expression of Jagged-2, Notch-1, and Hes-1. The immunofluorescence results further confirmed increased protein expression of Jagged-2, cleaved Notch-1, and Hes-1 in the intestinal crypts. The inhibition of Notch signaling with DAPT and the suppression of Jagged-2 and Hes-1 expression using siRNA both significantly inhibited the proliferation of IEC-6 cells. Conclusion: The Jagged-2/Notch-1/Hes-1 signaling pathway is involved in intestinal epithelium regeneration early after I/R injury by increasing crypt epithelial cell proliferation.	[Chen, Guoqing; Qiu, Yuan; Sun, Lihua; Yu, Min; Wang, Wensheng; Xiao, Weidong; Yang, Yang; Liu, Yong; Yang, Songwei; Ma, Yuanhang; Lu, Dingsong; Yang, Hua] Third Mil Med Univ, Xinqiao Hosp, Dept Gen Surg, Chongqing, Peoples R China; [Teitelbaum, Daniel H.] Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI USA	Army Medical University; University of Michigan System; University of Michigan	Yang, H (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Gen Surg, Chongqing, Peoples R China.	huayang@tmmu.edu.cn		Yu, Min/0000-0002-8845-8977	National Natural Science Foundation of China [NSFC 81020108023, NSFC 81272078, NSFC 81270451]; Chongqing Science and Technology Commission International Key Collaboration Project [CSTC 201110008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Science and Technology Commission International Key Collaboration Project	This work was supported by the National Natural Science Foundation of China (NSFC 81020108023 and NSFC 81272078 to H.Y., NSFC 81270451 to W.D.X.) and the Chongqing Science and Technology Commission International Key Collaboration Project (CSTC 201110008 to H.Y.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphe Christelle, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009890; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Bar Y, 2008, DIABETES, V57, P2413, DOI 10.2337/db07-1323; Baron M, 2003, SEMIN CELL DEV BIOL, V14, P113, DOI 10.1016/S1084-9521(02)00179-9; Cai YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044772; Chen G, 2013, DIG DIS SCI; Croquelois A, 2008, J EXP MED, V205, P3173, DOI 10.1084/jem.20081427; El-Assal Osama N, 2004, Semin Pediatr Surg, V13, P2, DOI 10.1053/j.sempedsurg.2003.09.002; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; FUJIMOTO K, 1992, J CLIN INVEST, V89, P126, DOI 10.1172/JCI115552; FUJIMOTO K, 1991, AM J PHYSIOL, V261, pG523, DOI 10.1152/ajpgi.1991.261.3.G523; Heath JK, 2010, CURR TOP DEV BIOL, V90, P159, DOI 10.1016/S0070-2153(10)90004-5; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Itoh H, 2002, DIGEST DIS SCI, V47, P2704, DOI 10.1023/A:1021049004188; JOHNSON LR, 1988, PHYSIOL REV, V68, P456, DOI 10.1152/physrev.1988.68.2.456; Kobayashi T, 2008, KIDNEY INT, V73, P1240, DOI 10.1038/ki.2008.74; Kohler C, 2004, HEPATOLOGY, V39, P1056, DOI 10.1002/hep.20156; Kokubo H, 1999, BIOCHEM BIOPH RES CO, V260, P459, DOI 10.1006/bbrc.1999.0880; Ma XB, 2009, CELL PROLIFERAT, V42, P15, DOI 10.1111/j.1365-2184.2008.00569.x; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; Okamoto R, 2004, J GASTROENTEROL, V39, P1, DOI 10.1007/s00535-003-1259-8; Okamoto R, 2009, AM J PHYSIOL-GASTR L, V296, pG23, DOI 10.1152/ajpgi.90225.2008; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; RIJKE RPC, 1976, GASTROENTEROLOGY, V71, P786; Sander GR, 2004, J HISTOCHEM CYTOCHEM, V52, P509, DOI 10.1177/002215540405200409; Schroeder Natalia, 2002, Gene Expression Patterns, V2, P247, DOI 10.1016/S1567-133X(02)00060-1; Shima Y, 2006, J PEDIATR SURG, V41, P830, DOI 10.1016/j.jpedsurg.2005.12.025; Sivere JT, 2008, GASTROENTEROLOGY, V134, P544, DOI 10.1053/j.gastro.2007.11.003; Stanger BZ, 2005, P NATL ACAD SCI USA, V102, P12443, DOI 10.1073/pnas.0505690102; Tsai S, 2000, BLOOD, V96, P950, DOI 10.1182/blood.V96.3.950.015k43_950_957; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Wang WS, 2012, PEDIATR SURG INT, V28, P533, DOI 10.1007/s00383-012-3075-9; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Xing F, 2011, ONCOGENE, V30, P4075, DOI 10.1038/onc.2011.122; Yamamoto S, 2001, J SURG RES, V99, P134, DOI 10.1006/jsre.2001.6106; Yeh KY, 1998, AM J PHYSIOL-GASTR L, V275, pG572, DOI 10.1152/ajpgi.1998.275.3.G572; Yeo SY, 2007, P NATL ACAD SCI USA, V104, P5913, DOI 10.1073/pnas.0607062104	39	15	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76274	10.1371/journal.pone.0076274	http://dx.doi.org/10.1371/journal.pone.0076274			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098462	Green Published, gold, Green Submitted			2022-12-25	WOS:000325483600035
J	Davidson, MG; Alonso, MN; Kenkel, JA; Suhoski, MM; Gonzalez, JC; Yuan, R; Engleman, EG				Davidson, Matthew G.; Alonso, Michael N.; Kenkel, Justin A.; Suhoski, Megan M.; Gonzalez, Joseph C.; Yuan, Robert; Engleman, Edgar G.			In Vivo T Cell Activation Induces the Formation of CD209(+) PDL-2(+) Dendritic Cells	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; COLONY-STIMULATING FACTOR; TOXIC-SHOCK-SYNDROME; PROGRAMMED DEATH-1; BLOOD MONOCYTES; PD-1; B7-DC; DIFFERENTIATE; RESPONSES; EFFECTOR	Two critical functions of dendritic cells (DC) are to activate and functionally polarize T cells. Activated T cells can, in turn, influence DC maturation, although their effect on de novo DC development is poorly understood. Here we report that activation of T cells in mice, with either an anti-CD3 antibody or super antigen, drives the rapid formation of CD209(+)CD11b(+)CD11c(+) MHC II+ DC from monocytic precursors (Mo-DC). GM-CSF is produced by T cells following activation, but surprisingly, it is not required for the formation of CD209(+) Mo-DC. CD40L, however, is critical for the full induction of Mo-DC following T cell activation. T cell induced CD209(+) Mo-DC are comparable to conventional CD209-DC in their ability to stimulate T cell proliferation. However, in contrast to conventional CD209(-) DC, CD209(+) Mo-DC fail to effectively polarize T cells, as indicated by a paucity of T cell cytokine production. The inability of CD209(+) Mo-DC to polarize T cells is partly explained by increased expression of PDL-2, since blockade of this molecule restores some polarizing capacity to the Mo-DC. These findings expand the range of signals capable of driving Mo-DC differentiation in vivo beyond exogenous microbial factors to include endogenous factors produced following T cell activation.	[Davidson, Matthew G.; Alonso, Michael N.; Kenkel, Justin A.; Suhoski, Megan M.; Gonzalez, Joseph C.; Yuan, Robert; Engleman, Edgar G.] Stanford Univ, Sch Med, Ctr Blood, Dept Pathol, Palo Alto, CA 94304 USA	Stanford University	Engleman, EG (corresponding author), Stanford Univ, Sch Med, Ctr Blood, Dept Pathol, Palo Alto, CA 94304 USA.	edengleman@stanford.edu			National Institutes of Health [HL075462, DK082537, DK096038]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL075462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082537, R01DK096038] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health grants HL075462, DK082537 and DK096038. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso MN, 2011, BLOOD, V118, P3311, DOI 10.1182/blood-2011-03-341065; Baban B, 2011, J IMMUNOL, V187, P2329, DOI 10.4049/jimmunol.1100276; Brossart P, 1998, BLOOD, V92, P4238, DOI 10.1182/blood.V92.11.4238.423k16_4238_4247; Brown JA, 2003, J IMMUNOL, V170, P1257, DOI 10.4049/jimmunol.170.3.1257; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Cheong C, 2010, J IMMUNOL METHODS, V360, P66, DOI 10.1016/j.jim.2010.06.006; Davidson MG, 2013, J IMMUNOL; Duffner UA, 2004, J IMMUNOL, V172, P7393, DOI 10.4049/jimmunol.172.12.7393; FERRAN C, 1990, EUR J IMMUNOL, V20, P509, DOI 10.1002/eji.1830200308; Ghiotto M, 2010, INT IMMUNOL, V22, P651, DOI 10.1093/intimm/dxq049; Jabara HH, 1996, INT IMMUNOL, V8, P1503, DOI 10.1093/intimm/8.10.1503; Koguchi Y, 2007, BLOOD, V110, P2520, DOI 10.1182/blood-2007-03-081299; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; MIETHKE T, 1993, EUR J IMMUNOL, V23, P1494, DOI 10.1002/eji.1830230715; Novak N, 2012, J ALLERGY CLIN IMMUN, V129, P879, DOI 10.1016/j.jaci.2012.01.062; Ochi A, 1993, Semin Immunol, V5, P57, DOI 10.1006/smim.1993.1008; Pfistershammer K, 2006, EUR J IMMUNOL, V36, P1104, DOI 10.1002/eji.200535344; Pilat N, 2011, SEMIN IMMUNOL, V23, P293, DOI 10.1016/j.smim.2011.04.002; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Rozali EN, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/656340; Santiago-Schwarz F, 2001, J IMMUNOL, V167, P1758, DOI 10.4049/jimmunol.167.3.1758; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shi YF, 2006, CELL RES, V16, P126, DOI 10.1038/sj.cr.7310017; Shin T, 2003, J EXP MED, V198, P31, DOI 10.1084/jem.20030242; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; Sporri R, 2003, J IMMUNOL, V171, P6406, DOI 10.4049/jimmunol.171.12.6406; Stenger EO, 2012, BLOOD, V119, P5088, DOI 10.1182/blood-2011-11-364091; Wang SD, 2003, J EXP MED, V197, P1083, DOI 10.1084/jem.20021752; Watanabe S, 2007, CLIN IMMUNOL, V122, P288, DOI 10.1016/j.clim.2006.10.013; Wei F, 2013, P NATL ACAD SCI USA, V110, pE2480, DOI 10.1073/pnas.1305394110; Youngnak P, 2003, BIOCHEM BIOPH RES CO, V307, P672, DOI 10.1016/S0006-291X(03)01257-9; Zaba LC, 2009, J INVEST DERMATOL, V129, P79, DOI 10.1038/jid.2008.194; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588	33	5	5	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76258	10.1371/journal.pone.0076258	http://dx.doi.org/10.1371/journal.pone.0076258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098455	gold, Green Submitted, Green Published			2022-12-25	WOS:000325434500056
J	Aranda, G; Abascal, FJ; Varela, JL; Medina, A				Aranda, Guillermo; Javier Abascal, Francisco; Luis Varela, Jose; Medina, Antonio			Spawning Behaviour and Post-Spawning Migration Patterns of Atlantic Bluefin Tuna (Thunnus thynnus) Ascertained from Satellite Archival Tags	PLOS ONE			English	Article							YELLOWFIN TUNA; DIVING BEHAVIOR; NORTH-ATLANTIC; POPULATION-STRUCTURE; HABITAT UTILIZATION; KATSUWONUS-PELAMIS; THERMAL BIOLOGY; PACIFIC-OCEAN; PELAGIC FISH; L. 1758	Spawning behaviour of Atlantic bluefin tuna (Thunnus thynnus) was investigated using electronic satellite tags deployed in the western Mediterranean spawning ground, around the Balearic Islands (years 2009-2011). All the fish were tagged underwater and released within schools. In general, the fish tagged in the same year/school displayed common migratory trends. Following extended residency around the Balearic Islands, most tagged tuna crossed the Strait of Gibraltar heading for the North Atlantic. Discrepancies between the migratory tracks reconstructed from this and previous electronic tagging studies suggest that the bluefin tuna Mediterranean population may comprise distinct units exhibiting differing migratory behaviours. The diving behaviour varied between oceanic regions throughout the migratory pathways, the shallowest distribution taking place in the spawning ground and the deepest at the Strait of Gibraltar. A unique diving pattern was found on the majority of nights while the fish stayed at the spawning ground; it consisted of frequent and brief oscillatory movements up and down through the mixed layer, resulting in thermal profiles characterized by oscillations about the thermocline. Such a pattern is believed to reflect recent courtship and spawning activity. Reproductive parameters inferred from the analysis of vertical profiles are consistent with those estimated in previous studies based on biological samples.	[Aranda, Guillermo; Luis Varela, Jose; Medina, Antonio] Univ Cadiz, Dept Biol, Fac Ciencias Mar & Ambientales, Cadiz, Spain; [Javier Abascal, Francisco] Inst Espanol Oceanog, Ctr Oceanog Canarias, Santa Cruz De Tenerife, Spain	Universidad de Cadiz; Spanish Institute of Oceanography	Medina, A (corresponding author), Univ Cadiz, Dept Biol, Fac Ciencias Mar & Ambientales, Campus Excelencia Int Mar CEI MAR, Cadiz, Spain.	antonio.medina@uca.es	Aranda, Guillermo/X-7556-2018; Abascal, Francisco/AAF-4118-2019; Medina, Antonio/A-1624-2008; Varela, Jose Luis/AAM-3303-2020; Abascal, Francisco/I-4222-2015	Aranda, Guillermo/0000-0002-9650-0856; Abascal, Francisco/0000-0002-8550-8617; Medina, Antonio/0000-0001-5609-3574; Abascal, Francisco/0000-0002-8550-8617; Varela, Jose Luis/0000-0002-5235-7605	Spanish government; EC FEDER [CTM2007-65178-C02-01/MAR, CTM2011-29525-C04]; Junta de Andalucia [RNM-02469]; Fundacion Migres	Spanish government(Spanish GovernmentEuropean Commission); EC FEDER(European CommissionEuropean Commission Joint Research Centre); Junta de Andalucia(Junta de Andalucia); Fundacion Migres	Grants from the Spanish government and EC FEDER (CTM2007-65178-C02-01/MAR, CTM2011-29525-C04), Junta de Andalucia (RNM-02469) and Fundacion Migres are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany F, 2010, PROG OCEANOGR, V86, P21, DOI 10.1016/j.pocean.2010.04.014; Aranda G, 2013, J SEA RES, V76, P154, DOI 10.1016/j.seares.2012.08.005; ARNOLD GP, 1974, BIOL REV, V49, P515, DOI 10.1111/j.1469-185X.1974.tb01173.x; BAGLIN RE, 1982, FISH B-NOAA, V80, P121; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; Block BA, 1997, MAR BIOL, V130, P119, DOI 10.1007/s002270050231; Brill R, 2002, FISH B-NOAA, V100, P155; BUSHNELL PG, 1990, CAN J ZOOL, V68, P1857, DOI 10.1139/z90-265; BUSHNELL PG, 1992, J COMP PHYSIOL B, V162, P131, DOI 10.1007/BF00398338; Cayre P, 1993, AQUAT LIVING RESOUR, V6, P1, DOI 10.1051/alr:1993001; Cermeno P, 2012, INT COMM CONS ATL CO, V68, P151; Corriero A, 2005, J APPL ICHTHYOL, V21, P483, DOI 10.1111/j.1439-0426.2005.00700.x; De Metrio G., 2002, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V54, P415; De Metrio G., 2005, P161; De Metrio G., 2001, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V52, P776; De Metrio G, 2005, COL VOL SCI PAP ICCA, V58, P1337; Evans K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034550; Fromentin Jean-Marc, 2010, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V65, P812; Fromentin JM, 2005, FISH FISH, V6, P281, DOI 10.1111/j.1467-2979.2005.00197.x; Galuardi B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037829; Galuardi B, 2010, CAN J FISH AQUAT SCI, V67, P966, DOI 10.1139/F10-033; Garcia H. E., 2010, WORLD OCEAN ATLAS, V3, P1; GORDOA A, 2010, COLLECTIVE VOLUMES S, V65, P837; Gordoa A, 2009, ICES J MAR SCI, V66, P2205, DOI 10.1093/icesjms/fsp211; Heinisch G, 2008, MAR BIOL, V154, P623, DOI 10.1007/s00227-008-0955-6; Hoolihan JP, 2011, ICES J MAR SCI, V68, P880, DOI 10.1093/icesjms/fsr024; Kitagawa T, 2007, FISHERIES SCI, V73, P98, DOI 10.1111/j.1444-2906.2007.01307.x; Klimley AP, 1999, MAR BIOL, V133, P307, DOI 10.1007/s002270050469; Lawson GL, 2010, MAR ECOL PROG SER, V400, P245, DOI 10.3354/meps08394; Lutcavage ME, 2000, MAR BIOL, V137, P347, DOI 10.1007/s002270000302; Lutcavage ME, 1999, CAN J FISH AQUAT SCI, V56, P173, DOI 10.1139/cjfas-56-2-173; Lutcavage Molly, 2001, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V52, P759; Medina A, 2002, J FISH BIOL, V60, P203, DOI [10.1111/j.1095-8649.2002.tb02398.x, 10.1006/jfbi.2001.1835]; Medina A, 2007, MAR ECOL PROG SER, V337, P221, DOI 10.3354/meps337221; Medina Antonio, 2011, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V66, P874; Muhling BA, 2011, B MAR SCI, V87, P687, DOI 10.5343/bms.2010.1101; Musyl MK, 2011, MAR ECOL PROG SER, V433, P1, DOI 10.3354/meps09202; Reglero P, 2012, MAR ECOL PROG SER, V463, P273, DOI 10.3354/meps09800; Riccioni G, 2010, P NATL ACAD SCI USA, V107, P2102, DOI 10.1073/pnas.0908281107; Rooker JR, 2008, MAR ECOL PROG SER, V368, P231, DOI 10.3354/meps07602; Rooker JR, 2007, REV FISH SCI, V15, P265, DOI 10.1080/10641260701484135; Royer F, 2009, REV-METHODS TECHNOL, V9, P323, DOI 10.1007/978-1-4020-9640-2_20; Sara G, 2007, MAR ECOL PROG SER, V331, P243, DOI 10.3354/meps331243; Schaefer KM, 2007, MAR BIOL, V152, P503, DOI 10.1007/s00227-007-0689-x; Schaefer KM, 2011, FISH RES, V112, P22, DOI 10.1016/j.fishres.2011.08.006; Semba Yasuko, 2009, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V64, P662; Sibert JR, 2006, CAN J FISH AQUAT SCI, V63, P2154, DOI 10.1139/F06-114; Simon M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048583; Stokesbury MJW, 2004, CAN J FISH AQUAT SCI, V61, P1976, DOI 10.1139/F04-130; Sumaila UR, 2012, MAR POLICY, V36, P502, DOI 10.1016/j.marpol.2011.08.010; Taylor NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027693; Teo SLH, 2007, MAR BIOL, V152, P1105, DOI 10.1007/s00227-007-0758-1; Teo SLH, 2007, MAR BIOL, V151, P1, DOI 10.1007/s00227-006-0447-5; TINTORE J, 1988, J PHYS OCEANOGR, V18, P1384, DOI 10.1175/1520-0485(1988)018<1384:ASOAID>2.0.CO;2; Tudela Sergi, 2011, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V66, P1157; Vinas J, 2011, REV FISH BIOL FISHER, V21, P527, DOI 10.1007/s11160-010-9174-6; Walli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006151; Webster DG, 2011, MAR POLICY, V35, P249, DOI 10.1016/j.marpol.2010.08.004; Wilson SG, 2005, MAR BIOL, V146, P409, DOI 10.1007/s00227-004-1445-0; Wilson Steven G., 2010, Endangered Species Research, V10, P355; Yamashita H, 2001, COL VOL SCI PAP ICCA, V52, P809; Zar J. H., 1996, BIOSTATISTICAL ANAL	63	72	72	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76445	10.1371/journal.pone.0076445	http://dx.doi.org/10.1371/journal.pone.0076445			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098502	gold, Green Published, Green Submitted			2022-12-25	WOS:000325427100067
J	Jennings, RM; Etter, RJ; Ficarra, L				Jennings, Robert M.; Etter, Ron J.; Ficarra, Lynn			Population Differentiation and Species Formation in the Deep Sea: The Potential Role of Environmental Gradients and Depth	PLOS ONE			English	Article							GENETIC-STRUCTURE; MITOCHONDRIAL-DNA; REPRODUCTIVE ISOLATION; ECOLOGICAL SPECIATION; LARVAL DISPERSAL; LOCAL ADAPTATION; HAPLOTYPE RECONSTRUCTION; BATHYMETRIC PATTERNS; PROTOBRANCH BIVALVES; ALTITUDINAL GRADIENT	Ecological speciation probably plays a more prominent role in diversification than previously thought, particularly in marine ecosystems where dispersal potential is great and where few obvious barriers to gene flow exist. This may be especially true in the deep sea where allopatric speciation seems insufficient to account for the rich and largely endemic fauna. Ecologically driven population differentiation and speciation are likely to be most prevalent along environmental gradients, such as those attending changes in depth. We quantified patterns of genetic variation along a depth gradient (1600-3800m) in the western North Atlantic for a protobranch bivalve (Nucula atacellana) to test for population divergence. Multilocus analyses indicated a sharp discontinuity across a narrow depth range, with extremely low gene flow inferred between shallow and deep populations for thousands of generations. Phylogeographical discordance occurred between nuclear and mitochondrial loci as might be expected during the early stages of species formation. Because the geographic distance between divergent populations is small and no obvious dispersal barriers exist in this region, we suggest the divergence might reflect ecologically driven selection mediated by environmental correlates of the depth gradient. As inferred for numerous shallow-water species, environmental gradients that parallel changes in depth may play a key role in the genesis and adaptive radiation of the deep-water fauna.	[Jennings, Robert M.; Etter, Ron J.; Ficarra, Lynn] Univ Massachusetts, Dept Biol, Boston, MA 02125 USA	University of Massachusetts System; University of Massachusetts Boston	Jennings, RM (corresponding author), Univ Massachusetts, Dept Biol, Boston, MA 02125 USA.	rob.jennings@umb.edu	Jennings, Robert/D-4393-2009	Jennings, Robert/0000-0003-4714-5824	NSF [OCE0726382, OCE1130541]	NSF(National Science Foundation (NSF))	This research was supported by NSF (nsf.gov) Grants OCE0726382 and OCE1130541. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 1996, PROG OCEANOGR, V38, P95, DOI 10.1016/S0079-6611(96)00011-0; Avise JC, 2004, TAXON, V53, P893, DOI 10.2307/4135555; Baco AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045555; Baco AR, 2005, ERLANGEN EARTH C SER, P663, DOI 10.1007/3-540-27673-4_33; Baird HP, 2011, MOL ECOL, V20, P3439, DOI 10.1111/j.1365-294X.2011.05173.x; Barber PH, 2002, MOL ECOL, V11, P659, DOI 10.1046/j.1365-294X.2002.01468.x; Barber PH, 2000, NATURE, V406, P692, DOI 10.1038/35021135; Barker JSF, 2011, J EVOLUTION BIOL, V24, P430, DOI 10.1111/j.1420-9101.2010.02180.x; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Benzie JAH, 1997, EVOLUTION, V51, P768, DOI 10.1111/j.1558-5646.1997.tb03660.x; Bierne N, 2003, P ROY SOC B-BIOL SCI, V270, P1399, DOI 10.1098/rspb.2003.2404; Bird CE, 2011, INTEGR COMP BIOL, V51, pE11; Bongaerts P, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-303; Bowen BW, 2013, TRENDS ECOL EVOL, V28, P359, DOI 10.1016/j.tree.2013.01.018; Bower A, 2011, DEEP-SEA RES PT II, V58, P1798, DOI 10.1016/j.dsr2.2010.10.060; Bower AS, 2013, DEEP-SEA RES PT II, V85, P15, DOI 10.1016/j.dsr2.2012.07.029; BOYLE EA, 1982, SCIENCE, V218, P784, DOI 10.1126/science.218.4574.784; Bradbury IR, 2007, MAR ECOL PROG SER, V340, P245, DOI 10.3354/meps340245; Brown A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028562; BUCKLIN A, 1987, DEEP-SEA RES, V34, P1795, DOI 10.1016/0198-0149(87)90054-9; Bulgarella M, 2012, MOL ECOL, V21, P350, DOI 10.1111/j.1365-294X.2011.05400.x; Burgess MD, 2011, J ANIM ECOL, V80, P688, DOI 10.1111/j.1365-2656.2011.01816.x; Butlin R, 2012, TRENDS ECOL EVOL, V27, P27, DOI 10.1016/j.tree.2011.09.002; Byars SG, 2009, ANN BOT-LONDON, V103, P885, DOI 10.1093/aob/mcp018; Carlon DB, 2002, EVOLUTION, V56, P2227; Carney RS, 2005, OCEANOGR MAR BIOL, V43, P211; Castelin M, 2011, DEEP-SEA RES PT I, V58, P637, DOI 10.1016/j.dsr.2011.03.008; Chase MR, 1998, MAR BIOL, V131, P301, DOI 10.1007/s002270050323; Cheviron ZA, 2009, EVOLUTION, V63, P1593, DOI 10.1111/j.1558-5646.2009.00644.x; Cho W, 2010, MAR ECOL-EVOL PERSP, V31, P121, DOI 10.1111/j.1439-0485.2010.00395.x; Clague GE, 2011, BIOL LETTERS, V7, P863, DOI 10.1098/rsbl.2011.0458; Clark MR, 2011, OCEAN COAST MANAGE, V54, P19, DOI 10.1016/j.ocecoaman.2010.10.006; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conover DO, 2009, ANN NY ACAD SCI, V1168, P100, DOI 10.1111/j.1749-6632.2009.04575.x; Costantini F, 2011, CORAL REEFS, V30, P991, DOI 10.1007/s00338-011-0771-1; Cowart DA, 2013, MOL ECOL, V22, P4147, DOI 10.1111/mec.12379; Coyne JA, 2004, SPECIATION, V37; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; Danovaro R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007006; Dennis AB, 2010, MOL ECOL, V19, P3206, DOI 10.1111/j.1365-294X.2010.04689.x; Dmitriev DA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000113; Doebeli M, 2003, NATURE, V421, P259, DOI 10.1038/nature01274; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dubey S, 2010, MOL ECOL, V19, P886, DOI 10.1111/j.1365-294X.2010.04539.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edwards SV, 2000, EVOLUTION, V54, P1839; Ehinger M, 2002, MOL ECOL, V11, P939, DOI 10.1046/j.1365-294X.2002.01487.x; Vega-Vela NE, 2012, ECOL EVOL, V2, P2669, DOI 10.1002/ece3.360; Etter RJ, 2005, EVOLUTION, V59, P1479, DOI 10.1111/j.0014-3820.2005.tb01797.x; Etter RJ, 1999, DEEP-SEA RES PT I, V46, P1095, DOI 10.1016/S0967-0637(98)00100-9; Etter RJ, 2011, MOL ECOL, V20, P829, DOI 10.1111/j.1365-294X.2010.04978.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Eytan RI, 2009, MOL ECOL, V18, P2375, DOI 10.1111/j.1365-294X.2009.04202.x; Falush D, 2003, GENETICS, V164, P1567; Felsenstein J, 2006, MOL BIOL EVOL, V23, P691, DOI 10.1093/molbev/msj079; France SC, 1996, MAR BIOL, V126, P633, DOI 10.1007/BF00351330; Gage J. D., 1991, DEEP SEA BIOL NATURA; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; GANZ HH, 1995, MAR BIOL, V123, P821, DOI 10.1007/BF00349126; Giordano AR, 2007, MOL ECOL, V16, P1625, DOI 10.1111/j.1365-294X.2006.03223.x; Glover AG, 2010, ADV MAR BIOL, V58, P1, DOI [10.1016/B978-0-12-381015-1.00001-0, 10.1016/S0065-2881(10)58001-5]; Hare MP, 2005, EVOLUTION, V59, P2509, DOI 10.1554/05-150.1; Harris PT, 2009, OCEAN COAST MANAGE, V52, P22, DOI 10.1016/j.ocecoaman.2008.09.009; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hellberg ME, 1996, EVOLUTION, V50, P1167, DOI 10.1111/j.1558-5646.1996.tb02357.x; Hellberg ME, 1999, MOL BIOL EVOL, V16, P839, DOI 10.1093/oxfordjournals.molbev.a026168; Hellberg ME, 2009, ANNU REV ECOL EVOL S, V40, P291, DOI 10.1146/annurev.ecolsys.110308.120223; Hensen I, 2012, GLOBAL ECOL BIOGEOGR, V21, P455, DOI 10.1111/j.1466-8238.2011.00691.x; Herrera S, 2012, MOL ECOL, V21, P6053, DOI 10.1111/mec.12074; HESSLER RR, 1967, DEEP-SEA RES, V14, P65; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hudson RR, 2003, EVOLUTION, V57, P182; Garcia-Merchan VH, 2012, MOL PHYLOGENET EVOL, V62, P664, DOI 10.1016/j.ympev.2011.11.009; Irwin DE, 2012, AM NAT, V180, P35, DOI 10.1086/666002; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jennings RM, 2011, MOL ECOL RESOUR, V11, P1102, DOI 10.1111/j.1755-0998.2011.03038.x; Johannesson K, 2010, PHILOS T R SOC B, V365, P1735, DOI 10.1098/rstb.2009.0256; Johnson SB, 2006, BIOL BULL-US, V210, P140, DOI 10.2307/4134603; Keigwin LD, 1999, SCIENCE, V286, P520, DOI 10.1126/science.286.5439.520; Keller I, 2012, MOL ECOL, V21, P782, DOI 10.1111/j.1365-294X.2011.05397.x; Keller I, 2011, MOL ECOL, V20, P1888, DOI 10.1111/j.1365-294X.2011.05067.x; Keller O, 2011, BIOINFORMATICS, V27, P757, DOI 10.1093/bioinformatics/btr010; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Kirk NL, 2009, MAR BIOL, V156, P1609, DOI 10.1007/s00227-009-1196-z; Knowles LL, 2007, SYST BIOL, V56, P887, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Laakmann S, 2012, MOL PHYLOGENET EVOL, V65, P535, DOI 10.1016/j.ympev.2012.07.007; LARKIN MA, 2007, CLUSTAL W CLUSTAL X; Lessios HA, 2008, ANNU REV ECOL EVOL S, V39, P63, DOI 10.1146/annurev.ecolsys.38.091206.095815; Lessios HA, 2011, INTEGR COMP BIOL, V51, P456, DOI 10.1093/icb/icr039; Levin LA, 2001, ECOSYSTEMS, V4, P430, DOI 10.1007/s10021-001-0021-4; Levin LA, 2003, OCEANOGR MAR BIOL, V41, P1; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; Levin LA, 2012, ANNU REV MAR SCI, V4, P79, DOI 10.1146/annurev-marine-120709-142714; Li N, 2003, GENETICS, V165, P2213; Lozier MS, 2013, DEEP-SEA RES PT II, V85, P147, DOI 10.1016/j.dsr2.2012.07.037; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Marko PB, 2002, MOL BIOL EVOL, V19, P2005, DOI 10.1093/oxfordjournals.molbev.a004024; Marshall DJ, 2010, ECOL LETT, V13, P128, DOI 10.1111/j.1461-0248.2009.01408.x; MARUYAMA T, 1984, GENETICS; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Meirmans PG, 2006, EVOLUTION, V60, P2399, DOI 10.1111/j.0014-3820.2006.tb01874.x; Metz EC, 1996, MOL BIOL EVOL, V13, P397, DOI 10.1093/oxfordjournals.molbev.a025598; Miller K, 2011, TLS-TIMES LIT SUPPL, P6; Moura CJ, 2008, ZOOL SCR, V37, P93, DOI 10.1111/j.1463-6409.2007.00312.x; Moura CJ, 2012, ZOOL SCR, V41, P79, DOI 10.1111/j.1463-6409.2011.00503.x; Near TJ, 2004, EVOLUTION, V58, P2798; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Nosil P, 2005, EVOLUTION, V59, P705; Ogden R, 2002, P NATL ACAD SCI USA, V99, P13612, DOI 10.1073/pnas.212248499; Ohsawa T, 2008, GLOBAL ECOL BIOGEOGR, V17, P152, DOI 10.1111/j.1466-8238.2007.00357.x; Oromi N, 2012, ECOL EVOL, V2, P2018, DOI 10.1002/ece3.323; Palumbi SR, 2009, HEREDITY, V102, P66, DOI 10.1038/hdy.2008.104; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.ecolsys.25.1.547; Palumbi SR, 2004, ANNU REV ENV RESOUR, V29, P31, DOI 10.1146/annurev.energy.29.062403.102254; Prada C, 2013, P NATL ACAD SCI USA, V110, P3961, DOI 10.1073/pnas.1208931110; Pritchard JK, 2000, GENETICS, V155, P945; Quattrini AM, 2013, MOL ECOL, V22, P4123, DOI 10.1111/mec.12370; Quattro JM, 2001, MAR BIOL, V139, P1107; Ramirez-Llodra E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022588; Raupach MJ, 2007, DEEP-SEA RES PT II, V54, P1820, DOI 10.1016/j.dsr2.2007.07.009; Raupach MJ, 2006, ANTARCT SCI, V18, P191, DOI 10.1017/S0954102006000228; Reveillaud J, 2010, MOL PHYLOGENET EVOL, V56, P104, DOI 10.1016/j.ympev.2010.03.034; Rex M. A, 2010, DEEP SEA BIODIVERSIT; Rocha LA, 2005, P ROY SOC B-BIOL SCI, V272, P573, DOI 10.1098/2004.3005; Rogers AD, 2000, DEEP-SEA RES PT II, V47, P119, DOI 10.1016/S0967-0645(99)00107-1; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sanford E, 2011, ANNU REV MAR SCI, V3, P509, DOI 10.1146/annurev-marine-120709-142756; SCHELTEMA RS, 1986, B MAR SCI, V39, P290; Scheltema RS, 2009, DEEP-SEA RES PT II, V56, P1835, DOI 10.1016/j.dsr2.2009.05.024; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Schuller M, 2011, POLAR BIOL, V34, P549, DOI 10.1007/s00300-010-0913-x; Scott JW, 2010, EVOL ECOL, V24, P1061, DOI 10.1007/s10682-010-9352-y; Shaw KL, 2002, P NATL ACAD SCI USA, V99, P16122, DOI 10.1073/pnas.242585899; SHULMAN MJ, 1995, EVOLUTION, V49, P897, DOI 10.1111/j.1558-5646.1995.tb02325.x; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; SNYDER LRG, 1988, EVOLUTION, V42, P689, DOI 10.1111/j.1558-5646.1988.tb02487.x; Sobel JM, 2010, EVOLUTION, V64, P295, DOI 10.1111/j.1558-5646.2009.00877.x; SOMERO GN, 1992, ANNU REV PHYSIOL, V54, P557, DOI 10.1146/annurev.ph.54.030192.003013; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Toole JM, 2011, DEEP-SEA RES PT II, V58, P1768, DOI 10.1016/j.dsr2.2010.10.058; van Oppen MJH, 2011, MOL ECOL, V20, P1647, DOI 10.1111/j.1365-294X.2011.05050.x; Vrijenhoek RC, 2010, MOL ECOL, V19, P4391, DOI 10.1111/j.1365-294X.2010.04789.x; Warner RR, 2002, B MAR SCI, V70, P245; White TA, 2011, MAR ECOL PROG SER, V434, P155, DOI 10.3354/meps09207; Zardus JD, 2006, MOL ECOL, V15, P639, DOI 10.1111/j.1365-294X.2005.02832.x; Zardus JD, 2002, ADV MAR BIOL, V42, P1; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; [No title captured]	156	45	45	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e77594	10.1371/journal.pone.0077594	http://dx.doi.org/10.1371/journal.pone.0077594			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098590	Green Published, Green Submitted, gold			2022-12-25	WOS:000325427100086
J	Ma, XY; Bao, HJ; Cui, L; Zou, J				Ma, Xiao-Yun; Bao, Hui-Jing; Cui, Lei; Zou, Jun			The Graft of Autologous Adipose-Derived Stem Cells in the Corneal Stromal after Mechanic Damage	PLOS ONE			English	Article							AMNIOTIC MEMBRANE; TRANSPLANTATION; TISSUE; RECONSTRUCTION; TRANSPARENCY; ORIENTATION; SCAFFOLDS; THERAPY; LENS	This study was designed to explore the feasibility of using autologous rabbit adipose derived stem cells (rASCs) as seed cells and polylactic-co-glycolic acid (PLGA) as a scaffold for repairing corneal stromal defects. rASCs isolated from rabbit nape adipose tissue were expanded and seeded on a PLGA scaffold to fabricate cell-scaffold constructs. After 1 week of cultivation in vitro, the cell-scaffold complexes were transplanted into corneal stromal defects in rabbits. In vivo, the autologous rASCs-PLGA constructed corneal stroma gradually became transparent without corneal neovascularization after 12 weeks. Hematoxylin and eosin staining and transmission electron microscopy examination revealed that their histological structure and collagen fibril distribution at 24 weeks after implantation were similar to native counterparts. As to the defect treated with PLGA alone, the stromal defects remained. And scar tissue was observed in the untreated-group. The implanted autologous ASCs survived up to 24 weeks post-transplantation and differentiated into functional keratocytes, as assessed by the expression of aldehyde-3-dehydrogenase 1A1 (ALDH1A1) and cornea-specific proteoglycan keratocan. Our results revealed that autologous rASCs could be one of the cell sources for corneal stromal restoration in diseased corneas or for tissue engineering of a corneal equivalent.	[Ma, Xiao-Yun] Guanghua Integrat Med Hosp, Dept Ophthalmol, Shanghai, Peoples R China; [Bao, Hui-Jing; Zou, Jun] Shanghai Jiao Tong Univ, Dept Ophthalmol, Shanghai Peoples Hosp 6, Shanghai 200030, Peoples R China; [Cui, Lei] Henan Sci & Technol Univ, Med Technol & Engn Inst, Luoyang, Henan, Peoples R China	Shanghai Jiao Tong University; Henan University of Science & Technology	Cui, L (corresponding author), Henan Sci & Technol Univ, Med Technol & Engn Inst, Luoyang, Henan, Peoples R China.	cuilei68@hotmail.com; zoujun70@126.com		Cui, Lei/0000-0002-4339-6629	Shanghai Committee of Science and Technology, China [08ZR1411400]	Shanghai Committee of Science and Technology, China(Shanghai Science & Technology Committee)	This project was supported by Shanghai Committee of Science and Technology, China (grant number 08ZR1411400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnalich-Montiel F, 2008, STEM CELLS, V26, P570, DOI 10.1634/stemcells.2007-0653; BENEDEK G, 1983, NATURE, V302, P383, DOI 10.1038/302383a0; BETTELHEIM FA, 1983, BIOPHYS J, V41, P29, DOI 10.1016/S0006-3495(83)84402-6; Borene ML, 2004, ANN BIOMED ENG, V32, P274, DOI 10.1023/B:ABME.0000012747.97620.3a; Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958; Cui L, 2007, BIOMATERIALS, V28, P5477, DOI 10.1016/j.biomaterials.2007.08.042; Doillon CJ, 2003, INT J ARTIF ORGANS, V26, P764, DOI 10.1177/039139880302600810; Du YQ, 2009, STEM CELLS, V27, P1635, DOI 10.1002/stem.91; Funderburgh JL, 2000, GLYCOBIOLOGY, V10, P951, DOI 10.1093/glycob/10.10.951; Griffith M, 1999, SCIENCE, V286, P2169, DOI 10.1126/science.286.5447.2169; Griffith M, 2002, CORNEA, V21, pS54, DOI 10.1097/01.ico.0000263120.68768.f8; Hu XX, 2008, BIOMATERIALS, V29, P3128, DOI 10.1016/j.biomaterials.2008.04.010; Hu XJ, 2005, TISSUE ENG, V11, P1710, DOI 10.1089/ten.2005.11.1710; Jack GS, 2009, BIOMATERIALS, V30, P3259, DOI 10.1016/j.biomaterials.2009.02.035; Jester JV, 1999, J CELL SCI, V112, P613; Joyce NC, 2012, MOL VIS, V18, P547; Kamma-Lorger CS, 2009, MOL VIS, V15, P378; Koizumi N, 2001, OPHTHALMOLOGY, V108, P1569, DOI 10.1016/S0161-6420(01)00694-7; Lan YN, 2012, INVEST OPHTH VIS SCI, V53, P3638, DOI 10.1167/iovs.11-9311; Liu HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010707; Liu LQ, 2010, ARTIF ORGANS, V34, P426, DOI 10.1111/j.1525-1594.2009.00884.x; Mimura T, 2005, INVEST OPHTH VIS SCI, V46, P3637, DOI 10.1167/iovs.05-0462; Mimura T, 2004, EXP EYE RES, V79, P231, DOI 10.1016/j.exer.2004.05.001; Mimura T, 2007, CURR EYE RES, V32, P617, DOI 10.1080/02713680701530589; Orwin EJ, 2000, TISSUE ENG, V6, P307, DOI 10.1089/107632700418038; Orwin EJ, 2003, J BIOMECH ENG-T ASME, V125, P439, DOI 10.1115/1.1589773; Gomes JAP, 2010, INVEST OPHTH VIS SCI, V51, P1408, DOI 10.1167/iovs.09-4029; RAWE IM, 1994, BIOPHYS J, V67, P1743, DOI 10.1016/S0006-3495(94)80648-4; SCOTT JE, 1990, BIOCHEM J, V270, P491, DOI 10.1042/bj2700491; Shimazaki J, 2002, OPHTHALMOLOGY, V109, P1285, DOI 10.1016/S0161-6420(02)01089-8; Stull RA, 2000, CYTOMETRY, V40, P126, DOI 10.1002/(SICI)1097-0320(20000601)40:2<126::AID-CYTO6>3.0.CO;2-M; Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202; Tseng SCG, 1998, ARCH OPHTHALMOL-CHIC, V116, P431, DOI 10.1001/archopht.116.4.431; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; Wu LB, 2004, BIOMATERIALS, V25, P5821, DOI 10.1016/j.biomaterials.2004.01.038; Yao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030842; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	37	14	18	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76103	10.1371/journal.pone.0076103	http://dx.doi.org/10.1371/journal.pone.0076103			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098428	Green Published, gold, Green Submitted			2022-12-25	WOS:000325427100042
J	Zhang, Y; He, XC; Yu, F; Xiang, ZM; Li, J; Thorpe, KL; Yu, ZN				Zhang, Yang; He, Xiaocui; Yu, Feng; Xiang, Zhiming; Li, Jun; Thorpe, Karen L.; Yu, Ziniu			Characteristic and Functional Analysis of Toll-like Receptors (TLRs) in the lophotrocozoan, Crassostrea gigas, Reveals Ancient Origin of TLR-Mediated Innate Immunity	PLOS ONE			English	Article							KAPPA-B; MOLECULAR-CLONING; PACIFIC OYSTER; RECOGNITION; MYD88; EXPRESSION; COMPONENTS; EVOLUTION; DEFENSE; PATHWAY	The evolution of TLR-mediated innate immunity is a fundamental question in immunology. Here, we report the characterization and functional analysis of four TLR members in the lophotrochozoans Crassostrea gigas (CgTLRs). All CgTLRs bear a conserved domain organization and have a close relationship with TLRs in ancient non-vertebrate chordates. In HEK293 cells, every CgTLR could constitutively activate NF-kappa B responsive reporter, but none of the PAMPs tested could stimulate CgTLR-activated NF-kappa B induction. Subcellular localization showed that CgTLR members have similar and dual distribution on late endosomes and plasma membranes. Moreover, CgTLRs and CgMyD88 mRNA show a consistent response to multiple PAMP challenges in oyster hemocytes. As CgTLR-mediated NF-kappa B activation is dependent on CgMyD88, we designed a blocking peptide for CgTLR signaling that would inhibit CgTLR-CgMyD88 dependent NF-kappa B activation. This was used to demonstrate that a Vibrio parahaemolyticus infection-induced enhancement of degranulation and increase of cytokines TNF mRNA in hemocytes, could be inhibited by blocking CgTLR signaling. In summary, our study characterized the primitive TLRs in the lophotrocozoan C. gigas and demonstrated a fundamental role of TLR signaling in infection-induced hemocyte activation. This provides further evidence for an ancient origin of TLR-mediated innate immunity.	[Zhang, Yang; Yu, Feng; Xiang, Zhiming; Li, Jun; Yu, Ziniu] Chinese Acad Sci, South China Sea Inst Oceanol, Lab Appl Marine Biol, Key Lab Marine Bioresources Sustainable Utilizat, Guangzhou, Guangdong, Peoples R China; [He, Xiaocui] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Immunol, Greifswald, Germany; [Thorpe, Karen L.] Univ Portsmouth, Inst Marine Sci, Portsmouth, Hants, England	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Friedrich Loeffler Institute; University of Portsmouth	Yu, ZN (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, Lab Appl Marine Biol, Key Lab Marine Bioresources Sustainable Utilizat, Guangzhou, Guangdong, Peoples R China.	carlzyu@scsio.ac.cn	Thorpe, Karen/F-9762-2012; Thorpe, Karen/M-8197-2015	Thorpe, Karen/0000-0002-2823-8032; Thorpe, Karen/0000-0002-7548-7189; Zhang, Yang/0000-0002-0789-4938	National Basic Research Program of China [2010CB126404]; National Natural Science Foundation of China [41176150, 31001130]; NSFC-Guangdong of China [U1201215]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC-Guangdong of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (No. 2010CB126404), the National Natural Science Foundation of China (No. 41176150 and 31001130) and Joint Funds of NSFC-Guangdong of China (U1201215). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; ANDERSON KV, 1985, CELL, V42, P779, DOI 10.1016/0092-8674(85)90274-0; Bachere E, 2004, IMMUNOL REV, V198, P149, DOI 10.1111/j.0105-2896.2004.00115.x; Barcia R, 1999, IUBMB LIFE, V48, P419, DOI 10.1080/713803540; Buckley KM, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00136; Choi HJ, 2011, KOREAN J PARASITOL, V49, P229, DOI 10.3347/kjp.2011.49.3.229; Goodson MS, 2005, APPL ENVIRON MICROB, V71, P6934, DOI 10.1128/AEM.71.11.6934-6946.2005; Guan Y, 2010, J IMMUNOL, V184, P5094, DOI 10.4049/jimmunol.0901888; He XC, 2011, FISH SHELLFISH IMMUN, V30, P870, DOI 10.1016/j.fsi.2011.01.009; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Huang SF, 2011, J IMMUNOL, V186, P2042, DOI 10.4049/jimmunol.1001824; Huang XD, 2012, FISH SHELLFISH IMMUN, V33, P659, DOI 10.1016/j.fsi.2012.06.029; Imler JL, 2004, J LEUKOCYTE BIOL, V75, P18, DOI 10.1189/jlb.0403160; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Kanzok SM, 2004, J MOL EVOL, V58, P442, DOI 10.1007/s00239-003-2565-8; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Leulier F, 2008, NAT REV GENET, V9, P165, DOI 10.1038/nrg2303; Loker ES, 2004, IMMUNOL REV, V198, P10, DOI 10.1111/j.0105-2896.2004.0117.x; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Qiu LM, 2007, FISH SHELLFISH IMMUN, V22, P451, DOI 10.1016/j.fsi.2006.05.003; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Sasaki N, 2009, J BIOL CHEM, V284, P27336, DOI 10.1074/jbc.M109.032433; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; Toshchakov VU, 2005, J IMMUNOL, V175, P494, DOI 10.4049/jimmunol.175.1.494; Toubiana M, 2013, DEV COMP IMMUNOL, V40, P158, DOI 10.1016/j.dci.2013.02.006; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Zhang LL, 2011, FISH SHELLFISH IMMUN, V30, P653, DOI 10.1016/j.fsi.2010.12.023; Zhang Y, 2011, FISH SHELLFISH IMMUN, V30, P1354, DOI 10.1016/j.fsi.2011.03.008; Zhang Y, 2011, FISH SHELLFISH IMMUN, V30, P954, DOI 10.1016/j.fsi.2011.01.031; Zheng L., 2005, ISJ, V2, P105	38	58	60	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76464	10.1371/journal.pone.0076464	http://dx.doi.org/10.1371/journal.pone.0076464			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098508	Green Published, Green Submitted, gold			2022-12-25	WOS:000325427100069
J	Chen, YC; Lin, YT; Huang, CT; Shih, CL; Yang, ZR; Hwang, IS				Chen, Yi-Ching; Lin, Yen-Ting; Huang, Chien-Ting; Shih, Chia-Li; Yang, Zong-Ru; Hwang, Ing-Shiou			Trajectory Adjustments Underlying Task-Specific Intermittent Force Behaviors and Muscular Rhythms	PLOS ONE			English	Article							SIGNAL-DEPENDENT NOISE; MANUAL TRACKING; VISUAL INFORMATION; MOTOR; RECTIFICATION; VARIABILITY; FEEDBACK; EMG; FREQUENCY; COHERENCE	Force intermittency is one of the major causes of motor variability. Focusing on the dynamics of force intermittency, this study was undertaken to investigate how force trajectory is fine-tuned for static and dynamic force-tracking of a comparable physical load. Twenty-two healthy adults performed two unilateral resistance protocols (static force-tracking at 75% maximal effort and dynamic force-tracking in the range of 50%-100% maximal effort) using the left hand. The electromyographic activity and force profile of the designated hand were monitored. Gripping force was off-line decomposed into a primary movement spectrally identical to the target motion and a force intermittency profile containing numerous force pulses. The results showed that dynamic force-tracking exhibited greater intermittency amplitude and force pulse but a smaller amplitude ratio of primary movement to force intermittency than static force-tracking. Multi-scale entropy analysis revealed that force intermittency during dynamic force-tracking was more complex on a low time scale but more regular on a high time scale than that of static force-tracking. Together with task-dependent force intermittency properties, dynamic force-tracking exhibited a smaller 8-12 Hz muscular oscillation but a more potentiated muscular oscillation at 35-50 Hz than static force-tracking. In conclusion, force intermittency reflects differing trajectory controls for static and dynamic force-tracking. The target goal of dynamic tracking is achieved through trajectory adjustments that are more intricate and more frequent than those of static tracking, pertaining to differing organizations and functioning of muscular oscillations in the alpha and gamma bands.	[Chen, Yi-Ching] Chung Shan Med Univ, Sch Phys Therapy, Taichung, Taiwan; [Chen, Yi-Ching] Chung Shan Med Univ Hosp, Taichung, Taiwan; [Lin, Yen-Ting] Asian Univ, Phys Educ Off, Taichung, Taiwan; [Huang, Chien-Ting; Yang, Zong-Ru; Hwang, Ing-Shiou] Natl Cheng Kung Univ, Coll Med, Inst Allied Hlth Sci, Tainan 70101, Taiwan; [Shih, Chia-Li; Hwang, Ing-Shiou] Natl Cheng Kung Univ, Coll Med, Dept Phys Therapy, Tainan 70101, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Asia University Taiwan; National Cheng Kung University; National Cheng Kung University	Hwang, IS (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Allied Hlth Sci, Tainan 70101, Taiwan.	ishwang@mail.ncku.edu.tw			National Science Council, R.O.C. [NSC-101-2410-H-040-017]	National Science Council, R.O.C.(Ministry of Science and Technology, Taiwan)	This research was supported by a grant from the National Science Council, R.O.C. (http://web1.nsc.gov.tw/mp.aspx?mp = 7), under Grant No. NSC-101-2410-H-040-017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrykiewicz A, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-101; Baweja HS, 2009, EXP BRAIN RES, V197, P35, DOI 10.1007/s00221-009-1883-5; Bedrov YA, 2007, BIOSYSTEMS, V89, P50, DOI 10.1016/j.biosystems.2006.04.011; Boonstra TW, 2012, J NEUROPHYSIOL, V107, P796, DOI 10.1152/jn.00066.2011; Bourguignon M, 2013, NEUROIMAGE, V66, P500, DOI 10.1016/j.neuroimage.2012.10.038; Costa M, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/68008; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; ELBLE RJ, 1976, J NEUROPHYSIOL, V39, P370, DOI 10.1152/jn.1976.39.2.370; Erim Z, 1996, MUSCLE NERVE, V19, P563, DOI 10.1002/(SICI)1097-4598(199605)19:5<563::AID-MUS3>3.0.CO;2-9; Gwin JT, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00258; HENNEMAN E, 1957, SCIENCE, V126, P1345, DOI 10.1126/science.126.3287.1345; Hong SL, 2008, EXP BRAIN RES, V189, P61, DOI 10.1007/s00221-008-1403-z; Hong SL, 2008, CHAOS, V18, DOI 10.1063/1.2979695; Hu XG, 2012, EXP BRAIN RES, V221, P191, DOI 10.1007/s00221-012-3161-1; Huang CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051417; Hwang IS, 2009, J APPL PHYSIOL, V106, P966, DOI 10.1152/japplphysiol.90851.2008; IYER MB, 1994, NEUROSCI LETT, V170, P94, DOI 10.1016/0304-3940(94)90247-X; Jones KE, 2002, J NEUROPHYSIOL, V88, P1533, DOI 10.1152/jn.2002.88.3.1533; Jordan K, 2004, EXP BRAIN RES, V156, P451, DOI 10.1007/s00221-003-1806-9; Kilner JM, 2000, J NEUROSCI, V20, P8838; Kuznetsov NA, 2010, NEUROSCI LETT, V470, P121, DOI 10.1016/j.neulet.2009.12.068; Liu JE, 2011, IEEE ENG MED BIO, P6335, DOI 10.1109/IEMBS.2011.6091564; McClelland VM, 2012, J NEUROSCI METH, V205, P190, DOI 10.1016/j.jneumeth.2011.11.001; MIALL RC, 1986, BEHAV BRAIN RES, V20, P185, DOI 10.1016/0166-4328(86)90003-3; MIALL RC, 1993, J MOTOR BEHAV, V25, P53, DOI 10.1080/00222895.1993.9941639; Muthukumaraswamy SD, 2010, J NEUROPHYSIOL, V104, P2873, DOI 10.1152/jn.00607.2010; Myers LJ, 2003, J NEUROSCI METH, V124, P157, DOI 10.1016/S0165-0270(03)00004-9; NAVAS F, 1968, BIOPHYS J, V8, P252, DOI 10.1016/S0006-3495(68)86488-4; Negro F, 2009, J PHYSIOL-LONDON, V587, P5925, DOI 10.1113/jphysiol.2009.178509; Omlor W, 2007, NEUROIMAGE, V34, P1191, DOI 10.1016/j.neuroimage.2006.10.018; Pasalar S, 2005, EXP BRAIN RES, V163, P214, DOI 10.1007/s00221-004-2169-6; Pincus SM, 2001, ANN NY ACAD SCI, V954, P245; Neto OP, 2010, J NEUROPHYSIOL, V103, P1093, DOI 10.1152/jn.00792.2009; Prochazka A, 1997, J NEUROPHYSIOL, V77, P3237, DOI 10.1152/jn.1997.77.6.3237; Roitman AV, 2004, J NEUROPHYSIOL, V91, P901, DOI 10.1152/jn.00261.2003; Schoffelen JM, 2011, J NEUROSCI, V31, P6750, DOI 10.1523/JNEUROSCI.4882-10.2011; Selen LPJ, 2006, J NEUROPHYSIOL, V96, P2750, DOI 10.1152/jn.00552.2006; Selen LPJ, 2009, J NEUROSCI, V29, P12606, DOI 10.1523/JNEUROSCI.2826-09.2009; Slifkin A, 1999, J EXP PSYCHOL HUMAN, V25, P837, DOI 10.1037/0096-1523.25.3.837; Slifkin AB, 2000, J NEUROPHYSIOL, V84, P1708, DOI 10.1152/jn.2000.84.4.1708; Sosnoff JJ, 2006, NEUROSCI LETT, V392, P165, DOI 10.1016/j.neulet.2005.09.010; Sosnoff JJ, 2005, J MOTOR BEHAV, V37, P325, DOI 10.3200/JMBR.37.4.325-336; Stegeman DF, 2010, CLIN NEUROPHYSIOL, V121, P1633, DOI 10.1016/j.clinph.2010.03.052; Svendsen JH, 2011, HUM MOVEMENT SCI, V30, P1039, DOI 10.1016/j.humov.2011.02.001; Vaillancourt DE, 2002, CLIN NEUROPHYSIOL, V113, P1325, DOI 10.1016/S1388-2457(02)00167-0; Walker N, 1997, J GERONTOL B-PSYCHOL, V52, pP40, DOI 10.1093/geronb/52B.1.P40; Yao WX, 2000, J NEUROPHYSIOL, V83, P441, DOI 10.1152/jn.2000.83.1.441	47	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74273	10.1371/journal.pone.0074273	http://dx.doi.org/10.1371/journal.pone.0074273			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098640	Green Published, gold, Green Submitted			2022-12-25	WOS:000325423500011
J	Haase, B; Signer-Hasler, H; Binns, MM; Obexer-Ruff, G; Hauswirth, R; Bellone, RR; Burger, D; Rieder, S; Wade, CM; Leeb, T				Haase, Bianca; Signer-Hasler, Heidi; Binns, Matthew M.; Obexer-Ruff, Gabriela; Hauswirth, Regula; Bellone, Rebecca R.; Burger, Dominik; Rieder, Stefan; Wade, Claire M.; Leeb, Tosso			Accumulating Mutations in Series of Haplotypes at the KIT and MITF Loci Are Major Determinants of White Markings in Franches-Montagnes Horses	PLOS ONE			English	Article							STATIONARY NIGHT BLINDNESS; GENOME-WIDE ASSOCIATION; CAT FELIS-CATUS; COAT COLOR; FACIAL MARKINGS; ARABIAN HORSE; MULTIFACTORIAL INHERITANCE; MELANOCYTE DEVELOPMENT; SUSCEPTIBILITY LOCI; MISSENSE MUTATION	Coat color and pattern variations in domestic animals are frequently inherited as simple monogenic traits, but a number are known to have a complex genetic basis. While the analysis of complex trait data remains a challenge in all species, we can use the reduced haplotypic diversity in domestic animal populations to gain insight into the genomic interactions underlying complex phenotypes. White face and leg markings are examples of complex traits in horses where little is known of the underlying genetics. In this study, Franches-Montagnes (FM) horses were scored for the occurrence of white facial and leg markings using a standardized scoring system. A genome-wide association study (GWAS) was performed for several white patterning traits in 1,077 FM horses. Seven quantitative trait loci (QTL) affecting the white marking score with p-values p <= 10(-4) were identified. Three loci, MC1R and the known white spotting genes, KIT and MITF, were identified as the major loci underlying the extent of white patterning in this breed. Together, the seven loci explain 54% of the genetic variance in total white marking score, while MITF and KIT alone account for 26%. Although MITF and KIT are the major loci controlling white patterning, their influence varies according to the basic coat color of the horse and the specific body location of the white patterning. Fine mapping across the MITF and KIT loci was used to characterize haplotypes present. Phylogenetic relationships among haplotypes were calculated to assess their selective and evolutionary influences on the extent of white patterning. This novel approach shows that KIT and MITF act in an additive manner and that accumulating mutations at these loci progressively increase the extent of white markings.	[Haase, Bianca; Wade, Claire M.] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Haase, Bianca; Obexer-Ruff, Gabriela; Hauswirth, Regula; Leeb, Tosso] Univ Bern, Inst Genet, Vetsuisse Fac, Bern, Switzerland; [Signer-Hasler, Heidi] Bern Univ Appl Sci, Dept Agr Forestry Food Sci & Management, Zollikofen, Switzerland; [Binns, Matthew M.] Equine Anal, Midway, KY USA; [Bellone, Rebecca R.] Univ Tampa, Dept Biol, Tampa, FL 33606 USA; [Burger, Dominik] ALP Haras, Swiss Inst Equine Med, Avenches, Switzerland; [Burger, Dominik] Univ Bern, Avenches, Switzerland; [Rieder, Stefan] Swiss Natl Stud Farm, Agroscope ALP Haras Res Stn, Avenches, Switzerland; [Leeb, Tosso] Univ Bern, DermFocus, Bern, Switzerland	University of Sydney; University of Bern; University of Tampa; University of Bern; Swiss Federal Research Station Agroscope; University of Bern	Haase, B (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	bianca.haase@sydney.edu.au	Leeb, Tosso/G-3187-2014	Leeb, Tosso/0000-0003-0553-4880; Bellone, Rebecca/0000-0001-8838-7227; Wade, Claire/0000-0003-3413-4771; Waud, Bianca/0000-0001-6493-9808	Swiss National Science Foundation [31003A_133034]; ALP-Haras Research Station	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ALP-Haras Research Station	This study was funded by the Swiss National Science Foundation grant no. 31003A_133034. The population wide SNP data of the Franches-Montagnes horse breed was generated with funds from the ALP-Haras Research Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberdam E, 1998, J BIOL CHEM, V273, P19560, DOI 10.1074/jbc.273.31.19560; Alhaidari Z, 1999, VET DERMATOL, V10, P3, DOI 10.1046/j.1365-3164.1999.00132.x; ALLEN WR, 1984, J REPROD FERTIL, V71, P607, DOI 10.1530/jrf.0.0710607; Anderson TM, 2009, SCIENCE, V323, P1339, DOI 10.1126/science.1165448; Andersson L, 2004, NAT REV GENET, V5, P202, DOI 10.1038/nrg1294; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bellone R, 2006, CYTOGENET GENOME RES, V114, p93A, DOI 10.1159/000091935; Bellone RR, 2010, ANIM GENET, V41, P207, DOI 10.1111/j.1365-2052.2010.02119.x; Bellone RR, 2008, GENETICS, V179, P1861, DOI 10.1534/genetics.108.088807; Brooks SA, 2007, CYTOGENET GENOME RES, V119, P225, DOI 10.1159/000112065; Brooks SA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000909; Cooper MP, 2006, ANIM GENET, V37, P163, DOI 10.1111/j.1365-2052.2005.01389.x; Crane JF, 2006, ANNU REV CELL DEV BI, V22, P267, DOI 10.1146/annurev.cellbio.22.010305.103814; Dobney K, 2006, J ZOOL, V269, P261, DOI 10.1111/j.1469-7998.2006.00042.x; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; GARDNER JM, 1992, SCIENCE, V257, P1121, DOI 10.1126/science.257.5073.1121; Giuffra E, 1999, MAMM GENOME, V10, P1132, DOI 10.1007/s003359901178; Grandin T, 1998, GENETICS AND THE BEHAVIOR OF DOMESTIC ANIMALS, P319; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Haase B, 2007, PLOS GENET, V3, P2101, DOI 10.1371/journal.pgen.0030195; Hasler H, 2012, PLOS ONE, V7; Hauswirth R, 2012, PLOS GENET, V8, P404, DOI 10.1371/journal.pgen.1002653; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Imes DL, 2006, ANIM GENET, V37, P175, DOI 10.1111/j.1365-2052.2005.01409.x; Kaelin CB, 2012, SCIENCE, V337, P1536, DOI 10.1126/science.1220893; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Ludwig A, 2009, SCIENCE, V324, P485, DOI 10.1126/science.1172750; Lyons LA, 2005, ANIM GENET, V36, P119, DOI 10.1111/j.1365-2052.2005.01253.x; Marklund L, 1996, MAMM GENOME, V7, P895, DOI 10.1007/s003359900264; Menotti-Raymond M, 2009, J HERED, V100, pS8, DOI 10.1093/jhered/esp018; Metallinos DL, 1998, MAMM GENOME, V9, P426, DOI 10.1007/s003359900790; Nebe HD, 1984, THESIS J LIEBIG U GE; Newton JM, 2000, MAMM GENOME, V11, P24, DOI 10.1007/s003350010005; Opdecamp K, 1997, DEVELOPMENT, V124, P2377; Pingault V, 2010, HUM MUTAT, V31, P391, DOI 10.1002/humu.21211; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Rieder S, 2001, MAMM GENOME, V12, P450, DOI 10.1007/s003350020017; Rieder S, 2008, J HERED, V99, P130, DOI 10.1093/jhered/esm115; Santschi EM, 2001, AM J VET RES, V62, P97, DOI 10.2460/ajvr.2001.62.97; Schmutz SM, 2007, ANIM GENET, V38, P539, DOI 10.1111/j.1365-2052.2007.01664.x; Silvers WK., 1979, COAT COLORS MICE, DOI [10.1007/978-1-4612-6164-3, DOI 10.1007/978-1-4612-6164-3]; Trut L, 2009, BIOESSAYS, V31, P349, DOI 10.1002/bies.200800070; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wen B, 2010, PIGM CELL MELANOMA R, V23, P441, DOI 10.1111/j.1755-148X.2010.00699.x; WOOLF CM, 1990, J HERED, V81, P250, DOI 10.1093/oxfordjournals.jhered.a110987; WOOLF CM, 1989, J HERED, V80, P173, DOI 10.1093/oxfordjournals.jhered.a110831; WOOLF CM, 1991, J HERED, V82, P167, DOI 10.1093/oxfordjournals.jhered.a111053; WOOLF CM, 1992, J HERED, V83, P73, DOI 10.1093/oxfordjournals.jhered.a111163; WOOLF CM, 1995, J HERED, V86, P129, DOI 10.1093/oxfordjournals.jhered.a111542; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	54	29	31	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75071	10.1371/journal.pone.0075071	http://dx.doi.org/10.1371/journal.pone.0075071			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098679	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500050
J	Hayashi, Y; Shigenobu, S; Watanabe, D; Toga, K; Saiki, R; Shimada, K; Bourguignon, T; Lo, N; Hojo, M; Maekawa, K; Miura, T				Hayashi, Yoshinobu; Shigenobu, Shuji; Watanabe, Dai; Toga, Kouhei; Saiki, Ryota; Shimada, Keisuke; Bourguignon, Thomas; Lo, Nathan; Hojo, Masaru; Maekawa, Kiyoto; Miura, Toru			Construction and Characterization of Normalized cDNA Libraries by 454 Pyrosequencing and Estimation of DNA Methylation Levels in Three Distantly Related Termite Species	PLOS ONE			English	Article							RETICULITERMES-SPERATUS ISOPTERA; EXPRESSED SEQUENCE TAGS; NASUTITERMES-TAKASAGOENSIS ISOPTERA; JUVENILE-HORMONE ANALOG; DAMP-WOOD TERMITE; SUBTERRANEAN TERMITE; DIFFERENTIATION; GENES; CPG; MORPHOGENESIS	In termites, division of labor among castes, categories of individuals that perform specialized tasks, increases colony-level productivity and is the key to their ecological success. Although molecular studies on caste polymorphism have been performed in termites, we are far from a comprehensive understanding of the molecular basis of this phenomenon. To facilitate future molecular studies, we aimed to construct expressed sequence tag (EST) libraries covering wide ranges of gene repertoires in three representative termite species, Hodotermopsis sjostedti, Reticulitermes speratus and Nasutitermes takasagoensis. We generated normalized cDNA libraries from whole bodies, except for guts containing microbes, of almost all castes, sexes and developmental stages and sequenced them with the 454 GS FLX titanium system. We obtained >1.2 million quality-filtered reads yielding >400 million bases for each of the three species. Isotigs, which are analogous to individual transcripts, and singletons were produced by assembling the reads and annotated using public databases. Genes related to juvenile hormone, which plays crucial roles in caste differentiation of termites, were identified from the EST libraries by BLAST search. To explore the potential for DNA methylation, which plays an important role in caste differentiation of honeybees, tBLASTn searches for DNA methyltransferases (dnmt1, dnmt2 and dnmt3) and methyl-CpG binding domain (mbd) were performed against the EST libraries. All four of these genes were found in the H. sjostedti library, while all except dnmt3 were found in R. speratus and N. takasagoensis. The ratio of the observed to the expected CpG content (CpG O/E), which is a proxy for DNA methylation level, was calculated for the coding sequences predicted from the isotigs and singletons. In all of the three species, the majority of coding sequences showed depletion of CpG O/E (less than 1), and the distributions of CpG O/E were bimodal, suggesting the presence of DNA methylation.	[Hayashi, Yoshinobu; Watanabe, Dai; Bourguignon, Thomas; Miura, Toru] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan; [Hayashi, Yoshinobu; Lo, Nathan] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Shigenobu, Shuji] Natl Inst Nat Sci, Natl Inst Basic Biol, NIBB Core Res Facil, Okazaki, Aichi 4448585, Japan; [Shigenobu, Shuji] Grad Univ Adv Studies, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi, Japan; [Watanabe, Dai; Toga, Kouhei; Saiki, Ryota; Shimada, Keisuke; Maekawa, Kiyoto] Toyama Univ, Grad Sch Sci & Engn, Toyama 930, Japan; [Toga, Kouhei] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Shimada, Keisuke] Ishikawa Museum Nat Hist, Kanazawa, Ishikawa, Japan; [Bourguignon, Thomas] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Hojo, Masaru] Univ Ryukyus, Trop Biosphere Res Ctr, Nishihara, Okinawa 90301, Japan	Hokkaido University; University of Sydney; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; University of Toyama; Nagoya University; National University of Singapore; University of the Ryukyus	Miura, T (corresponding author), Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan.	miu@ees.hokudai.ac.jp	Toga, Kouhei/AHC-4090-2022; Miura, Toru/P-2456-2019; Lo, Nathan/E-6115-2010; Shigenobu, Shuji/B-6239-2011	Toga, Kouhei/0000-0001-7244-5920; Miura, Toru/0000-0002-7456-4402; Lo, Nathan/0000-0003-2176-2840; Shigenobu, Shuji/0000-0003-4640-2323; Shimada, Keisuke/0000-0002-8483-7259; Bourguignon, Thomas/0000-0002-4035-8977; Maekawa, Kiyoto/0000-0002-2354-1059	Ministry of Education, Culture, Sports, Science and Technology of Japan [21677001]; JSPS [23770274, 2469, 12J03468, 249520]; Japan Society for the Promotion of Science [24570022]; Sumitomo Foundation; Australian Research Council; Grants-in-Aid for Scientific Research [25251041] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sumitomo Foundation; Australian Research Council(Australian Research Council); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Young Scientists (No. 21677001 to TM) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.mext.go.jp/english/), and by Grant-in-Aid for Young Scientists (No. 23770274 to MH), for JSPS Fellows (Nos. 2469, 12J03468 and 249520 to YH, DW and KT respectively) and for Scientific Research (C) (No. 24570022 to KM) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/). YH was also supported by Grant for Basic Science Research Projects from Sumitomo Foundation (http://www.sumitomo.or.jp/e/). NL was supported by the Australian Research Council (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeyenko A, 2006, BIOINFORMATICS, V22, pE9, DOI 10.1093/bioinformatics/btl213; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Cleveland LR, 1923, P NATL ACAD SCI USA, V9, P424, DOI 10.1073/pnas.9.12.424; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Dong QF, 2005, METHOD ENZYMOL, V395, P400; Glastad KM, 2013, INSECT MOL BIOL, V22, P143, DOI 10.1111/imb.12010; Glastad KM, 2011, INSECT MOL BIOL, V20, P553, DOI 10.1111/j.1365-2583.2011.01092.x; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Hattori A, 2013, J EXP ZOOL PART B, V320B, P295, DOI 10.1002/jez.b.22501; Hayashi Yoshinobu, 2003, Entomological Science, V6, P253, DOI 10.1046/j.1343-8786.2003.00030.x; Hojo M, 2012, INSECT MOL BIOL, V21, P545, DOI 10.1111/j.1365-2583.2012.01162.x; Hojo MU, 2004, SOCIOBIOLOGY, V44, P433; Holldobler B., 1990, pi; Huang QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050383; Husseneder C, 2012, COMP BIOCHEM PHYS D, V7, P14, DOI 10.1016/j.cbd.2011.10.002; Inoue T, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P275; Inward DJG, 2007, MOL PHYLOGENET EVOL, V44, P953, DOI 10.1016/j.ympev.2007.05.014; Jongeneel C V, 2000, Brief Bioinform, V1, P76, DOI 10.1093/bib/1.1.76; Jurkowski TP, 2008, RNA, V14, P1663, DOI 10.1261/rna.970408; Kambhampati S, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P1; Kawamura T, 1982, SHIROARI, V49, P44; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Lo N, 2012, INSECT SOC, V59, P257, DOI 10.1007/s00040-011-0213-7; Matsuura K, 2012, J CHEM ECOL, V38, P746, DOI 10.1007/s10886-012-0137-3; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; Miura T, 2004, INSECT SOC, V51, P247, DOI 10.1007/s00040-003-0736-2; Miura T, 2000, ECOL RES, V15, P83, DOI 10.1046/j.1440-1703.2000.00320.x; Miura T, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P211, DOI 10.1007/978-90-481-3977-4_9; Miyata H, 2004, ENTOMOL SCI, V7, P309, DOI 10.1111/j.1479-8298.2004.00078.x; Moczek AP, 2008, EVOL DEV, V10, P511, DOI 10.1111/j.1525-142X.2008.00264.x; Nagaraj SH, 2007, BRIEF BIOINFORM, V8, P6, DOI 10.1093/bib/bbl015; Nalepa CA, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P53; Nambu Y, 2010, SOCIOBIOLOGY, V55, P527; Nijhout H.F., 1994, INSECT HORMONES; NIJHOUT HF, 1982, Q REV BIOL, V57, P109, DOI 10.1086/412671; NOIROT C, 1991, ETHOL ECOL EVOL, P3; OGINO K, 1993, ZOOL SCI, V10, P361; Ohkuma M, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P413, DOI 10.1007/978-90-481-3977-4_15; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Oster G.F., 1978, Monographs in Population Biology, pi; OTT J, 1979, HUM GENET, V51, P79, DOI 10.1007/BF00278296; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Roberts SB, 2012, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00116; Robertson KD, 2002, ONCOGENE, V21, P5361, DOI 10.1038/sj.onc.1205609; Roisin Y, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P95; Rudd S, 2003, TRENDS PLANT SCI, V8, P321, DOI 10.1016/S1360-1385(03)00131-6; Saiki R, 2011, SOCIOBIOLOGY, V58, P499; SCHORDERET DF, 1992, P NATL ACAD SCI USA, V89, P957, DOI 10.1073/pnas.89.3.957; Shcheglov Alex S., 2007, P97, DOI 10.1007/978-1-4020-6040-3_5; Soares Marcelo Bento, 2009, V533, P109, DOI 10.1007/978-1-60327-136-3_6; Steller MM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-463; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Suzuki MM, 2007, GENOME RES, V17, P625, DOI 10.1101/gr.6163007; TAKEMATSU Y, 1992, Japanese Journal of Entomology, V60, P67; Toga K, 2012, EVOL DEV, V14, P286, DOI 10.1111/j.1525-142X.2012.00545.x; Toga K, 2009, ZOOL SCI, V26, P382, DOI 10.2108/zsj.26.382; Tsuchiya M, 2008, APPL ENTOMOL ZOOL, V43, P307, DOI 10.1303/aez.2008.307; WATANABE H, 1991, APPL ENTOMOL ZOOL, V26, P418, DOI 10.1303/aez.26.418; Waterhouse RM, 2013, NUCLEIC ACIDS RES, V41, pD358, DOI 10.1093/nar/gks1116; Wilson E.O., 1971, INSECT SOC; WILSON EO, 1965, SCIENCE, V149, P1064, DOI 10.1126/science.149.3688.1064; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yi SV, 2009, EPIGENETICS-US, V4, P551, DOI 10.4161/epi.4.8.10345; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhang D, 2012, INSECT MOL BIOL, V21, P235, DOI 10.1111/j.1365-2583.2011.01130.x	71	9	11	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76678	10.1371/journal.pone.0076678	http://dx.doi.org/10.1371/journal.pone.0076678			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098800	Green Submitted, Green Published, gold			2022-12-25	WOS:000325423500171
J	Shen, F; Tsuruda, PR; Smith, JAM; Obedencio, GP; Martin, WJ				Shen, Fei; Tsuruda, Pamela R.; Smith, Jacqueline A. M.; Obedencio, Glenmar P.; Martin, William J.			Relative Contributions of Norepinephrine and Serotonin Transporters to Antinociceptive Synergy between Monoamine Reuptake Inhibitors and Morphine in the Rat Formalin Model	PLOS ONE			English	Article							DESCENDING MODULATION; INDUCED NOCICEPTION; POSTOPERATIVE PAIN; 5-HT3 RECEPTORS; DULOXETINE; CLONIDINE; FACILITATION; TRAMADOL; COMBINATIONS; POTENTIATION	Multimodal analgesia is designed to optimize pain relief by coadministering drugs with distinct mechanisms of action or by combining multiple pharmacologies within a single molecule. In clinical settings, combinations of monoamine reuptake inhibitors and opioid receptor agonists have been explored and one currently available analgesic, tapentadol, functions as both a m-opioid receptor agonist and a norepinephrine transporter inhibitor. However, it is unclear whether the combination of selective norepinephrine reuptake inhibition and m-receptor agonism achieves an optimal antinociceptive synergy. In this study, we assessed the pharmacodynamic interactions between morphine and monoamine reuptake inhibitors that possess different affinities and selectivities for norepinephrine and serotonin transporters. Using the rat formalin model, in conjunction with measurements of ex vivo transporter occupancy, we show that neither the norepinephrine-selective inhibitor, esreboxetine, nor the serotonin-selective reuptake inhibitor, fluoxetine, produce antinociceptive synergy with morphine. Atomoxetine, a monoamine reuptake inhibitor that achieves higher levels of norepinephrine than serotonin transporter occupancy, exhibited robust antinociceptive synergy with morphine. Similarly, a fixed-dose combination of esreboxetine and fluoxetine which achieves comparable levels of transporter occupancy potentiated the antinociceptive response to morphine. By contrast, duloxetine, a monoamine reuptake inhibitor that achieves higher serotonin than norepinephrine transporter occupancy, failed to potentiate the antinociceptive response to morphine. However, when duloxetine was coadministered with the 5-HT3 receptor antagonist, ondansetron, potentiation of the antinociceptive response to morphine was revealed. These results support the notion that inhibition of both serotonin and norepinephrine transporters is required for monoamine reuptake inhibitor and opioid-mediated antinociceptive synergy; yet, excess serotonin, acting via 5-HT3 receptors, may reduce the potential for synergistic interactions. Thus, in the rat formalin model, the balance between norepinephrine and serotonin transporter inhibition influences the degree of antinociceptive synergy observed between monoamine reuptake inhibitors and morphine.	[Shen, Fei; Martin, William J.] Theravance Inc, Dept Pharmacol, San Francisco, CA USA; [Tsuruda, Pamela R.; Smith, Jacqueline A. M.; Obedencio, Glenmar P.] Theravance Inc, Dept Mol Biol, San Francisco, CA USA; [Tsuruda, Pamela R.; Smith, Jacqueline A. M.; Obedencio, Glenmar P.] Theravance Inc, Dept Cell Biol, San Francisco, CA USA; Theravance Inc, Dept Drug Metab, San Francisco, CA USA; Theravance Inc, Dept Pharmacokinet, San Francisco, CA USA	Theravance; Theravance; Theravance; Theravance; Theravance	Shen, F (corresponding author), Theravance Inc, Dept Pharmacol, San Francisco, CA USA.	fshen@theravance.com	Martin, William J/L-9033-2017	Martin, William J/0000-0002-2749-3365				ABBOTT FV, 1995, PAIN, V60, P91, DOI 10.1016/0304-3959(94)00095-V; Bajic D, 2010, BRAIN RES, V1306, P29, DOI 10.1016/j.brainres.2009.10.010; Bohn LM, 2000, J NEUROSCI, V20, P9040; Bourdet DL, 2012, J PHARMACOL EXP THER, V341, P137, DOI 10.1124/jpet.111.188417; BURNETT A, 1991, BRAIN RES, V546, P271, DOI 10.1016/0006-8993(91)91491-I; Chen S, 2010, CURR MED RES OPIN, V26, P2507, DOI 10.1185/03007995.2010.518438; Dogrul A, 2009, BRAIN RES, V1280, P52, DOI 10.1016/j.brainres.2009.05.001; DRASNER K, 1988, PAIN, V32, P309, DOI 10.1016/0304-3959(88)90042-5; Fields H., 1994, CENTRAL NERVOUS SYST, V3rd edi; Gao KM, 1998, J NEUROSCI, V18, P1860; GESSNER PK, 1970, J PHARMACOL EXP THER, V174, P247; Green GM, 2000, PAIN, V89, P81, DOI 10.1016/S0304-3959(00)00346-8; Hartrick CT, 2009, EXPERT OPIN PHARMACO, V10, P2687, DOI 10.1517/14656560903313734; Ho KY, 2010, BRIT J ANAESTH, V105, P371, DOI 10.1093/bja/aeq158; HYLDEN JLK, 1983, J PHARMACOL EXP THER, V226, P398; Jones CK, 2007, EUR J PAIN, V11, P208, DOI 10.1016/j.ejpain.2006.02.008; Jones CK, 2006, NEUROPHARMACOLOGY, V51, P1172, DOI 10.1016/j.neuropharm.2006.08.005; Le Bars D, 2001, PHARMACOL REV, V53, P597; LEVINE JD, 1986, PAIN, V27, P45, DOI 10.1016/0304-3959(86)90220-4; LIU MY, 1988, PAIN, V33, P123, DOI 10.1016/0304-3959(88)90211-4; Michelet D, 2012, ANESTH ANALG, V114, P393, DOI 10.1213/ANE.0b013e31823d0b45; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Montes A, 2000, BRIT J ANAESTH, V85, P217, DOI 10.1093/bja/85.2.217; Munro G, 2010, NEUROPHARMACOLOGY, V59, P208, DOI 10.1016/j.neuropharm.2010.05.010; Munro G, 2009, EUR J PHARMACOL, V605, P95, DOI 10.1016/j.ejphar.2009.01.004; Neil Nancy, 2013, J Med Econ, V16, P307, DOI 10.3111/13696998.2012.756401; Obata H, 2010, J PHARMACOL EXP THER, V334, P1059, DOI 10.1124/jpet.110.168336; Omote K, 1998, BRAIN RES, V814, P194, DOI 10.1016/S0006-8993(98)01086-5; OSSIPOV MH, 1990, J PHARMACOL EXP THER, V255, P1107; Paul D, 2001, J PHARMACOL EXP THER, V298, P674; Paul D, 1997, ANALGESIA, V3, P43; Persec J, 2007, COLLEGIUM ANTROPOL, V31, P1065; Pertovaara A, 2006, PROG NEUROBIOL, V80, P53, DOI 10.1016/j.pneurobio.2006.08.001; Pettersen VLA, 2009, ANESTH ANALG, V109, P1312, DOI 10.1213/ane.0b013e3181b16ff5; Porreca F, 2002, TRENDS NEUROSCI, V25, P319, DOI 10.1016/S0166-2236(02)02157-4; Puig MM, 2000, ANESTHESIOLOGY, V93, P219, DOI 10.1097/00000542-200007000-00033; Puig S, 1996, PAIN, V64, P345, DOI 10.1016/0304-3959(95)00121-2; RAFFA RB, 1992, J PHARMACOL EXP THER, V260, P275; Ren K, 2002, PAIN, V100, P1, DOI 10.1016/S0304-3959(02)00368-8; Robinson DA, 2004, CURR NEUROVASC RES, V1, P11, DOI 10.2174/1567202043480189; Schiene K, 2011, J PHARMACOL EXP THER, V339, P537, DOI 10.1124/jpet.111.181263; Schroder W, 2011, J PHARMACOL EXP THER, V337, P312, DOI 10.1124/jpet.110.175042; Snijdelaar DG, 2005, PAIN, V119, P159, DOI 10.1016/j.pain.2005.09.027; Suzuki R, 2005, NEUROSIGNALS, V14, P175, DOI 10.1159/000087656; Suzuki R, 2004, TRENDS PHARMACOL SCI, V25, P613, DOI 10.1016/j.tips.2004.10.002; Svensson CI, 2006, FEBS LETT, V580, P6629, DOI 10.1016/j.febslet.2006.11.012; Takano A, 2006, PSYCHOPHARMACOLOGY, V185, P395, DOI 10.1007/s00213-005-0304-0; Tallarida RJ, 1997, LIFE SCI, V61, pPL417, DOI 10.1016/S0024-3205(97)01030-8; TALLARIDA RJ, 1992, PAIN, V49, P93, DOI 10.1016/0304-3959(92)90193-F; Tallarida RJ., 2000, DRUG SYNERGISM DOSE; Trivedi MH, 2008, INT CLIN PSYCHOPHARM, V23, P161, DOI 10.1097/YIC.0b013e3282f41d7e; Tsuruda PR, 2010, J PHARMACOL TOXICOL, V61, P192, DOI 10.1016/j.vascn.2009.12.003; Tzschentke TM, 2007, J PHARMACOL EXP THER, V323, P265, DOI 10.1124/jpet.107.126052; van Rijn CM, 2004, EPILEPSY RES, V59, P181, DOI 10.1016/j.eplepsyres.2004.04.003; van Rijn CM, 1999, EUR J PHARMACOL, V371, P213, DOI 10.1016/S0014-2999(99)00178-8; Wei F, 2010, J NEUROSCI, V30, P8624, DOI 10.1523/JNEUROSCI.5389-09.2010; WILCOX GL, 1987, BRAIN RES, V405, P84, DOI 10.1016/0006-8993(87)90992-9; Wu CT, 2004, ANESTH ANALG, V99, P502, DOI 10.1213/01.ANE.0000117146.46373.51; Yaksh TL, 2001, J APPL PHYSIOL, V90, P2386, DOI 10.1152/jappl.2001.90.6.2386; YEOMANS DC, 1992, PAIN, V48, P449, DOI 10.1016/0304-3959(92)90098-V; Zeitz KP, 2002, J NEUROSCI, V22, P1010, DOI 10.1523/JNEUROSCI.22-03-01010.2002	61	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74891	10.1371/journal.pone.0074891	http://dx.doi.org/10.1371/journal.pone.0074891			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098676	Green Published, gold, Green Submitted			2022-12-25	WOS:000325423500047
J	Sundberg, M; Pfister, B; Fulton, D; Bischof, S; Delatte, T; Eicke, S; Stettler, M; Smith, SM; Streb, S; Zeeman, SC				Sundberg, Maria; Pfister, Barbara; Fulton, Daniel; Bischof, Sylvain; Delatte, Thierry; Eicke, Simona; Stettler, Michaela; Smith, Steven M.; Streb, Sebastian; Zeeman, Samuel C.			The Heteromultimeric Debranching Enzyme Involved in Starch Synthesis in Arabidopsis Requires Both Isoamylase1 and Isoamylase2 Subunits for Complex Stability and Activity	PLOS ONE			English	Article							DEVELOPING MAIZE ENDOSPERM; BIOSYNTHETIC-ENZYMES; GRANULE INITIATION; RICE ENDOSPERM; HOMO-OLIGOMER; METABOLISM; MUTANTS; PURIFICATION; AMYLOPECTIN; GLYCOGEN	Isoamylase-type debranching enzymes (ISAs) play an important role in determining starch structure. Amylopectin - a branched polymer of glucose - is the major component of starch granules and its architecture underlies the semi-crystalline nature of starch. Mutants of several species lacking the ISA1-subclass of isoamylase are impaired in amylopectin synthesis. Consequently, starch levels are decreased and an aberrant soluble glucan (phytoglycogen) with altered branch lengths and branching pattern accumulates. Here we use TAP (tandem affinity purification) tagging to provide direct evidence in Arabidopsis that ISA1 interacts with its homolog ISA2. No evidence for interaction with other starch biosynthetic enzymes was found. Analysis of the single mutants shows that each protein is destabilised in the absence of the other. Co-expression of both ISA1 and ISA2 Escherichia coli allowed the formation of the active recombinant enzyme and we show using site-directed mutagenesis that ISA1 is the catalytic subunit. The presence of the active isoamylase alters glycogen biosynthesis in E. coli, resulting in colonies that stain more starch-like with iodine. However, analysis of the glucans reveals that rather than producing an amylopectin like substance, cells expressing the active isoamylase still accumulate small amounts of glycogen together with a population of linear oligosaccharides that stain strongly with iodine. We conclude that for isoamylase to promote amylopectin synthesis it needs to act on a specific precursor (pre-amylopectin) generated by the combined actions of plant starch synthase and branching enzyme isoforms and when presented with an unsuitable substrate (i.e. E. coli glycogen) it simply degrades it.	[Sundberg, Maria; Pfister, Barbara; Bischof, Sylvain; Delatte, Thierry; Eicke, Simona; Stettler, Michaela; Streb, Sebastian; Zeeman, Samuel C.] ETH, Dept Biol, Zurich, Switzerland; [Fulton, Daniel] Univ Edinburgh, Inst Mol Plant Sci, Edinburgh, Midlothian, Scotland; [Smith, Steven M.] Univ Western Australia, Sch Chem & Biochem, Crawley, WA, Australia	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Edinburgh; University of Western Australia	Zeeman, SC (corresponding author), ETH, Dept Biol, Zurich, Switzerland.	szeeman@ethz.ch	Smith, Steven/HDM-9496-2022; Smith, Steven M/G-7183-2015	Smith, Steven M/0000-0001-5661-9994; Zeeman, Samuel/0000-0002-2791-0915; Streb, Sebastian/0000-0002-9095-6596	Swiss National Science Foundation [3100AO-116434/1, 31003A- 518 131074]; ETH Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich)	The work was funded by the Swiss National Science Foundation (Grant Nos. 3100AO-116434/1 and 31003A- 518 131074) and ETH Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burton RA, 2002, PLANT J, V31, P97, DOI 10.1046/j.1365-313X.2002.01339.x; Bustos R, 2004, P NATL ACAD SCI USA, V101, P2215, DOI 10.1073/pnas.0305920101; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DAMOTTE M, 1968, BIOCHEM BIOPH RES CO, V32, P916, DOI 10.1016/0006-291X(68)90114-9; Dauvillee D, 2005, J BACTERIOL, V187, P1465, DOI 10.1128/JB.187.4.1465-1473.2005; Delatte T, 2006, J BIOL CHEM, V281, P12050, DOI 10.1074/jbc.M513661200; Delatte T, 2005, PLANT J, V41, P815, DOI 10.1111/j.1365-313X.2005.02348.x; Deschamps P, 2008, GENETICS, V178, P2373, DOI 10.1534/genetics.108.087205; Fujita N, 1999, PLANTA, V208, P283, DOI 10.1007/s004250050560; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hennen-Bierwagen TA, 2008, PLANT PHYSIOL, V146, P1892, DOI 10.1104/pp.108.116285; Hussain H, 2003, PLANT CELL, V15, P133, DOI 10.1105/tpc.006635; JAMES MG, 1995, PLANT CELL, V7, P417, DOI 10.1105/tpc.7.4.417; Katsuya Y, 1998, J MOL BIOL, V281, P885, DOI 10.1006/jmbi.1998.1992; KNIGHT S, 1990, J MOL BIOL, V215, P113, DOI 10.1016/S0022-2836(05)80100-7; KRISMAN CR, 1962, ANAL BIOCHEM, V4, P17, DOI 10.1016/0003-2697(62)90014-3; Kubo A, 2010, PLANT PHYSIOL, V153, P956, DOI 10.1104/pp.110.155259; MACGREGOR EA, 1993, STARCH-STARKE, V45, P232, DOI 10.1002/star.19930450705; Mouille G, 1996, PLANT CELL, V8, P1353; Nakamura Y, 1997, PLANT J, V12, P143, DOI 10.1046/j.1365-313X.1997.12010143.x; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Smith AM, 2006, NAT PROTOC, V1, P1342, DOI 10.1038/nprot.2006.232; Smith SM, 2004, PLANT PHYSIOL, V136, P2687, DOI 10.1104/pp.104.044347; Streb S, 2012, J BIOL CHEM, V287, P41745, DOI 10.1074/jbc.M112.395244; Streb S, 2008, PLANT CELL, V20, P3448, DOI 10.1105/tpc.108.063487; Takashima Y, 2007, BIOSCI BIOTECH BIOCH, V71, P2308, DOI 10.1271/bbb.70215; Tetlow IJ, 2008, PLANT PHYSIOL, V146, P1878, DOI 10.1104/pp.108.116244; Utsumi Y, 2006, PLANTA, V225, P75, DOI 10.1007/s00425-006-0331-z; Utsumi Y, 2011, PLANT PHYSIOL, V156, P61, DOI 10.1104/pp.111.173435; Wattebled F, 2005, PLANT PHYSIOL, V138, P184, DOI 10.1104/pp.105.059295; Wu CY, 2002, ARCH BIOCHEM BIOPHYS, V406, P21, DOI 10.1016/S0003-9861(02)00412-5; Zeeman SC, 2007, BIOCHEM J, V401, P13, DOI 10.1042/BJ20061393; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301; Zeeman SC, 1998, PLANT CELL, V10, P1699, DOI 10.1105/tpc.10.10.1699	36	21	21	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75223	10.1371/journal.pone.0075223	http://dx.doi.org/10.1371/journal.pone.0075223			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098685	Green Published, gold, Green Submitted			2022-12-25	WOS:000325423500056
J	Watanabe, KP; Kawai, YK; Ikenaka, Y; Kawata, M; Ikushiro, SI; Sakaki, T; Ishizuka, M				Watanabe, Kensuke P.; Kawai, Yusuke K.; Ikenaka, Yoshinori; Kawata, Minami; Ikushiro, Shin-Ichi; Sakaki, Toshiyuki; Ishizuka, Mayumi			Avian Cytochrome P450 (CYP) 1-3 Family Genes: Isoforms, Evolutionary Relationships, and mRNA Expression in Chicken Liver	PLOS ONE			English	Article							ENZYMES; RAT; SUBFAMILY; SEQUENCE; RECEPTOR; CDNA; CXR	Cytochrome P450 (CYP) of chicken and other avian species have been studied primarily with microsomes or characterized by cloning and protein expression. However, the overall existing isoforms in avian CYP1-3 families or dominant isoforms in avian xenobiotic metabolism have not yet been elucidated. In this study, we aimed to clarify and classify all of the existing isoforms of CYP1-3 in avian species using available genome assemblies for chicken, zebra finch, and turkey. Furthermore, we performed qRT-PCR assay to identify dominant CYP genes in chicken liver. Our results suggested that avian xenobiotic-metabolizing CYP genes have undergone unique evolution such as CYP2C and CYP3A genes, which have undergone avian-specific gene duplications. qRT-PCR experiments showed that CYP2C45 was the most highly expressed isoform in chicken liver, while CYP2C23b was the most highly induced gene by phenobarbital. Considering together with the result of further enzymatic characterization, CYP2C45 may have a dominant role in chicken xenobiotic metabolism due to the constitutive high expression levels, while CYP2C23a and CYP2C23b can be greatly induced by chicken xenobiotic receptor (CXR) activators. These findings will provide not only novel insights into avian xenobiotic metabolism, but also a basis for the further characterization of each CYP gene.	[Watanabe, Kensuke P.; Kawai, Yusuke K.; Ikenaka, Yoshinori; Kawata, Minami; Ishizuka, Mayumi] Hokkaido Univ, Toxicol Lab, Sch Vet Med, Sapporo, Hokkaido, Japan; [Ikushiro, Shin-Ichi; Sakaki, Toshiyuki] Toyama Prefectural Univ, Fac Engn, Dept Biotechnol, Imizushi, Toyama Prefectu, Japan	Hokkaido University; Toyama Prefectural University	Ishizuka, M (corresponding author), Hokkaido Univ, Toxicol Lab, Sch Vet Med, Sapporo, Hokkaido, Japan.	ishizum@vetmed.hokudai.ac.jp	IKENAKA, Yoshinori/F-8529-2012	Kawai, Yusuke/0000-0002-4942-4432; Ikenaka, Yoshinori/0000-0002-6633-6637	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [24248056, 24405004]; JSPS [231864]	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) awarded to Prof. M. Ishizuka (Nos. 24248056 and 24405004) and JSPS Fellowship for KPW (231864). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baader M, 2002, J BIOL CHEM, V277, P15647, DOI 10.1074/jbc.M109882200; Blevins S, 2012, POULTRY SCI, V91, P322, DOI 10.3382/ps.2011-01764; Cai H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038395; Cheng JB, 2004, P NATL ACAD SCI USA, V101, P7711, DOI 10.1073/pnas.0402490101; Chuang SS, 2004, J BIOL CHEM, V279, P6305, DOI 10.1074/jbc.M311830200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Goldstone HMH, 2006, J MOL EVOL, V62, P708, DOI 10.1007/s00239-005-0134-z; Goriya Harshad V, 2005, J Vet Sci, V6, P279; Gupta RP, 1998, COMP BIOCHEM PHYS C, V121, P73, DOI 10.1016/S0742-8413(98)10031-2; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Handschin C, 2000, P NATL ACAD SCI USA, V97, P10769, DOI 10.1073/pnas.97.20.10769; HANSEN AJ, 1989, DNA-J MOLEC CELL BIO, V8, P179, DOI 10.1089/dna.1.1989.8.179; Ikushiro S, 2004, BBA-GEN SUBJECTS, V1672, P86, DOI 10.1016/j.bbagen.2004.02.012; Jonsson ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028257; Kirischian N, 2011, J MOL EVOL, V72, P56, DOI 10.1007/s00239-010-9402-7; Kubota A, 2011, COMP BIOCHEM PHYS C, V153, P280, DOI 10.1016/j.cbpc.2010.11.006; McArthur AG, 2003, J MOL EVOL, V57, P200, DOI 10.1007/s00239-003-2466-x; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; OEDA K, 1985, DNA-J MOLEC CELL BIO, V4, P203, DOI 10.1089/dna.1985.4.203; Ohtsuki S, 2012, DRUG METAB DISPOS, V40, P83, DOI 10.1124/dmd.111.042259; OMURA T, 1964, J BIOL CHEM, V239, P2370; Ourlin JC, 2000, ARCH BIOCHEM BIOPHYS, V373, P375, DOI 10.1006/abbi.1999.1566; Rawal S, 2009, CYTOGENET GENOME RES, V125, P67, DOI 10.1159/000218748; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Temesvari M, 2012, J PHARMACOL EXP THER, V341, P294, DOI 10.1124/jpet.111.189597; Thomas JH, 2007, PLOS GENET, V3, P720, DOI 10.1371/journal.pgen.0030067; Walker CH, 1998, COMP BIOCHEM PHYS C, V121, P65, DOI 10.1016/S0742-8413(98)10030-0; Watanabe KP, 2010, COMP BIOCHEM PHYS C, V152, P114, DOI 10.1016/j.cbpc.2010.03.006	29	41	42	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75689	10.1371/journal.pone.0075689	http://dx.doi.org/10.1371/journal.pone.0075689			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098714	Green Published, gold, Green Submitted			2022-12-25	WOS:000325423500085
J	Clayton, GM; Klein, DJ; Rickert, KW; Patel, SB; Kornienko, M; Zugay-Murphy, J; Reid, JC; Tummala, S; Sharma, S; Singh, SB; Miesel, L; Lumb, KJ; Soisson, SM				Clayton, Gina M.; Klein, Daniel J.; Rickert, Keith W.; Patel, Sangita B.; Kornienko, Maria; Zugay-Murphy, Joan; Reid, John C.; Tummala, Srivanya; Sharma, Sujata; Singh, Sheo B.; Miesel, Lynn; Lumb, Kevin J.; Soisson, Stephen M.			Structure of the Bacterial Deacetylase LpxC Bound to the Nucleotide Reaction Product Reveals Mechanisms of Oxyanion Stabilization and Proton Transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibiotics; Escherichia coli; Lipopolysaccharide (LPS); Protein Structure; X-ray Crystallography; LpxC; UDP	ZINC-DEPENDENT DEACETYLASE; SUBSTRATE-ANALOG INHIBITOR; ESCHERICHIA-COLI; HYDROXAMIC ACIDS; UDP-3-O-(R-3-HYDROXYMYRISTOYL)-N-ACETYLGLUCOSAMINE DEACETYLASE; CRYSTAL-STRUCTURE; AQUIFEX-AEOLICUS; BINDING; BIOSYNTHESIS; ENDOTOXIN	The emergence of antibiotic-resistant strains of pathogenic bacteria is an increasing threat to global health that underscores an urgent need for an expanded antibacterial armamentarium. Gram-negative bacteria, such as Escherichia coli, have become increasingly important clinical pathogens with limited treatment options. This is due in part to their lipopolysaccharide (LPS) outer membrane components, which dually serve as endotoxins while also protecting Gram-negative bacteria from antibiotic entry. The LpxC enzyme catalyzes the committed step of LPS biosynthesis, making LpxC a promising target for new antibacterials. Here, we present the first structure of an LpxC enzyme in complex with the deacetylation reaction product, UDP-(3-O-(R-3-hydroxymyristoyl))-glucosamine. These studies provide valuable insight into recognition of substrates and products by LpxC and a platform for structure-guided drug discovery of broad spectrum Gram-negative antibiotics.	[Clayton, Gina M.; Klein, Daniel J.; Patel, Sangita B.; Reid, John C.; Soisson, Stephen M.] Merck Res Labs, Global Struct Chem, West Point, PA 19486 USA; [Rickert, Keith W.; Kornienko, Maria; Zugay-Murphy, Joan; Tummala, Srivanya; Sharma, Sujata; Lumb, Kevin J.] Merck Res Labs, Screening & Prot Sci, West Point, PA 19486 USA; [Singh, Sheo B.] Merck Res Labs, Discovery Chem, Kenilworth, NJ 07033 USA; [Miesel, Lynn] Merck Res Labs, Infect Dis, Kenilworth, NJ 07033 USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company	Soisson, SM (corresponding author), Merck Res Labs, Global Struct Chem, West Point, PA 19486 USA.	stephen_soisson@merck.com		Lumb, Kevin/0000-0003-2778-9956	Hauptman-Woodward Medical Research Institute; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]	Hauptman-Woodward Medical Research Institute; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	We thank Paul McNicolas, Max Deng, Jun Lu, Gopal Parthasarathy, and Hua Su for helpful discussions; Lisa Keefe and the staff at the IMCA-CAT (Advanced Photon Source), and Joe Brunzelle for assistance with data collection. Use of the IMCA-CAT beamline 17-ID at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with Hauptman-Woodward Medical Research Institute. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Baltz RH, 2009, CURR OPIN CHEM BIOL, V13, P144, DOI 10.1016/j.cbpa.2009.02.031; Barb AW, 2008, CURR PHARM BIOTECHNO, V9, P9; Barb AW, 2007, P NATL ACAD SCI USA, V104, P18433, DOI 10.1073/pnas.0709412104; BRICOGNE G, 1993, ACTA CRYSTALLOGR D, V49, P37, DOI 10.1107/S0907444992010400; Buetow L, 2006, ACTA CRYSTALLOGR F, V62, P1082, DOI 10.1107/S1744309106041893; Clements JM, 2002, ANTIMICROB AGENTS CH, V46, P1793, DOI 10.1128/AAC.46.6.1793-1799.2002; Coggins BE, 2003, NAT STRUCT BIOL, V10, P645, DOI 10.1038/nsb948; Coggins BE, 2005, BIOCHEMISTRY-US, V44, P1114, DOI 10.1021/bi047820z; Coggins BE, 2004, J BIOMOL NMR, V28, P201, DOI 10.1023/B:JNMR.0000013817.29493.87; Cole K. E., BIOCHEMISTRY, V50, P258; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gennadios HA, 2006, BIOCHEMISTRY-US, V45, P7940, DOI 10.1021/bi060823m; Gennadios HA, 2006, BIOCHEMISTRY-US, V45, P15216, DOI 10.1021/bi0619021; Hale MR, 2013, BIOORG MED CHEM LETT, V23, P2362, DOI 10.1016/j.bmcl.2013.02.055; Hernick M, 2005, J BIOL CHEM, V280, P16969, DOI 10.1074/jbc.M413560200; Hernick M, 2006, BIOCHEMISTRY-US, V45, P15240, DOI 10.1021/bi061405k; Jackman JE, 1999, BIOCHEMISTRY-US, V38, P1902, DOI 10.1021/bi982339s; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lee CJ, 2011, CHEM BIOL, V18, P38, DOI 10.1016/j.chembiol.2010.11.011; Liang XF, 2011, BIOORGAN MED CHEM, V19, P852, DOI 10.1016/j.bmc.2010.12.017; LOTLIKAR PD, 1971, BIOCHEM J, V124, P69, DOI 10.1042/bj1240069; McClerren AL, 2005, BIOCHEMISTRY-US, V44, P16574, DOI 10.1021/bi0518186; McClerren AL, 2005, BIOCHEMISTRY-US, V44, P1106, DOI 10.1021/bi048001h; Metzger LE, 2009, BIOCHEMISTRY-US, V48, P11559, DOI 10.1021/bi901750f; Mochalkin I, 2008, PROTEIN SCI, V17, P450, DOI 10.1110/ps.073324108; Montgomery JI, 2012, J MED CHEM, V55, P1662, DOI 10.1021/jm2014875; MULDER GJ, 1983, ENVIRON HEALTH PERSP, V49, P27, DOI 10.2307/3429577; Norrby R, 2001, Expert Opin Pharmacother, V2, P293, DOI 10.1517/14656566.2.2.293; Onishi HR, 1996, SCIENCE, V274, P980, DOI 10.1126/science.274.5289.980; Pirrung MC, 2003, J AM CHEM SOC, V125, P1575, DOI 10.1021/ja0209114; Pirrung MC, 2002, J MED CHEM, V45, P4359, DOI 10.1021/jm020183v; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2006, J LIPID RES, V47, P1097, DOI 10.1194/jlr.M600027-JLR200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Roversi P, 2000, ACTA CRYSTALLOGR D, V56, P1316, DOI 10.1107/S0907444900008490; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wang J, 2006, NATURE, V441, P358, DOI 10.1038/nature04784; Wang XY, 2010, PROG LIPID RES, V49, P97, DOI 10.1016/j.plipres.2009.06.002; WEISBURGER JH, 1973, PHARMACOL REV, V25, P1; Whittaker M, 1999, CHEM REV, V99, P2735, DOI 10.1021/cr9804543; Whittington DA, 2003, P NATL ACAD SCI USA, V100, P8146, DOI 10.1073/pnas.1432990100	42	29	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34073	34080		10.1074/jbc.M113.513028	http://dx.doi.org/10.1074/jbc.M113.513028			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24108127	hybrid, Green Published			2022-12-25	WOS:000327250200050
J	Nagae, M; Ikeda, A; Hane, M; Hanashima, S; Kitajima, K; Sato, C; Yamaguchi, Y				Nagae, Masamichi; Ikeda, Akemi; Hane, Masaya; Hanashima, Shinya; Kitajima, Ken; Sato, Chihiro; Yamaguchi, Yoshiki			Crystal Structure of Anti-polysialic Acid Antibody Single Chain Fv Fragment Complexed with Octasialic Acid INSIGHT INTO THE BINDING PREFERENCE FOR POLYSIALIC ACID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibodies; Crystal Structure; Oligosaccharide; Sialic Acid; Site-directed Mutagenesis	CELL-ADHESION MOLECULE; CARBOHYDRATE-BINDING; DENDRITIC CELLS; LIGAND-BINDING; PEANUT LECTIN; POLYSACCHARIDE; BRAIN; GLYCOPROTEINS; RESIDUES; OLIGO	Polysialic acid is a linear homopolymer of 2-8-linked sialic acids attached mainly onto glycoproteins. Cell surface polysialic acid plays roles in cell adhesion and differentiation events in a manner that is often dependent on the degree of polymerization (DP). Anti-oligo/polysialic acid antibodies have DP-dependent antigenic specificity, and such antibodies are widely utilized in biological studies for detecting and distinguishing between different oligo/polysialic acids. A murine monoclonal antibody mAb735 has a unique preference for longer polymers of polysialic acid (DP >10), yet the mechanism of recognition at the atomic level remains unclear. Here, we report the crystal structure of mAb735 single chain variable fragment (scFv735) in complex with octasialic acid at 1.8 resolution. In the asymmetric unit, two scFv735 molecules associate with one octasialic acid. In both complexes of the unit, all the complementarity-determining regions except for L3 interact with three consecutive sialic acid residues out of the eight. A striking feature of the complex is that 11 ordered water molecules bridge the gap between antibody and ligand, whereas the direct antibody-ligand interaction is less extensive. The dihedral angles of the trisialic acid unit directly interacting with scFv735 are not uniform, indicating that mAb735 does not strictly favor the previously proposed helical conformation. Importantly, both reducing and nonreducing ends of the bound ligand are completely exposed to solvent. We suggest that mAb735 gains its apparent high affinity for a longer polysialic acid chain by recognizing every three sialic acid units in a paired manner.	[Nagae, Masamichi; Ikeda, Akemi; Hanashima, Shinya; Yamaguchi, Yoshiki] RIKEN Global Res Cluster, Struct Glycobiol Team, Syst Glycobiol Res Grp, RIKEN Max Planck Joint Res Ctr, Wako, Saitama 3510198, Japan; [Hane, Masaya; Kitajima, Ken; Sato, Chihiro] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan; [Hane, Masaya; Kitajima, Ken; Sato, Chihiro] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	RIKEN; Nagoya University; Nagoya University	Yamaguchi, Y (corresponding author), RIKEN Global Res Cluster, Struct Glycobiol Team, Syst Glycobiol Res Grp, RIKEN Max Planck Joint Res Ctr, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	yyoshiki@riken.jp	Hanashima, Shinya/AGN-0921-2022; Yamaguchi, Yoshiki/N-5246-2015; Naganawa, Shinji/I-1572-2012; SATO, Chihiro/B-7396-2014	Hanashima, Shinya/0000-0003-3102-7890; Yamaguchi, Yoshiki/0000-0003-0100-5439; Naganawa, Shinji/0000-0002-0214-613X; Nagae, Masamichi/0000-0002-5470-3807	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24110506, 24110520]; Grants-in-Aid for Scientific Research [23570133, 25460054] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research on Innovative Areas (deciphering sugar chain-based signals regulating integrative neuronal functions) 24110506 and 24110520 (to M. N. and C. S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Bax M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006987; BRISSON JR, 1992, BIOCHEMISTRY-US, V31, P4996, DOI 10.1021/bi00136a012; Drake PM, 2008, J IMMUNOL, V181, P6850, DOI 10.4049/jimmunol.181.10.6850; Drake PM, 2009, P NATL ACAD SCI USA, V106, P11995, DOI 10.1073/pnas.0905188106; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; EVANS SV, 1995, BIOCHEMISTRY-US, V34, P6737, DOI 10.1021/bi00020a019; FINNE J, 1982, J BIOL CHEM, V257, P1966; FINNE J, 1983, LANCET, V2, P355; Flint J, 2005, J BIOL CHEM, V280, P23718, DOI 10.1074/jbc.M501551200; FROSCH M, 1985, P NATL ACAD SCI USA, V82, P1194, DOI 10.1073/pnas.82.4.1194; HALLENBECK PC, 1987, J BIOL CHEM, V262, P3553; Hanashima S, 2013, BIOORGAN MED CHEM, V21, P6069, DOI 10.1016/j.bmc.2013.07.023; Hane M, 2012, PURE APPL CHEM, V84, P1895, DOI 10.1351/PAC-CON-11-12-10; Henderson TJ, 2003, J AM CHEM SOC, V125, P2930, DOI 10.1021/ja0210087; Imberty A, 1997, CURR OPIN STRUC BIOL, V7, P617, DOI 10.1016/S0959-440X(97)80069-3; Inoko E, 2010, GLYCOBIOLOGY, V20, P916, DOI 10.1093/glycob/cwq049; Jodar L, 2002, LANCET, V359, P1499, DOI 10.1016/S0140-6736(02)08416-7; Kanato Y, 2009, BIOSCI BIOTECH BIOCH, V73, P2735, DOI 10.1271/bbb.90637; KLEBERT S, 1993, BIOL CHEM H-S, V374, P993, DOI 10.1515/bchm3.1993.374.7-12.993; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lutteke T, 2006, GLYCOBIOLOGY, V16, p71R, DOI 10.1093/glycob/cwj049; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nairn AV, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.405233; Nakata D, 2005, J BIOL CHEM, V280, P38305, DOI 10.1074/jbc.M508762200; Ono S, 2012, J BIOL CHEM, V287, P3710, DOI 10.1074/jbc.M111.276618; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pell G, 2003, BIOCHEMISTRY-US, V42, P9316, DOI 10.1021/bi0347510; Ravishankar R, 1999, ACTA CRYSTALLOGR D, V55, P1375, DOI 10.1107/S0907444999006587; Ravishankar R, 1997, CURR SCI INDIA, V72, P855; Rey-Gallardo A, 2011, GLYCOBIOLOGY, V21, P655, DOI 10.1093/glycob/cwq216; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; SATO C, 1995, J BIOL CHEM, V270, P18923, DOI 10.1074/jbc.270.32.18923; Sato C, 1998, J BIOL CHEM, V273, P2575, DOI 10.1074/jbc.273.5.2575; Sato C, 2000, J BIOL CHEM, V275, P15422, DOI 10.1074/jbc.275.20.15422; Sato C, 2013, J BIOCHEM, V154, P115, DOI 10.1093/jb/mvt057; VAESEN M, 1991, BIOL CHEM H-S, V372, P451, DOI 10.1515/bchm3.1991.372.1.451; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; YAMASAKI R, 1991, BIOCHEMISTRY-US, V30, P851, DOI 10.1021/bi00217a039; Yongye AB, 2008, BIOCHEMISTRY-US, V47, P12493, DOI 10.1021/bi800431c	42	45	45	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33784	33796		10.1074/jbc.M113.496224	http://dx.doi.org/10.1074/jbc.M113.496224			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24100042	Green Published, hybrid			2022-12-25	WOS:000327250200024
J	Bleicken, S; Landeta, O; Landajuela, A; Basanez, G; Garcia-Saez, AJ				Bleicken, Stephanie; Landeta, Olatz; Landajuela, Ane; Basanez, Gorka; Garcia-Saez, Ana J.			Proapoptotic Bax and Bak Proteins Form Stable Protein-permeable Pores of Tunable Size	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Bcl-2 Proteins; Confocal Microscopy; Membrane Biophysics; Vesicles	BCL-2 FAMILY-MEMBERS; CYTOCHROME-C RELEASE; MITOCHONDRIAL-MEMBRANE; APOPTOSIS; OLIGOMERIZATION; ACTIVATION; PERMEABILIZATION; BCL-X(L); PEPTIDE; CYTOSOL	Background: During apoptosis Bax/Bak release differently sized proteins out of the mitochondria. Results: The size of Bax/Bak pores depends on protein concentration. Conclusion: Bax/Bak form stable toroidal pores tunable in size. Significance: Pore size-tuning constitutes a new level for the regulation of Bax/Bak activity. The Bcl-2 proapoptotic proteins Bax and Bak mediate the permeabilization of the mitochondrial outer membrane during apoptosis. Current models consider that Bax and Bak form pores at the mitochondrial outer membrane that are responsible for the release of cytochrome c and other larger mitochondrial apoptotic factors (i.e. Smac/DIABLO, AIF, and endoglycosidase G). However, the properties and nature of Bax/Bak apoptotic pores remain enigmatic. Here, we performed a detailed analysis of the membrane permeabilizing activity of Bax and Bak at the single vesicle level. We directly visualized that cBid-activated Bax and BakC21 can form membrane pores large enough to release not only cytochrome c, but also allophycocyanine, a protein of 104 kDa. Interestingly, the size of Bax and BakC21 pores is not constant, as typically observed in purely proteinaceous channels, but evolves with time and depends on protein concentration. We found that Bax and BakC21 formed long-lived pores, whose areas changed with the amount of Bax/BakC21 but not with cardiolipin concentration. Altogether, our results demonstrate that Bax and BakC21 follow similar mechanisms of membrane permeabilization characterized by the formation of protein-permeable pores of dynamic size, in agreement with the proteolipidic nature of these apoptotic pores.	[Bleicken, Stephanie; Garcia-Saez, Ana J.] BioQuant, German Canc Res Ctr, D-69120 Heidelberg, Germany; [Bleicken, Stephanie; Garcia-Saez, Ana J.] Max Planck Inst Intelligent Syst, D-70569 Stuttgart, Germany; [Landeta, Olatz; Landajuela, Ane; Basanez, Gorka] Univ Basque Country, CSIC, Unidad Biofis, Leioa 48940, Bizkaia, Spain	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Max Planck Society; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika	Basanez, G (corresponding author), Univ Basque Country, CSIC, Unidad Biofis, Barrio Sarriena S-N, Leioa 48940, Bizkaia, Spain.	gorka_basanez@ehu.es; ajegarsa@mf.mpg.de	Basanez, Gorka/L-9509-2014; Saez, Ana J. Garcia/U-1611-2019	Basanez, Gorka/0000-0002-7475-7861; Bleicken, Stephanie/0000-0002-4789-0974; Landeta, Olatz/0000-0002-5494-0271	Max Planck Society; German Cancer Research Center; Bundesministerium fur Bildung und Forschung Grant [0312040]; Basque Government; Ministerio de Economia y Competitividad [BFU2011-28566]	Max Planck Society(Max Planck SocietyFoundation CELLEX); German Cancer Research Center; Bundesministerium fur Bildung und Forschung Grant(Federal Ministry of Education & Research (BMBF)); Basque Government(Basque Government); Ministerio de Economia y Competitividad(Spanish Government)	Supported by the Max Planck Society, the German Cancer Research Center, and Bundesministerium fur Bildung und Forschung Grant 0312040.; Recipient of predoctoral fellowship from the Basque Government.; Supported by Grant BFU2011-28566 from the Ministerio de Economia y Competitividad. To whom correspondence may be addressed: Unidad de Biofisica (CSIC-UPV/EHU), Barrio Sarriena s/n, Leioa 48940. Tel.: 34-946013355, Fax: 34-94-6013360; E-mail: gorka_basanez@ehu.es.	ARDAIL D, 1990, J BIOL CHEM, V265, P18797; Arnoult D, 2002, J CELL BIOL, V159, P923, DOI 10.1083/jcb.200207071; Basanez G, 1999, P NATL ACAD SCI USA, V96, P5492, DOI 10.1073/pnas.96.10.5492; Basanez G, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001399; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Bender T., 2013, COLD SPRING HARBOR P, V5; Bhola PD, 2009, BIOPHYS J, V97, P2222, DOI 10.1016/j.bpj.2009.07.056; Bleicken S, 2013, BIOPHYS J, V104, P421, DOI 10.1016/j.bpj.2012.12.010; Bleicken S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035910; Bleicken S, 2010, J BIOL CHEM, V285, P6636, DOI 10.1074/jbc.M109.081539; Bleicken S, 2009, J BIOENERG BIOMEMBR, V41, P29, DOI 10.1007/s10863-009-9202-1; BREJC K, 1995, J MOL BIOL, V249, P424, DOI 10.1006/jmbi.1995.0307; Czabotar PE, 2013, CELL, V152, P519, DOI 10.1016/j.cell.2012.12.031; Dai HM, 2011, J CELL BIOL, V194, P38, DOI 10.1083/jcb.201102027; Danial NN, 2010, ADV EXP MED BIOL, V687, P1; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; Epand RF, 2003, BIOCHEMISTRY-US, V42, P14576, DOI 10.1021/bi035348w; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Etxebarria A, 2009, J BIOL CHEM, V284, P4200, DOI 10.1074/jbc.M808050200; Etxebarria A, 2008, BIOCHEM PHARMACOL, V76, P1563, DOI 10.1016/j.bcp.2008.08.003; Ferrer PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031510; Flanagan L, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.26; Fuertes G., 2011, THESIS U VALENCIA VA; Fuertes G, 2011, EUR BIOPHYS J BIOPHY, V40, P399, DOI 10.1007/s00249-011-0693-4; Fuertes G, 2010, BIOPHYS J, V99, P2917, DOI 10.1016/j.bpj.2010.08.068; Garcia-Saez AJ, 2012, CELL DEATH DIFFER, V19, P1733, DOI 10.1038/cdd.2012.105; Garcia-Saez AJ, 2006, FEBS J, V273, P971, DOI 10.1111/j.1742-4658.2006.05123.x; Garcia-Saez AJ, 2005, BIOPHYS J, V88, P3976, DOI 10.1529/biophysj.104.058008; Garcia-Saez AJ, 2007, BIOPHYS J, V93, P103, DOI 10.1529/biophysj.106.100370; Garcia-Saez AJ, 2010, ADV EXP MED BIOL, V677, P91; Garcia-Saez AJ, 2009, NAT STRUCT MOL BIOL, V16, P1178, DOI 10.1038/nsmb.1671; Huang HW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198304; Kucerka N, 2005, J MEMBRANE BIOL, V208, P193, DOI 10.1007/s00232-005-7006-8; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Landeta O, 2011, J BIOL CHEM, V286, P8213, DOI 10.1074/jbc.M110.165852; Leshchiner ES, 2013, P NATL ACAD SCI USA, V110, pE986, DOI 10.1073/pnas.1214313110; Lewis RNAH, 2009, BBA-BIOMEMBRANES, V1788, P2069, DOI 10.1016/j.bbamem.2009.03.014; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Llambi F, 2011, CURR OPIN GENET DEV, V21, P12, DOI 10.1016/j.gde.2010.12.001; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Martinez-Caballero S, 2009, J BIOL CHEM, V284, P12235, DOI 10.1074/jbc.M806610200; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Matsuzaki K, 1997, BIOPHYS J, V73, P831, DOI 10.1016/S0006-3495(97)78115-3; Mihajlovic M, 2010, BBA-BIOMEMBRANES, V1798, P1494, DOI 10.1016/j.bbamem.2010.02.023; Mirkin N, 2008, PROTEINS, V70, P83, DOI 10.1002/prot.21452; Moldoveanu T, 2013, NAT STRUCT MOL BIOL, V20, P589, DOI 10.1038/nsmb.2563; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; Munoz-Pinedo C, 2006, P NATL ACAD SCI USA, V103, P11573, DOI 10.1073/pnas.0603007103; Phillips DC, 2007, CANCER RES, V67, P756, DOI 10.1158/0008-5472.CAN-06-2374; Qian S, 2008, P NATL ACAD SCI USA, V105, P17379, DOI 10.1073/pnas.0807764105; Rehm M, 2003, J CELL BIOL, V162, P1031, DOI 10.1083/jcb.200303123; Roucou X, 2002, BIOCHEM J, V363, P547, DOI 10.1042/0264-6021:3630547; Saito M, 2000, NAT CELL BIOL, V2, P553, DOI 10.1038/35019596; Schafer B, 2009, MOL BIOL CELL, V20, P2276, DOI 10.1091/mbc.E08-10-1056; Schellenberg B, 2013, MOL CELL, V49, P959, DOI 10.1016/j.molcel.2012.12.022; Tamba Y, 2009, J PHYS CHEM B, V113, P4846, DOI 10.1021/jp8109622; Terrones O, 2004, J BIOL CHEM, V279, P30081, DOI 10.1074/jbc.M313420200; Terrones O, 2008, J BIOL CHEM, V283, P7790, DOI 10.1074/jbc.M708814200; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Xu XP, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.210; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	63	100	101	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33241	33252		10.1074/jbc.M113.512087	http://dx.doi.org/10.1074/jbc.M113.512087			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24100034	hybrid, Green Published			2022-12-25	WOS:000328841700038
J	Ferguson, L; How, JJ; Agoulnik, AI				Ferguson, Lydia; How, Javier J.; Agoulnik, Alexander I.			The Fate of Spermatogonial Stem Cells in the Cryptorchid Testes of RXFP2 Deficient Mice	PLOS ONE			English	Article							SELF-RENEWAL; MOUSE TESTIS; ADULT MICE; RECEPTOR; SPERMATOGENESIS; DIFFERENTIATION; GERMLINE; NANOS2; GDNF	The environmental niche of the spermatogonial stem cell pool is critical to ensure the continued generation of the germ cell population. To study the consequences of an aberrant testicular environment in cryptorchidism we used a mouse model with a deletion of Rxfp2 gene resulting in a high intra-abdominal testicular position. Mutant males were infertile with the gross morphology of the cryptorchid testis progressively deteriorating with age. Few spermatogonia were identifiable in 12 month old cryptorchid testes. Gene expression analysis showed no difference between mutant and control testes at postnatal day 10. In three month old males a decrease in expression of spermatogonial stem cell (SSC) markers Id4, Nanos2, and Ret was shown. The direct counting of ID4+ cells supported a significant decrease of SSCs. In contrast, the expression of Plzf, a marker for undifferentiated and differentiating spermatogonia was not reduced, and the number of PLZF+ cells in the cryptorchid testis was higher in three month old testes, but equal to control in six month old mutants. The PLZF+ cells did not show a higher rate of apoptosis in cryptorchid testis. The expression of the Sertoli cell FGF2 gene required for SSC maintenance was significantly reduced in mutant testis. Based on these findings we propose that the deregulation of somatic and germ cell genes in the cryptorchid testis, directs the SSCs towards the differentiation pathway. This leads to a depletion of the SSC pool and an increase in the number of PLZF+ spermatogonial cells, which too, eventually decreases with the exhaustion of the stem cell pool. Such a dynamic suggests that an early correction of cryptorchidism is critical for the retention of the SSC pool.	[Ferguson, Lydia; How, Javier J.; Agoulnik, Alexander I.] Florida Int Univ, Herbert Wertheim Coll Med, Dept Human & Mol Genet, Miami, FL 33199 USA; [Agoulnik, Alexander I.] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA	State University System of Florida; Florida International University; Baylor College of Medicine	Agoulnik, AI (corresponding author), Florida Int Univ, Herbert Wertheim Coll Med, Dept Human & Mol Genet, Miami, FL 33199 USA.	aagoulni@fiu.edu	Agoulnik, Alexander/AAK-3213-2020	Agoulnik, Alexander/0000-0001-6587-6845; How, Javier/0000-0002-9952-9304				Agoulnik AI, 2012, METHODS MOL BIOL, V825, P127, DOI 10.1007/978-1-61779-436-0_11; Bogatcheva NV, 2003, MOL ENDOCRINOL, V17, P2639, DOI 10.1210/me.2003-0096; Cataldo L, 1997, EXP CELL RES, V231, P206, DOI 10.1006/excr.1996.3447; Chiarini-Garcia H, 2001, BIOL REPROD, V65, P1179, DOI 10.1095/biolreprod65.4.1179; De Rooij DG, 2012, J ANDROL, V33, P1085, DOI 10.2164/jandrol.112.016832; Ferguson Lydia, 2013, Front Endocrinol (Lausanne), V4, P32, DOI 10.3389/fendo.2013.00032; Gorlov IP, 2002, HUM MOL GENET, V11, P2309, DOI 10.1093/hmg/11.19.2309; Grasso M, 2012, REPRODUCTION, V143, P325, DOI 10.1530/REP-11-0385; Huang ZH, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.103382; Ishii K, 2012, DEVELOPMENT, V139, P1734, DOI 10.1242/dev.076539; Jijiwa M, 2008, GENES CELLS, V13, P365, DOI 10.1111/j.1365-2443.2008.01171.x; Kaftanovskaya EM, 2012, MOL ENDOCRINOL, V26, P598, DOI 10.1210/me.2011-1283; Kaftanovskaya EM, 2011, MOL ENDOCRINOL, V25, P170, DOI 10.1210/me.2010-0330; Kamisawa H, 2012, J UROLOGY, V187, P1047, DOI 10.1016/j.juro.2011.10.170; Kokkinaki M, 2009, BIOL REPROD, V80, P707, DOI 10.1095/biolreprod.108.073809; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Li Y, 2009, J ANDROL, V30, P325, DOI 10.2164/jandrol.108.005934; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Naughton CK, 2006, BIOL REPROD, V74, P314, DOI 10.1095/biolreprod.105.047365; NISHIMUNE Y, 1978, FERTIL STERIL, V29, P95; Oatley JM, 2012, PHYSIOL REV, V92, P577, DOI 10.1152/physrev.00025.2011; Oatley MJ, 2011, BIOL REPROD, V85, P347, DOI 10.1095/biolreprod.111.091330; Oatley MJ, 2011, BIOL REPROD, V84, P639, DOI 10.1095/biolreprod.110.087320; Orwig KE, 2008, STEM CELLS, V26, P927, DOI 10.1634/stemcells.2007-0893; Overbeek PA, 2001, GENESIS, V30, P26, DOI 10.1002/gene.1029; Perez-Crespo M, 2008, MOL REPROD DEV, V75, P40, DOI 10.1002/mrd.20759; Sada A, 2012, STEM CELLS, V30, P280, DOI 10.1002/stem.790; Sada A, 2009, SCIENCE, V325, P1394, DOI 10.1126/science.1172645; Shinohara T, 2000, DEV BIOL, V220, P401, DOI 10.1006/dbio.2000.9655; Taran I, 2006, WORLD J UROL, V24, P231, DOI 10.1007/s00345-006-0056-4; TEGELENBOSCH RAJ, 1993, MUTAT RES, V290, P193; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Yin YZ, 1997, J ANDROL, V18, P159	33	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e77351	10.1371/journal.pone.0077351	http://dx.doi.org/10.1371/journal.pone.0077351			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098584	Green Submitted, Green Published, gold			2022-12-25	WOS:000325483600086
J	Liu, HT; Jiang, YH; Kuo, HC				Liu, Hsin-Tzu; Jiang, Yuan-Hong; Kuo, Hann-Chorng			Increased Serum Adipokines Implicate Chronic Inflammation in the Pathogenesis of Overactive Bladder Syndrome Refractory to Antimuscarinic Therapy	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; QUALITY-OF-LIFE; URINARY-BLADDER; INTRADETRUSOR INJECTIONS; INTERSTITIAL CYSTITIS; DETRUSOR OVERACTIVITY; MEDICAL-TREATMENT; CHEMOKINES; INVOLVEMENT; DYSFUNCTION	Objectives: Recent studies have shown that chronic inflammation is involved in overactive bladder (OAB) syndrome. OAB could be a subtype of neurogenic inflammation. This pilot study investigated serum adipokine levels in patients with OAB refractory to antimuscarinic therapy. Methods: Thirty consecutive patients with OAB-dry (n = 16) or OAB-wet (n = 14) refractory to previous antimuscarinic treatment were prospectively enrolled in this study, a group of 26 normal subjects without lower urinary tract symptoms served as controls. Concentrations of serum C-reactive protein (CRP), nerve growth factor (NGF), and adipokines including interleukins ([IL], IL-1 beta, IL-6, IL-8), tumor necrosis factor (TNF)-alpha, monocyte chemotactic protein (MCP)-1, insulin, and leptin were quantified using a bead-based human serum adipokine panel B kit. Data were analyzed using the LX 200 platform. Patients were further classified as having dry or wet OAB and having medical diseases or not. The serum CRP, NGF, and adipokine levels were compared between OAB patients and the controls, and between OAB subgroups. Results: The serum concentrations of CRP, NGF, IL-1 beta, IL-6, IL-8, and TNF-alpha in OAB-dry and OAB-wet patients were significantly higher than among the controls. There was no significant difference in adipokine levels between OAB-dry and OAB-wet, or between OAB patients with and without medical diseases. Serum CRP and NGF levels were significantly higher only in OAB-wet or OAB patients with medical diseases than among controls. The MCP-1 levels, on the other hand, were significantly higher in OAB-dry or OAB patients with disease, than the controls. Conclusions: Both OAB-dry and OAB-wet patients showed increased serum CRP, NGF, and adipokine levels compared with the controls, suggesting chronic inflammation of the bladder involving both peripheral and central mechanisms in all OAB patients refractory to antimuscarinic therapy. The increased serum adipokine levels were not relevant to medical diseases.	[Liu, Hsin-Tzu; Jiang, Yuan-Hong; Kuo, Hann-Chorng] Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan; [Liu, Hsin-Tzu; Jiang, Yuan-Hong; Kuo, Hann-Chorng] Tzu Chi Univ, Hualien, Taiwan; [Liu, Hsin-Tzu] Tzu Chi Univ, Inst Pharmacol & Toxicol, Hualien, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Tzu Chi University	Kuo, HC (corresponding author), Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan.	hck@tzuchi.com.tw						Abrams P, 2000, AM J MANAG CARE, V6, pS580; Apostolidis A, 2005, J UROLOGY, V174, P977, DOI 10.1097/01.ju.0000169481.42259.54; Apostolidis A, 2008, EUR UROL, V53, P1245, DOI 10.1016/j.eururo.2008.02.037; Avelino A, 2002, NEUROSCIENCE, V109, P787, DOI 10.1016/S0306-4522(01)00496-1; Bouchelouche K, 2004, J UROLOGY, V171, P462, DOI 10.1097/01.ju.0000090192.36436.d5; Brown JS, 2000, AM J MANAG CARE, V6, pS574; Rodriguez MAB, 2009, J UROLOGY, V182, P2123, DOI 10.1016/j.juro.2009.07.036; Chapple CR, 2000, UROLOGY, V55, P33, DOI 10.1016/S0090-4295(99)00492-6; Chung SD, 2011, NEUROUROL URODYNAM, V30, P417, DOI 10.1002/nau.20938; Davidoff R, 1997, J UROLOGY, V157, P1980, DOI 10.1016/S0022-5347(01)64914-0; Dupont MC, 2001, J UROLOGY, V166, P1111, DOI 10.1016/S0022-5347(05)65931-9; Gormley EA, 2012, J UROLOGY, V188, P2455, DOI 10.1016/j.juro.2012.09.079; Heinrich M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020792; JACOBSON SH, 1994, NEPHRON, V67, P172, DOI 10.1159/000187923; Kupelian V, 2012, BJU INT, V110, P401, DOI 10.1111/j.1464-410X.2011.10769.x; Ley K, 2003, MICROCIRCULATION, V10, P289, DOI 10.1038/sj.mn.7800194; Liao CH, 2011, UROLOGY, V78, P1373, DOI 10.1016/j.urology.2011.04.076; Liu HT, 2008, UROLOGY, V72, P104, DOI 10.1016/j.urology.2008.01.069; Liu HT, 2011, NEUROUROL URODYNAM, V30, P1525, DOI 10.1002/nau.21118; Lowe EM, 1997, BRIT J UROL, V79, P572, DOI 10.1046/j.1464-410X.1997.00097.x; Melville JL, 2002, AM J OBSTET GYNECOL, V187, P80, DOI 10.1067/mob.2002.124839; Nomiya M, 2012, NEUROUROL URODYNAM, V31, P185, DOI 10.1002/nau.21191; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC183, DOI 10.1152/ajpcell.1999.277.2.C183; Segerer S, 2005, THESCIENTIFICWORLDJO, V5, P835, DOI 10.1100/tsw.2005.105; Seki S, 2002, J UROLOGY, V168, P2269, DOI 10.1016/S0022-5347(05)64369-8; Serrano-Sanchez T, 2001, REV NEUROLOGIA, V32, P825, DOI 10.33588/rn.3209.2000496; Stanzani L, 2001, CEREBROVASC DIS, V12, P240, DOI 10.1159/000047710; Steers WD, 2006, NAT CLIN PRACT UROL, V3, P101, DOI 10.1038/ncpuro0408; STEERS WD, 1991, J CLIN INVEST, V88, P1709, DOI 10.1172/JCI115488; TUTTLE JB, 1994, J AUTONOM NERV SYST, V49, P147, DOI 10.1016/0165-1838(94)90134-1; Tyagi P, 2012, J UROLOGY, V187, P2243, DOI 10.1016/j.juro.2012.01.034; Vizzard MA, 2000, EXP NEUROL, V161, P273, DOI 10.1006/exnr.1999.7254; Wang W, 2012, MOL MED REP, V6, P434, DOI 10.3892/mmr.2012.928; Wennberg AL, 2009, EUR UROL, V55, P783, DOI 10.1016/j.eururo.2009.01.007; Yiangou Y, 2001, BJU INT, V87, P774, DOI 10.1046/j.1464-410x.2001.02190.x; Zhang ZF, 2008, EXP BIOL MED, V233, P1171, DOI 10.3181/0712-RM-328	36	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76706	10.1371/journal.pone.0076706	http://dx.doi.org/10.1371/journal.pone.0076706			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098552	Green Submitted, gold, Green Published			2022-12-25	WOS:000325427100083
J	Baek, KT; Frees, D; Renzoni, A; Barras, C; Rodriguez, N; Manzano, C; Kelley, WL				Baek, Kristoffer T.; Frees, Dorte; Renzoni, Adriana; Barras, Christine; Rodriguez, Natalia; Manzano, Caroline; Kelley, William L.			Genetic Variation in the Staphylococcus aureus 8325 Strain Lineage Revealed by Whole-Genome Sequencing	PLOS ONE			English	Article							COMPETENCE TRANSCRIPTION FACTOR; VIRULENCE-DETERMINANT EXPRESSION; FIBRONECTIN-BINDING; LABORATORY STRAINS; GLOBAL REGULATOR; IN-VITRO; RESISTANCE; SIGMA(B); PROTEIN; SARA	Staphylococcus aureus strains of the 8325 lineage, especially 8325-4 and derivatives lacking prophage, have been used extensively for decades of research. We report herein the results of our deep sequence analysis of strain 8325-4. Assignment of sequence variants compared with the reference strain 8325 (NRS77/PS47) required correction of errors in the 8325 reference genome, and reassessment of variation previously attributed to chemical mutagenesis of the restriction-defective RN4220. Using an extensive strain pedigree analysis, we discovered that 8325-4 contains 16 single nucleotide polymorphisms (SNP) arising prior to the construction of RN4220. We identified 5 indels in 8325-4 compared with 8325. Three indels correspond to expected Phi 11, 12, 13 excisions, one indel is explained by a sequence assembly artifact, and the final indel (Delta 63bp) in the spa-sarS intergenic region is common to only a sub-lineage of 8325-4 strains including SH1000. This deletion was found to significantly decrease (75%) steady state sarS but not spa transcript levels in post-exponential phase. The sub-lineage 8325-4 was also found to harbor 4 additional SNPs. We also found large sequence variation between 8325, 8325-4 and RN4220 in a cluster of repetitive hypothetical proteins (SA0282 homologs) near the Ess secretion cluster. The overall 8325-4 SNP set results in 17 alterations within coding sequences. Remarkably, we discovered that all tested strains of the 8325-4 lineage lack phenol soluble modulin alpha 3 (PSM alpha 3), a virulence determinant implicated in neutrophil chemotaxis, biofilm architecture and surface spreading. Collectively, our results clarify and define the 8325-4 pedigree and reveal clear evidence that mutations existing throughout all branches of this lineage, including the widely used RN6390 and SH1000 strains, could conceivably impact virulence regulation.	[Baek, Kristoffer T.; Frees, Dorte] Univ Copenhagen, Dept Vet Dis Biol, Frederiksberg, Denmark; [Renzoni, Adriana; Barras, Christine; Rodriguez, Natalia; Manzano, Caroline; Kelley, William L.] Univ Hosp, Infect Dis Serv, Geneva, Switzerland; [Renzoni, Adriana; Barras, Christine; Rodriguez, Natalia; Manzano, Caroline; Kelley, William L.] Med Sch Geneva, Geneva, Switzerland	University of Copenhagen; University of Geneva; University of Geneva	Kelley, WL (corresponding author), Univ Hosp, Infect Dis Serv, Geneva, Switzerland.	William.Kelley@unige.ch		Frees, Dorte/0000-0003-4946-2890; Renzoni, Adriana/0000-0002-4897-5208; Baek, Kristoffer Torbjorn/0000-0003-3243-3962	Swiss National Science Foundation [3100A0-120428, 310030-146540]; Danish Council for Independent Research [12-132527]; Nordic Joint Committee for Agricultural Research; Swiss Society for Infectious Diseases; Canton of Geneva	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Nordic Joint Committee for Agricultural Research; Swiss Society for Infectious Diseases; Canton of Geneva	This work was supported by grants from the Swiss National Science Foundation (3100A0-120428 and 310030-146540 to WLK), the Danish Council for Independent Research (12-132527 to KTB), the Nordic Joint Committee for Agricultural Research (to DF), a fellowship grant from the Swiss Society for Infectious Diseases (to NR), and the Canton of Geneva. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M, 2011, J BACTERIOL, V193, P1583, DOI 10.1128/JB.01096-10; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Ballal A, 2009, MICROBIOL-SGM, V155, P2342, DOI 10.1099/mic.0.027417-0; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; BERGERBACHI B, 1983, J BACTERIOL, V154, P479; Berscheid A, 2012, INT J MED MICROBIOL, V302, P84, DOI 10.1016/j.ijmm.2012.01.002; Bisognano C, 2004, J BIOL CHEM, V279, P9064, DOI 10.1074/jbc.M309836200; Brandenberger M, 2000, BBA-GEN SUBJECTS, V1523, P135, DOI 10.1016/S0304-4165(00)00133-1; Chan PF, 1998, MICROBIOL-SGM, V144, P2469, DOI 10.1099/00221287-144-9-2469; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Cheung AL, 2008, INT J BIOCHEM CELL B, V40, P355, DOI 10.1016/j.biocel.2007.10.032; Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226; Falord M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021323; Frees D, 2005, INFECT IMMUN, V73, P8100, DOI 10.1128/IAI.73.12.8100-8108.2005; Gao JX, 2004, J BACTERIOL, V186, P3738, DOI 10.1128/JB.186.12.3738-3748.2004; Geiger T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003016; Giachino P, 2001, J BACTERIOL, V183, P1843, DOI 10.1128/JB.183.6.1843-1852.2001; Gillaspy A. F., 2006, GRAM POSITIVE PATHOG, P381, DOI DOI 10.1128/; Hamoen LW, 1998, GENE DEV, V12, P1539, DOI 10.1101/gad.12.10.1539; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Horsburgh MJ, 2002, MOL MICROBIOL, V44, P1269, DOI 10.1046/j.1365-2958.2002.02944.x; Kullik I, 1998, J BACTERIOL, V180, P4814, DOI 10.1128/JB.180.18.4814-4820.1998; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; MAHAIRAS GG, 1989, J BACTERIOL, V171, P3968, DOI 10.1128/jb.171.7.3968-3972.1989; McCallum N, 2004, J BACTERIOL, V186, P2966, DOI 10.1128/JB.186.10.2966-2972.2004; Morikawa K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003003; Nair D, 2011, J BACTERIOL, V193, P2332, DOI 10.1128/JB.00027-11; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 2006, GRAM POSITIVE PATHOG, P496; O'Neill AJ, 2010, LETT APPL MICROBIOL, V51, P358, DOI 10.1111/j.1472-765X.2010.02885.x; Oscarsson J, 2006, J BACTERIOL, V188, P8526, DOI 10.1128/JB.00866-06; Pamp SJ, 2006, J BACTERIOL, V188, P4861, DOI 10.1128/JB.00194-06; Papanikolau Y, 2007, J MOL BIOL, V366, P1545, DOI 10.1016/j.jmb.2006.12.049; Paulander W, 2012, MBIO, V3, DOI 10.1128/mBio.00459-12; Periasamy S, 2012, P NATL ACAD SCI USA, V109, P1281, DOI 10.1073/pnas.1115006109; Queck SY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000533; Renzoni A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021577; Renzoni A, 2009, ANTIMICROB AGENTS CH, V53, P903, DOI 10.1128/AAC.01287-08; SCHAAPER RM, 1987, J MOL BIOL, V198, P187, DOI 10.1016/0022-2836(87)90305-6; Schmidt KA, 2003, INFECT IMMUN, V71, P5139, DOI 10.1128/IAI.71.9.5139-5148.2003; Somerville GA, 2002, J BACTERIOL, V184, P1430, DOI 10.1128/JB.184.5.1430-1437.2002; Surewaard BGJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002606; Susanna KA, 2004, J BACTERIOL, V186, P1120, DOI 10.1128/JB.186.4.1120-1128.2004; Tegmark K, 2000, MOL MICROBIOL, V37, P398, DOI 10.1046/j.1365-2958.2000.02003.x; Traber K, 2006, MOL MICROBIOL, V59, P1519, DOI 10.1111/j.1365-2958.2006.04986.x; Tsompanidou E, 2013, APPL ENVIRON MICROB, V79, P886, DOI 10.1128/AEM.03157-12; VANSINDEREN D, 1995, MOL MICROBIOL, V15, P455; Vaudaux P, 2002, INFECT IMMUN, V70, P5428, DOI 10.1128/IAI.70.10.5428-5437.2002; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	53	38	38	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e77122	10.1371/journal.pone.0077122	http://dx.doi.org/10.1371/journal.pone.0077122			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098817	Green Published, gold, Green Submitted			2022-12-25	WOS:000325423500188
J	Baggio, F; Bozzato, A; Benna, C; Leonardi, E; Romoli, O; Cognolato, M; Tosatto, SCE; Costa, R; Sandrelli, F				Baggio, Francesca; Bozzato, Andrea; Benna, Clara; Leonardi, Emanuela; Romoli, Ottavia; Cognolato, Moira; Tosatto, Silvio C. E.; Costa, Rodolfo; Sandrelli, Federica			2mit, an Intronic Gene of Drosophila melanogaster timeless2, Is Involved in Behavioral Plasticity	PLOS ONE			English	Article							LEUCINE-RICH REPEAT; DEPENDENT PROTEIN-KINASE; MUSHROOM BODIES; NESTED GENES; PREFERENTIAL EXPRESSION; NATURAL-SELECTION; RNA LOCALIZATION; DROSOPHILA; COURTSHIP; MEMORY	Background: Intronic genes represent similar to 6% of the total gene complement in Drosophila melanogaster and similar to 85% of them encode for proteins. We recently characterized the D. melanogaster timeless2 (tim2) gene, showing its active involvement in chromosomal stability and light synchronization of the adult circadian clock. The protein coding gene named 2mit maps on the 11th tim2 intron in the opposite transcriptional orientation. Methodology/Principal Findings: Here we report the molecular and functional characterization of 2mit. The 2mit gene is expressed throughout Drosophila development, localizing mainly in the nervous system during embryogenesis and mostly in the mushroom bodies and ellipsoid body of the central complex in the adult brain. In silico analyses revealed that 2mit encodes a putative leucine-Rich Repeat transmembrane receptor with intrinsically disordered regions, harboring several fully conserved functional interaction motifs in the cytosolic side. Using insertional mutations, tissue-specific over-expression, and down-regulation approaches, it was found that 2mit is implicated in adult short-term memory, assessed by a courtship conditioning assay. In D. melanogaster, tim2 and 2mit do not seem to be functionally related. Bioinformatic analyses identified 2MIT orthologs in 21 Drosophilidae, 4 Lepidoptera and in Apis mellifera. In addition, the tim2-2mit host-nested gene organization was shown to be present in A. mellifera and maintained among Drosophila species. Within the Drosophilidae 2mit-hosting tim2 intron, in silico approaches detected a neuronal specific transcriptional binding site which might have contributed to preserve the specific host-nested gene association across Drosophila species. Conclusions/Significance: Taken together, these results indicate that 2mit, a gene mainly expressed in the nervous system, has a role in the behavioral plasticity of the adult Drosophila. The presence of a putative 2mit regulatory enhancer within the 2mit-hosting tim2 intron could be considered an evolutionary constraint potentially involved in maintaining the tim2-2mit host-nested chromosomal architecture during the evolution of Drosophila species.	[Baggio, Francesca; Bozzato, Andrea; Benna, Clara; Leonardi, Emanuela; Romoli, Ottavia; Cognolato, Moira; Tosatto, Silvio C. E.; Costa, Rodolfo; Sandrelli, Federica] Univ Padua, Dipartimento Biol, Padua, Italy	University of Padua	Sandrelli, F (corresponding author), Univ Padua, Dipartimento Biol, Padua, Italy.	federica.sandrelli@unipd.it	Tosatto, Silvio/B-2840-2009; leonardi, emanuela/AAN-2392-2020; benna, clara/K-1083-2018	Tosatto, Silvio/0000-0003-4525-7793; leonardi, emanuela/0000-0001-8486-8461; BENNA, CLARA/0000-0002-9077-2471; Romoli, Ottavia/0000-0002-7608-2650; SANDRELLI, FEDERICA/0000-0002-5631-7467; Baggio, Francesca/0000-0001-5070-6165	Universita degli Studi di Padova [CPDR042471, CPDR100470, CPDA074398, CPDA098382]; CARIPARO (Progetti di Eccellenza); FIRB Futuro in Ricerca [RBFR08ZSXY]; CARIPLO [2011/0724]; European Community [018741]	Universita degli Studi di Padova; CARIPARO (Progetti di Eccellenza)(Fondazione Cariparo); FIRB Futuro in Ricerca(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); CARIPLO(Fondazione Cariplo); European Community(European Commission)	AB and CB were supported by postdoctoral fellowships from Universita degli Studi di Padova (CPDR042471 and CPDR100470). This work was funded by grants from Universita degli Studi di Padova (CPDA074398 to FS and CPDA098382 to SCET); CARIPARO (Progetti di Eccellenza, 2011/12) to FS, FIRB Futuro in Ricerca (RBFR08ZSXY) and CARIPLO (2011/0724) to SCET; and European Community (the 6th Framework Project EUCLOCK no. 018741) to RC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2003, PROTEIN ENG, V16, P459, DOI 10.1093/protein/gzg063; Aso Y, 2009, J NEUROGENET, V23, P156, DOI 10.1080/01677060802471718; Assis R, 2008, TRENDS GENET, V24, P475, DOI 10.1016/j.tig.2008.08.003; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Benna C, 2010, CURR BIOL, V20, P346, DOI 10.1016/j.cub.2009.12.048; Bhutkar A, 2007, GENOME RES, V17, P1880, DOI 10.1101/gr.7062307; Boden M, 2005, BIOINFORMATICS, V21, P2279, DOI 10.1093/bioinformatics/bti372; Bujnicki JM, 2001, BIOINFORMATICS, V17, P750, DOI 10.1093/bioinformatics/17.8.750; Cavallari N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001142; CHEN MS, 1992, J CELL SCI, V103, P619; CONNOLLY JB, 1998, BEHAVIOUR LEARNING A, V2, P265; de Wit J, 2011, ANNU REV CELL DEV BI, V27, P697, DOI 10.1146/annurev-cellbio-092910-154111; DRAIN P, 1991, NEURON, V6, P71, DOI 10.1016/0896-6273(91)90123-H; EDERY I, 1994, SCIENCE, V263, P237, DOI 10.1126/science.8284676; Fahrbach SE, 2006, ANNU REV ENTOMOL, V51, P209, DOI 10.1146/annurev.ento.51.110104.150954; FELSENSTEIN J, 1985, CONFIDENCE LIMITS ON; GAILEY DA, 1984, GENETICS, V106, P613; Gibson CW, 2005, GENE, V350, P15, DOI 10.1016/j.gene.2004.12.045; Gotter AL, 2007, J MOL BIOL, V366, P36, DOI 10.1016/j.jmb.2006.10.097; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; GRIFFITH LC, 1993, NEURON, V10, P501, DOI 10.1016/0896-6273(93)90337-Q; Griffith LC, 2009, LEARN MEMORY, V16, P743, DOI 10.1101/lm.956309; Grimaldi D. A., 2005, EVOLUTION INSECTS, VXV; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; Heger A, 2000, PROTEINS, V41, P224, DOI 10.1002/1097-0134(20001101)41:2<224::AID-PROT70>3.0.CO;2-Z; Hudson SG, 2007, GENETICS, V177, P1349, DOI 10.1534/genetics.107.071670; IP YT, 1994, EMBO J, V13, P5826, DOI 10.1002/j.1460-2075.1994.tb06926.x; Jin Y, 2008, ANNU REV CELL DEV BI, V24, P237, DOI 10.1146/annurev.cellbio.23.090506.123417; Joiner MLA, 1997, J NEUROSCI, V17, P9384; Joiner MLA, 1999, LEARN MEMORY, V6, P177; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jung HS, 2012, NAT REV NEUROSCI, V13, P308, DOI 10.1038/nrn3210; Jungreis I, 2011, GENOME RES, V21, P2096, DOI 10.1101/gr.119974.110; Kajava AV, 2002, PROTEIN SCI, V11, P1082, DOI 10.1110/ps.4010102; Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307; Kobayashi M, 2006, P NATL ACAD SCI USA, V103, P14417, DOI 10.1073/pnas.0606571103; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kondratov RV, 2007, CURR TOP DEV BIOL, V78, P173, DOI 10.1016/S0070-2153(06)78005-X; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kumar A, 2009, EUKARYOT CELL, V8, P1321, DOI 10.1128/EC.00143-09; LEHMANN R, 1994, METHOD CELL BIOL, V44, P575, DOI 10.1016/S0091-679X(08)60933-4; Marsella L, 2009, BIOINFORMATICS, V25, pI289, DOI 10.1093/bioinformatics/btp232; Martin JR, 2001, J NEUROGENET, V15, P205, DOI 10.3109/01677060109167377; MAUHIN V, 1993, NUCLEIC ACIDS RES, V21, P3951, DOI 10.1093/nar/21.17.3951; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; McGuire SE, 2005, PROG NEUROBIOL, V76, P328, DOI 10.1016/j.pneurobio.2005.09.003; MISRA S, 2002, GENOME BIOL RES, V83; NIGHORN A, 1991, NEURON, V6, P455, DOI 10.1016/0896-6273(91)90253-V; Peschel N, 2011, FEBS LETT, V585, P1435, DOI 10.1016/j.febslet.2011.02.028; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Philip N, 2001, J NEUROSCI, V21, P8417, DOI 10.1523/JNEUROSCI.21-21-08417.2001; Piccin A, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e55; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Rosato E, 2006, NAT PROTOC, V1, P559, DOI 10.1038/nprot.2006.79; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Salzberg A, 1997, GENETICS, V147, P1723; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Sandrelli F, 2007, SCIENCE, V316, P1898, DOI 10.1126/science.1138426; Saxena AK, 2008, SAR QSAR ENVIRON RES, V19, P11, DOI 10.1080/10629360701844126; Shishido E, 1998, SCIENCE, V280, P2118, DOI 10.1126/science.280.5372.2118; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Siwicki KK, 2003, BEHAV PROCESS, V64, P225, DOI 10.1016/S0376-6357(03)00137-2; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; Szklarczyk R, 2004, BIOINFORMATICS, V20, P311, DOI 10.1093/bioinformatics/bth911; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tauber E, 2007, SCIENCE, V316, P1895, DOI 10.1126/science.1138412; Tolino M, 2012, EUR J NEUROSCI, V35, P1818, DOI 10.1111/j.1460-9568.2012.08160.x; TOMPKINS L, 1984, BEHAV GENET, V14, P411, DOI 10.1007/BF01065443; Tosatto SCE, 2005, J COMPUT BIOL, V12, P1316, DOI 10.1089/cmb.2005.12.1316; Tsang WH, 2009, GENOMICS, V94, P177, DOI 10.1016/j.ygeno.2009.05.009; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Walsh I, 2011, NUCLEIC ACIDS RES, V39, pW190, DOI 10.1093/nar/gkr411; WILLMUND R, 1982, ANIM BEHAV, V30, P209, DOI 10.1016/S0003-3472(82)80256-X; Young JM, 2010, J COMP NEUROL, V518, P1500, DOI 10.1002/cne.22284; Zordan MA, 2006, GENETICS, V172, P229, DOI 10.1534/genetics.105.049072	80	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76351	10.1371/journal.pone.0076351	http://dx.doi.org/10.1371/journal.pone.0076351			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098788	Green Published, gold, Green Submitted			2022-12-25	WOS:000325423500159
J	Simonin-Le Jeune, K; Le Jeune, A; Jouneau, S; Belleguic, C; Roux, PF; Jaguin, M; Dimanche-Boitre, MT; Lecureur, V; Leclercq, C; Desrues, B; Brinchault, G; Gangneux, JP; Martin-Chouly, C				Simonin-Le Jeune, Karin; Le Jeune, Andre; Jouneau, Stephane; Belleguic, Chantal; Roux, Pierre-Francois; Jaguin, Marie; Dimanche-Boitre, Marie-Therese; Lecureur, Valerie; Leclercq, Caroline; Desrues, Benoit; Brinchault, Graziella; Gangneux, Jean-Pierre; Martin-Chouly, Corinne			Impaired Functions of Macrophage from Cystic Fibrosis Patients: CD11b, TLR-5 Decrease and sCD14, Inflammatory Cytokines Increase	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA INFECTION; INNATE IMMUNITY; LUNG-DISEASE; SOLUBLE CD14; MYCOBACTERIUM-TUBERCULOSIS; CEREBROSPINAL-FLUID; NONOPSONIC BINDING; HUMAN MONOCYTES; RECEPTOR; NEUTROPHILS	Background: Early in life, cystic fibrosis (CF) patients are infected with microorganisms. The role of macrophages has largely been underestimated in literature, whereas the focus being mostly on neutrophils and epithelial cells. Macrophages may however play a significant role in the initiating stages of this disease, via an inability to act as a suppressor cell. Yet macrophage dysfunction may be the first step in cascade of events leading to chronic inflammation/infection in CF. Moreover, reports have suggested that CFTR contribute to altered inflammatory response in CF by modification of normal macrophage functions. Objectives: In order to highlight possible intrinsic macrophage defects due to impaired CFTR, we have studied inflammatory cytokines secretions, recognition of pathogens and phagocytosis in peripheral blood monocyte-derived macrophages from stable adult CF patients and healthy subjects (non-CF). Results: In CF macrophage supernatants, concentrations of sCD14, IL-1 beta, IL-6, TNF-alpha and IL-10 were strongly raised. Furthermore expression of CD11b and TLR-5 were sorely decreased on CF macrophages. Beside, no difference was observed for mCD14, CD16, CD64, TLR-4 and TLR1/TLR-2 expressions. Moreover, a strong inhibition of phagocytosis was observed for CF macrophages. Elsewhere CFTR inhibition in non-CF macrophages also led to alterations of phagocytosis function as well as CD11b expression. Conclusions: Altogether, these findings demonstrate excessive inflammation in CF macrophages, characterized by overproduction of sCD14 and inflammatory cytokines, with decreased expression of CD11b and TLR-5, and impaired phagocytosis. This leads to altered clearance of pathogens and non-resolution of infection by CF macrophages, thereby inducing an exaggerated pro-inflammatory response.	[Simonin-Le Jeune, Karin; Le Jeune, Andre; Jouneau, Stephane; Roux, Pierre-Francois; Jaguin, Marie; Dimanche-Boitre, Marie-Therese; Lecureur, Valerie; Leclercq, Caroline; Gangneux, Jean-Pierre; Martin-Chouly, Corinne] Univ Rennes 1, Struct Federat Rech Biosit, F-35043 Rennes, France; [Simonin-Le Jeune, Karin; Roux, Pierre-Francois; Dimanche-Boitre, Marie-Therese; Leclercq, Caroline; Martin-Chouly, Corinne] INSERM, IRSET, U1085, Team Stress Membrane & Signaling, F-35043 Rennes, France; [Le Jeune, Andre] Equipe Microbiol Risques Infect EA 1254, F-35043 Rennes, France; [Jouneau, Stephane; Jaguin, Marie; Lecureur, Valerie] INSERM, IRSET, U1085, Team Chem Contaminant Immun & Inflammat, F-35043 Rennes, France; [Jouneau, Stephane; Belleguic, Chantal; Desrues, Benoit; Brinchault, Graziella; Gangneux, Jean-Pierre] Ctr Hosp Univ Rennes, Ctr Ressource & Competences Mucoviscidose, F-35064 Rennes, France; [Gangneux, Jean-Pierre] Ctr Hosp Univ Rennes, Serv Parasitol Mycol, F-35064 Rennes, France	Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Rennes; Universite de Rennes; CHU Rennes; Universite de Rennes	Martin-Chouly, C (corresponding author), Univ Rennes 1, Struct Federat Rech Biosit, F-35043 Rennes, France.	corinne.chouly@univ-rennes1.fr	LECUREUR, Valérie/J-9095-2015; MARTIN-CHOULY, Corinne AE/K-4288-2015; Dimanche-Boitrel, Marie-Therese M/I-4642-2015; Gangneux, Jean-Pierre/J-2960-2015; Roux, Pierre-François/J-8875-2019; Jouneau, Stephane/K-9956-2015	Roux, Pierre-François/0000-0002-0695-4206; MARTIN-CHOULY, corinne/0000-0001-7493-0612; Desrues, Benoit/0000-0002-1748-1694; Gangneux, Jean-Pierre/0000-0002-4974-5607	Vaincre La Mucoviscidose (cystic fibrosis association of France); Biosit (federative structure for research, Rennes 1 University, France)	Vaincre La Mucoviscidose (cystic fibrosis association of France); Biosit (federative structure for research, Rennes 1 University, France)	This work was supported by grants from Vaincre La Mucoviscidose (cystic fibrosis association of France) and Biosit (federative structure for research, Rennes 1 University, France) for grant and platform access. We thank the Faculty of Pharmacy of Rennes 1 University (France) for the support given to staff this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagawa KS, 2006, RESPIROLOGY, V11, pS32, DOI 10.1111/j.1440-1843.2006.00805.x; [Anonymous], 1997, CARDIOVASC RES, V35, P2, DOI DOI 10.1016/S0008-6363(97)00109-0.PUBMED:9302340; Bas S, 2004, J IMMUNOL, V172, P4470, DOI 10.4049/jimmunol.172.7.4470; Brettschneider J, 2002, J NEUROIMMUNOL, V133, P193, DOI 10.1016/S0165-5728(02)00353-3; Bruscia EM, 2011, J IMMUNOL, V186, P6990, DOI 10.4049/jimmunol.1100396; Bruscia EM, 2009, AM J RESP CELL MOL, V40, P295, DOI 10.1165/rcmb.2008-0170OC; Carnpodonico VL, 2008, TRENDS MOL MED, V14, P120, DOI 10.1016/j.molmed.2008.01.002; Conese Massimo, 2003, J Cyst Fibros, V2, P129, DOI 10.1016/S1569-1993(03)00063-8; Cywes C, 1996, INFECT IMMUN, V64, P5373, DOI 10.1128/IAI.64.12.5373-5383.1996; Del Porto P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019970; Descamps D, 2012, P NATL ACAD SCI USA, V109, P1619, DOI 10.1073/pnas.1108464109; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Dodge JA, 2007, EUR RESPIR J, V29, P522, DOI 10.1183/09031936.00099506; Dooring G, 2009, CELL MICROBIOL, V11, P208, DOI 10.1111/j.1462-5822.2008.01271.x; Douglas TA, 2009, EUR RESPIR J, V33, P305, DOI 10.1183/09031936.00043108; DURIEUX JJ, 1994, EUR J IMMUNOL, V24, P2006, DOI 10.1002/eji.1830240911; Egerer K, 2000, LUPUS, V9, P614, DOI 10.1191/096120300678828749; Eickmeier O, 2010, CYTOKINE, V50, P152, DOI 10.1016/j.cyto.2010.02.004; Fran R, 2010, EGISTRE FRANCAIS MUC; Hartl D, 2012, J CYST FIBROS, V11, P363, DOI 10.1016/j.jcf.2012.07.003; Hartl D, 2007, NAT MED, V13, P1423, DOI 10.1038/nm1690; Hauber Hans-Peter, 2005, Can Respir J, V12, P13; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; John G, 2011, EXP LUNG RES, V37, P319, DOI 10.3109/01902148.2011.569968; Jouneau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022655; Koller B, 2009, EUR J CLIN INVEST, V39, P535, DOI 10.1111/j.1365-2362.2009.02145.x; KRONBORG G, 1993, PEDIATR PULM, V15, P292, DOI 10.1002/ppul.1950150506; Le-Barillec K, 1999, J CLIN INVEST, V103, P1039, DOI 10.1172/JCI5779; Lin B, 2000, J INFECT DIS, V181, P1185, DOI 10.1086/315357; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Marcos V, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-32; Mogayzel PJ, 2011, AM J RESP CRIT CARE, V183, P1620, DOI 10.1164/rccm.201102-0275UP; Ngan DA, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-3; Nichols D, 2008, CLIN REV ALLERG IMMU, V34, P146, DOI 10.1007/s12016-007-8039-9; Nockher WA, 1999, J NEUROIMMUNOL, V101, P161, DOI 10.1016/S0165-5728(99)00141-1; Painter RG, 2008, J LEUKOCYTE BIOL, V83, P1345, DOI 10.1189/jlb.0907658; Painter RG, 2006, BIOCHEMISTRY-US, V45, P10260, DOI 10.1021/bi060490t; Perez A, 2007, AM J PHYSIOL-LUNG C, V292, pL383, DOI 10.1152/ajplung.00403.2005; Pier GB, 2000, P NATL ACAD SCI USA, V97, P8822, DOI 10.1073/pnas.97.16.8822; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; ROSS GD, 1993, CLIN EXP IMMUNOL, V92, P181; RUSSELL DG, 1988, J EXP MED, V168, P279, DOI 10.1084/jem.168.1.279; Schmitt-Grohe S, 2005, CYTOKINE, V29, P18, DOI 10.1016/j.cyto.2004.09.004; Shibata Y, 2001, IMMUNITY, V15, P557, DOI 10.1016/S1074-7613(01)00218-7; STOKES RW, 1993, J IMMUNOL, V151, P7067; Tang A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037689; Tiringer K, 2013, AM J RESP CRIT CARE, V187, P621, DOI 10.1164/rccm.201206-1150OC; van Grevenynghe J, 2003, J IMMUNOL, V170, P2374, DOI 10.4049/jimmunol.170.5.2374	48	39	38	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75667	10.1371/journal.pone.0075667	http://dx.doi.org/10.1371/journal.pone.0075667			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098711	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500082
J	Toubarro, D; Avila, MM; Montiel, R; Simoes, N				Toubarro, Duarte; Avila, Monica Martinez; Montiel, Rafael; Simoes, Nelson			A Pathogenic Nematode Targets Recognition Proteins to Avoid Insect Defenses	PLOS ONE			English	Article							PSEUDALETIA-UNIPUNCTA LEPIDOPTERA; STEINERNEMA-FELTIAE; IMMUNE-RESPONSES; BLOOD-CELLS; HOST; INHIBITOR; PROTEASE; COAGULATION; ACTIVATION; BACTERIA	Steinernema carpocapsae is a nematode pathogenic in a wide variety of insect species. The great pathogenicity of this nematode has been ascribed to its ability to overcome the host immune response; however, little is known about the mechanisms involved in this process. The analysis of an expressed sequence tags (EST) library in the nematode during the infective phase was performed and a highly abundant contig homologous to serine protease inhibitors was identified. In this work, we show that this contig is part of a 641-bp cDNA that encodes a BPTI-Kunitz family inhibitor (Sc-KU-4), which is up-regulated in the parasite during invasion and installation. Recombinant Sc-KU-4 protein was produced in Escherichia coli and shown to inhibit chymotrypsin and elastase activities in a dose-dependent manner by a competitive mechanism with K-i values of 1.8 nM and 2.6 nM, respectively. Sc-KU-4 also inhibited trypsin and thrombin activities to a lesser extent. Studies of the mode of action of Sc-KU-4 and its effects on insect defenses suggest that although Sc-KU-4 did not inhibit the activation of hemocytes or the formation of clotting fibers, it did inhibit hemocyte aggregation and the entrapment of foreign particles by fibers. Moreover, Sc-KU-4 avoided encapsulation and the deposition of clotting materials, which usually occurs in response to foreign particles. We show by protein-protein interaction that Sc-KU-4 targets recognition proteins of insect immune system such as masquerade-like and serine protease-like homologs. The interaction of Sc-KU-4 with these proteins explains the ability of the nematode to overcome host reactions and its large pathogenic spectrum, once these immune proteins are well conserved in insects. The discovery of this inhibitor targeting insect recognition proteins opens new avenues for the development of S. carpocapsae as a biological control agent and provides a new tool to study host-pathogen interactions.	[Toubarro, Duarte; Avila, Monica Martinez; Simoes, Nelson] Univ Acores, IBB, CBA, Ponta Delgada, Portugal; [Toubarro, Duarte; Avila, Monica Martinez; Simoes, Nelson] Univ Acores, CIRN, Dept Biol, Ponta Delgada, Portugal; [Montiel, Rafael] Inst Politecn Nacl CINVESTAV IPN, Ctr Invest & Estudios Avanzados, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico	Universidade dos Acores; Universidade dos Acores; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Simoes, N (corresponding author), Univ Acores, IBB, CBA, Ponta Delgada, Portugal.	simoes@uac.pt	Montiel, Rafael/A-6774-2008; Simoes, Nelson/K-3843-2013; Toubarro, Duarte/K-3881-2013	Montiel, Rafael/0000-0001-8052-0679; Simoes, Nelson/0000-0003-3612-6759; Toubarro, Duarte/0000-0003-2025-9696	Fundacao para a Ciencia e Tecnologia (FCT) [PDCT/AGR/AAM/104487/2008]; FLAD (Luso-American Foundation) [223/2006]; FCT [PDCT/AGR/AAM/104487/2008]; Regional Government of Acores (RGA) [M3.1.2/F/005/2007]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FLAD (Luso-American Foundation); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Regional Government of Acores (RGA)	This research was supported by Fundacao para a Ciencia e Tecnologia (FCT) (PDCT/AGR/AAM/104487/2008) and by FLAD (Luso-American Foundation) (Proj. 223/2006) awarded to NS. DT received a fellowship from FCT (PDCT/AGR/AAM/104487/2008), and MMA was a recipient of a fellowship from the Regional Government of Acores (RGA) (M3.1.2/F/005/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian N, 2010, PARASITE IMMUNOL, V32, P165, DOI 10.1111/j.1365-3024.2009.01172.x; Balasubramanian N, 2009, INT J PARASITOL, V39, P975, DOI 10.1016/j.ijpara.2009.01.012; Beck M, 2000, J INSECT PHYSIOL, V46, P1275, DOI 10.1016/S0022-1910(00)00048-2; Bidla G, 2005, DEV COMP IMMUNOL, V29, P669, DOI 10.1016/j.dci.2004.11.007; Brivio MF, 2004, MOL BIOCHEM PARASIT, V135, P111, DOI 10.1016/j.molbiopara.2004.01.012; Castillo JC, 2011, TRENDS PARASITOL, V27, P537, DOI 10.1016/j.pt.2011.09.001; Cruz N, 2001, J INVERTEBR PATHOL, V78, P272, DOI 10.1006/jipa.2001.5033; Dowds Barbara C.A., 2002, P79, DOI 10.1079/9780851995670.0079; Dushay MS, 2009, CELL MOL LIFE SCI, V66, P2643, DOI 10.1007/s00018-009-0036-0; DUTKY SR, 1964, J INSECT PATHOL, V6, P417; Dy CY, 2006, ACTA CRYSTALLOGR D, V62, P980, DOI [10.1107/S0907444906021123, 10.1107/S0907444906021122]; Eleftherianos I, 2007, CELL MICROBIOL, V9, P1137, DOI 10.1111/j.1462-5822.2006.00855.x; Eleftherianos I, 2011, J INNATE IMMUN, V3, P28, DOI 10.1159/000321931; Felfoldi G, 2011, J IMMUNOL, V186, P4828, DOI 10.4049/jimmunol.1003246; ffrench-Constant RH, 2007, TOXICON, V49, P436, DOI 10.1016/j.toxicon.2006.11.019; Forst S, 1997, ANNU REV MICROBIOL, V51, P47, DOI 10.1146/annurev.micro.51.1.47; GHENDLER Y, 1994, EXP PARASITOL, V78, P121, DOI 10.1006/expr.1994.1013; Gobert V, 2003, SCIENCE, V302, P2126, DOI 10.1126/science.1085432; GOTZ P, 1981, PROC R SOC SER B-BIO, V212, P333, DOI 10.1098/rspb.1981.0043; Gupta Ayodhya P., 1991, P19; Gupta S, 2005, INSECT BIOCHEM MOLEC, V35, P241, DOI 10.1016/j.ibmb.2004.12.003; Hallem EA, 2007, CURR BIOL, V17, P898, DOI 10.1016/j.cub.2007.04.027; Hao YJ, 2010, MOL BIOCHEM PARASIT, V169, P79, DOI 10.1016/j.molbiopara.2009.10.002; Helland R, 1999, ACTA CRYSTALLOGR D, V55, P139, DOI 10.1107/S090744499801052X; Huang TS, 2000, J BIOL CHEM, V275, P9996, DOI 10.1074/jbc.275.14.9996; Jitvaropas R, 2009, COMP BIOCHEM PHYS B, V153, P236, DOI 10.1016/j.cbpb.2009.03.007; KAYA HK, 1993, ANNU REV ENTOMOL, V38, P181, DOI 10.1146/annurev.en.38.010193.001145; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; LAUMOND C, 1979, ENTOMOPHAGA, V24, P13, DOI 10.1007/BF02377505; Lee SY, 2001, J IMMUNOL, V166, P7319, DOI 10.4049/jimmunol.166.12.7319; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li D, 2002, INSECT BIOCHEM MOLEC, V32, P919, DOI 10.1016/S0965-1748(02)00030-9; Li XY, 2009, MOL BIOCHEM PARASIT, V165, P162, DOI 10.1016/j.molbiopara.2009.02.001; Liu H, 2012, MOL BIOCHEM PARASIT, V185, P89, DOI 10.1016/j.molbiopara.2012.06.006; Loof TG, 2011, J INNATE IMMUN, V3, P34, DOI 10.1159/000321641; Lu ZQ, 2008, INSECT BIOCHEM MOLEC, V38, P89, DOI 10.1016/j.ibmb.2007.09.011; Medeiros J, 2000, J ECON ENTOMOL, V93, P1403, DOI 10.1603/0022-0493-93.5.1403; Milstone AM, 2000, J BIOL CHEM, V275, P29391, DOI 10.1074/jbc.M002715200; Nardi JB, 2005, J INSECT PHYSIOL, V51, P555, DOI 10.1016/j.jinsphys.2005.02.005; Peters A, 1997, J INVERTEBR PATHOL, V69, P218, DOI 10.1006/jipa.1996.4648; Pugia MJ, 2007, ADV CLIN CHEM, V44, P223, DOI 10.1016/S0065-2423(07)44007-0; Rhoads ML, 2000, EXP PARASITOL, V95, P36, DOI 10.1006/expr.2000.4502; Schmidt O, 2010, ANNU REV ENTOMOL, V55, P485, DOI 10.1146/annurev.ento.54.110807.090618; Simoes N, 1996, BIOCONTROL SCI TECHN, V6, P403, DOI 10.1080/09583159631370; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; Toubarro D, 2010, J BIOL CHEM, V285, P30666, DOI 10.1074/jbc.M110.129346; Toubarro D, 2009, INT J PARASITOL, V39, P1319, DOI 10.1016/j.ijpara.2009.04.013; Wang Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000763; WHITE G. F., 1927, SCIENCE, V66, P302, DOI 10.1126/science.66.1709.302-a; Yu XQ, 2003, INSECT BIOCHEM MOLEC, V33, P197, DOI 10.1016/S0965-1748(02)00191-1; Yu XQ, 2002, EUR J BIOCHEM, V269, P1827, DOI 10.1046/j.1432-1033.2002.02830.x; Zang XX, 2001, TRENDS BIOCHEM SCI, V26, P191, DOI 10.1016/S0968-0004(00)01761-8; ZHOU JM, 1989, BIOCHEMISTRY-US, V28, P1070, DOI 10.1021/bi00429a022; Zhu JY, 2011, J ZHEJIANG UNIV-SC B, V12, P93, DOI 10.1631/jzus.B1000158	56	35	36	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75691	10.1371/journal.pone.0075691	http://dx.doi.org/10.1371/journal.pone.0075691			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098715	Green Submitted, gold, Green Published			2022-12-25	WOS:000325423500086
J	Schiebel, J; Kapilashrami, K; Fekete, A; Bommineni, GR; Schaefer, CM; Mueller, MJ; Tonge, PJ; Kisker, C				Schiebel, Johannes; Kapilashrami, Kanishk; Fekete, Agnes; Bommineni, Gopal R.; Schaefer, Christin M.; Mueller, Martin J.; Tonge, Peter J.; Kisker, Caroline			Structural Basis for the Recognition of Mycolic Acid Precursors by KasA, a Condensing Enzyme and Drug Target from Mycobacterium Tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Inhibitors; Enzyme Mechanisms; Enzyme Structure; Lipid Synthesis; Mycobacterium tuberculosis; Phospholipid; KasA; Condensing Enzyme; Enzyme Dynamics; Induced Fit Substrate Recognition	ACYL CARRIER PROTEIN; FATTY-ACIDS; POSITIONAL DISTRIBUTION; SUBSTRATE RECOGNITION; CRYSTAL-STRUCTURE; RESIDENCE TIME; SYNTHASE-II; INHIBITOR; THIOLACTOMYCIN; BIOSYNTHESIS	Background: Although induced fit binding is central to molecular recognition, in most cases, the structural basis for this process remains to be elucidated. Results: We determined structural snapshots along the substrate binding reaction coordinate for the drug target Mycobacterium tuberculosis KasA. Conclusion: KasA binds acyl substrates via the induced fit concerted opening of a hydrophobic cavity. Significance: Improved understanding of induced fit binding is crucial for inhibitor design. The survival of Mycobacterium tuberculosis depends on mycolic acids, very long -alkyl--hydroxy fatty acids comprising 60-90 carbon atoms. However, despite considerable efforts, little is known about how enzymes involved in mycolic acid biosynthesis recognize and bind their hydrophobic fatty acyl substrates. The condensing enzyme KasA is pivotal for the synthesis of very long (C38-42) fatty acids, the precursors of mycolic acids. To probe the mechanism of substrate and inhibitor recognition by KasA, we determined the structure of this protein in complex with a mycobacterial phospholipid and with several thiolactomycin derivatives that were designed as substrate analogs. Our structures provide consecutive snapshots along the reaction coordinate for the enzyme-catalyzed reaction and support an induced fit mechanism in which a wide cavity is established through the concerted opening of three gatekeeping residues and several -helices. The stepwise characterization of the binding process provides mechanistic insights into the induced fit recognition in this system and serves as an excellent foundation for the development of high affinity KasA inhibitors.	[Schiebel, Johannes; Schaefer, Christin M.; Kisker, Caroline] Univ Wurzburg, Inst Biol Struct, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany; [Schiebel, Johannes] Univ Wurzburg, Inst Pharm & Food Chem, D-97074 Wurzburg, Germany; [Kapilashrami, Kanishk; Bommineni, Gopal R.; Tonge, Peter J.] SUNY Stony Brook, Dept Chem, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA; [Fekete, Agnes; Mueller, Martin J.] Univ Wurzburg, Dept Pharmaceut Biol, Bioctr, Julius von Sachs Inst Biosci, D-97082 Wurzburg, Germany	University of Wurzburg; University of Wurzburg; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Wurzburg	Kisker, C (corresponding author), Univ Wurzburg, Inst Biol Struct, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany.	caroline.kisker@virchow.uni-wuerzburg.de	mueller, martin j/C-7616-2019; Fekete, Agnes/C-8048-2019; Tonge, Peter J/A-7443-2009	Fekete, Agnes/0000-0003-3058-7570; Tonge, Peter J/0000-0003-1606-3471; Kisker, Caroline/0000-0002-0216-6026	National Institutes of Health [GM102864]; Deutsche Forschungsgemeinschaft [SFB630]; Forschungszentrum [FZ82]; German Excellence Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102864] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungszentrum; German Excellence Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM102864 (to P.J.T.). This work was also supported by Deutsche Forschungsgemeinschaft SFB630 and Forschungszentrum FZ82 (to C.K.).; Supported by a grant of the German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg.	Alhamadsheh MM, 2007, CHEM BIOL, V14, P513, DOI 10.1016/j.chembiol.2007.03.013; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Bhatt A, 2005, J BACTERIOL, V187, P7596, DOI 10.1128/JB.187.22.7596-7606.2005; Bhatt A, 2007, MOL MICROBIOL, V64, P1442, DOI 10.1111/j.1365-2958.2007.05761.x; Bissantz C, 2010, J MED CHEM, V53, P5061, DOI 10.1021/jm100112j; Borgaro JG, 2011, BIOCHEMISTRY-US, V50, P10678, DOI 10.1021/bi201199x; Brown MS, 2003, J AM CHEM SOC, V125, P10166, DOI 10.1021/ja034540i; BURGI HB, 1974, TETRAHEDRON, V30, P1563, DOI 10.1016/S0040-4020(01)90678-7; Chang A, 2013, BIOCHEMISTRY-US, V52, P4217, DOI 10.1021/bi400413c; Choi KH, 2000, J BIOL CHEM, V275, P28201; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fieulaine S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001066; FRENCH GL, 1987, LANCET, V2, P117; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kapilashrami K, 2013, J BIOL CHEM, V288, P6045, DOI 10.1074/jbc.M112.414516; Kremer L, 2000, J BIOL CHEM, V275, P16857, DOI 10.1074/jbc.M000569200; Kremer L, 2002, BIOCHEM J, V364, P423, DOI 10.1042/BJ20011628; Krug M, 2012, J APPL CRYSTALLOGR, V45, P568, DOI 10.1107/S0021889812011715; Lee W, 2011, BIOCHEMISTRY-US, V50, P5743, DOI 10.1021/bi200006t; LESLIE AGW, 1992, JNT CCP4 ESF EAMCB N, V26, P27; LI Y, 1990, J ORG CHEM, V55, P481, DOI 10.1021/jo00289a020; Lu C., 2012, PLOS ONE, V7; Lu H, 2010, CURR OPIN CHEM BIOL, V14, P467, DOI 10.1016/j.cbpa.2010.06.176; Luckner SR, 2010, J BIOL CHEM, V285, P14330, DOI 10.1074/jbc.M109.090373; Luckner SR, 2009, STRUCTURE, V17, P1004, DOI 10.1016/j.str.2009.04.012; Machutta CA, 2010, J BIOL CHEM, V285, P6161, DOI 10.1074/jbc.M109.077909; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McFadden JM, 2005, J MED CHEM, V48, P946, DOI 10.1021/jm049389h; McFadden JM, 2002, ORG LETT, V4, P3859, DOI 10.1021/ol026685k; Milletti F, 2007, J CHEM INF MODEL, V47, P2172, DOI 10.1021/ci700018y; MIYAKAWA S, 1982, J ANTIBIOT, V35, P411, DOI 10.7164/antibiotics.35.411; Muller P, 2003, ACTA CRYSTALLOGR D, V59, P32, DOI 10.1107/S0907444902018000; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OKUYAMA H, 1967, J BIOCHEM-TOKYO, V61, P732, DOI 10.1093/oxfordjournals.jbchem.a128607; Olsen JG, 2001, STRUCTURE, V9, P233, DOI 10.1016/S0969-2126(01)00583-4; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Price AC, 2003, J BACTERIOL, V185, P4136, DOI 10.1128/JB.185.14.4136-4143.2003; Price AC, 2001, J BIOL CHEM, V276, P6551, DOI 10.1074/jbc.M007101200; Qiu XY, 2001, J MOL BIOL, V307, P341, DOI 10.1006/jmbi.2000.4457; Richard JP, 2013, BIOCHEMISTRY-US, V52, P2009, DOI 10.1021/bi3017119; Sacco E, 2007, P NATL ACAD SCI USA, V104, P14628, DOI 10.1073/pnas.0704132104; Sachdeva S, 2008, CHEM BIOL, V15, P402, DOI 10.1016/j.chembiol.2008.03.007; Schaefer B, 2011, J COMPUT AID MOL DES, V25, P1053, DOI 10.1007/s10822-011-9483-4; Schaeffer ML, 2001, J BIOL CHEM, V276, P47029, DOI 10.1074/jbc.M108903200; Schiebel J, 2012, STRUCTURE, V20, P802, DOI 10.1016/j.str.2012.03.013; Schramm VL, 2011, ANNU REV BIOCHEM, V80, P703, DOI 10.1146/annurev-biochem-061809-100742; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Slayden RA, 2002, TUBERCULOSIS, V82, P149, DOI 10.1054/tube.2002.0333; Sridharan S, 2007, J MOL BIOL, V366, P469, DOI 10.1016/j.jmb.2006.11.006; Sullivan TJ, 2006, ACS CHEM BIOL, V1, P43, DOI 10.1021/cb0500042; Swanson S, 2009, STRUCTURE, V17, P914, DOI 10.1016/j.str.2009.06.006; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Theobald DL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040043; von Wettstein-Knowles P, 2006, FEBS J, V273, P695, DOI 10.1111/j.1742-4658.2005.05101.x; WALKER RW, 1970, LIPIDS, V5, P684, DOI 10.1007/BF02531435; Wang J, 2006, NATURE, V441, P358, DOI 10.1038/nature04784; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Wilmouth RC, 1997, NAT STRUCT BIOL, V4, P456, DOI 10.1038/nsb0697-456; Witkowski A, 2002, BIOCHEMISTRY-US, V41, P10877, DOI 10.1021/bi0259047; Wong HC, 2002, J BIOL CHEM, V277, P15874, DOI 10.1074/jbc.M112300200; Zhang HN, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 8: ENZYMES AND ENZYME MECHANISMS, P231; Zhang YM, 2006, J BIOL CHEM, V281, P17390, DOI 10.1074/jbc.M513199200	66	27	29	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34190	34204		10.1074/jbc.M113.511436	http://dx.doi.org/10.1074/jbc.M113.511436			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24108128	hybrid, Green Published			2022-12-25	WOS:000327250200062
J	Ganpule-Rao, A; Joglekar, C; Patkar, D; Chinchwadkar, M; Bhat, D; Lubree, H; Rege, S; Uradey, B; Yajnik, C; Yudkin, J				Ganpule-Rao, Anjali; Joglekar, Charudatta; Patkar, Deepak; Chinchwadkar, Manoj; Bhat, Dattatreya; Lubree, Himangi; Rege, Sonali; Uradey, Bhagyashree; Yajnik, Chittaranjan; Yudkin, John			Associations of Trunk Fat Depots with Insulin Resistance, beta Cell Function and Glycaemia - A Multiple Technique Study	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; ABDOMINAL ADIPOSITY; COMPUTED-TOMOGRAPHY; REGIONAL ADIPOSITY; INDIAN MEN; SENSITIVITY; OBESITY; TISSUE; HYPERGLYCEMIA; LIPOTOXICITY	Objective: Central (truncal) adiposity is associated strongly with insulin resistance and diabetes. There are very few reports comparing methods of trunk fat measurement in their ability to predict glycaemia and insulin resistance. We report a comparative analysis of different trunk fat measurements in predicting glycaemia and insulin resistance in middle aged Indian men. Materials and Methods: Trunk fat measurements were performed using anthropometry, magnetic resonance imaging (MRI), dual-energy X-ray absorptiometry (DXA) and computed tomography (CT) on 128 men. Additional measurements were taken to characterise insulin resistance (Matsuda index) and beta cell function (Insulinogenic Index), glycaemia (fasting and 120 min glucose concentrations). Using residual approach we compared the ability of different trunk fat measurement techniques to predict insulin resistance, beta cell function and glycaemia. Results: There was a strong association between trunk fat measures from each technique with glycaemia and insulin resistance indices but not with the Insulinogenic Index. Insulin resistance and glycaemia, were best predicted using anthropometric measurements, notably by waist circumference and subscapular skinfold thickness. Neither MRI measures of trunk or visceral fat nor DXA trunk fat added significantly. CT liver density contributed to some extent to predict insulin resistance and 120 min glucose after anthropometric measurements. Conclusions: Our results suggest that, in Indian men, anthropometric measurements are good predictors of glycaemia and insulin resistance. Other complex measurements such as MRI, DXA and CT make only a small addition to the prediction. This finding supports the application of anthropometry for determining trunk fat in clinical and epidemiological settings.	[Ganpule-Rao, Anjali; Joglekar, Charudatta; Chinchwadkar, Manoj; Bhat, Dattatreya; Lubree, Himangi; Rege, Sonali; Uradey, Bhagyashree; Yajnik, Chittaranjan] KEM Hosp, Diabet Unit, Pune, Maharashtra, India; [Patkar, Deepak] Dr Balabhai Nanavati Hosp, Bombay, Maharashtra, India; [Yudkin, John] UCL, Dept Med, London, England	University of London; University College London	Yajnik, C (corresponding author), KEM Hosp, Diabet Unit, Pune, Maharashtra, India.	diabetes@vsnl.com	Yudkin, John S/C-1988-2008		Nestle Foundation, Lausanne, Switzerland; International Atomic Energy Agency, Vienna, Austria	Nestle Foundation, Lausanne, Switzerland; International Atomic Energy Agency, Vienna, Austria(International Atomic Energy Agency)	The authors thank the Nestle Foundation, Lausanne, Switzerland and the International Atomic Energy Agency, Vienna, Austria for providing financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate N, 1997, AM J CLIN NUTR, V65, P403, DOI 10.1093/ajcn/65.2.403; ABATE N, 1995, J CLIN INVEST, V96, P88, DOI DOI 10.1172/JCI118083; Abd El Dayem SM, 2012, ANATOL J CARDIOL, V12, P60, DOI 10.5152/akd.2012.014; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; ALPHA B, 1992, EUR J CLIN CHEM CLIN, V30, P27; Anjana M, 2004, DIABETES CARE, V27, P2948, DOI 10.2337/diacare.27.12.2948; [Anonymous], 1999, DPX IQ OP MAN; Banerji MA, 1997, AM J PHYSIOL-ENDOC M, V273, pE425, DOI 10.1152/ajpendo.1997.273.2.E425; Bhat DS, 2005, INT J OBESITY, V29, P842, DOI 10.1038/sj.ijo.0802953; BORKAN GA, 1982, AM J PHYS ANTHROPOL, V58, P307, DOI 10.1002/ajpa.1330580309; Chandalia M, 1999, J CLIN ENDOCR METAB, V84, P2329, DOI 10.1210/jc.84.7.2329; dos Santos LC, 2008, SAO PAULO MED J, V126, P82, DOI 10.1590/S1516-31802008000200004; DWYER A, 1983, J COMPUT ASSIST TOMO, V7, P70, DOI 10.1097/00004728-198302000-00012; Garg A, 2004, J CLIN ENDOCR METAB, V89, P4206, DOI 10.1210/jc.2004-0631; Gradmark AMI, 2010, BRIT J NUTR, V104, P582, DOI 10.1017/S0007114510000796; Henderson M, 2011, DIABETES METAB, V37, P72, DOI 10.1016/j.diabet.2010.06.008; Lee CC, 2005, J GERONTOL A-BIOL, V60, P872, DOI 10.1093/gerona/60.7.872; Lee DE, 2009, AM J PHYSIOL-ENDOC M, V296, pE1210, DOI 10.1152/ajpendo.00015.2009; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Misra A, 1997, OBES RES, V5, P93, DOI 10.1002/j.1550-8528.1997.tb00648.x; Onat A, 2004, INT J OBESITY, V28, P1018, DOI 10.1038/sj.ijo.0802695; Racette SB, 2006, DIABETES CARE, V29, P673, DOI 10.2337/diacare.29.03.06.dc05-1605; SHELGIKAR KM, 1991, DIABETIC MED, V8, P712, DOI 10.1111/j.1464-5491.1991.tb01689.x; Snijder MB, 2004, OBES RES, V12, P1370, DOI 10.1038/oby.2004.173; Snijder MB, 2002, INT J OBESITY, V26, P984, DOI 10.1038/sj.ijo.0801968; Stewart Kerry J, 2003, J Cardiopulm Rehabil, V23, P109, DOI 10.1097/00008483-200303000-00008; Sun Q, 2010, AM J EPIDEMIOL, V172, P1442, DOI 10.1093/aje/kwq306; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Yajnik CS, 2008, DIABETOLOGIA, V51, P39, DOI 10.1007/s00125-007-0847-1; Yajnik CS, 2004, LANCET, V363, P163, DOI 10.1016/S0140-6736(03)15269-5	32	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75391	10.1371/journal.pone.0075391	http://dx.doi.org/10.1371/journal.pone.0075391			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116041	gold, Green Published, Green Submitted			2022-12-25	WOS:000325552200020
J	Gregory, TM; Sankey, A; Augereau, B; Vandenbussche, E; Amis, A; Emery, R; Hansen, U				Gregory, Thomas M.; Sankey, Andrew; Augereau, Bernard; Vandenbussche, Eric; Amis, Andrew; Emery, Roger; Hansen, Ulrich			Accuracy of Glenoid Component Placement in Total Shoulder Arthroplasty and Its Effect on Clinical and Radiological Outcome in a Retrospective, Longitudinal, Monocentric Open Study	PLOS ONE			English	Article							VERSION; INCLINATION; TOMOGRAPHY	Background: The success of Total Shoulder Arthroplasty (TSA) is believed to depend on the restoration of the natural anatomy of the joint and a key development has been the introduction of modular humeral components to more accurately restore the patient's anatomy. However, there are no peer-reviewed studies that have reported the degree of glenoid component mal-position achieved in clinical practice and the clinical outcome of such mal-position. The main purpose of this study was to assess the accuracy of glenoid implant positioning during TSA and to relate it to the radiological (occurrence of radiolucent lines and osteolysis on CT) and clinical outcomes. Methods: 68 TSAs were assessed with a mean follow-up of 38+/-227 months. The clinical evaluation consisted of measuring the mobility as well as of the Constant Score. The radiological evaluation was performed on CT-scans in which metal artefacts had been eliminated. From the CT-scans radiolucent lines and osteolysis were assessed. The positions of the glenoid and humeral components were also measured from the CT scans. Results: Four position glenoid component parameters were calculated The posterior version (6 degrees +/- 12 degrees; mean +/- SD), the superior tilt (12 degrees +/- 17 degrees), the rotation of the implant relative to the scapular plane (3 degrees +/- 14 degrees) and the off-set distance of the centre of the glenoid implant from the scapular plane (6 +/- 4 mm). An inferiorly inclined implant was found to be associated with higher levels of radiolucent lines while retroversion and non-neutral rotation were associated with a reduced range of motion. Conclusion: this study demonstrates that glenoid implants of anatomic TSA are poorly positioned and that this malposition has a direct effect on the clinical and radiological outcome. Thus, further developments in glenoid implantation techniques are required to enable the surgeon to achieve a desired implant position and outcome.	[Gregory, Thomas M.; Augereau, Bernard; Vandenbussche, Eric] Hop Europeen Georges Pompidou, APHP, Dept Orthopaed Surg, Paris, France; [Gregory, Thomas M.; Amis, Andrew; Emery, Roger; Hansen, Ulrich] Univ London Imperial Coll Sci Technol & Med, London, England; [Sankey, Andrew; Emery, Roger] St Marys Hosp, Dept Orthopaed Surg, London, England; [Emery, Roger] Univ London Imperial Coll Sci Technol & Med, Div Surg, London, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Imperial College London; Imperial College London; Imperial College London	Gregory, TM (corresponding author), Hop Europeen Georges Pompidou, APHP, Dept Orthopaed Surg, Paris, France.	tms.gregory@gmail.com	Hansen, Ulrich/K-3255-2014		Arthritis and Rheumatism Campaign [16326]	Arthritis and Rheumatism Campaign	The authors would like to thank the Arthritis and Rheumatism Campaign, who funded this study (grant reference 16326). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadi HO, 2008, J BIOMECH, V41, P2144, DOI 10.1016/j.jbiomech.2008.04.028; Bohsali KI, 2006, J BONE JOINT SURG AM, V88A, P2279, DOI 10.2106/JBJS.F.00125; Churchill RS, 2001, J SHOULDER ELB SURG, V10, P327, DOI 10.1067/mse.2001.115269; Favre P, 2008, CLIN BIOMECH, V23, P175, DOI 10.1016/j.clinbiomech.2007.09.009; Franklin J L, 1988, J Arthroplasty, V3, P39, DOI 10.1016/S0883-5403(88)80051-2; Franta AK, 2007, J SHOULDER ELB SURG, V16, P555, DOI 10.1016/j.jse.2006.11.004; FRIEDMAN RJ, 1992, J BONE JOINT SURG AM, V74A, P1032, DOI 10.2106/00004623-199274070-00009; Gregory T, 2007, P I MECH ENG H, V221, P87, DOI 10.1243/09544119JEIM167; Gregory T, 2009, J ORTHOP RES; Gregory T, 2007, 10 INT C SHOULD SURG; Gregory T, 2012, ACTA ORTHOP, V83, P529, DOI 10.3109/17453674.2012.733916; Hempfing A, 2001, J SHOULDER ELB SURG, V10, P460, DOI 10.1067/mse.2001.117127; Hopkins AR, 2004, J SHOULDER ELB SURG, V13, P668, DOI 10.1016/j.jse.2004.04.008; Iannotti JP, 2005, J SHOULDER ELBOW SUR, V12; Kircher J, 2009, J SHOULDER ELB SURG, V18, P515, DOI 10.1016/j.jse.2009.03.014; Konrad GG, 2006, CLIN BIOMECH, V21, P942, DOI 10.1016/j.clinbiomech.2006.04.013; Mole D., 1999, SHOULDER ARTHROPLAST, P163, DOI DOI 10.1007/978-3-642-58365-0_16; Moska MJ, 1998, 7 INT C SHOULD SURG, P5; Nyffeler RW, 2006, J SHOULDER ELB SURG, V15, P625, DOI 10.1016/j.jse.2005.09.016; Nyffeler RW, 2003, J SHOULDER ELB SURG, V12, P493, DOI 10.1016/S1058-2746(03)00181-2; Oosterom R, 2004, CLIN BIOMECH, V19, P1000, DOI 10.1016/j.clinbiomech.2004.07.001; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Rosset C, 2005, J DIGIT IMAGING, V18, P270, DOI 10.1007/s10278-005-6703-2; Terrier A, 2009, J SHOULDER ELB SURG, V18, P515	24	38	46	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75791	10.1371/journal.pone.0075791	http://dx.doi.org/10.1371/journal.pone.0075791			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116075	gold, Green Published, Green Submitted			2022-12-25	WOS:000325552200038
J	Donati, AJ; Lee, HI; Leveau, JHJ; Chang, WS				Donati, Andrew J.; Lee, Hae-In; Leveau, Johan H. J.; Chang, Woo-Suk			Effects of Indole-3-Acetic Acid on the Transcriptional Activities and Stress Tolerance of Bradyrhizobium japonicum	PLOS ONE			English	Article							PSEUDOMONAS-PUTIDA; AGROBACTERIUM-TUMEFACIENS; PHYSIOLOGICAL-RESPONSES; COLORIMETRIC METHOD; BIOFILM FORMATION; PLANT-GROWTH; NODULATION; AUXIN; EXOPOLYSACCHARIDES; DESICCATION	A genome-wide transcriptional profile of Bradyrhizobium japonicum, the nitrogen-fixing endosymbiont of the soybean plant, revealed differential expression of approximately 15% of the genome after a 1 mM treatment with the phytohormone indole-3-acetic acid (IAA). A total of 1,323 genes were differentially expressed (619 up-regulated and 704 down-regulated) at a two-fold cut off with q value <= 0.05. General stress response genes were induced, such as those involved in response to heat, cold, oxidative, osmotic, and desiccation stresses and in exopolysaccharide (EPS) biosynthesis. This suggests that IAA is effective in activating a generalized stress response in B. japonicum. The transcriptional data were corroborated by the finding that stress tolerance of B. japonicum in cell viability assays was enhanced when pre-treated with 1 mM IAA compared to controls. The IAA treatment also stimulated biofilm formation and EPS production by B. japonicum, especially acidic sugar components in the total EPS. The IAA pretreatment did not influence the nodulation ability of B. japonicum. The data provide a comprehensive overview of the potential transcriptional responses of the symbiotic bacterium when exposed to the ubiquitous hormone of its plant host.	[Donati, Andrew J.; Lee, Hae-In; Chang, Woo-Suk] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Leveau, Johan H. J.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA	University of Texas System; University of Texas Arlington; University of California System; University of California Davis	Chang, WS (corresponding author), Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA.	wschang@uta.edu	Leveau, Johan HJ/C-1096-2012	Leveau, Johan HJ/0000-0002-8376-4553	University of Texas-Arlington; UTA [14-7488-34]	University of Texas-Arlington; UTA	This research was supported in part by a Research Enhancement Program (REP) grant from the University of Texas-Arlington. UTA Grant Number is 14-7488-34. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	BERGERSEN F, 1961, AUST J BIOL SCI, V14, P349, DOI 10.1071/BI9610349; Bergmaier D, 2001, APPL MICROBIOL BIOT, V57, P401, DOI 10.1007/s002530100764; Bianco C, 2006, MICROBIOL-SGM, V152, P2421, DOI 10.1099/mic.0.28765-0; Bianco C, 2006, ARCH MICROBIOL, V185, P373, DOI 10.1007/s00203-006-0103-y; BINNS AN, 1988, ANNU REV MICROBIOL, V42, P575, DOI 10.1146/annurev.mi.42.100188.003043; Bittner M., 2003, P101; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; Boiero L, 2007, APPL MICROBIOL BIOT, V74, P874, DOI 10.1007/s00253-006-0731-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broughton WJ, 2000, J BACTERIOL, V182, P5641, DOI 10.1128/JB.182.20.5641-5652.2000; Bylund J, 2006, J BIOL CHEM, V281, P2526, DOI 10.1074/jbc.M510692200; Chang WS, 2007, MOL PLANT MICROBE IN, V20, P1298, DOI 10.1094/mpmi-20-10-1298; Chang WS, 2007, J BACTERIOL, V189, P8290, DOI 10.1128/JB.00727-07; Chang WS, 2003, J BACTERIOL, V185, P6199, DOI 10.1128/JB.185.20.6199-6204.2003; Cytryn EJ, 2007, J BACTERIOL, V189, P6751, DOI 10.1128/JB.00533-07; Djordjevic D, 2002, APPL ENVIRON MICROB, V68, P2950, DOI 10.1128/AEM.68.6.2950-2958.2002; Donati AJ, 2011, APPL ENVIRON MICROB, V77, P3633, DOI 10.1128/AEM.00047-11; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; EGEBO LA, 1991, J BACTERIOL, V173, P4897, DOI 10.1128/jb.173.15.4897-4901.1991; Figueiredo MVB, 2008, WORLD J MICROB BIOT, V24, P1187, DOI 10.1007/s11274-007-9591-4; HALVERSON LJ, 1986, APPL ENVIRON MICROB, V51, P753, DOI 10.1128/AEM.51.4.753-760.1986; HUNTER WJ, 1987, APPL ENVIRON MICROB, V53, P1051, DOI 10.1128/AEM.53.5.1051-1055.1987; Imperlini E, 2009, APPL MICROBIOL BIOT, V83, P727, DOI 10.1007/s00253-009-1974-z; JENSEN JB, 1995, J BACTERIOL, V177, P5762, DOI 10.1128/jb.177.20.5762-5766.1995; Jeon JM, 2011, MOL PLANT MICROBE IN, V24, P1472, DOI 10.1094/MPMI-03-11-0072; Kachlany SC, 2001, ENVIRON MICROBIOL, V3, P774, DOI 10.1046/j.1462-2920.2001.00248.x; KADO CI, 1991, CRIT REV PLANT SCI, V10, P1, DOI 10.1080/07352680490273310; KANESHIRO T, 1985, PLANT SCI, V42, P141, DOI 10.1016/0168-9452(85)90119-0; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; KLINE EL, 1980, P NATL ACAD SCI-BIOL, V77, P1768, DOI 10.1073/pnas.77.4.1768; Lee HI, 2012, APPL ENVIRON MICROB, V78, P2896, DOI 10.1128/AEM.07336-11; MAI XH, 1994, J BIOL CHEM, V269, P16726; MINAMISAWA K, 1991, PLANT CELL PHYSIOL, V32, P1; Niu C, 2004, APPL ENVIRON MICROB, V70, P6951, DOI 10.1128/AEM.70.12.6951-6956.2004; Paponov IA, 2008, MOL PLANT, V1, P321, DOI 10.1093/mp/ssm021; Parniske M, 2003, NATURE, V425, P569, DOI 10.1038/425569a; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pii Y, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-21; Preisig O, 1996, J BACTERIOL, V178, P1532, DOI 10.1128/JB.178.6.1532-1538.1996; PREISIG O, 1993, P NATL ACAD SCI USA, V90, P3309, DOI 10.1073/pnas.90.8.3309; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; READ RR, 1987, CAN J MICROBIOL, V33, P1080, DOI 10.1139/m87-189; SADOWSKY MJ, 1987, APPL ENVIRON MICROB, V53, P2624, DOI 10.1128/AEM.53.11.2624-2630.1987; Salkowski E., 1885, Z PHYSL CHEM, V9, P23; Salunkhe P, 2005, J BACTERIOL, V187, P2565, DOI 10.1128/JB.187.8.2565-2572.2005; Tamaru Y, 2005, APPL ENVIRON MICROB, V71, P7327, DOI 10.1128/AEM.71.11.7327-7333.2005; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Van Puyvelde S, 2011, MICROB ECOL, V61, P723, DOI 10.1007/s00248-011-9819-6; YAMADA T, 1993, ANNU REV PHYTOPATHOL, V31, P253, DOI 10.1146/annurev.py.31.090193.001345; YAMADA T, 1986, P NATL ACAD SCI USA, V83, P8263, DOI 10.1073/pnas.83.21.8263; Yuan ZC, 2008, CELL MICROBIOL, V10, P2339, DOI 10.1111/j.1462-5822.2008.01215.x; Zakharova EA, 1999, EUR J BIOCHEM, V259, P572, DOI 10.1046/j.1432-1327.1999.00033.x	53	48	50	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76559	10.1371/journal.pone.0076559	http://dx.doi.org/10.1371/journal.pone.0076559			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098533	Green Published, gold, Green Submitted			2022-12-25	WOS:000325434500074
J	Marjanska, M; Emir, UE; Deelchand, DK; Terpstra, M				Marjanska, Malgorzata; Emir, Uzay E.; Deelchand, Dinesh K.; Terpstra, Melissa			Faster Metabolite H-1 Transverse Relaxation in the Elder Human Brain	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; VIVO H-1-NMR SPECTROSCOPY; PROTON T-2 RELAXATION; WATER; TIME; RAT; QUANTIFICATION; ABNORMALITIES; QUANTITATION; DIFFUSION	H-1 magnetic resonance spectroscopy (MRS) is unique among imaging modalities because signals from several metabolites are measured during a single examination period. Each metabolite reflects a distinct intracellular process. Furthermore transverse (T-2) relaxation times probe the viability of the cell microenvironment, e.g., the viscosity of the cellular fluids, the microscopic susceptibility distribution within the cells, and the iron content. In this study, T(2)s of brain metabolites were measured in the occipital lobe of eighteen young and fourteen elderly subjects at a field strength of 4 tesla. The T(2)s of N-acetylaspartate, total creatine, and total choline were 23%, 16% and 10% shorter in elderly than in young subjects. The findings of this study suggest that noninvasive detection of T-2 provides useful biological information on changes in the cellular microenvironment that take place during aging.	[Marjanska, Malgorzata] Univ Minnesota, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Radiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Marjanska, M (corresponding author), Univ Minnesota, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA.	gosia@cmrr.umn.edu	Emir, Uzay/ABB-9979-2020; Deelchand, Dinesh/AAV-9776-2021	emir, uzay/0000-0001-5376-0431; Marjanska, Malgorzata/0000-0002-4727-2447; Deelchand, Dinesh/0000-0003-4266-4780	National Institutes of Health [R21 AG029582, RO1 AG039396, P41 RR008079, P41 EB015894, P30 NS057091, P30 NS507608, S10 RR023730]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023730, P41RR008079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057091, P30NS076408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG039396, R21AG029582] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health through grants R21 AG029582, RO1 AG039396, P41 RR008079, P41 EB015894, P30 NS057091, P30 NS507608, S10 RR023730. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriany G, 1997, J MAGN RESON, V125, P178, DOI 10.1006/jmre.1997.1113; BIRKEN DL, 1989, NEUROSCI BIOBEHAV R, V13, P23, DOI 10.1016/S0149-7634(89)80048-X; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Brooks JCW, 2001, CEREB CORTEX, V11, P598, DOI 10.1093/cercor/11.7.598; CHRISTIANSEN P, 1993, MAGN RESON IMAGING, V11, P799, DOI 10.1016/0730-725X(93)90197-L; De Graaf RA, 2007, IN VIVO NMR SPECTROS; Dickstein DL, 2007, AGING CELL, V6, P275, DOI 10.1111/j.1474-9726.2007.00289.x; Double KL, 2010, PROG NEUROBIOL, V92, P316, DOI 10.1016/j.pneurobio.2010.06.001; ERNST T, 1993, J MAGN RESON SER B, V102, P1, DOI 10.1006/jmrb.1993.1055; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; GRUETTER R, 1993, MAGNET RESON MED, V29, P804, DOI 10.1002/mrm.1910290613; Gruetter R, 2000, MAGNET RESON MED, V43, P319, DOI 10.1002/(SICI)1522-2594(200002)43:2<319::AID-MRM22>3.0.CO;2-1; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Henry PG, 2006, MAGN RESON MED, V55, P250, DOI 10.1002/mrm.20764; HETHERINGTON HP, 1994, MAGNET RESON MED, V32, P565, DOI 10.1002/mrm.1910320504; Kaiser LG, 2010, J MAGN RESON, V202, P259, DOI 10.1016/j.jmr.2009.11.013; Kirov II, 2008, MAGN RESON MED, V60, P790, DOI 10.1002/mrm.21715; Kreis R, 2005, MAGN RESON MED, V54, P761, DOI 10.1002/mrm.20673; KRUSE T, 1985, J NEUROL SCI, V70, P129, DOI 10.1016/0022-510X(85)90082-6; Larvaron P, 2006, NMR BIOMED, V19, P180, DOI 10.1002/nbm.997; Lei H, 2003, MAGNET RESON MED, V49, P979, DOI 10.1002/mrm.10490; Michaeli S, 2002, MAGN RESON MED, V47, P629, DOI 10.1002/mrm.10135; Mitsumori F, 2009, MAGN RESON MED, V62, P1326, DOI 10.1002/mrm.22097; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nicolay K, 2001, NMR BIOMED, V14, P94, DOI 10.1002/nbm.686; Ongur D, 2010, MAGN RESON MED, V63, P1, DOI 10.1002/mrm.22148; Onishi J, 2006, J GERIATR PSYCH NEUR, V19, P26, DOI 10.1177/0891988705284725; Peters A, 2002, J NEUROCYTOL, V31, P581, DOI 10.1023/A:1025731309829; Pfeuffer J, 1999, J MAGN RESON, V141, P104, DOI 10.1006/jmre.1999.1895; POSSE S, 1995, MAGNET RESON MED, V33, P246, DOI 10.1002/mrm.1910330215; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Ross B, 2001, ANAT RECORD, V265, P54, DOI 10.1002/ar.1058; SCHENKER C, 1993, NEURORADIOLOGY, V35, P119, DOI 10.1007/BF00593967; Tkac I, 2005, APPL MAGN RESON, V29, P139, DOI 10.1007/BF03166960; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Tkac I, 2009, MAGN RESON MED, V62, P868, DOI 10.1002/mrm.22086; Tunc-Skarka N, 2009, NEUROIMAGE, V48, P525, DOI 10.1016/j.neuroimage.2009.06.061; Valette J, 2007, J CEREBR BLOOD F MET, V27, P588, DOI 10.1038/sj.jcbfm.9600353; Wang XK, 2010, CURR GENOMICS, V11, P618, DOI 10.2174/138920210793360943	40	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e77572	10.1371/journal.pone.0077572	http://dx.doi.org/10.1371/journal.pone.0077572			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098589	Green Published, Green Submitted, gold			2022-12-25	WOS:000325434500102
J	Neto, LV; Wildemberg, LE; Colli, LM; Kasuki, L; Marques, NV; Moraes, AB; Gasparetto, EL; Takiya, CM; Castro, M; Gadelha, MR				Neto, Leonardo Vieria; Wildemberg, Luiz Eduardo; Colli, Leandro Machado; Kasuki, Leandro; Marques, Nelma Veronica; Moraes, Aline Barbosa; Gasparetto, Emerson L.; Takiya, Christina Maeda; Castro, Margaret; Gadelha, Monica Roberto			ZAC1 and SSTR2 Are Downregulated in Non-Functioning Pituitary Adenomas but Not in somatotropinomas	PLOS ONE			English	Article							SOMATOSTATIN ANALOG THERAPY; TUMOR-SUPPRESSOR GENE; EXPRESSION; PCR; HETEROZYGOSITY; OCTREOTIDE; DOPAMINE; GROWTH	Introduction: There are few data regarding ZAC1 expression in clinically non-functioning pituitary adenomas (NFPA). Because somatotropinomas and NFPA behave differently with respect to tumor shrinkage during somatostatin analogs (SA) therapy, we sought to compare the ZAC1 and somatostatin receptor (sstr) types 1, 2, 3 and 5 mRNA expression in these two pituitary adenoma subtypes and in normal human pituitaries. Methods: ZAC1 and SSTR mRNA expression levels were evaluated using real-time RT-PCR (TaqMan) in 20 NFPA and compared with the expression levels in 23 somatotropinomas and five normal pituitaries. The NFPA invasiveness was evaluated using magnetic resonance imaging with Hardy's modified criteria. Ki-67 and p53 were evaluated using immunohistochemistry. Results: A total of 20 patients with NFPA [6 males, median age 56 years (range: 30-78)], 23 with acromegaly [12 males, median age 43 years (range: 24-57)] and five normal pituitaries [4 males, median age 48 years (range: 3654)] were included. Four of the patients (20%) had Hardy's grade 2 tumors; all of the others had Hardy's grade 3 tumors. The Ki-67 median expression was 2.35 (range: 0.2-9.23), and only four of the tumors (20%) were positive for p53. The ZAC1 mRNA expression was significantly lower in NFPA than in somatotropinomas and in normal pituitaries (p<0.001 for both), as well as the SSTR2 (p=0.001 and 0.01, respectively). The SSTR3 expression was higher in the NFPA than in the somatotropinomas and in the normal pituitaries (p=0.03 and 0.02, respectively). No correlation was found between the ZAC1 mRNA expression and the tumor invasiveness, Ki-67 and p53. Conclusion: ZAC1 and SSTR2 are underexpressed and SSTR3 is overexpressed in NFPA compared to those in somatotropinomas and in normal pituitaries, which might explain the lack of tumor shrinkage that is observed in response to commercially available SA therapy in patients with NFPA.	[Neto, Leonardo Vieria; Wildemberg, Luiz Eduardo; Kasuki, Leandro; Marques, Nelma Veronica; Moraes, Aline Barbosa; Gadelha, Monica Roberto] Univ Fed Rio de Janeiro, Dept Internal Med, Sch Med, Rio De Janeiro, Brazil; [Neto, Leonardo Vieria; Wildemberg, Luiz Eduardo; Kasuki, Leandro; Marques, Nelma Veronica; Moraes, Aline Barbosa; Gadelha, Monica Roberto] Univ Fed Rio de Janeiro, Endocrine Unit, Sch Med, Rio De Janeiro, Brazil; [Neto, Leonardo Vieria; Wildemberg, Luiz Eduardo; Kasuki, Leandro; Marques, Nelma Veronica; Moraes, Aline Barbosa; Gasparetto, Emerson L.; Gadelha, Monica Roberto] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Rio De Janeiro, Brazil; [Neto, Leonardo Vieria] Fed Hosp Lagoa, Endocrinol Unit, Rio De Janeiro, Brazil; [Colli, Leandro Machado; Castro, Margaret] Univ Sao Paulo, Dept Internal Med, Med Sch Ribeirao Preto, Sao Paulo, Brazil; [Gasparetto, Emerson L.] Univ Fed Rio de Janeiro, Radiol Unit, Sch Med, Rio De Janeiro, Brazil; [Takiya, Christina Maeda] Univ Fed Rio de Janeiro, Biofis Carlos Chagas Filho Inst, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Gadelha, MR (corresponding author), Univ Fed Rio de Janeiro, Dept Internal Med, Sch Med, Rio De Janeiro, Brazil.	mgadelha@hucff.ufrj.br	Colli, Leandro/A-3445-2009; de Castro, Margaret/A-4918-2009; Takiya, Christina/AAU-5959-2021; Kasuki, Leandro/R-8117-2019; wildemberg, luiz/S-4712-2017	Colli, Leandro/0000-0001-6928-1195; de Castro, Margaret/0000-0003-4932-4623; Takiya, Christina/0000-0002-8019-628X; 	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Novartis Pharmaceuticals	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Novartis Pharmaceuticals(Novartis)	This work was supported by grants from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (to LVN) and Novartis Pharmaceuticals (to LVN and MRG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates AS, 1997, J CLIN ENDOCR METAB, V82, P818, DOI 10.1210/jc.82.3.818; Bevan JS, 2005, J CLIN ENDOCR METAB, V90, P1856, DOI 10.1210/jc.2004-1093; Bilanges B, 1999, ONCOGENE, V18, P3979, DOI 10.1038/sj.onc.1202933; Chahal HS, 2012, J CLIN ENDOCR METAB, V97, pE1411, DOI 10.1210/jc.2012-1111; Colao A, 2009, REV ENDOCR METAB DIS, V10, P111, DOI 10.1007/s11154-008-9107-z; Cvetkovic D, 2004, GYNECOL ONCOL, V95, P449, DOI 10.1016/j.ygyno.2004.08.051; Florio T, 2003, ENDOCRINOLOGY, V144, P1574, DOI 10.1210/en.2002-220949; Gadelha MR, 2013, TRENDS ENDOCRIN MET, V24, P238, DOI 10.1016/j.tem.2012.11.007; Gatto F, 2013, J CLIN ENDOCR METAB, V98, pE66, DOI 10.1210/jc.2012-2609; de Pinho LKJ, 2011, NEUROENDOCRINOLOGY, V94, P39, DOI 10.1159/000322787; Lemeta S, 2007, J NEUROPATH EXP NEUR, V66, P860, DOI 10.1097/nen.0b013e318149ee64; Lemeta S, 2006, HUM PATHOL, V37, P749, DOI 10.1016/j.humpath.2006.02.002; Michaelis KA, 2011, ENDOCRINOLOGY, V152, P3603, DOI 10.1210/en.2011-0109; Noh TW, 2009, J CLIN ENDOCR METAB, V94, P4406, DOI 10.1210/jc.2009-0471; Pabinger S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-268; Pagotto U, 1999, ENDOCRINOLOGY, V140, P987, DOI 10.1210/en.140.2.987; Pagotto U, 2000, CANCER RES, V60, P6794; Patel YC, 1999, FRONT NEUROENDOCRIN, V20, P157, DOI 10.1006/frne.1999.0183; Pyronnet S, 2008, MOL CELL ENDOCRINOL, V286, P230, DOI 10.1016/j.mce.2008.02.002; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Taboada GF, 2007, EUR J ENDOCRINOL, V156, P65, DOI 10.1530/eje.1.02313; Theodoropoulou M, 2006, CANCER RES, V66, P1576, DOI 10.1158/0008-5472.CAN-05-1189; Theodoropoulou M, 2012, J KLIN ENDOKRINOL ST, V5, P1; Theodoropoulou M, 2010, MOL CELL ENDOCRINOL, V326, P60, DOI 10.1016/j.mce.2010.01.033; Theodoropoulou M, 2009, INT J CANCER, V125, P2122, DOI 10.1002/ijc.24602; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Neto LV, 2011, ARQ BRAS ENDOCRINOL, V55, P725, DOI 10.1590/S0004-27302011000900011; Neto LV, 2009, J CLIN ENDOCR METAB, V94, P1931, DOI 10.1210/jc.2008-1826; Wildemberg LEA, 2013, J ENDOCRINOL INVEST, V36, P38, DOI 10.3275/8305; Wildemberg LEA, 2012, J ENDOCRINOL INVEST, V35, P580, DOI 10.3275/7906	30	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e77406	10.1371/journal.pone.0077406	http://dx.doi.org/10.1371/journal.pone.0077406			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098585	Green Submitted, gold, Green Published			2022-12-25	WOS:000325434500099
J	Begemann, MB; Zess, EK; Walters, EM; Schmitt, EF; Markley, AL; Pfleger, BF				Begemann, Matthew B.; Zess, Erin K.; Walters, Eric M.; Schmitt, Emily F.; Markley, Andrew L.; Pfleger, Brian F.			An Organic Acid Based Counter Selection System for Cyanobacteria	PLOS ONE			English	Article							SALMONELLA-ENTERICA; SYNECHOCOCCUS; 2-METHYLCITRATE; FERMENTATION; ACCUMULATION; TOXICITY	Cyanobacteria are valuable organisms for studying the physiology of photosynthesis and carbon fixation, as well as metabolic engineering for the production of fuels and chemicals. This work describes a novel counter selection method for the cyanobacterium Synechococcus sp. PCC 7002 based on organic acid toxicity. The organic acids acrylate, 3-hydroxypropionate, and propionate were shown to be inhibitory towards Synechococcus sp. PCC 7002 and other cyanobacteria at low concentrations. Inhibition was overcome by a loss of function mutation in the gene acsA, which is annotated as an acetyl-CoA ligase. Loss of AcsA function was used as a basis for an acrylate counter selection method. DNA fragments of interest were inserted into the acsA locus and strains harboring the insertion were isolated on selective medium containing acrylate. This methodology was also used to introduce DNA fragments into a pseudogene, glpK. Application of this method will allow for more advanced genetics and engineering studies in Synechococcus sp. PCC 7002 including the construction of markerless gene deletions and insertions. The acrylate counter-selection could be applied to other cyanobacterial species where AcsA activity confers acrylate sensitivity (e.g. Synechocystis sp. PCC 6803).	[Begemann, Matthew B.; Pfleger, Brian F.] Univ Wisconsin, Microbiol Doctoral Training Program, Madison, WI 53715 USA; [Begemann, Matthew B.; Zess, Erin K.; Walters, Eric M.; Schmitt, Emily F.; Markley, Andrew L.; Pfleger, Brian F.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53715 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Pfleger, BF (corresponding author), Univ Wisconsin, Microbiol Doctoral Training Program, Madison, WI 53715 USA.	pfleger@engr.wisc.edu	Pfleger, Brian Frederick/AAA-2559-2022	Pfleger, Brian Frederick/0000-0002-9232-9959	National Science Foundation [EFRI-1240268, CBET-1149678, SEES 12-15871]; US Air Force Office of Scientific Research [FA9550-11-1-0038]; US Department of Energy Genomics: GTL and SciDAC Programs [DE-FG02-04ER25627]; University of Wisconsin-Madison graduate school; Directorate For Engineering [1240268] Funding Source: National Science Foundation; Div Of Chem, Bioeng, Env, & Transp Sys [1149678] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); US Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); US Department of Energy Genomics: GTL and SciDAC Programs(United States Department of Energy (DOE)); University of Wisconsin-Madison graduate school; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was funded by the National Science Foundation (EFRI-1240268, CBET-1149678, SEES 12-15871), the US Air Force Office of Scientific Research (FA9550-11-1-0038), the US Department of Energy Genomics: GTL and SciDAC Programs (DE-FG02-04ER25627) and the University of Wisconsin-Madison graduate school. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheah YE, 2013, BIOTECHNOL PROGR, V29, P23, DOI 10.1002/btpr.1661; Ducat DC, 2011, TRENDS BIOTECHNOL, V29, P95, DOI 10.1016/j.tibtech.2010.12.003; Frigaard NU, 2004, METH MOL B, V274, P325; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Green PR, 2001, BIOMACROMOLECULES, V3, P208; Hashimoto Y, 2005, J BIOL CHEM, V280, P8660, DOI 10.1074/jbc.M405686200; Horswill AR, 2001, J BIOL CHEM, V276, P19094, DOI 10.1074/jbc.M100244200; Huang HH, 2010, NUCLEIC ACIDS RES, V38, P2577, DOI 10.1093/nar/gkq164; IHLENFELDT MJA, 1977, ARCH MICROBIOL, V113, P231, DOI 10.1007/BF00492030; JOSET F, 1988, ARCH MICROBIOL, V149, P417, DOI 10.1007/BF00425581; Liu XY, 2011, P NATL ACAD SCI USA, V108, P6899, DOI 10.1073/pnas.1103014108; Machado IMP, 2012, J BIOTECHNOL, V162, P50, DOI 10.1016/j.jbiotec.2012.03.005; Mendez-Perez D, 2011, APPL ENVIRON MICROB, V77, P4264, DOI 10.1128/AEM.00467-11; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pinto FL, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-79; Rocco CJ, 2010, J BACTERIOL, V192, P771, DOI 10.1128/JB.01301-09; Rosmarie R, 1988, METHOD ENZYMOL, P3; RUSSELL JB, 1992, J APPL BACTERIOL, V73, P363, DOI 10.1111/j.1365-2672.1992.tb04990.x; Schneider K, 2012, J BACTERIOL, V194, P225, DOI 10.1128/JB.05959-11; STEVENS SE, 1973, J PHYCOL, V9, P427, DOI 10.1111/j.1529-8817.1973.tb04116.x; Sunda W, 2002, NATURE, V418, P317, DOI 10.1038/nature00851; THIJSSE GJE, 1964, BIOCHIM BIOPHYS ACTA, V84, P195, DOI 10.1016/0926-6542(64)90078-2; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Wang B, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00344; Warnecke TE, 2010, METAB ENG, V12, P241, DOI 10.1016/j.ymben.2009.12.002; Xu Y, 2013, METAB ENG, V16, P56, DOI 10.1016/j.ymben.2012.12.002; Xu Y, 2011, METHODS MOL BIOL, V684, P273, DOI [10.1007/978.1.60761.925.3_21, 10.1007/978-1-60761-925-3_21]; Zaldivar J, 1999, BIOTECHNOL BIOENG, V66, P203, DOI [10.1002/(SICI)1097-0290(1999)66:4<203::AID-BIT1>3.0.CO;2-#, 10.1002/(SICI)1097-0290(1999)66:4&lt;203::AID-BIT1&gt;3.0.CO;2-#]; Zarzycki J, 2013, J EXP BOT, V64, P787, DOI 10.1093/jxb/ers294; Zhang SY, 2011, SCIENCE, V334, P1551, DOI 10.1126/science.1210858	30	44	45	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76594	10.1371/journal.pone.0076594	http://dx.doi.org/10.1371/journal.pone.0076594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098537	gold, Green Submitted, Green Published			2022-12-25	WOS:000325427100079
J	Leigh, NR; Schupp, MO; Li, KG; Padmanabhan, V; Gastonguay, A; Wang, L; Chun, CZ; Wilkinson, GA; Ramchandran, R				Leigh, Noah R.; Schupp, Marcus-Oliver; Li, Keguo; Padmanabhan, Vakeel; Gastonguay, Adam; Wang, Ling; Chun, Chang Z.; Wilkinson, George A.; Ramchandran, Ramani			Mmp17b Is Essential for Proper Neural Crest Cell Migration In Vivo	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE INHIBITOR; TRUNK; CARTILAGE; MT6-MMP; BINDING; SURFACE	The extracellular matrix plays a critical role in neural crest (NC) cell migration. In this study, we characterize the contribution of the novel GPI-linked matrix metalloproteinase (MMP) zebrafish mmp17b. Mmp17b is expressed post-gastrulation in the developing NC. Morpholino inactivation of mmp17b function, or chemical inhibition of MMP activity results in aberrant NC cell migration with minimal change in NC proliferation or apoptosis. Intriguingly, a GPI anchored protein with metalloproteinase inhibitor properties, Reversion-inducing-Cysteine-rich protein with Kazal motifs (RECK), which has previously been implicated in NC development, is expressed in close apposition to NC cells expressing mmp17b, raising the possibility that these two gene products interact. Consistent with this possibility, embryos silenced for mmp17b show defective development of the dorsal root ganglia (DRG), a crest-derived structure affected in RECK mutant fish sensory deprived (sdp). Taken together, this study has identified the first pair of MMP, and their putative MMP inhibitor RECK that functions together in NC cell migration.	[Leigh, Noah R.; Schupp, Marcus-Oliver; Li, Keguo; Padmanabhan, Vakeel; Gastonguay, Adam; Wang, Ling; Wilkinson, George A.; Ramchandran, Ramani] Med Coll Wisconsin, Dept Pediat, Dev Vasc Biol Program, Childrens Res Inst CRI, Milwaukee, WI 53226 USA; [Chun, Chang Z.] Univ Florida, Dept Med, Div Nephrol Hypertens & Renal Transplantat, Gainesville, FL USA	Medical College of Wisconsin; State University System of Florida; University of Florida	Ramchandran, R (corresponding author), Med Coll Wisconsin, Dept Pediat, Dev Vasc Biol Program, Childrens Res Inst CRI, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	rramchan@mcw.edu			Children's Research Institute (CRI) at Medical College of Wisconsin; National Institutes of Health (NIH) [HL090712]; T32 fellowship from NIH Heart, Lung and Blood Institute; NIH [HL102745, HL112639]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102745, R01HL090712, R01HL112639] Funding Source: NIH RePORTER	Children's Research Institute (CRI) at Medical College of Wisconsin; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32 fellowship from NIH Heart, Lung and Blood Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by start-up funds from Children's Research Institute (CRI) at Medical College of Wisconsin, and National Institutes of Health (NIH) HL090712 grant to RR. LW is supported by T32 fellowship from NIH Heart, Lung and Blood Institute. MOS, AG and VP are supported by NIH grants (HL102745, HL112639) to RR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders only provided resources to help perform the study.	Anderson RB, 2010, INT J DEV BIOL, V54, P63, DOI 10.1387/ijdb.082667ra; Ara T, 2000, J PEDIATR SURG, V35, P432, DOI 10.1016/S0022-3468(00)90208-2; Bedell VM, 2005, P NATL ACAD SCI USA, V102, P6373, DOI 10.1073/pnas.0408318102; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038; BRONNERFRASER M, 1991, J CRAN GENET DEV BIO, V11, P214; BRONNERFRASER M, 1986, DEV BIOL, V117, P528, DOI 10.1016/0012-1606(86)90320-9; BRONNERFRASER M, 1995, PERSPECT DEV NEUROBI, V3, P53; Cai DH, 2002, DEV DYNAM, V224, P441, DOI 10.1002/dvdy.10129; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; English WR, 2001, FEBS LETT, V491, P137, DOI 10.1016/S0014-5793(01)02150-0; Gammill LS, 2010, DEV BIOL, V344, P555, DOI 10.1016/j.ydbio.2010.04.009; Gao G, 2004, J BIOL CHEM, V279, P10042, DOI 10.1074/jbc.M312100200; Giambernardi TA, 2001, MATRIX BIOL, V20, P577, DOI 10.1016/S0945-053X(01)00166-4; Hegedus L, 2008, J CELL PHYSIOL, V216, P480, DOI 10.1002/jcp.21417; Kague E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047394; Kasemeier-Kulesa JC, 2010, J NEUROSCI, V30, P13078, DOI 10.1523/JNEUROSCI.0892-10.2010; Kirby BB, 2006, NAT NEUROSCI, V9, P1506, DOI 10.1038/nn1803; Kojima S, 2000, FEBS LETT, V480, P142, DOI 10.1016/S0014-5793(00)01919-0; Kolkenbrock H, 1999, BIOL CHEM, V380, P1103, DOI 10.1515/BC.1999.137; KRULL CE, 1995, DEVELOPMENT, V121, P3733; Kulesa PM, 2010, DEV BIOL, V344, P566, DOI 10.1016/j.ydbio.2010.05.005; Lee RTH, 2013, DEVELOPMENT, V140, P2923, DOI 10.1242/dev.093534; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Maxfield FR, 1997, ADV EXP MED BIOL, V419, P355; Nieto MA, 2001, MECH DEVELOP, V105, P27, DOI 10.1016/S0925-4773(01)00394-X; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; Prendergast A, 2012, DEVELOPMENT, V139, P1141, DOI 10.1242/dev.072439; RAIBLE DW, 1994, DEVELOPMENT, V120, P495; Sohail A, 2008, CANCER METAST REV, V27, P289, DOI 10.1007/s10555-008-9129-8; Sumanas S, 2006, PLOS BIOL, V4, P60, DOI 10.1371/journal.pbio.0040010; Sun L, 2011, BIOMATERIALS, V32, P5581, DOI 10.1016/j.biomaterials.2011.04.028; Theveneau E, 2012, DEV BIOL, V366, P34, DOI 10.1016/j.ydbio.2011.12.041; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Werb Z, 1998, ANN NY ACAD SCI, V857, P110, DOI 10.1111/j.1749-6632.1998.tb10111.x; Wyatt RA, 2009, ZEBRAFISH, V6, P347, DOI 10.1089/zeb.2009.0609; Yamada A, 2000, INFLAMM RES, V49, P144, DOI 10.1007/s000110050573; Zon LI, 2010, ZEBRAFISH, V7, P1, DOI 10.1089/zeb.2010.9996	38	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76484	10.1371/journal.pone.0076484	http://dx.doi.org/10.1371/journal.pone.0076484			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098510	Green Submitted, Green Published, gold			2022-12-25	WOS:000325427100070
J	Beck, J; Hennecke, S; Bornemann-Kolatzki, K; Urnovitz, HB; Neumann, S; Strobel, P; Kaup, FJ; Brenig, B; Schutz, E				Beck, Julia; Hennecke, Silvia; Bornemann-Kolatzki, Kirsten; Urnovitz, Howard B.; Neumann, Stephan; Stroebel, Philipp; Kaup, Franz-Josef; Brenig, Bertram; Schuetz, Ekkehard			Genome Aberrations in Canine Mammary Carcinomas and Their Detection in Cell-Free Plasma DNA	PLOS ONE			English	Article							HUMAN BREAST-CANCER; ESTROGEN-RECEPTOR-ALPHA; ANIMAL TUMOR REGISTRY; NUCLEIC-ACIDS; HUMAN-DISEASE; FEMALE DOG; PET DOGS; EXPRESSION; HYBRIDIZATION; ARRAY	Mammary tumors are the most frequent cancers in female dogs exhibiting a variety of histopathological differences. There is lack of knowledge about the genomes of these common dog tumors. Five tumors of three different histological subtypes were evaluated. Massive parallel sequencing (MPS) was performed in comparison to the respective somatic genome of each animal. Copy number and structural aberrations were validated using droplet digital PCR (ddPCR). Using mate-pair sequencing chromosomal aneuploidies were found in two tumors, frequent smaller deletions were found in one, inter-chromosomal fusions in one other, whereas one tumor was almost normal. These aberrations affect several known cancer associated genes such as cMYC, and KIT. One common deletion of the proximal end of CFA27, harboring the tumor suppressor gene PFDN5 was detected in four tumors. Using ddPCR, this deletion was validated and detected in 50% of tumors (N = 20). Breakpoint specific dPCRs were established for four tumors and tumor specific cell-free DNA (cfDNA) was detected in the plasma. In one animal tumor-specific cfDNA was found >1 year after surgery, attributable to a lung metastasis. Paired-end sequencing proved that copy-number imbalances of the tumor are reflected by the cfDNA. This report on chromosomal instability of canine mammary cancers reveals similarities to human breast cancers as well as special canine alterations. This animal model provides a framework for using MPS for screening for individual cancer biomarkers with cost effective confirmation and monitoring using ddPCR. The possibility exists that ddPCR can be expanded to screening for common cancer related variants.	[Beck, Julia; Bornemann-Kolatzki, Kirsten; Urnovitz, Howard B.; Schuetz, Ekkehard] Chronix Biomed, Gottingen, Germany; [Hennecke, Silvia; Neumann, Stephan; Brenig, Bertram; Schuetz, Ekkehard] Univ Gottingen, Inst Vet Med, D-37073 Gottingen, Germany; [Stroebel, Philipp] Univ Med, Dept Pathol, Gottingen, Germany; [Kaup, Franz-Josef] German Primate Ctr, Pathol Unit, Gottingen, Germany	University of Gottingen; Deutsches Primatenzentrum (DPZ)	Beck, J (corresponding author), Chronix Biomed, Gottingen, Germany.			Brenig, Bertram/0000-0002-7635-9656	Chronix Biomedical; Institute of Veterinary Medicine of the University of Gottingen	Chronix Biomedical; Institute of Veterinary Medicine of the University of Gottingen	The study was funded by Chronix Biomedical and the Institute of Veterinary Medicine of the University of Gottingen. Study design, data collection and analysis, decision to publish and preparation of the manuscript was conducted by employees of these institutions.	Aguirre-Hernandez J, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-27; Ahern TE, 1996, AM J VET RES, V57, P693; Allred DC, 1998, MODERN PATHOL, V11, P155; Angstadt AY, 2011, GENE CHROMOSOME CANC, V50, P859, DOI 10.1002/gcc.20908; Beck J, 2010, MOL CANCER RES, V8, P335, DOI 10.1158/1541-7786.MCR-09-0314; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Boerkamp Kim M, 2012, Cancers (Basel), V4, P1300, DOI 10.3390/cancers4041300; Bofin AM, 2004, AM J CLIN PATHOL, V122, P110, DOI 10.1309/8A2DJFT07NE6EWHE; BURKI E, 1948, OPHTHALMOLOGICA, V115, P241; de las Mulas JM, 2005, VET PATHOL, V42, P200, DOI 10.1354/vp.42-2-200; de las Mulas JM, 2003, BREAST CANCER RES TR, V80, P363, DOI 10.1023/A:1024929730165; Dobson JM, 2002, J SMALL ANIM PRACT, V43, P240, DOI 10.1111/j.1748-5827.2002.tb00066.x; DORN CR, 1968, JNCI-J NATL CANCER I, V40, P307; Drabsch Y, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2614; Dunn KA, 2000, VET J, V160, P77, DOI 10.1053/tvjl.2000.0495; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Fabarius A, 2003, CANCER GENET CYTOGEN, V143, P59, DOI 10.1016/S0165-4608(03)00003-7; Fujioka Y, 2001, J BIOL CHEM, V276, P45137, DOI 10.1074/jbc.M106127200; Gama A, 2008, VIRCHOWS ARCH, V453, P123, DOI 10.1007/s00428-008-0644-3; Geigl JB, 2008, TRENDS GENET, V24, P64, DOI 10.1016/j.tig.2007.11.006; Graham JC, 1999, AM J VET RES, V60, P627; Grzmil M, 2006, J PATHOL, V208, P340, DOI 10.1002/path.1902; Hagio Y, 2006, J CELL BIOCHEM, V97, P145, DOI 10.1002/jcb.20619; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hedan B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-201; Hellmen E, 2005, J DAIRY RES, V72, P90, DOI 10.1017/S002202990500124X; HELLMEN E, 1988, VET PATHOL, V25, P219, DOI 10.1177/030098588802500306; Hicks J, 2006, GENOME RES, V16, P1465, DOI 10.1101/gr.5460106; Kauraniemi P, 2000, CANCER RES, V60, P5323; Khanna C, 2006, NAT BIOTECHNOL, V24, P1065, DOI 10.1038/nbt0906-1065b; Klopfleisch R, 2011, VET PATHOL, V48, P98, DOI 10.1177/0300985810390826; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kwei KA, 2010, MOL ONCOL, V4, P255, DOI 10.1016/j.molonc.2010.04.001; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Liu PF, 2012, CURR OPIN GENET DEV, V22, P211, DOI 10.1016/j.gde.2012.02.012; Lo YMD, 2007, P NATL ACAD SCI USA, V104, P13116, DOI 10.1073/pnas.0705765104; Loeb LA, 2003, P NATL ACAD SCI USA, V100, P776, DOI 10.1073/pnas.0334858100; Maeda J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043355; Maher CA, 2012, CELL, V148, P29, DOI 10.1016/j.cell.2012.01.006; Martin Jeff W., 2012, Sarcoma, V2012, P627254, DOI 10.1155/2012/627254; McBride DJ, 2010, GENE CHROMOSOME CANC, V49, P1062, DOI 10.1002/gcc.20815; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Merlo DF, 2008, J VET INTERN MED, V22, P976, DOI 10.1111/j.1939-1676.2008.0133.x; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mitelman F, 2012, MITELMAN DATABASE CH; MORRIS JS, 1993, VET REC, V133, P539, DOI 10.1136/vr.133.22.539; Muller MH, 2012, TIERAERZTL PRAX K H, V40, P55; Naylor TL, 2005, BREAST CANCER RES, V7, pR1186, DOI 10.1186/bcr1356; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Nicholas TJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-414; Nieto A, 2000, VET PATHOL, V37, P239, DOI 10.1354/vp.37-3-239; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Owens Marilyn A, 2004, Clin Breast Cancer, V5, P63, DOI 10.3816/CBC.2004.n.011; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Pierotti MA, 2003, MECH ONCOGENE ACTIVA; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Queiroga FL, 2011, IN VIVO, V25, P455; Rao NAS, 2009, J PHYSIOL PHARMACOL, V60, P73; Reimann-Berg N, 2012, TIERAERZTL PRAX K H, V40, P267; ROSENBLATT M, 1956, ANN MATH STAT, V27, P832, DOI 10.1214/aoms/1177728190; Rowell JL, 2011, TRENDS MOL MED, V17, P380, DOI 10.1016/j.molmed.2011.02.004; Russnes HG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000611; RUTTEMAN GR, 1988, CANCER RES, V48, P3411; RUTTEMAN GR, 1988, BRIT J CANCER, V58, P594, DOI 10.1038/bjc.1988.266; Sassi F, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-5; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Schweiger MR, 2011, CANCER METAST REV, V30, P199, DOI 10.1007/s10555-011-9278-z; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shaw JA, 2012, GENOME RES, V22, P220, DOI 10.1101/gr.123497.111; Simon D, 2006, J VET INTERN MED, V20, P1184, DOI 10.1892/0891-6640(2006)20[1184:PATIMM]2.0.CO;2; Sleeckx N, 2011, REPROD DOMEST ANIM, V46, P1112, DOI 10.1111/j.1439-0531.2011.01816.x; SORENSON GD, 1994, CANCER EPIDEM BIOMAR, V3, P67; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; STRANDBERG JD, 1974, AM J PATHOL, V75, P225; Tang J, 2010, GENOME RES, V20, P341, DOI 10.1101/gr.092726.109; Thomas R, 2003, CYTOGENET GENOME RES, V102, P249, DOI 10.1159/000075757; Thomas R, 2003, BRIT J CANCER, V89, P1530, DOI 10.1038/sj.bjc.6601275; Thomas R, 2007, J HERED, V98, P474, DOI 10.1093/jhered/esm053; Thomas R, 2009, CHROMOSOME RES, V17, P365, DOI 10.1007/s10577-009-9028-z; Tsuda H, 2009, BREAST CANCER-TOKYO, V16, P186, DOI 10.1007/s12282-009-0124-x; Turner N, 2010, CANCER RES, V70, P2085, DOI 10.1158/0008-5472.CAN-09-3746; Uva P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-135; Vascellari M, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-39; VASIOUKHIN V, 1994, BRIT J HAEMATOL, V86, P774, DOI 10.1111/j.1365-2141.1994.tb04828.x; Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80; Zeitouni B, 2010, BIOINFORMATICS, V26, P1895, DOI 10.1093/bioinformatics/btq293	90	38	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75485	10.1371/journal.pone.0075485	http://dx.doi.org/10.1371/journal.pone.0075485			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098698	gold, Green Published			2022-12-25	WOS:000325423500069
J	Camell, C; Smith, CW				Camell, Christina; Smith, C. Wayne			Dietary Oleic Acid Increases M2 Macrophages in the Mesenteric Adipose Tissue	PLOS ONE			English	Article							SATURATED FATTY-ACIDS; PPAR-GAMMA; MESOTHELIAL CELLS; ACTIVATION; EXPRESSION; OBESITY; CYTOKINES; PALMITATE; PROTECTS; ADHESION	Several studies have implicated fatty-acids as inflammatory regulators, suggesting that there may be a direct role for common dietary fatty-acids in regulating innate immune cells. In humans, a single high-fat meal increases systemic cytokines and leukocytes. In mice, short term high-fat feeding increases adipose tissue (AT) leukocytes and alters the inflammatory profile of AT macrophages. We have seen that short term high fat feeding to C57BL/6J male mice increases palmitic and oleic acid within AT depots, but oleic acid increase is highest in the mesenteric AT (MAT). In vitro, oleic acid increases M2 macrophage markers (CD206, MGL1, and ARG1) in a murine macrophage cell line, while addition of palmitic acid is able to inhibit that increase. Three day supplementation of a chow diet, with oleic acid, induced an increase in M2 macrophage markers in the MAT, but not in the epididymal AT. We tested whether increases in M2 macrophages occur during short term ad lib feeding of a high fat diet, containing oleic acid. Experiments revealed two distinct populations of macrophages were altered by a three day high milk-fat diet. One population, phenotypically intermediate for F4/80, showed diet-induced increases in CD206, an anti-inflammatory marker characteristic of M2 macrophages intrinsic to the AT. Evidence for a second population, phenotypically F4/80(HI)CD11b(HI) macrophages, showed increased association with the MAT following short term feeding that is dependent on the adhesion molecule, ICAM-1. Collectively, we have shown that short term feeding of a high-fat diet changes two population of macrophages, and that dietary oleic acid is responsible for increases in M2 macrophage polarization.	[Camell, Christina; Smith, C. Wayne] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Smith, C. Wayne] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Smith, C. Wayne] Childrens Nutr Res Ctr, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine	Camell, C (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.	camell@bcm.edu			National Institute of Diabetes and Digestive and Kidney Diseases [F31DK084841]; United States Department of Agriculture/Agricultural Research Service [6250-51000-046];  [DK59637]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059637, F31DK084841, U2CDK059637] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); United States Department of Agriculture/Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The project described was supported by F31DK084841 from The National Institute of Diabetes and Digestive and Kidney Diseases, and United States Department of Agriculture/Agricultural Research Service grant 6250-51000-046. This funder did data collection but had no role in study design, analysis, decision to publish, or preparation of the manuscript. The MMPC/DRTC Lipid Lab in Vanderbilt is supported by the following award: DK59637. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shudiefat AAR, 2013, MOL CELL BIOCHEM, V372, P75, DOI 10.1007/s11010-012-1447-z; Benoit SC, 2009, J CLIN INVEST, V119, P2577, DOI 10.1172/JCI36714; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Brake DK, 2006, AM J PHYSIOL-CELL PH, V291, pC1232, DOI 10.1152/ajpcell.00008.2006; Brake Danett K., 2008, V456, P221, DOI 10.1007/978-1-59745-245-8_16; Burdge GC, 2005, BRIT J NUTR, V93, P3, DOI 10.1079/BJN20041282; Cardoso CR, 2011, IMMUNOBIOLOGY, V216, P409, DOI 10.1016/j.imbio.2010.06.007; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Davis JE, 2008, OBESITY, V16, P1248, DOI 10.1038/oby.2008.210; DIAMOND MS, 1990, J CELL BIOL, V111, P3129, DOI 10.1083/jcb.111.6.3129; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Haversen L, 2009, ATHEROSCLEROSIS, V202, P382, DOI 10.1016/j.atherosclerosis.2008.05.033; Huang SR, 2012, J LIPID RES, V53, P2002, DOI 10.1194/jlr.D029546; Ji YW, 2012, J BIOL CHEM, V287, P24378, DOI 10.1074/jbc.M112.371807; JONJIC N, 1992, J EXP MED, V176, P1165, DOI 10.1084/jem.176.4.1165; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Laine PS, 2007, BIOCHEM BIOPH RES CO, V358, P150, DOI 10.1016/j.bbrc.2007.04.092; Lanthier N, 2010, AM J PHYSIOL-GASTR L, V298, pG107, DOI 10.1152/ajpgi.00391.2009; Li FK, 1998, KIDNEY INT, V54, P2170, DOI 10.1046/j.1523-1755.1998.00174.x; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Moran-Salvador E, 2011, FASEB J, V25, P2538, DOI 10.1096/fj.10-173716; Morris DL, 2011, CURR OPIN CLIN NUTR, V14, P341, DOI 10.1097/MCO.0b013e328347970b; MULLER J, 1995, CLIN IMMUNOL IMMUNOP, V75, P231, DOI 10.1006/clin.1995.1076; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Prieur X, 2011, DIABETES, V60, P797, DOI 10.2337/db10-0705; Reardon M, 2012, LIPIDS, V47, P1043, DOI 10.1007/s11745-012-3711-0; Remels AHV, 2009, AM J PHYSIOL-ENDOC M, V297, pE174, DOI 10.1152/ajpendo.90632.2008; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Teres S, 2008, P NATL ACAD SCI USA, V105, P13811, DOI 10.1073/pnas.0807500105; Topley N, 1996, IMMUNOBIOLOGY, V195, P563, DOI 10.1016/S0171-2985(96)80022-2; Turchyn LR, 2007, COMPARATIVE MED, V57, P574; van Rossen MEE, 2001, J PATHOL, V193, P530; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080	39	38	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75147	10.1371/journal.pone.0075147	http://dx.doi.org/10.1371/journal.pone.0075147			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098682	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500053
J	Ghosh, S; Singh, UK; Meli, VS; Kumar, V; Kumar, A; Irfan, M; Chakraborty, N; Chakraborty, S; Datta, A				Ghosh, Sumit; Singh, Upendra Kumar; Meli, Vijaykumar S.; Kumar, Vinay; Kumar, Anil; Irfan, Mohammad; Chakraborty, Niranjan; Chakraborty, Subhra; Datta, Asis			Induction of Senescence and Identification of Differentially Expressed Genes in Tomato in Response to Monoterpene	PLOS ONE			English	Article							CULTURED SHOOT PRIMORDIA; TERPENOID METABOLISM; SIGNAL-TRANSDUCTION; CELL-DEATH; GERANIOL; VOLATILES; DEFENSE; CLONING; PROTEIN; APOPTOSIS	Monoterpenes, which are among the major components of plant essential oils, are known for their ecological roles as well for pharmaceutical properties. Geraniol, an acyclic monoterpene induces cell cycle arrest and apoptosis/senescence in various cancer cells and plants; however, the genes involved in the process and the underlying molecular mechanisms are not well understood. In this study, we demonstrate that treatment of tomato plants with geraniol results in induction of senescence due to a substantial alteration in transcriptome. We have identified several geraniol-responsive protein encoding genes in tomato using suppression subtractive hybridization (SSH) approach. These genes comprise of various components of signal transduction, cellular metabolism, reactive oxygen species (ROS), ethylene signalling, apoptosis and DNA damage response. Upregulation of NADPH oxidase and antioxidant genes, and increase in ROS level after geraniol treatment point towards the involvement of ROS in geraniol-mediated senescence. The delayed onset of seedling death and induced expression of geraniol-responsive genes in geraniol-treated ethylene receptor mutant (Nr) suggest that geraniol-mediated senescence involves both ethylene dependent and independent pathways. Moreover, expression analysis during tomato ripening revealed that geraniol-responsive genes are also associated with the natural organ senescence process.	[Ghosh, Sumit; Singh, Upendra Kumar; Meli, Vijaykumar S.; Kumar, Vinay; Kumar, Anil; Irfan, Mohammad; Chakraborty, Niranjan; Chakraborty, Subhra; Datta, Asis] Natl Inst Plant Genome Res, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Datta, A (corresponding author), Natl Inst Plant Genome Res, New Delhi, India.	asis_datta@rediffmail.com	Irfan, Mohammad/AAR-8004-2021; Kumar, Vinay/AAU-6954-2021; KUMAR, ANIL/AAH-1077-2022; KUMAR, ANIL/AES-0347-2022; Meli, Vijaykumar S/A-1879-2018	Irfan, Mohammad/0000-0002-7877-5530; Kumar, Vinay/0000-0002-6751-5741; Meli, Vijaykumar S/0000-0002-8690-4363; Chakraborty, Niranjan/0000-0002-6564-4734	Department of Biotechnology, the Ministry of Science and Technology, Government of India	Department of Biotechnology, the Ministry of Science and Technology, Government of India	This work was supported by the Department of Biotechnology, the Ministry of Science and Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2002, J EXP BOT, V53, P2073, DOI 10.1093/jxb/erf026; Alba R, 2005, PLANT CELL, V17, P2954, DOI 10.1105/tpc.105.036053; Alexander L, 2002, J EXP BOT, V53, P2039, DOI 10.1093/jxb/erf072; Antonelli A, 1997, J AGR FOOD CHEM, V45, P4435, DOI 10.1021/jf9702407; Arimura G, 2000, NATURE, V406, P512, DOI 10.1038/35020072; Ashida Y, 2002, BIOSCI BIOTECH BIOCH, V66, P168, DOI 10.1271/bbb.66.168; Ashida Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2511, DOI 10.1271/bbb.66.2511; Baldwin IT, 2006, SCIENCE, V311, P812, DOI 10.1126/science.1118446; BAYRAK A, 1994, J SCI FOOD AGR, V64, P441, DOI 10.1002/jsfa.2740640408; Besser K, 2009, PLANT PHYSIOL, V149, P499, DOI 10.1104/pp.108.126276; Beyene G, 2006, J EXP BOT, V57, P1431, DOI 10.1093/jxb/erj123; Bohlmann J, 2008, PLANT J, V54, P656, DOI 10.1111/j.1365-313X.2008.03449.x; Bolle C, 2004, PLANTA, V218, P683, DOI 10.1007/s00425-004-1203-z; Burke YD, 1997, LIPIDS, V32, P151, DOI 10.1007/s11745-997-0019-y; Chaimovitsh D, 2010, PLANT J, V61, P399, DOI 10.1111/j.1365-313X.2009.04063.x; Davidovich-Rikanati R, 2007, NAT BIOTECHNOL, V25, P899, DOI 10.1038/nbt1312; de Godoy A, 2010, SCI HORTIC-AMSTERDAM, V124, P51, DOI 10.1016/j.scienta.2009.12.014; Deprost D, 2005, BIOCHEM BIOPH RES CO, V326, P844, DOI 10.1016/j.bbrc.2004.11.117; Dolch R, 2000, OECOLOGIA, V125, P504, DOI 10.1007/s004420000482; Doukhanina EV, 2006, J BIOL CHEM, V281, P18793, DOI 10.1074/jbc.M511794200; Fabi JP, 2010, PLANT SCI, V179, P225, DOI 10.1016/j.plantsci.2010.05.007; Fabi JP, 2009, SCI HORTIC-AMSTERDAM, V121, P159, DOI 10.1016/j.scienta.2009.01.036; Fan J, 2009, PLANT CELL TISS ORG, V98, P281, DOI 10.1007/s11240-009-9561-7; Fonseca S, 2004, PLANT SCI, V167, P457, DOI 10.1016/j.plantsci.2004.03.033; Gan SS, 1997, PLANT PHYSIOL, V113, P313, DOI 10.1104/pp.113.2.313; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Godard KA, 2008, PHYTOCHEMISTRY, V69, P1838, DOI 10.1016/j.phytochem.2008.02.011; GRBIC V, 1995, PLANT J, V8, P595, DOI 10.1046/j.1365-313X.1995.8040595.x; Gupta S.K., 2009, J PROTEOM BIOINFORM, V2, P466, DOI DOI 10.4172/JPB; Hadfield KA, 2000, PLANT PHYSIOL, V122, P977, DOI 10.1104/pp.122.3.977; Han L, 2010, PLANT J, V64, P114, DOI 10.1111/j.1365-313X.2010.04318.x; Heil M, 2007, P NATL ACAD SCI USA, V104, P5467, DOI 10.1073/pnas.0610266104; Huang XZ, 2010, NEW PHYTOL, V187, P301, DOI 10.1111/j.1469-8137.2010.03275.x; Ichimura K, 2006, J BIOL CHEM, V281, P36969, DOI 10.1074/jbc.M605319200; Iijima Y, 2004, PLANT PHYSIOL, V134, P370, DOI 10.1104/pp.103.032946; Itai A, 2000, J EXP BOT, V51, P1163, DOI 10.1093/jexbot/51.347.1163; Izumi S, 1997, CHEM LETT, P837, DOI 10.1246/cl.1997.837; Izumi S, 1999, BIOCHEM BIOPH RES CO, V259, P519, DOI 10.1006/bbrc.1999.0813; Kappers IF, 2005, SCIENCE, V309, P2070, DOI 10.1126/science.1116232; Karban R, 2000, OECOLOGIA, V125, P66, DOI 10.1007/PL00008892; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kishimoto K, 2006, PHYTOCHEMISTRY, V67, P1520, DOI 10.1016/j.phytochem.2006.05.027; LANAHAN MB, 1994, PLANT CELL, V6, P521, DOI 10.1105/tpc.6.4.521; Lange B.M., 2012, PLANT BIOTECHNOL J, P1; LEWINSOHN E, 1991, PLANT PHYSIOL, V96, P38, DOI 10.1104/pp.96.1.38; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Luo M, 2004, ACTA BIOCH BIOPH SIN, V36, P277, DOI 10.1093/abbs/36.4.277; Masoudi-Nejad A, 2006, NUCLEIC ACIDS RES, V34, pW459, DOI 10.1093/nar/gkl066; MCGARVEY DJ, 1995, PLANT CELL, V7, P1015, DOI 10.1105/tpc.7.7.1015; Meli VS, 2010, P NATL ACAD SCI USA, V107, P2413, DOI 10.1073/pnas.0909329107; Miao Y, 2008, PLANT BIOLOGY, V10, P110, DOI 10.1111/j.1438-8677.2008.00083.x; Mondal K, 2004, BIOL PLANTARUM, V48, P49, DOI 10.1023/B:BIOP.0000024274.43874.5b; Ohlrogge J, 2000, CURR OPIN PLANT BIOL, V3, P224, DOI 10.1016/S1369-5266(00)00068-6; Pariasca JAT, 2001, POSTHARVEST BIOL TEC, V22, P239, DOI 10.1016/S0925-5214(01)00094-1; Perruc E, 2004, PLANT J, V38, P410, DOI 10.1111/j.1365-313X.2004.02062.x; Picaud S, 2003, FUNCT PLANT BIOL, V30, P621, DOI 10.1071/FP02116; Pichersky E, 2002, CURR OPIN PLANT BIOL, V5, P237, DOI 10.1016/S1369-5266(02)00251-0; Qin GZ, 2009, J PROTEOME RES, V8, P2449, DOI 10.1021/pr801046m; Ramonell K, 2005, PLANT PHYSIOL, V138, P1027, DOI 10.1104/pp.105.060947; Runyon JB, 2006, SCIENCE, V313, P1964, DOI 10.1126/science.1131371; Sarowar S, 2007, PLANT J, V51, P792, DOI 10.1111/j.1365-313X.2007.03174.x; Schilmiller AL, 2009, P NATL ACAD SCI USA, V106, P10865, DOI 10.1073/pnas.0904113106; SHOFF SM, 1991, CANCER RES, V51, P37; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Sterky F, 1998, P NATL ACAD SCI USA, V95, P13330, DOI 10.1073/pnas.95.22.13330; Tewari M, 1997, CANCER RES, V57, P4063; Tufekci M.A., 2005, J CELL MOL BIOL, V4, P9; Yamasaki Yumiko, 2007, Journal of General Plant Pathology, V73, P168, DOI 10.1007/s10327-007-0013-0; YU SG, 1995, J NUTR, V125, P2763; Zhu HF, 2009, MOL PLANT, V2, P513, DOI 10.1093/mp/ssp001	70	25	25	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76029	10.1371/journal.pone.0076029	http://dx.doi.org/10.1371/journal.pone.0076029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098759	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500129
J	Subira, M; Alonso, P; Segalas, C; Real, E; Lopez-Sola, C; Pujol, J; Martinez-Zalacain, I; Harrison, BJ; Menchon, JM; Cardoner, N; Soriano-Mas, C				Subira, Marta; Alonso, Pino; Segalas, Cinto; Real, Eva; Lopez-Sola, Clara; Pujol, Jesus; Martinez-Zalacain, Ignacio; Harrison, Ben J.; Menchon, Jose M.; Cardoner, Narcis; Soriano-Mas, Carles			Brain Structural Alterations in Obsessive-Compulsive Disorder Patients with Autogenous and Reactive Obsessions	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; SYMPTOM DIMENSIONS; REPETITIVE BEHAVIORS; NONCLINICAL SUBJECTS; INTRUSIVE THOUGHTS; TOURETTES-SYNDROME; TIC DISORDERS; NEURAL BASIS; SCALE; METAANALYSIS	Obsessive-compulsive disorder (OCD) is a clinically heterogeneous condition. Although structural brain alterations have been consistently reported in OCD, their interaction with particular clinical subtypes deserves further examination. Among other approaches, a two-group classification in patients with autogenous and reactive obsessions has been proposed. The purpose of the present study was to assess, by means of a voxel-based morphometry analysis, the putative brain structural correlates of this classification scheme in OCD patients. Ninety-five OCD patients and 95 healthy controls were recruited. Patients were divided into autogenous (n = 30) and reactive (n = 65) sub-groups. A structural magnetic resonance image was acquired for each participant and pre-processed with SPM8 software to obtain a volume-modulated gray matter map. Whole-brain and voxel-wise comparisons between the study groups were then performed. In comparison to the autogenous group, reactive patients showed larger gray matter volumes in the right Rolandic operculum. When compared to healthy controls, reactive patients showed larger volumes in the putamen (bilaterally), while autogenous patients showed a smaller left anterior temporal lobe. Also in comparison to healthy controls, the right middle temporal gyrus was smaller in both patient subgroups. Our results suggest that autogenous and reactive obsessions depend on partially dissimilar neural substrates. Our findings provide some neurobiological support for this classification scheme and contribute to unraveling the neurobiological basis of clinical heterogeneity in OCD.	[Subira, Marta; Alonso, Pino; Segalas, Cinto; Real, Eva; Lopez-Sola, Clara; Martinez-Zalacain, Ignacio; Menchon, Jose M.; Cardoner, Narcis; Soriano-Mas, Carles] Bellvitge Univ Hosp, Bellvitge Biomed Res Inst IDIBELL, Dept Psychiat, Barcelona, Spain; [Subira, Marta; Alonso, Pino; Segalas, Cinto; Real, Eva; Lopez-Sola, Clara; Menchon, Jose M.; Cardoner, Narcis; Soriano-Mas, Carles] Ctr Invest Biomed Red Salud Mental CIBERSAM, Carlos Hlth Inst 3, Barcelona, Spain; [Alonso, Pino; Lopez-Sola, Clara; Menchon, Jose M.; Cardoner, Narcis] Univ Barcelona, Sch Med, Dept Clin Sci, Barcelona, Spain; [Pujol, Jesus] Hosp del Mar, CRC, Magnet Resonance Unit, Barcelona, Spain; [Harrison, Ben J.] Univ Melbourne, Dept Psychiat, Melbourne Neuropsychiat Ctr, Melbourne, Vic, Australia	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Melbourne	Soriano-Mas, C (corresponding author), Bellvitge Univ Hosp, Bellvitge Biomed Res Inst IDIBELL, Dept Psychiat, Barcelona, Spain.	csoriano@idibell.cat	Alonso, Pino/AAI-3439-2020; Harrison, Ben J/I-2940-2014; Cardoner, Narcis/H-8436-2015; Soriano-Mas, Carles/E-4028-2019; Cardoner, Narcis/AAD-5449-2022; Menchon, Jose/A-5242-2009	Soriano-Mas, Carles/0000-0003-4574-6597; Cardoner, Narcis/0000-0001-9633-0888; Segalas, Cinto/0000-0002-0959-0356; Alonso, Pino/0000-0002-5779-9111; Menchon, Jose/0000-0002-6231-6524; Martinez-Zalacain, Ignacio/0000-0002-4036-0284	Carlos III Health Institute [PI09/01331 PI10/01753, PI10/01003, CP10/00604, CIBER-CB06/03/0034, CM11/00077]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) [2009SGR1554]; Bellvitge Biomedical Research Institute (IDIBELL); Spanish Ministry of Education, Culture and Sport [FPU12/01636]; National Health and Medical Research Council of Australia (NHMRC) [628509]	Carlos III Health Institute(Instituto de Salud Carlos III); Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Bellvitge Biomedical Research Institute (IDIBELL); Spanish Ministry of Education, Culture and Sport(Spanish Government); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported in part by the Carlos III Health Institute (PI09/01331 PI10/01753, PI10/01003, CP10/00604, CIBER-CB06/03/0034) and by the Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR; 2009SGR1554). M. S. is funded by the Bellvitge Biomedical Research Institute (IDIBELL). E. R. is supported by a 'Rio Hortega' contract from the Carlos III Health Institute (I. D. CM11/00077). C. L-S. is supported by the Spanish Ministry of Education, Culture and Sport (FPU12/01636). B. H. is supported by a National Health and Medical Research Council of Australia (NHMRC) Clinical Career Development Award (I. D. 628509). C.S-M. is funded by a 'Miguel Servet' contract from the Carlos III Health Institute (CP10/00604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarenga PG, 2012, J PSYCHIATR RES, V46, P1635, DOI 10.1016/j.jpsychires.2012.09.002; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; BAER L, 1994, J CLIN PSYCHIAT, V55, P18; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Belloch A, 2010, J ANXIETY DISORD, V24, P573, DOI 10.1016/j.janxdis.2010.03.017; Besiroglu L, 2006, CNS SPECTRUMS, V11, P179, DOI 10.1017/S1092852900014292; Besiroglu L, 2011, ACTA PSYCHIAT SCAND, V124, P141, DOI 10.1111/j.1600-0447.2011.01726.x; Besiroglu L, 2007, DEPRESS ANXIETY, V24, P461, DOI 10.1002/da.20240; Cardoner N, 2007, NEUROIMAGE, V38, P413, DOI 10.1016/j.neuroimage.2007.07.039; Carmona S, 2005, NEUROSCI LETT, V389, P88, DOI 10.1016/j.neulet.2005.07.020; COHEN AJ, 1992, J CLIN PSYCHIAT, V53, P319; de Mathis MA, 2006, CNS SPECTRUMS, V11, P762, DOI 10.1017/S1092852900014899; Eickhoff SB, 2006, CEREB CORTEX, V16, P268, DOI 10.1093/cercor/bhi106; Ferrao YA, 2012, PSYCHIAT RES, V197, P253, DOI 10.1016/j.psychres.2011.09.017; Fineberg NA, 2010, NEUROPSYCHOPHARMACOL, V35, P591, DOI 10.1038/npp.2009.185; Gilbert AR, 2008, J AFFECT DISORDERS, V109, P117, DOI 10.1016/j.jad.2007.12.223; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Harrison BJ, 2013, BIOL PSYCHIAT, V73, P321, DOI 10.1016/j.biopsych.2012.10.006; Harrison BJ, 2009, ARCH GEN PSYCHIAT, V66, P1189, DOI 10.1001/archgenpsychiatry.2009.152; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Hollander E, 2005, BIOL PSYCHIAT, V58, P226, DOI 10.1016/j.biopsych.2005.03.040; Kashyap H, 2012, J PSYCHIATR RES, V46, P1146, DOI 10.1016/j.jpsychires.2012.04.022; Leckman JE, 2010, DEPRESS ANXIETY, V27, P507, DOI 10.1002/da.20669; Leckman JF, 2003, BRAIN DEV-JPN, V25, pS24, DOI 10.1016/S0387-7604(03)90004-0; Lee HJ, 2010, BEHAV RES THER, V48, P571, DOI 10.1016/j.brat.2010.03.006; Lee HJ, 2009, BEHAV RES THER, V47, P294, DOI 10.1016/j.brat.2009.01.002; Lee HJ, 2005, DEPRESS ANXIETY, V21, P118, DOI 10.1002/da.20063; Lee HJ, 2005, BEHAV RES THER, V43, P999, DOI 10.1016/j.brat.2004.06.017; Lee HJ, 2003, BEHAV RES THER, V41, P11, DOI 10.1016/S0005-7967(01)00101-2; Lochner C, 2010, PSYCHOPATHOLOGY, V43, P389, DOI 10.1159/000321070; Mataix-Cols D, 2006, CURR OPIN PSYCHIATR, V19, P84, DOI 10.1097/01.yco.0000194809.98967.49; Mataix-Cols D, 2004, ARCH GEN PSYCHIAT, V61, P564, DOI 10.1001/archpsyc.61.6.564; Mataix-Cols D, 2005, AM J PSYCHIAT, V162, P228, DOI 10.1176/appi.ajp.162.2.228; Miguel EC, 2005, MOL PSYCHIATR, V10, P258, DOI 10.1038/sj.mp.4001617; Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768; Moreno-Lopez L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049185; Moulding R, 2007, J ANXIETY DISORD, V21, P677, DOI 10.1016/j.janxdis.2006.10.001; Murayama K, 2013, PROG NEURO-PSYCHOPH, V40, P160, DOI 10.1016/j.pnpbp.2012.09.002; Pujol J, 2004, ARCH GEN PSYCHIAT, V61, P720, DOI 10.1001/archpsyc.61.7.720; PURDON C, 1994, BEHAV RES THER, V32, P403, DOI 10.1016/0005-7967(94)90003-5; PURDON C, 1993, BEHAV RES THER, V31, P713, DOI 10.1016/0005-7967(93)90001-B; Radua J, 2009, BRIT J PSYCHIAT, V195, P393, DOI 10.1192/bjp.bp.108.055046; Ramos-Brieva J A, 1986, Actas Luso Esp Neurol Psiquiatr Cienc Afines, V14, P324; Rosario MC, 2009, CNS SPECTRUMS, V14, P315, DOI 10.1017/S1092852900020319; Rosario-Campos MC, 2006, MOL PSYCHIATR, V11, P495, DOI 10.1038/sj.mp.4001798; Rosas HJSY, 2002, ACTAS ESP PSIQUIATRI, V30, P30; Rotge JY, 2009, BIOL PSYCHIAT, V65, P75, DOI 10.1016/j.biopsych.2008.06.019; Roth RM, 2009, EPILEPSY BEHAV, V14, P677, DOI 10.1016/j.yebeh.2009.01.011; Ruge H, 2013, NEUROIMAGE, V68, P162, DOI 10.1016/j.neuroimage.2012.12.003; SANAVIO E, 1988, BEHAV RES THER, V26, P169, DOI 10.1016/0005-7967(88)90116-7; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Soriano-Mas C, 2007, NEUROIMAGE, V35, P1028, DOI 10.1016/j.neuroimage.2007.01.011; Szeszko PR, 2008, AM J PSYCHIAT, V165, P1299, DOI 10.1176/appi.ajp.2008.08010033; van den Heuvel OA, 2009, BRAIN, V132, P853, DOI 10.1093/brain/awn267; Wang ZS, 2011, AM J PSYCHIAT, V168, P1326, DOI 10.1176/appi.ajp.2011.09111692; Whiteside SP, 2004, PSYCHIAT RES-NEUROIM, V132, P69, DOI 10.1016/j.pscychresns.2004.07.001; Williams MT, 2011, DEPRESS ANXIETY, V28, P495, DOI 10.1002/da.20820; Yoo SY, 2008, J KOREAN MED SCI, V23, P24, DOI 10.3346/jkms.2008.23.1.24; Zahn R, 2009, CEREB CORTEX, V19, P276, DOI 10.1093/cercor/bhn080; Zarei M, 2011, BIOL PSYCHIAT, V70, P1083, DOI 10.1016/j.biopsych.2011.06.032	62	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75273	10.1371/journal.pone.0075273	http://dx.doi.org/10.1371/journal.pone.0075273			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098688	gold, Green Published			2022-12-25	WOS:000325423500059
J	Amengual, J; Widjaja-Adhi, MAK; Rodriguez-Santiago, S; Hessel, S; Golczak, M; Palczewski, K; von Lintig, J				Amengual, Jaume; Widjaja-Adhi, M. Airanthi K.; Rodriguez-Santiago, Susana; Hessel, Susanne; Golczak, Marcin; Palczewski, Krzysztof; von Lintig, Johannes			Two Carotenoid Oxygenases Contribute to Mammalian Provitamin A Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carotenoid; Enzymes; Liver; Metabolism; Vitamin A	LECITHIN-RETINOL ACYLTRANSFERASE; BETA-CAROTENE; VITAMIN-A; IN-VITRO; ENZYMATIC CLEAVAGE; OXIDATIVE CLEAVAGE; STRUCTURAL BASIS; CELLULAR UPTAKE; ACID; IDENTIFICATION	Background: Mammalian genomes encode two carotenoid oxygenases, but their contributions to vitamin A homeostasis remain undefined. Results: Mammals employ symmetric and eccentric cleaving carotenoid oxygenases to convert different provitamin A carotenoids to vitamin A. Conclusion: Both carotenoid oxygenases contribute to vitamin A production. Significance: Carotenoids are the major source for vitamin A in the human diet. Mammalian genomes encode two provitamin A-converting enzymes as follows: the -carotene-15,15-oxygenase (BCO1) and the -carotene-9,10-oxygenase (BCO2). Symmetric cleavage by BCO1 yields retinoids (-15-apocarotenoids, C-20), whereas eccentric cleavage by BCO2 produces long-chain (>C-20) apocarotenoids. Here, we used genetic and biochemical approaches to clarify the contribution of these enzymes to provitamin A metabolism. We subjected wild type, Bco1(-/-), Bco2(-/-), and Bco1(-/-)Bco2(-/-) double knock-out mice to a controlled diet providing -carotene as the sole source for apocarotenoid production. This study revealed that BCO1 is critical for retinoid homeostasis. Genetic disruption of BCO1 resulted in -carotene accumulation and vitamin A deficiency accompanied by a BCO2-dependent production of minor amounts of -apo-10-carotenol (APO10ol). We found that APO10ol can be esterified and transported by the same proteins as vitamin A but with a lower affinity and slower reaction kinetics. In wild type mice, APO10ol was converted to retinoids by BCO1. We also show that a stepwise cleavage by BCO2 and BCO1 with APO10ol as an intermediate could provide a mechanism to tailor asymmetric carotenoids such as -cryptoxanthin for vitamin A production. In conclusion, our study provides evidence that mammals employ both carotenoid oxygenases to synthesize retinoids from provitamin A carotenoids.	[Amengual, Jaume; Widjaja-Adhi, M. Airanthi K.; Rodriguez-Santiago, Susana; Hessel, Susanne; Golczak, Marcin; Palczewski, Krzysztof; von Lintig, Johannes] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University	von Lintig, J (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol W341, 10900 Euclid Ave, Cleveland, OH 44106 USA.	johannes.vonlintig@case.edu		von Lintig, Johannes/0000-0002-2079-2143; Widjaja-Adhi, Made Airanthi K./0000-0002-0589-2605	National Institutes of Health from NEI [RO1EY019641, RO1EY020551]; NATIONAL EYE INSTITUTE [R01EY019641, R01EY020551] Funding Source: NIH RePORTER	National Institutes of Health from NEI; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1EY019641 and RO1EY020551 from the NEI.	Amengual J, 2012, J BIOL CHEM, V287, P24216, DOI 10.1074/jbc.M112.353979; Amengual J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020644; Amengual J, 2011, FASEB J, V25, P948, DOI 10.1096/fj.10-173906; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; D'Ambrosio DN, 2011, NUTRIENTS, V3, P63, DOI 10.3390/nu3010063; Eroglu A, 2013, J LIPID RES, V54, P1719, DOI 10.1194/jlr.R039537; Eroglu A, 2012, J BIOL CHEM, V287, P15886, DOI 10.1074/jbc.M111.325142; Eroglu A, 2010, ARCH BIOCHEM BIOPHYS, V504, P11, DOI 10.1016/j.abb.2010.07.025; Fleshman MK, 2011, J AGR FOOD CHEM, V59, P4448, DOI 10.1021/jf200416a; Golczak M, 2008, J BIOL CHEM, V283, P9543, DOI 10.1074/jbc.M708982200; Golczak M, 2012, J BIOL CHEM, V287, P23790, DOI 10.1074/jbc.M112.361550; Golczak M, 2010, J BIOL CHEM, V285, P29217, DOI 10.1074/jbc.M110.152314; GOODMAN DS, 1965, SCIENCE, V149, P879, DOI 10.1126/science.149.3686.879; GRISCAVAGE JM, 1995, BIOCHEM BIOPH RES CO, V215, P721, DOI 10.1006/bbrc.1995.2523; Grune T., 2010, JOUNRAL NUTR, V140, P2268; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; HANDELMAN GJ, 1991, FREE RADICAL BIO MED, V10, P427, DOI 10.1016/0891-5849(91)90051-4; Hessel S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706763200; Hu KQ, 2006, J BIOL CHEM, V281, P19327, DOI 10.1074/jbc.M512095200; Isken A, 2008, CELL METAB, V7, P258, DOI 10.1016/j.cmet.2008.01.009; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kiefer C, 2001, J BIOL CHEM, V276, P14110, DOI 10.1074/jbc.M011510200; Kowatz T., 2013, ARCH BIOCH BIOPHYS, DOI 10.1016/j.abb.2013.05.007; Lietz G, 2010, ARCH BIOCHEM BIOPHYS, V502, P8, DOI 10.1016/j.abb.2010.06.032; Lindqvist A, 2002, J BIOL CHEM, V277, P23942, DOI 10.1074/jbc.M202756200; Liu LM, 2008, BIOCHEM PHARMACOL, V75, P2316, DOI 10.1016/j.bcp.2008.03.012; Lobo GP, 2012, DEVELOPMENT, V139, P2966, DOI 10.1242/dev.079632; Mein JR, 2011, ARCH BIOCHEM BIOPHYS, V506, P109, DOI 10.1016/j.abb.2010.11.005; Messing SAJ, 2010, PLANT CELL, V22, P2970, DOI 10.1105/tpc.110.074815; Noy N, 2010, ANNU REV NUTR, V30, P201, DOI 10.1146/annurev.nutr.28.061807.155509; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; Oberhauser V, 2008, P NATL ACAD SCI USA, V105, P19000, DOI 10.1073/pnas.0807805105; OLSON JA, 1965, P NATL ACAD SCI USA, V54, P1364, DOI 10.1073/pnas.54.5.1364; Paik J, 2001, J BIOL CHEM, V276, P32160, DOI 10.1074/jbc.M010086200; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Redmond TM, 2001, J BIOL CHEM, V276, P6560, DOI 10.1074/jbc.M009030200; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; SHARMA RV, 1976, BIOCHEM J, V158, P377, DOI 10.1042/bj1580377; SHARMA RV, 1977, BIOCHIM BIOPHYS ACTA, V486, P183, DOI 10.1016/0005-2760(77)90083-2; Shmarakov I, 2010, ARCH BIOCHEM BIOPHYS, V504, P3, DOI 10.1016/j.abb.2010.05.010; Sommer A, 2012, AM J CLIN NUTR, V96, p1204S, DOI 10.3945/ajcn.112.034868; TANG GW, 1991, BIOCHEMISTRY-US, V30, P9829, DOI 10.1021/bi00105a003; van Helden YGJ, 2010, CELL MOL LIFE SCI, V67, P2039, DOI 10.1007/s00018-010-0341-7; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; von Lintig J, 2010, ANNU REV NUTR, V30, P35, DOI 10.1146/annurev-nutr-080508-141027; von Lintig J, 2010, TRENDS BIOCHEM SCI, V35, P400, DOI 10.1016/j.tibs.2010.01.005; Wang XD, 1996, J BIOL CHEM, V271, P26490, DOI 10.1074/jbc.271.43.26490; WANG XD, 1991, ARCH BIOCHEM BIOPHYS, V285, P8, DOI 10.1016/0003-9861(91)90322-A; WOLF G, 1995, NUTR REV, V53, P134, DOI 10.1111/j.1753-4887.1995.tb01537.x; Wyss A, 2000, BIOCHEM BIOPH RES CO, V271, P334, DOI 10.1006/bbrc.2000.2619	54	113	116	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34081	34096		10.1074/jbc.M113.501049	http://dx.doi.org/10.1074/jbc.M113.501049			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24106281	Green Published, hybrid			2022-12-25	WOS:000327250200051
J	Shekhawat, UKS; Ganapathi, TR				Shekhawat, Upendra K. S.; Ganapathi, Thumballi R.			MusaWRKY71 Overexpression in Banana Plants Leads to Altered Abiotic and Biotic Stress Responses	PLOS ONE			English	Article							WRKY TRANSCRIPTION FACTORS; DISEASE RESISTANCE; SALICYLIC-ACID; ABSCISIC-ACID; GENE; ARABIDOPSIS; TOLERANCE; DEFENSE; RECOGNIZES; EXPRESSION	WRKY transcription factors are specifically involved in the transcriptional reprogramming following incidence of abiotic or biotic stress on plants. We have previously documented a novel WRKY gene from banana, MusaWRKY71, which was inducible in response to a wide array of abiotic or biotic stress stimuli. The present work details the effects of MusaWRKY71 overexpression in transgenic banana plants. Stable integration and overexpression of MusaWRKY71 in transgenic banana plants was proved by Southern blot analysis and quantitative real time PCR. Transgenic banana plants overexpressing MusaWRKY71 displayed enhanced tolerance towards oxidative and salt stress as indicated by better photosynthesis efficiency (Fv/Fm) and lower membrane damage of the assayed leaves. Further, differential regulation of putative downstream genes of MusaWRKY71 was investigated using real-time RT-PCR expression analysis. Out of a total of 122 genes belonging to WRKY, pathogenesis-related (PR) protein genes, non-expressor of pathogenesis-related genes 1 (NPR1) and chitinase families analyzed, 10 genes (six belonging to WRKY family, three belonging to PR proteins family and one belonging to chitinase family) showed significant differential regulation in MusaWRKY71 overexpressing lines. These results indicate that MusaWRKY71 is an important constituent in the transcriptional reprogramming involved in diverse stress responses in banana.	[Shekhawat, Upendra K. S.; Ganapathi, Thumballi R.] Bhabha Atom Res Ctr, Plant Cell Culture Technol Sect, Nucl Agr & Biotechnol Div, Bombay 400085, Maharashtra, India	Bhabha Atomic Research Center (BARC)	Ganapathi, TR (corresponding author), Bhabha Atom Res Ctr, Plant Cell Culture Technol Sect, Nucl Agr & Biotechnol Div, Bombay 400085, Maharashtra, India.	trgana@barc.gov.in		Shekhawat, Upendra/0000-0002-4012-2614				Bapat VA, 2010, BIOTECHNOL ADV, V28, P94, DOI 10.1016/j.biotechadv.2009.10.002; Chen L, 2011, PLANTA, V234, P377, DOI 10.1007/s00425-011-1410-3; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Dang FF, 2013, PLANT CELL ENVIRON, V36, P757, DOI 10.1111/pce.12011; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Eulgem T, 2006, PLOS PATHOG, V2, P1028, DOI 10.1371/journal.ppat.0020126; Ganapathi TR, 2001, PLANT CELL REP, V20, P157, DOI 10.1007/s002990000287; ISHIGURO S, 1994, MOL GEN GENET, V244, P563, DOI 10.1007/BF00282746; Ishihama N, 2012, CURR OPIN PLANT BIOL, V15, P431, DOI 10.1016/j.pbi.2012.02.003; Li H, 2013, PLANT GROWTH REGUL, V70, P207, DOI 10.1007/s10725-013-9792-9; Liu XQ, 2007, J PLANT PHYSIOL, V164, P969, DOI 10.1016/j.jplph.2006.07.006; Marchive C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054185; Mzid R, 2007, PHYSIOL PLANTARUM, V131, P434, DOI 10.1111/j.1399-3054.2007.00975.x; Niu CF, 2012, PLANT CELL ENVIRON, V35, P1156, DOI 10.1111/j.1365-3040.2012.02480.x; Oh SK, 2008, NEW PHYTOL, V177, P977, DOI 10.1111/j.1469-8137.2007.02310.x; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Ren XZ, 2010, PLANT J, V63, P417, DOI 10.1111/j.1365-313X.2010.04248.x; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Rushton PJ, 1998, CURR OPIN PLANT BIOL, V1, P311, DOI 10.1016/1369-5266(88)80052-9; Shekhawat UKS, 2011, PLANTA, V234, P915, DOI 10.1007/s00425-011-1455-3; Shekhawat UKS, 2011, MOL BIOL REP, V38, P4023, DOI 10.1007/s11033-010-0521-4; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Song Y, 2010, J BIOSCIENCES, V35, P459, DOI 10.1007/s12038-010-0051-1; Sreedharan S, 2012, PLANT MOL BIOL, V80, P503, DOI 10.1007/s11103-012-9964-4; van Verk MC, 2008, PLANT PHYSIOL, V146, P1983, DOI 10.1104/pp.107.112789; Wang HH, 2007, PLANT MOL BIOL, V65, P799, DOI 10.1007/s11103-007-9244-x; Yang PZ, 1999, PLANT J, V18, P141, DOI 10.1046/j.1365-313X.1999.00437.x; Yu DQ, 2001, PLANT CELL, V13, P1527, DOI 10.1105/tpc.13.7.1527; Yu FF, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-144	30	37	41	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75506	10.1371/journal.pone.0075506	http://dx.doi.org/10.1371/journal.pone.0075506			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116051	Green Submitted, Green Published, gold			2022-12-25	WOS:000325552200025
J	Yoon, JH; Kim, SK; Choi, HJ; Choi, SI; Cha, SY; Koh, SB; Kang, HT; Ahn, SV				Yoon, Jin-Ha; Kim, Sung-Kyung; Choi, Ho-June; Choi, Soo-In; Cha, So-Youn; Koh, Sang-Baek; Kang, Hee-Taik; Ahn, Song Vogue			Adiponectin Provides Additional Information to Conventional Cardiovascular Risk Factors for Assessing the Risk of Atherosclerosis in Both Genders	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; HOMEOSTASIS MODEL ASSESSMENT; METABOLIC SYNDROME; PLASMA ADIPONECTIN; INSULIN-RESISTANCE; ENDOTHELIAL-CELLS; ARTERY ATHEROSCLEROSIS; SERUM ADIPONECTIN; ENDOCRINE ORGAN; ADIPOSE-TISSUE	Background: This study evaluated the relation between adiponectin and atherosclerosis in both genders, and investigated whether adiponectin provides useful additional information for assessing the risk of atherosclerosis. Methods: We measured serum adiponectin levels and other cardiovascular risk factors in 1033 subjects (454 men, 579 women) from the Korean Genomic Rural Cohort study. Carotid intima-media-thickness (CIMT) was used as measure of atherosclerosis. Odds ratios (ORs) with 95% confidence intervals (95% CI) were calculated using multiple logistic regression, and receiver operating characteristic curves (ROC), the category-free net reclassification improvement (NRI) and integrated discrimination improvement (IDI) were calculated. Results: After adjustment for conventional cardiovascular risk factors, such as age, waist circumference, smoking history, low-density and high-density lipoprotein cholesterol, triglycerides, systolic blood pressure and insulin resistance, the ORs (95% CI) of the third tertile adiponectin group were 0.42 (0.25-0.72) in men and 0.47 (0.29-0.75) in women. The area under the curve (AUC) on the ROC analysis increased significantly by 0.025 in men and 0.022 in women when adiponectin was added to the logistic model of conventional cardiovascular risk factors (AUC in men: 0.655 to 0.680, p = 0.038; AUC in women: 0.654 to 0.676, p = 0.041). The NRI was 0.32 (95% CI: 0.13-0.50, p < 0.001), and the IDI was 0.03 (95% CI: 0.01-0.04, p < 0.001) for men. For women, the category-free NRI was 0.18 (95% CI: 0.02-0.34, p = 0.031) and the IDI was 0.003 (95% CI: -0.002-0.008, p = 0.189). Conclusion: Adiponectin and atherosclerosis were significantly related in both genders, and these relationships were independent of conventional cardiovascular risk factors. Furthermore, adiponectin provided additional information to conventional cardiovascular risk factors regarding the risk of atherosclerosis.	[Yoon, Jin-Ha; Kim, Sung-Kyung; Choi, Ho-June; Choi, Soo-In; Cha, So-Youn] Yonsei Univ, Wonju Coll Med, Inst Occupat & Environm Med, Seoul 120749, South Korea; [Yoon, Jin-Ha; Kim, Sung-Kyung; Koh, Sang-Baek; Ahn, Song Vogue] Yonsei Univ, Wonju Coll Med, Dept Prevent Med, Seoul 120749, South Korea; [Ahn, Song Vogue] Yonsei Univ, Wonju Coll Med, Inst Genom Cohort, Seoul 120749, South Korea; [Yoon, Jin-Ha] Yonsei Univ, Grad Sch Publ Hlth, Seoul 120749, South Korea; [Kang, Hee-Taik] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Family Med, Seoul, South Korea; [Yoon, Jin-Ha; Kang, Hee-Taik] Yonsei Univ, Grad Sch, Dept Med, Seoul 120749, South Korea	Yonsei University; Yonsei University; Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University	Kang, HT (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Family Med, Seoul, South Korea.	KANGHT@yuhs.ac; dodge@yonsei.ac.kr	Ahn, Song Vogue/AAK-2900-2021	Kim, Sung-Kyung/0000-0002-2742-6410; Kang, Hee-Taik/0000-0001-8048-6247	Korea Centers for Disease Control and Prevention [2005-E71013-00, 2006-E71002-00, 2007-E71013-00, 2008-E71004-00, 2009-E71006-00]	Korea Centers for Disease Control and Prevention	This study was supported in part by a grant from the Korea Centers for Disease Control and Prevention (2005-E71013-00, 2006-E71002-00, 2007-E71013-00, 2008-E71004-00, 2009-E71006-00). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2006, OBESITY, V14, P242, DOI 10.1038/oby.2006.317; Ahn MS, 2011, MOL CELL TOXICOL, V7, P33, DOI 10.1007/s13273-011-0005-1; Bottner A, 2004, J CLIN ENDOCR METAB, V89, P4053, DOI 10.1210/jc.2004-0303; Dullaart RPF, 2010, ATHEROSCLEROSIS, V211, P393, DOI 10.1016/j.atherosclerosis.2010.03.024; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fortuno A, 2003, J PHYSIOL BIOCHEM, V59, P51, DOI 10.1007/BF03179868; Goldstein BJ, 2004, J CLIN ENDOCR METAB, V89, P2563, DOI 10.1210/jc.2004-0518; Hanley AJG, 2002, DIABETES CARE, V25, P1177, DOI 10.2337/diacare.25.7.1177; Iglseder B, 2005, STROKE, V36, P2577, DOI 10.1161/01.STR.0000190834.00284.fd; Karakas M, 2010, ATHEROSCLEROSIS, V209, P220, DOI 10.1016/j.atherosclerosis.2009.08.020; Kotani K, 2008, STROKE, V39, pE32, DOI 10.1161/STROKEAHA.107.505669; Lakoski SG, 2005, AM HEART J, V150, P907, DOI 10.1016/j.ahj.2004.11.025; Lindberg S, 2013, AM J CARDIOL, V111, P1139, DOI 10.1016/j.amjcard.2012.12.043; Mahadev K, 2008, CARDIOVASC RES, V78, P376, DOI 10.1093/cvr/cvn034; Motoshima H, 2004, BIOCHEM BIOPH RES CO, V315, P264, DOI 10.1016/j.bbrc.2004.01.049; Nilsson PM, 2006, ARTERIOSCL THROM VAS, V26, P2758, DOI 10.1161/01.ATV.0000249638.01416.4b; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Ouedraogo R, 2007, J CLIN INVEST, V117, P1718, DOI 10.1172/JCI29623; Ouedraogo R, 2006, DIABETES, V55, P1840, DOI 10.2337/db05-1174; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Pitt B, 2000, CIRCULATION, V102, P1503, DOI 10.1161/01.CIR.102.13.1503; Seftel Allen D, 2005, J Urol, V174, P1045; Seino Y, 2009, METABOLISM, V58, P355, DOI 10.1016/j.metabol.2008.10.008; Shibata R, 2012, CURR MED CHEM, V19, P5459, DOI 10.2174/092986712803833164; Shimabukuro M, 2003, J CLIN ENDOCR METAB, V88, P3236, DOI 10.1210/jc.2002-021883; Wang JH, 2010, INTERNAL MED, V49, P739, DOI 10.2169/internalmedicine.49.3093; Yoon JH, 2011, CLIN CHIM ACTA, V412, P2199, DOI 10.1016/j.cca.2011.08.003; Yoon JH, 2011, ANN HUM BIOL, V38, P640, DOI 10.3109/03014460.2011.598188	28	15	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75535	10.1371/journal.pone.0075535	http://dx.doi.org/10.1371/journal.pone.0075535			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116054	Green Published, gold, Green Submitted			2022-12-25	WOS:000325552200027
J	del Amo, EM; Ghemtio, L; Xhaard, H; Yliperttula, M; Urtti, A; Kidron, H				del Amo, Eva M.; Ghemtio, Leo; Xhaard, Henri; Yliperttula, Marjo; Urtti, Arto; Kidron, Heidi			Applying Linear and Non-Linear Methods for Parallel Prediction of Volume of Distribution and Fraction of Unbound Drug	PLOS ONE			English	Article							PHARMACOKINETIC PARAMETERS; ORAL BIOAVAILABILITY; MODELS; HUMANS	Volume of distribution and fraction unbound are two key parameters in pharmacokinetics. The fraction unbound describes the portion of free drug in plasma that may extravasate, while volume of distribution describes the tissue access and binding of a drug. Reliable in silico predictions of these pharmacokinetic parameters would benefit the early stages of drug discovery, as experimental measuring is not feasible for screening purposes. We have applied linear and nonlinear multivariate approaches to predict these parameters: linear partial least square regression and non-linear recursive partitioning classification. The volume of distribution and fraction of unbound drug in plasma are predicted in parallel within the model, since the two are expected to be affected by similar physicochemical drug properties. Predictive models for both parameters were built and the performance of the linear models compared to models included in the commercial software Volsurf+. Our models performed better in predicting the unbound fraction (Q(2) 0.54 for test set compared to 0.38 with Volsurf+ model), but prediction accuracy of the volume of distribution was comparable to the Volsurf+ model (Q(2) of 0.70 for test set compared to 0.71 with Volsurf+ model). The nonlinear classification models were able to identify compounds with a high or low volume of distribution (sensitivity 0.81 and 0.71, respectively, for test set), while classification of fraction unbound was less successful. The interrelationship between the volume of distribution and fraction unbound is investigated and described in terms of physicochemical descriptors. Lipophilicity and solubility descriptors were found to have a high influence on both volume of distribution and fraction unbound, but with an inverse relationship.	[del Amo, Eva M.; Ghemtio, Leo; Xhaard, Henri; Urtti, Arto; Kidron, Heidi] Univ Helsinki, Ctr Drug Res, Fac Pharm, Helsinki, Finland; [Yliperttula, Marjo] Univ Helsinki, Fac Pharm, Div Biopharmaceut & Pharmacokinet, Helsinki, Finland	University of Helsinki; University of Helsinki	Kidron, H (corresponding author), Univ Helsinki, Ctr Drug Res, Fac Pharm, Helsinki, Finland.	heidi.kidron@helsinki.fi	Kidron, Heidi/A-5826-2015; del Amo, Eva María/AAX-1089-2020	Kidron, Heidi/0000-0001-6427-8042; del Amo, Eva María/0000-0002-5705-4515; ghemtio, leo/0000-0003-3591-5676	Graduate School in Pharmaceutical Research; Academy of Finland; Finnish Cultural Foundation; OrionPharma Ltd.; Biocenter Finland	Graduate School in Pharmaceutical Research; Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); OrionPharma Ltd.; Biocenter Finland	This work has been supported by the Graduate School in Pharmaceutical Research, the Academy of Finland, Biocenter Finland, the Finnish Cultural Foundation, and OrionPharma Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ACDLABS SOFTW; [Anonymous], SYBYL 8 0; [Anonymous], 2012, SUIT 2012 MAESTR 201; [Anonymous], ACD DICT; Balakin Konstantin V, 2005, Curr Drug Discov Technol, V2, P99, DOI 10.2174/1570163054064666; Berellini G, 2009, J MED CHEM, V52, P4488, DOI 10.1021/jm9004658; Chen C, 2004, 666 U BERK DEP STAT; Cruciani C, 2000, J MOL STRUC-THEOCHEM, V503, P17, DOI 10.1016/S0166-1280(99)00360-7; Demir-Kavuk O, 2011, J COMPUT AID MOL DES, V25, P1121, DOI 10.1007/s10822-011-9496-z; Fatemi MH, 2011, J SERB CHEM SOC, V76, P1003, DOI 10.2298/JSC101104091F; Gleeson MP, 2007, J MED CHEM, V50, P101, DOI 10.1021/jm060981b; Gleeson MP, 2006, J MED CHEM, V49, P1953, DOI 10.1021/jm0510070; Gombar VK, 2013, J CHEM INF MODEL; Hand DJ, 2001, MACH LEARN, V45, P171, DOI 10.1023/A:1010920819831; HIRONO S, 1994, BIOL PHARM BULL, V17, P686; Karalis V, 2003, EUR J PHARM SCI, V20, P115, DOI 10.1016/S0928-0987(03)00177-5; Karalis V, 2002, PHARM RES-DORDR, V19, P1827, DOI 10.1023/A:1021489323828; King AE, 2006, TRENDS PHARMACOL SCI, V27, P416, DOI 10.1016/j.tips.2006.06.004; LIM VS, 1991, AM J KIDNEY DIS, V18, P34; Lombardo F, 2006, J MED CHEM, V49, P2262, DOI 10.1021/jm050200r; Lullmann H, 2005, COLOR ATLAS PHARM, P402; Ma CY, 2008, J PHARMACEUT BIOMED, V47, P677, DOI 10.1016/j.jpba.2008.03.023; Moda TL, 2007, BIOORGAN MED CHEM, V15, P7738, DOI 10.1016/j.bmc.2007.08.060; MOE, 2008, MOE MOL OP ENV; Ng C, 2004, J PHARM SCI-US, V93, P2535, DOI 10.1002/jps.20117; Obach RS, 2008, DRUG METAB DISPOS, V36, P1385, DOI 10.1124/dmd.108.020479; Paul Y, 2010, ASIAN J CHEM, V22, P4880; Rowland M, 2011, CLIN PHARMACOKINET, P864; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; TETT SE, 1988, BRIT J CLIN PHARMACO, V26, P303, DOI 10.1111/j.1365-2125.1988.tb05281.x; Thompson AJ, 2011, MOL PHARMACOL, V80, P183, DOI 10.1124/mol.111.071415; Tropsha A, 2003, QSAR COMB SCI, V22, P69, DOI 10.1002/qsar.200390007; Turner JV, 2004, INT J PHARMACEUT, V270, P209, DOI 10.1016/j.ijpharm.2003.10.011; Watts NB, 2010, J CLIN ENDOCR METAB, V95, P1555, DOI 10.1210/jc.2009-1947; WHITE NJ, 1994, T ROY SOC TROP MED H, V88, P41, DOI 10.1016/0035-9203(94)90471-5; Zhang SX, 2006, J CHEM INF MODEL, V46, P1984, DOI 10.1021/ci060132x; Zhivkova Z, 2012, J PHARM SCI-US, V101, P1253, DOI 10.1002/jps.22819	37	12	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e74758	10.1371/journal.pone.0074758	http://dx.doi.org/10.1371/journal.pone.0074758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116008	Green Published, gold			2022-12-25	WOS:000325501300011
J	Kobayashi, H; Kumagai, K; Eguchi, T; Shigematsu, H; Kitaura, K; Kawano, M; Horikawa, T; Suzuki, S; Matsutani, T; Ogasawara, K; Hamada, Y; Suzuki, R				Kobayashi, Hiroshi; Kumagai, Kenichi; Eguchi, Takanori; Shigematsu, Hiroaki; Kitaura, Kazutaka; Kawano, Mitsuko; Horikawa, Tatsuya; Suzuki, Satsuki; Matsutani, Takaji; Ogasawara, Kouetsu; Hamada, Yoshiki; Suzuki, Ryuji			Characterization of T Cell Receptors of Th1 Cells Infiltrating Inflamed Skin of a Novel Murine Model of Palladium-Induced Metal Allergy	PLOS ONE			English	Article							CONTACT-DERMATITIS; NICKEL; RECOGNITION; REGION; USAGE; HYPERSENSITIVITY; REPERTOIRES; REACTIVITY; CD4(+); VIRUS	Metal allergy is categorized as a delayed-type hypersensitivity reaction, and is characterized by the recruitment of lymphocytes into sites of allergic inflammation. Because of the unavailability of suitable animal models for metal allergy, the role of T cells in the pathogenesis of metal allergy has not been explored. Thus, we developed a novel mouse model for metal allergy associated with infiltration of T cells by multiple injections of palladium (Pd) plus lipopolysaccharide into the footpad. Using this model, we characterized footpad-infiltrating T cells in terms of phenotypic markers, T cell receptor (TCR) repertoires and cytokine expression. CD3+ CD4+ T cells accumulated in the allergic footpads 7 days after Pd challenge. The expression levels of CD25, interleukin-2, interferon-gamma and tumor necrosis factor, but not interleukin-4 and interleukin-5, increased in the footpads after challenge, suggesting CD4+ T helper 1 (Th1) cells locally expanded in response to Pd. Infiltrated T cells in the footpads frequently expressed AV18-1 and BV8-2 T cell receptor (TCR) chains compared with T cells in the lymph nodes and exhibited oligoclonality. T-cell clones identified from Pd-allergic mouse footpads shared identical CDR3 sequences containing AV18-1 and BV8-2. These results suggest that TCR AV18-1 and BV8-2 play dominant and critical parts in the antigen specificity of Pd-specific Th1 cells.	[Kobayashi, Hiroshi; Kumagai, Kenichi; Eguchi, Takanori; Shigematsu, Hiroaki; Hamada, Yoshiki] Tsurumi Univ, Sch Dent Med, Dept Oral & Maxillofacial Surg, Yokohama, Kanagawa, Japan; [Kobayashi, Hiroshi; Kumagai, Kenichi; Eguchi, Takanori; Shigematsu, Hiroaki; Kitaura, Kazutaka; Matsutani, Takaji; Suzuki, Ryuji] Natl Hosp Org, Dept Rheumatol & Clin Immunol, Clin Res Ctr Rheumatol & Allergy, Sagamihara Natl Hosp, Sagamihara, Kanagawa, Japan; [Kobayashi, Hiroshi] Nagano Matsushiro Gen Hosp, Dept Oral & Maxillofacial Surg, Nagano, Japan; [Eguchi, Takanori] Toshiba Rinkan Hosp, Dept Oral & Maxillofacial Surg, Sagamihara, Kanagawa, Japan; [Kawano, Mitsuko; Ogasawara, Kouetsu] Tohoku Univ, Dept Immunobiol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Horikawa, Tatsuya] Nishi Kobe Med Ctr, Dept Dermatol, Kobe, Hyogo, Japan; [Suzuki, Satsuki] Nippon Dent Univ Tokyo, Sect Biol Sci, Res Ctr Odontol, Tokyo, Japan	Tsurumi University; Toshiba Corporation; Tohoku University; Kobe City Medical Center General Hospital; Nippon Dental University	Suzuki, R (corresponding author), Natl Hosp Org, Dept Rheumatol & Clin Immunol, Clin Res Ctr Rheumatol & Allergy, Sagamihara Natl Hosp, Sagamihara, Kanagawa, Japan.	r-suzuki@sagamihara-hosp.gr.jp	Suzuki, Satsuki/ABE-1283-2020; Ogasawara, Kouetsu/G-9892-2011	Eguchi, Takanori/0000-0003-4608-1347	Japan Society for the Promotion of Science (JSPS) KAKENHI [23593004, 23790352]; Ministry of Health, Labour and Welfare of Japan [H22-meneki-ippan-004]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 23593004 (H.Y. K. K. and S. S.) and 23790352(M. K.), and by Grants-in-Aid for Scientific Research from the Ministry of Health, Labour and Welfare of Japan H22-meneki-ippan-004 (K.O. and R. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara H, 1998, J VIROL, V72, P8032, DOI 10.1128/JVI.72.10.8032-8036.1998; Budinger L, 2001, J IMMUNOL, V167, P6038, DOI 10.4049/jimmunol.167.10.6038; Faurschou A, 2011, CONTACT DERMATITIS, V64, P185, DOI 10.1111/j.1600-0536.2011.01878.x; Gamerdinger K, 2003, J EXP MED, V197, P1345, DOI 10.1084/jem.20030121; Hashizume H, 2008, J IMMUNOL, V181, P8096, DOI 10.4049/jimmunol.181.11.8096; Hosoki M, 2009, BIO-MED MATER ENG, V19, P53, DOI 10.3233/BME-2009-0563; Ishihara K, 2009, INT ARCH ALLERGY IMM, V149, P57, DOI 10.1159/000210655; Kim JY, 2009, EXP MOL MED, V41, P288, DOI 10.3858/emm.2009.41.4.032; Kitaura K, 2011, J IMMUNOL, V187, P3919, DOI 10.4049/jimmunol.1100442; Kumagai K, 2010, ORAL SURG ORAL MED O, V110, P341, DOI 10.1016/j.tripleo.2010.03.030; Matsutani T, 1997, HUM IMMUNOL, V56, P57, DOI 10.1016/S0198-8859(97)00102-X; Minang JT, 2006, CLIN EXP IMMUNOL, V146, P417, DOI 10.1111/j.1365-2249.2006.03226.x; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Niiyama S, 2010, INT ARCH ALLERGY IMM, V153, P303, DOI 10.1159/000314372; Nikhil V, 2001, J CLIN DENT, V2, P94; Pennino D, 2010, J IMMUNOL, V184, P4880, DOI 10.4049/jimmunol.0901767; Raap U, 2009, CONTACT DERMATITIS, V60, P339, DOI 10.1111/j.1600-0536.2009.01524.x; Sato N, 2007, CLIN EXP ALLERGY, V37, P743, DOI 10.1111/j.1365-2222.2007.02705.x; Silvennoinen-Kassinen S, 1998, SCAND J IMMUNOL, V48, P99, DOI 10.1046/j.1365-3083.1998.00367.x; Takayama Kaoru, 2012, Arerugi, V61, P175; Thierse HJ, 2005, TOXICOLOGY, V209, P101, DOI 10.1016/j.tox.2004.12.015; TSURUTA Y, 1993, J IMMUNOL METHODS, V161, P7, DOI 10.1016/0022-1759(93)90193-B; Vollmer J, 1997, EUR J IMMUNOL, V27, P1865, DOI 10.1002/eji.1830270808; Vollmer J, 1999, J IMMUNOL, V163, P2723; Wataha JC, 2010, EXPERT REV MED DEVIC, V7, P489, DOI 10.1586/ERD.10.25; Yoshida R, 2000, IMMUNOGENETICS, V52, P35, DOI 10.1007/s002510000248	26	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76385	10.1371/journal.pone.0076385	http://dx.doi.org/10.1371/journal.pone.0076385			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098486	gold, Green Submitted, Green Published			2022-12-25	WOS:000325483600041
J	Fahrbach, KM; Malykhina, O; Stieh, DJ; Hope, TJ				Fahrbach, Kelly M.; Malykhina, Olga; Stieh, Daniel J.; Hope, Thomas J.			Differential Binding of IgG and IgA to Mucus of the Female Reproductive Tract	PLOS ONE			English	Article							HUMAN CERVICAL-MUCUS; HUMAN ENDOCERVIX; MUCOSAL BARRIER; MUCIN; EXPRESSION; PROTEIN; CELLS; IMMUNOGLOBULINS; IDENTIFICATION; ANTIBODIES	Cells of the endocervix are responsible for the secretion of mucins, which provide an additional layer of protection to the female reproductive tract (FRT). This barrier is likely fortified with IgA as has previously been shown in the gastrointestinal tract and lungs of mice. Mucus associated IgA can facilitate clearance of bacteria. While a similar function for IgG has been proposed, an association with mucus has not yet been demonstrated. Here we find that IgA and IgG are differentially associated with the different types of mucus of the FRT. We observed that while both IgA and IgG are stably associated with cervical mucus, only IgG is associated with cervicovaginal mucus. These findings reveal that antibodies can bind tightly to mucus, where they can play a significant role in the fortification of the mucus barriers of the FRT. It may be possible to harness this interaction in the development of vaccines designed to protect the FRT mucosal barriers from sexually transmitted diseases such as HIV.	[Fahrbach, Kelly M.; Malykhina, Olga; Stieh, Daniel J.; Hope, Thomas J.] Northwestern Univ, Dept Cell & Mol Biol, Northwestern Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Hope, TJ (corresponding author), Northwestern Univ, Dept Cell & Mol Biol, Northwestern Feinberg Sch Med, Chicago, IL 60611 USA.	thope@northwestern.edu			CAVD Global Health Grant [OPP1031734]; NIH [NIH R21 AI094584, NIH P01 AI082971]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094584, P01AI082971, R33AI094584] Funding Source: NIH RePORTER	CAVD Global Health Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by CAVD Global Health Grant OPP1031734, NIH grants Cervical/Vaginal Mucus and Microbicides NIH R21 AI094584, and Rush NIH P01 AI082971. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersch-Bjorkman Y, 2007, MOL CELL PROTEOMICS, V6, P708, DOI 10.1074/mcp.M600439-MCP200; AUDIE JP, 1995, HUM REPROD, V10, P98, DOI 10.1093/humrep/10.1.98; BARROS C, 1985, GAMETE RES, V12, P85, DOI 10.1002/mrd.1120120110; BIESBROCK AR, 1991, INFECT IMMUN, V59, P3492, DOI 10.1128/IAI.59.10.3492-3497.1991; Bonilla-Musoles F, 1983, Clin Exp Obstet Gynecol, V10, P151; BRONSON RA, 1987, FERTIL STERIL, V47, P985; Cohen M, 2012, JOVE-J VIS EXP, DOI 10.3791/3928; DAUNTER B, 1976, BRIT J OBSTET GYNAEC, V83, P738, DOI 10.1111/j.1471-0528.1976.tb00925.x; Gipson IK, 1997, BIOL REPROD, V56, P999, DOI 10.1095/biolreprod56.4.999; Gipson IK, 2001, FRONT BIOSCI-LANDMRK, V6, pD1245, DOI 10.2741/Gipson; Harada N, 1997, J BIOL CHEM, V272, P15232, DOI 10.1074/jbc.272.24.15232; Hovenberg HW, 1996, GLYCOCONJUGATE J, V13, P839, DOI 10.1007/BF00702348; HUGGINS G R, 1981, Clinical Obstetrics and Gynecology, V24, P355, DOI 10.1097/00003081-198106000-00005; Ito R, 2003, VACCINE, V21, P2362, DOI 10.1016/S0264-410X(03)00078-1; JAGER S, 1981, FERTIL STERIL, V36, P792; Johansson MEV, 2009, J PROTEOME RES, V8, P3549, DOI 10.1021/pr9002504; Junqueira LC, 2003, BASIC HISTOLOGY; Kobayashi K, 2002, GUT, V51, P169, DOI 10.1136/gut.51.2.169; Kutteh WH, 1998, AIDS RES HUM RETROV, V14, pS51; Lau SK, 2004, AM J CLIN PATHOL, V122, P61, DOI 10.1309/9R6673QEC06D86Y4; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; LINFORD E, 1974, J REPROD FERTIL, V37, P239, DOI 10.1530/jrf.0.0370239; MAGNUSSON KE, 1982, IMMUNOLOGY, V45, P239; MCSWEEGAN E, 1987, INFECT IMMUN, V55, P1431, DOI 10.1128/IAI.55.6.1431-1435.1987; Phalipon A, 2002, IMMUNITY, V17, P107, DOI 10.1016/S1074-7613(02)00341-2; Royle L, 2003, J BIOL CHEM, V278, P20140, DOI 10.1074/jbc.M301436200; SALTZMAN WM, 1994, BIOPHYS J, V66, P508, DOI 10.1016/S0006-3495(94)80802-1; Wickstrom C, 2000, BIOCHEM J, V351, P421, DOI 10.1042/0264-6021:3510421; Zhang MQ, 2007, AM J CLIN PATHOL, V128, P808, DOI 10.1309/JAF3KVGJHQCJ1QF9	29	65	68	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76176	10.1371/journal.pone.0076176	http://dx.doi.org/10.1371/journal.pone.0076176			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098437	gold, Green Submitted, Green Published			2022-12-25	WOS:000325434500048
J	Khajah, MA; Almohri, I; Mathew, PM; Luqmani, YA				Khajah, Maitham A.; Almohri, Iman; Mathew, Princy M.; Luqmani, Yunus A.			Extracellular Alkaline pH Leads to Increased Metastatic Potential of Estrogen Receptor Silenced Endocrine Resistant Breast Cancer Cells	PLOS ONE			English	Article							NA-H EXCHANGER; EPITHELIAL-MESENCHYMAL TRANSITION; MELANOMA-CELLS; MATRIX-METALLOPROTEINASE-9 EXPRESSION; ANTIESTROGEN ICI-182,780; TUMOR MICROENVIRONMENT; SIGNALING PATHWAYS; NA+/H+ EXCHANGE; GENE-EXPRESSION; ACTIN-BINDING	Introduction: Endocrine resistance in breast cancer is associated with enhanced metastatic potential and poor clinical outcome, presenting a significant therapeutic challenge. We have established several endocrine insensitive breast cancer lines by shRNA induced depletion of estrogen receptor (ER) by transfection of MCF-7 cells which all exhibit enhanced expression profile of mesenchymal markers with reduction of epithelial markers, indicating an epithelial to mesenchymal transition. In this study we describe their behaviour in response to change in extracellular pH, an important factor controlling cell motility and metastasis. Methods: Morphological changes associated with cell exposure to extracellular alkaline pH were assessed by live cell microscopy and the effect of various ion pumps on this behavior was investigated by pretreatment with chemical inhibitors. The activity and expression profile of key signaling molecules was assessed by western blotting. Cell motility and invasion were examined by scratch and under-agarose assays respectively. Total matrix metalloproteinase (MMP) activity and specifically of MMP2/9 was assessed in conditioned medium in response to brief alkaline pH exposure. Results: Exposure of ER -ve but not ER +ve breast cancer cells to extracellular alkaline pH resulted in cell shrinkage and spherical appearance (termed contractolation); this was reversed by returning the pH back to 7.4. Contractolation was blocked by targeting the Na+/K+ and Na+/H+ pumps with specific chemical inhibitors. The activity and expression profile of key signaling molecules critical for cell adhesion were modulated by the exposure to alkaline pH. Brief exposure to alkaline pH enhanced MMP2/9 activity and the invasive potential of ER -ve cells in response to serum components and epithelial growth factor stimulation without affecting unhindered motility. Conclusions: Endocrine resistant breast cancer cells behave very differently to estrogen responsive cells in alkaline pH, with enhanced invasive potential; these studies emphasise the crucial influence of extracellular pH and caution against indiscriminate application of alkalinising drug therapy.	[Khajah, Maitham A.; Almohri, Iman; Mathew, Princy M.; Luqmani, Yunus A.] Kuwait Univ, Fac Pharm, Safat, Kuwait	Kuwait University	Luqmani, YA (corresponding author), Kuwait Univ, Fac Pharm, Safat, Kuwait.	yunus@hsc.edu.kw	Khajah, Maitham/AAZ-8841-2020		Kuwait University [PT02/11]; Kuwait University Research Administration [GM01/01, GM01/05]	Kuwait University; Kuwait University Research Administration	This work was supported by Kuwait University research grant No. PT02/11. Parts of this work were supported by Grants GM01/01 and GM01/05 to the Research Core Facility from Kuwait University Research Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Saleh S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020610; Al Saleh S, 2011, INT J ONCOL, V38, P1197, DOI 10.3892/ijo.2011.942; Bartsch JE, 2003, J SURG RES, V110, P383, DOI 10.1016/S0022-4804(03)00007-6; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Bright MD, 2009, CELL SIGNAL, V21, P1738, DOI 10.1016/j.cellsig.2009.07.005; BRUNNER N, 1993, CANCER RES, V53, P3229; Busco G, 2010, FASEB J, V24, P3903, DOI 10.1096/fj.09-149518; Cereijido M, 2012, AM J PHYSIOL-CELL PH, V302, pC473, DOI 10.1152/ajpcell.00083.2011; Chiang YH, 2008, J CELL PHYSIOL, V214, P810, DOI 10.1002/jcp.21277; Dai Y, 2010, MOL CANCER THER, V9, P1554, DOI 10.1158/1535-7163.MCT-10-0359; de Rooij J, 2005, J CELL BIOL, V171, P153, DOI 10.1083/jcb.200506152; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Fan P, 2007, CANCER RES, V67, P1352, DOI 10.1158/0008-5472.CAN-06-1020; Frantz C, 2007, J CELL BIOL, V179, P403, DOI 10.1083/jcb.200704169; Frantz C, 2008, J CELL BIOL, V183, P865, DOI 10.1083/jcb.200804161; Garamszegi N, 2009, MOL CANCER RES, V7, P319, DOI 10.1158/1541-7786.MCR-08-0227; Garcia-Becerra R, 2013, INT J MOL SCI, V14, P108, DOI 10.3390/ijms14010108; Gatenby RA, 2006, CANCER RES, V66, P5216, DOI 10.1158/0008-5472.CAN-05-4193; Gillies RJ, 2002, J MAGN RESON IMAGING, V16, P430, DOI 10.1002/jmri.10181; Goldmann WH, 1999, EUR J BIOCHEM, V260, P439, DOI 10.1046/j.1432-1327.1999.00177.x; Grey MJ, 2006, J MOL BIOL, V355, P1078, DOI 10.1016/j.jmb.2005.11.001; Helmlinger G, 2002, CLIN CANCER RES, V8, P1284; Hirtenlehner K, 2002, EUR CYTOKINE NETW, V13, P234; Hiscox S, 2000, BREAST CANCER RES TR, V59, P245, DOI 10.1023/A:1006348317841; Hosogi S, 2012, CELL PHYSIOL BIOCHEM, V30, P1241, DOI 10.1159/000343315; Hung CM, 2011, J AGR FOOD CHEM, V59, P9683, DOI 10.1021/jf2021489; Johnson LL, 2000, J BIOL CHEM, V275, P11026, DOI 10.1074/jbc.275.15.11026; Kato Y, 2005, J BIOL CHEM, V280, P10938, DOI 10.1074/jbc.M411313200; Kato Y, 2007, FEBS J, V274, P3171, DOI 10.1111/j.1742-4658.2007.05848.x; Khajah MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041847; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; Kometiani P, 2005, MOL PHARMACOL, V67, P929, DOI 10.1124/mol.104.007302; Kumar AP, 2009, CANCER RES, V69, P8636, DOI 10.1158/0008-5472.CAN-09-0219; Larre I, 2011, P NATL ACAD SCI USA, V108, P20591, DOI 10.1073/pnas.1102617108; Larre I, 2011, METHODS MOL BIOL, V763, P155, DOI 10.1007/978-1-61779-191-8_10; Larre I, 2010, P NATL ACAD SCI USA, V107, P11387, DOI 10.1073/pnas.1000500107; Larre I, 2006, P NATL ACAD SCI USA, V103, P10911, DOI 10.1073/pnas.0604496103; Lee HS, 2004, J MOL BIOL, V343, P771, DOI 10.1016/j.jmb.2004.08.069; Lee WJ, 2008, TOXICOL APPL PHARM, V226, P178, DOI 10.1016/j.taap.2007.09.013; Li HC, 2004, BREAST CANCER RES TR, V88, P75, DOI 10.1007/s10549-004-1200-8; Liang CC, 2001, J BIOL CHEM, V276, P21146, DOI 10.1074/jbc.M010669200; Lin H, 2004, J BIOL CHEM, V279, P29302, DOI 10.1074/jbc.M403664200; Lucien F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028851; Luqmani YA, 2009, INT J ONCOL, V34, P231, DOI 10.3892/ijo_00000145; Maulik G, 2002, CLIN CANCER RES, V8, P620; McClelland RA, 2001, ENDOCRINOLOGY, V142, P2776, DOI 10.1210/en.142.7.2776; McConkey DJ, 2000, CANCER RES, V60, P3807; McLachlan GD, 2007, BIOCHEMISTRY-US, V46, P6931, DOI 10.1021/bi0602359; McLean LA, 2000, AM J PHYSIOL-CELL PH, V278, pC676, DOI 10.1152/ajpcell.2000.278.4.C676; Miraglia E, 2005, INT J CANCER, V115, P924, DOI 10.1002/ijc.20959; Moseley JB, 2006, J CELL SCI, V119, P1547, DOI 10.1242/jcs.02860; Onishi I, 2012, ONCOL REP, V27, P311, DOI 10.3892/or.2011.1542; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Patel H, 2005, J CELL BIOL, V169, P321, DOI 10.1083/jcb.200412145; Pope BJ, 2004, J BIOL CHEM, V279, P4840, DOI 10.1074/jbc.M310148200; Qin L, 2008, MOL CELL BIOL, V28, P5937, DOI 10.1128/MCB.00579-08; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Reshkin SJ, 2000, J BIOL CHEM, V275, P5361, DOI 10.1074/jbc.275.8.5361; Robey IF, 2009, CANCER RES, V69, P2260, DOI 10.1158/0008-5472.CAN-07-5575; ROZHIN J, 1994, CANCER RES, V54, P6517; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Somiari SB, 2006, CANCER LETT, V233, P98, DOI 10.1016/j.canlet.2005.03.003; Somiari SB, 2006, INT J CANCER, V119, P1403, DOI 10.1002/ijc.21989; Song RX, 2002, MOL CELL ENDOCRINOL, V193, P29, DOI 10.1016/S0303-7207(02)00093-X; Stella MC, 1999, INT J BIOCHEM CELL B, V31, P1357, DOI 10.1016/S1357-2725(99)00089-8; Stellas D, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-51; Stock C, 2005, J PHYSIOL-LONDON, V567, P225, DOI 10.1113/jphysiol.2005.088344; Stock C, 2008, EUR J CELL BIOL, V87, P591, DOI 10.1016/j.ejcb.2008.01.007; Stock C, 2007, CELL PHYSIOL BIOCHEM, V20, P679, DOI 10.1159/000107550; Stock C, 2009, PFLUG ARCH EUR J PHY, V458, P981, DOI 10.1007/s00424-009-0677-8; Stuwe L, 2007, J PHYSIOL-LONDON, V585, P351, DOI 10.1113/jphysiol.2007.145185; Thiery JP, 2013, CANCER CELL, V23, P272, DOI 10.1016/j.ccr.2013.03.004; Tian J, 2009, J BIOL CHEM, V284, P14921, DOI 10.1074/jbc.M808355200; Tse JC, 2007, J CELL BIOCHEM, V101, P816, DOI 10.1002/jcb.21215; Vasaturo F, 2005, ONCOL REP, V13, P745; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; Wertz IE, 2000, J BIOL CHEM, V275, P11470, DOI 10.1074/jbc.275.15.11470; WILHELM SM, 1993, J BIOL CHEM, V268, P21906; Willipinski-Stapelfeldt B, 2005, CLIN CANCER RES, V11, P8006, DOI 10.1158/1078-0432.CCR-05-0632; Winnicka K, 2008, BIOL PHARM BULL, V31, P1131, DOI 10.1248/bpb.31.1131; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	82	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76327	10.1371/journal.pone.0076327	http://dx.doi.org/10.1371/journal.pone.0076327			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098477	Green Published, Green Submitted, gold			2022-12-25	WOS:000325427100060
J	Wang, Z; Zhang, XX; Huang, KL; Miao, Y; Shi, P; Liu, B; Long, C; Li, AM				Wang, Zhu; Zhang, Xu-Xiang; Huang, Kailong; Miao, Yu; Shi, Peng; Liu, Bo; Long, Chao; Li, Aimin			Metagenomic Profiling of Antibiotic Resistance Genes and Mobile Genetic Elements in a Tannery Wastewater Treatment Plant	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; SEWAGE-TREATMENT PLANTS; COMMUNITY STRUCTURE; LIQUID-CHROMATOGRAPHY; PROTEIN-DEGRADATION; MICROBIAL DIVERSITY; ACTIVATED-SLUDGE; METAL RESISTANCE; SOIL; SEQUENCE	Antibiotics are often used to prevent sickness and improve production in animal agriculture, and the residues in animal bodies may enter tannery wastewater during leather production. This study aimed to use Illumina high-throughput sequencing to investigate the occurrence, diversity and abundance of antibiotic resistance genes (ARGs) and mobile genetic elements (MGEs) in aerobic and anaerobic sludge of a full-scale tannery wastewater treatment plant (WWTP). Metagenomic analysis showed that Proteobacteria, Firmicutes, Bacteroidetes and Actinobacteria dominated in the WWTP, but the relative abundance of archaea in anaerobic sludge was higher than in aerobic sludge. Sequencing reads from aerobic and anaerobic sludge revealed differences in the abundance of functional genes between both microbial communities. Genes coding for antibiotic resistance were identified in both communities. BLAST analysis against Antibiotic Resistance Genes Database (ARDB) further revealed that aerobic and anaerobic sludge contained various ARGs with high abundance, among which sulfonamide resistance gene sul1 had the highest abundance, occupying over 20% of the total ARGs reads. Tetracycline resistance genes (tet) were highly rich in the anaerobic sludge, among which tet33 had the highest abundance, but was absent in aerobic sludge. Over 70 types of insertion sequences were detected in each sludge sample, and class 1 integrase genes were prevalent in the WWTP. The results highlighted prevalence of ARGs and MGEs in tannery WWTPs, which may deserve more public health concerns.	[Wang, Zhu; Zhang, Xu-Xiang; Huang, Kailong; Miao, Yu; Shi, Peng; Liu, Bo; Long, Chao; Li, Aimin] Nanjing Univ, State Key Lab Pollut Control & Resource Reuse, Sch Environm, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Zhang, XX (corresponding author), Nanjing Univ, State Key Lab Pollut Control & Resource Reuse, Sch Environm, Nanjing 210008, Jiangsu, Peoples R China.	zhangxx@nju.edu.cn; liaimin@nju.edu.cn	Zhu, Wang/AAT-1740-2021; 王, 铸/I-3824-2016; Zhang, xiaoyu/GXA-3206-2022; Miao, Yu/AAY-4453-2020; zhang, xu/GYE-3558-2022; zhang, xian/GYA-0290-2022; Peng, Shi/AAP-7926-2021; zhang, xu/GRX-9733-2022	王, 铸/0000-0002-6763-8194; Miao, Yu/0000-0002-1145-7298; Peng, Shi/0000-0002-3333-0458; 	National Natural Science Foundation of China [51278240, 51008153]; National Science and Technology Major Project of China [2011ZX07210-001-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of China	This study was financially supported by National Natural Science Foundation of China (Grant No. 51278240 and 51008153; URL: http://www.nsfc.gov.cn) and National Science and Technology Major Project of China (Grant No. 2011ZX07210-001-1; URL: http://www.nmp.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MZ, 2011, ENVIRON MONIT ASSESS, V178, P281, DOI 10.1007/s10661-010-1689-8; Baker-Austin C, 2006, TRENDS MICROBIOL, V14, P176, DOI 10.1016/j.tim.2006.02.006; Bittencourt MS, 2012, FOOD ADDIT CONTAM A, V29, P508, DOI 10.1080/19440049.2011.606228; Borras S, 2012, J SEP SCI, V35, P2048, DOI 10.1002/jssc.201200302; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Chee-Sanford JC, 2001, APPL ENVIRON MICROB, V67, P1494, DOI 10.1128/AEM.67.4.1494-1502.2001; Chen J, 2012, GEOMICROBIOL J, V29, P226, DOI 10.1080/01490451.2011.558562; Cheong DY, 2006, APPL MICROBIOL BIOT, V72, P635, DOI 10.1007/s00253-006-0313-x; Depardieu F, 2003, ANTIMICROB AGENTS CH, V47, P7, DOI 10.1128/AAC.47.1.7-18.2003; Godon JJ, 1997, APPL ENVIRON MICROB, V63, P2802, DOI 10.1128/AEM.63.7.2802-2813.1997; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gomez-Alvarez V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-122; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Goto T, 2005, J CHROMATOGR A, V1100, P193, DOI 10.1016/j.chroma.2005.09.056; Gratacos-Cubarsi M, 2006, J CHROMATOGR B, V832, P121, DOI 10.1016/j.jchromb.2006.01.002; Hauser LJ, 2011, J BACTERIOL, V193, P4268, DOI 10.1128/JB.05400-11; Heise J, 2006, CHEMOSPHERE, V65, P2352, DOI 10.1016/j.chemosphere.2006.04.084; Hvistendahl M, 2012, SCIENCE, V336, P795, DOI 10.1126/science.336.6083.795; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Kim S, 2005, ENVIRON SCI TECHNOL, V39, P5816, DOI 10.1021/es050006u; Kristiansson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017038; Krober M, 2009, J BIOTECHNOL, V142, P38, DOI 10.1016/j.jbiotec.2009.02.010; Lefebvre O, 2006, EXTREMOPHILES, V10, P505, DOI 10.1007/s00792-006-0524-1; Leon G, 2003, J BACTERIOL, V185, P2036, DOI 10.1128/JB.185.6.2036-2041.2003; Li J, 2012, ENVIRON HEALTH PERSP, V120, P1144, DOI 10.1289/ehp.1104776; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Luo Y, 2011, ENVIRON SCI TECHNOL, V45, P1827, DOI 10.1021/es104009s; Ma LP, 2011, ECOTOXICOLOGY, V20, P968, DOI 10.1007/s10646-011-0652-y; Marcelino M, 2011, WATER SCI TECHNOL, V64, P1142, DOI 10.2166/wst.2011.398; Monier JM, 2011, CURR OPIN MICROBIOL, V14, P229, DOI 10.1016/j.mib.2011.04.010; Morris SM, 2007, J NUTR, V137, p1602S, DOI 10.1093/jn/137.6.1602S; Moura A, 2010, RES MICROBIOL, V161, P58, DOI 10.1016/j.resmic.2009.11.004; Moura A, 2009, BIOINFORMATICS, V25, P1096, DOI 10.1093/bioinformatics/btp105; Murugananthan M, 2004, SEP PURIF TECHNOL, V40, P69, DOI 10.1016/j.seppur.2004.01.005; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Overbeek R, 2004, PEER TO PEER ENV ANN; Pender S, 2004, WATER RES, V38, P619, DOI 10.1016/j.watres.2003.10.055; Pfister CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010518; Port JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048000; REEVE CA, 1984, J BACTERIOL, V157, P758, DOI 10.1128/JB.157.3.758-763.1984; Santegoeds CM, 1999, APPL ENVIRON MICROB, V65, P4618; Schleinitz KM, 2010, ANTIMICROB AGENTS CH, V54, P4321, DOI 10.1128/AAC.00006-10; Shi P, 2013, WATER RES, V47, P111, DOI 10.1016/j.watres.2012.09.046; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Silva CC, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-18; Singh KM, 2012, GENE, V507, P146, DOI 10.1016/j.gene.2012.07.037; Snaidr J, 1997, APPL ENVIRON MICROB, V63, P2884, DOI 10.1128/AEM.63.7.2884-2896.1997; Tariq SR, 2006, J ENVIRON MANAGE, V79, P20, DOI 10.1016/j.jenvman.2005.05.009; Tennstedt T, 2005, PLASMID, V53, P218, DOI 10.1016/j.plasmid.2004.09.004; Thomas F, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00093; Tisler T, 2004, WATER RES, V38, P3503, DOI 10.1016/j.watres.2004.05.011; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Uroz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055929; Vartoukian SR, 2007, ANAEROBE, V13, P99, DOI 10.1016/j.anaerobe.2007.05.004; Vejmelkova D, 2012, APPL MICROBIOL BIOT, V93, P401, DOI 10.1007/s00253-011-3409-x; Verma T, 2001, BIORESOURCE TECHNOL, V78, P31, DOI 10.1016/S0960-8524(00)00168-1; Xia SQ, 2010, ENVIRON SCI TECHNOL, V44, P7391, DOI 10.1021/es101554m; Xu WH, 2007, WATER RES, V41, P4526, DOI 10.1016/j.watres.2007.06.023; Yu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059831; Yu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038183; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188; Zhang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026041; Zhang XX, 2011, ENVIRON SCI TECHNOL, V45, P2598, DOI 10.1021/es103672x; Zhang XX, 2009, APPL MICROBIOL BIOT, V82, P1169, DOI 10.1007/s00253-009-1886-y; Zhao L, 2010, SCI TOTAL ENVIRON, V408, P1069, DOI 10.1016/j.scitotenv.2009.11.014	66	54	64	3	199	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76079	10.1371/journal.pone.0076079	http://dx.doi.org/10.1371/journal.pone.0076079			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098424	Green Submitted, gold, Green Published			2022-12-25	WOS:000325427100039
J	Li, YX; Cao, GS; Zheng, XD; Wang, J; Wei, HM; Tian, ZG; Sun, R				Li, Yangxi; Cao, Guoshuai; Zheng, Xiaodong; Wang, Jun; Wei, Haiming; Tian, Zhigang; Sun, Rui			CRACC-CRACC Interaction between Kupffer and NK Cells Contributes to Poly I:C/D-GalN Induced Hepatitis	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; SLAM FAMILY RECEPTORS; T-CELLS; SAP; INJURY; INVOLVEMENT; ACTIVATION; EXPRESSION; RESPONSES; MOLECULE	CD2-like receptor activating cytotoxic cells (CRACC) is known as a critical activating receptor of natural killer (NK) cells. We have previously reported that NK cells contribute to Poly I:C/D-galactosamine (D-GalN)-induced fulminant hepatitis. Since natural killer group 2, member D (NKG2D) is considered critical but not the only activating receptor for NK cells, we investigated the role of CRACC in this model. We found that CRACC was abundant on hepatic NK cells but with low expression levels on Kupffer cells under normal conditions. Expression of CRACC on NK cells and Kupffer cells was remarkably upregulated after poly I:C injection. Hepatic CRACC mRNA levels were also upregulated in Poly I:C/D-GalN-treated mice, and correlated positively with the serum alanine aminotransferase (ALT) levels. CRACC expression on Kupffer cells was specifically silenced by nano-particle encapsulated siRNA in vivo, which significantly reduced Poly I:C/D-GalN-induced liver injury. In co-culture experiments, it was further verified that silencing CRACC expression or blockade of CRACC activation by mAb reduced the production of interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha. Collectively, our findings suggest that CRACC-CRACC interaction between NK cells and resident Kupffer cells contributes to Poly I:C/D-GalN-induced fulminant hepatitis.	[Li, Yangxi; Cao, Guoshuai; Zheng, Xiaodong; Wang, Jun; Wei, Haiming; Tian, Zhigang; Sun, Rui] Univ Sci & Technol China, Sch Life Sci, Dept Immunol, Hefei, Anhui, Peoples R China; [Wang, Jun; Wei, Haiming; Tian, Zhigang; Sun, Rui] Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS	Sun, R (corresponding author), Univ Sci & Technol China, Sch Life Sci, Dept Immunol, Hefei, Anhui, Peoples R China.	sunr@ustc.edu.cn	Zheng, Xiaodong/N-2830-2013; Li, Yangxi/AFZ-9382-2022; Wang, Jun/F-9033-2011; Tian, Zhigang/J-3512-2013	Li, Yangxi/0000-0003-4579-1080; Wang, Jun/0000-0001-9957-9208; 	Ministry of Science & Technology of China (973 Basic Science Project) [2013CB530506, 2010CB911901]; Natural Science Foundation of China [91029303, 31021061, 30911120480]	Ministry of Science & Technology of China (973 Basic Science Project); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Science & Technology of China (973 Basic Science Project 2013CB530506, 2010CB911901), Natural Science Foundation of China (91029303, 31021061, 30911120480). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biburger M, 2005, J IMMUNOL, V175, P1540, DOI 10.4049/jimmunol.175.3.1540; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Chen M, 2005, J IMMUNOL, V175, P1047, DOI 10.4049/jimmunol.175.2.1047; Choi HG, 2012, INT IMMUNOPHARMACOL, V13, P271, DOI 10.1016/j.intimp.2012.04.016; Cruz-Munoz ME, 2009, NAT IMMUNOL, V10, P297, DOI 10.1038/ni.1693; Dong ZJ, 2004, J HEPATOL, V41, P966, DOI 10.1016/j.jhep.2004.08.021; Fasth AER, 2010, EUR J IMMUNOL, V40, P378, DOI 10.1002/eji.200939399; GALANOS C, 1979, P NATL ACAD SCI USA, V76, P5939, DOI 10.1073/pnas.76.11.5939; Gao B, 2009, J LEUKOCYTE BIOL, V86, P513, DOI [10.1189/JLB.0309135, 10.1189/jlb.0309135]; Hou X, 2009, HEPATOLOGY, V49, P940, DOI 10.1002/hep.22725; Hsi ED, 2008, CLIN CANCER RES, V14, P2775, DOI 10.1158/1078-0432.CCR-07-4246; Ishikawa E, 2005, J VIROL, V79, P7658, DOI 10.1128/JVI.79.12.7658-7663.2005; Kim JR, 2010, CLIN EXP IMMUNOL, V160, P348, DOI 10.1111/j.1365-2249.2010.04116.x; Kramer B, 2013, INFECT IMMUN, V81, P690, DOI [10.1128/IAI.00895-12, 10.1128/IAI.00895]; Li FA, 2012, J VIROL, V86, P2251, DOI 10.1128/JVI.06209-11; Miyazawa Y, 1998, HEPATOLOGY, V27, P497, DOI 10.1002/hep.510270225; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Rethi B, 2006, BLOOD, V107, P2821, DOI 10.1182/blood-2005-06-2265; Schroeder A, 2010, J INTERN MED, V267, P9, DOI 10.1111/j.1365-2796.2009.02189.x; SEGLEN PO, 1976, METHOD CELL BIOL, V13, P2, DOI DOI 10.1016/S0091-679X(08)61797-5.PUBMED:177845; Shi B, 2011, J HISTOCHEM CYTOCHEM, V59, P727, DOI 10.1369/0022155411410885; Sintes J, 2010, J LEUKOCYTE BIOL, V88, P687, DOI 10.1189/jlb.1109756; Tangye SG, 2000, J IMMUNOL, V165, P2932, DOI 10.4049/jimmunol.165.6.2932; Tassi I, 2005, J IMMUNOL, V175, P7996, DOI 10.4049/jimmunol.175.12.7996; Tian ZG, 2013, HEPATOLOGY, V57, P1654, DOI 10.1002/hep.26115; Veillette A, 2006, NAT REV IMMUNOL, V6, P56, DOI 10.1038/nri1761; Veillette A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002469; Waggoner SN, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00377; Wang J, 2006, J HEPATOL, V44, P446, DOI 10.1016/j.jhep.2005.08.015; Wang NH, 2004, J EXP MED, V199, P1255, DOI 10.1084/jem.20031835; Wu Y, 2013, HEPATOLOGY, V57, P1107, DOI 10.1002/hep.26192; Yang XZ, 2011, J CONTROL RELEASE, V156, P203, DOI 10.1016/j.jconrel.2011.07.035; Zhou Z, 2012, IEEE ICC, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0036928.PUBMED:22629344	34	7	8	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76681	10.1371/journal.pone.0076681	http://dx.doi.org/10.1371/journal.pone.0076681			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098802	gold, Green Published, Green Submitted			2022-12-25	WOS:000325423500173
J	Peterson, JS; McCall, K				Peterson, Jeanne S.; McCall, Kimberly			Combined Inhibition of Autophagy and Caspases Fails to Prevent Developmental Nurse Cell Death in the Drosophila melanogaster Ovary	PLOS ONE			English	Article							PRIMARY PHAGOCYTOSIS; DEGRADATION; REQUIREMENT; ENGULFMENT; APOPTOSIS; GROWTH	During the final stages of Drosophila melanogaster oogenesis fifteen nurse cells, sister cells to the oocyte, degenerate as part of normal development. This process involves at least two cell death mechanisms, caspase-dependent cell death and autophagy, as indicated by apoptosis and autophagy markers. In addition, mutations affecting either caspases or autophagy partially reduce nurse cell removal, leaving behind end-stage egg chambers with persisting nurse cell nuclei. To determine whether apoptosis and autophagy work in parallel to degrade and remove these cells as is the case with salivary glands during pupariation, we generated mutants doubly affecting caspases and autophagy. We found no significant increase in either the number of late stage egg chambers containing persisting nuclei or in the number of persisting nuclei per egg chamber in the double mutants compared to single mutants. These findings suggest that there is another cell death mechanism functioning in the ovary to remove all nurse cell remnants from late stage egg chambers.	[Peterson, Jeanne S.; McCall, Kimberly] Boston Univ, Dept Biol, Boston, MA 02215 USA	Boston University	McCall, K (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	kmccall@bu.edu			NIH [R01 GM060574]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060574] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by NIH R01 GM060574. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham MC, 2007, DEV CELL, V12, P73, DOI 10.1016/j.devcel.2006.11.012; Barger AJ, 1998, J NEUROSCI, V18, P2871; Barth JMI, 2011, CELL DEATH DIFFER, V18, P915, DOI 10.1038/cdd.2010.157; Barth JMI, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-35; Bartlett BJ, 2011, AUTOPHAGY, V7, P572, DOI 10.4161/auto.7.6.14943; Bass BP, 2009, CELL DEATH DIFFER, V16, P1362, DOI 10.1038/cdd.2009.79; Baum JS, 2007, CELL DEATH DIFFER, V14, P1508, DOI 10.1038/sj.cdd.4402155; Berry DL, 2007, CELL, V131, P1137, DOI 10.1016/j.cell.2007.10.048; Blum ES, 2012, SCIENCE, V335, P970, DOI 10.1126/science.1215156; Brown GC, 2012, TRENDS BIOCHEM SCI, V37, P325, DOI 10.1016/j.tibs.2012.05.002; Cavaliere V, 1998, DEV GENES EVOL, V208, P106, DOI 10.1007/s004270050160; Chou TB, 1996, GENETICS, V144, P1673; Denton D, 2009, CURR BIOL, V19, P1741, DOI 10.1016/j.cub.2009.08.042; Duffy JB, 1998, DEVELOPMENT, V125, P2263; Etchegaray JI, 2012, DEVELOPMENT, V139, P4029, DOI 10.1242/dev.082776; Foley K, 1998, DEVELOPMENT, V125, P1075; GIORGI F, 1976, J EMBRYOL EXP MORPH, V35, P521; Hall DH, 1997, J NEUROSCI, V17, P1033; Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707; King R. C., 1970, OVARIAN DEV DROSOPHI; Laundrie B, 2003, GENETICS, V165, P1881; Li W, 2007, CELL, V129, P1215, DOI 10.1016/j.cell.2007.03.054; Lindmo K, 2006, EXP CELL RES, V312, P2018, DOI 10.1016/j.yexcr.2006.03.002; McCall K, 1998, SCIENCE, V279, P230, DOI 10.1126/science.279.5348.230; McCall K, 2010, CURR OPIN CELL BIOL, V22, P882, DOI 10.1016/j.ceb.2010.09.002; Melendez A, 2008, DEVELOPMENT, V135, P2347, DOI 10.1242/dev.016105; Neher JJ, 2011, J IMMUNOL, V186, P4973, DOI 10.4049/jimmunol.1003600; Neniskyte U, 2011, J BIOL CHEM, V286, P39904, DOI 10.1074/jbc.M111.267583; Nezis IP, 2010, J CELL BIOL, V190, P523, DOI 10.1083/jcb.201002035; Overholtzer M, 2007, CELL, V131, P966, DOI 10.1016/j.cell.2007.10.040; Peterson JS, 2007, GENESIS, V45, P396, DOI 10.1002/dvg.20306; Peterson JS, 2003, DEV BIOL, V260, P113, DOI 10.1016/S0012-1606(03)00240-9; Pritchett TL, 2009, APOPTOSIS, V14, P969, DOI 10.1007/s10495-009-0369-z; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Spradling Allan C., 1993, P1; Varkey J, 1999, J CELL BIOL, V144, P701, DOI 10.1083/jcb.144.4.701	38	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76046	10.1371/journal.pone.0076046	http://dx.doi.org/10.1371/journal.pone.0076046			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098761	gold, Green Published, Green Submitted			2022-12-25	WOS:000325423500131
J	Shi, Q; Stell, WK				Shi, Qing; Stell, William K.			Die Fledermaus: Regarding Optokinetic Contrast Sensitivity and Light-Adaptation, Chicks Are Mice with Wings	PLOS ONE			English	Article							SCOTOPIC THRESHOLD RESPONSE; FORM-DEPRIVATION MYOPIA; PARAXIAL SCHEMATIC EYE; VISUAL-ACUITY; OPTOMOTOR RESPONSE; GANGLION-CELLS; AMACRINE CELLS; CAT RETINA; VISION; ROD	Background: Through adaptation, animals can function visually under an extremely broad range of light intensities. Light adaptation starts in the retina, through shifts in photoreceptor sensitivity and kinetics plus modulation of visual processing in retinal circuits. Although considerable research has been conducted on retinal adaptation in nocturnal species with rod-dominated retinas, such as the mouse, little is known about how cone-dominated avian retinas adapt to changes in mean light intensity. Methodology/Principal Findings: We used the optokinetic response to characterize contrast sensitivity (CS) in the chick retina as a function of spatial frequency and temporal frequency at different mean light intensities. We found that: 1) daytime, cone-driven CS was tuned to spatial frequency; 2) nighttime, presumably rod-driven CS was tuned to temporal frequency and spatial frequency; 3) daytime, presumably cone-driven CS at threshold intensity was invariant with temporal and spatial frequency; and 4) daytime photopic CS was invariant with clock time. Conclusion/Significance: Light-and dark-adaptational changes in CS were investigated comprehensively for the first time in the cone-dominated retina of an avian, diurnal species. The chick retina, like the mouse retina, adapts by using a "day/night" or "cone/rod" switch in tuning preference during changes in lighting conditions. The chick optokinetic response is an attractive model for noninvasive, behavioral studies of adaptation in retinal circuitry in health and disease.	[Shi, Qing] Univ Calgary, Fac Med, Grad Program Neurosci, Calgary, AB, Canada; [Stell, William K.] Univ Calgary, Fac Med, Dept Cell Biol & Anat, Calgary, AB, Canada; [Stell, William K.] Univ Calgary, Fac Med, Dept Surg, Calgary, AB, Canada; [Stell, William K.] Univ Calgary, Fac Med, Hotchkiss Brain Inst, Calgary, AB, Canada; [Stell, William K.] Univ Calgary, Fac Med, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Stell, WK (corresponding author), Univ Calgary, Fac Med, Dept Cell Biol & Anat, Calgary, AB, Canada.	wstell@ucalgary.ca		Shi, Qing/0000-0003-0690-7669	Natural Sciences and Engineering Research Coouncil of Canada (NSERC) [RGPIN 131-2013]; FFB (Foundation Fighting Blindness of Canada)-EYEGEYE Research Training Fund	Natural Sciences and Engineering Research Coouncil of Canada (NSERC); FFB (Foundation Fighting Blindness of Canada)-EYEGEYE Research Training Fund	This work was supported by (1) Natural Sciences and Engineering Research Coouncil of Canada (NSERC), #RGPIN 131-2013, "Retinal Control of Eye Growth and Myopia", W. K. Stell, PI. (2) FFB (Foundation Fighting Blindness of Canada)-EYEGEYE Research Training Fund, W. K. Stell, PI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby R, 2009, INVEST OPHTH VIS SCI, V50, P5348, DOI 10.1167/iovs.09-3419; Avila NV, 2010, J COMP PHYSIOL A, V196, P825, DOI 10.1007/s00359-010-0562-0; Bloomfield SA, 1997, VISUAL NEUROSCI, V14, P565, DOI 10.1017/S0952523800012220; BONAVENTURE N, 1992, VISION RES, V32, P601, DOI 10.1016/0042-6989(92)90176-J; BONAVENTURE N, 1992, VISION RES, V32, P611, DOI 10.1016/0042-6989(92)90177-K; Bonfield S, 2008, ARVO M APR 11 2008, V49, P3838; Bonfield SP, 2009, THESIS U CALGARY; BROCKERHOFF SE, 1995, P NATL ACAD SCI USA, V92, P10545, DOI 10.1073/pnas.92.23.10545; Burroughs SL, 2011, INVEST OPHTH VIS SCI, V52, P3654, DOI 10.1167/iovs.10-7106; Cahill H, 2011, J CLIN INVEST, V121, P3528, DOI 10.1172/JCI45557; Cajal S.L.C., 1892, CELLULE, V9, P17; Cameron MA, 2009, MOL VIS, V15, P2209; CAMPBELL FW, 1968, J PHYSIOL-LONDON, V197, P551, DOI 10.1113/jphysiol.1968.sp008574; Cantrup R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032795; COHEN B, 1992, ANN NY ACAD SCI, V656, P277; CROOKS J, 1992, J COMP NEUROL, V315, P287, DOI 10.1002/cne.903150305; DEVALOIS RL, 1974, VISION RES, V14, P75, DOI 10.1016/0042-6989(74)90118-7; Diether S, 2001, INVEST OPHTH VIS SCI, V42, P3072; Doering CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002538; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Emran F, 2007, P NATL ACAD SCI USA, V104, P19126, DOI 10.1073/pnas.0709337104; Fischer AJ, 1998, BRAIN RES, V794, P48, DOI 10.1016/S0006-8993(98)00188-7; Fleisch VC, 2006, ZEBRAFISH, V3, P191, DOI 10.1089/zeb.2006.3.191; FRISHMAN LJ, 1989, J NEUROPHYSIOL, V61, P1221, DOI 10.1152/jn.1989.61.6.1221; Gaillard F, 2008, J COMP NEUROL, V510, P525, DOI 10.1002/cne.21798; Ghim MM, 2006, J COMP PHYSIOL A, V192, P523, DOI 10.1007/s00359-005-0090-5; GHIM MM, 2003, THESIS U MARYLAND CO; Gover N, 2009, VISION RES, V49, P2747, DOI 10.1016/j.visres.2009.08.011; Jackson CR, 2012, J NEUROSCI, V32, P9359, DOI 10.1523/JNEUROSCI.0711-12.2012; JARDON B, 1992, VISION RES, V32, P541, DOI 10.1016/0042-6989(92)90246-F; Jarvis JR, 2009, VISION RES, V49, P1448, DOI 10.1016/j.visres.2009.02.019; Katti C, 2013, INVEST OPHTH VIS SCI, V54, P821, DOI 10.1167/iovs.12-10375; KOLB H, 1974, SCIENCE, V186, P47, DOI 10.1126/science.186.4158.47; KOLB H, 1983, VISION RES, V23, P301, DOI 10.1016/0042-6989(83)90078-0; Lisney TJ, 2012, VISION RES, V62, P125, DOI 10.1016/j.visres.2012.04.002; Lodha N, 2010, ADV EXP MED BIOL, V664, P549, DOI 10.1007/978-1-4419-1399-9_63; Manglapus MK, 1998, J NEUROSCI, V18, P4775; McGill TJ, 2007, INVEST OPHTH VIS SCI, V48, P5756, DOI 10.1167/iovs.07-0054; McGill TJ, 2012, EXP EYE RES, V104, P65, DOI 10.1016/j.exer.2012.09.006; MEYER DB, 1973, EXP EYE RES, V17, P347, DOI 10.1016/0014-4835(73)90244-3; Mora-Ferrer C, 2005, BRAIN RES, V1058, P17, DOI 10.1016/j.brainres.2005.07.073; MORRIS VB, 1970, J COMP NEUROL, V140, P359, DOI 10.1002/cne.901400308; NAARENDORP F, 1991, VISION RES, V31, P1, DOI 10.1016/0042-6989(91)90068-G; Prescott NB, 1999, BRIT POULTRY SCI, V40, P332, DOI 10.1080/00071669987412; Prusky GT, 2000, VISION RES, V40, P2201, DOI 10.1016/S0042-6989(00)00081-X; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Qian HH, 2005, ZEBRAFISH, V2, P189, DOI 10.1089/zeb.2005.2.189; QUESADA A, 1988, J MORPHOL, V197, P337, DOI 10.1002/jmor.1051970308; RAVIOLA E, 1973, P NATL ACAD SCI USA, V70, P1677, DOI 10.1073/pnas.70.6.1677; Ribelayga C, 2008, NEURON, V59, P790, DOI 10.1016/j.neuron.2008.07.017; Ribelayga C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011020; Saszik SM, 2002, J PHYSIOL-LONDON, V543, P899, DOI 10.1113/jphysiol.2002.019703; SCHAEFFEL F, 1991, VISUAL NEUROSCI, V6, P641, DOI 10.1017/S0952523800002637; SCHAEFFEL F, 1988, J OPT SOC AM A, V5, P2080, DOI 10.1364/JOSAA.5.002080; Schmid KL, 1998, VISION RES, V38, P2629, DOI 10.1016/S0042-6989(97)00446-X; Schmucker C, 2004, VISION RES, V44, P1857, DOI 10.1016/j.visres.2004.03.011; Shi Q, 2012, ARVO M, V53, P2451; SIEVING PA, 1986, J NEUROPHYSIOL, V56, P1049, DOI 10.1152/jn.1986.56.4.1049; Smirnakis SM, 1997, NATURE, V386, P69, DOI 10.1038/386069a0; Stockman A, 2006, OPHTHAL PHYSL OPT, V26, P225, DOI 10.1111/j.1475-1313.2006.00325.x; Tappeiner C, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-10; THOMPSON DA, 1994, INT J PSYCHOPHYSIOL, V16, P219, DOI 10.1016/0167-8760(89)90049-4; TROILO D, 1995, VISION RES, V35, P1211, DOI 10.1016/0042-6989(94)00230-J; Umino Y, 2008, J NEUROSCI, V28, P189, DOI 10.1523/JNEUROSCI.3551-07.2008; Umino Y, 2013, INVEST OPHTH VIS SCI, V54, P1536, DOI 10.1167/iovs.12-10825; Vaney DI, 2012, NAT REV NEUROSCI, V13, P194, DOI 10.1038/nrn3165; Vessey KA, 2005, INVEST OPHTH VIS SCI, V46, P3932, DOI 10.1167/iovs.04-1027; WALLMAN J, 1990, CIBA F SYMP, V155, P126; WALLMAN J, 1993, PROG RETIN RES, V12, P133, DOI 10.1016/0278-4327(93)90007-G; Wallman J, 2004, NEURON, V43, P447, DOI 10.1016/j.neuron.2004.08.008; WALLMAN J, 1978, SCIENCE, V201, P1249, DOI 10.1126/science.694514; Wan L, 2005, J NEUROSCI, V25, P941, DOI 10.1523/JNEUROSCI.4657-04.2005; Yonehara K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004320	74	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75375	10.1371/journal.pone.0075375	http://dx.doi.org/10.1371/journal.pone.0075375			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098693	gold, Green Published, Green Submitted			2022-12-25	WOS:000325423500064
J	Bishop, AC; Ganguly, S; Solis, NV; Cooley, BM; Jensen-Seaman, MI; Filler, SG; Mitchell, AP; Patton-Vogt, J				Bishop, Andrew C.; Ganguly, Shantanu; Solis, Norma V.; Cooley, Benjamin M.; Jensen-Seaman, Michael I.; Filler, Scott G.; Mitchell, Aaron P.; Patton-Vogt, Jana			Glycerophosphocholine Utilization by Candida albicans ROLE OF THE Git3 TRANSPORTER IN VIRULENCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Candida albicans; Pathogenesis; Phosphatidylcholine; Phospholipid Turnover; Transport; Yeast Genetics; Glycerophosphocholine; Phospholipid Metabolite	PHOSPHOLIPASE-B ACTIVITY; MOLECULAR CHARACTERIZATION; H-1-NMR SPECTROSCOPY; CHOLINE; PHOSPHODIESTERASE; GENE; GLYCEROPHOSPHOINOSITOL; PHOSPHATIDYLCHOLINE; TRANSPORT; GLYCEROPHOSPHODIESTERS	Candida albicans contains four ORFs (GIT1,2,3,4) predicted to encode proteins involved in the transport of glycerophosphodiester metabolites. Previously, we reported that Git1, encoded by ORF 19.34, is responsible for the transport of intact glycerophosphoinositol but not glycerophosphocholine (GroPCho). Here, we report that a strain lacking both GIT3 (ORF 19.1979) and GIT4 (ORF 19.1980) is unable to transport [H-3]GroPCho into the cell. In the absence of a GroPCho transporter, C. albicans can utilize GroPCho via a mechanism involving extracellular hydrolysis. Upon reintegration of either GIT3 or GIT4 into the genome, measurable uptake of [H-3]GroPCho is observed. Transport assays and kinetic analyses indicate that Git3 has the greater transport velocity. We present evidence that GDE1 (ORF 19.3936) codes for an enzyme with glycerophosphodiesterase activity against GroPCho. Homozygous deletion of GDE1 results in a buildup of internal GroPCho that is restored to wild type levels by reintegration of GDE1 into the genome. The transcriptional regulator, Pho4, is shown to regulate the expression of GIT3, GIT4, and GDE1. Finally, Git3 is shown to be required for full virulence in a mouse model of disseminated candidiasis, and Git3 sequence orthologs are present in other pathogenic Candida species. In summary, we have characterized multiple aspects of GroPCho utilization by C. albicans and have demonstrated that GroPCho transport plays a key role in the growth of the organism in the host.	[Bishop, Andrew C.; Cooley, Benjamin M.; Jensen-Seaman, Michael I.; Patton-Vogt, Jana] Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15282 USA; [Ganguly, Shantanu; Mitchell, Aaron P.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Solis, Norma V.; Filler, Scott G.] Harbor UCLA Med Ctr, Div Infect Dis, Los Angeles Biomed Res Inst, Torrance, CA 90502 USA; [Filler, Scott G.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90024 USA	Duquesne University; Carnegie Mellon University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Patton-Vogt, J (corresponding author), Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15282 USA.	pattonvogt@duq.edu		Mitchell, Aaron/0000-0002-0868-4000	National Institutes of Health [R15GM104876, R01AI070272, R01AI054928]; National Science Foundation [BCS-0922525]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054928, R01AI070272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM104876] Funding Source: NIH RePORTER; Division Of Behavioral and Cognitive Sci [0922525] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was supported, in whole or in part, by National Institutes of Health Grants R15GM104876 (to J.P.-V.), R01AI070272 (to A. P. M.), and R01AI054928 (to S. G. F.). This work was also supported by National Science Foundation Grant BCS-0922525 (to M. J. S.).	Almaguer C, 2004, J BIOL CHEM, V279, P31937, DOI 10.1074/jbc.M403648200; Backshall A, 2009, J PROTEOME RES, V8, P1423, DOI 10.1021/pr800793w; Bishop AC, 2011, EUKARYOT CELL, V10, P1618, DOI 10.1128/EC.05160-11; Braun BR, 2005, PLOS GENET, V1, P36, DOI 10.1371/journal.pgen.0010001; Bruno VM, 2010, GENOME RES, V20, P1451, DOI 10.1101/gr.109553.110; BRZOSKA P, 1988, J BACTERIOL, V170, P4125, DOI 10.1128/jb.170.9.4125-4135.1988; Cheng LY, 2011, PLANT PHYSIOL, V156, P1131, DOI 10.1104/pp.111.173724; Cheng YX, 2011, PLANT J, V66, P781, DOI 10.1111/j.1365-313X.2011.04538.x; Chrisman CJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002047; COOK SJ, 1989, BIOCHEM J, V263, P581, DOI 10.1042/bj2630581; Davis DA, 2002, GENETICS, V162, P1573; Dowd SR, 2001, J BIOL CHEM, V276, P3756, DOI 10.1074/jbc.M003694200; ELION EA, 1984, CELL, V39, P663, DOI 10.1016/0092-8674(84)90473-2; Farn JL, 2001, J BACTERIOL, V183, P6717, DOI 10.1128/JB.183.22.6717-6720.2001; Fernandez-Murray JP, 2005, J BIOL CHEM, V280, P38290, DOI 10.1074/jbc.M507700200; Fisher E, 2005, J BIOL CHEM, V280, P36110, DOI 10.1074/jbc.M507051200; Fisher JF, 2011, CLIN INFECT DIS, V52, pS437, DOI 10.1093/cid/cir110; Gallazzini M, 2008, P NATL ACAD SCI USA, V105, P11026, DOI 10.1073/pnas.0805496105; Gallazzini M, 2009, PHYSIOLOGY, V24, P245, DOI 10.1152/physiol.00009.2009; Ganguly Shantanu, 2012, Methods Mol Biol, V845, P19, DOI 10.1007/978-1-61779-539-8_2; Gaur M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-579; Ghannoum MA, 2000, CLIN MICROBIOL REV, V13, P122, DOI 10.1128/CMR.13.1.122-143.2000; Ghosh S, 2012, J PROTEOME RES, V11, P4992, DOI 10.1021/pr300562m; Hama H, 2000, METHODS, V20, P465, DOI 10.1006/meth.2000.0959; Hanes CS, 1932, BIOCHEM J, V26, P1406, DOI 10.1042/bj0261406; Heimburger DC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010687; Homann OR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000783; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Ilcol YO, 2005, J NUTR BIOCHEM, V16, P489, DOI 10.1016/j.jnutbio.2005.01.011; Jiang FY, 2012, BIORESOURCE TECHNOL, V104, P518, DOI 10.1016/j.biortech.2011.09.112; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; KLEIN J, 1993, NEUROCHEM INT, V22, P293, DOI 10.1016/0197-0186(93)90058-D; Kohler GA, 2006, BBA-MOL CELL BIOL L, V1761, P1391, DOI 10.1016/j.bbalip.2006.09.011; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leidich SD, 1998, J BIOL CHEM, V273, P26078, DOI 10.1074/jbc.273.40.26078; Mariggio S, 2006, FEBS LETT, V580, P6789, DOI 10.1016/j.febslet.2006.11.039; Moran GP, 2011, EUKARYOT CELL, V10, P34, DOI 10.1128/EC.00242-10; Mouillon JM, 2006, FEMS YEAST RES, V6, P171, DOI 10.1111/j.1567-1364.2006.00036.x; Ohshima N, 2008, J BACTERIOL, V190, P1219, DOI 10.1128/JB.01223-07; OVERDUIN P, 1988, MOL MICROBIOL, V2, P767, DOI 10.1111/j.1365-2958.1988.tb00088.x; Paban V, 2010, EUR J NEUROSCI, V31, P1063, DOI 10.1111/j.1460-9568.2010.07126.x; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; PATTON JL, 1995, J BACTERIOL, V177, P3379, DOI 10.1128/jb.177.12.3379-3385.1995; Patton-Vogt J, 2007, BBA-MOL CELL BIOL L, V1771, P337, DOI 10.1016/j.bbalip.2006.04.013; Persson BL, 2003, CURR GENET, V43, P225, DOI 10.1007/s00294-003-0400-9; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Romanowski K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030119; Santos MAS, 1997, MOL MICROBIOL, V26, P423, DOI 10.1046/j.1365-2958.1997.5891961.x; SENAR S, 1994, CELL SIGNAL, V6, P433, DOI 10.1016/0898-6568(94)90090-6; Taff HT, 2012, MED MYCOL, V50, P214, DOI 10.3109/13693786.2011.580016; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Theiss S, 2006, INT J MED MICROBIOL, V296, P405, DOI 10.1016/j.ijmm.2006.03.003; Walter A, 2004, NEUROBIOL AGING, V25, P1299, DOI 10.1016/j.neurobiolaging.2004.02.016; Wang YL, 2005, J PROTEOME RES, V4, P1324, DOI 10.1021/pr050032r; Wang Y, 2007, J PROTEOME RES, V6, P3944, DOI 10.1021/pr0702565; Wilson RB, 2000, YEAST, V16, P65, DOI 10.1002/(SICI)1097-0061(20000115)16:1&lt;65::AID-YEA508&gt;3.0.CO;2-M; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Xu SY, 2009, FEBS J, V276, P175, DOI 10.1111/j.1742-4658.2008.06771.x; Yanaka N, 2007, BIOSCI BIOTECH BIOCH, V71, P1811, DOI 10.1271/bbb.70062	59	16	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33939	33952		10.1074/jbc.M113.505735	http://dx.doi.org/10.1074/jbc.M113.505735			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24114876	Green Published, hybrid			2022-12-25	WOS:000327250200036
J	Gan, XQ; Wang, C; Patel, M; Kreutz, B; Zhou, M; Kozasa, T; Wu, DQ				Gan, Xiaoqing; Wang, Chen; Patel, Maulik; Kreutz, Barry; Zhou, Maggie; Kozasa, Tohru; Wu, Dianqing			Different Raf Protein Kinases Mediate Different Signaling Pathways to Stimulate E3 Ligase RFFL Gene Expression in Cell Migration Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Migration; Cell Signaling; G Proteins; Raf; Signal Transduction; Signaling	P115 RHOGEF; A-RAF; G-ALPHA(13); DEGRADATION; COMPLEX; G(13); ALPHA	We previously characterized a G12-specific signaling pathway that stimulates the transcription of the E3 ligase RFFL via the protein kinase ARAF and ERK. This pathway leads to persistent PKC activation and is important for sustaining fibroblast migration. However, questions remain regarding how G12 specifically activates ARAF, which transcription factor is involved in G12-mediated RFFL expression, and whether RFFL is important for cell migration stimulated by other signaling mechanisms that can activate ERK. In this study, we show that replacement of the G12 residue Arg-264 with Gln, which is the corresponding G13 residue, abrogates the ability of G12 to interact with or activate ARAF. We also show that G12 can no longer interact with and activate an ARAF mutant with its C-terminal sequence downstream of the kinase domain being replaced with the corresponding CRAF sequence. These results explain why G12, but not G13, specifically activates ARAF but not CRAF. Together with our finding that recombinant G12 is sufficient for stimulating the kinase activity of ARAF, this study reveals an ARAF activation mechanism that is different from that of CRAF. In addition, we show that this G12-ARAF-ERK pathway stimulates RFFL transcription through the transcription factor c-Myc. We further demonstrate that EGF, which signals through CRAF, and an activated BRAF mutant also activate PKC and stimulate cell migration through up-regulating RFFL expression. Thus, RFFL-mediated PKC activation has a broad significance in cell migration regulation.	[Gan, Xiaoqing; Wang, Chen; Zhou, Maggie; Wu, Dianqing] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Gan, Xiaoqing; Wang, Chen; Zhou, Maggie; Wu, Dianqing] Yale Univ, Sch Med, Program Vasc Biol & Therapeut, New Haven, CT 06520 USA; [Patel, Maulik; Kreutz, Barry; Kozasa, Tohru] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; [Kozasa, Tohru] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo 153, Japan	Yale University; Yale University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Tokyo	Wu, DQ (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA.	dan.wu@yale.edu	zhou, Maggie/GWQ-6970-2022	Zhou, Maggie/0000-0001-5308-0014	National Institutes of Health [HL070694, HL080706, GM061454]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070694, R01HL080706, R01HL120465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL070694 and HL080706 (to D. W.) and GM061454 (to T. K.).	Anliker B, 2004, SEMIN CELL DEV BIOL, V15, P457, DOI 10.1016/j.semcdb.2004.05.005; Baljuls A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702429200; Chen Z, 2005, NAT STRUCT MOL BIOL, V12, P191, DOI 10.1038/nsmb888; Gan XQ, 2012, NAT CELL BIOL, V14, P686, DOI 10.1038/ncb2507; Gong HX, 2010, SCIENCE, V327, P340, DOI 10.1126/science.1174779; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Herroeder S, 2009, IMMUNITY, V30, P708, DOI 10.1016/j.immuni.2009.02.010; Ki SH, 2007, J BIOL CHEM, V282, P1938, DOI 10.1074/jbc.M606080200; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kreutz B, 2006, BIOCHEMISTRY-US, V45, P167, DOI 10.1021/bi051729t; Marais R, 1997, J BIOL CHEM, V272, P4378, DOI 10.1074/jbc.272.7.4378; Moers A, 2003, NAT MED, V9, P1418, DOI 10.1038/nm943; Radhika V, 2005, ONCOGENE, V24, P4597, DOI 10.1038/sj.onc.1208665; Roskoski R, 2010, BIOCHEM BIOPH RES CO, V399, P313, DOI 10.1016/j.bbrc.2010.07.092; Shan DD, 2006, DEV CELL, V10, P707, DOI 10.1016/j.devcel.2006.03.014; Sivaraj KK, 2013, DEV CELL, V25, P427, DOI 10.1016/j.devcel.2013.04.008; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Udell CM, 2011, CELL MOL LIFE SCI, V68, P553, DOI 10.1007/s00018-010-0520-6; Won HY, 2010, BIOCHEM BIOPH RES CO, V394, P811, DOI 10.1016/j.bbrc.2010.03.079; Worzfeld T, 2008, TRENDS PHARMACOL SCI, V29, P582, DOI 10.1016/j.tips.2008.08.002	22	12	12	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33978	33984		10.1074/jbc.M113.477406	http://dx.doi.org/10.1074/jbc.M113.477406			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24114843	Green Published, hybrid			2022-12-25	WOS:000327250200039
J	Alves, AC; Bruhn, S; Ramasamy, A; Wang, H; Holloway, JW; Hartikainen, AL; Jarvelin, MR; Benson, M; Balding, DJ; Coin, LJM				Alves, Alexessander Couto; Bruhn, Soren; Ramasamy, Adaikalavan; Wang, Hui; Holloway, John W.; Hartikainen, Anna-Liisa; Jarvelin, Marjo-Riitta; Benson, Mikael; Balding, David J.; Coin, Lachlan J. M.			Dysregulation of Complement System and CD4+T Cell Activation Pathways Implicated in Allergic Response	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SET ENRICHMENT ANALYSIS; NETWORK-BASED ANALYSIS; T-CELLS; MICROARRAY EXPERIMENTS; IMMUNE-RESPONSES; GENE-EXPRESSION; NASAL-MUCOSA; RHINITIS; ASTHMA	Allergy is a complex disease that is likely to involve dysregulated CD4+ T cell activation. Here we propose a novel methodology to gain insight into how coordinated behaviour emerges between disease-dysregulated pathways in response to pathophysiological stimuli. Using peripheral blood mononuclear cells of allergic rhinitis patients and controls cultured with and without pollen allergens, we integrate CD4+ T cell gene expression from microarray data and genetic markers of allergic sensitisation from GWAS data at the pathway level using enrichment analysis; implicating the complement system in both cellular and systemic response to pollen allergens. We delineate a novel disease network linking T cell activation to the complement system that is significantly enriched for genes exhibiting correlated gene expression and protein-protein interactions, suggesting a tight biological coordination that is dysregulated in the disease state in response to pollen allergen but not to diluent. This novel disease network has high predictive power for the gene and protein expression of the Th2 cytokine profile (IL-4, IL-5, IL-10, IL-13) and of the Th2 master regulator (GATA3), suggesting its involvement in the early stages of CD4+ T cell differentiation. Dissection of the complement system gene expression identifies 7 genes specifically associated with atopic response to pollen, including C1QR1, CFD, CFP, ITGB2, ITGAX and confirms the role of C3AR1 and C5AR1. Two of these genes (ITGB2 and C3AR1) are also implicated in the network linking complement system to T cell activation, which comprises 6 differentially expressed genes. C3AR1 is also significantly associated with allergic sensitisation in GWAS data.	[Alves, Alexessander Couto; Ramasamy, Adaikalavan; Jarvelin, Marjo-Riitta; Balding, David J.] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London, England; [Ramasamy, Adaikalavan] Kings Coll London, Dept Med & Mol Genet, London, England; [Balding, David J.] UCL, Genet Inst, London WC1E 6BT, England; [Bruhn, Soren; Wang, Hui; Benson, Mikael] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Holloway, John W.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Wang, Hui] Gothenburg Univ, Dept Paediat, Gothenburg, Sweden; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Hosp Oulu, Unit Gen Practice, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Oulu, Finland; [Hartikainen, Anna-Liisa] Univ Oulu, Inst Clin Med, Dept Clin Sci Obstet & Gynecol, Oulu, Finland; [Coin, Lachlan J. M.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Genom Common Dis, London, England; [Coin, Lachlan J. M.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	Imperial College London; University of London; King's College London; University of London; University College London; Linkoping University; University of Southampton; University of Gothenburg; University of Oulu; University of Oulu; Finland National Institute for Health & Welfare; University of Oulu; Imperial College London; University of Queensland	Alves, AC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London, England.	acoutoal@imperial.ac.uk; l.coin@imperial.ac.uk	Balding, David/G-9898-2011; Ramasamy, Adaikalavan/G-2632-2010; Coin, Lachlan JM/A-9001-2014; Coin, Lachlan/O-4976-2019; Holloway, John W/B-5424-2009	Balding, David/0000-0002-1480-6115; Ramasamy, Adaikalavan/0000-0002-7598-2892; Coin, Lachlan JM/0000-0002-4300-455X; Coin, Lachlan/0000-0002-4300-455X; Holloway, John W/0000-0001-9998-0464; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Couto Alves, Alex/0000-0001-8519-7356	European Commission [223367]; Academy of Finland (Centre of Excellence in Complex Disease Genetics and SALVE) [104781, 120315, 129269, 1114194, 139900/24300796]; University Hospital Oulu; Biocenter; University of Oulu [75617]; NHLBI through STAMPEED program [5R01HL087679-02, 1RL1MH083268-01]; NIH/NIMH [5R01MH63706:02]; ENGAGE project [HEALTH-F4-2007-201413]; Medical Research Council, UK (PrevMetSyn/SALVE); Academy of Finland; Biocentrum Helsinki; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RL1MH083268, R01MH063706] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); Academy of Finland (Centre of Excellence in Complex Disease Genetics and SALVE); University Hospital Oulu; Biocenter; University of Oulu; NHLBI through STAMPEED program; NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ENGAGE project(General Electric); Medical Research Council, UK (PrevMetSyn/SALVE)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Finland(Academy of Finland); Biocentrum Helsinki; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	ACA, LC, DB, SB, JH, and MB acknowledge funding from European Commission, Framework 7, grant number 223367 (MultiMod). NFBC1966 received financial support from the Academy of Finland (project grants 104781, 120315, 129269, 1114194, 139900/24300796, Centre of Excellence in Complex Disease Genetics and SALVE), University Hospital Oulu, Biocenter, University of Oulu (75617), NHLBI grant 5R01HL087679-02 through the STAMPEED program (1RL1MH083268-01), NIH/NIMH (5R01MH63706:02), ENGAGE project HEALTH-F4-2007-201413, the Medical Research Council, UK (PrevMetSyn/SALVE). The DNA extractions, sample quality controls, biobank upkeep and aliquotting was performed in the National Public Health Institute, Biomedicum Helsinki, Finland and supported financially by the Academy of Finland and Biocentrum Helsinki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowicz M, 1970, PEDIATRICS, V46; Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; Alves A, 2005, P ECML PKDD DISC CHA, P60; ANDERSSON M, 1994, ALLERGY, V49, P242, DOI 10.1111/j.1398-9995.1994.tb02656.x; Barrenas F, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r46; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson M, 2006, GENES IMMUN, V7, P514, DOI 10.1038/sj.gene.6364322; Benson M, 2006, J ALLERGY CLIN IMMUN, V118, P220, DOI 10.1016/j.jaci.2006.03.006; Boussiotis VA, 1997, SCIENCE, V278, P124, DOI 10.1126/science.278.5335.124; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; CHEN A, 1994, J IMMUNOL, V153, P1430; Chen M, 2010, J AUTOIMMUN, V34, pJ276, DOI 10.1016/j.jaut.2009.11.014; Colak R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013348; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Deng J, 2002, INT IMMUNOL, V14, P513, DOI 10.1093/intimm/14.5.513; Fang C, 2011, BLOOD; Gandibleux X., 2002, MULTIPLE CRITERIA OP; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hansel NN, 2008, ALLERGY, V63, P366, DOI 10.1111/j.1398-9995.2007.01540.x; Hawlisch H, 2004, MOL IMMUNOL, V41, P123, DOI 10.1016/j.molimm.2004.03.019; Hong FX, 2008, BIOINFORMATICS, V24, P374, DOI 10.1093/bioinformatics/btm620; Hu PZ, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-106; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hunninghake GM, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-17; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Johnson T, 2010, QUICKTEST QUICK TEST; Jun SW, 2008, J ALLERGY CLIN IMMUN, V122, P119, DOI 10.1016/j.jaci.2008.04.028; Kawamoto S, 2004, J CLIN INVEST, V114, P399, DOI 10.1172/jci200419082; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Kemp KL, 2010, J IMMUNOL, V184, P4178, DOI 10.4049/jimmunol.0901282; Kemper C, 2003, NATURE, V421, P388, DOI 10.1038/nature01315; Kemper C, 2007, NAT REV IMMUNOL, V7, P9, DOI 10.1038/nri1994; Kneidinger M, 2008, BLOOD, V111, P3097, DOI 10.1182/blood-2007-08-104372; Kohl J, 2006, J CLIN INVEST, V116, P783, DOI 10.1172/JCI26582; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; Lalli PN, 2008, BLOOD, V112, P1759, DOI 10.1182/blood-2008-04-151068; Lalli PN, 2007, J IMMUNOL, V179, P5793, DOI 10.4049/jimmunol.179.9.5793; Lambrecht BN, 2006, J CLIN INVEST, V116, P628, DOI 10.1172/JCI27876; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Lim H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052666; Lo JC, 2006, BLOOD, V107, P1048, DOI 10.1182/blood-2005-06-2452; Lumley T, 2009, RMETA METAANALYSIS R; Mak TW, 1998, GENE KNOCKOUT FACTSB; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Paternoster L, 2012, NAT GENET, V44, P187, DOI 10.1038/ng.1017; Pekkarinen PT, 2011, IMMUNOBIOLOGY, V216, P737, DOI 10.1016/j.imbio.2010.10.004; Ramasamy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044008; Ramasamy A, 2011, J ALLERGY CLIN IMMUN, V128, P996, DOI 10.1016/j.jaci.2011.08.030; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; SCHWAEBLE W, 1993, J IMMUNOL, V151, P2521; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szczepankiewicz A, 2008, INT ARCH ALLERGY IMM, V145, P43, DOI 10.1159/000107465; Takeda K, 2011, J IMMUNOLOGY; Tamura T, 2001, J IMMUNOL, V167, P1962, DOI 10.4049/jimmunol.167.4.1962; VARNEY VA, 1992, AM REV RESPIR DIS, V146, P170, DOI 10.1164/ajrccm/146.1.170; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wambre E, 2011, CLIN EXP ALLERGY, V41, P192, DOI 10.1111/j.1365-2222.2010.03641.x; Wang H, 2011, ALLERGY, V66, P132, DOI 10.1111/j.1398-9995.2010.02444.x; Wang H, 2010, CLIN EXP ALLERGY, V40, P1194, DOI 10.1111/j.1365-2222.2010.03542.x; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang X, 2011, BIOINFORMATICS, V27, P879, DOI 10.1093/bioinformatics/btr028; Wills-Karp Marsha, 2007, Proc Am Thorac Soc, V4, P247, DOI 10.1513/pats.200704-046AW; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Xiong Q, 2012, GENOME RES, V22, P386, DOI 10.1101/gr.124370.111; Zhang KL, 2010, NUCLEIC ACIDS RES, V38, pW90, DOI 10.1093/nar/gkq324; Zhang XP, 2010, J BIOL CHEM, V285, P31571, DOI 10.1074/jbc.M110.134650; Zhang X, 2010, EXPERT REV CLIN IMMU, V6, P269, DOI 10.1586/ECI.09.84; Zhao YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039016	73	11	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e74821	10.1371/journal.pone.0074821	http://dx.doi.org/10.1371/journal.pone.0074821			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116013	Green Published, Green Accepted, gold			2022-12-25	WOS:000325552200004
J	Feroz, SR; Mohamad, SB; Bakri, ZSD; Malek, SNA; Tayyab, S				Feroz, Shevin R.; Mohamad, Saharuddin B.; Bakri, Zarith S. D.; Malek, Sri N. A.; Tayyab, Saad			Probing the Interaction of a Therapeutic Flavonoid, Pinostrobin with Human Serum Albumin: Multiple Spectroscopic and Molecular Modeling Investigations	PLOS ONE			English	Article							LIGAND-BINDING; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; SUBDOMAIN IIA; PROTEIN; THERMODYNAMICS; DENATURATION; STABILITY; BILIRUBIN; SITES	Interaction of a pharmacologically important flavonoid, pinostrobin (PS) with the major transport protein of human blood circulation, human serum albumin (HSA) has been examined using a multitude of spectroscopic techniques and molecular docking studies. Analysis of the fluorescence quenching data showed a moderate binding affinity (1.03 x 10(5) M-1 at 25 degrees C) between PS and HSA with a 1: 1 stoichiometry. Thermodynamic analysis of the binding data (Delta S = +44.06 J mol(-1) K-1 and Delta H = -15.48 kJ mol(-1)) and molecular simulation results suggested the involvement of hydrophobic and van der Waals forces, as well as hydrogen bonding in the complex formation. Both secondary and tertiary structural perturbations in HSA were observed upon PS binding, as revealed by intrinsic, synchronous, and three-dimensional fluorescence results. Far-UV circular dichroism data revealed increased thermal stability of the protein upon complexation with PS. Competitive drug displacement results suggested the binding site of PS on HSA as Sudlow's site I, located at subdomain IIA, and was well supported by the molecular modelling data.	[Feroz, Shevin R.; Bakri, Zarith S. D.; Malek, Sri N. A.; Tayyab, Saad] Univ Malaya, Fac Sci, Inst Biol Sci, Biomol Res Grp,Biochem Programme, Kuala Lumpur, Malaysia; [Mohamad, Saharuddin B.] Univ Malaya, Fac Sci, Inst Biol Sci, Bioinformat Programme, Kuala Lumpur, Malaysia; [Mohamad, Saharuddin B.; Tayyab, Saad] Univ Malaya, Fac Sci, Inst Biol Sci, Ctr Res Computat Sci & Informat Biol Bioind Envir, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Tayyab, S (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Biomol Res Grp,Biochem Programme, Kuala Lumpur, Malaysia.	saadtayyab2004@yahoo.com	TAYYAB, SAAD/B-5490-2010; Malek, Sri Nurestri/W-8556-2019; MOHAMAD, SAHARUDDIN/B-9665-2010; Malek, Sri Nurestri Abd/B-9834-2010; Feroz, Shevin Rizal/AAZ-9913-2020	TAYYAB, SAAD/0000-0003-1826-3098; Malek, Sri Nurestri/0000-0001-6278-8559; Malek, Sri Nurestri Abd/0000-0001-6278-8559; Feroz, Shevin Rizal/0000-0002-9426-2911	HIR Grant by the Ministry of Higer Education, Government of Malaysia [F000002-21001]	HIR Grant by the Ministry of Higer Education, Government of Malaysia	This work was financially supported by an HIR Grant (F000002-21001) sanctioned by the Ministry of Higer Education, Government of Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Zied OK, 2008, J AM CHEM SOC, V130, P10793, DOI 10.1021/ja8031289; Ahmad E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026186; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bi SY, 2004, J MOL STRUCT, V703, P37, DOI 10.1016/j.molstruc.2004.05.026; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; Celej MS, 2003, PROTEIN SCI, V12, P1496, DOI 10.1110/ps.0240003; Dangles O., 2006, Flavonoids: chemistry, biochemistry and applications, P443; Demchenko A.P., 2009, INTRO FLUORESCENCE S; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Fahey JF, 2002, J AGR FOOD CHEM, V50, P7472, DOI 10.1021/jf025692k; Faizul FM, 2008, J PHOTOCH PHOTOBIO B, V90, P1, DOI 10.1016/j.jphotobiol.2007.10.002; Feroz SR, 2012, J AGR FOOD CHEM, V60, P5899, DOI 10.1021/jf301139h; Freitas PG, 2012, J LUMIN, V132, P3027, DOI 10.1016/j.jlumin.2012.06.020; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; JACOBSEN J, 1974, CLIN CHEM, V20, P783; Kalanur SS, 2010, J PHARMACEUT BIOMED, V53, P660, DOI 10.1016/j.jpba.2010.05.025; KHANNA NC, 1986, J BIOL CHEM, V261, P8883; Kragh-Hansen U, 2002, BIOL PHARM BULL, V25, P695, DOI 10.1248/bpb.25.695; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; Le Bail JC, 2000, CANCER LETT, V156, P37, DOI 10.1016/S0304-3835(00)00435-3; Olsson TSG, 2008, J MOL BIOL, V384, P1002, DOI 10.1016/j.jmb.2008.09.073; Pedretti A, 2002, J MOL GRAPH MODEL, V21, P47, DOI 10.1016/S1093-3263(02)00123-7; Peters T., 1996, ALL ALBUMIN BIOCH GE; Petitpas I, 2001, J BIOL CHEM, V276, P22804, DOI 10.1074/jbc.M100575200; Ross PD, 1996, BIOPHYS J, V71, P2144, DOI 10.1016/S0006-3495(96)79415-8; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Saquib Q, 2011, FOOD CHEM TOXICOL, V49, P1787, DOI 10.1016/j.fct.2011.04.028; SHRAKE A, 1990, J BIOL CHEM, V265, P5055; SUDLOW G, 1975, MOL PHARMACOL, V11, P824; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Trnkova L, 2011, J MOL STRUCT, V985, P243, DOI 10.1016/j.molstruc.2010.11.001; Trynda-Lemiesz L, 2004, BIOORGAN MED CHEM, V12, P3269, DOI 10.1016/j.bmc.2004.03.073; Twine SM, 2003, ARCH BIOCHEM BIOPHYS, V414, P83, DOI 10.1016/S0003-9861(03)00173-5; van de Weert M, 2011, J MOL STRUCT, V998, P144, DOI 10.1016/j.molstruc.2011.05.023; Vermeer AWP, 2000, BIOPHYS J, V78, P394, DOI 10.1016/S0006-3495(00)76602-1; WALLEVIK K, 1973, J BIOL CHEM, V248, P2650; Watanabe H, 2000, BIOCHEM J, V349, P813, DOI 10.1042/bj3490813; Wu D, 2002, J AGR FOOD CHEM, V50, P701, DOI 10.1021/jf010963x; Wu N, 2011, PHYTOMEDICINE, V18, P110, DOI 10.1016/j.phymed.2010.07.001; Zaroog MS, 2012, PROCESS BIOCHEM, V47, P775, DOI 10.1016/j.procbio.2012.02.008	42	75	79	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76067	10.1371/journal.pone.0076067	http://dx.doi.org/10.1371/journal.pone.0076067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116089	Green Submitted, Green Published, gold			2022-12-25	WOS:000325552200048
J	Nagai, K; Tahara-Hanaoka, S; Morishima, Y; Tokunaga, T; Imoto, Y; Noguchi, E; Kanemaru, K; Imai, M; Shibayama, S; Hizawa, N; Fujieda, S; Yamagata, K; Shibuya, A				Nagai, Kei; Tahara-Hanaoka, Satoko; Morishima, Yuko; Tokunaga, Takahiro; Imoto, Yoshimasa; Noguchi, Emiko; Kanemaru, Kazumasa; Imai, Masamichi; Shibayama, Shiro; Hizawa, Nobuyuki; Fujieda, Shigeharu; Yamagata, Kunihiro; Shibuya, Akira			Expression and Function of Allergin-1 on Human Primary Mast Cells	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE RECEPTORS; BRONCHOALVEOLAR LAVAGE; IMMUNE-RESPONSES; ACTIVATION; IMMUNORECEPTOR; IDENTIFICATION; BASOPHILS; CYTOKINES; ANTIGENS; INNATE	Mast cells (MC) play an important role in allergic and non-allergic immune responses. Activation of human MC is modulated by several cell surface inhibitory receptors, including recently identified Allergin-1 expressed on both human and mouse MC. Although Allergin-1 suppresses IgE-mediated, mast cell-dependent anaphylaxis in mice, the expression profile and function of Allergin-1 on human primary MC remains undetermined. Here, we established a seven-color flow cytometry method for assessing expression and function of a very small number of human primary MC. We show that Allergin-1S1, a splicing isoform of Allergin-1, is predominantly expressed on human primary MC in both bronchoalveolar lavage (BAL) fluid and nasal scratching specimens. Moreover, Allergin-1S1 inhibits IgE-mediated activation from human primary MC in BAL fluid. These results indicate that Allergin-1 on human primary MC exhibits similar characteristics as mouse Allergin-1 in the expression profile and function.	[Nagai, Kei; Tahara-Hanaoka, Satoko; Kanemaru, Kazumasa; Shibuya, Akira] Univ Tsukuba, Dept Immunol, Fac Med, Tsukuba, Ibaraki, Japan; [Nagai, Kei; Yamagata, Kunihiro] Univ Tsukuba, Dept Nephrol, Fac Med, Tsukuba, Ibaraki, Japan; [Morishima, Yuko; Hizawa, Nobuyuki] Univ Tsukuba, Dept Pulm Med, Fac Med, Tsukuba, Ibaraki, Japan; [Noguchi, Emiko] Univ Tsukuba, Dept Med Genet, Fac Med, Tsukuba, Ibaraki, Japan; [Nagai, Kei; Tahara-Hanaoka, Satoko; Noguchi, Emiko; Kanemaru, Kazumasa; Shibuya, Akira] Japan Sci & Technol Agcy JST, CREST, Tokyo, Japan; [Tokunaga, Takahiro; Imoto, Yoshimasa; Fujieda, Shigeharu] Univ Fukui, Dept Otorhinolaryngol & Head & Neck Surg, Fukui 910, Japan; [Imai, Masamichi; Shibayama, Shiro] Ono Pharmaceut Co Ltd, Tsukuba Res Inst, Exploratory Res Labs, Tsukuba, Ibaraki, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba; University of Tsukuba; Japan Science & Technology Agency (JST); University of Fukui; Novartis; Ono Pharmaceutical Co Ltd	Shibuya, A (corresponding author), Univ Tsukuba, Dept Immunol, Fac Med, Tsukuba, Ibaraki, Japan.	ashibuya@md.tsukuba.ac.jp		Nagai, Kei/0000-0001-5050-5291	Ministry of Education, Culture, Sports, Science and Technology of Japan; Uehara Memorial Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation)	This research was supported in part by grants provided by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Uehara Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachelet I, 2005, J IMMUNOL, V175, P7989, DOI 10.4049/jimmunol.175.12.7989; Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; CASALE TB, 1987, J CLIN INVEST, V79, P1197, DOI 10.1172/JCI112937; Cheng LE, 2013, IMMUNITY, V38, P166, DOI 10.1016/j.immuni.2012.09.022; Chlap Z, 1998, Pneumonol Alergol Pol, V66, P321; Florian S, 2006, ALLERGY, V61, P1054, DOI 10.1111/j.1398-9995.2006.01171.x; Galli SJ, 2000, CURR OPIN HEMATOL, V7, P32, DOI 10.1097/00062752-200001000-00007; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Galli SJ, 2010, EUR J IMMUNOL, V40, P1843, DOI 10.1002/eji.201040559; Gekara NO, 2008, CELL MICROBIOL, V10, P225, DOI 10.1111/j.1462-5822.2007.01033.x; Grutzkau A, 2004, CYTOM PART A, V61A, P62, DOI 10.1002/cyto.a.20068; HASLAM PL, 1987, AM REV RESPIR DIS, V135, P35; Hauswirth Alexander W, 2006, Methods Mol Biol, V315, P77; Hitomi K, 2010, NAT IMMUNOL, V11, P601, DOI 10.1038/ni.1886; HUNT LW, 1992, MAYO CLIN PROC, V67, P941, DOI 10.1016/S0025-6196(12)60924-0; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Kumagai H, 2003, BIOCHEM BIOPH RES CO, V307, P719, DOI 10.1016/S0006-291X(03)01245-2; Lienard H, 1999, J BIOL CHEM, V274, P32493, DOI 10.1074/jbc.274.45.32493; Malbec O, 1998, J IMMUNOL, V160, P1647; Masuda A, 2007, J EXP MED, V204, P907, DOI 10.1084/jem.20060631; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Nakahashi-Oda C, 2012, BIOCHEM BIOPH RES CO, V417, P646, DOI 10.1016/j.bbrc.2011.12.025; Oskeritzian CA, 2010, J EXP MED, V207, P465, DOI 10.1084/jem.20091513; Saito H, 2006, NAT PROTOC, V1, P2178, DOI 10.1038/nprot.2006.344; Sandig H, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00185; Schildge J, 2003, Pneumologie, V57, P202, DOI 10.1055/s-2003-38569; SCHWARTZ LB, 1994, CURR OPIN IMMUNOL, V6, P91, DOI 10.1016/0952-7915(94)90039-6; SOLER P, 1987, THORAX, V42, P565, DOI 10.1136/thx.42.8.565; Valent F, 2001, IMMUNOL REV, V179, P74, DOI 10.1034/j.1600-065X.2001.790108.x; Yotsumoto K, 2003, J EXP MED, V198, P223, DOI 10.1084/jem.20021825; Zhao W, 2005, J IMMUNOL, V175, P2635, DOI 10.4049/jimmunol.175.4.2635	31	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76160	10.1371/journal.pone.0076160	http://dx.doi.org/10.1371/journal.pone.0076160			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116093	Green Submitted, gold, Green Published			2022-12-25	WOS:000325501300048
J	Abraham, DM; Wolf, MJ				Abraham, Dennis M.; Wolf, Matthew J.			Disruption of Sarcoendoplasmic Reticulum Calcium ATPase Function in Drosophila Leads to Cardiac Dysfunction	PLOS ONE			English	Article							MYOCARDIAL-CONTRACTILITY; MUSCLE DYSFUNCTION; HEART; GENE; PHOSPHOLAMBAN; MELANOGASTER; CA2+-ATPASE; EXPRESSION; CARDIOMYOPATHY; PHOSPHORYLATION	Abnormal sarcoendoplasmic reticulum Calcium ATPase (SERCA) function has been associated with poor cardiac function in humans. While modifiers of SERCA function have been identified and studied using animal models, further investigation has been limited by the absence of a model system that is amenable to large-scale genetic screens. Drosophila melanogaster is an ideal model system for the investigation of SERCA function due to the significant homology to human SERCA and the availability of versatile genetic screening tools. To further the use of Drosophila as a model for examining the role of SERCA in cardiac function, we examined cardiac function in adult flies. Using optical coherence tomography (OCT) imaging in awake, adult Drosophila, we have been able to characterize cardiac chamber dimensions in flies with disrupted in Drosophila SERCA (CaP60A). We found that the best studied CaP60A mutant, the conditional paralytic mutant CaP60A(kum170), develops marked bradycardia and chamber enlargement that is closely linked to the onset of paralysis and dependent on extra cardiac CaP60A. In contrast to prior work, we show that disruption of CaP60A in a cardiac specific manner results in cardiac dilation and dysfunction rather than alteration in heart rate. In addition, the co-expression of a calcium release channel mutation with CaP60A (kum170) is sufficient to rescue the cardiac phenotype but not paralysis. Finally, we show that CaP60A overexpression is able to rescue cardiac function in a model of Drosophila cardiac dysfunction similar to what is observed in mammals. Thus, we present a cardiac phenotype associated with Drosophila SERCA dysfunction that would serve as additional phenotyping for further large-scale genetic screens for novel modifiers of SERCA function.	[Abraham, Dennis M.; Wolf, Matthew J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University	Wolf, MJ (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	matthew.j.wolf@dm.duke.edu	WOLF, MATTHEW/AHC-5201-2022	Wolf, Matthew/0000-0001-8004-4852	NIH [T32 HL007101-35, R01 HL116581-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007101, R01HL116581] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by the NIH (T32 HL007101-35 to DMA and R01 HL116581-01 to MJW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allikian MJ, 2007, HUM MOL GENET, V16, P2933, DOI 10.1093/hmg/ddm254; Andersson KB, 2009, J MOL CELL CARDIOL, V47, P180, DOI 10.1016/j.yjmcc.2009.03.013; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Casad ME, 2011, GENETICS, V189, P861, DOI 10.1534/genetics.111.131482; FUJII J, 1989, J BIOL CHEM, V264, P12950; FUJII J, 1987, J CLIN INVEST, V79, P301, DOI 10.1172/JCI112799; Goldstein JA, 2011, HUM MOL GENET, V20, P894, DOI 10.1093/hmg/ddq528; Jessup M, 2011, CIRCULATION, V124, P304, DOI 10.1161/CIRCULATIONAHA.111.022889; Kim IM, 2010, CIRC RES, V106, P1233, DOI 10.1161/CIRCRESAHA.109.213785; Koss KL, 1996, CIRC RES, V79, P1059, DOI 10.1161/01.RES.79.6.1059; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Loukianov E, 1998, CIRC RES, V83, P889; Magny EG, 2013, SCIENCE, V341, P1116, DOI 10.1126/science.1238802; MAGYAR A, 1995, BIOCHEM J, V310, P757, DOI 10.1042/bj3100757; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Minamisawa S, 2003, J BIOL CHEM, V278, P9570, DOI 10.1074/jbc.M213132200; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Misquitta CM, 1999, BIOCHEM J, V338, P167, DOI 10.1042/0264-6021:3380167; Sakata S, 2007, AM J PHYSIOL-HEART C, V292, pH2356, DOI 10.1152/ajpheart.01310.2006; Sanyal S, 2006, J COMP PHYSIOL B, V176, P253, DOI 10.1007/s00360-005-0046-7; Sanyal S, 2005, GENETICS, V169, P737, DOI 10.1534/genetics.104.031930; SIMMERMAN HKB, 1986, J BIOL CHEM, V261, P3333; Sullivan KMC, 2000, P NATL ACAD SCI USA, V97, P5942, DOI 10.1073/pnas.110145997; Vazquez-Martinez O, 2003, J CELL SCI, V116, P2483, DOI 10.1242/jcs.00455; Wolf MJ, 2011, CIRC RES, V109, P794, DOI 10.1161/CIRCRESAHA.111.244897; Wolf MJ, 2006, P NATL ACAD SCI USA, V103, P1394, DOI 10.1073/pnas.0507359103; Yin ZZ, 1998, DEV GENET, V22, P187; Yu L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000969	28	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e77785	10.1371/journal.pone.0077785	http://dx.doi.org/10.1371/journal.pone.0077785			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098595	Green Submitted, Green Published, gold			2022-12-25	WOS:000325483600089
J	Al-Shorbagy, MY; El Sayeh, BM; Abdallah, DM				Al-Shorbagy, Muhammad Y.; El Sayeh, Bahia M.; Abdallah, Dalaal M.			Additional Antiepileptic Mechanisms of Levetiracetam in Lithium-Pilocarpine Treated Rats	PLOS ONE			English	Article							INDUCED STATUS EPILEPTICUS; OXIDATIVE STRESS; INTRAVENOUS LEVETIRACETAM; SEIZURE SUSCEPTIBILITY; SUPEROXIDE-DISMUTASE; DRUG LEVETIRACETAM; BRAIN; MODEL; INFLAMMATION; HIPPOCAMPUS	Several studies have addressed the antiepileptic mechanisms of levetiracetam (LEV); however, its effect on catecholamines and the inflammatory mediators that play a role in epilepsy remain elusive. In the current work, lithium (Li) pretreated animals were administered LEV (500 mg/kg i.p) 30 min before the induction of convulsions by pilocarpine (PIL). Li-PIL-induced seizures were accompanied by increased levels of hippocampal prostaglandin (PG) E-2, myeloperoxidase (MPO), tumor necrosis factor-a, and interleukin-10. Moreover, it markedly elevated hippocampal lipid peroxides and nitric oxide levels, while it inhibited the glutathione content. Li-PIL also reduced hippocampal noradrenaline, as well as dopamine contents. Pretreatment with LEV protected against Li-PIL-induced seizures, where it suppressed the severity and delayed the onset of seizures in Li-PIL treated rats. Moreover, LEV reduced PGE(2) and MPO, yet it did not affect the level of both cytokines in the hippocampus. LEV also normalized hippocampal noradrenaline, dopamine, glutathione, lipid peroxides, and nitric oxide contents. In conclusion, alongside its antioxidant property, LEV anticonvulsive effect involves catecholamines restoration, as well as inhibition of PGE(2), MPO, and nitric oxide.	[Al-Shorbagy, Muhammad Y.; El Sayeh, Bahia M.; Abdallah, Dalaal M.] Cairo Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University	Abdallah, DM (corresponding author), Cairo Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt.	dalabdallah@staff.cu.edu.eg	Al-Shorbagy, Muhammad/R-3968-2019; Abdallah, Dalaal/GVT-0783-2022	Al-Shorbagy, Muhammad/0000-0002-5104-6821; 				Abdallah DM, 2010, BRAIN RES, V1351, P246, DOI 10.1016/j.brainres.2010.06.034; Ahishali B, 2010, LIFE SCI, V87, P609, DOI 10.1016/j.lfs.2010.09.014; Aiguabella M, 2011, SEIZURE-EUR J EPILEP, V20, P60, DOI 10.1016/j.seizure.2010.10.009; ALAM AM, 1993, NEUROSCIENCE, V53, P425, DOI 10.1016/0306-4522(93)90206-U; Amantea D, 2009, FEBS J, V276, P13, DOI 10.1111/j.1742-4658.2008.06766.x; Balosso S, 2008, BRAIN, V131, P3256, DOI 10.1093/brain/awn271; Barczynski B, 2011, EUR J PHARMACOL, V650, P550, DOI 10.1016/j.ejphar.2010.10.039; Bellissimo MI, 2001, EPILEPSY RES, V46, P121, DOI 10.1016/S0920-1211(01)00269-8; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Cai F, 2007, FOLIA BIOL-PRAGUE, V53, P164; Chachua T, 2010, Georgian Med News, P34; Chuang YC, 2010, J NEUROSCI RES, V88, P1898, DOI 10.1002/jnr.22369; Clinckers R, 2010, J NEUROCHEM, V115, P1595, DOI 10.1111/j.1471-4159.2010.07065.x; ELHAMDI G, 1992, INT J DEV NEUROSCI, V10, P301; FEE JA, 1972, BIOCHEM BIOPH RES CO, V49, P150, DOI 10.1016/0006-291X(72)90022-8; Fornai F, 2011, EUR J NEUROSCI, V33, P2169, DOI 10.1111/j.1460-9568.2011.07707.x; Freitas RM, 2010, NEUROSCI LETT, V477, P129, DOI 10.1016/j.neulet.2010.04.048; Glien M, 2002, EPILEPSIA, V43, P350, DOI 10.1046/j.1528-1157.2002.18101.x; Gower AJ, 1995, EPILEPSY RES, V22, P207, DOI 10.1016/0920-1211(95)00077-1; Gurses C, 2009, BRAIN RES, V1281, P71, DOI 10.1016/j.brainres.2009.05.033; HSU KS, 1995, BRAIN RES, V690, P264, DOI 10.1016/0006-8993(95)00734-8; Husum H, 2004, EPILEPSY BEHAV, V5, P204, DOI 10.1016/j.yebeh.2003.12.004; Institute for Laboratory Animal Research (ILAR), 1996, GUIDE CARE USE LAB A; Janz R, 1999, NEURON, V24, P1003, DOI 10.1016/S0896-6273(00)81046-6; Jobe PC, 1999, CRIT REV NEUROBIOL, V13, P317, DOI 10.1615/CritRevNeurobiol.v13.i4.10; Kaminski RM, 2008, NEUROPHARMACOLOGY, V54, P715, DOI 10.1016/j.neuropharm.2007.11.021; Lee CY, 2009, BRIT J PHARMACOL, V158, P1753, DOI 10.1111/j.1476-5381.2009.00463.x; Liang LP, 2004, FREE RADICAL BIO MED, V36, P542, DOI 10.1016/j.freeradbiomed.2003.11.029; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Lyseng-Williamson KA, 2011, DRUGS, V71, P489, DOI 10.2165/11204490-000000000-00000; Marchi N, 2009, NEUROBIOL DIS, V33, P171, DOI 10.1016/j.nbd.2008.10.002; Marini H, 2004, LIFE SCI, V74, P1253, DOI 10.1016/j.lfs.2003.08.006; Mark KS, 2001, J PHARMACOL EXP THER, V297, P1051; Meehan AL, 2012, EPILEPSIA, V53, P469, DOI 10.1111/j.1528-1167.2011.03392.x; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; NAFFAHMAZZACORATTI MG, 1995, NEUROCHEM INT, V27, P461, DOI 10.1016/0197-0186(95)00053-B; Niespodziany I, 2001, NEUROSCI LETT, V306, P5, DOI 10.1016/S0304-3940(01)01884-5; Nogawa S, 1997, J NEUROSCI, V17, P2746; Oliveira AA, 2007, CELL MOL NEUROBIOL, V27, P395, DOI 10.1007/s10571-006-9132-y; OLNEY JW, 1990, EXP NEUROL, V108, P269, DOI 10.1016/0014-4886(90)90134-E; Page KM, 1998, J NEUROSCI, V18, P4815; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Rigo JM, 2002, BRIT J PHARMACOL, V136, P659, DOI 10.1038/sj.bjp.0704766; Scorza FA, 2009, AN ACAD BRAS CIENC, V81, P345, DOI 10.1590/S0001-37652009000300003; Sliva J, 2008, NEUROENDOCRINOL LETT, V29, P953; Szot P, 1999, J NEUROSCI, V19, P10985, DOI 10.1523/JNEUROSCI.19-24-10985.1999; Tariq M, 2008, EPILEPSY BEHAV, V12, P354, DOI 10.1016/j.yebeh.2007.12.004; Ueda Y, 2007, BRAIN RES, V1151, P55, DOI 10.1016/j.brainres.2007.03.021; Ueda Y, 2009, BRAIN RES, V1266, P1, DOI 10.1016/j.brainres.2009.02.040; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Voutsinos-Porche B, 2004, NEUROBIOL DIS, V17, P385, DOI 10.1016/j.nbd.2004.07.023; Weinshenker D, 2002, PHARMACOL THERAPEUT, V94, P213, DOI 10.1016/S0163-7258(02)00218-8; Yan Z, 1997, J NEUROPHYSIOL, V77, P1003, DOI 10.1152/jn.1997.77.2.1003; Yu X, 2008, BRAIN RES, V1200, P146, DOI 10.1016/j.brainres.2008.01.047; Zhang ZH, 2003, MOL BRAIN RES, V115, P29, DOI 10.1016/S0169-328X(03)00175-X; Zheng Y, 2010, NEUROPHARMACOLOGY, V58, P793, DOI 10.1016/j.neuropharm.2009.12.007	59	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76735	10.1371/journal.pone.0076735	http://dx.doi.org/10.1371/journal.pone.0076735			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098559	gold, Green Published, Green Submitted			2022-12-25	WOS:000325483600076
J	Pietraszek, K; Brezillon, S; Perreau, C; Malicka-Blaszkiewicz, M; Maquart, FX; Wegrowski, Y				Pietraszek, Katarzyna; Brezillon, Stephane; Perreau, Corinne; Malicka-Blaszkiewicz, Maria; Maquart, Francois-Xavier; Wegrowski, Yanusz			Lumican - Derived Peptides Inhibit Melanoma Cell Growth and Migration	PLOS ONE			English	Article							TYPE-1 MATRIX-METALLOPROTEINASE; ACTIVATION; INVASION; PROTEOGLYCAN; ANGIOGENESIS; PROGRESSION; METASTASIS; EXPRESSION; IDENTIFICATION; KERATINOCYTES	Lumican, a small leucine-rich proteoglycan of the extracellular matrix, presents potent anti-tumor properties. Previous works from our group showed that lumican inhibited melanoma cell migration and tumor growth in vitro and in vivo. Melanoma cells adhered to lumican, resulting in a remodeling of their actin cytoskeleton and preventing their migration. In addition, we identified a sequence of 17 amino acids within the lumican core protein, named lumcorin, which was able to inhibit cell chemotaxis and reproduce anti-migratory effect of lumican in vitro. The aim of the present study was to characterize the anti-tumor mechanism of action of lumcorin. Lumcorin significantly decreased the growth in monolayer and in soft agar of two melanoma cell lines - mice B16F1 and human SK-MEL-28 cells - in comparison to controls. Addition of lumcorin to serum free medium significantly inhibited spontaneous motility of these two melanoma cell lines. To characterize the mechanisms involved in the inhibition of cell migration by lumcorin, the status of the phosphorylation/dephosphorylation of proteins was examined. Inhibition of focal adhesion kinase phosphorylation was observed in presence of lumcorin. Since cancer cells have been shown to migrate and to invade by mechanisms that involve matrix metalloproteinases (MMPs), the expression and activity of MMPs were analyzed. Lumcorin induced an accumulation of an intermediate form of MMP-14 (similar to 59kDa), and inhibited MMP-14 activity. Additionally, we identified a short, 10 amino acids peptide within lumcorin sequence, which was able to reproduce its anti-tumor effect on melanoma cells. This peptide may have potential pharmacological applications.	[Pietraszek, Katarzyna; Brezillon, Stephane; Perreau, Corinne; Maquart, Francois-Xavier; Wegrowski, Yanusz] Univ Reims, Lab Biochim Med & Biol Mol, CNRS FRE 3481, Reims, France; [Malicka-Blaszkiewicz, Maria] Univ Wroclaw, Dept Cell Pathol, Fac Biotechnol, PL-50138 Wroclaw, Poland; [Maquart, Francois-Xavier] CHU Reims, Reims, France	Universite de Reims Champagne-Ardenne; University of Wroclaw; CHU de Reims	Brezillon, S (corresponding author), Univ Reims, Lab Biochim Med & Biol Mol, CNRS FRE 3481, Reims, France.	stephane.brezillon@univ-reims.fr	Pietraszek-Gremplewicz, Katarzyna/AAM-2454-2020	Pietraszek-Gremplewicz, Katarzyna/0000-0002-4081-5314; BREZILLON, stephane/0000-0001-7954-8340	Region Champagne-Ardenne; Fonds Europeen de Developpement Regional (FEDER); Les Contrats de Projets Etat-Region (CPER); PHC Polonium of the Ministry Foreign Affairs; Ligue Nationale contre le Cancer (comite de la Marne)	Region Champagne-Ardenne(Region Grand-Est); Fonds Europeen de Developpement Regional (FEDER)(European Commission); Les Contrats de Projets Etat-Region (CPER); PHC Polonium of the Ministry Foreign Affairs; Ligue Nationale contre le Cancer (comite de la Marne)(Ligue nationale contre le cancer)	The authors thank the Region Champagne-Ardenne, the Fonds Europeen de Developpement Regional (FEDER), Les Contrats de Projets Etat-Region (CPER 2007-2013), PHC Polonium of the Ministry Foreign Affairs and the Ligue Nationale contre le Cancer (comite de la Marne) for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Baumann P, 2000, BRIT J CANCER, V83, P1387, DOI 10.1054/bjoc.2000.1454; Bogenrieder T, 2003, ONCOGENE, V22, P6524, DOI 10.1038/sj.onc.1206757; Brassart-Pasco S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029587; Brezillon S, 2009, J PHYSIOL PHARMACOL, V60, P15; Brezillon S, 2009, CANCER LETT, V283, P92, DOI 10.1016/j.canlet.2009.03.032; CHAKRAVARTI S, 1995, GENOMICS, V27, P481, DOI 10.1006/geno.1995.1080; D'Onofrio MF, 2008, BIOCHEM BIOPH RES CO, V365, P266, DOI 10.1016/j.bbrc.2007.10.155; Han J, 1997, J BIOL CHEM, V272, P20395, DOI 10.1074/jbc.272.33.20395; Hofmann UB, 2000, J INVEST DERMATOL, V115, P337, DOI 10.1046/j.1523-1747.2000.00068.x; Iida J, 2004, J INVEST DERMATOL, V122, P167, DOI 10.1046/j.0022-202X.2003.22114.x; Iozzo RV, 2010, FEBS J, V277, P3864, DOI 10.1111/j.1742-4658.2010.07797.x; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Jarvelainen H, 2009, PHARMACOL REV, V61, P198, DOI 10.1124/pr.109.001289; Johnson J, 2006, MOL VIS, V12, P1057; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Kalamajski S, 2009, J BIOL CHEM, V284, P534, DOI 10.1074/jbc.M805721200; Leeman MF, 2003, J PATHOL, V201, P528, DOI 10.1002/path.1466; Li YY, 2004, CANCER RES, V64, P7058, DOI 10.1158/0008-5472.CAN-04-1038; Malinowski M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050709; Nagase H, 1998, Cell Res, V8, P179; Niewiarowska J, 2011, THROMB RES, V128, P452, DOI 10.1016/j.thromres.2011.06.011; Pasco S, 2000, CANCER RES, V60, P467; Pasco S, 2004, CRIT REV ONCOL HEMAT, V49, P221, DOI 10.1016/j.critrevonc.2003.09.006; Radwanska A, 2008, LIFE SCI, V83, P651, DOI 10.1016/j.lfs.2008.09.008; Santibanez JF, 2002, BIOCHEM BIOPH RES CO, V296, P267; Sato H, 2005, CANCER SCI, V96, P212, DOI 10.1111/j.1349-7006.2005.00039.x; Sulochana KN, 2005, J BIOL CHEM, V280, P27935, DOI 10.1074/jbc.M414320200; Takino T, 2004, CANCER RES, V64, P1044, DOI 10.1158/0008-5472.CAN-03-1843; Vivinus-Nebot M, 2004, J IMMUNOL, V172, P1397, DOI 10.4049/jimmunol.172.3.1397; Vuillermoz B, 2004, EXP CELL RES, V296, P294, DOI 10.1016/j.yexcr.2004.02.005; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Yana I, 2000, MOL BIOL CELL, V11, P2387, DOI 10.1091/mbc.11.7.2387; Yi M, 2001, P NATL ACAD SCI USA, V98, P620, DOI 10.1073/pnas.98.2.620; Zeltz C, 2010, EXP CELL RES, V316, P2922, DOI 10.1016/j.yexcr.2010.08.002; Zeltz C, 2009, FEBS LETT, V583, P3027, DOI 10.1016/j.febslet.2009.08.012	36	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76232	10.1371/journal.pone.0076232	http://dx.doi.org/10.1371/journal.pone.0076232			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098450	gold, Green Submitted, Green Published			2022-12-25	WOS:000325434500054
J	Vlasova, AN; Chattha, KS; Kandasamy, S; Liu, Z; Esseili, M; Shao, LL; Rajashekara, G; Saif, LJ				Vlasova, Anastasia N.; Chattha, Kuldeep S.; Kandasamy, Sukumar; Liu, Zhe; Esseili, Malak; Shao, Lulu; Rajashekara, Gireesh; Saif, Linda J.			Lactobacilli and Bifidobacteria Promote Immune Homeostasis by Modulating Innate Immune Responses to Human Rotavirus in Neonatal Gnotobiotic Pigs	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; COMMENSAL BACTERIA; CYTOKINE RESPONSES; DENDRITIC CELLS; GUT MICROBIOTA; GENE-EXPRESSION; COLONIZATION; PROBIOTICS; INFECTION; PROLIFERATION	The effects of co-colonization with Lactobacillus rhamnosus GG (LGG) and Bifidobacterium lactis Bb12 (Bb12) on 3-dose vaccination with attenuated HRV and challenge with virulent human rotavirus (VirHRV) were assessed in 4 groups of gnotobiotic (Gn) pigs: Pro+Vac (probiotic-colonized/ vaccinated), Vac (vaccinated), Pro (probiotic-colonized, non-vaccinated) and Control (non-colonized, non-vaccinated). Subsets of pigs were euthanized pre- [post-challenge day (PCD) 0] and post (PCD7)-VirHRV challenge to assess diarrhea, fecal HRV shedding and dendritic cell/innate immune responses. Post-challenge, Pro+Vac and Vac groups were completely protected from diarrhea; protection rates against HRV shedding were 100% and 83%, respectively. Diarrhea and HRV shedding were reduced in Pro compared to Control pigs following VirHRV challenge. Diarrhea scores and virus shedding were significantly higher in Controls, compared to all other groups, coincident with significantly higher serum interferon-alpha levels post-challenge. LGG+Bb12 colonization +/- vaccine promoted immunomaturation as reflected by increased frequencies of CD4, SWC3a, CD11R1, MHCII expressing mononuclear cells (MNCs) and conventional dendritic cells in intestinal tissues and blood post-challenge. Colonization decreased frequencies of toll-like receptors (TLR) 2 and TLR4 expressing MNCs from vaccinated pigs (Pro+Vac) pre-challenge and increased frequencies of TLR3 expressing MNCs from Pro pigs post-challenge, suggesting that probiotics likely exert anti-inflammatory (TLR2 and 4 down-regulation) and antiviral (TLR3 up-regulation by HRV dsRNA) actions via TLR signaling. Probiotic colonization alone (Pro) increased frequencies of intestinal and systemic apoptotic MNCs pre-challenge, thereby regulating immune hyperreactivity and tolerance. However, these frequencies were decreased in intestinal and systemic tissues post-challenge, moderating HRV-induced apoptosis. Additionally, post-challenge, Pro+Vac and Pro groups had significantly decreased MNC proliferation, suggesting that probiotics control excessive lymphoproliferative reactions upon VirHRV challenge. We conclude that in the neonatal Gn pig disease model, selected probiotics contribute to immunomaturation, regulate immune homeostasis and modulate vaccine and virulent HRV effects, thereby moderating HRV diarrhea.	[Vlasova, Anastasia N.; Chattha, Kuldeep S.; Kandasamy, Sukumar; Liu, Zhe; Esseili, Malak; Shao, Lulu; Rajashekara, Gireesh; Saif, Linda J.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Dept Vet Prevent Med, Wooster, OH 44691 USA	University System of Ohio; Ohio State University	Vlasova, AN (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Dept Vet Prevent Med, Wooster, OH 44691 USA.	vlasova.1@osu.edu; saif.2@osu.edu	Vlasova, Anastasia N/C-2062-2016; Shao, Lulu/I-4425-2019	Vlasova, Anastasia N/0000-0002-1447-6283; Shao, Lulu/0000-0002-1441-4744; Esseili, Malak/0000-0002-1024-0468	NIH, NCCAM [R21AT004716]; NIAID [R01 A1099451]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT004716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099451] Funding Source: NIH RePORTER	NIH, NCCAM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the NIH, NCCAM grant R21AT004716 (Linda J. Saif-PI), NIAID grant # R01 A1099451 and federal funds appropriated to the Ohio Agricultural Research and Development Center (OARDC) of The Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Azevedo MSP, 2006, J VIROL, V80, P372, DOI 10.1128/JVI.80.1.372-382.2006; Bailey M, 2001, P NUTR SOC, V60, P427, DOI 10.1079/PNS2001118; Boshuizen JA, 2003, J VIROL, V77, P13005, DOI 10.1128/JVI.77.24.13005-13016.2003; Brown K, 2012, NUTRIENTS, V4, P1552, DOI [10.3390/nu4081095, 10.3390/nu4111552]; Butler JE, 2002, J IMMUNOL, V169, P6822, DOI 10.4049/jimmunol.169.12.6822; Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S, DOI 10.1093/ajcn/69.5.1046s; Chattha KS, 2013, J IMMUNOL; Chattha KS, 2013, VACCINE, V31, P1916, DOI 10.1016/j.vaccine.2013.02.020; CRABBE PA, 1968, INT ARCH ALLER A IMM, V34, P362, DOI 10.1159/000230130; CROUCH CF, 1978, J MED MICROBIOL, V11, P325, DOI 10.1099/00222615-11-3-325; Fang SB, 2009, J TROP PEDIATRICS, V55, P297, DOI 10.1093/tropej/fmp001; FERGUSON A, 1994, GUT, V35, pS10, DOI 10.1136/gut.35.1_Suppl.S10; Foligne B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000313; Foye OT, 2012, FEMS IMMUNOL MED MIC, V65, P467, DOI 10.1111/j.1574-695X.2012.00978.x; Gourbeyre P, 2011, J LEUKOCYTE BIOL, V89, P685, DOI 10.1189/jlb.1109753; Grandy G, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-253; Gray J, 2011, J INTERN MED, V270, P206, DOI 10.1111/j.1365-2796.2011.02409.x; Guandalini S, 2011, J CLIN GASTROENTEROL, V45, pS149, DOI 10.1097/MCG.0b013e3182257e98; Ichikawa H, 1999, DIGEST DIS SCI, V44, P2119, DOI 10.1023/A:1026647024077; Ismail IH, 2012, PEDIAT ALLERGY IMMUN; Lorne E, 2010, INTENS CARE MED, V36, P1826, DOI 10.1007/s00134-010-1983-5; Meurens F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000677; MEYER RC, 1964, APPL MICROBIOL, V12, P295, DOI 10.1128/AEM.12.4.295-300.1964; Musso G, 2010, DIABETES CARE, V33, P2277, DOI 10.2337/dc10-0556; Nelson AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048224; Orlando A, 2009, IMMUNOPHARM IMMUNOT, V31, P108, DOI 10.1080/08923970802443631; Otani K, 2012, BIOCHEM BIOPH RES CO, V426, P342, DOI 10.1016/j.bbrc.2012.08.080; Pagnini C, 2010, P NATL ACAD SCI USA, V107, P454, DOI 10.1073/pnas.0910307107; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Pott J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002670; Preidis GA, 2011, GASTROENTEROLOGY, V140, P8, DOI 10.1053/j.gastro.2010.11.010; Rachmilewitz D, 2004, GASTROENTEROLOGY, V126, P520, DOI 10.1053/j.gastro.2003.11.019; Rosenfeldt V, 2002, PEDIATR INFECT DIS J, V21, P411, DOI 10.1097/00006454-200205000-00012; Saif L, 1997, ADV EXP MED BIOL, V412, P397; Saif LJ, 1996, ARCH VIROL, P153; Santacruz A, 2009, OBESITY, V17, P1906, DOI 10.1038/oby.2009.112; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Shirkey TW, 2006, EXP BIOL MED, V231, P1333, DOI 10.1177/153537020623100807; Solano-Aguilar G, 2008, APPL ENVIRON MICROB, V74, P6338, DOI 10.1128/AEM.00309-08; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; UMESAKI Y, 1995, MICROBIOL IMMUNOL, V39, P555, DOI 10.1111/j.1348-0421.1995.tb02242.x; Vickery BP, 2011, J ALLERGY CLIN IMMUN, V127, P576, DOI 10.1016/j.jaci.2010.12.1116; Vlasova AN, 2013, J IMMUNOL; Voltan S, 2007, CLIN VACCINE IMMUNOL, V14, P1138, DOI 10.1128/CVI.00079-07; Ward LA, 1996, J GEN VIROL, V77, P1431, DOI 10.1099/0022-1317-77-7-1431; Wen K, 2009, VET IMMUNOL IMMUNOP, V127, P304, DOI 10.1016/j.vetimm.2008.10.322; Willing BP, 2007, J ANIM SCI, V85, P3256, DOI 10.2527/jas.2007-0320; Xu J, 2006, CLIN EXP IMMUNOL, V144, P376, DOI 10.1111/j.1365-2249.2006.03079.x; Yuan LJ, 1996, J VIROL, V70, P3075, DOI 10.1128/JVI.70.5.3075-3083.1996; Zhang W, 2008, VACCINE, V26, P3655, DOI 10.1016/j.vaccine.2008.04.070; Zhang W, 2008, VET IMMUNOL IMMUNOP, V122, P175, DOI 10.1016/j.vetimm.2007.10.003; Zhang W, 2008, VET IMMUNOL IMMUNOP, V121, P222, DOI 10.1016/j.vetimm.2007.10.001	55	78	84	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76962	10.1371/journal.pone.0076962	http://dx.doi.org/10.1371/journal.pone.0076962			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098572	Green Submitted, gold, Green Published			2022-12-25	WOS:000325434500091
J	Potter, C; McKay, J; Groom, A; Ford, D; Coneyworth, L; Mathers, JC; Relton, CL				Potter, Catherine; McKay, Jill; Groom, Alexandra; Ford, Dianne; Coneyworth, Lisa; Mathers, John C.; Relton, Caroline L.			Influence of DNMT Genotype on Global and Site Specific DNA Methylation Patterns in Neonates and Pregnant Women	PLOS ONE			English	Article							DE-NOVO METHYLATION; LUNG-CANCER; RISK; EPIGENETICS; METHYLTRANSFERASES; POLYMORPHISMS; ENVIRONMENT; PROMOTER; GENES	This study examines the relationship between common genetic variation within DNA methyltransferase genes and inter-individual variation in DNA methylation. Eleven polymorphisms spanning DNMT1 and DNMT3B were genotyped. Global and gene specific (IGF2, IGFBP3, ZNT5) DNA methylation was quantified by LUMA and bisulfite Pyrosequencing assays, respectively, in neonatal cord blood and in maternal peripheral blood. Associations between maternal genotype and maternal methylation (n approximate to 333), neonatal genotype and neonatal methylation (n approximate to 454), and maternal genotype and neonatal methylation (n approximate to 137) were assessed. The findings of this study provide some support to the hypothesis that genetic variation in DNA methylating enzymes influence DNA methylation at global and gene-specific levels; however observations were not robust to correction for multiple testing. More comprehensive analysis of the influence of genetic variation on global and site specific DNA methylation is warranted.	[Potter, Catherine; Groom, Alexandra; Relton, Caroline L.] Newcastle Univ, Human Nutr Res Ctr, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [McKay, Jill] Newcastle Univ, Human Nutr Res Ctr, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Ford, Dianne; Coneyworth, Lisa] Newcastle Univ, Human Nutr Res Ctr, Inst Cell & Mol Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Mathers, John C.] Newcastle Univ, Human Nutr Res Ctr, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Relton, Caroline L.] Univ Bristol, Sch Social & Community Med, MRC Integrat Epidemiol Unit, Bristol, Avon, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; University of Bristol	Relton, CL (corresponding author), Newcastle Univ, Human Nutr Res Ctr, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	caroline.relton@newcastle.ac.uk	Relton, Caroline/AAC-5904-2019	McKay, Jill Ann/0000-0002-2711-0301; Mathers, John/0000-0003-3406-3002; Relton, Caroline/0000-0003-2052-4840	NIHR Newcastle Biomedical Research Centre; European Nutrigenomics Organisation (NuGO): linking genomics, nutrition and health research; FP6 European [CT-2004-505944]; Biotechnology and Biological Sciences Research Council (BBSRC) [BH081097, BB/G007993/1]; BBSRC [BB/G007993/1, BB/I025263/1] Funding Source: UKRI; MRC [MC_UU_12013/2, G0700718] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I025263/1, BB/G007993/1] Funding Source: researchfish; Medical Research Council [MC_UU_12013/2, G0700718] Funding Source: researchfish	NIHR Newcastle Biomedical Research Centre; European Nutrigenomics Organisation (NuGO): linking genomics, nutrition and health research; FP6 European(European Commission); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by the NIHR Newcastle Biomedical Research Centre and The European Nutrigenomics Organisation (NuGO): linking genomics, nutrition and health research. NuGO was a FP6 European funded Network of Excellence (CT-2004-505944). The Biotechnology and Biological Sciences Research Council (BBSRC) are also acknowledged for support (grant nos. BH081097 and BB/G007993/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera O, 2010, J APPL PHYSIOL, V109, P243, DOI 10.1152/japplphysiol.00068.2010; Babenko O, 2012, BRAIN RES, V1444, P96, DOI 10.1016/j.brainres.2012.01.038; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berdasco M, 2013, HUM GENET; BESTOR TH, 1994, CURR OPIN CELL BIOL, V6, P380, DOI 10.1016/0955-0674(94)90030-2; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003; Cebrian A, 2006, CARCINOGENESIS, V27, P1661, DOI 10.1093/carcin/bgi375; Chase DS, 1998, J MED GENET, V35, P413, DOI 10.1136/jmg.35.5.413; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Coolen MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025590; Cortessis VK, 2012, HUM GENET, V131, P1565, DOI 10.1007/s00439-012-1189-8; Daxinger L, 2010, GENOME RES, V20, P1623, DOI 10.1101/gr.106138.110; Fan H, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-12; Feil R, 2006, MUTAT RES-FUND MOL M, V600, P46, DOI 10.1016/j.mrfmmm.2006.05.029; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Gauderman WJ, 2003, GENET EPIDEMIOL, V25, P327, DOI 10.1002/gepi.10262; Gauderman WJ, 2006, UANTO 1 1 COMPUTER P; Gillio-Tos A, 2012, CANCER CAUSE CONTROL, V23, P1549, DOI 10.1007/s10552-012-0032-9; Heijmans BT, 2007, HUM MOL GENET, V16, P547, DOI 10.1093/hmg/ddm010; Jaenisch R, 1997, TRENDS GENET, V13, P323, DOI 10.1016/S0168-9525(97)01180-3; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Karimi M, 2006, EXP CELL RES, V312, P1989, DOI 10.1016/j.yexcr.2006.03.006; Kile ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013730; Lee SJ, 2005, CARCINOGENESIS, V26, P403, DOI 10.1093/carcin/bgh307; Lei H, 1996, DEVELOPMENT, V122, P3195; Mathers JC, 2010, ADV GENET, V71, P3, DOI [10.1016/B978-0-12-380864-6.00001-8, 10.1016/S0065-2660(10)71001-4]; McKay JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033290; Murphy TM, 2013, GENES BRAIN BEHAV, V12, P125, DOI 10.1111/j.1601-183X.2012.00865.x; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Quon G, 2013, NUCLEIC ACIDS RES, V41, P2095, DOI 10.1093/nar/gks1449; Relton CL, 2012, INT J EPIDEMIOL, V41, P5, DOI 10.1093/ije/dys006; Relton CL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000356; Shen HB, 2002, CANCER RES, V62, P4992; Singal R, 2005, ONCOL REP, V14, P569; Smith GD, 2012, INT J EPIDEMIOL, V41, P236, DOI 10.1093/ije/dys016; Tobi EW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037933; Wang L, 2004, P AM ASSOC CANC RES, V45; White Helen E, 2006, Clin Chem, V52, P1005, DOI 10.1373/clinchem.2005.065086	41	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76506	10.1371/journal.pone.0076506	http://dx.doi.org/10.1371/journal.pone.0076506			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098518	Green Published, Green Submitted, gold			2022-12-25	WOS:000325427100073
J	Pryde, DC; Jones, LH; Gervais, DP; Stead, DR; Blakemore, DC; Selby, MD; Brown, AD; Coe, JW; Badland, M; Beal, DM; Glen, R; Wharton, Y; Miller, GJ; White, P; Zhang, NL; Benoit, M; Robertson, K; Merson, JR; Davis, HL; McCluskie, MJ				Pryde, David C.; Jones, Lyn H.; Gervais, David P.; Stead, David R.; Blakemore, David C.; Selby, Matthew D.; Brown, Alan D.; Coe, Jotham W.; Badland, Matthew; Beal, David M.; Glen, Rebecca; Wharton, Yvonne; Miller, Gavin J.; White, Phil; Zhang, Ningli; Benoit, Michelle; Robertson, Karen; Merson, James R.; Davis, Heather L.; McCluskie, Michael J.			Selection of a Novel Anti-Nicotine Vaccine: Influence of Antigen Design on Antibody Function in Mice	PLOS ONE			English	Article							SMOKING-CESSATION; HAPTEN DESIGN; IMMUNOGENICITY; IMMUNIZATION; (S)-NICOTINE; LITHIATION; ADDICTION; SMOKERS; BRAIN; RATS	Anti-nicotine vaccines may aid smoking cessation via the induction of anti-nicotine antibodies (Ab) which reduce nicotine entering the brain, and hence the associated reward. Ab function depends on both the quantity (titer) and the quality (affinity) of the Ab. Anti-nicotine vaccines tested previously in clinical studies had poor efficacy despite high Ab titer, and this may be due to inadequate function if Ab of low affinity were induced. In this study, we designed and synthesized a series of novel nicotine-like haptens which were all linked to diphtheria toxoid (DT) as carrier, but which differed in the site of attachment of linker to nicotine, the nature of linker used, and the handle used to attach the hapten to DT. The resulting hapten conjugates were evaluated in a mouse model, using CpG (a TLR9 agonist) and aluminum hydroxide (Al(OH)(3)) as adjuvants, whereby Ab titers, affinity and function were evaluated using a radiolabeled nicotine challenge model. A series of additional linkers varying in length, rigidity and polarity were used with a single hapten to generate additional DT-conjugates, which were also tested in mice. Conjugates made with different haptens resulted in various titers of anti-nicotine Ab. Several haptens gave similarly high Ab titers, but among these, Ab affinity and hence function varied considerably. Linker also influenced Ab titer, affinity and function. These results demonstrate that immune responses induced in mice by nicotine-conjugate antigens are greatly influenced by hapten design including site of attachment of linker to nicotine, the nature of linker used, and the handle used to attach the hapten to DT. While both Ab titer and affinity contributed to function, affinity was more sensitive to antigen differences.	[Pryde, David C.; Blakemore, David C.; Brown, Alan D.] Pfizer Worldwide Med Chem, Cambridge, England; [Jones, Lyn H.; Selby, Matthew D.; Beal, David M.] Pfizer Worldwide Med Chem, BioTherapeut Chem, Cambridge, MA USA; [Gervais, David P.; Stead, David R.; White, Phil; Merson, James R.] Pfizer Vaccine Res, La Jolla, CA USA; [Coe, Jotham W.] Pfizer Worldwide Med Chem, Groton, CT USA; [Zhang, Ningli; Benoit, Michelle; Robertson, Karen; Davis, Heather L.; McCluskie, Michael J.] Pfizer Vaccine Res, Ottawa, ON, Canada; [Glen, Rebecca; Wharton, Yvonne; Miller, Gavin J.] Peakdale Mol Ltd, Chapel En Le Frith, Derby, England; [Badland, Matthew] Pfizer Chem Res & Dev, Sandwich, Kent, England	Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer	McCluskie, MJ (corresponding author), Pfizer Vaccine Res, Ottawa, ON, Canada.	michael.mccluskie@pfizer.com	Gervais, David/H-5183-2019; Beal, David M/Q-7314-2017; Miller, Gavin J/AAL-5783-2021	Gervais, David/0000-0002-4996-3217; Beal, David M/0000-0002-1819-315X; Miller, Gavin J/0000-0001-6533-3306; White, Phil/0000-0002-6078-9061; Jones, Lyn/0000-0002-8388-5865				BENOWITZ NL, 1984, CLIN PHARMACOL THER, V35, P499, DOI 10.1038/clpt.1984.67; Carroll FI, 2011, J MED CHEM, V54, P5221, DOI 10.1021/jm2004943; Carroll FI, 2009, J MED CHEM, V52, P7301, DOI 10.1021/jm901134w; Cerny EH, 2002, ONKOLOGIE, V25, P406, DOI 10.1159/000067433; Chen XY, 2012, VACCINE, V31, P159, DOI 10.1016/j.vaccine.2012.10.069; Choppin S, 2000, ORG LETT, V2, P803, DOI 10.1021/ol005538o; Cornuz J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002547; de Villiers SHL, 2010, VACCINE, V28, P2161, DOI 10.1016/j.vaccine.2009.12.051; Esterlis I, 2013, AM J PSYCHIAT, V170, P399, DOI 10.1176/appi.ajp.2012.12060793; Fevrier FC, 2005, ORG LETT, V7, P5457, DOI 10.1021/ol052196j; Gros PC, 2006, ORG BIOMOL CHEM, V4, P4331, DOI 10.1039/b612786j; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Hatsukami DK, 2011, CLIN PHARMACOL THER, V89, P392, DOI 10.1038/clpt.2010.317; Hatsukami DK, 2008, LANCET, V371, P2027, DOI 10.1016/S0140-6736(08)60871-5; Hieda Y, 2000, INT J IMMUNOPHARMACO, V22, P809, DOI 10.1016/S0192-0561(00)00042-4; Hughes JR, 2004, ADDICTION, V99, P29, DOI 10.1111/j.1360-0443.2004.00540.x; Isomura S, 2001, J ORG CHEM, V66, P4115, DOI 10.1021/jo001442w; Jones LH, 2002, ANGEW CHEM INT EDIT, V41, P4241, DOI 10.1002/1521-3773(20021115)41:22<4241::AID-ANIE4241>3.0.CO;2-N; Keyler DE, 2008, INT IMMUNOPHARMACOL, V8, P1589, DOI 10.1016/j.intimp.2008.07.001; LANGONE JJ, 1973, BIOCHEMISTRY-US, V12, P5025, DOI 10.1021/bi00748a032; MATSUKURA S, 1975, BIOCHEM BIOPH RES CO, V64, P574, DOI 10.1016/0006-291X(75)90360-5; McCluskie MJ, 2013, INT IMMUNOPHARMACOL, V16, P50, DOI 10.1016/j.intimp.2013.03.021; McCluskie MJ, 2013, 19 ANN M SOC RES NIC; Meijler MM, 2003, J AM CHEM SOC, V125, P7164, DOI 10.1021/ja034805t; Moreno AY, 2012, VACCINE, V30, P6665, DOI 10.1016/j.vaccine.2012.08.064; Moreno AY, 2011, J AM CHEM SOC, V133, P6587, DOI 10.1021/ja108807j; Moreno AY, 2010, MOL PHARMACEUT, V7, P431, DOI 10.1021/mp900213u; Murphy JM, 2007, J AM CHEM SOC, V129, P15434, DOI 10.1021/ja076498n; Nides M, 2008, AM J HEALTH BEHAV, V32, P664, DOI 10.5555/ajhb.2008.32.6.664; Pentel PR, 2000, PHARMACOL BIOCHEM BE, V65, P191, DOI 10.1016/S0091-3057(99)00206-3; Peterson EC, 2007, J PHARMACOL EXP THER, V322, P30, DOI 10.1124/jpet.106.117150; Pravetoni M, 2012, BIOCHEM PHARMACOL, V83, P543, DOI 10.1016/j.bcp.2011.11.004; Raupach Tobias, 2012, Drugs, V72, pe1, DOI 10.2165/11599900-000000000-00000; Storer RI, 2011, CHEM SOC REV, V40, P2330, DOI 10.1039/c0cs00200c; Ullrich T, 2002, J MED CHEM, V45, P4047, DOI 10.1021/jm020916b; World Health Organization, 2019, WHO REPORT GLOBAL TO; Xu Y, 2005, BIOORG MED CHEM LETT, V15, P4304, DOI 10.1016/j.bmcl.2005.06.052	37	58	64	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76557	10.1371/journal.pone.0076557	http://dx.doi.org/10.1371/journal.pone.0076557			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098532	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000325427100076
J	Beazley, KE; Lima, F; Borras, T; Nurminskaya, M				Beazley, Kelly E.; Lima, Florence; Borras, Teresa; Nurminskaya, Maria			Attenuation of Chondrogenic Transformation in Vascular Smooth Muscle by Dietary Quercetin in the MGP-Deficient Mouse Model	PLOS ONE			English	Article							TRANSGLUTAMINASE 2-MEDIATED ACTIVATION; CELL PHENOTYPIC PLASTICITY; BETA-CATENIN; GROWTH-FACTOR; CHONDROCYTE DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; CARTILAGE FORMATION; GENE-EXPRESSION; FACTOR-5 GDF-5; BLOOD-PRESSURE	Rationale: Cartilaginous metaplasia of vascular smooth muscle (VSM) is characteristic for arterial calcification in diabetes and uremia and in the background of genetic alterations in matrix Gla protein (MGP). A better understanding of the molecular details of this process is critical for the development of novel therapeutic approaches to VSM transformation and arterial calcification. Objective: This study aimed to identify the effects of bioflavonoid quercetin on chondrogenic transformation and calcification of VSM in the MGP-null mouse model and upon TGF-beta 3 stimulation in vitro, and to characterize the associated alterations in cell signaling. Methods and Results: Molecular analysis revealed activation of beta-catenin signaling in cartilaginous metaplasia in Mgp-/- aortae in vivo and during chondrogenic transformation of VSMCs in vitro. Quercetin intercepted chondrogenic transformation of VSM and blocked activation of beta-catenin both in vivo and in vitro. Although dietary quercetin drastically attenuated calcifying cartilaginous metaplasia in Mgp-/- animals, approximately one-half of total vascular calcium mineral remained as depositions along elastic lamellae. Conclusion: Quercetin is potent in preventing VSM chondrogenic transformation caused by diverse stimuli. Combined with the demonstrated efficiency of dietary quercetin in preventing ectopic chondrogenesis in the MGP-null vasculature, these findings indicate a potentially broad therapeutic applicability of this safe for human consumption bioflavonoid in the therapy of cardiovascular conditions linked to cartilaginous metaplasia of VSM. Elastocalcinosis is a major component of MGP-null vascular disease and is controlled by a mechanism different from chondrogenic transformation of VSM and not sensitive to quercetin.	[Beazley, Kelly E.; Lima, Florence; Nurminskaya, Maria] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Borras, Teresa] Univ N Carolina, Sch Med, Dept Ophthalmol, Chapel Hill, NC USA	University System of Maryland; University of Maryland Baltimore; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Nurminskaya, M (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.	mnurminskaya@som.umaryland.edu	Nurminskaya, Maria/GQH-4607-2022		National Institutes of Health (NIH) [R01HL099305, EY13126, T32AR007592]; NATIONAL EYE INSTITUTE [R01EY013126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007592] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health (NIH) grants R01HL099305 (to M.N.), EY13126 (to T. B.) and T32AR007592 (to K. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; Agrotis A, 2004, J BIOL CHEM, V279, P42221, DOI 10.1074/jbc.M408121200; Aitkenhead M, 2002, MICROVASC RES, V63, P159, DOI 10.1006/mvre.2001.2380; Amano O, 1999, ARCH ORAL BIOL, V44, P935, DOI 10.1016/S0003-9969(99)00086-2; Amen M, 2007, MOL CELL BIOL, V27, P7560, DOI 10.1128/MCB.00315-07; BEAZLEY KE, 2012, ARTERIOSCLER THROMB; Beazley KE, 2013, J BIOL CHEM, V288, P2632, DOI 10.1074/jbc.M112.368639; Beazley KE, 2012, J HEART LUNG TRANSPL, V31, P1009, DOI 10.1016/j.healun.2012.04.009; Beazley KE, 2012, ARTERIOSCL THROM VAS, V32, P123, DOI 10.1161/ATVBAHA.111.237834; Bhaskar S, 2013, NUTRITION, V29, P219, DOI 10.1016/j.nut.2012.01.019; Bostrom KI, 2011, CIRC RES, V109, P564, DOI 10.1161/CIRCRESAHA.110.234278; Bostrom KI, 2011, CIRC RES, V108, P446, DOI 10.1161/CIRCRESAHA.110.236596; Bostrom K, 2004, J BIOL CHEM, V279, P52904, DOI 10.1074/jbc.M406868200; Buxton P, 2001, J BONE JOINT SURG AM, V83A, pS23; Caira FC, 2006, J AM COLL CARDIOL, V47, P1707, DOI 10.1016/j.jacc.2006.02.040; Chun JS, 2008, BMB REP, V41, P485, DOI 10.5483/BMBRep.2008.41.7.485; Clements WK, 2011, NATURE, V474, P220, DOI 10.1038/nature10107; Crosier MD, 2009, J NUTR SCI VITAMINOL, V55, P59, DOI 10.3177/jnsv.55.59; Dufourcq P, 2008, AM J PATHOL, V172, P37, DOI 10.2353/ajpath.2008.070130; Edwards RL, 2007, J NUTR, V137, P2405, DOI 10.1093/jn/137.11.2405; Egert S, 2009, BRIT J NUTR, V102, P1065, DOI 10.1017/S0007114509359127; El-Maadawy S, 2003, CONNECT TISSUE RES, V44, P272, DOI 10.1080/03008200390181762; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Essalihi R, 2003, AM J HYPERTENS, V16, P103, DOI 10.1016/S0895-7061(02)03204-1; Faverman L, 2008, FEBS LETT, V582, P1552, DOI 10.1016/j.febslet.2008.03.053; French DM, 2004, AM J PATHOL, V165, P855, DOI 10.1016/S0002-9440(10)63348-2; Furlan F, 2007, J BONE MINER RES, V22, P1387, DOI 10.1359/JBMR.070516; Giachelli CM, 2009, KIDNEY INT, V75, P890, DOI 10.1038/ki.2008.644; Gonzalez-Fernandez R, 2010, FERTIL STERIL, V94, P99, DOI 10.1016/j.fertnstert.2009.02.074; Goodwin A. M., 2002, Angiogenesis, V5, P1, DOI 10.1023/A:1021563510866; Hamidouche Z, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-44; Harwood M, 2007, FOOD CHEM TOXICOL, V45, P2179, DOI 10.1016/j.fct.2007.05.015; Hendrickx M, 2008, DEV GROWTH DIFFER, V50, P229, DOI [10.1111/j.1440-169x.2008.01016.x, 10.1111/j.1440-169X.2008.01016.x]; Herrmann SM, 2000, ARTERIOSCL THROM VAS, V20, P2386, DOI 10.1161/01.ATV.20.11.2386; Hung IH, 2007, DEV BIOL, V307, P300, DOI 10.1016/j.ydbio.2007.04.048; Huxley RR, 2003, EUR J CLIN NUTR, V57, P904, DOI 10.1038/sj.ejcn.1601624; Ishizeki K, 1999, J ANAT, V194, P265, DOI 10.1046/j.1469-7580.1999.19420265.x; Iyemere VP, 2006, J INTERN MED, V260, P192, DOI 10.1111/j.1365-2796.2006.01692.x; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Johnstone SR, 2012, CIRC RES, V111, P201, DOI 10.1161/CIRCRESAHA.112.272302; Kaartinen MT, 2007, J HISTOCHEM CYTOCHEM, V55, P375, DOI 10.1369/jhc.6A7087.2006; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kleemann R, 2011, ATHEROSCLEROSIS, V218, P44, DOI 10.1016/j.atherosclerosis.2011.04.023; Lacolley P, 2012, CARDIOVASC RES, V95, P194, DOI 10.1093/cvr/cvs135; Liao YB, 2007, ARTERIOSCL THROM VAS, V27, P1037, DOI 10.1161/ATVBAHA.106.137182; Liu YW, 2011, ATHEROSCLEROSIS, V219, P440, DOI 10.1016/j.atherosclerosis.2011.08.033; Loiselle AE, 2013, BONE, V54, P205, DOI 10.1016/j.bone.2012.08.132; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Mason DP, 1999, CIRC RES, V85, P1179; Miceli-Libby L, 2008, J VASC RES, V45, P1, DOI 10.1159/000109072; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Moreno CS, 2005, CANCER RES, V65, P10214, DOI 10.1158/0008-5472.CAN-05-0884; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Mosig RA, 2007, HUM MOL GENET, V16, P1113, DOI 10.1093/hmg/ddm060; Naik V, 2012, CARDIOVASC RES, V94, P545, DOI 10.1093/cvr/cvs126; Nemenoff RA, 2011, ARTERIOSCL THROM VAS, V31, P1300, DOI 10.1161/ATVBAHA.111.223701; Ng K, 2011, AM J PHYSIOL-RENAL, V300, pF1431, DOI 10.1152/ajprenal.00079.2011; Nguyen AT, 2013, CIRC RES, V112, P17, DOI 10.1161/CIRCRESAHA.112.281048; Nurminsky D, 2011, MECH DEVELOP, V128, P234, DOI 10.1016/j.mod.2010.11.007; Otto WR, 2004, CELL PROLIFERAT, V37, P97, DOI 10.1111/j.1365-2184.2004.00303.x; Price PA, 1998, ARTERIOSCL THROM VAS, V18, P1400, DOI 10.1161/01.ATV.18.9.1400; Reis M, 2013, EXP CELL RES, V319, P1317, DOI 10.1016/j.yexcr.2012.12.023; ROSS R, 1971, J CELL BIOL, V50, P172, DOI 10.1083/jcb.50.1.172; Sage AP, 2010, NAT REV CARDIOL, V7, P528, DOI 10.1038/nrcardio.2010.115; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; SHANAHAN CM, 1993, CIRC RES, V73, P193, DOI 10.1161/01.RES.73.1.193; Shao JS, 2006, ARTERIOSCL THROM VAS, V26, P1423, DOI 10.1161/01.ATV.0000220441.42041.20; Shao JS, 2005, J CLIN INVEST, V115, P1210, DOI 10.1172/JCI200524140; Sharma B, 2013, MICROVASC RES, V85, P24, DOI 10.1016/j.mvr.2012.10.005; Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053; Speer MY, 2002, J EXP MED, V196, P1047, DOI 10.1084/jem.20020911; Spin JM, 2012, CARDIOVASC RES, V95, P147, DOI 10.1093/cvr/cvs098; Tchetina E, 2003, J BONE MINER RES, V18, P844, DOI 10.1359/jbmr.2003.18.5.844; Vadlamudi U, 2005, J CELL SCI, V118, P1129, DOI 10.1242/jcs.01706; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; van Gijn ME, 2002, CARDIOVASC RES, V55, P16, DOI 10.1016/S0008-6363(02)00221-3; Wamhoff BR, 2004, CIRC RES, V95, P981, DOI 10.1161/01.RES.0000147961.09840.fb; Wang XH, 2004, AM J PHYSIOL-HEART C, V287, pH2376, DOI 10.1152/ajpheart.01173.2003; Wong SCC, 2005, APPL IMMUNOHISTO M M, V13, P248, DOI 10.1097/01.pai.0000142845.91862.c8; Yano F, 2005, BIOCHEM BIOPH RES CO, V333, P1300, DOI 10.1016/j.bbrc.2005.06.041; Zeng Q, 2007, BONE, V40, P374, DOI 10.1016/j.bone.2006.09.022	81	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76210	10.1371/journal.pone.0076210	http://dx.doi.org/10.1371/journal.pone.0076210			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098781	Green Published, gold, Green Submitted			2022-12-25	WOS:000325423500151
J	Vajn, K; Viljetic, B; Degmecic, IV; Schnaar, RL; Heffer, M				Vajn, Katarina; Viljetic, Barbara; Degmecic, Ivan Veceslav; Schnaar, Ronald L.; Heffer, Marija			Differential Distribution of Major Brain Gangliosides in the Adult Mouse Central Nervous System	PLOS ONE			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; ANTIGANGLIOSIDE ANTIBODIES; TISSUE SECTIONS; MONOCLONAL-ANTIBODIES; MASS-SPECTROMETRY; NOGO-66 RECEPTOR; NEURITE OUTGROWTH; ANCHORED PROTEINS; RAT CEREBELLUM; LOCALIZATION	Gangliosides - sialic acid-bearing glycolipids - are major cell surface determinants on neurons and axons. The same four closely related structures, GM1, GD1a, GD1b and GT1b, comprise the majority of total brain gangliosides in mammals and birds. Gangliosides regulate the activities of proteins in the membranes in which they reside, and also act as cell-cell recognition receptors. Understanding the functions of major brain gangliosides requires knowledge of their tissue distribution, which has been accomplished in the past using biochemical and immunohistochemical methods. Armed with new knowledge about the stability and accessibility of gangliosides in tissues and new IgG-class specific monoclonal antibodies, we investigated the detailed tissue distribution of gangliosides in the adult mouse brain. Gangliosides GD1b and GT1b are widely expressed in gray and white matter. In contrast, GM1 is predominately found in white matter and GD1a is specifically expressed in certain brain nuclei/tracts. These findings are considered in relationship to the hypothesis that gangliosides GD1a and GT1b act as receptors for an important axon-myelin recognition protein, myelin-associated glycoprotein (MAG). Mediating axon-myelin interactions is but one potential function of the major brain gangliosides, and more detailed knowledge of their distribution may help direct future functional studies.	[Vajn, Katarina; Heffer, Marija] Univ Osijek Sch Med, Dept Med Biol, Osijek, Croatia; [Viljetic, Barbara] Univ Osijek Sch Med, Dept Chem Biochem & Clin Chem, Osijek, Croatia; [Degmecic, Ivan Veceslav] Univ Osijek Sch Med, Anim Facil, Osijek, Croatia; [Schnaar, Ronald L.] Johns Hopkins Sch Med, Dept Pharmacol, Baltimore, MD USA; [Schnaar, Ronald L.] Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Heffer, M (corresponding author), Univ Osijek Sch Med, Dept Med Biol, Osijek, Croatia.	marija.heffer.lauc@mefos.hr	Heffer, Marija/ABA-4694-2020; Schnaar, Ronald L/S-8967-2016	Schnaar, Ronald L/0000-0002-7701-5484; Heffer, Marija/0000-0001-6770-7359	Ministry of Science, Education and Sports of the Republic of Croatia [219-0061194-2157]; NIH [NS037096]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS037096, R01NS037096] Funding Source: NIH RePORTER	Ministry of Science, Education and Sports of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by Ministry of Science, Education and Sports of the Republic of Croatia grant #219-0061194-2157 ("Role of lipid rafts and glycoconjugates in development and regeneration of nervous system") to M. H. and NIH Grant NS037096 to R. L. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende ML, 2002, CURR OPIN STRUC BIOL, V12, P587, DOI 10.1016/S0959-440X(02)00376-7; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Byers DM, 2002, DEV NEUROSCI-BASEL, V24, P478, DOI 10.1159/000069358; Colsch B, 2011, ACS CHEM NEUROSCI, V2, P213, DOI 10.1021/cn100096h; Colsch B, 2010, GLYCOBIOLOGY, V20, P661, DOI 10.1093/glycob/cwq031; DEBAECQUE C, 1976, BRAIN RES, V114, P117, DOI 10.1016/0006-8993(76)91011-8; DEVRIES GH, 1980, J NEUROCHEM, V34, P424, DOI 10.1111/j.1471-4159.1980.tb06613.x; Giger RJ, 2008, RESTOR NEUROL NEUROS, V26, P97; Goh ELK, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-10; Gong Y, 2002, BRAIN, V125, P2491, DOI 10.1093/brain/awf258; Goto-Inoue N, 2010, J AM SOC MASS SPECTR, V21, P1940, DOI 10.1016/j.jasms.2010.08.002; Heffer-Lauc M, 2005, BBA-MOL CELL BIOL L, V1686, P200, DOI 10.1016/j.bbalip.2004.10.002; Heffer-Lauc M, 2007, J HISTOCHEM CYTOCHEM, V55, P805, DOI 10.1369/jhc.7A7195.2007; KOTANI M, 1993, GLYCOBIOLOGY, V3, P137, DOI 10.1093/glycob/3.2.137; LAEV H, 1978, BRAIN RES, V157, P136, DOI 10.1016/0006-8993(78)91002-8; LAEV H, 1989, NEUROSCI LETT, V102, P7, DOI 10.1016/0304-3940(89)90299-1; Lee JK, 2012, EXP NEUROL, V235, P33, DOI 10.1016/j.expneurol.2011.05.001; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; LLOYD KO, 1992, CANCER RES, V52, P4948; Lopez PHH, 2009, CURR OPIN STRUC BIOL, V19, P549, DOI 10.1016/j.sbi.2009.06.001; Lunn MPT, 2000, J NEUROCHEM, V75, P404, DOI 10.1046/j.1471-4159.2000.0750404.x; Mehta NR, 2007, J BIOL CHEM, V282, P27875, DOI 10.1074/jbc.M704055200; Molander M, 2000, J NEUROSCI RES, V60, P531, DOI 10.1002/(SICI)1097-4547(20000515)60:4<531::AID-JNR12>3.0.CO;2-6; NORES GA, 1987, J IMMUNOL, V139, P3171; Pan BH, 2005, EXP NEUROL, V195, P208, DOI 10.1016/j.expneurol.2005.04.017; Pignot V, 2003, J NEUROCHEM, V85, P717, DOI 10.1046/j.1471-4159.2003.01710.x; Schnaar RL, 2002, ANAL BIOCHEM, V302, P276, DOI 10.1006/abio.2001.5540; Schnaar RL, 2009, J NEUROSCI RES, V87, P3267, DOI 10.1002/jnr.21992; Schwarz A, 1997, J HISTOCHEM CYTOCHEM, V45, P611, DOI 10.1177/002215549704500413; Schwarz A, 1996, BBA-REV BIOMEMBRANES, V1286, P247, DOI 10.1016/S0304-4157(96)00011-1; Schwarz A, 2000, METHOD ENZYMOL, V312, P179; Sheikh KA, 1999, P NATL ACAD SCI USA, V96, P7532, DOI 10.1073/pnas.96.13.7532; Simpson MA, 2004, NAT GENET, V36, P1225, DOI 10.1038/ng1460; Sugiura Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003232; SVENNERHOLM L, 1994, PROG BRAIN RES, V101, pR11; Tagawa Y, 2002, NEUROCHEM RES, V27, P847, DOI 10.1023/A:1020221410895; TETTAMAN.G, 1973, BIOCHIM BIOPHYS ACTA, V296, P160, DOI 10.1016/0005-2760(73)90055-6; Venkatesh K, 2005, J NEUROSCI, V25, P808, DOI 10.1523/JNEUROSCI.4464-04.2005; Venkatesh K, 2007, J CELL BIOL, V177, P393, DOI 10.1083/jcb.200702102; Vyas AA, 2002, P NATL ACAD SCI USA, V99, P8412, DOI 10.1073/pnas.072211699	40	57	58	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75720	10.1371/journal.pone.0075720	http://dx.doi.org/10.1371/journal.pone.0075720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098718	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500089
J	Sugatani, J; Sadamitsu, S; Yamaguchi, M; Yamazaki, Y; Higa, R; Hattori, Y; Uchida, T; Ikari, A; Sugiyama, W; Watanabe, T; Ishii, S; Miwa, M; Shimizu, T				Sugatani, Junko; Sadamitsu, Satoshi; Yamaguchi, Masahiko; Yamazaki, Yasuhiro; Higa, Ryoko; Hattori, Yoshiki; Uchida, Takahiro; Ikari, Akira; Sugiyama, Wataru; Watanabe, Tatsuo; Ishii, Satoshi; Miwa, Masao; Shimizu, Takao			Antiobese function of platelet-activating factor: increased adiposity in platelet-activating factor receptor- deficient mice with age	FASEB JOURNAL			English	Article						(1); (3)-adrenergic receptor; uncoupling protein 1; UCP1; brown adipocytes; brown adipose tissue macrophages; thermogenesis	BROWN ADIPOCYTES; FACTOR PAF; ADAPTIVE THERMOGENESIS; LIPID MEDIATORS; ADULT HUMANS; TISSUE; OBESITY; METABOLISM; EXPRESSION; FAT	Platelet-activating factor receptor (PAFR)-deficient mice developed a more severe obese state characterized by higher body mass (approximate to 25%) and epididymal fat mass (approximate to 55%) with age than that of wild-type (WT) littermates. PAFR-deficient mice did not show changes in the expression of critical genes involved in anabolic and catabolic metabolism in adipose, liver, and muscle tissues between 6 and 36 wk. However, a 38-81% reduction in (3)/(1)-adrenergic receptor (AR) and uncoupling protein 1 (UCP1) mRNA and protein levels was observed in the interscapular brown adipose tissue (BAT) of PAFR-deficient mice. Whereas a single injection of the (3)-adrenergic agonist, CL-316,243 (25 g/kg) increased temperatures in the brown fat and rectums of WT mice, this increase in temperature was markedly suppressed in PAFR-deficient mice. Acetyl-CoA:lyso-platelet-activating factor (PAF) acetyltransferase, which is involved in PAF biosynthesis, and the PAF receptor were predominantly localized in BAT macrophages, whereas brown adipocytes possessed the enzyme and functional PAF receptors. The stimulation of brown adipocytes by PAF induced the expression of (3)-AR mRNA and protein (1.5- and 1.9-fold, respectively), but not that of UCP1. These results indicate that obesity in PAFR-deficient mice resulted from impaired BAT activity and suggest that the antiobese function of PAF occurs through (3)-AR/UCP1 expression in BAT.Sugatani, J., Sadamitsu, S., Yamaguchi, M., Yamazaki, Y., Higa, R., Hattori, Y., Uchida, T., Ikari, A., Sugiyama, W., Watanabe, T., Ishii, S., Miwa, M., Shimizu, T. Antiobese function of platelet-activating factor: increased adiposity in platelet-activating factor receptor-deficient mice with age.	[Sugatani, Junko; Sadamitsu, Satoshi; Yamaguchi, Masahiko; Yamazaki, Yasuhiro; Higa, Ryoko; Hattori, Yoshiki; Uchida, Takahiro; Ikari, Akira; Miwa, Masao] Univ Shizuoka, Sch Pharmaceut Sci, Dept Pharmacobiochem, Suruga Ku, Shizuoka 4228526, Japan; [Sugatani, Junko; Watanabe, Tatsuo] Univ Shizuoka, Sch Pharmaceut Sci, Global Ctr Excellence Innovat Human Hlth Sci, Suruga Ku, Shizuoka 4228526, Japan; [Sugiyama, Wataru; Watanabe, Tatsuo] Univ Shizuoka, Sch Food & Nutr Sci, Suruga Ku, Shizuoka 4228526, Japan; [Ishii, Satoshi] Akita Univ, Grad Sch Med, Dept Immunol, Akita 010, Japan; [Shimizu, Takao] Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Tokyo, Japan	University of Shizuoka; University of Shizuoka; University of Shizuoka; Akita University; National Center for Global Health & Medicine - Japan	Sugatani, J (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Pharmacobiochem, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	sugatani@u-shizuoka-ken.ac.jp	Shimizu, Takao/AAV-7052-2021	Higa, Ryoko/0000-0002-6720-7677	global Center of Excellence program; Ministry of Education, Culture, Sports, Science and Technology, Japan [21590170, 22590068]; Grants-in-Aid for Scientific Research [25116703] Funding Source: KAKEN	global Center of Excellence program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors gratefully acknowledge Masaki Imanishi, Kengo Yasuda, and Kouki Hiramoto for excellent technical assistance. This work was supported in part by the global Center of Excellence program and grants-in-aid for scientific research (21590170 and 22590068) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Bamshad M, 1999, AM J PHYSIOL-REG I, V276, pR1569, DOI 10.1152/ajpregu.1999.276.6.R1569; BLANK ML, 1981, LIFE SCI, V29, P769, DOI 10.1016/0024-3205(81)90031-X; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; FEVE B, 1992, J BIOL CHEM, V267, P15909; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Gettys TW, 1997, INT J OBESITY, V21, P865, DOI 10.1038/sj.ijo.0800479; Harayama T, 2008, J BIOL CHEM, V283, P11097, DOI 10.1074/jbc.M708909200; Hikiji H, 2004, J CLIN INVEST, V114, P85, DOI 10.1172/JC1200420504; Inokuma K, 2006, AM J PHYSIOL-ENDOC M, V290, pE1014, DOI 10.1152/ajpendo.00105.2005; Irie Y, 1999, BIOCHEM BIOPH RES CO, V255, P221, DOI 10.1006/bbrc.1998.9999; Ishii S, 2000, PROG LIPID RES, V39, P41, DOI 10.1016/S0163-7827(99)00016-8; Ishii S, 1998, J EXP MED, V187, P1779, DOI 10.1084/jem.187.11.1779; Ishii S, 1997, EMBO J, V16, P133, DOI 10.1093/emboj/16.1.133; Large V, 2004, DIABETES METAB, V30, P294, DOI 10.1016/S1262-3636(07)70121-0; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Mattsson CL, 2011, AM J PHYSIOL-ENDOC M, V301, pE1108, DOI 10.1152/ajpendo.00085.2011; MIWA M, 1988, J CLIN INVEST, V82, P1983, DOI 10.1172/JCI113818; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Prescott SM, 2000, ANNU REV BIOCHEM, V69, P419, DOI 10.1146/annurev.biochem.69.1.419; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Samra JS, 2000, P NUTR SOC, V59, P441, DOI 10.1017/S0029665100000604; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Shindou H, 2000, BIOCHEM BIOPH RES CO, V271, P812, DOI 10.1006/bbrc.2000.2723; SUGATANI J, 1989, FASEB J, V3, P65, DOI 10.1096/fasebj.3.1.2910739; Sugatani J, 2006, DRUG METAB DISPOS, V34, P1677, DOI 10.1124/dmd.106.010645; SUSULIC VS, 1995, J BIOL CHEM, V270, P29483, DOI 10.1074/jbc.270.49.29483; TOKUMURA A, 1987, BIOCHEM BIOPH RES CO, V145, P415, DOI 10.1016/0006-291X(87)91338-6; Tsujimura Y, 2008, IMMUNITY, V28, P581, DOI 10.1016/j.immuni.2008.02.008; Viengchareun S, 2001, AM J PHYSIOL-ENDOC M, V280, pE640, DOI 10.1152/ajpendo.2001.280.4.E640; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; YAMAZAKI R, 1994, BIOCHEM PHARMACOL, V47, P995, DOI 10.1016/0006-2952(94)90410-3; YASUDA K, 1986, BIOCHEM BIOPH RES CO, V138, P1231, DOI 10.1016/S0006-291X(86)80414-4; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	39	17	17	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					440	452		10.1096/fj.13-233262	http://dx.doi.org/10.1096/fj.13-233262			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24100020				2022-12-25	WOS:000333526100041
J	Abdalla, M; Goc, A; Segar, L; Somanath, PR				Abdalla, Maha; Goc, Anna; Segar, Lakshman; Somanath, Payaningal R.			Akt1 Mediates alpha-Smooth Muscle Actin Expression and Myofibroblast Differentiation via Myocardin and Serum Response Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; Differentiation; Fibronectin; Fibrosis; Myofibroblast; Myocardin; Serum Response Factor	TRANSFORMING GROWTH-FACTOR-BETA-1; GRANULATION-TISSUE; FIBROBLAST DIFFERENTIATION; GENE-EXPRESSION; IN-VITRO; ACTIVATION; KINASE; GROWTH; TRANSCRIPTION; MATRIX	Myofibroblast (MF) differentiation, marked by the de novo expression of smooth muscle -actin (SMA) stress fibers, plays a central role in wound healing and its persistence is a hallmark of fibrotic diseases. We have previously shown that Akt1 is necessary for wound healing through matrix regulation. However, the role of Akt1 in regulating MF differentiation with implications in fibrosis remains poorly defined. Here, we show that sustained activation of Akt1 was associated with a 6-fold increase in SMA expression and assembly; an effect that is blunted in cells expressing inactive Akt1 despite TGF stimulation. Mechanistically, Akt1 mediated TGF-induced SMA synthesis through the contractile gene transcription factors myocardin and serum response factor (SRF), independent of mammalian target of rapamycin in mouse embryonic fibroblasts and fibroblasts overexpressing active Akt1. Akt1 deficiency was associated with decreased myocardin, SRF, and SMA expressions in vivo. Furthermore, sustained Akt1-induced SMA synthesis markedly decreased upon RNA silencing of SRF and myocardin. In addition to its integral role in SMA synthesis, we also show that Akt1 mediates fibronectin splice variant expression, which is required for MF differentiation, as well as total fibronectin, which generates the contractile force that promotes MF differentiation. In summary, our results constitute evidence that sustained Akt1 activation is crucial for TGF-induced MF formation and persistent differentiation. These findings highlight Akt1 as a novel potential therapeutic target for fibrotic diseases.	[Abdalla, Maha; Goc, Anna; Segar, Lakshman; Somanath, Payaningal R.] Univ Georgia, Coll Pharm, Ctr Pharm & Expt Therapeut, Augusta, GA 30912 USA; [Abdalla, Maha; Goc, Anna; Segar, Lakshman; Somanath, Payaningal R.] Charlie Norwood Vet Affairs Med Ctr, Augusta, GA USA; [Somanath, Payaningal R.] Georgia Regents Univ, Dept Med, Augusta, GA 30912 USA; [Somanath, Payaningal R.] Georgia Regents Univ, Vasc Biol Ctr, Augusta, GA 30912 USA	University System of Georgia; University of Georgia; US Department of Veterans Affairs; Veterans Health Administration (VHA); University System of Georgia; Augusta University; University System of Georgia; Augusta University	Somanath, PR (corresponding author), Georgia Regents Univ, Univ Georgia, Coll Pharm, Ctr Pharm & Expt Therapeut, HM1200, Augusta, GA 30912 USA.	sshenoy@gru.edu		Rammohan Shenoy, Somanath/0000-0003-3017-0230; Abdalla, Maha/0000-0002-5644-3383	National Institutes of Health [R01HL103952]; American Heart Association Scientist Development Grant [0830326N]; American Heart Association Predoctoral Fellowship [13PRE17100070]; University of Georgia Research Foundation, University of Georgia College of Pharmacy Dean's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103952] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Scientist Development Grant(American Heart Association); American Heart Association Predoctoral Fellowship(American Heart Association); University of Georgia Research Foundation, University of Georgia College of Pharmacy Dean's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL103952, American Heart Association Scientist Development Grant 0830326N (to P. R. S.), American Heart Association Predoctoral Fellowship 13PRE17100070 (to M. A.), and grants from the University of Georgia Research Foundation, University of Georgia College of Pharmacy Dean's Foundation (to P. R. S.).	Akhmetshina A, 2008, ARTHRITIS RHEUM-US, V58, P2553, DOI 10.1002/art.23677; Anderson S, 2004, EXP CELL RES, V298, P574, DOI 10.1016/j.yexcr.2004.05.005; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Fan LZ, 2007, MOL BIOL CELL, V18, P1083, DOI 10.1091/mbc.E06-07-0602; GABBIANI G, 1971, EXPERIENTIA, V27, P549, DOI 10.1007/BF02147594; Goc A, 2011, J CELL PHYSIOL, V226, P3004, DOI 10.1002/jcp.22648; Greenberg RS, 2006, FASEB J, V20, P1006, DOI 10.1096/fj.05-4838fje; Guo WC, 2009, AM J PHYSIOL-LUNG C, V297, pL864, DOI 10.1152/ajplung.00128.2009; He ZY, 2009, J RECEPT SIG TRANSD, V29, P119, DOI 10.1080/10799890902845690; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Hinz B, 2003, CURR OPIN BIOTECH, V14, P538, DOI 10.1016/j.copbio.2003.08.006; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Horowitz JC, 2007, CELL SIGNAL, V19, P761, DOI 10.1016/j.cellsig.2006.10.001; Jeon ES, 2006, J CELL SCI, V119, P4994, DOI 10.1242/jcs.03281; Jun JB, 2005, J INVEST DERMATOL, V124, P298, DOI 10.1111/j.0022-202X.2004.23559.x; Karni R, 2008, P NATL ACAD SCI USA, V105, P15323, DOI 10.1073/pnas.0801376105; Kohan M, 2010, FASEB J, V24, P4503, DOI 10.1096/fj.10-154435; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; MAJNO G, 1971, SCIENCE, V173, P548, DOI 10.1126/science.173.3996.548; Maltseva O, 2001, INVEST OPHTH VIS SCI, V42, P2490; Mattey DL, 1997, ANN RHEUM DIS, V56, P426, DOI 10.1136/ard.56.7.426; Meyer-ter-Vehn T, 2006, INVEST OPHTH VIS SCI, V47, P1500, DOI 10.1167/iovs.05-0361; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Nicholson AG, 2002, AM J RESP CRIT CARE, V166, P173, DOI 10.1164/rccm.2109039; Phan SH, 2002, CHEST, V122, p286S, DOI 10.1378/chest.122.6_suppl.286S; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Qiu P, 2003, J MOL CELL CARDIOL, V35, P1407, DOI 10.1016/j.yjmcc.2003.09.002; RONNOVJESSEN L, 1993, LAB INVEST, V68, P696; Sandbo N, 2005, MOL PHARMACOL, V67, P789, DOI 10.1124/mol.104.006874; Sandbo N, 2011, AM J PHYSIOL-LUNG C, V301, pL656, DOI 10.1152/ajplung.00166.2011; Sandbo N, 2009, AM J RESP CELL MOL, V41, P332, DOI 10.1165/rcmb.2008-0288OC; Short M, 2004, AM J PHYSIOL-CELL PH, V286, pC416, DOI 10.1152/ajpcell.00169.2003; Small EM, 2010, CIRC RES, V107, P294, DOI 10.1161/CIRCRESAHA.110.223172; Somanath PR, 2007, J BIOL CHEM, V282, P22964, DOI 10.1074/jbc.M700241200; Somanath PR, 2009, J CELL PHYSIOL, V218, P394, DOI 10.1002/jcp.21612; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; White ES, 2010, EXP CELL RES, V316, P2644, DOI 10.1016/j.yexcr.2010.06.028; White ES, 2006, AM J RESP CRIT CARE, V173, P112, DOI 10.1164/rccm.200507-1058OC; Xu SW, 2004, MOL BIOL CELL, V15, P2707, DOI 10.1091/mbc.E03-12-0902; Zhang HY, 1999, AM J RESP CELL MOL, V21, P658, DOI 10.1165/ajrcmb.21.6.3720; Zhao XH, 2007, J CELL SCI, V120, P1801, DOI 10.1242/jcs.001586	50	42	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33483	33493		10.1074/jbc.M113.504290	http://dx.doi.org/10.1074/jbc.M113.504290			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24106278	hybrid, Green Published			2022-12-25	WOS:000328841700060
J	Horiuchi, K; Kawamura, T; Iwanari, H; Ohashi, R; Naito, M; Kodama, T; Hamakubo, T				Horiuchi, Keiko; Kawamura, Takeshi; Iwanari, Hiroko; Ohashi, Riuko; Naito, Makoto; Kodama, Tatsuhiko; Hamakubo, Takao			Identification of Wilms' Tumor 1-associating Protein Complex and Its Role in Alternative Splicing and the Cell Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alternative Splicing; Cell Cycle; Nuclear RNA; Protein Complexes; Proteomics	HEPATOCYTE NUCLEAR FACTOR-4-ALPHA; SEX-LETHAL; PROTEOMIC ANALYSIS; DOSAGE COMPENSATION; MOLECULAR PARTNER; HUMAN ENHANCER; CROSS-LINKING; GENE; RNA; DROSOPHILA	Background: WTAP is a ubiquitously expressed nuclear protein that is required for mammalian early embryo development and cell cycle progression. Results: WTAP forms a complex with several splicing regulators. Conclusion: WTAP regulates both the cell cycle and alternative splicing by the formation of a protein complex. Significance: Characterization of this protein complex will help to elucidate the critically important function of WTAP in alternative splicing and cell proliferation. Wilms' tumor 1-associating protein (WTAP) is a putative splicing regulator that is thought to be required for cell cycle progression through the stabilization of cyclin A2 mRNA and mammalian early embryo development. To further understand how WTAP acts in the context of the cellular machinery, we identified its interacting proteins in human umbilical vein endothelial cells and HeLa cells using shotgun proteomics. Here we show that WTAP forms a novel protein complex including Hakai, Virilizer homolog, KIAA0853, RBM15, the arginine/serine-rich domain-containing proteins BCLAF1 and THRAP3, and certain general splicing regulators, most of which have reported roles in post-transcriptional regulation. The depletion of these respective components of the complex resulted in reduced cell proliferation along with G(2)/M accumulation. Double knockdown of the serine/arginine-rich (SR)-like proteins BCLAF1 and THRAP3 by siRNA resulted in a decrease in the nuclear speckle localization of WTAP, whereas the nuclear speckles were intact. Furthermore, we found that the WTAP complex regulates alternative splicing of the WTAP pre-mRNA by promoting the production of a truncated isoform, leading to a change in WTAP protein expression. Collectively, these findings show that the WTAP complex is a novel component of the RNA processing machinery, implying an important role in both posttranscriptional control and cell cycle regulation.	[Horiuchi, Keiko; Kawamura, Takeshi; Iwanari, Hiroko; Hamakubo, Takao] Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Quantitat Biol & Med, Tokyo 1538904, Japan; [Kodama, Tatsuhiko] Univ Tokyo, Res Ctr Adv Sci & Technol, Lab Syst Biol & Med, Tokyo 1538904, Japan; [Ohashi, Riuko; Naito, Makoto] Niigata Univ, Grad Sch Med & Dent Sci, Div Cellular & Mol Pathol, Niigata 9518510, Japan	University of Tokyo; University of Tokyo; Niigata University	Hamakubo, T (corresponding author), Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Quantitat Biol & Med, Tokyo 1538904, Japan.	hamakubo@qbm.rcast.u-tokyo.ac.jp	Ohashi, Riuko/AAH-1415-2019	Ohashi, Riuko/0000-0001-5820-7870; HORIUCHI, KEIKO/0000-0003-4811-5133	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20221010, 08104737]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Scientific Research 20221010 and 08104737 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Amente S, 2005, FEBS LETT, V579, P683, DOI 10.1016/j.febslet.2004.12.045; Anczukow O, 2012, NAT STRUCT MOL BIOL, V19, P220, DOI 10.1038/nsmb.2207; BASHAW GJ, 1995, DEVELOPMENT, V121, P3245; BELL LR, 1991, CELL, V65, P229, DOI 10.1016/0092-8674(91)90157-T; Bernard D, 2010, EMBO J, V29, P3082, DOI 10.1038/emboj.2010.199; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Cook D, 2013, DEV NEUROBIOL, DOI 10.1002/dneu.22096; Daigo K, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015073; Daigo K, 2011, J BIOL CHEM, V286, P674, DOI 10.1074/jbc.M110.154732; Figueroa A, 2009, MOL BIOL CELL, V20, P3533, DOI 10.1091/mbc.E08-08-0845; FLICKINGER TW, 1994, GENE DEV, V8, P914, DOI 10.1101/gad.8.8.914; Forch P, 2001, RNA, V7, P1185, DOI 10.1017/S1355838201010536; Fujimura A, 2012, BIOCHEM BIOPH RES CO, V423, P588, DOI 10.1016/j.bbrc.2012.06.018; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Fukusumi Y, 2008, DEV DYNAM, V237, P618, DOI 10.1002/dvdy.21444; GRANADINO B, 1990, EMBO J, V9, P2597, DOI 10.1002/j.1460-2075.1990.tb07441.x; He X, 2011, ONCOGENE, V30, P356, DOI 10.1038/onc.2010.426; Hilfiker A, 1995, DEVELOPMENT, V121, P4017; HORABIN JI, 1993, MOL CELL BIOL, V13, P7734, DOI 10.1128/MCB.13.12.7734; Horiuchi K, 2006, P NATL ACAD SCI USA, V103, P17278, DOI 10.1073/pnas.0608357103; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; INOUE K, 1990, NATURE, V344, P461, DOI 10.1038/344461a0; Jin DI, 2012, CANCER SCI, V103, P2102, DOI 10.1111/cas.12022; Jo H.J., 2013, J GASTROENTEROL; Kaido M, 2009, GENES CELLS, V14, P1067, DOI 10.1111/j.1365-2443.2009.01335.x; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kelley RL, 1997, NATURE, V387, P195, DOI 10.1038/387195a0; Kim KM, 2012, METHODS, V56, P161, DOI 10.1016/j.ymeth.2011.10.013; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Li XL, 2005, GENE DEV, V19, P2705, DOI 10.1101/gad.1359305; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Little NA, 2000, HUM MOL GENET, V9, P2231, DOI 10.1093/oxfordjournals.hmg.a018914; Lukasik A, 2008, FEBS J, V275, P332, DOI 10.1111/j.1742-4658.2007.06203.x; Merendino L, 1999, NATURE, V402, P838, DOI 10.1038/45602; Merz C, 2007, RNA, V13, P116, DOI 10.1261/rna.336807; Mukherjee M, 2012, EMBO J, V31, P1308, DOI 10.1038/emboj.2011.496; NAGOSHI RN, 1988, CELL, V53, P229, DOI 10.1016/0092-8674(88)90384-4; Onyango P, 2011, P NATL ACAD SCI USA, V108, P16759, DOI 10.1073/pnas.1110904108; Ortega A, 2003, J BIOL CHEM, V278, P3040, DOI 10.1074/jbc.M210737200; Penn JKM, 2008, GENETICS, V178, P737, DOI 10.1534/genetics.107.081679; Potashkin J, 1998, CURR GENET, V34, P153, DOI 10.1007/s002940050381; Saitoh N, 2004, MOL BIOL CELL, V15, P3876, DOI 10.1091/mbc.E04-03-0253; SAKAMOTO H, 1992, NUCLEIC ACIDS RES, V20, P5533, DOI 10.1093/nar/20.21.5533; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Small TW, 2006, CIRC RES, V99, P1338, DOI 10.1161/01.RES.0000252289.79841.d3; Small TW, 2009, J BIOL CHEM, V284, P24684, DOI 10.1074/jbc.M109.034629; Smyk A, 2006, FEBS J, V273, P4728, DOI 10.1111/j.1742-4658.2006.05477.x; SOSNOWSKI BA, 1989, CELL, V58, P449, DOI 10.1016/0092-8674(89)90426-1; Tanaka T, 2006, J PATHOL, V208, P662, DOI 10.1002/path.1928; Tripathi V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003368; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; VALCARCEL J, 1993, NATURE, V362, P171, DOI 10.1038/362171a0; Vasilescu J, 2004, PROTEOMICS, V4, P3845, DOI 10.1002/pmic.200400856; Venables JP, 2009, NAT STRUCT MOL BIOL, V16, P670, DOI 10.1038/nsmb.1608; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; WANG JW, 1994, GENE DEV, V8, P2072, DOI 10.1101/gad.8.17.2072; Weng MT, 2012, P NATL ACAD SCI USA, V109, pE3659, DOI 10.1073/pnas.1207673110; Xiao R, 2007, MOL CELL BIOL, V27, P5393, DOI 10.1128/MCB.00288-07; Zafrakas M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-145; Zhong SL, 2008, PLANT CELL, V20, P1278, DOI 10.1105/tpc.108.058883; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	62	201	233	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33292	33302		10.1074/jbc.M113.500397	http://dx.doi.org/10.1074/jbc.M113.500397			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24100041	Green Published, hybrid			2022-12-25	WOS:000328841700043
J	Locatelli, A; Spor, A; Jolivet, C; Piveteau, P; Hartmann, A				Locatelli, Aude; Spor, Ayme; Jolivet, Claudy; Piveteau, Pascal; Hartmann, Alain			Biotic and Abiotic Soil Properties Influence Survival of Listeria monocytogenes in Soil	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; VBNC STATE; OUTBREAK; DIVERSITY; CONTAMINATION; SALMONELLA; PREVALENCE; INNOCUA; STORAGE	Listeria monocytogenes is a food-borne pathogen responsible for the potentially fatal disease listeriosis and terrestrial ecosystems have been hypothesized to be its natural reservoir. Therefore, identifying the key edaphic factors that influence its survival in soil is critical. We measured the survival of L. monocytogenes in a set of 100 soil samples belonging to the French Soil Quality Monitoring Network. This soil collection is meant to be representative of the pedology and land use of the whole French territory. The population of L. monocytogenes in inoculated microcosms was enumerated by plate count after 7, 14 and 84 days of incubation. Analysis of survival profiles showed that L. monocytogenes was able to survive up to 84 days in 71% of the soils tested, in the other soils (29%) only a short-term survival (up to 7 to 14 days) was observed. Using variance partitioning techniques, we showed that about 65% of the short-term survival ratio of L. monocytogenes in soils was explained by the soil chemical properties, amongst which the basic cation saturation ratio seems to be the main driver. On the other hand, while explaining a lower amount of survival ratio variance (11%), soil texture and especially clay content was the main driver of long-term survival of L. monocytogenes in soils. In order to assess the effect of the endogenous soils microbiota on L. monocytogenes survival, sterilized versus non-sterilized soils microcosms were compared in a subset of 9 soils. We found that the endogenous soil microbiota could limit L. monocytogenes survival especially when soil pH was greater than 7, whereas in acidic soils, survival ratios in sterilized and unsterilized microcosms were not statistically different. These results point out the critical role played by both the endogenous microbiota and the soil physic-chemical properties in determining the survival of L. monocytogenes in soils.	[Locatelli, Aude; Spor, Ayme; Piveteau, Pascal; Hartmann, Alain] INRA, Agroecol UMR1347, F-21034 Dijon, France; [Jolivet, Claudy; Piveteau, Pascal] INRA, US InfoSol 1106, Orleans, France; [Piveteau, Pascal] Univ Bourgogne, Agroecol UMR1347, Dijon, France	INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Hartmann, A (corresponding author), INRA, Agroecol UMR1347, F-21034 Dijon, France.	alain.hartmann@dijon.inra.fr	Hartmann, Alain/B-7862-2018; Spor, Aymé/A-6271-2012	Hartmann, Alain/0000-0001-6034-5068; Spor, Aymé/0000-0002-4707-9559; Jolivet, Claudy/0000-0001-5871-6413	French Agency for Environment and Energy Management (ADEME); INRA (Environnement Agronomie Department); Conseil Regional de Bourgogne; 'Agence Nationale de la Recherche' (ANR) [07 SEST, 018-01, 05 SEST, 009-01]	French Agency for Environment and Energy Management (ADEME)(French National Research Agency (ANR)); INRA (Environnement Agronomie Department); Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); 'Agence Nationale de la Recherche' (ANR)(French National Research Agency (ANR))	Ph.D. grant of Aude Locatelli was funded by the French Agency for Environment and Energy Management (ADEME) and INRA (Environnement Agronomie Department). Part of this work was funded by the Conseil Regional de Bourgogne. This work was also funded by the 'Agence Nationale de la Recherche' (ANR) (programs 07 SEST project 018-01, 05 SEST project 009-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALGHAZALI MR, 1990, J APPL BACTERIOL, V69, P642, DOI 10.1111/j.1365-2672.1990.tb01557.x; [Anonymous], 2009, NFISO103816; [Anonymous], 2002, ISO103811; Aureli P, 2000, NEW ENGL J MED, V342, P1236, DOI 10.1056/NEJM200004273421702; Aytac SA, 2010, J FOOD AGRIC ENVIRON, V8, P275; Besnard V, 2000, LETT APPL MICROBIOL, V31, P77, DOI 10.1046/j.1472-765X.2000.00771.x; Besnard V, 2002, VET RES, V33, P359, DOI 10.1051/vetres:2002022; Beuchat LR, 1996, FOOD CONTROL, V7, P223, DOI 10.1016/S0956-7135(96)00039-4; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borucki MK, 2005, APPL ENVIRON MICROB, V71, P5893, DOI 10.1128/AEM.71.10.5893-5899.2005; BOTZLER R G, 1974, Journal of Wildlife Diseases, V10, P204; COLBURN KG, 1990, APPL ENVIRON MICROB, V56, P2007, DOI 10.1128/AEM.56.7.2007-2011.1990; Cook R.D., 1999, RESPONSE TRANSFORMAT, DOI DOI 10.1002/9780470316948; Cunningham E, 2009, FOOD CONTROL, V20, P1141, DOI 10.1016/j.foodcont.2009.03.005; Dowe MJ, 1997, J FOOD PROTECT, V60, P1201, DOI 10.4315/0362-028X-60.10.1201; El Marrakchi A, 2005, LETT APPL MICROBIOL, V40, P87, DOI 10.1111/j.1472-765X.2004.01651.x; FARBER JM, 1991, MICROBIOL REV, V55, P476, DOI 10.1128/MMBR.55.3.476-511.1991; Fenlon DR, 2000, J APPL MICROBIOL, V88, p149S, DOI 10.1111/j.1365-2672.2000.tb05343.x; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Franz E, 2008, ENVIRON MICROBIOL, V10, P313, DOI 10.1111/j.1462-2920.2007.01453.x; Gaul LK, 2013, CLIN INFECT DIS, V56, P20, DOI 10.1093/cid/cis817; Girardin H, 2005, FEMS MICROBIOL ECOL, V54, P287, DOI 10.1016/j.femsec.2005.04.003; GRAY ML, 1966, BACTERIOL REV, V30, P309, DOI 10.1128/MMBR.30.2.309-382.1966; Grif K, 2003, EUR J CLIN MICROBIOL, V22, P16, DOI 10.1007/s10096-002-0835-9; Grolleau E., 2004, ETUDE GESTION SOLS, V11, P255; Guenther S, 2009, APPL ENVIRON MICROB, V75, P93, DOI 10.1128/AEM.01711-08; Hartman WH, 2008, P NATL ACAD SCI USA, V105, P17842, DOI 10.1073/pnas.0808254105; Hutchison ML, 2005, APPL ENVIRON MICROB, V71, P1231, DOI 10.1128/AEM.71.3.1231-1236.2005; Jablasone J, 2005, INT J FOOD MICROBIOL, V99, P7, DOI 10.1016/j.ijfoodmicro.2004.06.011; JACQUET C, 1995, APPL ENVIRON MICROB, V61, P2242, DOI 10.1128/AEM.61.6.2242-2246.1995; Jeyaletchumi P., 2011, Journal of Tropical Agriculture and Food Science, V39, P255; Jolivet C., 2006, ETUDE ET GESTION DES, V13, P149; Jones DL, 1999, SOIL USE MANAGE, V15, P76, DOI 10.1111/j.1475-2743.1999.tb00069.x; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lemunier M, 2005, APPL ENVIRON MICROB, V71, P5779, DOI 10.1128/AEM.71.10.5779-5786.2005; Lindback T, 2010, VET RES, V41, DOI 10.1051/vetres/2009056; Low JC, 1997, VET J, V153, P9, DOI 10.1016/S1090-0233(97)80005-6; Lyautey E, 2007, APPL ENVIRON MICROB, V73, P5401, DOI 10.1128/AEM.00354-07; McLaughlin HP, 2011, ARCH MICROBIOL, V193, P775, DOI 10.1007/s00203-011-0716-7; Mead PS, 2006, EPIDEMIOL INFECT, V134, P744, DOI 10.1017/S0950268805005376; Mubiru DN, 2000, J ENVIRON QUAL, V29, P1821, DOI 10.2134/jeq2000.00472425002900060012x; Nicholson FA, 2005, BIORESOURCE TECHNOL, V96, P135, DOI 10.1016/j.biortech.2004.02.030; Nightingale KK, 2004, APPL ENVIRON MICROB, V70, P4458, DOI 10.1128/AEM.70.8.4458-4467.2004; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Ranjard L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2431; Ranjard L, 2010, AGRON SUSTAIN DEV, V30, P359, DOI 10.1051/agro/2009033; Rocourt J, 2000, INT J FOOD MICROBIOL, V62, P197, DOI 10.1016/S0168-1605(00)00336-6; Siegman-Igra Y, 2002, EMERG INFECT DIS, V8, P305; Sim J, 2002, LETT APPL MICROBIOL, V35, P409, DOI 10.1046/j.1472-765X.2002.01207.x; Slutsker L., 1999, Listeria, listeriosis and food safety., P75; VANRENTERGHEM B, 1991, J APPL BACTERIOL, V71, P211; WEIS J, 1975, APPL MICROBIOL, V30, P29, DOI 10.1128/AEM.30.1.29-32.1975; WELSHIME.HJ, 1968, J BACTERIOL, V95, P300, DOI 10.1128/JB.95.2.300-303.1968; Welshimer H. J., 1975, Problems of listeriosis,, P59; WELSHIMER HJ, 1960, J BACTERIOL, V80, P316, DOI 10.1128/JB.80.3.316-320.1960; Wesley I. V., 1999, Listeria, listeriosis and food safety., P39; Wing EJ, 2002, J INFECT DIS, V185, pS18, DOI 10.1086/338465	57	69	68	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75969	10.1371/journal.pone.0075969	http://dx.doi.org/10.1371/journal.pone.0075969			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116083	Green Submitted, Green Published, gold			2022-12-25	WOS:000325501300044
J	Devereaux, K; Dall'Armi, C; Alcazar-Roman, A; Ogasawara, Y; Zhou, X; Wang, F; Yamamoto, A; De Camilli, P; Di Paolo, G				Devereaux, Kelly; Dall'Armi, Claudia; Alcazar-Roman, Abel; Ogasawara, Yuta; Zhou, Xiang; Wang, Fan; Yamamoto, Akitsugu; De Camilli, Pietro; Di Paolo, Gilbert			Regulation of Mammalian Autophagy by Class II and III PI 3-Kinases through PI3P Synthesis	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; KINASE VPS34; BECLIN 1; PROTEIN; COMPLEX; LOCALIZATION; 3-PHOSPHATE; DELETION; VACUOLE; MACROAUTOPHAGY	Synthesis of phosphatidylinositol-3-phosphate (PI3P) by Vps34, a class III phosphatidylinositol 3-kinase (PI3K), is critical for the initial steps of autophagosome (AP) biogenesis. Although Vps34 is the sole source of PI3P in budding yeast, mammalian cells can produce PI3P through alternate pathways, including direct synthesis by the class II PI3Ks; however, the physiological relevance of these alternate pathways in the context of autophagy is unknown. Here we generated Vps34 knockout mouse embryonic fibroblasts (MEFs) and using a higher affinity 4x-FYVE finger PI3P-binding probe found a Vps34-independent pool of PI3P accounting for (similar to)35% of the total amount of this lipid species by biochemical analysis. Importantly, WIPI-1, an autophagy-relevant PI3P probe, still formed some puncta upon starvation-induced autophagy in Vps34 knockout MEFs. Additional characterization of autophagy by electron microscopy as well as protein degradation assays showed that while Vps34 is important for starvation-induced autophagy there is a significant component of functional autophagy occurring in the absence of Vps34. Given these findings, class II PI3Ks (alpha and beta isoforms) were examined as potential positive regulators of autophagy. Depletion of class II PI3Ks reduced recruitment of WIPI-1 and LC3 to AP nucleation sites and caused an accumulation of the autophagy substrate, p62, which was exacerbated upon the concomitant ablation of Vps34. Our studies indicate that while Vps34 is the main PI3P source during autophagy, class II PI3Ks also significantly contribute to PI3P generation and regulate AP biogenesis.	[Devereaux, Kelly; Dall'Armi, Claudia; Di Paolo, Gilbert] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10027 USA; [Devereaux, Kelly; Dall'Armi, Claudia; Di Paolo, Gilbert] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, Med Ctr, New York, NY USA; [Alcazar-Roman, Abel; De Camilli, Pietro] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Alcazar-Roman, Abel; De Camilli, Pietro] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Ogasawara, Yuta; Yamamoto, Akitsugu] Nagahama Inst Biosci & Technol, Dept Anim Biosci, Fac Biosci, Nagahama, Shiga, Japan; [Zhou, Xiang; Wang, Fan] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Zhou, Xiang; Wang, Fan] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Columbia University; Columbia University; Yale University; Howard Hughes Medical Institute; Yale University; Duke University; Duke University	Di Paolo, G (corresponding author), Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10027 USA.	gil.dipaolo@columbia.edu	Ogasawara, Yuta/C-4021-2016	Alcazar-Roman, Abel R./0000-0003-1668-1886; Ogasawara, Yuta/0000-0001-5345-6472	NIH [R01 NS056049, R01 DE016550, P50 AG08702, P30 DK063608, T32 GM07367, DA018343, RO1 DK082700]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG045020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants R01 NS056049 (to G. D. P.), R01 DE016550 (to F. W.), P50 AG08702 (to Michael Shelanski, G. D. P. and C. D. A. projects), and P30 DK063608 (to Domenico Accili, G. D. P pilot project). K. A. D. is supported by NIH training grant T32 GM07367 (to Michael Shelanski). The work was also funded by NIH grants P30 DA018343 and RO1 DK082700 to P. D. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Bechtel W, 2013, AUTOPHAGY, V9, P1097, DOI 10.4161/auto.24634; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Bohdanowicz M, 2010, J CELL BIOL, V191, P999, DOI 10.1083/jcb.201004005; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Burman C, 2010, FEBS LETT, V584, P1302, DOI 10.1016/j.febslet.2010.01.011; Cebollero E, 2012, CURR BIOL, V22, P1545, DOI 10.1016/j.cub.2012.06.029; Codogno P, 2012, NAT REV MOL CELL BIO, V13, P7, DOI 10.1038/nrm3249; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Dall'Armi C, 2013, CURR BIOL, V23, pR33, DOI 10.1016/j.cub.2012.10.041; Dall'Armi C, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1144; Falasca M, 2007, BIOCHEM SOC T, V35, P211, DOI 10.1042/BST0350211; Falasca M, 2012, BIOCHEM J, V443, P587, DOI 10.1042/BJ20120008; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Futter CE, 2001, J CELL BIOL, V155, P1251, DOI 10.1083/jcb.200108152; Gaidarov I, 2005, J BIOL CHEM, V280, P40766, DOI 10.1074/jbc.M507731200; Gary JD, 2002, MOL BIOL CELL, V13, P1238, DOI 10.1091/mbc.01-10-0498; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Hakim S, 2012, CURR TOP MICROBIOL, V362, P246, DOI 10.1007/978-94-007-5025-8_12; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; Ho A, 2006, J NEUROSCI, V26, P13089, DOI 10.1523/JNEUROSCI.2855-06.2006; Itakura E, 2012, J CELL SCI, V125, P1488, DOI 10.1242/jcs.094110; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Jaber N, 2012, AUTOPHAGY, V8, P707, DOI 10.4161/auto.19627; Jaber N, 2012, P NATL ACAD SCI USA, V109, P2003, DOI 10.1073/pnas.1112848109; Johnson EE, 2006, J CELL SCI, V119, P1219, DOI 10.1242/jcs.02833; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Kiel JAKW, 1999, YEAST, V15, P741, DOI 10.1002/(SICI)1097-0061(19990630)15:9<741::AID-YEA416>3.0.CO;2-O; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; KIRK CJ, 1990, EPTIDE HORMONE ACTIO, P45237; Knaevelsrud H, 2013, J CELL BIOL, V202, P331, DOI 10.1083/jcb.201205129; Knaevelsrud H, 2012, BBA-MOL CELL BIOL L, V1821, P1133, DOI 10.1016/j.bbalip.2012.01.001; Lu N, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001245; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; McLeod IX, 2011, J IMMUNOL, V187, P5051, DOI 10.4049/jimmunol.1100710; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Morel E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3250; Morishita H, 2013, J BIOL CHEM, V288, P11436, DOI 10.1074/jbc.M112.437103; Nemazanyy I, 2013, EMBO MOL MED, V5, P870, DOI 10.1002/emmm.201202057; Noda T, 2010, SEMIN CELL DEV BIOL, V21, P671, DOI 10.1016/j.semcdb.2010.04.002; NORRIS FA, 1994, J BIOL CHEM, V269, P8716; Norris FA, 1997, J BIOL CHEM, V272, P23859, DOI 10.1074/jbc.272.38.23859; Obara K, 2008, GENES CELLS, V13, P537, DOI 10.1111/j.1365-2443.2008.01188.x; Parekh VV, 2013, J IMMUNOL, V190, P5086, DOI 10.4049/jimmunol.1202071; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Posor Y, 2013, NATURE, V499, P233, DOI 10.1038/nature12360; Proikas-Cezanne T, 2004, ONCOGENE, V23, P9314, DOI 10.1038/sj.onc.1208331; Proikas-Cezanne T, 2007, FEBS LETT, V581, P3396, DOI 10.1016/j.febslet.2007.06.040; Raiborg C, 2013, FEBS J, V280, P2730, DOI 10.1111/febs.12116; Rubinsztein DC, 2012, CURR BIOL, V22, pR29, DOI 10.1016/j.cub.2011.11.034; Rudge SA, 2004, MOL BIOL CELL, V15, P24, DOI 10.1091/mbc.E03-05-0297; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Stenmark H, 1999, J CELL SCI, V112, P4175; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; Stromhaug PE, 2004, MOL BIOL CELL, V15, P3553, DOI 10.1091/mbc.E04-02-0147; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Taguchi-Atarashi N, 2010, TRAFFIC, V11, P468, DOI 10.1111/j.1600-0854.2010.01034.x; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Velikkakath AKG, 2012, MOL BIOL CELL, V23, P896, DOI 10.1091/mbc.E11-09-0785; Vergne I, 2009, EMBO J, V28, P2244, DOI 10.1038/emboj.2009.159; Willinger T, 2012, P NATL ACAD SCI USA, V109, P8670, DOI 10.1073/pnas.1205305109; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180; Yoshioka K, 2012, NAT MED, V18, P1560, DOI 10.1038/nm.2928; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854; Zhou X, 2010, P NATL ACAD SCI USA, V107, P9424, DOI 10.1073/pnas.0914725107	80	119	121	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76405	10.1371/journal.pone.0076405	http://dx.doi.org/10.1371/journal.pone.0076405			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098492	Green Published, Green Submitted, gold			2022-12-25	WOS:000325483600044
J	Li, HT; Zhu, F; Sun, YW; Li, B; Oi, NM; Chen, HY; Lubet, RA; Bode, AM; Dong, ZG				Li, Haitao; Zhu, Feng; Sun, Yanwen; Li, Bing; Oi, Naomi; Chen, Hanyong; Lubet, Ronald A.; Bode, Ann M.; Dong, Zigang			Select Dietary Phytochemicals Function as Inhibitors of COX-1 but Not COX-2	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; EPITHELIAL-CELLS; CYCLOOXYGENASE-2 TRANSCRIPTION; CARDIOVASCULAR-DISEASE; SOYBEAN ISOFLAVONES; CANCER PREVENTION; PHARMACOKINETICS; BIOAVAILABILITY; ASPIRIN; RATS	Recent clinical trials raised concerns regarding the cardiovascular toxicity of selective cyclooxygenase-2 (COX-2) inhibitors. Many active dietary factors are reported to suppress carcinogenesis by targeting COX-2. A major question was accordingly raised: why has the lifelong use of phytochemicals that likely inhibit COX-2 presumably not been associated with adverse cardiovascular side effects. To answer this question, we selected a library of dietary-derived phytochemicals and evaluated their potential cardiovascular toxicity in human umbilical vein endothelial cells. Our data indicated that the possibility of cardiovascular toxicity of these dietary phytochemicals was low. Further mechanistic studies revealed that the actions of these phytochemicals were similar to aspirin in that they mainly inhibited COX-1 rather than COX-2, especially at low doses.	[Li, Haitao; Zhu, Feng; Sun, Yanwen; Li, Bing; Oi, Naomi; Chen, Hanyong; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Lubet, Ronald A.] NCI, NIH, Bethesda, MD 20892 USA	University of Minnesota System; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu	ZHU, Feng/C-1303-2010	Zhu, Feng/0000-0003-1172-0102	Hormel Foundation and National Institutes of Health [R37 CA081064, ES016548]; NCI [HHSN-261200533001C-NO1-CN9 53301, N01-CN-43309-18018-01WA 13B]; NATIONAL CANCER INSTITUTE [R21CA172457, R37CA081064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	Hormel Foundation and National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by The Hormel Foundation and National Institutes of Health grants R37 CA081064 and ES016548 and NCI Contract Numbers HHSN-261200533001C-NO1-CN9 53301 and N01-CN-43309-18018-01WA 13B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aneja R, 2004, MOL MED, V10, P55, DOI 10.2119/2004-00032.Aneja; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Chen ZP, 2010, FITOTERAPIA, V81, P1045, DOI 10.1016/j.fitote.2010.06.028; Chow HHS, 2001, CANCER EPIDEM BIOMAR, V10, P53; Chulada PC, 2000, CANCER RES, V60, P4705; Chun KS, 2003, CARCINOGENESIS, V24, P1515, DOI 10.1093/carcin/bgg107; Chun Kyung-Soo, 2006, Cancer Res Treat, V38, P152, DOI 10.4143/crt.2006.38.1.152; DINCHUK JE, 1995, NATURE, V378, P406, DOI 10.1038/378406a0; Gradolatto A, 2005, DRUG METAB DISPOS, V33, P49, DOI 10.1124/dmd.104.000893; Graefe EU, 1999, INT J CLIN PHARM TH, V37, P219; Gray PA, 2002, BRIT J PHARMACOL, V137, P1031, DOI 10.1038/sj.bjp.0704927; Hall MN, 2007, CANCER EPIDEM BIOMAR, V16, P314, DOI 10.1158/1055-9965.EPI-06-0346; Inserte J, 2009, J MOL CELL CARDIOL, V46, P160, DOI 10.1016/j.yjmcc.2008.11.011; Kanaze FI, 2007, EUR J CLIN NUTR, V61, P472, DOI 10.1038/sj.ejcn.1602543; Kuriyama S, 2006, JAMA-J AM MED ASSOC, V296, P1255, DOI 10.1001/jama.296.10.1255; Lee KW, 2011, NAT REV CANCER, V11, P211, DOI 10.1038/nrc3017; Lee KW, 2005, ANTIOXID REDOX SIGN, V7, P1612, DOI 10.1089/ars.2005.7.1612; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; Moon YJ, 2007, MOL PHARM, V4, P865, DOI 10.1021/mp7000928; Mutoh H, 2000, JPN J CANCER RES, V91, P686; Na HK, 2004, BIOFACTORS, V21, P149, DOI 10.1002/biof.552210130; Narko K, 1997, J BIOL CHEM, V272, P21455, DOI 10.1074/jbc.272.34.21455; PEDERSEN AK, 1984, NEW ENGL J MED, V311, P1206, DOI 10.1056/NEJM198411083111902; Perrone MG, 2010, CURR MED CHEM, V17, P3769; Reese J, 2000, P NATL ACAD SCI USA, V97, P9759, DOI 10.1073/pnas.97.17.9759; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Shinmura K, 2000, P NATL ACAD SCI USA, V97, P10197, DOI 10.1073/pnas.97.18.10197; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Subbaramaiah K, 1998, J BIOL CHEM, V273, P21875, DOI 10.1074/jbc.273.34.21875; Takeda H, 2003, CANCER RES, V63, P4872; Ulrich CM, 2006, NAT REV CANCER, V6, P130, DOI 10.1038/nrc1801; Wang DR, 2009, P NATL ACAD SCI USA, V106, P7548, DOI 10.1073/pnas.0805806106; XU X, 1995, J NUTR, V125, P2307, DOI 10.1093/jn/125.9.2307; Zhang F, 1999, CARCINOGENESIS, V20, P445, DOI 10.1093/carcin/20.3.445; Zubik L, 2003, AM J CLIN NUTR, V77, P1459, DOI 10.1093/ajcn/77.6.1459	35	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76452	10.1371/journal.pone.0076452	http://dx.doi.org/10.1371/journal.pone.0076452			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098505	Green Submitted, gold, Green Published			2022-12-25	WOS:000325483600055
J	Bienenstock, J; Buck, RH; Linke, H; Forsythe, P; Stanisz, AM; Kunze, WA				Bienenstock, John; Buck, Rachael H.; Linke, Hawley; Forsythe, Paul; Stanisz, Andrew M.; Kunze, Wolfgang A.			Fucosylated but Not Sialylated Milk Oligosaccharides Diminish Colon Motor Contractions	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; LONG-TERM POTENTIATION; BREAST-FED INFANTS; IN-VITRO; URINARY-EXCRETION; BOVINE-MILK; VAGUS NERVE; FED BABIES; FUCOSE; EXPRESSION	Human milk oligosaccharides (HMO) are being studied by different groups exploring a broad range of potential beneficial effects to the breastfed infant. Many of these effects have been attributed to a growth promotion effect on certain gut organisms such as bifidobacteria. Additionally, evidence indicates that HMO are able to directly promote positive changes in gut epithelium and immune responses under certain conditions. This study utilizes a standardized ex vivo murine colon preparation to examine the effects of sialylated, fucosylated and other HMO on gut motor contractions. Only the fucosylated molecules, 2'FL and 3'FL, decreased contractility in a concentration dependent fashion. On the basis of IC50 determinations 3'FL was greater than 2 times more effective than 2'FL. The HMO 3'SL and 6'SL, lacto-N-neotetraose (LNnT), and galactooligosaccharides (GOS) elicited no effects. Lactose was used as a negative control. Fucosylation seems to underlie this functional regulation of gut contractility by oligosaccharides, and L-fucose, while it was also capable of reducing contractility, was substantially less effective than 3'FL and 2'FL. These results suggest that specific HMO are unlikely to be having these effects via bifidogenesis, but though direct action on neuronally dependent gut migrating motor complexes is likely and fucosylation is important in providing this function, we cannot conclusively shown that this is not indirectly mediated. Furthermore they support the possibility that fucosylated sugars and fucose might be useful as therapeutic or preventative adjuncts in disorders of gut motility, and possibly also have beneficial central nervous system effects.	[Bienenstock, John; Stanisz, Andrew M.; Kunze, Wolfgang A.] St Josephs Healthcare, McMaster Brain Body Inst, Hamilton, ON, Canada; [Buck, Rachael H.; Linke, Hawley] Abbott Nutr, Columbus, OH USA; [Bienenstock, John] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Forsythe, Paul] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Forsythe, Paul] Firestone Inst Resp Hlth, Hamilton, ON, Canada; [Kunze, Wolfgang A.] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Kunze, Wolfgang A.] Farncombe Family Digest Hlth Inst, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University	Bienenstock, J (corresponding author), St Josephs Healthcare, McMaster Brain Body Inst, Hamilton, ON, Canada.	bienens@mcmaster.ca			Abbott Nutrition; Giovanni and Concetta Giulietti Family Foundation; St Joseph's Healthcare Hamilton Foundation; NSERC [371513-2009, 371955-2009]	Abbott Nutrition(Abbott Laboratories); Giovanni and Concetta Giulietti Family Foundation; St Joseph's Healthcare Hamilton Foundation; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported in part by a research grant from Abbott Nutrition who had no involvement in the conduct or execution of the project or the analysis of the data. Support was also provided by the The Giovanni and Concetta Giulietti Family Foundation, St Joseph's Healthcare Hamilton Foundation, NSERC 371513-2009 (PF) and NSERC 371955-2009 (WAK). The funders also had no role in study design or data collection, decision to publish, or preparation of the manuscript, but reviewed it before submission.	Albrecht S, 2011, CARBOHYD RES, V346, P2540, DOI 10.1016/j.carres.2011.08.009; Albrecht S, 2011, CARBOHYD RES, V346, P2173, DOI 10.1016/j.carres.2011.06.034; Asakuma S, 2011, J BIOL CHEM, V286, P34583, DOI 10.1074/jbc.M111.248138; BABA T, 1979, J IMMUNOL, V122, P838; Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074; Bonaz B, 2013, NEUROGASTROENT MOTIL, V25, P208, DOI 10.1111/nmo.12076; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Chaturvedi P, 2001, GLYCOBIOLOGY, V11, P365, DOI 10.1093/glycob/11.5.365; Chichlowski M, 2012, J PEDIATR GASTR NUTR, V55, P321, DOI 10.1097/MPG.0b013e31824fb899; Chow WL, 2008, BRIT J NUTR, V99, P449, DOI 10.1017/S0007114507812062; COPPA GV, 1993, PEDIATRICS, V91, P637; Coppa GV, 2001, ADV EXP MED BIOL, V501, P307; Cote M, 2011, BRAIN BEHAV IMMUN, V25, P1143, DOI 10.1016/j.bbi.2011.02.017; de Kivit S, 2011, EUR J PHARMACOL, V668, pS124, DOI 10.1016/j.ejphar.2011.05.086; Eiwegger T, 2010, PEDIAT ALLERG IMM-UK, V21, P1179, DOI 10.1111/j.1399-3038.2010.01062.x; Gensel JC, 2012, CELL TISSUE RES, V349, P201, DOI 10.1007/s00441-012-1425-5; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Gnoth MJ, 2001, J BIOL CHEM, V276, P34363, DOI 10.1074/jbc.M104805200; Jantscher-Krenn E, 2012, BR J NUTR, P1; Keating C, 2010, TOXICOL APPL PHARM, V245, P299, DOI 10.1016/j.taap.2010.03.014; Kobata A, 2010, P JPN ACAD B-PHYS, V86, P731, DOI 10.2183/pjab.86.731; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Kuhn L, 2008, NEW ENGL J MED, V359, P130, DOI 10.1056/NEJMoa073788; Kuntz S, 2008, BRIT J NUTR, V99, P462, DOI 10.1017/S0007114507824068; Kuntz S, 2009, BRIT J NUTR, V101, P1306, DOI 10.1017/S0007114508079622; Liu T, 2012, NEUROSCI BULL, V28, P131, DOI 10.1007/s12264-012-1219-5; Mao YK, 2013, NATURE COMM IN PRESS; Mao YK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2478; Matthies H, 1996, BRAIN RES, V725, P276, DOI 10.1016/0006-8993(96)00406-4; Matthies H, 2000, LEARN MEMORY, V7, P227, DOI 10.1101/lm.7.4.227; MCCABE NR, 1985, NEUROCHEM RES, V10, P1083, DOI 10.1007/BF00965883; Murrey HE, 2006, P NATL ACAD SCI USA, V103, P21, DOI 10.1073/pnas.0503381102; Nelson ED, 2012, NUTR NEUROSCI, V15, P149, DOI 10.1179/1476830512Y.0000000004; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; POHLE W, 1987, BRAIN RES, V410, P245, DOI 10.1016/0006-8993(87)90321-0; PRIETO PA, 1995, J BIOL CHEM, V270, P29515, DOI 10.1074/jbc.270.49.29515; Prieto PA, 2005, FOODS FOODS INGREDIE, V219, P1018; ROCKLIN RE, 1976, J IMMUNOL, V116, P816; Rudloff S, 1996, ACTA PAEDIATR, V85, P598, DOI 10.1111/j.1651-2227.1996.tb14095.x; Rudloff S, 2012, BRIT J NUTR, V107, P957, DOI 10.1017/S0007114511004016; Ruiz-Palacios GM, 2003, J BIOL CHEM, V278, P14112, DOI 10.1074/jbc.M207744200; Sarna SK, 2007, AM J PHYSIOL-GASTR L, V292, pG572, DOI 10.1152/ajpgi.00332.2006; Sela DA, 2012, APPL ENVIRON MICROB, V78, P795, DOI 10.1128/AEM.06762-11; Sotgiu S, 2006, Int J Biomed Sci, V2, P114; Sundekilde UK, 2012, J AGR FOOD CHEM, V60, P6188, DOI 10.1021/jf300015j; Wang BX, 2010, FASEB J, V24, P4078, DOI 10.1096/fj.09-153841; Wu RY, 2013, NEUROGASTROENT MOTIL, V25, pE205, DOI 10.1111/nmo.12072; Zivkovic AM, 2011, ADV NUTR, V2, P284, DOI 10.3945/an.111.000455	48	52	54	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76236	10.1371/journal.pone.0076236	http://dx.doi.org/10.1371/journal.pone.0076236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098451	Green Published, gold, Green Submitted			2022-12-25	WOS:000325434500055
J	Mielecki, D; Saumaa, S; Wrzesinski, M; Maciejewska, AM; Zuchniewicz, K; Sikora, A; Piwowarski, J; Nieminuszczy, J; Kivisaar, M; Grzesiuk, E				Mielecki, Damian; Saumaa, Signe; Wrzesinski, Michal; Maciejewska, Agnieszka M.; Zuchniewicz, Karolina; Sikora, Anna; Piwowarski, Jan; Nieminuszczy, Jadwiga; Kivisaar, Maia; Grzesiuk, Elzbieta			Pseudomonas putida AlkA and AlkB Proteins Comprise Different Defense Systems for the Repair of Alkylation Damage to DNA - In Vivo, In Vitro, and In Silico Studies	PLOS ONE			English	Article							STATIONARY-PHASE MUTAGENESIS; GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; ADAPTIVE RESPONSE; ADA PROTEIN; 3-METHYLADENINE DNA; TRANSCRIPTIONAL ACTIVATION; OXIDATIVE DEMETHYLATION; CHROMOSOMAL INSERTION; GLYCOSYLASE-II	Alkylating agents introduce cytotoxic and/or mutagenic lesions to DNA bases leading to induction of adaptive (Ada) response, a mechanism protecting cells against deleterious effects of environmental chemicals. In Escherichia coli, the Ada response involves expression of four genes: ada, alkA, alkB, and aidB. In Pseudomonas putida, the organization of Ada regulon is different, raising questions regarding regulation of Ada gene expression. The aim of the presented studies was to analyze the role of AlkA glycosylase and AlkB dioxygenase in protecting P. putida cells against damage to DNA caused by alkylating agents. The results of bioinformatic analysis, of survival and mutagenesis of methyl methanesulfonate (MMS) or N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) treated P. putida mutants in ada, alkA and alkB genes as well as assay of promoter activity revealed diverse roles of Ada, AlkA and AlkB proteins in protecting cellular DNA against alkylating agents. We found AlkA protein crucial to abolish the cytotoxic but not the mutagenic effects of alkylans since: (i) the mutation in the alkA gene was the most deleterious for MMS/MNNG treated P. putida cells, (ii) the activity of the alkA promoter was Ada-dependent and the highest among the tested genes. P. putida AlkB (PpAlkB), characterized by optimal conditions for in vitro repair of specific substrates, complementation assay, and M13/MS2 survival test, allowed to establish conservation of enzymatic function of P. putida and E. coli AlkB protein. We found that the organization of P. putida Ada regulon differs from that of E. coli. AlkA protein induced within the Ada response is crucial for protecting P. putida against cytotoxicity, whereas Ada prevents the mutagenic action of alkylating agents. In contrast to E. coli AlkB (EcAlkB), PpAlkB remains beyond the Ada regulon and is expressed constitutively. It probably creates a backup system that protects P. putida strains defective in other DNA repair systems against alkylating agents of exo-and endogenous origin.	[Mielecki, Damian; Wrzesinski, Michal; Maciejewska, Agnieszka M.; Zuchniewicz, Karolina; Sikora, Anna; Piwowarski, Jan; Nieminuszczy, Jadwiga; Grzesiuk, Elzbieta] Polish Acad Sci, Inst Biochem & Biophys, Dept Mol Biol, Warsaw, Poland; [Saumaa, Signe; Kivisaar, Maia] Univ Tartu, Dept Genet, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Tartu	Kivisaar, M (corresponding author), Univ Tartu, Dept Genet, Inst Mol & Cell Biol, Ulikooli 18, EE-50090 Tartu, Estonia.	maia.kivisaar@ut.ee; elag@ibb.waw.pl	Sikora, Anna/Y-4216-2019; Maciejewska, Agnieszka M/B-2287-2012; Wrzesiński, Michał/H-4820-2011	Sikora, Anna/0000-0002-9464-6851; Wrzesiński, Michał/0000-0002-6092-9431; Grzesiuk, Elzbieta/0000-0002-7833-7602; Maciejewska, Agnieszka M./0000-0002-1268-2606; Zuchniewicz, Karolina/0000-0002-7097-4025; Mielecki, Damian/0000-0003-2929-4500	National Center of Science, Poland [UMO-2012/05/B/NZ1/00693]; Estonian Science Foundation [9114]; Estonian Ministry of Research Targeted Financing Project [SF0180031s08]	National Center of Science, Poland; Estonian Science Foundation; Estonian Ministry of Research Targeted Financing Project	This work was funded by National Center of Science, Poland, grant number UMO-2012/05/B/NZ1/00693 to AS, DM, MW, and EG; by Estonian Science Foundation, grant number 9114 to MK, and by Estonian Ministry of Research Targeted Financing Project SF0180031s08 to MK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Abella M, 2004, MOL MICROBIOL, V54, P212, DOI 10.1111/j.1365-2958.2004.04260.x; Abril N, 1996, CARCINOGENESIS, V17, P1609, DOI 10.1093/carcin/17.8.1609; Adams MH, 1959, BACTERIOPHAGES; AKIMARU H, 1990, J MOL BIOL, V216, P261, DOI 10.1016/S0022-2836(05)80318-3; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BACHMANN BJ, 1987, ESCHERICHIA COLI SAL; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; BAYLEY SA, 1977, MOL GEN GENET, V154, P203, DOI 10.1007/BF00330838; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; Berdal KG, 1998, EMBO J, V17, P363, DOI 10.1093/emboj/17.2.363; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; CLARKE PH, 1982, A VAN LEEUW J MICROB, V48, P105, DOI 10.1007/BF00405197; DEHENESTROSA ARF, 1991, J BACTERIOL, V173, P7736, DOI 10.1128/jb.173.23.7736-7740.1991; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Erill I, 2006, NUCLEIC ACIDS RES, V34, P66, DOI 10.1093/nar/gkj412; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; HAKURA A, 1991, J BACTERIOL, V173, P3663, DOI 10.1128/JB.173.12.3663-3672.1991; He C, 2005, MOL CELL, V20, P117, DOI 10.1016/j.molcel.2005.08.013; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Horak R, 2004, MOL MICROBIOL, V54, P795, DOI 10.1111/j.1365-2958.2004.04311.x; Iyer LM, 2001, GENOME BIOL, V2; Kivisaar M, 2010, FEMS MICROBIOL LETT, V312, P1, DOI 10.1111/j.1574-6968.2010.02027.x; Koch B, 2001, J MICROBIOL METH, V45, P187, DOI 10.1016/S0167-7012(01)00246-9; Koorits L, 2007, DNA REPAIR, V6, P863, DOI 10.1016/j.dnarep.2007.01.010; Kurowski MA, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-48; Landini P, 1998, J BIOL CHEM, V273, P13307, DOI 10.1074/jbc.273.21.13307; LANDINI P, 1995, J BIOL CHEM, V270, P8285, DOI 10.1074/jbc.270.14.8285; Landini P, 2000, J BACTERIOL, V182, P6543, DOI 10.1128/JB.182.23.6543-6549.2000; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leiros I, 2007, EMBO J, V26, P2206, DOI 10.1038/sj.emboj.7601662; LINDAHL T, 1988, ANNU REV BIOCHEM, V57, P133, DOI 10.1146/annurev.bi.57.070188.001025; Maciejewska AM, 2013, J BIOL CHEM, V288, P432, DOI 10.1074/jbc.M112.353342; Maciejewska AM, 2011, MUTAGENESIS, V26, P401, DOI 10.1093/mutage/geq107; Maciejewska AM, 2010, MUTAT RES-FUND MOL M, V684, P24, DOI 10.1016/j.mrfmmm.2009.11.005; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Margison GP, 2007, DNA REPAIR, V6, P1222, DOI 10.1016/j.dnarep.2007.03.014; Martinez-Garcia E, 2011, ENVIRON MICROBIOL, V13, P2702, DOI 10.1111/j.1462-2920.2011.02538.x; Mielecki D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030588; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Moe E, 2012, ACTA CRYSTALLOGR D, V68, P703, DOI 10.1107/S090744491200947X; MOROHOSHI F, 1995, MUTAT RES-DNA REPAIR, V337, P97, DOI 10.1016/0921-8777(95)00013-A; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Nieminuszczy J, 2006, DNA REPAIR, V5, P181, DOI 10.1016/j.dnarep.2005.09.007; Nieminuszczy J, 2007, ACTA BIOCHIM POL, V54, P459, DOI 10.18388/abp.2007_3221; Nieminuszczy J, 2009, ENVIRON MOL MUTAGEN, V50, P791, DOI 10.1002/em.20497; Ougland R, 2004, MOL CELL, V16, P107, DOI 10.1016/j.molcel.2004.09.002; PAVEL H, 1994, J BACTERIOL, V176, P7550, DOI 10.1128/JB.176.24.7550-7557.1994; Regenhardt D, 2002, ENVIRON MICROBIOL, V4, P912, DOI 10.1046/j.1462-2920.2002.00368.x; Rippa V, 2011, DNA REPAIR, V10, P934, DOI 10.1016/j.dnarep.2011.06.001; RYDBERG B, 1982, EMBO J, V1, P211, DOI 10.1002/j.1460-2075.1982.tb01149.x; SAGET BM, 1994, P NATL ACAD SCI USA, V91, P9730, DOI 10.1073/pnas.91.21.9730; SAPARBAEV M, 1995, NUCLEIC ACIDS RES, V23, P3750, DOI 10.1093/nar/23.18.3750; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; SEDGWICK B, 1992, CANCER RES, V52, P3693; Sedgwick B, 2002, ONCOGENE, V21, P8886, DOI 10.1038/sj.onc.1205998; SEDGWICK B, 1991, MUTAT RES, V250, P211, DOI 10.1016/0027-5107(91)90178-Q; Sharma RC, 1996, BIOTECHNIQUES, V20, P42; TAKAHASHI K, 1988, J BIOL CHEM, V263, P13490; Taverna P, 1996, J BACTERIOL, V178, P5105, DOI 10.1128/jb.178.17.5105-5111.1996; TEO I, 1986, CELL, V45, P315, DOI 10.1016/0092-8674(86)90396-X; Terato H, 2002, NUCLEIC ACIDS RES, V30, P4975, DOI 10.1093/nar/gkf630; Timmis KN, 1999, TRENDS BIOTECHNOL, V17, P201, DOI 10.1016/S0167-7799(98)01295-5; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Wong SM, 2000, P NATL ACAD SCI USA, V97, P10191, DOI 10.1073/pnas.97.18.10191	72	9	9	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76198	10.1371/journal.pone.0076198	http://dx.doi.org/10.1371/journal.pone.0076198			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098441	Green Submitted, gold, Green Published			2022-12-25	WOS:000325434500049
J	Ferranti, F; D'Anselmi, F; Caruso, M; Lei, V; Dinicola, S; Pasqualato, A; Cucina, A; Palombo, A; Ricci, G; Catizone, A; Bizzarri, M				Ferranti, Francesca; D'Anselmi, Fabrizio; Caruso, Maria; Lei, Vittorio; Dinicola, Simona; Pasqualato, Alessia; Cucina, Alessandra; Palombo, Alessandro; Ricci, Giulia; Catizone, Angela; Bizzarri, Mariano			TCam-2 Seminoma Cells Exposed to Egg-Derived Microenvironment Modify Their Shape, Adhesive Pattern and Migratory Behaviour: A Molecular and Morphometric Analysis	PLOS ONE			English	Article							CARCINOMA-IN-SITU; TUMOR MICROENVIRONMENT; EMBRYONIC-DEVELOPMENT; MATURATION ARREST; FRACTAL ANALYSIS; CELLULAR-ORIGIN; E-CADHERIN; CANCER; TESTIS; CONNEXIN-43	Seminoma is one of the most common Testicular Germ Cell Tumours that originates during embryonic development due to an alteration of the local niche that in turn results in a delayed or blocked differentiation of Primordial Germ Cells. The block of differentiation is actually a common way to develop cancer disease as postulated by the "embryonic rest theory of cancer". In agreement with this theory different studies have demonstrated that embryonic cues display the capacity of reprogramming aggressive cancer cells towards a less aggressive phenotype. Herein we investigate the ability of a culture medium added with 10% egg albumen (EW, Egg White) to modulate seminoma cell phenotype and behaviour, by ensuring a proper set of morphogenetic signals. We chose to use the TCam-2 seminoma cell line that has been established as the only available cell line, obtained from a primary testicular seminoma. EW is able to: 1) modify TCam-2 cell spreading rate and cell-substrate adhesion without affecting proliferation and survival indexes; 2) modulate TCam-2 actin distribution pattern increasing cortical localization of actin filaments; 3) increase TCam-2 cell-cell junction capability; 4) decrease both chemo-sensitive and collective TCam-2 migratory behaviour. According to these observations morphometric fractal analysis revealed the ability of EW to increase Circularity and Solidity parameters and, consequently, to decrease Fractal dimension. Prompted by these observations we hypothesize that EW treatment could rescue, at least in part, the neoplastic-metastatic behaviour of seminoma cells.	[Ferranti, Francesca; Caruso, Maria; Catizone, Angela] Univ Roma La Sapienza, Dept Anat Histol Forens Med & Orthoped, Sect Histol & Med Embryol, I-00185 Rome, Italy; [D'Anselmi, Fabrizio; Cucina, Alessandra] Univ Roma La Sapienza, Dept Surg PietroValdoni, I-00185 Rome, Italy; [D'Anselmi, Fabrizio; Palombo, Alessandro; Bizzarri, Mariano] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Lei, Vittorio] Farnia Srl, Rome, Italy; [Dinicola, Simona] Univ Roma La Sapienza, Dept Clin & Mol Med, I-00185 Rome, Italy; [Pasqualato, Alessia] G DAnnunzio Univ Chieti Pescara, Dept Neurosci & Imaging, Sect Physiol & Physiopathol, Chieti, Italy; [Ricci, Giulia] Univ Naples 2, Dept Expt Med, Naples, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; G d'Annunzio University of Chieti-Pescara; Universita della Campania Vanvitelli	Ricci, G (corresponding author), Univ Naples 2, Dept Expt Med, Naples, Italy.	giulia.ricci@unina2.it	Tavecchia, Giacomo/N-3961-2014; Bizzarri, Mariano/U-8300-2017; Tanferna, Alessandro/L-6648-2015; Preatoni, Damiano G./A-8621-2010; Ricci, Giulia/AAO-1856-2020; Sergio, Fabrizio/B-3952-2015; Blas, Julio/A-2487-2012	Tavecchia, Giacomo/0000-0001-5435-2691; Bizzarri, Mariano/0000-0003-0408-4136; Tanferna, Alessandro/0000-0003-0799-301X; Preatoni, Damiano G./0000-0001-8760-1316; Ricci, Giulia/0000-0002-2199-170X; Sergio, Fabrizio/0000-0002-8024-1773; Blas, Julio/0000-0003-0589-3322; ferranti, francesca/0000-0002-4648-4069; catizone, angela/0000-0002-7836-9495; Cucina, Alessandra/0000-0001-5469-6419; caruso, maria/0000-0002-6221-1108	PRIN [2008NE3XPK_002]; Ateneo Federato [C26F09AHLB]	PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Ateneo Federato	The present study was supported by PRIN 2008 - Angela Catizone (grant number 2008NE3XPK_002; http://sito.cineca.it/) and by Ateneo Federato 2009 - Angela Catizone (grant number C26F09AHLB; http://uniroma1.cineca.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bizzarri M, 2011, SEMIN CANCER BIOL, V21, P175, DOI 10.1016/j.semcancer.2011.04.002; Brehm R, 2006, NEOPLASIA, V8, P499, DOI 10.1593/neo.05847; BRINSTER RL, 1974, J EXP MED, V140, P1049, DOI 10.1084/jem.140.4.1049; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Cucina A, 2006, APOPTOSIS, V11, P1617, DOI 10.1007/s10495-006-8895-4; D'Anselmi F, 2011, INT J BIOCHEM CELL B, V43, P1052, DOI 10.1016/j.biocel.2010.05.002; de Jong J, 2008, GENE CHROMOSOME CANC, V47, P185, DOI 10.1002/gcc.20520; Di Florio A, 2007, ENDOCR-RELAT CANCER, V14, P111, DOI 10.1677/erc.1.01318; Eckert D, 2008, CELL TISSUE RES, V331, P529, DOI 10.1007/s00441-007-0527-y; Farrow B, 2008, J SURG RES, V149, P319, DOI 10.1016/j.jss.2007.12.757; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferranti F, 2012, INT J ANDROL, V35, P758, DOI 10.1111/j.1365-2605.2012.01267.x; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Goddard NC, 2007, INT J ANDROL, V30, P337, DOI 10.1111/j.1365-2605.2007.00769.x; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hochedlinger K, 2004, GENE DEV, V18, P1875, DOI 10.1101/gad.1213504; Honecker F, 2004, J PATHOL, V204, P167, DOI 10.1002/path.1614; Kristensen DM, 2008, MOL CELL ENDOCRINOL, V288, P111, DOI 10.1016/j.mce.2008.02.018; Lee JT, 2006, NAT MED, V12, P882, DOI 10.1038/nm0806-882; Lee LMJ, 2005, DEV DYNAM, V233, P1560, DOI 10.1002/dvdy.20471; Looijenga LHJ, 2010, BEST PRACT RES CL EN, V24, P291, DOI 10.1016/j.beem.2009.10.002; Mann K, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-7; McSherry EA, 2007, CELL MOL LIFE SCI, V64, P3201, DOI 10.1007/s00018-007-7388-0; MINTZ B, 1975, P NATL ACAD SCI USA, V72, P3585, DOI 10.1073/pnas.72.9.3585; Mizuno Y, 1993, Nihon Hinyokika Gakkai Zasshi, V84, P1211; PIERCE GB, 1982, CANCER RES, V42, P1082; Pointis G, 2005, TRENDS ENDOCRIN MET, V16, P300, DOI 10.1016/j.tem.2005.07.001; Qiu N, 2012, J PROTEOMICS, V75, P1895, DOI 10.1016/j.jprot.2011.12.037; RISLEY MS, 1992, J CELL SCI, V103, P81; Risley MS, 2000, BIOL REPROD, V62, P748, DOI 10.1095/biolreprod62.3.748; Roger C, 2004, J PATHOL, V202, P241, DOI 10.1002/path.1509; Rohrschneider M, 2007, P ANN INT IEEE EMBS, P6272; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; SELL S, 1994, LAB INVEST, V70, P6; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; SELL S, 1993, ENVIRON HEALTH PERSP, V101, P15, DOI 10.2307/3431838; Siu MKY, 2003, ENDOCRINOLOGY, V144, P2141, DOI 10.1210/en.2002-221035; SKAKKEBAEK NE, 1972, LANCET, V2, P516; Steger K, 1999, HISTOCHEM CELL BIOL, V112, P215, DOI 10.1007/s004180050409; TIMMER A, 1994, AM J PATHOL, V144, P1035; Ulbright TM, 2005, MODERN PATHOL, V18, pS61, DOI 10.1038/modpathol.3800310; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; ZETTER BR, 1993, SEMIN CANCER BIOL, V4, P219	45	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76192	10.1371/journal.pone.0076192	http://dx.doi.org/10.1371/journal.pone.0076192			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098438	gold, Green Submitted, Green Published			2022-12-25	WOS:000325427100045
J	Jiang, W; Fang, YJ; Wu, XJ; Wang, FL; Lu, ZH; Zhang, RX; Ding, PR; Fan, WH; Pan, ZZ; Wan, DS				Jiang, Wu; Fang, Yu-Jing; Wu, Xiao-Jun; Wang, Fu-Long; Lu, Zhen-Hai; Zhang, Rong-Xin; Ding, Pei-Rong; Fan, Wen-Hua; Pan, Zhi-Zhong; Wan, De-Sen			Intraoperative Blood Loss Independently Predicts Survival and Recurrence after Resection of Colorectal Cancer Liver Metastasis	PLOS ONE			English	Article							HEPATIC METASTASES; TRANSFUSIONS; HEMORRHAGE	Background: Although numerous prognostic factors have been reported for colorectal cancer liver metastasis (CRLM), few studies have reported intraoperative blood loss (IBL) effects on clinical outcome after CRLM resection. Methods: We retrospectively evaluated the clinical and histopathological characteristics of 139 patients who underwent liver resection for CRLM. The IBL cutoff volume was calculated using receiver operating characteristic curves. Overall survival (OS) and recurrence free survival (RFS) were assessed using the Kaplan-Meier and Cox regression methods. Results: All patients underwent curative resection. The median follow up period was 25.0 months (range, 2.1-88.8). Body mass index (BMI) and CRLM number and tumor size were associated with increased IBL. BMI (P=0.01; 95% CI = 1.3-8.5) and IBL (P<0.01; 95% CI = 1.6-12.5) were independent OSOs predictors. Five factors, including IBL (P=0.02; 95% CI = 1.1-4.1), were significantly related to RFS via multivariate Cox regression analysis. In addition, OSOs and RFS significantly decreased with increasing IBL volumes. The 5-year OSOs of patients with IBL <= 250, 250-500, and >500mL were 71%, 33%, and 0%, respectively (P<0.01). RFS of patients within three IBL volumes at the end of the first year were 67%, 38%, and 18%, respectively (P<0.01). Conclusions: IBL during CRLM resection is an independent predictor of long term survival and tumor recurrence, and its prognostic value was confirmed by a dose-response relationship.	[Jiang, Wu; Fang, Yu-Jing; Wu, Xiao-Jun; Wang, Fu-Long; Lu, Zhen-Hai; Zhang, Rong-Xin; Ding, Pei-Rong; Fan, Wen-Hua; Pan, Zhi-Zhong; Wan, De-Sen] Sun Yat Sen Univ, Dept Colorectal Surg, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Fang, Yu-Jing] Sun Yat Sen Univ, Dept Expt Res, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Jiang, Wu; Fang, Yu-Jing; Wu, Xiao-Jun; Wang, Fu-Long; Lu, Zhen-Hai; Zhang, Rong-Xin; Ding, Pei-Rong; Fan, Wen-Hua; Pan, Zhi-Zhong; Wan, De-Sen] Sun Yat Sen Univ, State Key Lab Oncol South China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Pan, ZZ (corresponding author), Sun Yat Sen Univ, Dept Colorectal Surg, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	panzhzh@sysucc.org.cn; wds@medmail.com.cn			National Natural Science Foundation of the Republic of China [81101861]; Doctoral Fund of the Ministry of Education of China [20110171120100]; Natural Science Foundation of Guangdong Province, China [S2012010011132]	National Natural Science Foundation of the Republic of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of the Ministry of Education of China(Ministry of Education, China); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of the Republic of China (Grant No. 81101861) and the Doctoral Fund of the Ministry of Education of China (Grant No. 20110171120100) to Dr. Yu-Jing Fang, the Natural Science Foundation of Guangdong Province, China (Grant No. S2012010011132) to Dr. Xiao-Jun Wu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla EK, 2004, ANN SURG, V239, P818, DOI 10.1097/01.sla.0000128305.90650.71; ABRAHAM E, 1986, CIRC SHOCK, V18, P205; ABRAHAM E, 1984, ARCH SURG-CHICAGO, V119, P1154; Achavanuntakul K, 2012, ARCH GYNECOL OBSTET, V286, P1001, DOI 10.1007/s00404-012-2387-2; Acheson AG, 2012, ANN SURG, V256, P235, DOI 10.1097/SLA.0b013e31825b35d5; Bokemeyer C, 2012, EUR J CANCER, V48, P1466, DOI 10.1016/j.ejca.2012.02.057; BUSCH ORC, 1993, NEW ENGL J MED, V328, P1372, DOI 10.1056/NEJM199305133281902; Fernandez FG, 2004, ANN SURG, V240, P438, DOI 10.1097/01.sla.0000138076.72547.b1; Fong Y, 1999, ANN SURG, V230, P309, DOI 10.1097/00000658-199909000-00004; Katz SC, 2009, ANN SURG, V249, P617, DOI 10.1097/SLA.0b013e31819ed22f; Kohne CH, 2010, ANN ONCOL, V21, P134, DOI 10.1093/annonc/mdq374; Leo C, 2004, SEMIN RADIAT ONCOL, V14, P207, DOI 10.1016/j.semradonc.2004.04.007; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Nordlinger B, 1996, CANCER, V77, P1254, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1254::AID-CNCR5>3.0.CO;2-I; Pawlik TM, 2005, ANN SURG, V241, P715, DOI 10.1097/01.sla.0000160703.75808.7d; Qiu HB, 2011, WORLD J GASTROENTERO, V17, P804, DOI 10.3748/wjg.v17.i6.804; Quan D, 2012, SURGERY, V151, P860, DOI 10.1016/j.surg.2011.12.018; Rees M, 2008, ANN SURG, V247, P125, DOI 10.1097/SLA.0b013e31815aa2c2; Reynolds TY, 1996, CANCER RES, V56, P5754; TARTTER PI, 1992, ANN SURG, V216, P633, DOI 10.1097/00000658-199212000-00004; Tomlinson JS, 2007, J CLIN ONCOL, V25, P4575, DOI 10.1200/JCO.2007.11.0833; WAGNER JS, 1984, ANN SURG, V199, P502, DOI 10.1097/00000658-198405000-00002; Wood C B, 1976, Clin Oncol, V2, P285; Yan TD, 2007, ANN SURG ONCOL, V14, P2069, DOI 10.1245/s10434-007-9388-6; YOUNES RN, 1991, ANN SURG, V214, P107, DOI 10.1097/00000658-199108000-00003	25	25	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76125	10.1371/journal.pone.0076125	http://dx.doi.org/10.1371/journal.pone.0076125			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098431	Green Submitted, gold, Green Published			2022-12-25	WOS:000325427100043
J	Nascimbene, J; Marini, L; Ivan, D; Zottini, M				Nascimbene, Juri; Marini, Lorenzo; Ivan, Diego; Zottini, Michela			Management Intensity and Topography Determined Plant Diversity in Vineyards	PLOS ONE			English	Article							SPECIES-DIVERSITY; GRASSLANDS; RICHNESS; MEADOWS	Vineyards are amongst the most intensive forms of agriculture often resulting in simplified landscapes where semi-natural vegetation is restricted to small scattered patches. However, a tendency toward a more sustainable management is stimulating research on biodiversity in these poorly investigated agro-ecosystems. The main aim of this study was to test the effect on plant diversity of management intensity and topography in vineyards located in a homogenous intensive hilly landscape. Specifically, this study evaluated the role of slope, mowing and herbicide treatments frequency, and nitrogen supply in shaping plant diversity and composition of life-history traits. The study was carried out in 25 vineyards located in the area of the Conegliano-Valdobbiadene DOCG (Veneto, NE Italy). In each vineyard, 10 plots were placed and the abundance of all vascular plants was recorded in each plot. Linear multiple regression was used to test the effect of management and topography on plant diversity. Management intensity and topography were both relevant drivers of plant species diversity patterns in our vineyards. The two most important factors were slope and mowing frequency that respectively yielded positive and negative effects on plant diversity. A significant interaction between these two factors was also demonstrated, warning against the detrimental effects of increasing mowing intensity on steep slope where plant communities are more diverse. The response of plant communities to mowing frequency is mediated by a process of selection of resistant growth forms, such in the case of rosulate and reptant species. The other two management-related factors tested in this study, number of herbicide treatments and N fertilization, were less influential. In general, our study corroborates the idea that some simple changes in farming activities, which are compatible with grape production, should be encouraged for improving the natural and cultural value of the landscape by maintaining and improving wild plant diversity.	[Nascimbene, Juri; Ivan, Diego; Zottini, Michela] Univ Padua, Dept Biol, Padua, Italy; [Marini, Lorenzo] Univ Padua, DAFNAE Dept Agron, Padua, Italy	University of Padua; University of Padua	Nascimbene, J (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	junasc@libero.it	Zottini, Michela/Y-3763-2019; Marini, Lorenzo/B-1119-2009	Marini, Lorenzo/0000-0001-7429-7685; zottini, michela/0000-0001-8930-2969	Veneto Region (Mis. 124 PSR Veneto)	Veneto Region (Mis. 124 PSR Veneto)	This research was conducted in the framework of the "Biodivigna" project funded by the Veneto Region (Mis. 124 PSR Veneto). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN JD, 1975, OECOLOGIA, V18, P359, DOI 10.1007/BF00345855; Arlettaz R, 2012, J ORNITHOL, V153, P229, DOI 10.1007/s10336-011-0737-7; BALME OE, 1953, J ECOL, V41, P331, DOI 10.2307/2257045; Bennie J, 2006, J ECOL, V94, P355, DOI 10.1111/j.1365-2745.2006.01104.x; Bruggisser OT, 2010, BIOL CONSERV, V143, P1521, DOI 10.1016/j.biocon.2010.03.034; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Catorci A, 2011, POL J ECOL, V59, P115; Drobnik J, 2011, AGR ECOSYST ENVIRON, V145, P29, DOI 10.1016/j.agee.2010.12.021; Gago P, 2007, CROP PROT, V26, P584, DOI 10.1016/j.cropro.2006.05.012; Gillespie M, 2012, J INSECT CONSERV, V16, P13, DOI 10.1007/s10841-011-9390-y; Kramberger B, 2008, POL J ECOL, V56, P33; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; Marini L, 2008, BASIC APPL ECOL, V9, P365, DOI 10.1016/j.baae.2007.06.011; Marini L, 2008, J APPL ECOL, V45, P361, DOI 10.1111/j.1365-2664.2007.01402.x; Nascimbene J, 2012, ENVIRON MANAGE, V49, P1054, DOI 10.1007/s00267-012-9834-5; Pignatti S, 1982, BOLOGNA EDAGRICOLE, V1-3, P2302; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Roschewitz I, 2005, J APPL ECOL, V42, P873, DOI 10.1111/j.1365-2664.2005.01072.x; Sanguankeo PP, 2011, WEED RES, V51, P404, DOI 10.1111/j.1365-3180.2011.00853.x; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Zechmeister HG, 2003, BIOL CONSERV, V114, P165, DOI 10.1016/S0006-3207(03)00020-X	22	25	25	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76167	10.1371/journal.pone.0076167	http://dx.doi.org/10.1371/journal.pone.0076167			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098435	Green Published, gold, Green Submitted			2022-12-25	WOS:000325427100044
J	Sitkiewicz, E; Tarnowski, K; Poznanski, J; Kulma, M; Dadlez, M				Sitkiewicz, Ewa; Tarnowski, Krzysztof; Poznanski, Jaroslaw; Kulma, Magdalena; Dadlez, Michal			Oligomerization Interface of RAGE Receptor Revealed by MS-Monitored Hydrogen Deuterium Exchange	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; DITYROSINE CROSS-LINKS; AMYLOID-BETA; ALZHEIMERS-DISEASE; CELL-SURFACE; PATTERN-RECOGNITION; SIGNAL-TRANSDUCTION; SOLUBLE RECEPTOR; STRUCTURAL BASIS; PROTEINS	Activation of the receptor for advanced glycation end products ( RAGE) leads to a chronic proinflammatory signal, affecting patients with a variety of diseases. Potentially beneficial modification of RAGE activity requires understanding the signal transduction mechanism at the molecular level. The ligand binding domain is structurally uncoupled from the cytoplasmic domain, suggesting receptor oligomerization is a requirement for receptor activation. In this study, we used hydrogen-deuterium exchange and mass spectrometry to map structural differences between the monomeric and oligomeric forms of RAGE. Our results indicated the presence of a region shielded from exchange in the oligomeric form of RAGE and led to the identification of a new oligomerization interface localized at the linker region between domains C1 and C2. Based on this finding, a model of a RAGE dimer and higher oligomeric state was constructed.	[Sitkiewicz, Ewa; Tarnowski, Krzysztof; Poznanski, Jaroslaw; Kulma, Magdalena; Dadlez, Michal] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Dadlez, Michal] Warsaw Univ, Dept Biol, Inst Genet & Biotechnol, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Warsaw	Dadlez, M (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	michald@ibb.waw.pl	Poznanski, Jaroslaw/F-7705-2014	Poznanski, Jaroslaw/0000-0003-2684-1775; Sitkiewicz, Ewa/0000-0002-9511-8575; Dadlez, Michal/0000-0001-8811-5176	Foundation for Polish Science TEAM program [TEAM/2011-7/1]; CEPT [POIG.02.02.00-14-024/08-00]; NanoFun [POIGT.02.02.00-00-025/09-00]; International Centre for Genetic Engineering and Biotechnology, Trieste, Italy [CRP/08/011]	Foundation for Polish Science TEAM program; CEPT; NanoFun; International Centre for Genetic Engineering and Biotechnology, Trieste, Italy	Financial support was received from the Foundation for Polish Science TEAM program (TEAM/2011-7/1), CEPT (POIG.02.02.00-14-024/08-00), and NanoFun (POIGT.02.02.00-00-025/09-00). The molecular modeling was partially supported by grant CRP/08/011 (to JP) from the International Centre for Genetic Engineering and Biotechnology, Trieste, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AESCHBACH R, 1976, BIOCHIM BIOPHYS ACTA, V439, P292, DOI 10.1016/0005-2795(76)90064-7; Atwood CS, 2004, BIOCHEMISTRY-US, V43, P560, DOI 10.1021/bi0358824; Baldwin RL, 2007, J MOL BIOL, V371, P283, DOI 10.1016/j.jmb.2007.05.078; Bierhaus A, 2009, DIABETOLOGIA, V52, P2251, DOI 10.1007/s00125-009-1458-9; Brady JD, 1996, BIOCHEM J, V315, P323, DOI 10.1042/bj3150323; Brady JD, 1998, PHYTOCHEMISTRY, V47, P349, DOI 10.1016/S0031-9422(97)00592-X; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; Chen X, 2007, CURR MOL MED, V7, P735; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; Deane R, 2004, STROKE, V35, P2628, DOI 10.1161/01.STR.0000143452.85382.d1; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Endrizzi BJ, 2006, LANGMUIR, V22, P11305, DOI 10.1021/la0618216; Fritz G, 2011, TRENDS BIOCHEM SCI, V36, P625, DOI 10.1016/j.tibs.2011.08.008; Hanford LE, 2004, J BIOL CHEM, V279, P50019, DOI 10.1074/jbc.M409782200; He M, 2011, EMBO REP, V12, P358, DOI 10.1038/embor.2011.28; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hudson BI, 2008, J BIOL CHEM, V283, P34457, DOI 10.1074/jbc.M801465200; Ishihara K, 2003, FEBS LETT, V550, P107, DOI 10.1016/S0014-5793(03)00846-9; Jacob JS, 1996, J BIOL CHEM, V271, P19950, DOI 10.1074/jbc.271.33.19950; Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740; Kloniecki M, 2011, J MOL BIOL, V407, P110, DOI 10.1016/j.jmb.2011.01.012; Koch M, 2010, STRUCTURE, V18, P1342, DOI 10.1016/j.str.2010.05.017; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Kupniewska-Kozak A, 2010, J MOL BIOL, V403, P52, DOI 10.1016/j.jmb.2010.08.027; L-J Yan, 2009, CURRENT PROTOCOLS PR, DOI DOI 10.1002/0471140864.PS1404S55.ACCESSED; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Li JF, 1997, J BIOL CHEM, V272, P16498, DOI 10.1074/jbc.272.26.16498; Logsdon CD, 2007, CURR MOL MED, V7, P777, DOI 10.2174/156652407783220697; Malencik DA, 1996, ANAL BIOCHEM, V242, P202, DOI 10.1006/abio.1996.0454; Marcsisin SR, 2010, ANAL BIOANAL CHEM, V397, P967, DOI 10.1007/s00216-010-3556-4; Miyata T, 1996, J CLIN INVEST, V98, P1088, DOI 10.1172/JCI118889; Muhammad S, 2008, J NEUROSCI, V28, P12023, DOI 10.1523/JNEUROSCI.2435-08.2008; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Nlatsumoto S, 2008, BIOCHEMISTRY-US, V47, P12299, DOI 10.1021/bi800910v; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Park H, 2010, J BIOL CHEM, V285, P40762, DOI 10.1074/jbc.M110.169276; Qin GK, 2011, BIOMATERIALS, V32, P9231, DOI 10.1016/j.biomaterials.2011.06.010; Qiu J, 2008, J CEREBR BLOOD F MET, V28, P927, DOI 10.1038/sj.jcbfm.9600582; Rai V, 2012, J BIOL CHEM, V287, P5133, DOI 10.1074/jbc.M111.277731; Ramasamy R, 2011, ANN NY ACAD SCI, V1243, P88, DOI 10.1111/j.1749-6632.2011.06320.x; Ramasamy R, 2009, J LEUKOCYTE BIOL, V86, P505, DOI 10.1189/jlb.0409230; Sakaguchi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023132; Sarkany Z, 2011, J BIOL CHEM, V286, P37525, DOI 10.1074/jbc.M111.223438; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Sevillano N, 2009, J BIOCHEM, V145, P21, DOI 10.1093/jb/mvn137; Sousa MM, 2000, LAB INVEST, V80, P1101, DOI 10.1038/labinvest.3780116; Sturchler E, 2008, J NEUROSCI, V28, P5149, DOI 10.1523/JNEUROSCI.4878-07.2008; Tanaka N, 2000, J BIOL CHEM, V275, P25781, DOI 10.1074/jbc.M001235200; van Zoelen Marieke A D, 2011, Front Biosci (Schol Ed), V3, P1119; Win MTT, 2012, EXP DIABETES RES, DOI 10.1155/2012/894605; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200; Xue J, 2011, STRUCTURE, V19, P722, DOI 10.1016/j.str.2011.02.013; Yamamoto Y, 2011, J IMMUNOL, V186, P3248, DOI 10.4049/jimmunol.1002253; Yan SD, 2000, NAT MED, V6, P643, DOI 10.1038/76216; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Zong HL, 2010, J BIOL CHEM, V285, P23135, DOI 10.1074/jbc.M110.133827	60	21	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76353	10.1371/journal.pone.0076353	http://dx.doi.org/10.1371/journal.pone.0076353			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098480	Green Published, gold, Green Submitted			2022-12-25	WOS:000325427100061
J	Wang, C; Qiu, WY; Zheng, YQ; Li, H; Li, YJ; Feng, B; Guo, S; Yan, L; Cao, JM				Wang, Chen; Qiu, Wenying; Zheng, Yiqing; Li, Hui; Li, Yijia; Feng, Bing; Guo, Shu; Yan, Li; Cao, Ji-Min			Extraneuronal Monoamine Transporter Mediates the Permissive Action of Cortisol in the Guinea Pig Trachea: Possible Involvement of Tracheal Chondrocytes	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; HUMAN BRONCHIAL ARTERIAL; NOREPINEPHRINE TRANSPORTER; NONGENOMIC ACTIONS; HUMAN SPERM; IN-VITRO; ASTHMA; RAT; FAMOTIDINE; AIRWAY	Cortisol, a member of glucocorticoids, could potentiate the action of catecholamine by a non-genomic mechanism. Although this permissive effect has been well appreciated in the anti-asthmatic medication, the underlying signaling pathway has remained mysterious. Here, we show that extraneuronal monoamine transporter (EMT), a membraneous reuptake transporter for circulating catecholamine clearance, is the direct target of cortisol in its permissive effect. We found that BSA-conjugated cortisol, which functions as a cortisol but cannot penetrate cell membrane, enhanced the spasmolytic effect of beta-adrenoceptor agonist (isoprenaline) in histamine-sensitized tracheal spirals of guinea pigs, and pharmacological inhibition of EMT with famotidine was powerful enough to imitate the permissive action of cortisol. To our surprise, EMT protein expression was high in the chondrocytes of tracheal cartilage, but was undetectable in tracheal smooth muscle cells. The functionality of EMT was further confirmed with measurement of catecholamine uptake by tracheal chondrocytes. Moreover, cortisol-initiated membrane signaling could activate protein kinase C (PKC), which phosphorylates EMT and induces its internalization via a lipid raft-dependent pathway. Both of the mechanisms slow down the reuptake process by chondrocytes, leading to extracellular catecholamine accumulation and results in a more profound adrenergic signaling activation in tracheal smooth muscle cells. Thus, an EMT-centered pathway was proposed to explain the permissive action of cortisol. Collectively, our results highlight the role of EMT in the crosstalk between glucocorticoid and catecholamine. EMT may represent a promising target for adrenergic signaling modulation.	[Wang, Chen; Zheng, Yiqing; Li, Yijia; Feng, Bing] Peking Union Med Coll, Dept Med, Chinese Acad Med Sci, Beijing 100021, Peoples R China; [Qiu, Wenying] Peking Union Med Coll, Dept Anat Histol & Embryol, Inst Basic Med Sci, Chinese Acad Med Sci,Sch Basic Med, Beijing 100021, Peoples R China; [Li, Hui; Guo, Shu; Yan, Li; Cao, Ji-Min] Peking Union Med Coll, Dept Physiol & Pathophysiol, Inst Basic Med Sci, Chinese Acad Med,Sci Sch Basic Med, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Cao, JM (corresponding author), Peking Union Med Coll, Dept Physiol & Pathophysiol, Inst Basic Med Sci, Chinese Acad Med,Sci Sch Basic Med, Beijing 100021, Peoples R China.	caojimin@126.com	Li, Yijia/AAD-6744-2022; Wang, Chen/ABF-4024-2020	Li, Yijia/0000-0001-5300-0571; Wang, Chen/0000-0003-4055-7391	grants of Scientific Research and Entrepreneurship for Undergraduates in Beijing City; Natural Science Foundation of China (NSFC) [81071072]	grants of Scientific Research and Entrepreneurship for Undergraduates in Beijing City; Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by grants of Scientific Research and Entrepreneurship for Undergraduates in Beijing City, and a grant (81071072 to JMC) from the Natural Science Foundation of China (NSFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNING EN, 1979, BRIT J PHARMACOL, V65, P175, DOI 10.1111/j.1476-5381.1979.tb07816.x; BACHMANN K, 1995, J CLIN PHARMACOL, V35, P529, DOI 10.1002/j.1552-4604.1995.tb04100.x; Bai J, 2008, CAN J PHYSIOL PHARM, V86, P700, DOI [10.1139/Y08-075, 10.1139/y08-075]; Bourdet DL, 2005, J PHARMACOL EXP THER, V315, P1288, DOI 10.1124/jpet.105.091223; Cao JM, 2000, CIRCULATION, V101, P1960, DOI 10.1161/01.CIR.101.16.1960; Chen LG, 2010, PHARMACOGENET GENOM, V20, P687, DOI 10.1097/FPC.0b013e32833fe789; Choi JS, 2009, LUNG, V187, P165, DOI 10.1007/s00408-009-9142-x; Chu XP, 2007, J ETHNOPHARMACOL, V111, P490, DOI 10.1016/j.jep.2006.12.013; Contopoulos-Ioannidis DG, 2005, J ALLERGY CLIN IMMUN, V115, P963, DOI 10.1016/j.jaci.2004.12.1119; DeLano WL, 2002, PYMOL USERS MANUAL; DELATORRE JC, 1976, HISTOCHEMISTRY, V49, P81, DOI 10.1007/BF00495672; DRAZEN JM, 1978, J CLIN INVEST, V61, P1441, DOI 10.1172/JCI109063; Eisenhofer G, 2004, PHARMACOL REV, V56, P331, DOI 10.1124/pr.56.3.1; Hammes SR, 2007, ENDOCR REV, V28, P726, DOI 10.1210/er.2007-0022; HOLGATE ST, 1989, J ALLERGY CLIN IMMUN, V83, P537, DOI 10.1016/0091-6749(89)90035-3; Horvath G., 2003, Archives of Physiology and Biochemistry, V111, P341; Horvath G, 2003, AM J PHYSIOL-LUNG C, V285, pL829, DOI 10.1152/ajplung.00054.2003; Horvath G, 2001, AM J RESP CELL MOL, V25, P500, DOI 10.1165/ajrcmb.25.4.4559; Horvath G, 2011, PULM PHARMACOL THER, V24, P654, DOI 10.1016/j.pupt.2011.08.002; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; IVERSEN LL, 1965, BRIT J PHARM CHEMOTH, V25, P18, DOI 10.1111/j.1476-5381.1965.tb01753.x; IVERSEN LL, 1970, BRIT J PHARMACOL, V40, P528, DOI 10.1111/j.1476-5381.1970.tb10637.x; Jayanthi LD, 2006, J BIOL CHEM, V281, P23326, DOI 10.1074/jbc.M601156200; Jayanthi LD, 2004, J BIOL CHEM, V279, P19315, DOI 10.1074/jbc.M311172200; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; KALSNER S, 1969, CIRC RES, V24, P383, DOI 10.1161/01.RES.24.3.383; Kino T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003333; Kong MMC, 2007, MOL PHARMACOL, V72, P1157, DOI 10.1124/mol.107.034769; Kummer W, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-65; LIN JH, 1987, BRIT J CLIN PHARMACO, V24, P669, DOI 10.1111/j.1365-2125.1987.tb03228.x; Lishko PV, 2011, NATURE, V471, P387, DOI 10.1038/nature09767; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; Matsuse H, 2001, J ALLERGY CLIN IMMUN, V108, P715, DOI 10.1067/mai.2001.118791; Menger GJ, 2007, PHYSIOL GENOMICS, V29, P280, DOI 10.1152/physiolgenomics.00199.2006; MONTESANO R, 1979, P NATL ACAD SCI USA, V76, P6391, DOI 10.1073/pnas.76.12.6391; Nelson HS, 2003, J ALLERGY CLIN IMMUN, V112, P29, DOI 10.1067/mai.2003.1558; ODONNELL SR, 1976, BRIT J PHARMACOL, V57, P369, DOI 10.1111/j.1476-5381.1976.tb07675.x; ODONNELL SR, 1983, BRIT J PHARMACOL, V78, P417, DOI 10.1111/j.1476-5381.1983.tb09406.x; ODONNELL SR, 1984, N-S ARCH PHARMACOL, V325, P54, DOI 10.1007/BF00507054; ODONNELL SR, 1973, BRIT J PHARMACOL, V49, P267, DOI 10.1111/j.1476-5381.1973.tb08372.x; Richman JG, 1998, AM J PHYSIOL-CELL PH, V274, pC654, DOI 10.1152/ajpcell.1998.274.3.C654; Roth M, 2002, LANCET, V360, P1293, DOI 10.1016/S0140-6736(02)11319-5; Saito Y, 2001, INTERNAL MED, V40, P643, DOI 10.2169/internalmedicine.40.643; Strunker T, 2011, NATURE, V471, P382, DOI 10.1038/nature09769; Tregouet DA, 2009, NAT GENET, V41, P283, DOI 10.1038/ng.314; Wang C, 2012, RESP PHYSIOL NEUROBI, V183, P10, DOI 10.1016/j.resp.2012.05.008; Yamauchi K, 2011, YAKUGAKU ZASSHI, V131, P185, DOI 10.1248/yakushi.131.185	47	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76193	10.1371/journal.pone.0076193	http://dx.doi.org/10.1371/journal.pone.0076193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098439	Green Published, Green Submitted, gold			2022-12-25	WOS:000325427100046
J	Jonas, JB; Nangia, V; Khare, A; Kulkarni, M; Matin, A; Sinha, A; Bhojwani, K; Nangia, P; Panda-Jonas, S				Jonas, Jost B.; Nangia, Vinay; Khare, Anshu; Kulkarni, Maithili; Matin, Arshia; Sinha, Ajit; Bhojwani, Krishna; Nangia, Prabhat; Panda-Jonas, Songhomitra			Prevalence of Optic Disc Hemorrhages in Rural Central India. The Central India Eye and Medical Study	PLOS ONE			English	Article							GLAUCOMA; POPULATION; ASSOCIATIONS; PROGRESSION	Purpose: To determine the frequency of optic disc hemorrhages in a rural Indian population. Methods: The population-based Central Indian Eye and Medical Study included 4711 subjects. Mean age was 48.5 +/- 12.9 years (range:30-100 years). Color optic disc photographs were examined. Results: Optic disc photographs were available for 4570 (97.0%) subjects. Prevalence of disc hemorrhages was 17/8869 (0.19%; 95%CI:0.10,0.28) per eye and 16/4570 (0.35 +/- 0.09%; 95%CI:0.18,0.52) per subject. Prevalence of disc hemorrhages increased from 0.05% (95%CI:0.00,0.13) in the age group of 30-39 years to 0.25% (95CI: 0.00,0.49) in the age group of 60-69 years and to 0.91% (95%CI:0.24,1.58) in the age group of 70+ years. After adjusting for older age, higher systolic blood pressure, diabetes mellitus, myopic refractive error, smaller neuroretinal rim area and thinner retinal nerve fiber layer, occurrence of disc hemorrhages was associated only with glaucomatous optic nerve damage (P<0.001; Odds ratio:87; 95%CI:32,239). Eleven of the 17 (65%; 95%CI:39,90) disc hemorrhages were found in glaucomatous eyes. Out of 193 glaucomatous eyes, 11 eyes (5.7%; 95%CI:2.4,9.0) showed a disc hemorrhage. Out of the 8676 non-glaucomatous eyes, 6 eyes (0.07%; 95% CI:0.01,0.12) had an optic disc hemorrhage. Conclusions: Prevalence of disc hemorrhages (0.2% per eye; 0.4% per subject) in Indians aged 30+ years was strongly associated with glaucoma after adjustment for age, blood pressure and diabetes mellitus. A disc hemorrhage suggested glaucomatous optic nerve damage with a positive predictive value of 65%. About 6% of glaucomatous eyes showed a disc hemorrhage at the time of clinical examination highlighting the importance of optic disc hemorrhages for the diagnosis of glaucoma.	[Jonas, Jost B.; Nangia, Vinay; Khare, Anshu; Kulkarni, Maithili; Matin, Arshia; Sinha, Ajit; Bhojwani, Krishna; Nangia, Prabhat; Panda-Jonas, Songhomitra] Suraj Eye Inst, Nagpur, Maharashtra, India; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany	Suraj Eye Institute; Ruprecht Karls University Heidelberg	Jonas, JB (corresponding author), Suraj Eye Inst, Nagpur, Maharashtra, India.	Jost.Jonas@augen.ma.uni-heidelberg.de; nagpursuraj@gmail.com			Om Drishti Trust, Nagpur, India; Heidelberg Engineering Co., Heidelberg, Germany; Rotary Sight Saver Netherlands; ORBIS International; Carl Zeiss Meditec Co., Jena, Germany	Om Drishti Trust, Nagpur, India; Heidelberg Engineering Co., Heidelberg, Germany; Rotary Sight Saver Netherlands; ORBIS International; Carl Zeiss Meditec Co., Jena, Germany	Supported by an unrestricted grant from Om Drishti Trust, Nagpur, India; Heidelberg Engineering Co., Heidelberg, Germany; Rotary Sight Saver Netherlands; ORBIS International; and Carl Zeiss Meditec Co., Jena, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIRAKSINEN PJ, 1981, ARCH OPHTHALMOL-CHIC, V99, P1795, DOI 10.1001/archopht.1981.03930020669009; Bengtsson B, 2005, J GLAUCOMA, V14, P135, DOI 10.1097/01.ijg.0000151683.04410.f3; BENGTSSON B, 1981, ACTA OPHTHALMOL, V59, P1; Bourne RRA, 2003, BRIT J OPHTHALMOL, V87, P1069, DOI 10.1136/bjo.87.9.1069; DIEHL DLC, 1990, ARCH OPHTHALMOL-CHIC, V108, P545, DOI 10.1001/archopht.1990.01070060093056; DRANCE SM, 1977, ARCH OPHTHALMOL-CHIC, V95, P226; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Grodum K, 2002, J GLAUCOMA, V11, P226, DOI 10.1097/01.IJG.0000013483.08219.F0; Healey PR, 1998, OPHTHALMOLOGY, V105, P216, DOI 10.1016/S0161-6420(98)92704-X; HEIJL A, 1986, ACTA OPHTHALMOL, V64, P274; JONAS JB, 1994, AM J OPHTHALMOL, V118, P1; JONAS JB, 1997, INVEST OPHTH VIS SCI, V43, P2956; Jonas JB, 2013, DIABETES CARE, V36, pE69, DOI 10.2337/dc12-2377; Jonas JB, 2012, CLIN EXP OPHTHALMOL, V40, pE116, DOI 10.1111/j.1442-9071.2011.02731.x; Jonas JB, 2010, EPIDEMIOLOGY, V21, P754, DOI 10.1097/EDE.0b013e3181e66201; Jonasson F, 2003, EYE, V17, P747, DOI 10.1038/sj.eye.6700374; KLEIN BEK, 1992, OPHTHALMOLOGY, V99, P1499; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Nangia V, 2010, OPHTHALMOLOGY, V117, P1360, DOI 10.1016/j.ophtha.2009.11.040; Quigley HA, 2001, ARCH OPHTHALMOL-CHIC, V119, P1819, DOI 10.1001/archopht.119.12.1819; Siegner SW, 1996, OPHTHALMOLOGY, V103, P1014, DOI 10.1016/S0161-6420(96)30572-1; Sugiyama K, 1997, OPHTHALMOLOGY, V104, P1926, DOI 10.1016/S0161-6420(97)30005-0; Thomas R, 2007, CLIN EXP OPHTHALMOL, V35, P374, DOI 10.1111/j.1442-9071.2007.01489.x; Thomas R, 2012, INDIAN J OPHTHALMOL, V60, P446, DOI 10.4103/0301-4738.100546; Wang Y, 2006, AM J OPHTHALMOL, V142, P241, DOI 10.1016/j.ajo.2006.02.032; Xu L, 2008, ARCH OPHTHALMOL-CHIC, V126, P435, DOI 10.1001/archopht.126.3.435; Yamamoto T, 2004, J GLAUCOMA, V13, P356, DOI 10.1097/01.ijg.0000137436.68060.d2	27	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76154	10.1371/journal.pone.0076154	http://dx.doi.org/10.1371/journal.pone.0076154			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098775	Green Submitted, gold, Green Published			2022-12-25	WOS:000325423500145
J	Laws, TR; Nelson, M; Bonnafous, C; Sicard, H; Taylor, C; Salguero, FJ; Atkins, TP; Oyston, PCF; Rowland, CA				Laws, Thomas R.; Nelson, Michelle; Bonnafous, Cecile; Sicard, Helene; Taylor, Christopher; Salguero, Francisco Javier; Atkins, Timothy P.; Oyston, Petra C. F.; Rowland, Caroline A.			In Vivo Manipulation of gamma 9(+) T Cells in the Common Marmoset (Callithrix Jacchus) with Phosphoantigen and Effect on the Progression of Respiratory Melioidosis	PLOS ONE			English	Article							LETHAL INHALATIONAL INFECTION; BURKHOLDERIA-PSEUDOMALLEI; FRANCISELLA-TULARENSIS; INTRACELLULAR MULTIPLICATION; MYCOBACTERIUM-TUBERCULOSIS; BRUCELLA-SUIS; MODEL; ACTIVATION; RESPONSES; VITRO	Burkholderia pseudomallei is a dangerous human pathogen. Phosphoantigens specifically the target primate specific gamma 9(+)delta 2(+) T cells subset and some have been developed as potential immunotherapeutics. Previously, we demonstrated that, when stimulated with the phosphoantigen CHDMAPP, gamma 9(+)delta 2(+) T cells aid in the killing of intracellular B. pseudomallei bacteria. Moreover, we found that common marmoset (Callithrix Jacchus) gamma 9(+) T cells increase in frequency and respond to the phosphoantigen CHDMAPP and/or B. pseudomallei, in combination with IL-2, in a similar manner to human gamma 9(+) delta 2(+) T cells. Here we evaluate the efficacy of the phosphoantigen CHDMAPP, in combination with IL-2, as a therapy against B. pseudomallei infection, in vivo. We found that the previous studies predicted the in vivo responsiveness of gamma 9(+) T cells to the CHDMAPP+IL-2 treatment and significant expansion of the numbers of peripheral and splenic gamma 9(+) T cells were observed. This effect was similar to those reported in other primate species treated with phosphoantigen. Furthermore, splenocytes were retrieved 7 days post onset of treatment, restimulated with CHDMAPP or heat-killed B. pseudomallei and the cultured gamma 9(+) T cells demonstrated no reduction in IFN-gamma response when CHDMAPP+IL-2 animals were compared to IL-2 only treated animals. Using an established model of B. pseudomallei infection in the marmoset, we assessed the potential for using phosphoantigen as a novel immunotherapy. The CHDMAPP treatment regime had no effect on the progression of respiratory melioidosis and this was despite the presence of elevated numbers of gamma 9(+) T cells in the spleen, liver and lung and an increased proportion of IFN-gamma(+) cells in response to infection. We therefore report that the common marmoset has proven a good model for studying the effect in vivo of gamma 9(+) T cell stimulation; however, gamma 9(+) T cells have little or no effect on the progression of lethal, respiratory B. pseudomallei infection.	[Laws, Thomas R.; Nelson, Michelle; Taylor, Christopher; Atkins, Timothy P.; Oyston, Petra C. F.; Rowland, Caroline A.] Def Sci & Technol Lab DSTL Porton Down, Dept Biomed Sci, Salisbury, Wilts, England; [Bonnafous, Cecile; Sicard, Helene] Innate Pharma, Marseille, France; [Salguero, Francisco Javier] AHVLA, Weybridge, Surrey, England		Rowland, CA (corresponding author), Def Sci & Technol Lab DSTL Porton Down, Dept Biomed Sci, Salisbury, Wilts, England.	carowland@dstl.gov.uk	Salguero, Francisco J/A-7336-2010; Laws, Thomas/L-2935-2018	Laws, Thomas/0000-0002-0142-9162; Salguero, Francisco Javier/0000-0002-5315-3882	British Ministry of Defence	British Ministry of Defence	This work was funded by the British Ministry of Defence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrati C, 2011, AIDS REV, V13, P3; Ali Z, 2007, J IMMUNOL, V179, P8287, DOI 10.4049/jimmunol.179.12.8287; Ali Z, 2009, J IMMUNOL, V183, P5407, DOI 10.4049/jimmunol.0901760; Boedec A, 2008, J MED CHEM, V51, P1747, DOI 10.1021/jm701101g; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Chierakul W, 2005, CLIN INFECT DIS, V41, P982, DOI 10.1086/432942; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Dieli F, 2000, EUR J IMMUNOL, V30, P1512, DOI 10.1002/(SICI)1521-4141(200005)30:5<1512::AID-IMMU1512>3.0.CO;2-3; Eberl M, 2003, FEBS LETT, V544, P4, DOI 10.1016/S0014-5793(03)00483-6; Elkins KL, 2010, MICROBES INFECT, V12, P28, DOI 10.1016/j.micinf.2009.09.012; Gioia C, 2002, J IMMUNOL, V168, P1484, DOI 10.4049/jimmunol.168.3.1484; Gong GM, 2009, BLOOD, V113, P837, DOI 10.1182/blood-2008-06-162792; Huang D, 2008, INFECT IMMUN, V76, P426, DOI 10.1128/IAI.01008-07; Huang D, 2009, P NATL ACAD SCI USA, V106, P7553, DOI 10.1073/pnas.0811250106; INNATE Pharma, 2009, IPH1101 HCV PHAS 2A; JouenBeades F, 1997, INFECT IMMUN, V65, P4267, DOI 10.1128/IAI.65.10.4267-4272.1997; Lever MS, 2008, INT J EXP PATHOL, V89, P171, DOI 10.1111/j.1365-2613.2008.00581.x; Liu BP, 2002, INFECT IMMUN, V70, P504, DOI 10.1128/IAI.70.2.504-511.2002; Nelson M, 2011, INT J EXP PATHOL, V92, P428, DOI 10.1111/j.1365-2613.2011.00791.x; Nelson M, 2010, J MED MICROBIOL, V59, P1107, DOI 10.1099/jmm.0.020669-0; Nelson M, 2009, INT J EXP PATHOL, V90, P109, DOI 10.1111/j.1365-2613.2008.00631.x; Ottones F, 2000, IMMUNOLOGY, V100, P252, DOI 10.1046/j.1365-2567.2000.00024.x; Ottones F, 2000, J IMMUNOL, V165, P7133, DOI 10.4049/jimmunol.165.12.7133; PARKER CM, 1990, J EXP MED, V171, P1597, DOI 10.1084/jem.171.5.1597; Poquet Y, 1998, INFECT IMMUN, V66, P2107, DOI 10.1128/IAI.66.5.2107-2114.1998; Qin G, 2011, J VIROL, V85, P10109, DOI 10.1128/JVI.05341-11; RAJCHANUVONG A, 1995, T ROY SOC TROP MED H, V89, P546, DOI 10.1016/0035-9203(95)90104-3; Rowland CA, 2006, INFECT IMMUN, V74, P5333, DOI 10.1128/IAI.02046-05; Rowland CA, 2012, CELL IMMUNOL, V280, P132, DOI 10.1016/j.cellimm.2012.12.002; Rowland CA, 2012, MICROBES INFECT, V14, P584, DOI 10.1016/j.micinf.2012.02.001; Santanirand P, 1999, INFECT IMMUN, V67, P3593, DOI 10.1128/IAI.67.7.3593-3600.1999; Shao LY, 2009, J VIROL, V83, P11959, DOI 10.1128/JVI.00689-09; Sicard H, 2005, J IMMUNOL, V175, P5471, DOI 10.4049/jimmunol.175.8.5471; Smither S.J., 2012, INT J EXP PATH UNPUB; Tan GYG, 2008, J MED MICROBIOL, V57, P508, DOI 10.1099/jmm.0.47596-0; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Yeager JJ, 2012, INFECT IMMUN, V80, P3332, DOI 10.1128/IAI.00675-12	37	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74789	10.1371/journal.pone.0074789	http://dx.doi.org/10.1371/journal.pone.0074789			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098670	gold, Green Published, Green Submitted			2022-12-25	WOS:000325423500041
J	Skelsey, P; With, KA; Garrett, KA				Skelsey, Peter; With, Kimberly A.; Garrett, Karen A.			Pest and Disease Management: Why We Shouldn't Go against the Grain	PLOS ONE			English	Article							POTATO LATE BLIGHT; PHYTOPHTHORA-INFESTANS; DISPERSAL KERNELS; SPATIAL-PATTERN; SPATIOTEMPORAL MODEL; ANIMAL MOVEMENT; SPREAD; BACTERIA; DYNAMICS; TOMATO	Given the wide range of scales and mechanisms by which pest or disease agents disperse, it is unclear whether there might exist a general relationship between scale of host heterogeneity and spatial spread that could be exploited by available management options. In this model-based study, we investigate the interaction between host distributions and the spread of pests and diseases using an array of models that encompass the dispersal and spread of a diverse range of economically important species: a major insect pest of coniferous forests in western North America, the mountain pine beetle (Dendroctonus ponderosae); the bacterium Pseudomonas syringae, one of the most-widespread and best-studied bacterial plant pathogens; the mosquito Culex erraticus, an important vector for many human and animal pathogens, including West Nile Virus; and the oomycete Phytophthora infestans, the causal agent of potato late blight. Our model results reveal an interesting general phenomenon: a unimodal ('humpbacked') relationship in the magnitude of infestation (an index of dispersal or population spread) with increasing grain size (i.e., the finest scale of patchiness) in the host distribution. Pest and disease management strategies targeting different aspects of host pattern (e.g., abundance, aggregation, isolation, quality) modified the shape of this relationship, but not the general unimodal form. This is a previously unreported effect that provides insight into the spatial scale at which management interventions are most likely to be successful, which, notably, do not always match the scale corresponding to maximum infestation. Our findings could provide a new basis for explaining historical outbreak events, and have implications for biosecurity and public health preparedness.	[Skelsey, Peter] James Hutton Inst, Dundee, Scotland; [With, Kimberly A.] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; [Garrett, Karen A.] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA	James Hutton Institute; Kansas State University; Kansas State University	Skelsey, P (corresponding author), James Hutton Inst, Dundee, Scotland.	peter.skelsey@hutton.ac.uk	With, Kimberly/AAA-2637-2021; With, Kimberly/J-5124-2014; Skelsey, Peter/L-7786-2013	With, Kimberly/0000-0001-5570-1515; Skelsey, Peter/0000-0002-7316-1951	Scottish Government; National Science Foundation-National Institutes of Health Ecology of Infectious Disease program [EF-0525712]	Scottish Government; National Science Foundation-National Institutes of Health Ecology of Infectious Disease program	This research was supported by the Scottish Government and by the National Science Foundation-National Institutes of Health Ecology of Infectious Disease program (EF-0525712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JC, 2001, CHAOS SOLITON FRACT, V12, P333, DOI 10.1016/S0960-0779(00)00092-8; ANDERSEN M, 1991, MATH BIOSCI, V104, P135, DOI 10.1016/0025-5564(91)90034-G; Aylor DE, 2003, ECOLOGY, V84, P1989, DOI 10.1890/01-0619; Bartumeus F, 2007, FRACTALS, V15, P151, DOI 10.1142/S0218348X07003460; Bianchi FJJA, 2009, BIOL CONTROL, V50, P267, DOI 10.1016/j.biocontrol.2009.04.014; BIDLINGMAYER WL, 1994, J AM MOSQUITO CONTR, V10, P272; Birch PRJ, 2001, MOL PLANT PATHOL, V2, P257, DOI 10.1046/j.1464-6722.2001.00073.x; Blochl F, 2007, THESIS U REGENSBURG; Bock CH, 2012, PLANT PATHOL, V61, P829, DOI 10.1111/j.1365-3059.2011.02588.x; BOURKE PMA, 1964, NATURE, V203, P805, DOI 10.1038/203805a0; Brewster CC, 1997, ENVIRON ENTOMOL, V26, P473, DOI 10.1093/ee/26.3.473; Bruce T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036687; BUTTERWORTH J, 1991, J APPL BACTERIOL, V71, P484, DOI 10.1111/j.1365-2672.1991.tb03822.x; Centers for Disease Control and Prevention, 2012, 2012 W NIL VIR UPD S; Cevallos-Cevallos JM, 2012, INT J FOOD MICROBIOL, V160, P58, DOI 10.1016/j.ijfoodmicro.2012.09.021; Cevallos-Cevallos JM, 2012, J FOOD PROTECT, V75, P472, DOI 10.4315/0362-028X.JFP-11-399; Chen HP, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00172.1; Chipperfield JD, 2011, METHODS ECOL EVOL, V2, P668, DOI 10.1111/j.2041-210X.2011.00117.x; Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.2307/176541; Clark JS, 1998, AM NAT, V152, P204, DOI 10.1086/286162; Clark JS, 2001, AM NAT, V157, P537, DOI 10.1086/319934; CRANS W J, 1986, Bulletin of the Society of Vector Ecologists, V11, P178; Dale VH, 2001, BIOSCIENCE, V51, P723, DOI 10.1641/0006-3568(2001)051[0723:CCAFD]2.0.CO;2; Devroye L., 1986, NONUNIFORM RANDOM VA; Duncan J., 1999, Microbiology Today, V26, P114; Erwin DC, 1996, PHYTOPHTHORA DIS WOR; Evans HC, 2010, PLANT PATH 21ST, P53, DOI 10.1007/978-1-4020-8932-9_5; FADDOUL GP, 1965, AVIAN DIS, V9, P530, DOI 10.2307/1588135; Fahse L, 2011, ECOL MODEL, V222, P1833, DOI 10.1016/j.ecolmodel.2011.03.014; FERRANDINO FJ, 1993, PHYTOPATHOLOGY, V83, P795, DOI 10.1094/Phyto-83-795; Finckh MR, 2008, EUR J PLANT PATHOL, V121, P399, DOI 10.1007/s10658-008-9273-6; Francini RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054260; GILLIES MT, 1969, B ENTOMOL RES, V59, P441, DOI 10.1017/S0007485300003412; Graham John H., 2011, International Journal of Ecology, V2011, P1; Green S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010224; HAASE P, 1995, J VEG SCI, V6, P575, DOI 10.2307/3236356; Hastings A, 2005, ECOL LETT, V8, P91, DOI 10.1111/j.1461-0248.2004.00687.x; Hastings A, 2012, ENCY THEORETICAL ECO, Vxxiv; HAYES RO, 1962, AM J TROP MED HYG, V11, P115, DOI 10.4269/ajtmh.1962.11.115; Heavilin J, 2008, NAT RESOUR MODEL, V21, P489, DOI 10.1111/j.1939-7445.2008.00021.x; Jacob BG, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-12; Keitt TH, 2000, LANDSCAPE ECOL, V15, P479, DOI 10.1023/A:1008193015770; KOT M, 1986, MATH BIOSCI, V80, P109, DOI 10.1016/0025-5564(86)90069-6; Kot M, 1996, ECOLOGY, V77, P2027, DOI 10.2307/2265698; Kuuluvainen T, 2000, J VEG SCI, V11, P801, DOI 10.2307/3236550; LETSON GW, 1993, AM J TROP MED HYG, V49, P677, DOI 10.4269/ajtmh.1993.49.677; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002093; Lutaladio N, 2009, J FOOD COMPOS ANAL, V22, P491, DOI 10.1016/j.jfca.2009.05.002; Madden L.V., 2007, STUDY PLANT DIS EPID; Mandelbrot B, 1983, FRACTAL GEOMETRY NAT; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; May F, 2013, ECOGRAPHY, V36, P842, DOI 10.1111/j.1600-0587.2012.07793.x; Mizubuti ESG, 2000, PHYTOPATHOLOGY, V90, P78, DOI 10.1094/PHYTO.2000.90.1.78; MOLLISON D, 1977, J ROY STAT SOC B MET, V39, P283; Mundt CC, 2002, ANNU REV PHYTOPATHOL, V40, P381, DOI 10.1146/annurev.phyto.40.011402.113723; Mundt CC, 2011, ECOL APPL, V21, P321, DOI 10.1890/10-1004.1; Mundt CC, 2009, AM NAT, V173, P456, DOI 10.1086/597220; O'neill J. R., 2009, IRISH POTATO FAMINE; Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009; PETERSON CJ, 1995, J ECOL, V83, P847, DOI 10.2307/2261421; Press W. H., 1992, ART SCI COMPUTING; Reynolds A, 2013, LECT NOTES MATH, V2071, P53, DOI 10.1007/978-3-642-35497-7_3; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; SHAW MW, 1995, P ROY SOC B-BIOL SCI, V259, P243, DOI 10.1098/rspb.1995.0036; Shenge KC, 2007, PLANT DIS, V91, P462, DOI 10.1094/PDIS-91-4-0462C; Skelsey P, 2009, AGR FOREST METEOROL, V149, P419, DOI 10.1016/j.agrformet.2008.09.005; Skelsey P, 2008, AGR FOREST METEOROL, V148, P1383, DOI 10.1016/j.agrformet.2008.04.006; Skelsey P, 2005, PHYTOPATHOLOGY, V95, P328, DOI 10.1094/PHYTO-95-0328; Skelsey P, 2009, PHYTOPATHOLOGY, V99, P887, DOI 10.1094/PHYTO-99-7-0887; Skelsey P, 2009, PHYTOPATHOLOGY, V99, P290, DOI 10.1094/PHYTO-99-3-0290; Skelsey P, 2013, THEOR ECOL-NETH, V6, P203, DOI 10.1007/s12080-012-0171-3; Skelsey P, 2010, PHYTOPATHOLOGY, V100, P1146, DOI 10.1094/PHYTO-06-09-0148; Slone DH, 2011, ECOL MODEL, V222, P573, DOI 10.1016/j.ecolmodel.2010.11.023; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Voss R. F., 1985, FUNDAMENTAL ALGORITH, P805; Winder Richard S., 2010, Journal of the Entomological Society of British Columbia, V107, P43; With KA, 2004, RISK ANAL, V24, P803, DOI 10.1111/j.0272-4332.2004.00480.x; With KA, 1997, OIKOS, V79, P219, DOI 10.2307/3546007; With KA, 2002, CONSERV BIOL, V16, P1192, DOI 10.1046/j.1523-1739.2002.01064.x; With KA, 1997, OIKOS, V78, P151, DOI 10.2307/3545811; Zadoks JC, 2008, POTATO RES, V51, P5, DOI 10.1007/s11540-008-9091-4	81	8	8	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75892	10.1371/journal.pone.0075892	http://dx.doi.org/10.1371/journal.pone.0075892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098739	gold, Green Published, Green Submitted			2022-12-25	WOS:000325423500110
J	Slapeta, J; Linares, MC				Slapeta, Jan; Linares, Marjorie C.			Combined Amplicon Pyrosequencing Assays Reveal Presence of the Apicomplexan "type-N" (cf. Gemmocystis cylindrus) and Chromera velia on the Great Barrier Reef, Australia	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; MICROBIAL COMMUNITY; SEQUENCING REVEALS; CORAL; DIVERSITY; DISEASE; WATER; ASSOCIATIONS; PHYLOGENY; PATHOGENS	Background: The coral is predominantly composed of the metabolically dependent coral host and the photosynthetic dinoflagellate Symbiodinium sp. The system as a whole interacts with symbiotic eukaryotes, bacteria and viruses. Gemmocystis cylindrus (cf. "type-N" symbiont) belonging to the obligatory parasitic phylum Apicomplexa (Alveolata) is ubiquitous in the Caribbean coral, but its presence in the Great Barrier Reef coral has yet to be documented. Approaches allowing identification of the healthy community from the pathogenic or saprobic organisms are needed for sustainable coral reef monitoring. Methods & Principal Findings: We investigated the diversity of eukaryotes associated with a common reef-building corals from the southern Great Barrier Reef. We used three tag encoded 454 amplicon pyrosequencing assays targeting eukaryote small-subunit rRNA gene to demonstrate the presence of the apicomplexan type-N and a photosynthetic sister species to Apicomplexa - Chromera velia. Amplicon pyrosequencing revealed presence of the small-subunit rRNA genes of known eukaryotic pathogens (Cryptosporidium and Cryptococcus). We therefore conducted bacterial tag encoded amplicon pyrosequencing assay for small-subunit rRNA gene to support effluent exposure of the coral. Bacteria of faecal origin (Enterobacteriales) formed 41% of total sequences in contrast to 0-2% of the coral-associated bacterial communities with and without C. velia, respectively. Significance: This is the first time apicomplexan type-N has been detected in the Great Barrier Reef. Eukaryote tag encoded amplicon pyrosequencing assays demonstrate presence of apicomplexan type-N and C. Velia in total coral DNA. The data highlight the need for combined approaches for eukaryotic diversity studies coupled with bacterial community assessment to achieve a more realistic goals of defining the holobiont community and assessing coral disease. With increasing evidence of Apicomplexa in coral reef environments, it is important not only to understand the evolution of these organisms but also identify their potential as pathogens.	[Slapeta, Jan] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Linares, Marjorie C.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Slapeta, J (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	jan.slapeta@sydney.edu.au		Slapeta, Jan/0000-0003-1459-9117	Australian Research Council [DP0986372]; School of Molecular Bioscience, University of Sydney	Australian Research Council(Australian Research Council); School of Molecular Bioscience, University of Sydney(University of Sydney)	This study was financially supported by the Australian Research Council, Discovery Project DP0986372. MCL was supported by the WG Murrell International Research Scholarship (School of Molecular Bioscience, University of Sydney). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral-Zettler LA, 2011, ISME J, V5, P42, DOI 10.1038/ismej.2010.101; Barta JR, 2006, TRENDS PARASITOL, V22, P463, DOI 10.1016/j.pt.2006.08.001; Bongaerts P, 2011, MAR ECOL PROG SER, V439, P117, DOI 10.3354/meps09315; Bourne DG, 2009, TRENDS MICROBIOL, V17, P554, DOI 10.1016/j.tim.2009.09.004; Brate J, 2010, ISME J, V4, P1144, DOI 10.1038/ismej.2010.39; Cabral JPS, 2010, INT J ENV RES PUB HE, V7, P3657, DOI 10.3390/ijerph7103657; Cardenas A, 2012, ISME J, V6, P502, DOI 10.1038/ismej.2011.123; Cheung MK, 2010, ISME J, V4, P1053, DOI 10.1038/ismej.2010.26; Cumbo VR, 2013, PROTIST, V164, P237, DOI 10.1016/j.protis.2012.08.003; DUVAL B, 1995, SYMBIOSIS, V18, P181; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Findley K, 2009, EUKARYOT CELL, V8, P353, DOI 10.1128/EC.00373-08; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Holligan P M, 1975, Symp Soc Exp Biol, P205; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Janouskovec J, 2013, ISME J, V7, P444, DOI 10.1038/ismej.2012.129; Janouskovec J, 2012, CURR BIOL, V22, pR518, DOI 10.1016/j.cub.2012.04.047; Kirk NL, 2013, CORAL REEFS, V32, P847, DOI 10.1007/s00338-013-1038-9; Kumar S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-182; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; Kvennefors ECE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010401; Leclerc H, 2002, CRIT REV MICROBIOL, V28, P371, DOI 10.1080/1040-840291046768; Lee JJ, 2003, J EUKARYOT MICROBIOL, V50, P439, DOI 10.1111/j.1550-7408.2003.tb00270.x; Lee OO, 2012, APPL ENVIRON MICROB, V78, P7173, DOI 10.1128/AEM.01111-12; Lin XR, 2006, ANNU REV MICROBIOL, V60, P69, DOI 10.1146/annurev.micro.60.080805.142102; Loh WKW, 2001, MAR ECOL PROG SER, V222, P97, DOI 10.3354/meps222097; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Lynn DH, 2002, J EUKARYOT MICROBIOL, V49, P460, DOI 10.1111/j.1550-7408.2002.tb00229.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Medinger R, 2010, MOL ECOL, V19, P32, DOI 10.1111/j.1365-294X.2009.04478.x; Moore RB, 2008, NATURE, V451, P959, DOI 10.1038/nature06635; Morin-Adeline V, 2012, FEMS MICROBIOL LETT, V328, P144, DOI 10.1111/j.1574-6968.2011.02489.x; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Robertson LJ, 2007, INT J FOOD MICROBIOL, V120, P201, DOI 10.1016/j.ijfoodmicro.2007.07.058; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Scholthof KBG, 2007, NAT REV MICROBIOL, V5, P152, DOI 10.1038/nrmicro1596; Slapeta J, 2005, P ROY SOC B-BIOL SCI, V272, P2073, DOI 10.1098/rspb.2005.3195; Slapeta J, 2009, GIARDIA AND CRYPTOSPORIDIUM: FROM MOLECULES TO DISEASE, P31, DOI 10.1079/9781845933913.0031; Stat M, 2008, CORAL REEFS, V27, P763, DOI 10.1007/s00338-008-0412-5; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; Stoeck T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-72; Sun Y, 2011, METHODS MOL BIOL, V733, P129, DOI 10.1007/978-1-61779-089-8_9; Sweet M, 2012, J MAR BIOL ASSOC UK, V92, P791, DOI 10.1017/S0025315411001688; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Toller WW, 2002, CORAL REEFS, V21, P143, DOI 10.1007/s00338-002-0220-2; UPTON SJ, 1986, J INVERTEBR PATHOL, V47, P184, DOI 10.1016/0022-2011(86)90045-5	48	16	16	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76095	10.1371/journal.pone.0076095	http://dx.doi.org/10.1371/journal.pone.0076095			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098768	gold, Green Published, Green Submitted			2022-12-25	WOS:000325423500138
J	Zhou, Y; Wang, YQ; Schreader, BA; Nambu, JR				Zhou, Ying; Wang, Yiqin; Schreader, Barbara A.; Nambu, John R.			Drosophila Morgue Associates with SkpA and Polyubiquitin In Vivo	PLOS ONE			English	Article							UBIQUITIN-CONJUGATING ENZYME; STRUCTURAL BASIS; PROTEIN UBIQUITINATION; BINDING PROTEINS; CELL-DEATH; CHAINS; MELANOGASTER; DEGRADATION; PATHWAY; LIGASES	Morgue is a unique ubiquitination protein that influences programmed cell death and circadian rhythms in Drosophila. We have found that over-expression of wild-type Morgue results in organismal lethality. This over-expression phenotype was used as the basis for an in vivo functional assay to investigate the importance of the Morgue zinc finger, F box, Ubiquitin E2 Conjugase Variant (UEV) domain, and active site Glycine residue. Removal of the zinc finger or UEV domain reduced Morgue's ability to induce lethality and enhance cell death. In contrast, lack of the F box as well as several different substitutions of the active site Glycine did not alter Morgue-induced lethality or cell death enhancement. To further characterize Morgue functions, a Flag: Morgue protein was used to isolate Morgue-associated proteins from whole adult Drosophila. Mass spectrometry analysis of the Morgue-associated proteins identified SkpA as well as a ubiquitin multimer. The identification of SkpA is consistent with previous in vitro studies and further suggests Morgue acts in an SCF-type ubiquitin E3 ligase complex. The identification of poly-ubiquitin was unexpected and this interaction had not been previously identified. The associated poly-ubiquitin was found to exhibit a Lys-48 topology, consistent with distinct functions of Morgue in proteasome-mediated protein turnover. Multiple regions of Morgue were subsequently shown to be required for poly-ubiquitin binding. Overall, Morgue is a novel multi-functional ubiquitin-binding protein.	[Zhou, Ying; Wang, Yiqin; Schreader, Barbara A.; Nambu, John R.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Zhou, Ying; Nambu, John R.] Florida Atlantic Univ, Dept Biol Sci, Boca Raton, FL 33431 USA	University of Massachusetts System; University of Massachusetts Amherst; State University System of Florida; Florida Atlantic University	Nambu, JR (corresponding author), Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA.	jnambu@fau.edu			National Institutes of Health [AG025866]; NATIONAL INSTITUTE ON AGING [R01AG025866] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health award AG025866 to JRN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRIBAS C, 1986, BIOCHIM BIOPHYS ACTA, V868, P119, DOI 10.1016/0167-4781(86)90014-X; BRAND AH, 1993, DEVELOPMENT, V118, P401; Ciechanover A, 2005, CELL DEATH DIFFER, V12, P1178, DOI 10.1038/sj.cdd.4401692; Denuc A, 2010, BIOCHEM SOC T, V38, P34, DOI 10.1042/BST0380034; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; Hau DD, 2006, BIOCHEMISTRY-US, V45, P9866, DOI 10.1021/bi060631r; Hays R, 2002, NAT CELL BIOL, V4, P425, DOI 10.1038/ncb794; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Kaiser P, 2005, METHOD ENZYMOL, V399, P266, DOI 10.1016/S0076-6879(05)99018-6; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; LEE HS, 1988, MOL CELL BIOL, V8, P4727, DOI 10.1128/MCB.8.11.4727; Lewis MJ, 2006, J BIOMOL NMR, V34, P89, DOI 10.1007/s10858-005-5583-6; Lin DH, 2002, J BIOL CHEM, V277, P21740, DOI 10.1074/jbc.M108418200; Metzger MB, 2010, NAT CELL BIOL, V12, P1124, DOI 10.1038/ncb1210-1124; Mohseni N, 2009, AUTOPHAGY, V5, P329, DOI 10.4161/auto.5.3.7444; Murad A, 2007, NEURON, V53, P689, DOI 10.1016/j.neuron.2007.01.034; Nagy V, 2010, BIOL CHEM, V391, P163, DOI 10.1515/bc.2010.021; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; PATEL NH, 1994, DROSOPHILA MELANOGAS, V44, P446; Patushok L, 2007, FEBS LETT, V581, P5343; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Schreader BA, 2003, APOPTOSIS, V8, P129, DOI 10.1023/A:1022914524601; Schreader BA, 2010, INT J DEV BIOL, V54, P1425, DOI 10.1387/ijdb.092979bs; SINHA SK, 1981, J BIOL CHEM, V256, P4193; Sundquist WI, 2004, MOL CELL, V13, P783, DOI 10.1016/S1097-2765(04)00129-7; Trempe JF, 2011, CURR OPIN STRUC BIOL, V21, P792, DOI 10.1016/j.sbi.2011.09.009; Tsui C, 2005, J BIOL CHEM, V280, P19829, DOI 10.1074/jbc.M414060200; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; VAESSIN H, 1994, DEVELOPMENT, V120, P935; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; VanDemark AP, 2002, CURR OPIN STRUC BIOL, V12, P822, DOI 10.1016/S0959-440X(02)00389-5; Wang B, 2003, J BIOL CHEM, V278, P20225, DOI 10.1074/jbc.M300459200; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Wing JP, 2002, NAT CELL BIOL, V4, P451, DOI 10.1038/ncb800; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zhou Y, 2009, MOL BIOL EVOL, V26, P2245, DOI 10.1093/molbev/msp147	50	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74860	10.1371/journal.pone.0074860	http://dx.doi.org/10.1371/journal.pone.0074860			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098672	Green Submitted, Green Published, gold			2022-12-25	WOS:000325423500043
J	Zemoura, K; Schenkel, M; Acuna, MA; Yevenes, GE; Zeilhofer, HU; Benke, D				Zemoura, Khaled; Schenkel, Marisa; Acuna, Mario A.; Yevenes, Gonzalo E.; Zeilhofer, Hanns Ulrich; Benke, Dietmar			Endoplasmic Reticulum-associated Degradation Controls Cell Surface Expression of gamma-Aminobutyric Acid, Type B Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum (ER); ER-associated Degradation; GABA Receptors; Neurons; Proteasome; Ubiquitination	SMALL-MOLECULE INHIBITOR; GABA(B) RECEPTORS; LYSOSOMAL DEGRADATION; SYNAPTIC PLASTICITY; PROXIMITY LIGATION; MEMBRANE-PROTEINS; UBIQUITINATION; PROTEASOME; PATHWAY; EEYARESTATIN	Background: The amount of cell surface GABA(B) receptors determines the strength of GABA(B)-mediated inhibition of neuronal excitability. Results: GABA(B) receptors are Lys(48)-linked polyubiquitinated and degraded by proteasomes via ERAD. Conclusion: ERAD constitutively degrades GABA(B) receptors and thereby determines the number of functional receptors available for signaling. Significance: Modulation of ERAD activity may be a mechanism to adjust the level of functional GABA(B) receptors. Metabotropic GABA(B) receptors are crucial for controlling the excitability of neurons by mediating slow inhibition in the CNS. The strength of receptor signaling depends on the number of cell surface receptors, which is thought to be regulated by trafficking and degradation mechanisms. Although the mechanisms of GABA(B) receptor trafficking are studied to some extent, it is currently unclear whether receptor degradation actively controls the number of GABA(B) receptors available for signaling. Here we tested the hypothesis that proteasomal degradation contributes to the regulation of GABA(B) receptor expression levels. Blocking proteasomal activity in cultured cortical neurons considerably enhanced total and cell surface expression of GABA(B) receptors, indicating the constitutive degradation of the receptors by proteasomes. Proteasomal degradation required Lys(48)-linked polyubiquitination of lysines 767/771 in the C-terminal domain of the GABA(B2) subunit. Inactivation of these ubiquitination sites increased receptor levels and GABA(B) receptor signaling in neurons. Proteasomal degradation was mediated by endoplasmic reticulum-associated degradation (ERAD) as shown by the accumulation of receptors in the endoplasmic reticulum upon inhibition of proteasomes, by the increase of receptor levels, as well as receptor signaling upon blocking ERAD function, and by the interaction of GABA(B) receptors with the essential ERAD components Hrd1 and p97. In conclusion, the data support a model in which the fraction of GABA(B) receptors available for plasma membrane trafficking is regulated by degradation via the ERAD machinery. Thus, modulation of ERAD activity by changes in physiological conditions may represent a mechanism to adjust receptor numbers and thereby signaling strength.	[Zemoura, Khaled; Schenkel, Marisa; Acuna, Mario A.; Yevenes, Gonzalo E.; Zeilhofer, Hanns Ulrich; Benke, Dietmar] Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland; [Zemoura, Khaled; Acuna, Mario A.; Zeilhofer, Hanns Ulrich; Benke, Dietmar] Univ Zurich, Neurosci Ctr Zurich, CH-8057 Zurich, Switzerland; [Zemoura, Khaled; Acuna, Mario A.; Zeilhofer, Hanns Ulrich; Benke, Dietmar] Swiss Fed Inst Technol, CH-8057 Zurich, Switzerland; [Schenkel, Marisa; Zeilhofer, Hanns Ulrich] Swiss Fed Inst Technol, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland	University of Zurich; University of Zurich; ETH Zurich; ETH Zurich	Benke, D (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	benke@pharma.uzh.ch	Zeilhofer, Hanns Ulrich/A-4600-2008	Zeilhofer, Hanns Ulrich/0000-0001-6954-4629; Acuna, Mario A./0000-0002-0673-5150	Swiss National Science Foundation [31003A_121963, 31003A_138382]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grants 31003A_121963 and 31003A_138382 (to D.B.).	Benke D, 2010, ADV PHARMACOL, V58, P93, DOI 10.1016/S1054-3589(10)58004-9; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Buerli T, 2007, NAT PROTOC, V2, P3090, DOI 10.1038/nprot.2007.445; Cajigas IJ, 2010, EMBO J, V29, P2746, DOI 10.1038/emboj.2010.173; Chalifoux JR, 2011, CURR OPIN NEUROBIOL, V21, P339, DOI 10.1016/j.conb.2011.02.004; Djakovic SN, 2009, J BIOL CHEM, V284, P26655, DOI 10.1074/jbc.M109.021956; Fiebiger E, 2004, MOL BIOL CELL, V15, P1635, DOI 10.1091/mbc.E03-07-0506; Grampp T, 2007, J BIOL CHEM, V282, P24157, DOI 10.1074/jbc.M702626200; Grampp T, 2008, MOL CELL NEUROSCI, V39, P628, DOI 10.1016/j.mcn.2008.09.004; Hegde AN, 2010, LEARN MEMORY, V17, P314, DOI 10.1101/lm.1504010; Huang L, 2007, FEBS LETT, V581, P4955, DOI 10.1016/j.febslet.2007.09.031; Kantamneni S, 2008, J NEUROCHEM, V107, P86, DOI 10.1111/j.1471-4159.2008.05580.x; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Leuchowius KJ, 2010, MOL CELL PROTEOMICS, V9, P178, DOI 10.1074/mcp.M900331-MCP200; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Mabb AM, 2010, ANNU REV CELL DEV BI, V26, P179, DOI 10.1146/annurev-cellbio-100109-104129; Maier PJ, 2010, J BIOL CHEM, V285, P35606, DOI 10.1074/jbc.M110.142406; Melikova MS, 2006, CELL BIOL INT, V30, P31, DOI 10.1016/j.cellbi.2005.09.003; Na CH, 2012, J PROTEOME RES, V11, P4722, DOI 10.1021/pr300536k; Patnaik A, 2000, P NATL ACAD SCI USA, V97, P13069, DOI 10.1073/pnas.97.24.13069; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Saliba RS, 2007, J NEUROSCI, V27, P13341, DOI 10.1523/JNEUROSCI.3277-07.2007; Saliba RS, 2009, J BIOL CHEM, V284, P32544, DOI 10.1074/jbc.M109.040071; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang Q, 2004, J STRUCT BIOL, V146, P44, DOI 10.1016/j.jsb.2003.11.014; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Wojcikiewicz RJH, 2009, CELL CALCIUM, V46, P147, DOI 10.1016/j.ceca.2009.05.002	33	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34897	34905		10.1074/jbc.M113.514745	http://dx.doi.org/10.1074/jbc.M113.514745			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24114844	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000329812800056
J	Gelaye, E; Lamien, CE; Silber, R; Tuppurainen, ESM; Grabherr, R; Diallo, A				Gelaye, Esayas; Lamien, Charles Euloge; Silber, Roland; Tuppurainen, Eeva S. M.; Grabherr, Reingard; Diallo, Adama			Development of a Cost-Effective Method for Capripoxvirus Genotyping Using Snapback Primer and dsDNA Intercalating Dye	PLOS ONE			English	Article							LUMPY SKIN-DISEASE; PHYLOGENETIC ANALYSIS; MELTING ANALYSIS; SHEEP POX; VIRUS; IDENTIFICATION; THREAT; CATTLE; GENOME; GENE	Sheep pox virus (SPPV), goat pox virus (GTPV) and lumpy skin disease virus (LSDV) are very closely related viruses of the Capripoxvirus (CaPV) genus of the Poxviridae family. They are responsible for sheep pox, goat pox and lumpy skin disease which affect sheep, goat and cattle, respectively. The epidemiology of capripox diseases is complex, as some CaPVs are not strictly host-specific. Additionally, the three forms of the disease co-exist in many sub-Saharan countries which complicates the identification of the virus responsible for an outbreak. Genotyping of CaPVs using a low-cost, rapid, highly specific, and easy to perform method allows a swift and accurate identification of the causative agent and significantly assists in selecting appropriate control and eradication measures, such as the most suitable vaccine against the virus during the outbreaks. The objective of this paper is to describe the design and analytical performances of a new molecular assay for CaPV genotyping using unlabelled snapback primers in the presence of dsDNA intercalating EvaGreen dye. This assay was able to simultaneously detect and genotype CaPVs in 63 samples with a sensitivity and specificity of 100%. The genotyping was achieved by observing the melting temperature of snapback stems of the hairpins and those of the full-length amplicons, respectively. Fourteen CaPVs were genotyped as SPPVs, 25 as GTPVs and 24 as LSDVs. The method is highly pathogen specific and cross platform compatible. It is also cost effective as it does not use fluorescently labelled probes, nor require high-resolution melting curve analysis software. Thus it can be easily performed in diagnostic and research laboratories with limited resources. This genotyping method will contribute significantly to the early detection and genotyping of CaPV infection and to epidemiological studies.	[Gelaye, Esayas; Lamien, Charles Euloge; Diallo, Adama] IAEA, Anim Prod & Hlth Lab, Joint FAO IAEA Div Nucl Tech Food & Agr, Dept Nucl Sci & Applicat, A-1400 Vienna, Austria; [Silber, Roland] Austrian Agcy Hlth & Food Safety, Inst Vet Dis Control, Modling, Austria; [Tuppurainen, Eeva S. M.] Pirbright Inst, Capripoxvirus Reference Lab, Woking, Surrey, England; [Grabherr, Reingard] Univ Nat Resources & Life Sci, Inst Appl Microbiol, Vienna, Austria; [Gelaye, Esayas] Univ Nat Resources & Life Sci, Inst Appl Genet & Cell Biol, Vienna, Austria; [Gelaye, Esayas] Natl Vet Inst, Res & Diagnost Labs, Debre Zeit, Ethiopia	Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna	Lamien, CE (corresponding author), IAEA, Anim Prod & Hlth Lab, Joint FAO IAEA Div Nucl Tech Food & Agr, Dept Nucl Sci & Applicat, A-1400 Vienna, Austria.	C.Lamien@iaea.org		LAMIEN, Charles Euloge/0000-0003-1899-7614; Grabherr, Reingard/0000-0002-4501-927X	IAEA Peaceful Uses Initiatives (PUI) project; United States Department of State; tripartite FAO/OIE/WHO IDENTIFY Project of the USAID Emergent Pandemic Threats Program	IAEA Peaceful Uses Initiatives (PUI) project; United States Department of State; tripartite FAO/OIE/WHO IDENTIFY Project of the USAID Emergent Pandemic Threats Program(United States Agency for International Development (USAID))	This work was supported by the IAEA Peaceful Uses Initiatives (PUI) project funded by the United States Department of State and the tripartite FAO/OIE/WHO IDENTIFY Project of the USAID Emergent Pandemic Threats Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiuk S, 2008, TRANSBOUND EMERG DIS, V55, P263, DOI 10.1111/j.1865-1682.2008.01043.x; Bhanuprakash V, 2006, COMP IMMUNOL MICROB, V29, P27, DOI 10.1016/j.cimid.2005.12.001; Dames S, 2007, CLIN CHEM, V53, P1847, DOI 10.1373/clinchem.2007.090761; Farrar JS, 2011, CLIN CHEM, V57, P1303, DOI 10.1373/clinchem.2011.166306; Hosamani M, 2004, VIRUS GENES, V29, P73, DOI 10.1023/B:VIRU.0000032790.16751.13; KITCHING RP, 1989, EPIDEMIOL INFECT, V102, P335, DOI 10.1017/S0950268800030016; Lamien CE, 2011, VET MICROBIOL, V149, P30, DOI 10.1016/j.vetmic.2010.09.038; Lamien CE, 2011, J VIROL METHODS, V171, P134, DOI 10.1016/j.jviromet.2010.10.014; Le Goff C, 2009, J GEN VIROL, V90, P1967, DOI 10.1099/vir.0.010686-0; Liew M, 2004, CLIN CHEM, V50, P1156, DOI 10.1373/clinchem.2004.032136; NAWATHE DR, 1982, ZBL VET MED B, V29, P31; Oguzoglu TC, 2006, VET RES COMMUN, V30, P965, DOI 10.1007/s11259-006-3259-7; PROZESKY L, 1982, ONDERSTEPOORT J VET, V49, P167; Stram Y, 2008, J VIROL METHODS, V151, P225, DOI 10.1016/j.jviromet.2008.05.003; TANTAWI HH, 1979, TROP ANIM HEALTH PRO, V11, P208, DOI 10.1007/BF02237803; Tulman ER, 2002, J VIROL, V76, P6054, DOI 10.1128/JVI.76.12.6054-6061.2002; Tulman ER, 2001, J VIROL, V75, P7122, DOI 10.1128/JVI.75.15.7122-7130.2001; Tuppurainen ESM, 2012, TRANSBOUND EMERG DIS, V59, P40, DOI 10.1111/j.1865-1682.2011.01242.x; Verma S, 2011, TRANSBOUND EMERG DIS, V58, P79, DOI 10.1111/j.1865-1682.2010.01172.x; Weber O, 2007, POXVIRUSES, P167; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; World Organisation for Animal Health (OIE), 2012, MANUAL DIAGNOSTIC TE, V6th; Wu ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026534; YERUHAM I, 1995, VET REC, V137, P91, DOI 10.1136/vr.137.4.91; Zhou LM, 2008, CLIN CHEM, V54, P1648, DOI 10.1373/clinchem.2008.107615; Zhou LM, 2010, CLIN CHEM, V56, P814, DOI 10.1373/clinchem.2009.142034; Zhou T, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-25; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	28	26	26	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75971	10.1371/journal.pone.0075971	http://dx.doi.org/10.1371/journal.pone.0075971			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116084	Green Published, gold			2022-12-25	WOS:000325501300045
J	O'Neill, PK; Or, M; Erill, I				O'Neill, Patrick K.; Or, Mindy; Erill, Ivan			scnRCA: A Novel Method to Detect Consistent Patterns of Translational Selection in Mutationally-Biased Genomes	PLOS ONE			English	Article							CODON USAGE BIAS; TRANSFER-RNA GENES; ESCHERICHIA-COLI; ADAPTATION INDEX; EXPRESSION; PREDICTION; ORGANIZATION; EFFICIENCY; EVOLUTION; ABUNDANCE	Codon usage bias (CUB) results from the complex interplay between translational selection and mutational biases. Current methods for CUB analysis apply heuristics to integrate both components, limiting the depth and scope of CUB analysis as a technique to probe into the evolution and optimization of protein-coding genes. Here we introduce a self-consistent CUB index (scnRCA) that incorporates implicit correction for mutational biases, facilitating exploration of the translational selection component of CUB. We validate this technique using gene expression data and we apply it to a detailed analysis of CUB in the Pseudomonadales. Our results illustrate how the selective enrichment of specific codons among highly expressed genes is preserved in the context of genome-wide shifts in codon frequencies, and how the balance between mutational and translational biases leads to varying definitions of codon optimality. We extend this analysis to other moderate and fast growing bacteria and we provide unified support for the hypothesis that C- and A-ending codons of two-box amino acids, and the U-ending codons of four-box amino acids, are systematically enriched among highly expressed genes across bacteria. The use of an unbiased estimator of CUB allows us to report for the first time that the signature of translational selection is strongly conserved in the Pseudomonadales in spite of drastic changes in genome composition, and extends well beyond the core set of highly optimized genes in each genome. We generalize these results to other moderate and fast growing bacteria, hinting at selection for a universal pattern of gene expression that is conserved and detectable in conserved patterns of codon usage bias.	[O'Neill, Patrick K.; Or, Mindy; Erill, Ivan] Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21228 USA	University System of Maryland; University of Maryland Baltimore County	Erill, I (corresponding author), Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21228 USA.	erill@umbc.edu	Erill, Ivan/H-9405-2015	Erill, Ivan/0000-0002-7280-7191	UMBC Office of Research through a Special Research Assistantship/Initiative Support (SRAIS) award; UMBC; NSF [MCB-1158056]; Div Of Molecular and Cellular Bioscience [1158056] Funding Source: National Science Foundation	UMBC Office of Research through a Special Research Assistantship/Initiative Support (SRAIS) award; UMBC; NSF(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the UMBC Office of Research through a Special Research Assistantship/Initiative Support (SRAIS) award, by UMBC start-up funds and by NSF grant MCB-1158056. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKASHI H, 1994, GENETICS, V136, P927; Akashi H, 1998, CURR OPIN GENET DEV, V8, P688, DOI 10.1016/S0959-437X(98)80038-5; Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BULMER M, 1991, GENETICS, V129, P897; Carbone A, 2005, MOL BIOL EVOL, V22, P547, DOI 10.1093/molbev/msi040; Carbone A, 2003, BIOINFORMATICS, V19, P2005, DOI 10.1093/bioinformatics/btg272; Carbone A, 2006, J MOL EVOL, V63, P733, DOI 10.1007/s00239-005-0250-9; Chen SL, 2004, P NATL ACAD SCI USA, V101, P3480, DOI 10.1073/pnas.0307827100; Coghlan A, 2000, YEAST, V16, P1131, DOI 10.1002/1097-0061(20000915)16:12<1131::AID-YEA609>3.0.CO;2-F; Comeron JM, 1998, J MOL EVOL, V47, P268, DOI 10.1007/PL00006384; Davis JJ, 2011, MOL BIOL EVOL, V28, P211, DOI 10.1093/molbev/msq185; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; dos Reis M, 2003, NUCLEIC ACIDS RES, V31, P6976, DOI 10.1093/nar/gkg897; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Ermolaeva M D, 2001, Curr Issues Mol Biol, V3, P91; EyreWalker A, 1996, MOL BIOL EVOL, V13, P864, DOI 10.1093/oxfordjournals.molbev.a025646; Faith JJ, 2008, NUCLEIC ACIDS RES, V36, pD866, DOI 10.1093/nar/gkm815; Fox JM, 2010, DNA RES, V17, P185, DOI 10.1093/dnares/dsq012; Fuchsman CA, 2006, APPL ENVIRON MICROB, V72, P6841, DOI 10.1128/AEM.00429-06; Gilchrist MA, 2009, GENETICS, V183, P1493, DOI 10.1534/genetics.109.108209; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; Grocock RJ, 2002, GENE, V289, P131, DOI 10.1016/S0378-1119(02)00503-6; Guo FB, 2012, DNA RES, V19, P477, DOI 10.1093/dnares/dss027; GUTMAN GA, 1989, P NATL ACAD SCI USA, V86, P3699, DOI 10.1073/pnas.86.10.3699; Hershberg R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049060; Hershberg R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000556; Higgs PG, 2008, MOL BIOL EVOL, V25, P2279, DOI 10.1093/molbev/msn173; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Kanaya S, 2001, J MOL EVOL, V53, P290, DOI 10.1007/s002390010219; Karlin S, 2000, J BACTERIOL, V182, P5238, DOI 10.1128/JB.182.18.5238-5250.2000; KURLAND CG, 1991, FEBS LETT, V285, P165, DOI 10.1016/0014-5793(91)80797-7; Lafay B, 2000, MICROBIOL-UK, V146, P851, DOI 10.1099/00221287-146-4-851; Lobry JR, 2002, GENOME BIOL, V3; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MORTON BR, 1993, J MOL EVOL, V37, P273, DOI 10.1007/BF00175504; Mrazek J, 2006, ENVIRON MICROBIOL, V8, P273, DOI 10.1111/j.1462-2920.2005.00894.x; Percudani R, 1999, MOL BIOL EVOL, V16, P1752, DOI 10.1093/oxfordjournals.molbev.a026087; Puigbo P, 2007, NUCLEIC ACIDS RES, V35, pW126, DOI 10.1093/nar/gkm219; Raiford DW, 2010, IEEE ACM T COMPUT BI, V7, P238, DOI 10.1109/TCBB.2008.65; Ran WQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051652; Ran WQ, 2010, MOL BIOL EVOL, V27, P2129, DOI 10.1093/molbev/msq102; Rocha EPC, 2004, GENOME RES, V14, P2279, DOI 10.1101/gr.2896904; Rocha EPC, 2004, MICROBIOL-SGM, V150, P1609, DOI 10.1099/mic.0.26974-0; Shah P, 2011, P NATL ACAD SCI USA, V108, P10231, DOI 10.1073/pnas.1016719108; Sharp PM, 2010, PHILOS T R SOC B, V365, P1203, DOI 10.1098/rstb.2009.0305; Sharp PM, 2005, NUCLEIC ACIDS RES, V33, P1141, DOI 10.1093/nar/gki242; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SHIELDS DC, 1988, MOL BIOL EVOL, V5, P704; Stoletzki N, 2007, MOL BIOL EVOL, V24, P374, DOI 10.1093/molbev/msl166; Supek F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-182; Supek F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001004; von Mandach C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-617; Wald N, 2012, NUCLEIC ACIDS RES, V40, P7074, DOI 10.1093/nar/gks348; Wan XF, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-19; Wang R, 2005, GENOME RES, V15, P1118, DOI 10.1101/gr.3994105; Zhang Z, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-43	60	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76177	10.1371/journal.pone.0076177	http://dx.doi.org/10.1371/journal.pone.0076177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116094	Green Submitted, gold, Green Published			2022-12-25	WOS:000325501300049
J	Ogawa, M; Okamura, T; Ishikura, S; Doi, K; Matsuzaki, H; Tanaka, Y; Ota, T; Hayakawa, K; Suzuki, H; Tsunoda, T; Sasazuki, T; Shirasawa, S				Ogawa, Masahiro; Okamura, Tadashi; Ishikura, Shuhei; Doi, Keiko; Matsuzaki, Hiroshi; Tanaka, Yoko; Ota, Takeharu; Hayakawa, Kunihiro; Suzuki, Harumi; Tsunoda, Toshiyuki; Sasazuki, Takehiko; Shirasawa, Senji			Zfat-Deficiency Results in a Loss of CD3 xi Phosphorylation with Dysregulation of ERK and Egr Activities Leading to Impaired Positive Selection	PLOS ONE			English	Article							T-CELL DEVELOPMENT; AUTOIMMUNE THYROID-DISEASE; GENOME-WIDE ASSOCIATION; THYMOCYTE DEVELOPMENT; NEGATIVE SELECTION; TCR EXPRESSION; SURVIVAL; GENES; INDUCTION; THYMUS	The human ZFAT gene was originally identified as a susceptibility gene for autoimmune thyroid disease. Mouse Zfat is a critical transcriptional regulator for primitive hematopoiesis and required for peripheral T cell homeostasis. However, its physiological roles in T cell development remain poorly understood. Here, we generated Zfat(f/f)-LckCre mice and demonstrated that T cell-specific Zfat-deletion in Zfat(f/f)-LckCre mice resulted in a reduction in the number of CD4(+)CD8(+) double-positive (DP) cells, CD4(+) single positive cells and CD8(+) single positive cells. Indeed, in Zfat(f/f)-LckCre DP cells, positive selection was severely impaired. Defects of positive selection in Zfat-deficient thymocytes were not restored in the presence of the exogenous TCR by using TCR-transgenic mice. Furthermore, Zfat-deficient DP cells showed a loss of CD3 xi phosphorylation in response to T cell antigen receptor (TCR)-stimulation concomitant with dysregulation of extracellular signal-related kinase (ERK) and early growth response protein (Egr) activities. These results demonstrate that Zfat is required for proper regulation of the TCR-proximal signalings, and is a crucial molecule for positive selection through ERK and Egr activities, thus suggesting that a full understanding of the precise molecular mechanisms of Zfat will provide deeper insight into T cell development and immune regulation.	[Ogawa, Masahiro; Ishikura, Shuhei; Doi, Keiko; Matsuzaki, Hiroshi; Tanaka, Yoko; Ota, Takeharu; Tsunoda, Toshiyuki; Shirasawa, Senji] Fukuoka Univ, Dept Cell Biol, Fac Med, Jonan Ku, Fukuoka 81401, Japan; [Ogawa, Masahiro; Ishikura, Shuhei; Doi, Keiko; Ota, Takeharu; Tsunoda, Toshiyuki; Shirasawa, Senji] Fukuoka Univ, Cent Res Inst Adv Mol Med, Jonan Ku, Fukuoka 81401, Japan; [Okamura, Tadashi] Natl Ctr Global Hlth & Med, Div Anim Models, Dept Infect Dis, Res Inst, Tokyo, Japan; [Hayakawa, Kunihiro; Suzuki, Harumi] Natl Inst Global Hlth & Med, Dept Pathol & Immunol, Chiba, Japan; [Sasazuki, Takehiko] Kyushu Univ, Inst Adv Study, Fukuoka 812, Japan	Fukuoka University; Fukuoka University; National Center for Global Health & Medicine - Japan; Kyushu University	Shirasawa, S (corresponding author), Fukuoka Univ, Dept Cell Biol, Fac Med, Jonan Ku, Fukuoka 81401, Japan.	sshirasa@fukuoka-u.ac.jp	Suzuki, Harumi/L-1271-2013	Suzuki, Harumi/0000-0003-3616-9361; HAYAKAWA, Kunihiro/0000-0002-8053-746X	Japan Society for the Promotion of the Science; Ministry of Education, Culture, Sports, Science, and Technology, Japan	Japan Society for the Promotion of the Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of the Science and a Grant-in-Aid for the FCAM from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand PK, 2012, NATURE, V488, P389, DOI 10.1038/nature11250; Baniyash M, 2004, NAT REV IMMUNOL, V4, P675, DOI 10.1038/nri1434; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Basson MA, 2000, J IMMUNOL, V165, P2444, DOI 10.4049/jimmunol.165.5.2444; Bettini M, 2002, J IMMUNOL, V169, P1713, DOI 10.4049/jimmunol.169.4.1713; Bettini ML, 2007, P NATL ACAD SCI USA, V104, P16257, DOI 10.1073/pnas.0705321104; Carpenter AC, 2010, NAT IMMUNOL, V11, P666, DOI 10.1038/ni.1887; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Comabella M, 2009, ARCH NEUROL-CHICAGO, V66, P972, DOI 10.1001/archneurol.2009.150; DeSilva DR, 1998, J IMMUNOL, V160, P4175; Doi K, 2012, BIOCHEM BIOPH RES CO, V425, P107, DOI 10.1016/j.bbrc.2012.07.065; Doi K, 2011, CELL MOL BIOL LETT, V16, P89, DOI 10.2478/s11658-010-0041-1; Falahati R, 2008, J IMMUNOL, V181, P6082, DOI 10.4049/jimmunol.181.9.6082; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Fujimoto T, 2009, FEBS LETT, V583, P568, DOI 10.1016/j.febslet.2008.12.063; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Hamrouni A, 2007, EUR J IMMUNOL, V37, P1978, DOI 10.1002/eji.200636632; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Inoue N, 2012, J CLIN IMMUNOL, V32, P1243, DOI 10.1007/s10875-012-9721-0; Koyanagi M, 2008, GENOMICS, V91, P451, DOI 10.1016/j.ygeno.2008.01.009; Lauritsen JPH, 2008, J IMMUNOL, V181, P7778, DOI 10.4049/jimmunol.181.11.7778; Lawson VJ, 2010, EUR J IMMUNOL, V40, P232, DOI 10.1002/eji.200939567; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554; McNeil LK, 2005, P NATL ACAD SCI USA, V102, P13574, DOI 10.1073/pnas.0505110102; Michie AM, 2002, SEMIN IMMUNOL, V14, P311, DOI 10.1016/S1044-5323(02)00064-7; Miyazaki M, 2005, J IMMUNOL, V174, P2507, DOI 10.4049/jimmunol.174.5.2507; Myers MD, 2006, NAT IMMUNOL, V7, P57, DOI 10.1038/ni1291; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Ramakrishna M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009983; Schnell FJ, 2005, J IMMUNOL, V175, P2270, DOI 10.4049/jimmunol.175.4.2270; Shao H, 1997, J EXP MED, V185, P731, DOI 10.1084/jem.185.4.731; Shirasawa S, 2004, HUM MOL GENET, V13, P2221, DOI 10.1093/hmg/ddh245; Slavin TP, 2011, HUM GENET, V130, P725, DOI 10.1007/s00439-011-1009-6; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stojakovic M, 2008, J IMMUNOL, V181, P6770, DOI 10.4049/jimmunol.181.10.6770; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Takeuchi F, 2009, J HUM GENET, V54, P749, DOI 10.1038/jhg.2009.99; Tsunoda T, 2010, P NATL ACAD SCI USA, V107, P14199, DOI 10.1073/pnas.1002494107; Werlen G, 2002, CURR OPIN IMMUNOL, V14, P299, DOI 10.1016/S0952-7915(02)00339-4; Xi HK, 2004, J IMMUNOL, V172, P964, DOI 10.4049/jimmunol.172.2.964	42	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76254	10.1371/journal.pone.0076254	http://dx.doi.org/10.1371/journal.pone.0076254			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098453	Green Published, gold, Green Submitted			2022-12-25	WOS:000325483600032
J	Fresia, P; Azeredo-Espin, AML; Lyra, ML				Fresia, Pablo; Azeredo-Espin, Ana Maria L.; Lyra, Mariana L.			The Phylogeographic History of the New World Screwworm Fly, Inferred by Approximate Bayesian Computation Analysis	PLOS ONE			English	Article							POPULATION-GENETICS; MITOCHONDRIAL-DNA; SPECIES DISTRIBUTIONS; CLIMATE-CHANGE; FLIES DIPTERA; SPECIATION; PATTERNS; COASTAL; MODELS; CALLIPHORIDAE	Insect pest phylogeography might be shaped both by biogeographic events and by human influence. Here, we conducted an approximate Bayesian computation (ABC) analysis to investigate the phylogeography of the New World screwworm fly, Cochliomyia hominivorax, with the aim of understanding its population history and its order and time of divergence. Our ABC analysis supports that populations spread from North to South in the Americas, in at least two different moments. The first split occurred between the North/Central American and South American populations in the end of the Last Glacial Maximum (15,300-19,000 YBP). The second split occurred between the North and South Amazonian populations in the transition between the Pleistocene and the Holocene eras (9,100-11,000 YBP). The species also experienced population expansion. Phylogenetic analysis likewise suggests this north to south colonization and Maxent models suggest an increase in the number of suitable areas in South America from the past to present. We found that the phylogeographic patterns observed in C. hominivorax cannot be explained only by climatic oscillations and can be connected to host population histories. Interestingly we found these patterns are very coincident with general patterns of ancient human movements in the Americas, suggesting that humans might have played a crucial role in shaping the distribution and population structure of this insect pest. This work presents the first hypothesis test regarding the processes that shaped the current phylogeographic structure of C. hominivorax and represents an alternate perspective on investigating the problem of insect pests.	[Fresia, Pablo] Univ Sao Paulo, Dept Entomol & Acarol, Escola Super Agr Luiz de Queiroz, Sao Paulo, Brazil; [Azeredo-Espin, Ana Maria L.] Univ Estadual Campinas, Ctr Biol Mol & Engn Genet, Sao Paulo, Brazil; [Azeredo-Espin, Ana Maria L.] Univ Estadual Campinas, Inst Biol, Sao Paulo, Brazil; [Lyra, Mariana L.] Univ Estadual Paulista, Inst Biociencias, Dept Zool, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual Paulista	Fresia, P (corresponding author), Univ Sao Paulo, Dept Entomol & Acarol, Escola Super Agr Luiz de Queiroz, Sao Paulo, Brazil.	pfresia@gmail.com	FRESIA, pablo/AGF-5679-2022; Lyra, Mariana Lucio/O-6405-2014; Espin, Ana Maria Azeredo/N-2213-2015	Lyra, Mariana Lucio/0000-0002-7863-4965; Azeredo-Espin, Ana Maria/0000-0002-9664-6791	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP [03/13598-0]; FAO/IAEA [11822/RO]; FAPESP	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAO/IAEA(International Atomic Energy Agency); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Pablo Fresia was supported by a fellowship from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES. Mariana Lucio Lyra was supported by a fellowship from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP (grant no 03/13598-0). This work was supported by grants from FAO/IAEA (11822/RO) and FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anducho-Reyes MA, 2008, MOL PHYLOGENET EVOL, V49, P930, DOI 10.1016/j.ympev.2008.09.005; Antonelli A, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P386; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Beaumont MA, 2002, GENETICS, V162, P2025; Beaumont MA, 2010, ANNU REV ECOL EVOL S, V41, P379, DOI 10.1146/annurev-ecolsys-102209-144621; Beaumont MA, 2010, MOL ECOL, V19, P436, DOI 10.1111/j.1365-294X.2009.04515.x; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Bertorelle G, 2010, MOL ECOL, V19, P2609, DOI 10.1111/j.1365-294X.2010.04690.x; Bodner M, 2012, GENOME RES, V22, P811, DOI 10.1101/gr.131722.111; Busby JR, 1991, NATURE CONSERVATION, P64, DOI DOI 10.1046/J.1365-294X.2001.01244.X; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Castoe TA, 2009, J BIOGEOGR, V36, P88, DOI 10.1111/j.1365-2699.2008.01991.x; Chan LM, 2011, MOL PHYLOGENET EVOL, V59, P523, DOI 10.1016/j.ympev.2011.01.020; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Csillery K, 2010, TRENDS ECOL EVOL, V25, P410, DOI 10.1016/j.tree.2010.04.001; Da Silva MNF, 1998, MOL ECOL, V7, P475, DOI 10.1046/j.1365-294x.1998.00276.x; Daza JM, 2010, ECOGRAPHY, V33, P343, DOI 10.1111/j.1600-0587.2010.06281.x; de Thoisy B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-278; de Vivo M, 2004, J BIOGEOGR, V31, P943, DOI 10.1111/j.1365-2699.2004.01068.x; Dick CW, 2003, AM NAT, V162, P691, DOI 10.1086/379795; Eizirik E, 2001, MOL ECOL, V10, P65, DOI 10.1046/j.1365-294X.2001.01144.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Fagundes NJR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003157; Fix AG, 2005, AM J PHYS ANTHROPOL, V128, P430, DOI 10.1002/ajpa.20230; Fresia P, 2011, J MED ENTOMOL, V48, P280, DOI 10.1603/ME10153; Garcia R., 2007, P393, DOI 10.1007/978-1-4020-6059-5_37; Guimaraes J.H., 1983, Revista Brasileira de Zoologia, V1, P239; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Haffer J, 2001, AMAZONIANA, V16, P579; He YG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044788; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Hubbe M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011105; Klassen W, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P3, DOI 10.1007/1-4020-4051-2_1; Klopfstein S, 2006, MOL BIOL EVOL, V23, P482, DOI 10.1093/molbev/msj057; Knowles LL, 2007, CURR BIOL, V17, P940, DOI 10.1016/j.cub.2007.04.033; Knowles LL, 2010, MOL ECOL, V19, P3727, DOI 10.1111/j.1365-294X.2010.04702.x; Knowles LL, 2009, ANNU REV ECOL EVOL S, V40, P593, DOI 10.1146/annurev.ecolsys.38.091206.095702; Knowles LL, 2002, MOL ECOL, V11, P2623, DOI 10.1046/j.1365-294X.2002.01637.x; Kozak KH, 2006, EVOLUTION, V60, P2604, DOI 10.1111/j.0014-3820.2006.tb01893.x; Krafsur ES, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P389, DOI 10.1007/1-4020-4051-2_14; Lande R., 2003, OXFORD SERIES ECOLOG; Liebhold AM, 2008, ANNU REV ENTOMOL, V53, P387, DOI 10.1146/annurev.ento.52.110405.091401; Loaiza JR, 2010, MOL PHYLOGENET EVOL, V57, P1341, DOI 10.1016/j.ympev.2010.09.016; Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206; Lyra ML, 2009, MED VET ENTOMOL, V23, P32, DOI 10.1111/j.1365-2915.2008.00776.x; Lyra ML, 2005, J MED ENTOMOL, V42, P589, DOI 10.1603/0022-2585(2005)042[0589:AOMDVA]2.0.CO;2; MANGAN RL, 1989, ANN ENTOMOL SOC AM, V82, P332, DOI 10.1093/aesa/82.3.332; Martino LA, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031923; Matlock RB, 2009, MED VET ENTOMOL, V23, P111, DOI 10.1111/j.1365-2915.2009.00774.x; Mendizabal I, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-213; Mirabello L, 2006, HEREDITY, V96, P311, DOI 10.1038/sj.hdy.6800805; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; Otranto D, 2006, TRENDS PARASITOL, V22, P209, DOI 10.1016/j.pt.2006.03.003; Palsboll PJ, 2007, TRENDS ECOL EVOL, V22, P11, DOI 10.1016/j.tree.2006.09.003; PARKER FD, 1993, J ECON ENTOMOL, V86, P1359, DOI 10.1093/jee/86.5.1359; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pennington RT, 2004, PHILOS T R SOC B, V359, P515, DOI 10.1098/rstb.2003.1435; Perego UA, 2010, GENOME RES, V20, P1174, DOI 10.1101/gr.109231.110; Phillips PL, 2004, J MED ENTOMOL, V41, P121, DOI 10.1603/0022-2585-41.1.121; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Quijada-Mascarenas JA, 2007, J BIOGEOGR, V34, P1296, DOI 10.1111/j.1365-2699.2007.01707.x; Rambaut A., 2007, TRACER V1 4; Ray N, 2010, MOL BIOL EVOL, V27, P337, DOI 10.1093/molbev/msp238; Roderick GK, 1996, ANNU REV ENTOMOL, V41, P325, DOI 10.1146/annurev.en.41.010196.001545; ROEHRDANZ RL, 1989, BIOCHEM GENET, V27, P551, DOI 10.1007/BF02396152; Rull V, 2008, MOL ECOL, V17, P2722, DOI 10.1111/j.1365-294X.2008.03789.x; SILVA JMC, 2002, BIOSCIENCE, V52, P225, DOI DOI 10.1641/0006-3568(2002)052[; Slatkin M, 2012, GENETICS, V191, P171, DOI 10.1534/genetics.112.139022; Streicher JW, 2009, MOL PHYLOGENET EVOL, V53, P620, DOI 10.1016/j.ympev.2009.07.011; Suarez-Seoane S, 2008, ECOL MODEL, V219, P17, DOI 10.1016/j.ecolmodel.2008.07.035; Surovell TA, 2003, CURR ANTHROPOL, V44, P580, DOI 10.1086/377651; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor DB, 1996, MED VET ENTOMOL, V10, P63, DOI 10.1111/j.1365-2915.1996.tb00083.x; Torres TT, 2009, MED VET ENTOMOL, V23, P23, DOI 10.1111/j.1365-2915.2008.00786.x; Torres T. T., 2007, P183, DOI 10.1007/978-1-4020-6059-5_16; Vanzolini P. E, 1970, Archos Zool. S. Paulo, V19, P1; Vargas-Teran M, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P629, DOI 10.1007/1-4020-4051-2_24; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wuster W, 2005, MOL ECOL, V14, P1095, DOI 10.1111/j.1365-294X.2005.02471.x; Yang NN, 2010, ANN HUM GENET, V74, P525, DOI 10.1111/j.1469-1809.2010.00608.x	97	19	21	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76168	10.1371/journal.pone.0076168	http://dx.doi.org/10.1371/journal.pone.0076168			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098436	gold, Green Published, Green Submitted			2022-12-25	WOS:000325434500047
J	White, DA; Fang, L; Chan, W; Morand, EF; Kiriazis, H; Duffy, SJ; Taylor, AJ; Dart, AM; Du, XJ; Gao, XM				White, David A.; Fang, Lu; Chan, William; Morand, Eric F.; Kiriazis, Helen; Duffy, Stephen J.; Taylor, Andrew J.; Dart, Anthony M.; Du, Xiao-Jun; Gao, Xiao-Ming			Pro-Inflammatory Action of MIF in Acute Myocardial Infarction via Activation of Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							MIGRATION INHIBITORY FACTOR; TARGETED DELETION; PLASMA-LEVELS; EXPRESSION; RECEPTOR; ELEVATION; CYTOKINE; THERAPY; RUPTURE; PROFILE	Objectives: Macrophage migration inhibitory factor (MIF), a pro-inflammatory cytokine, has been implicated in the pathogenesis of multiple inflammatory disorders. We determined changes in circulating MIF levels, explored the cellular source of MIF, and studied the role of MIF in mediating inflammatory responses following acute myocardial infarction (MI). Methods and Results: We recruited 15 patients with MI, 10 patients with stable angina and 10 healthy volunteers and measured temporal changes of MIF in plasma. Expression of MIF, matrix metalloproteinase-9 (MMP-9) and interleukin-6 (IL-6) in cultured peripheral blood mononuclear cells (PBMCs) and the media were measured by ELISA or real-time PCR. Compared to controls, plasma levels of MIF and IL-6 were significantly elevated at admission and 72 h post-MI. In contrast, expression of MIF, MMP-9 and IL-6 by PBMCs from MI patients was unchanged at admission, but significantly increased at 72 h. Addition of MIF activated cultured PBMCs by upregulating expression of inflammatory molecules and also synergistically enhanced stimulatory action of IL-1 beta which were inhibited by anti-MIF interventions. In a mouse MI model we observed similar changes in circulating MIF as seen in patients, with reciprocal significant increases in plasma MIF and reduction of MIF content in the infarct myocardium at 3 h after MI. MIF content in the infarct myocardium was restored at 72 h post-MI and was associated with robust macrophage infiltration. Further, anti-MIF intervention significantly reduced inflammatory cell infiltration and expression of monocyte chemoattractant protein-1 at 24 h and incidence of cardiac rupture in mice post-MI. Conclusion: MI leads to a rapid release of MIF from the myocardium into circulation. Subsequently MIF facilitates PBMC production of pro-inflammatory mediators and myocardial inflammatory infiltration. Attenuation of these events, and post-MI cardiac rupture, by anti-MIF interventions suggests that MIF could be a potential therapeutic target following MI.	[White, David A.; Fang, Lu; Kiriazis, Helen; Dart, Anthony M.; Du, Xiao-Jun; Gao, Xiao-Ming] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Chan, William; Duffy, Stephen J.; Taylor, Andrew J.; Dart, Anthony M.] Alfred Hosp, Dept Cardiovasc Med, Melbourne, Vic, Australia; [Morand, Eric F.] Monash Univ, Ctr Inflammatory Dis, Melbourne, Vic 3004, Australia; [White, David A.; Duffy, Stephen J.; Taylor, Andrew J.; Dart, Anthony M.; Du, Xiao-Jun] Monash Univ, Dept Med, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Gao, Xiao-Ming] Monash Univ, Dept Surg, Cent Clin Sch, Melbourne, Vic 3004, Australia	Baker Heart and Diabetes Institute; Florey Institute of Neuroscience & Mental Health; Monash University; Monash University; Monash University	Du, XJ (corresponding author), Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia.	xiao-jun.du@bakeridi.edu.au; xiaoming.gao@bakeridi.edu.au	Morand, Eric F/I-4718-2013; Morand, Eric/AAT-3259-2021	Morand, Eric F/0000-0002-9507-3338; Morand, Eric/0000-0002-9507-3338; Taylor, Andrew/0000-0001-8920-7670	National Health and Medical Research Council (NHMRC) of Australia [ID472628, ID1004235, ID47260]; Victorian Government's Operational Infrastructure Support Program; Australian National Heart Foundation [PB 10M 5481]; NHMRC of Australia Early Career Fellowship [APP1052960]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; Australian National Heart Foundation(National Heart Foundation of Australia); NHMRC of Australia Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by project grants (ID472628 to XMG, ID1004235 to XJD) and a program grant (ID47260) from National Health and Medical Research Council (NHMRC) of Australia and also supported in part by the Victorian Government's Operational Infrastructure Support Program. DW is a recipient of an Australian National Heart Foundation PhD Scholarship (PB 10M 5481). WC is supported by the NHMRC of Australia Early Career Fellowship (Neil Hamilton Fairley - Clinical Overseas Fellowship) (APP1052960). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benigni F, 2000, J CLIN INVEST, V106, P1291, DOI 10.1172/JCI9900; BULKLEY BH, 1974, AM J MED, V56, P244, DOI 10.1016/0002-9343(74)90603-2; Buratti T, 2001, INFLAMMATION, V25, P97, DOI 10.1023/A:1007166521791; Burger-Kentischer A, 2002, CIRCULATION, V105, P1561, DOI 10.1161/01.CIR.0000012942.49244.82; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Cao WG, 2005, BIOL REPROD, V73, P565, DOI 10.1095/biolreprod.104.038331; Chung ES, 2003, CIRCULATION, V107, P3133, DOI 10.1161/01.CIR.0000077913.60364.D2; Cvetkovic I, 2006, INT IMMUNOPHARMACOL, V6, P1527, DOI 10.1016/j.intimp.2006.06.009; Donnelly SC, 1997, NAT MED, V3, P320, DOI 10.1038/nm0397-320; Ducharme A, 2000, J CLIN INVEST, V106, P55, DOI 10.1172/JCI8768; Fan HP, 2011, J IMMUNOL, V186, P4915, DOI 10.4049/jimmunol.1003713; Fang L, 2010, CLIN SCI, V119, P175, DOI 10.1042/CS20100011; Faxon DP, 2002, J AM COLL CARDIOL, V40, P1199, DOI 10.1016/S0735-1097(02)02136-8; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Frantz S, 2009, CARDIOVASC RES, V81, P474, DOI 10.1093/cvr/cvn292; Gao XM, 2011, J MOL CELL CARDIOL, V50, P991, DOI 10.1016/j.yjmcc.2010.12.022; Gao XM, 2000, CARDIOVASC RES, V45, P330, DOI 10.1016/S0008-6363(99)00274-6; Gao XM, 2005, AM J PHYSIOL-HEART C, V288, pH2702, DOI 10.1152/ajpheart.00836.2004; Gao XM, 2005, CARDIOVASC RES, V65, P469, DOI 10.1016/j.cardiores.2004.10.014; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gregory JL, 2006, J IMMUNOL, V177, P8072, DOI 10.4049/jimmunol.177.11.8072; Grzybowski M, 2004, ACAD EMERG MED, V11, P1049, DOI 10.1197/j.aem.2004.06.005; Hayashidani S, 2003, AM J PHYSIOL-HEART C, V285, pH1229, DOI 10.1152/ajpheart.00207.2003; Hoi Alberta Y., 2007, Inflammation & Allergy Drug Targets, V6, P183, DOI 10.2174/187152807781696455; Koga K, 2011, ANTIOXID REDOX SIGN, V14, P1191, DOI 10.1089/ars.2010.3163; Kong YZ, 2005, ATHEROSCLEROSIS, V178, P207, DOI 10.1016/j.atherosclerosis.2004.08.030; Lindsey M, 2001, CIRCULATION, V103, P2181; Liu Y, 2011, ARTERIOSCL THROM VAS, V31, P834, DOI 10.1161/ATVBAHA.110.220467; Lu F, 2007, J MOL CELL CARDIOL, V43, P535, DOI 10.1016/j.yjmcc.2007.06.011; Maekawa Y, 2002, J AM COLL CARDIOL, V39, P241, DOI 10.1016/S0735-1097(01)01721-1; Makino A, 2010, ATHEROSCLEROSIS, V213, P573, DOI 10.1016/j.atherosclerosis.2010.09.004; Matsusaka H, 2006, CARDIOVASC RES, V70, P457, DOI 10.1016/j.cardiores.2006.02.001; Miller EJ, 2008, NATURE, V451, P578, DOI 10.1038/nature06504; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Muller II, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038376; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Qi D, 2009, J CLIN INVEST, V119, P3807, DOI 10.1172/JCI39738; Ren Guofeng, 2003, Current Drug Targets - Inflammation and Allergy, V2, P242, DOI 10.2174/1568010033484098; ROBERTS R, 1976, CIRCULATION, V53, P204; Sobierajski J, 2013, FREE RADICAL BIO MED, V63, P236, DOI 10.1016/j.freeradbiomed.2013.05.018; Takahashi M, 2001, CARDIOVASC RES, V52, P438, DOI 10.1016/S0008-6363(01)00408-4; Takahashi M, 2002, AM J CARDIOL, V89, P248, DOI 10.1016/S0002-9149(01)02251-2; Vinten-Johansen J, 2004, CARDIOVASC RES, V61, P481, DOI 10.1016/j.cardiores.2003.10.011; Webb CS, 2006, CIRCULATION, V114, P1020, DOI 10.1161/CIRCULATIONAHA.105.600353; WEISMAN HF, 1990, SCIENCE, V249, P146, DOI 10.1126/science.2371562; Yin F, 2006, J MOL CELL CARDIOL, V40, P384, DOI 10.1016/j.yjmcc.2005.12.005; Yu CM, 2003, J HISTOCHEM CYTOCHEM, V51, P625, DOI 10.1177/002215540305100508; Yu CM, 2001, AM J CARDIOL, V88, P774, DOI 10.1016/S0002-9149(01)01850-1	48	49	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76206	10.1371/journal.pone.0076206	http://dx.doi.org/10.1371/journal.pone.0076206			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098445	Green Published, gold			2022-12-25	WOS:000325427100048
J	Biondi, A; Zappala, L; Stark, JD; Desneux, N				Biondi, Antonio; Zappala, Lucia; Stark, John D.; Desneux, Nicolas			Do Biopesticides Affect the Demographic Traits of a Parasitoid Wasp and Its Biocontrol Services through Sublethal Effects?	PLOS ONE			English	Article							ABSOLUTA LEPIDOPTERA-GELECHIIDAE; PHYTOSEIULUS-PERSIMILIS ACARI; APHIDIUS-COLEMANI HYMENOPTERA; ORIUS-INSIDIOSUS HEMIPTERA; TUTA-ABSOLUTA; NATURAL ENEMIES; DEVELOPMENTAL STRATEGIES; BENEFICIAL ARTHROPODS; MULTISTEP BIOASSAY; AZADIRACHTA-INDICA	Pesticide risk assessments are usually based on short-term acute toxicity tests, while longer-term population dynamic related traits, critical to the success of biological control and Integrated Pest Management (IPM) programs, are often overlooked. This is increasingly important with respect to new biopesticides that frequently cause no short-term acute effects, but that can induce multiple physiological and behavioral sublethal effects, leading to a decrease in population growth and ecosystem services. In this study we assessed the lethal and sublethal effects of six biopesticides [abamectin, azadirachtin, Bacillus thuringiensis, borax plus citrus oil (Prev-AmH), emamectin benzoate, and spinosad], used in tomato crops to control the invasive pest Tuta absoluta (Lepidoptera: Gelechiidae), on adults and pupae of the parasitoid Bracon nigricans (Hymenoptera: Braconidae). Data on female survival and production of female offspring were used to calculate population growth indexes as a measure of population recovery after pesticide exposure. Spinosad caused 100% and 80% mortality in exposed adults (even 10 d after the treatment) and pupae, respectively. Although most of the biopesticides had low levels of acute toxicity, multiple sublethal effects were observed. The biocontrol activity of both females that survived 1h and 10-d old residues, and females that emerged from topically treated pupae was significantly affected by the application of the neurotoxic insecticides emamectin benzoate and abamectin. Furthermore, very low B. nigricans demographic growth indices were estimated for these two insecticides, indicating potential local extinction of the wasp populations. Among the tested products, Bt proved to be the safest for B. nigricans adults and pupae. Our findings emphasize that acute toxicity assessment alone cannot fully predict the actual impact of pesticides on non-target parasitoids. Thus, sublethal effects related to the species specific life-history variables must be carefully considered in order to assess pesticide risks and to incorporate new pesticides, including biopesticides, into IPM programmes.	[Biondi, Antonio; Zappala, Lucia] Univ Catania, Dept Agri Food & Environm Syst Management, Catania, Italy; [Biondi, Antonio; Desneux, Nicolas] French Natl Inst Agr Res INRA, Sophia Antipolis, France; [Stark, John D.] Washington State Univ, Puyallup Res & Extens Ctr, Dept Entomol, Puyallup, WA 98371 USA	University of Catania; INRAE; Washington State University	Biondi, A (corresponding author), Univ Catania, Dept Agri Food & Environm Syst Management, Catania, Italy.	antonio.biondi@unict.it	Zappalà, Lucia/B-9740-2014; Desneux, Nicolas/J-6262-2013; BIONDI, Antonio/I-6381-2012	Zappalà, Lucia/0000-0002-2804-3980; BIONDI, Antonio/0000-0002-1982-7716	Italian Ministry of Education, University and Research (PRIN project) [2010CXXHJE_004]; French Ministry of Agriculture (CASDAR project) [10063]; University of Catania	Italian Ministry of Education, University and Research (PRIN project)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); French Ministry of Agriculture (CASDAR project); University of Catania	This research was partially funded by the Italian Ministry of Education, University and Research (PRIN project 2010CXXHJE_004) and the French Ministry of Agriculture (CASDAR project 10063). Antonio Biondi received a PhD grant from the University of Catania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2012, J PEST SCI, V85, P359, DOI 10.1007/s10340-012-0426-1; Arno J, 2011, J PEST SCI, V84, P513, DOI 10.1007/s10340-011-0384-z; ASCHER KRS, 1993, ARCH INSECT BIOCHEM, V22, P433, DOI 10.1002/arch.940220311; Banks HT, 2007, B MATH BIOL, V69, P2139, DOI 10.1007/s11538-007-9207-z; Banks JE, 2011, BIOL CONTROL, V59, P336, DOI 10.1016/j.biocontrol.2011.09.005; Beltra A, 2013, J PEST SCI, V86, P253, DOI 10.1007/s10340-012-0475-5; Bengochea P, 2013, CHEMOSPHERE, V91, P1189, DOI 10.1016/j.chemosphere.2013.01.034; Biondi A, 2013, J ECON ENTOMOL, V106, P1638, DOI 10.1603/EC12518; Biondi A, 2012, PEST MANAG SCI, V68, P1523, DOI 10.1002/ps.3396; Biondi A, 2012, CHEMOSPHERE, V87, P803, DOI 10.1016/j.chemosphere.2011.12.082; Bostanian NJ, 2006, PEST MANAG SCI, V62, P334, DOI 10.1002/ps.1171; Bostanian NJ, 2004, PEST MANAG SCI, V60, P1231, DOI 10.1002/ps.938; Cabral S, 2011, J PEST SCI, V84, P373, DOI 10.1007/s10340-011-0373-2; Campos MR, 2011, CROP PROT, V30, P1535, DOI 10.1016/j.cropro.2011.08.013; Canale A, 2012, J PEST SCI, V85, P65, DOI 10.1007/s10340-011-0382-1; Copping LG, 2000, PEST MANAG SCI, V56, P651, DOI 10.1002/1526-4998(200008)56:8<651::AID-PS201>3.0.CO;2-U; Cordeiro EMG, 2010, CHEMOSPHERE, V81, P1352, DOI 10.1016/j.chemosphere.2010.08.021; Croft B. A., 1990, ARTHROPOD BIOL CONTR; Desneux N, 2004, PEST MANAG SCI, V60, P381, DOI 10.1002/ps.822; Desneux N, 2004, CHEMOSPHERE, V54, P619, DOI 10.1016/j.chemosphere.2003.09.007; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Desneux N, 2006, CHEMOSPHERE, V65, P1697, DOI 10.1016/j.chemosphere.2006.04.082; Desneux N, 2006, ENVIRON TOXICOL CHEM, V25, P2675, DOI 10.1897/05-562R.1; Desneux N, 2012, ECOL LETT, V15, P453, DOI 10.1111/j.1461-0248.2012.01754.x; Desneux N, 2011, J PEST SCI, V84, P403, DOI 10.1007/s10340-011-0398-6; Desneux N, 2010, J PEST SCI, V83, P197, DOI 10.1007/s10340-010-0321-6; Duso C, 2008, BIOCONTROL SCI TECHN, V18, P1027, DOI 10.1080/09583150802521251; El-Zahi ES, 2012, EGYPT J BIOL PEST CO, V22, P211; GILL SS, 1992, ANNU REV ENTOMOL, V37, P615, DOI 10.1146/annurev.en.37.010192.003151; Gontijo PC, 2013, ANN APPL BIOL, V162, P50, DOI 10.1111/aab.12000; Gonzalez-Cabrera J, 2011, BIOCONTROL, V56, P71, DOI 10.1007/s10526-010-9310-1; Han P, 2012, ECOTOXICOLOGY, V21, P2214, DOI 10.1007/s10646-012-0976-2; Haseeb M, 2002, J APPL ENTOMOL, V126, P8, DOI 10.1046/j.1439-0418.2002.00596.x; He YX, 2013, INT J BIOL SCI, V9, P246, DOI 10.7150/ijbs.5762; He YX, 2012, ECOTOXICOLOGY, V21, P1291, DOI 10.1007/s10646-012-0883-6; Heimpel GE, 2008, ANNU REV ENTOMOL, V53, P209, DOI 10.1146/annurev.ento.53.103106.093441; Hewa-Kapuge S, 2003, J ECON ENTOMOL, V96, P1083, DOI 10.1603/0022-0493-96.4.1083; Iqbal M, 1996, ENTOMOPHAGA, V41, P117, DOI 10.1007/BF02893298; Isman MB, 2000, CROP PROT, V19, P603, DOI 10.1016/S0261-2194(00)00079-X; Kawazu K, 2011, J APPL ENTOMOL, V135, P647, DOI 10.1111/j.1439-0418.2010.01596.x; Kim DS, 2006, BIOCONTROL, V51, P465, DOI 10.1007/s10526-005-1028-0; Kobori Y, 2004, APPL ENTOMOL ZOOL, V39, P255, DOI 10.1303/aez.2004.255; Mansour R, 2011, PHYTOPARASITICA, V39, P369, DOI 10.1007/s12600-011-0170-8; Marcic D, 2012, J PEST SCI, V85, P395, DOI 10.1007/s10340-012-0442-1; Molla O, 2011, BIOCONTROL, V56, P883, DOI 10.1007/s10526-011-9353-y; Nannini M, 2011, ACTA HORTIC, P47, DOI 10.17660/ActaHortic.2011.917.5; Nukenine EN, 2011, J PEST SCI, V84, P479, DOI 10.1007/s10340-011-0371-4; Pennacchio F, 2006, ANNU REV ENTOMOL, V51, P233, DOI 10.1146/annurev.ento.51.110104.151029; Pizzol J, 2012, J PEST SCI, V85, P489, DOI 10.1007/s10340-012-0434-1; Planes L, 2013, J PEST SCI, V86, P321, DOI 10.1007/s10340-012-0440-3; Rahman T, 2011, PEST MANAG SCI, V67, P993, DOI 10.1002/ps.2144; Seagraves MP, 2012, J PEST SCI, V85, P125, DOI 10.1007/s10340-011-0374-1; Stara J, 2011, J PEST SCI, V84, P25, DOI 10.1007/s10340-010-0322-5; STARK JD, 1992, J ECON ENTOMOL, V85, P1125, DOI 10.1093/jee/85.4.1125; Stark JD, 2004, P NATL ACAD SCI USA, V101, P732, DOI 10.1073/pnas.0304903101; Stark JD, 2003, ANNU REV ENTOMOL, V48, P505, DOI 10.1146/annurev.ento.48.091801.112621; Stark JD, 2007, J ECON ENTOMOL, V100, P1027, DOI 10.1603/0022-0493(2007)100[1027:IERMOP]2.0.CO;2; Sterk G, 1999, BIOCONTROL, V44, P99, DOI 10.1023/A:1009959009802; Tan Y, 2012, ECOTOXICOLOGY, V21, P1989, DOI 10.1007/s10646-012-0933-0; Tena A, 2013, ECOL ENTOMOL, V38, P278, DOI 10.1111/een.12018; Tome HVV, 2013, CROP PROT, V46, P63, DOI 10.1016/j.cropro.2012.12.021; Tropea Garzia G., 2012, Bulletin OEPP, V42, P205, DOI 10.1111/epp.2556; VAN ACTHERBERG C., 2010, SPECIES 2000 IT IS C; Vanaclocha P, 2013, J PEST SCI, V86, P329, DOI 10.1007/s10340-012-0448-8; Warton RA, 1993, ANNU REV ENTOMOL, V38, P121; Wu G, 2005, PESTIC BIOCHEM PHYS, V82, P79, DOI 10.1016/j.pestbp.2005.01.001; Zappala L, 2012, J APPL ENTOMOL, V136, P401, DOI 10.1111/j.1439-0418.2011.01662.x; Zappala L, 2012, EUR J ENTOMOL, V109, P561, DOI 10.14411/eje.2012.070; Zappala L, 2012, B INSECTOL, V65, P51	69	242	250	4	198	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76548	10.1371/journal.pone.0076548	http://dx.doi.org/10.1371/journal.pone.0076548			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098793	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500164
J	Chopra, M; Lang, I; Salzmann, S; Pachel, C; Kraus, S; Bauerlein, CA; Brede, C; Garrote, ALJ; Mattenheimer, K; Ritz, M; Schwinn, S; Graf, C; Schafer, V; Frantz, S; Einsele, H; Wajant, H; Beilhack, A				Chopra, Martin; Lang, Isabell; Salzmann, Steffen; Pachel, Christina; Kraus, Sabrina; Baeuerlein, Carina A.; Brede, Christian; Garrote, Ana-Laura Jordan; Mattenheimer, Katharina; Ritz, Miriam; Schwinn, Stefanie; Graf, Carolin; Schaefer, Viktoria; Frantz, Stefan; Einsele, Hermann; Wajant, Harald; Beilhack, Andreas			Tumor Necrosis Factor Induces Tumor Promoting and Anti-Tumoral Effects on Pancreatic Cancer via TNFR1	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; FACTOR-KAPPA-B; DUCTAL ADENOCARCINOMA; INCREASED EXPRESSION; EXPERIMENTAL METASTASIS; SIGNALING PATHWAYS; ADJUVANT TREATMENT; FACTOR RECEPTOR; T-CELLS; CARCINOMA	Multiple activities are ascribed to the cytokine tumor necrosis factor (TNF) in health and disease. In particular, TNF was shown to affect carcinogenesis in multiple ways. This cytokine acts via the activation of two cell surface receptors, TNFR1, which is associated with inflammation, and TNFR2, which was shown to cause anti-inflammatory signaling. We assessed the effects of TNF and its two receptors on the progression of pancreatic cancer by in vivo bioluminescence imaging in a syngeneic orthotopic tumor mouse model with Panc02 cells. Mice deficient for TNFR1 were unable to spontaneously reject Panc02 tumors and furthermore displayed enhanced tumor progression. In contrast, a fraction of wild type (37.5%), TNF deficient (12.5%), and TNFR2 deficient mice (22.2%) were able to fully reject the tumor within two weeks. Pancreatic tumors in TNFR1 deficient mice displayed increased vascular density, enhanced infiltration of CD4(+) T cells and CD4(+) forkhead box P3 (FoxP3)(+) regulatory T cells (T-reg) but reduced numbers of CD8(+) T cells. These alterations were further accompanied by transcriptional upregulation of IL4. Thus, TNF and TNFR1 are required in pancreatic ductal carcinoma to ensure optimal CD8(+) T cell-mediated immunosurveillance and tumor rejection. Exogenous systemic administration of human TNF, however, which only interacts with murine TNFR1, accelerated tumor progression. This suggests that TNFR1 has basically the capability in the Panc02 model to trigger pro-and anti-tumoral effects but the spatiotemporal availability of TNF seems to determine finally the overall outcome.	[Chopra, Martin; Kraus, Sabrina; Baeuerlein, Carina A.; Brede, Christian; Garrote, Ana-Laura Jordan; Mattenheimer, Katharina; Ritz, Miriam; Schwinn, Stefanie; Graf, Carolin; Einsele, Hermann; Beilhack, Andreas] Wurzburg Univ Clin, Dept Internal Med 2, Wurzburg, Germany; [Chopra, Martin; Kraus, Sabrina; Baeuerlein, Carina A.; Brede, Christian; Garrote, Ana-Laura Jordan; Mattenheimer, Katharina; Ritz, Miriam; Schwinn, Stefanie; Graf, Carolin; Beilhack, Andreas] Univ Wurzburg, Ctr Interdisciplinary Clin Res, D-97070 Wurzburg, Germany; [Lang, Isabell; Salzmann, Steffen; Schaefer, Viktoria; Wajant, Harald] Wurzburg Univ Clin, Dept Internal Med 2, Div Mol Internal Med, Wurzburg, Germany; [Pachel, Christina; Frantz, Stefan] Wurzburg Univ Clin, Dept Internal Med 1, Wurzburg, Germany; [Pachel, Christina; Frantz, Stefan] Univ Wurzburg, Comprehens Heart Failure Ctr, D-97070 Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg	Beilhack, A (corresponding author), Wurzburg Univ Clin, Dept Internal Med 2, Wurzburg, Germany.	beilhack_a@ukw.de	Wajant, Harald/A-3020-2017; Frantz, Stefan/G-1723-2012	Wajant, Harald/0000-0002-2005-3949; Kraus, Sabrina/0000-0001-8954-4220; Lang, Isabell/0000-0002-6369-4973	Interdisziplinare Zentrum fur Klinische Forschung der Universitat Wurzburg [B-149, B-233]; Deutsche Jose Carreras Leukamie-Stiftung e.V. [R/06/17]; Deutsche Forschungsgemeinschaft [SFBTR 52 Z2, Wa 1025/18-1, KFO 216 TP8, Ma 760/19-1]; Else-Kroner-Fresenius-Stiftung [2010_Kolleg.52]	Interdisziplinare Zentrum fur Klinische Forschung der Universitat Wurzburg; Deutsche Jose Carreras Leukamie-Stiftung e.V.; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else-Kroner-Fresenius-Stiftung	This work was supported by the Interdisziplinare Zentrum fur Klinische Forschung der Universitat Wurzburg [grants B-149, B-233], Deutsche Jose Carreras Leukamie-Stiftung e.V. (R/06/17), the Deutsche Forschungsgemeinschaft [grants SFBTR 52 Z2, Wa 1025/18-1, KFO 216 TP8, and Ma 760/19-1] and the Else-Kroner-Fresenius-Stiftung (2010_Kolleg.52). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariapart P, 2002, PANCREATOLOGY, V2, P491, DOI 10.1159/000064719; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Beilhack A, 2005, BLOOD, V106, P1113, DOI 10.1182/blood-2005-02-0509; Chandler NM, 2004, J SURG RES, V118, P9, DOI 10.1016/S0022-4804(03)00354-8; Chee J, 2011, J IMMUNOL, V187, P1702, DOI 10.4049/jimmunol.1100511; Chen X, 2007, J IMMUNOL, V179, P154, DOI 10.4049/jimmunol.179.1.154; Chen X, 2013, J IMMUNOL, V190, P1076, DOI 10.4049/jimmunol.1202659; Chopra M, 2013, CARCINOGENESIS, V34, P1296, DOI 10.1093/carcin/bgt038; Conroy T, 2011, CURR OPIN ONCOL, V23, P390, DOI 10.1097/CCO.0b013e3283473610; CORBETT TH, 1984, CANCER RES, V44, P717; Egberts JH, 2008, CANCER RES, V68, P1443, DOI 10.1158/0008-5472.CAN-07-5704; Fallon PG, 2002, IMMUNITY, V17, P7, DOI 10.1016/S1074-7613(02)00332-1; Franco L, 2004, PROSTAG OTH LIPID M, V73, P51, DOI 10.1016/j.prostaglandins.2003.12.001; Fujioka S, 2003, CLIN CANCER RES, V9, P346; Furukawa K, 2011, CANCER LETT, V306, P92, DOI 10.1016/j.canlet.2011.02.036; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Hafner M, 1996, INT J CANCER, V66, P388; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kawakami K, 2002, CANCER RES, V62, P3575; Li H, 2012, HEPATOLOGY, V56, P1342, DOI 10.1002/hep.25777; Maier HJ, 2010, CANCER LETT, V295, P214, DOI 10.1016/j.canlet.2010.03.003; McCleary-Wheeler AL, 2012, MOL CARCINOGEN, V51, P25, DOI 10.1002/mc.20827; Mochizuki Y, 2004, CLIN EXP METASTAS, V21, P39, DOI 10.1023/B:CLIN.0000017181.01474.35; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Muller-Hermelink N, 2008, CANCER CELL, V13, P507, DOI 10.1016/j.ccr.2008.04.001; Murugesan SR, 2009, CANCER GENE THER, V16, P841, DOI 10.1038/cgt.2009.32; Oomizu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048574; OROSZ P, 1993, J EXP MED, V177, P1391, DOI 10.1084/jem.177.5.1391; Perez-Mancera PA, 2012, GASTROENTEROLOGY, V142, P1079, DOI 10.1053/j.gastro.2012.03.002; Prokopchuk O, 2005, BRIT J CANCER, V92, P921, DOI 10.1038/sj.bjc.6602416; Roder C, 2011, EUR J CELL BIOL, V90, P450, DOI 10.1016/j.ejcb.2010.10.008; Schneider G, 2008, ANTICANCER RES, V28, P1541; Takahashi M, 2008, CARCINOGENESIS, V29, P1608, DOI 10.1093/carcin/bgn152; Tepel J, 2004, PANCREAS, V28, P1, DOI 10.1097/00006676-200401000-00001; Tepel J, 2006, PANCREATOLOGY, V6, P240, DOI 10.1159/000092027; Van Laethem JL, 2012, ANN ONCOL, V23, P570, DOI 10.1093/annonc/mdr351; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wajant H, 2009, RESULTS PROBL CELL D, V49, P1, DOI 10.1007/400_2008_26; Wang WX, 1999, CLIN CANCER RES, V5, P119	40	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75737	10.1371/journal.pone.0075737	http://dx.doi.org/10.1371/journal.pone.0075737			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098720	gold, Green Published, Green Submitted			2022-12-25	WOS:000325423500091
J	Huang, HL; Cheng, F; Wang, RA; Zhang, DB; Yang, LT				Huang, Huali; Cheng, Fang; Wang, Ruoan; Zhang, Dabing; Yang, Litao			Evaluation of Four Endogenous Reference Genes and Their Real-Time PCR Assays for Common Wheat Quantification in GMOs Detection	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; GENETICALLY-MODIFIED ORGANISMS; QUANTITATION; CHALLENGES; BARLEY; RICE	Proper selection of endogenous reference genes and their real-time PCR assays is quite important in genetically modified organisms (GMOs) detection. To find a suitable endogenous reference gene and its real-time PCR assay for common wheat (Triticum aestivum L.) DNA content or copy number quantification, four previously reported wheat endogenous reference genes and their real-time PCR assays were comprehensively evaluated for the target gene sequence variation and their real-time PCR performance among 37 common wheat lines. Three SNPs were observed in the PKABA1 and ALMT1 genes, and these SNPs significantly decreased the efficiency of real-time PCR amplification. GeNorm analysis of the real-time PCR performance of each gene among common wheat lines showed that the Waxy-D1 assay had the lowest M values with the best stability among all tested lines. All results indicated that the Waxy-D1 gene and its real-time PCR assay were most suitable to be used as an endogenous reference gene for common wheat DNA content quantification. The validated Waxy-D1 gene assay will be useful in establishing accurate and creditable qualitative and quantitative PCR analysis of GM wheat.	[Huang, Huali; Cheng, Fang; Wang, Ruoan; Zhang, Dabing; Yang, Litao] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, SJTU Bor Luh Food Safety Ctr, Natl Ctr Mol Characterizat Genetically Modified O, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Yang, LT (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, SJTU Bor Luh Food Safety Ctr, Natl Ctr Mol Characterizat Genetically Modified O, Shanghai 200030, Peoples R China.	yylltt@sjtu.edu.cn	Zhang, Dabing/AAR-6473-2020	Yang, Litao/0000-0002-4515-5722	National Transgenic Plant Special Fund 339 [2013ZX08012-003]; Shanghai Ring Star project [11QA1403300]	National Transgenic Plant Special Fund 339; Shanghai Ring Star project	This work was supported by the National Transgenic Plant Special Fund 339 (2013ZX08012-003) and Shanghai Ring Star project (11QA1403300). The funders joined the experiment design and sample collection.	Ahmed FE, 2002, TRENDS BIOTECHNOL, V20, P215, DOI 10.1016/S0167-7799(01)01920-5; Anand A, 2003, J EXP BOT, V54, P1101, DOI 10.1093/jxb/erg110; [Anonymous], 2003, OFF J EUR UNION, V46, P268; Bhalla PL, 2006, TRENDS BIOTECHNOL, V24, P305, DOI 10.1016/j.tibtech.2006.04.008; Broothaerts W, 2008, J AGR FOOD CHEM, V56, P8825, DOI 10.1021/jf801636d; Bru D, 2008, APPL ENVIRON MICROB, V74, P1660, DOI 10.1128/AEM.02403-07; Elenis DS, 2008, ANAL BIOANAL CHEM, V392, P347, DOI 10.1007/s00216-008-1868-4; Ghedira R, 2009, J AGR FOOD CHEM, V57, P9370, DOI 10.1021/jf901976a; Guo JC, 2011, ANAL CHEM, V83, P1579, DOI 10.1021/ac103266w; Hernandez M, 2005, J AGR FOOD CHEM, V53, P7003, DOI 10.1021/jf050797j; Hernandez M, 2001, J AGR FOOD CHEM, V49, P3622, DOI 10.1021/jf010173n; Iida M, 2005, J AGR FOOD CHEM, V53, P6294, DOI 10.1021/jf0505731; Jones HD, 2005, J CEREAL SCI, V41, P137, DOI 10.1016/j.jcs.2004.08.009; Klungthong C, 2010, J CLIN VIROL, V48, P91, DOI 10.1016/j.jcv.2010.03.012; Obert JC, 2004, J AGR FOOD CHEM, V52, P1375, DOI 10.1021/jf035218u; Papazova N, 2010, ANAL BIOANAL CHEM, V396, P2189, DOI 10.1007/s00216-009-3386-4; Querci M, 2010, ANAL BIOANAL CHEM, V396, P1991, DOI 10.1007/s00216-009-3237-3; Ronning SB, 2006, J AGR FOOD CHEM, V54, P682, DOI 10.1021/jf052328n; Stadhouders R, 2010, J MOL DIAGN, V12, P109, DOI 10.2353/jmoldx.2010.090035; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vautrin S, 2007, J AOAC INT, V90, P794; Wang C, 2010, J AGR FOOD CHEM, V58, P11543, DOI 10.1021/jf102092c; Xia LQ, 2012, J EXP BOT, V63, P1785, DOI 10.1093/jxb/err342; Zhang DB, 2011, J INTEGR PLANT BIOL, V53, P539, DOI 10.1111/j.1744-7909.2011.01060.x; Zhang M, 2013, ANAL CHEM, V85, P75, DOI 10.1021/ac301640p	25	5	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75850	10.1371/journal.pone.0075850	http://dx.doi.org/10.1371/journal.pone.0075850			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098735	gold, Green Published, Green Submitted			2022-12-25	WOS:000325423500106
J	Lepais, O; Muller, SD; Ben Saad-Limam, S; Benslama, M; Rhazi, L; Belouahem-Abed, D; Daoud-Bouattour, A; Gammar, AM; Ghrabi-Gammar, Z; Bacles, CFE				Lepais, Olivier; Muller, Serge D.; Ben Saad-Limam, Samia; Benslama, Mohamed; Rhazi, Laila; Belouahem-Abed, Djamila; Daoud-Bouattour, Amina; Gammar, Amor Mokhtar; Ghrabi-Gammar, Zeineb; Bacles, Cecile Fanny Emilie			High Genetic Diversity and Distinctiveness of Rear-Edge Climate Relicts Maintained by Ancient Tetraploidisation for Alnus glutinosa	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; VEGETATION HISTORY; GLACIAL REFUGIA; POPULATION HISTORY; SEED DISPERSAL; DI-MONTICCHIO; R-PACKAGE; L GAERTN; INFERENCE; ALDER	Populations located at the rear-edge of a species' distribution may have disproportionate ecological and evolutionary importance for biodiversity conservation in a changing global environment. Yet genetic studies of such populations remain rare. This study investigates the evolutionary history of North-African low latitude marginal populations of Alnus glutinosa Gaertn., a European tree species that plays a significant ecological role as a keystone of riparian ecosystems. We genotyped 551 adults from 19 populations located across North Africa at 12 microsatellite loci and applied a coalescent-based simulation approach to reconstruct the demographic and evolutionary history of these populations. Surprisingly, Moroccan trees were tetraploids demonstrating a strong distinctiveness of these populations within a species otherwise known as diploid. Best-fitting models of demographic reconstruction revealed the relict nature of Moroccan populations that were found to have withstood past climate change events and to be much older than Algerian and Tunisian populations. This study highlights the complex demographic history that can be encountered in rear-edge distribution margins that here consist of both old stable climate relict and more recent populations, distinctively diverse genetically both quantitatively and qualitatively. We emphasize the high evolutionary and conservation value of marginal rear-edge populations of a keystone riparian species in the context of on-going climate change in the Mediterranean region.	[Lepais, Olivier; Bacles, Cecile Fanny Emilie] Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland; [Lepais, Olivier] INRA, UMR 1224, St Pee Sur Nivelle, France; [Lepais, Olivier] Univ Pau & Pays Adour, UMR 1224, Anglet, France; [Muller, Serge D.] Univ Montpellier 2, CNRS, UMR 5554, Inst Sci Evolut, Montpellier, France; [Ben Saad-Limam, Samia; Daoud-Bouattour, Amina] Univ Tunis El Manar, Fac Sci Tunis, Dept Biol, Tunis, Tunisia; [Ben Saad-Limam, Samia; Daoud-Bouattour, Amina; Gammar, Amor Mokhtar; Ghrabi-Gammar, Zeineb] Univ Manouba, UR Biogeog Climatol Appl & Dynam Eros, Fac Lettres Arts & Humanites Manouba, Manouba, Tunisia; [Benslama, Mohamed] Univ Badji Mokhtar, Lab Biol Veg & Environm, Annaba, Algeria; [Rhazi, Laila] Univ Hassan II Casablanca, Fac Sci Ain Chock, Lab Ecol Aquat & Environm, Casablanca, Morocco; [Belouahem-Abed, Djamila] Inst Natl Rech Forestiere, Stn Rech, El Kala, Algeria; [Ghrabi-Gammar, Zeineb] Univ Carthage, Inst Natl Agron Tunisie, Tunis, Tunisia	University of Stirling; INRAE; Universite de Pau et des Pays de l'Adour; Universite de Pau et des Pays de l'Adour; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); Universite de la Manouba; Universite Badji Mokhtar - Annaba; Hassan II University of Casablanca; Universite de Carthage	Lepais, O (corresponding author), Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland.	olepais@st-pee.inra.fr	Lepais, Olivier/D-1849-2009; Rhazi, Laila/AAQ-1459-2020; Bacles, Cecile FE/D-3093-2010	Lepais, Olivier/0000-0002-6102-9478; Bacles, Cecile FE/0000-0002-1061-1898	Leverhulme Trust; University of Stirling Strategic Research Development Fund [ECF/2010/0166]; Natural Environmental Research Council [NE/H012435/1]; Projects Hubert Curien	Leverhulme Trust(Leverhulme Trust); University of Stirling Strategic Research Development Fund; Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Projects Hubert Curien	Molecular analyses and manuscript elaboration benefited from funding by the Leverhulme Trust (http://www.leverhulme.ac.uk/) and the University of Stirling Strategic Research Development Fund (http://www.stir.ac.uk/) in the form of a Leverhulme Early Career Fellowship ECF/2010/0166 awarded to OL and a Natural Environmental Research Council (http://www.nerc.ac.uk/) Grant NE/H012435/1 awarded to CFEB. Material collection in North Africa was funded by three Projects Hubert Curien (http://www.egide.asso.fr/jahia/Jahia/accueil/appels/phc/general) coordinated by SDM, together with SBSL, MB and LR, respectively in Tunisia (PHC Utique 07G0908), Algeria (PHC Tassili 09mdu786) and Morocco (PHC Volubilis MA/07/172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto F, 2009, J HERED, V100, P394, DOI 10.1093/jhered/esn110; [Anonymous], 2010, R LANG ENV STAT COMP; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Barthelmes A, 2006, REV PALAEOBOT PALYNO, V141, P33, DOI 10.1016/j.revpalbo.2006.04.002; Beaumont MA, 2002, GENETICS, V162, P2025; Ben Tiba B., 1982, ECOL MEDITERR, V8, P75; BENNETT KD, 1990, J QUATERNARY SCI, V5, P123, DOI 10.1002/jqs.3390050204; BENNETT KD, 1991, J BIOGEOGR, V18, P103, DOI 10.2307/2845248; Benslama M, 2010, CR BIOL, V333, P744, DOI 10.1016/j.crvi.2010.08.002; Bertorelle G, 2010, MOL ECOL, V19, P2609, DOI 10.1111/j.1365-294X.2010.04690.x; Bialozyt R, 2006, J EVOLUTION BIOL, V19, P12, DOI 10.1111/j.1420-9101.2005.00995.x; BURJACHS F, 1994, QUATERNARY RES, V42, P308, DOI 10.1006/qres.1994.1081; CHAKRABORTY R, 1993, EXS, V67, P153; Clark LV, 2011, MOL ECOL RESOUR, V11, P562, DOI 10.1111/j.1755-0998.2011.02985.x; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; DAVID F, 1993, CR ACAD SCI II, V316, P1815; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, GENETICS, V169, P1727, DOI 10.1534/genetics.104.036236; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Flagel LE, 2009, NEW PHYTOL, V183, P557, DOI 10.1111/j.1469-8137.2009.02923.x; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hampe A, 2011, ANNU REV ECOL EVOL S, V42, P313, DOI 10.1146/annurev-ecolsys-102710-145015; Hampe A, 2011, ACTA OECOL, V37, P666, DOI 10.1016/j.actao.2011.05.001; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hof C, 2011, GLOBAL CHANGE BIOL, V17, P2987, DOI 10.1111/j.1365-2486.2011.02418.x; Hofstetter S, 2006, VEG HIST ARCHAEOBOT, V15, P87, DOI 10.1007/s00334-005-0005-y; Husband BC, 1997, EVOLUTION, V51, P737, DOI [10.2307/2411150, 10.1111/j.1558-5646.1997.tb03657.x]; Johnson PCD, 2007, GENETICS, V175, P827, DOI 10.1534/genetics.106.064618; JOHNSSON H, 1950, HEREDITAS, V36, P205; Jombart T., 2010, BMC GENET, V11, P1, DOI [10.1186/1471-2156-11-94, DOI 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; King RA, 1998, MOL ECOL, V7, P1151, DOI 10.1046/j.1365-294x.1998.00432.x; Landergott U, 2006, THEOR APPL GENET, V113, P453, DOI 10.1007/s00122-006-0310-6; Lepais O, 2011, J HERED, V102, P627, DOI 10.1093/jhered/esr062; Loader CR, 1996, ANN STAT, V24, P1602; LYNCH M, 1990, MOL BIOL EVOL, V7, P478; Macaya-Sanz D, 2012, MOL ECOL, V21, P3593, DOI 10.1111/j.1365-294X.2012.05619.x; MCVEAN DN, 1953, J ECOL, V41, P447, DOI 10.2307/2257070; Medail F, 2009, J BIOGEOGR, V36, P1333, DOI 10.1111/j.1365-2699.2008.02051.x; Feliner GN, 2011, TAXON, V60, P365, DOI 10.1002/tax.602007; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parisod C, 2010, NEW PHYTOL, V186, P5, DOI 10.1111/j.1469-8137.2009.03142.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Petit RJ, 2005, TAXON, V54, P877, DOI 10.2307/25065474; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; PONS A, 1988, PALAEOGEOGR PALAEOCL, V66, P243, DOI 10.1016/0031-0182(88)90202-7; Pritchard J, 2003, DOCUMENTATION STRUCT; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2010, DOCUMENTATION STRUCT; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Rausch JH, 2005, EVOLUTION, V59, P1867; Reille M, 1997, NEW PHYTOL, V135, P547, DOI 10.1046/j.1469-8137.1997.00683.x; Reille M., 1977, B AFEQ INQUA S, V50, P53; Rodriguez-Sanchez F, 2008, QUATERNARY SCI REV, V27, P2100, DOI 10.1016/j.quascirev.2008.08.006; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Stambouli-Essassi S., 2007, Geo-Eco-Trop, V31, P171; STEBBINS GL, 1984, BOT HELV, V94, P1; Stift M, 2008, GENETICS, V179, P2113, DOI 10.1534/genetics.107.085027; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TALLANTIRE PA, 1974, NEW PHYTOL, V73, P529, DOI 10.1111/j.1469-8137.1974.tb02131.x; Thuiller W, 2008, PERSPECT PLANT ECOL, V9, P137, DOI 10.1016/j.ppees.2007.09.004; Toonen RJ, 2001, BIOTECHNIQUES, V31, P1320; Vallejo-Marin M, 2013, HEREDITY, V110, P111, DOI 10.1038/hdy.2012.91; Van Zeist W., 1975, PALAEOHISTORIA, V17, P53; Watts WA, 1996, QUATERNARY SCI REV, V15, P133, DOI 10.1016/0277-3791(95)00093-3; Watts WA, 1996, QUATERNARY SCI REV, V15, P113, DOI 10.1016/0277-3791(95)00038-0; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; WIJMSTRA TA, 1969, ACTA BOT NEERL, V18, P511, DOI 10.1111/j.1438-8677.1969.tb00591.x; Willis KJ, 2004, QUATERNARY SCI REV, V23, P2369, DOI 10.1016/j.quascirev.2004.06.002	74	42	43	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75029	10.1371/journal.pone.0075029	http://dx.doi.org/10.1371/journal.pone.0075029			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098677	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500048
J	Liao, YWK; Sun, ZH; Zhou, YH; Shi, K; Li, X; Zhang, GQ; Xia, XJ; Chen, ZX; Yu, JQ				Liao, Yang-Wen-Ke; Sun, Zeng-Hui; Zhou, Yan-Hong; Shi, Kai; Li, Xin; Zhang, Guan-Qun; Xia, Xiao-Jian; Chen, Zhi-Xiang; Yu, Jing-Quan			The Role of Hydrogen Peroxide and Nitric Oxide in the Induction of Plant-Encoded RNA-Dependent RNA Polymerase 1 in the Basal Defense against Tobacco Mosaic Virus	PLOS ONE			English	Article							SALICYLIC-ACID; ARABIDOPSIS; H2O2; CATALASE; LEVEL; GENE; TRANSCRIPTION; ACCUMULATION; GENERATION; RESISTANCE	Plant RNA-dependent RNA Polymerase 1 (RDR1) is an important element of the RNA silencing pathway in the plant defense against viruses. RDR1 expression can be elicited by viral infection and salicylic acid (SA), but the mechanisms of signaling during this process remains undefined. The involvement of hydrogen peroxide (H2O2) and nitric oxide (NO) in RDR1 induction in the compatible interactions between Tobacco mosaic tobamovirus (TMV) and Nicotiana tabacum, Nicotiana benthamiana, and Arabidopsis thaliana was examined. TMV inoculation onto the lower leaves of N. tabacum induced the rapid accumulation of H2O2 and NO followed by the increased accumulation of RDR1 transcripts in the non-inoculated upper leaves. Pretreatment with exogenous H2O2 and NO on upper leaf led to increased RDR1 expression and systemic TMV resistance. Conversely, dimethylthiourea (an H2O2 scavenger) and 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (an NO scavenger) partly blocked TMV- and SA-induced RDR1 expression and increased TMV susceptibility, whereas pretreatment with exogenous H2O2 and NO failed to diminish TMV infection in N. benthamiana plants with naturally occurring RDR1 loss-of-function. Furthermore, in N. tabacum and A. thaliana, TMV-induced H2O2 accumulation was NO-dependent, whereas NO generation was not affected by H2O2. These results suggest that, in response to TMV infection, H2O2 acts downstream of NO to mediate induction of RDR1, which plays a critical role in strengthening RNA silencing to restrict systemic viral infection.	[Liao, Yang-Wen-Ke; Sun, Zeng-Hui; Zhou, Yan-Hong; Shi, Kai; Li, Xin; Zhang, Guan-Qun; Xia, Xiao-Jian; Chen, Zhi-Xiang; Yu, Jing-Quan] Zhejiang Univ, Dept Hort, Hangzhou 310003, Zhejiang, Peoples R China; [Yu, Jing-Quan] Agr Minist China, Key Lab Hort Plants Growth Dev & Qual Improvement, Hangzhou, Zhejiang, Peoples R China; [Chen, Zhi-Xiang] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA	Zhejiang University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Shi, K (corresponding author), Zhejiang Univ, Dept Hort, Hangzhou 310003, Zhejiang, Peoples R China.	kaishi@zju.edu.cn	Yu, J.Q./C-9509-2015	Yu, J.Q./0000-0002-7626-1165	National Basic Research Program of China [2009CB119000]; National Natural Science Foundation of China [31071832]; National Key Technology R&D Program of China [2011BAD12B04, 2013AA102406]; Fundamental Research Funds for the Central Universities	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program of China(National Key Technology R&D Program); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Basic Research Program of China (2009CB119000), the National Natural Science Foundation of China (31071832), the National Key Technology R&D Program of China (2011BAD12B04, 2013AA102406) and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist P, 2002, SCIENCE, V296, P1270, DOI 10.1126/science.1069132; Asai S, 2009, MOL PLANT MICROBE IN, V22, P619, DOI 10.1094/MPMI-22-6-0619; Bright J, 2006, PLANT J, V45, P113, DOI 10.1111/j.1365-313X.2005.02615.x; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; CHEN ZX, 1993, SCIENCE, V262, P1883, DOI 10.1126/science.8266079; Clark D, 2000, MOL PLANT MICROBE IN, V13, P1380, DOI 10.1094/MPMI.2000.13.12.1380; Cui JX, 2011, PLANT CELL ENVIRON, V34, P347, DOI 10.1111/j.1365-3040.2010.02248.x; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dat JF, 1998, PLANT PHYSIOL, V116, P1351, DOI 10.1104/pp.116.4.1351; Diaz-Pendon JA, 2007, PLANT CELL, V19, P2053, DOI 10.1105/tpc.106.047449; Floryszak-Wieczorek J, 2007, NEW PHYTOL, V175, P718, DOI 10.1111/j.1469-8137.2007.02142.x; Fu LJ, 2010, MOL PLANT MICROBE IN, V23, P39, DOI 10.1094/MPMI-23-1-0039; Graves DB, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/26/263001; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Klessig DF, 2000, P NATL ACAD SCI USA, V97, P8849, DOI 10.1073/pnas.97.16.8849; Liao YWK, 2012, PLANTA, V235, P225, DOI 10.1007/s00425-011-1483-z; Lin AH, 2012, PLANT PHYSIOL, V158, P451, DOI 10.1104/pp.111.184531; Liu Y, 2009, PLANT PHYSIOL BIOCH, V47, P359, DOI 10.1016/j.plaphy.2008.12.017; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Miao Y, 2007, PLANT MOL BIOL, V65, P63, DOI 10.1007/s11103-007-9198-z; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Nakagami H, 2006, J BIOL CHEM, V281, P38697, DOI 10.1074/jbc.M605293200; OKUDA T, 1991, PLANT PHYSIOL, V97, P1265, DOI 10.1104/pp.97.3.1265; Pasqualini S, 2009, NEW PHYTOL, V181, P860, DOI 10.1111/j.1469-8137.2008.02711.x; Plasterk RHA, 2002, SCIENCE, V296, P1263, DOI 10.1126/science.1072148; Qi XP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004971; Qu F, 2010, MOL PLANT MICROBE IN, V23, P1248, DOI 10.1094/MPMI-06-10-0124; Rakhshandehroo F, 2012, J PHYTOPATHOL, V160, P187, DOI 10.1111/j.1439-0434.2012.01882.x; Schiebel W, 1998, PLANT CELL, V10, P2087, DOI 10.1105/tpc.10.12.2087; Siddiqui SA, 2008, MOL PLANT MICROBE IN, V21, P178, DOI 10.1094/MPMI-21-2-0178; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Wendehenne D, 2004, CURR OPIN PLANT BIOL, V7, P449, DOI 10.1016/j.pbi.2004.04.002; Willekens H, 1997, EMBO J, V16, P4806, DOI 10.1093/emboj/16.16.4806; Xie ZX, 2001, P NATL ACAD SCI USA, V98, P6516, DOI 10.1073/pnas.111440998; Yang SJ, 2004, P NATL ACAD SCI USA, V101, P6297, DOI 10.1073/pnas.0304346101; Ying XB, 2010, PLANT CELL, V22, P1358, DOI 10.1105/tpc.109.072058; Yu DQ, 2003, MOL PLANT MICROBE IN, V16, P206, DOI 10.1094/MPMI.2003.16.3.206; Zhang X, 2001, PLANT PHYSIOL, V126, P1438, DOI 10.1104/pp.126.4.1438; Zhou BY, 2005, J EXP BOT, V56, P3223, DOI 10.1093/jxb/eri319; Zottini M, 2007, J EXP BOT, V58, P1397, DOI 10.1093/jxb/erm001	41	33	33	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76090	10.1371/journal.pone.0076090	http://dx.doi.org/10.1371/journal.pone.0076090			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098767	Green Published, gold, Green Submitted			2022-12-25	WOS:000325423500137
J	Weis, AJ; Huxlin, KR; Callan, CL; DeMagistris, MA; Hindman, HB				Weis, Adam J.; Huxlin, Krystel R.; Callan, Christine L.; DeMagistris, Margaret A.; Hindman, Holly B.			Keratocyte Apoptosis and Not Myofibroblast Differentiation Mark the Graft/Host Interface at Early Time-Points Post-DSAEK in a Cat Model	PLOS ONE			English	Article							STRIPPING ENDOTHELIAL KERATOPLASTY; POSTERIOR LAMELLAR KERATOPLASTY; OPTICAL COHERENCE TOMOGRAPHY; LASER CONFOCAL MICROSCOPY; SMOOTH MUSCLE ACTIN; PHOTOREFRACTIVE KERATECTOMY; CORNEAL WOUNDS; VISUAL-ACUITY; LIGHT-SCATTERING; HAZE DEVELOPMENT	Purpose: To evaluate myofibroblast differentiation as an etiology of haze at the graft-host interface in a cat model of Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK). Methods: DSAEK was performed on 10 eyes of 5 adult domestic short-hair cats. In vivo corneal imaging with slit lamp, confocal, and optical coherence tomography (OCT) were performed twice weekly. Cats were sacrificed and corneas harvested 4 hours, and 2, 4, 6, and 9 days post-DSAEK. Corneal sections were stained with the TUNEL method and immunohistochemistry was performed for a-smooth muscle actin (alpha-SMA) and fibronectin with DAPI counterstain. Results: At all in vivo imaging time-points, corneal OCT revealed an increase in backscatter of light and confocal imaging revealed an acellular zone at the graft-host interface. At all post-mortem time-points, immunohistochemistry revealed a complete absence of alpha-SMA staining at the graft-host interface. At 4 hours, extracellular fibronectin staining was identified along the graft-host interface and both fibronectin and TUNEL assay were positive within adjacent cells extending into the host stroma. By day 2, fibronectin and TUNEL staining diminished and a distinct acellular zone was present in the region of previously TUNEL-positive cells. Conclusions: OCT imaging consistently showed increased reflectivity at the graft-host interface in cat corneas in the days post-DSAEK. This was not associated with myofibroblast differentiation at the graft-host interface, but rather with apoptosis and the development of a subsequent acellular zone. The roles of extracellular matrix changes and keratocyte cell death and repopulation should be investigated further as potential contributors to the interface optical changes.	[Weis, Adam J.] Univ Rochester Sch Med & Dent, Rochester, NY USA; [Huxlin, Krystel R.; Callan, Christine L.; DeMagistris, Margaret A.; Hindman, Holly B.] Univ Rochester Med Ctr, Flaum Eye Inst, Rochester, NY USA; [Huxlin, Krystel R.; Hindman, Holly B.] Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA	University of Rochester; University of Rochester; University of Rochester	Hindman, HB (corresponding author), Univ Rochester Med Ctr, Flaum Eye Inst, Rochester, NY USA.	holly_hindman@urmc.rochester.edu		Huxlin, Krystel/0000-0001-7138-6156	Research to Prevent Blindness; CTSI [5 TL1 RR024135-05]; University of Rochester CTSA from the National Center for Research Resources [L1 RR024135]; National Center for Advancing Translational Sciences of the National Institutes of Health;  [K23EY019353];  [K23EY019353-01S1];  [EY015836]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000096] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024135] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015836, P30EY001319, K23EY019353] Funding Source: NIH RePORTER	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); CTSI; University of Rochester CTSA from the National Center for Research Resources; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Grant Support: K23EY019353 (HBH) K23EY019353-01S1 (HBH), EY015836 (KRH), Research to Prevent Blindness, CTSI grant 5 TL1 RR024135-05 (AJW, PI - Thomas A. Pearson, Director of CTSI, Rochester, NY). Funding acknowledgment: The project described in this publication was supported by the University of Rochester CTSA award number TL1 RR024135 from the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed KA, 2010, AM J OPHTHALMOL, V150, P490, DOI 10.1016/j.ajo.2010.05.011; BAHN CF, 1982, INVEST OPHTH VIS SCI, V22, P73; BAHN CF, 1982, OPHTHALMOLOGY, V89, P687; Baratz KH, 2012, ARCH OPHTHALMOL-CHIC, V130, P868, DOI 10.1001/archophthalmol.2012.73; Brunette I, 2011, VET OPHTHALMOL, V14, P365, DOI 10.1111/j.1463-5224.2011.00886.x; Buhren J, 2009, INVEST OPHTH VIS SCI, V50, P634, DOI 10.1167/iovs.08-2277; Caldwell MC, 2009, AM J OPHTHALMOL, V148, P277, DOI 10.1016/j.ajo.2009.03.025; Chaurasia SS, 2009, EXP EYE RES, V89, P133, DOI 10.1016/j.exer.2009.02.022; Chen J, 2007, CLIN EXP OPTOM, V90, P317, DOI 10.1111/j.1444-0938.2007.00151.x; COHEN KL, 1990, CURR EYE RES, V9, P445, DOI 10.3109/02713689008999610; Dawson DG, 2005, ARCH OPHTHALMOL-CHIC, V123, P741, DOI 10.1001/archopht.123.6.741; DESMOULIERE A, 1992, EXP CELL RES, V201, P64, DOI 10.1016/0014-4827(92)90348-C; DESMOULIERE A, 1992, LAB INVEST, V67, P716; Ferrari G, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-32; Fini ME, 1999, PROG RETIN EYE RES, V18, P529, DOI 10.1016/S1350-9462(98)00033-0; GIPSON IK, 1993, INT OPHTHALMOL CLIN, V33, P149; HABIB MS, 1995, ARCH OPHTHALMOL-CHIC, V113, P499, DOI 10.1001/archopht.1995.01100040121037; Hassell JR, 2010, EXP EYE RES, V91, P326, DOI 10.1016/j.exer.2010.06.021; Haydari MN, 2012, INVEST OPHTH VIS SCI, V53, P6343, DOI 10.1167/iovs.12-9708; Hindman HB, 2013, CORNEA IN PRESS; Hindman HB, 2007, OPHTHALMOLOGY, V114, P2006, DOI 10.1016/j.ophtha.2007.01.009; HUANG PT, 1989, INVEST OPHTH VIS SCI, V30, P1794; Hughes A., 1977, HDB SENSORY PHYSL, V7/5; Ivarsen A, 2005, CURR EYE RES, V30, P363, DOI 10.1080/02713680590964848; Ivarsen A, 2003, BRIT J OPHTHALMOL, V87, P1272, DOI 10.1136/bjo.87.10.1272; Jester JV, 2012, INVEST OPHTH VIS SCI, V53, P770, DOI 10.1167/iovs.11-9092; JESTER JV, 1987, AM J PATHOL, V127, P140; Jester JV, 1999, INVEST OPHTH VIS SCI, V40, P1959; Jester JV, 1999, PROG RETIN EYE RES, V18, P311, DOI 10.1016/S1350-9462(98)00021-4; Kapur R, 2006, CORNEA, V25, P851, DOI 10.1097/01.ico.0000214223.13615.ff; KLOUCEK F., 1966, FOLIA MORPHOL, V14, P200; Kobayashi A, 2008, AM J OPHTHALMOL, V145, P977, DOI 10.1016/j.ajo.2008.02.009; Landry H, 2011, INVEST OPHTH VIS SCI, V52, P2279, DOI 10.1167/iovs.10-6187; Li JY, 2012, OPHTHALMOLOGY, V119, P1126, DOI 10.1016/j.ophtha.2011.12.037; Lord RK, 2006, CORNEA, V25, P1093, DOI 10.1097/01.ico.0000230322.21332.20; LUTTRULL JK, 1985, INVEST OPHTH VIS SCI, V26, P1449; MAURICE DM, 1957, J PHYSIOL-LONDON, V136, P263, DOI 10.1113/jphysiol.1957.sp005758; McCally RL, 2007, INVEST OPHTH VIS SCI, V48, P157, DOI 10.1167/iovs.06-0935; McLaren JW, 2009, AM J OPHTHALMOL, V147, P959, DOI 10.1016/j.ajo.2008.12.039; Meek KM, 2003, EYE, V17, P927, DOI 10.1038/sj.eye.6700574; Melles GRJ, 1998, CORNEA, V17, P618, DOI 10.1097/00003226-199811000-00010; Moller-Pedersen T, 1998, INVEST OPHTH VIS SCI, V39, P487; Moller-Pedersen T, 2000, OPHTHALMOLOGY, V107, P1235, DOI 10.1016/S0161-6420(00)00142-1; Moller-Pedersen T, 1998, CURR EYE RES, V17, P736, DOI 10.1076/ceyr.17.7.736.5163; Nagy LJ, 2007, J CATARACT REFR SURG, V33, P1051, DOI 10.1016/j.jcrs.2007.02.021; Ohno K, 2002, CRYOBIOLOGY, V44, P142, DOI 10.1016/S0011-2240(02)00016-0; Ohno K, 2002, INVEST OPHTH VIS SCI, V43, P1025; Pantanelli SM, 2012, INVEST OPHTH VIS SCI, V53, P4797, DOI 10.1167/iovs.12-10003; Patel SV, 2009, ARCH OPHTHALMOL-CHIC, V127, P153, DOI 10.1001/archophthalmol.2008.581; Ramos JLB, 2009, CLIN EXP OPHTHALMOL, V37, P81, DOI 10.1111/j.1442-9071.2008.01823.x; Seery LS, 2011, AM J OPHTHALMOL, V152, P910, DOI 10.1016/j.ajo.2011.05.003; Shinton AJ, 2012, BRIT J OPHTHALMOL, V96, P246, DOI 10.1136/bjophthalmol-2011-300462; Short BG, 2008, TOXICOL PATHOL, V36, P49, DOI 10.1177/0192623307310955; Stramer BM, 2003, INVEST OPHTH VIS SCI, V44, P4237, DOI 10.1167/iovs.02-1188; Telfair WB, 2000, J REFRACT SURG, V16, P32; Terry MA, 2012, OPHTHALMOLOGY, V119, P1988, DOI 10.1016/j.ophtha.2012.05.021; Tripoli N K, 1992, Refract Corneal Surg, V8, P196; Uchino Y, 2011, CORNEA, V30, P287, DOI 10.1097/ICO.0b013e3181eeafd6; van der Meulen IJE, 2012, CORNEA, V31, P380, DOI 10.1097/ICO.0b013e31823f8ab7; van der Meulen IJE, 2011, ARCH OPHTHALMOL-CHIC, V129, P1537, DOI 10.1001/archophthalmol.2011.247; VANHORN DL, 1977, INVEST OPHTH VIS SCI, V16, P597; Wilson SE, 2000, CORNEA, V19, pS7, DOI 10.1097/00003226-200005001-00003; Wilson SE, 2003, EXP EYE RES, V76, P193, DOI 10.1016/S0014-4835(02)00277-4; Wilson SE, 2007, EXP EYE RES, V85, P305, DOI 10.1016/j.exer.2007.06.009; Woodward MA, 2012, CORNEA; Zaniolo K, 2006, INVEST OPHTH VIS SCI, V47, P4199, DOI 10.1167/iovs.06-0176; Zhang CR, 2008, CLIN OPHTHALMOL, V2, P217	67	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75623	10.1371/journal.pone.0075623	http://dx.doi.org/10.1371/journal.pone.0075623			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098706	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500077
J	Yin, HY; Guo, Y; Zeng, T; Zhao, XL; Xie, KQ				Yin, Hongyin; Guo, Ying; Zeng, Tao; Zhao, Xiulan; Xie, Keqin			Correlation between Levels of 2, 5-Hexanedione and Pyrrole Adducts in Tissues of Rats Exposure to n-Hexane for 5-Days	PLOS ONE			English	Article							PROTEIN CROSS-LINKING; MOLECULAR PATHOGENESIS; URINARY-EXCRETION; INHALATION EXPOSURE; 2,5-HEXANEDIONE; METABOLITES; NEUROTOXICITY; BINDING; AUTOXIDATION; INHIBITION	Background: The formation of pyrrole adducts might be responsible for peripheral nerve injury caused by n-hexane. The internal dose of pyrrole adducts would supply more information for the neurotoxicity of n-hexane. The current study was designed to investigate the tissue distributions of 2, 5-hexanedione (2,5-HD) and pyrrole adducts in rats exposed to n-hexane, and analyze the correlation between pyrrole adducts and 2,5-HD in tissues. Methods: Male Wistar rats were given daily dose of 500,1000, 2000, 4000 mg/kg bw n-hexane by gavage for 5 days. The rats were sacrificed 24 hours after the last administration. The levels of 2, 5-hexanedione and pyrrole adducts in tissues were measured by gas chromatography and Ehrlich's reagent, respectively. The correlations between 2, 5-hexanedione and pyrrole adducts were analyzed by linear regression Results: Dose-dependent effects were observed between the dosage of n-hexane and 2, 5-hexanedione, and pyrrole adducts in tissues. The highest level of 2, 5-hexanedione was found in urine and the lowest in sciatic nerve, while the highest level of pyrrole adducts was seen in liver and the lowest in serum. There were significant correlations among the free 2, 5-hexanedione, total 2, 5-hexanedione and pyrrole adducts within the same tissues. Pyrrole adducts in serum showed the most significant correlation with free 2, 5-hexanedione or pyrrole adducts in tissues. Conclusion: The findings suggested that pyrrole adducts in serum might be a better indicator for the internal dose of free 2, 5-hexanedione and pyrrole adducts in tissues.	[Yin, Hongyin; Guo, Ying; Zeng, Tao; Zhao, Xiulan; Xie, Keqin] Shandong Univ, Inst Toxicol, Sch Publ Hlth, Jinan 250100, Shandong, Peoples R China; [Yin, Hongyin] Jinan Municipal Ctr Dis Control & Prevent, Jinan, Shandong, Peoples R China	Shandong University	Xie, KQ (corresponding author), Shandong Univ, Inst Toxicol, Sch Publ Hlth, Jinan 250100, Shandong, Peoples R China.	keqinx@sdu.edu.cn			Doctoral Fund of Ministry of Education of China [20120131110058]	Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	This research was supported by grants from Doctoral Fund of Ministry of Education of China (20120131110058). http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/2012/12/1354173228937804.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER TS, 1981, TOXICOL APPL PHARM, V61, P414, DOI 10.1016/0041-008X(81)90364-1; Bus J S, 1982, Fundam Appl Toxicol, V2, P226, DOI 10.1016/S0272-0590(82)80031-6; BUS JS, 1979, TOXICOL APPL PHARM, V51, P295, DOI 10.1016/0041-008X(79)90472-1; BUS JS, 1981, DRUG METAB DISPOS, V9, P386; COURI D, 1982, ANNU REV PHARMACOL, V22, P145, DOI 10.1146/annurev.pa.22.040182.001045; CROSBIE SJ, 1994, BIOCHEM SOC T, V22, pS130, DOI 10.1042/bst022130s; DeCaprio AP, 2009, J TOXICOL ENV HEAL A, V72, P861, DOI 10.1080/15287390902959508; DECAPRIO AP, 1982, TOXICOL APPL PHARM, V65, P440, DOI 10.1016/0041-008X(82)90389-1; DECAPRIO AP, 1983, TOXICOL APPL PHARM, V68, P297, DOI 10.1016/0041-008X(83)90014-5; DECAPRIO AP, 1988, TOXICOL APPL PHARM, V92, P75, DOI 10.1016/0041-008X(88)90229-3; DECAPRIO AP, 1987, NEUROTOXICOLOGY, V8, P199; DECAPRIO AP, 1986, MOL PHARMACOL, V30, P452; dos Santos CR, 2002, J CHROMATOGR B, V778, P237, DOI 10.1016/S1570-0232(02)00036-3; FEDTKE N, 1986, INT ARCH OCC ENV HEA, V57, P149, DOI 10.1007/BF00381383; GRAHAM DG, 1980, J TOXICOL ENV HEALTH, V6, P621, DOI 10.1080/15287398009529880; GRAHAM DG, 1982, NEUROBEH TOXICOL TER, V4, P629; GRAHAM DG, 1982, TOXICOL APPL PHARM, V64, P415, DOI 10.1016/0041-008X(82)90237-X; IWATA M, 1983, INT ARCH OCC ENV HEA, V53, P1, DOI 10.1007/BF00406172; KAWAI T, 1991, INT ARCH OCC ENV HEA, V63, P285, DOI 10.1007/BF00386379; KESSLER W, 1990, ARCH TOXICOL, V64, P242, DOI 10.1007/BF02010731; Manini P, 1999, TOXICOL LETT, V108, P225, DOI 10.1016/S0378-4274(99)00093-4; Mateus ML, 2002, NEUROTOXICOLOGY, V23, P747, DOI 10.1016/S0161-813X(02)00011-6; MATTOCKS AR, 1970, ANAL BIOCHEM, V38, P529, DOI 10.1016/0003-2697(70)90478-1; PERBELLINI L, 1979, INT ARCH OCC ENV HEA, V42, P349, DOI 10.1007/BF00377790; Perbellini L, 1981, Ann Ist Super Sanita, V17, P615; PERBELLINI L, 1993, INT ARCH OCC ENV HEA, V65, P49, DOI 10.1007/BF00586058; PERBELLINI L, 1981, BRIT J IND MED, V38, P20; PERBELLINI L, 1982, ARCH TOXICOL, V50, P203, DOI 10.1007/BF00310852; SANZ P, 1995, TOXICOL IN VITRO, V9, P783, DOI 10.1016/0887-2333(95)00017-3; SCHAUMBURG HH, 1976, BRAIN, V99, P183, DOI 10.1093/brain/99.2.183; Song FY, 2008, BIOCHEM PHARMACOL, V75, P737, DOI 10.1016/j.bcp.2007.10.001; Soriano T, 1996, HUM EXP TOXICOL, V15, P497, DOI 10.1177/096032719601500607; STCLAIR MBG, 1988, CHEM RES TOXICOL, V1, P179, DOI 10.1021/tx00003a009; ZHU MS, 1995, CHEM RES TOXICOL, V8, P764, DOI 10.1021/tx00047a017; ZHU MS, 1994, CHEM RES TOXICOL, V7, P551, DOI 10.1021/tx00040a011	35	21	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76011	10.1371/journal.pone.0076011	http://dx.doi.org/10.1371/journal.pone.0076011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098756	gold, Green Published, Green Submitted			2022-12-25	WOS:000325423500126
J	Yu, ACL; Abrego-Collier, C; Sonderegger, M				Yu, Alan C. L.; Abrego-Collier, Carissa; Sonderegger, Morgan			Phonetic Imitation from an Individual-Difference Perspective: Subjective Attitude, Personality and "Autistic" Traits	PLOS ONE			English	Article							SPECTRUM QUOTIENT AQ; VOICE-ONSET-TIME; SPEECH-PERCEPTION; WORKING-MEMORY; FUNCTIONING AUTISM; TALKER DIFFERENCES; EMPATHY QUOTIENT; COGNITIVE STYLES; CONVERGENCE; ATTENTION	Numerous studies have documented the phenomenon of phonetic imitation: the process by which the production patterns of an individual become more similar on some phonetic or acoustic dimension to those of her interlocutor. Though social factors have been suggested as a motivator for imitation, few studies has established a tight connection between language-external factors and a speaker's likelihood to imitate. The present study investigated the phenomenon of phonetic imitation using a within-subject design embedded in an individual-differences framework. Participants were administered a phonetic imitation task, which included two speech production tasks separated by a perceptual learning task, and a battery of measures assessing traits associated with Autism-Spectrum Condition, working memory, and personality. To examine the effects of subjective attitude on phonetic imitation, participants were randomly assigned to four experimental conditions, where the perceived sexual orientation of the narrator (homosexual vs. heterosexual) and the outcome (positive vs. negative) of the story depicted in the exposure materials differed. The extent of phonetic imitation by an individual is significantly modulated by the story outcome, as well as by the participant's subjective attitude toward the model talker, the participant's personality trait of openness and the autistic-like trait associated with attention switching.	[Yu, Alan C. L.; Abrego-Collier, Carissa] Univ Chicago, Dept Linguist, Phonol Lab, Chicago, IL 60637 USA; [Sonderegger, Morgan] McGill Univ, Dept Linguist, Montreal, PQ, Canada	University of Chicago; McGill University	Yu, ACL (corresponding author), Univ Chicago, Dept Linguist, Phonol Lab, Chicago, IL 60637 USA.	aclyu@uchicago.edu		Sonderegger, Morgan/0000-0001-7675-2370				Abdelli-Beruh NB, 2004, PHONETICA, V61, P201, DOI 10.1159/000084158; Abrego-Collier C., 2011, ICPHS, P192; Allen JS, 2003, J ACOUST SOC AM, V113, P544, DOI 10.1121/1.1528172; [Anonymous], 2017, MULTILEVEL ANAL TECH, DOI DOI 10.4324/9781315650982; AUSBURN LJ, 1978, ECTJ-EDUC COMMUN TEC, V26, P337; Austin EJ, 2005, PERS INDIV DIFFER, V38, P451, DOI 10.1016/j.paid.2004.04.022; Babel M., 2009, THESIS U CALIFORNIA; Babel M, 2012, J PHONETICS, V40, P177, DOI 10.1016/j.wocn.2011.09.001; Babel M, 2010, LANG SOC, V39, P437, DOI 10.1017/S0047404510000400; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D., 2011, PACKAGE LME4 LINEAR; BELSLEY D. A, 1980, REGRESSION DIAGNOSTI; Benor Sarah., 2001, PENN WORKING PAPERS, V7, P1; BOERSMA P, 2007, PRAAT; Bonnel A, 2003, J COGNITIVE NEUROSCI, V15, P226, DOI 10.1162/089892903321208169; Bourhis R. Y., 1977, LANGUAGE ETHNICITY I, P119; Bucholtz Mary, 2001, J LINGUIST ANTHROPOL, V11, P84, DOI DOI 10.1525/JLIN.2001.11.1.84; Cheshire Jenny, 2008, SOCIOLINGUISTICA, V22, P1, DOI DOI 10.1515/9783484605299.1; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; CONWAY ARA, 1994, J EXP PSYCHOL GEN, V123, P354, DOI 10.1037/0096-3445.123.4.354; Delvaux V, 2007, PHONETICA, V64, P145, DOI 10.1159/000107914; Dijksterhuis A, 2001, ADV EXP SOC PSYCHOL, V33, P1, DOI 10.1016/S0065-2601(01)80003-4; Eckert P, 2008, J SOCIOLING, V12, P453, DOI 10.1111/j.1467-9841.2008.00374.x; Ettlinger M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00211; Fischer E, 2010, J COMMUN DISORD, V43, P21, DOI 10.1016/j.jcomdis.2009.07.004; Flemming E., 2004, PHONETIC BASES MARKE, P232, DOI DOI 10.1017/CBO9780511486401; Flemming E, 2001, AUDITORY REPRESENTAT; Francis AL, 2002, J EXP PSYCHOL HUMAN, V28, P349, DOI 10.1037//0096-1523.28.2.349; Francis AL, 2009, ATTEN PERCEPT PSYCHO, V71, P1360, DOI 10.3758/APP.71.6.1360; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; GILES H, 1973, ANTHROPOL LINGUIST, V15, P87; Giles H, 1991, LANGUAGE CONTEXTS CO; Giles Howard, 1973, LANG SOC, V2, P177, DOI [10.1017/S0047404500000701, DOI 10.1017/S0047404500000701]; Goldinger SD, 1998, PSYCHOL REV, V105, P251, DOI 10.1037/0033-295X.105.2.251; Goldinger SD, 2003, J PHONETICS, V31, P305, DOI 10.1016/S0095-4470(03)00030-5; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; Happe F, 2001, J CHILD PSYCHOL PSYC, V42, P299, DOI 10.1111/1469-7610.00723; Harald Baayen R., 1996, CELEX2; Hay J, 2006, J PHONETICS, V34, P458, DOI 10.1016/j.wocn.2005.10.001; Jaffe J., 1970, RHYTHMS DIALOGUE, V8; John O, 1991, BIG 5 INVENTORY VERS; John O.P., 2008, PARADIGM SHIFT INTEG, V3rd ed., P114, DOI DOI 10.1016/S0191-8869(97)81000-8; Johnson K., 1997, TALKER VARIABILITY S, P146; Kane MJ, 2001, J EXP PSYCHOL GEN, V130, P169, DOI 10.1037/0096-3445.130.2.169; Kim Midam, 2011, Lab Phonol, V2, P125; Kirby J., 2013, ORIGINS SOUND CHANGE, P228, DOI [10.1093/acprof:oso/9780199573745.003.0011, DOI 10.1093/ACPROF:OSO/9780199573745.003.0011]; LABOV W, 1963, WORD, V19, P273, DOI 10.1080/00437956.1963.11659799; Lewandowski N, 2007, COGNITIVE SCI 2007; LISKER L, 1964, WORD, V20, P384, DOI 10.1080/00437956.1964.11659830; Lubowicz A., 2003, THESIS U MASSACHUSET; MacDonald MC, 2002, PSYCHOL REV, V109, P35, DOI 10.1037//0033-295X.109.1.35; Messick S., 1976, INDIVIDUALITY LEARNI; MILLER JL, 1986, PHONETICA, V43, P106, DOI 10.1159/000261764; Misyak JB, 2012, LANG LEARN, V62, P302, DOI 10.1111/j.1467-9922.2010.00626.x; Mitterer H, 2008, COGNITION, V109, P168, DOI 10.1016/j.cognition.2008.08.002; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; Namy LL, 2002, J LANG SOC PSYCHOL, V21, P422, DOI 10.1177/026192702237958; NATALE M, 1975, J PERS SOC PSYCHOL, V32, P790, DOI 10.1037/0022-3514.32.5.790; Nettle D, 2007, BRIT J PSYCHOL, V98, P237, DOI 10.1348/000712606X117612; Nielsen K, 2008, THESIS UCLA; Nielsen K. Y., 2007, P 16 INT C PHON SCI, P1961; Nielsen K, 2011, J PHONETICS, V39, P132, DOI 10.1016/j.wocn.2010.12.007; Pardo JS, 2010, ATTEN PERCEPT PSYCHO, V72, P2254, DOI 10.3758/APP.72.8.2254; Pardo JS, 2006, J ACOUST SOC AM, V119, P2382, DOI 10.1121/1.2178720; Pickering MJ, 2004, BEHAV BRAIN SCI, V27, P169; Podesva RJ, LANGUAGE VA IN PRESS; Podesva RJ, 2007, J SOCIOLING, V11, P478, DOI 10.1111/j.1467-9841.2007.00334.x; PRATTO F, 1991, J PERS SOC PSYCHOL, V61, P380, DOI 10.1037/0022-3514.61.3.380; Shockley K, 2004, PERCEPT PSYCHOPHYS, V66, P422, DOI 10.3758/BF03194890; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Sonderegger M, 2012, THESIS U CHICAGO; Stewart ME, 2008, COGNITION, V109, P157, DOI 10.1016/j.cognition.2008.07.010; Stuart-Smith J, 2009, LANGUAGE IDENTITIES, P39; Summerfield Q., 1975, SPEECH PERC, V2, P61; Theodore RM, 2009, J ACOUST SOC AM, V125, P3974, DOI 10.1121/1.3106131; Unsworth N, 2005, BEHAV RES METHODS, V37, P498, DOI 10.3758/BF03192720; Wakabayashi A, 2006, PERS INDIV DIFFER, V41, P873, DOI 10.1016/j.paid.2006.04.003; Webb JT, 1970, STUDIES DYADIC COMMU, P115; Wheelwright S, 2006, BRAIN RES, V1079, P47, DOI 10.1016/j.brainres.2006.01.012; WITKIN HA, 1977, REV EDUC RES, V47, P1; Yu A. C. L., 2011, P INT C PHON SCI 17, P2236; Yu Alan, 2013, ORIGINS SOUND CHANGE, P201, DOI DOI 10.1093/ACPROF:OSO/9780199573745.003.0010; Yu ACL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011950; Yuan J, 2008, J ACOUST SOC AM, V124, P2078, DOI 10.1121/1.2968700	86	66	66	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74746	10.1371/journal.pone.0074746	http://dx.doi.org/10.1371/journal.pone.0074746			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231NL	24098665	Green Submitted, Green Published, gold			2022-12-25	WOS:000325423500036
J	Ricketson, LJ; Nettel-Aguirre, A; Vanderkooi, OG; Laupland, KB; Kellner, JD				Ricketson, Leah J.; Nettel-Aguirre, Alberto; Vanderkooi, Otto G.; Laupland, Kevin B.; Kellner, James D.			Factors Influencing Early and Late Mortality in Adults with Invasive Pneumococcal Disease in Calgary, Canada: A Prospective Surveillance Study	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; STREPTOCOCCUS-PNEUMONIAE; POLYSACCHARIDE VACCINE; ASSOCIATION; DEATH; RISK	Background: Invasive pneumococcal disease continues to be an important cause of mortality. In Calgary, 60% of deaths occur within 5 days of presenting to hospital. This proportion has not changed since before the era of penicillin. The purpose of this study was to investigate what factors may influence death within 5 days of presentation with pneumococcal disease. Methods and Findings: Demographic and clinical data from the CASPER (Calgary Area Streptococcus pneumoniae Epidemiology Research) study on 1065 episodes of invasive pneumococcal disease in adults (>= 18 years) from 2000 to 2010 were analyzed. Adjusted multinomial regression was performed to analyze 3 outcomes: early mortality (<5 days post - presentation), late mortality (5 - 30 days post - presentation), and survival, generating relative risk ratios (RRR). Patients with severe disease had increased risk of early and late death. In multinomial regression with survivors as baseline, the risk of early death increased in those with a Charlson index >= 2 (RRR: 6.3, 95% CI: 1.8-21.9); the risk of late death increased in those with less severe disease and a Charlson >= 2 (RRR: 6.1, 95% CI: 1.4-27.7). Patients who never received appropriate antibiotics had 5.6X (95% CI: 2.4 - 13.1) the risk of early death. Risk of both early and late death increased by a RRR of 1.3 (95% CI: 1.2 - 1.4) per 5 - year increase in age. In multinomial regression, there were no significant differences in the effects of the factors tested between early and late mortality. Conclusions: Presenting with severe invasive pneumococcal disease, multiple comorbidities, and older age increases the risk of both early and late death. Patients who died early often presented too late for effective antibiotic therapy, highlighting the need for an effective vaccine.	[Ricketson, Leah J.; Nettel-Aguirre, Alberto; Vanderkooi, Otto G.; Kellner, James D.] Univ Calgary, Dept Pediat, Calgary, AB T2N 1N4, Canada; [Ricketson, Leah J.; Nettel-Aguirre, Alberto; Laupland, Kevin B.; Kellner, James D.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB T2N 1N4, Canada; [Nettel-Aguirre, Alberto; Kellner, James D.] Univ Calgary, Alberta Childrens Hosp, Res Inst Child & Maternal Hlth, Calgary, AB T2N 1N4, Canada; [Vanderkooi, Otto G.; Kellner, James D.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 1N4, Canada; [Vanderkooi, Otto G.] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB T2N 1N4, Canada; [Laupland, Kevin B.] Univ Calgary, Dept Crit Care Med, Calgary, AB T2N 1N4, Canada; [Laupland, Kevin B.] Univ Calgary, Dept Med, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary; Alberta Childrens Hospital; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Kellner, JD (corresponding author), Univ Calgary, Dept Pediat, Calgary, AB T2N 1N4, Canada.	Jim.Kellner@albertahealthservices.ca	Nettel-Aguirre, Alberto/ABB-9412-2021; Laupland, kevin/AAJ-6339-2020; Laupland, Kevin/AAG-3656-2020; Kellner, James Duncan/D-6358-2011	Laupland, kevin/0000-0002-1205-5354; Kellner, James Duncan/0000-0002-9083-2980; Ricketson, Leah/0000-0003-1369-8391; Nettel-Aguirre, Alberto/0000-0001-6604-0652	Pfizer Canada; Alberta Children's Hospital Foundation	Pfizer Canada(Pfizer); Alberta Children's Hospital Foundation	This work and the CASPER project are supported in part by an unrestricted grant from Pfizer Canada (www.pfizer.ca) and the Alberta Children's Hospital Foundation (www.childrenshospital.ab.ca) to Otto Vanderkooi and James Kellner. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanee SRJ, 2007, CLIN INFECT DIS, V45, P46, DOI 10.1086/518538; AUSTRIAN R, 1964, ANN INTERN MED, V60, P759, DOI 10.7326/0003-4819-60-5-759; Balakrishnan I, 2000, J INFECTION, V40, P256, DOI 10.1053/jinf.2000.0653; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Benin AL, 2003, J INFECT DIS, V188, P81, DOI 10.1086/375782; Blanco J, 2008, CRIT CARE, V12, DOI 10.1186/cc7157; BURMAN LA, 1985, REV INFECT DIS, V7, P133; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; *CLINICALLABORATOR, 2011, 20 PERF STAND ANT S, P96; Feldman C, 2011, DRUGS, V71, P131, DOI 10.2165/11585310-000000000-00000; Garau J, 2008, CLIN MICROBIOL INFEC, V14, P322, DOI 10.1111/j.1469-0691.2007.01915.x; Garcia-Vidal C, 2008, EUR RESPIR J, V32, P733, DOI 10.1183/09031936.00128107; Harboe ZB, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000081; Johnstone J, 2010, CLIN INFECT DIS, V51, P15, DOI 10.1086/653114; Macias WL, 2004, CRIT CARE MED, V32, pS223, DOI 10.1097/01.CCM.0000126120.49367.AC; Marrie TJ, 2011, MEDICINE, V90, P171, DOI 10.1097/MD.0b013e31821a5a76; Ortqvist A, 1998, LANCET, V351, P399, DOI 10.1016/S0140-6736(97)07358-3; SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101; Sleeman K, 2001, J INFECT DIS, V183, P239, DOI 10.1086/317924; Valles X, 2006, CHEST, V130, P800, DOI 10.1378/chest.130.3.800; Vanderkooi OG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028547; Vila-Corcoles A, 2009, VACCINE, V27, P1504, DOI 10.1016/j.vaccine.2009.01.013; Weinberger DM, 2010, CLIN INFECT DIS, V51, P692, DOI 10.1086/655828; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	24	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e71924	10.1371/journal.pone.0071924	http://dx.doi.org/10.1371/journal.pone.0071924			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24115997	Green Submitted, Green Published, gold			2022-12-25	WOS:000325552200002
J	Oliveira, TA; Koakoski, G; Kreutz, LC; Ferreira, D; da Rosa, JGS; de Abreu, MS; Giacomini, ACV; Oliveira, RP; Fagundes, M; Piato, AL; Barreto, RE; Barcellos, LJG				Oliveira, Thiago Acosta; Koakoski, Gessi; Kreutz, Luiz Carlos; Ferreira, Daiane; Santos da Rosa, Joao Gabriel; de Abreu, Murilo Sander; Vendrametto Giacomini, Ana Cristina; Oliveira, Ricardo Pimentel; Fagundes, Michele; Piato, Angelo Luis; Barreto, Rodrigo Egydio; Gil Barcellos, Leonardo Jose			Alcohol Impairs Predation Risk Response and Communication in Zebrafish	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; WHOLE-BODY CORTISOL; DANIO-RERIO; ADULT ZEBRAFISH; FAMILY-HISTORY; ETHANOL; STRESS; ALARM; RECOGNITION; BEHAVIOR	The effects of ethanol exposure on Danio rerio have been studied from the perspectives of developmental biology and behavior. However, little is known about the effects of ethanol on the prey-predator relationship and chemical communication of predation risk. Here, we showed that visual contact with a predator triggers stress axis activation in zebrafish. We also observed a typical stress response in zebrafish receiving water from these conspecifics, indicating that these fish chemically communicate predation risk. Our work is the first to demonstrate how alcohol effects this prey-predator interaction. We showed for the first time that alcohol exposure completely blocks stress axis activation in both fish seeing the predator and in fish that come in indirect contact with a predator by receiving water from these conspecifics. Together with other research results and with the translational relevance of this fish species, our data points to zebrafish as a promising animal model to study human alcoholism.	[Oliveira, Thiago Acosta; Koakoski, Gessi; Ferreira, Daiane; Santos da Rosa, Joao Gabriel; de Abreu, Murilo Sander; Vendrametto Giacomini, Ana Cristina] Univ Fed Santa Maria, Programa Posgrad Farmacol, BR-97119900 Santa Maria, RS, Brazil; [Kreutz, Luiz Carlos; Vendrametto Giacomini, Ana Cristina; Oliveira, Ricardo Pimentel; Fagundes, Michele; Gil Barcellos, Leonardo Jose] Univ Passo Fundo, Programa Posgrad Bioexpt, Passo Fundo, RS, Brazil; [Piato, Angelo Luis] Univ Comunitaria Regiao Chapeco, Programa Posgrad Ciencias Ambientais, Chapeco, SC, Brazil; [Barreto, Rodrigo Egydio] UNESP, Caunesp, Biosci Inst, Dept Physiol, Botucau, SP, Brazil	Universidade Federal de Santa Maria (UFSM); Universidade de Passo Fundo; Universidade Comunitaria Regional de Chapeco; Universidade Estadual Paulista	Barcellos, LJG (corresponding author), Univ Passo Fundo, Programa Posgrad Bioexpt, Passo Fundo, RS, Brazil.	lbarcellos@upf.br	PIATO, ANGELO/K-3444-2012; Sander de Abreu, Murilo/J-9756-2015; Kreutz, Luiz C/A-3729-2015; Barreto, Rodrigo E/A-3440-2013; Fagundes, Michele/AAY-6703-2020	PIATO, ANGELO/0000-0001-5109-7306; Sander de Abreu, Murilo/0000-0001-5562-0715; Kreutz, Luiz C/0000-0002-7685-7401; Barreto, Rodrigo E/0000-0002-4611-0059; Fagundes, Michele/0000-0002-7880-8961	CNPq [302073/2011-6]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	There are no funders. L.J.G.B. has a CNPq research fellowship (302073/2011-6). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcellos LJG, 2010, J FISH BIOL, V76, P1032, DOI 10.1111/j.1095-8649.2010.02542.x; Barcellos LJG, 2007, AQUACULTURE, V272, P774, DOI 10.1016/j.aquaculture.2007.09.002; Barreto RE, 2003, BEHAV PROCESS, V60, P235, DOI 10.1016/S0376-6357(02)00127-4; Bell AM, 2007, PHYSIOL BEHAV, V91, P15, DOI 10.1016/j.physbeh.2007.01.012; Bryer PJ, 2001, J CHEM ECOL, V27, P533, DOI 10.1023/A:1010332820944; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; Croissant B, 2008, BIOL PSYCHOL, V79, P268, DOI 10.1016/j.biopsycho.2008.07.001; Dai X, 2007, PSYCHONEUROENDOCRINO, V32, P293, DOI 10.1016/j.psyneuen.2007.01.004; Eskay RL, 1993, NATL I ALCOHOL ABUSE, V23; Gebauer DL, 2011, PHARMACOL BIOCHEM BE, V99, P480, DOI 10.1016/j.pbb.2011.04.021; Gerlai R, 2000, PHARMACOL BIOCHEM BE, V67, P773, DOI 10.1016/S0091-3057(00)00422-6; Gerlai R, 2006, PHARMACOL BIOCHEM BE, V85, P752, DOI 10.1016/j.pbb.2006.11.010; Barcellos LJG, 2011, PHYSIOL BEHAV, V103, P372, DOI 10.1016/j.physbeh.2011.03.009; Gilman JM, 2008, J NEUROSCI, V28, P4583, DOI 10.1523/JNEUROSCI.0086-08.2008; Jordao LC, 2000, BEHAVIOUR, V137, P681, DOI 10.1163/156853900502286; KALANT H, 1990, CRIT REV BIOTECHNOL, V9, P265; Koakoski G, 2013, ZEBRAFISH CHEM UNPUB; Korpi NL, 2001, ENVIRON BIOL FISH, V61, P205, DOI 10.1023/A:1011091426030; Kottelat M., 1993, FRESHWATER FISHES W; Kumar S, 2009, PSYCHOPHARMACOLOGY, V205, P529, DOI 10.1007/s00213-009-1562-z; Li J, 2011, ADDICT BIOL, V16, P600, DOI 10.1111/j.1369-1600.2011.00344.x; Luca MR, 2012, BEHAV BRAIN RES, V229, P194; Miller N, 2013, BEHAV BRAIN RES, V240, P192, DOI 10.1016/j.bbr.2012.11.033; Radcliffe KA, 1999, ANN NY ACAD SCI, V868, P591, DOI 10.1111/j.1749-6632.1999.tb11332.x; Ramsay JM, 2006, AQUACULTURE, V258, P565, DOI 10.1016/j.aquaculture.2006.04.020; Sink TD, 2008, FISH PHYSIOL BIOCHEM, V34, P95, DOI 10.1007/s10695-007-9150-9; Smith N. J., 1981, MAN FISHES AMAZON; SPENCER RL, 1990, NEUROENDOCRINOLOGY, V52, P481, DOI 10.1159/000125632; Sripada CS, 2011, NEUROIMAGE, V55, P371, DOI 10.1016/j.neuroimage.2010.11.062; WALTMAN C, 1993, J CLIN ENDOCR METAB, V77, P518, DOI 10.1210/jc.77.2.518; WAND GS, 1991, J CLIN ENDOCR METAB, V72, P1290, DOI 10.1210/jcem-72-6-1290; WISENDEN BD, 1995, ANIM BEHAV, V49, P623	32	47	47	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75780	10.1371/journal.pone.0075780	http://dx.doi.org/10.1371/journal.pone.0075780			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116073	Green Published, Green Submitted, gold			2022-12-25	WOS:000325501300041
J	Amer, AAA; Costa, TRD; Farag, SI; Avican, U; Forsberg, A; Francis, MS				Amer, Ayad A. A.; Costa, Tiago R. D.; Farag, Salah I.; Avican, Ummehan; Forsberg, Ake; Francis, Matthew S.			Genetically Engineered Frameshifted YopN-TyeA Chimeras Influence Type III Secretion System Function in Yersinia pseudotuberculosis	PLOS ONE			English	Article							SHINE-DALGARNO SEQUENCE; SUBSTRATE-SPECIFICITY; INNER-ROD; EFFECTOR PROTEINS; SHIGELLA-FLEXNERI; GENE-EXPRESSION; MESSENGER-RNA; PESTIS-YOPN; TRANSLOCATION; BACTERIAL	Type III secretion is a tightly controlled virulence mechanism utilized by many gram negative bacteria to colonize their eukaryotic hosts. To infect their host, human pathogenic Yersinia spp. translocate protein toxins into the host cell cytosol through a preassembled Ysc-Yop type III secretion device. Several of the Ysc-Yop components are known for their roles in controlling substrate secretion and translocation. Particularly important in this role is the YopN and TyeA heterodimer. In this study, we confirm that Y. pseudotuberculosis naturally produce a 42 kDa YopN-TyeA hybrid protein as a result of a +1 frame shift near the 3 prime of yopN mRNA, as has been previously reported for the closely related Y. pestis. To assess the biological role of this YopN-TyeA hybrid in T3SS by Y. pseudotuberculosis, we used in cis site-directed mutagenesis to engineer bacteria to either produce predominately the YopN-TyeA hybrid by introducing +1 frame shifts to yopN after codon 278 or 287, or to produce only singular YopN and TyeA polypeptides by introducing yopN sequence from Y. enterocolitica, which is known not to produce the hybrid. Significantly, the engineered 42 kDa YopN-TyeA fusions were abundantly produced, stable, and were efficiently secreted by bacteria in vitro. Moreover, these bacteria could all maintain functionally competent needle structures and controlled Yops secretion in vitro. In the presence of host cells however, bacteria producing the most genetically altered hybrids (+1 frameshift after 278 codon) had diminished control of polarized Yop translocation. This corresponded to significant attenuation in competitive survival assays in orally infected mice, although not at all to the same extent as Yersinia lacking both YopN and TyeA proteins. Based on these studies with engineered polypeptides, most likely a naturally occurring YopN-TyeA hybrid protein has the potential to influence T3S control and activity when produced during Yersinia-host cell contact.	[Amer, Ayad A. A.; Costa, Tiago R. D.; Farag, Salah I.; Avican, Ummehan; Forsberg, Ake; Francis, Matthew S.] Umea Univ, Dept Mol Biol, Umea, Sweden; [Amer, Ayad A. A.; Costa, Tiago R. D.; Avican, Ummehan; Forsberg, Ake; Francis, Matthew S.] Umea Univ, UCMR, Umea, Sweden; [Avican, Ummehan; Forsberg, Ake] Umea Univ, Lab Mol Infect Med Sweden MIMS, Umea, Sweden	Umea University; Umea University; Umea University	Francis, MS (corresponding author), Umea Univ, Dept Mol Biol, Umea, Sweden.	matthew.francis@molbiol.umu.se	Costa, Tiago/V-8203-2017; Costa, Tiago/K-8999-2019	Costa, Tiago/0000-0003-2716-9669; Costa, Tiago/0000-0003-2716-9669; Francis, Matthew/0000-0001-6817-9535	Swedish Research Council; Foundation for Medical Research at Umea University; J C Kempe Memorial Fund	Swedish Research Council(Swedish Research CouncilEuropean Commission); Foundation for Medical Research at Umea University; J C Kempe Memorial Fund	This work was supported by grants from the Swedish Research Council (AF, MSF) (http://www.vr.se/), Foundation for Medical Research at Umea University (MSF) and J C Kempe Memorial Fund (AAA, TRC, UA). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of manuscript.	Agrain C, 2005, MOL MICROBIOL, V56, P54, DOI 10.1111/j.1365-2958.2005.04534.x; Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Akopyan K, 2011, P NATL ACAD SCI USA, V108, P1639, DOI 10.1073/pnas.1013888108; Amer AAA, 2011, J BACTERIOL, V193, P6683, DOI 10.1128/JB.00210-11; Anderson DM, 2002, J BACTERIOL, V184, P1287, DOI 10.1128/JB.184.5.1287-1295.2002; Baranov PV, 2002, GENE, V286, P187, DOI 10.1016/S0378-1119(02)00423-7; Bartra S, 2001, BMC Microbiol, V1, P22, DOI 10.1186/1471-2180-1-22; Bjornfot AC, 2009, J BACTERIOL, V191, P4259, DOI 10.1128/JB.01730-08; BOLIN I, 1984, INFECT IMMUN, V43, P72; Botteaux A, 2009, MOL MICROBIOL, V71, P449, DOI 10.1111/j.1365-2958.2008.06537.x; Brutinel ED, 2008, CURR OPIN MICROBIOL, V11, P128, DOI 10.1016/j.mib.2008.02.010; Buchan JR, 2007, BIOL CELL, V99, P475, DOI 10.1042/BC20070037; Buttner D, 2012, MICROBIOL MOL BIOL R, V76, P262, DOI 10.1128/MMBR.05017-11; CHEN HY, 1994, NUCLEIC ACIDS RES, V22, P4953, DOI 10.1093/nar/22.23.4953; Chen YQ, 2011, MOL MICROBIOL, V80, P966, DOI 10.1111/j.1365-2958.2011.07623.x; Cheng LW, 2000, J BACTERIOL, V182, P3183, DOI 10.1128/JB.182.11.3183-3190.2000; Cheng LW, 2001, J BACTERIOL, V183, P5293, DOI 10.1128/JB.183.18.5293-5301.2001; Cherradi Y, 2013, MOL MICROBIOL, V87, P1183, DOI 10.1111/mmi.12158; Costa TRD, 2013, CELL MICROBIOL, V15, P1088, DOI 10.1111/cmi.12100; Costa TRD, 2012, INFECT GENET EVOL, V12, P1729, DOI 10.1016/j.meegid.2012.07.016; Day JB, 1998, MOL MICROBIOL, V30, P777, DOI 10.1046/j.1365-2958.1998.01110.x; Day JB, 2003, MOL MICROBIOL, V47, P807, DOI 10.1046/j.1365-2958.2003.03343.x; Deane JE, 2010, CELL MOL LIFE SCI, V67, P1065, DOI 10.1007/s00018-009-0230-0; Deng WY, 2005, INFECT IMMUN, V73, P2135, DOI 10.1128/IAI.73.4.2135-2146.2005; Dewoody RS, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00004; Dinman JD, 2012, WIRES RNA, V3, P661, DOI 10.1002/wrna.1126; Edgren T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002669; Edqvist PJ, 2006, MOL MICROBIOL, V59, P31, DOI 10.1111/j.1365-2958.2005.04923.x; Edqvist PJ, 2003, J BACTERIOL, V185, P2259, DOI 10.1128/JB.185.7.2259-2266.2003; Farabaugh PJ, 1996, ANNU REV GENET, V30, P507, DOI 10.1146/annurev.genet.30.1.507; Feldman MF, 2002, MOL MICROBIOL, V46, P1183, DOI 10.1046/j.1365-2958.2002.03241.x; Ferracci F, 2005, MOL MICROBIOL, V57, P970, DOI 10.1111/j.1365-2958.2005.04738.x; Ferracci F, 2004, J BACTERIOL, V186, P5160, DOI [10.1128/JB.186.15.5160-5166.2004, 10.1128/jb.186.15.5160-5166.2004]; Flores-Kim J, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00125; FORSBERG A, 1991, MOL MICROBIOL, V5, P977, DOI 10.1111/j.1365-2958.1991.tb00773.x; Francis MS, 2011, ADV M C M, P185, DOI 10.1079/9781845937607.0185; Francis MS, 2010, CELL BIO RES PROG, P79; Francis MS, 1998, MOL MICROBIOL, V29, P799, DOI 10.1046/j.1365-2958.1998.00973.x; Frost S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049349; Galan JE, 2007, CELL, V130, P192, DOI 10.1016/j.cell.2007.06.042; Goss JW, 2004, J BACTERIOL, V186, P6320, DOI 10.1128/JB.186.18.6320-6324.2004; Hansen TM, 2007, P NATL ACAD SCI USA, V104, P5830, DOI 10.1073/pnas.0608668104; Higashi K, 2006, J BIOL CHEM, V281, P9527, DOI 10.1074/jbc.M513752200; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Iriarte M, 1998, EMBO J, V17, P1907, DOI 10.1093/emboj/17.7.1907; Jelsbak L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036149; Joseph SS, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00001; Kim JS, 2013, MICROBIOL-SGM, V159, P446, DOI 10.1099/mic.0.061689-0; Kontos H, 2001, MOL CELL BIOL, V21, P8657, DOI 10.1128/MCB.21.24.8657-8670.2001; Kubori T, 2002, J BACTERIOL, V184, P4699, DOI 10.1128/JB.184.17.4699-4708.2002; Lavander M, 2002, J BACTERIOL, V184, P4500, DOI 10.1128/JB.184.16.4500-4509.2002; Lee VT, 1998, MOL MICROBIOL, V28, P593, DOI 10.1046/j.1365-2958.1998.00822.x; Lee VT, 2001, J BACTERIOL, V183, P4970, DOI 10.1128/JB.183.17.4970-4978.2001; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Lorenz C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000094; Magdalena J, 2002, J BACTERIOL, V184, P3433, DOI 10.1128/JB.184.13.3433-3441.2002; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; MARIOVITS T, 2006, NATURE, V441, P637, DOI DOI 10.1038/NATURE04822; Martinez-Argudo I, 2010, MOL MICROBIOL, V78, P1365, DOI 10.1111/j.1365-2958.2010.07413.x; McNulty DE, 2003, PROTEIN EXPRES PURIF, V27, P365, DOI 10.1016/S1046-5928(02)00610-1; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Feria JM, 2012, J BACTERIOL, V194, P6029, DOI 10.1128/JB.01215-12; MORALES VM, 1991, GENE, V97, P39, DOI 10.1016/0378-1119(91)90007-X; Namy O, 2004, MOL CELL, V13, P157, DOI 10.1016/S1097-2765(04)00031-0; O'Connell CB, 2004, MOL MICROBIOL, V52, P1613, DOI 10.1111/j.1365-2958.2004.04101.x; Osborne SE, 2011, FUTURE MICROBIOL, V6, P193, DOI 10.2217/FMB.10.172; Pallen MJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-9; PERSSON C, 1995, MOL MICROBIOL, V18, P135, DOI 10.1111/j.1365-2958.1995.mmi_18010135.x; Pettersson J, 1996, SCIENCE, V273, P1231, DOI 10.1126/science.273.5279.1231; PORTNOY DA, 1981, INFECT IMMUN, V31, P775, DOI 10.1128/IAI.31.2.775-782.1981; ROSQVIST R, 1991, INFECT IMMUN, V59, P4562, DOI 10.1128/IAI.59.12.4562-4569.1991; ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x; ROSQVIST R, 1990, MOL MICROBIOL, V4, P657, DOI 10.1111/j.1365-2958.1990.tb00635.x; Sal-Man N, 2012, BIOCHEM J, V442, P119, DOI 10.1042/BJ20111620; Schiano CA, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00129; Schubot FD, 2005, J MOL BIOL, V346, P1147, DOI 10.1016/j.jmb.2004.12.036; Schwartz R, 1997, NUCLEIC ACIDS RES, V25, P2005, DOI 10.1093/nar/25.10.2005; Shah P, 2008, MOL MICROBIOL, V68, P4, DOI 10.1111/j.1365-2958.2008.06126.x; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; STRALEY SC, 1986, INFECT IMMUN, V51, P445, DOI 10.1128/IAI.51.2.445-454.1986; Sundberg L, 2003, CELL MICROBIOL, V5, P187, DOI 10.1046/j.1462-5822.2003.00267.x; Tamano K, 2002, J BACTERIOL, V184, P1244, DOI 10.1128/JB.184.5.1244-1252.2002; Thomassin JL, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-205; Troisfontaines P, 2005, PHYSIOLOGY, V20, P326, DOI 10.1152/physiol.00011.2005; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Wang D, 2008, MOL MICROBIOL, V69, P1499, DOI 10.1111/j.1365-2958.2008.06377.x; WEISS RB, 1988, EMBO J, V7, P1503, DOI 10.1002/j.1460-2075.1988.tb02969.x; Wood SE, 2008, J BACTERIOL, V190, P4252, DOI 10.1128/JB.00328-08; Yang HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054121; Zarivach R, 2008, NATURE, V453, P124, DOI 10.1038/nature06832; Zhou L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001291	91	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e77767	10.1371/journal.pone.0077767	http://dx.doi.org/10.1371/journal.pone.0077767			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098594	Green Submitted, Green Published, gold			2022-12-25	WOS:000325483600088
J	Crickenberger, S; Moran, A				Crickenberger, Sam; Moran, Amy			Rapid Range Shift in an Introduced Tropical Marine Invertebrate	PLOS ONE			English	Article							MEGABALANUS-COCCOPOMA DARWIN; SOUTHEASTERN UNITED-STATES; CLIMATE-CHANGE; CIRRIPEDIA BALANOMORPHA; THERMAL TOLERANCE; CONTINENTAL-SHELF; MASS MORTALITY; PERNA-VIRIDIS; SEVERE WINTER; FLORIDA-KEYS	The barnacle Megabalanus coccopoma is native to shorelines from Baja California to Peru and has been introduced to a number of other locations including the Atlantic US SE coast, where it was first recorded in 2006. In 2009, the range of M. coccopoma in the SE US extended from Ft. Pierce, FL north to Cape Hatteras, NC with seasonal populations found as far north as Kitty Hawk, NC. During the exceptionally cold winter of 2009/2010, the range of M. coccopoma shifted dramatically due to the dieback of all monitored populations north of Florida. We examined body size, distribution, and density of M. coccopoma during the summers of 2010, 2011, and 2012 to describe the extent of the range retraction and the rate of range re-expansion. In 2010, recruits were found as far north as Tybee Island, Ga, but no established populations were found north of Florida. In 2011 recruits were found at Rodanthe, NC but established populations were still limited to Florida. By 2012 populations were established in Rodanthe, NC, slightly north of its previously known range limit. Estimated rates of range re-expansion were 255.8 km/yr in 2010 and 794.1 km/yr in 2011. Rates of re-expansion to the north in 2010 and 2011 were faster than have previously been reported for any marine species, and are one of the few rates published for any tropical marine invertebrate.	[Crickenberger, Sam; Moran, Amy] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Moran, Amy] Univ Hawaii, Dept Biol, Honolulu, HI 96822 USA	Clemson University; University of Hawaii System	Crickenberger, S (corresponding author), Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA.	scricke@gmail.com	Crickenberger, Sam/U-8139-2019	Moran, Amy/0000-0002-0604-5096; Crickenberger, Sam/0000-0001-9359-8782	Estuarine Reserves Division, Office of Ocean and Coastal Resource Management, National Ocean Service, National Oceanic and Atmospheric Administration; NSF [OCE-0961996]	Estuarine Reserves Division, Office of Ocean and Coastal Resource Management, National Ocean Service, National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); NSF(National Science Foundation (NSF))	This research was conducted under an award from the Estuarine Reserves Division, Office of Ocean and Coastal Resource Management, National Ocean Service, National Oceanic and Atmospheric Administration and NSF OCE-0961996 to ALM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker P, 2007, J SHELLFISH RES, V26, P345, DOI 10.2983/0730-8000(2007)26[345:RADOAT]2.0.CO;2; Bennie J, 2013, ECOL LETT, V16, P921, DOI 10.1111/ele.12129; Blanton BO, 2003, J GEOPHYS RES, V108, P2156, DOI [10.1029/2002JB001929, DOI 10.1029/2002JB001929]; BLANTON JO, 1985, COAST ESTUAR STUD, V2, P10, DOI DOI 10.1029/C0002P0010; BOHNSACK JA, 1983, ENVIRON BIOL FISH, V9, P41, DOI 10.1007/BF00001057; Bourget E., 1987, BARNACLE BIOL; Breves-Ramos A, 2005, BRAZ ARCH BIOL TECHN, V48, P951, DOI 10.1590/S1516-89132005000800012; Camargo R., 2007, J BRAZ SOC ECOTOXICO, V2, P7; Canning-Clode J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0029657, DOI 10.1371/J0URNAL.P0NE.0029657]; Carlton JT, 2011, ENCY BIOL INVASIONS, P385; Carolina South Department of Natural Resources, 2008, S C AQ INV SPEC MAN, P95; Celis A, 2007, REV MEX BIODIVERS, V78, P325; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; CRISP DJ, 1958, J MAR BIOL ASSOC UK, V37, P483, DOI 10.1017/S0025315400023833; CRISP DJ, 1964, J ANIM ECOL, V33, P165, DOI 10.2307/2355; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Edwards KP, 2006, CONT SHELF RES, V26, P1375, DOI 10.1016/j.csr.2006.01.020; Epifanio CE, 2001, ESTUAR COAST SHELF S, V52, P51, DOI 10.1006/ecss.2000.0727; Figueira WF, 2010, GLOBAL CHANGE BIOL, V16, P506, DOI 10.1111/j.1365-2486.2009.01934.x; Firth LB, 2011, J EXP MAR BIOL ECOL, V400, P250, DOI 10.1016/j.jembe.2011.02.007; Gilg MR, 2010, J CRUSTACEAN BIOL, V30, P146, DOI 10.1651/09-3148.1; Hare JA, 2007, CAN J FISH AQUAT SCI, V64, P1234, DOI 10.1139/F07-089; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Harley CDG, 2008, MAR ECOL PROG SER, V371, P37, DOI 10.3354/meps07711; Harrison JR, 2007, SOUTHEAST NAT, V6, P173, DOI 10.1656/1528-7092(2007)6[173:OOMOAC]2.0.CO;2; Hartman M, 2001, 16 BIENN C EST RES F; Hawkins SJ, 2009, MAR ECOL PROG SER, V396, P245, DOI 10.3354/meps08378; Henry D. P., 1986, ZOOLOGISCHE VERHANDE, V235, P69; Innocenti G., 2006, Atti della Societa Toscana di Scienze Naturali Residente in Pisa Memorie Serie B, V113, P1; Kemp DW, 2011, GLOBAL CHANGE BIOL, V17, P3468, DOI 10.1111/j.1365-2486.2011.02487.x; Kent A, 2003, J ANIM ECOL, V72, P941, DOI 10.1046/j.1365-2656.2003.00762.x; Kerckhof F, 2010, AFR J MAR SCI, V32, P265, DOI 10.2989/1814232X.2010.501573; Kerckhof F, 2001, SENCK MARIT, V31, P245, DOI 10.1007/BF03043033; Kerckhof F., 2002, B I R SCI NAT BELG B, V72, P93; Kimball ME, 2004, MAR ECOL PROG SER, V283, P269, DOI 10.3354/meps283269; Laboy-Nieves EN, 2001, B MAR SCI, V68, P163; LACOMBE D, 1974, Revista Brasileira de Biologia, V34, P633; Lacombe D, 1977, RIO DE JANEIRO, V129, P1; Lima FP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1713; Ling SD, 2008, OECOLOGIA, V156, P883, DOI 10.1007/s00442-008-1043-9; Meister HS, 2005, SOUTHEAST NAT, V4, P193, DOI 10.1656/1528-7092(2005)004[0193:FEFTIA]2.0.CO;2; Mieszkowska N, 2007, J MAR BIOL ASSOC UK, V87, P537, DOI 10.1017/S0025315407053799; National Climate Data Center, 2009, NAT CLIM DAT CTR 200, P2010; NEWMAN W A, 1987, Pacific Science, V41, P31; Nilsson-Cantell C. A., 1932, Verhandlungen der Naturforschenden Gesellschaft in Basel, V42, P103; Parry M. L., 2007, CLIMATE CHANGE 2007; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Perrault R. T., 2004, P LA ACAD SCI, V66, P13; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Precht WF, 2004, FRONT ECOL ENVIRON, V2, P307; Rahel FJ, 2008, CONSERV BIOL, V22, P521, DOI 10.1111/j.1523-1739.2008.00950.x; Farrapeira CMR, 2007, BRAZ J OCEANOGR, V55, P207, DOI 10.1590/S1679-87592007000300005; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Silveira NG, 2007, BIOCIENCIAS, P14; Smale DA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2829; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; Spinuzzi Samantha, 2013, Marine Biodiversity Records, V6, pe55, DOI 10.1017/S1755267213000316; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Stillman JH, 2003, SCIENCE, V301, P65, DOI 10.1126/science.1083073; Storey M, 1936, ECOLOGY, V17, P640, DOI 10.2307/1932762; Strasser M, 2001, HELGOLAND MAR RES, V55, P176, DOI 10.1007/s101520100081; Szuchy MTM., 2000, REV BRASILEIRA BOT, V23, P121, DOI [10.1590/S0100-84042000000200002, DOI 10.1590/S0100-84042000000200002]; Taylor CM, 2005, ECOL LETT, V8, P895, DOI 10.1111/j.1461-0248.2005.00787.x; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Urian AG, 2011, J EXP ZOOL PART A, V315A, P12, DOI 10.1002/jez.644; Vincenty T., 1975, SURV REV, V23, P88, DOI [10.1179/sre.1975.23.176.88, DOI 10.1179/SRE.1975.23.176.88]; Walker N.D., 1982, Coral Reefs, V1, P83, DOI 10.1007/BF00301689; Wang CZ, 2010, ATMOS SCI LETT, V11, P161, DOI 10.1002/asl.278; WEBER AH, 1980, J PHYS OCEANOGR, V10, P1256, DOI 10.1175/1520-0485(1980)010<1256:MMWFFT>2.0.CO;2; Wethey DS, 2011, J EXP MAR BIOL ECOL, V400, P132, DOI 10.1016/j.jembe.2011.02.008; WITHERINGTON BE, 1989, COPEIA, P696; Wolff W. J., 2005, Zoologische Mededelingen (Leiden), V79, P1; Yamaguchi T, 2009, BIOFOULING, V25, P325, DOI 10.1080/08927010902738048; Young Paulo S., 2000, Zoosystema, V22, P85; Zeidberg LD, 2007, P NATL ACAD SCI USA, V104, P12946, DOI 10.1073/pnas.0702043104	75	12	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e78008	10.1371/journal.pone.0078008	http://dx.doi.org/10.1371/journal.pone.0078008			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098598	gold, Green Published, Green Submitted			2022-12-25	WOS:000325483600091
J	Feliciano, A; Castellvi, J; Artero-Castro, A; Leal, JA; Romagosa, C; Hernandez-Losa, J; Peg, V; Fabra, A; Vidal, F; Kondoh, H; Cajal, SRY; LLeonart, ME				Feliciano, Andrea; Castellvi, Josep; Artero-Castro, Ana; Leal, Jose A.; Romagosa, Cleofe; Hernandez-Losa, Javier; Peg, Vicente; Fabra, Angels; Vidal, Francisco; Kondoh, Hiroshi; Ramon y Cajal, Santiago; LLeonart, Matilde E.			miR-125b Acts as a Tumor Suppressor in Breast Tumorigenesis via Its Novel Direct Targets ENPEP, CK2-alpha, CCNJ, and MEGF9	PLOS ONE			English	Article							PROTEIN-KINASE CK2; CELL-PROLIFERATION; AMINOPEPTIDASE-A; METASTATIC BEHAVIOR; MESSENGER-RNAS; IN-VITRO; MICRORNA; EXPRESSION; CANCER; GENE	MicroRNAs (miRNAs) play important roles in diverse biological processes and are emerging as key regulators of tumorigenesis and tumor progression. To explore the dysregulation of miRNAs in breast cancer, a genome-wide expression profiling of 939 miRNAs was performed in 50 breast cancer patients. A total of 35 miRNAs were aberrantly expressed between breast cancer tissue and adjacent normal breast tissue and several novel miRNAs were identified as potential oncogenes or tumor suppressor miRNAs in breast tumorigenesis. miR-125b exhibited the largest decrease in expression. Enforced miR-125b expression in mammary cells decreased cell proliferation by inducing G2/M cell cycle arrest and reduced anchorage-independent cell growth of cells of mammary origin. miR-125b was found to perform its tumor suppressor function via the direct targeting of the 3'-UTRs of ENPEP, CK2-alpha, CCNJ, and MEGF9 mRNAs. Silencing these miR-125b targets mimicked the biological effects of miR-125b overexpression, confirming that they are modulated by miR-125b. Analysis of ENPEP, CK2-alpha, CCNJ, and MEGF9 protein expression in breast cancer patients revealed that they were overexpressed in 56%, 40-56%, 20%, and 32% of the tumors, respectively. The expression of ENPEP and CK2-alpha was inversely correlated with miR-125b expression in breast tumors, indicating the relevance of these potential oncogenic proteins in breast cancer patients. Our results support a prognostic role for CK2-alpha, whose expression may help clinicians predict breast tumor aggressiveness. In particular, our results show that restoration of miR-125b expression or knockdown of ENPEP, CK2-alpha, CCNJ, or MEGF9 may provide novel approaches for the treatment of breast cancer.	[Feliciano, Andrea; Castellvi, Josep; Artero-Castro, Ana; Leal, Jose A.; Romagosa, Cleofe; Hernandez-Losa, Javier; Peg, Vicente; Ramon y Cajal, Santiago; LLeonart, Matilde E.] Inst Recerca Hosp Vall dHebron, Oncol & Mol Pathol Grp, Dept Pathol, Barcelona, Spain; [Fabra, Angels] Inst Invest Biomed Bellvitge IDIBELL, Barcelona, Spain; [Vidal, Francisco] Banc Sang & Teixits, Barcelona, Spain; [Kondoh, Hiroshi] Kyoto Univ, Dept Geriatr Med, Grad Sch Med, Kyoto, Japan	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Kyoto University	LLeonart, ME (corresponding author), Inst Recerca Hosp Vall dHebron, Oncol & Mol Pathol Grp, Dept Pathol, Barcelona, Spain.	melleona@ir.vhebron.net	Peg., Vicente/AAC-9447-2020; LLeonart, Matilde E./Q-2662-2019; Javier, Hernandez Losa/C-1173-2008; Pérez-Portabell, Cleofé Romagosa/Q-3342-2016; Peg, Vicente/E-9160-2018; Ramon y Cajal, Santiago/H-4955-2016; Artero, Ana/AAD-2247-2022; Castellvi, Josep/C-5092-2014	Peg., Vicente/0000-0002-5203-6166; LLeonart, Matilde E./0000-0002-6196-7405; Javier, Hernandez Losa/0000-0003-1526-3201; Peg, Vicente/0000-0002-5203-6166; Ramon y Cajal, Santiago/0000-0002-3867-1390; Castellvi, Josep/0000-0001-5745-9996; Vidal, Francisco/0000-0001-8089-4945; Feliciano, Andrea/0000-0002-3189-3441	"Banco Bilbao Vizcaya Argentaria" (BBVA) Foundation [056/09]; FIS fellowship; Grants-in-Aid for Scientific Research [23390186] Funding Source: KAKEN	"Banco Bilbao Vizcaya Argentaria" (BBVA) Foundation(BBVA Foundation); FIS fellowship; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the "Banco Bilbao Vizcaya Argentaria" (BBVA) Foundation Grant number 056/09. MLL is an FIS investigator (CP03/00101). A. Feliciano is funded by a FIS fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061064; Artero-Castro A, 2009, MOL CELL BIOL, V29, P1855, DOI 10.1128/MCB.01386-08; Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Borgdorff V, 2010, ONCOGENE, V29, P2262, DOI 10.1038/onc.2009.497; Bousquet M, 2010, P NATL ACAD SCI USA, V107, P21558, DOI 10.1073/pnas.1016611107; Brandt-Bohne U, 2007, BIOCHEM J, V401, P447, DOI 10.1042/BJ20060691; Brown MS, 2010, CLIN CANCER RES, V16, P2295, DOI 10.1158/1078-0432.CCR-09-3200; Buffa FM, 2011, CANCER RES, V71, P5635, DOI 10.1158/0008-5472.CAN-11-0489; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054213; Cui Y, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-116; Cunha IW, 2010, TRANSL ONCOL, V3, P23, DOI 10.1593/tlo.09166; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Drukker M, 2012, NAT BIOTECHNOL, V30, P531, DOI 10.1038/nbt.2239; Ferretti E, 2008, EMBO J, V27, P2616, DOI 10.1038/emboj.2008.172; Finley RL, 1996, P NATL ACAD SCI USA, V93, P3011, DOI 10.1073/pnas.93.7.3011; Giusiano S, 2011, EUR J CANCER, V47, P792, DOI 10.1016/j.ejca.2010.11.028; Gong J, 2013, ONCOGENE, V32, P3071, DOI 10.1038/onc.2012.318; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guan Y, 2011, INT J CANCER, V128, P2274, DOI 10.1002/ijc.25575; Hannafon BN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2839; Harvey RC, 2010, BLOOD, V116, P4874, DOI 10.1182/blood-2009-08-239681; Huang L, 2011, INT J CANCER, V128, P1758, DOI 10.1002/ijc.25509; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Janssen EAM, 2010, MODERN PATHOL, V23, P1567, DOI 10.1038/modpathol.2010.177; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kappelmann M, 2013, ONCOGENE, V32, P2984, DOI 10.1038/onc.2012.307; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kolonin MG, 2000, DEV BIOL, V227, P661, DOI 10.1006/dbio.2000.9916; Landesman-Bollag E, 2001, ONCOGENE, V20, P3247, DOI 10.1038/sj.onc.1204411; Le MTN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002242; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Liang LH, 2010, HEPATOLOGY, V52, P1731, DOI 10.1002/hep.23904; Lin KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017193; Liu LH, 2011, BIOCHEM BIOPH RES CO, V416, P31, DOI 10.1016/j.bbrc.2011.10.117; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Lukiw WJ, 2012, MOL NEUROBIOL, V46, P11, DOI 10.1007/s12035-012-8234-4; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mandke P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042034; Marchio S, 2004, CANCER CELL, V5, P151, DOI 10.1016/S1535-6108(04)00025-X; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Mohri T, 2009, INT J CANCER, V125, P1328, DOI 10.1002/ijc.24459; Morrell NW, 1999, AM J PHYSIOL-LUNG C, V277, pL440, DOI 10.1152/ajplung.1999.277.3.L440; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Saini S, 2012, CANCER RES, V72, P3618, DOI 10.1158/0008-5472.CAN-12-0540; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Siddiqui-Jain A, 2010, CANCER RES, V70, P10288, DOI 10.1158/0008-5472.CAN-10-1893; Song LJ, 1999, HYPERTENSION, V33, P746, DOI 10.1161/01.HYP.33.2.746; Stockler M, 2000, CANCER TREAT REV, V26, P151, DOI 10.1053/ctrv.1999.0161; Suganuma T, 2004, LAB INVEST, V84, P639, DOI 10.1038/labinvest.3700072; Ting HJ, 2013, J BIOL CHEM, V288, P1, DOI 10.1074/jbc.M112.395947; van Schooneveld E, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3127; Wu LG, 2005, MOL CELL BIOL, V25, P9198, DOI 10.1128/MCB.25.21.9198-9208.2005; Xia HF, 2009, CELL PHYSIOL BIOCHEM, V23, P347, DOI 10.1159/000218181; Xu N, 2011, J INVEST DERMATOL, V131, P1521, DOI 10.1038/jid.2011.55; Yan LX, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2803; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Zhang Y, 2011, CANCER RES, V71, P3552, DOI 10.1158/0008-5472.CAN-10-2435; Zhao AH, 2012, J GENET GENOMICS, V39, P29, DOI 10.1016/j.jgg.2011.12.003; Zou JJ, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-97	66	113	120	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76247	10.1371/journal.pone.0076247	http://dx.doi.org/10.1371/journal.pone.0076247			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098452	Green Submitted, Green Published, gold			2022-12-25	WOS:000325483600031
J	Gokulan, K; Khare, S; Rooney, AW; Han, J; Lynne, AM; Foley, SL				Gokulan, Kuppan; Khare, Sangeeta; Rooney, Anthony W.; Han, Jing; Lynne, Aaron M.; Foley, Steven L.			Impact of Plasmids, Including Those EncodingVirB4/D4 Type IV Secretion Systems, on Salmonella enterica serovar Heidelberg Virulence in Macrophages and Epithelial Cells	PLOS ONE			English	Article							ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; BRUCELLA-ABORTUS; INTRACELLULAR SURVIVAL; ENDOPLASMIC-RETICULUM; IMMUNE-RESPONSE; UNITED-STATES; VIRB OPERON; INFECTION; MICE	Salmonella enterica serovar Heidelberg (S. Heidelberg) can cause foodborne illness in humans following the consumption of contaminated meat and poultry products. Recent studies from our laboratory have demonstrated that certain S. Heidelberg isolated from food-animal sources harbor multiple transmissible plasmids with genes that encode antimicrobial resistance, virulence and a VirB4/D4 type-IV secretion system. This study examines the potential role of these transmissible plasmids in bacterial uptake and survival in intestinal epithelial cells and macrophages, and the molecular basis of host immune system modulation that may be associated with disease progression. A series of transconjugant and transformant strains were developed with different combinations of the plasmids to determine the roles of the individual and combinations of plasmids on virulence. Overall the Salmonella strains containing the VirB/D4 T4SS plasmids entered and survived in epithelial cells and macrophages to a greater degree than those without the plasmid, even though they carried other plasmid types. During entry in macrophages, the VirB/D4 T4SS encoding genes are up-regulated in a time-dependent fashion. When the potential mechanisms for increased virulence were examined using an antibacterial Response PCR Array, the strain containing the T4SS down regulated several host innate immune response genes which likely contributed to the increased uptake and survival within macrophages and epithelial cells.	[Gokulan, Kuppan; Khare, Sangeeta; Rooney, Anthony W.; Han, Jing; Foley, Steven L.] US FDA, Div Microbiol, Natl Ctr Toxicol Res, Jefferson, AR USA; [Rooney, Anthony W.] Univ Minnesota, Dept Chem, Morris, MN 56267 USA; [Lynne, Aaron M.] Sam Houston State Univ, Dept Biol Sci, Huntsville, TX 77340 USA	US Food & Drug Administration (FDA); University of Minnesota System; University of Minnesota Morris; Texas State University System; Sam Houston State University	Foley, SL (corresponding author), US FDA, Div Microbiol, Natl Ctr Toxicol Res, Jefferson, AR USA.	steven.foley@fda.hhs.gov	Khare, SangeetA/Q-5470-2019	Khare, SangeetA/0000-0002-9496-6636; Foley, Steven/0000-0003-3146-4548; Gokulan, Kuppan/0000-0003-4045-5993	FDA-National Center for Toxicological Research	FDA-National Center for Toxicological Research	The research is internally funded through the FDA-National Center for Toxicological Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2004, ANTIMICROB AGENTS CH, V48, P1916, DOI 10.1128/AAC.48.5.1916-1917.2004; APPELMELK BJ, 1994, INFECT IMMUN, V62, P2628, DOI 10.1128/IAI.62.6.2628-2632.1994; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; Bessler HC, 2006, MICROBIOL IMMUNOL, V50, P877, DOI 10.1111/j.1348-0421.2006.tb03863.x; Blander JM, 2012, NAT REV IMMUNOL, V12, P215, DOI 10.1038/nri3167; Boschiroli ML, 2002, VET MICROBIOL, V90, P341, DOI 10.1016/S0378-1135(02)00219-5; Boschiroli ML, 2002, P NATL ACAD SCI USA, V99, P1544, DOI 10.1073/pnas.032514299; Broz P, 2011, IMMUNOL REV, V243, P174, DOI 10.1111/j.1600-065X.2011.01041.x; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Centers for Disease Control and Prevention, 2011, SALM SURV ANN SUMM; Chan YR, 2009, J IMMUNOL, V182, P4947, DOI 10.4049/jimmunol.0803282; Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; David DE, 2010, APPL ENVIRON MICROB, V76, P7509, DOI 10.1128/AEM.00726-10; de Jong MF, 2008, MOL MICROBIOL, V70, P1378, DOI 10.1111/j.1365-2958.2008.06487.x; Debbabi H, 1998, J DAIRY RES, V65, P283, DOI 10.1017/S0022029997002732; Del Olmo A, 2010, J DAIRY SCI, V93, P3965, DOI 10.3168/jds.2010-3152; den Hartigh AB, 2004, INFECT IMMUN, V72, P5143, DOI 10.1128/IAI.72.9.5143-5149.2004; Dutil L, 2010, EMERG INFECT DIS, V16, P48, DOI 10.3201/eid1601.090729; Elinav E, 2011, IMMUNITY, V34, P665, DOI 10.1016/j.immuni.2011.05.007; Drago-Serrano ME, 2010, IMMUNOL LETT, V134, P35, DOI 10.1016/j.imlet.2010.08.007; FDA, 2010, NAT ANT RES MON SYST; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Fluit AC, 2005, FEMS IMMUNOL MED MIC, V43, P1, DOI 10.1016/j.femsim.2004.10.007; Fricke WF, 2009, J BACTERIOL, V191, P4750, DOI 10.1128/JB.00189-09; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Gomez Thomas M., 1997, World Health Statistics Quarterly, V50, P81; Han J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051160; Han J, 2011, J CLIN MICROBIOL, V49, P1130, DOI 10.1128/JCM.01931-10; Health Canada, 2009, COMMUN DISORD REP S3, V35, P1; Hoffmann M, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00004-12; Hoffmann M, 2012, J BACTERIOL, V194, P3274, DOI 10.1128/JB.00419-12; Hong PC, 2000, INFECT IMMUN, V68, P4102, DOI 10.1128/IAI.68.7.4102-4107.2000; Johnson TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015524; Kaldhone P, 2008, APPL ENVIRON MICROB, V74, P5038, DOI 10.1128/AEM.00409-08; Kennedy M, 2004, CLIN INFECT DIS, V38, pS142, DOI 10.1086/381580; Khare S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042127; Lynne AM, 2009, FOODBORNE PATHOG DIS, V6, P207, DOI 10.1089/fpd.2008.0172; Nolan LK, 2003, VET RES COMMUN, V27, P101, DOI 10.1023/A:1022854902700; O'Callaghan D, 1999, MOL MICROBIOL, V33, P1210, DOI 10.1046/j.1365-2958.1999.01569.x; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Pegues DA, 2005, PRINCIPLES PRACTICE, V2, P2636; Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011; Rietschel ET, 1996, CURR TOP MICROBIOL, V216, P39; Rotger R, 1999, Int Microbiol, V2, P177; Roux CM, 2007, CELL MICROBIOL, V9, P1851, DOI 10.1111/j.1462-5822.2007.00922.x; Roy CR, 2002, J CELL BIOL, V158, P415, DOI 10.1083/jcb.200205011; Russell MW, 2005, INNATE HUMORAL DEFEN; Rychlik I, 2006, VET MICROBIOL, V112, P1, DOI 10.1016/j.vetmic.2005.10.030; Sajjan SU, 2008, INFECT IMMUN, V76, P5447, DOI 10.1128/IAI.00451-08; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Sheppard M, 2003, CELL MICROBIOL, V5, P593, DOI 10.1046/j.1462-5822.2003.00296.x; Sieira R, 2004, MOL MICROBIOL, V54, P808, DOI 10.1111/j.1365-2958.2004.04316.x; Tegtmeyer N, 2010, J BIOL CHEM, V285, P23513, DOI 10.1074/jbc.M109.096214; WANG ZL, 1994, BIOTECHNIQUES, V16, P460; Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; WILMSHURST P, 1995, CLIN INFECT DIS, V21, P1065, DOI 10.1093/clinids/21.4.1065; WRIGHT GC, 1990, J CLIN INVEST, V85, P1925, DOI 10.1172/JCI114655; Zhao S, 2006, FOODBORNE PATHOG DIS, V3, P106, DOI 10.1089/fpd.2006.3.106	62	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e77866	10.1371/journal.pone.0077866	http://dx.doi.org/10.1371/journal.pone.0077866			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098597	Green Submitted, gold, Green Published			2022-12-25	WOS:000325483600090
J	Roussin, A; Bouyssi, A; Pouche, L; Pourcel, L; Lapeyre-Mestre, M				Roussin, Anne; Bouyssi, Annabelle; Pouche, Lucie; Pourcel, Laure; Lapeyre-Mestre, Maryse			Misuse and Dependence on Non-Prescription Codeine Analgesics or Sedative H1 Antihistamines by Adults: A Cross-Sectional Investigation in France	PLOS ONE			English	Article							THE-COUNTER MEDICINES; COMMUNITY PHARMACIES; ABUSE; ABUSE/MISUSE; MEDICATION; INSOMNIA; DRUGS; MODEL	Background: Given the growing worldwide market of non-prescription drugs, monitoring their misuse in the context of self-medication represents a particular challenge in Public Health. The aim of this study was to investigate the prevalence of misuse, abuse, and dependence on non-prescription psychoactive drugs. Method: During one month, in randomly solicited community pharmacies, an anonymous questionnaire was offered to adults requesting paracetamol (control group), codeine combined with paracetamol in analgesics, or sedative H1 antihistamines. Responses about misuse (drug use not in agreement with the Patient Information Leaflet) abuse (excessive drug use having detrimental consequences), and dependence (established according to questions adapted from the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition criteria) on psychoactive drugs were compared to those of the paracetamol control group. Results: 295 patients (mean age 48.5 years, 68.5% of women) having used one of the studied drugs during the previous month were included. Misuse and dependence to codeine analgesics concerned 6.8% and 17.8% of the patients exposed to these drugs, respectively, (n = 118), which was significantly higher than for paracetamol. 19.5% had used codeine analgesics daily for more than six months. Headache was the most frequent reason for persistent daily use. A high prevalence of persistent daily users of sedative H1 antihistamines was also observed. Whereas these drugs are recommended only for short treatment courses of occasional insomnia, 72.2% of the participants having taken doxylamine (n = 36) were daily users, predominantly for more than six months. Conclusions: Results on misuse and dependence on non-prescription codeine analgesics suggest that chronic pain, in particular chronic cephalalgia, requires better medical care. In addition, as for hypnotics on prescription, persistent use of doxylamine for self-medication is not justified until an acceptable benefit-risk ratio for chronic sleep disturbance is shown by clinical data.	[Roussin, Anne; Bouyssi, Annabelle; Pouche, Lucie; Pourcel, Laure; Lapeyre-Mestre, Maryse] Univ Toulouse 3, Equipe Pharmacoepidemiol, INSERM, UMR1027, F-31062 Toulouse, France; [Roussin, Anne; Lapeyre-Mestre, Maryse] Hop Toulouse, Serv Pharmacol Clin, Addictovigilance Ctr, Ctr Evaluat & Informat Pharmacodependance, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Roussin, A (corresponding author), Univ Toulouse 3, Equipe Pharmacoepidemiol, INSERM, UMR1027, F-31062 Toulouse, France.	anne.roussin@univ-tlse3.fr	Roussin, Anne/E-3557-2018; Lapeyre-Mestre, Maryse/C-8710-2012	Lapeyre-Mestre, Maryse/0000-0002-5494-5873	Mission Interministerielle de la Lutte contre les Drogues et Toxicomanies (MILDT);  [0802707]	Mission Interministerielle de la Lutte contre les Drogues et Toxicomanies (MILDT); 	This work was supported by the Mission Interministerielle de la Lutte contre les Drogues et Toxicomanies (MILDT) (http://www.drogues.gouv.fr/) in relationship with the French Health Products Safety Agency (Afssaps) which has been renamed the Agence Nationale de Securite des Medicaments et Produits de Sante (ANSM) (http://www.ansm.sante.fr/Activites/Appels-a-projets-de-recherche). The reference grant number was: 0802707. The Scientific Commission of Afssaps has had a role in the study design by recommending to randomly select community pharmacies instead to use national sentinel network of pharmacies. Afssaps gave its agreement to publish results. However the funders did not have any role in data collection and analysis as well as preparation of the manuscript.	AFIPA, CHIFFR MARCH AUT FRA; Afssaps, 2011, ANAL VENTES MEDICAME; [Anonymous], 2008, PRESCRIRE INT, V97, P206; Bendtsen L, 2012, J HEADACHE PAIN, V13, pS1, DOI 10.1007/s10194-011-0402-9; CRAIG DF, 1990, CAN MED ASSOC J, V142, P970; Djezzar S, 2009, INT J LEGAL MED, V123, P213, DOI 10.1007/s00414-008-0291-x; Ferrari A, 2006, CEPHALALGIA, V26, P187, DOI 10.1111/j.1468-2982.2005.01020.x; Fleming GF, 2004, PHARM WORLD SCI, V26, P282, DOI 10.1023/B:PHAR.0000042891.66983.60; Frei MY, 2010, MED J AUSTRALIA, V193, P294, DOI 10.5694/j.1326-5377.2010.tb03911.x; Gauvin DV, 1995, EUR J PHARMACOL, V294, P281, DOI 10.1016/0014-2999(95)00550-1; Gonzales R, 2011, J SUBST ABUSE TREAT, V40, P224, DOI 10.1016/j.jsat.2010.11.003; Gracious B, 2010, J CHILD ADOL PSYCHOP, V20, P521, DOI 10.1089/cap.2010.0031; Howard ME, 2004, AM J RESP CRIT CARE, V170, P1014, DOI 10.1164/rccm.200312-1782oc; Hughes GF, 1999, PHARM WORLD SCI, V21, P251, DOI 10.1023/A:1008788726842; Kripke DF, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000850; Lusher J, 2006, CLIN J PAIN, V22, P316, DOI 10.1097/01.ajp.0000176360.94644.41; MATHESON C, 2002, PHARM J, V269, P66; McDonough MA, 2011, MED J AUSTRALIA, V194, P486, DOI 10.5694/j.1326-5377.2011.tb03069.x; Meoli AL, 2005, J CLIN SLEEP MED, V1, P173; MHRA (No author listed), 2009, DRUG SAFETY UPDATE, V3, P6; Morin AK, 2007, PHARMACOTHERAPY, V27, P89, DOI 10.1592/phco.27.1.89; Orriols L, 2010, PLOS MED, V7, DOI [10.1371/journal.pmed.1000366, DOI 10.1371/J0URNAL.PMED.1000366]; Orriols L, 2009, DRUG SAFETY, V32, P859, DOI 10.2165/11316590-000000000-00000; Pates R, 2002, PHARM J, V268, P179; Richardson GS, 2002, J CLIN PSYCHOPHARM, V22, P511, DOI 10.1097/00004714-200210000-00012; Schadeck B, 1996, SEM HOP PARIS, V72, P428; Sinclair HK, 1999, PHARMACOEPIDEM DR S, V8, P479, DOI 10.1002/(SICI)1099-1557(199912)8:7<479::AID-PDS462>3.3.CO;2-2; Skurtveit S, 2011, PAIN, V152, P1555, DOI 10.1016/j.pain.2011.02.045; Thomas A, 2009, J PSYCHOPHARMACOL, V23, P101, DOI 10.1177/0269881107083809; Vallejo R, 2011, PAIN PHYSICIAN, V14, pE343; Wazaify M, 2006, PATIENT EDUC COUNS, V64, P136, DOI 10.1016/j.pec.2005.12.008; Weiler JM, 2000, ANN INTERN MED, V133, P657, DOI 10.7326/0003-4819-133-8-200010170-00024	32	56	58	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76499	10.1371/journal.pone.0076499	http://dx.doi.org/10.1371/journal.pone.0076499			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098516	Green Published, Green Submitted, gold			2022-12-25	WOS:000325483600059
J	Abujamel, T; Cadnum, JL; Jury, LA; Sunkesula, VCK; Kundrapu, S; Jump, RL; Stintzi, AC; Donskey, CJ				Abujamel, Turki; Cadnum, Jennifer L.; Jury, Lucy A.; Sunkesula, Venkata C. K.; Kundrapu, Sirisha; Jump, Robin L.; Stintzi, Alain C.; Donskey, Curtis J.			Defining the Vulnerable Period for Re-Establishment of Clostridium difficile Colonization after Treatment of C. difficile Infection with Oral Vancomycin or Metronidazole	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; RESISTANT ENTEROCOCCI; INTRAVENOUS THERAPY; DISEASE; ANTIBIOTICS	Background: Clostridium difficile is an anaerobic, spore-forming bacterium that is the most common cause of healthcare-associated diarrhea in developed countries. A significant proportion of patients receiving oral vancomycin or metronidazole for treatment of Clostridium difficile infection (CDI) develop recurrences. However, the period of vulnerability to re-establishment of colonization by C. difficile after therapy is not well defined. Principal Findings: In a prospective study of CDI patients, we demonstrated that most vancomycin-treated patients maintained inhibitory concentrations of vancomycin in stool for 4 to 5 days after therapy, whereas metronidazole was only detectable during therapy. From the time of elimination of the antibiotics to 14 to 21 days after therapy, a majority of stool suspensions supported growth of C. difficile and deep 16S rRNA sequencing demonstrated persistent marked alteration of the indigenous microbiota. By 21 to 28 days after completion of CDI treatment, a majority of stool suspensions inhibited growth of C. difficile and there was evidence of some recovery of the microbiota. Conclusions: These data demonstrate that there is a vulnerable period for re-establishment of C. difficile colonization after CDI treatment that begins within a few days after discontinuation of treatment and extends for about 3 weeks in most patients.	[Abujamel, Turki; Stintzi, Alain C.] Univ Ottawa, Ottawa Inst Syst Biol, Dept Biochem Microbiol & Immunol, Fac Med, Ottawa, ON K1N 6N5, Canada; [Cadnum, Jennifer L.] Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH USA; [Jury, Lucy A.; Jump, Robin L.; Donskey, Curtis J.] Geriatr Res Educ & Clin Ctr, Cleveland, OH USA; [Sunkesula, Venkata C. K.; Kundrapu, Sirisha; Donskey, Curtis J.] Case Western Reserve Univ, Sch Med, Dept Med, Div Infect Dis, Cleveland, OH 44106 USA	University of Ottawa; Geriatric Research Education & Clinical Center; Case Western Reserve University	Stintzi, AC (corresponding author), Univ Ottawa, Ottawa Inst Syst Biol, Dept Biochem Microbiol & Immunol, Fac Med, Ottawa, ON K1N 6N5, Canada.	astintzi@uottawa.ca; curtisd123@yahoo.com	Abujamel, Turki/GRS-5606-2022; Jump, Robin/AAD-8364-2019		ViroPharma, Incorporated by the Canadian Institutes of Health Research (CIHR); King Abdulaziz University, through the Saudi Arabian Cultural Bureau in Canada	ViroPharma, Incorporated by the Canadian Institutes of Health Research (CIHR); King Abdulaziz University, through the Saudi Arabian Cultural Bureau in Canada	This work was supported by a grant from ViroPharma, Incorporated to CJD by the Canadian Institutes of Health Research (CIHR) to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. TA was supported by a scholarship from King Abdulaziz University, through the Saudi Arabian Cultural Bureau in Canada.	Al-Nassir WN, 2008, ANTIMICROB AGENTS CH, V52, P2403, DOI 10.1128/AAC.00090-08; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Bidet P, 2000, J CLIN MICROBIOL, V38, P2484, DOI 10.1128/JCM.38.7.2484-2487.2000; BOLTON RP, 1986, GUT, V27, P1169, DOI 10.1136/gut.27.10.1169; BORRIELLO SP, 1986, J MED MICROBIOL, V21, P299, DOI 10.1099/00222615-21-4-299; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Currie BP, 2004, ANTIMICROB AGENTS CH, V48, P4427, DOI 10.1128/AAC.48.11.4427-4429.2004; Dabard J, 2001, APPL ENVIRON MICROB, V67, P4111, DOI 10.1128/AEM.67.9.4111-4118.2001; Edlund C, 1997, CLIN INFECT DIS, V25, P729, DOI 10.1086/513755; Hickson M, 2007, BMJ-BRIT MED J, V335, P80, DOI 10.1136/bmj.39231.599815.55; JOHNSON S, 1992, ANN INTERN MED, V117, P297, DOI 10.7326/0003-4819-117-4-297; Lau SKP, 2007, J CLIN MICROBIOL, V45, P395, DOI 10.1128/JCM.01831-06; Lau SKP, 2012, J CLIN MICROBIOL, V50, P2239, DOI 10.1128/JCM.00128-12; Louie TJ, 2009, ANTIMICROB AGENTS CH, V53, P261, DOI 10.1128/AAC.01443-07; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Malaguarnera G, 2012, J NUTR HEALTH AGING, V16, P402, DOI 10.1007/s12603-011-0357-1; Nerandzic MM, 2009, J CLIN MICROBIOL, V47, P397, DOI 10.1128/JCM.01591-08; Robinson CJ, 2010, GUT MICROBES, V1, P279, DOI 10.4161/gmic.1.4.12614; ROLFE RD, 1983, J INFECT DIS, V147, P227, DOI 10.1093/infdis/147.2.227; Sambol SP, 2002, J INFECT DIS, V186, P1781, DOI 10.1086/345676; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sethi AK, 2009, INFECT CONT HOSP EP, V30, P13, DOI 10.1086/592710; Sommer MOA, 2011, CURR OPIN MICROBIOL, V14, P556, DOI 10.1016/j.mib.2011.07.005; Terhes G, 2004, J CLIN MICROBIOL, V42, P4316, DOI 10.1128/JCM.42.9.4316-4318.2004; Villano SA, 2012, ANTIMICROB AGENTS CH, V56, P5224, DOI 10.1128/AAC.00913-12	26	64	85	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76269	10.1371/journal.pone.0076269	http://dx.doi.org/10.1371/journal.pone.0076269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098459	Green Submitted, gold, Green Published			2022-12-25	WOS:000325434500057
J	Bjork, S; Hurt, CM; Ho, VK; Angelotti, T				Bjork, Susann; Hurt, Carl M.; Ho, Vincent K.; Angelotti, Timothy			REEPs Are Membrane Shaping Adapter Proteins That Modulate Specific G Protein-Coupled Receptor Trafficking by Affecting ER Cargo Capacity	PLOS ONE			English	Article							HEREDITARY SPASTIC PARAPLEGIA; ENDOPLASMIC-RETICULUM EXIT; GLUTAMATE TRANSPORTER; YEAST HOMOLOG; GENE; ORGANIZATION; MUTATIONS; YIP1P; RAB; IDENTIFICATION	Receptor expression enhancing proteins (REEPs) were identified by their ability to enhance cell surface expression of a subset of G protein-coupled receptors (GPCRs), specifically GPCRs that have proven difficult to express in heterologous cell systems. Further analysis revealed that they belong to the Yip (Ypt-interacting protein) family and that some REEP subtypes affect ER structure. Yip family comparisons have established other potential roles for REEPs, including regulation of ER-Golgi transport and processing/neuronal localization of cargo proteins. However, these other potential REEP functions and the mechanism by which they selectively enhance GPCR cell surface expression have not been clarified. By utilizing several REEP family members (REEP1, REEP2, and REEP6) and model GPCRs (alpha 2A and alpha 2C adrenergic receptors), we examined REEP regulation of GPCR plasma membrane expression, intracellular processing, and trafficking. Using a combination of immunolocalization and biochemical methods, we demonstrated that this REEP subset is localized primarily to ER, but not plasma membranes. Single cell analysis demonstrated that these REEPs do not specifically enhance surface expression of all GPCRs, but affect ER cargo capacity of specific GPCRs and thus their surface expression. REEP co-expression with alpha 2 adrenergic receptors (ARs) revealed that this REEP subset interacts with and alter glycosidic processing of alpha 2C, but not alpha 2A ARs, demonstrating selective interaction with cargo proteins. Specifically, these REEPs enhanced expression of and interacted with minimally/non-glycosylated forms of alpha 2C ARs. Most importantly, expression of a mutant REEP1 allele (hereditary spastic paraplegia SPG31) lacking the carboxyl terminus led to loss of this interaction. Thus specific REEP isoforms have additional intracellular functions besides altering ER structure, such as enhancing ER cargo capacity, regulating ER-Golgi processing, and interacting with select cargo proteins. Therefore, some REEPs can be further described as ER membrane shaping adapter proteins.	[Bjork, Susann] Univ Turku, Inst Biomed, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland; [Bjork, Susann; Hurt, Carl M.; Ho, Vincent K.; Angelotti, Timothy] Stanford Univ, Dept Anesthesia CCM, Sch Med, Stanford, CA 94305 USA	University of Turku; Stanford University	Angelotti, T (corresponding author), Stanford Univ, Dept Anesthesia CCM, Sch Med, Stanford, CA 94305 USA.	timangel@stanford.edu	Angelotti, Timothy/AAD-3714-2022	Angelotti, Timothy/0000-0002-0100-2011	NINDS National Institute of Neurological Disorders and Stroke (NINDS) [K08NS050654-01A1]; Finnish Cultural Foundation; Swedish Cultural Foundation; Magnus Ehrnrooth Foundation; Maud Kuistila Memorial Foundation; Emil Aaltonen Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS050654] Funding Source: NIH RePORTER	NINDS National Institute of Neurological Disorders and Stroke (NINDS); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Swedish Cultural Foundation; Magnus Ehrnrooth Foundation; Maud Kuistila Memorial Foundation; Emil Aaltonen Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants from NINDS National Institute of Neurological Disorders and Stroke (NINDS) K08NS050654-01A1 (TA) and supported by grants from the Finnish Cultural Foundation, the Swedish Cultural Foundation, The Magnus Ehrnrooth Foundation, the Maud Kuistila Memorial Foundation as well as the Emil Aaltonen Foundation (SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelotti T, 2010, TRAFFIC, V11, P560, DOI 10.1111/j.1600-0854.2010.01033.x; Barrowman J, 2003, J BIOL CHEM, V278, P19878, DOI 10.1074/jbc.M302406200; Bauer M, 2006, FEBS LETT, V580, P5559, DOI 10.1016/j.febslet.2006.08.077; Beetz C, 2008, BRAIN, V131, P1078, DOI 10.1093/brain/awn026; Behrens M, 2006, J BIOL CHEM, V281, P20650, DOI 10.1074/jbc.M513637200; Blackstone C, 2011, NAT REV NEUROSCI, V12, P31, DOI 10.1038/nrn2946; Brands A, 2002, PLANT PHYSIOL, V130, P1121, DOI 10.1104/pp.007716; Brum PC, 2006, NEUROPHARMACOLOGY, V51, P397, DOI 10.1016/j.neuropharm.2006.03.032; Butchbach MER, 2002, GENE, V292, P81, DOI 10.1016/S0378-1119(02)00669-8; Calero M, 2002, FEBS LETT, V515, P89, DOI 10.1016/S0014-5793(02)02442-0; Calero M, 2001, J BIOL CHEM, V276, P12100, DOI 10.1074/jbc.M008439200; Carrel D, 2008, J NEUROSCI, V28, P8063, DOI 10.1523/JNEUROSCI.4487-07.2008; Daunt DA, 1997, MOL PHARMACOL, V51, P711, DOI 10.1124/mol.51.5.711; de Brito OM, 2010, EMBO J, V29, P2715, DOI 10.1038/emboj.2010.177; De Matteis MA, 2011, NEW ENGL J MED, V365, P927, DOI 10.1056/NEJMra0910494; Goizet C, 2011, HUM MUTAT, V32, P1118, DOI 10.1002/humu.21542; Heidtman M, 2003, J CELL BIOL, V163, P57, DOI 10.1083/jcb.200306118; Hinners I, 1999, ANAL BIOCHEM, V276, P1, DOI 10.1006/abio.1999.4325; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Hurt CM, 2013, METHOD ENZYMOL, V521, P171, DOI 10.1016/B978-0-12-391862-8.00009-0; Hurt CM, 2000, J BIOL CHEM, V275, P35424, DOI 10.1074/jbc.M006241200; Ilegems E, 2010, J NEUROSCI, V30, P13774, DOI 10.1523/JNEUROSCI.0091-10.2010; Johnson C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005751; Liu SG, 2009, SYNAPSE, V63, P201, DOI 10.1002/syn.20602; Liu YW, 2011, TRAFFIC, V12, P1620, DOI 10.1111/j.1600-0854.2011.01250.x; Martincic I, 1997, J BIOL CHEM, V272, P26991, DOI 10.1074/jbc.272.43.26991; Matern H, 2000, EMBO J, V19, P4485, DOI 10.1093/emboj/19.17.4485; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Nishikawa M, 2007, GENE, V386, P42, DOI 10.1016/j.gene.2006.06.030; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Otte S, 2001, J CELL BIOL, V152, P503, DOI 10.1083/jcb.152.3.503; Papp S, 2003, J CELL BIOL, V160, P475, DOI 10.1083/jcb.200207136; Park SH, 2010, EMBO REP, V11, P515, DOI 10.1038/embor.2010.92; Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Ruggiero AM, 2008, J BIOL CHEM, V283, P6175, DOI 10.1074/jbc.M701008200; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Schlaitz AL, 2013, DEV CELL; Schlang KJ, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-71; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Soderblom C, 2006, PHARMACOL THERAPEUT, V109, P42, DOI 10.1016/j.pharmthera.2005.06.001; Spisni E, 2005, BIOCHEM BIOPH RES CO, V338, P1383, DOI 10.1016/j.bbrc.2005.10.099; Tang BL, 2001, J BIOL CHEM, V276, P40008, DOI 10.1074/jbc.M106189200; Tinti M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120103; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; VONZASTROW M, 1993, J BIOL CHEM, V268, P763; Wozniak M, 1996, J BIOL CHEM, V271, P5017; Yang XP, 1998, EMBO J, V17, P4954, DOI 10.1093/emboj/17.17.4954; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002; Zuchner S, 2006, AM J HUM GENET, V79, P365, DOI 10.1086/505361; Zurek N, 2011, TRAFFIC, V12, P28, DOI 10.1111/j.1600-0854.2010.01134.x	53	52	55	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76366	10.1371/journal.pone.0076366	http://dx.doi.org/10.1371/journal.pone.0076366			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098485	Green Published, Green Submitted, gold			2022-12-25	WOS:000325434500064
J	Gorman, E; Ashe, MC; Dunstan, DW; Hanson, HM; Madden, K; Winkler, EAH; McKay, HA; Healy, GN				Gorman, Erin; Ashe, Maureen C.; Dunstan, David W.; Hanson, Heather M.; Madden, Ken; Winkler, Elisabeth A. H.; McKay, Heather A.; Healy, Genevieve N.			Does an 'Activity-Permissive' Workplace Change Office Workers' Sitting and Activity Time?	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SEDENTARY TIME; CARDIOVASCULAR-DISEASE; ACTIVITY MONITOR; US ADULTS; INTERVENTION; OPPORTUNITIES; ENVIRONMENT; BEHAVIORS; OBESITY	Introduction: To describe changes in workplace physical activity, and health-, and work-related outcomes, in workers who transitioned from a conventional to an 'activity-permissive' workplace. Methods: A natural pre-post experiment conducted in Vancouver, Canada in 2011. A convenience sample of office-based workers (n=24, 75% women, mean [SD] age = 34.5 [8.1] years) were examined four months following relocation from a conventional workplace (pre) to a newly-constructed, purpose-built, movement-oriented physical environment (post). Workplace activity-(activPAL3-derived stepping, standing, and sitting time), health-(body composition and fasting cardio-metabolic blood profile), and work-(performance; job satisfaction) related outcomes were measured pre- and post-move and compared using paired t-tests. Results: Pre-move, on average (mean [SD]) the majority of the day was spent sitting (364 [43.0] mins/8-hr workday), followed by standing (78.2 [32.1] mins/8-hr workday) and stepping (37.7 [15.6] mins/8-hr workday). The transition to the 'activity-permissive' workplace resulted in a significant increase in standing time (+18.5, 95% CI: 1.8, 35.2 mins/8hr workday), likely driven by reduced sitting time (-19.7, 95% CI: -42.1, 2.8 mins/8-hr workday) rather than increased stepping time (+1.2, 95% CI: -6.2, 8.5 mins/8-hr workday). There were no statistically significant differences observed in health-or work-related outcomes. Discussion: This novel, opportunistic study demonstrated that the broader workplace physical environment can beneficially impact on standing time in office workers. The long-term health and work-related benefits, and the influence of individual, organizational, and social factors on this change, requires further evaluation.	[Gorman, Erin; Ashe, Maureen C.; Hanson, Heather M.; McKay, Heather A.] Ctr Hip Hlth & Mobil, Vancouver, BC, Canada; [Gorman, Erin; Ashe, Maureen C.; Hanson, Heather M.; McKay, Heather A.] Univ British Columbia, Dept Family Practice, Vancouver, BC V5Z 1M9, Canada; [Dunstan, David W.; Healy, Genevieve N.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Madden, Ken] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [McKay, Heather A.] Univ British Columbia, Dept Orthopaed, Vancouver, BC V5Z 1M9, Canada; [Dunstan, David W.; Winkler, Elisabeth A. H.; Healy, Genevieve N.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Dunstan, David W.] Monash Univ, Melbourne, Vic 3004, Australia; [Dunstan, David W.] Univ Western Australia, Sch Sports Sci Exercise & Hlth, Perth, WA 6009, Australia	University of British Columbia; Baker Heart and Diabetes Institute; University of British Columbia; University of British Columbia; University of Queensland; Monash University; University of Western Australia	Healy, GN (corresponding author), Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia.	g.healy@uq.edu.au	ashe, maureen/AAI-1350-2021; Dunstan, David Wayne/E-8473-2010; Healy, Genevieve/A-7408-2008; Winkler, Elisabeth/AAD-7153-2022	Dunstan, David Wayne/0000-0003-2629-9568; Healy, Genevieve/0000-0001-7093-7892; Winkler, Elisabeth/0000-0003-1452-6102; Ashe, Maureen C./0000-0002-6820-4435; Hanson, Heather M./0000-0003-2297-7253	University of Queensland Early Career Research Grant; Canadian Institutes of Health Research (CIHR); CIHR New Investigator Award; Michael Smith for Health Research Scholar Award; RC Future Fellowship; NHMRC [569861]	University of Queensland Early Career Research Grant; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR)); Michael Smith for Health Research Scholar Award; RC Future Fellowship; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by a University of Queensland Early Career Research Grant. Gorman was supported through a Canadian Institutes of Health Research (CIHR) Masters' Award. Ashe was supported through a CIHR New Investigator Award and a Michael Smith for Health Research Scholar Award. Dunstan was supported by an ARC Future Fellowship. Madden is supported by a CIHR Operating Grant. Healy was supported by an NHMRC [#569861] training Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhajah TA, 2012, AM J PREV MED, V43, P298, DOI 10.1016/j.amepre.2012.05.027; [Anonymous], 2010, ACTIVE DESIGN GUIDEL; [Anonymous], 2012, REDUCING PROLONGED S; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Duvivier BMFM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055542; Evans RE, 2012, AM J PREV MED, V43, P293, DOI 10.1016/j.amepre.2012.05.010; Grant PM, 2006, BRIT J SPORT MED, V40, P992, DOI 10.1136/bjsm.2006.030262; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Healy GN, 2008, MED SCI SPORT EXER, V40, P639, DOI 10.1249/MSS.0b013e3181607421; Healy GN, 2013, PREV MED, V57, P43, DOI 10.1016/j.ypmed.2013.04.004; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Hologic Inc, 2000, OL QDR SER US GUID; Kozey-Keadle S, 2011, MED SCI SPORT EXER, V43, P1561, DOI 10.1249/MSS.0b013e31820ce174; LaMontagne A.D., 2012, IMPROVING ORG INTERV; Lanningham-Foster L, 2008, OBESITY, V16, P1849, DOI 10.1038/oby.2008.282; Matthews CE, 2012, AM J CLIN NUTR, V95, P437, DOI 10.3945/ajcn.111.019620; Owen N, 2011, AM J PREV MED, V41, P189, DOI 10.1016/j.amepre.2011.05.013; Ryan CG, 2006, BRIT J SPORT MED, V40, P779, DOI 10.1136/bjsm.2006.027276; Ryan CG, 2011, ERGONOMICS, V54, P531, DOI 10.1080/00140139.2011.570458; SUNDSTROM E, 1994, ENVIRON BEHAV, V26, P195, DOI 10.1177/001391659402600204; Thorp AA, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-128; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Tikkanen O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052228; Tucker P, 2007, PUBLIC HEALTH, V121, P909, DOI 10.1016/j.puhe.2007.04.009; van Uffelen JGZ, 2010, AM J PREV MED, V39, P379, DOI 10.1016/j.amepre.2010.05.024; Wells NM, 2007, ENVIRON BEHAV, V39, P6, DOI 10.1177/0013916506295570; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z; Zimring C, 2005, AM J PREV MED, V28, P186, DOI 10.1016/j.amepre.2004.10.025	29	65	65	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76723	10.1371/journal.pone.0076723	http://dx.doi.org/10.1371/journal.pone.0076723			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231RG	24098555	Green Published, gold			2022-12-25	WOS:000325434500083
J	Leclerc, D; Rivest, M; Babin, C; Lopez-Macias, C; Savard, P				Leclerc, Denis; Rivest, Marie; Babin, Cindy; Lopez-Macias, Constantino; Savard, Pierre			A Novel M2e Based Flu Vaccine Formulation for Dogs	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; INTEGRAL MEMBRANE-PROTEIN; SALMONELLA-TYPHI; INFLUENZA; EPITOPE; CELL; PEPTIDE; MICE; IMMUNOGENICITY; EXPRESSION	Background: The USA 2004 influenza virus outbreak H3N8 in dogs heralded the emergence of a new disease in this species. A new inactivated H3N8 vaccine was developed to control the spread of the disease but, as in humans and swine, it is anticipated that the virus will mutate shift and drift in the dog population. Therefore, there is a need for a vaccine that can trigger a broad protection to prevent the spread of the virus and the emergence of new strains. Methodology and Principal Findings: The universal M2e peptide is identical in almost all the H3N8 influenza strains sequenced to date and known to infect dogs. This epitope is therefore a good choice for development of a vaccine to provide broad protection. Malva mosaic virus (MaMV) nanoparticles were chosen as a vaccine platform to improve the stability of the M2e peptide and increase its immunogenicity in animals. The addition of an adjuvant (OmpC) purified from Salmonella typhi membrane in the vaccine formulation increased the immune response directed to the M2e peptide significantly and enlarged the protection to include the heterosubtypic strain of influenza in a mouse model. An optimal vaccine formulation was also shown to be immunogenic in dogs. Conclusions and Significance: The MaMV vaccine platform triggered an improved immune response directed towards the universal M2e peptide. The adjuvant OmpC increased the immune response to the M2e peptide and protection to a heterosubtypic influenza strain that harbors a different M2e peptide in a mouse model. Antibodies generated by the vaccine formulation showed cross-reactivity with M2e peptides derived from influenza strains H9N2, H5N1 and H1N1. The vaccine formulation shows a potential for commercialization of a new M2e based vaccine in dogs.	[Leclerc, Denis; Rivest, Marie; Babin, Cindy] Univ Laval, Microbiol Infectiol & Immunol Infect Dis Res Ctr, Quebec City, PQ, Canada; [Lopez-Macias, Constantino] Specialties Hosp, Med Res Unit Immunochem, Natl Med Ctr Siglo 21, IMSS, Mexico City, DF, Mexico; [Savard, Pierre] Univ Laval, Quebec City, PQ, Canada	Laval University; Instituto Mexicano del Seguro Social; Laval University	Leclerc, D (corresponding author), Univ Laval, Microbiol Infectiol & Immunol Infect Dis Res Ctr, Quebec City, PQ, Canada.	Denis.Leclerc@crchul.ulaval.ca	Leclerc, Denis/P-1604-2019; Leclerc, Denis/AAG-6112-2019; López Macías, Constatino III Roberto/ABG-3414-2021	López Macías, Constatino III Roberto/0000-0003-0530-492X; savard, pierre/0000-0003-4134-0709; Lopez-Macias, Constantino III Roberto/0000-0002-7756-8468	'Ministere du Developpement economique, de l'innovation et de l'exportation (MDEIE)' of Quebec/Canada; Natural Sciences and Engineering Research Council (NSERC)-Canada [269445 - 03]	'Ministere du Developpement economique, de l'innovation et de l'exportation (MDEIE)' of Quebec/Canada; Natural Sciences and Engineering Research Council (NSERC)-Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research project was funded by the 'Programme de soutient a la valorisation et au transfert (PSVT)' of the 'Ministere du Developpement economique, de l'innovation et de l'exportation (MDEIE)' of Quebec/Canada and the grant Natural Sciences and Engineering Research Council (NSERC)-Canada (grant # 269445 - 03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alurkar V, 1997, INFECT IMMUN, V65, P2382, DOI 10.1128/IAI.65.6.2382-2388.1997; Babin C, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-10; Cervantes-Barragan L, 2009, EUR J IMMUNOL, V39, P126, DOI 10.1002/eji.200838185; Cote F, 2008, INFECT GENET EVOL, V8, P83, DOI 10.1016/j.meegid.2007.10.006; Crawford PC, 2005, SCIENCE, V310, P482, DOI 10.1126/science.1117950; Daly JM, 2008, EMERG INFECT DIS, V14, P461, DOI 10.3201/eid1403.070643; De Filette M, 2008, VACCINE, V26, P6503, DOI 10.1016/j.vaccine.2008.09.038; Denis J, 2008, VACCINE, V26, P3395, DOI 10.1016/j.vaccine.2008.04.052; Denis J, 2007, VIROLOGY, V363, P59, DOI 10.1016/j.virol.2007.01.011; Deshpande MS, 2009, VET THER, V10, P29; Ebrahimi SM, 2011, VIRUS GENES, V42, P1, DOI 10.1007/s11262-010-0547-7; Fiers W, 2004, VIRUS RES, V103, P173, DOI 10.1016/j.virusres.2004.02.030; Fu TM, 2009, VACCINE, V27, P1440, DOI 10.1016/j.vaccine.2008.12.034; Gao X, 2013, ANTIVIR RES, V98, P4, DOI 10.1016/j.antiviral.2013.01.010; Grandea AG, 2010, P NATL ACAD SCI USA, V107, P12658, DOI 10.1073/pnas.0911806107; Hanafi LA, 2010, VACCINE, V28, P5617, DOI 10.1016/j.vaccine.2010.06.024; Hashemi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045765; HOLSINGER LJ, 1991, VIROLOGY, V183, P32, DOI 10.1016/0042-6822(91)90115-R; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; Kim MC, 2013, MOL THER, V21, P485, DOI 10.1038/mt.2012.246; Lacasse P, 2008, J VIROL, V82, P785, DOI 10.1128/JVI.01811-07; LAMB RA, 1985, CELL, V40, P627, DOI 10.1016/0092-8674(85)90211-9; Leclerc D, 2011, CURR TOP MICROBIOL I, V183, P2; Leclerc D, 2007, J VIROL, V81, P1319, DOI 10.1128/JVI.01720-06; Lico C, 2006, J GEN VIROL, V87, P3103, DOI 10.1099/vir.0.82097-0; Liu WL, 2004, IMMUNOL LETT, V93, P131, DOI 10.1016/j.imlet.2004.03.003; Martinez-Flores I, 1999, J BACTERIOL, V181, P556; Marusic C, 2001, J VIROL, V75, P8434, DOI 10.1128/JVI.75.18.8434-8439.2001; Mathieu C, 2013, NANOMEDECINE; Matic S, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-106; O'Hagan DT, 2009, DRUG DISCOV TODAY, V14, P541, DOI 10.1016/j.drudis.2009.02.009; Rioux G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031925; Savard C, 2012, VACCINE, V30, P2535, DOI 10.1016/j.vaccine.2012.01.085; Savard C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021522; Secundino I, 2006, IMMUNOLOGY, V117, P59, DOI 10.1111/j.1365-2567.2005.02263.x; Seidel UJE, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00076; Song JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014538; Stuart-Harris CH, 1939, LANCET, V1, P497; SUGRUE RJ, 1991, VIROLOGY, V180, P617, DOI 10.1016/0042-6822(91)90075-M; Tissot AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009809; Uhde K, 2005, ARCH VIROL, V150, P327, DOI 10.1007/s00705-004-0402-z	41	11	11	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e77084	10.1371/journal.pone.0077084	http://dx.doi.org/10.1371/journal.pone.0077084			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098576	gold, Green Published, Green Submitted			2022-12-25	WOS:000325434500094
J	Hamajima, N; Johmura, Y; Suzuki, S; Nakanishi, M; Saitoh, S				Hamajima, Naoki; Johmura, Yoshikazu; Suzuki, Satoshi; Nakanishi, Makoto; Saitoh, Shinji			Increased Protein Stability of CDKN1C Causes a Gain-of-Function Phenotype in Patients with IMAGe Syndrome	PLOS ONE			English	Article							BECKWITH-WIEDEMANN SYNDROME; DEPENDENT KINASE INHIBITOR; CELL NUCLEAR ANTIGEN; PROTEASOMAL DEGRADATION; ADRENAL HYPOPLASIA; GROWTH-RETARDATION; MICE LACKING; P57(KIP2); ASSOCIATION; BINDING	Mutations in the proliferating cell nuclear antigen (PCNA)-binding domain of the CDKN1C gene were recently identified in patients with IMAGe syndrome. However, loss of PCNA binding and suppression of CDKN1C monoubiquitination by IMAGe-associated mutations hardly explain the reduced-growth phenotype characteristic of IMAGe syndrome. We demonstrate here that IMAGe-associated mutations in the CDKN1C gene dramatically increased the protein stability. We identified a novel heterozygous mutation, c.815T>G (p.Ile272Ser), in the CDKN1C gene in three siblings manifesting clinical symptoms associated with IMAGe syndrome and their mother (unaffected carrier). PCNA binding to CDKN1C was disrupted in the case of p.Ile272Ser, and for two other IMAGe-associated mutations, p.Asp274Asn and p.Phe276Val. Intriguingly, the IMAGe-associated mutant CDKN1C proteins were fairly stable even in the presence of cycloheximide, whereas the wild-type protein was almost completely degraded via the proteasome pathway, as shown by the lack of degradation with addition of a proteasome inhibitor, MG132. These results thus suggested that the reduced-growth phenotype of IMAGe syndrome derives from CDKN1C gain-of-function due to IMAGe-associated mutations driving increased protein stability.	[Hamajima, Naoki; Suzuki, Satoshi] Nagoya City West Med Ctr, Dept Pediat, Nagoya, Aichi, Japan; [Johmura, Yoshikazu; Nakanishi, Makoto] Nagoya City Univ, Grad Sch Med Sci, Dept Cell Biol, Nagoya, Aichi, Japan; [Saitoh, Shinji] Nagoya City Univ, Grad Sch Med Sci, Dept Pediat & Neonatol, Nagoya, Aichi, Japan	Nagoya City University; Nagoya City University	Hamajima, N (corresponding author), Nagoya City West Med Ctr, Dept Pediat, Nagoya, Aichi, Japan.	nhamajim@med.nagoya-cu.ac.jp		Saitoh, Shinji/0000-0001-6911-3351	Grants-in-Aid for Scientific Research [24659137] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Amano N, 2008, AM J MED GENET A, V146A, P2130, DOI 10.1002/ajmg.a.32425; Arboleda VA, 2012, NAT GENET, V44, P788, DOI 10.1038/ng.2275; Balasubramanian M, 2010, AM J MED GENET A, V152A, P3138, DOI 10.1002/ajmg.a.33716; Bergada I, 2005, J CLIN ENDOCR METAB, V90, P3186, DOI 10.1210/jc.2004-1589; Hatada I, 1996, NAT GENET, V14, P171, DOI 10.1038/ng1096-171; Hutz JE, 2006, MOL GENET METAB, V88, P66, DOI 10.1016/j.ymgme.2006.01.006; Jin Y, 2008, MOL CELL BIOL, V28, P1218, DOI 10.1128/MCB.01198-07; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Kamura T, 2003, P NATL ACAD SCI USA, V100, P10231, DOI 10.1073/pnas.1831009100; Kim M, 2008, EMBO REP, V9, P878, DOI 10.1038/embor.2008.125; LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639; Lienhardt A, 2002, HORM RES, V57, P71, DOI 10.1159/000058105; Lu ZM, 2010, CELL CYCLE, V9, P2342, DOI 10.4161/cc.9.12.11988; NAKANISHI M, 1995, J BIOL CHEM, V270, P17060, DOI 10.1074/jbc.270.29.17060; Pateras IS, 2009, MOL CANCER RES, V7, P1902, DOI 10.1158/1541-7786.MCR-09-0317; Pedreira CC, 2004, J PEDIATR-US, V144, P274, DOI 10.1016/j.jpeds.2003.09.052; Sarostina NG, 2012, TRENDS CELL BIOL, V22, P33; Takahashi K, 2000, J BIOCHEM-TOKYO, V127, P73, DOI 10.1093/oxfordjournals.jbchem.a022586; Tan TY, 2006, AM J MED GENET A, V140A, P1778, DOI 10.1002/ajmg.a.31365; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367; Vilain E, 1999, J CLIN ENDOCR METAB, V84, P4335, DOI 10.1210/jc.84.12.4335; Wang B, 2010, MOL CELL BIOL, V30, P1508, DOI 10.1128/MCB.01335-09; Watanabe H, 1998, P NATL ACAD SCI USA, V95, P1392, DOI 10.1073/pnas.95.4.1392; Yan Y, 1997, GENE DEV, V11, P973, DOI 10.1101/gad.11.8.973; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0	25	29	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75137	10.1371/journal.pone.0075137	http://dx.doi.org/10.1371/journal.pone.0075137			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098681	Green Published, gold, Green Submitted			2022-12-25	WOS:000325423500052
J	Lo, TF; Tsai, WC; Chen, ST				Lo, Ting-Fang; Tsai, Wei-Chung; Chen, Shui-Tein			MicroRNA-21-3p, a Berberine-Induced miRNA, Directly Down-Regulates Human Methionine Adenosyltransferases 2A and 2B and Inhibits Hepatoma Cell Growth	PLOS ONE			English	Article							LIVER-CANCER CELLS; ADENOSYL-L-METHIONINE; S-ADENOSYLMETHIONINE; HEPATOCELLULAR-CARCINOMA; INDUCED APOPTOSIS; COPTIDIS-RHIZOMA; GENE-EXPRESSION; UP-REGULATION; MAT2A GENE; PROLIFERATION	Methionine adenosyltransferase (MAT) is the cellular enzyme that catalyzes the synthesis of S-adenosylmethionine (SAM), the principal biological methyl donor and a key regulator of hepatocyte proliferation, death and differentiation. Two genes, MAT1A and MAT2A, encode 2 distinct catalytic MAT isoforms. A third gene, MAT2B, encodes a MAT2A regulatory subunit. In hepatocellular carcinoma (HCC), MAT1A downregulation and MAT2A upregulation occur, known as the MAT1A: MAT2A switch. The switch is accompanied with an increasing expression of MAT2B, which results in decreased SAM levels and facilitates cancer cell growth. Berberine, an isoquinoline alkaloid isolated from many medicinal herbs such as Coptis chinensis, has a wide range of pharmacological effects including anti-cancer effects. Because drug-induced microRNAs have recently emerged as key regulators in guiding their pharmacological effects, we examined whether microRNA expression is differentially altered by berberine treatment in HCC. In this study, we used microRNA microarrays to find that the expression level of miR-21-3p (previously named miR-21*) increased after berberine treatment in the HepG2 human hepatoma cell line. To predict the putative targets of miR-21-3p, we integrated the gene expression profiles of HepG2 cells after berberine treatment by comparing with a gene list generated from sequence-based microRNA target prediction software. We then confirmed these predictions through transfection of microRNA mimics and a 3' UTR reporter assay. Our findings provide the first evidence that miR-21-3p directly reduces the expression of MAT2A and MAT2B by targeting their 3' UTRs. In addition, an overexpression of miR-21-3p increased intracellular SAM contents, which have been proven to be a growth disadvantage for hepatoma cells. The overexpression of miR-21-3p suppresses growth and induces apoptosis in HepG2 cells. Overall, our results demonstrate that miR-21-3p functions as a tumor suppressor by directly targeting both MAT2A and MAT2B, indicating its therapeutic potential in HCC.	[Lo, Ting-Fang; Tsai, Wei-Chung; Chen, Shui-Tein] Natl Taiwan Univ, Inst Biochem Sci, Coll Life Sci, Taipei, Taiwan; [Lo, Ting-Fang; Tsai, Wei-Chung; Chen, Shui-Tein] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Lo, Ting-Fang; Tsai, Wei-Chung; Chen, Shui-Tein] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan	National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Chen, ST (corresponding author), Natl Taiwan Univ, Inst Biochem Sci, Coll Life Sci, Taipei, Taiwan.	bcchen@gate.sinica.edu.tw			National Science Council; National Health Research Institutes	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes(National Health Research Institutes, Japan)	Funded by National Science Council (http://web1.nsc.gov.tw/) and National Health Research Institutes (http://www.nhri.org.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Auyeung KKW, 2009, INT J MOL MED, V24, P571, DOI 10.3892/ijmm_00000267; Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Braig S, 2013, ONCOGENE, V32, P837, DOI 10.1038/onc.2012.115; Cai JX, 1998, CANCER RES, V58, P1444; Frau M, 2012, HEPATOLOGY, V56, P165, DOI 10.1002/hep.25643; GARCEA R, 1989, CANCER RES, V49, P1850; Goff LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007192; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guo L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011387; Hu HY, 2013, ACTA PHARMACOL SIN, V34, P157, DOI 10.1038/aps.2012.161; Huang ZZ, 1999, HEPATOLOGY, V29, P1471, DOI 10.1002/hep.510290525; Huang ZZ, 1998, AM J PHYSIOL-GASTR L, V275, pG14, DOI 10.1152/ajpgi.1998.275.1.G14; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Hwang JM, 2006, ARCH TOXICOL, V80, P62, DOI 10.1007/s00204-005-0014-8; Iizuka N, 2000, CANCER LETT, V148, P19, DOI 10.1016/S0304-3835(99)00264-5; Iorio MV, 2012, CARCINOGENESIS, V33, P1126, DOI 10.1093/carcin/bgs140; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jansson MD, 2012, MOL ONCOLOGY; Kim S, 2008, MOLECULES, V13, P2975, DOI 10.3390/molecules13122975; Kotb M, 1997, TRENDS GENET, V13, P51, DOI 10.1016/S0168-9525(97)01013-5; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; LeGros HL, 2000, J BIOL CHEM, V275, P2359, DOI 10.1074/jbc.275.4.2359; LeGros L, 2001, J BIOL CHEM, V276, P24918, DOI 10.1074/jbc.M102816200; Liu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021416; Liu QY, 2007, HEPATOL RES, V37, P376, DOI 10.1111/j.1872-034X.2007.00041.x; Liu XY, 2012, CHINESE MED J-PEKING, V125, P2908, DOI 10.3760/cma.j.issn.0366-6999.2012.16.020; Lu SC, 2008, J GASTROEN HEPATOL, V23, pS73, DOI 10.1111/j.1440-1746.2007.05289.x; Ma C, 2013, CHEM BIOL DRUG DESIG; Mantena SK, 2006, MOL CANCER THER, V5, P296, DOI 10.1158/1535-7163.MCT-05-0448; Martinez-Chantar ML, 2002, FASEB J, V16, P1292, DOI 10.1096/fj.02-0078fje; Martinez-Chantar ML, 2003, METHIONINE ADENOSYLT; Martinez-Sanchez Aida, 2013, Biology (Basel), V2, P189, DOI 10.3390/biology2010189; Mato JM, 1997, PHARMACOL THERAPEUT, V73, P265, DOI 10.1016/S0163-7258(96)00197-0; Mato JM, 2002, FASEB J, V16, P15, DOI 10.1096/fj.01-0401rev; Mato JM, 2007, HEPATOLOGY, V45, P1306, DOI 10.1002/hep.21650; Molloy A, 2011, BIOINFORMATIC GENETI; Okamura K, 2008, CELL CYCLE, V7, P2840, DOI 10.4161/cc.7.18.6734; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Paneda C, 2002, HEPATOLOGY, V35, P1381, DOI 10.1053/jhep.2002.32538; Peng PL, 2006, TOXICOL APPL PHARM, V214, P8, DOI 10.1016/j.taap.2005.11.010; Ramani K, 2008, HEPATOLOGY, V47, P521, DOI 10.1002/hep.22064; Rodrigues AC, 2011, BIOPHARM DRUG DISPOS, V32, P355, DOI 10.1002/bdd.764; Rodriguez JL, 2007, INT J BIOCHEM CELL B, V39, P842, DOI 10.1016/j.biocel.2007.01.009; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Tang J, 2009, J ETHNOPHARMACOL, V126, P5, DOI 10.1016/j.jep.2009.08.009; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Wang LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056666; Wang LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036418; Wang N, 2010, J CELL BIOCHEM, V111, P1426, DOI 10.1002/jcb.22869; Wang Q, 2008, WORLD J GASTROENTERO, V14, P4633, DOI 10.3748/wjg.14.4633; Wang Q, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-72; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Yan GR, 2011, PROTEOMICS, V11, P912, DOI 10.1002/pmic.201000539; Yang HP, 2004, HEPATOLOGY, V40, P221, DOI 10.1002/hep.20274; Yang HP, 2001, FASEB J, V15, P1507, DOI 10.1096/fj.01-0040com; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911; Yokoi T, 2013, ANNU REV PHARMACOL, V53, P377, DOI 10.1146/annurev-pharmtox-011112-140250; Zhu MF, 2011, EXP THER MED, V2, P27, DOI 10.3892/etm.2010.164	60	84	87	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75628	10.1371/journal.pone.0075628	http://dx.doi.org/10.1371/journal.pone.0075628			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098708	gold, Green Published, Green Submitted			2022-12-25	WOS:000325423500079
J	Marquard, E; Schmid, B; Roscher, C; De Luca, E; Nadrowski, K; Weisser, WW; Weigelt, A				Marquard, Elisabeth; Schmid, Bernhard; Roscher, Christiane; De Luca, Enrica; Nadrowski, Karin; Weisser, Wolfgang W.; Weigelt, Alexandra			Changes in the Abundance of Grassland Species in Monocultures versus Mixtures and Their Relation to Biodiversity Effects	PLOS ONE			English	Article							PLANT-SOIL FEEDBACKS; PRODUCTIVITY RELATIONSHIP; TEMPORAL STABILITY; DIVERSITY; COMMUNITIES; PATHOGENS; PATTERNS; COMPLEMENTARITY; COMPETITION; POPULATION	Numerous studies have reported positive effects of species richness on plant community productivity. Such biodiversity effects are usually quantified by comparing the performance of plant mixtures with reference monocultures. However, several mechanisms, such as the lack of resource complementarity and facilitation or the accumulation of detrimental agents, suggest that monocultures are more likely than mixtures to deteriorate over time. Increasing biodiversity effects over time could therefore result from declining monocultures instead of reflecting increases in the functioning of mixtures. Commonly, the latter is assumed when positive trends in biodiversity effects occur. Here, we analysed the performance of 60 grassland species growing in monocultures and mixtures over 9 years in a biodiversity experiment to clarify whether their temporal biomass dynamics differed and whether a potential decline of monocultures contributed significantly to the positive net biodiversity effect observed. Surprisingly, individual species' populations produced, on average, significantly more biomass per unit area when growing in monoculture than when growing in mixture. Over time, productivity of species decreased at a rate that was, on average, slightly more negative in monocultures than in mixtures. The mean net biodiversity effect across all mixtures was continuously positive and ranged between 64-217 g per m(2). Short-term increases in the mean net biodiversity effect were only partly due to deteriorating monocultures and were strongly affected by particular species gaining dominance in mixtures in the respective years. We conclude that our species performed, on average, comparably in monocultures and mixtures; monoculture populations being slightly more productive than mixture populations but this trend decreased over time. This suggested that negative feedbacks had not yet affected monocultures strongly but could potentially become more evident in the future. Positive biodiversity effects on aboveground productivity were heavily driven by a small, but changing, set of species that behaved differently from the average species.	[Marquard, Elisabeth] UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Germany; [Schmid, Bernhard; De Luca, Enrica] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Schmid, Bernhard; De Luca, Enrica] Univ Zurich, Zurich Basel Plant Sci Ctr, Zurich, Switzerland; [Roscher, Christiane] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany; [Nadrowski, Karin; Weigelt, Alexandra] Univ Leipzig, Inst Biol, D-04109 Leipzig, Germany; [Weisser, Wolfgang W.] Tech Univ Munich, Terr Ecol Dept Ecol & Ecosyst Management, Freising Weihenstephan, Germany; [Weigelt, Alexandra] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Zurich; University of Zurich; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University; Technical University of Munich	Marquard, E (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Germany.	lisa.marquard@ufz.de	Schmid, Bernhard/C-8625-2009; Weisser, Wolfgang W/B-9718-2014	Schmid, Bernhard/0000-0002-8430-3214; Weisser, Wolfgang W/0000-0002-2757-8959; Nadrowski, Karin/0000-0001-5358-5469; Marquard, Elisabeth/0000-0002-3418-9396	German Research Foundation [FOR 456, FOR 1451]; Friedrich Schiller University of Jena; Max Planck Institute for Biogeochemistry, Jena; Swiss National Science Foundation [31-65224-01]	German Research Foundation(German Research Foundation (DFG)); Friedrich Schiller University of Jena; Max Planck Institute for Biogeochemistry, Jena; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The Jena Experiment is funded by the German Research Foundation (FOR 456, FOR 1451) and supported by the Friedrich Schiller University of Jena and the Max Planck Institute for Biogeochemistry, Jena. Additional support was provided by the Swiss National Science Foundation (grant no. 31-65224-01 to B. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan E, 2011, P NATL ACAD SCI; Bartelt-Ryser J, 2005, PERSPECT PLANT ECOL, V7, P27, DOI 10.1016/j.ppees.2004.11.002; Bell T, 2006, ECOL LETT, V9, P569, DOI 10.1111/j.1461-0248.2006.00905.x; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; Bonanomi G, 2008, PLANT ECOL, V197, P207, DOI 10.1007/s11258-007-9371-0; Burdon JJ., 1987, DIS PLANT POPULATION; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Casper BB, 2007, ECOL LETT, V10, P394, DOI 10.1111/j.1461-0248.2007.01030.x; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; de la Pena E, 2010, BIOL INVASIONS, V12, P3637, DOI 10.1007/s10530-010-9756-1; Diez JM, 2010, ECOL LETT, V13, P803, DOI 10.1111/j.1461-0248.2010.01474.x; Dimitrakopoulos PG, 2004, ECOL LETT, V7, P574, DOI 10.1111/j.1461-0248.2004.00607.x; Fargione J, 2007, P ROY SOC B-BIOL SCI, V274, P871, DOI 10.1098/rspb.2006.0351; Hector A, 2002, ECOL LETT, V5, P502, DOI 10.1046/j.1461-0248.2002.00337.x; Heisse K, 2007, OECOLOGIA, V152, P435, DOI 10.1007/s00442-007-0666-6; Hendriks M, 2013, J ECOL, V101, P287, DOI 10.1111/1365-2745.12032; HilleRisLambers J, 2004, ECOL LETT, V7, P661, DOI 10.1111/j.1461-0248.2004.00623.x; Isbell FI, 2009, ECOL LETT, V12, P443, DOI 10.1111/j.1461-0248.2009.01299.x; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Kulmatiski A, 2008, ECOL LETT, V11, P980, DOI 10.1111/j.1461-0248.2008.01209.x; Kulmatiski A, 2012, P ROY SOC B-BIOL SCI, V279, P3020, DOI 10.1098/rspb.2012.0285; Latz E, 2012, J ECOL, V100, P597, DOI 10.1111/j.1365-2745.2011.01940.x; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Maron JL, 2011, ECOL LETT, V14, P36, DOI 10.1111/j.1461-0248.2010.01547.x; Marquard E, 2009, ECOLOGY, V90, P3290, DOI 10.1890/09-0069.1; Marquard E, 2009, J ECOL, V97, P696, DOI 10.1111/j.1365-2745.2009.01521.x; Mitchell CE, 2002, ECOLOGY, V83, P1713, DOI 10.1890/0012-9658(2002)083[1713:EOGPSD]2.0.CO;2; Mordecai EA, 2011, ECOL MONOGR, V81, P429, DOI 10.1890/10-2241.1; Mundt CC, 2002, ANNU REV PHYTOPATHOL, V40, P381, DOI 10.1146/annurev.phyto.40.011402.113723; Mwangi PN, 2007, J ECOL, V95, P65, DOI 10.1111/j.1365-2745.2006.01189.x; Petermann JS, 2008, ECOLOGY, V89, P2399, DOI 10.1890/07-2056.1; Reich PB, 2012, SCIENCE, V336, P589, DOI 10.1126/science.1217909; Roscher C, 2005, ECOL LETT, V8, P419, DOI 10.1111/j.1461-0248.2005.00736.x; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Roscher C, 2007, OECOLOGIA, V154, P535, DOI 10.1007/s00442-007-0846-4; Roscher C, 2011, J ECOL, V99, P1460, DOI 10.1111/j.1365-2745.2011.01875.x; Roscher C, 2011, PERSPECT PLANT ECOL, V13, P1, DOI 10.1016/j.ppees.2010.11.001; Schenk HJ, 2006, J ECOL, V94, P725, DOI 10.1111/j.1365-2745.2006.01124.x; Schnitzer SA, 2011, ECOLOGY, V92, P296, DOI 10.1890/10-0773.1; Singh HP, 1999, CRIT REV PLANT SCI, V18, P757, DOI 10.1080/07352689991309478; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Suding KN, 2013, J ECOL, V101, P298, DOI 10.1111/1365-2745.12057; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; TOFT CA, 1983, AM NAT, V122, P618, DOI 10.1086/284162; Troumbis AY, 2000, OIKOS, V90, P549, DOI 10.1034/j.1600-0706.2000.900313.x; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Putten WH, 2013, J ECOL, V101, P265, DOI 10.1111/1365-2745.12054; van Ruijven J, 2003, ECOL LETT, V6, P170, DOI 10.1046/j.1461-0248.2003.00427.x; van Ruijven J, 2009, OIKOS, V118, P101, DOI 10.1111/j.1600-0706.2008.17119.x; van Ruijven J, 2007, OIKOS, V116, P1323, DOI [10.1111/j.0030-1299.2007.16005.x, 10.1111/j.2007.0030-1299.16005.x]; VANDERPUTTEN WH, 1993, NATURE, V362, P53; Wagg C, 2011, ECOLOGY, V92, P1303, DOI 10.1890/10-1915.1; Weigelt A., 2010, ECOLOGY, V91, P930, DOI DOI 10.1890/09-0863.1	54	25	25	5	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75599	10.1371/journal.pone.0075599	http://dx.doi.org/10.1371/journal.pone.0075599			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098704	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000325423500075
J	Wang, XQ; Huang, GH; Yu, DY; Ge, BS; Wang, JQ; Xu, FX; Huang, F; Xu, H; Lu, JR				Wang, Xiaoqiang; Huang, Guihong; Yu, Daoyong; Ge, Baosheng; Wang, Jiqian; Xu, Fengxi; Huang, Fang; Xu, Hai; Lu, Jian R.			Solubilization and Stabilization of Isolated Photosystem I Complex with Lipopeptide Detergents	PLOS ONE			English	Article							MEMBRANE-PROTEIN; PEPTIDE SURFACTANTS; KINETICS	It is difficult to maintain a target membrane protein in a soluble and functional form in aqueous solution without biological membranes. Use of surfactants can improve solubility, but it remains challenging to identify adequate surfactants that can improve solubility without damaging their native structures and biological functions. Here we report the use of a new class of lipopeptides to solubilize photosystem I (PS-I), a well known membrane protein complex. Changes in the molecular structure of these surfactants affected their amphiphilicity and the goal of this work was to exploit a delicate balance between detergency and biomimetic performance in PS-I solubilization via their binding capacity. Meanwhile, the effects of these surfactants on the thermal and structural stability and functionality of PS-I in aqueous solution were investigated by circular dichroism, fluorescence spectroscopy, SDS-PAGE analysis and O-2 uptake measurements, respectively. Our studies showed that the solubility of PS-I depended on both the polarity and charge in the hydrophilic head of the lipopeptides and the length of its hydrophobic tail. The best performing lipopeptides in favour of PS-I solubility turned out to be C14DK and C16DK, which were comparable to the optimal amphiphilicity of the conventional chemical surfactants tested. Lipopeptides showed obvious advantages in enhancing PS-I thermostability over sugar surfactant DDM and some full peptide amphiphiles reported previously. Fluorescence spectroscopy along with SDS-PAGE analysis demonstrated that lipopeptides did not undermine the polypeptide composition and conformation of PS-I after solubilization; instead they showed better performance in improving the structural stability and integrity of this multi-subunit membrane protein than conventional detergents. Furthermore, O-2 uptake measurements indicated that PS-I solubilized with lipopeptides maintained its functionality. The underlying mechanism for the favorable actions of lipopeptide in PS-I solubilization and stabilization is discussed.	[Wang, Xiaoqiang; Huang, Guihong; Yu, Daoyong; Ge, Baosheng; Wang, Jiqian; Xu, Fengxi; Huang, Fang; Xu, Hai] China Univ Petr East China, State Key Lab Heavy Oil Proc, Qingdao, Shandong, Peoples R China; [Wang, Xiaoqiang; Huang, Guihong; Yu, Daoyong; Ge, Baosheng; Wang, Jiqian; Xu, Fengxi; Huang, Fang; Xu, Hai] China Univ Petr East China, Ctr Bioengn & Biotechnol, Qingdao, Shandong, Peoples R China; [Lu, Jian R.] Univ Manchester, Sch Phys & Astron, Phys Biol Lab, Manchester, Lancs, England	China University of Petroleum; China University of Petroleum; University of Manchester	Huang, F (corresponding author), China Univ Petr East China, State Key Lab Heavy Oil Proc, Qingdao, Shandong, Peoples R China.	fhuang@upc.edu.cn; xuh@upc.edu.cn	Ge, Baosheng/AAT-4788-2020; Wang, Jiqian/H-4213-2014; Yu, Daoyong/E-5269-2013; Lu, Jian/GRY-4556-2022	Ge, Baosheng/0000-0001-9906-2081; Yu, Daoyong/0000-0002-3380-1897; Yu, Hai/0000-0002-6386-9761; Wang, Jiqian/0000-0002-7525-5943	National Key Basic Research Program of China [2012CB518000]; Fundamental Research Funds for the Central Universities; Project of Science and Technology Program for Basic Research of Qingdao [13-1-4-237-jch]; National Natural Science Foundation of China [31000377, 20906105, 21033005]; Shandong Province Natural Science Foundation [ZR2010BL008]; program for New Century Excellent Talents in University of Ministry of Education of China [NCET-10-0815]; Natural Science Foundation for Distinguished Young Scholar of Shandong Province [JQ201008]	National Key Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Project of Science and Technology Program for Basic Research of Qingdao; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province); program for New Century Excellent Talents in University of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); Natural Science Foundation for Distinguished Young Scholar of Shandong Province	This work was financially supported in part by the National Key Basic Research Program of China (2012CB518000), the Fundamental Research Funds for the Central Universities, the Project of Science and Technology Program for Basic Research of Qingdao (13-1-4-237-jch), the National Natural Science Foundation of China (No. 31000377, 20906105, 21033005), Shandong Province Natural Science Foundation (No. ZR2010BL008), the program for New Century Excellent Talents in University of Ministry of Education of China (NCET-10-0815) and the Natural Science Foundation for Distinguished Young Scholar of Shandong Province (No. JQ201008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2010, MOL BIOSYST, V6, P677, DOI 10.1039/b925791h; Alkhalfioui F, 2009, CURR OPIN PHARMACOL, V9, P629, DOI 10.1016/j.coph.2009.04.002; Allen SJ, 2004, J MOL BIOL, V342, P1279, DOI 10.1016/j.jmb.2004.07.040; Arnold T., 2008, CURR PROTOC PROTEIN, DOI [10.1002/0471140864.ps0408s53, DOI 10.1002/0471140864.PS0408S53]; BRUCE BD, 1988, J BIOL CHEM, V263, P7302; Columbus L, 2009, J AM CHEM SOC, V131, P7320, DOI 10.1021/ja808776j; Cometta A, 2000, BIOPHYS J, V79, P3235, DOI 10.1016/S0006-3495(00)76556-8; Compton ELR, 2006, J MOL BIOL, V357, P325, DOI 10.1016/j.jmb.2005.12.042; Cook BL, 2009, P NATL ACAD SCI USA, V106, P11925, DOI 10.1073/pnas.0811089106; COOPER DG, 1981, APPL ENVIRON MICROB, V42, P408, DOI 10.1128/AEM.42.3.408-412.1981; Croce R, 1996, BIOCHEMISTRY-US, V35, P8572, DOI 10.1021/bi960214m; Duhring U, 2006, BBA-BIOENERGETICS, V1757, P3, DOI 10.1016/j.bbabio.2005.11.001; Engelmann E, 2001, FEBS LETT, V499, P112, DOI 10.1016/S0014-5793(01)02533-9; FERSHT A, STRUCTURE MECH PROTE, P510; FORD RC, 1988, EMBO J, V7, P2287, DOI 10.1002/j.1460-2075.1988.tb03071.x; Ge BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010233; Gutmann DAP, 2007, PROTEIN SCI, V16, P1422, DOI 10.1110/ps.072759907; Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999; HILL BC, 1988, BIOCHEMISTRY-US, V27, P4741, DOI 10.1021/bi00413a024; Iwuchukwu IJ, 2010, NAT NANOTECHNOL, V5, P73, DOI [10.1038/NNANO.2009.315, 10.1038/nnano.2009.315]; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Jia DH, 2011, SOFT MATTER, V7, P1777, DOI 10.1039/c0sm00581a; Kiley P, 2005, PLOS BIOL, V3, P1180, DOI 10.1371/journal.pbio.0030230; Kruip J, 1999, J BIOL CHEM, V274, P18181, DOI 10.1074/jbc.274.26.18181; LAM E, 1984, FEBS LETT, V168, P10, DOI 10.1016/0014-5793(84)80197-0; Li DH, 2004, ACTA BOT SIN, V46, P423; LU RJ, 2007, CURR OPIN COLLOID IN, V12, P60, DOI DOI 10.1016/J.C0CIS.2007.05.004; Matsumoto K, 2009, J PHYS CHEM B, V113, P75, DOI 10.1021/jp8021425; McGregor CL, 2003, NAT BIOTECHNOL, V21, P171, DOI 10.1038/nbt776; Muh F, 2005, BBA-BIOENERGETICS, V1708, P219, DOI 10.1016/j.bbabio.2005.03.005; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; PETER NC, 2010, ADV FUNCT MAT F, V20, P4048; Prive GG, 2007, METHODS, V41, P388, DOI 10.1016/j.ymeth.2007.01.007; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; SHRAKE A, 1990, J BIOL CHEM, V265, P5055; Tjus SE, 1998, PLANT PHYSIOL, V116, P755, DOI 10.1104/pp.116.2.755; WANG X, PLOS ONE, V6; Wang XQ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00102; Wang XQ, 2011, P NATL ACAD SCI USA, V108, P9049, DOI 10.1073/pnas.1018185108; YANG F, 2009, SEPARATION CHARACTER, P22; Yeh JI, 2005, BIOCHEMISTRY-US, V44, P16912, DOI 10.1021/bi051357o; Zhao BB, 2008, PLANT SCI, V175, P556, DOI 10.1016/j.plantsci.2008.06.003; Zhao XJ, 2006, P NATL ACAD SCI USA, V103, P17707, DOI 10.1073/pnas.0607167103	43	5	5	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76256	10.1371/journal.pone.0076256	http://dx.doi.org/10.1371/journal.pone.0076256			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098786	Green Submitted, Green Published, gold			2022-12-25	WOS:000325423500157
J	Zhang, Y; Cheng, SQ; Zhang, MY; Zhen, LN; Pang, D; Zhang, QY; Li, ZG				Zhang, Yue; Cheng, Shaoqiang; Zhang, Mingyan; Zhen, Lina; Pang, Da; Zhang, Qingyuan; Li, Zhigao			High-Infiltration of Tumor-Associated Macrophages Predicts Unfavorable Clinical Outcome for Node-Negative Breast Cancer	PLOS ONE			English	Article							VEGF EXPRESSION; T-CELLS; MICROENVIRONMENT; PROGRESSION; PLASTICITY; BIOMARKERS; SUBSETS; STROMA	The tumor microenvironment is composed of tumor cells, fibroblasts, endothelial cells and infiltrating immune cells, which may inhibit or promote tumor growth and progression. The objectives of this retrospective study were to characterize the density of tumor-associated macrophages (TAMs) in breast cancer, and to correlate the density of TAMs with clinicopathological parameters. Paraffin-embedded specimens and clinicopathological data, including up to 5 years follow-up information, were obtained from 172 breast cancer patients. Immunohistochemical staining for CD68 (marker for macrophages) was performed and evaluated in a blinded fashion. We found that TAMs were significantly frequent in high histopathological grade breast cancer patients. Breast cancer patients with a high density of TAMs had significantly lower rates of disease-free survival and 5-year overall survival than patients with low density of TAMs. Furthermore, high-infiltration of TAMs indicated worse survival rate for patients with node-negative breast cancer. In conclusion, the number of TAMs in the tumor stroma is an independent predictor of survival time for breast cancer patients. High-infiltration of TAMs is a significant unfavorable prognostic factor for patients with invasive breast cancer and, as such, is a potentially useful prognostic marker for breast cancer.	[Zhang, Yue; Cheng, Shaoqiang; Zhang, Mingyan; Zhen, Lina; Pang, Da; Zhang, Qingyuan; Li, Zhigao] Harbin Med Univ, Affiliated Tumor Hosp, Harbin, Peoples R China	Harbin Medical University	Zhang, QY (corresponding author), Harbin Med Univ, Affiliated Tumor Hosp, Harbin, Peoples R China.	zhangqingyuan96@hotmail.com; zhigaoLi909@163.com	cheng, sq/GPT-4112-2022	LI, ZHIGAO/0000-0002-4169-143X	Foundation of Educational Commission of Heilongjiang Province for Returned Overseas Chinese Scholars [1154h19]	Foundation of Educational Commission of Heilongjiang Province for Returned Overseas Chinese Scholars	The study was supported by Foundation of Educational Commission of Heilongjiang Province for Returned Overseas Chinese Scholars (1154h19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 2008, IMMUNOL REV, V222, P155, DOI 10.1111/j.1600-065X.2008.00607.x; Becker JC, 2013, CANC IMMUNOL IMMUNOT; Biswas S.K., 2013, SEMIN IMMUNOPATHOL; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bolat F, 2006, J EXP CLIN CANC RES, V25, P365; Brouckaert O, 2013, ANN ONCOL; Cardoso F, 2012, ANN ONCOL, V23, P11, DOI 10.1093/annonc/mds232; Coffelt SB, 2009, BBA-REV CANCER, V1796, P11, DOI 10.1016/j.bbcan.2009.02.004; Connelly L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2935; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hao NB, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/948098; Harbeck N, 2011, ONCOLOGIST, V16, P51, DOI 10.1634/theoncologist.2011-S1-51; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Karlsson E, 2007, CANCER GENET CYTOGEN, V172, P139, DOI 10.1016/j.cancergencyto.2006.09.019; Kimura YN, 2007, CANCER SCI, V98, P2009, DOI 10.1111/j.1349-7006.2007.00633.x; Kong LQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059771, 10.1371/journal.pone.0078275]; Laoui D, 2011, INT J DEV BIOL, V55, P861, DOI 10.1387/ijdb.113371dl; Li HC, 2007, J CELL BIOCHEM, V101, P805, DOI 10.1002/jcb.21159; Lindau D, 2013, IMMUNOLOGY, V138, P105, DOI 10.1111/imm.12036; Maciejczyk A, 2013, ADV CLIN EXP MED, V22, P5; Mahmoud SMA, 2012, J CLIN PATHOL, V65, P159, DOI 10.1136/jclinpath-2011-200355; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Medrek C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-306; Mukhtar RA, 2011, EXPERT REV MOL DIAGN, V11, P91, DOI 10.1586/ERM.10.97; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Ong SM, 2012, EUR J IMMUNOL, V42, P89, DOI 10.1002/eji.201141825; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Smith RA, 2012, ONCOLOGY-NY, V26, P471; Tang XQ, 2013, CANCER LETT, V332, P3, DOI 10.1016/j.canlet.2013.01.024; Tsutsui S, 2005, ONCOL REP, V14, P425; Witz IP, 2006, CANCER LETT, V242, P1, DOI 10.1016/j.canlet.2005.12.005; Yoshikawa K, 2012, CANCER SCI, V103, P2012, DOI 10.1111/j.1349-7006.2012.02411.x; Zhang QL, 2012, LECT NOTES CONTR INF, V421, P7	36	74	77	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76147	10.1371/journal.pone.0076147	http://dx.doi.org/10.1371/journal.pone.0076147			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098773	Green Submitted, Green Published, gold			2022-12-25	WOS:000325423500143
J	Condliffe, SB; Fratangeli, A; Munasinghe, NR; Saba, E; Passafaro, M; Montrasio, C; Ferrari, M; Rosa, P; Carrera, P				Condliffe, Steven B.; Fratangeli, Alessandra; Munasinghe, Nehan R.; Saba, Elena; Passafaro, Maria; Montrasio, Cristina; Ferrari, Maurizio; Rosa, Patrizia; Carrera, Paola			The E1015K Variant in the Synprint Region of the Ca(V)2.1 Channel Alters Channel Function and Is Associated with Different Migraine Phenotypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Channels; Genetics; Neurological Diseases; Protein-Protein Interactions; SNARE Proteins; Migraine	FAMILIAL HEMIPLEGIC MIGRAINE; GATED CALCIUM-CHANNELS; PROTEIN-INTERACTION SITE; EPISODIC ATAXIA TYPE-2; CA2+ CHANNEL; GLUTAMATERGIC NEURONS; SYNAPTIC PLASTICITY; ALPHA(1) SUBUNIT; N-TYPE; MUTATIONS	Mutations in the CACNA1A gene, which encodes the pore-forming 1A subunit of the Ca(V)2.1 voltage-gated calcium channel, cause a number of human neurologic diseases including familial hemiplegic migraine. We have analyzed the functional impact of the E1015K amino acid substitution located in the synprint domain of the 1A subunit. This variant was identified in two families with hemiplegic migraine and in one patient with migraine with aura. The wild type (WT) and the E1015K forms of the GFP-tagged 1A subunit were expressed in cultured hippocampal neurons and HEK cells to understand the role of the variant in the transport activity and physiology of Ca(V)2.1. The E1015K variant does not alter Ca(V)2.1 protein expression, and its transport to the cell surface and synaptic terminals is similar to that observed for WT channels. Electrophysiological data demonstrated that E1015K channels have increased current density and significantly altered inactivation properties compared with WT. Furthermore, the SNARE proteins syntaxin 1A and SNAP-25 were unable to modulate voltage-dependent inactivation of E1015K channels. Overall, our findings describe a genetic variant in the synprint site of the Ca(V)2.1 channel which is characterized by a gain-of-function and associated with both hemiplegic migraine and migraine with aura in patients.	[Condliffe, Steven B.; Munasinghe, Nehan R.] Univ Otago, Dept Physiol, Dunedin 9054, New Zealand; [Fratangeli, Alessandra; Saba, Elena; Passafaro, Maria; Rosa, Patrizia] Univ Milan, Dept Med Biotechnol & Translat Med BIOMETRA, CNR, Inst Neurosci, I-20129 Milan, Italy; [Montrasio, Cristina; Ferrari, Maurizio; Carrera, Paola] Hosp San Raffaele, Ctr Translat Genom & Bioinformat & Laboraf, I-20132 Milan, Italy; [Ferrari, Maurizio] Univ Vita Salute San Raffaele, I-20132 Milan, Italy	University of Otago; Consiglio Nazionale delle Ricerche (CNR); University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Condliffe, SB (corresponding author), Univ Otago, Dept Physiol, POB 56, Dunedin 9054, New Zealand.	steven.condliffe@otago.ac.nz; p.rosa@in.cnr.it; carrera.paola@hsr.it	Saba, Elena/ABH-9313-2020	Saba, Elena/0000-0002-8217-5968; Rosa, Patrizia/0000-0002-2590-6955; Carrera, Paola/0000-0001-7376-2119; Condliffe, Steven/0000-0002-5621-3924	University of Otago; Department of Physiology, University of Otago; Fondazione Cariplo Grants [2004.1600, 2012.0546]; Regione Lombardia Project [NUTEC 30263049]	University of Otago; Department of Physiology, University of Otago; Fondazione Cariplo Grants(Fondazione Cariplo); Regione Lombardia Project(Regione Lombardia)	This work was supported by a University of Otago research grant and the Department of Physiology, University of Otago (to S. B. C.), Fondazione Cariplo Grants 2004.1600 (to P. R. and P. C.) and 2012.0546, and Regione Lombardia Project NUTEC 30263049 (to P. R. and M. P.)	Adams PJ, 2010, P NATL ACAD SCI USA, V107, P18694, DOI 10.1073/pnas.1009500107; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; Cao YQ, 2004, NEURON, V43, P387, DOI 10.1016/j.neuron.2004.07.014; Catterall WA, 2013, J BIOL CHEM, V288, P10742, DOI 10.1074/jbc.R112.411645; Cohen-Kutner M, 2010, CHANNELS, V4, P266, DOI 10.4161/chan.4.4.12130; Condliffe SB, 2011, CHANNELS, V5, P304, DOI 10.4161/chan.5.4.16228; Condliffe SB, 2010, J BIOL CHEM, V285, P24968, DOI 10.1074/jbc.M110.145813; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; de Vries B, 2009, HUM GENET, V126, P115, DOI 10.1007/s00439-009-0684-z; Dichgans M, 2005, LANCET, V366, P371, DOI 10.1016/S0140-6736(05)66786-4; Garza-Lopez E, 2012, BBA-MOL BASIS DIS, V1822, P1238, DOI 10.1016/j.bbadis.2012.04.008; Hans M, 1999, J NEUROSCI, V19, P1610; Jarvis SE, 2007, CURR OPIN CELL BIOL, V19, P474, DOI 10.1016/j.ceb.2007.04.020; Kraus RL, 1998, J BIOL CHEM, V273, P5586, DOI 10.1074/jbc.273.10.5586; Kraus RL, 2000, J BIOL CHEM, V275, P9239, DOI 10.1074/jbc.275.13.9239; Linetti A, 2010, J CELL SCI, V123, P595, DOI 10.1242/jcs.060681; Liu HY, 1996, J BIOL CHEM, V271, P13804, DOI 10.1074/jbc.271.23.13804; Melliti K, 2003, J PHYSIOL-LONDON, V546, P337, DOI 10.1113/jphysiol.2002.026716; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2819, DOI 10.1073/pnas.262787699; Mullner C, 2004, J BIOL CHEM, V279, P51844, DOI 10.1074/jbc.M408756200; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Pichler M, 1997, J BIOL CHEM, V272, P13877, DOI 10.1074/jbc.272.21.13877; Rettig J, 1996, P NATL ACAD SCI USA, V93, P7363, DOI 10.1073/pnas.93.14.7363; Serra SA, 2010, P NATL ACAD SCI USA, V107, P1672, DOI 10.1073/pnas.0908359107; Sheng ZH, 1996, NATURE, V379, P451, DOI 10.1038/379451a0; Sutton KG, 1999, NATURE, V401, P800, DOI 10.1038/44586; Taverna E, 2007, J NEUROCHEM, V100, P664, DOI 10.1111/j.1471-4159.2006.04225.x; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Tottene A, 2005, J BIOL CHEM, V280, P17678, DOI 10.1074/jbc.M501110200; Tottene A, 2002, P NATL ACAD SCI USA, V99, P13284, DOI 10.1073/pnas.192242399; Tottene A, 2009, NEURON, V61, P762, DOI 10.1016/j.neuron.2009.01.027; van den Maagdenberg AMJM, 2002, J NEUROL, V249, P1515, DOI 10.1007/s00415-002-0860-8; Wappl E, 2002, J BIOL CHEM, V277, P6960, DOI 10.1074/jbc.M110948200; WITCHER DR, 1995, J BIOL CHEM, V270, P18088, DOI 10.1074/jbc.270.30.18088; Yokoyama CT, 2005, MOL CELL NEUROSCI, V28, P1, DOI 10.1016/j.mcn.2004.08.019; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; Zhong HJ, 1999, NAT NEUROSCI, V2, P939, DOI 10.1038/14721; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	39	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33873	33883		10.1074/jbc.M113.497701	http://dx.doi.org/10.1074/jbc.M113.497701			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24108129	Green Published, hybrid			2022-12-25	WOS:000327250200031
J	Tuohimaa, P; Wang, JH; Khan, S; Kuuslahti, M; Qian, K; Manninen, T; Auvinen, P; Vihinen, M; Lou, YR				Tuohimaa, Pentti; Wang, Jing-Huan; Khan, Sofia; Kuuslahti, Marianne; Qian, Kui; Manninen, Tommi; Auvinen, Petri; Vihinen, Mauno; Lou, Yan-Ru			Gene Expression Profiles in Human and Mouse Primary Cells Provide New Insights into the Differential Actions of Vitamin D-3 Metabolites	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; 1-ALPHA,25 DIHYDROXYVITAMIN D3; FRIZZLED-RELATED PROTEIN-1; KAPPA-B LIGAND; 25-HYDROXYVITAMIN D-3; D-RECEPTOR; 1,25-DIHYDROXYVITAMIN D-3; KOREAN POPULATION; INHIBITORY FACTOR; EPITHELIAL-CELLS	1 alpha,25-Dihydroxyvitamin D-3 (1 alpha,25(OH)(2)D-3) had earlier been regarded as the only active hormone. The newly identified actions of 25-hydroxyvitamin D-3 (25(OH)D-3) and 24R,25-dihydroxyvitamin D-3 (24R,25(OH)(2)D-3) broadened the vitamin D-3 endocrine system, however, the current data are fragmented and a systematic understanding is lacking. Here we performed the first systematic study of global gene expression to clarify their similarities and differences. Three metabolites at physiologically comparable levels were utilized to treat human and mouse fibroblasts prior to DNA microarray analyses. Human primary prostate stromal P29SN cells (hP29SN), which convert 25(OH)D-3 into 1 alpha,25(OH)(2)D-3 by 1 alpha-hydroxylase (encoded by the gene CYP27B1), displayed regulation of 164, 171, and 175 genes by treatment with 1 alpha,25(OH)(2)D-3, 25(OH)D-3, and 24R,25(OH)(2)D-3, respectively. Mouse primary Cyp27b1 knockout fibroblasts (mCyp27b1(-/-)), which lack 1 alpha-hydroxylation, displayed regulation of 619, 469, and 66 genes using the same respective treatments. The number of shared genes regulated by two metabolites is much lower in hP29SN than in mCyp27b1(-/-). By using DAVID Functional Annotation Bioinformatics Microarray Analysis tools and Ingenuity Pathways Analysis, we identified the agonistic regulation of calcium homeostasis and bone remodeling between 1 alpha,25(OH)(2)D-3 and 25(OH)D-3 and unique non-classical actions of each metabolite in physiological and pathological processes, including cell cycle, keratinocyte differentiation, amyotrophic lateral sclerosis signaling, gene transcription, immunomodulation, epigenetics, cell differentiation, and membrane protein expression. In conclusion, there are three distinct vitamin D-3 hormones with clearly different biological activities. This study presents a new conceptual insight into the vitamin D-3 endocrine system, which may guide the strategic use of vitamin D-3 in disease prevention and treatment.	[Tuohimaa, Pentti; Wang, Jing-Huan; Kuuslahti, Marianne] Univ Tampere, Dept Anat, Sch Med, FIN-33101 Tampere, Finland; [Tuohimaa, Pentti] Univ Tampere, Tampere Univ Hosp, Dept Clin Chem, FIN-33101 Tampere, Finland; [Wang, Jing-Huan] Univ Tampere, Tampere Grad Sch Biomed & Biotechnol, FIN-33101 Tampere, Finland; [Wang, Jing-Huan] Univ Turku, Drug Discovery Grad Sch, Turku, Finland; [Khan, Sofia; Vihinen, Mauno] Univ Tampere, Inst Biomed Technol & BioMediTech, FIN-33101 Tampere, Finland; [Khan, Sofia] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; [Khan, Sofia] Helsinki Univ Cent Hosp, Helsinki, Finland; [Qian, Kui; Auvinen, Petri] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Manninen, Tommi] Univ Tampere, Sch Med, Dept Cell Biol, FIN-33101 Tampere, Finland; [Vihinen, Mauno] Lund Univ, Inst Expt Med Sci, Lund, Sweden; [Vihinen, Mauno] Tampere Univ Hosp, Tampere, Finland; [Lou, Yan-Ru] Univ Helsinki, Fac Pharm, Div Biopharmaceut & Pharmacokinet, Helsinki, Finland	Tampere University; Tampere University; Tampere University Hospital; Tampere University; University of Turku; Tampere University; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Tampere University; Lund University; Tampere University; Tampere University Hospital; University of Helsinki	Lou, YR (corresponding author), Univ Helsinki, Fac Pharm, Div Biopharmaceut & Pharmacokinet, Helsinki, Finland.	yan-ru.lou@helsinki.fi	Auvinen, Petri/D-5044-2009; Auvinen, Petri/AAP-8117-2021; Vihinen, Mauno/A-8452-2012; Lou, Yan-Ru/AAX-4008-2020; Lou, Yan-Ru/K-4348-2012; Qian, Kui/J-1942-2014	Auvinen, Petri/0000-0002-3947-4778; Vihinen, Mauno/0000-0002-9614-7976; Lou, Yan-Ru/0000-0001-7717-6010; Lou, Yan-Ru/0000-0001-7717-6010; Qian, Kui/0000-0001-7170-533X; Khan, Sofia/0000-0003-4185-8882	Tampere University Hospital; Drug Discovery Graduate School (University of Turku); Academy of Finland; Finnish Cancer Foundation; Sigrid Juselius Foundation; Medical Research Fund of Tampere University Hospital [EVO-9G143, EVO-9H160]; Medical Research Fund of Tampere University Hospital (Viikki Doctoral Program in Molecular Biosciences)	Tampere University Hospital; Drug Discovery Graduate School (University of Turku); Academy of Finland(Academy of Finland); Finnish Cancer Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Medical Research Fund of Tampere University Hospital; Medical Research Fund of Tampere University Hospital (Viikki Doctoral Program in Molecular Biosciences)	This work was supported by grants from Tampere University Hospital, Drug Discovery Graduate School (University of Turku), the Academy of Finland, the Finnish Cancer Foundation, Sigrid Juselius Foundation, the Medical Research Fund of Tampere University Hospital (EVO-9G143 and EVO-9H160) and Viikki Doctoral Program in Molecular Biosciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JS, 2008, NAT CLIN PRACT ENDOC, V4, P80, DOI 10.1038/ncpendmet0716; Adams JS, 2005, CELL, V122, P647, DOI 10.1016/j.cell.2005.08.024; Aiyar SE, 2007, INT J BIOL SCI, V3, P486; Ajibade DV, 2010, ENDOCRINOLOGY, V151, P2974, DOI 10.1210/en.2010-0033; Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Azoitei N, 2007, ONCOGENE, V26, P6536, DOI 10.1038/sj.onc.1210476; Barreto AM, 2000, CANCER EPIDEM BIOMAR, V9, P265; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Bell TD, 2010, J CELL BIOCHEM, V111, P7, DOI 10.1002/jcb.22661; Bergh JJ, 2004, ENDOCRINOLOGY, V145, P426, DOI 10.1210/en.2003-0319; Bikle DD, 2010, J BONE MINER METAB, V28, P117, DOI 10.1007/s00774-009-0153-8; Boyan BD, 2003, J CELL BIOCHEM, V90, P1207, DOI 10.1002/jcb.10716; Campbell MJ, 2000, ONCOGENE, V19, P5091, DOI 10.1038/sj.onc.1203888; Campos LT, 2013, J STEROID BIOCHEM, V133, P12, DOI 10.1016/j.jsbmb.2012.08.002; Chae SC, 2004, HUM IMMUNOL, V65, P1427, DOI 10.1016/j.humimm.2004.07.002; Chae SC, 2004, IMMUNOL LETT, V95, P91, DOI 10.1016/j.imlet.2004.06.008; Chen FF, 2002, BIOCHEM J, V364, P571, DOI 10.1042/BJ20011703; Dardenne O, 2001, ENDOCRINOLOGY, V142, P3135, DOI 10.1210/en.142.7.3135; Diesel B, 2005, CLIN CANCER RES, V11, P5370, DOI 10.1158/1078-0432.CCR-04-1968; Durup D, 2012, J CLIN ENDOCR METAB, V97, P2644, DOI 10.1210/jc.2012-1176; Eyles D.W., 2012, FRONT NEUROENDOCRINO; Gaur T, 2009, J CELL PHYSIOL, V220, P174, DOI 10.1002/jcp.21747; Giovannucci E, 2006, JNCI-J NATL CANCER I, V98, P451, DOI 10.1093/jnci/djj101; Gosens I, 2007, EXP CELL RES, V313, P3959, DOI 10.1016/j.yexcr.2007.08.025; Grgurevic L, 2011, BIOCHEM BIOPH RES CO, V408, P26, DOI 10.1016/j.bbrc.2011.03.109; Ha BG, 2008, PROTEOMICS, V8, P2625, DOI 10.1002/pmic.200701192; Hausler KD, 2004, J BONE MINER RES, V19, P1873, DOI 10.1359/JBMR.040807; Hibino T, 2004, J DERMATOL SCI, V35, P9, DOI 10.1016/j.jdermsci.2003.12.003; Hofbauer LC, 2001, J MOL MED, V79, P243, DOI 10.1007/s001090100226; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Jang WG, 2012, J BIOL CHEM, V287, P905, DOI 10.1074/jbc.M111.253187; Karam C, 2011, MED HYPOTHESES, V76, P643, DOI 10.1016/j.mehy.2011.01.021; Koguchi K, 2006, J EXP MED, V203, P1413, DOI 10.1084/jem.20060210; Kopinke D, 2011, DEVELOPMENT, V138, P431, DOI 10.1242/dev.053843; Kriebitzsch C, 2009, ANTICANCER RES, V29, P3471; Krishnan AV, 2004, PROSTATE, V59, P243, DOI 10.1002/pros.20006; Laaksi I, 2007, AM J CLIN NUTR, V86, P714, DOI 10.1093/ajcn/86.3.714; Li J, 2008, J STEROID BIOCHEM, V112, P122, DOI 10.1016/j.jsbmb.2008.09.006; Liao WP, 2008, PROTEOMICS, V8, P2640, DOI 10.1002/pmic.200700954; Liu YZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006827; Lou YR, 2006, J STEROID BIOCHEM, V99, P44, DOI 10.1016/j.jsbmb.2005.11.006; Lou YR, 2010, J STEROID BIOCHEM, V118, P162, DOI 10.1016/j.jsbmb.2009.11.011; Lou YR, 2003, FASEB J, V17, P332, DOI 10.1096/fj.03-0140fje; McGowan KM, 2002, GENE DEV, V16, P1412, DOI 10.1101/gad.979502; Monahan P, 2009, ENDOCRINOLOGY, V150, P4386, DOI 10.1210/en.2009-0206; Morishima N, 2011, J BIOL CHEM, V286, P35227, DOI 10.1074/jbc.M111.233502; Munetsuna E, 2011, J MOL ENDOCRINOL, V47, P209, DOI 10.1530/JME-11-0008; Nanba D, 2003, ANAT REC PART A, V270A, P97, DOI 10.1002/ar.a.10012; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Palmqvist P, 2002, J IMMUNOL, V169, P3353, DOI 10.4049/jimmunol.169.6.3353; Park DY, 2007, AM J PATHOL, V171, P1509, DOI 10.2353/ajpath.2007.070331; Peng XJ, 2010, J CELL BIOCHEM, V110, P1324, DOI 10.1002/jcb.22646; Peng XJ, 2009, BREAST CANCER RES TR, V113, P31, DOI 10.1007/s10549-008-9900-0; Pham L, 2007, GENE EXPR PATTERNS, V7, P846, DOI 10.1016/j.modgep.2007.07.002; Porojnicu A, 2007, J STEROID BIOCHEM, V103, P675, DOI 10.1016/j.jsbmb.2006.12.031; Rauch T, 2005, CELL CYCLE, V4, P1078; Ren YS, 2000, MOL CELL BIOL, V20, P5433, DOI 10.1128/MCB.20.15.5433-5446.2000; Ritter CS, 2006, KIDNEY INT, V70, P654, DOI 10.1038/sj.ki.5000394; Ritter CS, 2011, J MOL ENDOCRINOL, V46, P63, DOI 10.1677/JME-10-0128; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Ruohola JP, 2006, J BONE MINER RES, V21, P1483, DOI 10.1359/JBMR.060607; Sato Y, 1997, EUR NEUROL, V37, P225, DOI 10.1159/000117447; SEAMARK DA, 1980, CLIN CHIM ACTA, V106, P51, DOI 10.1016/0009-8981(80)90374-5; Sebastian S, 2009, P NATL ACAD SCI USA, V106, P4719, DOI 10.1073/pnas.0807136106; Shalhoub V, 2010, J CELL BIOCHEM, V111, P911, DOI 10.1002/jcb.22779; Shen L, 2011, MED HYPOTHESES, V77, P698, DOI 10.1016/j.mehy.2011.07.057; Shibata K, 2011, BLOOD, V118, P586, DOI 10.1182/blood-2011-02-334995; Sims AM, 2008, J BONE MINER RES, V23, P499, DOI 10.1359/JBMR.071113; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Solomon JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029354; St-Arnaud R, 2011, MOL CELL ENDOCRINOL, V347, P48, DOI 10.1016/j.mce.2011.05.018; Tarroni P, 2012, J CELL BIOCHEM, V113, P640, DOI 10.1002/jcb.23392; Tashiro K, 2004, MOL CELL ENDOCRINOL, V226, P27, DOI 10.1016/j.mce.2004.07.012; Thibodeau J, 2008, EUR J IMMUNOL, V38, P1225, DOI 10.1002/eji.200737902; Tuohimaa P, 2012, ANTICANCER RES, V32, P373; Tuohimaa P, 2004, INT J CANCER, V108, P104, DOI 10.1002/ijc.11375; van Driel M, 2006, FASEB J, V20, P2417, DOI 10.1096/fj.06-6374fje; van Driel M, 2006, J CELL BIOCHEM, V99, P922, DOI 10.1002/jcb.20875; Vieth R, 2002, LANCET, V359, P672, DOI 10.1016/S0140-6736(02)07814-5; Wang JH, 2006, BIOCHEM BIOPH RES CO, V345, P720, DOI 10.1016/j.bbrc.2006.04.156; Wang WLW, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-58; Wang XN, 2007, EXP CELL RES, V313, P3034, DOI 10.1016/j.yexcr.2007.05.021; Wu W, 2005, CANCER RES, V65, P7509, DOI 10.1158/0008-5472.CAN-04-3350; Yasuda H, 1998, ENDOCRINOLOGY, V139, P1329, DOI 10.1210/en.139.3.1329; Zhang ZL, 2011, ENDOCR RES, V36, P101, DOI 10.3109/07435800.2010.542415	89	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75338	10.1371/journal.pone.0075338	http://dx.doi.org/10.1371/journal.pone.0075338			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116037	gold, Green Published, Green Submitted			2022-12-25	WOS:000325552200017
J	Avtar, R; Suzuki, R; Takeuchi, W; Sawada, H				Avtar, Ram; Suzuki, Rikie; Takeuchi, Wataru; Sawada, Haruo			PALSAR 50 m Mosaic Data Based National Level Biomass Estimation in Cambodia for Implementation of REDD plus Mechanism	PLOS ONE			English	Article							TROPICAL FOREST BIOMASS; LANDSAT TM DATA; ABOVEGROUND BIOMASS; RADAR BACKSCATTER; CARBON STOCKS; BAND SAR; DENSITY; DEFORESTATION; ALOS/PALSAR; SENSITIVITY	Tropical countries like Cambodia require information about forest biomass for successful implementation of climate change mitigation mechanism related to Reducing Emissions from Deforestation and forest Degradation (REDD+). This study investigated the potential of Phased Array-type L-band Synthetic Aperture Radar Fine Beam Dual (PALSAR FBD) 50 m mosaic data to estimate Above Ground Biomass (AGB) in Cambodia. AGB was estimated using a bottom-up approach based on field measured biomass and backscattering (sigma(o)) properties of PALSAR data. The relationship between the PALSAR sigma(o) HV and HH/HV with field measured biomass was strong with R-2 = 0.67 and 0.56, respectively. PALSAR estimated AGB show good results in deciduous forests because of less saturation as compared to dense evergreen forests. The validation results showed a high coefficient of determination R-2 = 0.61 with RMSE = 21 Mg/ha using values up to 200 Mg/ha biomass. There were some uncertainties because of the uncertainty in the field based measurement and saturation of PALSAR data. AGB map of Cambodian forests could be useful for the implementation of forest management practices for REDD+ assessment and policies implementation at the national level.	[Avtar, Ram; Takeuchi, Wataru; Sawada, Haruo] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo, Japan; [Avtar, Ram; Suzuki, Rikie] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Res Inst Global Change, Yokohama, Kanagawa, Japan; [Avtar, Ram] UNU ISP, Tokyo, Japan	University of Tokyo; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); United Nations University	Avtar, R (corresponding author), Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo, Japan.	ram.envjnu@gmail.com	Avtar, Ram/C-7394-2012	Avtar, Ram/0000-0003-3653-5771; Takeuchi, Wataru/0000-0002-9138-6601	Ministry of Environment, Japan [F-1101]	Ministry of Environment, Japan(Ministry of the Environment, Japan)	This study was supported by the Environmental Research and Technology Development Fund (F-1101) of the Ministry of Environment, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akatsuka S, 2009, 30 AS C REM SENS ACR; Angelsen A, 2008, VINNV PROGR REN MOV; Austin JM, 2003, FOREST ECOL MANAG, V176, P575, DOI 10.1016/S0378-1127(02)00314-6; Avtar R., 2013, ENVIRON MONIT ASSESS, V185, P2013; Avtar Ram, 2013, Environment Development and Sustainability, V15, P1593, DOI 10.1007/s10668-013-9448-y; Avtar R, 2013, ARAB J GEOSCI, V6, P4859, DOI 10.1007/s12517-012-0768-2; Avtar R, 2012, GEOCARTO INT, V27, P119, DOI 10.1080/10106049.2011.626081; Avtar R, 2013, INT J DIGIT EARTH, V6, P255, DOI 10.1080/17538947.2011.620639; Beaudoin A, 1994, INT J REMOTE SENS, V15, P414; Brown S, 1995, ENVIRON MONIT ASSESS, V38, P157, DOI 10.1007/BF00546760; Brown S., 1997, ESTIMATING BIOMASS B, P5; Carreiras JMB, 2012, REMOTE SENS ENVIRON, V121, P426, DOI 10.1016/j.rse.2012.02.012; Cartus O, 2012, REMOTE SENS ENVIRON, V124, P466, DOI 10.1016/j.rse.2012.05.029; Castro KL, 2003, INT J REMOTE SENS, V24, P1853, DOI 10.1080/01431160210154056; Collins JN, 2009, INT J REMOTE SENS, V30, P1141, DOI 10.1080/01431160802448935; DeFries R, 2007, ENVIRON SCI POLICY, V10, P385, DOI 10.1016/j.envsci.2007.01.010; Djomo AN, 2011, FOREST ECOL MANAG, V261, P1448, DOI 10.1016/j.foreco.2011.01.031; DOBSON MC, 1992, IEEE T GEOSCI REMOTE, V30, P412, DOI 10.1109/36.134090; Englhart S, 2011, REMOTE SENS ENVIRON, V115, P1260, DOI 10.1016/j.rse.2011.01.008; Foody GM, 2003, REMOTE SENS ENVIRON, V85, P463, DOI 10.1016/S0034-4257(03)00039-7; FRA, 2010, GLOB FOR RES ASS; Gama FF, 2010, REMOTE SENS-BASEL, V2, P939, DOI 10.3390/rs2040939; Gaughan AE, 2009, APPL GEOGR, V29, P212, DOI 10.1016/j.apgeog.2008.09.007; Gibbs HK, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045023; Hajnsek I, 2009, IEEE T GEOSCI REMOTE, V47, P481, DOI 10.1109/TGRS.2008.2009437; Hame T, 2013, IEEE J-STARS, V6, P92, DOI 10.1109/JSTARS.2013.2241020; Harrell PA, 1997, REMOTE SENS ENVIRON, V59, P223, DOI 10.1016/S0034-4257(96)00155-1; Harrell PA, 1995, REMOTE SENS ENVIRON, V54, P247, DOI 10.1016/0034-4257(95)00127-1; IMHOFF ML, 1995, IEEE T GEOSCI REMOTE, V33, P511, DOI 10.1109/36.377953; Kasischke ES, 1997, REMOTE SENS ENVIRON, V59, P141, DOI 10.1016/S0034-4257(96)00148-4; Keith H, 2009, P NATL ACAD SCI USA, V106, P11635, DOI 10.1073/pnas.0901970106; Kenzo T, 2009, J FOREST RES-JPN, V14, P365, DOI 10.1007/s10310-009-0149-1; Kiyono Y, 2010, JARQ-JPN AGR RES Q, V44, P81, DOI 10.6090/jarq.44.81; Kuplich TM, 2005, INT J REMOTE SENS, V26, P4829, DOI 10.1080/01431160500239107; Le Toan T, 2011, REMOTE SENS ENVIRON, V115, P2850, DOI 10.1016/j.rse.2011.03.020; LETOAN T, 1992, IEEE T GEOSCI REMOTE, V30, P403, DOI 10.1109/36.134089; Lu D, 2005, INT J REMOTE SENS, V26, P2509, DOI 10.1080/01431160500142145; Lu DS, 2006, INT J REMOTE SENS, V27, P1297, DOI 10.1080/01431160500486732; Lucas R, 2010, IEEE J-STARS, V3, P576, DOI 10.1109/JSTARS.2010.2086436; Lucas RM, 2007, AQUAT CONSERV, V17, P245, DOI 10.1002/aqc.833; Luckman A, 1998, REMOTE SENS ENVIRON, V63, P126, DOI 10.1016/S0034-4257(97)00133-8; Luckman A, 1997, REMOTE SENS ENVIRON, V60, P1, DOI 10.1016/S0034-4257(96)00121-6; Maniatis D, 2010, CARBON BALANCE MANAG, V5, DOI [10.1186/1750-0680-5-9, DOI 10.1186/1750-0680-5-9)]; Mitchard ETA, 2011, REMOTE SENS ENVIRON, V115, P2861, DOI 10.1016/j.rse.2010.02.022; Mitchard ETA, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040692; Mutanga O, 2012, INT J APPL EARTH OBS, V18, P399, DOI 10.1016/j.jag.2012.03.012; Muukkonen P, 2007, REMOTE SENS ENVIRON, V107, P617, DOI 10.1016/j.rse.2006.10.011; Page Susan, 2009, P263, DOI 10.1007/978-3-540-77381-8_9; RANSON KJ, 1994, IEEE T GEOSCI REMOTE, V32, P388, DOI 10.1109/36.295053; RAUSTE Y, 1994, INT J REMOTE SENS, V15, P2797, DOI 10.1080/01431169408954285; Ravindranath NH, 2008, CARBON INVENTORY MET, P113; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; SADER SA, 1989, REMOTE SENS ENVIRON, V28, P143, DOI 10.1016/0034-4257(89)90112-0; Sales MH, 2007, ECOL MODEL, V205, P221, DOI 10.1016/j.ecolmodel.2007.02.033; Sandberg G, 2011, REMOTE SENS ENVIRON, DOI [10.1016/j.rse.2011.03.018, DOI 10.1016/J.RSE.2011.03.018]; Santos JR, 2003, REMOTE SENS ENVIRON, V87, P482, DOI 10.1016/j.rse.2002.12.001; Sato T, 2011, INT TECHN SEM REDD K; Schulze ED, 2006, BIOGEOSCIENCES, V3, P147, DOI 10.5194/bg-3-147-2006; Shimada M, 2010, IEEE J-STARS, V3, P657, DOI 10.1109/JSTARS.2010.2072984; Shimada M, 2009, IEEE T GEOSCI REMOTE, V47, P3915, DOI 10.1109/TGRS.2009.2023909; Sivanpillai R, 2006, FOREST ECOL MANAG, V223, P247, DOI 10.1016/j.foreco.2005.11.013; Skutsch M, 2007, ENVIRON SCI POLICY, V10, P322, DOI 10.1016/j.envsci.2006.08.009; Steininger MK, 2000, INT J REMOTE SENS, V21, P1139, DOI 10.1080/014311600210119; Sun GQ, 2011, REMOTE SENS ENVIRON, V115, P2906, DOI 10.1016/j.rse.2011.03.021; Suzuki R, 2013, POLAR SCI, V7, P100, DOI 10.1016/j.polar.2013.03.001; UNEP, 2009, CAMB ENV OUTL; VANZYL JJ, 1993, IEEE T GEOSCI REMOTE, V31, P153, DOI 10.1109/36.210456; Visseren-Hamakers IJ, 2012, CURR OPIN ENV SUST, V4, P646, DOI 10.1016/j.cosust.2012.10.005; Wang GX, 2011, SCAND J FOREST RES, V26, P360, DOI 10.1080/02827581.2011.564204; Watanabe M, 2006, IEEE T GEOSCI REMOTE, V44, P3154, DOI 10.1109/TGRS.2006.880632	70	34	37	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e74807	10.1371/journal.pone.0074807	http://dx.doi.org/10.1371/journal.pone.0074807			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116012	Green Submitted, gold, Green Published			2022-12-25	WOS:000325501300014
J	Maldonado, MB; Lomascolo, SB; Vazquez, DP				Belen Maldonado, Maria; Beatriz Lomascolo, Silvia; Pedro Vazquez, Diego			The Importance of Pollinator Generalization and Abundance for the Reproductive Success of a Generalist Plant	PLOS ONE			English	Article							SPECIALIST; POPULATION; VISITORS; DESERT	Previous studies have examined separately how pollinator generalization and abundance influence plant reproductive success, but none so far has evaluated simultaneously the relative importance of these pollinator attributes. Here we evaluated the extent to which pollinator generalization and abundance influence plant reproductive success per visit and at the population level on a generalist plant, Opuntia sulphurea (Cactaceae). We used field experiments and path analysis to evaluate whether the per-visit effect is determined by the pollinator's degree of generalization, and whether the population level effect (pollinator impact) is determined by the pollinator's degree of generalization and abundance. Based on the models we tested, we concluded that the per-visit effect of a pollinator on plant reproduction was not determined by the pollinators' degree of generalization, while the population-level impact of a pollinator on plant reproduction was mainly determined by the pollinators' degree of generalization. Thus, generalist pollinators have the greatest species impact on pollination and reproductive success of O. sulphurea. According to our analysis this greatest impact of generalist pollinators may be partly explained by pollinator abundance. However, as abundance does not suffice as an explanation of pollinator impact, we suggest that vagility, need for resource consumption, and energetic efficiency of generalist pollinators may also contribute to determine a pollinator's impact on plant reproduction.	[Belen Maldonado, Maria; Beatriz Lomascolo, Silvia; Pedro Vazquez, Diego] Consejo Nacl Invest Cient & Tecn, Inst Argentino Invest Zonas Aridas, CC 507, Mendoza, Argentina; [Belen Maldonado, Maria; Beatriz Lomascolo, Silvia; Pedro Vazquez, Diego] Univ Nacl Cuyo, Inst Ciencias Basicas, Ctr Univ, RA-5500 Mendoza, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza	Maldonado, MB (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Argentino Invest Zonas Aridas, CC 507, Mendoza, Argentina.	mmaldonado@mendoza-conicet.gob.ar		Vazquez, Diego P./0000-0002-3449-5748; Lomascolo, Silvia/0000-0002-4422-7851	CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas) [PIP 6564, 2781]; Fondo para la Investigacion Cientifica y Tecnologica [PICT 20805, 1471, 2010-2779]; BBVA Foundation [BIOCON03-162]; BBVA bank; Universidad Nacional de Cuyo; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas)	CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fondo para la Investigacion Cientifica y Tecnologica; BBVA Foundation(BBVA Foundation); BBVA bank(BBVA Foundation); Universidad Nacional de Cuyo; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	Funding came from CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas) (PIP 6564 and 2781), Fondo para la Investigacion Cientifica y Tecnologica (PICT 20805, 1471 and 2010-2779) and BBVA Foundation ("BBVA is the official name of the foundation funded by BBVA bank, and there is no full name for it'')(BIOCON03-162). M.B. Maldonado was supported by an undergraduate fellowship from the Universidad Nacional de Cuyo, and S. B. Lomascolo by a CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas) post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen Marcelo A, 2007, Ecol. austral, V17, P7; Bascompte J, 2007, ANNU REV ECOL SYST, V38, P367; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Burnham K.P., 2010, MODEL SELECTION MULT; Chacoff NP, 2012, J ANIM ECOL, V81, P190, DOI 10.1111/j.1365-2656.2011.01883.x; DALMASSO AD, 1999, MULTEQUINA, V8, P11; Darwin C., 1877, VARIOUS CONTRIVANCES; Dupont YL, 2003, ECOGRAPHY, V26, P301, DOI 10.1034/j.1600-0587.2003.03443.x; FOX J, 2010, SEM STRUCTURAL EQUAT; Gomez JM, 2000, OECOLOGIA, V122, P90, DOI 10.1007/PL00008840; Gomez JM, 2009, ECOL EVOL INTERACCIO, P61; Gruter Christoph, 2011, Communicative & Integrative Biology, V4, P633; Javorek SK, 2002, ANN ENTOMOL SOC AM, V95, P345, DOI 10.1603/0013-8746(2002)095[0345:CPEABH]2.0.CO;2; Kearns C. A., 1993, TECHNIQUES POLLINATI; Kiesling R., 2005, 100 CACTUS ARGENTINO; Larsson M, 2005, OECOLOGIA, V146, P394, DOI 10.1007/s00442-005-0217-y; Mitchell R.J., 2001, DESIGN ANAL ECOLOGIC, P217; Morales CL, 2008, CRIT REV PLANT SCI, V27, P221, DOI 10.1080/07352680802205631; MOTTEN AF, 1981, ECOLOGY, V62, P1278, DOI 10.2307/1937292; Olsen KM, 1997, OECOLOGIA, V109, P114, DOI [10.1007/s004420050065, 10.1007/PL00008811]; Padron B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006275; R Development Core Team, 2010, R A LANGUAGE AND ENV; Richards SA, 2005, ECOLOGY, V86, P2805, DOI 10.1890/05-0074; Sahli HF, 2006, OECOLOGIA, V148, P365, DOI 10.1007/s00442-006-0396-1; Shipley B., 2000, CAUSE CORRELATIONS B; Shipley B, 2013, ECOLOGY, V94, P560, DOI 10.1890/12-0976.1; STEBBINS G. L., 1970, Annual review of ecology and systematics., V1, P307, DOI 10.1146/annurev.es.01.110170.001515; Thostesen AM, 1996, OIKOS, V77, P77, DOI 10.2307/3545587; Vazquez DP, 2012, ECOLOGY, V93, P719, DOI 10.1890/11-1356.1; Vazquez DP, 2009, ECOLOGY, V90, P2039, DOI 10.1890/08-1837.1; Vazquez DP, 2005, ECOL LETT, V8, P1088, DOI 10.1111/j.1461-0248.2005.00810.x; Vazquez DP, 2003, ECOLOGY, V84, P2493, DOI 10.1890/02-0587; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; ZIMMERMAN M, 1990, PLANT REPRODUCTIVE E, P157	34	13	19	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75482	10.1371/journal.pone.0075482	http://dx.doi.org/10.1371/journal.pone.0075482			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116049	Green Submitted, Green Published, gold			2022-12-25	WOS:000325501300031
J	Dutra, SGV; Pereira, APM; Tezini, GCSV; Mazon, JH; Martins-Pinge, MC; Souza, HCD				Dutra, Sabrina G. V.; Pereira, Ana Paula M.; Tezini, Geisa C. S. V.; Mazon, Jose H.; Martins-Pinge, Marli C.; Souza, Hugo C. D.			Cardiac Autonomic Modulation Is Determined by Gender and Is Independent of Aerobic Physical Capacity in Healthy Subjects	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; ALL-CAUSE MORTALITY; BLOOD-PRESSURE; CARDIORESPIRATORY FITNESS; NITRIC-OXIDE; NEURAL REGULATION; ENDURANCE; EXERCISE; HYPERTENSION; WOMEN	Background: Aerobic physical capacity plays an important role in reducing morbidity and mortality rates in subjects with cardiovascular diseases. This action is often related to an improvement in the autonomic modulation of heart rate variability (HRV). However, controversies remain regarding the effects of physical training on cardiac autonomic control in healthy subjects. Therefore, our objective was to investigate whether aerobic capacity interferes with the autonomic modulation of HRV and whether gender differences exist. Methods: Healthy men and women (N=96) were divided into groups according to aerobic capacity: low (VO2: 22-38 ml/kg(-1) min(-1)), moderate (VO2: 38-48 ml/kg(-1) min(-1)) and high (VO2 >48 ml/kg(-1) min(-1).) We evaluated the hemodynamic parameters and body composition. The autonomic modulation of HRV was investigated using spectral analysis. This procedure decomposes the heart rate oscillatory signal into frequency bands: low frequency (LF=0.04-0.15Hz) is mainly related to sympathetic modulation, and high frequency (HF=0.15-0.5Hz) corresponds to vagal modulation. Results: Aerobic capacity, regardless of gender, determined lower values of body fat percentage, blood pressure and heart rate. In turn, the spectral analysis of HRV showed that this parameter did not differ when aerobic capacity was considered. However, when the genders were compared, women had lower LF values and higher HF values than the respective groups of men. Conclusion: The results suggest that aerobic physical capacity does not interfere with HRV modulation; however, the cardiac modulatory balance differs between genders and is characterized by a greater influence of the autonomic vagal component in women and by the sympathetic component in men.	[Dutra, Sabrina G. V.; Pereira, Ana Paula M.; Tezini, Geisa C. S. V.; Mazon, Jose H.; Souza, Hugo C. D.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Biomech Med & Rehabil, Sao Paulo, Brazil; [Martins-Pinge, Marli C.] Univ Estadual Londrina, Dept Physiol Sci, Londrina, Parana, Brazil	Universidade de Sao Paulo; Universidade Estadual de Londrina	Souza, HCD (corresponding author), Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Biomech Med & Rehabil, Sao Paulo, Brazil.	hugocds@fmrp.usp.br	Pinge, Marli C Martins/C-4417-2014; Souza, Hugo/C-5818-2012; de Souza, Hugo Celso Dutra/N-7434-2019; Mazon, Jose/I-7949-2015	Pinge, Marli C Martins/0000-0002-9444-1530; Souza, Hugo/0000-0002-0009-0005; de Souza, Hugo Celso Dutra/0000-0002-0009-0005; Veloso Dutra Malvar, Sabrina Graziani/0000-0003-1603-9797; Mazon, Jose/0000-0002-2157-1430	FAPESP [2011/07878-1]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by the FAPESP (2011/07878-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	August P, 1999, J CLIN ENDOCR METAB, V84, P1862, DOI 10.1210/jc.84.6.1862; Baumert M, 2006, CLIN J SPORT MED, V16, P412, DOI 10.1097/01.jsm.0000244610.34594.07; BEASTONWIMMER P, 1991, DEV BRAIN RES, V58, P123, DOI 10.1016/0165-3806(91)90244-D; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Boegli Y, 2003, J INVEST DERMATOL, V121, P1197, DOI 10.1046/j.1523-1747.2003.12518.x; Bosquet L, 2007, EUR J APPL PHYSIOL, V100, P363, DOI 10.1007/s00421-007-0438-3; Brunetto AF, 2005, PEDIATR CARDIOL, V26, P418, DOI 10.1007/s00246-004-0808-0; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Calhoun, 1998, Cardiol Rev, V6, P356, DOI 10.1097/00045415-199811000-00012; Camm AJ, 1996, CIRCULATION, V93, P1043; Chase NL, 2009, AM J HYPERTENS, V22, P417, DOI 10.1038/ajh.2009.6; Christou DD, 2005, CIRCULATION, V111, P494, DOI 10.1161/01.CIR.0000153864.24034.A6; Collier SR, 2009, ACTA PHYSIOL, V195, P339, DOI 10.1111/j.1748-1716.2008.01897.x; Cornelissen VA, 2005, HYPERTENSION, V46, P667, DOI 10.1161/01.HYP.0000184225.05629.51; Cozza IC, 2012, HYPERTENS RES, V35, P82, DOI 10.1038/hr.2011.162; DIXON EM, 1992, CARDIOVASC RES, V26, P713, DOI 10.1093/cvr/26.7.713; DU XJ, 1994, CLIN EXP PHARMACOL P, V21, P485, DOI 10.1111/j.1440-1681.1994.tb02545.x; Ellestad M.H., 1986, J OCCUP ENVIRON MED, V28, P1142; Ettinger SM, 1996, J APPL PHYSIOL, V80, P245, DOI 10.1152/jappl.1996.80.1.245; Evans JM, 2001, J APPL PHYSIOL, V91, P2611, DOI 10.1152/jappl.2001.91.6.2611; Fagard RH, 2007, EUR J CARDIOV PREV R, V14, P12, DOI 10.1097/HJR.0b013e3280128bbb; Figueroa A, 2007, EUR J APPL PHYSIOL, V100, P437, DOI 10.1007/s00421-007-0446-3; Goulopoulou S, 2010, METABOLISM, V59, P901, DOI 10.1016/j.metabol.2009.10.011; Hautala AJ, 2003, AM J PHYSIOL-HEART C, V285, pH1747, DOI 10.1152/ajpheart.00202.2003; Huikuri HV, 1996, CIRCULATION, V94, P122, DOI 10.1161/01.CIR.94.2.122; JAMES GD, 1986, J HYPERTENS, V4, pS387; Kienitz T, 2008, KIDNEY BLOOD PRESS R, V31, P71, DOI 10.1159/000119417; Kiviniemi AM, 2006, EUR J APPL PHYSIOL, V96, P686, DOI 10.1007/s00421-005-0130-4; Kiviniemi AM, 2007, EUR J APPL PHYSIOL, V101, P743, DOI 10.1007/s00421-007-0552-2; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Kokkinos P, 2008, CIRCULATION, V117, P614, DOI 10.1161/CIRCULATIONAHA.107.734764; Kokkinos P, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/924945; Kuo TBJ, 1999, AM J PHYSIOL-HEART C, V277, pH2233, DOI 10.1152/ajpheart.1999.277.6.H2233; Lee DC, 2011, BRIT J SPORT MED, V45, P504, DOI 10.1136/bjsm.2009.066209; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; Martinelli FS, 2005, BRAZ J MED BIOL RES, V38, P639, DOI 10.1590/S0100-879X2005000400019; Mazon J, 2013, SCAND J MED SCI SPOR, V23, P114, DOI 10.1111/j.1600-0838.2011.01357.x; Melanson EL, 2000, MED SCI SPORT EXER, V32, P1894, DOI 10.1097/00005768-200011000-00012; Middleton N, 2005, CLIN PHYSIOL FUNCT I, V25, P83, DOI 10.1111/j.1475-097X.2004.00594.x; Migliaro ER, 2001, BRAZ J MED BIOL RES, V34, P493, DOI 10.1590/S0100-879X2001000400009; Mora S, 2003, JAMA-J AM MED ASSOC, V290, P1600, DOI 10.1001/jama.290.12.1600; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI 10.1161/CIRCULATIONAHA.107.185650; Perini R, 2003, EUR J APPL PHYSIOL, V90, P317, DOI 10.1007/s00421-003-0953-9; PERONNET F, 1989, J APPL PHYSIOL, V67, P453, DOI 10.1152/jappl.1989.67.1.453; Perseguini NM, 2011, BRAZ J MED BIOL RES, V44, P29, DOI 10.1590/S0100-879X2011000100005; Piotrowicz E, 2009, PACING CLIN ELECT S1, V32, pS113, DOI [10.1111/j.1540-8159.2008.02266.x, DOI 10.1111/J.1540-8159.2008.02266.X]; Poveda JJ, 1997, EUR J CLIN INVEST, V27, P967, DOI 10.1046/j.1365-2362.1997.2220763.x; Reckelhoff JF, 1998, HYPERTENSION, V31, P435, DOI 10.1161/01.HYP.31.1.435; Reckelhoff JF, 2001, HYPERTENSION, V37, P1199, DOI 10.1161/01.HYP.37.5.1199; Reckelhoff JF, 2000, HYPERTENSION, V35, P480, DOI 10.1161/01.HYP.35.1.480; Rogers J, 2004, J APPL PHYSIOL, V97, P756, DOI 10.1152/japplphysiol.00115.2004; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; SANDVIK L, 1993, NEW ENGL J MED, V328, P533, DOI 10.1056/NEJM199302253280803; Seely EW, 1999, HYPERTENSION, V33, P1190, DOI 10.1161/01.HYP.33.5.1190; Sloan RP, 2009, AM J PUBLIC HEALTH, V99, P921, DOI 10.2105/AJPH.2007.133165; Souza HCD, 2009, AUTON NEUROSCI-BASIC, V150, P38, DOI 10.1016/j.autneu.2009.04.007; Sztajzel J, 2008, J SPORT MED PHYS FIT, V48, P495; Tezini GCSV, 2009, MENOPAUSE, V16, P110, DOI [10.1097/gme.0b013e318182d352, 10.1097/GME.0b013e318182d352]; Tulppo MP, 1998, AM J PHYSIOL-HEART C, V274, pH424, DOI 10.1152/ajpheart.1998.274.2.H424; van Ittersum FJ, 1998, AM J HYPERTENS, V11, P1147, DOI 10.1016/S0895-7061(98)00165-4	60	48	51	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e77092	10.1371/journal.pone.0077092	http://dx.doi.org/10.1371/journal.pone.0077092			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098577	gold, Green Submitted, Green Published			2022-12-25	WOS:000325483600083
J	Fonseca, LS; da Silva, JB; Milanez, JS; Monteiro-Vitorello, CB; Momo, L; de Morais, ZM; Vasconcellos, SA; Marques, MV; Ho, PL; da Costa, RMA				Fonseca, Luciane S.; da Silva, Josefa B.; Milanez, Juliana S.; Monteiro-Vitorello, Claudia B.; Momo, Leonardo; de Morais, Zenaide M.; Vasconcellos, Silvio A.; Marques, Marilis V.; Ho, Paulo L.; da Costa, Renata M. A.			Leptospira interrogans serovar Copenhageni Harbors Two lexA Genes Involved in SOS Response	PLOS ONE			English	Article							DNA-DAMAGE; ESCHERICHIA-COLI; RECA; EXPRESSION; BINDING; PROTEIN; MUTAGENESIS; REPRESSOR; INSIGHTS; CLEAVAGE	Bacteria activate a regulatory network in response to the challenges imposed by DNA damage to genetic material, known as the SOS response. This system is regulated by the RecA recombinase and by the transcriptional repressor lexA. Leptospira interrogans is a pathogen capable of surviving in the environment for weeks, being exposed to a great variety of stress agents and yet retaining its ability to infect the host. This study aims to investigate the behavior of L. interrogans serovar Copenhageni after the stress induced by DNA damage. We show that L. interrogans serovar Copenhageni genome contains two genes encoding putative LexA proteins (lexA1 and lexA2) one of them being potentially acquired by lateral gene transfer. Both genes are induced after DNA damage, but the steady state levels of both LexA proteins drop, probably due to auto-proteolytic activity triggered in this condition. In addition, seven other genes were up-regulated following UV-C irradiation, recA, recN, dinP, and four genes encoding hypothetical proteins. This set of genes is potentially regulated by LexA1, as it showed binding to their promoter regions. All these regions contain degenerated sequences in relation to the previously described SOS box, TTTGN (5)CAAA. On the other hand, LexA2 was able to bind to the palindrome TTGTAN (10)TACAA, found in its own promoter region, but not in the others. Therefore, the L. interrogans serovar Copenhageni SOS regulon may be even more complex, as a result of LexA1 and LexA2 binding to divergent motifs. New possibilities for DNA damage response in Leptospira are expected, with potential influence in other biological responses such as virulence.	[Fonseca, Luciane S.; da Silva, Josefa B.; Milanez, Juliana S.; Ho, Paulo L.] Inst Butantan, Ctr Biotecnol, Sao Paulo, Brazil; [Fonseca, Luciane S.; Ho, Paulo L.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Monteiro-Vitorello, Claudia B.] Escola Super Agr Luis Dequeiroz, Dept Genet, Piracicaba, Brazil; [Momo, Leonardo; da Costa, Renata M. A.] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Santo Andre, Brazil; [de Morais, Zenaide M.; Vasconcellos, Silvio A.] Univ Sao Paulo, Dept Med Vet Prevent & Saude Anim, BR-05508 Sao Paulo, Brazil; [Marques, Marilis V.] Univ Sao Paulo, Dept Microbiol, Inst Ciencias Biomed, BR-05508 Sao Paulo, Brazil	Instituto Butantan; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do ABC (UFABC); Universidade de Sao Paulo; Universidade de Sao Paulo	Ho, PL (corresponding author), Inst Butantan, Ctr Biotecnol, Sao Paulo, Brazil.	hoplee@butantan.gov.br; renata.costa@ufabc.edu.br	Marques, Marilis V/C-3085-2013; Ho, Paulo/P-8267-2015; Monteiro-Vitorello, Claudia B/F-2436-2012; da Silva, Josefa Bezerra/I-3515-2015	Ho, Paulo/0000-0003-3652-241X; Monteiro-Vitorello, Claudia B/0000-0002-1238-9354; Marques, Marilis/0000-0003-1542-8221	Fundacao Instituto Butantan; FAPESP [2010/51365-0, 2009/17123-2]; CNPq [482043/2009-1]	Fundacao Instituto Butantan; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was funded by Fundacao Instituto Butantan (www.butantan.gov.br), FAPESP (projects 2010/51365-0; 2009/17123-2, www.fapesp.br) and CNPq (project 482043/2009-1), www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella M, 2004, MOL MICROBIOL, V54, P212, DOI 10.1111/j.1365-2958.2004.04260.x; Abella M, 2007, J BACTERIOL, V189, P8855, DOI 10.1128/JB.01213-07; Adler B, 2006, PROKARYOTES, V7, P294; Aertsen A, 2006, TRENDS MICROBIOL, V14, P421, DOI 10.1016/j.tim.2006.08.006; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Aranda J, 2011, J BACTERIOL, V193, P3740, DOI 10.1128/JB.00389-11; Bisognano C, 2004, J BIOL CHEM, V279, P9064, DOI 10.1074/jbc.M309836200; BURATOWSKI S, 2001, MOBILITY SHIFT DNA B, P45237; Butala M, 2011, NUCLEIC ACIDS RES, V39, P6546, DOI 10.1093/nar/gkr265; Cambray G, 2010, ANNU REV GENET, V44, P141, DOI 10.1146/annurev-genet-102209-163504; Campoy S, 2005, J BACTERIOL, V187, P5367, DOI 10.1128/JB.187.15.5367-5375.2005; CAREY MF, 2012, COLD SPRING HARBOR P, V2012, P67470; Courcelle J, 2001, GENETICS, V158, P41; Croda J, 2008, INFECT IMMUN, V76, P5826, DOI 10.1128/IAI.00989-08; Cune J, 2005, J BACTERIOL, V187, P5841, DOI 10.1128/JB.187.16.5841-5845.2005; da Rocha RP, 2008, J BACTERIOL, V190, P1209, DOI 10.1128/JB.01419-07; da Silva JB, 2012, MICROB PATHOGENESIS, V52, P206, DOI 10.1016/j.micpath.2012.01.002; da Silva JB, 2011, CURR MICROBIOL, V62, P518, DOI 10.1007/s00284-010-9738-7; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eichenbaum Z, 1998, GENETICS, V149, P1173; Erill I, 2007, FEMS MICROBIOL REV, V31, P637, DOI 10.1111/j.1574-6976.2007.00082.x; Faine S., 1998, BACT INFECT HUMANS, V3rth, P395; Fernandez de Henestrosa AR, 2000, MOL MICROBIOL, V35, P1560, DOI 10.1046/j.1365-2958.2000.01826.x; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Gawel D, 2011, VIRULENCE, V2, P222, DOI 10.4161/viru.2.3.16143; Giese KC, 2008, J MOL BIOL, V377, P148, DOI 10.1016/j.jmb.2007.12.025; Goranov AI, 2006, J BACTERIOL, V188, P5595, DOI 10.1128/JB.00342-06; GRANGERSCHNARR M, 1988, FEBS LETT, V231, P437, DOI 10.1016/0014-5793(88)80866-4; Groban ES, 2005, NUCLEIC ACIDS RES, V33, P6287, DOI 10.1093/nar/gki939; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hamoen LW, 2011, MOL MICROBIOL, V81, P1, DOI 10.1111/j.1365-2958.2011.07693.x; Hauk P, 2005, BIOCHEM BIOPH RES CO, V333, P1341, DOI 10.1016/j.bbrc.2005.06.045; Hauk P, 2008, INFECT IMMUN, V76, P2642, DOI 10.1128/IAI.01639-07; Jara M, 2003, J BACTERIOL, V185, P2493, DOI 10.1128/JB.185.8.2493-2502.2003; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Justice SS, 2008, NAT REV MICROBIOL, V6, P162, DOI 10.1038/nrmicro1820; Kameni APT, 2002, J BACTERIOL, V184, P452, DOI 10.1128/JB.184.2.452-458.2002; Kelley WL, 2006, MOL MICROBIOL, V62, P1228, DOI 10.1111/j.1365-2958.2006.05444.x; LEFEBVRE RB, 2004, VET MICROBIOL, P536; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; LITTLE JW, 1981, P NATL ACAD SCI-BIOL, V78, P4199, DOI 10.1073/pnas.78.7.4199; Liveris D, 2008, INFECT IMMUN, V76, P4009, DOI 10.1128/IAI.00027-08; Luo Y, 2001, CELL, V106, P585, DOI 10.1016/S0092-8674(01)00479-2; Mazon G, 2006, MICROBIOL-SGM, V152, P1109, DOI 10.1099/mic.0.28376-0; Mazon G, 2004, MICROBIOL-SGM, V150, P3783, DOI 10.1099/mic.0.27315-0; Mazon G, 2006, ANTON LEEUW INT J G, V90, P123, DOI 10.1007/s10482-006-9066-x; Murray GL, 2009, INFECT IMMUN, V77, P810, DOI 10.1128/IAI.01293-08; Nascimento ALTO, 2004, BRAZ J MED BIOL RES, V37, P459, DOI 10.1590/S0100-879X2004000400003; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; Ni M, 2008, CURR MICROBIOL, V57, P521, DOI 10.1007/s00284-008-9235-4; NICHOLAS KB, 1997, EMBNEW, P45237; Ramos CRR, 2004, BRAZ J MED BIOL RES, V37, P1103, DOI 10.1590/S0100-879X2004000800001; Romero Eliete Caló, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P245, DOI 10.1590/S0036-46652003000500002; Salgado H, 2000, P NATL ACAD SCI USA, V97, P6652, DOI 10.1073/pnas.110147297; Simmons LA, 2007, P NATL ACAD SCI USA, V104, P1360, DOI 10.1073/pnas.0607123104; SLILATY SN, 1987, P NATL ACAD SCI USA, V84, P3987, DOI 10.1073/pnas.84.12.3987; SMOLLETT KL, 2012, J BIOL CHEM, P45237; STAMM LV, 1988, APPL ENVIRON MICROB, V54, P728, DOI 10.1128/AEM.54.3.728-733.1988; Sutton MD, 2000, ANNU REV GENET, V34, P479, DOI 10.1146/annurev.genet.34.1.479; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Toshima H, 2007, APPL ENVIRON MICROB, V73, P7582, DOI 10.1128/AEM.01326-07; Yang MK, 2008, MOL GENET GENOMICS, V280, P49, DOI 10.1007/s00438-008-0344-3; Zhang APP, 2010, NATURE, V466, P883, DOI 10.1038/nature09200; Zhong Y, 2011, CELL RES, V21, P1210, DOI 10.1038/cr.2011.46	65	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76419	10.1371/journal.pone.0076419	http://dx.doi.org/10.1371/journal.pone.0076419			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098496	Green Published, Green Submitted, gold			2022-12-25	WOS:000325483600048
J	Behrens, C; Binotti, B; Schmidt, C; Robinson, CV; Chua, JJE; Kuhnel, K				Behrens, Caroline; Binotti, Beyenech; Schmidt, Carla; Robinson, Carol V.; Chua, John Jia En; Kuehnel, Karin			Crystal Structure of the Human Short Coiled Coil Protein and Insights into SCOC-FEZ1 Complex Formation	PLOS ONE			English	Article							GCN4 LEUCINE-ZIPPER; AXONAL-TRANSPORT; HUMAN FEZ1; SEQUENCE; INTERACTS; ROTATION; STRATEGY; REVEALS; UNC-76	The short coiled coil protein (SCOC) forms a complex with fasciculation and elongation protein zeta 1 (FEZ1). This complex is involved in autophagy regulation. We determined the crystal structure of the coiled coil domain of human SCOC at 2.7 angstrom resolution. SCOC forms a parallel left handed coiled coil dimer. We observed two distinct dimers in the crystal structure, which shows that SCOC is conformationally flexible. This plasticity is due to the high incidence of polar and charged residues at the core a/d-heptad positions. We prepared two double mutants, where these core residues were mutated to either leucines or valines (E93V/K97L and N125L/N132V). These mutations led to a dramatic increase in stability and change of oligomerisation state. The oligomerisation state of the mutants was characterized by multi-angle laser light scattering and native mass spectrometry measurements. The E93V/K97 mutant forms a trimer and the N125L/N132V mutant is a tetramer. We further demonstrate that SCOC forms a stable homogeneous complex with the coiled coil domain of FEZ1. SCOC dimerization and the SCOC surface residue R117 are important for this interaction.	[Behrens, Caroline; Binotti, Beyenech; Chua, John Jia En; Kuehnel, Karin] Max Planck Inst Biophys Chem, Dept Neurobiol, Gottingen, Germany; [Schmidt, Carla; Robinson, Carol V.] Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England	Max Planck Society; University of Oxford	Kuhnel, K (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, POB 2841, Gottingen, Germany.	kkuehne@gwdg.de	Chua, John Jia En/G-8639-2012	Chua, John Jia En/0000-0002-5615-1014; Schmidt, Carla/0000-0001-9410-1424; robinson, carol/0000-0001-7829-5505; Kuehnel, Karin/0000-0002-2663-703X	Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB); Wellcome Trust; European Union (PROSPECTS grant) [HEALTH-F4-2008-201648]; Royal Society	Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB); Wellcome Trust(Wellcome Trust); European Union (PROSPECTS grant); Royal Society(Royal Society of London)	CB was funded by an excellence stipend of the Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB). CS and CVR acknowledge funding from the Wellcome Trust and the European Union (PROSPECTS grant number HEALTH-F4-2008-201648) together with funding from the Royal Society (CVR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alborghetti MR, 2010, J PROTEOME RES, V9, P4595, DOI 10.1021/pr100314q; Assmann EM, 2006, J BIOL CHEM, V281, P9869, DOI 10.1074/jbc.M513280200; Barszczewski M, 2008, MOL BIOL CELL, V19, P776, DOI 10.1091/mbc.E07-05-0498; Blasius TL, 2007, J CELL BIOL, V176, P11, DOI 10.1083/jcb.200605099; Bloom L, 1997, P NATL ACAD SCI USA, V94, P3414, DOI 10.1073/pnas.94.7.3414; Chua JJE, 2012, P NATL ACAD SCI USA, V109, P5862, DOI 10.1073/pnas.1113819109; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gindhart JG, 2003, MOL BIOL CELL, V14, P3356, DOI 10.1091/mbc.E02-12-0800; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Lanza DCF, 2010, MOL CELL BIOCHEM, V338, P35, DOI 10.1007/s11010-009-0317-9; Lanza DCF, 2009, PROTEINS, V74, P104, DOI 10.1002/prot.22135; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; McKnight NC, 2012, EMBO J, V31, P1931, DOI 10.1038/emboj.2012.36; Morgner N, 2012, ANAL CHEM, V84, P2939, DOI 10.1021/ac300056a; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016; Schrodinger L., 2020, PYMOL; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454; Su Cheng-Wen, 2006, J Biol, V5, P9, DOI 10.1186/jbiol39; Suzuki T, 2005, J BIOL CHEM, V280, P24948, DOI 10.1074/jbc.M411499200; Toda H, 2008, GENE DEV, V22, P3292, DOI 10.1101/gad.1734608; Van Valkenburgh H, 2001, J BIOL CHEM, V276, P22826, DOI 10.1074/jbc.M102359200; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Wang YQ, 2012, MOL BIOL CELL, V23, P3911, DOI 10.1091/mbc.E12-05-0396; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33	36	5	7	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76355	10.1371/journal.pone.0076355	http://dx.doi.org/10.1371/journal.pone.0076355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098481	Green Published, Green Submitted, gold			2022-12-25	WOS:000325427100062
J	Dole, M; Meunier, F; Hoen, M				Dole, Marjorie; Meunier, Fanny; Hoen, Michel			Gray and White Matter Distribution in Dyslexia: A VBM Study of Superior Temporal Gyrus Asymmetry	PLOS ONE			English	Article							ALTERED HEMISPHERIC-ASYMMETRY; VOXEL-BASED MORPHOMETRY; DEVELOPMENTAL DYSLEXIA; SPEECH-PERCEPTION; PLANUM-TEMPORALE; SPOKEN LANGUAGE; BRAIN RESPONSES; CHILDREN; ADULTS; ACTIVATION	In the present study, we investigated brain morphological signatures of dyslexia by using a voxel-based asymmetry analysis. Dyslexia is a developmental disorder that affects the acquisition of reading and spelling abilities and is associated with a phonological deficit. Speech perception disabilities have been associated with this deficit, particularly when listening conditions are challenging, such as in noisy environments. These deficits are associated with known neurophysiological correlates, such as a reduction in the functional activation or a modification of functional asymmetry in the cortical regions involved in speech processing, such as the bilateral superior temporal areas. These functional deficits have been associated with macroscopic morphological abnormalities, which potentially include a reduction in gray and white matter volumes, combined with modifications of the leftward asymmetry along the perisylvian areas. The purpose of this study was to investigate gray/white matter distribution asymmetries in dyslexic adults using automated image processing derived from the voxel-based morphometry technique. Correlations with speech-in-noise perception abilities were also investigated. The results confirmed the presence of gray matter distribution abnormalities in the superior temporal gyrus (STG) and the superior temporal Sulcus (STS) in individuals with dyslexia. Specifically, the gray matter of adults with dyslexia was symmetrically distributed over one particular region of the STS, the temporal voice area, whereas normal readers showed a clear rightward gray matter asymmetry in this area. We also identified a region in the left posterior STG in which the white matter distribution asymmetry was correlated to speech-in-noise comprehension abilities in dyslexic adults. These results provide further information concerning the morphological alterations observed in dyslexia, revealing the presence of both gray and white matter distribution anomalies and the potential involvement of these defects in speech-in-noise deficits.	[Dole, Marjorie] Univ Pierre Mendes France, CNRS UMR 5105, Lab Psychol & NeuroCognit, Grenoble, France; [Meunier, Fanny] Inst Cognit Sci, CNRS UMR 5304, L2C2, Lyon, France; [Hoen, Michel] INSERM U1028, Lyon Neurosci Res Ctr, Brain Dynam & Cognit Team, Lyon, France; [Hoen, Michel] CNRS UMR 5292, Lyon Neuroscience Res Ctr, Brain Dynam & Cognit Team, Lyon, France; [Meunier, Fanny; Hoen, Michel] Univ Lyon 1, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Dole, M (corresponding author), Univ Pierre Mendes France, CNRS UMR 5105, Lab Psychol & NeuroCognit, Grenoble, France.	marjorie.dole@isc.cnrs.fr	Michel, Hoen/C-7721-2012	Michel, Hoen/0000-0003-2099-8130	Rhone-Alpes Region, France through the "Cluster regional de recherche Handicap, Vieillissement et Neurosciences; European Research Council [209234]	Rhone-Alpes Region, France through the "Cluster regional de recherche Handicap, Vieillissement et Neurosciences(Region Auvergne-Rhone-Alpes); European Research Council(European Research Council (ERC)European Commission)	The first author is funded by a PhD grant from the Rhone-Alpes Region, France, attributed through the "Cluster regional de recherche Handicap, Vieillissement et Neurosciences. This research was supported by a European Research Council grant to the SpiN project (n degrees 209234). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann CF, 2008, NEUROIMAGE, V41, P69, DOI 10.1016/j.neuroimage.2008.02.013; Altmann CF, 2007, NEUROIMAGE, V35, P1192, DOI 10.1016/j.neuroimage.2007.01.007; [Anonymous], 2003, OVERCOMING DYSLEXIA; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Belin P, 2002, COGNITIVE BRAIN RES, V13, P17, DOI 10.1016/S0926-6410(01)00084-2; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Best M, 1999, NEUROREPORT, V10, P607, DOI 10.1097/00001756-199902250-00030; Bloom JS, 2013, NEUROPSYCHOLOGIA, V51, P1684, DOI 10.1016/j.neuropsychologia.2013.05.012; Boets B, 2007, BRAIN LANG, V101, P19, DOI 10.1016/j.bandl.2006.06.009; Boets B, 2007, NEUROPSYCHOLOGIA, V45, P1608, DOI 10.1016/j.neuropsychologia.2007.01.009; Bradlow AR, 2003, J SPEECH LANG HEAR R, V46, P80, DOI 10.1044/1092-4388(2003/007); BRADY S, 1983, J EXP CHILD PSYCHOL, V35, P345, DOI 10.1016/0022-0965(83)90087-5; Brambati SM, 2004, NEUROLOGY, V63, P742, DOI 10.1212/01.WNL.0000134673.95020.EE; Brett M, 2002, NEUROIMAGE, V16; Brunswick N, 1999, BRAIN, V122, P1901, DOI 10.1093/brain/122.10.1901; Cao F, 2006, J CHILD PSYCHOL PSYC, V47, P1041, DOI 10.1111/j.1469-7610.2006.01684.x; Charest I, 2013, CEREB CORTEX, V23, P958, DOI 10.1093/cercor/bhs090; Dalby MA, 1998, BRAIN LANG, V62, P51, DOI 10.1006/brln.1997.1887; Darwin CJ, 2003, J ACOUST SOC AM, V114, P2913, DOI 10.1121/1.1616924; Davis MH, 2003, J NEUROSCI, V23, P3423; DENCKLA MB, 1976, NEUROPSYCHOLOGIA, V14, P471, DOI 10.1016/0028-3932(76)90075-0; Derflinger S, 2011, J ALZHEIMERS DIS, V25, P347, DOI 10.3233/JAD-2011-110041; Deutsch GK, 2005, CORTEX, V41, P354, DOI 10.1016/S0010-9452(08)70272-7; Dole M, 2012, NEUROPSYCHOLOGIA, V50, P1543, DOI 10.1016/j.neuropsychologia.2012.03.007; Eckert MA, 2008, NEUROIMAGE, V41, P813, DOI 10.1016/j.neuroimage.2008.03.002; FESTEN JM, 1990, J ACOUST SOC AM, V88, P1725, DOI 10.1121/1.400247; FRAUENHEIM JG, 1978, J LEARN DISABIL, V11, P476, DOI 10.1177/002221947801100803; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; GALABURDA AM, 1985, ANN NEUROL, V18, P222, DOI 10.1002/ana.410180210; Giraud AL, 2007, NEURON, V56, P1127, DOI 10.1016/j.neuron.2007.09.038; Glasel H, 2011, NEUROIMAGE, V58, P716, DOI 10.1016/j.neuroimage.2011.06.016; Goswami U, 2011, TRENDS COGN SCI, V15, P3, DOI 10.1016/j.tics.2010.10.001; Grataloup C, 2009, J SPEECH LANG HEAR R, V52, P827, DOI [10.1044/1092-4388(2008/06-0235), 10.1044/1092-4388(2008/06-0235]; Grossmann T, 2010, NEURON, V65, P852, DOI 10.1016/j.neuron.2010.03.001; Habib M, 2000, BRAIN, V123, P2373, DOI 10.1093/brain/123.12.2373; Hamalainen JA, 2012, NEUROIMAGE, V59, P2952, DOI 10.1016/j.neuroimage.2011.09.075; Heiervang E, 2000, NEUROPSYCHOLOGIA, V38, P1704, DOI 10.1016/S0028-3932(00)00085-3; Heim S, 2003, EUR J NEUROSCI, V17, P1715, DOI 10.1046/j.1460-9568.2003.02596.x; Heim S, 2003, NEUROREPORT, V14, P501, DOI 10.1097/01.wnr.0000058778.36017.f0; Herve PY, 2006, NEUROIMAGE, V29, P1066, DOI 10.1016/j.neuroimage.2005.08.031; Hickok G, 2009, PHYS LIFE REV, V6, P121, DOI 10.1016/j.plrev.2009.06.001; Hoeft F, 2007, P NATL ACAD SCI USA, V104, P4234, DOI 10.1073/pnas.0609399104; Hugdahl K, 2003, NEUROPSYCHOLOGIA, V41, P666, DOI 10.1016/S0028-3932(02)00224-5; HUMPHREYS P, 1990, ANN NEUROL, V28, P727, DOI 10.1002/ana.410280602; Jacquier-Roux M., 2017, LABORATOIRE SCI LEDU, V5; Kast M, 2011, BRAIN LANG, V119, P136, DOI 10.1016/j.bandl.2011.04.002; Klein ME, 2011, NEUROPSYCHOLOGIA, V49, P878, DOI 10.1016/j.neuropsychologia.2011.01.008; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; Kronbichler M, 2008, HUM BRAIN MAPP, V29, P613, DOI 10.1002/hbm.20425; Kronbichler M, 2006, NEUROPSYCHOLOGIA, V44, P1822, DOI 10.1016/j.neuropsychologia.2006.03.010; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; LARSEN JP, 1990, BRAIN LANG, V39, P289, DOI 10.1016/0093-934X(90)90015-9; Latinus M, 2011, CURR BIOL, V21, pR143, DOI 10.1016/j.cub.2010.12.033; Lefavrais P., 1967, TEST ALOUETTE; Lehongre K, 2011, NEURON, V72, P1080, DOI 10.1016/j.neuron.2011.11.002; Leonard C, 2006, BRAIN, V129, P3329, DOI 10.1093/brain/awl262; LEONARD CM, 1993, ARCH NEUROL-CHICAGO, V50, P461, DOI 10.1001/archneur.1993.00540050013008; LIEM F, 2013, HUM BRAIN M IN PRESS, P99152; Lorenzi C, 2000, J SPEECH LANG HEAR R, V43, P1367, DOI 10.1044/jslhr.4306.1367; Luders E, 2004, NEUROIMAGE, V22, P656, DOI 10.1016/j.neuroimage.2004.01.032; NELSON HE, 1980, BRIT J PSYCHOL, V71, P487, DOI 10.1111/j.2044-8295.1980.tb01762.x; Obleser J, 2007, CEREB CORTEX, V17, P2251, DOI 10.1093/cercor/bhl133; Obleser J, 2007, J NEUROSCI, V27, P2283, DOI 10.1523/JNEUROSCI.4663-06.2007; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paulesu E, 1996, BRAIN, V119, P143, DOI 10.1093/brain/119.1.143; Paulesu E, 2001, SCIENCE, V291, P2165, DOI 10.1126/science.1057179; Perre L, 2009, BRAIN RES, V1275, P73, DOI 10.1016/j.brainres.2009.04.018; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Pugh KR, 2000, PSYCHOL SCI, V11, P51, DOI 10.1111/1467-9280.00214; Rajapakse JC, 1997, IEEE T MED IMAGING, V16, P176, DOI 10.1109/42.563663; Ramus F, 2003, BRAIN, V126, P841, DOI 10.1093/brain/awg076; Raven J.C., 1938, PROGR MATRICES PERCE; Richards T, 2008, AM J NEURORADIOL, V29, P1134, DOI 10.3174/ajnr.A1007; Rimrodt SL, 2010, CORTEX, V46, P739, DOI 10.1016/j.cortex.2009.07.008; Robichon F, 2000, EUR J NEUROL, V7, P35, DOI 10.1046/j.1468-1331.2000.00020.x; Rocheron I, 2002, NEUROREPORT, V13, P1683, DOI 10.1097/00001756-200209160-00023; Salo E, 2013, BRAIN RES, V1496, P55, DOI 10.1016/j.brainres.2012.12.013; Sarkari Shirin, 2002, Semin Pediatr Neurol, V9, P229, DOI 10.1053/spen.2002.35506; Scott SK, 2009, J ACOUST SOC AM, V125, P1737, DOI 10.1121/1.3050255; Sharda M, 2012, NEUROSCIENCE, V214, P49, DOI 10.1016/j.neuroscience.2012.03.053; Shaywitz BA, 2002, BIOL PSYCHIAT, V52, P101, DOI 10.1016/S0006-3223(02)01365-3; Shaywitz SE, 2003, BIOL PSYCHIAT, V54, P25, DOI 10.1016/S0006-3223(02)01836-X; Silani G, 2005, BRAIN, V128, P2453, DOI 10.1093/brain/awh579; Spironelli C, 2010, BRAIN, V133, P3385, DOI 10.1093/brain/awq199; Sprenger-Charolles L, 2000, CAN J EXP PSYCHOL, V54, P87, DOI 10.1037/h0087332; Steinbrink C, 2008, NEUROPSYCHOLOGIA, V46, P3170, DOI 10.1016/j.neuropsychologia.2008.07.015; Summerlin JL., 1997, NEUROIMAGE, V5, pS633, DOI DOI 10.1002/(SICI)1097-0193(1997)5:4<238:AID-HBM6>3.0.C0;2-4; Takao H, 2011, HUM BRAIN MAPP, V32, P1762, DOI 10.1002/hbm.21145; Tohka J, 2004, NEUROIMAGE, V23, P84, DOI 10.1016/j.neuroimage.2004.05.007; Trecy MP, 2013, RES DEV DISABIL, V34, P2211, DOI 10.1016/j.ridd.2013.04.005; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vestergaard MD, 2009, J ACOUST SOC AM, V125, P1114, DOI 10.1121/1.3050321; Veuillet E, 2007, BRAIN, V130, P2915, DOI 10.1093/brain/awm235; Vinckenbosch E, 2005, NEUROPSYCHOLOGIA, V43, P324, DOI 10.1016/j.neuropsychologia.2004.06.023; von Kriegstein K, 2003, COGNITIVE BRAIN RES, V17, P48, DOI 10.1016/S0926-6410(03)00079-X; Wong PCM, 2008, J SPEECH LANG HEAR R, V51, P1026, DOI 10.1044/1092-4388(2008/075); Zatorre RJ, 2004, J NEUROSCI, V24, P3637, DOI 10.1523/JNEUROSCI.5458-03.2004; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zekveld AA, 2006, NEUROIMAGE, V32, P1826, DOI 10.1016/j.neuroimage.2006.04.199; Zhang LJ, 2010, HUM BRAIN MAPP, V31, P1106, DOI 10.1002/hbm.20922; Ziegler JC, 2009, DEVELOPMENTAL SCI, V12, P732, DOI 10.1111/j.1467-7687.2009.00817.x	104	17	18	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76823	10.1371/journal.pone.0076823	http://dx.doi.org/10.1371/journal.pone.0076823			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098565	Green Published, Green Submitted, gold			2022-12-25	WOS:000325427100085
J	Qin, R; Shen, HL; Cao, Y; Fang, Y; Li, H; Chen, QY; Xu, WL				Qin, Rong; Shen, Huiling; Cao, Yuan; Fang, Yue; Li, Hao; Chen, Qiaoyun; Xu, Wenlin			Tetrandrine Induces Mitochondria-Mediated Apoptosis in Human Gastric Cancer BGC-823 Cells	PLOS ONE			English	Article							IN-VITRO; ACTIVATION; RESISTANCE; INDUCTION; PATHWAYS; REVERSAL; CASCADE; PROTEIN	Tetrandrine, a bis-benzylisoquinoline alkaloid isolated from the dried root of Hang-Fang-Chi (Stephania tetrandra S. Moore), has been reported to possess anti-cancer effects on many tumors. In this study, we investigated tetrandrine-induced apoptosis on human gastric cancer BGC-823 cells in vitro and in vivo. The results showed that tetrandrine significantly inhibited cell viability in a dose- and time-dependent manner and induced apoptosis. It increased the apoptosis; upregulation of Bax, Bak, and Bad; and downregulation of Bcl-2 and Bcl-xl in BGC-823 cells. Moreover, tetrandrine increased the activation of caspase-3 and -9, release of cytochrome c, and upregulation of apaf-1, suggesting that tetrandrine-induced apoptosis was related to the mitochondrial pathway. Meanwhile, pretreatment with the pan-caspase inhibitor z-VAD-fmk in BGC-823 cells reduced tetrandrine-induced apoptosis by blocking activation of caspases. Furthermore, tetrandrine effectively inhibited tumor growth via apoptosis induction, which was verified by immunohistochemical analysis in a nude mouse xenograft model. Taken together, we concluded that tetrandrine significantly inhibited the proliferation of gastric cancer BGC-823 cells through mitochondria-dependent apoptosis, which may play a promising role in gastric cancer therapy.	[Qin, Rong; Shen, Huiling; Cao, Yuan; Fang, Yue; Chen, Qiaoyun] Jiangsu Univ, Affiliated Peoples Hosp, Dept Oncol, Zhenjiang, Jiangsu, Peoples R China; [Li, Hao; Xu, Wenlin] Jiangsu Univ, Affiliated Peoples Hosp 4, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University	Xu, WL (corresponding author), Jiangsu Univ, Affiliated Peoples Hosp 4, Zhenjiang, Jiangsu, Peoples R China.	xuwenlin0511@163.com			National Natural Science Foundation of China [81070423, 81101677]; Natural Science Foundation of Jiangsu Province [BK 2010332]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by the following grants: the grants from National Natural Science Foundation of China (81070423 and 81101677), the grants from the Natural Science Foundation of Jiangsu Province (BK 2010332). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsumi T, 2007, PATHOL INT, V57, P635, DOI 10.1111/j.1440-1827.2007.02152.x; BISSERY MC, 1995, ANTI-CANCER DRUG, V6, P339, DOI 10.1097/00001813-199506000-00001; Chen BA, 2008, INT J NANOMED, V3, P277; Chen Y, 2009, INT J CANCER, V124, P2260, DOI 10.1002/ijc.24208; Cho HS, 2009, J VET SCI, V10, P23, DOI 10.4142/jvs.2009.10.1.23; Dai CL, 2007, CANCER CHEMOTH PHARM, V60, P741, DOI 10.1007/s00280-007-0420-0; Dorr R T, 1994, Ann Pharmacother, V28, pS11; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; FORD AC, 2011, CLIN GASTROENTEROLOG, V25, P581, DOI DOI 10.1016/J.BPG.2011.09.002.PUBMED:22122773; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Gu WJ, 2013, ANTI-CANCER DRUG, V24, P566, DOI 10.1097/CAD.0b013e3283608bc5; Hirsch T, 1997, BIOSCIENCE REP, V17, P67, DOI 10.1023/A:1027339418683; Jang BC, 2004, BIOCHEM PHARMACOL, V67, P1819, DOI 10.1016/j.bcp.2004.01.018; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Jiang M, 2009, AM J PHYSIOL-RENAL, V296, pF983, DOI 10.1152/ajprenal.90579.2008; Lee HJ, 2008, CANCER LETT, V270, P342, DOI 10.1016/j.canlet.2008.05.040; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Li XL, 2012, MOL PHARMACEUT, V9, P222, DOI 10.1021/mp2002736; Li XD, 2011, J SURG RES, V166, pE45, DOI 10.1016/j.jss.2010.10.034; Lochhead P, 2008, BRIT MED BULL, V85, P87, DOI 10.1093/bmb/ldn007; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Meyer HJ, 2011, DTSCH ARZTEBL INT, V108, P698, DOI 10.3238/arztebl.2011.0698; Ng LT, 2006, AM J CHINESE MED, V34, P125, DOI 10.1142/S0192415X06003692; Pan XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056679; Pang LH, 1997, BIOCHEM PHARMACOL, V53, P773, DOI 10.1016/S0006-2952(96)00817-9; Parkin DM, 2004, ONCOGENE, V23, P6329, DOI 10.1038/sj.onc.1207726; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Rogalska A, 2013, TOXICOL IN VITRO, V27, P239, DOI 10.1016/j.tiv.2012.09.006; Roukos DH, 2005, NAT CLIN PRACT ONCOL, V2, P98, DOI 10.1038/ncponc0099; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Tabuchi Y, 2009, INT J ONCOL, V34, P313, DOI 10.3892/ijo_00000153; Vogiatzi P, 2007, J CELL PHYSIOL, V211, P287, DOI 10.1002/jcp.20982; Wei J, 2007, CANCER CHEMOTH PHARM, V60, P703, DOI 10.1007/s00280-007-0416-9; Wei N, 2011, BIOCHEM PHARMACOL, V82, P1593, DOI 10.1016/j.bcp.2011.08.012; Wu JM, 2010, CANCER LETT, V287, P187, DOI 10.1016/j.canlet.2009.06.009; Wu YY, 2007, APOPTOSIS, V12, P593, DOI 10.1007/s10495-006-0007-y; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Zhang L, 2012, ASIAN PAC J CANCER P, V13, P3803, DOI 10.7314/APJCP.2012.13.8.3803; Zhu XM, 2005, ANTICANCER RES, V25, P1953	40	40	50	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76486	10.1371/journal.pone.0076486	http://dx.doi.org/10.1371/journal.pone.0076486			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098511	Green Submitted, gold, Green Published			2022-12-25	WOS:000325427100071
J	Jagielska, A; Wilhite, KD; Van Vliet, KJ				Jagielska, Anna; Wilhite, Kristen D.; Van Vliet, Krystyn J.			Extracellular Acidic pH Inhibits Oligodendrocyte Precursor Viability, Migration, and Differentiation	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS LESIONS; DIRECTIONAL CELL-MIGRATION; CENTRAL-NERVOUS-SYSTEM; NA+/H+ EXCHANGER NHE1; GROWTH-FACTOR BINDING; HUMAN-MELANOMA CELLS; INTRACELLULAR PH; PROGENITOR CELLS; IN-VIVO; DEMYELINATING LESIONS	Axon remyelination in the central nervous system requires oligodendrocytes that produce myelin. Failure of this repair process is characteristic of neurodegeneration in demyelinating diseases such as multiple sclerosis, and it remains unclear how the lesion microenvironment contributes to decreased remyelination potential of oligodendrocytes. Here, we show that acidic extracellular pH, which is characteristic of demyelinating lesions, decreases the migration, proliferation, and survival of oligodendrocyte precursor cells (OPCs), and reduces their differentiation into oligodendrocytes. Further, OPCs exhibit directional migration along pH gradients toward acidic pH. These in vitro findings support a possible in vivo scenario whereby pH gradients attract OPCs toward acidic lesions, but resulting reduction in OPC survival and motility in acid decreases progress toward demyelinated axons and is further compounded by decreased differentiation into myelin-producing oligodendrocytes. As these processes are integral to OPC response to nerve demyelination, our results suggest that lesion acidity could contribute to decreased remyelination.	[Jagielska, Anna; Van Vliet, Krystyn J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Wilhite, Kristen D.; Van Vliet, Krystyn J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Van Vliet, KJ (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.	krystyn@mit.edu			Human Frontier Science Program [RGP0015]	Human Frontier Science Program(Human Frontier Science Program)	This work was funded by the Human Frontier Science Program, RGP0015; http://www.hfsp.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso G, 2005, GLIA, V49, P318, DOI 10.1002/glia.20121; Amat JA, 1998, GLIA, V22, P64, DOI 10.1002/(SICI)1098-1136(199801)22:1<64::AID-GLIA6>3.0.CO;2-8; Anand-Apte B, 1997, J BIOL CHEM, V272, P30688, DOI 10.1074/jbc.272.49.30688; Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279; Baer AS, 2009, BRAIN, V132, P465, DOI 10.1093/brain/awn334; Bernard F, 2006, J NEUROSCI RES, V84, P1392, DOI 10.1002/jnr.21051; Bitsch A, 1999, AM J NEURORADIOL, V20, P1619; Blaschuk KL, 2000, DEVELOPMENT, V127, P1961; BLUMENTHAL SS, 1989, AM J PHYSIOL, V257, pC419, DOI 10.1152/ajpcell.1989.257.3.C419; Bonneh-Barkay D, 2009, BRAIN PATHOL, V19, P573, DOI 10.1111/j.1750-3639.2008.00195.x; Boussouf A, 2000, J NEUROSCI RES, V59, P731, DOI 10.1002/(SICI)1097-4547(20000315)59:6<731::AID-JNR5>3.0.CO;2-G; Boussouf A, 1997, GLIA, V19, P74, DOI 10.1002/(SICI)1098-1136(199701)19:1<74::AID-GLIA8>3.0.CO;2-A; Boyd A, 2013, ACTA NEUROPATHOL, V125, P841, DOI 10.1007/s00401-013-1112-y; Buttery PC, 1999, MOL CELL NEUROSCI, V14, P199, DOI 10.1006/mcne.1999.0781; CARROLL WM, 1994, BRAIN, V117, P563, DOI 10.1093/brain/117.3.563; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Chari DM, 2003, J NEUROPATH EXP NEUR, V62, P908, DOI 10.1093/jnen/62.9.908; Chari DM, 2002, GLIA, V37, P307, DOI 10.1002/glia.10038; Charles P, 2002, BRAIN, V125, P1972, DOI 10.1093/brain/awf216; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; CHESLER M, 1989, J NEUROSCI, V9, P2011; CHOPP M, 1990, STROKE, V21, P463, DOI 10.1161/01.STR.21.3.463; Cutaia M, 2005, APOPTOSIS, V10, P1457, DOI 10.1007/s10495-005-1402-5; de Castro F, 2005, BRAIN RES REV, V49, P227, DOI 10.1016/j.brainresrev.2004.12.034; Deitmer JW, 1996, PROG NEUROBIOL, V48, P73, DOI 10.1016/0301-0082(95)00039-9; Deng WB, 2003, P NATL ACAD SCI USA, V100, P6801, DOI 10.1073/pnas.1136624100; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; DeStefano N, 1995, ANN NEUROL, V38, P901, DOI 10.1002/ana.410380610; DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6; Duncan ID, 2009, P NATL ACAD SCI USA, V106, P6832, DOI 10.1073/pnas.0812500106; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Eble JA, 2003, BIOCHEM J, V376, P77, DOI 10.1042/BJ20030373; Edgar JM, 2009, CURR OPIN NEUROBIOL, V19, P498, DOI 10.1016/j.conb.2009.08.003; Faff L, 2000, BRAIN RES, V853, P22, DOI 10.1016/S0006-8993(99)02221-0; Fancy SPJ, 2011, ANNU REV NEUROSCI, V34, P21, DOI 10.1146/annurev-neuro-061010-113629; Fancy SPJ, 2010, EXP NEUROL, V225, P18, DOI 10.1016/j.expneurol.2009.12.020; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Feldman DH, 2008, GLIA, V56, P1238, DOI 10.1002/glia.20693; Franklin RJM, 1997, J NEUROSCI RES, V50, P337, DOI 10.1002/(SICI)1097-4547(19971015)50:2<337::AID-JNR21>3.0.CO;2-3; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Franklin RJM, 2008, J NEUROL, V255, P19, DOI 10.1007/s00415-008-1004-6; Freire E, 2000, J BIOL CHEM, V275, P817, DOI 10.1074/jbc.275.2.817; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Frost EE, 1999, CURR BIOL, V9, P1251, DOI 10.1016/S0960-9822(99)80506-5; Fulton D, 2010, ASN NEURO, V2, DOI 10.1042/AN20090051; Gallo V, 2008, CURR OPIN NEUROL, V21, P278, DOI 10.1097/WCO.0b013e3282fd1875; Gatenby RA, 2006, CANCER RES, V66, P5216, DOI 10.1158/0008-5472.CAN-05-4193; GIFFARD RG, 1992, STROKE, V23, P1817, DOI 10.1161/01.STR.23.12.1817; GILLIES RJ, 1994, AM J PHYSIOL, V267, pC195, DOI 10.1152/ajpcell.1994.267.1.C195; Glunde K, 2003, NEOPLASIA, V5, P533, DOI 10.1016/S1476-5586(03)80037-4; Goerges AL, 2003, J BIOL CHEM, V278, P19518, DOI 10.1074/jbc.M211208200; Goerges AL, 2004, J BIOL CHEM, V279, P2307, DOI 10.1074/jbc.M308482200; Goldschmidt T, 2009, NEUROLOGY, V72, P1914, DOI 10.1212/WNL.0b013e3181a8260a; Gudz TI, 2006, J NEUROSCI, V26, P2458, DOI 10.1523/JNEUROSCI.4054-05.2006; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; HERTZ H, 1881, J REINE ANGEW MATH, V92, P155; Hinks GL, 1999, MOL CELL NEUROSCI, V14, P153, DOI 10.1006/mcne.1999.0771; Hinks GL, 2000, MOL CELL NEUROSCI, V16, P542, DOI 10.1006/mcne.2000.0897; Huang JK, 2011, NAT NEUROSCI, V14, P45, DOI 10.1038/nn.2702; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; HUNT TK, 1969, AM J SURG, V118, P521, DOI 10.1016/0002-9610(69)90174-3; HUTCHISON C, 1995, CELL CYCLE CONTROL; HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970; Irvine KA, 2008, BRAIN, V131, P1464, DOI 10.1093/brain/awn080; Jagielska A, 2012, STEM CELLS DEV; Jarjour AA, 2004, NEUROSCIENTIST, V10, P99, DOI 10.1177/1073858403260751; Jeffery ND, 1999, EUR J NEUROSCI, V11, P1508, DOI 10.1046/j.1460-9568.1999.00564.x; JOHNSON ES, 1981, ACTA NEUROPATHOL, V53, P93, DOI 10.1007/BF00689988; KATO Y, 1992, J BIOL CHEM, V267, P11424; KETTENMANN H, 1988, J PHYSIOL-LONDON, V406, P147, DOI 10.1113/jphysiol.1988.sp017373; Kippert A, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-71; Klein M, 2000, J GEN PHYSIOL, V115, P599, DOI 10.1085/jgp.115.5.599; Knutson P, 1997, J NEUROSCI, V17, P2669, DOI 10.1523/jneurosci.17-08-02669.1997; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Kotter MR, 2011, BRAIN, V134, P1882, DOI 10.1093/brain/awr014; Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006; KRAIG RP, 1985, BRAIN RES, V342, P281, DOI 10.1016/0006-8993(85)91127-8; KRAIG RP, 1986, AM J PHYSIOL, V250, pR348, DOI 10.1152/ajpregu.1986.250.3.R348; KRAIG RP, 1983, J NEUROPHYSIOL, V49, P831, DOI 10.1152/jn.1983.49.3.831; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; KUHNE HH, 1985, INFECTION, V13, P52, DOI 10.1007/BF01660413; Kukley M, 2007, NAT NEUROSCI, V10, P311, DOI 10.1038/nn1850; LARSSON SH, 1990, AM J PHYSIOL, V258, pF697, DOI 10.1152/ajprenal.1990.258.3.F697; Lassmann H, 2007, J NEUROL SCI, V259, P3, DOI 10.1016/j.jns.2006.08.016; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lauritzen G, 2012, CANCER LETT, V317, P172, DOI 10.1016/j.canlet.2011.11.023; Lehenkari PP, 1999, BIOCHEM BIOPH RES CO, V259, P645, DOI 10.1006/bbrc.1999.0827; Levine JM, 1999, EXP NEUROL, V160, P333, DOI 10.1006/exnr.1999.7224; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; Liebetanz D, 2006, EXP NEUROL, V202, P217, DOI 10.1016/j.expneurol.2006.05.032; Lucchinetti C, 1999, BRAIN, V122, P2279, DOI 10.1093/brain/122.12.2279; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; LUDWIN SK, 1980, LAB INVEST, V43, P382; MABE H, 1983, J CEREBR BLOOD F MET, V3, P109, DOI 10.1038/jcbfm.1983.13; Majima HJ, 1998, J BIOL CHEM, V273, P8217, DOI 10.1074/jbc.273.14.8217; Marta M, 2012, CNS NEUROL DISORD-DR, V11, P610, DOI 10.2174/187152712801661301; MARTIN GR, 1994, CANCER RES, V54, P5670; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Milner R, 1997, GLIA, V19, P85, DOI 10.1002/(SICI)1098-1136(199701)19:1<85::AID-GLIA9>3.0.CO;2-9; Milner R, 1996, J NEUROSCI, V16, P7240; Milner R, 1997, CLIN SCI, V92, P113, DOI 10.1042/cs0920113; MUTCH WAC, 1984, J CEREBR BLOOD F MET, V4, P17, DOI 10.1038/jcbfm.1984.3; NEDERGAARD M, 1991, AM J PHYSIOL, V260, pR581, DOI 10.1152/ajpregu.1991.260.3.R581; Niehaus A, 1999, J NEUROSCI, V19, P4948; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; O'Meara Ryan W, 2011, J Signal Transduct, V2011, P354091, DOI 10.1155/2011/354091; Palecek SP, 1998, J CELL SCI, V111, P929; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; PAPPAS CA, 1994, NEUROREPORT, V6, P193, DOI 10.1097/00001756-199412300-00049; Paradise RK, 2013, EXP CELL RES, V319, P487, DOI 10.1016/j.yexcr.2012.11.006; Paradise RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015746; Patel JR, 2010, P NATL ACAD SCI USA, V107, P11062, DOI 10.1073/pnas.1006301107; PERONA R, 1988, NATURE, V334, P438, DOI 10.1038/334438a0; PFAFF M, 1994, EUR J BIOCHEM, V225, P975, DOI 10.1111/j.1432-1033.1994.0975b.x; Piao JH, 2013, GLIA, V61, P361, DOI 10.1002/glia.22438; Piaton G, 2009, PROG BRAIN RES, V175, P453, DOI 10.1016/S0079-6123(09)17530-1; PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349, DOI 10.1091/mbc.6.10.1349; PRINEAS JW, 1993, BRAIN, V116, P681, DOI 10.1093/brain/116.3.681; Redwine JM, 1998, J NEUROBIOL, V37, P413, DOI 10.1002/(SICI)1097-4695(19981115)37:3<413::AID-NEU7>3.0.CO;2-8; REHNCRONA S, 1981, J CEREBR BLOOD F MET, V1, P297, DOI 10.1038/jcbfm.1981.34; Relvas JB, 2001, CURR BIOL, V11, P1039, DOI 10.1016/S0960-9822(01)00292-5; REMENSNYDER JP, 1968, AM J PATHOL, V52, P301; Rhoads DS, 2007, EXP CELL RES, V313, P3859, DOI 10.1016/j.yexcr.2007.06.005; Rofstad EK, 2006, CANCER RES, V66, P6699, DOI 10.1158/0008-5472.CAN-06-0983; Saidha S, 2012, ANN NY ACAD SCI, V1247, P117, DOI 10.1111/j.1749-6632.2011.06272.x; Schneider LA, 2007, ARCH DERMATOL RES, V298, P413, DOI 10.1007/s00403-006-0713-x; Schregel K, 2012, P NATL ACAD SCI USA, V109, P6650, DOI 10.1073/pnas.1200151109; Schwab A, 2005, J PHYSIOL-LONDON, V568, P445, DOI 10.1113/jphysiol.2005.092957; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; Shields SA, 1999, GLIA, V28, P77, DOI 10.1002/(SICI)1098-1136(199910)28:1<77::AID-GLIA9>3.0.CO;2-F; SIESJO BK, 1988, NEUROCHEM PATHOL, V9, P31; Sim FJ, 2002, J NEUROSCI, V22, P2451, DOI 10.1523/JNEUROSCI.22-07-02451.2002; Sirn FJ, 2006, ANN NEUROL, V59, P763, DOI 10.1002/ana.20812; Smith JT, 2004, LANGMUIR, V20, P8279, DOI 10.1021/la0489763; SMITH KJ, 1979, NATURE, V280, P395, DOI 10.1038/280395a0; SOBEL RA, 1989, AM J PATHOL, V135, P161; Srivastava J, 2008, P NATL ACAD SCI USA, V105, P14436, DOI 10.1073/pnas.0805163105; Stock C, 2006, ACTA PHYSIOL, V187, P149, DOI 10.1111/j.1748-1716.2006.01543.x; Stock C, 2005, J PHYSIOL-LONDON, V567, P225, DOI 10.1113/jphysiol.2005.088344; Stock C, 2007, CELL PHYSIOL BIOCHEM, V20, P679, DOI 10.1159/000107550; Stock C, 2009, PFLUG ARCH EUR J PHY, V458, P981, DOI 10.1007/s00424-009-0677-8; Stuwe L, 2007, J PHYSIOL-LONDON, V585, P351, DOI 10.1113/jphysiol.2007.145185; TOURBAH A, 1992, J NEUROSCI RES, V33, P47, DOI 10.1002/jnr.490330107; Tsai HH, 2002, CELL, V110, P373, DOI 10.1016/S0092-8674(02)00838-3; VONHANWEHR R, 1986, J NEUROCHEM, V46, P331; Waxman SG, 2006, TRENDS MOL MED, V12, P192, DOI 10.1016/j.molmed.2006.03.001; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; WIKEHOOLEY JL, 1984, RADIOTHER ONCOL, V2, P343, DOI 10.1016/S0167-8140(84)80077-8; Wolswijk G, 1998, J NEUROSCI, V18, P601; Woodruff RH, 2004, MOL CELL NEUROSCI, V25, P252, DOI 10.1016/j.mcn.2003.10.014; XIE DC, 1995, J NEUROCYTOL, V24, P435, DOI 10.1007/BF01181605; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; YIM SH, 1993, J NEUROSCI RES, V34, P401, DOI 10.1002/jnr.490340405; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606; Ziskin JL, 2007, NAT NEUROSCI, V10, P321, DOI 10.1038/nn1854	159	14	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76048	10.1371/journal.pone.0076048	http://dx.doi.org/10.1371/journal.pone.0076048			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098762	Green Published, gold			2022-12-25	WOS:000325423500132
J	Tian, L; Fang, YX; Xue, JL; Chen, JZ				Tian, Ling; Fang, Yu-xiang; Xue, Jing-lun; Chen, Jin-zhong			Four MicroRNAs Promote Prostate Cell Proliferation with Regulation of PTEN and Its Downstream Signals In Vitro	PLOS ONE			English	Article							KEY ONCOGENIC COMPONENT; CANCER; EXPRESSION; CARCINOMA; GROWTH; CLUSTER; GENE; DIFFERENTIATION; 3-KINASES; RADIATION	Background: Phosphatase and tensin homologue (PTEN), as a tumor suppressor, plays vital roles in tumorigenesis and progression of prostate cancer. However, the mechanisms of PTEN regulation still need further investigation. We here report that a combination of four microRNAs (miR-19b, miR-23b, miR-26a and miR-92a) promotes prostate cell proliferation by regulating PTEN and its downstream signals in vitro. Methodology/Principal Findings: We found that the four microRNAs (miRNAs) could effectively suppress PTEN expression by directly interacting with its 3' UTR in prostate epithelial and cancer cells. Under-expression of the four miRNAs by antisense neutralization up-regulates PTEN expression, while overexpression of the four miRNAs accelerates epithelial and prostate cancer cell proliferation. Furthermore, the expression of the four miRNAs could, singly or jointly, alter the expression of the key components in the phosphoinositide 3-kinase (PI3K)/Akt pathway, including PIK3CA, PIK3CD, PIK3R1 and Akt, along with their downstream signal, cyclin D1. Conclusions: These results suggested that the four miRNAs could promote prostate cancer cell proliferation by co-regulating the expression of PTEN, PI3K/Akt pathway and cyclin D1 in vitro. These findings increase understanding of the molecular mechanisms of prostate carcinogenesis and progression, even provide valuable insights into the diagnosis, prognosis, and rational design of novel therapeutics for prostate cancer.	[Tian, Ling; Fang, Yu-xiang; Xue, Jing-lun; Chen, Jin-zhong] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Tian, Ling; Fang, Yu-xiang; Xue, Jing-lun; Chen, Jin-zhong] Fudan Univ, Sch Life Sci, Inst Genet, Shanghai 200433, Peoples R China; [Tian, Ling] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Expt Res Ctr, Shanghai 200030, Peoples R China; [Tian, Ling] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Ctr Canc, Shanghai 200030, Peoples R China; [Fang, Yu-xiang] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Stem Cell Res Ctr, Shanghai 200030, Peoples R China	Fudan University; Fudan University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Tian, L (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	TL09168@hotmail.com; kingbellchen@fudan.edu.cn			National Natural Science Foundation of China [81172030]; National High Technology Research and Development Program of China (863 Program) [2012AA020810]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This study was supported by grants from National Natural Science Foundation of China (Grant No. 81172030) and National High Technology Research and Development Program of China (863 Program) (Grant No. 2012AA020810). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTHON P, 1995, INT J ONCOL, V6, P333; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen LZ, 2011, MOL THER, V19, P1521, DOI 10.1038/mt.2011.64; Chen Zhao-li, 2011, J Biol Chem, V286, P10725, DOI 10.1074/jbc.M110.165654; Coppola V, 2010, ENDOCR-RELAT CANCER, V17, pF1, DOI 10.1677/ERC-09-0172; DEGEORGES A, 1995, INT J CANCER, V62, P724, DOI 10.1002/ijc.2910620613; Drobnjak M, 2000, CLIN CANCER RES, V6, P1891; Dunn Mary Weinstein, 2011, Semin Oncol Nurs, V27, P241, DOI 10.1016/j.soncn.2011.07.002; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fang YX, 2010, MOL BIOTECHNOL, V45, P71, DOI 10.1007/s12033-010-9244-y; Fang Y, 2012, ARTERIOSCL THROM VAS, V32, P979, DOI 10.1161/ATVBAHA.111.244053; Geering B, 2007, P NATL ACAD SCI USA, V104, P7809, DOI 10.1073/pnas.0700373104; HAYWARD SW, 1995, IN VITRO CELL DEV-AN, V31, P14; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; He L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3146pe39; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; Hughes C, 2005, J CLIN PATHOL, V58, P673, DOI 10.1136/jcp.2002.003954; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Jiang XN, 2010, J BIOL CHEM, V285, P14980, DOI 10.1074/jbc.M109.085696; Jindra PT, 2010, J IMMUNOL, V185, P990, DOI 10.4049/jimmunol.1000793; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Kurokawa K, 2012, J GASTROENTEROL, V47, P883, DOI 10.1007/s00535-012-0547-6; Lee CYF, 2010, MOL THER, V18, P929, DOI 10.1038/mt.2010.26; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lou YH, 2010, INT J MOL MED, V26, P819, DOI 10.3892/ijmm_00000530; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Nair VS, 2012, JNCI-J NATL CANCER I, V104, P1, DOI [10.1093/jnci/djs001, DOI 10.1093/JNCI/DJS001.PUBMED:22395642]; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Rogler CE, 2009, HEPATOLOGY, V50, P575, DOI 10.1002/hep.22982; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Salvi A, 2009, FEBS J, V276, P2966, DOI 10.1111/j.1742-4658.2009.07014.x; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Schwarzenbach H, 2012, BREAST CANCER RES TR, V134, P933, DOI 10.1007/s10549-012-1988-6; Shand RL, 2006, CURR OPIN UROL, V16, P123, DOI 10.1097/01.mou.0000193384.39351.64; Shi XB, 2011, PROSTATE, V71, P538, DOI 10.1002/pros.21270; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; Tan GY, 2012, BIOCHEM BIOPH RES CO, V417, P546, DOI 10.1016/j.bbrc.2011.11.160; Tsuchida A, 2011, CANCER SCI, V102, P2264, DOI 10.1111/j.1349-7006.2011.02081.x; Vlietstra RJ, 1998, CANCER RES, V58, P2720; Wang KC, 2010, P NATL ACAD SCI USA, V107, P3234, DOI 10.1073/pnas.0914825107; Wang V, 2009, BIODRUGS, V23, P15, DOI 10.2165/00063030-200923010-00002; Wilmott JS, 2011, PATHOLOGY, V43, P657, DOI 10.1097/PAT.0b013e32834a7358; Wu W, 2011, CIRCULATION, V124, P633, DOI 10.1161/CIRCULATIONAHA.110.005108; Zhang BG, 2012, ONCOL REP, V27, P1019, DOI 10.3892/or.2012.1645; Zhang CZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-367; Zhang CZ, 2011, INT J RADIAT ONCOL, V80, P240, DOI 10.1016/j.ijrobp.2010.12.049; Zhang HS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1555; Zhang JG, 2010, CLIN CHIM ACTA, V411, P846, DOI 10.1016/j.cca.2010.02.074; Zhang SY, 2010, CLIN CANCER RES, V16, P4325, DOI 10.1158/1078-0432.CCR-09-2990	61	88	89	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75885	10.1371/journal.pone.0075885	http://dx.doi.org/10.1371/journal.pone.0075885			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098737	gold, Green Published, Green Submitted			2022-12-25	WOS:000325423500108
J	Williamson, TE; Brusatte, SL				Williamson, Thomas E.; Brusatte, Stephen L.			New Specimens of the Rare Taeniodont Wortmania (Mammalia: Eutheria) from the San Juan Basin of New Mexico and Comments on the Phylogeny and Functional Morphology of "Archaic" Mammals	PLOS ONE			English	Article							POSTCRANIAL SKELETON; PALEOCENE	Background: Taeniodonta is a clade of Late Cretaceous - Paleogene mammals remarkable for their relatively extreme cranial, dental, and postcranial adaptations and notable for being among the first mammals to achieve relatively large size following the Cretaceous-Paleogene mass extinction. Previous workers have hypothesized that taeniodonts can be divided into two clades: Conoryctidae, a group of small-bodied taeniodonts with supposedly "generalized" postcranial skeletons, and Stylinodontidae, a group of large-bodied, robust animals with massive forelimbs and claws adapted for scratch-digging. However, many taeniodont taxa are poorly known and few are represented by postcranial material, leaving many details about their anatomy, biology, and evolution ambiguous. Methodology/Principal Findings: In this paper, we describe three new specimens of the rare taxon Wortmania otariidens from the early Paleocene (Puercan) of New Mexico. Among these specimens is one that includes remarkably complete cranial and dental material, including associated upper and lower teeth, and another that consists of partial forelimbs. These specimens allow for an updated anatomical description of this unusual taxon, supply new data for phylogenetic analyses, and enable a more constrained discussion of taeniodont biology and functional morphology. Conclusions/Significance: The new specimen of Wortmania that includes associated upper and lower teeth indicates that previous interpretations of the upper dentition of this taxon were not accurate and the taxon Robertschochia sullivani is a junior synonym of W. otariidens. New specimens that include partial forelimbs indicate that Wortmania is very similar to later, large-bodied taeniodonts, with marked and distinctive adaptations for scratch-digging. Comparisons with other taeniodont taxa that include postcranial material suggest that all taeniodonts may have had scratch-digging adaptations. A phylogenetic analysis shows that Schowalteria and Onychodectes are basal taeniodonts, Stylinodontidae (including Wortmania) is monophyletic, and a monophyletic Conoryctidae (but not including Onychodectes) is only recovered when certain characters are ordered.	[Williamson, Thomas E.] New Mexico Museum Nat Hist & Sci, Dept Res & Collect, Albuquerque, NM USA; [Brusatte, Stephen L.] Univ Edinburgh, Sch GeoSci, Edinburgh, Midlothian, Scotland; [Brusatte, Stephen L.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Brusatte, Stephen L.] Columbia Univ, Dept Earth & Environm Sci, Palisades, NY USA	University of Edinburgh; American Museum of Natural History (AMNH); Columbia University	Williamson, TE (corresponding author), New Mexico Museum Nat Hist & Sci, Dept Res & Collect, Albuquerque, NM USA.	thomas.williamson@state.nm.us	Williamson, Thomas/AAW-9320-2020; Brusatte, Stephen/O-9663-2014	Brusatte, Stephen/0000-0001-7525-7319; Williamson, Thomas/0000-0002-2856-9632	The Bureau of Land Management, National Landscapes Conservation System [L10AC20135-0005]; National Science Foundation [EAR 0207750]; Directorate For Geosciences [1325612, 1325544] Funding Source: National Science Foundation	The Bureau of Land Management, National Landscapes Conservation System; National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The Bureau of Land Management, National Landscapes Conservation System (L10AC20135-0005) and the National Science Foundation (EAR 0207750 to TEW) for support of fieldwork. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1982, ANAL VERTEBRATE STRU; Argot C, 2012, J MAMM EVOL, P1; Bergqvist LP, 2010, J PALEONTOL, V84, P858, DOI 10.1666/09-084.1; COOMBS MC, 1983, T AM PHILOS SOC, V73, P1, DOI 10.2307/3137420; Cope E. D., 1888, Transactions of the American Philosophical Society, Vxvi, P298; Cope E. D., 1885, American Naturalist, Vxix, P493; Cope E.D., 1876, P NATL ACAD SCI PHIL, V28, P39; Eberle JJ, 1999, J PALEONTOL, V73, P936, DOI 10.1017/S0022336000040762; Fox RC, 2003, NEUES JAHRB GEOL P-A, V229, P393, DOI 10.1127/njgpa/229/2003/393; Gasin C. L., 1936, Proceedings of the American Philosophical Society, V76, P597; Gill T., 1872, SMITHSONIAN MISCELL, V11, P1, DOI DOI 10.5962/BHL.TITLE.14607; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Hay O P, 1899, Science, V9, P593, DOI 10.1126/science.9.225.593; Hildebrand M., 1985, P89; Horovitz I, 2003, J VERTEBR PALEONTOL, V23, P857, DOI 10.1671/2399-10; Linnaeus C., 1758, SYSTEMA NATURAE REGN, VI, DOI 10.5962/bhl.title.542; Lofgren Donald L., 2004, P43; LUCAS SG, 1993, J MAMMAL, V74, P175, DOI 10.2307/1381918; Lucas SG, 2011, J PALEONTOL, V85, P1216; Lucas Spencer G., 1998, P260; MACPHEE RDE, 1994, B AM MUS NAT HIST, P1; MARSH O. C, 1875, AM J SCI, V3, 9, P221; Matthew WD, 1937, T AM PHILOS SOC, V30, P510; Miller M.E., 1964, ANATOMY DOG; OLEARY MA, 1995, J VERTEBR PALEONTOL, V15, P401, DOI 10.1080/02724634.1995.10011238; Patterson B., 1949, Genetics Paleontology and Evolution, P243; Rook DL, 2011, J VERTEBR PALEONTOL, V31, P422, DOI 10.1080/02724634.2011.550364; Rose KD, 1999, J VERTEBR PALEONTOL, V19, P355, DOI 10.1080/02724634.1999.10011147; Rose KD, 2000, J VERTEBR PALEONTOL, V20, P139, DOI 10.1671/0272-4634(2000)020[0139:AEPPMP]2.0.CO;2; ROSE KD, 2006, BEGINNING AGE MAMMAL; Schoch RM, 1986, B PEABODY MUS NAT HI, V42, P1; Simpson G.G., 1981, P3; Simpson GG, 1959, AM MUSEUM NOTIVATES; Sinclair WJ, 1914, B AM MUS NAT HIST, V33, P297; THEWISSEN JGM, 1986, ANAT ANZEIGER, V162, P109; Tidwell LS, 1981, ADV SAN JUAN BASIN P; Turnbull William D., 2004, Bulletin of Carnegie Museum of Natural History, V36, P302; Von Koenigswald W, 2010, J VERTEBR PALEONTOL, V30, P1797, DOI 10.1080/02724634.2010.521931; West R. M., 1971, AM MUS NOVIT, V2461, P1; Williamson T. E., 1992, B NEW MEXICO MUSEUM, V1, P1; Williamson T. E., 1993, NEW MEXICO MUSEUM NA, P105; Williamson TE, 1996, B NEW MEXICO MUSEUM, V8, P1; Wortman J. L., 1897, Bulletin of the American Museum, Vix, P59	43	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75886	10.1371/journal.pone.0075886	http://dx.doi.org/10.1371/journal.pone.0075886			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098738	gold, Green Published, Green Submitted			2022-12-25	WOS:000325423500109
J	Opefi, CA; South, K; Reynolds, CA; Smith, SO; Reeves, PJ				Opefi, Chikwado A.; South, Kieron; Reynolds, Christopher A.; Smith, Steven O.; Reeves, Philip J.			Retinitis Pigmentosa Mutants Provide Insight into the Role of the N-terminal Cap in Rhodopsin Folding, Structure, and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G-protein-coupled Receptor (GPCR); Membrane Proteins; Phototransduction; Protein Misfolding; Protein Stability; Retinal Degeneration; Retinoid; Rhodopsin	PROTEIN-COUPLED-RECEPTOR; SCHIFF-BASE STABILITY; OPSIN MUTANT; INTRADISCAL DOMAIN; CRYSTAL-STRUCTURE; QUALITY-CONTROL; EXPRESSION; GENE; ACTIVATION; FLUORESCENCE	Autosomal dominant retinitis pigmentosa (ADRP) mutants (T4K, N15S, T17M, V20G, P23A/H/L, and Q28H) in the N-terminal cap of rhodopsin misfold when expressed in mammalian cells. To gain insight into the causes of misfolding and to define the contributions of specific residues to receptor stability and function, we evaluated the responses of these mutants to 11-cis-retinal pharmacological chaperone rescue or disulfide bond-mediated repair. Pharmacological rescue restored folding in all mutants, but the purified mutant pigments in all cases were thermo-unstable and exhibited abnormal photobleaching, metarhodopsin II decay, and G protein activation. As a complementary approach, we superimposed this panel of ADRP mutants onto a rhodopsin background containing a juxtaposed cysteine pair (N2C/D282C) that forms a disulfide bond. This approach restored folding in T4K, N15S, V20G, P23A, and Q28H but not T17M, P23H, or P23L. ADRP mutant pigments obtained by disulfide bond repair exhibited enhanced stability, and some also displayed markedly improved photobleaching and signal transduction properties. Our major conclusion is that the N-terminal cap stabilizes opsin during biosynthesis and contributes to the dark-state stability of rhodopsin. Comparison of these two restorative approaches revealed that the correct position of the cap relative to the extracellular loops is also required for optimal photochemistry and efficient G protein activation.	[Opefi, Chikwado A.; South, Kieron; Reynolds, Christopher A.; Reeves, Philip J.] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England; [Smith, Steven O.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	University of Essex; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Reeves, PJ (corresponding author), Univ Essex, Sch Biol Sci, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England.	preeves@essex.ac.uk	Smith, Steven/HDM-9496-2022; Reynolds, Christopher/G-1036-2010	Reynolds, Christopher/0000-0001-9267-5141; South, Kieron/0000-0002-9141-3438	National Institutes of Health [R01 GM41412]; RP Fighting Blindness Grant [GR572]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041412] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RP Fighting Blindness Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM41412 (to S. O. S.). This work was also supported by RP Fighting Blindness Grant GR572 (to P. J. R.).	Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; ANUKANTH A, 1994, J BIOL CHEM, V269, P19738; Bernier V, 2004, TRENDS ENDOCRIN MET, V15, P222, DOI 10.1016/j.tem.2004.05.003; Bosch-Presegue L, 2011, FEBS J, V278, P1493, DOI 10.1111/j.1742-4658.2011.08066.x; Cha KW, 2000, P NATL ACAD SCI USA, V97, P3016, DOI 10.1073/pnas.97.7.3016; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; DAVIDSON FF, 1994, P NATL ACAD SCI USA, V91, P4029, DOI 10.1073/pnas.91.9.4029; DOI T, 1990, P NATL ACAD SCI USA, V87, P4991, DOI 10.1073/pnas.87.13.4991; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; Fanelli F, 2010, FASEB J, V24, P3196, DOI 10.1096/fj.09-151084; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; FAUROBERT E, 1993, EMBO J, V12, P4191, DOI 10.1002/j.1460-2075.1993.tb06103.x; Haeri M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030101; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Hwa J, 1997, P NATL ACAD SCI USA, V94, P10571, DOI 10.1073/pnas.94.20.10571; Janz JM, 2004, J BIOL CHEM, V279, P55886, DOI 10.1074/jbc.M408766200; Janz JM, 2003, VISION RES, V43, P2991, DOI 10.1016/j.visres.2003.08.010; Janz JM, 2003, J BIOL CHEM, V278, P16982, DOI 10.1074/jbc.M210567200; Janz JM, 2001, BIOCHEMISTRY-US, V40, P7219, DOI 10.1021/bi002937i; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; KITO Y, 1968, NATURE, V218, P955, DOI 10.1038/218955a0; Krebs MP, 2010, J MOL BIOL, V395, P1063, DOI 10.1016/j.jmb.2009.11.015; KUHN H, 1980, NATURE, V283, P587, DOI 10.1038/283587a0; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; Li TS, 1998, P NATL ACAD SCI USA, V95, P11933, DOI 10.1073/pnas.95.20.11933; Majumdar S, 2006, J BIOL CHEM, V281, P9219, DOI 10.1074/jbc.M513837200; MIN KC, 1993, J BIOL CHEM, V268, P9400; Newton CL, 2011, P NATL ACAD SCI USA, V108, P7172, DOI 10.1073/pnas.1015723108; Noorwez SM, 2004, J BIOL CHEM, V279, P16278, DOI 10.1074/jbc.M312101200; Noorwez SM, 2003, J BIOL CHEM, V278, P14442, DOI 10.1074/jbc.M300087200; OMAHONEY JV, 1994, DNA CELL BIOL, V13, P1227, DOI 10.1089/dna.1994.13.1227; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48; Pattabiraman N, 1995, J MOL RECOGNIT, V8, P334, DOI 10.1002/jmr.300080603; Peeters MC, 2011, TRENDS PHARMACOL SCI, V32, P35, DOI 10.1016/j.tips.2010.10.001; PHILLIPS WJ, 1988, J BIOL CHEM, V263, P15498; Reeves PJ, 1996, P NATL ACAD SCI USA, V93, P11487, DOI 10.1073/pnas.93.21.11487; RICHARDS FM, 1993, Q REV BIOPHYS, V26, P423, DOI 10.1017/S0033583500002845; Ridge KD, 1996, J BIOL CHEM, V271, P7860, DOI 10.1074/jbc.271.13.7860; RIDGE KD, 1995, BIOCHEMISTRY-US, V34, P3261, DOI 10.1021/bi00010a016; Saliba RS, 2002, J CELL SCI, V115, P2907; Shichida Y, 2007, PHOTOCHEM PHOTOBIOL, V83, P70, DOI 10.1562/2006-03-22-IR-854; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Smith SO, 2010, ANNU REV BIOPHYS, V39, P309, DOI 10.1146/annurev-biophys-101209-104901; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; SUNG CH, 1993, J BIOL CHEM, V268, P26645; Tam BM, 2007, J NEUROSCI, V27, P9043, DOI 10.1523/JNEUROSCI.2245-07.2007; Teller DC, 2001, BIOCHEMISTRY-US, V40, P7761, DOI 10.1021/bi0155091; WALD G, 1953, J GEN PHYSIOL, V37, P189, DOI 10.1085/jgp.37.2.189; Xie GF, 2003, BIOCHEMISTRY-US, V42, P1995, DOI 10.1021/bi020611z; Yan ECY, 2003, P NATL ACAD SCI USA, V100, P9262, DOI 10.1073/pnas.1531970100	57	29	30	0	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33912	33926		10.1074/jbc.M113.483032	http://dx.doi.org/10.1074/jbc.M113.483032			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24106275	Green Published, hybrid			2022-12-25	WOS:000327250200034
J	Golden, BDO; Wuebben, EL; Rizzino, A				Golden, Briana D. Ormsbee; Wuebben, Erin L.; Rizzino, Angie			Sox2 Expression Is Regulated by a Negative Feedback Loop in Embryonic Stem Cells That Involves AKT Signaling and FoxO1	PLOS ONE			English	Article							3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN-KINASE; SELF-RENEWAL; NANOG AUTOREPRESSION; GENE-EXPRESSION; OCT-3/4 GENE; ES CELLS; PHOSPHORYLATION; DIFFERENTIATION; PLURIPOTENCY; MOUSE	The self-renewal and pluripotency of embryonic stem cells (ESC) is regulated by a highly integrated network of essential transcription factors, which includes Sox2. Previous studies have shown that elevating Sox2 on its own in mouse ESC induces differentiation and inhibits the expression of endogenous Sox2 at the protein and mRNA level. These findings led us to hypothesize that increases in Sox2 activate a negative feedback loop that inhibits the transcription of the endogenous Sox2 gene. To test this hypothesis, we used i-OSKM-ESC, which elevate Sox2 in conjunction with Oct4, Klf4, and c-Myc when treated with doxycycline (Dox). Elevating the expression of these four transcription factors in i-OSKM-ESC does not induce differentiation, but it represses expression of endogenous Sox2. We determined that increases of Sox2 in i-OSKM-ESC lead to increases in activated AKT and inactivation of FoxO1 (an activator of Sox2), as well as decreases in binding of FoxO1 to the 5'flanking region of Sox2. Importantly, we determined that inhibition of AKT in Dox-treated i-OSKM-ESC leads to re-expression of endogenous Sox2 at the mRNA and protein level and reactivation of FoxO1. These findings argue that AKT signaling is part of the negative feedback loop that helps carefully control the transcription of Sox2 in ESC by modulating the binding of FoxO1 to the Sox2 gene. Collectively, our findings provide new insights into the mechanisms that enable ESC to carefully regulate the levels of Sox2 and retain their stem cell properties.	[Golden, Briana D. Ormsbee; Wuebben, Erin L.; Rizzino, Angie] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center	Rizzino, A (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA.	arizzino@unmc.edu			National Institutes of Health [GM080751]; National Cancer Institute [CA74771, CA009476]; NATIONAL CANCER INSTITUTE [R01CA074771, T32CA009476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080751] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a grant from the National Institutes of Health (GM080751). Core facilities of the UNMC Eppley Cancer Center were supported in part by a grant from the National Cancer Institute (CA74771). ELW was supported in part by a Cancer Biology Training Grant from the National Cancer Institute (CA009476). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Marques-Torrejon MA, 2013, CELL STEM CELL, V12, P88, DOI 10.1016/j.stem.2012.12.001; Bechard M, 2009, MOL CELL BIOL, V29, P2092, DOI 10.1128/MCB.01405-08; Boer B, 2007, NUCLEIC ACIDS RES, V35, P1773, DOI 10.1093/nar/gkm059; Breuleux M, 2009, MOL CANCER THER, V8, P742, DOI 10.1158/1535-7163.MCT-08-0668; Brumbaugh J, 2012, P NATL ACAD SCI USA, V109, P7162, DOI 10.1073/pnas.1203874109; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fidalgo M, 2012, P NATL ACAD SCI USA, V109, P16202, DOI 10.1073/pnas.1208533109; Gao ZH, 2012, J BIOL CHEM, V287, P11384, DOI 10.1074/jbc.M111.320143; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hamazaki T, 2006, MOL CELL BIOL, V26, P7539, DOI 10.1128/MCB.00508-06; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hirai H, 2011, BIOCHEM J, V438, P11, DOI 10.1042/BJ20102152; Jeong CH, 2010, STEM CELLS, V28, P2141, DOI 10.1002/stem.540; Kim MO, 2012, NAT STRUCT MOL BIOL, V19, P283, DOI 10.1038/nsmb.2217; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Lin Y, 2012, MOL CELL; Mallanna SK, 2010, STEM CELLS, V28, P1715, DOI 10.1002/stem.494; Mallanna SK, 2008, MOL REPROD DEV, V75, P1247, DOI 10.1002/mrd.20871; Nakamura T, 2008, GENES CELLS, V13, P1269, DOI 10.1111/j.1365-2443.2008.01243.x; Navarro P, 2012, EMBO J, V31, P4547, DOI 10.1038/emboj.2012.321; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Polajeva J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-378; Rizzino A, 2013, STEM CELLS; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shanmugasundaram K, 2012, ONCOGENE; Storm MP, 2007, J BIOL CHEM, V282, P6265, DOI 10.1074/jbc.M610906200; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yamaguchi S, 2011, STEM CELL RES, V6, P177, DOI 10.1016/j.scr.2010.09.004; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu Y, 2013, STEM CELLS; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200; Zhang X, 2011, NAT CELL BIOL, V13, P1092, DOI 10.1038/ncb2293	44	26	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76345	10.1371/journal.pone.0076345	http://dx.doi.org/10.1371/journal.pone.0076345			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116102	Green Published, gold, Green Submitted			2022-12-25	WOS:000325552200050
J	Liang, B; Xiong, F; Wu, HP; Wang, Y; Dong, XJ; Cheng, SF; Feng, GS; Zhou, GF; Xiong, B; Liang, HM; Xia, XW; Zheng, CS				Liang, Bin; Xiong, Fu; Wu, Hanping; Wang, Yong; Dong, Xiangjun; Cheng, Shaofeng; Feng, Gansheng; Zhou, Guofeng; Xiong, Bin; Liang, Huimin; Xia, Xiangwen; Zheng, Chuansheng			Effect of Transcatheter Intraarterial Therapies on the Distribution of Doxorubicin in Liver Cancer in a Rabbit Model	PLOS ONE			English	Article							UNRESECTABLE HEPATOCELLULAR-CARCINOMA; HEPATIC ARTERIAL EMBOLIZATION; RANDOMIZED CONTROLLED TRIAL; DRUG-ELUTING BEADS; SOLID TUMORS; TRANSARTERIAL CHEMOEMBOLIZATION; LYMPHOGRAPHIC AGENT; CHEMOTHERAPY; DELIVERY; MALIGNANCY	Background and Aims: Transcatheter intraarterial techniques can effectively deliver chemotherapeutic agents to tumor and improve the efficacy of chemotherapy. The present study is designed to evaluate the effect of transcatheter intraarterial techniques on the distribution of doxorubicin in relation to blood vessels in liver cancer. Methods: VX2 tumors were implanted in the livers of 32 rabbits. The animals were divided into 4 groups of 8 animals each. Group 1 (doxo iv) animals received doxorubicin intravenous injection; group 2 (doxo ia) received doxorubicin hepatic intraarterial infusion; group 3 (doxo ia + E) received doxorubicin hepatic intraarterial infusion followed by embolization; group 4 (doxo + L ia + E) received hepatic intraarterial infusion of doxorubicin mixed with Lipiodol followed by embolization. Ten minutes or 4 hours after treatment, the animals were sacrificed and tumors were sampled. Immunofluorescence techniques were used to evaluate the distribution of doxorubicin in relation to blood vessels. Results: Doxorubicin fluorescence was distributed around tumor blood vessels and decreased with distance from the blood vessels. Tumor cells in avascular and adjacent regions were not exposed to detectable concentrations of doxorubicin. Tumors in the group 2, 3 and 4 had a significant increase in doxorubicin penetration compared with the group 1 tumors (P<0.05). Among the three groups of transcatheter therapies, doxorubicin penetration distance in group 3 was significantly larger than that in group 2 and 4 (P<0.05), and no significant difference was found between group 2 and 4 tumors (P>0.05) at 10 minutes. In contrast, at 4 hours and in total, both group 3 and 4 tumors had significant increases in drug penetration compared with group 2 (P<0.05), and no significant difference was noted between group 3 and 4 tumors (P>0.05). Conclusion: Transcatheter intraarterial therapies improve doxorubicin penetration in liver cancer; nevertheless their effect on drug distribution is somewhat limited.	[Liang, Bin; Xiong, Fu; Wang, Yong; Dong, Xiangjun; Cheng, Shaofeng; Feng, Gansheng; Zhou, Guofeng; Xiong, Bin; Liang, Huimin; Xia, Xiangwen; Zheng, Chuansheng] Huazhong Univ Sci & Technol, Dept Radiol, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Wu, Hanping] Case Western Reserve Univ, Dept Radiol, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA	Huazhong University of Science & Technology; Case Western Reserve University; Case Western Reserve University Hospital	Zheng, CS (corresponding author), Huazhong Univ Sci & Technol, Dept Radiol, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	hqzcsxh@mails.tjmu.edu.cn	Xiong, Bin/AGX-8289-2022; Wang, Yong/B-6207-2015	Wang, Yong/0000-0003-4707-5280	National Natural Sciences Foundation of China [81101134]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by grant from National Natural Sciences Foundation of China (No. 81101134). The funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BREEDIS C, 1954, AM J PATHOL, V30, P969; Brown DB, 2007, J VASC INTERV RADIOL, V18, P1469, DOI 10.1016/j.jvir.2007.08.027; Brown DB, 2006, J VASC INTERV RADIOL, V17, P225, DOI 10.1097/01.RVI.0000195330.47954.48; Bruix J, 2004, GASTROENTEROLOGY, V127, pS179, DOI 10.1053/j.gastro.2004.09.032; CADY B, 1974, SURG GYNECOL OBSTET, V138, P381; Camma C, 2002, RADIOLOGY, V224, P47, DOI 10.1148/radiol.2241011262; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; FURUTA T, 1988, J SURG ONCOL, V39, P229, DOI 10.1002/jso.2930390404; Geschwind JFH, 2002, J VASC INTERV RADIOL, V13, P991, DOI 10.1016/S1051-0443(07)61862-4; HIGUCHI T, 1994, CANCER, V73, P2259, DOI 10.1002/1097-0142(19940501)73:9<2259::AID-CNCR2820730905>3.0.CO;2-P; Hong K, 2005, J VASC INTERV RADIOL, V16, P1711, DOI 10.1097/01.RVI.0000184535.26360.5A; Huxham LA, 2004, CANCER RES, V64, P6537, DOI 10.1158/0008-5472.CAN-04-0986; JAIN RK, 1994, SCI AM, V271, P58, DOI 10.1038/scientificamerican0794-58; Jang SH, 2003, PHARM RES-DORDR, V20, P1337, DOI 10.1023/A:1025785505977; KANEMATSU T, 1989, HEPATOLOGY, V10, P98, DOI 10.1002/hep.1840100119; KONNO T, 1983, EUR J CANCER CLIN ON, V19, P1053, DOI 10.1016/0277-5379(83)90028-7; Lankelma J, 1999, CLIN CANCER RES, V5, P1703; Lewis AL, 2006, J VASC INTERV RADIOL, V17, P335, DOI 10.1097/01.RVI.0000195323.46152.B3; Lewis AL, 2006, J VASC INTERV RADIOL, V17, P1335, DOI 10.1097/01.RVI.0000228416.21560.7F; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Lo CM, 2002, HEPATOLOGY, V35, P1164, DOI 10.1053/jhep.2002.33156; Maeda S, 2002, HEPATOL RES, V23, P202, DOI 10.1016/S1386-6346(01)00174-7; Moreira PL, 2003, CARDIOVASC INTER RAD, V26, P100, DOI 10.1007/s00270-003-2632-y; Namur J, 2011, J HEPATOL, V55, P1332, DOI 10.1016/j.jhep.2011.03.024; Namur J, 2010, J VASC INTERV RADIOL, V21, P259, DOI 10.1016/j.jvir.2009.10.026; Patel KJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-356; Primeau AJ, 2005, CLIN CANCER RES, V11, P8782, DOI 10.1158/1078-0432.CCR-05-1664; SHIBATA J, 1989, CANCER, V64, P1586, DOI 10.1002/1097-0142(19891015)64:8<1586::AID-CNCR2820640805>3.0.CO;2-E; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101	29	21	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76388	10.1371/journal.pone.0076388	http://dx.doi.org/10.1371/journal.pone.0076388			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116106	Green Published, gold, Green Submitted			2022-12-25	WOS:000325552200054
J	Zhao, F; Li, M; Qian, Y; Tsien, JZ				Zhao, Fang; Li, Meng; Qian, Yi; Tsien, Joe Z.			Remote Measurements of Heart and Respiration Rates for Telemedicine	PLOS ONE			English	Article							NONCONTACT; DYNAMICS; CAMERA	Non-contact and low-cost measurements of heart and respiration rates are highly desirable for telemedicine. Here, we describe a novel technique to extract blood volume pulse and respiratory wave from a single channel images captured by a video camera for both day and night conditions. The principle of our technique is to uncover the temporal dynamics of heart beat and breathing rate through delay-coordinate transformation and independent component analysis-based deconstruction of the single channel images. Our method further achieves robust elimination of false positives via applying ratio-variation probability distributions filtering approaches. Moreover, it enables a much needed low-cost means for preventing sudden infant death syndrome in new born infants and detecting stroke and heart attack in elderly population in home environments. This noncontact-based method can also be applied to a variety of animal model organisms for biomedical research.	[Zhao, Fang; Li, Meng; Tsien, Joe Z.] Georgia Regents Univ, Brain & Behav Discovery Inst, Augusta, GA USA; [Zhao, Fang; Li, Meng; Tsien, Joe Z.] Georgia Regents Univ, Dept Neurol, Augusta, GA USA; [Zhao, Fang; Qian, Yi] Yunnan Banna Primate Model Res Ctr, BanNa Biomed Res Inst, Xishuangbanna, Yunnan, Peoples R China	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Tsien, JZ (corresponding author), Georgia Regents Univ, Brain & Behav Discovery Inst, Augusta, GA USA.	jtsien@gru.edu			Georgia Research Alliance; Yunnan Department of Science and Technology [2012BA009]	Georgia Research Alliance; Yunnan Department of Science and Technology	This work is supported in part by Georgia Research Alliance (JZT) and Yunnan Department of Science and Technology grant number 2012BA009 (FZ and YQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cardoso JF, 1999, NEURAL COMPUT, V11, P157, DOI 10.1162/089976699300016863; CHIALVO DR, 1987, NATURE, V330, P749, DOI 10.1038/330749a0; COMON P, 1994, SIGNAL PROCESS, V36, P287, DOI 10.1016/0165-1684(94)90029-9; de Chaumont F, 2012, NAT METHODS, V9, P410, DOI [10.1038/NMETH.1924, 10.1038/nmeth.1924]; de Chazal P, 2008, IEEE ENG MED BIO, P514, DOI 10.1109/IEMBS.2008.4649203; Diraco G, 2010, DES AUT TEST EUROPE, P1536; Eedy DJ, 2001, BRIT J DERMATOL, V144, P696, DOI 10.1046/j.1365-2133.2001.04124.x; Garbey M, 2007, IEEE T BIO-MED ENG, V54, P1418, DOI 10.1109/TBME.2007.891930; Greneker EF, 1997, IEE CONF PUBL, P150, DOI 10.1049/cp:19971650; Higashikaturagi K, 2008, HANN BEITR NACHRICHT, V1, P101, DOI 10.1109/ICUWB.2008.4653294; Hu SJ, 2008, INT CONF BIOMED, P72, DOI 10.1109/BMEI.2008.365; Humphreys K, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2724789; Hyvarinen A, 1997, NEURAL COMPUT, V9, P1483, DOI 10.1162/neco.1997.9.7.1483; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Hyvarinen A, 1999, NEURAL PROCESS LETT, V10, P1, DOI 10.1023/A:1018647011077; James CJ, 2003, ARTIF INTELL MED, V28, P89, DOI 10.1016/S0933-3657(03)00037-X; Krupinski EA, 1999, TELEMED J, V5, P257, DOI 10.1089/107830299312005; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Lazaro A, 2010, PROG ELECTROMAGN RES, V100, P265, DOI 10.2528/PIER09120302; Ledwidge M, 1998, ARCH DIS CHILD, V78, P481, DOI 10.1136/adc.78.5.481; Lienhart R, 2002, IEEE IMAGE PROC, P900; Liu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063590; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Matthews G, 2000, CRIT REV BIOMED ENG, V28, P173, DOI 10.1615/CritRevBiomedEng.v28.i12.290; McSharry PE, 2004, P SOC PHOTO-OPT INS, V5467, P1; Poh MZ, 2011, IEEE T BIO-MED ENG, V58, P7, DOI 10.1109/TBME.2010.2086456; Poh MZ, 2010, OPT EXPRESS, V18, P10762, DOI 10.1364/OE.18.010762; STEINSCHNEIDER A, 1972, PEDIATRICS, V50, P646; Stiedl O, 2004, AUTON NEUROSCI-BASIC, V115, P15, DOI 10.1016/j.autneu.2004.07.006; Stiedl O, 1997, BEHAV NEUROSCI, V111, P703, DOI 10.1037/0735-7044.111.4.703; Stiedl O, 2009, NEUROSCI BIOBEHAV R, V33, P181, DOI 10.1016/j.neubiorev.2008.08.015; Takens F, 1981, LECT NOTES MATH, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; Tarvainen MP, 2002, IEEE T BIO-MED ENG, V49, P172, DOI 10.1109/10.979357; ULYANOV SS, 1993, P SOC PHOTO-OPT INS, V1884, P160, DOI 10.1117/12.148363; Viola P, 2001, PROC CVPR IEEE, P511, DOI 10.1109/cvpr.2001.990517; Wieringa FP, 2005, ANN BIOMED ENG, V33, P1034, DOI 10.1007/s10439-005-5763-2; Williams A, 2007, P 15 INT C MULT, P892; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046686	42	111	123	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e71384	10.1371/journal.pone.0071384	http://dx.doi.org/10.1371/journal.pone.0071384			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24115996	Green Published, Green Submitted, gold			2022-12-25	WOS:000325552200001
J	Lee, SH; Choi, BH; Lim, D; Gondro, C; Cho, YM; Dang, CG; Sharma, A; Jang, GW; Lee, KT; Yoon, D; Lee, HK; Yeon, SH; Yang, BS; Kang, HS; Hong, SK				Lee, Seung Hwan; Choi, Bong Hwan; Lim, Dajeong; Gondro, Cedric; Cho, Young Min; Dang, Chang Gwon; Sharma, Aditi; Jang, Gul Won; Lee, Kyung Tai; Yoon, Duhak; Lee, Hak Kyo; Yeon, Seong Heum; Yang, Boh Suk; Kang, Hee Seol; Hong, Seong Koo			Genome-Wide Association Study Identifies Major Loci for Carcass Weight on BTA14 in Hanwoo (Korean Cattle)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; LINKAGE DISEQUILIBRIUM; POPULATION; SCAN; QTL; EXPRESSION; VARIANTS; STATURE; IMPACT; GROWTH	This genome-wide association study (GWAS) was conducted to identify major loci that are significantly associated with carcass weight, and their effects, in order to provide increased understanding of the genetic architecture of carcass weight in Hanwoo. This genome-wide association study identified one major chromosome region ranging from 23 Mb to 25 Mb on chromosome 14 as being associated with carcass weight in Hanwoo. Significant Bonferroni-corrected genome-wide associations (P<1.52x10(-6)) were detected for 6 Single Nucleotide Polymorphic (SNP) loci for carcass weight on chromosome 14. The most significant SNP was BTB-01280026 (P=4.02x10(-11)), located in the 25 Mb region on Bos taurus autosome 14 (BTA14). The other 5 significant SNPs were Hapmap27934-BTC-065223 (P=4.04x10(-11)) in 25.2 Mb, BTB-01143580 (P=6.35x10(-11)) in 24.3 Mb, Hapmap30932-BTC-011225 (P=5.92x10(-10)) in 24.8 Mb, Hapmap27112-BTC-063342 (P=5.18x10(-9)) in 25.4 Mb, and Hapmap24414-BTC-073009 (P=7.38x10(-8)) in 25.4 Mb, all on BTA 14. One SNP (BTB-01143580; P=6.35x10(-11)) lies independently from the other 5 SNPs. The 5 SNPs that lie together showed a large Linkage disequilibrium (LD) block (block size of 553 kb) with LD coefficients ranging from 0.53 to 0.89 within the block. The most significant SNPs accounted for 6.73% to 10.55% of additive genetic variance, which is quite a large proportion of the total additive genetic variance. The most significant SNP (BTB-01280026; P=4.02x10(-11)) had 16.96 kg of allele substitution effect, and the second most significant SNP (Hapmap27934-BTC-065223; P=4.04x10(-11)) had 18.06 kg of effect on carcass weight, which correspond to 44% and 47%, respectively, of the phenotypic standard deviation for carcass weight in Hanwoo cattle. Our results demonstrated that carcass weight was affected by a major Quantitative Trait Locus (QTL) with a large effect and by many SNPs with small effects that are normally distributed.	[Lee, Seung Hwan; Dang, Chang Gwon; Sharma, Aditi; Yeon, Seong Heum; Yang, Boh Suk; Kang, Hee Seol; Hong, Seong Koo] RDA, Natl Inst Anim Sci, Hanwoo Expt Stn, Pyeongchang, South Korea; [Choi, Bong Hwan; Lim, Dajeong; Cho, Young Min; Jang, Gul Won; Lee, Kyung Tai; Hong, Seong Koo] RDA, Natl Inst Anim Sci, Anim Genome & Bioinformat Div, Suwon, South Korea; [Gondro, Cedric] Univ New England, Sch Rural & Environm Sci, Armidale, NSW, Australia; [Yoon, Duhak] Kyungpook Natl Univ, Dept Anim Sci, Sangju, South Korea; [Lee, Hak Kyo] Hankyong Natl Univ, Dept Anim Sci, Anseong, South Korea	National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; University of New England; Kyungpook National University; Hankyong National University	Lee, SH (corresponding author), RDA, Natl Inst Anim Sci, Hanwoo Expt Stn, Pyeongchang, South Korea.	slee46@korea.kr	gondro, cedric/B-4362-2010	gondro, cedric/0000-0003-0666-656X; Lee, Seung Hwan/0000-0003-1508-4887	AGENDA project [PJ907008062012]; Molecular Breeding program of Next Generation BIOGREEN21 project in the National Institute of Animal Science, RDA [PJ0081882012]	AGENDA project; Molecular Breeding program of Next Generation BIOGREEN21 project in the National Institute of Animal Science, RDA	This study was supported by awards from the AGENDA project (grant no. PJ907008062012) and Molecular Breeding program (PJ0081882012) of Next Generation BIOGREEN21 project in the National Institute of Animal Science, RDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APGS, 1995, REP BUS AN PROD GRAD; Barendse W, 2007, GENETICS, V176, P1893, DOI 10.1534/genetics.107.072637; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Choi GS, 1978, J ANIMSCI TECH KOR, V20, P177; Daetwyler HD, 2008, J DAIRY SCI, V91, P3225, DOI 10.3168/jds.2007-0333; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Fortes MRS, 2011, J ANIM SCI, V89, P1669, DOI 10.2527/jas.2010-3681; Gilmour A., 2006, ASREML USER GUIDE RE; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Hulett D. L., 2007, Genetic improvement: making it happen. Proceedings of the Seventeenth Conference of the Association for the Advancement of Animal Breeding and Genetics, Armidale, New South Wales, Australia, 23rd - 26th September 2007, P384; Karim L, 2011, NAT GENET, V43, P405, DOI 10.1038/ng.814; Kim ES, 2009, ANIM GENET, V40, P300, DOI 10.1111/j.1365-2052.2008.01832.x; Kim GS, 1985, J ANIM SCI TECH KOR, V27, P193; Kneeland J, 2004, J ANIM SCI, V82, P3405; Kolbehdari D, 2009, J ANIM BREED GENET, V126, P216, DOI 10.1111/j.1439-0388.2008.00793.x; Koshkoih A E, 2006, P 8 WORLD C GEN APPL, P13; Lee SH, 2011, ASIAN AUSTRAL J ANIM, V24, P1660, DOI 10.5713/ajas.2011.11165; Lee SH, 2011, MAMM GENOME, V22, P589, DOI 10.1007/s00335-011-9331-9; MacLeod IM, 2006, 8 WORLD C GEN APPL L; Maltecca C, 2009, ANIM GENET, V40, P27, DOI 10.1111/j.1365-2052.2008.01793.x; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Mizoshita K, 2004, J ANIM SCI, V82, P3415; Nishimura S, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-40; Pausch H, 2011, GENETICS, V187, P289, DOI 10.1534/genetics.110.124057; Pritchard JK, 2000, GENETICS, V155, P945; Rolf MM, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-24; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	31	51	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e74677	10.1371/journal.pone.0074677	http://dx.doi.org/10.1371/journal.pone.0074677			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116007	Green Submitted, Green Published, gold			2022-12-25	WOS:000325501300010
J	Yang, SW; Cheng, JH; Sun, J; Hu, YY; Liang, XY				Yang, Shewei; Cheng, Jianhua; Sun, Jian; Hu, Yongyou; Liang, Xiaoyan			Defluorination of Aqueous Perfluorooctanesulfonate by Activated Persulfate Oxidation	PLOS ONE			English	Article							EFFICIENT DECOMPOSITION; PERFLUOROCARBOXYLIC ACIDS; SULFONATE PFOS; WATER; SURFACTANTS; 1,1,1-TRICHLOROETHANE; FLUOROCHEMICALS; KINETICS; REMOVAL; IRON	Activated persulfate oxidation technologies based on sulfate radicals were first evaluated for defluorination of aqueous perfluorooctanesulfonate (PFOS). The influences of catalytic method, time, pH and K2S2O8 amounts on PFOS defluorination were investigated. The intermediate products during PFOS defluorination were detected by using LC/MS/MS. The results showed that the S2O82- had weak effect on the defluorination of PFOS, while the PFOS was oxidatively defluorinated by sulfate radicals in water. The defluorination efficiency of PFOS under various treatment was followed the order: HT (hydrothermal)/K2S2O8. UV (ultraviolet)/K2S2O8. Fe2+/K2S2O8. US (ultrasound)/K2S2O8. Low pH was favorable for the PFOS defluorination with sulfate radicals. Increase in the amount of S2O82- had positive effect on PFOS defluorination. However, further increase in amounts of S2O82- caused insignificant improvement in PFOS defluorination due to elimination of sulfate radicals under high concentration of S2O82-. CF3(CF2)(n)COOH (n = 0-6) were detected as intermediates during PFOS defluorination. Sulfate radicals oxidation and hydrolysis were the main mechanisms involved in defluorination process of PFOS.	[Yang, Shewei; Cheng, Jianhua; Sun, Jian; Hu, Yongyou; Liang, Xiaoyan] S China Univ Technol, Coll Environm & Energy, Minist Educ, Key Lab Pollut Control & Ecol Remediat Ind Agglom, Guangzhou, Guangdong, Peoples R China; [Cheng, Jianhua; Hu, Yongyou] S China Univ Technol, Coll Light Ind & Food Sci, State Key Lab Pulp & Paper Engn, Guangzhou, Guangdong, Peoples R China	South China University of Technology; South China University of Technology	Cheng, JH (corresponding author), S China Univ Technol, Coll Environm & Energy, Minist Educ, Key Lab Pollut Control & Ecol Remediat Ind Agglom, Guangzhou, Guangdong, Peoples R China.	jhcheng@scut.edu.cn	liang, xiaoyan/GYJ-5006-2022		Project of Science and Technology Excellent Scholar of Zhu Jiang [0501-64]; Fundamental research funds for the National Central Universities [2116520]	Project of Science and Technology Excellent Scholar of Zhu Jiang; Fundamental research funds for the National Central Universities	The authors wish to gratefully acknowledge the Project of Science and Technology Excellent Scholar of Zhu Jiang (No. 0501-64) and Fundamental research funds for the National Central Universities (No. 2116520) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anipsitakis GP, 2006, ENVIRON SCI TECHNOL, V40, P1000, DOI 10.1021/es050634b; Carter KE, 2008, ENVIRON SCI TECHNOL, V42, P6111, DOI 10.1021/es703273s; Cheng J, 2008, ENVIRON SCI TECHNOL, V42, P8057, DOI 10.1021/es8013858; Cheng J, 2010, ENVIRON SCI TECHNOL, V44, P445, DOI 10.1021/es902651g; Hollingsworth J, 2005, CHEMOSPHERE, V59, P1219, DOI 10.1016/j.chemosphere.2004.11.067; Hori H, 2006, ENVIRON SCI TECHNOL, V40, P1049, DOI 10.1021/es0517419; Hori H, 2005, ENVIRON SCI TECHNOL, V39, P2383, DOI 10.1021/es0484754; Hori H, 2008, ENVIRON SCI TECHNOL, V42, P7438, DOI 10.1021/es800832p; Huang KC, 2002, CHEMOSPHERE, V49, P413, DOI 10.1016/S0045-6535(02)00330-2; Kannan K, 2004, ENVIRON SCI TECHNOL, V38, P4489, DOI 10.1021/es0493446; Key BD, 1998, ENVIRON SCI TECHNOL, V32, P2283, DOI 10.1021/es9800129; Lee YC, 2012, CHEM ENG J, V198, P27, DOI 10.1016/j.cej.2012.05.073; Lee YC, 2010, WATER RES, V44, P886, DOI 10.1016/j.watres.2009.09.055; Lee YC, 2009, WATER RES, V43, P2811, DOI 10.1016/j.watres.2009.03.052; Li BZ, 2013, ULTRASON SONOCHEM, V20, P855, DOI 10.1016/j.ultsonch.2012.11.014; Liang CJ, 2007, CHEMOSPHERE, V66, P106, DOI 10.1016/j.chemosphere.2006.05.026; Liang CJ, 2003, SOIL SEDIMENT CONTAM, V12, P207, DOI 10.1080/713610970; Lin AYC, 2012, J HAZARD MATER, V243, P272, DOI 10.1016/j.jhazmat.2012.10.029; Liu CS, 2012, SEP PURIF TECHNOL, V87, P95, DOI 10.1016/j.seppur.2011.11.027; Moriwaki H, 2005, ENVIRON SCI TECHNOL, V39, P3388, DOI 10.1021/es040342v; Ochoa-Herrera V, 2008, ENVIRON SCI TECHNOL, V42, P3260, DOI 10.1021/es702842q; Park H, 2010, REV ROUM CHIM, V55, P611; Park H, 2009, J PHYS CHEM A, V113, P690, DOI 10.1021/jp807116q; Schroder HF, 2005, J CHROMATOGR A, V1082, P110, DOI 10.1016/j.chroma.2005.02.070; Schultz MM, 2006, ENVIRON SCI TECHNOL, V40, P7350, DOI 10.1021/es061025m; Sinclair E, 2006, ENVIRON SCI TECHNOL, V40, P1408, DOI 10.1021/es051798v; Vecitis CD, 2008, J PHYS CHEM C, V112, P16850, DOI 10.1021/jp804050p; Vecitis CD, 2008, J PHYS CHEM A, V112, P4261, DOI 10.1021/jp801081y; Vecitis CD, 2010, ENVIRON SCI TECHNOL, V44, P432, DOI 10.1021/es902444r; Waldemer RH, 2007, ENVIRON SCI TECHNOL, V41, P1010, DOI 10.1021/es062237m; Yamamoto T, 2007, ENVIRON SCI TECHNOL, V41, P5660, DOI 10.1021/es0706504	31	48	51	16	152	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e74877	10.1371/journal.pone.0074877	http://dx.doi.org/10.1371/journal.pone.0074877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116016	gold, Green Published, Green Submitted			2022-12-25	WOS:000325501300017
J	Giraud, I; Valette, V; Bech, N; Grandjean, F; Cordaux, R				Giraud, Isabelle; Valette, Victorien; Bech, Nicolas; Grandjean, Frederic; Cordaux, Richard			Isolation and Characterization of Microsatellite Loci for the Isopod Crustacean Armadillidium vulgare and Transferability in Terrestrial Isopods	PLOS ONE			English	Article							SEX-RATIO DISTORTERS; MITOCHONDRIAL-DNA POLYMORPHISM; FEMINIZING WOLBACHIA; LATR CRUSTACEA; POPULATION; INFECTION; EVOLUTION; TRANSMISSION; MECHANISMS; ONISCIDEA	Armadillidium vulgare is a terrestrial isopod (Crustacea, Oniscidea) which harbors Wolbachia bacterial endosymbionts. A. vulgare is the major model for the study of Wolbachia-mediated feminization of genetic males in crustaceans. As a consequence of their impact on host sex determination mechanisms, Wolbachia endosymbionts are thought to significantly influence A. vulgare evolution on various grounds, including population genetic structure, diversity and reproduction strategies. To provide molecular tools for examining these questions, we isolated microsatellite loci through 454 pyrosequencing of a repeat-enriched A. vulgare genomic library. We selected 14 markers and developed three polymorphic microsatellite multiplex kits. We tested the kits on two A. vulgare natural populations and found high genetic variation, thereby making it possible to investigate the impact of Wolbachia endosymbionts on A. vulgare nuclear variation at unprecedented resolution. In addition, we tested the transferability of these kits by cross-species amplification in five other terrestrial isopod species harboring Wolbachia endosymbionts. The microsatellite loci showed good transferability in particular in Armadillidium nasatum and Chaetophiloscia elongata, for which these markers represent promising tools for future genetic studies.	[Giraud, Isabelle; Valette, Victorien; Bech, Nicolas; Grandjean, Frederic; Cordaux, Richard] Univ Poitiers, UMR CNRS Ecol & Biol Interact 7267, Equipe Ecol Evolut Symbiose, Poitiers, France	Universite de Poitiers	Cordaux, R (corresponding author), Univ Poitiers, UMR CNRS Ecol & Biol Interact 7267, Equipe Ecol Evolut Symbiose, Poitiers, France.	richard.cordaux@univ-poitiers.fr	Bech, Nicolas/F-7253-2010; grandjean, frederic/H-2017-2012	grandjean, frederic/0000-0002-8494-0985; BECH, Nicolas/0000-0003-3625-3686	European Research Council [260729 EndoSexDet]	European Research Council(European Research Council (ERC)European Commission)	This work was funded by a European Research Council Starting Grant (FP7/2007-2013, grant 260729 EndoSexDet) to RC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouchon D, 2008, INSECT SYMBIOSIS, V3, P273, DOI DOI 10.1201/9781420064117.CH12; Cordaux R, 2004, HEREDITY, V93, P78, DOI 10.1038/sj.hdy.6800482; Cordaux R, 2001, J EVOLUTION BIOL, V14, P237, DOI 10.1046/j.1420-9101.2001.00279.x; Cordaux R, 2012, ZOOKEYS, P123, DOI 10.3897/zookeys.176.2284; Cordaux R, 2011, TRENDS GENET, V27, P332, DOI 10.1016/j.tig.2011.05.002; Goudet J., 2001, FSTAT PROGRAM ESTIMA; GRANDJEAN F, 1993, GENETICA, V92, P55, DOI 10.1007/BF00057507; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; LEGRAND JJ, 1984, GENET SEL EVOL, V16, P57, DOI 10.1186/1297-9686-16-1-57; Malausa T, 2011, MOL ECOL RESOUR, V11, P638, DOI 10.1111/j.1755-0998.2011.02992.x; Meglecz E, 2010, BIOINFORMATICS, V26, P403, DOI 10.1093/bioinformatics/btp670; Michel-Salzat A, 2001, HEREDITY, V87, P428, DOI 10.1046/j.1365-2540.2001.00920.x; NEI M, 1978, GENETICS, V89, P583; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rigaud T, 1997, INFLUENTIAL PASSENGERS, P81; RIGAUD T, 1992, HEREDITY, V68, P47, DOI 10.1038/hdy.1992.6; Rigaud T, 1997, BIOESSAYS, V19, P409, DOI 10.1002/bies.950190508; RIGAUD T, 1993, GENETICS, V133, P247; Rigaud T, 1999, GENETICS, V152, P1669; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Verne S, 2006, MOL ECOL NOTES, V6, P328, DOI 10.1111/j.1471-8286.2006.01220.x; Verne S, 2012, J EVOLUTION BIOL, V25, P264, DOI 10.1111/j.1420-9101.2011.02413.x; Verne S, 2007, GENE, V397, P58, DOI 10.1016/j.gene.2007.04.006; Verne S, 2007, J CRUSTACEAN BIOL, V27, P217, DOI 10.1651/S-2752.1; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969	27	9	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76639	10.1371/journal.pone.0076639	http://dx.doi.org/10.1371/journal.pone.0076639			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098543	Green Published, Green Submitted, gold			2022-12-25	WOS:000325483600068
J	Scolaro, L; Parrino, C; Coroniti, R; Otvos, L; Surmacz, E				Scolaro, Laura; Parrino, Cristina; Coroniti, Roberta; Otvos, Laszlo, Jr.; Surmacz, Eva			Exploring Leptin Antagonism in Ophthalmic Cell Models	PLOS ONE			English	Article							CHOROIDAL ENDOTHELIAL-CELLS; BREAST-CANCER; DIABETIC-RETINOPATHY; VITREOUS LEPTIN; EXPRESSION; RECEPTOR; GROWTH; VEGF; NEOVASCULARIZATION; PROLIFERATION	Background: Emerging evidence suggests that angiogenic and pro-inflammatory cytokine leptin might be implicated in ocular neovascularization. However, the potential of inhibiting leptin function in ophthalmic cells has never been explored. Here we assessed mitogenic, angiogenic, and signaling leptin activities in retinal and corneal endothelial cells and examined the capability of a specific leptin receptor (ObR) antagonist, Allo-aca, to inhibit these functions. Methods and Results: The experiments were carried out in monkey retinal (RF/6A) and bovine corneal (BCE) endothelial cells. Leptin at 50-250 ng/mL stimulated the growth of both cell lines in a dose-dependent manner. The maximal mitogenic response (35+/-7 and 27+/-3% in RF6A and BCE cells, respectively) was noted at 24 h of 250 ng/mL leptin treatments. Leptin-dependent proliferation was reduced to base levels with 10 and 100 nM Allo-aca in BCE and RF6A cells, respectively. In both cell lines, leptin promoted angiogenic responses, with the maximal increase in tube formation (163+/-10 and 133+/-8% in RF6A and BCE cultures, respectively) observed under a 250 ng/mL leptin treatment for 3 h. Furthermore, in both cell lines 250 ng/mL leptin modulated the activity or expression of several signaling molecules involved in proliferation, inflammatory activity and angiogenesis, such as STAT3, Akt, and ERK1/2, COX2, and NF kappa B. In both cell lines, leptin-induced angiogenic and signaling responses were significantly inhibited with 100 nM Allo-aca. We also found that leptin increased its own mRNA and protein expression in both cell lines, and this autocrine effect was abolished by 100-250 nM Allo-aca. Conclusions: Our data provide new insights into the role of leptin in ocular endothelial cells and represent the first original report on targeting ObR in ophthalmic cell models.	[Scolaro, Laura; Parrino, Cristina; Coroniti, Roberta; Surmacz, Eva] Temple Univ, Ctr Biotechnol, Sbarro Inst Canc Res & Mol Med, Philadelphia, PA 19122 USA; [Otvos, Laszlo, Jr.] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Surmacz, E (corresponding author), Temple Univ, Ctr Biotechnol, Sbarro Inst Canc Res & Mol Med, Philadelphia, PA 19122 USA.	surmacz@temple.edu	Parrino, Cristina/ABA-7496-2020; Parrino, Cristina/H-4009-2018	Parrino, Cristina/0000-0002-1367-6208; Parrino, Cristina/0000-0002-1367-6208	Novo Nordisk Diabetes Innovation Award	Novo Nordisk Diabetes Innovation Award	The work was supported by the Novo Nordisk Diabetes Innovation Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Truong A, 2011, J MOL MED, V89, P343, DOI 10.1007/s00109-010-0709-z; Anagnostoulis S, 2008, CYTOKINE, V42, P353, DOI 10.1016/j.cyto.2008.03.009; Artwohl M, 2002, INT J OBESITY, V26, P577, DOI 10.1038/sj.ijo.0801947; Balaiya S, 2012, MOL VIS, V18, P114; Basak S, 2012, EUR J OBSTET GYN R B, V164, P24, DOI 10.1016/j.ejogrb.2012.05.033; Beccari S, 2013, PEPTIDES; Bjorbaek C, 2001, J BIOL CHEM, V276, P4747, DOI 10.1074/jbc.M007439200; Bouloumie A, 1998, CIRC RES, V83, P1059, DOI 10.1161/01.RES.83.10.1059; Cao RH, 2001, P NATL ACAD SCI USA, V98, P6390, DOI 10.1073/pnas.101564798; Cascio S, 2008, ONCOGENE, V27, P540, DOI 10.1038/sj.onc.1210660; Chang JH, 2012, SURV OPHTHALMOL, V57, P415, DOI 10.1016/j.survophthal.2012.01.007; Dong X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018481; Ferla R, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-303; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gariano RF, 2000, INVEST OPHTH VIS SCI, V41, P3576; Garofalo C, 2006, J CELL PHYSIOL, V207, P12, DOI 10.1002/jcp.20472; Garofalo C, 2004, CLIN CANCER RES, V10, P6466, DOI 10.1158/1078-0432.CCR-04-0203; Garonna E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018823; Gonzalez RR, 2006, J BIOL CHEM, V281, P26320, DOI 10.1074/jbc.M601991200; Gonzalez-Perez RR, 2010, CELL SIGNAL, V22, P1350, DOI 10.1016/j.cellsig.2010.05.003; Hernandez C, 2004, RETINA-J RET VIT DIS, V24, P30, DOI 10.1097/00006982-200402000-00005; Huang LZ, 2009, MOL VIS, V15, P1057; Kovalszky I, 2010, DIABETES OBES METAB, V12, P393, DOI 10.1111/j.1463-1326.2009.01170.x; Lee P, 1998, SURV OPHTHALMOL, V43, P245, DOI 10.1016/S0039-6257(98)00035-6; Lukiw WJ, 2003, INVEST OPHTH VIS SCI, V44, P4163, DOI 10.1167/iovs.02-0655; Maberley D, 2006, EYE, V20, P801, DOI 10.1038/sj.eye.6702011; Margetic S, 2002, INT J OBESITY, V26, P1407, DOI 10.1038/sj.ijo.0802142; Misra GP, 2010, EDINBURGH RETINAL PH, V2010, P133; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Oda Akihiko, 2001, Kobe Journal of Medical Sciences, V47, P141; Ottino P, 2004, MOL VIS, V10, P341; Otvos L, 2011, EXPERT REV ANTICANC, V11, P1147, DOI [10.1586/era.11.109, 10.1586/ERA.11.109]; Otvos L, 2011, PEPTIDES, V32, P1567, DOI 10.1016/j.peptides.2011.06.015; Otvos L, 2011, EUR J CANCER, V47, P1578, DOI 10.1016/j.ejca.2011.01.018; Otvos L, 2011, BIOPOLYMERS, V96, P117, DOI 10.1002/bip.21377; Otvos L, 2009, ADV EXP MED BIOL, V611, P497, DOI 10.1007/978-0-387-73657-0_215; Park HY, 2001, EXP MOL MED, V33, P95, DOI 10.1038/emm.2001.17; Praidou A, 2010, CURR DIABETES REV, V6, P304, DOI 10.2174/157339910793360815; Qazi Y, 2009, J GENET, V88, P495, DOI 10.1007/s12041-009-0068-0; Ricker LJAG, 2012, EXP EYE RES, V94, P56, DOI 10.1016/j.exer.2011.11.006; Rouet-Benzineb R, 2004, J BIOL CHEM, V279, P16495, DOI 10.1074/jbc.M312999200; Rusovici R, 2013, CLIN OPHTHALMOL, V7, P321, DOI 10.2147/OPTH.S41556; Rusovici R, 2011, MOL VIS, V17, P3339; Scolaro L, 2010, EXPERT REV ENDOCRINO, V5, P875, DOI [10.1586/eem.10.61, 10.1586/EEM.10.61]; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; Stewart MW, 2012, MAYO CLIN PROC, V87, P77, DOI 10.1016/j.mayocp.2011.10.001; Suganami E, 2004, DIABETES, V53, P2443, DOI 10.2337/diabetes.53.9.2443; Sweeney G, 2002, CELL SIGNAL, V14, P655, DOI 10.1016/S0898-6568(02)00006-2; Sweeney G, 2010, NAT REV CARDIOL, V7, P22, DOI 10.1038/nrcardio.2009.224; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Villanueva EC, 2008, INT J OBESITY, V32, pS8, DOI 10.1038/ijo.2008.232; Wauters M, 2000, EUR J ENDOCRINOL, V143, P293, DOI 10.1530/eje.0.1430293; Willard AL, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/209538; Xu Y, 2010, MOL VIS, V16, P1982; Yeh WL, 2009, GLIA, V57, P454, DOI 10.1002/glia.20773; Zabeau L, 2003, FEBS LETT, V546, P45, DOI 10.1016/S0014-5793(03)00440-X; Zhang FM, 2005, VITAM HORM, V71, P345, DOI 10.1016/S0083-6729(05)71012-8	57	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76437	10.1371/journal.pone.0076437	http://dx.doi.org/10.1371/journal.pone.0076437			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098500	Green Published, Green Submitted, gold			2022-12-25	WOS:000325483600051
J	Cao, WQ; Cao, J; Huang, JM; Yao, J; Yan, GQ; Xu, HQ; Yang, PY				Cao, Weiqian; Cao, Jing; Huang, Jiangming; Yao, Jun; Yan, Guoquan; Xu, Haoqi; Yang, Pengyuan			Discovery and Confirmation of O-GlcNAcylated Proteins in Rat Liver Mitochondria by Combination of Mass Spectrometry and Immunological Methods	PLOS ONE			English	Article							LINKED N-ACETYLGLUCOSAMINE; NUCLEOCYTOPLASMIC PROTEINS; POSTTRANSLATIONAL MODIFICATIONS; GLOBAL IDENTIFICATION; CYTOSKELETAL PROTEINS; PHOSPHORYLATION; GLYCOSYLATION; NUCLEAR; PROTEOME; ROLES	O-linked beta-N-acetylglucosamine (O-GlcNAc) is an important post-translational modification (PTM) consisting of a single N-acetylglucosamine moiety attached via an O-beta-glycosidic linkage to serine and threonine residues. Glycosylation with O-GlcNAc occurs on myriad nuclear and cytosolic proteins from almost all functional classes. However, with respect to O-GlcNAcylated proteins special in mitochondria, little attention has been paid. In this study, we combined mass spectrometry and immunological methods to perform global exploration of O-GlcNAcylated proteins specific in mitochondria of rat liver. First, highly purified mitochondrial proteins were obviously shown to be O-GlcNAcylated by immunoblot profiling. Then, beta-elimination followed by Michael Addition with Dithiothreitol (BEMAD) treatment and LC-MS/MS were performed to enrich and identify O-GlcNAcylated mitochondrial proteins, resulting in an unambiguous assignment of 14 O-GlcNAcylation sites, mapping to 11 O-GlcNAcylated proteins. Furthermore, the identified O-GlcNAcylated mitochondrial proteins were fully validated by both electron transfer dissociation tandem mass spectrometry (ETD/MS/MS) and western blot. Thus, for the first time, our study definitely not only identified but also validated that some mitochondrial proteins in rat liver are O-GlcNAcylated. Interestingly, all of these O-GlcNAcylated mitochondrial proteins are enzymes, the majority of which are involved in a wide variety of biological processes, such as urea cycle, tricarboxylic acid cycle and lipid metabolism, indicating a role for protein O-GlcNAcylation in mitochondrial function.	[Yang, Pengyuan] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; Fudan Univ, Dept Chem, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Yang, PY (corresponding author), Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China.	pyyang@fudan.edu.cn			National Key Scientific Program of China [2008ZX10208, 2008ZX10207]; National Science and Technology Key Project of China [2011CB910600]; National Natural Science Foundation of China [31100590, 20975024]; Shanghai Municipal Natural Science Foundation [11ZR1403000]	National Key Scientific Program of China; National Science and Technology Key Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Natural Science Foundation	This work was supported in part by National Key Scientific Program of China (2008ZX10208, 2008ZX10207), National Science and Technology Key Project of China (2011CB910600), National Natural Science Foundation of China (31100590 and 20975024), Shanghai Municipal Natural Science Foundation (11ZR1403000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro JF, 2012, P NATL ACAD SCI USA, V109, P7280, DOI 10.1073/pnas.1200425109; Ande SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004586; Bond MR, 2013, ANNU REV NUTR, V33, P205, DOI 10.1146/annurev-nutr-071812-161240; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Cao J, 2009, J PROTEOME RES, V8, P662, DOI 10.1021/pr800826u; Cheng XG, 2000, BIOCHEMISTRY-US, V39, P11609, DOI 10.1021/bi000755i; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; Colaert N, 2011, J PROTEOME RES, V10, P3840, DOI 10.1021/pr2005154; Cole RN, 1999, J NEUROCHEM, V73, P418, DOI 10.1046/j.1471-4159.1999.0730418.x; Copeland RJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE17, DOI 10.1152/ajpendo.90281.2008; Deng WJ, 2010, MOL CELL PROTEOMICS, V9, P100, DOI 10.1074/mcp.M900020-MCP200; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Forner F, 2009, CELL METAB, V10, P324, DOI 10.1016/j.cmet.2009.08.014; Gu YY, 2011, ARCH BIOCHEM BIOPHYS, V505, P98, DOI 10.1016/j.abb.2010.09.024; Guinez C, 2005, INT J BIOCHEM CELL B, V37, P765, DOI 10.1016/j.biocel.2004.12.001; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2013, CELL METAB, V17, P155, DOI 10.1016/j.cmet.2013.01.008; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hart GW, 1997, ANNU REV BIOCHEM, V66, P315, DOI 10.1146/annurev.biochem.66.1.315; Hart GW, 1996, GLYCOBIOLOGY, V6, P711, DOI 10.1093/glycob/6.7.711; Henze K, 2003, NATURE, V426, P127, DOI 10.1038/426127a; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Hu P, 2010, FEBS LETT, V584, P2526, DOI 10.1016/j.febslet.2010.04.044; Hu Y, 2009, J BIOL CHEM, V284, P547, DOI 10.1074/jbc.M808518200; Issad T, 2010, M S-MED SCI, V26, P753, DOI 10.1051/medsci/2010268-9753; Jiang XS, 2004, MOL CELL PROTEOMICS, V3, P441, DOI 10.1074/mcp.M300117-MCP200; Kamemura K, 2002, J BIOL CHEM, V277, P19229, DOI 10.1074/jbc.M201729200; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5; Love DC, 2003, J CELL SCI, V116, P647, DOI 10.1242/jcs.00246; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Medina L, 1998, GLYCOBIOLOGY, V8, P383, DOI 10.1093/glycob/8.4.383; Mishra S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-1; Nandi A, 2006, ANAL CHEM, V78, P452, DOI 10.1021/ac051207j; Park J, 2009, BBA-PROTEINS PROTEOM, V1794, P254, DOI 10.1016/j.bbapap.2008.10.003; Pozo KBK, 2011, BBA-MOL CELL RES, V1813, P269, DOI 10.1016/j.bbamcr.2010.10.011; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Teo CF, 2010, NAT CHEM BIOL, V6, P338, DOI 10.1038/nchembio.338; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; Virginia LJ, 2012, PHYSIOL GENOMICS, V45, P17; Vocadlo DJ, 2003, P NATL ACAD SCI USA, V100, P9116, DOI 10.1073/pnas.1632821100; Vosseller K, 2005, PROTEOMICS, V5, P388, DOI 10.1002/pmic.200401066; Vosseller K, 2002, CURR OPIN CHEM BIOL, V6, P851, DOI 10.1016/S1367-5931(02)00384-8; Wang Z, 2009, DIABETES, V58, P309, DOI 10.2337/db08-0994; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Whelan SA, 2006, METHOD ENZYMOL, V415, P113, DOI 10.1016/S0076-6879(06)15008-9; Whelan SA, 2010, J BIOL CHEM, V285, P5204, DOI 10.1074/jbc.M109.077818; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678; Zhao P, 2011, J PROTEOME RES, V10, P4088, DOI 10.1021/pr2002726; Zhao XL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000299	57	34	45	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76399	10.1371/journal.pone.0076399	http://dx.doi.org/10.1371/journal.pone.0076399			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098488	Green Published, Green Submitted, gold			2022-12-25	WOS:000325434500065
J	Claassens, MM; Van Schalkwyk, C; du Toit, E; Roest, E; Lombard, CJ; Enarson, DA; Beyers, N; Borgdorff, MW				Claassens, Mareli M.; Van Schalkwyk, Cari; du Toit, Elizabeth; Roest, Eline; Lombard, Carl J.; Enarson, Donald A.; Beyers, Nulda; Borgdorff, Martien W.			Tuberculosis in Healthcare Workers and Infection Control Measures at Primary Healthcare Facilities in South Africa	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; NOSOCOMIAL TRANSMISSION; MULTIDRUG-RESISTANT; INCREASED RISK; PREVALENCE; DISEASE; IMPACT; CHINA; TB	Background: Challenges exist regarding TB infection control and TB in hospital-based healthcare workers in South Africa. However, few studies report on TB in non-hospital based healthcare workers such as primary or community healthcare workers. Our objectives were to investigate the implementation of TB infection control measures at primary healthcare facilities, the smear positive TB incidence rate amongst primary healthcare workers and the association between TB infection control measures and all types of TB in healthcare workers. Methods: One hundred and thirty three primary healthcare facilities were visited in five provinces of South Africa in 2009. At each facility, a TB infection control audit and facility questionnaire were completed. The number of healthcare workers who had had TB during the past three years was obtained. Results: The standardised incidence ratio of smear positive TB in primary healthcare workers indicated an incidence rate of more than double that of the general population. In a univariable logistic regression, the infection control audit score was significantly associated with reported cases of TB in healthcare workers (OR=1.04, 95% CI 1.01-1.08, p=0.02) as was the number of staff (OR=3.78, 95% CI 1.77-8.08). In the multivariable analysis, the number of staff remained significantly associated with TB in healthcare workers (OR=3.33, 95% CI 1.37-8.08). Conclusion: The high rate of TB in healthcare workers suggests a substantial nosocomial transmission risk, but the infection control audit tool which was used did not perform adequately as a measure of this risk. Infection control measures should be monitored by validated tools developed and tested locally. Different strategies, such as routine surveillance systems, could be used to evaluate the burden of TB in healthcare workers in order to calculate TB incidence, monitor trends and implement interventions to decrease occupational TB.	[Claassens, Mareli M.; du Toit, Elizabeth; Roest, Eline; Lombard, Carl J.; Enarson, Donald A.; Beyers, Nulda] Univ Stellenbosch, Desmond Tutu TB Ctr, Dept Paediat & Child Hlth, Parow, South Africa; [Van Schalkwyk, Cari] Univ Stellenbosch, South African Dept Sci & Technol, Natl Res Fdn Ctr Excellence Epidemiol Modelling &, ZA-7600 Stellenbosch, South Africa; [Lombard, Carl J.] MRC, Biostat Unit, Parow, South Africa; [Enarson, Donald A.] Int Union TB & Lung Dis, Paris, France; [Claassens, Mareli M.; Borgdorff, Martien W.] Univ Amsterdam, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam, Netherlands	Stellenbosch University; National Research Foundation - South Africa; Stellenbosch University; University of Amsterdam	Claassens, MM (corresponding author), Univ Stellenbosch, Desmond Tutu TB Ctr, Dept Paediat & Child Hlth, Parow, South Africa.	mcla@sun.ac.za	Claassens, Mareli/Y-3544-2019	Claassens, Mareli/0000-0002-5927-284X; van Schalkwyk, Cari/0000-0001-5154-1390; Lombard, Carl/0000-0002-2136-6533	University Research Corporation (URC) under USAID [FY09-G03-4710, GHS-I-00-03-00032-00]	University Research Corporation (URC) under USAID(United States Agency for International Development (USAID))	This study was funded by University Research Corporation (URC) Grant FY09-G03-4710 under USAID Contract No. GHS-I-00-03-00032-00 (TASCII TB South Africa). The authors had full control over the data and did not have an agreement with the funders that may have limited the completion of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balt E, 1998, S AFR MED J, V88, P1363; Bamford CM, 2010, SAMJ S AFR MED J, V100, P438, DOI 10.7196/SAMJ.3501; Baussano I, 2011, EMERG INFECT DIS, V17, P488, DOI 10.3201/eid1703.100947; Buregyeya E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046069; BURRILL D, 1985, CAN MED ASSOC J, V132, P137; Chai SJ, 2013, HEALTH POLICY PLANN, V28, P100, DOI 10.1093/heapol/czs029; Churchyard G, 2008, S AFR J HIV MED  SUM, P23; Claassens MM, 2010, INT J TUBERC LUNG D, V14, P1576; Connelly D, 2007, SAMJ S AFR MED J, V97, P115; Dimitrova B, 2005, INT J TUBERC LUNG D, V9, P43; Escombe A Roderick, 2007, PLoS Med, V4, pe68, DOI 10.1371/journal.pmed.0040068; Farley JE, 2012, INT J TUBERC LUNG D, V16, P82, DOI 10.5588/ijtld.10.0791; FRENCH GL, 1993, J HOSP INFECT, V24, P301, DOI 10.1016/0195-6701(93)90062-5; He GX, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-313; Jarand J, 2010, TROP MED INT HEALTH, V15, P1179, DOI 10.1111/j.1365-3156.2010.02590.x; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Kehinde AO, 2011, INDIAN J MED RES, V133, P613; Kranzer K, 2010, SAMJ S AFR MED J, V100, P224, DOI 10.7196/SAMJ.3903; Mathew A, 2013, J CLIN EPIDEMIOL, V66, P67, DOI 10.1016/j.jclinepi.2011.12.010; McCarthy K, 2009, IMPLEMENTING TB INFE, P23; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Mhlongo-Sigwebela N, 2009, TASC 2 TUBERCULOSIS, P1; Naidoo S, 2006, INT J TUBERC LUNG D, V10, P676; Naidoo S, 2012, INT J TUBERC LUNG D, V16, P1600, DOI 10.5588/ijtld.12.0041; O'Donnell MR, 2010, ANN INTERN MED, V153, P516, DOI 10.7326/0003-4819-153-8-201010190-00008; Padayatchi N, 2010, INT J TUBERC LUNG D, V14, P960; Partnership Stop TB, 2011, ACC IMPL 3 IS HIV TB, P1; Reid MJA, 2012, INT J TUBERC LUNG D, V16, P1605, DOI 10.5588/ijtld.12.0033; Scano F., 2009, WHO POLICY TB INFECT; Shisana O, 2004, SAMJ S AFR MED J, V94, P846; Sissolak D, 2010, INT J INFECT DIS, V14, pE423, DOI 10.1016/j.ijid.2009.06.030; SMITH T, 1990, BRIT MED J, V300, P65, DOI 10.1136/bmj.300.6717.65; South African National Department of Health, 2007, NAT INF PREV CONTR P, P1; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Wilkinson D, 1998, T ROY SOC TROP MED H, V92, P500, DOI 10.1016/S0035-9203(98)90889-6; World Health Organization, 2012, GUID MEAS PREV ACT T	36	55	57	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76272	10.1371/journal.pone.0076272	http://dx.doi.org/10.1371/journal.pone.0076272			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098461	gold, Green Published, Green Submitted			2022-12-25	WOS:000325434500058
J	Akhouayri, IG; Habtewold, T; Christophides, GK				Akhouayri, Idir G.; Habtewold, Tibebu; Christophides, Georges K.			Melanotic Pathology and Vertical Transmission of the Gut Commensal Elizabethkingia meningoseptica in the Major Malaria Vector Anopheles gambiae	PLOS ONE			English	Article							GENE-BASED IDENTIFICATION; PLASMODIUM-FALCIPARUM; INSECTICIDE RESISTANCE; MELANIZATION REACTION; IMMUNE ACTIVATION; MOSQUITO; DROSOPHILA; STEPHENSI; BACTERIA; INFECTION	Background: The resident gut flora is known to have significant impacts on the life history of the host organism. Endosymbiotic bacterial species in the Anopheles mosquito gut are potent modulators of sexual development of the malaria parasite, Plasmodium, and thus proposed as potential control agents of malaria transmission. Results: Here we report a melanotic pathology in the major African malaria vector Anopheles gambiae, caused by the dominant mosquito endosymbiont Elizabethkingia meningoseptica. Transfer of melanised tissues into the haemolymph of healthy adult mosquitoes or direct haemolymph inoculation with isolated E. meningoseptica bacteria were the only means for transmission and de novo formation of melanotic lesions, specifically in the fat body tissues of recipient individuals. We show that E. meningoseptica can be vertically transmitted from eggs to larvae and that E. meningoseptica-mono-associated mosquitoes display significant mortality, which is further enhanced upon Plasmodium infection, suggesting a synergistic impact of E. meningoseptica and Plasmodium on mosquito survival. Conclusion: The high pathogenicity and permanent association of E. meningoseptica with An. Gambiae through vertical transmission constitute attractive characteristics towards the potential design of novel mosquito/malaria biocontrol strategies.	[Akhouayri, Idir G.; Habtewold, Tibebu; Christophides, Georges K.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Div Cell & Mol Biol, London, England	Imperial College London	Akhouayri, IG (corresponding author), Univ Grenoble 1, CNRS UMR 5553, Lab Ecol Alpine, Grenoble, France.	ig.akhouayri@yahoo.com		Christophides, George/0000-0002-3323-1687	EU TransMalariaBlock; Wellcome Trust [093587/Z/10/Z];  [BBSRC S19551]; Biotechnology and Biological Sciences Research Council [S19551] Funding Source: researchfish	EU TransMalariaBlock; Wellcome Trust(Wellcome TrustEuropean Commission); ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was partially supported by a PhD studentship (BBSRC S19551) to IA and EU TransMalariaBlock to TH. This work was funded by the Wellcome Trust (093587/Z/10/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi Y, 2003, INT J PARASITOL, V33, P933, DOI 10.1016/S0020-7519(03)00112-7; Avet-Rochex A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-65; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Beard CB, 1998, EMERG INFECT DIS, V4, P581, DOI 10.3201/eid0404.980408; BEIER MS, 1994, J MED ENTOMOL, V31, P561, DOI 10.1093/jmedent/31.4.561; Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192; Bisi DC, 2011, APPL ENVIRON MICROB, V77, P4669, DOI 10.1128/AEM.00514-11; Blandin S, 2002, EMBO REP, V3, P852, DOI 10.1093/embo-reports/kvf180; Boissiere Anne, 2012, PLoS Pathog, V8, pe1002742, DOI 10.1371/journal.ppat.1002742; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Chouaia B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S2; Christensen BM, 2005, TRENDS PARASITOL, V21, P192, DOI 10.1016/j.pt.2005.02.007; Cirimotich CM, 2011, CELL HOST MICROBE, V10, P307, DOI 10.1016/j.chom.2011.09.006; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Curtis CF, 2002, AM J TROP MED HYG, V66, P1; Damiani C, 2010, MICROB ECOL, V60, P644, DOI 10.1007/s00248-010-9704-8; DeMaio J, 1996, AM J TROP MED HYG, V54, P219, DOI 10.4269/ajtmh.1996.54.219; Dias M, 2012, J CLIN DIAGN RES, V6, P1550, DOI 10.7860/JCDR/2012/4076.2557; Dimopoulos G, 1998, EMBO J, V17, P6115, DOI 10.1093/emboj/17.21.6115; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Durvasula RV, 1997, P NATL ACAD SCI USA, V94, P3274, DOI 10.1073/pnas.94.7.3274; Farenhorst M, 2009, P NATL ACAD SCI USA, V106, P17443, DOI 10.1073/pnas.0908530106; Favia G, 2008, ADV EXP MED BIOL, V627, P49, DOI 10.1007/978-0-387-78225-6_4; Favia G, 2007, P NATL ACAD SCI USA, V104, P9047, DOI 10.1073/pnas.0610451104; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; GATEFF E, 1978, SCIENCE, V200, P1448, DOI 10.1126/science.96525; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Harrison G, 1978, MOSQUITOES MALARIA M; HARSHBAR.JC, 1968, ANNU REV ENTOMOL, V13, P159, DOI 10.1146/annurev.en.13.010168.001111; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Kampfer P, 2011, INT J SYST EVOL MICR, V61, P2670, DOI 10.1099/ijs.0.026393-0; Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531; Kim KK, 2005, INT J SYST EVOL MICR, V55, P1287, DOI 10.1099/ijs.0.63541-0; KING EO, 1959, AM J CLIN PATHOL, V31, P241; Lee WJ, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.121pe24; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Li JY, 1996, INSECT BIOCHEM MOLEC, V26, P309, DOI 10.1016/0965-1748(95)00099-2; Lindblade KA, 2006, J MED ENTOMOL, V43, P428, DOI 10.1093/jmedent/43.2.428; Lindh JM, 2008, ACTA TROP, V107, P242, DOI 10.1016/j.actatropica.2008.06.008; Lindh JM, 2005, APPL ENVIRON MICROB, V71, P7217, DOI 10.1128/AEM.71.11.7217-7223.2005; Lowenberger CA, 1999, EXP PARASITOL, V91, P59, DOI 10.1006/expr.1999.4350; Meister S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000542; Minakhina S, 2006, GENETICS, V174, P253, DOI 10.1534/genetics.106.061978; NAPPI AJ, 1973, EXP PARASITOL, V33, P285, DOI 10.1016/0014-4894(73)90034-9; Ngwa CJ, 2013, J MED ENTOMOL, V50, P404, DOI 10.1603/ME12180; Noden BH, 2011, PARASITOL INT, V60, P440, DOI 10.1016/j.parint.2011.07.007; Paddibhatla I, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001234; Park JW, 2007, P NATL ACAD SCI USA, V104, P6602, DOI 10.1073/pnas.0610924104; Pates H, 2005, ANNU REV ENTOMOL, V50, P53, DOI 10.1146/annurev.ento.50.071803.130439; Pumpuni CB, 1996, AM J TROP MED HYG, V54, P214, DOI 10.4269/ajtmh.1996.54.214; PUMPUNI CB, 1993, EXP PARASITOL, V77, P195, DOI 10.1006/expr.1993.1076; Rani A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-96; Ricci I, 2011, ANTON LEEUW INT J G, V99, P43, DOI 10.1007/s10482-010-9532-3; Rodriguez A, 1996, GENETICS, V143, P929; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Schnitger AKD, 2007, J BIOL CHEM, V282, P21884, DOI 10.1074/jbc.M701635200; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Storelli G, 2011, CELL METAB, V14, P403, DOI 10.1016/j.cmet.2011.07.012; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; SUGUMARAN M, 1991, FEBS LETT, V295, P233, DOI 10.1016/0014-5793(91)81431-7; Tang HP, 2009, FLY, V3, P105, DOI 10.4161/fly.3.1.7747; Tetreau G, 2013, AQUAT TOXICOL, V140, P389, DOI 10.1016/j.aquatox.2013.07.004; Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044; Wang SB, 2012, P NATL ACAD SCI USA, V109, P12734, DOI 10.1073/pnas.1204158109; WANG YH, 2011, PLOS ONE; WHO, 2011, WORLD MALARIA REPORT 2011, P1; *WHO, 1982, WHO SER RAPP TECHN, V679	67	24	25	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e77619	10.1371/journal.pone.0077619	http://dx.doi.org/10.1371/journal.pone.0077619			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098592	Green Published, gold, Green Submitted			2022-12-25	WOS:000325427100088
J	Jeong, W; Lim, W; Ahn, SE; Lim, CH; Lee, JY; Bae, SM; Kim, J; Bazer, FW; Song, G				Jeong, Wooyoung; Lim, Whasun; Ahn, Suzie E.; Lim, Chul-Hong; Lee, Jin-Young; Bae, Seung-Min; Kim, Jinyoung; Bazer, Fuller W.; Song, Gwonhwa			Recrudescence Mechanisms and Gene Expression Profile of the Reproductive Tracts from Chickens during the Molting Period	PLOS ONE			English	Article							HIGH DIETARY ZINC; JAK-STAT PATHWAY; BETA-DEFENSIN 11; LAYING HENS; CAGED LAYERS; FORCED MOLT; EGGSHELL QUALITY; EGG-PRODUCTION; BODY-WEIGHT; SALMONELLA-ENTERITIDIS	The reproductive system of chickens undergoes dynamic morphological and functional tissue remodeling during the molting period. The present study identified global gene expression profiles following oviductal tissue regression and regeneration in laying hens in which molting was induced by feeding high levels of zinc in the diet. During the molting and recrudescence processes, progressive morphological and physiological changes included regression and re-growth of reproductive organs and fluctuations in concentrations of testosterone, progesterone, estradiol and corticosterone in blood. The cDNA microarray analysis of oviductal tissues revealed the biological significance of gene expression-based modulation in oviductal tissue during its remodeling. Based on the gene expression profiles, expression patterns of selected genes such as, TF, ANGPTL3, p20K, PTN, AvBD11 and SERPINB3 exhibited similar patterns in expression with gradual decreases during regression of the oviduct and sequential increases during resurrection of the functional oviduct. Also, miR-1689* inhibited expression of Sp1, while miR-17-3p, miR-22* and miR-1764 inhibited expression of STAT1. Similarly, chicken miR-1562 and miR-138 reduced the expression of ANGPTL3 and p20K, respectively. These results suggest that these differentially regulated genes are closely correlated with the molecular mechanism(s) for development and tissue remodeling of the avian female reproductive tract, and that miRNA-mediated regulation of key genes likely contributes to remodeling of the avian reproductive tract by controlling expression of those genes post-transcriptionally. The discovered global gene profiles provide new molecular candidates responsible for regulating morphological and functional recrudescence of the avian reproductive tract, and provide novel insights into understanding the remodeling process at the genomic and epigenomic levels.	[Jeong, Wooyoung; Lim, Whasun; Ahn, Suzie E.; Lim, Chul-Hong; Lee, Jin-Young; Bae, Seung-Min] Seoul Natl Univ, Dept Anim Biotechnol, Seoul, South Korea; [Kim, Jinyoung] Dankook Univ, Dept Anim Resources Sci, Cheonan, South Korea; [Bazer, Fuller W.] Texas A&M Univ, Ctr Anim Biotechnol & Genom, College Stn, TX USA; [Bazer, Fuller W.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA; [Song, Gwonhwa] Korea Univ, Coll Life Sci & Biotechnol, Div Biotechnol, Seoul, South Korea	Seoul National University (SNU); Dankook University; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Korea University	Song, G (corresponding author), Korea Univ, Coll Life Sci & Biotechnol, Div Biotechnol, Seoul, South Korea.	ghsong@korea.ac.kr	Bazer, Fuller/AAF-4317-2021; gwonhwa, song/H-3208-2015; Song, Gwonhwa/H-3647-2015; Lim, Whasun/AAP-3156-2020	Bazer, Fuller/0000-0002-5823-5086; Lim, Whasun/0000-0002-1328-0465	Next-Generation BioGreen 21 Program through Rural Development Administration, Republic of Korea [PJ008142]	Next-Generation BioGreen 21 Program through Rural Development Administration, Republic of Korea	This research was funded by the Next-Generation BioGreen 21 Program (No. PJ008142) through Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahim M, 2002, J BIOL CHEM, V277, P28815, DOI 10.1074/jbc.M203828200; ALBATSHAN HA, 1994, POULTRY SCI, V73, P1590, DOI 10.3382/ps.0731590; Alodan MA, 1999, POULTRY SCI, V78, P171, DOI 10.1093/ps/78.2.171; Ariyadi B, 2012, POULTRY SCI, V91, P1173, DOI 10.3382/ps.2011-02079; BAKER M, 1981, POULTRY SCI, V60, P1594; Berman DM, 2004, CANCER RES, V64, P6820, DOI 10.1158/0008-5472.CAN-04-1916; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; BERRY WD, 1985, POULTRY SCI, V64, P2027, DOI 10.3382/ps.0642027; Berry WD, 2003, POULTRY SCI, V82, P971, DOI 10.1093/ps/82.6.971; BERRY WD, 1987, POULTRY SCI, V66, P218, DOI 10.3382/ps.0660218; BRAKE J, 1979, POULTRY SCI, V58, P707, DOI 10.3382/ps.0580707; BRAKE J, 1979, POULTRY SCI, V58, P699, DOI 10.3382/ps.0580699; BREEDING SW, 1992, POULTRY SCI, V71, P168, DOI 10.3382/ps.0710168; Carletti MZ, 2009, J ANIM SCI, V87, pE29, DOI 10.2527/jas.2008-1331; CHEN LH, 1987, J BIOL CHEM, V262, P17247; Conklin D, 1999, GENOMICS, V62, P477, DOI 10.1006/geno.1999.6041; CREGER CR, 1977, POULTRY SCI, V56, P1706; D'Alessandro A, 2010, J PROTEOMICS, V73, P1028, DOI 10.1016/j.jprot.2010.01.002; DAMME K, 1987, POULTRY SCI, V66, P881, DOI 10.3382/ps.0660881; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; DESJARDINS E, 1993, MOL CELL BIOL, V13, P5710, DOI 10.1128/MCB.13.9.5710; Dunn IC, 2009, GEN COMP ENDOCR, V163, P225, DOI 10.1016/j.ygcen.2009.03.006; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; DYNAN WS, 1983, CELL, V32, P669, DOI 10.1016/0092-8674(83)90053-3; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; GARLICH J, 1984, POULTRY SCI, V63, P339, DOI 10.3382/ps.0630339; Geva E, 2000, OBSTET GYNECOL SURV, V55, P511, DOI 10.1097/00006254-200008000-00024; HEIM MH, 1995, SCIENCE, V267, P1347, DOI 10.1126/science.7871432; Herve-Grepinet V, 2010, ANTIMICROB AGENTS CH, V54, P4401, DOI 10.1128/AAC.00204-10; Heryanto B, 1997, POULTRY SCI, V76, P67, DOI 10.1093/ps/76.1.67; Heryanto B, 1997, POULTRY SCI, V76, P1580, DOI 10.1093/ps/76.11.1580; HOLT PS, 1994, POULTRY SCI, V73, P1267, DOI 10.3382/ps.0731267; HOSHINO S, 1988, COMP BIOCHEM PHYS A, V90, P355, DOI 10.1016/0300-9629(88)91128-0; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; Jabbour HN, 2006, ENDOCR REV, V27, P17, DOI 10.1210/er.2004-0021; Jeong W, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.098186; KATO H, 1977, CANCER, V40, P1621, DOI 10.1002/1097-0142(197710)40:4<1621::AID-CNCR2820400435>3.0.CO;2-I; Kavurma MM, 2001, J BIOL CHEM, V276, P4964, DOI 10.1074/jbc.M009251200; Kavurma MM, 2003, J BIOL CHEM, V278, P32537, DOI 10.1074/jbc.M305650200; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; Kondoh M, 2002, EUR J BIOCHEM, V269, P6204, DOI 10.1046/j.1432-1033.2002.03339.x; Lagger G, 2003, MOL CELL BIOL, V23, P2669, DOI 10.1128/MCB.23.8.2669-2679.2003; LEE DC, 1978, J BIOL CHEM, V253, P3494; Lee JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034215; LEGGETT RW, 1995, J BIOL CHEM, V270, P25879, DOI 10.1074/jbc.270.43.25879; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Lim W, 2013, MOL CELL ENDOCRINOL, V366, P1, DOI 10.1016/j.mce.2012.10.031; Lim W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049869; Lim W, 2012, GEN COMP ENDOCR, V175, P65, DOI 10.1016/j.ygcen.2011.09.019; Liu ZY, 2004, J BIOL CHEM, V279, P14120, DOI 10.1074/jbc.M309547200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maity B, 2011, J BIOL CHEM, V286, P1409, DOI 10.1074/jbc.M110.186700; MAO PL, 1993, J BIOL CHEM, V268, P8131; MASTRANGELO IA, 1991, P NATL ACAD SCI USA, V88, P5670, DOI 10.1073/pnas.88.13.5670; MCCORMICK CC, 1984, POULTRY SCI, V63, P1201, DOI 10.3382/ps.0631201; MCLENNAN CE, 1965, OBSTET GYNECOL, V26, P605; MILNER PG, 1989, BIOCHEM BIOPH RES CO, V165, P1096, DOI 10.1016/0006-291X(89)92715-0; Monroe DG, 2002, MOL ENDOCRINOL, V16, P1322, DOI 10.1210/me.16.6.1322; Moore RW, 2004, POULTRY SCI, V83, P1276, DOI 10.1093/ps/83.8.1276; MROSOVSKY N, 1980, SCIENCE, V207, P837, DOI 10.1126/science.6928327; Muramatsu T, 2002, J BIOCHEM, V132, P359, DOI 10.1093/oxfordjournals.jbchem.a003231; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; Olofsson BA, 2007, MOL CANCER RES, V5, P1319, DOI 10.1158/1541-7786.MCR-07-0374; PAGEAUX JF, 1986, BIOL REPROD, V35, P657, DOI 10.1095/biolreprod35.3.657; Park SY, 2004, POULTRY SCI, V83, P24, DOI 10.1093/ps/83.1.24; Ponka P, 1998, SEMIN HEMATOL, V35, P35; Ponnampalam AP, 2004, MOL HUM REPROD, V10, P879, DOI 10.1093/molehr/gah121; RAULAIS D, 1991, BIOCHEM BIOPH RES CO, V174, P708, DOI 10.1016/0006-291X(91)91475-R; Ruszler PL, 1998, POULTRY SCI, V77, P1789, DOI 10.1093/ps/77.12.1789; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; SCOTT JT, 1976, POULTRY SCI, V55, P2089; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SHIPPEE RL, 1979, POULTRY SCI, V58, P949, DOI 10.3382/ps.0580949; Silphaduang U, 2006, BIOCHEM BIOPH RES CO, V340, P648, DOI 10.1016/j.bbrc.2005.12.054; Song GH, 2006, ENDOCRINOLOGY, V147, P3478, DOI 10.1210/en.2006-0122; Song G, 2011, BIOL REPROD, V85, P306, DOI 10.1095/biolreprod.110.089227; SU W, 1991, GENE DEV, V5, P820, DOI 10.1101/gad.5.5.820; Sundaresan NR, 2008, CELL TISSUE RES, V332, P543, DOI 10.1007/s00441-008-0599-3; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; VIGNY M, 1989, EUR J BIOCHEM, V186, P733, DOI 10.1111/j.1432-1033.1989.tb15267.x; Webster AB, 2003, POULTRY SCI, V82, P992, DOI 10.1093/ps/82.6.992; WILLIAMS JB, 1985, BRIT POULTRY SCI, V26, P25, DOI 10.1080/00071668508416783; Xiao YJ, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-56; Yuan L, 2007, J MED FOOD, V10, P657, DOI 10.1089/jmf.2006.123	86	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76784	10.1371/journal.pone.0076784	http://dx.doi.org/10.1371/journal.pone.0076784			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098561	Green Published, gold, Green Submitted			2022-12-25	WOS:000325427100084
J	McFeat, GD; Allinson, SL; McMillan, TJ				McFeat, Gillian D.; Allinson, Sarah L.; McMillan, Trevor J.			Characterisation of the p53-Mediated Cellular Responses Evoked in Primary Mouse Cells Following Exposure to Ultraviolet Radiation	PLOS ONE			English	Article							DNA-DAMAGE RESPONSES; CYCLE ARREST; PYRIMIDINE DIMERS; UVA-RADIATION; P53; INDUCTION; ACCUMULATION; INSTABILITY; ACTIVATION; LIGHT	Exposure to ultraviolet (UV) light can cause significant damage to mammalian cells and, although the spectrum of damage produced varies with the wavelength of UV, all parts of the UV spectrum are recognised as being detrimental to human health. Characterising the cellular response to different wavelengths of UV therefore remains an important aim so that risks and their moderation can be evaluated, in particular in relation to the initiation of skin cancer. The p53 tumour suppressor protein is central to the cellular response that protects the genome from damage by external agents such as UV, thus reducing the risk of tumorigenesis. In response to a variety of DNA damaging agents including UV light, wild-type p53 plays a role in mediating cell-cycle arrest, facilitating apoptosis and stimulating repair processes, all of which prevent the propagation of potentially mutagenic defects. In this study we examined the induction of p53 protein and its influence on the survival of primary mouse fibroblasts exposed to different wavelengths of UV light. UVC was found to elevate p53 protein and its sequence specific DNA binding capacity. Unexpectedly, UVA treatment failed to induce p53 protein accumulation or sequence specific DNA binding. Despite this, UVA exposure of wild-type cells induced a p53 dependent G1 cell cycle arrest followed by a wave of p53 dependent apoptosis, peaking 12 hours post-insult. Thus, it is demonstrated that the elements of the p53 cellular response evoked by exposure to UV radiation are wavelength dependent. Furthermore, the interrelationship between various endpoints is complex and not easily predictable. This has important implications not only for understanding the mode of action of p53 but also for the use of molecular endpoints in quantifying exposure to different wavelengths of UV in the context of human health protection.	[McFeat, Gillian D.; Allinson, Sarah L.; McMillan, Trevor J.] Univ Lancaster, Div Biomed & Life Sci, Fac Hlth & Med, Lancaster, England	Lancaster University	McMillan, TJ (corresponding author), Univ Lancaster, Div Biomed & Life Sci, Fac Hlth & Med, Lancaster, England.	t.mcmillan@lancaster.ac.uk	Allinson, Sarah/AAM-6064-2021	Allinson, Sarah/0000-0003-1937-5550	Eleanor Peel Trust; North West Cancer Research Fund	Eleanor Peel Trust; North West Cancer Research Fund	The work was funded by the Eleanor Peel Trust and the North West Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6; AGRAWAL RS, 1994, CYTOMETRY, V17, P237, DOI 10.1002/cyto.990170307; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Beattie PE, 2005, BRIT J DERMATOL, V152, P1001, DOI 10.1111/j.1365-2133.2005.06557.x; Burren R, 1998, INT J CANCER, V76, P201, DOI 10.1002/(SICI)1097-0215(19980413)76:2<201::AID-IJC6>3.0.CO;2-0; CAMPBELL C, 1993, CANCER RES, V53, P2697; Dahle J, 2003, CANCER RES, V63, P1464; El Ghissassi F, 2009, LANCET ONCOL, V10, P751, DOI 10.1016/S1470-2045(09)70213-X; FRITSCHE M, 1993, ONCOGENE, V8, P307; Haapajarvi T, 1997, MOL CELL BIOL, V17, P3074, DOI 10.1128/MCB.17.6.3074; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Latonen L, 2001, ONCOGENE, V20, P6784, DOI 10.1038/sj.onc.1204883; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; LU X, 1993, CELL, V75, P765, DOI 10.1016/0092-8674(93)90496-D; Marrot L, 2005, MUTAT RES-FUND MOL M, V571, P175, DOI 10.1016/j.mrfmmm.2004.07.020; Matsumura Y, 2002, FRONT BIOSCI-LANDMRK, V7, pD765, DOI 10.2741/matsumur; McMillan TJ, 2008, J PHARM PHARMACOL, V60, P969, DOI 10.1211/jpp.60.8.0004; NELSON WG, 1994, MOL CELL BIOL, V14, P1815, DOI 10.1128/MCB.14.3.1815; Novarina D, 2011, DNA REPAIR, V10, P751, DOI 10.1016/j.dnarep.2011.04.030; Reinhardt HC, 2012, TRENDS GENET, V28, P128, DOI 10.1016/j.tig.2011.12.002; Runger TM, 2012, PHOTOCH PHOTOBIO SCI, V11, P207, DOI 10.1039/c1pp05232b; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano MA, 2011, THEOR APPL CLIMATOL, V103, P95, DOI 10.1007/s00704-010-0284-9; Smith ML, 2002, MUTAGENESIS, V17, P149, DOI 10.1093/mutage/17.2.149; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tornaletti S, 1996, MOL CARCINOGEN, V17, P192, DOI 10.1002/(SICI)1098-2744(199612)17:4<192::AID-MC2>3.0.CO;2-G; TYRRELL RM, 1990, J PHOTOCH PHOTOBIO B, V4, P349, DOI 10.1016/1011-1344(90)85014-N; Vousden KH, 2002, BBA-REV CANCER, V1602, P47, DOI 10.1016/S0304-419X(02)00035-5; Waster PK, 2009, J INVEST DERMATOL, V129, P1769, DOI 10.1038/jid.2008.421	31	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75800	10.1371/journal.pone.0075800	http://dx.doi.org/10.1371/journal.pone.0075800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098727	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000325423500098
J	Pekkonen, M; Ketola, T; Laakso, JT				Pekkonen, Minna; Ketola, Tarmo; Laakso, Jouni T.			Resource Availability and Competition Shape the Evolution of Survival and Growth Ability in a Bacterial Community	PLOS ONE			English	Article							SPECIES INTERACTIONS; STABLE COEXISTENCE; BIOFILM FORMATION; TRADE-OFFS; DIVERSITY; ENVIRONMENT; MAINTENANCE; POPULATIONS; MECHANISMS; SELECTION	Resource availability is one of the main factors determining the ecological dynamics of populations or species. Fluctuations in resource availability can increase or decrease the intensity of resource competition. Resource availability and competition can also cause evolutionary changes in life-history traits. We studied how community structure and resource fluctuations affect the evolution of fitness related traits using a two-species bacterial model system. Replicated populations of Serratia marcescens (copiotroph) and Novosophingobium capsulatum (oligotroph) were reared alone or together in environments with intergenerational, pulsed resource renewal. The comparison of ancestral and evolved bacterial clones with 1 or 13 weeks history in pulsed resource environment revealed species-specific changes in life-history traits. Co-evolution with S. marcescens caused N. capsulatum clones to grow faster. The evolved S. marcescens clones had higher survival and slower growth rate then their ancestor. The survival increased in all treatments after one week, and thereafter continued to increase only in the S. marcescens monocultures that experienced large resource pulses. Though adaptive radiation is often reported in evolution studies with bacteria, clonal variation increased only in N. capsulatum growth rate. Our results suggest that S. marcescens adapted to the resource renewal cycle whereas N. capsulatum was more affected by the interspecific competition. Our results exemplify species-specific evolutionary response to both competition and environmental variation.	[Pekkonen, Minna; Laakso, Jouni T.] Univ Helsinki, Dept Biosci, Integrat Ecol Unit, Ctr Excellence Biol Interact, Helsinki, Finland; [Ketola, Tarmo; Laakso, Jouni T.] Univ Jyvaskyla, Dept Biol & Environm Sci, Ctr Excellence Biol Interact, Jyvaskyla, Finland	University of Helsinki; University of Jyvaskyla	Pekkonen, M (corresponding author), Univ Helsinki, Dept Biosci, Integrat Ecol Unit, Ctr Excellence Biol Interact, Helsinki, Finland.	minna.pekkonen@helsinki.fi	Ketola, Tarmo/AAD-2609-2019; Laakso, Jouni/I-7794-2013	Ketola, Tarmo/0000-0001-5151-7980; Laakso, Jouni/0000-0001-8245-9912	Academy of Finland [106993, 1106312, 1255572, 128888]; Ella and Georg Ehrnrooth Foundation; Alfred Kordelin Foundation; Finnish Concordia foundation for Pekkonen	Academy of Finland(Academy of Finland); Ella and Georg Ehrnrooth Foundation; Alfred Kordelin Foundation; Finnish Concordia foundation for Pekkonen	This study was supported by the Academy of Finland (http://www.aka.fi/) projects 106993, 1106312, 1255572 for Laakso, and project 128888 for Ketola; Ella and Georg Ehrnrooth Foundation (www.ellageorg.fi/), Alfred Kordelin Foundation (http://www.kordelin.fi/), and Finnish Concordia foundation (http://www.konkordia-liitto.com/) for Pekkonen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSKY Z, 1982, ECOLOGY, V63, P1242, DOI 10.2307/1938850; Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; Andersson S, 2008, FEMS MICROBIOL LETT, V283, P83, DOI 10.1111/j.1574-6968.2008.01149.x; [Anonymous], 1988, AM ANTHROPOL; ARMSTRONG RA, 1980, AM NAT, V115, P151, DOI 10.1086/283553; Battin TJ, 2007, NAT REV MICROBIOL, V5, P76, DOI 10.1038/nrmicro1556; Begon M., 1996, ECOLOGY; Chesson P, 2004, OECOLOGIA, V141, P236, DOI 10.1007/s00442-004-1551-1; Chesson P, 1997, AM NAT, V150, P519, DOI 10.1086/286080; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Collins S, 2007, GENETICS, V176, P1089, DOI 10.1534/genetics.107.072926; Collins S, 2011, P ROY SOC B-BIOL SCI, V278, P247, DOI 10.1098/rspb.2010.1173; Darwin C., 1859, ORIGIN SPECIES MEANS; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Descamps-Julien B, 2005, ECOLOGY, V86, P2815, DOI 10.1890/04-1700; Finkel SE, 2006, NAT REV MICROBIOL, V4, P113, DOI 10.1038/nrmicro1340; Finkel SE, 1999, P NATL ACAD SCI USA, V96, P4023, DOI 10.1073/pnas.96.7.4023; Foster KR, 2012, CURR BIOL, V22, P1845, DOI 10.1016/j.cub.2012.08.005; Freilich S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1597; Friman VP, 2008, P ROY SOC B-BIOL SCI, V275, P1625, DOI 10.1098/rspb.2008.0174; Gause G. F., 1934, STRUGGLE EXISTENCE; Goldberg D, 1997, J ECOL, V85, P409, DOI 10.2307/2960565; GOTTSCHAL JC, 1993, ANTON LEEUW INT J G, V63, P299, DOI 10.1007/BF00871225; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Grimont F, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P219, DOI 10.1007/0-387-30746-x_11; GRIMONT PAD, 1978, ANNU REV MICROBIOL, V32, P221, DOI 10.1146/annurev.mi.32.100178.001253; Grover J. P., 1997, RESOURCE COMPETITION; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hansen SK, 2007, NATURE, V445, P533, DOI 10.1038/nature05514; HELLING RB, 1987, GENETICS, V116, P349; Hiltunen T, 2008, ACTA OECOL, V33, P291, DOI 10.1016/j.actao.2007.12.002; Holt RD, 2008, ECOLOGY, V89, P671, DOI 10.1890/07-0348.1; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Jasmin JN, 2007, ECOL LETT, V10, P272, DOI 10.1111/j.1461-0248.2007.01021.x; Kirk KL, 2002, FRESHWATER BIOL, V47, P1089, DOI 10.1046/j.1365-2427.2002.00841.x; Krieg NR, 1984, BERGEYS MANUAL SYSTE, V1, P964; Lankau RA, 2011, ANNU REV ECOL EVOL S, V42, P335, DOI 10.1146/annurev-ecolsys-102710-145100; Lawrence D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001330; LEIFSON E, 1962, INT B BACT NOMENCL T, V12, P161, DOI 10.1099/0096266X-12-4-161; LEVINS RICHARD, 1968; Little AEF, 2008, ANNU REV MICROBIOL, V62, P375, DOI 10.1146/annurev.micro.030608.101423; LUCKINBILL LS, 1978, SCIENCE, V202, P1201, DOI 10.1126/science.202.4373.1201; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; MacLean RC, 2005, J EVOLUTION BIOL, V18, P1376, DOI 10.1111/j.1420-9101.2005.00931.x; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; Meyers LA, 2002, TRENDS ECOL EVOL, V17, P551, DOI 10.1016/S0169-5347(02)02633-2; NEWMAN EI, 1973, NATURE, V244, P310, DOI 10.1038/244310a0; Novak M, 2006, AM NAT, V168, P242, DOI 10.1086/506527; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Osmond MM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0085; Paerl HW, 1996, MICROB ECOL, V31, P225; Pekkonen M, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-18; Pekkonen M, 2011, EVOL ECOL RES, V13, P1; Poisot T, 2011, BIOL LETTERS, V7, P201, DOI 10.1098/rsbl.2010.0774; RANTA E, 2002, TILASTOTIEDETTA EKOL; Roff DA, 2007, J EVOLUTION BIOL, V20, P433, DOI 10.1111/j.1420-9101.2006.01255.x; Rozen DE, 2009, ECOL LETT, V12, P34, DOI 10.1111/j.1461-0248.2008.01257.x; Spencer CC, 2007, EVOL ECOL RES, V9, P775; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; Takeuchi M, 2001, INT J SYST EVOL MICR, V51, P1405, DOI 10.1099/00207713-51-4-1405; Tilman D., 1982, Monographs in Population Biology, pi; Treves DS, 1998, MOL BIOL EVOL, V15, P789, DOI 10.1093/oxfordjournals.molbev.a025984; Turner PE, 1996, ECOLOGY, V77, P2119, DOI 10.2307/2265706; Velicer GJ, 1999, ECOLOGY, V80, P1168, DOI 10.2307/177064; Whitlock MC, 1996, AM NAT, V148, pS65, DOI 10.1086/285902; Yang LH, 2008, ECOLOGY, V89, P621, DOI 10.1890/07-0175.1	66	29	29	4	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76471	10.1371/journal.pone.0076471	http://dx.doi.org/10.1371/journal.pone.0076471			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098791	Green Submitted, Green Published, gold			2022-12-25	WOS:000325423500162
J	Rotte, A; Bhandaru, M; Cheng, YB; Sjoestroem, C; Martinka, M; Li, G				Rotte, Anand; Bhandaru, Madhuri; Cheng, Yabin; Sjoestroem, Cecilia; Martinka, Magdalena; Li, Gang			Decreased Expression of Nuclear p300 Is Associated with Disease Progression and Worse Prognosis of Melanoma Patients	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR P300; NUCLEOTIDE EXCISION-REPAIR; HISTONE DEACETYLASE INHIBITORS; METASTATIC MELANOMA; PROTEIN-KINASE; BREAST-CANCER; PHOSPHORYLATION; ACETYLTRANSFERASE; ACETYLATION; MUTATIONS	Background: Genomic instability due to UV radiation is one of the leading causes for melanoma. Histone acetyltransferase p300 plays an indispensible role in DNA repair and maintenance of genomic integrity. The present study was performed to analyze the correlation between p300 expression, melanoma progression and patient survival. Methods: Tissue microarray and immunohistochemical analysis was employed to study the expression of p300 in melanoma patients. A total of 358 melanoma patients (250 primary melanoma and 108 metastatic melanoma) were used for the study. Kaplan-Meier, univariate and multivariate Cox regression analysis, and receiver-operating characteristic curves, were used to elucidate the prognostic significance of p300 expression. Results: Our results demonstrate that p300 is expressed in both nucleus and cytoplasm but the nuclear expression of p300 is predominant. The progression of disease from dysplastic nevi to primary melanoma and to metastatic melanoma was associated with decreased nuclear and increased cytoplasmic p300 expression. Especially, the loss of nuclear and gain in cytoplasmic p300 was correlated with the progression of melanoma from AJCC stage II to stage III, which requires the migration and metastasis of cancer cells from primary sites to lymph nodes. Similarly, decrease in nuclear, and increase in cytoplasmic p300 expression correlated with worse survival of melanoma patients. Nuclear p300 but not cytoplasmic p300 could predict the patient survival independent of AJCC stage, age and gender. Conclusion: Loss of nuclear p300 expression is an indicator of worse patient survival and is an independent prognostic marker for melanoma.	[Rotte, Anand; Bhandaru, Madhuri; Cheng, Yabin; Sjoestroem, Cecilia; Li, Gang] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada; [Martinka, Magdalena] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Rotte, A (corresponding author), Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada.	anand.rotte@ubc.ca	Cheng, Yabin/AAY-2178-2020; Rotte, Anand/H-4774-2019; Cheng, Yabin/P-7071-2015	Cheng, Yabin/0000-0002-6205-3648; Cheng, Yabin/0000-0002-6205-3648; Rotte, Anand/0000-0002-3452-7068	Canadian Institutes of Health Research [MOP-93810, MOP-110974, CCI-117958]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This project is funded by grants from the Canadian Institutes of Health Research (MOP-93810, MOP-110974 and CCI-117958). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Habib RJ, 2005, MOL CANCER THER, V4, P1303, DOI 10.1158/1535-7163.MCT-05-0145; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Bandyopadhyay D, 2002, CANCER RES, V62, P6231; Bricambert J, 2010, J CLIN INVEST, V120, P4316, DOI 10.1172/JCI41624; BYERS HR, 1991, AM J PATHOL, V139, P423; Chen GD, 2011, CANCER EPIDEM BIOMAR, V20, P2212, DOI 10.1158/1055-9965.EPI-11-0472; Chen GD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017578; Chen J, 2004, CELL MOL LIFE SCI, V61, P1675, DOI 10.1007/s00018-004-4103-9; Chen JH, 2011, EPIGENETICS-US, V6, P957, DOI 10.4161/epi.6.8.16065; Chen YJ, 2007, J BIOL CHEM, V282, P27215, DOI 10.1074/jbc.M700264200; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Elsheikh SE, 2009, CANCER RES, V69, P3802, DOI 10.1158/0008-5472.CAN-08-3907; Finn L, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-23; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Giannini G, 2012, FUTURE MED CHEM, V4, P1439, DOI [10.4155/FMC.12.80, 10.4155/fmc.12.80]; Gonzaga Evelyn R, 2009, Am J Clin Dermatol, V10 Suppl 1, P19, DOI 10.2165/0128071-200910001-00004; Huang WC, 2005, MOL CELL BIOL, V25, P6592, DOI 10.1128/MCB.25.15.6592-6602.2005; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Landreville S, 2012, CLIN CANCER RES, V18, P408, DOI 10.1158/1078-0432.CCR-11-0946; Le Gallo M, 2012, NAT GENET, V44, P1310, DOI 10.1038/ng.2455; Li Y, 2011, ANN THORAC SURG, V91, P1531, DOI 10.1016/j.athoracsur.2010.12.012; Liu Y, 2006, J BIOL CHEM, V281, P31359, DOI 10.1074/jbc.M604478200; Manuyakorn A, 2010, J CLIN ONCOL, V28, P1358, DOI 10.1200/JCO.2009.24.5639; Murakami T, 2008, J INVEST DERMATOL, V128, P1506, DOI 10.1038/sj.jid.5701216; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Pavey S, 2004, ONCOGENE, V23, P4060, DOI 10.1038/sj.onc.1207563; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Poizat C, 2005, MOL CELL BIOL, V25, P2673, DOI 10.1128/MCB.25.7.2673-2687.2005; Price BD, 2013, CELL, V152, P1344, DOI 10.1016/j.cell.2013.02.011; Reed SH, 2011, DNA REPAIR, V10, P734, DOI 10.1016/j.dnarep.2011.04.029; REMMELE W, 1987, PATHOLOGE, V8, P138; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Tillhon M, 2012, DNA REPAIR, V11, P844, DOI 10.1016/j.dnarep.2012.08.001; Wang QE, 2013, NUCLEIC ACIDS RES, V41, P1722, DOI 10.1093/nar/gks1312; Yan G, 2013, J INVEST DERMATOL; Yokomizo C, 2011, CANCER LETT, V310, P140, DOI 10.1016/j.canlet.2011.06.030; Yuan LW, 2000, J BIOL CHEM, V275, P40946, DOI 10.1074/jbc.M007832200; Zhang GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045037; Zhang ZZ, 2011, CANCER-AM CANCER SOC, V117, P2719, DOI 10.1002/cncr.25838	40	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75405	10.1371/journal.pone.0075405	http://dx.doi.org/10.1371/journal.pone.0075405			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098694	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500065
J	Schob, S; Schicht, M; Sel, S; Stiller, D; Kekule, A; Paulsen, F; Maronde, E; Brauer, L				Schob, Stefan; Schicht, Martin; Sel, Saadettin; Stiller, Dankwart; Kekule, Alexander; Paulsen, Friedrich; Maronde, Erik; Braeuer, Lars			The Detection of Surfactant Proteins A, B, C and D in the Human Brain and Their Regulation in Cerebral Infarction, Autoimmune Conditions and Infections of the CNS	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; INNATE IMMUNE-SYSTEM; PULMONARY SURFACTANT; IN-VIVO; IMMUNOLOGICAL PRIVILEGE; APOPTOTIC NEUTROPHILS; BIOPHYSICAL ACTIVITY; LUNG INFLAMMATION; CHOROID-PLEXUS; DEFICIENCY	Surfactant proteins (SP) have been studied intensively in the respiratory system. Surfactant protein A and surfactant protein D are proteins belonging to the family of collectins each playing a major role in the innate immune system. The ability of surfactant protein A and surfactant protein D to bind various pathogens and facilitate their elimination has been described in a vast number of studies. Surfactant proteins are very important in modulating the host's inflammatory response and participate in the clearance of apoptotic cells. Surfactant protein B and surfactant protein C are proteins responsible for lowering the surface tension in the lungs. The aim of this study was an investigation of expression of surfactant proteins in the central nervous system to assess their specific distribution patterns. The second aim was to quantify surfactant proteins in cerebrospinal fluid of healthy subjects compared to patients suffering from different neuropathologies. The expression of mRNA for the surfactant proteins was analyzed with RT-PCR done with samples from different parts of the human brain. The production of the surfactant proteins in the brain was verified using immunohistochemistry and Western blot. The concentrations of the surfactant proteins in cerebrospinal fluid from healthy subjects and patients suffering from neuropathologic conditions were quantified using ELISA. Our results revealed that surfactant proteins are present in the central nervous system and that the concentrations of one or more surfactant proteins in healthy subjects differed significantly from those of patients affected by central autoimmune processes, CNS infections or cerebral infarction. Based on the localization of the surfactant proteins in the brain, their different levels in normal versus pathologic samples of cerebrospinal fluid and their well-known functions in the lungs, it appears that the surfactant proteins may play roles in host defense of the brain, facilitation of cerebrospinal fluid secretion and maintenance of the latter's rheological properties.	[Schob, Stefan] Univ Halle Wittenberg, Inst Anat & Cell Biol, D-06108 Halle, Saale, Germany; [Schicht, Martin; Paulsen, Friedrich; Braeuer, Lars] Univ Erlangen Nurnberg, Inst Anat, Dept 2, D-91054 Erlangen, Germany; [Maronde, Erik] Goethe Univ Frankfurt, Inst Anat, Dept 3, D-60054 Frankfurt, Germany; [Sel, Saadettin] Heidelberg Univ, Dept Ophthalmol, Heidelberg, Germany; [Stiller, Dankwart] Univ Halle Wittenberg, Inst Forens Med, D-06108 Halle, Saale, Germany; [Kekule, Alexander] Univ Halle Wittenberg, Inst Med Microbiol, D-06108 Halle, Saale, Germany	Martin Luther University Halle Wittenberg; University of Erlangen Nuremberg; Goethe University Frankfurt; Ruprecht Karls University Heidelberg; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Schob, S (corresponding author), Univ Halle Wittenberg, Inst Anat & Cell Biol, D-06108 Halle, Saale, Germany.	schob.stefan@googlemail.com	Maronde, Erik/J-1915-2019	Maronde, Erik/0000-0002-5574-6323; Sel, Prof. Dr. med. Saadettin/0000-0003-3307-3305; Paulsen, Friedrich/0000-0002-0527-0953; schob, stefan/0000-0003-2846-5443; Schicht, Martin/0000-0001-5155-5477	German Research Foundation (DFG) [1329/12-1 BR, BR 3681/2-1]; Wilhelm Roux Program, Halle, Germany [FKZ 17/20]	German Research Foundation (DFG)(German Research Foundation (DFG)); Wilhelm Roux Program, Halle, Germany	The study was supported by the German Research Foundation (DFG, Program Grants 1329/12-1 BR and BR 3681/2-1) and the Wilhelm Roux Program, Halle, Germany (Program Grants FKZ 17/20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almlen A, 2008, J APPL PHYSIOL, V104, P1101, DOI 10.1152/japplphysiol.00865.2007; Augusto L, 2001, AM J PHYSIOL-LUNG C, V281, pL776, DOI 10.1152/ajplung.2001.281.4.L776; Brauer L, 2007, CURR EYE RES, V32, P931, DOI 10.1080/02713680701694369; Braeuer L, 2007, INVEST OPHTH VIS SCI, V48, P3945, DOI 10.1167/iovs.07-0201; Brauer L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053705; Brauer L, 2009, HISTOCHEM CELL BIOL, V132, P331, DOI 10.1007/s00418-009-0609-x; Brauer L, 2012, BIOMED TECH, V2011, P0113; Carson MJ, 2006, IMMUNOL REV, V213, P48, DOI 10.1111/j.1600-065X.2006.00441.x; Chaiworapongsa T, 2008, J MATERN-FETAL NEO M, V21, P663, DOI 10.1080/14767050802215664; Chang RCC, 2009, CELL MOL IMMUNOL, V6, P317, DOI 10.1038/cmi.2009.42; Chroneos ZC, 2009, TUBERCULOSIS, V89, pS10, DOI 10.1016/S1472-9792(09)70005-8; Chuang CY, 2009, TOXICOL LETT, V191, P132, DOI 10.1016/j.toxlet.2009.08.015; Clark H, 2002, J IMMUNOL, V169, P2892, DOI 10.4049/jimmunol.169.6.2892; CURSTEDT T, 1987, EUR J BIOCHEM, V168, P255, DOI 10.1111/j.1432-1033.1987.tb13414.x; El Kebir D, 2010, THESCIENTIFICWORLDJO, V10, P1731, DOI 10.1100/tsw.2010.169; Epaud R, 2003, AM J RESP CELL MOL, V28, P373, DOI 10.1165/rcmb.2002-0071OC; Fraser DA, 2006, J LEUKOCYTE BIOL, V80, P107, DOI 10.1189/jlb.1105683; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004; Gander R, 2002, J LIPID RES, V43, P636; Gortner L, 2004, Z Geburtshilfe Neonatol, V208, P91, DOI 10.1055/s-2004-819002; Hamvas A, 2006, SEMIN PERINATOL, V30, P316, DOI 10.1053/j.semperi.2005.11.002; Hao HN, 2001, J NEUROCHEM, V77, P1027, DOI 10.1046/j.1471-4159.2001.00305.x; Harrod KS, 1999, AM J PHYSIOL-LUNG C, V277, pL580, DOI 10.1152/ajplung.1999.277.3.L580; Ikegami M, 2005, AM J PHYSIOL-LUNG C, V289, pL962, DOI 10.1152/ajplung.00214.2005; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Jakel A, 2010, PROTEIN CELL, V1, P563, DOI 10.1007/s13238-010-0076-0; Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200; Kiefer M, 2012, DTSCH ARZTEBL INT, V109, P15, DOI 10.3238/arztebl.2012.0015; Lee EB, 2005, FEBS LETT, V579, P2564, DOI 10.1016/j.febslet.2005.03.070; LeVine AM, 2000, J IMMUNOL, V165, P3934, DOI 10.4049/jimmunol.165.7.3934; LUMB RH, 1989, AM J PHYSIOL, V257, pL190, DOI 10.1152/ajplung.1989.257.4.L190; Mayo L, 2012, IMMUNOL REV, V248, P170, DOI 10.1111/j.1600-065X.2012.01135.x; McCormack FX, 2003, J BIOL CHEM, V278, P36250, DOI 10.1074/jbc.M303086200; Motzkus D, 2006, FASEB J, V20, P1701, DOI 10.1096/fj.05-4970fje; Moya F, 2011, SEMIN FETAL NEONAT M, V16, P269, DOI 10.1016/j.siny.2011.03.006; Muldoon LL, 2013, J CEREBR BLOOD F MET, V33, P13, DOI 10.1038/jcbfm.2012.153; NOTTER RH, 1987, CHEM PHYS LIPIDS, V44, P1, DOI 10.1016/0009-3084(87)90002-8; O'Keeffe J, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1827; Ofek I, 2001, INFECT IMMUN, V69, P24, DOI 10.1128/IAI.69.1.24-33.2001; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; Parra E, 2011, BIOCHEM J, V438, P555, DOI 10.1042/BJ20110681; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Reinke E, 2006, IMMUNOL LETT, V104, P102, DOI 10.1016/j.imlet.2005.11.009; Restrepo CI, 1999, AM J RESP CELL MOL, V21, P576, DOI 10.1165/ajrcmb.21.5.3334; Schagat TL, 2001, J IMMUNOL, V166, P2727, DOI 10.4049/jimmunol.166.4.2727; Schicht M, 2013, AM J RHINOL ALLERGY, V27, P24, DOI 10.2500/ajra.2013.27.3838; Sever-Chroneos Z, 2011, J BIOL CHEM, V286, P4854, DOI 10.1074/jbc.M110.125567; Speake T, 2001, MICROSC RES TECHNIQ, V52, P49, DOI 10.1002/1097-0029(20010101)52:1<49::AID-JEMT7>3.0.CO;2-C; Stadelmann C, 2011, BBA-MOL BASIS DIS, V1812, P275, DOI 10.1016/j.bbadis.2010.07.007; Tolle A, 2002, CHEM PHYS LIPIDS, V114, P159, DOI 10.1016/S0009-3084(01)00204-3; Vandivier RW, 2002, J IMMUNOL, V169, P3978, DOI 10.4049/jimmunol.169.7.3978; Veerhuis R, 2011, MOL IMMUNOL, V48, P1592, DOI 10.1016/j.molimm.2011.04.003; Wemhoner A, 2009, METHOD FIND EXP CLIN, V31, P317, DOI [10.1358/mf.2009.31.5.1386592, 10.1358/mf.2009.31.5.1380462]; Willander H, 2012, P NATL ACAD SCI US; Williams WM, 2012, SCI WORLD J, DOI 10.1100/2012/905785; Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9; Yang L, 2010, J IMMUNOL, V184, P975, DOI 10.4049/jimmunol.0900650; Yue X, 2005, P NATL ACAD SCI USA, V102, P19198, DOI 10.1073/pnas.0505203102	59	32	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74412	10.1371/journal.pone.0074412	http://dx.doi.org/10.1371/journal.pone.0074412			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098648	gold, Green Published, Green Submitted			2022-12-25	WOS:000325423500019
J	Unno, M; Ardevol, A; Rovira, C; Ikeda-Saito, M				Unno, Masaki; Ardevol, Albert; Rovira, Carme; Ikeda-Saito, Masao			Structures of the Substrate-free and Product-bound Forms of HmuO, a Heme Oxygenase from Corynebacterium diphtheriae X-RAY CRYSTALLOGRAPHY AND MOLECULAR DYNAMICS INVESTIGATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Structure; Heme; Heme Oxygenase; Molecular Dynamics; X-ray Crystallography; Bacterial Iron Acquisition	GRAM-NEGATIVE BACTERIA; CRYSTAL-STRUCTURE; DEGRADATION; IRON; MECHANISM; COMPLEX; BINDING; ACQUISITION; PROTEINS; SYSTEM	Background: Heme oxygenase (HO) converts heme to biliverdin, carbon monoxide, and Fe2+. Results: HO crystal structures were determined for substrate-free Fe3+-biliverdin and biliverdin forms, as well as intermediates of the last two. Conclusion: HO reaction center is built with substrate-induced conformational changes, and Fe2+ is released without major structural changes. Significance: Elucidation of these HO structures is fundamental for understanding its enzyme mechanism. Heme oxygenase catalyzes the degradation of heme to biliverdin, iron, and carbon monoxide. Here, we present crystal structures of the substrate-free, Fe3+-biliverdin-bound, and biliverdin-bound forms of HmuO, a heme oxygenase from Corynebacterium diphtheriae, refined to 1.80, 1.90, and 1.85 resolution, respectively. In the substrate-free structure, the proximal and distal helices, which tightly bracket the substrate heme in the substrate-bound heme complex, move apart, and the proximal helix is partially unwound. These features are supported by the molecular dynamic simulations. The structure implies that the heme binding fixes the enzyme active site structure, including the water hydrogen bond network critical for heme degradation. The biliverdin groups assume the helical conformation and are located in the heme pocket in the crystal structures of the Fe3+-biliverdin-bound and the biliverdin-bound HmuO, prepared by in situ heme oxygenase reaction from the heme complex crystals. The proximal His serves as the Fe3+-biliverdin axial ligand in the former complex and forms a hydrogen bond through a bridging water molecule with the biliverdin pyrrole nitrogen atoms in the latter complex. In both structures, salt bridges between one of the biliverdin propionate groups and the Arg and Lys residues further stabilize biliverdin at the HmuO heme pocket. Additionally, the crystal structure of a mixture of two intermediates between the Fe3+-biliverdin and biliverdin complexes has been determined at 1.70 resolution, implying a possible route for iron exit.	[Unno, Masaki; Ikeda-Saito, Masao] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Unno, Masaki] Ibaraki Univ, Frontier Res Ctr Appl Atom Sci, Naka, Ibaraki 3191106, Japan; [Unno, Masaki] Ibaraki Univ, Grad Sch Sci & Engn, Hitachi, Ibaraki 3168511, Japan; [Unno, Masaki; Ikeda-Saito, Masao] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan; [Ardevol, Albert] Comp Simulat & Modeling Lab, Barcelona 08028, Spain; [Rovira, Carme] Univ Barcelona, Dept Quim Organ, E-08028 Barcelona, Spain; [Rovira, Carme] Univ Barcelona, Inst Quim Teor & Computac, E-08028 Barcelona, Spain; [Rovira, Carme] Inst Catalana Recerca & Estudis Avancats, Barcelona 08020, Spain	Tohoku University; Ibaraki University; Ibaraki University; RIKEN; University of Barcelona; University of Barcelona; University of Barcelona; ICREA	Ikeda-Saito, M (corresponding author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan.	mis2@tagen.tohoku.ac.jp	Ikeda-Saito, Masao/A-5992-2008; Ikeda-Saito, Masao/K-2703-2015; Rovira, Carme/K-5195-2014; Ardevol, Albert/I-4401-2012	Rovira, Carme/0000-0003-1477-5010; Ardevol, Albert/0000-0003-2614-5526	Japan Society for Promotion of Science [21350087, 2412006, 24350081, 18770080, 22770096, 24570122]; Management Expenses Grant for National Universities Corporations from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Spanish Ministry of Economy and Competitiveness [CTQ2011-25871]; Generalitat de Catalunya [2009SGR-1309]; European Molecular Biology Organization; ICREA Funding Source: Custom; Grants-in-Aid for Scientific Research [24120001, 24570122] Funding Source: KAKEN	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Management Expenses Grant for National Universities Corporations from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Spanish Ministry of Economy and Competitiveness(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); ICREA(ICREA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research 21350087, 2412006, and 24350081 (to M.I.-S.) and 18770080, 22770096, and 24570122 (to M. U.) from the Japan Society for Promotion of Science, the Management Expenses Grant for National Universities Corporations from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, Spanish Ministry of Economy and Competitiveness Grant CTQ2011-25871, and Generalitat de Catalunya Grant 2009SGR-1309.; Supported by a long term fellowship from the European Molecular Biology Organization.	Allen CE, 2009, J BACTERIOL, V191, P2638, DOI 10.1128/JB.01784-08; Anzaldi LL, 2010, INFECT IMMUN, V78, P4977, DOI 10.1128/IAI.00613-10; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barker KD, 2012, J BIOL CHEM, V287, P18342, DOI 10.1074/jbc.M112.359265; Beitlich T, 2007, J SYNCHROTRON RADIAT, V14, P11, DOI 10.1107/S0909049506049806; Bhakta MN, 2006, BIOCHEMISTRY-US, V45, P11642, DOI 10.1021/bi060980l; Bianchetti CM, 2007, J BIOL CHEM, V282, P37624, DOI 10.1074/jbc.M707396200; Boehning D, 2003, ANNU REV NEUROSCI, V26, P105, DOI 10.1146/annurev.neuro.26.041002.131047; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chu GC, 1999, J BIOL CHEM, V274, P21319, DOI 10.1074/jbc.274.30.21319; Colas C, 2003, CHEM REV, V103, P2305, DOI 10.1021/cr0204303; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Drazek ES, 2000, MOL MICROBIOL, V36, P68, DOI 10.1046/j.1365-2958.2000.01818.x; Du ZM, 2010, J INORG BIOCHEM, V104, P1063, DOI 10.1016/j.jinorgbio.2010.06.003; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Friedman J, 2004, BIOCHEMISTRY-US, V43, P5239, DOI 10.1021/bi049687g; Hirotsu S, 2004, J BIOL CHEM, V279, P11937, DOI 10.1074/jbc.M311631200; Ikeda-Saito M, 2003, ACS SYM SER, V858, P97; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Lad L, 2004, BIOCHEMISTRY-US, V43, P3793, DOI 10.1021/bi035451l; Lad L, 2003, J BIOL CHEM, V278, P7834, DOI 10.1074/jbc.M211450200; Lai WZ, 2010, J AM CHEM SOC, V132, P12960, DOI 10.1021/ja104674q; Li YM, 2003, J BIOL CHEM, V278, P6651, DOI 10.1074/jbc.M211249200; Liu Y, 2000, J BIOL CHEM, V275, P5297, DOI 10.1074/jbc.275.8.5297; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Marechal JD, 2008, EUR BIOPHYS J BIOPHY, V37, P1157, DOI 10.1007/s00249-008-0279-y; Matsui T, 2013, BIOCHEMISTRY-US, V52, P3025, DOI 10.1021/bi400382p; Matsui T, 2010, INORG CHEM, V49, P3602, DOI 10.1021/ic901869t; Matsui T, 2010, ACCOUNTS CHEM RES, V43, P240, DOI 10.1021/ar9001685; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nambu S, 2013, J BIOL CHEM, V288, P10101, DOI 10.1074/jbc.M112.448399; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paul BD, 2012, NAT REV MOL CELL BIO, V13, P499, DOI 10.1038/nrm3391; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Pereira PJB, 2001, NAT STRUCT BIOL, V8, P215, DOI 10.1038/84948; Pietrucci F, 2009, J CHEM THEORY COMPUT, V5, P2197, DOI 10.1021/ct900202f; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Ratliff M, 2001, J BACTERIOL, V183, P6394, DOI 10.1128/JB.183.21.6394-6403.2001; Reniere ML, 2010, MOL MICROBIOL, V75, P1529, DOI 10.1111/j.1365-2958.2010.07076.x; Sawai H, 2012, J BIOL CHEM, V287, P30755, DOI 10.1074/jbc.M112.370916; SCHACTER BA, 1972, J BIOL CHEM, V247, P3601; Schmitt MP, 1997, J BACTERIOL, V179, P838, DOI 10.1128/jb.179.3.838-845.1997; SCHOMAKER V, 1968, ACTA CRYSTALL B-STRU, VB 24, P63, DOI 10.1107/S0567740868001718; Schuller DJ, 1999, NAT STRUCT BIOL, V6, P860; Schuller DJ, 2001, BIOCHEMISTRY-US, V40, P11552, DOI 10.1021/bi0110239; Sheldrick W. S., 1976, J CHEM SOC PERK T, V2, P1453; Sugishima M, 2003, J BIOL CHEM, V278, P32352, DOI 10.1074/jbc.M303682200; Sugishima M, 2002, BIOCHEMISTRY-US, V41, P7293, DOI 10.1021/bi025662a; Unno M, 2004, J BIOL CHEM, V279, P21055, DOI 10.1074/jbc.M400491200; Unno M, 2007, NAT PROD REP, V24, P553, DOI 10.1039/b604180a; Unno M, 2012, J INORG BIOCHEM, V113, P102, DOI 10.1016/j.jinorgbio.2012.04.012; WAGNER UG, 1995, J MOL BIOL, V247, P326, DOI 10.1006/jmbi.1994.0142; Wang JL, 2003, J BIOL CHEM, V278, P20069, DOI 10.1074/jbc.M300989200; Wilks A, 1998, J BIOL CHEM, V273, P837, DOI 10.1074/jbc.273.2.837; Wilks A, 2002, ANTIOXID REDOX SIGN, V4, P603, DOI 10.1089/15230860260220102; Wilks A, 2007, NAT PROD REP, V24, P511, DOI 10.1039/b604193k; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200; YOSHIDA T, 1978, J BIOL CHEM, V253, P4230; Zhu WM, 2000, J BACTERIOL, V182, P6783, DOI 10.1128/JB.182.23.6783-6790.2000	63	15	15	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34443	34458		10.1074/jbc.M113.486936	http://dx.doi.org/10.1074/jbc.M113.486936			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24106279	Green Published, hybrid			2022-12-25	WOS:000329812800015
J	Brindle, NPJ; Sale, JE; Arakawa, H; Buerstedde, JM; Nuamchit, T; Sharma, S; Steele, KH				Brindle, Nicholas P. J.; Sale, Julian E.; Arakawa, Hiroshi; Buerstedde, Jean-Marie; Nuamchit, Teonchit; Sharma, Shikha; Steele, Kathryn H.			Directed Evolution of an Angiopoietin-2 Ligand Trap by Somatic Hypermutation and Cell Surface Display	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiogenesis; Cell Surface Receptor; Directed Evolution; Endothelial Cell; Ligand-binding Protein; Protein Engineering	AFFINITY MATURATION; TIE2 RECEPTOR; TUMOR-GROWTH; ANGIOGENESIS; METASTASIS; PROTEIN; INHIBITION; ANTIBODIES	Background: The ligand angiopoietin2 contributes to vascular diseases. Results: A new directed evolution method was used to create a specific angiopoietin2-binding protein from a nonspecific angiopoietin receptor. Conclusion: The receptor binding specificity can be switched with just three residue changes. Significance: The new protein has therapeutic potential, and the directed evolution method has advantages for evolving mammalian proteins. Tie2 is a receptor tyrosine kinase that is essential for the development and maintenance of blood vessels through binding the soluble ligands angiopoietin 1 (Ang1) and 2 (Ang2). Ang1 is constitutively produced by perivascular cells and is protective of the adult vasculature. Ang2 plays an important role in blood vessel formation and is normally expressed during development. However, its re-expression in disease states, including cancer and sepsis, results in destabilization of blood vessels contributing to the pathology of these conditions. Ang2 is thus an attractive therapeutic target. Here we report the directed evolution of a ligand trap for Ang2 by harnessing the B cell somatic hypermutation machinery and coupling this to selectable cell surface display of a Tie2 ectodomain. Directed evolution produced an unexpected combination of mutations resulting in loss of Ang1 binding but maintenance of Ang2 binding. A soluble form of the evolved ectodomain binds Ang2 but not Ang1. Furthermore, the soluble evolved ectodomain blocks Ang2 effects on endothelial cells without interfering with Ang1 activity. Our study has created a novel Ang2 ligand trap and provided proof of concept for combining surface display and exogenous gene diversification in B cells for evolution of a non-immunoglobulin target.	[Brindle, Nicholas P. J.; Nuamchit, Teonchit; Sharma, Shikha; Steele, Kathryn H.] Univ Leicester, Dept Cardiovasc Sci, Leicester LE1 9HN, Leics, England; [Brindle, Nicholas P. J.] Univ Leicester, Depts Biochem, Leicester LE1 9HN, Leics, England; [Sale, Julian E.] MRC, Mol Biol Lab, Div Prot & Nucle Acid Chem, Cambridge CB2 0QH, England; [Arakawa, Hiroshi] European Inst Oncol, Italian Fdn Canc Res Inst Mol Oncol, I-20139 Milan, Italy; [Buerstedde, Jean-Marie] Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA	University of Leicester; University of Leicester; MRC Laboratory Molecular Biology; IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); Yale University	Brindle, NPJ (corresponding author), Univ Leicester, Depts Biochem, Henry Wellcome Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	npjb1@le.ac.uk		Brindle, Nicholas/0000-0002-4221-677X; Sale, Julian/0000-0002-5031-3780	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/E019404/1]; Wellcome Trust [097828/z/11/z, 097828/z/11/a]; Medical Research Council [U105178808]; BBSRC [BB/E019404/1] Funding Source: UKRI; MRC [MC_U105178808] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E019404/1] Funding Source: researchfish; Medical Research Council [MC_U105178808] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by funding from Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/E019404/1 (to N. P. J. B.), Wellcome Trust Grants 097828/z/11/z and 097828/z/11/a (to N. P. J. B.), and Medical Research Council Grant U105178808 (to J. E. S.).	Arakawa H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm616; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Barton WA, 2006, NAT STRUCT MOL BIOL, V13, P524, DOI 10.1038/nsmb1101; Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12; Cumbers SJ, 2002, NAT BIOTECHNOL, V20, P1129, DOI 10.1038/nbt752; Daugherty PS, 2000, P NATL ACAD SCI USA, V97, P2029, DOI 10.1073/pnas.030527597; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Economides AN, 2003, NAT MED, V9, P47, DOI 10.1038/nm811; Holopainen T, 2012, J NATL CANCER I, V104, P461, DOI 10.1093/jnci/djs009; Huang CC, 2009, CURR OPIN BIOTECH, V20, P692, DOI 10.1016/j.copbio.2009.10.010; Huang HH, 2010, NAT REV CANCER, V10, P575, DOI 10.1038/nrc2894; Jackel C, 2008, ANNU REV BIOPHYS, V37, P153, DOI 10.1146/annurev.biophys.37.032807.125832; Koh YJ, 2010, CANCER CELL, V18, P171, DOI 10.1016/j.ccr.2010.07.001; Macdonald PR, 2006, J BIOL CHEM, V281, P28408, DOI 10.1074/jbc.M605219200; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Mazzieri R, 2011, CANCER CELL, V19, P512, DOI 10.1016/j.ccr.2011.02.005; Oliner J, 2004, CANCER CELL, V6, P507, DOI 10.1016/j.ccr.2004.09.030; Sale JE, 2001, NATURE, V412, P921, DOI 10.1038/35091100; Tabruyn SP, 2010, AM J PATHOL, V177, P3233, DOI 10.2353/ajpath.2010.100059; Tracewell CA, 2009, CURR OPIN CHEM BIOL, V13, P3, DOI 10.1016/j.cbpa.2009.01.017; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101; Watson PJ, 2012, NATURE, V481, P335, DOI 10.1038/nature10728; Welford AF, 2011, J CLIN INVEST, V121, P1969, DOI 10.1172/JCI44562; White RR, 2003, P NATL ACAD SCI USA, V100, P5028, DOI 10.1073/pnas.0831159100; Yu XH, 2013, P NATL ACAD SCI USA, V110, P7205, DOI 10.1073/pnas.1216890110; Yuan HT, 2009, MOL CELL BIOL, V29, P2011, DOI 10.1128/MCB.01472-08	27	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33205	33212		10.1074/jbc.M113.510578	http://dx.doi.org/10.1074/jbc.M113.510578			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24106271	Green Published, hybrid			2022-12-25	WOS:000328841700035
J	Wang, JS; Wang, XM; Yuan, BH; Qiang, S				Wang, Jianshu; Wang, Xuemin; Yuan, Bohua; Qiang, Sheng			Differential Gene Expression for Curvularia eragrostidis Pathogenic Incidence in Crabgrass (Digitaria sanguinalis) Revealed by cDNA-AFLP Analysis	PLOS ONE			English	Article							ABSCISIC-ACID; ALDEHYDE OXIDASE; SENSITIVITY; DROUGHT; STEP; DNA	Gene expression profiles of Digitaria sanguinalis infected by Curvularia eragrostidis strain QZ-2000 at two concentrations of conidia and two dew durations were analyzed by cDNA amplified fragment length polymorphisms (cDNA-AFLP). Inoculum strength was more determinant of gene expression than dew duration. A total of 256 primer combinations were used for selective amplification and 1214 transcript-derived fragments (TDFs) were selected for their differential expression. Of these, 518 up-regulated differentially expressed TDFs were identified. Forty-six differential cDNA fragments were chosen to be cloned and 35 of them were successfully cloned and sequenced, of which 25 were homologous to genes of known function according to the GenBank database. Only 6 genes were up-regulated in Curvularia eragrostidis-inoculated D. sanguinalis, with functions involved in signal transduction, energy metabolism, cell growth and development, stress responses, abscisic acid biosynthesis and response. It appears that a few pathways may be important parts of the pathogenic strategy of C. eragrostidis strain QZ-2000 on D. sanguinalis. Our study provides the fundamentals to further study the pathogenic mechanism, screen for optimal C. eragrostidis strains as potential mycoherbicide and apply this product to control D. sanguinalis.	[Wang, Jianshu; Qiang, Sheng] Nanjing Agr Univ, Weed Res Lab, Nanjing, Jiangsu, Peoples R China; [Wang, Jianshu; Wang, Xuemin; Yuan, Bohua] Hebei Univ Engn, Coll Agr, Handan, Peoples R China	Nanjing Agricultural University; Hebei University of Engineering	Qiang, S (corresponding author), Nanjing Agr Univ, Weed Res Lab, Nanjing, Jiangsu, Peoples R China.	wrl@njau.edu.cn	Qiang, Sheng/A-6161-2012		National 863 Hi-tech Research Program [2011AA10A206]	National 863 Hi-tech Research Program(National High Technology Research and Development Program of China)	The National 863 Hi-tech Research Program (2011AA10A206) provided financial support for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachem CWB, 1998, PLANT MOL BIOL REP, V16, P157, DOI 10.1023/A:1007468801806; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Chandramohan S, 2001, BIOL CONTROL, V22, P246, DOI 10.1006/bcon.2001.0974; Guo J, 2006, FUNGAL GENET BIOL, V43, P111, DOI 10.1016/j.fgb.2005.11.001; Holm L. G., 1977, WORLDS WORST WEEDS D; Holm LG, 1979, GEOGRAPHICAL ATLAW; Johnson DA, 1997, BIOL CONTROL, V10, P92, DOI 10.1006/bcon.1997.0555; Kim T. J, 1997, WEED SCI SOC AM ABST, V37, P112; Laurindo FRM, 2012, FREE RADICAL BIO MED, V52, P1954, DOI 10.1016/j.freeradbiomed.2012.02.037; Li XY, 2011, AFR J BIOTECHNOL, V10, P17907, DOI 10.5897/AJB10.2523; Lu D., 1995, ACTA PHYTOECCOL SIN, V1, P55; Malc E, 2009, MUTAT RES-FUND MOL M, V669, P95, DOI 10.1016/j.mrfmmm.2009.05.008; Martin A, 2009, MOL PLANT, V2, P1359, DOI 10.1093/mp/ssp076; Ondzighi CA, 2008, PLANT CELL, V20, P2205, DOI 10.1105/tpc.108.058339; Rosado A, 2006, PLANT PHYSIOL, V142, P1113, DOI 10.1104/pp.106.085191; Seo M, 2000, P NATL ACAD SCI USA, V97, P12908, DOI 10.1073/pnas.220426197; Seo PJ, 2011, PLANTA, V233, P189, DOI 10.1007/s00425-010-1293-8; Tilley AM, 2002, BIOL CONTROL, V25, P12, DOI 10.1016/S1049-9644(02)00035-X; Gonzalez CV, 2012, PLANT CELL ENVIRON, V35, P1958, DOI 10.1111/j.1365-3040.2012.02529.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Walker Robert H., 1998, Weed Technology, V12, P707; WIEDERHOLT RJ, 1995, WEED TECHNOL, V9, P518; Wiederholt RJ, 1993, P N CENTRAL WEED SCI, V48, P20; Yesbergenova Z, 2005, PLANT J, V42, P862, DOI 10.1111/j.1365-313X.2005.02422.x; Zhu Y, 2003, ACTA PHYTOPATHOLOGIC, V33, P524; Zhu YZ, 2004, BIOCONTROL SCI TECHN, V14, P769, DOI 10.1080/09583150410001720699	26	4	4	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75430	10.1371/journal.pone.0075430	http://dx.doi.org/10.1371/journal.pone.0075430			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116044	Green Submitted, Green Published, gold			2022-12-25	WOS:000325552200022
J	Chia, JH; Lai, HC; Su, LH; Kuo, AJ; Wu, TL				Chia, Ju-Hsin; Lai, Hsin-Chih; Su, Lin-Hui; Kuo, An-Jing; Wu, Tsu-Lan			Molecular Epidemiology of Clostridium difficile at a Medical Center in Taiwan: Persistence of Genetically Clustering of A(-)B(+) Isolates and Increase of A(+)B(+) Isolates	PLOS ONE			English	Article							ANTIBIOTIC-ASSOCIATED DIARRHEA; TANDEM-REPEAT ANALYSIS; TOXIN-A; BINARY TOXIN; INFECTION; DISEASE; STRAINS; DIAGNOSIS; PCR; TOXINOTYPES	Introduction: We investigated the changing trend of various toxigenic Clostridium difficile isolates at a 3 500-bed hospital in Taiwan. Genetic relatedness and antimicrobial susceptibility of toxigenic C. difficile isolates were also examined. Methods: A total of 110 non-repeat toxigenic C. difficile isolates from different patients were collected between 2002 and 2007. Characterization of the 110 toxigenic isolates was performed using agar dilution method, multilocus variable-number tandem-repeat analysis (MLVA) genotyping, tcdC genotyping, and toxinotyping. Results: Among the 110 toxigenic isolates studied, 70 isolates harbored tcdA and tcdB (A(+)B(+)) and 40 isolates harbored tcdB only (A(-)B(+)). The annual number of A(+)B(+) isolates considerably increased over the 6-year study (P = 0.055). A total of 109 different MLVA genotypes were identified, in which A(+)B(+) isolates and A(-)B(+) isolates were differentiated into two genetic clusters with similarity of 17.6%. Twenty-four (60%) of the 40 A(-)B(+) isolates formed a major cluster, MLVA-group 1, with a similarity of 85%. Seven (6.4%) resistant isolates were identified, including two metronidazole-resistant and five vancomycin-resistant isolates. Conclusions: This study indicated a persistence of a MLVA group 1 A(-)B(+) isolates and an increase of A(+)B(+) isolates with diverse MLVA types. Moreover, C. difficile isolates with antimicrobial resistance to metronidazole or vancomycin were found to have emerged. Continuous surveillance is warranted to understand the recent situation and control the further spread of the toxigenic C. difficile isolates, especially among hospitalized patients.	[Chia, Ju-Hsin; Su, Lin-Hui; Kuo, An-Jing; Wu, Tsu-Lan] Chang Gung Mem Hosp, Dept Lab Med, Tao Yuan, Taiwan; [Chia, Ju-Hsin; Lai, Hsin-Chih; Su, Lin-Hui; Kuo, An-Jing; Wu, Tsu-Lan] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Chia, Ju-Hsin] Chang Gung Univ, Grad Inst Biomed Sci, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Wu, TL (corresponding author), Chang Gung Mem Hosp, Dept Lab Med, Tao Yuan, Taiwan.	wutsulan@cgmh.org.tw		LAI, HSIN-CHIH/0000-0002-0605-5040	National Science Council, Taiwan [NSC 98-2320-B-182A-003-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the grants NSC 98-2320-B-182A-003-MY3 from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	al-Barrak A, 1999, Can Commun Dis Rep, V25, P65; Bakker D, 2010, J CLIN MICROBIOL, V48, P3744, DOI 10.1128/JCM.01171-10; Clinical and Laboratory Standards Institute, 2007, METH ANT SUSC TEST A; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Curry SR, 2007, J CLIN MICROBIOL, V45, P215, DOI 10.1128/JCM.01599-06; Elliott B, 2009, ANAEROBE, V15, P249, DOI 10.1016/j.anaerobe.2009.08.006; European Committee on Antimicrobial Susceptibility Testing, 2013, BREAKP TABL INT MICS; Fawley WN, 2008, J CLIN MICROBIOL, V46, P954, DOI 10.1128/JCM.01764-07; Geric B, 2006, J INFECT DIS, V193, P1143, DOI 10.1086/501368; Goldenberg SD, 2011, J INFECTION, V62, P355, DOI 10.1016/j.jinf.2011.03.001; Huang HH, 2009, INT J ANTIMICROB AG, V34, P516, DOI 10.1016/j.ijantimicag.2009.09.012; Kato H, 1998, J CLIN MICROBIOL, V36, P2178, DOI 10.1128/JCM.36.8.2178-2182.1998; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; KELLY CP, 1994, NEW ENGL J MED, V330, P257, DOI 10.1056/NEJM199401273300406; Kim H, 2008, J CLIN MICROBIOL, V46, P1116, DOI 10.1128/JCM.01188-07; KNOOP FC, 1993, CLIN MICROBIOL REV, V6, P251, DOI 10.1128/CMR.6.3.251-265.1993; Koh TH, 2007, PATHOLOGY, V39, P438, DOI 10.1080/00313020701444507; Komatsu M, 2003, EUR J CLIN MICROBIOL, V22, P525, DOI 10.1007/s10096-003-0992-5; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Larson AM, 2010, J CLIN MICROBIOL, V48, P124, DOI 10.1128/JCM.00734-09; Lee YC, 2011, J MICROBIOL IMMUNOL; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Pelaez T, 2002, ANTIMICROB AGENTS CH, V46, P1647, DOI 10.1128/AAC.46.6.1647-1650.2002; Persson S, 2008, CLIN MICROBIOL INFEC, V14, P1057, DOI 10.1111/j.1469-0691.2008.02092.x; Peterson LR, 2007, CLIN INFECT DIS, V45, P1152, DOI 10.1086/522185; Pituch H, 2001, CLIN MICROBIOL INFEC, V7, P442, DOI 10.1046/j.1198-743x.2001.00312.x; Pupaibool Jakrapan, 2008, Journal of the Medical Association of Thailand, V91, P37; Rupnik M, 1998, J CLIN MICROBIOL, V36, P2240, DOI 10.1128/JCM.36.8.2240-2247.1998; Rupnik M, 2003, J CLIN MICROBIOL, V41, P1118, DOI 10.1128/JCM.41.3.1118-1125.2003; Rupnik M, 2008, FEMS MICROBIOL REV, V32, P541, DOI 10.1111/j.1574-6976.2008.00110.x; Sawabe E, 2007, EUR J CLIN MICROBIOL, V26, P695, DOI 10.1007/s10096-007-0355-8; Shah D, 2010, EXPERT REV ANTI-INFE, V8, P555, DOI [10.1586/eri.10.28, 10.1586/ERI.10.28]; Shin BM, 2008, J MED MICROBIOL, V57, P697, DOI 10.1099/jmm.0.47771-0; Spigaglia P, 2002, J CLIN MICROBIOL, V40, P3470, DOI 10.1128/JCM.40.9.3470-3475.2002; Sundriyal A, 2010, PROTEIN EXPR PURIF; Terhes G, 2004, J CLIN MICROBIOL, V42, P4316, DOI 10.1128/JCM.42.9.4316-4318.2004; van den Berg RJ, 2007, J CLIN MICROBIOL, V45, P1024, DOI 10.1128/JCM.02023-06; Verdoorn BP, 2010, DIAGN MICR INFEC DIS, V66, P24, DOI 10.1016/j.diagmicrobio.2009.08.015; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Wilkins TD, 2003, J CLIN MICROBIOL, V41, P531, DOI 10.1128/JCM.41.2.531-534.2003; Wroblewski D, 2009, J CLIN MICROBIOL, V47, P2142, DOI 10.1128/JCM.02498-08	42	27	28	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75471	10.1371/journal.pone.0075471	http://dx.doi.org/10.1371/journal.pone.0075471			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116048	Green Published, gold, Green Submitted			2022-12-25	WOS:000325501300030
J	Kwekel, JC; Desai, VG; Moland, CL; Vijay, V; Fuscoe, JC				Kwekel, Joshua C.; Desai, Varsha G.; Moland, Carrie L.; Vijay, Vikrant; Fuscoe, James C.			Life Cycle Analysis of Kidney Gene Expression in Male F344 Rats	PLOS ONE			English	Article							AGE-RELATED DIFFERENCES; INCREASED SUSCEPTIBILITY; NEPHROTOXICITY; INJURY; ASSOCIATION; BIOMARKERS; INFANTS; FDA	Age is a predisposing condition for susceptibility to chronic kidney disease and progression as well as acute kidney injury that may arise due to the adverse effects of some drugs. Age-related differences in kidney biology, therefore, are a key concern in understanding drug safety and disease progression. We hypothesize that the underlying suite of genes expressed in the kidney at various life cycle stages will impact susceptibility to adverse drug reactions. Therefore, establishing changes in baseline expression data between these life stages is the first and necessary step in evaluating this hypothesis. Untreated male F344 rats were sacrificed at 2, 5, 6, 8, 15, 21, 78, and 104 weeks of age. Kidneys were collected for histology and gene expression analysis. Agilent whole-genome rat microarrays were used to query global expression profiles. An ANOVA (p<0.01) coupled with a fold-change>1.5 in relative mRNA expression, was used to identify 3,724 unique differentially expressed genes (DEGs). Principal component analyses of these DEGs revealed three major divisions in life-cycle renal gene expression. K-means cluster analysis identified several groups of genes that shared age-specific patterns of expression. Pathway analysis of these gene groups revealed age-specific gene networks and functions related to renal function and aging, including extracellular matrix turnover, immune cell response, and renal tubular injury. Large age-related changes in expression were also demonstrated for the genes that code for qualified renal injury biomarkers KIM-1, Clu, and Tff3. These results suggest specific groups of genes that may underlie age-specific susceptibilities to adverse drug reactions and disease. This analysis of the basal gene expression patterns of renal genes throughout the life cycle of the rat will improve the use of current and future renal biomarkers and inform our assessments of kidney injury and disease.	[Kwekel, Joshua C.; Desai, Varsha G.; Moland, Carrie L.; Vijay, Vikrant; Fuscoe, James C.] US FDA, Personalized Med Branch, Div Syst Biol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA	US Food & Drug Administration (FDA)	Kwekel, JC (corresponding author), US FDA, Personalized Med Branch, Div Syst Biol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.	Joshua.Kwekel@fda.hhs.gov; James.Fuscoe@fda.hhs.gov	Vijay, Vikrant/E-7651-2010	Vijay, Vikrant/0000-0001-8425-1285	U.S. Food and Drug Administration; FDA Office of Women's Health	U.S. Food and Drug Administration; FDA Office of Women's Health	This work was funded by the U.S. Food and Drug Administration. The research was supported in part by an appointment to the Research Participation Program at the National Center for Toxicological Research administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and the U. S. Food and Drug Administration. The authors thank the FDA Office of Women's Health for support of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn J, 2002, CLIN PHARMACOKINET, V41, P959, DOI 10.2165/00003088-200241120-00003; BEIERSCHMITT WP, 1986, LIFE SCI, V39, P2335, DOI 10.1016/0024-3205(86)90664-8; Chen G, 2007, AM J PHYSIOL-RENAL, V293, pF1272, DOI 10.1152/ajprenal.00138.2007; Dieterle F, 2010, NAT BIOTECHNOL, V28, P455, DOI 10.1038/nbt.1625; Espandiari P, 2010, J APPL TOXICOL, V30, P172, DOI 10.1002/jat.1484; Espandiari P, 2007, TOXICOL SCI, V99, P637, DOI 10.1093/toxsci/kfm184; Fang H, 2009, METHODS MOL BIOL, V563, P379, DOI 10.1007/978-1-60761-175-2_20; Hewitt NJ, 2007, XENOBIOTICA, V37, P1196, DOI 10.1080/00498250701534893; Kearns GL, 2003, NEW ENGL J MED, V349, P1157, DOI 10.1056/NEJMra035092; Klaassen CD, 2010, PHARMACOL REV, V62, P1, DOI 10.1124/pr.109.002014; Kwekel JC, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-14; Kwekel JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-675; LAFAYETTE RA, 1993, J AM SOC NEPHROL, V3, P1892; Mei CL, 2009, SEMIN NEPHROL, V29, P555, DOI 10.1016/j.semnephrol.2009.07.002; Melk A, 2005, KIDNEY INT, V68, P2667, DOI 10.1111/j.1523-1755.2005.00738.x; Mendrick DL, 2011, PHARMACOGENOMICS, V12, P235, DOI 10.2217/PGS.10.184; MIURA K, 1987, TOXICOL APPL PHARM, V87, P284, DOI 10.1016/0041-008X(87)90290-0; Musso CG, 2011, NEPHRON PHYSIOL, V119, P1, DOI 10.1159/000328010; Ozer JS, 2010, NAT BIOTECHNOL, V28, P486, DOI 10.1038/nbt.1627; Pannu N, 2011, AM J KIDNEY DIS, V58, P206, DOI 10.1053/j.ajkd.2011.01.028; Quinn R, 2005, NUTRITION, V21, P775, DOI 10.1016/j.nut.2005.04.002; Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427; Rule AD, 2010, ANN INTERN MED, V152, P561, DOI 10.7326/0003-4819-152-9-201005040-00006; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Surendran K, 2004, KIDNEY INT, V65, P2212, DOI 10.1111/j.1523-1755.2004.00641.x; Travis L B, 1991, Tex Med, V87, P50; van Muiswinkel FL, 2005, CNS NEUROL DISORD-DR, V4, P267, DOI 10.2174/1568007054038238; Zoetis T, 2003, BIRTH DEFECTS RES B, V68, P111, DOI 10.1002/bdrb.10013	28	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75305	10.1371/journal.pone.0075305	http://dx.doi.org/10.1371/journal.pone.0075305			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116033	Green Published, Green Submitted, gold			2022-12-25	WOS:000325501300024
J	Vinn, O				Vinn, Olev			Occurrence, Formation and Function of Organic Sheets in the Mineral Tube Structures of Serpulidae (Polychaeta, Annelida)	PLOS ONE			English	Article							ULTRASTRUCTURE	A scanning electron microscopy study of organic sheets in serpulid tube mineral structures was carried out to discern their function, formation and evolution. The organic sheets may have some taxonomic value in distinguishing the two major clades of serpulids previously identified. The organic sheets in the mineral tube structure occur only in certain taxa belonging to clade A, but not all species in clade A have them. Organic sheets are best developed in genus Spirobranchus. One could speculate that organic sheets have evolved as an adaption to further strengthen the mechanical properties of the tubes in clade A, which contains serpulids with the most advanced mineral tube microstructures. The organic sheets are presumably secreted with at least some mineral phase.	Univ Tartu, Dept Geol, EE-50090 Tartu, Estonia	University of Tartu	Vinn, O (corresponding author), Univ Tartu, Dept Geol, Ulikooli 18, EE-50090 Tartu, Estonia.	olev.vinn@ut.ee	Vinn, Olev/AAG-6806-2020	Vinn, Olev/0000-0002-2889-2544	Estonian Science Foundation [ETF9064]; Estonian Ministry of Education and Science [SF0180051s08]	Estonian Science Foundation; Estonian Ministry of Education and Science(Ministry of Education and Research, Estonia)	The author is indebted to a Sepkoski Grant (Paleontological Society), Estonian Science Foundation grant ETF9064 and the target-financed project (from the Estonian Ministry of Education and Science) SF0180051s08 for financial support. SYNTHESYS support under the European Commission's FPVI European-funded Integrated Infrastructure Initiative to the projects NL-TAF-111 and SE-TAF-113 is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDADI L, 1992, ANGEW CHEM INT EDIT, V31, P153, DOI 10.1002/anie.199201531; Chan VBS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042718; Schone BR, 2005, PALAEOGEOGR PALAEOCL, V228, P149, DOI 10.1016/j.palaeo.2005.03.054; Smith AM, 2013, MAR BIOL IN PRESS; Tanur AE, 2010, J STRUCT BIOL, V169, P145, DOI 10.1016/j.jsb.2009.09.008; Ten Hove HA, 2009, ZOOTAXA, P1; TENHOVE HA, 1993, GEOL MIJNBOUW, V72, P23; Vinn O, 2011, ROLE INTERNAL ORGANI, V2011; Vinn O, 2011, EVOLUTION DENSE OUTE, V201; Vinn O, 2008, NEUES JAHRB GEOL P-A, V248, P79, DOI 10.1127/0077-7749/2008/0248-0079; Vinn O, 2011, ZOOMORPHOLOGY, V130, P181, DOI 10.1007/s00435-011-0133-0; Vinn O, 2009, EST J EARTH SCI, V58, P286, DOI 10.3176/earth.2009.4.07; Vinn O, 2008, ZOOL J LINN SOC-LOND, V154, P633, DOI 10.1111/j.1096-3642.2008.00421.x	13	15	17	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75330	10.1371/journal.pone.0075330	http://dx.doi.org/10.1371/journal.pone.0075330			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116035	Green Submitted, gold, Green Published			2022-12-25	WOS:000325501300025
J	Werfel, J; Krause, S; Bischof, AG; Mannix, RJ; Tobin, H; Bar-Yam, Y; Bellin, RM; Ingber, DE				Werfel, Justin; Krause, Silva; Bischof, Ashley G.; Mannix, Robert J.; Tobin, Heather; Bar-Yam, Yaneer; Bellin, Robert M.; Ingber, Donald E.			How Changes in Extracellular Matrix Mechanics and Gene Expression Variability Might Combine to Drive Cancer Progression	PLOS ONE			English	Article							NONLINEAR SIMULATION; BREAST-CANCER; TUMOR-GROWTH; CELL-SHAPE; STEM-CELL; DIFFERENTIATION; APOPTOSIS; DISEASE; MODEL; MICROENVIRONMENT	Changes in extracellular matrix (ECM) structure or mechanics can actively drive cancer progression; however, the underlying mechanism remains unknown. Here we explore whether this process could be mediated by changes in cell shape that lead to increases in genetic noise, given that both factors have been independently shown to alter gene expression and induce cell fate switching. We do this using a computer simulation model that explores the impact of physical changes in the tissue microenvironment under conditions in which physical deformation of cells increases gene expression variability among genetically identical cells. The model reveals that cancerous tissue growth can be driven by physical changes in the microenvironment: when increases in cell shape variability due to growth-dependent increases in cell packing density enhance gene expression variation, heterogeneous autonomous growth and further structural disorganization can result, thereby driving cancer progression via positive feedback. The model parameters that led to this prediction are consistent with experimental measurements of mammary tissues that spontaneously undergo cancer progression in transgenic C3(1)-SV40Tag female mice, which exhibit enhanced stiffness of mammary ducts, as well as progressive increases in variability of cell-cell relations and associated cell shape changes. These results demonstrate the potential for physical changes in the tissue microenvironment (e.g., altered ECM mechanics) to induce a cancerous phenotype or accelerate cancer progression in a clonal population through local changes in cell geometry and increased phenotypic variability, even in the absence of gene mutation.	[Werfel, Justin; Ingber, Donald E.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Krause, Silva; Bischof, Ashley G.; Mannix, Robert J.; Tobin, Heather; Ingber, Donald E.] Boston Childrens Hosp, Vasc Biol Program, Boston, MA USA; [Krause, Silva; Bischof, Ashley G.; Mannix, Robert J.; Tobin, Heather; Ingber, Donald E.] Boston Childrens Hosp, Dept Surg, Boston, MA USA; [Krause, Silva; Bischof, Ashley G.; Mannix, Robert J.; Tobin, Heather; Ingber, Donald E.] Harvard Univ, Sch Med, Boston, MA USA; [Bischof, Ashley G.] Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; [Bar-Yam, Yaneer] New England Complex Syst Inst, Cambridge, MA USA; [Bellin, Robert M.] Coll Holy Cross, Dept Biol, Worcester, MA 01610 USA; [Ingber, Donald E.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; College of the Holy Cross; Harvard University	Ingber, DE (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.	don.ingber@wyss.harvard.edu	Ingber, Donald E/AAC-5894-2019		DOD Breast Cancer Innovator Award [BC074986]; DOD Breast Cancer Multi-Team Award [W81XWH-10-1-0565]; Susan G. Komen postdoctoral fellowship [KG101329]; Wyss Institute for Biologically Inspired Engineering at Harvard University	DOD Breast Cancer Innovator Award(United States Department of Defense); DOD Breast Cancer Multi-Team Award; Susan G. Komen postdoctoral fellowship(Susan G. Komen Breast Cancer Foundation); Wyss Institute for Biologically Inspired Engineering at Harvard University	This work was supported by a DOD Breast Cancer Innovator Award (BC074986 to DEI), a DOD Breast Cancer Multi-Team Award (W81XWH-10-1-0565 to DEI), a Susan G. Komen postdoctoral fellowship (KG101329 to SK), and the Wyss Institute for Biologically Inspired Engineering at Harvard University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahangar R, 2004, BIODYNAMIC MODELING; Amyot F, 2009, MICROVASC RES, V77, P87, DOI 10.1016/j.mvr.2007.11.001; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Bissell MJ, 1999, CANCER RES, V59, p1763S; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; BISSELL MJ, 1982, J THEOR BIOL, V99, P31, DOI 10.1016/0022-5193(82)90388-5; Brock A, 2009, NAT REV GENET, V10, P336, DOI 10.1038/nrg2556; Cai Y, 2009, ACTA MECH SINICA-PRC, V25, P889, DOI 10.1007/s10409-009-0301-3; Capp JP, 2005, BIOESSAYS, V27, P1277, DOI 10.1002/bies.20326; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; CRAWLEY WA, 1978, PLAST RECONSTR SURG, V62, P407, DOI 10.1097/00006534-197809000-00012; Cristini V, 2003, J MATH BIOL, V46, P191, DOI 10.1007/s00285-002-0174-6; DECOSSE JJ, 1975, J NATL CANCER I, V54, P913; DECOSSE JJ, 1973, SCIENCE, V181, P1057, DOI 10.1126/science.181.4104.1057; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Enderling H, 2007, J THEOR BIOL, V246, P245, DOI 10.1016/j.jtbi.2006.12.010; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Galle J, 2005, BIOPHYS J, V88, P62, DOI 10.1529/biophysj.104.041459; GOWING N F, 1961, J Forensic Med, V8, P116; Green JE, 2000, ONCOGENE, V19, P1020, DOI 10.1038/sj.onc.1203280; Haddow A, 1974, Adv Cancer Res, V20, P343, DOI 10.1016/S0065-230X(08)60113-X; Hoffmann M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002922; Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044; Huang Sui, 2006, Breast Dis, V26, P27; Huang S, 2012, PROG BIOPHYS MOL BIO, V110, P69, DOI 10.1016/j.pbiomolbio.2012.05.001; Ingber DE, 2002, DIFFERENTIATION, V70, P547, DOI 10.1046/j.1432-0436.2002.700908.x; INGBER DE, 1981, P NATL ACAD SCI-BIOL, V78, P3901, DOI 10.1073/pnas.78.6.3901; Ingber DE., 1985, GENE EXPRESSION NORM, P13; Ingber DE, 2008, SEMIN CANCER BIOL, V18, P356, DOI 10.1016/j.semcancer.2008.03.016; Jeon J, 2010, BIOPHYS J, V98, P37, DOI 10.1016/j.bpj.2009.10.002; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kashiwagi A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000049; KEENAN KP, 1989, CANCER RES, V49, P1528; Laforge B, 2005, PROG BIOPHYS MOL BIO, V89, P93, DOI 10.1016/j.pbiomolbio.2004.11.004; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Macklin P, 2007, J THEOR BIOL, V245, P677, DOI 10.1016/j.jtbi.2006.12.004; Maffini MV, 2005, AM J PATHOL, V167, P1405, DOI 10.1016/S0002-9440(10)61227-8; Mammoto A, 2009, CURR OPIN CELL BIOL, V21, P864, DOI 10.1016/j.ceb.2009.08.001; MAROULAKOU IG, 1994, P NATL ACAD SCI USA, V91, P11236, DOI 10.1073/pnas.91.23.11236; McCullough KD, 1998, P NATL ACAD SCI USA, V95, P15333, DOI 10.1073/pnas.95.26.15333; MINTZ B, 1975, P NATL ACAD SCI USA, V72, P3585, DOI 10.1073/pnas.72.9.3585; Moore KA, 2005, DEV DYNAM, V232, P268, DOI 10.1002/dvdy.20237; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; PIENTA KJ, 1989, CANCER RES, V49, P2525; Polte TR, 2004, AM J PHYSIOL-CELL PH, V286, pC518, DOI 10.1152/ajpcell.00280.2003; Quaranta V, 2008, SEMIN CANCER BIOL, V18, P338, DOI 10.1016/j.semcancer.2008.03.018; Sanga S, 2007, NEUROIMAGE, V37, pS120, DOI 10.1016/j.neuroimage.2007.05.043; Shirinifard A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007190; Sternlicht MD, 2000, ONCOGENE, V19, P1102, DOI 10.1038/sj.onc.1203347; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0; Venugopalan G, 2012, BREAST CANC CELLS GR; WATANABE TK, 1984, CANCER RES, V44, P5361; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; WITTELSBERGER SC, 1981, CELL, V24, P859, DOI 10.1016/0092-8674(81)90111-2; Zheng X, 2005, B MATH BIOL, V67, P211, DOI 10.1016/j.bulm.2004.08.001	57	24	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76122	10.1371/journal.pone.0076122	http://dx.doi.org/10.1371/journal.pone.0076122			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098430	Green Published, Green Submitted, gold			2022-12-25	WOS:000325483600028
J	Komaki, R; Togashi, H; Takai, Y				Komaki, Ryouhei; Togashi, Hideru; Takai, Yoshimi			Regulation of Dendritic Filopodial Interactions by ZO-1 and Implications for Dendrite Morphogenesis	PLOS ONE			English	Article							CELL-ADHESION; SELF-AVOIDANCE; ALPHA-CATENIN; NECTIN; PROTEIN; PROTOCADHERINS; IDENTIFICATION; ESTABLISHMENT; INVOLVEMENT; MECHANISMS	Neuronal dendrites dynamically protrude many fine filopodia in the early stages of neuronal development and gradually establish complex structures. The importance of the dendritic filopodia in the formation of axo-dendritic connections is established, but their role in dendrite morphogenesis remains unknown. Using time-lapse imaging of cultured rat hippocampal neurons, we revealed here that many filopodia dynamically protruded from dendrites and transiently interacted with each other to form dendritic filopodia-filopodia contacts in the early stages of neuronal development. The MAGUK family member, Zonula Occludens-1 (ZO-1), which is known to be associated with the nectin and cadherin cell adhesion systems, was concentrated at these dendritic filopodia-filopodia contact sites and also at the tips of free dendritic filopodia. Overexpression of ZO-1 increased the formation of dendritic filopodia and their interactions, and induced abnormal dendrite morphology. Conversely, knockdown of ZO-1 decreased the formation of dendritic filopodia and their interactions, and induced abnormal dendrite morphology which was different from that induced by the overexpression of ZO-1. The components of the nectin and cadherin systems were co-localized with ZO-1 at the dendritic filopodia-filopodia contact sites, but not at the tips of free dendritic filopodia. Overexpression of ZO-1 increased the accumulation of these cell adhesive components at the dendritic filopodia-filopodia contact sites and stabilized their interactions, whereas knockdown of ZO-1 reduced their accumulation at the dendritic filopodia-filopodia contact sites. These results indicate that ZO-1 regulates dendritic filopodial dynamics, which is implicated in dendrite morphogenesis cooperatively with the nectin and cadherin systems in cultured neurons.	[Komaki, Ryouhei; Togashi, Hideru; Takai, Yoshimi] Kobe Univ, Grad Sch Med, Div Mol & Cellular Biol, Dept Biochem & Mol Biol, Kobe, Hyogo 657, Japan; [Takai, Yoshimi] Kobe Univ, Grad Sch Med, Div Pathogenet Signaling, Dept Biochem & Mol Biol, Kobe, Hyogo 657, Japan; [Takai, Yoshimi] Japan Sci & Technol Agcy, CREST, Kobe, Hyogo, Japan	Kobe University; Kobe University; Japan Science & Technology Agency (JST)	Takai, Y (corresponding author), Kobe Univ, Grad Sch Med, Div Mol & Cellular Biol, Dept Biochem & Mol Biol, Kobe, Hyogo 657, Japan.	ytakai@med.kobe-u.ac.jp		Togashi, Hideru/0000-0002-3967-5940	Global COE Program "Global Center for Education and Research in Integrative Membrane Biology"; Japan Society for the Promotion of Science	Global COE Program "Global Center for Education and Research in Integrative Membrane Biology"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Global COE Program "Global Center for Education and Research in Integrative Membrane Biology" (to YT) and Grants-in-Aid for Scientific Research (S) (to YT) and (C) (to HT) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dailey ME, 1996, J NEUROSCI, V16, P2983; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Fuerst PG, 2009, NEURON, V64, P484, DOI 10.1016/j.neuron.2009.09.027; Gonzalez-Mariscal L, 2000, KIDNEY INT, V57, P2386, DOI 10.1046/j.1523-1755.2000.00098.x; GOSLIN K, 1998, CULTURING NERVE CELL; Grueber WB, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001750; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Inagaki M, 2003, J COMP NEUROL, V460, P514, DOI 10.1002/cne.10653; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; ITOH M, 1993, J CELL BIOL, V121, P491, DOI 10.1083/jcb.121.3.491; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Mizoguchi A, 2002, J CELL BIOL, V156, P555, DOI 10.1083/jcb.200103113; Ooshio T, 2010, J BIOL CHEM, V285, P5003, DOI 10.1074/jbc.M109.043760; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; Salazar MA, 2003, J BIOL CHEM, V278, P49031, DOI 10.1074/jbc.M308104200; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Stepanyants A, 2005, TRENDS NEUROSCI, V28, P387, DOI 10.1016/j.tins.2005.05.006; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Togashi H, 2006, J CELL BIOL, V174, P141, DOI 10.1083/jcb.200601089; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Yokoyama S, 2001, MOL BIOL CELL, V12, P1595, DOI 10.1091/mbc.12.6.1595; Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	34	7	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76201	10.1371/journal.pone.0076201	http://dx.doi.org/10.1371/journal.pone.0076201			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098443	Green Published, Green Submitted, gold			2022-12-25	WOS:000325434500050
J	Renganathan, K; Gu, JY; Rayborn, ME; Crabb, JS; Salomon, RG; Collier, RJ; Kapin, MA; Romano, C; Hollyfield, JG; Crabb, JW				Renganathan, Kutralanathan; Gu, Jiayin; Rayborn, Mary E.; Crabb, John S.; Salomon, Robert G.; Collier, Robert J.; Kapin, Michael A.; Romano, Carmelo; Hollyfield, Joe G.; Crabb, John W.			CEP Biomarkers as Potential Tools for Monitoring Therapeutics	PLOS ONE			English	Article							5-HT1A RECEPTOR AGONIST; TRAUMATIC BRAIN-INJURY; FACTOR-H POLYMORPHISM; FACTOR-KAPPA-B; MACULAR DEGENERATION; BRUCHS MEMBRANE; SUPEROXIDE-DISMUTASE; DONOR EYES; DAMAGE; RAT	Background: Carboxyethylpyrrole (CEP) adducts are oxidative modifications derived from docosahexaenoate-containing lipids that are elevated in ocular tissues and plasma in age-related macular degeneration (AMD) and in rodents exposed to intense light. The goal of this study was to determine whether light-induced CEP adducts and autoantibodies are modulated by pretreatment with AL-8309A under conditions that prevent photo-oxidative damage of rat retina. AL-8309A is a serotonin 5-HT1A receptor agonist. Methods: Albino rats were dark adapted prior to blue light exposure. Control rats were maintained in normal cyclic light. Rats were injected subcutaneously 3x with 10 mg/kg AL-8309A (2 days, 1 day and 0 hours) before light exposure for 6 h (3.1 mW/cm(2), lambda=450 nm). Animals were sacrificed immediately following light exposure and eyes, retinas and plasma were collected. CEP adducts and autoantibodies were quantified by Western analysis or ELISA. Results: ANOVA supported significant differences in mean amounts of CEP adducts and autoantibodies among the light + vehicle, light + drug and dark control groups from both retina and plasma. Light-induced CEP adducts in retina were reduced similar to 20% following pretreatment with AL-8309A (n = 62 rats, p = 0.006) and retinal CEP immunoreactivity was less intense by immunohistochemistry. Plasma levels of light-induced CEP adducts were reduced at least 30% (n = 15 rats, p = 0.004) by drug pretreatment. Following drug treatment, average CEP autoantibody titer in light exposed rats (n = 22) was unchanged from dark control levels, and similar to 20% (p = 0.046) lower than in vehicle-treated rats. Conclusions: Light-induced CEP adducts in rat retina and plasma were significantly decreased by pretreatment with AL-8309A. These results are consistent with and extend previous studies showing AL-8309A reduces light-induced retinal lesions in rats and support CEP biomarkers as possible tools for monitoring the efficacy of select therapeutics.	[Renganathan, Kutralanathan; Gu, Jiayin; Rayborn, Mary E.; Crabb, John S.; Hollyfield, Joe G.; Crabb, John W.] Cleveland Clin Fdn, Cole Eye Inst, Cleveland, OH 44195 USA; [Renganathan, Kutralanathan; Gu, Jiayin; Rayborn, Mary E.; Crabb, John S.; Hollyfield, Joe G.; Crabb, John W.] Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44195 USA; [Renganathan, Kutralanathan; Gu, Jiayin; Salomon, Robert G.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Collier, Robert J.; Kapin, Michael A.; Romano, Carmelo; Crabb, John W.] Novartis Inst Biomed Res, Ft Worth, TX USA; [Hollyfield, Joe G.; Crabb, John W.] Case Western Reserve Univ, Dept Ophthalmol, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Hollyfield, Joe G.; Crabb, John W.] Case Western Reserve Univ, Dept Mol Med, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Novartis; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Crabb, JW (corresponding author), Cleveland Clin Fdn, Cole Eye Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	crabbj@ccf.org		Salomon, Robert/0000-0001-9456-3557	National Institutes of Health (NIH) [GM21249, EY14239, EY14240, EY15638]; Ohio Biomedical Research Technology Transfer grant [05-29]; Research Center grant from The Foundation Fighting Blindness; Llura and Gordon Gund Foundation; Research to Prevent Blindness (RPB); Macular Vision Research Foundation award; RPB Senior Investigator Award; Steinbach Award; Alcon Research Ltd; Cleveland Clinic Foundation; NATIONAL EYE INSTITUTE [R21EY022134, R56EY014240, R01EY014239, R01EY014240, R01EY016813, R24EY015638, P30EY011373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021249] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio Biomedical Research Technology Transfer grant; Research Center grant from The Foundation Fighting Blindness; Llura and Gordon Gund Foundation; Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB)); Macular Vision Research Foundation award; RPB Senior Investigator Award; Steinbach Award; Alcon Research Ltd(Novartis); Cleveland Clinic Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by National Institutes of Health (NIH) grants GM21249, EY14239, EY14240, EY15638, Ohio Biomedical Research Technology Transfer grant 05-29, a Research Center grant from The Foundation Fighting Blindness, the Llura and Gordon Gund Foundation, an unrestricted grant from Research to Prevent Blindness (RPB), a Macular Vision Research Foundation award to JGH, an RPB Senior Investigator Award to JWC, a Steinbach Award to JWC, Alcon Research Ltd, and The Cleveland Clinic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adayev T, 2003, BBA-MOL CELL RES, V1640, P85, DOI 10.1016/S0167-4889(03)00023-5; Alessandri B, 1999, BRAIN RES, V845, P232, DOI 10.1016/S0006-8993(99)01948-4; ALVAREZ RA, 1994, INVEST OPHTH VIS SCI, V35, P402; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Bando H, 2007, EXP EYE RES, V84, P135, DOI 10.1016/j.exer.2006.09.008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bradford MM, 1976, CNS DRUGS, V72, P248, DOI 10.1016/0003-2697(76) 90527-3; Collier RJ, 2010, INVEST OPHTH VIS SCI, V52, P2118; Collier RJ, 2011, INVEST OPHTH VIS SCI, V52, P8108, DOI 10.1167/iovs.10-6418; Cosi C, 2005, BRAIN RES, V1043, P32, DOI 10.1016/j.brainres.2005.02.072; Cowen DS, 1997, MOL PHARMACOL, V52, P221, DOI 10.1124/mol.52.2.221; Crabb JW, 2012, OXID STRESS APPL BAS, P65, DOI 10.1007/978-1-61779-606-7_3; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; DELMELLE M, 1975, EXP EYE RES, V21, P369, DOI 10.1016/0014-4835(75)90047-0; Ding XY, 2009, PROG RETIN EYE RES, V28, P1, DOI 10.1016/j.preteyeres.2008.10.001; DIXON WJ, 1953, BIOMETRICS, V9, P74, DOI 10.2307/3001634; Druse MJ, 2006, BRAIN RES, V1092, P79, DOI 10.1016/j.brainres.2006.02.065; Ebrahem Q, 2006, P NATL ACAD SCI USA, V103, P13480, DOI 10.1073/pnas.0601552103; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Fulton B, 1997, CNS DRUGS, V7, P68, DOI 10.2165/00023210-199707010-00007; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Gu JY, 2009, MOL CELL PROTEOMICS, V8, P1338, DOI 10.1074/mcp.M800453-MCP200; Gu XR, 2003, J BIOL CHEM, V278, P42027, DOI 10.1074/jbc.M305460200; Gu XR, 2003, J ORG CHEM, V68, P3749, DOI 10.1021/jo026721t; Guo Z, 2003, J BIOL CHEM, V278, P23570, DOI 10.1074/jbc.M303431200; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Johnson LR, 2000, IEEE ANN HIST COMPUT, V22, P70; Justilien V, 2007, INVEST OPHTH VIS SCI, V48, P4407, DOI 10.1167/iovs.07-0432; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kline AE, 2002, NEUROSCI LETT, V333, P179, DOI 10.1016/S0304-3940(02)01101-1; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Marc RE, 2008, MOL VIS, V14, P782; Mauler F, 2005, J CEREBR BLOOD F MET, V25, P451, DOI 10.1038/sj.jcbfm.9600038; Miyagi M, 2002, MOL CELL PROTEOMICS, V1, P293, DOI 10.1074/mcp.M100034-MCP200; Nakata K, 2005, EXP EYE RES, V80, P821, DOI 10.1016/j.exer.2004.12.011; Oosterink BJ, 2003, NEUROREPORT, V14, P57, DOI 10.1097/00001756-200301200-00011; Organisciak D, 2012, PHOTOCHEM PHOTOBIOL, V88, P1396, DOI 10.1111/j.1751-1097.2012.01134.x; *R DEV TEAM, 2008, R LANG ENV STAT COMP; Ramos AJ, 2004, BRAIN RES, V1030, P201, DOI 10.1016/j.brainres.2004.10.019; Rojo AI, 2004, J NEUROSCI, V24, P7324, DOI 10.1523/JNEUROSCI.2111-04.2004; RORABACHER DB, 1991, J ANAL CHEM+, V83, P139, DOI DOI 10.1021/AC00003A730; Seddon JM, 1996, JAMA-J AM MED ASSOC, V276, P1141, DOI 10.1001/jama.276.14.1141; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; WANG N, 1992, CURR EYE RES, V11, P783, DOI 10.3109/02713689209000751; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yuan XL, 2010, MOL CELL PROTEOMICS, V9, P1031, DOI 10.1074/mcp.M900523-MCP200	56	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76325	10.1371/journal.pone.0076325	http://dx.doi.org/10.1371/journal.pone.0076325			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098476	Green Submitted, Green Published, gold			2022-12-25	WOS:000325427100059
J	Shashikala, S; Kumar, R; Thomas, NE; Sivadasan, D; James, J; Sengupta, S				Shashikala, Sasidharan; Kumar, Rohith; Thomas, Nisha E.; Sivadasan, Dhanesh; James, Jackson; Sengupta, Suparna			Fodrin in Centrosomes: Implication of a Role of Fodrin in the Transport of Gamma-Tubulin Complex in Brain	PLOS ONE			English	Article							MICROTUBULE-ORGANIZING CENTERS; INTERSTRAND CROSS-LINKS; RING COMPLEX; BETA-SPECTRIN; NONERYTHROID SPECTRIN; MEMBRANE SKELETON; AXONAL-TRANSPORT; ACTIN-BINDING; GOLGI-COMPLEX; CELL-CYCLE	Gamma-tubulin is the major protein involved in the nucleation of microtubules from centrosomes in eukaryotic cells. It is present in both cytoplasm and centrosome. However, before centrosome maturation prior to mitosis, gamma-tubulin concentration increases dramatically in the centrosome, the mechanism of which is not known. Earlier it was reported that cytoplasmic gamma-tubulin complex isolated from goat brain contains non-erythroid spectrin/fodrin. The major role of erythroid spectrin is to help in the membrane organisation and integrity. However, fodrin or non-erythroid spectrin has a distinct pattern of localisation in brain cells and evidently some special functions over its erythroid counterpart. In this study, we show that fodrin and gamma-tubulin are present together in both the cytoplasm and centrosomes in all brain cells except differentiated neurons and astrocytes. Immunoprecipitation studies in purified centrosomes from brain tissue and brain cell lines confirm that fodrin and gamma-tubulin interact with each other in centrosomes. Fodrin dissociates from centrosome just after the onset of mitosis, when the concentration of gamma-tubulin attains a maximum at centrosomes. Further it is observed that the interaction between fodrin and gamma-tubulin in the centrosome is dependent on actin as depolymerisation of microfilaments stops fodrin localization. Image analysis revealed that gamma-tubulin concentration also decreased drastically in the centrosome under this condition. This indicates towards a role of fodrin as a regulatory transporter of gamma-tubulin to the centrosomes for normal progression of mitosis.	[Shashikala, Sasidharan; Kumar, Rohith; Thomas, Nisha E.; Sengupta, Suparna] Rajiv Gandhi Ctr Biotechnol, Canc Res Programme 3, Thiruvananthapuram, Kerala, India; [Sivadasan, Dhanesh; James, Jackson] Rajiv Gandhi Ctr Biotechnol, Thiruvananthapuram, Kerala, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Sengupta, S (corresponding author), Rajiv Gandhi Ctr Biotechnol, Canc Res Programme 3, Thiruvananthapuram, Kerala, India.	sengupta_suparna@hotmail.com	S B, Dr. Dhanesh/AAZ-6786-2021	S B, Dr. Dhanesh/0000-0002-1545-1547; Sengupta, Suparna/0000-0003-3639-4630; James, Jackson/0000-0002-7038-2687	RGCB; University Grants Commission, Government of India [10-2(5)/2006(i)-E.U.II.]	RGCB; University Grants Commission, Government of India(University Grants Commission, India)	This work was supported by RGCB core funding and University Grants Commission, Government of India for fellowships to S. Shashikala (F. No. 10-2(5)/2006(i)-E.U.II.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An XL, 2005, BIOCHEMISTRY-US, V44, P10681, DOI 10.1021/bi047331z; Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; BECK KA, 1994, J CELL BIOL, V127, P707, DOI 10.1083/jcb.127.3.707; Boutros R, 2007, CANCER RES, V67, P11557, DOI 10.1158/0008-5472.CAN-07-2415; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; Choi YK, 2010, J CELL BIOL, V191, P1089, DOI 10.1083/jcb.201007030; Currle D Spencer, 2007, J Vis Exp, P152, DOI 10.3791/152; Das A, 2008, J BIOL CHEM, V283, P12643, DOI 10.1074/jbc.M800094200; De Matteis MA, 2000, J CELL SCI, V113, P2331; Doxsey S, 2001, NAT REV MOL CELL BIO, V2, P688, DOI 10.1038/35089575; Drykova D, 2003, PLANT CELL, V15, P465, DOI 10.1105/tpc.007005; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; FLANAGAN MD, 1980, J BIOL CHEM, V255, P835; GLENNEY JR, 1982, J BIOL CHEM, V257, P9781; GOODMAN SR, 1983, AM J PHYSIOL, V244, pC121, DOI 10.1152/ajpcell.1983.244.3.C121; GOODMAN SR, 1986, AM J PHYSIOL, V250, pC347, DOI 10.1152/ajpcell.1986.250.3.C347; GRATZER WB, 1975, EUR J BIOCHEM, V58, P403, DOI 10.1111/j.1432-1033.1975.tb02387.x; Gunawardane RN, 2000, J CELL BIOL, V151, P1513, DOI 10.1083/jcb.151.7.1513; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; HARRIS AS, 1990, P NATL ACAD SCI USA, V87, P3009, DOI 10.1073/pnas.87.8.3009; HERIOT K, 1985, J CELL BIOL, V100, P1167, DOI 10.1083/jcb.100.4.1167; Holleran EA, 1996, J CELL BIOL, V135, P1815, DOI 10.1083/jcb.135.6.1815; Honda S, 2004, J BIOL CHEM, V279, P10615, DOI 10.1074/jbc.M308841200; Hubert T, 2011, BIOCHEM BIOPH RES CO, V408, P248, DOI 10.1016/j.bbrc.2011.04.007; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; ISHIKAWA M, 1983, J BIOCHEM-TOKYO, V94, P1209, DOI 10.1093/oxfordjournals.jbchem.a134466; Karcher RL, 2002, TRENDS CELL BIOL, V12, P21, DOI 10.1016/S0962-8924(01)02184-5; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; Kollman JM, 2011, NAT REV MOL CELL BIO, V12, P709, DOI 10.1038/nrm3209; Korenbaum E, 2002, J CELL SCI, V115, P3543, DOI 10.1242/jcs.00003; Leask A, 1997, NEUROSCI LETT, V229, P17, DOI 10.1016/S0304-3940(97)00412-6; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Machnicka B, 2012, CELL MOL LIFE SCI, V69, P191, DOI 10.1007/s00018-011-0804-5; MARTIN SJ, 1995, J BIOL CHEM, V270, P6425, DOI 10.1074/jbc.270.12.6425; McMahon LW, 2001, BIOCHEMISTRY-US, V40, P7025, DOI 10.1021/bi002917g; MITCHISON TJ, 1986, METHOD ENZYMOL, V134, P261; Mogensen MM, 2000, J CELL SCI, V113, P3013; Moudjou M, 1996, J CELL SCI, V109, P875; Oegema K, 1999, J CELL BIOL, V144, P721, DOI 10.1083/jcb.144.4.721; Perez-Ferreiro CM, 2004, J CELL SCI, V117, P6197, DOI 10.1242/jcs.01544; RIEDERER BM, 1986, J CELL BIOL, V102, P2088, DOI 10.1083/jcb.102.6.2088; Rivero S, 2009, EMBO J, V28, P1016, DOI 10.1038/emboj.2009.47; SAMSON F, 1979, J PHARMACOL EXP THER, V208, P411; Santella L, 1998, CELL CALCIUM, V23, P123, DOI 10.1016/S0143-4160(98)90110-5; Sato K, 2004, J BIOCHEM, V136, P777, DOI 10.1093/jb/mvh187; SIMAN R, 1984, P NATL ACAD SCI-BIOL, V81, P3572, DOI 10.1073/pnas.81.11.3572; Simonovic M, 2006, J BIOL CHEM, V281, P34333, DOI 10.1074/jbc.M604613200; Sridharan D, 2003, J CELL SCI, V116, P823, DOI 10.1242/jcs.00294; Stankewich MC, 1998, P NATL ACAD SCI USA, V95, P14158, DOI 10.1073/pnas.95.24.14158; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; SUNKEL CE, 1995, EMBO J, V14, P28, DOI 10.1002/j.1460-2075.1995.tb06972.x; Takeda S, 2000, J CELL BIOL, V148, P1255, DOI 10.1083/jcb.148.6.1255; Tang Y, 2003, SCIENCE, V299, P574, DOI 10.1126/science.1075994; Teixido-Travesa N, 2010, MOL BIOL CELL, V21, P3963, DOI 10.1091/mbc.E10-05-0408; Thomas NE, 2010, J CELL BIOCHEM, V110, P1334, DOI 10.1002/jcb.22647; Thompson HM, 2004, NAT CELL BIOL, V6, P335, DOI 10.1038/ncb1112; VERTESSY BG, 1989, BIOPHYS J, V55, P255, DOI 10.1016/S0006-3495(89)82800-0; Wang KKW, 1998, ARCH BIOCHEM BIOPHYS, V356, P187, DOI 10.1006/abbi.1998.0748; Watabe H, 2008, J INVEST DERMATOL, V128, P162, DOI 10.1038/sj.jid.5701019; Wiese C, 1999, CURR OPIN STRUC BIOL, V9, P250, DOI 10.1016/S0959-440X(99)80035-9; Zhang J, 2007, MOL BIOL CELL, V18, P4037, DOI 10.1091/mbc.E07-05-0474; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	64	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76613	10.1371/journal.pone.0076613	http://dx.doi.org/10.1371/journal.pone.0076613			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098540	Green Submitted, gold, Green Published			2022-12-25	WOS:000325427100080
J	Annaratone, L; Marchio, C; Russo, R; Ciardo, L; Rondon-Lagos, SM; Goia, M; Scalzo, MS; Bolla, S; Castellano, I; di Cantogno, LV; Bussolati, G; Sapino, A				Annaratone, Laura; Marchio, Caterina; Russo, Rosalia; Ciardo, Luigi; Rondon-Lagos, Sandra Milena; Goia, Margherita; Scalzo, Maria Stella; Bolla, Stefania; Castellano, Isabella; di Cantogno, Ludovica Verdun; Bussolati, Gianni; Sapino, Anna			A Collection of Primary Tissue Cultures of Tumors from Vacuum Packed and Cooled Surgical Specimens: A Feasibility Study	PLOS ONE			English	Article							COLD ISCHEMIC TIME; IMMUNOHISTOCHEMICAL EVALUATION; PROGESTERONE-RECEPTOR; ESTROGEN-RECEPTOR; FORMALIN FIXATION; HER2 EXPRESSION; WARM ISCHEMIA; TRANSPLANTATION; PRESERVATION; VIMENTIN	Primary cultures represent an invaluable tool to set up functional experimental conditions; however, creation of tissue cultures from solid tumors is troublesome and often unproductive. Several features can affect the success rate of primary cultures, including technical issues from pre-analytical procedures employed in surgical theaters and pathology laboratories. We have recently introduced a new method of collection, transfer, and preservation of surgical specimens that requires immediate vacuum sealing of excised specimens at surgical theaters, followed by time-controlled transferring at 4 degrees C to the pathology laboratory. Here we investigate the feasibility and performance of short-term primary cell cultures derived from vacuum packed and cooled (VPAC) preserved tissues. Tissue fragments were sampled from 52 surgical specimens of tumors larger than 2 cm for which surgical and VPAC times (the latter corresponding to cold ischemia time) were recorded. Cell viability was determined by trypan blue dye-exclusion assay and hematoxylin and eosin and immunohistochemical stainings were performed to appreciate morphological and immunophenotypical features of cultured cells. Cell viability showed a range of 84-100% in 44 out of 52 (85%) VPAC preserved tissues. Length of both surgical and VPAC times affected cell viability: the critical surgical time was set around 1 hour and 30 minutes, while cells preserved a good viability when kept for about 24 hours of vacuum at 4 degrees C. Cells were maintained in culture for at least three passages. Immunocytochemistry confirmed the phenotype of distinct populations, that is, expression of cytokeratins in epithelioid cells and of vimentin in spindle cells. Our results suggest that VPAC preserved tissues may represent a reliable source for creation of primary cell cultures and that a careful monitoring of surgical and cold ischemia times fosters a good performance of primary tissue cultures.	[Annaratone, Laura; Marchio, Caterina; Russo, Rosalia; Ciardo, Luigi; Rondon-Lagos, Sandra Milena; Goia, Margherita; Scalzo, Maria Stella; Bolla, Stefania; Castellano, Isabella; Bussolati, Gianni; Sapino, Anna] Univ Turin, Dept Med Sci, Turin, Italy; [Marchio, Caterina; Scalzo, Maria Stella; Bolla, Stefania; Castellano, Isabella; di Cantogno, Ludovica Verdun; Sapino, Anna] Azienda Osped Citta Salute & Sci Torino, Dept Lab Med, Turin, Italy; [Bussolati, Gianni] Victor Babes Inst, R-76201 Bucharest, Romania	University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; Victor Babes National Institute of Pathology	Sapino, A (corresponding author), Univ Turin, Dept Med Sci, Turin, Italy.	anna.sapino@unito.it	Sapino, Anna/J-4113-2018; Castellano, Isabella/K-1888-2018; Sapino, Anna/AGY-9901-2022; Marchio, Caterina/J-9152-2016; Annaratone, Laura/J-9261-2016	Sapino, Anna/0000-0003-3542-9571; Sapino, Anna/0000-0003-3542-9571; Marchio, Caterina/0000-0003-2024-6131; Annaratone, Laura/0000-0001-5750-1445; Castellano, isabella/0000-0002-9072-1615; Rondon Lagos, Milena/0000-0002-3160-9316	Ricerca Sanitaria Finalizzata [RF-2010-2310674]; AIRC [IG 10787, MFAG 13310]; Persother [SMIS-CSRN:549/12.024]	Ricerca Sanitaria Finalizzata(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF)); AIRC(Fondazione AIRC per la ricerca sul cancro); Persother	This work was supported by Ricerca Sanitaria Finalizzata RF-2010-2310674 and AIRC Grants (IG 10787 to AS and MFAG 13310 to CM). GB is funded in part by Persother (SMIS-CSRN:549/12.024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELZER FO, 1988, TRANSPLANTATION, V45, P673, DOI 10.1097/00007890-198804000-00001; Bernat JL, 2006, AM J TRANSPLANT, V6, P281, DOI 10.1111/j.1600-6143.2005.01194.x; Berton F, 2012, J OCCUP HEALTH, V54, P74, DOI 10.1539/joh.11-0089-OA; Bussolati G, 2008, VIRCHOWS ARCH, V452, P229, DOI 10.1007/s00428-007-0529-x; Bussolati G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021043; Chung JY, 2008, J HISTOCHEM CYTOCHEM, V56, P1033, DOI 10.1369/jhc.2008.951863; Comanescu Maria, 2012, Recent Pat DNA Gene Seq, V6, P22; D'Alessandro AM, 2002, AM J TRANSPLANT, V2, P689, DOI 10.1034/j.1600-6143.2002.20718.x; DAIRKEE SH, 1985, IN VITRO CELL DEV B, V21, P321; Di Novi C, 2010, SCI TOTAL ENVIRON, V408, P3092, DOI 10.1016/j.scitotenv.2010.04.022; Halazun KJ, 2007, TRANSPL P, V39, P1329, DOI 10.1016/j.transproceed.2007.02.061; Hicks David G., 2011, Journal of the National Cancer Institute Monographs, P43, DOI 10.1093/jncimonographs/lgr003; Kristensen T, 2011, APPL IMMUNOHISTO M M, V19, P460, DOI 10.1097/PAI.0b013e318214e523; Lin DW, 2006, J CLIN ONCOL, V24, P3763, DOI 10.1200/JCO.2005.05.1458; Medeiros F, 2007, ARCH PATHOL LAB MED, V131, P1805; Mukherjee S, 2011, DRUGS DIS PROCEDURES; Neumeister VM, 2012, JNCI-J NATL CANCER I, V104, P1815, DOI 10.1093/jnci/djs438; Pekmezci M, 2012, PATHOLOG RES INT; Piazza O, 2013, TRENDS ANAESTH CRIT, V3, P72, DOI 10.1016/j.tacc.2013.01.002; PIEPER FR, 1992, EUR J BIOCHEM, V210, P509, DOI 10.1111/j.1432-1033.1992.tb17449.x; Portier BP, 2013, MODERN PATHOL, V26, P1, DOI 10.1038/modpathol.2012.123; Speirs V, 2004, CULTURE TUMOR CELLS, P205; Thepot A, 2011, J SKIN CANCER, V2011, DOI 10.1155/2011/936546; Wang CS, 2000, CANCER GENET CYTOGEN, V120, P58, DOI 10.1016/S0165-4608(99)00253-8; Yildiz-Aktas IZ, 2012, MODERN PATHOL, V25, P1098, DOI 10.1038/modpathol.2012.59; Yildiz-Aktas IZ, 2012, AM J CLIN PATHOL, V137, P691, DOI 10.1309/AJCPQRAG67GJRPMT	26	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75193	10.1371/journal.pone.0075193	http://dx.doi.org/10.1371/journal.pone.0075193			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098684	Green Published, gold			2022-12-25	WOS:000325423500055
J	Luo, ZR; Zhuang, XJ; Kumar, D; Wu, XR; Yue, C; Han, CK; Lv, JC				Luo, Zhuren; Zhuang, Xiongjie; Kumar, Dushyant; Wu, Xiurong; Yue, Cen; Han, Chengkun; Lv, Jiancheng			The Correlation of Hippocampal T-2-Mapping with Neuropsychology Test in Patients with Alzheimer's Disease	PLOS ONE			English	Article							TRANSVERSE RELAXATION RATES; NEUROFIBRILLARY TANGLES; REGIONAL-DISTRIBUTION; T-2 RELAXATION; SENILE PLAQUES; BRAIN-REGIONS; IRON; MYELIN; PROLONGATION; PARKINSONS	Objectives: 1) To deduce T-2, the inverse of the transverse relaxation rate (R-2), in the hippocampus of healthy adults; 2) to investigate the brain iron deposition in Alzheimer's disease (AD) patients and age-matched healthy controls using T-2-values. Methods: T-2-weighted data from the bilateral-hippocampi of ten AD patients and sixty healthy controls were collected at six echo time points using multi-slice multi-echo turbo spin echo (MSME-TSE) imaging on a 3.0 T MR-scanner, followed by the neuropsychological testing. The correlations between T-2-values and Mini-Mental State Examination (MMSE) scores were investigated on group-wise basis (covariates in the group-wise analyses: gender, age, side and healthy/AD). Results: There were no significant differences in hippocampal T-2-values on intra-gender and inter-gender basis (P > 0.05). Hippocampal T-2-values of both sides were similar (right: 85.2 +/- 2.4 milliseconds; left: 85.3 +/- 2.5 milliseconds). The bilateral hippocampal T-2 values correlated moderately with age (right: r = -0.59; left: -0.58; P < 0.001). The AD-group had significantly lower T-2-values in the hippocampus when compared to normal controls (P < 0.001) and such low T-2-values had a strong positive correlation with the MMSE score (R2 = 0.97; P < 0.05). Conclusion: Patients with AD showed significantly lower T-2 values, which can be attributed to the increased iron depositions in the hippocampus. A positive correlation between T-2-values and cognition scores suggests that quantitative T-2 can be used in the early diagnosis of AD and in the monitoring of the treatment response.	[Luo, Zhuren; Zhuang, Xiongjie; Wu, Xiurong; Han, Chengkun; Lv, Jiancheng] Xiamen Univ, Dept Radiol, Affiliated Hosp 1, Xiamen, Peoples R China; [Kumar, Dushyant] Univ Med Ctr Hamburg Eppendorf UKE, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany; [Kumar, Dushyant] Univ Med Ctr Hamburg Eppendorf UKE, Multiple Sclerosis Imaging Sect, Hamburg, Germany; [Yue, Cen] Xiamen Univ, Dept Neurol, Affiliated Hosp 1, Xiamen, Peoples R China	Xiamen University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Xiamen University	Zhuang, XJ (corresponding author), Xiamen Univ, Dept Radiol, Affiliated Hosp 1, Xiamen, Peoples R China.	xiongjiezhuang@gmail.com			Youth Foundation of Health Department of Fujian Province of China [2012-2-75]	Youth Foundation of Health Department of Fujian Province of China	This work was financially supported by the Youth Foundation of Health Department of Fujian Province of China (No. 2012-2-75) (http://www.fjphb.gov.cn/show.aspx?ctlgid=448882&id=77384). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Bartzokis G, 2003, ARCH NEUROL-CHICAGO, V60, P393, DOI 10.1001/archneur.60.3.393; BESSON JAO, 1992, BRIT J PSYCHIAT, V160, P187, DOI 10.1192/bjp.160.2.187; BRAAK H, 1993, EUR NEUROL, V33, P403, DOI 10.1159/000116984; BREGER RK, 1989, RADIOLOGY, V171, P273, DOI 10.1148/radiology.171.1.2928538; Brittenham GM, 2003, BLOOD, V101, P15, DOI 10.1182/blood-2002-06-1723; BROWNSTEIN KR, 1977, J MAGN RESON, V26, P17, DOI 10.1016/0022-2364(77)90230-X; Campeau NG, 1997, RADIOLOGY, V205, P197, DOI 10.1148/radiology.205.1.9314985; Cherubini A, 2009, NEUROIMAGE, V48, P29, DOI 10.1016/j.neuroimage.2009.06.035; Collingwood JF, 2005, J ALZHEIMERS DIS, V7, P267; CONNOR JR, 1992, J NEUROSCI RES, V31, P327, DOI 10.1002/jnr.490310214; Cornett CR, 1998, NEUROTOXICOLOGY, V19, P339; DEDMAN DJ, 1992, BIOCHEM J, V287, P509, DOI 10.1042/bj2870509; Deibel MA, 1996, J NEUROL SCI, V143, P137, DOI 10.1016/S0022-510X(96)00203-1; Doraiswamy PM, 2004, LANCET NEUROL, V3, P431, DOI 10.1016/S1474-4422(04)00809-9; EHMANN WD, 1986, NEUROTOXICOLOGY, V7, P197; ENGLUND E, 1988, BRAIN, V111, P1425, DOI 10.1093/brain/111.6.1425; Englund E, 1987, Alzheimer Dis Assoc Disord, V1, P156; Gelman N, 1999, RADIOLOGY, V210, P759, DOI 10.1148/radiology.210.3.r99fe41759; GIANNAKOPOULOS P, 1995, ARCH NEUROL-CHICAGO, V52, P1150, DOI 10.1001/archneur.1995.00540360028012; Haley AP, 2004, NEUROSCI LETT, V362, P167, DOI 10.1016/j.neulet.2004.01.031; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; Hasan KM, 2012, MAGN RESON MED, V67, P731, DOI 10.1002/mrm.23054; Honda K, 2004, ANN NY ACAD SCI, V1012, P179, DOI 10.1196/annals.1306.015; House MJ, 2007, MAGN RESON MED, V57, P172, DOI 10.1002/mrm.21118; House MJ, 2006, AM J NEURORADIOL, V27, P430; HUESGEN CT, 1993, NEUROLOGY, V43, P145, DOI 10.1212/WNL.43.1_Part_1.145; KIRSCH SJ, 1992, NEUROSCI LETT, V134, P187, DOI 10.1016/0304-3940(92)90513-7; Kolind SH, 2009, MAGN RESON MED, V62, P106, DOI 10.1002/mrm.21966; Laakso MP, 1996, NEUROBIOL AGING, V17, P535, DOI 10.1016/0197-4580(96)00036-X; LeVine SM, 1997, BRAIN RES, V760, P298, DOI 10.1016/S0006-8993(97)00470-8; Liu G, 2005, BBA-MOL BASIS DIS, V1741, P246, DOI 10.1016/j.bbadis.2005.06.006; LOEFFLER DA, 1995, J NEUROCHEM, V65, P710; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Novellino F, 2013, MOVEMENT DISORD, V28, P196, DOI 10.1002/mds.25263; PEARSON RCA, 1985, P NATL ACAD SCI USA, V82, P4531, DOI 10.1073/pnas.82.13.4531; Peran P, 2010, BRAIN, V133, P3423, DOI 10.1093/brain/awq212; Pitkanen A, 1996, NEUROLOGY, V46, P1724, DOI 10.1212/WNL.46.6.1724; REINIKAINEN KJ, 1989, NEUROSCI LETT, V106, P229, DOI 10.1016/0304-3940(89)90230-9; Roher AE, 2002, BIOCHEMISTRY-US, V41, P11080, DOI 10.1021/bi026173d; Sayre LM, 2000, J NEUROCHEM, V74, P270, DOI 10.1046/j.1471-4159.2000.0740270.x; Schenck John F, 2006, Top Magn Reson Imaging, V17, P41, DOI 10.1097/01.rmr.0000245455.59912.40; Sjobeck M, 2003, NEUROPATH APPL NEURO, V29, P159, DOI 10.1046/j.1365-2990.2003.00456.x; Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866; THOMAS LO, 1993, AM J NEURORADIOL, V14, P1043; THOMPSON CM, 1988, NEUROTOXICOLOGY, V9, P1; [王东 Wang Dong], 2010, [中华神经科杂志, Chinese Journal of Neurology], V43, P626; Wang HL, 2004, NEUROSCI LETT, V363, P150, DOI 10.1016/j.neulet.2004.03.061; Zheng HL, 2005, BIOORGAN MED CHEM, V13, P773, DOI 10.1016/j.bmc.2004.10.037	49	26	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76203	10.1371/journal.pone.0076203	http://dx.doi.org/10.1371/journal.pone.0076203			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098779	gold, Green Published, Green Submitted			2022-12-25	WOS:000325423500149
J	Paul, CD; Kiss, C; Traore, DAK; Gong, L; Wilce, MCJ; Devenish, RJ; Bradbury, A; Prescott, M				Paul, Craig Don; Kiss, Csaba; Traore, Daouda A. K.; Gong, Lan; Wilce, Matthew C. J.; Devenish, Rodney J.; Bradbury, Andrew; Prescott, Mark			Phanta: A Non-Fluorescent Photochromic Acceptor for pcFRET	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; SEQUENCE SPACE; FRET; GFP; EVOLUTION; NANOSCOPY; DRONPA; CELLS	We have developed an orange non-fluorescent photochromic protein (quantum yield, 0.003) we call Phanta that is useful as an acceptor in pcFRET applications. Phanta can be repeatedly inter-converted between the two absorbing states by alternate exposure to cyan and violet light. The absorption spectra of Phanta in one absorbing state shows excellent overlap with the emission spectra of a number of donor green fluorescent proteins including the commonly used EGFP. We show that the Phanta-EGFP FRET pair is suitable for monitoring the activation of caspase 3 in live cells using readily available instrumentation and a simple protocol that requires the acquisition of two donor emission images corresponding to Phanta in each of its photoswitched states. This the first report of a genetically encoded non-fluorescent acceptor for pcFRET.	[Paul, Craig Don; Wilce, Matthew C. J.; Devenish, Rodney J.; Prescott, Mark] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Kiss, Csaba; Traore, Daouda A. K.; Gong, Lan; Bradbury, Andrew] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA	Monash University; United States Department of Energy (DOE); Los Alamos National Laboratory	Prescott, M (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton Campus, Melbourne, Vic 3004, Australia.	Mark.Prescott@monash.edu	Gong, Lan/J-6368-2016; Traore, Daouda/B-5242-2013; Gong, Lan/O-7886-2019	Gong, Lan/0000-0003-3136-1565; Traore, Daouda/0000-0003-1001-4716; Gong, Lan/0000-0003-3136-1565; Bradbury, Andrew/0000-0002-5567-8172				Adam V, 2011, CHEM BIOL, V18, P1241, DOI 10.1016/j.chembiol.2011.08.007; Adam V, 2008, P NATL ACAD SCI USA, V105, P18343, DOI 10.1073/pnas.0805949105; Ai HW, 2008, NAT METHODS, V5, P401, DOI [10.1038/nmeth.1207, 10.1038/NMETH.1207]; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Andresen M, 2008, NAT BIOTECHNOL, V26, P1035, DOI 10.1038/nbt.1493; Andresen M, 2007, P NATL ACAD SCI USA, V104, P13005, DOI 10.1073/pnas.0700629104; Bornberg-Bauer E, 1999, P NATL ACAD SCI USA, V96, P10689, DOI 10.1073/pnas.96.19.10689; Brakemann T, 2011, NAT BIOTECHNOL, V29, P942, DOI 10.1038/nbt.1952; Cho S., 2013, SCI REP, V3; Chudakov DM, 2003, NAT BIOTECHNOL, V21, P191, DOI 10.1038/nbt778; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Ganesan S, 2006, P NATL ACAD SCI USA, V103, P4089, DOI 10.1073/pnas.0509922103; Henderson JN, 2007, P NATL ACAD SCI USA, V104, P6672, DOI 10.1073/pnas.0700059104; Higgins GC, 2009, CELL MOL LIFE SCI, V66, P2773, DOI 10.1007/s00018-009-0079-2; Hou BH, 2011, NAT PROTOC, V6, P1818, DOI 10.1038/nprot.2011.392; Kiss C, 2009, PROTEIN ENG DES SEL, V22, P313, DOI 10.1093/protein/gzp006; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Lukyanov KA, 2005, NAT REV MOL CELL BIO, V6, P885, DOI 10.1038/nrm1741; Murakoshi H, 2008, BRAIN CELL BIOL, V36, P31, DOI 10.1007/s11068-008-9024-9; Paul CD, 2011, ACTA CRYSTALLOGR F, V67, P1266, DOI 10.1107/S1744309111028156; Pettikiriarachchi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041028; Prescott M, 2003, STRUCTURE, V11, P275, DOI 10.1016/S0969-2126(03)00028-5; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Stiel AC, 2008, BIOPHYS J, V95, P2989, DOI 10.1529/biophysj.108.130146; Subach FV, 2010, CHEM BIOL, V17, P745, DOI 10.1016/j.chembiol.2010.05.022; Wilmann PG, 2006, J MOL BIOL, V364, P213, DOI 10.1016/j.jmb.2006.08.089; Zapata-Hommer O, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-5	30	12	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75835	10.1371/journal.pone.0075835	http://dx.doi.org/10.1371/journal.pone.0075835			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098733	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000325423500104
J	Wang, L; Liao, WB; Chen, CQ; Fan, Q				Wang, Lei; Liao, Wenbo; Chen, Chunquan; Fan, Qiang			The Seed Plant Flora of the Mount Jinggangshan Region, Southeastern China	PLOS ONE			English	Article								The Mount Jinggangshan region is located between Jiangxi and Hunan provinces in southeastern China in the central section of the Luoxiao Mountains. A detailed investigation of Mount Jinggangshan region shows that the seed plant flora comprises 2,958 species in 1,003 genera and 210 families (Engler's system adjusted according to Zhengyi Wu's concept). Among them, 23 species of gymnospermae belong to 17 genera and 9 families, and 2,935 species of angiosperms are in 986 genera and 201 families. Moreover, they can also be sorted into woody plants (350 genera and 1,295 species) and herbaceous plants (653 genera and 1,663 species). The dominant families are mainly Fagaceae, Lauraceae, Theaceae, Hamamelidaceae, Magnoliaceae, Ericaceae, Styracaceae, Aquifoliaceae, Elaeocarpaceae, Aceraceae, Rosaceae, Corylaceae, Daphniphyllaceae, Symplocaceae, Euphorbiaceae, Pinaceae, Taxodiaceae, Cupressaceae and Taxaceae. Ancient and relic taxa include Ginkgo biloba, Fokienia hodginsii, Amentotaxus argotaenia, Disanthus cercidifolia subsp. longipes, Hamamelis mollis, Manglietia fordiana, Magnolia officinalis, Tsoongiodendron odorum, Fortunearia sinensis, Cyclocarya paliurus, Eucommia ulmoides, Sargentodoxa cuneata, Bretschneidera sinensis, Camptotheca acuminata, Tapiscia sinensis, etc. The flora of Mount Jinggangshan region includes 79 cosmopolitan genera and 924 non-cosmopolitan genera, which are 7.88% and 92.12% of all genera. The latter includes 452 tropical genera (48.92%) and 472 temperate genera (51.08%). The temperate elements include 44 genera endemic to China, accounting for 4.76% of all genera. Among 1,003 genera, 465 have only a single species and 401 are oligotypic genera (with 2-5 species). These genera account for 86.34% of all genera. The floristic analysis indicates that the flora of Mount Jinggangshan region is closely related to the flora of Mount Wuyishan region in southeastern China. The flora of Mount Jinggangshan region also contains many elements of central and southern China. Mount Jinggangshan region is an important north-south floristic passageway and is also a boundary between the floras of eastern, central and south China.	[Wang, Lei] Capital Normal Univ, Coll Resource Environm & Tourism, Beijing, Peoples R China; [Liao, Wenbo; Fan, Qiang] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Liao, Wenbo; Fan, Qiang] Sun Yat Sen Univ, Sch Life Sci, Guangdong Key Lab Plant Resources, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Chunquan] Jinggangshan Adm Jiangxi Prov, Jinggangshan, Jiangxi, Peoples R China	Capital Normal University; Sun Yat Sen University; Sun Yat Sen University; Jinggangshan University	Liao, WB (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	lsslwb@mail.sysu.edu.cn			integrated scientific survey of the biodiversity of Jinggang Shan, Jiangxi Province, China; National Natural Science Foundation of China [31170202, 31061160184]; Doctor Station foundation project of the Ministry of Education [20110171110032]	integrated scientific survey of the biodiversity of Jinggang Shan, Jiangxi Province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctor Station foundation project of the Ministry of Education	This project was partially funded by the integrated scientific survey of the biodiversity of Jinggang Shan, Jiangxi Province, China, and by the National Natural Science Foundation of China (31170202, 31061160184) and Doctor Station foundation project of the Ministry of Education (20110171110032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang HT, 1994, ACTA SCI NATURALIUM, V33, P1; China Vegetation Editorial Committee, 1980, VEGETATION CHINA, P1; He JY, 1994, WUYISHAN RES SERIES, P222; He LZ, 2010, SCI SURVEY STUDY BIO, P60; Hou BQ, 1993, COMPREHENSIVE INVEST, P1; Hsieh Chang-Fu, 2002, Taiwania, V47, P298; Huang XF, 2008, JIANGXI NANFENGMIAN, P1; Li H, 2000, FLORA GAOLIGONG MOUN, P1; Li Xi-Wen, 1996, Acta Botanica Yunnanica, V18, P363; Li ZY, 2007, PLANTS MOUNT EMEI, P225; Liao WB, 2013, COMPREHENSI IN PRESS, P1; Lin Y, 1993, FLORA JIANGXI, V1, P1; Lin Y, 2004, FLORA JIANGXI, V2, P1; Lin Y. J., 1990, Special Publication - Taichung District Agricultural Improvement Station, P1; Ling LK, 1981, J WUYI SCI, V12, P17; Liu RL, 2010, LIST JIANGXI SEED PL, P1; Liu RL, 1995, J WUHAN BOT RES, V13, P210; Liu X., 2010, COLLECTION SCI EXPLO, P1; Liu XZ, 2010, SCI SURVEY STUDY BIO, P539; Liu XZ, 2001, SCI SURVEY WUYISHAN, P1; Mabberley DJ, 2008, PORTABLE DICT PLANTS, P1; Manchester SR, 1999, ANN MO BOT GARD, V86, P472, DOI 10.2307/2666183; Ren Y, 2006, BIODIVERS CONSERV, P157; Tahktajan AL, 1978, REGIONALIZATION FLOR, P1; TIFFNEY BH, 1986, ANN MO BOT GARD, V73, P394, DOI 10.2307/2399119; Wang WC, 1995, KEYS VASCULAR PLANTS, P1; Wu DL, 1994, CHECKLIST FLOWERING, P1; Wu Z., 2003, FLORA CHINA, P1; Wu Z. Y., 1993, ACTA BOT YUNNANICA A, VIV, P141; Wu Z. Y., 1996, FLORISTIC CHARACTERI, P1; Wu Z.-Y., 2006, AREAL TYPES SEED PLA, P1; Wu Zheng-Yi, 2003, Acta Botanica Yunnanica, V25, P245; Wu ZY, 1995, FLORA CHINA, V1-25; Wu ZY, 2011, FLORISTICS SEED PLAN, P74; WU ZY, 1991, ACTA BOT YUNNAN S, V4, P1; Xiang QP, 2001, GUIHAIA, V21, P113, DOI DOI 10.3969/J.ISSN.1000-3142.2001.02.007; Xing FW, 2011, INVENTORY PLANT SPEC, P1; Zhang MZ, 1993, SPECIES CHECKLIST 5, P1; Zhang Zhiyun, 1995, ACTA PHYTOTAX SINICA, V33, P313; Zhu H., 2012, NATIVE SEED PLANTS X, P1; Zhu Z.C, 1999, STRUCTURAL GEOLOGY, P1; 吴征镒, 2003, [云南植物研究, Acta Botanica Yunnanica], V25, P535	42	4	7	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75834	10.1371/journal.pone.0075834	http://dx.doi.org/10.1371/journal.pone.0075834			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098732	gold, Green Published			2022-12-25	WOS:000325423500103
J	Wang, P; McInnes, C; Zhu, BT				Wang, Pan; McInnes, Campbell; Zhu, Bao Ting			Structural Characterization of the Binding Interactions of Various Endogenous Estrogen Metabolites with Human Estrogen Receptor alpha and beta Subtypes: A Molecular Modeling Study	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; BREAST-CANCER; ANTAGONISM; PREVENTION; DOMAIN	In the present study, we used the molecular docking approach to study the binding interactions of various derivatives of 17 beta-estradiol (E-2) with human estrogen receptor (ER) alpha and beta. First, we determined the suitability of the molecular docking method to correctly predict the binding modes and interactions of two representative agonists (E-2 and diethylstilbesterol) in the ligand binding domain (LBD) of human ER alpha. We showed that the docked structures of E-2 and diethylstilbesterol in the ER alpha LBD were almost exactly the same as the known crystal structures of ER alpha in complex with these two estrogens. Using the same docking approach, we then characterized the binding interactions of 27 structurally similar E-2 derivatives with the LBDs of human ER alpha and ER beta. While the binding modes of these E-2 derivatives are very similar to that of E-2, there are distinct subtle differences, and these small differences contribute importantly to their differential binding affinities for ERs. In the case of A-ring estrogen derivatives, there is a strong inverse relationship between the length of the hydrogen bonds formed with ERs and their binding affinity. We found that a better correlation between the computed binding energy values and the experimentally determined logRBA values could be achieved for various A-ring derivatives by re-adjusting the relative weights of the van der Waals interaction energy and the Coulomb interaction energy in computing the overall binding energy values.	[Wang, Pan] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China; [McInnes, Campbell] Univ S Carolina, South Carolina Coll Pharm, Dept Drug Discovery & Biomed Sci, Columbia, SC 29208 USA; [Zhu, Bao Ting] Univ Kansas, Med Ctr, Sch Med, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA; [Zhu, Bao Ting] South Univ Sci & Technol China, Dept Biol, Shenzhen, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Kansas; University of Kansas Medical Center; Southern University of Science & Technology	Zhu, BT (corresponding author), Univ Kansas, Med Ctr, Sch Med, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.	BTZhu@kumc.edu	McInnes, Campbell/A-6721-2009		National Institutes of Health [RO1CA97109]; Department of Defense Breast Cancer Research Program [W81XWH-09-1-0035]; NATIONAL CANCER INSTITUTE [R01CA097109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the National Institutes of Health (Grant No. RO1CA97109) and an award from the Department of Defense Breast Cancer Research Program (W81XWH-09-1-0035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaci Ayhan, 2009, Pediatr Endocrinol Rev, V6, P464; BARNEA ER, 1983, STEROIDS, V41, P643, DOI 10.1016/0039-128X(83)90030-2; Brody JG, 2007, CANCER-AM CANCER SOC, V109, P2667, DOI 10.1002/cncr.22655; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Enyedy IJ, 2008, J COMPUT AID MOL DES, V22, P161, DOI 10.1007/s10822-007-9165-4; FALCK F, 1992, ARCH ENVIRON HEALTH, V47, P143; HENDERSON BE, 1991, SCIENCE, V254, P1131, DOI 10.1126/science.1957166; LEWIS PJ, 1994, BRIT MED J, V309, P1662, DOI 10.1136/bmj.309.6969.1662a; Ma L, 2009, TRENDS ENDOCRIN MET, V20, P357, DOI 10.1016/j.tem.2009.03.009; Manas ES, 2004, STRUCTURE, V12, P2197, DOI 10.1016/j.str.2004.09.015; Manas ES, 2004, J AM CHEM SOC, V126, P15106, DOI 10.1021/ja047633o; Mocklinghoff S, 2010, CHEMBIOCHEM, V11, P2251, DOI 10.1002/cbic.201000532; Pike ACW, 1999, EMBO J, V18, P4608, DOI 10.1093/emboj/18.17.4608; Pike ACW, 2000, J STEROID BIOCHEM, V74, P261, DOI 10.1016/S0960-0760(00)00102-3; Rogan WJ, 2003, PEDIATRICS, V112, P247; Roncaglioni A, 2008, CHEM SOC REV, V37, P441, DOI 10.1039/b616276m; Rudel RA, 2007, CANCER-AM CANCER SOC, V109, P2635, DOI 10.1002/cncr.22653; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Tanenbaum DM, 1998, P NATL ACAD SCI USA, V95, P5998, DOI 10.1073/pnas.95.11.5998; Warren GL, 2012, DRUG DISCOV TODAY, V17, P1270, DOI 10.1016/j.drudis.2012.06.011; Zhu BT, 2006, ENDOCRINOLOGY, V147, P4132, DOI 10.1210/en.2006-0113; Zhu BT, 1998, CARCINOGENESIS, V19, P1, DOI 10.1093/carcin/19.1.1	24	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74615	10.1371/journal.pone.0074615	http://dx.doi.org/10.1371/journal.pone.0074615			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098659	gold, Green Published, Green Submitted			2022-12-25	WOS:000325423500030
J	Zyriax, BC; Salazar, R; Hoeppner, W; Vettorazzi, E; Herder, C; Windler, E				Zyriax, Birgit-Christiane; Salazar, Ramona; Hoeppner, Wolfgang; Vettorazzi, Eik; Herder, Christian; Windler, Eberhard			The Association of Genetic Markers for Type 2 Diabetes with Prediabetic Status - Cross-Sectional Data of a Diabetes Prevention Trial	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; GENOME-WIDE ASSOCIATION; LARGE-SCALE ASSOCIATION; FASTING GLUCOSE; INSULIN-RESISTANCE; LIFE-STYLE; SUSCEPTIBILITY LOCI; ADIPONECTIN LEVELS; PLASMA-GLUCOSE; RISK-FACTORS	Objective: To investigate the association of risk alleles for type 2 diabetes with prediabetes accounting for age, anthropometry, inflammatory markers and lifestyle habits. Design: Cross-sectional study of 129 men and 157 women of medium-sized companies in northern Germany in the Delay of Impaired Glucose Tolerance by a Healthy Lifestyle Trial (DELIGHT). Methods: Besides established risk factors, 41 single nucleotide polymorphisms (SNPs) that have previously been found to be associated with type 2 diabetes were analyzed. As a nonparametric test a random forest approach was used that allows processing of a large number of predictors. Variables with the highest impact were entered into a multivariate logistic regression model to estimate their association with prediabetes. Results: Individuals with prediabetes were characterized by a slightly, but significantly higher number of type 2 diabetes risk alleles (42.5 +/- 4.1 vs. 41.3 +/- 4.1, p = 0.013). After adjustment for age and waist circumference 6 SNPs with the highest impact in the random forest analysis were associated with risk for prediabetes in a logistic regression model. At least 5 of these SNPs were positively related to prediabetic status (odds ratio for prediabetes 1.57 per allele (Cl 1.21-2.10, p = 0.001)). Conclusions: This explorative analysis of data of DELIGHT demonstrates that at least 6 out of 41 genetic variants characteristic of individuals with type 2 diabetes may also be associated with prediabetes. Accumulation of these risk alleles may markedly increase the risk for prediabetes. However, prospective studies are required to corroborate these findings and to demonstrate the predictive value of these genetic variants for the risk to develop prediabetes.	[Zyriax, Birgit-Christiane; Windler, Eberhard] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; [Salazar, Ramona; Hoeppner, Wolfgang] Bioglobe GmbH, Med Genet, Hamburg, Germany; [Vettorazzi, Eik] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany; [Herder, Christian] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, D-40225 Dusseldorf, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf	Zyriax, BC (corresponding author), Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany.	bzyriax@uke.de	Vettorazzi, Eik/B-8130-2019; Windler, Eberhard/AAN-3249-2020	Vettorazzi, Eik/0000-0002-3737-6402; 	legal health insurence AOK NordWest, Kiel-Wellsee, Germany; Merck KGaA, Darmstadt, Germany	legal health insurence AOK NordWest, Kiel-Wellsee, Germany; Merck KGaA, Darmstadt, Germany	Basic funding was provided by the legal health insurence AOK NordWest, Kiel-Wellsee, Germany. Additional support for the analysis of this paper came from Merck KGaA, Darmstadt, Germany as an unrestricted research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2010, DIABETES CARE, V33, P557, DOI 10.2337/dc09-1145; Abdul-Ghani MA, 2009, DIABETES CARE, V32, P281, DOI 10.2337/dc08-1264; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Balion CM, 2007, CLIN CHEM LAB MED, V45, P1180, DOI 10.1515/CCLM.2007.250; Barr ELM, 2007, CIRCULATION, V116, P151, DOI 10.1161/CIRCULATIONAHA.106.685628; Boeing H, 1999, ANN NUTR METAB, V43, P195, DOI 10.1159/000012786; BohlscheidThomas S, 1997, INT J EPIDEMIOL, V26, pS71, DOI 10.1093/ije/26.suppl_1.S71; BohlscheidThomas S, 1997, INT J EPIDEMIOL, V26, pS59, DOI 10.1093/ije/26.suppl_1.S59; Bureau A, 2005, GENET EPIDEMIOL, V28, P171, DOI 10.1002/gepi.20041; Cardellini M, 2007, DIABETES-METAB RES, V23, P141, DOI 10.1002/dmrr.679; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Chen GJ, 2012, HUM MOL GENET, V21, P4530, DOI 10.1093/hmg/dds282; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Culverhouse R, 2002, AM J HUM GENET, V70, P461, DOI 10.1086/338759; de Vegt F, 2001, JAMA-J AM MED ASSOC, V285, P2109, DOI 10.1001/jama.285.16.2109; Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Fukuda H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046263; Heidema AG, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-23; Herder C, 2011, EUR J CLIN INVEST, V41, P679, DOI 10.1111/j.1365-2362.2010.02454.x; Hothorn T, 2006, BIOSTATISTICS, V7, P355, DOI 10.1093/biostatistics/kxj011; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; International Diabetes Federation, 2011, IDF DIABETES ATLAS; Janghorbani Mohsen, 2009, Rev Diabet Stud, V6, P117, DOI 10.1900/RDS.2009.6.117; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Lam DW, 2012, CURR OPIN ENDOCRINOL, V19, P93, DOI 10.1097/MED.0b013e328350583a; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Linder K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038224; Lindstrom J, 2008, DIABETES CARE, V31, P857, DOI 10.2337/dc07-2162; Liu Y, 2010, OBESITY, V18, P1619, DOI 10.1038/oby.2009.469; Lunetta KL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-32; Marques-Vidal P, 2002, DIABETES CARE, V25, P1371, DOI 10.2337/diacare.25.8.1371; Marques-Vidal P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051768; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Molarius A, 1999, INT J OBESITY, V23, P116, DOI 10.1038/sj.ijo.0800772; Moore JH, 2005, BIOESSAYS, V27, P637, DOI 10.1002/bies.20236; Ng MCY, 2013, DIABETES, V62, P965, DOI 10.2337/db12-0266; Oeth P, 2009, METHODS MOL BIOL, V578, P307, DOI 10.1007/978-1-60327-411-1_20; Ohshige T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026911; Ortega-Azorin C, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-137; Port SC, 2005, AM HEART J, V150, P209, DOI 10.1016/j.ahj.2004.09.031; Qi L, 2006, DIABETES CARE, V29, P1501, DOI 10.2337/dc06-0221; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; Qi L, 2010, CURR OPIN LIPIDOL, V21, P31, DOI 10.1097/MOL.0b013e3283346cb6; Qiao Q, 2003, DIABETES CARE, V26, P2910, DOI 10.2337/diacare.26.10.2910; R Core Team, 2012, R LANG ENV STAT COMP; Raynor LA, 2013, DIABETES CARE, V36, P70, DOI 10.2337/dc12-0609; Rees SD, 2011, DIABETOLOGIA, V54, P1368, DOI 10.1007/s00125-011-2063-2; Regitz-Zagrosek V, 2006, CLIN RES CARDIOL, V95, P136, DOI 10.1007/s00392-006-0351-5; Rijkelijkhuizen JM, 2007, DIABETES CARE, V30, P332, DOI 10.2337/dc06-1238; Ruchat SM, 2009, J NUTRIGENET NUTRIGE, V2, P225, DOI 10.1159/000259341; Schottker B, 2013, DIABETES CARE, V36, P1703, DOI 10.2337/dc12-1416; Schulze MB, 2002, BLOOD PRESS MONIT, V7, P95, DOI 10.1097/00126097-200204000-00002; Scott RA, 2013, DIABETOLOGIA, V56, P60, DOI 10.1007/s00125-012-2715-x; Shaw JA, 1999, DIABETES CARE, V22, P399, DOI 10.2337/diacare.22.3.399; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Stephanie-May R, 2009, DIABETES RES CLIN PR, V84, P211, DOI 10.1016/j.diabres.2009.03.012; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Thorand B, 2010, DIABETIC MED, V27, P1004, DOI 10.1111/j.1464-5491.2010.03043.x; Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x; Vimaleswaran KS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001389; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wannamethee SG, 2007, DIABETES CARE, V30, P1200, DOI 10.2337/dc06-2416; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Zhang J, 2011, J MOL BIOL, V411, P537, DOI 10.1016/j.jmb.2011.06.011; Zhang Z, 2011, EUR J CLIN NUTR, V65, P415, DOI 10.1038/ejcn.2010.273; Zyriax BC, 2005, EUR J CLIN NUTR, V59, P1201, DOI 10.1038/sj.ejcn.1602233; Zyriax BC, 2008, ATHEROSCLEROSIS, V200, P403, DOI 10.1016/j.atherosclerosis.2007.12.033; Zyriax BC, 2012, PUBLIC HEALTH NUTR, V15, P860, DOI 10.1017/S1368980011002370	79	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75807	10.1371/journal.pone.0075807	http://dx.doi.org/10.1371/journal.pone.0075807			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098730	Green Submitted, Green Published, gold			2022-12-25	WOS:000325423500101
J	Liao, GX; van Driel, B; Magelky, E; O'Keeffe, MS; Malefyt, RD; Engel, P; Herzog, RW; Mizoguchi, E; Bhan, AK; Terhorst, C				Liao, Gongxian; van Driel, Boaz; Magelky, Erica; O'Keeffe, Michael S.; Malefyt, Rene de Waal; Engel, Pablo; Herzog, Roland W.; Mizoguchi, Emiko; Bhan, Atul K.; Terhorst, Cox			Glucocorticoid-induced TNF receptor family- related protein ligand regulates the migration of monocytes to the inflamed intestine	FASEB JOURNAL			English	Article						GITR-L; TNFSF18; macrophage; experimental colitis	CD4(+) T-CELLS; SPLENIC RESERVOIR; DENDRITIC CELLS; BONE-MARROW; GITR; EXPRESSION; COLITIS; RECRUITMENT; MACROPHAGES; ENGAGEMENT	Glucocorticoid-induced TNF receptor family-related protein (GITR) regulates the function of both T cells and antigen-presenting cells (APCs), while the function of GITR ligand (GITR-L) is largely unknown. Here we evaluate the role of GITR-L, whose expression is restricted to APCs, in the development of enterocolitis. On injecting naive CD4(+) T cells, GITR-L(-/-)Rag(-/-) mice develop a markedly milder colitis than Rag(-/-) mice, which correlates with a 50% reduction of Ly6C(+)CD11b(+)MHCII(+) macrophages in the lamina propria and mesenteric lymph nodes. The same result was observed in CD40-induced acute colitis and during peritonitis, suggesting an altered monocyte migration. In line with these observations, the number of nondifferentiated monocytes was approximately 3-fold higher in the spleen of GITR-L(-/-)Rag(-/-) mice than in Rag(-/-) mice after CD40 induction. Consistent with the dynamic change in the formation of an active angiotensin II type 1 receptor (AT1) dimer in GITR-L-/- splenic monocytes during intestinal inflammation, the migratory capability of splenic monocytes from GITR-L-deficient mice was impaired in an in vitro transwell migration assay. Conversely, GITR-L reduces the number of splenic Ly6C(hi) monocytes, concomitantly with an increase in AT1 dimers. We conclude that GITR-L regulates the number of proinflammatory macrophages in sites of inflammation by controlling the egress of monocytes from the splenic reservoir.Liao, G., van Driel, B., Magelky, E., O'Keeffe, M. S., de Waal Malefyt, R., Engel, P., Herzog, R. W., Mizoguchi, E., Bhan, A. K., Terhorst, C. Glucocorticoid-induced TNF receptor family-related protein ligand regulates the migration of monocytes to the inflamed intestine.	[Liao, Gongxian; van Driel, Boaz; Magelky, Erica; O'Keeffe, Michael S.; Terhorst, Cox] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Beth Israel Deaconess Med Ctr,Div Immunol, Boston, MA 02115 USA; [Mizoguchi, Emiko] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit,Dept Med, Boston, MA 02115 USA; [Bhan, Atul K.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Malefyt, Rene de Waal] Merck Res Labs, Biol Discovery, Palo Alto, CA USA; [Engel, Pablo] Univ Barcelona, Sch Med, Dept Cell Biol Immunol & Neurosci, Immunol Unit, Barcelona, Spain; [Herzog, Roland W.] Univ Florida, Dept Pediat, Gainesville, FL USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Merck & Company; University of Barcelona; State University System of Florida; University of Florida	Liao, GX (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Immunol, 3 Blackfan Circle,CLS 928, Boston, MA 02115 USA.	gliao@bidmc.harvard.edu; cterhors@bidmc.harvard.edu	Engel, Pablo/R-5907-2019	Engel, Pablo/0000-0001-8410-252X; Magelky, Erica/0000-0003-2393-0713; de Waal Malefyt, Rene/0000-0002-2663-383X	U.S. National Institutes of Health [R01 DK-52510, P01 HL078810, 5T32DK007760, P30 DK-43351]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007760, P30DK043351, R01DK052510] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank members of the C. T. laboratory for helpful discussions and the Beth Israel Deaconess Medical Center histology core for processing colon tissue slides with H&E staining. This work was sponsored by the U.S. National Institutes of Health (R01 DK-52510 to C. T., P01 HL078810 to C. T. and R. H., 5T32DK007760 to G. L., and P30 DK-43351 to A. B., C. T., and E. M.). The authors declare no conflicts of interest.	AbdAlla S, 2004, CELL, V119, P343, DOI 10.1016/j.cell.2004.10.006; Azuma M, 2010, CRIT REV IMMUNOL, V30, P547, DOI 10.1615/CritRevImmunol.v30.i6.40; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Carrier Y, 2012, EUR J IMMUNOL, V42, P1393, DOI 10.1002/eji.201142162; de Jong YP, 2001, NAT IMMUNOL, V2, P1061, DOI 10.1038/ni720; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Griseri T, 2012, IMMUNITY, V37, P1116, DOI 10.1016/j.immuni.2012.08.025; Grohmann U, 2007, NAT MED, V13, P579, DOI 10.1038/nm1563; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Huber S, 2011, IMMUNITY, V34, P554, DOI 10.1016/j.immuni.2011.01.020; Ji HB, 2004, J IMMUNOL, V172, P5823, DOI 10.4049/jimmunol.172.10.5823; Kintscher U, 2001, HYPERTENSION, V37, P587, DOI 10.1161/01.HYP.37.2.587; Kurotaki D, 2011, J IMMUNOL, V186, P2229, DOI 10.4049/jimmunol.1001345; Lacal PM, 2013, J PHARMACOL EXP THER, V347, P164, DOI 10.1124/jpet.113.207605; Leuschner F, 2010, CIRC RES, V107, P1364, DOI 10.1161/CIRCRESAHA.110.227454; Liao GX, 2012, GASTROENTEROLOGY, V142, P582, DOI 10.1053/j.gastro.2011.11.031; Liao GX, 2010, INT IMMUNOL, V22, P259, DOI 10.1093/intimm/dxq001; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; MOMBAERTS P, 1993, CELL, V75, P275, DOI 10.1016/0092-8674(93)80069-Q; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nardelli B, 2006, ENDOCRINOLOGY, V147, P70, DOI 10.1210/en.2005-0518; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Ronchetti S, 2004, EUR J IMMUNOL, V34, P613, DOI 10.1002/eji.200324804; Santucci L, 2007, GUT, V56, P52, DOI 10.1136/gut.2006.091181; Segal BH, 2002, J LEUKOCYTE BIOL, V71, P410; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Siddiqui KRR, 2010, IMMUNITY, V32, P557, DOI 10.1016/j.immuni.2010.03.017; Simpson SJ, 1997, EUR J IMMUNOL, V27, P17, DOI 10.1002/eji.1830270104; Stephens GL, 2004, J IMMUNOL, V173, P5008, DOI 10.4049/jimmunol.173.8.5008; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; van Driel B, 2012, GASTROENTEROLOGY, V143, P1544, DOI 10.1053/j.gastro.2012.08.042; van Olffen RW, 2009, J IMMUNOL, V182, P7490, DOI 10.4049/jimmunol.0802751; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Williams MR, 2011, TRENDS IMMUNOL, V32, P461, DOI 10.1016/j.it.2011.06.009	38	10	11	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					474	484		10.1096/fj.13-236505	http://dx.doi.org/10.1096/fj.13-236505			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24107315	Green Published			2022-12-25	WOS:000333526100044
J	Wang, R; McGrath, BC; Kopp, RF; Roe, MW; Tang, X; Chen, G; Cavener, DR				Wang, Rong; McGrath, Barbara C.; Kopp, Richard F.; Roe, Michael W.; Tang, Xin; Chen, Gong; Cavener, Douglas R.			Insulin Secretion and Ca2+ Dynamics in beta-Cells Are Regulated by PERK (EIF2AK3) in Concert with Calcineurin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcineurin; Calcium Imaging; Diabetes; ER Stress; Insulin Secretion; Calcium Dynamics; PERK; Sarcoplasmic Endoplasmic Reticulum-Calcium ATPase; Store-operated Calcium Entry	ENDOPLASMIC-RETICULUM STRESS; STORE-OPERATED INFLUX; TRANSLATIONAL CONTROL; EIF2-ALPHA KINASE; CALCIUM; ACTIVATION; MICE; INHIBITOR; TRANSLOCATION; DYSFUNCTION	Protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK) (EIF2AK3) is essential for normal development and function of the insulin-secreting -cell. Although genetic ablation of PERK in -cells results in permanent neonatal diabetes in humans and mice, the underlying mechanisms remain unclear. Here, we used a newly developed and highly specific inhibitor of PERK to determine the immediate effects of acute ablation of PERK activity. We found that inhibition of PERK in human and rodent -cells causes a rapid inhibition of secretagogue-stimulated subcellular Ca2+ signaling and insulin secretion. These dysfunctions stem from alterations in store-operated Ca2+ entry and sarcoplasmic endoplasmic reticulum Ca2+-ATPase activity. We also found that PERK regulates calcineurin, and pharmacological inhibition of calcineurin results in similar defects on stimulus-secretion coupling. Our findings suggest that interplay between calcineurin and PERK regulates -cell Ca2+ signaling and insulin secretion, and that loss of this interaction may have profound implications in insulin secretion defects associated with diabetes.	[Wang, Rong; McGrath, Barbara C.; Tang, Xin; Chen, Gong; Cavener, Douglas R.] Penn State Univ, Dept Biol, Ctr Cellular Dynam, University Pk, PA 16802 USA; [Kopp, Richard F.; Roe, Michael W.] SUNY Upstate Med Univ, Dept Med Cell & Dev Biol, Syracuse, NY 13210 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Cavener, DR (corresponding author), 101 LSB, University Pk, PA 16802 USA.	drc9@psu.edu	Tang, Xin/E-8191-2016; Wang, Rong/M-4503-2019	Kopp, Richard/0000-0001-8190-1748	National Institutes of Health NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088140, R01DK092616] Funding Source: NIH RePORTER	National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Richard Ordway and Dr. Fumiko Kawasaki for advice and technical assistance with the FRET-based Ca<SUP>2+</SUP> imaging experiments. We thank Dr. Jeff Axten and Dr. Rakesh Kumar for providing the GSK414 PERK inhibitor and discussions about the effects of PERK inhibition. We thank the National Institutes of Health NIDDK-funded Integrated Islet Distribution Program (IIDP) at City of Hope for providing human pancreatic islets. We thank Cavener Lab members Elyse Munoz, Carrie Lewis, Jingjie Hu, and Siying Zhu for technical assistance and Dr. Fumihiko Urano, Dr. Christopher Newgard, Dr. Jun-Ichi Miyazaki, and Dr. Jonathan Lytton for providing experimental materials.	Aguilar-Bryan L, 2008, ENDOCR REV, V29, P265, DOI 10.1210/er.2007-0029; Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322; Atkins C, 2013, CANCER RES, V73, P1993, DOI 10.1158/0008-5472.CAN-12-3109; Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bird GS, 2008, METHODS, V46, P204, DOI 10.1016/j.ymeth.2008.09.009; Bollo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011925; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Cavener DR, 2010, TRENDS ENDOCRIN MET, V21, P714, DOI 10.1016/j.tem.2010.08.005; Chen LY, 2003, DIABETES, V52, P1723, DOI 10.2337/diabetes.52.7.1723; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Dyachok O, 2001, J CELL SCI, V114, P2179; ENAN E, 1992, BIOCHEM PHARMACOL, V43, P1777, DOI 10.1016/0006-2952(92)90710-Z; Evans-Molina C, 2009, MOL CELL BIOL, V29, P2053, DOI 10.1128/MCB.01179-08; Feng DR, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-61; GILL DL, 2004, SCI STKE, pPE39, DOI DOI 10.1126/ST5E.2432004PE39; Gilon P, 2001, ENDOCR REV, V22, P565, DOI 10.1210/er.22.5.565; Goodyer WR, 2012, DEV CELL, V23, P21, DOI 10.1016/j.devcel.2012.05.014; Gupta S, 2010, DIABETES, V59, P1937, DOI 10.2337/db09-1064; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Heit JJ, 2007, BIOESSAYS, V29, P1011, DOI 10.1002/bies.20644; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Islam MS, 2010, ADV EXP MED BIOL, V654, P235, DOI 10.1007/978-90-481-3271-3_11; Jacobson D. A., 2007, V179, P409; Kitamura T, 2001, MOL CELL BIOL, V21, P5624, DOI 10.1128/MCB.21.16.5624-5630.2001; Kono T, 2012, MOL ENDOCRINOL, V26, P257, DOI 10.1210/me.2011-1181; Liang SH, 2006, BIOCHEM J, V393, P201, DOI 10.1042/BJ20050374; Liu YJ, 1997, CELL CALCIUM, V22, P277, DOI 10.1016/S0143-4160(97)90066-X; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; Moore CE, 2011, MOL ENDOCRINOL, V25, P315, DOI 10.1210/me.2010-0309; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Quesada I, 2008, J ENDOCRINOL, V199, P5, DOI 10.1677/JOE-08-0290; Ravier MA, 2011, DIABETES, V60, P2533, DOI 10.2337/db10-1543; Roderick HL, 2000, J CELL BIOL, V149, P1235, DOI 10.1083/jcb.149.6.1235; Roe Michael Wm., 2006, V319, P37; Rubio-Cabezas O, 2009, J CLIN ENDOCR METAB, V94, P4162, DOI 10.1210/jc.2009-1137; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Senee V, 2004, DIABETES, V53, P1876, DOI 10.2337/diabetes.53.7.1876; Shaw JA, 2012, NEUROSCIENCE, V203, P144, DOI 10.1016/j.neuroscience.2011.12.010; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Tamarina NA, 2008, CELL CALCIUM, V44, P533, DOI 10.1016/j.ceca.2008.03.007; Thore S, 2005, J CELL SCI, V118, P4463, DOI 10.1242/jcs.02577; Togashi K, 2008, BRIT J PHARMACOL, V153, P1324, DOI 10.1038/sj.bjp.0707675; Tong L, 2007, IUBMB LIFE, V59, P402, DOI 10.1080/15216540701411244; Trinh MA, 2012, CELL REP, V1, P676, DOI 10.1016/j.celrep.2012.04.010; Turner H, 1998, J EXP MED, V188, P527, DOI 10.1084/jem.188.3.527; Uchida K, 2011, ENDOCR J, V58, P1021, DOI 10.1507/endocrj.EJ11-0130; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang W, 2006, CELL METAB, V4, P491, DOI 10.1016/j.cmet.2006.11.002	56	65	66	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33824	33836		10.1074/jbc.M113.503664	http://dx.doi.org/10.1074/jbc.M113.503664			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24114838	Green Published, hybrid			2022-12-25	WOS:000327250200027
J	Corona, ED; Jacquelin, D; Gatica, L; Rosa, AL				Daniel Corona, Edgardo; Jacquelin, Daniela; Gatica, Laura; Luis Rosa, Alberto			Multiple Protein Domains Contribute to Nuclear Import and Cell Toxicity of DUX4, a Candidate Pathogenic Protein for Facioscapulohumeral Muscular Dystrophy	PLOS ONE			English	Article							LOCALIZATION SIGNALS; DNA-BINDING; HOMEODOMAIN; D4Z4; GENE; SEQUENCE; REPEAT; LOCUS; CONSERVATION; EXPRESSION	DUX4 (Double Homeobox Protein 4) is a nuclear transcription factor encoded at each D4Z4 unit of a tandem-repeat array at human chromosome 4q35. DUX4 constitutes a major candidate pathogenic protein for facioscapulohumeral muscular dystrophy (FSHD), the third most common form of inherited myopathy. A low-level expression of DUX4 compromises cell differentiation in myoblasts and its overexpression induces apoptosis in cultured cells and living organisms. In this work we explore potential molecular determinants of DUX4 mediating nuclear import and cell toxicity. Deletion of the hypothetical monopartite nuclear localization sequences RRRR23, RRKR98 and RRAR(148) (i.e. NLS1, NLS2 and NLS3, respectively) only partially delocalizes DUX4 from the cell nuclei. Nuclear entrance guided by NLS1, NLS2 and NLS3 does not follow the classical nuclear import pathway mediated by alpha/beta importins. NLS and homeodomain mutants from DUX4 are dramatically less cell-toxic than the wild type molecule, independently of their subcellular localization. A triple Delta NLS1-2-3 deletion mutant is still partially localized in the nuclei, indicating that additional sequences in DUX4 contribute to nuclear import. Deletion of >= 111 amino acids from the C-terminal of DUX4, on a Delta NLS1-2-3 background, almost completely re-localizes DUX4 to the cytoplasm, indicating that the C-ter tail contributes to subcellular trafficking of DUX4. Also, C-terminal deletion mutants of DUX4 on a NLS wild type background are less toxic than wild type DUX4. Results reported here indicate that DUX4 possesses redundant mechanisms to assure nuclear entrance and that its various transcription-factor associated domains play an essential role in cell toxicity.	[Daniel Corona, Edgardo; Jacquelin, Daniela; Gatica, Laura; Luis Rosa, Alberto] Fdn Allende, Lab Biol Celular & Mol, Cordoba, Argentina; [Luis Rosa, Alberto] Sanatorio Allende, Cordoba, Argentina		Rosa, AL (corresponding author), Fdn Allende, Lab Biol Celular & Mol, Cordoba, Argentina.	alberto_l_rosa@yahoo.com.ar			CONICET (Argentina); FONCYT (Argentina)	CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FONCYT (Argentina)(FONCyT)	We thank R. Defago for English editing, H.J.F. Maccioni for critical reading of the manuscript and H. Lujan and his team at UCC for their generous sharing of microscope facilities. EDC and DJ held fellowships from CONICET (Argentina). LG held a fellowship from FONCYT (Argentina). ALR is Medical Investigator from the National Research Council from Argentina (CONICET)	ADES SE, 1994, BIOCHEMISTRY-US, V33, P9187, DOI 10.1021/bi00197a022; Ansseau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007482; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Boulikas Teni, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P193; Briata P, 1999, FEBS LETT, V445, P160, DOI 10.1016/S0014-5793(99)00113-1; Cabianca DS, 2010, J CELL BIOL, V191, P1049, DOI 10.1083/jcb.201007028; CHAN SK, 1993, GENE DEV, V7, P796, DOI 10.1101/gad.7.5.796; Christophe-Hobertus C, 1999, EUR J BIOCHEM, V265, P491, DOI 10.1046/j.1432-1327.1999.00796.x; Clapp J, 2007, AM J HUM GENET, V81, P264, DOI 10.1086/519311; de Greef JC, 2010, NEUROLOGY, V75, P1548, DOI 10.1212/WNL.0b013e3181f96175; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Dmitriev P, 2009, NEUROMUSCULAR DISORD, V19, P17, DOI 10.1016/j.nmd.2008.09.004; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; HEWITT JE, 1994, HUM MOL GENET, V3, P1287, DOI 10.1093/hmg/3.8.1287; Kawamura-Saito M, 2006, HUM MOL GENET, V15, P2125, DOI 10.1093/hmg/ddl136; Kosugi S, 2008, CHEM BIOL, V15, P940, DOI 10.1016/j.chembiol.2008.07.019; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; LACASSE EC, 1995, NUCLEIC ACIDS RES, V23, P1647, DOI 10.1093/nar/23.10.1647; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Lemmers RJLF, 2002, NAT GENET, V32, P235, DOI 10.1038/ng999; LYLE R, 1995, GENOMICS, V28, P389, DOI 10.1006/geno.1995.1166; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Offterdinger M, 2002, J CELL BIOL, V157, P929, DOI 10.1083/jcb.200109033; Ostlund C, 2005, BIOCHEMISTRY-US, V44, P2378, DOI 10.1021/bi047992w; Padberg GW, 1998, NEUROMUSCULAR DISORD; PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0; Plaza S, 2008, P NATL ACAD SCI USA, V105, P13439, DOI 10.1073/pnas.0806106105; QIAN YQ, 1994, J MOL BIOL, V238, P333, DOI 10.1006/jmbi.1994.1296; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Tawil R, 2006, MUSCLE NERVE, V34, P1, DOI 10.1002/mus.20522; TSAO DHH, 1995, J MOL BIOL, V251, P297, DOI 10.1006/jmbi.1995.0435; Tupler R, 1996, J MED GENET, V33, P366, DOI 10.1136/jmg.33.5.366; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; Vanderplanck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026820; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; Wallace LM, 2011, ANN NEUROL, V69, P540, DOI 10.1002/ana.22275; Wilson DS, 1996, P NATL ACAD SCI USA, V93, P6886, DOI 10.1073/pnas.93.14.6886; Wuebbles RD, 2010, INT J CLIN EXP PATHO, V3, P386	44	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75614	10.1371/journal.pone.0075614	http://dx.doi.org/10.1371/journal.pone.0075614			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116060	Green Published, gold, Green Submitted			2022-12-25	WOS:000325552200030
J	Malleret, B; Xu, FG; Mohandas, N; Suwanarusk, R; Chu, C; Leite, JA; Low, K; Turner, C; Sriprawat, K; Zhang, R; Bertrand, O; Colin, Y; Costa, FTM; Ong, CN; Ng, ML; Lim, CT; Nosten, F; Renia, L; Russell, B				Malleret, Benoit; Xu, Fenggao; Mohandas, Narla; Suwanarusk, Rossarin; Chu, Cindy; Leite, Juliana A.; Low, Kayen; Turner, Claudia; Sriprawat, Kanlaya; Zhang, Rou; Bertrand, Olivier; Colin, Yves; Costa, Fabio T. M.; Ong, Choon Nam; Ng, Mah Lee; Lim, Chwee Teck; Nosten, Francois; Renia, Laurent; Russell, Bruce			Significant Biochemical, Biophysical and Metabolic Diversity in Circulating Human Cord Blood Reticulocytes	PLOS ONE			English	Article							FLOW CYTOMETRIC ANALYSIS; MEMBRANE DEFORMABILITY; TRANSFERRIN RECEPTOR; SHEEP RETICULOCYTES; PLASMODIUM-VIVAX; THIAZOLE ORANGE; MATURITY INDEX; CELL MEMBRANE; ERYTHROCYTES; MATURATION	Background: The transition from enucleated reticulocytes to mature normocytes is marked by substantial remodeling of the erythrocytic cytoplasm and membrane. Despite conspicuous changes, most studies describe the maturing reticulocyte as a homogenous erythropoietic cell type. While reticulocyte staging based on fluorescent RNA stains such as thiazole orange have been useful in a clinical setting; these 'sub-vital' stains may confound delicate studies on reticulocyte biology and may preclude their use in heamoparasite invasion studies. Design and Methods: Here we use highly purified populations of reticulocytes isolated from cord blood, sorted by flow cytometry into four sequential subpopulations based on transferrin receptor (CD71) expression: CD71high, CD71medium, CD71low and CD71negative. Each of these subgroups was phenotyped in terms of their, morphology, membrane antigens, biomechanical properties and metabolomic profile. Results: Superficially CD71high and CD71medium reticulocytes share a similar gross morphology (large and multilobular) when compared to the smaller, smooth and increasingly concave reticulocytes as seen in the in the CD71low and CD71negativesamples. However, between each of the four sample sets we observe significant decreases in shear modulus, cytoadhesive capacity, erythroid receptor expression (CD44, CD55, CD147, CD235R, and CD242) and metabolite concentrations. Interestingly increasing amounts of boric acid was found in the mature reticulocytes. Conclusions: Reticulocyte maturation is a dynamic and continuous process, confounding efforts to rigidly classify them. Certainly this study does not offer an alternative classification strategy; instead we used a nondestructive sampling method to examine key phenotypic changes of in reticulocytes. Our study emphasizes a need to focus greater attention on reticulocyte biology.	[Malleret, Benoit; Suwanarusk, Rossarin; Leite, Juliana A.; Renia, Laurent] ASTAR, Biopolis, Lab Malaria Immunobiol, Singapore Immunol Network SIgN, Singapore, Singapore; [Xu, Fenggao; Ong, Choon Nam] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Mohandas, Narla] New York Blood Ctr, Red Cell Physiol Lab, New York, NY 10021 USA; [Chu, Cindy; Turner, Claudia; Sriprawat, Kanlaya] Shoklo Malaria Res Unit, Mae Sot, Thailand; [Leite, Juliana A.; Costa, Fabio T. M.] Univ Estadual Campinas UNICAMP, Inst Biol, Dept Genet Evolucao & Bioagentes, Sao Paulo, Brazil; [Low, Kayen] JEOL Asia Pte Ltd, Singapore, Singapore; [Zhang, Rou; Lim, Chwee Teck] Natl Univ Singapore, Singapore MIT Alliance, Singapore 117548, Singapore; [Bertrand, Olivier; Colin, Yves] INSERM, UMR S Unite Mixte Rech 665, Paris, France; [Bertrand, Olivier; Colin, Yves] Inst Natl Transfus Sanguine, F-75015 Paris, France; [Bertrand, Olivier; Colin, Yves] Univ Paris 07, Paris, France; [Ng, Mah Lee; Russell, Bruce] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Natl Univ Hlth Syst, Singapore 117595, Singapore; [Lim, Chwee Teck] Natl Univ Singapore, Dept Bioengn, Singapore 117548, Singapore; [Lim, Chwee Teck] Natl Univ Singapore, Dept Mech Engn, Singapore 117548, Singapore; [Nosten, Francois] Mahidol Oxford Univ, Res Unit, Bangkok, Thailand; [Nosten, Francois] Univ Oxford, Churchill Hosp, Ctr Trop Med, Oxford, England	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore; New York Blood Center; Mahidol University; Universidade de Sao Paulo; Universidade Estadual de Campinas; Jeol Ltd; Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Singapore-MIT Alliance for Research & Technology Centre (SMART); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; National University of Singapore; National University of Singapore; National University of Singapore; Mahidol University; University of Oxford	Renia, L (corresponding author), ASTAR, Biopolis, Lab Malaria Immunobiol, Singapore Immunol Network SIgN, Singapore, Singapore.	renia_laurent@immunol.a-star.edu.sg; micbmr@nus.edu.sg	Suwanarusk, Rossarin/E-2115-2013; Russell, Bruce/A-9240-2011; Chu, Cindy S/E-3135-2014; Costa, Fabio/E-1181-2012; Renia, Laurent/E-2117-2011; colin, yves/O-1910-2017; Lim, chwee Teck/B-3307-2011; Malleret, Benoit/E-9159-2011; Leite, Juliana/G-2563-2013; Nosten, Francois/AAC-5509-2019; Ng, Mei Li/Q-3704-2016	Suwanarusk, Rossarin/0000-0002-7310-245X; Russell, Bruce/0000-0003-2333-4348; Chu, Cindy S/0000-0001-9465-8214; Costa, Fabio/0000-0001-9969-7300; Renia, Laurent/0000-0003-0349-1557; colin, yves/0000-0001-5196-4254; Lim, chwee Teck/0000-0003-4019-9782; Malleret, Benoit/0000-0001-9658-7528; Nosten, Francois/0000-0002-7951-0745; Ng, Mei Li/0000-0001-9917-4534; Ong, Choon Nam/0000-0002-4002-1725	Singapore Ministry of Health NMRC [CBRG12nov036]; SIgN; Horizontal Programme on Infectious Diseases under the Agency for Science, Technology and Research (A*STAR, Singapore); Wellcome Trust of Great Britain; Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/52013-3]; Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM); National University of Singapore; National University Health System, Singapore 'Start Up' Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK026263] Funding Source: NIH RePORTER	Singapore Ministry of Health NMRC(Ministry of Health-SingaporeNational Medical Research Council, Singapore); SIgN; Horizontal Programme on Infectious Diseases under the Agency for Science, Technology and Research (A*STAR, Singapore)(Agency for Science Technology & Research (A*STAR)); Wellcome Trust of Great Britain(Wellcome Trust); Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)(Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)); National University of Singapore(National University of Singapore); National University Health System, Singapore 'Start Up' Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study received funding from Singapore Ministry of Health NMRC (CBRG12nov036) grant, SIgN and from the Horizontal Programme on Infectious Diseases under the Agency for Science, Technology and Research (A*STAR, Singapore). SMRU is sponsored by The Wellcome Trust of Great Britain, as part of the Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University. JAL was supported by a fellowship from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - Process no. 2009/52013-3), and FTMC is enrolled at the Programa Estrategico de Ciencia, Tecnologia & Inovacao nas Fundacoes Estaduais de Saude (PECTI/AM Saude) from Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM). BR also received financial support from the National University of Singapore and National University Health System, Singapore 'Start Up' Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTLES JF, 1962, J BIOL CHEM, V237, P3770; Bessis M., 1973, LIVING BLOOD CELLS T; BRECHER G, 1950, AM J CLIN PATHOL, V20, P1079, DOI 10.1093/ajcp/20.11_ts.1079; BRUN A, 1990, BLOOD, V76, P2397; CABANTCHIK ZI, 1974, J MEMBRANE BIOL, V15, P227, DOI 10.1007/BF01870089; Carvalho BO, 2010, J INFECT DIS, V202, P638, DOI 10.1086/654815; CHAMBERLAIN JK, 1978, BLOOD, V52, P959; CHASIS JA, 1989, BLOOD, V74, P2562; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; Colella GM, 1991, BLOOD, V78; Coste I, 2001, BLOOD, V97, P3984, DOI 10.1182/blood.V97.12.3984; DAVIS BH, 1995, CYTOMETRY, V22, P35, DOI 10.1002/cyto.990220107; DAVIS BH, 1989, ARCH PATHOL LAB MED, V113, P684; Dertinger SD, 2002, MUTAT RES-GEN TOX EN, V515, P3, DOI 10.1016/S1383-5718(02)00009-8; Ehrlich P, 1881, BERL KLIN WSCHR, V18, P43; Eshghi S, 2007, J CELL BIOL, V177, P871, DOI 10.1083/jcb.200702080; Goel MS, 2002, BLOOD, V100, P3797, DOI 10.1182/blood-2002-03-0712; Goh SH, 2007, PHYSIOL GENOMICS, V30, P172, DOI 10.1152/physiolgenomics.00247.2006; Griffiths RE, 2012, BLOOD, V119, P6296, DOI 10.1182/blood-2011-09-376475; Heilmeyer L., 1932, ZTSCHR KLIN MED, V121, P361; Ihanus E, 2007, BLOOD, V109, P802, DOI 10.1182/blood-2006-04-014878; Jeremy KP, 2009, HAEMATOL-HEMATOL J, V94, P1354, DOI 10.3324/haematol.2009.006585; Key JA, 1921, ARCH INTERN MED, V28, P511, DOI 10.1001/archinte.1921.00100170012002; Khandelwal S, 2006, EXP GERONTOL, V41, P855, DOI 10.1016/j.exger.2006.06.045; Kono M, 2009, CLIN CHIM ACTA, V404, P105, DOI 10.1016/j.cca.2009.03.017; KOSENOW W, 1952, Z Kinderheilkd, V70, P552; LACELLE PL, 1970, SEMIN HEMATOL, V7, P355; LEBLOND PF, 1971, BLOOD-J HEMATOL, V37, P40, DOI 10.1182/blood.V37.1.40.40; Lee G, 2006, BLOOD, V108, P2064, DOI 10.1182/blood-2006-03-006759; LEE LG, 1986, CYTOMETRY, V7, P508, DOI 10.1002/cyto.990070603; LEWIS M, 1977, AM J HUM GENET, V29, P101; LOWENSTEIN LM, 1959, INT REV CYTOL, V8, P135, DOI 10.1016/S0074-7696(08)62730-8; Malleret B, 2011, SCI REP-UK, V1, DOI 10.1038/srep00118; MEL HC, 1977, BLOOD, V49, P1001; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; NOBES PR, 1990, J CLIN PATHOL, V43, P675, DOI 10.1136/jcp.43.8.675; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; PAPAYANNOPOULOU T, 1975, BLOOD CELLS, V1, P535; Park M, 2004, MOL CELL, V16, P331, DOI 10.1016/j.molcel.2004.09.030; PATERAKIS GS, 1993, ACTA HAEMATOL-BASEL, V90, P182; Pushkin A, 2006, AM J PHYSIOL-RENAL, V290, pF580, DOI 10.1152/ajprenal.00252.2005; Riley RS, 2001, J CLIN LAB ANAL, V15, P267, DOI 10.1002/jcla.1039; Russell B, 2011, BLOOD, V118, pE74, DOI 10.1182/blood-2011-04-348748; SAGE BH, 1983, CYTOMETRY, V4, P222, DOI 10.1002/cyto.990040306; Salomao M, 2008, P NATL ACAD SCI USA, V105, P8026, DOI 10.1073/pnas.0803225105; Sathyanarayana P, 2007, BLOOD, V110, P509, DOI 10.1182/blood-2006-11-056465; Seip M, 1953, ACTA MED SCANDINAVIC, V146; Southcott MJG, 1999, BLOOD, V93, P4425, DOI 10.1182/blood.V93.12.4425.412k22_4425_4435; Turkez H, 2012, CYTOTECHNOLOGY; Xu FG, 2009, RAPID COMMUN MASS SP, V23, P3243, DOI 10.1002/rcm.4246	51	89	89	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76062	10.1371/journal.pone.0076062	http://dx.doi.org/10.1371/journal.pone.0076062			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116088	Green Submitted, gold, Green Published			2022-12-25	WOS:000325552200047
J	Gupta, P; Zheng, YF; Ting, TW; Lamoureux, EL; Cheng, CY; Wong, TY				Gupta, Preeti; Zheng, Yingfeng; Ting, Tay Wan; Lamoureux, Ecosse L.; Cheng, Ching-Yu; Wong, Tien-Yin			Prevalence of Cataract Surgery and Visual Outcomes in Indian Immigrants in Singapore: The Singapore Indian Eye Study	PLOS ONE			English	Article							RISK-FACTORS; POPULATION; BLINDNESS; BARRIERS; CHINESE; IMPAIRMENT; EXTRACTION; VISION; ACUITY	Objective: To determine the prevalence of cataract surgery and factors associated with post-surgical visual outcomes in migrant Indians living in Singapore. Research Design and Methods: We conducted a population-based study in 3,400 Indian immigrants residing in Singapore-the Singapore Indian Eye Study (SINDI). All participants underwent comprehensive medical eye examination and a standardized interview. Post-operative visual impairment (VI) was defined as best-corrected or presenting visual acuity (BCVA or PVA) of 20/60 or worse. Results: The age-and gender-standardized prevalence of cataract surgery was 9.7% (95% confidence interval [CI]: 8.9%, 10.7%) in Singapore resident Indians. Post-operative VI defined by BCVA occurred in 10.9% eyes (87/795). The main causes of post-operative VI were diabetic retinopathy (20.7%), posterior capsular opacification (18.4%), and age-related macular degeneration (12.6%). Undercorrected refractive error doubled the prevalence of post-operative VI when PVA was used. Conclusions: The rate of cataract surgery is about 10% in Indian residents in Singapore. Socioeconomic variables and migration had no significant impact on the prevalence of cataract surgery. Diabetic retinopathy was a major cause of postoperative VI in migrant Indians living in Singapore. Uncorrected postoperative refractive error remains an efficient way to improve vision.	[Gupta, Preeti; Zheng, Yingfeng; Ting, Tay Wan; Lamoureux, Ecosse L.; Cheng, Ching-Yu; Wong, Tien-Yin] Singapore Eye Res Inst, Singapore, Singapore; [Gupta, Preeti; Zheng, Yingfeng; Ting, Tay Wan; Lamoureux, Ecosse L.; Cheng, Ching-Yu; Wong, Tien-Yin] Singapore Natl Eye Ctr, Singapore, Singapore; [Lamoureux, Ecosse L.; Wong, Tien-Yin] Univ Melbourne, Ctr Eye Res Australia, Royal Victorian Eye & Ear Hosp, Melbourne, Vic 3010, Australia; [Cheng, Ching-Yu; Wong, Tien-Yin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117595, Singapore; [Cheng, Ching-Yu] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Cheng, Ching-Yu] Duke NUS Grad Med Sch, Off Clin Sci, Ctr Quantitat Med, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; National University of Singapore; National University of Singapore; National University of Singapore	Cheng, CY (corresponding author), Singapore Eye Res Inst, Singapore, Singapore.	ching-yu_cheng@nuhs.edu.sg	Zheng, Yingfeng/CAE-9225-2022; Cheng, Ching-Yu/Y-2229-2019; Lamoureux, Ecosse/Z-5482-2019; Wong, Tien Yin/AAC-9724-2020; Zheng, Yingfeng/AAE-2983-2022	Zheng, Yingfeng/0000-0002-0914-7864; Cheng, Ching-Yu/0000-0003-0655-885X; Wong, Tien Yin/0000-0002-8448-1264; 	Biomedical Research Council (BMRC) [08/1/35/19/550]; National Medical Research Council (NMRC), Singapore [StaR/0003/2008]	Biomedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR)); National Medical Research Council (NMRC), Singapore(National Medical Research Council, Singapore)	This study was funded by Biomedical Research Council (BMRC), 08/1/35/19/550 and National Medical Research Council (NMRC), StaR/0003/2008, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, OPHTHALMOLOGY, V98, P786; Baranano AE, 2008, OPHTHALMOLOGY, V115, P815, DOI 10.1016/j.ophtha.2007.05.052; Broman AT, 2005, ARCH OPHTHALMOL-CHIC, V123, P1231, DOI 10.1001/archopht.123.9.1231; Chiang PPC, 2011, INVEST OPHTH VIS SCI, V52, P7586, DOI 10.1167/iovs.11-7698; Congdon NG, 2007, ARCH OPHTHALMOL-CHIC, V125, P1546, DOI 10.1001/archopht.125.11.eeb70014; Dandona L, 1999, AM J OPHTHALMOL, V127, P650, DOI 10.1016/S0002-9394(99)00044-6; Desai P, 1996, BRIT J OPHTHALMOL, V80, P868, DOI 10.1136/bjo.80.10.868; Foster PJ, 2003, BRIT J OPHTHALMOL, V87, P1112, DOI 10.1136/bjo.87.9.1112; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Huang WY, 2011, INVEST OPHTH VIS SCI, V52, P16, DOI 10.1167/iovs.10-5382; Jeganathan VSE, 2008, DIABETES CARE, V31, P1905, DOI 10.2337/dc08-0342; Khanna RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035701; KHOO D H C, 1990, Annals Academy of Medicine Singapore, V19, P484; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Lau J, 2002, BRIT J OPHTHALMOL, V86, P12, DOI 10.1136/bjo.86.1.12; Lavanya R, 2009, BRIT J OPHTHALMOL, V93, P299, DOI 10.1136/bjo.2008.148650; Lavanya R, 2009, OPHTHAL EPIDEMIOL, V16, P325, DOI 10.3109/09286580903144738; Liu B, 2009, OPHTHALMOLOGY, V116, P1322, DOI 10.1016/j.ophtha.2009.01.030; Murthy GVS, 2009, OPHTHAL EPIDEMIOL, V16, P400, DOI 10.3109/09286580903315809; Nangia V, 2011, J CATARACT REFR SURG, V37, P1932, DOI 10.1016/j.jcrs.2011.08.020; Nirmalan PK, 2002, BRIT J OPHTHALMOL, V86, P505, DOI 10.1136/bjo.86.5.505; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Singapore Department of Statistics, 2009, SING FIG 2010 ETHN D; Tan CE, 1999, DIABETES CARE, V22, P241, DOI 10.2337/diacare.22.2.241; United Nations Development Programme, 2009, HUM DEV REP 2009 OV; United States Census Bureau, SEL POP PROF US POP; Vaidyanathan K, 1999, B WORLD HEALTH ORGAN, V77, P104; Vijaya L, 2010, INDIAN J OPHTHALMOL, V58, P223, DOI 10.4103/0301-4738.62648; Wong TY, 2008, ARCH OPHTHALMOL-CHIC, V126, P1091, DOI 10.1001/archopht.126.8.1091; Wong TY, 2001, ARCH OPHTHALMOL-CHIC, V119, P727, DOI 10.1001/archopht.119.5.727; World Health Organization International Agency for the Prevention of Blindness, 2002, REP WORLD VIS 2002 S; Yin QX, 2009, INVEST OPHTH VIS SCI, V50, P1069, DOI 10.1167/iovs.08-2783; Yorston D, 2005, EYE, V19, P1083, DOI 10.1038/sj.eye.6701966; Zhao JL, 2010, OPHTHALMOLOGY, V117, P2120, DOI 10.1016/j.ophtha.2010.03.005; Zheng YF, 2011, OPHTHALMOLOGY, V118, P1798, DOI 10.1016/j.ophtha.2011.02.014	35	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75584	10.1371/journal.pone.0075584	http://dx.doi.org/10.1371/journal.pone.0075584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116058	Green Published, gold			2022-12-25	WOS:000325501300035
J	Cheng, J; Wang, S; Su, XO				Cheng, Jie; Wang, Shi; Su, Xiao-Ou			Simultaneous Identification and Quantification of 20 beta-Receptor Agonists in Feed Using Gas Chromatography-Tandem Mass Spectrometry	PLOS ONE			English	Article							URINE	"Lean meat powder" is a class of toxic chemicals that have structures similar to that of beta-adrenergic receptor agonists. At least 16 chemicals from this class have been specifically banned by the 176th bulletin of the Chinese Department of Agriculture on breeding animals, and methods for monitoring the illicit use of beta-agonists in animal feed are required. Herein, a method to quantify 20 beta-agonists in feed, via analyte derivatization followed by gas chromatography-tandem mass spectrometry, has been developed. The optimized method has a good linear correlation (calibration coefficient > 0.99) between the quantitative ion peak area and the concentration of beta-agonists over a large working range (0.05-1 mg/kg). The limit of detection (LOD) was 0.01 mg/kg, the recoveries for three beta-agonists spikes (0.05, 0.1, and 1 mu g/g) in feed ranged from 75.6 to 102.4%, repeatability ranged from 1.2 to 9.4% for all of the compounds, and intermediate precisions were lower than 13.8%. This precise, accurate method was applied to quantify 20 beta-agonists in actual feed samples and represents an excellent complement to existing quantification methods.	[Cheng, Jie; Wang, Shi; Su, Xiao-Ou] Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Quality Standards & Testing Technology for Agro-Products, CAAS	Su, XO (corresponding author), Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Beijing 100193, Peoples R China.	suxiaoou@caas.cn	Li, Xiaomin/ABI-2638-2020		Chinese Agro-scientific Research in the Public Interest [201203088-01]	Chinese Agro-scientific Research in the Public Interest	This work was supported in part by a special fund for Chinese Agro-scientific Research in the Public Interest (No. 201203088-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bullet 1063-6-2008, 2008, DET BET REC AG FEEDS, P5; Bullet 1063-7-2008, 2008, SIM DET 8 KINDS BET, V4; Caban M, 2011, J CHROMATOGR A, V1218, P8110, DOI 10.1016/j.chroma.2011.08.093; Christine W, 2004, J CHROMATOGR B, V804, P85, DOI [10.1016/j.jchromb. 2003.12.034, DOI 10.1016/J.JCHR0MB.2003.12.034]; Commission European, 2002, OFF J EUR COMMUN L, VL221, P15; Commission European, 2007, CRL VIEW STAT ART AN; Daniele DC, 2010, CHROMATOGR BIOMED, V24, P358; DEGAND G, 1993, ANAL CHIM ACTA, V275, P241, DOI 10.1016/0003-2670(93)80298-Y; Fernando R, 1998, J CHROMATOGR B, V716, P366, DOI [10.1016/S0378-4347(98)00292-8, DOI 10.1016/S0378-4347(98)00292-8]; He LM, 2007, ANIM FEED SCI TECH, V132, P316, DOI 10.1016/j.anifeedsci.2006.03.013; Juan C, 2010, J CHROMATOGR A, V1217, P6061, DOI 10.1016/j.chroma.2010.07.034; Li C, 2010, J CHROMATOGR A, V1217, P7873, DOI 10.1016/j.chroma.2010.10.055; Lucia D, 2002, J CHROMATOGR B, V780, P61, DOI [10.1016/S1570-0232(02)00414-2, DOI 10.1016/S1570-0232(02)00414-2]; Lucia D, 2000, J MASS SPECTROM, V35, P1285, DOI [10.1002/1096-9888(200011)35:11, DOI 10.1002/1096-9888(200011)35:11.PUBMED:11114086]; Nielen MWF, 2008, ANAL BIOANAL CHEM, V391, P199, DOI 10.1007/s00216-007-1760-7; Philipson L. H., 2002, Journal of Allergy and Clinical Immunology, V110, pS313, DOI 10.1067/mai.2002.129702; [王建平 Wang Jianping], 2005, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V36, P397; Wang PL, 2012, CHINESE J ANAL CHEM, V40, P470, DOI 10.3724/SP.J.1096.2012.10414; Wang XJ, 2013, J CHROMATOGR A, V1278, P82, DOI 10.1016/j.chroma.2012.12.060; Zhu J, 2005, J CHINESE MASS SPECT, V3, P129	20	75	76	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76400	10.1371/journal.pone.0076400	http://dx.doi.org/10.1371/journal.pone.0076400			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098489	Green Published, Green Submitted, gold			2022-12-25	WOS:000325483600042
J	Bowtell, JL; Avenell, G; Hunter, SP; Mileva, KN				Bowtell, Joanna L.; Avenell, Gareth; Hunter, Steven P.; Mileva, Katya N.			Effect of Hypohydration on Peripheral and Corticospinal Excitability and Voluntary Activation	PLOS ONE			English	Article							LOWER-LIMB MUSCLES; NEUROMUSCULAR FUNCTION; MOTOR CORTEX; HEAT-STRESS; EMG CHANGES; EXERCISE; FATIGUE; CONTRACTIONS; DEHYDRATION; HYPERTHERMIA	We investigated whether altered peripheral and/or corticospinal excitatory output and voluntary activation are implicated in hypohydration-induced reductions in muscle isometric and isokinetic (90 degrees.s(-1)) strength. Nine male athletes completed two trials (hypohydrated, euhydrated) comprising 90 min cycling at 40 degrees C, with body weight losses replaced in euhydrated trial. Peripheral nerve and transcranial magnetic stimulations were applied during voluntary contractions pre- and 40 min post-exercise to quantify voluntary activation and peripheral (M-wave) and corticospinal (motor evoked potential) evoked responses in m. vastus medialis. Both maximum isometric (-15.3 +/- 3.1 vs -5.4 +/- 3.5%) and isokinetic eccentric (-24.8 +/- 4.6 vs -7.3 +/- 7.2%) torque decreased to a greater extent in hypohydrated than euhydrated trials (p<0.05). Half relaxation time of the twitch evoked by peripheral nerve stimulation during maximal contractions increased after exercise in the hypohydrated (21.8 +/- 9.3%) but stayed constant in the euhydrated (1.6 +/- 10.7%; p = 0.017) condition. M-wave amplitude during maximum voluntary contraction increased after exercise in the heat in hypohydrated (10.7 +/- 18.0%) but decreased in euhydrated condition (-17.4 +/- 16.9%; p = 0.067). Neither peripheral nor cortical voluntary activation were significantly different between conditions. Motor evoked potential amplitude increased similarly in both conditions (hypohydrated: 25.7 +/- 28.5%; euhydrated: 52.9 +/- 33.5%) and was accompanied by lengthening of the cortical silent period in euhydrated but not hypohydrated condition (p = 0.019). Different neural strategies seem to be adopted to regulate neural drive in the two conditions, with increases in inhibitory input of either intracortical or corticospinal origin during the euhydrated trial. Such changes were absent in the hypohydrated condition, yet voluntary activation was similar to the euhydrated condition, perhaps due to smaller increases in excitatory drive rather than increased inhibition. Despite this maximal isometric and eccentric strength were impaired in the hypohydrated condition. The increase in peripheral muscle excitability evident in the hypohydrated condition was not sufficient to preserve performance in the face of reduced muscle contractility or impaired excitation-contraction coupling.	[Bowtell, Joanna L.; Avenell, Gareth; Hunter, Steven P.; Mileva, Katya N.] London S Bank Univ, London, England; [Bowtell, Joanna L.] Univ Exeter, Exeter, Devon, England	London South Bank University; University of Exeter	Bowtell, JL (corresponding author), London S Bank Univ, London, England.	j.bowtell@exeter.ac.uk			European Hydration Institute	European Hydration Institute	This work was funded in part by a graduate research student grant from the European Hydration Institute. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigard AX, 2001, MED SCI SPORT EXER, V33, P1694, DOI 10.1097/00005768-200110000-00013; BIGLANDRITCHIE B, 1983, J PHYSIOL-LONDON, V340, P335, DOI 10.1113/jphysiol.1983.sp014765; Cheuvront SN, 2010, EUR J APPL PHYSIOL, V109, P1163, DOI 10.1007/s00421-010-1458-y; Coburn JW, 2006, MUSCLE NERVE, V33, P664, DOI 10.1002/mus.20509; Del Coso J, 2008, MED SCI SPORT EXER, V40, P744, DOI 10.1249/MSS.0b013e3181621336; DILL DB, 1974, J APPL PHYSIOL, V37, P247, DOI 10.1152/jappl.1974.37.2.247; Dimitrova NA, 2003, J ELECTROMYOGR KINES, V13, P13, DOI 10.1016/S1050-6411(02)00083-4; Evetovich TK, 2002, MUSCLE NERVE, V26, P225, DOI 10.1002/mus.10203; Ftaiti F, 2001, EUR J APPL PHYSIOL, V84, P87, DOI 10.1007/s004210000339; Green HJ, 2011, ACTA PHYSIOL, V203, P441, DOI 10.1111/j.1748-1716.2011.02335.x; Gruet M, 2013, NEUROSCIENCE, V231, P384, DOI 10.1016/j.neuroscience.2012.10.058; Hackney KJ, 2012, EXTREME PHYSIOL MED, V1, DOI 10.1186/2046-7648-1-3; Hayes LD, 2010, EUR J APPL PHYSIOL, V108, P701, DOI 10.1007/s00421-009-1288-y; Judelson DA, 2007, SPORTS MED, V37, P907, DOI 10.2165/00007256-200737100-00006; Kossev AR, 1998, MUSCLE NERVE, V21, P413, DOI 10.1002/(SICI)1097-4598(199803)21:3<413::AID-MUS20>3.0.CO;2-Z; LAWRENCE JH, 1983, J APPL PHYSIOL, V54, P1653, DOI 10.1152/jappl.1983.54.6.1653; Marino FE, 2010, BRIT J SPORT MED, V44, P961, DOI 10.1136/bjsm.2009.054973; McKenna MJ, 2008, J APPL PHYSIOL, V104, P288, DOI 10.1152/japplphysiol.01037.2007; Mileva KN, 2012, EUR J APPL PHYSIOL, V112, P3959, DOI 10.1007/s00421-012-2381-1; MILNERBR.HS, 1973, J PHYSIOL-LONDON, V230, P371, DOI 10.1113/jphysiol.1973.sp010193; Montain SJ, 2010, APPL PHYSIOL NUTR ME, V35, P456, DOI 10.1139/H10-032; Morrison S, 2004, EUR J APPL PHYSIOL, V91, P729, DOI 10.1007/s00421-004-1063-z; Periard JD, 2011, MED SCI SPORT EXER, V43, P1657, DOI 10.1249/MSS.0b013e3182148a9a; Racinais S, 2008, J PHYSIOL-LONDON, V586, P4751, DOI 10.1113/jphysiol.2008.157420; Racinais S, 2010, SCAND J MED SCI SPOR, V20, P1, DOI 10.1111/j.1600-0838.2010.01204.x; Rainoldi A, 2004, J NEUROSCI METH, V134, P37, DOI 10.1016/j.jneumeth.2003.10.014; Saboisky J, 2003, EXP PHYSIOL, V88, P783, DOI 10.1113/eph8802611; Shirreffs SM, 2011, J SPORT SCI, V29, pS39, DOI 10.1080/02640414.2011.614269; Stevens-Lapsley JE, 2013, ARCH GERONTOL GERIAT, V56, P279, DOI 10.1016/j.archger.2012.06.017; Todd G, 2005, J PHYSIOL-LONDON, V563, P621, DOI 10.1113/jphysiol.2004.077115; Todd G, 2003, J PHYSIOL-LONDON, V551, P661, DOI 10.1113/jphysiol.2003.044099; Vallier JM, 2005, BRIT J SPORT MED, V39, DOI 10.1136/bjsm.2004.012393; Verges S, 2009, J APPL PHYSIOL, V106, P701, DOI 10.1152/japplphysiol.01051.2007	33	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e77004	10.1371/journal.pone.0077004	http://dx.doi.org/10.1371/journal.pone.0077004			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098574	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000325434500092
J	Chen, Y; Dorjgochoo, T; Bao, PP; Zheng, Y; Cai, H; Lu, W; Shu, XO				Chen, Yong; Dorjgochoo, Tsogzolmaa; Bao, Ping-Ping; Zheng, Ying; Cai, Hui; Lu, Wei; Shu, Xiao-Ou			Menopausal Symptoms among Breast Cancer Patients: A Potential Indicator of Favorable Prognosis	PLOS ONE			English	Article							QUALITY-OF-LIFE; VASOMOTOR SYMPTOMS; HOT FLASH; WOMEN; PREVALENCE; ESTROGEN; HORMONES; METABOLITES; MANAGEMENT; RECURRENCE	Menopausal symptoms have been suggested to be an indicator of better prognosis among patients treated for breast cancer, because women who experience these symptoms usually have a lower level of estrogen. We tested this hypothesis in a population-based, prospective cohort study involving 4,842 women with stage 0 to III primary breast cancer who were enrolled in the Shanghai Breast Cancer Survival Study between March 2002 and April 2006, were aged 20 to 75 years, and were recruited 6 months post-diagnosis. They were followed-up by in-person surveys and record linkages with the vital statistics registry. Cox regression analysis was used to evaluate the association of menopausal symptoms at baseline with breast cancer recurrence. Approximately 56% of patients experienced at least one menopausal symptom, including hot flashes, night sweats, and/or vaginal dryness at baseline. During a median follow-up period of 5.3 years, 720 women had a recurrence. Experiencing hot flashes or having >= 2 menopausal symptoms was associated with lower risk of recurrence among premenopausal women (hazard ratio [HR]=0.77, 95% confidence interval [CI]: 0.62-0.96 for hot flashes; 0.73, 0.56-0.96 for >= 2 menopausal symptoms). Lower recurrence risk in relation to hot flashes was also observed among women who were not overweight/obese (HR=0.78, 95% CI: 0.64-0.99), those with relatively low waist-to-hip ratio (WHR) (HR=0.77, 95% CI: 0.61-0.97), and those who used tamoxifen (HR=0.75, 95% CI: 0.58-0.98). Consistently experiencing multiple menopausal symptoms was associated with lower recurrence risk among women with low WHR or who used tamoxifen. This large, population-based cohort study of women with breast cancer confirms that experiencing menopausal symptoms is an indicator of favorable breast cancer prognosis.	[Chen, Yong] Shanghai Municipal Ctr Dis Control & Prevent, Dept Sci & Educ, Shanghai, Peoples R China; [Dorjgochoo, Tsogzolmaa; Cai, Hui; Shu, Xiao-Ou] Vanderbilt Univ, Sch Med, Dept Med, Div Epidemiol, Nashville, TN 37212 USA; [Dorjgochoo, Tsogzolmaa; Cai, Hui; Shu, Xiao-Ou] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Bao, Ping-Ping] Shanghai Municipal Ctr Dis Control & Prevent, Dept Canc Prevent & Control, Shanghai, Peoples R China; [Zheng, Ying; Lu, Wei] Shanghai Inst Prevent Med, Dept Canc Prevent & Control, Shanghai, Peoples R China	Shanghai Center for Disease Control & Prevention; Vanderbilt University; Vanderbilt University; Shanghai Center for Disease Control & Prevention	Shu, XO (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Epidemiol, Nashville, TN 37212 USA.	xiao-ou.shu@vanderbilt.edu	Lu, Wei/AAE-2921-2022	Lu, Wei/0000-0002-4150-8674	Department of Defense Breast Cancer Research Program [DAMD 17-02-1-0607]; National Cancer Institute [R01 CA118229]; Fogarty International Center [D43 TW008313]; FOGARTY INTERNATIONAL CENTER [D43TW008313] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA118229] Funding Source: NIH RePORTER	Department of Defense Breast Cancer Research Program(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants from the Department of Defense Breast Cancer Research Program (DAMD 17-02-1-0607 to XOS) and the National Cancer Institute (R01 CA118229 to XOS). YC and PPB were supported by a training grant from the Fogarty International Center (D43 TW008313 to XOS). The content of this manuscript does not necessarily reflect the position or the policy of the United States Government, and no official endorsement should be inferred. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1990, J AM MED REC ASS S, V61, P1; BOULET MJ, 1994, MATURITAS, V19, P157, DOI 10.1016/0378-5122(94)90068-X; Brown Kristy A, 2012, Front Biosci (Elite Ed), V4, P2515; Carney PI, 2010, MENOPAUSE, V17, P678, DOI 10.1097/gme.0b013e3181e3a10a; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen WQ, 2013, CHIN J CANCER, V32, P106, DOI 10.5732/cjc.013.10018; Clemons M, 2002, CANCER TREAT REV, V28, P321, DOI 10.1016/S0305-7372(02)00089-0; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Dorjgochoo T, 2011, BREAST CANCER RES TR, V130, P879, DOI 10.1007/s10549-010-1096-4; Dorjgochoo T, 2010, BREAST CANCER RES TR, V119, P725, DOI 10.1007/s10549-009-0434-x; Dorjgochoo T, 2009, MENOPAUSE, V16, P1205, DOI 10.1097/gme.0b013e3181aac32b; FELDMAN BM, 1985, RES NURS HEALTH, V8, P261, DOI 10.1002/nur.4770080308; Fenlon D R, 2007, Cancer Nurs, V30, pE19, DOI 10.1097/01.NCC.0000281731.95113.a3; Ganz Patricia A, 2005, Am J Med, V118 Suppl 12B, P136, DOI 10.1016/j.amjmed.2005.09.047; Glaus A, 2006, ANN ONCOL, V17, P801, DOI 10.1093/annonc/mdl030; Goetz MP, 2003, JNCI-J NATL CANCER I, V95, P1734, DOI 10.1093/jnci/djg129; Gupta P, 2006, CLIMACTERIC, V9, P49, DOI 10.1080/13697130500487224; Harris PF, 2002, J PAIN SYMPTOM MANAG, V23, P501, DOI 10.1016/S0885-3924(02)00395-0; Hoda Daanish, 2003, Breast J, V9, P431, DOI 10.1046/j.1524-4741.2003.09526.x; Howlader N, 1975, SEER CANC STAT REV 1; Hwang CS, 2006, J STEROID BIOCHEM, V101, P246, DOI 10.1016/j.jsbmb.2006.06.020; Kurosumi M, 2008, BREAST CANCER-TOKYO, V15, P5, DOI 10.1007/s12282-007-0016-x; Loprinzi CL, 2008, LANCET ONCOL, V9, P993, DOI 10.1016/S1470-2045(08)70256-0; McTiernan A, 2003, J CLIN ONCOL, V21, P1961, DOI 10.1200/JCO.2003.07.057; Moore HCF, 2001, CLEV CLIN J MED, V68, P243; Mortimer JE, 2008, BREAST CANCER RES TR, V108, P421, DOI 10.1007/s10549-007-9612-x; Nelson HD, 2008, LANCET, V371, P760, DOI 10.1016/S0140-6736(08)60346-3; Oleske DM, 2004, ONCOL NURS FORUM, V31, P1081, DOI 10.1188/04.ONF.1081-1088; Randolph JF, 2005, J CLIN ENDOCR METAB, V90, P6106, DOI 10.1210/jc.2005-1374; Rock CL, 2008, CANCER EPIDEM BIOMAR, V17, P614, DOI 10.1158/1055-9965.EPI-07-0761; Roy SS, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/654698; Ruiter R, 2010, PHARMACOGENOMICS, V11, P1367, DOI 10.2217/PGS.10.112; Russo J, 2003, J STEROID BIOCHEM, V87, P1, DOI 10.1016/S0960-0760(03)00390-X; Shen W, 2009, EXPERT OPIN PHARMACO, V10, P1133, DOI [10.1517/14656560902868217, 10.1517/14656560902868217 ]; Shu XO, 2004, EUR J CLIN NUTR, V58, P17, DOI 10.1038/sj.ejcn.1601738; Shyu YK, 2012, J NURS RES, V20, P208, DOI 10.1097/jnr.0b013e318265619b; Sievert LL, 2007, MENOPAUSE, V14, P261, DOI 10.1097/01.gme.0000233496.13088.24; Simpson ER, 2003, J STEROID BIOCHEM, V86, P225, DOI 10.1016/S0960-0760(03)00360-1; Yang Y. X., 2002, CHINA FOOD COMPOSITI; Zollner YF, 2005, QUAL LIFE RES, V14, P309, DOI 10.1007/s11136-004-0688-z	40	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75926	10.1371/journal.pone.0075926	http://dx.doi.org/10.1371/journal.pone.0075926			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098745	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500115
J	Diaz-Nieto, LM; Macia, A; Parisi, G; Farina, JL; Vidal-Dominguez, ME; Perotti, MA; Beron, CM				Diaz-Nieto, Leonardo M.; Macia, Arnaldo; Parisi, Gustavo; Farina, Juan L.; Vidal-Dominguez, Maria E.; Perotti, M. Alejandra; Beron, Corina M.			Distribution of Mosquitoes in the South East of Argentina and First Report on the Analysis Based on 18S rDNA and COI Sequences	PLOS ONE			English	Article							WEST-NILE-VIRUS; LOUIS ENCEPHALITIS-VIRUS; OCHLEROTATUS-ALBIFASCIATUS DIPTERA; CULEX-QUINQUEFASCIATUS DIPTERA; BUENOS-AIRES PROVINCE; AEDES-AEGYPTI; MAXIMUM-LIKELIHOOD; UNITED-STATES; CULICIDAE; DNA	Although Mar del Plata is the most important city on the Atlantic coast of Argentina, mosquitoes inhabiting such area are almost uncharacterized. To increase our knowledge in their distribution, we sampled specimens of natural populations. After the morphological identification based on taxonomic keys, sequences of DNA from small ribosomal subunit (18S rDNA) and cytochrome c oxidase I (COI) genes were obtained from native species and the phylogenetic analysis of these sequences were done. Fourteen species from the genera Uranotaenia, Culex, Ochlerotatus and Psorophora were found and identified. Our 18S rDNA and COI-based analysis indicates the relationships among groups at the supra-species level in concordance with mosquito taxonomy. The introduction and spread of vectors and diseases carried by them are not known in Mar del Plata, but some of the species found in this study were reported as pathogen vectors.	[Diaz-Nieto, Leonardo M.; Vidal-Dominguez, Maria E.; Beron, Corina M.] Consejo Nacl Invest Cient & Tecn, Inst Invest Biodiversidad & Biotecnol INBIOTEC, Mar Del Plata, Argentina; [Macia, Arnaldo] Univ Nacl La Plata, Fac Ciencias Nat & Museo, Div Entomol, La Plata, Argentina; [Parisi, Gustavo] Univ Nacl Quilmes, Dept Ciencia & Tecnol, Buenos Aires, DF, Argentina; [Farina, Juan L.] Museo Municipal Ciencias Nat Lorenzo Scaglia, Area Entomol, Mar Del Plata, Argentina; [Perotti, M. Alejandra] Univ Reading, Sch Biol Sci, Ecol & Evolutionary Biol Sect, Reading, Berks, England	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata; University of Reading	Beron, CM (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Invest Biodiversidad & Biotecnol INBIOTEC, Mar Del Plata, Argentina.	cberon@fiba.org.ar	Nieto, Leonardo Díaz/AAK-8763-2020	Nieto, Leonardo Díaz/0000-0003-4661-7084; Beron, Corina/0000-0002-0365-3571; parisi, gustavo/0000-0001-7444-1624; Macia, Arnaldo/0000-0002-3729-1425	Agencia Nacional de Promocion Cientifica y Tecnologica [ANPCyT PICT-2007-02069]; Universidad Nacional de Mar del Plata [15E/329 EXA 382/07]; CONICET; Fundacion para Investigaciones Biologicas Aplicadas (FIBA)	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Universidad Nacional de Mar del Plata(National University of La Plata); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fundacion para Investigaciones Biologicas Aplicadas (FIBA)	This investigation was supported by Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT PICT-2007-02069), by the Universidad Nacional de Mar del Plata (grant 15E/329 EXA 382/07), CONICET and Fundacion para Investigaciones Biologicas Aplicadas (FIBA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Diaz LA, 2006, EMERG INFECT DIS, V12, P1752, DOI 10.3201/eid1211.060486; Diaz LA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001177; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALMIRON WR, 1995, MEM I OSWALDO CRUZ, V90, P469, DOI 10.1590/S0074-02761995000400007; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bachmann AO, 1963, REV SOC ENTOMOL ARGE, V25, P21; Beebe NW, 2000, MOL PHYLOGENET EVOL, V17, P430, DOI 10.1006/mpev.2000.0853; Belkin JN, 1970, CONTRIBUTIONS AM ENT, V4, P1, DOI DOI 10.1007/S13398-014-0173-7.2; BRAM R. A., 1967, Proceedings of the United States National Museum, V120, P1; Brewer M., 1987, REV PER ENTOMOL, V29, P69; Campos Raul E., 1995, Acta Entomologica Chilena, V19, P113; Campos RE, 2004, HYDROBIOLOGIA, V524, P91, DOI 10.1023/B:HYDR.0000036122.10578.d0; Campos RE, 2003, MEM I OSWALDO CRUZ, V98, P199, DOI 10.1590/S0074-02762003000200006; Carpenter SJ, 1955, MOSQUITOES N AM N ME; Cionchi JL, 2000, EXPLOTACION RACIONAL, P72; Crans WJ, 2004, J VECTOR ECOL, V29, P1; Cywinska A, 2006, MED VET ENTOMOL, V20, P413, DOI 10.1111/j.1365-2915.2006.00653.x; DARSIE R F JR, 1985, Mosquito Systematics, V17, P153; Demari-Silva B, 2011, J MED ENTOMOL, V48, P272, DOI 10.1603/ME09293; Diaz LA, 2009, THESIS U NACL CORDOB; Diaz-Nieto Leonardo M, 2013, PLoS Negl Trop Dis, V7, pe1963, DOI 10.1371/journal.pntd.0001963; Diez Fernando, 2012, Check List, V8, P251; DURET J P, 1953, Rev Sanid Milit Argent, V52, P272; Farina JL, 2006, TALARES BONAERENSES, P166; Fischer S, 2011, J VECTOR ECOL, V36, P94, DOI 10.1111/j.1948-7134.2011.00145.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Francia Analía, 2011, Rev. Soc. Entomol. Argent., V70, P305; GALINDO PEDRO, 1954, ANN ENT SOC AMER, V47, P107; Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Harbach RE, 2007, ZOOTAXA, P591; Harbach RE, 1998, SYST ENTOMOL, V23, P327, DOI 10.1046/j.1365-3113.1998.00072.x; Harbach RE, 2013, CULEX CLASSIFICATION; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; Hribar LJ, 2004, CARIBB J SCI, V40, P362; Huang SM, 2011, AM J TROP MED HYG, V85, P434, DOI 10.4269/ajtmh.2011.10-0679; Humeres SG, 1998, MEM I OSWALDO CRUZ, V93, P57, DOI 10.1590/S0074-02761998000100011; Ishii T, 1991, AKAIEKA NEWSLETTER, V14, P5; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kilpatrick AM, 2007, AM J TROP MED HYG, V77, P667, DOI 10.4269/ajtmh.2007.77.667; LANE J., 1953, Neotropical Culicidae. Volume I. Dixinae, Chaoborinae and Culicinae, tribes Anophelini, Toxorhynohitini and Culicini (Genus Culex only). Volume II. Tribe Culicini, Deinocerites, Uranotaenia, Man-sonia, Orthopodomyia, Aedomyia, Aedes, Psorophora, Haemagogus, tribe Sabethini, Trichoprosopon, Wyeomyia, Phoniomyia, Limatus and Sabethes.; Macia Arnaldo, 1995, Neotropica (La Plata), V41, P43; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Micieli MV, 2013, J MED ENTOMOL, V50, P853, DOI 10.1603/ME12226; MITCHELL C J, 1984, Mosquito Systematics, V16, P308; MITCHELL CJ, 1987, AM J TROP MED HYG, V36, P107, DOI 10.4269/ajtmh.1987.36.107; Morales MA, 2006, EMERG INFECT DIS, V12, P1559, DOI 10.3201/eid1210.060852; Munstermann LE, 1997, ANNU REV ENTOMOL, V42, P351, DOI 10.1146/annurev.ento.42.1.351; OPS/OMS, 2010, DENG GUIAS DIAGN TRA; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Pisano MB, 2010, TROP MED INT HEALTH, V15, P865, DOI 10.1111/j.1365-3156.2010.02541.x; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Puigbo P, 2007, BIOINFORMATICS, V23, P1556, DOI 10.1093/bioinformatics/btm135; Reinert JF, 2000, J AM MOSQUITO CONTR, V16, P175; Rossi G, 2002, PROBIOTA, V3, P1; Sambrook J., 2001, MOL CLONING LAB MANU, P2344; Shepard JJ, 2006, J MED ENTOMOL, V43, P443, DOI 10.1603/0022-2585(2006)43[443:MPAERA]2.0.CO;2; SIRIVANAKARN S, 1978, P ENTOMOL SOC WASH, V80, P360; Smith JL, 2004, AM J TROP MED HYG, V70, P339, DOI 10.4269/ajtmh.2004.70.339; Spinsanti L, 2003, EMERG INFECT DIS, V9, P271; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tauro L, 2012, MEM I OSWALDO CRUZ, V107, P553, DOI 10.1590/S0074-02762012000400019; Turell MJ, 2005, J MED ENTOMOL, V42, P891, DOI 10.1603/0022-2585(2005)042[0891:IOVFMD]2.0.CO;2; Unlu I, 2010, J MED ENTOMOL, V47, P625, DOI 10.1603/ME09087; Vasconcelos HB, 2011, EMERG INFECT DIS, V17, P800, DOI 10.3201/eid1705.101333; Vinogradova EB, 2000, CULEX PIPIENS PIPIEN	70	10	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75516	10.1371/journal.pone.0075516	http://dx.doi.org/10.1371/journal.pone.0075516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098700	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000325423500071
J	Narendran, R; Himes, M; Mason, NS				Narendran, Rajesh; Himes, Michael; Mason, N. Scott			Reproducibility of Post-Amphetamine [C-11]FLB 457 Binding to Cortical D-2/3 Receptors	PLOS ONE			English	Article							INDUCED DOPAMINE RELEASE; POSITRON-EMISSION-TOMOGRAPHY; SPECT MEASUREMENT; HUMAN CORTEX; TRANSMISSION; DEPENDENCE; QUANTIFICATION; RADIOTRACERS; COCAINE; BRAIN	In a recent positron emission tomography (PET) study, we demonstrated the ability to measure amphetamine-induced dopamine (DA) release in the human cortex with the relatively high affinity dopamine D-2/3 radioligand [C-11]FLB 457. Herein we report on reproducibility and reliability of [C-11]FLB 457 binding potential relative to non-displaceable uptake (BPND) following an acute amphetamine challenge. Ten healthy human subjects were studied twice with [C-11]FLB 457 following an acute amphetamine (oral, 0.5 mg kg(-1) dose) challenge on two-separate days approximately one week apart. D-2/3 receptor binding parameters were estimated using a two-tissue compartment kinetic analysis in the cortical regions of interest and cerebellum (reference region). The test-retest variability and intraclass correlation coefficient were assessed for distribution volume (V-T), binding potential relative to plasma concentration (BPP), and BPND of [C-11]FLB 457. The test-retest variability of [C-11]FLB 457 V-T, BPP and BPND were <= 17%, 22% and 11% respectively. These results, which are consistent with the published test-retest variability for this ligand measured under baseline conditions demonstrate that the post-amphetamine [C-11]FLB 457 BPND is reproducible. These data further support the use [C-11]FLB 457 and amphetamine to characterize cortical dopamine transmission in neuropsychiatric disorders.	[Narendran, Rajesh; Himes, Michael; Mason, N. Scott] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Narendran, R (corresponding author), Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA.	narendranr@upmc.edu			National Institute on Drug Abuse [RO1 DA026472]; National Institute on Alcohol Abuse and Alcoholism [RO1 AA018330]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026472] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Awards from the National Institute on Drug Abuse (RO1 DA026472) and National Institute on Alcohol Abuse and Alcoholism (RO1 AA018330) supported this work. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABI-DARGHAM A, 1994, J NUCL MED, V35, P228; Bailer UF, 2012, INT J EAT DISORDER, V45, P263, DOI 10.1002/eat.20937; Breier A, 1997, P NATL ACAD SCI USA, V94, P2569, DOI 10.1073/pnas.94.6.2569; Carson RE, 1997, J CEREBR BLOOD F MET, V17, P437, DOI 10.1097/00004647-199704000-00009; Cropley VL, 2008, SYNAPSE, V62, P399, DOI 10.1002/syn.20506; DEUITCH L, 2012, IMAGING PREFRONTAL C; Endres CJ, 1997, J CEREBR BLOOD F MET, V17, P932, DOI 10.1097/00004647-199709000-00002; GANDELMAN MS, 1994, J PHARM SCI, V83, P1014, DOI 10.1002/jps.2600830718; Gunn RN, 1998, NEUROIMAGE, V8, P426, DOI 10.1006/nimg.1998.0379; HALLDIN C, 1995, J NUCL MED, V36, P1275; HILL AV, 1910, PHYS MED BIOL, V1991, P749; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Kegeles LS, 1999, SYNAPSE, V31, P302; Kirk Roger, 1982, EXPT DESIGN PROCEDUR, V2nd; Laruelle M, 2000, J CEREBR BLOOD F MET, V20, P423, DOI 10.1097/00004647-200003000-00001; Laruelle M, 1997, SYNAPSE, V25, P1, DOI 10.1002/(SICI)1098-2396(199701)25:1<1::AID-SYN1>3.0.CO;2-H; LARUELLE M, 1995, J NUCL MED, V36, P1182; Laruelle M, 1996, P NATL ACAD SCI USA, V93, P9235, DOI 10.1073/pnas.93.17.9235; Martinez D, 2005, BIOL PSYCHIAT, V58, P779, DOI 10.1016/j.biopsych.2005.04.044; Martinez D, 2003, J CEREBR BLOOD F MET, V23, P285, DOI 10.1097/01.WCB.0000048520.34839.1A; Martinez D, 2007, AM J PSYCHIAT, V164, P622, DOI 10.1176/appi.ajp.164.4.622; Martinez D, 2012, BIOL PSYCHIAT, V71, P192, DOI 10.1016/j.biopsych.2011.08.024; Mawlawi O, 2001, J CEREBR BLOOD F MET, V21, P1034, DOI 10.1097/00004647-200109000-00002; NARENDRAN R, 2010, J PHARMACOL EXP THER, V63, P574; NARENDRAN R, 2013, MOL PSYCHIA IN PRESS; Narendran R, 2011, SYNAPSE, V65, P991, DOI 10.1002/syn.20926; Narendran R, 2011, SYNAPSE, V65, P35, DOI 10.1002/syn.20813; Narendran R, 2010, J PHARMACOL EXP THER, V333, P533, DOI 10.1124/jpet.109.163501; Narendran R, 2009, SYNAPSE, V63, P574, DOI 10.1002/syn.20633; Narendran R, 2009, SYNAPSE, V63, P447, DOI 10.1002/syn.20628; Olsson H, 1999, J CEREBR BLOOD F MET, V19, P1164, DOI 10.1097/00004647-199910000-00013; REIMER MLJ, 1993, BIOL MASS SPECTROM, V22, P235, DOI 10.1002/bms.1200220404; Riccardi P, 2006, NEUROPSYCHOPHARMACOL, V31, P1016, DOI 10.1038/sj.npp.1300916; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sudo Y, 2001, NUCL MED COMMUN, V22, P1215, DOI 10.1097/00006231-200111000-00008; Vilkman H, 2000, EUR J NUCL MED, V27, P1666, DOI 10.1007/s002590000342; Villemagne VL, 1999, SYNAPSE, V33, P268, DOI 10.1002/(SICI)1098-2396(19990915)33:4<268::AID-SYN3>3.3.CO;2-N; Volkow ND, 1997, NATURE, V386, P830, DOI 10.1038/386830a0; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	39	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76905	10.1371/journal.pone.0076905	http://dx.doi.org/10.1371/journal.pone.0076905			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098812	gold, Green Submitted, Green Published			2022-12-25	WOS:000325423500183
J	Pusic, K; Clements, D; Kobuch, S; Hui, G				Pusic, Kae; Clements, Danielle; Kobuch, Sophie; Hui, George			Antibody and T Cell Responses in Reciprocal Prime-Boost Studies with Full-Length and Truncated Merozoite Surface Protein 1-42 Vaccines	PLOS ONE			English	Article							C-TERMINAL FRAGMENT; PLASMODIUM-FALCIPARUM; INHIBITORY ANTIBODIES; ADJUVANT FORMULATIONS; AOTUS MONKEYS; MALARIA; PARASITE; ANTIGEN; IMMUNITY; YOELII	The P. falciparum Merozoite Surface Protein 1-42 (MSP1-42) is one of the most studied malaria subunit vaccine candidates. The N-terminal fragment of MSP1-42, MSP1-33, is primarily composed of allelic sequences, and has been shown to possess T helper epitopes that influence protective antibody responses toward the C-terminal region, MSP1-19. A truncated MSP1-42 vaccine, Construct 33-I, consisting of exclusively conserved T epitope regions of MSP1-33 expressed in tandem with MSP1-19, was previously shown to be a more effective immunogen than the full-length MSP1-42 vaccine. Here, by way of reciprocal priming/boosting immunization regimens, we studied the immunogenicity of Construct 33-I in the context of recognition by immune responses induced by the full-length native MSP1-42 protein, in order to gauge the effects of pre- and post-exposures to MSP1-42 on vaccine induced responses. Judging by immune responsiveness, antibody and T cell responses, Construct 33-I was effective as the priming antigen followed by full-length MSP1-42 boosting, as well as the boosting antigen following full-length MSP1-42 priming. In particular, Construct 33-I priming elicited the broadest responsiveness in immunized animals subsequently exposed to MSP1-42. Moreover, Construct 33-I, with its conserved MSP1-33 specific T cell epitopes, was equally well recognized by homologous and heterologous allelic forms of MSP1-42. Serum antibodies raised against Construct 33-I efficiently inhibited the growth of parasites carrying the heterologous MSP1-42 allele. These results suggest that Construct 33-I maintains and/or enhances its immunogenicity in an allelic or strain transcending fashion when deployed in populations having prior or subsequent exposures to native MSP1-42s.	[Pusic, Kae; Clements, Danielle; Kobuch, Sophie; Hui, George] Univ Hawaii, Dept Trop Med, Sch Med, Honolulu, HI 96822 USA	University of Hawaii System	Pusic, K (corresponding author), Univ Hawaii, Dept Trop Med, Sch Med, Honolulu, HI 96822 USA.	kae@hawaii.edu			National Institutes of Health/National Institute of Allergy and Infectious [A1076955]; NIH/National Institute of General Medical Sciences [P20GM103516]; NIH/National Institute of Diabetes and Digestive and Kidney Diseases [DK078386]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R25DK078386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103516] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious; NIH/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from National Institutes of Health/National Institute of Allergy and Infectious (A1076955) and NIH/National Institute of General Medical Sciences:(P20GM103516). KPusic was supported by NIH/National Institute of Diabetes and Digestive and Kidney Diseases (DK078386). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlYaman F, 1996, AM J TROP MED HYG, V54, P443, DOI 10.4269/ajtmh.1996.54.443; Bergmann-Leitner ES, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-315; BLACKMAN MJ, 1991, MOL BIOCHEM PARASIT, V49, P29, DOI 10.1016/0166-6851(91)90127-R; BURNS JM, 1988, P NATL ACAD SCI USA, V85, P602, DOI 10.1073/pnas.85.2.602; BURNS JM, 1989, J IMMUNOL, V142, P2835; CHANG SP, 1994, J IMMUNOL, V152, P3483; Chang SP, 1996, INFECT IMMUN, V64, P253, DOI 10.1128/IAI.64.1.253-261.1996; CHANG SP, 1992, J IMMUNOL, V149, P548; CHANG SP, 1989, P NATL ACAD SCI USA, V86, P6343, DOI 10.1073/pnas.86.16.6343; Egan AF, 1999, PARASITE IMMUNOL, V21, P133, DOI 10.1046/j.1365-3024.1999.00209.x; Hirunpetcharat C, 1997, J IMMUNOL, V159, P3400; HOLDER AA, 1984, J EXP MED, V160, P624, DOI 10.1084/jem.160.2.624; HOLDER AA, 1985, NATURE, V317, P270, DOI 10.1038/317270a0; HOLDER AA, 1994, BIOCHEM SOC T, V22, P291, DOI 10.1042/bst0220291; Hui G, 2008, CLIN VACCINE IMMUNOL, V15, P1145, DOI 10.1128/CVI.00058-08; Hui G, 2007, VACCINE, V25, P8549, DOI 10.1016/j.vaccine.2007.10.010; HUI GSN, 1991, INFECT IMMUN, V59, P1585, DOI 10.1128/IAI.59.5.1585-1591.1991; HUI GSN, 1994, J IMMUNOL, V153, P2544; HUI GSN, 1993, INFECT IMMUN, V61, P3403, DOI 10.1128/IAI.61.8.3403-3411.1993; HUI GSN, 1992, INFECT IMMUN, V60, P1422, DOI 10.1128/IAI.60.4.1422-1433.1992; John CC, 2004, J IMMUNOL, V173, P666, DOI 10.4049/jimmunol.173.1.666; Kadekoppala M, 2010, INT J PARASITOL, V40, P1155, DOI 10.1016/j.ijpara.2010.04.008; Kumar S, 2000, INFECT IMMUN, V68, P2215, DOI 10.1128/IAI.68.4.2215-2223.2000; Lee EAM, 2001, AM J TROP MED HYG, V64, P194, DOI 10.4269/ajtmh.2001.64.194; Leung WH, 2004, BBA-GEN SUBJECTS, V1675, P62, DOI 10.1016/j.bbagen.2004.08.005; Lyon JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002830; Malhotra I, 2008, J IMMUNOL, V180, P3383, DOI 10.4049/jimmunol.180.5.3383; McIntosh RS, 2007, PLOS PATHOG, V3, P647, DOI 10.1371/journal.ppat.0030072; MILLER LH, 1993, MOL BIOCHEM PARASIT, V59, P1, DOI 10.1016/0166-6851(93)90002-F; O'Donnell RA, 2001, J EXP MED, V193, P1403, DOI 10.1084/jem.193.12.1403; Olotu A, 2013, NEW ENGL J MED, V368, P1111, DOI 10.1056/NEJMoa1207564; Ouattara A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-175; Pang ALY, 2002, INFECT IMMUN, V70, P2772, DOI 10.1128/IAI.70.6.2772-2779.2002; Perraut R, 2005, J INFECT DIS, V191, P264, DOI 10.1086/426398; Pusic KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024782; Renia L, 1997, INFECT IMMUN, V65, P4419; Richards JS, 2009, IMMUNOL CELL BIOL, V87, P377, DOI 10.1038/icb.2009.27; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Singh S, 2006, INFECT IMMUN, V74, P4573, DOI 10.1128/IAI.01679-05; Stanisic DI, 2003, INFECT IMMUN, V71, P5700, DOI 10.1128/IAI.71.10.5700-5713.2003; Stephens R, 2005, BLOOD, V106, P1676, DOI 10.1182/blood-2004-10-4047; Stowers AW, 2001, INFECT IMMUN, V69, P1536, DOI 10.1128/IAI.69.3.1536-1546.2001; Tian JH, 1998, PARASITE IMMUNOL, V20, P263, DOI 10.1046/j.1365-3024.1998.00138.x; Tian JH, 1996, J IMMUNOL, V157, P1176; UDHAYAKUMAR V, 1995, J IMMUNOL, V154, P6022; Vekemans J, 2008, EXPERT REV VACCINES, V7, P223, DOI 10.1586/14760584.7.2.223	46	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75939	10.1371/journal.pone.0075939	http://dx.doi.org/10.1371/journal.pone.0075939			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098747	gold, Green Published, Green Submitted			2022-12-25	WOS:000325423500117
J	Reyskens, KMSE; Fisher, TL; Schisler, JC; O'Connor, WG; Rogers, AB; Willis, MS; Planesse, C; Rondeau, P; Bourdon, E; Essop, MF				Reyskens, Kathleen M. S. E.; Fisher, Tarryn-Lee; Schisler, Jonathan C.; O'Connor, Wendi G.; Rogers, Arlin B.; Willis, Monte S.; Planesse, Cynthia; Rondeau, Philippe; Bourdon, Emmanuel; Essop, M. Faadiel			The Maladaptive Effects of HIV Protease Inhibitors (Lopinavir/Ritonavir) on the Rat Heart	PLOS ONE			English	Article							ELEMENT-BINDING PROTEINS; INSULIN SENSITIVITY; PERIPHERAL LIPODYSTROPHY; T-LYMPHOCYTES; ATHEROSCLEROSIS; HYPERLIPIDEMIA; DEGRADATION; PGC-1-ALPHA; PREVALENCE; MECHANISMS	Although antiretroviral treatment decreases HIV-AIDS morbidity/mortality, long-term effects include onset of insulin resistance and cardiovascular diseases. Increased oxidative stress and dysregulation of the ubiquitin-proteasome system (UPS) are implicated in protease-inhibitor (PI)-mediated cardio-metabolic pathophysiology. We hypothesized that PI treatment (Lopinavir/Ritonavir) elevates myocardial oxidative stress and concomitantly inhibits the UPS, thereby attenuating cardiac function. Lopinavir/Ritonavir was dissolved in 1% ethanol (vehicle) and injected into mini-osmotic pumps that were surgically implanted into Wistar rats for 8 weeks vs. vehicle and sham controls. Subsequently, we evaluated metabolic parameters and heart function (ex vivo Langendorff perfusions) at baseline and following ischemia-reperfusion. PI-treated rats exhibited weight gain, increased serum LDL-cholesterol, higher tissue triglycerides (heart, liver), but no evidence of insulin resistance. It also upregulated hepatic gene expression of acetyl-CoA carboxylase beta and 3-hydroxy-3-methylglutaryl-CoA-reductase, key regulators of fatty acid oxidation and cholesterol synthesis, respectively. PI-treated hearts displayed impaired UPS, increased SOD activity and unaltered superoxide levels, and elevated peroxisome proliferator-activated receptor-gamma coactivator 1-alpha (PGC-1 alpha) peptide levels. Perfusion data revealed contractile dysfunction at baseline and following ischemia-reperfusion, while post-ischemic hearts exhibited decreased ATPase specific activity vs. matched controls. Early changes initiated by PI treatment resemble the metabolic syndrome and reflect a pre-atherogenic profile. Moreover, the effects of PIs on cardiac contractile function may in part be triggered by impaired UPS activity together with strain on the mitochondrial energetic system. Our study alerts to cardio-metabolic side effects of PI treatment and raises the question of the most appropriate co-therapies for patients on chronic antiretroviral treatment.	[Reyskens, Kathleen M. S. E.; Fisher, Tarryn-Lee; Essop, M. Faadiel] Univ Stellenbosch, Dept Physiol Sci, Cardiometab Res Grp, ZA-7600 Stellenbosch, South Africa; [Schisler, Jonathan C.; O'Connor, Wendi G.; Rogers, Arlin B.; Willis, Monte S.] Univ N Carolina, Dept Pathol & Lab Med, McAllister Heart Inst, Chapel Hill, NC USA; [Planesse, Cynthia; Rondeau, Philippe; Bourdon, Emmanuel] Univ Reunion, Grp Etud Inflammat Chron & Obes, Plateforme CYROI, St Denis, Reunion, France	Stellenbosch University; University of North Carolina; University of North Carolina Chapel Hill; University of La Reunion	Essop, MF (corresponding author), Univ Stellenbosch, Dept Physiol Sci, Cardiometab Res Grp, ZA-7600 Stellenbosch, South Africa.	mfessop@sun.ac.za	Bourdon, Emmanuel/P-8455-2019; rondeau, philippe/Q-1967-2019; Willis, Monte S/J-9994-2015; rondeau, philippe/F-6755-2015; Schisler, Jonathan C./C-1301-2008	rondeau, philippe/0000-0002-4652-1376; Willis, Monte S/0000-0002-0769-5816; Schisler, Jonathan C./0000-0001-7382-2783; Essop, Faadiel/0000-0002-8434-4294; Bourdon, Emmanuel/0000-0003-3731-150X	South African National Research Foundation; Stellenbosch University; Conseil Regional de La Reunion; l'Europethe Jefferson; Pilot Fellowship in Academic Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104129] Funding Source: NIH RePORTER	South African National Research Foundation(National Research Foundation - South Africa); Stellenbosch University; Conseil Regional de La Reunion; l'Europethe Jefferson; Pilot Fellowship in Academic Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the South African National Research Foundation and Stellenbosch University (MFE), the Conseil Regional de La Reunion and l'Europethe Jefferson (EB), and a Pilot Fellowship in Academic Medicine (MSW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Armstrong W, 2005, CLEV CLIN J MED, V72, P73, DOI 10.3949/ccjm.72.1.73; Becker AC, 2010, J INTERV CARDIOL, V23, P70, DOI 10.1111/j.1540-8183.2009.00520.x; Bernal E, 2012, MED CLIN-BARCELONA, V139, P561, DOI 10.1016/j.medcli.2012.03.037; Boudina S, 2005, CIRCULATION, V112, P2686, DOI 10.1161/CIRCULATIONAHA.105.554360; Cacho J, 2008, AM J PHYSIOL-ENDOC M, V295, pE1269, DOI 10.1152/ajpendo.90207.2008; Carr A, 1999, LANCET, V353, P2093, DOI 10.1016/S0140-6736(98)08468-2; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Carr A, 1998, LANCET, V351, P1881, DOI 10.1016/S0140-6736(98)03391-1; Carr A, 2008, AIDS, V22, P2313, DOI 10.1097/QAD.0b013e328315a7a5; Darley-Usmar VM, 2012, J MOL CELL CARDIOL, V52, P538, DOI 10.1016/j.yjmcc.2011.08.009; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Farhoud MH, 2012, PROTEOMICS, V12, P1349, DOI 10.1002/pmic.201100326; Ferrer E, 2011, AIDS RES HUM RETROV, V27, P1061, DOI [10.1089/aid.2010.0254, 10.1089/AID.2010.0254]; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Gan SK, 2002, DIABETES, V51, P3163, DOI 10.2337/diabetes.51.11.3163; GREENSPAN HC, 1994, IMMUNOL TODAY, V15, P209, DOI 10.1016/0167-5699(94)90245-3; Grinspoon SK, 2008, JAIDS-J ACQ IMM DEF, V48, P369, DOI 10.1161/CIRCULATIONAHA.107.189622; Hecker PA, 2012, AM J PHYSIOL-ENDOC M, V303, pE959, DOI 10.1152/ajpendo.00202.2012; Hirano Y, 2001, J BIOL CHEM, V276, P36431, DOI 10.1074/jbc.M105200200; Hui DY, 2003, PROG LIPID RES, V42, P81, DOI 10.1016/S0163-7827(02)00046-2; Jeon HB, 2007, BIOCHEM BIOPH RES CO, V357, P731, DOI 10.1016/j.bbrc.2007.04.015; Jerico C, 2006, STROKE, V37, P812, DOI 10.1161/01.STR.0000204037.26797.7f; Jiang B, 2007, TOXICOL APPL PHARM, V224, P60, DOI 10.1016/j.taap.2007.06.010; Lagathu C, 2005, BIOCHIMIE, V87, P65, DOI 10.1016/j.biochi.2004.12.007; Lekakis J, 2008, CLIN SCI, V115, P189, DOI 10.1042/CS20070353; Levine RL, 2000, METH MOL B, V99, P15; Liang JS, 2001, NAT MED, V7, P1327, DOI 10.1038/nm1201-1327; Lo J, 2010, AIDS, V24, P243, DOI 10.1097/QAD.0b013e328333ea9e; MACHO A, 1995, BLOOD, V86, P2481; Mapanga RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047322; Matarrese P, 2003, J IMMUNOL, V170, P6006, DOI 10.4049/jimmunol.170.12.6006; Melekhin VV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006961; Mondy KE, 2011, CLIN INFECT DIS, V52, P378, DOI 10.1093/cid/ciq066; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Panther LA, 2002, AM J PHYSIOL-HEART C, V283, pH1, DOI 10.1152/ajpheart.00212.2002; Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905; Punga T, 2006, J BIOL CHEM, V281, P25278, DOI 10.1074/jbc.M604983200; Riddle TM, 2001, J BIOL CHEM, V276, P37514, DOI 10.1074/jbc.M104557200; Rudich A, 2005, ACTA PHYSIOL SCAND, V183, P75, DOI 10.1111/j.1365-201X.2004.01383.x; Schmidtke G, 1999, J BIOL CHEM, V274, P35734, DOI 10.1074/jbc.274.50.35734; Sivitz W, 2010, ANTIOXID REDOX SIGN, V12, P1; Spiegelman BM, 2007, NOVART FDN SYMP, V287, P60; Taylor EB, 2011, BIOCHEM SOC T, V39, P1509, DOI 10.1042/BST0391509; Trausch-Azar J, 2010, J BIOL CHEM, V285, P40192, DOI 10.1074/jbc.M110.131615; Vallett SM, 1996, J BIOL CHEM, V271, P12247, DOI 10.1074/jbc.271.21.12247; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vernochet C, 2005, J BIOL CHEM, V280, P2238, DOI 10.1074/jbc.M408687200; Walmsley S, 2002, NEW ENGL J MED, V346, P2039, DOI 10.1056/NEJMoa012354; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Willis MS, 2007, CIRC RES, V100, P456, DOI 10.1161/01.RES.0000259559.48597.32; Willis MS, 2009, CIRC RES, V105, P80, DOI 10.1161/CIRCRESAHA.109.194928	54	31	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e73347	10.1371/journal.pone.0073347	http://dx.doi.org/10.1371/journal.pone.0073347			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098634	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500006
J	Wijeyesakere, SJ; Rizvi, SM; Raghavan, M				Wijeyesakere, Sanjeeva J.; Rizvi, Syed M.; Raghavan, Malini			Glycan-dependent and -independent Interactions Contribute to Cellular Substrate Recruitment by Calreticulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum (ER); Fluorescence Resonance Energy Transfer (FRET); Glycosylation; Molecular Chaperone; Protein Folding; Calreticulin; ERp57	MOLECULAR CHAPERONE; MUTATIONAL ANALYSIS; BINDING; CALNEXIN; INSIGHT; LECTIN; ERP57; ROLES	Background: We investigated the different modes of calreticulin-substrate binding. Results: Calreticulin binds glycosylated and nonglycosylated proteins with similar affinities but distinct kinetics and P-domain conformations. Conclusion: Successful substrate recruitment by calreticulin requires glycan and P-domain-dependent interactions. Significance: Elucidation of the distinct modes of calreticulin binding to substrate glycan and polypeptide components and their combined contributions to substrate recruitment in cells. Calreticulin is an endoplasmic reticulum chaperone with specificity for monoglucosylated glycoproteins. Calreticulin also inhibits precipitation of nonglycosylated proteins and thus contains generic protein-binding sites, but their location and contributions to substrate folding are unknown. We show that calreticulin binds glycosylated and nonglycosylated proteins with similar affinities but distinct interaction kinetics. Although both interactions involve the glycan-binding site or its vicinity, the arm-like proline-rich (P-) domain of calreticulin contributes to binding non/deglycosylated proteins. Correspondingly, ensemble FRET spectroscopy measurements indicate that glycosylated and nonglycosylated proteins induce open and closed P-domain conformations, respectively. The co-chaperone ERp57 influences substrate-binding kinetics and induces a closed P-domain conformation. Together with analysis of the interactions of calreticulin with cellular proteins, these findings indicate that the recruitment of monoglucosylated proteins to calreticulin is kinetically driven, whereas the P-domain and co-chaperone contribute to stable substrate binding. Substrate sequestration in the cleft between the glycan-binding site and P-domain is a likely mechanism for calreticulin-assisted protein folding.	[Wijeyesakere, Sanjeeva J.; Rizvi, Syed M.; Raghavan, Malini] Univ Michigan, Sch Med Sch, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Raghavan, M (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, 5641 Med Sci Bldg 2, Ann Arbor, MI 48109 USA.	malinir@umich.edu			National Institutes of Health [AI066131, AI044115, DK020572]; American Heart Association [12POST8810006]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI044115, R01AI044115, R01AI066131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, P60DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health grants (AI066131 and AI044115 to M. R.). This work was also supported by an American Heart Association grant (12POST8810006 to S. J. W.) and utilized the DNA sequencing cores of the Michigan Diabetes Research and Training Center funded by a National Institutes of Health grant (DK020572).	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Brockmeier A, 2009, J BIOL CHEM, V284, P3433, DOI 10.1074/jbc.M804866200; Chouquet A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017886; Coe H, 2009, GEN PHYSIOL BIOPHYS, V28, pF96; D'Alessio C, 2010, SEMIN CELL DEV BIOL, V21, P491, DOI 10.1016/j.semcdb.2009.12.014; Del Cid N, 2010, J BIOL CHEM, V285, P4520, DOI 10.1074/jbc.M109.085407; DelProposto J, 2009, PROTEIN EXPRES PURIF, V63, P40, DOI 10.1016/j.pep.2008.08.011; Donnelly MI, 2006, PROTEIN EXPRES PURIF, V47, P446, DOI 10.1016/j.pep.2005.12.011; Ellgaard L, 2003, CELL BIOCHEM BIOPHYS, V39, P223, DOI 10.1385/CBB:39:3:223; Ellgaard L, 2001, P NATL ACAD SCI USA, V98, P3133, DOI 10.1073/pnas.051630098; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; Garboczi DN, 1996, J IMMUNOL, V157, P5403; HAMMERLING GJ, 1982, P NATL ACAD SCI-BIOL, V79, P4737, DOI 10.1073/pnas.79.15.4737; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Ihara Y, 1999, MOL CELL, V4, P331, DOI 10.1016/S1097-2765(00)80335-4; Jeffery E, 2011, J BIOL CHEM, V286, P2402, DOI 10.1074/jbc.M110.180877; Kapoor M, 2004, BIOCHEMISTRY-US, V43, P97, DOI 10.1021/bi0355286; Kozlov G, 2010, J BIOL CHEM, V285, P38612, DOI 10.1074/jbc.M110.168294; Marcinowski M, 2011, NAT STRUCT MOL BIOL, V18, P150, DOI 10.1038/nsmb.1970; Martin V, 2006, J BIOL CHEM, V281, P2338, DOI 10.1074/jbc.M508302200; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; Mollegaard KM, 2011, BBA-PROTEINS PROTEOM, V1814, P889, DOI 10.1016/j.bbapap.2011.03.015; Nakamura K, 2001, J CELL BIOL, V154, P961, DOI 10.1083/jcb.200102073; OHTA M, 1991, GLYCOCONJUGATE J, V8, P400, DOI 10.1007/BF00731292; Pocanschi CL, 2011, J BIOL CHEM, V286, P27266, DOI 10.1074/jbc.M111.258467; Raghavan M, 2013, TRENDS IMMUNOL, V34, P13, DOI 10.1016/j.it.2012.08.002; Rizvi SM, 2004, MOL CELL, V15, P913, DOI 10.1016/j.molcel.2004.09.001; Rutkevich LA, 2011, CURR OPIN CELL BIOL, V23, P157, DOI 10.1016/j.ceb.2010.10.011; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; SAUL R, 1985, P NATL ACAD SCI USA, V82, P93, DOI 10.1073/pnas.82.1.93; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Schuerch DW, 2005, P NATL ACAD SCI USA, V102, P12537, DOI 10.1073/pnas.0500558102; Wijeyesakere SJ, 2011, J BIOL CHEM, V286, P8771, DOI 10.1074/jbc.M110.169193; Yan Q, 2010, BIOCHEMISTRY-US, V49, P3685, DOI 10.1021/bi902067f; Zapun A, 1999, STRUCT FOLD DES, V7, pR173, DOI 10.1016/S0969-2126(99)80112-9	38	21	21	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35104	35116		10.1074/jbc.M113.507921	http://dx.doi.org/10.1074/jbc.M113.507921			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24100026	Green Published, hybrid			2022-12-25	WOS:000329867600012
J	Chang, YN; Guo, HL; Li, J; Song, Y; Zhang, MY; Jin, JJ; Xing, GM; Zhao, YL				Chang, Ya-Nan; Guo, Haili; Li, Juan; Song, Yan; Zhang, Mingyi; Jin, Junjiang; Xing, Gengmei; Zhao, Yuliang			Adjusting the Balance between Effective Loading and Vector Migration of Macrophage Vehicles to Deliver Nanoparticles	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; IRON-OXIDE NANOPARTICLES; CELL-MIGRATION; DRUG-DELIVERY; TUMOR; ADHESION; NANOTECHNOLOGY; RECOGNITION; METASTASIS; PARTICLES	The nature of macrophage allows the possibility that this cell type could be used as drug delivery system to track therapeutic drug nanoparticles (NPs) in cancer. However, there is no existing research on the regulation between effective loading of NPs and targeted delivery of macrophages. Here, we investigated the important parameters of intracellular NP quantity and the vector migration rate. Macrophage loading capacity was obtained by comparing the uptake quantity of varisized NPs, and the delivery ability of loaded cells was determined by measuring vector migration rates. We observed a positive correlation between the size of NPs and directed macrophage migration. Our findings suggest that the molecular mechanism of migration vector rate regulation involved increased expression levels of colony-stimulating factor-1 (CSF-1) receptor and integrin induced by 100-nm and 500-nm particles. The ability of macrophages uptake to varisized NPs showed the opposite trend, with the increased vector rate of cell migration influenced by NPs. We are able to demonstrate the important balance between effective macrophage loading and targeted delivery. By adjusting the balance parameters, it will be possible to utilize NPs in macrophage-mediated disease diagnosis and therapy.	[Chang, Ya-Nan; Guo, Haili; Li, Juan; Song, Yan; Zhang, Mingyi; Jin, Junjiang; Xing, Gengmei; Zhao, Yuliang] Chinese Acad Sci, Inst High Energy Phys, Key Lab Biomed Effects Nanomat & Nanosafety, Beijing, Peoples R China; [Zhao, Yuliang] Chinese Acad Sci, Natl Ctr Nanosci & Technol China, Key Lab Biomed Effects Nanomat & Nanosafety, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Chinese Academy of Sciences; National Center for Nanoscience & Technology - China	Xing, GM (corresponding author), Chinese Acad Sci, Inst High Energy Phys, Key Lab Biomed Effects Nanomat & Nanosafety, Beijing, Peoples R China.	xinggm@ihep.ac.cn; zhaoyuliang@ihep.ac.cn		Chang, Yanan/0000-0003-4745-6876; Li, Juan/0000-0003-4110-3295	National Basic Research Program of China (973 Program) [2013CB932703, 2012CB932601]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	The authors are grateful for the support of the National Basic Research Program of China (973 Program) (2013CB932703 and 2012CB932601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banno A, 2008, BIOCHEM SOC T, V36, P229, DOI 10.1042/BST0360229; Beduneau A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004343; Chellat F, 2005, BIOMATERIALS, V26, P7260, DOI 10.1016/j.biomaterials.2005.05.044; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cui ZG, 2004, PHARM RES-DORDR, V21, P1018, DOI 10.1023/B:PHAM.0000029292.66792.4f; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498; Gendelman HE, 2009, J NEUROIMMUNE PHARM, V4, P47, DOI 10.1007/s11481-008-9135-1; Horwitz R, 2003, CURR BIOL, V13, pR756, DOI 10.1016/j.cub.2003.09.014; Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214; Ikehara Y, 2006, CANCER RES, V66, P8740, DOI 10.1158/0008-5472.CAN-06-0470; Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30; Kindwall-Keller TL, 2008, CYTOKINE, V43, P114, DOI 10.1016/j.cyto.2008.04.015; Kingsley JD, 2006, J NEUROIMMUNE PHARM, V1, P340, DOI 10.1007/s11481-006-9032-4; Kluth DC, 2004, KIDNEY INT, V66, P542, DOI 10.1111/j.1523-1755.2004.00773.x; KOLBBACHOFEN V, 1991, CARBOHYD RES, V213, P201, DOI 10.1016/S0008-6215(00)90609-8; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee JY, 2008, N-S ARCH PHARMACOL, V377, P111, DOI 10.1007/s00210-008-0266-y; McCarthy JR, 2006, SMALL, V2, P983, DOI 10.1002/smll.200600139; Meng FY, 1998, EMBO J, V17, P4391, DOI 10.1093/emboj/17.15.4391; Nahrendorf M, 2008, CIRCULATION, V117, P379, DOI 10.1161/CIRCULATIONAHA.107.741181; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Raynal I, 2004, INVEST RADIOL, V39, P56, DOI 10.1097/01.rli.0000101027.57021.28; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Schwartz MA, 2006, CELL, V125, P1223, DOI 10.1016/j.cell.2006.06.015; Settles M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025197; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Valois CRA, 2010, BIOMATERIALS, V31, P366, DOI 10.1016/j.biomaterials.2009.09.053; Wang L, 2008, CANCER RES, V68, P5639, DOI 10.1158/0008-5472.CAN-07-5804; Xia T, 2008, ACS NANO, V2, P85, DOI 10.1021/nn700256c; Zahr AS, 2005, LANGMUIR, V21, P403, DOI 10.1021/la0478595; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240; Zhang MY, 2011, ARCH TOXICOL, V85, P1575, DOI 10.1007/s00204-011-0725-y; Zhao YL, 2011, NANOMEDICINE-UK, V6, P25, DOI [10.2217/nnm.10.129, 10.2217/NNM.10.129]	39	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76024	10.1371/journal.pone.0076024	http://dx.doi.org/10.1371/journal.pone.0076024			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116086	Green Published, gold, Green Submitted			2022-12-25	WOS:000325552200046
J	Chinnaswamy, S; Chatterjee, S; Boopathi, R; Mukherjee, S; Bhattacharjee, S; Kundu, TK				Chinnaswamy, Sreedhar; Chatterjee, Snehajyoti; Boopathi, Ramachandran; Mukherjee, Shuvolina; Bhattacharjee, Samsiddhi; Kundu, Tapas K.			A Single Nucleotide Polymorphism Associated with Hepatitis C Virus Infections Located in the Distal Region of the IL28B Promoter Influences NF-kappa B-Mediated Gene Transcription	PLOS ONE			English	Article							NECROSIS FACTOR-ALPHA; INTERFERON-ALPHA; RIBAVIRIN THERAPY; INNATE IMMUNITY; PLUS RIBAVIRIN; EXPRESSION; LAMBDA; RECOGNITION; CLEARANCE; GENOTYPE	Persistence of hepatitis C virus (HCV) infection is observed only in a subset of infected individuals and among them only some respond to treatment. Genome-wide association studies (GWAS) carried out around the world identified single nucleotide polymorphisms (SNPs) in the IL28B locus that are strongly associated with both HCV clearance and treatment response. The functional significance of these associations however, is not clear. In this report we show that an SNP rs28416813 in the distal promoter region of IL28B that is in close proximity to a non-consensus NF-kappa B-binding site affects downstream reporter gene expression. The effect is likely due to differential binding of NF-kappa B at the non-consensus site. The non-protective allele showed a reduction in luciferase reporter gene expression compared to the protective allele in HEK293T cells under different experimental conditions including treatment with tumor necrosis factor alpha (TNF-alpha) and 5' triphosphorylated dsRNA. Furthermore, the HCV RNA polymerase was able to induce transcription from the IL28B promoter in a RIG-I-dependent manner. This induction was influenced by the alleles present at rs28416813. We also demonstrate strong linkage disequilibrium between rs28416813 and another important SNP rs12979860 in two ethnic populations. These results suggest possible mechanisms by which SNPs at the IL28B locus influence spontaneous clearance and treatment response in chronic HCV infections.	[Chinnaswamy, Sreedhar; Mukherjee, Shuvolina; Bhattacharjee, Samsiddhi] Natl Inst Biomed Genom, Kalyani, W Bengal, India; [Chatterjee, Snehajyoti; Boopathi, Ramachandran; Kundu, Tapas K.] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Transcript & Dis Lab, Mol Biol & Genet Unit, Bangalore 560012, Karnataka, India	Department of Biotechnology (DBT) India; National Institute of Biomedical Genomics (NIBMG); Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Chinnaswamy, S (corresponding author), Natl Inst Biomed Genom, PO NSS, Kalyani, W Bengal, India.	sc2@nibmg.ac.in	Chatterjee, Snehajyoti/AAV-3919-2021; Chinnaswamy, Sreedhar/GMX-0166-2022	Chatterjee, Snehajyoti/0000-0002-4873-9416; Mukherjee, Shuvolina/0000-0002-2005-5274; Kundu, Tapas/0000-0001-7790-214X; Bhattacharjee, Samsiddhi/0000-0002-8549-1130; Chinnaswamy, Sreedhar/0000-0003-0095-3453	Science and Engineering Research Board (SERB), Department of Science and Technology, Ministry of Science and Technology, Government of India, [SR/FT/LS-26/2011]; National Institute of Biomedical Genomics, Kalyani	Science and Engineering Research Board (SERB), Department of Science and Technology, Ministry of Science and Technology, Government of India,; National Institute of Biomedical Genomics, Kalyani	The funding for this work was provided to SC1 by the Science and Engineering Research Board (SERB), Department of Science and Technology, Ministry of Science and Technology, Government of India, under the SERB young scientist project #SR/FT/LS-26/2011 and by the National Institute of Biomedical Genomics, Kalyani. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2011, J HEPATOL, V54, P1094, DOI 10.1016/j.jhep.2010.09.019; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Asahina Y, 2012, HEPATOLOGY, V55, P20, DOI 10.1002/hep.24623; Balachandran S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002165; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Chen JY, 2011, GENES IMMUN, V12, P300, DOI 10.1038/gene.2011.1; Clark PJ, 2012, J GASTROEN HEPATOL, V27, P212, DOI 10.1111/j.1440-1746.2011.06918.x; de Castellarnau M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031016; Diegelmann J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015200; Ding Q, 2012, EUR J IMMUNOL, V42, P2374, DOI 10.1002/eji.201242388; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hayes CN, 2012, NAT REV GASTRO HEPAT, V9, P406, DOI 10.1038/nrgastro.2012.101; Hohler T, 1998, J Med Virol, V54, P173, DOI 10.1002/(SICI)1096-9071(199803)54:3&lt;173::AID-JMV5&gt;3.0.CO;2-2; Huang CF, 2012, ANTIVIR RES, V93, P239, DOI 10.1016/j.antiviral.2011.12.002; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kohli A, 2012, J VIRAL HEPATITIS, V19, P843, DOI 10.1111/j.1365-2893.2012.01610.x; Langhans B, 2011, J HEPATOL, V54, P859, DOI 10.1016/j.jhep.2010.08.020; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Li W, 2012, ANTIVIR RES, V94, P54, DOI 10.1016/j.antiviral.2012.02.007; Liu HM, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/548390; Lyoo K, 2011, J CLIN VIROL, V52, P363, DOI 10.1016/j.jcv.2011.08.006; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Murata K, 2014, J GASTROENTEROL, V49, P126, DOI 10.1007/s00535-013-0814-1; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Osterlund PI, 2007, J IMMUNOL, V179, P3434, DOI 10.4049/jimmunol.179.6.3434; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; R Core Team, 2021, R LANG ENV STAT COMP; Ranjith-Kumar CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022575; Reynolds JM, 2012, PLOS ONE, V7, P271, DOI 10.1371/journal.pone.0029983; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Shi XD, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037054, 10.1371/journal.pone.0030828]; Shin JH, 2006, J STAT SOFT, P16; Shindo H, 2013, J VIRAL HEPATITIS, V20, P281, DOI 10.1111/j.1365-2893.2012.01649.x; Simonin Y, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003234; Smale ST, 2011, NAT IMMUNOL, V12, P689, DOI 10.1038/ni.2070; Smith KR, 2011, GENOME MED, V3, DOI 10.1186/gm273; Stone AEL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003316; Stranger BE, 2011, GENETICS, V187, P367, DOI 10.1534/genetics.110.120907; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Subba-Reddy CV, 2011, J VIROL, V85, P13027, DOI 10.1128/JVI.06191-11; Sugiyama M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026620; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thomas E, 2012, GASTROENTEROLOGY, V142, P978, DOI 10.1053/j.gastro.2011.12.055; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Venegas M, 2011, WORLD J GASTROENTERO, V17, P3636, DOI 10.3748/wjg.v17.i31.3636; Yu GY, 2012, MOL CELL, V48, P313, DOI 10.1016/j.molcel.2012.07.032	51	21	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75495	10.1371/journal.pone.0075495	http://dx.doi.org/10.1371/journal.pone.0075495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116050	gold, Green Submitted, Green Published			2022-12-25	WOS:000325552200024
J	Hofman, J; Kucera, R; Cihalova, D; Klimes, J; Ceckova, M; Staud, F				Hofman, Jakub; Kucera, Radim; Cihalova, Daniela; Klimes, Jiri; Ceckova, Martina; Staud, Frantisek			Olomoucine II, but Not Purvalanol A, Is Transported by Breast Cancer Resistance Protein (ABCG2) and P-Glycoprotein (ABCB1)	PLOS ONE			English	Article							DEPENDENT KINASE INHIBITORS; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; IN-VITRO; AFFINITY-CHROMATOGRAPHY; CAMPTOTHECIN ANALOGS; CELLS; IDENTIFICATION; ROSCOVITINE; SELICICLIB	Purine cyclin-dependent kinase inhibitors have been recognized as promising candidates for the treatment of various cancers; nevertheless, data regarding interaction of these substances with drug efflux transporters is still lacking. Recently, we have demonstrated inhibition of breast cancer resistance protein (ABCG2) by olomoucine II and purvalanol A and shown that these compounds are able to synergistically potentiate the antiproliferative effect of mitoxantrone, an ABCG2 substrate. In this follow up study, we investigated whether olomoucine II and purvalanol A are transported by ABCG2 and ABCB1 (P-glycoprotein). Using monolayers of MDCKII cells stably expressing human ABCB1 or ABCG2, we demonstrated that olomoucine II, but not purvalanol A, is a dual substrate of both ABCG2 and ABCB1. We, therefore, assume that pharmacokinetics of olomoucine II will be affected by both ABCB1 and ABCG2 transport proteins, which might potentially result in limited accumulation of the compound in tumor tissues or lead to drug-drug interactions. Pharmacokinetic behavior of purvalanol A, on the other hand, does not seem to be affected by either ABCG2 or ABCB1, theoretically favoring this drug in the potential treatment of efflux transporter-based multidrug resistant tumors. In addition, we observed intensive sulfatation of olomoucine II in MDCKII cell lines with subsequent active efflux of the metabolite out of the cells. Therefore, care should be taken when performing pharmacokinetic studies in MDCKII cells, especially if radiolabeled substrates are used; the generated sulfated conjugate may largely contaminate pharmacokinetic analysis and result in misleading interpretation. With regard to chemical structures of olomoucine II and purvalanol A, our data emphasize that even drugs with remarkable structure similarity may show different pharmacokinetic behavior such as interactions with ABC transporters or biotransformation enzymes.	[Hofman, Jakub; Cihalova, Daniela; Ceckova, Martina; Staud, Frantisek] Charles Univ Prague, Fac Pharm, Dept Pharmacol & Toxicol, Hradec Kralove, Czech Republic; [Kucera, Radim; Klimes, Jiri] Charles Univ Prague, Fac Pharm, Dept Pharmaceut Chem & Drug Anal, Hradec Kralove, Czech Republic	Charles University Prague; Charles University Prague	Staud, F (corresponding author), Charles Univ Prague, Fac Pharm, Dept Pharmacol & Toxicol, Hradec Kralove, Czech Republic.	frantisek.staud@faf.cuni.cz	Ceckova, Martina/M-1849-2018; Staud, Frantisek/F-4596-2010; Klimes, Jiri/T-7803-2017; Kučera, Radim/AAD-7444-2019; Kučera, Radim/S-6366-2017; Hofman, Jakub/T-6461-2017	Ceckova, Martina/0000-0003-2936-7212; Staud, Frantisek/0000-0001-6712-097X; Klimes, Jiri/0000-0002-0708-1435; Kučera, Radim/0000-0003-3052-7965; Kučera, Radim/0000-0003-3052-7965; Hofman, Jakub/0000-0002-4285-7681	Grant Agency of Charles University [700912/C/2012, SVV/2013/267-003]; European Social Fund; state budget of the Czech Republic [CZ.1.07/2.3.00/30.0061]	Grant Agency of Charles University; European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic	This work was supported by Grant Agency of Charles University 700912/C/2012 and SVV/2013/267-003. The publication is co-financed by the European Social Fund and the state budget of the Czech Republic, Project no. CZ.1.07/2.3.00/30.0061. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldoss IT, 2009, EXPERT OPIN INV DRUG, V18, P1957, DOI 10.1517/13543780903418445; Allen JD, 2002, MOL CANCER THER, V1, P427; An R, 2009, PHARM RES-DORDR, V26, P449, DOI 10.1007/s11095-008-9738-5; Bachmeier CJ, 2005, PHARM RES-DORDR, V22, P113, DOI 10.1007/s11095-004-9016-0; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Cicenas J, 2011, J CANCER RES CLIN, V137, P1409, DOI 10.1007/s00432-011-1039-4; Dantzig AH, 1996, CANCER RES, V56, P4171; DIAZPADILLA I, 2009, INVEST NEW DRUGS; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Goh LB, 2002, BIOCHEM PHARMACOL, V64, P1569, DOI 10.1016/S0006-2952(02)01355-2; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; Han B., 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P31, DOI 10.2174/1568011043482205; Hikita T, 2010, GENES CELLS, V15, P1051, DOI 10.1111/j.1365-2443.2010.01439.x; Hofman J, 2012, PHARMACOL RES, V65, P312, DOI 10.1016/j.phrs.2011.11.017; Holcapek M, 2008, ANAL BIOANAL CHEM, V391, P59, DOI 10.1007/s00216-008-1962-7; Ishikawa T, 2006, CURR PHARM DESIGN, V12, P313, DOI 10.2174/138161206775201992; Knockaert M, 2002, BIOCHEM PHARMACOL, V64, P819, DOI 10.1016/S0006-2952(02)01144-9; Knockaert M, 2000, CHEM BIOL, V7, P411, DOI 10.1016/S1074-5521(00)00124-1; Krystof V, 2005, CELL MOL LIFE SCI, V62, P1763, DOI 10.1007/s00018-005-5185-1; Krystof V, 2002, BIOORG MED CHEM LETT, V12, P3283, DOI 10.1016/S0960-894X(02)00693-5; Krystof V, 2010, CURR DRUG TARGETS, V11, P291, DOI 10.2174/138945010790711950; Kuteykin-Teplyakov K, 2010, BRIT J PHARMACOL, V160, P1453, DOI 10.1111/j.1476-5381.2010.00801.x; Monaco EA, 2004, BIOCHEM PHARMACOL, V67, P1947, DOI 10.1016/j.bcp.2004.02.007; Nakagawa H, 2006, CANCER LETT, V234, P81, DOI 10.1016/j.canlet.2005.05.052; Ng KH, 2003, KIDNEY INT, V63, P976, DOI 10.1046/j.1523-1755.2003.00818.x; Rabindran SK, 2000, CANCER RES, V60, P47; Rajnai Z, 2010, DRUG METAB DISPOS, V38, P2000, DOI 10.1124/dmd.110.032805; Seamon JA, 2006, MOL CANCER THER, V5, P2459, DOI 10.1158/1535-7163.MCT-06-0339; Shepard RL, 2003, INT J CANCER, V103, P121, DOI 10.1002/ijc.10792; Shukla S, 2011, CURR DRUG TARGETS, V12, P621, DOI 10.2174/138945011795378540; Staud F, 2005, INT J BIOCHEM CELL B, V37, P720, DOI 10.1016/j.biocel.2004.11.004; Staud F, 2010, METHODS MOL BIOL, V596, P199, DOI 10.1007/978-1-60761-416-6_10; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Villerbu N, 2002, INT J CANCER, V97, P761, DOI 10.1002/ijc.10125; Yang KH, 2008, BIOSCI TRENDS, V2, P137	35	4	4	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75520	10.1371/journal.pone.0075520	http://dx.doi.org/10.1371/journal.pone.0075520			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116053	Green Published, Green Submitted, gold			2022-12-25	WOS:000325552200026
J	van Seeters, T; Biessels, GJ; Niesten, JM; van der Schaaf, IC; Dankbaar, JW; Horsch, AD; Mali, WPTM; Kappelle, LJ; van der Graaf, Y; Velthuis, BK				van Seeters, Tom; Biessels, Geert Jan; Niesten, Joris M.; van der Schaaf, Irene C.; Dankbaar, Jan Willem; Horsch, Alexander D.; Mali, Willem P. T. M.; Kappelle, L. Jaap; van der Graaf, Yolanda; Velthuis, Birgitta K.		Dust Investigators	Reliability of Visual Assessment of Non-Contrast CT, CT Angiography Source Images and CT Perfusion in Patients with Suspected Ischemic Stroke	PLOS ONE			English	Article							FINAL INFARCT EXTENT; ALBERTA STROKE; THROMBOLYTIC THERAPY; COMPUTED-TOMOGRAPHY; NONCONTRAST CT; SCORE ASPECTS; AGREEMENT; PREDICTION; MISMATCH; VALIDITY	Background and Purpose: Good reliability of methods to assess the extent of ischemia in acute stroke is important for implementation in clinical practice, especially between observers with varying experience. Our aim was to determine inter- and intra-observer reliability of the 1/3 middle cerebral artery (MCA) rule and the Alberta Stroke Program Early CT Score (ASPECTS) for different CT modalities in patients suspected of acute ischemic stroke. Methods: We prospectively included 105 patients with acute neurological deficit due to suspected acute ischemic stroke within 9 hours after symptom onset. All patients underwent non-contrast CT, CT perfusion and CT angiography on admission. All images were evaluated twice for presence of ischemia, ischemia with >1/3 MCA involvement, and ASPECTS. Four observers evaluated twenty scans twice for intra-observer agreement. We used kappa statistics and intraclass correlation coefficient to calculate agreement. Results: Inter-observer agreement for the 1/3 MCA rule and ASPECTS was fair to good for non-contrast CT, poor to good for CT angiography source images, but excellent for all CT perfusion maps (cerebral blood volume, mean transit time, and predicted penumbra and infarct maps). Intra-observer agreement for the 1/3 MCA rule and ASPECTS was poor to good for non-contrast CT, fair to moderate for CT angiography source images, and good to excellent for all CT perfusion maps. Conclusion: Between observers with a different level of experience, agreement on the radiological diagnosis of cerebral ischemia is much better for CT perfusion than for non-contrast CT and CT angiography source images, and therefore CT perfusion is a very reliable addition to standard stroke imaging.	[van Seeters, Tom; Niesten, Joris M.; van der Schaaf, Irene C.; Dankbaar, Jan Willem; Horsch, Alexander D.; Mali, Willem P. T. M.; Velthuis, Birgitta K.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Biessels, Geert Jan; Kappelle, L. Jaap] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht Stroke Ctr, Utrecht, Netherlands; [Horsch, Alexander D.] Rijnstate Hosp, Dept Radiol, Arnhem, Netherlands; [van der Graaf, Yolanda] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Rijnstate Hospital; Utrecht University; Utrecht University Medical Center	van Seeters, T (corresponding author), Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands.	T.vanSeeters@umcutrecht.nl	Meijer, Frederick J.A./L-4516-2015; Horsch, Alexander D./U-3330-2019; van Dijk, Ewoud J/J-7951-2012; Mali, Willem PThM/I-1123-2014	Meijer, Frederick J.A./0000-0001-5921-639X; Mali, Willem PThM/0000-0003-4391-0904; Horsch, Alexander/0000-0001-8213-2784; Dippel, Diederik/0000-0002-9234-3515	Dutch Heart Foundation [2008T034]; NutsOhra Foundation [0903-012]	Dutch Heart Foundation(Netherlands Heart Foundation); NutsOhra Foundation	This study was supported by a grant from the Dutch Heart Foundation (grant 2008T034; http://www.hartstichting.nl) and the NutsOhra Foundation (grant 0903-012; http://www.stichtingnutsohra.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviv RI, 2007, AM J NEURORADIOL, V28, P1975, DOI 10.3174/ajnr.A0689; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Butcher K, 2008, STROKE, V39, P75, DOI 10.1161/STROKEAHA.107.490524; Camargo ECS, 2007, RADIOLOGY, V244, P541, DOI 10.1148/radiol.2442061028; Coutts SB, 2004, STROKE, V35, P2472, DOI 10.1161/01.STR.0000145330.14928.2a; Coutts SB, 2004, STROKE, V35, pE103, DOI 10.1161/01.STR.0000127082.19473.45; Dippel DWJ, 2000, NEURORADIOLOGY, V42, P629, DOI 10.1007/s002340000369; Eckert B, 2011, NEURORADIOLOGY, V53, P79, DOI 10.1007/s00234-010-0702-9; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Finlayson O, 2013, STROKE, V44, P234, DOI 10.1161/STROKEAHA.112.665208; Gamer M, 2010, IRR VARIOUS COEFFICI; Grotta JC, 1999, STROKE, V30, P1528, DOI 10.1161/01.STR.30.8.1528; Kloska SP, 2007, EUR RADIOL, V17, P2491, DOI 10.1007/s00330-007-0696-9; Lev MH, 1999, RADIOLOGY, V213, P150, DOI 10.1148/radiology.213.1.r99oc10150; Lin K, 2008, AM J NEURORADIOL, V29, P931, DOI 10.3174/ajnr.A0975; Lin K, 2007, AM J NEURORADIOL, V28, P1292, DOI 10.3174/ajnr.A0539; Lin K, 2009, NEURORADIOLOGY, V51, P17, DOI 10.1007/s00234-008-0454-y; Mak HKF, 2003, STROKE, V34, P1194, DOI 10.1161/01.STR.0000069162.64966.71; Marks MP, 1999, STROKE, V30, P389, DOI 10.1161/01.STR.30.2.389; Muir KW, 2006, J NEUROL NEUROSUR PS, V77, P334, DOI 10.1136/jnnp.2005.074179; Parsons MW, 2005, ANN NEUROL, V58, P672, DOI 10.1002/ana.20638; Pexman JHW, 2001, AM J NEURORADIOL, V22, P1534; Puetz V, 2009, INT J STROKE, V4, P354, DOI 10.1111/j.1747-4949.2009.00337.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Schaefer PW, 2008, STROKE, V39, P2986, DOI 10.1161/STROKEAHA.107.513358; Sharma M, 2011, AM J NEURORADIOL, V32, P359, DOI 10.3174/ajnr.A2282; Tan JC, 2007, ANN NEUROL, V61, P533, DOI 10.1002/ana.21130; vonKummer R, 1997, RADIOLOGY, V205, P327, DOI 10.1148/radiology.205.2.9356611; Wintermark M, 2007, NEUROLOGY, V68, P694, DOI 10.1212/01.wnl.0000255959.30107.08; Wintermark M, 2006, STROKE, V37, P979, DOI 10.1161/01.STR.0000209238.61459.39	30	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75615	10.1371/journal.pone.0075615	http://dx.doi.org/10.1371/journal.pone.0075615			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116061	gold, Green Submitted, Green Published			2022-12-25	WOS:000325552200031
J	Williams, S; Bateman, A; O'Kelly, I				Williams, Sarah; Bateman, Andrew; O'Kelly, Ita			Altered Expression of Two-Pore Domain Potassium (K-2P) Channels in Cancer	PLOS ONE			English	Article							ION CHANNELS; K+ CHANNELS; CELL-PROLIFERATION; UP-REGULATION; DIFFERENTIAL EXPRESSION; ABERRANT EXPRESSION; GENE PROMOTER; MIGRATION; PROTEIN; ETHER	Potassium channels have become a focus in cancer biology as they play roles in cell behaviours associated with cancer progression, including proliferation, migration and apoptosis. Two-pore domain (K-2P) potassium channels are background channels which enable the leak of potassium ions from cells. As these channels are open at rest they have a profound effect on cellular membrane potential and subsequently the electrical activity and behaviour of cells in which they are expressed. The K-2P family of channels has 15 mammalian members and already 4 members of this family (K(2P)2.1, K(2P)3.1, K(2P)9.1, K(2P)5.1) have been implicated in cancer. Here we examine the expression of all 15 members of the K-2P family of channels in a range of cancer types. This was achieved using the online cancer microarray database, Oncomine (www.oncomine.org). Each gene was examined across 20 cancer types, comparing mRNA expression in cancer to normal tissue. This analysis revealed all but 3 K-2P family members (K(2P)4.1, K(2P)16.1, K(2P)18.1) show altered expression in cancer. Overexpression of K-2P channels was observed in a range of cancers including breast, leukaemia and lung while more cancers (brain, colorectal, gastrointestinal, kidney, lung, melanoma, oesophageal) showed underexpression of one or more channels. K(2P)1.1, K(2P)3.1, K(2P)12.1, were overexpressed in a range of cancers. While K(2P)1.1, K(2P)3.1, K(2P)5.1, K(2P)6.1, K(2P)7.1 and K(2P)10.1 showed significant underexpression across the cancer types examined. This analysis supports the view that specific K-2P channels may play a role in cancer biology. Their altered expression together with their ability to impact the function of other ion channels and their sensitivity to environmental stimuli (pO2, pH, glucose, stretch) makes understanding the role these channels play in cancer of key importance.	[Williams, Sarah; O'Kelly, Ita] Univ Southampton, Fac Med, Ctr Human Dev Stem Cells & Regenerat, Southampton SO9 5NH, Hants, England; [Bateman, Andrew] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England	University of Southampton; University of Southampton	O'Kelly, I (corresponding author), Univ Southampton, Fac Med, Ctr Human Dev Stem Cells & Regenerat, Southampton SO9 5NH, Hants, England.	I.M.O'Kelly@southampton.ac.uk			Gerald Kerkut Charitable Trust	Gerald Kerkut Charitable Trust	Work funded by the Gerald Kerkut Charitable Trust (http://www.southampton.ac.uk/similar to gktrust/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul M, 2006, J MEMBRANE BIOL, V214, P99, DOI 10.1007/s00232-006-0065-7; Rodriguez-Rasgado JA, 2012, SENSORS-BASEL, V12, P5986, DOI 10.3390/s120505986; Afrasiabi E, 2010, CELL SIGNAL, V22, P57, DOI 10.1016/j.cellsig.2009.09.010; Agarwal JR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-18; Alvarez-Baron CP, 2011, MOL ENDOCRINOL, V25, P1326, DOI 10.1210/me.2011-0045; Arcangeli A, 1995, J PHYSIOL-LONDON, V489, P455, DOI 10.1113/jphysiol.1995.sp021065; Arvind S, 2012, BRIT J NEUROSURG, V26, P16, DOI 10.3109/02688697.2011.583365; Asher V, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-6; Banderali U, 2011, CELL PHYSIOL BIOCHEM, V28, P1169, DOI 10.1159/000335850; Bittner S, 2010, BRAIN PATHOL, V20, P999, DOI 10.1111/j.1750-3639.2010.00407.x; Bortner CD, 2007, ARCH BIOCHEM BIOPHYS, V462, P176, DOI 10.1016/j.abb.2007.01.020; Brevet M, 2009, PANCREAS, V38, P649, DOI 10.1097/MPA.0b013e3181a56ebf; Brevet M, 2009, CELL PHYSIOL BIOCHEM, V24, P25, DOI 10.1159/000227810; Callies C, 2011, J CELL SCI, V124, P1936, DOI 10.1242/jcs.084657; Cambien B, 2008, INT J CANCER, V123, P365, DOI 10.1002/ijc.23511; Campanucci VA, 2005, NEUROSCIENCE, V135, P1087, DOI 10.1016/j.neuroscience.2005.07.009; Catacuzzeno L, 2011, J CELL PHYSIOL, V226, P1926, DOI 10.1002/jcp.22523; Chantome A, 2009, EXP CELL RES, V315, P3620, DOI 10.1016/j.yexcr.2009.07.021; Choi M, 2011, SCIENCE, V331, P768, DOI 10.1126/science.1198785; Coiret G, 2007, MOL PHARMACOL, V71, P843, DOI 10.1124/mol.106.028290; Cuddapah VA, 2011, AM J PHYSIOL-CELL PH, V301, pC541, DOI 10.1152/ajpcell.00102.2011; D'Amico M, 2013, RECENT PAT ANTI-CANC, V8, P53; DECOURSEY TE, 1984, NATURE, V307, P465, DOI 10.1038/307465a0; Ding XW, 2008, DIGEST DIS SCI, V53, P2039, DOI 10.1007/s10620-007-0116-7; Ding XW, 2008, J SURG ONCOL, V97, P57, DOI 10.1002/jso.20891; Ding XW, 2007, WORLD J GASTROENTERO, V13, P1257, DOI 10.3748/wjg.v13.i8.1257; Duprat F, 2005, J PHYSIOL-LONDON, V562, P235, DOI 10.1113/jphysiol.2004.071266; Duprat F, 2007, TRENDS NEUROSCI, V30, P573, DOI 10.1016/j.tins.2007.08.003; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Faouzi M, 2010, J MEMBRANE BIOL, V234, P47, DOI 10.1007/s00232-010-9238-5; Felipe A, 2006, CANCER DETECT PREV, V30, P375, DOI 10.1016/j.cdp.2006.06.002; Ferlay J, 2010, IARC CANCERBASE; Fiske JL, 2006, CANCER METAST REV, V25, P493, DOI 10.1007/s10555-006-9017-z; Fortunato P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-504; Fraser SP, 2008, EMBO REP, V9, P512, DOI 10.1038/embor.2008.75; Glassmeier G, 2012, PFLUG ARCH EUR J PHY, V463, P365, DOI 10.1007/s00424-011-1045-z; Goldstein SAN, 2005, PHARMACOL REV, V57, P527, DOI 10.1124/pr.57.4.12; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Hammadi M, 2012, J CELL PHYSIOL, V227, P3837, DOI 10.1002/jcp.24095; Han XB, 2008, BIOCHEM BIOPH RES CO, V375, P205, DOI 10.1016/j.bbrc.2008.07.161; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang LY, 2009, CARCINOGENESIS, V30, P737, DOI 10.1093/carcin/bgp034; Huang X, 2012, GENE DEV, V26, P1780, DOI 10.1101/gad.193789.112; Jang SH, 2009, BMB REP, V42, P535, DOI 10.5483/BMBRep.2009.42.8.535; Jang SH, 2009, BIOCHEM BIOPH RES CO, V384, P180, DOI 10.1016/j.bbrc.2009.04.108; Khaitan D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-258; Kim CJ, 2004, APMIS, V112, P588, DOI 10.1111/j.1600-0463.2004.apm1120905.x; Kim HJ, 2010, BIOL PHARM BULL, V33, P1754, DOI 10.1248/bpb.33.1754; Kosztka L, 2011, MELANOMA RES, V21, P308, DOI 10.1097/CMR.0b013e3283462713; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Lai W, 2011, ONCOL REP, V26, P909, DOI 10.3892/or.2011.1366; Lallet-Daher H, 2009, ONCOGENE, V28, P1792, DOI 10.1038/onc.2009.25; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Lang F, 2005, J MEMBRANE BIOL, V205, P147, DOI 10.1007/s00232-005-0780-5; Lastraioli E, 2004, CANCER RES, V64, P606, DOI 10.1158/0008-5472.CAN-03-2360; Lauritzen I, 2003, J BIOL CHEM, V278, P32068, DOI 10.1074/jbc.M302631200; Lee GW, 2012, ACTA PHYSIOL, V204, P513, DOI 10.1111/j.1748-1716.2011.02359.x; Lee I, 2010, MOL CANCER THER, V9, P2951, DOI 10.1158/1535-7163.MCT-10-0511; Ma YG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037451; Mant A, 2012, J BIOL CHEM; Mu D, 2003, CANCER CELL, V3, P297, DOI 10.1016/S1535-6108(03)00054-0; Nogueira EF, 2010, CLIN ENDOCRINOL, V73, P22, DOI 10.1111/j.1365-2265.2009.03738.x; Nunez M, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-6; O'Kelly I, 1999, AM J PHYSIOL-LUNG C, V276, pL96, DOI 10.1152/ajplung.1999.276.1.L96; Ousingsawat J, 2007, CLIN CANCER RES, V13, P824, DOI 10.1158/1078-0432.CCR-06-1940; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Pardo LA, 2004, PHYSIOLOGY, V19, P285, DOI 10.1152/physiol.00011.2004; Park SH, 2008, GYNECOL ENDOCRINOL, V24, P250, DOI 10.1080/09513590801893315; Pei L, 2003, P NATL ACAD SCI USA, V100, P7803, DOI 10.1073/pnas.1232448100; Plummer HK, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-104; Pocsai K, 2006, CELL MOL LIFE SCI, V63, P2364, DOI 10.1007/s00018-006-6166-8; Potier M, 2006, MOL CANCER THER, V5, P2946, DOI 10.1158/1535-7163.MCT-06-0194; Potier M, 2010, BIOCHEM BIOPH RES CO, V397, P42, DOI 10.1016/j.bbrc.2010.05.046; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Schmidt J, 2010, CELL RES, V20, P1224, DOI 10.1038/cr.2010.121; Schonherr R, 2005, J MEMBRANE BIOL, V205, P175, DOI 10.1007/s00232-005-0782-3; Schwab A, 2012, PHYSIOL REV, V92, P1865, DOI 10.1152/physrev.00018.2011; Shao XD, 2008, CANCER BIOL THER, V7, P45, DOI 10.4161/cbt.7.1.5126; Spitzner M, 2008, J BIOL CHEM, V283, P7421, DOI 10.1074/jbc.M703758200; Steinle M, 2011, RADIOTHER ONCOL, V101, P122, DOI 10.1016/j.radonc.2011.05.069; Stringer BK, 2001, CANCER RES, V61, P582; Suzuki Y, 2012, INT J ONCOL, V41, P465, DOI 10.3892/ijo.2012.1483; Tan G, 2008, BIOCHEM BIOPH RES CO, V367, P743, DOI 10.1016/j.bbrc.2008.01.014; Menendez ST, 2012, J MOL MED, V90, P1173, DOI 10.1007/s00109-012-0893-0; Menendez ST, 2010, J PATHOL, V221, P402, DOI 10.1002/path.2722; Veeravalli KK, 2012, CELL SIGNAL, V24, P272, DOI 10.1016/j.cellsig.2011.09.011; Voloshyna I, 2008, CANCER RES, V68, P1197, DOI 10.1158/0008-5472.CAN-07-5163; Wadhwa S, 2009, INT UROL NEPHROL, V41, P251, DOI 10.1007/s11255-008-9459-z; Wang LH, 2012, BBA-MOL CELL RES, V1823, P505, DOI 10.1016/j.bbamcr.2011.11.012; Wang ZG, 2004, PFLUG ARCH EUR J PHY, V448, P274, DOI 10.1007/s00424-004-1258-5; Williams C, 2008, ONCOGENE, V27, P1019, DOI 10.1038/sj.onc.1210712; Wonderlin WF, 1996, J MEMBRANE BIOL, V154, P91, DOI 10.1007/s002329900135; Wu J, 2012, NEOPLASMA, V59, P207, DOI 10.4149/neo_2012_027; Zheng YA, 2011, CLIN BIOCHEM, V44, P1405, DOI 10.1016/j.clinbiochem.2011.09.006	96	43	43	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e74589	10.1371/journal.pone.0074589	http://dx.doi.org/10.1371/journal.pone.0074589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116006	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000325501300009
J	Dissard, R; Klein, J; Caubet, C; Breuil, B; Siwy, J; Hoffman, J; Sicard, L; Ducasse, L; Rascalou, S; Payre, B; Buleon, M; Mullen, W; Mischak, H; Tack, I; Bascands, JL; Buffin-Meyer, B; Schanstra, JP				Dissard, Romain; Klein, Julie; Caubet, Cecile; Breuil, Benjamin; Siwy, Justyna; Hoffman, Janosch; Sicard, Laurent; Ducasse, Laure; Rascalou, Simon; Payre, Bruno; Buleon, Marie; Mullen, William; Mischak, Harald; Tack, Ivan; Bascands, Jean-Loup; Buffin-Meyer, Benedicte; Schanstra, Joost P.			Long Term Metabolic Syndrome Induced by a High Fat High Fructose Diet Leads to Minimal Renal Injury in C57BL/6 Mice	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; BODY-MASS INDEX; SUGAR-SWEETENED BEVERAGES; US ADULTS; URINARY PROTEOMICS; HEPATIC STEATOSIS; LIPID-METABOLISM; MOUSE MODEL; OBESITY; PROGRESSION	Metabolic syndrome can induce chronic kidney disease in humans. Genetically engineered mice on a C57BL/6 background are highly used for mechanistic studies. Although it has been shown that metabolic syndrome induces cardiovascular lesions in C57BL/6 mice, in depth renal phenotyping has never been performed. Therefore in this study we characterized renal function and injury in C57BL/6 mice with long-term metabolic syndrome induced by a high fat and fructose diet (HFFD). C57BL/6 mice received an 8 months HFFD diet enriched with fat (45% energy from fat) and drinking water enriched with fructose (30%). Body weight, food/water consumption, energy intake, fat/lean mass ratio, plasma glucose, HDL, LDL, triglycerides and cholesterol levels were monitored. At 3, 6 and 8 months, renal function was determined by inulin clearance and measure of albuminuria. At sacrifice, kidneys and liver were collected. Metabolic syndrome in C57BL/6 mice fed a HFFD was observed as early 4 weeks with development of type 2 diabetes at 8 weeks after initiation of diet. However, detailed analysis of kidney structure and function showed only minimal renal injury after 8 months of HFFD. HFFD induced moderate glomerular hyperfiltration (436,4 mu L/min vs 289,8 mu L/min; p-value=0.0418) together with a 2-fold increase in albuminuria only after 8 months of HFFD. This was accompanied by a 2-fold increase in renal inflammation (p-value=0.0217) but without renal fibrosis or mesangial matrix expansion. In addition, electron microscopy did not show alterations in glomeruli such as basal membrane thickening and foot process effacement. Finally, comparison of the urinary peptidome of these mice with the urinary peptidome from humans with diabetic nephropathy also suggested absence of diabetic nephropathy in this model. This study provides evidence that the HFFD C57BL/6 model is not the optimal model to study the effects of metabolic syndrome on the development of diabetic kidney disease.	[Dissard, Romain; Caubet, Cecile; Breuil, Benjamin; Sicard, Laurent; Ducasse, Laure; Rascalou, Simon; Buleon, Marie; Tack, Ivan; Bascands, Jean-Loup; Buffin-Meyer, Benedicte; Schanstra, Joost P.] Fac Med Toulouse, INSERM, U1048, Inst Cardiovasc & Metab Dis, F-31073 Toulouse, France; [Dissard, Romain; Caubet, Cecile; Sicard, Laurent; Ducasse, Laure; Rascalou, Simon; Buleon, Marie; Tack, Ivan; Bascands, Jean-Loup; Buffin-Meyer, Benedicte; Schanstra, Joost P.] Univ Toulouse 3, F-31062 Toulouse, France; [Klein, Julie; Breuil, Benjamin] Inst Cardiovasc & Metab Dis, Toulouse, France; [Siwy, Justyna; Hoffman, Janosch; Mischak, Harald] Mosaiques Diagnost GmbH, Hannover, Germany; [Siwy, Justyna] Charite, D-13353 Berlin, Germany; [Payre, Bruno] Ctr Microscopie Elect Appl Biol, Toulouse, France; [Mullen, William; Mischak, Harald] Univ Glasgow, Dept Prote & Syst Med, BHF Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci,Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Mosaiques Diagnostics GmbH (MOS); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Glasgow	Schanstra, JP (corresponding author), Fac Med Toulouse, INSERM, U1048, Inst Cardiovasc & Metab Dis, U317, F-31073 Toulouse, France.	joost-peter.schanstra@inserm.fr	Schanstra, Joost P/X-7724-2018; Buffin-Meyer, Bénédicte/X-7705-2018; Klein, Julie/ABE-2622-2020; Mullen, William/GWC-8078-2022; Klein, Julie/M-7088-2017	Schanstra, Joost P/0000-0002-7471-372X; Buffin-Meyer, Bénédicte/0000-0002-4805-1558; Klein, Julie/0000-0002-3279-0559; Klein, Julie/0000-0002-3279-0559; Bascands, Jean-loup/0000-0002-1667-5913; Mullen, William/0000-0002-5685-1563; Siwy, Justyna/0000-0003-1407-2534; Mischak, Harald/0000-0003-0323-0306	FP7 program "Improvement of tools and portability of mass spectrometry based clinical proteomics as applied to chronic kidney disease" (Protoclin) [PEOPLE-2009-IAPP, GA 251368]; French Ministry of Education, Research and Technology	FP7 program "Improvement of tools and portability of mass spectrometry based clinical proteomics as applied to chronic kidney disease" (Protoclin); French Ministry of Education, Research and Technology	Part of this work was supported by the FP7 program "Improvement of tools and portability of mass spectrometry based clinical proteomics as applied to chronic kidney disease" (Protoclin, PEOPLE-2009-IAPP, GA 251368). Romain Dissard is a recipient of a research grant from the French Ministry of Education, Research and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuaisha B, 1998, DIABETES RES CLIN PR, V39, P93, DOI 10.1016/S0168-8227(97)00111-3; Aoyama M, 2012, BIOCHEM BIOPH RES CO, V419, P244, DOI 10.1016/j.bbrc.2012.02.001; Axelsen LN, 2010, AM J PHYSIOL-REG I, V298, pR1560, DOI 10.1152/ajpregu.00392.2009; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Bleich SN, 2009, AM J CLIN NUTR, V89, P372, DOI 10.3945/ajcn.2008.26883; Bonnet F, 2006, J HYPERTENS, V24, P1157, DOI 10.1097/01.hjh.0000226206.03560.ac; BOUBY N, 1990, AM J PHYSIOL, V258, pF973, DOI 10.1152/ajprenal.1990.258.4.F973; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Buleon M, 2008, AM J PHYSIOL-RENAL, V294, pF1249, DOI 10.1152/ajprenal.00501.2007; Calderan L, 2006, OBESITY, V14, P405, DOI 10.1038/oby.2006.54; Carty DM, 2011, HYPERTENSION, V57, P561, DOI 10.1161/HYPERTENSIONAHA.110.164285; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Couturier K, 2011, METABOLISM, V60, P1590, DOI 10.1016/j.metabol.2011.03.016; Deji N, 2009, AM J PHYSIOL-RENAL, V296, pF118, DOI 10.1152/ajprenal.00110.2008; Dekker MJ, 2010, AM J PHYSIOL-ENDOC M, V299, pE685, DOI 10.1152/ajpendo.00283.2010; Drewnowski A, 1997, NUTR REV, V55, P31, DOI 10.1111/j.1753-4887.1997.tb01593.x; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Gersch MS, 2007, AM J PHYSIOL-RENAL, V293, pF1256, DOI 10.1152/ajprenal.00181.2007; Good DM, 2010, MOL CELL PROTEOMICS, V9, P2424, DOI 10.1074/mcp.M110.001917; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Gurley SB, 2006, AM J PHYSIOL-RENAL, V290, pF214, DOI 10.1152/ajprenal.00204.2005; Han BG, 2008, AM J PHYSIOL-ENDOC M, V295, pE981, DOI 10.1152/ajpendo.90283.2008; Hudkins KL, 2010, J AM SOC NEPHROL, V21, P1533, DOI 10.1681/ASN.2009121290; INGALLS AM, 1950, J HERED, V41, P317, DOI 10.1093/oxfordjournals.jhered.a106073; Iseki K, 2004, KIDNEY INT, V65, P1870, DOI 10.1111/j.1523-1755.2004.00582.x; Isomaa B, 2001, DIABETOLOGIA, V44, P1148, DOI 10.1007/s001250100615; Jurgens H, 2005, OBES RES, V13, P1146, DOI 10.1038/oby.2005.136; Kume S, 2007, J AM SOC NEPHROL, V18, P2715, DOI 10.1681/ASN.2007010089; Kurella M, 2005, J AM SOC NEPHROL, V16, P2134, DOI 10.1681/ASN.2005010106; Levine DZ, 2008, AM J PHYSIOL-REG I, V294, pR1840, DOI 10.1152/ajpregu.00457.2007; Ma LJ, 2003, KIDNEY INT, V64, P350, DOI 10.1046/j.1523-1755.2003.00058.x; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Menard SL, 2010, AM J PHYSIOL-ENDOC M, V298, pE1049, DOI 10.1152/ajpendo.00560.2009; Mischak H, 2013, CLIN BIOCHEM, V46, P432, DOI 10.1016/j.clinbiochem.2012.09.025; Mischak H, 2012, PROTEOM CLIN APPL, V6, P437, DOI 10.1002/prca.201200027; MOGENSEN CE, 1983, DIABETES, V32, P64, DOI 10.2337/diab.32.2.S64; Molin L, 2012, J PROTEOMICS, V75, P5888, DOI 10.1016/j.jprot.2012.07.024; Montagutelli X, 2000, J AM SOC NEPHROL, V11, pS101; Mullen W, 2011, CURR OPIN NEPHROL HY, V20, P654, DOI 10.1097/MNH.0b013e32834b7ffa; National Diabetes Fact Sheet, 2011, NAT DIAB FACT SHEET; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Palaniappan L, 2003, AM J HYPERTENS, V16, P952, DOI 10.1016/S0895-7061(03)01009-4; Panchal SK, 2011, J CARDIOVASC PHARM, V57, P611, DOI [10.1097/FJC.0b013e3181feb90a, 10.1097/FJC.0b013e31821b1379]; Panchal SK, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/351982; Puri TS, 2010, AM J PHYSIOL-RENAL, V298, pF1024, DOI 10.1152/ajprenal.00384.2009; Qi ZH, 2005, DIABETES, V54, P2628, DOI 10.2337/diabetes.54.9.2628; REBUFFESCRIVE M, 1993, METABOLISM, V42, P1405, DOI 10.1016/0026-0495(93)90190-Y; Reedy J, 2010, J AM DIET ASSOC, V110, P1477, DOI 10.1016/j.jada.2010.07.010; Roscioni SS, 2013, DIABETOLOGIA, V56, P259, DOI 10.1007/s00125-012-2755-2; Rossing K, 2008, PROTEOM CLIN APPL, V2, P997, DOI 10.1002/prca.200780166; Rowley Kevin, 2003, Curr Diab Rep, V3, P80, DOI 10.1007/s11892-003-0058-1; Siwy J, 2011, PROTEOM CLIN APPL, V5, P367, DOI 10.1002/prca.201000155; Stalmach A, 2013, ELECTROPHORESIS, V34, P1452, DOI 10.1002/elps.201200708; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Tappy L, 2010, NUTRITION, V26, P1044, DOI 10.1016/j.nut.2010.02.014; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; Tetri LH, 2008, AM J PHYSIOL-GASTR L, V295, pG987, DOI 10.1152/ajpgi.90272.2008; van den Berg JG, 2004, KIDNEY INT, V66, P1901, DOI 10.1111/j.1523-1755.2004.00964.x; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; von zur Muhlen C, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013847; Wada T, 2010, ENDOCRINOLOGY, V151, P2040, DOI 10.1210/en.2009-0869; Wittke S, 2003, J CHROMATOGR A, V1013, P173, DOI 10.1016/S0021-9673(03)00713-1; World Health Organization, 2011, DIAB FACT SHEET; Yilmaz Y, 2012, ALIMENT PHARM THER, V35, P1135, DOI 10.1111/j.1365-2036.2012.05080.x; Zhang HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032746; Zurbig P, 2006, ELECTROPHORESIS, V27, P2111, DOI 10.1002/elps.200500827; Zurbig P, 2012, DIABETES, V61, P3304, DOI 10.2337/db12-0348	68	37	39	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76703	10.1371/journal.pone.0076703	http://dx.doi.org/10.1371/journal.pone.0076703			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098551	Green Accepted, Green Submitted, gold, Green Published			2022-12-25	WOS:000325483600071
J	Wiesner, D; Merdian, I; Lewerenz, J; Ludolph, AC; Dupuis, L; Witting, A				Wiesner, Diana; Merdian, Irma; Lewerenz, Jan; Ludolph, Albert C.; Dupuis, Luc; Witting, Anke			Fumaric Acid Esters Stimulate Astrocytic VEGF Expression through HIF-1 alpha and Nrf2	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; DIMETHYL FUMARATE; KAPPA-B; HYPOXIA; ACTIVATION; CELLS; ANGIOGENESIS; DEGRADATION; DELIVERY; STRESS	Fumaric acid esters (FAE) are oral analogs of fumarate that have recently been shown to decrease relapse rate and disease progression in multiple sclerosis (MS), prompting to investigate their protective potential in other neurological diseases such as amyotrophic lateral sclerosis (ALS). Despite efficacy in MS, mechanisms of action of FAEs are still largely unknown. FAEs are known to activate the transcription factor Nrf2 and downstream anti-oxidant responses through the succination of Nrf2 inhibitor KEAP1. However, fumarate is also a known inhibitor of prolyl-hydroxylases domain enzymes (PhD), and PhD inhibition might lead to stabilization of the HIF-1 alpha transcription factor under normoxic conditions and subsequent activation of a pseudo hypoxic response. Whether Nrf2 activation is associated with HIF-1 alpha stabilization in response to FAEs in cell types relevant to MS or ALS remains unknown. Here, we show that FAEs elicit HIF-1 alpha accumulation, and VEGF release as its expected consequence, in astrocytes but not in other cell types of the central nervous system. Reporter assays demonstrated that increased astrocytic VEGF release in response to FAEs was dependent upon both HIF-1 alpha and Nrf2 activation. Last, astrocytes of transgenic mice expressing SOD1(G93A), an animal model of ALS, displayed reduced VEGF release in response to FAEs. These studies show that FAEs elicit different signaling pathways in cell types from the central nervous system, in particular a pseudo-hypoxic response in astrocytes. Disease relevant mutations might affect this response.	[Wiesner, Diana; Merdian, Irma; Lewerenz, Jan; Ludolph, Albert C.; Witting, Anke] Univ Ulm, Dept Neurol, D-89069 Ulm, Germany; [Dupuis, Luc] INSERM, Mecanismes Cent & Peripher Neurodegenerescence U1, Strasbourg, France; [Dupuis, Luc] Univ Strasbourg, Federat Med Translat, UMRS1118, Strasbourg, France	Ulm University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Dupuis, L (corresponding author), INSERM, Mecanismes Cent & Peripher Neurodegenerescence U1, Strasbourg, France.	ldupuis@unistra.fr; anke.witting@uni-ulm.de	Dupuis, Luc/A-6981-2012		Biogen Idec Germany	Biogen Idec Germany(Biogen)	Partial support to this work was provided by Biogen Idec Germany. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam J, 2003, AM J PHYSIOL-RENAL, V284, pF743, DOI 10.1152/ajprenal.00376.2002; Albrecht P, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-163; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Arbiser JL, 2011, J INVEST DERMATOL, V131, P1189, DOI 10.1038/jid.2011.45; Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842; Ashrafian H, 2012, CELL METAB, V15, P361, DOI 10.1016/j.cmet.2012.01.017; Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Bolanos JP, 2010, TRENDS BIOCHEM SCI, V35, P145, DOI 10.1016/j.tibs.2009.10.006; Chen J, 2010, BRIT J CANCER, V102, P351, DOI 10.1038/sj.bjc.6605486; Chun YS, 2001, BIOCHEM PHARMACOL, V61, P947, DOI 10.1016/S0006-2952(01)00564-0; Dungwa JV, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-390; Emerling BM, 2008, P NATL ACAD SCI USA, V105, P2622, DOI 10.1073/pnas.0706790105; Fan WL, 2010, AUTOPHAGY, V6, P614, DOI 10.4161/auto.6.5.12189; Ferger AI, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-45; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; Kim HL, 2006, INT J ONCOL, V29, P255; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Lee JM, 2003, BBA-GENE STRUCT EXPR, V1629, P92, DOI 10.1016/j.bbaexp.2003.08.006; Lin SX, 2011, ASN NEURO, V3, DOI 10.1042/AN20100033; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; Linker RA, 2010, BRAIN, V133, P2248, DOI 10.1093/brain/awq179; Loureiro RMB, 2005, CYTOKINE GROWTH F R, V16, P77, DOI 10.1016/j.cytogfr.2005.01.005; Moreau C, 2006, J NEUROL NEUROSUR PS, V77, P255, DOI 10.1136/jnnp.2005.070904; Moreau C, 2011, NEUROSCIENCE, V172, P110, DOI 10.1016/j.neuroscience.2010.10.040; Nagara Y, 2013, BRAIN PATHOL; Oh CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045870; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Peng HY, 2012, J BIOL CHEM, V287, P28017, DOI 10.1074/jbc.M112.383380; Scannevin RH, 2012, J PHARMACOL EXP THER, V341, P274, DOI 10.1124/jpet.111.190132; Semenza GL, 2011, COLD SH Q B, V76, P347, DOI 10.1101/sqb.2011.76.010678; Serra-Perez A, 2010, J BIOL CHEM, V285, P18217, DOI 10.1074/jbc.M110.101048; Storkebaum E, 2005, NAT NEUROSCI, V8, P85, DOI 10.1038/nn1360; Sun HL, 2007, ONCOGENE, V26, P3941, DOI 10.1038/sj.onc.1210169; Suswam E, 2008, CANCER RES, V68, P674, DOI 10.1158/0008-5472.CAN-07-2751; Vangeison G, 2008, J NEUROSCI, V28, P1988, DOI 10.1523/JNEUROSCI.5323-07.2008; Yan JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027798; Yeo EJ, 2003, J NATL CANCER I, V95, P516, DOI 10.1093/jnci/95.7.516	39	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76670	10.1371/journal.pone.0076670	http://dx.doi.org/10.1371/journal.pone.0076670			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098549	Green Published, gold, Green Submitted			2022-12-25	WOS:000325483600070
J	Kramer, M; Sponholz, C; Slaba, M; Wissuwa, B; Claus, RA; Menzel, U; Huse, K; Platzer, M; Bauer, M				Kramer, Marcel; Sponholz, Christoph; Slaba, Monique; Wissuwa, Bianka; Claus, Ralf A.; Menzel, Uwe; Huse, Klaus; Platzer, Matthias; Bauer, Michael			Alternative 5 ' Untranslated Regions Are Involved in Expression Regulation of Human Heme Oxygenase-1	PLOS ONE			English	Article							GENE PROMOTER; MICROSATELLITE POLYMORPHISM; SUSCEPTIBILITY; INDUCTION; CELLS	The single nucleotide polymorphism rs2071746 and a (GT)(n) microsatellite within the human gene encoding heme oxygenase-1 (HMOX1) are associated with incidence or outcome in a variety of diseases. Most of these associations involve either release of heme or oxidative stress. Both polymorphisms are localized in the promoter region, but previously reported correlations with heme oxygenase-1 expression remain not coherent. This ambiguity suggests a more complex organization of the 5' gene region which we sought to investigate more fully. We evaluated the 5` end of HMOX1 and found a novel first exon 1a placing the two previously reported polymorphisms in intronic or exonic positions within the 5' untranslated region respectively. Expression of exon 1a can be induced in HepG2 hepatoma cells by hemin and is a repressor of heme oxygenase-1 translation as shown by luciferase reporter assays. Moreover, minigene approaches revealed that the quantitative outcome of alternative splicing within the 5' untranslated region is affected by the (GT)(n) microsatellite. This data supporting an extended HMOX1 gene model and provide further insights into expression regulation of heme oxygenase-1. Alternative splicing within the HMOX1 5' untranslated region contributes to translational regulation and is a mechanistic feature involved in the interplay between genetic variations, heme oxygenase-1 expression and disease outcome.	[Kramer, Marcel; Sponholz, Christoph; Slaba, Monique; Wissuwa, Bianka; Claus, Ralf A.; Bauer, Michael] Jena Univ Hosp, Integrated Res & Treatment Ctr, CSCC, Jena, Germany; [Kramer, Marcel; Sponholz, Christoph; Huse, Klaus; Platzer, Matthias] Leibniz Inst Age Res Fritz Lipmann Inst, Jena, Germany; [Sponholz, Christoph; Bauer, Michael] Jena Univ Hosp, Dept Anaesthesiol & Intens Care Therapy, Jena, Germany; [Menzel, Uwe] Leibniz Inst, Hans Knoll Inst Nat Prod Res & Infect Biol, Jena, Germany	Friedrich Schiller University of Jena; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Friedrich Schiller University of Jena; Hans Knoll Institute (HKI)	Kramer, M (corresponding author), Jena Univ Hosp, Integrated Res & Treatment Ctr, CSCC, Jena, Germany.	Marcel.Kramer@med.uni-jena.de	Sponholz, Christoph/I-3585-2019; Claus, Ralf A./Q-4035-2016	Sponholz, Christoph/0000-0002-1746-7024; Claus, Ralf A./0000-0001-7232-4088; Bauer, Michael/0000-0002-1521-3514; Huse, Klaus/0000-0003-3854-1884	Federal Ministry of Education and Research (BMBF, Germany) [FKZ: 01EO1002]; Deutsche Forschungsgemeinschaft [DFG Hu498/3, Ba1601/8-1]	Federal Ministry of Education and Research (BMBF, Germany)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Federal Ministry of Education and Research (BMBF, Germany, FKZ: 01EO1002 to MB) and by the Deutsche Forschungsgemeinschaft (DFG Hu498/3 to KH and Ba1601/8-1 to MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu Y, 2004, FASEB J, V18, P771, DOI 10.1096/fj.03-0921fje; Bao W, 2010, AM J EPIDEMIOL, V172, P631, DOI 10.1093/aje/kwq162; Bauer I, 2003, SHOCK, V20, P116, DOI 10.1097/01.shk.0000075568.93053.fa; Bauer M, 2008, INTENS CARE MED, V34, P640, DOI 10.1007/s00134-008-1010-2; Blydt-Hansen TD, 2003, J AM SOC NEPHROL, V14, P745, DOI 10.1097/01.ASN.0000050760.87113.25; Brosius J, 2005, CYTOGENET GENOME RES, V110, P8, DOI 10.1159/000084934; Buis CI, 2008, AM J TRANSPLANT, V8, P377, DOI 10.1111/j.1600-6143.2007.02048.x; Doberer D, 2010, BRIT J PHARMACOL, V161, P1751, DOI 10.1111/j.1476-5381.2010.00990.x; Euskirchen GM, 2007, GENOME RES, V17, P898, DOI 10.1101/gr.5583007; Exner M, 2004, FREE RADICAL BIO MED, V37, P1097, DOI 10.1016/j.freeradbiomed.2004.07.008; Hirai H, 2003, BLOOD, V102, P1619, DOI 10.1182/blood-2002-12-3733; Hughes TA, 2006, TRENDS GENET, V22, P119, DOI 10.1016/j.tig.2006.01.001; Kramer M, 2011, GENETICS, V187, P761, DOI 10.1534/genetics.110.125096; Krull M, 2007, GENOME RES, V17, P1139, DOI 10.1101/gr.6320607; KUTTY RK, 1994, GENOMICS, V20, P513, DOI 10.1006/geno.1994.1213; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nagasaki H, 2005, GENE, V364, P53, DOI 10.1016/j.gene.2005.07.027; NAYLOR LH, 1990, NUCLEIC ACIDS RES, V18, P1595, DOI 10.1093/nar/18.6.1595; Ono K, 2004, ATHEROSCLEROSIS, V173, P315, DOI 10.1016/j.atherosclerosis.2003.11.021; Reichard JF, 2007, NUCLEIC ACIDS RES, V35, P7074, DOI 10.1093/nar/gkm638; Resch AM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-162; Rosenstiel P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-472; Scott JR, 2007, TRENDS PHARMACOL SCI, V28, P200, DOI 10.1016/j.tips.2007.03.006; Sheu CC, 2009, INTENS CARE MED, V35, P1343, DOI 10.1007/s00134-009-1504-6; SHIBAHARA S, 1989, EUR J BIOCHEM, V179, P557, DOI 10.1111/j.1432-1033.1989.tb14583.x; Sponholz C, 2012, SHOCK, V38, P459, DOI 10.1097/SHK.0b013e31826ae951; Tanaka G, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-117; Vesely MJJ, 1998, AM J PHYSIOL-CELL PH, V275, pC1087, DOI 10.1152/ajpcell.1998.275.4.C1087; Wang GR, 2005, AM J PHYSIOL-LUNG C, V289, pL497, DOI 10.1152/ajplung.00100.2005; Yamada N, 2000, AM J HUM GENET, V66, P187, DOI 10.1086/302729	31	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e77224	10.1371/journal.pone.0077224	http://dx.doi.org/10.1371/journal.pone.0077224			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098580	gold, Green Published, Green Submitted			2022-12-25	WOS:000325434500096
J	Maliniemi, P; Vincendeau, M; Mayer, J; Frank, O; Hahtola, S; Karenko, L; Carlsson, E; Mallet, F; Seifarth, W; Leib-Mosch, C; Ranki, A				Maliniemi, Pilvi; Vincendeau, Michelle; Mayer, Jens; Frank, Oliver; Hahtola, Sonja; Karenko, Leena; Carlsson, Emilia; Mallet, Francois; Seifarth, Wolfgang; Leib-Moesch, Christine; Ranki, Annamari			Expression of Human Endogenous Retrovirus-W Including Syncytin-1 in Cutaneous T-Cell Lymphoma	PLOS ONE			English	Article							MYCOSIS-FUNGOIDES; SEZARY-SYNDROME; MULTIPLE-SCLEROSIS; ENVELOPE PROTEIN; HERV-W; TRANSCRIPTIONAL ACTIVITY; TRANSPOSABLE ELEMENTS; HUMAN TISSUES; COPY NUMBER; NO EVIDENCE	The pathomechanism of mycosis fungoides (MF), the most common type of primary cutaneous T-cell lymphomas (CTCLs) and a malignancy of non-recirculating, skin-resident T-cells, is unknown albeit underlying viral infections have been sought for. Human endogenous retroviruses (HERVs) are ancient retroviral sequences in the human genome and their transcription is often deregulated in cancers. We explored the transcriptional activity of HERV sequences in a total of 34 samples comprising MF and psoriasis skin lesions, as well as corresponding nonmalignant skin using a retrovirus-specific microarray and quantitative RT-PCR. To identify active HERV-W loci, we cloned the HERV-W specific RT-PCR products, sequenced the cDNA clones and assigned the sequences to HERV-W loci. Finally, we used immunohistochemistry on MF patient and non-malignant inflammatory skin samples to confirm specific HERV-encoded protein expression. Firstly, a distinct, skin-specific transcription profile consisting of five constitutively active HERV groups was established. Although individual variability was common, HERV-W showed significantly increased transcription in MF lesions compared to clinically intact skin from the same patient. Predominantly transcribed HERV-W loci were found to be located in chromosomes 6q21 and 7q21.2, chromosomal regions typically altered in CTCL. Surprisingly, we also found the expression of 7q21.2/ERVWE1-encoded Syncytin-1 (Env) protein in MF biopsies and expression of Syncytin-1 was seen in malignant lymphocytes, especially in the epidermotropic ones, in 15 of 30 cases studied. Most importantly, no Syncytin-1 expression was detected in inflammatory dermatosis (Lichen ruber planus) with skin-homing, non-malignant T lymphocytes. The expression of ERVWE1 mRNA was further confirmed in 3/7 MF lesions analyzed. Our observations strengthen the association between activated HERVs and cancer. The study offers a new perspective into the pathogenesis of CTCL since we demonstrate that differences in HERV-W transcription levels between lesional MF and non-malignant skin are significant, and that ERVWE1-encoded Syncytin-1 is expressed in MF lymphoma cells.	[Maliniemi, Pilvi; Hahtola, Sonja; Karenko, Leena; Carlsson, Emilia; Ranki, Annamari] Univ Helsinki, Helsinki Univ Cent Hosp, Dept Dermatol & Allergol, Helsinki, Finland; [Vincendeau, Michelle; Leib-Moesch, Christine] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Virol, Neuherberg, Germany; [Mayer, Jens] Univ Saarland, Fac Med, Dept Human Genet, Ctr Human & Mol Biol, Homburg, Germany; [Frank, Oliver; Seifarth, Wolfgang; Leib-Moesch, Christine] Heidelberg Univ, Dept Hematol & Oncol, Mannheim Med Ctr, Mannheim, Germany; [Mallet, Francois] Ctr Hosp Lyon Sud, Canc Biomarkers Res Grp, Joint Unit Hosp Civils Lyon BioMerieux, F-69310 Pierre Benite, France; [Vincendeau, Michelle] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Mol Toxicol & Pharmacol, Res Unit Cellular Signal Integrat, Neuherberg, Germany	University of Helsinki; Helsinki University Central Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Saarland University; Ruprecht Karls University Heidelberg; CHU Lyon; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Maliniemi, P (corresponding author), Univ Helsinki, Helsinki Univ Cent Hosp, Dept Dermatol & Allergol, Helsinki, Finland.	pilvi.maliniemi@helsinki.fi	Maliniemi, Pilvi Helena/J-1001-2016; Mayer, Jens/P-4777-2019; Vincendeau, Michelle/AAD-4320-2022; Mallet, Francois/G-4812-2014; Mayer, Jens/B-8506-2013	Maliniemi, Pilvi Helena/0000-0002-7360-154X; Mayer, Jens/0000-0002-1090-5765; Mayer, Jens/0000-0002-1090-5765; MALLET, Francois/0000-0002-1331-096X	Helsinki University Hospital Research funds (EVO); Finnish Cancer Foundation; Sigrid Juselius Foundation; Helsinki University Research Fund/Tiedesaatio and Finska Lakaresallskapet/Doctorandstipendium; Deutsche Forschungsgemeinschaft	Helsinki University Hospital Research funds (EVO); Finnish Cancer Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Helsinki University Research Fund/Tiedesaatio and Finska Lakaresallskapet/Doctorandstipendium; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This investigation was supported by Helsinki University Hospital Research funds (EVO), Finnish Cancer Foundation and Sigrid Juselius Foundation. P.M. also acknowledged support from the Helsinki University Research Fund/Tiedesaatio and Finska Lakaresallskapet/Doctorandstipendium. J.M. is supported by the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony JM, 2004, NAT NEUROSCI, V7, P1088, DOI 10.1038/nn1319; Antony JM, 2007, J IMMUNOL, V179, P1210, DOI 10.4049/jimmunol.179.2.1210; Antony JM, 2011, BBA-MOL BASIS DIS, V1812, P162, DOI 10.1016/j.bbadis.2010.07.016; Batista DAS, 2006, GENE CHROMOSOME CANC, V45, P383, DOI 10.1002/gcc.20302; Bazarbachi A, 1997, BRIT J HAEMATOL, V98, P927, DOI 10.1046/j.1365-2141.1997.3213138.x; Belshaw R, 2005, MOL BIOL EVOL, V22, P814, DOI 10.1093/molbev/msi088; Beyer M, 2011, J DTSCH DERMATOL GES, V9, P594, DOI 10.1111/j.1610-0387.2011.07635.x; Bhat RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019176; Blond JL, 2000, J VIROL, V74, P3321, DOI 10.1128/JVI.74.7.3321-3329.2000; Blond JL, 1999, J VIROL, V73, P1175, DOI 10.1128/JVI.73.2.1175-1185.1999; Brudek T, 2008, SCAND J IMMUNOL, V67, P295, DOI 10.1111/j.1365-3083.2007.02067.x; Campbell JJ, 2010, BLOOD, V116, P767, DOI 10.1182/blood-2009-11-251926; Cheynet V, 2005, J VIROL, V79, P5585, DOI 10.1128/JVI.79.9.5585-5593.2005; Clark RA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003008; Conley AB, 2008, BIOINFORMATICS, V24, P1563, DOI 10.1093/bioinformatics/btn243; Costas J, 2002, MOL BIOL EVOL, V19, P526, DOI 10.1093/oxfordjournals.molbev.a004108; Dereure O, 2013, J INVEST DERMATOL, V133, P853, DOI 10.1038/jid.2012.371; Espinet B, 2004, HAEMATOLOGICA, V89, P165; Feschotte C, 2012, NAT REV GENET, V13, P283, DOI 10.1038/nrg3199; Fischer TC, 2004, J INVEST DERMATOL, V122, P579, DOI 10.1111/j.0022-202X.2004.22301.x; Flockerzi A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-354; Frank O, 2005, J VIROL, V79, P10890, DOI 10.1128/JVI.79.17.10890-10901.2005; Frank O, 2008, J VIROL, V82, P1808, DOI 10.1128/JVI.02115-07; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Garrison KE, 2007, PLOS PATHOG, V3, P1617, DOI 10.1371/journal.ppat.0030165; Gosenca D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049341; Greenwood AD, 2005, VIROLOGY, V334, P203, DOI 10.1016/j.virol.2005.01.045; Handwerger S, 2010, MOL CELL ENDOCRINOL, V323, P94, DOI 10.1016/j.mce.2009.12.015; Haupt S, 2011, J GEN VIROL, V92, P2356, DOI 10.1099/vir.0.031518-0; Hohenadl C, 1999, J INVEST DERMATOL, V113, P587, DOI 10.1046/j.1523-1747.1999.00728.x; Jern P, 2008, ANNU REV GENET, V42, P709, DOI 10.1146/annurev.genet.42.110807.091501; Johnston JB, 2001, ANN NEUROL, V50, P434, DOI 10.1002/ana.1131; Karenko L, 2005, CANCER RES, V65, P8101, DOI 10.1158/0008-5472.CAN-04-0366; Karenko L, 1999, J INVEST DERMATOL, V112, P392, DOI 10.1038/sj.jid.5600444; Katsumata K, 1999, CLIN IMMUNOL, V93, P75, DOI 10.1006/clim.1999.4762; Katzourakis A, 2005, TRENDS MICROBIOL, V13, P463, DOI 10.1016/j.tim.2005.08.004; Kempf W, 2010, HISTOPATHOLOGY, V56, P57, DOI 10.1111/j.1365-2559.2009.03455.x; Kikuchi A, 1997, BLOOD, V89, P1529, DOI 10.1182/blood.V89.5.1529.1529_1529_1532; Kozeretska I. A., 2011, Experimental Oncology, V33, P198; Laharanne E, 2010, MODERN PATHOL, V23, P547, DOI 10.1038/modpathol.2009.196; Laufer G, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-37; Lin WM, 2010, J INVEST DERMATOL, V130, P926, DOI 10.1038/jid.2009.370; MAGER DL, 2003, ANONYMOUS ENCY HUMAN, V5, P57; Mallet F, 2004, P NATL ACAD SCI USA, V101, P1731, DOI 10.1073/pnas.0305763101; Mameli G, 2007, VIROLOGY, V362, P120, DOI 10.1016/j.virol.2006.12.019; Mao X, 2003, GENE CHROMOSOME CANC, V36, P250, DOI 10.1002/gcc.10152; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Moles JP, 2005, BRIT J DERMATOL, V153, P83, DOI 10.1111/j.1365-2133.2005.06555.x; Moyes D, 2007, TRENDS GENET, V23, P326, DOI 10.1016/j.tig.2007.05.004; Muche JM, 2003, DIAGN MOL PATHOL, V12, P142, DOI 10.1097/00019606-200309000-00005; Mullins CS, 2012, WORLD J GASTROENTERO, V18, P6027, DOI 10.3748/wjg.v18.i42.6027; NOWELL PC, 1986, CANCER GENET CYTOGEN, V19, P219, DOI 10.1016/0165-4608(86)90050-6; PANCAKE BA, 1995, J CLIN INVEST, V95, P547, DOI 10.1172/JCI117697; Parker SRS, 2009, GIORN ITAL DERMAT V, V144, P467; Pavlicek A, 2002, GENOME RES, V12, P391, DOI 10.1101/gr.216902; Perot P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040194; Perron H, 1997, P NATL ACAD SCI USA, V94, P7583, DOI 10.1073/pnas.94.14.7583; Perron H, 2009, J NEUROL SCI, V286, P65, DOI 10.1016/j.jns.2009.04.034; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pichon JP, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl086; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; RANKI A, 1990, ARCH DERMATOL RES, V282, P532, DOI 10.1007/BF00371949; Rebollo R, 2012, ANNU REV GENET, V46, P21, DOI 10.1146/annurev-genet-110711-155621; Roebke C, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-69; Rolland A, 2006, J IMMUNOL, V176, P7636, DOI 10.4049/jimmunol.176.12.7636; Romanish MT, 2010, SEMIN CANCER BIOL, V20, P246, DOI 10.1016/j.semcancer.2010.05.005; Ruprecht K, 2008, CELL MOL LIFE SCI, V65, P3366, DOI 10.1007/s00018-008-8496-1; Ruprecht K, 2006, J NEUROVIROL, V12, P65, DOI 10.1080/13550280600614973; SAXINGER WC, 1985, SCAND J HAEMATOL, V34, P455; Schechner JS, 1999, LAB INVEST, V79, P601; Seifarth W, 2005, J VIROL, V79, P341, DOI 10.1128/JVI.79.1.341-352.2005; Seifarth W, 2003, J VIROL METHODS, V112, P79, DOI 10.1016/S0166-0934(03)00194-0; Seifarth W, 2000, AIDS RES HUM RETROV, V16, P721, DOI 10.1089/088922200308729; Seifarth W, 2011, ENCY DNA RES; Stauffer Yves, 2004, Cancer Immun, V4, P2; Stoye JP, 2012, NAT REV MICROBIOL, V10, P395, DOI 10.1038/nrmicro2783; TAN RSH, 1974, BRIT J DERMATOL, V91, P607, DOI 10.1111/j.1365-2133.1974.tb12449.x; van de Lagemaat LN, 2003, TRENDS GENET, V19, P530, DOI 10.1016/j.tig.2003.08.004; Vermeer MH, 2008, CANCER RES, V68, P2689, DOI 10.1158/0008-5472.CAN-07-6398; Weiss RA, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-67; Wood GS, 1997, AM J PATHOL, V150, P667; Zeilfelder U, 2007, GENE, V390, P175, DOI 10.1016/j.gene.2006.08.019; Zendri E, 2008, J INVEST DERMATOL, V128, P489, DOI 10.1038/sj.jid.5701034	84	39	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76281	10.1371/journal.pone.0076281	http://dx.doi.org/10.1371/journal.pone.0076281			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098463	gold, Green Published, Green Submitted			2022-12-25	WOS:000325427100053
J	Dartnell, LR; Roberts, TA; Moore, G; Ward, JM; Muller, JP				Dartnell, Lewis R.; Roberts, Tom A.; Moore, Ginny; Ward, John M.; Muller, Jan-Peter			Fluorescence Characterization of Clinically-Important Bacteria	PLOS ONE			English	Article							FLOW-CYTOMETRY; CLOSTRIDIUM-DIFFICILE; SPECTROSCOPY; IDENTIFICATION; CLASSIFICATION; WATER; MICROORGANISMS; OUTBREAK; SPECTRA; LIFE	Healthcare-associated infections (HCAI/HAI) represent a substantial threat to patient health during hospitalization and incur billions of dollars additional cost for subsequent treatment. One promising method for the detection of bacterial contamination in a clinical setting before an HAI outbreak occurs is to exploit native fluorescence of cellular molecules for a hand-held, rapid-sweep surveillance instrument. Previous studies have shown fluorescence-based detection to be sensitive and effective for food-borne and environmental microorganisms, and even to be able to distinguish between cell types, but this powerful technique has not yet been deployed on the macroscale for the primary surveillance of contamination in healthcare facilities to prevent HAI. Here we report experimental data for the specification and design of such a fluorescence-based detection instrument. We have characterized the complete fluorescence response of eleven clinically-relevant bacteria by generating excitation-emission matrices (EEMs) over broad wavelength ranges. Furthermore, a number of surfaces and items of equipment commonly present on a ward, and potentially responsible for pathogen transfer, have been analyzed for potential issues of background fluorescence masking the signal from contaminant bacteria. These include bedside handrails, nurse call button, blood pressure cuff and ward computer keyboard, as well as disinfectant cleaning products and microfiber cloth. All examined bacterial strains exhibited a distinctive double-peak fluorescence feature associated with tryptophan with no other cellular fluorophore detected. Thus, this fluorescence survey found that an emission peak of 340nm, from an excitation source at 280nm, was the cellular fluorescence signal to target for detection of bacterial contamination. The majority of materials analysed offer a spectral window through which bacterial contamination could indeed be detected. A few instances were found of potential problems of background fluorescence masking that of bacteria, but in the case of the microfiber cleaning cloth, imaging techniques could morphologically distinguish between stray strands and bacterial contamination.	[Dartnell, Lewis R.] UCL, UCL Inst Origins, London, England; [Dartnell, Lewis R.; Muller, Jan-Peter] UCL, UCL Birkbeck, Ctr Planetary Sci, London, England; [Roberts, Tom A.] UCL, Ctr Math & Phys Life Sci & Expt Biol CoMPLEX, London, England; [Moore, Ginny] Univ Coll London Hosp NHS Fdn Trust, London, England; [Ward, John M.] UCL, Adv Ctr Biochem Engn, London, England; [Muller, Jan-Peter] Univ Coll London, Mullard Space Sci Lab, Surrey, England	University of London; University College London; University of London; Birkbeck University London; University College London; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; University of London; University College London	Dartnell, LR (corresponding author), UCL, UCL Inst Origins, London, England.	lewis@lewisdartnell.com	Muller, Jan-Peter/Q-8886-2019	Muller, Jan-Peter/0000-0002-5077-3736; Roberts, Tom/0000-0003-0385-1057; Ward, John/0000-0002-4415-5544; Moore, Ginny/0000-0001-6969-3528	Science and Technology Facilities Council (STFC) Challenge Led Applied Systems Programme (CLASP) [ST/I003258/1]; STFC [ST/H00260X/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/H00260X/1, ST/J00216X/1] Funding Source: researchfish	Science and Technology Facilities Council (STFC) Challenge Led Applied Systems Programme (CLASP)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work was supported by the Science and Technology Facilities Council (STFC; www.stfc.ac.uk) Challenge Led Applied Systems Programme (CLASP) Grant ST/I003258/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts JJ, 2004, ORG GEOCHEM, V35, P1141, DOI 10.1016/j.orggeochem.2004.06.010; Ammor MS, 2007, J FLUORESC, V17, P455, DOI 10.1007/s10895-007-0180-6; Ammor S, 2004, J MICROBIOL METH, V59, P271, DOI 10.1016/j.mimet.2004.07.014; Bhartia R, 2008, APPL SPECTROSC, V62, P1070, DOI 10.1366/000370208786049123; Bhatta H, 2006, APPL MICROBIOL BIOT, V71, P121, DOI 10.1007/s00253-005-0309-y; CAMPBELL L, 1988, LIMNOL OCEANOGR, V33, P1196, DOI 10.4319/lo.1988.33.5.1196; Chapman GV, 2000, J IMMUNOL METHODS, V243, P3, DOI 10.1016/S0022-1759(00)00224-6; Cornelis P, 2010, APPL MICROBIOL BIOT, V86, P1637, DOI 10.1007/s00253-010-2550-2; Cory RM, 2005, ENVIRON SCI TECHNOL, V39, P8142, DOI 10.1021/es0506962; Dartnell LR, 2012, METEORIT PLANET SCI, V47, P806, DOI 10.1111/j.1945-5100.2012.01351.x; Dartnell LR, 2011, ASTROBIOLOGY, V11, P997, DOI 10.1089/ast.2011.0663; Dartnell LR, 2010, INT J ASTROBIOL, V9, P245, DOI 10.1017/S1473550410000224; Diagaradjane P, 2005, LASER SURG MED, V37, P382, DOI 10.1002/lsm.20248; Elliott S, 2006, WATER RES, V40, P2075, DOI 10.1016/j.watres.2006.03.017; Engelhart S, 2002, J HOSP INFECT, V52, P93, DOI 10.1053/jhin.2002.1279; Estes C, 2003, BIOSENS BIOELECTRON, V18, P511, DOI 10.1016/S0956-5663(03)00008-3; Georgakoudi I, 2002, CANCER RES, V62, P682; Giana HE, 2003, J FLUORESC, V13, P489, DOI 10.1023/B:JOFL.0000008059.74052.3c; Hayden MK, 2006, CLIN INFECT DIS, V42, P1552, DOI 10.1086/503845; Health Protection Agency, 2012, HEALTHC ASS INF ANT, P2010; Hua B, 2007, INT J ENVIRON AN CH, V87, P135, DOI 10.1080/03067310600922154; Jiji RD, 1999, ANAL CHIM ACTA, V397, P61, DOI 10.1016/S0003-2670(99)00392-X; LAYTON MC, 1993, INFECT CONT HOSP EP, V14, P369; Leblanc L, 2002, FEMS MICROBIOL LETT, V211, P147, DOI 10.1111/j.1574-6968.2002.tb11217.x; Manian FA, 1996, INFECT CONT HOSP EP, V17, P180; McNamara L, 2009, AM J CRIT CARE, V18, P41, DOI 10.4037/ajcc2009483; MUIRHEAD KA, 1985, BIO-TECHNOL, V3, P337, DOI 10.1038/nbt0485-337; Nadeau JL, 2008, ASTROBIOLOGY, V8, P859, DOI 10.1089/ast.2007.0043; NATO, 2010, SET098RTG55 NATO, P1; OLDHAM PB, 1985, J MAR RES, V43, P893; Palmer GM, 2003, PHOTOCHEM PHOTOBIOL, V78, P462, DOI 10.1562/0031-8655(2003)078<0462:ASONAM>2.0.CO;2; Pan YL, 1999, OPT LETT, V24, P116, DOI 10.1364/OL.24.000116; Patra D, 2001, TALANTA, V55, P143, DOI 10.1016/S0039-9140(01)00404-0; Pratt RJ, 2007, J HOSP INFECT, V65, pS1, DOI 10.1016/S0195-6701(07)60002-4; Rohde RA, 2007, P NATL ACAD SCI USA, V104, P16592, DOI 10.1073/pnas.0708183104; Rosenstein R, 2013, CURR TOP MICROBIOL, V358, P33, DOI 10.1007/82_2012_286; SHELLY DC, 1980, CLIN CHEM, V26, P1127; SHELLY DC, 1980, CLIN CHEM, V26, P1419; Smyth ETM, 2008, J HOSP INFECT, V69, P230, DOI 10.1016/j.jhin.2008.04.020; Sohn M, 2009, APPL SPECTROSC, V63, P1251, DOI 10.1366/000370209789806993; Stone PW, 2005, AM J INFECT CONTROL, V33, P501, DOI 10.1016/j.ajic.2005.04.246; Storrie-Lombardi MC, 2009, ASTROBIOLOGY, V9, P659, DOI 10.1089/ast.2009.0351; Veal DA, 2000, J IMMUNOL METHODS, V243, P191, DOI 10.1016/S0022-1759(00)00234-9; Vermes I, 2000, J IMMUNOL METHODS, V243, P167, DOI 10.1016/S0022-1759(00)00233-7; Weber DJ, 2010, AM J INFECT CONTROL, V38, pS25, DOI 10.1016/j.ajic.2010.04.196; Weinstein S, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2006JG000319; Zhang QQ, 2006, SPECTROCHIM ACTA A, V63, P361, DOI 10.1016/j.saa.2005.05.041; Ziegmann M, 2010, WATER RES, V44, P195, DOI 10.1016/j.watres.2009.09.035	48	47	49	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75270	10.1371/journal.pone.0075270	http://dx.doi.org/10.1371/journal.pone.0075270			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098687	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000325423500058
J	Hwang, HJ; Jung, TW; Hong, HC; Choi, HY; Seo, JA; Kim, SG; Kim, NH; Choi, KM; Choi, DS; Baik, SH; Yoo, HJ				Hwang, Hwan-Jin; Jung, Tae Woo; Hong, Ho Cheol; Choi, Hae Yoon; Seo, Ji-A; Kim, Sin Gon; Kim, Nan Hee; Choi, Kyung Mook; Choi, Dong Seop; Baik, Sei Hyun; Yoo, Hye Jin			Progranulin Protects Vascular Endothelium against Atherosclerotic Inflammatory Reaction via Akt/eNOS and Nuclear Factor-kappa B Pathways	PLOS ONE			English	Article							GROWTH-FACTOR; SERUM PROGRANULIN; HOST-DEFENSE; CELLS; EXPRESSION; CONVERSION; ELASTASE; LIGAND; BINDS	Objective: Atherosclerosis is considered a chronic inflammatory disease, initiated by activation and dysfunction of the endothelium. Recently, progranulin has been regarded as an important modulator of inflammatory processes; however, the role for prgranulin in regulating inflammation in vascular endothelial cells has not been described. Method and Results: Signaling pathways mediated by progranulin were analyzed in human umbilical vein endothelial cells (HUVECs) treated with progranulin. Progranulin significantly induced Akt and endothelial nitric oxide synthase (eNOS) phosphorylation in HUVECs, an effect that was blocked with Akt inhibitor. Furthermore, nitric oxide (NO) level, the end product of Akt/eNOS pathway, was significantly upregulated after progranulin treatment. Next, we showed that progranulin efficiently inhibited lipopolysaccharide (LPS)-mediated pro-inflammatory signaling. LPS-induced phosphorylation of I kappa B and nuclear factor-kappa B (NF-kappa B) levels decreased after progranulin treatment. Also, progranulin blocked translocation of NF-kappa B from the cytosol to the nucleus. In addition, progranulin significantly reduced the expression of vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) by inhibiting binding of NF-kappa B to their promoter regions and blocked attachment of monocytes to HUVECs. Progranulin also significantly reduced the expression of tumor necrosis factor receptor-alpha (TNF-alpha) and monocyte chemo-attractant protein-1 (MCP-1), the crucial inflammatory molecules known to aggravate atherosclerosis. Conclusion: Progranulin efficiently inhibited LPS-mediated pro-inflammatory signaling in endothelial cells through activation of the Akt/eNOS pathway and attenuation of the NF-kappa B pathway, suggesting its protective roles in vascular endothelium against inflammatory reaction underlying atherosclerosis.	[Hwang, Hwan-Jin; Jung, Tae Woo; Hong, Ho Cheol; Choi, Hae Yoon; Seo, Ji-A; Kim, Sin Gon; Kim, Nan Hee; Choi, Kyung Mook; Choi, Dong Seop; Baik, Sei Hyun; Yoo, Hye Jin] Korea Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul 136705, South Korea	Korea University; Korea University Medicine (KU Medicine)	Yoo, HJ (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul 136705, South Korea.	deisy21@naver.com	Choi, Kyung Mook/C-4195-2018; Kim, Nan Hee/T-8627-2019; SEO, JI A/AAU-7968-2020	Choi, Kyung Mook/0000-0001-6175-0225; SEO, JI A/0000-0002-1927-2618; Kim, Sin Gon/0000-0002-7430-3675; Kim, Nan Hee/0000-0003-4378-520X	National Research Foundation of Korea; Ministry of Education, Science and Technology [2012R1A1A1005257]; Korea University Grant [K1325151]; Korean Diabetes Association; Brain Korea 21 Project of the Ministry of Education and Human Resources Development, Republic of Korea [HI10V-0007-010013]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea University Grant; Korean Diabetes Association; Brain Korea 21 Project of the Ministry of Education and Human Resources Development, Republic of Korea(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2012R1A1A1005257), Korea University Grant (K1325151) and a grant (HJY, 2013) from Korean Diabetes Association (HJY) and by the Brain Korea 21 Project of the Ministry of Education and Human Resources Development, Republic of Korea (HI10V-0007-010013) (KMC and SHB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; BHANDARI V, 1992, BIOCHEM BIOPH RES CO, V188, P57, DOI 10.1016/0006-291X(92)92349-3; Brand K, 1996, J CLIN INVEST, V97, P1715, DOI 10.1172/JCI118598; Cenik B, 2012, J BIOL CHEM, V287, P32298, DOI 10.1074/jbc.R112.399170; de Winther MPJ, 2005, ARTERIOSCL THROM VAS, V25, P904, DOI 10.1161/01.ATV.0000160340.72641.87; Diamant Michaela, 2006, Curr Diab Rep, V6, P279, DOI 10.1007/s11892-006-0061-4; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; Huang PL, 2003, CURR HYPERTENS REP, V5, P473, DOI 10.1007/s11906-003-0055-4; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Kojima Y, 2009, ATHEROSCLEROSIS, V206, P102, DOI 10.1016/j.atherosclerosis.2009.02.017; Lee CW, 2006, J CELL PHYSIOL, V207, P174, DOI 10.1002/jcp.20549; Liu CJ, 2012, PHARMACOL THERAPEUT, V133, P124, DOI 10.1016/j.pharmthera.2011.10.003; Liu CJ, 2011, FEBS LETT, V585, P3675, DOI 10.1016/j.febslet.2011.04.065; Lu RQ, 2001, P NATL ACAD SCI USA, V98, P142, DOI 10.1073/pnas.011525198; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Matsubara T, 2012, CELL METAB, V15, P38, DOI 10.1016/j.cmet.2011.12.002; Okura H, 2010, J ATHEROSCLER THROMB, V17, P568, DOI 10.5551/jat.3921; Pickford F, 2011, AM J PATHOL, V178, P284, DOI 10.1016/j.ajpath.2010.11.002; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Tung SY, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-91; Yilmaz Y, 2011, DIS MARKERS, V31, P205, DOI [10.1155/2011/126240, 10.3233/DMA-2011-0815]; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Yoo HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055744; Youn BS, 2009, DIABETES, V58, P627, DOI 10.2337/db08-1147; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	27	44	46	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76679	10.1371/journal.pone.0076679	http://dx.doi.org/10.1371/journal.pone.0076679			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098801	Green Published, gold, Green Submitted			2022-12-25	WOS:000325423500172
J	Lu, H; Yang, ST; Lin, LN; Li, BM; Wei, H				Lu, Hu; Yang, Shengtao; Lin, Longnian; Li, Baoming; Wei, Hui			Prediction of Rat Behavior Outcomes in Memory Tasks Using Functional Connections among Neurons	PLOS ONE			English	Article							MODULAR ORGANIZATION; COMMUNITY STRUCTURE; CORTICAL-NEURONS; UNIT-ACTIVITY; SMALL-WORLD; BRAIN; NETWORKS; PATTERNS; HIPPOCAMPUS	Background: Analyzing the neuronal organizational structures and studying the changes in the behavior of the organism is key to understanding cognitive functions of the brain. Although some studies have indicated that spatiotemporal firing patterns of neuronal populations have a certain relationship with the behavioral responses, the issues of whether there are any relationships between the functional networks comprised of these cortical neurons and behavioral tasks and whether it is possible to take advantage of these networks to predict correct and incorrect outcomes of single trials of animals are still unresolved. Methodology/Principal Findings: This paper presents a new method of analyzing the structures of whole-recorded neuronal functional networks (WNFNs) and local neuronal circuit groups (LNCGs). The activity of these neurons was recorded in several rats. The rats performed two different behavioral tasks, the Y-maze task and the U-maze task. Using the results of the assessment of the WNFNs and LNCGs, this paper describes a realization procedure for predicting the behavioral outcomes of single trials. The methodology consists of four main parts: construction of WNFNs from recorded neuronal spike trains, partitioning the WNFNs into the optimal LNCGs using social community analysis, unsupervised clustering of all trials from each dataset into two different clusters, and predicting the behavioral outcomes of single trials. The results show that WNFNs and LNCGs correlate with the behavior of the animal. The U-maze datasets show higher accuracy for unsupervised clustering results than those from the Y-maze task, and these datasets can be used to predict behavioral responses effectively. Conclusions/Significance: The results of the present study suggest that a methodology proposed in this paper is suitable for analysis of the characteristics of neuronal functional networks and the prediction of rat behavior. These types of structures in cortical ensemble activity may be critical to information representation during the execution of behavior.	[Lu, Hu; Wei, Hui] Fudan Univ, Sch Comp Sci, Shanghai 200433, Peoples R China; [Yang, Shengtao; Li, Baoming] Fudan Univ, Inst Neurobiol, Shanghai 200433, Peoples R China; [Yang, Shengtao; Li, Baoming] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Lin, Longnian] E China Normal Univ, Shanghai Inst Brain Funct Genom, Key Labs, MOE, Shanghai 200062, Peoples R China; [Lin, Longnian] E China Normal Univ, Shanghai Inst Brain Funct Genom, STCSM, Shanghai 200062, Peoples R China	Fudan University; Fudan University; Fudan University; East China Normal University; East China Normal University; Science & Technology Commission of Shanghai Municipality (STCSM)	Li, BM (corresponding author), Fudan Univ, Inst Neurobiol, Shanghai 200433, Peoples R China.	bmli@fudan.edu.cn; weihui@fudan.edu.cn	Wei, Hui/K-5819-2019; Yang, Shengtao/ACP-5447-2022		National Natural Science Foundation of China [30990260, 61375122, 61105042]; 973 Program [2010CB327900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China)	This study was supported by the National Natural Science Foundation of China (No. 30990260, 61375122, 61105042) and 973 Program (No. 2010CB327900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Ahmadlou M, 2011, NEUROIMAGE, V58, P401, DOI 10.1016/j.neuroimage.2011.04.070; Ahmadlou M, 2011, CLIN EEG NEUROSCI, V42, P6, DOI 10.1177/155005941104200105; Bai F, 2012, J NEUROSCI, V32, P4307, DOI 10.1523/JNEUROSCI.5061-11.2012; Behrens TEJ, 2012, CURR OPIN NEUROBIOL, V22, P144, DOI 10.1016/j.conb.2011.08.005; Brown EN, 2004, NAT NEUROSCI, V7, P456, DOI 10.1038/nn1228; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chapin JK, 2004, NAT NEUROSCI, V7, P452, DOI 10.1038/nn1234; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Feldt S, 2011, TRENDS NEUROSCI, V34, P225, DOI 10.1016/j.tins.2011.02.007; Fellous JM, 2004, J NEUROSCI, V24, P2989, DOI 10.1523/JNEUROSCI.4649-03.2004; Fenton AA, 1998, P NATL ACAD SCI USA, V95, P3182, DOI 10.1073/pnas.95.6.3182; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Gerhard F, 2011, FRONT COMPUT NEUROSC, V5, P1, DOI [10.3389/fncom.2011.00004, 10.3389/fncom.2011.00023]; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Kaiser M, 2011, NEUROIMAGE, V57, P892, DOI 10.1016/j.neuroimage.2011.05.025; Laubach M, 2000, NATURE, V405, P567, DOI 10.1038/35014604; Laurienti P, 2009, NATURE PRECEDINGS, V4; Li L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022357; Liang ZF, 2011, J NEUROSCI, V31, P3776, DOI 10.1523/JNEUROSCI.4557-10.2011; Lin LN, 2006, J NEUROSCI METH, V155, P28, DOI 10.1016/j.jneumeth.2005.12.032; Lopes-dos-Santos V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020996; Lu H, 2012, PHYSICA A, V391, P6156, DOI 10.1016/j.physa.2012.06.062; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Ng AY, 2002, ADV NEUR IN, V14, P849; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Paiva A, 2009, NEURAL COMPUT APPL, V18, P1; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Quiroga RQ, 2009, NAT REV NEUROSCI, V10, P173, DOI 10.1038/nrn2578; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schreiber S, 2003, NEUROCOMPUTING, V52-4, P925, DOI 10.1016/S0925-2312(02)00838-X; Schwarz AJ, 2009, NEUROIMAGE, V47, P302, DOI 10.1016/j.neuroimage.2009.03.064; Shen X, 2010, NEUROIMAGE, V50, P1027, DOI 10.1016/j.neuroimage.2009.12.119; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Shmiel T, 2005, P NATL ACAD SCI USA, V102, P18655, DOI 10.1073/pnas.0509346102; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Stevenson IH, 2011, NAT NEUROSCI, V14, P139, DOI 10.1038/nn.2731; Talwar SK, 2002, NATURE, V417, P37, DOI 10.1038/417037a; van den Heuvel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002001; Villa AEP, 1999, P NATL ACAD SCI USA, V96, P1106, DOI 10.1073/pnas.96.3.1106; Wang JH, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00016; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517	53	10	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e74298	10.1371/journal.pone.0074298	http://dx.doi.org/10.1371/journal.pone.0074298			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098641	Green Submitted, gold, Green Published			2022-12-25	WOS:000325423500012
J	Ryoo, HD; Li, J; Kang, MJ				Ryoo, Hyung Don; Li, Josepher; Kang, Min-Ji			Drosophila XBP1 Expression Reporter Marks Cells under Endoplasmic Reticulum Stress and with High Protein Secretory Load	PLOS ONE			English	Article							ACCESSORY-GLAND; ER STRESS; MESSENGER-RNAS; ACTIVATION; SIGNALS; MODEL; DECAY	Expression of genes in the endoplasmic reticulum (ER) beyond its protein folding capacity activates signaling pathways that are collectively referred to as the Unfolded Protein Response (UPR). A major branch of the UPR pathway is mediated by IRE1, an ER-tethered endonuclease. Upon ER stress-induced activation, IRE1 splices the mRNA of XBP1, thereby generating an active isoform of this transcription factor. During normal Drosophila development, tissues with high protein secretory load show signs of IRE1/XBP1 activity indicative of inherent ER stress associated with those cell types. Here, we report that the XBP1 promoter activity itself is enhanced in secretory tissues of Drosophila, and it can be induced by excessive ER stress. Specifically, we developed a Drosophila XBP1 transcription reporter by placing dsRed under the control of the XBP1 intergenic sequence. DsRed expression in these xbp1(p)>dsRed transgenic flies showed patterns similar to that of xbp1 transcript distribution. In healthy developing flies, the reporter expression was highest in salivary glands and the intestine. In the adult, the male reproductive organs showed high levels of dsRed. These tissues are known to have high protein secretory load. Consistently, the xbp1(p)>dsRed reporter was induced by excessive ER stress caused by mutant Rhodopsin-1 overexpression. These results suggest that secretory cells suffer from inherent ER stress, and the xbp1(p)>dsRed flies provide a useful tool in studying the function and homeostasis of those cells.	[Ryoo, Hyung Don; Li, Josepher; Kang, Min-Ji] New York Univ Sch Med, Dept Cell Biol, New York, NY USA; [Kang, Min-Ji] Univ Ulsan Coll Med, Dept Biomed Sci, Seoul, South Korea	New York University; University of Ulsan	Ryoo, HD (corresponding author), New York Univ Sch Med, Dept Cell Biol, New York, NY USA.	hyungdon.ryoo@nyumc.org; mjkang@amc.seoul.kr			National Institutes of Health (NIH) [R01 EY020866]; NATIONAL EYE INSTITUTE [R01EY020866] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health (NIH) grant R01 EY020866. The web address for NIH is http://www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barolo S, 2004, BIOTECHNIQUES, V36, P436, DOI 10.2144/04363ST03; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Casas-Tinto S, 2011, HUM MOL GENET, V20, P2144, DOI 10.1093/hmg/ddr100; CHOU TB, 1992, GENETICS, V131, P643; Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Kang MJ, 2012, NAT CELL BIOL, V14, P409, DOI 10.1038/ncb2447; Kang MJ, 2009, P NATL ACAD SCI USA, V106, P17043, DOI 10.1073/pnas.0905566106; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kimmig P, 2012, ELIFE, V1, DOI 10.7554/eLife.00048; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Kumita JR, 2012, FASEB J, V26, P192, DOI 10.1096/fj.11-185983; Li H, 2010, P NATL ACAD SCI USA, V107, P16113, DOI 10.1073/pnas.1010580107; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Lung O, 2001, J INSECT PHYSIOL, V47, P617, DOI 10.1016/S0022-1910(00)00151-7; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Mendes CS, 2009, EMBO J, V28, P1296, DOI 10.1038/emboj.2009.76; Mueller JL, 2005, GENETICS, V171, P131, DOI 10.1534/genetics.105.043844; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Ryoo HD, 2007, CELL CYCLE, V6, P830, DOI 10.4161/cc.6.7.4064; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sone M, 2013, CELL STRESS CHAPERON, V18, P307, DOI 10.1007/s12192-012-0383-x; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tsuda H, 2008, CELL, V133, P963, DOI 10.1016/j.cell.2008.04.039; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wolfner MF, 1997, INSECT BIOCHEM MOLEC, V27, P179, DOI 10.1016/S0965-1748(96)00084-7; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yoshida H, 2001, MOL CELL BIOL, V21, P1239, DOI 10.1128/MCB.21.4.1239-1248.2001	33	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e75774	10.1371/journal.pone.0075774	http://dx.doi.org/10.1371/journal.pone.0075774			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098723	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500094
J	Grishin, AA; Cuny, H; Hung, A; Clark, RJ; Brust, A; Akondi, K; Alewood, PF; Craik, DJ; Adams, DJ				Grishin, Anton A.; Cuny, Hartmut; Hung, Andrew; Clark, Richard J.; Brust, Andreas; Akondi, Kalyana; Alewood, Paul F.; Craik, David J.; Adams, David J.			Identifying Key Amino Acid Residues That Affect alpha-Conotoxin AuIB Inhibition of alpha 3 beta 4 Nicotinic Acetylcholine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electrophysiology; Molecular Docking; Molecular Modeling; Nicotinic Acetylcholine Receptors; NMR; Peptide Chemical Synthesis; Site-directed Mutagenesis; Xenopus Oocyte; Cyonotoxin	COMPETITIVE ANTAGONIST; CALCIUM-CHANNELS; STRUCTURAL DETERMINANTS; SUBUNIT INTERFACES; BINDING-PROTEIN; CHEMICAL-SHIFTS; SENSORY NEURONS; CONUS VENOMS; RICH SOURCE; VC1.1	Background: -Conotoxin AuIB interacts with 34 nAChRs and GABA(B) receptors, but structural determinants of these interactions are unknown. Results: Using alanine scanning mutagenesis and molecular dynamics, we identified residues crucial for AuIB34 nAChR interaction. Conclusion: We identified the key residues that mediate AuIB34 nAChR interaction. Significance: Ability to direct -conotoxin binding to nAChRs or GABA(B) receptors will improve analgesic conopeptides. -Conotoxin AuIB is a selective 34 nicotinic acetylcholine receptor (nAChR) subtype inhibitor. Its analgesic properties are believed to result from it activating GABA(B) receptors and subsequently inhibiting Ca(V)2.2 voltage-gated calcium channels. The structural determinants that mediate diverging AuIB activity at these targets are unknown. We performed alanine scanning mutagenesis of AuIB and 34 nAChR, homology modeling, and molecular dynamics simulations to identify the structural determinants of the AuIB34 nAChR interaction. Two alanine-substituted AuIB analogues, [P6A]AuIB and [F9A]AuIB, did not inhibit the 34 nAChR. NMR and CD spectroscopy studies demonstrated that [F9A]AuIB retains its native globular structure, so its activity loss is probably due to loss of specific toxin-receptor residue pairwise contacts. Compared with AuIB, the concentration-response curve for inhibition of 34 by [F9A]AuIB shifted rightward more than 10-fold, and its subtype selectivity profile changed. Homology modeling and molecular dynamics simulations suggest that Phe-9 of AuIB interacts with a two-residue binding pocket on the 4 nAChR subunit. This hypothesis was confirmed by site-directed mutagenesis of the 4-Trp-59 and 4-Lys-61 residues of loop D, which form a putative binding pocket. AuIB analogues with Phe-9 substitutions corroborated the finding of a binding pocket on the 4 subunit and gave further insight into how AuIB Phe-9 interacts with the 4 subunit. In summary, we identified critical residues that mediate interactions between AuIB and its cognate nAChR subtype. These findings might help improve the design of analgesic conopeptides that selectively avoid nAChR receptors while targeting receptors involved with nociception.	[Grishin, Anton A.; Cuny, Hartmut; Hung, Andrew; Adams, David J.] RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic 3083, Australia; [Clark, Richard J.; Brust, Andreas; Akondi, Kalyana; Alewood, Paul F.; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	Royal Melbourne Institute of Technology (RMIT); University of Queensland	Adams, DJ (corresponding author), RMIT Univ, Hlth Innovat Res Inst, POB 71, Bundoora, Vic 3083, Australia.	david.adams@rmit.edu.au	Alewood, Paul F/J-2412-2014; Craik, David/B-1695-2010; Adams, David/J-9125-2014; Adams, David John/K-3578-2019; Clark, Richard J/G-8848-2012	Craik, David/0000-0003-0007-6796; Adams, David/0000-0002-7030-2288; Adams, David John/0000-0002-7030-2288; Clark, Richard J/0000-0002-6807-5426; Brust, Andreas/0000-0003-4238-5706; Cuny, Hartmut/0000-0002-1551-2354; Hung, Andrew/0000-0003-3569-2951; Alewood, Paul/0000-0001-7454-6522	National Health and Medical Research Council [569927]; Australian Research Council [DP 1093115]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by National Health and Medical Research Council Program Grant 569927 and Australian Research Council Discovery Grant DP 1093115.	Adams DJ, 2013, BBA-BIOMEMBRANES, V1828, P1619, DOI 10.1016/j.bbamem.2013.01.019; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Armishaw CJ, 2005, CURR PROTEIN PEPT SC, V6, P221, DOI 10.2174/1389203054065437; Azam L, 2005, J BIOL CHEM, V280, P80, DOI 10.1074/jbc.M406281200; Azam L, 2009, ACTA PHARMACOL SIN, V30, P771, DOI 10.1038/aps.2009.47; Billen B, 2012, P NATL ACAD SCI USA, V109, P9173, DOI 10.1073/pnas.1116397109; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Brams M, 2011, J BIOL CHEM, V286, P4420, DOI 10.1074/jbc.M110.188730; Callaghan B, 2008, J NEUROSCI, V28, P10943, DOI 10.1523/JNEUROSCI.3594-08.2008; Callaghan B, 2010, CHANNELS, V4, P51, DOI 10.4161/chan.4.1.10281; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Clark RJ, 2006, J BIOL CHEM, V281, P23254, DOI 10.1074/jbc.M604550200; Clark RJ, 2006, BIOCHEM J, V394, P85, DOI 10.1042/BJ20051691; CUNY H, 2012, P AUST PHYSL SOC, V43, pP65; Cuny H, 2012, J BIOL CHEM, V287, P23948, DOI 10.1074/jbc.M112.342998; Dutertre S, 2005, J BIOL CHEM, V280, P30460, DOI 10.1074/jbc.M504229200; Dutton JL, 2002, J BIOL CHEM, V277, P48849, DOI 10.1074/jbc.M208842200; Franco A, 2012, BIOCHEM PHARMACOL, V83, P419, DOI 10.1016/j.bcp.2011.11.006; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Gay EA, 2008, J PHYSIOL-LONDON, V586, P1105, DOI 10.1113/jphysiol.2007.149492; Gay EA, 2007, MOL PHARMACOL, V72, P838, DOI 10.1124/mol.107.035527; Gehrmann J, 1999, J MED CHEM, V42, P2364, DOI 10.1021/jm990114p; Goddard T. D., 2008, SPARKY 3; Grishin AA, 2010, J BIOL CHEM, V285, P22254, DOI 10.1074/jbc.M110.111880; Halai R, 2009, J BIOL CHEM, V284, P20275, DOI 10.1074/jbc.M109.015339; Han TS, 2008, CURR PHARM DESIGN, V14, P2462, DOI 10.2174/138161208785777469; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2007, J MOL BIOL, V369, P895, DOI 10.1016/j.jmb.2007.03.067; Harvey SC, 1997, MOL PHARMACOL, V51, P336, DOI 10.1124/mol.51.2.336; Harvey SC, 1996, J NEUROSCI, V16, P3798; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Improgo MRD, 2010, PROG NEUROBIOL, V92, P212, DOI 10.1016/j.pneurobio.2010.05.003; Innocent N, 2008, J PHARMACOL EXP THER, V327, P529, DOI 10.1124/jpet.108.142943; Inserra MC, 2013, BIOCHEM PHARMACOL, V86, P791, DOI 10.1016/j.bcp.2013.07.016; Janes RW, 2005, CURR OPIN PHARMACOL, V5, P280, DOI 10.1016/j.coph.2005.01.013; Kapono CA, 2013, TOXICON, V70, P170, DOI 10.1016/j.toxicon.2013.04.022; Kesters D, 2013, EMBO REP, V14, P49, DOI 10.1038/embor.2012.189; Klimis H, 2011, PAIN, V152, P259, DOI 10.1016/j.pain.2010.09.007; Lee C, 2012, BMB REP, V45, P275, DOI 10.5483/BMBRep.2012.45.5.275; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; Luo SQ, 1998, J NEUROSCI, V18, P8571; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; MacKerell A. D., 1998, ENCY COMPUTATIONAL C, V1, P271; Marx UC, 2006, MAGN RESON CHEM, V44, pS41, DOI 10.1002/mrc.1821; Millar NS, 2009, NEUROPHARMACOLOGY, V56, P237, DOI 10.1016/j.neuropharm.2008.07.041; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; OLIVERA BM, 1990, SCIENCE, V249, P257, DOI 10.1126/science.2165278; Parker MJ, 2001, J PHARMACOL EXP THER, V299, P385; Pereira EFR, 1996, J PHARMACOL EXP THER, V278, P1472; Puskar NL, 2011, J BIOL CHEM, V286, P14618, DOI 10.1074/jbc.M110.206565; Quiram PA, 1999, J BIOL CHEM, V274, P19517, DOI 10.1074/jbc.274.28.19517; Rogers JP, 1999, BIOCHEMISTRY-US, V38, P3874, DOI 10.1021/bi9826254; Rucktooa P, 2009, BIOCHEM PHARMACOL, V78, P777, DOI 10.1016/j.bcp.2009.06.098; Samanta U, 1999, ACTA CRYSTALLOGR D, V55, P1421, DOI 10.1107/S090744499900726X; Sandall DW, 2003, BIOCHEMISTRY-US, V42, P6904, DOI 10.1021/bi034043e; Satkunanathan N, 2005, BRAIN RES, V1059, P149, DOI 10.1016/j.brainres.2005.08.009; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Seo S, 2009, J NEUROSCI, V29, P8734, DOI 10.1523/JNEUROSCI.1859-09.2009; Shiembob DL, 2006, BIOCHEMISTRY-US, V45, P11200, DOI 10.1021/bi0611715; Shimomura M, 2006, MOL PHARMACOL, V70, P1255, DOI 10.1124/mol.106.026815; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Ulens C, 2006, P NATL ACAD SCI USA, V103, P3615, DOI 10.1073/pnas.0507889103; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Lierop BJ, 2013, ACS CHEM BIOL, V8, P1815, DOI 10.1021/cb4002393; Williams DK, 2009, J PHARMACOL EXP THER, V330, P40, DOI 10.1124/jpet.109.151225; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wu J, 2004, J BIOL CHEM, V279, P37842, DOI 10.1074/jbc.M400335200; Xie Y, 2001, J BIOL CHEM, V276, P2417, DOI 10.1074/jbc.M009085200; Xiu XA, 2009, NATURE, V458, P534, DOI 10.1038/nature07768; Young GT, 2007, MOL PHARMACOL, V71, P389, DOI 10.1124/ml.106.030809; Yu RL, 2013, J MED CHEM, V56, P3557, DOI 10.1021/jm400041h; Yu RL, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002011	78	39	42	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34428	34442		10.1074/jbc.M113.512582	http://dx.doi.org/10.1074/jbc.M113.512582			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24100032	Green Published, hybrid			2022-12-25	WOS:000329812800014
J	Girard, PM; Graindorge, D; Smirnova, V; Rigolet, P; Francesconi, S; Scanlon, S; Sage, E				Girard, Pierre-Marie; Graindorge, Dany; Smirnova, Violetta; Rigolet, Pascal; Francesconi, Stefania; Scanlon, Susan; Sage, Evelyne			Oxidative Stress in Mammalian Cells Impinges on the Cysteines Redox State of Human XRCC3 Protein and on Its Cellular Localization	PLOS ONE			English	Article							STRAND BREAK REPAIR; SINGLET OXYGEN; MOLECULAR-MECHANISMS; S-GLUTATHIONYLATION; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE; N-ACETYLCYSTEINE; UVA RADIATION; DIETHYL ESTER; HUMAN RAD51C	In vertebrates, XRCC3 is one of the five Rad51 paralogs that plays a central role in homologous recombination (HR), a key pathway for maintaining genomic stability. While investigating the potential role of human XRCC3 (hXRCC3) in the inhibition of DNA replication induced by UVA radiation, we discovered that hXRCC3 cysteine residues are oxidized following photosensitization by UVA. Our in silico prediction of the hXRCC3 structure suggests that 6 out of 8 cysteines are potentially accessible to the solvent and therefore potentially exposed to ROS attack. By non-reducing SDS-PAGE we show that many different oxidants induce hXRCC3 oxidation that is monitored in Chinese hamster ovarian (CHO) cells by increased electrophoretic mobility of the protein and in human cells by a slight decrease of its immunodetection. In both cell types, hXRCC3 oxidation was reversed in few minutes by cellular reducing systems. Depletion of intracellular glutathione prevents hXRCC3 oxidation only after UVA exposure though depending on the type of photosensitizer. In addition, we show that hXRCC3 expressed in CHO cells localizes both in the cytoplasm and in the nucleus. Mutating all hXRCC3 cysteines to serines (XR3/S protein) does not affect the subcellular localization of the protein even after exposure to camptothecin (CPT), which typically induces DNA damages that require HR to be repaired. However, cells expressing mutated XR3/S protein are sensitive to CPT, thus highlighting a defect of the mutant protein in HR. In marked contrast to CPT treatment, oxidative stress induces relocalization at the chromatin fraction of both wild-type and mutated protein, even though survival is not affected. Collectively, our results demonstrate that the DNA repair protein hXRCC3 is a target of ROS induced by environmental factors and raise the possibility that the redox environment might participate in regulating the HR pathway.	[Girard, Pierre-Marie; Graindorge, Dany; Smirnova, Violetta; Rigolet, Pascal; Francesconi, Stefania; Scanlon, Susan; Sage, Evelyne] Inst Curie, Ctr Rech, F-91405 Orsay, France; [Girard, Pierre-Marie; Graindorge, Dany; Smirnova, Violetta; Rigolet, Pascal; Francesconi, Stefania; Scanlon, Susan; Sage, Evelyne] CNRS, UMR3348, F-91405 Orsay, France; [Rigolet, Pascal] Univ Paris 11, Orsay, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Girard, PM (corresponding author), Inst Curie, Ctr Rech, F-91405 Orsay, France.	pierre-marie.girard@curie.fr	Rigolet, Pascal/S-8602-2018; Francesconi, Stefania/J-7910-2016	Rigolet, Pascal/0000-0001-6868-4953; francesconi, stefania/0000-0002-9665-349X; girard, pierre-marie/0000-0001-9703-4407; Gueble, Susan/0000-0002-8043-1147	La Region Ile de France on DIM SenT program; La Ligue Contre le Cancer; Centre National de la Recherche Scientifique; Institut Curie	La Region Ile de France on DIM SenT program(Region Ile-de-France); La Ligue Contre le Cancer(Ligue nationale contre le cancer); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut Curie	D.G. was the recipient of a doctoral fellowship from La Region Ile de France on DIM SenT program and La Ligue Contre le Cancer. This work was funded by the Centre National de la Recherche Scientifique and Institut Curie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNER ESJ, 1995, J BIOL CHEM, V270, P3479, DOI 10.1074/jbc.270.8.3479; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Bae SI, 2008, BIOCHEM PHARMACOL, V76, P1653, DOI 10.1016/j.bcp.2008.09.003; Baier J, 2006, BIOPHYS J, V91, P1452, DOI 10.1529/biophysj.106.082388; BELLOMO G, 1990, METHOD ENZYMOL, V186, P627; Bishop DK, 1998, J BIOL CHEM, V273, P21482, DOI 10.1074/jbc.273.34.21482; Biswas S, 2006, BIOCHEM PHARMACOL, V71, P551, DOI 10.1016/j.bcp.2005.10.044; Biverstal A, 2008, MUTAT RES-FUND MOL M, V648, P32, DOI 10.1016/j.mrfmmm.2008.09.011; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Bracchitta G, 2013, PHOTOCH PHOTOBIO SCI, V12, P911, DOI 10.1039/c3pp25326k; Bravard A, 2006, MOL CELL BIOL, V26, P7430, DOI 10.1128/MCB.00624-06; Bravard A, 2009, CANCER RES, V69, P3642, DOI 10.1158/0008-5472.CAN-08-3943; BUETTNER GR, 1987, BIOCHIM BIOPHYS ACTA, V923, P501, DOI 10.1016/0304-4165(87)90060-2; CATALFO A, 2005, PHOTOCH PHOTOBIO SCI, V4, P304, DOI DOI 10.1039/B406908K; Chen J, 2010, NUCLEIC ACIDS RES, V38, P4889, DOI 10.1093/nar/gkq209; Chen LT, 2007, NUCLEIC ACIDS RES, V35, P1787, DOI 10.1093/nar/gkl1131; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; Czaplewski C, 2004, PROTEIN ENG DES SEL, V17, P29, DOI 10.1093/protein/gzh003; Dalle-Donne I, 2008, ANTIOXID REDOX SIGN, V10, P445, DOI 10.1089/ars.2007.1716; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Dardalhon D, 2008, CELL CYCLE, V7, P611, DOI 10.4161/cc.7.5.5400; Davies MJ, 2004, PHOTOCH PHOTOBIO SCI, V3, P17, DOI 10.1039/b307576c; DEVASAGAYAM TPA, 1991, J PHOTOCH PHOTOBIO B, V9, P105, DOI 10.1016/1011-1344(91)80008-6; Gallogly MM, 2009, ANTIOXID REDOX SIGN, V11, P1059, DOI [10.1089/ars.2008.2291, 10.1089/ARS.2008.2291]; Ghezzi P, 2005, ANTIOXID REDOX SIGN, V7, P964, DOI 10.1089/ars.2005.7.964; Gildemeister OS, 2009, J BIOL CHEM, V284, P31945, DOI 10.1074/jbc.M109.024646; Girard PM, 2008, DNA REPAIR, V7, P1500, DOI 10.1016/j.dnarep.2008.05.004; Girard PM, 2004, HUM MOL GENET, V13, P2369, DOI 10.1093/hmg/ddh274; Girotti AW, 2004, ANTIOXID REDOX SIGN, V6, P301, DOI 10.1089/152308604322899369; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Henry-Mowatt J, 2003, MOL CELL, V11, P1109, DOI 10.1016/S1097-2765(03)00132-1; Hill JW, 2006, NUCLEIC ACIDS RES, V34, P1620, DOI 10.1093/nar/gkl060; Hinz JM, 2003, CARCINOGENESIS, V24, P249, DOI 10.1093/carcin/24.2.249; Kanofsky JR, 2011, PHOTOCHEM PHOTOBIOL, V87, P14, DOI 10.1111/j.1751-1097.2010.00855.x; KOSOWER NS, 1995, METHOD ENZYMOL, V251, P123, DOI 10.1016/0076-6879(95)51116-4; Kozmin S, 2005, P NATL ACAD SCI USA, V102, P13538, DOI 10.1073/pnas.0504497102; Kurumizaka H, 2001, P NATL ACAD SCI USA, V98, P5538, DOI 10.1073/pnas.091603098; Lambert S, 2000, EMBO J, V19, P3090, DOI 10.1093/emboj/19.12.3090; Lambert S, 2002, ONCOGENE, V21, P4065, DOI 10.1038/sj.onc.1205535; Lee AJ, 2005, CANCER EPIDEM BIOMAR, V14, P497, DOI 10.1158/1055-9965.EPI-04-0295; LEVY EJ, 1993, P NATL ACAD SCI USA, V90, P9171, DOI 10.1073/pnas.90.19.9171; Liang F, 1996, P NATL ACAD SCI USA, V93, P8929, DOI 10.1073/pnas.93.17.8929; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Lio YC, 2004, J BIOL CHEM, V279, P42313, DOI 10.1074/jbc.M405212200; Liu N, 2002, NUCLEIC ACIDS RES, V30, P1009, DOI 10.1093/nar/30.4.1009; Maresca V, 2006, J INVEST DERMATOL, V126, P182, DOI 10.1038/sj.jid.5700021; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Masson JY, 2001, GENE DEV, V15, P3296, DOI 10.1101/gad.947001; Masson JY, 2001, P NATL ACAD SCI USA, V98, P8440, DOI 10.1073/pnas.111005698; MEISTER A, 1995, METHOD ENZYMOL, V251, P3, DOI 10.1016/0076-6879(95)51106-7; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; MINHAS HS, 1995, BIOCHEM PHARMACOL, V49, P1475, DOI 10.1016/0006-2952(94)00518-Q; Montaner B, 2007, EMBO REP, V8, P1074, DOI 10.1038/sj.embor.7401084; Noda T, 2001, FASEB J, V15, P2131, DOI 10.1096/fj.01-0131com; Pattison DI, 2012, PHOTOCH PHOTOBIO SCI, V11, P38, DOI 10.1039/c1pp05164d; Pryor WA, 2006, AM J PHYSIOL-REG I, V291, pR491, DOI 10.1152/ajpregu.00614.2005; Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028; Redmond RW, 2006, PHOTOCHEM PHOTOBIOL, V82, P1178, DOI 10.1562/2006-04-14-IR-874; Ridley AJ, 2009, INT J RADIAT BIOL, V85, P177, DOI 10.1080/09553000902740150; Sage E, 2012, PHOTOCH PHOTOBIO SCI, V11, P74, DOI 10.1039/c1pp05219e; Schweitzer C, 2003, CHEM REV, V103, P1685, DOI 10.1021/cr010371d; Shackelford RE, 2005, ANTIOXID REDOX SIGN, V7, P940, DOI 10.1089/ars.2005.7.940; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Soeur J, 2011, MUTAT RES-GEN TOX EN, V718, P24, DOI 10.1016/j.mrgentox.2010.10.009; Somyajit K, 2013, MOL CELL BIOL, V33, P1830, DOI 10.1128/MCB.01521-12; Sonoda E, 2007, DNA REPAIR, V6, P280, DOI 10.1016/j.dnarep.2006.10.025; Stefani M, 2008, INT J MOL SCI, V9, P2515, DOI 10.3390/ijms9122515; TEBBS RS, 1995, P NATL ACAD SCI USA, V92, P6354, DOI 10.1073/pnas.92.14.6354; Thacker J, 2005, CANCER LETT, V219, P125, DOI 10.1016/j.canlet.2004.08.018; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TYRRELL RM, 1989, PHOTOCHEM PHOTOBIOL, V49, P407, DOI 10.1111/j.1751-1097.1989.tb09187.x; von Montfort C, 2006, BIOL CHEM, V387, P1399, DOI 10.1515/BC.2006.175; Wan LL, 2008, MOL CELL, V31, P244, DOI 10.1016/j.molcel.2008.06.004; Watanabe N, 2004, METHOD ENZYMOL, V378, P319; Wu Y, 2005, J BIOL CHEM, V280, P722, DOI 10.1074/jbc.M411093200; Yamada NA, 2004, J BIOL CHEM, V279, P23250, DOI 10.1074/jbc.M402247200; Yoshihara T, 2004, EMBO J, V23, P670, DOI 10.1038/sj.emboj.7600087; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001	79	21	22	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75751	10.1371/journal.pone.0075751	http://dx.doi.org/10.1371/journal.pone.0075751			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116071	Green Published, Green Submitted, gold			2022-12-25	WOS:000325552200036
J	Lau, DH; Middeldorp, ME; Brooks, AG; Ganesan, AN; Roberts-Thomson, KC; Stiles, MK; Leong, DP; Abed, HS; Lim, HS; Wong, CX; Willoughby, SR; Young, GD; Kalman, JM; Abhayaratna, WP; Sanders, P				Lau, Dennis H.; Middeldorp, Melissa E.; Brooks, Anthony G.; Ganesan, Anand N.; Roberts-Thomson, Kurt C.; Stiles, Martin K.; Leong, Darryl P.; Abed, Hany S.; Lim, Han S.; Wong, Christopher X.; Willoughby, Scott R.; Young, Glenn D.; Kalman, Jonathan M.; Abhayaratna, Walter P.; Sanders, Prashanthan			Aortic Stiffness in Lone Atrial Fibrillation: A Novel Risk Factor for Arrhythmia Recurrence	PLOS ONE			English	Article							ARTERY FUNCTION EVALUATION; BLOOD-PRESSURE; EUROPEAN-SOCIETY; FOLLOW-UP; PREVENTION; IMPACT; HEART; RECOMMENDATIONS; HEMODYNAMICS; ASSOCIATION	Background: Recent community-based research has linked aortic stiffness to the development of atrial fibrillation. We posit that aortic stiffness contributes to adverse atrial remodeling leading to the persistence of atrial fibrillation following catheter ablation in lone atrial fibrillation patients, despite the absence of apparent structural heart disease. Here, we aim to evaluate aortic stiffness in lone atrial fibrillation patients and determine its association with arrhythmia recurrence following radio-frequency catheter ablation. Methods: We studied 68 consecutive lone atrial fibrillation patients who underwent catheter ablation procedure for atrial fibrillation and 50 healthy age-and sex-matched community controls. We performed radial artery applanation tonometry to obtain central measures of aortic stiffness: pulse pressure, augmentation pressure and augmentation index. Following ablation, arrhythmia recurrence was monitored at months 3, 6, 9, 12 and 6 monthly thereafter. Results: Compared to healthy controls, lone atrial fibrillation patients had significantly elevated peripheral pulse pressure, central pulse pressure, augmentation pressure and larger left atrial dimensions (all P<0.05). During a mean follow-up of 2.9 +/- 1.4 years, 38 of the 68 lone atrial fibrillation patients had atrial fibrillation recurrence after initial catheter ablation procedure. Neither blood pressure nor aortic stiffness indices differed between patients with and without atrial fibrillation recurrence. However, patients with highest levels (>= 75th percentile) of peripheral pulse pressure, central pulse pressure and augmentation pressure had higher atrial fibrillation recurrence rates (all P<0.05). Only central aortic stiffness indices were associated with lower survival free from atrial fibrillation using Kaplan-Meier analysis. Conclusion: Aortic stiffness is an important risk factor in patients with lone atrial fibrillation and contributes to higher atrial fibrillation recurrence following catheter ablation procedure.	[Lau, Dennis H.; Middeldorp, Melissa E.; Brooks, Anthony G.; Ganesan, Anand N.; Roberts-Thomson, Kurt C.; Stiles, Martin K.; Leong, Darryl P.; Abed, Hany S.; Lim, Han S.; Wong, Christopher X.; Willoughby, Scott R.; Young, Glenn D.; Sanders, Prashanthan] Univ Adelaide, Ctr Heart Rhythm Disorders, Adelaide, SA, Australia; [Lau, Dennis H.; Middeldorp, Melissa E.; Brooks, Anthony G.; Ganesan, Anand N.; Roberts-Thomson, Kurt C.; Stiles, Martin K.; Leong, Darryl P.; Abed, Hany S.; Lim, Han S.; Wong, Christopher X.; Willoughby, Scott R.; Young, Glenn D.; Sanders, Prashanthan] Royal Adelaide Hosp, Adelaide, SA 5000, Australia; [Kalman, Jonathan M.] Royal Melbourne Hosp, Dept Cardiol, Melbourne, Vic, Australia; [Kalman, Jonathan M.] Univ Melbourne, Dept Med, Melbourne, Vic 3010, Australia; [Abhayaratna, Walter P.] Canberra Hosp, Acad Unit Internal Med, Canberra, ACT, Australia	University of Adelaide; Royal Adelaide Hospital; Royal Melbourne Hospital; University of Melbourne; Australian National University; Canberra Hospital	Sanders, P (corresponding author), Univ Adelaide, Ctr Heart Rhythm Disorders, Adelaide, SA, Australia.	prash.sanders@adelaide.edu.au	Lau, Dennis H/G-6234-2013; Ganesan, Anand/AAG-9125-2021; Ganesan, Anand N/A-4902-2019; Middeldorp, Melissa/C-6414-2019; Sanders, Prashanthan/D-7641-2013; Wong, Christopher X/A-3227-2011	Lau, Dennis H/0000-0001-7753-1318; Ganesan, Anand/0000-0002-2734-3025; Ganesan, Anand N/0000-0002-2734-3025; Middeldorp, Melissa/0000-0002-4106-9771; Sanders, Prashanthan/0000-0003-3803-8429; Abhayaratna, Walter/0000-0002-4908-0641; Wong, Christopher/0000-0002-1913-6675	National Health and Medical Research Council of Australia (NHMRC); Heart Foundation of Australia (HFA); CVL from Pfizer Australia; University of Adelaide; NHMRC; Rhodes scholarship; Tom Simpson Trust Fund, HFA	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Heart Foundation of Australia (HFA); CVL from Pfizer Australia(PfizerPfizer Australia); University of Adelaide; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Rhodes scholarship; Tom Simpson Trust Fund, HFA	Drs. Lau and Leong are supported by a Postdoctoral Fellowship from the National Health and Medical Research Council of Australia (NHMRC). Drs. Brooks, Roberts-Thomson and Sanders are supported by the Heart Foundation of Australia (HFA). Dr. Ganesan is supported by a CVL grant from Pfizer Australia. Dr. Abed is supported by an Australian Postgraduate Award and an Earl Bakken Fellowship from the University of Adelaide. Dr. Lim is supported by a Postgraduate Scholarship from NHMRC. Dr. Wong is supported by the Rhodes scholarship. Dr. Willoughby is supported by the NHMRC. This work is supported by an equipment grant from Tom Simpson Trust Fund, HFA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agabiti-Rosei E, 2007, HYPERTENSION, V50, P154, DOI 10.1161/HYPERTENSIONAHA.107.090068; Belluzzi F, 2009, J AM COLL CARDIOL, V53, P24, DOI 10.1016/j.jacc.2008.08.071; Benjamin EJ, 2009, CIRCULATION, V119, P606, DOI 10.1161/CIRCULATIONAHA.108.825380; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Cecelja M, 2009, HYPERTENSION, V54, P1328, DOI 10.1161/HYPERTENSIONAHA.109.137653; Celik T, 2009, AM J HYPERTENS, V22, P1270, DOI 10.1038/ajh.2009.157; Chen CH, 1997, CIRCULATION, V95, P1827; Chung MK, 2001, CIRCULATION, V104, P2886, DOI 10.1161/hc4901.101760; Conen D, 2009, CIRCULATION, V119, P2146, DOI 10.1161/CIRCULATIONAHA.108.830042; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Gedikli O, 2010, CLIN EXP HYPERTENS, V32, P84, DOI 10.3109/10641960902993103; Jais P, 2000, J CARDIOVASC ELECTR, V11, P623, DOI 10.1111/j.1540-8167.2000.tb00023.x; KOPECKY SL, 1987, NEW ENGL J MED, V317, P669, DOI 10.1056/NEJM198709103171104; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lau DH, 2010, HEART RHYTHM, V7, P1282, DOI 10.1016/j.hrthm.2010.05.010; Lau DH, 2010, HEART RHYTHM, V7, P396, DOI 10.1016/j.hrthm.2009.11.031; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Mahnkopf C, 2010, HEART RHYTHM, V7, P1475, DOI 10.1016/j.hrthm.2010.06.030; Mancia G, 2003, J HYPERTENS, V21, P1011, DOI 10.1097/01.hjh.0000059051.65882.32; McEniery CM, 2010, HYPERTENSION, V56, P591, DOI 10.1161/HYPERTENSIONAHA.110.156950; McEniery CM, 2010, HYPERTENSION, V56, P36, DOI 10.1161/HYPERTENSIONAHA.110.150896; Mitchell GF, 2007, JAMA-J AM MED ASSOC, V297, P709, DOI 10.1001/jama.297.7.709; Sakuragi S, 2010, INT J CARDIOL, V138, P112, DOI 10.1016/j.ijcard.2009.04.027; Schnabel R, 2008, HYPERTENSION, V51, P1651, DOI 10.1161/HYPERTENSIONAHA.107.105668; Schneider MP, 2010, J AM COLL CARDIOL, V55, P2299, DOI 10.1016/j.jacc.2010.01.043; Stiles MK, 2009, J AM COLL CARDIOL, V53, P1182, DOI 10.1016/j.jacc.2008.11.054; Vlachopoulos C, 2010, EUR HEART J, V31, P1865, DOI 10.1093/eurheartj/ehq024; Williams B, 2006, CIRCULATION, V113, P1213, DOI 10.1161/CIRCULATIONAHA.105.595496; Williams B, 2009, J AM COLL CARDIOL, V54, P705, DOI [10.1016/j.jacc.2009.02.088, 10.1016/j.jacc.2009.06.043]; Wong CX, 2010, HEART RHYTHM, V7, P1192, DOI 10.1016/j.hrthm.2010.05.037; Yasmin, 2004, ARTERIOSCL THROM VAS, V24, P969, DOI 10.1161/01.ATV.zhq0504.0173	32	39	43	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76776	10.1371/journal.pone.0076776	http://dx.doi.org/10.1371/journal.pone.0076776			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098560	gold, Green Published, Green Submitted			2022-12-25	WOS:000325483600077
J	Mitchell, RJ; Wilson, WG; Holmquist, KG; Karron, JD				Mitchell, Randall J.; Wilson, William G.; Holmquist, Karsten G.; Karron, Jeffrey D.			Influence of Pollen Transport Dynamics on Sire Profiles and Multiple Paternity in Flowering Plants	PLOS ONE			English	Article							FLORAL DISPLAY SIZE; REPRODUCTIVE SUCCESS; GENE FLOW; BUMBLEBEES; POPULATIONS; EVOLUTION; PATTERNS; FRUITS; PERSPECTIVES; POLLINATORS	In many flowering plants individual fruits contain a mixture of half- and full-siblings, reflecting pollination by several fathers. To better understand the mechanisms generating multiple paternity within fruits we present a theoretical framework linking pollen carryover with patterns of pollinator movement. This 'sire profile' model predicts that species with more extensive pollen carryover will have a greater number of mates. It also predicts that flowers on large displays, which are often probed consecutively during a single pollinator visitation sequence, will have a lower effective number of mates. We compared these predictions with observed values for bumble bee-pollinated Mimulus ringens, which has restricted carryover, and hummingbird-pollinated Ipomopsis aggregata, which has extensive carryover. The model correctly predicted that the effective number of mates is much higher in the species with more extensive carryover. This work extends our knowledge of plant mating systems by highlighting mechanisms influencing the genetic composition of sibships.	[Mitchell, Randall J.] Univ Akron, Dept Biol, Akron, OH 44325 USA; [Wilson, William G.] Duke Univ, Dept Biol, Durham, NC USA; [Holmquist, Karsten G.; Karron, Jeffrey D.] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA	University System of Ohio; University of Akron; Duke University; University of Wisconsin System; University of Wisconsin Milwaukee	Mitchell, RJ (corresponding author), Univ Akron, Dept Biol, Akron, OH 44325 USA.	rjm2@uakron.edu	Mitchell, Randall J/G-6380-2010	Mitchell, Randall J/0000-0001-7961-3560	NSF [DEB 9816712, DEB 9903308]; University of Akron; Glenny Endowment; Department of Biology	NSF(National Science Foundation (NSF)); University of Akron; Glenny Endowment; Department of Biology	This research was supported by NSF Grants DEB 9816712 to JDK, and DEB 9903308 to RJM. RJM also received support from the University of Akron's Faculty Summer Research Grant Faculty Improvement Leave, the Glenny Endowment, and the Department of Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2007, ECOLOGY, V88, P271, DOI 10.1890/06-1017; Bernasconi G, 2004, PERSPECT PLANT ECOL, V6, P149, DOI 10.1078/1433-8319-00075; Bernasconi G, 2004, SCIENCE, V303, P971, DOI 10.1126/science.1092180; Brunet J, 2006, EVOLUTION, V60, P234, DOI 10.1111/j.0014-3820.2006.tb01102.x; Brunet J, 2009, MOL ECOL, V18, P3745, DOI 10.1111/j.1365-294X.2009.04304.x; Campbell DR, 1998, AM J BOT, V85, P1022, DOI 10.2307/2446369; CAMPBELL DR, 1991, EVOLUTION, V45, P1965, DOI 10.1111/j.1558-5646.1991.tb02702.x; Castellanos MC, 2003, EVOLUTION, V57, P2742, DOI 10.1111/j.0014-3820.2003.tb01516.x; Cresswell JE, 2002, OIKOS, V98, P375, DOI 10.1034/j.1600-0706.2002.980302.x; CRESSWELL JE, 1990, OECOLOGIA, V82, P450, DOI 10.1007/BF00319785; DUDASH MR, 1991, AM J BOT, V78, P1746, DOI 10.2307/2444854; ELLSTRAND NC, 1986, EVOLUTION, V40, P837, DOI 10.1111/j.1558-5646.1986.tb00543.x; Falconer D. S., 1989, Introduction to quantitative genetics.; Flanagan RJ, 2009, AM J BOT, V96, P809, DOI 10.3732/ajb.0800317; Harder LD, 2008, INT J PLANT SCI, V169, P59, DOI 10.1086/523364; Harder LD, 1997, ACTA HORTIC, P83, DOI 10.17660/ActaHortic.1997.437.7; Harder LD, 1996, FLORAL BIOL STUDIES, P140, DOI DOI 10.1007/978-1-4613-1165-2_6; Holmquist KG, 2012, PLANT SPEC BIOL, V27, P77, DOI 10.1111/j.1442-1984.2011.00329.x; Holmquist KG, 2005, EFFECT FLORAL DISPLA; Karron JD, 2006, AM J BOT, V93, P1306, DOI 10.3732/ajb.93.9.1306; Karron JD, 2012, ANN BOT-LONDON, V109, P493, DOI 10.1093/aob/mcr319; Karron JD, 2012, ANN BOT-LONDON, V109, P563, DOI 10.1093/aob/mcr193; Karron JD, 2009, ANN BOT-LONDON, V103, P1379, DOI 10.1093/aob/mcp030; Krauss SL, 1999, MOL ECOL, V8, P217, DOI 10.1046/j.1365-294X.1999.00552.x; Llaurens V, 2008, MOL ECOL, V17, P1577, DOI 10.1111/j.1365-294X.2007.03683.x; MARSHALL DL, 1991, AM J BOT, V78, P1404, DOI 10.2307/2445279; MARSHALL DL, 1991, ANNU REV ECOL SYST, V22, P37, DOI 10.1146/annurev.es.22.110191.000345; Mayfield MM, 2001, ANN BOT-LONDON, V88, P591, DOI 10.1006/anbo.2001.1500; Mitchell RJ, 2009, ANN BOT-LONDON, V103, P1403, DOI 10.1093/aob/mcp062; Mitchell RJ, 2009, ANN BOT-LONDON, V103, P1355, DOI 10.1093/aob/mcp122; Mitchell RJ, 2005, AM J BOT, V92, P885, DOI 10.3732/ajb.92.5.885; Mitchell RJ, 2004, FUNCT ECOL, V18, P116, DOI 10.1111/j.1365-2435.2004.00812.x; MORRIS WF, 1994, OIKOS, V71, P431, DOI 10.2307/3545831; Paschke M, 2002, AM J BOT, V89, P1250, DOI 10.3732/ajb.89.8.1250; RITLAND K, 1989, EVOLUTION, V43, P848, DOI 10.1111/j.1558-5646.1989.tb05182.x; ROBERTSON AW, 1992, BIOL J LINN SOC, V46, P333, DOI 10.1111/j.1095-8312.1992.tb00868.x; Smouse PE, 2005, HEREDITY, V94, P640, DOI 10.1038/sj.hdy.6800674; Spira TP, 1996, OECOLOGIA, V105, P230, DOI 10.1007/BF00328551; Teixeira S, 2007, MOL ECOL, V16, P4370, DOI 10.1111/j.1365-294X.2007.03493.x; Vazquez DP, 2005, ECOL LETT, V8, P1088, DOI 10.1111/j.1461-0248.2005.00810.x; Waser NM, 1988, FUNCT ECOL, V2, P41, DOI 10.2307/2389458	41	22	22	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76312	10.1371/journal.pone.0076312	http://dx.doi.org/10.1371/journal.pone.0076312			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098473	gold, Green Published			2022-12-25	WOS:000325483600039
J	Chen, FF; Hao, FH; Li, CF; Gou, JB; Lu, DY; Gong, FJ; Tang, HR; Zhang, YS				Chen, Fangfang; Hao, Fuhua; Li, Changfu; Gou, Junbo; Lu, Dayan; Gong, Fujun; Tang, Huiru; Zhang, Yansheng			Identifying Three Ecological Chemotypes of Xanthium strumarium Glandular Trichomes Using a Combined NMR and LC-MS Method	PLOS ONE			English	Article							BIOLOGICAL-ACTIVITIES; MEDICINAL-PLANTS; ARTEMISIA-ANNUA; BIOSYNTHESIS; XANTHATIN; LOCALIZATION; INHIBITORS; L.	Xanthanolides, as the sesquiterpene lactones, are reportedly the major components for the pharmacological properties of X. strumarium L. species. Phytochemical studies indicated that the glandular structures on the surface of plant tissues would form the primary sites for the accumulation of this class of the compounds. As the interface between plants and their natural enemies, glandular trichomes may vary with respect to which of their chemicals are sequestered against different herbivores in different ecologies. However, to date, no data are available on the chemical characterisation of X. strumarium glandular cells. In this study, the trichome secretions of the X. strumarium species originating from nineteen unique areas across eleven provinces in China, were analysed by HPLC, LC-ESI-MS and NMR. For the first time three distinct chemotypes of X. strumarium glandular trichomes were discovered along with the qualitative and quantitative evaluations of their presence of xanthanolides; these were designated glandular cell Types I, II, and III, respectively. The main xanthanolides in Type I cells were 8-epi-xanthatin and xanthumin while no xanthatin was detected. Xanthatin, 8-epi-xanthatin, and xanthumin dominated in Type II cells with comparable levels of each being present. For Type III cells, significantly higher concentrations of 8-epi-xanthatin or xanthinosin (relative to xanthatin) were detected with xanthinosin only being observed in this type. Further research will focus on understanding the ecological and molecular mechanism causing these chemotype differences in X. strumarium glandular structures.	[Chen, Fangfang; Li, Changfu; Gou, Junbo; Lu, Dayan; Gong, Fujun; Zhang, Yansheng] Chinese Acad Sci, CAS Key Lab Plant Germplasm Enhancement & Special, Wuhan Bot Garden, Wuhan, Peoples R China; [Hao, Fuhua; Tang, Huiru] Chinese Acad Sci, CAS Key Lab Magnet Resonance Biol Syst, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan Ctr Magnet Resonance,Wuhan Inst Phys & Math, Wuhan, Peoples R China; [Gou, Junbo] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Tang, HR (corresponding author), Chinese Acad Sci, CAS Key Lab Magnet Resonance Biol Syst, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan Ctr Magnet Resonance,Wuhan Inst Phys & Math, Wuhan, Peoples R China.	huiru.tang@wipm.ac.cn; zhangys@wbgcas.cn	Hao, Fuhua/ABC-6062-2021; Tang, Huiru/F-9849-2011	Hao, Fuhua/0000-0002-0865-5269; Tang, Huiru/0000-0002-7139-2756	Chinese Academy of Science, China [Y129441R01]; National Natural Science Foundation of China [31270341]	Chinese Academy of Science, China(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The project was supported by the Grant for One Hundred Talents Program of the Chinese Academy of Science, China (project no. Y129441R01) and the National Natural Science Foundation of China (project no. 31270341). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjoo Kamboj, 2010, International Journal of Green Pharmacy, V4, P129; Chandel S, 2012, PARASITOL RES, V110, P1179, DOI 10.1007/s00436-011-2611-1; Chen FF, 2011, J PROTEOME RES, V10, P2273, DOI 10.1021/pr101095t; Covello PS, 2007, PHYTOCHEMISTRY, V68, P1864, DOI 10.1016/j.phytochem.2007.02.016; Dai H, 2010, J PROTEOME RES, V9, P1565, DOI 10.1021/pr901045c; Dai H, 2010, J PROTEOME RES, V9, P1460, DOI 10.1021/pr900995m; DUKE MV, 1994, INT J PLANT SCI, V155, P365, DOI 10.1086/297173; Gautam R, 2007, J ETHNOPHARMACOL, V110, P200, DOI 10.1016/j.jep.2006.12.031; GINESTAPERIS E, 1994, LETT APPL MICROBIOL, V18, P206, DOI 10.1111/j.1472-765X.1994.tb00848.x; Gou JY, 2011, PLANT CELL, V23, P1512, DOI 10.1105/tpc.111.084525; Hammerschmidt DE, 1998, J LAB CLIN MED, V132, P86, DOI 10.1016/S0022-2143(98)90030-0; KAWAZU K, 1979, EXPERIENTIA, V35, P1294, DOI 10.1007/BF01963966; Kim YS, 2003, PLANTA MED, V69, P375, DOI 10.1055/s-2003-38879; Klecakova-Karlickova J, 2005, Ceska Slov Farm, V54, P141; Kovacs A, 2009, Z NATURFORSCH C, V64, P343; KUPCHAN SM, 1971, J MED CHEM, V14, P1147, DOI 10.1021/jm00294a001; Ma YT, 1998, PHYTOCHEMISTRY, V48, P1083, DOI 10.1016/S0031-9422(98)00084-3; Majdi M, 2011, PHYTOCHEMISTRY, V72, P1739, DOI 10.1016/j.phytochem.2011.04.021; McMillan C, 1975, BIOCHEM SYST ECOL, V2, P181; Nibret E, 2011, PHYTOTHER RES, V25, P1883, DOI 10.1002/ptr.3651; Polichuk DR, 2010, PHYTOCHEMISTRY, V71, P1264, DOI 10.1016/j.phytochem.2010.04.026; Ramirez AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065030; Ramirez-Erosa I, 2007, CAN J PHYSIOL PHARM, V85, P1160, DOI 10.1139/Y07-104; RODRIGUEZ E, 1976, PHYTOCHEMISTRY, V15, P1573, DOI 10.1016/S0031-9422(00)97430-2; Sato Y, 1997, J PHARM PHARMACOL, V49, P1042, DOI 10.1111/j.2042-7158.1997.tb06038.x; Soo Kim Hyun, 2003, Korean Society for Biotechnology and Bioengineering Journal, V18, P324; Wallaart TE, 2000, PLANTA MED, V66, P57, DOI 10.1055/s-2000-11115; Wang HH, 2009, PLANTA MED, V75, P1625, DOI 10.1055/s-0029-1185814; Xiao CN, 2008, J AGR FOOD CHEM, V56, P10142, DOI 10.1021/jf8016833; Yin MH, 2005, J ETHNOPHARMACOL, V99, P113, DOI 10.1016/j.jep.2005.02.013	30	17	20	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76621	10.1371/journal.pone.0076621	http://dx.doi.org/10.1371/journal.pone.0076621			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098541	Green Submitted, gold, Green Published			2022-12-25	WOS:000325434500077
J	Palm, S; Daoura, L; Roman, E; Nylander, I				Palm, Sara; Daoura, Loudin; Roman, Erika; Nylander, Ingrid			Effects of Rearing Conditions on Behaviour and Endogenous Opioids in Rats with Alcohol Access during Adolescence	PLOS ONE			English	Article							MALE WISTAR RATS; NEONATAL MATERNAL SEPARATION; CONCENTRIC SQUARE FIELD; ETHANOL INTAKE; ADULT RATS; POSTNATAL ENVIRONMENT; RISK PREFERENCE; PEPTIDE LEVELS; SOCIAL PLAY; STRESS	Causal links between early-life stress, genes and later psychiatric diagnoses are not possible to fully address in human studies. Animal models therefore provide an important complement in which conditions can be well controlled and are here used to study and distinguish effects of early-life stress and alcohol exposure. The objective of this study was to investigate the impact of rearing conditions on behaviour in young rats and if these changes could be followed over time and to examine interaction effects between early-life environment and adolescent alcohol drinking on behaviour and immunoreactive levels of the opioid peptides dynorphin B, met-enkephalin-Arg(6)Phe(7) and beta-endorphin. We employed a rodent model, maternal separation, to study the impact of rearing conditions on behaviour, voluntary alcohol consumption and alcohol-induced effects. The consequences of short, 15 min (MS 15), and long, 360 min (MS 360), maternal separation in combination with adolescent voluntary alcohol consumption on behaviour and peptides were examined. A difference in the development of risk taking behaviour was found between the MS15 and MS360 while the development of general activity was found to differ between intake groups. Beta-endorphin levels in the pituitary and the periaqueductal gray area was found to be higher in the MS15 than the MS360. Adolescent drinking resulted in higher dynorphin B levels in the hippocampus and higher met-enkephalin-Arg(6)Phe(7) levels in the amygdala. Amygdala and hippocampus are involved in addiction processes and changes in these brain areas after adolescent alcohol drinking may have consequences for cognitive function and drug consumption behaviour in adulthood. The study shows that individual behavioural profiling over time in combination with neurobiological investigations provides means for studies of causality between early-life stress, behaviour and vulnerability to psychiatric disorders.	[Palm, Sara; Daoura, Loudin; Roman, Erika; Nylander, Ingrid] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden	Uppsala University	Palm, S (corresponding author), Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden.	Sara.Palm@farmbio.uu.se	Roman, Erika/AAG-3089-2020	Roman, Erika/0000-0001-5418-8289	Alcohol Research Council of the Swedish Alcohol Retailing Monopoly [SRA 2011-0062, SRA 10-21:1, SRA 2011-0056]; Swedish Medical Research Council [2012-61X-22090-01-3]; European Research Area Board [EA 11 30]; Facias foundation	Alcohol Research Council of the Swedish Alcohol Retailing Monopoly; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); European Research Area Board; Facias foundation	Financial support came from the Alcohol Research Council of the Swedish Alcohol Retailing Monopoly (SRA 2011-0062; ER, SRA 10-21:1 and SRA 2011-0056; IN), the Swedish Medical Research Council (2012-61X-22090-01-3; IN), the European Research Area Board (EA 11 30; IN) and the Facias foundation (SP) supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux-Cantin S, 2013, NEUROPHARMACOLOGY, V67, P521, DOI 10.1016/j.neuropharm.2012.12.007; ALTSHULER HL, 1980, LIFE SCI, V26, P679, DOI 10.1016/0024-3205(80)90257-X; Andersen SL, 2009, NEUROSCI BIOBEHAV R, V33, P516, DOI 10.1016/j.neubiorev.2008.09.009; Bazov I, 2013, ADDICT BIOL, V18, P161, DOI 10.1111/j.1369-1600.2011.00366.x; Becker HC, 2011, PSYCHOPHARMACOLOGY, V218, P131, DOI 10.1007/s00213-011-2443-9; Bilkei-Gorzo A, 2004, PSYCHOPHARMACOLOGY, V176, P343, DOI 10.1007/s00213-004-1904-9; Chang GQ, 2010, ALCOHOL CLIN EXP RES, V34, P761, DOI 10.1111/j.1530-0277.2010.01148.x; CHRISTENSSONNYLANDER I, 1985, REGUL PEPTIDES, V11, P65, DOI 10.1016/0167-0115(85)90032-1; Clark JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037357; CLONINGER C R, 1988, Advances in Alcohol and Substance Abuse, V7, P3; Cowen MS, 2001, ALCOHOL CLIN EXP RES, V25, P1126, DOI 10.1111/j.1530-0277.2001.tb02326.x; Crews FT, 2000, ALCOHOL CLIN EXP RES, V24, P1712, DOI 10.1111/j.1530-0277.2000.tb01973.x; Crews F, 2007, PHARMACOL BIOCHEM BE, V86, P189, DOI 10.1016/j.pbb.2006.12.001; Daoura L, 2011, PHARMACOL BIOCHEM BE, V99, P626, DOI 10.1016/j.pbb.2011.06.004; Daoura L, 2011, ALCOHOL CLIN EXP RES, V35, P506, DOI 10.1111/j.1530-0277.2010.01367.x; Drews E, 2010, PROG NEUROBIOL, V90, P1, DOI 10.1016/j.pneurobio.2009.09.004; Farkas J, 2009, BRAIN RES BULL, V79, P208, DOI 10.1016/j.brainresbull.2008.12.011; FENTON MC, 2012, PSYCHOL MED, V43, P1; FLEMING AS, 1974, J COMP PHYSIOL PSYCH, V86, P957, DOI 10.1037/h0036414; Fone KCF, 2008, NEUROSCI BIOBEHAV R, V32, P1087, DOI 10.1016/j.neubiorev.2008.03.003; Garcia-Burgos D, 2009, ALCOHOL CLIN EXP RES, V33, P722, DOI 10.1111/j.1530-0277.2008.00889.x; Gianoulakis C, 2004, CURR TOP MED CHEM, V4, P39, DOI 10.2174/1568026043451573; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Goepfrich AA, 2013, PHYSIOL BEHAV, V110, P102, DOI 10.1016/j.physbeh.2012.12.019; Gonzales RA, 1998, J NEUROSCI, V18, P10663; GROTA LJ, 1969, ANIM BEHAV, V17, P722, DOI 10.1016/S0003-3472(69)80019-9; Gustafsson L, 2007, NEUROSCIENCE, V146, P1137, DOI 10.1016/j.neuroscience.2007.02.037; Gustafsson L, 2008, NEUROPEPTIDES, V42, P177, DOI 10.1016/j.npep.2007.10.006; Gustafsson L, 2006, ALCOHOL CLIN EXP RES, V30, P2008, DOI 10.1111/j.1530-0277.2006.00247.x; Heilig M, 2011, NAT REV NEUROSCI, V12, P670, DOI 10.1038/nrn3110; Hopf FW, 2010, ALCOHOL CLIN EXP RES, V34, P1565, DOI 10.1111/j.1530-0277.2010.01241.x; Huot RL, 2001, PSYCHOPHARMACOLOGY, V158, P366, DOI 10.1007/s002130100701; Hyytia P, 2001, ALCOHOL CLIN EXP RES, V25, P25, DOI 10.1097/00000374-200101000-00005; Jaworski JN, 2005, PSYCHOPHARMACOLOGY, V181, P8, DOI 10.1007/s00213-005-2232-4; JIANG HK, 1989, P NATL ACAD SCI USA, V86, P2948, DOI 10.1073/pnas.86.8.2948; Kalinichev M, 2001, BRAIN RES BULL, V54, P649, DOI 10.1016/S0361-9230(01)00485-3; Kang W, 2000, NEUROPSYCHOPHARMACOL, V22, P77, DOI 10.1016/S0893-133X(99)00090-1; KISSLER JL, 2013, BIOL PSYCHIAT, P11261; Konig M, 1996, NATURE, V383, P535, DOI 10.1038/383535a0; Koob G, 2007, AM J PSYCHIAT, V164, P1149, DOI 10.1176/appi.ajp.2007.05030503; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Kosten TA, 2012, NEUROSCI BIOBEHAV R, V36, P1985, DOI 10.1016/j.neubiorev.2012.07.003; Langeland W, 2004, ALCOHOL CLIN EXP RES, V28, P441, DOI 10.1097/01.ALC.0000117831.17383.72; Leggio L, 2009, NEUROPSYCHOL REV, V19, P115, DOI 10.1007/s11065-008-9080-z; LESCH OM, 1990, PSYCHOPATHOLOGY, V23, P88, DOI 10.1159/000284644; Lesscher HMB, 2010, ALCOHOL CLIN EXP RES, V34, P1219, DOI 10.1111/j.1530-0277.2010.01199.x; Mayfield RD, 2008, BRIT J PHARMACOL, V154, P275, DOI 10.1038/bjp.2008.88; McCrory Eamon, 2011, Front Psychiatry, V2, P48, DOI 10.3389/fpsyt.2011.00048; Meyerson BJ, 2006, BEHAV BRAIN RES, V168, P100, DOI 10.1016/j.bbr.2005.10.020; MEYERSON BJ, 2013, BEHAV BRAIN IN PRESS; Moffett MC, 2007, BIOCHEM PHARMACOL, V73, P321, DOI 10.1016/j.bcp.2006.08.003; Monti PM, 2005, ALCOHOL CLIN EXP RES, V29, P207, DOI 10.1097/01.ALC.0000153551.11000.F3; Nasrallah NA, 2011, P NATL ACAD SCI USA, V108, P5466, DOI 10.1073/pnas.1017732108; Nasrallah NA, 2009, P NATL ACAD SCI USA, V106, P17600, DOI 10.1073/pnas.0906629106; Nelson EE, 1998, NEUROSCI BIOBEHAV R, V22, P437, DOI 10.1016/S0149-7634(97)00052-3; Nguyen XV, 2005, BEHAV BRAIN RES, V161, P254, DOI 10.1016/j.bbr.2005.02.010; Nylander I, 1997, NEUROPEPTIDES, V31, P357, DOI 10.1016/S0143-4179(97)90072-X; NYLANDER I, 1998, PROGR HPLC, V7, P171; Nylander I, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00077; OMALLEY SS, 1992, ARCH GEN PSYCHIAT, V49, P881; Oswald LM, 2004, PHYSIOL BEHAV, V81, P339, DOI 10.1016/j.physbeh.2004.02.008; Palm S, 2011, APPL ANIM BEHAV SCI, V135, P128, DOI 10.1016/j.applanim.2011.08.010; PANKSEPP J, 1980, NEUROSCI BIOBEHAV R, V4, P473, DOI 10.1016/0149-7634(80)90036-6; Pechtel P, 2011, PSYCHOPHARMACOLOGY, V214, P55, DOI 10.1007/s00213-010-2009-2; Ploj K, 2003, NEUROPEPTIDES, V37, P149, DOI 10.1016/S0143-4179(03)00043-X; Ploj K, 2002, PHARMACOL BIOCHEM BE, V73, P123, DOI 10.1016/S0091-3057(02)00778-5; Ploj K, 2003, NEUROSCIENCE, V121, P787, DOI 10.1016/S0306-4522(03)00499-8; Poulin JF, 2006, J COMP NEUROL, V496, P859, DOI 10.1002/cne.20956; Pryce CR, 2003, NEUROSCI BIOBEHAV R, V27, P57, DOI 10.1016/S0149-7634(03)00009-5; Randall-Thompson JF, 2010, PSYCHOPHARMACOLOGY, V212, P585, DOI 10.1007/s00213-010-1980-y; Roman E, 2005, STRESS, V8, P157, DOI 10.1080/10253890500188666; Roman E, 2007, BEHAV BRAIN RES, V183, P195, DOI 10.1016/j.bbr.2007.06.009; Roman E, 2006, HORM BEHAV, V50, P736, DOI 10.1016/j.yhbeh.2006.06.016; Roman E, 2012, ADDICT BIOL, V17, P33, DOI 10.1111/j.1369-1600.2011.00327.x; Romeo RD, 2006, ANN NY ACAD SCI, V1094, P202, DOI 10.1196/annals.1376.022; Sanchis-Segura C, 2005, ALCOHOL CLIN EXP RES, V29, P1522, DOI 10.1097/01.alc.0000174913.60384.e8; Sandin J, 1998, NEUROSCIENCE, V85, P375, DOI 10.1016/S0306-4522(97)00605-2; Seif T, 2013, NAT NEUROSCI, V16, P1094, DOI 10.1038/nn.3445; Spanagel R, 2009, PHYSIOL REV, V89, P649, DOI 10.1152/physrev.00013.2008; Sprow GM, 2012, PHYSIOL BEHAV, V106, P325, DOI 10.1016/j.physbeh.2011.12.026; Tottenham N, 2010, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.068.2009; Trezza V, 2008, EUR NEUROPSYCHOPHARM, V18, P519, DOI 10.1016/j.euroneuro.2008.03.001; Trezza V, 2011, J NEUROSCI, V31, P6362, DOI 10.1523/JNEUROSCI.5492-10.2011; Trezza V, 2010, TRENDS PHARMACOL SCI, V31, P463, DOI 10.1016/j.tips.2010.06.008; Unterwald EM, 2001, BRAIN RES, V900, P103, DOI 10.1016/S0006-8993(01)02269-7; VANDERSCHUREN LJMJ, 1995, EUR J PHARMACOL, V276, P257, DOI 10.1016/0014-2999(95)00040-R; Vengeliene V, 2008, BRIT J PHARMACOL, V154, P299, DOI 10.1038/bjp.2008.30; Vetter CS, 2007, ALCOHOL CLIN EXP RES, V31, P1159, DOI 10.1111/j.1530-0277.2007.00417.x; VOLPICELLI JR, 1992, ARCH GEN PSYCHIAT, V49, P876; White AM, 2000, ALCOHOL CLIN EXP RES, V24, P1251, DOI 10.1111/j.1530-0277.2000.tb02091.x; Wiedenmayer CP, 2009, NEUROSCI BIOBEHAV R, V33, P432, DOI 10.1016/j.neubiorev.2008.11.004; Wilson MA, 2003, ANN NY ACAD SCI, V985, P472	92	15	15	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76591	10.1371/journal.pone.0076591	http://dx.doi.org/10.1371/journal.pone.0076591			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098535	Green Published, gold, Green Submitted			2022-12-25	WOS:000325434500075
J	Yang, YQ; Wang, Z; Yang, H; Wang, LY; Gillespie, SR; Wolosin, JM; Bernstein, AM; Reinach, PS				Yang, Yuanquan; Wang, Zheng; Yang, Hua; Wang, Lingyan; Gillespie, Stephanie R.; Wolosin, J. Mario; Bernstein, Audrey M.; Reinach, Peter S.			TRPV1 Potentiates TGF beta-Induction of Corneal Myofibroblast Development through an Oxidative Stress-Mediated p38-SMAD2 Signaling Loop	PLOS ONE			English	Article							POSITIVE FEEDBACK; OXIDASE EXPRESSION; TISSUE FIBROSIS; MAP KINASE; FIBROBLASTS; DIFFERENTIATION; RECEPTOR; CELLS; KERATOCYTES; ACTIVATION	Injuring mouse corneas with alkali causes myofibroblast expression leading to tissue opacification. However, in transient receptor potential vanilloid 1 channel (TRPV1-/-) knockout mice healing results in transparency restoration. Since TGF beta is the primary inducer of the myofibroblast phenotype, we examined the mechanism by which TRPV1 affects TGF beta-induced myofibroblast development. Experiments were performed in pig corneas and human corneal fibroblasts (HCFs). Immunohistochemical staining of a-smooth muscle actin (alpha-SMA) stress fibers was used to visualize myofibroblasts. Protein and phosphoprotein were determined by Western blotting. siRNA transfection silenced TRPV1 gene expression. Flow cytometry with a reactive oxygen species (ROS) reporting dye analyzed intracellular ROS. [Ca2+] I was measured by loading HCF with fura2. In organ cultured corneas, the TRPV1 antagonist capsazepine drastically reduced by 75% wound-induced myofibroblast development. In HCF cell culture, TGF-beta 1 elicited rapid increases in Ca2+ influx, phosphorylation of SMAD2 and MAPKs (ERK1/2, JNK1/2 and p38), ROS generation and, after 72 hrs myofibroblast development. SMAD2 and p38 activation continued for more than 16 h, whereas p-ERK1/2 and p-JNK1/2 waned within 90 min. The long-lived SMAD2 activation was dependent on activated p38 and vice versa, and it was essential to generate a > 13-fold increase in a-SMA protein and a fully developed myofibroblast phenotype. These later changes were markedly reduced by inhibition of TRPV1 or reduction of the ROS generation rate. Taken together our results indicate that in corneal derived fibroblasts, TGF beta-induced myofibroblast development is highly dependent on a positive feedback loop where p-SMAD2-induced ROS activates TRPV1, TRPV1 causes activation of p38, the latter in turn further enhances the activation of SMAD2 to establish a recurrent loop that greatly extends the residency of the activated state of SMAD2 that drives myofibroblast development.	[Yang, Yuanquan; Yang, Hua; Reinach, Peter S.] SUNY Coll Optometry, Dept Biol Sci, New York, NY 10036 USA; [Wang, Zheng; Wang, Lingyan; Gillespie, Stephanie R.; Wolosin, J. Mario; Bernstein, Audrey M.] Icahn Sch Med Mt Sinai, Dept Ophthalmol, New York, NY USA	State University of New York (SUNY) System; SUNY Optometry; Icahn School of Medicine at Mount Sinai	Bernstein, AM (corresponding author), Icahn Sch Med Mt Sinai, Dept Ophthalmol, New York, NY USA.	audrey.bernstein@mssm.edu; preinach@sunyopt.edu	Reinach, Peter/AAI-3582-2021	Bernstein, Audrey/0000-0002-2537-2594; wolosin, j. mario/0000-0002-6751-2794	National Eye Institute [EY04795 (PSR), EY01478]; NYSTEM CO [26540, EY09414]; NEI [P30-EY01867]; Research to Prevent Blindness grant; Resolvyx Pharmaceuticals; National Disease Research Interchange; NIH [5 U42 RR006042, 1S10RR09145-01]; NIH National Cancer Institute [5R24CA095823-04]; National Science Foundation Major Research Instrumentation [DBI-9724504]; NATIONAL CANCER INSTITUTE [R24CA095823] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR006042, S10RR009145] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY004795, R56EY009414, R01EY014878, R01EY009414, R56EY004795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM062754] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NYSTEM CO; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness grant(Research to Prevent Blindness (RPB)); Resolvyx Pharmaceuticals; National Disease Research Interchange; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation Major Research Instrumentation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by National Eye Institute Grants EY04795 (PSR), EY01478 and NYSTEM CO 26540 (JMW), EY09414 (AMB), and by NEI core Grant P30-EY01867 and a Research to Prevent Blindness grant. In addition, the financial support provided by Resolvyx Pharmaceuticals to PSR is deeply appreciated. The authors acknowledge use of human tissues provided by the National Disease Research Interchange, supported by NIH Grant 5 U42 RR006042. Microscopy was performed at the Icahn School of Medicine Microscopy Shared Resource Facility, supported by NIH National Cancer Institute shared resources Grant 5R24CA095823-04, National Science Foundation Major Research Instrumentation Grant DBI-9724504 and NIH shared instrumentation Grant 1S10RR09145-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara N, 2010, THORAX, V65, P733, DOI 10.1136/thx.2009.113456; Barbosa FL, 2010, EXP EYE RES, V91, P92, DOI 10.1016/j.exer.2010.04.007; Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Bernstein AM, 2004, INVEST OPHTH VIS SCI, V45, P2967, DOI 10.1167/iovs.04-0030; Bondi CD, 2010, J AM SOC NEPHROL, V21, P93, DOI 10.1681/ASN.2009020146; Buss DG, 2010, VET OPHTHALMOL, V13, P37, DOI 10.1111/j.1463-5224.2009.00755.x; Chuang HH, 2009, P NATL ACAD SCI USA, V106, P20097, DOI 10.1073/pnas.0902675106; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; Daniluk J, 2012, J CLIN INVEST, V122, P1519, DOI 10.1172/JCI59743; Gilleron M, 2009, BIOCHEM BIOPH RES CO, V388, P727, DOI 10.1016/j.bbrc.2009.08.085; Hao N, 2003, J BIOL CHEM, V278, P46506, DOI 10.1074/jbc.M308432200; Huang W, 2010, J HYPERTENS, V28, P367, DOI 10.1097/HJH.0b013e328333af48; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jain M, 2013, J BIOL CHEM, V288, P770, DOI 10.1074/jbc.M112.431973; Jester JV, 1996, CORNEA, V15, P505; Jester JV, 2002, EXP EYE RES, V75, P645, DOI 10.1006/exer.2002.2066; Jester JV, 1999, PROG RETIN EYE RES, V18, P311, DOI 10.1016/S1350-9462(98)00021-4; Junn E, 2000, J IMMUNOL, V165, P2190, DOI 10.4049/jimmunol.165.4.2190; Koli K, 2008, ANTIOXID REDOX SIGN, V10, P333, DOI 10.1089/ars.2007.1914; Kurosaka H, 1998, INVEST OPHTH VIS SCI, V39, P699; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Masur SK, 1996, P NATL ACAD SCI USA, V93, P4219, DOI 10.1073/pnas.93.9.4219; Matten WT, 1996, DEV BIOL, V179, P485, DOI 10.1006/dbio.1996.0277; Mitrophanov AY, 2008, BIOESSAYS, V30, P542, DOI 10.1002/bies.20769; O'Brien WJ, 2009, MOL VIS, V15, P2535; Okada Y, 2011, AM J PATHOL, V178, P2654, DOI 10.1016/j.ajpath.2011.02.043; Saika S, 2004, INVEST OPHTH VIS SCI, V45, P100, DOI 10.1167/iovs.03-0700; Samarakoon R, 2013, CELL SIGNAL, V25, P264, DOI 10.1016/j.cellsig.2012.10.003; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shukla A, 2013, ONCOGENE; Singh V, 2011, EXP EYE RES, V93, P810, DOI 10.1016/j.exer.2011.09.012; Spanakis SG, 1998, INVEST OPHTH VIS SCI, V39, P1320; Tominaga M, 2005, PFLUG ARCH EUR J PHY, V451, P143, DOI 10.1007/s00424-005-1457-8; Utreras E, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-24; Utreras E, 2012, J BIOL CHEM, V287, P16917, DOI 10.1074/jbc.M111.329979; Vennekens R, 2008, CURR PHARM DESIGN, V14, P18; Wang S, 2011, J BIOL CHEM, V286, P40601, DOI 10.1074/jbc.M111.256669; Wang YP, 2011, MOL MED, V17, P1204, DOI 10.2119/molmed.2011.00063; Wilson SE, 2012, EXP EYE RES, V99, P78, DOI 10.1016/j.exer.2012.03.018; Yang YQ, 2013, EXP EYE RES, V107, P121, DOI 10.1016/j.exer.2012.11.004	41	30	30	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e77300	10.1371/journal.pone.0077300	http://dx.doi.org/10.1371/journal.pone.0077300			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098582	Green Published, Green Submitted, gold			2022-12-25	WOS:000325434500098
J	Carvalho, SB; Botelho, HM; Leal, SS; Cardoso, I; Fritz, G; Gomes, CM				Carvalho, Sofia B.; Botelho, Hugo M.; Leal, Sonia S.; Cardoso, Isabel; Fritz, Guenter; Gomes, Claudio M.			Intrinsically Disordered and Aggregation Prone Regions Underlie beta-Aggregation in S100 Proteins	PLOS ONE			English	Article							AMYLOID FIBRIL FORMATION; CRYSTAL-STRUCTURE; OLIGOMERS; PREDICTION; CONFORMATION; CALPROTECTIN; CA2+-FREE; MECHANISM; TOXICITY; INSIGHTS	S100 proteins are small dimeric calcium-binding proteins which control cell cycle, growth and differentiation via interactions with different target proteins. Intrinsic disorder is a hallmark among many signaling proteins and S100 proteins have been proposed to contain disorder-prone regions. Interestingly, some S100 proteins also form amyloids: S100A8/A9 forms fibrils in prostatic inclusions and S100A6 fibrillates in vitro and seeds SOD1 aggregation. Here we report a study designed to investigate whether beta-aggregation is a feature extensive to more members of S100 family. In silico analysis of seven human S100 proteins revealed a direct correlation between aggregation and intrinsic disorder propensity scores, suggesting a relationship between these two independent properties. Averaged position-specific analysis and structural mapping showed that disorder-prone segments are contiguous to aggregation-prone regions and that whereas disorder is prominent on the hinge and target protein-interaction regions, segments with high aggregation propensity are found in ordered regions within the dimer interface. Acidic conditions likely destabilize the seven S100 studied by decreasing the shielding of aggregation-prone regions afforded by the quaternary structure. In agreement with the in silico analysis, hydrophobic moieties become accessible as indicated by strong ANS fluorescence. ATR-FTIR spectra support a structural inter-conversion from alpha-helices to intermolecular beta-sheets, and prompt ThT-binding takes place with no noticeable lag phase. Dot blot analysis using amyloid conformational antibodies denotes a high diversity of conformers; subsequent analysis by TEM shows fibrils as dominant species. Altogether, our data suggests that beta-aggregation and disorder-propensity are related properties in S100 proteins, and that the onset of aggregation is likely triggered by loss of protective tertiary and quaternary interactions.	[Carvalho, Sofia B.; Botelho, Hugo M.; Leal, Sonia S.; Gomes, Claudio M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Cardoso, Isabel] Inst Biol Mol & Celular, Mol Neurobiol Unit, Oporto, Portugal; [Cardoso, Isabel] Escola Super Tecnol Saude Porto, Inst Politecn, Oporto, Vila Nova De Ga, Portugal; [Fritz, Guenter] Univ Freiburg, Dept Neuropathol, D-79106 Freiburg, Germany	Universidade Nova de Lisboa; Universidade do Porto; Polytechnic Institute of Porto; University of Freiburg	Gomes, CM (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal.	gomes@itqb.unl.pt	Botelho, Hugo M/B-3092-2008; Gomes, Cláudio M./A-8152-2008; de Carvalho, Sofia Baptista/V-7549-2017; Fritz, Guenter/E-2933-2013; Cardoso, Isabel/K-3903-2013; Leal, Sónia/F-1129-2015	Botelho, Hugo M/0000-0002-4208-1086; Gomes, Cláudio M./0000-0003-4662-6933; de Carvalho, Sofia Baptista/0000-0001-5000-7217; Fritz, Guenter/0000-0002-4571-8812; Cardoso, Isabel/0000-0003-2472-7055; Leal, Sónia/0000-0001-8445-0065	Fundacao para a Ciencia e a Tecnologia (FCT/MCTES, Portugal) [PTDC/EBB-BIO/117793/2010, PTDC/QUIBIQ/117789/2010, SFRH/BD/31126/2006, B017/BI-BI/2012, SFRH/BPD/47477/2008, PEst-OE/EQB/LA0004/2011]; Liga Portuguesa contra o Cancro - LPCC-NRS (Portugal); Heisenberg fellowship of the Deutsche Forschungsgemeinschaft [FR 1488/3-2]	Fundacao para a Ciencia e a Tecnologia (FCT/MCTES, Portugal)(Portuguese Foundation for Science and Technology); Liga Portuguesa contra o Cancro - LPCC-NRS (Portugal); Heisenberg fellowship of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Fundacao para a Ciencia e a Tecnologia (FCT/MCTES, Portugal) through research grants PTDC/EBB-BIO/117793/2010 and PTDC/QUIBIQ/117789/2010 (to CMG) and doctoral fellowship SFRH/BD/31126/2006 (to HMB), Research fellowship B017/BI-BI/2012 (to SBC), post-doctoral fellowship(SFRH/BPD/47477/2008 (to SSL) and by the strategic Grant PEst-OE/EQB/LA0004/2011 (to the ITQB Laboratorio Associado) and partly by a Terry Fox research grant from Liga Portuguesa contra o Cancro - LPCC-NRS (Portugal). GF is supported by a Heisenberg fellowship of the Deutsche Forschungsgemeinschaft (FR 1488/3-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Bemporad F, 2012, CHEM BIOL, V19, P315, DOI 10.1016/j.chembiol.2012.02.003; Boom A, 2004, BBA-MOL CELL RES, V1742, P161, DOI 10.1016/j.bbamcr.2004.09.011; Botelho HM, 2012, J BIOL CHEM, V287, P42233, DOI 10.1074/jbc.M112.396416; Botelho HM, 2012, METHODS MOL BIOL, V849, P373, DOI 10.1007/978-1-61779-551-0_25; Boye K, 2010, AM J PATHOL, V176, P528, DOI 10.2353/ajpath.2010.090526; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breydo L, 2012, BBA-MOL BASIS DIS, V1822, P261, DOI 10.1016/j.bbadis.2011.10.002; Calero M, 2012, METHODS MOL BIOL, V849, P53, DOI 10.1007/978-1-61779-551-0_5; Cohen SIA, 2012, J MOL BIOL, V421, P160, DOI 10.1016/j.jmb.2012.02.031; Damo SM, 2013, P NATL ACAD SCI USA, V110, P3841, DOI 10.1073/pnas.1220341110; de Groot NS, 2012, BIOCHEM SOC T, V40, P1032, DOI 10.1042/BST20120160; DiCostanzo AC, 2012, J BIOL CHEM, V287, P27997, DOI 10.1074/jbc.M112.362921; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Fritz G, 2002, J BIOL CHEM, V277, P33092, DOI 10.1074/jbc.M200574200; Fritz G., 2004, HDB METALLOPROTEINS; Fritz G, 2010, FEBS J, V277, P4578, DOI 10.1111/j.1742-4658.2010.07887.x; Garrett SC, 2006, J BIOL CHEM, V281, P677, DOI 10.1074/jbc.R500017200; Ghodke S, 2012, FEBS J, V279, P752, DOI 10.1111/j.1742-4658.2011.08465.x; Hadley KC, 2011, CELL STRESS CHAPERON, V16, P549, DOI 10.1007/s12192-011-0266-6; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Ismail TM, 2008, CARCINOGENESIS, V29, P2259, DOI 10.1093/carcin/bgn217; Johnson SM, 2012, J MOL BIOL, V421, P185, DOI 10.1016/j.jmb.2011.12.060; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Khare SD, 2006, AMYLOID, V13, P226, DOI 10.1080/13506120600960486; Kizawa K, 2008, J BIOL CHEM, V283, P5004, DOI 10.1074/jbc.M709357200; Koch M, 2008, J MOL BIOL, V378, P933, DOI 10.1016/j.jmb.2008.03.019; Korndorfer IP, 2007, J MOL BIOL, V370, P887, DOI 10.1016/j.jmb.2007.04.065; Leal SS, 2012, COORDIN CHEM REV, V256, P2253, DOI 10.1016/j.ccr.2012.04.004; LEE SW, 1992, P NATL ACAD SCI USA, V89, P2504, DOI 10.1073/pnas.89.6.2504; Lindgren M, 2010, FEBS J, V277, P1380, DOI 10.1111/j.1742-4658.2010.07571.x; Linding R, 2004, J MOL BIOL, V342, P345, DOI 10.1016/j.jmb.2004.06.088; Liu HN, 2012, J NEUROSCI, V32, P8791, DOI 10.1523/JNEUROSCI.5053-11.2012; Malik S, 2008, PROTEINS, V73, P28, DOI 10.1002/prot.22037; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Marenholz I, 2006, BBA-MOL CELL RES, V1763, P1282, DOI 10.1016/j.bbamcr.2006.07.013; Marlatt NM, 2009, BIOCHEMISTRY-US, V48, P1954, DOI 10.1021/bi802086a; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; Mittl PRE, 2002, ACTA CRYSTALLOGR D, V58, P1255, DOI 10.1107/S0907444902008430; Mori T, 2010, GLIA, V58, P300, DOI 10.1002/glia.20924; Moroz OV, 2009, J MOL BIOL, V391, P536, DOI 10.1016/j.jmb.2009.06.004; Moroz OV, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-11; Mrak RE, 2001, NEUROBIOL AGING, V22, P915, DOI 10.1016/S0197-4580(01)00293-7; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Otterbein LR, 2002, STRUCTURE, V10, P557, DOI 10.1016/S0969-2126(02)00740-2; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Permyakov SE, 2011, MOL BIOSYST, V7, P2164, DOI 10.1039/c0mb00305k; Peskind ER, 2001, NEUROCHEM INT, V39, P409, DOI 10.1016/S0197-0186(01)00048-1; Salama I, 2008, EJSO-EUR J SURG ONC, V34, P357, DOI 10.1016/j.ejso.2007.04.009; Sarell CJ, 2010, J BIOL CHEM, V285, P41533, DOI 10.1074/jbc.M110.171355; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Tompa P., 2010, STRUCTURE FUNCTION I; Uversky VN, 2013, CURR PHARM DESIGN, V19, P4191, DOI 10.2174/1381612811319230005; Uversky VN, 2013, PROTEIN SCI, V22, P693, DOI 10.1002/pro.2261; Uversky VN, 2011, BBA-PROTEINS PROTEOM, V1814, P693, DOI 10.1016/j.bbapap.2011.03.010; Vallely KM, 2002, BIOCHEMISTRY-US, V41, P12670, DOI 10.1021/bi020365r; Vogl T, 2012, INT J MOL SCI, V13, P2893, DOI 10.3390/ijms13032893; Yanamandra K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005562	62	20	20	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76629	10.1371/journal.pone.0076629	http://dx.doi.org/10.1371/journal.pone.0076629			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098542	gold, Green Published, Green Submitted			2022-12-25	WOS:000325427100082
J	Smith, RC; Kizito, C; Rasgon, JL; Jacobs-Lorena, M				Smith, Ryan C.; Kizito, Christopher; Rasgon, Jason L.; Jacobs-Lorena, Marcelo			Transgenic Mosquitoes Expressing a Phospholipase A(2) Gene Have a Fitness Advantage When Fed Plasmodium falciparum-Infected Blood	PLOS ONE			English	Article							MALARIA PARASITE DEVELOPMENT; AEDES-AEGYPTI; ANOPHELES-GAMBIAE; TRANSMISSION; MIDGUT; COSTS; TRANSFORMATION; MANIPULATION; ANTIBODIES; FECUNDITY	Background: Genetically modified mosquitoes have been proposed as an alternative strategy to reduce the heavy burden of malaria. In recent years, several proof-of-principle experiments have been performed that validate the idea that mosquitoes can be genetically modified to become refractory to malaria parasite development. Results: We have created two transgenic lines of Anopheles stephensi, a natural vector of Plasmodium falciparum, which constitutively secrete a catalytically inactive phospholipase A(2) (mPLA(2)) into the midgut lumen to interfere with Plasmodium ookinete invasion. Our experiments show that both transgenic lines expressing mPLA2 significantly impair the development of rodent malaria parasites, but only one line impairs the development of human malaria parasites. In addition, when fed on malaria-infected blood, mosquitoes from both transgenic lines are more fecund than non-transgenic mosquitoes. Consistent with these observations, cage experiments with mixed populations of transgenic and non-transgenic mosquitoes show that the percentage of transgenic mosquitoes increases when maintained on Plasmodium-infected blood. Conclusions: Our results suggest that the expression of an anti-Plasmodium effector gene gives transgenic mosquitoes a fitness advantage when fed malaria-infected blood. These findings have important implications for future applications of transgenic mosquito technology in malaria control.	[Smith, Ryan C.; Kizito, Christopher; Jacobs-Lorena, Marcelo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Malaria Res Inst, Baltimore, MD USA; [Rasgon, Jason L.] Penn State Univ, Dept Entomol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Rasgon, Jason L.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Jacobs-Lorena, M (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Malaria Res Inst, Baltimore, MD USA.	mlorena@jhsph.edu	Smith, Ryan C./H-9360-2019	Smith, Ryan C./0000-0003-0245-2265; Rasgon, Jason/0000-0002-4050-8429	National Research Service Award [F32AI088835]; National Institutes of Health/National Institute of Allergy and Infectious Diseases [R01AI031478]; Johns Hopkins Malaria Research Institute Parasite and Insectary Core facilities; Bloomberg Family Foundation; National Institutes of Health [RR00052]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031478, F32AI088835] Funding Source: NIH RePORTER	National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Johns Hopkins Malaria Research Institute Parasite and Insectary Core facilities; Bloomberg Family Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by a National Research Service Award F32AI088835 (to RCS) and by grant R01AI031478 (to MJL) from the National Institutes of Health/National Institute of Allergy and Infectious Diseases. Additional support was provided by a Calvin S. and Helen H. Lang Post-doctoral fellowship (to RCS), from the Johns Hopkins Malaria Research Institute Parasite and Insectary Core facilities and from the Bloomberg Family Foundation. Supply of human blood was supported by National Institutes of Health Grant RR00052. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham EG, 2005, INSECT MOL BIOL, V14, P271, DOI 10.1111/j.1365-2583.2004.00557.x; Ahmed AM, 2006, MICROBES INFECT, V8, P308, DOI 10.1016/j.micinf.2005.06.026; Catteruccia F, 2000, P NATL ACAD SCI USA, V97, P2157, DOI 10.1073/pnas.040568397; Catteruccia F, 2003, SCIENCE, V299, P1225, DOI 10.1126/science.1081453; Coates CJ, 1998, P NATL ACAD SCI USA, V95, P3748, DOI 10.1073/pnas.95.7.3748; Corby-Harris V, 2010, PLOS PATHOG, V6, DOI [10.1371/journal.ppat.1001003, 10.1371/annotation/738ac91f-8c41-4bf5-9a39-bddf0b777a89]; Dinglasan RR, 2007, P NATL ACAD SCI USA, V104, P13461, DOI 10.1073/pnas.0702239104; Dong YM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002458; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Hogg JC, 1997, PARASITOLOGY, V114, P325, DOI 10.1017/S0031182096008542; HOGG JC, 1995, MED VET ENTOMOL, V9, P176, DOI 10.1111/j.1365-2915.1995.tb00175.x; Hurd H, 2005, EVOLUTION, V59, P2560, DOI 10.1111/j.0014-3820.2005.tb00969.x; Hurd H, 2003, ANNU REV ENTOMOL, V48, P141, DOI 10.1146/annurev.ento.48.091801.112722; Irvin N, 2004, P NATL ACAD SCI USA, V101, P891, DOI 10.1073/pnas.0305511101; Isaacs AT, 2012, P NATL ACAD SCI USA, V109, pE1922, DOI 10.1073/pnas.1207738109; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; Kokoza V, 2010, P NATL ACAD SCI USA, V107, P8111, DOI 10.1073/pnas.1003056107; Lawson D, 2007, NUCLEIC ACIDS RES, V35, pD503, DOI 10.1093/nar/gkl960; Li CY, 2008, J HERED, V99, P275, DOI 10.1093/jhered/esn004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marrelli MT, 2007, P NATL ACAD SCI USA, V104, P5580, DOI 10.1073/pnas.0609809104; Marrelli MT, 2006, TRENDS PARASITOL, V22, P197, DOI 10.1016/j.pt.2006.03.004; Moreira LA, 2004, GENETICS, V166, P1337, DOI 10.1534/genetics.166.3.1337; Moreira LA, 2002, J BIOL CHEM, V277, P40839, DOI 10.1074/jbc.M206647200; Nimmo DD, 2006, INSECT MOL BIOL, V15, P129, DOI 10.1111/j.1365-2583.2006.00615.x; O'Brochta DA, 2011, P NATL ACAD SCI USA, V108, P16339, DOI 10.1073/pnas.1110628108; Potter CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010168; Ramakrishnan Chandra, 2013, Methods Mol Biol, V923, P51; Rodrigues FG, 2008, INSECT MOL BIOL, V17, P175, DOI 10.1111/j.1365-2583.2008.00791.x; Rono MK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000434; Smith RC, 2007, INSECT MOL BIOL, V16, P61, DOI 10.1111/j.1365-2583.2006.00701.x; Smith RC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002965; Smith RC, 2011, GENETICA, V139, P7, DOI 10.1007/s10709-010-9459-7; Wang SB, 2013, TRENDS BIOTECHNOL, V31, P185, DOI 10.1016/j.tibtech.2013.01.001; Yoshida S, 2007, PLOS PATHOG, V3, P1962, DOI 10.1371/journal.ppat.0030192; Zieler H, 2001, J EXP BIOL, V204, P4157	36	10	10	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76097	10.1371/journal.pone.0076097	http://dx.doi.org/10.1371/journal.pone.0076097			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098427	gold, Green Submitted, Green Published			2022-12-25	WOS:000325427100041
J	Belkin, DA; Chen, J; Mo, JL; Rosoff, JS; Goldenberg, S; Poppas, DP; Krueger, JG; Herschman, M; Mitsui, H; Felsen, D; Carucci, JA				Belkin, Daniel A.; Chen, Jie; Mo, Jonathan L.; Rosoff, James S.; Goldenberg, Sagit; Poppas, Dix P.; Krueger, James G.; Herschman, Miriam; Mitsui, Hiroshi; Felsen, Diane; Carucci, John A.			An Animal Explant Model for the Study of Human Cutaneous Squamous Cell Carcinoma	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR MICROENVIRONMENT; XENOGRAFT MODEL; NUDE RATS; CANCER; TRANSFORMATION; METASTASIS; APOPTOSIS; MIGRATION; INVASION	We established a human tissue explant model to facilitate study of cutaneous squamous cell carcinoma. We accomplished this by implanting debulked SCC, from surgical discard, into nude rats. Human SCC remained viable and continued to proliferate for at least 4 weeks and showed evidence of neovascularization. At 4 weeks, SCC implants showed a trend toward increased PCNA positive cells compared to fresh SCC cells/mm(2) tissue) supporting continued proliferation throughout engraftment. Von Willebrand's Factor (VWF) positive cells were found within implants and likely represented rat vessel neovascularization. Human Langerhans' (Langerin+) cells, but no T cells (CD3+, CD8+, FoxP3+), macrophages (CD163), or NK cells (NKp46), were present in SCC implants at 4 weeks. These findings support the possibility that LCs fail to migrate from cutaneous SCC and thus contribute to lack of effective antitumor response. Our findings also provide a novel model system for further study of primary cutaneous SCC.	[Belkin, Daniel A.] Weill Cornell Med Coll, Dept Dermatol, New York, NY USA; [Chen, Jie; Mo, Jonathan L.; Rosoff, James S.; Goldenberg, Sagit; Poppas, Dix P.; Felsen, Diane] Weill Cornell Med Coll, Dept Urol, Inst Pediat Urol, New York, NY USA; [Krueger, James G.; Mitsui, Hiroshi] Rockefeller Univ, Invest Dermatol Lab, New York, NY 10021 USA; [Herschman, Miriam; Carucci, John A.] NYU, Langone Med Ctr, Ronald O Perelman Dept Dermatol, New York, NY 10003 USA	Cornell University; Cornell University; Rockefeller University; New York University; NYU Langone Medical Center	Carucci, JA (corresponding author), NYU, Langone Med Ctr, Ronald O Perelman Dept Dermatol, New York, NY 10003 USA.	john.carucci@nyumc.org		carucci, john/0000-0001-6817-9439	Dana Foundation Human Immunology Consortium Grant	Dana Foundation Human Immunology Consortium Grant	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. These studies were funded in part by the Dana Foundation Human Immunology Consortium Grant.	Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; Bao A, 2006, OTOLARYNG HEAD NECK, V135, P853, DOI 10.1016/j.otohns.2006.06.1257; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Billings SD, 2003, AM J PATHOL, V163, P2451, DOI 10.1016/S0002-9440(10)63600-0; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013; Bluth MJ, 2009, J INVEST DERMATOL, V129, P2451, DOI 10.1038/jid.2009.96; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Diepgen TL, 2002, BRIT J DERMATOL, V146, P1, DOI 10.1046/j.1365-2133.146.s61.2.x; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; FIEBIG HH, 1989, STRAHLENTHER ONKOL, V165, P522; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Fujita H, 2012, J INVEST DERMATOL, V132, P1645, DOI 10.1038/jid.2012.34; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Karia PS, 2013, J AM ACAD DERMATOL; Khavari PA, 2006, NAT REV CANCER, V6, P270, DOI 10.1038/nrc1838; Kriehuber E, 2005, BLOOD, V106, P175, DOI 10.1182/blood-2004-08-3072; Lazarov M, 2002, NAT MED, V8, P1105, DOI 10.1038/nm779; Miyajima A, 2000, KIDNEY INT, V58, P2301, DOI 10.1046/j.1523-1755.2000.00414.x; Moussai D, 2011, J INVEST DERMATOL, V131, P229, DOI 10.1038/jid.2010.266; Park YW, 2005, CLIN CANCER RES, V11, P1963, DOI 10.1158/1078-0432.CCR-04-1665; Petratos PB, 2003, PLAST RECONSTR SURG, V111, P1988, DOI 10.1097/01.PRS.0000056831.87062.4B; Pettersen JS, 2011, J INVEST DERMATOL; Polyak K, 2009, TRENDS GENET, V25, P30, DOI 10.1016/j.tig.2008.10.012; Proby CM, 2000, EXP DERMATOL, V9, P104, DOI 10.1034/j.1600-0625.2000.009002104.x; Smith LP, 2006, INT J CANCER, V118, P2111, DOI 10.1002/ijc.21694; Vishwanath M, 2006, J INVEST DERMATOL, V126, P2452, DOI 10.1038/sj.jid.5700448; Weinberg AS, 2007, DERMATOL SURG, V33, P885, DOI 10.1111/j.1524-4725.2007.33190.x; Weinberg RA, 2008, NAT GENET, V40, P494, DOI 10.1038/ng0508-494; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995	34	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76156	10.1371/journal.pone.0076156	http://dx.doi.org/10.1371/journal.pone.0076156			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116092	Green Submitted, Green Published, gold			2022-12-25	WOS:000325552200049
J	Kimura, Y; Fujita, Y; Shibata, K; Mori, M; Yamashita, T				Kimura, Yuriko; Fujita, Yuki; Shibata, Kumi; Mori, Megumi; Yamashita, Toshihide			Sigma-1 Receptor Enhances Neurite Elongation of Cerebellar Granule Neurons via TrkB Signaling	PLOS ONE			English	Article							BRAIN; NEUROTROPHINS; ACTIVATION; CHAPERONES; OUTGROWTH	Sigma-1 receptor (Sig-1R) is an integral membrane protein predominantly expressed in the endoplasmic reticulum. Sig-1R demonstrates a high affinity to various synthetic compounds including well-known psychotherapeutic drugs in the central nervous system (CNS). For that, it is considered as an alternative target for psychotherapeutic drugs. On the cellular level, when Sig-1R is activated, it is known to play a role in neuroprotection and neurite elongation. These effects are suggested to be mediated by its ligand-operated molecular chaperone activity, and/or upregulation of various Ca2+ signaling. In addition, recent studies show that Sig-1R activation induces neurite outgrowth via neurotrophin signaling. Here, we tested the hypothesis that Sig-1R activation promotes neurite elongation through activation of tropomyosin receptor kinase (Trk), a family of neurotrophin receptors. We found that 2-(4-morpholinethyl) 1-phenylcyclohexanecarboxylate (PRE-084), a selective Sig-1R agonist, significantly promoted neurite outgrowth, and K252a, a Trk inhibitor, attenuated Sig-1R-mediated neurite elongation in cerebellar granule neurons (CGNs). Moreover, we revealed that Sig-1R interacts with TrkB, and PRE-084 treatment enhances phosphorylation of Y515, but not Y706. Thus, our results indicate that Sig-1R activation promotes neurite outgrowth in CGNs through Y515 phosphorylation of TrkB.	[Kimura, Yuriko; Fujita, Yuki; Shibata, Kumi; Mori, Megumi; Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka, Japan; [Kimura, Yuriko; Fujita, Yuki; Yamashita, Toshihide] CREST, JST, Chiyoda Ku, Tokyo, Japan	Osaka University; Japan Science & Technology Agency (JST)	Yamashita, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka, Japan.	yamashita@molneu.med.osaka-u.ac.jp		Yamashita, Toshihide/0000-0003-4559-7018; Mori, Megumi/0000-0002-4810-5480	Japan Science and Technology Agency	Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by a grant for Core Research for Evolutional Science and Technology from the Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydar E, 2002, NEURON, V34, P399, DOI 10.1016/S0896-6273(02)00677-3; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; Carnally SM, 2010, BIOPHYS J, V98, P1182, DOI 10.1016/j.bpj.2009.12.4293; Fobian K, 2010, J NEUROSCI RES, V88, P1170, DOI 10.1002/jnr.22285; Fujita Y, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.85; Ginty DD, 2002, CURR OPIN NEUROBIOL, V12, P268, DOI 10.1016/S0959-4388(02)00326-4; Guzman-Lenis MS, 2009, NEUROSCIENCE, V162, P31, DOI 10.1016/j.neuroscience.2009.03.067; Hashimoto Kenji, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P197; Hata K, 2009, J CELL BIOL, V184, P737, DOI 10.1083/jcb.200807029; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hayashi T, 2011, EXPERT OPIN THER TAR, V15, P557, DOI 10.1517/14728222.2011.560837; Hayashi T, 2010, MOL PHARMACOL, V77, P517, DOI 10.1124/mol.109.062539; Hayashi T, 2010, J PHARMACOL EXP THER, V332, P1054, DOI 10.1124/jpet.109.159244; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Ishikawa M, 2007, BIOL PSYCHIAT, V62, P878, DOI 10.1016/j.biopsych.2007.04.001; Ishikawa M, 2010, J RECEPT LIGAND CH R, V3, P25; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kim HW, 2008, BRIT J PHARMACOL, V154, P1125, DOI 10.1038/bjp.2008.159; KNUSEL B, 1994, J NEUROSCI, V14, P1542, DOI 10.1523/JNEUROSCI.14-03-01542.1994; Langa F, 2003, EUR J NEUROSCI, V18, P2188, DOI 10.1046/j.1460-9568.2003.02950.x; Liu HY, 2002, J BIOL CHEM, V277, P26046, DOI 10.1074/jbc.M111659200; Martin WR, 1967, J PHARMACOL EXP THER, V197, P517; Nishimura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002558; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Tchedre KT, 2008, INVEST OPHTH VIS SCI, V49, P4993, DOI 10.1167/iovs.08-1867; Yagasaki Y, 2006, J BIOL CHEM, V281, P12941, DOI 10.1074/jbc.M508157200; Zamanillo D, 2000, NEUROSCI LETT, V282, P169, DOI 10.1016/S0304-3940(00)00884-3	28	40	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e75760	10.1371/journal.pone.0075760	http://dx.doi.org/10.1371/journal.pone.0075760			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24116072	Green Published, gold, Green Submitted			2022-12-25	WOS:000325552200037
J	Csukly, G; Stefanics, G; Komlosi, S; Czigler, I; Czobor, P				Csukly, Gabor; Stefanics, Gabor; Komlosi, Sarolta; Czigler, Istvan; Czobor, Pal			Emotion-Related Visual Mismatch Responses in Schizophrenia: Impairments and Correlations with Emotion Recognition	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; MEMORY-BASED DETECTION; NEGATIVITY GENERATION; FACIAL EXPRESSIONS; IRRELEVANT CHANGES; SENSORY MEMORY; HUMAN BRAIN; MMN; LOCALIZATION; PERCEPTION	Background and Objectives: Mismatch negativity (MMN) is an event-related potential (ERP) measure of preattentional sensory processing. While deficits in the auditory MMN are robust electrophysiological findings in schizophrenia, little is known about visual mismatch response and its association with social cognitive functions such as emotion recognition in schizophrenia. Our aim was to study the potential deficit in the visual mismatch response to unexpected facial emotions in schizophrenia and its association with emotion recognition impairments, and to localize the sources of the mismatch signals. Experimental Design: The sample comprised 24 patients with schizophrenia and 24 healthy control subjects. Controls were matched individually to patients by gender, age, and education. ERPs were recorded using a high-density 128-channel BioSemi amplifier. Mismatch responses to happy and fearful faces were determined in 2 time windows over six regions of interest (ROIs). Emotion recognition performance and its association with the mismatch response were also investigated. Principal Observations: Mismatch signals to both emotional conditions were significantly attenuated in patients compared to controls in central and temporal ROIs. Controls recognized emotions significantly better than patients. The association between overall emotion recognition performance and mismatch response to the happy condition was significant in the 250-360 ms time window in the central ROI. The estimated sources of the mismatch responses for both emotional conditions were localized in frontal regions, where patients showed significantly lower activity. Conclusions: Impaired generation of mismatch signals indicate insufficient automatic processing of emotions in patients with schizophrenia, which correlates strongly with decreased emotion recognition.	[Csukly, Gabor; Komlosi, Sarolta; Czobor, Pal] Semmelweis Univ, Dept Psychiat & Psychotherapy, H-1085 Budapest, Hungary; [Stefanics, Gabor] Univ Zurich, Inst Biomed Engn, TNU, Zurich, Switzerland; [Stefanics, Gabor] ETH, Zurich, Switzerland; [Stefanics, Gabor] Univ Zurich, Dept Econ, Lab Social & Neural Syst Res, Zurich, Switzerland; [Stefanics, Gabor; Czigler, Istvan] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Cognit Neurosci & Psychol, Budapest, Hungary; [Czobor, Pal] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA	Semmelweis University; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Nathan Kline Institute for Psychiatric Research	Csukly, G (corresponding author), Semmelweis Univ, Dept Psychiat & Psychotherapy, H-1085 Budapest, Hungary.	csukly.gabor@med.semmelweis-univ.hu	Stefanics, Gabor/M-9955-2019; Csukly, Gabor/J-8244-2017	Stefanics, Gabor/0000-0002-0324-0996; Csukly, Gabor/0000-0002-5006-9407; Czigler, Istvan/0000-0003-1661-3808	"Ambient Assisted Living Joint Programme - Call 2'' grant [AAL_08-1-2011-0005 M3W]; National Research Fund of Hungary (OTKA) [71600]	"Ambient Assisted Living Joint Programme - Call 2'' grant; National Research Fund of Hungary (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	The study was partially supported by the "Ambient Assisted Living Joint Programme - Call 2'' grant (Project Identifier: AAL_08-1-2011-0005 M3W). (http://www.aal-europe.eu). The additional part of the study was supported by the National Research Fund of Hungary (OTKA, 71600; http://www.otka.hu/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington J, 2006, BRIT J PSYCHIAT, V189, P373, DOI 10.1192/bjp.bp.105.021022; American Psychiatric Association DSM-IV, 1994, DSM 4 DIAGN STAT MAN; Astikainen P, 2004, NEUROSCI LETT, V368, P231, DOI 10.1016/j.neulet.2004.07.025; Astikainen P, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-30; Astikainen P, 2008, EUR J NEUROSCI, V28, P2319, DOI 10.1111/j.1460-9568.2008.06510.x; Baldeweg T, 2004, SCHIZOPHR RES, V69, P203, DOI 10.1016/j.schres.2003.09.009; Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; Calvo MG, 2008, COGN AFFECT BEHAV NE, V8, P41, DOI 10.3758/CABN.8.1.41; Calvo MG, 2007, J EXP PSYCHOL GEN, V136, P347, DOI 10.1037/0096-3445.136.3.347; Calvo MG, 2006, COGNITION EMOTION, V20, P1049, DOI 10.1080/02699930500298351; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Czigler I, 2002, PSYCHOPHYSIOLOGY, V39, P869, DOI 10.1111/1469-8986.3960869; Czigler I, 2007, PSYCHOPHYSIOLOGY, V44, P610, DOI 10.1111/j.1469-8986.2007.00530.x; Czigler I, 2010, NEUROPSYCHOLOGIA, V48, P1277, DOI 10.1016/j.neuropsychologia.2009.12.029; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Derogatis L., 1994, SCL 90 R SYMPTOM CHE; Eimer M, 2007, NEUROPSYCHOLOGIA, V45, P15, DOI 10.1016/j.neuropsychologia.2006.04.022; Ekman P., 1976, PICTURES FACIAL AFFE; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; Halgren E, 2000, CEREB CORTEX, V10, P69, DOI 10.1093/cercor/10.1.69; Heekeren K, 2008, PSYCHOPHARMACOLOGY, V199, P77, DOI 10.1007/s00213-008-1129-4; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; Javitt DC, 1996, P NATL ACAD SCI USA, V93, P11962, DOI 10.1073/pnas.93.21.11962; JEFFREYS DA, 1989, EXP BRAIN RES, V78, P193; Jung HT, 2012, SCHIZOPHR RES, V136, P150, DOI 10.1016/j.schres.2011.10.023; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kee KS, 2003, SCHIZOPHRENIA BULL, V29, P487, DOI 10.1093/oxfordjournals.schbul.a007021; Kimura M, 2012, CEREB CORTEX, V22, P1774, DOI 10.1093/cercor/bhr244; Kimura M, 2012, INT J PSYCHOPHYSIOL, V83, P144, DOI 10.1016/j.ijpsycho.2011.11.010; Kimura M, 2009, PSYCHOPHYSIOLOGY, V46, P402, DOI 10.1111/j.1469-8986.2008.00767.x; Kohler Christian G, 2010, Schizophr Bull, V36, P1009, DOI 10.1093/schbul/sbn192; Korostenskaja M, 2005, PROG NEURO-PSYCHOPH, V29, P543, DOI 10.1016/j.pnpbp.2005.01.019; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Leucht S, 2005, SCHIZOPHR RES, V79, P231, DOI 10.1016/j.schres.2005.04.008; Li XY, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-7; Light GA, 2005, ARCH GEN PSYCHIAT, V62, P127, DOI 10.1001/archpsyc.62.2.127; Maekawa T, 2012, CURR PSYCHIATRY REV, V8, P97, DOI 10.2174/1573400511208020097; Mancuso F, 2011, SCHIZOPHR RES, V125, P143, DOI 10.1016/j.schres.2010.11.007; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Naatanen R, 2011, PSYCHOPHYSIOLOGY, V48, P4, DOI 10.1111/j.1469-8986.2010.01114.x; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pazo-Alvarez P, 2004, NEUROSCI LETT, V371, P111, DOI 10.1016/j.neulet.2004.08.073; Schendan HE, 1998, PSYCHOPHYSIOLOGY, V35, P240, DOI 10.1017/S004857729897010X; Schmidt A, 2013, CEREB CORTEX, V23, P2394, DOI 10.1093/cercor/bhs238; Srinivasan R, 1998, BEHAV RES METH INS C, V30, P8, DOI 10.3758/BF03209412; Stagg C, 2004, NEUROREPORT, V15, P659, DOI 10.1097/00001756-200403220-00017; Stefanics G, 2012, NEUROIMAGE, V63, P253, DOI 10.1016/j.neuroimage.2012.06.068; Stefanics G, 2012, NEUROIMAGE, V59, P3042, DOI 10.1016/j.neuroimage.2011.10.041; Stefanics G, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00046; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005; Sulykos I, 2011, BRAIN RES, V1398, P64, DOI 10.1016/j.brainres.2011.05.009; Tikhonravov D, 2008, BRAIN RES, V1203, P97, DOI 10.1016/j.brainres.2008.02.006; Umbricht D, 1998, BIOL PSYCHIAT, V44, P716, DOI 10.1016/S0006-3223(97)00524-6; Umbricht D, 2005, SCHIZOPHR RES, V76, P1, DOI 10.1016/j.schres.2004.12.002; Unoka Z., 2004, PSYCHIAT HUNG, V19, P235; Urban A, 2008, SCHIZOPHR RES, V102, P320, DOI 10.1016/j.schres.2008.03.014; VANRIJN ACM, 1990, MED BIOL ENG COMPUT, V28, P389, DOI 10.1007/BF02441961; Wagner M, 2004, BRAIN TOPOGR, V16, P277; Yao J, 2005, NEUROIMAGE, V25, P369, DOI 10.1016/j.neuroimage.2004.11.036; Zhao L, 2006, NEUROSCI LETT, V410, P126, DOI 10.1016/j.neulet.2006.09.081	65	40	43	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75444	10.1371/journal.pone.0075444	http://dx.doi.org/10.1371/journal.pone.0075444			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232NS	24116046	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000325501300029
J	Drazic, A; Tsoutsoulopoulos, A; Peschek, J; Gundlach, J; Krause, M; Bach, NC; Gebendorfer, KM; Winter, J				Drazic, Adrian; Tsoutsoulopoulos, Amelie; Peschek, Jirka; Gundlach, Jasmin; Krause, Maike; Bach, Nina C.; Gebendorfer, Katharina M.; Winter, Jeannette			Role of Cysteines in the Stability and DNA-Binding Activity of the Hypochlorite-Specific Transcription Factor HypT	PLOS ONE			English	Article							REDOX-REGULATED CHAPERONE; HYDROGEN-PEROXIDE; DISULFIDE BOND; HYDROXYL RADICALS; THIOL; SUPEROXIDE; ACID; SWITCH; INACTIVATION; OXIDATION	Reactive oxygen species are important components of the immune response. Hypochlorite (HOCl) is produced by neutrophils to kill invading microorganisms. The bactericidal activity of HOCl is due to proteome-wide unfolding and oxidation of proteins at cysteine and methionine residues. Escherichia coli cells are protected from HOCl-killing by the previously identified dodecameric transcription factor HypT (YjiE). Here, we aimed to unravel whether HOCl activates HypT directly or via a reaction product of HOCl with a cellular component. Bacterial viability assays and analysis of target gene regulation indicate that HypT is highly specific to activation by HOCl and that no reaction products of HOCl such as monochloramine, hydroxyl radicals, or methionine sulfoxide activate HypT in vivo. Surprisingly, purified HypT lost its DNA-binding activity upon incubation with HOCl or reaction products that oxidize HypT to form a disulfide-linked dimer, and regained DNA-binding activity upon reduction. Thus, we postulate that the cysteines in HypT contribute to control the DNA-binding activity of HypT in vitro. HypT contains five cysteine residues; a HypT mutant with all cysteines substituted by serine is aggregation-prone and forms tetramers in addition to the typical dodecamers. Using single and multiple cysteine-to-serine mutants, we identified Cys150 to be required for stability and Cys4 being important for oligomerization of HypT to dodecamers. Further, oxidation of Cys4 is responsible for the loss of DNA-binding of HypT upon oxidation in vitro. It appears that Cys4 oxidation upon conditions that are insufficient to stimulate the DNA-binding activity of HypT prevents unproductive interactions of HypT with DNA. Thus, Cys4 oxidation may be a check point in the activation process of HypT.	[Drazic, Adrian; Tsoutsoulopoulos, Amelie; Peschek, Jirka; Gundlach, Jasmin; Krause, Maike; Bach, Nina C.; Gebendorfer, Katharina M.; Winter, Jeannette] Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci Munich, Garching, Germany	Technical University of Munich	Winter, J (corresponding author), Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci Munich, Garching, Germany.	jeannette.winter@tum.de	Drazic, Adrian/AAC-6120-2019	Drazic, Adrian/0000-0001-9263-5502; Peschek, Jirka/0000-0001-8158-9301; Krause, Maike/0000-0003-4068-8172	Emmy-Noether Program of the Deutsche Forschungsgemeinschaft [WI 3200/1-1]; Center for Integrated Protein Science Munich; Elitenetzwerk Bayern; Studienstiftung des deutschen Volkes;  [SFB1035]	Emmy-Noether Program of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Integrated Protein Science Munich; Elitenetzwerk Bayern; Studienstiftung des deutschen Volkes; 	The study was funded by the Emmy-Noether Program of the Deutsche Forschungsgemeinschaft (Grant number: WI 3200/1-1) and the Center for Integrated Protein Science Munich. AD, JG and KMG were supported by the Elitenetzwerk Bayern, JP was supported by the Studienstiftung des deutschen Volkes, MK was supported by SFB1035. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRICH JM, 1986, J CLIN INVEST, V78, P177, DOI 10.1172/JCI112548; Anjem A, 2012, J BIOL CHEM, V287, P15544, DOI 10.1074/jbc.M111.330365; Antelmann H, 2011, ANTIOXID REDOX SIGN, V14, P1049, DOI 10.1089/ars.2010.3400; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; BORS W, 1979, EUR J BIOCHEM, V95, P621, DOI 10.1111/j.1432-1033.1979.tb13003.x; CANDEIAS LP, 1994, FREE RADICAL RES, V20, P241, DOI 10.3109/10715769409147520; Chi BK, 2013, ANTIOXID REDOX SIGN, V18, P1273, DOI 10.1089/ars.2012.4686; Chi BK, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009506; Cho SH, 2012, MBIO, V3, DOI 10.1128/mBio.00291-11; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484; Davies BW, 2009, MOL CELL, V36, P845, DOI 10.1016/j.molcel.2009.11.024; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Day AM, 2012, MOL CELL, V45, P398, DOI 10.1016/j.molcel.2011.11.027; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Depuydt M, 2011, ANTIOXID REDOX SIGN, V15, P49, DOI 10.1089/ars.2010.3575; Drazic A, 2013, P NATL ACAD SCI USA, V110, P9493, DOI 10.1073/pnas.1300578110; FLINT DH, 1993, J BIOL CHEM, V268, P22369; Foit L, 2011, ANTIOXID REDOX SIGN, V14, P973, DOI 10.1089/ars.2010.3712; FOLKES LK, 1995, ARCH BIOCHEM BIOPHYS, V323, P120, DOI 10.1006/abbi.1995.0017; Gardner PR, 1997, BIOSCIENCE REP, V17, P33, DOI 10.1023/A:1027383100936; Gebendorfer KM, 2012, J BIOL CHEM, V287, P6892, DOI 10.1074/jbc.M111.287219; Gleiter S, 2008, BBA-MOL CELL RES, V1783, P530, DOI 10.1016/j.bbamcr.2008.02.009; Gonzalez-Segura L, 2005, BIOCHIMIE, V87, P1056, DOI 10.1016/j.biochi.2005.06.007; Gray MJ, 2013, J BIOL CHEM, V288, P13789, DOI 10.1074/jbc.M113.454421; GREENBERG JT, 1990, P NATL ACAD SCI USA, V87, P6181, DOI 10.1073/pnas.87.16.6181; Gu MZ, 2011, MOL MICROBIOL, V79, P1136, DOI 10.1111/j.1365-2958.2010.07520.x; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI 10.1089/ARS.2009.2466; Hondorp ER, 2004, PLOS BIOL, V2, P1738, DOI 10.1371/journal.pbio.0020336; Ilbert M, 2007, NAT STRUCT MOL BIOL, V14, P556, DOI 10.1038/nsmb1244; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Kaur Y, 2004, PROTEIN J, V23, P255, DOI 10.1023/B:JOPC.0000027850.01893.2e; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kiley PJ, 2004, PLOS BIOL, V2, P1714, DOI 10.1371/journal.pbio.0020400; Kumsta C, 2009, BIOCHEMISTRY-US, V48, P4666, DOI 10.1021/bi9003556; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Leichert LI, 2008, P NATL ACAD SCI USA, V105, P8197, DOI 10.1073/pnas.0707723105; Leichert LI, 2004, PLOS BIOL, V2, P1723, DOI 10.1371/journal.pbio.0020333; Luo S, 2009, FASEB J, V23, P464, DOI 10.1096/fj.08-118414; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; Morales EH, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-63; Palm GJ, 2012, NUCLEIC ACIDS RES, V40, P4178, DOI 10.1093/nar/gkr1316; Parsonage D, 2005, BIOCHEMISTRY-US, V44, P10583, DOI 10.1021/bi050448i; Pattison DI, 2001, CHEM RES TOXICOL, V14, P1453, DOI 10.1021/tx0155451; Poole LB, 2005, ARCH BIOCHEM BIOPHYS, V433, P240, DOI 10.1016/j.abb.2004.09.006; Reichmann D, 2012, CELL, V148, P947, DOI 10.1016/j.cell.2012.01.045; Roos D, 2002, SCIENCE, V296, P669, DOI 10.1126/science.1071271; Rosen H, 2009, P NATL ACAD SCI USA, V106, P18686, DOI 10.1073/pnas.0909464106; SAXENA VP, 1970, BIOCHEMISTRY-US, V9, P5015; Schulenburg C, 2010, CHEMBIOCHEM, V11, P978, DOI 10.1002/cbic.200900773; Sivey JD, 2013, BIOCHEMISTRY-US, V52, P1260, DOI 10.1021/bi301523s; Weber H, 2004, MOL MICROBIOL, V52, P133, DOI 10.1111/j.1365-2958.2004.03971.x; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024; Winter J, 2005, MOL CELL, V17, P381, DOI 10.1016/j.molcel.2004.12.027; Winter J, 2011, PROTEIN SCI, V20, P588, DOI 10.1002/pro.592; Winterbourn CC, 1999, FREE RADICAL BIO MED, V27, P322, DOI 10.1016/S0891-5849(99)00051-9; Winterbourn CC, 2006, J BIOL CHEM, V281, P39860, DOI 10.1074/jbc.M605898200; Xu H, 2009, PROTEOMICS, V9, P1548, DOI 10.1002/pmic.200700322	61	19	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e75683	10.1371/journal.pone.0075683	http://dx.doi.org/10.1371/journal.pone.0075683			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116067	Green Published, Green Submitted, gold			2022-12-25	WOS:000325501300039
J	Gu, SH; Chen, DD; Zhang, JN; Lv, XM; Wang, K; Duan, LP; Nie, Y; Wu, XL				Gu, Shenghua; Chen, Dandan; Zhang, Jin-Na; Lv, Xiaoman; Wang, Kun; Duan, Li-Ping; Nie, Yong; Wu, Xiao-Lei			Bacterial Community Mapping of the Mouse Gastrointestinal Tract	PLOS ONE			English	Article							GUT MICROBIOTA; MICE; DIET; DIVERSITY; PHENOTYPE; RESISTANT; EVOLUTION; MUTUALISM; SEQUENCES; DISEASE	Keeping mammalian gastrointestinal (GI) tract communities in balance is crucial for host health maintenance. However, our understanding of microbial communities in the GI tract is still very limited. In this study, samples taken from the GI tracts of C57BL/6 mice were subjected to 16S rRNA gene sequence-based analysis to examine the characteristic bacterial communities along the mouse GI tract, including those present in the stomach, duodenum, jejunum, ileum, cecum, colon and feces. Further analyses of the 283,234 valid sequences obtained from pyrosequencing revealed that the gastric, duodenal, large intestinal and fecal samples had higher phylogenetic diversity than the jejunum and ileum samples did. The microbial communities found in the small intestine and stomach were different from those seen in the large intestine and fecal samples. A greater proportion of Lactobacillaceae were found in the stomach and small intestine, while a larger proportion of anaerobes such as Bacteroidaceae, Prevotellaceae, Rikenellaceae, Lachnospiraceae, and Ruminococcaceae were found in the large intestine and feces. In addition, inter-mouse variations of microbiota were observed between the large intestinal and fecal samples, which were much smaller than those between the gastric and small intestinal samples. As far as we can ascertain, ours is the first study to systematically characterize bacterial communities from the GI tracts of C57BL/6 mice.	[Gu, Shenghua; Chen, Dandan; Zhang, Jin-Na; Nie, Yong; Wu, Xiao-Lei] Peking Univ, Coll Engn, Beijing 100871, Peoples R China; [Zhang, Jin-Na] Kunming Med Univ, Kunming, Yunnan, Peoples R China; [Lv, Xiaoman] Yunnan Univ Tradit Chinese Med, Kunming, Yunnan, Peoples R China; [Wang, Kun; Duan, Li-Ping] Peking Univ, Hosp 3, Beijing 100871, Peoples R China	Peking University; Kunming Medical University; Yunnan University of Chinese Medicine; Peking University	Nie, Y (corresponding author), Peking Univ, Coll Engn, Beijing 100871, Peoples R China.	nieyong@gmail.com; xiaolei_wu@pku.edu.cn	Chen, Dan/GRY-2691-2022; Wu, Xiao-Lei/G-6882-2011	Chen, Dan/0000-0002-1570-9034; Wu, Xiao-Lei/0000-0002-9897-6903	National "Twelfth Five-Year'' Plan for Science & Technology of China [2012BAI06B02]	National "Twelfth Five-Year'' Plan for Science & Technology of China	This study was supported by the National "Twelfth Five-Year'' Plan for Science & Technology of China (2012BAI06B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Booijink CCGM, 2010, ENVIRON MICROBIOL, V12, P3213, DOI 10.1111/j.1462-2920.2010.02294.x; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Caricilli AM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001212; Chu FF, 2004, CANCER RES, V64, P962, DOI 10.1158/0008-5472.CAN-03-2272; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Deiteren A, 2010, NEUROGASTROENT MOTIL, V22, P413, DOI 10.1111/j.1365-2982.2009.01441.x; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Hopkins MJ, 2002, DIGEST LIVER DIS, V34, pS12, DOI 10.1016/S1590-8658(02)80157-8; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mentula S, 2005, APPL ENVIRON MICROB, V71, P4169, DOI 10.1128/AEM.71.8.4169-4175.2005; Neufeld KM, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01620.x; Perkins GA, 2012, APPL ENVIRON MICROB, V78, P2522, DOI 10.1128/AEM.06252-11; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Rabot S, 2010, FASEB J, V24, P4948, DOI 10.1096/fj.10-164921; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zoetendal Erwin G., 2001, Microbial Ecology in Health and Disease, V13, P129, DOI 10.1080/089106001750462669	31	225	237	5	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e74957	10.1371/journal.pone.0074957	http://dx.doi.org/10.1371/journal.pone.0074957			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116019	gold, Green Published, Green Submitted			2022-12-25	WOS:000325501300019
J	Kooij, V; Zhang, PB; Piersma, SR; Sequeira, V; Boontje, NM; Wijnker, PJM; Jimenez, CR; Jaquet, KE; dos Remedios, C; Murphy, AM; van Eyk, JE; van der Velden, J; Stienen, GJM				Kooij, Viola; Zhang, Pingbo; Piersma, Sander R.; Sequeira, Vasco; Boontje, Nicky M.; Wijnker, Paul J. M.; Jimenez, Connie R.; Jaquet, Kornelia E.; dos Remedios, Cris; Murphy, Anne M.; van Eyk, Jennifer E.; van der Velden, Jolanda; Stienen, Ger J. M.			PKC alpha-Specific Phosphorylation of the Troponin Complex in Human Myocardium: A Functional and Proteomics Analysis	PLOS ONE			English	Article							PROTEIN-KINASE-C; FAILING HUMAN HEART; CARDIAC CONTRACTILITY; DIASTOLIC FUNCTION; SITES; IDENTIFICATION; FAILURE; MUSCLE; SENSITIVITY; FILAMENT	Aims: Protein kinase C alpha (PKC alpha) is one of the predominant PKC isoforms that phosphorylate cardiac troponin. PKC alpha is implicated in heart failure and serves as a potential therapeutic target, however, the exact consequences for contractile function in human myocardium are unclear. This study aimed to investigate the effects of PKC alpha phosphorylation of cardiac troponin (cTn) on myofilament function in human failing cardiomyocytes and to resolve the potential targets involved. Methods and Results: Endogenous cTn from permeabilized cardiomyocytes from patients with end-stage idiopathic dilated cardiomyopathy was exchanged (similar to 69%) with PKC alpha-treated recombinant human cTn (cTn (DD+PKC alpha)). This complex has Ser23/24 on cTnI mutated into aspartic acids (D) to rule out in vitro cross-phosphorylation of the PKA sites by PKC alpha. Isometric force was measured at various [Ca2+] after exchange. The maximal force (F-max) in the cTn (DD+PKC alpha) group (17.1 +/- 1.9 kN/m(2)) was significantly reduced compared to the cTn (DD) group (26.1 +/- 1.9 kN/m(2)). Exchange of endogenous cTn with cTn (DD+PKC alpha) increased Ca2+-sensitivity of force (pCa(50) = 5.59 +/- 0.02) compared to cTn (DD) (pCa(50) = 5.51 +/- 0.02). In contrast, subsequent PKC alpha treatment of the cells exchanged with cTn (DD+PKC alpha) reduced pCa(50) to 5.45 +/- 0.02. Two PKC alpha-phosphorylated residues were identified with mass spectrometry: Ser198 on cTnI and Ser179 on cTnT, although phosphorylation of Ser198 is very low. Using mass spectrometry based-multiple reaction monitoring, the extent of phosphorylation of the cTnI sites was quantified before and after treatment with PKC alpha and showed the highest phosphorylation increase on Thr143. Conclusion: PKC alpha-mediated phosphorylation of the cTn complex decreases F-max and increases myofilament Ca2+-sensitivity, while subsequent treatment with PKC alpha in situ decreased myofilament Ca2+-sensitivity. The known PKC sites as well as two sites which have not been previously linked to PKC alpha are phosphorylated in human cTn complex treated with PKC alpha with a high degree of specificity for Thr143.	[Kooij, Viola; Sequeira, Vasco; Boontje, Nicky M.; Wijnker, Paul J. M.; van der Velden, Jolanda; Stienen, Ger J. M.] Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res, Physiol Lab, Amsterdam, Netherlands; [Kooij, Viola; Zhang, Pingbo; van Eyk, Jennifer E.] Johns Hopkins Univ, Sch Med, Dept Med, Johns Hopkins Bayview Prote Ctr, Baltimore, MD 21205 USA; [Piersma, Sander R.; Jimenez, Connie R.] Vrije Univ Amsterdam Med Ctr, Dept Med Oncol, OncoProte Lab, Amsterdam, Netherlands; [Jaquet, Kornelia E.] Clin Ruhr Univ Bochum, St Josef Hosp Bergmannsheil, Bochum, Germany; [dos Remedios, Cris] Univ Sydney, Inst Biomed Res, Muscle Res Unit, Sydney, NSW 2006, Australia; [Murphy, Anne M.] Johns Hopkins Univ, Sch Med, Dept Pediat, Inst Mol Cardiobiol, Baltimore, MD 21205 USA; [Stienen, Ger J. M.] Vrije Univ Amsterdam, Dept Phys & Astron, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Johns Hopkins University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Ruhr University Bochum; University of Sydney; Johns Hopkins University; Vrije Universiteit Amsterdam	Kooij, V (corresponding author), Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res, Physiol Lab, Amsterdam, Netherlands.	vkooij1@jhmi.edu	Jimenez, Connie/AAI-3763-2020; Sequeira, Vasco/AAU-4724-2020; van der Velden, J/D-1925-2016	Sequeira, Vasco/0000-0002-9192-7674; Jimenez, Connie R/0000-0002-3103-4508; van der Velden, Jolanda/0000-0001-5224-5788; Stienen, Ger/0000-0001-5829-0328	National Institutes of Health [R01 HL 63038]; American Heart Association [12POST11520006]; Netherlands Foundation "De Drie Lichten"; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028180] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Netherlands Foundation "De Drie Lichten"; DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant R01 HL 63038; and in part by American Heart Association post-doctoral fellowship 12POST11520006 (V. K.); and this project has been supported by a travel grant from the Netherlands Foundation "De Drie Lichten:. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barefield D, 2010, J MOL CELL CARDIOL, V48, P866, DOI 10.1016/j.yjmcc.2009.11.014; Belin RJ, 2007, CIRC RES, V101, P195, DOI 10.1161/CIRCRESAHA.107.148288; Bowling N, 1999, CIRCULATION, V99, P384, DOI 10.1161/01.CIR.99.3.384; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Burkart EM, 2003, J BIOL CHEM, V278, P11265, DOI 10.1074/jbc.M210712200; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; Gundry Rebekah L, 2009, Curr Protoc Mol Biol, VChapter 10, DOI 10.1002/0471142727.mb1025s88; Hahn HS, 2003, CIRC RES, V93, P1111, DOI 10.1161/01.RES.0000105087.79373.17; Hambleton M, 2006, CIRCULATION, V114, P574, DOI 10.1161/CIRCULATIONAHA.105.592550; Hidalgo C, 2009, CIRC RES, V105, P631, DOI 10.1161/CIRCRESAHA.109.198465; HOFMANN PA, 1993, CIRC RES, V72, P50, DOI 10.1161/01.RES.72.1.50; Jideama NM, 1996, J BIOL CHEM, V271, P23277, DOI 10.1074/jbc.271.38.23277; Kirk JA, 2009, CIRC RES, V105, P1232, DOI 10.1161/CIRCRESAHA.109.205427; Kooij V, 2010, J MOL CELL CARDIOL, V48, P954, DOI 10.1016/j.yjmcc.2010.01.002; Kooij V, 2010, BASIC RES CARDIOL, V105, P289, DOI 10.1007/s00395-009-0053-z; Layland J, 2005, CARDIOVASC RES, V66, P12, DOI 10.1016/j.cardiores.2004.12.022; McClellan G, 2004, J MOL CELL CARDIOL, V37, P823, DOI 10.1016/j.yjmcc.2004.05.023; Metzger JM, 2004, CIRC RES, V94, P146, DOI 10.1161/01.RES.0000110083.17024.60; Mohamed AS, 1998, ARCH BIOCHEM BIOPHYS, V358, P313, DOI 10.1006/abbi.1998.0857; Narolska NA, 2006, CIRC RES, V99, P1012, DOI 10.1161/01.RES.0000248753.30340.af; NOLAND TA, 1995, J BIOL CHEM, V270, P25445, DOI 10.1074/jbc.270.43.25445; NOLAND TA, 1993, BIOCHEM BIOPH RES CO, V193, P254, DOI 10.1006/bbrc.1993.1617; NOLAND TA, 1989, J BIOL CHEM, V264, P20778; Pyle WG, 2002, AM J PHYSIOL-HEART C, V283, pH1215, DOI 10.1152/ajpheart.00128.2002; Solis RS, 2008, J MUSCLE RES CELL M, V29, P203, DOI 10.1007/s10974-009-9168-y; Steinberg SF, 2012, PHYSIOLOGY, V27, P130, DOI 10.1152/physiol.00009.2012; Sumandea MP, 2003, J BIOL CHEM, V278, P35135, DOI 10.1074/jbc.M306325200; van der Velden J, 2006, CARDIOVASC RES, V69, P876, DOI 10.1016/j.cardiores.2005.11.021; van der Velden J, 1998, CARDIOVASC RES, V38, P414, DOI 10.1016/S0008-6363(98)00019-4; Wang H, 2006, J MOL CELL CARDIOL, V41, P823, DOI 10.1016/j.yjmcc.2006.08.016; Zhang PB, 2012, CIRCULATION, V126, P1828, DOI 10.1161/CIRCULATIONAHA.112.096388	31	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e74847	10.1371/journal.pone.0074847	http://dx.doi.org/10.1371/journal.pone.0074847			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24116014	gold, Green Published, Green Submitted			2022-12-25	WOS:000325501300015
J	Emamgholipour, S; Eshaghi, SM; Hossein-nezhad, A; Mirzaei, K; Maghbooli, Z; Sahraian, MA				Emamgholipour, Solaleh; Eshaghi, Seyede Mahdieh; Hossein-nezhad, Arash; Mirzaei, Khadijeh; Maghbooli, Zhila; Sahraian, Mohammad Ali			Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; REGULATORY T-CELLS; INSULIN-RESISTANCE; BODY-COMPOSITION; ADIPOSE-TISSUE; IMMUNE-SYSTEM; LEPTIN; INFLAMMATION; RECEPTOR; ADIPONECTIN	Background: Adipocytokines may be involved in multiple sclerosis (MS) as well as other autoimmune and inflammatory-related diseases. This study aims to compare levels of resistin, visfatin and leptin in three subgroups of MS patients with healthy subjects and also to study their relationship with Foxp3 expression and levels of several pro-inflammatory mediators such as interleukine-1 beta(IL-1 beta), tumor necrosis factor-alpha (TNF-alpha) and human sensitive C-reactive protein (hs-CRP). Methods: A total of 391 subjects including 200 healthy controls and 191 MS patients were recruited for this case-control study. Circulating adipocytokines and inflammatory mediators were measured using immunoassay methods. Foxp3 gene expression in peripheral blood mononuclear cells (PBMC) was determined by quantitative real-time PCR. Fat tissue mass was evaluated by using dual energy X-ray absorptiometery (DEXA). Results: A significant difference was observed in levels of inflammatory mediators, adipocytokines, Foxp3 gene expression and adipose tissue mass between MS patients and healthy controls. All adipocytokines were positively correlated with levels of inflammatory mediators and negatively correlated with Foxp3 expression in MS patients. In controls, there were positive correlations between circulating leptin and resistin with TNF-alpha and IL-1 beta in subgroup analysis, the highest levels of TNF-alpha, IL-1 beta, hs-CRP, resistin and leptin were observed in primary progressive-MS (PP-MS) patients. Also, expression of Foxp3 and levels of visfatin in relapsing remitting-MS(RR-MS) patients were higher compared with the other subgroups. Conclusions: Our findings suggest the potential role of adipocytokines in pathogenesis and severity of MS. Notably, the relationship of adipocytokines levels with inflammatory cytokines as well as clinical features of MS could be considerable in translational medicine and biomarker studies.	[Emamgholipour, Solaleh] Univ Tehran Med Sci, Sch Med, Dept Clin Biochem, Tehran, Iran; [Eshaghi, Seyede Mahdieh; Hossein-nezhad, Arash] Boston Univ, Med Ctr, Dept Med, Sect Endocrinol Nutr & Diabet,Vitamin D Skin & Bo, Boston, MA USA; [Eshaghi, Seyede Mahdieh; Hossein-nezhad, Arash; Maghbooli, Zhila] Univ Tehran Med Sci, Tehran, Iran; [Mirzaei, Khadijeh] Univ Tehran Med Sci, Sina Hosp, Sch Publ Hlth, Tehran, Iran; [Mirzaei, Khadijeh] Univ Tehran Med Sci, Sina Hosp, Publ Hlth Res Inst, Tehran, Iran; [Sahraian, Mohammad Ali] Univ Tehran Med Sci, Sina Hosp, Sina MS Res Ctr, Dept Neurol, Tehran, Iran	Tehran University of Medical Sciences; Boston University; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences	Hossein-nezhad, A (corresponding author), Boston Univ, Med Ctr, Dept Med, Sect Endocrinol Nutr & Diabet,Vitamin D Skin & Bo, Boston, MA USA.	arash_hsi@yahoo.com	Shirvani, Arash/AAD-6246-2020; Emamgholipour, Solaleh/T-6035-2017; Mirzaei, Khadijeh/D-5408-2018; Shirvani, Arash H/A-2847-2010	Mirzaei, Khadijeh/0000-0003-0231-0478; Shirvani, Arash H/0000-0003-2847-4737; Emamgholipour, Solaleh/0000-0002-9949-5773; Maghbooli, Zhila/0000-0001-8858-6269; Sahraian, Mohammad Ali/0000-0002-3224-8807				Alatab S, 2011, MINERVA MED, V102, P461; Alatab S, 2011, J MOL NEUROSCI, V44, P6, DOI 10.1007/s12031-010-9486-y; Bennett JL, 2009, CLIN NEUROPHARMACOL, V32, P121, DOI 10.1097/WNF.0b013e3181880359; Bettini M, 2009, CURR OPIN IMMUNOL, V21, P612, DOI 10.1016/j.coi.2009.09.011; Bjerg L, 2012, J NEUROIMMUNOL, V249, P76, DOI 10.1016/j.jneuroim.2012.04.012; Bruzzone S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007897; Busso N, 2002, J IMMUNOL, V168, P875, DOI 10.4049/jimmunol.168.2.875; Carbone F, 2012, BIOCHIMIE, V94, P2082, DOI 10.1016/j.biochi.2012.05.018; Chatzantoni K, 2004, J AUTOIMMUN, V23, P169, DOI 10.1016/j.jaut.2004.05.007; Dahl TB, 2012, ANNU REV NUTR, V32, P229, DOI 10.1146/annurev-nutr-071811-150746; De Rosa V, 2007, IMMUNITY, V26, P241, DOI 10.1016/j.immuni.2007.01.011; Della Libera C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019460; Duran I, 2001, MULT SCLER, V7, P151, DOI 10.1177/135245850100700303; Fantuzzi G, 2009, BRAIN BEHAV IMMUN, V23, P405, DOI 10.1016/j.bbi.2008.10.007; Filkova M, 2009, CLIN IMMUNOL, V133, P157, DOI 10.1016/j.clim.2009.07.013; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Frisullo G, 2004, J CLIN IMMUNOL, V24, P287, DOI 10.1023/B:JOCI.0000025450.48267.a5; Fritzsching B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017988; Gove ME, 2009, J LEUKOCYTE BIOL, V85, P491, DOI 10.1189/jlb.0808508; Graber JJ, 2011, J NEUROL SCI, V305, P1, DOI 10.1016/j.jns.2011.03.026; GREGOIRE F, 1992, J CELL PHYSIOL, V151, P300, DOI 10.1002/jcp.1041510211; Gutierrez DA, 2009, CURR DIABETES REP, V9, P26, DOI 10.1007/s11892-009-0006-9; Hagman S, 2011, J NEUROIMMUNOL, V234, P141, DOI 10.1016/j.jneuroim.2011.02.009; Hietaharju A, 2010, EUR J NEUROL, V17, P332, DOI 10.1111/j.1468-1331.2009.02701.x; Hong J, 2009, INT IMMUNOL, V21, P1329, DOI 10.1093/intimm/dxp100; Hubert S, 2010, J EXP MED, V207, P2561, DOI 10.1084/jem.20091154; Kasper LH, 2010, NEUROLOGY, V74, pS2, DOI 10.1212/WNL.0b013e3181c97c8f; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kraszula L, 2012, NEUROL NEUROCHIR POL, V46, P22, DOI 10.5114/ninp.2012.27211; Lagathu C, 2006, DIABETOLOGIA, V49, P2162, DOI 10.1007/s00125-006-0335-z; Lago R, 2008, CELL IMMUNOL, V252, P139, DOI 10.1016/j.cellimm.2007.09.004; Lambert CP, 2002, ARCH PHYS MED REHAB, V83, P1559, DOI 10.1053/apmr.2002.35663; Lassmann H, 2001, TRENDS MOL MED, V7, P115, DOI 10.1016/S1471-4914(00)01909-2; Lee CH, 2005, DIABETES, V54, P2525, DOI 10.2337/diabetes.54.9.2525; Luk T, 2008, J LEUKOCYTE BIOL, V83, P804, DOI 10.1189/jlb.0807581; MacLaren R, 2008, ADV EXP MED BIOL, V632, P1, DOI 10.1007/978-0-387-78952-1_1; Mahler A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043675; Martins TB, 2011, AM J CLIN PATHOL, V136, P696, DOI 10.1309/AJCP7UBK8IBVMVNR; Matarese G, 2005, P NATL ACAD SCI USA, V102, P5150, DOI 10.1073/pnas.0408995102; Matarese G, 2001, J IMMUNOL, V166, P5909, DOI 10.4049/jimmunol.166.10.5909; Mikulkova Z, 2011, J NEUROL SCI, V300, P135, DOI 10.1016/j.jns.2010.08.053; Mirzaei K, 2011, EUR J INFLAMM, V9, P31, DOI 10.1177/1721727X1100900105; Otero M, 2005, FEBS LETT, V579, P295, DOI 10.1016/j.febslet.2004.11.024; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Procaccini C, 2012, MOL ASPECTS MED, V33, P35, DOI 10.1016/j.mam.2011.10.012; Robinson WH, 2003, CURR OPIN IMMUNOL, V15, P660, DOI 10.1016/j.coi.2003.09.015; Rongvaux A, 2008, J IMMUNOL, V181, P4685, DOI 10.4049/jimmunol.181.7.4685; Rovaris M, 2006, LANCET NEUROL, V5, P343, DOI 10.1016/S1474-4422(06)70410-0; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sioka C, 2011, J CLIN DENSITOM, V14, P465, DOI 10.1016/j.jocd.2011.04.012; Stofkova A, 2010, Endocr Regul, V44, P25; Su KG, 2009, CURR NEUROL NEUROSCI, V9, P411, DOI 10.1007/s11910-009-0060-3; Suh SW, 2007, GLIA, V55, P1280, DOI 10.1002/glia.20440; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; van Boxel-Dezaire AHH, 2001, J NEUROIMMUNOL, V120, P152, DOI 10.1016/S0165-5728(01)00398-8; Venken K, 2008, IMMUNOLOGY, V123, P79, DOI 10.1111/j.1365-2567.2007.02690.x; Venken K, 2010, TRENDS MOL MED, V16, P58, DOI 10.1016/j.molmed.2009.12.003; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028	58	49	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76555	10.1371/journal.pone.0076555	http://dx.doi.org/10.1371/journal.pone.0076555			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098530	Green Submitted, Green Published, gold			2022-12-25	WOS:000325483600065
J	Fujimoto, K; Hayashi, A; Kamata, Y; Ogawa, A; Watanabe, T; Ichikawa, R; Iso, Y; Koba, S; Kobayashi, Y; Koyama, T; Shichiri, M				Fujimoto, Kazumi; Hayashi, Akinori; Kamata, Yuji; Ogawa, Akifumi; Watanabe, Takuya; Ichikawa, Raishi; Iso, Yoshitaka; Koba, Shinji; Kobayashi, Youichi; Koyama, Takatoshi; Shichiri, Masayoshi			Circulating Levels of Human salusin-beta,a Potent Hemodynamic and Atherogenesis Regulator	PLOS ONE			English	Article							IDENTIFIED BIOACTIVE PEPTIDES; ALPHA; BETA; SALUSINS; SERUM; ATHEROSCLEROSIS; RELEASE	Using bioinformatics analysis, we previously identified salusin-beta, an endogenous bioactive peptide with diverse physiological activities. Salusin-beta is abundantly expressed in the neuroendocrine system and in systemic endocrine cells/macrophages. Salusin-beta acutely regulates hemodynamics and chronically induces atherosclerosis, but its unique physicochemical characteristics to tightly adhere to all types of plastic and glassware have prevented elucidation of its precise pathophysiological role. To quantitate plasma total salusin-beta concentrations, we produced rabbit and chicken polyclonal antibodies against the C-and N-terminal end sequences, circumvented its sticky nature, and successfully established a sandwich enzyme-linked immunosorbent assay (ELISA). Salusin-beta was abundantly present in the plasma of healthy volunteers, ranging from 1.9 to 6.6 nmol/L. Reverse phase-high performance liquid chromatography analysis showed that a single immunoreactive salusin-beta peak coincided with synthetic authentic salusin-beta. Plasma salusin-beta concentrations were unaffected by postural changes and by potent vasopressin release stimuli, such as hypertonic saline infusion or smoking. However, salusin-beta concentrations showed significant circadian variation; concentrations were high during the daytime and reached the lowest concentrations in the early morning. Plasma salusin-beta levels in subjects with diabetes mellitus, coronary artery disease, and cerebrovascular disease showed distinctly higher levels than healthy controls. Patients with panhypopituitarism combined with complete central diabetes insipidus also showed significantly higher plasma salusin-beta levels. Therefore, the ELISA system developed in this study will be useful for evaluating circulating total salusin-beta levels and for confirming the presence of authentic salusin-beta in human plasma. The obtained results suggest a limited contribution of the neuroendocrine system to peripheral total salusin-beta concentrations and a role for plasma total salusin-beta concentrations as an indicator of systemic vascular diseases.	[Fujimoto, Kazumi; Koyama, Takatoshi] Tokyo Med & Dent Univ, Lab Mol Genet Hematol, Grad Sch Hlth Care Sci, Tokyo, Japan; [Fujimoto, Kazumi; Hayashi, Akinori; Kamata, Yuji; Ogawa, Akifumi; Ichikawa, Raishi; Shichiri, Masayoshi] Kitasato Univ, Sch Med, Dept Endocrinol Diabet & Metab, Kanagawa, Japan; [Watanabe, Takuya] Tokyo Univ Pharm & Life Sci, Lab Cardiovasc Med, Tokyo, Japan; [Iso, Yoshitaka; Koba, Shinji; Kobayashi, Youichi] Showa Univ, Sch Med, Dept Med, Div Cardiol, Tokyo 142, Japan	Tokyo Medical & Dental University (TMDU); Kitasato University; Tokyo University of Pharmacy & Life Sciences; Showa University	Shichiri, M (corresponding author), Kitasato Univ, Sch Med, Dept Endocrinol Diabet & Metab, Kanagawa, Japan.	shichiri@kitasato-u.ac.jp	Hayashi, Akinori/AAD-2469-2020; Koba, Shinji/GZK-2961-2022	Hayashi, Akinori/0000-0002-9946-1004; Shichiri, Masayoshi/0000-0002-5704-1378	Kitasato University Hospital Shogaku-Kifukin	Kitasato University Hospital Shogaku-Kifukin	The study was supported in part by Grant-in-Aid from Kitasato University Hospital Shogaku-Kifukin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Gardiner SM, 2007, NAT MED, V13, P661, DOI 10.1038/nm0607-661a; Izumiyama H, 2005, HYPERTENSION, V45, P419, DOI 10.1161/01.HYP.0000156496.15668.62; Kimoto S, 2010, REGUL PEPTIDES, V162, P129, DOI 10.1016/j.regpep.2010.03.009; Koya T, 2012, AM J PHYSIOL-HEART C, V303, pH96, DOI 10.1152/ajpheart.00009.2012; Nagashima M, 2010, ATHEROSCLEROSIS, V212, P70, DOI 10.1016/j.atherosclerosis.2010.04.027; Saito T, 2008, J NEUROENDOCRINOL, V20, P207, DOI 10.1111/j.1365-2826.2007.01632.x; Sato K, 2006, PEPTIDES, V27, P2561, DOI 10.1016/j.peptides.2006.06.005; Sato K, 2010, REGUL PEPTIDES, V162, P68, DOI 10.1016/j.regpep.2010.02.010; Sato K, 2009, REGUL PEPTIDES, V158, P63, DOI 10.1016/j.regpep.2009.07.017; Sato K, 2008, PEPTIDES, V29, P2203, DOI 10.1016/j.peptides.2008.08.015; Shichiri M, 2003, NAT MED, V9, P1166, DOI 10.1038/nm913; SHICHIRI M, 2008, Patent No. 2010071237; Shichiri M, 2007, NAT MED, V13, P661, DOI 10.1038/nm0607-661b; Suzuki N, 2007, HYPERTENS RES, V30, P1255, DOI 10.1291/hypres.30.1255; Suzuki N, 2011, PEPTIDES, V32, P805, DOI 10.1016/j.peptides.2010.12.012; Takenoya AF, 2005, NEUROSCI LETT, V385, P110, DOI 10.1016/j.neulet.2005.05.061; TI Y, 2011, J HUM HYPERTENS, P45237; Watanabe T, 2008, HYPERTENS RES, V31, P463, DOI 10.1291/hypres.31.463; Watanabe T, 2008, CIRCULATION, V117, P638, DOI 10.1161/CIRCULATIONAHA.107.712539; Watanabe T, 2012, SENSORS-BASEL, V12, P4974, DOI 10.3390/s120404974; Watanabe T, 2011, J AM SOC HYPERTENS, V5, P359, DOI 10.1016/j.jash.2011.06.003	21	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76714	10.1371/journal.pone.0076714	http://dx.doi.org/10.1371/journal.pone.0076714			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098553	Green Published, gold, Green Submitted			2022-12-25	WOS:000325483600072
J	Koehler, BC; Scherr, AL; Lorenz, S; Urbanik, T; Kautz, N; Elssner, C; Welte, S; Bermejo, JL; Jager, D; Schulze-Bergkamen, H				Koehler, Bruno Christian; Scherr, Anna-Lena; Lorenz, Stephan; Urbanik, Toni; Kautz, Nicole; Elssner, Christin; Welte, Stefan; Bermejo, Justo Lorenzo; Jaeger, Dirk; Schulze-Bergkamen, Henning			Beyond Cell Death - Antiapoptotic Bcl-2 Proteins Regulate Migration and Invasion of Colorectal Cancer Cells In Vitro	PLOS ONE			English	Article							BREAST-CANCER; APOPTOSIS RESISTANCE; OBATOCLAX MESYLATE; METASTASIS; FAMILY; AUTOPHAGY; LIFE; XL; OVEREXPRESSION; PROGRESSION	Migration and invasion of malignant cells are prerequisites for cancer progression and metastasis. The Bcl-2 family of proteins consists of about 25 members and has been extensively studied in the context of apoptosis. Despite the fact that small molecules targeting Bcl-2 proteins have already entered clinical trials, very few studies investigated a role of antiapoptotic Bcl-2 proteins beside cell death in the context of metastasis. The aim of this study was to dissect a potential role of the antiapoptotic Bcl-2 proteins Mcl-1, Bcl-2 and Bcl-xL on migration and invasion of colorectal cancer cells independent of their cell death control function. We used migration and invasion assays as well as three dimensional cell cultures to analyze colorectal cancer cell lines (HT29 and SW480) after siRNA mediated knockdown or overexpression of Mcl-1, Bcl-2 or Bcl-xL. We observed neither spontaneous cell death induction nor impaired proliferation of cells lacking Mcl-1, Bcl-2 or Bcl-xL. In contrast, knockdown of Mcl-1 led to increased proliferation. Strikingly, we demonstrate a profound impairment of both, migration and invasion, of colorectal cancer cells after Mcl-1, Bcl-2 or Bcl-xL knockdown. This phenotype was completely revised in cells overexpressing Mcl-1, Bcl-2 or Bcl-xL. The most pronounced effect among the investigated proteins was observed for Bcl-2. The data presented indicate a pivotal role of Mcl-1, Bcl-2 and Bcl-xL for migration and invasion of colorectal cancer cells independent of their known antiapoptotic effects. Thus, our study illustrates novel antitumoral mechanisms of Bcl-2 protein targeting.	[Koehler, Bruno Christian; Scherr, Anna-Lena; Lorenz, Stephan; Urbanik, Toni; Kautz, Nicole; Elssner, Christin; Welte, Stefan; Jaeger, Dirk; Schulze-Bergkamen, Henning] Univ Heidelberg Hosp, Dept Med Oncol, Natl Ctr Tumor Dis, Heidelberg, Germany; [Bermejo, Justo Lorenzo] Univ Heidelberg Hosp, Inst Med Biometry & Informat, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Koehler, BC (corresponding author), Univ Heidelberg Hosp, Dept Med Oncol, Natl Ctr Tumor Dis, Heidelberg, Germany.	bruno.koehler@nct-heidelberg.de		Lorenzo Bermejo, Justo/0000-0002-6568-5333	Medical Faculty of the University of Heidelberg, Germany; German Research Foundation (Deutsche Forschungsgemeinschaft) [DFG SCHU 1443/4-1]; Merck Serono GmbH (Darmstadt, Germany)	Medical Faculty of the University of Heidelberg, Germany; German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Merck Serono GmbH (Darmstadt, Germany)	This study was supported by a Postdoctoral-Fellowship granted to BCK from the Medical Faculty of the University of Heidelberg, Germany (http://www.medizinische-fakultaet-hd.uni-heidelberg.de), and grants to HSB from the German Research Foundation (Deutsche Forschungsgemeinschaft, http://www.dfg.de/, DFG SCHU 1443/4-1) and from Merck Serono GmbH (Darmstadt, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2011, INT J ONCOL, V38, P71, DOI 10.3892/ijo_00000825; Alderton GK, 2013, NAT REV CANCER, V13, P3, DOI 10.1038/nrc3428; Bokhari M, 2007, J ANAT, V211, P567, DOI 10.1111/j.1469-7580.2007.00778.x; Buglioni S, 1999, INT J CANCER, V84, P545, DOI 10.1002/(SICI)1097-0215(19991222)84:6<545::AID-IJC1>3.0.CO;2-2; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Cragg MS, 2009, NAT REV CANCER, V9, P321, DOI 10.1038/nrc2615; DelBufalo D, 1997, FASEB J, V11, P947, DOI 10.1096/fasebj.11.12.9337147; DEVRIES JE, 1995, BRIT J CANCER, V71, P271, DOI 10.1038/bjc.1995.55; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Dubois F, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2357174; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fernandez Y, 2002, INT J CANCER, V101, P317, DOI 10.1002/ijc.10628; Fujise K, 2000, J BIOL CHEM, V275, P39458, DOI 10.1074/jbc.M006626200; Glinsky GV, 1997, CANCER LETT, V115, P185, DOI 10.1016/S0304-3835(97)04738-1; Goard CA, 2013, CORE EVID, V8, P15, DOI 10.2147/CE.S42568; Gordy C, 2012, PROTEIN CELL, V3, P17, DOI 10.1007/s13238-011-1127-x; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Henderson-Jackson EB, 2010, INT J CLIN EXP PATHO, V3, P768; Janumyan YM, 2003, EMBO J, V22, P5459, DOI 10.1093/emboj/cdg533; Joudeh J, 2012, EXPERT OPIN INV DRUG, V21, P363, DOI 10.1517/13543784.2012.652302; Koehler BC, 2009, WORLD J GASTROENTERO, V15, P5924, DOI 10.3748/wjg.15.5924; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; Krishna S, 2011, BIOCHEM J, V435, P545, DOI 10.1042/BJ20101996; Labi V, 2008, CELL DEATH DIFFER, V15, P977, DOI 10.1038/cdd.2008.37; Laulier C, 2012, MUTAT RES-REV MUTAT, V751, P247, DOI 10.1016/j.mrrev.2012.05.002; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Liu YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038000; Low ICC, 2011, ANTIOXID REDOX SIGN, V15, P2975, DOI 10.1089/ars.2010.3851; Martin SS, 2004, ONCOGENE, V23, P4641, DOI 10.1038/sj.onc.1207595; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Mitry E, 2002, BRIT J SURG, V89, P1557, DOI 10.1046/j.1365-2168.2002.02276.x; Ni F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038802; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Olopade OI, 1997, CANCER J SCI AM, V3, P230; Perciavalle RM, 2012, NAT CELL BIOL, V14, P575, DOI 10.1038/ncb2488; Schulze-Bergkamen H, 2008, WORLD J GASTROENTERO, V14, P3829, DOI 10.3748/wjg.14.3829; Schutte M, 2011, ASSAY DRUG DEV TECHN, V9, P475, DOI 10.1089/adt.2011.0371; Sethi N, 2011, NAT REV CANCER, V11, P735, DOI 10.1038/nrc3125; Tischner D, 2012, APOPTOSIS, V17, P1197, DOI 10.1007/s10495-012-0756-8; Um JH, 2004, J PHARMACOL EXP THER, V311, P1062, DOI 10.1124/jpet.104.070938; Wanebo HJ, 2012, CLIN EXP METASTAS, V29, P821, DOI 10.1007/s10585-012-9517-x; Wick W, 2001, J NEURO-ONCOL, V53, P177, DOI 10.1023/A:1012209518843; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Yang JS, 2011, ACTA HISTOCHEM, V113, P810, DOI 10.1016/j.acthis.2011.01.002; Yang JS, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-117; Zhou FF, 2011, FEBS J, V278, P403, DOI 10.1111/j.1742-4658.2010.07965.x; Zinkel SS, 2008, METHOD ENZYMOL, V442, P231, DOI 10.1016/S0076-6879(08)01412-2	48	70	72	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76446	10.1371/journal.pone.0076446	http://dx.doi.org/10.1371/journal.pone.0076446			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098503	Green Published, gold, Green Submitted			2022-12-25	WOS:000325483600053
J	Qian, ZH; Dominguez, SR; Holmes, KV				Qian, Zhaohui; Dominguez, Samuel R.; Holmes, Kathryn V.			Role of the Spike Glycoprotein of Human Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Virus Entry and Syncytia Formation	PLOS ONE			English	Article							RECEPTOR-INDEPENDENT INFECTION; MURINE CORONAVIRUS; CATHEPSIN-L; FUNCTIONAL RECEPTOR; AMINOPEPTIDASE-N; INFLUENZA-VIRUS; PROTEIN; TMPRSS2; FUSION; MECHANISMS	Little is known about the biology of the emerging human group c betacoronavirus, Middle East Respiratory Syndrome coronavirus (MERS-CoV). Because coronavirus spike glycoproteins (S) mediate virus entry, affect viral host range, and elicit neutralizing antibodies, analyzing the functions of MERS-CoV S protein is a high research priority. MERS-CoV S on lentivirus pseudovirions mediated entry into a variety of cell types including embryo cells from New World Eptesicus fuscus bats. Surprisingly, a polyclonal antibody to the S protein of MHV, a group a murine betacoronavirus, cross-reacted in immunoblots with the S2 domain of group c MERS-CoV spike protein. MERS pseudovirions released from 293T cells contained only uncleaved S, and pseudovirus entry was blocked by lysosomotropic reagents NH4Cl and bafilomycin and inhibitors of cathepsin L. However, when MERS pseudovirions with uncleaved S protein were adsorbed at 4 degrees C to Vero E6 cells, brief trypsin treatment at neutral pH triggered virus entry at the plasma membrane and syncytia formation. When 293T cells producing MERS pseudotypes co-expressed serine proteases TMPRSS-2 or -4, large syncytia formed at neutral pH, and the pseudovirions produced were non-infectious and deficient in S protein. These experiments show that if S protein on MERS pseudovirions is uncleaved, then viruses enter by endocytosis in a cathepsin L-dependent manner, but if MERS-CoV S is cleaved, either during virus maturation by serine proteases or on pseudovirions by trypsin in extracellular fluids, then viruses enter at the plasma membrane at neutral pH and cause massive syncytia formation even in cells that express little or no MERS-CoV receptor. Thus, whether MERS-CoV enters cells within endosomes or at the plasma membrane depends upon the host cell type and tissue, and is determined by the location of host proteases that cleave the viral spike glycoprotein and activate membrane fusion.	[Qian, Zhaohui; Dominguez, Samuel R.; Holmes, Kathryn V.] Univ Colorado, Sch Med, Dept Microbiol, Aurora, CO 80045 USA; [Qian, Zhaohui] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100730, Peoples R China; [Qian, Zhaohui] Peking Union Med Coll, Beijing 100021, Peoples R China; [Dominguez, Samuel R.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Colorado System; University of Colorado Anschutz Medical Campus	Holmes, KV (corresponding author), Univ Colorado, Sch Med, Dept Microbiol, Aurora, CO 80045 USA.	kathryn.holmes@ucdenver.edu	Qian, Zhaohui/AFR-9488-2022	Qian, Zhaohui/0000-0003-4116-4450	State of Colorado Bioscience Discovery Evaluation Grant Program [HB-07-1001]; NIH [K08 AI-073525]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI073525] Funding Source: NIH RePORTER	State of Colorado Bioscience Discovery Evaluation Grant Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the State of Colorado Bioscience Discovery Evaluation Grant Program (HB-07-1001) and NIH grant K08 AI-073525 to SRD. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Annan A, 2013, EMERG INFECT DIS, V19, P456, DOI 10.3201/eid1903.121503; [Anonymous], 2013, MIDDL E RESP SYNDR C; Anthony SJ, 2013, J GEN VIROL, V94, P1028, DOI 10.1099/vir.0.049759-0; Baron J, 2013, J VIROL, V87, P1811, DOI 10.1128/JVI.02320-12; Belouzard S, 2012, VIRUSES-BASEL, V4, P1011, DOI 10.3390/v4061011; Bertram S, 2010, J VIROL, V84, P10016, DOI 10.1128/JVI.00239-10; Bosch BJ, 2004, P NATL ACAD SCI USA, V101, P8455, DOI 10.1073/pnas.0400576101; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; Carrington CVF, 2008, EMERG INFECT DIS, V14, P1890, DOI 10.3201/eid1412.080642; Chan JFW, 2013, J INFECT DIS, V207, P1743, DOI 10.1093/infdis/jit123; Chan KH, 2013, J INFECT; Chan RW, 2013, J VIROL; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; DELMAS B, 1992, NATURE, V357, P417, DOI 10.1038/357417a0; Dominguez SR, 2007, EMERG INFECT DIS, V13, P1295, DOI 10.3201/eid1309.070491; DOMS RW, 1985, J BIOL CHEM, V260, P2973; Donaldson EF, 2010, J VIROL, V84, P13004, DOI 10.1128/JVI.01255-10; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; DVEKSLER GS, 1991, J VIROL, V65, P6881, DOI 10.1128/JVI.65.12.6881-6891.1991; Ebert DH, 2002, J BIOL CHEM, V277, P24609, DOI 10.1074/jbc.M201107200; FRANA MF, 1985, J VIROL, V56, P912, DOI 10.1128/JVI.56.3.912-920.1985; GALLAGHER TM, 1992, VIROLOGY, V191, P517, DOI 10.1016/0042-6822(92)90223-C; Gierer S, 2013, J VIROL, V87, P5502, DOI 10.1128/JVI.00128-13; Giroglou T, 2004, J VIROL, V78, P9007, DOI 10.1128/JVI.78.17.9007-9015.2004; Glowacka I, 2011, J VIROL, V85, P4122, DOI 10.1128/JVI.02232-10; Graham RL, 2010, J VIROL, V84, P3134, DOI 10.1128/JVI.01394-09; Gramberg T, 2005, VIROLOGY, V340, P224, DOI 10.1016/j.virol.2005.06.026; GrayOwen SD, 1997, EMBO J, V16, P3435, DOI 10.1093/emboj/16.12.3435; Heald-Sargent T, 2012, VIRUSES-BASEL, V4, P557, DOI 10.3390/v4040557; Holmes KV, 2013, MBIO, V4, DOI 10.1128/mBio.00548-12; Howard MW, 2008, J VIROL, V82, P2883, DOI 10.1128/JVI.01805-07; Huang IC, 2006, J BIOL CHEM, V281, P3198, DOI 10.1074/jbc.M508381200; Huynh J, 2012, J VIROL, V86, P12816, DOI 10.1128/JVI.00906-12; Jeffers SA, 2004, P NATL ACAD SCI USA, V101, P15748, DOI 10.1073/pnas.0403812101; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kawase M, 2009, J VIROL, V83, P712, DOI 10.1128/JVI.01933-08; Kindler E, 2013, MBIO, V4, DOI 10.1128/mBio.00611-12; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Li F, 2010, CELL STEM CELL, V7, P508, DOI 10.1016/j.stem.2010.09.003; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; LIFSON JD, 1986, NATURE, V323, P725, DOI 10.1038/323725a0; Lontok E, 2004, J VIROL, V78, P5913, DOI 10.1128/JVI.78.11.5913-5922.2004; LOOK AT, 1989, J CLIN INVEST, V83, P1299, DOI 10.1172/JCI114015; Matsuyama S, 2010, J VIROL, V84, P12658, DOI 10.1128/JVI.01542-10; Miura TA, 2008, J VIROL, V82, P755, DOI 10.1128/JVI.01851-07; Mothes W, 2000, CELL, V103, P679, DOI 10.1016/S0092-8674(00)00170-7; Muller MA, 2012, MBIO, V3, DOI 10.1128/mBio.00515-12; Ontiveros E, 2003, J VIROL, V77, P10260, DOI 10.1128/JVI.77.19.10260-10269.2003; Osborne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019156; Peng GQ, 2012, J BIOL CHEM, V287, P41931, DOI 10.1074/jbc.M112.418210; Pfefferle S, 2009, EMERG INFECT DIS, V15, P1377, DOI 10.3201/eid1509.090224; Qian ZH, 2004, J VIROL, V78, P5766, DOI 10.1128/JVI.78.11.5766-5772.2004; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Rockx B, 2010, J INFECT DIS, V201, P946, DOI 10.1086/651022; Shirogane Y, 2008, J VIROL, V82, P8942, DOI 10.1128/JVI.00676-08; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Simmons G, 2004, P NATL ACAD SCI USA, V101, P4240, DOI 10.1073/pnas.0306446101; STURMAN LS, 1980, J VIROL, V33, P449, DOI 10.1128/JVI.33.1.449-462.1980; Tresnan DB, 1996, J VIROL, V70, P8669, DOI 10.1128/JVI.70.12.8669-8674.1996; Tripet B, 2007, J CHROMATOGR A, V1141, P212, DOI 10.1016/j.chroma.2006.12.024; van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12; Vijgen L, 2005, J VIROL, V79, P1595, DOI 10.1128/JVI.79.3.1595-1604.2005; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Woo PCY, 2007, J VIROL, V81, P1574, DOI 10.1128/JVI.02182-06; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zelus BD, 2003, J VIROL, V77, P830, DOI 10.1128/JVI.77.2.830-840.2003	68	129	137	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76469	10.1371/journal.pone.0076469	http://dx.doi.org/10.1371/journal.pone.0076469			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098509	gold, Green Published, Green Submitted			2022-12-25	WOS:000325483600057
J	Li, M; Chen, SC; Zheng, HL; Chen, DH; Zhu, MH; Wang, W; Liu, F; Zhang, CY				Li, Meng; Chen, Shicai; Zheng, Hongliang; Chen, Donghui; Zhu, Minhui; Wang, Wei; Liu, Fei; Zhang, Caiyun			Reinnervation of Bilateral Posterior Cricoarytenoid Muscles Using the Left Phrenic Nerve in Patients with Bilateral Vocal Fold Paralysis	PLOS ONE			English	Article							LARYNGEAL REINNERVATION; INNERVATION; PEDICLE; BRANCH; GRAFT	Objective: To evaluate the feasibility, effectiveness, and safety of reinnervation of the bilateral posterior cricoarytenoid (PCA) muscles using the left phrenic nerve in patients with bilateral vocal fold paralysis. Methods: Forty-four patients with bilateral vocal fold paralysis who underwent reinnervation of the bilateral PCA muscles using the left phrenic nerve were enrolled in this study. Videostroboscopy, perceptual evaluation, acoustic analysis, maximum phonation time, pulmonary function testing, and laryngeal electromyography were performed preoperatively and postoperatively. Patients were followed-up for at least 1 year after surgery. Results: Videostroboscopy showed that within 1 year after reinnervation, abductive movement could be observed in the left vocal folds of 87% of patients and the right vocal folds of 72% of patients. Abductive excursion on the left side was significantly larger than that on the right side (P < 0.05); most of the vocal function parameters were improved postoperatively compared with the preoperative parameters, albeit without a significant difference (P > 0.05). No patients developed immediate dyspnea after surgery, and the pulmonary function parameters recovered to normal reference value levels within 1 year. Postoperative laryngeal electromyography confirmed successful reinnervation of the bilateral PCA muscles. Eighty-seven percent of patients in this series were decannulated and did not show obvious dyspnea after physical activity. Those who were decannulated after subsequent arytenoidectomy were not included in calculating the success rate of decannulation. Conclusions: Reinnervation of the bilateral PCA muscles using the left phrenic nerve can restore inspiratory vocal fold abduction to a physiologically satisfactory extent while preserving phonatory function at the preoperative level without evident morbidity.	[Li, Meng; Chen, Shicai; Zheng, Hongliang; Chen, Donghui; Zhu, Minhui; Wang, Wei; Liu, Fei; Zhang, Caiyun] Second Mil Med Univ, Dept Otolaryngol Head & Neck Surg, Changhai Hosp, Shanghai, Peoples R China	Naval Medical University	Zheng, HL (corresponding author), Second Mil Med Univ, Dept Otolaryngol Head & Neck Surg, Changhai Hosp, Shanghai, Peoples R China.	zheng_hl2004@163.com		Li, Meng/0000-0001-8502-7621	National Natural Science Foundation of China [81100724, 81170899, 81070774]; Science and Technology Commission of Shanghai Municipality [10XD1405500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by Grant No. 81100724, 81170899, 81070774 for science research from National Natural Science Foundation of China, and Grant No. 10XD1405500 from the Science and Technology Commission of Shanghai Municipality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDISSERA F, 1989, LARYNGOSCOPE, V99, P1286; Chen DH, 2011, LARYNGOSCOPE, V121, P1035, DOI 10.1002/lary.21739; Chen Shi-cai, 2004, Zhonghua Er Bi Yan Hou Ke Za Zhi, V39, P464; CRUMLEY RL, 1982, LARYNGOSCOPE, V92, P1, DOI 10.1288/00005537-198209001-00001; CRUMLEY RL, 1983, LARYNGOSCOPE, V93, P425; CRUMLEY RL, 1980, OTOLARYNG HEAD NECK, V88, P159, DOI 10.1177/019459988008800212; Crumley RL, 2000, ANN OTO RHINOL LARYN, V109, P365, DOI 10.1177/000348940010900405; CRUMLEY RL, 1984, ANN OTO RHINOL LARYN, V93, P351, DOI 10.1177/000348948409300414; DOYLE PJ, 1993, ANN OTO RHINOL LARYN, V102, P837, DOI 10.1177/000348949310201103; ELIES W, 1992, LARYNGO RHINO OTOL, V71, P35, DOI 10.1055/s-2007-997241; FACKLER CD, 1967, J APPL PHYSIOL, V23, P923, DOI 10.1152/jappl.1967.23.6.923; FATA JJ, 1987, ANN OTO RHINOL LARYN, V96, P479, DOI 10.1177/000348948709600501; GREEN DC, 1992, LARYNGOSCOPE, V102, P14; Kwak PE, 2010, LARYNGOSCOPE, V120, P463, DOI 10.1002/lary.20752; Lorenz RR, 2008, ANN OTO RHINOL LARYN, V117, P40, DOI 10.1177/000348940811700109; Luedemann W, 2002, J NEUROSURG, V96, P523, DOI 10.3171/jns.2002.96.3.0523; MANIGLIA AJ, 1989, ANN OTO RHINOL LARYN, V98, P907, DOI 10.1177/000348948909801113; Maranillo E, 2003, LARYNGOSCOPE, V113, P602, DOI 10.1097/00005537-200304000-00004; Marie JP, 2010, SURGERY OF LARYNX AND TRACHEA, P279, DOI 10.1007/978-3-540-79136-2_16; MARIE JP, 1989, ANN OTO RHINOL LARYN, V98, P530, DOI 10.1177/000348948909800707; Marina MB, 2011, CURR OPIN OTOLARYNGO, V19, P434, DOI 10.1097/MOO.0b013e32834c7d30; Misiolek M, 2007, EUR ARCH OTO-RHINO-L, V264, P895, DOI 10.1007/s00405-007-0288-y; Paniello RC, 2004, OTOLARYNG CLIN N AM, V37, P161, DOI 10.1016/S0030-6665(03)00164-6; Paniello RC, 2001, ANN OTO RHINOL LARYN, V110, P532, DOI 10.1177/000348940111000607; Banzatto MGP, 2010, INT J PEDIATR OTORHI, V74, P860, DOI 10.1016/j.ijporl.2010.04.012; Rosen CA, 2005, LARYNGOSCOPE, V115, P423, DOI 10.1097/01.mlg.0000157830.38627.85; SANDERS I, 1993, ARCH OTOLARYNGOL, V119, P934; Shiotani A, 2001, LARYNGOSCOPE, V111, P472, DOI 10.1097/00005537-200103000-00017; Toth A, 2005, OTOLARYNG HEAD NECK, V132, P701, DOI 10.1016/j.otohns.2005.01.045; TUCKER HM, 1989, ANN OTO RHINOL LARYN, V98, P674, DOI 10.1177/000348948909800903; TUCKER HM, 1970, ARCHIV OTOLARYNGOL, V92, P530; van Lith-Bijl JT, 1998, ARCH OTOLARYNGOL, V124, P393, DOI 10.1001/archotol.124.4.393; VanLithBijl JT, 1997, ARCH OTOLARYNGOL, V123, P406; Wang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019128; WU H, 1990, J MED COLL PLA, V5, P95; Wu YZ, 2004, ARCH OTOLARYNGOL, V130, P1070, DOI 10.1001/archotol.130.9.1070; Xu WD, 2005, J NEUROSURG, V103, P464, DOI 10.3171/jns.2005.103.3.0464; Xu Wei, 2006, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V41, P408; Zabrodsky M, 2012, ACTA OTORHINOLARYNGO, V32, P222; Zheng HL, 1998, OTOLARYNG HEAD NECK, V119, P540, DOI 10.1016/S0194-5998(98)70122-6; Zheng Hongliang, 2002, Zhonghua Er Bi Yan Hou Ke Za Zhi, V37, P210	41	17	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e77233	10.1371/journal.pone.0077233	http://dx.doi.org/10.1371/journal.pone.0077233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098581	gold, Green Published, Green Submitted			2022-12-25	WOS:000325434500097
J	Aguilera, O; Lundberg, J; Birindelli, J; Perez, MS; Jaramillo, C; Sanchez-Villagra, MR				Aguilera, Orangel; Lundberg, John; Birindelli, Jose; Perez, Mark Sabaj; Jaramillo, Carlos; Sanchez-Villagra, Marcelo R.			Palaeontological Evidence for the Last Temporal Occurrence of the Ancient Western Amazonian River Outflow into the Caribbean	PLOS ONE			English	Article							ANDEAN TECTONICS; EARLY MIOCENE; FALCON STATE; BASIN; SILURIFORMES; VENEZUELA; NEOGENE; URUMACO; SEDIMENTATION; CATFISHES	Fossil catfishes from fluvio-lacustrine facies of late Miocene Urumaco, early Pliocene Castilletes and late Pliocene San Gregorio formations provide evidence of a hydrographic connection in what is today desert regions of northern Colombia and Venezuela. New discoveries and reevaluation of existing materials leads to the recognition of two new records of the pimelodid Brachyplatystoma cf. vaillantii, and of three distinct doradid taxa: Doraops sp., Rhinodoras sp., and an unidentified third form. The presence of fossil goliath long-whiskered catfishes and thorny catfishes are indicative of the persistence of a fluvial drainage system inflow into the South Caribbean during the Pliocene/Pleistocene boundary, complementary to the previous western Amazonian hydrographic system described from the Middle Miocene Villavieja Formation in central Colombia and Late Miocene Urumaco Formation in northwestern Venezuela. The Pliocene Castilletes and San Gregorio formations potentially represent the last lithostratigraphic units related with an ancient western Amazonian fish fauna and that drainage system in the Caribbean. Alternatively, it may preserve faunas from a smaller, peripheral river basin that was cut off earlier from the Amazon-Orinoco, today found in the Maracaibo basin and the Magdalena Rivers.	[Aguilera, Orangel] Univ Fed Fluminense, Inst Biol, Programa Posgrad Biol Marinha, Rio De Janeiro, Brazil; [Lundberg, John; Perez, Mark Sabaj] Acad Nat Sci Philadelphia, Dept Ichthyol, Philadelphia, PA 19103 USA; [Birindelli, Jose] Univ Estadual Londrina, Dept Biol Anim & Vegetal, Londrina, Parana, Brazil; [Jaramillo, Carlos] Smithsonian Trop Res Inst, Ancon, Panama, Panama; [Sanchez-Villagra, Marcelo R.] Univ Zurich, Palaeontol Inst & Museum, Zurich, Switzerland	Universidade Federal Fluminense; Drexel University; Universidade Estadual de Londrina; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Zurich	Sanchez-Villagra, MR (corresponding author), Univ Zurich, Palaeontol Inst & Museum, Zurich, Switzerland.	m.sanchez@pim.uzh.ch	Birindelli, Jose LO/F-4991-2015; Aguilera, Orangel/D-5055-2013; Birindelli, José L.O./AAS-7096-2020	Birindelli, José L.O./0000-0001-9646-9636; Sanchez-Villagra, Marcelo Ricardo/0000-0001-7587-3648; Aguilera, Orangel/0000-0003-4418-8351	Museum Paraense Emilio Goeldi (MPEG); Universidade Federal Fluminense (UFF); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil [CNPq 311783/2011-2]; Universidad Francisco de Miranda (UNEFM) in Venezuela; Smithsonian Tropical Research Institute (STRI) in Panama; U.S. National Science Foundation [DEB-1257813, DEB-0315963]; Swiss National Science Foundation Sinergia [CRSII3-136293]; Direct For Biological Sciences [1257813] Funding Source: National Science Foundation	Museum Paraense Emilio Goeldi (MPEG); Universidade Federal Fluminense (UFF); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Universidad Francisco de Miranda (UNEFM) in Venezuela; Smithsonian Tropical Research Institute (STRI) in Panama; U.S. National Science Foundation(National Science Foundation (NSF)); Swiss National Science Foundation Sinergia(Swiss National Science Foundation (SNSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the Museum Paraense Emilio Goeldi (MPEG)(http://www.museu-goeldi.br/), the Universidade Federal Fluminense (UFF)(http://www.uff.br/), the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Process CNPq 311783/2011-2 to OA) in Brazil (http://www.cnpq.br/), the Universidad Francisco de Miranda (UNEFM) in Venezuela (www.unefm.edu.ve), the Smithsonian Tropical Research Institute (STRI) in Panama (http://www.stri.si.edu), and the U.S. National Science Foundation (DEB-1257813 and DEB-0315963, All Catfish Species Inventory) (http://www.nsf.gov/). Marcelo R. Sanchez-Villagra was supported by the Swiss National Science Foundation Sinergia (CRSII3-136293)(www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera O.A., 2004, TESOROS PALEONTOLOGI; Aguilera OA, 2008, PALAEONTOL Z, V82, P231, DOI 10.1007/BF02988412; Aguilera Orangel Antonio, 2013, Swiss Journal of Palaeontology, V132, P45, DOI 10.1007/s13358-013-0052-4; Albert JS, 2006, J S AM EARTH SCI, V21, P14, DOI 10.1016/j.jsames.2005.07.010; Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P1; Arce HM, 2013, MOL PHYLOGENET EVOL, V67, P560, DOI 10.1016/j.ympev.2013.02.021; Audemard FA, 1999, TECTONOPHYSICS, V308, P23, DOI 10.1016/S0040-1951(99)00081-5; Berg L.S., 1940, TRAVAUX I ZOOLOGIQUE, V5, P1; Betancur-R R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011566; Birindelli J. L. O., 2010, THESIS U SAO PAULO S; Birindelli JLO, 2008, NEOTROP ICHTHYOL, V6, P465, DOI 10.1590/S1679-62252008000300020; Bleeker, 1862, ATLAS ICHTHYOLOGIQUE, VII; BORDYNE B, 1974, THESIS LOUISIANA STA; Burgl H., 1960, Boletin Geologico Instituto Geologico Nacional Colombia, V6, P129; Campbell KE, 2006, PALAEOGEOGR PALAEOCL, V239, P166, DOI 10.1016/j.palaeo.2006.01.020; Chardon M., 1968, Annls Mus r Afr cent (Ser Zool), VNo. 169, P1; Cushman JA, 1919, FOSSIL FORAMINIFERA, V291, P21; deGamero MLD, 1996, PALAEOGEOGR PALAEOCL, V123, P385, DOI 10.1016/0031-0182(96)00115-0; Estratigrafico de Lexico, 1997, LEXICO ESTRATIGRAFIC, V12, P1; Figueiredo J, 2009, GEOLOGY, V37, P619, DOI 10.1130/G25567A.1; Frailey C.D., 1986, CONTRIBUTIONS SCI NA, V374, P1; Garner AH, 1926, AM MIN METALL ENG T, P677; GAYET M, 1990, Journal of African Zoology, V104, P241; GIEGENGACK R, 1984, GEOL SOC AM MEM, V162, P343; Vucetich MG, 2010, J MAMM EVOL, V17, P265, DOI 10.1007/s10914-010-9142-x; Guzman J, 2006, AAPG BULL, P625; Hedberg HD, 1937, B GEOL MIN VENEZUELA, V1, P73; Higgs R., 2008, AAPG ANN CONV SAN AN; HOORN C, 1993, PALAEOGEOGR PALAEOCL, V105, P267, DOI 10.1016/0031-0182(93)90087-Y; HOORN C, 1995, GEOLOGY, V23, P237, DOI 10.1130/0091-7613(1995)023<0237:ATAACF>2.3.CO;2; Hoorn C, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P1; HOORN C, 1994, PALAEOGEOGR PALAEOCL, V109, P1, DOI 10.1016/0031-0182(94)90117-1; Hovikoski J, 2005, GEOLOGY, V33, P177, DOI 10.1130/G21102.1; Irving E.M., 1972, MAPA GEOLOGICO PENIN; Jaramillo C, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P317; Johnson KG, 2009, PALAIOS, V24, P59, DOI 10.2110/palo.2008.p08-004r; Kay R., 1997, VERTEBRATE PALEONTOL; KELLOGG JN, 1984, GEOL SOC AM MEM, V162, P239; Kullander SO., 2003, CHECK LIST FRESHWATE, P437; Lund Judith H., 2010, AMERICAN OFFSHORE WH, P1; Lundberg JG, 2005, COPEIA, P492; Lundberg John G., 1998, P13; Lundberg John G., 2005, Neotrop. ichthyol., V3, P597, DOI 10.1590/S1679-62252005000400017; Lundberg John G., 2003, Neotrop. ichthyol., V1, P97, DOI 10.1590/S1679-62252003000200004; Lundberg John G., 1997, P67; MACELLARI CE, 1995, AAPG MEMOIR, V62, P757; Ministerio de Energia y Minas, 1997, B GEOLOGICO PUBLICAC, V12, P1; Nogueira A.C.R., 2008, SCI AM BRASIL, P22; Perez MHS, 2007, P ACAD NAT SCI PHILA, V156, P157, DOI 10.1635/0097-3157(2007)156[157:FCOTFD]2.0.CO;2; Potter PE, 1997, J S AM EARTH SCI, V10, P331, DOI 10.1016/S0895-9811(97)00031-X; Quiroz L.I, 2010, URUMACO VENEZUELAN P, P153; Renz O., 1960, B GEOLOGICO PUBLICAC, V3, P317; Restrepo JD, 2000, J HYDROL, V235, P137, DOI 10.1016/S0022-1694(00)00269-9; Ribas CC, 2012, P ROY SOC B-BIOL SCI, V279, P681, DOI 10.1098/rspb.2011.1120; Rod E, 1981, GEOS, V26, P54; Roddaz M, 2005, TECTONOPHYSICS, V399, P87, DOI 10.1016/j.tecto.2004.12.017; Roddaz M, 2005, EARTH PLANET SC LETT, V239, P57, DOI 10.1016/j.epsl.2005.08.007; Rollins J. F., 1965, University of Nebraska Studies NS, VNo. 30, P1; Rossetti DD, 2005, QUATERNARY RES, V63, P78, DOI 10.1016/j.yqres.2004.10.001; Sabaj M.H., 2003, CHECK LIST FRESHWATE, P456; Sanchez-Villagra MR, 2006, J SYST PALAEONTOL, V4, P213, DOI 10.1017/S1477201906001829; Sanchez-Villagra MR., 2010, URUMACO VENEZUELAN P; Scheyer TM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2940; Schultz Leonard P., 1944, PROC U S NATION MUS, V94, P173; Shephard GE, 2010, MIOCENE DRAINAGE AMA, DOI [10.1038/NGEO1017, DOI 10.1038/NGE01017]; Smith CJ, 2010, J FORAMIN RES, V40, P266, DOI 10.2113/gsjfr.40.3.266; STEPHAN JF, 1990, B SOC GEOL FR, V6, P915; TAPHORN DC, 1984, REV UNELLEZ CIENCIA, V2, P87; Valenciennes A, 1840, SILUROIDES, V14, P1; VERNETTE G, 1992, TECTONOPHYSICS, V202, P335, DOI 10.1016/0040-1951(92)90118-P; Villamil T, 1999, PALAEOGEOGR PALAEOCL, V153, P239, DOI 10.1016/S0031-0182(99)00075-9; Wesselingh FP., 2002, CAINOZOIC RES, V1, P35; Zrbani F, 2004, GEOLOGICAL MAP VENEZ	73	28	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76202	10.1371/journal.pone.0076202	http://dx.doi.org/10.1371/journal.pone.0076202			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098778	Green Published, gold, Green Accepted			2022-12-25	WOS:000325423500148
J	Benhajali, H; Ezzaouia, M; Lunel, C; Charfi, F; Hausberger, M				Benhajali, Haifa; Ezzaouia, Mohammed; Lunel, Christophe; Charfi, Faouzia; Hausberger, Martine			Temporal Feeding Pattern May Influence Reproduction Efficiency, the Example of Breeding Mares	PLOS ONE			English	Article							STRESS-LIKE CONCENTRATIONS; LUTEINIZING-HORMONE; ESTROUS BEHAVIOR; TIME BUDGET; SECRETION; CORTISOL; LEPTIN; LH; TRANSPORTATION; INHIBITION	Discomfort in farm animals may be induced by inappropriate types or timing of food supplies. Thus, time restriction of meals and lack of roughage have been shown to be one source of emergence of oral stereotypies and abnormal behaviour in horses which have evolved to eat high-fibre diets in small amounts over long periods of time. This feeding pattern is often altered in domestic environment where horses are often fed low fibre meals that can be rapidly consumed. This study aimed at determining the effect of the temporal pattern of feeding on reproductive efficiency of breeding mares, One hundred Arab breeding mares were divided into two groups that differed only in the temporal pattern of roughage availability: only at night for the standard feeding pattern group (SFP mares), night and day for the "continuous feeding" group (CF mares). The total amount of roughage provided was the same as the CF mares received half of the hay during the day while in paddock (haynets). Mares were tested for oestrus detection by teasing with one stallion and were then examined clinically by rectal palpations and ultrasound before being mated naturally or inseminated by fresh or frozen semen. Multivariate logistic regression was used to analyse data. The treatment affected significantly the reproductive efficiency of the mares with fewer oestrus abnormalities (p = 0.0002) and more fertility (p = 0.024) in CF mares (conception rate = 81% versus 55% in SFP mares). Ensuring semi-continous feeding by providing roughage may be a way of fulfilling the basic physiological needs of the horses' digestive system, reducing stress and associated inhibitors of reproduction. To our knowledge, this study provides the first evidence of an impact of temporal feeding patterns on reproductive success in a Mammal. Temporal patterns of feeding may be a major and underestimated factor in breeding.	[Benhajali, Haifa; Lunel, Christophe; Hausberger, Martine] Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France; [Benhajali, Haifa; Ezzaouia, Mohammed] Haras Natl Sidi Thabet, Sidi Thabet, Tunisia; [Charfi, Faouzia] Univ Tunis ElManar, Unite Biol Anim & Systemat Evolut, Tunis, Tunisia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Universite de Tunis-El-Manar	Hausberger, M (corresponding author), Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France.	martine.hausberger@univ-rennes1.fr			Universite Rennes 1	Universite Rennes 1	Universite Rennes 1 (http://www.univ-rennes1.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam CL, 2003, REPRODUCTION, P283; Amstalden M, 2003, BIOL REPROD, V69, P1539, DOI 10.1095/biolreprod.103.018119; BALDWIN DM, 1974, ENDOCRINOLOGY, V94, P1397, DOI 10.1210/endo-94-5-1397; Barb CR, 1999, J ANIM SCI, V77, P1249; BARB CR, 1982, J REPROD FERTIL, V64, P85, DOI 10.1530/jrf.0.0640085; BARNETT JL, 1991, ANIM REPROD SCI, V25, P265, DOI 10.1016/0378-4320(91)90021-Q; BAUCUS KL, 1990, J ANIM SCI, V68, P345; BAUCUS KL, 1990, J ANIM SCI, V68, P419; Benhajali H, 2009, ANIMAL, V3, P1308, DOI 10.1017/S1751731109004820; Benhajali H, 2007, HORSE BEHAV WELFARE; Benhajali H, 2008, APPL ANIM BEHAV SCI, V112, P196, DOI 10.1016/j.applanim.2007.08.007; Berger A, 1999, APPL ANIM BEHAV SCI, V64, P1, DOI 10.1016/S0168-1591(99)00026-X; Berghold P, 2007, ANIM REPROD SCI, V102, P276, DOI 10.1016/j.anireprosci.2006.11.009; Bhardwaj SK, 2004, REPROD NUTR DEV, V44, P29, DOI 10.1051/rnd:2004014; BOISSY A, 1995, Q REV BIOL, V70, P165, DOI 10.1086/418981; BOYD LE, 1988, APPL ANIM BEHAV SCI, V21, P5, DOI 10.1016/0168-1591(88)90098-6; Broom D. M., 1993, Equine Veterinary Education, V5, P151, DOI 10.1111/j.2042-3292.1993.tb01026.x; Buff PR, 2007, DOMEST ANIM ENDOCRIN, V33, P430, DOI 10.1016/j.domaniend.2006.08.007; Chebel RC, 2007, ANIM REPROD SCI, V101, P208, DOI 10.1016/j.anireprosci.2006.09.010; CHEN MD, 1992, NEUROENDOCRINOLOGY, V56, P666, DOI 10.1159/000126291; Chrousos George P., 1998, Annals of Internal Medicine, V129, P229; Daley CA, 1999, BIOL REPROD, V60, P158, DOI 10.1095/biolreprod60.1.158; Dobson H, 1999, J REPROD FERTIL, V116, P1, DOI 10.1530/jrf.0.1160001; Dobson H, 2000, ANIM REPROD SCI, V60, P743, DOI 10.1016/S0378-4320(00)00080-4; DUBEY AK, 1985, BIOL REPROD, V33, P423, DOI 10.1095/biolreprod33.2.423; EHNERT K, 1991, J ANIM SCI, V69, P2988, DOI 10.2527/1991.6972988x; Ferreira-Dias G, 2005, DOMEST ANIM ENDOCRIN, V29, P203, DOI 10.1016/j.domaniend.2005.02.006; Fitzgerald BP, 2000, BIOL REPROD, V63, P335, DOI 10.1095/biolreprod63.1.335; Gastal M. O., 2004, Animal Reproduction, V1, P115; Guillaume D, 2007, EQUIDEE, V59, P52; Harris P, 2005, VET J, V170, P10, DOI 10.1016/j.tvjl.2004.08.007; HARRIS PA, 1999, P BEVA SPEC M NUTR B, P45; Hausberger M, 2004, J COMP PSYCHOL, V118, P434, DOI 10.1037/0735-7036.118.4.434; HENNEKE DR, 1984, THERIOGENOLOGY, V21, P897, DOI 10.1016/0093-691X(84)90383-2; HENNEKE DR, 1983, EQUINE VET J, V15, P371, DOI 10.1111/j.2042-3306.1983.tb01826.x; Komesaroff PA, 1998, AM J PHYSIOL-ENDOC M, V275, pE671, DOI 10.1152/ajpendo.1998.275.4.E671; LEE AH, 1986, AM J VET RES, V47, P2000; Macfarlane MS, 2000, ANIM REPROD SCI, V63, P167, DOI 10.1016/S0378-4320(00)00179-2; Madhuranath B N, 2006, Indian J Exp Biol, V44, P28; Mann GE, 2001, VET J, V161, P301, DOI 10.1053/tvjl.2000.0522; MCGREEVY PD, 1995, EQUINE VET J, V27, P86, DOI 10.1111/j.2042-3306.1995.tb03041.x; Merl S, 2000, J EQUINE VET SCI, V20, P586, DOI 10.1016/S0737-0806(00)70267-X; Murray MJ, 1996, EQUINE VET J, V28, P368, DOI 10.1111/j.2042-3306.1996.tb03107.x; Nambo Yasuo, 1996, Journal of Equine Science, V7, P1, DOI 10.1294/jes.7.1; Nicol CJ, 2002, VET REC, V151, P658, DOI 10.1136/vr.151.22.658; Phogat JB, 1999, J REPROD FERTIL, V116, P9, DOI 10.1530/jrf.0.1160009; Piccione G, 2013, BIOL RHYTHM RES, V44, P143, DOI 10.1080/09291016.2012.656245; RABIN DS, 1990, BIOL REPROD, V42, P74, DOI 10.1095/biolreprod42.1.74; SAKAKURA M, 1975, J CLIN ENDOCR METAB, V40, P774, DOI 10.1210/jcem-40-5-774; SMITH ER, 1971, NEUROENDOCRINOLOGY, V8, P94, DOI 10.1159/000121997; Soede NM, 1997, ANIM REPROD SCI, V46, P133, DOI 10.1016/S0378-4320(96)01609-0; STOEBEL DP, 1982, J DAIRY SCI, V65, P1016, DOI 10.3168/jds.S0022-0302(82)82303-5; Tischner M, 2006, ANIM REPROD SCI, V94, P234, DOI 10.1016/j.anireprosci.2006.04.043; TSUMA VT, 1995, J VET MED A, V42, P153, DOI 10.1111/j.1439-0442.1995.tb00367.x; Waring G.H., 2003, HORSE BEHAV, V2; WILLARD JG, 1977, J ANIM SCI, V45, P87, DOI 10.2527/jas1977.45187x; Wronska-Fortuna D, 1997, P 6 INT S MOL PHYS A, P417; ZIECIK AJ, 1995, ANIM REPROD SCI, V37, P337, DOI 10.1016/0378-4320(94)01336-K	58	14	14	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e73858	10.1371/journal.pone.0073858	http://dx.doi.org/10.1371/journal.pone.0073858			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231NL	24098636	Green Published, Green Submitted, gold			2022-12-25	WOS:000325423500007
J	Fredriksson, NJ; Hermansson, M; Wilen, BM				Fredriksson, Nils Johan; Hermansson, Malte; Wilen, Britt-Marie			The Choice of PCR Primers Has Great Impact on Assessments of Bacterial Community Diversity and Dynamics in a Wastewater Treatment Plant	PLOS ONE			English	Article							ESTIMATING PROKARYOTIC DIVERSITY; RNA GENE DATABASE; WEB-BASED TOOL; ACTIVATED-SLUDGE; MICROBIAL COMMUNITIES; TREATMENT SYSTEM; 16S; LIBRARIES; QUANTIFICATION; SPECIFICITY	Assessments of bacterial community diversity and dynamics are fundamental for the understanding of microbial ecology as well as biotechnological applications. We show that the choice of PCR primers has great impact on the results of analyses of diversity and dynamics using gene libraries and DNA fingerprinting. Two universal primer pairs targeting the 16S rRNA gene, 27F&1492R and 63F&M1387R, were compared and evaluated by analyzing the bacterial community in the activated sludge of a large-scale wastewater treatment plant. The two primer pairs targeted distinct parts of the bacterial community, none encompassing the other, both with similar richness. Had only one primer pair been used, very different conclusions had been drawn regarding dominant phylogenetic and putative functional groups. With 27F&1492R, Betaproteobacteria would have been determined to be the dominating taxa while 63F&M1387R would have described Alphaproteobacteria as the most common taxa. Microscopy and fluorescence in situ hybridization analysis showed that both Alphaproteobacteria and Betaproteobacteria were abundant in the activated sludge, confirming that the two primer pairs target two different fractions of the bacterial community. Furthermore, terminal restriction fragment polymorphism analyses of a series of four activated sludge samples showed that the two primer pairs would have resulted in different conclusions about community stability and the factors contributing to changes in community composition. In conclusion, different PCR primer pairs, although considered universal, target different ranges of bacteria and will thus show the diversity and dynamics of different fractions of the bacterial community in the analyzed sample. We also show that while a database search can serve as an indicator of how universal a primer pair is, an experimental assessment is necessary to evaluate the suitability for a specific environmental sample.	[Fredriksson, Nils Johan; Wilen, Britt-Marie] Chalmers Univ Technol, Dept Civil & Environm Engn, S-41296 Gothenburg, Sweden; [Hermansson, Malte] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden	Chalmers University of Technology; University of Gothenburg	Fredriksson, NJ (corresponding author), Chalmers Univ Technol, Dept Civil & Environm Engn, S-41296 Gothenburg, Sweden.	johan.fredriksson@chalmers.se	Fredriksson, Nils Johan/AAC-8083-2020; Wilen, Britt-Marie/B-5042-2016	Fredriksson, Nils Johan/0000-0002-5763-6777; Wilen, Britt-Marie/0000-0001-6155-7759; Steensland, Pia/0000-0003-4443-5017	FORMAS, The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning	FORMAS, The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas)	This work was funded by a research grant from FORMAS, The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akarsubasi AT, 2009, ENVIRON SCI TECHNOL, V43, P2950, DOI 10.1021/es8026488; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; [Anonymous], 2003, PROGRAM SPADE SPECIE; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Bramucci M, 2003, APPL MICROBIOL BIOT, V62, P594, DOI 10.1007/s00253-003-1372-x; Chouari R, 2005, ENVIRON MICROBIOL, V7, P1104, DOI 10.1111/j.1462-2920.2005.00795.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Curtis TP, 2006, WATER SCI TECHNOL, V54, P227, DOI 10.2166/wst.2006.391; Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Daims H, 2006, TRENDS BIOTECHNOL, V24, P483, DOI 10.1016/j.tibtech.2006.09.002; Dedysh SN, 2004, MICROBIOL-SGM, V150, P1301, DOI 10.1099/mic.0.26585-0; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dunbar J, 2001, APPL ENVIRON MICROB, V67, P190, DOI 10.1128/AEM.67.1.190-197.2001; Dykhuizen DE, 1998, ANTON LEEUW INT J G, V73, P25, DOI 10.1023/A:1000665216662; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Figuerola ELM, 2007, ENVIRON MICROBIOL, V9, P1780, DOI 10.1111/j.1462-2920.2007.01298.x; Fortuna AM, 2011, APPL MICROBIOL BIOT, V91, P1193, DOI 10.1007/s00253-011-3363-7; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Hong SH, 2009, ISME J, V3, P1365, DOI 10.1038/ismej.2009.89; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Hugenholtz P, 2002, GENOME BIOL, V3; Jin DC, 2011, J ENVIRON SCI-CHINA, V23, P1880, DOI 10.1016/S1001-0742(10)60621-3; Kemp PF, 2004, LIMNOL OCEANOGR-METH, V2, P114, DOI 10.4319/lom.2004.2.114; Khan ST, 2002, APPL ENVIRON MICROB, V68, P3206, DOI 10.1128/AEM.68.7.3206-3214.2002; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kong YH, 2007, MICROBIOL-SGM, V153, P4061, DOI 10.1099/mic.0.2007/007245-0; Lane D.J., 1991, NUCL ACID TECHNIQUES, P115, DOI DOI 10.4135/9781446279281.N7; Layton AC, 2000, APPL ENVIRON MICROB, V66, P1167, DOI 10.1128/AEM.66.3.1167-1174.2000; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Lowe BA, 2011, VET MICROBIOL, V147, P346, DOI 10.1016/j.vetmic.2010.06.025; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; Marzorati M, 2008, ENVIRON MICROBIOL, V10, P1571, DOI 10.1111/j.1462-2920.2008.01572.x; McMahon KD, 2007, CURR OPIN BIOTECH, V18, P287, DOI 10.1016/j.copbio.2007.04.007; Mertens B, 2005, ENVIRON MICROBIOL, V7, P660, DOI 10.1111/j.1462-2920.2005.00735.x; Morales SE, 2009, APPL ENVIRON MICROB, V75, P2677, DOI 10.1128/AEM.02166-08; Nadarajah N, 2007, WATER RES, V41, P2563, DOI 10.1016/j.watres.2007.02.002; Nielsen PH, 2010, WATER RES, V44, P5070, DOI 10.1016/j.watres.2010.07.036; Pholchan MK, 2010, WATER RES, V44, P1341, DOI 10.1016/j.watres.2009.11.005; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Saikaly PE, 2005, APPL ENVIRON MICROB, V71, P5814, DOI 10.1128/AEM.71.10.5814-5822.2005; Saikaly PE, 2004, MICROB ECOL, V48, P274, DOI 10.1007/s00248-003-1027-6; Schloss PD, 2004, MICROBIOL MOL BIOL R, V68, P686, DOI 10.1128/MMBR.68.4.686-691.2004; Shyu C, 2007, MICROB ECOL, V53, P562, DOI 10.1007/s00248-006-9106-0; Singleton DR, 2001, APPL ENVIRON MICROB, V67, P4374, DOI 10.1128/AEM.67.9.4374-4376.2001; Sipos R, 2007, FEMS MICROBIOL ECOL, V60, P341, DOI 10.1111/j.1574-6941.2007.00283.x; Sloan WT, 2006, ENVIRON MICROBIOL, V8, P732, DOI 10.1111/j.1462-2920.2005.00956.x; Smith CJ, 2005, FEMS MICROBIOL ECOL, V54, P375, DOI 10.1016/j.femsec.2005.05.002; Stackebrandt E, 2006, MICROBIOLOGY TODAY, V06, P152, DOI DOI 10.1038/MSB.2013.22; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; URAKAMI T, 1995, INT J SYST BACTERIOL, V45, P528, DOI 10.1099/00207713-45-3-528; Valentin-Vargas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042524; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wartiainen I, 2006, INT J SYST EVOL MICR, V56, P541, DOI 10.1099/ijs.0.63912-0; Wells GF, 2011, WATER RES, V45, P5476, DOI 10.1016/j.watres.2011.08.006; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wilen BM, 2010, WATER ENVIRON RES, V82, P155, DOI 10.2175/106143009X426004; Yang C, 2011, ENVIRON SCI TECHNOL, V45, P7408, DOI 10.1021/es2010545; Yuan ZG, 2002, WATER RES, V36, P482, DOI 10.1016/S0043-1354(01)00230-5; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188	68	133	135	6	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76431	10.1371/journal.pone.0076431	http://dx.doi.org/10.1371/journal.pone.0076431			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	23977009	Green Published, gold, Green Submitted			2022-12-25	WOS:000325427100066
J	Seo, EH; Lee, DY; Lee, JM; Park, JS; Sohn, BK; Lee, DS; Choe, YM; Woo, JI				Seo, Eun Hyun; Lee, Dong Young; Lee, Jong-Min; Park, Jun-Sung; Sohn, Bo Kyung; Lee, Dong Soo; Choe, Young Min; Woo, Jong Inn			Whole-brain Functional Networks in Cognitively Normal, Mild Cognitive Impairment, and Alzheimer's Disease	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; RESTING-STATE NETWORKS; DEFAULT-MODE NETWORK; NEUROPSYCHOLOGICAL ASSESSMENT; TOPOLOGICAL PATTERNS; CORTICAL NETWORKS; CEREBRAL-CORTEX; BLOOD-FLOW; CONNECTIVITY; DEMENTIA	The conceptual significance of understanding functional brain alterations and cognitive deficits associated with Alzheimer's disease (AD) process has been widely established. However, the whole-brain functional networks of AD and its prodromal stage, mild cognitive impairment (MCI), are not well clarified yet. In this study, we compared the characteristics of the whole-brain functional networks among cognitively normal (CN), MCI, and AD individuals by applying graph theoretical analyses to [F-18] fluorodeoxyglucose positron emission tomography (FDG-PET) data. Ninety-four CN elderly, 183 with MCI, and 216 with AD underwent clinical evaluation and FDG-PET scan. The overall small-world property as seen in the CN whole-brain network was preserved in MCI and AD. In contrast, individual parameters of the network were altered with the following patterns of changes: local clustering of networks was lower in both MCI and AD compared to CN, while path length was not different among the three groups. Then, MCI had a lower level of local clustering than AD. Subgroup analyses for AD also revealed that very mild AD had lower local clustering and shorter path length compared to mild AD. Regarding the local properties of the whole-brain networks, MCI and AD had significantly decreased normalized betweenness centrality in several hubs regionally associated with the default mode network compared to CN. Our results suggest that the functional integration in whole-brain network progressively declines due to the AD process. On the other hand, functional relatedness between neighboring brain regions may not gradually decrease, but be the most severely altered in MCI stage and gradually re-increase in clinical AD stages.	[Seo, Eun Hyun; Lee, Dong Young; Sohn, Bo Kyung; Choe, Young Min; Woo, Jong Inn] Seoul Natl Univ Hosp, Dept Neuropsychiat, Seoul 110744, South Korea; [Seo, Eun Hyun; Lee, Dong Young; Sohn, Bo Kyung; Choe, Young Min; Woo, Jong Inn] Seoul Natl Univ Hosp, Biomed Res Inst, Seoul 110744, South Korea; [Seo, Eun Hyun; Lee, Dong Young; Woo, Jong Inn] Seoul Natl Univ, Interdisciplinary Program Cognit Sci, Seoul, South Korea; [Lee, Jong-Min; Park, Jun-Sung] Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea; [Lee, Dong Soo] Seoul Natl Univ Hosp, Dept Nucl Med, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Hanyang University; Seoul National University (SNU); Seoul National University Hospital	Lee, DS (corresponding author), Seoul Natl Univ Hosp, Dept Nucl Med, Seoul 110744, South Korea.	selfpsy@snu.ac.kr	Lee, Jeong Min/V-3429-2019	Lee, Jeong Min/0000-0003-0561-8777; Kim, Jae Ho/0000-0003-4323-4790; Jang, Il Ho/0000-0002-0820-3035	Seoul National University Hospital [2011-0564]; Korea Healthcare Technology R & D Project, Ministry of Health, Welfare & Family Affairs, Republic of Korea [A092145]; Korea government (MEST) [2011-0028333]	Seoul National University Hospital; Korea Healthcare Technology R & D Project, Ministry of Health, Welfare & Family Affairs, Republic of Korea; Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This study was supported by a grant from the Seoul National University Hospital (Grant No. 2011-0564), a grant from the Korea Healthcare Technology R & D Project, Ministry of Health, Welfare & Family Affairs, Republic of Korea (Grant No. A092145), and a grant from the Korea government (MEST) (Grant No. 2011-0028333). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Braak E, 1999, EUR ARCH PSY CLIN N, V249, P14; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brown JA, 2011, P NATL ACAD SCI USA, V108, P20760, DOI 10.1073/pnas.1109038108; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Buldu JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019584; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Chetelat G, 2003, NEUROLOGY, V60, P1374, DOI 10.1212/01.WNL.0000055847.17752.E6; Choo IH, 2007, ALZ DIS ASSOC DIS, V21, P77, DOI 10.1097/WAD.0b013e3180687418; Del Sole A, 2008, EUR J NUCL MED MOL I, V35, P1357, DOI 10.1007/s00259-008-0773-6; DELACOSTE MC, 1993, NEUROBIOL AGING, V14, P1, DOI 10.1016/0197-4580(93)90015-4; Delbeuck X, 2003, NEUROPSYCHOL REV, V13, P79, DOI 10.1023/A:1023832305702; Dickerson BC, 2005, NEUROLOGY, V65, P404, DOI 10.1212/01.wnl.0000171450.97464.49; Dukart J, 2010, NEUROIMAGE, V49, P1490, DOI 10.1016/j.neuroimage.2009.09.017; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Golob EJ, 2001, NEUROBIOL AGING, V22, P755, DOI 10.1016/S0197-4580(01)00244-5; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Grady CL, 2008, ANN NY ACAD SCI, V1124, P127, DOI 10.1196/annals.1440.009; GRADY CL, 1989, ARCH NEUROL-CHICAGO, V46, P317, DOI 10.1001/archneur.1989.00520390083021; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Ishii K, 2003, J NEUROL SCI, V215, P71, DOI 10.1016/S0022-510X(03)00206-5; Jhoo JH, 2010, PSYCHIAT RES-NEUROIM, V183, P237, DOI 10.1016/j.pscychresns.2010.03.006; JUEPTNER M, 1995, NEUROIMAGE, V2, P148, DOI 10.1006/nimg.1995.1017; Lee DY, 2009, NEUROLOGY, V73, P1722, DOI 10.1212/WNL.0b013e3181c33afb; Lee DY, 2010, STROKE, V41, P1791, DOI 10.1161/STROKEAHA.110.582163; Lee DY, 2004, J INT NEUROPSYCH SOC, V10, P72, DOI 10.1017/s1355617704101094; Lee JH, 2002, J GERONTOL B-PSYCHOL, V57, pP47, DOI 10.1093/geronb/57.1.P47; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MOHR E, 1990, J CLIN EXP NEUROPSYC, V12, P235, DOI 10.1080/01688639008400970; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Mosconi L, 2005, NEUROLOGY, V64, P1860, DOI 10.1212/01.WNL.0000163856.13524.08; Nestor PJ, 2003, ANN NEUROL, V54, P343, DOI 10.1002/ana.10669; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Perry RJ, 1999, BRAIN, V122, P383, DOI 10.1093/brain/122.3.383; Pihlajamaki M, 2009, BEHAV NEUROL, V21, P77, DOI 10.3233/BEN-2009-0231; Pihlajamaki M, 2009, CURR ALZHEIMER RES, V6, P179, DOI 10.2174/156720509787602898; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; Qi ZG, 2010, NEUROIMAGE, V50, P48, DOI 10.1016/j.neuroimage.2009.12.025; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; SOKOLOFF L, 1981, FED PROC, V40, P2311; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sperling RA, 2010, NEUROMOL MED, V12, P27, DOI 10.1007/s12017-009-8109-7; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Sydykova D, 2007, CEREB CORTEX, V17, P2276, DOI 10.1093/cercor/bhl136; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vecchio Fabrizio, 2011, Int J Alzheimers Dis, V2011, P214580, DOI 10.4061/2011/214580; Wada Y, 1998, ALZ DIS ASSOC DIS, V12, P175, DOI 10.1097/00002093-199809000-00009; Wang JH, 2013, BIOL PSYCHIAT, V73, P472, DOI 10.1016/j.biopsych.2012.03.026; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Westlye ET, 2011, J NEUROSCI, V31, P7775, DOI 10.1523/JNEUROSCI.1230-11.2011; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006; Yun JY, 2011, DEMENT GER COGN D EX, V1, P190, DOI 10.1159/000329517; Zhu WL, 2012, NEUROBIOL AGING, V33, P899, DOI 10.1016/j.neurobiolaging.2010.06.022	73	109	111	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2013	8	1							e53922	10.1371/journal.pone.0053922	http://dx.doi.org/10.1371/journal.pone.0053922			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086SQ	24098810	gold, Green Published, Green Submitted			2022-12-25	WOS:000314707700038
J	Kirchner, SM; Hiltunen, L; Doring, TF; Virtanen, E; Palohuhta, JP; Valkonen, JPT				Kirchner, Sascha M.; Hiltunen, Lea; Doering, Thomas F.; Virtanen, Elina; Palohuhta, Jukka P.; Valkonen, Jari P. T.			Seasonal Phenology and Species Composition of the Aphid Fauna in a Northern Crop Production Area	PLOS ONE			English	Article							POTATO-VIRUS-Y; HEMIPTERA APHIDIDAE; RHOPALOSIPHUM-PADI; NEW-BRUNSWICK; STRAW MULCH; VECTOR; FLIGHT; EPIDEMIOLOGY; TRANSMISSION; SELECTION	Background: The species diversity of aphids and seasonal timing of their flight activity can have significant impacts on crop production, as aphid species differ in their ability to transmit plant viruses and flight timing affects virus epidemiology. The aim of the study was to characterise the species composition and phenology of aphid fauna in Finland in one of the northernmost intensive crop production areas of the world (latitude 64 degrees). Methodology/Principal Findings: Flight activity was monitored in four growing seasons (2007-010) using yellow pan traps (YPTs) placed in 4-8 seed potato fields and a Rothamsted suction trap. A total of 58,528 winged aphids were obtained, identified to 83 taxa based on morphology, and 34 species were additionally characterised by DNA barcoding. Seasonal flight activity patterns analysed based on YPT catch fell into three main phenology clusters. Monoecious taxa showed early or middle-season flight activity and belonged to species living on shrubs/trees or herbaceous plants, respectively. Heteroecious taxa occurred over the entire potato growing season (ca. 90 days). Abundance of aphids followed a clear 3-year cycle based on suction trap data covering a decade. Rhopalosiphum padi occurring at the end of the potato growing season was the most abundant species. The flight activity of Aphis fabae, the main vector of Potato virus Y in the region, and Aphis gossypii peaked in the beginning of potato growing season. Conclusions/Significance: Detailed information was obtained on phenology of a large number aphid species, of which many are agriculturally important pests acting as vectors of plant viruses. Aphis gossypii is known as a pest in greenhouses, but our study shows that it occurs also in the field, even far in the north. The novel information on aphid phenology and ecology has wide implications for prospective pest management, particularly in light of climate change.	[Kirchner, Sascha M.; Valkonen, Jari P. T.] Univ Helsinki, Dept Agr Sci, Helsinki, Finland; [Kirchner, Sascha M.; Hiltunen, Lea; Virtanen, Elina] MTT AgriFood Res Finland, Oulu, Finland; [Doering, Thomas F.] Humboldt Univ, Dept Crop & Anim Sci, D-10099 Berlin, Germany; [Palohuhta, Jukka P.] Finnish Seed Potato Ctr, Tyrnava, Finland	University of Helsinki; Natural Resources Institute Finland (Luke); Humboldt University of Berlin	Kirchner, SM (corresponding author), Univ Helsinki, Dept Agr Sci, Helsinki, Finland.	sascha.kirchner@helsinki.fi	; Wittbrodt, Joachim/D-4735-2014	Kirchmaier, Stephan/0000-0002-3870-8624; Valkonen, Jari/0000-0002-3704-9911; Lust, Katharina/0000-0002-2580-5492; Wittbrodt, Joachim/0000-0001-8550-7377; Doring, Thomas/0000-0001-9074-5978	Ministry of Agriculture and Forestry, Finland [618/502/2008, 2383/312/2009]	Ministry of Agriculture and Forestry, Finland	This work was supported by the Ministry of Agriculture and Forestry, Finland (grants 618/502/2008 and 2383/312/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht A, 2012, ATLAS APHIDS FINLAND; [Anonymous], 2015, SPRINGERPLUS, DOI DOI 10.1186/s40064-015-1263-5; BAGNALL RH, 1992, CAN J PLANT PATHOL, V14, P137, DOI 10.1080/07060669209500890; Bagnall RH, 1991, ADV DIS VECTOR RES, P53; Bale Jeffrey S., 1999, Ecological Bulletins, V47, P38; Basky Z, 2003, ANZ SCHADL-J PEST SC, V76, P83, DOI 10.1046/j.1439-0280.2003.03019.x; BEEMSTER, 1972, Virus translocation in Potato plants and mature-plant resistance., P144; Bisnieks M, 2004, ARCH VIROL, V149, P843, DOI 10.1007/s00705-003-0242-2; BLACKMAN RL, 1974, B ENTOMOL RES, V63, P595, DOI 10.1017/S0007485300047830; Blackman RL, 2000, APHIDS WORLDS CROPS, V2nd, DOI 10.1016/0261-2194(96)89825-5; Blackman RL, 2007, APHIDS AS CROP PESTS, P1, DOI 10.1079/9780851998190.0001; BOITEAU G, 1988, AM POTATO J, V65, P639, DOI 10.1007/BF02854832; Carletto J, 2009, SYST ENTOMOL, V34, P307, DOI 10.1111/j.1365-3113.2008.00458.x; CHAN CK, 1991, AGR CAN RES BRANCH T; Chittka L, 2007, PLOS BIOL, V5, P1640, DOI 10.1371/journal.pbio.0050187; Cocu N, 2005, AGR FOREST ENTOMOL, V7, P31, DOI 10.1111/j.1461-9555.2005.00245.x; Cocuzza G, 2008, B INSECTOL, V61, P125; DEGUINE JP, 1997, SERIE DEPREDATEURS C, V11; Doring TF, 2011, POTATO RES, V54, P341, DOI 10.1007/s11540-011-9195-0; Doring TF, 2009, P ROY SOC B-BIOL SCI, V276, P121, DOI 10.1098/rspb.2008.0858; Doring TF, 2004, ENTOMOL EXP APPL, V113, P53, DOI 10.1111/j.0013-8703.2004.00208.x; EASTOP VF, 1955, NATURE, V176, P936, DOI 10.1038/176936b0; Foottit RG, 2008, MOL ECOL RESOUR, V8, P1189, DOI 10.1111/j.1755-0998.2008.02297.x; GONZALEZ D, 1968, J ECON ENTOMOL, V61, P109, DOI 10.1093/jee/61.1.109; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Halkka A, 2010, SUOMEN LUONTO, V5, P8; HARDIE J, 1989, J INSECT PHYSIOL, V35, P619, DOI 10.1016/0022-1910(89)90124-8; Harrington R., 1995, P125; Heie O.E., 1980, APHIDOIDEA HEMIPTERA, V9; Heie O.E., 1995, APHIDOIDEA HEMIPTE 3; Heie OE, 1986, APHIDOIDEA HEMIPTE 1, VIII; Heie OE, 1982, APHIDOIDEA HEMIPTE 1; HEIE OE, 1994, APHIDOIDEA HEMIPTE 2; HEIE OE, 1992, APHIDOIDEA HEMIPTE 1; Holman J., 2009, HOST PLANT CATALOG A; HULLE M, 1994, J APPL ECOL, V31, P49, DOI 10.2307/2404598; Huusela-Veistola E, 2009, 8 INT S APH CAT, P167; Kindlmann P, 2007, APHIDS AS CROP PESTS, P311, DOI 10.1079/9780851998190.0311; Kirchner SM, 2011, ANN APPL BIOL, V159, P414, DOI 10.1111/j.1744-7348.2011.00501.x; KRING JB, 1972, ANNU REV ENTOMOL, V17, P461, DOI 10.1146/annurev.en.17.010172.002333; KURPPA A, 1989, ANN AGR FENN, V28, P309; KURPPA S, 1989, ANN AGR FENN, V28, P349; KURPPA S, 1986, ANN AGR FENN, V25, P199; Lambers DHR, 1955, ANN APPL BIOL, V42, P355, DOI 10.1111/j.1744-7348.1955.tb02440.x; LAMBERS DHR, 1966, ANNU REV ENTOMOL, V11, P47, DOI 10.1146/annurev.en.11.010166.000403; MACAULAY EDM, 1988, B ENTOMOL RES, V78, P121, DOI 10.1017/S0007485300016126; MOERICKE V, 1969, ENTOMOL EXP APPL, V12, P524, DOI 10.1007/BF00297083; Moericke V., 1955, Zeitschrift fuer Angewandte Entomologie, V37, P29; MOERICKE V., 1962, Zeitschrift fur Angewandte Entomologie, V50, P70; Mueller EE, 2010, J ECON ENTOMOL, V103, P1670, DOI 10.1603/EC09411; Official Statistics of Finland, 2012, CROP PROD STAT; Peltonen-Sainio P, 2009, AGR FOOD SCI, V18, P171, DOI 10.2137/145960609790059479; PERRY JN, 1983, ECOL ENTOMOL, V8, P383, DOI 10.1111/j.1365-2311.1983.tb00518.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Saucke H, 2009, ANN APPL BIOL, V154, P239, DOI 10.1111/j.1744-7348.2008.00288.x; Saucke H, 2004, ANN APPL BIOL, V144, P347, DOI 10.1111/j.1744-7348.2004.tb00350.x; SIGVALD R, 1985, POTATO RES, V28, P135, DOI 10.1007/BF02357439; SIGVALD R, 1987, POTATO RES, V30, P267, DOI 10.1007/BF02357668; Simola H, 2012, COMMUNICATION; STROYAN H.L.G., 1984, HDB IDENTIFICATION 6; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Taylor L. R., 1974, Report of the Rothamsted Experimental Station 1973, P202; Taylor L.R., 1984, HDB APHID IDENTIFICA; Thieme Th., 1994, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes (Stuttgart), V46, P65; Vanninen I, 2011, AGR FOOD SCI, V20, P96, DOI 10.2137/145960611795163033; WIKTELIUS S, 1987, ANN APPL BIOL, V110, P1, DOI 10.1111/j.1744-7348.1987.tb03226.x; Williams IS, 2007, APHIDS AS CROP PESTS, P69, DOI 10.1079/9780851998190.0069; ZHOU XL, 1995, GLOB CHANGE BIOL, V1, P303, DOI 10.1111/j.1365-2486.1995.tb00029.x	68	42	43	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e71030	10.1371/journal.pone.0071030	http://dx.doi.org/10.1371/journal.pone.0071030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	24116091	Green Published, gold, Green Submitted			2022-12-25	WOS:000323115800033
J	Xu, C; Wang, CS; Sun, XY; Zhang, R; Gleason, ML; Eiji, T; Sun, GY				Xu, Chao; Wang, Chunsheng; Sun, Xinyao; Zhang, Rong; Gleason, Mark L.; Eiji, Tanaka; Sun, Guangyu			Multiple Group I Introns in the Small-Subunit rDNA of Botryosphaeria dothidea: Implication for Intraspecific Genetic Diversity	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; SCYTALIDIUM-DIMIDIATUM; TERTIARY INTERACTIONS; POPULATION-STRUCTURE; SECONDARY; PISTACHIO; REPRESENTATION; PATHOGENICITY; HYALINUM; BINDING	Botryosphaeria dothidea is a widespread and economically important pathogen on various fruit trees, and it often causes die-back and canker on limbs and fruit rot. In characterizing intraspecies genetic variation within this fungus, group I introns, rich in rDNA of fungi, may provide a productive region for exploration. In this research, we analysed complete small subunit (SSU) ribosomal DNA (rDNA) sequences of 37 B. dothidea strains, and found four insertions, designated Bdo.S943, Bdo.S1199-A, Bdo.S1199-B and Bdo.S1506, at three positions. Sequence analysis and structure prediction revealed that both Bdo.S943 and Bdo.S1506 belonged to subgroup IC1 of group I introns, whereas Bdo.S1199-A and Bdo.S1199-B corresponded to group IE introns. Moreover, Bdo.S1199-A was found to host an open reading frame (ORF) for encoding the homing endonuclease (HE), whereas Bdo.S1199-B, an evolutionary descendant of Bdo.S1199-A, included a degenerate HE. The above four introns were novel, and were the first group I introns observed and characterized in this species. Differential distribution of these introns revealed that all strains could be separated into four genotypes. Genotype III (no intron) and genotype IV (Bdo.S1199-B) were each found in only one strain, whereas genotype I (Bdo.S1199-A) and genotype II (Bdo.S943 and Bdo.S1506) occurred in 95% of the strains. There is a correlation between B. dothidea genotypes and hosts or geographic locations. Thus, these newly discovered group I introns can help to advance understanding of genetic differentiation within B. dothidea.	[Xu, Chao; Wang, Chunsheng; Sun, Xinyao; Zhang, Rong; Sun, Guangyu] Northwest A&F Univ, Coll Plant Protect, Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Gleason, Mark L.] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA USA; [Eiji, Tanaka] Ishikawa Prefectural Univ, Nonoichi, Ishikawa, Japan	Northwest A&F University - China; Iowa State University; Ishikawa Prefecture University	Sun, GY (corresponding author), Northwest A&F Univ, Coll Plant Protect, Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	sgy@nwsuaf.edu.cn	Zhang, Xinyu/S-4946-2016	Zhang, Xinyu/0000-0001-8154-9334; CAI, LEI/0000-0002-8131-7274; chao, xu/0000-0002-6398-4129; Tanaka, Eiji/0000-0003-4752-8825	National Natural Science Foundation of China [31170015, 31171797]; 111 Project from Education Ministry of China [B07049]; Top Talent Project of Northwest AF University; earmarked fund for Modern Agro-industry Technology Research System [nycytx-08-04-04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project from Education Ministry of China(Ministry of Education, China - 111 Project); Top Talent Project of Northwest AF University; earmarked fund for Modern Agro-industry Technology Research System	This work was supported by National Natural Science Foundation of China (31170015, 31171797), the 111 Project from Education Ministry of China (B07049), Top Talent Project of Northwest A&F University and the earmarked fund for Modern Agro-industry Technology Research System (nycytx-08-04-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr ME, 1972, PRELIMINARY STUDIES, P525; Belfort M, 1995, J BIOL CHEM, V270, P30237, DOI 10.1074/jbc.270.51.30237; BURKE JM, 1987, NUCLEIC ACIDS RES, V15, P7217, DOI 10.1093/nar/15.18.7217; CECH TR, 1988, GENE, V73, P259, DOI 10.1016/0378-1119(88)90492-1; CECH TR, 1994, NAT STRUCT BIOL, V1, P273, DOI 10.1038/nsb0594-273; CECH TR, 1990, ANNU REV BIOCHEM, V59, P543, DOI 10.1146/annurev.bi.59.070190.002551; Cech TR, 2002, BIOCHEM SOC T, V30, P1162, DOI 10.1042/BST0301162; Choi IY, 2011, PLANT DIS, V95, P227, DOI 10.1094/PDIS-05-10-0371; De Rijk P, 2003, BIOINFORMATICS, V19, P299, DOI 10.1093/bioinformatics/19.2.299; Flick KE, 1998, NATURE, V394, P96, DOI 10.1038/27952; Goddard MR, 1999, P NATL ACAD SCI USA, V96, P13880, DOI 10.1073/pnas.96.24.13880; Hall TA., NUCL ACIDS S SER OXF, V41, P95; Haugen P, 2005, TRENDS GENET, V21, P111, DOI 10.1016/j.tig.2004.12.007; Haugen P, 2004, MOL BIOL EVOL, V21, P129, DOI 10.1093/molbev/msh005; Haugen P, 2002, EUR J BIOCHEM, V269, P1641, DOI 10.1046/j.1432-1327.2002.02802.x; Jurica MS, 1999, CELL MOL LIFE SCI, V55, P1304, DOI 10.1007/s000180050372; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lehnert V, 1996, CHEM BIOL, V3, P993, DOI 10.1016/S1074-5521(96)90166-0; Li ZJ, 2005, NUCLEIC ACIDS RES, V33, P2118, DOI 10.1093/nar/gki517; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Ma ZH, 2004, PHYTOPATHOLOGY, V94, P326, DOI 10.1094/PHYTO.2004.94.4.326; Ma ZH, 2002, PHYTOPATHOLOGY, V92, P519, DOI 10.1094/PHYTO.2002.92.5.519; Ma ZH, 2001, PHYTOPATHOLOGY, V91, P665, DOI 10.1094/PHYTO.2001.91.7.665; Machouart M, 2004, FEMS MICROBIOL LETT, V238, P455, DOI 10.1016/j.femsle.2004.08.011; Machouart M, 2011, FUNGAL BIOL-UK, V115, P1038, DOI 10.1016/j.funbio.2011.05.002; Machouart-Dubach M, 2002, FEMS MICROBIOL LETT, V208, P187, DOI 10.1111/j.1574-6968.2002.tb11080.x; MICHAILIDES TJ, 1991, PHYTOPATHOLOGY, V81, P566, DOI 10.1094/Phyto-81-566; MICHEL F, 1989, NATURE, V342, P391, DOI 10.1038/342391a0; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; Muller KM, 2001, MOL BIOL EVOL, V18, P1654, DOI 10.1093/oxfordjournals.molbev.a003954; Nikoh N, 2001, MOL BIOL EVOL, V18, P1631, DOI 10.1093/oxfordjournals.molbev.a003952; Slippers B, 2004, MYCOLOGIA, V96, P83, DOI 10.2307/3761991; Suh SO, 1999, J MOL EVOL, V48, P493, DOI 10.1007/PL00006493; Takizawa K, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-94; Tang W, 2012, PLANT DIS, V96, P486, DOI 10.1094/PDIS-08-11-0635; Taylor A, 2005, AUSTRALAS PLANT PATH, V34, P187, DOI 10.1071/AP05018; WEAVER DJ, 1974, PHYTOPATHOLOGY, V64, P1429, DOI 10.1094/Phyto-64-1429; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Zhang Y, 2000, RNA, V6, P937, DOI 10.1017/S1355838200991726; Zhang Y, 2009, FEBS LETT, V583; Zhou Z, 2011, SCI AGR SINICA, V6, P009; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	42	28	31	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2013	8	7							e67808	10.1371/journal.pone.0067808	http://dx.doi.org/10.1371/journal.pone.0067808			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176XV	24098811	Green Submitted, Green Published, gold			2022-12-25	WOS:000321341000101
J	Liu, YX; Wang, XJ; Liu, YX; Sun, DP; Ding, SJ; Zhang, BB; Du, ZH; Xue, FZ				Liu, Yunxia; Wang, Xianjun; Liu, Yanxun; Sun, Dapeng; Ding, Shujun; Zhang, Bingbing; Du, Zhaohui; Xue, Fuzhong			Detecting Spatial-Temporal Clusters of HFMD from 2007 to 2011 in Shandong Province, China	PLOS ONE			English	Article							MOUTH-DISEASE; FOOT; HAND; OUTBREAK; ONYCHOMADESIS; EPIDEMIOLOGY; INFECTIONS; CITY	Background: Hand, foot, and mouth disease (HFMD) has caused major public health concerns worldwide, and has become one of the leading causes of children death. China is the most serious epidemic area with a total of 3,419,149 reported cases just from 2008 to 2010, and its different geographic areas might have different spatial epidemiology characteristics at different spatial-temporal scale levels. We conducted spatial and spatial-temporal epidemiology analysis to HFMD at county level in Shandong Province, China. Methods: Based on the China National Disease Surveillance Reporting and Management System, the spatial-temporal database of HFMD from 2007 to 2011 was built. The global autocorrelation statistic (Moran's I) was first used to detect the spatial autocorrelation of HFMD cases in each year. Purely Spatial scan statistics combined with Space-time scan statistic were used to detect epidemic clusters. Results: The annual average incidence rate was 93.70 per 100,000 in Shandong Province. Most HFMD cases (93.94%) were aged within 0-5 years old with an average male-to-female sex ratio 1.71, and the incidence seasonal peak was between April and July. The dominant pathogen was EV71 (47.35%), and CoxA16 (26.59%). HFMD had positive spatial autocorrelation at medium spatial scale level (county level) with higher Moran's I from 0.31 to 0.62 (P<0.001). Seven spatial-temporal clusters were detected from 2007 to 2011 in the landscape of the whole Shandong, with EV71 or CoxA16 as the dominant pathogen for most hotspots areas. Conclusions: The spatial-temporal clusters of HFMD wandered around the whole Shandong Province during 2007 to 2011, with EV71 or CoxA16 as the dominant pathogen. These findings suggested that a real-time spatial-temporal surveillance system should be established for identifying high incidence region and conducting prevention to HFMD timely.	[Liu, Yunxia; Liu, Yanxun; Zhang, Bingbing; Du, Zhaohui; Xue, Fuzhong] Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Jinan 250100, Peoples R China; [Wang, Xianjun; Sun, Dapeng; Ding, Shujun] Shandong Ctr Dis Control & Prevent, Jinan, Peoples R China	Shandong University	Xue, FZ (corresponding author), Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Jinan 250100, Peoples R China.	xuefzh@sdu.edu.cn	Du, Zhaohui/AAK-6231-2021; Xue, Fuzhong/AAG-4808-2020; zhang, liwen/L-7005-2016; He, Huiguang/AAD-7643-2020	Du, Zhaohui/0000-0002-7125-8928; He, Huiguang/0000-0002-0684-1711; Xue, Fuzhong/0000-0003-0378-7956	National Natural Science Foundation of China [81001292]; Shandong Province science and technology development plan [2009GG10002055]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province science and technology development plan	This work was supported by No.81001292 of the National Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default152.htm), 2009GG10002055 of Shandong Province science and technology development plan in 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang LW, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-270; Anselin L, 2004, GEODA0 95I RELEASE N; Bracho MA, 2011, EMERG INFECT DIS, V17, P2223, DOI 10.3201/eid1712.110395; Cao Li-Hua, 2011, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V25, P227; Chang Zhao-rui, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P676; Chinese Center for Disease Control and Prevention(China CDC), 2010, NAT INC DEATH CAS NO; Chinese Ministry of Health, 2008, HAND FOOT MOUTH DIS; Chong CY, 2003, ACTA PAEDIATR, V92, P1163, DOI 10.1080/08035250310005242; Coleman M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-68; Fujimoto T, 2002, MICROBIOL IMMUNOL, V46, P621, DOI 10.1111/j.1348-0421.2002.tb02743.x; Gopalkrishna V, 2012, J MED MICROBIOL, V61, P420, DOI 10.1099/jmm.0.036400-0; Higgs BW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001284; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M, 1998, AM J PUBLIC HEALTH, V88, P1377, DOI 10.2105/AJPH.88.9.1377; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Liu MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025287; Liu Wen-dong, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P813; Ma E, 2010, JPN J INFECT DIS, V63, P422; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Morrison AC, 1998, AM J TROP MED HYG, V58, P287, DOI 10.4269/ajtmh.1998.58.287; Ni HX, 2012, J CLIN VIROL, V54, P342, DOI 10.1016/j.jcv.2012.04.021; Onozuka D, 2011, SCI TOTAL ENVIRON, V410, P119, DOI 10.1016/j.scitotenv.2011.09.055; Pfeiffer DU, 2008, Spatial Analysis in Epidemiology, P1, DOI 10.1093/acprof:oso/9780198509882.001.0001; Puenpa J, 2011, ARCH VIROL, V156, P2007, DOI 10.1007/s00705-011-1098-5; Tang Xian-yan, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P274; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wang JF, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-25; Wang Y, 2011, EPIDEMIOLOGY, V22, P781, DOI 10.1097/EDE.0b013e318231d67a; Wei SH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-346; Xiao Ge-xin, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P808; Yan XF, 2012, SCAND J INFECT DIS, V44, P297, DOI 10.3109/00365548.2011.634433; Yang F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-508; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu Q, 2011, BIOMED ENVIRON SCI, V24, P349, DOI 10.3967/0895-3988.2011.04.005; Zou XN, 2012, BRAZ J INFECT DIS, V16, P457, DOI 10.1016/j.bjid.2012.08.001	36	38	53	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e63447	10.1371/journal.pone.0063447	http://dx.doi.org/10.1371/journal.pone.0063447			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	24098769	Green Published, gold, Green Submitted			2022-12-25	WOS:000319330200039
J	Li, SH; Zhang, XJ; Sun, Z; Li, FH; Xiang, JH				Li, Shihao; Zhang, Xiaojun; Sun, Zheng; Li, Fuhua; Xiang, Jianhai			Transcriptome Analysis on Chinese Shrimp Fenneropenaeus chinensis during WSSV Acute Infection	PLOS ONE			English	Article							SPOT-SYNDROME-VIRUS; BLACK TIGER SHRIMP; DIFFERENTIALLY EXPRESSED GENES; SUPPRESSION SUBTRACTIVE HYBRIDIZATION; PROPHENOLOXIDASE-ACTIVATING SYSTEM; ANTILIPOPOLYSACCHARIDE FACTOR ALF; RNA INTERFERENCE PATHWAY; PENAEUS-MONODON; MOLECULAR-CLONING; ANTIMICROBIAL ACTIVITY	Previous studies have discovered a lot of immune-related genes responding to white spot syndrome virus (WSSV) infection in crustacean. However, little information is available in relation to underlying mechanisms of host responses during the WSSV acute infection stage in naturally infected shrimp. In this study, we employed next-generation sequencing and bioinformatic techniques to observe the transcriptome differences of the shrimp between latent infection stage and acute infection stage. A total of 64,188,426 Illumina reads, including 31,685,758 reads from the latent infection group and 32,502,668 reads from the acute infection group, were generated and assembled into 46,676 unigenes (mean length: 676 bp; range: 200-15,094 bp). Approximately 24,000 peptides were predicted and classified based on homology searches, gene ontology, clusters of orthologous groups of proteins, and biological pathway mapping. Among which, 805 differentially expressed genes were identified and categorized into 11 groups based on their possible function. Genes in the Toll and IMD pathways, the Ras-activated endocytosis process, the RNA interference pathway, anti-lipopolysaccharide factors and many other genes, were found to be activated in shrimp from latent infection stage to acute infection stage. The anti-bacterially proPO-activating cascade was firstly uncovered to be probably participated in antiviral process. These genes contain not only members playing function in host defense against WSSV, but also genes utilized by WSSV for its rapid proliferation. In addition, the transcriptome data provides detail information for identifying novel genes in absence of the genome database of shrimp.	[Li, Shihao; Zhang, Xiaojun; Sun, Zheng; Li, Fuhua; Xiang, Jianhai] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS	Li, FH (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	fhli@ms.qdio.ac.cn; jhxiang@ms.qdio.ac.cn	zhang, jin/GXV-9154-2022; xiang, jianhai/A-4767-2012	xiang, jianhai/0000-0001-5395-7787; Sun, Zheng/0000-0002-8537-8576; Grimmelikhuijzen, Cornelis Johannes Pieter/0000-0001-6486-2046	Major State Basic Research Development Program [2012CB114403]; National High Tech Research and Development Program [2012AA10A404, 2012AA092205]; National Natural Science Foundation Program [31072203]; China Agriculture Research System-47 [CARS-47]; Special Fund for Agro-scientific Research in the Public Interest [201103034]	Major State Basic Research Development Program(National Basic Research Program of China); National High Tech Research and Development Program(National High Technology Research and Development Program of China); National Natural Science Foundation Program(National Natural Science Foundation of China (NSFC)); China Agriculture Research System-47; Special Fund for Agro-scientific Research in the Public Interest	This work was financially supported by the Major State Basic Research Development Program (2012CB114403), National High Tech Research and Development Program (2012AA10A404, 2012AA092205), National Natural Science Foundation Program (31072203), China Agriculture Research System-47 (CARS-47), and Special Fund for Agro-scientific Research in the Public Interest (201103034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amparyup P, 2009, DEV COMP IMMUNOL, V33, P247, DOI 10.1016/j.dci.2008.09.003; Assavalapsakul W, 2009, DIS AQUAT ORGAN, V84, P167, DOI 10.3354/dao02044; Avadhanula V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000582; Beale KM, 2008, COMP BIOCHEM PHYS D, V3, P263, DOI 10.1016/j.cbd.2008.07.001; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Charoensapsri W, 2009, DEV COMP IMMUNOL, V33, P811, DOI 10.1016/j.dci.2009.01.006; Chen LL, 2000, DIS AQUAT ORGAN, V40, P157, DOI 10.3354/dao040157; Chen P, 2010, FISH SHELLFISH IMMUN, V28, P106, DOI 10.1016/j.fsi.2009.10.002; Chen WY, 2008, DEV COMP IMMUNOL, V32, P1142, DOI 10.1016/j.dci.2008.03.003; Chen YH, 2012, FISH SHELLFISH IMMUN, V32, P373, DOI 10.1016/j.fsi.2011.11.032; Codran A, 2006, J GEN VIROL, V87, P2583, DOI 10.1099/vir.0.81710-0; Dechklar M, 2008, BIOCHEM BIOPH RES CO, V367, P768, DOI 10.1016/j.bbrc.2008.01.031; Dhar AK, 2003, ARCH VIROL, V148, P2381, DOI 10.1007/s00705-003-0172-z; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Flegel T.W., 2008, DIS ASIAN AQUACULTUR, V6, P355; Fujioka Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016324; Gai YC, 2008, FISH SHELLFISH IMMUN, V24, P156, DOI 10.1016/j.fsi.2007.08.006; Gao HW, 2009, MOL BIOL REP, V36, P1159, DOI 10.1007/s11033-008-9292-6; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Han F, 2012, GENE, V495, P65, DOI 10.1016/j.gene.2011.11.048; He NH, 2005, ANTIVIR RES, V66, P39, DOI 10.1016/j.antiviral.2004.12.010; HOESS A, 1993, EMBO J, V12, P3351, DOI 10.1002/j.1460-2075.1993.tb06008.x; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Hossain MS, 2004, VIROLOGY, V325, P106, DOI 10.1016/j.virol.2004.05.005; Huang XD, 2010, DEV COMP IMMUNOL, V34, P107, DOI 10.1016/j.dci.2009.08.009; Huang XD, 2009, FISH SHELLFISH IMMUN, V27, P230, DOI 10.1016/j.fsi.2009.05.003; Imjongjirak C, 2007, MOL IMMUNOL, V44, P3195, DOI 10.1016/j.molimm.2007.01.028; Jiang HB, 2000, INSECT BIOCHEM MOLEC, V30, P95, DOI 10.1016/S0965-1748(99)00113-7; Jimenez-Vega F, 2007, J SHELLFISH RES, V26, P1169, DOI 10.2983/0730-8000(2007)26[1169:IOLVAA]2.0.CO;2; Jiravanichpaisal P, 2006, FISH SHELLFISH IMMUN, V20, P718, DOI 10.1016/j.fsi.2005.09.002; Jiravanichpaisal P, 2004, FISH SHELLFISH IMMUN, V17, P265, DOI 10.1016/j.fsi.2004.03.010; Kanost MR, 2004, IMMUNOL REV, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; Khadijah S, 2003, J VIROL, V77, P10162, DOI 10.1128/JVI.77.18.10162-10167.2003; Kim JG, 2012, J BIOL CHEM, V287, P5145, DOI 10.1074/jbc.M111.257634; Ko CF, 2007, DEV COMP IMMUNOL, V31, P12, DOI 10.1016/j.dci.2006.05.002; Krishnan P, 2009, DIS AQUAT ORGAN, V86, P263, DOI 10.3354/dao02126; Lai CY, 2005, FISH SHELLFISH IMMUN, V18, P417, DOI 10.1016/j.fsi.2004.10.004; Leclerc V, 2004, IMMUNOL REV, V198, P59, DOI 10.1111/j.0105-2896.2004.0130.x; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leu JH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-120; Li CH, 2008, DEV COMP IMMUNOL, V32, P784, DOI 10.1016/j.dci.2007.11.008; Li FH, 2010, DEV COMP IMMUNOL, V34, P874, DOI 10.1016/j.dci.2010.03.008; Li FH, 2009, DEV COMP IMMUNOL, V33, P1093, DOI 10.1016/j.dci.2009.06.001; Liu B, 2006, AQUACULTURE, V253, P163, DOI 10.1016/j.aquaculture.2005.08.022; Liu CH, 2006, FISH SHELLFISH IMMUN, V21, P60, DOI 10.1016/j.fsi.2005.10.004; Liu FS, 2005, MAR BIOTECHNOL, V7, P600, DOI 10.1007/s10126-005-5006-4; Liu H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706113200; Liu HP, 2006, J VIROL, V80, P10365, DOI 10.1128/JVI.01101-06; Liu WF, 2009, J PROTEOME RES, V8, P1198, DOI 10.1021/pr800840x; Magbanua FO, 2000, DIS AQUAT ORGAN, V42, P77, DOI 10.3354/dao042077; Maningas MBB, 2008, MOL IMMUNOL, V45, P1269, DOI 10.1016/j.molimm.2007.09.016; Masuda T, 2012, FISH SHELLFISH IMMUN, V32, P61, DOI 10.1016/j.fsi.2011.10.020; Mekata T, 2011, MOL CELL PROBE, V25, P94, DOI 10.1016/j.mcp.2011.02.001; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Naitza S, 2004, MOL IMMUNOL, V40, P887, DOI 10.1016/j.molimm.2003.10.008; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Olazabal IM, 2002, CURR BIOL, V12, P1413, DOI 10.1016/S0960-9822(02)01069-2; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Prapavorarat A, 2010, J BIOL CHEM, V285, P21467, DOI 10.1074/jbc.M110.130526; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Ren Q, 2009, FISH SHELLFISH IMMUN, V26, P787, DOI 10.1016/j.fsi.2009.03.004; Robalino J, 2005, J VIROL, V79, P13561, DOI 10.1128/JVI.79.21.13561-13571.2005; Roux MM, 2002, J VIROL, V76, P8978, DOI 10.1128/JVI.76.17.8978.2002; Rutschmann S, 2002, J IMMUNOL, V168, P1542, DOI 10.4049/jimmunol.168.4.1542; Saksmerprome V, 2009, J VIROL METHODS, V162, P213, DOI 10.1016/j.jviromet.2009.08.010; Sarathi M, 2008, MAR BIOTECHNOL, V10, P198, DOI 10.1007/s10126-007-9052-y; Shekhar MS, 2009, MAR BIOTECHNOL, V11, P1, DOI 10.1007/s10126-008-9155-0; Shi XZ, 2009, FISH SHELLFISH IMMUN, V27, P610, DOI 10.1016/j.fsi.2009.07.005; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Somboonwiwat K, 2005, DEV COMP IMMUNOL, V29, P841, DOI 10.1016/j.dci.2005.02.004; Sritunyalucksana K, 1999, DEV COMP IMMUNOL, V23, P179, DOI 10.1016/S0145-305X(99)00005-1; Sritunyalucksana K, 2000, AQUACULTURE, V191, P53, DOI 10.1016/S0044-8486(00)00411-7; Sritunyalucksana K, 2006, J VIROL, V80, P10734, DOI 10.1128/JVI.00349-06; Su JS, 2008, FISH SHELLFISH IMMUN, V24, P223, DOI 10.1016/j.fsi.2007.11.006; Sun C, 2011, MOL BIOL REP, V38, P5313, DOI 10.1007/s11033-011-0681-x; Sun YM, 2013, AQUACULTURE, V376, P124, DOI 10.1016/j.aquaculture.2012.11.014; Supungul P, 2004, DIS AQUAT ORGAN, V61, P123, DOI 10.3354/dao061123; Supungul P, 2002, MAR BIOTECHNOL, V4, P487, DOI 10.1007/s10126-002-0043-8; Swift ML, 1997, J CHEM INF COMP SCI, V37, P411, DOI 10.1021/ci960402j; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan LT, 2001, J FISH DIS, V24, P315, DOI 10.1046/j.1365-2761.2001.00286.x; Tanji T, 2005, TRENDS IMMUNOL, V26, P193, DOI 10.1016/j.it.2005.02.006; Tanji T, 2010, P NATL ACAD SCI USA, V107, P14715, DOI 10.1073/pnas.1009473107; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Taylor MP, 2011, NAT REV MICROBIOL, V9, P427, DOI 10.1038/nrmicro2574; Thakur PC, 2002, DIS AQUAT ORGAN, V49, P235, DOI 10.3354/dao049235; Tharntada S, 2009, J GEN VIROL, V90, P1491, DOI 10.1099/vir.0.009621-0; Tirasophon W, 2005, BIOCHEM BIOPH RES CO, V334, P102, DOI 10.1016/j.bbrc.2005.06.063; Tirasophon W, 2007, ANTIVIR RES, V74, P150, DOI 10.1016/j.antiviral.2006.11.002; Tsai MF, 1999, DIS AQUAT ORGAN, V38, P107, DOI 10.3354/dao038107; Unajak S, 2006, COMP BIOCHEM PHYS B, V145, P179, DOI 10.1016/j.cbpb.2006.07.002; Van Hamme E, 2008, J GEN VIROL, V89, P2147, DOI 10.1099/vir.0.2008/001602-0; Wang B, 2006, MAR BIOTECHNOL, V8, P491, DOI 10.1007/s10126-005-6136-4; Wang DD, 2012, CHIN J OCEANOL LIMN, V30, P611, DOI 10.1007/s00343-012-1195-7; Wang LL, 2011, AFR J BIOTECHNOL, V10, P17678, DOI 10.5897/AJB11.2017; Wang PH, 2012, DEV COMP IMMUNOL, V36, P359, DOI 10.1016/j.dci.2011.07.007; Wang PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024773; Wang PH, 2011, DEV COMP IMMUNOL, V35, P105, DOI 10.1016/j.dci.2010.08.013; Wang W, 2008, FISH SHELLFISH IMMUN, V25, P522, DOI 10.1016/j.fsi.2008.07.016; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Westenberg M, 2005, VIRUS RES, V114, P133, DOI 10.1016/j.virusres.2005.06.006; Wu WL, 2008, J PROTEOME RES, V7, P424, DOI 10.1021/pr700639t; Wu Y, 2007, AQUACULTURE, V271, P21, DOI 10.1016/j.aquaculture.2007.06.029; Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098; Xu JY, 2007, ANTIVIR RES, V73, P126, DOI 10.1016/j.antiviral.2006.08.007; Yodmuang S, 2006, BIOCHEM BIOPH RES CO, V341, P351, DOI 10.1016/j.bbrc.2005.12.186; You XX, 2010, AQUACULTURE, V305, P133, DOI 10.1016/j.aquaculture.2010.04.024; Zeng Y, 2009, FISH SHELLFISH IMMUN, V26, P646, DOI 10.1016/j.fsi.2008.11.005; Zhang Y, 2010, DEV COMP IMMUNOL, V34, P945, DOI 10.1016/j.dci.2010.04.002; Zhao PC, 2007, INSECT BIOCHEM MOLEC, V37, P952, DOI 10.1016/j.ibmb.2007.05.001; Zhao PC, 2011, INSECT BIOCHEM MOLEC, V41, P645, DOI 10.1016/j.ibmb.2011.04.006; Zhao ZY, 2007, FISH SHELLFISH IMMUN, V22, P520, DOI 10.1016/j.fsi.2006.07.003; Zhu F, 2012, MAR BIOTECHNOL, V14, P63, DOI 10.1007/s10126-011-9387-2; Zong RR, 2008, FISH SHELLFISH IMMUN, V25, P258, DOI 10.1016/j.fsi.2008.05.006	119	131	138	2	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2013	8	3							e58627	10.1371/journal.pone.0058627	http://dx.doi.org/10.1371/journal.pone.0058627			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SR	24098432	Green Published, gold, Green Submitted			2022-12-25	WOS:000317562100033
J	Liu, Y; Miao, W; Wang, JQ; Gao, PY; Yin, GH; Zhang, LP; Lv, CK; Ji, ZY; Yu, T; Sabel, BA; He, HG; Peng, Y				Liu, Yue; Miao, Wen; Wang, Jieqiong; Gao, Peiyi; Yin, Guangheng; Zhang, Liping; Lv, Chuankai; Ji, Zhiying; Yu, Tong; Sabel, B. A.; He, Huiguang; Peng, Yun			Structural Abnormalities in Early Tourette Syndrome Children: A Combined Voxel-Based Morphometry and Tract-Based Spatial Statistics Study	PLOS ONE			English	Article							TIC SEVERITY; FRONTAL-LOBE; BRAIN; VOLUMES; CONNECTIVITY; LOCALIZATION; INHIBITION; PREVALENCE; ATTENTION; SYSTEM	Tourette Syndrome (TS) is characterized with chronic motor and vocal tics beginning in childhood. Abnormality of both gray (GM) and white matter (WM) has been observed in cortico-striato-thalamo-cortical circuits and sensory-motor cortex of adult TS patient. It is not clear if these morphological changes are also present in TS children and if there are any microstructural changes of WM. To understand the developmental cause of such changes, we investigated volumetric changes of GM and WM using VBM and microstructural changes of WM using DTI, and correlated these changes with tic severity and duration. T1 images and Diffusion Tensor Images (DTI) from 21 TS children were compared with 20 age and gender matched health control children using a 1.5T Philips scanner. All of the 21 TS children met the DSM-IV-TR criteria. T1 images were analyzed using DARTEL-VBM in conjunction with statistical parametric mapping (SPM). Diffusion tensor imaging (DTI) analysis was performed using Tract-Based Spatial Statistics (TBSS). Brain volume changes were found in left superior temporal gyrus, left and right paracentral gyrus, right precuneous cortex, right pre- and post-central gyrus, left temporal occipital fusiform cortex, right frontal pole, and left lingual gyrus. Significant axial diffusivity (AD) and mean diffusivity (MD) increases were found in anterior thalamic radiation, right cingulum bundle projecting to the cingulate gurus and forceps minor. Decreases in white matter volume (WMV) in the right frontal pole were inversely related with tic severity (YGTSS), and increases in AD and MD were positively correlated with tic severity and duration, respectively. These changes in TS children can be interpreted as signs of neural plasticity in response to the experiential demand. Our findings may suggest that the morphological and microstructural measurements from structural MRI and DTI can potentially be used as a biomarker of the pathophysiologic pattern of early TS children.	[Liu, Yue; Yin, Guangheng; Lv, Chuankai; Yu, Tong; Peng, Yun] Capital Med Univ, Beijing Childrens Hosp, Dept Radiol, Beijing, Peoples R China; [Miao, Wen; Wang, Jieqiong; Sabel, B. A.; He, Huiguang] Chinese Acad Sci, State Key Lab Management & Control Complex Syst, Inst Automat, Beijing, Peoples R China; [Liu, Yue; Yin, Guangheng; Lv, Chuankai; Yu, Tong; Peng, Yun] Capital Med Univ, Beijing Key Lab Magnet Imaging Device & Tech, Beijing Childrens Hosp, Beijing, Peoples R China; [Gao, Peiyi] Capital Med Univ, Beijing Tiantan Hosp, Dept Neuroradiol, Beijing, Peoples R China; [Zhang, Liping; Ji, Zhiying] Capital Med Univ, Dept Med, Beijing Childrens Hosp, Beijing, Peoples R China; [Sabel, B. A.] Univ Magdeburg, Fac Med, Inst Med Psychol, D-39106 Magdeburg, Germany	Capital Medical University; Chinese Academy of Sciences; Institute of Automation, CAS; Capital Medical University; Capital Medical University; Capital Medical University; Otto von Guericke University	He, HG (corresponding author), Chinese Acad Sci, State Key Lab Management & Control Complex Syst, Inst Automat, Beijing, Peoples R China.	huiguang.he@ia.ac.cn; ppengyun@yahoo.com	Du, Zhaohui/AAK-6231-2021; Xue, Fuzhong/AAG-4808-2020; zhang, liwen/L-7005-2016; He, Huiguang/AAD-7643-2020	Du, Zhaohui/0000-0002-7125-8928; He, Huiguang/0000-0002-0684-1711; Xue, Fuzhong/0000-0003-0378-7956	National Natural Science Foundation of China [61271151, 61228103, 31271161]; capital health research and development of special [2011-2009-03]; Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); capital health research and development of special; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China (61271151, 61228103, and 31271161) and the capital health research and development of special (2011-2009-03). SB was partly supported by Chinese Academy of Sciences Senior Visiting Professorships Programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bloch MH, 2005, NEUROLOGY, V65, P1253, DOI 10.1212/01.wnl.0000180957.98702.69; Bohlhalter S, 2006, BRAIN, V129, P2029, DOI 10.1093/brain/awl050; Boroojerdi B, 1999, BRIT J PSYCHIAT, V175, P375, DOI 10.1192/bjp.175.4.375; CDE MR, 2011, MULT SCLER INT, V2011, P4875; COMINGS DE, 1984, AM J HUM GENET, V36, P586; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; Draganski B, 2010, BRAIN, V133, P3661, DOI 10.1093/brain/awq300; Fahim C, 2009, BRAIN TOPOGR, V22, P176, DOI 10.1007/s10548-009-0105-6; Fan Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035889; Fredericksen KA, 2002, NEUROLOGY, V58, P85, DOI 10.1212/WNL.58.1.85; Gerard E, 2003, J PSYCHOSOM RES, V55, P13, DOI 10.1016/S0022-3999(02)00581-0; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hugdahl K, 1998, BEHAV BRAIN SCI, V21, P335, DOI 10.1017/S0140525X98301211; Huppi PS, 2006, SEMIN FETAL NEONAT M, V11, P489, DOI 10.1016/j.siny.2006.07.006; Kates WR, 2002, PSYCHIAT RES-NEUROIM, V116, P63, DOI 10.1016/S0925-4927(02)00066-5; Knight T, 2012, PEDIATR NEUROL, V47, P77, DOI 10.1016/j.pediatrneurol.2012.05.002; LECKMAN JF, 1989, J AM ACAD CHILD PSY, V28, P566, DOI 10.1097/00004583-198907000-00015; Lucas A R, 1982, Adv Neurol, V35, P267; Makki MI, 2008, MOVEMENT DISORD, V23, P2349, DOI 10.1002/mds.22264; Marsh R, 2007, AM J PSYCHIAT, V164, P955, DOI 10.1176/appi.ajp.164.6.955; Mason A, 1998, DEV MED CHILD NEUROL, V40, P292; Miao W, 2013, AM J NEURORADIOL, V34, P1264, DOI 10.3174/ajnr.A3370; Muller-Vahl KR, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-47; Neuner I, 2010, NEUROIMAGE, V51, P1184, DOI 10.1016/j.neuroimage.2010.02.049; Neuner Irene, 2009, Biol Psychiatry, V65, pe5, DOI 10.1016/j.biopsych.2008.09.030; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Petek E, 2001, AM J HUM GENET, V68, P848, DOI 10.1086/319523; Peterson BS, 2003, ARCH GEN PSYCHIAT, V60, P415, DOI 10.1001/archpsyc.60.4.415; Peterson BS, 2001, ARCH GEN PSYCHIAT, V58, P427, DOI 10.1001/archpsyc.58.5.427; Plessen KJ, 2009, J PSYCHOSOM RES, V67, P559, DOI 10.1016/j.jpsychores.2009.07.005; Plessen KJ, 2004, AM J PSYCHIAT, V161, P2028, DOI 10.1176/appi.ajp.161.11.2028; Retz-Junginger P, 2003, NERVENARZT, V74, P987, DOI 10.1007/s00115-002-1447-4; Rueda MR, 2005, DEV NEUROPSYCHOL, V28, P573, DOI 10.1207/s15326942dn2802_2; Scahill L, 1997, J AM ACAD CHILD PSY, V36, P844, DOI 10.1097/00004583-199706000-00023; Schiffer B, 2007, J PSYCHIATR RES, V41, P753, DOI 10.1016/j.jpsychires.2006.06.003; Shprecher D, 2009, MOVEMENT DISORD, V24, P15, DOI 10.1002/mds.22378; Singer HS, 2005, LANCET NEUROL, V4, P149, DOI 10.1016/S1474-4422(05)01012-4; Singer HS, 2003, BRAIN DEV-JPN, V25, pS70, DOI 10.1016/S0387-7604(03)90012-X; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sowell ER, 2008, NAT NEUROSCI, V11, P637, DOI 10.1038/nn.2121; Stern JS, 2005, POSTGRAD MED J, V81, P12, DOI 10.1136/pgmj.2004.023614; STOKES A, 1991, PEDIATRICS, V87, P936; Thomalla G, 2009, BRAIN, V132, P765, DOI 10.1093/brain/awn339; Uddin LQ, 2011, J NEUROSCI, V31, P18578, DOI 10.1523/JNEUROSCI.4465-11.2011	50	38	53	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2013	8	9							e76105	10.1371/journal.pone.0076105	http://dx.doi.org/10.1371/journal.pone.0076105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231NL	24098769	Green Submitted, Green Published, gold			2022-12-25	WOS:000325423500139
J	Okumura, N; Kay, EP; Nakahara, M; Hamuro, J; Kinoshita, S; Koizumi, N				Okumura, Naoki; Kay, EunDuck P.; Nakahara, Makiko; Hamuro, Junji; Kinoshita, Shigeru; Koizumi, Noriko			Inhibition of TGF-beta Signaling Enables Human Corneal Endothelial Cell Expansion In Vitro for Use in Regenerative Medicine	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; ALLOGRAFT-REJECTION; AMNIOTIC MEMBRANE; ROCK INHIBITOR; AQUEOUS-HUMOR; RABBIT MODEL; TRANSPLANTATION; KERATOPLASTY; PRIMATE; VIVO	Corneal endothelial dysfunctions occurring in patients with Fuchs' endothelial corneal dystrophy, pseudoexfoliation syndrome, corneal endotheliitis, and surgically induced corneal endothelial damage cause blindness due to the loss of endothelial function that maintains corneal transparency. Transplantation of cultivated corneal endothelial cells (CECs) has been researched to repair endothelial dysfunction in animal models, though the in vitro expansion of human CECs (HCECs) is a pivotal practical issue. In this study we established an optimum condition for the cultivation of HCECs. When exposed to culture conditions, both primate and human CECs showed two distinct phenotypes: contact-inhibited polygonal monolayer and fibroblastic phenotypes. The use of SB431542, a selective inhibitor of the transforming growth factor-beta (TGF-beta) receptor, counteracted the fibroblastic phenotypes to the normal contact-inhibited monolayer, and these polygonal cells maintained endothelial physiological functions. Expression of ZO-1 and Na+/K+-ATPase maintained their subcellular localization at the plasma membrane. Furthermore, expression of type I collagen and fibronectin was greatly reduced. This present study may prove to be the substantial protocol to provide the efficient in vitro expansion of HCECs with an inhibitor to the TGF-beta receptor, and may ultimately provide clinicians with a new therapeutic modality in regenerative medicine for the treatment of corneal endothelial dysfunctions.	[Okumura, Naoki; Kay, EunDuck P.; Nakahara, Makiko; Koizumi, Noriko] Doshisha Univ, Fac Life & Med Sci, Dept Biomed Engn, Kyotanabe, Japan; [Okumura, Naoki; Hamuro, Junji; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan	Doshisha University; Kyoto Prefectural University of Medicine	Koizumi, N (corresponding author), Doshisha Univ, Fac Life & Med Sci, Dept Biomed Engn, Kyotanabe, Japan.	nkoizumi@mail.doshisha.ac.jp			Highway Program for realization of regenerative medicine; Funding Program for Next Generation World-Leading Researchers from the Cabinet Office in Japan [LS117]; Grants-in-Aid for Scientific Research [23659818] Funding Source: KAKEN	Highway Program for realization of regenerative medicine; Funding Program for Next Generation World-Leading Researchers from the Cabinet Office in Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was supported in part by the Highway Program for realization of regenerative medicine (Kinoshita and Okumura); http://www.mext.go.jp/english/; and the Funding Program for Next Generation World-Leading Researchers from the Cabinet Office in Japan (Koizumi: LS117); http://www.jsps.go.jp/english/e-jisedai/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRY PA, 1995, INVEST OPHTH VIS SCI, V36, P1115; Buijs JT, 2007, AM J PATHOL, V171, P1047, DOI 10.2353/ajpath.2007.070168; Chen KH, 1999, INVEST OPHTH VIS SCI, V40, P2513; Coster DJ, 2005, AM J OPHTHALMOL, V140, P1112, DOI 10.1016/j.ajo.2005.07.024; Darlington JK, 2006, OPHTHALMOLOGY, V113, P2171, DOI 10.1016/j.ophtha.2006.06.034; Engelmann K, 2004, EXP EYE RES, V78, P573, DOI 10.1016/S0014-4835(03)00209-4; Gorovoy MS, 2006, CORNEA, V25, P886, DOI 10.1097/01.ico.0000214224.90743.01; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Ishino Y, 2004, INVEST OPHTH VIS SCI, V45, P800, DOI 10.1167/iovs.03-0016; Joyce Nancy C, 2004, Cornea, V23, pS8, DOI 10.1097/01.ico.0000136666.63870.18; Kaimori A, 2007, J BIOL CHEM, V282, P22089, DOI 10.1074/jbc.M700998200; Kawaguchi R, 2001, CORNEA, V20, P100, DOI 10.1097/00003226-200101000-00019; Khaireddin R, 2003, GRAEF ARCH CLIN EXP, V241, P1020, DOI 10.1007/s00417-003-0759-9; Kim TY, 2001, INVEST OPHTH VIS SCI, V42, P3142; Ko MK, 2001, EXP CELL RES, V264, P363, DOI 10.1006/excr.2000.5155; Koizumi N, 2000, INVEST OPHTH VIS SCI, V41, P2506; Koizumi N, 2008, CORNEA, V27, pS48, DOI 10.1097/ICO.0b013e31817f2298; Koizumi N, 2008, OPHTHALMOLOGY, V115, P292, DOI 10.1016/j.ophtha.2007.04.053; Koizumi N, 2007, INVEST OPHTH VIS SCI, V48, P4519, DOI 10.1167/iovs.07-0567; Koizumi N, 2012, EXP EYE RES, V95, P60, DOI 10.1016/j.exer.2011.10.014; Li W, 2007, INVEST OPHTH VIS SCI, V48, P614, DOI 10.1167/iovs.06-1126; Ma Frank Y, 2009, Front Biosci (Schol Ed), V1, P171, DOI 10.2741/s17; Melles GRJ, 2000, OPHTHALMOLOGY, V107, P1850, DOI 10.1016/S0161-6420(00)00253-0; Mimura T, 2005, INVEST OPHTH VIS SCI, V46, P3128, DOI 10.1167/iovs.05-0251; Mimura T, 2004, INVEST OPHTH VIS SCI, V45, P2992, DOI 10.1167/iovs.03-1174; Mimura T, 2003, EXP EYE RES, V76, P745, DOI 10.1016/S0014-4835(03)00057-5; Miyata K, 2001, CORNEA, V20, P59, DOI 10.1097/00003226-200101000-00012; Naumann GOH, 2000, OPHTHALMOLOGY, V107, P1111, DOI 10.1016/S0161-6420(00)00087-7; Okumura N, 2012, AM J PATHOL, V181, P268, DOI 10.1016/j.ajpath.2012.03.033; Okumura N, 2009, INVEST OPHTH VIS SCI, V50, P3680, DOI 10.1167/iovs.08-2634; Parsons CJ, 2007, J GASTROEN HEPATOL, V22, pS79, DOI 10.1111/j.1440-1746.2006.04659.x; Patel SV, 2009, INVEST OPHTH VIS SCI, V50, P2123, DOI 10.1167/iovs.08-2653; Peh GSL, 2011, TRANSPLANTATION, V91, P811, DOI 10.1097/TP.0b013e3182111f01; Price FW, 2005, J REFRACT SURG, V21, P339; Price MO, 2010, CLIN EXP OPHTHALMOL, V38, P128, DOI 10.1111/j.1442-9071.2010.02213.x; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Saika S, 2006, LAB INVEST, V86, P106, DOI 10.1038/labinvest.3700375; Simic P, 2007, EMBO REP, V8, P327, DOI 10.1038/sj.embor.7400943; Song JS, 2010, INVEST OPHTH VIS SCI, V51, P822, DOI 10.1167/iovs.09-4240; Sumide T, 2006, FASEB J, V20, P392, DOI 10.1096/fj.04-3035fje; Wendt MK, 2009, FUTURE ONCOL, V5, P1145, DOI 10.2217/FON.09.90; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200; Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs.03-0814	45	147	152	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e58000	10.1371/journal.pone.0058000	http://dx.doi.org/10.1371/journal.pone.0058000			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451286	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500147
J	Toh, HS; Cao, MJ; Daniels, E; Bateman, A				Toh, Huishi; Cao, Mingju; Daniels, Eugene; Bateman, Andrew			Expression of the Growth Factor Progranulin in Endothelial Cells Influences Growth and Development of Blood Vessels: A Novel Mouse Model	PLOS ONE			English	Article							GRANULIN-EPITHELIN PRECURSOR; PERLECAN PROTEIN CORE; GENE-EXPRESSION; EXTRACELLULAR-MATRIX; TRANSGENIC MICE; BREAST-CANCER; HOST-DEFENSE; IN-VIVO; ANGIOGENESIS; VASCULOGENESIS	Progranulin is a secreted glycoprotein that regulates cell proliferation, migration and survival. It has roles in development, tumorigenesis, wound healing, neurodegeneration and inflammation. Endothelia in tumors, wounds and placenta express elevated levels of progranulin. In culture, progranulin activates endothelial proliferation and migration. This suggested that progranulin might regulate angiogenesis. It was, however, unclear how elevated endothelial progranulin levels influence vascular growth in vivo. To address this issue, we generated mice with progranulin expression targeted specifically to developing endothelial cells using a Tie2-promoter/enhancer construct. Three Tie2-Grn mouse lines were generated with varying Tie2-Grn copy number, and were called GrnLo, GrnMid, and GrnHi. All three lines showed increased mortality that correlates with Tie2-Grn copy number, with greatest mortality and lowest germline transmission in the GrnHi line. Death of the transgenic animals occurred around birth, and continued for three days after birth. Those that survived beyond day 3 survived into adulthood. Transgenic neonates that died showed vascular abnormalities of varying severity. Some exhibited bleeding into body cavities such as the pericardial space. Smaller localized hemorrhages were seen in many organs. Blood vessels were often dilated and thin-walled. To establish the development of these abnormalities, we examined mice at early (E10.5-14.5) and later (E15.5-17.5) developmental phases. Early events during vasculogenesis appear unaffected by Tie2-Grn as apparently normal primary vasculature had been established at E10.5. The earliest onset of vascular abnormality was at E15.5, with focal cerebral hemorrhage and enlarged vessels in various organs. Aberrant Tie2-Grn positive vessels showed thinning of the basement membrane and reduced investiture with mural cells. We conclude that progranulin promotes exaggerated vessel growth in vivo, with subsequent effects in the formation of the mural cell layer and weakening of vessel integrity. These results demonstrate that overexpression of progranulin in endothelial cells influences normal angiogenesis in vivo.	[Toh, Huishi; Cao, Mingju; Bateman, Andrew] McGill Univ, Ctr Hlth, Royal Victoria Hosp, Dept Med,Div Endocrinol & Metab, Montreal, PQ, Canada; [Daniels, Eugene] McGill Univ, Fac Med, Dept Anat & Cell Biol, Montreal, PQ, Canada	McGill University; Royal Victoria Hospital; McGill University	Bateman, A (corresponding author), McGill Univ, Ctr Hlth, Royal Victoria Hosp, Dept Med,Div Endocrinol & Metab, Montreal, PQ, Canada.	andrew.bateman@muhc.mcgill.ca		Bateman, Andrew/0000-0003-0597-769X; Toh, Huishi/0000-0002-8843-8263	Canadian Institute of Health Sciences (CIHR); Canadian Cancer Society Research Institute [CCSRI 700379]	Canadian Institute of Health Sciences (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	This study was supported by grants from Canadian Institute of Health Sciences (CIHR) and Canadian Cancer Society Research Institute (CCSRI 700379.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsson A, 2002, CIRCULATION, V105, P112, DOI 10.1161/hc0102.101437; Andres AC, 2010, J MAMMARY GLAND BIOL, V15, P319, DOI 10.1007/s10911-010-9186-9; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bao P, 2009, J SURG RES, V153, P347, DOI 10.1016/j.jss.2008.04.023; Bateman A, 2009, BIOESSAYS, V31, P1245, DOI 10.1002/bies.200900086; Bishop A, 2008, J Wound Care, V17, P399; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chen XY, 2008, CHINESE MED J-PEKING, V121, P881, DOI 10.1097/00029330-200805020-00004; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; Davidson B, 2004, CANCER-AM CANCER SOC, V100, P2139, DOI 10.1002/cncr.20219; Demir R, 2010, ACTA HISTOCHEM, V112, P203, DOI 10.1016/j.acthis.2009.04.004; Desmarais JA, 2008, REPRODUCTION, V136, P247, DOI 10.1530/REP-08-0044; Drake CJ, 2000, BLOOD, V95, P1671, DOI 10.1182/blood.V95.5.1671.005k39_1671_1679; Elkabets M, 2011, J CLIN INVEST, V121, P784, DOI 10.1172/JCI43757; Evans V, 2000, PHYSIOL GENOMICS, V2, P67, DOI 10.1152/physiolgenomics.2000.2.2.67; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Gonzalez EM, 2003, J BIOL CHEM, V278, P38113, DOI 10.1074/jbc.C300310200; Handler M, 1997, DEV DYNAM, V210, P130, DOI 10.1002/(SICI)1097-0177(199710)210:2<130::AID-AJA6>3.0.CO;2-H; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; Heazell AEP, 2007, PLACENTA, V28, pS33, DOI 10.1016/j.placenta.2006.10.007; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Ho JC, 2008, HEPATOLOGY, V47, P1524, DOI 10.1002/hep.22191; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Khalid MEM, 1997, INT J GYNECOL OBSTET, V57, P259, DOI 10.1016/S0020-7292(97)00067-2; Li LQ, 2012, PATHOL RES PRACT, V208, P210, DOI 10.1016/j.prp.2012.02.001; Lijnen HR, 2008, CARDIOVASC RES, V78, P286, DOI 10.1093/cvr/cvm007; Miko I., 2008, NATURE ED, V1; Mongiat M, 2003, J BIOL CHEM, V278, P17491, DOI 10.1074/jbc.M210529200; Nakagawa T, 2009, DIABETES, V58, P1471, DOI 10.2337/db09-0119; Ong CHP, 2003, HISTOL HISTOPATHOL, V18, P1275, DOI 10.14670/HH-18.1275; Papetti M, 2002, AM J PHYSIOL-CELL PH, V282, pC947, DOI 10.1152/ajpcell.00389.2001; Park B, 2011, IMMUNITY, V34, P505, DOI 10.1016/j.immuni.2011.01.018; PEREIRA R, 1994, J CLIN INVEST, V93, P1765, DOI 10.1172/JCI117161; Person AD, 2005, INT REV CYTOL, V243, P287, DOI 10.1016/S0074-7696(05)43005-3; Ponce ML, 2001, ANGIOGENESIS PROTOCO; Praidou A, 2010, CURR DIABETES REV, V6, P304, DOI 10.2174/157339910793360815; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; SCHNURCH H, 1993, DEVELOPMENT, V119, P957; Schroeder JA, 2003, J MOL MED-JMM, V81, P392, DOI 10.1007/s00109-003-0456-5; Segev A, 2004, CARDIOVASC RES, V63, P603, DOI 10.1016/j.cardiores.2004.03.028; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Silver L.M., 1995, MOUSE GENETICS CONCE; Sullivan DD, 2003, BRIT J CANCER, V89, P228, DOI 10.1038/sj.bjc.6601107; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Tangkeangsirisin W, 2004, CARCINOGENESIS, V25, P1587, DOI 10.1093/carcin/bgh171; Toh H, 2011, J MOL NEUROSCI, V45, P538, DOI 10.1007/s12031-011-9569-4; Trampont P, 2004, HUM PATHOL, V35, P1353, DOI 10.1016/j.humpath.2004.07.003; Wang M, 2012, MED ONCOLOGY; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zeng X, 1998, DEV DYNAM, V211, P215, DOI 10.1002/(SICI)1097-0177(199803)211:3<215::AID-AJA3>3.0.CO;2-K; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	55	101	105	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64989	10.1371/journal.pone.0064989	http://dx.doi.org/10.1371/journal.pone.0064989			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	24116025	Green Submitted, gold, Green Published			2022-12-25	WOS:000319799900154
J	Luo, JL; Li, WF; Qiu, J; Wei, DT; Liu, YJ; Zhang, QL				Luo, Junlong; Li, Wenfu; Qiu, Jiang; Wei, Dongtao; Liu, Yijun; Zhang, Qinlin			Neural Basis of Scientific Innovation Induced by Heuristic Prototype	PLOS ONE			English	Article							DIVERGENT THINKING; CREATIVE-THINKING; INSIGHT; EEG; MEMORY; RECOGNITION; PERFORMANCE; LOCUS; FMRI	A number of major inventions in history have been based on bionic imitation. Heuristics, by applying biological systems to the creation of artificial devices and machines, might be one of the most critical processes in scientific innovation. In particular, prototype heuristics propositions that innovation may engage automatic activation of a prototype such as a biological system to form novel associations between a prototype's function and problem-solving. We speculated that the cortical dissociation between the automatic activation and forming novel associations in innovation is critical point to heuristic creativity. In the present study, novel and old scientific innovations (NSI and OSI) were selected as experimental materials in using learning-testing paradigm to explore the neural basis of scientific innovation induced by heuristic prototype. College students were required to resolve NSI problems (to which they did not know the answers) and OSI problems (to which they knew the answers). From two fMRI experiments, our results showed that the subjects could resolve NSI when provided with heuristic prototypes. In Experiment 1, it was found that the lingual gyrus (LG; BA18) might be related to prototype heuristics in college students resolving NSI after learning a relative prototype. In Experiment 2, the LG (BA18) and precuneus (BA31) were significantly activated for NSI compared to OSI when college students learned all prototypes one day before the test. In addition, the mean beta-values of these brain regions of NSI were all correlated with the behavior accuracy of NSI. As our hypothesis indicated, the findings suggested that the LG might be involved in forming novel associations using heuristic information, while the precuneus might be involved in the automatic activation of heuristic prototype during scientific innovation.	[Luo, Junlong; Li, Wenfu; Qiu, Jiang; Wei, Dongtao; Liu, Yijun; Zhang, Qinlin] Southwest Univ, Sch Psychol, Key Lab Cognit & Personal, Chongqing, Peoples R China; [Luo, Junlong] Shanghai Normal Univ, Coll Educ, Shanghai, Peoples R China	Southwest University - China; Shanghai Normal University	Qiu, J (corresponding author), Southwest Univ, Sch Psychol, Key Lab Cognit & Personal, Chongqing, Peoples R China.	qiuj318@swu.edu.cn; qlzhang.swu@gmail.com	Luo, Jianfei/O-9548-2019; Luo, Jianfei/P-7219-2017	Luo, Jianfei/0000-0002-9570-4224; Luo, Jianfei/0000-0002-9570-4224	National Natural Science Foundation of China [31170983, 30970892, 31200768, 31070900, 31271087]; Program for New Century Excellent Talents in University by the Ministry of Education; Program for Talents in Colleges and Universities in Chongqing; Fundamental Research Funds for the Central Universities [SWU1209101]; Key Discipline Fund of National 211 Project [NSKD11007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University by the Ministry of Education(Program for New Century Excellent Talents in University (NCET)); Program for Talents in Colleges and Universities in Chongqing; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Key Discipline Fund of National 211 Project	This research was supported by the National Natural Science Foundation of China (31170983; 30970892; 31200768; 31070900; 31271087), the Program for New Century Excellent Talents in University (2011) by the Ministry of Education, the Program for Talents in Colleges and Universities in Chongqing, the Fundamental Research Funds for the Central Universities (SWU1209101) and the Key Discipline Fund of National 211 Project (NSKD11007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischof M, 2004, ANN NEUROL, V56, P583, DOI 10.1002/ana.20246; BLAGROVE M, 1994, PERS INDIV DIFFER, V16, P981, DOI 10.1016/0191-8869(94)90242-9; Blagrove M, 2000, PERS INDIV DIFFER, V28, P41, DOI 10.1016/S0191-8869(99)00078-1; Bowden EM, 2005, TRENDS COGN SCI, V9, P322, DOI 10.1016/j.tics.2005.05.012; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Carlsson I, 2000, NEUROPSYCHOLOGIA, V38, P873, DOI 10.1016/S0028-3932(99)00128-1; Dickinson MH, 1999, P NATL ACAD SCI USA, V96, P14208, DOI 10.1073/pnas.96.25.14208; Dietrich A, 2010, PSYCHOL BULL, V136, P822, DOI 10.1037/a0019749; Dobbins IG, 2003, NEUROPSYCHOLOGIA, V41, P318, DOI 10.1016/S0028-3932(02)00164-1; DOMINO G, 1970, J CONSULT CLIN PSYCH, V35, P48, DOI 10.1037/h0029624; Fink A, 2006, EUR J NEUROSCI, V23, P2241, DOI 10.1111/j.1460-9568.2006.04751.x; Fink A, 2007, METHODS, V42, P68, DOI 10.1016/j.ymeth.2006.12.001; Fink A, 2010, NEUROIMAGE, V52, P1687, DOI 10.1016/j.neuroimage.2010.05.072; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Jausovec N, 2000, INT J PSYCHOPHYSIOL, V36, P73, DOI 10.1016/S0167-8760(99)00113-0; Jausovec N, 2000, BRAIN TOPOGR, V12, P229, DOI 10.1023/A:1023446024923; Jin SH, 2006, BRAIN COGNITION, V62, P191, DOI 10.1016/j.bandc.2006.05.001; Jung RE, 2010, HUM BRAIN MAPP, V31, P398, DOI 10.1002/hbm.20874; Jung-Beeman M, 2004, PLOS BIOL, V2, P500, DOI 10.1371/journal.pbio.0020097; Luo J, 2004, NEUROREPORT, V15, P2013, DOI 10.1097/00001756-200409150-00004; Luo J, 2003, HIPPOCAMPUS, V13, P316, DOI 10.1002/hipo.10069; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Molle M, 1999, PSYCHOPHYSIOLOGY, V36, P95, DOI 10.1017/S0048577299961619; Morrison I, 2011, J NEUROSCI, V31, P9554, DOI 10.1523/JNEUROSCI.0397-11.2011; Nyberg L, 2000, J COGNITIVE NEUROSCI, V12, P163, DOI 10.1162/089892900561805; Qiu J, 2010, CORTEX, V46, P397, DOI 10.1016/j.cortex.2009.06.006; Razoumnikova OM, 2000, COGNITIVE BRAIN RES, V10, P11, DOI 10.1016/S0926-6410(00)00017-3; Rugg MD, 1998, NEUROIMAGE, V8, P262, DOI 10.1006/nimg.1998.0363; Stoppel CM, 2009, HUM BRAIN MAPP, V30, P3759, DOI 10.1002/hbm.20804; Takeuchi H, 2011, NEUROIMAGE, V55, P681, DOI 10.1016/j.neuroimage.2010.11.052; Talairach J., 1988, COPLANAR STEREOTAXIC; Tian F, 2011, BEHAV BRAIN RES, V216, P626, DOI 10.1016/j.bbr.2010.09.005; Vogel S, 2000, CATS PAWS CATAPULTS	34	87	108	12	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e49231	10.1371/journal.pone.0049231	http://dx.doi.org/10.1371/journal.pone.0049231			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093RV	24098501	Green Published, Green Submitted, gold			2022-12-25	WOS:000315210400001
J	Luo, JF; Wang, Y; Tang, SS; Liang, JW; Lin, WT; Luo, LX				Luo, Jianfei; Wang, Yuan; Tang, Shuishui; Liang, Jianwen; Lin, Weitie; Luo, Lixin			Isolation and Identification of Algicidal Compound from Streptomyces and Algicidal Mechanism to Microcystis aeruginosa	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; TOXIC DINOFLAGELLATE; BIOLOGICAL-ACTIVITY; RED-TIDE; CYANOBACTERIA; BACTERIUM; SAPONIN; METABOLITES; BLOOMS; FUNGUS	The biological control of cyanobacterial harmful algal blooms (cyanoHABs) is important to promote human health, environmental protection, and economic growth. Active algicidal compounds and algicidal mechanisms should be identified and investigated to control cyanoHABs. In this study, the algicidal actinobacterium Streptomyces sp. L74 was isolated from the soil of a nearby pond which located in the center lake of Guanghzou Higher Education Mega Center. Results showed that the algicidal activities of cyanoHABs are mainly achieved via an indirect attack by producing algicidal compounds. All active algicidal compounds are hydrophilic substances that are heat and pH stable. In the present study, an active compound (B3) was isolated and purified by high-performance liquid chromatography and identified as a type of triterpenoid saponin (2-hydroxy-12-oleanene-3, 28-O-D- glucopyranosyl) with a molecular formula of C42H70O13 as determined by infrared spectrometry, electrospray ionization mass spectrometry, and nuclear magnetic resonance. Active algicidal compounds from Streptomyces sp. L74 were shown to disrupt the antioxidant systems of Microcystis aeruginosa cells.	[Luo, Jianfei; Wang, Yuan; Tang, Shuishui; Liang, Jianwen; Lin, Weitie; Luo, Lixin] S China Univ Technol, Coll Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China	South China University of Technology	Lin, WT (corresponding author), S China Univ Technol, Coll Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China.	weitie@21cn.com; btlxluo@scut.edu.cn	Luo, Jianfei/O-9548-2019; Luo, Jianfei/P-7219-2017	Luo, Jianfei/0000-0002-9570-4224; Luo, Jianfei/0000-0002-9570-4224	National Natural Science Foundation of China [21076090, 21276099]; Specialized Research Found for the Doctoral Program of Higher Education of China [20120172120045]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Found for the Doctoral Program of Higher Education of China	This work was supported by the National Natural Science Foundation of China (21076090 and 21276099) and the Specialized Research Found for the Doctoral Program of Higher Education of China (20120172120045)(http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H E, 1983, METHOD ENZYMATIC ANA, P273, DOI DOI 10.1016/B978-0-12-091302-2.50032-3; Ahn CY, 2003, BIOTECHNOL LETT, V25, P1137, DOI 10.1023/A:1024508927361; Aliyu AB, 2011, J MED PLANTS RES, V5, P6709, DOI 10.5897/JMPR10.708; Anderson DM, 1997, NATURE, V388, P513, DOI 10.1038/41415; Arabski M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/286216; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Bai SJJ, 2011, CURR MICROBIOL, V62, P1774, DOI 10.1007/s00284-011-9927-z; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Choi HJ, 2005, BIOL CONTROL, V33, P335, DOI 10.1016/j.biocontrol.2005.03.007; CIVELLO PM, 1995, J AGR FOOD CHEM, V43, P2596, DOI 10.1021/jf00058a008; DAFT MJ, 1975, FRESHWATER BIOL, V5, P577, DOI 10.1111/j.1365-2427.1975.tb00157.x; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Gause GF, 2004, HDB MICROBIOLOGICAL, P704; Hasegawa H, 1996, PLANTA MED, V62, P453, DOI 10.1055/s-2006-957938; Isaka M, 2011, J NAT PROD, V74, P300, DOI 10.1021/np100873t; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lee SO, 2000, APPL ENVIRON MICROB, V66, P4334, DOI 10.1128/AEM.66.10.4334-4339.2000; Mayali X, 2004, J EUKARYOT MICROBIOL, V51, P139, DOI 10.1111/j.1550-7408.2004.tb00538.x; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mu RM, 2007, J ENVIRON SCI-CHINA, V19, P1336, DOI 10.1016/S1001-0742(07)60218-6; Nakamura N, 2003, J BIOSCI BIOENG, V95, P179, DOI 10.1263/jbb.95.179; Noike M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042090; Noike M, 2012, CHEMBIOCHEM, V13, P566, DOI 10.1002/cbic.201100725; Pelaez F, 2000, SYST APPL MICROBIOL, V23, P333, DOI 10.1016/S0723-2020(00)80062-4; Podolak Irma, 2007, Acta Pol Pharm, V64, P39; REDHEAD K, 1978, APPL ENVIRON MICROB, V35, P962, DOI 10.1128/AEM.35.5.962-969.1978; SAFFERMAN RS, 1963, SCIENCE, V140, P679, DOI 10.1126/science.140.3567.679; SAFFERMAN RS, 1962, APPL MICROBIOL, V10, P289, DOI 10.1128/AEM.10.4.289-292.1962; Sakata T, 2011, FISHERIES SCI, V77, P397, DOI 10.1007/s12562-011-0345-8; Sengco MR, 2004, J EUKARYOT MICROBIOL, V51, P169, DOI 10.1111/j.1550-7408.2004.tb00541.x; SHIGEMATSU N, 1992, J ANTIBIOT, V45, P704, DOI 10.7164/antibiotics.45.704; Skerratt JH, 2002, MAR ECOL PROG SER, V244, P1, DOI 10.3354/meps244001; Son JW, 2008, BIOTECHNOL LETT, V30, P713, DOI 10.1007/s10529-007-9590-4; Tan H, 2009, LETT APPL MICROBIOL, V49, P248, DOI 10.1111/j.1472-765X.2009.02649.x; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Volk RB, 2005, J APPL PHYCOL, V17, P339, DOI 10.1007/s10811-005-7292-7; Wang BX, 2012, HARMFUL ALGAE, V13, P83, DOI 10.1016/j.hal.2011.10.006; Wang XL, 2005, HARMFUL ALGAE, V4, P433, DOI 10.1016/j.hal.2004.06.001; WHYTE LG, 1985, J APPL BACTERIOL, V58, P195, DOI 10.1111/j.1365-2672.1985.tb01447.x; WINTERMANS JF, 1965, BIOCHIM BIOPHYS ACTA, V109, P448, DOI 10.1016/0926-6585(65)90170-6; Yamamoto Y, 1998, J APPL PHYCOL, V10, P391, DOI 10.1023/A:1008077414808; Yang JD, 2009, INT J MOL SCI, V10, P4157, DOI 10.3390/ijms10094157; Zhou LH, 2007, HARMFUL ALGAE, V6, P354, DOI 10.1016/j.hal.2006.10.002; Zuo WJ, 2011, PLANTA MED, V77, P1835, DOI 10.1055/s-0030-1271164	44	87	108	12	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76444	10.1371/journal.pone.0076444	http://dx.doi.org/10.1371/journal.pone.0076444			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098501	Green Published, Green Submitted, gold			2022-12-25	WOS:000325483600052
J	Chen, YH; Li, M; Li, B; Wang, WF; Lin, AJ; Sheng, MJ				Chen, Yihui; Li, Min; Li, Bing; Wang, Weifang; Lin, Anjuan; Sheng, Minjie			Effect of Reactive Oxygen Species Generation in Rabbit Corneal Epithelial Cells on Inflammatory and Apoptotic Signaling Pathways in the Presence of High Osmotic Pressure	PLOS ONE			English	Article							NF-KAPPA-B; FAS-LIGAND; DRY EYE; HYPEROSMOTIC ACTIVATION; CD95 LIGAND; EXPRESSION; STRESS; SYSTEM; JNK; REJECTION	It is generally accepted that high osmotic pressure (HOP) of lacrimal fluid is the core mechanism causing ocular inflammation and injury. However, the association between HOP and the regulation of cell inflammatory response and apoptotic pathways remains unclear. In the present study, we used HOP to interfere with in vitro cultured rabbit corneal epithelial cells, and found that HOP increased the generation of reactive oxygen species (ROS) in rabbit corneal epithelial cells, and increased ROS in turn induced the activation of JNK inflammatory signaling pathway, which further promoted the expression of pro-inflammatory factor NF-kappa beta and induced the generation of inflammatory factor IL-1 beta and TNF-alpha. In addition, HOP-induced ROS in rabbit corneal epithelial cells regulated the CD95/CD95L-mediated cell apoptotic signaling pathway by activating JNK inflammatory signaling pathway. These findings may serve as new theoretical basis and a new way of thinking about the treatment of ocular diseases, especially dry eye.	[Chen, Yihui; Li, Min; Li, Bing; Wang, Weifang; Lin, Anjuan; Sheng, Minjie] Tongji Univ, Dept Ophthalmol, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China	Tongji University	Sheng, MJ (corresponding author), Tongji Univ, Dept Ophthalmol, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China.	cyh80h@163.com	Woo, Patrick Chiu Yat/C-4449-2009	Woo, Patrick Chiu Yat/0000-0001-9401-1832; hu, yong fei/0000-0002-2158-6018	Natural Science Foundation of Shanghai [11ZR1427900]; Youth Research Project of Shanghai Municipal Health Bureau [2010Y164]; Young Talent Training Plan of Tongji University [2010KJ018]; Young Talent Training Plan of Shanghai Tenth PeopleShanghai Tenth People?? Hospital [11RQ108]; Shanghai Health Hospital Development Center Foundation Project [SHDC12007104]	Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Youth Research Project of Shanghai Municipal Health Bureau; Young Talent Training Plan of Tongji University; Young Talent Training Plan of Shanghai Tenth PeopleShanghai Tenth People?? Hospital; Shanghai Health Hospital Development Center Foundation Project	This work was supported by grants from the Natural Science Foundation of Shanghai (No. 11ZR1427900); the Youth Research Project of Shanghai Municipal Health Bureau(No. 2010Y164); the Young Talent Training Plan of Tongji University(No. 2010KJ018); the Young Talent Training Plan of Shanghai Tenth PeopleShanghai Tenth People?? Hospital (No. 11RQ108); Shanghai Health Hospital Development Center Foundation Project (SHDC12007104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri Elena, 2012, J Signal Transduct, V2012, P982794, DOI 10.1155/2012/982794; BELLGRAU D, 1995, NATURE, V377, P630, DOI 10.1038/377630a0; Brignole F, 1998, EXP EYE RES, V67, P687, DOI 10.1006/exer.1998.0566; Bron AJ, 2009, OCUL SURF, V7, P78, DOI 10.1016/S1542-0124(12)70299-9; Chwa M, 2006, INVEST OPHTH VIS SCI, V47, P1902, DOI 10.1167/iovs.05-0828; Eisner V, 2006, FEBS LETT, V580, P4495, DOI 10.1016/j.febslet.2006.07.029; Green DR, 2001, NAT REV MOL CELL BIO, V2, P917, DOI 10.1038/35103104; Guo J, 2005, ACTA PHARMACOL SIN, V26, P780, DOI 10.1111/j.1745-7254.2005.00140.x; Lam H, 2009, AM J OPHTHALMOL, V147, P198, DOI 10.1016/j.ajo.2008.08.032; Li DQ, 2006, EXP EYE RES, V82, P588, DOI 10.1016/j.exer.2005.08.019; Li HL, 2005, INT J MOL MED, V16, P41; Liu HX, 2009, INVEST OPHTH VIS SCI, V50, P3671, DOI 10.1167/iovs.08-2689; Luo Lihui, 2005, Eye Contact Lens, V31, P186, DOI 10.1097/01.ICL.0000162759.79740.46; Mohan RR, 1997, EXP EYE RES, V65, P575, DOI 10.1006/exer.1997.0371; Nakamura S, 2007, INVEST OPHTH VIS SCI, V48, P1552, DOI 10.1167/iovs.06-1027; Perry Henry D, 2008, Am J Manag Care, V14, pS79; Pinkenburg O, 2004, J VIROL METHODS, V120, P119, DOI 10.1016/j.jviromet.2004.04.007; Png E, 2011, J CELL PHYSIOL, V226, P693, DOI 10.1002/jcp.22389; Rakhorst HA, 2006, INT J ORAL MAX SURG, V35, P935, DOI 10.1016/j.ijom.2006.06.011; Reinehr R, 2006, ACTA PHYSIOL, V187, P199, DOI 10.1111/j.1748-1716.2006.01541.x; Reinehr R, 2007, METHOD ENZYMOL, V428, P145, DOI 10.1016/S0076-6879(07)28008-5; Sagrista ML, 2002, FREE RADICAL RES, V36, P329, DOI 10.1080/10715760290019354; Shimizu H, 2012, LIFE SCI, V90, P525, DOI 10.1016/j.lfs.2012.01.013; Stuart PM, 1997, J CLIN INVEST, V99, P396, DOI 10.1172/JCI119173; Tong JK, 2010, AM J RESP CELL MOL, V43, P342, DOI 10.1165/rcmb.2008-0454OC; Uchino Yuichi, 2012, Cornea, V31 Suppl 1, pS63, DOI 10.1097/ICO.0b013e31826a5de1; VAUX DL, 1995, NATURE, V377, P576, DOI 10.1038/377576a0; Wilson SE, 1996, INVEST OPHTH VIS SCI, V37, P1582; Xie CM, 2011, FREE RADICAL BIO MED, V51, P1365, DOI 10.1016/j.freeradbiomed.2011.06.016; Yamagami S, 1997, TRANSPLANTATION, V64, P1107, DOI 10.1097/00007890-199710270-00004; Zietz C, 2001, AM J PATHOL, V159, P963, DOI 10.1016/S0002-9440(10)61772-5	31	34	36	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e72900	10.1371/journal.pone.0072900	http://dx.doi.org/10.1371/journal.pone.0072900			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	24098729	Green Submitted, Green Published, gold			2022-12-25	WOS:000323378000116
J	Suchankova, P; Steensland, P; Fredriksson, I; Engel, JA; Jerlhag, E				Suchankova, Petra; Steensland, Pia; Fredriksson, Ida; Engel, Jorgen A.; Jerlhag, Elisabet			Ghrelin Receptor (GHS-R1A) Antagonism Suppresses Both Alcohol Consumption and the Alcohol Deprivation Effect in Rats following Long-Term Voluntary Alcohol Consumption	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; STIMULATES LOCOMOTOR-ACTIVITY; CONDITIONED PLACE PREFERENCE; ACCUMBAL DOPAMINE-OVERFLOW; NUCLEUS-ACCUMBENS; ETHANOL INTAKE; SYSTEMIC GHRELIN; DRUG-ADDICTION; MESSENGER-RNA; REWARD	Alcohol dependence is a heterogeneous disorder where several signalling systems play important roles. Recent studies implicate that the gut-brain hormone ghrelin, an orexigenic peptide, is a potential mediator of alcohol related behaviours. Ghrelin increases whereas a ghrelin receptor (GHS-R1A) antagonist decreases alcohol consumption as well as operant self-administration of alcohol in rodents that have consumed alcohol for twelve weeks. In the present study we aimed at investigating the effect of acute and repeated treatment with the GHS-R1A antagonist JMV2959 on alcohol intake in a group of rats following voluntarily alcohol consumption for two, five and eight months. After approximately ten months of voluntary alcohol consumption the expression of the GHS-R1A gene (Ghsr) as well as the degree of methylation of a CpG island found in Ghsr was examined in reward related brain areas. In a separate group of rats, we examined the effect of the JMV2959 on alcohol relapse using the alcohol deprivation paradigm. Acute JMV2959 treatment was found to decrease alcohol intake and the effect was more pronounced after five, compared to two months of alcohol exposure. In addition, repeated JMV2959 treatment decreased alcohol intake without inducing tolerance or rebound increase in alcohol intake after the treatment. The GHS-R1A antagonist prevented the alcohol deprivation effect in rats. There was a significant down-regulation of the Ghsr expression in the ventral tegmental area (VTA) in high-compared to low-alcohol consuming rats after approximately ten months of voluntary alcohol consumption. Further analysis revealed a negative correlation between Ghsr expression in the VTA and alcohol intake. No differences in methylation degree were found between high-compared to low-alcohol consuming rats. These findings support previous studies showing that the ghrelin signalling system may constitute a potential target for development of novel treatment strategies for alcohol dependence.	[Suchankova, Petra; Engel, Jorgen A.; Jerlhag, Elisabet] Univ Gothenburg, Sahlgrenska Acad, Dept Pharmacol, Inst Neurosci & Physiol, Gothenburg, Sweden; [Steensland, Pia; Fredriksson, Ida] Karolinska Inst, Div Psychiat, Dept Clin Neurosci, Stockholm, Sweden	University of Gothenburg; Karolinska Institutet	Engel, JA (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Pharmacol, Inst Neurosci & Physiol, Gothenburg, Sweden.	Jorgen.engel@pharm.gu.se	Fredriksson, Nils Johan/AAC-8083-2020; Wilen, Britt-Marie/B-5042-2016	Fredriksson, Nils Johan/0000-0002-5763-6777; Wilen, Britt-Marie/0000-0001-6155-7759; Steensland, Pia/0000-0003-4443-5017	Swedish Research Council [K2006-21X-04247-33-3, 2009-2782, K2010-80X-21496-01-6]; Swedish Brain Foundation; LUA/ALF from the Sahlgrenska University Hospital [148251]; Alcohol Research Council of the Swedish Alcohol Retailing Monopoly; foundation of Adlerbertska; foundation of Fredrik and Ingrid Thuring; foundation of Tore Nilsson; foundation of Langmanska; foundation of Torsten and Ragnar Soderberg; foundation of Wilhelm and Martina Lundgren; foundation of NovoNordisk; foundation of Knut and Alice Wallenberg; foundation of Magnus Bergvall; foundation of Aners; foundation of Jeansons; foundation of AkeWiberg; Swedish Society of Medicine; Swedish Society for Medical Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation; LUA/ALF from the Sahlgrenska University Hospital; Alcohol Research Council of the Swedish Alcohol Retailing Monopoly; foundation of Adlerbertska; foundation of Fredrik and Ingrid Thuring; foundation of Tore Nilsson; foundation of Langmanska; foundation of Torsten and Ragnar Soderberg; foundation of Wilhelm and Martina Lundgren; foundation of NovoNordisk; foundation of Knut and Alice Wallenberg(Knut & Alice Wallenberg Foundation); foundation of Magnus Bergvall; foundation of Aners; foundation of Jeansons; foundation of AkeWiberg; Swedish Society of Medicine; Swedish Society for Medical Research	The research was supported by grants from the Swedish Research Council (grant no. K2006-21X-04247-33-3, 2009-2782 and K2010-80X-21496-01-6), The Swedish Brain Foundation, LUA/ALF (grant no. 148251) from the Sahlgrenska University Hospital, Alcohol Research Council of the Swedish Alcohol Retailing Monopoly and the foundations of Adlerbertska, Fredrik and Ingrid Thuring, Tore Nilsson, Langmanska, Torsten and Ragnar Soderberg, Wilhelm and Martina Lundgren, NovoNordisk, Knut and Alice Wallenberg, Magnus Bergvall, Aners, Jeansons, AkeWiberg, the Swedish Society of Medicine, Swedish Society for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Addolorato G, 2006, ALCOHOL CLIN EXP RES, V30, p140A; Anton RF, 2006, JAMA-J AM MED ASSOC, V295, P2003, DOI 10.1001/jama.295.17.2003; Blednov YA, 2004, ALCOHOL CLIN EXP RES, V28, P1683, DOI 10.1097/01.ALC.0000145790.60216.C8; Blomqvist O, 1997, EUR J PHARMACOL, V334, P149, DOI 10.1016/S0014-2999(97)01220-X; Camicella S, 2009, ALCOHOL, V43, P35, DOI 10.1016/j.alcohol.2008.12.001; Davis KW, 2007, REGUL PEPTIDES, V140, P148, DOI 10.1016/j.regpep.2006.12.003; Delcuve GP, 2009, J CELL PHYSIOL, V219, P243, DOI 10.1002/jcp.21678; Egecioglu E, 2012, PSYCHONEUROENDOCRINO; Egecioglu E, 2010, ADDICT BIOL, V15, P304, DOI 10.1111/j.1369-1600.2010.00216.x; Ericson M, 2003, EUR J PHARMACOL, V467, P85, DOI 10.1016/S0014-2999(03)01564-4; Guan XM, 1997, MOL BRAIN RES, V48, P23, DOI 10.1016/S0169-328X(97)00071-5; Hansson C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050409; Heyser CJ, 2003, NEUROPSYCHOPHARMACOL, V28, P1463, DOI 10.1038/sj.npp.1300175; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Horvath TL, 2001, ENDOCRINOLOGY, V142, P4163, DOI 10.1210/en.142.10.4163; Jerlhag E, 2008, ADDICT BIOL, V13, P358, DOI 10.1111/j.1369-1600.2008.00125.x; Jerlhag E, 2008, EUR NEUROPSYCHOPHARM, V18, P508, DOI 10.1016/j.euroneuro.2008.02.006; Jerlhag E, 2007, ADDICT BIOL, V12, P6, DOI 10.1111/j.1369-1600.2006.00041.x; Jerlhag E, 2006, ALCOHOL ALCOHOLISM, V41, P486, DOI 10.1093/alcalc/agl049; Jerlhag E, 2006, ADDICT BIOL, V11, P45, DOI 10.1111/j.1369-1600.2006.00002.x; Jerlhag E, 2011, DRUG ALCOHOL DEPEN, V117, P126, DOI 10.1016/j.drugalcdep.2011.01.010; Jerlhag E, 2011, ALCOHOL, V45, P341, DOI 10.1016/j.alcohol.2010.10.002; Jerlhag E, 2011, ADDICT BIOL, V16, P82, DOI 10.1111/j.1369-1600.2010.00231.x; Jerlhag E, 2010, PSYCHOPHARMACOLOGY, V211, P415, DOI 10.1007/s00213-010-1907-7; Jerlhag E, 2009, P NATL ACAD SCI USA, V106, P11318, DOI 10.1073/pnas.0812809106; Jiang H, 2006, MOL ENDOCRINOL, V20, P1772, DOI 10.1210/me.2005-0084; Kaur S, 2010, ALCOHOL CLIN EXP RES, V34, P1525, DOI 10.1111/j.1530-0277.2010.01237.x; Kern A, 2012, NEURON, V73, P317, DOI 10.1016/j.neuron.2011.10.038; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Koopmann A, 2012, PSYCHONEUROENDOCRINO, V37, P980, DOI 10.1016/j.psyneuen.2011.11.005; Kuzmin A, 2009, PSYCHOPHARMACOLOGY, V203, P99, DOI 10.1007/s00213-008-1375-5; Landgren S, 2008, ALCOHOL CLIN EXP RES, V32, P2054, DOI 10.1111/j.1530-0277.2008.00793.x; Landgren S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018170; Landgren S, 2011, BEHAV BRAIN RES, V221, P182, DOI 10.1016/j.bbr.2011.03.003; Landgren S, 2012, ADDICT BIOL, V17, P86, DOI 10.1111/j.1369-1600.2010.00280.x; Landgren S, 2010, ALCOHOL CLIN EXP RES, V34, P1519, DOI 10.1111/j.1530-0277.2010.01236.x; Larsson A, 2004, ALCOHOL, V34, P239, DOI 10.1016/j.alcohol.2004.10.002; Larsson A, 2004, NEUROSCI BIOBEHAV R, V27, P713, DOI 10.1016/j.neubiorev.2003.11.010; Leggio L, 2012, ADDICT BIOL, V17, P452, DOI 10.1111/j.1369-1600.2010.00308.x; Lewis MJ, 2004, ALCOHOL CLIN EXP RES, V28, P1822, DOI 10.1097/01.ALC.0000148099.12344.C8; Litten RZ, 2013, J ADDICT MED; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lof E, 2007, PSYCHOPHARMACOLOGY, V195, P333, DOI 10.1007/s00213-007-0899-4; McKee SA, 2009, BIOL PSYCHIAT, V66, P185, DOI 10.1016/j.biopsych.2009.01.029; Mitchell JM, 2012, PSYCHOPHARMACOLOGY, V223, P299, DOI 10.1007/s00213-012-2717-x; Moulin A, 2007, J MED CHEM, V50, P5790, DOI 10.1021/jm0704550; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Quarta D, 2009, NEUROCHEM INT, V54, P89, DOI 10.1016/j.neuint.2008.12.006; Rada P, 2004, ALCOHOL, V33, P91, DOI 10.1016/j.alcohol.2004.05.002; Salome N, 2009, J NEUROENDOCRINOL, V21, P777, DOI 10.1111/j.1365-2826.2009.01895.x; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; Skibicka KP, 2011, NEUROSCIENCE, V180, P129, DOI 10.1016/j.neuroscience.2011.02.016; Skibicka KP, 2012, ADDICT BIOL, V17, P95, DOI 10.1111/j.1369-1600.2010.00294.x; Soderpalm B, 2009, PHARMACOPSYCHIATRY, V42, pS87, DOI 10.1055/s-0029-1220690; Soyka Michael, 2008, Curr Drug Abuse Rev, V1, P280; Spanagel R, 2000, ALCOHOL RES HEALTH, V24, P124; Spanagel R, 1997, TRENDS PHARMACOL SCI, V18, P54, DOI 10.1016/S0165-6147(97)89800-8; Steensland P, 2007, P NATL ACAD SCI USA, V104, P12518, DOI 10.1073/pnas.0705368104; Tessari M, 2007, ADDICT BIOL, V12, P22, DOI 10.1111/j.1369-1600.2007.00052.x; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Tupala E, 2004, PROG NEURO-PSYCHOPH, V28, P1221, DOI 10.1016/j.pnpbp.2004.06.022; Volkow ND, 2004, NAT REV NEUROSCI, V5, P963, DOI 10.1038/nrn1539; Wellman PJ, 2007, PHARMACOL BIOCHEM BE, V88, P89, DOI 10.1016/j.pbb.2007.07.008; Wellman PJ, 2011, REGUL PEPTIDES, V172, P77, DOI 10.1016/j.regpep.2011.08.014; Wellman PJ, 2005, REGUL PEPTIDES, V125, P151, DOI 10.1016/j.regpep.2004.08.013; WISE RA, 1973, PSYCHOPHARMACOLOGIA, V29, P203, DOI 10.1007/BF00414034; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992; Wren AM, 2001, DIABETES, V50, P2540, DOI 10.2337/diabetes.50.11.2540; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823	71	133	135	6	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71284	10.1371/journal.pone.0071284	http://dx.doi.org/10.1371/journal.pone.0071284			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977009	Green Published, gold, Green Submitted			2022-12-25	WOS:000324527300010
J	Jiang, FS; Li, WP; Huang, YF; Chen, YT; Jin, B; Chen, NP; Ding, ZS; Ding, XH				Jiang, Fusheng; Li, Weiping; Huang, Yanfen; Chen, Yitao; Jin, Bo; Chen, Nipi; Ding, Zhishan; Ding, Xinghong			Antioxidant, Antityrosinase and Antitumor Activity Comparison: The Potential Utilization of Fibrous Root Part of Bletilla striata (Thunb.) Reichb.f.	PLOS ONE			English	Article							PHENOLIC-COMPOUNDS; TYROSINASES; PREVENTION; EXTRACTS; SEQUENCE; ORCHIDS; AGENTS; PLANT	This study was carried out to evaluate the utilization probability of the fibrous root part (FRP) of Bletilla striata, which was usually discarded and harvesting pseudobulb part (PSP). The chemical composition, total phenolic content, DPPH radical scavenging activity, Ferric-reducing antioxidant power and tyrosinase inhibition activity were compared between FRP and PSP. Antioxidant and pro-oxidant effect as well as antitumor effect of the extract of FRP and PSP were analyzed by in vitro cell system as well. Thin layer chromatography and high performance liquid chromatography analysis indicated that the chemical compositions in the two parts were similar, but the content in FRP was much higher than PSP. Meanwhile, the FRP extracts showed higher phenolic content, stronger DPPH scavenging activity, Ferric-reducing antioxidant capacity and tyrosinase inhibition activity. Sub-fraction analysis revealed that the distribution characteristic of phenolic components and other active constituents in FRP and PSP were consistent, and mainly deposited in chloroform and acetoacetate fractions. Especially, the chloroform sub-fraction (sch) of FRP showed extraordinary DPPH scavenging activity and tyrosinase inhibition activity, with IC50 0.848 mg/L and 4.3 mg/L, respectively. Besides, tyrosinase inhibition activity was even stronger than the positive compound arbutin (31.8 mg/L). Moreover, In vitro cell system analysis confirmed that FRP extract exerts comparable activity with PSP, especially, the sub-fraction sch of FRP showed better antioxidant activity at low dosage and stronger per-oxidant activity at high dosage, and both sch of FRP and PSP can dose-dependent induce HepG2 cells apoptosis, which implied tumor therapeutic effect. Considering that an additional 0.3 kg FRP would be obtained when producing 1.0 kg PSP, our work demonstrated that FRP is very potential to be used together with PSP.	[Jiang, Fusheng; Huang, Yanfen; Chen, Yitao; Jin, Bo; Chen, Nipi; Ding, Zhishan] Zhejiang Chinese Med Univ, Inst Biotechnol, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Li, Weiping] Zhejiang Chinese Med Univ, Dept Med Chem, Coll Pharmaceut Sci, Hangzhou, Zhejiang, Peoples R China; [Ding, Xinghong] Zhejiang Chinese Med Univ, Anal & Testing Ctr, Hangzhou, Zhejiang, Peoples R China	Zhejiang Chinese Medical University; Zhejiang Chinese Medical University; Zhejiang Chinese Medical University	Ding, XH (corresponding author), Zhejiang Chinese Med Univ, Anal & Testing Ctr, Hangzhou, Zhejiang, Peoples R China.	xinghongding@163.com	黎, 伟/GXM-4040-2022; li, wj/HGD-7322-2022; Sinnaeve, Davy/F-2293-2013; Rokni-Zadeh, Hassan/B-8098-2008	Madder, Annemieke/0000-0003-0179-7608; Sinnaeve, Davy/0000-0003-2556-5895; Rokni-Zadeh, Hassan/0000-0001-5503-0344; Dai, Haibin/0000-0002-5768-2714; Martins, Jose/0000-0001-7350-2253; De Vleeschouwer, Matthias/0000-0001-6889-1928; Rozenski, Jef/0000-0001-9624-5536	Public Welfare Technology Research Projects of Zhejiang Province [2011C22047]; New-Shoot Talented Man Plan Project of Zhejiang Province [2010R4100581/4CE2011R4100191/4CE2012R410038]	Public Welfare Technology Research Projects of Zhejiang Province; New-Shoot Talented Man Plan Project of Zhejiang Province	This research was supported by the Public Welfare Technology Research Projects of Zhejiang Province (No. 2011C22047, http://www.zjkjt.gov.cn/) and New-Shoot Talented Man Plan Project of Zhejiang Province (No. 2010R4100581/4CE2011R4100191/4CE2012R410038, http://www.zjkjt.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai YZ, 2004, LIFE SCI, V74, P2157, DOI 10.1016/j.lfs.2003.09.047; Canadanovic-Brunet JM, 2009, INT J FOOD SCI TECH, V44, P269, DOI 10.1111/j.1365-2621.2007.01680.x; Claus H, 2006, SYST APPL MICROBIOL, V29, P3, DOI 10.1016/j.syapm.2005.07.012; Ding ZS, 2008, MOLECULES, V13, P220, DOI 10.3390/molecules13020220; Duan XW, 2007, MOLECULES, V12, P759, DOI 10.3390/12040759; Gan RY, 2010, J MED PLANTS RES, V4, P2438; Kaji H, 2009, J CLIN PHARM THER, V34, P197, DOI 10.1111/j.1365-2710.2008.00993.x; Kong JM, 2003, ACTA PHARMACOL SIN, V24, P7; Lei TC, 1999, CHINESE TRADITIONAL, V30, P336; Liang QY, 2006, J GUANGXI MED U, V23, P36; Lin SQ, 1994, THESIS NATL CHENG KU; Luo Y, 2010, J BIOMED MATER RES A, V94A, P193, DOI 10.1002/jbm.a.32711; Maisuthisakul P, 2009, FOOD CHEM, V117, P332, DOI 10.1016/j.foodchem.2009.04.010; Mao XL, 2011, CENTRAL S PHARM, V9, P604; MARTINEZ MV, 1995, TRENDS FOOD SCI TECH, V6, P195, DOI 10.1016/S0924-2244(00)89054-8; Marxen K, 2007, SENSORS-BASEL, V7, P2080, DOI 10.3390/s7102080; Morita H, 2005, BIOORG MED CHEM LETT, V15, P1051, DOI 10.1016/j.bmcl.2004.12.026; Pasciu V, 2010, TOXICOL SCI, V114, P101, DOI 10.1093/toxsci/kfp301; Gutierrez RMP, 2010, J MED PLANTS RES, V4, P592; PONNAZHAGAN S, 1994, J INVEST DERMATOL, V102, P744, DOI 10.1111/1523-1747.ep12376924; [黄海云 Rui Haiyun], 2003, [南京师大学报. 自然科学版, Journal of Nanjing Normal University. Natural Science], V26, P94; Shi J, 2009, THESIS HAINAN U HAIN; SLINKARD K, 1977, AM J ENOL VITICULT, V28, P49; Smit N, 2009, INT J MOL SCI, V10, P5326, DOI 10.3390/ijms10125326; Sun DF, 2006, CHINESE WILD PLANT R, V25, P34; Sun F, 2007, J DALIAN I LIGHT IND, V26, P97; TAKAGI S, 1983, PHYTOCHEMISTRY, V22, P1011, DOI 10.1016/0031-9422(83)85044-4; VanGelder CWG, 1997, PHYTOCHEMISTRY, V45, P1309, DOI 10.1016/S0031-9422(97)00186-6; VIDENSEK N, 1990, J NAT PROD, V53, P1609, DOI 10.1021/np50072a039; Wang CM, 2006, BIOTECHNOL LETT, V28, P539, DOI 10.1007/s10529-006-0011-x; Wazir D, 2011, J PLANT BIOCHEM BIOT, V20, P234, DOI 10.1007/s13562-011-0051-8; Wojdylo A, 2007, FOOD CHEM, V105, P940, DOI 10.1016/j.foodchem.2007.04.038; Yang Y, 2009, ASIA PACIFIC TRADITI, V5, P23; Zhang HH, 2010, FREE RADICAL BIO MED, V49, P2010, DOI 10.1016/j.freeradbiomed.2010.09.031; Zhu JY, 2011, THESIS FUJIAN U TRAD	35	73	82	6	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e58004	10.1371/journal.pone.0058004	http://dx.doi.org/10.1371/journal.pone.0058004			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	24098758	Green Published, Green Submitted, gold			2022-12-25	WOS:000315524900220
J	Wang, W; Zhou, MW; Huang, WB; Zhang, XL				Wang, Wei; Zhou, Minwen; Huang, Wenbin; Zhang, Xiulan			Ex-PRESS Implantation Versus Trabeculectomy in Uncontrolled Glaucoma: A Meta-Analysis	PLOS ONE			English	Article							EX-PRESS(TM) MINI GLAUCOMA; FILTRATION DEVICE; SHUNT	Objective: To evaluate the efficacy and tolerability of Ex-PRESS implantation (Ex-Press) compared with trabeculectomy (Trab) in the treatment of patients with uncontrolled glaucoma. Methods: A comprehensive literature meta-analysis was performed according to the Cochrane Collaboration methodology to identify controlled clinical trials comparing Ex-Press with Trab. Efficacy estimates were measured by weight mean difference (WMD) for the percentage intraocular pressure (IOP) reduction from baseline to end-point, odds ratio (OR) for complete success, and qualified success rates. Tolerability estimates were measured by OR for adverse events. All outcomes were reported with a 95% confidence interval (CI). Data were synthesized by Stata 11.0 SE for Windows. Results: Eight controlled clinical trials meeting the predefined criteria were included in the meta-analysis. A total of 605 eyes from 559 patients with medically uncontrolled glaucoma were included. The weighted mean difference of the percentage IOP reduction from baseline was 2.33 (95% confidence interval: -22.59-7.24) when comparing Ex-Press with Trab. Ex-Press was associated with numerically greater, but nonsignificant, IOP lowering efficacy than Trab. The pooled odds ratio comparing Ex-Press with Trab were 0.93 (0.39, 2.23) for the complete success rate and 1.00 (0.39, 2.56) for the qualified success rate. Ex-Press was associated with a significantly lower frequency of hypotony and hyphema than Trab, with pooled ORs of 0.29 (0.13, 0.65) and 0.36 (0.13, 0.97), respectively. Conclusion: Ex-Press was associated with equivalent efficacy to Trab in lowering IOP. Comparable proportions of patients reached the IOP target with Ex-Press and Trab. Ex-Press was better tolerated than Trab.	[Wang, Wei; Zhou, Minwen; Huang, Wenbin; Zhang, Xiulan] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhang, XL (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	zhangxl2@mail.sysu.edu.cn	Zhao, Zenghui/F-8061-2013	Zhao, Zenghui/0000-0002-6335-1655	National Natural Science Foundation of China [81170849]; Guangdong Provincial Natural Science Foundation [S2011020002401]; Fundamental Research Funds of State Key Laboratory of Ophthalmology [2011C02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Fundamental Research Funds of State Key Laboratory of Ophthalmology	This work was supported in whole or in part by the National Natural Science Foundation of China (81170849), Guangdong Provincial Natural Science Foundation (S2011020002401), and the Fundamental Research Funds of State Key Laboratory of Ophthalmology (2011C02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz Hassan, 2011, Ophthalmic Surg Lasers Imaging, V42 Online, pe94, DOI 10.3928/15428877-20110922-01; Dahan E, 2005, J GLAUCOMA, V14, P98, DOI 10.1097/01.ijg.0000151688.34904.b7; Dahan E, 2012, EYE, V26, P703, DOI 10.1038/eye.2012.13; De Feo F, 2009, CAN J OPHTHALMOL, V44, P457, DOI 10.3129/i09-120; de Jong L, 2011, CLIN OPHTHALMOL, V5, P527, DOI 10.2147/OPTH.S18565; de Jong LAMS, 2009, ADV THER, V26, P336, DOI 10.1007/s12325-009-0017-6; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Francis BA, 2011, OPHTHALMOLOGY, V118, P1466, DOI 10.1016/j.ophtha.2011.03.028; Gallego-Pinazo R., 2009, Arch Soc Esp Oftalmol, V84, P293; Good TJ, 2011, AM J OPHTHALMOL, V151, P507, DOI 10.1016/j.ajo.2010.09.004; Hendrick AM, 2008, EXPERT REV MED DEVIC, V5, P673, DOI 10.1586/17434440.5.6.673; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Maris PJG, 2007, J GLAUCOMA, V16, P14, DOI 10.1097/01.ijg.0000243479.90403.cd; Marzette L, 2011, OPHTHAL SURG LAS IM, V42, P453, DOI 10.3928/15428877-20111017-03; Mosaed S, 2010, EXPERT REV MED DEVIC, V7, P661, DOI 10.1586/ERD.10.32; Nyska A, 2003, J GLAUCOMA, V12, P275, DOI 10.1097/00061198-200306000-00017; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rouse JM, 2012, DEV OPHTHALMOL, V50, P90, DOI 10.1159/000334780; Salim S, 2012, CURR OPIN OPHTHALMOL, V23, P89, DOI 10.1097/ICU.0b013e32834ff401; Seider MI, 2012, J GLAUCOMA, V21, P469, DOI 10.1097/IJG.0b013e3182182bfb; Sugiyama T, 2011, CLIN OPHTHALMOL, V5, P1063, DOI 10.2147/OPTH.S23129	21	93	100	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e63591	10.1371/journal.pone.0063591	http://dx.doi.org/10.1371/journal.pone.0063591			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	24489511	Green Published, Green Submitted, gold			2022-12-25	WOS:000319799900008
